PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Torres-Fuentes, C; Golubeva, AV; Zhdanov, AV; Wallace, S; Arboleya, S; Papkovsky, DB; El Aidy, S; Ross, P; Roy, BL; Stanton, C; Dinan, TG; Cryan, JF; Schellekens, H				Torres-Fuentes, Cristina; Golubeva, Anna V.; Zhdanov, Alexander V.; Wallace, Shauna; Arboleya, Silvia; Papkovsky, Dimitri B.; El Aidy, Sahar; Ross, Paul; Roy, Bernard L.; Stanton, Catherine; Dinan, Timothy G.; Cryan, John F.; Schellekens, Harriet			Short-chain fatty acids and microbiota metabolites attenuate ghrelin receptor signaling	FASEB JOURNAL			English	Article						GHSR-1a; SCFA; lactate; probiotics; gut bacteria	GUT-BRAIN AXIS; HORMONE SECRETAGOGUE RECEPTOR; HIGH CONSTITUTIVE ACTIVITY; ACUTE LUNG INJURY; EXPRESSION; MECHANISMS; INCREASE; MOTILITY; CELLS; DIET	The gastrointestinal microbiota is emerging as a unique and inexhaustible source for metabolites with potential to modulate G-protein coupled receptors (GPCRs). The ghrelin receptor [growth hormone secretagogue receptor (GHSR)-1a] is a GPCR expressed throughout both the gut and the brain and plays a crucial role in maintaining energy balance, metabolism, and the central modulation of food intake, motivation, reward, and mood. To date, few studies have investigated the potential of the gastrointestinal microbiota and its metabolites to modulate GPCR signaling. Here we investigate the ability of short-chain fatty acids (SCFAs), lactate, and different bacterial strains, including Bifidobacterium and Lactobacillus genera, to modulate GHSR-1a signaling. We identify, for what is to our knowledge the first time, a potent effect of microbiota-derived metabolites on GHSR-1a signaling with potential significant consequences for host metabolism and physiology. We show that SCFAs, lactate, and bacterial supernatants are able to attenuate ghrelin-mediated signaling through the GHSR-1a. We suggest a novel route of communication between the gut microbiota and the host via modulation of GHSR-1a receptor signaling. Together, this highlights the emerging therapeutic potential in the exploration of the microbiota metabolome in the specific targeting of key GPCRs, with pleiotropic actions that span both the CNS and periphery.	[Torres-Fuentes, Cristina; Golubeva, Anna V.; Wallace, Shauna; Arboleya, Silvia; El Aidy, Sahar; Ross, Paul; Stanton, Catherine; Dinan, Timothy G.; Cryan, John F.; Schellekens, Harriet] Univ Coll Cork, Alimentary Pharmabiot Ctr APC Microbiome Ireland, Cork, Ireland; [Golubeva, Anna V.; Cryan, John F.; Schellekens, Harriet] Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland; [Zhdanov, Alexander V.; Papkovsky, Dimitri B.] Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland; [Dinan, Timothy G.] Univ Coll Cork, Dept Psychiat & Neurobehav Sci, Cork, Ireland; [Arboleya, Silvia; Stanton, Catherine] TEAGASC, Food Res Ctr, Cork, Ireland; [Roy, Bernard L.] Cremo SA, Fribourg, Switzerland; [Torres-Fuentes, Cristina] Rovira & Virgili Univ, Tarragona, Spain; [Wallace, Shauna] MSD, Brinny, Cork, Ireland; [Arboleya, Silvia] CSIC, IPLA, Asturias, Spain; [El Aidy, Sahar] Groningen Biomol Sci & Biotechnol Inst GBB, Groningen, Netherlands	University College Cork; University College Cork; University College Cork; University College Cork; Teagasc; Universitat Rovira i Virgili; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA); University of Groningen	Schellekens, H (corresponding author), Univ Coll Cork, Alimentary Pharmabot Ctr APC Microbiome Ireland, Dept Anat & Neurosci, Western Rd,Western Gateway Bldg, Cork T12 XF62, Ireland.	h.schellekens@ucc.ie	Dinan, Timothy/ABA-8284-2020; Torres-Fuentes, Cristina/J-5551-2019; Ross, Paul/A-7584-2015; Aidy, Sahar El/J-5246-2017; Cryan, John F./A-6950-2013; Stanton, Catherine/A-9549-2015; arboleya, silvia/Q-2385-2018	Torres-Fuentes, Cristina/0000-0002-2917-6910; Ross, Paul/0000-0003-4876-8839; Aidy, Sahar El/0000-0001-8950-4392; Cryan, John F./0000-0001-5887-2723; Stanton, Catherine/0000-0002-6724-7011; Roy, L. B./0000-0003-4209-6007; arboleya, silvia/0000-0002-6155-5822; Zhdanov, Alexander/0000-0001-5787-2035; Schellekens, Harriet/0000-0002-6065-3797	Science Foundation Ireland Research Centre Grant [SFI/12/RC/2273]; Student/Faculty Interaction (SFI) Grant [12/RC/2276]; APC Microbiome Ireland industry partner Cremo SA	Science Foundation Ireland Research Centre Grant(Science Foundation Ireland); Student/Faculty Interaction (SFI) Grant; APC Microbiome Ireland industry partner Cremo SA	This study was supported by Science Foundation Ireland Research Centre Grant SFI/12/RC/2273 to the Alimentary Pharmabiotic Centre (APC) Microbiome Ireland, Student/Faculty Interaction (SFI) Grant 12/RC/2276 DBP and APC Microbiome Ireland industry partner Cremo SA. The authors declare no conflicts of interest.	Altier Christophe, 2012, Subcell Biochem, V63, P241, DOI 10.1007/978-94-007-4765-4_13; Altier C, 2011, METHODS MOL BIOL, V756, P215, DOI 10.1007/978-1-61779-160-4_11; Altindis E, 2018, P NATL ACAD SCI USA, V115, P2461, DOI 10.1073/pnas.1721117115; Araujo A, 2019, INT CONF SYST SIGNAL, P175, DOI 10.1109/IWSSIP.2019.8787250; Baldanzi G, 2002, J CELL BIOL, V159, P1029, DOI 10.1083/jcb.200207165; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Bhattarai Y, 2018, CELL HOST MICROBE, V23, P775, DOI 10.1016/j.chom.2018.05.004; Camina JP, 2004, ENDOCRINOLOGY, V145, P930, DOI 10.1210/en.2003-0974; Cani PD, 2004, BRIT J NUTR, V92, P521, DOI 10.1079/BJN20041225; Chen HW, 2019, CELL, V177, P1217, DOI 10.1016/j.cell.2019.03.036; Chen J, 2008, MED SCI MONITOR, V14, pBR141; Cherbut C, 1998, AM J PHYSIOL-GASTR L, V275, pG1415, DOI 10.1152/ajpgi.1998.275.6.G1415; Cohen LJ, 2017, NATURE, V549, P48, DOI 10.1038/nature23874; Colosimo DA, 2019, CELL HOST MICROBE, V26, P273, DOI 10.1016/j.chom.2019.07.002; Cryan JF, 2018, CELL HOST MICROBE, V23, P691, DOI 10.1016/j.chom.2018.05.020; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Dalile B, 2019, NAT REV GASTRO HEPAT, V16, P461, DOI 10.1038/s41575-019-0157-3; Damian M, 2012, J BIOL CHEM, V287, P3630, DOI 10.1074/jbc.M111.288324; Dass NB, 2007, NEUROGASTROENT MOTIL, V19, P66, DOI 10.1111/j.1365-2982.2006.00853.x; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Dinan TG, 2017, J PHYSIOL-LONDON, V595, P489, DOI 10.1113/JP273106; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Duca FA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039748; Els S, 2010, METHOD ENZYMOL, V485, P103, DOI [10.1016/S0076-6879(10)85006-2, 10.1016/B978-0-12-381296-4.00006-3]; Frost G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4611; Garbison K. E., 2012, ASSAY GUIDANCE MANUA; Holliday ND, 2007, MOL ENDOCRINOL, V21, P3100, DOI 10.1210/me.2007-0254; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Howick K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020273; Husted AS, 2017, CELL METAB, V25, P777, DOI 10.1016/j.cmet.2017.03.008; Huuskonen J, 2004, BRIT J PHARMACOL, V141, P874, DOI 10.1038/sj.bjp.0705682; Queipo-Ortuno MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065465; Jain R, 2018, INT REV CEL MOL BIO, V338, P79, DOI 10.1016/bs.ircmb.2018.02.003; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Layden BT, 2013, TRANSL RES, V161, P131, DOI 10.1016/j.trsl.2012.10.007; Li GA, 2010, TOHOKU J EXP MED, V222, P7, DOI 10.1620/tjem.222.7; Liu Ke, 2008, Curr Chem Genomics, V1, P70, DOI 10.2174/1875397300801010070; Liu Y, 2018, INT J MOL MED, V42, P3037, DOI 10.3892/ijmm.2018.3886; Soto EJL, 2015, J GEN PHYSIOL, V146, P205, DOI 10.1085/jgp.201511383; M'Kadmi C, 2015, J BIOL CHEM, V290, P27021, DOI 10.1074/jbc.M115.659250; Muccioli G, 2011, PEPTIDES, V32, P2514, DOI 10.1016/j.peptides.2011.10.020; Muller TD, 2015, MOL METAB, V4, P437, DOI 10.1016/j.molmet.2015.03.005; Mustafa ER, 2017, J CELL SCI, V130, P3907, DOI 10.1242/jcs.207886; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Nohr MK, 2015, NEUROSCIENCE, V290, P126, DOI 10.1016/j.neuroscience.2015.01.040; Park J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156334; Pastor-Cavada E, 2016, SCI REP-UK, V6, DOI 10.1038/srep36456; Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309; Qiang XL, 2017, NPJ BIOFILMS MICROBI, V3, DOI 10.1038/s41522-017-0039-9; Ramirez VT, 2019, FASEB J, V33, P518, DOI 10.1096/fj.201800655R; Rivas PMS, 2017, HORM BEHAV, V93, P166, DOI 10.1016/j.yhbeh.2017.05.018; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Sandhu KV, 2017, TRANSL RES, V179, P223, DOI 10.1016/j.trsl.2016.10.002; Sato T, 2005, ENDOCRINOLOGY, V146, P2510, DOI 10.1210/en.2005-0174; Schellekens H, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00148; Schellekens H, 2013, J PHARM PHARMACOL, V65, P528, DOI 10.1111/jphp.12010; Schellekens H, 2012, PHARMACOL THERAPEUT, V135, P316, DOI 10.1016/j.pharmthera.2012.06.004; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Stievenard A, 2017, NEUROSCI BIOBEHAV R, V73, P255, DOI 10.1016/j.neubiorev.2016.11.021; Sun MM, 2017, J GASTROENTEROL, V52, P1, DOI 10.1007/s00535-016-1242-9; Takeshita E, 2006, J GASTROENTEROL, V41, P223, DOI 10.1007/s00535-005-1739-0; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Torres-Fuentes C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061605; Torres-Fuentes C, 2017, LANCET GASTROENTEROL, V2, P747, DOI 10.1016/S2468-1253(17)30147-4; Torres-Fuentes C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103118; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; van de Wouw M, 2017, J NUTR, V147, P727, DOI 10.3945/jn.116.240481; Yin Y, 2014, INT J MOL SCI, V15, P4837, DOI 10.3390/ijms15034837; Zarogoulidis P, 2014, ONCOL LETT, V8, P2367, DOI 10.3892/ol.2014.2608; Zhdanov AV, 2015, EXP CELL RES, V330, P13, DOI 10.1016/j.yexcr.2014.10.005	72	48	50	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13546	13559		10.1096/fj.201901433R	http://dx.doi.org/10.1096/fj.201901433R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31545915	Green Submitted, Bronze			2022-12-28	WOS:000507466100040
J	Khan, NS; Lukason, DP; Feliu, M; Ward, RA; Lord, AK; Reedy, JL; Ramirez-Ortiz, ZG; Tam, JM; Kasperkovitz, PV; Negoro, PE; Vyas, TD; Xu, SY; Brinkmann, MM; Acharaya, M; Artavanis-Tsakonas, K; Frickel, EM; Becker, CE; Dagher, Z; Kim, YM; Latz, E; Ploegh, HL; Mansour, MK; Miranti, CK; Levitz, SM; Vyas, JM				Khan, Nida S.; Lukason, Daniel P.; Feliu, Marianela; Ward, Rebecca A.; Lord, Allison K.; Reedy, Jennifer L.; Ramirez-Ortiz, Zaida G.; Tam, Jenny M.; Kasperkovitz, Pia V.; Negoro, Paige E.; Vyas, Tammy D.; Xu, Shuying; Brinkmann, Melanie M.; Acharaya, Mridu; Artavanis-Tsakonas, Katerina; Frickel, Eva-Maria; Becker, Christine E.; Dagher, Zeina; Kim, You-Me; Latz, Eicke; Ploegh, Hidde L.; Mansour, Michael K.; Miranti, Cindy K.; Levitz, Stuart M.; Vyas, Jatin M.			CD82 controls CpG-dependent TLR9 signaling	FASEB JOURNAL			English	Article						tetraspanins; TLRs; myddosome; macrophages	RECEPTOR 9; PROTEOLYTIC CLEAVAGE; ANTIGEN PRESENTATION; INNATE IMMUNITY; DECTIN-1; ACTIVATION; PROTEIN; TRAFFICKING; INDUCTION; PATHWAY	The tetraspanin CD82 is a potent suppressor of tumor metastasis and regulates several processes including signal transduction, cell adhesion, motility, and aggregation. However, the mechanisms by which CD82 participates in innate immunity are unknown. We report that CD82 is a key regulator of TLR9 trafficking and signaling. TLR9 recognizes unmethylated cytosine-phosphate-guanine (CpG) motifs present in viral, bacterial, and fungal DNA. We demonstrate that TLR9 and CD82 associate in macrophages, which occurs in the endoplasmic reticulum (ER) and post-ER. Moreover, CD82 is essential for TLR9-dependent myddosome formation in response to CpG stimulation. Finally, CD82 modulates TLR9-dependent NF-kappa B nuclear translocation, which is critical for inflammatory cytokine production. To our knowledge, this is the first time a tetraspanin has been implicated as a key regulator of TLR signaling. Collectively, our study demonstrates that CD82 is a specific regulator of TLR9 signaling, which may be critical in cancer immunotherapy approaches and coordinating the innate immune response to pathogens.	[Khan, Nida S.; Lukason, Daniel P.; Feliu, Marianela; Ward, Rebecca A.; Lord, Allison K.; Reedy, Jennifer L.; Tam, Jenny M.; Negoro, Paige E.; Vyas, Tammy D.; Xu, Shuying; Dagher, Zeina; Mansour, Michael K.; Vyas, Jatin M.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA; [Khan, Nida S.] Univ Massachusetts Med Sch, Biomed Engn & Biotechnol, Boston, MA USA; [Latz, Eicke; Levitz, Stuart M.] Univ Massachusetts Med Sch, Dept Med, Boston, MA USA; [Lukason, Daniel P.] Univ Massachusetts, Biomed Engn & Biotechnol, Lowell, MA USA; [Khan, Nida S.; Reedy, Jennifer L.; Ramirez-Ortiz, Zaida G.; Mansour, Michael K.; Vyas, Jatin M.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Boston, MA 02115 USA; [Ramirez-Ortiz, Zaida G.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02115 USA; [Ramirez-Ortiz, Zaida G.] Harvard Med Sch, Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Becker, Christine E.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02115 USA; [Kasperkovitz, Pia V.] F Hoffmann La Roche Innovat Ctr Basel, Basel, Switzerland; [Brinkmann, Melanie M.] Helmholtz Ctr Infect Res, Viral Immune Modulat Res Grp, Braunschweig, Germany; [Brinkmann, Melanie M.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Genet, Braunschweig, Germany; [Acharaya, Mridu] Benaroya Res Inst, Seattle, WA USA; [Acharaya, Mridu] Seattle Childrens Res Inst, Ctr Immun & Immunotherapy, Seattle, WA USA; [Artavanis-Tsakonas, Katerina] Univ Cambridge, Dept Pathol, Cambridge, England; [Frickel, Eva-Maria] Francis Crick Inst, Host Toxoplasma Interact Lab, London, England; [Kim, You-Me] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Latz, Eicke] Univ Bonn, Univ Hosp Bonn, Inst Innate Immun, Bonn, Germany; [Latz, Eicke] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Ploegh, Hidde L.] Boston Childrens Hosp, Boston, MA USA; [Miranti, Cindy K.] Van Andel Res Inst, Lab Integrin Signaling & Tumorigenesis, Grand Rapids, MI USA; [Miranti, Cindy K.] Univ Arizona, Canc Ctr, Dept Cellular & Mol Med, Tucson, AZ USA	Harvard University; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Lowell; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Helmholtz Association; Helmholtz-Center for Infection Research; Braunschweig University of Technology; Benaroya Research Institute; Seattle Children's Hospital; University of Cambridge; Francis Crick Institute; Korea Advanced Institute of Science & Technology (KAIST); University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Harvard University; Boston Children's Hospital; Van Andel Institute; University of Arizona	Vyas, JM (corresponding author), Massachusetts Gen Hosp, Dept Infect Dis, 55 Fruit St, Boston, MA 02114 USA.	jvyas@mgh.harvard.edu	Vyas, Jatin/Q-1627-2016; Miranti, Cindy/AAJ-3783-2020; Kim, You-Me/I-5553-2013; Latz, Eicke/H-3951-2014	Vyas, Jatin/0000-0002-9985-9565; Kim, You-Me/0000-0001-8780-704X; Lukason, Daniel/0000-0003-1829-5735; Latz, Eicke/0000-0003-1488-5666; Ramirez Ortiz, Zaida/0000-0002-0253-0473; Xu, Shuying/0000-0003-4572-8663	U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases [R01 AI092084, R01 AI097519, R01 AI025780, R01 AI139615]; Francis Crick Institute - Cancer Research UK [FC001076]; UK Medical Research Council [FC001076]; Wellcome Trust [FC001076]; MRC [MC_UP_1202/12] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI136529, R01AI025780, R01AI097519, R01AI139615] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Francis Crick Institute - Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Nicole Wolf for the artwork displayed in the graphical abstract (Fig. 7), Shizuo Akira (Osaka University, Osaka, Japan) for the TLR9 knockout (TLR9KO) mice, and Douglas Golenbock (University of Massachusetts Medical Center, Worcester, MA, USA) for the TLR9KO macrophage cell line. The authors also thank Kensuyke Miyake and Ryutaro Fukui (University of Tokyo, Tokyo, Japan) for the TLR9 monoclonal and polyclonal antibodies (41), and Gregory Barton and Bo Liu (University of California-Berkeley, Berkeley, CA, USA) for the TLR7-FLAG construct. This work was supported by U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases Grants R01 AI092084 and R01 AI097519 (to J.M.V.) and R01 AI025780 and R01 AI139615 (to S.M.L.). This work was also supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001076), the UK Medical Research Council (FC001076), and the Wellcome Trust (FC001076). The authors declare no conflicts of interest.	Artavanis-Tsakonas K, 2011, INFECT IMMUN, V79, P1098, DOI 10.1128/IAI.01135-10; Avalos AM, 2013, J IMMUNOL, V190, P695, DOI 10.4049/jimmunol.1202342; Babdor J, 2017, NAT IMMUNOL, V18, P509, DOI 10.1038/ni.3711; Bandyopadhyay S, 2006, NAT MED, V12, P933, DOI 10.1038/nm1444; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Blanque R, 1998, GEN PHARMACOL, V31, P301, DOI 10.1016/S0306-3623(97)00434-5; Bonham KS, 2014, CELL, V156, P705, DOI 10.1016/j.cell.2014.01.019; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Danglot L, 2010, J CELL SCI, V123, P723, DOI 10.1242/jcs.062497; Delos Santos RC, 2015, CELL SIGNAL, V27, P1963, DOI 10.1016/j.cellsig.2015.07.004; den Brok MHMGM, 2006, CANCER RES, V66, P7285, DOI 10.1158/0008-5472.CAN-06-0206; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Fukui R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01491; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hammond C, 1998, J IMMUNOL, V161, P3282; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2014, NAT REV CANCER, V14, P49, DOI 10.1038/nrc3640; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Herbst S, 2015, EMBO MOL MED, V7, P240, DOI 10.15252/emmm.201404556; Hur J, 2016, CELL STEM CELL, V18, P508, DOI 10.1016/j.stem.2016.01.013; Inoue M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003873; Jahrsdorfer Bernd, 2008, Update Cancer Ther, V3, P27, DOI 10.1016/j.uct.2007.11.003; Jones EL, 2016, J IMMUNOL, V196, P978, DOI 10.4049/jimmunol.1500357; Kagan JC, 2014, NAT REV IMMUNOL, V14, P821, DOI 10.1038/nri3757; Kasperkovitz PV, 2010, J IMMUNOL, V185, P7614, DOI 10.4049/jimmunol.1002760; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Khan NS, 2016, J IMMUNOL, V196, P2249, DOI 10.4049/jimmunol.1401545; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Koh HJ, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0091-4; Kropshofer H, 2002, NAT IMMUNOL, V3, P61, DOI 10.1038/ni750; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; LEBELBINAY S, 1995, J LEUKOCYTE BIOL, V57, P956, DOI 10.1002/jlb.57.6.956; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Ligeon LA, 2014, AUTOPHAGY, V10, P1588, DOI 10.4161/auto.29411; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Liu WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051797; Marjon KD, 2016, ONCOGENE, V35, P4132, DOI 10.1038/onc.2015.449; Meyer-Wentrup F, 2007, J IMMUNOL, V178, P154, DOI 10.4049/jimmunol.178.1.154; Mollinedo F, 1997, CLIN DIAGN LAB IMMUN, V4, P229, DOI 10.1128/CDLI.4.2.229-231.1997; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Murakami Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep44042; Newman ZR, 2016, P NATL ACAD SCI USA, V113, pE1362, DOI 10.1073/pnas.1518976113; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Rocha-Perugini V, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00653; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Sepulveda FE, 2009, IMMUNITY, V31, P737, DOI 10.1016/j.immuni.2009.09.013; Shirota H, 2001, J IMMUNOL, V167, P66, DOI 10.4049/jimmunol.167.1.66; Sparwasser T, 1997, EUR J IMMUNOL, V27, P1671, DOI 10.1002/eji.1830270712; Suzuki M, 2009, J IMMUNOL, V182, P6485, DOI 10.4049/jimmunol.0802797; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Tam JM, 2019, J IMMUNOL, V202, P3256, DOI 10.4049/jimmunol.1801384; Tan YH, 2019, CELL, V177, P384, DOI 10.1016/j.cell.2019.01.039; Tonoli H, 2005, TRENDS MOL MED, V11, P563, DOI 10.1016/j.molmed.2005.10.002; Tsai YC, 2011, FEBS LETT, V585, P3166, DOI 10.1016/j.febslet.2011.08.031; Uchtmann K, 2015, EXP CELL RES, V339, P261, DOI 10.1016/j.yexcr.2015.11.006; van den Hoorn T, 2012, J CELL SCI, V125, P328, DOI 10.1242/jcs.088047; van Spriel AB, 2010, MICROBES INFECT, V12, P106, DOI 10.1016/j.micinf.2009.11.001; van Zelm MC, 2010, J CLIN INVEST, V120, P1265, DOI 10.1172/JCI39748; Vyas JM, 2007, J IMMUNOL, V178, P7199, DOI 10.4049/jimmunol.178.11.7199; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yi AK, 2006, J BIOL CHEM, V281, P15001, DOI 10.1074/jbc.M601337200; Yoshizaki M, 2009, BLOOD, V114, P1518, DOI 10.1182/blood-2008-12-192344; Zhou YF, 2017, J NEUROL SCI, V373, P95, DOI 10.1016/j.jns.2016.12.027	69	13	15	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12500	12514		10.1096/fj.201901547R	http://dx.doi.org/10.1096/fj.201901547R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31408613	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000507461600070
J	Marin-Royo, G; Rodriguez, C; Le Pape, A; Jurado-Lopez, R; Luaces, M; Antequera, A; Martinez-Gonzalez, J; Souza-Neto, FV; Nieto, ML; Martinez-Martinez, E; Cachofeiro, V				Marin-Royo, Gema; Rodriguez, Cristina; Le Pape, Aliaume; Jurado-Lopez, Raquel; Luaces, Maria; Antequera, Alfonso; Martinez-Gonzalez, Jose; Souza-Neto, Francisco V.; Luisa Nieto, Maria; Martinez-Martinez, Ernesto; Cachofeiro, Victoria			The role of mitochondrial oxidative stress in the metabolic alterations in diet-induced obesity in rats	FASEB JOURNAL			English	Article						insulin resistance; mitochondrial function; adipose tissue	ADIPOSE-TISSUE; INSULIN-RESISTANCE; LINKING OBESITY; WEIGHT-GAIN; PROFILE; GAMMA; INFLAMMATION; ANTIOXIDANT; DYSFUNCTION; BIOGENESIS	The impact of the mitochondria-targeted antioxidant MitoQ was evaluated in the metabolic alterations and the adipose tissue remodeling associated with obesity. Male Wistar rats were fed either a high-fat diet (HFD; 35% fat) or a standard diet (3.5% fat) for 7 wk and treated with MitoQ (200 mu M). A proteomic analysis of visceral adipose tissue from patients with obesity and patients without obesity was performed. MitoQ partially prevented the increase in body weight, adiposity, homeostasis model assessment index, and adipose tissue remodeling in HFD rats. It also ameliorated protein level changes of factors involved in insulin signaling observed in adipose tissue of obese rats: reductions in adiponectin and glucose transporter 4 (GLUT 4) and increases in dipeptidylpeptidase 4, suppressor of cytokine signaling 3 (SOCS3), and insulin receptor substrate 1 phosphorylation. MitoQ prevented down-regulation of adiponectin and GLUT 4 and increases in SOCS3 levels in a TNF-alpha-induced insulin-resistant 3T3-L1 adipocyte model. MitoQ also ameliorated alterations in mitochondrial proteins observed in obese rats: increases in cyclophylin F and camitine palmitoyl transferase 1A and reductions in mitofusinl, peroxiredoxin 4, and fumarate hydratase. The proteomic analysis of the visceral adipose tissue from patients with obesity show alterations in mitochondrial proteins similar to those observed in obese rats. Therefore, the data show the beneficial effect of MitoQ in the metabolic dysfunction induced by obesity.	[Marin-Royo, Gema; Le Pape, Aliaume; Jurado-Lopez, Raquel; Souza-Neto, Francisco V.; Martinez-Martinez, Ernesto; Cachofeiro, Victoria] Univ Complutense Madrid, IiSGM, Fac Med, Dept Fisiol, Madrid, Spain; [Rodriguez, Cristina] Hosp Santa Creu & Sant Pau, Inst Recerca, Inst Invest Biomed IIB St Pau, Barcelona, Spain; [Rodriguez, Cristina; Martinez-Gonzalez, Jose; Luisa Nieto, Maria; Martinez-Martinez, Ernesto; Cachofeiro, Victoria] Inst Salud Carlos III, Ciber Enfermedades Cardiovasc CIBERCV, Madrid, Spain; [Luaces, Maria] Hosp Clin San Carlos, Inst Cardiovasc, Serv Cardiol, Madrid, Spain; [Antequera, Alfonso] St Bernards Hosp, Surg Dept, Gibraltar Gi, Gibraltar; [Martinez-Gonzalez, Jose] CSIC, IIB St Pau, IIBB, Barcelona, Spain; [Luisa Nieto, Maria] Univ Valladolid, CSIC, Inst Biol & Genet Mol, Valladolid, Spain	Complutense University of Madrid; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Instituto de Salud Carlos III; Hospital Clinico San Carlos; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid	Martinez-Martinez, E; Cachofeiro, V (corresponding author), Univ Complutense, Fac Med, Dept Fisiol, Ave Complutense S-N, E-28040 Madrid, Spain.	ernmarti@ucm.es; vcara@ucm.es	Rodriguez, Cristina/D-3099-2011; Martinez-Martinez, Ernesto/M-1376-2017; Antequera, Alfonso/ABB-1579-2021; Nieto, Marisa/G-7492-2015	Rodriguez, Cristina/0000-0002-6472-5647; Martinez-Martinez, Ernesto/0000-0002-3011-2041; Jurado Lopez, Raquel/0000-0002-9149-1073; Luaces, Maria/0000-0001-9529-9655; Nieto, Marisa/0000-0001-6842-799X; Vasconcelos de Souza Neto, Francisco das Chagas/0000-0003-3704-494X	Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (FEDER) [PI15/01060, PI18/00257, PI18/0919]; Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (FEDER) [Ciber de Enfermedades Cardiovasculares (CIBERCV)]; Way to Build Europe, Ministerio de Economia y Competitividad [SAF2016-81063]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR; Program of Support to Research Groups) [2017-SGR-00333]; Complementary and Alternative Medicine (Comunidad Aut'onoma de Madrid) (Atraccion de Talento);  [PT13/0001]	Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (FEDER) [Ciber de Enfermedades Cardiovasculares (CIBERCV)]; Way to Build Europe, Ministerio de Economia y Competitividad; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR; Program of Support to Research Groups); Complementary and Alternative Medicine (Comunidad Aut'onoma de Madrid) (Atraccion de Talento); 	The authors thank Avelina Hidalgo, Blanca Martinez, Virginia Peinado, and Roberto Canadas (Departamento de Fisiologia, Facultad de Medicina, Universidad Complutense de Madrid) for technical help; Isabel Ruppen, Javier Munoz, and Pilar Ximenez-Embun [Proteomics Unit of the Centro Nacional de Investigaciones Oncologicas (CNIO), ProteoRed, PRB2-ISCIII], supported by Grant PT13/0001; and Anthony DeMarco for help in editing. MitoQ was provided by M. P. Murphy (Medical Research Council Mitochondrial Biology Unit, Cambridge BioMedical Campus, Cambridge, United Kingdom). This work was supported by Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (FEDER) [PI15/01060, PI18/00257, PI18/0919, and Ciber de Enfermedades Cardiovasculares (CIBERCV)], a Way to Build Europe, Ministerio de Economia y Competitividad (SAF2016-81063), and Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR; Program of Support to Research Groups, 2017-SGR-00333). E.M.-M. was supported by a contract from Complementary and Alternative Medicine (Comunidad Aut ' onoma de Madrid) (Atraccion de Talento). The authors declare no conflicts of interest.	Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010; Bond ST, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00543; Coudray C, 2016, BRIT J NUTR, V115, P1155, DOI 10.1017/S0007114515005528; Cydylo MA, 2017, OBESITY, V25, P290, DOI 10.1002/oby.21720; Elrayess MA, 2017, FREE RADICAL BIO MED, V104, P129, DOI 10.1016/j.freeradbiomed.2017.01.015; Feillet-Coudray C, 2014, FREE RADICAL RES, V48, P1232, DOI 10.3109/10715762.2014.945079; Feng DR, 2011, DIABETES, V60, P2134, DOI 10.2337/db10-1411; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; Fink BD, 2014, J PHARMACOL EXP THER, V351, P699, DOI 10.1124/jpet.114.219329; Frasca D, 2017, FRONT IMMUNOL, V8, DOI [10.3389/fimmu.2017.01745, 10.3389/fimmu.2017.01003]; Fruhbeck G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06997-0; Fukui Y, 2000, DIABETES, V49, P759, DOI 10.2337/diabetes.49.5.759; Goossens GH, 2008, PHYSIOL BEHAV, V94, P206, DOI 10.1016/j.physbeh.2007.10.010; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Haczeyni F, 2018, OBES REV, V19, P406, DOI 10.1111/obr.12646; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Heinonen S, 2015, DIABETES, V64, P3135, DOI 10.2337/db14-1937; Ibarrola J, 2018, INT J CARDIOL, V258, P217, DOI 10.1016/j.ijcard.2017.12.103; Imai Y, 2018, PHARMACOL RES PERSPE, V6, DOI 10.1002/prp2.393; Jeong EM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003046; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kelly LJ, 1998, ENDOCRINOLOGY, V139, P4920, DOI 10.1210/en.139.12.4920; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kline KG, 2008, J PROTEOME RES, V7, P5055, DOI 10.1021/pr800239e; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Lopez-Lluch G, 2017, MECH AGEING DEV, V162, P108, DOI 10.1016/j.mad.2016.12.005; Ly LD, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2016.157; McQuaid SE, 2011, DIABETES, V60, P47, DOI 10.2337/db10-0867; Miana M, 2015, DIS MODEL MECH, V8, P543, DOI 10.1242/dmm.020107; Monzo-Beltran L, 2017, REDOX BIOL, V12, P389, DOI 10.1016/j.redox.2017.02.003; Palanivel R, 2012, DIABETOLOGIA, V55, P3083, DOI 10.1007/s00125-012-2665-3; Rivera-Barahona A, 2017, MOL GENET METAB, V122, P43, DOI 10.1016/j.ymgme.2017.07.009; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Rovira-Llopis S, 2017, REDOX BIOL, V11, P637, DOI 10.1016/j.redox.2017.01.013; Sell H, 2004, ENDOCRINOLOGY, V145, P3925, DOI 10.1210/en.2004-0321; Tian ZM, 2009, HYPERTENSION, V54, P255, DOI 10.1161/HYPERTENSIONAHA.109.129528; Tol MJ, 2016, DIABETES, V65, P2591, DOI 10.2337/db16-0243; Wei YH, 1998, ANN NY ACAD SCI, V854, P155, DOI 10.1111/j.1749-6632.1998.tb09899.x; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Yin X, 2014, J CLIN ENDOCR METAB, V99, pE209, DOI 10.1210/jc.2013-3042; Zamora-Mendoza R, 2018, INT J OBESITY, V42, P618, DOI 10.1038/ijo.2017.274	41	23	23	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12060	12072		10.1096/fj.201900347RR	http://dx.doi.org/10.1096/fj.201900347RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31370681	Green Published			2022-12-28	WOS:000507461600036
J	Yang, J; Dang, GH; Lu, SL; Liu, HY; Ma, XL; Han, LL; Deng, JC; Miao, YT; Li, XP; Shao, FY; Jiang, CT; Xu, QB; Wang, X; Feng, J				Yang, Juan; Dang, Guohui; Lu, Silin; Liu, Huiying; Ma, Xiaolong; Han, Lulu; Deng, Jiacheng; Miao, Yutong; Li, Xiaopeng; Shao, Fangyu; Jiang, Changtao; Xu, Qingbo; Wang, Xian; Feng, Juan			T-cell-derived extracellular vesicles regulate B-cell IgG production via pyruvate kinase muscle isozyme 2	FASEB JOURNAL			English	Article						lymphocyte; antibody; ceramide	EXOSOMES; HOMOCYSTEINE; SECRETION; MITOCHONDRIA; BIOGENESIS; INITIATION; PROTEINS; BIOLOGY	Intercellular communication between lymphocytes plays a fundamental role in numerous immune responses. Previously, we demonstrated that hyperhomocysteinemia (HHcy) induced T cell intracellular glycolytic-lipogenic reprogramming and IFN-gamma secretion via pyruvate kinase muscle isozyme 2 (PKM2) to accelerate atherosclerosis. Usually, B cells partially obtain help from T cells in antibody responses. However, whether PKM2 activation in T cells regulates B cell antibody production is unknown. Extracellular vesicles (EVs) are important cellular communication vehicles. Here, we found that PKM2 activator TEPP46-stimulated T-cell-derived EVs promoted B-cell IgG secretion. Conversely, EVs secreted from PKM2-null T cells were internalized into B cells and markedly inhibited B-cell mitochondrial programming, activation, and IgG production. Mechanistically, lipidomics analyses showed that increased ceramides in PKM2-activated T-cell EVs were mainly responsible for enhanced B cell IgG secretion induced by these EVs. Finally, quantum dots (QDs) were packaged with PKM2-null T cell EVs and anti-CD19 antibody to exert B-cell targeting and inhibit IgG production, eventually ameliorating HHcy-accelerated atherosclerosis in vivo. Thus, PKM2-mediated EV ceramides in T cells maybe an important cargo for T-cell-regulated B cell IgG production, and QD-CD19-PKM2-null T cell EVs hold high potential to treat B cell overactivation-related diseases.	[Yang, Juan; Dang, Guohui; Liu, Huiying; Ma, Xiaolong; Han, Lulu; Miao, Yutong; Li, Xiaopeng; Shao, Fangyu; Jiang, Changtao; Wang, Xian; Feng, Juan] Peking Univ, Minist Educ, Key Lab Mol Cardiovasc Sci, Dept Physiol & Pathophysiol,Sch Basic Med Sci, 38 Xueyuan Rd, Beijing 100191, Peoples R China; [Lu, Silin] Chinese Acad Med Sci, Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing, Peoples R China; [Deng, Jiacheng; Xu, Qingbo] Kings Coll London, Ctr Vasc Regenerat, BHF, Cardiovasc Div, London, England	Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Peking Union Medical College; University of London; King's College London	Wang, X; Feng, J (corresponding author), Peking Univ, Minist Educ, Key Lab Mol Cardiovasc Sci, Dept Physiol & Pathophysiol,Sch Basic Med Sci, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	xwang@bjmu.edu.cn; juanfeng@bjmu.edu.cn		Jiang, Changtao/0000-0002-5206-2372; Deng, Jiacheng/0000-0002-3216-3774	National Natural Science Foundation of China [91739303, 81770445]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors are grateful to Prof. Wei Kong (Peking University) for the helpful advice. The authors thank Prof. Shiqiang Wang, Prof. Xuemei Hao, and Prof. Yingchun Hu (Peking University) for assistance with the extracellular vesicle transmission electron microscope assays. This work was supported by the National Natural Science Foundation of China (91739303 and 81770445). The funder of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the article. The authors were not paid to write this manuscript by a pharmaceutical company or other agency. The authors declare no conflicts of interest.	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Avitabile E, 2018, NANOSCALE, V10, P11719, DOI 10.1039/c8nr02796j; Besse B, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1071008; Biswas SK, 2015, IMMUNITY, V43, P435, DOI 10.1016/j.immuni.2015.09.001; Boulanger CM, 2017, NAT REV CARDIOL, V14, P259, DOI 10.1038/nrcardio.2017.7; Burger JA, 2018, NAT REV CANCER, V18, P148, DOI 10.1038/nrc.2017.121; Buschow SI, 2010, IMMUNOL CELL BIOL, V88, P851, DOI 10.1038/icb.2010.64; Chen G, 2018, NATURE, V560, P382, DOI 10.1038/s41586-018-0392-8; Clayton A., 2006, CURR PROTOC CELL BIO; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Crewe C, 2018, CELL, V175, P695, DOI 10.1016/j.cell.2018.09.005; Cubuk C, 2018, CANCER RES, V78, P6059, DOI 10.1158/0008-5472.CAN-17-2705; Deng JC, 2017, J IMMUNOL, V198, P170, DOI 10.4049/jimmunol.1600613; Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334; Dibble CC, 2015, TRENDS CELL BIOL, V25, P545, DOI 10.1016/j.tcb.2015.06.002; Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194; Escudier B, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-10; Feng J, 2016, PROTEIN CELL, V7, P391, DOI 10.1007/s13238-016-0245-x; Feng J, 2009, CARDIOVASC RES, V84, P155, DOI 10.1093/cvr/cvp182; Gallet R, 2017, EUR HEART J, V38, P201, DOI 10.1093/eurheartj/ehw240; Gao YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040258; Gaya M, 2018, CELL, V172, P517, DOI 10.1016/j.cell.2017.11.036; Hauck TS, 2010, SMALL, V6, P138, DOI 10.1002/smll.200900626; Herrmann M, 2006, EUR J HEART FAIL, V8, P571, DOI 10.1016/j.ejheart.2005.11.016; HIROHATA S, 1988, J IMMUNOL, V140, P3726; Hoshino D, 2013, CELL REP, V5, P1159, DOI 10.1016/j.celrep.2013.10.050; Ibrahim A, 2016, ANNU REV PHYSIOL, V78, P67, DOI 10.1146/annurev-physiol-021115-104929; Jalali HB, 2018, ACS NANO, V12, P8104, DOI 10.1021/acsnano.8b02976; Jenks SA, 2018, IMMUNITY, V49, P725, DOI 10.1016/j.immuni.2018.08.015; Jesko H, 2019, MOL NEUROBIOL, V56, P3501, DOI 10.1007/s12035-018-1286-3; Kallies A, 2007, IMMUNITY, V26, P555, DOI 10.1016/j.immuni.2007.04.007; Kamerkar S, 2017, NATURE, V546, P498, DOI 10.1038/nature22341; Lindenbergh MFS, 2018, ANNU REV IMMUNOL, V36, P435, DOI 10.1146/annurev-immunol-041015-055700; Liu F, 2017, NEURO-ONCOLOGY, V19, P2; Lo Giudice MC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13475; Lu SL, 2018, J MOL MED, V96, P585, DOI 10.1007/s00109-018-1645-6; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Manna I, 2018, FASEB J, V32, P4241, DOI 10.1096/fj.201701533R; Mathieu M, 2019, NAT CELL BIOL, V21, P9, DOI 10.1038/s41556-018-0250-9; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Mitchison NA, 2004, NAT REV IMMUNOL, V4, P308, DOI 10.1038/nri1334; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Morse MA, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-9; Nelson BH, 2010, J IMMUNOL, V185, P4977, DOI 10.4049/jimmunol.1001323; Park C, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e34; Plebanek MP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01433-3; Puhm F, 2019, CIRC RES, V125, P43, DOI 10.1161/CIRCRESAHA.118.314601; Regnier M, 2019, BIOCHIMIE, V159, P9, DOI 10.1016/j.biochi.2018.07.021; Sasaki Y, 2018, J IMMUNOL, V200, P3438, DOI 10.4049/jimmunol.1701526; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shi CH, 2019, FASEB J, V33, P1617, DOI 10.1096/fj.201800987R; Steed MM, 2011, ANTIOXID REDOX SIGN, V15, P1927, DOI 10.1089/ars.2010.3721; Stienstra R, 2017, CELL METAB, V26, P142, DOI 10.1016/j.cmet.2017.06.001; Tang N, 2016, FASEB J, V30, P3097, DOI 10.1096/fj.201600368RR; Tassew NG, 2017, CELL REP, V20, P99, DOI 10.1016/j.celrep.2017.06.009; Tay C, 2018, ARTERIOSCL THROM VAS, V38, pE71, DOI 10.1161/ATVBAHA.117.310678; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Todorova D, 2017, CIRC RES, V120, P1658, DOI 10.1161/CIRCRESAHA.117.309681; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Tsoi KM, 2013, ACCOUNTS CHEM RES, V46, P662, DOI 10.1021/ar300040z; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Wang RS, 2015, J BIOL CHEM, V290, P30684, DOI 10.1074/jbc.M115.671735; Wegner KD, 2015, CHEM SOC REV, V44, P4792, DOI 10.1039/c4cs00532e; Wei Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14041; Weinstein JS, 2016, NAT IMMUNOL, V17, P1197, DOI 10.1038/ni.3554; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yang LC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5436; Yun YH, 2015, J CONTROL RELEASE, V219, P2, DOI 10.1016/j.jconrel.2015.10.005; Zhang FH, 2019, IMMUNITY, V50, P738, DOI 10.1016/j.immuni.2019.01.010	74	9	10	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12780	12799		10.1096/fj.201900863R	http://dx.doi.org/10.1096/fj.201900863R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31480861	Green Published			2022-12-28	WOS:000507461600092
J	Zheng, YJ; Zhao, JY; Liang, TS; Wang, P; Wang, J; Yang, DK; Liu, ZS				Zheng, Ying-Juan; Zhao, Jing-Yi; Liang, Tian-Song; Wang, Ping; Wang, Juan; Yang, Dao-Ke; Liu, Zhang-Suo			Long noncoding RNA SMAD5-AS1 acts as a microRNA-106a-5p sponge to promote epithelial mesenchymal transition in nasopharyngeal carcinoma	FASEB JOURNAL			English	Article						ceRNA; SMAD5; proliferation; migration; invasion	POOR-PROGNOSIS; CELL-PROLIFERATION; CANCER-CELLS; N-CADHERIN; METASTASIS; EXPRESSION; MIGRATION; INVASION; LNCRNA; PROGRESSION	Nasopharyngeal carcinoma (NPC) is a malignant epithelial cancer of the head and neck with high prevalence in southern China, which is accompanied by notable invasiveness and metastasis. Long noncoding RNAs (lncRNAs) participate in the progression of various cancers including NPC. Microarray-based analysis identified highly expressed IncRNA mothers against decapentaplegic homolog 5 (SMAD5)-antisense RNA 1 (AS1) related to NPC. Interestingly, it is found that SMAD5-AS1 competitively bound to microRNA (miR)-106a-5p to regulate SMAD5. Herein, the study aimed to clarify the role of SMAD5-AS1/miR-106a-5p/SMAD5 axis in the process of epithelial mesenchymal transition (EMT) in NPC. SMAD5-AS1 was highly expressed and miR-106a-5p was poorly expressed in NPC tissues and cell lines. The NPC cells were treated with a series of small interfering RNAs, mimics, or inhibitors to explore the effects of SMAD5-AS1, SMAD5, and miR-106a-5p on EMT, cell proliferation, migration, and invasion in NPC. Of note, SMAD5-AS1 silencing or miR-106a-5p overexpression reduced expression of N-cadherin, matrix metallopeptidase 9, Snail, and Vimentin while elevating E-cadherin expression, thus inhibiting EMT, cell proliferation, migration, and invasion in NPC by down-regulation of SMAD5. Moreover, SMAD5 silencing could reduce the ability of EMT induced by SMAD5-AS1 up-regulation. SMAD5-AS1 silencing or miR-106a-5p elevation inhibited tumorigenesis in nude mice. Taken together, SMAD5-AS1 silencing suppressed EMT, cell proliferation, migration, and invasion in NPC by elevating miR-106a-5p to down-regulate SMAD5, which provided a novel therapeutic target for NPC treatment.	[Zheng, Ying-Juan; Zhao, Jing-Yi; Liang, Tian-Song; Wang, Ping; Wang, Juan; Yang, Dao-Ke; Liu, Zhang-Suo] Zhengzhou Univ, Affiliated Hosp 1, Dept Radiotherapy, Zhengzhou, Peoples R China	Zhengzhou University	Yang, DK; Liu, ZS (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Radiotherapy, Zhengdong Branch, Zhengzhou 475000, Henan, Peoples R China.	dryang_yangdaoke@yeah.net; zhangsuoliu_lzs@126.com						Bo H, 2015, ONCOTARGET, V6, P20404, DOI 10.18632/oncotarget.4057; Cheng N, 2017, ONCOTARGETS THER, V10, P5843, DOI 10.2147/OTT.S151800; Cho JH, 2014, PEDIATR CARDIOL, V35, P601, DOI 10.1007/s00246-013-0826-x; Clendenon SG, 2012, DEV DYNAM, V241, P442, DOI 10.1002/dvdy.23729; Du BW, 2016, MOLECULES, V21, DOI 10.3390/molecules21070965; Fang T, 2016, MOL MED REP, V14, P1269, DOI 10.3892/mmr.2016.5363; Feng SY, 2017, CELL CYCLE, V16, P869, DOI 10.1080/15384101.2017.1308617; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; He QY, 2016, DNA CELL BIOL, V35, P506, DOI 10.1089/dna.2015.3121; He RZ, 2017, ONCOTARGET, V8, P16075, DOI 10.18632/oncotarget.14211; Hu ZY, 2015, BBA-MOL BASIS DIS, V1852, P1876, DOI 10.1016/j.bbadis.2015.06.009; Huang HP, 2015, TUMOR BIOL, V36, P4123, DOI 10.1007/s13277-015-3046-6; Lai IL, 2017, ONCOTARGET, V8, P98148, DOI 10.18632/oncotarget.21465; Lan XT, 2019, J CELL MOL MED, V23, P2351, DOI 10.1111/jcmm.13497; Lee AWM, 2011, EUR J CANCER, V47, P656, DOI 10.1016/j.ejca.2010.10.026; Li L, 2016, CANCER SCI, V107, P1215, DOI 10.1111/cas.12989; Li T, 2011, ONCOL REP, V25, P1353, DOI 10.3892/or.2011.1204; Li XJ, 2012, CARCINOGENESIS, V33, P1302, DOI 10.1093/carcin/bgs181; Liang WC, 2015, ONCOTARGET, V6, P22513, DOI 10.18632/oncotarget.4154; Liu YJ, 2017, BIOCHEM BIOPH RES CO, V491, P374, DOI 10.1016/j.bbrc.2017.07.093; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Luo WR, 2012, HISTOPATHOLOGY, V61, P237, DOI 10.1111/j.1365-2559.2012.04212.x; Nie MY, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.130690; Pan YJ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.561; Qi GY, 2016, CELL PHYSIOL BIOCHEM, V40, P589, DOI 10.1159/000452572; Qi XM, 2014, FEBS LETT, V588, P3732, DOI 10.1016/j.febslet.2014.08.021; Qu CJ, 2012, CELL CYCLE, V11, P785, DOI 10.4161/cc.11.4.19228; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Song XD, 2014, J CELL MOL MED, V18, P991, DOI 10.1111/jcmm.12243; Su ZW, 2016, ONCOL REP, V36, P72, DOI 10.3892/or.2016.4768; Sun H, 2017, ONCOL LETT, V13, P1725, DOI 10.3892/ol.2017.5645; Sun XJ, 2014, ASIAN PAC J CANCER P, V15, P4019, DOI 10.7314/APJCP.2014.15.9.4019; Wang F, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0292-4; Wang H, 2017, PANCREATOLOGY, V17, P237, DOI 10.1016/j.pan.2017.01.010; Wang QR, 2014, INT J ONCOL, V44, P858, DOI 10.3892/ijo.2013.2237; Wang T, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-160; Wang ZL, 2015, INT J CLIN EXP MED, V8, P18765; Wei FL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16720-8; Wu JH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21708-z; Wu YD, 2010, CELL ADHES MIGR, V4, P199, DOI 10.4161/cam.4.2.10943; Xiao C, 2016, EUR REV MED PHARMACO, V20, P2819; Xu J, 2017, J ECON ENTOMOL, V110, P683, DOI 10.1093/jee/tow297; Yue B, 2015, CANCER SCI, V106, P1323, DOI 10.1111/cas.12759; Zheng J, 2016, NAT GENET, V48, P747, DOI 10.1038/ng.3568; Zhi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054867; Zou ZW, 2016, ONCOTARGET, V7, P61741, DOI 10.18632/oncotarget.11437	46	31	32	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12915	12928		10.1096/fj.201900803R	http://dx.doi.org/10.1096/fj.201900803R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31557058	Green Published, Bronze			2022-12-28	WOS:000507461600101
J	Duan, TY; Cil, O; Tse, CM; Sarker, R; Lin, RX; Donowitz, M; Verkman, AS				Duan, Tianying; Cil, Onur; Tse, C. Ming; Sarker, Rafiquel; Lin, Ruxian; Donowitz, Mark; Verkman, Alan S.			Inhibition of CFTR-mediated intestinal chloride secretion as potential therapy for bile acid diarrhea	FASEB JOURNAL			English	Article						chloride channel; BAD; intestinal fluid secretion; cystic fibrosis; CFTR inhibitor	IRRITABLE-BOWEL-SYNDROME; ION-TRANSPORT; CL-SECRETION; FLUID SECRETION; PHYSIOLOGY; PREVALENCE; MECHANISMS; (R)-BPO-27; MODEL; SALTS	Bile acid diarrhea (BAD) is common with ileal resection, Crohn's disease, and diarrhea-predominant irritable bowel syndrome. Here, we demonstrate the efficacy of cystic fibrosis transmembrane conductance regulator (CFTR) inhibitor (R)-benzopyrimido-pyrrolo-oxazine-dione-27 (BPO-27) in reducing bile acid-induced fluid and electrolyte secretion in colon. Short-circuit current measurements in human T84 colonic epithelial cells and planar colonic enteroid cultures showed a robust secretory response following mucosal but not serosal addition of chenodeoxycholic acid (CDCA) or its taurine conjugate, which was fully blocked by CFTR inhibitors, including (R)-BPO-27. (R)-BPO-27 also fully blocked CDCA-induced secretory current in murine colon. CFTR activation by CDCA primarily involved Ca2+ signaling. In closed colonic loops in vivo, luminal CDCA produced a robust secretory response, which was reduced by similar to 70% by (R)-BPO-27 or in CFTR-deficient mice. In a rat model of BAD produced by intracolonic infusion of CDCA, (R)-BPO-27 reduced the elevation in stool water content by >55%. These results implicate CFTR activation in the colon as a major prosecretory mechanism of CDCA, a bile acid implicated in BAD, and support the potential therapeutic efficacy of CFTR inhibition in bile acid-associated diarrheas.-Duan, T., Cil, O., Tse, C. M., Sarker, R., Lin, R., Donowitz, M., Verkman, A. S. Inhibition of CFTR-mediated intestinal chloride secretion as potential therapy for bile acid diarrhea.	[Duan, Tianying; Cil, Onur; Verkman, Alan S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Duan, Tianying; Verkman, Alan S.] Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA; [Cil, Onur] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Duan, Tianying] Cent S Univ, Xiangya Hosp 2, Dept Gastroenterol, Changsha, Hunan, Peoples R China; [Tse, C. Ming; Sarker, Rafiquel; Lin, Ruxian; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Physiol, Gastroenterol Div, Baltimore, MD 21205 USA; [Lin, Ruxian; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Central South University; Johns Hopkins University; Johns Hopkins University	Verkman, AS (corresponding author), Univ Calif San Francisco, 1246 Hlth Sci E Tower,513 Parnassus Ave, San Francisco, CA 94143 USA.	alan.verkman@ucsf.edu	Cil, Onur/AAK-5166-2020	Cil, Onur/0000-0001-5178-0199	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK099803, DK72517, DK101373, DK089502]; NIH National Eye Institute [EY13574]; Cystic Fibrosis Foundation; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101373, P30DK072517, P30DK089502, R24DK099803] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Paul Dawson (Emory University, Atlanta, GA, USA), Stephen Keely (Royal College of Surgeons in Ireland, Dublin, Ireland), and Jerry Turner (Harvard Medical School, Boston, MA, USA) for helpful advice and suggestions. This study was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants DK099803, DK72517, DK101373, and DK089502, and NIH National Eye Institute Grant EY13574, and a research grant from the Cystic Fibrosis Foundation. A.S.V. is a named inventor on CFTR inhibitor patent applications owned by the University of California. The other authors declare no conflicts of interest.	Ahuja M, 2014, CELL CALCIUM, V55, P385, DOI 10.1016/j.ceca.2014.01.006; Alrefai WA, 2007, DIGEST DIS SCI, V52, P1270, DOI 10.1007/s10620-006-9090-8; Ao M, 2013, AM J PHYSIOL-CELL PH, V305, pC447, DOI 10.1152/ajpcell.00416.2012; Barcelo A, 2001, DIGEST DIS SCI, V46, P1223, DOI 10.1023/A:1010607127822; Barshop K, 2017, THER ADV CHRONIC DIS, V8, P153, DOI 10.1177/2040622317714389; Camilleri M, 2015, GUT LIVER, V9, P332, DOI 10.5009/gnl14397; Camilleri M, 2014, EXPERT REV GASTROENT, V8, P49, DOI 10.1586/17474124.2014.851599; Cil O, 2017, FASEB J, V31, P751, DOI 10.1096/fj.201600891R; CONLEY DR, 1976, AM J DIG DIS, V21, P453, DOI 10.1007/BF01072128; Dey I, 2018, CURR TOP MEMBR, V81, P337, DOI 10.1016/bs.ctm.2018.08.003; DHARMSATHAPHORN K, 1989, J CLIN INVEST, V84, P945, DOI 10.1172/JCI114257; Domingue JC, 2016, AM J PHYSIOL-CELL PH, V311, pC777, DOI 10.1152/ajpcell.00168.2016; Duan TY, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126444; Duboc H, 2012, NEUROGASTROENT MOTIL, V24, P513, DOI 10.1111/j.1365-2982.2012.01893.x; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Foulke-Abel J, 2016, GASTROENTEROLOGY, V150, P638, DOI 10.1053/j.gastro.2015.11.047; Gracie DJ, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2012.01953.x; Haggie PM, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121370; Halls ML, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004143; HOFMANN AF, 1969, NEW ENGL J MED, V281, P397, DOI 10.1056/NEJM196908212810801; Hoque KM, 2010, J GEN PHYSIOL, V135, P43, DOI 10.1085/jgp.200910339; In J, 2016, CELL MOL GASTROENTER, V2, P48, DOI 10.1016/j.jcmgh.2015.10.001; In JG, 2016, NAT REV GASTRO HEPAT, V13, P633, DOI 10.1038/nrgastro.2016.142; Khan S, 2010, NAT REV GASTRO HEPAT, V7, P565, DOI 10.1038/nrgastro.2010.137; Kim Y, 2015, MOL PHARMACOL, V88, P689, DOI 10.1124/mol.115.098368; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Lee JM, 2018, J LIPID RES, V59, P429, DOI 10.1194/jlr.M078279; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; MASCOLO N, 1994, EUR J PHARMACOL, V264, P21, DOI 10.1016/0014-2999(94)90630-0; MEKHJIAN HS, 1971, J CLIN INVEST, V50, P1569, DOI 10.1172/JCI106644; Momen Mohammed Abdul, 2002, Journal of Medical Investigation, V49, P67; Mroz MS, 2014, GUT, V63, P808, DOI 10.1136/gutjnl-2013-305088; Nee Judy, 2015, Curr Treat Options Gastroenterol, V13, P432, DOI 10.1007/s11938-015-0068-5; Odunsi-Shiyanbade ST, 2010, CLIN GASTROENTEROL H, V8, P159, DOI 10.1016/j.cgh.2009.10.020; Pallagi-Kunstar E, 2015, PFLUG ARCH EUR J PHY, V467, P1277, DOI 10.1007/s00424-014-1560-9; Sarathy J, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13294; Shin A, 2013, CLIN GASTROENTEROL H, V11, P1270, DOI 10.1016/j.cgh.2013.04.020; Snyder DS, 2013, ACS MED CHEM LETT, V4, P456, DOI 10.1021/ml400069k; Snyder DS, 2011, J MED CHEM, V54, P5468, DOI 10.1021/jm200505e; Thiagarajah JR, 2015, NAT REV GASTRO HEPAT, V12, P446, DOI 10.1038/nrgastro.2015.111; Thiagarajah JR, 2004, GASTROENTEROLOGY, V126, P511, DOI 10.1053/j.gastro.2003.11.005; Venkatasubramanian J, 2010, CURR OPIN GASTROEN, V26, P123, DOI 10.1097/MOG.0b013e3283358a45; Walters Julian R F, 2010, Therap Adv Gastroenterol, V3, P349, DOI 10.1177/1756283X10377126; Wedlake L, 2009, ALIMENT PHARM THER, V30, P707, DOI 10.1111/j.1365-2036.2009.04081.x; Wong BS, 2012, CLIN GASTROENTEROL H, V10, P1009, DOI 10.1016/j.cgh.2012.05.006; Zachos NC, 2016, J BIOL CHEM, V291, P3759, DOI 10.1074/jbc.R114.635995; ZHANG R, 2017, JOVE J VIS EXP AUG, V126, DOI DOI 10.3791/55728	47	6	8	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10924	10934		10.1096/fj.201901166R	http://dx.doi.org/10.1096/fj.201901166R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31268738	Green Published, Bronze			2022-12-28	WOS:000489166300028
J	Lee, D; Lee, S; Shin, Y; Song, Y; Kang, SW				Lee, Duri; Lee, Sohee; Shin, Yejin; Song, Youngsup; Kang, Sang-Wook			Thiol-disulfide status regulates quality control of prion protein at the plasma membrane	FASEB JOURNAL			English	Article						RESET; PrP endocytosis; PrP misfolding; pmQC	ENDOPLASMIC-RETICULUM; DEGRADATION; STABILITY	Rapid endoplasmic reticulum (ER) stress-induced export (RESET) is undoubtedly beneficial in that it eliminates misfolded prion protein (PrP) from a stressed ER. Considering that RESET induces rapid endocytosis of misfolded PrP for degradation, it is questionable whether RESET is beneficial when its product amount overwhelms the capacity of subsequent clearance pathways. We require a strategy to monitor the endocytic flux rate of misfolded PrPs. Here, we stabilized misfolded PrPs by inserting red fluorescent protein (RFP) and indirectly determined this rate by monitoring the lysosomal free RFP. We discovered a surveillance mechanism that limits endocytosis of misfolded PrPs through plasma membrane quality control (pmQC). pmQC was regulated by the thiol-disulfide status of misfolded PrPs and consequently accumulates nonpathogenic PrP variants at the plasma membrane. This variant alleviated prion proteotoxicity induced by persistent RESET. Thus, PrP endocytosis is regulated by pmQC to ensure the safety of endolysosomal pathway from persistent internalization of misfolded PrP.-Lee, D., Lee, S., Shin, Y., Song, Y., Kang, S.-W. Thiol-disulfide status regulates quality control of prion protein at the plasma membrane.	[Lee, Duri; Lee, Sohee; Shin, Yejin; Song, Youngsup; Kang, Sang-Wook] Univ Ulsan, Dept Biomed Sci, Coll Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea; [Song, Youngsup; Kang, Sang-Wook] Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea	University of Ulsan; University of Ulsan; Asan Medical Center	Kang, SW (corresponding author), Univ Ulsan, Dept Biomed Sci, Coll Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.	swkang@amc.seoul.kr		Kang, Sang-Wook/0000-0002-8000-4823	National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [NRF-2016R1D1A1B03931606, NRF-2019R1F1A1062659]	National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	The authors thank the members of Cellular Adaptation To Stress (CATS) for insightful discussions and use of the Confocal Microscope Core at Asan Institute for Life Sciences for image generation. This work was supported by grants from the Basic Science Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (NRF-2016R1D1A1B03931606 and NRF-2019R1F1A1062659). The authors declare no conflicts of interest.	Aguilar-Calvo P, 2017, SCI REP-UK, V7, DOI 10.1038/srep43295; Altmeppen HC, 2015, ELIFE, V4, DOI 10.7554/eLife.04260; Altmeppen HC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-36; Araki Kazutaka, 2012, Cold Spring Harb Perspect Biol, V4, pa015438, DOI 10.1101/cshperspect.a015438; Araki K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007526; Arvan P, 2002, TRAFFIC, V3, P771, DOI 10.1034/j.1600-0854.2002.31102.x; Ashok A, 2008, MOL BIOL CELL, V19, P3463, DOI 10.1091/mbc.E08-01-0087; Ashok A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000479; Braakman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013201; Bulleid NJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013219; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Forrester A, 2019, EMBO J, V38, DOI 10.15252/embj.201899847; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; Goold R, 2015, MOL CELL NEUROSCI, V66, P12, DOI 10.1016/j.mcn.2014.12.009; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Hooper NM, 2005, BIOCHEM SOC T, V33, P335, DOI 10.1042/BST0330335; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Kiachopoulos S, 2004, TRAFFIC, V5, P426, DOI 10.1111/j.1398-9219.2004.00185.x; Knowles TPJ, 2006, BIOPHYS J, V91, P1494, DOI 10.1529/biophysj.106.081653; Kuffer A, 2016, NATURE, V536, P464, DOI 10.1038/nature19312; LASZLO L, 1992, J PATHOL, V166, P333, DOI 10.1002/path.1711660404; Maiti NR, 2001, J BIOL CHEM, V276, P2427, DOI 10.1074/jbc.M007862200; Okiyoneda T, 2011, CURR OPIN CELL BIOL, V23, P483, DOI 10.1016/j.ceb.2011.04.012; Pankiewicz JE, 2019, MOL NEUROBIOL, V56, P2073, DOI 10.1007/s12035-018-1208-4; Puig B, 2014, PRION, V8, P11, DOI 10.4161/pri.27892; RAPOPORT TA, 1992, SCIENCE, V258, P931, DOI 10.1126/science.1332192; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Satpute-Krishnan P, 2014, CELL, V158, P522, DOI 10.1016/j.cell.2014.06.026; Shim SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep21658; Snapp EL, 2004, J CELL BIOL, V164, P997, DOI 10.1083/jcb.200312079; STAHL N, 1990, BIOCHEMISTRY-US, V29, P5405, DOI 10.1021/bi00474a028; Welker E, 2001, P NATL ACAD SCI USA, V98, P4334, DOI 10.1073/pnas.071066598; Yim YI, 2015, J CELL SCI, V128, P1434, DOI 10.1242/jcs.165472; Zavodszky E, 2019, ELIFE, V8, DOI 10.7554/eLife.46740	38	1	1	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11567	11578		10.1096/fj.201901052R	http://dx.doi.org/10.1096/fj.201901052R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31331210	Bronze			2022-12-28	WOS:000489166300079
J	Mediouni, S; Kessing, CF; Jablonski, JA; Thenin-Houssier, S; Clementz, M; Kovach, MD; Mousseau, G; de Vera, IMS; Li, C; Kojetin, DJ; Evans, DT; Valente, ST				Mediouni, Sonia; Kessing, Can F.; Jablonski, Joseph A.; Thenin-Houssier, Suzie; Clementz, Mark; Kovach, Melia D.; Mousseau, Guillaume; de Vera, Ian Mitchelle S.; Li, Chuan; Kojetin, Douglas J.; Evans, David T.; Valente, Susana T.			The Tat inhibitor didehydro-cortistatin A suppresses SIV replication and reactivation	FASEB JOURNAL			English	Article						simian immunodeficiency virus; dCA; block-and-lock; transcription inhibition; latency	HUMAN-IMMUNODEFICIENCY-VIRUS; ARGININE-RICH MOTIF; HIV-1 TAT; P-TEFB; IN-VIVO; TRANSCRIPTION FACTOR; ACTIVATION; RNA; PROMOTER; COMPLEX	The HIV-1 transactivation protein (Tat) binds the HIV mRNA transactivation responsive element (TAR), regulating transcription and reactivation from latency. Drugs against Tat are unfortunately not clinically available. We reported that didehydro-cortistatin A (dCA) inhibits HIV-1 Tat activity. In human CD4(+) T cells isolated from aviremic individuals and in the humanized mouse model of latency, combining dCA with antiretroviral therapy accelerates HIV-1 suppression and delays viral rebound upon treatment interruption. This drug class is amenable to block-and-lock functional cure approaches, aimed at a durable state of latency. Simian immunodeficiency virus (SIV) infection of rhesus macaques (RhMs) is the best-characterized model for AIDS research. Here, we demonstrate, using in vitro and cell-based assays, that dCA directly binds to SIV Tat's basic domain. dCA specifically inhibits SIV Tat binding to TAR, but not a Tat-Rev fusion protein, which activates transcription when Rev binds to its cognate RNA binding site replacing the apical region of TAR. Tat-TAR inhibition results in loss of RNA polymerase II recruitment to the SIV promoter. Importantly, dCA potently inhibits SIV reactivation from latently infected Hut78 cells and from primary CD4(+) T cells explanted from SIV(mac)239-infected RhMs. In sum, dCA's remarkable breadth of activity encourages SIV-infected RhM use for dCA preclinical evaluation.-Mediouni, S., Kessing, C. F., Jablonski, J. A., Thenin-Houssier, S., Clementz, M., Kovach, M. D., Mousseau, G., de Vera, I.M.S., Li, C., Kojetin, D. J., Evans, D. T., Valente, S. T. The Tat inhibitor didehydro-cortistatin A suppresses SIV replication and reactivation.	[Mediouni, Sonia; Kessing, Can F.; Jablonski, Joseph A.; Clementz, Mark; Kovach, Melia D.; Mousseau, Guillaume; Li, Chuan; Valente, Susana T.] Scripps Res Inst, Dept Immunol & Microbiol, Jupiter, FL 33458 USA; [Kojetin, Douglas J.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Evans, David T.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Thenin-Houssier, Suzie] Univ Montpelier, CNRS, Inst Human Genet IGH, Montpellier, France; [de Vera, Ian Mitchelle S.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol, St Louis, MO USA	Scripps Research Institute; Scripps Research Institute; University of Wisconsin System; University of Wisconsin Madison; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Saint Louis University	Valente, ST (corresponding author), Scripps Res Inst, 130 Scripps Way,3C1, Jupiter, FL 33458 USA.	svalente@scripps.edu		de Vera, Ian Mitchelle/0000-0003-4682-901X	U.S. National Institute of Health (NIH), National Institute of Allergy and Infectious Diseases [R21 AI116226, RO1AI118432, RO1AI097012]; NIH T32 Training Grant [2T32AI007354-26A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007354, R01AI097012, R01AI148379, R01AI095098, R33AI116226, R01AI118432] Funding Source: NIH RePORTER	U.S. National Institute of Health (NIH), National Institute of Allergy and Infectious Diseases; NIH T32 Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Dr. Farzan for helpful discussions and critical reading of the manuscript and Fernando Toledo for technical support. The authors thank the AIDS Reagent Program for reagents. This work was supported by the U.S. National Institute of Health (NIH), National Institute of Allergy and Infectious Diseases (R21 AI116226, RO1AI118432, and RO1AI097012 to S.T.V.). C.F.K. is supported by NIH T32 Training Grant (2T32AI007354-26A1). The authors declare no conflicts of interest.	ANDERSON MG, 1991, J VIROL, V65, P51, DOI 10.1128/JVI.65.1.51-60.1991; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Cardarelli F, 2008, TRAFFIC, V9, P528, DOI 10.1111/j.1600-0854.2007.00696.x; Cardarelli F, 2007, MOL THER, V15, P1313, DOI 10.1038/sj.mt.6300172; Centlivre M, 2008, J VIROL, V82, P9171, DOI 10.1128/JVI.00530-08; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023177; Cline AN, 2005, J MED PRIMATOL, V34, P303; d'Alencon E, 2004, INSECT BIOCHEM MOLEC, V34, P331, DOI 10.1016/j.ibmb.2003.12.004; DANIEL MD, 1985, SCIENCE, V228, P1201, DOI 10.1126/science.3159089; Das AT, 2007, J VIROL, V81, P11159, DOI 10.1128/JVI.01354-07; Del Prete GQ, 2013, J VIROL, V87, P4584, DOI 10.1128/JVI.03507-12; Easley R, 2010, VIROLOGY, V405, P322, DOI 10.1016/j.virol.2010.06.009; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Galati D, 2003, J INFECT DIS, V188, P1483, DOI 10.1086/379249; Gerbi SA, 2003, CURR OPIN CELL BIOL, V15, P318, DOI 10.1016/S0955-0674(03)00049-8; Hatziioannou T, 2012, NAT REV MICROBIOL, V10, P852, DOI 10.1038/nrmicro2911; Jarboui MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048702; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; JONES KA, 1986, SCIENCE, V232, P755, DOI 10.1126/science.3008338; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Karn J, 2011, CURR OPIN HIV AIDS, V6, P4, DOI 10.1097/COH.0b013e328340ffbb; Kessing CF, 2017, CELL REP, V21, P600, DOI 10.1016/j.celrep.2017.09.080; KODAMA T, 1989, J VIROL, V63, P4709, DOI 10.1128/JVI.63.11.4709-4714.1989; Mahmoudi T, 2012, TRANSCR-AUSTIN, V3, P171, DOI 10.4161/trns.20541; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; Martin RM, 2015, NUCLEUS-PHILA, V6, P314, DOI 10.1080/19491034.2015.1079680; Mediouni S, 2019, MBIO, V10, DOI 10.1128/mBio.02662-18; Mediouni S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01164; Mediouni S, 2015, CURR HIV RES, V13, P64, DOI 10.2174/1570162X13666150121111548; Michienzi A, 2002, P NATL ACAD SCI USA, V99, P14047, DOI 10.1073/pnas.212229599; Mousseau G, 2017, CURR PHARM DESIGN, V23, P4079, DOI 10.2174/1381612823666170622104355; Mousseau G, 2016, EXPERT REV ANTI-INFE, V14, P145, DOI 10.1586/14787210.2016.1122525; Mousseau G, 2015, MBIO, V6, DOI 10.1128/mBio.00465-15; Mousseau G, 2015, CURR TOP MICROBIOL, V389, P121, DOI 10.1007/82_2015_435; Mousseau G, 2012, CELL HOST MICROBE, V12, P97, DOI 10.1016/j.chom.2012.05.016; Mylvaganam GH, 2015, CURR OPIN IMMUNOL, V35, P1, DOI 10.1016/j.coi.2015.05.001; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; OLSEN HS, 1992, J VIROL, V66, P5594, DOI 10.1128/JVI.66.9.5594-5597.1992; Postler TS, 2012, J VIROL, V86, P1145, DOI 10.1128/JVI.06463-11; Razooky BS, 2015, CELL, V160, P990, DOI 10.1016/j.cell.2015.02.009; Rong LB, 2009, J THEOR BIOL, V260, P308, DOI 10.1016/j.jtbi.2009.06.011; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; SOUTHGATE C, 1990, NATURE, V345, P640, DOI 10.1038/345640a0; Sperandio S, 2015, P NATL ACAD SCI USA, V112, pE3392, DOI 10.1073/pnas.1500857112; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; TILEY LS, 1992, GENE DEV, V6, P2077, DOI 10.1101/gad.6.11.2077; TOOHEY MG, 1989, GENE DEV, V3, P265, DOI 10.1101/gad.3.3.265; Van Lint C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-67; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	54	15	16	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8280	8293		10.1096/fj.201801165R	http://dx.doi.org/10.1096/fj.201801165R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	31021670	Green Published			2022-12-28	WOS:000476234700039
J	Kenawi, M; Rouger, E; Island, ML; Leroyer, P; Robin, F; Remy, S; Tesson, L; Anegon, I; Nay, K; Derbre, F; Brissot, P; Ropert, M; Cavey, T; Loreal, O				Kenawi, Moussa; Rouger, Emmanuel; Island, Marie-Laure; Leroyer, Patricia; Robin, Francois; Remy, Severine; Tesson, Laurent; Anegon, Ignacio; Nay, Kevin; Derbre, Frederic; Brissot, Pierre; Ropert, Martine; Cavey, Thibault; Loreal, Olivier			Ceruloplasmin deficiency does not induce macrophagic iron overload: lessons from a new rat model of hereditary aceruloplasminemia	FASEB JOURNAL			English	Article						hepcidin; CRISPR/Cas9; genetic disease; metals; hepatocyte	GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED FORM; MESSENGER-RNA EXPRESSION; TRANSFERRIN RECEPTOR 2; BRAIN IRON; FERROXIDASE ACTIVITY; COPPER INCORPORATION; SERUM CERULOPLASMIN; HEPCIDIN; METABOLISM; HFE	Hereditary aceruloplasminemia (HA), related to mutations in the ceruloplasmin (Cp) gene, leads to iron accumulation. Ceruloplasmin ferroxidase activity being considered essential for macrophage iron release, macrophage iron overload is expected, but it is not found in hepatic and splenic macrophages in humans. Our objective was to get a better understanding of the mechanisms leading to iron excess in HA. A clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR associated protein 9 (Cas9) knockout of the Cp gene was performed on Sprague-Dawley rats. We evaluated the iron status in plasma, the expression of iron metabolism genes, and the status of other metals whose interactions with iron are increasingly recognized. In Cp-/- rats, plasma ceruloplasmin and ferroxidase activity were absent, together with decreased iron concentration and transferrin saturation. Similarly as in humans, the hepatocytes were iron overloaded conversely to hepatic and splenic macrophages. Despite a relative hepcidin deficiency in Cp-/- rats and the loss of ferroxidase activity, potentially expected to limit the interaction of iron with transferrin, no increase of plasma non-transferrin-bound iron level was found. Copper was decreased in the spleen, whereas manganese was increased in the plasma. These data suggest that the reported role of ceruloplasmin cannot fully explain the iron hepatosplenic phenotype in HA, encouraging the search for additional mechanisms.	[Kenawi, Moussa; Rouger, Emmanuel; Island, Marie-Laure; Leroyer, Patricia; Robin, Francois; Brissot, Pierre; Ropert, Martine; Cavey, Thibault; Loreal, Olivier] Univ Rennes, Ctr Hosp Univ CHU Pontchaillou, Inst NuMeCan Nutr Metab & Canc,UMR 1241, INSERM,INRA,Platform Anal Elementaire & Metab Met, Rennes, France; [Remy, Severine; Tesson, Laurent; Anegon, Ignacio] INSERM, UMR 1064, CRTI, Transgen Rats ImmunoPhen Facil, Nantes, France; [Nay, Kevin; Derbre, Frederic] Univ Rennes 2, Ecole Normale Super ENS Rennes, Lab Movement Sport & Hlth Sci M2S EA7470, Bruz, France	CHU Rennes; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Rennes 2	Loreal, O (corresponding author), H op Pontchaillou, Inst NuMeCan, INSERM, UMR 1241, F-35033 Rennes, France.	olivier.loreal@univ-rennes1.fr	Anegon, Ignacio/I-7760-2018; ROBIN, François/AAH-1986-2021; Loreal, Olivier/G-3366-2013; Derbre, Frederic/R-8776-2017	Loreal, Olivier/0000-0002-7428-3766; Nay, Kevin/0000-0003-0859-992X; Derbre, Frederic/0000-0002-1531-6425; Martine, Ropert/0000-0003-1227-9427	Fondation Maladies Rares; Region Bretagne; INSERM; Association Fer et Metaux Essentiels et Recherche en Sante (AFEMERS); Transgenese pour les Etudes Fonctionnelles sur les Organismes Mod`eles (TEFOR) project - Investissements d'Avenir French Government Program [ANRII-INSB-0014]; Labex Immunotherapy Grand Ouest (IGO) project part of the Investissements d'Avenir French Government Program [ANR-11-LABX-0016-01]; Institut Hospitalo Universitaire (IHU-Cesti) project part of the Investissements d'Avenir French Government Program [ANR-10-IBHU-005]; Nantes Metropole; Region Pays de la Loire; UMR7196 TacGene [U1154]	Fondation Maladies Rares; Region Bretagne(Region Bretagne); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Fer et Metaux Essentiels et Recherche en Sante (AFEMERS); Transgenese pour les Etudes Fonctionnelles sur les Organismes Mod`eles (TEFOR) project - Investissements d'Avenir French Government Program(French National Research Agency (ANR)); Labex Immunotherapy Grand Ouest (IGO) project part of the Investissements d'Avenir French Government Program(French National Research Agency (ANR)); Institut Hospitalo Universitaire (IHU-Cesti) project part of the Investissements d'Avenir French Government Program(French National Research Agency (ANR)); Nantes Metropole(Region Pays de la Loire); Region Pays de la Loire(Region Pays de la Loire); UMR7196 TacGene	This work was supported by the Fondation Maladies Rares, Region Bretagne (to M.K.), INSERM, and Association Fer et Metaux Essentiels et Recherche en Sante (AFEMERS). This work was partially supported by the Transgenese pour les Etudes Fonctionnelles sur les Organismes Mod`eles (TEFOR) project funded by the Investissements d'Avenir French Government Program (ANRII-INSB-0014) and also a member of Celphedia infrastructure. This work was realized in the context of the Labex Immunotherapy Grand Ouest (IGO) project (ANR-11-LABX-0016-01) and the Institut Hospitalo Universitaire (IHU-Cesti) project (ANR-10-IBHU-005), both of which are part of the Investissements d'Avenir French Government Program. The IHU-Cesti Project is also supported by Nantes Metropole and Region Pays de la Loire. The authors thank the U1154-UMR7196 TacGene for design and production of the single guide RNA4.	Armitage AE, 2011, BLOOD, V118, P4129, DOI 10.1182/blood-2011-04-351957; BACON BR, 1983, J CLIN INVEST, V71, P429, DOI 10.1172/JCI110787; Bosio S, 2002, BLOOD, V100, P2246, DOI 10.1182/blood-2002-02-0584; Breuer W, 2001, ANAL BIOCHEM, V299, P194, DOI 10.1006/abio.2001.5378; Brissot P, 2016, J HEPATOL, V64, P505, DOI 10.1016/j.jhep.2015.11.009; Brissot P, 2012, BBA-GEN SUBJECTS, V1820, P403, DOI 10.1016/j.bbagen.2011.07.014; Brower Marcia, 2015, Lab Anim Res, V31, P166, DOI 10.5625/lar.2015.31.4.166; Canonne-Hergaux F, 1999, BLOOD, V93, P4406, DOI 10.1182/blood.V93.12.4406.412k21_4406_4417; CARTWRIGHT GE, 1964, AM J CLIN NUTR, V14, P224, DOI 10.1093/ajcn/14.4.224; Cavey T, 2017, EXP PHYSIOL, V102, P291, DOI 10.1113/EP086188; Cavey T, 2015, BIOMETALS, V28, P733, DOI 10.1007/s10534-015-9862-8; Chen HJ, 2009, BIOMETALS, V22, P827, DOI 10.1007/s10534-009-9229-0; Chen L, 2007, J BIOL CHEM, V282, P5582, DOI 10.1074/jbc.M609273200; Cherukuri S, 2004, BLOOD CELL MOL DIS, V33, P346, DOI 10.1016/j.bcmd.2004.07.003; Cornejo P, 2005, NITRIC OXIDE-BIOL CH, V13, P54, DOI 10.1016/j.niox.2005.04.009; Courselaud B, 2004, BLOOD CELL MOL DIS, V32, P283, DOI 10.1016/j.bcmd.2003.11.003; De Domenico I, 2007, EMBO J, V26, P2823, DOI 10.1038/sj.emboj.7601735; De Domenico I, 2007, MOL BIOL CELL, V18, P2569, DOI 10.1091/mbc.E07-01-0060; De Domenico I, 2010, J CLIN INVEST, V120, P2395, DOI 10.1172/JCI42011; Dupic F, 2002, GUT, V51, P648, DOI 10.1136/gut.51.5.648; Dupic F, 2002, GASTROENTEROLOGY, V122, P745, DOI 10.1053/gast.2002.31877; Finkenstedt A, 2010, J HEPATOL, V53, P1101, DOI 10.1016/j.jhep.2010.04.039; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Fuqua BK, 2018, CELL MOL GASTROENTER, V6, P405, DOI 10.1016/j.jcmgh.2018.06.006; Gouya L, 2007, GASTROENTEROLOGY, V132, P679, DOI 10.1053/j.gastro.2006.11.024; Guo P, 2009, PEPTIDES, V30, P262, DOI 10.1016/j.peptides.2008.09.017; Harris ZL, 1999, P NATL ACAD SCI USA, V96, P10812, DOI 10.1073/pnas.96.19.10812; Hellman NE, 2002, J BIOL CHEM, V277, P46632, DOI 10.1074/jbc.M206246200; Huang H, 2009, BLOOD, V113, P3593, DOI 10.1182/blood-2008-08-173641; Ilyin G, 2003, FEBS LETT, V542, P22, DOI 10.1016/S0014-5793(03)00329-6; Jenkitkasemwong S, 2015, CELL METAB, V22, P138, DOI 10.1016/j.cmet.2015.05.002; Jiang RW, 2015, J NUTR, V145, P1003, DOI 10.3945/jn.114.207316; Kersten C, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-9; Kono S, 2006, GASTROENTEROLOGY, V131, P240, DOI 10.1053/j.gastro.2006.04.017; Kono S, 2010, BBA-MOL BASIS DIS, V1802, P968, DOI 10.1016/j.bbadis.2010.07.011; Laine F, 2002, J HEPATOL, V36, P60, DOI 10.1016/S0168-8278(01)00254-9; Li YQ, 2013, BIOMED ENVIRON SCI, V26, P808, DOI 10.3967/bes2013.004; Loreal O, 2002, J HEPATOL, V36, P851, DOI 10.1016/S0168-8278(02)00042-9; Loreal O, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00128; Marques L, 2012, BLOOD CELL MOL DIS, V48, P110, DOI 10.1016/j.bcmd.2011.11.005; Meyer LA, 2001, J BIOL CHEM, V276, P36857, DOI 10.1074/jbc.M105361200; Miyajima H, 2015, NEUROPATHOLOGY, V35, P83, DOI 10.1111/neup.12149; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Ogimoto M, 2011, INTERNAL MED, V50, P1415, DOI 10.2169/internalmedicine.50.5108; OSAKI S, 1966, J BIOL CHEM, V241, P2746; Patel BN, 2000, J BIOL CHEM, V275, P4305, DOI 10.1074/jbc.275.6.4305; Patel BN, 1997, J BIOL CHEM, V272, P20185, DOI 10.1074/jbc.272.32.20185; Pietrangelo A, 2004, BLOOD CELL MOL DIS, V32, P131, DOI 10.1016/j.bcmd.2003.08.003; Pietrangelo A, 2017, HAEMATOLOGICA, V102, P1972, DOI 10.3324/haematol.2017.170720; Piperno A, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00903; Poll M, 2010, HAEMATOL-HEMATOL J, V95, P1832, DOI 10.3324/haematol.2010.027003; Remy S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16328-y; Salaun E, 2016, J APPL PHYSIOL, V120, P178, DOI 10.1152/japplphysiol.00720.2015; SATO M, 1991, J BIOL CHEM, V266, P5128; Skidmore FM, 2008, J NEUROL NEUROSUR PS, V79, P467, DOI 10.1136/jnnp.2007.120568; SMITH AG, 1990, HEPATOLOGY, V12, P1399, DOI 10.1002/hep.1840120622; Tangudu NK, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12020070; Theurl I, 2008, BLOOD, V111, P2392, DOI 10.1182/blood-2007-05-090019; Tuttle AH, 2018, NAT METHODS, V15, P994, DOI 10.1038/s41592-018-0224-7; Wallace DF, 2009, HEPATOLOGY, V50, P1992, DOI 10.1002/hep.23198; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Yamamoto K, 2002, BBA-MOL BASIS DIS, V1588, P195, DOI 10.1016/S0925-4439(02)00165-5; YANG F, 1986, P NATL ACAD SCI USA, V83, P3257, DOI 10.1073/pnas.83.10.3257; Young SP, 1997, FEBS LETT, V411, P93, DOI 10.1016/S0014-5793(97)00478-X; Zhang AS, 2004, BLOOD, V103, P1509, DOI 10.1182/blood-2003-07-2378; Zhang Y, 2014, FOOD FUNCT, V5, P1381, DOI 10.1039/c4fo00006d	66	11	11	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13492	13502		10.1096/fj.201901106R	http://dx.doi.org/10.1096/fj.201901106R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31560858	Green Submitted, Bronze			2022-12-28	WOS:000507466100036
J	Shamshoum, H; Medak, KD; Townsend, LK; Ashworth, KE; Bush, ND; Hahn, MK; Kemp, BE; Wright, DC				Shamshoum, Hesham; Medak, Kyle D.; Townsend, Logan K.; Ashworth, Kristen E.; Bush, Natasha D.; Hahn, Margaret K.; Kemp, Bruce E.; Wright, David C.			AMPK beta 1 activation suppresses antipsychotic-induced hyperglycemia in mice	FASEB JOURNAL			English	Article						olanzapine; A769662; liver; glucose; lipids	PROTEIN-KINASE; INSULIN-RESISTANCE; LOADING CONTROL; 2ND-GENERATION ANTIPSYCHOTICS; GLUCOSE-HOMEOSTASIS; SKELETAL-MUSCLE; OLANZAPINE; METABOLISM; WEIGHT; ACTIN	Olanzapine (OLZ) is a second-generation antipsychotic that is used to treat schizophrenia but also causes acute hyperglycemia. This study aimed to determine if the ablation of AMPK beta 1-containing complexes potentiates acute OLZ-induced metabolic dysfunction and if the activation of AMPK beta 1 suppresses these effects. Female AMPK beta 1(-/-) or wild-type (WT) control mice were treated with OLZ, and changes in blood glucose, serum and liver metabolites, whole-body fuel oxidation, and pyruvate-induced increases in blood glucose were measured. Additionally, WT mice were cotreated with OLZ and A769662, a specific AMPK beta 1 activator, and we determined if cotreatment protected against acute, OLZ-induced metabolic dysfunction. OLZ-induced increases in blood glucose were exacerbated in AMPK beta 1 mice compared with WT mice, and this was paralleled by greater OLZ-induced increases in markers of liver glucose production, such as pyruvate tolerance, serum glucagon, and glucagon responsiveness. Cotreatment with A769662 attenuated OLZ-induced increases in blood glucose, serum nonesterified fatty acid, and glycerol. Furthermore, this effect was absent in AMPK beta 1(-/-) mice, consistent with A769662's specificity for the AMPK beta 1 subunit. Reductions in AMPK activity potentiate the effects of acute OLZ treatment on blood glucose, whereas specifically targeting AMPK beta 1-containing complexes is sufficient to protect against OLZ-induced hyperglycemia.	[Shamshoum, Hesham; Medak, Kyle D.; Townsend, Logan K.; Ashworth, Kristen E.; Wright, David C.] Univ Guelph, Dept Human Hlth & Nutr Sci, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada; [Bush, Natasha D.] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Hahn, Margaret K.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Kemp, Bruce E.] Univ Melbourne, St Vincents Inst, Dept Med, Melbourne, Vic, Australia; [Kemp, Bruce E.] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Fitzroy, Vic, Australia	University of Guelph; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; St. Vincent's Institute of Medical Research; University of Melbourne; Australian Catholic University	Wright, DC (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	dcwright@uoguelph.ca	Kemp, Bruce/G-9602-2019	Kemp, Bruce/0000-0001-6735-5082; Hahn, Margaret/0000-0001-8884-9946; Wright, David/0000-0003-3867-8901	Canadian Institutes of Health Research (CIHR); Ontario Graduate Scholarship; Dairy Farmers of Ontario Doctoral Research Assistantship; Natural Sciences and Engineering Research Council of Canada (NSERC) Postgraduate Scholarship; Australian Research Council [DP170101196]; NHMRC [APP1085460]; University of Guelph	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Dairy Farmers of Ontario Doctoral Research Assistantship; Natural Sciences and Engineering Research Council of Canada (NSERC) Postgraduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of Guelph	This work was funded by a Canadian Institutes of Health Research (CIHR) grant to D.C.W., who is a Tier II Canada Research Chair in Lipids, Metabolism, and Health. H.S. was supported by an Ontario Graduate Scholarship. L.K.T. was supported by a Dairy Farmers of Ontario Doctoral Research Assistantship and a Natural Sciences and Engineering Research Council of Canada (NSERC) Postgraduate Scholarship. B.E.K. is a National Health and Medical Research Council of Australia Fellow supported by the Australian Research Council (DP170101196 and NHMRC, APP1085460). K.E.A. was supported by the University of Guelph President's Scholarship. The authors declare no conflicts of interest.	Albaugh VL, 2012, SCHIZOPHRENIA BULL, V38, P153, DOI 10.1093/schbul/sbq053; Albaugh VL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022662; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Boyda HN, 2012, J PSYCHIATR NEUROSCI, V37, P407, DOI 10.1503/jpn.110140; Bush ND, 2018, J PHARMACOL EXP THER, V365, P526, DOI 10.1124/jpet.118.248393; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; CARLING D, 1994, J BIOL CHEM, V269, P11442; Castellani LN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19260-x; Castellani LN, 2017, PSYCHONEUROENDOCRINO, V82, P38, DOI 10.1016/j.psyneuen.2017.05.005; Chintoh AF, 2009, SCHIZOPHR RES, V108, P127, DOI 10.1016/j.schres.2008.12.012; Coccurello R, 2009, J CLIN PSYCHOPHARM, V29, P576, DOI 10.1097/JCP.0b013e3181bfe13e; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Deng C, 2013, ENDOCRIN METAB CLIN, V42, P545, DOI 10.1016/j.ecl.2013.05.006; Dittmer A, 2006, ELECTROPHORESIS, V27, P2844, DOI 10.1002/elps.200500785; Divac N, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/656370; Dzamko N, 2010, J BIOL CHEM, V285, P115, DOI 10.1074/jbc.M109.056762; Gilda JE, 2013, ANAL BIOCHEM, V440, P186, DOI 10.1016/j.ab.2013.05.027; Graff-Guerrero A, 2015, JAMA PSYCHIAT, V72, P927, DOI 10.1001/jamapsychiatry.2015.0891; Hahn MK, 2013, J CLIN PSYCHOPHARM, V33, P740, DOI 10.1097/JCP.0b013e31829e8333; Han YM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08585-4; Hasenour CM, 2014, J BIOL CHEM, V289, P5950, DOI 10.1074/jbc.M113.528232; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hu YS, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093310, 10.1371/journal.pone.0093425, 10.1371/journal.pone.0092099]; Hughey CC, 2014, MAMM GENOME, V25, P522, DOI 10.1007/s00335-014-9533-z; Ikegami M, 2013, DIABETES OBES METAB, V15, P1128, DOI 10.1111/dom.12148; Jassim G, 2012, PSYCHOPHARMACOLOGY, V219, P783, DOI 10.1007/s00213-011-2397-y; Johanns M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10856; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kim SJ, 2016, MOL CELL BIOL, V36, P1961, DOI 10.1128/MCB.00244-16; Kjobsted R, 2015, DIABETES, V64, P2042, DOI 10.2337/db14-1402; Klingerman CM, 2014, SCHIZOPHRENIA BULL, V40, P327, DOI 10.1093/schbul/sbs196; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacPherson REK, 2014, AM J PHYSIOL-ENDOC M, V307, pE563, DOI 10.1152/ajpendo.00287.2014; Maher AR, 2011, JAMA-J AM MED ASSOC, V306, P1359, DOI 10.1001/jama.2011.1360; Mattiuz E, 1997, DRUG METAB DISPOS, V25, P573; Miller Del D, 2004, Prim Care Companion J Clin Psychiatry, V6, P3; MITCHELHILL KI, 1994, J BIOL CHEM, V269, P2361; Mottillo EP, 2016, CELL METAB, V24, P118, DOI 10.1016/j.cmet.2016.06.006; Navari RM, 2016, NEW ENGL J MED, V375, P134, DOI 10.1056/NEJMoa1515725; Oakhill JS, 2012, TRENDS ENDOCRIN MET, V23, P125, DOI 10.1016/j.tem.2011.12.006; Peppler WT, 2018, AM J PHYSIOL-ENDOC M, V314, pE66, DOI 10.1152/ajpendo.00226.2017; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; Pringsheim Tamara, 2014, CMAJ Open, V2, pE225, DOI 10.9778/cmajo.20140009; Procyshyn RM, 2010, J CLIN PSYCHIAT, V71, P566, DOI 10.4088/JCP.08m04912gre; Remington GJ, 2015, J ENDOCRINOL, V227, P71, DOI 10.1530/JOE-15-0074; Rojo LE, 2015, PHARMACOL RES, V101, P74, DOI 10.1016/j.phrs.2015.07.022; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Sharpley AL, 2005, J CLIN PSYCHIAT, V66, P450, DOI 10.4088/JCP.v66n0407; Smith BK, 2017, CURR OPIN CLIN NUTR, V20, P248, DOI 10.1097/MCO.0000000000000380; Smith BK, 2016, DIABETES, V65, P3352, DOI 10.2337/db16-0564; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Souza RP, 2012, J PSYCHIATR RES, V46, P462, DOI 10.1016/j.jpsychires.2012.01.010; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; STEELE R, 1971, AM J PHYSIOL, V221, P883, DOI 10.1152/ajplegacy.1971.221.3.883; Takeuchi Y, 2015, DRUG SAFETY, V38, P641, DOI 10.1007/s40264-015-0298-4; Thornton C, 1998, J BIOL CHEM, V273, P12443, DOI 10.1074/jbc.273.20.12443; Townsend LK, 2018, PSYCHONEUROENDOCRINO, V88, P121, DOI 10.1016/j.psyneuen.2017.12.004; Wan ZX, 2014, OBESITY, V22, P730, DOI 10.1002/oby.20605; Watt MJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE500, DOI 10.1152/ajpendo.00361.2005; Wirshing DA, 1999, J CLIN PSYCHIAT, V60, P358, DOI 10.4088/JCP.v60n0602	62	9	9	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14010	14021		10.1096/fj.201901820R	http://dx.doi.org/10.1096/fj.201901820R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31581839				2022-12-28	WOS:000507466100073
J	Lee, HS; Hua, HS; Wang, CH; Yu, MC; Chen, BC; Lin, CH				Lee, Hong-Sheng; Hua, Hung-Sheng; Wang, Cheng-Hui; Yu, Ming-Chih; Chen, Bing-Chang; Lin, Chien-Huang			Mycobacterium tuberculosis induces connective tissue growth factor expression through the TLR2-JNK-AP-1 pathway in human lung fibroblasts	FASEB JOURNAL			English	Article						M.tb; CTGF; HLFs	NF-KAPPA-B; INNATE IMMUNITY; P38 MAPK; COLLAGEN; CTGF; ACTIVATION; SECRETION; REQUIRES; AP-1; CCN2	Mycobacterium tuberculosis (M.tb) infection in lung causes pulmonary fibrosis, which leads to the irreversible reduction of pulmonary function. Fibrotic protein connective tissue growth factor (CTGF) expression has been confirmed to play a crucial role in lung fibrosis. However, the underlying signal pathway and effect of M.tb on CTGF expression in human lung fibroblasts are unclear. Our results revaled that M.tb caused time- and concentration-dependent increases in CTGF expression in human lung fibroblasts. A mechanistic investigation revealed that M.tb induced CTGF expression through TLR2 but not TLR4. The promoter activity assay indicated that M.tb-induced CTGF activity was mainly controlled by the promoter region at -747 to -184 bp, which contained signal transducer and activator of transcription 3 and activator protein 1 (AP-1) binding sites. Moreover, curcumin (AP-1 inhibitor) restrained M.tb-induced CTGF expression. M.tb also induced increases in AP-1 luciferase activity and DNA binding activity of c-Jun and c-Fos on the CTGF promoter. Furthermore, the knockdown of c-Jun by small interfering RNA attenuated M.tb-induced CTGF expression and AP-1 luciferase activity. A JNK inhibitor (SP600125) and a JNK dominant-negative mutant suppressed M.tb-induced CTGF expression. We also discovered that M.tb could induce the phosphorylation of JNK and c-Jun. Furthermore, SP600125 inhibited M.tb-induced c-Jun phosphorylation and AP-1-luciferase activity. M.tb-induced fibronectin expression was inhibited by anti-CTGF antibody. These results demonstrate that M.tb is activated through TLR2 to induce JNK activation, further increasing the DNA binding activity of c-Jun and c-Fos and finally inducing CTGF expression and extracellular matrix production.	[Lee, Hong-Sheng; Hua, Hung-Sheng; Lin, Chien-Huang] Taipei Med Univ, Wanfang Hosp, Grad Inst Med Sci, Taipei, Taiwan; [Yu, Ming-Chih; Chen, Bing-Chang] Taipei Med Univ, Wanfang Hosp, Sch Resp Therapy, Taipei, Taiwan; [Chen, Bing-Chang] Taipei Med Univ, Wanfang Hosp, Dept Internal Med, Sch Med,Coll Med, Taipei, Taiwan; [Wang, Cheng-Hui] Taipei Med Univ, Wanfang Hosp, Dept Lab Med, Taipei, Taiwan; [Wang, Cheng-Hui; Yu, Ming-Chih] Taipei Med Univ, Wanfang Hosp, Pulm Res Ctr, Taipei, Taiwan; [Yu, Ming-Chih] Taipei Med Univ, Wanfang Hosp, Div Pulm Med, Dept Internal Med, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital	Chen, BC (corresponding author), Taipei Med Univ, Sch Resp Therapy, Coll Med, 250 Wu Hsing St, Taipei 11031, Taiwan.; Lin, CH (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Coll Med, 250 Wu Hsing St, Taipei 110, Taiwan.	bcchen@tmu.edu.tw; chlin@tmu.edu.tw		Lin, Chien-Huang/0000-0002-0916-8737	Taiwan Ministry of Science and Technology [MOST-101-2320-B-038-024-MY3]	Taiwan Ministry of Science and Technology	' This study was supported by the Taiwan Ministry of Science and Technology (MOST-101-2320-B-038-024-MY3). The authors declare no conflicts of interest.	Bai KJ, 2013, J LEUKOCYTE BIOL, V93, P101, DOI 10.1189/jlb.0911449; Bauer AK, 2005, J NATL CANCER I, V97, P1778, DOI 10.1093/jnci/dji403; Black SA, 2007, J BIOL CHEM, V282, P15416, DOI 10.1074/jbc.M610432200; Blom IE, 2001, J CLIN PATHOL-MOL PA, V54, P192, DOI 10.1136/mp.54.3.192; Bozinovski S, 2002, J BIOL CHEM, V277, P42808, DOI 10.1074/jbc.M207840200; Chang Y, 2010, MOL CELL BIOCHEM, V335, P83, DOI 10.1007/s11010-009-0245-8; Chen BC, 2004, J BIOL CHEM, V279, P20889, DOI 10.1074/jbc.M311279200; Chen WL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137979; Chiou MJ, 2006, BIOCHEM BIOPH RES CO, V349, P750, DOI 10.1016/j.bbrc.2006.08.095; Chu Arthur J., 2014, Inflammation & Allergy Drug Targets, V13, P34; Dheda K, 2005, J INFECT DIS, V192, P1201, DOI 10.1086/444545; Driessche KV, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/781320; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Ferrer Sancho J, 1996, Curr Opin Pulm Med, V2, P327; Fu Jian-Hua, 2011, Zhongguo Dang Dai Er Ke Za Zhi, V13, P36; Gu J, 2012, EXP CELL RES, V318, P2105, DOI 10.1016/j.yexcr.2012.06.015; Harris JE, 2007, J LEUKOCYTE BIOL, V81, P548, DOI 10.1189/jlb.0806512; Huang Min, 2010, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V28, P729; Kawasaki H, 1997, Tanpakushitsu Kakusan Koso, V42, P424; Kendall RT, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00123; Khalil N, 2005, J BIOL CHEM, V280, P43000, DOI 10.1074/jbc.M510441200; Ko WC, 2012, ACTA PHARMACOL SIN, V33, P49, DOI 10.1038/aps.2011.178; Lin CH, 2013, BBA-MOL CELL RES, V1833, P2823, DOI 10.1016/j.bbamcr.2013.07.016; Lin CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085354; Lipson KE, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S24; Liu SX, 2011, ARTHRITIS RHEUM-US, V63, P239, DOI 10.1002/art.30074; Marshall BG, 1996, THORAX, V51, P1253, DOI 10.1136/thx.51.12.1253; Matsui F, 2013, AM J PHYSIOL-RENAL, V305, pF1014, DOI 10.1152/ajprenal.00620.2012; Moussad EEDA, 2000, MOL GENET METAB, V71, P276, DOI 10.1006/mgme.2000.3059; Mun JH, 2014, WOUND REPAIR REGEN, V22, P125, DOI 10.1111/wrr.12136; O'Kane CM, 2007, J IMMUNOL, V178, P3767, DOI 10.4049/jimmunol.178.6.3767; O'Kane CM, 2010, AM J RESP CELL MOL, V43, P465, DOI 10.1165/rcmb.2009-0211OC; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Ryffel B, 2005, TUBERCULOSIS, V85, P395, DOI 10.1016/j.tube.2005.08.021; Simmons DP, 2010, J IMMUNOL, V185, P2405, DOI 10.4049/jimmunol.0904005; Sullivan DE, 2009, J CELL MOL MED, V13, P1866, DOI 10.1111/j.1582-4934.2009.00647.x; Tall EG, 2010, INVEST OPHTH VIS SCI, V51, P5002, DOI 10.1167/iovs.09-5110; Tao L, 2010, MOL MED REP, V3, P941, DOI 10.3892/mmr.2010.349; van Almen GC, 2011, AGING CELL, V10, P769, DOI 10.1111/j.1474-9726.2011.00714.x; Van Beek JP, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1890; Wang CY, 2014, J FORMOS MED ASSOC, V113, P50, DOI 10.1016/j.jfma.2012.04.004; Wang QJ, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-4; Weng CM, 2014, BIOCHEM PHARMACOL, V88, P402, DOI 10.1016/j.bcp.2014.01.030; Wickremasinghe MI, 2004, J BIOL CHEM, V279, P27199, DOI 10.1074/jbc.M403107200; Worrall JAR, 2011, FEBS J, V278, P663, DOI 10.1111/j.1742-4658.2010.07988.x; Xia W, 2007, ANN SURG, V246, P886, DOI 10.1097/SLA.0b013e318070d54f; Yu CC, 2009, J IMMUNOL, V182, P7916, DOI 10.4049/jimmunol.0801582; Yu XW, 2014, BIOCHIMIE, V102, P1, DOI 10.1016/j.biochi.2014.02.012	48	9	10	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12554	12564		10.1096/fj.201900487R	http://dx.doi.org/10.1096/fj.201900487R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31451010	Green Published			2022-12-28	WOS:000507461600074
J	Liu, Y; Liu, QL; Chen, SM; Liu, YJ; Huang, YM; Chen, P; Li, XY; Gao, G; Xu, KQ; Fan, SQ; Zeng, ZY; Xiong, W; Tan, M; Li, GY; Zhang, WL				Liu, Yi; Liu, Qingluan; Chen, Shumin; Liu, Yijun; Huang, Yumei; Chen, Pan; Li, Xiayu; Gao, Ge; Xu, Keqian; Fan, Songqing; Zeng, Zhaoyang; Xiong, Wei; Tan, Ming; Li, Guiyuan; Zhang, Wenling			APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling	FASEB JOURNAL			English	Article						all-trans-RA; prognosis; proliferation; metastasis	TRANS-RETINOIC ACID; GELATINASE-ASSOCIATED LIPOCALIN; ACUTE PROMYELOCYTIC LEUKEMIA; APELIN; EXPRESSION; RECEPTOR; CANCER; METASTASIS; PROMOTES; TISSUE	The apelin receptor (APLNR) is a GPCR involved in many pathophysiological processes; however, the correlation between APLNR expression and nasopharyngeal carcinoma (NPC) has not been reported. In this study, we used cDNA microarray data to determine APLNR expression levels in NPC tissues. We found that APLNR expression was reduced in NPC tissues compared with noncancerous nasopharyngeal epithelial tissues. Subsequently, a large-scale sample of 1015 tissues was used to validate this discovery and explore the relationship between APLNR expression and prognosis of NPC. Expression levels of APLNR in NPC tissues were indeed down-regulated. Furthermore, positive expression of APLNR in NPC predicted a better prognosis (disease-free survival: P = 0.001; overall survival: P < 0.001). Moreover, ingenuity pathway analysis revealed that an indirect interaction existed between APLNR and retinoic acid (RA) in the cancer regulatory network. Consistently, after treatment with all-trans-RA (ATRA), we found that APLNR was significantly up-regulated in NPC cell lines (5-8F and HNE1), and proliferation of NPC cells was inhibited. Cell cycle arrest occurred in the G(0)/G(1) phase. In contrast, knockdown of APLNR diminished ATRA-induced growth inhibition of NPC cells. In addition, we surprisingly found that APLNR also played an important role in migration and invasion of NPC. Wound-healing and Transwell assays revealed that APLNR overexpression led to reduced migratory and invasive properties in 2 NPC cell lines. Western blot results revealed that hallmarks of epithelial-mesenchymal transition (EMT) were altered as well, suggesting that APLNR was capable of inhibiting EMT in NPC cells. Our study further demonstrated that low expression of APLNR promoted EMT in NPC cells by activating the PI3K-protein kinase B-mammalian target of rapamycin signaling pathway. Taken together, our data suggest that APLNR could potentially predict prognosis for patients with NPC and inhibit proliferation, migration, invasion, and EMT in nasopharyngeal cancer cells.	[Liu, Yi; Liu, Qingluan; Liu, Yijun; Huang, Yumei; Gao, Ge; Xu, Keqian; Zhang, Wenling] Cent South Univ, Xiangya Hosp 3, Dept Med Lab Sci, Tongzipo Rd 172, Changsha 410013, Hunan, Peoples R China; [Chen, Pan] Cent South Univ, Affiliated Canc Hosp Xiangya, Sch Med, Hunan Canc Hosp, Changsha, Peoples R China; [Li, Xiayu; Zeng, Zhaoyang; Xiong, Wei; Tan, Ming; Li, Guiyuan] Cent South Univ, Chinese Minist Educ, Canc Res Inst, Key Lab Carcinogenesis & Canc Invas, Changsha, Peoples R China; [Fan, Songqing] Cent South Univ, Xiangya Hosp 2, Dept Pathol, Changsha, Peoples R China; [Chen, Shumin] Peking Univ, Peoples Hosp, Dept Hematol, Beijing, Peoples R China; [Tan, Ming] Univ S Alabama, USA Hlth, Mitchell Canc Inst, Mobile, AL 36688 USA	Central South University; Central South University; Central South University; Central South University; Peking University; University of South Alabama	Zhang, WL (corresponding author), Cent South Univ, Xiangya Hosp 3, Dept Med Lab Sci, Tongzipo Rd 172, Changsha 410013, Hunan, Peoples R China.	zhangwenling73@126.com	Tan, Ming/ABD-5847-2021; li, xia/HHZ-7468-2022	Tan, Ming/0000-0003-2007-9898; 	National Natural Science Foundation of China [81672688, 81372907, 81472531, 81472595, 81672683, 81772928]; Central South University Innovation Foundation for Postgraduates [2018zzts881]; Natural Science Foundation of Hunan Province [2019JJ50359]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central South University Innovation Foundation for Postgraduates; Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province)	This study was supported by grants from the National Natural Science Foundation of China (81672688, 81372907, 81472531, 81472595, 81672683, and 81772928), the Central South University Innovation Foundation for Postgraduates (2018zzts881), and the Natural Science Foundation of Hunan Province (Grant 2019JJ50359). The authors declare no conflicts of interest.	Akcilar R, 2015, INT J CLIN EXP MED, V8, P18793; Berta J, 2014, ONCOTARGET, V5, P4426, DOI 10.18632/oncotarget.2032; Brabletz T, 2012, CANCER CELL, V22, P699, DOI 10.1016/j.ccr.2012.11.009; Bulbul M, 2016, AM J PHYSIOL-GASTR L, V310, pG249, DOI 10.1152/ajpgi.00145.2015; Cai LM, 2015, ONCOGENE, V34, P2156, DOI 10.1038/onc.2014.341; Chapman NA, 2014, BIOCHEM CELL BIOL, V92, P431, DOI 10.1139/bcb-2014-0072; Chaves-Almagro C, 2015, EUR J PHARMACOL, V763, P149, DOI 10.1016/j.ejphar.2015.05.017; Chiang KC, 2016, SCI REP-UK, V6, DOI 10.1038/srep36138; Chng SC, 2013, DEV CELL, V27, P672, DOI 10.1016/j.devcel.2013.11.002; Chua MLK, 2016, LANCET, V387, P1012, DOI 10.1016/S0140-6736(15)00055-0; Cudnoch-Jedrzejewska A, 2015, CLIN EXP PHARMACOL P, V42, P52, DOI 10.1111/1440-1681.12324; Dey Biswajit, 2015, Middle East J Dig Dis, V7, P220; Fan SQ, 2006, HUM PATHOL, V37, P593, DOI 10.1016/j.humpath.2006.01.010; Hall C, 2017, CANCER LETT, V386, P179, DOI 10.1016/j.canlet.2016.11.025; Han MY, 2018, CELL PHYSIOL BIOCHEM, V50, P694, DOI 10.1159/000494236; Hwangbo C, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aad4000; Kalin RE, 2007, DEV BIOL, V305, P599, DOI 10.1016/j.ydbio.2007.03.004; Kong H, 2016, ONCOL REP, V35, P1868, DOI 10.3892/or.2015.4535; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28906-9; Lim R, 2007, INT J CANCER, V120, P2426, DOI 10.1002/ijc.22352; Lin YZ, 2018, CANCER MANAG RES, V10, P4191, DOI 10.2147/CMAR.S178219; Liu F, 2018, GENE, V676, P269, DOI 10.1016/j.gene.2018.08.060; Liu L, 2018, EXP CELL RES, V362, P532, DOI 10.1016/j.yexcr.2017.12.019; Liu WH, 2018, BIOMED PHARMACOTHER, V104, P94, DOI 10.1016/j.biopha.2018.05.015; Liu WJ, 2016, MOL MED REP, V13, P4221, DOI 10.3892/mmr.2016.5086; Lv XR, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00221; Martin N, 2014, TRENDS MOL MED, V20, P667, DOI 10.1016/j.molmed.2014.09.008; Martinez-Cuadron D, 2018, LEUKEMIA, V32, P21, DOI 10.1038/leu.2017.178; Masri Bernard, 2015, Med Sci (Paris), V31, P275, DOI 10.1051/medsci/20153103013; Murata K, 2016, J BIOL CHEM, V291, P11241, DOI 10.1074/jbc.M115.699009; Muto J, 2014, ANTICANCER RES, V34, P5313; Narayanan S, 2016, BIOORGAN MED CHEM, V24, P3758, DOI 10.1016/j.bmc.2016.06.018; Nellessen CM, 2018, ARCH GYNECOL OBSTET, V297, P281, DOI 10.1007/s00404-017-4583-6; Patrad E, 2018, CYTOTECHNOLOGY, V70, P865, DOI 10.1007/s10616-018-0199-3; Peng R, 2018, CANCER MED-US, V7, P796, DOI 10.1002/cam4.1313; Picault FX, 2014, EUR J CANCER, V50, P663, DOI 10.1016/j.ejca.2013.11.017; Salk JJ, 2010, ANNU REV PATHOL-MECH, V5, P51, DOI 10.1146/annurev-pathol-121808-102113; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Tong ZM, 2008, CANCER RES, V68, P6100, DOI 10.1158/0008-5472.CAN-08-0540; Wang JH, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-2; Watanabe M, 2009, J VET MED SCI, V71, P1413, DOI 10.1292/jvms.001413; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Xiao WW, 2011, CANCER-AM CANCER SOC, V117, P1874, DOI 10.1002/cncr.25754; Yang H, 2015, INT J SPORTS MED, V36, P535, DOI 10.1055/s-0034-1398653; Yang L, 2014, ACTA BIOCH BIOPH SIN, V46, P100, DOI 10.1093/abbs/gmt140; Yeh HW, 2018, NAT CELL BIOL, V20, P479, DOI 10.1038/s41556-018-0062-y; Zeng Z, 2016, CLIN TRANSL ONCOL, V18, P206, DOI 10.1007/s12094-015-1354-3; Zeng ZY, 2007, HUM PATHOL, V38, P120, DOI 10.1016/j.humpath.2006.06.023; Zeng ZY, 2007, J CANCER RES CLIN, V133, P71, DOI 10.1007/s00432-006-0136-2; Zhang HY, 2014, J CELL MOL MED, V18, P542, DOI 10.1111/jcmm.12208; Zhang WL, 2014, FEBS J, V281, P4815, DOI 10.1111/febs.13020; Zhang WL, 2013, J MOL HISTOL, V44, P545, DOI 10.1007/s10735-013-9503-x; Zhang WL, 2012, J MOL HISTOL, V43, P297, DOI 10.1007/s10735-012-9392-4; Zhang Y, 2012, CANCER EPIDEMIOL, V36, pE294, DOI 10.1016/j.canep.2012.05.012; Zhong JC, 2005, CARDIOVASC RES, V65, P743, DOI 10.1016/j.cardiores.2004.10.020; Zong JF, 2016, CHIN CLIN ONCOL, V5, DOI 10.21037/cco.2016.03.04	57	19	19	1	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11959	11972		10.1096/fj.201802416RR	http://dx.doi.org/10.1096/fj.201802416RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31408612				2022-12-28	WOS:000507461600029
J	Higgins, CE; Tang, JQ; Mian, BM; Higgins, SP; Gifford, CC; Conti, DJ; Meldrum, KK; Samarakoon, R; Higgins, PJ				Higgins, Craig E.; Tang, Jiaqi; Mian, Badar M.; Higgins, Stephen P.; Gifford, Cody C.; Conti, David J.; Meldrum, Kirstan K.; Samarakoon, Rohan; Higgins, Paul J.			TGF-beta 1-p53 cooperativity regulates a profibrotic genomic program in the kidney: molecular mechanisms and clinical implications	FASEB JOURNAL			English	Review						renal disease; fibrosis; SMADs; gene expression; PAI-1	PLASMINOGEN-ACTIVATOR INHIBITOR-1; TOLL-LIKE RECEPTORS; ACUTE-RENAL-FAILURE; CELL-CYCLE ARREST; TGF-BETA; TUMOR-SUPPRESSOR; TRANSCRIPTIONAL REGULATION; FIBROBLAST ACTIVATION; GENE-TRANSCRIPTION; TARGET GENES	Chronic kidney disease affects >15% of the U.S. population and >850 million individuals worldwide. Fibrosis is the common outcome of many chronic renal disorders and, although the etiology varies (i.e., diabetes, hypertension, ischemia, acute injury, and urologic obstructive disorders), persistently elevated renal TGF-beta 1 levels result in the relentless progression of fibrotic disease. TGF-beta 1 orchestrates the multifaceted program of renal fibrogenesis involving proximal tubular dysfunction, failed epithelial recovery and redifferentiation, and subsequent tubulointerstitial fibrosis, eventually leading to chronic renal disease. Recent findings implicate p53 as a cofactor in the TGF-beta 1-induced signaling pathway and a transcriptional coregulator of several TGF-beta 1 profibrotic response genes by complexing with receptor-activated SMADs, which are homologous to the small worms (SMA) and Drosophilia mothers against decapentaplegic (MAD) gene families. The cooperative p53-TGF-beta 1 genomic cluster includes genes involved in cell growth control and extracellular matrix remodeling [e.g., plasminogen activator inhibitor-1 (PAI-1; serine protease inhibitor, clade E, member 1), connective tissue growth factor, and collagen I]. Although the molecular basis for this codependency is unclear, many TGF-beta 1-responsive genes possess p53 binding motifs. p53 up-regulation and increased p53 phosphorylation; moreover, they are evident in nephrotoxin- and ischemia/reperfusion-induced injury, diabetic nephropathy, ureteral obstructive disease, and kidney allograft rejection. Pharmacologic and genetic approaches that target p53 attenuate expression of the involved genes and mitigate the fibrotic response, confirming a key role for p53 in renal disorders. This review focuses on mechanisms whereby p53 functions as a transcriptional regulator within the TGF-beta 1 cluster with an emphasis on the potent fibrosis-promoting PAI-1 gene.-Higgins, C. E., Tang, J., Mian, B. M., Higgins, S. P., Gifford, C. C., Conti, D. J., Meldrum, K. K., Samarakoon, R., Higgins, P. J. TGF-beta 1-p53 cooperativity regulates a profibrotic genomic program in the kidney: molecular mechanisms and clinical implications.	[Higgins, Craig E.; Tang, Jiaqi; Higgins, Stephen P.; Gifford, Cody C.; Samarakoon, Rohan; Higgins, Paul J.] Albany Med Coll, Dept Regenerat & Canc Cell Biol, 47 New Scotland Ave, Albany, NY 12208 USA; [Mian, Badar M.; Higgins, Paul J.] Albany Med Coll, Dept Surg, Div Urol, Albany, NY 12208 USA; [Conti, David J.] Albany Med Coll, Div Transplantat Surg, Dept Surg, Albany, NY 12208 USA; [Mian, Badar M.; Higgins, Paul J.] Urol Inst Northeastern New York, Albany, NY USA; [Meldrum, Kirstan K.] Cent Michigan Univ, Div Pediat Urol, Mt Pleasant, MI 48859 USA	Albany Medical College; Albany Medical College; Albany Medical College; Central Michigan University	Higgins, PJ (corresponding author), Albany Med Coll, Dept Regenerat & Canc Cell Biol, 47 New Scotland Ave, Albany, NY 12208 USA.	higginp@amc.edu	Mian, Badar M/GYJ-4637-2022	Mian, Badar M/0000-0002-1698-9525; Tang, Jiaqi/0000-0002-3544-3456	U.S. National Institutes of Health, National Institute of General Medical Sciences [GM057242]; Roach Family Foundation; Graver Family Endowment; Friedman Cancer Research Fund; Butler Family Foundation	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Roach Family Foundation; Graver Family Endowment; Friedman Cancer Research Fund; Butler Family Foundation	This work was supported by grants from the U.S. National Institutes of Health, National Institute of General Medical Sciences (GM057242 to P.J.H.), the Roach Family Foundation, the Graver Family Endowment, the Friedman Cancer Research Fund, and The Butler Family Foundation. The authors declare no conflicts of interest.	Ali A, 2014, CANCER LETT, V354, P87, DOI 10.1016/j.canlet.2014.07.045; Allen RR, 2005, J CELL PHYSIOL, V203, P156, DOI 10.1002/jcp.20211; Anders HJ, 2014, J AM SOC NEPHROL, V25, P1387, DOI 10.1681/ASN.2014010117; Anorga S, 2018, FASEB J, V32, P2644, DOI 10.1096/fj.201700722R; Araki S, 2010, J CLIN INVEST, V120, P290, DOI 10.1172/JCI39194; Atfi A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.126pe33; Bagshaw SM, 2008, RENAL FAILURE, V30, P581, DOI 10.1080/08860220802134649; Basile DP, 2016, J AM SOC NEPHROL, V27, P687, DOI 10.1681/ASN.2015030309; Basile DP, 2004, CURR OPIN NEPHROL HY, V13, P1, DOI 10.1097/00041552-200401000-00001; Bonventre JV, 2010, CONTRIB NEPHROL, V165, P9, DOI 10.1159/000313738; Bouafia A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004309; Brennan EP, 2012, BBA-MOL BASIS DIS, V1822, P589, DOI 10.1016/j.bbadis.2012.01.008; Bryant CE, 2015, CRIT REV BIOCHEM MOL, V50, P359, DOI 10.3109/10409238.2015.1033511; Bu S, 2008, J BIOL CHEM, V283, P19593, DOI 10.1074/jbc.M802417200; Chang GS, 2014, CELL REP, V8, P513, DOI 10.1016/j.celrep.2014.06.030; Chang YG, 2017, J AM SOC NEPHROL, V28, P1998, DOI 10.1681/ASN.2015050585; Chang-Panesso M, 2017, NAT REV NEPHROL, V13, P39, DOI 10.1038/nrneph.2016.169; Chen L, 2018, BIOMED PHARMACOTHER, V101, P670, DOI 10.1016/j.biopha.2018.02.090; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Chung SJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.123563; Cook HT, 2010, AM J PATHOL, V176, P22, DOI 10.2353/ajpath.2010.090898; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; Czekay R.-P., 2018, ENCY SIGNALING MOL, P4902; Czekay Ralf-Peter, 2011, Int J Cell Biol, V2011, P562481, DOI 10.1155/2011/562481; Das F, 2008, J CELL PHYSIOL, V214, P513, DOI 10.1002/jcp.21236; Ding X, 2015, CURR MOL MED, V15, P368, DOI 10.2174/1566524015666150505162015; Du XX, 2018, CURR MED SCI, V38, P455, DOI 10.1007/s11596-018-1900-7; Duffield JS, 2014, J CLIN INVEST, V124, P2299, DOI 10.1172/JCI72267; Dupont S, 2004, CANCER LETT, V213, P129, DOI 10.1016/j.canlet.2004.06.008; Dupont S, 2016, EXP CELL RES, V343, P42, DOI 10.1016/j.yexcr.2015.10.034; Eleftheriadis Theodoros, 2012, Inflammation & Allergy Drug Targets, V11, P464; Elston Rebecca, 2012, J Signal Transduct, V2012, P294097, DOI 10.1155/2012/294097; Emlet DR, 2015, SEMIN NEPHROL, V35, P85, DOI 10.1016/j.semnephrol.2015.01.009; Engeland K, 2018, CELL DEATH DIFFER, V25, P114, DOI 10.1038/cdd.2017.172; Feng M, 2018, MOL THER, V26, P148, DOI 10.1016/j.ymthe.2017.09.024; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Ferenbach DA, 2015, NAT REV NEPHROL, V11, P264, DOI 10.1038/nrneph.2015.3; Fine LG, 2008, KIDNEY INT, V74, P867, DOI 10.1038/ki.2008.350; Fischer M, 2017, ONCOGENE, V36, P3943, DOI 10.1038/onc.2016.502; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Gentle ME, 2013, J AM SOC NEPHROL, V24, P787, DOI 10.1681/ASN.2012101024; Gomez IG, 2014, KIDNEY INT SUPPL, V4, P26, DOI 10.1038/kisup.2014.6; Grabias BM, 2014, AM J PHYSIOL-RENAL, V306, pF473, DOI 10.1152/ajprenal.00503.2013; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; Hageman J, 2005, CLIN CANCER RES, V11, P5956, DOI 10.1158/1078-0432.CCR-05-0427; Herrera J, 2018, J CLIN INVEST, V128, P45, DOI 10.1172/JCI93557; Higgins SP, 2018, CELL SIGNAL, V43, P1, DOI 10.1016/j.cellsig.2017.11.005; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; Horikawa I, 2017, CELL DEATH DIFFER, V24, P1017, DOI 10.1038/cdd.2017.48; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Imamura R, 2010, CELL TRANSPLANT, V19, P1659, DOI 10.3727/096368910X516619; Inazaki K, 2004, KIDNEY INT, V66, P597, DOI 10.1111/j.1523-1755.2004.00779.x; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Jorgenson AJ, 2017, AM J PHYSIOL-CELL PH, V312, pC277, DOI 10.1152/ajpcell.00205.2016; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kastenhuber ER, 2017, CELL, V170, P1062, DOI 10.1016/j.cell.2017.08.028; Kawarada Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep35483; Kodama T, 2011, J CLIN INVEST, V121, P3343, DOI 10.1172/JCI44957; Kortlever RM, 2008, J BIOL CHEM, V283, P24308, DOI 10.1074/jbc.M803341200; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004; Kramann R, 2014, SEMIN NEPHROL, V34, P374, DOI 10.1016/j.semnephrol.2014.06.004; Kumar S, 2018, KIDNEY INT, V93, P27, DOI 10.1016/j.kint.2017.07.030; Kung CP, 2016, J ENDOCRINOL, V231, pR61, DOI 10.1530/JOE-16-0324; KUNZ C, 1995, NUCLEIC ACIDS RES, V23, P3710, DOI 10.1093/nar/23.18.3710; Lahav G, 2008, ADV EXP MED BIOL, V641, P28; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Leslie PL, 2015, J BIOL CHEM, V290, P12941, DOI 10.1074/jbc.M115.644435; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Liu F, 2015, AM J PHYSIOL-LUNG C, V308, pL344, DOI 10.1152/ajplung.00300.2014; Liu LM, 2019, J MOL CELL BIOL, V11, P371, DOI 10.1093/jmcb/mjy042; Liu S, 2007, AM J PHYSIOL-RENAL, V293, pF1727, DOI 10.1152/ajprenal.00316.2007; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Mack M, 2015, KIDNEY INT, V87, P297, DOI 10.1038/ki.2014.287; Maclaine NJ, 2009, AGING-US, V1, P490, DOI 10.18632/aging.100047; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Massague J, 2000, GENE DEV, V14, P627; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Molitoris BA, 2009, J AM SOC NEPHROL, V20, P1754, DOI 10.1681/ASN.2008111204; Moonen L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072038; Mulay SR, 2012, KIDNEY INT, V81, P1199, DOI 10.1038/ki.2011.482; Nastase MV, 2018, MATRIX BIOL, V68-69, P293, DOI 10.1016/j.matbio.2017.12.002; Nayak G, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.138; Nie J, 2010, J BIOL CHEM, V285, P22816, DOI 10.1074/jbc.M110.126920; O'Brien T., 2019, KIDNEY NEWS, V11, P1; Overstreet JM, 2015, FASEB J, V29, P1258, DOI 10.1096/fj.14-262527; Overstreet JM, 2014, CELL SIGNAL, V26, P1427, DOI 10.1016/j.cellsig.2014.02.017; Parra M, 2001, J BIOL CHEM, V276, P36303, DOI 10.1074/jbc.M103735200; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Peng JP, 2015, KIDNEY INT, V87, P137, DOI 10.1038/ki.2014.226; Perico N, 2012, NEPHROL DIAL TRANSPL, V27, P19, DOI 10.1093/ndt/gfs284; Picard N, 2008, HISTOCHEM CELL BIOL, V130, P141, DOI 10.1007/s00418-008-0433-8; Piccolo S, 2008, CELL, V133, P767, DOI 10.1016/j.cell.2008.05.013; Qi L, 2006, J CELL BIOCHEM, V99, P495, DOI 10.1002/jcb.20885; Qi L, 2014, J CELL BIOCHEM, V115, P1840, DOI 10.1002/jcb.24861; Qi RC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1157-x; Qi WE, 2006, INT J BIOCHEM CELL B, V38, P1, DOI 10.1016/j.biocel.2005.09.005; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Richter K, 2015, REDOX BIOL, V6, P344, DOI 10.1016/j.redox.2015.08.015; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Samarakoon R, 2016, FASEB J, V30, P3308, DOI 10.1096/fj.201500105R; Samarakoon R, 2015, J PATHOL, V236, P421, DOI 10.1002/path.4538; Samarakoon R, 2012, CELL TISSUE RES, V347, P117, DOI 10.1007/s00441-011-1181-y; Sanchez AP, 2011, AM J PHYSIOL-RENAL, V301, pF271, DOI 10.1152/ajprenal.00221.2011; Schnaper HW, 2017, ADV CHRONIC KIDNEY D, V24, P107, DOI 10.1053/j.ackd.2016.11.011; Sczaniecka M, 2012, J BIOL CHEM, V287, P14052, DOI 10.1074/jbc.M111.303875; Shi LH, 2008, J CELL BIOCHEM, V103, P1952, DOI 10.1002/jcb.21585; Simonsson M, 2006, J BIOL CHEM, V281, P39870, DOI 10.1074/jbc.M607868200; Sun YBY, 2016, DIFFERENTIATION, V92, P102, DOI 10.1016/j.diff.2016.05.008; Szoltysek K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5211-y; Takaori K, 2016, J AM SOC NEPHROL, V27, P2393, DOI 10.1681/ASN.2015060647; Takebayashi-Suzuki K, 2003, DEVELOPMENT, V130, P3929, DOI 10.1242/dev.00615; Tan YW, 2019, CELL SIGNAL, V53, P49, DOI 10.1016/j.cellsig.2018.09.013; Tang CY, 2019, PHARMACOL THERAPEUT, V195, P5, DOI 10.1016/j.pharmthera.2018.10.013; Tang JQ, 2018, CANCERS, V10, DOI 10.3390/cancers10060159; Tanikawa C, 2017, EBIOMEDICINE, V20, P109, DOI 10.1016/j.ebiom.2017.05.017; ten Dijke P, 2015, CANCER CELL, V27, P151, DOI 10.1016/j.ccell.2015.01.005; Thomasova D, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.390; Thomasova D, 2015, NEPHROL DIAL TRANSPL, V30, P1622, DOI 10.1093/ndt/gfu395; Totaro A, 2018, NAT CELL BIOL, V20, P888, DOI 10.1038/s41556-018-0142-z; Tu AW, 2007, J BIOL CHEM, V282, P21187, DOI 10.1074/jbc.M700085200; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Vasilaki E, 2010, FASEB J, V24, P891, DOI 10.1096/fj.09-134742; Venkatachalam MA, 2015, J AM SOC NEPHROL, V26, P1765, DOI 10.1681/ASN.2015010006; Wang LQ, 2001, J BIOL CHEM, V276, P43604, DOI 10.1074/jbc.M106570200; Wang Shuxia, 2015, Front Biol (Beijing), V10, P221; Wang WN, 2016, INT J MOL MED, V37, P1181, DOI 10.3892/ijmm.2016.2527; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Wei QQ, 2007, AM J PHYSIOL-RENAL, V293, pF1282, DOI 10.1152/ajprenal.00230.2007; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Ye L, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0030-y; Ying Y, 2014, J AM SOC NEPHROL, V25, P2707, DOI 10.1681/ASN.2013121270; Zhang DF, 2018, BIOCHEM BIOPH RES CO, V505, P432, DOI 10.1016/j.bbrc.2018.08.111; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhou L, 2010, J AM SOC NEPHROL, V21, P31, DOI 10.1681/ASN.2008111133; Zhu FX, 2016, ONCOTARGET, V7, P25604, DOI 10.18632/oncotarget.8238; Zhu YQ, 2005, DIABETES, V54, P1976, DOI 10.2337/diabetes.54.7.1976	142	14	15	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10596	10606		10.1096/fj.201900943R	http://dx.doi.org/10.1096/fj.201900943R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31284746	Green Published			2022-12-28	WOS:000489166300003
J	Liu, GQ; Xie, YH; Su, JW; Qin, HJ; Wu, HT; Li, KQ; Yu, B; Zhang, XR				Liu, Guanqiao; Xie, Yongheng; Su, Jianwen; Qin, Hanjun; Wu, Hangtian; Li, Kaiqun; Yu, Bin; Zhang, Xianrong			The role of EGFR signaling in age-related osteoporosis in mouse cortical bone	FASEB JOURNAL			English	Article						degeneration; senescence; Ezh2; aging; ERK1; 2	EPIDERMAL-GROWTH-FACTOR; PROLIFERATION; SENESCENCE; CELLS; MECHANISMS; POROSITY; SURFACE; MASS	So far, there has been no effective cure for osteoporotic cortical bone, the most significant change in long bone structure during aging and the main cause of bone fragility fractures, because its underlying molecular and cellular mechanisms remain largely unknown. We used 3- and 15-mo-old mice as well as 15-mo-old mice treated with vehicle and gefitinib to evaluate structural, cellular, and molecular changes in cortical bone. We found that the senescence of osteoprogenitors was increased, whereas the expression of phosphorylated epidermal growth factor receptor (EGFR) on the endosteal surface of cortical bone down-regulated in middle-aged 15-mo-old mice compared with young 3-mo-old mice. Further decreasing EGFR signaling by gefitinib treatment in middle-aged mice resulted in promoted senescence of osteoprogenitors and accelerated cortical bone degeneration. Moreover, inhibiting EGFR signaling suppressed the expression of enhancer of zeste homolog 2 (Ezh2), the repressor of cell senescence-inducer genes, through ERK1/2 pathway, thereby promoting senescence in osteoprogenitors. Down-regulated EGFR signaling plays a physiologically significant role during aging by reducing Ezh2 expression, leading to the senescence of osteoprogenitors and the decline in bone formation on the endosteal surface of cortical bone.-Liu, G., Xie, Y., Su, J., Qin, H., Wu, H., Li, K., Yu, B., Zhang, X. The role of EGFR signaling in age-related osteoporosis in mouse cortical bone.	[Liu, Guanqiao; Xie, Yongheng; Su, Jianwen; Qin, Hanjun; Wu, Hangtian; Li, Kaiqun; Yu, Bin; Zhang, Xianrong] Southern Med Univ, Nanfang Hosp, Dept Orthopaed & Traumatol, 1838 North Guangzhou Ave, Guangzhou 510515, Guangdong, Peoples R China; [Liu, Guanqiao; Xie, Yongheng; Su, Jianwen; Qin, Hanjun; Wu, Hangtian; Li, Kaiqun; Yu, Bin; Zhang, Xianrong] Southern Med Univ, Nanfang Hosp, Key Lab Bone & Cartilage Regenerat Med, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Yu, B; Zhang, XR (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Orthopaed & Traumatol, 1838 North Guangzhou Ave, Guangzhou 510515, Guangdong, Peoples R China.	yubinol@163.com; xianrongzh@smu.edu.cn		Qin, Hanjun/0000-0002-9982-6157; liu, guanqiao/0000-0003-4119-3796	Major Program of National Natural Science Foundation of China [81830079]; National Natural Science Foundation of China [81573515, 81572165]	Major Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Allen P. Liang (Nanfang Hospital, Southern Medical University) for English proofreading of this manuscript. This work was supported by The Major Program of National Natural Science Foundation of China (81830079) and the National Natural Science Foundation of China (81573515, 81572165). The authors declare no conflicts of interest.	Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Alexander PB, 2015, CELL RES, V25, P135, DOI 10.1038/cr.2014.141; Anam K, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt323; Andreasen CM, 2018, BONE, V117, P70, DOI 10.1016/j.bone.2018.09.011; Andreasen CM, 2018, J BONE MINER RES, V33, P606, DOI 10.1002/jbmr.3354; Bai TT, 2017, STEM CELLS DEV, V26, P113, DOI 10.1089/scd.2016.0234; Bakalova LP, 2018, J BONE MINER RES, V33, P2177, DOI 10.1002/jbmr.3561; Birkhold AI, 2016, SCI REP-UK, V6, DOI 10.1038/srep23480; Bjornerem A, 2018, J BONE MINER RES, V33, P598, DOI 10.1002/jbmr.3333; BROCKSTEDT H, 1993, BONE, V14, P681, DOI 10.1016/8756-3282(93)90092-O; Buenzli PR, 2013, INT J NUMER METH BIO, V29, P1307, DOI 10.1002/cnm.2567; Chandra A, 2013, J BIOL CHEM, V288, P20488, DOI 10.1074/jbc.M112.447250; Cooper DML, 2007, BONE, V40, P957, DOI 10.1016/j.bone.2006.11.011; Dai GD, 2013, BIOCHEM BIOPH RES CO, V440, P479, DOI 10.1016/j.bbrc.2013.08.070; Ding CY, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0781-9; Dong YP, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171589; Farr JN, 2017, NAT MED, V23, P1072, DOI 10.1038/nm.4385; Farr JN, 2016, J BONE MINER RES, V31, P1920, DOI 10.1002/jbmr.2892; Gerber PA, 2016, SUPPORT CARE CANCER, V24, P4241, DOI 10.1007/s00520-016-3254-7; Halloran BP, 2002, J BONE MINER RES, V17, P1044, DOI 10.1359/jbmr.2002.17.6.1044; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Kim HN, 2017, AGING CELL, V16, P693, DOI 10.1111/acel.12597; Li CJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01509-0; McHugh D, 2018, J CELL BIOL, V217, P65, DOI 10.1083/jcb.201708092; Piemontese M, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93771; Ramchand SK, 2018, CURR OSTEOPOROS REP, V16, P561, DOI 10.1007/s11914-018-0478-0; Savickiene J, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2019498; Schneider P, 2007, J BONE MINER RES, V22, P1557, DOI 10.1359/JBMR.070703; Seeman E, 2013, J GERONTOL A-BIOL, V68, P1218, DOI 10.1093/gerona/glt071; Siclari VA, 2013, BONE, V53, P575, DOI 10.1016/j.bone.2012.12.013; Tamama K, 2006, STEM CELLS, V24, P686, DOI 10.1634/stemcells.2005-0176; Yarden Y, 2001, EUR J CANCER, V37, pS3; Zebaze R, 2015, J BONE MINER RES, V30, P24, DOI 10.1002/jbmr.2419; Zhang XR, 2011, J BONE MINER RES, V26, P1022, DOI 10.1002/jbmr.295	36	11	11	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11137	11147		10.1096/fj.201900436RR	http://dx.doi.org/10.1096/fj.201900436RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31298955				2022-12-28	WOS:000489166300047
J	Preising, MN; Gorg, B; Friedburg, C; Qvartskhava, N; Budde, BS; Bonus, M; Toliat, MR; Pfleger, C; Altmuller, J; Herebian, D; Beyer, M; Zollner, HJ; Wittsack, HJ; Schaper, J; Klee, D; Zechner, U; Nurnberg, P; Schipper, J; Schnitzler, A; Gohlke, H; Lorenz, B; Haussinger, D; Bolz, HJ				Preising, Markus N.; Goerg, Boris; Friedburg, Christoph; Qvartskhava, Natalia; Budde, Birgit S.; Bonus, Michele; Toliat, Mohammad R.; Pfleger, Christopher; Altmueller, Janine; Herebian, Diran; Beyer, Mila; Zoellner, Helge J.; Wittsack, Hans-Joerg; Schaper, Joerg; Klee, Dirk; Zechner, Ulrich; Nuernberg, Peter; Schipper, Joerg; Schnitzler, Alfons; Gohlke, Holger; Lorenz, Birgit; Haeussinger, Dieter; Bolz, Hanno J.			Biallelic mutation of human SLC6A6 encoding the taurine transporter TAUT is linked to early retinal degeneration	FASEB JOURNAL			English	Article						exome sequencing; homozygosity mapping; consanguinity	MOLECULAR-DYNAMICS SIMULATIONS; RIGIDITY THEORY; ISCEV STANDARD; SOFTWARE; KNOCKOUT; MOUSE; ACCURACY; SODIUM; MODEL; FLEXIBILITY	We previously reported that inactivation of the transmembrane taurine transporter (TauT or solute carrier 6a6) causes early retinal degeneration in mice. Compatible with taurine's indispensability for cell volume homeostasis, protein stabilization, cytoprotection, antioxidation, and immuno- and neuromodulation, mice develop multisystemic dysfunctions (hearing loss; liver fibrosis; and behavioral, heart, and skeletal muscle abnormalities) later on. Here, by genetic, cell biologic, in vivo H-1-magnetic resonance spectroscopy and molecular dynamics simulation studies, we conducted in-depth characterization of a novel disorder: human TAUT deficiency. Loss of TAUT function due to a homozygous missense mutation caused panretinal degeneration in 2 brothers. TAUT(p.A78E) still localized in the plasma membrane but is predicted to impact structural stabilization. H-3-taurine uptake by peripheral blood mononuclear cells was reduced by 95%, and taurine levels were severely reduced in plasma, skeletal muscle, and brain. Extraocular dysfunctions were not yet detected, but significantly increased urinary excretion of 8-oxo-7,8-dihydroguanosine indicated generally enhanced (yet clinically unapparent) oxidative stress and RNA oxidation, warranting continuous broad surveillance.-Preising, M. N., Gorg, B., Friedburg, C., Qvartskhava, N., Budde, B. S., Bonus, M., Toliat, M. R., Pfleger, C., Altmuller, J., Herebian, D., Beyer, M., Zollner, H. J., Wittsack, H.-J., Schaper, J., Klee, D., Zechner, U., Nurnberg, P., Schipper, J., Schnitzler, A., Gohlke, H., Lorenz, B., Haussinger, D., Bolz, H. J. Biallelic mutation of human SLC6A6 encoding the taurine transporter TAUT is linked to early retinal degeneration.	[Preising, Markus N.; Friedburg, Christoph; Lorenz, Birgit] Justus Liebig Univ Giessen, Dept Ophthalmol, Giessen, Germany; [Goerg, Boris; Qvartskhava, Natalia; Beyer, Mila; Haeussinger, Dieter] Heinrich Heine Univ Dusseldorf, Univ Hosp Dusseldorf, Dept Gastroenterol Hepatol & Infect Dis, Dusseldorf, Germany; [Herebian, Diran] Heinrich Heine Univ Dusseldorf, Univ Hosp Dusseldorf, Dept Gen Pediat Neonatol & Pediat Cardiol, Med Fac, Dusseldorf, Germany; [Zoellner, Helge J.; Schnitzler, Alfons] Heinrich Heine Univ Dusseldorf, Univ Hosp Dusseldorf, Inst Clin Neurosci & Med Psychol, Dusseldorf, Germany; [Wittsack, Hans-Joerg; Schaper, Joerg; Klee, Dirk] Heinrich Heine Univ Dusseldorf, Univ Hosp Dusseldorf, Dept Diagnost & Intervent Radiol, Dusseldorf, Germany; [Schipper, Joerg] Heinrich Heine Univ Dusseldorf, Univ Hosp Dusseldorf, Klin Hals Nasen Ohren Heilkunde, Dusseldorf, Germany; [Budde, Birgit S.; Toliat, Mohammad R.; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Altmueller, Janine; Nuernberg, Peter] Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany; [Bolz, Hanno J.] Univ Cologne, Inst Human Genet, Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Bonus, Michele; Pfleger, Christopher; Gohlke, Holger] Heinrich Heine Univ Dusseldorf, Inst Pharmaceut & Med Chem, Dusseldorf, Germany; [Zechner, Ulrich; Bolz, Hanno J.] Senckenberg Ctr Human Genet, Weismullerstr 50, D-60314 Frankfurt, Germany; [Zechner, Ulrich] Mainz Univ, Med Ctr, Inst Human Genet, Mainz, Germany; [Gohlke, Holger] John von Neumann Inst Comp NIC, Res Ctr Julich, Julich Supercomp Ctr JSC Struct Biochem, Inst Complex Syst ICS 6, Julich, Germany	Justus Liebig University Giessen; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Heinrich Heine University Dusseldorf; Johannes Gutenberg University of Mainz; Helmholtz Association; Research Center Julich	Bolz, HJ (corresponding author), Senckenberg Ctr Human Genet, Weismullerstr 50, D-60314 Frankfurt, Germany.; Haussinger, D (corresponding author), Univ Klinikum Dusseldorf, Dept Gastroenterol Hepatol & Infect Dis, Moorenstr 5, D-40225 Dusseldorf, Germany.	haeussin@uni-duesseldorf.de; h.bolz@senckenberg-humangenetik.de	Schnitzler, Alfons/AAT-1054-2021; Preising, Markus/GQA-9591-2022; Wittsack, Hans-Joerg/AAM-3179-2020; Lorenz, Birgit/AAJ-1351-2020; Zöllner, Helge/ABE-2726-2020; Bonus, Michele/P-4170-2018; Schnitzler, Alfons/Q-5520-2019	Wittsack, Hans-Joerg/0000-0002-5830-423X; Lorenz, Birgit/0000-0002-9737-8127; Bonus, Michele/0000-0003-4411-7342; Schnitzler, Alfons/0000-0002-6414-7939; Altmuller, Janine/0000-0003-4372-1521; Budde, Birgit/0000-0001-9385-4168; Dr. Herebian, Diran/0000-0002-8528-0122; Gorg, Boris/0000-0002-4630-9420	PRO RETINA Deutschland, Stiftung Auge (Deutsche Ophthalmologische Gesellschaft); Dr. Senckenbergische Stiftung; Deutsche Forschungsgemeinschaft (DFG) [190586431-SFB, 9741367/2-1]	PRO RETINA Deutschland, Stiftung Auge (Deutsche Ophthalmologische Gesellschaft); Dr. Senckenbergische Stiftung; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors thank Mrs. Ursula Wiggen (University Hospital Dusseldorf-Heinrich Heine University Dusseldorf) for the patient handling during the magnetic resonance spectroscopy measurement, Dr. Ute Albrecht for coordinating clinical examinations and Ina Park for SLC6A6 mutation analyses. The authors are grateful for computational support and infrastructure provided by the Zentrum fur Informations und Medientechnologie (ZIM) at Heinrich Heine University Dusseldorf, and the computing time provided by the John von Neumann Institute for Computing (NIC) to H.G. on the supercomputer Julich Wizard for European Leadership Science (JUWELS) at the Julich Supercomputing Centre (JSC) (ID: HKF7). This study was supported by grants from PRO RETINA Deutschland, Stiftung Auge (Deutsche Ophthalmologische Gesellschaft), Dr. Senckenbergische Stiftung; the Deutsche Forschungsgemeinschaft (DFG; Projektnummer 190586431-SFB 974) Communication and Systems Relevance in Liver Injury and Regeneration (Dusseldorf, Germany), and Research Group FOR 2518 DynIon (Project P7, GO 1367/2-1 to H.G.). M.N.P. and B.G. are joint first authors. D.H. and H.J.B. share senior authorship. The authors declare no conflicts of interest.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Alagramam KN, 2016, NAT CHEM BIOL, V12, P444, DOI [10.1038/nchembio.2069, 10.1038/NCHEMBIO.2069]; AMENT ME, 1986, J AM COLL NUTR, V5, P127; Beck BB, 2014, HUM MUTAT, V35, P1153, DOI 10.1002/humu.22618; Behnen P, 2018, ISCIENCE, V4, P1, DOI 10.1016/j.isci.2018.05.001; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Case D. A., 2018, AMBER 2019; Chavent M, 2016, CURR OPIN STRUC BIOL, V40, P8, DOI 10.1016/j.sbi.2016.06.007; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dahiyat BI, 1997, PROTEIN SCI, V6, P1333, DOI 10.1002/pro.5560060622; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dickson CJ, 2014, J CHEM THEORY COMPUT, V10, P865, DOI 10.1021/ct4010307; Ehnes A, 2014, TRANSL VIS SCI TECHN, V3, DOI 10.1167/tvst.3.1.1; Elsayed SM, 2015, HUM MOL GENET, V24, P2594, DOI 10.1093/hmg/ddv022; Farrar GJ, 2017, HUM MOL GENET, V26, pR2, DOI 10.1093/hmg/ddx185; Forrest LR, 2006, BIOPHYS J, V91, P508, DOI 10.1529/biophysj.106.082313; Froger N, 2013, ADV EXP MED BIOL, V775, P69, DOI 10.1007/978-1-4614-6130-2_6; Galindo-Murillo R, 2015, BBA-GEN SUBJECTS, V1850, P1041, DOI 10.1016/j.bbagen.2014.09.007; Gan W, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00034; Garcia-Ayuso D, 2018, INVEST OPHTH VIS SCI, V59, P1396, DOI 10.1167/iovs.17-23258; Garcia-Canaveras JC, 2012, J LIPID RES, V53, P2231, DOI 10.1194/jlr.D028803; GEGGEL HS, 1985, NEW ENGL J MED, V312, P142, DOI 10.1056/NEJM198501173120302; Gorg B, 2015, GLIA, V63, P37, DOI 10.1002/glia.22731; HAYES KC, 1975, SCIENCE, V188, P949, DOI 10.1126/science.1138364; Heller-Stilb B, 2001, FASEB J, V15, P231, DOI 10.1096/fj.01-0691fje; Hermans SMA, 2017, WIRES COMPUT MOL SCI, V7, DOI 10.1002/wcms.1311; Hespenheide BM, 2002, J MOL GRAPH MODEL, V21, P195, DOI 10.1016/S1093-3263(02)00146-8; Hood DC, 2012, DOC OPHTHALMOL, V124, P1, DOI 10.1007/s10633-011-9296-8; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Huxtable RJ, 2000, ADV EXP MED BIOL, V483, P1; Imaki H, 1996, ADV EXP MED BIOL, V403, P351; IMAKI H, 1993, J NEUROSCI RES, V36, P290, DOI 10.1002/jnr.490360307; Jacobs DJ, 2001, PROTEINS, V44, P150, DOI 10.1002/prot.1081; Jacobs DJ, 1997, J COMPUT PHYS, V137, P346, DOI 10.1006/jcph.1997.5809; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kantcheva AK, 2013, P NATL ACAD SCI USA, V110, P8489, DOI 10.1073/pnas.1221279110; Kawalia A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126321; Le Grand S, 2013, COMPUT PHYS COMMUN, V184, P374, DOI 10.1016/j.cpc.2012.09.022; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; LIU QR, 1992, P NATL ACAD SCI USA, V89, P12145, DOI 10.1073/pnas.89.24.12145; LONCHARICH RJ, 1992, BIOPOLYMERS, V32, P523, DOI 10.1002/bip.360320508; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; McCulloch DL, 2015, DOC OPHTHALMOL, V130, P1, DOI 10.1007/s10633-014-9473-7; Moukarzel C, 1999, PHYS REV E, V59, P2614, DOI 10.1103/PhysRevE.59.2614; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Otte M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33050-5; Pagani G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23778-5; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Pfleger C, 2017, J CHEM THEORY COMPUT, V13, P6343, DOI 10.1021/acs.jctc.7b00529; Pfleger C, 2013, J CHEM INF MODEL, V53, P1007, DOI 10.1021/ci400044m; Pierce EA, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a017285; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Rader AJ, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016002; Rader AJ, 2002, P NATL ACAD SCI USA, V99, P3540, DOI 10.1073/pnas.062492699; Radestock S, 2008, ENG LIFE SCI, V8, P507, DOI 10.1002/elsc.200800043; Rascher K, 2004, VISION RES, V44, P2091, DOI 10.1016/j.visres.2004.03.027; Rathi PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130289; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Scholl HPN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2838; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Skolnick J, 1997, PROTEIN SCI, V6, P676; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Venable RM, 2015, CHEM PHYS LIPIDS, V192, P60, DOI 10.1016/j.chemphyslip.2015.07.014; Vinnakota S, 1997, J NEUROCHEM, V69, P2238; Wakeling M. N., 2018, GENET MED, V21, P21; Wakeling MN, 2019, GENET MED, V21, P982, DOI 10.1038/s41436-018-0281-4; Wakeling MN, 2019, GENET MED, V21, P766, DOI 10.1038/s41436-018-0357-1; Warskulat U, 2006, FASEB J, V20, P574, DOI 10.1096/fj.05-5016fje; Warskulat U, 2004, FASEB J, V18, P577, DOI 10.1096/fj.03-0496fje; Warskulat U, 2007, METHOD ENZYMOL, V428, P439, DOI 10.1016/S0076-6879(07)28025-5; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Wilson M, 2011, MAGN RESON MED, V65, P1, DOI 10.1002/mrm.22579; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	79	20	20	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11507	11527		10.1096/fj.201900914RR	http://dx.doi.org/10.1096/fj.201900914RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31345061				2022-12-28	WOS:000489166300075
J	Duan, YH; Zhong, YZ; Xiao, H; Zheng, CB; Song, B; Wang, WL; Guo, QP; Li, YY; Han, H; Gao, J; Xu, K; Li, TJ; Yin, YL; Li, FN; Yin, J; Kong, XF				Duan, Yehui; Zhong, Yinzhao; Xiao, Hao; Zheng, Changbing; Song, Bo; Wang, Wenlong; Guo, Qiuping; Li, Yuying; Han, Hui; Gao, Jing; Xu, Kang; Li, Tiejun; Yin, Yulong; Li, Fengna; Yin, Jie; Kong, Xiangfeng			Gut microbiota mediates the protective effects of dietary beta-hydroxy-beta-methylbutyrate (HMB) against obesity induced by high-fat diets	FASEB JOURNAL			English	Article						insulin resistance; propionic acid; gut microbiota transplantation; lipid metabolism	BODY-MASS INDEX; INSULIN SENSITIVITY; PROTEIN-METABOLISM; IMPROVES GLUCOSE; SKELETAL-MUSCLE; GLOBAL BURDEN; LEUCINE; OVERWEIGHT; EXPRESSION; CANCER	Obesity increases the risk of developing insulin resistance and diabetes and is a major public health concern. Our previous study shows that dietary beta-hydroxy-beta-methylbutyrate (HMB) improves lipid metabolism in a pig model. However, it remains unclear whether HMB blocks obesity through gut microbiota. In this study, we found that HMB reduced body weight, alleviated the whitening of brown adipose tissue, and improved insulin resistance in mice fed a high-fat diet (HFD). High-throughput pyrosequencing of the 16S rRNA demonstrated that HMB administration significantly reversed the gut microbiota dysbiosis in HFD-fed mice, including the diversity of gut microbiota and relative abundances of Bacteroidetes and Firmicutes. Moreover, microbiota transplantation from HMB-treated mice attenuated HFD-induced lipid metabolic disorders. Furthermore, HFD-fed mice showed lower short-chain fatty acids, whereas administration of HMB increased the propionic acid production. Correlation analysis identified a significant correlation between propionic acid production and the relative Bacteroidetes abundance. Sodium propionate treatment also attenuated HFD-induced lipid metabolic disorders. Collectively, our results indicated that HMB might be used as a probiotic agent to reverse HFD-induced obesity, and the potential mechanism was associated with reprogramming gut microbiota and metabolism, especially Bacteroidetes-mediated propionic acid production. In future studies, more efforts should be made to confirm and expand the beneficial effects of HMB to human models.-Duan, Y., Zhong, Y., Xiao, H., Zheng, C., Song, B., Wang, W., Guo, Q., Li, Y., Han, H., Gao, J., Xu, K., Li, T., Yin, Y., Li, F., Yin, J., Kong, X. Gut microbiota mediates the protective effects of dietary beta-hydroxy-beta-methylbutyrate (HMB) against obesity induced by high-fat diets.	[Duan, Yehui; Zhong, Yinzhao; Wang, Wenlong; Guo, Qiuping; Li, Yuying; Han, Hui; Gao, Jing; Xu, Kang; Li, Tiejun; Yin, Yulong; Li, Fengna; Yin, Jie; Kong, Xiangfeng] Chinese Acad Sci, Hunan Prov Key Lab Anim Nutr Physiol & Metab Proc, Hunan Prov Engn Res Ctr Hlth Livestock & Poultry, Key Lab Agroecol Proc Subtrop Reg,Inst Subtrop Ag, Changsha, Hunan, Peoples R China; [Zhong, Yinzhao; Zheng, Changbing; Song, Bo; Yin, Yulong] South China Agr Univ, Guangdong Prov Key Lab Anim Nutr Regulat, Guangzhou, Guangdong, Peoples R China; [Xiao, Hao] Guangdong Acad Agr Sci, Minist Agr, Inst Anim Sci, Key Lab Anim Nutr & Feed Sci South China, Guangzhou, Guangdong, Peoples R China; [Li, Fengna] Hunan Coinnovat Ctr Anim Prod Safety CICAPS, Hunan Collaborat Innovat Ctr Utilizat Bot Funct I, Changsha, Hunan, Peoples R China	Chinese Academy of Sciences; South China Agricultural University; Guangdong Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Li, FN; Yin, J (corresponding author), Chinese Acad Sci, Inst Subtrop Agr, 644 Yuanda Rd, Changsha 410125, Hunan, Peoples R China.	lifengna@isa.ac.cn; yinjie2014@126.com		Han, Hui/0000-0002-8163-8932; Wang, Wenlong/0000-0003-1669-613X	National Natural Science Foundation of China [31802077]; Science and Technology Project of Guangxi Province [2018JJB130239]; National Key R D Program [2018YFD0500405, 2016YFD0501204, 2017YFD0500503]; Youth Innovation Promotion Association of the Chinese Academy of Sciences (CAS) [2016326]; Science and Technology Projects of Hunan Province [2016SK3022, 2017RS3058]; Key Project of Research and Development Plan of Hunan Province [2016NK2170]; Youth Innovation Team Project of the Institute of Subtropical Agriculture (ISA) [2017QNCXTD_ZCS]; Earmarked Fund for China Agriculture Research System [CARS-35]; Special Fund for Ability Construction - Guangdong Academy of Science [2017GDASCX-0702]; Major Project for Changsha City [kq1706147]; Science and Technology Service (STS) regional key project of the CAS [AD17195043]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Guangxi Province; National Key R D Program; Youth Innovation Promotion Association of the Chinese Academy of Sciences (CAS); Science and Technology Projects of Hunan Province; Key Project of Research and Development Plan of Hunan Province; Youth Innovation Team Project of the Institute of Subtropical Agriculture (ISA); Earmarked Fund for China Agriculture Research System; Special Fund for Ability Construction - Guangdong Academy of Science; Major Project for Changsha City; Science and Technology Service (STS) regional key project of the CAS	This study was jointly supported by the National Natural Science Foundation of China (Grant 31802077), the Science and Technology Project of Guangxi Province (Grant 2018JJB130239), the National Key R & D Program (Grants 2018YFD0500405, 2016YFD0501204, and 2017YFD0500503), the Youth Innovation Promotion Association of the Chinese Academy of Sciences (CAS; Grant 2016326), the Science and Technology Projects of Hunan Province (Grants 2016SK3022 and 2017RS3058), the Key Project of Research and Development Plan of Hunan Province (Grant 2016NK2170), the Youth Innovation Team Project of the Institute of Subtropical Agriculture (ISA; Grant 2017QNCXTD_ZCS), the Earmarked Fund for China Agriculture Research System (Grant CARS-35), Special Fund for Ability Construction Supported by Guangdong Academy of Science (Grant 2017GDASCX-0702), the Major Project for Changsha City (Grant kq1706147), the Science and Technology Service (STS) regional key project of the CAS (Grant AD17195043). The authors declare no conflicts of interest.	Adams SH, 2011, ADV NUTR, V2, P445, DOI 10.3945/an.111.000737; [Anonymous], INT J OBES; Arakawa M, 2011, ENDOCR J, V58, P161, DOI 10.1507/endocrj.K10E-221; Arnold M, 2015, LANCET ONCOL, V16, P36, DOI 10.1016/S1470-2045(14)71123-4; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Binder E, 2014, OBESITY, V22, P713, DOI 10.1002/oby.20578; Bruckbauer A, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-77; Chambers ES, 2015, GUT, V64, P1744, DOI 10.1136/gutjnl-2014-307913; Chen H, 2012, J NEUROENDOCRINOL, V24, P1356, DOI 10.1111/j.1365-2826.2012.02339.x; Duan YH, 2018, FOOD FUNCT, V9, P4836, DOI 10.1039/c8fo00898a; Duan YH, 2018, J AGR FOOD CHEM, V66, P170, DOI 10.1021/acs.jafc.7b04841; Duan YH, 2017, NUTRITION, V36, P8, DOI 10.1016/j.nut.2016.10.016; Duan YH, 2015, ANIM NUTR, V1, P30, DOI 10.1016/j.aninu.2015.02.005; Duan YH, 2016, AMINO ACIDS, V48, P41, DOI 10.1007/s00726-015-2067-1; Federico A, 2017, MINERVA GASTROENTERO, V63, P337, DOI 10.23736/S1121-421X.17.02376-5; Fu LZ, 2015, METABOLISM, V64, P1426, DOI 10.1016/j.metabol.2015.07.006; Fu LZ, 2015, DIABET METAB SYND OB, V8, P227, DOI 10.2147/DMSO.S82338; Fu LZ, 2015, METABOLISM, V64, P845, DOI 10.1016/j.metabol.2015.03.007; Gannon NP, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700756; Giron MD, 2016, J CACHEXIA SARCOPENI, V7, P68, DOI 10.1002/jcsm.12032; Guo KY, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-57; HALL TR, 1993, J BIOL CHEM, V268, P3092; Hernandez JB, 2015, NAT COMMUN, V6, DOI [10.1038/ncomms8216, 10.1038/ncomms8489]; Holecek M, 2017, J CACHEXIA SARCOPENI, V8, P529, DOI 10.1002/jcsm.12208; Hsieh LC, 2010, ASIA PAC J CLIN NUTR, V19, P200; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Lackey DE, 2013, AM J PHYSIOL-ENDOC M, V304, pE1175, DOI 10.1152/ajpendo.00630.2012; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Layman DK, 2003, J NUTR, V133, p261S, DOI 10.1093/jn/133.1.261S; Layman DK, 2006, J NUTR, V136, p319S, DOI 10.1093/jn/136.1.319S; Lemieux-Labonte V, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0334-y; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liou AP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005687; Liu W, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201601082; Louis P, 2017, ENVIRON MICROBIOL, V19, P29, DOI 10.1111/1462-2920.13589; Lynch CJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE621, DOI 10.1152/ajpendo.00462.2005; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; Morgen CS, 2014, NAT REV ENDOCRINOL, V10, P513, DOI 10.1038/nrendo.2014.124; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nissen SL, 1997, J NUTR BIOCHEM, V8, P300, DOI 10.1016/S0955-2863(97)00048-X; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Salonen A, 2014, ISME J, V8, P2218, DOI 10.1038/ismej.2014.63; Slater GJ, 2000, SPORTS MED, V30, P105, DOI 10.2165/00007256-200030020-00004; Smith HJ, 2005, CANCER RES, V65, P277; Stancliffe RA, 2012, FASEB J, V26; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Tong LC, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00253; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Torres-Leal FL, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-62; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; van Kruijsdijk RCM, 2009, CANCER EPIDEM BIOMAR, V18, P2569, DOI 10.1158/1055-9965.EPI-09-0372; VANKOEVERING M, 1992, AM J PHYSIOL, V262, pE27, DOI 10.1152/ajpendo.1992.262.1.E27; Wang ZY, 2018, EAT WEIGHT DISORD-ST, V23, P267, DOI 10.1007/s40519-017-0428-3; Wheatley SM, 2014, AM J PHYSIOL-ENDOC M, V306, pE91, DOI 10.1152/ajpendo.00500.2013; Wilson GJ, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-1; Xu PF, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12399; Yao K, 2016, TRENDS PHARMACOL SCI, V37, P714, DOI 10.1016/j.tips.2016.05.004; Yin J, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12524; Zemel MB, 2012, NUTRIENTS, V4, P529, DOI 10.3390/nu4060529; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123	65	44	49	8	54	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10019	10033		10.1096/fj.201900665RR	http://dx.doi.org/10.1096/fj.201900665RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31167080				2022-12-28	WOS:000482214200025
J	Jiang, YZ; Tuan, RS				Jiang, Yangzi; Tuan, Rocky S.			Role of NGF-TrkA signaling in calcification of articular chondrocytes	FASEB JOURNAL			English	Article						IHH-PTHrP; osteoarthritis; pathological calcification	NERVE GROWTH-FACTOR; IN-VIVO MODEL; INTRAARTICULAR INJECTION; OSTEOARTHRITIS; CARTILAGE; PAIN; EXPRESSION; DIFFERENTIATION; RECEPTORS; APOPTOSIS	Nerve growth factor (NGF) is a key regulator of chronic osteoarthritic pain, but the exact targets of NGF action on human articular cartilage is unknown. This study aimed to test the hypothesis that the NGF-tropomyosin receptor kinase A (TrkA) (high-affinity NGF receptor) pathway plays a role in the calcification process of human articular chondrocytes (hACs). A 14-aa small peptide of NGF (Nsp) previously shown to activate NGF signaling in rat PC12 cells was used as an NGF signaling agonist, and recombinant NGF and the pan-Trk inhibitor GNF-5837 were employed as signaling modulating agents. The functional consequences of NGF-TrkA signaling were examined in human healthy articular chondrocytes maintained under conditions supportive of osteogenesis in vitro. The NGF-mimetic bioactivity of Nsp was first confirmed on the basis of maintenance of neurite outgrowth in PC12 cells. Primary human chondrocytes responded to Nsp in vitro. Perturbation of NGF signaling with NGF, Nsp, and GNF-5837 resulted in a strong induction of chondrocyte calcification, and gene expression data suggested that the Indian Hedgehog-parathyroid hormone-related protein signaling axis was involved. These findings suggest functional involvement of NGF signaling in calcification of hACs and the importance of NGF signaling in articular cartilage homeostasis.-Jiang, Y., Tuan, R. S. Role of NGF-TrkA signaling in calcification of articular chondrocytes.	[Jiang, Yangzi; Tuan, Rocky S.] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Ctr Cellular & Mol Engn, 450 Technol Dr, Pittsburgh, PA 15219 USA; [Jiang, Yangzi; Tuan, Rocky S.] Chinese Univ Hong Kong, Inst Tissue Engn & Regenerat Med, Hong Kong, Peoples R China; [Jiang, Yangzi; Tuan, Rocky S.] Chinese Univ Hong Kong, Sch Biomed Sci, Fac Med, Hong Kong, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chinese University of Hong Kong; Chinese University of Hong Kong	Tuan, RS (corresponding author), Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Ctr Cellular & Mol Engn, 450 Technol Dr, Pittsburgh, PA 15219 USA.; Jiang, YZ (corresponding author), Chinese Univ Hong Kong, Inst Tissue Engn & Regenerat Med, Shatin, R412,Lo Kwee Seong Integrated Biomed Sci Bldg, Hong Kong, Peoples R China.	yangzjiang21@cuhk.edu.hk; rst13@pitt.edu	Jiang, Yangzi/AAY-9232-2020	Jiang, Yangzi/0000-0002-7475-3182	Commonwealth of Pennsylvania Department of Health [SAP4100050913]; Arthur J. Rooney, Sr. Endowment (University of Pittsburgh); Chinese University of Hong Kong	Commonwealth of Pennsylvania Department of Health; Arthur J. Rooney, Sr. Endowment (University of Pittsburgh); Chinese University of Hong Kong(Chinese University of Hong Kong)	This work was supported, in part, by funding from Commonwealth of Pennsylvania Department of Health (SAP4100050913) (to R.S.T.), Arthur J. Rooney, Sr. Endowment (University of Pittsburgh) (to R.S.T.), and The Chinese University of Hong Kong (to Y.J.). The authors declare no conflicts of interest.	Albaugh P, 2012, ACS MED CHEM LETT, V3, P140, DOI 10.1021/ml200261d; Alman BA, 2015, NAT REV RHEUMATOL, V11, P552, DOI 10.1038/nrrheum.2015.84; Ashraf S, 2014, ANN RHEUM DIS, V73, P1710, DOI 10.1136/annrheumdis-2013-203416; Burr DB, 2012, NAT REV RHEUMATOL, V8, P665, DOI 10.1038/nrrheum.2012.130; Center for Drug Evaluation and Research, 2018, VOICE PATIENT; Chang DS, 2016, J PAIN RES, V9, P373, DOI 10.2147/JPR.S89061; Chang JK, 2009, ARTHRITIS RHEUM-US, V60, P3049, DOI 10.1002/art.24843; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Dvir-Ginzberg M, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0591-y; Fischer J, 2010, ARTHRITIS RHEUM-US, V62, P2696, DOI 10.1002/art.27565; Fuerst M, 2009, ARTHRITIS RHEUM, V60, P2694, DOI 10.1002/art.24774; Gigante A, 2003, EUR J HISTOCHEM, V47, P339, DOI 10.4081/844; Grassel S, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0485-1; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Iannone F, 2002, RHEUMATOLOGY, V41, P1413, DOI 10.1093/rheumatology/41.12.1413; Jiang J, 2008, OSTEOARTHR CARTILAGE, V16, P70, DOI 10.1016/j.joca.2007.05.014; Jiang YZ, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0840-x; Jiang YZ, 2015, NAT REV RHEUMATOL, V11, P206, DOI 10.1038/nrrheum.2014.200; Kc R, 2016, ANN RHEUM DIS, V75, P2133, DOI 10.1136/annrheumdis-2015-208444; Lane NE, 2010, NEW ENGL J MED, V363, P1521, DOI 10.1056/NEJMoa0901510; LESAUTEUR L, 1995, J BIOL CHEM, V270, P6564, DOI 10.1074/jbc.270.12.6564; Malfait AM, 2009, OSTEOARTHR CARTILAGE, V17, P627, DOI 10.1016/j.joca.2008.10.005; Mapp PI, 2012, NAT REV RHEUMATOL, V8, P390, DOI 10.1038/nrrheum.2012.80; Matsushita T, 2013, J ORTHOP RES, V31, P531, DOI 10.1002/jor.22268; Oppenheimer H, 2012, ARTHRITIS RHEUM-US, V64, P718, DOI 10.1002/art.33407; Takayama K, 2009, ARTHRITIS RHEUM-US, V60, P2731, DOI 10.1002/art.24864; Tomlinson RE, 2017, P NATL ACAD SCI USA, V114, pE3632, DOI 10.1073/pnas.1701054114; Tomlinson RE, 2016, CELL REP, V16, P2723, DOI 10.1016/j.celrep.2016.08.002; Travaglia A, 2015, ACS CHEM NEUROSCI, V6, P1379, DOI 10.1021/acschemneuro.5b00069; Travaglia A, 2011, CHEM-EUR J, V17, P3726, DOI 10.1002/chem.201002294; Tsang KY, 2014, BIRTH DEFECTS RES C, V102, P52, DOI 10.1002/bdrc.21060; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wheaton AJ, 2004, ACAD RADIOL, V11, P21, DOI 10.1016/S1076-6332(03)00574-9; Wood JN, 2010, NEW ENGL J MED, V363, P1572, DOI 10.1056/NEJMe1004416; Zhang W, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4025	35	14	15	5	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10231	10239		10.1096/fj.201900970	http://dx.doi.org/10.1096/fj.201900970			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31238006				2022-12-28	WOS:000482214200041
J	Li, WJ; Li, N; Dai, SY; Hou, GQ; Guo, KL; Chen, XZ; Yi, CH; Liu, WY; Deng, F; Wu, YS; Cao, X				Li, Wenjiao; Li, Ning; Dai, Shiyu; Hou, Guoqing; Guo, Kanglin; Chen, Xuanzuo; Yi, Changhua; Liu, Weiyong; Deng, Fei; Wu, Yaosong; Cao, Xuan			Zika virus circumvents host innate immunity by targeting the adaptor proteins MAVS and MITA	FASEB JOURNAL			English	Article						ZIKV; immune evasion; IFN-beta	ANTIVIRAL SIGNALING PROTEIN; UBIQUITINATION; DEGRADATION; COMPLEX; GENES	Recently, Zika virus (ZIKV) has generated extraordinary concern because of its severe neurotoxicity. Disturbingly, there is no vaccine or specific drug to prevent or treat the diseases caused by ZIKV infection. Thus, it is extremely urgent to characterize the pathogenesis of ZIKV. It has been documented that ZIKV can evade antiviral responses of host cells. Here, we demonstrate that ZIKV strain SZ-WIV01 down-regulates the production of type I IFN and IFN-stimulated genes along with the expression of mitochondrial antiviral signaling protein (MAVS) and mediator of IFN regulatory factor 3 activation (MITA). In the mechanism, ZIKV nonstructural (NS) 3 and NS2B3 negatively regulate IFN-related retinoic acid-inducible gene I-like receptor signaling pathway by targeting MAVS and MITA, respectively. Overexpression of ZIKV NS3 and NS2B3 dramatically inhibits expression of IFN-beta. ZIKV NS3 interacts with MAVS, and NS2B3 interacts with MITA, which catalyzes K48-linked polyubiquitination of MAVS and MITA for degradation. Further investigations suggest that ZIKV NS2B3 impairs polyinosinic:polycytidylic acid-triggered K63-linked polyubiquitination of MITA, thereby subverting the activation of downstream sensors. Our study reveals an undiscovered mechanism for ZIKV to escape the innate immune response, providing new insights into clinical study of vaccines or effective drugs.-Li, W., Li, N., Dai, S., Hou, G., Guo, K., Chen, X., Yi, C., Liu, W., Deng, F., Wu, Y., Cao, X. Zika virus circumvents host innate immunity by targeting the adaptor proteins MAVS and MITA.	[Li, Wenjiao; Hou, Guoqing; Guo, Kanglin; Chen, Xuanzuo; Cao, Xuan] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Hangkong Rd 13, Wuhan 430030, Hubei, Peoples R China; [Liu, Weiyong] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Clin Lab, Wuhan, Hubei, Peoples R China; [Li, Ning; Wu, Yaosong] Henan Univ Tradit Chinese Med, Sch Basic Med, Inst Canc Mol Mech & Drug Targets, Zhengzhou, Henan, Peoples R China; [Dai, Shiyu; Deng, Fei] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China; [Yi, Changhua] Chinese Acad Sci, State Key Lab Resp Dis, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Henan University of Traditional Chinese Medicine; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease	Cao, X (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Hangkong Rd 13, Wuhan 430030, Hubei, Peoples R China.; Wu, YS (corresponding author), Henan Univ Tradit Chinese Med, Inst Canc Mol Mech & Drug Targets, Jinshuidong Rd 156, Zhengzhou 450046, Henan, Peoples R China.	178028972@qq.com; caoxuanwhu@126.com	guo, kanglin/GRX-2778-2022; Dai, Shiyu/HDO-2698-2022		National Natural Science Foundation of China [31571431, 31771541, 81503490]; Natural Science Foundation of Hubei Province of China [2016CFA053]; Intergovernmental Special Program of State Key Research and Development Plan from the Ministry of Science and Technology of China [2016YFE0113500]; National Mega Project on Major Infectious Diseases Prevention [2017ZX10103005-007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); Intergovernmental Special Program of State Key Research and Development Plan from the Ministry of Science and Technology of China; National Mega Project on Major Infectious Diseases Prevention	The authors thank Dr. Hong-Bing Shu (Wuhan University, Wuhan, China) for providing the plasmid pRK-Flag-MITA/TBK1/IRF3/IRF3-5D and Dr. Hong-Bo Zhou (Huazhong Agricultural University, Wuhan, China) for providing the IFN-beta luciferase reporter plasmid (pIFN-beta-luci) and Renilla luciferase reporter plasmid (pRL-TK) as gifts. This work was supported by the National Natural Science Foundation of China (31571431, 31771541, 81503490), the Natural Science Foundation of Hubei Province of China (2016CFA053), the Intergovernmental Special Program of State Key Research and Development Plan from the Ministry of Science and Technology of China (2016YFE0113500), and the National Mega Project on Major Infectious Diseases Prevention (2017ZX10103005-007). The authors declare no conflicts of interest.	Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640; Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Chan YK, 2016, NAT IMMUNOL, V17, P523, DOI 10.1038/ni.3393; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Davis ME, 2015, VIROLOGY, V479, P52, DOI 10.1016/j.virol.2015.02.033; Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5; DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2; Ebner P, 2017, CRIT REV BIOCHEM MOL, V52, P425, DOI 10.1080/10409238.2017.1325829; Eisenacher K, 2012, EUR J CELL BIOL, V91, P36, DOI 10.1016/j.ejcb.2011.01.011; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009; Hou WH, 2017, GENE, V628, P117, DOI 10.1016/j.gene.2017.07.049; Jin SH, 2017, MOL CELL, V68, P308, DOI 10.1016/j.molcel.2017.09.005; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z; Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Liu BY, 2017, NAT IMMUNOL, V18, P214, DOI 10.1038/ni.3641; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Liu SQ, 2013, ELIFE, V2, DOI 10.7554/eLife.00785; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Ma JF, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00459; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mottin M, 2017, BIOCHEM BIOPH RES CO, V492, P643, DOI 10.1016/j.bbrc.2017.03.070; Pan Y, 2014, J IMMUNOL, V192, P4758, DOI 10.4049/jimmunol.1302632; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821; Suhara W, 2000, J BIOCHEM-TOKYO, V128, P301, DOI 10.1093/oxfordjournals.jbchem.a022753; Sun H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15534; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Wang JN, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13101031; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI DOI 10.1093/JTM/TAY044; Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6; Xing JJ, 2018, J IMMUNOL, V201, P183, DOI 10.4049/jimmunol.1701569; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Yu CY, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005350; Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780; Zhang HL, 2017, J VIROL, V91, DOI [10.1128/JVI.02396-16, 10.1128/jvi.02396-16]; Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2010, J IMMUNOL, V184, P6249, DOI 10.4049/jimmunol.0903748	50	21	21	1	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9929	9944		10.1096/fj.201900260R	http://dx.doi.org/10.1096/fj.201900260R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31180720				2022-12-28	WOS:000482214200019
J	Pera, T; Tompkins, E; Katz, M; Wang, B; Deshpande, DA; Weinman, EJ; Penn, RB				Pera, Tonio; Tompkins, Eric; Katz, Michael; Wang, Bin; Deshpande, Deepak A.; Weinman, Edward J.; Penn, Raymond B.			Specificity of NHERF1 regulation of GPCR signaling and function in human airway smooth muscle	FASEB JOURNAL			English	Article						EBP50; compartmentalized signaling; PKA; c/EBP; asthma	PROTEIN-KINASE-A; ADENYLYL-CYCLASE; BETA(2)-ADRENERGIC RECEPTOR; COMPARTMENTALIZED CAMP; ADAPTER PROTEINS; BETA; MEMBRANE; BINDING; C/EBP; EBP50	Na+/H+ exchanger regulatory factor 1 (NHERF1; also known as ezrin-radixin-moesin-binding phosphoprotein 50) is a PSD-95, disc large, zona occludens-1 adapter that acts as a scaffold for signaling complexes and cytoskeletal-plasma membrane interactions. NHERF1 is crucial to beta-2-adrenoceptor (beta(2)AR)-mediated activation of cystic fibrosis transmembrane conductance regulator (CFTR) in epithelial cells, and NHERF1 has been proposed to mediate the recycling of internalized beta(2)AR back to the cell membrane. In the current study, we assessed the role of NHERF1 in regulating cAMP-mediated signaling and immunomodulatory functions in airway smooth muscle (ASM). NHERF1 knockdown attenuated the induction of (protein kinase A) phospho-vasodilator-stimulated phosphoprotein (p-VASP) by isoproterenol (ISO), prostaglandin E-2 (PGE(2)), or forskolin (FSK) as well as the induction of p-heat shock protein 20 after 4 h of stimulation with ISO and FSK. NHERF1 knockdown fully abrogated the ISO-, PGE(2)-, and FSK-induced IL-6 gene expression and cytokine production without affecting cAMP-mediated phosphodiesterase 4D (PDE4D) gene expression, phospho-cAMP response element-binding protein (p-CREB), and cAMP response element (CRE)-Luc, or PDGF-induced cyclin D1 expression. Interestingly, NHERF1 knockdown prevented ISO-induced chromatin-binding of the transcription factor CCAAT-enhancer-binding protein-beta (c/EBP beta). c/EBP beta knockdown almost completely abrogated the cAMP-mediated IL-6 but not PDE4D gene expression. The differential regulation of cAMP-induced signaling and gene expression in our study indicates a role for NHERF1 in the compartmentalization of cAMP signaling in ASM.-Pera, T., Tompkins, E., Katz, M., Wang, B., Deshpande, D. A., Weinman, E. J., Penn, R. B. Specificity of NHERF1 regulation of GPCR signaling and function in human airway smooth muscle.	[Pera, Tonio; Tompkins, Eric; Katz, Michael; Wang, Bin; Deshpande, Deepak A.; Penn, Raymond B.] Thomas Jefferson Univ, Dept Med, Jane & Leonard Korman Resp Inst, Div Pulm & Crit Care Med,Ctr Translat Med, Philadelphia, PA 19107 USA; [Weinman, Edward J.] Univ Maryland, Dept Med, Baltimore, MD 21201 USA	Jefferson University; University System of Maryland; University of Maryland Baltimore	Pera, T; Penn, RB (corresponding author), Thomas Jefferson Univ, Ctr Translat Med, Room 543 JAH,1020 Locust St, Philadelphia, PA 19107 USA.	tonio.pera@jefferson.edu; raymond.penn@jefferson.edu			U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL58506, HL136209, HL140064]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL140064, R01HL058506, R01HL136209, R01HL137030] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants HL58506, HL136209 (to R.B.P.), and HL140064 (to T.P.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; Ammit AJ, 2002, AM J RESP CELL MOL, V26, P465, DOI 10.1165/ajrcmb.26.4.4681; Ardura JA, 2011, PHARMACOL REV, V63, P882, DOI 10.1124/pr.110.004176; Baillie GS, 2009, FEBS J, V276, P1790, DOI 10.1111/j.1742-4658.2009.06926.x; Billington CK, 1999, AM J RESP CELL MOL, V21, P597, DOI 10.1165/ajrcmb.21.5.3759; Billington CK, 2001, AM J RESP CELL MOL, V24, P633, DOI 10.1165/ajrcmb.24.5.4215; Brdickova N, 2001, FEBS LETT, V507, P133, DOI 10.1016/S0014-5793(01)02955-6; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Claperon A, 2012, ONCOGENE, V31, P1376, DOI 10.1038/onc.2011.334; Clark BJ, 2016, CELL PHYSIOL BIOCHEM, V39, P1, DOI 10.1159/000445601; Cornez I, 2010, FEBS LETT, V584, P2681, DOI 10.1016/j.febslet.2010.04.056; Damera G, 2009, PULM PHARMACOL THER, V22, P353, DOI 10.1016/j.pupt.2008.12.006; Deshpande DA, 2008, FASEB J, V22, P2134, DOI 10.1096/fj.07-102459; Ediger TR, 1999, ENDOCRINOLOGY, V140, P2976, DOI 10.1210/en.140.7.2976; Goncharova EA, 2003, AM J RESP CELL MOL, V29, P19, DOI 10.1165/rcmb.2002-0254OC; Guo MH, 2005, BIOCHEMISTRY-US, V44, P13771, DOI 10.1021/bi051255y; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; Horvat SJ, 2012, FASEB J, V26, P3670, DOI 10.1096/fj.11-201020; Itoh K, 2002, J IMMUNOL, V168, P541, DOI 10.4049/jimmunol.168.2.541; Jiang YY, 2014, BIOCHEM BIOPH RES CO, V446, P638, DOI 10.1016/j.bbrc.2014.03.028; John AE, 2009, J IMMUNOL, V183, P4682, DOI 10.4049/jimmunol.0803832; Johnstone TB, 2018, AM J RESP CELL MOL, V58, P530, DOI 10.1165/rcmb.2017-0294OC; Johnstone TB, 2018, MOL PHARMACOL, V93, P270, DOI 10.1124/mol.117.110825; Kong KC, 2008, BIOCHEMISTRY-US, V47, P9279, DOI 10.1021/bi801056w; Koziol-White CJ, 2011, IMMUNOL REV, V242, P178, DOI 10.1111/j.1600-065X.2011.01022.x; Lamprecht G, 2006, AM J PHYSIOL-GASTR L, V291, pG766, DOI 10.1152/ajpgi.00135.2006; Le Jeune IR, 2002, J BIOL CHEM, V277, P35980, DOI 10.1074/jbc.M204832200; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Lin YY, 2012, J CLIN INVEST, V122, P1881, DOI 10.1172/JCI45661; Liu L, 2012, J BIOL CHEM, V287, P43312, DOI 10.1074/jbc.M112.422766; Lobo MJ, 2016, J CELL SCI, V129, P2599, DOI 10.1242/jcs.185629; Misior AM, 2008, MOL PHARMACOL, V73, P566, DOI 10.1124/mol.107.040519; Misior AM, 2009, AM J RESP CELL MOL, V41, P24, DOI 10.1165/rcmb.2008-0266OC; Monterisi S, 2012, J CELL SCI, V125, P1106, DOI 10.1242/jcs.089086; Morgan SJ, 2014, J BIOL CHEM, V289, P23065, DOI 10.1074/jbc.M114.557652; Mundell SJ, 2001, AM J RESP CELL MOL, V24, P155, DOI 10.1165/ajrcmb.24.2.4243; MURRAY RK, 1993, AM J PHYSIOL, V264, pC485, DOI 10.1152/ajpcell.1993.264.2.C485; Pan Y, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1846; PANETTIERI RA, 1989, AM J PHYSIOL, V256, pC329, DOI 10.1152/ajpcell.1989.256.2.C329; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Saxena H, 2012, BRIT J PHARMACOL, V166, P981, DOI 10.1111/j.1476-5381.2011.01807.x; Shibata T, 2003, HEPATOLOGY, V38, P178, DOI 10.1053/jhep.2003.50270; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Stokka AJ, 2010, BIOCHEM J, V425, P381, DOI 10.1042/BJ20091136; Sundfeldt K, 1999, BRIT J CANCER, V79, P1240, DOI 10.1038/sj.bjc.6690199; TAE HJ, 1995, J BIOL CHEM, V270, P21487, DOI 10.1074/jbc.270.37.21487; Vaquero J, 2017, ONCOGENE, V36, P3067, DOI 10.1038/onc.2016.462; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang B, 2009, MOL PHARMACOL, V75, P1189, DOI 10.1124/mol.108.054486; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; Wheeler DS, 2011, ONCOGENE, V30, P32, DOI 10.1038/onc.2010.389; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200	55	6	6	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9008	9016		10.1096/fj.201900323R	http://dx.doi.org/10.1096/fj.201900323R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31042404	Green Published			2022-12-28	WOS:000478832900026
J	Richardson, L; Jeong, S; Kim, S; Han, A; Menon, R				Richardson, Lauren; Jeong, Sehoon; Kim, Sungjin; Han, Arum; Menon, Ramkumar			Amnion membrane organ-on-chip: an innovative approach to study cellular interactions	FASEB JOURNAL			English	Article						amnion epithelial cells; amnion mesenchymal cells; cellular transition; cellular migration; fetal membrane	HUMAN FETAL MEMBRANES; OXIDATIVE STRESS; PREMATURE RUPTURE; SENESCENCE; MICROSCOPY; PLATFORM; CULTURE; CELLS; MODEL	The amnion membrane that lines the human intrauterine cavity is composed of amnion epithelial cells (AECs) connected to an extracellular matrix containing amnion mesenchymal cells (AMCs) through a basement membrane. Cellular interactions and transitions are mechanisms that facilitate membrane remodeling to maintain its integrity. Dysregulation of cellular remodeling, primarily mediated by oxidative stress (OS), is often associated with preterm birth. However, the mechanisms that maintain membrane homeostasis remain unclear. To understand these mechanisms, we developed an amnion membrane organ-on-chip (AM-OOC) and tested the interactive and transition properties of primary human AECs and AMCs under normal and OS conditions. AM-OOC contained 2 chambers connected by type IV collagen-coated microchannels, allowing independent culture conditions that permitted cellular migration and interactions. Cells grown either independently or coculture were exposed to OS inducing cigarette smoke extract, antioxidant N-acetyl-l-cysteine (NAC), or both. When grown independently, AECs transitioned to AMCs and migrated, whereas AMCs migrated without transition. OS caused AECs' transition but prevented migration, whereas AMCs' migration was unhindered. Coculture of cells facilitated transition, migration, and eventual integration in the contiguous population. OS cotreatment in both chambers facilitated AECs' transition, prevented migration, and increased inflammation, a process that was prevented by NAC. AM-OOC recapitulated cellular mechanisms observed in utero and enabled experimental manipulation of cells to determine their roles during pregnancy and parturition.-Richardson, L., Jeong, S., Kim, S., Han, A., Menon, R. Amnion membrane organ-on-chip: an innovative approach to study cellular interactions.	[Richardson, Lauren; Menon, Ramkumar] Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med & Perinatal Res, 301 Univ Blvd, Galveston, TX 77555 USA; [Richardson, Lauren] Univ Texas Med Branch, Dept Neurosci, Galveston, TX 77555 USA; [Jeong, Sehoon; Kim, Sungjin; Han, Arum] Texas A&M Univ, Dept Biomed Engn, Dept Elect & Comp Engn, College Stn, TX USA; [Jeong, Sehoon] Inje Univ, Dept Healthcare Informat Technol, Gimhae, South Korea	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Texas A&M University System; Texas A&M University College Station; Inje University	Menon, R (corresponding author), Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med & Perinatal Res, 301 Univ Blvd, Galveston, TX 77555 USA.	ram.menon@utmb.edu	Jeong, Sehoon/AAK-7146-2021; Han, Arum/C-7078-2013	Jeong, Sehoon/0000-0003-4174-0219; Han, Arum/0000-0002-9223-8301; Richardson, Lauren/0000-0001-8392-2833	National Institute of Environmental Health Sciences (NIEHS) of the U.S. National Institutes of Health (NIH) [T32ES007254]; NIH, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [1R01HD084532-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD084532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007254] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS) of the U.S. National Institutes of Health (NIH); NIH, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	L.R. is a predoctoral trainee in the Environmental Toxicology Training Program (T32ES007254), which is supported by the National Institute of Environmental Health Sciences (NIEHS) of the U.S. National Institutes of Health (NIH) and administered through the University of Texas Medical Branch in Galveston, TX. This study is supported by an NIH, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Grant 1R01HD084532-01A1 to R.M. The authors declare no conflicts of interest.	An F, 2015, ANAL CHEM INSIGHTS, V10, P39, DOI [10.4137/ACICI.S28905, 10.4137/ACI.S28905]; Avila C, 2014, PLACENTA, V35, P1065, DOI 10.1016/j.placenta.2014.09.011; Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989; Bogusiewicz M, 1998, EUR J OBSTET GYN R B, V77, P141, DOI 10.1016/S0301-2115(97)00245-5; Bryant-Greenwood GD, 1998, PLACENTA, V19, P1, DOI 10.1016/S0143-4004(98)90092-3; Canciello A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03908-1; Casey ML, 1996, BIOL REPROD, V55, P1253, DOI 10.1095/biolreprod55.6.1253; Castillo-Castrejon M, 2014, AM J REPROD IMMUNOL, V71, P86, DOI 10.1111/aji.12179; Chen WL, 2012, COMPUT MED IMAG GRAP, V36, P519, DOI 10.1016/j.compmedimag.2012.06.003; Dixon CL, 2018, AM J REPROD IMMUNOL, V79, DOI 10.1111/aji.12790; Esch EW, 2015, NAT REV DRUG DISCOV, V14, P248, DOI 10.1038/nrd4539; GIBBS RS, 1982, OBSTET GYNECOL, V60, P671; Gnecco JS, 2017, CURR PHARM DESIGN, V23, P6115, DOI 10.2174/1381612823666170825142649; Gnecco JS, 2017, ANN BIOMED ENG, V45, P1758, DOI 10.1007/s10439-017-1797-5; Jabareen M, 2009, EUR J OBSTET GYN R B, V144, pS134, DOI 10.1016/j.ejogrb.2009.02.032; Jin J, 2018, PLACENTA, V67, P15, DOI 10.1016/j.placenta.2018.05.008; King AE, 2007, PLACENTA, V28, P1099, DOI 10.1016/j.placenta.2007.06.002; Lee J, 2016, J MATERN-FETAL NEO M, V29, P707, DOI 10.3109/14767058.2015.1020293; MALAK TM, 1993, PLACENTA, V14, P385, DOI 10.1016/S0143-4004(05)80460-6; Mauri A, 2013, PLACENTA, V34, P1020, DOI 10.1016/j.placenta.2013.09.002; Mauri A, 2015, J BIOMECH, V48, P1606, DOI 10.1016/j.jbiomech.2015.01.045; Mauri A, 2015, ACTA BIOMATER, V11, P314, DOI 10.1016/j.actbio.2014.09.012; Menon R, 2011, PLACENTA, V32, P317, DOI 10.1016/j.placenta.2011.01.015; Menon R, 2017, SEMIN PERINATOL, V41, P409, DOI 10.1053/j.semperi.2017.07.012; Menon R, 2016, PLACENTA, V44, P1, DOI 10.1016/j.placenta.2016.05.013; Menon R, 2014, AM J PATHOL, V184, P1740, DOI 10.1016/j.ajpath.2014.02.011; Menon R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083416; Park J, 2012, LAB CHIP, V12, P3296, DOI 10.1039/c2lc40303j; Park J, 2009, BIOMED MICRODEVICES, V11, P1145, DOI 10.1007/s10544-009-9331-7; Perrini M, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4030054; Polettini J, 2018, PLACENTA, V63, P26, DOI 10.1016/j.placenta.2018.01.009; Polettini J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137188; Pomduk K, 2015, ANN HEMATOL, V94, P319, DOI 10.1007/s00277-014-2210-1; Richardson L., 2017, ENCY REPROD, P387; Richardson L., 2019, REPROD SCI; Richardson L, 2018, AM J PATHOL, V188, P2004, DOI 10.1016/j.ajpath.2018.05.019; Richardson L, 2018, BIOL REPROD, V99, P1100, DOI 10.1093/biolre/ioy135; Richardson L, 2017, PLACENTA, V53, P66, DOI 10.1016/j.placenta.2017.03.017; Richardson LS, 2017, AM J PATHOL, V187, P2821, DOI 10.1016/j.ajpath.2017.08.019; Roy R, 2015, CELL TRANSPLANT, V24, P985, DOI 10.3727/096368913X675151; Sato BL, 2016, PLACENTA, V44, P69, DOI 10.1016/j.placenta.2016.06.005; Sheller S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157614; Sheller-Miller S, 2017, J REPROD IMMUNOL, V123, P3, DOI 10.1016/j.jri.2017.08.003; Stinson LF, 2014, REPRODUCTION, V147, P313, DOI 10.1530/REP-13-0576; Sweeney EL, 2017, CLIN MICROBIOL REV, V30, P349, DOI 10.1128/CMR.00091-16; Xiao S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14584	46	25	26	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					8945	8960		10.1096/fj.201900020RR	http://dx.doi.org/10.1096/fj.201900020RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31039044	Green Published			2022-12-28	WOS:000478832900021
J	Gumucio, JP; Qasawa, AH; Ferrara, PJ; Malik, AN; Funai, K; McDonagh, B; Mendias, CL				Gumucio, Jonathan P.; Qasawa, Austin H.; Ferrara, Patrick J.; Malik, Afshan N.; Funai, Katsuhiko; McDonagh, Brian; Mendias, Christopher L.			Reduced mitochondrial lipid oxidation leads to fat accumulation in myosteatosis	FASEB JOURNAL			English	Article						muscle injury; rotator cuff; fatty degeneration; muscle atrophy	SKELETAL-MUSCLE; ROTATOR-CUFF; FORCE PRODUCTION; TGF-BETA; EXERCISE; FIBROSIS; ATROPHY; GENERATION; EXPRESSION; CAPACITY	Myosteatosis is the pathologic accumulation of lipid that can occur in conjunction with atrophy and fibrosis following skeletal muscle injury. Little is known about the mechanisms by which lipid accumulates in myosteatosis, but many clinical studies have demonstrated that the degree of lipid infiltration negatively correlates with muscle function and regeneration. Our objective was to determine the pathologic changes that result in lipid accumulation in injured muscle fibers. We used a rat model of rotator cuff injury in this study because the rotator cuff muscle group is particularly prone to the development of myosteatosis after injury. Muscles were collected from uninjured controls or 10, 30, or 60 d after injury and analyzed using a combination of muscle fiber contractility assessments, RNA sequencing, and undirected metabolomics, lipidomics, and proteomics, along with bioinformatics techniques to identify potential pathways and cellular processes that are dysregulated after rotator cuff tear. Bioinformatics analyses indicated that mitochondrial function was likely disrupted after injury. Based on these findings and given the role that mitochondria play in lipid metabolism, we then performed targeted biochemical and imaging studies and determined that mitochondrial dysfunction and reduced fatty acid oxidation likely leads to the accumulation of lipid in myosteatosis.-Gumucio, J. P., Qasawa, A. H., Ferrara, P. J., Malik, A. N., Funai, K., McDonagh, B., Mendias, C. L. Reduced mitochondrial lipid oxidation leads to fat accumulation in myosteatosis.	[Gumucio, Jonathan P.; Qasawa, Austin H.; Mendias, Christopher L.] Univ Michigan, Dept Orthoped Surg, Ann Arbor, MI 48109 USA; [Gumucio, Jonathan P.; Mendias, Christopher L.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Ferrara, Patrick J.; Funai, Katsuhiko] Univ Utah, Diabet & Metab Res Ctr, Salt Lake City, UT USA; [Malik, Afshan N.] Kings Coll London, Fac Life Sci & Med, Sch Life Course Sci, Dept Diabet, London, England; [McDonagh, Brian] Natl Univ Ireland, Sch Med, Dept Physiol, Galway, Ireland; [Mendias, Christopher L.] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA; [Mendias, Christopher L.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah; University of London; King's College London; Ollscoil na Gaillimhe-University of Galway; Cornell University	Mendias, CL (corresponding author), Hosp Special Surg, Res Inst, 535 E 70th St,S-602, New York, NY 10021 USA.	mendiasc@hss.edu	Mendias, Christopher/C-5557-2018	Mendias, Christopher/0000-0002-2384-0171; Malik, Afshan/0000-0001-7207-1666	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and skin Diseases [F31-AR065931, R01-AR063649]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK107397, R03-DK109888, U24-DK097153]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107397, R03DK109888, U24DK097153] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge technical contributions from Dr. Richard McEachin, Dr. James Markworth (both from the University of Michigan, Ann Arbor, MI), and Jacob Swanson (Hospital for Special Surgery, New York, NY). This work was supported by Grants from the U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and skin Diseases (F31-AR065931, R01-AR063649), and from the NIH National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK107397, R03-DK109888, and U24-DK097153). The authors declare no conflicts of interest.	Afshinnia F, 2018, J AM SOC NEPHROL, V29, P295, DOI 10.1681/ASN.2017030350; Ajaz Saima, 2015, Methods Mol Biol, V1264, P117, DOI 10.1007/978-1-4939-2257-4_12; Aon MA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00282; Baumer TG, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116666506; Bedi A, 2010, J BONE JOINT SURG AM, V92A, P1894, DOI 10.2106/JBJS.I.01531; Bhattacharya A, 2011, FREE RADICAL BIO MED, V50, P592, DOI 10.1016/j.freeradbiomed.2010.12.014; Bhattacharya A, 2009, J BIOL CHEM, V284, P46, DOI 10.1074/jbc.M806311200; Biever A, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00075; Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Carda S, 2013, EUR J PHYS REHAB MED, V49, P119; Carter HN, 2015, PHYSIOLOGY, V30, P208, DOI 10.1152/physiol.00039.2014; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Claflin DR, 2011, J APPL PHYSIOL, V111, P1021, DOI 10.1152/japplphysiol.01119.2010; COGSWELL AM, 1993, AM J PHYSIOL, V264, pC383, DOI 10.1152/ajpcell.1993.264.2.C383; Colvin AC, 2012, J BONE JOINT SURG AM, V94A, P227, DOI [10.2106/JBJS.J.00739, 10.2106/JBJS.J.01886]; Davis ME, 2015, J SHOULDER ELB SURG, V24, P280, DOI 10.1016/j.jse.2014.06.048; Davis ME, 2015, CLIN ORTHOP RELAT R, V473, P226, DOI 10.1007/s11999-014-3860-y; Demine S, 2014, METABOLITES, V4, P831, DOI 10.3390/metabo4030831; DOHM GL, 1972, AM J PHYSIOL, V223, P783, DOI 10.1152/ajplegacy.1972.223.4.783; Drake JC, 2017, J PHYSIOL-LONDON, V595, P6391, DOI 10.1113/JP274337; Elenich LA, 1999, IMMUNOGENETICS, V49, P835, DOI 10.1007/s002510050562; Ferreira R, 2010, PROTEOMICS, V10, P3142, DOI 10.1002/pmic.201000173; Flores DV, 2018, RADIOGRAPHICS, V38, P124, DOI 10.1148/rg.2018170072; Fry CS, 2017, J ORTHOP RES, V35, P1876, DOI 10.1002/jor.23502; Gerber C, 2007, J SHOULDER ELB SURG, V16, P691, DOI 10.1016/j.jse.2007.02.122; Gibbons MC, 2017, J BONE JOINT SURG AM, V99, DOI 10.2106/JBJS.16.00335; Gibbons MC, 2016, J ORTHOP RES, V34, P2089, DOI 10.1002/jor.23256; Gigliotti D, 2015, AM J PHYSIOL-CELL PH, V309, pC383, DOI 10.1152/ajpcell.00143.2015; Gladstone JN, 2007, AM J SPORT MED, V35, P719, DOI 10.1177/0363546506297539; Glancy B, 2015, NATURE, V523, P617, DOI 10.1038/nature14614; Gram M, 2015, J PHYSIOL-LONDON, V593, P4011, DOI 10.1113/JP270211; Gumucio JP, 2015, EXERC SPORT SCI REV, V43, P93, DOI 10.1249/JES.0000000000000041; Gumucio JP, 2012, J ORTHOP RES, V30, P1963, DOI 10.1002/jor.22168; Iijima Y, 2002, J BIOL CHEM, V277, P23065, DOI 10.1074/jbc.M200328200; Jia Z, 2004, PROTEIN EXPRES PURIF, V38, P153, DOI 10.1016/j.pep.2004.08.013; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; Killian ML, 2013, J ORTHOP RES, V31, P1240, DOI 10.1002/jor.22345; Kim JK, 2002, METABOLISM, V51, P460, DOI 10.1053/meta.2002.31326; Kind T, 2013, NAT METHODS, V10, P755, DOI 10.1038/nmeth.2551; Koves TR, 2005, AM J PHYSIOL-CELL PH, V288, pC1074, DOI 10.1152/ajpcell.00391.2004; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Liu XH, 2011, J ORTHOP RES, V29, P588, DOI 10.1002/jor.21266; Lorenz MA, 2011, ANAL CHEM, V83, P3406, DOI 10.1021/ac103313x; Ma SP, 2016, ANTIOXID REDOX SIGN, V24, P486, DOI 10.1089/ars.2015.6336; MacPherson REK, 2015, APPL PHYSIOL NUTR ME, V40, P641, DOI 10.1139/apnm-2014-0485; Marabita M, 2016, CELL REP, V17, P501, DOI 10.1016/j.celrep.2016.09.020; Mathewson MA, 2014, J EXP BIOL, V217, P261, DOI 10.1242/jeb.083923; McDonagh B, 2014, J PROTEOME RES, V13, P5008, DOI 10.1021/pr5006394; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Mendias CL, 2017, J APPL PHYSIOL, V122, P571, DOI 10.1152/japplphysiol.00719.2016; Mendias CL, 2015, J SHOULDER ELB SURG, V24, P111, DOI 10.1016/j.jse.2014.06.037; Mendias CL, 2012, MUSCLE NERVE, V45, P55, DOI 10.1002/mus.22232; Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534; Meyer GA, 2015, J ORTHOP RES, V33, P421, DOI 10.1002/jor.22786; Morag Y, 2006, RADIOGRAPHICS, V26, P1045, DOI 10.1148/rg.264055087; Overmyer KA, 2015, CELL METAB, V21, P468, DOI 10.1016/j.cmet.2015.02.007; Patel KD, 2016, BBA-BIOENERGETICS, V1857, P1284, DOI 10.1016/j.bbabio.2016.02.014; Pollock N, 2017, FREE RADICAL BIO MED, V112, P84, DOI 10.1016/j.freeradbiomed.2017.07.017; Powers SK, 2016, FREE RADICAL BIO MED, V98, P208, DOI 10.1016/j.freeradbiomed.2016.02.021; Richter K, 2016, CELL TISSUE RES, V365, P591, DOI 10.1007/s00441-016-2445-3; Roche SM, 2015, JOVE-J VIS EXP, DOI 10.3791/52695; Sartori R, 2014, TRENDS ENDOCRIN MET, V25, P464, DOI 10.1016/j.tem.2014.06.002; Sarver DC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02754-5; Soslowsky L J, 1996, J Shoulder Elbow Surg, V5, P383; Sugg KB, 2017, FEBS LETT, V591, P801, DOI 10.1002/1873-3468.12571; Tavares MR, 2015, LIFE SCI, V131, P1, DOI 10.1016/j.lfs.2015.03.001; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tryon LD, 2014, INTEGR MED RES, V3, P161, DOI 10.1016/j.imr.2014.09.001; Valencia AP, 2018, AM J SPORT MED, V46, P2161, DOI 10.1177/0363546518769267; Ward SR, 2010, J ORTHOP SPORT PHYS, V40, P729, DOI 10.2519/jospt.2010.3279; Watabe S, 1997, EUR J BIOCHEM, V249, P52, DOI 10.1111/j.1432-1033.1997.t01-1-00052.x; Watt MJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1315, DOI 10.1152/ajpendo.00561.2011; West DWD, 2016, J PHYSIOL-LONDON, V594, P453, DOI 10.1113/JP271365; Wicks SE, 2015, P NATL ACAD SCI USA, V112, pE3300, DOI 10.1073/pnas.1418560112; Wilde JM, 2016, J SHOULDER ELB SURG, V25, P1501, DOI 10.1016/j.jse.2016.01.035; Yamaguchi K, 2006, J BONE JOINT SURG AM, V88A, P1699, DOI 10.2106/JBJS.E.00835; Yamaki T, 2012, AM J PHYSIOL-CELL PH, V303, pC135, DOI 10.1152/ajpcell.00111.2012; Zhang C, 2014, J BIOMECH, V47, P944, DOI 10.1016/j.jbiomech.2014.01.026; Zoico E, 2013, ARCH GERONTOL GERIAT, V57, P411, DOI 10.1016/j.archger.2013.06.001	80	35	36	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					7863	7881		10.1096/fj.201802457RR	http://dx.doi.org/10.1096/fj.201802457RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30939247	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000476234700007
J	Hashimoto, M; Kusudo, T; Takeuchi, T; Kataoka, N; Mukai, T; Yamashita, H				Hashimoto, Michihiro; Kusudo, Tatsuya; Takeuchi, Tamaki; Kataoka, Naoya; Mukai, Takako; Yamashita, Hitoshi			CREG1 stimulates brown adipocyte formation and ameliorates diet-induced obesity in mice	FASEB JOURNAL			English	Article						brown adipose tissue; transgenic mouse; uncoupling protein 1; browning	MITOCHONDRIAL UNCOUPLING PROTEIN; ADIPOSE-TISSUE; E1A-STIMULATED GENES; CELLULAR REPRESSOR; BEIGE FAT; GROWTH; ENERGY; FGF21; CONTRIBUTES; RESISTANCE	Increased formation of brown and beige adipocytes is critical for adaptive thermogenesis to maintain homeothermy in cold or to circumvent diet-induced obesity (DIO). Cellular repressor of adenovirus early region 1A-stimulated genes 1 (CREG1) exhibits the ability to stimulate brown adipogenesis, including the induction of uncoupling protein 1 (UCP1), in vitro. Thus, we aimed to clarify whether CREG1 promotes brown adipocyte formation and inhibits DIO at the whole-animal level. In mouse brown adipose tissue (BAT), CREG1 expression was markedly increased in cold but was decreased under thermoneutrality, suggesting CREG1 involvement in BAT thermogenesis. Moreover, in BAT and white adipose tissue, expression of UCP1 and fibroblast growth factor-21 and browning were both significantly higher in adipocyte P2-Creg1-transgenic (Tg) mice than in wild-type (WT) littermates. Following stimulation with a beta 3-adrenergic agonist, energy consumption was elevated in the Tg mice, which showed increased resistance to DIO and improvement of obesity-associated complications including fatty liver relative to WT mice. The CREG1 stimulatory effect on brown adipogenesis was confirmed in Tg-BAT primary cultures. It was also found that CREG1 binds to retinoid X receptor alpha, which interacts with thyroid hormone receptor for brown adipogenesis. Our findings demonstrate that CREG1 stimulates brown adipocyte formation and browning, ameliorating obesity and its related pathology in vivo.-Hashimoto, M., Kusudo, T., Takeuchi, T., Kataoka, N., Mukai, T., Yamashita, H. CREG1 stimulates brown adipocyte formation and ameliorates diet-induced obesity in mice.	[Hashimoto, Michihiro; Kusudo, Tatsuya; Takeuchi, Tamaki; Kataoka, Naoya; Yamashita, Hitoshi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, 1200 Matsumoto Cho, Kasugai, Aichi 4878501, Japan; [Kusudo, Tatsuya; Mukai, Takako] Tezukayama Gakuin Univ, Fac Human Sci, Dept Nutr & Food Sci, Sakai, Osaka, Japan; [Kataoka, Naoya] Nagoya Univ, Dept Integrat Physiol, Sch Med, Nagoya, Aichi, Japan	Chubu University; Nagoya University	Yamashita, H (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, 1200 Matsumoto Cho, Kasugai, Aichi 4878501, Japan.	hyamashi@isc.chubu.ac.jp	Kataoka, Naoya/AGY-5263-2022	Kataoka, Naoya/0000-0002-2339-5522; Yamashita, Hitoshi/0000-0002-5785-5208	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [S1201007]; Japan Society for the Promotion of Science [24580499, 15K07846, 15K07446, 16K21453]; Chubu University	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Chubu University	The authors thank Y. Yamashita, Y. Ohmi, A. Nozaki, and Y. Endo (all from Chubu University) for technical support and Dr. Y. Kamei (Kyoto Prefectural University) for adipocyte protein 2 promoter. This work was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT)-supported program for the Strategic Research Foundation at Private Universities (S1201007), Grant-in-Aid for Scientific Research (Kakenhi) from the Japan Society for the Promotion of Science (Grants 24580499 and 15K07846 to H.Y., 15K07446 to T.K., and 16K21453 to M.H.), and Chubu University Grant A (to H.Y.). The authors declare no conflicts of interest.	Bergman D, 2013, GERONTOLOGY, V59, P240, DOI 10.1159/000343995; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2012, J CLIN INVEST, V122, P486, DOI 10.1172/JCI60941; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Di Bacco A, 2003, ONCOGENE, V22, P5436, DOI 10.1038/sj.onc.1206670; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fisher FM, 2016, ANNU REV PHYSIOL, V78, P223, DOI 10.1146/annurev-physiol-021115-105339; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gordon PV, 2005, J ENDOCRINOL, V185, P265, DOI 10.1677/joe.1.06093; Han YL, 2008, CARDIOVASC RES, V78, P597, DOI 10.1093/cvr/cvn036; Ikushima H, 2000, P NATL ACAD SCI USA, V97, P8439, DOI 10.1073/pnas.97.15.8439; Inokuma K, 2006, AM J PHYSIOL-ENDOC M, V290, pE1014, DOI 10.1152/ajpendo.00105.2005; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kontani Y, 2005, AGING CELL, V4, P147, DOI 10.1111/j.1474-9726.2005.00157.x; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Kozak LP, 2000, ANNU REV NUTR, V20, P339, DOI 10.1146/annurev.nutr.20.1.339; Kusudo T, 2019, J BIOCHEM, V165, P47, DOI 10.1093/jb/mvy083; Kusudo T, 2012, J APPL PHYSIOL, V112, P1223, DOI 10.1152/japplphysiol.01070.2011; Li LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122024; Liu J, 2016, STEM CELLS, V34, P2648, DOI 10.1002/stem.2434; Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; Ni B, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00148; Nishio M, 2012, CELL METAB, V16, P394, DOI 10.1016/j.cmet.2012.08.001; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Samms RJ, 2015, CELL REP, V11, P991, DOI 10.1016/j.celrep.2015.04.046; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Tian XX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176873; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Veal E, 1998, MOL CELL BIOL, V18, P5032, DOI 10.1128/MCB.18.9.5032; Veal E, 2000, ONCOGENE, V19, P2120, DOI 10.1038/sj.onc.1203529; Veniant MM, 2015, CELL METAB, V21, P731, DOI 10.1016/j.cmet.2015.04.019; Villarroya F, 2013, CELL METAB, V17, P638, DOI 10.1016/j.cmet.2013.02.020; Wang T, 2008, ENDOCRINOLOGY, V149, P358, DOI 10.1210/en.2007-0467; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Yamada K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062304; YAMASHITA H, 1994, PFLUG ARCH EUR J PHY, V428, P352, DOI 10.1007/BF00724518	44	11	11	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8069	8082		10.1096/fj.201802147RR	http://dx.doi.org/10.1096/fj.201802147RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30917000	Bronze			2022-12-28	WOS:000476234700022
J	Charsar, BA; Brinton, MA; Locke, K; Chen, AY; Ghosh, B; Urban, MW; Komaravolu, S; Krishnamurthy, K; Smit, R; Pasinelli, P; Wright, MC; Smith, GM; Lepore, AC				Charsar, Brittany A.; Brinton, Michael A.; Locke, Katherine; Chen, Anna Y.; Ghosh, Biswarup; Urban, Mark W.; Komaravolu, Sreeya; Krishnamurthy, Karthik; Smit, Rupert; Pasinelli, Piera; Wright, Megan C.; Smith, George M.; Lepore, Angelo C.			AAV2-BDNF promotes respiratory axon plasticity and recovery of diaphragm function following spinal cord injury	FASEB JOURNAL			English	Article						SCI; cervical; phrenic; sprouting	PHRENIC MOTONEURONS; NEUROTROPHIC FACTOR; SYNAPTIC-TRANSMISSION; BDNF; DEGENERATION; INTERNEURONS; REGENERATION; FACILITATION; MODULATION; INHIBITORS	More than half of spinal cord injury (SCI) cases occur in the cervical region, leading to respiratory dysfunction due to damaged neural circuitry that controls critically important muscles such as the diaphragm. The C3-C5 spinal cord is the location of phrenic motor neurons (PhMNs) that are responsible for diaphragm activation; PhMNs receive bulbospinal excitatory drive predominately from supraspinal neurons of the rostral ventral respiratory group (rVRG). Cervical SCI results in rVRG axon damage, PhMN denervation, and consequent partial-to-complete paralysis of hemidiaphragm. In a rat model of C2 hemisection SCI, we expressed the axon guidance molecule, brain-derived neurotrophic factor (BDNF), selectively at the location of PhMNs (ipsilateral to lesion) to promote directed growth of rVRG axons toward PhMN targets by performing intraspinal injections of adeno-associated virus serotype 2 (AAV2)-BDNF vector. AAV2-BDNF promoted significant functional diaphragm recovery, as assessed by in vivo electromyography. Within the PhMN pool ipsilateral to injury, AAV2-BDNF robustly increased sprouting of both spared contralateral-originating rVRG axons and serotonergic fibers. Furthermore, AAV2-BDNF significantly increased numbers of putative monosynaptic connections between PhMNs and these sprouting rVRG and serotonergic axons. These findings show that targeting circuit plasticity mechanisms involving the enhancement of synaptic inputs from spared axon populations is a powerful strategy for restoring respiratory function post-SCI.	[Charsar, Brittany A.; Brinton, Michael A.; Locke, Katherine; Chen, Anna Y.; Ghosh, Biswarup; Urban, Mark W.; Komaravolu, Sreeya; Lepore, Angelo C.] Thomas Jefferson Univ, Jefferson Coll Life Sci, Sidney Kimmel Med Coll, Dept Neurosci,Vickie & Jack Farber Inst Neurosci, 233 South 10th St,BLSB 245, Philadelphia, PA 19107 USA; [Krishnamurthy, Karthik; Pasinelli, Piera] Thomas Jefferson Univ, Jefferson Coll Life Sci, Sidney Kimmel Med Coll, Dept Neurosci,Jefferson Weinberg Amyotrophic Late, Philadelphia, PA 19107 USA; [Smit, Rupert; Smith, George M.] Temple Univ, Lewis Katz Sch Med, Shriners Hosp Pediat Res Ctr, Dept Anat & Cell Biol,Dept Neurosci, Philadelphia, PA 19122 USA; [Wright, Megan C.] Arcadia Univ, Dept Biol, Philadelphia, PA USA	Jefferson University; Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Shriners Hospitals Children Philadelphia	Lepore, AC (corresponding author), Thomas Jefferson Univ, Jefferson Coll Life Sci, Sidney Kimmel Med Coll, Dept Neurosci,Vickie & Jack Farber Inst Neurosci, 233 South 10th St,BLSB 245, Philadelphia, PA 19107 USA.	angelo.lepore@jefferson.edu	Krishnamurthy, Karthik/W-2306-2017	Krishnamurthy, Karthik/0000-0003-2552-8912; Pasinelli, Piera/0000-0002-3385-2707	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS) [2R01NS079702, 1F30NS103436]; Craig H. Neilsen Foundation [476686]; Shriners Hospitals for Children Viral Core Grant [SHC 84051]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS103436, R01NS079702] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS); Craig H. Neilsen Foundation; Shriners Hospitals for Children Viral Core Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Dr. Rich Smeyne (Thomas Jefferson University) for sharing his expertise in 2-dimensional stereology counting techniques, and for his help with implementing these methods, and Dr. Robert Sterling (Thomas Jefferson University) for his patience and assistance with statistical analysis. This work was supported by the U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS; 2R01NS079702 to A.C.L. and 1F30NS103436 to B.A.C.), the Craig H. Neilsen Foundation (476686 to A.C.L.), and the Shriners Hospitals for Children Viral Core Grant SHC 84051 (to G.M.S.). The authors declare no conflicts of interest.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Baker-Herman TL, 2004, NAT NEUROSCI, V7, P48, DOI 10.1038/nn1166; Bartus K, 2012, EXP NEUROL, V235, P5, DOI 10.1016/j.expneurol.2011.08.008; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Busch SA, 2010, J NEUROSCI, V30, P255, DOI 10.1523/JNEUROSCI.3705-09.2010; CastroMoure F, 1997, EXP NEUROL, V147, P299, DOI 10.1006/exnr.1997.6615; Ciesielska A, 2011, MOL THER, V19, P922, DOI 10.1038/mt.2010.248; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Daubert EA, 2010, TRENDS NEUROSCI, V33, P424, DOI 10.1016/j.tins.2010.05.005; Desai NS, 1999, LEARN MEMORY, V6, P284; Dias DO, 2018, CELL, V173, P153, DOI 10.1016/j.cell.2018.02.004; DiPasquale E, 1997, NEUROSCI LETT, V230, P29, DOI 10.1016/S0304-3940(97)00469-2; DOBBINS EG, 1994, J COMP NEUROL, V347, P64, DOI 10.1002/cne.903470106; ELLENBERGER HH, 1990, J COMP NEUROL, V302, P707, DOI 10.1002/cne.903020403; ELLENBERGER HH, 1988, J COMP NEUROL, V269, P47, DOI 10.1002/cne.902690104; Ghosh B, 2018, J NEUROSCI, V38, P5982, DOI 10.1523/JNEUROSCI.3084-17.2018; Gill LC, 2016, RESP PHYSIOL NEUROBI, V226, P128, DOI 10.1016/j.resp.2015.10.009; Goshgarian HG, 2003, J APPL PHYSIOL, V94, P795, DOI 10.1152/japplphysiol.00847.2002; GOSHGARIAN HG, 1991, EXP NEUROL, V111, P135, DOI 10.1016/0014-4886(91)90061-G; Gransee HM, 2015, J NEUROTRAUM, V32, P185, DOI 10.1089/neu.2014.3464; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Hernandez-Torres V, 2017, J NEUROPHYSIOL, V117, P537, DOI 10.1152/jn.00654.2016; Keefe KM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030548; Lane MA, 2008, TRENDS NEUROSCI, V31, P538, DOI 10.1016/j.tins.2008.07.002; Lane MA, 2008, J COMP NEUROL, V511, P692, DOI 10.1002/cne.21864; Lane MA, 2009, RESP PHYSIOL NEUROBI, V169, P123, DOI 10.1016/j.resp.2009.08.007; LASKOWSKI MB, 1987, J NEUROSCI, V7, P252; Lee JK, 2012, EXP NEUROL, V235, P33, DOI 10.1016/j.expneurol.2011.05.001; Lessmann V, 1998, GEN PHARMACOL-VASC S, V31, P667; LEWIS LJ, 1951, AM J PHYSIOL, V166, P241, DOI 10.1152/ajplegacy.1951.166.2.241; Li K, 2015, EXP NEUROL, V271, P479, DOI 10.1016/j.expneurol.2015.07.020; Li K, 2015, MOL THER, V23, P533, DOI 10.1038/mt.2014.236; LINDSAY AD, 1993, J PHYSIOL-LONDON, V461, P213, DOI 10.1113/jphysiol.1993.sp019510; Liu Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095043, 10.1371/journal.pone.0086026]; Luo XT, 2012, INT REV NEUROBIOL, V105, P141, DOI 10.1016/B978-0-12-398309-1.00008-1; MacFarlane PM, 2009, J PHYSIOL-LONDON, V587, P5469, DOI 10.1113/jphysiol.2009.176982; Mantilla CB, 2013, EXP NEUROL, V247, P101, DOI 10.1016/j.expneurol.2013.04.002; Mantilla CB, 2009, J NEUROSCI METH, V182, P244, DOI 10.1016/j.jneumeth.2009.06.016; Martin M., 2015, JOVE-J VIS EXP, V99; Miletic G, 2002, NEUROSCI LETT, V319, P137, DOI 10.1016/S0304-3940(01)02576-9; MORENO DE, 1992, EXP NEUROL, V116, P219, DOI 10.1016/0014-4886(92)90001-7; Nicaise C, 2013, J NEUROTRAUM, V30, P1092, DOI 10.1089/neu.2012.2728; Nicaise C, 2012, J NEUROTRAUM, V29, P2748, DOI 10.1089/neu.2012.2467; Nicaise C, 2012, EXP NEUROL, V235, P539, DOI 10.1016/j.expneurol.2012.03.007; NOVIKOV L, 1995, NEUROSCI LETT, V200, P45, DOI 10.1016/0304-3940(95)12078-I; Novikov LN, 2000, NEUROSCIENCE, V100, P171, DOI 10.1016/S0306-4522(00)00256-6; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Pezet S, 2002, MOL CELL NEUROSCI, V21, P51, DOI 10.1006/mcne.2002.1166; Porter W T, 1895, J Physiol, V17, P455; Quraishe S, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/2952386; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Satkunendrarajah K, 2018, NATURE, V562, P419, DOI 10.1038/s41586-018-0595-z; Schinder AF, 2000, TRENDS NEUROSCI, V23, P639, DOI 10.1016/S0166-2236(00)01672-6; Schizas N, 2018, CELL TISSUE RES, V372, P493, DOI 10.1007/s00441-018-2808-z; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Smith JC, 2009, PHILOS T R SOC B, V364, P2577, DOI 10.1098/rstb.2009.0081; Soderblom C, 2013, J NEUROSCI, V33, P13882, DOI 10.1523/JNEUROSCI.2524-13.2013; Takeuchi T, 2017, BEHAV NEUROL, V2017, DOI 10.1155/2017/7514681; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Tosolini AP, 2012, NEUROSCIENCE, V200, P19, DOI 10.1016/j.neuroscience.2011.10.054; Urban MW, 2018, EXP NEUROL, V303, P108, DOI 10.1016/j.expneurol.2018.02.007; Weishaupt N, 2012, EXP NEUROL, V238, P254, DOI 10.1016/j.expneurol.2012.09.001; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zholudeva LV, 2017, J NEUROTRAUM, V34, P3058, DOI 10.1089/neu.2017.5045; Zimmer MB, 2007, J SPINAL CORD MED, V30, P319, DOI 10.1080/10790268.2007.11753947	65	7	7	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13775	13793		10.1096/fj.201901730R	http://dx.doi.org/10.1096/fj.201901730R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31577916	Bronze, Green Published			2022-12-28	WOS:000507466100057
J	Montgomery, MK; Bayliss, J; Keenan, S; Rhost, S; Ting, SB; Watt, MJ				Montgomery, Magdalene K.; Bayliss, Jacqueline; Keenan, Stacey; Rhost, Sarah; Ting, Stephen B.; Watt, Matthew J.			The role of Ap2a2 in PPAR alpha-mediated regulation of lipolysis in adipose tissue	FASEB JOURNAL			English	Article						PPAR alpha; endocytosis; beta-adrenergic signaling	ACTIVATED RECEPTOR-ALPHA; PROTEIN COMPLEX 2; BETA(2)-ADRENERGIC RECEPTOR; MOLECULAR-MECHANISM; AP2-SIGMA MUTATIONS; LIPID-METABOLISM; SKELETAL-MUSCLE; CLATHRIN; ADAPTER; SUBUNIT	Adipose tissue plays a major role in the regulation of systemic metabolic homeostasis, with the AP2 adaptor complex being important in clathrin-mediated endocytosis (CME) of various cell surface receptors, including glucose transporter 4, the insulin receptor, and beta-adrenergic receptors (ARs). One of the AP2 subunits, adaptor-related protein complex 2, alpha 2 subunit (Ap2a2), has recently been identified as a peroxisome proliferator activated receptor (PPAR)alpha target gene. The effects of PPAR alpha on the AP2 adaptor complex and CME are unknown. We generated adipocyte-specific Ap2a2 knockout mice and investigated their metabolism when fed a standard chow or high-fat diet, without and with supplementation with the PPAR alpha-agonist WY-14643 (WY). Although Ap2a2 deletion had only minor effects on glycaemic control, it led to substantial impairment in beta-adrenergic activation of lipolysis, as evidenced by a loss of cAMP response, PKA activation, and glycerol/fatty acid release. These differences were related to increased cell surface localization of the beta 2- and beta 3-ARs. Lipolytic defects were accompanied by impaired WY-mediated loss of fat mass and whole-body fat oxidation. This study demonstrates a novel role for PPAR alpha in beta-adrenergic regulation of adipose tissue lipolysis and for adipose tissue in supplying adequate substrate to other peripheral tissues to accommodate the increase in systemic fatty acid oxidation that occurs upon treatment with PPAR alpha agonists.	[Montgomery, Magdalene K.; Bayliss, Jacqueline; Keenan, Stacey; Watt, Matthew J.] Univ Melbourne, Sch Biomed Sci, Dept Physiol, Med Bldg 181,Cnr Grattan St & Royal Parade, Melbourne, Vic, Australia; [Rhost, Sarah; Ting, Stephen B.] Monash Univ, Alfred Ctr, Australian Ctr Blood Dis, Melbourne, Vic, Australia; [Ting, Stephen B.] Eastern Hlth, Box Hill Hosp, Dept Haematol, Melbourne, Vic, Australia	University of Melbourne; Monash University; Box Hill Hospital	Montgomery, MK (corresponding author), Univ Melbourne, Sch Biomed Sci, Dept Physiol, Med Bldg 181,Cnr Grattan St & Royal Parade, Melbourne, Vic, Australia.	magdalene.montgomery@unimelb.edu.au	Keenan, Stacey N/AAQ-2449-2020		Australian National Health and Medical Research Council (NHMRC) [APP1077703, APP1006420, APP1047554, APP1143224]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	The authors acknowledge support by research fellowships and project grants from the Australian National Health and Medical Research Council (NHMRC) (APP1077703 to M.J.W., APP1006420 and APP1047554 to S.B.T., and APP1143224 to M.K.M.). S.B.T. and M.J.W. share senior authorship. The authors declare no conflicts of interest.	Ahn S, 1999, J BIOL CHEM, V274, P1185, DOI 10.1074/jbc.274.3.1185; [Anonymous], 2013, BIO-PROTOCOL, DOI DOI 10.21769/BIOPROTOC.857; Arner P, 2018, CELL METAB, V28, P45, DOI 10.1016/j.cmet.2018.05.004; Beautrait A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15054; Bernhardt U, 2009, BIOL CHEM, V390, P883, DOI 10.1515/BC.2009.095; Brodsky FM, 2012, ANNU REV CELL DEV BI, V28, P309, DOI 10.1146/annurev-cellbio-101011-155716; Buroker NE, 2012, PROTEIN J, V31, P75, DOI 10.1007/s10930-011-9379-0; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; CARLSON LA, 1976, P ROY SOC MED, V69, P101, DOI 10.1177/00359157760690S226; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5; CARPENTIER JL, 1994, DIABETOLOGIA, V37, pS117, DOI 10.1007/BF00400835; Choi E, 2016, CELL, V166, P567, DOI 10.1016/j.cell.2016.05.074; Clarke SD, 1999, AM J CLIN NUTR, V70, P566; Ding QR, 2009, CELL RES, V19, P317, DOI 10.1038/cr.2008.299; Dong ZW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02360-5; Feinstein TN, 2013, J BIOL CHEM, V288, P27849, DOI 10.1074/jbc.M112.445098; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; Gaidarov I, 1996, J BIOL CHEM, V271, P20922, DOI 10.1074/jbc.271.34.20922; Gorvin CM, 2018, HUM MOL GENET, V27, P901, DOI 10.1093/hmg/ddy010; Gorvin CM, 2018, CELL REP, V22, P1054, DOI 10.1016/j.celrep.2017.12.089; Goto T, 2011, J LIPID RES, V52, P873, DOI 10.1194/jlr.M011320; Guzman M, 2004, J BIOL CHEM, V279, P27849, DOI 10.1074/jbc.M404087200; Han YH, 2016, DIABETES, V65, P2639, DOI 10.2337/db16-0283; HERTEL C, 1985, J BIOL CHEM, V260, P2547; Huijsman E, 2009, AM J PHYSIOL-ENDOC M, V297, pE505, DOI 10.1152/ajpendo.00190.2009; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jean-Alphonse F, 2014, J BIOL CHEM, V289, P3960, DOI 10.1074/jbc.M113.526350; Jockers R, 1996, J BIOL CHEM, V271, P9355, DOI 10.1074/jbc.271.16.9355; Kelly BT, 2014, SCIENCE, V345, P459, DOI 10.1126/science.1254836; Kersten S, 2017, BIOCHIMIE, V136, P75, DOI 10.1016/j.biochi.2016.12.019; KOKATNUR MG, 1969, J ATHEROSCLER RES, V10, P319, DOI 10.1016/S0368-1319(69)80035-9; Kotowski SJ, 2011, NEURON, V71, P278, DOI 10.1016/j.neuron.2011.05.036; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; Lee MS, 2008, GENES NUTR, V2, P327, DOI 10.1007/s12263-007-0068-8; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Li PP, 2005, AM J PHYSIOL-ENDOC M, V289, pE617, DOI 10.1152/ajpendo.00010.2005; Liu MH, 2014, SCI REP-UK, V4, DOI 10.1038/srep05538; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Miranda J, 2011, LIPIDS, V46, P1005, DOI 10.1007/s11745-011-3615-4; Mohktar RAM, 2016, AM J PHYSIOL-ENDOC M, V311, pE128, DOI 10.1152/ajpendo.00084.2016; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Moore RH, 1999, J CELL SCI, V112, P329; Mottillo EP, 2012, J BIOL CHEM, V287, P25038, DOI 10.1074/jbc.M112.374041; Nesbit MA, 2013, NEW ENGL J MED, V368, P2476, DOI 10.1056/NEJMoa1300253; Nesbit MA, 2013, NAT GENET, V45, P93, DOI 10.1038/ng.2492; Pagnon J, 2012, ENDOCRINOLOGY, V153, P4278, DOI 10.1210/en.2012-1127; Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039; Raajendiran A, 2019, CELL REP, V27, P1528, DOI 10.1016/j.celrep.2019.04.010; Ramakrishnan VM, 2018, TISSUE ENG PART B-RE, V24, P289, DOI [10.1089/ten.teb.2017.0061, 10.1089/ten.TEB.2017.0061]; Sahebkar A, 2014, EXPERT OPIN PHARMACO, V15, P493, DOI 10.1517/14656566.2014.876992; Schoonjans K, 1996, BBA-LIPID LIPID MET, V1302, P93, DOI 10.1016/0005-2760(96)00066-5; Stienstra R, 2007, PPAR RES, V2007, DOI 10.1155/2007/95974; Sugden MC, 2002, BIOCHEM J, V364, P361, DOI 10.1042/BJ20011699; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Tenenbaum A, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-140; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Traub LM, 1999, P NATL ACAD SCI USA, V96, P8907, DOI 10.1073/pnas.96.16.8907; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; Urrutia R, 1997, P NATL ACAD SCI USA, V94, P377, DOI 10.1073/pnas.94.2.377; van Hall G, 2015, SPORTS MED, V45, pS23, DOI 10.1007/s40279-015-0394-8; Volovyk ZM, 2006, J BIOL CHEM, V281, P9773, DOI 10.1074/jbc.M511435200; Watt MJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE500, DOI 10.1152/ajpendo.00361.2005; Wei J, 2014, J BIOL CHEM, V289, P33689, DOI 10.1074/jbc.M114.593764	66	10	10	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13267	13279		10.1096/fj.201900909RR	http://dx.doi.org/10.1096/fj.201900909RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31533003				2022-12-28	WOS:000507466100019
J	Royal, JM; Oh, YJ; Grey, MJ; Lencer, WI; Ronquillo, N; Galandiuk, S; Matoba, N				Royal, Joshua M.; Oh, Young Jun; Grey, Michael J.; Lencer, Wayne I.; Ronquillo, Nemencio; Galandiuk, Susan; Matoba, Nobuyuki			A modified cholera toxin B subunit containing an ER retention motif enhances colon epithelial repair via an unfolded protein response	FASEB JOURNAL			English	Article						TGF-beta; epithelial restitution; wound healing; IBD	ENDOPLASMIC-RETICULUM STRESS; INFLAMMATORY-BOWEL-DISEASE; QUALITY-CONTROL; MESENCHYMAL TRANSITION; CLINICAL-IMPLICATIONS; GASTRIC-MUCOSA; COLITIS; RESTITUTION; BINDING; SPECIFICITY	Cholera toxin B subunit (CTB) exhibits broad-spectrum biologic activity upon mucosal administration. Here, we found that a recombinant CTB containing an endoplasmic reticulum (ER) retention motif (CTB-KDEL) induces colon epithelial wound healing in colitis via the activation of an unfolded protein response (UPR) in colon epithelial cells. In a Caco2 cell wound healing model, CTB-KDEL, but not CTB or CTB-KDE, facilitated cell migration via interaction with the KDEL receptor, localization in the ER, UPR activation, and subsequent TGF-beta signaling. Inhibition of the inositol-requiring enzyme 1/X-box binding protein 1 arm of UPR abolished the cell migration effect of CTB-KDEL, indicating that the pathway is indispensable for the activity. CTB-KDEL's capacity to induce UPR and epithelial restitution or wound healing was corroborated in a dextran sodium sulfate-induced acute colitis mouse model. Furthermore, CTB-KDEL induced a UPR, up-regulated wound healing pathways, and maintained viable crypts in colon explants from patients with inflammatory bowel disease (IBD). In summary, CTB-KDEL exhibits unique wound healing effects in the colon that are mediated by its localization to the ER and subsequent activation of UPR in epithelial cells. The results provide implications for a novel therapeutic approach for mucosal healing, a significant unmet need in IBD treatment.	[Royal, Joshua M.; Oh, Young Jun; Matoba, Nobuyuki] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, James Graham Brown Canc Ctr,Ctr Predict Med, Louisville, KY 40292 USA; [Ronquillo, Nemencio] Univ Louisville, Sch Med, Dept Pathol & Lab Med, Div Anat Pathol, Louisville, KY 40292 USA; [Grey, Michael J.; Lencer, Wayne I.] Boston Childrens Hosp, Div Gastroenterol Nutr & Hepatol, Boston, MA USA; [Grey, Michael J.; Lencer, Wayne I.] Harvard Med Sch, Harvard Digest Dis Ctr, Dept Pediat, Boston, MA 02115 USA; [Galandiuk, Susan] Univ Louisville, Hiram C Polk Jr MD Dept Surg, Price Inst Surg Res, Louisville, KY 40292 USA	University of Louisville; University of Louisville; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Louisville	Matoba, N (corresponding author), Univ Louisville, Sch Med, 505 S Hancock St,Room 615, Louisville, KY 40202 USA.	n.matoba@louisville.edu		Matoba, Nobuyuki/0000-0001-7231-3004; Lencer, Wayne/0000-0001-7346-2730	Helmsley Charitable Trust Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK048106] Funding Source: NIH RePORTER	Helmsley Charitable Trust Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Chi Li (University Louisville) for technical advice on KDELR and endoplasmic reticulum immunofluorescence staining. The authors are also grateful to Dr. Brian Ceresa and Jamie Rush (University of Louisville) for technical expertise on the proximity ligation assay. This work was supported by the Helmsley Charitable Trust Fund. J.M.R. and N.M. filed a patent application pertinent to the findings in this manuscript (PCT/US2016/040041). The remaining authors declare no conflicts of interest.	Araki K, 2011, BRIT J CANCER, V105, P1885, DOI 10.1038/bjc.2011.452; Bagchi S, 2015, METHODS MOL BIOL, V1318, P149, DOI 10.1007/978-1-4939-2742-5_15; Baldauf KJ, 2017, MUCOSAL IMMUNOL, V10, P887, DOI 10.1038/mi.2016.95; Becker B, 2016, SCI REP-UK, V6, DOI 10.1038/srep28940; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Boirivant M, 2001, J IMMUNOL, V166, P3522, DOI 10.4049/jimmunol.166.5.3522; Cabrera M, 2003, MOL BIOL CELL, V14, P4114, DOI 10.1091/mbc.E03-04-0194; Capitani M, 2009, FEBS LETT, V583, P3863, DOI 10.1016/j.febslet.2009.10.053; Chinnapen DJF, 2007, FEMS MICROBIOL LETT, V266, P129, DOI 10.1111/j.1574-6968.2006.00545.x; Cho HJ, 2007, BIOCHEM BIOPH RES CO, V353, P337, DOI 10.1016/j.bbrc.2006.12.035; Cho JA, 2013, CELL HOST MICROBE, V13, P558, DOI 10.1016/j.chom.2013.03.011; Chusri P, 2016, SCI REP-UK, V6, DOI 10.1038/srep22487; Clapper ML, 2007, ACTA PHARMACOL SIN, V28, P1450, DOI 10.1111/j.1745-7254.2007.00695.x; Clemens J, 2011, NAT REV GASTRO HEPAT, V8, P701, DOI 10.1038/nrgastro.2011.174; Coccia EM, 2005, GUT, V54, P1558, DOI 10.1136/gut.2004.062174; CUATRECASAS P, 1973, BIOCHEMISTRY-US, V12, P3547, DOI 10.1021/bi00742a031; Dame MK, 2014, LAB INVEST, V94, P222, DOI 10.1038/labinvest.2013.145; Dawson RM, 2005, J APPL TOXICOL, V25, P30, DOI 10.1002/jat.1015; de Chambrun GP, 2010, NAT REV GASTRO HEPAT, V7, P15, DOI 10.1038/nrgastro.2009.203; DENECKE J, 1992, EMBO J, V11, P2345, DOI 10.1002/j.1460-2075.1992.tb05294.x; DIGNASS AU, 1993, GASTROENTEROLOGY, V105, P1323, DOI 10.1016/0016-5085(93)90136-Z; Dionne S, 1998, CLIN EXP IMMUNOL, V112, P435; Eletto D, 2014, MOL CELL, V53, P562, DOI 10.1016/j.molcel.2014.01.004; Ferrari L, 2016, WORLD J GASTRO SURG, V8, P363, DOI 10.4240/wjgs.v8.i5.363; Frakes AE, 2017, MOL CELL, V66, P761, DOI 10.1016/j.molcel.2017.05.031; Geiger R, 2013, TRAFFIC, V14, P36, DOI 10.1111/tra.12018; Hamorsky K, 2016, METHODS MOL BIOL, V1404, P511, DOI 10.1007/978-1-4939-3389-1_33; Hamorsky KT, 2015, SCI REP-UK, V5, DOI 10.1038/srep08003; Hamorsky KT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002046; Hwang S, 2012, J BIOL CHEM, V287, P22227, DOI 10.1074/jbc.M112.367979; Iizuka M, 2011, WORLD J GASTROENTERO, V17, P2161, DOI 10.3748/wjg.v17.i17.2161; Kaser A, 2011, EXP CELL RES, V317, P2772, DOI 10.1016/j.yexcr.2011.07.008; Kiesler P, 2015, CELL MOL GASTROENTER, V1, P154, DOI 10.1016/j.jcmgh.2015.01.006; Kuziemko GM, 1996, BIOCHEMISTRY-US, V35, P6375, DOI 10.1021/bi952314i; LACY ER, 1984, LAB INVEST, V51, P573; Lamriben L, 2016, TRAFFIC, V17, P308, DOI 10.1111/tra.12358; Leight JL, 2012, MOL BIOL CELL, V23, P781, DOI 10.1091/mbc.E11-06-0537; LENCER WI, 1995, J CELL BIOL, V131, P951, DOI 10.1083/jcb.131.4.951; Luissint AC, 2016, GASTROENTEROLOGY, V151, P616, DOI 10.1053/j.gastro.2016.07.008; MacKenzie CR, 1997, J BIOL CHEM, V272, P5533, DOI 10.1074/jbc.272.9.5533; Matsuzaki S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123578; McCaffrey K, 2016, ESSAYS BIOCHEM, V60, P227, DOI 10.1042/EBC20160003; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Moore L, 2016, METHODS MOL BIOL, V1385, P129, DOI 10.1007/978-1-4939-3289-4_9; Okamoto R, 2016, J GASTROENTEROL, V51, P11, DOI 10.1007/s00535-015-1098-4; Orlando A, 2013, DIGEST LIVER DIS, V45, P986, DOI 10.1016/j.dld.2013.07.005; Park HJ, 2015, TISSUE ENG PT A, V21, P1982, DOI [10.1089/ten.tea.2014.0687, 10.1089/ten.TEA.2014.0687]; Randall KJ, 2011, CELL BIOL TOXICOL, V27, P267, DOI 10.1007/s10565-011-9187-5; Roberson EC, 2012, AM J RESP CELL MOL, V46, P573, DOI 10.1165/rcmb.2010-0460OC; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Royal JM, 2017, TOXINS, V9, DOI 10.3390/toxins9120379; Sanchez J, 2008, CELL MOL LIFE SCI, V65, P1347, DOI 10.1007/s00018-008-7496-5; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sepulveda D, 2018, MOL CELL, V69, P238, DOI 10.1016/j.molcel.2017.12.028; Siyan S, 2012, INFLAMM BOWEL DIS, V18, P1735, DOI 10.1002/ibd.22878; Sturm A, 2008, WORLD J GASTROENTERO, V14, P348, DOI 10.3748/wjg.14.348; Tarnawski AS, 2018, WORLD J GASTROENTERO, V24, P4721, DOI 10.3748/wjg.v24.i42.4721; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Vaughn Byron P, 2014, Curr Treat Options Gastroenterol, V12, P103, DOI 10.1007/s11938-013-0008-1; Villanacci V, 2013, WORLD J GASTROENTERO, V19, P968, DOI 10.3748/wjg.v19.i7.968; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang JM, 2017, DIABETES, V66, P177, DOI 10.2337/db16-0052; Wernick NLB, 2010, TOXINS, V2, P310, DOI 10.3390/toxins2030310; Yamamoto K, 2003, J BIOL CHEM, V278, P34525, DOI 10.1074/jbc.M304188200; Yamamoto K, 2001, EMBO J, V20, P3082, DOI 10.1093/emboj/20.12.3082; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang DL, 2009, BIOCHEM BIOPH RES CO, V378, P149, DOI 10.1016/j.bbrc.2008.11.011; Zhang LL, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-29; ZHANG RG, 1995, J MOL BIOL, V251, P563, DOI 10.1006/jmbi.1995.0456; Zhang X, 2017, NAT COMMUN, V8, P1, DOI [10.1038/ncomms14542, 10.1038/s41467-017-00321-0, 10.1038/s41467-017-01968-5]	70	4	4	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13527	13545		10.1096/fj.201901255R	http://dx.doi.org/10.1096/fj.201901255R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31560862	Green Published, hybrid			2022-12-28	WOS:000507466100039
J	Zhang, BY; Swamy, S; Balijepalli, S; Panicker, S; Mooliyil, J; Sherman, MA; Parkkinen, J; Raghavendran, K; Suresh, MV				Zhang, Boya; Swamy, Samantha; Balijepalli, Sanjay; Panicker, Sreehari; Mooliyil, Jashitha; Sherman, Matthew A.; Parkkinen, Jaakko; Raghavendran, Krishnan; Suresh, Madathilparambil V.			Direct pulmonary delivery of solubilized curcumin reduces severity of lethal pneumonia	FASEB JOURNAL			English	Article						phagocytosis; macrophages; apoptosis; capillary Western blot; MTT	RESPIRATORY-DISTRESS-SYNDROME; NF-KAPPA-B; ACUTE INFLAMMATORY RESPONSE; GRAM-NEGATIVE PNEUMONIA; NLRP3 INFLAMMASOME; LUNG INJURY; MOUSE MODEL; KLEBSIELLA-PNEUMONIAE; PROTECTIVE ROLE; ACTIVATION	Acute respiratory distress syndrome (ARDS), the most severe form of acute lung injury, is associated with reduced lung compliance and hypoxemia. Curcumin exhibits potent anti-inflammatory properties but has poor solubility and rapid plasma clearance. To overcome these physiochemical limitations and uncover the full therapeutic potential of curcumin in lung inflammation, in this study we utilized a novel water-soluble curcumin formulation (CDC) and delivered it directly into the lungs of C57BL/6 mice inoculated with a lethal dose of Klebsiella pneumoniae (KP). Administration of CDC led to a significant reduction in mortality, in bacterial presence within blood and lungs, as well as in lung injury, inflammation, and oxidative stress. The expression of Klebsiella hemolysin gene; TNF-alpha; IFN-beta; nucleotide-binding domain, leucine-rich containing family, pyrin domain-containing-3; hypoxia-inducible factor 1/2 alpha; and NF-kappa B were also decreased following CDC treatment, suggesting modulation of the inflammasome complex and hypoxia signaling pathways as an underlying mechanism by which CDC reduces the severity of pneumonia. On a cellular level, CDC led to diminished cell death, improved viability, and protection of human lung epithelial cells in vitro. Overall, our studies demonstrate that CDC administration improves cell survival and reduces injury, inflammation, and mortality in a murine model of lethal gram-negative pneumonia. CDC, therefore, has promising anti-inflammatory potential in pneumonia and likely other inflammatory lung diseases, demonstrating the importance of optimizing the physicochemical properties of active natural products to optimize their clinical application.	[Zhang, Boya; Swamy, Samantha; Balijepalli, Sanjay; Panicker, Sreehari; Mooliyil, Jashitha; Raghavendran, Krishnan; Suresh, Madathilparambil V.] Univ Michigan, Dept Surg, 1150 West Med Ctr Dr, Ann Arbor, MI 48109 USA; [Sherman, Matthew A.] Childrens Natl Med Ctr, Dept Pediat, Washington, DC 20010 USA; [Parkkinen, Jaakko] Univ Helsinki, Inst Biomed, Helsinki, Finland	University of Michigan System; University of Michigan; Children's National Health System; University of Helsinki	Suresh, MV (corresponding author), Univ Michigan, Dept Surg, 1150 West Med Ctr Dr, Ann Arbor, MI 48109 USA.	madathil@umich.edu		Sherman, Matthew/0000-0002-5448-1538	U.S. National Institutes of Health, National Institute of General Medical Sciences [R01 GM111305-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111305] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge the support of U.S. National Institutes of Health, National Institute of General Medical Sciences Grant R01 GM111305-01 (to K.R.). The authors declare no conflicts of interest.	Aggarwal BB, 2013, MOL NUTR FOOD RES, V57, P1529, DOI 10.1002/mnfr.201200838; Ahn D, 2019, AM J RESP CELL MOL, V60, P158, DOI 10.1165/rcmb.2018-0021OC; Arroliga AC, 2002, CHEST, V121, P1972, DOI 10.1378/chest.121.6.1972; Ayodele OE, 2010, NEPHROLOGY, V15, P482, DOI 10.1111/j.1440-1797.2010.01290.x; Bauer T T, 2000, Semin Respir Infect, V15, P272; Bauer TT, 2006, CLIN INFECT DIS, V43, P748, DOI 10.1086/506430; Beekman C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195850; Cai SS, 2010, J IMMUNOL, V185, P6214, DOI 10.4049/jimmunol.0903843; Chen W, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001849; Jin CY, 2007, ACTA PHARMACOL SIN, V28, P1645, DOI 10.1111/j.1745-7254.2007.00651.x; Cochi SE, 2016, ANN AM THORAC SOC, V13, P1742, DOI 10.1513/AnnalsATS.201512-841OC; Codo AC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1214-5; Cooney JM, 2016, J NUTR BIOCHEM, V27, P181, DOI 10.1016/j.jnutbio.2015.08.030; D'Ignazio L, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5010010; D'Ignazio L, 2016, FEBS J, V283, P413, DOI 10.1111/febs.13578; Davidson BA, 1999, ANESTHESIOLOGY, V91, P486, DOI 10.1097/00000542-199908000-00024; Dolgachev VA, 2016, GENE THER, V23, P785, DOI 10.1038/gt.2016.58; Dolgachev V, 2018, GENE THER, V25, P359, DOI 10.1038/s41434-018-0022-y; Dolgachev VA, 2012, J TRAUMA ACUTE CARE, V72, P614, DOI 10.1097/TA.0b013e318243d9b1; Fadus Matthew C, 2017, J Tradit Complement Med, V7, P339, DOI 10.1016/j.jtcme.2016.08.002; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; Hoth JJ, 2007, SHOCK, V28, P447, DOI 10.1097/shk.0b013e318048801a; Hua KF, 2015, INFECT IMMUN, V83, P3396, DOI 10.1128/IAI.00125-15; Huet O, 2017, CRIT CARE MED, V45, pE184, DOI 10.1097/CCM.0000000000002070; Iregui M, 2002, CHEST, V122, P262, DOI 10.1378/chest.122.1.262; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Karo-Atar D, 2016, MUCOSAL IMMUNOL, V9, P240, DOI 10.1038/mi.2015.56; Kim JJ, 2013, J KOREAN MED SCI, V28, P1415, DOI 10.3346/jkms.2013.28.10.1415; Kochanek Kenneth D, 2014, NCHS Data Brief, P1; Machado-Aranda DA, 2012, J TRAUMA ACUTE CARE, V72, P32, DOI 10.1097/TA.0b013e31823f0606; Miller PR, 2001, J TRAUMA, V51, P223, DOI 10.1097/00005373-200108000-00003; Obi AT, 2016, J VASC RES, V53, P186, DOI 10.1159/000447299; Peter Y, 2009, MOL CARCINOGEN, V48, P488, DOI 10.1002/mc.20485; Qin S, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0293-y; Raghavendran K, 2005, SHOCK, V24, P132, DOI 10.1097/01.shk.0000169725.80068.4a; Reddy PH, 2018, J ALZHEIMERS DIS, V61, P843, DOI 10.3233/JAD-170512; Riviello ED, 2016, AM J RESP CRIT CARE, V193, P52, DOI 10.1164/rccm.201503-0584OC; Saidi SA, 2018, BIOPHARM DRUG DISPOS, V39, P18, DOI 10.1002/bdd.2108; Seligman R, 2008, CRIT CARE, V12, DOI 10.1186/cc6780; Serezani CHC, 2005, BLOOD, V106, P1067, DOI 10.1182/blood-2004-08-3323; Sharma N, 2018, INFLAMMOPHARMACOLOGY, V26, P349, DOI 10.1007/s10787-017-0402-8; Sherman MA, 2018, ANN SURG, V267, P382, DOI 10.1097/SLA.0000000000002070; Standiford TJ, 1996, J LEUKOCYTE BIOL, V59, P24, DOI 10.1002/jlb.59.1.24; Steinhauser ME, 1999, J IMMUNOL, V162, P392; STRIETER RM, 1994, J INVEST MED, V42, P640; Sun YF, 2017, J INTERF CYTOK RES, V37, P449, DOI 10.1089/jir.2017.0069; Suresh M. V., 2018, SHOCK; Suresh MV, 2016, CRIT CARE MED, V44, pE1054, DOI 10.1097/CCM.0000000000001879; Suresh MV, 2014, CRIT CARE MED, V42, pE642, DOI 10.1097/CCM.0000000000000488; Suresh MV, 2013, SURGERY, V154, P980, DOI 10.1016/j.surg.2013.05.023; Suresh MV, 2012, AM J RESP CELL MOL, V47, P280, DOI 10.1165/rcmb.2011-0175OC; Suresh MV, 2012, AM J RESP CELL MOL, V46, P797, DOI 10.1165/rcmb.2011-0358OC; Takala A, 2002, ANN MED, V34, P614, DOI 10.1080/078538902321117841; Taylor M, 2011, GASTROENTEROLOGY, V140, P2044, DOI 10.1053/j.gastro.2011.03.007; Tonnesen HH, 2002, INT J PHARMACEUT, V244, P127, DOI 10.1016/S0378-5173(02)00323-X; Wang XZ, 2017, ONCOL LETT, V13, P4825, DOI 10.3892/ol.2017.6053; Ward PA, 1999, ARCH SURG-CHICAGO, V134, P666, DOI 10.1001/archsurg.134.6.666; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; Xu YM, 2017, INFLUENZA OTHER RESP, V11, P457, DOI 10.1111/irv.12459; Zheng CY, 2011, JOVE-J VIS EXP, DOI 10.3791/2568	61	17	20	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13294	13309		10.1096/fj.201901047RR	http://dx.doi.org/10.1096/fj.201901047RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31530014	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000507466100021
J	Kendall, AC; Pilkington, SM; Murphy, SA; Del Carratore, F; Sunarwidhi, AL; Kiezel-Tsugunova, M; Urquhart, P; Watson, REB; Breitling, R; Rhodes, LE; Nicolaou, A				Kendall, Alexandra C.; Pilkington, Suzanne M.; Murphy, Sharon A.; Del Carratore, Francesco; Sunarwidhi, Anggit L.; Kiezel-Tsugunova, Magdalena; Urquhart, Paula; Watson, Rachel E. B.; Breitling, Rainer; Rhodes, Lesley E.; Nicolaou, Anna			Dynamics of the human skin mediator lipidome in response to dietary omega-3 fatty acid supplementation	FASEB JOURNAL			English	Article						eicosapentaenoic acid; docosahexaenoic acid; inflammation; lipidomics; mass spectrometry	POLYUNSATURATED FATTY-ACIDS; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; DHA SUPPLEMENTATION; ENDOTHELIAL-CELLS; BRAIN-REGIONS; UVR EXPOSURE; EXPRESSION; EPA; N-3	Nutritional supplementation with fish oil or omega-3 (n-3) polyunsaturated fatty acids (PUFAs) has potential benefits for skin inflammation. Although the differential metabolism of the main n-3PUFA eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) could lead to distinct activities, there are no clinical studies comparing their relative efficacy in human skin. Following a 10-wk oral supplementation of healthy volunteers and using mass spectrometry-based lipidomics, we found that n-3PUFA mainly affected the epidermal mediator lipidome. EPA was more efficient than DHA in reducing production of arachidonic acid-derived lipids, and both n-3PUFA lowered N-acyl ethanolamines. In UV radiation-challenged skin (3 times the minimum erythemal dose), EPA attenuated the production of proinflammatory lipids, whereas DHA abrogated the migration of Langerhans cells, as assessed by immunohistochemistry. Interestingly, n-3PUFA increased the infiltration of CD4(+) and CD8(+) T cells but did not alter the erythemal response, either the sunburn threshold or the resolution of erythema, as assessed by spectrophotometric hemoglobin index readings. As EPA and DHA differentially impact cutaneous inflammation through changes in the network of epidermal lipids and dendritic and infiltrating immune cells, they should be considered separately when designing interventions for cutaneous disease.	[Kendall, Alexandra C.; Murphy, Sharon A.; Sunarwidhi, Anggit L.; Kiezel-Tsugunova, Magdalena; Urquhart, Paula; Nicolaou, Anna] Univ Manchester, Div Pharm & Optometry, Lab Lipid & Lipid Biol, Manchester, Lancs, England; [Pilkington, Suzanne M.; Watson, Rachel E. B.; Rhodes, Lesley E.] Univ Manchester, Div Musculoskeletal & Dermatol Sci, Sch Biol Sci, Fac Biol Med & Hlth, Manchester, Lancs, England; [Pilkington, Suzanne M.; Watson, Rachel E. B.; Rhodes, Lesley E.] Univ Manchester, Salford Royal Natl Hlth Serv NHS Fdn Trust, Ctr Dermatol Res, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Del Carratore, Francesco; Breitling, Rainer] Univ Manchester, Sch Chem, Fac Sci & Engn, Manchester, Lancs, England; [Watson, Rachel E. B.; Rhodes, Lesley E.; Nicolaou, Anna] Univ Manchester, Lydia Becker Inst Immunol & Inflammat, Fac Biol Med & Hlth, Manchester, Lancs, England; [Watson, Rachel E. B.; Rhodes, Lesley E.; Nicolaou, Anna] Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Natl Inst Hlth Res, Manchester Biomed Res Ctr, Manchester, Lancs, England	University of Manchester; University of Manchester; Salford Royal NHS Foundation Trust; University of Manchester; University of Manchester; University of Manchester; University of Manchester	Nicolaou, A (corresponding author), Univ Manchester, Div Pharm & Optometry, 2-019c Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	anna.nicolaou@manchester.ac.uk	Watson, Rachel E B/F-1090-2013; Nicolaou, Anna/D-4025-2018; Del Carratore, Francesco/AAH-9752-2019; Sunarwidhi, Anggit/AAF-3938-2021; Rhodes, Lesley/H-5324-2015; Kendall, Alexandra/D-3717-2014	Watson, Rachel E B/0000-0002-5162-7503; Nicolaou, Anna/0000-0002-1314-413X; Del Carratore, Francesco/0000-0003-1647-7818; Rhodes, Lesley/0000-0002-9107-6654; Pilkington, Suzanne/0000-0002-0426-1414; Kendall, Alexandra/0000-0003-4419-0013	Wellcome Trust [WT094028/AIA, WT094028/B]; National Institute of Health Research (NIHR) Clinical Research Network (CRN); NIHR Manchester Biomedical Research Centre; Biotechnology and Biological Sciences Research Council (BBSRC); University of Manchester Strategic Fund; Lembaga Pengelola Dana Pendidikan (LPDP), Republik Indonesia	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Health Research (NIHR) Clinical Research Network (CRN)(National Institute for Health Research (NIHR)); NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Manchester Strategic Fund; Lembaga Pengelola Dana Pendidikan (LPDP), Republik Indonesia	The authors thank Roger Meadows for his help with the microscopy and image analysis, Kanwal Sakhi for work on immunohistochemistry assays, Neil O'Hara for excellent technical support, and Jo Osman (all from University of Manchester) for excellent clinical support. This project was supported by The Wellcome Trust (Grants WT094028/AIA and WT094028/B). The authors acknowledge the support of the National Institute of Health Research (NIHR) Clinical Research Network (CRN) and the NIHR Manchester Biomedical Research Centre. The bioimaging facility microscopes used in this study were purchased with grants from the Biotechnology and Biological Sciences Research Council (BBSRC) and The Wellcome Trust, and the University of Manchester Strategic Fund. L.E.R., A.N., and R.E.B.W. were supported, in part, by the NIHR Manchester Biomedical Research Centre. A.L.S. was supported by a scholarship from Lembaga Pengelola Dana Pendidikan (LPDP), Republik Indonesia. The authors declare no conflicts of interest.	Ahmad N, 2004, J INVEST DERMATOL, V123, P417, DOI 10.1111/j.0022-202X.2004.23307.x; Allaire J, 2016, AM J CLIN NUTR, V104, P280, DOI 10.3945/ajcn.116.131896; Astarita G, 2015, BBA-MOL CELL BIOL L, V1851, P456, DOI 10.1016/j.bbalip.2014.11.012; Bascoul-Colombo C, 2016, BBA-MOL CELL BIOL L, V1861, P524, DOI 10.1016/j.bbalip.2016.03.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breitling R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-34; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; CHAPKIN RS, 1986, J LIPID RES, V27, P945; Chen HJ, 2003, J MOL CELL CARDIOL, V35, P769, DOI 10.1016/S0022-2828(03)00120-2; Chene G, 2007, BBA-MOL CELL BIOL L, V1771, P576, DOI 10.1016/j.bbalip.2007.02.014; Davidson EA, 2016, FASEB J, V30; Felton SJ, 2017, PHOTOCH PHOTOBIO SCI, V16, P564, DOI 10.1039/c6pp00337k; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Green P, 2009, PROSTAG LEUKOTR ESS, V80, P213, DOI 10.1016/j.plefa.2009.02.005; Han SC, 2015, J INVEST DERMATOL, V135, P1556, DOI 10.1038/jid.2014.488; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Hong S, 2014, AM J PHYSIOL-CELL PH, V307, pC1058, DOI 10.1152/ajpcell.00270.2014; Huang CY, 2015, MOL NUTR FOOD RES, V59, P751, DOI 10.1002/mnfr.201400687; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Hussain Z, 2017, BBA-MOL CELL BIOL L, V1862, P1546, DOI 10.1016/j.bbalip.2017.08.006; Kendall AC, 2016, BRIT J DERMATOL, V175, P163, DOI 10.1111/bjd.14521; Kendall AC, 2017, BBA-BIOMEMBRANES, V1859, P1679, DOI 10.1016/j.bbamem.2017.03.016; Kendall AC, 2015, J INVEST DERMATOL, V135, P1510, DOI 10.1038/jid.2015.41; Kendall AC, 2013, PROG LIPID RES, V52, P141, DOI 10.1016/j.plipres.2012.10.003; Kiezel-Tsugunova M, 2018, BIOCHEM SOC T, V46, P119, DOI 10.1042/BST20160469; Koch C, 2008, BRIT J DERMATOL, V158, P786, DOI 10.1111/j.1365-2133.2007.08430.x; KOJIMA T, 1991, DERMATOLOGICA, V182, P225, DOI 10.1159/000247800; Laidlaw BJ, 2016, NAT REV IMMUNOL, V16, P102, DOI 10.1038/nri.2015.10; Landman S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28346-5; Leishman E, 2016, BBA-MOL CELL BIOL L, V1861, P491, DOI 10.1016/j.bbalip.2016.03.003; Massey KA, 2013, FREE RADICAL BIO MED, V59, P45, DOI 10.1016/j.freeradbiomed.2012.08.565; Massey KA, 2011, BIOCHEM SOC T, V39, P1240, DOI 10.1042/BST0391240; Mayser P, 2002, BRIT J NUTR, V87, pS77, DOI 10.1079/BJN2001459; McDaniel JC, 2011, WOUND REPAIR REGEN, V19, P189, DOI 10.1111/j.1524-475X.2010.00659.x; Meijerink J, 2013, BRIT J PHARMACOL, V169, P772, DOI 10.1111/bph.12030; Nicolaou A, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00075; Nicolaou A, 2013, PROSTAG LEUKOTR ESS, V88, P131, DOI 10.1016/j.plefa.2012.03.009; Pilkington SM, 2016, EXP DERMATOL, V25, P962, DOI 10.1111/exd.13177; Pilkington SM, 2015, EXP DERMATOL, V24, P790, DOI 10.1111/exd.12734; Pilkington SM, 2014, MOL NUTR FOOD RES, V58, P580, DOI 10.1002/mnfr.201300405; Pilkington SM, 2013, AM J CLIN NUTR, V97, P646, DOI 10.3945/ajcn.112.049494; Pilkington SM, 2011, EXP DERMATOL, V20, P537, DOI 10.1111/j.1600-0625.2011.01294.x; Pinto AM, 2017, BRIT J NUTR, V118, P877, DOI 10.1017/S0007114517002628; Plourde M, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-5; Rahman MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028065; Ralf M, 2001, RADIAT RES, V156, P36, DOI 10.1667/0033-7587(2001)156[0036:DEAPSI]2.0.CO;2; Rhodes LE, 2009, FASEB J, V23, P3947, DOI 10.1096/fj.09-136077; Sampath H, 2005, ANNU REV NUTR, V25, P317, DOI 10.1146/annurev.nutr.25.051804.101917; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuchardt JP, 2016, PROSTAG LEUKOTR ESS, V115, P12, DOI 10.1016/j.plefa.2016.10.005; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shaikh SR, 2012, MOL ASPECTS MED, V33, P46, DOI 10.1016/j.mam.2011.10.002; Shaikh SR, 2009, J NUTR, V139, P1632, DOI 10.3945/jn.109.108720; Tang YN, 2013, DIABETES, V62, P618, DOI 10.2337/db12-0684; Toth BI, 2011, J INVEST DERMATOL, V131, P1095, DOI 10.1038/jid.2010.421; Verlengia R, 2004, J NUTR BIOCHEM, V15, P657, DOI 10.1016/j.jnutbio.2004.04.008; Walker CG, 2015, NUTRIENTS, V7, P6281, DOI 10.3390/nu7085285; Wood JT, 2010, J LIPID RES, V51, P1416, DOI 10.1194/jlr.M002436	60	20	20	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					13014	13027		10.1096/fj.201901501R	http://dx.doi.org/10.1096/fj.201901501R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31518521	Green Published			2022-12-28	WOS:000507461600108
J	Liu, ZG; Li, N; Fang, H; Chen, XJ; Guo, YX; Gong, SH; Niu, MW; Zhou, HW; Jiang, Y; Chang, P; Chen, P				Liu, Zhanguo; Li, Na; Fang, Heng; Chen, Xiaojiao; Guo, Yuexun; Gong, Shenhai; Niu, Mengwei; Zhou, Hongwei; Jiang, Yong; Chang, Ping; Chen, Peng			Enteric dysbiosis is associated with sepsis in patients	FASEB JOURNAL			English	Article						gut microbiota; metabolomics; metaproteomics	GUT MICROBIOTA; WIDE ASSOCIATION; CRITICAL ILLNESS; INTENSIVE-CARE; LIVER-INJURY; DEFINITIONS; DYSFUNCTION; INHIBITION; METABOLISM; CIRRHOSIS	Sepsis is defined as a life-threatening organ dysfunction caused by a dysregulated host response to microbial infection. For decades, the potential role of gut microbiota in sepsis pathogenesis has been revealed. However, the systemic and functional link between gut microbiota and sepsis has remained unexplored. To address this gap in knowledge, we carried out systematic analyses on clinical stool samples from patients with sepsis, including 16S rDNA sequencing, metabolomics, and metaproteomics analyses. In addition, we performed fecal microbiota transplantation from human to mice to validate the roles of gut microbiota on sepsis progression. We found that the composition of gut microbiota was significantly disrupted in patients with sepsis compared with healthy individuals. Besides, the microbial functions were significantly altered in septic feces as identified by metabolomics and metaproteomics analyses. Interestingly, mice that received septic feces exhibited more severe hepatic inflammation and injury than mice that received healthy feces after cecal ligation and puncture. Finally, several strains of intestinal microbiota and microbial metabolites were corelated with serum total bilirubin levels in patients with sepsis. Taken together, our data indicated that sepsis development is associated with the disruption of gut microbiota at both compositional and functional levels, and such enteric dysbiosis could promote organ inflammation and injury during sepsis.	[Liu, Zhanguo; Fang, Heng; Guo, Yuexun; Chang, Ping; Chen, Peng] Southern Med Univ, Dept Intens Care Unit, Guangzhou, Peoples R China; [Chen, Xiaojiao; Zhou, Hongwei; Chen, Peng] Southern Med Univ, Microbiome Med Ctr, Guangzhou, Peoples R China; [Chen, Xiaojiao; Zhou, Hongwei] Southern Med Univ, Zhujiang Hosp, Div Lab Med, Guangzhou, Peoples R China; [Li, Na; Gong, Shenhai; Niu, Mengwei; Jiang, Yong; Chen, Peng] Southern Med Univ, Dept Pathophysiol, Guangdong Prov Key Lab Prote, Guangzhou, Peoples R China; [Li, Na; Gong, Shenhai; Niu, Mengwei; Jiang, Yong; Chen, Peng] Southern Med Univ, State Key Lab Organ Failure Res, Guangzhou, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Chang, P (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Intens Care Unit, Guangzhou 510515, Peoples R China.; Chen, P (corresponding author), Southern Med Univ, Dept Pathophysiol, Guangzhou 510515, Peoples R China.	changp963@163.com; perchen@smu.edu.cn	Zhou, Hongwei/B-4193-2008		National Science Funds for Distinguished Young Scholars of the Guangdong Province [2016A030306043]; Young Pearl Scholar of the Guangdong Province Award [81873926]; National Natural Science Foundation of China (NSFC) [81873926]; NSFCGuangdong Joint Fund of China [U1601225]; Key Science and Technology Projects Program of Guangzhou City [201607020016]; Clinical Research Startup Program of Southern Medical University by High-Level University Construction Funding of the Guangdong Provincial Department of Education [LC2019ZD014]	National Science Funds for Distinguished Young Scholars of the Guangdong Province(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Young Pearl Scholar of the Guangdong Province Award; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFCGuangdong Joint Fund of China; Key Science and Technology Projects Program of Guangzhou City; Clinical Research Startup Program of Southern Medical University by High-Level University Construction Funding of the Guangdong Provincial Department of Education	This study was supported, in part, by the National Science Funds for Distinguished Young Scholars of the Guangdong Province (2016A030306043), the Young Pearl Scholar of the Guangdong Province Award and National Natural Science Foundation of China (NSFC) (81873926 to P.C.), the NSFCGuangdong Joint Fund of China (Grant U1601225) and Key Science and Technology Projects Program of Guangzhou City (201607020016 to Y.J.), and the Clinical Research Startup Program of Southern Medical University by High-Level University Construction Funding of the Guangdong Provincial Department of Education (LC2019ZD014 to Z.L.). Z.L., N.L., H.F., and X.C. share co-first authorship. The authors declare no conflicts of interest.	Bajaj JS, 2017, ALCOHOL CLIN EXP RES, V41, P1857, DOI 10.1111/acer.13498; Beyaert R, 2018, CELL HOST MICROBE, V23, P283, DOI 10.1016/j.chom.2018.02.007; Blasi A, 2018, HEPATOLOGY, V68, P2325, DOI 10.1002/hep.30103; Bloemen JG, 2009, CLIN NUTR, V28, P657, DOI 10.1016/j.clnu.2009.05.011; CARRICO CJ, 1986, ARCH SURG-CHICAGO, V121, P196; Chu HK, 2019, GUT, V68, P359, DOI 10.1136/gutjnl-2018-316307; DOI F, 1993, HEPATOLOGY, V17, P1086, DOI 10.1016/0270-9139(93)90127-9; Gando S, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.37; Gilbert JA, 2018, NAT MED, V24, P392, DOI 10.1038/nm.4517; Gilbert JA, 2016, NATURE, V535, P94, DOI 10.1038/nature18850; Gong SH, 2019, HEPATOLOGY, V69, P1751, DOI 10.1002/hep.30361; Gong SH, 2018, J HEPATOL, V69, P51, DOI 10.1016/j.jhep.2018.02.024; Gotts JE, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1585; Haak BW, 2017, LANCET GASTROENTEROL, V2, P135, DOI 10.1016/S2468-1253(16)30119-4; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Kaakoush NO, 2015, FRONT CELL INFECT MI, V5, DOI [10.3309/fcimb.2015.00004, 10.3389/fcimb.2015.00084]; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Klingensmith NJ, 2016, CRIT CARE CLIN, V32, P203, DOI 10.1016/j.ccc.2015.11.004; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Lin GL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02147; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Lyons JD, 2017, PEDIATR CRIT CARE ME, V18, pS46, DOI 10.1097/PCC.0000000000001046; Mao JW, 2015, INT J CLIN EXP PATHO, V8, P3648; Meng M, 2017, CURR OPIN CRIT CARE, V23, P143, DOI 10.1097/MCC.0000000000000386; Ojima M, 2016, DIGEST DIS SCI, V61, P1628, DOI 10.1007/s10620-015-4011-3; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Rainer F, 2018, ALIMENT PHARM THER, V47, P657, DOI 10.1111/apt.14474; Schafer C, 2002, ALCOHOL ALCOHOLISM, V37, P81, DOI 10.1093/alcalc/37.1.81; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Surewaard BGJ, 2018, CELL HOST MICROBE, V24, P271, DOI 10.1016/j.chom.2018.06.017; Tripodi A, 2011, NEW ENGL J MED, V365, P147, DOI 10.1056/NEJMra1011170; Vincent JL, 2014, LANCET RESP MED, V2, P380, DOI 10.1016/S2213-2600(14)70061-X; Vincent JL, 2013, LANCET, V381, P774, DOI 10.1016/S0140-6736(12)61815-7; Wang LR, 2015, J IMMUNOL METHODS, V421, P44, DOI 10.1016/j.jim.2014.12.015; Wang ZN, 2015, CELL, V163, P1585, DOI 10.1016/j.cell.2015.11.055; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wiersinga WJ, 2014, VIRULENCE, V5, P36, DOI 10.4161/viru.25436; Wu GY, 2018, BIOCHEM BIOPH RES CO, V501, P16, DOI 10.1016/j.bbrc.2018.04.095; Wu KC, 2017, MOLECULES, V22, DOI 10.3390/molecules22040573; Yang J, 2019, NEPHROL DIAL TRANSPL, V34, P419, DOI 10.1093/ndt/gfy172; Zaborin A, 2014, MBIO, V5, DOI 10.1128/mBio.01361-14; Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645; Zhang F, 2010, AMINO ACIDS, V38, P237, DOI 10.1007/s00726-009-0233-z; Zhang X, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05357-4; Zhao KL, 2014, MOL MED REP, V10, P3185, DOI 10.3892/mmr.2014.2650; Zhou X, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0441-4; Zhu LL, 2018, INFECT DRUG RESIST, V11, P1105, DOI 10.2147/IDR.S167616	49	38	41	3	41	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12299	12310		10.1096/fj.201900398RR	http://dx.doi.org/10.1096/fj.201900398RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31465241	Green Published			2022-12-28	WOS:000507461600055
J	Xu, Y; Andrade, J; Ueberheide, B; Neel, BG				Xu, Yang; Andrade, Joshua; Ueberheide, Beatrix; Neel, Benjamin G.			Activated Thiol Sepharose-based proteomic approach to quantify reversible protein oxidation	FASEB JOURNAL			English	Article						redox regulation; PKM2; HLRCC; ATSP	TYROSINE-PHOSPHATASE 1B; TUMOR-SUPPRESSOR PTEN; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; INACTIVATION; FUMARATE; PATHWAY; IDENTIFICATION; STABILIZATION; SUCCINATION; GENERATION	Reactive oxygen species (ROS) can act as second messengers in various signaling pathways, and abnormal oxidation contributes to multiple diseases, including cancer. Detecting and quantifying protein oxidation is crucial for a detailed understanding of reduction-oxidation reaction (redox) signaling. We developed an Activated Thiol Sepharose-based proteomic (ATSP) approach to quantify reversible protein oxidation. ATSP can enrich H2O2-sensitive thiol peptides, which are more likely to contain reactive cysteines involved in redox signaling. We applied our approach to analyze hereditary leiomyomatosis and renal cell carcinoma (HLRCC), a type of kidney cancer that harbors fumarate hydratase (FH)-inactivating mutations and has elevated ROS levels. Multiple proteins were oxidized in FH-deficient cells, including many metabolic proteins such as the pyruvate kinase M2 isoform (PKM2). Treatment of HLRCC cells with dimethyl fumarate or PKM2 activators altered PKM2 oxidation levels. Finally, we found that ATSP could detect Src homology region 2 domain-containing phosphatase-2 and PKM2 oxidation in cells stimulated with platelet-derived growth factor. This newly developed redox proteomics workflow can detect reversible oxidation of reactive cysteines and can be employed to analyze multiple physiologic and pathologic conditions.	[Xu, Yang; Neel, Benjamin G.] Univ Toronto, Univ Hlth Network, Dept Med Biophys, Toronto, ON, Canada; [Xu, Yang; Neel, Benjamin G.] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Xu, Yang; Neel, Benjamin G.] NYU, Langone Med Ctr, Laura & Isaac Perlmutter Canc Ctr, 522 First Ave,Smilow Bldg,Room 1201A, New York, NY 10016 USA; [Andrade, Joshua; Ueberheide, Beatrix] New York Univ NYU Langone Hlth, Div Adv Res Technol, Prote Lab, New York, NY USA; [Ueberheide, Beatrix] New York Univ NYU Langone Hlth, Dept Biochem & Mol Pharmacol, New York, NY USA; [Xu, Yang] Geneseeq Technol Inc, Translat Med Res Inst, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; New York University; NYU Langone Medical Center; Geneseeq Technology Inc.	Neel, BG (corresponding author), NYU, Langone Med Ctr, Laura & Isaac Perlmutter Canc Ctr, 522 First Ave,Smilow Bldg,Room 1201A, New York, NY 10016 USA.	benjamin.neel@nyulangone.org	Xu, Yang/CAG-8877-2022	Xu, Yang/0000-0003-1670-6131; Ueberheide, Beatrix/0000-0003-2512-0204	NIH/NCI [R01CA49152]; Princess Margaret Cancer Foundation; Laura and Isaac Perlmutter Cancer Center Support Grant from the NCI [P30CA016087]; NIH Office of the Director [1S10OD010582-01A1]; NATIONAL CANCER INSTITUTE [P30CA016087, R01CA049152] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Princess Margaret Cancer Foundation(University of Toronto); Laura and Isaac Perlmutter Cancer Center Support Grant from the NCI; NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. Nicholas Tonks (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA) for providing Rat1 cells, and Dr. W. Marston Linehan [U.S. National Institutes of Health (NIH) National Cancer Institute (NCI)] for providing HLRCC cells. This work was supported by NIH/NCI Grant R01CA49152 (to B.G.N.) and the Princess Margaret Cancer Foundation. The mass spectrometric analysis is, in part, supported by the Laura and Isaac Perlmutter Cancer Center Support Grant P30CA016087 from the NCI, and a shared instrumentation grant from the NIH Office of the Director (1S10OD010582-01A1) for the purchase of an Orbitrap Fusion Lumos Mass Spectrometer. B.G.N. is a cofounder of, receives consulting fees from, and holds equity in Northern Biologics (Toronto, ON, Canada) and Navire Pharma (San Francisco, CA, USA). He also is an expert witness for Johnson and Johnson (New Brunswick, NJ, USA). His spouse holds equity in Mirati Therapeutics (San Diego, CA, USA) and Array BioPharma (Boulder, CO, USA). Y.X. is an employee of Geneseeq. The remaining authors declare no conflicts of interest.	Adam J, 2011, CANCER CELL, V20, P524, DOI 10.1016/j.ccr.2011.09.006; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Biatnik M, 2008, ANN NY ACAD SCI, V1126, P272, DOI 10.1196/annals.1433.047; Blatnik M, 2008, DIABETES, V57, P41, DOI 10.2337/db07-0838; Boivin B, 2008, P NATL ACAD SCI USA, V105, P9959, DOI 10.1073/pnas.0804336105; Boivin B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3137pl2; Caldas TD, 1998, PROTEIN EXPRES PURIF, V14, P65, DOI 10.1006/prep.1998.0922; CLAIBORNE A, 1993, FASEB J, V7, P1483, DOI 10.1096/fasebj.7.15.8262333; Dalla Rizza J, 2019, PROTEIN SCI, V28, P191, DOI 10.1002/pro.3520; Dayton TL, 2016, EMBO REP, V17, P1721, DOI 10.15252/embr.201643300; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; EHRING R, 1969, J BIOL CHEM, V244, P4589; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Frijhoff J, 2014, ANTIOXID REDOX SIGN, V20, P1994, DOI 10.1089/ars.2013.5643; Garcia FJ, 2016, MOL BIOSYST, V12, P1790, DOI 10.1039/c5mb00847f; Guo J, 2014, NAT PROTOC, V9, P64, DOI 10.1038/nprot.2013.161; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Hu WT, 2010, ANAL BIOCHEM, V398, P245, DOI 10.1016/j.ab.2009.11.002; Hurd TR, 2008, J BIOL CHEM, V283, P24801, DOI 10.1074/jbc.M803432200; Ishii T, 1999, BIOCHEM PHARMACOL, V58, P133, DOI 10.1016/S0006-2952(99)00060-X; Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001; Karisch R, 2013, FEBS J, V280, P459, DOI 10.1111/j.1742-4658.2012.08626.x; Karisch R, 2011, CELL, V146, P826, DOI 10.1016/j.cell.2011.07.020; KNOWLES JR, 1976, CRC CR REV BIOCH MOL, V4, P165, DOI 10.3109/10409237609105457; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lee JG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2532; Lee K, 2004, ELECTROPHORESIS, V25, P532, DOI 10.1002/elps.200305677; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; LEWIS CT, 1989, J BIOL CHEM, V264, P27; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Liu MA, 2010, ANAL CHEM, V82, P7160, DOI 10.1021/ac100569d; Maller C, 2011, ANTIOXID REDOX SIGN, V14, P49, DOI 10.1089/ars.2010.3149; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Ostman A, 2011, J BIOCHEM, V150, P345, DOI 10.1093/jb/mvr104; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; Raju K, 2012, BBA-GEN SUBJECTS, V1820, P684, DOI 10.1016/j.bbagen.2011.05.009; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Sethuraman M, 2004, J PROTEOME RES, V3, P1228, DOI 10.1021/pr049887e; Sudarshan S, 2009, MOL CELL BIOL, V29, P4080, DOI 10.1128/MCB.00483-09; Sun JH, 2001, P NATL ACAD SCI USA, V98, P11158, DOI 10.1073/pnas.201289098; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Templeton DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015012; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Tsutsumi R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00503-w; Victor KG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032527; Voss AA, 2004, J BIOL CHEM, V279, P34514, DOI 10.1074/jbc.M404290200; Wani R, 2011, P NATL ACAD SCI USA, V108, P10550, DOI 10.1073/pnas.1011665108; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Winterbourn CC, 2013, METHOD ENZYMOL, V528, P3, DOI 10.1016/B978-0-12-405881-1.00001-X; Xu Y, 2018, CANCER RES, V78, P6539, DOI 10.1158/0008-5472.CAN-18-0901; Yang Y, 2010, CANCER GENET CYTOGEN, V196, P45, DOI 10.1016/j.cancergencyto.2009.08.018	54	2	2	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12336	12347		10.1096/fj.201900693R	http://dx.doi.org/10.1096/fj.201900693R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31451050	Green Submitted, Green Published			2022-12-28	WOS:000507461600058
J	Kim, HY; Yoo, TH; Cho, JY; Kim, HC; Lee, WW				Kim, Hee Young; Yoo, Tae-Hyun; Cho, Joo-Youn; Kim, Hyeon Chang; Lee, Won-Woo			Indoxyl sulfate-induced TNF-alpha is regulated by crosstalk between the aryl hydrocarbon receptor, NF-kappa B, and SOCS2 in human macrophages	FASEB JOURNAL			English	Article						ESRD; HMDM; AhR; IS; CVD	CHRONIC KIDNEY-DISEASE; DOWN-REGULATION; UREMIC TOXINS; POTENTIAL MECHANISM; HEPATIC STEATOSIS; RENAL-DISEASE; AH RECEPTOR; ACTIVATION; INFLAMMATION; EXPRESSION	Indoxyl sulfate (IS) is a uremic toxin associated with increased prevalence of cardiovascular diseases (CVDs) in patients with chronic kidney disease. Despite the crucial role of uremia-related immune dysfunction, a majority of studies attempting to elucidate its pathogenic role in CVD have focused on IS-mediated endothelial dysfunction. Thus, we investigated the underlying molecular mechanisms involved in IS-induced production of TNF-alpha, a major cardiotoxic cytokine, by human macrophages. We found that crosstalk between the aryl hydrocarbon receptor (AhR), NF-kappa B, and the suppressor of cytokine signaling (SOCS)2 is important for TNF-alpha production in IS-stimulated human macrophages. IS-activated AhR rapidly associates with the p65 NF-kappa B subunit, resulting in mutual inhibition of AhR and NF-kappa B and inhibition of TNF-alpha production at an early time point. Later, this repression of TNF-alpha production is alleviated when SOCS2, a negative modulator of NF-kappa B, is directly induced by IS-activated AhR. In addition, once free of inhibition, activated AhR induces TNF-alpha expression by interacting with AhR binding sites in the TNF-alpha gene. Lastly, we confirmed decreased AhR and increased SOCS2 expression in monocytes of patients with end-stage renal disease, indicating the activation of AhR. Taken together, our results suggest that IS-induced TNF-alpha production in macrophages is regulated through a complicated mechanism involving interaction of AhR, NF-kappa B, and SOCS2.-Kim, H. Y., Yoo, T.-H., Cho, J.-Y., Kim, H. C., Lee, W.-W. Indoxyl sulfate-induced TNF-alpha is regulated by crosstalk between the aryl hydrocarbon receptor, NF-kappa B, and SOCS2 in human macrophages.	[Kim, Hee Young; Lee, Won-Woo] Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Seoul, South Korea; [Kim, Hee Young; Lee, Won-Woo] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Lee, Won-Woo] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Lee, Won-Woo] Seoul Natl Univ, Coll Med, Ischem Hypox Dis Inst, Seoul, South Korea; [Yoo, Tae-Hyun] Yonsei Univ, Coll Med, Div Nephrol, Dept Internal Med, Seoul, South Korea; [Kim, Hyeon Chang] Yonsei Univ, Coll Med, Cardiovasc & Metab Dis Etiol Res Ctr, Seoul, South Korea; [Kim, Hyeon Chang; Lee, Won-Woo] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Cho, Joo-Youn] Seoul Natl Univ, Dept Clin Pharmacol & Therapeut, Coll Med Hosp, Seoul, South Korea; [Lee, Won-Woo] Seoul Natl Univ, Seoul Natl Univ Hosp, Inst Infect Dis, Biomed Res Inst,Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Lee, WW (corresponding author), Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Dept Biomed Sci, 103 Daehak Ro, Seoul 03080, South Korea.	wonwoolee@snu.ac.kr	Cho, Joo-Youn/ABC-2044-2021; Cho, Joo-Youn/J-5672-2012; Kim, Hyeon Chang/F-8796-2019	Cho, Joo-Youn/0000-0001-9270-8273; Cho, Joo-Youn/0000-0001-9270-8273; Kim, Hyeon Chang/0000-0001-7867-1240	Ministry of Health and Welfare, Sejong City, South Korea [HI13C0715]; National Research Foundation (Daejeon, South Korea) - Korean government [Ministry of Science and Information and Communications Technology (MSIT) [NRF-2018R1A2B2006310, NRF-2013R1A1A2060080, NRF-2016R1A2B1009767]	Ministry of Health and Welfare, Sejong City, South Korea; National Research Foundation (Daejeon, South Korea) - Korean government [Ministry of Science and Information and Communications Technology (MSIT)	The authors thank Jiyeon Jang (Seoul National University College of Medicine) for assisting in the recruitment of human subjects. This study was supported partially by a grant (HI13C0715 to W.-W.L.) from the Korean Health Technology Research and Development Project (Ministry of Health and Welfare, Sejong City, South Korea), and grants (NRF-2018R1A2B2006310 to W.-W.L.; NRF-2013R1A1A2060080 and NRF-2016R1A2B1009767 to H.Y.K.) from the National Research Foundation (Daejeon, South Korea) funded by the Korean government [Ministry of Science and Information and Communications Technology (MSIT). The authors declare no conflicts of interest.	Adesso S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076778; Barisione C, 2015, CURR DRUG TARGETS, V16, P366, DOI 10.2174/1389450116666141230114500; Brito JS, 2017, NEPHRON, V137, P1, DOI 10.1159/000476074; Cheon H, 2007, EXP MOL MED, V39, P524, DOI 10.1038/emm.2007.58; Cohen G, 2007, NEPHROL DIAL TRANSPL, V22, P3381, DOI 10.1093/ndt/gfm210; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Di Meglio P, 2014, IMMUNITY, V40, P989, DOI 10.1016/j.immuni.2014.04.019; Dou L, 2018, KIDNEY INT, V93, P986, DOI 10.1016/j.kint.2017.11.010; Ellis RJ, 2016, NEPHROLOGY, V21, P170, DOI 10.1111/nep.12580; Enomoto A, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022017.96399.B2; Falvo JV, 2010, CURR DIR AUTOIMMUN, V11, P27, DOI 10.1159/000289196; Gao HC, 2017, LIFE SCI, V185, P23, DOI 10.1016/j.lfs.2017.07.027; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gutierrez-Vazquez C, 2018, IMMUNITY, V48, P19, DOI 10.1016/j.immuni.2017.12.012; Hankinson O, 2005, ARCH BIOCHEM BIOPHYS, V433, P379, DOI 10.1016/j.abb.2004.09.031; Hidaka T, 2017, NAT IMMUNOL, V18, P64, DOI 10.1038/ni.3614; Hollingshead BD, 2008, CANCER RES, V68, P3609, DOI 10.1158/0008-5472.CAN-07-6168; Hung SC, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005022; Hung SC, 2016, KIDNEY INT, V89, P574, DOI 10.1016/j.kint.2015.11.020; Ikuta T, 1998, J BIOL CHEM, V273, P2895, DOI 10.1074/jbc.273.5.2895; Ito S, 2016, J ATHEROSCLER THROMB, V23, P960, DOI 10.5551/jat.34462; Ito S, 2014, TOXINS, V6, P665, DOI 10.3390/toxins6020665; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Ke S, 2001, J BIOL CHEM, V276, P39638, DOI 10.1074/jbc.M106286200; Kim DW, 2000, ONCOGENE, V19, P5498, DOI 10.1038/sj.onc.1203945; Kim HY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03130-z; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Koelwyn GJ, 2018, NAT IMMUNOL, V19, P526, DOI 10.1038/s41590-018-0113-3; Kolachalama VB, 2018, J AM SOC NEPHROL, V29, P1063, DOI 10.1681/ASN.2017080929; Leong SC, 2016, TOXINS, V8, DOI 10.3390/toxins8120358; Liu HT, 2000, J IMMUNOL, V164, P4277, DOI 10.4049/jimmunol.164.8.4277; Matsuo K, 2015, TOXINS, V7, P3155, DOI 10.3390/toxins7083155; Murray IA, 2014, NAT REV CANCER, V14, P801, DOI 10.1038/nrc3846; Muteliefu G, 2009, J RENAL NUTR, V19, P29, DOI 10.1053/j.jrn.2008.10.014; Nakano T, 2019, CIRCULATION, V139, P78, DOI 10.1161/CIRCULATIONAHA.118.034588; Paul I, 2017, SCI REP-UK, V7, DOI 10.1038/srep42800; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; Powe NR, 1999, KIDNEY INT, V55, P1081, DOI 10.1046/j.1523-1755.1999.0550031081.x; PROKIPCAK RD, 1991, CAN J PHYSIOL PHARM, V69, P1204, DOI 10.1139/y91-176; Rastmanesh MM, 2009, EUR J PHARMACOL, V602, P163, DOI 10.1016/j.ejphar.2008.11.014; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Rothschild DE, 2018, J LEUKOCYTE BIOL, V103, P1131, DOI 10.1002/JLB.3MIR0817-346RRR; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Sakai J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01600-y; Sarnak MJ, 2000, KIDNEY INT, V58, P1758, DOI 10.1111/j.1523-1755.2000.00337.x; Schroeder JC, 2010, BIOCHEMISTRY-US, V49, P393, DOI 10.1021/bi901786x; Sethi G, 2008, FRONT BIOSCI-LANDMRK, V13, P5094, DOI 10.2741/3066; Shi DD, 2012, CELL BIOCHEM FUNCT, V30, P664, DOI 10.1002/cbf.2846; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stenvinkel P, 2005, KIDNEY INT, V67, P1216, DOI 10.1111/j.1523-1755.2005.00200.x; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Tian Y, 1999, J BIOL CHEM, V274, P510, DOI 10.1074/jbc.274.1.510; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Vanholder R, 2001, INT J ARTIF ORGANS, V24, P695, DOI 10.1177/039139880102401004; Vanholder R, 2014, J AM SOC NEPHROL, V25, P1897, DOI 10.1681/ASN.2013101062; Vielhauer V, 2007, SEMIN NEPHROL, V27, P286, DOI 10.1016/j.semnephrol.2007.02.004; Vogel CFA, 2014, J BIOL CHEM, V289, P1866, DOI 10.1074/jbc.M113.505578; Vogel CFA, 2009, BIOCHEM PHARMACOL, V77, P734, DOI 10.1016/j.bcp.2008.09.036; Wada T, 2016, J BIOL CHEM, V291, P7004, DOI 10.1074/jbc.M115.693655; Wu DL, 2011, ARTERIOSCL THROM VAS, V31, P1260, DOI 10.1161/ATVBAHA.110.220202; Yeste A, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad0612; Zadjali F, 2012, FASEB J, V26, P3282, DOI 10.1096/fj.12-205583	63	22	23	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10844	10858		10.1096/fj.201900730R	http://dx.doi.org/10.1096/fj.201900730R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31284759				2022-12-28	WOS:000489166300022
J	Su, YL; Chen, Z; Du, HX; Liu, RH; Wang, WZ; Li, HF; Ning, B				Su, Yanlin; Chen, Zhe; Du, Hongxia; Liu, Ronghan; Wang, Wenzhao; Li, Hongfei; Ning, Bin			Silencing miR-21 induces polarization of astrocytes to the A2 phenotype and improves the formation of synapses by targeting glypican 6 via the signal transducer and activator of transcription-3 pathway after acute ischemic spinal cord injury	FASEB JOURNAL			English	Article						microRNA-21; neurotrophic reactive astrocytes; neurotoxic reactive astrocytes; STAT3	REGENERATION; MICRORNAS	Ischemic spinal cord injury (ISCI) results in the motor sensory dysfunction of the limbs below the injury site. In response to the injury, astrocytes develop into neuroprotective astrocytes [(neurotrophic reactive astrocytes (A2s)] to mitigate the damage. MicroRNA (miR)-21 can promote the development of neuroinflammation in previous studies. Our aim was to investigate the effect of miR-21 on its polarization. We used the abdominal aortic occlusion model in vivo. Immunohistochemistry was used to detect the distribution of A2s in the spinal cord. We used an oxygen glucose deprivation method to model astrocytes ischemia in vitro and tested proliferation, migration, and excitability of A2s using an 5-ethynyl -2'-deoxyuridine kit, wound scratch assay, and calcium-ion probe. After adjustment, we detected the model and target genes of A2s using PCR, Western blot, immunofluorescence, and chromatin immunoprecipitation. We demonstrated in vivo that naive astrocytes were transformed into A2s by ischemia. And in vitro miR-21, which can regulate the signal transducer and activator of transcription-3 pathway, can transform neurotoxic reactive astrocyte into A2. Moreover, we also verified the mechanism of A2s promoting synaptic formation and nerve growth. miR-21 is a switch to regulate the polarization of reactive astrocyte, and it promoted synapsis formation and nerites growth after acute ISCI.-Su, Y., Chen, Z., Du, H., Liu, R., Wang, W., Li, H., Ning, B. Silencing miR-21 induces polarization of astrocytes to the A2 phenotype and improves the formation of synapses by targeting glypican 6 via the signal transducer and activator of transcription-3 pathway after acute ischemic spinal cord injury.	[Su, Yanlin; Du, Hongxia; Liu, Ronghan; Wang, Wenzhao; Li, Hongfei; Ning, Bin] Shandong Univ, Jinan Cent Hosp, 105 Jiefang Rd, Jinan 250013, Shandong, Peoples R China; [Su, Yanlin] Shandong First Med Univ, Tai An, Shandong, Peoples R China; [Chen, Zhe] South China Normal Univ, Sch Phys Educ & Sports Sci, Guangzhou, Guangdong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; South China Normal University	Ning, B (corresponding author), Shandong Univ, Jinan Cent Hosp, 105 Jiefang Rd, Jinan 250013, Shandong, Peoples R China.	ningbin@sdu.edu.cn	Liu, Ronghan/ABH-1619-2021	Liu, Ronghan/0000-0002-6897-0279; Wang, Wenzhao/0000-0001-5106-4862	National Natural Science Funds of China [81401014, 81771346]; Chinese Postdoctoral Science Foundation [2014M561935, 2015T80725]; Technology Research and Development Program of Jinan City [201704133]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Technology Research and Development Program of Jinan City	Grant support was provided by the National Natural Science Funds of China (81401014, 81771346), the Chinese Postdoctoral Science Foundation (2014M561935), the Chinese Postdoctoral Science Foundation (2015T80725), and Technology Research and Development Program of Jinan City (201704133). B.N. is a Taishan scholar, young expert, director, and founder of the Jinan Institute of Biomechanics who participated in the study design, decision to publish, and preparation of the manuscript. All applicable international, national, and institutional guidelines for the care and use of animals were followed. This article does not contain any studies with human participants performed by any of the authors. The authors declare no conflicts of interest.	Allen NJ, 2018, SCIENCE, V362, P181, DOI 10.1126/science.aat0473; Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059; Tran AP, 2018, PHYSIOL REV, V98, P881, DOI 10.1152/physrev.00017.2017; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Bindocci E, 2017, SCIENCE, V356, DOI 10.1126/science.aai8185; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Chivukula RR, 2008, TRENDS BIOCHEM SCI, V33, P474, DOI 10.1016/j.tibs.2008.06.008; El Fatimy R, 2018, ACTA NEUROPATHOL, V136, P537, DOI 10.1007/s00401-018-1880-5; Fujita A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1251-0; Ghosh G, 2010, J CLIN INVEST, V120, P4141, DOI 10.1172/JCI42980; Her LS, 2017, THERANOSTICS, V7, P2452, DOI 10.7150/thno.18813; Hinkel R, 2013, CIRCULATION, V128, P1066, DOI 10.1161/CIRCULATIONAHA.113.001904; Karadimas SK, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac6524; Kinoshita C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4823; Levine J, 2016, GLIA, V64, P668, DOI 10.1002/glia.22953; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Liu RH, 2018, AGING-US, V10, P1474, DOI 10.18632/aging.101484; Morizawa YM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00037-1; Ning B, 2014, INT J BIOL SCI, V10, P997, DOI 10.7150/ijbs.9058; Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084; Renault-Mihara F, 2017, J CELL BIOL, V216, P2533, DOI 10.1083/jcb.201610102; Shi J, 2017, THERANOSTICS, V7, P664, DOI 10.7150/thno.15162; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Tyzack GE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5294; Verma P, 2015, NAT NEUROSCI, V18, P379, DOI 10.1038/nn.3935; Xu XT, 2019, J CELL PHYSIOL, V234, P904, DOI 10.1002/jcp.26918; Yamashita T, 2005, J NEUROCHEM, V94, P459, DOI 10.1111/j.1471-4159.2005.03227.x; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang F, 2018, BIOMED PHARMACOTHER, V107, P1523, DOI 10.1016/j.biopha.2018.08.136	31	35	39	6	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10859	10871		10.1096/fj.201900743R	http://dx.doi.org/10.1096/fj.201900743R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31266356				2022-12-28	WOS:000489166300023
J	Weinstein-Marom, H; Hendel, L; Laron, EA; Sharabi-Nov, A; Margalit, A; Gross, G				Weinstein-Marom, Hadas; Hendel, Liron; Laron, Efrat Avigad; Sharabi-Nov, Adi; Margalit, Alon; Gross, Gideon			MHC-I presentation of peptides derived from intact protein products of the pioneer round of translation	FASEB JOURNAL			English	Article						nonsense-mediated decay; peptide presentation; immunopeptidome	MESSENGER-RNA; NONSENSE CODONS; DOWN-REGULATION; EXPRESSION; SURVEILLANCE; DEGRADATION; MUTATIONS; SYSTEM; GENES; CELLS	Among the earliest protein products of most cellular genes are those synthesized during the pioneer round of translation (PRT), a key step in nonsense-mediated mRNA decay (NMD) that allows scanning of new transcripts for the presence of a premature termination codon (PTC). It has been demonstrated that at least some PRT degradation products can be targeted to major histocompatibility (MHC)-I presentation. To gain new insight into this putative PRT-to-MHC-I route, we have assembled 2 pairs of reporter genes so that the 2 genes in each pair encode an identical fusion protein between a model antigenic peptide and enhanced green fluorescent protein (EGFP), one of which harbors a PTC. We expressed these genes in different mouse and human cell lines and confirmed enhanced NMD activity for the PTC(+) gene in each pair by monitoring the effect of cycloheximide on the level of the respective mRNA. We then exploited several strategies for establishing the ratio between level of peptide presentation and total amount of protein product. We consistently observed significantly higher ratios for the PTC(+) mRNAs compared with the PTC(-) ones, pointing to correlation between the turnover of otherwise identical proteins and the fate of their template mRNA. Using confocal microscopy, we showed a clear link between NMD, the presence of misfolded EGFP polypeptides, and enhanced MHC-I peptide presentation. Altogether, these findings imply that identical full-length gene products differing only in 3 ' noncoding sequences can be differentially degraded and targeted to the MHC-I presentation pathway, suggesting a more general role for the PRT in establishing the MHC-I peptidome.-Weinstein-Marom, H., Hendel, L., Laron, E. A., Sharabi-Nov, A., Margalit, A., Gross, G. MHC-I presentation of peptides derived from intact protein products of the pioneer round of translation.	[Weinstein-Marom, Hadas; Hendel, Liron; Laron, Efrat Avigad; Margalit, Alon; Gross, Gideon] MIGAL Galilee Res Inst, Lab Immunol, Kiryat Shmona, Israel; [Weinstein-Marom, Hadas; Hendel, Liron; Laron, Efrat Avigad; Sharabi-Nov, Adi; Margalit, Alon; Gross, Gideon] Tel Hai Coll, Upper Galilee, Israel; [Weinstein-Marom, Hadas] Hebrew Univ Jerusalem, Interfac Biotechnol Program, Jerusalem, Israel	Tel Hai Academy College; Hebrew University of Jerusalem	Gross, G (corresponding author), MIGAL Galilee Res Inst, IL-11016 Kiryat Shmona, Israel.	gidi@migal.org.il			Israel Science Foundation [910/10]	Israel Science Foundation(Israel Science Foundation)	This research was supported by the Israel Science Foundation (Grant 910/10). The authors declare no conflicts of interest.	Anton LC, 2014, J LEUKOCYTE BIOL, V95, P551, DOI 10.1189/jlb.1113599; Aoufouchi S, 1996, CELL, V85, P415, DOI 10.1016/S0092-8674(00)81119-8; Apcher S, 2016, CURR OPIN IMMUNOL, V40, P117, DOI 10.1016/j.coi.2016.04.002; Apcher S, 2013, P NATL ACAD SCI USA, V110, P17951, DOI 10.1073/pnas.1309956110; Apcher S, 2011, P NATL ACAD SCI USA, V108, P11572, DOI 10.1073/pnas.1104104108; BAUMANN B, 1985, EMBO J, V4, P351, DOI 10.1002/j.1460-2075.1985.tb03636.x; Bourdetsky D, 2014, P NATL ACAD SCI USA, V111, pE1591, DOI 10.1073/pnas.1321902111; Buhler M, 2004, NUCLEIC ACIDS RES, V32, P3304, DOI 10.1093/nar/gkh651; Buzina A, 1999, MOL BIOL CELL, V10, P515, DOI 10.1091/mbc.10.3.515; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; CONNOR A, 1994, J BIOL CHEM, V269, P25178; Duvallet E, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1198865; Eberle AB, 2009, RNA, V15, P1021, DOI 10.1261/rna.1516409; Fortier MH, 2008, J EXP MED, V205, P595, DOI 10.1084/jem.20071985; Gudikote JP, 2002, EMBO J, V21, P125, DOI 10.1093/emboj/21.1.125; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Iizuka R, 2011, ANAL BIOCHEM, V414, P173, DOI 10.1016/j.ab.2011.03.036; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; JACK HM, 1989, EUR J IMMUNOL, V19, P843, DOI 10.1002/eji.1830190510; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; KOHLER G, 1976, EUR J IMMUNOL, V6, P511, DOI 10.1002/eji.1830060713; Li SL, 1998, IMMUNITY, V8, P135, DOI 10.1016/S1074-7613(00)80466-5; LIN AY, 1990, SCIENCE, V249, P677, DOI 10.1126/science.1696397; LOZANO F, 1994, EMBO J, V13, P4617, DOI 10.1002/j.1460-2075.1994.tb06783.x; Maquat LE, 2010, CELL, V142, P368, DOI 10.1016/j.cell.2010.07.022; Meyuhas R, 2005, MOL IMMUNOL, V42, P1099, DOI 10.1016/j.molimm.2004.11.002; Milner E, 2006, MOL CELL PROTEOMICS, V5, P357, DOI 10.1074/mcp.M500241-MCP200; Paillusson A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni052; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Rock KL, 2002, ADV IMMUNOL, V80, P1, DOI 10.1016/S0065-2776(02)80012-8; RUSCONI S, 1985, NATURE, V314, P330, DOI 10.1038/314330a0; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Stalder L, 2008, TRENDS CELL BIOL, V18, P315, DOI 10.1016/j.tcb.2008.04.005; Starck SR, 2011, CELL MOL LIFE SCI, V68, P1471, DOI 10.1007/s00018-011-0655-0; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008	38	0	0	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11458	11468		10.1096/fj.201802717RRR	http://dx.doi.org/10.1096/fj.201802717RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31343935	Bronze			2022-12-28	WOS:000489166300071
J	Guadagni, V; Biagioni, M; Novelli, E; Aretini, P; Mazzanti, CM; Strettoi, E				Guadagni, Viviana; Biagioni, Martina; Novelli, Elena; Aretini, Paolo; Mazzanti, Chiara Maria; Strettoi, Enrica			Rescuing cones and daylight vision in retinitis pigmentosa mice	FASEB JOURNAL			English	Article						rod; bystander effect; environmental enrichment; microglia; cytokines	CHRONIC INFLAMMATORY REACTION; MOUSE MODEL; RETINAL DEGENERATION; PHOTORECEPTOR DEGENERATION; MACULAR EDEMA; ENVIRONMENTAL ENRICHMENT; MICROGLIAL PHAGOCYTOSIS; CELL-DEATH; DEXAMETHASONE; ACTIVATION	Hallmark of retinitis pigmentosa (RP) is the primary, genetic degeneration of rods followed by secondary loss of cones, caused by still elusive biologic mechanisms. We previously shown that exposure of rd10 mutant mice, modeling autosomal recessive RP, to environmental enrichment (EE), with enhanced motor, sensorial and social stimuli, results into a sensible delay of retinal degeneration and vision loss. Searching for effectors of EE-mediated retinal protection, we performed transcriptome analysis of the retina of rd10 enriched and control mice and found that gene expression at the peaks of rod and cone degeneration is characterized by a strong inflammatory/immune response, which is however measurably lower in enrichment conditions. Treating rd10 mice with dexamethasone during the period of maximum photoreceptors death lowered retinal inflammation and caused a preservation of cones and cone-mediated vision. Our findings indicate a link between retinal inflammation and bystander cone degeneration, reinforcing the notion that cone vision in RP can be preserved using anti-inflammatory approaches.-Guadagni, V., Biagioni, M., Novelli, E., Aretini, P., Mazzanti, C. M., Strettoi, E. Rescuing cones and daylight vision in retinitis pigmentosa mice.	[Guadagni, Viviana; Biagioni, Martina; Novelli, Elena; Strettoi, Enrica] CNR, Inst Neurosci, Pisa, Italy; [Aretini, Paolo; Mazzanti, Chiara Maria] Fdn Pisana Sci, Lab Genom & Transcript, Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Strettoi, E (corresponding author), CNR, Italian Natl Res Council, Ist Neurosci, Via Giuseppe Moruzzi 1, I-56124 Pisa, Italy.	enrica.strettoi@in.cnr.it	Mazzanti, Chiara/AAX-6539-2021; Aretini, Paolo/AAF-1205-2020; Biagioni, Martina/HII-7196-2022	Aretini, Paolo/0000-0003-1075-4319; Biagioni, Martina/0000-0002-9599-2430	Fondazione Roma (Rome, Italy); Velux Foundation Stiftung (Zurich, Switzerland); EU Horizon 2020 research and innovation program - Marie Sklodowska-Curie grant [674901]	Fondazione Roma (Rome, Italy)(Fondazione Roma); Velux Foundation Stiftung (Zurich, Switzerland); EU Horizon 2020 research and innovation program - Marie Sklodowska-Curie grant	The authors thank Francesca Lessi and Sara Franceschi (Pisa Science Foundation) for valuable support with next generation sequencing experiments; Renzo Di Renzo (Institute of Neuroscience, Consiglio Nazionale delle Ricerche, Pisa, Italy) for technical assistance; Tommaso Pizzorusso (University of Florence, Italy) for the generous use of quantitative real-time PCR apparatus. Macula Vision Research Foundation (Conshohocken, PA, USA). Funded by Fondazione Roma (Rome, Italy), retinitis pigmentosa call; and by Velux Foundation Stiftung (Zurich, Switzerland). ES was beneficiary of a EU Horizon 2020 research and innovation program - Marie Sklodowska-Curie grant agreement No 674901. The sponsors had no role in the study design, in the collection, analysis, and interpretation of data, in writing the report, or in the decision to submit the paper for publication. The authors declare no conflicts of interest.	Ahn SJ, 2014, OPHTHAL SURG LAS IM, V45, P160, DOI 10.3928/23258160-20140131-03; Ait-Ali N, 2015, CELL, V161, P817, DOI 10.1016/j.cell.2015.03.023; Arango-Gonzalez B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112142; Barone I, 2014, MOL VIS, V20, P1545; Barone I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050726; Bessinis DP, 2013, NEUROSCIENCE, V254, P130, DOI 10.1016/j.neuroscience.2013.09.013; Brown J, 2007, OPHTHALMOLOGY, V114, P1876, DOI 10.1016/j.ophtha.2007.04.035; Campochiaro PA, 2018, PROG RETIN EYE RES, V62, P24, DOI 10.1016/j.preteyeres.2017.08.004; Cao JH, 2014, OPHTHALMOLOGY, V121, P1871, DOI 10.1016/j.ophtha.2014.04.012; CHANT SM, 1985, BRIT J OPHTHALMOL, V69, P19, DOI 10.1136/bjo.69.1.19; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Chia EM, 2004, INVEST OPHTH VIS SCI, V45, P71, DOI 10.1167/iovs.03-0661; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dienel GA, 2019, PHYSIOL REV, V99, P949, DOI 10.1152/physrev.00062.2017; Dornbos D, 2013, J NEUROSCI RES, V91, P818, DOI 10.1002/jnr.23203; Eandi CM, 2016, ELIFE, V5, DOI 10.7554/eLife.16490; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Grinan-Ferre C, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00241; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Heckenlively J R, 1996, Trans Am Ophthalmol Soc, V94, P179; HECKENLIVELY JR, 1985, BRIT J OPHTHALMOL, V69, P758, DOI 10.1136/bjo.69.10.758; Herring A, 2010, BRAIN PATHOL, V20, P166, DOI 10.1111/j.1750-3639.2008.00257.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Lawson EC, 2014, J NEUROSCI, V34, P2406, DOI 10.1523/JNEUROSCI.2062-13.2014; Liang KJ, 2009, INVEST OPHTH VIS SCI, V50, P4444, DOI 10.1167/iovs.08-3357; Lin B, 2009, EXP EYE RES, V88, P589, DOI 10.1016/j.exer.2008.11.022; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; McMurtrey JJ, 2018, SURV OPHTHALMOL, V63, P769, DOI 10.1016/j.survophthal.2018.03.002; Mitchell P, 2018, LANCET, V392, P1147, DOI 10.1016/S0140-6736(18)31550-2; Nagasaka Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep33921; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; NEWSOME DA, 1988, AM J OPHTHALMOL, V105, P596, DOI 10.1016/0002-9394(88)90050-5; Owens Trevor, 2002, Expert Opin Ther Targets, V6, P203, DOI 10.1517/14728222.6.2.203; Ozkan A, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-16; Pardue MT, 2015, PROG MOL BIOL TRANSL, V134, P491, DOI 10.1016/bs.pmbts.2015.06.011; Peng B, 2014, J NEUROSCI, V34, P8139, DOI 10.1523/JNEUROSCI.5200-13.2014; Perez VL, 2015, TRENDS IMMUNOL, V36, P354, DOI 10.1016/j.it.2015.04.003; Rana I, 2014, J NEUROENDOCRINOL, V26, P413, DOI 10.1111/jne.12161; Villanueva JR, 2017, INT J PHARMACEUT, V516, P342, DOI 10.1016/j.ijpharm.2016.11.053; Sale A, 2014, PHYSIOL REV, V94, P189, DOI 10.1152/physrev.00036.2012; Stewart MW, 2012, CURR DIABETES REP, V12, P364, DOI 10.1007/s11892-012-0281-8; Strettoi E, 2010, P NATL ACAD SCI USA, V107, P18706, DOI 10.1073/pnas.1007644107; Syeda S, 2015, EXP NEUROL, V267, P1, DOI 10.1016/j.expneurol.2015.02.027; Uren PJ, 2014, MOL VIS, V20, P1612; van Praag H, 2014, J NEUROSCI, V34, P15139, DOI 10.1523/JNEUROSCI.2814-14.2014; Wenzel A, 2001, INVEST OPHTH VIS SCI, V42, P1653; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Wrobel A, 2005, PHARMACOL REP, V57, P451; Wrobel A, 2014, PROG NEURO-PSYCHOPH, V54, P243, DOI 10.1016/j.pnpbp.2014.06.008; Xu HX, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201808931; Yao Y, 2014, INT J BIOCHEM CELL B, V55, P51, DOI 10.1016/j.biocel.2014.08.002; Yoshida N, 2013, OPHTHALMOLOGY, V120, pE5, DOI 10.1016/j.ophtha.2012.07.008; Yoshida N, 2013, OPHTHALMOLOGY, V120, P100, DOI 10.1016/j.ophtha.2012.07.006; Zabel MK, 2016, GLIA, V64, P1479, DOI 10.1002/glia.23016; Zeng H, 2014, NEUROSCIENCE, V275, P54, DOI 10.1016/j.neuroscience.2014.05.065; Zhao L, 2015, EMBO MOL MED, V7, P1179, DOI 10.15252/emmm.201505298; Zhao L, 2011, AM J PATHOL, V179, P1265, DOI 10.1016/j.ajpath.2011.05.042; Zhou Y, 2007, J NEUROCHEM, V102, P667, DOI 10.1111/j.1471-4159.2007.04535.x; Zobor D, 2012, OPHTHALMOLOGE, V109, P501, DOI 10.1007/s00347-012-2555-6	60	18	18	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10177	10192		10.1096/fj.201900414R	http://dx.doi.org/10.1096/fj.201900414R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31199887	Bronze, Green Published			2022-12-28	WOS:000482214200037
J	Kim, YY; Um, JH; Yoon, JH; Kim, H; Lee, DY; Lee, YJ; Jee, HJ; Kim, YM; Jang, JS; Jang, YG; Chung, J; Park, HT; Finkel, T; Koh, H; Yun, J				Kim, Young Yeon; Um, Jee-Hyun; Yoon, Jeong-Hyun; Kim, Hyunjin; Lee, Da-Ye; Lee, Yoon Jung; Jee, Hye Jin; Kim, Young Mi; Jang, Jae Sung; Jang, Yoon-Gu; Chung, Jongkyeong; Park, Hwan Tae; Finkel, Toren; Koh, Hyongjong; Yun, Jeanho			Assessment of mitophagy in mt-Keima Drosophila revealed an essential role of the PINK1-Parkin pathway in mitophagy induction in vivo	FASEB JOURNAL			English	Article						in vivo mitophagy; Drosophila model; confocal microscopy; quantitation of mitophagy	MITOCHONDRIAL DYSFUNCTION; PINK1/PARKIN MITOPHAGY; PROGRAMMED AUTOPHAGY; FLY; NEURODEGENERATION; MELANOGASTER; DISEASES; PROTEIN; PINK1; GENE	Mitophagy has been implicated in mitochondrial quality control and in various human diseases. However, the study of in vivo mitophagy remains limited. We previously explored in vivo mitophagy using a transgenic mouse expressing the mitochondria-targeted fluorescent protein Keima (mt-Keima). Here, we generated mt-Keima Drosophila to extend our efforts to study mitophagy in vivo. A series of experiments confirmed that mitophagy can be faithfully and quantitatively measured in mt-Keima Drosophila. We also showed that alterations in mitophagy upon environmental and genetic perturbation can be measured in mt-Keima Drosophila. Analysis of different tissues revealed a variation in basal mitophagy levels in Drosophila tissues. In addition, we found a significant increase in mitophagy levels during Drosophila embryogenesis. Importantly, loss-of-function genetic analysis demonstrated that the phosphatase and tensin homolog-induced putative kinase 1 (PINK1)-Parkin pathway is essential for the induction of mitophagy in vivo in response to hypoxic exposure and rotenone treatment. These studies showed that the mt-Keima Drosophila system is a useful tool for understanding the role and molecular mechanism of mitophagy in vivo. In addition, we demonstrated the essential role of the PINK1-Parkin pathway in mitophagy induction in response to mitochondrial dysfunction.-Kim, Y. Y., Um, J.-H., Yoon, J.-H., Kim, H., Lee, D.-Y., Lee, Y. J., Jee, H. J., Kim, Y. M., Jang, J. S., Jang, Y.-G., Chung, J., Park, H. T., Finkel, T., Koh, H., Yun, J. Assessment of mitophagy in mt-Keima Drosophila revealed an essential role of the PINK1-Parkin pathway in mitophagy induction in vivo.	[Kim, Young Yeon; Um, Jee-Hyun; Yoon, Jeong-Hyun; Kim, Hyunjin; Lee, Da-Ye; Lee, Yoon Jung; Jee, Hye Jin; Kim, Young Mi; Jang, Jae Sung; Park, Hwan Tae; Koh, Hyongjong; Yun, Jeanho] Dong A Univ, Peripheral Neuropathy Res Ctr, Coll Med, Busan, South Korea; [Kim, Young Yeon; Um, Jee-Hyun; Yoon, Jeong-Hyun; Lee, Da-Ye; Lee, Yoon Jung; Jee, Hye Jin; Kim, Young Mi; Jang, Jae Sung; Yun, Jeanho] Dong A Univ, Dept Biochem, Coll Med, 32,Daesingongwon Ro, Busan 49201, South Korea; [Kim, Hyunjin; Koh, Hyongjong] Dong A Univ, Dept Pharmacol, Coll Med, 32,Daesingongwon Ro, Busan 49201, South Korea; [Park, Hwan Tae] Dong A Univ, Dept Mol Neurosci, Coll Med, Busan, South Korea; [Jang, Yoon-Gu; Chung, Jongkyeong] Seoul Natl Univ, Natl Creat Res Initiat, Ctr Energy Homeostasis Regulat, Sch Biol Sci, Seoul, South Korea; [Jang, Yoon-Gu; Chung, Jongkyeong] Seoul Natl Univ, Inst Mol Biol & Genet, Seoul, South Korea; [Finkel, Toren] Univ Pittsburgh, Sch Med, Dept Med, Aging Inst, Pittsburgh, PA 15213 USA	Dong A University; Dong A University; Dong A University; Dong A University; Seoul National University (SNU); Seoul National University (SNU); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yun, J (corresponding author), Dong A Univ, Dept Biochem, Coll Med, 32,Daesingongwon Ro, Busan 49201, South Korea.; Koh, H (corresponding author), Dong A Univ, Dept Pharmacol, Coll Med, 32,Daesingongwon Ro, Busan 49201, South Korea.	hjkoh@dau.ac.kr; yunj@dau.ac.kr		Jang, Yoon-Gu/0000-0002-4773-6053; Koh, Hyongjong/0000-0003-2594-4799	National Research foundation of Korea (NRF) - Korea government [2016R1A5A2007009, 2019R1A2C2003991]	National Research foundation of Korea (NRF) - Korea government(National Research Foundation of Korea)	This work was supported by the National Research foundation of Korea (NRF) grant funded by the Korea government (2016R1A5A2007009 and 2019R1A2C2003991). The authors declare no conflicts of interest.	Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Beira JV, 2016, CHROMOSOMA, V125, P573, DOI 10.1007/s00412-016-0595-4; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; CRONMILLER C, 1988, GENE DEV, V2, P1666, DOI 10.1101/gad.2.12a.1666; Cummins N, 2018, CELL MOL LIFE SCI, V75, P1151, DOI 10.1007/s00018-017-2692-9; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Esteban-Martinez L, 2017, EMBO J, V36, P1688, DOI 10.15252/embj.201695916; Featherstone D. E., 2009, JOVE-J VIS EXP, P1347, DOI DOI 10.3791/1347; Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946; Hales KG, 2015, GENETICS, V201, P815, DOI 10.1534/genetics.115.183392; Jang JY, 2018, J CLIN INVEST, V128, P3662, DOI 10.1172/JCI120842; Kang DC, 2005, CURR MED CHEM, V12, P429, DOI 10.2174/0929867053363081; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017; Kim H, 2016, J BIOL CHEM, V291, P1841, DOI 10.1074/jbc.M115.656934; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; Koh H, 2012, J BIOL CHEM, V287, P12750, DOI 10.1074/jbc.M111.337907; Lee JJ, 2018, J CELL BIOL, V217, P1613, DOI 10.1083/jcb.201801044; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Lindmo K, 2006, EXP CELL RES, V312, P2018, DOI 10.1016/j.yexcr.2006.03.002; Lu XD, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aap8526; McWilliams TG, 2018, CELL METAB, V27, P439, DOI 10.1016/j.cmet.2017.12.008; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Palikaras K, 2018, NAT CELL BIOL, V20, P1013, DOI 10.1038/s41556-018-0176-2; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Perkins G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045344; Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Romanello V, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00422; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Russell AP, 2014, BBA-GEN SUBJECTS, V1840, P1276, DOI 10.1016/j.bbagen.2013.11.016; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Sin J, 2016, AUTOPHAGY, V12, P369, DOI 10.1080/15548627.2015.1115172; Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9; St Johnston D, 2002, NAT REV GENET, V3, P176, DOI 10.1038/nrg751; Sun N, 2017, NAT PROTOC, V12, P1576, DOI 10.1038/nprot.2017.060; Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028; Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009; Um JH, 2017, BMB REP, V50, P299, DOI 10.5483/BMBRep.2017.50.6.056; Vazquez-Martin A, 2016, AGING-US, V8, P1330, DOI 10.18632/aging.100976; Whitworth AJ, 2017, CURR OPIN GENET DEV, V44, P47, DOI 10.1016/j.gde.2017.01.016; Wong PM, 2013, AUTOPHAGY, V9, P124, DOI 10.4161/auto.23323; Xu G, 2018, AUTOPHAGY, V14, P1818, DOI 10.1080/15548627.2018.1501251; Yamashita S, 2016, J CELL BIOL, V215, P649, DOI 10.1083/jcb.201605093; Zhu JH, 2013, AUTOPHAGY, V9, P1663, DOI 10.4161/auto.24135	50	38	38	2	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9742	9751		10.1096/fj.201900073R	http://dx.doi.org/10.1096/fj.201900073R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31120803	Bronze			2022-12-28	WOS:000482214200005
J	Tao, SY; Bai, Y; Li, TT; Li, N; Wang, JJ				Tao, Shiyu; Bai, Yu; Li, Tiantian; Li, Na; Wang, Junjun			Original low birth weight deteriorates the hindgut epithelial barrier function in pigs at the growing stage	FASEB JOURNAL			English	Article						intestinal barrier function; mucin; tight junction; microbiota	INTRAUTERINE GROWTH RESTRICTION; INTESTINAL MUCOSAL BARRIER; MICROBIOTA; PERMEABILITY; INTERLEUKIN-8; INFLAMMATION; HOMEOSTASIS; DISRUPTION; EXPRESSION; RESISTANCE	The deteriorative effect of low birth weight (LBW) on the mucosal permeability of the small intestine in piglets has been widely confirmed. However, whether the hindgut epithelial barrier function in LBW pigs is deteriorated during the growing stage is still unclear. Our study investigated differences in the hindgut epithelial barrier function between LBW and normal birth weight pigs during the growing stage (d 90). Our data demonstrated that the hindgut epithelium of LBW pigs has a high histopathological score, accompanied by decreased antioxidant capacity and increased apoptosis rate, as well as elevated expression and activity of caspase-3. In addition, the number of intestinal goblet cells and gene expression of mucin 2 were significantly down-regulated in LBW pigs. The expression of tight junction proteins (ZO-1 and occludin) was markedly inhibited by the LBW. The mRNA abundance of inflammatory cytokines such as TNF-alpha, IL-1 beta, and IL-8 was significantly increased in the hindgut mucosa of LBW pigs. Furthermore, our data revealed that LBW altered the intestinal microbial community in the hindgut mucosa of pigs. Collectively, these finding add to our understanding of the mechanisms responsible for hindgut epithelial barrier dysfunction in LBW pigs during the growing stage and facilitate the development of nutritional intervention strategies.-Tao, S., Bai, Y., Li, T., Li, N., Wang, J. Original low birth weight deteriorates the hindgut epithelial barrier function in pigs at the growing stage.	[Tao, Shiyu; Bai, Yu; Li, Tiantian; Li, Na; Wang, Junjun] China Agr Univ, State Key Lab Anim Nutr, Coll Anim Sci & Technol, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China	China Agricultural University	Wang, JJ (corresponding author), China Agr Univ, State Key Lab Anim Nutr, Coll Anim Sci & Technol, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.	wangjj@cau.edu.cn		Tao, Shiyu/0000-0003-2600-3309	National Natural Science Foundation of China [31630074]; Beijing Municipal Natural Science Foundation [S170001]; China Postdoctoral Science Foundation [2018M641549]; 111 Project [B16044]; Jinxinnong Animal Science Developmental Foundation; Hunan Co-Innovation Center of Animal Production Safety (CICAPS)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); 111 Project(Ministry of Education, China - 111 Project); Jinxinnong Animal Science Developmental Foundation; Hunan Co-Innovation Center of Animal Production Safety (CICAPS)	This research was financially supported by the National Natural Science Foundation of China (31630074), the Beijing Municipal Natural Science Foundation (S170001), the China Postdoctoral Science Foundation (2018M641549), the 111 Project (B16044), the Jinxinnong Animal Science Developmental Foundation, and the Hunan Co-Innovation Center of Animal Production Safety (CICAPS). The authors declare no conflicts of interest.	Al-Sadi R, 2011, AM J PHYSIOL-GASTR L, V300, pG1054, DOI 10.1152/ajpgi.00055.2011; Albu A R, 2014, J Med Life, V7, P165; BALLARD ST, 1995, ANNU REV NUTR, V15, P35, DOI 10.1146/annurev.nu.15.070195.000343; Bjuland KJ, 2014, EUR J PAEDIATR NEURO, V18, P578, DOI 10.1016/j.ejpn.2014.04.004; Blasig IE, 2011, ANTIOXID REDOX SIGN, V15, P1163, DOI 10.1089/ars.2011.4003; Brew R, 2000, CYTOKINE, V12, P78, DOI 10.1006/cyto.1999.0518; Brynskov J, 2002, GUT, V51, P37, DOI 10.1136/gut.51.1.37; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Che LQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157314; Chen LM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01688; Cheng ZX, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00389; Chin AC, 2006, CAN J PHYSIOL PHARM, V84, P1043, DOI 10.1139/Y06-056; De Santis S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00612; Dong L, 2014, J HISTOCHEM CYTOCHEM, V62, P510, DOI 10.1369/0022155414532655; Fanca-Berthon P, 2010, J PEDIATR GASTR NUTR, V51, P402, DOI 10.1097/MPG.0b013e3181d75d52; Fung CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146542; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Hong XT, 2016, SCI REP-UK, V6, DOI 10.1038/srep26621; Hu J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00897; Hu J, 2017, INT J BIOCHEM CELL B, V89, P42, DOI 10.1016/j.biocel.2017.05.026; Hu L, 2017, EUR J NUTR, V56, P1753, DOI 10.1007/s00394-016-1223-z; Hu Y, 2018, MOL GENET GENOMICS, V293, P807, DOI 10.1007/s00438-018-1422-9; Jain V, 2012, REV ENDOCR METAB DIS, V13, P141, DOI 10.1007/s11154-012-9216-6; Jensen CB, 2007, J CLIN ENDOCR METAB, V92, P1530, DOI 10.1210/jc.2006-2360; Ji JJ, 2018, INT J MOL MED, V41, P137, DOI 10.3892/ijmm.2017.3229; Jiang PP, 2014, PROTEOM CLIN APPL, V8, P700, DOI 10.1002/prca.201300097; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Lee SI, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16561-5; Lee SH, 2015, INTEST RES, V13, P11, DOI 10.5217/ir.2015.13.1.11; Li N, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01798; Li N, 2017, BRIT J NUTR, V117, P1390, DOI [10.1017/s000711451700126x, 10.1017/S000711451700126X]; Li Y, 2017, J ANIM SCI, V95, P3972, DOI [10.2527/jas.2017.1652, 10.2527/jas2017.1652]; Liu JH, 2015, J CLIN INVEST, V125, P1056, DOI 10.1172/JCI73193; Longhi S, 2015, J ENDOCRINOL INVEST, V38, P563, DOI 10.1007/s40618-014-0230-2; Ma XS, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01271; Mach N, 2015, ENV MICROBIOL REP, V7, P554, DOI 10.1111/1758-2229.12285; Mani V, 2012, J ANIM SCI, V90, P1452, DOI 10.2527/jas.2011-4627; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Palatinus JA, 2011, AM J PHYSIOL-HEART C, V300, pH583, DOI 10.1152/ajpheart.00999.2010; Pusceddu MM, 2018, CURR PATHOBIOL REP, V6, P1, DOI 10.1007/s40139-018-0160-3; Renes IB, 2002, AM J PHYSIOL-GASTR L, V282, pG382, DOI 10.1152/ajpgi.00229.2001; Rescigno M, 2011, TRENDS IMMUNOL, V32, P256, DOI 10.1016/j.it.2011.04.003; Shen LY, 2018, CELL PHYSIOL BIOCHEM, V50, P1764, DOI 10.1159/000494794; Shen LY, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00291; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Takiishi T, 2017, TISSUE BARRIERS, V5, DOI 10.1080/21688370.2017.1373208; Tao SY, 2019, J CELL PHYSIOL, V234, P3621, DOI 10.1002/jcp.27132; Tao SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep28778; Tao SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111596; Tao SY, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0235-2; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Wang JJ, 2017, MOL REPROD DEV, V84, P897, DOI 10.1002/mrd.22842; Wang W, 2016, FASEB J, V30, P863, DOI 10.1096/fj.15-274779; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Wu X, 2008, AM J PHYSIOL-GASTR L, V294, pG295, DOI 10.1152/ajpgi.00173.2007; Yan L, 2013, MICROBIOL RES, V168, P389, DOI 10.1016/j.micres.2013.02.008; Yang CC, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011739; Zhu YH, 2017, AM J PHYSIOL-GASTR L, V312, pG434, DOI 10.1152/ajpgi.00020.2017	64	23	23	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9897	9912		10.1096/fj.201900204RR	http://dx.doi.org/10.1096/fj.201900204RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31170357	Bronze			2022-12-28	WOS:000482214200017
J	Akcora, BO; Dathathri, E; Ortiz-Perez, A; Gabriel, AV; Storm, G; Prakash, J; Bansal, R				Akcora, Busra Ozturk; Dathathri, Eshwari; Ortiz-Perez, Ana; Gabriel, Alexandros Vassilios; Storm, Gert; Prakash, Jai; Bansal, Ruchi			TG101348, a selective JAK2 antagonist, ameliorates hepatic fibrogenesis in vivo	FASEB JOURNAL			English	Article						myofibroblasts; inflammatory macrophages; liver fibrosis; intrahepatic inflammation	HEPATOCELLULAR-CARCINOMA; LIVER FIBROSIS; STAT PATHWAY; MYOFIBROBLAST; MACROPHAGES; TRANSDUCER; ACTIVATION; MECHANISMS; DELETION; DAMAGE	Hepatic fibrosis, characterized by an excessive extracellular matrix (ECM) accumulation, leading to scar-tissue formation is a growing health problem worldwide. Hepatocellular damage due to liver injury triggers inflammation and transdifferentiation of quiescent hepatic stellate cells (HSCs) into proliferative, contractile, and ECM-producing myofibroblasts. Involvement of the Janus kinase (JAK)-2 pathway in the pathogenesis of fibrosis has been reported earlier. However, in this study, we have investigated the effect of selective JAK2 antagonist TG101348 in fibroblasts and inflammatory macrophages and in vivo in an acute carbon tetrachloride-induced liver injury mouse model. In vitro, TG101348 significantly inhibited TGF-beta-induced collagen I expression in murine 3T3 fibroblasts. In human HSCs (LX2 cells), TG101348 potently attenuated TGF-beta-induced contractility and the protein and gene expression of major fibrotic parameters (collagen I, vimentin, and alpha-smooth muscle actin). In LPS- and IFN-gamma-stimulated inflammatory macrophages, TG101348 significantly reduced the NO release and strongly inhibited the expression of inflammatory markers (inducible nitric oxide synthase, C-C motif chemokine ligand 2, IL-1 beta, IL-6, and C-C chemokine receptor type 2). In vivo in an acute liver injury mouse model, TG101348 significantly attenuated collagen accumulation and HSC activation. Interestingly, TG101348 drastically inhibited macrophage infiltration and intrahepatic inflammation. Pharmacological inhibition of the JAK2 signaling pathway in activated HSCs and inflammatory macrophages using TG101348 suggests a potential therapeutic approach for the treatment of liver fibrosis.-Akcora, B. O., Dathathri, E., Ortiz-Perez, A., Gabriel, A. V., Storm, G., Prakash, J., Bansal, R. TG101348, a selective JAK2 antagonist, ameliorates hepatic fibrogenesis in vivo.	[Akcora, Busra Ozturk; Dathathri, Eshwari; Ortiz-Perez, Ana; Gabriel, Alexandros Vassilios; Storm, Gert; Prakash, Jai; Bansal, Ruchi] Univ Twente, Fac Sci & Technol, Dept Biomat Sci & Technol, Tech Med Ctr, Drienerlolaan 5, NL-7522 NB Enschede, Netherlands; [Storm, Gert] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut, Fac Sci, Utrecht, Netherlands; [Bansal, Ruchi] Univ Groningen, Dept Pharmacokinet Toxicol & Targeting, Groningen Res Inst Pharm, Groningen, Netherlands	University of Twente; Utrecht University; University of Groningen	Bansal, R (corresponding author), Univ Twente, Fac Sci & Technol, Dept Biomat Sci & Technol, Tech Med Ctr, Drienerlolaan 5, NL-7522 NB Enschede, Netherlands.	r.bansal@utwente.nl	Prakash, Jai/C-8015-2014; Bansal, Ruchi/D-4796-2016	Prakash, Jai/0000-0003-1050-650X; Bansal, Ruchi/0000-0003-2470-5876	Netherlands Organization for Health Research and Development (ZonMw; NWO) [916.151.94]	Netherlands Organization for Health Research and Development (ZonMw; NWO)	The authors thank B. Klomphaar (University of Twente, The Netherlands) for technical assistance during the animal experiments. This project was supported by The Netherlands Organization for Health Research and Development (ZonMw; NWO) Veni Grant 916.151.94 (to R.B.). The authors declare no conflicts of interest.	Akcora BO, 2018, BBA-MOL BASIS DIS, V1864, P804, DOI 10.1016/j.bbadis.2017.12.001; Atallah E, 2009, EXPERT REV ANTICANC, V9, P663, DOI 10.1586/ERA.09.14; Bansal R, 2015, SCI REP-UK, V5, DOI 10.1038/srep18272; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; Elpek GO, 2014, WORLD J GASTROENTERO, V20, P7260, DOI 10.3748/wjg.v20.i23.7260; Fabregat I, 2016, FEBS J, V283, P2219, DOI 10.1111/febs.13665; Freitas MCS, 2010, LIVER TRANSPLANT, V16, P600, DOI 10.1002/lt.22036; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gao B, 2005, CELL MOL IMMUNOL, V2, P92; Granzow M, 2014, HEPATOLOGY, V60, P334, DOI 10.1002/hep.27117; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Ju C, 2016, CELL MOL IMMUNOL, V13, P316, DOI 10.1038/cmi.2015.104; Kaltenecker D, 2019, CYTOKINE, V124, DOI 10.1016/j.cyto.2018.10.010; Klein S, 2017, GUT, V66, P145, DOI 10.1136/gutjnl-2015-309600; Kolodziejczyk AA, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809302; Mas VR, 2009, MOL MED, V15, P85, DOI 10.2119/molmed.2008.00110; Mohan CD, 2014, J BIOL CHEM, V289, P34296, DOI 10.1074/jbc.M114.601104; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Shi SY, 2017, J BIOL CHEM, V292, P3789, DOI 10.1074/jbc.M116.752519; Shi SY, 2012, J BIOL CHEM, V287, P10277, DOI 10.1074/jbc.M111.317453; Tacke F, 2017, J HEPATOL, V66, P1300, DOI 10.1016/j.jhep.2017.02.026; Themanns M, 2016, SCI REP-UK, V6, DOI 10.1038/srep34719; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Zhang L, 2014, HEPATOLOGY, V59, P178, DOI 10.1002/hep.26628	26	12	12	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9466	9475		10.1096/fj.201900215RR	http://dx.doi.org/10.1096/fj.201900215RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31100032	Green Submitted			2022-12-28	WOS:000478832900059
J	Zhao, KX; Jia, YW; Peng, JX; Pang, C; Zhang, T; Han, WQ; Jiang, JW; Lu, XY; Zhu, JL; Qian, Y				Zhao, Kangxian; Jia, Yewei; Peng, Jiaxuan; Pang, Cong; Zhang, Tan; Han, Weiqi; Jiang, Jiawei; Lu, Xuanyuan; Zhu, Jiling; Qian, Yu			Anacardic acid inhibits RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced bone loss in vivo	FASEB JOURNAL			English	Article						osteoclast; TAK1; NF-kappa B; MAPK; AKT	NF-KAPPA-B; HISTONE ACETYLTRANSFERASE; RECEPTOR ACTIVATOR; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNALING COMPLEX; LIGAND RANKL; KINASE TAK1; C-FOS; DIFFERENTIATION; CELLS	Postmenopausal osteoporosis is the most common form of primary osteoporosis, and the incidence of the condition is rapidly increasing. In consideration of the limitations of current therapeutic options for the treatment of postmenopausal osteoporosis, there is an urgent need to develop safer alternatives. Anacardic acid, a natural phenolic acid compound extracted from cashew nut shell, possesses potent antitumor and anti-inflammatory effects and inhibits NF-kappa B signaling. However, its effect on osteoclasts remains unknown. This study reports the first evidence for the antiosteoclastogenic and antiresorptive effects of anacardic acid on bone marrow-derived macrophage-derived osteoclasts. Mechanistically, anacardic acid disrupts the phosphorylation of TGF-beta activated kinase 1 and subsequently suppresses multiple receptor activator of NF-kappa B ligand-induced signaling cascades, ultimately inhibiting the induction and activation of the crucial osteoclast transcriptional factor nuclear factor of activated T-cell cytoplasmic 1. Consistent with cellular results in vitro, anacardic acid treatment improves bone density in the murine model of ovariectomy-induced bone loss. Taken together, our study provides promising evidence for the therapeutic application of anacardic acid as a new potential pharmacological treatment for osteoporosis.-Zhao, K., Jia, Y., Peng, J., Pang, C., Zhang, T., Han, W., Jiang, J., Lu, X., Zhu, J., Qian, Y. Anacardic acid inhibits RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced bone loss in vivo.	[Zhao, Kangxian; Zhang, Tan; Han, Weiqi; Jiang, Jiawei; Lu, Xuanyuan; Qian, Yu] Zhejiang Univ, Sch Med, Shaoxing Peoples Hosp, Dept Orthoped, Shaoxing, Peoples R China; [Jia, Yewei; Jiang, Jiawei; Qian, Yu] Zhejiang Univ, Sch Med, Shaoxing Hosp, Dept Orthoped, Shaoxing, Peoples R China; [Zhao, Kangxian; Qian, Yu] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou, Peoples R China; [Zhao, Kangxian; Qian, Yu] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China; [Peng, Jiaxuan; Pang, Cong; Qian, Yu] Guangxi Med Univ, Guangxi Key Lab Regenerat Med, Nanning, Peoples R China; [Zhu, Jiling] Shaoxing Univ, Coll Med, Dept Clin Med, Shaoxing, Peoples R China	Zhejiang University; Zhejiang University; Wenzhou Medical University; Wenzhou Medical University; Guangxi Medical University; Shaoxing University	Qian, Y (corresponding author), Zhejiang Univ, Sch Med, Shaoxing Hosp, Dept Orthoped,Shaoxing Peoples Hosp, 568 Zhongxing North Rd, Shaoxing 312000, Zhejiang, Peoples R China.	doctor120@hotmail.com		Jia, Yewei/0000-0001-5447-973X	National Natural Science Foundation of China [81572126, 81871801]; Natural Science Foundation of Zhejiang Province [LQ16H160013]; Zhejiang Basic Public Welfare Research Project [LGF18H060010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang Basic Public Welfare Research Project	The authors thank Zeng Linghui from Zhejiang University for help with operating the confocal laser scanning microscope and Wang Linxia from Shaoxing University for molecular technical assistance. This study was funded by the National Natural Science Foundation of China (Grant 81572126, 81871801), the Natural Science Foundation of Zhejiang Province (Grant LY15H060005), Natural Science Foundation of Zhejiang Province (LQ16H160013), and Zhejiang Basic Public Welfare Research Project (LGF18H060010). K.Z. and Y.J. are co-first authors. The authors declare no conflicts of interest.	Arai A, 2012, J CELL SCI, V125, P2910, DOI 10.1242/jcs.099986; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cao JT, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00062; Darnay BG, 2007, ADV EXP MED BIOL, V597, P152; David JP, 2002, J CELL SCI, V115, P4317, DOI 10.1242/jcs.00082; Del Puente A, 2015, J BIOL REG HOMEOS AG, V29, P527; Deliloglu-Gurhan SI, 2006, ACTA HISTOCHEM, V108, P49, DOI 10.1016/j.acthis.2005.11.001; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Ghizzoni M, 2010, BIOORGAN MED CHEM, V18, P5826, DOI 10.1016/j.bmc.2010.06.089; Gibney ER, 2010, HEREDITY, V105, P4, DOI 10.1038/hdy.2010.54; Gingery A, 2003, J CELL BIOCHEM, V89, P165, DOI 10.1002/jcb.10503; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; He YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024780; Ikeda F, 2004, J CLIN INVEST, V114, P475, DOI 10.1172/JCI200419657; Inoue K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06446-0; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Jakob F, 2015, UNFALLCHIRURG, V118, P925, DOI 10.1007/s00113-015-0085-9; Jang HD, 2011, J BIOL CHEM, V286, P39043, DOI 10.1074/jbc.M111.256768; Kennel KA, 2009, MAYO CLIN PROC, V84, P632, DOI 10.1016/S0025-6196(11)60752-0; Kim Jung Ha, 2014, J Bone Metab, V21, P233, DOI 10.11005/jbm.2014.21.4.233; Lee SE, 2002, BONE, V30, P71, DOI 10.1016/S8756-3282(01)00657-3; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Li XT, 2002, ENDOCRINOLOGY, V143, P3105, DOI 10.1210/en.143.8.3105; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Rafael PM, 2018, NEFROLOGIA, V38, P97, DOI 10.1016/j.nefro.2017.01.004; Moon JB, 2012, J IMMUNOL, V188, P163, DOI 10.4049/jimmunol.1101254; Nakashima T, 2011, ANN NY ACAD SCI, V1240, pE13, DOI 10.1111/j.1749-6632.2011.06373.x; Nich Christophe, 2011, Arthritis Res Ther, V13, pR100, DOI 10.1186/ar3381; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Pangrazio A, 2010, HUM MUTAT, V31, pE1071, DOI 10.1002/humu.21167; Peserico A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/371832; Reginster JY, 2006, BONE, V38, pS2, DOI 10.1016/j.bone.2006.01.150; Roodman GD, 1999, EXP HEMATOL, V27, P1229, DOI 10.1016/S0301-472X(99)00061-2; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shen YQ, 2012, INT J MOL SCI, V13, P2877, DOI 10.3390/ijms13032877; Sheridan CM, 2002, J BIOL CHEM, V277, P48664, DOI 10.1074/jbc.M207029200; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Soysa NS, 2009, BIOCHEM BIOPH RES CO, V378, P1, DOI 10.1016/j.bbrc.2008.10.146; Sunagawa Y, 2011, CIRC J, V75, P2151, DOI 10.1253/circj.CJ-10-1072; Sung B, 2008, BLOOD, V111, P4880, DOI 10.1182/blood-2007-10-117994; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2005, J MOL MED, V83, P170, DOI 10.1007/s00109-004-0612-6; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Tan EM, 2017, J BONE MINER RES, V32, P846, DOI 10.1002/jbmr.3031; Tan J, 2012, CHINESE J CANCER RES, V24, P275, DOI [10.3978/j.issn.1000-9604.2012.10.07, 10.1007/s11670-012-0264-y]; Tsai YJ, 2015, FREE RADICAL BIO MED, V86, P118, DOI 10.1016/j.freeradbiomed.2015.05.009; Wagner EF, 2010, ANN RHEUM DIS, V69, P86, DOI 10.1136/ard.2009.119396; Wang C, 2003, J BONE MINER RES, V18, P2159, DOI 10.1359/jbmr.2003.18.12.2159; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Wu HP, 2009, J BONE MINER RES, V24, P871, DOI [10.1359/JBMR.081239, 10.1359/jbmr.081239]; Wu YY, 2011, J PHARMACOL EXP THER, V339, P403, DOI 10.1124/jpet.111.181891; Xie H, 2012, OSTEOPOROSIS INT, V23, P1425, DOI 10.1007/s00198-011-1697-8; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Yang HL, 2016, BIOMATERIALS, V80, P1, DOI 10.1016/j.biomaterials.2015.11.046; Yarom N, 2018, OR SURG OR MED OR PA, V125, P27, DOI 10.1016/j.oooo.2017.09.014; Zhang T, 2019, J CELL PHYSIOL, V234, P2719, DOI 10.1002/jcp.27087; Zhao QH, 2013, FEBS J, V280, P5801, DOI 10.1111/febs.12500	62	9	11	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9100	9115		10.1096/fj.201802575RR	http://dx.doi.org/10.1096/fj.201802575RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31050917				2022-12-28	WOS:000478832900033
J	Gao, PY; Li, N; Ji, KH; Wang, Y; Xu, C; Liu, Y; Wang, Q; Wang, JH; He, NN; Sun, ZJ; Du, LQ; Liu, Q				Gao, Piaoyang; Li, Na; Ji, Kaihua; Wang, Yan; Xu, Chang; Liu, Yang; Wang, Qin; Wang, Jihan; He, Ningning; Sun, Zhijuan; Du, Liqing; Liu, Qiang			Resveratrol targets TyrRS acetylation to protect against radiation-induced damage	FASEB JOURNAL			English	Article						irradiation; DNA damage; SIRT1	TRANSFER-RNA SYNTHETASES; PREVENTION; APOPTOSIS	Resveratrol (RSV) has broad prospective applications as a radiation protection drug, but its mechanism of action is not yet clear. Here, we found that 5 mu M RSV can effectively reduce the cell death caused by irradiation. Irradiation leads to G(2)/M phase arrest in the cell cycle, whereas RSV treatment increases S-phase cell cycle arrest, which is associated with sirtuin 1 (SIRT1) regulation. Meanwhile, RSV promotes DNA damage repair, mainly by accelerating the efficiency of homologous recombination repair. Under oxidative stress, tyrosyl-tRNA synthetase (TyrRS) is transported to the nucleus to protect against DNA damage. RSV can promote TyrRS acetylation, thus promoting TyrRS to enter the nucleus, where it regulates the relevant signaling proteins and reduces apoptosis and DNA damage. SIRT1 is a deacetylase, and SIRT1 knockdown or inhibition can increase TyrRS acetylation levels, further reducing radiation-induced apoptosis after RSV treatment. Our study revealed a new radiation protection mechanism for RSV, in which the acetylation of TyrRS and its translocation into the nucleus is promoted, and this mechanism may also represent a novel protective target against irradiation.-Gao, P., Li, N., Ji, K., Wang, Y., Xu, C., Liu, Y., Wang, Q., Wang, J., He, N., Sun, Z., Du, L., Liu, Q. Resveratrol targets TyrRS acetylation to protect against radiation-induced damage.	[Gao, Piaoyang; Li, Na; Ji, Kaihua; Wang, Yan; Xu, Chang; Liu, Yang; Wang, Qin; Wang, Jihan; He, Ningning; Sun, Zhijuan; Du, Liqing; Liu, Qiang] Chinese Acad Med Sci, Inst Radiat Med, Tianjin Key Lab Radiat Med & Mol Nucl Med, Peking Union Med Coll, Tianjin, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Radiation Medicine - CAMS; Peking Union Medical College	Du, LQ; Liu, Q (corresponding author), Chinese Acad Med Sci, Inst Radiat Med, 238 Baidi Rd, Tianjin 300192, Peoples R China.	duliqing2004@126.com; liuqiang@irm-cams.ac.cn	Liu, Qiang/HHZ-3181-2022; Liu, Qiang/AFK-6590-2022; liu, liu yang/Y-8494-2019	Liu, Qiang/0000-0002-7668-6868; 	National Natural Science Foundation of China [31670859, 81302803]; Concord Youth Fund; Central University Basic Scientific Research Business [3332016100]; Concord Small-Scale Characteristics of School Funding [100232016016 02]; Chinese Academy of Medical Sciences, Medical and Health Science and Technology Innovation Project [2017-I2M-1-02]; Fundamental Research Funds for the Central Universities [3332018158]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Concord Youth Fund; Central University Basic Scientific Research Business; Concord Small-Scale Characteristics of School Funding; Chinese Academy of Medical Sciences, Medical and Health Science and Technology Innovation Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National Natural Science Foundation of China (31670859 and 81302803), the Concord Youth Fund, special funds from the Central University Basic Scientific Research Business (3332016100), the Concord Small-Scale Characteristics of School Funding (100232016016 02), the Chinese Academy of Medical Sciences, Medical and Health Science and Technology Innovation Project (2017-I2M-1-02), and The Fundamental Research Funds for the Central Universities (3332018158). The authors declare no conflicts of interest.	Afaq F, 2003, TOXICOL APPL PHARM, V186, P28, DOI 10.1016/S0041-008X(02)00014-5; Ahmed KM, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00672-17; Becatti M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061572; Boczonadi V, 2018, FEBS LETT, V592, P703, DOI 10.1002/1873-3468.12962; Bonnefond L, 2005, BIOCHIMIE, V87, P873, DOI 10.1016/j.biochi.2005.03.008; Bradamante S, 2004, CARDIOVASC DRUG REV, V22, P169; Cao DF, 2015, GENE DEV, V29, P1316, DOI 10.1101/gad.265462.115; Cao XY, 2017, P NATL ACAD SCI USA, V114, P687, DOI 10.1073/pnas.1608488114; Carsten RE, 2008, RADIAT RES, V169, P633, DOI 10.1667/RR1190.1; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Das Samarjit, 2007, Inflammation & Allergy Drug Targets, V6, P168, DOI 10.2174/187152807781696464; de la Lastra CA, 2005, MOL NUTR FOOD RES, V49, P405; Deng HY, 2016, NEUROCHEM RES, V41, P2367, DOI 10.1007/s11064-016-1950-9; Fabre KM, 2011, CANCER BIOL THER, V12, P915, DOI 10.4161/cbt.12.10.17714; Giege R, 2006, J BIOSCIENCES, V31, P477, DOI 10.1007/BF02705187; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Han CF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01654-6; Howitz KT, 2008, CELL, V133, P387, DOI 10.1016/j.cell.2008.04.019; Hu YD, 2014, CANCER DISCOV, V4, P1430, DOI 10.1158/2159-8290.CD-13-0891; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Kanaji T, 2018, P NATL ACAD SCI USA, V115, pEB228, DOI 10.1073/pnas.1807000115; Kim S, 2011, NAT REV CANCER, V11, P708, DOI 10.1038/nrc3124; Kumari A, 2015, CELL DEATH DIFFER, V22, P311, DOI 10.1038/cdd.2014.146; Lahusen TJ, 2018, ONCOGENE, V37, P2343, DOI 10.1038/s41388-018-0127-1; Lee IC, 2018, CELL DEATH DIFFER, V25, P255, DOI 10.1038/cdd.2017.152; Li CQ, 2017, MOL CELL ONCOL, V4, DOI 10.1080/23723556.2017.1293597; Li YB, 2006, PHARMACOL RES, V53, P6, DOI 10.1016/j.phrs.2005.08.002; Losa GA, 2003, EUR J CLIN INVEST, V33, P818, DOI 10.1046/j.1365-2362.2003.01219.x; Luna Augustin, 2013, Genome Integr, V4, P6, DOI 10.1186/2041-9414-4-6; Markus MA, 2008, CLIN INTERV AGING, V3, P331; Mirando AC, 2014, INT J MOL SCI, V15, P23725, DOI 10.3390/ijms151223725; Mueck K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112473; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2851, DOI [10.1089/ars.2008.2412, 10.1089/ARS.2008.2412]; Sa L. I., 2011, KEXUE JISHU YU GONGC, V11, P8271; Sajish M, 2015, NATURE, V519, P370, DOI 10.1038/nature14028; Sanders TH, 2000, J AGR FOOD CHEM, V48, P1243, DOI 10.1021/jf990737b; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Wei N, 2014, MOL CELL, V56, P323, DOI 10.1016/j.molcel.2014.09.006; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626; Zhang H, 2018, INT J RADIAT BIOL, V94, P28, DOI 10.1080/09553002.2018.1408976; Zhang H, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1915-9; Zhang JL, 2017, INT IMMUNOPHARMACOL, V43, P33, DOI 10.1016/j.intimp.2016.12.002; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	45	6	7	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8083	8093		10.1096/fj.201802474RR	http://dx.doi.org/10.1096/fj.201802474RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30939244	Bronze			2022-12-28	WOS:000476234700023
J	Yao, LP; Zhu, ZY; Wu, JY; Zhang, YZ; Zhang, HB; Sun, X; Qian, C; Wang, BY; Xie, LH; Zhang, SZ; Lu, GH				Yao, Longping; Zhu, Zhiyuan; Wu, Jiayu; Zhang, Yizhou; Zhang, Hongbo; Sun, Xiang; Qian, Chen; Wang, Baoyan; Xie, Linghai; Zhang, Shizhong; Lu, Guohui			MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease	FASEB JOURNAL			English	Article						microglial cells; neuroinflammation; proinflammatory cytokines; MPTP; therapeutic target	DOWN-REGULATION; CELLS; MICROGLIA; PATHWAY; MIR-124; BRAIN; ACTIVATION; APOPTOSIS; TARGET; MODEL	Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor and nonmotor symptoms due to the selective loss of midbrain dopaminergic neurons. The evidence for a chronic inflammatory reaction mediated by microglial cells in the brain is particularly strong in PD. In our previous study, we have shown that brain-specific microRNA-124 (miR-124) is significantly down-regulated in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of PD and that it can also inhibit neuroinflammation during the development of PD. However, further investigation is required to understand whether the abnormal expression of miR-124 regulates microglial activation. In this study, we found that the expression of sequestosome 1 (p62) and phospho-p38 mitogen-activated protein kinases (p-p38) showed a significant increase in LPS-treated immortalized murine microglial cell line BV2 cells in an MPTP-induced mouse model of PD. Knockdown of p62 could suppress the secretion of proinflammatory cytokines and p-p38 of microglia. Besides, inhibition of p38 suppressed the secretion of proinflammatory cytokines and promoted autophagy in BV2 cells. Moreover, our study is the first to identify a unique role of miR-124 in mediating the microglial inflammatory response by targeting p62 and p38 in PD. In the microglial culture supernatant transfer model, the knockdown of p62 in BV2 cells prevented apoptosis and death of human neuroblastoma cell lines SH-SY5Y (SH-SY5Y) cells following microglia activation. In addition, the exogenous delivery of miR-124 could suppress p62 and p-p38 expression and could also attenuate the activation of microglia in the substantia nigra par compacta of MPTP-treated mice. Taken together, our data suggest that miR-124 could inhibit neuroinflammation during the development of PD by targeting p62, p38, and autophagy, indicating that miR-124 could be a potential therapeutic target for regulating the inflammatory response in PD.-Yao, L., Zhu, Z., Wu, J., Zhang, Y., Zhang, H., Sun, X., Qian, C., Wang, B., Xie, L., Zhang, S., Lu, G. MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease.	[Yao, Longping; Lu, Guohui] Nanchang Univ, Affiliated Hosp 1, Dept Neurosurg, 17 Yongwaizheng St, Nanchang 330006, Jiangxi, Peoples R China; [Yao, Longping; Zhu, Zhiyuan; Zhang, Hongbo; Sun, Xiang; Qian, Chen; Wang, Baoyan; Xie, Linghai; Zhang, Shizhong] Southern Med Univ, Zhujiang Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China; [Wu, Jiayu] Southern Med Univ, Zhujiang Hosp, Dept Nephrol, Guangzhou, Guangdong, Peoples R China; [Yao, Longping; Zhu, Zhiyuan; Zhang, Hongbo; Sun, Xiang; Qian, Chen; Wang, Baoyan; Xie, Linghai; Zhang, Shizhong] Southern Med Univ, Neurosurg Inst Guangdong Prov, Guangdong Prov Key Lab Brain Funct Repair & Regen, Natl Key Clin Specialty, Guangzhou, Guangdong, Peoples R China; [Zhang, Yizhou] Tarbut VTorah Community Day Sch, Irvine, CA USA	Nanchang University; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Lu, GH (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Neurosurg, 17 Yongwaizheng St, Nanchang 330006, Jiangxi, Peoples R China.; Zhang, SZ (corresponding author), Southern Med Univ, Guangzhou 510282, Guangdong, Peoples R China.	zhangshizhong@smu.edu.cn; guohui-lu@163.com	Xie, Linghai/C-6771-2008	Xie, Linghai/0000-0001-6294-5833; Yao, Longping/0000-0002-7239-1392	National Natural Science Foundation of China [81371397, 81671240, 81560220]; Youth Science Fund of Jiangxi Province [20151BAB215014]; Key project of Jiangxi Youth Science Foundation [20171ACB21054]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Science Fund of Jiangxi Province; Key project of Jiangxi Youth Science Foundation	This study was supported by National Natural Science Foundation of China (81371397, 81671240, 81560220), Youth Science Fund of Jiangxi Province (20151BAB215014), and Key project of Jiangxi Youth Science Foundation (20171ACB21054). L.Y., Z.Z., and J.W. are first authors. The authors declare no conflicts of interest.	Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ebrahimi SS, 2017, TOXICOL LETT, V276, P108, DOI 10.1016/j.toxlet.2017.05.018; Fischer R, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/610813; Fujikake N, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00255; Gan-Or Z, 2015, AUTOPHAGY, V11, P1443, DOI 10.1080/15548627.2015.1067364; Ghosh A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag2210; Gu H, 2016, CANCER MED-US, V5, P1174, DOI 10.1002/cam4.664; Nguyen HTT, 2014, GASTROENTEROLOGY, V146, P508, DOI 10.1053/j.gastro.2013.10.021; He Q, 2017, GLIA, V65, P1251, DOI 10.1002/glia.23153; He YL, 2018, J CELL BIOL, V217, P315, DOI 10.1083/jcb.201701049; Hemandez-Romero MD, 2008, J NEUROCHEM, V105, P445, DOI 10.1111/j.1471-4159.2007.05148.x; Hickman S, 2018, NAT NEUROSCI, V21, P1359, DOI 10.1038/s41593-018-0242-x; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kabaria S, 2015, FREE RADICAL BIO MED, V89, P548, DOI 10.1016/j.freeradbiomed.2015.09.010; Kanagaraj N, 2014, NEUROSCIENCE, V272, P167, DOI 10.1016/j.neuroscience.2014.04.039; Kavanagh E, 2015, AGING-US, V7, P673, DOI 10.18632/aging.100805; Kawai K, 2008, J BIOCHEM, V143, P765, DOI 10.1093/jb/mvn027; Kim J, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0121-4; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Lawson SK, 2013, MOL CELL BIOL, V33, P127, DOI 10.1128/MCB.00695-12; Liu J, 2018, AUTOPHAGY, V14, P845, DOI 10.1080/15548627.2017.1390636; Liu J, 2015, BIOCHEM BIOPH RES CO, V463, P262, DOI 10.1016/j.bbrc.2015.05.042; Liu WW, 2018, INT C PATT RECOG, P25, DOI 10.1109/ICPR.2018.8545331; Liu Y, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-135; Luan YA, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00301; Ma J, 2018, EXP CELL RES, V366, P103, DOI 10.1016/j.yexcr.2018.02.037; Miki Y, 2018, NEUROBIOL AGING, V63, P33, DOI 10.1016/j.neurobiolaging.2017.11.006; Mishima T, 2007, BRAIN RES, V1131, P37, DOI 10.1016/j.brainres.2006.11.035; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Nash Y, 2017, J NEUROCHEM, V143, P584, DOI 10.1111/jnc.14222; Ning H, 2019, NEUROPATH APPL NEURO, V45, P398, DOI 10.1111/nan.12524; Oh SE, 2018, REDOX BIOL, V19, P62, DOI 10.1016/j.redox.2018.07.021; Ormel PR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06684-2; Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004; Poillet-Perez L, 2018, NATURE, V563, P569, DOI 10.1038/s41586-018-0697-7; Saraiva C, 2016, J CONTROL RELEASE, V235, P291, DOI 10.1016/j.jconrel.2016.06.005; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Shim H. J., 2016, THESIS; Song JX, 2014, AUTOPHAGY, V10, P144, DOI 10.4161/auto.26751; Stansley B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-115; Su LY, 2015, AUTOPHAGY, V11, P1745, DOI 10.1080/15548627.2015.1082020; Sudo T, 2000, BIOCHEM BIOPH RES CO, V269, P521, DOI 10.1006/bbrc.2000.2333; Thome AD, 2016, J NEUROSCI, V36, P2383, DOI 10.1523/JNEUROSCI.3900-15.2016; Wang P, 2013, GASTROENTEROLOGY, V145, P1133, DOI 10.1053/j.gastro.2013.07.048; Xing B, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-84; Yao LP, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1053-4; Ye YY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0821-5; Yu Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep43684; Zhu H, 2009, AUTOPHAGY, V5, P816, DOI 10.4161/auto.9064	52	59	61	2	26	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8648	8665		10.1096/fj.201900363R	http://dx.doi.org/10.1096/fj.201900363R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30995872	Bronze			2022-12-28	WOS:000476234700067
J	Ma, J; Li, JH; Qian, MR; He, N; Cao, Y; Liu, YP; Wu, KC; He, SX				Ma, Jing; Li, Jianhui; Qian, Meirui; He, Nan; Cao, Ying; Liu, Yaping; Wu, Kaichun; He, Shuixiang			The comprehensive pathophysiological changes in a novel rat model of postinflammatory visceral hypersensitivity	FASEB JOURNAL			English	Article						intestinal permeability; CUMS; fecal microbiota transplantation	IRRITABLE-BOWEL-SYNDROME; FECAL MICROBIOTA TRANSPLANTATION; IMPAIRED STRESS-RESPONSE; GUT MICROBIOTA; ANXIETY; EXPRESSION; SYSTEM; ACTIVATION; MECHANISMS; MUCOSAL	So far, a comprehensive animal model that can mimic both the central and peripheral pathophysiological changes of irritable bowel syndrome (IBS) is lacking. Here, we developed a novel IBS rat model combining trinitro-benzene-sulfonic acid (TNBS) and chronic unpredictable mild stress (CUMS) (designated as TC-IBS) and compared it with the TNBS-induced and CUMS-induced models. TC-IBS showed a pronounced depression phenotype with increased corticotropin-releasing hormone receptor (CRHR)1 and CRHR2 expression at the frontal cortex and increased serum ACTH concentration. Visceral hypersensitivity (VH), as evidenced by colorectal distention (CRD) test, was highest in TC-IBS, accompanied by increased serum 5-hydroxytryptamine (5-HT) level and colonic 5-HT receptor 3A (5-HT3AR)/5-HT receptor 2B expression, impaired tight junction protein expression including occludin, zonula occludens-1, and phosphorylated myosin light chain. Palonosetron, a second generation of 5-HT3AR antagonist, alleviated VH significantly in TC-IBS. 16S rRNA sequencing showed that TNBS plus CUMS induced a significant disturbance of the gut microbiota. Cytokine profile analysis of TC-IBS model indicated an innate immune activation both in serum and colonic mucosa. Further, fecal microbiota transplantation improved VH and some pathophysiological changes in TC-IBS. In summary, we established a postinflammatory IBS model covering multifactorial pathophysiological changes, which may help to develop therapies that target specific IBS subtype.	[Ma, Jing; Liu, Yaping; He, Shuixiang] Xi An Jiao Tong Univ, Dept Digest Dis, Affiliated Hosp 1, Xian, Peoples R China; [Ma, Jing; Qian, Meirui; He, Nan; Wu, Kaichun] Fourth Mil Med Univ, Xijing Hosp, State Key Lab Canc Biol, Xian, Peoples R China; [Ma, Jing; Qian, Meirui; He, Nan; Wu, Kaichun] Fourth Mil Med Univ, Xijing Hosp, Inst Digest Dis, Xian, Peoples R China; [Li, Jianhui] Fourth Mil Med Univ, Tangdu Hosp, Dept Infect Dis, Xian, Peoples R China; [Cao, Ying] Northwest Univ, Sch Life Sci, Xian, Peoples R China	Xi'an Jiaotong University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Northwest University Xi'an	Wu, KC (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Peoples R China.; Wu, KC (corresponding author), Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Peoples R China.; He, SX (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp, Dept Gastroenterol, Xian 710032, Peoples R China.	kaicwu@fmmu.edu.cn; dyyyjxk@mail.xjtu.edu.cn			State Key Laboratory of Cancer Biology	State Key Laboratory of Cancer Biology	The authors thank Prof. Huang Niu and Dr. Zhou Yu (both from National Institute of Biological Sciences, Beijing, China) for developing the animal model. This study was funded by State Key Laboratory of Cancer Biology. The authors declare no conflicts of interest.	Bale TL, 2002, J NEUROSCI, V22, P193, DOI 10.1523/JNEUROSCI.22-01-00193.2002; Barbara G., 2016, GASTROENTEROLOGY, DOI [10.1053/j.gas-tro.2016.02.028, DOI 10.1053/J.GAS-TRO.2016.02.028]; Bashashati M, 2014, NEUROGASTROENT MOTIL, V26, P1036, DOI 10.1111/nmo.12358; Bennet SMP, 2015, GUT LIVER, V9, P318, DOI 10.5009/gnl14344; Bertiaux-Vandaele N, 2011, AM J GASTROENTEROL, V106, P2165, DOI 10.1038/ajg.2011.257; Bhattarai Y, 2017, AM J PHYSIOL-GASTR L, V312, pG52, DOI 10.1152/ajpgi.00338.2016; Camilleri M, 2012, AM J PHYSIOL-GASTR L, V303, pG775, DOI 10.1152/ajpgi.00155.2012; Chadwick VS, 2002, GASTROENTEROLOGY, V122, P1778, DOI 10.1053/gast.2002.33579; Chang L, 2011, GASTROENTEROLOGY, V140, P761, DOI 10.1053/j.gastro.2011.01.032; Fond G, 2014, EUR ARCH PSY CLIN N, V264, P651, DOI 10.1007/s00406-014-0502-z; Ford AC, 2009, AM J GASTROENTEROL, V104, P1831, DOI 10.1038/ajg.2009.223; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Halkjaer SI, 2018, GUT, V67, P2107, DOI 10.1136/gutjnl-2018-316434; Halkjaer SI, 2017, WORLD J GASTROENTERO, V23, P4112, DOI 10.3748/wjg.v23.i22.4112; Holtmann GJ, 2016, LANCET GASTROENTEROL, V1, P133, DOI 10.1016/S2468-1253(16)30023-1; Johnsen PH, 2018, LANCET GASTROENTEROL, V3, P17, DOI 10.1016/S2468-1253(17)30338-2; Jones MP, 2017, CLIN GASTROENTEROL H, V15, P1014, DOI 10.1016/j.cgh.2016.12.032; Kelly CR, 2015, GASTROENTEROLOGY, V149, P223, DOI 10.1053/j.gastro.2015.05.008; Liebregts T, 2007, GASTROENTEROLOGY, V132, P913, DOI 10.1053/j.gastro.2007.01.046; Lin SY, 2011, J NEUROSCI, V31, P1410, DOI 10.1523/JNEUROSCI.4682-10.2011; Martinez C, 2013, GUT, V62, P1160, DOI 10.1136/gutjnl-2012-302093; Mayer EA, 2002, GASTROENTEROLOGY, V122, P2032, DOI 10.1053/gast.2002.33584; Mayer EA, 2014, GASTROENTEROLOGY, V146, P1500, DOI 10.1053/j.gastro.2014.02.037; O'Mahony Siobhain M, 2012, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0940s61; Overman EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039935; Qin HY, 2012, WORLD J GASTROENTERO, V18, P2481, DOI 10.3748/wjg.v18.i20.2481; RITCHIE J, 1973, GUT, V14, P125, DOI 10.1136/gut.14.2.125; Saito YA, 2011, GASTROENTEROL CLIN N, V40, P45, DOI 10.1016/j.gtc.2010.12.011; Sanovic S, 1999, AM J PATHOL, V155, P1051, DOI 10.1016/S0002-9440(10)65207-8; Shao Y, 2015, CAN J PHYSIOL PHARM, V93, P633, DOI 10.1139/cjpp-2015-0039; Simpson J, 2008, NEUROGASTROENT MOTIL, V20, P392, DOI 10.1111/j.1365-2982.2007.01037.x; Simren M, 2018, GUT, V67, P255, DOI 10.1136/gutjnl-2016-312361; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; Spiller R, 2007, LANCET, V369, P1586, DOI 10.1016/S0140-6736(07)60726-0; Spiller R, 2009, GASTROENTEROLOGY, V136, P1979, DOI 10.1053/j.gastro.2009.02.074; Szyf M, 2007, REPROD TOXICOL, V24, P9, DOI 10.1016/j.reprotox.2007.05.001; Tap J, 2017, GASTROENTEROLOGY, V152, P111, DOI 10.1053/j.gastro.2016.09.049; Traini C, 2017, J CELL MOL MED, V21, P735, DOI 10.1111/jcmm.13016; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; Walsh SV, 2001, GASTROENTEROLOGY, V121, P566, DOI 10.1053/gast.2001.27060; WILLIAMS CL, 1988, GASTROENTEROLOGY, V94, P611, DOI 10.1016/0016-5085(88)90231-4; Wu J, 2017, WORLD J GASTROENTERO, V23, P6339, DOI 10.3748/wjg.v23.i34.6339	42	4	5	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13560	13571		10.1096/fj.201901489R	http://dx.doi.org/10.1096/fj.201901489R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31570003	Bronze			2022-12-28	WOS:000507466100041
J	Bravo-Ferrer, I; Cuartero, MI; Medina, V; Ahedo-Quero, D; Pena-Martinez, C; Perez-Ruiz, A; Fernandez-Valle, ME; Hernandez-Sanchez, C; Fernandez-Salguero, PM; Lizasoain, I; Moro, MA				Bravo-Ferrer, Isabel; Cuartero, Maria I.; Medina, Violeta; Ahedo-Quero, Dalia; Pena-Martinez, Carolina; Perez-Ruiz, Alberto; Encarnacion Fernandez-Valle, M.; Hernandez-Sanchez, Catalina; Fernandez-Salguero, Pedro M.; Lizasoain, Ignacio; Moro, Maria A.			Lack of the aryl hydrocarbon receptor accelerates aging in mice	FASEB JOURNAL			English	Article						AhR; inflammaging; neuroinflammation	AGE; ACTIVATION; BRAIN; INFLAMMATION; CELLS; DIFFERENTIATION; CYTOKINES; GENDER; IL-22; GFAP	The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor, largely known for its role in xenobiotic metabolism and detoxification as well as its crucial role as a regulator of inflammation. Here, we have compared a cohort wild-type and AhR-null mice along aging to study the relationship between this receptor and age-associated inflammation, termed as "inflammaging," both at a systemic and the CNS level. Our results show that AhR deficiency is associated with a premature aged phenotype, characterized by early inflammaging, as shown by an increase in plasma cytokines levels. The absence of AhR also promotes the appearance of brain aging anatomic features, such as the loss of the white matter integrity. In addition, AhR(-/-) mice present an earlier spatial memory impairment and an enhanced astrogliosis in the hippocampus when compared with their age-matched AhR(+)(/+) controls. Importantly, we have found that AhR protein levels decrease with age in this brain structure, strongly suggesting a link between AhR and aging.	[Bravo-Ferrer, Isabel; Cuartero, Maria I.; Medina, Violeta; Pena-Martinez, Carolina; Perez-Ruiz, Alberto; Lizasoain, Ignacio; Moro, Maria A.] UCM, Fac Med, Dept Farmacol & Toxicol, Madrid, Spain; [Bravo-Ferrer, Isabel; Cuartero, Maria I.; Medina, Violeta; Pena-Martinez, Carolina; Perez-Ruiz, Alberto; Lizasoain, Ignacio; Moro, Maria A.] UCM, IUIN, Madrid, Spain; [Encarnacion Fernandez-Valle, M.] UCM, Ctr Apoyo Invest CAI Bioimagen, Unidad Resonancia Magnet Nucl RMN, Madrid, Spain; [Bravo-Ferrer, Isabel; Cuartero, Maria I.; Medina, Violeta; Pena-Martinez, Carolina; Perez-Ruiz, Alberto; Lizasoain, Ignacio; Moro, Maria A.] Hosp 12 Octubre i 12, Inst Invest, Madrid, Spain; [Ahedo-Quero, Dalia] Inst Politecn Nacl, Escuela Super Med, Mexico City, DF, Mexico; [Hernandez-Sanchez, Catalina] CSIC, Ctr Invest Biol, Madrid, Spain; [Hernandez-Sanchez, Catalina] Inst Salud Carlos III ISCIII, Ctr Invest Biom ed Red Diabet & Enfermedades Meta, Madrid, Spain; [Fernandez-Salguero, Pedro M.] Univ Extremadura, Fac Ciencias, Dept Bioquim & Biol Mol, Badajoz, Badajoz, Spain; [Cuartero, Maria I.] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid; Hospital Universitario 12 de Octubre; Instituto Politecnico Nacional - Mexico; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Universidad de Extremadura; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Moro, MA (corresponding author), Univ Complutense Madrid, Unidad Invest Neurovasc, Fac Med, Dept Farmacol & Toxicol, Plaza Ramon y Cajal,Ave Complutense S-N, E-28040 Madrid, Spain.	neurona@ucm.es	Moro, María Ángeles/K-6396-2014; Fernández-Valle, Encarnación/M-2316-2014; Pena-Martinez, Carolina/AAD-5312-2022; Cuartero, Maria Isabel/E-8103-2012; Lizasoain, Ignacio/K-9844-2014	Moro, María Ángeles/0000-0003-1010-8237; Fernández-Valle, Encarnación/0000-0002-7433-5976; Cuartero, Maria Isabel/0000-0003-4728-068X; Medina Alonso, Violeta/0000-0001-9143-9892; Lizasoain, Ignacio/0000-0002-6028-7379; Bravo-Ferrer, Isabel/0000-0003-4566-2617	Spanish Ministry of Economy and Competitiveness [SAF2015-68632-R, SAF2016-81716-REDC]; Instituto de Salud Carlos III; Fondo Europeo de Desarrollo Regional (FEDER) Una Manera de Hacer Europa [PI17/01601, RD16/0019/0009]; Regional Madrid Government [B2017/BMD-3688]; Formacion del Personal Universitario (FPU) program of the Spanish Ministry of Education, Culture, and Sports; Formacion del Personal Investigador (FPI) program of the Spanish Ministry of Education, Culture, and Sports	Spanish Ministry of Economy and Competitiveness(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER) Una Manera de Hacer Europa(European Commission); Regional Madrid Government; Formacion del Personal Universitario (FPU) program of the Spanish Ministry of Education, Culture, and Sports; Formacion del Personal Investigador (FPI) program of the Spanish Ministry of Education, Culture, and Sports	This work was supported by the Spanish Ministry of Economy and Competitiveness (Grants SAF2015-68632-R and SAF2016-81716-REDC to M.A.M.), Instituto de Salud Carlos III, cofinanced by Fondo Europeo de Desarrollo Regional (FEDER) Una Manera de Hacer Europa (Grants PI17/01601 and RD16/0019/0009 to I.L.), and the Regional Madrid Government (Grant B2017/BMD-3688 to I.L.). V.M., C.P.-M., and A.P.-R. were recipients of contracts from the Formacion del Personal Universitario (FPU) (to V.M.) and the Formacion del Personal Investigador (FPI) (to C.P.-M. and A.P.-R.) programs of the Spanish Ministry of Education, Culture, and Sports. The authors declare no conflicts of interest.	Andreola F, 1997, CANCER RES, V57, P2835; Benson JM, 2011, TOXICOL SCI, V120, P68, DOI 10.1093/toxsci/kfq360; Bernal GM, 2014, AGING-US, V6, P931, DOI 10.18632/aging.100702; Bodles AM, 2004, TRENDS NEUROSCI, V27, P621, DOI 10.1016/j.tins.2004.07.011; Carter RJ, 1999, J NEUROSCI, V19, P3248; Climaco-Arvizu S, 2016, LIFE SCI, V155, P76, DOI 10.1016/j.lfs.2016.05.001; Cuartero MI, 2014, CIRCULATION, V130, P2040, DOI 10.1161/CIRCULATIONAHA.114.011394; Denison Michael S., 2017, Current Opinion in Toxicology, V2, P124, DOI 10.1016/j.cotox.2017.01.006; Eckers A, 2016, SCI REP-UK, V6, DOI 10.1038/srep19618; Fahlstrom A, 2011, NEUROBIOL AGING, V32, P1868, DOI 10.1016/j.neurobiolaging.2009.11.003; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; FernandezSalguero PM, 1997, VET PATHOL, V34, P605, DOI 10.1177/030098589703400609; Filbrandt CR, 2004, NEUROTOXICOLOGY, V25, P605, DOI 10.1016/j.neuro.2003.08.007; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4; Goetzl EJ, 2010, FASEB J, V24, P3580, DOI 10.1096/fj.10-160911; Gonzalez FJ, 1998, DRUG METAB DISPOS, V26, P1194; Grigoletto J, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0439-3; Haas K, 2016, J INVEST DERMATOL, V136, P2260, DOI 10.1016/j.jid.2016.06.627; Hernandez-Ochoa I, 2010, BIOL REPROD, V83, P698, DOI 10.1095/biolreprod.110.087015; Hu P, 2013, P NATL ACAD SCI USA, V110, pE4069, DOI 10.1073/pnas.1307574110; Huai WW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5738; Juricek L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09621-3; Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Lemaitre H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.013; Liu H, 2017, AGEING RES REV, V34, P64, DOI 10.1016/j.arr.2016.11.006; Mayer AK, 2019, BRAIN, V142, P1528, DOI 10.1093/brain/awz098; Michaud M, 2013, J AM MED DIR ASSOC, V14, P877, DOI 10.1016/j.jamda.2013.05.009; Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007; Morgan TE, 1997, FREE RADICAL BIO MED, V23, P524, DOI 10.1016/S0891-5849(97)00120-2; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; NICHOLS NR, 1993, NEUROBIOL AGING, V14, P421, DOI 10.1016/0197-4580(93)90100-P; Palmer AL, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00337; Pietschmann P, 2003, EXP GERONTOL, V38, P1119, DOI 10.1016/S0531-5565(03)00189-X; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Ramirez JM, 2010, EUR J IMMUNOL, V40, P2450, DOI 10.1002/eji.201040461; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Sartori AC, 2012, J NEUROSCI NURS, V44, P206, DOI 10.1097/JNN.0b013e3182527690; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Sharma S, 2010, LIFE SCI, V87, P521, DOI 10.1016/j.lfs.2010.09.004; Singh KP, 2014, STEM CELLS DEV, V23, P95, DOI 10.1089/scd.2013.0346; Singh KP, 2011, STEM CELLS DEV, V20, P769, DOI 10.1089/scd.2010.0333; Soreq L, 2017, CELL REP, V18, P557, DOI 10.1016/j.celrep.2016.12.011; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Valdez Kelli E, 2004, Reprod Biol, V4, P243; Wheeler MA, 2017, J BIOL CHEM, V292, P12383, DOI 10.1074/jbc.R116.767723; WHO, 2011, NIH PUBLICATION, V11; Zhang LN, 2010, INVEST OPHTH VIS SCI, V51, P2109, DOI 10.1167/iovs.09-3993	50	22	22	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12644	12654		10.1096/fj.201901333R	http://dx.doi.org/10.1096/fj.201901333R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31483997	Green Submitted, Bronze			2022-12-28	WOS:000507461600081
J	Shin, WS; Lee, HW; Lee, ST				Shin, Won-Sik; Lee, Hae Won; Lee, Seung-Taek			Catalytically inactive receptor tyrosine kinase PTK7 activates FGFR1 independent of FGF	FASEB JOURNAL			English	Article						FGF receptor; RPTK; oncogenicity; ESCC	ENDOTHELIAL-CELLS; POOR-PROGNOSIS; AMPLIFICATION; PROTEIN; PHOSPHORYLATION; MIGRATION; POLARITY; GROWTH	Protein tyrosine kinase 7 (PTK7), a catalytically defective receptor protein tyrosine kinase (RPTK), plays an oncogenic role by activating an unidentified TKI-258 (dovitinib)-sensitive RPTK in esophageal squamous cell carcinoma (ESCC) cells. Here, we demonstrate that among TKI-258-sensitive RPTKs, fibroblast growth factor receptor (FGFR) 1 is significantly up-regulated in ESCC tissues and cell lines. We show that PTK7 colocalizes with FGFR1 and binds it via its extracellular domain in human embryonic kidney 293 and ESCC TE-10 cells. PTK7 knockdown not only reduced ligand-free and fibroblast growth factor (FGF)-induced phosphorylation of FGFR1 but also the interaction of signaling adaptor proteins with FGFR1 and activation of downstream signaling proteins in TE-10 cells. In addition, PTK7 knockdown reduced FGF-induced oncogenic phenotypes including proliferation, anchorage-independent colony formation, wound healing, and invasion in ESCC cells. Taken together, our data demonstrate that PTK7 binds and activates FGFR1 independent of FGF and thus increases oncogenicity of PTK7- and FGFR1-positive cancers such as ESCC.	[Shin, Won-Sik; Lee, Seung-Taek] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 03722, South Korea; [Lee, Hae Won] Korea Inst Radiol & Med Sci, Korea Canc Ctr Hosp, Dept Thorac Surg, Seoul, South Korea	Yonsei University; Korea Institute of Radiological & Medical Sciences; National Cancer Center - Korea (NCC)	Lee, ST (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 03722, South Korea.	stlee@yonsei.ac.kr		Shin, Won-Sik/0000-0001-9432-1320	National Research Foundation of Korea [2016R1A2B4007904, 2019M3A9A8065054, 2019R1C1C1005027]; Yonsei Frontier Laboratory Young Researcher Supporting Program of the Yonsei University Research Fund	National Research Foundation of Korea(National Research Foundation of Korea); Yonsei Frontier Laboratory Young Researcher Supporting Program of the Yonsei University Research Fund	This work was supported by grants from the National Research Foundation of Korea (2016R1A2B4007904 and 2019M3A9A8065054 to S.-T.L. and 2019R1C1C1005027 to W.-S.S.). W.-S.S. is a recipient of the Yonsei Frontier Laboratory Young Researcher Supporting Program of the Yonsei University Research Fund. The authors declare no conflicts of interest.	Andre P, 2012, J BIOL CHEM, V287, P44518, DOI 10.1074/jbc.M112.414441; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Babina IS, 2017, NAT REV CANCER, V17, P318, DOI 10.1038/nrc.2017.8; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Chen BQ, 2018, CANCER BIOL THER, V19, P76, DOI 10.1080/15384047.2017.1394541; Chioni AM, 2012, J CELL BIOL, V197, P801, DOI 10.1083/jcb.201108077; Duan X, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.15; Gobble RM, 2011, CANCER RES, V71, P2697, DOI 10.1158/0008-5472.CAN-10-3588; Gorringe KL, 2005, GENE CHROMOSOME CANC, V42, P247, DOI 10.1002/gcc.20136; Jacobsen AV, 2017, BIOCHEM SOC T, V45, P665, DOI 10.1042/BST20160331; Jin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090247; Kashyap MK, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0790-4; Kim HS, 2015, ONCOTARGET, V6, P2562, DOI 10.18632/oncotarget.2944; Kim JH, 2014, ONCOL REP, V31, P2708, DOI 10.3892/or.2014.3164; Lee YH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112734; Liu K, 2017, WORLD J SURG ONCOL, V15, DOI 10.1186/s12957-017-1172-x; Martinez S, 2015, J BIOL CHEM, V290, P30562, DOI 10.1074/jbc.M115.697615; Meng L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014018; MOSSIE K, 1995, ONCOGENE, V11, P2179; Muller-Tidow C, 2004, CLIN CANCER RES, V10, P1241, DOI 10.1158/1078-0432.CCR-0954-03; Nikas I, 2018, CANCER LETT, V434, P160, DOI 10.1016/j.canlet.2018.07.030; Podleschny M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145169; Prebet T, 2010, BLOOD, V116, P2315, DOI 10.1182/blood-2010-01-262352; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Sarabipour S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10262; Shin WS, 2008, BIOCHEM BIOPH RES CO, V371, P793, DOI 10.1016/j.bbrc.2008.04.168; Shin WS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26957-6; Shin WS, 2017, J CELL BIOCHEM, V118, P2887, DOI 10.1002/jcb.25939; Shin WS, 2016, ONCOTARGET, V7, P73242, DOI 10.18632/oncotarget.12303; Shin WS, 2015, BBA-MOL CELL RES, V1853, P2251, DOI 10.1016/j.bbamcr.2015.05.015; Shin WS, 2013, CANCER SCI, V104, P1120, DOI 10.1111/cas.12194; Sobhani N, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7070076; Sugiura K, 2007, ONCOL REP, V17, P557; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Wang HY, 2014, INT J CLIN EXP PATHO, V7, P7881; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; White KE, 2005, AM J HUM GENET, V76, P361, DOI 10.1086/427956; Wigler M, 1992, Biotechnology, V24, P444	38	10	10	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12960	12971		10.1096/fj.201900932R	http://dx.doi.org/10.1096/fj.201900932R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31490704	Green Published			2022-12-28	WOS:000507461600104
J	Thuringer, D; Garrido, C				Thuringer, Dominique; Garrido, Carmen			Molecular chaperones in the brain endothelial barrier: neurotoxicity or neuroprotection?	FASEB JOURNAL			English	Review						heat shock protein; brain injury; microvascular endothelial cells; extracellular vesicles	HEAT-SHOCK PROTEINS; FOCAL CEREBRAL-ISCHEMIA; EXTRACELLULAR VESICLES; MOUSE MODEL; HSP90; CELLS; HSP70; EXOSOMES; COMMUNICATION; EXPRESSION	Brain microvascular endothelial cells (BMECs) interact with astrocytes and pericytes to form the blood-brain barrier (BBB). Their compromised function alters the BBB integrity, which is associated with early events in the pathogenesis of cancer, neurodegenerative diseases, and epilepsy. Interestingly, these conditions also induce the expression of heat shock proteins (HSPs). Here we review the contribution of major HSP families to BMEC and BBB function. Although investigators mainly report protective effects of HSPs in brain, contrasted results were obtained in BMEC, which depend both on the HSP and on its location, intra- or extracellular. The therapeutic potential of HSPs must be scrupulously analyzed before targeting them in patients to reduce the progression of brain lesions and improve neurologic outcomes in the long term.	[Thuringer, Dominique; Garrido, Carmen] Univ Bourgogne Franche Comte, Fac Med, Inst Fed Rech Sante Sci & Tech Informat & Commun, INSERM,UMR 1231, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Thuringer, D (corresponding author), Univ Bourgogne Franche Comte, Fac Med, IFR Sante STIC, INSERM,UMR 1231, 7 Blvd Jeanne dArc, F-21000 Dijon, France.	dominique.thuringer@u-bourgogne.fr	Thuringer, Dominique/AAA-7448-2020; Garrido, Carmen/G-1633-2018	Garrido, Carmen/0000-0003-1368-1493				Abdullahi W, 2018, AM J PHYSIOL-CELL PH, V315, pC343, DOI 10.1152/ajpcell.00095.2018; Abisambra JF, 2010, J NEUROSCI, V30, P15374, DOI 10.1523/JNEUROSCI.3155-10.2010; Abruzzo PM, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/329607; Alexiou GA, 2014, TURK NEUROSURG, V24, P745, DOI 10.5137/1019-5149.JTN.9852-13.0; Andras IE, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2015.1131804; Andrews AM, 2017, CELL MOL BIOENG, V10, P30, DOI 10.1007/s12195-016-0456-5; Andrews AM, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00043; Aridon P, 2011, NEURODEGENER DIS, V8, P155, DOI 10.1159/000321548; Arispe N, 2018, J ALZHEIMERS DIS, V63, P927, DOI 10.3233/JAD-180161; Armijo G, 2014, CELL STRESS CHAPERON, V19, P877, DOI 10.1007/s12192-014-0511-x; Asea A, 2003, EXERC IMMUNOL REV, V9, P25; Asea Alexzander, 2008, V183, P111; Asea Alexzander, 2008, Novartis Found Symp, V291, P173; Austin SA, 2016, CIRC RES, V119, P1128, DOI 10.1161/CIRCRESAHA.116.309686; Balogi Z, 2019, PROG LIPID RES, V74, P18, DOI 10.1016/j.plipres.2019.01.004; Balusu S, 2016, EMBO MOL MED, V8, P1162, DOI 10.15252/emmm.201606271; Batulan Z, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00285; Bavisotto CC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020434; Bavisotto CC, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092626; Bavisotto CC, 2017, EXPERT REV MOL DIAGN, V17, P815, DOI 10.1080/14737159.2017.1356230; Belkacemi L, 2014, ANTICANCER RES, V34, P4915; Binder DC, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1130207; Binder RJ, 2004, P NATL ACAD SCI USA, V101, P6128, DOI 10.1073/pnas.0308180101; Blair LJ, 2014, EXPERT OPIN THER TAR, V18, P1219, DOI 10.1517/14728222.2014.943185; Borovski T, 2013, ONCOGENE, V32, P1539, DOI 10.1038/onc.2012.172; Boudesco C, 2018, METHODS MOL BIOL, V1709, P371, DOI 10.1007/978-1-4939-7477-1_27; Brea D, 2011, J CEREBR BLOOD F MET, V31, P1424, DOI 10.1038/jcbfm.2010.231; Broekman ML, 2018, NAT REV NEUROL, V14, P482, DOI 10.1038/s41582-018-0025-8; Bross P, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00049; Brown IR, 2007, ANN NY ACAD SCI, V1113, P147, DOI 10.1196/annals.1391.032; Budnik V, 2016, NAT REV NEUROSCI, V17, P160, DOI 10.1038/nrn.2015.29; Bustamante FA, 2019, TRANSL RES, V210, P57, DOI 10.1016/j.trsl.2019.02.014; Cai HQ, 2018, J CLIN PATHOL, V71, P702, DOI 10.1136/jclinpath-2018-205000; Calderwood SK, 2007, FEBS LETT, V581, P3689, DOI 10.1016/j.febslet.2007.04.044; Calderwood SK, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00192; Calderwood SK, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00159; Calderwood SK, 2016, ADV CANCER RES, V129, P89, DOI 10.1016/bs.acr.2015.08.002; Campanella C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020236; Campanella C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092603; Cappello F, 2017, EUR J PHARM SCI, V96, P93, DOI 10.1016/j.ejps.2016.09.010; Cazzaniga A, 2019, FASEB J, V33, P5957, DOI 10.1096/fj.201801586RR; Chen CM, 2018, NEUROTOXICOLOGY, V67, P259, DOI 10.1016/j.neuro.2018.06.009; Chen CY, 2006, MOL BIOL CELL, V17, P3494, DOI 10.1091/mbc.E05-12-1096; Chen YM, 2014, J NEUROSCI, V34, P2464, DOI 10.1523/JNEUROSCI.0151-13.2014; Chen YZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179978; Cheng WJ, 2014, MOL MED REP, V10, P2172, DOI 10.3892/mmr.2014.2411; Choi DS, 2015, MASS SPECTROM REV, V34, P474, DOI 10.1002/mas.21420; Ciregia F, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00276; Couch Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09710-3; Tirapelli DPD, 2010, ARQ NEURO-PSIQUIAT, V68, P592, DOI 10.1590/S0004-282X2010000400021; Dabrowski A, 2019, CURR NEUROL NEUROSCI, V19, DOI 10.1007/s11910-019-0920-4; De Maio A, 2014, CURR PROTEIN PEPT SC, V15, P225, DOI 10.2174/1389203715666140331113057; De Maio A, 2013, SHOCK, V40, P239, DOI 10.1097/SHK.0b013e3182a185ab; De Maio A, 2011, CELL STRESS CHAPERON, V16, P235, DOI 10.1007/s12192-010-0236-4; DeGracia DJ, 2007, NEUROL RES, V29, P356, DOI 10.1179/016164107X204666; Dehghani R, 2018, REV NEUROSCIENCE, V29, P161, DOI 10.1515/revneuro-2017-0042; Deighton RF, 2010, BRAIN PATHOL, V20, P691, DOI 10.1111/j.1750-3639.2010.00376.x; Ding FJ, 2016, EXP THER MED, V12, P823, DOI 10.3892/etm.2016.3413; Dozio V, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1302705; El-Ansary A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-265; Eroglu B, 2014, J NEUROCHEM, V130, P626, DOI 10.1111/jnc.12781; Eroglu B, 2010, MOL CELL BIOL, V30, P4626, DOI 10.1128/MCB.01493-09; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; Fink SL, 1997, J NEUROCHEM, V68, P961; Fontaine SN, 2016, EMBO J, V35, P1537, DOI 10.15252/embj.201593489; Ghaemi A, 2016, MOL NEUROBIOL, V53, P143, DOI 10.1007/s12035-014-8995-z; Gorenberg EL, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00248; Graziano F, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8060110; Guelfi S, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2759403; Harris SF, 2004, STRUCTURE, V12, P1087, DOI 10.1016/j.str.2004.03.020; Hasegawa T, 2018, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00743; Hashikawa N, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603014; Holm MM, 2018, TRENDS NEUROSCI, V41, P360, DOI 10.1016/j.tins.2018.03.006; Horvath I, 2008, BBA-BIOMEMBRANES, V1778, P1653, DOI 10.1016/j.bbamem.2008.02.012; Hosono J, 2017, BRAIN TUMOR PATHOL, V34, P120, DOI 10.1007/s10014-017-0291-y; Hossain MF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173553; Hua QA, 2010, J ETHNOPHARMACOL, V129, P306, DOI 10.1016/j.jep.2010.03.024; Jansen Felix, 2017, JACC Basic Transl Sci, V2, P790, DOI 10.1016/j.jacbts.2017.08.004; Jee H, 2016, J EXERC REHABIL, V12, P255, DOI 10.12965/jer.1632642.321; Jiang XC, 2017, ACS CHEM NEUROSCI, V8, P128, DOI 10.1021/acschemneuro.6b00253; Kafel J, 2006, BRAIN RES BULL, V70, P304, DOI 10.1016/j.brainresbull.2006.06.004; Katakowski M, 2016, CELL MOL NEUROBIOL, V36, P343, DOI 10.1007/s10571-015-0280-9; Katakowski M, 2010, CANCER RES, V70, P8259, DOI 10.1158/0008-5472.CAN-10-0604; Katt ME, 2018, FLUIDS BARRIERS CNS, V15, DOI 10.1186/s12987-018-0092-7; Kim DG, 2016, ONCOTARGET, V7, P29400, DOI 10.18632/oncotarget.8837; Kim JY, 2018, EXPERT OPIN THER TAR, V22, P191, DOI 10.1080/14728222.2018.1439477; Kim JY, 2013, NEUROBIOL DIS, V58, P289, DOI 10.1016/j.nbd.2013.06.012; Kimura A, 2012, J STROKE CEREBROVASC, V21, P305, DOI 10.1016/j.jstrokecerebrovasdis.2010.09.003; Kiyatkin EA, 2011, J NEURAL TRANSM, V118, P47, DOI 10.1007/s00702-010-0477-5; Kourtis Nikos, 2018, BioMolecular Concepts, V9, P94, DOI 10.1515/bmc-2018-0009; Kurachi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159158; Lackie RE, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00254; Lamichhane TN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14356-2; Lauwers E, 2018, MOL CELL, V71, P689, DOI 10.1016/j.molcel.2018.07.016; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Lippmann ES, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-2; Liu ZZ, 2019, CELL CHEM BIOL, V26, P352, DOI 10.1016/j.chembiol.2018.11.009; Lotz GP, 2008, J CELL SCI, V121, P717, DOI 10.1242/jcs.015610; Lucivero V, 2007, NEUROL SCI, V28, P165, DOI 10.1007/s10072-007-0814-0; Luo WJ, 2007, P NATL ACAD SCI USA, V104, P9511, DOI 10.1073/pnas.0701055104; Madani R, 2006, J NEUROSCI RES, V84, P1871, DOI 10.1002/jnr.21074; Mei X, 2017, NEURO-ONCOLOGY, V19, P1109, DOI 10.1093/neuonc/nox016; Meldolesi J, 2018, CURR BIOL, V28, pR435, DOI 10.1016/j.cub.2018.01.059; Meng QL, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00035; Miller DJ, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00821; Moriarty N, 2019, EUR J NEUROSCI, V49, P472, DOI 10.1111/ejn.14051; Nakazono A, 2018, J BIOL CHEM, V293, P14758, DOI 10.1074/jbc.RA118.002913; Obermeier B, 2016, HAND CLINIC, V133, P39, DOI 10.1016/B978-0-444-63432-0.00003-7; Osawa S, 2017, BIOCHEM BIOPH RES CO, V488, P232, DOI 10.1016/j.bbrc.2017.05.049; Ouyang YB, 2013, TRANSL STROKE RES, V4, P693, DOI 10.1007/s12975-013-0280-3; Pan QW, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0243-1; Paolicelli RC, 2019, NEUROSCIENCE, V405, P148, DOI 10.1016/j.neuroscience.2018.04.003; Pardridge WM, 2002, ARCH NEUROL-CHICAGO, V59, P35, DOI 10.1001/archneur.59.1.35; Qi J, 2015, AM J TRANSL RES, V7, P1826; Rajesh Y, 2017, EXP CELL RES, V359, P299, DOI 10.1016/j.yexcr.2017.08.032; Ramakrishnan DP, 2016, ARTERIOSCL THROM VAS, V36, P534, DOI 10.1161/ATVBAHA.115.307085; Ramani B, 2017, HUM MOL GENET, V26, P3362, DOI 10.1093/hmg/ddx224; Ramirez SH, 2018, FLUIDS BARRIERS CNS, V15, DOI 10.1186/s12987-018-0104-7; Rampelt H, 2018, METHODS MOL BIOL, V1709, P179, DOI 10.1007/978-1-4939-7477-1_13; Reddy VS, 2018, CELL STRESS CHAPERON, V23, P441, DOI 10.1007/s12192-017-0856-z; Reifenberger G, 2017, NAT REV CLIN ONCOL, V14, P434, DOI 10.1038/nrclinonc.2016.204; Renard HF, 2018, TRENDS CELL BIOL, V28, P274, DOI 10.1016/j.tcb.2017.12.001; Rivera I, 2018, CELL STRESS CHAPERON, V23, P269, DOI 10.1007/s12192-017-0839-0; Sarko DK, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00082; Sawarkar R, 2012, CELL, V149, P807, DOI 10.1016/j.cell.2012.02.061; Senn R, 2014, CEREBROVASC DIS, V38, P395, DOI 10.1159/000366470; Sharma HS, 2012, INT REV NEUROBIOL, V102, P249, DOI 10.1016/B978-0-12-386986-9.00010-7; Shelton LB, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00724; Shevtsov MA, 2014, DRUG DES DEV THER, V8, P639, DOI 10.2147/DDDT.S62024; Shi CH, 2019, FASEB J, V33, P1617, DOI 10.1096/fj.201800987R; Shi YJ, 2017, P NATL ACAD SCI USA, V114, pE1243, DOI 10.1073/pnas.1621174114; Shin N, 2019, ANTIOXID REDOX SIGN, V30, P1601, DOI 10.1089/ars.2017.7280; SHIVERS RR, 1988, EUR J CELL BIOL, V46, P181; Shorter J, 2017, CURR OPIN GENET DEV, V44, P1, DOI 10.1016/j.gde.2017.01.008; Sochocka M, 2017, MOL NEUROBIOL, V54, P8071, DOI 10.1007/s12035-016-0297-1; Sun Y, 2017, EXP THER MED, V14, P5267, DOI 10.3892/etm.2017.5253; Sweeney MD, 2018, NAT NEUROSCI, V21, P1318, DOI 10.1038/s41593-018-0234-x; Tang HP, 2016, SCI REP-UK, V6, DOI 10.1038/srep28388; Thorsteinsdottir J, 2017, J NEURO-ONCOL, V135, P443, DOI 10.1007/s11060-017-2600-z; Thuringer D, 2015, ONCOTARGET, V6, P10267, DOI 10.18632/oncotarget.3522; Thuringer D, 2013, FASEB J, V27, P4169, DOI 10.1096/fj.12-226977; Thuringer D, 2011, J BIOL CHEM, V286, P3418, DOI 10.1074/jbc.M110.154823; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Tsan MF, 2004, AM J PHYSIOL-CELL PH, V286, pC739, DOI 10.1152/ajpcell.00364.2003; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Turturici G, 2014, J NEUROPATH EXP NEUR, V73, P1092, DOI 10.1097/NEN.0000000000000136; Turturici G, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/618127; van der Weerd L, 2005, EXP NEUROL, V195, P257, DOI 10.1016/j.expneurol.2005.05.002; van Ommeren R, 2016, J NEURO-ONCOL, V127, P209, DOI 10.1007/s11060-016-2070-8; Vijayan M, 2018, HUM MOL GENET, V27, P2318, DOI 10.1093/hmg/ddy136; Vishwakarma Sandeep Kumar, 2017, Basic Clin Neurosci, V8, P453, DOI 10.29252/NIRP.BCN.8.6.453; Wacker JL, 2009, J NEUROSCI, V29, P9104, DOI 10.1523/JNEUROSCI.2250-09.2009; Wagstaff MJD, 1996, MOL BRAIN RES, V42, P236, DOI 10.1016/S0169-328X(96)00127-1; Wang B, 2017, MOL PSYCHIATR, V22, P990, DOI 10.1038/mp.2016.104; Wang PF, 2014, J IMMUNOL, V192, P4783, DOI 10.4049/jimmunol.1303108; Xiao B, 2017, INT J MOL MED, V40, P1201, DOI 10.3892/ijmm.2017.3106; Xu ZH, 2019, FASEB J, V33, P1742, DOI 10.1096/fj.201800428R; Yamagishi N, 2006, EXP CELL RES, V312, P3215, DOI 10.1016/j.yexcr.2006.06.007; Yenari MA, 2002, ADV EXP MED BIOL, V513, P281; Yin XL, 2010, AM J PATHOL, V176, P1600, DOI 10.2353/ajpath.2010.090406; Yu QJ, 2015, NEURAL REGEN RES, V10, P1882, DOI 10.4103/1673-5374.170324; Zagrean AM, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00811; Zhan XH, 2010, STROKE, V41, P538, DOI 10.1161/STROKEAHA.109.572537; Zhang DM, 2012, NEUROCHEM INT, V61, P1021, DOI 10.1016/j.neuint.2012.07.019; Zhang MH, 2018, BBA-BIOMEMBRANES, V1860, P611, DOI 10.1016/j.bbamem.2017.11.011; Zhang ZG, 2016, J CLIN INVEST, V126, P1190, DOI 10.1172/JCI81133; Zhao Z, 2017, CELL RES, V27, P849, DOI 10.1038/cr.2017.71; Zhuang YG, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/5078627; Zucchi E, 2018, NEURODEGENER DIS, V18, P255, DOI 10.1159/000493986	170	9	9	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11629	11639		10.1096/fj.201900895R	http://dx.doi.org/10.1096/fj.201900895R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31348679	Green Published			2022-12-28	WOS:000507461600005
J	Willis, KA; Purvis, JH; Myers, ED; Aziz, MM; Karabayir, I; Gomes, CK; Peters, BM; Akbilgic, O; Talati, AJ; Pierre, JF				Willis, Kent A.; Purvis, John H.; Myers, Erin D.; Aziz, Michael M.; Karabayir, Ibrahim; Gomes, Charles K.; Peters, Brian M.; Akbilgic, Oguz; Talati, Ajay J.; Pierre, Joseph F.			Fungi form interkingdom microbial communities in the primordial human gut that develop with gestational age	FASEB JOURNAL			English	Article						meconium; microbiome; mycobiome; premature birth; Candida	MECONIUM; COLONIZATION; MODE	Fungal and bacterial commensal organisms play a complex role in the health of the human host. Expansion of commensal ecology after birth is a critical period in human immune development. However, the initial fungal colonization of the primordial gut remains undescribed. To investigate primordial fungal ecology, we performed amplicon sequencing and culture based techniques of first-pass meconium, which forms in the intestine prior to birth, from a prospective observational cohort of term and preterm newborns. Here, we describe fungal ecologies in the primordial gut that develop complexity with advancing gestational age at birth. Our findings suggest homeostasis of fungal commensals may represent an important aspect of human biology present even before birth. Unlike bacterial communities that gradually develop complexity, the domination of the fungal communities of some preterm infants by Saccromycetes, specifically Candida, may suggest a pathologic association with preterm birth.	[Willis, Kent A.; Purvis, John H.; Talati, Ajay J.] UTHSC, Dept Pediat, Div Neonatol, Memphis, TN USA; [Aziz, Michael M.; Talati, Ajay J.] UTHSC, Dept Obstet & Gynecol, Memphis, TN USA; [Gomes, Charles K.; Pierre, Joseph F.] UTHSC, Dept Pediat Obes, Memphis, TN USA; [Pierre, Joseph F.] UTHSC, Dept Microbiol Immunol & Biochem, Memphis, TN USA; [Willis, Kent A.; Purvis, John H.; Myers, Erin D.; Talati, Ajay J.] UTHSC, Coll Med, Memphis, TN USA; [Peters, Brian M.] UTHSC, Dept Clin Pharm & Translat Sci, Coll Pharm, Memphis, TN USA; [Karabayir, Ibrahim; Akbilgic, Oguz] Loyola Univ, Stritch Sch Med, Dept Hlth Informat & Data Sci, Chicago, IL 60611 USA; [Akbilgic, Oguz] Loyola Univ, Ctr Hlth Outcome & Informat Res, Chicago, IL 60611 USA; [Karabayir, Ibrahim] Kirklareli Univ, Dept Econometr, Fac Econ & Adm Sci, Kirklareli, Turkey	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Loyola University Chicago; Loyola University Chicago; Kirklareli University	Pierre, JF (corresponding author), Univ Tennessee, Hlth Sci Ctr, 71 S Manassas St,Room 425, Memphis, TN 38103 USA.	jpierre1@uthsc.edu	Talati, Ajay/AGY-6999-2022; Karabayir, Ibrahim/AAC-3262-2019; Pierre, Joseph/HCH-3993-2022; akbilgic, oguz/F-9407-2013; Akbilgic, Oguz/ABF-9333-2021	Talati, Ajay/0000-0003-1798-9970; Karabayir, Ibrahim/0000-0002-7928-176X; akbilgic, oguz/0000-0003-0313-9254; Aziz, Michael/0000-0002-7344-0547; Willis, Kent/0000-0001-7338-0399; Myers, Erin/0000-0003-3939-8995; Pierre, Joseph/0000-0002-4248-1290; Klazer Gomes, Charles/0000-0002-4560-9413				Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Ahanya SN, 2005, OBSTET GYNECOL SURV, V60, P45, DOI 10.1097/01.ogx.0000149659.89530.c2; Ardissone AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090784; Arrieta MC, 2018, J ALLERGY CLIN IMMUN, V142, P424, DOI 10.1016/j.jaci.2017.08.041; Arrieta MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00427; Becattini S, 2016, TRENDS MOL MED, V22, P458, DOI 10.1016/j.molmed.2016.04.003; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chernikova DA, 2018, PEDIATR RES, V84, P71, DOI 10.1038/s41390-018-0022-z; Chu DM, 2017, NAT MED, V23, P314, DOI 10.1038/nm.4272; Collin MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep21589; DiGiulio DB, 2012, SEMIN FETAL NEONAT M, V17, P2, DOI 10.1016/j.siny.2011.10.001; DiGiulio DB, 2010, AM J REPROD IMMUNOL, V64, P38, DOI 10.1111/j.1600-0897.2010.00830.x; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Gosalbes MJ, 2013, CLIN EXP ALLERGY, V43, P198, DOI 10.1111/cea.12063; Hansen R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133320; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Iliev ID, 2017, NAT REV IMMUNOL, V17, P635, DOI 10.1038/nri.2017.55; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Kong LH, 2019, JAMA PEDIATR, V173, P371, DOI 10.1001/jamapediatrics.2018.5541; Koskella B, 2017, NAT ECOL EVOL, V1, P1606, DOI 10.1038/s41559-017-0340-2; Limon JJ, 2017, CELL HOST MICROBE, V22, P156, DOI 10.1016/j.chom.2017.07.002; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Maki Y., 2017, INFECT DIS OBSTET GY, V2017; Martinez I, 2018, ELIFE, V7, DOI 10.7554/eLife.36521; Martinez I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069621; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Mueller NT, 2017, GENES-BASEL, V8, DOI 10.3390/genes8120364; Neville BA, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov081; Nilsson RH, 2019, NUCLEIC ACIDS RES, V47, pD259, DOI 10.1093/nar/gky1022; Olin A, 2018, CELL, V174, P1277, DOI 10.1016/j.cell.2018.06.045; Palmer KL, 2019, METHODS MOL BIOL, V1872, P191, DOI 10.1007/978-1-4939-8823-5_18; Parry G, 2003, LANCET, V361, P1789, DOI 10.1016/S0140-6736(03)13397-1; Payne MS, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00595; Romano-Keeler J, 2015, PEDIATR RES, V77, P189, DOI 10.1038/pr.2014.163; Rouge C, 2010, ANAEROBE, V16, P362, DOI 10.1016/j.anaerobe.2010.06.002; SAMONIS G, 1993, ANTIMICROB AGENTS CH, V37, P51, DOI 10.1128/AAC.37.1.51; Schei K, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0319-x; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sordillo JE, 2017, J ALLERGY CLIN IMMUN, V139, P482, DOI 10.1016/j.jaci.2016.08.045; Stewart CJ, 2012, ACTA PAEDIATR, V101, P1121, DOI 10.1111/j.1651-2227.2012.02801.x; Strati F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01227; Tapiainen T, 2018, PEDIATR RES, V84, DOI 10.1038/pr.2018.29; Ward TL, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00140-17; Zakrzewski M, 2017, BIOINFORMATICS, V33, P782, DOI 10.1093/bioinformatics/btw725; Zhan GW, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-06269-z, 10.1038/s41467-017-02251-3]; Zheng J, 2015, NUTRIENTS, V7, P6924, DOI 10.3390/nu7085315	48	20	21	1	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12825	12837		10.1096/fj.201901436RR	http://dx.doi.org/10.1096/fj.201901436RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31480903	Green Submitted, Green Published			2022-12-28	WOS:000507461600095
J	Bartoszewska, S; Cabaj, A; Dabrowski, M; Collawn, JF; Bartoszewski, R				Bartoszewska, Sylwia; Cabaj, Aleksandra; Dabrowski, Michal; Collawn, James F.; Bartoszewski, Rafal			miR-34c-5p modulates X-box-binding protein 1 (XBP1) expression during the adaptive phase of the unfolded protein response	FASEB JOURNAL			English	Article						XBP1; UPR; ER stress; miRNA	ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA; ER STRESS; ACTIVATOR PXBP1(S); INDUCED APOPTOSIS; PROSTATE-CANCER; CFTR EXPRESSION; ATF6; TARGETS; COORDINATION	During endoplasmic reticulum (ER) stress conditions, an adaptive signaling network termed the unfolded protein response (UPR) is activated. The UPR's function is to increase ER protein-folding capacity in order to attenuate ER stress, restore ER homeostasis, and, most importantly, promote cell survival. X-box-binding protein 1 (XBP1) is one component of the UPR and is a proadaptive transcription factor that is subject to transcriptional, post-transcriptional, and post-translational control. In the present study, we identified a post-transcriptional mechanism mediated by miR-34c-5p that governs the expression of both the spliced (active) and unspliced (latent) forms of XBP1 mRNAs. We showed that miR-34c-5p directly attenuates spliced XBP1 (XBP1s) mRNA levels during ER stress and thus regulates the proadaptive component of the UPR that is mediated by XBP1s without interfering with the induction of apoptotic responses.-Bartoszewska, S., Cabaj, A., Dabrowski, M., Collawn, J. F., Bartoszewski, R. miR-34c-5p modulates X-box-binding protein 1 (XBP1) expression during the adaptive phase of the unfolded protein response.	[Bartoszewska, Sylwia] Med Univ Gdansk, Dept Inorgan Chem, PL-80416 Gdansk, Poland; [Bartoszewski, Rafal] Med Univ Gdansk, Dept Biol & Pharmaceut Bot, Hallera 107, PL-80416 Gdansk, Poland; [Cabaj, Aleksandra; Dabrowski, Michal] Polish Acad Sci, Nencki Inst Expt Biol, Lab Bioinformat, Warsaw, Poland; [Collawn, James F.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Alabama System; University of Alabama Birmingham	Bartoszewska, S (corresponding author), Med Univ Gdansk, Dept Inorgan Chem, PL-80416 Gdansk, Poland.; Bartoszewski, R (corresponding author), Med Univ Gdansk, Dept Biol & Pharmaceut Bot, Hallera 107, PL-80416 Gdansk, Poland.	sylwiabart@gumed.edu.pl; rafalbar@gumed.edu.pl	Cabaj, Aleksandra/U-9449-2019; Bartoszewska, Sylwia/L-3922-2019; Dąbrowski, Michał/K-4384-2012; Bartoszewski, Rafal A/D-6311-2011	Cabaj, Aleksandra/0000-0002-3341-9137; Bartoszewska, Sylwia/0000-0001-8063-1272; Bartoszewski, Rafal A/0000-0002-2864-6757; Collawn, James/0000-0002-2528-2759; Dabrowski, Michal/0000-0002-5335-158X	National Science Center OPUS Program [UMO-2015/17/B/NZ3/01485]; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [P30 DK072482]; Cystic Fibrosis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482] Funding Source: NIH RePORTER	National Science Center OPUS Program; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Science Center OPUS Program (UMO-2015/17/B/NZ3/01485 to R.B.); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant P30 DK072482; and a Research Development Program Grant from the Cystic Fibrosis Foundation (to J.F.C.). The authors declare no conflicts of interest.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Amin-Wetzel N, 2017, CELL, V171, P1625, DOI 10.1016/j.cell.2017.10.040; Back SH, 2006, J BIOL CHEM, V281, P18691, DOI 10.1074/jbc.M602030200; Bartoszewska S, 2017, CELL MOL BIOL LETT, V22, DOI 10.1186/s11658-017-0054-0; Bartoszewska S, 2013, CELL MOL BIOL LETT, V18, P555, DOI 10.2478/s11658-013-0106-z; Bartoszewski R, 2008, J BIOL CHEM, V283, P12154, DOI 10.1074/jbc.M707610200; Bartoszewski R, 2017, EUR J CELL BIOL, V96, P758, DOI 10.1016/j.ejcb.2017.10.001; Bartoszewski R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092128; Bartoszewski R, 2011, J BIOL CHEM, V286, P41862, DOI 10.1074/jbc.M111.304956; Bartoszewski R, 2011, METHOD ENZYMOL, V491, P3, DOI 10.1016/B978-0-12-385928-0.00001-8; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Behrman S, 2011, J CELL BIOL, V192, P919, DOI 10.1083/jcb.201010055; Boriushkin Evgenii, 2014, J Ophthalmic Vis Res, V9, P134; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Byrd AE, 2013, IUBMB LIFE, V65, P373, DOI 10.1002/iub.1151; Byrd AE, 2012, J CELL BIOL, V196, P689, DOI 10.1083/jcb.201201077; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; Chang TK, 2018, MOL CELL, V71, P629, DOI 10.1016/j.molcel.2018.06.038; Chen H, 2010, BIOCHEM J, V429, P95, DOI 10.1042/BJ20100193; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Duan QL, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0725-4; Duan QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031518; Fromme JC, 2008, TRENDS CELL BIOL, V18, P330, DOI 10.1016/j.tcb.2008.04.006; Gallagher CM, 2016, ELIFE, V5, DOI 10.7554/eLife.11880; Gallagher CM, 2016, ELIFE, V5, DOI 10.7554/eLife.11878; Gebert M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34861-2; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hagman Z, 2013, BRIT J CANCER, V109, P1271, DOI 10.1038/bjc.2013.449; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Ji H, 2019, BIOCHEM BIOPH RES CO, V508, P203, DOI 10.1016/j.bbrc.2018.11.112; Karagoz GE, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a033886; Kiezun Adam, 2012, BMC Res Notes, V5, P92, DOI 10.1186/1756-0500-5-92; Krystkowiaky I, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat069; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee JS, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep126; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Lu M, 2014, SCIENCE, V345, P98, DOI 10.1126/science.1254312; Majumder M, 2012, MOL CELL BIOL, V32, P992, DOI 10.1128/MCB.06665-11; Malhi Harmeet, 2014, Curr Pathobiol Rep, V2, P117; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Rabouw HH, 2019, P NATL ACAD SCI USA, V116, P2097, DOI 10.1073/pnas.1815767116; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sheng X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08152-3; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.05033; Stefanowicz-Hajduk J, 2016, BIOTECHNIQUES, V61, P117, DOI 10.2144/000114450; Stefanowicz-Hajduk J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135993; Sun YN, 2018, ONCOL REP, V40, P988, DOI 10.3892/or.2018.6498; Tirosh B, 2006, J BIOL CHEM, V281, P5852, DOI 10.1074/jbc.M509061200; Uemura A, 2009, J CELL SCI, V122, P2877, DOI 10.1242/jcs.040584; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang FM, 2011, BIOCHEM J, V433, P245, DOI 10.1042/BJ20101293; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Witzel F, 2015, BIOINFORMATICS, V31, P2705, DOI 10.1093/bioinformatics/btv216; Wolstencroft K, 2013, NUCLEIC ACIDS RES, V41, pW557, DOI 10.1093/nar/gkt328; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yanagitani K, 2011, SCIENCE, V331, P586, DOI 10.1126/science.1197142; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Yoshida H, 2009, CELL STRUCT FUNCT, V34, P1, DOI 10.1247/csf.06028	67	20	20	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11541	11554		10.1096/fj.201900600RR	http://dx.doi.org/10.1096/fj.201900600RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31314593	Green Published, Bronze			2022-12-28	WOS:000489166300077
J	Cavey, T; Latour, C; Island, ML; Leroyer, P; Guggenbuhl, P; Coppin, H; Roth, MP; Bendavid, C; Brissot, P; Ropert, M; Loreal, O				Cavey, Thibault; Latour, Chloe; Island, Marie-Laure; Leroyer, Patricia; Guggenbuhl, Pascal; Coppin, Helene; Roth, Marie-Paule; Bendavid, Claude; Brissot, Pierre; Ropert, Martine; Loreal, Olivier			Spleen iron, molybdenum, and manganese concentrations are coregulated in hepcidin-deficient and secondary iron overload models in mice	FASEB JOURNAL			English	Article						metals; metabolism; hemochromatosis; disease	ANTIMICROBIAL PEPTIDE HEPCIDIN; GENE-EXPRESSION; MOUSE MODEL; METABOLISM; LIVER; FERROPORTIN; BMP6; ACERULOPLASMINEMIA; HEMOCHROMATOSIS; MEN	Iron excess increases the hepatic expression of hepcidin, the systemic iron metabolism regulator that favors iron sequestration in the spleen. Genetic iron overload related to hepcidin insufficiency decreases the spleen iron concentration and increases hepatic iron concentration, whereas during secondary iron overload, the hepcidin expression increases together with spleen iron concentration in addition to hepatic iron concentrations increase. Links between iron metabolism and other metals being suggested, our aim was to investigate, during iron overload, the relationships between the hepatic hepcidin expression level and the hepatic and splenic concentrations of iron, manganese, copper, zinc, and molybdenum, determined using inductively coupled plasma mass spectrometry. Hepcidin-deficient mice, secondary iron overload mice models, and their respective controls were studied. Spleen molybdenum and manganese concentrations paralleled the modulation of both spleen iron concentrations, increasing in secondary iron overload and decreasing in hepcidin deficiency related iron overload, as well as hepatic hepcidin mRNA expression. Our data suggest that iron, manganese, and molybdenum metabolisms could share mechanisms controlling their distribution that are associated to hepcidin modulation. In diseases with abnormal hepcidin levels, including chronic inflammation, special attention should be paid to those metals that can participate with the phenotype.-Cavey, T., Latour, C., Island, M.-L., Leroyer, P., Guggenbuhl, P., Coppin, H., Roth, M.-P., Bendavid, C., Brissot, P., Ropert, M., Loreal, O. Spleen iron, molybdenum, and manganese concentrations are coregulated in hepcidin-deficient and secondary iron overload models in mice.	[Cavey, Thibault; Island, Marie-Laure; Leroyer, Patricia; Guggenbuhl, Pascal; Bendavid, Claude; Brissot, Pierre; Ropert, Martine; Loreal, Olivier] Univ Rennes, INSERM, Anal Elementaire & Metab Metaux AEM2 Platform, CHU Pontchaillou,INRA,UMR 1241,Nutr Metab & Canc, Rennes, France; [Latour, Chloe; Coppin, Helene; Roth, Marie-Paule] Univ Toulouse, UPS, ENVT, INRA,IRSD,INSERM, Toulouse, France	CHU Rennes; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Toulouse III - Paul Sabatier	Loreal, O (corresponding author), CHU Pontchaillou, INSERM, UMR1241, 2 Rue Henri Le Guilloux, F-35033 Rennes, France.	olivier.loreal@univ-rennes1.fr	bendavid, claude/AAL-7345-2020; Coppin, Hélène/G-4326-2013; Roth, Marie-Paule/Q-2866-2018; Loreal, Olivier/G-3366-2013	bendavid, claude/0000-0003-2459-9567; Coppin, Hélène/0000-0001-7911-6353; Roth, Marie-Paule/0000-0001-9691-4234; Loreal, Olivier/0000-0002-7428-3766; Guggenbuhl, Pascal/0000-0002-8260-1824; Martine, Ropert/0000-0003-1227-9427	INSERM; Association Hemochromatose Ouest (AHO); University of Rennes 1; Region Bretagne; Afemers	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Hemochromatose Ouest (AHO); University of Rennes 1; Region Bretagne(Region Bretagne); Afemers	This work was supported by INSERM, University of Rennes 1, Region Bretagne, the Afemers, and the Association Hemochromatose Ouest (AHO). The authors declare no conflicts of interest.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Ahmad KA, 2002, BLOOD CELL MOL DIS, V29, P361, DOI 10.1006/bcmd.2002.0575; Alsulimani HH, 2015, TOX RESEARCH, V31, P347, DOI 10.5487/TR.2015.31.4.347; AVAKYAN M A, 1978, Zhurnal Eksperimental'noi i Klinicheskoi Meditsiny, V18, P69; Balesaria S, 2010, FEBS LETT, V584, P719, DOI 10.1016/j.febslet.2009.12.023; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P293, DOI 10.1081/CLT-100102427; Bardou-Jacquet E, 2014, HEPATOLOGY, V59, P839, DOI 10.1002/hep.26570; Brissot P, 2016, J HEPATOL, V64, P505, DOI 10.1016/j.jhep.2015.11.009; Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; Camberlein E, 2010, BBA-MOL BASIS DIS, V1802, P339, DOI 10.1016/j.bbadis.2009.12.007; Cao HB, 2016, BIOL TRACE ELEM RES, V170, P237, DOI 10.1007/s12011-015-0442-0; CHESLEY R F, 1948, Bull Jersey City Margaret Hague Mat Hosp, V1, P68; Choi EK, 2019, FASEB J, V33, P2228, DOI 10.1096/fj.201800831R; Doyard M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148292; Flais J, 2017, JOINT BONE SPINE, V84, P293, DOI 10.1016/j.jbspin.2016.05.020; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Gehrke SG, 2003, BLOOD, V102, P371, DOI 10.1182/blood-2002-11-3610; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Henn BC, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-97; Hosokawa S, 1994, ASAIO J, V40, pM445, DOI 10.1097/00002480-199407000-00039; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Joitihan HA, 2008, MOL MED, V14, P98, DOI 10.2119/2007-00114.Jouihan; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064944; Kono S, 2013, INT REV NEUROBIOL, V110, P125, DOI 10.1016/B978-0-12-410502-7.00007-7; Latour C, 2014, HEPATOLOGY, V59, P683, DOI 10.1002/hep.26648; Loreal O, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00128; Madejczyk MS, 2012, BBA-BIOMEMBRANES, V1818, P651, DOI 10.1016/j.bbamem.2011.12.002; Mendel RR, 2013, METAL IONS LIFE SCI, V12, P503, DOI 10.1007/978-94-007-5561-1_15; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Miyajima H, 2015, NEUROPATHOLOGY, V35, P83, DOI 10.1111/neup.12149; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Novotny JA, 2007, J NUTR, V137, P37, DOI 10.1093/jn/137.1.37; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Pfalzer Anna C, 2017, Curr Environ Health Rep, V4, P223, DOI 10.1007/s40572-017-0136-1; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Pigeon C, 2001, BBA-MOL BASIS DIS, V1535, P275, DOI 10.1016/S0925-4439(01)00024-2; Rivera-Mancia S, 2011, BIOMETALS, V24, P811, DOI 10.1007/s10534-011-9454-1; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; SEELIG MS, 1973, AM J CLIN NUTR, V26, P657, DOI 10.1093/ajcn/26.6.657; Seo YA, 2016, BIOMETALS, V29, P147, DOI 10.1007/s10534-015-9904-2; Seo YA, 2015, FASEB J, V29, P2726, DOI 10.1096/fj.14-262592; Solloway MJ, 1998, DEV GENET, V22, P321, DOI 10.1002/(SICI)1520-6408(1998)22:4<321::AID-DVG3>3.3.CO;2-7; Thompson KH, 1996, J APPL PHYSIOL, V81, P1404, DOI 10.1152/jappl.1996.81.3.1404; Troadec MB, 2010, BLOOD, V116, P4657, DOI 10.1182/blood-2010-04-278614; TURNLUND JR, 1995, AM J CLIN NUTR, V61, P1102, DOI 10.1093/ajcn/61.5.1102; Videt-Gibou D, 2009, BLOOD, V114, P2360, DOI 10.1182/blood-2009-06-226175; Vyskocil A, 1999, J APPL TOXICOL, V19, P185, DOI 10.1002/(SICI)1099-1263(199905/06)19:3<185::AID-JAT555>3.0.CO;2-Z; WALRAVENS PA, 1979, ARCH ENVIRON HEALTH, V34, P302, DOI 10.1080/00039896.1979.10667421; Yang F, 2011, BIOL TRACE ELEM RES, V140, P308, DOI 10.1007/s12011-010-8697-y; Zhang MM, 2017, J VET SCI, V18, P193, DOI 10.4142/jvs.2017.18.2.193	53	5	5	2	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11072	11081		10.1096/fj.201801381RR	http://dx.doi.org/10.1096/fj.201801381RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31298936	Green Submitted, Bronze			2022-12-28	WOS:000489166300042
J	Kim, DY; Park, JA; Kim, Y; Noh, M; Park, S; Lie, E; Kim, E; Kim, YM; Kwon, YG				Kim, Dong Young; Park, Jeong Ae; Kim, Yeomyung; Noh, Minyoung; Park, Songyi; Lie, Eunkyung; Kim, Eunjoon; Kim, Young-Myeong; Kwon, Young-Guen			SALM4 regulates angiogenic functions in endothelial cells through VEGFR2 phosphorylation at Tyr1175	FASEB JOURNAL			English	Article						VEGF signaling; endothelial leakage; vascular permeability; ischemia reperfusion	VASCULAR-PERMEABILITY; GROWTH-FACTOR; ISCHEMIC-STROKE; EXPRESSION; FAMILY; INFLAMMATION; INHIBITION; MECHANISMS; SURVIVAL; BIOLOGY	Angiogenesis depends on VEGF-mediated signaling. However, the regulatory mechanisms and functions of individual VEGF receptor 2 (VEGFR2) phosphorylation sites remain unclear. Here, we report that synaptic adhesion-like molecule 4 (SALM4) regulates a specific VEGFR2 phosphorylation site. SALM4 silencing in HUVECs and Salm4 knockout (KO) in lung endothelial cells (ECs) of Salm4(-/-) mice suppressed phosphorylation of VEGFR2 tyrosine (Y) 1175 (Y1173 in mice) and downstream signaling upon VEGF-A stimulation. However, VEGFR2 phosphorylation at Y951 (Y949 in mice) and Y1214 (Y1212 in mice) remained unchanged. Knockdown and KO of SALM4 inhibited VEGF-A-induced angiogenic functions of ECs. SALM4 depletion reduced endothelial leakage, sprouting, and migratory activities. Furthermore, in an ischemia and reperfusion (I/R) model, brain injury was attenuated in Salm4(-/-) mice compared with wild-type (WT) mice. In brain lysates after I/R, VEGFR2 phosphorylation at Y949, Y1173, and Y1212 were induced in WT brains, but only Y1173 phosphorylation of VEGFR2 was reduced in Salm4(-/-) brains. Taken together, our results demonstrate that SALM4 specifically regulates VEGFR2 phosphorylation at Y1175 (Y1173 in mice), thereby fine-tuning VEGF signaling in ECs.-Kim, D. Y., Park, J. A., Kim, Y., Noh, M., Park, S., Lie, E., Kim, E., Kim, Y.-M., Kwon, Y.-G. SALM4 regulates angiogenic functions in endothelial cells through VEGFR2 phosphorylation at Tyr1175.	[Kim, Dong Young; Park, Jeong Ae; Kim, Yeomyung; Noh, Minyoung; Park, Songyi; Kwon, Young-Guen] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, 50 Yonsei Ro, Seoul 03722, South Korea; [Lie, Eunkyung; Kim, Eunjoon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea; [Kim, Young-Myeong] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chuncheon Si, South Korea	Yonsei University; Korea Advanced Institute of Science & Technology (KAIST); Kangwon National University	Kwon, YG (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, 50 Yonsei Ro, Seoul 03722, South Korea.	ygkwon@yonsei.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communications Technology, and Future Planning (MSIP) [NRF-2019R1A2C3007142]; NRF - MSIP [NRF-2015M3A9B6066835]; Korea Health Industry Development Institute (KHIDI) - Korean Ministry of Health and Welfare [HI16C1501]	National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communications Technology, and Future Planning (MSIP); NRF - MSIP; Korea Health Industry Development Institute (KHIDI) - Korean Ministry of Health and Welfare	This research was supported by the Basic Science Research Program from the National Research Foundation of Korea (NRF), funded by the Ministry of Science, Information and Communications Technology, and Future Planning (MSIP; NRF-2019R1A2C3007142) and the Bio and Medical Technology Development Program of the NRF funded by the MSIP (NRF-2015M3A9B6066835). This work was also supported by a Korea Health Technology Research and Development Project grant from the Korea Health Industry Development Institute (KHIDI), funded by the Korean Ministry of Health and Welfare (Grant HI16C1501). The authors declare no conflicts of interest.	Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; Akarasereenont P, 2002, MEDIAT INFLAMM, V11, P17, DOI 10.1080/09629350210311; Ambesi A, 2014, J CELL SCI, V127, P3805, DOI 10.1242/jcs.150458; Ao R, 2018, J CELL BIOCHEM, V119, P4420, DOI 10.1002/jcb.26524; Bagri A, 2009, CLIN CANCER RES, V15, P1860, DOI 10.1158/1078-0432.CCR-08-0563; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Batori R, 2017, SCI REP-UK, V7, DOI 10.1038/srep44698; Chislock EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085231; Choi YS, 2009, BLOOD, V114, P3117, DOI 10.1182/blood-2009-02-203372; Corti F, 2017, PHARMACOL RES, V115, P107, DOI 10.1016/j.phrs.2016.11.022; Di Lorenzo A, 2013, J CELL SCI, V126, P5541, DOI 10.1242/jcs.115972; Dieterich LC, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.106; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Geiseler SJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051362; Graziani G, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00125; Greenberg DA, 2013, CELL MOL LIFE SCI, V70, P1753, DOI 10.1007/s00018-013-1282-8; Guruswamy R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030496; Hayashi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2683; Jiang XY, 2018, PROG NEUROBIOL, V163, P144, DOI 10.1016/j.pneurobio.2017.10.001; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim JY, 2016, EXP NEUROBIOL, V25, P241, DOI 10.5607/en.2016.25.5.241; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Komarova YA, 2017, CIRC RES, V120, P179, DOI 10.1161/CIRCRESAHA.116.306534; Kuchmiy AA, 2016, J EXP MED, V213, P2851, DOI 10.1084/jem.20160900; Lanahan AA, 2014, CIRCULATION, V130, P902, DOI 10.1161/CIRCULATIONAHA.114.009683; Li XJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11017; Lie E, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00105; Lie E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12328; Maeng YS, 2009, BLOOD, V113, P233, DOI 10.1182/blood-2008-06-162891; Mah W, 2010, J NEUROSCI, V30, P5559, DOI 10.1523/JNEUROSCI.4839-09.2010; Marin V, 2001, J IMMUNOL METHODS, V254, P183, DOI 10.1016/S0022-1759(01)00408-2; Matsumoto T, 2002, J CELL BIOL, V156, P149, DOI 10.1083/jcb.200103096; Min JK, 2007, BLOOD, V109, P1495, DOI 10.1182/blood-2006-06-029298; Morimura N, 2006, GENE, V380, P72, DOI 10.1016/j.gene.2006.05.014; Otto GP, 2011, J CELL SCI, V124, P3933, DOI 10.1242/jcs.092015; Park H, 2015, J CELL BIOL, V211, P619, DOI 10.1083/jcb.201503113; Pedram A, 2002, J BIOL CHEM, V277, P44385, DOI 10.1074/jbc.M202391200; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Pintucci G, 2002, FASEB J, V16, P598, DOI 10.1096/fj.01-0815fje; Pircher A, 2014, ONCOLOGY-BASEL, V86, P46, DOI 10.1159/000356871; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Rocha SF, 2014, CIRC RES, V115, P581, DOI 10.1161/CIRCRESAHA.115.304718; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Senis YA, 2018, MOLECULES, V23, DOI 10.3390/molecules23030569; Simons M, 2016, NAT REV MOL CELL BIO, V17, P611, DOI 10.1038/nrm.2016.87; Smith GA, 2015, J INHERIT METAB DIS, V38, P753, DOI 10.1007/s10545-015-9838-4; Sobczak Magdalena, 2010, J Vis Exp, DOI 10.3791/2316; Swanwick CC, 2010, MOL CELL NEUROSCI, V45, P213, DOI 10.1016/j.mcn.2010.06.012; Tai-Nagara I, 2017, DEVELOPMENT, V144, P2392, DOI 10.1242/dev.149757; Tobin MK, 2014, J CEREBR BLOOD F MET, V34, P1573, DOI 10.1038/jcbfm.2014.130; Walchli T, 2015, NEURON, V87, P271, DOI 10.1016/j.neuron.2015.06.038; Wang PY, 2008, MOL CELL NEUROSCI, V39, P83, DOI 10.1016/j.mcn.2008.05.019; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wang XM, 2013, NATURE, V499, P306, DOI 10.1038/nature12345; Zhang F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13517; Zhang H, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0897-3; Zhang X, 2014, ARTERIOSCL THROM VAS, V34, P1831, DOI 10.1161/ATVBAHA.114.303217	57	7	7	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9842	9857		10.1096/fj.201802516RR	http://dx.doi.org/10.1096/fj.201802516RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31170000	Green Published, hybrid			2022-12-28	WOS:000482214200013
J	Wang, SL; Wang, WW; Ma, Q; Shen, ZF; Zhang, MQ; Zhou, NM; Zhang, CX				Wang, Si-Liang; Wang, Wei-Wei; Ma, Qiang; Shen, Zhang-Fei; Zhang, Meng-Qiu; Zhou, Nai-Ming; Zhang, Chuan-Xi			Elevenin signaling modulates body color through the tyrosine-mediated cuticle melanism pathway	FASEB JOURNAL			English	Article						salivary gland; intracellular signaling pathway; Nilarparvata lugens; GPCR	PROTEIN COUPLED RECEPTORS; BROWN PLANTHOPPER; ENCODING NEUROPEPTIDES; PHENOTYPIC PLASTICITY; CALCINEURIN; METABOLISM	Elevenin is a newly discovered novel neuropeptide. Knockdown of either elevenin or orphan receptor NlA42 transcript expression by RNA interference caused severe cuticle melanization in the brown planthopper (BPH). Injection of a synthetic elevenin peptide not only rescued the body color phenotype in dselevenin-pretreated individuals but also suppressed melanization of black insects grown in natural conditions. Real-time quantitative PCR results revealed that elevenin expression levels were highest in the brain and salivary gland. Immunohistochemistry analysis confirmed that a precursor peptide of elevenin was generated in the salivary gland, suggesting that the salivary gland might be an important neurosecretory tissue in addition to the brain in BPH. Furthermore, double-strand RNA-mediated silencing of elevenin and NlA42 resulted in down-regulation of arylalkylamine-N-acetyltransferase and up-regulation of tyrosine hydroxylase, whereas elevenin peptide injection resulted in up-regulation of N-beta-alanyldopamine synthase and aspartate 1-decarboxylase, indicating a complex regulation network for cuticle pigmentation. In addition, functional characterization demonstrated that NlA42 is a cognate receptor for elevenin, and couples to Gq and Gs proteins, triggering both PLC/Ca2+/PKC and AC/cAMP/PKA signaling pathways in response to elevenin treatment. These findings suggest that the elevenin signaling functions control BPH body color through the tyrosine-mediated cuticle melanism pathway.-Wang, S.-L., Wang, W.-W., Ma, Q., Shen, Z.-F., Zhang, M.-Q., Zhou, N.-M., Zhang, C.-X. Elevenin signaling modulates body color through the tyrosine-mediated cuticle melanism pathway.	[Wang, Si-Liang; Zhang, Meng-Qiu; Zhang, Chuan-Xi] Zhejiang Univ, State Key Lab Rice Biol, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Si-Liang; Zhang, Meng-Qiu; Zhang, Chuan-Xi] Zhejiang Univ, Minist Agr, Key Lab Mol Biol Crop Pathogens & Insect Pests, Inst Insect Sci, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Wei-Wei; Ma, Qiang; Shen, Zhang-Fei; Zhou, Nai-Ming] Zhejiang Univ, Inst Biochem, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Ministry of Agriculture & Rural Affairs; Zhejiang University; Zhejiang University	Zhang, CX (corresponding author), Zhejiang Univ, State Key Lab Rice Biol, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China.; Zhang, CX (corresponding author), Zhejiang Univ, Minist Agr, Key Lab Mol Biol Crop Pathogens & Insect Pests, Inst Insect Sci, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China.; Zhou, NM (corresponding author), Zhejiang Univ, Inst Biochem, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China.	zhounaiming@zju.edu.cn; chxzhang@zju.edu.cn	Zhou, Naiming/AHC-1121-2022	shen, zhangfei/0000-0002-3707-2265; Zhang, Chuan-Xi/0000-0002-7784-1188	National Natural Science Foundation of China [31630057, 31871954]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grants 31630057 and 31871954). The authors declare no conflicts of interest.	Adamson KJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1510-8; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; Arakane Y., 2016, EXTRACELLULAR COMPOS; Arakane Y, 2009, J BIOL CHEM, V284, P16584, DOI 10.1074/jbc.M901629200; Bai H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-388; Bauknecht P, 2015, CELL REP, V12, P684, DOI 10.1016/j.celrep.2015.06.052; Conzelmann M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-906; Dai FY, 2010, J BIOL CHEM, V285, P19553, DOI 10.1074/jbc.M109.096743; Derst C, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0621-4; Du MF, 2017, MOL CELL PROTEOMICS, V16, P2138, DOI [10.1074/mcp.ra117.000065, 10.1074/mcp.RA117.000065]; Futahashi R, 2005, DEV GENES EVOL, V215, P519, DOI 10.1007/s00427-005-0014-y; Gade G, 2004, ANNU REV ENTOMOL, V49, P93, DOI 10.1146/annurev.ento.49.061802.123354; Gibert JM, 2007, PLOS GENET, V3, P266, DOI 10.1371/journal.pgen.0030030; Huang HJ, 2015, INSECT BIOCHEM MOLEC, V66, P77, DOI 10.1016/j.ibmb.2015.10.007; Kim D, 2018, INSECT BIOCHEM MOLEC, V101, P66, DOI 10.1016/j.ibmb.2018.07.005; Lapadula D, 2019, MOL CANCER RES, V17, P963, DOI 10.1158/1541-7786.MCR-18-0574; Liu J, 2016, GENETICS, V203, P403, DOI 10.1534/genetics.115.186684; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Q, 2017, EXPERT OPIN DRUG DIS, V12, P511, DOI 10.1080/17460441.2017.1303473; MASLER EP, 1993, ARCH INSECT BIOCHEM, V22, P87, DOI 10.1002/arch.940220109; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Qiao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042968; Robinson SD, 2017, GEN COMP ENDOCR, V244, P11, DOI 10.1016/j.ygcen.2015.07.012; Tanaka S, 2016, CURR OPIN INSECT SCI, V17, P10, DOI 10.1016/j.cois.2016.05.011; Tanaka Y, 2014, PEPTIDES, V53, P125, DOI 10.1016/j.peptides.2013.07.027; TAUSSIG R, 1984, P NATL ACAD SCI-BIOL, V81, P4988, DOI 10.1073/pnas.81.15.4988; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; Nguyen TV, 2016, SCI REP-UK, V6, DOI 10.1038/srep38658; Uchiyama H, 2018, GEN COMP ENDOCR, V258, P33, DOI 10.1016/j.ygcen.2017.07.017; Veenstra JA, 2016, PEERJ, V4, DOI 10.7717/peerj.2043; Veenstra JA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00454; Veenstra JA, 2012, INSECT BIOCHEM MOLEC, V42, P277, DOI 10.1016/j.ibmb.2011.12.009; Veenstra JA, 2011, GEN COMP ENDOCR, V171, P160, DOI 10.1016/j.ygcen.2011.01.005; Veenstra JA, 2010, GEN COMP ENDOCR, V167, P86, DOI 10.1016/j.ygcen.2010.02.010; Walter MF, 1996, ARCH INSECT BIOCHEM, V31, P219, DOI 10.1002/(SICI)1520-6327(1996)31:2&lt;219::AID-ARCH9&gt;3.0.CO;2-U; Wittkopp PJ, 2009, SEMIN CELL DEV BIOL, V20, P65, DOI 10.1016/j.semcdb.2008.10.002; Xu HJ, 2013, INSECT MOL BIOL, V22, P635, DOI 10.1111/imb.12051; Xu HJ, 2015, NATURE, V519, P464, DOI 10.1038/nature14286; Yamada K, 2010, SCIENCE, V329, P1647, DOI 10.1126/science.1192020; Yang HP, 2013, INSECT BIOCHEM MOLEC, V43, P1028, DOI 10.1016/j.ibmb.2013.08.011; Yu B, 2016, INSECT MOL BIOL, V25, P778, DOI 10.1111/imb.12262	41	5	5	3	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9731	9741		10.1096/fj.201802786RR	http://dx.doi.org/10.1096/fj.201802786RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31162939				2022-12-28	WOS:000482214200004
J	Yan, J; Zhao, WH; Gao, C; Liu, X; Zhao, XL; Wei, T; Gao, ZD				Yan, Jing; Zhao, Wenhui; Gao, Chao; Liu, Xia; Zhao, Xiuliang; Wei, Ting; Gao, Zhaodi			Leucine-rich repeat kinase 2 regulates mouse dendritic cell migration by ORAI2	FASEB JOURNAL			English	Article						SOCE; DC; Ca2+ signaling; sodium-calcium exchanger	NA+/CA2+ EXCHANGER ACTIVITY; STIM2; LRRK2; CRAC; INHIBITION; RELEASE; ENTRY	The leucine-rich repeat kinase 2 (LRRK2) is expressed in various immune cells and involved in regulating inflammatory processes. LRRK2 facilitates calcium extrusion exchanger and sodium-calcium exchanger activity and hence influences intracellular Ca2+ concentration in dendritic cells (DCs). DC maturation and migration are governed by the intracellular Ca2+ concentration, but the related mechanisms whereby LRRK2 regulates DC function and involved Ca2+ channels are still under investigation. In the previous study, we found that LRRK2(-/-) DCs exhibited higher store-operated Ca2+ entry (SOCE) activity than LRRK2(+/+) DCs. Herein, we ascertained the exact SOCE components by using genetic, pharmacological, and fluorescent approaches. Ca2+ imaging showed that LRRK2 kinase activity negatively modulated SOCE activity. Moreover, LRRK2 deficiency resulted in an enhanced migration capacity of DCs but had little effect on the maturation process. SOCE is widely known to regulate DC functions; we wanted to dissect the reason why LRRK2 specifically influenced DC migration and therefore silenced ORAI1, ORAI2, and ORAI3, respectively. Transwell assays showed that both ORAI1 and ORAI2 silencing markedly decreased the migration of DCs, but only ORAI1 deficiency influenced the expression of maturation markers CD11c, CD86, and major histocompatibility complex class II. Of note, LRRK2 deficiency increased ORAI2 expression but not that of ORAI1 and ORAI3. Thus, we suggest that LRRK2 modulates DC migration by interfering with ORAI2.-Yan, J., Zhao, W., Gao, C., Liu, X., Zhao, X., Wei, T., Gao, Z. Leucine-rich repeat kinase 2 regulates mouse dendritic cell migration by ORAI2.	[Yan, Jing; Gao, Chao; Liu, Xia; Zhao, Xiuliang; Wei, Ting; Gao, Zhaodi] Jining Med Univ, Dept Physiol, Hehua Rd 16, Jining 272067, Peoples R China; [Zhao, Wenhui] Huaian Nursing Coll, Dept Pathol, Huaian, Peoples R China; [Yan, Jing; Gao, Chao; Liu, Xia; Zhao, Xiuliang; Wei, Ting; Gao, Zhaodi] Xinxiang Med Univ, Dept Physiol, Xinxiang, Henan, Peoples R China	Jining Medical University; Xinxiang Medical University	Yan, J (corresponding author), Jining Med Univ, Dept Physiol, Hehua Rd 16, Jining 272067, Peoples R China.	jane102@live.cn		Yan, Jing/0000-0002-5202-3146; Yan, Jing/0000-0002-0307-1635	National Natural Science Fund of China [31801172]; Young Talent Project of Henan Province [31]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Young Talent Project of Henan Province	This work was supported by National Natural Science Fund of China (Grant 31801172) and the Young Talent Project (Grant 31) of Henan Province. The authors declare no conflicts of interests.	Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bisaillon JM, 2010, AM J PHYSIOL-CELL PH, V298, pC993, DOI 10.1152/ajpcell.00325.2009; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Clemens RA, 2017, BLOOD, V130, P1565, DOI 10.1182/blood-2016-11-751230; De Wit T, 2018, NEUROSCIENTIST, V24, P486, DOI 10.1177/1073858418756309; Decuypere JP, 2010, CELL CALCIUM, V48, P161, DOI 10.1016/j.ceca.2010.08.003; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; den Haan JMM, 2000, P NATL ACAD SCI USA, V97, P12950, DOI 10.1073/pnas.97.24.12950; Felix R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061595; Feske S, 2011, ANN NY ACAD SCI, V1238, P74, DOI 10.1111/j.1749-6632.2011.06240.x; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Hakimi M, 2011, J NEURAL TRANSM, V118, P795, DOI 10.1007/s00702-011-0653-2; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Koski GK, 1999, J IMMUNOL, V163, P82; Kuss M, 2014, J NEUROCHEM, V129, P980, DOI 10.1111/jnc.12668; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu ZH, 2012, CELL RES, V22, P1092, DOI 10.1038/cr.2012.42; Lopez E, 2012, J PHYSIOL BIOCHEM, V68, P619, DOI 10.1007/s13105-012-0163-1; Ma JA, 2010, EUR J IMMUNOL, V40, P3028, DOI 10.1002/eji.201040614; Matzner N, 2008, J IMMUNOL, V181, P6803, DOI 10.4049/jimmunol.181.10.6803; Moehle MS, 2012, J NEUROSCI, V32, P1602, DOI 10.1523/JNEUROSCI.5601-11.2012; Nunes-Hasler P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01600-6; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Putney JW, 2007, J CELL SCI, V120, P1959, DOI 10.1242/jcs.03462; Shi YK, 2010, EXP BIOL MED, V235, P317, DOI 10.1258/ebm.2009.009237; Shim AHR, 2015, J MOL BIOL, V427, P77, DOI 10.1016/j.jmb.2014.09.021; Shumilina E, 2011, AM J PHYSIOL-CELL PH, V300, pC1205, DOI 10.1152/ajpcell.00039.2011; Stathopulos PB, 2013, CURR TOP MEMBR, V71, P59, DOI 10.1016/B978-0-12-407870-3.00003-2; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Thevenet J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021519; Vaeth M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14714; Yamazaki S, 2009, J DERMATOL SCI, V54, P69, DOI 10.1016/j.jdermsci.2009.02.001; Yan J, 2018, BIOCHEM BIOPH RES CO, V503, P1747, DOI 10.1016/j.bbrc.2018.07.108; Yan J, 2016, CELL PHYSIOL BIOCHEM, V40, P982, DOI 10.1159/000453155; Yan J, 2015, CELL PHYSIOL BIOCHEM, V36, P2287, DOI 10.1159/000430192; Yan J, 2015, FASEB J, V29, P1701, DOI 10.1096/fj.14-264028	38	9	9	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9775	9784		10.1096/fj.201802550R	http://dx.doi.org/10.1096/fj.201802550R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31166814				2022-12-28	WOS:000482214200008
J	Birkl, D; O'Leary, MN; Quiros, M; Azcutia, V; Schaller, M; Reed, M; Nishio, H; Keeney, J; Neish, AS; Lukacs, NW; Parkos, CA; Nusrat, A				Birkl, Dorothee; O'Leary, Monique N.; Quiros, Miguel; Azcutia, Veronica; Schaller, Matthew; Reed, Michelle; Nishio, Hikaru; Keeney, Justin; Neish, Andrew S.; Lukacs, Nicholas W.; Parkos, Charles A.; Nusrat, Asma			Formyl peptide receptor 2 regulates monocyte recruitment to promote intestinal mucosal wound repair	FASEB JOURNAL			English	Article						epithelium; GPCRs; FPR2; inflammation; inflammatory bowel disease	INFLAMMATORY PROTEIN 3-ALPHA; DENDRITIC CELLS; CROSS-DESENSITIZATION; INTERNATIONAL UNION; CHEMOKINE RECEPTORS; EPITHELIAL-CELLS; ACTIVATION; RESOLUTION; RESPONSES; MACROPHAGES	Mucosal wound repair is coordinated by dynamic crosstalk between endogenous and exogenous mediators and specific receptors on epithelial cells and infiltrating immune cells. One class of such receptor-ligand pairs involves formyl peptide receptors (FPRs) that have been shown to influence inflammatory response and repair. Here we explored the role of murine Fpr2/3, an ortholog of human FPR2/receptor for lipoxin A4 (ALX), in orchestrating intestinal mucosal repair. Compared with wild-type (WT) mice, Fpr2/3(-/-) mice exhibited delayed recovery from acute experimental colitis and perturbed repair after biopsy-induced colonic mucosal injury. Decreased numbers of infiltrating monocytes were observed in healing wounds from Fpr2/3(-/-) mice compared with WT animals. Bone marrow transplant experiments revealed that Fpr2/3(-/-) monocytes showed a competitive disadvantage when infiltrating colonic wounds. Moreover, Fpr2/3(-/-) monocytes were defective in chemotactic responses to the chemokine CC chemokine ligand (CCL)20, which is up-regulated during early phases of inflammation. Analysis of Fpr2/3(-/-) monocytes revealed altered expression of the CCL20 receptor CC chemokine receptor (CCR)6, suggesting that Fpr2/3 regulates CCL20-CCR6-mediated monocyte chemotaxis to sites of mucosal injury in the gut. These findings demonstrate an important contribution of Fpr2/3 in facilitating monocyte recruitment to sites of mucosal injury to influence wound repair.	[Birkl, Dorothee; O'Leary, Monique N.; Quiros, Miguel; Azcutia, Veronica; Schaller, Matthew; Reed, Michelle; Keeney, Justin; Lukacs, Nicholas W.; Parkos, Charles A.; Nusrat, Asma] Univ Michigan, Dept Pathol, 109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA; [Nishio, Hikaru; Neish, Andrew S.] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA	University of Michigan System; University of Michigan; Emory University	Nusrat, A (corresponding author), Univ Michigan, Dept Pathol, 109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	anusrat@umich.edu	Schaller, Matthew/AAL-7640-2020; Azcutia, Veronica/AAW-2443-2020	Azcutia, Veronica/0000-0003-2160-5175; Quiros, Miguel/0000-0002-0089-3502; Keeney, Justin/0000-0003-1748-0971	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK055679, DK089763, DK059888, DK072564, DK079392, DK061379]; German Research Foundation (DFG) Research Fellowship [SI 2282/1-1]; Crohn's and Colitis Foundation Career Development Award [544599]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061379] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); German Research Foundation (DFG) Research Fellowship(German Research Foundation (DFG)); Crohn's and Colitis Foundation Career Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Prof. Mauro Perretti (Queen Mary University of London London, United Kingdom) for providing the Fpr2/3<SUP>-/-</SUP> mice, and Madeline R. Barron and Darius Feier (University of Michigan) for experimental help during their experimental rotation in the researchers' laboratory. This work was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants DK055679, DK089763, and DK059888 (to A.N.) and DK072564, DK079392, and DK061379 (to C.A.P.); German Research Foundation (DFG) Research Fellowship SI 2282/1-1 (to D.B.); and Crohn's and Colitis Foundation Career Development Award 544599 (to M.Q.). The authors declare no conflicts of interest.	Alam A, 2014, MUCOSAL IMMUNOL, V7, P645, DOI 10.1038/mi.2013.84; Ali H, 1999, J BIOL CHEM, V274, P6027, DOI 10.1074/jbc.274.10.6027; Baba M, 1997, J BIOL CHEM, V272, P14893, DOI 10.1074/jbc.272.23.14893; Babbin BA, 2008, J IMMUNOL, V181, P5035, DOI 10.4049/jimmunol.181.7.5035; Babbin BA, 2007, J IMMUNOL, V179, P8112, DOI 10.4049/jimmunol.179.12.8112; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Bednar F, 2014, J IMMUNOL, V192, P5305, DOI 10.4049/jimmunol.1302983; Birkl D, 2019, MUCOSAL IMMUNOL, V12, P909, DOI 10.1038/s41385-019-0150-8; Blackwood RA, 1996, J LEUKOCYTE BIOL, V60, P88, DOI 10.1002/jlb.60.1.88; Bradford EM, 2017, J IMMUNOL, V199, P1886, DOI 10.4049/jimmunol.1601066; Brown AJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01248; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Chen KD, 2013, J CLIN INVEST, V123, P1694, DOI 10.1172/JCI65569; Chen KQ, 2017, J AUTOIMMUN, V85, P64, DOI 10.1016/j.jaut.2017.06.012; Chen KQ, 2013, J BIOL CHEM, V288, P16262, DOI 10.1074/jbc.M113.450635; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Dieu-Nosjean MC, 2000, J EXP MED, V192, P705, DOI 10.1084/jem.192.5.705; Dominguez PM, 2010, IMMUNOL REV, V234, P90, DOI 10.1111/j.0105-2896.2009.00876.x; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; Fujiie S, 2001, INT IMMUNOL, V13, P1255, DOI 10.1093/intimm/13.10.1255; Fullerton JN, 2016, NAT REV DRUG DISCOV, V15, P551, DOI 10.1038/nrd.2016.39; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; Giebeler A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100522; Gobbetti T, 2014, P NATL ACAD SCI USA, V111, P18685, DOI 10.1073/pnas.1410938111; Gouwy M, 2014, IMMUNOBIOLOGY, V219, P218, DOI 10.1016/j.imbio.2013.10.004; Harant H, 2001, FEBS LETT, V509, P439, DOI 10.1016/S0014-5793(01)03138-6; He HQ, 2017, MOLECULES, V22, DOI 10.3390/molecules22030455; Hughes CE, 2018, FEBS J, V285, P2944, DOI 10.1111/febs.14466; Kagnoff MF, 2014, J CLIN INVEST, V124, P2841, DOI 10.1172/JCI75225; Kucharzik T, 2002, EUR J IMMUNOL, V32, P104, DOI 10.1002/1521-4141(200201)32:1<104::AID-IMMU104>3.0.CO;2-C; Kwon JH, 2002, GUT, V51, P818, DOI 10.1136/gut.51.6.818; Kwon YW, 2015, WOUND REPAIR REGEN, V23, P575, DOI 10.1111/wrr.12315; Laukoetter MG, 2007, J EXP MED, V204, P3067, DOI 10.1084/jem.20071416; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Le YY, 2001, CYTOKINE GROWTH F R, V12, P91, DOI 10.1016/S1359-6101(01)00003-X; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Leoni G, 2015, J CLIN INVEST, V125, P1215, DOI 10.1172/JCI76693; Leoni G, 2013, J CLIN INVEST, V123, P443, DOI 10.1172/JCI65831; Li BQ, 2001, BLOOD, V97, P2941, DOI 10.1182/blood.V97.10.2941; Liu MX, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084408, 10.1371/journal.pone.0102344, 10.1371/journal.pone.0108012]; Liu MY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00786; Luissint AC, 2016, GASTROENTEROLOGY, V151, P616, DOI 10.1053/j.gastro.2016.07.008; McArthur S, 2015, J IMMUNOL, V195, P1139, DOI 10.4049/jimmunol.1500733; Menzies-Gow A, 2002, J IMMUNOL, V169, P2712, DOI 10.4049/jimmunol.169.5.2712; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Murphy PM, 2000, PHARMACOL REV, V52, P145; Muto Y, 2015, J MOL EVOL, V80, P130, DOI 10.1007/s00239-015-9666-z; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Petri MH, 2015, CARDIOVASC RES, V105, P65, DOI 10.1093/cvr/cvu224; Power CA, 1997, J EXP MED, V186, P825, DOI 10.1084/jem.186.6.825; Provoost S, 2012, J ALLERGY CLIN IMMUN, V129, P483, DOI 10.1016/j.jaci.2011.07.051; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Quiros M, 2017, J CLIN INVEST, V127, P3516, DOI 10.1172/JCI90229; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shen WP, 2000, BLOOD, V96, P2887, DOI 10.1182/blood.V96.8.2887.h8002887_2887_2894; Southgate EL, 2008, J IMMUNOL, V181, P1429, DOI 10.4049/jimmunol.181.2.1429; Starner TD, 2003, AM J RESP CELL MOL, V29, P627, DOI 10.1165/rcmb.2002-0272OC; TOMHAVE ED, 1994, J IMMUNOL, V153, P3267; Trivedi PJ, 2018, J CROHNS COLITIS, V12, pS641, DOI 10.1093/ecco-jcc/jjx145; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	63	15	15	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13632	13643		10.1096/fj.201901163R	http://dx.doi.org/10.1096/fj.201901163R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31585047	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000507466100046
J	Kowaltowski, AJ; Menezes, SL; Assali, EA; Goncalves, IG; Cabral-Costa, JV; Abreu, P; Miller, N; Nolasco, P; Laurindo, FRM; Bruni-Cardoso, A; Shirihai, OS				Kowaltowski, Alicia J.; Menezes-Filho, Sergio L.; Assali, Essam A.; Goncalves, Isabela G.; Cabral-Costa, Joao Victor; Abreu, Phablo; Miller, Nathanael; Nolasco, Patricia; Laurindo, Francisco R. M.; Bruni-Cardoso, Alexandre; Shirihai, Orian S.			Mitochondrial morphology regulates organellar Ca2+ uptake and changes cellular Ca2+ homeostasis	FASEB JOURNAL			English	Article						mitochondria; calcium; ER stress; metabolism; bioenergetics	ENDOPLASMIC-RETICULUM; MITOFUSIN 2; REACTIVE OXYGEN; CALCIUM-ENTRY; ER-STRESS; DYNAMICS; PROTECTS; FUSION; FISSION; ACTIVATION/MAINTENANCE	Changes in mitochondrial size and shape have been implicated in several physiologic processes, but their role in mitochondrial Ca2+ uptake regulation and overall cellular Ca2+ homeostasis is largely unknown. Here we show that modulating mitochondrial dynamics toward increased fusion through expression of a dominant negative (DN) form of the fission protein [dynamin-related protein 1 (DRP1)1 markedly increased both mitochondrial Ca2+ retention capacity and Ca2+ uptake rates in permeabilized C2C12 cells. Similar results were seen using the pharmacological fusion-promoting M1 molecule. Conversely, promoting a fission phenotype through the knockdown of the fusion protein mitofusin (MFN)-2 strongly reduced the mitochondrial Ca2+ (u)ptake speed and capacity in these cells. These changes were not dependent on modifications in mitochondrial calcium uniporter expression, inner membrane potentials, or the mitochondrial permeability transition. Implications of mitochondrial morphology modulation on cellular calcium homeostasis were measured in intact cells; mitochondrial fission promoted lower basal cellular calcium levels and lower endoplasmic reticulum (ER) calcium stores, as indicated by depletion with thapsigargin. Indeed, mitochondrial fission was associated with ER stress. Additionally, the calcium-replenishing process of store-operated calcium entry was impaired in MFN2 knockdown cells, whereas DRP1-DN promoted fusion resulted in faster cytosolic Ca2+ increase rates. Overall, our results show a novel role for mitochondrial morphology in the regulation of mitochondrial Ca2+ uptake, which impacts cellular Ca2+ homeostasis.	[Kowaltowski, Alicia J.; Menezes-Filho, Sergio L.; Goncalves, Isabela G.; Cabral-Costa, Joao Victor; Abreu, Phablo; Bruni-Cardoso, Alexandre] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil; [Assali, Essam A.; Miller, Nathanael; Shirihai, Orian S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Assali, Essam A.; Miller, Nathanael; Shirihai, Orian S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Endocrinol, Los Angeles, CA 90095 USA; [Nolasco, Patricia; Laurindo, Francisco R. M.] Univ Sao Paulo, Fac Med, Inst Coracao InCor,Hosp Clin, Lab Biol Vasc,Biol Cardiovasc Translac LIM 64, Sao Paulo, Brazil	Universidade de Sao Paulo; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universidade de Sao Paulo	Kowaltowski, AJ; Shirihai, OS (corresponding author), Univ Sao Paulo, Inst Quim, Ave Prof Lineu Prestes 748, BR-05508900 Sao Paulo, SP, Brazil.	alicia@iq.usp.br; oshirihai@mednet.ucla.edu	Cabral-Costa, João Victor/F-6666-2012; Bruni-Cardoso, Alexandre/K-6443-2013; Kowaltowski, Alicia J/H-8698-2012; Nolasco, Patricia/ABC-1004-2020; Assali, Essam/AAA-7601-2021; Cabral-Costa, João Victor/GSI-6093-2022; Abreu, Phablo/M-5266-2016	Cabral-Costa, João Victor/0000-0001-5441-1807; Cabral-Costa, João Victor/0000-0001-5441-1807; Abreu, Phablo/0000-0002-4143-6949	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) CEPID Grants [2014-10492-0, 2013/07937-8]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de N'ivel Superior) [001]; Conselho Nacional de Pesquisa e Desenvolvimento (CNPq); U.S. National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK099618-02, RO1DK56690]; University of California, Los Angeles (UCLA) Department of Medicine Chair commitment; University of California, San Diego (UCSD)/UCLA Diabetes Research Center pilot grant; NIH/NIDDK [P30 DK063491]; Sao Paulo Research Foundation (FAPESP) [2014/24511-7]; CAPES; FAPESP [2017/14713-0, 2016/18633-8]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) CEPID Grants(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de N'ivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); U.S. National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of California, Los Angeles (UCLA) Department of Medicine Chair commitment; University of California, San Diego (UCSD)/UCLA Diabetes Research Center pilot grant; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors acknowledge Edson Alves Gomes and Camille Caldeira da Silva (both from Universidade de Sao Paulo) for their outstanding technical support. This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) CEPID Grants 2014-10492-0 and 2013/07937-8, CAPES (Coordenacao de Aperfeicoamento de Pessoal de N ' ivel Superior Finance Code 001), Conselho Nacional de Pesquisa e Desenvolvimento (CNPq), the U.S. National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grants R01DK099618-02 and RO1DK56690, University of California, Los Angeles (UCLA) Department of Medicine Chair commitment and University of California, San Diego (UCSD)/UCLA Diabetes Research Center pilot grant, and NIH/NIDDK P30 DK063491. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript P.N. is supported by Sao Paulo Research Foundation (FAPESP) Fellowship 2014/24511-7. S.L.M.-F. was a CAPES Ph.D. fellowship recipient. J.V.C.-C. is supported by FAPESP Grant 2017/14713-0. P.A. is supported by FAPESP Grant 2016/18633-8. The authors declare no conflicts of interest.	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Alsabeeh N, 2018, BBA-MOL CELL BIOL L, V1863, P143, DOI 10.1016/j.bbalip.2017.11.006; Amigo I, 2017, AGING CELL, V16, P73, DOI 10.1111/acel.12527; Anesti V, 2006, BBA-BIOENERGETICS, V1757, P692, DOI 10.1016/j.bbabio.2006.04.013; Arruda AP, 2017, ELIFE, V6, DOI [10.7554/elife.29968, 10.7554/eLife.29968]; Arruda AP, 2015, CELL METAB, V22, P381, DOI 10.1016/j.cmet.2015.06.010; Arruda AP, 2014, NAT MED, V20, P1427, DOI 10.1038/nm.3735; Baixauli F, 2011, EMBO J, V30, P1238, DOI 10.1038/emboj.2011.25; Bambrick LL, 2006, J BIOENERG BIOMEMBR, V38, P43, DOI 10.1007/s10863-006-9004-7; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Benador IY, 2019, CELL METAB, V29, P827, DOI 10.1016/j.cmet.2019.02.011; Biasutto L, 2016, BBA-MOL CELL RES, V1863, P2515, DOI 10.1016/j.bbamcr.2016.02.012; Bordt EA, 2017, DEV CELL, V40, P583, DOI 10.1016/j.devcel.2017.02.020; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Cerqueira FM, 2016, FEBS J, V283, P822, DOI 10.1111/febs.13632; Chakrabarti R, 2018, J CELL BIOL, V217, P251, DOI 10.1083/jcb.201709111; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Favaro G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10226-9; Figueira TR, 2013, ANTIOXID REDOX SIGN, V18, P2029, DOI 10.1089/ars.2012.4729; Filadi R, 2015, P NATL ACAD SCI USA, V112, pE2174, DOI 10.1073/pnas.1504880112; FISKUM G, 1980, P NATL ACAD SCI-BIOL, V77, P3430, DOI 10.1073/pnas.77.6.3430; FLATT PR, 1980, BIOCHEM J, V190, P361, DOI 10.1042/bj1900361; Fonteriz R, 2016, ADV EXP MED BIOL, V898, P405, DOI 10.1007/978-3-319-26974-0_17; Forni MF, 2016, STEM CELLS, V34, P743, DOI 10.1002/stem.2248; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Gunter TE, 2009, BBA-BIOENERGETICS, V1787, P1291, DOI 10.1016/j.bbabio.2008.12.011; Gutierrez-Martin Y, 2005, BBA-BIOMEMBRANES, V1711, P33, DOI 10.1016/j.bbamem.2005.02.017; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Jackson JG, 2015, J NEUROSCI, V35, P15199, DOI 10.1523/JNEUROSCI.2049-15.2015; Khraiwesh H, 2014, EXP GERONTOL, V56, P77, DOI 10.1016/j.exger.2014.03.023; Klecker T, 2014, TRENDS CELL BIOL, V24, P537, DOI 10.1016/j.tcb.2014.04.004; Kowaltowski AJ, 2002, J BIOL CHEM, V277, P42802, DOI 10.1074/jbc.M207765200; Kowaltowski AJ, 2019, REDOX BIOL, V21, DOI 10.1016/j.redox.2018.101065; Krebs J, 2015, BIOCHEM BIOPH RES CO, V460, P114, DOI 10.1016/j.bbrc.2015.02.004; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lewis TL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07416-2; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Malli R, 2017, ADV EXP MED BIOL, V993, P297, DOI 10.1007/978-3-319-57732-6_16; Menezes SL, 2019, BBA-BIOENERGETICS, V1860, P129, DOI 10.1016/j.bbabio.2018.11.017; Menezes SL, 2017, FREE RADICAL BIO MED, V110, P219, DOI 10.1016/j.freeradbiomed.2017.06.013; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Naon D, 2016, P NATL ACAD SCI USA, V113, P11249, DOI 10.1073/pnas.1606786113; Nicholls DG, 2009, BBA-BIOENERGETICS, V1787, P1416, DOI 10.1016/j.bbabio.2009.03.010; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Nissim TBK, 2017, EMBO J, V36, P797, DOI 10.15252/embj.201592481; OTTO DA, 1978, J BIOL CHEM, V253, P789; Palty R, 2012, CELL CALCIUM, V52, P9, DOI 10.1016/j.ceca.2012.02.010; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; Rambold AS, 2015, DEV CELL, V32, P678, DOI 10.1016/j.devcel.2015.01.029; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Sin J, 2016, AUTOPHAGY, V12, P369, DOI 10.1080/15548627.2015.1115172; Spat A, 2017, ADV EXP MED BIOL, V993, P257, DOI 10.1007/978-3-319-57732-6_14; Stiles L, 2012, BEST PRACT RES CL EN, V26, P725, DOI 10.1016/j.beem.2012.05.004; Stotland A, 2015, BBA-MOL CELL RES, V1853, P2802, DOI 10.1016/j.bbamcr.2014.12.041; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Tonelli FMP, 2012, ADV EXP MED BIOL, V740, P891, DOI 10.1007/978-94-007-2888-2_40; Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001; Valm AM, 2017, NATURE, V546, P162, DOI 10.1038/nature22369; Vercesi AE, 2018, FREE RADICAL BIO MED, V129, P1, DOI 10.1016/j.freeradbiomed.2018.08.034; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Wang DL, 2012, ANGEW CHEM INT EDIT, V51, P9302, DOI 10.1002/anie.201204589; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wikstrom JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033023; Wu HX, 2018, SCIENCE, V361, pCP15, DOI 10.1126/science.aan5835	75	39	39	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13176	13188		10.1096/fj.201901136R	http://dx.doi.org/10.1096/fj.201901136R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31480917	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000507466100012
J	Schadeli, D; Serricchio, M; Ben Hamidane, H; Loffreda, A; Hemphill, A; Beneke, T; Gluenz, E; Graumann, J; Butikofer, P				Schadeli, David; Serricchio, Mauro; Ben Hamidane, Hisham; Loffreda, Alessio; Hemphill, Andrew; Beneke, Tom; Gluenz, Eva; Graumann, Johannes; Butikofer, Peter			Cardiolipin depletion-induced changes in the Trypanosoma brucei proteome	FASEB JOURNAL			English	Article						mitochondria; phospholipid; SILAC; oxidative phosphorylation; protozoa	SUBSTRATE LEVEL PHOSPHORYLATION; MEMBRANE-PROTEIN; ATP SYNTHASE; CYTOCHROME-C; SACCHAROMYCES-CEREVISIAE; COMPLEX-III; METABOLISM; BACTERIAL; TURNOVER; GROWTH	The mitochondrial signature glycerophospholipid, cardiolipin (CL), binds to transporters of the inner mitochondrial membrane and plays a central role in formation and stability of respiratory supercomplexes. Functional and structural requirement of CL for mitochondrial membrane proteins has been studied in vitro using purified reconstituted proteins or in CL synthesis knockout cells that are viable under specific growth conditions. However, no information is available on mitochondrial function, protein stability, or expression levels in cells during CL depletion. In contrast to yeast and mammalian cells, CL synthesis is essential in Trypanosoma brucei. By stable isotope labeling with amino acids in cell culture and mass spectrometry, we analyzed protein levels in T. brucei procyclic forms at different time points during depletion of CL using tightly controllable conditional CL synthase knockout mutants and identified a set of novel CL-dependent proteins (CLDPs) with unknown functions. Depletion of individual CLDPs using knockout or knockdown technologies showed that although CL synthesis is essential, expression of a given CLDP is not. In addition, ablation of CL synthesis leads to respiratory supercomplex instability and altered mitochondrial ultrastructure and function. Our findings suggest that CL may bind to and affect many more proteins in eukaryotes than previously thought.	[Schadeli, David; Serricchio, Mauro; Loffreda, Alessio; Butikofer, Peter] Univ Bern, Vetsuisse Fac, Inst Biochem & Mol Med, Bern, Switzerland; [Schadeli, David; Loffreda, Alessio] Univ Bern, Vetsuisse Fac, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Hemphill, Andrew] Univ Bern, Vetsuisse Fac, Inst Parasitol, Bern, Switzerland; [Ben Hamidane, Hisham; Graumann, Johannes] Weill Cornell Med Coll Qatar, Doha, Qatar; [Beneke, Tom; Gluenz, Eva] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England; [Graumann, Johannes] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany	University of Bern; University of Bern; University of Bern; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Oxford; Max Planck Society	Butikofer, P (corresponding author), Inst Biochem & Mol Med, B uhlstr 28, CH-3012 Bern, Switzerland.	peter.buetikofer@ibmm.unibe.ch	Graumann, Johannes/C-5241-2008	Graumann, Johannes/0000-0002-3015-5850; Hemphill, Andrew/0000-0002-0622-2128; Beneke, Tom/0000-0001-9117-2649; Serricchio, Mauro/0000-0002-7094-9807	Swiss National Science Foundation [149353, 169355]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors thank Alena P. Zikova (University of South Bohemia, Ceske Budejovice, Czech Republic), Andre Schneider (University of Bern), and James D. Bangs (University of Buffalo, Buffalo, NY, USA) for antibodies, and Anant K. Menon (Weill Cornell Medical College New York, NY, USA) for advice. M.S. thanks K.D. for support. P.B. thanks A. Niederer and W. White for advice and stimulation. This work was supported by Swiss National Science Foundation Grants 149353 and 169355 (to P.B.). The authors declare no conflicts of interest.	Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Acestor N, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006908; Allemann N, 2000, MOL BIOCHEM PARASIT, V111, P87, DOI 10.1016/S0166-6851(00)00303-0; ARDAIL D, 1990, J BIOL CHEM, V265, P18797; BALL WB, 2018, FEBS LETT, V592, P1273, DOI DOI 10.1002/1873-3468.12887; Ban T, 2017, NAT CELL BIOL, V19, P856, DOI 10.1038/ncb3560; Bangs JD, 1996, J BIOL CHEM, V271, P18387, DOI 10.1074/jbc.271.31.18387; Beneke T, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170095; Besteiro S, 2005, TRENDS PARASITOL, V21, P185, DOI 10.1016/j.pt.2005.02.008; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Boyd KJ, 2018, BIOPHYS J, V114, P2116, DOI 10.1016/j.bpj.2018.04.001; Bruggisser J, 2017, J BIOL CHEM, V292, P3400, DOI 10.1074/jbc.M116.755983; Burkard GS, 2011, MOL BIOCHEM PARASIT, V175, P91, DOI 10.1016/j.molbiopara.2010.09.002; Charriere F, 2006, P NATL ACAD SCI USA, V103, P6847, DOI 10.1073/pnas.0602362103; Choi SY, 2007, CELL DEATH DIFFER, V14, P597, DOI 10.1038/sj.cdd.4402020; Cirovic O, 2014, METHODS MOL BIOL, V1188, P47, DOI 10.1007/978-1-4939-1142-4_4; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; Coustou V, 2003, J BIOL CHEM, V278, P49625, DOI 10.1074/jbc.M307872200; Dean S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140197; Desy S, 2012, MOL BIOCHEM PARASIT, V185, P161, DOI 10.1016/j.molbiopara.2012.07.005; Dobson L, 2015, NUCLEIC ACIDS RES, V43, pW408, DOI 10.1093/nar/gkv451; Dowhan W, 2004, BBA-BIOMEMBRANES, V1666, P19, DOI 10.1016/j.bbamem.2004.04.010; Duncan AL, 2016, P NATL ACAD SCI USA, V113, P8687, DOI 10.1073/pnas.1608396113; EBLE KS, 1990, J BIOL CHEM, V265, P19434; Farine L, 2013, BBA-MOL CELL BIOL L, V1831, P533, DOI 10.1016/j.bbalip.2012.09.008; Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794; FRY M, 1981, J BIOL CHEM, V256, P1874; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gohil VM, 2004, J BIOL CHEM, V279, P42612, DOI 10.1074/jbc.M402545200; Gomez B, 1999, BIOCHEMISTRY-US, V38, P9031, DOI 10.1021/bi990603r; Gupta K, 2017, NATURE, V541, P421, DOI 10.1038/nature20820; Haines TH, 2009, BBA-BIOMEMBRANES, V1788, P1997, DOI 10.1016/j.bbamem.2009.09.008; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Klingenberg M, 2009, BBA-BIOMEMBRANES, V1788, P2048, DOI 10.1016/j.bbamem.2009.06.007; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Laage S, 2015, BBA-BIOMEMBRANES, V1848, P260, DOI 10.1016/j.bbamem.2014.08.021; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamb JR, 2001, J BIOL CHEM, V276, P21512, DOI 10.1074/jbc.M100235200; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; LANDRISCINA C, 1976, LIPIDS, V11, P61, DOI 10.1007/BF02532585; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Lewis RNAH, 2009, BBA-BIOMEMBRANES, V1788, P2069, DOI 10.1016/j.bbamem.2009.03.014; Lykidis A, 2007, PROG LIPID RES, V46, P171, DOI 10.1016/j.plipres.2007.03.003; Maguire JJ, 2017, BBA-MOL CELL BIOL L, V1862, P8, DOI 10.1016/j.bbalip.2016.08.001; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; McCann AK, 2008, MOL BIOCHEM PARASIT, V159, P146, DOI 10.1016/j.molbiopara.2008.02.003; Mileykovskaya E, 2014, CHEM PHYS LIPIDS, V179, P42, DOI 10.1016/j.chemphyslip.2013.10.012; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Naguleswaran A, 2015, MBIO, V6, DOI 10.1128/mBio.00114-15; Nejad LD, 2018, MOL MICROBIOL, V109, P105, DOI 10.1111/mmi.13976; Niemann M, 2013, MOL CELL PROTEOMICS, V12, P515, DOI 10.1074/mcp.M112.023093; NOLAN DP, 1992, EUR J BIOCHEM, V209, P207, DOI 10.1111/j.1432-1033.1992.tb17278.x; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Ortiz A, 1999, BIOPHYS J, V77, P2003, DOI 10.1016/S0006-3495(99)77041-4; Peikert CD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15272; Pennington ER, 2018, J BIOL CHEM, V293, P15933, DOI 10.1074/jbc.RA118.004948; Peyta L, 2016, BBA-BIOENERGETICS, V1857, P443, DOI 10.1016/j.bbabio.2016.01.002; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Pineau B, 2013, PLANT CELL, V25, P4195, DOI 10.1105/tpc.113.118018; Planas-Iglesias J, 2015, BIOPHYS J, V109, P1282, DOI 10.1016/j.bpj.2015.07.034; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; Pusnik M, 2011, CURR BIOL, V21, P1738, DOI 10.1016/j.cub.2011.08.060; Raemy E, 2016, CELL DEATH DIFFER, V23, P1165, DOI 10.1038/cdd.2015.166; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; Ruepp S, 1997, J CELL BIOL, V137, P1369, DOI 10.1083/jcb.137.6.1369; Sakamoto T, 2012, J BIOL CHEM, V287, P4590, DOI 10.1074/jbc.M111.314823; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHLAME M, 1990, BIOCHEM J, V265, P79, DOI 10.1042/bj2650079; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Schlame M, 2017, BBA-MOL CELL BIOL L, V1862, P3, DOI 10.1016/j.bbalip.2016.08.010; Schmidt RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093875; Sedlak E, 1999, BIOCHEMISTRY-US, V38, P14966, DOI 10.1021/bi9914053; Serricchio M, 2013, MOL MICROBIOL, V87, P569, DOI 10.1111/mmi.12116; Serricchio M, 2012, P NATL ACAD SCI USA, V109, pE954, DOI 10.1073/pnas.1121528109; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Singha UK, 2008, MOL BIOCHEM PARASIT, V159, P30, DOI 10.1016/j.molbiopara.2008.01.003; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Tan BK, 2012, P NATL ACAD SCI USA, V109, P16504, DOI 10.1073/pnas.1212797109; Tian HF, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-32; Tielens AGM, 1998, PARASITOL TODAY, V14, P265, DOI 10.1016/S0169-4758(98)01263-0; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xu Y, 2016, NAT CHEM BIOL, V12, P641, DOI [10.1038/NCHEMBIO.2113, 10.1038/nchembio.2113]; Xu Y, 2014, CHEM PHYS LIPIDS, V179, P17, DOI 10.1016/j.chemphyslip.2013.10.005; Zhang M, 2003, J BIOL CHEM, V278, P35204, DOI 10.1074/jbc.M306729200; Zikova A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000436	90	7	7	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13161	13175		10.1096/fj.201901184RR	http://dx.doi.org/10.1096/fj.201901184RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31536395	Bronze			2022-12-28	WOS:000507466100011
J	Shan, SZ; Fang, B; Zhang, YF; Wang, CD; Zhou, J; Niu, CG; Gao, Y; Zhao, DY; He, JH; Wang, J; Zhang, XL; Li, QF				Shan, Shengzhou; Fang, Bin; Zhang, Yifan; Wang, Chuandong; Zhou, Jia; Niu, Chenguang; Gao, Ya; Zhao, Danyang; He, Jiahao; Wang, Jing; Zhang, Xiaoling; Li, Qingfeng			Mechanical stretch promotes tumoricidal M1 polarization via the FAK/NF-kappa B signaling pathway	FASEB JOURNAL			English	Article						mechanical force; macrophage polarization; cancer; immunotherapy; focal adhesion kinase	FOCAL ADHESION KINASE; NITRIC-OXIDE SYNTHASE; MACROPHAGE POLARIZATION; SHEAR-STRESS; ACTIVATION; INFLAMMATION; STRAIN; CELLS; MECHANOTRANSDUCTION; EXPRESSION	Macrophages (M phi s) can be used as a part of cell-based cancer immunotherapy. However, they may be hampered by a failure to effectively and stably regulate their polarization state to enhance their tumoricidal effects. In this work, mechanical stretch (MS), as a biology-free modulatory method, was shown to enhance M1 polarization and tumoricidal effects. By using an in vitro Flexcell Tension system, we found that murine M phi RAW264.7 cells showed higher M1 polarization related mRNA expression and cytokine release after MS. Further molecular analyses found that focal adhesion kinase and NF-kappa B activation occurred in the MS-induced M1 polarization. Coculture of MS-preconditioned M phi with B16F10 skin melanoma cells in vitro showed that the proliferation of B16F10 cells decreased, whereas caspase-3 induced apoptosis increased. Importantly, the injection of MS-preconditioned M phi into murine skin melanomas in vivo impeded tumor growth; lesions were characterized by increased amounts of M1 M phi, decreased tumor cell proliferation, and increased tumor cell apoptosis in the tumor microenvironment. Together, our results suggest that MS could be used as a simple preconditioning approach to prepare tumoricidal M1 M phi for cancer immunotherapy.	[Shan, Shengzhou; Fang, Bin; Zhang, Yifan; Zhou, Jia; Gao, Ya; Zhao, Danyang; He, Jiahao; Li, Qingfeng] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Plast & Reconstruct Surg, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China; [Wang, Chuandong; Zhang, Xiaoling] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Orthoped Surg, 1665 Kongjiang Rd, Shanghai 200062, Peoples R China; [Niu, Chenguang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Endodont, Shanghai, Peoples R China; [Wang, Jing] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Dept Otorhinolaryngol Head & Neck Surg, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, QF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Plast & Reconstruct Surg, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.; Zhang, XL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Orthoped Surg, 1665 Kongjiang Rd, Shanghai 200062, Peoples R China.	xlzhang@shsmu.edu.cn; dr.liqingfeng@yahoo.com	Zhang, Yifan/AAL-3403-2021	Zhang, Yifan/0000-0002-0283-0468; Gao, Ya/0000-0001-8104-3069	National Natural Science Foundation of China [81601698, 81601688, 81620108019, 81830078]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China (81601698, 81601688, 81620108019, and 81830078). The authors declare no conflicts of interest.	BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Ballotta V, 2014, BIOMATERIALS, V35, P4919, DOI 10.1016/j.biomaterials.2014.03.002; Banes AJ, 1995, BIOCHEM CELL BIOL, V73, P349, DOI 10.1139/o95-043; Boniakowski AE, 2017, J IMMUNOL, V199, P17, DOI 10.4049/jimmunol.1700223; Brown JM, 2017, CLIN CANCER RES, V23, P3241, DOI 10.1158/1078-0432.CCR-16-3122; Chen DG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03225-9; Chu SY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09402-8; Cuhlmann S, 2011, CIRC RES, V108, P950, DOI 10.1161/CIRCRESAHA.110.233841; Dai Z, 2014, J PATHOL, V234, P316, DOI 10.1002/path.4395; Fereol S, 2006, CELL MOTIL CYTOSKEL, V63, P321, DOI 10.1002/cm.20130; Genard G, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0757-9; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gudipaty SA, 2017, NATURE, V543, P118, DOI 10.1038/nature21407; Guerra AD, 2017, THERANOSTICS, V7, P3732, DOI 10.7150/thno.20251; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; He L, 2018, NATURE, V555, P103, DOI 10.1038/nature25744; Huang Y, 2012, FASEB J, V26, P3351, DOI 10.1096/fj.11-199240; Ishida T, 1996, CIRC RES, V79, P310, DOI 10.1161/01.RES.79.2.310; Iwanowycz S, 2016, J BIOL CHEM, V291, P11491, DOI 10.1074/jbc.M115.702092; Knapik DM, 2014, ANTIOXID REDOX SIGN, V20, P970, DOI 10.1089/ars.2013.5467; Lee E, 2014, CELL TRANSPLANT, V23, P285, DOI 10.3727/096368912X663541; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liao M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/683739; Liu LN, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan2966; Long KB, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26860; Maa MC, 2011, BBA-MOL CELL RES, V1813, P136, DOI 10.1016/j.bbamcr.2010.09.004; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mayer IA, 2016, ANNU REV MED, V67, P11, DOI 10.1146/annurev-med-062913-051343; Mennens SFB, 2017, RESULTS PROBL CELL D, V62, P209, DOI 10.1007/978-3-319-54090-0_9; Mills CD, 2016, CANCER RES, V76, P513, DOI 10.1158/0008-5472.CAN-15-1737; Mills CD, 2014, J INNATE IMMUN, V6, P716, DOI 10.1159/000364945; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moon DG, 2008, TISSUE ENG PT A, V14, P473, DOI 10.1089/tea.2007.0104; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nguyen QD, 2009, P NATL ACAD SCI USA, V106, P16375, DOI 10.1073/pnas.0901310106; O'Sullivan T, 2012, J EXP MED, V209, P1869, DOI 10.1084/jem.20112738; Oakes PW, 2014, CURR OPIN CELL BIOL, V30, P68, DOI 10.1016/j.ceb.2014.06.003; Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093; Perske C, 2010, AM J PATHOL, V177, P2046, DOI 10.2353/ajpath.2010.091111; Petzold T, 2009, AM J PHYSIOL-CELL PH, V297, pC814, DOI 10.1152/ajpcell.00226.2009; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Pitsillides AA, 1995, FASEB J, V9, P1614, DOI 10.1096/fasebj.9.15.8529841; Pongkitwitoon S, 2016, J BIOMECH, V49, P793, DOI 10.1016/j.jbiomech.2016.01.027; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Pugin J, 1998, AM J PHYSIOL-LUNG C, V275, pL1040, DOI 10.1152/ajplung.1998.275.6.L1040; Quinlan AMT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023272; Ransom RC, 2018, NATURE, V563, P514, DOI 10.1038/s41586-018-0650-9; Rivilis I, 2002, AM J PHYSIOL-HEART C, V283, pH1430, DOI 10.1152/ajpheart.00082.2002; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Sager HB, 2016, CIRC RES, V119, P853, DOI 10.1161/CIRCRESAHA.116.309001; Shikata Y, 2005, EXP CELL RES, V304, P40, DOI 10.1016/j.yexcr.2004.11.001; Shiratsuchi H, 2004, AM J PHYSIOL-CELL PH, V286, pC1358, DOI 10.1152/ajpcell.00553.2003; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Simanovich E, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01931; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tanaka Y, 2018, J CONTROL RELEASE, V270, P177, DOI 10.1016/j.jconrel.2017.12.006; Tomakidi P, 2014, CELL TISSUE RES, V357, P515, DOI 10.1007/s00441-014-1945-2; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang J, 2015, CELL MOL LIFE SCI, V72, P2091, DOI 10.1007/s00018-015-1853-y; Wang PP, 2019, THERANOSTICS, V9, P1714, DOI 10.7150/thno.30716; Wang Y, 2017, BIOMATERIALS, V112, P153, DOI 10.1016/j.biomaterials.2016.09.034; Watkins SK, 2007, J IMMUNOL, V178, P1357, DOI 10.4049/jimmunol.178.3.1357; Wehner S, 2010, AM J PHYSIOL-GASTR L, V299, pG1187, DOI 10.1152/ajpgi.00452.2009; Wong VW, 2012, NAT MED, V18, P148, DOI 10.1038/nm.2574; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Xu G, 2016, INT IMMUNOPHARMACOL, V38, P175, DOI 10.1016/j.intimp.2016.05.027; Xu XL, 2014, INFLAMMATION, V37, P956, DOI 10.1007/s10753-014-9816-2; Yang JH, 2000, AM J PATHOL, V156, P1797, DOI 10.1016/S0002-9440(10)65051-1; Yao Z, 2006, CANCER IMMUNOL IMMUN, V55, P56, DOI 10.1007/s00262-005-0024-7; Young SRL, 2010, BONE, V47, P74, DOI 10.1016/j.bone.2010.03.014; Zaman G, 1999, J BONE MINER RES, V14, P1123, DOI 10.1359/jbmr.1999.14.7.1123; Zhang M, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1387347; Zhang YM, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.145; Zhu ZL, 2015, BIOCHEM BIOPH RES CO, V468, P601, DOI 10.1016/j.bbrc.2015.10.157	79	13	13	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13254	13266		10.1096/fj.201900799RR	http://dx.doi.org/10.1096/fj.201900799RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31539281	Bronze			2022-12-28	WOS:000507466100018
J	Fujita, N; Fujimoto, H; Hamamatsu, K; Murakami, T; Kimura, H; Toyoda, K; Saji, H; Inagaki, N				Fujita, Naotaka; Fujimoto, Hiroyuki; Hamamatsu, Keita; Murakami, Takaaki; Kimura, Hiroyuki; Toyoda, Kentaro; Saji, Hideo; Inagaki, Nobuya			Noninvasive longitudinal quantification of beta-cell mass with [In-111]-labeled exendin-4	FASEB JOURNAL			English	Article						in vivo radioisotope; GLP-1 receptor; SPECT	EXENDIN(9-39) DERIVATIVES; PEPTIDE-1 RECEPTOR; PANCREAS; MICE; PET	Currently, quantifying beta-cell mass (BCM) requires harvesting the pancreas. In this study, we investigated a potential noninvasive method to quantify BCM changes longitudinally using [Lys(12)(In-111-BnDTPA-Ahx)] exendin-4 ([In-111]-Ex4) and single-photon emission computed tomography (SPECT). We used autoradiography and transgenic mice expressing green fluorescent protein under the control of mouse insulin 1 gene promotor to evaluate the specificity of [In-111]-Ex4 toward beta cells. Using nonobese diabetic (NOD) mice, we injected [In-111]-Ex4 (3.0 MBq) intravenously and performed SPECT 30 min later, repeating this at a 2-wk interval. After the second scan, we harvested the pancreas and calculated BCM from immunohistochemically stained pancreatic sections. Specific accumulation of [In-111]-Ex4 in beta cells was confirmed by autoradiography, with a significant correlation (r = 0.94) between the fluorescent and radioactive signal intensities. The radioactive signal from the pancreas in the second SPECT scan significantly correlated (r = 0.89) with BCM calculated from the immunostained pancreatic sections. We developed a regression formula to estimate BCM from the radioactive signals from the pancreas in SPECT scans. BCM can be quantified longitudinally and noninvasively by SPECT imaging with [In-111]-Ex4. This technique successfully demonstrated longitudinal changes in BCM in NOD mice before and after onset of hyperglycemia.	[Fujita, Naotaka; Fujimoto, Hiroyuki; Hamamatsu, Keita; Murakami, Takaaki; Toyoda, Kentaro; Inagaki, Nobuya] Kyoto Univ, Dept Diabet Endocrinol & Nutr, Grad Sch Med, Kyoto, Japan; [Fujimoto, Hiroyuki] Kyoto Univ, Radioisotope Res Ctr, Agcy Hlth Safety & Environm, Kyoto, Japan; [Saji, Hideo] Kyoto Univ, Dept Pathofunct Bioanal, Grad Sch Pharmaceut Sci, Kyoto, Japan; [Kimura, Hiroyuki] Kyoto Pharmaceut Univ, Dept Analyt & Bioinorgan Chem, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto Pharmaceutical University	Inagaki, N (corresponding author), Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Sakyo Ku, Shogoin kawahara Cho 54, Kyoto 6068507, Japan.	inagaki@kuhp.kyoto-u.ac.jp			Translational Research Network Program from the Japan Agency for Medical Research and Development (AMED); Practical Research for Innovative Cancer Control from the Japan Agency for Medical Research and Development (AMED); Center of Innovation Program from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science (JSPS) [JP18K08475]	Translational Research Network Program from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Practical Research for Innovative Cancer Control from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Center of Innovation Program from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors thank Asami Mori (Kyoto University) for technical support. This study was funded by the Translational Research Network Program and the Practical Research for Innovative Cancer Control from the Japan Agency for Medical Research and Development (AMED), the Center of Innovation Program from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), the Japan Science and Technology Agency (JST), and the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI; JP18K08475); however, they played no role in the study design or conduct, data collection, analysis, or interpretation, or the preparation, review, or approval of the manuscript. H.S. received grants from Nihon Medi-Physics Co. Ltd., outside the submitted work. N.I. received grants from Sumitomo Dainippon Pharma Co. Ltd., and personal fees from MSD Co. Ltd., Mitsubishi Tanabe Pharma Corp., AstraZeneca Co. Ltd., Ono Pharmaceutical Co. Ltd., and Daiichi-Sankyo Co. Ltd., outside the submitted work. Moreover, H.K., H.S., and N.I. have a patent, WO2011071083A1, issued to Kyoto University and Arkray, Inc. All remaining authors declare no conflicts of interest.	Alavi A, 2018, DIABETOLOGIA, V61, P2512, DOI 10.1007/s00125-018-4676-1; BOLENDER RP, 1974, J CELL BIOL, V61, P269, DOI 10.1083/jcb.61.2.269; Brom M, 2014, DIABETOLOGIA, V57, P950, DOI 10.1007/s00125-014-3166-3; Brom M, 2010, EUR J NUCL MED MOL I, V37, P1345, DOI 10.1007/s00259-009-1363-y; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cline GW, 2018, DIABETOLOGIA, V61, P2671, DOI 10.1007/s00125-018-4718-8; Cline GW, 2018, DIABETOLOGIA, V61, P2598, DOI 10.1007/s00125-018-4624-0; Eriksson O, 2016, DIABETOLOGIA, V59, P1340, DOI 10.1007/s00125-016-3959-7; Eriksson O, 2010, NUCL MED BIOL, V37, P357, DOI 10.1016/j.nucmedbio.2009.12.004; Freeby MJ, 2016, MOL IMAGING BIOL, V18, P292, DOI 10.1007/s11307-015-0888-7; Gotthardt M, 2018, DIABETOLOGIA, V61, P2516, DOI 10.1007/s00125-018-4745-5; Hamamatsu K, 2018, NUCL MED BIOL, V64-65, P22, DOI 10.1016/j.nucmedbio.2018.06.002; HARADA M, 1984, DIABETOLOGIA, V27, P604, DOI 10.1007/BF00276978; IDF International Diabetes Federation, 2017, DIABETES ATLAS, V8th; Jodal A, 2017, EUR J NUCL MED MOL I, V44, P712, DOI 10.1007/s00259-016-3592-1; Kimura H, 2018, BIOORGAN MED CHEM, V26, P463, DOI 10.1016/j.bmc.2017.12.007; Kimura H, 2017, BIOORGAN MED CHEM, V25, P5772, DOI 10.1016/j.bmc.2017.09.005; Kimura H, 2017, BIOORGAN MED CHEM, V25, P1406, DOI 10.1016/j.bmc.2016.12.051; Mathijs I, 2015, MOL IMAGING BIOL, V17, P58, DOI 10.1007/s11307-014-0771-y; Meier JJ, 2009, DIABETES, V58, P1595, DOI 10.2337/db08-1611; Mukai E, 2009, BIOCHEM BIOPH RES CO, V389, P523, DOI 10.1016/j.bbrc.2009.09.014; Normandin MD, 2012, J NUCL MED, V53, P908, DOI 10.2967/jnumed.111.100545; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Sakuraba H, 2002, DIABETOLOGIA, V45, P85, DOI 10.1007/s125-002-8248-z; Selvaraju RK, 2013, J NUCL MED, V54, P1458, DOI 10.2967/jnumed.112.114066; Souza F, 2006, J CLIN INVEST, V116, P1506, DOI 10.1172/JCI27645; TURNER RC, 1995, DIABETES, V44, P1249; van der Kroon I, 2016, MOL PHARMACEUT, V13, P3478, DOI 10.1021/acs.molpharmaceut.6b00495; Vinet L, 2015, DIABETOLOGIA, V58, P304, DOI 10.1007/s00125-014-3442-2; Virostko J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057784; Wild D, 2006, J NUCL MED, V47, P2025; YASUNAMI R, 1988, EUR J IMMUNOL, V18, P481, DOI 10.1002/eji.1830180325; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735	34	9	9	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11836	11844		10.1096/fj.201900555RR	http://dx.doi.org/10.1096/fj.201900555RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31370679	Green Published			2022-12-28	WOS:000507461600020
J	Preston, KJ; Rom, I; Vrakas, C; Landesberg, G; Etwebi, Z; Muraoka, S; Autieri, M; Eguchi, S; Scalia, R				Preston, Kyle J.; Rom, Inna; Vrakas, Christine; Landesberg, Gavin; Etwebi, Zienab; Muraoka, Sanae; Autieri, Michael; Eguchi, Satoru; Scalia, Rosario			Postprandial activation of leukocyte-endothelium interaction by fatty acids in the visceral adipose tissue microcirculation	FASEB JOURNAL			English	Article						free fatty acids; inflammation; insulin resistance; adipocyte	NECROSIS-FACTOR-ALPHA; INDUCED INSULIN-RESISTANCE; P-SELECTIN EXPRESSION; ALIMENTARY LIPEMIA; METABOLIC SYNDROME; CONVERTING-ENZYME; HUMAN OBESITY; INFLAMMATION; MYELOPEROXIDASE; ADIPONECTIN	High-fat diet (HFD)-induced obesity is associated with accumulation of inflammatory cells predominantly in visceral adipose depots [visceral adipose tissue (VAT)] rather than in subcutaneous ones [subcutaneous adipose tissue (SAT)]. The cellular and molecular mechanisms responsible for this phenotypic difference remain poorly understood. Controversy also exists on the overall impact that adipose tissue inflammation has on metabolic health in diet-induced obesity. The endothelium of the microcirculation regulates both the transport of lipids and the trafficking of leukocytes into organ tissue. We hypothesized that the VAT and SAT microcirculations respond differently to postprandial processing of dietary fat. We also tested whether inhibition of endothelial postprandial responses to high-fat meals (HFMs) preserves metabolic health in chronic obesity. We demonstrate that administration of a single HFM or ad libitum access to a HFD for 24 h quickly induces a transient P-selectin- dependent inflammatory phenotype in the VAT but not the SAT microcirculation of lean wild-type mice. Studies in P-selectin-deficient mice confirmed a mechanistic role for P-selectin in the initiation of leukocyte trafficking, myeloperoxidase accumulation, and acute reduction in adiponectin mRNA expression by HFMs. Despite reduced VAT inflammation in response to HFMs, P-selectin-deficient mice still developed glucose intolerance and insulin resistance when chronically fed an HFD. Our data uncover a novel nutrient-sensing role of the vascular endothelium that instigates postprandial VAT inflammation. They also demonstrate that inhibition of this transient postprandial inflammatory response fails to correct metabolic dysfunction in diet-induced obesity.	[Preston, Kyle J.; Rom, Inna; Vrakas, Christine; Landesberg, Gavin; Etwebi, Zienab; Muraoka, Sanae] Temple Univ, Cardiovasc Res Ctr, Philadelphia, PA 19122 USA; [Autieri, Michael; Eguchi, Satoru; Scalia, Rosario] Temple Univ, Dept Physiol, Lewis Katz Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Scalia, R (corresponding author), Temple Univ, Dept Physiol, 3500 N Broad St,MERB Room 1049, Philadelphia, PA 19140 USA.	rscalia@temple.edu			U.S. National Institutes of Health (NIH) [DK59637]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [DK096521, DK111042]; NIH National Heart, Lung, and Blood Institute [HL133248]; American Diabetes Association (ADA) [1-12-BS-180]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096521, R01DK111042] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Diabetes Association (ADA)(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Serum TNF-alpha analysis and plasma insulin levels were performed by ELISA at Case Western University Mouse Metabolic Phenotyping Center (Cleveland, OH, USA). Free fatty acid (FFA) analysis was performed at the Vanderbilt University Mouse Metabolic Phenotyping Center (Nashville, TN, USA), which is supported by U.S. National Institutes of Health (NIH) Grant DK59637. This study was supported by NIH National Institute of Diabetes and Digestive and Kidney Diseases Grants DK096521 (to R.S.), DK111042 (to R.S. and S.E.), NIH National Heart, Lung, and Blood Institute Grant HL133248 (to S.E.), and American Diabetes Association (ADA) Grant 1-12-BS-180 (to R.S.). The authors declare no conflicts of interest.	Arnoldussen IAC, 2016, J NUTR BIOCHEM, V30, P177, DOI 10.1016/j.jnutbio.2015.12.011; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Aye MM, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000706; BLAAK EE, 1995, METABOLISM, V44, P183, DOI 10.1016/0026-0495(95)90262-7; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Broijersen A, 1998, ATHEROSCLEROSIS, V137, P107, DOI 10.1016/S0021-9150(97)00260-8; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Davies BSJ, 2010, CELL METAB, V12, P42, DOI 10.1016/j.cmet.2010.04.016; De Pergola G, 2008, NUTR METAB CARDIOVAS, V18, P227, DOI 10.1016/j.numecd.2006.09.010; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Fiorentino L, 2010, HEPATOLOGY, V51, P103, DOI 10.1002/hep.23250; Fu XY, 2003, J BIOL CHEM, V278, P28403, DOI 10.1074/jbc.M304739200; Gallistl S, 2000, BLOOD COAGUL FIBRIN, V11, P755, DOI 10.1097/00001721-200012000-00009; Garcia AG, 2015, DIABETES METAB J, V39, P59, DOI 10.4093/dmj.2015.39.1.59; Graf D, 2014, EUR J NUTR, V53, P211, DOI 10.1007/s00394-013-0518-6; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; He YD, 2016, ENDOCRINE, V51, P456, DOI 10.1007/s12020-015-0741-4; Hirata T, 2000, J EXP MED, V192, P1669, DOI 10.1084/jem.192.11.1669; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Ichimura H, 2003, J CLIN INVEST, V111, P691, DOI 10.1172/JCI200317271; JOHNSON RC, 1995, BLOOD, V86, P1106; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; Junyent M, 2010, NUTR METAB CARDIOVAS, V20, P698, DOI 10.1016/j.numecd.2009.06.011; Kabon B, 2004, ANESTHESIOLOGY, V100, P274, DOI 10.1097/00000542-200402000-00015; Kalsch T, 2007, THROMB RES, V120, P703, DOI 10.1016/j.thromres.2006.12.022; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Kato H, 2006, ARTERIOSCL THROM VAS, V26, P224, DOI 10.1161/01.ATV.0000194076.84568.81; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Koutsari C, 2011, DIABETES, V60, P2032, DOI 10.2337/db11-0154; Kranendonk MEG, 2015, ATHEROSCLEROSIS, V239, P419, DOI 10.1016/j.atherosclerosis.2015.01.035; Kuo A, 2017, CIRC RES, V120, P1289, DOI 10.1161/CIRCRESAHA.116.310498; Kwon EY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-450; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Lau D, 2006, PHARMACOL THERAPEUT, V111, P16, DOI 10.1016/j.pharmthera.2005.06.023; Lee MJ, 2013, MOL ASPECTS MED, V34, P1, DOI 10.1016/j.mam.2012.10.001; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu ML, 2014, BEST PRACT RES CL EN, V28, P25, DOI 10.1016/j.beem.2013.06.003; LORANT DE, 1995, J CLIN INVEST, V96, P171, DOI 10.1172/JCI118018; LORANT DE, 1993, J CLIN INVEST, V92, P559, DOI 10.1172/JCI116623; Mansuy-Aubert V, 2013, CELL METAB, V17, P534, DOI 10.1016/j.cmet.2013.03.005; MULLANE KM, 1985, J PHARMACOL METHOD, V14, P157, DOI 10.1016/0160-5402(85)90029-4; Nappo F, 2002, J AM COLL CARDIOL, V39, P1145, DOI 10.1016/S0735-1097(02)01741-2; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Noyan H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130658; Ohtsu H, 2006, ARTERIOSCL THROM VAS, V26, pE133, DOI 10.1161/01.ATV.0000236203.90331.d0; Oike Hideaki, 2014, Curr Nutr Rep, V3, P204; Olza J, 2012, DIABETES CARE, V35, P2373, DOI 10.2337/dc12-0614; Ozeke O, 2011, MED HYPOTHESES, V76, P61, DOI 10.1016/j.mehy.2010.08.030; Pasarica M, 2010, J CLIN ENDOCR METAB, V95, P4052, DOI 10.1210/jc.2009-2377; Pasarica M, 2009, J CLIN ENDOCR METAB, V94, P5155, DOI 10.1210/jc.2009-0947; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Patel MS, 2017, TRANSL RES, V183, P1, DOI [10.1016/j.trs1.2016.11.007, 10.1016/j.trsl.2016.11.007]; Perez-Martinez P, 2014, EUR J CLIN INVEST, V44, P1053, DOI 10.1111/eci.12339; Pruefer D, 1999, GEN PHARMACOL, V33, P487, DOI 10.1016/S0306-3623(99)00045-2; Rao RM, 2007, CIRC RES, V101, P234, DOI 10.1161/CIRCRESAHA.107.151860b; Russo HM, 2010, CIRC RES, V107, P388, DOI 10.1161/CIRCRESAHA.110.218651; SAKO D, 1995, CELL, V83, P323, DOI 10.1016/0092-8674(95)90173-6; Sato C, 2011, DIABETES, V60, P189, DOI 10.2337/db09-1894; Scalia R, 1997, P NATL ACAD SCI USA, V94, P9967, DOI 10.1073/pnas.94.18.9967; Scalia R, 2013, REV ENDOCR METAB DIS, V14, P69, DOI 10.1007/s11154-013-9236-x; Scalia R, 2011, CIRC RES, V108, P1102, DOI 10.1161/CIRCRESAHA.110.229393; Schneider DJ, 2009, DIABETES CARE, V32, P944, DOI 10.2337/dc08-1308; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Sell H, 2012, NAT REV ENDOCRINOL, V8, P709, DOI 10.1038/nrendo.2012.114; Serino M, 2007, DIABETES, V56, P2541, DOI 10.2337/db07-0360; Shore SA, 2006, J ALLERGY CLIN IMMUN, V118, P389, DOI 10.1016/j.jaci.2006.04.021; Stadtmann A, 2013, J EXP MED, V210, P2171, DOI 10.1084/jem.20130664; Stalker TJ, 2005, DIABETES, V54, P1132, DOI 10.2337/diabetes.54.4.1132; Strzepa A, 2017, CELL IMMUNOL, V317, P1, DOI 10.1016/j.cellimm.2017.05.002; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Takano M, 2002, AM J PHYSIOL-HEART C, V283, pH2054, DOI 10.1152/ajpheart.01001.2001; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; van Oostrom AJHHM, 2003, J LIPID RES, V44, P576, DOI 10.1194/jlr.M200419-JLR200; Wang LM, 2009, J LIPID RES, V50, P204, DOI 10.1194/jlr.M700505-JLR200; Wang QL, 2014, DIABETES, V63, P4172, DOI 10.2337/db14-0026; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu F, 2012, ENDOCRINOLOGY, V153, P1706, DOI 10.1210/en.2011-1667; Xu HY, 2002, DIABETES, V51, P1876, DOI 10.2337/diabetes.51.6.1876; Yamauchi T, 2008, INT J OBESITY, V32, pS13, DOI 10.1038/ijo.2008.233; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Zheng YF, 2002, J BIOL CHEM, V277, P42463, DOI 10.1074/jbc.M207459200	87	7	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11993	12007		10.1096/fj.201802637RR	http://dx.doi.org/10.1096/fj.201802637RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31393790	Green Published			2022-12-28	WOS:000507461600031
J	Zhang, P; Li, T; Liu, YQ; Zhang, H; Xue, SM; Li, G; Cheng, HYM; Cao, JM				Zhang, Peng; Li, Tao; Liu, Ya-Qin; Zhang, Hao; Xue, Si-Meng; Li, Guang; Cheng, Hai-Ying Mary; Cao, Ji-Min			Contribution of DNA methylation in chronic stress-induced cardiac remodeling and arrhythmias in mice	FASEB JOURNAL			English	Article						chronic restraint stress; cardiovascular diseases; reduced representation bisulfite sequencing	CHRONIC RESTRAINT STRESS; PARAVENTRICULAR NUCLEUS; DEPRESSIVE SYMPTOMS; HEART-FAILURE; ANXIETY; EXPRESSION; BEHAVIORS; DISEASE; METAANALYSIS; DYSFUNCTION	It is recognized that stress can induce cardiac dysfunction, but the underlying mechanisms are not well understood. The present study aimed to test the hypothesis that chronic negative stress leads to alterations in DNA methylation of certain cardiac genes, which in turn contribute to pathologic remodeling of the heart. We found that mice that were exposed to chronic restraint stress (CRS) for 4 wk exhibited cardiac remodeling toward heart failure, as characterized by ventricular chamber dilatation, wall thinning, and decreased contractility. CRS also induced cardiac arrhythmias, including intermittent sinus tachycardia and bradycardia, frequent premature ventricular contraction, and sporadic atrioventricular conduction block. Circulating levels of stress hormones were elevated, and the cardiac expression of tyrosine hydroxylase, a marker of sympathetic innervation, was increased in CRS mice. Using reduced representation bisulfite sequencing, we found that although CRS did not lead to global changes in DNA methylation in the murine heart, it nevertheless altered methylation at specific genes that are associated with the dilated cardiomyopathy (DCM) (e.g., desmin) and adrenergic signaling of cardiomyocytes (ASPC) (e.g., adrenergic receptor-al) pathways. We conclude that CRS induces cardiac remodeling and arrhythmias, potentially through altered methylation of myocardial genes associated with the DCM and ASPC pathways.	[Zhang, Peng; Li, Tao; Liu, Ya-Qin; Zhang, Hao; Xue, Si-Meng; Li, Guang; Cao, Ji-Min] Southwest Med Univ, Med Electrophysiol Key Lab Sichuan Prov, Minist Educ, Inst Cardiovasc Res,Key Lab Med Electrophysiol, Luzhou, Peoples R China; [Zhang, Peng; Li, Tao; Liu, Ya-Qin; Xue, Si-Meng; Cao, Ji-Min] Southwest Med Univ, Collaborat Innovat Ctr Prevent & Treatment Cardio, Luzhou, Peoples R China; [Cheng, Hai-Ying Mary] Univ Toronto Mississauga, Dept Biol, Mississauga, ON, Canada; [Cao, Ji-Min] Shanxi Med Univ, Dept Physiol, Key Lab Cellular Physiol, Minist Educ, Taiyuan, Peoples R China	Southwest Medical University; Southwest Medical University; University of Toronto; University Toronto Mississauga; Shanxi Medical University	Zhang, P (corresponding author), Southwest Med Univ, Minist Educ, Key Lab Med Electrophysiol, Inst Cardiovasc Res, Zhongshanlu San Duan 319, Luzhou 646000, Peoples R China.; Zhang, P (corresponding author), Southwest Med Univ, Med Electrophysiol Key Lab Sichuan Prov, Zhongshanlu San Duan 319, Luzhou 646000, Peoples R China.; Cao, JM (corresponding author), Shanxi Med Univ, Minist Educ, Key Lab Cellular Physiol, Taiyuan 030001, Shanxi, Peoples R China.; Cao, JM (corresponding author), Shanxi Med Univ, Dept Physiol, Taiyuan 030001, Shanxi, Peoples R China.	zhangpeng@swmu.edu.cn; caojimin@126.com		Zhang, Peng/0000-0001-9053-7327	Sichuan Science and Technology Program [2019YJ0472, 2019YJ0409]; Luzhou Science and Technology Program [2018LZXNYD-ZK44]; Collaborative Innovation Center for Prevention and Treatment of Cardiovascular Disease of Sichuan Province, Southwest Medical University [xtcx-2016-11]; fund for Shanxi "1331 Project" Key Subjects Construction [1331KSC]; National Natural Science Foundation of China (NSFC) [81670313]; Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Councils of Canada (NSERC)	Sichuan Science and Technology Program; Luzhou Science and Technology Program; Collaborative Innovation Center for Prevention and Treatment of Cardiovascular Disease of Sichuan Province, Southwest Medical University; fund for Shanxi "1331 Project" Key Subjects Construction; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Councils of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Sichuan Science and Technology Program (2019YJ0472 to P.Z. and 2019YJ0409 to T.L.), the Luzhou Science and Technology Program (2018LZXNYD-ZK44 to P.Z.), the Collaborative Innovation Center for Prevention and Treatment of Cardiovascular Disease of Sichuan Province, Southwest Medical University xtcx-2016-11 to P.Z.), a fund for Shanxi "1331 Project" Key Subjects Construction (1331KSC), and a National Natural Science Foundation of China (NSFC) grant (81670313 to J.-M.C.). H.-Y.M.C. was supported by operating grants from the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Councils of Canada (NSERC). The authors declare no conflicts of interest.	Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R87, 10.1186/gb-2012-13-10-r87]; BRUHN JG, 1970, AM J PUBLIC HEALTH N, V60, P1477, DOI 10.2105/AJPH.60.8.1477; BRUHN JG, 1969, PSYCHOSOM MED, V31, P8, DOI 10.1097/00006842-196901000-00002; Burgi K, 2011, AM J PHYSIOL-REG I, V300, pR264, DOI 10.1152/ajpregu.00687.2009; Cao JM, 2000, CIRC RES, V86, P816, DOI 10.1161/01.RES.86.7.816; Chatterjee N, 2017, BIOMATERIALS, V115, P167, DOI 10.1016/j.biomaterials.2016.11.005; Chiba S, 2012, PROG NEURO-PSYCHOPH, V39, P112, DOI 10.1016/j.pnpbp.2012.05.018; Christiansen SH, 2011, BEHAV BRAIN RES, V216, P585, DOI 10.1016/j.bbr.2010.08.044; Cotecchia S, 2015, CELL SIGNAL, V27, P1984, DOI 10.1016/j.cellsig.2015.06.009; Flak JN, 2014, EUR J NEUROSCI, V39, P1903, DOI 10.1111/ejn.12587; Frasure-Smith N, 2005, PSYCHOSOM MED, V67, pS19, DOI 10.1097/01.psy.0000162253.07959.db; Gardner RT, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.115.001359; Gervin K, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0277-3; Gottlieb SS, 2009, AM J CARDIOL, V103, P1285, DOI 10.1016/j.amjcard.2009.01.025; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Guichard JL, 2017, AM J PHYSIOL-HEART C, V313, pH32, DOI 10.1152/ajpheart.00027.2017; Haider S, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R90, 10.1186/gb-2012-13-10-r90]; Hein S, 2000, CARDIOVASC RES, V45, P273, DOI 10.1016/S0008-6363(99)00268-0; Januzzi JL, 2000, ARCH INTERN MED, V160, P1913, DOI 10.1001/archinte.160.13.1913; Khalid A, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0239-x; Kim SY, 2016, CURR OPIN CARDIOL, V31, P255, DOI 10.1097/HCO.0000000000000276; Koczor CA, 2015, TOXICOL SCI, V148, P183, DOI 10.1093/toxsci/kfv170; Kokoz YM, 2016, J MOL CELL CARDIOL, V100, P9, DOI 10.1016/j.yjmcc.2016.09.006; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Lapmanee S, 2013, BEHAV BRAIN RES, V250, P316, DOI 10.1016/j.bbr.2013.05.018; Li-Tempel T, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0180-y; Lin QXX, 2019, NUCLEIC ACIDS RES, V47, pD145, DOI 10.1093/nar/gky1005; Maloyan A, 2009, CIRC RES, V104, P1021, DOI 10.1161/CIRCRESAHA.108.193516; del Campo CMZM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041224; Mendonca MM, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00670; Moraska AR, 2013, CIRC-HEART FAIL, V6, P387, DOI 10.1161/CIRCHEARTFAILURE.112.000118; Movassagh M, 2011, CIRCULATION, V124, P2411, DOI 10.1161/CIRCULATIONAHA.111.040071; Movassagh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008564; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; Naert G, 2011, MOL CELL NEUROSCI, V46, P55, DOI 10.1016/j.mcn.2010.08.006; Nakatochi M, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0353-3; Nemeroff CB, 2012, NAT REV CARDIOL, V9, P526, DOI 10.1038/nrcardio.2012.91; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Norman M, 2005, CIRCULATION, V112, P636, DOI 10.1161/CIRCULATIONAHA.104.532234; Osler W, 1910, LANCET, V1, P973; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Perrino C, 2017, CARDIOVASC RES, V113, P725, DOI 10.1093/cvr/cvx070; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Powell R C, 1977, Psychiatr Q, V49, P133, DOI 10.1007/BF01071661; Powell R C, 1978, Psychiatr Q, V50, P144, DOI 10.1007/BF01064814; Pyner S, 2014, EXP PHYSIOL, V99, P332, DOI 10.1113/expphysiol.2013.072678; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Ruo B, 2003, JAMA-J AM MED ASSOC, V290, P215, DOI 10.1001/jama.290.2.215; Salter EW, 2018, J PHYSIOL-LONDON, V596, P4157, DOI 10.1113/JP275669; Sanchez-Gonzalez MA, 2013, AM J HYPERTENS, V26, P1389, DOI 10.1093/ajh/hpt131; Sato M, 2018, BIOCHEM PHARMACOL, V148, P27, DOI 10.1016/j.bcp.2017.11.016; Slavich GM, 2014, PSYCHOL BULL, V140, P774, DOI 10.1037/a0035302; Tsikitis Mary, 2018, Biophys Rev, V10, P1007, DOI 10.1007/s12551-018-0443-2; Vujic A, 2015, J MOL CELL CARDIOL, V82, P174, DOI 10.1016/j.yjmcc.2015.03.007; WEISS E, 1957, ARCH INTERN MED, V99, P628, DOI 10.1001/archinte.1957.00260040128013; Xiao JJ, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00074; Xie YF, 2005, J APPL PHYSIOL, V99, P2416, DOI 10.1152/japplphysiol.00267.2005; Zhang P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01046-2; Zhao X, 2013, NEUROSCIENCE, V246, P82, DOI 10.1016/j.neuroscience.2013.04.046; Zhu SH, 2014, NEUROREPORT, V25, P1151, DOI 10.1097/WNR.0000000000000243	61	6	7	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12240	12252		10.1096/fj.201900100R	http://dx.doi.org/10.1096/fj.201900100R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31431066	Green Published			2022-12-28	WOS:000507461600050
J	Zhou, D; Fu, HY; Liu, SJ; Zhang, L; Xiao, LX; Bastacky, SI; Liu, YH				Zhou, Dong; Fu, Haiyan; Liu, Shijia; Zhang, Lu; Xiao, Liangxiang; Bastacky, Sheldon I.; Liu, Youhua			Early activation of fibroblasts is required for kidney repair and regeneration after injury	FASEB JOURNAL			English	Article						acute kidney injury; sonic hedgehog; Wnt-beta-catenin; injury repair	ACUTE-RENAL-FAILURE; GROWTH-FACTOR RECEPTOR; SONIC HEDGEHOG; AKI; PATHOPHYSIOLOGY; FIBROSIS; RECOVERY; CKD; EPIDEMIOLOGY; MECHANISMS	Acute kidney injury (AKI) is a devastating condition with high morbidity and mortality. AKI is characterized by tubular injury, inflammation, and vascular impairment. However, the role of interstitial fibroblasts in the pathogenesis of AKI is largely unknown. Here, we show that fibroblasts were activated, as defined by vimentin expression, at 1 h after AKI triggered by ischemia-reperfusion injury (IRI). They rapidly entered the cell cycle with Ki-67-positive staining, which started at 1 h and peaked at 12 h after IRI, whereas tubular cell proliferation peaked at 3 d. The trigger for such an early activation of fibroblasts was identified as sonic hedgehog (Shh), which was rapidly induced in renal tubules and could target interstitial fibroblasts. Tubule-specific knockout of Shh in mice inhibited fibroblast activation and aggravated kidney injury and functional decline after IRI. Likewise, pharmacologic inhibition of Shh signaling with cyclopamine also hindered fibroblast activation and exacerbated kidney damage. These studies uncover that tubule-derived Shh triggers the early activation of fibroblasts, which is required for kidney repair and regeneration. Our findings for the first time illustrate a previously unrecognized importance of interstitial fibroblasts in conferring renal protection in AKI.	[Zhou, Dong; Bastacky, Sheldon I.; Liu, Youhua] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Fu, Haiyan; Xiao, Liangxiang; Liu, Youhua] Southern Med Univ, Nanfang Hosp, Natl Clin Res Ctr Kidney Dis, State Key Lab Organ Failure Res, Guangzhou, Peoples R China; [Liu, Shijia] Nanjing Univ Chinese Med, Dept Clin Pharmacol, Affiliated Hosp, Nanjing, Peoples R China; [Zhang, Lu] Nanjing Univ Chinese Med, Dept Nephrol, Affiliated Hosp, Nanjing, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Southern Medical University - China; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine	Zhou, D (corresponding author), Univ Pittsburgh, Dept Pathol, 200 Lothrop St, Pittsburgh, PA 15261 USA.; Liu, YH (corresponding author), Univ Pittsburgh, Dept Pathol, BST, S-405,200 Lothrop St, Pittsburgh, PA 15261 USA.	zhoudong@pitt.edu; yhliu@pitt.edu	liu, shijia/AAH-3838-2021	Liu, Youhua/0000-0002-4740-805X	U.S. National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK064005, DK106049]; NIH/NIDDK [1K01DK116816]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK116816, R01DK106049, R01DK064005] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors are grateful to the Center for Biologic Imaging at the University of Pittsburgh for the use of core facilities. This work was supported by the U.S. National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grants DK064005 and DK106049. D.Z. was supported by NIH/NIDDK Grant 1K01DK116816. The authors declare no conflicts of interest.	Bai CB, 2002, DEVELOPMENT, V129, P4753; Bonventre Joseph V, 2014, Trans Am Clin Climatol Assoc, V125, P293; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Chen JC, 2013, J AM SOC NEPHROL, V24, P2023, DOI 10.1681/ASN.2013010076; Chen JC, 2012, KIDNEY INT, V82, P45, DOI 10.1038/ki.2012.43; Chen JL, 2011, KIDNEY INT, V79, P288, DOI 10.1038/ki.2010.381; Chiba Takuto, 2015, Curr Pathobiol Rep, V3, P67; Cosentino CC, 2013, J AM SOC NEPHROL, V24, P943, DOI 10.1681/ASN.2012111055; Dai CS, 2002, J AM SOC NEPHROL, V13, P411, DOI 10.1681/ASN.V132411; Dhaun N, 2013, KIDNEY INT, V84, P637, DOI 10.1038/ki.2013.158; Fu HY, 2017, J AM SOC NEPHROL, V28, P785, DOI 10.1681/ASN.2016020165; Fujigaki Y, 2005, VIRCHOWS ARCH, V446, P164, DOI 10.1007/s00428-004-1155-5; Gao GF, 2013, AM J PHYSIOL-RENAL, V304, pF515, DOI 10.1152/ajprenal.00533.2012; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; Humphreys BD, 2016, J AM SOC NEPHROL, V27, P990, DOI 10.1681/ASN.2015030286; Kaddourah A, 2017, NEW ENGL J MED, V376, P11, DOI 10.1056/NEJMoa1611391; Kaissling B, 2008, HISTOCHEM CELL BIOL, V130, P247, DOI 10.1007/s00418-008-0452-5; Kinsey GR, 2014, J AM SOC NEPHROL, V25, P209, DOI 10.1681/ASN.2013101110; Kramann R, 2015, J CLIN INVEST, V125, P2935, DOI 10.1172/JCI74929; Kramann R, 2014, J AM SOC NEPHROL, V25, P1924, DOI 10.1681/ASN.2013101121; Kuzet SE, 2016, CELL TISSUE RES, V365, P607, DOI 10.1007/s00441-016-2467-x; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lech M, 2014, J AM SOC NEPHROL, V25, P292, DOI 10.1681/ASN.2013020152; Little MH, 2017, J AM SOC NEPHROL, V28, P34, DOI 10.1681/ASN.2016070748; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Ma ZW, 2014, BBA-MOL BASIS DIS, V1842, P1088, DOI 10.1016/j.bbadis.2014.04.002; Maisel AS, 2016, J AM COLL CARDIOL, V68, P1420, DOI 10.1016/j.jacc.2016.06.055; Rewa O, 2014, NAT REV NEPHROL, V10, P193, DOI 10.1038/nrneph.2013.282; Schiessl IM, 2018, J AM SOC NEPHROL, V29, P1383, DOI 10.1681/ASN.2017101069; Sharfuddin AA, 2011, NAT REV NEPHROL, V7, P189, DOI 10.1038/nrneph.2011.16; Singbartl K, 2012, KIDNEY INT, V81, P819, DOI 10.1038/ki.2011.339; Sun DF, 2002, AM J PATHOL, V161, P217, DOI 10.1016/S0002-9440(10)64173-9; Tan RJ, 2014, KIDNEY INT SUPPL, V4, P84, DOI 10.1038/kisup.2014.16; Xiao LX, 2019, BBA-MOL BASIS DIS, V1865, P1313, DOI 10.1016/j.bbadis.2019.01.027; Xiao LX, 2016, J AM SOC NEPHROL, V27, P1727, DOI 10.1681/ASN.2015040449; Xiao X, 2014, AM J PHYSIOL-RENAL, V306, pF1318, DOI 10.1152/ajprenal.00036.2014; Yang L, 2011, CONTRIB NEPHROL, V174, P149, DOI 10.1159/000329385; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Zhou D, 2018, J AM SOC NEPHROL, V29, P1257, DOI 10.1681/ASN.2017080903; Zhou D, 2017, J AM SOC NEPHROL, V28, P2322, DOI 10.1681/ASN.2016080902; Zhou D, 2016, SCI CHINA LIFE SCI, V59, P920, DOI 10.1007/s11427-016-0020-y; Zhou D, 2016, NAT REV NEPHROL, V12, P68, DOI 10.1038/nrneph.2015.215; Zhou D, 2014, J AM SOC NEPHROL, V25, P2187, DOI 10.1681/ASN.2013080893; Zhou D, 2013, KIDNEY INT, V84, P509, DOI 10.1038/ki.2013.102; Zhou D, 2012, KIDNEY INT, V82, P537, DOI 10.1038/ki.2012.173	45	14	14	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12576	12587		10.1096/fj.201900651RR	http://dx.doi.org/10.1096/fj.201900651RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31461626	Green Published			2022-12-28	WOS:000507461600076
J	De Oliveira, DMP; Everest-Dass, A; Hartley-Tassell, L; Day, CJ; Indraratna, A; Brouwer, S; Cleary, A; Kautto, L; Gorman, J; Packer, NH; Jennings, MP; Walker, MJ; Sanderson-Smith, ML				De Oliveira, David M. P.; Everest-Dass, Arun; Hartley-Tassell, Lauren; Day, Christopher J.; Indraratna, Anuk; Brouwer, Stephan; Cleary, Ailish; Kautto, Liisa; Gorman, Jody; Packer, Nicolle H.; Jennings, Michael P.; Walker, Mark J.; Sanderson-Smith, Martina L.			Human glycan expression patterns influence Group A streptococcal colonization of epithelial cells	FASEB JOURNAL			English	Article						glycosylation; M protein; pathogenesis; blood group antigens	ABO BLOOD-GROUPS; STRUCTURAL-ANALYSIS; TISSUE TROPISMS; BINDING; INFECTION; PYOGENES; PROTEIN; ENDOGLYCOSIDASE; INHIBITORS; PHENOTYPE	Colonization of the oropharynx is the initial step in Group A Streptococcus (GAS) pharyngeal infection. We have previously reported that the highly virulent M1T1 GAS clone attaches to oral epithelial cells via M1 protein interaction with blood group antigen carbohydrate structures. Here, we have identified that colonization of human oral epithelial cells by GAS serotypes M3 and M12 is mediated by human blood group antigens [ABO(H)] and Lewis (Le) antigen expression. Removal of linkage-specific fucose, galactose, N-acetylgalactosamine, and sialic acid modulated GAS colonization, dependent on host ABO(H) blood group and Le expression profile. Furthermore, N-linked glycans from human salivary glycoproteins, when released and purified, were potent inhibitors of M1, M3, and M12 GAS colonization ex vivo. These data highlight the important role played by human protein glycosylation patterns in GAS attachment to oral epithelial cell surfaces.-De Oliveira, D. M. P., Everest-Dass, A., Hartley-Tassell, L., Day, C. J., Indraratna, A., Brouwer, S., Cleary, A., Kautto, L., Gorman, J., Packer, N. H., Jennings, M. P., Walker, M. J., Sanderson-Smith, M. L. Human glycan expression patterns influence Group A streptococcal colonization of epithelial cells.	[De Oliveira, David M. P.; Indraratna, Anuk; Cleary, Ailish; Gorman, Jody; Sanderson-Smith, Martina L.] Univ Wollongong, Sch Chem & Mol Biosci, Mol Horizons & Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [De Oliveira, David M. P.; Brouwer, Stephan; Walker, Mark J.] Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Everest-Dass, Arun; Kautto, Liisa; Packer, Nicolle H.] Macquarie Univ, Dept Mol Sci, Sydney, NSW, Australia; [Everest-Dass, Arun; Hartley-Tassell, Lauren; Day, Christopher J.; Packer, Nicolle H.; Jennings, Michael P.] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia	University of Wollongong; University of Queensland; Macquarie University; Griffith University	Sanderson-Smith, ML (corresponding author), Univ Wollongong, Northfields Ave, Wollongong, NSW 2522, Australia.	martina@uow.edu.au	Dass, Arun/C-1290-2014; Jennings, Michael P/G-4822-2013; Everest-Dass, Arun/AAF-3322-2019; Sanderson-Smith, Martina/H-9614-2013	Jennings, Michael P/0000-0002-1027-4684; Packer, Nicolle/0000-0002-7532-4021; Sanderson-Smith, Martina/0000-0002-6366-4993; Walker, Mark/0000-0001-7423-2769; Everest-Dass, Arun/0000-0002-3795-0291; Indraratna, Anuk Dulanta/0000-0003-0003-4860; Kautto, Liisa/0000-0002-4724-8818; De Oliveira, David/0000-0002-5085-7163; Brouwer, Stephan/0000-0002-9777-2992	National Health and Medical Research Council of Australia (NHMRC) [1143266]; NHMRC [1071659, 1138466]; Illawarra Health and Medical Research Institute (IHMRI)	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Illawarra Health and Medical Research Institute (IHMRI)	This work was funded by the National Health and Medical Research Council of Australia (NHMRC) Project Grant 1143266 to M.S-S, A.E-D and N.H.P; NHMRC Program Grant 1071659 to M.P.J and M.J.W; the Illawarra Health and Medical Research Institute (IHMRI) Career Development Grant (to D.M.P.D) and NHMRC Principal Research Fellowship 1138466 (to M.P.J).	[Anonymous], [No title captured]; Armah GE, 2010, J INFECT DIS, V202, pS64, DOI 10.1086/653571; Aziz RK, 2008, EMERG INFECT DIS, V14, P1511, DOI 10.3201/eid1410.071660; Bessen DE, 2016, CURR OPIN INFECT DIS, V29, P295, DOI 10.1097/QCO.0000000000000262; Bessen DE, 2010, FUTURE MICROBIOL, V5, P623, DOI [10.2217/fmb.10.28, 10.2217/FMB.10.28]; Brouwer S, 2016, FEBS LETT, V590, P3739, DOI 10.1002/1873-3468.12254; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chang JS, 2010, BLOOD, V116, P1779, DOI 10.1182/blood-2009-12-260513; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Cooling L, 2015, CLIN MICROBIOL REV, V28, P801, DOI 10.1128/CMR.00109-14; Day CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004927; De Oliveira DMP, 2017, MBIO, V8, DOI 10.1128/mBio.02237-16; Dean L., 2005, BLOOD CELLS IT CONTA; Everest-Dass AV, 2012, GLYCOBIOLOGY, V22, P1465, DOI 10.1093/glycob/cws112; Gallegos KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030368; Goodfellow JJ, 2012, J AM CHEM SOC, V134, P8030, DOI 10.1021/ja301334b; HASTY DL, 1992, INFECT IMMUN, V60, P2147, DOI 10.1128/IAI.60.6.2147-2152.1992; HAVERKORN MJ, 1969, AM J HUM GENET, V21, P360; Hong YJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/573652; Hutson AM, 2003, J VIROL, V77, P405, DOI 10.1128/JVI.77.1.405-415.2003; Jaff MS, 2011, CLIN EXP GASTROENTER, V4, P221, DOI 10.2147/CEG.S23019; Jaff MS, 2010, INT J NANOMED, V5, P901, DOI 10.2147/IJN.S13980; Kautto L, 2016, EXP EYE RES, V145, P278, DOI 10.1016/j.exer.2016.01.013; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Kouki A, 2011, J BIOL CHEM, V286, P38854, DOI 10.1074/jbc.M111.260992; Lee JL, 2009, AUTOIMMUN REV, V9, P117, DOI 10.1016/j.autrev.2009.04.002; MCCORKLE LP, 1955, NEW ENGL J MED, V252, P1066, DOI 10.1056/NEJM195506232522502; McNamara C, 2008, SCIENCE, V319, P1405, DOI 10.1126/science.1154470; Murakami J, 2012, J BIOL CHEM, V287, P22266, DOI 10.1074/jbc.M112.350082; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; Ryan PA, 2001, INFECT IMMUN, V69, P7402, DOI 10.1128/IAI.69.12.7402-7412.2001; Sanderson-Smith M, 2014, J INFECT DIS, V210, P1325, DOI 10.1093/infdis/jiu260; Schneider M, 2017, GLYCOBIOLOGY, V27, P601, DOI 10.1093/glycob/cwx034; Shewell LK, 2014, P NATL ACAD SCI USA, V111, pE5312, DOI 10.1073/pnas.1412703111; Sims Sanyahumbi A, 2016, STREPTOCOCCUS PYOGEN; Tse H, 2012, J INFECT DIS, V206, P341, DOI 10.1093/infdis/jis362; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Walker MJ, 2014, CLIN MICROBIOL REV, V27, P264, DOI 10.1128/CMR.00101-13; WANG JR, 1994, INFECT IMMUN, V62, P1268, DOI 10.1128/IAI.62.4.1268-1274.1994; Ziegler T, 2004, INT J ANTIMICROB AG, V24, pS70, DOI 10.1016/j.ijantimicag.2004.03.002	41	5	5	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10808	10818		10.1096/fj.201900559R	http://dx.doi.org/10.1096/fj.201900559R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31262188				2022-12-28	WOS:000489166300019
J	Kim, J; Kim, J; Jeong, J; Hong, SH; Kim, D; Choi, S; Choi, I; Oh, JS; Cho, C				Kim, Jaehwan; Kim, Jihye; Jeong, Juri; Hong, Seong Hyeon; Kim, Donghyun; Choi, Seungho; Choi, Inchul; Oh, Jeong Su; Cho, Chunghee			Identification of a novel embryo-prevalent gene, Gm11545, involved in preimplantation embryogenesis in mice	FASEB JOURNAL			English	Article						cell lineage specification; blastocyst; inner cell mass; trophectoderm	CELL; TROPHECTODERM; CDX2; BLASTOCYST; NOTCH; DIFFERENTIATION; SPECIFICATION; INTERFERENCE; CONVERGE; LINEAGE	In mammals, the early embryo travels down the oviduct to the uterus and prepares for implantation. The unique features of preimplantation development include compaction followed by blastocyst formation. This first cell lineage specification involves various proteins including cell polarity regulators, kinases, and transcription factors. In this study, a novel gene named predicted gene 11545 (Gm11545) expressed predominantly in mouse early embryos was identified and characterized at the transcript, protein, cellular, and functional levels. The Gm11545 protein localized to both cytoplasmic and membrane regions of preimplantation embryos. Remarkably, knockdown of Gm11545 led to arrest of mouse embryos at the morula stage and consequent impairment of blastocyst formation. Expression patterns of the key transcription factors critical for early lineage specification, octamer-binding transcription factor 4 and caudal type homeobox 2, were affected by Gm11545 depletion. Based on the collective findings, we propose that the novel protein identified in this study, Gm11545, is implicated in cell proliferation and cell lineage specification critical for blastocyst formation.-Kim, J., Kim, J., Jeong, J., Hong, S. H., Kim, D., Choi, S., Choi, I., Oh, J. S., Cho, C. Identification of a novel embryo-prevalent gene, Gm11545, involved in preimplantation embryogenesis in mice.	[Kim, Jaehwan; Kim, Jihye; Jeong, Juri; Hong, Seong Hyeon; Kim, Donghyun; Choi, Seungho; Cho, Chunghee] Gwangju Inst Sci & Technol, Sch Life Sci, Gwangju 61005, South Korea; [Choi, Inchul] Chungnam Natl Univ, Coll Agr & Life Sci, Dept Anim & Dairy Sci, Daejeon, South Korea; [Oh, Jeong Su] Sungkyunkwan Univ, Coll Biotechnol & Bioengn, Dept Integrat Biotechnol, Suwon 16419, South Korea	Gwangju Institute of Science & Technology (GIST); Chungnam National University; Sungkyunkwan University (SKKU)	Cho, C (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Gwangju 61005, South Korea.; Oh, JS (corresponding author), Sungkyunkwan Univ, Coll Biotechnol & Bioengn, Dept Integrat Biotechnol, Suwon 16419, South Korea.	icchoi@cnu.ac.kr; ohjs@skku.edu; choch@gist.ac.kr	Choi, Inchul/AAF-6264-2021	Choi, Inchul/0000-0001-5011-2658	National Research Foundation of Korea (NRF) - Ministry of Education [2017R1A6A1A03015642, 2019R1H1A2039663]; Gwangju Institute of Science and Technology (GIST) Research Institute (GRI) in Korea	National Research Foundation of Korea (NRF) - Ministry of Education; Gwangju Institute of Science and Technology (GIST) Research Institute (GRI) in Korea	I.C. (icchoi@cnu.ac.kr) made contributions to this study equal to those of the corresponding authors. The authors thank Dr. Hiroshi Sasaki (Osaka University, Osaka, Japan) for providing anti-angiomotin antibody. This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), and funded by the Ministry of Education (2017R1A6A1A03015642 to J.S.O. and 2019R1H1A2039663 to C.C.) and the Gwangju Institute of Science and Technology (GIST) Research Institute (GRI) in Korea (to C.C.). The authors declare no conflicts of interest.	Alarcon VB, 2010, BIOL REPROD, V83, P347, DOI 10.1095/biolreprod.110.084400; BIGGERS JD, 1988, AM J PHYSIOL, V255, pC419, DOI 10.1152/ajpcell.1988.255.4.C419; Chen YJ, 2003, MAMM GENOME, V14, P859, DOI 10.1007/s00335-003-2296-6; Chen YC, 2006, BIOINFORMATICS, V22, P2180, DOI 10.1093/bioinformatics/btl358; Cockburn K, 2010, J CLIN INVEST, V120, P995, DOI 10.1172/JCI41229; Cui W, 2016, MOL REPROD DEV, V83, P124, DOI 10.1002/mrd.22600; Edwards R G, 2003, Reprod Biomed Online, V6, P97; Fleming TP, 2001, FRONT BIOSCI-LANDMRK, V6, pD1000, DOI 10.2741/Fleming; Frum T, 2013, DEV CELL, V25, P610, DOI 10.1016/j.devcel.2013.05.004; Hirate Y, 2013, CURR BIOL, V23, P1181, DOI 10.1016/j.cub.2013.05.014; HYAFIL F, 1981, CELL, V26, P447, DOI 10.1016/0092-8674(81)90214-2; Korotkevich E, 2017, DEV CELL, V40, P235, DOI 10.1016/j.devcel.2017.01.006; LATHAM KE, 1991, MOL REPROD DEV, V30, P182, DOI 10.1002/mrd.1080300303; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Lykke-Andersen K, 2008, MOL BIOL CELL, V19, P4383, DOI 10.1091/mbc.E08-02-0219; Maserati M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022516; Mittal V, 2004, NAT REV GENET, V5, P355, DOI 10.1038/nrg1323; Nance J, 2014, J CELL BIOL, V206, P823, DOI 10.1083/jcb.201407064; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Plusa B, 2005, J CELL SCI, V118, P505, DOI 10.1242/jcs.01666; Rayon T, 2014, DEV CELL, V30, P410, DOI 10.1016/j.devcel.2014.06.019; Santenard A, 2010, NAT CELL BIOL, V12, P853, DOI 10.1038/ncb2089; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Siddall LS, 2002, MOL REPROD DEV, V63, P413, DOI 10.1002/mrd.10202; Stephenson RO, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008235; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Su YQ, 2007, DEV BIOL, V302, P104, DOI 10.1016/j.ydbio.2006.09.008; Takada Y, 2016, DEVELOPMENT, V143, P3532, DOI 10.1242/dev.141549; Wang K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010622; Watanabe Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep46135; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Wu T, 2011, STEM CELLS, V29, P755, DOI 10.1002/stem.617; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844	34	0	0	2	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11326	11337		10.1096/fj.201900370RR	http://dx.doi.org/10.1096/fj.201900370RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31322925	Bronze			2022-12-28	WOS:000489166300061
J	Alldred, MJ; Chao, HM; Lee, SH; Beilin, J; Powers, BE; Petkova, E; Strupp, BJ; Ginsberg, SD				Alldred, Melissa J.; Chao, Helen M.; Lee, Sang Han; Beilin, Judah; Powers, Brian E.; Petkova, Eva; Strupp, Barbara J.; Ginsberg, Stephen D.			Long-term effects of maternal choline supplementation on CA1 pyramidal neuron gene expression in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease	FASEB JOURNAL			English	Article						hippocampus; laser capture microdissection; early choline delivery; microarray; trisomic	BASAL FOREBRAIN NEURONS; TC RNA AMPLIFICATION; AMYLOID-BETA; CATHEPSIN-B; SYNAPTIC PLASTICITY; MICROARRAY ANALYSIS; HEALTHY-ADULTS; PEMT PATHWAY; DOUBLE-BLIND; BRAIN	Choline is critical for normative function of 3 major pathways in the brain, including acetylcholine biosynthesis, being a key mediator of epigenetic regulation, and serving as the primary substrate for the phosphatidylethanolamine N-methyltransferase pathway. Sufficient intake of dietary choline is critical for proper brain function and neurodevelopment. This is especially important for brain development during the perinatal period. Current dietary recommendations for choline intake were undertaken without critical evaluation of maternal choline levels. As such, recommended levels may be insufficient for both mother and fetus. Herein, we examined the impact of perinatal maternal choline supplementation (MCS) in a mouse model of Down syndrome and Alzheimer's disease, the Ts65Dn mouse relative to normal disomic littermates, to examine the effects on gene expression within adult offspring at similar to 6 and 11 mo of age. We found MCS produces significant changes in offspring gene expression levels that supersede age-related and genotypic gene expression changes. Alterations due to MCS impact every gene ontology category queried, including GABAergic neurotransmission, the endosomal-lysosomal pathway and autophagy, and neurotrophins, highlighting the importance of proper choline intake during the perinatal period, especially when the fetus is known to have a neurodevelopmental disorder such as trisomy.-Alldred, M. J., Chao, H. M., Lee, S. H., Beilin, J., Powers, B. E., Petkova, E., Strupp, B. J., Ginsberg, S. D. Long-term effects of maternal choline supplementation on CA1 pyramidal neuron gene expression in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.	[Alldred, Melissa J.; Chao, Helen M.; Beilin, Judah; Ginsberg, Stephen D.] Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, 140 Old Orangeburg Rd, Orangeburg, NY 10962 USA; [Lee, Sang Han] Nathan S Kline Inst Psychiat Res, Ctr Biomed Imaging & Neuromodulat, Orangeburg, NY USA; [Petkova, Eva] Nathan S Kline Inst Psychiat Res, Child Psychiat, Orangeburg, NY USA; [Alldred, Melissa J.; Chao, Helen M.; Ginsberg, Stephen D.] NYU, Dept Psychiat, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Lee, Sang Han; Ginsberg, Stephen D.] NYU, Dept Neurosci & Physiol, Langone Med Ctr, New York, NY USA; [Petkova, Eva] NYU, Dept Child & Adolescent Psychiat, Langone Med Ctr, New York, NY USA; [Ginsberg, Stephen D.] NYU, Neuroscience Inst, Langone Med Ctr, New York, NY USA; [Powers, Brian E.; Strupp, Barbara J.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Strupp, Barbara J.] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA	Nathan Kline Institute for Psychiatric Research; Nathan Kline Institute for Psychiatric Research; Nathan Kline Institute for Psychiatric Research; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Cornell University; Cornell University	Ginsberg, SD (corresponding author), Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, 140 Old Orangeburg Rd, Orangeburg, NY 10962 USA.	ginsberg@nki.rfmh.org	, SDG/AAB-3329-2022; Petkova, Eva/AAA-5618-2020	Petkova, Eva/0000-0001-5129-9442; Lee, Sang Han/0000-0001-9760-393X; Chao, Helen/0000-0001-7427-0757; Ginsberg, Stephen/0000-0002-1797-4288	U.S. National Institutes of Health, National Institute on Aging [AG014449, AG043375, AG055328, AG107617]; Alzheimer's Association; NATIONAL INSTITUTE ON AGING [R01AG043375, P01AG014449, R01AG055328, P01AG017617] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Arthur Saltzman at the Nathan Kline Institute for expert technical assistance. This study was supported by U.S. National Institutes of Health, National Institute on Aging Grants AG014449, AG043375, AG055328, and AG107617 and the Alzheimer's Association. The authors declare no conflicts of interest.	Al-Onaizi MA, 2017, CEREB CORTEX, V27, P1615, DOI 10.1093/cercor/bhv349; Alldred MJ, 2018, HIPPOCAMPUS, V28, P251, DOI 10.1002/hipo.22832; Alldred MJ, 2015, BRAIN STRUCT FUNCT, V220, P2983, DOI 10.1007/s00429-014-0839-0; Alldred MJ, 2015, J COMP NEUROL, V523, P61, DOI 10.1002/cne.23663; Alldred MJ, 2012, NEUROBIOL DIS, V45, P751, DOI 10.1016/j.nbd.2011.10.022; Alldred MJ, 2008, INT J MOL SCI, V9, P2091, DOI 10.3390/ijms9112091; Alldred MJ, 2009, J NEUROSCI METH, V177, P381, DOI 10.1016/j.jneumeth.2008.10.027; Applied Biosystems, 2004, GUID PERF QUANT GEN, P1; Ash JA, 2014, NEUROBIOL DIS, V70, P32, DOI 10.1016/j.nbd.2014.06.001; Belichenko PV, 2009, J COMP NEUROL, V512, P453, DOI 10.1002/cne.21895; Belichenko PV, 2004, J COMP NEUROL, V480, P281, DOI 10.1002/cne.20337; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein HG, 2013, AMINO ACIDS, V45, P1373, DOI 10.1007/s00726-013-1601-2; Bhaskar K, 2010, NEUROPATH APPL NEURO, V36, P462, DOI 10.1111/j.1365-2990.2010.01103.x; Blusztajn JK, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080815; Blusztajn JK, 2013, CLIN CHEM LAB MED, V51, P591, DOI 10.1515/cclm-2012-0635; Blusztajn JK, 1998, SCIENCE, V281, P794, DOI 10.1126/science.281.5378.794; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cao YJ, 2016, NEUROSCI LETT, V620, P169, DOI 10.1016/j.neulet.2016.03.039; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Caudill MA, 2018, FASEB J, V32, P2172, DOI 10.1096/fj.201700692RR; Che SL, 2004, LAB INVEST, V84, P131, DOI 10.1038/labinvest.3700005; Cheatham CL, 2012, AM J CLIN NUTR, V96, P1465, DOI 10.3945/ajcn.112.037184; Chen D, 2012, BIOORGAN MED CHEM, V20, P3031, DOI 10.1016/j.bmc.2012.03.002; Chio CC, 2016, J NEUROSURG, V124, P1654, DOI 10.3171/2015.6.JNS1535; Contestabile A, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00054; Counts SE, 2008, NEURODEGENER DIS, V5, P228, DOI 10.1159/000113710; Counts SE, 2009, J ALZHEIMERS DIS, V18, P885, DOI 10.3233/JAD-2009-1196; Davenport C, 2015, J NUTR BIOCHEM, V26, P903, DOI 10.1016/j.jnutbio.2015.03.004; Deidda G, 2015, NAT MED, V21, P318, DOI 10.1038/nm.3827; Detopoulou P, 2008, AM J CLIN NUTR, V87, P424, DOI 10.1093/ajcn/87.2.424; Du CP, 2012, CNS NEUROSCI THER, V18, P754, DOI 10.1111/j.1755-5949.2012.00357.x; Duchon A, 2011, MAMM GENOME, V22, P674, DOI 10.1007/s00335-011-9356-0; Efron B, 2007, J AM STAT ASSOC, V102, P93, DOI 10.1198/016214506000001211; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Fontaine SN, 2016, EMBO J, V35, P1537, DOI 10.15252/embj.201593489; Foster DJ, 2012, DISCOV MED, V14, P413; Furuya TK, 2012, NEUROSCIENCE, V220, P41, DOI 10.1016/j.neuroscience.2012.06.035; Ganz AB, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020252; Gardiner K, 2003, GENE, V318, P137, DOI 10.1016/S0378-1119(03)00769-8; Gerschutz A, 2014, J ALZHEIMERS DIS, V40, P135, DOI 10.3233/JAD-131280; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Ginsberg AD, 2014, SYNTHETIC AESTHETICS: INVESTIGATING SYNTHETIC BIOLOGY'S DESIGNS ON NATURE, P1; Ginsberg SD, 2005, AM J GERIAT PSYCHIAT, V13, P1052, DOI 10.1176/appi.ajgp.13.12.1052; Ginsberg SD, 2005, METHODS, V37, P229, DOI 10.1016/j.ymeth.2005.09.003; Ginsberg SD, 2006, J NEUROCHEM, V97, P475, DOI 10.1111/j.1471-4159.2006.03764.x; Ginsberg SD, 2018, ANN NEUROL, V83, P406, DOI 10.1002/ana.25160; Ginsberg SD, 2019, HIPPOCAMPUS, V29, P422, DOI 10.1002/hipo.22802; Ginsberg SD, 2010, BIOL PSYCHIAT, V68, P885, DOI 10.1016/j.biopsych.2010.05.030; Ginsberg SD, 2010, ANAL BIOANAL CHEM, V397, P3349, DOI 10.1007/s00216-010-3826-1; Ginsberg Stephen D., 2008, V439, P147, DOI 10.1007/978-1-59745-188-8_10; Granholm AC, 2003, HIPPOCAMPUS, V13, P905, DOI 10.1002/hipo.10130; Granholm ACE, 2000, EXP NEUROL, V161, P647, DOI 10.1006/exnr.1999.7289; Gupta M, 2016, MAMM GENOME, V27, P538, DOI 10.1007/s00335-016-9661-8; GWEE MCE, 1978, CLIN EXP PHARMACOL P, V5, P649, DOI 10.1111/j.1440-1681.1978.tb00721.x; Hamlett ED, 2016, CURR ALZHEIMER RES, V13, P35, DOI 10.2174/1567205012666150921095505; Hartley D, 2015, ALZHEIMERS DEMENT, V11, P700, DOI 10.1016/j.jalz.2014.10.007; Hartley SL, 2014, BRAIN, V137, P2556, DOI 10.1093/brain/awu173; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Henderson MX, 2016, ACTA NEUROPATHOL, V131, P621, DOI 10.1007/s00401-015-1512-2; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Hook G, 2014, J ALZHEIMERS DIS, V41, P129, DOI 10.3233/JAD-131370; Insausti AM, 1998, NEUROSCI LETT, V253, P175, DOI 10.1016/S0304-3940(98)00641-7; Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate Other B Vitamins and Choline, 1998, DIETARY REFERENCE IN; Jacobson SW, 2018, ALCOHOL CLIN EXP RES, V42, P1327, DOI 10.1111/acer.13769; Jacobson SW, 2018, ALCOHOL CLIN EXP RES, V42, P1315, DOI 10.1111/acer.13768; Jiang Y, 2010, P NATL ACAD SCI USA, V107, P1630, DOI 10.1073/pnas.0908953107; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kaufman AC, 2015, ANN NEUROL, V77, P953, DOI 10.1002/ana.24394; Kelley CM, 2016, CURR ALZHEIMER RES, V13, P84, DOI 10.2174/1567205012666150921100515; Kelley CM, 2014, J COMP NEUROL, V522, P1390, DOI 10.1002/cne.23492; Kelley CM, 2014, BRAIN PATHOL, V24, P33, DOI 10.1111/bpa.12073; Kim EK, 2015, ARCH TOXICOL, V89, P867, DOI 10.1007/s00204-015-1472-2; Kindy MS, 2012, J ALZHEIMERS DIS, V29, P827, DOI 10.3233/JAD-2012-111604; Kollmann K, 2013, BBA-MOL BASIS DIS, V1832, P1866, DOI 10.1016/j.bbadis.2013.01.019; Kurt MA, 2000, BRAIN RES, V858, P191, DOI 10.1016/S0006-8993(00)01984-3; Kwan ST, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040417; LAI F, 1989, ARCH NEUROL-CHICAGO, V46, P849, DOI 10.1001/archneur.1989.00520440031017; Lee V, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00003; Leverenz JB, 1998, EXP NEUROL, V150, P296, DOI 10.1006/exnr.1997.6777; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; MANN DMA, 1986, NEUROPATH APPL NEURO, V12, P447, DOI 10.1111/j.1365-2990.1986.tb00053.x; McCulloch CE., 2011, GEN LINEAR MIXED MOD, V2; McGowan PO, 2008, BRAIN RES, V1237, P12, DOI 10.1016/j.brainres.2008.07.074; MECK WH, 1989, BEHAV NEUROSCI, V103, P1234, DOI 10.1037/0735-7044.103.6.1234; Mellott TJ, 2007, BRAIN RES, V1151, P1, DOI 10.1016/j.brainres.2007.03.004; Mellott TJ, 2004, FASEB J, V18, P545, DOI 10.1096/fj.03-0877fje; Mengozzi M, 2012, P NATL ACAD SCI USA, V109, P9617, DOI 10.1073/pnas.1200554109; Moon J, 2010, BEHAV NEUROSCI, V124, P346, DOI 10.1037/a0019590; Morales-Corraliza J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007134; Nanostring nCounter, 2017, MANC001104; Napoli I, 2008, BRAIN RES, V1237, P124, DOI 10.1016/j.brainres.2008.08.046; Noor A, 2017, INT J NEUROSCI, V127, P805, DOI 10.1080/00207454.2016.1248240; Parcon PA, 2018, ALZHEIMERS DEMENT, V14, P230, DOI 10.1016/j.jalz.2017.07.754; Powers BE, 2017, NEUROSCIENCE, V340, P501, DOI 10.1016/j.neuroscience.2016.11.001; Powers BE, 2016, BRAIN STRUCT FUNCT, V221, P4337, DOI 10.1007/s00429-015-1164-y; Recabarren D, 2017, LIFE SCI, V183, P83, DOI 10.1016/j.lfs.2017.06.009; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Ross RG, 2013, AM J PSYCHIAT, V170, P290, DOI 10.1176/appi.ajp.2012.12070940; Rouaux C, 2004, BIOCHEM PHARMACOL, V68, P1157, DOI 10.1016/j.bcp.2004.05.035; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Sandstrom NJ, 2002, BRAIN RES, V947, P9, DOI 10.1016/S0006-8993(02)02900-1; Saran NG, 2003, HUM MOL GENET, V12, P2013, DOI 10.1093/hmg/ddg217; Schafer MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133923; Sendera TJ, 2000, J NEUROCHEM, V74, P1185; Sharma M, 2012, EMBO J, V31, P829, DOI 10.1038/emboj.2011.467; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Araujo BHS, 2015, EPILEPSY BEHAV, V53, P120, DOI 10.1016/j.yebeh.2015.10.004; Spitzer Philipp, 2011, Int J Alzheimers Dis, V2011, P739847, DOI 10.4061/2011/739847; Strupp BJ, 2016, CURR ALZHEIMER RES, V13, P97, DOI 10.2174/1567205012666150921100311; Sturgeon X, 2011, MAMM GENOME, V22, P261, DOI 10.1007/s00335-011-9321-y; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; Velazquez R, 2013, NEUROBIOL DIS, V58, P92, DOI 10.1016/j.nbd.2013.04.016; Veldman-Jones MH, 2015, CANCER RES, V75, P2587, DOI 10.1158/0008-5472.CAN-15-0262; WISNIEWSKI KE, 1985, NEUROLOGY, V35, P957, DOI 10.1212/WNL.35.7.957; Yan J, 2014, FASEB J, V28, P4312, DOI 10.1096/fj.14-251736; Yang ZF, 2015, J BIOL CHEM, V290, P26549, DOI 10.1074/jbc.M115.658088; Zeisel SH, 2018, ADV NUTR, V9, P58, DOI 10.1093/advances/nmx004; Zeisel SH, 2013, INT J WOMENS HEALTH, V5, P193, DOI 10.2147/IJWH.S36610; Zhang L, 2016, CANCER LETT, V373, P19, DOI 10.1016/j.canlet.2016.01.022	121	11	11	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9871	9884		10.1096/fj.201802669RR	http://dx.doi.org/10.1096/fj.201802669RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31180719	Green Published			2022-12-28	WOS:000482214200015
J	Martinsen, A; Tejera, N; Vauzour, D; Harden, G; Dick, J; Shinde, S; Barden, A; Mori, TA; Minihane, AM				Martinsen, Anneloes; Tejera, Noemi; Vauzour, David; Harden, Glenn; Dick, James; Shinde, Sujata; Barden, Anne; Mori, Trevor A.; Minihane, Anne Marie			Altered SPMs and age-associated decrease in brain DHA in APOE4 female mice	FASEB JOURNAL			English	Article						Alzheimer disease; fatty acids; specialized proresolving mediators; neuroinflammation; cortex	FATTY-ACID SUPPLEMENTATION; APOLIPOPROTEIN-E GENOTYPE; DOCOSAHEXAENOIC ACID; ALZHEIMERS-DISEASE; PRORESOLVING MEDIATORS; COGNITIVE DEFICITS; NEUROPROTECTIN D1; RISK; INCREASES; SEX	An apolipoprotein E (APOE) 4 genotype is the most important, common genetic determinant for Alzheimer disease (AD), and female APOE4 carriers present with an increased risk compared with males. The study quantified cortical and hippocampal fatty acid and phospholipid profiles along with select eicosapentaenoic acid (EPA)- and docosahexaenoic acid (DHA)-derived specialized proresolving mediators (SPMs) in 2-, 9-, and 18-mo-old APOE3 and APOE4 male and female mice. A 10% lower cortical DHA was evident in APOE4 females at 18 mo compared with 2 mo, with no significant decrease in APOE3 or APOE4 males. This decrease was associated with a reduction in DHA-phosphatidylethanolamine. Older APOE4 females had a 15% higher oleic acid content compared with young mice. Although no sex*APOE genotype interactions were observed for SPMs expressed as a ratio of their parent compound, higher cortical 18R/S-hydroxy-5Z,8Z,11Z,14Z,16E-EPA, resolvin D3, protectin D1, 10S,17S-dihydroxy-4Z,7Z,11E,13E,15Z,19Z-DHA (10S,17S-diHDHA), maresin 1, 17S-hydroxy-4Z,7Z,10Z,13Z,15E,19Z-DHA, and 14S-hydroxy-4Z,7Z,10Z,12E,16Z,19Z-DHA were evident in females, and lower cortical 17R-resolvin D1, 10S,17S-diHDHA, and 18-HEPE in APOE4. Our findings show a strong association between age, female sex, and an APOE4 genotype, with decreased cortical DHA and a number of SPMs, which together may contribute to the development of cognitive decline and AD pathology.-Martinsen, A., Tejera, N., Vauzour, D., Harden, G., Dick, J., Shinde, S., Barden, A., Mori, T. A., Minihane, A. M. Altered SPMs and age-associated decrease in brain DHA in APOE4 female mice.	[Martinsen, Anneloes; Tejera, Noemi; Vauzour, David; Harden, Glenn; Minihane, Anne Marie] Univ East Anglia, Norwich Med Sch, Dept Nutr & Prevent Med, Norwich, Norfolk, England; [Dick, James] Univ Stirling, Nutr Analyt Serv, Inst Aquaculture, Stirling, Scotland; [Shinde, Sujata; Barden, Anne; Mori, Trevor A.] Univ Western Australia, Med Sch, Perth, WA, Australia	University of East Anglia; University of Stirling; University of Western Australia	Minihane, AM (corresponding author), UEA, Norwich Med Sch, BCRE, Dept Nutr & Prevent Med, James Watson Rd, Norwich NR4 7UQ, Norfolk, England.	a.minihane@uea.ac.uk	Vauzour, Dr David/C-2245-2008	Vauzour, Dr David/0000-0001-5952-8756; Mori, Trevor A/0000-0002-5264-9229; Minihane, Anne Marie/0000-0001-9042-4226; Barden, Anne/0000-0001-7631-0767	Biotechnology and Biological Sciences Research Council (BBSRC) Institute Programme Grant [BB/J004545/1]; BBSRC [BB/M004449/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC) Institute Programme Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank the staff of the Disease Modelling Unit at the University of East Anglia for expertise and help with the conduct of the rodent studies. The research was funded as part of a Biotechnology and Biological Sciences Research Council (BBSRC) Institute Programme Grant (BB/J004545/1). The authors declare no conflicts of interest.	Abdullah L, 2017, AGING-US, V9, P964, DOI 10.18632/aging.101203; Ackman R.G., 1980, ADV FISH SCI TECHNOL, P83; Althouse AD, 2016, ANN THORAC SURG, V101, P1644, DOI 10.1016/j.athoracsur.2015.11.024; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; Astarita G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024777; Barberger-Gateau P, 2007, NEUROLOGY, V69, P1921, DOI 10.1212/01.wnl.0000278116.37320.52; Barden A, 2014, J LIPID RES, V55, P2401, DOI 10.1194/jlr.M045583; Barden AE, 2016, CURR OPIN LIPIDOL, V27, P26, DOI 10.1097/MOL.0000000000000262; Bazan NG, 2013, PROSTAG LEUKOTR ESS, V88, P127, DOI 10.1016/j.plefa.2012.08.008; Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Breitner JCS, 1999, NEUROLOGY, V53, P321, DOI 10.1212/WNL.53.2.321; Chouinard-Watkins R, 2017, NEUROBIOL AGING, V57, P28, DOI 10.1016/j.neurobiolaging.2017.05.003; Christie W.W., 2003, LIPID ANAL ISOLATION, V3rd ed., P205; Cunnane SC, 2013, PROSTAG LEUKOTR ESS, V88, P61, DOI 10.1016/j.plefa.2012.04.006; da Silva-Santi LG, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091277; Dalli J, 2013, CHEM BIOL, V20, P188, DOI 10.1016/j.chembiol.2012.11.010; Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Fjell AM, 2014, PROG NEUROBIOL, V117, P20, DOI 10.1016/j.pneurobio.2014.02.004; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fraser T, 2010, NEUROCHEM RES, V35, P503, DOI 10.1007/s11064-009-0087-5; Ghioni C, 1996, COMP BIOCHEM PHYS B, V114, P161, DOI 10.1016/0305-0491(96)00019-3; Hamilton J, 2000, LIPIDS, V35, P863, DOI 10.1007/S11745-000-0595-x; Heffernan AL, 2016, J MOL NEUROSCI, V60, P316, DOI 10.1007/s12031-016-0804-x; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Hussain G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00144; Kariv-Inbal Z, 2012, J ALZHEIMERS DIS, V28, P667, DOI 10.3233/JAD-2011-111265; Lacombe RJS, 2018, MOL ASPECTS MED, V64, P109, DOI 10.1016/j.mam.2017.12.004; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Massey KA, 2013, FREE RADICAL BIO MED, V59, P45, DOI 10.1016/j.freeradbiomed.2012.08.565; Neu SC, 2017, JAMA NEUROL, V74, P1178, DOI 10.1001/jamaneurol.2017.2188; Nock TG, 2017, BBA-MOL CELL BIOL L, V1862, P1068, DOI 10.1016/j.bbalip.2017.07.004; Pontifex M, 2018, NEUROBIOL AGING, V69, P209, DOI 10.1016/j.neurobiolaging.2018.05.017; Pottala JV, 2014, NEUROLOGY, V82, P435, DOI 10.1212/WNL.0000000000000080; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Rathod KS, 2017, J CLIN INVEST, V127, P169, DOI 10.1172/JCI89429; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Schaefer EJ, 2006, ARCH NEUROL-CHICAGO, V63, P1545, DOI 10.1001/archneur.63.11.1545; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Sharman MJ, 2010, J ALZHEIMERS DIS, V20, P105, DOI 10.3233/JAD-2010-1348; Snowden SG, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002266; Somjen D, 2016, J STEROID BIOCHEM, V163, P28, DOI 10.1016/j.jsbmb.2016.03.032; Tao QS, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.3597; Terrando N, 2013, FASEB J, V27, P3564, DOI 10.1096/fj.13-230276; Vandal M, 2014, J NEUROCHEM, V129, P516, DOI 10.1111/jnc.12640; Whittington RA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01464; Yassine HN, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0194-x; Zhu YG, 2012, GLIA, V60, P559, DOI 10.1002/glia.22289	53	13	13	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10315	10326		10.1096/fj.201900423R	http://dx.doi.org/10.1096/fj.201900423R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31251078	Green Accepted, Bronze			2022-12-28	WOS:000482214200048
J	O'Brien, DP; Cannella, SE; Voegele, A; Raoux-Barbot, D; Davi, M; Douche, T; Matondo, M; Brier, S; Ladant, D; Chenal, A				O'Brien, Darragh P.; Cannella, Sara E.; Voegele, Alexis; Raoux-Barbot, Dorothee; Davi, Marilyne; Douche, Thibaut; Matondo, Mariette; Brier, Sebastien; Ladant, Daniel; Chenal, Alexandre			Post-translational acylation controls the folding and functions of the CyaA RTX toxin	FASEB JOURNAL			English	Article						post-translational modification; protein folding; calcium-binding protein; adenylate cyclase; bordetella pertussis	PERTUSSIS ADENYLATE-CYCLASE; BORDETELLA-PERTUSSIS; CATALYTIC DOMAIN; HDX-MS; CALCIUM; PROTEIN; IDENTIFICATION; TRANSLOCATION; CALMODULIN; SECRETION	The adenylate cyclase (CyaA) toxin is a major virulence factor of Bordetella pertussis, the causative agent of whooping cough. CyaA is synthetized as a pro-toxin, pro-CyaA, and converted into its cytotoxic form upon acylation of two lysines. After secretion, CyaA invades eukaryotic cells and produces cAMP, leading to host defense subversion. To gain further insights into the effect of acylation, we compared the functional and structural properties of pro-CyaA and CyaA proteins. HDX-MS results show that the refolding process of both proteins upon progressive urea removal is initiated by calcium binding to the C-terminal RTX domain. We further identified a critical hydrophobic segment, distal from the acylation region, that folds at higher urea concentration in CyaA than in pro-CyaA. Once refolded into monomers, CyaA is more compact and stable than pro-CyaA, due to a complex set of interactions between domains. Our HDX-MS data provide direct evidence that the presence of acyl chains in CyaA induces a significant stabilization of the apolar segments of the hydrophobic domain and of most of the acylation region. We propose a refolding model dependent on calcium and driven by local and distal acylation-dependent interactions within CyaA. Therefore, CyaA acylation is not only critical for cell intoxication, but also for protein refolding into its active conformation. Our data shed light on the complex relationship between post-translational modifications, structural disorder and protein folding. Coupling calcium-binding and acylation-driven folding is likely pertinent for other repeat-in-toxin cytolysins produced by many Gram-negative bacterial pathogens.-O'Brien, D. P., Cannella, S. E., Voegele, A., Raoux-Barbot, D., Davi, M., Douche, T., Matondo, M., Brier, S., Ladant, D., Chenal, A. Post-translational acylation controls the folding and functions of the CyaA RTX toxin.	[O'Brien, Darragh P.; Cannella, Sara E.; Voegele, Alexis; Raoux-Barbot, Dorothee; Davi, Marilyne; Brier, Sebastien; Ladant, Daniel; Chenal, Alexandre] Inst Pasteur, Chem & Struct Biol Dept, Paris, France; [Brier, Sebastien] CNRS, UMR 3528, Ctr Technol Resources & Res, Biol NMR Tech Platform, Paris, France; [Voegele, Alexis] Univ Paris Diderot Paris VII, Sorbonne Paris Cite, Paris, France; [Douche, Thibaut; Matondo, Mariette] Inst Pasteur, CNRS, USR 2000, Mass Spectrometry Biol Unit,Prote Platform, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ladant, D (corresponding author), Inst Pasteur, CNRS, UMR 3528, Chem & Struct Biol Dept, F-75724 Paris 15, France.; Chenal, A (corresponding author), Inst Pasteur, 25 Rue Dr Roux, F-75015 Paris, France.	daniel.ladant@pasteur.fr; alexandre.chenal@pasteur.fr	Matondo, Mariette/AAA-4163-2020	Matondo, Mariette/0000-0003-3958-7710; Voegele, Alexis/0000-0002-0452-6814; LADANT, Daniel/0000-0003-1955-548X; Chenal, Alexandre/0000-0002-4959-1003; Brier, Sebastien/0000-0003-1758-8237; Douche, Thibaut/0000-0001-8627-6726	CACSICE Equipex [ANR-11-EQPX-0008]; Pasteur-Paris University (PPU) International PhD Program; DIM MalInf (infectious diseases) grant from Conseil Regional Ile-de-France; Institut Pasteur, PasteurInnov [PIV15-197]; PTR grant [PTR451]; CNRS; Fondation Recherche Medicale [FRM DBS20140930771];  [PasteurInnov2015-197]	CACSICE Equipex; Pasteur-Paris University (PPU) International PhD Program; DIM MalInf (infectious diseases) grant from Conseil Regional Ile-de-France; Institut Pasteur, PasteurInnov; PTR grant; CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation Recherche Medicale; 	The authors thank Bertrand Raynal and Sebastien Brule from the Plate-forme de Biophysique Moleculaire (PFBMI) for excellent technical expertise with analytical ultracentrifugation. The authors thank the CACSICE Equipex ANR-11-EQPX-0008. D.P.O. was supported by PasteurInnov2015-197 and PTR451 grants. S.E.C. was supported by a stipend from the Pasteur-Paris University (PPU) International PhD Program. A.V. was supported by a DIM MalInf (infectious diseases) grant from Conseil Regional Ile-de-France. Running costs were supported by Institut Pasteur, PasteurInnov (PIV15-197), PTR grant (PTR451), CNRS, and Fondation Recherche Medicale (FRM DBS20140930771). The authors declare no conflicts of interest.	BARRY EM, 1991, J BACTERIOL, V173, P720, DOI 10.1128/jb.173.2.720-726.1991; Basar T, 2001, J BIOL CHEM, V276, P348, DOI 10.1074/jbc.M006463200; Bauche C, 2006, J BIOL CHEM, V281, P16914, DOI 10.1074/jbc.M601594200; BELLALOU J, 1990, INFECT IMMUN, V58, P1195, DOI 10.1128/IAI.58.5.1195-1200.1990; BELLALOU J, 1990, INFECT IMMUN, V58, P3242, DOI 10.1128/IAI.58.10.3242-3247.1990; Benz R, 2016, BBA-BIOMEMBRANES, V1858, P526, DOI 10.1016/j.bbamem.2015.10.025; Bouchez V, 2017, TOXINS, V9, DOI 10.3390/toxins9100304; Bumba L, 2016, MOL CELL, V62, P47, DOI 10.1016/j.molcel.2016.03.018; Cannella SE, 2017, SCI REP-UK, V7, DOI 10.1038/srep42065; Carbonetti NH, 2010, FUTURE MICROBIOL, V5, P455, DOI 10.2217/FMB.09.133; Chenal A, 2015, COMPREHENSIVE SOURCEBOOK OF BACTERIAL PROTEIN TOXINS, 4TH EDITION, P677, DOI 10.1016/B978-0-12-800188-2.00023-9; Chenal A, 2018, TOXINS, V10, DOI 10.3390/toxins10070302; Chenal A, 2010, BIOPHYS J, V99, P3744, DOI 10.1016/j.bpj.2010.10.016; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; El-Azami-El-Idrissi M, 2003, J BIOL CHEM, V278, P38514, DOI 10.1074/jbc.M304387200; Fedele G, 2017, TOXINS, V9, DOI 10.3390/toxins9100293; GLASER P, 1988, EMBO J, V7, P3997, DOI 10.1002/j.1460-2075.1988.tb03288.x; Gmira S, 2001, RES MICROBIOL, V152, P889, DOI 10.1016/S0923-2508(01)01272-4; Guiso N, 2017, TOXINS, V9, DOI 10.3390/toxins9090277; HACKETT M, 1994, SCIENCE, V266, P433, DOI 10.1126/science.7939682; Hourdel V, 2016, BIOINFORMATICS, V32, P3413, DOI 10.1093/bioinformatics/btw420; ISSARTEL JP, 1991, NATURE, V351, P759, DOI 10.1038/351759a0; Karimova G, 1998, P NATL ACAD SCI USA, V95, P12532, DOI 10.1073/pnas.95.21.12532; Karst JC, 2014, J BIOL CHEM, V289, P30702, DOI 10.1074/jbc.M114.580852; Karst Johanna C, 2012, Methods Mol Biol, V896, P163, DOI 10.1007/978-1-4614-3704-8_10; Karst JC, 2012, J BIOL CHEM, V287, P9200, DOI 10.1074/jbc.M111.316166; Karst JC, 2010, BIOCHEMISTRY-US, V49, P318, DOI 10.1021/bi9016389; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; LADANT D, 1988, J BIOL CHEM, V263, P2612; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; Martin C, 2004, J BACTERIOL, V186, P3760, DOI 10.1128/JB.186.12.3760-3765.2004; Masin J, 2005, BIOCHEMISTRY-US, V44, P12759, DOI 10.1021/bi050459b; Masin J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29137; Novak J, 2017, TOXINS, V9, DOI 10.3390/toxins9100300; O'Brien DP, 2018, TOXICON, V149, P37, DOI 10.1016/j.toxicon.2018.01.007; O'Brien DP, 2018, BIOTECHNOL APPL BIOC, V65, P62, DOI 10.1002/bab.1577; O'Brien DP, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2004486; O'Brien DP, 2015, SCI REP-UK, V5, DOI 10.1038/srep14223; ROSE T, 1995, J BIOL CHEM, V270, P26370, DOI 10.1074/jbc.270.44.26370; Ryslava H, 2013, J PROTEOMICS, V92, P80, DOI 10.1016/j.jprot.2013.03.025; SAKAMOTO H, 1992, J BIOL CHEM, V267, P13598; SEBO P, 1991, GENE, V104, P19, DOI 10.1016/0378-1119(91)90459-O; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Siman P, 2012, ORG BIOMOL CHEM, V10, P5684, DOI 10.1039/c2ob25149c; Sotomayor Perez AC, 2010, J MOL BIOL, V397, P534, DOI 10.1016/j.jmb.2010.01.031; Sotomayor-Perez Ana Cristina, 2012, Methods Mol Biol, V896, P331, DOI 10.1007/978-1-4614-3704-8_22; Sotomayor-Perez AC, 2011, J BIOL CHEM, V286, P16997, DOI 10.1074/jbc.M110.210393; Sotomayor-Perez AC, 2015, TOXINS, V7, P1, DOI 10.3390/toxins7010001; Sotomayor-Perez AC, 2013, J AM CHEM SOC, V135, P11929, DOI 10.1021/ja404790f; Subrini O, 2013, J BIOL CHEM, V288, P32585, DOI 10.1074/jbc.M113.508838; Veneziano R, 2013, P NATL ACAD SCI USA, V110, P20473, DOI 10.1073/pnas.1312975110; Voegele A, 2017, TOXINS, V9, DOI 10.3390/toxins9110369; Vojtova J, 2006, CURR OPIN MICROBIOL, V9, P69, DOI 10.1016/j.mib.2005.12.011; Welch RA, 2001, CURR TOP MICROBIOL, V257, P85; WELCH RA, 1991, MOL MICROBIOL, V5, P521, DOI 10.1111/j.1365-2958.1991.tb00723.x; Westrop GD, 1996, GENE, V180, P91, DOI 10.1016/S0378-1119(96)00412-X	59	16	16	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10065	10076		10.1096/fj.201802442RR	http://dx.doi.org/10.1096/fj.201802442RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31226003	Green Submitted			2022-12-28	WOS:000482214200028
J	Cao, YM; Li, MR; Liu, F; Ni, XB; Wang, S; Zhang, H; Sui, XS; Huo, R				Cao, Yumeng; Li, Mingrui; Liu, Fei; Ni, XiaoBei; Wang, Shuai; Zhang, Hao; Sui, Xuesong; Huo, Ran			Deletion of maternal UHRF1 severely reduces mouse oocyte quality and causes developmental defects in preimplantation embryos	FASEB JOURNAL			English	Article						infertility; aneuploidy; epigenetic modification; DNA damage	DNA METHYLATION; EPIGENETIC MODIFICATIONS; HISTONE ACETYLATION; PERIVITELLINE SPACE; GENE; REPLICATION; ANEUPLOIDY; PROTEIN; ICBP90; NP95	The ubiquitin-like, containing PHD and RING finger domains, 1 (UHRF1) protein recognizes DNA methylation and histone modification and plays a critical role in epigenetic regulation. Recently, UHRF1 was shown to have a role in DNA methylation in oocytes and early embryos. Here, we reveal that maternal UHRF1 determines the quality of mouse oocytes. We generated oocyte-specific Uhrf1-knockout mice and found that females were sterile, and few maternal UHRF1-null embryos developed into blastocysts. The UHRF1-null oocytes had an increased incidence of aneuploidy and DNA damage. In addition to defective DNA methylation, histone modification was affected during oogenesis, with UHRF1-null germinal vesicle and metaphase II-stage oocytes exhibiting reduced global histone H3 lysine 9 dimethylation levels and elevated acetylation of histone H4 lysine 12. Taken together, our results suggest that UHRF1 plays an important role in determining oocyte quality and affects epigenetic regulation of oocyte maturation as a maternal protein, which is crucial for embryo developmental potential. Further exploration of the biologic function and underlying mechanisms of maternal UHRF1 will enhance our understanding of the maternal control of the oocyte and early embryonic development.-Cao, Y., Li, M., Liu, F., Ni, X., Wang, S., Zhang, H., Sui, X., Huo, R. Deletion of maternal UHRF1 severely reduces mouse oocyte quality and causes developmental defects in preimplantation embryos.	[Cao, Yumeng; Li, Mingrui; Liu, Fei; Ni, XiaoBei; Wang, Shuai; Zhang, Hao; Sui, Xuesong; Huo, Ran] Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, 101 Longmian Rd, Nanjing 211166, Jiangsu, Peoples R China	Nanjing Medical University	Huo, R (corresponding author), Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, 101 Longmian Rd, Nanjing 211166, Jiangsu, Peoples R China.	huoran@njmu.edu.cn			National Key Research and Development Program of China [2017YFC1001301, 2018YFC1004002]; National Natural Science Foundation of China (NSFC) [31471107]	National Key Research and Development Program of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	The authors thank Zhaojia Ge (College of Life Sciences, Qingdao Agricultural University, Qingdao, China) for providing technology and guidance on bisulfite sequencing. This work was supported by the National Key Research and Development Program of China (2017YFC1001301, 2018YFC1004002) and the National Natural Science Foundation of China (NSFC) (31471107). The authors declare no conflicts of interest.	Akiyama T, 2004, MOL REPROD DEV, V69, P222, DOI 10.1002/mrd.20121; Akiyama T, 2006, P NATL ACAD SCI USA, V103, P7339, DOI 10.1073/pnas.0510946103; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Cloutier JM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005462; De Felici M, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/425863; Gelato KA, 2014, MOL CELL, V54, P905, DOI 10.1016/j.molcel.2014.04.004; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Han LS, 2018, NAT GENET, V50, P768, DOI 10.1038/s41588-018-0077-0; Hashimoto H, 2009, EPIGENETICS-US, V4, P8, DOI 10.4161/epi.4.1.7370; Hassan-Ali H, 1998, HUM REPROD, V13, P3425, DOI 10.1093/humrep/13.12.3425; Henne WM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016766; Hiura H, 2006, GENES CELLS, V11, P353, DOI 10.1111/j.1365-2443.2006.00943.x; Howe K, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.112151; Jeanblanc M, 2005, ONCOGENE, V24, P7337, DOI 10.1038/sj.onc.1208878; Jin F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001147; Jones KT, 2013, DEVELOPMENT, V140, P3719, DOI 10.1242/dev.090589; Kageyama S, 2007, REPRODUCTION, V133, P85, DOI 10.1530/REP-06-0025; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Karg E, 2017, J MOL BIOL, V429, P3814, DOI 10.1016/j.jmb.2017.10.014; Kim J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005970; Kim JM, 2003, J CELL BIOL, V162, P37, DOI 10.1083/jcb.200303047; Kim JK, 2009, NUCLEIC ACIDS RES, V37, P493, DOI 10.1093/nar/gkn961; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Liang XW, 2011, FERTIL STERIL, V96, P1479, DOI 10.1016/j.fertnstert.2011.09.022; Liu HL, 2004, DEVELOPMENT, V131, P2269, DOI 10.1242/dev.01116; Lonergan P, 2003, Reprod Biomed Online, V7, P657; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; Maenohara S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007042; Meilinger D, 2009, EMBO REP, V10, P1259, DOI 10.1038/embor.2009.201; Mtango NR, 2008, INT REV CEL MOL BIO, V268, P223, DOI 10.1016/S1937-6448(08)00807-1; Muto M, 2002, J BIOL CHEM, V277, P34549, DOI 10.1074/jbc.M205189200; Pan ZX, 2012, J GENET GENOMICS, V39, P111, DOI 10.1016/j.jgg.2012.02.004; Papait R, 2007, MOL BIOL CELL, V18, P1098, DOI 10.1091/mbc.E06-09-0874; Qu Y, 2018, CELL CYCLE, V17, P2447, DOI 10.1080/15384101.2018.1542896; Racedo SE, 2009, REPROD FERT DEVELOP, V21, P738, DOI 10.1071/RD09039; Reik W, 2001, NAT GENET, V27, P255, DOI 10.1038/85804; Saitou M, 2012, DEVELOPMENT, V139, P15, DOI 10.1242/dev.050849; Sirard MA, 2006, THERIOGENOLOGY, V65, P126, DOI 10.1016/j.theriogenology.2005.09.020; Suo L, 2010, FERTIL STERIL, V93, P945, DOI 10.1016/j.fertnstert.2008.12.128; Swales AKE, 2005, REPRODUCTION, V130, P389, DOI 10.1530/rep.1.00395; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Titus S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004925; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; van den Berg IM, 2011, HUM REPROD, V26, P1181, DOI 10.1093/humrep/der030; von Meyenn F, 2016, MOL CELL, V62, P848, DOI 10.1016/j.molcel.2016.04.025; Watson AJ, 1999, THERIOGENOLOGY, V51, P117, DOI 10.1016/S0093-691X(98)00236-2; Xia P, 1997, HUM REPROD, V12, P1750, DOI 10.1093/humrep/12.8.1750; Xu QH, 2018, TRENDS CELL BIOL, V28, P237, DOI 10.1016/j.tcb.2017.10.008; Yin S, 2017, DEVELOPMENT, V144, P2165, DOI 10.1242/dev.149518; Yuan JS, 2013, P NATL ACAD SCI USA, V110, P10640, DOI 10.1073/pnas.1220662110; Zhang HX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10201; Zhang K, 2015, REPROD FERT DEVELOP, V27, P880, DOI 10.1071/RD14441	52	10	10	2	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8294	8305		10.1096/fj.201801696RRRR	http://dx.doi.org/10.1096/fj.201801696RRRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30995416				2022-12-28	WOS:000476234700040
J	Christie, CF; Fang, DN; Hunt, EG; Morris, ME; Rovini, A; Heslop, KA; Beeson, GC; Beeson, CC; Maldonado, EN				Christie, Charleston F.; Fang, Diana; Hunt, Elizabeth G.; Morris, Morgan E.; Rovini, Amandine; Heslop, Kareem A.; Beeson, Gyda C.; Beeson, Craig C.; Maldonado, Eduardo N.			Statin-dependent modulation of mitochondrial metabolism in cancer cells is independent of cholesterol content	FASEB JOURNAL			English	Article						glycolysis; lovastatin; mitochondrial membrane potential; oxidative phosphorylation; simvastatin	CYCLE ARREST; HEPATOCELLULAR-CARCINOMA; SIMVASTATIN; APOPTOSIS; LOVASTATIN; ATORVASTATIN; INHIBITION; MYOPATHY; RISK; ATP	Statins, widely used to treat hypercholesterolemia, inhibit the 3-hydroxy-3-methylglutaryl-coenzyme A reductase, the rate-limiting enzyme of de novo cholesterol (Chol) synthesis. Statins have been also reported to slow tumor progression. In cancer cells, ATP is generated both by glycolysis and oxidative phosphorylation. Mitochondrial membrane potential (Delta Psi), a readout of mitochondrial metabolism, is sustained by the oxidation of respiratory substrates in the Krebs cycle to generate NADH and flavin adenine dinucleotide, which are further oxidized by the respiratory chain. Here, we studied the short-term effects of statins (3-24 h) on mitochondrial metabolism on cancer cells. Lovastatin (LOV) and simvastatin (SIM) increased Delta Psi in HepG2 and Huh7 human hepatocarcinoma cells and HCC4006 human lung adenocarcinoma cells. Mitochondrial hyperpolarization after LOV and SIM was dose and time dependent. Maximal increase in Delta Psi occurred at 10 mu M and 24 h for both statins. The structurally unrelated atorvastatin also hyperpolarized mitochondria in HepG2 cells. Cellular and mitochondrial Chol remained unchanged after SIM. Both LOV and SIM decreased basal respiration, ATP-linked respiration, and ATP production. LOV and SIM did not change the rate of lactic acid production. In summary, statins modulate mitochondrial metabolism in cancer cells independently of the Chol content in cellular membranes without affecting glycolysis.-Christie, C. F., Fang, D., Hunt, E. G., Morris, M. E., Rovini, A., Heslop, K. A., Beeson, G. C., Beeson, C. C., Maldonado, E. N. Statin-dependent modulation of mitochondrial metabolism in cancer cells is independent of cholesterol content.	[Christie, Charleston F.; Fang, Diana; Hunt, Elizabeth G.; Morris, Morgan E.; Rovini, Amandine; Heslop, Kareem A.; Beeson, Gyda C.; Beeson, Craig C.; Maldonado, Eduardo N.] Med Univ South Carolina, Dept Drug Discovery & Biomed Sci, Drug Discovery Bldg 506,70 President St-MSC 139, Charleston, SC 29425 USA; [Maldonado, Eduardo N.] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Maldonado, EN (corresponding author), Med Univ South Carolina, Dept Drug Discovery & Biomed Sci, Drug Discovery Bldg 506,70 President St-MSC 139, Charleston, SC 29425 USA.	maldona@musc.edu	Maldonado, Eduardo/AAN-3907-2020; rovini, amandine/W-1703-2019	Rovini, Amandine/0000-0003-0483-9092; Maldonado, Eduardo/0000-0002-5285-3027; Heslop, Kareem/0000-0002-2618-2530	U.S. National Institutes of Health (NIH) National Cancer Institute (NCI) [RO1 CA184456]; NIH National Institute of General Medical Sciences [P20 GM103542]; NCI [R01CA184456-02]; South Carolina COBRE in Oxidants, Redox Balance, and Stress Signaling (NIH National Institute of General Medical Sciences Grant) [P20 GM103542]; NATIONAL CANCER INSTITUTE [R01CA184456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM072643, P20GM103542] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); South Carolina COBRE in Oxidants, Redox Balance, and Stress Signaling (NIH National Institute of General Medical Sciences Grant); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by the U.S. National Institutes of Health (NIH) National Cancer Institute (NCI) Grant RO1 CA184456 and NIH National Institute of General Medical Sciences Grant P20 GM103542 [Centers of Biomedical Research Excellence (COBRE) Investigator] to E.N.M., and an NCI Administrative Supplement (R01CA184456-02) to M.E.M. The Cell and Molecular Imaging Shared Resource and the Medical University of South Carolina (MUSC) Bioenergetic Profiling Core Facility are supported, in part, by the South Carolina COBRE in Oxidants, Redox Balance, and Stress Signaling (NIH National Institute of General Medical Sciences Grant P20 GM103542). The authors declare no conflicts of interest.	Allen SC, 2017, J PHARMACOL EXP THER, V362, P319, DOI 10.1124/jpet.117.242081; Arca M, 2011, DIABETES METAB SYNDR, V4, P155, DOI 10.2147/DMSO.S11244; Ballantyne CM, 2003, ARCH INTERN MED, V163, P553, DOI 10.1001/archinte.163.5.553; Beeson CC, 2010, ANAL BIOCHEM, V404, P75, DOI 10.1016/j.ab.2010.04.040; Bergstrom JD, 1998, BBA-LIPID LIPID MET, V1389, P213, DOI 10.1016/S0005-2760(97)00182-3; Bitzur R, 2013, DIABETES CARE, V36, pS325, DOI 10.2337/dcS13-2038; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boudreau DM, 2010, EXPERT OPIN DRUG SAF, V9, P603, DOI 10.1517/14740331003662620; Cui QB, 2017, FUTURE MED CHEM, V9, P929, DOI 10.4155/fmc-2017-0011; du Souich P, 2017, PHARMACOL THERAPEUT, V175, P1, DOI 10.1016/j.pharmthera.2017.02.029; Fang D, 2018, ADV CANCER RES, V138, P41, DOI 10.1016/bs.acr.2018.02.002; Gazzerro P, 2012, PHARMACOL REV, V64, P102, DOI 10.1124/pr.111.004994; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Griguer CE, 2005, J NEURO-ONCOL, V74, P123, DOI 10.1007/s11060-004-6404-6; Kawata S, 2001, BRIT J CANCER, V84, P886, DOI 10.1054/bjoc.2000.1716; Keibler MA, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0156-6; Kerkweg U, 2003, TRANSPLANTATION, V76, P501, DOI 10.1097/01.TP.0000069830.78758.1C; Kim JH, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-56; Knox JJ, 2005, EUR J CANCER, V41, P523, DOI 10.1016/j.ejca.2004.12.013; Lemasters JJ, 2007, METHOD CELL BIOL, V80, P283, DOI 10.1016/S0091-679X(06)80014-2; Lemasters JJ, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00303; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Maldonado E. N., 2009, BIOPHYS J, V96, p245A; Maldonado EN, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00004; Maldonado EN, 2016, J BIOL CHEM, V291, P19642, DOI 10.1074/jbc.M116.734814; Maldonado EN, 2013, J BIOL CHEM, V288, P11920, DOI 10.1074/jbc.M112.433847; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; Manjeri GR, 2016, J INHERIT METAB DIS, V39, P59, DOI 10.1007/s10545-015-9885-x; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Mullen PJ, 2011, BBA-MOL CELL RES, V1813, P2079, DOI 10.1016/j.bbamcr.2011.07.019; Mullen PJ, 2010, BIOCHEM PHARMACOL, V79, P1200, DOI 10.1016/j.bcp.2009.12.007; Qi XF, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.44; Ramachandran R, 2017, J CLIN MED, V6, DOI 10.3390/jcm6080075; Relja B, 2010, INT J MOL MED, V26, P733, DOI 10.3892/ijmm_00000520; Sanchez CA, 2008, CANCER INVEST, V26, P698, DOI 10.1080/07357900701874658; Scharnagl H, 2001, BIOCHEM PHARMACOL, V62, P1545, DOI 10.1016/S0006-2952(01)00790-0; Schirris TJJ, 2015, CELL METAB, V22, P399, DOI 10.1016/j.cmet.2015.08.002; Shen YY, 2015, MOL MED REP, V12, P623, DOI 10.3892/mmr.2015.3411; Staffa JA, 2002, NEW ENGL J MED, V346, P539, DOI 10.1056/NEJM200202143460721; Stryjkowska-Gora A, 2015, WSPOLCZESNA ONKOL, V19, P167, DOI 10.5114/wo.2014.44294; Sutter AP, 2005, J HEPATOL, V43, P808, DOI 10.1016/j.jhep.2005.04.010; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; Tomiyama N, 2008, BIOL PHARM BULL, V31, P369, DOI 10.1248/bpb.31.369; Wang Y, 2013, EXP EYE RES, V113, P128, DOI 10.1016/j.exer.2013.05.013; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wei N, 2007, CELL MOL BIOL LETT, V12, P1, DOI 10.2478/s11658-006-0050-2; Zeiser R, 2018, IMMUNOLOGY, V154, P69, DOI 10.1111/imm.12902	48	19	19	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8186	8201		10.1096/fj.201802723R	http://dx.doi.org/10.1096/fj.201802723R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30951369	Green Published, Bronze			2022-12-28	WOS:000476234700031
J	Lynn, EG; Lhotak, S; Lebeau, P; Byun, JH; Chen, J; Platko, K; Shi, CH; O'Brien, ER; Austin, RC				Lynn, Edward G.; Lhotak, Sarka; Lebeau, Paul; Byun, Jae Hyun; Chen, Jack; Platko, Khrystyna; Shi, Chunhua; O'Brien, Edward R.; Austin, Richard C.			4-Phenylbutyrate protects against atherosclerotic lesion growth by increasing the expression of HSP25 in macrophages and in the circulation of Apoe(-/-) mice	FASEB JOURNAL			English	Article						atherosclerosis; mouse; chaperones; small HSP	ENDOPLASMIC-RETICULUM STRESS; HIGH-DENSITY-LIPOPROTEIN; ER STRESS; PROTEOMIC APPROACH; PLAQUE NECROSIS; APOPTOSIS; HEAT-SHOCK-PROTEIN-27; ACTIVATION; PROGRESSION; ESTROGEN	Endoplasmic reticulum stress plays an important role in cardiovascular disease (CVD) and atherosclerosis. We aimed to assess the ability of 4-phenylbutyrate (4-PBA), a small chemical chaperone administered via drinking water, to reduce atherosclerotic lesion size in chow-fed apolipoprotein (Apo) e(-/-) mice and to identify mechanisms that contribute to its antiatherogenic effect. Chow-fed 17-wk-old female Apoe(-/-) mice treated with 4-PBA-supplemented drinking water for 5 wk exhibited smaller lesions as well as increased plasma levels of heat shock protein (HSP) 25, the mouse homolog of human HSP27, compared with controls. In addition, 4-PBA inhibited cell death and increased HSP27 expression as measured by real-time PCR and immunoblotting, as well as induced nuclear localization of its transcription factor, heat shock factor 1, in human monocyte/macrophage (THP-1) cells. Furthermore, HSP27 small interfering RNA diminished the protective effect of 4-PBA on THP-1 macrophage attachment and differentiation. In summary, drinking water containing 4-PBA attenuated early lesion growth in Apoe(-/-) mice fed a chow diet and increased expression of HSP25 and HSP27 in macrophages and HSP25 in the circulation of Apoe(-/-) mice. Given that increased expression of HSP27 is inversely correlated with CVD risk, our findings suggest that 4-PBA protects against the early stages of atherogenesis in part by enhancing HSP27 levels, leading to inhibition of both macrophage cell death and monocyte-macrophage differentiation.-Lynn, E. G., Lhotak, S., Lebeau, P., Byun, J. H., Chen, J., Platko, K., Shi, C., O'Brien, E. R., Austin, R. C. 4-Phenylbutyrate protects against atherosclerotic lesion growth by increasing the expression of HSP25 in macrophages and in the circulation of Apoe(-/-) mice.	[Lynn, Edward G.; Lhotak, Sarka; Lebeau, Paul; Byun, Jae Hyun; Chen, Jack; Platko, Khrystyna; Austin, Richard C.] McMaster Univ, St Joes Hamilton Hamilton Ctr Kidney Res, Res Inst, Div Nephrol,Dept Med, Hamilton, ON, Canada; [Shi, Chunhua; O'Brien, Edward R.] Univ Calgary, Cumming Sch Med, Libin Cardiovasc Inst Alberta, Dept Cardiac Sci, Calgary, AB, Canada	McMaster University; Libin Cardiovascular Institute Of Alberta; University of Calgary	Austin, RC (corresponding author), McMaster Univ, 50 Charlton St East, Hamilton, ON L8N 4A6, Canada.; Austin, RC (corresponding author), St Josephs Healthcare, 50 Charlton St East, Hamilton, ON L8N 4A6, Canada.	austinr@taari.ca	Chen, Jack/Y-1940-2019	Chen, Jack/0000-0002-3939-8672; Byun, Jae Hyun/0000-0002-1231-511X; Lynn, Edward/0000-0002-8011-5558	Heart and Stroke Foundation of Canada [G-15-0009389]; Canadian Institutes of Health Research (CIHR) [MOP-286787]; CIHR; Medtronic Canada [IRC 57093]; Canadian Foundation for Innovation Leaders Opportunity Fund; Institute of St. Joe's Hamilton	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Medtronic Canada(Medtronic); Canadian Foundation for Innovation Leaders Opportunity Fund(Canada Foundation for Innovation); Institute of St. Joe's Hamilton	The authors thank Kaushik Sripada and Baofeng Jia (both from McMaster University) for technical assistance. This work was supported, in part, by research grants to R.C.A. from the Heart and Stroke Foundation of Canada (G-15-0009389) and the Canadian Institutes of Health Research (CIHR) (MOP-286787). Financial support from The Institute of St. Joe's Hamilton is acknowledged. This work was also supported by a research operation grant to E.R.O. from the CIHR and Medtronic Canada (ISO 110836). CIHR and Medtronic Canada collectively provided E.R.O. with a peer-reviewed Research Chair (IRC 57093). E.R.O. also received a Canadian Foundation for Innovation, Leaders Opportunity Fund grant to acquire major research equipment. R.C.A. is a Career Investigator of the Heart and Stroke Foundation of Ontario and holds the Amgen Canada Research Chair in the Division of Nephrology at St. Joseph's Healthcare and McMaster University. The authors declare no conflicts of interest.	Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Arrigo AP, 2007, ADV EXP MED BIOL, V594, P14; Ayaub EA, 2016, J PATHOL, V239, P411, DOI 10.1002/path.4738; Batulan Z, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00285; Canfran-Duque A, 2017, EMBO MOL MED, V9, P1244, DOI 10.15252/emmm.201607492; Carlisle RE, 2016, J HYPERTENS, V34, P1556, DOI 10.1097/HJH.0000000000000943; Cuerrier CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055867; Di MX, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.277; Dickhout JG, 2007, CIRCULATION, V116, P1214, DOI 10.1161/CIRCULATIONAHA.107.728378; Dickhout JG, 2011, FASEB J, V25, P576, DOI 10.1096/fj.10-159319; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Gong B, 2010, MOL VIS, V16, P997; Hossain GS, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000134; Huang A, 2017, ATHEROSCLEROSIS, V266, P103, DOI 10.1016/j.atherosclerosis.2017.09.034; ISNER JM, 1995, CIRCULATION, V91, P2703, DOI 10.1161/01.CIR.91.11.2703; Jian L, 2016, MED SCI MONITOR, V22, P5218, DOI 10.12659/MSM.898623; Jin YH, 2015, BIOCHEM BIOPH RES CO, V464, P561, DOI 10.1016/j.bbrc.2015.07.006; Kemter E, 2014, J BIOL CHEM, V289, P10715, DOI 10.1074/jbc.M113.537035; Kuang HJ, 2017, EUR J PHARMACOL, V810, P57, DOI 10.1016/j.ejphar.2017.06.015; Lebeau P, 2017, J BIOL CHEM, V292, P1510, DOI 10.1074/jbc.M116.744235; Lepedda AJ, 2009, ATHEROSCLEROSIS, V203, P112, DOI 10.1016/j.atherosclerosis.2008.07.001; Lhotak S, 2011, METHOD ENZYMOL, V489, P23, DOI 10.1016/B978-0-12-385116-1.00002-9; Liang WZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26231; Liao D, 2006, CIRC RES, V99, P598, DOI 10.1161/01.RES.0000242559.42077.22; Lin Y, 2016, MOL MED REP, V13, P1509, DOI 10.3892/mmr.2015.4708; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Martin-Ventura JL, 2004, CIRCULATION, V110, P2216, DOI 10.1161/01.CIR.0000136814.87170.B1; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Miller AC, 2017, INT J RADIAT BIOL, V93, P907, DOI 10.1080/09553002.2017.1350301; Miller H, 2005, ARTERIOSCL THROM VAS, V25, pE10, DOI 10.1161/01.ATV.0000156536.89752.8e; Mohammadi A, 2015, CELL MOL BIOL, V61, P94; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Naidu SD, 2017, FEBS J, V284, P1606, DOI 10.1111/febs.13999; Park CG, 1996, IMMUNITY, V4, P583, DOI 10.1016/S1074-7613(00)80484-7; Park HK, 2006, CIRCULATION, V114, P886, DOI 10.1161/CIRCULATIONAHA.105.541219; Pruliere-Escabasse V, 2007, J BIOL CHEM, V282, P34048, DOI 10.1074/jbc.M702384200; Rayner K, 2008, CIRC RES, V103, P133, DOI 10.1161/CIRCRESAHA.108.172155; Seibert TA, 2013, J AM COLL CARDIOL, V62, P1446, DOI 10.1016/j.jacc.2013.05.041; Shafi S, 2016, INT J EXP PATHOL, V97, P56, DOI 10.1111/iep.12167; Sharma D, 2016, NEUROSCI LETT, V635, P83, DOI 10.1016/j.neulet.2016.10.038; Takaguri A, 2017, EUR J PHARMACOL, V815, P470, DOI 10.1016/j.ejphar.2017.09.033; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Tian X, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4847874; Venu VKP, 2017, FASEB J, V31, P2364, DOI 10.1096/fj.201601188R; Wang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087787; Wang HF, 2018, CNS NEUROSCI THER, V24, P29, DOI 10.1111/cns.12771; Weng S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054625; West JD, 2012, CHEM RES TOXICOL, V25, P2036, DOI 10.1021/tx300264x; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Yang MY, 2018, ACTA PHARMACOL SIN, V39, P48, DOI 10.1038/aps.2017.81; Yao ST, 2017, J LIPID RES, V58, P164, DOI 10.1194/jlr.M071142; Yao ST, 2014, J BIOL CHEM, V289, P4032, DOI 10.1074/jbc.M113.524512; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1	57	9	9	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8406	8422		10.1096/fj.201802293RR	http://dx.doi.org/10.1096/fj.201802293RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30964709	Bronze			2022-12-28	WOS:000476234700048
J	Sinha, KM; Tseng, C; Guo, P; Lu, AP; Pan, HY; Gao, XQ; Andrews, R; Eltzschig, H; Huard, J				Sinha, Krishna M.; Tseng, Chieh; Guo, Ping; Lu, Aiping; Pan, Haiying; Gao, Xueqin; Andrews, Reid; Eltzschig, Holger; Huard, Johnny			Hypoxia-inducible factor 1 alpha (HIF-1 alpha) is a major determinant in the enhanced function of muscle-derived progenitors from MRL/MpJ mice	FASEB JOURNAL			English	Article						stem cell potency; muscle progenitor cells; myogenic differentiation; tissue regeneration	MORPHOGENETIC PROTEIN 4; HEMATOPOIETIC STEM; CARTILAGE REPAIR; REGULATES PAX7; SELF-RENEWAL; CELLS; ANGIOGENESIS; REGENERATION; METABOLISM; ACTIVATION	Although the mouse strain Murphy Roths Large (MRL/MpJ) possesses high regenerative potential, the mechanism of tissue regeneration, including skeletal muscle, in MRL/MpJ mice after injury is still unclear. Our previous studies have shown that muscle-derived stem/progenitor cell (MDSPC) function is significantly enhanced in MRL/MpJ mice when compared with MDSPCs isolated from age-matched wild-type (WT) mice. Using mass spectrometry-based proteomic analysis, we identified increased expression of hypoxia-inducible factor (HIF) 1 alpha target genes (expression of glycolytic factors and antioxidants) in sera from MRL/MpJ mice compared with WT mice. Therefore, we hypothesized that HIF-1 alpha promotes the high muscle healing capacity of MRL/MpJ mice by increasing the potency of MDSPCs. We demonstrated that treating MRL/MpJ MDSPCs with dimethyloxalylglycine and CoCl2 increased the expression of HIF-1 alpha and target genes, including angiogenic and cell survival genes. We also observed that HIF-1 alpha activated the expression of paired box (Pax)7 through direct interaction with the Pax7 promoter. Furthermore, we also observed a higher myogenic potential of MDSPCs derived from prolyl hydroxylase (Phd) 3-knockout (Phd3(-/-)) mice, which displayed higher stability of HIF-1 alpha. Taken together, our findings suggest that HIF-1 alpha is a major determinant in the increased MDSPC function of MRL/MpJ mice through enhancement of cell survival, proliferation, and myogenic differentiation.-Sinha, K. M., Tseng, C., Guo, P., Lu, A., Pan, H., Gao, X., Andrews, R., Eltzschig, H., Huard, J. Hypoxia-inducible factor 1 alpha (HIF-1 alpha) is a major determinant in the enhanced function of muscle-derived progenitors from MRL/MpJ mice.	[Sinha, Krishna M.; Tseng, Chieh; Guo, Ping; Lu, Aiping; Pan, Haiying; Gao, Xueqin; Andrews, Reid; Huard, Johnny] Univ Texas Hlth Sci Ctr Houston, Dept Orthoped Surg, McGovern Med Sch, 1881 East Rd,3SCR6-4623, Houston, TX 77054 USA; [Eltzschig, Holger] Univ Texas Hlth Sci Ctr Houston, Dept Anesthesiol, McGovern Med Sch, Houston, TX 77054 USA; [Huard, Johnny] Steadman Philippon Res Inst, Vail, CO USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Steadman Philippon Research Institute	Sinha, KM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Orthoped Surg, McGovern Med Sch, 1881 East Rd,3SCR6-4623, Houston, TX 77054 USA.; Huard, J (corresponding author), Steadman Philippon Res Inst, Ctr Regenerat Sports Med, Steadman Clin, 181 West Meadow Dr,Suite 1000, Vail, CO 81657 USA.	krish-na.m.sinha@uth.tmc.edu; jhuard@sprivail.org		Gao, Xueqin/0000-0001-5833-1548	U.S. National Institutes of Health (NIH) National Institute on Aging [PO1AG043376]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [RO1AR065445]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK097075, R01-DK109574, POI-HL114457, R01-HL109233]; NIH National Heart, Lung, and Blood Institute [R01-HL119837, R01-HL133900]; Department of Orthopedic Surgery, McGovern Medical School, University of Texas Health Science Center-Houston; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114457, R01HL119837, R01HL109233, R01HL133900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK109574, R01DK097075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG043376] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute on Aging; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Orthopedic Surgery, McGovern Medical School, University of Texas Health Science Center-Houston; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Ling Zhong (University of Texas Health Science Center) for microscopy work, and Dr. Mary A. Hall (University of Texas Health Science Center) for editorial assistance. This research was supported, in part, by grants from the U.S. National Institutes of Health (NIH) National Institute on Aging (PO1AG043376, to J.H.) and the NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (RO1AR065445, to J.H.), and institutional startup funding from the Department of Orthopedic Surgery, McGovern Medical School, University of Texas Health Science Center-Houston. Funding for H.E. comes from NIH National Institute of Diabetes and Digestive and Kidney Diseases Grants R01-DK097075 and R01-DK109574, POI-HL114457, R01-HL109233, and NIH National Heart, Lung, and Blood Institute Grants R01-HL119837, and R01-HL133900. The authors declare no conflicts of interest.	Aranha AMF, 2010, J ENDODONT, V36, P1633, DOI 10.1016/j.joen.2010.05.013; Befani C, 2013, INT J BIOCHEM CELL B, V45, P2359, DOI 10.1016/j.biocel.2013.07.025; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Bustos F, 2015, STEM CELLS, V33, P3138, DOI 10.1002/stem.2125; Chen H. C., 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/3595374506838; Cirillo F, 2017, FASEB J, V31, P2146, DOI 10.1096/fj.201600878R; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Corrado C, 2013, INT J MOL SCI, V14, P5338, DOI 10.3390/ijms14035338; De Miguel MP, 2015, CURR MOL MED, V15, P343; Fitzgerald J, 2017, SEMIN CELL DEV BIOL, V62, P78, DOI 10.1016/j.semcdb.2016.04.018; Gao XQ, 2014, FASEB J, V28, P3792, DOI 10.1096/fj.13-247965; Gao XQ, 2014, BIOMATERIALS, V35, P6859, DOI 10.1016/j.biomaterials.2014.04.113; Gao XQ, 2013, CELL TRANSPLANT, V22, P2393, DOI 10.3727/096368912X658854; Gonzalez N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154919; Gumucio JP, 2017, BONE JOINT RES, V6, P57, DOI 10.1302/2046-3758.61.BJR-2016-0232.R1; Haigis MC, 2010, MOL CELL, V40, P333, DOI 10.1016/j.molcel.2010.10.002; Harms KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009767; Hasko G, 2018, BIOCHEM PHARMACOL, V151, P307, DOI 10.1016/j.bcp.2018.02.002; Heydemann Ahlke, 2012, Front Biol (Beijing), V7, P522; Heydemann A, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-26; Hill P, 2008, J AM SOC NEPHROL, V19, P39, DOI 10.1681/ASN.2006090998; Jash S, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/961307; Kaufman DS, 2010, NAT CELL BIOL, V12, P926, DOI 10.1038/ncb1010-926; Kuroda R, 2006, ARTHRITIS RHEUM-US, V54, P433, DOI 10.1002/art.21632; Kwiatkowski A, 2016, BIOCHEM BIOPH RES CO, V473, P907, DOI 10.1016/j.bbrc.2016.03.149; Leibovich SJ, 2002, AM J PATHOL, V160, P2231, DOI 10.1016/S0002-9440(10)61170-4; Leonard CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131661; Li HS, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.65; Liu WY, 2012, DEVELOPMENT, V139, P2857, DOI 10.1242/dev.079665; Majmundar AJ, 2015, DEVELOPMENT, V142, P2405, DOI 10.1242/dev.123026; Mannello F, 2011, INT J DEV BIOL, V55, P569, DOI 10.1387/ijdb.103186fm; Matsumoto T, 2009, ARTHRITIS RHEUM-US, V60, P1390, DOI 10.1002/art.24443; Michaeli TF, 2015, AGING CELL, V14, P698, DOI 10.1111/acel.12286; Montesinos MC, 2004, AM J PATHOL, V164, P1887, DOI 10.1016/S0002-9440(10)63749-2; Myllyharju J, 2013, BIOL CHEM, V394, P435, DOI 10.1515/hsz-2012-0328; Palomaki S, 2013, STEM CELLS, V31, P1902, DOI 10.1002/stem.1435; Park HS, 2016, MOL MED REP, V14, P4706, DOI 10.3892/mmr.2016.5796; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Quattrocelli M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.401; Rai MF, 2014, MATRIX BIOL, V39, P50, DOI 10.1016/j.matbio.2014.08.011; Rigamonti E, 2013, J IMMUNOL, V190, P1767, DOI 10.4049/jimmunol.1202903; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; Speth JM, 2014, BLOOD, V123, P203, DOI 10.1182/blood-2013-07-516336; Sun K, 2013, MOL CELL BIOL, V33, P904, DOI 10.1128/MCB.00951-12; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Tseng C, 2019, STEM CELLS, V37, P357, DOI 10.1002/stem.2957; Turner NJ, 2010, ARCH HISTOL CYTOL, V73, P103, DOI 10.1679/aohc.73.103; Ueno M, 2005, INVEST OPHTH VIS SCI, V46, P4097, DOI 10.1167/iovs.05-0548; van der Horst IWJM, 2011, PEDIATR DEVEL PATHOL, V14, P384, DOI 10.2350/09-09-0705-OA.1; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Wang KY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195156; Wen YF, 2012, MOL CELL BIOL, V32, P2300, DOI 10.1128/MCB.06753-11; Yang X, 2017, J BIOL CHEM, V292, P5981, DOI 10.1074/jbc.M116.756312; Yuan Q, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/s12896-014-0112-x; Zhang CC, 2014, ANTIOXID REDOX SIGN, V20, P1891, DOI 10.1089/ars.2012.5019; Zhang Y., 2015, SCI TRANSL MED, V7, P290; Zheng B, 2007, NAT BIOTECHNOL, V25, P1025, DOI 10.1038/nbt1334; Zins SR, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-25	60	10	10	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8321	8334		10.1096/fj.201801794R	http://dx.doi.org/10.1096/fj.201801794R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30970214	Bronze, Green Published			2022-12-28	WOS:000476234700042
J	Tran, TTT; Corsini, S; Kellingray, L; Hegarty, C; Le Gall, G; Narbad, A; Muller, M; Tejera, N; O'Toole, PW; Minihane, AM; Vauzour, D				Tran, Tam T. T.; Corsini, Simone; Kellingray, Lee; Hegarty, Claire; Le Gall, Gwenaelle; Narbad, Arjan; Muller, Michael; Tejera, Noemi; O'Toole, Paul W.; Minihane, Anne-Marie; Vauzour, David			APOE genotype influences the gut microbiome structure and function in humans and mice: relevance for Alzheimer's disease pathophysiology	FASEB JOURNAL			English	Article						apolipoprotein E; gut microbiota; metabolomics; butyrate; SCFAs	APOLIPOPROTEIN-E GENOTYPE; BUTYRATE-PRODUCING BACTERIA; CHAIN FATTY-ACIDS; SIGNAL-TRANSDUCTION; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; HOST GENETICS; MOUSE MODEL; DIVERSITY; BRAIN	Apolipoprotein E (APOE) genotype is the strongest prevalent genetic risk factor for Alzheimer's disease (AD). Numerous studies have provided insights into the pathologic mechanisms. However, a comprehensive understanding of the impact of APOE genotype on microflora speciation and metabolism is completely lacking. In this study, we investigated the association between APOE genotype and the gut microbiome composition in human and APOE-targeted replacement (TR) transgenic mice. Fecal microbiota amplicon sequencing from matched individuals with different APOE genotypes revealed no significant differences in overall microbiota diversity in group-aggregated human APOE genotypes. However, several bacterial taxa showed significantly different relative abundance between APOE genotypes. Notably, we detected an association of Prevotellaceae and Ruminococcaceae and several butyrate-producing genera abundances with APOE genotypes. These findings were confirmed by comparing the gut microbiota of APOE-TR mice. Furthermore, metabolomic analysis of murine fecal water detected significant differences in microbe-associated amino acids and short-chain fatty acids between APOE genotypes. Together, these findings indicate that APOE genotype is associated with specific gut microbiome profiles in both humans and APOE-TR mice. This suggests that the gut microbiome is worth further investigation as a potential target to mitigate the deleterious impact of the APOE4 allele on cognitive decline and the prevention of AD.-Tran, T. T. T., Corsini, S., Kellingray, L., Hegarty, C., Le Gall, G., Narbad, A., Muller, M., Tejera, N., O'Toole, P. W., Minihane, A.-M., Vauzour, D. APOE genotype influences the gut microbiome structure and function in humans and mice: relevance for Alzheimer's disease pathophysiology.	[Tran, Tam T. T.; Hegarty, Claire; O'Toole, Paul W.] Univ Coll Cork, Alimentary Pharmabiot Ctr APC Microbiome Ireland, Cork, Ireland; [Tran, Tam T. T.; Hegarty, Claire; O'Toole, Paul W.] Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Corsini, Simone; Muller, Michael; Tejera, Noemi; Minihane, Anne-Marie; Vauzour, David] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England; [Kellingray, Lee; Le Gall, Gwenaelle; Narbad, Arjan] Quadram Inst Biosci, Norwich Res Pk, Norwich, Norfolk, England	University College Cork; University College Cork; University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute	Vauzour, D (corresponding author), Univ East Anglia, Fac Med & Hlth Sci, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England.	d.vauzour@uea.ac.uk	O'Toole, Paul W/G-1593-2012; Le+Gall, Gwenaelle/AAC-6938-2019; Vauzour, Dr David/C-2245-2008; Muller, Michael/B-5795-2008	O'Toole, Paul W/0000-0001-5377-0824; Le+Gall, Gwenaelle/0000-0002-1379-2196; Vauzour, Dr David/0000-0001-5952-8756; Muller, Michael/0000-0002-5930-9905; Tran, Tam/0000-0002-7691-2888	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M004449/1]; Science Foundation Ireland [APC/SFI/12/RC/2273]; Food Institutional Research Measure (FIRM) Program; Immunomet Project of the Government of Ireland's Department of Agriculture, Food, and the Marine; NCBI Sequence Read Archive (SRA), under BioProject [PRJNA533610]; BBSRC [BBS/E/F/000PR10353, BBS/E/F/00044453, BB/M004449/1, BBS/E/F/000PR10356] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Food Institutional Research Measure (FIRM) Program; Immunomet Project of the Government of Ireland's Department of Agriculture, Food, and the Marine; NCBI Sequence Read Archive (SRA), under BioProject; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank the study participants for contributing samples and time to the studies used to generate the data. The authors also acknowledge the many CANN and COB trial colleagues who facilitated this study. This project was supported, in part by a Biotechnology and Biological Sciences Research Council (BBSRC) grant to the laboratory of A.-M.M. and D.V. (BB/M004449/1). Work in P.W.O.'s laboratory was supported, in part, by a Grant from the Science Foundation Ireland (APC/SFI/12/RC/2273) in the form of the Alimentary Pharmabiotic Centre (APC) Microbiome Ireland, the Food Institutional Research Measure (FIRM) Program, and the Immunomet Project of the Government of Ireland's Department of Agriculture, Food, and the Marine. A.-M.M. and D.V. share senior authorship. The datasets used and/or analyzed during the current study are available at the NCBI Sequence Read Archive (SRA), under BioProject PRJNA533610. The authors declare no conflicts of interest.	[Anonymous], 2021, LANG ENV STAT COMP; Beaumont M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1052-7; Bennett MC, 2005, PHARMACOL THERAPEUT, V105, P311, DOI 10.1016/j.pharmthera.2004.10.010; Bhattacharjee S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00153; Bonder MJ, 2016, NAT GENET, V48, P1407, DOI 10.1038/ng.3663; Calabuig-Navarro MV, 2014, J NUTR, V144, P1775, DOI 10.3945/jn.114.197244; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Crews L, 2009, NEUROTOX RES, V16, P306, DOI 10.1007/s12640-009-9073-6; de-Almada BVP, 2012, BRAZ J MED BIOL RES, V45, P8, DOI [10.1590/S0100-879X2011007500151, 10.1590/S0100-879X2012000100002]; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Duncan SH, 2002, APPL ENVIRON MICROB, V68, P5186, DOI 10.1128/AEM.68.10.5186-5190.2002; Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Flemer B, 2017, GUT MICROBES, V8, P428, DOI 10.1080/19490976.2017.1334033; Forsyth CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028032; Friedland RP, 2015, J ALZHEIMERS DIS, V45, P349, DOI 10.3233/JAD-142841; Ghaisas S, 2016, PHARMACOL THERAPEUT, V158, P52, DOI 10.1016/j.pharmthera.2015.11.012; GOSSLING J, 1975, INT J SYST BACTERIOL, V25, P202, DOI 10.1099/00207713-25-2-202; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Heo MS, 1998, COMMUN STAT-SIMUL C, V27, P843, DOI 10.1080/03610919808813512; Ho L, 2018, EXPERT REV NEUROTHER, V18, P83, DOI 10.1080/14737175.2018.1400909; Hoffman JD, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00298; Holmqvist S, 2014, ACTA NEUROPATHOL, V128, P805, DOI 10.1007/s00401-014-1343-6; Huang YD, 2004, J MOL NEUROSCI, V23, P189, DOI 10.1385/JMN:23:3:189; HUI DY, 1980, J BIOL CHEM, V255, P1775; Ishigami M, 1998, J BIOL CHEM, V273, P20156, DOI 10.1074/jbc.273.32.20156; Jellinger KA, 2003, ACTA NEUROPATHOL, V106, P191, DOI 10.1007/s00401-003-0725-y; Jofre-Monseny L, 2008, MOL NUTR FOOD RES, V52, P131, DOI 10.1002/mnfr.200700322; Kellingray L, 2018, J INFECTION, V77, P107, DOI 10.1016/j.jinf.2018.04.012; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kostidis S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2351-7; Lamichhane S, 2015, ANAL CHEM, V87, P5930, DOI 10.1021/acs.analchem.5b00977; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Le Gall Gwenaelle, 2018, Oncotarget, V9, P33278, DOI 10.18632/oncotarget.26022; Le Gall Gwenaelle, 2015, Methods Mol Biol, V1277, P29, DOI 10.1007/978-1-4939-2377-9_3; Le Gall G, 2011, J PROTEOME RES, V10, P4208, DOI 10.1021/pr2003598; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; MACY JM, 1978, J BACTERIOL, V134, P84, DOI 10.1128/JB.134.1.84-91.1978; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Maukonen J, 2006, FEMS MICROBIOL ECOL, V58, P517, DOI 10.1111/j.1574-6941.2006.00179.x; Minter MR, 2016, SCI REP-UK, V6, DOI 10.1038/srep30028; Neu SC, 2017, JAMA NEUROL, V74, P1178, DOI 10.1001/jamaneurol.2017.2188; O'Toole PW, 2015, SCIENCE, V350, P1214, DOI 10.1126/science.aac8469; PEPE MG, 1986, J IMMUNOL, V136, P3716; Pontifex M, 2018, NEUROBIOL AGING, V69, P209, DOI 10.1016/j.neurobiolaging.2018.05.017; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; REYLAND ME, 1991, J BIOL CHEM, V266, P21099; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Rune I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146439; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Saric J, 2008, J PROTEOME RES, V7, P352, DOI 10.1021/pr070340k; Scheperjans F, 2015, MOVEMENT DISORD, V30, P350, DOI 10.1002/mds.26069; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shi Y, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01948; SHORE VG, 1973, BIOCHEMISTRY-US, V12, P502, DOI 10.1021/bi00727a022; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Tremlett H, 2017, ANN NEUROL, V81, P369, DOI 10.1002/ana.24901; Turpin W, 2016, NAT GENET, V48, P1413, DOI 10.1038/ng.3693; Unger MM, 2016, PARKINSONISM RELAT D, V32, P66, DOI 10.1016/j.parkreldis.2016.08.019; Van den Abbeele P, 2013, ISME J, V7, P949, DOI 10.1038/ismej.2012.158; Vauzour D, 2012, NUTR AGING, V1, P41; Vogt NM, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0451-2; Vogt NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13601-y; Wu JF, 2010, ANALYST, V135, P1023, DOI 10.1039/b927543f; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhang D, 2016, ENVIRON SCI POLLUT R, V23, P23972, DOI 10.1007/s11356-016-7579-z; Zhang L, 2017, J ALZHEIMERS DIS, V60, P1241, DOI 10.3233/JAD-170020; Zhu YG, 2012, GLIA, V60, P559, DOI 10.1002/glia.22289	76	66	69	4	27	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8221	8231		10.1096/fj.201900071R	http://dx.doi.org/10.1096/fj.201900071R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30958695	Green Submitted, Green Published, hybrid, Green Accepted			2022-12-28	WOS:000476234700034
J	Xu, HJ; Liao, W; Liu, XZ; Hu, J; Zou, WZ; Ning, Y; Yang, Y; Li, ZH				Xu, Hai-Jia; Liao, Wen; Liu, Xiang-Zhong; Hu, Jing; Zou, Wen-Zhong; Ning, Yu; Yang, Yi; Li, Zhang-Hua			Down-regulation of exosomal microRNA-224-3p derived from bone marrow-derived mesenchymal stem cells potentiates angiogenesis in traumatic osteonecrosis of the femoral head	FASEB JOURNAL			English	Article						exosomes; FIP200; proliferation; endothelial cells; targeting regulation	PROMOTE TUMOR-GROWTH; EXPRESSION; INHIBITOR; PROTECT; VEGF	Traumatic osteonecrosis of the femoral head (ONFH) is a condition leading to the collapse of the femoral head, and the primary treatment is a total hip replacement, which has a poor prognosis. The current study was conducted with the aim of investigating the role of exosomes from bone marrow-derived mesenchymal stem cells (BM-MSCs) carrying microRNA-224-3p (miR-224-3p) in traumatic ONFH. Initially, a microarray analysis was performed to screen the differentially expressed genes and miRs associated with traumatic ONFH. Patients with traumatic and nontraumatic ONFH were enrolled, and HUVECs were obtained. The BM-MSCs-derived exosomes were purified and characterized, after which HUVECs were cocultured with exosomes. The functional role of miR-224-3p in traumatic ONFH was determined using ectopic expression, depletion, and reporter assay experiments. Endothelial cell proliferation, migration, invasion abilities, and angiogenesis were evaluated. Based on microarray analysis, miR-224-3p was found to be down-regulated, whereas focal adhesion kinase family interacting protein of 200 kDa (FIP200) was up-regulated in ONFH. Traumatic ONFH exosomes resulted in the up-regulation of FIP200 and down-regulation of miR-224-3p. FIP200 was confirmed to be a target gene of miR-224-3p. Exosomes were internalized by vascular endothelial cells. The down-regulation of exosomal miR-224-3p was observed to promote endothelial cell proliferation, migration, invasion abilities, angiogenesis, and FIP200 expression. In addition, FIP200 overexpression promoted angiogenesis. In summary, the results highly indicated that lower miR-224-3p levels in exosomes derived from BM-MSCs promote angiogenesis of traumatic ONFH by up-regulating FIP200. The present study provides a potential strategy for the treatment of traumatic ONFH.-Xu, H.-J., Liao, W., Liu, X.-Z., Hu, J., Zou, W.-Z., Ning, Y., Yang, Y., Li, Z.-H. Down-regulation of exosomal microRNA-224-3p derived from bone marrow-derived mesenchymal stem cells potentiates angiogenesis in traumatic osteonecrosis of the femoral head.	[Xu, Hai-Jia; Liao, Wen; Liu, Xiang-Zhong; Li, Zhang-Hua] Wuhan Univ, Dept Orthopaed, Wuhan Hosp 3, Tongren Hosp, 216 Guanshan Ave, Wuhan 430074, Hubei, Peoples R China; [Hu, Jing; Zou, Wen-Zhong; Yang, Yi] Wuhan Sports Univ, Wuhan, Hubei, Peoples R China; [Ning, Yu] Hubei Univ Chinese Med, Wuhan, Hubei, Peoples R China	Wuhan University; Wuhan Sports University; Hubei University of Chinese Medicine	Li, ZH (corresponding author), Wuhan Univ, Dept Orthopaed, Wuhan Hosp 3, Tongren Hosp, 216 Guanshan Ave, Wuhan 430074, Hubei, Peoples R China.	lizhanghua_lzh@163.com		Xiangzhong, Liu/0000-0002-9664-9167	National Natural Science Foundation of China [81472103, 81071463]; Key Project of the Natural Science Foundation of Hubei Province [2015CFA079]; Applied Basic Research Program of Wuhan Municipal Bureau of Science and Technology [2015061701011626]; Wuhan Innovative Talent Development; Training Program for Young and Middle-aged Medical Talents in Wuhan Municipal Planning Commission; Health Family Planning Research Fund of Wuhan City [WX18M01]; Wuhan City Huanghe Talent Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the Natural Science Foundation of Hubei Province; Applied Basic Research Program of Wuhan Municipal Bureau of Science and Technology; Wuhan Innovative Talent Development; Training Program for Young and Middle-aged Medical Talents in Wuhan Municipal Planning Commission; Health Family Planning Research Fund of Wuhan City; Wuhan City Huanghe Talent Program	The authors thank all participants enrolled in the present study. This work is supported by the National Natural Science Foundation of China (81472103, 81071463), Key Project of the Natural Science Foundation of Hubei Province (2015CFA079), the Applied Basic Research Program of Wuhan Municipal Bureau of Science and Technology (2015061701011626), Wuhan Innovative Talent Development Funding Project, Training Program for Young and Middle-aged Medical Talents in Wuhan Municipal Planning Commission, Health Family Planning Research Fund of Wuhan City (WX18M01), and Wuhan City Huanghe Talent Program. The authors declare no conflicts of interest.	Aoyama K, 2016, APPETITE, V105, P8, DOI 10.1016/j.appet.2016.05.008; Cao ZX, 2011, CELL PHYSIOL BIOCHEM, V27, P565, DOI 10.1159/000329978; Chen YX, 2017, CELL PHYSIOL BIOCHEM, V42, P2391, DOI 10.1159/000480181; Chiba M, 2012, ONCOL REP, V28, P1551, DOI 10.3892/or.2012.1967; Dong YL, 2017, MOL MED REP, V16, P9331, DOI 10.3892/mmr.2017.7808; Gao YS, 2010, INT ORTHOP, V34, P779, DOI 10.1007/s00264-010-1009-5; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Geng S, 2016, J CELL MOL MED, V20, P1611, DOI 10.1111/jcmm.12852; Guo SC, 2016, INT J BIOL SCI, V12, P1262, DOI 10.7150/ijbs.16150; Guo X, 2015, ONCOTARGET, V6, P41620, DOI 10.18632/oncotarget.5871; Hang DH, 2012, CELLS TISSUES ORGANS, V195, P495, DOI 10.1159/000329502; Hao C, 2016, SCI REP-UK, V6, DOI 10.1038/srep22599; Kusuma RJ, 2016, AM J PHYSIOL-CELL PH, V310, pC800, DOI 10.1152/ajpcell.00169.2015; Li H, 2018, THERANOSTICS, V8, P2079, DOI 10.7150/thno.21895; Li XC, 2016, CYTOTHERAPY, V18, P253, DOI 10.1016/j.jcyt.2015.11.009; Liu XL, 2017, INT J BIOL SCI, V13, P232, DOI 10.7150/ijbs.16951; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; Ono M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005231; Qi J, 2017, CELL PHYSIOL BIOCHEM, V42, P2242, DOI 10.1159/000479998; Radke S, 2006, J ORTHOP RES, V24, P945, DOI 10.1002/jor.20097; Rager TM, 2016, J PEDIATR SURG, V51, P942, DOI 10.1016/j.jpedsurg.2016.02.061; Ramachandran M, 2007, J BONE JOINT SURG AM, V89A, P1727, DOI 10.2106/JBJS.F.00964; Sasahira T, 2012, BRIT J CANCER, V107, P700, DOI 10.1038/bjc.2012.330; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Tian T, 2013, J CELL PHYSIOL, V228, P1487, DOI 10.1002/jcp.24304; Vicencio JM, 2015, J AM COLL CARDIOL, V65, P1525, DOI 10.1016/j.jacc.2015.02.026; Wang F, 2016, SCI REP-UK, V6, DOI 10.1038/srep33229; Wen Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037503; Yamasaki K, 2012, J ORTHOP RES, V30, P1263, DOI 10.1002/jor.22079; Yang F, 2018, CELL PHYSIOL BIOCHEM, V46, P2561, DOI 10.1159/000489684; Yuan KF, 2013, GASTROENTEROLOGY, V145, P853, DOI 10.1053/j.gastro.2013.06.008; Zalavras CG, 2014, J AM ACAD ORTHOP SUR, V22, P455, DOI 10.5435/JAAOS-22-07-455; Zhao HX, 2017, J CELL BIOCHEM, V118, P2072, DOI 10.1002/jcb.25812; Zhao WJ, 2017, MOL MED REP, V16, P5434, DOI 10.3892/mmr.2017.7230; Zhao WY, 2013, BIOCHEM BIOPH RES CO, V435, P466, DOI 10.1016/j.bbrc.2013.05.010; Zhi Y, 2016, CELL PHYSIOL BIOCHEM, V39, P1787, DOI 10.1159/000447878; Zhu HY, 2016, BONE JOINT RES, V5, P276, DOI 10.1302/2046-3758.56.BJR-2015-0014.R1; Zhu W, 2012, CANCER LETT, V315, P28, DOI 10.1016/j.canlet.2011.10.002	40	23	25	4	26	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8055	8068		10.1096/fj.201801618RRR	http://dx.doi.org/10.1096/fj.201801618RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30964699	Bronze			2022-12-28	WOS:000476234700021
J	Disser, NP; Sugg, KB; Talarek, JR; Sarver, DC; Rourke, BJ; Mendias, CL				Disser, Nathaniel P.; Sugg, Kristoffer B.; Talarek, Jeffrey R.; Sarver, Dylan C.; Rourke, Brennan J.; Mendias, Christopher L.			Insulin-like growth factor 1 signaling in tenocytes is required for adult tendon growth	FASEB JOURNAL			English	Article						tendon fibroblasts; protein synthesis; hypertrophy; extracellular matrix; IGF1	FACTOR-I; COLLAGEN-SYNTHESIS; PROTEIN-SYNTHESIS; TGF-BETA; RECEPTOR SUBSTRATE-1; BINDING-PROTEINS; STEM-CELLS; PHOSPHORYLATION; EXPRESSION; MUSCLE	Tenocytes serve to synthesize and maintain collagen fibrils and other extracellular matrix proteins in tendon. Despite the high prevalence of tendon injury, the underlying biologic mechanisms of postnatal tendon growth and repair are not well understood. IGF1 plays an important role in the growth and remodeling of numerous tissues but less is known about IGF1 in tendon. We hypothesized that IGF1 signaling is required for proper tendon growth in response to mechanical loading through regulation of collagen synthesis and cell proliferation. To test this hypothesis, we conditionally deleted the IGF1 receptor (IGF1R) in scleraxis (Scx)-expressing tenocytes using a tamoxifen-inducible Cre-recombinase system and caused tendon growth in adult mice via mechanical overload of the plantaris tendon. Compared with control Scx-expressing IGFIR-positive (Scx:IGFIR(+)) mice, in which IGF1R is present in tenocytes, mice that lacked IGF1R in their tenocytes [Scx-expressing IGFIR-negative (Scx:IGF1R(Delta)) mice] demonstrated reduced cell proliferation and smaller tendons in response to mechanical loading. Additionally, we identified that both the PI3K/protein kinase B and ERK pathways are activated downstream of IGF1 and interact in a coordinated manner to regulate cell proliferation and protein synthesis. These studies indicate that IGF1 signaling is required for proper postnatal tendon growth and support the potential use of IGF1 in the treatment of tendon disorders.	[Disser, Nathaniel P.; Talarek, Jeffrey R.; Rourke, Brennan J.; Mendias, Christopher L.] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA; [Sugg, Kristoffer B.; Talarek, Jeffrey R.; Sarver, Dylan C.; Rourke, Brennan J.; Mendias, Christopher L.] Univ Michigan, Med Sch, Dept Orthopaed Surg, Ann Arbor, MI 48109 USA; [Sugg, Kristoffer B.; Talarek, Jeffrey R.] Univ Michigan, Med Sch, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Sugg, Kristoffer B.] Univ Michigan, Dept Surg, Med Sch, Sect Plast & Reconstruct Surg, Ann Arbor, MI 48109 USA; [Mendias, Christopher L.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cornell University	Mendias, CL (corresponding author), Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA.	mendiasc@hss.edu	Mendias, Christopher/C-5557-2018	Mendias, Christopher/0000-0002-2384-0171	U.S. National Institutes of Health (NIH) [R01-AR063649, F32-AR067086]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063649, F32AR067086] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors acknowledge technical contributions from Dr. David Oliver (Hospital for Special Surgery) and Dr. James Markworth (University of Michigan). The ScxCreERT2 mice were kindly provided by Dr. Ronen Schweitzer (Shriners Hospital for Children, Portland, OR, USA). This work was supported by U.S. National Institutes of Health (NIH) Grants R01-AR063649 and F32-AR067086. The authors declare no conflicts of interest.	Andreozzi F, 2004, CIRC RES, V94, P1211, DOI 10.1161/01.RES.0000126501.34994.96; Arndt S., 2019, J INVEST DERMATOL; Bahrami Shahram, 2016, Advances in Biological Regulation, V62, P37, DOI 10.1016/j.jbior.2016.05.001; Boros J, 2009, GENOME RES, V19, P1963, DOI 10.1101/gr.093047.109; Cook SJ, 1999, MOL CELL BIOL, V19, P330; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Couppe C, 2008, J APPL PHYSIOL, V105, P805, DOI 10.1152/japplphysiol.90361.2008; Dahlgren LA, 2002, J ORTHOP RES, V20, P910, DOI 10.1016/S0736-0266(02)00009-8; DeFea K, 1997, J BIOL CHEM, V272, P31400, DOI 10.1074/jbc.272.50.31400; Dietrich P, 2000, MAMM GENOME, V11, P196, DOI 10.1007/s003350010037; Doessing S, 2010, EUR J ENDOCRINOL, V163, P853, DOI 10.1530/EJE-10-0818; Ebi H, 2013, P NATL ACAD SCI USA, V110, P21124, DOI 10.1073/pnas.1314124110; Gehmert S, 2008, BIOCHEM BIOPH RES CO, V371, P752, DOI 10.1016/j.bbrc.2008.04.151; Geremia JM, 2018, EUR J APPL PHYSIOL, V118, P1725, DOI 10.1007/s00421-018-3904-1; Goodman CA, 2013, EXERC SPORT SCI REV, V41, P107, DOI 10.1097/JES.0b013e3182798a95; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Gumucio JP, 2019, FASEB J, V33, P7863, DOI 10.1096/fj.201802457RR; Gumucio JP, 2015, EXERC SPORT SCI REV, V43, P93, DOI 10.1249/JES.0000000000000041; Gumucio JP, 2014, J APPL PHYSIOL, V117, P1287, DOI 10.1152/japplphysiol.00720.2014; Gumucio JP, 2013, ENDOCRINE, V43, P12, DOI 10.1007/s12020-012-9751-7; Hamilton DL, 2014, AM J PHYSIOL-ENDOC M, V307, pE365, DOI 10.1152/ajpendo.00674.2013; Hansen M, 2013, SCAND J MED SCI SPOR, V23, P614, DOI 10.1111/j.1600-0838.2011.01431.x; Havis E, 2016, DEVELOPMENT, V143, P3839, DOI 10.1242/dev.136242; Heinemeier KM, 2012, SCAND J MED SCI SPOR, V22, pE1, DOI 10.1111/j.1600-0838.2012.01459.x; Herchenhan A, 2015, GROWTH HORM IGF RES, V25, P13, DOI 10.1016/j.ghir.2014.09.001; Howell K, 2017, SCI REP-UK, V7, DOI 10.1038/srep45238; Hudgens JL, 2016, AM J SPORT MED, V44, P1931, DOI 10.1177/0363546516637176; Huisman E, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-386; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kersten C, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-9; Kongsgaard M, 2009, SCAND J MED SCI SPOR, V19, P790, DOI 10.1111/j.1600-0838.2009.00949.x; Kongsgaard M, 2010, AM J SPORT MED, V38, P749, DOI 10.1177/0363546509350915; Lee CH, 2015, J CLIN INVEST, V125, P2690, DOI [10.1172/JCI84508, 10.1172/JCI81589]; Lejard V, 2011, J BIOL CHEM, V286, P5855, DOI 10.1074/jbc.M110.153106; Lelbach A., 2005, ACTA PHYSIOLOGICA HUNGARICA, V92, P97, DOI 10.1556/APhysiol.92.2005.2.1; Liao JF, 1997, J BIOL CHEM, V272, P25951, DOI 10.1074/jbc.272.41.25951; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Mead Matthew P, 2018, Transl Sports Med, V1, P5, DOI 10.1002/tsm2.6; Mendias CL, 2012, J APPL PHYSIOL, V113, P56, DOI 10.1152/japplphysiol.00301.2012; Millar NL, 2017, NAT REV RHEUMATOL, V13, P110, DOI 10.1038/nrrheum.2016.213; Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Nielsen RH, 2014, J APPL PHYSIOL, V117, P694, DOI 10.1152/japplphysiol.00157.2014; Nielsen RH, 2014, J APPL PHYSIOL, V116, P42, DOI 10.1152/japplphysiol.01084.2013; Olesen JL, 2006, J APPL PHYSIOL, V101, P183, DOI 10.1152/japplphysiol.00636.2005; Paxton JZ, 2012, TISSUE ENG PT A, V18, P277, DOI [10.1089/ten.tea.2011.0336, 10.1089/ten.TEA.2011.0336]; Pickard A, 2019, FASEB J, V33, P7479, DOI 10.1096/fj.201802366RR; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rutledge RG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009731; Schwartz AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120044; Scott A, 2005, J ORTHOP RES, V23, P1219, DOI 10.1016/j.orthres.2004.12.011; Scott A, 2007, ARTHRITIS RHEUM-US, V56, P871, DOI 10.1002/art.22426; Spindler KP, 1996, J ORTHOP RES, V14, P542, DOI 10.1002/jor.1100140407; Stefanovic B, 2013, WIRES RNA, V4, P535, DOI 10.1002/wrna.1177; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; Sugg KB, 2018, AM J PHYSIOL-CELL PH, V314, pC389, DOI 10.1152/ajpcell.00258.2017; Sugg KB, 2017, FEBS LETT, V591, P801, DOI 10.1002/1873-3468.12571; Svensson RB, 2016, J APPL PHYSIOL, V121, DOI 10.1152/japplphysiol.00328.2016; Tahimic CGT, 2016, J BIOL CHEM, V291, P8140, DOI 10.1074/jbc.M115.693598; Tahimic Candice G T, 2013, Front Endocrinol (Lausanne), V4, P6, DOI 10.3389/fendo.2013.00006; Tan Q, 2013, STEM CELLS DEV, V22, P3128, DOI 10.1089/scd.2013.0073; Thomopoulos S, 2009, J ORTHOP RES, V27, P1209, DOI 10.1002/jor.20875; Vassilakos G, 2019, FASEB J, V33, P181, DOI 10.1096/fj.201800459R; Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011; Yakar S, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.234; Yeung CYC, 2019, CURR TOP DEV BIOL, V133, P309, DOI 10.1016/bs.ctdb.2018.11.004	66	17	17	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12680	12695		10.1096/fj.201901503R	http://dx.doi.org/10.1096/fj.201901503R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31536390	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000507461600084
J	Guo, Y; Wei, XB; Yan, H; Qin, Y; Yan, SQ; Liu, J; Zhao, Y; Jiang, F; Lou, HY				Guo, Ying; Wei, Xinbing; Yan, Hua; Qin, Yue; Yan, Shaoqi; Liu, Jia; Zhao, Yong; Jiang, Fan; Lou, Haiyan			TREM2 deficiency aggravates alpha-synuclein-induced neurodegeneration and neuroinflammation in Parkinson's disease models	FASEB JOURNAL			English	Article						microglia; PD; alpha-syn; inflammation	MYELOID CELLS 2; ATTENUATES NEUROINFLAMMATION; MICROGLIAL RESPONSE; UP-REGULATION; ACTIVATION; M1; DIFFERENTIATION; POLARIZATION; VARIANTS; PROTECTS	Variants in the gene encoding the triggering receptor expressed on myeloid cells 2 (TREM2) are known to increase the risk of developing Alzheimer disease and Parkinson's disease (PD). However, the potential role of TREM2 effect on synucleinopathy has not been characterized. In this study, we investigated whether loss of TREM2 function affects alpha-synucleinopathy both in vitro and in vivo. In vitro, BV2 microglial cells were exposed to alpha-synuclein (alpha-syn) in the presence or absence of TREM2 small interference RNA. For in vivo studies, wild-type controls and TREM2 gene knockout mice were intracranially injected in the substantia nigra with adeno-associated viral vectors expressing human alpha-syn (AAV-SYN) to induce PD. Our results revealed that knockdown of TREM2 aggravated alpha-syn-induced inflammatory responses in BV2 cells and caused greater apoptosis in SH-SY5Y cells treated with BV2-conditioned medium. In mice, TREM2 knockout exacerbated dopaminergic neuron loss in response to AAV-SYN. Moreover, both in vitro and in vivo TREM2 deficiency induced a shift from an anti-inflammatory toward a proinflammatory activation status of microglia. These data suggest that impairing microglial TREM2 signaling aggravates proinflammatory responses to alpha-syn and exacerbates alpha-syn-induced neurodegeneration by modulating microglial activation state.	[Guo, Ying; Wei, Xinbing; Qin, Yue; Yan, Shaoqi; Liu, Jia; Zhao, Yong; Lou, Haiyan] Shandong Univ, Sch Med, Dept Pharmacol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China; [Jiang, Fan] Shandong Univ, Sch Med, Dept Pathophysiol, Jinan, Peoples R China; [Yan, Hua] Shandong Univ Tradit Chinese Med, Affiliated Hosp, Dept Gastroenterol, Jinan, Peoples R China	Shandong University; Shandong University; Shandong University of Traditional Chinese Medicine	Lou, HY (corresponding author), Shandong Univ, Sch Med, Dept Pharmacol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	louhaiyan@sdu.edu.cn			Shandong Natural Science Foundation [ZR2018MH043]; Shandong Province Science and Technology Program [2017GSF18187]	Shandong Natural Science Foundation(Natural Science Foundation of Shandong Province); Shandong Province Science and Technology Program	The authors are thankful to Dr. Ruth G. Perez (Texas Tech University Health Science Center, El Paso, TX, USA) for editorial assistance with the manuscript. This work was supported by grants from the Shandong Natural Science Foundation (ZR2018MH043) and the Shandong Province Science and Technology Program (2017GSF18187). The authors declare no conflicts of interest.	Allen Reish HE, 2015, J PARKINSON DIS, V5, P1, DOI DOI 10.3233/JPD-140491; Arcuri C, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00191; Belloli S, 2017, NEUROBIOL AGING, V53, P159, DOI 10.1016/j.neurobiolaging.2017.01.010; Benitez BA, 2013, NEW ENGL J MED, V369, P1567, DOI 10.1056/NEJMc1306509; Butovsky O, 2018, NAT REV NEUROSCI, V19, P622, DOI 10.1038/s41583-018-0057-5; Cantoni C, 2015, ACTA NEUROPATHOL, V129, P429, DOI 10.1007/s00401-015-1388-1; Colonna M, 2016, NAT REV NEUROSCI, V17, P201, DOI 10.1038/nrn.2016.7; Dickson DW, 2018, PARKINSONISM RELAT D, V46, pS30, DOI 10.1016/j.parkreldis.2017.07.033; Gawish R, 2015, FASEB J, V29, P1247, DOI 10.1096/fj.14-260067; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Jay TR, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0197-5; Jha MK, 2016, BIOCHEM PHARMACOL, V103, P1, DOI 10.1016/j.bcp.2015.11.003; Jiang T, 2014, NEUROBIOL AGING, V35, P1243, DOI 10.1016/j.neurobiolaging.2013.11.026; Jiang YH, 2018, CELL PHYSIOL BIOCHEM, V46, P1398, DOI 10.1159/000489155; Joers V, 2017, PROG NEUROBIOL, V155, P57, DOI 10.1016/j.pneurobio.2016.04.006; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kawabori M, 2015, J NEUROSCI, V35, P3384, DOI 10.1523/JNEUROSCI.2620-14.2015; Lastres-Becker I, 2016, ANTIOXID REDOX SIGN, V25, P61, DOI 10.1089/ars.2015.6549; Le WD, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00089; Leyns CEG, 2017, P NATL ACAD SCI USA, V114, P11524, DOI 10.1073/pnas.1710311114; Liu GY, 2016, MOL NEUROBIOL, V53, P4931, DOI 10.1007/s12035-015-9416-7; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Moehle MS, 2015, NEUROSCIENCE, V302, P59, DOI 10.1016/j.neuroscience.2014.11.018; Oliveras-Salva M, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-44; Owens R, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00056; Painter MM, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0040-9; Paloneva J, 2003, J EXP MED, V198, P669, DOI 10.1084/jem.20030027; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Perry VH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009373; Poliani PL, 2015, J CLIN INVEST, V125, P2161, DOI 10.1172/JCI77983; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Rayaprolu S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-19; Ren MR, 2018, EXP NEUROL, V302, P205, DOI 10.1016/j.expneurol.2018.01.016; Saber M, 2017, J NEUROTRAUM, V34, P423, DOI 10.1089/neu.2016.4401; Sheldon KE, 2013, J IMMUNOL, V191, P2290, DOI 10.4049/jimmunol.1202102; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Ulrich JD, 2017, NEURON, V94, P237, DOI 10.1016/j.neuron.2017.02.042; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Zhai Q, 2017, ANESTHESIOLOGY, V127, P98, DOI 10.1097/ALN.0000000000001628; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zhang YW, 2018, BIOCHEM BIOPH RES CO, V499, P797, DOI 10.1016/j.bbrc.2018.03.226; Zheng HH, 2017, J NEUROSCI, V37, P1772, DOI 10.1523/JNEUROSCI.2459-16.2017; Zheng HH, 2016, NEUROBIOL AGING, V42, P132, DOI 10.1016/j.neurobiolaging.2016.03.004	47	20	22	3	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12164	12174		10.1096/fj.201900992R	http://dx.doi.org/10.1096/fj.201900992R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31370707	Green Published			2022-12-28	WOS:000507461600044
J	Lee, JY; Lee, YJ; Jeon, HY; Han, ET; Park, WS; Hong, SH; Kim, YM; Ha, KS				Lee, Jee-Yeon; Lee, Yeon-Ju; Jeon, Hye-Yoon; Han, Eun-Taek; Park, Won Sun; Hong, Seok-Ho; Kim, Young-Myeong; Ha, Kwon-Soo			The vicious cycle between transglutaminase 2 and reactive oxygen species in hyperglycemic memory-induced endothelial dysfunction	FASEB JOURNAL			English	Article						diabetes mellitus; ROS; TGase2; inflammation; apoptosis	C-PEPTIDE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; TISSUE TRANSGLUTAMINASE; VASCULAR LEAKAGE; FOLLOW-UP; INHIBITION; APOPTOSIS; PATHWAYS; P66(SHC); STRESS	Clinical trials suggested that the vascular system can remember episodes of poor glycemic control through a phenomenon known as hyperglycemic memory (HGM). HGM is associated with long-term diabetic vascular complications in type 1 and type 2 diabetes, although the molecular mechanism of that association is not clearly understood. We hypothesized that transglutaminase 2 (TGase2) and intracellular reactive oxygen species (ROS) play a key role in HGM-induced vascular dysfunction. We found that hyperglycemia induced persistent oxidative stress, expression of inflammatory adhesion molecules, and apoptosis in the aortic endothelium of HGM mice whose blood glucose levels had been normalized by insulin supplementation. TGase2 activation and ROS generation were in a vicious cycle in the aortic endothelium of HGM mice and also in human aortic endothelial cells after glucose normalization, which played a key role in the sustained expression of inflammatory adhesion molecules and apoptosis. Our findings suggest that the TGase2-ROS vicious cycle plays an important role in HGM-induced endothelial dysfunction.	[Lee, Jee-Yeon; Lee, Yeon-Ju; Jeon, Hye-Yoon; Kim, Young-Myeong; Ha, Kwon-Soo] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Kangwondaehak Gil 1, Chunchon 24341, Kangwon Do, South Korea; [Han, Eun-Taek] Kangwon Natl Univ, Sch Med, Dept Med Environm Biol & Trop Med, Chunchon, South Korea; [Park, Won Sun] Kangwon Natl Univ, Sch Med, Dept Physiol, Chunchon, South Korea; [Hong, Seok-Ho] Kangwon Natl Univ, Sch Med, Dept Internal Med, Chunchon, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Kangwon National University	Ha, KS (corresponding author), Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Kangwondaehak Gil 1, Chunchon 24341, Kangwon Do, South Korea.	ksha@kangwon.ac.kr	Ha, Kwon-Soo/AAU-4417-2020	Ha, Kwon-Soo/0000-0002-4219-1787	National Research Foundation of Korea [2015R1A4A1038666, 2016R1A2A1A05004975]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (2015R1A4A1038666 and 2016R1A2A1A05004975). K.-S.H. is the guarantor of this work, had full access to all of the data in the study, and takes responsibility for the integrity of the data and the accuracy of the data analysis. The authors declare no conflicts of interest.	Albers JW, 2010, DIABETES CARE, V33, P1090, DOI 10.2337/dc09-1941; Bhatt MP, 2016, J ENDOCRINOL, V231, P97, DOI 10.1530/JOE-16-0349; Bhatt MP, 2014, CARDIOVASC RES, V104, P234, DOI 10.1093/cvr/cvu211; Bhatt MP, 2013, DIABETES, V62, P3851, DOI 10.2337/db13-0039; Bhatt MP, 2013, DIABETES, V62, P243, DOI 10.2337/db12-0293; Brasacchio D, 2009, DIABETES, V58, P1229, DOI 10.2337/db08-1666; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cooper AJL, 1997, P NATL ACAD SCI USA, V94, P12604, DOI 10.1073/pnas.94.23.12604; Di Sabatino A, 2012, AUTOIMMUN REV, V11, P746, DOI 10.1016/j.autrev.2012.01.007; Du XL, 2003, J CLIN INVEST, V112, P1049, DOI 10.1172/JCI200318127; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; ENGERMAN RL, 1987, DIABETES, V36, P808, DOI 10.2337/diabetes.36.7.808; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; Ihnat MA, 2007, DIABETOLOGIA, V50, P1523, DOI 10.1007/s00125-007-0684-2; Jeon HY, 2019, FASEB J, V33, P750, DOI 10.1096/fj.201800723R; Kim DS, 2010, BIOCHEM BIOPH RES CO, V403, P479, DOI 10.1016/j.bbrc.2010.11.063; King P, 1999, BRIT J CLIN PHARMACO, V48, P643, DOI 10.1046/j.1365-2125.1999.00092.x; Kirkland RA, 2003, ANTIOXID REDOX SIGN, V5, P589, DOI 10.1089/152308603770310257; Lee YJ, 2018, FASEB J, V32; Lee YJ, 2017, J ENDOCRINOL, V235, P39, DOI 10.1530/JOE-17-0109; Lee YJ, 2016, DIABETES, V65, P2414, DOI 10.2337/db15-1594; Lim YC, 2014, CARDIOVASC RES, V101, P155, DOI 10.1093/cvr/cvt238; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Okabe J, 2012, CIRC RES, V110, P1067, DOI 10.1161/CIRCRESAHA.112.266171; Paneni F, 2013, DIABETES, V62, P1800, DOI 10.2337/db12-1648; Paneni F, 2012, CIRC RES, V111, P278, DOI 10.1161/CIRCRESAHA.112.266593; Park D, 2010, AMINO ACIDS, V39, P619, DOI 10.1007/s00726-010-0500-z; Pirola L, 2010, NAT REV ENDOCRINOL, V6, P665, DOI 10.1038/nrendo.2010.188; Rodolfo C, 2004, J BIOL CHEM, V279, P54783, DOI 10.1074/jbc.M410938200; Ruan QM, 2007, FRONT BIOSCI-LANDMRK, V12, P891, DOI 10.2741/2111; Ruoppolo M, 2003, PROTEIN SCI, V12, P170, DOI 10.1110/ps.0216103; Sane DC, 2007, FRONT BIOSCI-LANDMRK, V12, P2530, DOI 10.2741/2253; Schisano B, 2011, DIABETOLOGIA, V54, P1219, DOI 10.1007/s00125-011-2049-0	37	18	19	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12655	12667		10.1096/fj.201901358RR	http://dx.doi.org/10.1096/fj.201901358RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31462079	Green Published			2022-12-28	WOS:000507461600082
J	Conseil, G; Arama-Chayoth, M; Tsfadia, Y; Cole, SPC				Conseil, Gwenaelle; Arama-Chayoth, May; Tsfadia, Yossi; Cole, Susan P. C.			Structure-guided probing of the leukotriene C-4 binding site in human multidrug resistance protein 1 (MRP1; ABCC1)	FASEB JOURNAL			English	Article						ABC transporter; homology modeling; structure-function; bipartite binding site	ORGANIC ANION TRANSPORTER; AMINO-ACID-RESIDUES; ALTERS SUBSTRATE-SPECIFICITY; DRUG-RESISTANCE; ATP-BINDING; PHARMACOLOGICAL CHARACTERIZATION; TRANSMEMBRANE HELICES; FUNCTIONAL IMPORTANCE; POLYMORPHIC VARIANTS; MUTATIONAL ANALYSIS	The human multidrug resistance protein 1 (hMRP1) transporter is implicated in cancer multidrug resistance as well as immune responses involving its physiologic substrate, glutathione (GSH)-conjugated leukotriene C-4 (LTC4). LTC4 binds a bipartite site on hMRP1, which a recent cryoelectron microscopy structure of LTC4-bound bovine Mrp1 depicts as composed of a positively charged pocket and a hydrophobic (H) pocket that binds the GSH moiety and surrounds the fatty acid moiety, respectively, of LTC4. Here, we show that single Ala and Leu substitutions of H-pocket hMRP1-Met(1093) have no effect on LTC4 binding or transport. Estrone 3-sulfate transport is also unaffected, but both hMRP1-Met(1093) mutations eliminate estradiol glucuronide transport, demonstrating that these steroid conjugates have binding sites distinct from each other and from LTC4. To eliminate LTC4 transport by hMRP1, mutation of 3 H-pocket residues was required (W553/M1093/W1246A), indicating that H-pocket amino acids are key to the vastly different affinities of hMRP1 for LTC4 vs. GSH alone. Unlike organic anion transport, hMRP1-mediated drug resistance was more diminished by Ala than Leu substitution of Met(1093). Although our findings generally support a structure in which H-pocket residues bind the lipid tail of LTC4, their critical and differential role in the transport of conjugated estrogens and anticancer drugs remains unexplained.-Conseil, G., Arama-Chayoth, M., Tsfadia, Y., Cole, S. P. C. Structure-guided probing of the leukotriene C-4 binding site in human multidrug resistance protein 1 (MRP1; ABCC1).	[Conseil, Gwenaelle; Cole, Susan P. C.] Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Dept Pathol & Mol Med, 10 Stuart St, Kingston, ON K7L 3N6, Canada; [Arama-Chayoth, May; Tsfadia, Yossi] Tel Aviv Univ, Dept Biochem & Mol Biol, Tel Aviv, Israel	McMaster University; Queens University - Canada; Tel Aviv University	Cole, SPC (corresponding author), Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Dept Pathol & Mol Med, 10 Stuart St, Kingston, ON K7L 3N6, Canada.	spc.cole@queensu.ca	Cole, Susan/I-6389-2017	Cole, Susan/0000-0001-6571-6884	Canadian Institutes for Health Research [133584]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	The authors thank Dr. Richard Callaghan (Australia National University, Canberra, ACT, Australia) for advice on sulforhodamine B assays, and Robyn Millott (Cole Laboratory, Queen's University) for establishing some of the stable FlpIN293 cell lines. This work was supported by Grant 133584 from the Canadian Institutes for Health Research. The authors declare no conflicts of interest.	Banerjee M, 2016, BIOCHEM PHARMACOL, V120, P72, DOI 10.1016/j.bcp.2016.09.016; Bao XY, 2005, J BIOL CHEM, V280, P8647, DOI 10.1074/jbc.M413536200; Blokzijl H, 2008, J BIOL CHEM, V283, P35630, DOI 10.1074/jbc.M804374200; Budulac SE, 2012, EUR J PHARMACOL, V696, P136, DOI 10.1016/j.ejphar.2012.08.015; Campbell JD, 2004, J BIOL CHEM, V279, P463, DOI 10.1074/jbc.M310711200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cole SPC, 2014, J BIOL CHEM, V289, P30880, DOI 10.1074/jbc.R114.609248; Cole SPC, 2014, ANNU REV PHARMACOL, V54, P95, DOI 10.1146/annurev-pharmtox-011613-135959; Conseil G, 2009, MOL PHARMACOL, V75, P397, DOI 10.1124/mol.108.052860; Conseil G, 2013, DRUG METAB DISPOS, V41, P2187, DOI 10.1124/dmd.113.054213; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; DeGorter MK, 2008, BIOCHEM BIOPH RES CO, V365, P29, DOI 10.1016/j.bbrc.2007.10.141; Esser L, 2017, J BIOL CHEM, V292, P446, DOI 10.1074/jbc.M116.755884; Gordillo GM, 2016, J BIOL CHEM, V291, P10089, DOI 10.1074/jbc.M115.688879; Grant CE, 2008, DRUG METAB DISPOS, V36, P2571, DOI 10.1124/dmd.108.022491; Haimeur A, 2004, MOL PHARMACOL, V65, P1375, DOI 10.1124/mol.65.6.1375; Haimeur A, 2002, J BIOL CHEM, V277, P41326, DOI 10.1074/jbc.M206228200; HEISTERKAMP N, 1991, P NATL ACAD SCI USA, V88, P6303, DOI 10.1073/pnas.88.14.6303; Hipfner DR, 1996, CANCER RES, V56, P3307; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Ito K, 2001, J BIOL CHEM, V276, P15616, DOI 10.1074/jbc.M011246200; Ito K, 2001, J BIOL CHEM, V276, P38108; Jedlitschky G, 1996, CANCER RES, V56, P988; Jehle J, 2017, ARCH MED SCI, V13, P930, DOI 10.5114/aoms.2017.68239; Johnson ZL, 2018, CELL, V172, P81, DOI 10.1016/j.cell.2017.12.005; Johnson ZL, 2017, CELL, V168, P1075, DOI 10.1016/j.cell.2017.01.041; Keppler D, 2011, HANDB EXP PHARMACOL, V201, P299, DOI 10.1007/978-3-642-14541-4_8; Koike K, 2004, J BIOL CHEM, V279, P12325, DOI 10.1074/jbc.M311435200; Koike K, 2002, J BIOL CHEM, V277, P49495, DOI 10.1074/jbc.M206896200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee KPK, 2017, ELIFE, V6, DOI 10.7554/eLife.32481; LEIER I, 1994, J BIOL CHEM, V269, P27807; Li MS, 2018, J BIOL CHEM, V293, P5649, DOI 10.1074/jbc.RA117.001373; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Loe DW, 1996, J BIOL CHEM, V271, P9683, DOI 10.1074/jbc.271.16.9683; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; Maeno K, 2009, DRUG METAB DISPOS, V37, P1411, DOI 10.1124/dmd.109.026633; Martin GM, 2017, ELIFE, V6, DOI 10.7554/eLife.31054; Neuser J, 2016, J DIABETES COMPLICAT, V30, P623, DOI 10.1016/j.jdiacomp.2016.02.002; Nunoya K, 2003, DRUG METAB DISPOS, V31, P1016, DOI 10.1124/dmd.31.8.1016; Oleschuk CJ, 2003, AM J PHYSIOL-GASTR L, V284, pG280, DOI 10.1152/ajpgi.00331.2002; Petrova SS, 1997, HIST MATH, V24, P361, DOI 10.1006/hmat.1996.2146; Robey RW, 2018, NAT REV CANCER, V18, P452, DOI 10.1038/s41568-018-0005-8; Salerno M, 2001, EUR J PHARMACOL, V421, P1, DOI 10.1016/S0014-2999(01)00992-X; Shukalek CB, 2016, MOL PHARMACOL, V90, P127, DOI 10.1124/mol.116.103648; Situ D, 2004, J BIOL CHEM, V279, P38871, DOI 10.1074/jbc.M403832200; Slot AJ, 2011, ESSAYS BIOCHEM, V50, P179, DOI [10.1042/BSE0500179, 10.1042/bse0500179]; Stride BD, 1997, MOL PHARMACOL, V52, P344, DOI 10.1124/mol.52.3.344; Tabas LB, 2002, ANAL BIOCHEM, V310, P61, DOI 10.1016/S0003-2697(02)00282-8; Taguchi Y, 2002, FEBS LETT, V521, P211, DOI 10.1016/S0014-5793(02)02816-8; Taylor NMI, 2017, NATURE, V546, P504, DOI 10.1038/nature22345; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Weigl KE, 2018, MOL PHARMACOL, V94, P1069, DOI 10.1124/mol.118.112615; Wijnholds J, 1997, NAT MED, V3, P1275, DOI 10.1038/nm1197-1275; Wu P, 2005, MOL PHARMACOL, V68, P1455, DOI 10.1124/mol.105.016576; Zelcer N, 2001, J BIOL CHEM, V276, P46400, DOI 10.1074/jbc.M107041200; Zhang DW, 2006, DRUG METAB DISPOS, V34, P539, DOI 10.1124/dmd.105.007740; Zhang DW, 2003, J BIOL CHEM, V278, P46052, DOI 10.1074/jbc.M308403200; Zhang DW, 2002, J BIOL CHEM, V277, P20934, DOI 10.1074/jbc.M201311200; Zhang DW, 2001, J BIOL CHEM, V276, P34966, DOI 10.1074/jbc.M105063200	61	13	13	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10692	10704		10.1096/fj.201900140R	http://dx.doi.org/10.1096/fj.201900140R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31268744	Bronze			2022-12-28	WOS:000489166300010
J	Li, XX; Zhu, QL; Wang, WS; Qi, J; He, YQ; Wang, Y; Lu, Y; Wu, H; Ding, Y; Sun, Y				Li, Xiaoxue; Zhu, Qinling; Wang, Wangsheng; Qi, Jia; He, Yaqiong; Wang, Yuan; Lu, Yao; Wu, Hasiximuke; Ding, Ying; Sun, Yun			Elevated chemerin induces insulin resistance in human granulosa-lutein cells from polycystic ovary syndrome patients	FASEB JOURNAL			English	Article						CMKLR1; glucose metabolism; IRS1	STIMULATED GLUCOSE-UPTAKE; PROGESTERONE PRODUCTION; RECEPTOR SUBSTRATE-1; OBESITY; PHOSPHORYLATION; ASSOCIATION; WOMEN; ADIPOGENESIS; SENSITIVITY; PREVALENCE	The insulin resistance (IR) of ovarian granulosa cells from polycystic ovary syndrome (PCOS) aggravates the abnormalities in steroidogenesis and anovulation, and chemerin is an adipokine involved in regulating adipogenesis and glucose homeostasis. The role and underlying mechanism of chemerin in developing IR of the granulosa cells from PCOS remain unclear. Plasma, follicular fluid, and human granulosa-lutein cells (hGLs) were collected from non-PCOS and patients with PCOS with or without IR. The chemerin levels were elevated in both follicular fluid and hGL samples from patients with PCOS with IR, and the hGLs from patients with PCOS with IR showed decreased insulin sensitivity and impaired glucose uptake capacity. Moreover, treatment of chemerin attenuated insulin-stimulated glucose uptake by decreasing phosphorylation of insulin receptor substrate (IRS)1/2 Tyr612, phosphorylation of protein kinase B Ser473, and membrane translocation of glucose transporter type 4 through increasing Ser307 phosphorylation of IRS1 in cultured hGLs. These effects could be abolished by small interfering RNA-mediated knockdown of chemokine-like receptor 1. Furthermore, insulin induced the expression of chemerin in hGLs. Our findings demonstrate a novel role of chemerin in the metabolic dysfunction of PCOS, which suggested that chemerin and its receptor can be further implicated as potential therapeutic targets in the future treatment of PCOS.-Li, X., Zhu, Q., Wang, W., Qi, J., He, Y., Wang, Y., Lu, Y., Wu, H., Ding, Y., Sun, Y. Elevated chemerin induces insulin resistance in human granulosa-lutein cells from polycystic ovary syndrome patients.	[Li, Xiaoxue; Zhu, Qinling; Wang, Wangsheng; Qi, Jia; He, Yaqiong; Wang, Yuan; Lu, Yao; Wu, Hasiximuke; Ding, Ying; Sun, Yun] Shanghai Jiao Tong Univ, Renji Hosp, Ctr Reprod Med, Sch Med, 845 Lingshan Rd, Shanghai 200135, Peoples R China; [Li, Xiaoxue; Zhu, Qinling; Wang, Wangsheng; Qi, Jia; He, Yaqiong; Wang, Yuan; Lu, Yao; Wu, Hasiximuke; Ding, Ying; Sun, Yun] Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai, Peoples R China	Shanghai Jiao Tong University	Sun, Y (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Ctr Reprod Med, Sch Med, 845 Lingshan Rd, Shanghai 200135, Peoples R China.	syun163@163.com	Zhu, Qinling/AAG-1700-2021; Wang, Wang-sheng/E-9811-2017	Wang, Wang-sheng/0000-0003-1429-9237; Li, Xiaoxue/0000-0002-8992-8002	National Key Research and Development Program of China [2017YFC1001403]; National Natural Science Foundation of China [81571499, 81771648]; Innovative Research Team of High-Level Local Universities in Shanghai, Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support [20161413]; Program of Shanghai Academic Research Leader in Shanghai Municipal Commission of Health and Family Planning [2017BR015]; Hospital Development Center of Shanghai [16CR1022A]; Shanghai Technological Innovation Plan [18140902400]; Shanghai Commission of Science and Technology [17DZ2271100]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Research Team of High-Level Local Universities in Shanghai, Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support; Program of Shanghai Academic Research Leader in Shanghai Municipal Commission of Health and Family Planning; Hospital Development Center of Shanghai; Shanghai Technological Innovation Plan; Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee)	The authors thank Xiaoming Zhao, Yan Hong, and Minzhi Gao (Center for Reproductive Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China) for help with patient recruitment and sample collection, and Guangxin Yao, Xiaoping Zhao, Li Zhao, Panli Li, and Chuyue Zhang (Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China) for skillful technical support. This study was supported by National Key Research and Development Program of China (2017YFC1001403), the National Natural Science Foundation of China (81571499, 81771648), Shanghai Leading Talent Program, Innovative Research Team of High-Level Local Universities in Shanghai, Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support (20161413), Program of Shanghai Academic Research Leader in Shanghai Municipal Commission of Health and Family Planning (2017BR015), Clinical Skills Improvement Project of Major Disorders, Hospital Development Center of Shanghai (16CR1022A), Shanghai Technological Innovation Plan (18140902400), and Shanghai Commission of Science and Technology (17DZ2271100). The authors declare no conflicts of interest.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Belani M, 2016, TOXICOL APPL PHARM, V313, P119, DOI 10.1016/j.taap.2016.10.019; Bonhomme S, 2011, NUTRITION, V27, P73, DOI 10.1016/j.nut.2010.08.005; Boots C, 2011, SEMIN REPROD MED, V29, P507, DOI 10.1055/s-0031-1293204; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; CIARALDI TP, 1992, J CLIN ENDOCR METAB, V75, P577, DOI 10.1210/jc.75.2.577; Dang X, 2017, ENDOCRINOLOGY, V158, P3281, DOI 10.1210/en.2017-00029; DeUgarte CM, 2005, FERTIL STERIL, V83, P1454, DOI 10.1016/j.fertnstert.2004.11.070; Diamanti-Kandarakis E, 2016, EXP BIOL MED, V241, P1438, DOI 10.1177/1535370215584937; Diamanti-Kandarakis E, 2012, ENDOCR REV, V33, P981, DOI 10.1210/er.2011-1034; DUNAIF A, 1995, J CLIN INVEST, V96, P801, DOI 10.1172/JCI118126; DUNAIF A, 1992, DIABETES, V41, P1257, DOI 10.2337/diabetes.41.10.1257; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; Harrison CL, 2011, HUM REPROD UPDATE, V17, P171, DOI 10.1093/humupd/dmq045; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Huang R, 2015, CLIN CHIM ACTA, V450, P366, DOI 10.1016/j.cca.2015.09.015; Huang Zefeng, 2015, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V31, P725; Kim SH, 2014, CLIN ENDOCRINOL, V80, P825, DOI 10.1111/cen.12249; Kralisch S, 2009, REGUL PEPTIDES, V154, P102, DOI 10.1016/j.regpep.2009.02.010; Li JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074623; Lima PDA, 2018, BIOL REPROD, V99, P838, DOI 10.1093/biolre/ioy096; Lin Y, 1997, HUM REPROD, V12, P2469, DOI 10.1093/humrep/12.11.2469; Lin Y, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0321-y; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Mariani F, 2015, INFLAMM RES, V64, P85, DOI 10.1007/s00011-014-0792-7; Maruthini D, 2014, HUM REPROD, V29, P2302, DOI 10.1093/humrep/deu187; Muruganandan S, 2010, J BONE MINER RES, V25, P222, DOI 10.1359/jbmr.091106; Pundir J, 2019, HUM REPROD UPDATE, V25, P243, DOI 10.1093/humupd/dmy045; Purcell SH, 2012, ENDOCRINOLOGY, V153, P2444, DOI 10.1210/en.2011-1974; Reverchon M, 2012, HUM REPROD, V27, P1790, DOI 10.1093/humrep/des089; Rice S, 2005, HUM REPROD, V20, P373, DOI 10.1093/humrep/deh609; Roh SG, 2007, BIOCHEM BIOPH RES CO, V362, P1013, DOI 10.1016/j.bbrc.2007.08.104; Salha T, 2017, ACTA CLIN CROAT, V56, P663, DOI 10.20471/acc.2017.56.04.13; Sell H, 2009, DIABETES, V58, P2731, DOI 10.2337/db09-0277; Senagolage MD, 2018, CELL REP, V25, P3283, DOI 10.1016/j.celrep.2018.11.074; Seow KM, 2007, HUM REPROD, V22, P1003, DOI 10.1093/humrep/del466; Shi YY, 2012, NAT GENET, V44, P1020, DOI 10.1038/ng.2384; Soto M, 2018, MOL PSYCHIATR, V23, P2287, DOI 10.1038/s41380-018-0086-5; Takahashi M, 2008, FEBS LETT, V582, P573, DOI 10.1016/j.febslet.2008.01.023; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Viscarra JA, 2011, AM J PHYSIOL-REG I, V300, pR150, DOI 10.1152/ajpregu.00478.2010; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Xu Y, 2017, ADV CLIN EXP MED, V26, P333, DOI 10.17219/acem/61609; Zabel BA, 2008, J EXP MED, V205, P2207, DOI 10.1084/jem.20080300; Zhang RN, 2014, PHARMACOLOGY, V94, P259, DOI 10.1159/000369171; Zhu QL, 2016, J CLIN ENDOCR METAB, V101, P2168, DOI 10.1210/jc.2015-3899	50	18	20	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11303	11313		10.1096/fj.201802829R	http://dx.doi.org/10.1096/fj.201802829R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31311314	Bronze			2022-12-28	WOS:000489166300059
J	Manville, RW; Abbott, GW				Manville, Rian W.; Abbott, Geoffrey W.			Cilantro leaf harbors a potent potassium channel-activating anticonvulsant	FASEB JOURNAL			English	Article						herbal medicine; epilepsy; KCNQ1; KCNQ2; KCNQ3	K(V)7 K+ CHANNEL; MUTATION; KCNQ5; COMPONENT; SUBUNITS; EXPRESSION; RETIGABINE; JERVELL; KVLQT1; CELLS	Herbs have a long history of use as folk medicine anticonvulsants, yet the underlying mechanisms often remain unknown. Neuronal voltage-gated potassium channel subfamily Q (KCNQ) dysfunction can cause severe epileptic encephalopathies that are resistant to modern anticonvulsants. Here we report that cilantro (Coriandrum sativum), a widely used culinary herb that also exhibits antiepileptic and other therapeutic activities, is a highly potent KCNQ channel activator. Screening of cilantro leaf metabolites revealed that one, the long-chain fatty aldehyde (E)-2-dodecenal, activates multiple KCNQs, including the predominant neuronal isoform, KCNQ2/KCNQ3 [half maximal effective concentration (EC50), 60 +/- 20 nM], and the predominant cardiac isoform, KCNQ1 in complexes with the type I transmembrane ancillary subunit (KCNE1) (EC50, 260 +/- 100 nM). (E)-2-dodecenal also recapitulated the anticonvulsant action of cilantro, delaying pentylene tetrazole-induced seizures. In silico docking and mutagenesis studies identified the (E)-2-dodecenal binding site, juxtaposed between residues on the KCNQ S5 transmembrane segment and S4-5 linker. The results provide a molecular basis for the therapeutic actions of cilantro and indicate that this ubiquitous culinary herb is surprisingly influential upon clinically important KCNQ channels.-Manville, R. W., Abbott, G. W. Cilantro leaf harbors a potent potassium channel-activating anticonvulsant.	[Manville, Rian W.; Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Bioelect Lab, Med Sci D337,ZOT 4560, Irvine, CA 92697 USA	University of California System; University of California Irvine	Abbott, GW (corresponding author), Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Bioelect Lab, Med Sci D337,ZOT 4560, Irvine, CA 92697 USA.	abbottg@uci.edu		Manville, Rian/0000-0002-0057-3541	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [GM115189, GM130377]; NIH National Institute of Neurological Disorders and Stroke [NS107671]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM130377, R01GM115189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS107671] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are grateful to Angele De Silva (University of California-Irvine) for generating mutant channel constructs, and to Bo Abbott for botanical photography. This study was supported by the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (Grants GM115189 and GM130377 to G.W.A.) and NIH National Institute of Neurological Disorders and Stroke (Grant NS107671 to G.W.A.). The authors declare no conflicts of interest.	Abbott GW, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005025; Abbott GW, 2014, NEW J SCI, V2014, P1, DOI [10.1155/2014/237431, DOI 10.1155/2014/237431]; Amato G, 2011, ACS MED CHEM LETT, V2, P481, DOI 10.1021/ml200053x; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Brueggemann LI, 2014, MOL PHARMACOL, V86, P330, DOI 10.1124/mol.114.093799; Cumo C, 2013, ENCY CULTIVATED PLAN; De Silva AM, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aav0824; Dhyani N, 2020, J DIET SUPPL, V17, P13, DOI 10.1080/19390211.2018.1481483; Etxeberria A, 2004, J NEUROSCI, V24, P9146, DOI 10.1523/JNEUROSCI.3194-04.2004; Gilling Mette, 2013, Frontiers in Genetics, V4, P54, DOI 10.3389/fgene.2013.00054; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Grosdidier A, 2011, J COMPUT CHEM, V32, P2149, DOI 10.1002/jcc.21797; Hardy K, 2012, NATURWISSENSCHAFTEN, V99, P617, DOI 10.1007/s00114-012-0942-0; Hoffmann D, 2003, MED HERBALISM SCI PR; Inskeep RR., 1969, S AFR ARCHAEOL BULL, V24, P21; Jabeen Q, 2009, J ETHNOPHARMACOL, V122, P123, DOI 10.1016/j.jep.2008.12.016; Jepps TA, 2009, AM J PHYSIOL-GASTR L, V297, pG107, DOI 10.1152/ajpgi.00057.2009; Johansson MU, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-173; Kang CB, 2008, BIOCHEMISTRY-US, V47, P7999, DOI 10.1021/bi800875q; Karami R, 2015, IRAN J NEUROL, V14, P59; Kim RY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9116; Klinger F, 2011, NEUROIMAGE, V58, P761, DOI 10.1016/j.neuroimage.2011.07.003; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Kubo I, 2004, J AGR FOOD CHEM, V52, P3329, DOI 10.1021/jf0354186; Lau E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132198; Lehman A, 2017, AM J HUM GENET, V101, P65, DOI 10.1016/j.ajhg.2017.05.016; Lerche C, 2000, J BIOL CHEM, V275, P22395, DOI 10.1074/jbc.M002378200; Mackie AR, 2008, J PHARMACOL EXP THER, V325, P475, DOI 10.1124/jpet.107.135764; Main MJ, 2000, MOL PHARMACOL, V58, P253, DOI 10.1124/mol.58.2.253; Manville RW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06339-2; Manville RW, 2018, MOL PHARMACOL, V94, P1155, DOI 10.1124/mol.118.112953; Manville RW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04266-w; Melamed Y, 2016, P NATL ACAD SCI USA, V113, P14674, DOI 10.1073/pnas.1607872113; Miceli F, 2013, P NATL ACAD SCI USA, V110, P4386, DOI 10.1073/pnas.1216867110; Moerman D.E., 2009, NATIVE AM MED PLANTS; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Panaghie G, 2007, J GEN PHYSIOL, V129, P121, DOI 10.1085/jgp.200609612; Paul JHA, 2011, FITOTERAPIA, V82, P302, DOI 10.1016/j.fitote.2010.11.010; Potter TL, 1996, J AGR FOOD CHEM, V44, P1824, DOI 10.1021/jf950814c; Rosti G, 2019, EUR J MED GENET, V62, DOI 10.1016/j.ejmg.2018.10.007; Sahib NG, 2013, PHYTOTHER RES, V27, P1439, DOI 10.1002/ptr.4897; Schenzer A, 2005, J NEUROSCI, V25, P5051, DOI 10.1523/JNEUROSCI.0128-05.2005; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Sun J, 2017, CELL, V169, P1042, DOI 10.1016/j.cell.2017.05.019; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; Tyson J, 1997, HUM MOL GENET, V6, P2179, DOI 10.1093/hmg/6.12.2179; Tzingounis AV, 2010, P NATL ACAD SCI USA, V107, P10232, DOI 10.1073/pnas.1004644107; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Vetter DE, 1996, NEURON, V17, P1251, DOI 10.1016/S0896-6273(00)80255-X; Walker NM, 2002, GASTROENTEROLOGY, V123, P531, DOI 10.1053/gast.2002.34757; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Weyrich LS, 2017, NATURE, V544, P357, DOI 10.1038/nature21674; Wickenden AD, 2008, MOL PHARMACOL, V73, P977, DOI 10.1124/mol.107.043216; Wickenden AD, 2000, MOL PHARMACOL, V58, P591, DOI 10.1124/mol.58.3.591; Yeung SYM, 2008, BRIT J PHARMACOL, V155, P62, DOI 10.1038/bjp.2008.231; Yeung SYM, 2007, BRIT J PHARMACOL, V151, P758, DOI 10.1038/sj.bjp.0707284; Zviely M., 2009, Perfumer & Flavorist, V34, P26	59	12	12	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11349	11363		10.1096/fj.201900485R	http://dx.doi.org/10.1096/fj.201900485R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31311306	Green Published, Bronze			2022-12-28	WOS:000489166300063
J	Cansby, E; Kulkarni, NM; Magnusson, E; Kurhe, Y; Amrutkar, M; Nerstedt, A; Stahlman, M; Sihlbom, C; Marschall, HU; Boren, J; Bluher, M; Mahlapuu, M				Cansby, Emmelie; Kulkarni, Nagaraj M.; Magnusson, Elin; Kurhe, Yeshwant; Amrutkar, Manoj; Nerstedt, Annika; Stahlman, Marcus; Sihlbom, Carina; Marschall, Hanns-Ulrich; Boren, Jan; Blueher, Matthias; Mahlapuu, Margit			Protein kinase MST3 modulates lipid homeostasis in hepatocytes and correlates with nonalcoholic steatohepatitis in humans	FASEB JOURNAL			English	Article						ectopic lipid storage; intrahepatocellular lipid droplets; liver lipid metabolism; nonalcoholic fatty liver disease	FATTY LIVER-DISEASE; INSULIN-RESISTANCE; CELL-MIGRATION; MITOCHONDRIAL-FUNCTION; STK25; GLUCOSE; MICE; ASSOCIATION; REVEALS; HEPATOSTEATOSIS	Ectopic lipid storage in the liver is considered the main risk factor for nonalcoholic steatohepatitis (NASH). Understanding the molecular networks controlling hepatocellular lipid deposition is therefore essential for developing new strategies to effectively prevent and treat this complex disease. Here, we describe a new regulator of lipid partitioning in human hepatocytes: mammalian sterile 20-like (MST) 3. We found that MST3 protein coats lipid droplets in mouse and human liver cells. Knockdown of MST3 attenuated lipid accumulation in human hepatocytes by stimulating beta-oxidation and triacylglycerol secretion while inhibiting fatty acid influx and lipid synthesis. We also observed that lipogenic gene expression and acetyl-coenzyme A carboxylase protein abundance were reduced in MST3-deficient hepatocytes, providing insight into the molecular mechanisms underlying the decreased lipid storage. Furthermore, MST3 expression was positively correlated with key features of NASH (i.e., hepatic lipid content, lobular inflammation, and hepatocellular ballooning) in human liver biopsies. In summary, our results reveal a role of MST3 in controlling the dynamic metabolic balance of liver lipid catabolism vs. lipid anabolism. Our findings highlight MST3 as a potential drug target for the prevention and treatment of NASH and related complex metabolic diseases.-Cansby, E., Kulkarni, N. M., Magnusson, E., Kurhe, Y., Amrutkar, M., Nerstedt, A., Stahlman, M., Sihlbom, C., Marschall, H.-U., Boren, J., Bluher, M., Mahlapuu, M. Protein kinase MST3 modulates lipid homeostasis in hepatocytes and correlates with nonalcoholic steatohepatitis in humans.	[Cansby, Emmelie; Kulkarni, Nagaraj M.; Magnusson, Elin; Kurhe, Yeshwant; Nerstedt, Annika; Mahlapuu, Margit] Univ Gothenburg, Dept Chem & Mol Biol, Box 462, SE-40530 Gothenburg, Sweden; [Stahlman, Marcus; Marschall, Hanns-Ulrich; Boren, Jan] Univ Gothenburg, Inst Med, Wallenberg Lab, Dept Mol & Clin Med, Gothenburg, Sweden; [Stahlman, Marcus; Marschall, Hanns-Ulrich; Boren, Jan] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Amrutkar, Manoj] Univ Oslo, Inst Clin Med, Dept Hepatopancreatobiliary Surg, Oslo, Norway; [Sihlbom, Carina] Univ Gothenburg, Prote Core Facil, Gothenburg, Sweden; [Blueher, Matthias] Univ Leipzig, Dept Med, Leipzig, Germany	University of Gothenburg; University of Gothenburg; Sahlgrenska University Hospital; University of Oslo; University of Gothenburg; Leipzig University	Mahlapuu, M (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, Box 462, SE-40530 Gothenburg, Sweden.	margit.mahlapuu@gu.se	Marschall, Hanns-Ulrich/K-8842-2017; Kulkarni, Nagaraj/Z-1787-2019	Marschall, Hanns-Ulrich/0000-0001-7347-3085; Kulkarni, Nagaraj/0000-0003-1668-5406; Mahlapuu, Margit/0000-0001-8740-8874	Swedish Research Council; European Foundation for the Study of Diabetes/Lilly European Diabetes Research Programme; West Sweden Avtal om Lakarutbildning och Forskning (ALF) Program; Novo Nordisk Foundation; Swedish Heart-Lung Foundation; Torsten Soderbergs Foundation; Swedish Diabetes Foundation; Royal Society of Arts and Sciences in Gothenburg; Wiberg Foundation; Adlerbert Research Foundation; I. Hultman Foundation; S. and E. Goljes Foundation; F. Neubergh Foundation; Professor Nanna Svartz Foundation; I. B. and A. Lundbergs Research Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Foundation for the Study of Diabetes/Lilly European Diabetes Research Programme; West Sweden Avtal om Lakarutbildning och Forskning (ALF) Program; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Torsten Soderbergs Foundation; Swedish Diabetes Foundation; Royal Society of Arts and Sciences in Gothenburg; Wiberg Foundation; Adlerbert Research Foundation; I. Hultman Foundation; S. and E. Goljes Foundation; F. Neubergh Foundation; Professor Nanna Svartz Foundation; I. B. and A. Lundbergs Research Foundation	Proteomics Core Facility at Sahlgrenska Academy, University of Gothenburg, performed the quantitative proteomic analysis. The Proteomics Core Facility is grateful to the I. B. and A. Lundbergs Research Foundation for the donation of the Orbitrap Fusion Tribrid mass spectrometer. This work was supported by grants from the Swedish Research Council, the European Foundation for the Study of Diabetes/Lilly European Diabetes Research Programme, the West Sweden Avtal om Lakarutbildning och Forskning (ALF) Program, the Novo Nordisk Foundation, the Swedish Heart-Lung Foundation, the Torsten Soderbergs Foundation, the Swedish Diabetes Foundation, the Royal Society of Arts and Sciences in Gothenburg, the Wiberg Foundation, the Adlerbert Research Foundation, the I. Hultman Foundation, the S. and E. Goljes Foundation, the F. Neubergh Foundation, the Professor Nanna Svartz Foundation, and the I. B. and A. Lundbergs Research Foundation. The authors declare no conflicts of interest.	Amrutkar M, 2016, FASEB J, V30, P3628, DOI 10.1096/fj.201600562R; Amrutkar M, 2016, DIABETOLOGIA, V59, P341, DOI 10.1007/s00125-015-3801-7; Amrutkar M, 2015, DIABETES, V64, P2791, DOI 10.2337/db15-0060; Amrutkar M, 2015, FASEB J, V29, P1564, DOI 10.1096/fj.14-264937; Andersson L, 2017, INT J BIOCHEM CELL B, V91, P9, DOI 10.1016/j.biocel.2017.07.021; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Cansby E, 2019, CELL MOL GASTROENTER, V7, P597, DOI 10.1016/j.jcmgh.2018.12.004; Cansby E, 2018, ARTERIOSCL THROM VAS, V38, P1723, DOI 10.1161/ATVBAHA.118.311241; Cansby E, 2013, FASEB J, V27, P3660, DOI 10.1096/fj.13-228494; Chang BHJ, 2010, J LIPID RES, V51, P2132, DOI 10.1194/jlr.M004515; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Chursa U, 2017, DIABETOLOGIA, V60, P553, DOI 10.1007/s00125-016-4171-5; Crunk AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067631; Ding YF, 2013, NAT PROTOC, V8, P43, DOI 10.1038/nprot.2012.142; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; Gavin JR, 2000, DIABETES CARE, V23, pS4; GeneCopoeia Inc, OMICSLINK EXPRESSION; Gluchowski NL, 2017, NAT REV GASTRO HEPAT, V14, P343, DOI 10.1038/nrgastro.2017.32; Guo F, 2013, J LIPID RES, V54, P2109, DOI 10.1194/jlr.M035519; Huang CYF, 2002, J BIOL CHEM, V277, P34367, DOI 10.1074/jbc.M202468200; Hussain HK, 2005, RADIOLOGY, V237, P1048, DOI 10.1148/radiol.2373041639; Iglesias C, 2017, DIABETOLOGIA, V60, P2453, DOI 10.1007/s00125-017-4433-x; Imai N, 2018, HEPATOLOGY, V68, P2062, DOI 10.1002/hep.30206; Imai Y, 2007, GASTROENTEROLOGY, V132, P1947, DOI 10.1053/j.gastro.2007.02.046; Kanda T, 2018, WORLD J GASTROENTERO, V24, P2661, DOI 10.3748/wjg.v24.i25.2661; Kannt A, 2015, DIABETOLOGIA, V58, P799, DOI 10.1007/s00125-014-3490-7; Karlas T, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1208-6; Khan RS, 2018, NAT REV GASTRO HEPAT, V15, P71, DOI 10.1038/nrgastro.2017.181; Khan SA, 2015, J LIPID RES, V56, P2260, DOI 10.1194/jlr.M056812; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004; Krahmer N, 2013, MOL CELL PROTEOMICS, V12, P1115, DOI 10.1074/mcp.M112.020230; Lassailly G, 2011, EUR J GASTROEN HEPAT, V23, P499, DOI 10.1097/MEG.0b013e3283464111; Lee KT, 2018, AM J CANCER RES, V8, P2130; Lee WS, 2004, FEBS LETT, V572, P41, DOI 10.1016/j.febslet.2004.07.007; Lofgren L, 2016, SCI REP-UK, V6, DOI 10.1038/srep27688; Lu TJ, 2006, J BIOL CHEM, V281, P38405, DOI 10.1074/jbc.M605035200; Lykke-Andersen S, 2015, NAT REV MOL CELL BIO, V16, P665, DOI 10.1038/nrm4063; Madsen CD, 2015, NAT CELL BIOL, V17, P68, DOI 10.1038/ncb3083; Mashek DG, 2015, HEPATOLOGY, V62, P964, DOI 10.1002/hep.27839; McManaman JL, 2013, J LIPID RES, V54, P1346, DOI 10.1194/jlr.M035063; Mummadi RR, 2008, CLIN GASTROENTEROL H, V6, P1396, DOI 10.1016/j.cgh.2008.08.012; Nunez-Duran E, 2018, HEPATOL COMMUN, V2, P69, DOI 10.1002/hep4.1128; Nunez-Duran E, 2017, J ENDOCRINOL, V234, P15, DOI 10.1530/JOE-17-0018; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Ricchi M, 2009, J GASTROEN HEPATOL, V24, P830, DOI 10.1111/j.1440-1746.2008.05733.x; Rotman Y, 2010, HEPATOLOGY, V52, P894, DOI 10.1002/hep.23759; Samanez CH, 2012, ARCH PHYSIOL BIOCHEM, V118, P102, DOI 10.3109/13813455.2012.683442; Schinkmann K, 1997, J BIOL CHEM, V272, P28695, DOI 10.1074/jbc.272.45.28695; Schuster S, 2018, NAT REV GASTRO HEPAT, V15, P349, DOI 10.1038/s41575-018-0009-6; Senkal CE, 2017, CELL METAB, V25, P686, DOI 10.1016/j.cmet.2017.02.010; Singaravelu R, 2013, BIOCHEM BIOPH RES CO, V441, P447, DOI 10.1016/j.bbrc.2013.10.080; Strange K, 2006, PHYSIOLOGY, V21, P61, DOI 10.1152/physiol.00139.2005; Su W, 2014, P NATL ACAD SCI USA, V111, P11437, DOI 10.1073/pnas.1410741111; Sutt S, 2018, J ENDOCRINOL, V238, P187, DOI 10.1530/JOE-18-0182; Takahashi Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20975; Tanaka S, 2016, HEPATOLOGY, V64, P1994, DOI 10.1002/hep.28820; Tang J, 2014, J NEUROSCI, V34, P7425, DOI 10.1523/JNEUROSCI.5449-13.2014; Thompson BJ, 2015, J CELL BIOL, V210, P871, DOI 10.1083/jcb.201507005; Ultanir SK, 2014, NEURON, V84, P968, DOI 10.1016/j.neuron.2014.10.025; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Younes R, 2019, NAT REV GASTRO HEPAT, V16, P80, DOI 10.1038/s41575-018-0094-6; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Zhang HN, 2011, J PROTEOME RES, V10, P4757, DOI 10.1021/pr200553c; Zhang YL, 2013, CELL METAB, V18, P546, DOI 10.1016/j.cmet.2013.09.005; Zheng XJ, 2010, J CLIN INVEST, V120, P2795, DOI 10.1172/JCI39679; Zhou TH, 2000, J BIOL CHEM, V275, P2513, DOI 10.1074/jbc.275.4.2513	70	10	10	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9974	9989		10.1096/fj.201900356RR	http://dx.doi.org/10.1096/fj.201900356RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31173506	Bronze			2022-12-28	WOS:000482214200022
J	Zhou, XM; Wu, Q; Lu, Y; Zhang, XS; Lv, SY; Shao, J; Zhou, Y; Chen, JG; Hou, LJ; Huang, CG; Zhang, X				Zhou, Xiaoming; Wu, Qi; Lu, Yue; Zhang, Xiangsheng; Lv, Shengyin; Shao, Jiang; Zhou, Yuan; Chen, Jigang; Hou, Lijun; Huang, Chengguang; Zhang, Xin			Crosstalk between soluble PDGF-BB and PDGFR beta promotes astrocytic activation and synaptic recovery in the hippocampus after subarachnoid hemorrhage	FASEB JOURNAL			English	Article						SAH; neurovascular unit; astrocytic PDGFR beta; neuroprotection	MOUSE MODEL	Platelet-derived growth factor receptor beta (PDGFR beta) dynamically changes after brain injury, possibly mediating the neuroprotective role of soluble homodimers of the platelet-derived growth factor beta subunit (PDGF-BB) that is secreted by microcirculation cells. The aim of this study was to determine whether binding of PDGF-BB to astrocytic PDGFR beta enhanced crosstalk among the various components of the neurovascular unit, leading to synaptic recovery after subarachnoid hemorrhage (SAH). The soluble PDGF-BB from the cerebrospinal fluid (CSF) of patients with SAH was measured. The relationship between PDGF-BB treatment and astrocytic PDGFR beta signaling was further explored in vivo and in vitro in experimental SAH models. Compared with the levels in the control samples, the PDGF-BB protein levels in the CSF of patients with SAH were significantly increased. After the generation of experimental SAH, astrocyte activation markers were markedly induced by the binding of PDGF-BB to astrocytic PDGFR beta, accompanied by improved levels of synaptic recovery and cognitive function. Soluble PDGF-BB and astrocytic PDGFR beta signaling are essential for the neuroprotective effect in the hippocampus and the coculture system in vitro after SAH that otherwise leads to cognitive dysfunction and neuronal damage.-Zhou, X., Wu, Q., Lu, Y., Zhang, X., Lv, S., Shao, J., Zhou, Y., Chen, J., Hou, L., Huang, C., Zhang, X. Crosstalk between soluble PDGF-BB and PDGFR beta promotes astrocytic activation and synaptic recovery in the hippocampus after subarachnoid hemorrhage.	[Zhou, Xiaoming; Chen, Jigang; Hou, Lijun; Huang, Chengguang] Second Mil Med Univ, Dept Neurosurg, Changzheng Hosp, Shanghai 200003, Peoples R China; [Wu, Qi; Zhang, Xiangsheng; Zhou, Yuan; Zhang, Xin] Nanjing Univ, Jinling Hosp, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China; [Lu, Yue] Nanjing Univ, Drum Tower Hosp, Dept Neurosurg, Sch Med, Nanjing, Jiangsu, Peoples R China; [Lv, Shengyin; Shao, Jiang] Southern Med Univ, Jinling Hosp, Dept Neurosurg, Sch Med, Nanjing, Jiangsu, Peoples R China	Naval Medical University; Nanjing University; Nanjing University; Southern Medical University - China	Huang, CG (corresponding author), Second Mil Med Univ, Dept Neurosurg, Changzheng Hosp, Shanghai 200003, Peoples R China.; Zhang, X (corresponding author), Nanjing Univ, Jinling Hosp, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China.	huang64@163.com; zhangxsp@163.com			National Natural Science Foundation, China [81171130, 81671206, 81471183]	National Natural Science Foundation, China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Foundation, China (81171130, 81671206, and 81471183). The authors declare that there are no conflicts of interest that could be perceived as prejudicing the impartiality of the reported research.	Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Arango-Lievano M, 2018, CELL REP, V23, P1045, DOI 10.1016/j.celrep.2018.03.110; Cabezas R, 2018, MOL NEUROBIOL, V55, P3085, DOI 10.1007/s12035-017-0567-6; Cai Y, 2016, J CELL BIOL, V215, P245, DOI 10.1083/jcb.201605065; Chen Q, 2016, J NEUROL SCI, V369, P126, DOI 10.1016/j.jns.2016.08.017; Chung WS, 2015, NAT NEUROSCI, V18, P1539, DOI 10.1038/nn.4142; Diaz A, 2017, J NEUROSCI, V37, P10310, DOI 10.1523/JNEUROSCI.1630-17.2017; Gaceb A, 2018, J CEREBR BLOOD F MET, V38, P45, DOI 10.1177/0271678X17719645; Jones EV, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/321209; Klinkhammer BM, 2018, MOL ASPECTS MED, V62, P44, DOI 10.1016/j.mam.2017.11.008; Kyyriainen J, 2017, GLIA, V65, P322, DOI 10.1002/glia.23094; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Luo C, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.63; Macdonald RL, 2017, LANCET, V389, P655, DOI 10.1016/S0140-6736(16)30668-7; Miners JS, 2018, J CEREBR BLOOD F MET, V38, P103, DOI 10.1177/0271678X17690761; Ostergaard L, 2013, J CEREBR BLOOD F MET, V33, P1825, DOI 10.1038/jcbfm.2013.173; Oztop-Cakmak O, 2017, CURR DRUG TARGETS, V18, P1386, DOI 10.2174/1389450117666160613104523; Padel T, 2016, NEUROBIOL DIS, V94, P95, DOI 10.1016/j.nbd.2016.06.002; Paul G, 2015, J CLIN INVEST, V125, P1339, DOI 10.1172/JCI79635; Schallner N, 2015, J CLIN INVEST, V125, P2609, DOI 10.1172/JCI78443; Shen J, 2012, J CEREBR BLOOD F MET, V32, P353, DOI 10.1038/jcbfm.2011.136; Sompol P, 2017, J NEUROSCI, V37, P6132, DOI 10.1523/JNEUROSCI.0877-17.2017; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Tyzack GE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5294	24	16	18	2	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9588	9601		10.1096/fj.201900195R	http://dx.doi.org/10.1096/fj.201900195R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31162947				2022-12-28	WOS:000478832900069
J	Shi, PB; Nie, JX; Liu, H; Li, YH; Lu, X; Shen, X; Ge, FF; Yuan, TF; Guan, XW				Shi, Pengbo; Nie, Jiaxun; Liu, Hou; Li, Yuehan; Lu, Xue; Shen, Xu; Ge, Feifei; Yuan, Ti-Fei; Guan, Xiaowei			Adolescent cocaine exposure enhances the GABAergic transmission in the prelimbic cortex of adult mice	FASEB JOURNAL			English	Article						adult PrL; drugs of abuse; GABA transmission	MEDIAL PREFRONTAL CORTEX; GABA CIRCUITRY; NEURONS; EXPRESSION; INTERNEURONS; BEHAVIOR; BRAIN; RATS; AMPHETAMINE; INHIBITION	We have recently shown in rats that adolescent cocaine exposure induces prolonged modifications on synapses in medial prefrontal cortex (mPFC), which might contribute to long-term behavioral outcomes in adulthood. In this study, we further investigated the molecular mechanisms underlying adolescent cocaine exposure-related psychiatric problems in adulthood, especially focusing on the alterations of GABAergic transmission in prelimbic cortex (PrL), 1 subregion of mPFC. Consistent with a previous study, adolescent cocaine-exposed mice exhibited enhanced anxiety-like behaviors in their adulthood. In the same mice models, depression-like behaviors increased as well, but the conditioned place preference formed normally. In parallel, activities of pyramidal neurons at layer V of PrL were reduced after adolescent cocaine exposure, accompanied by an increase in the percentage of symmetric synapses in PrL of adult mice. Additionally, miniature inhibitory postsynaptic currents rather than miniature excitatory postsynaptic currents were increased on these pyramidal neurons, and increased levels of GABA were found in adult PrL. The molecules in the GABAergic system in adult PrL were also changed by adolescent cocaine use, as indicated by increased glutamate decarboxylase 67 kDa, GABA(A)-alpha 1, and decreased GABA transporter 1. In the same mice, some regulators to GABAergic transmission such as neuregulin 1/ErbB4 signals were heightened as well. Collectively, these findings revealed that adolescent cocaine exposure results in permanent enhancement of GABAergic transmission on pyramidal neurons in PrL, which subsequently attenuate the activities of these neurons and ultimately contributes to the development of psychiatric disorders in later life.-Shi, P., Nie, J., Liu, H., Li, Y., Lu, X., Shen, X., Ge, F., Yuan, T.-F., Guan, X. Adolescent cocaine exposure enhances the GABAergic transmission in the prelimbic cortex of adult mice.	[Shi, Pengbo; Nie, Jiaxun; Li, Yuehan; Lu, Xue; Shen, Xu; Ge, Feifei; Guan, Xiaowei] Nanjing Univ Chinese Med, Sch Med & Life Sci, Dept Human Anat & Histoembryol, Nanjing, Jiangsu, Peoples R China; [Liu, Hou] Nanjing Normal Univ, Sch Psychol, Dept Psychol, Nanjing, Jiangsu, Peoples R China; [Yuan, Ti-Fei] Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Shanghai Key Lab Psychot Disorders, Shanghai, Peoples R China	Nanjing University of Chinese Medicine; Nanjing Normal University; Shanghai Jiao Tong University	Ge, FF; Guan, XW (corresponding author), Nanjing Univ Chinese Med, Sch Med & Life Sci, 138 Xianlin Rd, Nanjing 210023, Jiangsu, Peoples R China.	ffge@njucm.edu.cn; guanxw918@njucm.edu.cn		Ge, Feifei/0000-0003-1336-8587	National Nature and Science Foundation of China (NSFC) [81571303, 31771215]	National Nature and Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	The authors thank Prof. Jun Wang (Nanjing Medical University, Nanjing, China) for assistance in liquid chromatography-mass spectrometry tests. This research was supported by National Nature and Science Foundation of China (NSFC) Grants (81571303 and 31771215). The authors declare no conflicts of interest.	Abe Y, 2011, J NEUROSCI, V31, P5699, DOI 10.1523/JNEUROSCI.3477-10.2011; Butkovich LM, 2015, EUR J NEUROSCI, V42, P2114, DOI 10.1111/ejn.12995; Caballero A, 2014, PSYCHOPHARMACOLOGY, V231, P1789, DOI 10.1007/s00213-013-3216-4; Caffino L, 2017, PSYCHOPHARMACOLOGY, V234, P1217, DOI 10.1007/s00213-017-4559-z; Cass DK, 2014, MOL PSYCHIATR, V19, P536, DOI 10.1038/mp.2014.14; Cass DK, 2013, BIOL PSYCHIAT, V74, P490, DOI 10.1016/j.biopsych.2013.02.021; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Chen Q, 2007, BIOCHEM BIOPH RES CO, V356, P733, DOI 10.1016/j.bbrc.2007.03.041; Chocyk A, 2013, EUR J NEUROSCI, V38, P2089, DOI 10.1111/ejn.12208; Czeh B, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00148; Delli Pizzi S, 2017, BRAIN STRUCT FUNCT, V222, P1267, DOI 10.1007/s00429-016-1276-z; DePoy LM, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.150; Depoy LM, 2017, BIOL PSYCHIAT, V81, P595, DOI 10.1016/j.biopsych.2016.09.023; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Ferguson BR, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00037; Ferguson BR, 2018, BIOL PSYCHIAT, V83, P657, DOI 10.1016/j.biopsych.2017.11.033; Fuhrmann D, 2015, TRENDS COGN SCI, V19, P558, DOI 10.1016/j.tics.2015.07.008; Giannotti G, 2015, PSYCHOPHARMACOLOGY, V232, P713, DOI 10.1007/s00213-014-3708-x; Hearing M, 2013, NEURON, V80, P159, DOI 10.1016/j.neuron.2013.07.019; James MH, 2018, INT J NEUROPSYCHOPH, V21, P89, DOI 10.1093/ijnp/pyx107; Kang S, 2016, NEUROSCIENCE, V324, P40, DOI 10.1016/j.neuroscience.2016.02.064; Lee KFH, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/704103; Lubbers BR, 2014, BIOL PSYCHIAT, V76, P750, DOI 10.1016/j.biopsych.2014.02.001; Maguire EP, 2014, J NEUROSCI, V34, P823, DOI 10.1523/JNEUROSCI.3232-13.2014; Marenco S, 2011, J NEUROSCI, V31, P11628, DOI 10.1523/JNEUROSCI.1529-11.2011; MINELLI A, 1995, J NEUROSCI, V15, P7734, DOI 10.1523/jneurosci.15-11-07734.1995; Nikonenko A, 2003, J COMP NEUROL, V456, P338, DOI 10.1002/cne.10537; O'Neill CE, 2016, PSYCHONEUROENDOCRINO, V67, P40, DOI 10.1016/j.psyneuen.2016.01.030; Pandey SC, 2015, NEUROBIOL DIS, V82, P607, DOI 10.1016/j.nbd.2015.03.019; Paul K, 2016, BEHAV BRAIN RES, V309, P9, DOI 10.1016/j.bbr.2016.04.018; Pittarast EC, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00171; Schneider S, 2012, AM J PSYCHIAT, V169, P39, DOI 10.1176/appi.ajp.2011.11030489; Sherrill LK, 2018, BRAIN RES, V1694, P111, DOI 10.1016/j.brainres.2018.05.028; Slaker ML, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0221-18.2018; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Trantham-Davidson H, 2017, NEUROPSYCHOPHARMACOL, V42, P1024, DOI 10.1038/npp.2016.190; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Wang GQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8660; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Yang JM, 2013, J NEUROSCI, V33, P19724, DOI 10.1523/JNEUROSCI.1584-13.2013; Yang WQ, 2017, EUR ADDICT RES, V23, P28, DOI 10.1159/000452657; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yuan Q, 2016, BIOL PSYCHIAT, V80, P312, DOI 10.1016/j.biopsych.2015.08.019; Zhu W, 2016, NEUROSCIENCE, V313, P174, DOI 10.1016/j.neuroscience.2015.11.041; Zhu W, 2018, BRAIN STRUCT FUNCT, V223, P1829, DOI 10.1007/s00429-017-1590-0	45	10	10	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8614	8622		10.1096/fj.201802192RR	http://dx.doi.org/10.1096/fj.201802192RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	31034782				2022-12-28	WOS:000476234700064
J	Nascimento, CHV; Webber, LP; Borgato, GB; Goloni-Bertollo, EM; Squarize, CH; Castilho, RM				Nascimento-Filho, Carlos H. V.; Webber, Liana P.; Borgato, Gabriell B.; Goloni-Bertollo, Eny M.; Squarize, Cristiane H.; Castilho, Rogerio M.			Hypoxic niches are endowed with a protumorigenic mechanism that supersedes the protective function of PTEN	FASEB JOURNAL			English	Article						ROS; mTOR; EMT; epithelial-mesenchymal transition; cancer stem cell	CANCER STEM-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; INDUCIBLE FACTOR-1-ALPHA; MAMMALIAN TARGET; PROGNOSTIC VALUE; BREAST-CANCER; EXPRESSION; HEAD; MARKER; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA	Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy worldwide and is characterized by a fast-paced growth. Like other solid tumors, the HNSCC growth rate results in the development of hypoxic regions identified by the expression of hypoxia-inducible factor 1 alpha (HIF-1 alpha). Interestingly, clinical data have shown that pharmacological induction of intratumoral hypoxia caused an unexpected rise in tumor metastasis and the accumulation of cancer stem cells (CSCs). However, little is known on the molecular circuitries involved in the presence of intratumoral hypoxia and the augmented population of CSCs. Here we explore the impact of hypoxia on the behavior of HNSCC and define that the controlling function of phosphatase and tensin homolog (PTEN) over HIF-1 alpha expression and CSC accumulation are de-regulated during hypoxic events. Our findings indicate that hypoxic niches are poised to accumulate CSCs in a molecular process driven by the loss of PTEN activity. Furthermore, our data suggest that targeted therapies aiming at the PTEN/PI3K signaling may constitute an effective strategy to counteract the development of intratumoral hypoxia and the accumulation of CSCs.	[Nascimento-Filho, Carlos H. V.; Webber, Liana P.; Borgato, Gabriell B.; Squarize, Cristiane H.; Castilho, Rogerio M.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Lab Epithelial Biol, Ann Arbor, MI 48109 USA; [Nascimento-Filho, Carlos H. V.; Goloni-Bertollo, Eny M.] Sch Med Sao Jose Rio Preto, Dept Mol Biol, Genet & Mol Biol Res Unit, Sao Paulo, Brazil; [Webber, Liana P.] Univ Fed Rio Grande do Sul, Sch Dent, Dept Oral Pathol, Porto Alegre, RS, Brazil; [Borgato, Gabriell B.] Univ Estadual Campinas, Sch Dent, Dept Oral Biol, Piracicaba, SP, Brazil; [Squarize, Cristiane H.; Castilho, Rogerio M.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Universidade Federal do Rio Grande do Sul; Universidade Estadual de Campinas; University of Michigan System; University of Michigan	Castilho, RM (corresponding author), Univ Michigan, Lab Epithelial Biol, Dept Periodont & Oral Med, 1011 N Univ Ave,Room 2029c, Ann Arbor, MI 48109 USA.	rcastilh@umich.edu	Castilho, Rogerio M/E-4987-2010; do Nascimento Filho, Carlos Viesi/AAR-7766-2021	Castilho, Rogerio M/0000-0001-5358-612X; do Nascimento Filho, Carlos Viesi/0000-0002-6870-2602; Bonifacio Borgato, Gabriell/0000-0003-0798-2484; Squarize, Cristiane/0000-0002-6782-3429; Preto Webber, Liana/0000-0003-1812-5904	Capes Foundation within the Brazilian Ministry of Education [BEX/88881.135014/2016-01 PDSE]; University of Michigan Cancer Center Support Grant [P30 CA046592]; U.S. National Institutes of Health (NIH), National Institute of General Medical Sciences Research Grant [5R01GM120056]; University of Michigan School of Dentistry faculty; Robert Wood Johnson Foundation [AMFDP-72425]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120056] Funding Source: NIH RePORTER	Capes Foundation within the Brazilian Ministry of Education(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); University of Michigan Cancer Center Support Grant; U.S. National Institutes of Health (NIH), National Institute of General Medical Sciences Research Grant; University of Michigan School of Dentistry faculty; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was conducted during a visiting scholar period at the University of Michigan, sponsored by the Capes Foundation within the Brazilian Ministry of Education (Grant BEX/88881.135014/2016-01 PDSE). This work was partially supported by University of Michigan Cancer Center Support Grant P30 CA046592, and by the U.S. National Institutes of Health (NIH), National Institute of General Medical Sciences Research Grant 5R01GM120056. This grant was funded by the University of Michigan School of Dentistry faculty, and by The Robert Wood Johnson Foundation (AMFDP-72425). The monoclonal antibody AMF-17b, developed by A. B. Fulton, was obtained from the Developmental Studies Hybridoma Bank, created by the NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and maintained at The University of Iowa (Iowa City, IA, USA). The authors declare no conflict of interest.	Aebersold DM, 2001, CANCER RES, V61, P2911; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Baba Y, 2010, AM J PATHOL, V176, P2292, DOI 10.2353/ajpath.2010.090972; Beasley NJP, 2002, CANCER RES, V62, P2493; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; BOUSQUET PF, 1995, CANCER RES, V55, P1176; Brennan MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120254; Cannito S, 2010, ANTIOXID REDOX SIGN, V12, P1383, DOI 10.1089/ars.2009.2737; Cannito S, 2008, CARCINOGENESIS, V29, P2267, DOI 10.1093/carcin/bgn216; Charafe-Jauffret E, 2008, PATHOBIOLOGY, V75, P75, DOI 10.1159/000123845; Choi BJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15139-5; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; Coller HA, 2007, NAT REV MOL CELL BIO, V8, P667, DOI 10.1038/nrm2223; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Enomoto K, 2017, J CLIN ENDOCR METAB, V102, P2268, DOI 10.1210/jc.2016-3771; Faustino-Rocha A, 2013, LAB ANIMAL, V42, P217, DOI 10.1038/laban.254; Feldman R, 2016, HEAD NECK-J SCI SPEC, V38, pE1625, DOI 10.1002/hed.24290; Flores IL, 2016, CLIN SCI, V130, P785, DOI 10.1042/CS20150646; Fukushima S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178064; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Giudice FS, 2013, J CARCINOG MUTAGE S5, V5, P003, DOI [10.4172/2157-2518.S5-003., DOI 10.4172/2157-2518.S5-003]; Gruber G, 2004, BREAST CANCER RES, V6, pR191, DOI 10.1186/bcr775; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Hung JJ, 2009, THORAX, V64, P1082, DOI 10.1136/thx.2009.115691; Ichikawa T, 2015, SCI REP-UK, V5, DOI 10.1038/srep12841; Ito A, 2015, J STEM CELLS REGEN, V11, pP25; Itoi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047512; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Kessler J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-605; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lin CS, 2017, INT J MED SCI, V14, P785, DOI 10.7150/ijms.19512; Linge A, 2016, CLIN CANCER RES, V22, P2639, DOI 10.1158/1078-0432.CCR-15-1990; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; Matsumoto CS, 2016, ONCOTARGET, V7, P42393, DOI 10.18632/oncotarget.9877; Miyake K, 2008, PANCREAS, V36, pE1, DOI 10.1097/MPA.0b013e31815f2c2a; Mullendore ME, 2009, CLIN CANCER RES, V15, P2291, DOI 10.1158/1078-0432.CCR-08-2004; Nakahata S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4393; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Redza-Dutordoir M, 2016, BBA-MOL CELL RES, V1863, P2977, DOI 10.1016/j.bbamcr.2016.09.012; Roh JL, 2009, ORAL ONCOL, V45, P63, DOI 10.1016/j.oraloncology.2008.03.017; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Squarize CH, 2013, NEOPLASIA, V15, P461, DOI 10.1593/neo.121024; Tomita H, 2016, ONCOTARGET, V7, P11018, DOI 10.18632/oncotarget.6920; Webber LP, 2019, CANCER LETT, V461, P10, DOI 10.1016/j.canlet.2019.06.019; Wu Danli, 2011, J Vis Exp, DOI 10.3791/2899; Zagni C, 2017, STEM CELL REP, V9, P304, DOI 10.1016/j.stemcr.2017.05.006; Zhang L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-108; Zhang Y, 2013, STEM CELL RES, V11, P772, DOI 10.1016/j.scr.2013.04.011; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P19655, DOI 10.1073/pnas.0710050104; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	56	7	7	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13435	13449		10.1096/fj.201900722R	http://dx.doi.org/10.1096/fj.201900722R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31560860	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000507466100032
J	Nagasu, H; Sogawa, Y; Kidokoro, K; Itano, S; Yamamoto, T; Satoh, M; Sasaki, T; Suzuki, T; Yamamoto, M; Wigley, WC; Proksch, JW; Meyer, CJ; Kashihara, N				Nagasu, Hajime; Sogawa, Yuji; Kidokoro, Kengo; Itano, Seiji; Yamamoto, Toshiya; Satoh, Minoru; Sasaki, Tamaki; Suzuki, Takafumi; Yamamoto, Masayuki; Wigley, W. Christian; Proksch, Joel W.; Meyer, Colin J.; Kashihara, Naoki			Bardoxolone methyl analog attenuates proteinuria-induced tubular damage by modulating mitochondrial function	FASEB JOURNAL			English	Article						dh404; Nrf2; reactive oxidative species; inflammation	TRANSCRIPTION FACTOR NRF2; ISCHEMIA-REPERFUSION INJURY; OXIDATIVE STRESS; KIDNEY-DISEASE; DH404; INFLAMMATION; FILTRATION; MOUSE; RATS	Multiple clinical studies have shown that bardoxolone methyl, a potent activator of nuclear factor erythroid 2-related factor 2 (Nrf2), is effective in increasing glomerular filtration rate in patients with chronic kidney disease. However, whether an Nrf2 activator can protect tubules from proteinuria-induced tubular damage via anti-inflammatory and antioxidative stress mechanisms is unknown. Using an Institute of Cancer Research-derived glomerulonephritis (ICGN) mouse model of nephrosis, we examined the effects of dihydro-CDDO-trifluoroethyl amide (dh404), a rodent-tolerable bardoxolone methyl analog, in protecting the tubulointerstitium; dh404 markedly suppressed tubular epithelial cell damage in the renal interstitium of ICGN mice. The tubular epithelial cells of ICGN mice showed a decrease in the size and number of mitochondria, as well as the breakdown of the crista structure, whereas the number and ultrastructure of mitochondria were maintained by the dh404 treatment. To further determine the effect of dh404 on mitochondrial function, we used human proximal tubular cells in vitro. Stimulation with albumin and free fatty acid increased mitochondrial reactive oxygen species (ROS). However, dh404 administration diminished mitochondrial ROS. Our data show that dh404 significantly reduced proteinuria-induced tubular cell mitochondrial damage, suggesting that improved redox balance and mitochondrial function and suppression of inflammation underlie the cytoprotective mechanism of Nrf2 activators, induding bardoxolone methyl, in diabetic kidney disease.	[Nagasu, Hajime; Sogawa, Yuji; Kidokoro, Kengo; Itano, Seiji; Yamamoto, Toshiya; Satoh, Minoru; Sasaki, Tamaki; Kashihara, Naoki] Kawasaki Med Sch, Dept Nephrol & Hypertens, 577 Matsushima, Kurashiki, Okayama 7010192, Japan; [Suzuki, Takafumi; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi, Japan; [Wigley, W. Christian; Proksch, Joel W.; Meyer, Colin J.] Reata Pharmaceut, Irving, TX USA	Kawasaki Medical School; Tohoku University	Nagasu, H (corresponding author), Kawasaki Med Sch, Dept Nephrol & Hypertens, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	hajimenagasu@med.kawasaki-m.ac.jp	Yamamoto, Masayuki/A-4873-2010; Suzuki, Takafumi/ABC-6582-2020	Yamamoto, Masayuki/0000-0002-9073-9436; Suzuki, Takafumi/0000-0002-3425-8208	Japan Society for the Promotion of Science (JSPS) Kakenhi [24591220, 18H02828]; Kawasaki Medical School [30B-75]	Japan Society for the Promotion of Science (JSPS) Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kawasaki Medical School	The authors thank Etsuko Yorimasa, Yuriko Katayama, and Ayano Higashi (Kawasaki Medical School) for providing animal care, and Satomi Hanada, Keiko Shirakiya, and Keiko Satoh (Kawasaki Medical School) for assisting with the in vitro assays. The authors also thank Kyowa Hakko Kirin Co., Ltd. (Tokyo, Japan) for supporting the preparation of this manuscript. This work was supported, in part, by the Japan Society for the Promotion of Science (JSPS) Kakenhi Grants 24591220 and 18H02828 (to H.N. and N.K.), and Kawasaki Medical School Grant 30B-75 (to T.Y.). W. Christian Wigley, Joel W. Proksch, and Colin J. Meyer have ownership of Reata Pharmaceuticals stock. The remaining authors delcare no conflicts of interest.	Aminzadeh MA, 2014, XENOBIOTICA, V44, P570, DOI 10.3109/00498254.2013.852705; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Bellezza I, 2012, J NUTR BIOCHEM, V23, P1583, DOI 10.1016/j.jnutbio.2011.10.012; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Chin M, 2013, AM J PHYSIOL-RENAL, V304, pF1438, DOI 10.1152/ajprenal.00387.2012; Cho AR, 2006, MAMM GENOME, V17, P407, DOI 10.1007/s00335-005-0167-z; de Cavanagh EMV, 2006, AM J PHYSIOL-REG I, V290, pR1616, DOI 10.1152/ajpregu.00615.2005; de Zeeuw D, 2013, NEW ENGL J MED, V369, P2492, DOI 10.1056/NEJMoa1306033; Dinkova-Kostova AT, 2015, FREE RADICAL BIO MED, V88, P179, DOI 10.1016/j.freeradbiomed.2015.04.036; Erkan E, 2007, J AM SOC NEPHROL, V18, P1199, DOI 10.1681/ASN.2006040407; Gilbert RE, 2017, DIABETES, V66, P791, DOI 10.2337/db16-0796; Haruna Y, 2007, P NATL ACAD SCI USA, V104, P2331, DOI 10.1073/pnas.0611079104; Holmstrom KM, 2013, BIOL OPEN, V2, P761, DOI 10.1242/bio.20134853; Ishii Y, 2005, J IMMUNOL, V175, P6968, DOI 10.4049/jimmunol.175.10.6968; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kadoya H, 2015, FASEB J, V29, P3899, DOI 10.1096/fj.15-271734; Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Liu MC, 2014, KIDNEY INT, V85, P134, DOI 10.1038/ki.2013.357; Mori KP, 2017, J AM SOC NEPHROL, V28, P278, DOI 10.1681/ASN.2015101168; Nezu M, 2017, KIDNEY INT, V91, P387, DOI 10.1016/j.kint.2016.08.023; Nishi Y, 2013, KIDNEY INT, V83, P662, DOI 10.1038/ki.2012.475; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Robles L, 2016, PANCREAS, V45, P720, DOI 10.1097/MPA.0000000000000518; Ruiz S, 2013, KIDNEY INT, V83, P1029, DOI 10.1038/ki.2012.439; Satoh M, 2011, LAB INVEST, V91, P190, DOI 10.1038/labinvest.2010.175; Seng S, 2010, J BIOL CHEM, V285, P26190, DOI 10.1074/jbc.M109.095786; Suzuki T, 2017, J BIOL CHEM, V292, P16817, DOI 10.1074/jbc.R117.800169; Taal MW, 2008, KIDNEY INT, V73, P1216, DOI 10.1038/ki.2008.36; Tan SM, 2014, DIABETES, V63, P3091, DOI 10.2337/db13-1743; Thomas B, 2017, J AM SOC NEPHROL, V28, P2167, DOI 10.1681/ASN.2016050562; Xiao L, 2017, REDOX BIOL, V11, P297, DOI 10.1016/j.redox.2016.12.022; Zhuang YB, 2015, AM J PHYSIOL-RENAL, V308, pF1012, DOI 10.1152/ajprenal.00509.2014	36	26	28	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12253	12263		10.1096/fj.201900217R	http://dx.doi.org/10.1096/fj.201900217R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31431054	Green Published, hybrid			2022-12-28	WOS:000507461600051
J	Tsai, SH; Huang, PH; Tsai, HY; Hsu, YJ; Chen, YW; Wang, JC; Chen, YH; Lin, SJ				Tsai, Shih-Hung; Huang, Po-Hsun; Tsai, Hsiao-Ya; Hsu, Yu-Juei; Chen, Yen-Wen; Wang, Jen-Chun; Chen, Ying-Hsin; Lin, Shing-Jong			Roles of the hypoximir microRNA-424/322 in acute hypoxia and hypoxia-induced pulmonary vascular leakage	FASEB JOURNAL			English	Article						hypoxia-inducible factor-1 alpha; vascular endothelial growth factor; miR-424/322; endothelial function; acute mountain sickness	ENDOTHELIAL GROWTH-FACTOR; HIGH-ALTITUDE; EXPRESSION PROFILE; CELLS; ACETAZOLAMIDE; HIF-1-ALPHA; ACTIVATION; ISCHEMIA; PROTECTS; MIR-210	Acute mountain sickness (AMS) occurs in up to 25% of unacclimatized persons who ascend to 3000 m and can result in high-altitude pulmonary edema (HAPE). MicroRNAs (miRs) can regulate gene expression at the post-transcriptional level. Hypoxia selectively disrupts endothelial tight junction complexes through a hypoxia-inducible factor-1 alpha (HIF-1 alpha)-dependent mechanism. Though increased HIF-1 alpha expression is associated with adaptation and protection from AMS development in the early stage of hypoxia, a downstream effector of HIF-1 alpha, VEGF, can induce overzealous endothelial barrier dysfunction, increase vascular permeability, and ultimately result in HAPE and high-altitude cerebral edema. We hypothesized that the fine-tuning of downstream effectors by miRs is paramount for the preservation of endothelial barrier integrity and the prevention of vascular leakage. We found that several miRs were up-regulated in healthy volunteers who were subjected to a 3100-m height. By reviewing the literature and using online bioinformatics prediction software, we specifically selected miR-424 for further investigation because it can modulate both HIF-1 alpha and VEGF. Hypoxia-induced miR-424 overexpression is HIF-1 alpha dependent, and miR-424 stabilized HIF-1 alpha, decreased VEGF expression, and promoted vascular endothelial cadherin phosphorylation. In addition, hypoxia resulted in endothelial barrier dysfunction with increased permeability; miR-424 thus attenuated hypoxia-induced endothelial cell senescence and apoptosis. miR-322 knockout mice were susceptible to hypoxia-induced pulmonary vascular leakage. miR-322 mimics improved hypoxia-induced pulmonary vascular leakage in vivo. We conclude that several miRs were up-regulated in healthy adult volunteers subjected to hypobaric hypoxemia. miR-424/322 could modulate the HIF-1 alpha-VEGF axis and prevent hypoxia-induced pulmonary vascular leakage under hypoxic conditions.	[Tsai, Shih-Hung; Tsai, Hsiao-Ya; Wang, Jen-Chun; Chen, Ying-Hsin] Natl Def Med Ctr, Triserv Gen Hosp, Dept Emergency Med, 325,Sec 2,Cheng Kung Rd, Taipei 11490, Taiwan; [Hsu, Yu-Juei] Natl Def Med Ctr, Triserv Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan; [Tsai, Shih-Hung] Natl Def Med Ctr, Grad Inst Physiol, Dept Physiol & Biophys, Taipei, Taiwan; [Huang, Po-Hsun; Wang, Jen-Chun; Lin, Shing-Jong] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Huang, Po-Hsun; Lin, Shing-Jong] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei, Taiwan; [Huang, Po-Hsun; Lin, Shing-Jong] Taipei Vet Gen Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan; [Huang, Po-Hsun] Taipei Vet Gen Hosp, Dept Crit Care Med, Taipei, Taiwan; [Chen, Yen-Wen] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan; [Lin, Shing-Jong] Taipei Vet Gen Hosp, Healthcare & Serv Ctr, Taipei, Taiwan; [Lin, Shing-Jong] Taipei Med Univ, Taipei Heart Inst, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Medical University	Tsai, SH (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Emergency Med, 325,Sec 2,Cheng Kung Rd, Taipei 11490, Taiwan.; Lin, SJ (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, Dept Med, 201,Sec 2,Shih Pai Rd, Taipei, Taiwan.	tsaishihung@yahoo.com.tw; sjlin@vghtpe.gov.tw		Tsai, Hsaio Ya/0000-0002-5704-507X	Tri-Service General Hospital of the National Defense Medical Center [TSGH-C105-056, TSGH-C107-047, TSGH-C108-067]; Ministry of Science and Technology [MOST 106-2314-B-016031, MOST 106-2314-B-016-008-MY3, MOST-107-2314-B-016061, MOST-108-2314-B-016-047-MY3]; National Defense Medical Center [MAB-C107-013, MAB-C108-018]	Tri-Service General Hospital of the National Defense Medical Center; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Defense Medical Center	This study was supported by grants from the Tri-Service General Hospital of the National Defense Medical Center (TSGH-C105-056, TSGH-C107-047, and TSGH-C108-067), the Ministry of Science and Technology (MOST 106-2314-B-016031, MOST 106-2314-B-016-008-MY3, MOST-107-2314-B-016061, and MOST-108-2314-B-016-047-MY3), and the National Defense Medical Center (MAB-C107-013 and MAB-C108-018). The authors declare no conflicts of interest.	Abu Taha A, 2014, CELL ADHES MIGR, V8, P125, DOI 10.4161/cam.28243; An Y, 2013, CELL PHYSIOL BIOCHEM, V32, P1151, DOI 10.1159/000354515; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartsch P, 2013, NEW ENGL J MED, V368, P2294, DOI 10.1056/NEJMcp1214870; Baneke A, 2010, TRAVEL MED INFECT DI, V8, P257, DOI 10.1016/j.tmaid.2010.04.006; Baptista R, 2018, CARDIOVASC RES, V114, P53, DOI 10.1093/cvr/cvx187; Bienertova-Vasku J, 2015, J AM SOC HYPERTENS, V9, P221, DOI 10.1016/j.jash.2014.12.011; Braza-Boils A, 2015, HUM REPROD, V30, P2292, DOI 10.1093/humrep/dev204; Braza-Boils A, 2014, HUM REPROD, V29, P978, DOI 10.1093/humrep/deu019; Chamorro-Jorganes A, 2011, ARTERIOSCL THROM VAS, V31, P2595, DOI 10.1161/ATVBAHA.111.236521; Chan YC, 2012, MICROCIRCULATION, V19, P215, DOI 10.1111/j.1549-8719.2011.00154.x; Chen Z, 2013, J CLIN INVEST, V123, P1057, DOI 10.1172/JCI65344; Ding H, 2012, J INT MED RES, V40, P2135, DOI 10.1177/030006051204000611; Dorward DA, 2007, RESP MED, V101, P587, DOI 10.1016/j.rmed.2006.06.014; Eckle T, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001665; Engebretsen BJ, 2007, HIGH ALT MED BIOL, V8, P312, DOI 10.1089/ham.2007.1031; Engelhardt S, 2014, J CELL PHYSIOL, V229, P1096, DOI 10.1002/jcp.24544; Epiphanio S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000916; Gavard J, 2013, CELL ADHES MIGR, V7, P455, DOI 10.4161/cam.27330; Ghosh G, 2010, J CLIN INVEST, V120, P4141, DOI 10.1172/JCI42980; Gill SE, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0266-7; Hegeman MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057374; Irwin DC, 2009, FREE RADICAL BIO MED, V47, P55, DOI 10.1016/j.freeradbiomed.2009.03.027; Krouwer VJD, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-12; Kubo K, 1996, THORAX, V51, P739, DOI 10.1136/thx.51.7.739; Lee SH, 2013, ARTERIOSCL THROM VAS, V33, P2407, DOI 10.1161/ATVBAHA.113.301931; Liu B, 2017, BIOCHEM BIOPH RES CO, V482, P1080, DOI 10.1016/j.bbrc.2016.11.161; Liu P, 2015, STROKE, V46, P513, DOI 10.1161/STROKEAHA.114.007482; Luks AM, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0096-2016; Luo J, 2012, MICROVASC RES, V83, P138, DOI 10.1016/j.mvr.2011.11.004; Maggiorini M, 2006, CARDIOVASC RES, V72, P41, DOI 10.1016/j.cardiores.2006.07.004; Maggiorini M, 2010, PROG CARDIOVASC DIS, V52, P500, DOI 10.1016/j.pcad.2010.03.001; Maloney J, 2000, CHEST, V118, P47, DOI 10.1378/chest.118.1.47; Marchand A, 2016, BBA-MOL BASIS DIS, V1862, P611, DOI 10.1016/j.bbadis.2016.01.010; Mounier R, 2009, EUR J APPL PHYSIOL, V106, P713, DOI 10.1007/s00421-009-1072-z; Murray F, 2006, RESP PHYSIOL NEUROBI, V151, P192, DOI 10.1016/j.resp.2005.10.003; Nagamine Y, 2016, AM J RESP CELL MOL, V55, P878, DOI 10.1165/rcmb.2015-0266OC; Schlosser K, 2015, CHEST, V148, P481, DOI 10.1378/chest.14-2169; Schommer K, 2011, HIGH ALT MED BIOL, V12, P323, DOI 10.1089/ham.2011.1020; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Seys SF, 2013, THORAX, V68, P906, DOI 10.1136/thoraxjnl-2013-203280; Takagi K, 2018, CELL SIGNAL, V42, P270, DOI 10.1016/j.cellsig.2017.10.019; Tan Y, 2015, HIGH ALT MED BIOL, V16, P43, DOI 10.1089/ham.2013.1081; Valera VA, 2011, J CANCER, V2, P515, DOI 10.7150/jca.2.515; van Patot MCT, 2009, FREE RADICAL BIO MED, V46, P1551, DOI 10.1016/j.freeradbiomed.2009.03.009; Wang JC, 2014, AM J EMERG MED, V32, P1183, DOI 10.1016/j.ajem.2014.07.007; Whitehead CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078487; Wu KM, 2013, PATHOL ONCOL RES, V19, P739, DOI 10.1007/s12253-013-9637-x; Xu JJ, 2009, NEUROSCI LETT, V451, P274, DOI 10.1016/j.neulet.2009.01.008; Yang S, 2011, ACTA CHROMATOGR, V23, P539, DOI 10.1556/AChrom.23.2011.4.1; Zeng Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep12098; Zhang D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.240; Zhang DX, 2015, CELL REP, V10, P1335, DOI 10.1016/j.celrep.2015.02.006; Zhang YZ, 2017, CLIN LAB, V63, P1667, DOI 10.7754/Clin.Lab.2017.170420; Zhu ZZ, 2017, INTENS CARE MED EXP, V5, DOI 10.1186/s40635-017-0155-0	55	15	17	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12565	12575		10.1096/fj.201900564RR	http://dx.doi.org/10.1096/fj.201900564RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31461385				2022-12-28	WOS:000507461600075
J	Zhang, TY; Ouyang, H; Mei, XY; Lu, B; Yu, ZY; Chen, KX; Wang, ZT; Ji, LL				Zhang, Tianyu; Ouyang, Hao; Mei, Xiyu; Lu, Bin; Yu, Zengyang; Chen, Kaixian; Wang, Zhengtao; Ji, Lili			Erianin alleviates diabetic retinopathy by reducing retinal inflammation initiated by microglial cells via inhibiting hyperglycemia-mediated ERK1/2-NF-kappa B signaling pathway	FASEB JOURNAL			English	Article						BRB breakdown; GLUT1; TNF-alpha; tight junctions; molecular docking analysis	MAJOR RISK-FACTORS; GLOBAL PREVALENCE; ENDOTHELIAL-CELL; ACTIVATION; MODULATION; TRANSPORT; INSIGHTS; BARRIER; HEALTH	Blood-retinal barrier (BRB) breakdown is a typical event in the early stage of diabetic retinopathy (DR). This study aims to elucidate the protection of erianin, a natural compound isolated from Dendrobium chrysotoxum Lindl, against DR development. Erianin alleviated BRB breakdown and rescued the reduced claudinl and occludin expression in retinas from streptozotocin-induced diabetic mice. Erianin reduced microglial activation, ERK1/2 phosphorylation, NF-kappa B transcriptional activation, and the elevated TNF-alpha expression both in vitro and in vivo. ERK1/2 inhibitor U0126 abrogated NF-kappa B activation in D-glucose-treated BV2 cells. Erianin reduced cellular glucose uptake, and molecular docking analysis indicated the potential interaction of erianin with glucose transporter (GLUT)1. GLUT1 inhibitor (STF31) reduced the activation of the ERK1/2-NF-kappa B signaling pathway. Co culture with D-glucose-stimulated microglial BV2 cells and with TNF-alpha stimulation both induced inner BRB and outer BRB damage in human retinal endothelial cells and APRE19 cells, but erianin improved all these damages. In summary, erianin attenuated BRB breakdown during DR development by inhibiting microglia-triggered retinal inflammation via reducing cellular glucose uptake and abrogating the subsequent activation of the downstream ERK1/2-NF-kappa B pathway. Moreover, erianin also alleviated BRB damage induced by TNF-alpha released from the activated microglia.	[Zhang, Tianyu; Ouyang, Hao; Mei, Xiyu; Lu, Bin; Yu, Zengyang; Chen, Kaixian; Wang, Zhengtao; Ji, Lili] Shanghai Univ Tradit Chinese Med, Key Lab New Resources & Qual Evaluat Chinese Med, Shanghai Key Lab Compound Chinese Med,Minist Educ, MOE Key Lab Standardizat Chinese Med,Inst Chinese, 1200 Cailun Rd, Shanghai 201203, Peoples R China	Shanghai University of Traditional Chinese Medicine	Wang, ZT; Ji, LL (corresponding author), Shanghai Univ Tradit Chinese Med, Key Lab New Resources & Qual Evaluat Chinese Med, Shanghai Key Lab Compound Chinese Med,Minist Educ, MOE Key Lab Standardizat Chinese Med,Inst Chinese, 1200 Cailun Rd, Shanghai 201203, Peoples R China.	lichenyue1307@126.com; lichenyue1307@126.com	Mei, Xiyu/GYA-4526-2022	Mei, Xiyu/0000-0003-2206-7647; Hao, Ouyang/0000-0001-6930-2363	Leadership in Science and Technology Innovation of the third batch of the national "Ten Thousand People Plan"; National Natural Science Foundation of China [81322053, 81173517, 81573679]	Leadership in Science and Technology Innovation of the third batch of the national "Ten Thousand People Plan"; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Prof. Yu Chen (Shanghai University of Traditional Chinese Medicine) and Prof. Xinhua Liu (Fudan University, Shanghai, China) for kindly gifting ARPE19 and BV2 cells. This work was financially supported by the Leadership in Science and Technology Innovation of the third batch of the national "Ten Thousand People Plan" and the National Natural Science Foundation of China (81322053, 81173517, and 81573679 to L.J.). The authors declare no conflicts of interest.	Adams DJ, 2014, ACS CHEM BIOL, V9, P2247, DOI 10.1021/cb500347p; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS7, DOI 10.2337/dc18-S001; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Arroba AI, 2017, ACTA DIABETOL, V54, P527, DOI 10.1007/s00592-017-0984-z; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Bharadwaj AS, 2013, PROG RETIN EYE RES, V32, P102, DOI 10.1016/j.preteyeres.2012.08.004; Campbell M, 2013, ADV EXP MED BIOL, V763, P70; Chan DA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002394; Chen LQ, 2015, ANNU REV BIOCHEM, V84, P865, DOI 10.1146/annurev-biochem-060614-033904; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Chinese Pharmacopeia Commission, 2010, PHARMACOPOEIA PEOPLE, V1, P150; Coughlin BA, 2017, VISION RES, V139, P93, DOI 10.1016/j.visres.2017.03.013; Cunha-Vaz J, 2011, EUR J OPHTHALMOL, V21, pS3, DOI 10.5301/EJO.2010.6049; CUNHAVAZ JG, 1976, DOC OPHTHALMOL, V41, P287, DOI 10.1007/BF00146764; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fischer AJ, 2015, GLIA, V63, P313, DOI 10.1002/glia.22752; Gerriets VA, 2016, NAT IMMUNOL, V17, P1459, DOI 10.1038/ni.3577; Gologorsky D, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/629452; Gong CY, 2014, VASC PHARMACOL, V62, P134, DOI 10.1016/j.vph.2014.04.007; Ioacara S, 2009, DIABETES RES CLIN PR, V86, P146, DOI 10.1016/j.diabres.2009.08.012; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jiang XS, 2014, J NEUROSCI RES, V92, P424, DOI 10.1002/jnr.23337; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kaur C, 2008, PROG RETIN EYE RES, V27, P622, DOI 10.1016/j.preteyeres.2008.09.003; Keenan HA, 2007, DIABETES CARE, V30, P1995, DOI 10.2337/dc06-2222; Kur J, 2012, PROG RETIN EYE RES, V31, P377, DOI 10.1016/j.preteyeres.2012.04.004; Lin FL, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00326; Mitic LL, 1998, ANNU REV PHYSIOL, V60, P121, DOI 10.1146/annurev.physiol.60.1.121; Okunuki Y, 2018, P NATL ACAD SCI USA, V115, pE6264, DOI 10.1073/pnas.1719601115; Popiolek-Barczyk K, 2016, CURR MED CHEM, V23, P2908, DOI 10.2174/0929867323666160607120124; Rashid K, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00176; Scanlon PH, 2013, MIDDLE EAST AFR J OP, V20, P293, DOI 10.4103/0974-9233.120007; Semeraro F, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/582060; SHAKIB M, 1966, EXP EYE RES, V5, P229, DOI 10.1016/S0014-4835(66)80011-8; Sun J, 2017, INT J MOL MED, V39, P1338, DOI 10.3892/ijmm.2017.2962; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Ting DSW, 2016, CLIN EXP OPHTHALMOL, V44, P260, DOI 10.1111/ceo.12696; van Dijk HW, 2012, INVEST OPHTH VIS SCI, V53, P2715, DOI 10.1167/iovs.11-8997; Wang MH, 2014, J NEUROSCI, V34, P3793, DOI 10.1523/JNEUROSCI.3153-13.2014; Wang YH, 2017, CELL PHYSIOL BIOCHEM, V44, P479, DOI 10.1159/000485085; Willis JR, 2017, JAMA OPHTHALMOL, V135, P926, DOI 10.1001/jamaophthalmol.2017.2553; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Yu Z., 2016, SCI REP, V6; Yu ZY, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/518317; Zeng HY, 2008, ARCH OPHTHALMOL-CHIC, V126, P227, DOI 10.1001/archophthalmol.2007.65; Zhang Q, 2016, BRIT J OPHTHALMOL, V100, P1443, DOI 10.1136/bjophthalmol-2015-308199; Zhu SH, 2017, INFLAMMATION, V40, P1475, DOI 10.1007/s10753-017-0571-z	50	42	46	3	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11776	11790		10.1096/fj.201802614RRR	http://dx.doi.org/10.1096/fj.201802614RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31365278	Bronze, Green Published			2022-12-28	WOS:000507461600016
J	Farkas, Z; Petric, M; Liu, XH; Herit, F; Rajnavolgyi, E; Szondy, Z; Budai, Z; Orban, LI; Sandor, S; Mehta, A; Bajtay, Z; Kovacs, T; Jung, SY; Shakir, MA; Qin, J; Zhou, Z; Niedergang, F; Boissan, M; Takacs-Vellai, K				Farkas, Zsolt; Petric, Metka; Liu, Xianghua; Herit, Floriane; Rajnavolgyi, Eva; Szondy, Zsuzsa; Budai, Zsofia; Orban, Limas, I; Sandor, Sara; Mehta, Anil; Bajtay, Zsuzsa; Kovacs, Tibor; Jung, Sung Yun; Shakir, Muhammed Afaq; Qin, Jun; Zhou, Zheng; Niedergang, Florence; Boissan, Mathieu; Takacs-Vellai, Krisztina			The nucleoside diphosphate kinase NDK-1/NME1 promotes phagocytosis in concert with DYN-1/Dynamin	FASEB JOURNAL			English	Article						metastasis inhibitor; apoptotic clearance; phagosome formation; phagosome maturation; actin cup	PHAGOSOME MATURATION; RECEPTOR CED-1; DYNAMIN; GTP; ENGULFMENT; PROTEINS; NEMATODE	Phagocytosis of various targets, such as apoptotic cells or opsonized pathogens, by macrophages is coordinated by a complex signaling network initiated by distinct phagocytic receptors. Despite the different initial signaling pathways, each pathway ends up regulating the actin cytoskeletal network, phagosome formation and closure, and phagosome maturation leading to degradation of the engulfed particle. Herein, we describe a new phagocytic function for the nucleoside diphosphate kinase 1 (NDK-1), the nematode counterpart of the first identified metastasis inhibitor NM23-H1 (nonmetastatic clone number 23) nonmetastatic clone number 23 or nonmetastatic isoform 1 (NME1). We reveal by coimmunoprecipitation, Duolink proximity ligation assay, and mass spectrometry that NDK-1/NME1 works in a complex with DYN-1/Dynamin (Caenorhabditis elegans/human homolog proteins), which is essential for engulfment and phagosome maturation. Time-lapse microscopy shows that NDK-1 is expressed on phagosomal surfaces during cell corpse clearance in the same time window as DYN-1. Silencing of NM23-M1 in mouse bone marrow-derived macrophages resulted in decreased phagocytosis of apoptotic thymocytes. In human macrophages, NM23-H1 and Dynamin are corecruited at sites of phagosome formation in F-actin-rich cups. In addition, NM23-H1 was required for efficient phagocytosis. Together, our data demonstrate that NDK-1/NME1 is an evolutionarily conserved element of successful phagocytosis.-Farkas, Z., Petric, M., Liu, X., Herit, F., Rajnavolgyi, e., Szondy, Z., Budai, Z., Orban, T. I., Sandor, S., Mehta, A., Bajtay, Z., Kovacs, T., Jung, S. Y., Afaq Shakir, M., Qin, J., Zhou, Z., Niedergang, F., Boissan, M., Takacs-Vellai, K. The nucleoside diphosphate kinase NDK-1/NME1 promotes phagocytosis in concert with DYN-1/dynamin.	[Farkas, Zsolt; Takacs-Vellai, Krisztina] Eotvos Lorand Univ, Dept Biol Anthropol, Pazmany Peter Stny 1-C, H-1117 Budapest, Hungary; [Bajtay, Zsuzsa] Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary; [Bajtay, Zsuzsa] Eotvos Lorand Univ, MTA ELTE Immunol Res Grp, Budapest, Hungary; [Kovacs, Tibor] Eotvos Lorand Univ, Dept Genet, Budapest, Hungary; [Petric, Metka; Herit, Floriane; Niedergang, Florence] INSERM, Unite 1016, Inst Cochin, Paris, France; [Petric, Metka; Herit, Floriane; Niedergang, Florence] CNRS, UMR 8104, Paris, France; [Petric, Metka; Herit, Floriane; Niedergang, Florence] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Liu, Xianghua; Jung, Sung Yun; Shakir, Muhammed Afaq; Qin, Jun; Zhou, Zheng] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Jung, Sung Yun; Qin, Jun] Baylor Coll Med, Verna & Marrs McLean Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Rajnavolgyi, Eva] Univ Debrecen, Dept Immunol, Debrecen, Hungary; [Szondy, Zsuzsa; Budai, Zsofia] Univ Debrecen, Dept Biochem & Mol Biol, Debrecen, Hungary; [Orban, Limas, I; Sandor, Sara] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary; [Mehta, Anil] Ninewells Hosp Med Sch, Div Med Sci, Dundee, Scotland; [Boissan, Mathieu] UPMC Paris 06, Sorbonne Univ, INSERM, UMR S938,St Antoine Res Ctr, Paris, France; [Boissan, Mathieu] Hosp Tenon, AP HP, Serv Biochim & Hormonol, Paris, France	Eotvos Lorand University; Eotvos Lorand University; Eotvos Lorand University; Eotvos Lorand University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Baylor College of Medicine; Baylor College of Medicine; University of Debrecen; University of Debrecen; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Dundee; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Takacs-Vellai, K (corresponding author), Eotvos Lorand Univ, Dept Biol Anthropol, Pazmany Peter Stny 1-C, H-1117 Budapest, Hungary.	takacsk@falco.elte.hu	Farkas, Zsolt/AAF-9966-2020; Takacs-Vellai, Krisztina/AAF-9062-2020; Kovács, Tibor/AAF-9714-2020; bajtay, zsuzsa/AAI-1267-2020; Orban, Tamas/N-1160-2016	Farkas, Zsolt/0000-0001-8531-8912; Takacs-Vellai, Krisztina/0000-0002-4472-0363; Sandor, Sara/0000-0002-2945-8379; Kovacs, Tibor/0000-0002-0632-9128; Jung, Sung Yun/0000-0003-1521-7977; Niedergang, Florence/0000-0002-7064-830X; Orban, Tamas/0000-0002-3424-3428	Hungarian Scientific Research Fund (OTKA) [K115587, K112112, K124244]; European Union [GINOP-2.3.2-15-2016-00006]; European Regional Development Fund; uNKP-17-3 New National Excellence Program of the Ministry of Human Capacities grant; Hungarian Ministry of Human Capacities [1783-3/2018/FEKUTSRAT]; Centre National de la Recherche Scientifique (CNRS); INSERM; Universite Paris Descartes; Agence Nationale de la Recherche [ANR 16-CE13-0007-01]; U.S. National Institutes of Health, National Institute of General Medical Sciences [R01GM067848]; Sorbonne Universite; Groupe des Entreprises Francaises de Lutte Contre le Cancer (GEFLUC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067848, R01GM104279] Funding Source: NIH RePORTER	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Union(European Commission); European Regional Development Fund(European Commission); uNKP-17-3 New National Excellence Program of the Ministry of Human Capacities grant; Hungarian Ministry of Human Capacities; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris Descartes; Agence Nationale de la Recherche(French National Research Agency (ANR)); U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Sorbonne Universite; Groupe des Entreprises Francaises de Lutte Contre le Cancer (GEFLUC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Hungarian Scientific Research Fund (OTKA) Grants K115587 (to K.T.-V.), K112112 (to T.I.O.), and K124244 (to Z.S.); the GINOP-2.3.2-15-2016-00006 Project (cofinanced by the European Union and the European Regional Development Fund) (to Z.S.); and the uNKP-17-3 New National Excellence Program of the Ministry of Human Capacities grant (to Z.F.). This work was completed in the ELTE Institutional Excellence Program (1783-3/2018/FEKUTSRAT) supported by the Hungarian Ministry of Human Capacities. Work in the F.N. laboratory was supported by Centre National de la Recherche Scientifique (CNRS), INSERM, Universite Paris Descartes, and the Agence Nationale de la Recherche (ANR 16-CE13-0007-01). The work of the Z.Z. laboratory was financed by U.S. National Institutes of Health, National Institute of General Medical Sciences Grant R01GM067848. Work in the M.B. laboratory was supported by INSERM, Sorbonne Universite, and Groupe des Entreprises Francaises de Lutte Contre le Cancer (GEFLUC). Z.Z., F.N., M.B., and K.T.-V. are colast authors. The authors declare no conflicts of interest.	Allen LAH, 1996, J EXP MED, V184, P627, DOI 10.1084/jem.184.2.627; Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414; Boissan M, 2014, SCIENCE, V344, P1510, DOI 10.1126/science.1253768; Braun V, 2004, EMBO J, V23, P4166, DOI 10.1038/sj.emboj.7600427; BRENNER S, 1974, GENETICS, V77, P71; Chiu H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07291-x; Conradt B, 2016, GENETICS, V203, P1533, DOI 10.1534/genetics.115.186247; Dumas A, 2015, J CELL BIOL, V211, P359, DOI 10.1083/jcb.201503124; Fancsalszky L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092687; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; He B, 2010, MOL BIOL CELL, V21, P610, DOI 10.1091/mbc.E09-05-0440; Jin YS, 1999, PRACT APPROACH SER, V213, P69; Krishnan KS, 2001, NEURON, V30, P197, DOI 10.1016/S0896-6273(01)00273-2; Li Zao, 2013, Methods Mol Biol, V1004, P183, DOI 10.1007/978-1-62703-383-1_14; Lu N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001245; Lu N, 2012, INT REV CEL MOL BIO, V293, P269, DOI 10.1016/B978-0-12-394304-0.00013-0; Marie-Anais F, 2016, TRAFFIC, V17, P487, DOI 10.1111/tra.12386; Marion S, 2012, DEV CELL, V23, P954, DOI 10.1016/j.devcel.2012.09.021; Masoudi N, 2013, DEVELOPMENT, V140, P3486, DOI 10.1242/dev.094011; Mazzolini J, 2010, BLOOD, V115, P4226, DOI 10.1182/blood-2009-12-259473; Rocheleau CE, 1999, CELL, V97, P717, DOI 10.1016/S0092-8674(00)80784-9; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Steeg PS, 2003, CANCER LETT, V190, P1, DOI 10.1016/S0304-3835(02)00499-8; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Yu XM, 2008, PLOS BIOL, V6, P581, DOI 10.1371/journal.pbio.0060061; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	34	5	5	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11606	11614		10.1096/fj.201900220R	http://dx.doi.org/10.1096/fj.201900220R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31242766	Green Published, Bronze			2022-12-28	WOS:000489166300082
J	Fay, KT; Klingensmith, NJ; Chen, CW; Zhang, WX; Sun, YN; Morrow, KN; Liang, Z; Burd, EM; Ford, ML; Coopersmith, CM				Fay, Katherine T.; Klingensmith, Nathan J.; Chen, Ching-Wen; Zhang, Wenxiao; Sun, Yini; Morrow, Kristen N.; Liang, Zhe; Burd, Eileen M.; Ford, Mandy L.; Coopersmith, Craig M.			The gut microbiome alters immunophenotype and survival from sepsis	FASEB JOURNAL			English	Article						T lymphocyte; CD4(+) T cells; intestine; microbiota; cohousing	INTERNATIONAL CONSENSUS DEFINITIONS; SEPTIC SHOCK; PSEUDOMONAS-AERUGINOSA; COMMENSAL MICROBES; DISEASE TOLERANCE; CECAL LIGATION; MORTALITY; HEALTH; CELLS; RESPONSES	The microbiome is increasingly implicated in immune regulation and mortality from sepsis. Mice with identical genetic backgrounds but distinct microbiomes were obtained from different vendors and analyzed following cecal ligation and puncture (CLP). beta diversity of the microbiome measured from feces demonstrated significant differences between The Jackson Laboratory (Jax; Bar Harbor, ME, USA) and Charles River Laboratories (CR; Wilmington, MA, USA) C57/B6 mice. Jax mice had 7-d mortality of 90% following CLP, whereas CR mice had a mortality of 53%. Differences in vendor were associated with altered immunophenotype with increased splenic IFN-gamma(+)CD4(+) T cells, effector memory CD4(+) T cells, and central memory CD4(+) T cells and increased Peyer's patch effector memory CD4(+) T cells in septic CR mice. To determine whether differences in the microbiome were responsible for these differences, Jax and CR mice were cohoused for 3 wk, after which they assumed a similar microbiota composition. Cohoused mice had improved survival following CLP compared to Jax mice and had similar survival regardless of their vendor of origin. All differences in immunophenotype between septic Jax and CR mice disappeared following cohousing. These findings suggest that the microbiome plays a crucial role in survival and the host immune response from sepsis and represents a potential target for therapeutic intervention.-Fay, K. T., Klingensmith, N. J., Chen, C.-W., Zhang, W., Sun, Y., Morrow, K. N., Liang, Z., Burd, E. M., Ford, M. L., Coopersmith, C. M. The gut microbiome alters immunophenotype and survival from sepsis.	[Fay, Katherine T.; Klingensmith, Nathan J.; Chen, Ching-Wen; Zhang, Wenxiao; Sun, Yini; Morrow, Kristen N.; Liang, Zhe; Coopersmith, Craig M.] Emory Crit Care Ctr, Dept Surg, Atlanta, GA USA; [Zhang, Wenxiao] Zhengzhou Univ, Dept Crit Care Med, Peoples Hosp, Henan Prov Peoples Hosp, Zhengzhou, Henan, Peoples R China; [Sun, Yini] China Med Univ, Dept Crit Care Med, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China; [Burd, Eileen M.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Ford, Mandy L.] Emory Univ, Sch Med, Dept Surg, Emory Transplant Ctr, Atlanta, GA 30322 USA	Zhengzhou University; China Medical University; Emory University; Emory University	Coopersmith, CM (corresponding author), Emory Univ, 101 Woodruff Circle,Suite WMB 5105, Atlanta, GA 30322 USA.	cmcoop3@emory.edu	Chen, Ching-wen/ABH-8484-2020	Morrow, Kristen/0000-0001-9468-0462	U.S. National Institutes of Health, National Institute of General Medical Sciences [GM072808, GM095442, GM104323, GM109779, GM113228]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113228, R01GM104323, R01GM072808, T32GM095442, R01GM109779] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the U.S. National Institutes of Health, National Institute of General Medical Sciences (Grants GM072808, GM095442, GM104323, GM109779, and GM113228). The authors declare no conflicts of interest.	Ackerman J, 2012, SCI AM, V306, P36, DOI 10.1038/scientificamerican0612-36; Alverdy JC, 2017, BRIT J SURG, V104, pE14, DOI 10.1002/bjs.10405; Alverdy JC, 2017, CRIT CARE MED, V45, P337, DOI [10.1097/CCM.0000000000002172, 10.1097/ccm.0000000000002172]; Babrowski T, 2013, SURGERY, V153, P36, DOI 10.1016/j.surg.2012.06.022; BAKER CC, 1983, SURGERY, V94, P331; Cabrera-Perez J, 2017, EXP BIOL MED, V242, P127, DOI 10.1177/1535370216669610; Cabrera-Perez J, 2016, J IMMUNOL, V197, P1692, DOI 10.4049/jimmunol.1600940; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen CW, 2017, J IMMUNOL, V199, P1961, DOI 10.4049/jimmunol.1700375; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Dasgupta S, 2014, CELL HOST MICROBE, V15, P413, DOI 10.1016/j.chom.2014.03.006; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fagundes CT, 2012, J IMMUNOL, V188, P1411, DOI 10.4049/jimmunol.1101682; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Fox AC, 2012, SHOCK, V38, P508, DOI 10.1097/SHK.0b013e31826e47e8; Hayakawa M, 2011, DIGEST DIS SCI, V56, P2361, DOI 10.1007/s10620-011-1649-3; Hilbert T, 2017, J SURG RES, V211, P126, DOI 10.1016/j.jss.2016.12.008; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Ivanov II, 2012, CELL HOST MICROBE, V12, P496, DOI 10.1016/j.chom.2012.09.009; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Lam YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034233; Lankelma JM, 2017, INTENS CARE MED, V43, P59, DOI 10.1007/s00134-016-4613-z; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Lobo LA, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.32; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Lyons JD, 2017, PEDIATR CRIT CARE ME, V18, pS46, DOI 10.1097/PCC.0000000000001046; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; McClave SA, 2018, CURR OPIN CRIT CARE, V24, P105, DOI 10.1097/MCC.0000000000000489; McDonald D, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00199-16; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Ojima M, 2016, DIGEST DIS SCI, V61, P1628, DOI 10.1007/s10620-015-4011-3; Price R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2197; Reinhart K, 2017, NEW ENGL J MED, V377, P414, DOI 10.1056/NEJMp1707170; Rhee C, 2017, JAMA-J AM MED ASSOC, V318, P1241, DOI 10.1001/jama.2017.13836; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Rogers MB, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0211-0; Ruiz Stephanie, 2016, Intensive Care Med Exp, V4, P22, DOI 10.1186/s40635-016-0096-z; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Shankar-Hari M, 2016, JAMA-J AM MED ASSOC, V315, P775, DOI 10.1001/jama.2016.0289; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Song TZ, 2016, J SURG RES, V203, P476, DOI 10.1016/j.jss.2016.03.019; Villarino NF, 2016, P NATL ACAD SCI USA, V113, P2235, DOI 10.1073/pnas.1504887113; Weis S, 2017, CELL, V169, P1263, DOI 10.1016/j.cell.2017.05.031; Weng H, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00717; Wilmore JR, 2018, CELL HOST MICROBE, V23, P302, DOI 10.1016/j.chom.2018.01.005	45	32	33	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11258	11269		10.1096/fj.201802188R	http://dx.doi.org/10.1096/fj.201802188R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31306584	Green Published, Bronze			2022-12-28	WOS:000489166300056
J	Butovich, IA; Wilkerson, A; Bhat, N; McMahon, A; Yuksel, S				Butovich, Igor A.; Wilkerson, Amber; Bhat, Nita; McMahon, Anne; Yuksel, Seher			On the pivotal role of Elovl3/ELOVL3 in meibogenesis and ocular physiology of mice	FASEB JOURNAL			English	Article						meibomian glands; tarsal plates; fatty acid elongation; meibum	CHAIN FATTY-ACIDS; MEIBOMIAN GLAND; HUMAN MEIBUM; CHOLESTERYL ESTERS; LIPID-METABOLISM; ELOVL3; BIOSYNTHESIS; MOUSE; STEER	The purpose of this study was to examine the role of Elovl3 gene in meibogenesis and the impact of ELOVL3 protein ablation on the physiology of the mouse ocular surface and Meibomian glands (MGs). Elovl3 knockout, ELOVL3-ablated (E3hom) mice and their wild type littermates (E3wt) were studied side by side. E3hom mice had abnormal ocular phenotypes such as delayed eye opening, weeping eyes, crusty eyelids, eyelid edema, highly vascularized cornea and tarsal plates (TPs), slit eye, and increased tearing that resemble symptoms observed in human subjects with various forms of dry eye, MG dysfunction and blepharitis. Lipid profiling of E3hom TPs was conducted using chromatography and mass spectrometry. The analyses revealed that the lipid composition of E3hom TPs was strikingly different from that of their E3wt littermates. The mutation affected major classes of meibomian lipids - cholesteryl esters, wax esters, and cholesteryl esters of (O)-acylated w-hydroxy fatty acids. The studies illuminated the central role of ELOVL3 in producing C-21:0-C-29:0 fatty acids, including odd-chain and branched ones. Ablation of ELOVL3 leads to selective changes in the lipid composition of meibum, making E3hom mice instrumental in studying the mechanisms of the biosynthesis of meibum and modeling various pathologies of human ocular surface and adnexa.-Butovich, I. A., Wilkerson, A., Bhat, N., McMahon, A., Yuksel, S. On the pivotal role of Elovl3/ELOVL3 in meibogenesis and ocular physiology of mice.	[Butovich, Igor A.; Wilkerson, Amber; Bhat, Nita; McMahon, Anne; Yuksel, Seher] Univ Texas Southwestern Med Ctr Dallas, Dept Ophthalmol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Butovich, Igor A.] Univ Texas Southwestern Med Ctr Dallas, Grad Sch Biomed Sci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Butovich, IA (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Ophthalmol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	igor.butovich@utsouthwestern.edu		Yuksel, Seher/0000-0003-2373-7809	U.S. National Institutes of Health, National Eye Institute [R01EY024324]; Research to Prevent Blindness (New York, NY, USA); 2219-International Postdoctoral Research Scholarship from the Scientific and Technological Research Council of Turkey (TuBITAK; Ankara, Turkey); NATIONAL EYE INSTITUTE [R01EY024324] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness (New York, NY, USA)(Research to Prevent Blindness (RPB)); 2219-International Postdoctoral Research Scholarship from the Scientific and Technological Research Council of Turkey (TuBITAK; Ankara, Turkey); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in part, by U.S. National Institutes of Health, National Eye Institute Grant R01EY024324 (to I.A.B.), an unrestricted grant from Research to Prevent Blindness (New York, NY, USA), and also, in part, by a 2219-International Postdoctoral Research Scholarship from the Scientific and Technological Research Council of Turkey (TuBITAK; Ankara, Turkey) to S.Y. The authors declare no conflicts of interest.	AMENDT BA, 1992, PEDIATR RES, V31, P552, DOI 10.1203/00006450-199206000-00003; BUTOVICH IA, 2009, METHODS MOL BIOL 1, V579, P221, DOI DOI 10.1007/978-1-60761-322-0_11; Butovich IA, 2008, INVEST OPHTH VIS SCI, V49, P3779, DOI 10.1167/iovs.08-1889; Butovich IA, 2007, J LIPID RES, V48, P2220, DOI 10.1194/jlr.M700237-JLR200; Butovich IA, 2019, OCUL SURF, V17, P793, DOI 10.1016/j.jtos.2019.03.002; Butovich IA, 2017, EXP EYE RES, V163, P2, DOI 10.1016/j.exer.2017.06.020; Butovich IA, 2016, BBA-MOL CELL BIOL L, V1861, P538, DOI 10.1016/j.bbalip.2016.03.024; Butovich IA, 2014, INVEST OPHTH VIS SCI, V55, P87, DOI 10.1167/iovs.13-13355; Butovich IA, 2012, INVEST OPHTH VIS SCI, V53, P6881, DOI 10.1167/iovs.12-10516; Butovich IA, 2012, INVEST OPHTH VIS SCI, V53, P3766, DOI 10.1167/iovs.11-9333; Butovich IA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00024; Butovich IA, 2011, INVEST OPHTH VIS SCI, V52, P639, DOI 10.1167/iovs.10-7028; Butovich IA, 2010, INVEST OPHTH VIS SCI, V51, P6908, DOI 10.1167/iovs.10-6328; Butovich IA, 2010, STEROIDS, V75, P726, DOI 10.1016/j.steroids.2010.04.011; Butovich IA, 2009, J LIPID RES, V50, P2471, DOI 10.1194/jlr.M900252-JLR200; Butovich IA, 2009, J LIPID RES, V50, P501, DOI 10.1194/jlr.M800426-JLR200; Chen JZ, 2010, INVEST OPHTH VIS SCI, V51, P6220, DOI 10.1167/iovs.10-5687; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Defour M, 2018, MOL METAB, V10, P39, DOI 10.1016/j.molmet.2018.01.023; Fehrenschild D, 2012, J INVEST DERMATOL, V132, P337, DOI 10.1038/jid.2011.301; Gudjonsson JE, 2010, J INVEST DERMATOL, V130, P1829, DOI 10.1038/jid.2010.36; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Kelly CL, 1996, MAMM GENOME, V7, P262, DOI 10.1007/s003359900078; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; NICOLAIDES N, 1985, LIPIDS, V20, P454, DOI 10.1007/BF02534237; NICOLAIDES N, 1981, INVEST OPHTH VIS SCI, V20, P522; Sassa T, 2018, FASEB J, V32, P2966, DOI 10.1096/fj.201700947R; Westerberg R, 2006, J BIOL CHEM, V281, P4958, DOI 10.1074/jbc.M511588200; Westerberg R, 2004, J BIOL CHEM, V279, P5621, DOI 10.1074/jbc.M310529200; Xu CS, 2011, DIGEST DIS SCI, V56, P2299, DOI 10.1007/s10620-011-1599-9; Zadravec D, 2010, FASEB J, V24, P4366, DOI 10.1096/fj.09-152298	31	20	20	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10034	10048		10.1096/fj.201900725R	http://dx.doi.org/10.1096/fj.201900725R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31208226	Green Published, Bronze			2022-12-28	WOS:000482214200026
J	Di Ceglie, I; Blom, AB; Davar, R; Logie, C; Martens, JHA; Habibi, E; Bottcher, LM; Roth, J; Vogl, T; Goodyear, CS; van der Kraan, PM; van Lent, PL; van den Bosch, MH				Di Ceglie, Irene; Blom, Arjen B.; Davar, Robab; Logie, Colin; Martens, Joost H. A.; Habibi, Ehsan; Bottcher, Lisa-Marie; Roth, Johannes; Vogl, Thomas; Goodyear, Carl S.; van der Kraan, Peter M.; van Lent, Peter L.; van den Bosch, Martijn H.			The alarmin S100A9 hampers osteoclast differentiation from human circulating precursors by reducing the expression of RANK	FASEB JOURNAL			English	Article						A9; epigenetic regulation; bone	COLONY-STIMULATING FACTOR; FACTOR-KAPPA-B; BONE-RESORPTION; MOLECULAR-MECHANISM; TNF-ALPHA; C-FMS; M-CSF; MACROPHAGES; ACTIVATION; RECEPTOR	The alarmin S100A8/A9 is implicated in sterile inflammation-induced bone resorption and has been shown to increase the bone-resorptive capacity of mature osteoclasts. Here, we investigated the effects of S100A9 on osteoclast differentiation from human CD14(+) circulating precursors. Hereto, human CD14(+) monocytes were isolated and differentiated toward osteoclasts with M-CSF and receptor activator of NF-kappa B (RANK) ligand (RANKL) in the presence or absence of S100A9. Tartrate-resistant acid phosphatase staining showed that exposure to S100A9 during monocyte-to-osteoclast differentiation strongly decreased the numbers of multinucleated osteoclasts. This was underlined by a decreased resorption of a hydroxyapatite-like coating. The thus differentiated cells showed a high mRNA and protein production of proinflammatory factors after 16 h of exposure. In contrast, at d 4, the cells showed a decreased production of the osteoclast-promoting protein TNF-alpha. Interestingly, S100A9 exposure during the first 16 h of culture only was sufficient to reduce osteoclastogenesis. Using fluorescently labeled RANKL, we showed that, within this time frame, S100A9 inhibited the M-CSF-mediated induction of RANK. Chromatin immunoprecipitation showed that this was associated with changes in various histone marks at the epigenetic level. This S100A9-induced reduction in RANK was in part recovered by blocking TNF-alpha but not IL-1. Together, our data show that S100A9 impedes monocyte-to-osteoclast differentiation, probably via a reduction in RANK expression.-Di Ceglie, I., Blom, A. B., Davar, R., Logie, C., Martens, J. H. A., Habibi, E., Bottcher, L.-M., Roth, J., Vogl, T., Goodyear, C. S., van der Kraan, P. M., van Lent, P. L., van den Bosch, M. H. The alarmin S100A9 hampers osteoclast differentiation from human circulating precursors by reducing the expression of RANK.	[Di Ceglie, Irene; Blom, Arjen B.; Bottcher, Lisa-Marie; van der Kraan, Peter M.; van Lent, Peter L.; van den Bosch, Martijn H.] Radboud Univ Nijmegen, Med Ctr, Expt Rheumatol, Nijmegen, Netherlands; [Davar, Robab; Logie, Colin; Martens, Joost H. A.; Habibi, Ehsan] Radboud Univ Nijmegen, Fac Sci, Dept Mol Biol, Nijmegen, Netherlands; [Roth, Johannes; Vogl, Thomas] Univ Munster, Inst Immunol, Munster, Germany; [Goodyear, Carl S.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	Radboud University Nijmegen; Radboud University Nijmegen; University of Munster; University of Glasgow	van Lent, PL (corresponding author), Radboud Univ Nijmegen, Med Ctr, Geert Grootepl 28, NL-6525 GA Nijmegen, Netherlands.	peter.vanlent@radboudumc.nl	Logie, Colin/A-1528-2010; Logie, Colin/L-9833-2019; Habibi, Ehsan/E-3196-2016; Martens, Joost/D-4966-2012; Di Ceglie, Irene/HGD-5908-2022; van der Kraan, Peter M/D-9115-2011; Habibi, Ehsan/AAE-6053-2021; Di Ceglie, Irene/G-9740-2016	Logie, Colin/0000-0002-8534-6582; Logie, Colin/0000-0002-8534-6582; Habibi, Ehsan/0000-0002-7208-7999; Martens, Joost/0000-0003-2008-6537; Di Ceglie, Irene/0000-0002-5966-2186	Dutch Arthritis Foundation [08-1-309, 13-3-402]; 7th Framework Programme of the European Union [289150]	Dutch Arthritis Foundation; 7th Framework Programme of the European Union(European Commission)	The authors thank Annet Sloetjes (Experimental Rheumatology, Radboud university medical center, Nijmegen, The Netherlands) for excellent technical assistance. This work was supported by a grant from the Dutch Arthritis Foundation (Grants 08-1-309 and 13-3-402) and a grant from the 7th Framework Programme of the European Union, Project Osteoimmune (Grant 289150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Abu-Amer Y, 2009, CURR OPIN PHARMACOL, V9, P427, DOI 10.1016/j.coph.2009.06.007; Amarasekara DS, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e8; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Austermann J, 2014, CELL REP, V9, P2112, DOI 10.1016/j.celrep.2014.11.020; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; Bekker PJ, 2004, J BONE MINER RES, V19, P1059, DOI 10.1359/JBMR.040305; Bendre MS, 2003, BONE, V33, P28, DOI 10.1016/S8756-3282(03)00086-3; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cao YX, 2017, J CELL PHYSIOL, V232, P3273, DOI 10.1002/jcp.26024; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Ehlermann P, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-6; Fassl SK, 2015, J IMMUNOL, V194, P575, DOI 10.4049/jimmunol.1401085; Ginaldi L, 2016, CURR MED CHEM, V23, P3754, DOI 10.2174/0929867323666160907162546; Glantschnig H, 2003, CELL DEATH DIFFER, V10, P1165, DOI 10.1038/sj.cdd.4401285; Grevers LC, 2011, ARTHRITIS RHEUM-US, V63, P1365, DOI 10.1002/art.30290; Humphrey MB, 2016, CLIN REV ALLERG IMMU, V51, P48, DOI 10.1007/s12016-015-8521-8; Ji JD, 2009, J IMMUNOL, V183, P7223, DOI 10.4049/jimmunol.0900072; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; KODAMA H, 1991, J EXP MED, V173, P1291, DOI 10.1084/jem.173.5.1291; Krishnamurthy A, 2016, ANN RHEUM DIS, V75, P721, DOI 10.1136/annrheumdis-2015-208093; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lee B, 2010, J IMMUNOL, V185, P5926, DOI 10.4049/jimmunol.1001591; Lee SP, 2001, J BIOL CHEM, V276, P29826, DOI 10.1074/jbc.M101822200; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu JZ, 2009, J BIOL CHEM, V284, P12512, DOI 10.1074/jbc.M809789200; Odgren PR, 2003, CONNECT TISSUE RES, V44, P264, DOI 10.1080/03008200390181753; Patro PS, 2016, J RHEUMATOL, V43, P731, DOI 10.3899/jrheum.150998; Petersen B, 2013, EMBO J, V32, P100, DOI 10.1038/emboj.2012.309; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ross FP, 2006, ANN NY ACAD SCI, V1068, P110, DOI 10.1196/annals.1346.014; Shiratori T, 2018, J IMMUNOL, V200, P218, DOI 10.4049/jimmunol.1602035; Simard JC, 2014, FEBS LETT, V588, P2141, DOI 10.1016/j.febslet.2014.04.027; Soyfoo MS, 2009, J RHEUMATOL, V36, P2190, DOI 10.3899/jrheum.081302; Sunahori K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1939; TANAKA S, 1993, J CLIN INVEST, V91, P257, DOI 10.1172/JCI116179; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; ten Harkel B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139564; Tibbe JA, 2001, WORLD J GASTROENTERO, V7, P460; van den Bosch MH, 2016, J RHEUMATOL, V43, P1874, DOI 10.3899/jrheum.160270; van Lent PL, 2010, ARTHRITIS RHEUM-US, V62, P3353, DOI 10.1002/art.27654; Viemann D, 2005, BLOOD, V105, P2955, DOI 10.1182/blood-2004-07-2520; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Vogl T, 2018, J CLIN INVEST, V128, P1852, DOI 10.1172/JCI89867; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wang J, 2015, FASEB J, V29, P250, DOI 10.1096/fj.14-255992; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Yang D, 2017, IMMUNOL REV, V280, P41, DOI 10.1111/imr.12577; Zhang YH, 2001, J BIOL CHEM, V276, P563, DOI 10.1074/jbc.M008198200; Zreiqat H, 2007, J MOL HISTOL, V38, P381, DOI 10.1007/s10735-007-9117-2	50	5	5	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10104	10115		10.1096/fj.201802691RR	http://dx.doi.org/10.1096/fj.201802691RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31199668	Bronze			2022-12-28	WOS:000482214200031
J	Kennedy, L; Francis, H; Invernizzi, P; Venter, J; Wu, N; Carbone, M; Gershwin, ME; Bernuzzi, F; Franchitto, A; Alvaro, D; Marzioni, M; Onori, P; Gaudio, E; Sybenga, A; Fabris, L; Meng, FY; Glaser, S; Alpini, G				Kennedy, Lindsey; Francis, Heather; Invernizzi, Pietro; Venter, Julie; Wu, Nan; Carbone, Marco; Gershwin, M. Eric; Bernuzzi, Francesca; Franchitto, Antonio; Alvaro, Domenico; Marzioni, Marco; Onori, Paolo; Gaudio, Eugenio; Sybenga, Amelia; Fabris, Luca; Meng, Fanyin; Glaser, Shannon; Alpini, Gianfranco			Secretin/secretin receptor signaling mediates biliary damage and liver fibrosis in early-stage primary biliary cholangitis	FASEB JOURNAL			English	Article						angiogenesis; cellular senescence; cholangiopathies; miR-125b; liver damage	NONSUPPURATIVE DESTRUCTIVE CHOLANGITIS; PLACEBO-CONTROLLED TRIAL; FUNCTIONAL-HETEROGENEITY; CELLULAR SENESCENCE; OBETICHOLIC ACID; UP-REGULATION; BILE-DUCTS; EXPRESSION; CIRRHOSIS; SECRETIN	Primary biliary cholangitis (PBC) primarily targets cholangiocytes and is characterized by liver fibrosis and biliary proliferation. Activation of the secretin (Sct)/secretin receptor (SR) axis, expressed only by cholangiocytes, increases biliary proliferation, liver fibrosis, and bicarbonate secretion. We evaluated the effectiveness of SR antagonist treatment for early-stage PBC. Male and female dominant-negative TGF-beta receptor II (dnTGF-beta RII) (model of PBC) and wild-type mice at 12 wk of age were treated with saline or the SR antagonist, Sec 5-27, for 1 wk. dnTGF-beta RII mice expressed features of early-stage PBC along with enhanced Sct/SR axis activation and Sct secretion. dnTGF-beta RII mice had increased biliary proliferation or senescence, inflammation, and liver fibrosis. In dnTGF-beta RII mice, there was increased microRNA-125b/TGF-beta 1/TGF-beta receptor 1/VEGF-A signaling. Human early-stage PBC patients had an increase in hepatobiliary Sct and SR expression and serum Sct levels. Increased biliary Sct/SR signaling promotes biliary and hepatic damage during early-stage PBC.-Kennedy, L., Francis, H., Invernizzi, P., Venter, J., Wu, N., Carbone, M., Gershwin, M. E., Bernuzzi, F., Franchitto, A., Alvaro, D., Marzioni, M., Onori, P., Gaudio, E., Sybenga, A., Fabris, L., Meng, F., Glaser, S., Alpini, G. Secretin/secretin receptor signaling mediates biliary damage and liver fibrosis in early-stage primary biliary cholangitis.	[Kennedy, Lindsey; Francis, Heather; Meng, Fanyin; Alpini, Gianfranco] Cent Texas Vet Hlth Care Syst, Res, Temple, TX USA; [Kennedy, Lindsey; Francis, Heather; Venter, Julie; Wu, Nan; Glaser, Shannon; Alpini, Gianfranco] Texas A&M Univ, Coll Med, Dept Med Physiol, Temple, TX 76508 USA; [Francis, Heather; Meng, Fanyin; Glaser, Shannon; Alpini, Gianfranco] Baylor Scott & White Hlth, Digest Dis Res Ctr, Temple, TX USA; [Invernizzi, Pietro; Carbone, Marco; Bernuzzi, Francesca] Humanitas Clin & Res Ctr, Rozzano, MI, Italy; [Gershwin, M. Eric] Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA; [Franchitto, Antonio] Eleonora Lorillard Spencer Cenci Fdn, Rome, Italy; [Alvaro, Domenico] Sapienza Univ Rome, Dept Internal Med & Med Specialties, Rome, Italy; [Onori, Paolo; Gaudio, Eugenio] Sapienza Univ Rome, Dept Anat Histol Forens Med & Orthoped Sci, Rome, Italy; [Marzioni, Marco] Univ Politecn Marche, Clin Gastroenterol & Hepatol, Ancona, Italy; [Sybenga, Amelia] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Fabris, Luca] Univ Padua, Sch Med, Dept Mol Med, Padua, Italy; [Fabris, Luca] Yale Univ, Sch Med, Digest Dis Sect, New Haven, CT USA; [Kennedy, Lindsey; Francis, Heather; Venter, Julie; Wu, Nan; Meng, Fanyin; Alpini, Gianfranco] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Invernizzi, Pietro; Carbone, Marco; Bernuzzi, Francesca] Univ Milano Bicocca, Sch Med & Surg, Monza, Italy	Texas A&M University System; Baylor Health Care System; IRCCS Humanitas Research Hospital; University of California System; University of California Davis; Sapienza University Rome; Sapienza University Rome; Marche Polytechnic University; Vanderbilt University; University of Padua; Yale University; Indiana University System; Indiana University Bloomington; University of Milano-Bicocca	Alpini, G (corresponding author), Indiana Univ Sch Med, Indiana Ctr Liver Res, Div Gastroenterol & Hepatol, Dept Med,Richard L Roudebush VA Med Ctr, 1481 W 10th St Dedicat Wing Room C-7151, Indianapolis, IN 46202 USA.	galpini@iu.edu	bernuzzi, francesca/AAQ-7073-2020; Fabris, Luca/J-7565-2018; Marzioni, Marco/A-8153-2011; Invernizzi, Pietro/AAB-8367-2022; Onori, Paolo/J-9394-2013; ALVARO, Domenico/J-8600-2018	Fabris, Luca/0000-0001-8538-6317; Marzioni, Marco/0000-0001-6014-6165; Invernizzi, Pietro/0000-0003-3262-1998; Onori, Paolo/0000-0002-7195-3760; ALVARO, Domenico/0000-0003-3771-9644; Cadamuro, Massimiliano/0000-0002-0899-7613	Veterans Affairs Merit Awards from the United States Department of Veteran's Affairs, Biomedical Laboratory Research and Development Service [1I01BX003031, 4I01BX000574, 1I01BX001724]; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK054811, DK076898, DK107310, DK110035, DK062975, DK108959]; NIH National Institute on Alcohol Abuse and Alcoholism Grants [AA025997, AA025157]; Partners Seeking a Cure (PSC) [460933-00001]; Baylor Scott White Health; University of Rome "La Sapienza"; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK108959, R01DK076898, R01DK110035, R01DK054811, R01DK107310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA025997, R21AA025157] Funding Source: NIH RePORTER; Veterans Affairs [IK6BX004601, I01BX001724, I01BX000574, I01BX003031] Funding Source: NIH RePORTER	Veterans Affairs Merit Awards from the United States Department of Veteran's Affairs, Biomedical Laboratory Research and Development Service(US Department of Veterans Affairs); U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute on Alcohol Abuse and Alcoholism Grants; Partners Seeking a Cure (PSC); Baylor Scott White Health; University of Rome "La Sapienza"; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	Portions of this work were supported by Veterans Affairs Merit Awards (1I01BX003031 to H.F., 4I01BX000574 to G.A., and 1I01BX001724 to F.M.) from the United States Department of Veteran's Affairs, Biomedical Laboratory Research and Development Service; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants DK054811, DK076898, DK107310, DK110035, DK062975 (to G.A., S.G., and F.M.), DK108959 (to H.F.), and NIH National Institute on Alcohol Abuse and Alcoholism Grants AA025997 and AA025157 to F.M., S.G., and G.A.; The Partners Seeking a Cure (PSC) Grant Award 460933-00001 and Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology from Baylor Scott & White Health (to G.A.); and Development Service by University of Rome "La Sapienza" (to P.O.). This material is the result of work supported with resources and the use of facilities at the Central Texas Veterans Health Care System (Temple, Texas, USA). The content is the responsibility of the authors alone and does not necessarily reflect the views or policies of the Department of Veteran's Affairs or the United States Government. F.M., S.G., and G.A. share senior authorship. The authors declare no conflicts of interest.	Aiba Y, 2014, LIVER INT, V34, P679, DOI 10.1111/liv.12296; ALPINI G, 1994, AM J PHYSIOL, V266, pG922, DOI 10.1152/ajpgi.1994.266.5.G922; Alpini G, 1996, GASTROENTEROLOGY, V110, P1636, DOI 10.1053/gast.1996.v110.pm8613073; Alpini Gianfranco, 1997, American Journal of Physiology, V272, pG1064; ALVARO D, 1993, J CLIN INVEST, V92, P1314, DOI 10.1172/JCI116705; Antoniades CG, 2012, HEPATOLOGY, V56, P735, DOI 10.1002/hep.25657; Banales JM, 2012, HEPATOLOGY, V56, P687, DOI 10.1002/hep.25691; Barnes BH, 2009, LIVER INT, V29, P1253, DOI 10.1111/j.1478-3231.2008.01921.x; Berg PA, 1997, SEMIN LIVER DIS, V17, P115, DOI 10.1055/s-2007-1007189; Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Corpechot C, 2000, HEPATOLOGY, V32, P1196, DOI 10.1053/jhep.2000.20240; Erice O, 2018, HEPATOLOGY, V67, P1420, DOI 10.1002/hep.29533; Glaser S, 2014, GASTROENTEROLOGY, V146, P1795, DOI 10.1053/j.gastro.2014.02.030; Glaser S, 2010, HEPATOLOGY, V52, P204, DOI 10.1002/hep.23657; Glaser SS, 2009, LAB INVEST, V89, P456, DOI 10.1038/labinvest.2009.6; Harada K, 2005, HEPATOLOGY, V41, P1329, DOI 10.1002/hep.20705; Harada K, 1997, HEPATOLOGY, V26, P1399; Heathcote EJ, 2000, HEPATOLOGY, V31, P1005, DOI 10.1053/he.2000.5984; Hirschfield GM, 2015, GASTROENTEROLOGY, V148, P751, DOI 10.1053/j.gastro.2014.12.005; Hisamoto S, 2016, J AUTOIMMUN, V75, P150, DOI 10.1016/j.jaut.2016.08.006; Hohenester S, 2011, DIGEST DIS, V29, P62, DOI 10.1159/000324687; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; KNITTEL T, 1995, HEPATOLOGY, V21, P470, DOI 10.1002/hep.1840210231; Korner M, 2006, J HEPATOL, V45, P825, DOI 10.1016/j.jhep.2006.06.016; Lazaridis KN, 2004, GASTROENTEROLOGY, V127, P1565, DOI 10.1053/j.gastro.2004.08.006; Lertkiatmongkol P, 2016, CURR OPIN HEMATOL, V23, P253, DOI 10.1097/MOH.0000000000000239; LeSage GD, 1999, AM J PHYSIOL-GASTR L, V276, pG1289, DOI 10.1152/ajpgi.1999.276.5.G1289; Lleo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25906; LUDWIG J, 1978, VIRCHOWS ARCH A, V379, P103, DOI 10.1007/BF00432479; Mancinelli R, 2010, AM J PATHOL, V176, P1790, DOI 10.2353/ajpath.2010.090677; MARTINEZANSO E, 1994, HEPATOLOGY, V19, P1400, DOI 10.1002/hep.1840190613; Medina J, 2005, J HEPATOL, V42, P124, DOI 10.1016/j.jhep.2004.09.024; Nevens F, 2016, NEW ENGL J MED, V375, P631, DOI 10.1056/NEJMoa1509840; Podda M, 2013, J AUTOIMMUN, V46, P81, DOI 10.1016/j.jaut.2013.06.015; ROLL J, 1983, NEW ENGL J MED, V308, P1, DOI 10.1056/NEJM198301063080101; Rudic JS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000551.pub3; Salas JT, 2008, GASTROENTEROLOGY, V134, P1482, DOI 10.1053/j.gastro.2008.02.020; Sasaki M, 2005, J PATHOL, V205, P451, DOI 10.1002/path.1729; Sasaki M, 2008, J AUTOIMMUN, V31, P73, DOI 10.1016/j.jaut.2008.03.005; Sasaki M, 2014, DIGEST DIS SCI, V59, P358, DOI 10.1007/s10620-013-2920-6; SCHEUER PJ, 1967, P ROY SOC MED, V60, P1257, DOI 10.1177/003591576706001205; Sica A, 2014, HEPATOLOGY, V59, P2034, DOI 10.1002/hep.26754; Sood S, 2004, GASTROENTEROLOGY, V127, P470, DOI 10.1053/j.gastro.2004.04.064; Tsuda M, 2013, HEPATOLOGY, V57, P806, DOI 10.1002/hep.25829; VUORISTO M, 1995, GASTROENTEROLOGY, V108, P1470, DOI 10.1016/0016-5085(95)90696-7; Wan Y, 2017, HEPATOLOGY, V66, P528, DOI 10.1002/hep.29138; Wu N, 2016, HEPATOLOGY, V64, P865, DOI 10.1002/hep.28622; Yin H, 2015, EXP CELL RES, V339, P252, DOI 10.1016/j.yexcr.2015.09.015; Zhou TH, 2018, LAB INVEST, V98, P1449, DOI 10.1038/s41374-018-0093-9	51	20	20	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10269	10279		10.1096/fj.201802606R	http://dx.doi.org/10.1096/fj.201802606R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31251081	Bronze, Green Published			2022-12-28	WOS:000482214200044
J	Rasmuson, J; Kenne, E; Wahlgren, M; Soehnlein, O; Lindbom, L				Rasmuson, Joel; Kenne, Ellinor; Wahlgren, Mats; Soehnlein, Oliver; Lindbom, Lennart			Heparinoid sevuparin inhibits Streptococcus-induced vascular leak through neutralizing neutrophil-derived proteins	FASEB JOURNAL			English	Article						inflammation; vascular permeability; heparin; sepsis	NONANTICOAGULANT HEPARIN; BINDING PROTEIN; IN-VITRO; INCREASE; SEPSIS; MYELOPEROXIDASE; PERMEABILITY	Acute lung injury (ALI) and respiratory distress can develop as a consequence of sepsis with pathogens such as group A Streptococcus (GAS). In the pathogenesis of sepsis-associated ALI, endothelial barrier disruption brought on by phagocyte activation is considered a causative factor. Here, we find that sevuparin, a heparinoid with low anticoagulant activity, prevents neutrophil-induced lung plasma leakage in a murine model of systemic inflammation evoked by heat-killed GAS (hkGAS). Furthermore, using human neutrophils and endothelial cell monolayers, we demonstrate that sevuparin inhibits hkGAS-induced endothelial barrier disruption by neutralizing the activity of neutrophil-derived proteins. By mass spectrometry of neutrophil secretion, we identify proteins, including serprocidins, S100 proteins, and histone H4, that interact with sevuparin and that are responsible for the disruptive effect on endothelial integrity. Collectively, our results demonstrate the critical role of neutrophil-derived proteins in vascular hyperpermeability caused by GAS and suggest sevuparin as a potential therapeutic in acute neutrophilic inflammation.-Rasmuson, J., Kenne, E., Wahlgren, M., Soehnlein, O., Lindbom, L. Heparinoid sevuparin inhibits Streptococcus-induced vascular leak through neutralizing neutrophil-derived proteins.	[Rasmuson, Joel; Kenne, Ellinor; Soehnlein, Oliver; Lindbom, Lennart] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Wahlgren, Mats] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Wahlgren, Mats] Modus Therapeut AB, Stockholm, Sweden; [Soehnlein, Oliver] Ludwig Maximilian Univ Munich, Inst Cardiovasc Prevent, Munich, Germany; [Soehnlein, Oliver] German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Berlin, Germany	Karolinska Institutet; Karolinska Institutet; University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance	Lindbom, L (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden.	lennart.lindbom@ki.se	Kenne, Ellinor/HCH-1218-2022		Swedish Research Council; Swedish Heart-Lung Foundation; Torsten Soderberg Foundation; Lars Hierta Memorial Fund; Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Torsten Soderberg Foundation; Lars Hierta Memorial Fund; Karolinska Institutet(Karolinska Institutet)	The authors acknowledge Drs. Anna Leitgeb (Dilaforette, Stockholm, Sweden) and Alexey Chernobrovkin (Karolinska Institutet, Stockholm, Sweden) for contributing valuable information and advice. Proteomic analysis was carried out at Proteomics Karolinska (PK/KI; http://ki.se/en/mbb/proteomics-karolinska-pkki). This work was supported by the Swedish Research Council, the Swedish Heart-Lung Foundation, the Torsten Soderberg Foundation, the Lars Hierta Memorial Fund, and Karolinska Institutet. M.W. holds shares in and is the chief scientific officer of Modus Therapeutics. The other authors declare no conflicts of interest.	ARDITI M, 1994, INFECT IMMUN, V62, P3930, DOI 10.1128/IAI.62.9.3930-3936.1994; Bentzer Peter, 2016, Intensive Care Med Exp, V4, P33; Brown RA, 2003, BRIT J PHARMACOL, V139, P845, DOI 10.1038/sj.bjp.0705291; Byfield FJ, 2011, AM J PHYSIOL-CELL PH, V300, pC105, DOI 10.1152/ajpcell.00158.2010; DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012; Erga KS, 2001, ACTA PHYSIOL SCAND, V171, P419, DOI 10.1046/j.1365-201X.2001.00810.x; Fryer A, 1997, J PHARMACOL EXP THER, V282, P208; Gautam N, 2001, NAT MED, V7, P1123, DOI 10.1038/nm1001-1123; Gautam N, 2000, J EXP MED, V191, P1829, DOI 10.1084/jem.191.11.1829; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Kenne E, 2019, FASEB J, V33, P2599, DOI 10.1096/fj.201801329R; Kim SH, 2012, BLOOD, V120, P4892, DOI 10.1182/blood-2012-05-428243; Lewis SM, 2013, INT IMMUNOPHARMACOL, V17, P1226, DOI 10.1016/j.intimp.2013.10.002; Li X, 2017, BRIT J HAEMATOL, V179, P389, DOI 10.1111/bjh.14885; Lin QH, 2013, CRIT CARE, V17, DOI 10.1186/cc12834; Linder A, 2009, CLIN INFECT DIS, V49, P1044, DOI 10.1086/605563; Malmstrom E, 2014, THROMB HAEMOSTASIS, V112, P1230, DOI 10.1160/TH14-04-0312; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; MINNICOZZI M, 1994, J IMMUNOL, V153, P2664; Mulloy B, 2016, PHARMACOL REV, V68, P76, DOI 10.1124/pr.115.011247; Patterson EK, 2014, FREE RADICAL BIO MED, V70, P167, DOI 10.1016/j.freeradbiomed.2014.02.020; Peter K, 1999, CIRCULATION, V100, P1533, DOI 10.1161/01.CIR.100.14.1533; PETERSON MW, 1987, J APPL PHYSIOL, V62, P1521, DOI 10.1152/jappl.1987.62.4.1521; Rao NV, 2010, AM J PHYSIOL-CELL PH, V299, pC97, DOI 10.1152/ajpcell.00009.2010; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Soehnlein O, 2008, EUR RESPIR J, V32, P405, DOI 10.1183/09031936.00173207; SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2; Telen MJ, 2016, BRIT J HAEMATOL, V175, P935, DOI 10.1111/bjh.14303; Vogt AM, 2006, PLOS PATHOG, V2, P853, DOI 10.1371/journal.ppat.0020100; Wang LK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096765; Wildhagen KCAA, 2014, BLOOD, V123, P1098, DOI 10.1182/blood-2013-07-514984; Wittkowski H, 2007, CRIT CARE MED, V35, P1369, DOI 10.1097/01.CCM.0000262386.32287.29; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Zhou JY, 2013, PROTEOM CLIN APPL, V7, P571, DOI 10.1002/prca.201200109	37	14	15	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10443	10452		10.1096/fj.201900627R	http://dx.doi.org/10.1096/fj.201900627R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31216421				2022-12-28	WOS:000482214200057
J	Ortega, FJ; Moreno-Navarrete, JM; Mercader, JM; Gomez-Serrano, M; Garcia-Santos, E; Latorre, J; Lluch, A; Sabater, M; Caballano-Infantes, E; Guzman, R; Macias-Gonzalez, M; Buxo, M; Girones, J; Vilallonga, R; Naon, D; Botas, P; Delgado, E; Corella, D; Burcelin, R; Fruhbeck, G; Ricart, W; Simo, R; Castrillon-Rodriguez, I; Tinahones, FJ; Bosch, F; Vidal-Puig, A; Malagon, MM; Peral, B; Zorzano, A; Fernandez-Real, JM				Ortega, Francisco J.; Moreno-Navarrete, Jose M.; Mercader, Josep M.; Gomez-Serrano, Maria; Garcia-Santos, Eva; Latorre, Jessica; Lluch, Aina; Sabater, Monica; Caballano-Infantes, Estefania; Guzman, Rocio; Macias-Gonzalez, Manuel; Buxo, Maria; Girones, Jordi; Vilallonga, Ramon; Naon, Deborah; Botas, Patricia; Delgado, Elias; Corella, Dolores; Burcelin, Remy; Fruhbeck, Gema; Ricart, Wifredo; Simo, Rafael; Castrillon-Rodriguez, Ignacio; Tinahones, Francisco J.; Bosch, Fatima; Vidal-Puig, Antonio; Malagon, Maria M.; Peral, Belen; Zorzano, Antonio; Fernandez-Real, Jose M.			Cytoskeletal transgelin 2 contributes to gender-dependent adipose tissue expandability and immune function	FASEB JOURNAL			English	Article						cytoskeleton; adipocytes; inflammation; obesity	ACTIN CYTOSKELETON; GENE POLYMORPHISMS; LIPID DROPLETS; ASSOCIATION; OBESITY; CELLS; ADIPOGENESIS; SENSITIVITY; PLASTICITY; SOFTWARE	During adipogenesis, preadipocytes' cytoskeleton reorganizes in parallel with lipid accumulation. Failure to do so may impact the ability of adipose tissue (AT) to shift between lipid storage and mobilization. Here, we identify cytoskeletal transgelin 2 (TAGLN2) as a protein expressed in AT and associated with obesity and inflammation, being normalized upon weight loss. TAGLN2 was primarily found in the adipose stromovascular cell fraction, but inflammation, TGF-beta, and estradiol also prompted increased expression in human adipocytes. Tagln2 knockdown revealed a key functional role, being required for proliferation and differentiation of fat cells, whereas transgenic mice overexpressing Tagln2 using the adipocyte protein 2 promoter disclosed remarkable sex-dependent variations, in which females displayed healthy obesity and hypertrophied adipocytes but preserved insulin sensitivity, and males exhibited physiologic changes suggestive of defective AT expandability, including increased number of small adipocytes, activation of immune cells, mitochondrial dysfunction, and impaired metabolism together with decreased insulin sensitivity. The metabolic relevance and sexual dimorphism of TAGLN2 was also outlined by genetic variants that may modulate its expression and are associated with obesity and the risk of ischemic heart disease in men. Collectively, current findings highlight the contribution of cytoskeletal TAGLN2 to the obese phenotype in a gender-dependent manner.-Ortega, F. J., Moreno-Navarrete, J. M., Mercader, J. M., Gomez-Serrano, M., Garcia-Santos, E., Latorre, J., Lluch, A., Sabater, M., Caballano-Infantes, E., Guzman, R., Macias-Gonzalez, M., Buxo, M., Girones, J., Vilallonga, R., Naon, D., Botas, P., Delgado, E., Corella, D., Burcelin, R., Fruhbeck, G., Ricart, W., Simo, R., Castrillon-Rodriguez, I., Tinahones, F. J., Bosch, F., Vidal-Puig, A., Malagon, M. M., Peral, B., Zorzano, A., Fernandez-Real, J. M. Cytoskeletal transgelin 2 contributes to gender-dependent adipose tissue expandability and immune function.	[Ortega, Francisco J.; Moreno-Navarrete, Jose M.; Sabater, Monica; Caballano-Infantes, Estefania; Guzman, Rocio; Macias-Gonzalez, Manuel; Corella, Dolores; Fruhbeck, Gema; Ricart, Wifredo; Tinahones, Francisco J.; Malagon, Maria M.; Fernandez-Real, Jose M.] Inst Salud Carlos III ISCIII, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Naon, Deborah; Simo, Rafael; Castrillon-Rodriguez, Ignacio; Bosch, Fatima; Zorzano, Antonio] Inst Salud Carlos III ISCIII, Ctr Invest Biomed Metab Asociadas CIBERDEM, Madrid, Spain; [Ortega, Francisco J.; Moreno-Navarrete, Jose M.; Latorre, Jessica; Lluch, Aina; Sabater, Monica; Caballano-Infantes, Estefania; Buxo, Maria; Ricart, Wifredo; Fernandez-Real, Jose M.] Inst Invest Biomed Girona IdIBGi, Dept Diabet Endocrinol & Nutr UDEN, Girona, Spain; [Girones, Jordi] Inst Invest Biomed Girona IdIBGi, Dept Surg, Girona, Spain; [Mercader, Josep M.] Barcelona Supercomp Ctr BSC, Joint BSC CRG IRB Res Program Computat Biol, Barcelona, Spain; [Gomez-Serrano, Maria; Garcia-Santos, Eva; Peral, Belen] CSIC, Dept Endocrinol Physiopathol & Nervous Syst, Inst Invest Biomed Alberto Sols IIBM, Madrid, Spain; [Guzman, Rocio; Malagon, Maria M.] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Inst Maimonides Invest Biomed Cordoba IMIBIC, Reina Sofia Univ Hosp, Cordoba, Spain; [Macias-Gonzalez, Manuel; Tinahones, Francisco J.] Hosp Clin Univ Virgen Victoria Malaga, Serv Endocrinol & Nutr, Malaga, Spain; [Vilallonga, Ramon] Hosp Univ Vall dHebron, European Ctr Excellence EAC BS, Unidad Cirugia Endocrina Bariatr & Metab, Serv Cirugia Gen, Barcelona, Spain; [Naon, Deborah; Castrillon-Rodriguez, Ignacio; Zorzano, Antonio] Univ Barcelona, Inst Res Biomed IRB Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Barcelona, Spain; [Botas, Patricia; Delgado, Elias] Univ Oviedo, Hosp Univ Cent Asturias HUCA, Dept Med, Endocrinol & Nutr Serv, Oviedo, Spain; [Botas, Patricia; Delgado, Elias] Inst Invest Sanitaria Principado Asturias ISPA, Oviedo, Spain; [Corella, Dolores] Univ Valencia, Sch Med, Dept Prevent Med & Publ Hlth, Genet & Mol Epidemiol Unit, Valencia, Spain; [Burcelin, Remy] Univ Paul Sabatier, INSERM, Unite 858, Inst Med Mol Ranguil,IFR31, Toulouse, France; [Fruhbeck, Gema] Clin Univ Navarra IdiSNA, Dept Endocrinol & Nutr, Pamplona, Spain; [Simo, Rafael] Vall dHebron Res Inst, Diabet & Metab Res Unit, Barcelona, Spain; [Bosch, Fatima] Autonomous Univ Barcelona, Sch Vet Med, Dept Biochem & Mol Biol, Ctr Anim Biotechnol & Gene Therapy, Barcelona, Spain; [Vidal-Puig, Antonio] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Wellcome Trust MRC Inst Metab Sci, Cambridge, England	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Universidad de Cordoba; Hospital Universitari Vall d'Hebron; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Central University Hospital Asturias; University of Oviedo; Instituto de Investigacion Sanitaria del Principado de Asturias (ISPA); University of Valencia; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Autonomous University of Barcelona; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Ortega, FJ; Fernandez-Real, JM (corresponding author), Hosp Girona Dr Josep Trueta, Dept Diabet Endocrinol & Nutr UDEN, Inst Invest Biomed Girona IDIBGI, Carretera Franca S-N, Girona 17007, Spain.	fortega@idibgi.org; jmfreal@idibgi.org	Malagon, Maria M/L-5386-2014; , VILALLONGA/AAO-5437-2020; Fernández-Real, Jose Manuel/AGH-3599-2022; Moreno-Navarrete, José María/H-9772-2015; Gómez-Serrano, María/AAZ-3953-2021; Moreno-Navarrete, José María/ABG-5548-2021; Delgado, Elias/B-2634-2013; Balaña, Aina Lluch/A-5098-2019; Ortega, Francisco José J/F-3883-2016; Caballano-Infantes, Estefanía/AAA-5547-2020; Zorzano, Antonio/R-5479-2018; Tinahones, Francisco José/AAB-2882-2020; PERAL, BELEN/F-4562-2015	Malagon, Maria M/0000-0002-2419-2727; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Moreno-Navarrete, José María/0000-0002-2883-511X; Gómez-Serrano, María/0000-0002-9669-091X; Moreno-Navarrete, José María/0000-0002-2883-511X; Delgado, Elias/0000-0001-6114-9712; Balaña, Aina Lluch/0000-0003-4216-4436; Ortega, Francisco José J/0000-0003-2111-769X; Caballano Infantes, Estefania/0000-0001-8269-9158; BOSCH, FATIMA/0000-0002-7705-5515; Tinahones, Francisco J/0000-0001-6871-4403; PERAL, BELEN/0000-0003-4984-4020; Naon, Deborah Paola/0000-0002-9726-4664; Latorre Luque, Jessica/0000-0002-7603-1458; Simo Canonge, Rafael/0000-0003-0475-3096	Ministerio de Educacion y Ciencia [GEN2001-4758, SAF2008-02073, SAF2009-10461, SAF2012-33014]; Instituto de Salud Carlos III (ISCIII) [PI15/01934, PI18/00550]; Instituto de Salud Carlos III (CIBEROBN); Instituto de Salud Carlos III (CIBERDEM); Pla estrategic de recerca i innovacio en salut and the Govern de la Generalitat (PERIS 2016); Agencia de Gestio d'Ajuts Universitaris de Recerca (AGAUR, FI-DGR 2015); Universidad Autonoma de Madrid (FPI-UAM); Fondo Europeo de Desarrollo Regional (FEDER); AGAUR; Agence Nationale de la Recherche; Institute Nationale du Diabete; MRC [MC_UU_12012/2, G0600717, G0802051, MC_UU_00014/2, G0400192] Funding Source: UKRI	Ministerio de Educacion y Ciencia(Spanish Government); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Instituto de Salud Carlos III (CIBEROBN)(Instituto de Salud Carlos III); Instituto de Salud Carlos III (CIBERDEM)(Instituto de Salud Carlos III); Pla estrategic de recerca i innovacio en salut and the Govern de la Generalitat (PERIS 2016); Agencia de Gestio d'Ajuts Universitaris de Recerca (AGAUR, FI-DGR 2015); Universidad Autonoma de Madrid (FPI-UAM); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Institute Nationale du Diabete; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work of all the members of the Multidisciplinary Obesity Team of the Clinica Universitaria de Navarra is gratefully acknowledged. The authors are indebted to the Institut d'Investigacio Biomedica de Girona (IDIBGI) Biobank, integrated in the Spanish National Biobank Network, for the sample and data procurement. GenDiab Consortium was constituted with funds from the Ministerio de Educacion y Ciencia (Grant GEN2001-4758). This work was also supported by research funds from the Instituto de Salud Carlos III (ISCIII; PI15/01934 to J.M.F-R., and PI18/00550 to F.J.O.) and the Ministerio de Educacion y Ciencia (SAF2008-02073 to J.M.F.-R., SAF2009-10461 and SAF2012-33014 to B.P.), the Instituto de Salud Carlos III (CIBEROBN and CIBERDEM), the Pla estrategic de recerca i innovacio en salut and the Govern de la Generalitat (PERIS 2016 to F.J.O.), the Agencia de Gestio d'Ajuts Universitaris de Recerca (AGAUR, FI-DGR 2015 to J.L.), the Universidad Autonoma de Madrid (FPI-UAM to M.G.-S.), and the Fondo Europeo de Desarrollo Regional (FEDER). J.M.M. was supported by a Beatriu de Pinos fellowship from the AGAUR. R.B. is recipient of funding from the Agence Nationale de la Recherche (Florinflam and Floradip programs) and the Institute Nationale du Diabete. The authors declare no conflicts of interest.	Ariotti N, 2012, MOL BIOL CELL, V23, P1826, DOI 10.1091/mbc.E11-10-0847; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Bupp MRG, 2015, CELL IMMUNOL, V294, P102, DOI 10.1016/j.cellimm.2015.02.002; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Clegg DJ, 2006, DIABETES, V55, P978, DOI 10.2337/diabetes.55.04.06.db05-1339; Cnop M, 2002, DIABETES, V51, P1005, DOI 10.2337/diabetes.51.4.1005; Cutolo M, 2014, EXPERT REV CLIN IMMU, V10, P31, DOI 10.1586/1744666X.2014.863149; Feizi S, 2013, NAT BIOTECHNOL, V31, P726, DOI 10.1038/nbt.2635; Fong TH, 2001, BIOCHEM BIOPH RES CO, V289, P1168, DOI 10.1006/bbrc.2001.6080; Frances R, 2006, MOL IMMUNOL, V43, P2124, DOI 10.1016/j.molimm.2005.12.011; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; Fu YP, 2000, J APPL PHYSIOL, V89, P1985, DOI 10.1152/jappl.2000.89.5.1985; Galarraga M, 2012, J LIPID RES, V53, P2791, DOI 10.1194/jlr.D023788; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Grove KL, 2010, INT J OBESITY, V34, P989, DOI 10.1038/ijo.2010.12; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jo S, 2018, J LEUKOCYTE BIOL, V104, P903, DOI 10.1002/JLB.MR1117-470R; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Kawaguchi N, 2003, J CELL SCI, V116, P3893, DOI 10.1242/jcs.00699; Kee AJ, 2015, TRAFFIC, V16, P691, DOI 10.1111/tra.12282; Kim HR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23816-2; Kim HR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09144-x; Kim IG, 2018, CANCER SCI, V109, P3519, DOI 10.1111/cas.13791; Lancha A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098398; Latorre J, 2018, CELL PHYSIOL BIOCHEM, V51, P1051, DOI 10.1159/000495487; Leung WKC, 2011, ONCOGENE, V30, P4464, DOI 10.1038/onc.2011.161; Liang XL, 2019, FASEB J, V33, P5667, DOI 10.1096/fj.201802158RRR; Macotela Y, 2009, DIABETES, V58, P803, DOI 10.2337/db08-1054; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Fernandez-Real JM, 2010, EUR J CLIN INVEST, V40, P600, DOI 10.1111/j.1365-2362.2010.02306.x; Moreno-Navarrete JM, 2008, CLIN CHEM, V54, P301, DOI 10.1373/clinchem.2007.095943; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Medrikova D, 2012, INT J OBESITY, V36, P262, DOI 10.1038/ijo.2011.87; Meng T, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317702650; Moreno-Castellanos N, 2017, DIABETOLOGIA, V60, P324, DOI 10.1007/s00125-016-4155-5; Na BR, 2015, J CELL BIOL, V209, P143, DOI 10.1083/jcb.201407130; Nobusue H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4368; O'Hara A, 2009, PFLUG ARCH EUR J PHY, V458, P1103, DOI 10.1007/s00424-009-0693-8; Ortega FJ, 2015, J CLIN ENDOCR METAB, V100, pE1467, DOI 10.1210/jc.2015-2357; Ortega FJ, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0083-3; Pederson T, 2008, J CELL BIOL, V180, P1061, DOI 10.1083/jcb.200709082; Pellegrinelli V, 2016, DIABETOLOGIA, V59, P1075, DOI 10.1007/s00125-016-3933-4; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200; Sotos-Prieto M, 2013, BRIT J NUTR, V109, P193, DOI 10.1017/S0007114512000918; Staley JR, 2016, BIOINFORMATICS, V32, P3207, DOI 10.1093/bioinformatics/btw373; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Valdes S, 2007, DIABETES CARE, V30, P2258, DOI 10.2337/dc06-2461; VALERA A, 1994, P NATL ACAD SCI USA, V91, P9151, DOI 10.1073/pnas.91.19.9151; Verstraeten VLRM, 2011, HISTOCHEM CELL BIOL, V135, P251, DOI 10.1007/s00418-011-0792-4; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Yang WL, 2013, BIOCHEM J, V449, P605, DOI 10.1042/BJ20121121	58	3	3	2	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9656	9671		10.1096/fj.201900479R	http://dx.doi.org/10.1096/fj.201900479R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31145872	Bronze			2022-12-28	WOS:000478832900074
J	Shi, E; Shi, KB; Qiu, SF; Sheth, KN; Lawton, MT; Ducruet, AF				Shi, Elaine; Shi, Kaibin; Qiu, Shenfeng; Sheth, Kevin N.; Lawton, Michael T.; Ducruet, Andrew F.			Chronic inflammation, cognitive impairment, and distal brain region alteration following intracerebral hemorrhage	FASEB JOURNAL			English	Article						microglia; delayed cognitive impairment; LTP	MOUSE MODEL; INJURY; SPHINGOSINE-1-PHOSPHATE; NEUROINFLAMMATION; NEUROGENESIS; FINGOLIMOD; ACTIVATION; MEDIATORS; MEMORY; DAMAGE	Delayed cognitive decline commonly occurs following intracerebral hemorrhage (ICH), but the mechanisms underlying this phenomenon remain obscure. We therefore investigated the potential mechanisms responsible for impaired cognitive function in a mouse collagenase model of ICH. Following recovery of motor and sensory deficits in the chronic phase of ICH, we noted significant cognitive impairment, which was assessed by the Morris water maze. This finding was accompanied by reduced dendrite spine density of ipsilateral hippocampal CA1 neurons. Reduced synaptic plasticity, manifested by impaired long-term potentiation in hippocampal neurons, was also evident in both ipsilateral and contralateral hemispheres, suggesting that ICH also induces functional alterations in distal brain regions remote from the site of injury. In addition, the accumulation of microglia, infiltration of peripheral immune cells, and generation of reactive oxygen species were observed in both contralateral and ipsilateral hemispheres up to 5 wk post-ICH. Furthermore, depletion of microglia using PLX3397, which inhibits colony stimulating factor 1 receptor, ameliorated this delayed cognitive impairment. Collectively, these results suggest that persistent and diffuse brain inflammation may contribute to cognitive impairment in the chronic stage of ICH recovery.-Shi, E., Shi, K., Qiu, S., Sheth, K. N., Lawton, M. T., Ducruet, A. F. Chronic inflammation, cognitive impairment, and distal brain region alteration following intracerebral hemorrhage.	[Shi, Elaine; Shi, Kaibin; Lawton, Michael T.; Ducruet, Andrew F.] St Josephs Hosp, Dept Neurol, Barrow Neurol Inst, 350 W Thomas Rd,NRC 220, Phoenix, AZ 85013 USA; [Shi, Elaine; Shi, Kaibin; Lawton, Michael T.; Ducruet, Andrew F.] St Josephs Hosp, Dept Neurosurg, Barrow Neurol Inst, 350 W Thomas Rd,NRC 220, Phoenix, AZ 85013 USA; [Qiu, Shenfeng] Univ Arizona, Dept Basic Med Sci, Coll Med, Phoenix, AZ USA; [Sheth, Kevin N.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA	Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; University of Arizona; Yale University	Ducruet, AF (corresponding author), St Josephs Hosp, Dept Neurol, Barrow Neurol Inst, 350 W Thomas Rd,NRC 220, Phoenix, AZ 85013 USA.; Ducruet, AF (corresponding author), St Josephs Hosp, Dept Neurosurg, Barrow Neurol Inst, 350 W Thomas Rd,NRC 220, Phoenix, AZ 85013 USA.	andrew.ducruet@barrowbrainandspine.com			Barrow Neurological Foundation	Barrow Neurological Foundation	The authors thank Dr. Jie Wu (Barrow Neurological Institute) for technical support. This study was supported by the Barrow Neurological Foundation. The authors declare no conflicts of interest.	Barratt HE, 2014, J CEREBR BLOOD F MET, V34, P1463, DOI 10.1038/jcbfm.2014.107; Biffi A, 2016, JAMA NEUROL, V73, P969, DOI 10.1001/jamaneurol.2016.0955; Chang CF, 2017, NEUROBIOL DIS, V103, P54, DOI 10.1016/j.nbd.2017.03.016; Chen Z, 2011, STROKE, V42, P465, DOI 10.1161/STROKEAHA.110.602755; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Dendrou CA, 2016, NAT REV NEUROL, V12, P685, DOI 10.1038/nrneurol.2016.171; Doyle KP, 2015, J NEUROSCI, V35, P2133, DOI 10.1523/JNEUROSCI.4098-14.2015; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Fu Y, 2015, NAT REV NEUROL, V11, P524, DOI 10.1038/nrneurol.2015.144; Fu Y, 2014, JAMA NEUROL, V71, P1092, DOI 10.1001/jamaneurol.2014.1065; Gan Y, 2014, P NATL ACAD SCI USA, V111, P2704, DOI 10.1073/pnas.1315943111; Garber C, 2018, NAT IMMUNOL, V19, P151, DOI 10.1038/s41590-017-0021-y; Hammond MD, 2014, J NEUROSCI, V34, P3901, DOI 10.1523/JNEUROSCI.4070-13.2014; Hartman R, 2009, BRAIN RES, V1280, P148, DOI 10.1016/j.brainres.2009.05.038; He P, 2012, FASEB J, V26, P334, DOI 10.1096/fj.11-192716; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Kim DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035476; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Leys D, 2005, LANCET NEUROL, V4, P752, DOI 10.1016/S1474-4422(05)70221-0; Li MS, 2017, J CEREBR BLOOD F MET, V37, P2383, DOI 10.1177/0271678X16666551; Li YJ, 2015, NEUROSCI BULL, V31, P755, DOI 10.1007/s12264-015-1532-2; Liu Q, 2017, IMMUNITY, V46, P474, DOI 10.1016/j.immuni.2017.02.015; MacLellan CL, 2008, J CEREBR BLOOD F MET, V28, P516, DOI 10.1038/sj.jcbfm.9600548; MacLellan CL, 2009, BEHAV BRAIN RES, V198, P321, DOI 10.1016/j.bbr.2008.11.004; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Shi KB, 2018, STROKE VASC NEUROL, V3, P34, DOI 10.1136/svn-2017-000123; Shi KB, 2016, J IMMUNOL, V197, P3471, DOI 10.4049/jimmunol.1600135; Sun GZ, 2017, CNS NEUROSCI THER, V23, P748, DOI 10.1111/cns.12720; Sun N, 2016, STROKE, V47, P1899, DOI 10.1161/STROKEAHA.115.012236; Taylor RA, 2017, J CLIN INVEST, V127, P280, DOI 10.1172/JCI88647; Wu H, 2010, NEUROCHEM INT, V57, P248, DOI 10.1016/j.neuint.2010.06.002; Wu JM, 2002, BRAIN RES, V953, P45, DOI 10.1016/S0006-8993(02)03268-7; Xiong XY, 2016, CIRCULATION, V134, P1025, DOI 10.1161/CIRCULATIONAHA.116.021881; Yang Y, 2015, NEUROSCI LETT, V599, P133, DOI 10.1016/j.neulet.2015.05.049; Zhang J, 2018, FASEB J, V32, P220, DOI 10.1096/fj.201700324R; Zhao XR, 2007, STROKE, V38, P3280, DOI 10.1161/STROKEAHA.107.486506; Zhao XR, 2015, J NEUROCHEM, V133, P144, DOI 10.1111/jnc.12974	39	28	28	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9616	9626		10.1096/fj.201900257R	http://dx.doi.org/10.1096/fj.201900257R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31145859	Bronze			2022-12-28	WOS:000478832900071
J	van Putten, M; Putker, K; Overzier, M; Adamzek, WA; Pasteuning-Vuhman, S; Plomp, JJ; Aartsma-Rus, A				van Putten, Maaike; Putker, Kayleigh; Overzier, Maurice; Adamzek, W. A.; Pasteuning-Vuhman, Svetlana; Plomp, Jaap J.; Aartsma-Rus, Annemieke			Natural disease history of the D2-mdx mouse model for Duchenne muscular dystrophy	FASEB JOURNAL			English	Article						pathology; fibrosis; calcification; muscle function; regeneration	MDX MOUSE; SATELLITE CELLS; MICE; REGENERATION; PHENOTYPE; GENE	The C57BL/10ScSn-Dmd(mdx)/J (BL10-mdx) mouse has been the most commonly used model for Duchenne muscular dystrophy (DMD) for decades. Their muscle dysfunction and pathology is, however, less severe than in patients with DMD, which complicates preclinical studies. Recent discoveries indicate that disease severity is exacerbated when muscular dystrophy mouse models are generated on a DBA2/J genetic background. Knowledge on the natural history of animal models is pivotal for high-quality preclinical testing. However, for BL10-mdx mice on a DBA2/J background (D2-mdx), limited data are available. We addressed this gap in the natural history knowledge. First, we compared histopathological aspects in skeletal muscles of young D2-mdx, BL10-mdx, and wild-type mice. Pathology was more pronounced in D2-mdx mice and differed in severity between muscles within individuals. Secondly, we subjected D2-mdx mice to a functional test regime for 34 weeks and identified that female D2-mdx mice outperform severely impaired males, making females less useful for functional preclinical studies. Direct comparisons between 10- and 34-wk-old D2-mdx mice revealed that disease pathology ameliorates with age. Heart pathology was progressive, with some features already evident at a young age. This natural history study of the D2-mdx mouse will be instrumental for experimental design of future preclinical studies.-Van Putten, M., Putker, K., Overzier, M., Adamzek, W. A., Pasteuning-Vuhman, S., Plomp, J. J., Aartsma-Rus, A. Natural disease history of the D2-mdx mouse model for Duchenne muscular dystrophy.	[van Putten, Maaike; Putker, Kayleigh; Overzier, Maurice; Adamzek, W. A.; Pasteuning-Vuhman, Svetlana; Aartsma-Rus, Annemieke] Leiden Univ, Med Ctr, Dept Human Genet, Einthovenweg 20,Postzone S4-P,Albinusdreef 2, NL-2333 ZA Leiden, Netherlands; [Plomp, Jaap J.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Aartsma-Rus, A (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Einthovenweg 20,Postzone S4-P,Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	a.m.rus@lumc.nl		Overzier, Maurice/0000-0002-8143-4884	Duchenne Parent Project, French Muscular Dystrophy Association (AFM) Telethon [20251]; ZonMw [113302001]; Italpharmaco; Alpha Anomeric	Duchenne Parent Project, French Muscular Dystrophy Association (AFM) Telethon; ZonMw(Netherlands Organization for Health Research and Development); Italpharmaco; Alpha Anomeric	The authors are grateful for the experimental help of Davy van de Vijver, Mandy Kater, and Joris van der Hurk [Leiden University Medical Centre (LUMC)]. This work was supported by funding from Duchenne Parent Project, French Muscular Dystrophy Association (AFM) Telethon (Grant 20251) and ZonMw (Grant 113302001) for researchers' salaries. A.A.-R. is employed by Leiden University Medical Center (LUMC), which has patents on exon skipping technology, some of which has been licensed to BioMarin and subsequently sublicensed to Sarepta. As co-inventor of some of these patents, A.A.-R. is entitled to a share of royalties. A.A.-R. is also an ad hoc consultant for PTC Therapeutics, Summit PLC, Alpha Anomeric, BioMarin Pharmaceuticals, Eisai, Global Guidepoint and GLG consultancy, Grunenthal, Wave, and BioClinica. A.A.-R. was also a member of the Duchenne Network Steering Committee (BioMarin) and a member of the scientific advisory boards of ProQR, MirrX Therapeutics, and Philae Pharmaceuticals. Remuneration for these activities is paid to LUMC. LUMC also received speaker honoraria from PTC Therapeutics and BioMarin Pharmaceuticals and funding for contract research from Italpharmaco and Alpha Anomeric. The remaining authors declare no conflicts of interest.	Aartsma-Rus A, 2014, JOVE-J VIS EXP, DOI 10.3791/51303; Aherrahrou Z, 2007, PHYSIOL GENOMICS, V28, P203, DOI 10.1152/physiolgenomics.00133.2006; Bladen CL, 2015, HUM MUTAT, V36, P395, DOI 10.1002/humu.22758; Boldrin L, 2015, STEM CELL RES, V14, P20, DOI 10.1016/j.scr.2014.10.007; Coley WD, 2016, HUM MOL GENET, V25, P130, DOI 10.1093/hmg/ddv460; De Luca Annamaria, 2012, Acta Myol, V31, P40; DIMARIO JX, 1991, DEV BIOL, V148, P314, DOI 10.1016/0012-1606(91)90340-9; Emery AE, 2015, OXFORD MONOGRAPHS G, V67; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Flanigan KM, 2013, ANN NEUROL, V73, P481, DOI 10.1002/ana.23819; Fukada S, 2010, AM J PATHOL, V176, P2414, DOI 10.2353/ajpath.2010.090887; Gissel H, 2005, ANN NY ACAD SCI, V1066, P166, DOI 10.1196/annals.1363.013; Gordish-Dressman Heather, 2018, J Neuromuscul Dis, V5, P407, DOI 10.3233/JND-180324; Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008; Hakim CH, 2017, MOL THER-METH CLIN D, V6, P216, DOI 10.1016/j.omtm.2017.06.006; Hakim CH, 2012, MUSCLE NERVE, V45, P250, DOI 10.1002/mus.22275; Heydemann A, 2009, J CLIN INVEST, V119, P3703, DOI 10.1172/JCI39845; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hourde C, 2013, MUSCLE NERVE, V48, P68, DOI 10.1002/mus.23700; Kim S, 2015, J CHILD NEUROL, V30, P1275, DOI 10.1177/0883073814558120; Klingler Werner, 2012, Acta Myol, V31, P184; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Meng HJ, 2007, P NATL ACAD SCI USA, V104, P4530, DOI 10.1073/pnas.0607620104; Moat SJ, 2013, EUR J HUM GENET, V21, P1049, DOI 10.1038/ejhg.2012.301; Moxley RT, 2010, J CHILD NEUROL, V25, P1116, DOI 10.1177/0883073810371004; Pasteuning-Vuhman S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182704; Roberts NW, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/131436; Rodrigues M, 2016, SCI REP-UK, V6, DOI 10.1038/srep38371; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Straub V, 2016, LANCET NEUROL, V15, P882, DOI 10.1016/S1474-4422(16)30035-7; Swaggart KA, 2014, P NATL ACAD SCI USA, V111, P6004, DOI 10.1073/pnas.1324242111; van den Bergen JC, 2015, J NEUROL NEUROSUR PS, V86, P1060, DOI 10.1136/jnnp-2014-308409; van der Pijl EM, 2018, NEUROMUSCULAR DISORD, V28, P427, DOI 10.1016/j.nmd.2018.02.013; van der Pijl EM, 2016, EUR J NEUROSCI, V43, P1623, DOI 10.1111/ejn.13249; Vohra R, 2017, AM J PATHOL, V187, P2060, DOI 10.1016/j.ajpath.2017.05.010; Wallace GQ, 2009, ANNU REV PHYSIOL, V71, P37, DOI 10.1146/annurev.physiol.010908.163216; Weiss RB, 2018, ANN NEUROL, V84, P234, DOI 10.1002/ana.25283	38	51	51	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8110	8124		10.1096/fj.201802488R	http://dx.doi.org/10.1096/fj.201802488R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30933664	Green Published, hybrid			2022-12-28	WOS:000476234700025
J	Zhang, XF; Grosfeld, A; Williams, E; Vasiliauskas, D; Barretto, S; Smith, L; Mariadassou, M; Philippe, C; Devime, F; Melchior, C; Gourcerol, G; Dourmap, N; Lapaque, N; Larraufie, P; Blottiere, HM; Herberden, C; Gerard, P; Rehfeld, JF; Ferraris, RP; Fritton, JC; Ellero-Simatos, S; Douard, V				Zhang, Xufei; Grosfeld, Alexandra; Williams, Edek; Vasiliauskas, Daniel; Barretto, Sharon; Smith, Lorraine; Mariadassou, Mahendra; Philippe, Catherine; Devime, Fabienne; Melchior, Chloe; Gourcerol, Guillaume; Dourmap, Nathalie; Lapaque, Nicolas; Larraufie, Pierre; Blottiere, Herve M.; Herberden, Christine; Gerard, Philippe; Rehfeld, Jens F.; Ferraris, Ronaldo P.; Fritton, J. Christopher; Ellero-Simatos, Sandrine; Douard, Veronique			Fructose malabsorption induces cholecystokinin expression in the ileum and cecum by changing microbiota composition and metabolism	FASEB JOURNAL			English	Article						CCK; KHK; propionate	CHAIN FATTY-ACIDS; Y GASTRIC BYPASS; GLUCAGON-LIKE PEPTIDE-1; ENTEROENDOCRINE CELLS; DIETARY FRUCTOSE; HORMONE EXPRESSION; RECEPTOR; CCK; GLUCOSE; GLP-1	Current fructose consumption levels often overwhelm the intestinal capacity to absorb fructose. We investigated the impact of fructose malabsorption on intestinal endocrine function and addressed the role of the microbiota in this process. To answer this question, a mouse model of moderate fructose malabsorption [ketohexokinase mutant (KHK)(-/-)] and wild-type (WT) littermate mice were used and received a 20%-fructose (KHK-F and WT-F) or 20%-glucose diet. Cholecystokinin (Cck) mRNA and protein expression in the ileum and cecum, as well as preproglucagon (Gcg) and neurotensin (Nts) mRNA expression in the cecum, increased in KHK-F mice. In KHK-F mice, triple-label immunohistochemistry showed major up-regulation of CCK in enteroendocrine cells (EECs) that were glucagon-like peptide-1 (GLP-1)(+)/Peptide YY (PYY-) in the ileum and colon and GLP-1(-)/PYY- in the cecum. The cecal microbiota composition was drastically modified in the KHK-F in association with an increase in glucose, propionate, succinate, and lactate concentrations. Antibiotic treatment abolished fructose malabsorption-dependent induction of cecal Cck mRNA expression and, in mouse GLUTag and human NCI-H716 cells, Cck mRNA expression levels increased in response to propionate, both suggesting a microbiota-dependent process. Fructose reaching the lower intestine can modify the composition and metabolism of the microbiota, thereby stimulating the production of CCK from the EECs possibly in response to propionate.-Zhang, X., Grosfeld, A., Williams, E., Vasiliauskas, D., Barretto, S., Smith, L., Mariadassou, M., Philippe, C., Devime, F., Melchior, C., Gourcerol, G., Dourmap, N., Lapaque, N., Larraufie, P., Blottiere, H. M., Herberden, C., Gerard, P., Rehfeld, J. F., Ferraris, R. P., Fritton, J. C., Ellero-Simatos, S., Douard, V. Fructose malabsorption induces cholecystokinin expression in the ileum and cecum by changing microbiota composition and metabolism.	[Zhang, Xufei; Philippe, Catherine; Devime, Fabienne; Lapaque, Nicolas; Larraufie, Pierre; Blottiere, Herve M.; Herberden, Christine; Gerard, Philippe; Douard, Veronique] Univ Paris Saclay, AgroParisTech, INRA, Micalis Inst, Jouy En Josas, France; [Zhang, Xufei] Sorbonne Univ, Coll Doctoral, Paris, France; [Grosfeld, Alexandra] UPD, Sorbonne Univ, Sorbonne Cites,CNRS,IHU,ICAN, Ctr Rech Cordeliers,INSERM Unite Mixte Rech UMR S, Paris, France; [Williams, Edek; Fritton, J. Christopher] Rutgers State Univ, Dept Orthoped, Newark, NJ USA; [Ferraris, Ronaldo P.] Rutgers State Univ, Dept Pharmacol Physiol & Neurosci, Newark, NJ USA; [Vasiliauskas, Daniel] Univ Paris Saclay, CNRS, Univ Paris Sud, Paris Saclay Inst Neurosci, Gif Sur Yvette, France; [Barretto, Sharon; Smith, Lorraine; Ellero-Simatos, Sandrine] Univ Toulouse, INRA, Toxalim, Toulouse, France; [Mariadassou, Mahendra] INRA, Unite Rech UR 1404, Math & Informat Appl Genome Environm MaIAGE, Jouy En Josas, France; [Melchior, Chloe; Gourcerol, Guillaume] Normandie Univ, Univ Rouen UNIROUEN, INSERM, U1073, Rouen, France; [Dourmap, Nathalie] Normandy Univ, UNIROUEN, INSERM U1245, Rouen, France; [Dourmap, Nathalie] Normandy Univ, Rouen Univ Hosp, Normandy Ctr Genom & Personalized Med, Rouen, France; [Rehfeld, Jens F.] Univ Copenhagen, Rigshosp, Dept Clin Biochem, Copenhagen, Denmark	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Rouen; Rigshospitalet; University of Copenhagen	Douard, V (corresponding author), INRA, Micalis Inst, F-78352 Jouy En Josas, France.	veronique.douard@inra.fr	Larraufie, Pierre/P-7063-2015; Grosfeld, Alexandra/R-1404-2017; Gérard, Philippe/H-8138-2019; Lapaque, Nicolas/AAB-4530-2021; Larraufie, Pierre/ABH-2988-2021; BLOTTIERE, Hervé M/C-6120-2011; Melchior, Chloé/AAM-8148-2020; Vasiliauskas, Daniel/AAV-1981-2020; Douard, veronique/AAU-6271-2020; Grosfeld, Alexandra/AAH-3510-2020	Larraufie, Pierre/0000-0001-7718-6200; Grosfeld, Alexandra/0000-0002-9508-036X; Gérard, Philippe/0000-0001-9521-0067; Lapaque, Nicolas/0000-0003-0824-0108; BLOTTIERE, Hervé M/0000-0002-8390-0607; Vasiliauskas, Daniel/0000-0002-0570-2322; Melchior, Chloe/0000-0002-8146-1540; Fritton, James/0000-0002-6475-7622; Gourcerol, Guillaume/0000-0001-8220-9155; DOURMAP, nathalie/0000-0002-9453-5828	Institut Benjamin Delessert; INRA; China Scholarship Council (CSC); National Center for Complementary & Integrative Health [R01AT010243] Funding Source: NIH RePORTER	Institut Benjamin Delessert; INRA; China Scholarship Council (CSC)(China Scholarship Council); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank J.P. Furet (Micalis Institute, INRA, Jouyen-Josas, France), F. Rouyer (Paris-Saclay Institute of Neuroscience, Universite Paris Sud, CNRS, Universite Paris-Saclay, Gif-sur-Yvette, France), and S. P. Shirazi-Beechey (Institute of Integrative Biology, University of Liverpool, United Kingdom) for sharing reagents and equipment. The authors are grateful to the INRA Migale bioinformatics platform (http://migale.jouy.inra.fr/) for providing computational resources, the Genotoul high-throughput sequencing platform (http://bioinfo.genotoul.fr/), and the histology facility of UMR 1313 Genetique Animale et Biologie Integrative (GABI). This work was supported by grants from Institut Benjamin Delessert and by INRA. The China Scholarship Council (CSC) and INRA funded PhD fellowships to X.Z. The authors declare no conflicts of interest.	AIKEN KD, 1994, DEV DYNAM, V201, P63, DOI 10.1002/aja.1002010107; Akiba Y, 2015, J PHYSIOL-LONDON, V593, P585, DOI 10.1113/jphysiol.2014.280792; Arora T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18079-2; Barrett TD, 2008, BRIT J PHARMACOL, V153, P1650, DOI 10.1038/bjp.2008.44; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/NMETH.2276, 10.1038/nmeth.2276]; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Cani PD, 2007, BRIT J NUTR, V98, P32, DOI 10.1017/S0007114507691648; Cao B, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-19; Cavin JB, 2016, GASTROENTEROLOGY, V150, P454, DOI 10.1053/j.gastro.2015.10.009; Chua ASB, 2006, WORLD J GASTROENTERO, V12, P2688, DOI 10.3748/wjg.v12.i17.2688; Daly K, 2013, AM J PHYSIOL-GASTR L, V304, pG271, DOI 10.1152/ajpgi.00074.2012; DAVIDSON NO, 1992, AM J PHYSIOL, V262, pC795, DOI 10.1152/ajpcell.1992.262.3.C795; De Gregoris TB, 2011, J MICROBIOL METH, V86, P351, DOI 10.1016/j.mimet.2011.06.010; Delmee E, 2006, LIFE SCI, V79, P1007, DOI 10.1016/j.lfs.2006.05.013; Diehl J, 2016, CELL TISSUE RES, V364, P245, DOI 10.1007/s00441-015-2318-1; Diggle CP, 2010, PHYSIOL GENOMICS, V42A, P235, DOI 10.1152/physiolgenomics.00128.2010; Douard V, 2008, AM J PHYSIOL-ENDOC M, V295, pE227, DOI 10.1152/ajpendo.90245.2008; Douard V, 2013, J PHYSIOL-LONDON, V591, P401, DOI 10.1113/jphysiol.2011.215731; Egerod KL, 2012, ENDOCRINOLOGY, V153, P5782, DOI 10.1210/en.2012-1595; Escudie F, 2018, BIOINFORMATICS, V34, P1287, DOI 10.1093/bioinformatics/btx791; Fakhry J, 2017, CELL TISSUE RES, V369, P245, DOI 10.1007/s00441-017-2612-1; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Ganzle MG, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00340; Gill RK, 2005, AM J PHYSIOL-CELL PH, V289, pC846, DOI 10.1152/ajpcell.00112.2005; Gillard L, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00224; Gillard L, 2016, SCI REP-UK, V6, DOI 10.1038/srep28345; Gribble FM, 2016, ANNU REV PHYSIOL, V78, P277, DOI 10.1146/annurev-physiol-021115-105439; Grunddal KV, 2016, ENDOCRINOLOGY, V157, P176, DOI 10.1210/en.2015-1600; Habib AM, 2012, ENDOCRINOLOGY, V153, P3054, DOI 10.1210/en.2011-2170; HARVEY RF, 1973, LANCET, V1, P1; Hill ME, 1999, MOL ENDOCRINOL, V13, P1474, DOI 10.1210/me.13.9.1474; Ishimoto T, 2012, P NATL ACAD SCI USA, V109, P4320, DOI 10.1073/pnas.1119908109; Jang C, 2018, CELL METAB, V27, P351, DOI 10.1016/j.cmet.2017.12.016; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649; Jones HF, 2011, J PEDIATR GASTR NUTR, V52, P581, DOI 10.1097/MPG.0b013e3181fd1315; Jones HF, 2011, AM J PHYSIOL-GASTR L, V300, pG202, DOI 10.1152/ajpgi.00457.2010; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lan A, 2008, BRIT J NUTR, V100, P1251, DOI 10.1017/S0007114508978284; Larraufie P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18259-0; Ledochowski M, 2001, CLIN CHIM ACTA, V311, P119, DOI 10.1016/S0009-8981(01)00580-0; LOPEZ MJ, 1995, J BIOL CHEM, V270, P885, DOI 10.1074/jbc.270.25.14989; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lukowicz C, 2018, ENVIRON HEALTH PERSP, V126, DOI [10.1289/EHP2877, 10.1289/ehp2877]; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; Marriott BP, 2009, J NUTR, V139, pS1228, DOI 10.3945/jn.108.098277; Mumphrey MB, 2013, NEUROGASTROENT MOTIL, V25, pE70, DOI 10.1111/nmo.12034; Nakanishi Y, 2006, APPL ENVIRON MICROB, V72, P6271, DOI 10.1128/AEM.00477-06; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Nergard BJ, 2015, SURG OBES RELAT DIS, V11, P1237, DOI 10.1016/j.soard.2015.03.021; Nohr MK, 2013, ENDOCRINOLOGY, V154, P3552, DOI 10.1210/en.2013-1142; Patel C, 2015, AM J PHYSIOL-GASTR L, V309, pG779, DOI 10.1152/ajpgi.00188.2015; Patel C, 2015, AM J PHYSIOL-REG I, V309, pR499, DOI 10.1152/ajpregu.00128.2015; Patel C, 2015, FASEB J, V29, P4046, DOI 10.1096/fj.15-272195; Plovier Hubert, 2017, Endocr Dev, V32, P139, DOI 10.1159/000475736; Pouteau E, 2003, P NUTR SOC, V62, P87, DOI 10.1079/PNS2003208; Psichas A, 2015, INT J OBESITY, V39, P424, DOI 10.1038/ijo.2014.153; Putkonen L, 2013, CURR OPIN CLIN NUTR, V16, P473, DOI 10.1097/MCO.0b013e328361c556; Ranganathan P, 2018, J IMMUNOL, V200, P1781, DOI 10.4049/jimmunol.1700604; Rehfeld JF, 1998, REGUL PEPTIDES, V78, P31, DOI 10.1016/S0167-0115(98)00133-5; Reichardt N, 2014, ISME J, V8, P1323, DOI 10.1038/ismej.2014.14; Rhee NA, 2015, DIABETOLOGIA, V58, P2254, DOI 10.1007/s00125-015-3696-3; Richards P, 2016, PEPTIDES, V77, P21, DOI 10.1016/j.peptides.2015.06.006; Schonhoff SE, 2004, ENDOCRINOLOGY, V145, P2639, DOI 10.1210/en.2004-0051; SEALY L, 1978, CELL, V14, P115, DOI 10.1016/0092-8674(78)90306-9; Sun SR, 2017, PHYSIOLOGY, V32, P453, DOI 10.1152/physiol.00016.2017; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Wichmann A, 2013, CELL HOST MICROBE, V14, P582, DOI 10.1016/j.chom.2013.09.012; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	69	23	23	4	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7126	7142		10.1096/fj.201801526RR	http://dx.doi.org/10.1096/fj.201801526RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30939042	Green Published, Bronze			2022-12-28	WOS:000476114200038
J	Peng, MX; Li, Z; Niu, DH; Liu, XJ; Dong, ZG; Li, JL				Peng, Maoxiao; Li, Zhi; Niu, Donghong; Liu, Xiaojun; Dong, Zhiguo; Li, Jiale			Complement factor B/C2 in molluscs regulates agglutination and illuminates evolution of the Bf/C2 family	FASEB JOURNAL			English	Article						gene duplication; Sinonovacula constricta; invertebrate complement system; bivalve; innate immunity	INNATE IMMUNE-RESPONSE; RAZOR CLAM; FACTOR-B; EXPRESSION CHARACTERIZATION; MOLECULAR-CLONING; PROTEIN-B; C3 GENE; ACTIVATION; HOMOLOG; PATHWAY	Complement factor B/C2 family (Bf/C2F) proteins are core complement system components in vertebrates that are absent in invertebrates and have been lost by numerous species, raising evolutionary questions. At least 3 duplication events have occurred from Cnidaria (ancestor) to mammals. Type II Bf/C2 genes appeared during separation of Proterostomia and Deuterostomes. The second event occurred during separation of vertebrates and invertebrates, yielding type II-2 Bf/C2. The third event occurred when jawed and jawless fish were separated, eventually producing Bf and C2 genes. Herein, we report the second mollusc Sinonovacula constricta Bf/C2-type gene (Sept). ScBf is similar to Ruditapes decussatus Bf-like because both lack the first complement control protein module at the N terminus present in mammalian Bf/C2 proteins. Uniquely, the Ser protease (SP) module at the C terminus of ScBf is similar to 50 aa longer than in other complement factor B/C2-type (Bf/C2T) proteins, and is Glu-rich. Bf/C2T proteins in molluscs lack the catalytic Ser in the SP module. Surprisingly, ScBf regulates rabbit erythrocyte agglutination, during which it is localized on the erythrocyte surface. Thus, ScBf may mediate the agglutination cascade and may be an upstream regulator of this process. Our findings provide new insight into the origin of the Bf/C2F.	[Peng, Maoxiao; Li, Zhi; Niu, Donghong; Liu, Xiaojun; Dong, Zhiguo; Li, Jiale] Shanghai Ocean Univ, Key Lab Explorat & Utilizat Aquat Genet Resources, 999 Huchenghuan Rd, Shanghai 201306, Peoples R China; [Peng, Maoxiao; Li, Zhi; Niu, Donghong; Liu, Xiaojun; Dong, Zhiguo; Li, Jiale] Shanghai Ocean Univ, Coll Fisheries & Life Sci, 999 Huchenghuan Rd, Shanghai 201306, Peoples R China; [Niu, Donghong] Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China; [Li, Jiale] Shanghai Ocean Univ, Shanghai Engn Res Ctr Aquaculture, Shanghai, Peoples R China; [Niu, Donghong; Dong, Zhiguo; Li, Jiale] Jiangsu Ocean Univ, Coinnovat Ctr Jiangsu Marine Bioind Technol, Lianyungang, Peoples R China	Shanghai Ocean University; Shanghai Ocean University; Shanghai Ocean University; Shanghai Ocean University; Jiangsu Ocean University	Li, JL (corresponding author), Shanghai Ocean Univ, Key Lab Explorat & Utilizat Aquat Genet Resources, 999 Huchenghuan Rd, Shanghai 201306, Peoples R China.; Li, JL (corresponding author), Shanghai Ocean Univ, Coll Fisheries & Life Sci, 999 Huchenghuan Rd, Shanghai 201306, Peoples R China.	jlli2009@126.com	Dong, Zhiguo/AAT-7015-2020; li, jia/GVT-7587-2022	Dong, Zhiguo/0000-0001-7652-3316; Liu, Xiaojun/0000-0002-0332-2940; Peng, Maoxiao/0000-0002-4855-1202; Li, Zhi/0000-0002-4255-4170	National Natural Science Foundation of China [31101897]; 863 Hi-Tech Research and Development Program of China [2012AA10A400-3]; Shanghai Universities Knowledge Service Platform [ZF1206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Shanghai Universities Knowledge Service Platform	The authors thank Joao C. R. Cardoso (Universidade do Algarve) and Deborah M. Power (Universidade do Algarve, Faro, Portugal) for their guidance on building a phylogenetic tree. This work was supported by grants from the National Natural Science Foundation of China (Grant 31101897), the 863 Hi-Tech Research and Development Program of China (Grant 2012AA10A400-3), and the Shanghai Universities Knowledge Service Platform (Grant ZF1206). The authors declare no conflicts of interest.	AHEARN JM, 1989, ADV IMMUNOL, V46, P183, DOI 10.1016/S0065-2776(08)60654-9; Ariki S, 2008, J IMMUNOL, V181, P7994, DOI 10.4049/jimmunol.181.11.7994; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; Ding YL, 2019, EMBO J, V38, DOI 10.15252/embj.201899819; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Guo YM, 2014, CELL REP, V9, P1183, DOI 10.1016/j.celrep.2014.10.020; He YN, 2008, FISH SHELLFISH IMMUN, V24, P768, DOI 10.1016/j.fsi.2008.03.004; HOURCADE D, 1989, ADV IMMUNOL, V45, P381, DOI 10.1016/S0065-2776(08)60697-5; KAM CM, 1987, J BIOL CHEM, V262, P3444; Kimura A, 2009, IMMUNOBIOLOGY, V214, P165, DOI 10.1016/j.imbio.2009.01.003; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Mathern DR, 2015, CLIN J AM SOC NEPHRO, V10, P1636, DOI 10.2215/CJN.06230614; Matsumoto M, 1997, P NATL ACAD SCI USA, V94, P8720, DOI 10.1073/pnas.94.16.8720; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257; Milder FJ, 2007, NAT STRUCT MOL BIOL, V14, P224, DOI 10.1038/nsmb1210; Morikis D, 2005, STRUCTURAL BIOLOGY OF THE COMPLEMENT SYSTEM, P1; Nakao M, 2016, EVOLUTION OF THE IMMUNE SYSTEM: CONSERVATION AND DIVERSIFICATION, P151, DOI 10.1016/B978-0-12-801975-7.00006-2; Niu DH, 2018, FISH SHELLFISH IMMUN, V79, P11, DOI 10.1016/j.fsi.2018.04.062; Niu DH, 2015, GENE, V555, P297, DOI 10.1016/j.gene.2014.11.020; Niu DH, 2013, FISH SHELLFISH IMMUN, V35, P581, DOI 10.1016/j.fsi.2013.06.001; Nonaka M, 2004, IMMUNOL REV, V198, P203, DOI 10.1111/j.0105-2896.2004.00118.x; NONAKA M, 1994, J IMMUNOL, V152, P2263; Nonaka M., 2014, EVOLUTION COMPLEMENT; Nonaka M, 2006, IMMUNOGENETICS, V58, P701, DOI 10.1007/s00251-006-0142-1; PANGBURN MK, 1986, BIOCHEM J, V235, P723, DOI 10.1042/bj2350723; Peng MX, 2017, DEV COMP IMMUNOL, V73, P184, DOI 10.1016/j.dci.2017.03.027; Peng MX, 2016, FISH SHELLFISH IMMUN, V55, P223, DOI 10.1016/j.fsi.2016.05.024; Pinto MR, 2007, ADV EXP MED BIOL, V598, P372; Prado-Alvarez M, 2009, FISH SHELLFISH IMMUN, V26, P305, DOI 10.1016/j.fsi.2008.11.015; Sarma JV, 2011, CELL TISSUE RES, V343, P227, DOI 10.1007/s00441-010-1034-0; Sekiguchi R, 2015, DEV COMP IMMUNOL, V50, P58, DOI 10.1016/j.dci.2014.12.008; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; SMITH CA, 1984, J EXP MED, V159, P324, DOI 10.1084/jem.159.1.324; Smith LC, 1998, J IMMUNOL, V161, P6784; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Terado T, 2003, J IMMUNOL, V171, P2461, DOI 10.4049/jimmunol.171.5.2461; UEDA A, 1987, J IMMUNOL, V138, P1143; Volanakis JE, 1996, PROTEIN SCI, V5, P553; Wei Z, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08681-5; Wei Z, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06812-y; Xie ShuMei, 2015, Journal of Fisheries of China, V39, P799; Xu YY, 2001, P NATL ACAD SCI USA, V98, P14577, DOI 10.1073/pnas.261428398; Yee A, 2014, SEMIN THROMB HEMOST, V40, P17, DOI 10.1055/s-0033-1363155; Yoshizaki FY, 2005, IMMUNOGENETICS, V56, P930, DOI 10.1007/s00251-004-0752-4; Zhong L, 2012, FISH SHELLFISH IMMUN, V33, P504, DOI 10.1016/j.fsi.2012.06.001; Zhu Y, 2005, EMBO J, V24, P382, DOI 10.1038/sj.emboj.7600533	48	4	4	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13323	13333		10.1096/fj.201901142RR	http://dx.doi.org/10.1096/fj.201901142RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31550175	Bronze			2022-12-28	WOS:000507466100023
J	Tiek, DM; Khatib, SA; Trepicchio, CJ; Heckler, MM; Divekar, SD; Sarkaria, JN; Glasgow, E; Riggins, RB				Tiek, Deanna M.; Khatib, Subreen A.; Trepicchio, Colin J.; Heckler, Mary M.; Divekar, Shailaja D.; Sarkaria, Jann N.; Glasgow, Eric; Riggins, Rebecca B.			Estrogen-related receptor beta activation and isoform shifting by cdc2-like kinase inhibition restricts migration and intracranial tumor growth in glioblastoma	FASEB JOURNAL			English	Article						GBM; ERR-beta; alternative splicing; cortactin; CLK	BLOOD-BRAIN-BARRIER; THERAPEUTIC TARGET; PROSTATE-CANCER; ERR-BETA; IDENTIFICATION; EXPRESSION; GENE; CORTACTIN; GAMMA; PROLIFERATION	Glioblastoma (GBM; grade 4 glioma) is a highly aggressive and incurable tumor. GBM has recently been characterized as highly dependent on alternative splicing, a critical driver of tumor heterogeneity and plasticity. Estrogen-related receptor beta (ERR-beta) is an orphan nuclear receptor expressed in the brain, where alternative splicing of the 3' end of the pre-mRNA leads to the production of 3 validated ERR-beta protein products: ERR-beta short form (ERR-(beta sf), ERR-beta 2, and ERR-beta exon 10 deleted. Our prior studies have shown the ERR-beta isoform to play a role in G(2)/M cell cycle arrest and induction of apoptosis, in contrast to the function of the shorter ERR-beta 2 isoform in senescence and G1 cell cycle arrest. In this study, we sought to better define the role of the proapoptotic ERR-beta 2 isoform in GBM. We show that the ERR-beta 2 isoform is located not only in the nucleus but also in the cytoplasm. ERR-beta 2 suppresses GBM cell migration and interacts with the actin nucleation-promoting factor cortactin, and an ERR-beta agonist is able to remodel the actin cytoskeleton and similarly suppress GBM cell migration. We further show that inhibition of the splicing regulatory cdc2-like kinases in combination with an ERR-beta agonist shifts isoform expression in favor of ERR-beta 2 and potentiates inhibition of growth and migration in GBM cells and intracranial tumors.	[Tiek, Deanna M.; Khatib, Subreen A.; Trepicchio, Colin J.; Heckler, Mary M.; Divekar, Shailaja D.; Glasgow, Eric; Riggins, Rebecca B.] Georgetown Univ, Med Ctr, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Khatib, Subreen A.] NCI, Human Carcinogenesis Lab, Bldg 37, Bethesda, MD 20892 USA; [Sarkaria, Jann N.] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA	Georgetown University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic	Tiek, DM; Riggins, RB (corresponding author), Georgetown Univ, Sch Med, E412 Res Bldg,3970 Reservoir Rd NW, Washington, DC 20057 USA.	dmt53@georgetown.edu; rbr7@georgetown.edu	Riggins, Rebecca/GQH-4466-2022	Glasgow, Eric/0000-0001-7729-3954	U.S. National Institutes of Health/National Cancer Institute Grant (NIH/NCI) [R21 CA191444]; Georgetown University Medical Center (GUMC) Dean for Research's Toulmin Pilot Project Award; Partners in Research Breakthrough Award; NIH/NCI [F99 CA234799]; Medical Center Graduate Student Organization (MCGSO); Tumor Biology Training Grant [T32 CA009686]; NIH/NCI Cancer Center Support Grant [P30 CA051008];  [P50 CA108961]; NATIONAL CANCER INSTITUTE [T32CA009686, P30CA051008] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Cancer Institute Grant (NIH/NCI); Georgetown University Medical Center (GUMC) Dean for Research's Toulmin Pilot Project Award; Partners in Research Breakthrough Award; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Center Graduate Student Organization (MCGSO); Tumor Biology Training Grant; NIH/NCI Cancer Center Support Grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank members of the R.B.R. laboratory, as well as Drs. Maria Laura Avantaggiati, Deborah Berry, Karen Creswell, Brent Harris, Peter Johnson, Supti Sen, Alexandra Taraboletti, Jeffrey Toretsky, Todd Waldman, and Dan Xun (Lombardi Comprehensive Cancer Center, Georgetown University) for sharing reagents, scientific insights, technical assistance, and/or editorial comments on the manuscript. This work was supported by U.S. National Institutes of Health/National Cancer Institute Grant (NIH/NCI) R21 CA191444 (to R.B.R.), a Georgetown University Medical Center (GUMC) Dean for Research's Toulmin Pilot Project Award (to R.B.R.), and a Partners in Research Breakthrough Award (to R.B.R.), as well as NIH/NCI Grant F99 CA234799 (to D.M.T.) and a student research grant from the Medical Center Graduate Student Organization (MCGSO; to D.M.T.). Additional fellowship funding for D.M.T. and M.M.H. was provided by the Tumor Biology Training Grant [T32 CA009686, principal investigator (PI): Dr. Anna T. Riegel]. Technical services were provided by the GUMC Animal Models, Flow Cytometry and Cell Sorting, Histopathology and Tissue, Microscopy and Imaging, and Tissue Culture Shared Resources, which are supported, in part, by NIH/NCI Cancer Center Support Grant P30 CA051008 (PI: Dr. Louis M. Weiner). The Mayo Clinic Brain Tumor Patient-Derived Xenograft National Resource is supported, in part, by P50 CA108961 (to J.N.S., PI: Dr. Patrick O'Neill). The content of this article is the sole responsibility of the authors and does not represent the official views of the NIH. The authors declare no conflicts of interest.	[Anonymous], 2004, IMAGEJ COMPUTER PROG; Barriuso J, 2015, CLIN CANCER RES, V21, P969, DOI 10.1158/1078-0432.CCR-14-2921; Bidinosti M, 2016, SCIENCE, V351, P1199, DOI 10.1126/science.aad5487; Braun CJ, 2017, CANCER CELL, V32, P411, DOI 10.1016/j.ccell.2017.08.018; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Byerly Mardi S., 2013, BMC Physiology, V13, P10, DOI 10.1186/1472-6793-13-10; Byerly MS, 2013, EUR J NEUROSCI, V37, P1033, DOI 10.1111/ejn.12122; Carlson Brett L, 2011, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1416s52; Corkery DP, 2015, NUCLEUS-PHILA, V6, P279, DOI 10.1080/19491034.2015.1062194; Coutadeur S, 2015, J NEUROCHEM, V133, P440, DOI 10.1111/jnc.13018; Craft B., 2019, BRILL REF LIBR JUD, DOI DOI 10.1163/9789004367135_002d; Das M, 2019, NUCLEIC ACID THER, V29, P61, DOI 10.1089/nat.2018.0762; Ernst A, 2009, CLIN CANCER RES, V15, P6541, DOI 10.1158/1078-0432.CCR-09-0695; Ferrarese R, 2014, J CLIN INVEST, V124, P2861, DOI 10.1172/JCI68836; Fujimura A, 2013, NEOPLASIA, V15, P1272, DOI 10.1593/neo.131440; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Golan-Gerstl R, 2011, CANCER RES, V71, P4464, DOI 10.1158/0008-5472.CAN-10-4410; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Heckler MM, 2016, ONCOTARGET, V7, P47201, DOI 10.18632/oncotarget.9719; Heckler MM, 2015, CELL CYCLE, V14, P31, DOI 10.4161/15384101.2014.972886; Jensen MA, 2014, NAT STRUCT MOL BIOL, V21, P189, DOI 10.1038/nsmb.2756; Jeong JY, 2008, BRAIN RES BULL, V75, P619, DOI 10.1016/j.brainresbull.2007.10.043; Kirkbride KC, 2011, CELL ADHES MIGR, V5, P187, DOI 10.4161/cam.5.2.14773; Lee JA, 2016, NEURON, V89, P113, DOI 10.1016/j.neuron.2015.11.025; Lim KRQ, 2018, METHODS MOL BIOL, V1828, P3, DOI 10.1007/978-1-4939-8651-4_1; Lindsay SJ, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00086; MacGrath SM, 2012, J CELL SCI, V125, P1621, DOI 10.1242/jcs.093781; Marcel V, 2014, CELL DEATH DIFFER, V21, P1377, DOI 10.1038/cdd.2014.73; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Murnyak B, 2017, ONCOTARGET, V8, P46348, DOI 10.18632/oncotarget.18013; O'Brown NM, 2018, GENE DEV, V32, P466, DOI 10.1101/gad.309823.117; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Papatheodorou I, 2018, NUCLEIC ACIDS RES, V46, pD246, DOI 10.1093/nar/gkx1158; Park SY, 2016, ONCOTARGET, V7, P26793, DOI 10.18632/oncotarget.8471; Parrish KE, 2015, CLIN PHARMACOL THER, V97, P336, DOI 10.1002/cpt.71; Patel SR, 2015, MOL CELL ENDOCRINOL, V418, P298, DOI 10.1016/j.mce.2015.07.009; Paz I, 2014, NUCLEIC ACIDS RES, V42, pW361, DOI 10.1093/nar/gku406; Perazzoli G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140131; Prados MD, 2015, NEURO-ONCOLOGY, V17, P1051, DOI 10.1093/neuonc/nov031; Puchalski RB, 2018, SCIENCE, V360, P660, DOI 10.1126/science.aaf2666; Rahman MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep13208; Robins HI, 2006, NEURO-ONCOLOGY, V8, P47, DOI 10.1215/S1522851705000311; Sakuma M, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0044-6; Seiler M, 2018, NAT MED, V24, P497, DOI 10.1038/nm.4493; Shepard PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-242; Sparks AB, 1996, P NATL ACAD SCI USA, V93, P1540, DOI 10.1073/pnas.93.4.1540; Tiek DM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25588-1; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Wang Y, 2012, ACS CHEM BIOL, V7, P1040, DOI 10.1021/cb300028a; Welker AM, 2017, NEUROSCIENCE, V356, P35, DOI 10.1016/j.neuroscience.2017.05.010; Welker AM, 2016, DIS MODEL MECH, V9, P199, DOI 10.1242/dmm.022921; Yu DD, 2005, BIOORG MED CHEM LETT, V15, P1311, DOI 10.1016/j.bmcl.2005.01.025; Yu S, 2008, ONCOGENE, V27, P3313, DOI 10.1038/sj.onc.1210986; Yu SA, 2007, CANCER RES, V67, P4904, DOI 10.1158/0008-5472.CAN-06-3855; Zhou W, 2006, J CLIN ENDOCR METAB, V91, P569, DOI 10.1210/jc.2004-1957; Zuercher WJ, 2005, J MED CHEM, V48, P3107, DOI 10.1021/jm050161j	56	9	9	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13476	13491		10.1096/fj.201901075R	http://dx.doi.org/10.1096/fj.201901075R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31570001	Green Published, Green Submitted			2022-12-28	WOS:000507466100035
J	Colas, RA; Nhat, LTH; Thuong, NTT; Gomez, EA; Ly, L; Thanh, HH; Mai, NTH; Phu, NH; Thwaites, GE; Dalli, J				Colas, Romain A.; Le Thanh Hoang Nhat; Nguyen Thuy Thuong Thuong; Gomez, Esteban A.; Ly, Lucy; Hai Hoang Thanh; Nguyen Thi Hoang Mai; Nguyen Hoan Phu; Thwaites, Guy E.; Dalli, Jesmond			Proresolving mediator profiles in cerebrospinal fluid are linked with disease severity and outcome in adults with tuberculous meningitis	FASEB JOURNAL			English	Article						resolution; essential fatty acids; eicosanoids; aspirin; tuberculosis	ASPIRIN; CELL; INFLAMMATION; RESOLUTION; RESOLVINS; INCREASE; RECEPTOR	Tuberculous meningitis (TBM) is the most lethal form of tuberculosis infection, characterized by a dysregulated immune response that frequently leads to neurologic injury and death despite the best available treatment. The mechanisms driving the inflammatory response in TBM are not well understood. To gain insights into these mechanisms, we used a lipid mediator-profiling approach to investigate the regulation of a novel group of host protective mediators, termed specialized proresolving mediators (SPMs), in the cerebrospinal fluid (CSF) of adults with TBM. Herein, using CSF from patients enrolled into a randomized placebo-controlled trial of adjunctive aspirin treatment, we found distinct lipid mediator profiles with increasing disease severity. These changes were linked with an up-regulation of inflammatory eicosanoids in patients with severe TBM and a decrease in the production of a number of SPMs. CSF proresolving mediator concentrations were also associated with 80-d survival. In survivors, we found a significant increase in proresolving mediator concentrations, including the lipoxygenase 5-derived 13-series resolvin (RvT)2, RvT4, and 15-epi-lipoxin B-4, compared with those who died. Of note, treatment of patients with high-dose aspirin led to a decrease in the concentrations of the prothrombic mediator thromboxane A(2), reduced brain infarcts, and decreased death in patients with TBM. Together, these findings identify a CSF SPM signature that is associated with disease severity and 80-d mortality in TBM.	[Colas, Romain A.; Gomez, Esteban A.; Ly, Lucy; Dalli, Jesmond] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Dalli, Jesmond] Queen Mary Univ London, Ctr Inflammat & Therapeut Innovat, London, England; [Le Thanh Hoang Nhat; Nguyen Thuy Thuong Thuong; Hai Hoang Thanh; Nguyen Thi Hoang Mai; Nguyen Hoan Phu; Thwaites, Guy E.] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [Thwaites, Guy E.] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of Oxford; University of Oxford	Dalli, J (corresponding author), Queen Mary Univ London, John Vane Sci Ctr, William Harvey Res Inst, Barts & London Sch Med & Dent, Charterhouse Sq, London EC1M 6BQ, England.	j.dalli@qmul.ac.uk	Thi, Nguyen/AAM-7074-2020	Dalli, Jesmond/0000-0001-6328-3640; Thwaites, Guy/0000-0002-2858-2087	European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Programme [677542]; Barts Charity [MGU0343]; Sir Henry Dale Fellowship - Wellcome Trust [107613/Z/15/Z]; Sir Henry Dale Fellowship - Royal Society [107613/Z/15/Z]; Wellcome Trust Investigator award [110179/Z/15/Z]; Wellcome Trust Core Award [106680/Z/14/Z]	European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Programme(European Research Council (ERC)); Barts Charity; Sir Henry Dale Fellowship - Wellcome Trust(Wellcome Trust); Sir Henry Dale Fellowship - Royal Society; Wellcome Trust Investigator award(Wellcome Trust); Wellcome Trust Core Award(Wellcome Trust)	The authors thank all the patients who took part in this study, and the ward nurses and doctors who cared for them during the trial. The authors also thank Prof. Lalita Ramakrishnan (University of Cambridge, Cambridge, United Kingdom) and Prof. Paul Edelstein (University of Pennsylvania, Philadelphia, PA, USA) for insightful comments and critical review of the manuscript. J.D. received funding from the European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Programme (Grant 677542) and the Barts Charity (Grant MGU0343). J.D. was also supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant 107613/Z/15/Z). G. E. T. was supported by a Wellcome Trust Investigator award (Grant 110179/Z/15/Z), and G.E.T., N.T.T.T., T.H.P., and N.T.H.M. were supported by a Wellcome Trust Core Award to the Vietnam Asia Programme (Grant 106680/Z/14/Z). R.A.C. and L.T.H.N. are first authors. G.E.T. and J.D. are senior authors. The authors declare no conflicts of interest.	Atar S, 2006, AM J PHYSIOL-HEART C, V290, pH1960, DOI 10.1152/ajpheart.01137.2005; Bankova LG, 2016, P NATL ACAD SCI USA, V113, P6242, DOI 10.1073/pnas.1605957113; Chiang N, 2006, ARTERIOSCL THROM VAS, V26, pE14, DOI 10.1161/01.ATV.0000196729.98651.bf; Chiang N, 2015, J EXP MED, V212, P1203, DOI 10.1084/jem.20150225; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; CLARIA J, 1995, P NATL ACAD SCI USA, V92, P9475, DOI 10.1073/pnas.92.21.9475; Colas RA, 2018, CIRC RES, V122, P855, DOI 10.1161/CIRCRESAHA.117.312472; Dalli J, 2018, CURR OPIN IMMUNOL, V50, P48, DOI 10.1016/j.coi.2017.10.007; Dalli J, 2018, METHODS MOL BIOL, V1730, P59, DOI 10.1007/978-1-4939-7592-1_4; Dalli J, 2015, NAT MED, V21, P1071, DOI 10.1038/nm.3911; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; El Kebir D, 2012, P NATL ACAD SCI USA, V109, P14983, DOI 10.1073/pnas.1206641109; Fredman G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12859; Fredman G, 2014, P NATL ACAD SCI USA, V111, P14530, DOI 10.1073/pnas.1410851111; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gao Y, 2015, J IMMUNOL, V195, P3086, DOI 10.4049/jimmunol.1500610; HAMBERG M, 1975, P NATL ACAD SCI USA, V72, P2994, DOI 10.1073/pnas.72.8.2994; Heemskerk AD, 2016, NEW ENGL J MED, V374, P124, DOI 10.1056/NEJMoa1507062; Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041; Maderna P, 2009, BRIT J PHARMACOL, V158, P947, DOI 10.1111/j.1476-5381.2009.00386.x; Mai NTH, 2018, ELIFE, V7, DOI [10.7554/elife.33478, 10.7554/eLife.33478]; MARSHALL G, 1948, LANCET, V254, P582; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; Pistorius K, 2018, CELL CHEM BIOL, V25, P749, DOI 10.1016/j.chembiol.2018.04.017; Prasad K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002244.pub4; R Development Core Team, 2016, R LANG ENV STAT COMP; Radmark O, 2015, BBA-MOL CELL BIOL L, V1851, P331, DOI 10.1016/j.bbalip.2014.08.012; Ruslami R, 2013, LANCET INFECT DIS, V13, P27, DOI 10.1016/S1473-3099(12)70264-5; Samuelsson B, 2012, J BIOL CHEM, V287, P10070, DOI 10.1074/jbc.X112.351437; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Subirana I, 2014, J STAT SOFTW, V57; Thuong NTT, 2017, J INFECT DIS, V215, P1020, DOI 10.1093/infdis/jix050; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; VANE JR, 1990, STROKE, V21, P12; Werz O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02538-5; Wilkinson RJ, 2017, NAT REV NEUROL, V13, P581, DOI 10.1038/nrneurol.2017.120	37	25	25	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					13028	13039		10.1096/fj.201901590R	http://dx.doi.org/10.1096/fj.201901590R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31500466	hybrid, Green Published			2022-12-28	WOS:000507461600109
J	Koutsogiannaki, S; Hou, LF; Babazada, H; Okuno, T; Blazon-Brown, N; Soriano, SG; Yokomizo, T; Yuki, K				Koutsogiannaki, Sophia; Hou, Lifei; Babazada, Hasan; Okuno, Toshiaki; Blazon-Brown, Nathan; Soriano, Sulpicio G.; Yokomizo, Takehiko; Yuki, Koichi			The volatile anesthetic sevoflurane reduces neutrophil apoptosis via Fas death domain-Fas-associated death domain interaction	FASEB JOURNAL			English	Article						Sepsis; splenic apoptosis; anesthesia	SURGICAL SITE INFECTIONS; IMPROVES SURVIVAL; INNATE IMMUNE; LIPOXIN A(4); CELL-DEATH; SEPSIS; INFLAMMATION; ISOFLURANE; NEURODEGENERATION; INHIBITION	Sepsis remains a significant health care burden, with high morbidities and mortalities. Patients with sepsis often require general anesthesia for procedures and imaging studies. Knowing that anesthetic drugs can pose immunomodulatory effects, it would be critical to understand the impact of anesthetics on sepsis pathophysiology. The volatile anesthetic sevoflurane is a common general anesthetic derived from ether as a prototype. Using a murine sepsis model induced by cecal ligation and puncture surgery, we examined the impact of sevoflurane on sepsis outcome. Different from volatile anesthetic isoflurane, sevoflurane exposure significantly improved the outcome of septic mice. This was associated with less apoptosis in the spleen. Because splenic apoptosis was largely attributed to the apoptosis of neutrophils, we examined the effect of sevoflurane on FasL-induced neutrophil apoptosis. Sevoflurane exposure significantly attenuated apoptosis. Sevoflurane did not affect the binding of FasL to the extracellular domain of Fas receptor. Instead, in silico analysis suggested that sevoflurane would bind to the interphase between Fas death domain (DD) and Fas-associated DD (FADD). The effect of sevoflurane on Fas DD-FADD interaction was examined using fluorescence resonance energy transfer (FRET). Sevoflurane attenuated FRET efficiency, indicating that sevoflurane hindered the interaction between Fas DD and FADD. The predicted sevoflurane binding site is known to play a significant role in Fas DD-FADD interaction, supporting our in vitro and in vivo apoptosis results.	[Koutsogiannaki, Sophia; Hou, Lifei; Blazon-Brown, Nathan; Soriano, Sulpicio G.; Yuki, Koichi] Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Cardiac Anesthesia Div, Boston, MA USA; [Koutsogiannaki, Sophia; Hou, Lifei; Soriano, Sulpicio G.; Yuki, Koichi] Harvard Med Sch, Dept Anaesthesia, Boston, MA 02115 USA; [Babazada, Hasan] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [Okuno, Toshiaki; Yokomizo, Takehiko] Juntendo Univ, Fac Med, Dept Biochem, Tokyo, Japan	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Pennsylvania; Juntendo University	Yuki, K (corresponding author), Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, 300 Longwood Ave, Boston, MA 02115 USA.	koichi.yuki@childrens.harvard.edu	Soriano, Sulpicio/K-3501-2019	Koutsogiannaki, Sophia/0000-0003-3555-1681; Babazada, Hasan/0000-0001-8705-2396	Children's Hospital Medical Center (CHMC) Anesthesia Foundation; U.S. National Institutes of Health, National Institute of General Medical Sciences [R01GM118277]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118277] Funding Source: NIH RePORTER	Children's Hospital Medical Center (CHMC) Anesthesia Foundation; U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by Children's Hospital Medical Center (CHMC) Anesthesia Foundation (to K.Y.), and U.S. National Institutes of Health, National Institute of General Medical Sciences Grant R01GM118277 (to K.Y.). The authors declare no conflicts of interest.	Abdulnour REE, 2014, P NATL ACAD SCI USA, V111, P16526, DOI 10.1073/pnas.1407123111; Ayala A, 1998, J SURG RES, V76, P165, DOI 10.1006/jsre.1998.5314; Benjamim CF, 2005, J IMMUNOL, V174, P1616, DOI 10.4049/jimmunol.174.3.1616; Butts Cherie L, 2007, Nucl Recept Signal, V5, pe007; Carbo C, 2013, J ANESTH, V27, P261, DOI 10.1007/s00540-012-1508-1; Chamberlain M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170089; Chang CC, 2010, ANESTHESIOLOGY, V113, P279, DOI 10.1097/ALN.0b013e3181e2c1c3; Choi HJ, 2016, J HOSP INFECT, V93, P339, DOI 10.1016/j.jhin.2015.12.021; Chung CS, 2003, J LEUKOCYTE BIOL, V74, P344, DOI 10.1189/jlb.0102006; Chung CS, 2001, SURGERY, V130, P339, DOI 10.1067/msy.2001.116540; Croker BA, 2011, P NATL ACAD SCI USA, V108, P13135, DOI 10.1073/pnas.1110358108; Dahan A, 2001, ANESTHESIOLOGY, V94, P824, DOI 10.1097/00000542-200105000-00021; Ebert TJ, 1998, ANESTHESIOLOGY, V89, P1524, DOI 10.1097/00000542-199812000-00032; El Kebir D, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00060; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Herrmann IK, 2013, ANESTHESIOLOGY, V119, P901, DOI 10.1097/ALN.0b013e3182a2a38c; Hill JM, 2004, J BIOL CHEM, V279, P1474, DOI 10.1074/jbc.M304996200; Hiller JG, 2018, NAT REV CLIN ONCOL, V15, P205, DOI 10.1038/nrclinonc.2017.194; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Hotchkiss RS, 1999, J IMMUNOL, V162, P4148; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hymowitz SG, 2010, NAT STRUCT MOL BIOL, V17, P1289, DOI 10.1038/nsmb1110-1289; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; Janeway CA, 2001, P NATL ACAD SCI USA, V98, P7461, DOI 10.1073/pnas.131202998; Jenkins A, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0002.2001; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Jun IJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14147-9; Jung S, 2016, J IMMUNOTOXICOL, V13, P148, DOI 10.3109/1547691X.2015.1019596; KHARASCH ED, 1995, ANESTHESIOLOGY, V82, P1369, DOI 10.1097/00000542-199506000-00008; Koutsogiannaki S, 2019, J SURG RES, V233, P323, DOI 10.1016/j.jss.2018.07.075; Koutsogiannaki S, 2017, TOXICOL SCI, V156, P402, DOI 10.1093/toxsci/kfw261; Krammer P H, 1999, Adv Immunol, V71, P163; Li RD, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9203716; Liu JR, 2014, SHOCK, V42, P532, DOI 10.1097/SHK.0000000000000250; Loop T, 2005, ANESTHESIOLOGY, V102, P1147, DOI 10.1097/00000542-200506000-00014; Matsuoka H, 2001, ANESTHESIOLOGY, V95, P1467, DOI 10.1097/00000542-200112000-00028; McCann ME, 2019, LANCET, V393, P664, DOI 10.1016/S0140-6736(18)32485-1; Mukherjee V, 2017, CURR OPIN CRIT CARE, V23, P412, DOI 10.1097/MCC.0000000000000438; Navarini AA, 2009, P NATL ACAD SCI USA, V106, P7107, DOI 10.1073/pnas.0901162106; Oberholzer C, 2001, P NATL ACAD SCI USA, V98, P11503, DOI 10.1073/pnas.181338198; Okuno T, 2017, FASEB J, V31, P1584, DOI 10.1096/fj.201601095R; Schneider P, 1997, J BIOL CHEM, V272, P18827, DOI 10.1074/jbc.272.30.18827; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shen JL, 2017, SCI REP-UK, V7, DOI 10.1038/srep41067; Shu Y, 2012, NEUROBIOL DIS, V45, P743, DOI 10.1016/j.nbd.2011.10.021; Skeldal Sune, 2015, Int J Biochem Mol Biol, V6, P17; Sonego F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00155; Sonner JM, 1999, ANESTH ANALG, V89, P1030, DOI 10.1097/00000539-199910000-00039; Souza DG, 2007, J IMMUNOL, V179, P8533, DOI 10.4049/jimmunol.179.12.8533; SQUIER MKT, 1995, J LEUKOCYTE BIOL, V57, P2, DOI 10.1002/jlb.57.1.2; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Urner M, 2015, CLIN EXP IMMUNOL, V181, P468, DOI 10.1111/cei.12648; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Wesche DE, 2005, J LEUKOCYTE BIOL, V78, P325, DOI 10.1189/jlb.0105017; Wesche-Soldato DE, 2005, BLOOD, V106, P2295, DOI 10.1182/blood-2004-10-4086; Wesche-Soldato DE, 2007, AM J PATHOL, V171, P87, DOI 10.2353/ajpath.2007.061099; Wu B, 2015, PROSTAG LEUKOTR ESS, V94, P55, DOI 10.1016/j.plefa.2014.11.005; Wu ZF, 2018, ANESTHESIOLOGY, V129, P932, DOI 10.1097/ALN.0000000000002357; YAGUPSKY P, 1990, CLIN MICROBIOL REV, V3, P269, DOI 10.1128/CMR.3.3.269-279.1990; Yuki K, 2016, ANESTH ANALG, V123, P326, DOI 10.1213/ANE.0000000000001403; Yuki K, 2010, ANESTHESIOLOGY, V113, P600, DOI 10.1097/ALN.0b013e3181e89a77; Yuki K, 2008, FASEB J, V22, P4109, DOI 10.1096/fj.08-113324; Zha H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216163	66	15	16	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12668	12679		10.1096/fj.201901360R	http://dx.doi.org/10.1096/fj.201901360R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31513427	Green Published			2022-12-28	WOS:000507461600083
J	Majtan, T; Park, I; Cox, A; Branchford, BR; di Paola, J; Bublil, EM; Kraus, JP				Majtan, Tomas; Park, Insun; Cox, Allaura; Branchford, Brian R.; di Paola, Jorge; Bublil, Erez M.; Kraus, Jan P.			Behavior, body composition, and vascular phenotype of homocystinuric mice on methionine-restricted diet or enzyme replacement therapy	FASEB JOURNAL			English	Article						cystathionine beta-synthase; homocysteine; anxiety; endothelial dysfunction; thrombosis	CYSTATHIONINE BETA-SYNTHASE; MOUSE MODELS; DEFICIENCY; OSTEOPOROSIS; MASS	Classic homocystinuria (HCU) is an inherited disorder characterized by elevated homocysteine (Hcy) in plasma and tissues resulting from cystathionine beta-synthase (CBS) deficiency. There is no cure, and patients are predominantly managed by methionine-restricted diet (MRD) to limit the production of Hcy. In this study, we used the I278T mouse model of HCU to evaluate the long-term impact of a novel enzyme replacement therapy [truncated human CBS C155 mutant modified with linear 20-kDa N-hydroxysuccinimide ester polyethylene glycol OT-58)] on clinical end points relevant to human patients with HCU. In addition, we compared its efficacy on a background of either MRD or normal methionine intake [regular diet (REG)] to that of MRD alone. We found that, compared with untreated I278T mice, OT-58 treatment of I278T mice fed with the REG diet resulted in a 90% decrease in plasma Hcy concentrations and correction of learning/cognition, endothelial dysfunction, hemostasis, bone mineralization, and body composition. On background of the MRD, OT-58 performed equally well with plasma Hcy entirely normalized. The MRD alone decreased plasma Hcy by 67% and corrected the HCU phenotype in I278T mice. However, the MRD increased anxiety and reduced bone mineral content in both I278T mice and wild-type controls. This study shows that OT-58 is a highly efficacious novel treatment for HCU on the background of either normal or restricted methionine intake.	[Majtan, Tomas; Park, Insun; Kraus, Jan P.] Univ Colorado, Sect Genet, Aurora, CO USA; [Cox, Allaura; Branchford, Brian R.; di Paola, Jorge] Univ Colorado, Sch Med, Dept Pediat, Sect Hematol Oncol, Aurora, CO USA; [Cox, Allaura; Branchford, Brian R.; di Paola, Jorge] Univ Colorado, Hemophilia & Thrombosis Ctr, Aurora, CO USA; [Bublil, Erez M.] Orphan Technol Ltd, Rapperswil, Switzerland	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Majtan, T (corresponding author), Univ Colorado, Sch Med, 12800 E 19th Ave,Mail Stop 8313, Aurora, CO 80045 USA.	tomas.majtan@ucdenver.edu	Majtan, Tomas/AAE-8426-2021	Majtan, Tomas/0000-0002-2751-2124	American Heart Association Scientist Development Grant [16SDG30040000]; Orphan Technologies, Ltd., a private pharmaceutical company developing an enzyme replacement therapy for cystathionine b-synthase (CBS)-deficient homocystinuria; U.S. National Institutes of Health, Office of the Director [1S10OD018156-01]	American Heart Association Scientist Development Grant(American Heart Association); Orphan Technologies, Ltd., a private pharmaceutical company developing an enzyme replacement therapy for cystathionine b-synthase (CBS)-deficient homocystinuria; U.S. National Institutes of Health, Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Teodoro Bottiglieri (Institute of Metabolic Disease, Baylor Scott and White Research Institute, Dallas, TX, USA) for plasma metabolites measurements; Nicolas Busquet and Stacey Zander (University of Colorado) for help with behavioral assessment; Korey Haefner, Sara Wennersten, and Maria Cavasin (University of Colorado) for assistance with flow-mediated vasodilation (FMD) measurements; and Kimberley Bruce (University of Colorado Anschutz Medical Campus, Aurora, CO, USA) for access to the dual-energy X-ray absorptiometry (DXA) scanner. T.M. is a recipient of American Heart Association Scientist Development Grant 16SDG30040000. This study was supported by research grants from Orphan Technologies, Ltd., a private pharmaceutical company developing an enzyme replacement therapy for cystathionine b-synthase (CBS)-deficient homocystinuria (to J.P.K. and T.M.). Shared resources funded by Grant 1S10OD018156-01 from the U.S. National Institutes of Health, Office of the Director were used. The authors declare the following conflicts of interest: T.M., E.M. B., and J. P.K. are inventors on patents related to the processes and products referred here (U.S. patents 9034318 and 9243239). T.M. provides consulting services to Orphan Technologies, Ltd. E.M.B. is an employee of Orphan Technologies, Ltd.	ABBOTT MH, 1987, AM J MED GENET, V26, P959, DOI 10.1002/ajmg.1320260427; Anthony TG, 2013, CURR OPIN CLIN NUTR, V16, P96, DOI 10.1097/MCO.0b013e32835b618b; Arning E, 2016, METHODS MOL BIOL, V1378, P255, DOI 10.1007/978-1-4939-3182-8_27; Ben Abdallah NMB, 2011, EXP NEUROL, V227, P42, DOI 10.1016/j.expneurol.2010.09.008; Bublil EM, 2016, J CLIN INVEST, V126, P2372, DOI 10.1172/JCI85396; Dayal S, 2006, BLOOD, V108, P2237, DOI 10.1182/blood-2006-02-005991; Dayal S, 2012, BLOOD, V119, P3176, DOI 10.1182/blood-2011-09-380568; El Bashir H, 2015, JIMD REP, V21, P89, DOI 10.1007/8904_2014_394; FINKELSTEIN JD, 1990, J NUTR BIOCHEM, V1, P228, DOI 10.1016/0955-2863(90)90070-2; Gupta S, 2014, FASEB J, V28, P781, DOI 10.1096/fj.13-240770; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Kluijtmans LAJ, 1999, AM J HUM GENET, V65, P59, DOI 10.1086/302439; Kruger WD, 2016, ANN NY ACAD SCI, V1363, P80, DOI 10.1111/nyas.12967; Maclean KN, 2010, MOL GENET METAB, V101, P153, DOI 10.1016/j.ymgme.2010.06.010; Maclean KN, 2010, MOL GENET METAB, V101, P163, DOI 10.1016/j.ymgme.2010.06.007; Majtan T, 2018, LIFE SCI, V200, P15, DOI 10.1016/j.lfs.2018.03.018; Majtan T, 2018, MOL THER, V26, P834, DOI 10.1016/j.ymthe.2017.12.014; Majtan T, 2018, HUM MUTAT, V39, P210, DOI 10.1002/humu.23360; Majtan T, 2017, FASEB J, V31, P5495, DOI 10.1096/fj.201700565R; Majtan T, 2017, BIOMACROMOLECULES, V18, P1747, DOI 10.1021/acs.biomac.7b00154; Majtan T, 2016, CURR DRUG TARGETS, V17, P1455, DOI 10.2174/1389450117666160302094910; Marchi R, 2012, THROMB HAEMOSTASIS, V108, P516, DOI 10.1160/TH12-05-0355; Morris AAM, 2017, J INHERIT METAB DIS, V40, P49, DOI 10.1007/s10545-016-9979-0; Mudd S., 2001, METABOLIC MOL BASES, P2007; MUDD SH, 1970, J CLIN INVEST, V49, P1762, DOI 10.1172/JCI106394; Parrot F, 2000, J INHERIT METAB DIS, V23, P338, DOI 10.1023/A:1005618927729; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Schiff M, 2012, NEUROPEDIATRICS, V43, P295, DOI 10.1055/s-0032-1329883; Schuler D, 2014, ARTERIOSCL THROM VAS, V34, P2651, DOI 10.1161/ATVBAHA.114.304699; Walter JH, 1998, EUR J PEDIATR, V157, pS71, DOI 10.1007/PL00014308; Wang LQ, 2005, HUM MOL GENET, V14, P2201, DOI 10.1093/hmg/ddi224; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585	32	12	13	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12477	12486		10.1096/fj.201901203R	http://dx.doi.org/10.1096/fj.201901203R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31450979	Green Published			2022-12-28	WOS:000507461600068
J	Schloer, S; Hubel, N; Masemann, D; Pajonczyk, D; Brunotte, L; Ehrhardt, C; Brandenburg, LO; Ludwig, S; Gerke, V; Rescher, U				Schloer, Sebastian; Huebel, Nicole; Masemann, Doerthe; Pajonczyk, Denise; Brunotte, Linda; Ehrhardt, Christina; Brandenburg, Lars-Ove; Ludwig, Stephan; Gerke, Volker; Rescher, Ursula			The annexin A1/FPR2 signaling axis expands alveolar macrophages, limits viral replication, and attenuates pathogenesis in the murine influenza A virus infection model	FASEB JOURNAL			English	Article						pattern recognition receptors; innate immune system; mucosal immunity	FORMYL PEPTIDE RECEPTOR; COLONY-STIMULATING FACTORS; GM-CSF; DENDRITIC CELLS; INNATE IMMUNITY; DEFICIENT MICE; LUNG INJURY; TISSUE; ACTIVATION; MONOCYTES	Pattern recognition receptors (PRRs) are key elements in the innate immune response. Formyl peptide receptor (FPR) 2 is a PRR that, in addition to proinflammatory, pathogen-derived compounds, also recognizes the anti-inflammatory endogenous ligand annexin A1 (ArixA1). Because the contribution of this signaling axis in viral infections is undefined, we investigated AnxA1-mediated FPR2 activation on influenza A virus (IAV) infection in the murine model. AnxA1-treated mice displayed significantly attenuated pathology upon a subsequent IAV infection with significantly improved survival, impaired viral replication in the respiratory tract, and less severe lung damage. The AnxA1-mediated protection against IAV infection was not caused by priming of the type I LEN response but was associated with an increase in the number of alveolar macrophages (AMs) and enhanced pulmonary expression of the AM-regulating cytokine granulocyte-M-CSF (GM-CSF). Both AnxA1-mediated increase in AM levels and GM-CSF production were abrogated when mouse (m)FPR2 signaling was antagonized but remained up-regulated in mice genetically deleted for mFPR1, an mFPR2 isoform also serving as AnxA1 receptor. Our results indicate a novel protective function of the AnxA1-FPR2 signaling axis in IAV pathology via GM-CSF-associated maintenance of AMs, expanding knowledge on the potential use of proresolving mediators in host defense against pathogens.	[Schloer, Sebastian; Huebel, Nicole; Pajonczyk, Denise; Gerke, Volker; Rescher, Ursula] Univ Munster, Inst Virol, Inst Med Biochem, Ctr Mol Biol Inflammat, Munster, Germany; [Schloer, Sebastian; Huebel, Nicole; Masemann, Doerthe; Pajonczyk, Denise; Brunotte, Linda; Ehrhardt, Christina; Ludwig, Stephan; Gerke, Volker; Rescher, Ursula] Univ Munster, Cells In Mot Cluster Excellence, Munster, Germany; [Masemann, Doerthe; Brunotte, Linda; Ehrhardt, Christina; Ludwig, Stephan] Univ Munster, Ctr Mol Biol Inflammat, Munster, Germany; [Ehrhardt, Christina] Jena Univ Hosp, Inst Med Microbiol, Sect Expt Virol, Jena, Germany; [Brandenburg, Lars-Ove] Rhein Westfal TH Aachen, Dept Anat & Cell Biol, Aachen, Germany; [Brandenburg, Lars-Ove] Rostock Univ, Med Ctr, Inst Anat, Rostock, Germany	University of Munster; University of Munster; University of Munster; Friedrich Schiller University of Jena; RWTH Aachen University; University of Rostock	Rescher, U (corresponding author), Univ Munster, Inst Med Biochem, Ctr Mol Biol Inflammat, Von Esmarch Str 56, D-48149 Munster, Germany.	rescher@uni-muenster.de	Schloer, Sebastian/AAQ-4008-2021	Ludwig, Stephan/0000-0003-4490-3052	German Research Foundation (DFG) [SFB1009/A06, SFB1009/B02, Lu477/23-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	The authors are grateful to Andreas Wilbers (Institute of Medical Biochemistry, University of Muenster) for technical assistance. This work was supported by funding from the German Research Foundation (DFG; SFB1009/A06 and B02, Lu477/23-1 to C.E., S.L., V.G., and U.R.). C.E., S.L., V.G., and U.R. are members of the Pathogen Host Interplay (PHI) Club of the Muenster Alliance for Infection Research. The authors declare no conflicts of interest.	Alessi MC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01719; Allard B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01777; Areschoug Thomas, 2008, V15, P45, DOI 10.1159/000135685; Bae YS, 2004, J IMMUNOL, V173, P607, DOI 10.4049/jimmunol.173.1.607; Berclaz PY, 2002, J IMMUNOL, V169, P6332, DOI 10.4049/jimmunol.169.11.6332; Cardani A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006140; Chen KQ, 2018, J BIOL CHEM, V293, P13452, DOI 10.1074/jbc.RA118.002683; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Cline TD, 2017, J GEN VIROL, V98, P2401, DOI 10.1099/jgv.0.000922; Courtin N, 2017, ANTIVIR RES, V143, P252, DOI 10.1016/j.antiviral.2017.05.001; CRANDALL BF, 1986, PRENATAL DIAG, V6, P237, DOI 10.1002/pd.1970060402; D'Amico M, 2000, FASEB J, V14, P1867; Dalli J, 2015, NAT MED, V21, P1071, DOI 10.1038/nm.3911; Damazo AS, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-59; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Duvigneau S, 2016, SCI REP-UK, V6, DOI 10.1038/srep37045; Ernst S, 2004, CELL MOL LIFE SCI, V61, P1684, DOI 10.1007/s00018-004-4116-x; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gavins FNE, 2007, FASEB J, V21, P1751, DOI 10.1096/fj.06-7842com; Gavins FNE, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00354; Ghoneim HE, 2013, J IMMUNOL, V191, P1250, DOI 10.4049/jimmunol.1300014; Goebeler V, 2006, FEBS LETT, V580, P2430, DOI 10.1016/j.febslet.2006.03.076; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Halstead ES, 2018, RESP RES, V19, DOI 10.1186/s12931-017-0708-5; Halstead ES, 2015, EXPERT REV ANTI-INFE, V13, P1425, DOI 10.1586/14787210.2015.1094375; Halstead E, 2015, J IMMUNOL, V194; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hamilton JA, 2013, TRENDS IMMUNOL, V34, P81, DOI 10.1016/j.it.2012.08.006; Happle C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009750; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; He HQ, 2017, MOLECULES, V22, DOI 10.3390/molecules22030455; He HQ, 2014, J BIOL CHEM, V289, P2295, DOI 10.1074/jbc.M113.509216; He HQ, 2013, MOL PHARMACOL, V83, P389, DOI 10.1124/mol.112.081315; Heitzig N, 2018, BBA-MOL CELL BIOL L, V1863, P349, DOI 10.1016/j.bbalip.2018.01.001; Helft J, 2012, J CLIN INVEST, V122, P4037, DOI 10.1172/JCI60659; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Kaufmann SHE, 2018, NAT REV DRUG DISCOV, V17, P35, DOI 10.1038/nrd.2017.162; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; Kuiken T, 2008, VACCINE, V26, pD59, DOI 10.1016/j.vaccine.2008.07.025; Lee SH, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-017-0557-5; LeVine AM, 1999, J CLIN INVEST, V103, P563, DOI 10.1172/JCI5212; Maddox JF, 1997, J BIOL CHEM, V272, P6972, DOI 10.1074/jbc.272.11.6972; Maderna P, 2005, J IMMUNOL, V174, P3727, DOI 10.4049/jimmunol.174.6.3727; Manicassamy B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000745; Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P403, DOI 10.1513/pats.200508-090JS; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Musiol A, 2013, MBIO, V4, DOI 10.1128/mBio.00608-13; Nadkarni S, 2011, ARTERIOSCL THROM VAS, V31, P2749, DOI 10.1161/ATVBAHA.111.235176; NISHINAKAMURA R, 1995, IMMUNITY, V2, P211, DOI 10.1016/1074-7613(95)90046-2; Paine R, 2001, AM J PHYSIOL-LUNG C, V281, pL1210, DOI 10.1152/ajplung.2001.281.5.L1210; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Pupjalis D, 2011, EMBO MOL MED, V3, P102, DOI 10.1002/emmm.201000113; Rahman F, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051400; Rescher U, 2002, J IMMUNOL, V169, P1500, DOI 10.4049/jimmunol.169.3.1500; Rigaux P, 2012, VIROLOGY, V422, P338, DOI 10.1016/j.virol.2011.10.031; Rong BX, 2017, INT J BIOL MARKER, V32, pE132, DOI 10.5301/jbm.5000243; Rosler Barbara, 2016, Mol Cell Pediatr, V3, P29, DOI 10.1186/s40348-016-0055-5; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Schattgen SA, 2016, J IMMUNOL, V196, P29, DOI 10.4049/jimmunol.1501048; Schloer S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061781; Schneider C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004053; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; Shoemaker JE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004856; Short KR, 2016, EUR RESPIR J, V47, P954, DOI 10.1183/13993003.01282-2015; Short KR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00653; Smith HK, 2015, FASEB J, V29, P2161, DOI 10.1096/fj.14-263160; Subramaniam R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124593; Takabayshi K, 2006, IMMUNITY, V24, P475, DOI 10.1016/j.immuni.2006.02.008; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Tavares LP, 2016, AM J RESP CELL MOL, V55, P24, DOI 10.1165/rcmb.2015-0083OC; Tcherniuk S, 2016, J INFECT DIS, V214, P237, DOI 10.1093/infdis/jiw127; Trapnell BC, 2002, ANNU REV PHYSIOL, V64, P775, DOI 10.1146/annurev.physiol.64.090601.113847; Trentin PG, 2015, BRIT J PHARMACOL, V172, P3058, DOI 10.1111/bph.13109; Tzelepis F, 2015, J CLIN INVEST, V125, P752, DOI 10.1172/JCI77014; Vazquez AI, 2018, AM J RESP CRIT CARE, V197; Villarroya-Beltri C, 2017, J CELL SCI, V130, P2961, DOI 10.1242/jcs.205468; Vong L, 2007, J BIOL CHEM, V282, P29998, DOI 10.1074/jbc.M702876200; Yona S, 2006, BRIT J PHARMACOL, V148, P469, DOI 10.1038/sj.bjp.0706730; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhang HB, 2017, J IMMUNOL, V198, P4383, DOI 10.4049/jimmunol.1600714	86	30	30	2	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12188	12199		10.1096/fj.201901265R	http://dx.doi.org/10.1096/fj.201901265R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31398292	Green Published, hybrid			2022-12-28	WOS:000507461600046
J	Bruen, R; Curley, S; Kajani, S; Lynch, G; O'Reilly, ME; Dillon, ET; Fitzsimons, S; Mthunzi, L; McGillicuddy, FC; Belton, O				Bruen, Robyn; Curley, Sean; Kajani, Sarina; Lynch, Gina; O'Reilly, Marcella E.; Dillon, Eugene T.; Fitzsimons, Stephen; Mthunzi, Liberty; McGillicuddy, Fiona C.; Belton, Orina			Different monocyte phenotypes result in proresolving macrophages in conjugated linoleic acid-induced attenuated progression and regression of atherosclerosis	FASEB JOURNAL			English	Article						inflammation; ApoE-; -mouse model; plaque microenvironment	CHOLESTEROL; CELLS; OMEGA-3-FATTY-ACIDS; PATHOGENESIS; INFLAMMATION; LIPOPROTEIN; ACTIVATION; EXPRESSION; RESOLUTION; DIVERGENT	Monocytes/macrophages drive progression and regression of atherosclerosis. Conjugated linoleic acid (CLA), an anti-inflammatory lipid, mediates atheroprotective effects. We investigated how CLA alters monocyte/macrophage phenotype during attenuated progression and regression of atherosclerosis. Apolipoprotein E knockout (ApoE(-/-)) mice were fed a high-fat (60%) high-cholesterol (1%) diet (HFHCD) for 2 wk, followed by 6-wk 1% CLA 80:20 supplementation to investigate disease progression. Simultaneously, ApoE(-/-) mice were fed a 12-wk HFHCD with/without CLA for the final 4 wk to investigate regression. Aortic lesions were quantified by en face staining. Proteomic analysis, real-time quantitative PCR and flow cytometry were used to interrogate monocyte/macrophage phenotypes. CLA supplementation inhibited atherosclerosis progression coincident with decreased proinflammatory and increased anti-inflammatory macrophages. However, CLA-induced regression was associated with increased proinflammatory monocytes resulting in increased proresolving M2 bone marrow-derived macrophages, splenic macrophages, and dendritic cells in lesion-draining lymph nodes. Proteomic analysis confirmed regulation of a proinflammatory bone marrow response, which was abolished upon macrophage differentiation. Thus, in attenuation and regression of atherosclerosis, regardless of the monocyte signature, during monocyte to macrophage differentiation, proresolving macrophages prevail, mediating vascular repair. This study provides novel mechanistic insight into the monocyte/macrophage phenotypes in halted atherosclerosis progression and regression of atherosclerosis.-Bruen, R., Curley, S., Kajani, S., Lynch, G., O'Reilly, M. E., Dillon, E. T., Fitzsimons, S., Mthunzi, L., McGillicuddy, F. C., Belton, O. Different monocyte phenotypes result in proresolving macrophages in conjugated linoleic acid-induced attenuated progression and regression of atherosclerosis.	[Bruen, Robyn; Fitzsimons, Stephen; Belton, Orina] Univ Coll Dublin, UCD Conway Inst, Sch Biomol & Biomed Sci, Diabet Complicat Res Ctr, Dublin 4, Ireland; [Curley, Sean; Kajani, Sarina; Mthunzi, Liberty; McGillicuddy, Fiona C.] Univ Coll Dublin, UCD Conway Inst, Sch Med, Diabet Complicat Res Ctr, Dublin, Ireland; [Lynch, Gina; O'Reilly, Marcella E.] Univ Coll Dublin, UCD Conway Inst, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin, Ireland; [Dillon, Eugene T.] Univ Coll Dublin, UCD Conway Inst, Mass Spectrometry Resource, Dublin, Ireland	University College Dublin; University College Dublin; University College Dublin; University College Dublin	Belton, O (corresponding author), Univ Coll Dublin, UCD Conway Inst, Sch Biomol & Biomed Sci, Diabet Complicat Res Ctr, Dublin 4, Ireland.	orina.belton@ucd.ie	Kajani, Sarina/GPX-8306-2022	Belton, Orina/0000-0002-7701-6540; Fitzsimons, Stephen/0000-0002-1576-8632; O'Reilly, Marcella/0000-0001-6346-1881; McGillicuddy, Fiona/0000-0003-3623-3503; Mthunzi, Liberty/0000-0002-4636-4884	AstraZeneca	AstraZeneca(AstraZeneca)	The authors thank the University College Dublin (UCD) Biomedical Facility for their assistance with animal husbandry and breeding; without their help and advice this study would not have been possible. The authors also acknowledge the UCD Core Facilities, specifically Dr. Dimitri Scholz (UCD Imaging Core), Catherine Moss (UCD Genomics Core), and Dr. Alfonso Blanco (UCD Flow Cytometry Core). The European Foundation for the Study of Diabetes (EFSD) awarded an "EFSD Clinical Diabetes Research Program in Macrovascular Complications of Diabetes" grant supported by AstraZeneca to O.B. and F.C.M. for all work carried out by all authors. The authors declare no conflicts of interest.	Abdgawad M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032439, 10.1371/journal.pone.0046057]; Angerer P, 2002, CARDIOVASC RES, V54, P183, DOI 10.1016/S0008-6363(02)00229-8; [Anonymous], 2007, NURSING, V37, P34; Arbones-Mainar JM, 2006, ATHEROSCLEROSIS, V189, P318, DOI 10.1016/j.atherosclerosis.2006.01.015; Boyle JJ, 2012, CIRC RES, V110, P20, DOI 10.1161/CIRCRESAHA.111.247577; Boyle JJ, 2011, ARTERIOSCL THROM VAS, V31, P2685, DOI 10.1161/ATVBAHA.111.225813; Brown AL, 2012, ARTERIOSCL THROM VAS, V32, P2122, DOI 10.1161/ATVBAHA.112.253435; Bruen R, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0626-3; Bruen R, 2017, BRIT J CLIN PHARMACO, V83, P46, DOI 10.1111/bcp.12948; Chinetti-Gbaguidi G, 2015, NAT REV CARDIOL, V12, P10, DOI 10.1038/nrcardio.2014.173; Cooper MH, 2008, ATHEROSCLEROSIS, V200, P294, DOI 10.1016/j.atherosclerosis.2007.12.040; de Gaetano M, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0060-9; de Gaetano M, 2013, J IMMUNOL, V191, P4326, DOI 10.4049/jimmunol.1300990; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; El Hadri K, 2012, ARTERIOSCL THROM VAS, V32, P1445, DOI 10.1161/ATVBAHA.112.249334; Erbel C, 2015, INNATE IMMUN-LONDON, V21, P255, DOI 10.1177/1753425914526461; Falk E, 2006, J AM COLL CARDIOL, V47, pC7, DOI 10.1016/j.jacc.2005.09.068; Gleissner CA, 2007, THROMB HAEMOSTASIS, V98, P917, DOI 10.1160/TH07-09-0567; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Holm S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028785; Kadl A, 2011, FREE RADICAL BIO MED, V51, P1903, DOI 10.1016/j.freeradbiomed.2011.08.026; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Kolodgie FD, 2003, NEW ENGL J MED, V349, P2316, DOI 10.1056/NEJMoa035655; Kostogrys RB, 2010, J PRECLINICAL CLIN R, V4, P87; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Libby P, 2000, BBA-MOL CELL BIOL L, V1529, P299, DOI 10.1016/S1388-1981(00)00161-X; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; McCarthy C, 2013, EMBO MOL MED, V5, P1443, DOI 10.1002/emmm.201302587; McCarthy C, 2013, FASEB J, V27, P499, DOI 10.1096/fj.12-215442; McCarthy C, 2010, ATHEROSCLEROSIS, V213, P400, DOI 10.1016/j.atherosclerosis.2010.09.025; McClelland S, 2010, ATHEROSCLEROSIS, V211, P96, DOI 10.1016/j.atherosclerosis.2010.02.003; Mitchell PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052634; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nelson JR, 2017, VASC PHARMACOL, V91, P1, DOI 10.1016/j.vph.2017.02.004; Pitsilos S, 2003, THROMB HAEMOSTASIS, V90, P1112, DOI 10.1160/TH03-02-0069; Rahman K, 2017, J CLIN INVEST, V127, P2904, DOI 10.1172/JCI75005; Randolph GJ, 2008, CURR OPIN LIPIDOL, V19, P462, DOI 10.1097/MOL.0b013e32830d5f09; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Reynolds CM, 2013, J NUTR BIOCHEM, V24, P401, DOI 10.1016/j.jnutbio.2011.12.006; Scott J, 2002, J NEURAL TRANSM-SUPP, P1; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Toomey S, 2006, ATHEROSCLEROSIS, V187, P40, DOI 10.1016/j.atherosclerosis.2005.08.024; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; TUSHINSKI RJ, 1982, CELL, V28, P71, DOI 10.1016/0092-8674(82)90376-2; Viola JR, 2016, CIRC RES, V119, P1030, DOI 10.1161/CIRCRESAHA.116.309492; Yeganeh A, 2017, J NUTR BIOCHEM, V49, P123, DOI 10.1016/j.jnutbio.2017.08.003; Zaromitidou M, 2016, CARDIOVASCULAR DISEASES: GENETIC SUSCEPTIBILITY, ENVIRONMENTAL FACTORS AND THEIR INTERACTION, P3, DOI 10.1016/B978-0-12-803312-8.00002-1; Zhao JY, 2013, ATHEROSCLEROSIS, V226, P238, DOI 10.1016/j.atherosclerosis.2012.10.048	50	5	5	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11006	11020		10.1096/fj.201900922R	http://dx.doi.org/10.1096/fj.201900922R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31284764				2022-12-28	WOS:000489166300036
J	Hung, C; Napoli, E; Ross-Inta, C; Graham, J; Flores-Torres, AL; Stanhope, KL; Froment, P; Havel, PJ; Giulivi, C				Hung, Connie; Napoli, Eleonora; Ross-Inta, Catherine; Graham, James; Flores-Torres, Amanda L.; Stanhope, Kimber L.; Froment, Pascal; Havel, Peter J.; Giulivi, Cecilia			Ileal interposition surgery targets the hepatic TGF-beta pathway, influencing gluconeogenesis and mitochondrial bioenergetics in the UCD-T2DM rat model of diabetes	FASEB JOURNAL			English	Article						IT surgery; metabolomics; type 2 diabetes mellitus	GENE-EXPRESSION; STELLATE CELLS; GLUCOSE-TOLERANCE; LIVER FIBROSIS; CARDIOLIPIN; DYSFUNCTION; ACTIVATION; TRANSPOSITION; BIOSYNTHESIS; INFLAMMATION	Ileal interposition (IT) is a surgical procedure that increases the delivery of incompletely digested nutrients and biliary and pancreatic secretions to the distal intestinal mucosa. Here, we investigated the metabolic impact of this intervention in 2-mo-old prediabetic University of California, Davis type 2 diabetes mellitus rats by assessing liver gene expression at 1.5 mo post-IT surgery. Pathway analysis indicated decreased signaling via TGF-beta/Smad (a family of proteins named mothers against decapentaplegic homologs), peroxisome proliferator-activated receptor (PPAR), and PI3K-Akt-AMPK-mechanistic target of rapamycin, likely targeting hepatic stellate cells because differentiation and activation of these cells is associated with decreased signaling via PPAR and TGF-beta/Smad. IT surgery up-regulated the expression of genes involved in regulation of cholesterol and terpenoid syntheses and down-regulated those involved in glycerophospholipid metabolism [including cardiolipin (CL)], lipogenesis, and gluconeogenesis. Consistent with the down-regulation of the hepatic CL pathway, IT surgery produced a metabolic switch in liver, kidney cortex, and fat depots toward decreased mitochondrial fatty acid beta-oxidation, the process required to fuel high energy-demanding pathways (e.g., gluconeogenesis and glyceroneogenesis), whereas opposite effects were observed in skeletal and cardiac muscles. This study demonstrates for the first time the presence of metabolic pathways that complement the effects of IT surgery to maximize its benefits and potentially identify similarly effective, durable, and less invasive therapeutic options for metabolic disease, including inhibitors of TGF-beta signaling.-Hung, C., Napoli, E., Ross-Inta, C., Graham, J., Flores-Torres, A. L., Stanhope, K. L., Froment, P., Havel, P. J., Giulivi, C. Ileal interposition surgery targets the hepatic TGF-beta pathway, influencing gluconeogenesis and mitochondrial bioenergetics in the UCD-T2DM rat model of diabetes.	[Hung, Connie; Napoli, Eleonora; Ross-Inta, Catherine; Flores-Torres, Amanda L.; Stanhope, Kimber L.; Havel, Peter J.; Giulivi, Cecilia] Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA; [Graham, James; Stanhope, Kimber L.; Havel, Peter J.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Giulivi, Cecilia] Univ Calif Davis, MIND Inst, Davis, CA 95616 USA; [Flores-Torres, Amanda L.] Univ Puerto Rico, Dept Biochem, Med Sci Campus, San Juan, PR 00936 USA; [Froment, Pascal] INRA, Unite Physiol Reprod & Comportements, UMR 85, Paris, France	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; INRAE	Giulivi, C (corresponding author), Univ Calif Davis, Dept Mol Biosci, 1089 Vet Dr,3017 VetMed3B, Davis, CA 95616 USA.	cgiulivi@ucdavis.edu	Giulivi, Cecilia/ABB-7809-2020; Giulivi, Cecilia/AAV-6774-2021; Napoli, Eleonora/AAQ-6079-2021	Giulivi, Cecilia/0000-0003-1033-7435; Napoli, Eleonora/0000-0001-8808-4242; Graham, James/0000-0001-6507-8149; Havel, Peter/0000-0003-3652-8301	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [RC1 DK087307]; Genome Core Center at the University of California, Davis	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Genome Core Center at the University of California, Davis	The authors thank Dr. Bethany Cummings (University of California Davis; current affiliation: Cornell University College of Veterinary Medicine, Ithaca, NY, USA) for her skillful performance of all surgeries, and Sarah Wong (University of California Davis) for running all gene expression experiments. This study was funded by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant RC1 DK087307 (to P.J.H. and C.G.), and microarray studies were funded by a pilot grant from the Genome Core Center at the University of California, Davis (to C.G.). The authors declare no conflicts of interest.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Andrzejewski S, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-12; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Centers for Disease Control and Prevention, 2017, NAT DIAB STAT REP 20; Cummings BP, 2013, DIS MODEL MECH, V6, P443, DOI 10.1242/dmm.010421; Cummings BP, 2010, GASTROENTEROLOGY, V138, P2437, DOI 10.1053/j.gastro.2010.03.005; Cummings BP, 2008, AM J PHYSIOL-REG I, V295, pR1782, DOI 10.1152/ajpregu.90635.2008; Duthie SJ, 1996, CANCER RES, V56, P1291; Duthie SJ, 2000, NUTR CANCER, V37, P245, DOI 10.1207/S15327914NC372_18; Fox CS, 2010, TRENDS CARDIOVAS MED, V20, P90, DOI 10.1016/j.tcm.2010.08.001; Giulivi C, 2011, J BIOL CHEM, V286, P99, DOI 10.1074/jbc.M110.153247; Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706; Gohil VM, 2009, J CELL BIOL, V184, P468, DOI 10.1083/jcb.200901127; Gohil VM, 2004, J BIOL CHEM, V279, P42612, DOI 10.1074/jbc.M402545200; Gonzalvez F, 2013, BBA-MOL BASIS DIS, V1832, P1194, DOI 10.1016/j.bbadis.2013.03.005; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Griffen SC, 2001, DIABETES, V50, P63, DOI 10.2337/diabetes.50.1.63; Gupta S, 2001, J BIOL CHEM, V276, P15816, DOI 10.1074/jbc.M010878200; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; Hou W, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00150; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hung C, 2018, BIOCHEM J, V475, P649, DOI 10.1042/BCJ20170899; Kannel W B, 1979, Diabetes Care, V2, P120, DOI 10.2337/diacare.2.2.120; Kleinert M, 2018, NAT REV ENDOCRINOL, V14, P140, DOI 10.1038/nrendo.2017.161; Kutmon M, 2016, NUCLEIC ACIDS RES, V44, pD488, DOI 10.1093/nar/gkv1024; Kutmon M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004085; Lanthier N, 2009, CURR OPIN CLIN NUTR, V12, P404, DOI 10.1097/MCO.0b013e32832c7819; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Luo WJ, 2017, NUCLEIC ACIDS RES, V45, pW501, DOI 10.1093/nar/gkx372; Matsunami T, 2010, INT J CLIN EXP PATHO, V3, P472; Napoli E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29421-7; Napoli E, 2016, CEREBELLUM, V15, P552, DOI 10.1007/s12311-016-0779-8; Napoli E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042504; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Patriti A, 2005, OBES SURG, V15, P1258, DOI 10.1381/096089205774512573; Patriti A, 2007, SURGERY, V142, P74, DOI 10.1016/j.surg.2007.03.001; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Pscherer S, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-48; Qiao YC, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006583; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Saisho Y, 2015, ENDOCR METAB IMMUNE, V15, P196, DOI 10.2174/1871530315666150316124019; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200; Shi XR, 2008, J BIOL CHEM, V283, P30658, DOI 10.1074/jbc.M800510200; Strader AD, 2009, OBES SURG, V19, P96, DOI 10.1007/s11695-008-9754-x; Sugimoto R, 2005, LIVER INT, V25, P1018, DOI 10.1111/j.1478-3231.2005.01130.x; Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138; Thakur V, 2006, AM J PHYSIOL-GASTR L, V290, pG998, DOI 10.1152/ajpgi.00553.2005; Tomita K, 2008, HEPATOLOGY, V48, P458, DOI 10.1002/hep.22365; Tsukamoto H, 2005, ALCOHOL CLIN EXP RES, V29, p132S, DOI 10.1097/01.alc.0000189279.92602.f0; Vlahcevic ZR, 2000, GASTROENTEROLOGY, V118, P599, DOI 10.1016/S0016-5085(00)70267-8; Wobser H, 2009, CELL RES, V19, P996, DOI 10.1038/cr.2009.73; Woo SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091111; Yadav H, 2017, J BIOL CHEM, V292, P3420, DOI 10.1074/jbc.M116.764910; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yuan N, 2018, EXP CLIN ENDOCR DIAB, V126, P96, DOI 10.1055/s-0043-113454; Zhang CY, 2016, WORLD J GASTROENTERO, V22, P10512, DOI 10.3748/wjg.v22.i48.10512	60	1	1	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11270	11283		10.1096/fj.201802714R	http://dx.doi.org/10.1096/fj.201802714R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31307210	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000489166300057
J	Kanwal, A; Pillai, VB; Samant, S; Gupta, M; Gupta, MP				Kanwal, Abhinav; Pillai, Vinodkumar B.; Samant, Sadhana; Gupta, Madhu; Gupta, Mahesh P.			The nuclear and mitochondrial sirtuins, Sirt6 and Sirt3, regulate each other's activity and protect the heart from developing obesity-mediated diabetic cardiomyopathy	FASEB JOURNAL			English	Article						diabetes; insulin resistance; diabetic cardiomyopathy; NRF2; Keap1	FATTY-ACID OXIDATION; CALORIE RESTRICTION; CARDIAC-HYPERTROPHY; INSULIN-RESISTANCE; GENE-EXPRESSION; LIFE-SPAN; METABOLISM; BLOCKS; STRESS; ACTIVATION	Sirtuins (Sirts) are implicated in regulating a myriad of biologic functions ranging from cell growth and metabolism to longevity. Here, we show that nuclear Sirt, Sirt6, and mitochondrial Sirt, Sirt3, regulate each other's activity and protect the heart from developing diabetic cardiomyopathy. We found that expression of both Sirt6 and Sirt3 was reduced in cardiomyocytes treated with palmitate and in hearts of mice fed with a high-fat, high-sucrose (HF-HS) diet to develop obesity and diabetes. Conversely, whole-body overexpressing Sirt6 transgenic (Tg.Sirt6) mice were protected from developing obesity and insulin resistance when fed with the same HF-HS diet. The hearts of Tg.Sirt6 mice were also protected from mitochondrial fragmentation and decline of Sirt3, resulting otherwise from HF-HS diet feeding. Mechanistic studies showed that Sirt3 preserves Sirt6 levels by reducing oxidative stress, whereas Sirt6 maintains Sirt3 levels by up-regulating nuclear respiratory factor 2 (Nrf2)-dependent Sirt3 gene transcription. We found that Sirt6 regulates Nrf2-mediated cardiac gene expression in 2 ways; first, Sirt6 suppresses expression of Kelch-like ECH-associated protein 1 (Keap1), a negative regulator of Nrf2, and second, Sirt6 binds to Nrf2 and antagonizes its interaction with Keap1, thereby stabilizing Nrf2 levels in cardiomyocytes. Together, these studies demonstrate that Sirt6 and Sirt3 maintain each other's activity and protect the heart from developing diabetic cardiomyopathy.-Kanwal, A., Pillai, V. B., Samant, S., Gupta, M., Gupta, M. P. The nuclear and mitochondrial sirtuins, Sirt6 and Sirt3, regulate each other's activity and protect the heart from developing obesity-mediated diabetic cardiomyopathy.	[Kanwal, Abhinav; Pillai, Vinodkumar B.; Samant, Sadhana; Gupta, Madhu; Gupta, Mahesh P.] Univ Chicago, Dept Surg, 5841 South Maryland Ave,MC-5040, Chicago, IL 60637 USA; [Gupta, Mahesh P.] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Kanwal, Abhinav] Manipal Acad Higher Educ, Manipal, Karnataka, India	University of Chicago; University of Chicago; Manipal Academy of Higher Education (MAHE)	Gupta, MP (corresponding author), Univ Chicago, Dept Surg, 5841 South Maryland Ave,MC-5040, Chicago, IL 60637 USA.	mgupta@surgery.bsd.uchicago.edu	Kanwal, Abhinav/B-5468-2016	Kanwal, Abhinav/0000-0002-6814-3011	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL136712, HL143488]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL143488, R01HL136712] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank the investigators who provided plasmids and technical help in doing experiments of this study. Expression plasmid for Keap1 was obtained from Prof. John D. Hayes (University of Dundee, Dundee, United Kingdom). Ad. Mt-GFP was provided by Paul Schumacker (Northwestern University, Chicago, IL, USA). The Sirt3 promoter-reporter plasmids and the Nrf2 expression plasmid were kindly provided by M. Haigis (Harvard Medical School, Boston, MA, USA) and H. Ardehali (Northwestern University), respectively. Mass spectroscopy analysis was performed by Dr. Don Wolfgehar (University of Chicago Chicago, IL, USA). This study was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute R01 Grants HL136712 and HL143488 (to M.P.G.). The authors declare no conflicts of interest.	Abel ED, 2004, CURR HYPERTENS REP, V6, P416, DOI 10.1007/s11906-004-0034-4; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Akamata K, 2016, ONCOTARGET, V7, P69321, DOI 10.18632/oncotarget.12504; Alrob OA, 2014, CARDIOVASC RES, V103, P485, DOI 10.1093/cvr/cvu156; An D, 2006, AM J PHYSIOL-HEART C, V291, pH1489, DOI 10.1152/ajpheart.00278.2006; Bao JJ, 2010, FREE RADICAL BIO MED, V49, P1230, DOI 10.1016/j.freeradbiomed.2010.07.009; Battiprolu PK, 2012, J CLIN INVEST, V122, P1109, DOI 10.1172/JCI60329; Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003; Bindu S, 2017, AM J PHYSIOL-LUNG C, V312, pL68, DOI 10.1152/ajplung.00188.2016; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Bruni F, 2010, J BIOL CHEM, V285, P3939, DOI 10.1074/jbc.M109.044305; Cheng Q, 2011, J MOL ENDOCRINOL, V47, P13, DOI 10.1530/JME-10-0106; Dinkova-Kostova AT, 2015, FREE RADICAL BIO MED, V88, P179, DOI 10.1016/j.freeradbiomed.2015.04.036; Dolinsky VW, 2011, BBA-MOL BASIS DIS, V1812, P1477, DOI 10.1016/j.bbadis.2011.06.010; Edgett BA, 2016, EXP PHYSIOL, V101, P1101, DOI 10.1113/EP085744; Fritz KS, 2012, J PROTEOME RES, V11, P1633, DOI 10.1021/pr2008384; Gao ZG, 2011, J BIOL CHEM, V286, P22227, DOI 10.1074/jbc.M111.228874; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Jing EX, 2011, P NATL ACAD SCI USA, V108, P14608, DOI 10.1073/pnas.1111308108; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035; Kanwal A, 2012, ANAL BIOCHEM, V429, P70, DOI 10.1016/j.ab.2012.07.003; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Kwon S, 2017, J BIOL CHEM, V292, P17312, DOI 10.1074/jbc.M117.778720; Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349; Lin JB, 2016, CELL REP, V17, P69, DOI 10.1016/j.celrep.2016.08.073; Miteva YV, 2014, MOL CELL PROTEOMICS, V13, P168, DOI 10.1074/mcp.M113.032847; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Pan HZ, 2016, CELL RES, V26, P190, DOI 10.1038/cr.2016.4; Pillai VB, 2016, AM J PHYSIOL-HEART C, V310, pH962, DOI 10.1152/ajpheart.00832.2015; Pillai VB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7656; Pillai VB, 2014, CIRC RES, V114, P368, DOI 10.1161/CIRCRESAHA.113.300536; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Rodrigues B, 1998, MOL CELL BIOCHEM, V180, P53, DOI 10.1023/A:1006882805197; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Samant SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10838-5; Samant SA, 2014, MOL CELL BIOL, V34, P807, DOI 10.1128/MCB.01483-13; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Satterstrom FK, 2015, AGING CELL, V14, P818, DOI 10.1111/acel.12360; Schwer B, 2010, P NATL ACAD SCI USA, V107, P21790, DOI 10.1073/pnas.1016306107; Sears B, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0123-1; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Sun Z, 2007, MOL CELL BIOL, V27, P6334, DOI 10.1128/MCB.00630-07; Sun Z, 2011, MOL CELL BIOL, V31, P1800, DOI 10.1128/MCB.05036-11; Sundaresan NR, 2016, MOL CELL BIOL, V36, P678, DOI 10.1128/MCB.00586-15; Sundaresan NR, 2012, NAT MED, V18, P1643, DOI 10.1038/nm.2961; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Sykiotis GP, 2001, MOL ENDOCRINOL, V15, P1864, DOI 10.1210/me.15.11.1864; Tasselli L, 2017, TRENDS ENDOCRIN MET, V28, P168, DOI 10.1016/j.tem.2016.10.002; Thirumurthi U, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005076; Wagner GR, 2017, CELL METAB, V25, P823, DOI 10.1016/j.cmet.2017.03.006; Wagner GR, 2014, MOL CELL, V54, P5, DOI 10.1016/j.molcel.2014.03.027; Wang XL, 2006, DIABETES, V55, P2301, DOI 10.2337/db05-1574; Yang SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025131	65	44	45	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10872	10888		10.1096/fj.201900767R	http://dx.doi.org/10.1096/fj.201900767R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31318577	Green Published			2022-12-28	WOS:000489166300024
J	LeBlanc, ME; Saez-Torres, KL; Cano, I; Hu, ZP; Saint-Geniez, M; Ng, YS; D'Amore, PA				LeBlanc, Michelle E.; Saez-Torres, Kahira L.; Cano, Issahy; Hu, Zhengping; Saint-Geniez, Magali; Ng, Yin-Shan; D'Amore, Patricia A.			Glycocalyx regulation of vascular endothelial growth factor receptor 2 activity	FASEB JOURNAL			English	Article						endothelium; angiogenesis; VEGF; endocytosis	VEGFR2; CADHERIN; INTERNALIZATION; COLOCALIZATION; ANGIOGENESIS; TRAFFICKING; ENDOCYTOSIS; EXPRESSION	We have previously shown that knockdown of endomucin (EMCN), an integral membrane glycocalyx glycoprotein, prevents VEGF-induced proliferation, migration, and tube formation in vitro and angiogenesis in vivo. In the endothelium, VEGF mediates most of its angiogenic effects through VEGF receptor 2 (VEGFR2). To understand the role of EMCN, we examined the effect of EMCN depletion on VEGFR2 endocytosis and activation. Results showed that although VEGF stimulation promoted VEGFR2 internalization in control endothelial cells (ECs), loss of EMCN prevented VEGFR2 endocytosis. Cell surface analysis revealed a decrease in VEGFR2 following VEGF stimulation in control but not siRNA directed against EMCN-transfected ECs. EMCN depletion resulted in heightened phosphorylation following VEGF stimulation with an increase in total VEGFR2 protein. These results indicate that EMCN modulates VEGFR2 endocytosis and activity and point to EMCN as a potential therapeutic target.-LeBlanc, M. E., Saez-Torres, K. L., Cano, I., Hu, Z., Saint-Geniez, M., Ng, Y.-S., D'Amore, P. A. Glycocalyx regulation of vascular endothelial growth factor receptor 2 activity.	[LeBlanc, Michelle E.; Saez-Torres, Kahira L.; Cano, Issahy; Hu, Zhengping; Saint-Geniez, Magali; Ng, Yin-Shan; D'Amore, Patricia A.] Massachusetts Eye & Ear, Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA; [LeBlanc, Michelle E.; Saez-Torres, Kahira L.; Cano, Issahy; Hu, Zhengping; Saint-Geniez, Magali; Ng, Yin-Shan; D'Amore, Patricia A.] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA; [D'Amore, Patricia A.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	D'Amore, PA (corresponding author), Massachusetts Eye & Ear, Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA.	patricia_damore@meei.harvard.edu	Ng, Wing Yin/HHN-1743-2022; D'Amore, Patricia/G-5660-2017	Hu, Zhengping/0000-0001-7369-1314; Ng, Yin Shan/0000-0002-4982-1999; D'Amore, Patricia/0000-0001-9652-8974	U.S. National Institutes of Health/National Eye Institute (NIH/NEI) Grant [R01EY026539]; Vitreo Retinal Surgery Foundation; Training Program in the Molecular Bases of Eye Diseases Grant [2T32EY007145]; NIH/NEI Core Grant for Vision Research [P30 EY003790]; NATIONAL EYE INSTITUTE [P30EY003790, T32EY007145, R01EY026539] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Eye Institute (NIH/NEI) Grant; Vitreo Retinal Surgery Foundation; Training Program in the Molecular Bases of Eye Diseases Grant; NIH/NEI Core Grant for Vision Research; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Dr. Jinling Yang for design and use of the tagged endomucin construct and Dr. Ashley Mackey for technical assistance on the cell surface protein biotinylation assay (both from Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, MA, USA). The study was supported by U.S. National Institutes of Health/National Eye Institute (NIH/NEI) Grant R01EY026539 (to P.A.D.), the Vitreo Retinal Surgery Foundation (to M.E.L.), and the Training Program in the Molecular Bases of Eye Diseases Grant 2T32EY007145 (to M.E.L.). The authors acknowledge the NIH/NEI Core Grant for Vision Research P30 EY003790. The authors declare no conflicts of interest.	Basagiannis D, 2016, J CELL SCI, V129, P4091, DOI 10.1242/jcs.188219; Becker PM, 2005, CIRC RES, V96, P1257, DOI 10.1161/01.RES.0000171756.13554.49; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bryant DM, 2007, J CELL SCI, V120, P1818, DOI 10.1242/jcs.000653; Clegg LW, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004158; Coon BG, 2015, J CELL BIOL, V208, P975, DOI 10.1083/jcb.201408103; D'Amore PA, 2007, AM J PATHOL, V171, P14, DOI 10.2353/ajpath.2007.070385; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Hayashi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2683; Kinoshita M, 2001, FEBS LETT, V499, P121, DOI 10.1016/S0014-5793(01)02520-0; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lanahan A, 2013, DEV CELL, V25, P156, DOI 10.1016/j.devcel.2013.03.019; Lanahan AA, 2014, CIRCULATION, V130, P902, DOI 10.1161/CIRCULATIONAHA.114.009683; Mattila E, 2008, J CELL SCI, V121, P3570, DOI 10.1242/jcs.031898; Park-Windhol C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16852-x; Pasula S, 2012, J CLIN INVEST, V122, P4424, DOI 10.1172/JCI64537; Saint-Geniez M, 2006, INVEST OPHTH VIS SCI, V47, P3135, DOI 10.1167/iovs.05-1229; Salikhova A, 2008, CIRC RES, V103, pE71, DOI 10.1161/CIRCRESAHA.108.183327; Samulowitz U, 2002, AM J PATHOL, V160, P1669, DOI 10.1016/S0002-9440(10)61114-5; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Simons M, 2016, NAT REV MOL CELL BIO, V17, P611, DOI 10.1038/nrm.2016.87; Simons M, 2012, PHYSIOLOGY, V27, P213, DOI 10.1152/physiol.00016.2012; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Tian HY, 2018, FASEB J, V32, P2934, DOI 10.1096/fj.201700867RR; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Winderlich M, 2009, J CELL BIOL, V185, P657, DOI 10.1083/jcb.200811159; Yadav L, 2015, J CLIN DIAGN RES, V9, pXE1, DOI 10.7860/JCDR/2015/12016.6135; Zhu WQ, 2017, J CLIN INVEST, V127, P4569, DOI 10.1172/JCI91770	31	14	14	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9362	9373		10.1096/fj.201900011R	http://dx.doi.org/10.1096/fj.201900011R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31141406	Green Published, Bronze			2022-12-28	WOS:000478832900052
J	Leitao, L; Alves, CJ; Sousa, DM; Neto, E; Conceicao, F; Lamghari, M				Leitao, Luis; Alves, Cecilia J.; Sousa, Daniela M.; Neto, Estrela; Conceicao, Francisco; Lamghari, Meriem			The alliance between nerve fibers and stem cell populations in bone marrow: life partners in sickness and health	FASEB JOURNAL			English	Review						sympathetic; sensorial; mesenchymal stromal cells; hematopoietic stem cells; endothelial cells	ENDOTHELIAL PROGENITOR CELLS; NITRIC-OXIDE SYNTHASE; HEMATOPOIETIC STEM; SUBSTANCE-P; FUNCTIONAL RECOVERY; SENSORY NEURONS; Y1 RECEPTOR; IN-VITRO; INNERVATION; INJURY	The bone marrow (BM) is the central hematopoietic organ in adult mammals, with great potential to be used as a tool to improve the efficacy of the body's response to a number of malignancies and stressful conditions. The nervous system emerges as a critical regulatory player of the BM both under homeostatic and pathologic settings, with essential roles in cellular anchorage and egress, stem cell differentiation, and endothelial cell permeability. This review collects the current knowledge on the interplay between the nervous system and the BM cell populations, with a focus on how the nervous system modulates hematopoietic stem and progenitor cell, mesenchymal stromal cell, and endothelial progenitor cell activity in BM. We have also highlighted the pathologies that have been associated with disturbances in the neuronal signaling in BM and discussed if targeting the nervous system, either by modulating the activity of specific neuronal circuits or by pharmacologically leveling the activity of sympathetic and sensorial signaling-responsive cells in BM, is a promising therapeutic approach to tackling pathologies from BM origin.-LeitAo, L., Alves, C. J., Sousa, D. M., Neto, E., ConceicAo, F., Lamghari, M. The alliance between nerve fibers and stem cell populations in bone marrow: life partners in sickness and health.	[Leitao, Luis; Alves, Cecilia J.; Sousa, Daniela M.; Neto, Estrela; Conceicao, Francisco; Lamghari, Meriem] Univ Porto, Inst Invest & Inovacao Saude i3S, Rua Alfredo Allen 280, P-4200135 Porto, Portugal; [Leitao, Luis; Alves, Cecilia J.; Sousa, Daniela M.; Neto, Estrela; Conceicao, Francisco; Lamghari, Meriem] Univ Porto, Inst Engn Biomed INEB, Porto, Portugal; [Leitao, Luis; Conceicao, Francisco; Lamghari, Meriem] Univ Porto, ICBAS, Porto, Portugal	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto	Lamghari, M (corresponding author), Univ Porto, Inst Invest & Inovacao Saude i3S, Rua Alfredo Allen 280, P-4200135 Porto, Portugal.	lamghari@ineb.up.pt	Conceição, Francisco/HCI-8740-2022; Neto, Estrela C/M-2561-2013; Sousa, Daniela/C-1485-2014; Lamghari, Meriem/K-2159-2013	Neto, Estrela C/0000-0003-2334-2292; Sousa, Daniela/0000-0001-8498-0664; Conceicao, Francisco/0000-0003-4587-2470; Lamghari, Meriem/0000-0002-2500-4548	Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF) [NORTE-01-0145-FEDER-000012]; Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao [PTDC/MED-PAT/30158/2017];  [SFRH/BD/109686/2015];  [SFRH/BD/128771/2017];  [SFRH/BPD/115341/2016]	Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF); Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao(Portuguese Foundation for Science and Technology); ; ; 	This article is a result of the project NORTE-01-0145-FEDER-000012, supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF), and by Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao in the framework of the financed project PTDC/MED-PAT/30158/2017. L.L and F.C. are recipients of Ph.D. fellowships (SFRH/BD/109686/2015 and SFRH/BD/128771/2017, respectively). D.M.S. is the recipient of postdoc fellowship (SFRH/BPD/115341/2016). The authors declare no conflicts of interest.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Amiya Eisuke, 2014, Ann Vasc Dis, V7, P109, DOI 10.3400/avd.ra.14-00048; Arranz L, 2014, NATURE, V512, P78, DOI 10.1038/nature13383; Artico M, 2002, INT J MOL MED, V10, P77; Bajayo A, 2012, P NATL ACAD SCI USA, V109, P15455, DOI 10.1073/pnas.1206061109; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; BJURHOLM A, 1988, J AUTONOM NERV SYST, V25, P119, DOI 10.1016/0165-1838(88)90016-1; Busik JV, 2009, J EXP MED, V206, P2897, DOI 10.1084/jem.20090889; CALVO W, 1968, AM J ANAT, V123, P315, DOI 10.1002/aja.1001230206; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Castaneda-Corral G, 2011, NEUROSCIENCE, V178, P196, DOI 10.1016/j.neuroscience.2011.01.039; Chartier SR, 2018, NEUROSCIENCE, V387, P178, DOI 10.1016/j.neuroscience.2018.01.047; Chavakis T, 2004, MICROBES INFECT, V6, P1219, DOI 10.1016/j.micinf.2004.08.004; Christopherson KW, 2003, EXP HEMATOL, V31, P1126, DOI 10.1016/j.exphem.2003.07.002; Cole SW, 2015, NAT REV CANCER, V15, P563, DOI 10.1038/nrc3978; Colmone A, 2008, TRANSL RES, V151, P1, DOI 10.1016/j.trsl.2007.09.003; Cook KM, 2013, J AM COLL SURGEONS, V216, P57, DOI 10.1016/j.jamcollsurg.2012.08.028; Crane GM, 2017, NAT REV IMMUNOL, V17, P573, DOI 10.1038/nri.2017.53; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Du ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087975; Fadini GP, 2013, ACTA DIABETOL, V50, P977, DOI 10.1007/s00592-013-0517-3; Felson DT, 2001, ANN INTERN MED, V134, P541, DOI 10.7326/0003-4819-134-7-200104030-00007; Fonseca Rodrigo B, 2004, Surg Infect (Larchmt), V5, P385, DOI 10.1089/sur.2004.5.385; Fonseca-Pereira D, 2014, NATURE, V514, P98, DOI 10.1038/nature13498; Frattini F, 2012, TISSUE ENG PT A, V18, P2030, DOI [10.1089/ten.tea.2011.0496, 10.1089/ten.TEA.2011.0496]; Fukuda T, 2013, NATURE, V497, P490, DOI 10.1038/nature12115; Golan K, 2018, CELL STEM CELL, V23, P572, DOI 10.1016/j.stem.2018.08.002; Hanoun M, 2015, NEURON, V86, P360, DOI 10.1016/j.neuron.2015.01.026; Hanoun M, 2014, CELL STEM CELL, V15, P365, DOI 10.1016/j.stem.2014.06.020; HaraIrie F, 1996, BONE, V18, P29, DOI 10.1016/8756-3282(95)00425-4; Harzenetter MD, 2002, EXP HEMATOL, V30, P306, DOI 10.1016/S0301-472X(02)00772-5; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; Jiang QJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101774; Jimenez-Andrade JM, 2010, J NEUROSCI, V30, P14649, DOI 10.1523/JNEUROSCI.3300-10.2010; Jung WC, 2017, SEMIN CELL DEV BIOL, V61, P60, DOI 10.1016/j.semcdb.2016.08.010; Juranek JK, 2013, DIABETES, V62, P931, DOI 10.2337/db12-0632; Kalinkovich A, 2009, BRAIN BEHAV IMMUN, V23, P1059, DOI 10.1016/j.bbi.2009.03.008; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kawakami M, 2004, LEUKEMIA, V18, P912, DOI 10.1038/sj.leu.2403330; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Kojima H, 2014, TRENDS ENDOCRIN MET, V25, P178, DOI 10.1016/j.tem.2014.01.002; Laroni A, 2015, IMMUNOL LETT, V168, P183, DOI 10.1016/j.imlet.2015.08.007; Lemoli RM, 2004, BLOOD, V104, P1662, DOI 10.1182/blood-2004-03-0834; Li B, 2010, STEM CELL RES, V4, P17, DOI 10.1016/j.scr.2009.08.001; Li GY, 2012, DIABETES, V61, P3294, DOI 10.2337/db11-1249; Li Y, 2000, J HEMATOTH STEM CELL, V9, P445, DOI 10.1089/152581600419107; Lin LY, 2018, NEUROCHEM INT, V115, P80, DOI 10.1016/j.neuint.2018.02.007; Liu XR, 2013, EXPERT OPIN THER TAR, V17, P485, DOI 10.1517/14728222.2013.773975; Lucas D, 2013, NAT MED, V19, P695, DOI 10.1038/nm.3155; Maayan C, 2002, OSTEOPOROSIS INT, V13, P429, DOI 10.1007/s001980200050; Mach DB, 2002, NEUROSCIENCE, V113, P155, DOI 10.1016/S0306-4522(02)00165-3; Maestroni GJM, 1998, EXP HEMATOL, V26, P1172; Martin L, 2017, SCI REP-UK, V7, DOI 10.1038/srep44995; Maryanovich M, 2018, NAT MED, V24, P782, DOI 10.1038/s41591-018-0030-x; Maryanovich M, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a031344; Mead B, 2017, STEM CELL TRANSL MED, V6, P1273, DOI 10.1002/sctm.16-0428; Mead B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109305; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mendez-Ferrer S, 2010, ANN NY ACAD SCI, V1192, P139, DOI 10.1111/j.1749-6632.2010.05390.x; Mesentier-Louro LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110722; Monfrini M, 2018, MOL CELL NEUROSCI, V86, P16, DOI 10.1016/j.mcn.2017.11.004; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Muthu K, 2007, J NEUROIMMUNOL, V186, P27, DOI 10.1016/j.jneuroim.2007.02.007; Nencini S, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00157; Neto E, 2016, J NEUROSCI, V36, P11573, DOI 10.1523/JNEUROSCI.1748-16.2016; Neto E, 2014, INTEGR BIOL-UK, V6, P586, DOI 10.1039/c4ib00035h; Niedermair T, 2014, MATRIX BIOL, V38, P22, DOI 10.1016/j.matbio.2014.06.007; Niv D, 2003, PAIN, V105, P387, DOI 10.1016/S0304-3959(03)00277-X; Offley SC, 2005, J BONE MINER RES, V20, P257, DOI 10.1359/JBMR.041108; Oh SH, 2017, STEM CELLS, V35, P1934, DOI 10.1002/stem.2650; Okuda A, 2017, J NEUROSURG-SPINE, V26, P388, DOI 10.3171/2016.8.SPINE16250; Park MH, 2016, STEM CELLS, V34, P2145, DOI 10.1002/stem.2383; Park MH, 2015, EMBO J, V34, P1648, DOI 10.15252/embj.201490174; Pasupuleti LV, 2014, J TRAUMA ACUTE CARE, V76, P970, DOI 10.1097/TA.0000000000000181; Recalde A, 2012, ARTERIOSCL THROM VAS, V32, P643, DOI 10.1161/ATVBAHA.111.244392; Rennert RC, 2012, REGEN MED, V7, P833, DOI [10.2217/RME.12.82, 10.2217/rme.12.82]; Riddell NE, 2015, BRAIN BEHAV IMMUN, V49, P49, DOI 10.1016/j.bbi.2015.02.028; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Scuteri A, 2006, BRAIN RES, V1116, P75, DOI 10.1016/j.brainres.2006.07.127; Sheng Yulan, 2018, Int J Physiol Pathophysiol Pharmacol, V10, P17; Silva DI, 2017, CELL DEATH DIS, V8, DOI 10.1038/s41419-017-0034-3; Singh P, 2017, J CLIN INVEST, V127, P4527, DOI 10.1172/JCI94687; Sousa DM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33470; Sousa DM, 2012, BONE, V51, P8, DOI 10.1016/j.bone.2012.03.020; Spiegel A, 2007, NAT IMMUNOL, V8, P1123, DOI 10.1038/ni1509; Steidl U, 2004, BLOOD, V104, P81, DOI 10.1182/blood-2004-01-0373; Takeda S, 2008, J NEUROENDOCRINOL, V20, P802, DOI 10.1111/j.1365-2826.2008.01732.x; Teixeira FG, 2013, CELL MOL LIFE SCI, V70, P3871, DOI 10.1007/s00018-013-1290-8; Teraa M, 2014, CIRC RES, V114, P311, DOI 10.1161/CIRCRESAHA.114.302791; Togel F, 2007, DEV DYNAM, V236, P3321, DOI 10.1002/dvdy.21258; Wang LP, 2010, BONE, V46, P1369, DOI 10.1016/j.bone.2009.11.029; Wang LP, 2009, BONE, V45, P309, DOI 10.1016/j.bone.2009.04.203; WEIHE E, 1991, INT J NEUROSCI, V59, P1; Xiong LL, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00213; Zhang M, 2014, CURR OPIN HEMATOL, V21, P224, DOI 10.1097/MOH.0000000000000041; Zubcevic J, 2014, HYPERTENSION, V63, pE129, DOI 10.1161/HYPERTENSIONAHA.114.02440	100	6	7	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					8697	8710		10.1096/fj.201900454R	http://dx.doi.org/10.1096/fj.201900454R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31017803	hybrid			2022-12-28	WOS:000478832900002
J	Tomer, E; Cohen, EM; Drayman, N; Afriat, A; Weitzman, MD; Zaritsky, A; Kobiler, O				Tomer, Enosh; Cohen, Efrat M.; Drayman, Nir; Afriat, Amichay; Weitzman, Matthew D.; Zaritsky, Assaf; Kobiler, Oren			Coalescing replication compartments provide the opportunity for recombination between coinfecting herpesviruses	FASEB JOURNAL			English	Article						DNA recombination; herpes simplex virus; nuclear spatial constraints; viral nuclear interactions	SIMPLEX-VIRUS TYPE-1; TEMPERATURE-SENSITIVE MUTANTS; DNA-BINDING-PROTEIN; REPAIR; ATR; COMPLEMENTATION; ORGANIZATION; ASSOCIATION; POPULATIONS; EXPRESSION	Homologous recombination (HR) is considered a major driving force of evolution because it generates and expands genetic diversity. Evidence of HR between coinfecting herpesvirus DNA genomes can be found frequently both in vitro and in clinical isolates. Each herpes simplex virus type 1 (HSV-1) replication compartment (RC) derives from a single incoming genome and maintains a specific territory within the nucleus. This raises intriguing questions about where and when coinfecting viral genomes interact. To study the spatiotemporal requirements for intergenomic recombination, we developed an assay with dual-color FISH that enables detection of HR between different pairs of coinfecting HSV-1 genomes. Our results revealed that HR increases intermingling of RCs derived from different genomes. Furthermore, inhibition of RC movement reduces the rate of HR events among coinfecting viruses. Finally, we observed correlation between nuclear size and the number of RCs per nucleus. Our findings suggest that both viral replication and recombination are subject to nuclear spatial constraints. Other DNA viruses and cellular DNA are likely to encounter similar restrictions.-Tomer, E., Cohen, E. M., Drayman, N., Afriat, A., Weitzman, M. D., Zaritsky, A., Kobiler, O. Coalescing replication compartments provide the opportunity for recombination between coinfecting herpesviruses.	[Tomer, Enosh; Cohen, Efrat M.; Afriat, Amichay; Kobiler, Oren] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel; [Drayman, Nir] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Drayman, Nir] Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA; [Weitzman, Matthew D.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Weitzman, Matthew D.] Childrens Hosp Philadelphia, Div Protect Immun, Philadelphia, PA 19104 USA; [Zaritsky, Assaf] Ben Gurion Univ Negev, Dept Software & Informat Syst Engn, Beer Sheva, Israel	Tel Aviv University; Sackler Faculty of Medicine; University of Chicago; University of Chicago; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Ben Gurion University	Kobiler, O (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel.	okobiler@tauex.tau.ac.il	Kobiler, Oren/J-2268-2012	Kobiler, Oren/0000-0001-9914-3770; Zaritsky, Assaf/0000-0002-1477-5478	Israel Science Foundation [1387/14]; European Union Career Integration Grant (EU CIG) [FP7-2012-333653]; U.S. National Institutes of Health (NIH), National Institute of Neurological disorders [NS082240]; United States - Israel Binational Science Foundation [2015395]; Marguerite Stolz Research Fellowship; Buchman Scholarship; NIH, National Institute of General Medical Sciences [P01 GM103723]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM103723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082240] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); European Union Career Integration Grant (EU CIG); U.S. National Institutes of Health (NIH), National Institute of Neurological disorders; United States - Israel Binational Science Foundation(US-Israel Binational Science Foundation); Marguerite Stolz Research Fellowship; Buchman Scholarship; NIH, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Eitan Erez Zahavi, Ariel Ionescu, and Eran Perlson for advice and valuable support and all Kobiler lab members for their comments. This work was supported by grants from the Israel Science Foundation (Grant 1387/14) to O.K., the European Union Career Integration Grant (EU CIG) (FP7-2012-333653) to O.K., the U.S. National Institutes of Health (NIH), National Institute of Neurological disorders (NS082240) to M.D.W., the United States - Israel Binational Science Foundation (Grant 2015395) to O.K. and M.D.W., a Marguerite Stolz Research Fellowship to O.K. and E.T. is supported by the Buchman Scholarship, and A.Z. was supported by a Grant from the NIH, National Institute of General Medical Sciences (P01 GM103723) to Gaudenz Danuser (Departments of Bioinformatics and Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Advani SJ, 2003, P NATL ACAD SCI USA, V100, P4825, DOI 10.1073/pnas.0730735100; Alandijany T, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006769; Bowden R, 2004, INFECT GENET EVOL, V4, P115, DOI 10.1016/j.meegid.2004.01.009; BROWN SM, 1973, J GEN VIROL, V18, P329, DOI 10.1099/0022-1317-18-3-329; Burkham J, 1998, J VIROL, V72, P10100, DOI 10.1128/JVI.72.12.10100-10107.1998; Chang L, 2011, P NATL ACAD SCI USA, V108, pE136, DOI 10.1073/pnas.1103411108; Cohen EM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006082; Cremer Marion, 2008, V463, P205, DOI 10.1007/978-1-59745-406-3_15; De Chiara G, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00242; Dembowski JA, 2018, MBIO, V9, DOI 10.1128/mBio.01182-18; Dembowski JA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004939; Drayman N, 2017, MBIO, V8, DOI 10.1128/mBio.01612-17; Edwards TG, 2018, J VIROL, V92, DOI 10.1128/JVI.01884-17; FELSENSTEIN J, 1974, GENETICS, V78, P737; Hancock MH, 2006, VIROLOGY, V352, P237, DOI 10.1016/j.virol.2006.04.021; HAYWARD GS, 1975, P NATL ACAD SCI USA, V72, P4243, DOI 10.1073/pnas.72.11.4243; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Holmes EC, 2008, ANNU REV MICROBIOL, V62, P307, DOI 10.1146/annurev.micro.62.081307.162912; HONESS RW, 1980, J VIROL, V34, P716, DOI 10.1128/JVI.34.3.716-742.1980; Kobiler O, 2011, MBIO, V2, DOI 10.1128/mBio.00278-11; Kobiler O, 2012, NUCLEUS-PHILA, V3, P526, DOI 10.4161/nucl.21979; Kolb AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076267; KOPS AD, 1988, CELL, V55, P857, DOI 10.1016/0092-8674(88)90141-9; Law GA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050220; Lee K, 2015, J VIROL, V89, P7214, DOI 10.1128/JVI.00880-15; Lee SW, 2012, SCIENCE, V337, P188, DOI 10.1126/science.1217134; Lilley CE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002084; Lilley CE, 2005, P NATL ACAD SCI USA, V102, P5844, DOI 10.1073/pnas.0501916102; Liptak LM, 1996, J VIROL, V70, P1759, DOI 10.1128/JVI.70.3.1759-1767.1996; Lukonis CJ, 1996, J VIROL, V70, P1751, DOI 10.1128/JVI.70.3.1751-1758.1996; Mahiet C, 2012, J VIROL, V86, P8592, DOI 10.1128/JVI.00223-12; McCord RP, 2018, ADV EXP MED BIOL, V1044, P113, DOI 10.1007/978-981-13-0593-1_8; McSwiggen DT, 2019, ELIFE, V8, DOI 10.7554/eLife.47098; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mohni KN, 2013, J VIROL, V87, P531, DOI 10.1128/JVI.02504-12; Mohni KN, 2010, J VIROL, V84, P12152, DOI 10.1128/JVI.01643-10; MORSE LS, 1977, J VIROL, V24, P231, DOI 10.1128/JVI.24.1.231-248.1977; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Parkinson J, 1999, J VIROL, V73, P650, DOI 10.1128/JVI.73.1.650-657.1999; QUINLAN MP, 1984, CELL, V36, P857, DOI 10.1016/0092-8674(84)90035-7; Renner DW, 2018, J VIROL, V92, DOI 10.1128/JVI.00908-17; Reuven NB, 2003, J VIROL, V77, P7425, DOI 10.1128/JVI.77.13.7425-7433.2003; Reyes ED, 2017, MOL CELL PROTEOMICS, V16, P2079, DOI 10.1074/mcp.M117.067116; Rijsewijk FAM, 1999, ARCH VIROL, V144, P1527, DOI 10.1007/s007050050608; Roizman B, 2015, VIROLOGY, V479, P562, DOI 10.1016/j.virol.2015.02.036; Sanjuan R, 2016, CELL MOL LIFE SCI, V73, P4433, DOI 10.1007/s00018-016-2299-6; SCHAFFER PA, 1973, VIROLOGY, V52, P57, DOI 10.1016/0042-6822(73)90398-X; Schumacher AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002862; Sekine E, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006721; Shapira L, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01970; Smith S, 2015, FUTURE VIROL, V10, P383, DOI 10.2217/FVL.15.18; Smith S, 2014, J VIROL, V88, P10146, DOI 10.1128/JVI.01723-14; Sourvinos G, 2002, EMBO J, V21, P4989, DOI 10.1093/emboj/cdf458; SPRUANCE SL, 1977, NEW ENGL J MED, V297, P69, DOI 10.1056/NEJM197707142970201; Szpara ML, 2014, J VIROL, V88, P1209, DOI 10.1128/JVI.01987-13; Tang KW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111584; Taylor MP, 2012, P NATL ACAD SCI USA, V109, P17046, DOI 10.1073/pnas.1212926109; Taylor TJ, 2004, J VIROL, V78, P5856, DOI 10.1128/JVI.78.11.5856-5866.2004; Taylor TJ, 2003, VIROLOGY, V309, P232, DOI 10.1016/S0042-6822(03)00107-7; Trigg BJ, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110342; Vogel JL, 2013, VIRUSES-BASEL, V5, P1272, DOI 10.3390/v5051272; Weller SK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013011; Wilkinson DE, 2006, J CELL SCI, V119, P2695, DOI 10.1242/jcs.02981; YAO F, 1995, J VIROL, V69, P6249, DOI 10.1128/JVI.69.10.6249-6258.1995; Zhong L, 1997, J VIROL, V71, P3146, DOI 10.1128/JVI.71.4.3146-3160.1997	66	21	21	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9388	9403		10.1096/fj.201900032R	http://dx.doi.org/10.1096/fj.201900032R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31107607	Green Published			2022-12-28	WOS:000478832900054
J	Zhu, K; Takada, Y; Nakajima, K; Sun, YH; Jiang, JX; Zhang, Y; Zeng, QL; Takada, Y; Zhao, M				Zhu, Kan; Takada, Yoko; Nakajima, Kenichi; Sun, Yaohui; Jiang, Jianxin; Zhang, Yan; Zeng, Qunli; Takada, Yoshikazu; Zhao, Min			Expression of integrins to control migration direction of electrotaxis	FASEB JOURNAL			English	Article						directional cell migration; galvanotaxis; alpha 9; directional reversal; motility	LIGAND-BINDING SITES; CELL-MIGRATION; ALPHA(9) INTEGRIN; ELECTRICAL-FIELDS; EPITHELIAL-CELLS; STEM-CELLS; IN-VITRO; ADHESION; SUBUNIT; CANCER	Proper control of cell migration is critically important in many biologic processes, such as wound healing, immune surveillance, and development. Much progress has been made in the initiation of cell migration; however, little is known about termination and sometimes directional reversal. During active cell migration, as in wound healing, development, and immune surveillance, the integrin expression profile undergoes drastic changes. Here, we uncovered the extensive regulatory and even opposing roles of integrins in directional cell migration in electric fields (EFs), a potentially important endogenous guidance mechanism. We established cell lines that stably express specific integrins and determined their responses to applied EFs with a high throughput screen. Expression of specific integrins drove cells to migrate to the cathode or to the anode or to lose migration direction. Cells expressing alpha M beta 2, beta 1, alpha 2, alpha IIb beta 3, and alpha 5 migrated to the cathode, whereas cells expressing beta 3, alpha 6, and alpha 9 migrated to the anode. Cells expressing alpha 4, alpha V, and alpha 6 beta 4 lost directional electrotaxis. Manipulation of alpha 9 molecules, one of the molecular directional switches, suggested that the intracellular domain is critical for the directional reversal. These data revealed an unreported role for integrins in controlling stop, go, and reversal activity of directional migration of mammalian cells in EFs, which might ensure that cells reach their final destination with well-controlled speed and direction.-Zhu, K., Takada, Y., Nakajima, K., Sun, Y., Jiang, J., Zhang, Y., Zeng, Q., Takada, Y., Zhao, M. Expression of integrins to control migration direction of electrotaxis.	[Zhu, Kan; Takada, Yoko; Nakajima, Kenichi; Sun, Yaohui; Zhang, Yan; Takada, Yoshikazu; Zhao, Min] Univ Calif Davis, Sch Med, Dept Dermatol, 4645 Second Ave,Res 3 Suite 3300, Sacramento, CA 95817 USA; [Zhao, Min] Univ Calif Davis, Sch Med, Dept Ophthalmol & Vis Sci, Sacramento, CA 95817 USA; [Zhu, Kan; Nakajima, Kenichi; Sun, Yaohui; Zhang, Yan; Zhao, Min] Univ Calif Davis, Inst Regenerat Cures, 2921 Stockton Blvd, Sacramento, CA 95817 USA; [Zhu, Kan; Jiang, Jianxin] Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China; [Zhang, Yan; Zeng, Qunli] Zhejiang Univ, Sch Med, Bioelectromagnet Lab, Hangzhou, Zhejiang, Peoples R China	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Army Medical University; Zhejiang University	Takada, Y; Zhao, M (corresponding author), Univ Calif Davis, Sch Med, Dept Dermatol, 4645 Second Ave,Res 3 Suite 3300, Sacramento, CA 95817 USA.; Zhao, M (corresponding author), Univ Calif Davis, Inst Regenerat Cures, 2921 Stockton Blvd, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu; minzhao@ucdavis.edu	Zhu, Kan/AAJ-7450-2021	Zhu, Kan/0000-0002-1146-8130	U.S. National Institutes of Health (NIH); National Eye Institute [EY019101]; U.S. Air Force Office of Scientific Research (AFOSR) Multidisciplinary University Research Initiatives (MURI) [FA9550-16-1-0052]; NIH National Cancer Institute Grant [CA131015]; UC-Davis Dermatology and Ophthalmology developmental funds; UC-Davis Bridging Fund; NATIONAL EYE INSTITUTE [R01EY019101] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); U.S. Air Force Office of Scientific Research (AFOSR) Multidisciplinary University Research Initiatives (MURI); NIH National Cancer Institute Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UC-Davis Dermatology and Ophthalmology developmental funds; UC-Davis Bridging Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Liu Sui (Touro University-California, College of Pharmacy, Vallejo, CA, USA) and Michael Yen (Nova Southeastern University, College Of Osteopathic Medicine, Fort Lauderdale, FL, USA) for assistance in data analysis, Zijie Zhu [University of California-Davis, Sacremento, CA, USA (UC-Davis)] for polydimethylsiloxane electrotactic chamber fabrication, and Dr. Adam J. Contreras (UC-Davis) for proofreading and editing. This work was supported by U.S. National Institutes of Health (NIH), National Eye Institute Grant EY019101, U.S. Air Force Office of Scientific Research (AFOSR) Multidisciplinary University Research Initiatives (MURI) Grant FA9550-16-1-0052, and NIH National Cancer Institute Grant CA131015. This work was also supported in part by UC-Davis Dermatology and Ophthalmology developmental funds and the UC-Davis Bridging Fund. The authors declare no conflicts of interest.	Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; BROWN MJ, 1994, J CELL BIOL, V127, P117, DOI 10.1083/jcb.127.1.117; CHAN BMC, 1991, SCIENCE, V251, P1600, DOI 10.1126/science.2011740; Danen EHJ, 2005, J CELL BIOL, V169, P515, DOI 10.1083/jcb.200412081; Dehart GW, 2008, P NATL ACAD SCI USA, V105, P7188, DOI 10.1073/pnas.0708044105; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Feng JF, 2012, STEM CELLS, V30, P349, DOI 10.1002/stem.779; Fraser SP, 2005, CLIN CANCER RES, V11, P5381, DOI 10.1158/1078-0432.CCR-05-0327; Frederich BJ, 2017, HEART RHYTHM, V14, P1685, DOI 10.1016/j.hrthm.2017.06.038; Fujita M, 2015, J BIOL CHEM, V290, P259, DOI 10.1074/jbc.M114.579946; Guess CM, 2009, MATRIX BIOL, V28, P445, DOI 10.1016/j.matbio.2009.07.008; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Han J, 2011, OPHTHALMIC RES, V45, P15, DOI 10.1159/000313552; Holroyd AK, 2018, IMMUNOL LETT, V196, P74, DOI 10.1016/j.imlet.2018.01.015; HOTARY KB, 1992, DEVELOPMENT, V114, P985; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang L, 2009, J CELL PHYSIOL, V219, P162, DOI 10.1002/jcp.21660; Hughes AL, 2001, J MOL EVOL, V52, P63, DOI 10.1007/s002390010134; Hutcheon AEK, 2005, INVEST OPHTH VIS SCI, V46, P2362, DOI 10.1167/iovs.04-0759; Huttenlocher A, 2005, NAT CELL BIOL, V7, P336, DOI 10.1038/ncb0405-336; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; IRIE A, 1995, EMBO J, V14, P5550, DOI 10.1002/j.1460-2075.1995.tb00242.x; KAMATA T, 1995, BIOCHEM J, V305, P945, DOI 10.1042/bj3050945; KAMATA T, 1994, J BIOL CHEM, V269, P9659; Kamata T, 1996, J BIOL CHEM, V271, P18610, DOI 10.1074/jbc.271.31.18610; Kim MH, 2018, TRENDS BIOTECHNOL, V36, P89, DOI 10.1016/j.tibtech.2017.10.006; Koivisto L, 2014, ADV WOUND CARE, V3, P762, DOI 10.1089/wound.2013.0436; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Lawson CD, 2018, J CELL BIOL, V217, P447, DOI 10.1083/jcb.201612069; Levin M, 2012, BIOSYSTEMS, V109, P243, DOI 10.1016/j.biosystems.2012.04.005; Li L, 2017, ONCOTARGET, V8, P95741, DOI 10.18632/oncotarget.21306; Lin F, 2008, J IMMUNOL, V181, P2465, DOI 10.4049/jimmunol.181.4.2465; Masopust D, 2013, NAT REV IMMUNOL, V13, P309, DOI 10.1038/nri3442; Nakajima K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9532; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; Pullar CE, 2006, MOL BIOL CELL, V17, P4925, DOI 10.1091/mbc.E06-05-0433; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Saghizadeh M, 2001, AM J PATHOL, V158, P723, DOI 10.1016/S0002-9440(10)64015-1; SCHREINER CL, 1989, J CELL BIOL, V109, P3157, DOI 10.1083/jcb.109.6.3157; Sechler JL, 1996, J CELL BIOL, V134, P573, DOI 10.1083/jcb.134.2.573; SEFTOR REB, 1992, P NATL ACAD SCI USA, V89, P1557, DOI 10.1073/pnas.89.5.1557; Seguin L, 2015, TRENDS CELL BIOL, V25, P234, DOI 10.1016/j.tcb.2014.12.006; SHI RY, 1995, DEV DYNAM, V202, P101, DOI 10.1002/aja.1002020202; Song B, 2007, NAT PROTOC, V2, P1479, DOI 10.1038/nprot.2007.205; SRIRAMARAO P, 1993, J BIOL CHEM, V268, P22036; Stepp MA, 1997, J HISTOCHEM CYTOCHEM, V45, P189, DOI 10.1177/002215549704500205; STEPP MA, 1995, J HISTOCHEM CYTOCHEM, V43, P353, DOI 10.1177/43.4.7534781; Stepp MA, 2006, EXP EYE RES, V83, P3, DOI 10.1016/j.exer.2006.01.010; Stewart RL, 2015, LAB INVEST, V95, P976, DOI 10.1038/labinvest.2015.82; TAKADA Y, 1992, J CELL BIOL, V119, P913, DOI 10.1083/jcb.119.4.913; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takagi J, 1997, J BIOL CHEM, V272, P19794, DOI 10.1074/jbc.272.32.19794; Tarui T, 2001, J BIOL CHEM, V276, P3983, DOI 10.1074/jbc.M008220200; Thomas GJ, 2006, J ORAL PATHOL MED, V35, P1, DOI 10.1111/j.1600-0714.2005.00374.x; Tomczuk M, 2003, EXP CELL RES, V290, P68, DOI 10.1016/S0014-4827(03)00307-0; Tsai CH, 2013, J ORTHOP RES, V31, P322, DOI 10.1002/jor.22215; Veeravalli KK, 2012, CELL SIGNAL, V24, P272, DOI 10.1016/j.cellsig.2011.09.011; Wang ET, 2003, EXP EYE RES, V76, P29, DOI 10.1016/S0014-4835(02)00257-9; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Young BA, 2001, MOL BIOL CELL, V12, P3214, DOI 10.1091/mbc.12.10.3214; Zhang GF, 2016, J INVEST DERMATOL, V136, P2229, DOI 10.1016/j.jid.2016.05.129; Zhang JP, 2011, STEM CELL REV REP, V7, P987, DOI 10.1007/s12015-011-9247-5; Zhang XP, 1998, J BIOL CHEM, V273, P7345, DOI 10.1074/jbc.273.13.7345; Zhao M, 2004, J CELL SCI, V117, P397, DOI 10.1242/jcs.00868; Zhao M, 2002, J CELL BIOL, V157, P921, DOI 10.1083/jcb.200112070; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Zhao M, 2010, ADV WOUND CARE-SER, V1, P567, DOI 10.1089/awc.2009.0021; Zhao M, 2009, SEMIN CELL DEV BIOL, V20, P674, DOI 10.1016/j.semcdb.2008.12.009; Zhao SW, 2014, LAB CHIP, V14, P4398, DOI 10.1039/c4lc00745j	73	11	11	3	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9131	9141		10.1096/fj.201802657R	http://dx.doi.org/10.1096/fj.201802657R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31116572	Green Published, Green Submitted			2022-12-28	WOS:000478832900035
J	Arroyo, M; Kuriyama, R; Guerrero, I; Keifenheim, D; Canuelo, A; Calahorra, J; Sanchez, A; Clarke, DJ; Marchal, JA				Arroyo, Maria; Kuriyama, Ryoko; Guerrero, Israel; Keifenheim, Daniel; Canuelo, Ana; Calahorra, Jesus; Sanchez, Antonio; Clarke, Duncan J.; Alberto Marchal, J.			MCPH1 is essential for cellular adaptation to the G(2)-phase decatenation checkpoint	FASEB JOURNAL			English	Article						cell cycle control; checkpoint adaptation; chromosome condensation; topoisomerase II; MCPH1	DNA-DAMAGE RESPONSE; TOPOISOMERASE-II; G(2) CHECKPOINT; MITOTIC ENTRY; CHROMOSOME CONDENSATION; MICROCEPHALIN; TRANSITION; MUTATIONS; MITOSIS	Cellular checkpoints controlling entry into mitosis monitor the integrity of the DNA and delay mitosis onset until the alteration is fully repaired. However, this canonical response can weaken, leading to a spontaneous bypass of the checkpoint, a process referred to as checkpoint adaptation. Here, we have investigated the contribution of microcephalin 1 (MCPH1), mutated in primary microcephaly, to the decatenation checkpoint, a less-understood G(2) pathway that delays entry into mitosis until chromosomes are properly disentangled. Our results demonstrate that, although MCPH1 function is dispensable for activation and maintenance of the decatenation checkpoint, it is required for the adaptive response that bypasses the topoisomerase II inhibition-mediated G(2) arrest. MCPH1, however, does not confer adaptation to the G(2) arrest triggered by the ataxia telangiectasia mutated- and ataxia telangiectasia and rad3 related-based DNA damage checkpoint. In addition to revealing a new role for MCPH1 in cell cycle control, our study provides new insights into the genetic requirements that allow cellular adaptation to G(2) checkpoints, a process that remains poorly understood.-Arroyo, M., Kuriyama, R., Guerrero, I., Keifenheim, D., Canuelo, A., Calahorra, J., Sanchez, A., Clarke, D. J., Marchal, J. A. MCPH1 is essential for cellular adaptation to the G(2)-phase decatenation checkpoint.	[Arroyo, Maria; Canuelo, Ana; Calahorra, Jesus; Sanchez, Antonio; Alberto Marchal, J.] Univ Jaen, Dept Biol Expt, Jaen, Spain; [Kuriyama, Ryoko; Keifenheim, Daniel; Clarke, Duncan J.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Guerrero, Israel] IFAPA Ctr Toruno, Inst Invest & Formac Agr & Pesquera, El Puerto De Santa Maria, Spain	Universidad de Jaen; University of Minnesota System; University of Minnesota Twin Cities	Marchal, JA (corresponding author), Univ Jaen, Dept Biol Expt, Fac Ciencias Expt, Paraje Las Lagunillas S-N, E-23071 Jaen, Spain.	jamaor@ujaen.es	Sanchez, Antonio/N-4174-2015; García-Moreno, Jesús Calahorra/AAN-2835-2020; Marchal, Juan Alberto/K-7963-2012; Arroyo-Lopez, Maria C/S-5238-2016	Sanchez, Antonio/0000-0002-6715-8158; García-Moreno, Jesús Calahorra/0000-0002-6399-751X; Marchal, Juan Alberto/0000-0002-2008-610X; Arroyo-Lopez, Maria C/0000-0002-5837-8060; Keifenheim, Daniel/0000-0002-4235-8903; Clarke, Duncan/0000-0002-7795-3294	Junta de Andalucia (funding program Ayudas a Grupos de Investigacion) [BIO 220]; EMBO; National Science Foundation [MCB1140033]; U.S. National Institutes of Health (NIH), National Institute of General Medical Sciences [R01GM112793, R01GM130858]; Escuela de Doctorado (UJA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM130858, R01GM112793] Funding Source: NIH RePORTER	Junta de Andalucia (funding program Ayudas a Grupos de Investigacion)(Junta de Andalucia); EMBO(European Molecular Biology Organization (EMBO)); National Science Foundation(National Science Foundation (NSF)); U.S. National Institutes of Health (NIH), National Institute of General Medical Sciences; Escuela de Doctorado (UJA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors express gratitude to H. Neitzel (Charite Virchow-Klinikum Hospital, Berlin, Germany) for providing the lymphoblast cell lines used in this study, G. Marques (University of Minnesota-Minneapolis, Minneapolis, MN, USA) for technical assistance, and J. F. Gimenez-Abian [Centre for Biological Research (CIB), Madrid, Spain] and V. Rodriguez-Bravo (Sidney Kimmel Cancer Center, Baltimore, MD, USA) for helpful discussions. Technical and human support provided by Centro de Instrumentacion Cientifico-Tecnica [CICT; Universidad de Jaen, Ministry of Economy and Competitiveness (MINECO), Junta de Andalucia, Federacion Espanola de Enfermedades Raras (FEDER)] is gratefully acknowledged. This work was supported by Junta de Andalucia (funding program Ayudas a Grupos de Investigacion, BIO 220). M.A. was provided with travelling grants to perform short-term stays at the University of Minnesota by EMBO and Escuela de Doctorado (UJA), respectively. Research at the laboratory of R.K. was financially supported by the National Science Foundation (MCB1140033). Studies performed in the laboratory of D.J.C. were funded by U.S. National Institutes of Health (NIH), National Institute of General Medical Sciences Grants R01GM112793 and R01GM130858. The authors declare no conflicts of interest.	Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Arroyo M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12793-7; Arroyo M, 2015, CHROMOSOMA, V124, P491, DOI 10.1007/s00412-015-0512-2; Bower JJ, 2010, ONCOGENE, V29, P4787, DOI 10.1038/onc.2010.232; Bower JJ, 2010, CELL CYCLE, V9, P1617, DOI 10.4161/cc.9.8.11470; Brown JAL, 2010, ONCOGENE, V29, P5537, DOI 10.1038/onc.2010.302; Brownlow N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6685; Chaplet M, 2006, CELL CYCLE, V5, P2579, DOI 10.4161/cc.5.22.3471; Clarke DJ, 2006, CELL CYCLE, V5, P1925, DOI 10.4161/cc.5.17.3200; Damelin M, 2007, BRIT J CANCER, V96, P201, DOI 10.1038/sj.bjc.6603537; Deming PB, 2002, J BIOL CHEM, V277, P36832, DOI 10.1074/jbc.M206109200; Deming PB, 2001, P NATL ACAD SCI USA, V98, P12044, DOI 10.1073/pnas.221430898; DOWNES CS, 1994, NATURE, V372, P710, DOI 10.1038/372710a0; Gavvovidis I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040387; Gavvovidis I, 2010, CELL CYCLE, V9, P4893, DOI 10.4161/cc.9.24.14157; Gimenez-Abian JF, 2000, CHROMOSOMA, V109, P235, DOI 10.1007/s004120000065; Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342; Jeffers LJ, 2008, ONCOGENE, V27, P139, DOI 10.1038/sj.onc.1210595; Kukkonen-Macchi A, 2011, J CELL SCI, V124, P216, DOI 10.1242/jcs.068254; Lee K, 2010, MOL BIOL CELL, V21, P2150, DOI 10.1091/mbc.E10-02-0125; Liang Y, 2015, ONCOGENE, V34, P4368, DOI 10.1038/onc.2014.367; Luo KT, 2009, NAT CELL BIOL, V11, P204, DOI 10.1038/ncb1828; Martin CA, 2016, GENE DEV, V30, P2158, DOI 10.1101/gad.286351.116; Matsusaka T, 2004, J CELL BIOL, V166, P507, DOI 10.1083/jcb.200401139; Mekel-Bobrov N, 2005, SCIENCE, V309, P1720, DOI 10.1126/science.1116815; Mikhailov A, 2004, J CELL BIOL, V166, P517, DOI 10.1083/jcb.200405167; Neitzel H, 2002, AM J HUM GENET, V70, P1015, DOI 10.1086/339518; Paulovich AG, 1997, CELL, V88, P315, DOI 10.1016/S0092-8674(00)81870-X; Peng G, 2009, EPIGENETICS-US, V4, P457, DOI 10.4161/epi.4.7.10032; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Rieder CL, 2000, CURR BIOL, V10, P1067, DOI 10.1016/S0960-9822(00)00678-3; Serrano D, 2016, CELL CYCLE, V15, P3339, DOI 10.1080/15384101.2016.1237769; Serrano Diego, 2014, Syst Synth Biol, V8, P195, DOI 10.1007/s11693-014-9151-9; Syljuasen RG, 2007, ONCOGENE, V26, P5833, DOI 10.1038/sj.onc.1210402; Tibelius A, 2009, J CELL BIOL, V185, P1149, DOI 10.1083/jcb.200810159; Trimborn M, 2006, CELL CYCLE, V5, P322, DOI 10.4161/cc.5.3.2412; Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Wood JL, 2007, J BIOL CHEM, V282, P35416, DOI 10.1074/jbc.M705245200; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Zhou ZW, 2013, DNA REPAIR, V12, P645, DOI 10.1016/j.dnarep.2013.04.017	41	4	4	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8363	8374		10.1096/fj.201802009RR	http://dx.doi.org/10.1096/fj.201802009RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30964711	Green Published, Bronze			2022-12-28	WOS:000476234700045
J	Khanal, T; Leung, YK; Jiang, W; Timchenko, N; Ho, SM; Kim, K				Khanal, Tilak; Leung, Yuet-Kin; Jiang, Wang; Timchenko, Nicolai; Ho, Shuk-Mei; Kim, Kyounghyun			NR2E3 is a key component in p53 activation by regulating a long noncoding RNA DINO in acute liver injuries	FASEB JOURNAL			English	Article						NR2E3; p53; DINO; long noncoding RNA	ORPHAN NUCLEAR RECEPTOR; ACETAMINOPHEN OVERDOSE; HISTONE MODIFICATION; N-ACETYLCYSTEINE; OXIDATIVE STRESS; MICE; GENE; HEPATOTOXICITY; PLAYS; DIFFERENTIATION	Damage-induced long noncoding RNA (DINO) is a long noncoding RNA that directly interacts with p53 and thereby enhances p53 stability and activity in response to various cellular stresses. Here, we demonstrate that nuclear receptor subfamily 2 group E member 3 (NR2E3) plays a crucial role in maintaining active DINO epigenetic status for its proper induction and subsequent p53 activation. In acetaminophen (APAP)- or carbon tetrachloride-induced acute liver injuries, NR2E3 knockout (KO) mice exhibited far more severe liver injuries due to impaired DINO induction and p53 activation. Mechanistically, NR2E3 loss both in vivo and in vitro induced epigenetic DINO repression accompanied by reduced DINO chromatin accessibility. Furthermore, compared with the efficient reversal by a typical antidote N-acetylcysteine (NAC) treatment of APAP-induced liver injury in wild-type mice, the liver injury of NR2E3 KO mice was not effectively reversed, indicating that an intact NR2E3-DINO-p53-signaling axis is essential for NAC-mediated recovery against APAP-induced hepatotoxicity. These findings establish that NR2E3 is a critical component in p53 activation and a novel susceptibility factor to drug- or toxicant-induced acute liver injuries.-Khanal, T., Leung, Y.-K., Jiang, W., Timchenko, N., Ho, S.-M., Kim, K. NR2E3 is a key component in p53 activation by regulating a long noncoding RNA DINO in acute liver injuries.	[Khanal, Tilak; Leung, Yuet-Kin; Ho, Shuk-Mei; Kim, Kyounghyun] Univ Cincinnati, Dept Environm Hlth, Coll Med, 160 Panzeca Way, Cincinnati, OH 45267 USA; [Jiang, Wang] Univ Cincinnati, Dept Pathol & Lab Med, Coll Med, Cincinnati, OH 45267 USA; [Timchenko, Nicolai] Cincinnati Childrens Hosp Med Ctr, Div Pediat Gen & Thorac Surg, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Kim, K (corresponding author), Univ Cincinnati, Dept Environm Hlth, Coll Med, 160 Panzeca Way, Cincinnati, OH 45267 USA.	kim2ku@uc.edu	Leung, Ricky/H-5958-2019	Leung, Ricky/0000-0003-2063-277X; Kim, Kyounghyun/0000-0002-7240-2768	U.S. National Institutes of Health/National Institute of Environmental Health Sciences (NIEHS) [P30-ES006096]; Center for Environmental Genetics at the University of Cincinnati; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Institute of Environmental Health Sciences (NIEHS); Center for Environmental Genetics at the University of Cincinnati; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank for Prof. Howard Chang (Department of Genetics, School of Medicine, Stanford University) for kindly providing the damage-induced long noncoding RNA plasmid. This work was supported by U.S. National Institutes of Health/National Institute of Environmental Health Sciences (NIEHS) Grant P30-ES006096 from the Center for Environmental Genetics at the University of Cincinnati. The authors declare no conflicts of interest.	Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; CORCORAN GB, 1986, J PHARMACOL EXP THER, V238, P54; Deng M, 2012, CURR MOL MED, V12, P901, DOI 10.2174/156652412802480899; Du K, 2017, ARCH TOXICOL, V91, P761, DOI 10.1007/s00204-016-1692-0; Elgawish RAR, 2015, TOXICOL REP, V2, P1149, DOI 10.1016/j.toxrep.2015.08.001; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Farombi EO, 2006, J BIOCHEM MOL BIOL, V39, P479; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Graupner V, 2011, CELL DEATH DIFFER, V18, P1130, DOI 10.1038/cdd.2010.179; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; Guo XL, 2013, WORLD J GASTROENTERO, V19, P3781, DOI 10.3748/wjg.v19.i24.3781; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Huo YZ, 2017, FREE RADICAL BIO MED, V106, P111, DOI 10.1016/j.freeradbiomed.2017.02.028; Iyer V, 2015, NAT METHODS, V12, P479, DOI 10.1038/nmeth.3408; Jaeschke H, 2006, TOXICOL SCI, V89, P31, DOI 10.1093/toxsci/kfi336; Khanal T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11106-2; Khanal T, 2015, TOXICOL LETT, V237, P228, DOI 10.1016/j.toxlet.2015.06.1708; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Lee SST, 1996, J BIOL CHEM, V271, P12063, DOI 10.1074/jbc.271.20.12063; Lee WM, 2008, HEPATOLOGY, V47, P1401, DOI 10.1002/hep.22177; Loewer A, 2010, CELL, V142, P89, DOI 10.1016/j.cell.2010.05.031; LoGuidice A, 2011, HEPATOLOGY, V54, P969, DOI 10.1002/hep.24464; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Milam AH, 2002, P NATL ACAD SCI USA, V99, P473, DOI 10.1073/pnas.022533099; MINERS JO, 1984, BIOCHEM PHARMACOL, V33, P2995, DOI 10.1016/0006-2952(84)90599-9; Park YY, 2012, EMBO MOL MED, V4, P52, DOI 10.1002/emmm.201100187; PRESCOTT LF, 1977, LANCET, V2, P432; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002; Saito C, 2010, TOXICOL APPL PHARM, V246, P8, DOI 10.1016/j.taap.2010.04.015; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schmitt AM, 2016, NAT GENET, V48, P1370, DOI 10.1038/ng.3673; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; SMILKSTEIN MJ, 1988, NEW ENGL J MED, V319, P1557, DOI 10.1056/NEJM198812153192401; Wen Z, 2012, MOL CELL BIOL, V32, P26, DOI 10.1128/MCB.05513-11; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Yang WS, 2014, NEOPLASIA, V16, P1059, DOI 10.1016/j.neo.2014.09.011; Yuan CL, 2017, ADV EXP MED BIOL, V1016, P75, DOI 10.1007/978-3-319-63904-8_4; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	48	8	9	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8335	8348		10.1096/fj.201801881RR	http://dx.doi.org/10.1096/fj.201801881RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30991008	Green Published			2022-12-28	WOS:000476234700043
J	Munroe, M; Dvoretskiy, S; Lopez, A; Leong, JY; Dyle, MC; Kong, H; Adams, CM; Boppart, MD				Munroe, Michael; Dvoretskiy, Svyatoslav; Lopez, Amber; Leong, Jiayu; Dyle, Michael C.; Kong, Hyunjoon; Adams, Christopher M.; Boppart, Marni D.			Pericyte transplantation improves skeletal muscle recovery following hindlimb immobilization	FASEB JOURNAL			English	Article						disuse atrophy; rehabilitation; stem cells; muscle growth; capillary	MESENCHYMAL STEM-CELLS; FIBER HYPERTROPHY; SATELLITE CELLS; BED REST; PROTEIN-SYNTHESIS; DISUSE ATROPHY; IMPAIRS; REGROWTH; EXPRESSION; MYONUCLEI	Conditions of extended bed rest and limb immobilization can initiate rapid and significant loss of skeletal muscle mass and function. Physical rehabilitation is standard practice following a period of disuse, yet mobility may be severely compromised, and recovery is commonly delayed or incomplete in special populations. Thus, a novel approach toward recovery of muscle mass is highly desired. Pericytes [neuron-glial antigen 2 (NG2)(+)CD31(-)CD45(-) (Lineage(-) [Lin(-)]) and CD146(+)Lin(-)] demonstrate capacity to facilitate muscle repair, yet the ability to enhance myofiber growth following disuse is unknown. In the current study, 3-4-mo-old mice were unilaterally immobilized for 14 d (IM) or immobilized for 14 d followed by 14 d of remobilization (RE). Flow cytometry and targeted gene expression analyses were completed to assess pericyte quantity and function following IM and RE. In addition, a transplantation study was conducted to assess the impact of pericytes on recovery. Results from targeted analyses suggest minimal impact of disuse on pericyte gene expression, yet NG2(+)Lin(-) pericyte quantity is reduced following IM (P < 0.05). Remarkably, pericyte transplantation recovered losses in myofiber cross-sectional area and the capillary-to-fiber ratio following RE, whereas deficits remained with vehicle alone (P = 0.01). These findings provide the first evidence that pericytes effectively rehabilitate skeletal muscle mass following disuse atrophy.-Munroe, M., Dvoretskiy, S., Lopez, A., Leong, J., Dyle, M. C., Kong, H., Adams, C. M., Boppart, M. D. Pericyte transplantation improves skeletal muscle recovery following hindlimb immobilization.	[Munroe, Michael; Dvoretskiy, Svyatoslav; Lopez, Amber; Boppart, Marni D.] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL USA; [Munroe, Michael; Dvoretskiy, Svyatoslav; Lopez, Amber; Boppart, Marni D.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL USA; [Leong, Jiayu; Kong, Hyunjoon] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL USA; [Kong, Hyunjoon; Boppart, Marni D.] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL USA; [Dyle, Michael C.; Adams, Christopher M.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Dyle, Michael C.; Adams, Christopher M.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Iowa; University of Iowa	Boppart, MD (corresponding author), Beckman Inst Adv Sci & Technol, 405 N Mathews Ave,MC-251, Urbana, IL 61801 USA.	mboppart@illinois.edu	Leong, Eunice/GOE-3744-2022	Leong, Eunice/0000-0002-4895-4044; Lopez, Amber N./0000-0003-0357-7051	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the U.S. National Institutes of Health (NIH) [R01AR072735]; National Heart, Lung, and Blood Institute (NHLBI) [R21HL131469]; University of Illinois-Urbana-Champaign (UIUC) Research Board Grant; UIUC Dissertation Completion Award; National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the NIH [T32EB019944]; American College of Sports Medicine National Aeronautics and Space Administration (NASA) Space Physiology Research Grant [18-00664]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL131469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR072735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB019944] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the U.S. National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Illinois-Urbana-Champaign (UIUC) Research Board Grant; UIUC Dissertation Completion Award; National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the NIH; American College of Sports Medicine National Aeronautics and Space Administration (NASA) Space Physiology Research Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors thank Dr. Barbara Pilas and the Flow Cytometry Center at the Roy J. Carver Biotechnology Center (University of Illinois-Urbana-Champaign) for advice and assistance. Research reported in this publication was supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the U.S. National Institutes of Health (NIH) under award number R01AR072735 (to M.D.B.), National Heart, Lung, and Blood Institute (NHLBI) under award number R21HL131469 (to H.K. and M.D.B.), and a University of Illinois-Urbana-Champaign (UIUC) Research Board Grant (to M.D.B.). M.M. was supported by a UIUC Dissertation Completion Award. S.D. was supported by National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the NIH under award number T32EB019944 and an American College of Sports Medicine National Aeronautics and Space Administration (NASA) Space Physiology Research Grant (18-00664). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	Adams CM, 2017, CURR OPIN CLIN NUTR, V20, P164, DOI 10.1097/MCO.0000000000000362; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Baehr LM, 2016, AGING-US, V8, P127, DOI 10.18632/aging.100879; Birbrair A, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00245; Birbrair A, 2014, AM J PHYSIOL-CELL PH, V307, pC25, DOI 10.1152/ajpcell.00084.2014; Birbrair A, 2013, STEM CELLS DEV, V22, P2298, DOI 10.1089/scd.2012.0647; Bodine SC, 2013, INT J BIOCHEM CELL B, V45, P2200, DOI 10.1016/j.biocel.2013.06.011; Brooks NE, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00099; Caron AZ, 2009, J APPL PHYSIOL, V106, P2049, DOI 10.1152/japplphysiol.91505.2008; Chen CW, 2013, STEM CELLS, V31, P305, DOI 10.1002/stem.1285; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dar A, 2012, CIRCULATION, V125, P87, DOI 10.1161/CIRCULATIONAHA.111.048264; Dirks ML, 2014, J NUTR, V144, P1196, DOI 10.3945/jn.114.194217; Drummond MJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1113, DOI 10.1152/ajpendo.00603.2011; Ebert SM, 2012, J BIOL CHEM, V287, P27290, DOI 10.1074/jbc.M112.374777; Egner IM, 2016, DEVELOPMENT, V143, P2898, DOI 10.1242/dev.134411; Eliasberg CD, 2017, J BONE JOINT SURG AM, V99, P331, DOI 10.2106/JBJS.16.00645; Fox DK, 2014, AM J PHYSIOL-ENDOC M, V307, pE245, DOI 10.1152/ajpendo.00010.2014; Fry CS, 2017, CELL STEM CELL, V20, P56, DOI 10.1016/j.stem.2016.09.010; Geevarghese A, 2014, TRANSL RES, V163, P296, DOI 10.1016/j.trsl.2014.01.011; Goh Q, 2017, ELIFE, V6, DOI 10.7554/eLife.20007; Guimaraes-Camboa N, 2017, CELL STEM CELL, V20, P345, DOI 10.1016/j.stem.2016.12.006; Hayes KL, 2018, AM J PHYSIOL-CELL PH, V314, pC534, DOI 10.1152/ajpcell.00158.2017; HU GF, 1994, P NATL ACAD SCI USA, V91, P12096, DOI 10.1073/pnas.91.25.12096; Huntsman HD, 2018, EXP GERONTOL, V103, P35, DOI 10.1016/j.exger.2017.12.012; Huntsman HD, 2013, AM J PHYSIOL-HEART C, V304, pH72, DOI [10.1152/ajpheart.00541.2012, 10.1152/ajpheart.00541-2012]; Hvid L, 2010, J APPL PHYSIOL, V109, P1628, DOI 10.1152/japplphysiol.00637.2010; Hvid LG, 2013, EXP GERONTOL, V48, P154, DOI 10.1016/j.exger.2012.11.005; Hwee DT, 2009, J GERONTOL A-BIOL, V64, P618, DOI 10.1093/gerona/glp026; Jackson JR, 2012, AM J PHYSIOL-CELL PH, V303, pC854, DOI 10.1152/ajpcell.00207.2012; Kaneguchi A, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-315; Kano Y, 2000, ACTA PHYSIOL SCAND, V169, P271; Kong HJ, 2003, BIOMATERIALS, V24, P4023, DOI 10.1016/S0142-9612(03)00295-3; Kortebein P, 2007, JAMA-J AM MED ASSOC, V297, P1772, DOI 10.1001/jama.297.16.1772-b; Kostallari E, 2015, DEVELOPMENT, V142, P1242, DOI 10.1242/dev.115386; Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003; Lee MK, 2015, BIOMATERIALS, V58, P26, DOI 10.1016/j.biomaterials.2015.04.014; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Lyons SM, 2017, RNA BIOL, V14, P171, DOI 10.1080/15476286.2016.1272746; Mahmassani ZS, 2017, AM J PHYSIOL-CELL PH, V312, pC638, DOI 10.1152/ajpcell.00106.2016; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Miyake M, 2015, ONCOGENE, V34, P890, DOI 10.1038/onc.2014.2; Murach KA, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0132-z; Roudier E, 2010, J PHYSIOL-LONDON, V588, P4579, DOI 10.1113/jphysiol.2010.193243; Sacchetti B, 2016, STEM CELL REP, V6, P897, DOI 10.1016/j.stemcr.2016.05.011; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Snijders T, 2017, J CACHEXIA SARCOPENI, V8, P267, DOI 10.1002/jcsm.12137; Suetta C, 2013, J PHYSIOL-LONDON, V591, P3789, DOI 10.1113/jphysiol.2013.257121; Tanner RE, 2015, J PHYSIOL-LONDON, V593, P4259, DOI 10.1113/JP270699; Tyml K, 2001, FRONT BIOSCI, V6, pD45, DOI 10.2741/Tyml; Valenzuela PL, 2018, AGEING RES REV, V47, P80, DOI 10.1016/j.arr.2018.07.003; Valero MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029760; Vanlandewijck M, 2018, NATURE, V554, P475, DOI 10.1038/nature25739; Wall BT, 2013, J CLIN ENDOCR METAB, V98, P4872, DOI 10.1210/jc.2013-2098; White JR, 2015, EXP GERONTOL, V64, P17, DOI 10.1016/j.exger.2015.02.007; Zou K, 2015, MED SCI SPORT EXER, V47, P315, DOI 10.1249/MSS.0000000000000405	56	16	16	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7694	7706		10.1096/fj.201802580R	http://dx.doi.org/10.1096/fj.201802580R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	31021652	Green Published			2022-12-28	WOS:000476114200082
J	Gruntman, AM; Flotte, TR				Gruntman, Alisha M.; Flotte, Terence R.			The rapidly evolving state of gene therapy	FASEB JOURNAL			English	Review						AAV; lentivirus; gammaretrovirus; approved clinical products; vector platforms; gene editing	HERPES-SIMPLEX-VIRUS; HUMAN VISUAL-CORTEX; DOUBLE-STRANDED-RNA; IMMUNE-RESPONSES; MESSENGER-RNA; ADENOASSOCIATED VIRUSES; CONGENITAL AMAUROSIS; MALIGNANT GLIOMAS; CLINICAL-TRIAL; WILD-TYPE	Gene therapy is emerging as a viable option for clinical therapy of monogenic disorders and other genetically defined diseases, with approved gene therapies available in Europe and newly approved gene therapies in the United States. In the past 10 years, gene therapy has moved from a distant possibility, even in the minds of much of the scientific community, to being widely realized as a valuable therapeutic tool with wide-ranging potential. The U.S. Food and Drug Administration has recently approved Luxturna (Spark Therapeutics Inc, Philadelphia, PA, USA), a recombinant adeno-associated virus (rAAV) 2 gene therapy for one type of Leber congenital amaurosis 2 (1, 2). The European Medicines Agency (EMA) has approved 3 recombinant viral vector products: Glybera (UniQure, Amsterdam, The Netherlands), an rAAV vector for lipoprotein lipase deficiency; Strimvelis (Glaxo Smith-Kline, Brentford, United Kingdom), an ex vivo gammaretrovirus-based therapy for patients with adenosine deaminase-deficient severe combined immune deficiency (ADA-SCID); and Kymriah (Novartis, Basel, Switzerland), an ex vivo lentivirus-based therapy to engineer autologous chimeric antigen-receptor T (CAR-T) cells targeting CD19-positive cells in acute lymphoblastic leukemia. These examples will be followed by the clinical approval of other gene therapy products as this field matures. In this review we provide an overview of the state of gene therapy by discussing where the field stands with respect to the different gene therapy vector platforms and the types of therapies that are available.	[Gruntman, Alisha M.; Flotte, Terence R.] Univ Massachusetts, Sch Med, Dept Pediat, Horae Gene Therapy Ctr, Worcester, MA 01655 USA; [Gruntman, Alisha M.] Tufts Univ, Cummings Sch Vet Med, Dept Clin Sci, North Grafton, MA USA	University of Massachusetts System; University of Massachusetts Worcester; Tufts University	Flotte, TR (corresponding author), Univ Massachusetts, Sch Med, Suite 340,55 Lake Ave North, Worcester, MA 01655 USA.	terry.flotte@umassmed.edu						Aartsma-Rus A, 2002, NEUROMUSCULAR DISORD, V12, pS71, DOI 10.1016/S0960-8966(02)00086-X; Abdelaziz M, 2016, REPROD SCI, V23, P464, DOI 10.1177/1933719116630413; Alton EWFW, 2015, AM J RESP CRIT CARE, V192, P1389, DOI 10.1164/rccm.201506-1193LE; Antoszczyk S, 2014, NEURO-ONCOLOGY, V16, P1057, DOI 10.1093/neuonc/not317; Ashtari M, 2017, OPHTHALMOLOGY, V124, P873, DOI 10.1016/j.ophtha.2017.01.029; Ashtari M, 2011, J CLIN INVEST, V121, P2160, DOI 10.1172/JCI57377; Asif A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02169; Bailer SM, 2017, VIRUS GENES, V53, P741, DOI 10.1007/s11262-017-1482-7; BISHOP JM, 1980, COLD SPRING HARB SYM, V44, P919, DOI 10.1101/SQB.1980.044.01.099; BLAESE RM, 1995, SCIENCE, V270, P475, DOI 10.1126/science.270.5235.475; Chahal JS, 2016, P NATL ACAD SCI USA, V113, pE4133, DOI 10.1073/pnas.1600299113; Choi AH, 2016, BIOMEDICINES, V4, DOI 10.3390/biomedicines4030018; Churchill L, 2006, BRAIN RES, V1120, P64, DOI 10.1016/j.brainres.2006.08.083; Cirak S, 2012, MOL THER, V20, P462, DOI 10.1038/mt.2011.248; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; CRYSTAL RG, 1994, NAT GENET, V8, P42, DOI 10.1038/ng0994-42; Cullis PR, 2017, MOL THER, V25, P1467, DOI 10.1016/j.ymthe.2017.03.013; Dahlman JE, 2014, NAT NANOTECHNOL, V9, P648, DOI [10.1038/NNANO.2014.84, 10.1038/nnano.2014.84]; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; de Melo SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128922; Dobbins GC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145272; Du BJ, 2015, SMALL, V11, P2333, DOI 10.1002/smll.201402470; Duffy MR, 2017, HUM GENE THER, V28, P1033, DOI 10.1089/hum.2017.112; Eissa Ibrahim Ragab, 2017, Front Oncol, V7, P149, DOI 10.3389/fonc.2017.00149; Felgner P L, 1991, Methods Mol Biol, V7, P81, DOI 10.1385/0-89603-178-0:81; Felgner PL, 1997, HUM GENE THER, V8, P511, DOI 10.1089/hum.1997.8.5-511; FELGNER PL, 1989, NATURE, V337, P387, DOI 10.1038/337387a0; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fukuhara H, 2016, CANCER SCI, V107, P1373, DOI 10.1111/cas.13027; Futami M, 2017, MOL THER-ONCOLYTICS, V6, P57, DOI 10.1016/j.omto.2017.07.001; Gambini E, 2012, MOL THER, V20, P994, DOI 10.1038/mt.2012.22; Gao GP, 2003, P NATL ACAD SCI USA, V100, P6081, DOI 10.1073/pnas.0937739100; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Goins WF, 2014, METHODS MOL BIOL, V1144, P63, DOI 10.1007/978-1-4939-0428-0_5; Goss JR, 2014, J PAIN RES, V7, P71, DOI 10.2147/JPR.S36619; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Greig JA, 2017, HUM GENE THER, V28, P392, DOI 10.1089/hum.2016.128; Guedon JMG, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0018-1; Haddad D, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00096; Hartmann J, 2016, AM J HEMATOL, V91, P1252, DOI 10.1002/ajh.24543; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; JOHNSTON SA, 1994, METHOD CELL BIOL, V43, P353; Kanda H, 2016, GENE THER, V23, P340, DOI 10.1038/gt.2016.3; Kaplan JM, 1997, HUM GENE THER, V8, P45, DOI 10.1089/hum.1997.8.1-45; Kaplan JM, 1996, GENE THER, V3, P117; Keeler AM, 2017, CTS-CLIN TRANSL SCI, V10, P242, DOI 10.1111/cts.12466; Kibaly C, 2016, INT REV CEL MOL BIO, V327, P89, DOI 10.1016/bs.ircmb.2016.06.002; Kuruppu D, 2015, CANCER GENE THER, V22, P506, DOI 10.1038/cgt.2015.43; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; LEGENDRE JY, 1992, PHARMACEUT RES, V9, P1235, DOI 10.1023/A:1015836829670; Li BZ, 2015, HUM GENE THER METHOD, V26, P211, DOI 10.1089/hgtb.2015.115; Li Y, 2017, BIOCHEM BIOPH RES CO, V491, P134, DOI 10.1016/j.bbrc.2017.07.062; Loskog A, 2016, BRIT J CANCER, V114, P872, DOI 10.1038/bjc.2016.42; Loskog A, 2015, VIRUSES-BASEL, V7, P5780, DOI 10.3390/v7112899; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; Mazzacurati L, 2015, MOL THER, V23, P99, DOI 10.1038/mt.2014.177; McCormack MP, 2004, NEW ENGL J MED, V350, P913, DOI 10.1056/NEJMra032207; Meidahl AC, 2017, GENE THER, V24, P482, DOI 10.1038/gt.2017.55; Miao L, 2014, BRIT J CANCER, V110, P94, DOI 10.1038/bjc.2013.692; MILLER AD, 1983, P NATL ACAD SCI-BIOL, V80, P4709, DOI 10.1073/pnas.80.15.4709; Miller JB, 2017, ANGEW CHEM INT EDIT, V56, P1059, DOI 10.1002/anie.201610209; Morral N, 1997, HUM GENE THER, V8, P1275, DOI 10.1089/hum.1997.8.10-1275; Msaouel P, 2018, CURR CANCER DRUG TAR, V18, P177, DOI 10.2174/1568009617666170222125035; Mueller C, 2012, MOL THER, V20, P590, DOI 10.1038/mt.2011.292; Nagasato M, 2017, ANTICANCER RES, V37, P3599, DOI 10.21873/anticanres.11730; Nair JK, 2014, J AM CHEM SOC, V136, P16958, DOI 10.1021/ja505986a; Nathwani A, 2017, HUM GENE THER, V28, pA2; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Ortmann KLM, 2014, BRAIN BEHAV IMMUN, V41, P144, DOI 10.1016/j.bbi.2014.05.009; Orzechowska BU, 2017, J CANCER, V8, P2369, DOI 10.7150/jca.19473; Pacholska A, 2012, CANCER GENE THER, V19, P870, DOI 10.1038/cgt.2012.76; PARKER RC, 1981, P NATL ACAD SCI-BIOL, V78, P5842, DOI 10.1073/pnas.78.9.5842; Pierce EA, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a017285; Porter DL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5415; Rahal A, 2017, J SURG ONCOL, V116, P94, DOI 10.1002/jso.24626; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robinson S, 2017, EXPERT OPIN BIOL TH, V17, P353, DOI 10.1080/14712598.2017.1288713; ROSENBERG SA, 1990, NEW ENGL J MED, V323, P570, DOI 10.1056/NEJM199008303230904; Sanchala DS, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00270; Santiago DN, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9090239; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Sontheimer EJ, 2015, HUM GENE THER, V26, P413, DOI 10.1089/hum.2015.091; SORSCHER EJ, 1994, HUM GENE THER, V5, P1259, DOI 10.1089/hum.1994.5.10-1259; STUHLMANN H, 1989, MOL CELL BIOL, V9, P100, DOI 10.1128/MCB.9.1.100; SWANSTROM R, 1983, P NATL ACAD SCI-BIOL, V80, P2519, DOI 10.1073/pnas.80.9.2519; Tang MX, 1996, BIOCONJUGATE CHEM, V7, P703, DOI 10.1021/bc9600630; Todo T, 2012, ADV EXP MED BIOL, V746, P178, DOI 10.1007/978-1-4614-3146-6_14; Urtti A, 2000, J DRUG TARGET, V7, P413, DOI 10.3109/10611860009102216; Wang M, 2016, P NATL ACAD SCI USA, V113, P2868, DOI 10.1073/pnas.1520244113; Wang WW, 2013, CURR PHARM BIOTECHNO, V14, P46; Wang YG, 2016, WORLD J GASTROENTERO, V22, P326, DOI 10.3748/wjg.v22.i1.326; Watanabe N, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2014.66; Waters AM, 2017, HUM GENE THER CL DEV, V28, P7, DOI 10.1089/humc.2017.002; WESTON A, 1981, J BACTERIOL, V145, P780, DOI 10.1128/JB.145.2.780-787.1981; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xenariou S, 2010, ACTA BIOCH BIOPH SIN, V42, P45, DOI 10.1093/abbs/gmp100; Xu YH, 1999, BIOPHYS J, V77, P341, DOI 10.1016/S0006-3495(99)76894-3; Yamada T, 2018, CURR CANCER DRUG TAR, V18, P188, DOI 10.2174/1568009617666170330123841; YANG YP, 1995, J VIROL, V69, P2004, DOI 10.1128/JVI.69.4.2004-2015.1995; Ye JF, 2017, CELL IMMUNOL, V318, P35, DOI 10.1016/j.cellimm.2017.06.002; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Yin J, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00136; Yoon AR, 2016, EXPERT OPIN DRUG DEL, V13, P843, DOI 10.1517/17425247.2016.1158707; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhang J, 2017, BIOCHEM BIOPH RES CO, V491, P469, DOI 10.1016/j.bbrc.2017.07.041; Zhao F, 2014, J NEURO-ONCOL, V118, P239, DOI 10.1007/s11060-014-1444-z; Zheng WW, 2014, ANESTH ANALG, V119, P693, DOI 10.1213/ANE.0000000000000311	110	22	23	3	53	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1733	1740		10.1096/fj.201700982R	http://dx.doi.org/10.1096/fj.201700982R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	31282760				2022-12-28	WOS:000429051400002
J	Orrego, LM; Cabello-Donayre, M; Vargas, P; Martinez-Garcia, M; Sanchez, C; Pineda-Molina, E; Jimenez, M; Molina, R; Perez-Victoria, JM				Orrego, Lina M.; Cabello-Donayre, Maria; Vargas, Paola; Martinez-Garcia, Marta; Sanchez, Clara; Pineda-Molina, Estela; Jimenez, Maribel; Molina, Ricardo; Perez-Victoria, Jose M.			Heme synthesis through the life cycle of the heme auxotrophic parasite Leishmania major	FASEB JOURNAL			English	Article						porphyrins; trypanosomatid protozoa; ferrochelatase; leishmaniasis	PORPHYRIN BIOSYNTHESIS; TRYPANOSOMA-CRUZI; HUMAN FERROCHELATASE; GENE-EXPRESSION; HEMOGLOBIN; RESISTANCE; PATHWAY; PROTEIN; PROMASTIGOTES; UROPORPHYRIA	Heme is an essential molecule synthetized through a broadly conserved 8-step route that has been lost in trypanosomatid parasites. Interestingly, Leishmania reacquired by horizontal gene transfer from gamma-proteobacteria the genes coding for the last 3 enzymes of the pathway. Here we show that intracellular amastigotes of Leishmania major can scavenge heme precursors from the host cell to fulfill their heme requirements, demonstrating the functionality of this partial pathway. To dissect its role throughout the L. major life cycle, the significance of L. major ferrochelatase (LmFeCH), the terminal enzyme of the route, was evaluated. LmFeCH expression in a heterologous system demonstrated its activity. Knockout promastigotes lacking imfech were not able to use the ferrochelatase substrate protoporphyrin IX as a source of heme. In vivo infection of Phlebotomus perniciosus with knockout promastigotes shows that LmFeCH is not required for their development in the sandfly. In contrast, the replication of intracellular amastigotes was hampered in vitro by the deletion of lmfech. However, LmFeCH(-/-) parasites produced disease in a cutaneous leishmaniasis murine model in a similar way as control parasites. Therefore, although L. major can synthesize de novo heme from macrophage precursors, this activity is dispensable being an unsuited target for leishmaniasis treatment.	[Orrego, Lina M.; Cabello-Donayre, Maria; Vargas, Paola; Martinez-Garcia, Marta; Sanchez, Clara; Pineda-Molina, Estela; Perez-Victoria, Jose M.] CSIC, IPBLN, PTS Granada, Granada 18016, Spain; [Jimenez, Maribel; Molina, Ricardo] Inst Salud Carlos III, Ctr Nacl Microbiol, Serv Parasitol, Unidad Entomol Med, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Perez-Victoria, JM (corresponding author), CSIC, IPBLN, PTS Granada, Granada 18016, Spain.	josepv@ipb.csic.es	/AAB-5411-2019; Vargas, Paola/V-8566-2018; Zapata, Lina María Orrego/AAU-5152-2021; García, Marta Martínez/AAA-1218-2020; Donayre, María Cabello/AAB-2142-2020	/0000-0003-0552-5837; Vargas, Paola/0000-0002-9034-1006; Cabello-Donayre, Maria/0000-0002-6196-5813	Spanish Ministerio de Economia y Competitividad [SAF2016-80228-R]; Junta de Andalucia [BIO1786]; European Regional Development Fund (FEDER) from the European Union; Administrative Department of Science, Technology and Innovation (COLCIENCIAS) fellowship from the Colombian Ministerio de Ciencia, Tecnologia e Innovacion	Spanish Ministerio de Economia y Competitividad(Spanish Government); Junta de Andalucia(Junta de Andalucia); European Regional Development Fund (FEDER) from the European Union; Administrative Department of Science, Technology and Innovation (COLCIENCIAS) fellowship from the Colombian Ministerio de Ciencia, Tecnologia e Innovacion(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	The authors thank Santiago Castanys [Instituto de Parasitologia y Biomedicina Lopez-Neyra-Consejo Superior de Investigaciones Cientificas (IPBLN-CSIC)] for critical reading of the manuscript. The authors also thank Dr. Harry A. Dailey (University of Georgia, Athens, GA, USA), Stephen M. Beverley (Washington University School of Medicine, St. Louis, MO, USA), Santiago Castanys (IPBLN-CSIC) and Martin C. Taylor (London School of Hygiene and Tropical Medicine, London, United Kingdom), and Bruce Branchini (Connecticut College, New London, CT, USA) for kindly providing, respectively, the Delta hemG and Delta hemH bacteria strains, the Leishmania pXG vectors, the anti-LRos3 antibody, and the luciferase vector pTb-AMLuc used throughout this research work. The authors thank Dr. Eva Gluenz and Dr. Tom Beneke (University of Oxford, Oxford, United Kingdom) and Dr. Yvon Sterkers and Jose-Juan Lopez-Rubio (University of Montpellier, Montpellier, France) for kindly providing the plasmids and for valuable technical advice used in CRISPR/Cas9 systems. The authors also thank Miguel Angel Toro for assistance in bioinformatics tools. This work was supported by the Spanish Ministerio de Economia y Competitividad (SAF2016-80228-R to J.M.P.-V.), the Junta de Andalucia (BIO1786 to J.M.P.-V.), and European Regional Development Fund (FEDER) from the European Union to J.M.P.-V. L.M.O. is a student of the Ph.D. Biochemistry and Molecular Biology Program of the University of Granada, and recipient of an Administrative Department of Science, Technology and Innovation (COLCIENCIAS) fellowship from the Colombian Ministerio de Ciencia, Tecnologia e Innovacion. The authors declare no conflicts of interest.	Akilov OE, 2007, EXP DERMATOL, V16, P651, DOI 10.1111/j.1600-0625.2007.00578.x; Alam MZ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00033; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Alves JMP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023518; Armas AM, 2019, BIOCHIMIE, V156, P118, DOI 10.1016/j.biochi.2018.10.009; Bates PA, 2007, INT J PARASITOL, V37, P1097, DOI 10.1016/j.ijpara.2007.04.003; Beneke T, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170095; Bonday ZQ, 1997, J BIOL CHEM, V272, P21839, DOI 10.1074/jbc.272.35.21839; Burden AE, 1999, BBA-PROTEIN STRUCT M, V1435, P191, DOI 10.1016/S0167-4838(99)00196-X; Burza S, 2018, LANCET, V392, P951, DOI 10.1016/S0140-6736(18)31204-2; Cabello-Donayre M, 2020, CELL MOL LIFE SCI, V77, P1827, DOI 10.1007/s00018-019-03258-3; Cabello-Donayre M, 2016, MOL MICROBIOL, V101, P895, DOI 10.1111/mmi.13430; CAMADRO JM, 1991, BIOCHEM J, V277, P17, DOI 10.1042/bj2770017; Campos-Salinas J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002179; Campos-Salinas J, 2011, MOL MICROBIOL, V79, P1430, DOI 10.1111/j.1365-2958.2010.07531.x; Carvalho S, 2009, ACTA TROP, V109, P131, DOI 10.1016/j.actatropica.2008.10.007; Cenci U, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0664-6; CHANG CS, 1985, MOL BIOCHEM PARASIT, V16, P267, DOI 10.1016/0166-6851(85)90069-6; CHANG KP, 1975, P NATL ACAD SCI USA, V72, P2979, DOI 10.1073/pnas.72.8.2979; Huynh C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002795; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dailey HA, 2000, CELL MOL LIFE SCI, V57, P1909, DOI 10.1007/PL00000672; Dillon LAL, 2015, NUCLEIC ACIDS RES, V43, P6799, DOI 10.1093/nar/gkv656; Dutta S, 2008, EUKARYOT CELL, V7, P1146, DOI 10.1128/EC.00365-07; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Fernandes MC, 2016, MBIO, V7, DOI 10.1128/mBio.00027-16; Ghobakhloo N, 2019, TROP MED INT HEALTH, V24, P116, DOI 10.1111/tmi.13042; Ghorbani M, 2018, DRUG DES DEV THER, V12, P25, DOI 10.2147/DDDT.S146521; Ghosh S, 2012, J CLIN MICROBIOL, V50, P2774, DOI 10.1128/JCM.00966-12; Goldberg DE, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006511; Goto Y, 2017, PARASITOL RES, V116, P457, DOI 10.1007/s00436-016-5313-x; Hao GF, 2011, CHIMIA, V65, P961, DOI 10.2533/chimia.2011.961; Heinemann IU, 2008, ARCH BIOCHEM BIOPHYS, V474, P238, DOI 10.1016/j.abb.2008.02.015; Hunter GA, 2011, J PORPHYR PHTHALOCYA, V15, P350, DOI 10.1142/S108842461100332X; Inbar E, 2017, MBIO, V8, DOI [10.1128/mBio.00029-17, 10.1128/mbio.00029-17]; Jimenez MI, 1996, LANCET, V347, P264, DOI 10.1016/S0140-6736(96)90441-9; Kamhawi S, 2006, TRENDS PARASITOL, V22, P439, DOI 10.1016/j.pt.2006.06.012; Ke HJ, 2014, J BIOL CHEM, V289, P34827, DOI 10.1074/jbc.M114.615831; Kelly JX, 2003, MOL BIOCHEM PARASIT, V126, P43, DOI 10.1016/S0166-6851(02)00248-7; Koreny L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003088; Koreny L, 2010, INT J PARASITOL, V40, P149, DOI 10.1016/j.ijpara.2009.11.007; Kraeva N, 2014, MOL BIOCHEM PARASIT, V198, P11, DOI 10.1016/j.molbiopara.2014.11.002; Krishnamurthy G, 2005, J BIOL CHEM, V280, P5884, DOI 10.1074/jbc.M411845200; Lara FA, 2007, BIOCHEM BIOPH RES CO, V355, P16, DOI 10.1016/j.bbrc.2006.12.238; Lechuga GC, 2019, J DRUG TARGET, V27, P767, DOI 10.1080/1061186X.2018.1536982; Liu D, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00083; Lukes J, 2014, MOL BIOCHEM PARASIT, V195, P115, DOI 10.1016/j.molbiopara.2014.05.007; Luz NF, 2012, J IMMUNOL, V188, P4460, DOI 10.4049/jimmunol.1103072; Lwoff M., 1933, ANN I PASTEUR PARIS, V51, P703; Martinez-Garcia M, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-015-1284-5; Martins VT, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002148, 10.1371/annotation/427655ac-c278-41f5-95ca-6279c562752f]; MCGHEE RB, 1980, MICROBIOL REV, V44, P140, DOI 10.1128/MMBR.44.1.140-173.1980; McLatchie AP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002571; Mittra B, 2013, J EXP MED, V210, P401, DOI 10.1084/jem.20121368; Molina R., 1993, Research and Reviews in Parasitology, V51, P87; Molina R., 2017, METHODS SAND FLY RES; Morio F, 2008, J CLIN MICROBIOL, V46, P3845, DOI 10.1128/JCM.01098-08; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Nagaraj VA, 2017, TRENDS PARASITOL, V33, P583, DOI 10.1016/j.pt.2017.04.005; Nagaraj VA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003522; NAKAHIGASHI K, 1991, P NATL ACAD SCI USA, V88, P10520, DOI 10.1073/pnas.88.23.10520; Opperdoes FR, 2007, TRENDS PARASITOL, V23, P149, DOI 10.1016/j.pt.2007.02.004; Opperdoes Fred R., 2008, P123; Pace D, 2014, J INFECTION, V69, pS10, DOI 10.1016/j.jinf.2014.07.016; PADMANABAN G, 1989, TRENDS BIOCHEM SCI, V14, P492, DOI 10.1016/0968-0004(89)90182-5; Patzoldt WL, 2006, P NATL ACAD SCI USA, V103, P12329, DOI 10.1073/pnas.0603137103; Perez-Victoria JM, 2011, ANTIMICROB AGENTS CH, V55, P3838, DOI 10.1128/AAC.00065-11; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Qin XH, 2011, FASEB J, V25, P653, DOI 10.1096/fj.10-170811; Rastrojo A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-223; Rathnapala UL, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006396; Rochette Annie, 2008, BMC Genomics, V9, P255, DOI 10.1186/1471-2164-9-255; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; Sah JF, 2002, J BIOL CHEM, V277, P14902, DOI 10.1074/jbc.M200107200; Saha S, 2019, J IMMUNOL, V202, P827, DOI 10.4049/jimmunol.1800958; SALZMAN TA, 1982, COMP BIOCHEM PHYS B, V72, P663, DOI 10.1016/0305-0491(82)90523-5; Sant'Anna C, 2009, PROTEOMICS, V9, P1782, DOI 10.1002/pmic.200800730; SASARMAN A, 1979, J GEN MICROBIOL, V113, P297, DOI 10.1099/00221287-113-2-297; SCHLEIN Y, 1994, PARASITOLOGY, V109, P23, DOI 10.1017/S0031182000077726; Sengupta S, 1999, J BIOL CHEM, V274, P2758, DOI 10.1074/jbc.274.5.2758; Soares MP, 2016, IMMUNITY, V44, P492, DOI 10.1016/j.immuni.2016.02.016; Sollelis L, 2015, CELL MICROBIOL, V17, P1405, DOI 10.1111/cmi.12456; Srivastava P, 2010, INFECT GENET EVOL, V10, P1145, DOI 10.1016/j.meegid.2010.07.009; Svarovska Anna, 2010, PLoS Negl Trop Dis, V4, pe580, DOI 10.1371/journal.pntd.0000580; Thakur AK, 2013, EXP PARASITOL, V135, P595, DOI 10.1016/j.exppara.2013.09.008; Tripodi Karina E J, 2011, Enzyme Res, V2011, P873230, DOI 10.4061/2011/873230; van Zandbergen G, 2004, J IMMUNOL, V173, P6521, DOI 10.4049/jimmunol.173.11.6521; Vasudevan D, 2016, NITRIC OXIDE-BIOL CH, V59, P54, DOI 10.1016/j.niox.2016.08.002; Vikeved E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004326; Wu B, 2013, P NATL ACAD SCI USA, V110, P7748, DOI 10.1073/pnas.1304049110; Wu B, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000475; Wu CK, 2001, NAT STRUCT BIOL, V8, P156, DOI 10.1038/84152; Zaidi A, 2015, BIOCHIMIE, V115, P120, DOI 10.1016/j.biochi.2015.05.016; Zwerschke D, 2014, BIOSCIENCE REP, V34, P391, DOI 10.1042/BSR20140081	95	8	8	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13367	13385		10.1096/fj.201901274RR	http://dx.doi.org/10.1096/fj.201901274RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31553893	Bronze			2022-12-28	WOS:000507466100027
J	Chen, JL; Zhou, RP; Liang, YM; Fu, XJ; Wang, DR; Wang, C				Chen, Jialin; Zhou, Renpeng; Liang, Yimin; Fu, Xiujun; Wang, Danru; Wang, Chen			Blockade of lncRNA-ASLNCS5088-enriched exosome generation in M2 macrophages by GW4869 dampens the effect of M2 macrophages on orchestrating fibroblast activation	FASEB JOURNAL			English	Article						hypertrophic scar; exosome inhibitor; TGF-beta 1; microRNA; glutaminase	DEPLETION; REPAIR; CELLS	In hypertrophic scar (HS) formation, the type 2 immune response induces the alternatively activated macrophages (M2), which manipulate fibroblasts to differentiate into myofibroblasts with active biologic functions and proliferation. Myofibroblasts express a-smooth muscle actin (a-SMA) and synthesize and produce additional collagen type I and collagen type III, inducing HS formation. However, studies on the mechanism of M2 macrophage modulation are only based on the recognition of profibrotic factors such as TGF-beta 1 secreted by macrophages. The influence of exosomes from M2 macrophages on scar formation is still unknown. Both M2 macrophages and myofibroblasts highly express glutaminases (GLSs). GLS is a critical enzyme in glutaminolysis and is important for M2 macrophage and fibroblast polarization. In this study, we found that in a TGF-beta 1-stimulated coculture system, a long noncoding RNA (lncRNA) named lncRNA-ASLNCS5088 was enriched in M2 macrophage-derived exosomes. This lncRNA could be transferred with high efficiency to fibroblasts and acted as an endogenous sponge to adsorb microRNA-200c-3p, resulting in increased GLS and alpha-SMA expression. Pretreatment with GW4869, which impairs M2 macrophage exosome synthesis, ameliorated these pathologic changes in fibroblasts in vitro. Local injection in the late scar formation period with GW4869 reduced alpha-SMA + fibroblasts and alleviated the fibrosis of tissue after wound healing in vivo.	[Chen, Jialin; Zhou, Renpeng; Liang, Yimin; Fu, Xiujun; Wang, Danru; Wang, Chen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Plast & Reconstruct Surg, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China	Shanghai Jiao Tong University	Wang, DR; Wang, C (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Plast & Reconstruct Surg, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China.	wangdanru1776@163.com; wangchen1075@163.com		Chen, Jialin/0000-0001-8445-0823				Barile L, 2017, PHARMACOL THERAPEUT, V174, P63, DOI 10.1016/j.pharmthera.2017.02.020; Bernard K, 2018, J BIOL CHEM, V293, P1218, DOI 10.1074/jbc.RA117.000444; Bosurgi L, 2017, SCIENCE, V356, P1072, DOI 10.1126/science.aai8132; Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236; Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153; Gezer U, 2014, CELL BIOL INT, V38, P1076, DOI 10.1002/cbin.10301; Gieseck RL, 2018, NAT REV IMMUNOL, V18, P62, DOI 10.1038/nri.2017.90; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gundra UM, 2014, BLOOD, V123, pE110, DOI 10.1182/blood-2013-08-520619; Guo BB, 2015, J BIOL CHEM, V290, P3455, DOI 10.1074/jbc.M114.605253; Hesketh M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071545; Hewson Chris, 2016, Noncoding RNA Res, V1, P3, DOI 10.1016/j.ncrna.2016.06.001; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Kalluri R, 2016, J CLIN INVEST, V126, P1208, DOI 10.1172/JCI81135; Kant S, 2019, ADV SKIN WOUND CARE, V32, P26, DOI 10.1097/01.ASW.0000547415.38888.c4; Kim MH, 2008, J INVEST DERMATOL, V128, P1812, DOI 10.1038/sj.jid.5701223; Klinkert K, 2017, EUR SURG RES, V58, P109, DOI 10.1159/000451078; Knipper JA, 2015, IMMUNITY, V43, P803, DOI 10.1016/j.immuni.2015.09.005; Kogure Takayuki, 2013, Genes Cancer, V4, P261, DOI 10.1177/1947601913499020; Li-Tsang CWP, 2005, BURNS, V31, P610, DOI 10.1016/j.burns.2005.01.022; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Marshall CD, 2018, ADV WOUND CARE, V7, P29, DOI 10.1089/wound.2016.0696; Milane L, 2015, J CONTROL RELEASE, V219, P278, DOI 10.1016/j.jconrel.2015.06.029; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Naderi-Meshkin H, 2019, BIOINFORMATICS, V35, P352, DOI 10.1093/bioinformatics/bty527; Ploeger DTA, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-29; Shook B, 2016, J INVEST DERMATOL, V136, P1885, DOI 10.1016/j.jid.2016.05.107; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Xue ML, 2015, ADV WOUND CARE, V4, P119, DOI 10.1089/wound.2013.0485; Zhang ZT, 2019, EUR J PHARM BIOPHARM, V137, P122, DOI 10.1016/j.ejpb.2019.02.009; Zhu ZS, 2016, WOUND REPAIR REGEN, V24, P644, DOI 10.1111/wrr.12442	33	45	47	2	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12200	12212		10.1096/fj.201901610	http://dx.doi.org/10.1096/fj.201901610			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31373848	Green Published, Bronze			2022-12-28	WOS:000507461600047
J	Nouri, K; Azad, T; Lightbody, E; Khanal, P; Nicol, CJ; Yang, XL				Nouri, Kazem; Azad, Taha; Lightbody, Elizabeth; Khanal, Prem; Nicol, Christopher J.; Yang, Xiaolong			A kinome-wide screen using a NanoLuc LATS luminescent biosensor identifies ALK as a novel regulator of the Hippo pathway in tumorigenesis and immune evasion	FASEB JOURNAL			English	Article						PD-L1; kinases; lung cancer; immunotherapy; breast cancer	SIGNALING PATHWAYS; KINASES; CANCER; REPORTER	The Hippo pathway is an emerging signaling pathway that plays important roles in organ size control, tissue homeostasis, tumorigenesis, metastasis, drug resistance, and immune response. Although many regulators of the Hippo pathway have been reported, the extracellular stimuli and kinase regulators of the Hippo pathway remain largely unknown. To identify novel regulars of the Hippo pathway, in this study we created the first ultra-bright NanoLuc biosensor (BS) to monitor the activity of large tumor suppressor (LATS) kinase 1, a central player of the Hippo pathway. We show that this NanoLuc BS achieves significantly advanced sensitivity and stability both in vitro using purified proteins and in vivo in living cells and mice. Using this BS, we perform the first kinome-wide screen and identify many kinases regulating LATS and its effectors yes-associated protein (YAP) and transcriptional co-activator with PDZ- binding motif (TAZ). We also show for the first time that activation of receptor tyrosine kinase anaplastic lymphoma kinase (ALK) by its extracellular ligand family with sequence similarity (FAM)150 activates Hippo effector YAP/TAZ by increasing their nuclear translocation. Significantly, we show that constitutively active ALK induces tumorigenic phenotypes, such as increased cancer cell proliferation/colony formation via YAP/TAZ and elevated immune evasion via YAP/TAZ-programmed death-ligand 1 in breast and lung cancer cells. In summary, we have developed a new LATS BS for cancer biology and therapeutics research and uncovered a novel ALK-LATS-YAP/TAZ signaling axis that may play important roles in cancer and possibly other biologic processes.	[Nouri, Kazem; Azad, Taha; Lightbody, Elizabeth; Khanal, Prem; Nicol, Christopher J.; Yang, Xiaolong] Queens Univ, Dept Pathol & Mol Med, 88 Stuart St,Richardson Lab Room 306A, Kingston, ON K7L 3N6, Canada	McMaster University; Queens University - Canada	Yang, XL (corresponding author), Queens Univ, Dept Pathol & Mol Med, 88 Stuart St,Richardson Lab Room 306A, Kingston, ON K7L 3N6, Canada.	yangx@queensu.ca	Azad, Taha/AAO-7975-2020; Azad, Taha/AAF-5600-2020	Nouri, Kazem/0000-0001-7787-1304; Azad, Taha/0000-0002-9498-0657	Queen's University Terry Fox Research Institute Transdisciplinary Training Program in Cancer Research Fellowship; Dr. Robert John Wilson Graduate Fellowship; Canadian Institute of Health Research (CIHR) [119325, 148629]; Canadian Breast Cancer Foundation/Canadian Cancer Society (CBCF/CRS); Breast Cancer Action Kingston and Kingston General Hospital Foundation; Vanier Canada Graduate Scholarship; Ontario International Graduate Scholarship	Queen's University Terry Fox Research Institute Transdisciplinary Training Program in Cancer Research Fellowship; Dr. Robert John Wilson Graduate Fellowship; Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation/Canadian Cancer Society (CBCF/CRS); Breast Cancer Action Kingston and Kingston General Hospital Foundation; Vanier Canada Graduate Scholarship; Ontario International Graduate Scholarship	The authors thank Yawei Hao (Queen's University) for performing the quantitative RT-PCR and technical support. The authors also thank Dr. Ruth Palmer (Gothenburg University, Gothenburg, Sweden) and Dr. Jikui Guan (Gothenburg University) for providing the FAM150 plasmid, and Dr. Alessandro Datti (S.M.A.R.T. Laboratory for the High-Throughput Screening Programs of the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada) for high-throughput screen for kinases regulating large tumor suppressor kinase 1. E.L. was supported by the Queen's University Terry Fox Research Institute Transdisciplinary Training Program in Cancer Research Fellowship and the Dr. Robert John Wilson Graduate Fellowship. This work was supported by grants from Canadian Institute of Health Research (CIHR; 119325 and 148629 to X.Y.), the Canadian Breast Cancer Foundation/Canadian Cancer Society (CBCF/CRS; to X. Y. and C.J.N.), and the Breast Cancer Action Kingston and Kingston General Hospital Foundation (to C.J.N.). T.A. was supported by the Vanier Canada Graduate Scholarship and Ontario International Graduate Scholarship. The authors declare no conflicts of interest.	Azad T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03278-w; Azad T., 2018, JOVE-J VIS EXP, V139; Baltussen LL, 2018, PROG NEURO-PSYCHOPH, V84, P343, DOI 10.1016/j.pnpbp.2017.12.006; Beauchamp RL, 2015, ONCOTARGET, V6, P16981, DOI 10.18632/oncotarget.4858; Burke JE, 2018, MOL CELL, V71, P653, DOI 10.1016/j.molcel.2018.08.005; Cao ZF, 2019, ONCOL LETT, V17, P2020, DOI 10.3892/ol.2018.9856; Clark CA, 2017, AUTOPHAGY, V13, P987, DOI 10.1080/15548627.2017.1280223; Clark CA, 2016, CANCER RES, V76, P6964, DOI 10.1158/0008-5472.CAN-16-0258; Della Corte CM, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0776-2; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; England CG, 2016, BIOCONJUGATE CHEM, V27, P1175, DOI 10.1021/acs.bioconjchem.6b00112; Fu V, 2017, CURR OPIN CELL BIOL, V49, P99, DOI 10.1016/j.ceb.2017.12.012; Furth N, 2017, CELL DEATH DIFFER, V24, P1488, DOI 10.1038/cdd.2017.99; Golding B, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0810-4; Guan JK, 2015, ELIFE, V4, DOI 10.7554/eLife.09811; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hallberg B, 2016, ANN ONCOL, V27, P4, DOI 10.1093/annonc/mdw301; Hansen CG, 2015, TRENDS CELL BIOL, V25, P499, DOI 10.1016/j.tcb.2015.05.002; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Ho KC, 2011, P NATL ACAD SCI USA, V108, P4870, DOI 10.1073/pnas.1101273108; Jaiswal M, 2012, METHODS MOL BIOL, V827, P37, DOI 10.1007/978-1-61779-442-1_3; Kim JM, 2016, ANN ONCOL, V27, P1492, DOI 10.1093/annonc/mdw217; Koh J, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1108514; Loirand G, 2015, PHARMACOL REV, V67, P1074, DOI 10.1124/pr.115.010595; Nandipati KC, 2017, MOL CELL BIOCHEM, V426, P27, DOI 10.1007/s11010-016-2878-8; Nouri K, 2016, J BIOL CHEM, V291, P26364, DOI 10.1074/jbc.M116.752121; Ota K, 2015, CLIN CANCER RES, V21, P4014, DOI 10.1158/1078-0432.CCR-15-0016; Pavan S, 2018, ONCOGENE, V37, P4197, DOI 10.1038/s41388-018-0270-8; Regad T, 2015, CANCERS, V7, P1758, DOI 10.3390/cancers7030860; Reuven N, 2019, METHODS MOL BIOL, V1893, P215, DOI 10.1007/978-1-4939-8910-2_17; Salmaninejad A, 2019, J CELL PHYSIOL, V234, P16824, DOI 10.1002/jcp.28358; Shen J, 2018, CELL DEATH DIFFER, V25, P2053, DOI 10.1038/s41418-018-0080-0; Shin CH, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020178; Siraj AK, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0610-3; Taha Z, 2018, CANCERS, V10, DOI 10.3390/cancers10040094; Thompson BJ, 2015, J CELL BIOL, V210, P871, DOI 10.1083/jcb.201507005; Tzeng YDT, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01285; van Rensburg HJJ, 2018, CANCER RES, V78, P1457, DOI 10.1158/0008-5472.CAN-17-3139; van Rensburg HJJ, 2016, CELL SIGNAL, V28, P1761, DOI 10.1016/j.cellsig.2016.08.004; Wang L, 2020, MOL PSYCHIATR, V25, P2504, DOI 10.1038/s41380-018-0325-9; Yang XL, 2011, CELL RES, V21, P715, DOI 10.1038/cr.2011.63; Yokota T, 2016, GENE, V575, P369, DOI 10.1016/j.gene.2015.09.030; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhao YR, 2018, 2018 3RD IEEE INTERNATIONAL CONFERENCE ON ADVANCED ROBOTICS AND MECHATRONICS (IEEE ICARM), P165, DOI 10.1109/ICARM.2018.8610786; Zhao YL, 2018, MOL CANCER RES, V16, P1046, DOI 10.1158/1541-7786.MCR-17-0593; Zhao YL, 2015, INT J CANCER, V137, P2767, DOI 10.1002/ijc.29293	46	24	24	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12487	12499		10.1096/fj.201901343R	http://dx.doi.org/10.1096/fj.201901343R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31431076	Green Published			2022-12-28	WOS:000507461600069
J	Wu, W; Liu, LY; Zhu, HR; Sun, YT; Wu, Y; Liao, HZ; Gui, YH; Li, L; Liu, L; Sun, F; Lin, HW				Wu, Wei; Liu, Liyun; Zhu, Hongrui; Sun, Yating; Wu, Ying; Liao, Hongze; Gui, Yuhan; Li, Lei; Liu, Lei; Sun, Fan; Lin, Houwen			Butyrolactone-I, an efficient alpha-glucosidase inhibitor, improves type 2 diabetes with potent TNF-alpha-lowering properties through modulating gut microbiota in db/db mice	FASEB JOURNAL			English	Article						inflammatory cytokines; antidiabetic; anti-inflammation	CHAIN FATTY-ACIDS; INDUCED INFLAMMATION; ASPERGILLUS-TERREUS; INNATE IMMUNITY; BETA-CELLS; FUNGUS; OBESITY; DERIVATIVES; IMPACT; DYSFUNCTION	The aim of this study was to evaluate the effects of butyrolactone-I (A6) on type 2 diabetes (T2D) in db/db mice because A6 was found to inhibit alpha-glucosidase activities and TNF-alpha release, which were associated with improving T2D. Male db/db mice were divided into 6 groups and given an equivalent volume of olive oil, acarbose, or different doses of A6 for 4 wk (n = 8/group). In this study, 11 butenolide derivatives were screened for their alpha-glucosidase and TNF-alpha suppressive activity in vitro. A6, an efficient alpha-glucosidase inhibitor, exerts hypoglycemic and multiple activities in reducing weight, improving glucose tolerance and insulin resistance, increasing short-chain fatty acid (SCFA) levels, activating SCFA-induced increases in glucagon-like peptide 1 and peroxisome proliferator-activated receptor-gamma expression, enhancing intestinal mucosal barrier function and mitigating endoxemia in db/db mice. These effects may result from mediation of gut microbiota by A6. Meanwhile, A6, with potent TNF-alpha-lowering properties, was demonstrated to have multiple salutary effects with excellent structural stability and long-term safety in vivo. A6, an effective alpha-glucosidase inhibitor with high security and stability, exerted potent antidiabetic effects in vivo. Furthermore, the modulation of gut microbiota of A6 was demonstrated to be one of the mechanisms contributing to anti-inflammation properties and improving endoxemia. Our work confirms that the compound A6 is a prospective drug candidate for T2D.	[Wu, Wei; Liu, Liyun; Sun, Yating; Wu, Ying; Liao, Hongze; Gui, Yuhan; Li, Lei; Liu, Lei; Sun, Fan; Lin, Houwen] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Res Ctr Marine Drugs, Dept Pharm,Sch Med,Ren Ji Hosp, Pujian Rd 160, Shanghai 200127, Peoples R China; [Zhu, Hongrui] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut Sci, Shenyang, Liaoning, Peoples R China	Shanghai Jiao Tong University; Shenyang Pharmaceutical University	Sun, F; Lin, HW (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Res Ctr Marine Drugs, Dept Pharm,Sch Med,Ren Ji Hosp, Pujian Rd 160, Shanghai 200127, Peoples R China.	sunfan2017@163.com; franklin67@126.com		Lin, Hou-Wen/0000-0002-7097-0876	National Key Research and Development Program of China [2018YFC0310900]; National Natural Science Foundation of China [U1605221, 81502936, 21502113]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Key Research and Development Program of China (2018YFC0310900) and National Natural Science Foundation of China Grants/Awards: U1605221, 81502936, and 21502113. The authors declare no conflicts of interest.	An X, 2017, XENOBIOTICA, V47, P236, DOI 10.3109/00498254.2016.1172280; Andoh A, 2016, J CLIN BIOCHEM NUTR, V59, P65, DOI 10.3164/jcbn.15-152; Anuradha R, 2014, DNA CELL BIOL, V33, P743, DOI 10.1089/dna.2014.2352; Byndloss MX, 2017, SCIENCE, V357, P570, DOI 10.1126/science.aam9949; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Chassaing B, 2015, NATURE, V519, P92, DOI 10.1038/nature14232; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Christiansen CB, 2018, AM J PHYSIOL-GASTR L, V315, pG53, DOI 10.1152/ajpgi.00346.2017; da Silva IP, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2228-3; DiNicolantonio JJ, 2015, OPEN HEART, V2, DOI [10.1136/openhrt-2015-000326, 10.1136/openhrt-2014-000230]; Frydrych L, 2018, J LEUKOCYTE BIOL, V104, P525, DOI 10.1002/JLB.5VMR0118-021RR; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Goutam J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01334; Gu YY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01682-2; Han LP, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2641248; Ibrahim M, 2018, DIABETES-METAB RES, V34, DOI 10.1002/dmrr.3021; Jiang CY, 2016, APPL ENVIRON MICROB, V82, P2210, DOI 10.1128/AEM.03588-15; KIRIYAMA N, 1977, CHEM PHARM BULL, V25, P2593; Lepoittevin JP, 2009, CHEM REC, V9, P258, DOI 10.1002/tcr.200900013; Li Z, 2018, GUT, V67, P1269, DOI 10.1136/gutjnl-2017-314050; Lin X., 2016, MOLECULES, V22, pE3; Ling ZX, 2014, SCI REP-UK, V4, DOI 10.1038/srep07485; Liu GM, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700954; Luo C, 2015, INT IMMUNOPHARMACOL, V28, P744, DOI 10.1016/j.intimp.2015.07.018; Manco M, 2010, ENDOCR REV, V31, P817, DOI 10.1210/er.2009-0030; MAURY J, 1993, DIABETOLOGIA, V36, P503, DOI 10.1007/BF02743265; Meehan CJ, 2014, GENOME BIOL EVOL, V6, P703, DOI 10.1093/gbe/evu050; Miller DN, 1999, APPL ENVIRON MICROB, V65, P4715; Mohammad MK, 2006, INT IMMUNOL, V18, P1101, DOI 10.1093/intimm/dxl045; Morrison DJ, 2016, GUT MICROBES, V7, P189, DOI 10.1080/19490976.2015.1134082; Naguib G, 2004, J INVEST DERMATOL, V123, P87, DOI 10.1111/j.0022-202X.2004.22711.x; Nishio K, 1996, ANTICANCER RES, V16, P3387; Niu XM, 2008, J NAT PROD, V71, P689, DOI 10.1021/np070341r; Palonen Elina K, 2014, Microorganisms, V2, P111, DOI 10.3390/microorganisms2020111; Priyadarshini M, 2016, TRENDS ENDOCRIN MET, V27, P653, DOI 10.1016/j.tem.2016.03.011; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Raina S, 2012, PROCESS BIOCHEM, V47, P843, DOI 10.1016/j.procbio.2012.02.021; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Rutledge PJ, 2015, NAT REV MICROBIOL, V13, P509, DOI 10.1038/nrmicro3496; Schimmel TG, 1998, APPL ENVIRON MICROB, V64, P3707; Shang QS, 2017, TOXICOL LETT, V279, P87, DOI 10.1016/j.toxlet.2017.07.904; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shen F, 2017, HEPATOB PANCREAT DIS, V16, P375, DOI 10.1016/S1499-3872(17)60019-5; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Su BL, 2015, J DIABETES, V7, P729, DOI 10.1111/1753-0407.12232; Sun YT, 2018, BIOORG MED CHEM LETT, V28, P315, DOI 10.1016/j.bmcl.2017.12.049; Tsou YC, 2016, NEUROSCI LETT, V628, P186, DOI 10.1016/j.neulet.2016.06.040; Ubeda M, 2016, J HEPATOL, V64, P1049, DOI 10.1016/j.jhep.2015.12.010; Wang B, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012633; Wang C, 2016, J NAT PROD, V79, P2977, DOI 10.1021/acs.jnatprod.6b00766; Wang K, 2018, J MED CHEM, V61, P3609, DOI 10.1021/acs.jmedchem.8b00107; Wu W, 2016, INT IMMUNOPHARMACOL, V39, P218, DOI 10.1016/j.intimp.2016.07.031; Zhang LH, 2016, BIOORG MED CHEM LETT, V26, P346, DOI 10.1016/j.bmcl.2015.12.009; Zhang YY, 2018, MAR DRUGS, V16, DOI 10.3390/md16060202; Ziegler TR, 2008, AM J PHYSIOL-REG I, V294, pR402, DOI 10.1152/ajpregu.00650.2007; Zuo Yi-Nan, 2017, Sichuan Da Xue Xue Bao Yi Xue Ban, V48, P368	56	13	13	4	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12616	12629		10.1096/fj.201901061R	http://dx.doi.org/10.1096/fj.201901061R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31450982	Green Published			2022-12-28	WOS:000507461600079
J	Xia, W; Ci, SS; Li, MH; Wang, MN; Dianov, GL; Ma, Z; Li, LL; Hua, K; Alagamuthu, KK; Qing, LH; Luo, LB; Edick, AM; Liu, LJ; Hu, ZG; He, LF; Pan, FY; Guo, ZG				Xia, Wen; Ci, Shusheng; Li, Menghan; Wang, Meina; Dianov, Grigory L.; Ma, Zhuang; Li, Lulu; Hua, Ke; Alagamuthu, Karthick Kumar; Qing, Lihong; Luo, Libo; Edick, Ashlin M.; Liu, Lingjie; Hu, Zhigang; He, Lingfeng; Pan, Feiyan; Guo, Zhigang			Two-way crosstalk between BER and c-NHEJ repair pathway is mediated by Pol-beta and Ku70	FASEB JOURNAL			English	Article						DNA repair; base excision repair; double-strand break	BASE EXCISION-REPAIR; DNA-POLYMERASE-BETA; STRAND BREAK REPAIR; END-JOINING PATHWAYS; HOMOLOGOUS RECOMBINATION; PROTEIN; DAMAGE; MAINTENANCE; MECHANISM; COMPLEX	Multiple DNA repair pathways may be involved in the removal of the same DNA lesion caused by endogenous or exogenous agents. Although distinct DNA repair machinery fulfill overlapping roles in the repair of DNA lesions, the mechanisms coordinating different pathways have not been investigated in detail. Here, we show that Ku70, a core protein of nonhomologous end-joining (NHEJ) repair pathway, can directly interact with DNA polymerase-beta (Pol-beta), a central player in the DNA base excision repair (BER), and this physical complex not only promotes the polymerase activity of Pol-beta and BER efficiency but also enhances the classic NHEJ repair. Moreover, we find that DNA damages caused by methyl methanesulfonate (MMS) or etoposide promote the formation of Ku70-Pol-beta complexes at the repair foci. Furthermore, suppression of endogenous Ku70 expression by small interfering RNA reduces BER efficiency and leads to higher sensitivity to MMS and accumulation of the DNA strand breaks. Similarly, Pol-beta knockdown impairs total-NHEJ capacity but only has a slight influence on alternative NHEJ. These results suggest that Pol-beta and Ku70 coordinate 2-way crosstalk between the BER and NHEJ pathways.	[Xia, Wen; Ci, Shusheng; Li, Menghan; Wang, Meina; Dianov, Grigory L.; Ma, Zhuang; Li, Lulu; Hua, Ke; Alagamuthu, Karthick Kumar; Hu, Zhigang; He, Lingfeng; Pan, Feiyan; Guo, Zhigang] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, 1 WenYuan Rd, Nanjing 210023, Peoples R China; [Dianov, Grigory L.] Novosibirsk State Univ, Dept Nat Sci, Novosibirsk, Russia; [Dianov, Grigory L.] Univ Oxford, Oxford Inst Radiat Oncol, Dept Oncol, Oxford, England; [Qing, Lihong; Luo, Libo] Seventh Peoples Hosp, Changzhou, Jiangsu, Peoples R China; [Edick, Ashlin M.] McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ, Canada; [Liu, Lingjie] Southern Univ Sci & Technol, Coll Life Sci, Shenzhen, Peoples R China	Nanjing Normal University; Novosibirsk State University; University of Oxford; McGill University; Southern University of Science & Technology	Pan, FY; Guo, ZG (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, 1 WenYuan Rd, Nanjing 210023, Peoples R China.	panfeiyan@njnu.edu.cn; guozgang@gmail.com	kumar, Alagamuthu Karthick/X-4468-2019	He, Lingfeng/0000-0002-9668-419X	National Natural Science Foundation of China [81872284]; Changzhou Science and Technology Program [CE20175035]; Jiangsu Key Research and Development Program [BE2018714]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [18KJA180006]; National Nature Science Foundation [31701179]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Russian Foundation for Basic Research (RFBR) [19-04-00067]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Changzhou Science and Technology Program; Jiangsu Key Research and Development Program; Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR))	The authors thank Dr. Songbai Liu (Suzhou Vocational Health College, Suzhou, China) for providing the U2OS EJ5-GFP cell line, and Dr. Jun Huang (Zhejiang University, Hangzhou, China) for providing the U2OS alt-NHEJ-EGFP cell line, which were very helpful for testing NHEJ efficiency in vivo. This work was supported by the National Natural Science Foundation of China (81872284), the Changzhou Science and Technology Program (CE20175035), the Jiangsu Key Research and Development Program (Grant BE2018714), the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (18KJA180006), the National Nature Science Foundation (31701179), and the Priority Academic Program Development of Jiangsu Higher Education Institutions. G.L.D. was funded by the Russian Foundation for Basic Research (RFBR) according to Research Project No 19-04-00067. The authors declare no conflicts of interest.	Allinson SL, 2001, EMBO J, V20, P6919, DOI 10.1093/emboj/20.23.6919; Amsel AD, 2008, P NATL ACAD SCI USA, V105, P5117, DOI 10.1073/pnas.0706700105; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Beard WA, 2006, METHOD ENZYMOL, V408, P91, DOI 10.1016/S0076-6879(06)08007-4; Benedict CL, 2000, IMMUNOL REV, V175, P150, DOI 10.1034/j.1600-065X.2000.017518.x; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; BLIER PR, 1993, J BIOL CHEM, V268, P7594; Boboila C, 2012, ADV IMMUNOL, V116, P1, DOI 10.1016/B978-0-12-394300-2.00001-6; Budke B, 2013, J MED CHEM, V56, P254, DOI 10.1021/jm301565b; Cabelof DC, 2003, CANCER RES, V63, P5799; Chen L, 2000, J BIOL CHEM, V275, P26196, DOI 10.1074/jbc.M000491200; Fan W, 2004, BIOCHEM BIOPH RES CO, V323, P1328, DOI 10.1016/j.bbrc.2004.09.002; Fang QM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6513; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; Guo ZG, 2009, NUCLEIC ACIDS RES, V37, P3431, DOI 10.1093/nar/gkp201; Hasan S, 2002, MOL CELL, V10, P1213, DOI 10.1016/S1097-2765(02)00745-1; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Jin SF, 1997, EMBO J, V16, P6874, DOI 10.1093/emboj/16.22.6874; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Mahajan KN, 2002, MOL CELL BIOL, V22, P5194, DOI 10.1128/MCB.22.14.5194-5202.2002; Mansour WY, 2008, NUCLEIC ACIDS RES, V36, P4088, DOI 10.1093/nar/gkn347; Nakamura J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng105; Pan FY, 2016, SCI REP-UK, V6, DOI 10.1038/srep28614; Parsons JL, 2008, MOL CELL, V29, P477, DOI 10.1016/j.molcel.2007.12.027; Parsons JL, 2011, MOL CELL, V41, P609, DOI 10.1016/j.molcel.2011.02.016; Parsons JL, 2009, EMBO J, V28, P3207, DOI 10.1038/emboj.2009.243; Pascucci B, 1999, J BIOL CHEM, V274, P33696, DOI 10.1074/jbc.274.47.33696; Prasad R, 2000, J BIOL CHEM, V275, P4460, DOI 10.1074/jbc.275.6.4460; Prasad R, 2012, NUCLEIC ACIDS RES, V40, P11571, DOI 10.1093/nar/gks898; Ray S, 2018, NUCLEIC ACIDS RES, V46, P242, DOI 10.1093/nar/gkx1147; Roberts SA, 2010, NATURE, V464, P1214, DOI 10.1038/nature08926; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schulte-Uentrop L, 2008, NUCLEIC ACIDS RES, V36, P2561, DOI 10.1093/nar/gkn094; Shahi A, 2011, NUCLEIC ACIDS RES, V39, P2130, DOI 10.1093/nar/gkq1095; Simonelli V, 2017, ONCOTARGET, V8, P84827, DOI 10.18632/oncotarget.10185; Sobol RW, 2001, PROG NUCLEIC ACID RE, V68, P57; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Stauffer W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33592-8; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Wang B, 2014, CELL DEATH DIFFER, V21, P1160, DOI 10.1038/cdd.2014.42; Wang HL, 2012, J BIOL CHEM, V287, P21471, DOI 10.1074/jbc.M112.355354; Wang HC, 2003, NUCLEIC ACIDS RES, V31, P5377, DOI 10.1093/nar/gkg728; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Wilson TE, 1999, J BIOL CHEM, V274, P23599, DOI 10.1074/jbc.274.33.23599; Yano KI, 2008, EMBO REP, V9, P91, DOI 10.1038/sj.embor.7401137; Zhou T, 2016, ONCOTARGET, V7, P6902, DOI 10.18632/oncotarget.6849	51	8	8	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11668	11681		10.1096/fj.201900308R	http://dx.doi.org/10.1096/fj.201900308R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31348687	Green Published, Bronze			2022-12-28	WOS:000507461600008
J	Defnet, AE; Huang, WL; Polischak, S; Yadav, SK; Kane, MA; Shapiro, P; Deshpande, DA				Defnet, Amy E.; Huang, Weiliang; Polischak, Steven; Yadav, Santosh Kumar; Kane, Maureen A.; Shapiro, Paul; Deshpande, Deepak A.			Effects of ATP-competitive and function-selective ERK inhibitors on airway smooth muscle cell proliferation	FASEB JOURNAL			English	Article						asthma; airway inflammation; activator protein-1; proteomics; kinase inhibitor	SIGNAL-REGULATED KINASE; PROTEIN-COUPLED RECEPTORS; GROWTH-FACTOR RECEPTOR; TRANSCRIPTION FACTORS; GENE-EXPRESSION; DOCKING MOTIF; ACTIVATION; ASTHMA; COMPONENTS; PATHWAYS	Increased airway smooth muscle (ASM) cell mass and secretory functions are characteristics of airway inflammatory diseases, such as asthma. To date, there are no effective therapies to combat ASM cell proliferation, which contributes to bronchoconstriction and airway obstruction. Growth factors such as platelet-derived growth factor (PDGF) and the activation of the ERK1/2 are major regulators of ASM cell proliferation and airway remodeling in asthma. However, given the ubiquitous expression and multiple functions of ERK1/2, complete inhibition of ERK1/2 using ATP-competitive inhibitors may lead to unwanted off-target effects. Alternatively, we have identified compounds that are designed to target substrate docking sites and act as function-selective inhibitors of ERK1/2 signaling. Here, we show that both function-selective and ATP-competitive ERK1/2 inhibitors are effective at inhibiting PDGF-mediated proliferation, collagen production, and IL-6 secretion in ASM cells. Proteomic analysis revealed that both types of inhibitors had similar effects on reducing proteins related to TGF-beta and IL-6 signaling that are relevant to airway remodeling. However, function-selective ERK1/2 inhibitors caused fewer changes in protein expression compared with ATP-competitive inhibitors. These studies provide a molecular basis for the development of function-selective ERK1/2 inhibitors to mitigate airway remodeling in asthma with defined regulation of ERK1/2 signaling.-Defnet, A. E., Huang, W., Polischak, S., Yadav, S. K., Kane, M. A., Shapiro, P., Deshpande, D. A. Effects of ATP-competitive and function-selective ERK inhibitors on airway smooth muscle cell proliferation.	[Defnet, Amy E.; Huang, Weiliang; Kane, Maureen A.; Shapiro, Paul] Univ Maryland, Dept Pharmaceut Sci, 20 Penn St,Rm 561, Baltimore, MD 21201 USA; [Polischak, Steven; Yadav, Santosh Kumar; Deshpande, Deepak A.] Jefferson Univ, Dept Med, 1020 Locust St,Rm 543B, Philadelphia, PA 19107 USA	University System of Maryland; University of Maryland Baltimore; Jefferson University	Shapiro, P (corresponding author), Univ Maryland, Dept Pharmaceut Sci, 20 Penn St,Rm 561, Baltimore, MD 21201 USA.; Deshpande, DA (corresponding author), Jefferson Univ, Dept Med, 1020 Locust St,Rm 543B, Philadelphia, PA 19107 USA.	pshapiro@rx.umaryland.edu; deshpande@jefferson.edu	Yadav, Santosh/GQZ-7569-2022; YADAV, SANTOSH KUMAR/AAU-6594-2020	YADAV, SANTOSH KUMAR/0000-0001-7375-1698	U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases [AI26492]; University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center [SOP1841-IQB2014]; NIH National Institute of General Medical Sciences [T32 GM066706]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI126492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066706] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases; University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center; NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a grant from the U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (AI26492; to P.S. and D.A.D.), and, in part, by the University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center (SOP1841-IQB2014). This work was also supported by NIH National Institute of General Medical Sciences Grant T32 GM066706 (to A.E.D.). A.E.D. and W.H. are co-first authors. The authors declare no conflicts of interest.	Ammit AJ, 2001, J APPL PHYSIOL, V91, P1431, DOI 10.1152/jappl.2001.91.3.1431; Amrani Y, 2003, INT J BIOCHEM CELL B, V35, P272, DOI 10.1016/S1357-2725(02)00259-5; Aronov AM, 2009, J MED CHEM, V52, P6362, DOI 10.1021/jm900630q; Ather JL, 2011, AM J RESP CELL MOL, V44, P631, DOI 10.1165/rcmb.2010-0106OC; Baud'huin M, 2013, CYTOKINE GROWTH F R, V24, P401, DOI 10.1016/j.cytogfr.2013.06.001; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Bentley J Kelley, 2008, Proc Am Thorac Soc, V5, P89, DOI 10.1513/pats.200705-063VS; Billington CK, 2005, BIOCHEMISTRY-US, V44, P14595, DOI 10.1021/bi0510734; Black JL, 2001, AM J RESP CRIT CARE, V164, pS63, DOI 10.1164/ajrccm.164.supplement_2.2106059; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Bottoms SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009674; Bourke JE, 2011, EUR RESPIR J, V37, P173, DOI 10.1183/09031936.00008109; Burgess JK, 2008, J CELL PHYSIOL, V216, P673, DOI 10.1002/jcp.21450; Burkhard K, 2009, CURR TOP MED CHEM, V9, P678, DOI 10.2174/156802609789044416; Caramori G, 2013, CELL COMMUN ADHES, V20, P21, DOI 10.3109/15419061.2013.775257; Chen FM, 2006, BIOORG MED CHEM LETT, V16, P6281, DOI 10.1016/j.bmcl.2006.09.038; Chiappara G, 2007, ALLERGY, V62, P787, DOI 10.1111/j.1398-9995.2007.01417.x; Chiba Takahito, 2012, J Allergy (Cairo), V2012, P372384, DOI 10.1155/2012/372384; Dekkers Bart G J, 2009, Proc Am Thorac Soc, V6, P683, DOI 10.1513/pats.200907-056DP; DEMOLY P, 1992, AM J RESP CELL MOL, V7, P128, DOI 10.1165/ajrcmb/7.2.128; Deshpande DA, 2006, CELL SIGNAL, V18, P2105, DOI 10.1016/j.cellsig.2006.04.008; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Eng JK, 2008, J PROTEOME RES, V7, P4598, DOI 10.1021/pr800420s; Fantz DA, 2001, J BIOL CHEM, V276, P27256, DOI 10.1074/jbc.M102512200; FROST JA, 1994, P NATL ACAD SCI USA, V91, P3844, DOI 10.1073/pnas.91.9.3844; Gauderman WJ, 2013, GENET EPIDEMIOL, V37, P603, DOI 10.1002/gepi.21748; Germann UA, 2017, MOL CANCER THER, V16, P2351, DOI 10.1158/1535-7163.MCT-17-0456; Girodet PO, 2011, PHARMACOL THERAPEUT, V130, P325, DOI 10.1016/j.pharmthera.2011.02.001; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Halwani R, 2010, CURR OPIN PHARMACOL, V10, P236, DOI 10.1016/j.coph.2010.06.004; Hancock CN, 2005, J MED CHEM, V48, P4586, DOI 10.1021/jm0501174; Hedges JC, 2000, AM J RESP CELL MOL, V23, P86, DOI 10.1165/ajrcmb.23.1.4014; Hershenson MB, 1999, AM J RESP CELL MOL, V21, P651, DOI 10.1165/ajrcmb.21.6.f168; Hirst Stuart J, 2004, J Allergy Clin Immunol, V114, pS2, DOI 10.1016/j.jaci.2004.04.039; Hou CC, 2011, MOL MED, V17, P807, DOI 10.2119/molmed.2010.00173; Johnson PRA, 2006, AM J RESP CRIT CARE, V173, P32, DOI 10.1164/rccm.200406-703OC; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kassel KM, 2009, AM J PHYSIOL-LUNG C, V296, pL693, DOI 10.1152/ajplung.90446.2008; Kong KC, 2006, FASEB J, V20, P1558, DOI 10.1096/fj.05-5622fje; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Krymskaya VP, 2000, AM J RESP CELL MOL, V23, P546, DOI 10.1165/ajrcmb.23.4.4115; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Loke TK, 2006, J ALLERGY CLIN IMMUN, V118, P368, DOI 10.1016/j.jaci.2006.04.055; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Morris EJ, 2013, CANCER DISCOV, V3, P742, DOI 10.1158/2159-8290.CD-13-0070; Oliver BGG, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-71; Oram JF, 2001, J LIPID RES, V42, P1173; Orsini MJ, 1999, AM J PHYSIOL-LUNG C, V277, pL479, DOI 10.1152/ajplung.1999.277.3.L479; PANETTIERI RA, 1989, AM J PHYSIOL, V256, pC329, DOI 10.1152/ajpcell.1989.256.2.C329; Panettieri Reynold A. Jr., 2002, Journal of Allergy and Clinical Immunology, V110, pS269, DOI 10.1067/mai.2002.129429; Pera T., 2019, FASEB J; Pera T, 2018, FASEB J, V32, P862, DOI 10.1096/fj.201700555R; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Qi D, 2012, OMICS, V16, P489, DOI 10.1089/omi.2012.0042; Rincon M, 2012, INT J BIOL SCI, V8, P1281, DOI 10.7150/ijbs.4874; Samadani R, 2015, BIOCHEM J, V467, P425, DOI 10.1042/BJ20131571; Sharma P, 2017, SCI REP-UK, V7, DOI 10.1038/srep46166; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sullivan RJ, 2018, CANCER DISCOV, V8, P184, DOI 10.1158/2159-8290.CD-17-1119; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Williamson JC, 2016, PROTEOMICS, V16, P907, DOI 10.1002/pmic.201400545; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Xu T, 2015, J IMMUNOL, V195, P5539, DOI 10.4049/jimmunol.1501198; Zhou LM, 2003, RESP PHYSIOL NEUROBI, V137, P295, DOI 10.1016/S1569-9048(03)00154-X; Zuyderduyn S, 2008, EUR RESPIR J, V32, P265, DOI 10.1183/09031936.00051407	68	16	16	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10833	10843		10.1096/fj.201900680R	http://dx.doi.org/10.1096/fj.201900680R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31266368	Green Published, Bronze			2022-12-28	WOS:000489166300021
J	Forster, R; Sarginson, A; Velichkova, A; Hogg, C; Dorning, A; Horne, AW; Saunders, PTK; Greaves, E				Forster, Rachel; Sarginson, Alexandra; Velichkova, Atanaska; Hogg, Chloe; Dorning, Ashley; Horne, Andrew W.; Saunders, Philippa T. K.; Greaves, Erin			Macrophage-derived insulin-like growth factor-1 is a key neurotrophic and nerve-sensitizing factor in pain associated with endometriosis	FASEB JOURNAL			English	Article						hyperalgesia; leukocytes; neurotrophin; nerve	QUALITY-OF-LIFE; MOUSE MODEL; MOLECULAR-MECHANISMS; RAT MODEL; RECEPTOR; CELLS; WOMEN; EXPRESSION; INHIBITION; PATHWAYS	Endometriosis is a common incurable inflammatory disorder that is associated with debilitating pelvic pain in women. Macrophages are central to the pathophysiology of endometriosis: they dictate the growth and vascularization of endometriosis lesions and more recently have been shown to promote lesion innervation. The aim of this study was to determine the mechanistic role of macrophages in producing pain associated with endometriosis. Herein, we show that macrophage depletion in a mouse model of endometriosis can reverse abnormal changes in pain behavior. We identified that disease-modified macrophages exhibit increased expression of IGF-1 in an in vitro model of endometriosis-associated macrophages and confirmed expression by lesion-resident macrophages in mice and women. Concentrations of IGF-1 were elevated in peritoneal fluid from women with endometriosis and positively correlate with their pain scores. Mechanistically, we demonstrate that macrophage-derived IGF-1 promotes sprouting neurogenesis and nerve sensitization in vitro. Finally, we show that the Igf-1 receptor inhibitor linsitinib reverses the pain behavior observed in mice with endometriosis. Our data support a role for macrophage-derived IGF-1 as a key neurotrophic and sensitizing factor in endometriosis, and we propose that therapies that modify macrophage phenotype may be attractive therapeutic options for the treatment of women with endometriosis-associated pain.-Forster, R., Sarginson, A., Velichkova, A., Hogg, C., Dorning, A., Horne, A. W., Saunders, P. T. K., Greaves, E. Macrophage-derived insulin-like growth factor-1 is a key neurotrophic and nerve-sensitizing factor in pain associated with endometriosis.	[Forster, Rachel; Sarginson, Alexandra; Velichkova, Atanaska; Hogg, Chloe; Dorning, Ashley; Horne, Andrew W.] Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Saunders, Philippa T. K.] Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Greaves, Erin] Univ Warwick, Warwick Med Sch, Div Biomed Sci, Coventry CV2 2DX, W Midlands, England	University of Edinburgh; University of Edinburgh; University of Warwick	Greaves, E (corresponding author), Univ Warwick, Warwick Med Sch, Div Biomed Sci, Coventry CV2 2DX, W Midlands, England.	erin.greaves@warwick.ac.uk	Forster, Rachel/AAS-2634-2021; Saunders, Philippa/C-7489-2013	Velichkova, Atanaska/0000-0002-6941-1188; Saunders, Philippa/0000-0001-9051-9380; Hogg, Chloe/0000-0002-3277-5359	Medical Research Council Career Development Award [MR/M009238/1]; Rosetree's Trust research grant [A1759]; Medical Research Council Programme grant [MR/N024524/1]; Wellbeing of Women grant [R42533]; Medical Research Council (MRC) Centre grant [MR/N022556/1]; MRC [MR/M009238/2, MR/N024524/1, 1789503] Funding Source: UKRI	Medical Research Council Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rosetree's Trust research grant; Medical Research Council Programme grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellbeing of Women grant(Wellbeing of Women (WoW)); Medical Research Council (MRC) Centre grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank all the women who gave informed consent for the use of material in this study, research nurses Helen Dewart and Jennifer Devlin [National Health Service (NHS) Lothian, Edinburgh, United Kingdom] who organized tissue collection, and Halima Hassan and Kathryn Newton (University of Edinburgh) for technical support. The authors also thank Ronnie Grant (University of Edinburgh) for the figure preparation. This work was supported by a Medical Research Council Career Development Award (MR/M009238/1; to E.G.), a Rosetree's Trust research grant (A1759; to E.G.), a Medical Research Council Programme grant (MR/N024524/1; to P.T.K.S.), a Wellbeing of Women grant (R42533 to A.W.H.), and a Medical Research Council (MRC) Centre grant (MR/N022556/1). The authors declare no conflicts of interest.	Andon FT, 2017, SEMIN IMMUNOL, V34, P103, DOI 10.1016/j.smim.2017.09.004; Bacci M, 2009, AM J PATHOL, V175, P547, DOI 10.2353/ajpath.2009.081011; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Becker CM, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.07.709; Berkley KJ, 2004, P NATL ACAD SCI USA, V101, P11094, DOI 10.1073/pnas.0403663101; Beste MT, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007988; Bulun SE, 2002, J REPROD IMMUNOL, V55, P21, DOI 10.1016/S0165-0378(01)00132-2; Capobianco A, 2011, AM J PATHOL, V179, P2651, DOI 10.1016/j.ajpath.2011.07.029; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Cousins FL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086378; Coxon L, 2018, BEST PRACT RES CL OB, V51, P53, DOI 10.1016/j.bpobgyn.2018.01.014; Dodds KN, 2019, REPROD SCI, V26, P357, DOI 10.1177/1933719118773405; Fassbender A, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.07.1209; Gao X, 2006, CURR MED RES OPIN, V22, P1787, DOI 10.1185/030079906X121084; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ghasemlou N, 2015, P NATL ACAD SCI USA, V112, pE6808, DOI 10.1073/pnas.1501372112; Gogacz M, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/3175394; Greaves E, 2017, SCI REP-UK, V7, DOI 10.1038/srep44169; Greaves E, 2015, AM J PATHOL, V185, P2286, DOI 10.1016/j.ajpath.2015.04.012; Greaves E, 2014, ENDOCRINOLOGY, V155, P4015, DOI 10.1210/en.2014-1086; Greaves E, 2014, J CLIN ENDOCR METAB, V99, pE1738, DOI 10.1210/jc.2014-2282; Greaves E, 2014, AM J PATHOL, V184, P1930, DOI 10.1016/j.ajpath.2014.03.011; Guo SW, 2009, HUM REPROD UPDATE, V15, P441, DOI 10.1093/humupd/dmp007; HALME J, 1987, AM J OBSTET GYNECOL, V156, P783, DOI 10.1016/0002-9378(87)90333-4; HALME J, 1991, ANN NY ACAD SCI, V622, P266; Ho HN, 1997, HUM REPROD, V12, P2528, DOI 10.1093/humrep/12.11.2528; Jacobson TZ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001300.pub2; Ji RR, 2016, SCIENCE, V354, P572, DOI 10.1126/science.aaf8924; Ji RR, 2014, NAT REV DRUG DISCOV, V13, P533, DOI 10.1038/nrd4334; Johnson NP, 2013, HUM REPROD, V28, P1552, DOI 10.1093/humrep/det050; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kim JG, 2000, FERTIL STERIL, V73, P996, DOI 10.1016/S0015-0282(00)00493-3; Koutsilieris M, 2001, MOL MED, V7, P20, DOI 10.1007/BF03401835; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Li Y, 2014, EUR J PAIN, V18, P774, DOI 10.1002/j.1532-2149.2013.00420.x; Lin SF, 2016, NEUROREPORT, V27, P737, DOI 10.1097/WNR.0000000000000607; McKinnon BD, 2015, TRENDS ENDOCRIN MET, V26, P1, DOI 10.1016/j.tem.2014.10.003; Mert T, 2009, N-S ARCH PHARMACOL, V379, P445, DOI 10.1007/s00210-008-0387-3; Miller RE, 2012, P NATL ACAD SCI USA, V109, P20602, DOI 10.1073/pnas.1209294110; Miller Richard J, 2009, Handb Exp Pharmacol, P417, DOI 10.1007/978-3-540-79090-7_12; Mirkin D, 2007, J MANAGE CARE PHARM, V13, P262, DOI 10.18553/jmcp.2007.13.3.262; Miura M, 2011, PAIN, V152, P888, DOI 10.1016/j.pain.2011.01.004; Old EA, 2014, J CLIN INVEST, V124, P2023, DOI 10.1172/JCI71389; OOSTERLYNCK DJ, 1993, ARCH GYNECOL OBSTET, V253, P197, DOI 10.1007/BF02766646; Rahmioglu N, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.07.1208; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Simoens S, 2012, HUM REPROD, V27, P1292, DOI 10.1093/humrep/des073; Tokushige N, 2006, HUM REPROD, V21, P3001, DOI 10.1093/humrep/del260; Tran LVP, 2009, HUM REPROD, V24, P835, DOI 10.1093/humrep/den483; Vardeh D, 2009, J CLIN INVEST, V119, P287, DOI 10.1172/JCI37098; Vitonis AF, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.07.1244; Wang H, 2014, ENDOCRINOLOGY, V155, P168, DOI 10.1210/en.2013-1559; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Yan X, 2017, J NEUROCHEM, V140, P963, DOI 10.1111/jnc.13952; Zhang Y, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005283; Zhou Y, 2016, J MOL MED, V94, P887, DOI 10.1007/s00109-016-1396-1	56	53	57	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11210	11222		10.1096/fj.201900797R	http://dx.doi.org/10.1096/fj.201900797R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31291762	Green Published, hybrid			2022-12-28	WOS:000489166300052
J	Li, X; Li, ZH; Wang, JR; Li, ZM; Cui, HW; Dai, G; Chen, SW; Zhang, ML; Zheng, ZM; Zhan, ZP; Liu, H				Li, Xiang; Li, Zihao; Wang, Jianru; Li, Zemin; Cui, Haowen; Dai, Guo; Chen, Siwen; Zhang, Mingliang; Zheng, Zhaomin; Zhan, Zhongping; Liu, Hui			Wnt4 signaling mediates protective effects of melatonin on new bone formation in an inflammatory environment	FASEB JOURNAL			English	Article						inflammation; bone loss; osteogenesis	MESENCHYMAL STEM-CELLS; PROMOTES OSTEOBLAST DIFFERENTIATION; ALKALINE-PHOSPHATASE ACTIVITY; QUALITY-OF-LIFE; TNF-ALPHA; POSTMENOPAUSAL WOMEN; UP-REGULATION; ACTIVATION; RUNX2; MINERALIZATION	Growing evidence shows that the inhibitory effect of inflammatory cytokines on new bone formation by osteogenic precursor cells is a critical cause of net bone-density reduction. Melatonin has been proven to be a potential therapeutic candidate for osteoporosis. However, whether it is capable of antagonizing the suppressing effect of inflammatory cytokines on osteogenic precursor cells is so far elusive. In this study, using the cell culture system of human bone marrow stromal cells and MC3T3-E1 preosteoblasts, we recorded the following vital observations that provided insights of melatonin-induced bone formation: 1) melatonin induced bone formation in both normal and inflammatory conditions; 2) Wnt4 was essential for melatonin-induced bone formation in inflammatory stimulation; 3) melatonin- and Wnt4-induced bone formation occurred via activation of beta-catenin and p38-JNK MAPK pathways by interaction with a distinct frizzled LDL receptor-related protein complex; 4) melatonin suppressed the inhibitory effect of NF-kappa B on osteogenesis in a Wnt4-dependent manner; and 5) melatonin induced Wnt4 expression through the ERK1/2-Pax2-Egr1 pathway. In summary, we showed a novel mechanism of melatonin-induced bone formation in an inflammatory environment. Melatonin-induced Wnt4 expression is essential for its osteoinductive effect and the inhibitory effect of NF-kappa B on bone formation. Our novel findings may provide useful information for its potential translational application.-Li, X., Li, Z., Wang, J., Li, Z., Cui, H., Dai, G., Chen, S., Zhang, M., Zheng, Z., Zhan, Z., Liu, H. Wnt4 signaling mediates protective effects of melatonin on new bone formation in an inflammatory environment.	[Li, Xiang; Li, Zihao; Wang, Jianru; Li, Zemin; Cui, Haowen; Dai, Guo; Chen, Siwen; Zhang, Mingliang; Zheng, Zhaomin; Liu, Hui] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Spine Surg, Guangzhou, Guangdong, Peoples R China; [Zhan, Zhongping] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Rheumatol & Immunol, Guangzhou, Guangdong, Peoples R China; [Wang, Jianru; Li, Zemin; Zheng, Zhaomin; Liu, Hui] Guangdong Prov Key Lab Orthopaed & Traumatol, 58 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Liu, H (corresponding author), Guangdong Prov Key Lab Orthopaed & Traumatol, 58 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.; Liu, H (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, 58 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.	liuhui58@mail.sysu.edu.cn			National Natural Science Foundation of China [81572103, 81772307]; Science and Technology Planning Project of Guangdong Province, China [2016A020215052, 2017A050501016]; Special Support Plan for High-Level Talent of Guangdong Province, China [20167Q03R667]; Pearl River Nova Program of Guangzhou [201504282219058]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, China; Special Support Plan for High-Level Talent of Guangdong Province, China; Pearl River Nova Program of Guangzhou	The authors thank Xingjie Chen for the talented experimental assistance. This work was supported by the National Natural Science Foundation of China (Grants 81572103 and 81772307), the Science and Technology Planning Project of Guangdong Province, China (Grants 2016A020215052 and 2017A050501016), the Special Support Plan for High-Level Talent of Guangdong Province, China (Grant 20167Q03R667), and the Pearl River Nova Program of Guangzhou (Grant 201504282219058). The authors declare no conflicts of interest.	Amstrup AK, 2013, OSTEOPOROSIS INT, V24, P2919, DOI 10.1007/s00198-013-2404-8; Amstrup AK, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0093-1; Amstrup AK, 2015, J PINEAL RES, V59, P221, DOI 10.1111/jpi.12252; Braun T, 2012, CURR OSTEOPOROS REP, V10, P101, DOI 10.1007/s11914-012-0104-5; Briolay A, 2013, BIOCHEM BIOPH RES CO, V430, P1072, DOI 10.1016/j.bbrc.2012.12.036; Chang J, 2007, J BIOL CHEM, V282, P30938, DOI 10.1074/jbc.M702391200; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Conti A, 2000, J PINEAL RES, V28, P193, DOI 10.1034/j.1600-079X.2000.280401.x; Cutando A, 2012, ANTICANCER RES, V32, P2747; Ding J, 2009, LIFE SCI, V84, P499, DOI 10.1016/j.lfs.2009.01.013; Dore RK, 2010, ANN RHEUM DIS, V69, P872, DOI 10.1136/ard.2009.112920; Favero G, 2017, INT J ENDOCRINOL, V2017, DOI 10.1155/2017/1835195; Gilbert L, 2002, J BIOL CHEM, V277, P2695, DOI 10.1074/jbc.M106339200; Huang H, 2011, CELL PROLIFERAT, V44, P420, DOI 10.1111/j.1365-2184.2011.00769.x; HUGHES FJ, 1993, BONE MINER, V21, P21, DOI 10.1016/S0169-6009(08)80117-1; HUGHES FJ, 1993, CALCIFIED TISSUE INT, V53, P362, DOI 10.1007/BF01351844; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; Kim HJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061142; Kotlarczyk MP, 2012, J PINEAL RES, V52, P414, DOI 10.1111/j.1600-079X.2011.00956.x; Koyama H, 2002, J BONE MINER RES, V17, P1219, DOI 10.1359/jbmr.2002.17.7.1219; Krum SA, 2010, NAT REV RHEUMATOL, V6, P607, DOI 10.1038/nrrheum.2010.133; Li QX, 2013, ENDOCRINOLOGY, V154, P446, DOI 10.1210/en.2012-1585; Li X, 2018, ARTHRITIS RHEUMATOL, V70, P1056, DOI 10.1002/art.40468; Li Y, 2007, J BONE MINER RES, V22, P646, DOI 10.1359/JBMR.070121; Lu XH, 2006, J BIOL CHEM, V281, P6297, DOI 10.1074/jbc.M507804200; Majidinia M, 2018, AGEING RES REV, V47, P198, DOI 10.1016/j.arr.2018.07.010; Maria S, 2014, J PINEAL RES, V56, P115, DOI 10.1111/jpi.12116; Mukai T, 2007, BIOCHEM BIOPH RES CO, V356, P1004, DOI 10.1016/j.bbrc.2007.03.099; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; Neubauer DN, 2015, DRUG TODAY, V51, P29, DOI 10.1358/dot.2015.51.1.2258364; Pan HH, 2015, J BONE MINER RES, V30, P1523, DOI 10.1002/jbmr.2481; Park KH, 2011, J PINEAL RES, V51, P187, DOI 10.1111/j.1600-079X.2011.00875.x; Ping ZC, 2017, ACTA BIOMATER, V51, P513, DOI 10.1016/j.actbio.2017.01.034; Radio NM, 2006, J PINEAL RES, V40, P332, DOI 10.1111/j.1600-079X.2006.00318.x; Redlich K, 2012, NAT REV DRUG DISCOV, V11, P234, DOI 10.1038/nrd3669; REDMAN J, 1983, SCIENCE, V219, P1089, DOI 10.1126/science.6823571; Reiter RJ, 2010, PROG BRAIN RES, V181, P127, DOI 10.1016/S0079-6123(08)81008-4; Roth JA, 1999, J BIOL CHEM, V274, P22041, DOI 10.1074/jbc.274.31.22041; Satomura K, 2007, J PINEAL RES, V42, P231, DOI 10.1111/j.1600-079X.2006.00410.x; Son JH, 2014, J PINEAL RES, V57, P385, DOI 10.1111/jpi.12177; Straub RH, 2015, SEMIN ARTHRITIS RHEU, V45, P220, DOI 10.1016/j.semarthrit.2015.04.014; Tan DX, 1999, BBA-GEN SUBJECTS, V1472, P206, DOI 10.1016/S0304-4165(99)00125-7; Tu XL, 2007, DEV CELL, V12, P113, DOI 10.1016/j.devcel.2006.11.003; Veneroso C, 2009, J PINEAL RES, V47, P184, DOI 10.1111/j.1600-079X.2009.00699.x; Wang LS, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0640-0; Yao ZQ, 2014, J BONE MINER RES, V29, P866, DOI 10.1002/jbmr.2108; Yu B, 2014, NAT MED, V20, P1009, DOI 10.1038/nm.3586; Zhang LM, 2010, J PINEAL RES, V49, P364, DOI 10.1111/j.1600-079X.2010.00803.x	49	16	16	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10126	10139		10.1096/fj.201900093RR	http://dx.doi.org/10.1096/fj.201900093RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31216173				2022-12-28	WOS:000482214200033
J	Liu, H; Zhao, YL; Zou, YC; Huang, WT; Zhu, LY; Liu, F; Wang, DX; Guo, KM; Hu, J; Chen, J; Ye, LX; Li, XK; Lin, L				Liu, Huan; Zhao, Yeli; Zou, Yuchi; Huang, Wenting; Zhu, Liyun; Liu, Fei; Wang, Dongxue; Guo, Kaiming; Hu, Jian; Chen, Jun; Ye, Lixia; Li, Xiaokun; Lin, Li			Heparin-poloxamer hydrogel-encapsulated rhFGF21 enhances wound healing in diabetic mice	FASEB JOURNAL			English	Article						biomaterial; skin wound; T2DM; sustained release	FACTOR 21 PROTECTS; CHITOSAN SCAFFOLD; MOUSE MODEL; STEM-CELLS; FIBROBLAST; PROLIFERATION; REGENERATION; COLLAGEN; NANOPARTICLES; INFLAMMATION	Wound healing, especially for diabetic wounds, is a lengthy and complicated process involving interactions and responses at the protein, cell, and tissue levels. Loading of growth factors into a hydrogel to construct a sustained-release system is considered a promising approach to improve wound healing. The present study investigates the effect of thermosensitive heparin-poloxamer (HP) hydrogel-encapsulated recombinant human fibroblast growth factor 21 (rhFGF21) on wound healing in mice with streptozotocin-induced diabetes mellitus. First, we studied the in vitro release of rhFGF21 from the rhFGF21-HP coacervate. The results showed that HP might control the release of rhFGF21. Next, we examined the effect of rhFGF21-HP on skin wound healing in diabetic mice. Our data showed that rhFGF21-HP significantly improved wound closure; promoted granulation, collagen deposition, and re-epithelialization; and enhanced the expression of CD31. Moreover, rhFGF21-HP had obvious advantages in diabetic wound healing. Therefore, the results suggest that the rhFGF21-HP hydrogel polymer plays an important role in skin wound healing. This work provides a suitable sustained-release delivery system that can continuously release rhFGF21 and presents a promising therapeutic strategy for wound healing in patients with diabetes.-Liu, H., Zhao, Y., Zou, Y., Huang, W., Zhu, L., Liu, F., Wang, D., Guo, K., Hu, J., Chen, J., Ye, L., Li, X., Lin, L. Heparin-poloxamer hydrogel-encapsulated rhFGF21 enhances wound healing in diabetic mice.	[Liu, Huan; Zhao, Yeli; Zhu, Liyun; Liu, Fei; Wang, Dongxue; Guo, Kaiming; Hu, Jian; Chen, Jun; Li, Xiaokun; Lin, Li] Wenzhou Med Univ, Affiliated Hosp 2, Sch Pharmaceut Sci, Wenzhou, Zhejiang, Peoples R China; [Huang, Wenting] Wenzhou Med Univ, Affiliated Hosp 2, Sch Clin Med Sci 1, Wenzhou, Zhejiang, Peoples R China; [Ye, Lixia] Wenzhou Med Univ, Affiliated Hosp 2, Dept Neonatol, Wenzhou, Zhejiang, Peoples R China; [Ye, Lixia] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Zhejiang, Peoples R China; [Zou, Yuchi] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Li, XK; Lin, L (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Key Lab Biotechnol & Pharmaceut Engn, Chashan High Educ Pk Ctr North Rd, Wenzhou 325035, Zhejiang, Peoples R China.	profxiaokunli@163.com; linliwz@163.com	Guo, Kaiming/AAI-3702-2020		National Key R&D Program of China [2017YFA0506000]; National Natural Science Foundation of China [81771284]; Public Welfare Technology Application Research Foundation of Zhejiang Province [2017C33080]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Welfare Technology Application Research Foundation of Zhejiang Province	This study was supported by research grants from the National Key R&D Program of China (Grant 2017YFA0506000), the National Natural Science Foundation of China (Grant 81771284), and the Public Welfare Technology Application Research Foundation of Zhejiang Province (Grant 2017C33080). The authors declare no conflicts of interest.	Amini A, 2018, J PHOTOCH PHOTOBIO B, V182, P42, DOI 10.1016/j.jphotobiol.2018.03.010; Attia ABE, 2011, CURR OPIN COLLOID IN, V16, P182, DOI 10.1016/j.cocis.2010.10.003; Benomar Y, 2016, DIABETES, V65, P913, DOI 10.2337/db15-1029; Cerqueira MT, 2016, ADV WOUND CARE, V5, P164, DOI 10.1089/wound.2014.0607; Chang EI, 2011, NAT MED, V17, P1147, DOI 10.1038/nm.2424; Chen J, 2018, J NEUROTRAUM, V35, P2091, DOI 10.1089/neu.2017.5271; Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4; CLARK RAF, 1993, J DERMATOL SURG ONC, V19, P693, DOI 10.1111/j.1524-4725.1993.tb00413.x; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Dong YX, 2014, ACTA BIOMATER, V10, P2076, DOI 10.1016/j.actbio.2013.12.045; Edwards N, 2018, J BIOMATER APPL, V33, P553, DOI 10.1177/0885328218803754; El Masry MS, 2019, FASEB J, V33, P2144, DOI 10.1096/fj.201800352R; Evanko SP, 2015, MATRIX BIOL, V42, P74, DOI 10.1016/j.matbio.2014.12.001; Fonder MA, 2008, J AM ACAD DERMATOL, V58, P185, DOI 10.1016/j.jaad.2007.08.048; Fu ZJ, 2018, DIABETES, V67, P974, DOI 10.2337/db17-0830; Gao SQ, 2018, DRUG DELIV, V25, P1779, DOI 10.1080/10717544.2018.1513608; [龚琦 Gong Qi], 2015, [中国细胞生物学学报, Chinese Journal of Cell Biology], V37, P460; Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002; Houreld NN, 2014, SCI WORLD J, DOI 10.1155/2014/398412; Huang YW, 2019, FASEB J, V33, P953, DOI 10.1096/fj.201800337R; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Jin LG, 2016, DIABETES METAB J, V40, P22, DOI 10.4093/dmj.2016.40.1.22; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Landen NX, 2016, CELL MOL LIFE SCI, V73, P3861, DOI 10.1007/s00018-016-2268-0; Li R, 2018, BIOMATERIALS, V168, P24, DOI 10.1016/j.biomaterials.2018.03.044; Li SB, 2018, DIABETES RES CLIN PR, V143, P215, DOI 10.1016/j.diabres.2018.07.014; Liang YK, 2014, ACTA BIOMATER, V10, P1588, DOI 10.1016/j.actbio.2013.07.031; Lorz LR, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051043; Lu YF, 2019, J CELL MOL MED, V23, P497, DOI 10.1111/jcmm.13952; Nath S, 2017, J PHARMACOL TOX MET, V84, P20, DOI 10.1016/j.vascn.2016.10.007; Razdan N, 2018, AGING CELL, V17, DOI 10.1111/acel.12838; Rezaii M, 2019, MAT SCI ENG C-MATER, V98, P347, DOI 10.1016/j.msec.2018.12.143; Schmidt A, 2019, THERANOSTICS, V9, P1066, DOI 10.7150/thno.29754; Shi Q, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00904; Shi YC, 2019, INT J BIOL SCI, V15, P138, DOI 10.7150/ijbs.28873; Shibata S, 2012, J IMMUNOL, V189, P3231, DOI 10.4049/jimmunol.1101739; Torres P, 2017, FASEB J, V31, P4946, DOI 10.1096/fj.201700085R; Wu HJ, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.020501; Wu J, 2016, ACS APPL MATER INTER, V8, P18710, DOI 10.1021/acsami.6b06047; Wu J, 2016, BIOMACROMOLECULES, V17, P2168, DOI 10.1021/acs.biomac.6b00398; Wu XJ, 2015, WOUND REPAIR REGEN, V23, P104, DOI 10.1111/wrr.12258; Xu HL, 2018, INT J NANOMED, V13, P681, DOI 10.2147/IJN.S152246; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yang CT, 2019, MOL CELL ENDOCRINOL, V480, P74, DOI 10.1016/j.mce.2018.10.013; Yang H, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0307-5; Yong CS, 2001, INT J PHARM, V226, P195, DOI 10.1016/S0378-5173(01)00809-2; Yu ZY, 2019, MOL NEUROBIOL, V56, P2314, DOI 10.1007/s12035-018-1234-2; Zhang C, 2018, BRIT J PHARMACOL, V175, P4218, DOI 10.1111/bph.14482; Zhang C, 2015, DIABETOLOGIA, V58, P1937, DOI 10.1007/s00125-015-3630-8; Zhang SS, 2017, INT J NANOMED, V12, P5643, DOI 10.2147/IJN.S137237; Zhang X, 2019, J DIABETES, V11, P418, DOI 10.1111/1753-0407.12871; Zhao YZ, 2016, ACTA BIOMATER, V29, P71, DOI 10.1016/j.actbio.2015.10.014	52	15	17	4	38	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9858	9870		10.1096/fj.201802600RR	http://dx.doi.org/10.1096/fj.201802600RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31166803				2022-12-28	WOS:000482214200014
J	Toral, M; Robles-Vera, I; Romero, M; de la Visitacion, N; Sanchez, M; O'Valle, F; Rodriguez-Nogales, A; Galvez, J; Duarte, J; Jimenez, R				Toral, Marta; Robles-Vera, Inaki; Romero, Miguel; de la Visitacion, Nestor; Sanchez, Manuel; O'Valle, Francisco; Rodriguez-Nogales, Alba; Galvez, Julio; Duarte, Juan; Jimenez, Rosario			Lactobacillus fermentum CECT5716: a novel alternative for the prevention of vascular disorders in a mouse model of systemic lupus erythematosus	FASEB JOURNAL			English	Article						hypertension; endothelial dysfunction; oxidative stress; gut dysbiosis; probiotics	IMPROVES ENDOTHELIAL DYSFUNCTION; INTESTINAL ALKALINE-PHOSPHATASE; LACTIC-ACID BACTERIA; PROTECTS KIDNEY; IN-VITRO; HYPERTENSION; LIPOPOLYSACCHARIDE; ACTIVATION; DYSBIOSIS; RECEPTOR	The aim of the present study was to examine whether the immune-modulatory bacteria Lactobacillus fermentum CECT5716 (LC40) ameliorates disease activity and cardiovascular complications in a female mouse model of lupus. Eighteen-week-old NZBWF1 [systemic lupus erythematosus (SLE)] and NZW/LacJ (control) mice were treated with vehicle or LC40 (5 x 10(8) colony-forming units/d) for 15 wk. LC40 treatment reduced lupus disease activity, blood pressure, cardiac and renal hypertrophy, and splenomegaly in SLE mice. LC40 reduced the elevated T, B, regulatory T cells (T-reg), and T helper (T-h)-1 cells in mesenteric lymph nodes of lupus mice. LC40 lowered the higher plasma concentration of proinflammatory cytokines observed in lupus mice. Aortas from SLE mice showed reduced endothelium-dependent vasodilator responses to acetylcholine. Endothelial dysfunction found in SLE is related to an increase of both NADPH oxidase-driven superoxide production and eNOS phosphorylation at the inhibitory Thr(495). These activities returned to normal values after a treatment with LC40. Probiotic administration to SLE mice reduced plasma LPS levels, which might be related to an improvement of the gut barrier integrity. LC40 treatment increases the Bifidobacterium count in gut microbiota of SLE mice. In conclusion, our findings identify the gut microbiota manipulation with LC40 as an alternative approach to the prevention of SLE and its associated vascular damage.-Toral, M., Robles-Vera, I., Romero, M., de la Visitacion, N., Sanchez, M., O'Valle, F., Rodriguez-Nogales, A., Galvez, J., Duarte, J., Jimenez, R. Lactobacillus fermentum CECT5716: a novel alternative for the prevention of vascular disorders in a mouse model of systemic lupus erythematosus.	[Toral, Marta; Robles-Vera, Inaki; Romero, Miguel; de la Visitacion, Nestor; Sanchez, Manuel; Rodriguez-Nogales, Alba; Galvez, Julio; Duarte, Juan; Jimenez, Rosario] Univ Granada, Sch Pharm, Dept Pharmacol, Campus Cartuja S-N, E-18071 Granada, Spain; [O'Valle, Francisco] Univ Granada, Sch Med, Dept Pathol, Granada, Spain; [Galvez, Julio] Univ Granada, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Granada, Spain; [Galvez, Julio; Duarte, Juan] Univ Granada, Ctr Biomed Res CIBM, Granada, Spain; [Romero, Miguel; Sanchez, Manuel; O'Valle, Francisco; Rodriguez-Nogales, Alba; Galvez, Julio; Duarte, Juan; Jimenez, Rosario] Inst Invest Biosanitaria Granada Ibs GRANADA, Granada, Spain; [Duarte, Juan; Jimenez, Rosario] Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Granada, Spain	University of Granada; University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Granada; University of Granada; Instituto de Investigacion Biosanitaria IBS Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV	Duarte, J (corresponding author), Univ Granada, Sch Pharm, Dept Pharmacol, Campus Cartuja S-N, E-18071 Granada, Spain.	jmduarte@ugr.es	de la Visitación, Néstor/K-5729-2017; Duarte, Juan/K-6472-2014; OValle, Francisco/AAA-9151-2019; Duarte, Juan/AAH-1574-2020; Toral, Marta/K-6709-2014; Romero, Miguel/K-6053-2014; perez, miguel/GXF-5077-2022; JIMENEZ, ROSARIO/K-9701-2014; Sanchez, Manuel/C-4401-2008; Robles-Vera, Iñaki/AAF-8562-2019; Gálvez, Julio/K-6875-2014	de la Visitación, Néstor/0000-0001-7229-9601; Duarte, Juan/0000-0002-9153-5857; Duarte, Juan/0000-0002-9153-5857; Toral, Marta/0000-0001-5324-8569; Romero, Miguel/0000-0003-0578-1099; JIMENEZ, ROSARIO/0000-0003-3872-2669; Sanchez, Manuel/0000-0002-3975-3398; Robles-Vera, Iñaki/0000-0001-6002-9241; Gálvez, Julio/0000-0001-6876-3782	Comision Interministerial de Ciencia y Tecnologia, Ministerio de Economia y Competitividad (MINECO) [SAF2014-55523-R, AGL2015-67995-C3-3-R, SAF2017-84894-R]; Junta de Andalucia (Proyecto de excelencia) [P12-CTS-2722, AGR-6826, CTS 164]; European Union; Ministerio de Economia y Competitividad, Instituto de Salud Carlos III (CIBER-ehd, CIBER-CV)	Comision Interministerial de Ciencia y Tecnologia, Ministerio de Economia y Competitividad (MINECO); Junta de Andalucia (Proyecto de excelencia)(Junta de Andalucia); European Union(European Commission); Ministerio de Economia y Competitividad, Instituto de Salud Carlos III (CIBER-ehd, CIBER-CV)	The authors thank Nutraceutical Translations (Granada, Spain) for English language editing of this manuscript. This work was supported by grants from the Comision Interministerial de Ciencia y Tecnologia, Ministerio de Economia y Competitividad (MINECO) (SAF2014-55523-R, AGL2015-67995-C3-3-R, SAF2017-84894-R), Junta de Andalucia (Proyecto de excelencia P12-CTS-2722, AGR-6826, and CTS 164) with funds from the European Union, and by the Ministerio de Economia y Competitividad, Instituto de Salud Carlos III (CIBER-ehd, CIBER-CV). M.S. is a postdoctoral fellow of Junta de Andalucia, I.R.-V. is a predoctoral fellow of MINECO, M.R. is postdoctoral fellow of the University of Granada, and N.D.L.V. is a predoctoral fellow of Junta de Andalucia and Fondo Social Europeo. "FEDER una manera de hacer Europa." The authors declare no conflicts of interest.	Al-Herz A, 2003, J RHEUMATOL, V30, P493; Alunno A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/823085; Antharam VC, 2013, J CLIN MICROBIOL, V51, P2884, DOI 10.1128/JCM.00845-13; Bartels CM, 2014, J RHEUMATOL, V41, P680, DOI 10.3899/jrheum.130874; Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; CAVALLO T, 1990, AM J PATHOL, V137, P971; DAR O, 1988, CLIN EXP IMMUNOL, V73, P430; Dhillion P, 2012, AM J PHYSIOL-REG I, V303, pR353, DOI 10.1152/ajpregu.00051.2012; Dole VS, 2013, J AM ASSOC LAB ANIM, V52, P458; Edgar RC, 2015, BIOINFORMATICS, V31, P3476, DOI 10.1093/bioinformatics/btv401; Elinav E, 2013, MUCOSAL IMMUNOL, V6, P4, DOI 10.1038/mi.2012.115; Frostegard J, 2008, LUPUS, V17, P364, DOI 10.1177/0961203308089988; Geddes K, 2008, GASTROENTEROLOGY, V135, P8, DOI 10.1053/j.gastro.2008.06.006; Gil-Campos M, 2012, PHARMACOL RES, V65, P231, DOI 10.1016/j.phrs.2011.11.016; Gomez-Guzman M, 2015, MOL NUTR FOOD RES, V59, P2326, DOI 10.1002/mnfr.201500290; Gomez-Guzman M, 2014, HYPERTENSION, V64, P330, DOI 10.1161/HYPERTENSIONAHA.114.03587; GRANHOLM NA, 1994, LUPUS, V3, P507, DOI 10.1177/096120339400300614; Haarman M, 2006, APPL ENVIRON MICROB, V72, P2359, DOI 10.1128/AEM.72.4.2359-2365.2006; Harrison OJ, 2015, MUCOSAL IMMUNOL, V8, P1226, DOI 10.1038/mi.2015.13; Heilig HGHJ, 2002, APPL ENVIRON MICROB, V68, P114, DOI 10.1128/AEM.68.1.114-123.2002; Hevia A, 2014, MBIO, V5, DOI 10.1128/mBio.01548-14; Nguyen H, 2013, CARDIOVASC RES, V97, P696, DOI 10.1093/cvr/cvs422; Hsieh CY, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12327; Kaliannan K, 2015, SCI REP-UK, V5, DOI 10.1038/srep11276; Kelley VR, 1999, SEMIN NEPHROL, V19, P57; Kim F, 2005, ARTERIOSCL THROM VAS, V25, P989, DOI 10.1161/01.ATV.0000160549.60980.a8; Lauwerys BR, 1998, EUR J IMMUNOL, V28, P2017, DOI 10.1002/(SICI)1521-4141(199806)28:06<2017::AID-IMMU2017>3.0.CO;2-2; Liang CF, 2013, ARTERIOSCL THROM VAS, V33, P777, DOI 10.1161/ATVBAHA.112.301087; Liu ZH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01687; Lopez P, 2016, CURR OPIN RHEUMATOL, V28, P515, DOI 10.1097/BOR.0000000000000309; Luo XM, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02288-17; Ma KY, 2015, INT J MOL SCI, V16, P13084, DOI 10.3390/ijms160613084; Mack DR, 1999, AM J PHYSIOL-GASTR L, V276, pG941, DOI 10.1152/ajpgi.1999.276.4.G941; Mardani F, 2019, J CELL PHYSIOL, V234, P642, DOI 10.1002/jcp.26819; Martin R, 2005, J HUM LACT, V21, P8, DOI 10.1177/0890334404272393; Martin R, 2003, J PEDIATR-US, V143, P754, DOI 10.1016/j.jpeds.2003.09.028; Mathis KW, 2014, HYPERTENSION, V64, P792, DOI 10.1161/HYPERTENSIONAHA.114.04006; McMurray RW, 1997, CLIN IMMUNOL IMMUNOP, V84, P260, DOI 10.1006/clin.1997.4390; Mu QH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14223-0; Mu QH, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0300-8; Robles-Vera I, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800298; Romero M, 2017, HYPERTENSION, V69, P641, DOI 10.1161/HYPERTENSIONAHA.116.08655; RUDOFSKY UH, 1984, AM J PATHOL, V116, P107; Ryan MJ, 2007, AM J PHYSIOL-REG I, V292, pR736, DOI 10.1152/ajpregu.00168.2006; Ryan MJ, 2013, HYPERTENSION, V62, P226, DOI 10.1161/HYPERTENSIONAHA.113.00603; Ryan MJ, 2009, AM J PHYSIOL-REG I, V296, pR1258, DOI 10.1152/ajpregu.90864.2008; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Small HY, 2018, FREE RADICAL BIO MED, V125, P104, DOI 10.1016/j.freeradbiomed.2018.05.085; Spolski R, 2014, NAT REV DRUG DISCOV, V13, P381, DOI 10.1038/nrd4296; Talaat RM, 2015, CYTOKINE, V72, P146, DOI 10.1016/j.cyto.2014.12.027; Toral M, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800033; Toral M, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1478-7; Toral M, 2014, CLIN SCI, V127, P33, DOI 10.1042/CS20130339; Tschudi MR, 1996, J CLIN INVEST, V98, P899, DOI 10.1172/JCI118872; Tzang BS, 2017, BRIT J NUTR, V118, P333, DOI [10.1017/S0007114517002112, 10.1017/s0007114517002112]; Venegas-Pont M, 2009, AM J PHYSIOL-REG I, V296, pR1282, DOI 10.1152/ajpregu.90992.2008; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WOFSY D, 1988, J AUTOIMMUN, V1, P415, DOI 10.1016/0896-8411(88)90065-0; Wu J, 2016, J CLIN INVEST, V126, P1607, DOI 10.1172/JCI87425; Yang T, 2015, HYPERTENSION, V65, P1331, DOI 10.1161/HYPERTENSIONAHA.115.05315; Zhang HS, 2014, APPL ENVIRON MICROB, V80, P7551, DOI 10.1128/AEM.02676-14; Zhang M, 2015, ARTHRITIS RHEUMATOL, V67, P2723, DOI 10.1002/art.39233; Zhou HW, 2011, ISME J, V5, P741, DOI 10.1038/ismej.2010.160; Zuo L, 2014, WORLD J GASTROENTERO, V20, P18316, DOI 10.3748/wjg.v20.i48.18316	65	38	40	2	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10005	10018		10.1096/fj.201900545RR	http://dx.doi.org/10.1096/fj.201900545RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31173526	Bronze			2022-12-28	WOS:000482214200024
J	Hori, S; Hiramuki, Y; Nishimura, D; Sato, F; Sehara-Fujisawa, A				Hori, Shimpei; Hiramuki, Yosuke; Nishimura, Daigo; Sato, Fuminori; Sehara-Fujisawa, Atsuko			PDH-mediated metabolic flow is critical for skeletal muscle stem cell differentiation and myotube formation during regeneration in mice	FASEB JOURNAL			English	Article						satellite cell; tissue regeneration; cell division; metabolic control	PYRUVATE-DEHYDROGENASE KINASE; INHIBITS MYOGENIC DIFFERENTIATION; HYPOXIA-INDUCIBLE FACTORS; SELF-RENEWAL; E1-ALPHA SUBUNIT; SATELLITE CELLS; GENE; DEFICIENCY; GLYCOLYSIS; EXPRESSION	Skeletal muscle satellite cells (SMSCs), the major stem cells responsible for the regeneration of skeletal muscle, are normally cell cycle arrested but differentiate to generate myocytes upon muscle damage, forming new myofibers along with self-renewing stem cells in preparation for subsequent injury. In this study, we investigated which factors stimulate the proliferation and differentiation of SMSCs and found that pyruvate, the end product of glycolysis, stimulates their differentiation. Pyruvate antagonizes the effects of hypoxia on preferential self-renewal of SMSCs through dephosphorylation or activation of pyruvate dehydrogenase (PDH), which mediates opening of the gateway from glycolysis to the tricarboxylic acid (TCA) cycle by producing acetyl coenzyme A from pyruvate. PDH kinase 1, highly expressed under hypoxia, is down-regulated under normoxic conditions, leading to an increase in dephosphorylated PDH. Conditional deletion of PDH in SMSCs affects cell divisions generating myocytes and subsequent myotube formation, inefficient skeletal muscle regeneration upon injury, and aggravated pathogenesis of a dystrophin-deficient mouse model of Duchenne muscular dystrophy. Thus, the flow from glycolysis to the TCA cycle mediated by PDH plays a pivotal role in the differentiation of SMSCs, which is critical for the progression of skeletal muscle regeneration.-Hori, S., Hiramuki, Y., Nishimura, D., Sato, F., Sehara-Fujisawa, A. PDH-mediated metabolic flow is critical for skeletal muscle stem cell differentiation and myotube formation during regeneration in mice.	[Hori, Shimpei; Hiramuki, Yosuke; Nishimura, Daigo; Sato, Fuminori; Sehara-Fujisawa, Atsuko] Kyoto Univ, Dept Growth Regulat, Inst Frontier Life & Med Sci, Kyoto, Japan; [Hiramuki, Yosuke] Fred Hutchinson Canc Res Ctr, Human Biol Div, 1124 Columbia St, Seattle, WA 98104 USA	Kyoto University; Fred Hutchinson Cancer Center	Sehara-Fujisawa, A (corresponding author), Kyoto Univ, Dept Growth Regulat, Inst Frontier Life & Med Sci, Sakyo Ku, 53 Shogoin Kawara Cho, Kyoto, Kyoto 6068507, Japan.	sehara.atsuko.3m@kyoto-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [16H04793, 15H05938, 15H05935, 15K21745]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Dr. H. Harada (Kyoto University) for helpful discussion, and Drs. S. Fukada (Osaka University, Osaka, Japan) and K. Hanaoka (Kitasato University, Tokyo, Japan) for providing SM/C-2.6 mouse IgG biotin and dystrophin-knockout mice, respectively. This work was supported by the Japan Society for the Promotion of Science KAKENHI Grants 16H04793 [Grant-in-Aid for Scientific Research (B)], 15H05938, 15H05935, and 15K21745 (Grant-in-Aid for Scientific Research on Innovative Areas). The authors declare no conflicts of interest.	Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Buckingham M, 2015, SEMIN CELL DEV BIOL, V44, P115, DOI 10.1016/j.semcdb.2015.09.017; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Chaillou T, 2016, FASEB J, V30, P3929, DOI 10.1096/fj.201600757R; Chang NC, 2018, CELL STEM CELL, V22, P755, DOI 10.1016/j.stem.2018.03.022; Charville GW, 2015, STEM CELL REP, V5, P621, DOI 10.1016/j.stemcr.2015.08.004; DAHL HHM, 1990, GENOMICS, V8, P225, DOI 10.1016/0888-7543(90)90275-Y; Di Carlo A, 2004, J BIOL CHEM, V279, P16332, DOI 10.1074/jbc.M313931200; Dumon NA, 2015, DEVELOPMENT, V142, P1572, DOI 10.1242/dev.114223; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; Garcia-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187; GUDI R, 1995, J BIOL CHEM, V270, P28989, DOI 10.1074/jbc.270.48.28989; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Held NM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27875-3; Hou XJ, 2015, J CELL SCI, V128, P2319, DOI 10.1242/jcs.167049; Ito K, 2018, EXP HEMATOL, V64, P1, DOI 10.1016/j.exphem.2018.05.005; Jian BX, 2010, SHOCK, V34, P169, DOI 10.1097/SHK.0b013e3181cffe7d; Johnson MT, 2001, MOL GENET METAB, V74, P293, DOI 10.1006/mgme.2001.3249; Jones NC, 2005, J CELL BIOL, V169, P105, DOI 10.1083/jcb.200408066; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Kudoh H, 2005, BIOCHEM BIOPH RES CO, V328, P507, DOI 10.1016/j.bbrc.2004.12.191; L'honore A, 2018, ELIFE, V7, DOI 10.7554/eLife.32991; Liu WY, 2012, DEVELOPMENT, V139, P2857, DOI 10.1242/dev.079665; Majmundar AJ, 2015, DEVELOPMENT, V142, P2405, DOI 10.1242/dev.123026; Majmundar AJ, 2012, MOL CELL BIOL, V32, P36, DOI 10.1128/MCB.05857-11; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; MARAGOS C, 1989, J BIOL CHEM, V264, P12294; Mathieu J, 2017, DEVELOPMENT, V144, P541, DOI 10.1242/dev.128389; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Mora A, 2003, EMBO J, V22, P4666, DOI 10.1093/emboj/cdg469; Moussaieff A, 2015, CELL METAB, V21, P392, DOI 10.1016/j.cmet.2015.02.002; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Nemeria NS, 2006, BIOORG CHEM, V34, P362, DOI 10.1016/j.bioorg.2006.09.001; Oginuma M, 2017, DEV CELL, V40, P342, DOI 10.1016/j.devcel.2017.02.001; Pala F, 2018, J CELL SCI, V131, DOI 10.1242/jcs.212977; Patel MS, 2014, J BIOL CHEM, V289, P16615, DOI 10.1074/jbc.R114.563148; Pliss L, 2004, J NEUROCHEM, V91, P1082, DOI 10.1111/j.1471-4159.2004.02790.x; PRATT ML, 1979, J BIOL CHEM, V254, P7191; Rajagopalan KN, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0134-4; Rardin MJ, 2009, ANAL BIOCHEM, V389, P157, DOI 10.1016/j.ab.2009.03.040; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Semba H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11635; Sidhu S, 2008, AM J PHYSIOL-HEART C, V295, pH946, DOI 10.1152/ajpheart.00363.2008; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Srinivasan M, 2010, AM J PHYSIOL-ENDOC M, V299, pE910, DOI 10.1152/ajpendo.00339.2010; TAKAKUBO F, 1992, EXP CELL RES, V199, P39, DOI 10.1016/0014-4827(92)90459-L; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Tang AH, 2014, EMBO J, V33, P2782, DOI 10.15252/embj.201488278; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Wang C, 2015, J BIOL CHEM, V290, P29707, DOI 10.1074/jbc.M115.688671; Willkomm L, 2014, STEM CELL RES, V12, P742, DOI 10.1016/j.scr.2014.03.004; Xie LW, 2018, J CLIN INVEST, V128, P2339, DOI 10.1172/JCI96208; Yang X, 2017, J BIOL CHEM, V292, P5981, DOI 10.1074/jbc.M116.756312; Yu WM, 2013, CELL STEM CELL, V12, P62, DOI 10.1016/j.stem.2012.11.022; Zhang HB, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.143420; Zheng X, 2016, ELIFE, V5, DOI [10.7554/eLife.18638, 10.7554/eLife.13374]	61	12	12	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8094	8109		10.1096/fj.201802479R	http://dx.doi.org/10.1096/fj.201802479R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30939245	Green Submitted, Bronze			2022-12-28	WOS:000476234700024
J	Ali, A; Anthony, RV; Bouma, GJ; Winger, QA				Ali, Asghar; Anthony, Russell V.; Bouma, Gerrit J.; Winger, Quinton A.			LIN28-let-7 axis regulates genes in immortalized human trophoblast cells by targeting the ARID3B-complex	FASEB JOURNAL			English	Article						intrauterine growth restriction; placenta; gene regulation	INTRAUTERINE GROWTH RESTRICTION; MICRORNA BIOGENESIS; C-MYC; ARID3B; DIFFERENTIATION; PREECLAMPSIA; INHIBITION; MATURATION; PLACENTA; LIN-28	Abnormal placental development is one of the main etiological factors for intrauterine growth restriction (IUGR). Here, we show that LIN28A and LIN28B are significantly lower and lethal-7 (let-7) microRNAs (miRNAs) significantly higher in term human IUGR vs. normal placentas. We hypothesize that let-7 miRNAs regulate genes with known importance for human placental development [high-mobility group AT-hook 1 (HMGA1), transcriptional regulator Myc-like (c-myc), vascular endothelial growth factor A (VEGF-A), and Wnt family member 1 (WNT1)] by targeting the AT-rich interacting domain (ARID)-3B complex. ACH-3P cells with LIN28A and LIN28B knockout (DKOs) significantly increased let-7 miRNAs, leading to significantly decreased ARID3A, ARID3B, and lysine demethylase 4C (KDM4C). Similarly, Sw.71 cells overexpressing LIN28A and LIN28B (DKIs) significantly decreased let-7 miRNAs, leading to significantly increased ARID3A, ARID3B, and KDM4C. In ACH-3P cells, ARID3A, ARID3B, and KDM4C make a triprotein complex [triprotein complex comprising ARID3A, ARID3B, and KDM4C (ARID3B-complex)] that binds the promoter regions of HMGA1, c-MYC, VEGF-A, and WNT1. ARID3B knockout in ACH-3P cells disrupted the ARID3B-complex, leading to a significant decrease in HMGA1, c-MYC, VEGF-A, and WNT1. DKOs had a significant reduction, whereas DKIs had a significant increase in HMGA1, c-MYC, VEGF-A, and WNT1, potentially due to regulation by the ARID3B-complex. This is the first study showing regulation of let-7 targets in immortalized human trophoblast cells by the ARID3B-complex.	[Ali, Asghar; Anthony, Russell V.; Bouma, Gerrit J.; Winger, Quinton A.] Colorado State Univ, Dept Biomed Sci, Anim Reprod & Biotechnol Lab, 1683 Campus Delivery, Ft Collins, CO 80523 USA	Colorado State University	Winger, QA (corresponding author), Colorado State Univ, Dept Biomed Sci, Anim Reprod & Biotechnol Lab, 1683 Campus Delivery, Ft Collins, CO 80523 USA.	quinton.winger@colostate.edu	Bouma, Gerrit/AAT-4644-2020	Bouma, Gerrit/0000-0003-2433-5086; Ali, Asghar/0000-0002-5137-2547	Agriculture and Food Research Initiative Competitive Grant from the U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture [2017-67015-26460]; Institute of International Education (IIE); United States Education Foundation in Pakistan (USEFP)	Agriculture and Food Research Initiative Competitive Grant from the U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture; Institute of International Education (IIE); United States Education Foundation in Pakistan (USEFP)	The authors thank Dr. Marcin Jozwik (University of Warmia and Mazury, Olsztyn, Poland) and Dr. Maciej Jozwik (Medical University of Bialystok, Bialystok, Poland) for providing the human placental tissue samples (53). This project was supported by Agriculture and Food Research Initiative Competitive Grant 2017-67015-26460 from the U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture. The authors thank the Institute of International Education (IIE) and United States Education Foundation in Pakistan (USEFP) for funding the doctoral studies of A.A. at Colorado State University through the Foreign Fulbright Scholarship Program. The authors declare no conflicts of interest.	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Barker DJP, 1999, ANN MED, V31, P3, DOI 10.1080/07853890.1999.11904392; Beune IM, 2018, J PEDIATR-US, V196, P71, DOI 10.1016/j.jpeds.2017.12.059; Bobbs A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131961; Canfield J, 2019, FASEB J, V33, P2759, DOI 10.1096/fj.201801163R; Casanova JC, 2011, DEVELOPMENT, V138, P1195, DOI 10.1242/dev.057570; DEVOR EJ, 2014, OBSTET GYNECOLOGY IN, V2014, P1, DOI DOI 10.1155/2014/678984; Djakovic A, 2007, Z Geburtshilfe Neonatol, V211, P169, DOI 10.1055/s-2007-981219; Feng C, 2012, CELL CYCLE, V11, P2486, DOI 10.4161/cc.20893; Habir K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01387; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Heinonen S, 2001, PLACENTA, V22, P399, DOI 10.1053/plac.2001.0630; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hiden U, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-137; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Jin B, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2904-y; Jozwik M, 2009, PLACENTA, V30, P607, DOI 10.1016/j.placenta.2009.05.005; Kim D, 2007, J BIOL CHEM, V282, P15768, DOI 10.1074/jbc.M700397200; Kobayashi K, 2006, CANCER RES, V66, P8331, DOI 10.1158/0008-5472.CAN-06-0756; Kortschak RD, 2000, TRENDS BIOCHEM SCI, V25, P294, DOI 10.1016/S0968-0004(00)01597-8; Kumar P, 2013, MOL CELL BIOL, V33, P1782, DOI 10.1128/MCB.01228-12; Lala N, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.097881; Li Y, 2015, ENDOCRINOLOGY, V156, P4257, DOI 10.1210/en.2015-1228; Liao TT, 2016, CELL REP, V14, P520, DOI 10.1016/j.celrep.2015.12.064; Liu FL, 2018, MOL MED REP, V17, P5627, DOI 10.3892/mmr.2018.8558; Lyons P., 2006, OBSTET FAMILY MED PR; Ma W, 2013, CELL CYCLE, V12, P88, DOI 10.4161/cc.23028; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Norwitz Errol R, 2007, Reprod Biomed Online, V14 Spec No 1, P101, DOI 10.1016/S1472-6483(10)61464-2; Pang V, 2017, CLIN SCI, V131, P2763, DOI 10.1042/CS20171252; Park J, 2015, BIOINFORMATICS, V31, P4014, DOI 10.1093/bioinformatics/btv537; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Rahman MM, 2009, BRIT J CANCER, V100, P501, DOI 10.1038/sj.bjc.6604883; Raney BJ, 2011, NUCLEIC ACIDS RES, V39, pD871, DOI 10.1093/nar/gkq1017; Ratliff ML, 2016, J IMMUNOL, V196, P614, DOI 10.4049/jimmunol.1500355; Rhee C, 2017, DEV BIOL, V422, P83, DOI 10.1016/j.ydbio.2016.12.003; Roy L, 2014, ONCOTARGET, V5, P8355, DOI 10.18632/oncotarget.2247; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Scifres CM, 2009, J PHYSIOL-LONDON, V587, P3453, DOI 10.1113/jphysiol.2009.173252; Seabrook JL, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109868; Sharma D, 2016, J MATERN-FETAL NEO M, V29, P3977, DOI 10.3109/14767058.2016.1152249; Sonderegger S, 2007, PLACENTA, V28, pS97, DOI 10.1016/j.placenta.2006.11.003; Straszewski-Chavez SL, 2009, PLACENTA, V30, P939, DOI 10.1016/j.placenta.2009.08.007; Takebe A, 2006, DEV BIOL, V293, P25, DOI 10.1016/j.ydbio.2005.12.016; Uchikura Y., 2015, PREGNANCY HYPERTENS, V5, P243; Uchikura Y, 2017, REPROD SCI, V24, P1630, DOI 10.1177/1933719117697254; Wagner S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/376326; Wang XF, 2018, J MOL HISTOL, V49, P317, DOI 10.1007/s10735-018-9770-7; Webb CF, 2011, MOL CELL BIOL, V31, P1041, DOI 10.1128/MCB.01448-10; West RC, 2019, BIOL REPROD, V100, P227, DOI 10.1093/biolre/ioy183; Wilkins-Haug L, 2006, PRENATAL DIAG, V26, P428, DOI 10.1002/pd.1430; Wilsker D, 2005, GENOMICS, V86, P242, DOI 10.1016/j.ygeno.2005.03.013; Wood JJ, 2016, J VIROL, V90, P9543, DOI 10.1128/JVI.03262-15; Wu KJ, 2019, REPROD FERT DEVELOP, V31, P377, DOI 10.1071/RD18118; Yang XJ, 2015, ONCOL REP, V33, P1723, DOI 10.3892/or.2015.3757; Yu KM, 1992, ZHONGHUA FU CHAN KE, V27, P250	57	11	12	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12348	12363		10.1096/fj.201900718RR	http://dx.doi.org/10.1096/fj.201900718RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31415216	Bronze, Green Published			2022-12-28	WOS:000507461600059
J	An, YA; Zhang, HF; Wang, C; Jiao, FT; Xu, HY; Wang, XF; Luan, WJ; Ma, FX; Ni, LH; Tang, XD; Liu, MY; Guo, WY; Yu, L				An, Yanan; Zhang, Haifeng; Wang, Chao; Jiao, Fangtai; Xu, Hongyue; Wang, Xuefei; Luan, Wenjing; Ma, Fangxue; Ni, Lihui; Tang, Xudong; Liu, Mingyuan; Guo, Weiying; Yu, Lu			Activation of ROS/MAPKs/NF-kappa B/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis	FASEB JOURNAL			English	Article						diabetes mellitus osteoporosis; reactive oxygen species; osteoclasts; infalmmasome	NF-KAPPA-B; BONE LOSS; OXIDATIVE STRESS; LIPOPOLYSACCHARIDE; INFLAMMASOME; MACROPHAGES; RESOLUTION; CLEARANCE; RECEPTOR; DIFFERENTIATION	Diabetes mellitus (DM) affects bone metabolism and leads to osteoporosis; however, its pathogenetic mechanisms remain unknown. We found that high glucose (HG) conditions induced the production of reactive oxygen species (ROS) and the expression of proteins related to MAPKs [phosphorylated (p)-ERK, p-JNK, and p-p38], NF-kappa B (NF-kappa B, p-I kappa B, and IKK), and NACHT-LRR-PYD domains-containing protein 3 (NALP3) (NLRP3) [apoptosis-associated speck-like protein containing a caspase activation and recruitment domain (ASC), caspase-1, IL-18, IL-1 beta, and NLRP3] in osteoclasts (OCs) in vitro. Further analysis showed that in HG-induced OCs, ROS is an upstream signal for MAPKs, NF-kappa B, and the NLRP3 inflammasome. Moreover, MAPKs mediated the activation of NF-kappa B and NLRP3, whereas NF-kappa B up-regulated the NLRP3 inflammasome response. Interestingly, HG inducement enhanced the bone resorption of OCs but inhibited their efferocytosis, whereas insulin and lipoxin A4 (4) treatment reversed this phenomenon. In streptozotocin-induced diabetic rats in vivo, the numbers and the bone-resorption capacity of OCs as well as the serum levels of TRACP-5b were significantly increased, and the expression of MAPK-, NF-kappa B-, and NLRP3 inflammasome- related proteins in the proximal tibia were also significantly elevated; however, treatment with insulin and LXA4 reversed this elevation. Together, these results demonstrated that the activation of ROS/MAPKs/NF-kappa B/NLRP3 and the inhibition of efferocytosis in OCs are the main causes of osteoporosis in DM.	[An, Yanan; Zhang, Haifeng; Wang, Chao; Jiao, Fangtai; Xu, Hongyue; Wang, Xuefei; Luan, Wenjing; Ma, Fangxue; Ni, Lihui; Liu, Mingyuan; Guo, Weiying; Yu, Lu] Jilin Univ, Key Lab Zoonosis Res, Dept Intervent Therapy, Dept Endocrinol,Minist Educ,Hosp 1, Changchun, Peoples R China; [An, Yanan; Zhang, Haifeng; Wang, Chao; Jiao, Fangtai; Xu, Hongyue; Wang, Xuefei; Luan, Wenjing; Ma, Fangxue; Ni, Lihui; Liu, Mingyuan; Guo, Weiying; Yu, Lu] Jilin Univ, Coll Vet Med, Inst Zoonosis, Changchun, Peoples R China; [Tang, Xudong] Tsinghua Univ Shenzhen, Res Inst, Key Lab New Drugs Res Tradit Chinese Med TCM, Shenzhen, Peoples R China; [Liu, Mingyuan] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Jilin University; Jilin University; Tsinghua University	Guo, WY (corresponding author), Jilin Univ, Hosp 1, Dept Endocrine & Metab, Xinmin St 71, Changchun 130021, Peoples R China.; Yu, L (corresponding author), Jilin Univ, Coll Vet Med, Inst Zoonosis, Key Lab Zoonosis Res,Minist Educ, Xian Rd 5333, Changchun 130000, Peoples R China.	guowy@jlu.edu.cn; yu_lu@jlu.edu.cn			Project of Science and Technology Department of Jilin Province [20180414036GH]; Education Department of Jilin Province [2016444]; State Key Project of Research and Development Plan [2017YFD0502200, 2016YFD0501302]; National Nature Science Foundation of China [31172364, 81801972]; Fund for Science and Technology Development of Jilin Province [20150101108JC]; Important National Science and Technology Specific Projects [2012ZX10003002]; Program for New Century Excellent Talents in University [NCET-09-0434]; Science, Technology and Innovation Commission of Shenzhen Municipality [JCYJ2016031100720906, JSGG20160301100442775]	Project of Science and Technology Department of Jilin Province; Education Department of Jilin Province; State Key Project of Research and Development Plan; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund for Science and Technology Development of Jilin Province; Important National Science and Technology Specific Projects; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Science, Technology and Innovation Commission of Shenzhen Municipality	The authors thank Dr. Yang Wang (Jilin University) for her help in manuscript revision. This work was supported by the Project of Science and Technology Department of Jilin Province (20180414036GH); the Education Department of Jilin Province (2016444); the State Key Project of Research and Development Plan (2017YFD0502200 and 2016YFD0501302); the National Nature Science Foundation of China (31172364 and 81801972); the Fund for Science and Technology Development of Jilin Province (20150101108JC); the Important National Science and Technology Specific Projects (2012ZX10003002); the Program for New Century Excellent Talents in University (NCET-09-0434); and the Science, Technology and Innovation Commission of Shenzhen Municipality (JCYJ2016031100720906 and JSGG20160301100442775). The authors declare no conflicts of interest.	Ajizian SJ, 1999, J INFECT DIS, V179, P939, DOI 10.1086/314659; Alippe Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07014-0; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Aziz Monowar, 2013, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1431s100; Baichwal VR, 1997, CURR BIOL, V7, pR94, DOI 10.1016/S0960-9822(06)00046-7; Bain S, 1997, BONE, V21, P147, DOI 10.1016/S8756-3282(97)00104-X; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brancaleone V, 2013, BLOOD, V122, P608, DOI 10.1182/blood-2013-04-496661; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Douda DN, 2015, P NATL ACAD SCI USA, V112, P2817, DOI 10.1073/pnas.1414055112; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Fredman G, 2015, SCI TRANSL MED, V7; Fredman G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1065; Fredman G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00639; Garbin U, 2013, CARDIOVASC RES, V97, P125, DOI 10.1093/cvr/cvs301; Ghonime MG, 2014, J IMMUNOL, V192, P3881, DOI 10.4049/jimmunol.1301974; Green DR, 2016, CELL DEATH DIFFER, V23, P915, DOI 10.1038/cdd.2015.172; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; HERSKIND AM, 1992, DIABETES METAB, V18, P63; Hie M, 2009, EUR J PHARMACOL, V621, P1, DOI 10.1016/j.ejphar.2009.08.025; Irwin R, 2006, ENDOCRINOLOGY, V147, P5760, DOI 10.1210/en.2006-0700; Jaghsi Sawsan, 2018, Open Rheumatol J, V12, P1, DOI 10.2174/1874312901812010001; Jeong DW, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/3231784; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Li NX, 1999, FASEB J, V13, P1137, DOI 10.1096/fasebj.13.10.1137; Liang W, 2011, EUR J PHARMACOL, V670, P317, DOI 10.1016/j.ejphar.2011.08.014; Lu HF, 2003, ENDOCRINOLOGY, V144, P346, DOI 10.1210/en.2002-220072; Lukens JR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00315; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Martinez R.M., 2018, J DERMATOL SCI; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Mendis E, 2008, BIOORGAN MED CHEM, V16, P8390, DOI 10.1016/j.bmc.2008.08.037; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Morimoto K, 2006, J IMMUNOL, V176, P7657, DOI 10.4049/jimmunol.176.12.7657; Nassar H, 2007, PERIODONTOL 2000, V43, P233, DOI 10.1111/j.1600-0757.2006.00168.x; Pisoschi AM, 2015, EUR J MED CHEM, V97, P55, DOI 10.1016/j.ejmech.2015.04.040; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schwartz AV, 2003, CALCIFIED TISSUE INT, V73, P515, DOI 10.1007/s00223-003-0023-7; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Suzuki K, 2002, J BONE MINER RES, V17, P1486, DOI 10.1359/jbmr.2002.17.8.1486; Tabas I, 2016, CIRC RES, V118, P653, DOI 10.1161/CIRCRESAHA.115.306256; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Thorp E, 2011, J BIOL CHEM, V286, P33335, DOI 10.1074/jbc.M111.263020; Toker H, 2012, J PERIODONTAL RES, V47, P793, DOI 10.1111/j.1600-0765.2012.01497.x; Vestergaard P, 2009, CURR OPIN ENDOCRINOL, V16, P125, DOI 10.1097/MED.0b013e328325d155; Viola JR, 2016, CIRC RES, V119, P1030, DOI 10.1161/CIRCRESAHA.116.309492; Wang TL, 2002, INT IMMUNOPHARMACOL, V2, P1509, DOI 10.1016/S1567-5769(02)00058-9; Wei F, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2016.00334, 10.3389/fmicb.2016.00502]; Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010	54	111	120	9	48	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12515	12527		10.1096/fj.201802805RR	http://dx.doi.org/10.1096/fj.201802805RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31461386	Bronze, Green Published			2022-12-28	WOS:000507461600071
J	Gimenez-Gomez, P; Perez-Hernandez, M; O'Shea, E; Caso, JR; Martin-Hernandez, D; Cervera, LA; Centelles, MLGL; Gutierrez-Lopez, MD; Colado, MI				Gimenez-Gomez, Pablo; Perez-Hernandez, Mercedes; O'Shea, Esther; Caso, Javier R.; Martin-Hernandez, David; Alou Cervera, Luis; Gomez-Lus Centelles, Maria Luisa; Dolores Gutierrez-Lopez, Maria; Isabel Colado, Maria			Changes in brain kynurenine levels via gut microbiota and gut-barrier disruption induced by chronic ethanol exposure in mice	FASEB JOURNAL			English	Article						LPS; MMPs; iNOS	ALCOHOL-USE DISORDERS; TRYPTOPHAN-METABOLISM; NITRIC-OXIDE; INDOLEAMINE 2,3-DIOXYGENASE; BACTERIAL TRANSLOCATION; INTESTINAL PERMEABILITY; INDUCED NEUROINFLAMMATION; CALMETTE-GUERIN; LEAKY GUT; EXPRESSION	Inflammatory processes have been shown to modify tryptophan (Trp) metabolism. Gut microbiota appears to play a significant role in the induction of peripheral and central inflammation. Ethanol (EtOH) exposure alters gut permeability, but its effects on Tip metabolism and the involvement of gut microbiota have not been studied. We analyzed several parameters of gut-barrier and of peripheral and central Tip metabolism following 2 different EtOH consumption patterns in mice, the binge model, drinking in the dark (DID), and the chronic intermittent (CI) consumption paradigm. Antibiotic treatment was used to evaluate gut microbiota involvement in the CI model. Mice exposed to CI EtOH intake, but not DID, show bacterial translocation and increased plasma LPS immediately after EtOH removal. Gut-barrier permeability to FITC-dextran is increased by CI, and, furthermore, intestinal epithelial tight-junction (TJ) disruption is observed (decreased expression of zonula occludens 1 and occludin) associated with increased matrix metalloproteinase (MMP)-9 activity and iNOS expression. CI EtOH, but not DID, increases kynurenine (Kyn) levels in plasma and limbic forebrain. Intestinal bacterial decontamination prevents the LPS increase but not the permeability to FITC-dextran, TJ disruption, or the increase in MMP-9 activity and iNOS expression. Although plasma Kyn levels are not affected by antibiotic treatment, the elevation of Kyn in brain is prevented, pointing to an involvement of microbiota in CI EtOH-induced changes in brain Trp metabolism. Additionally, CI EtOH produces depressive-like symptoms of anhedonia, which are prevented by the antibiotic treatment thus pointing to an association between anhedonia and the increase in brain Kyn and to the involvement of gut microbiota.	[Gimenez-Gomez, Pablo; Perez-Hernandez, Mercedes; O'Shea, Esther; Caso, Javier R.; Martin-Hernandez, David; Dolores Gutierrez-Lopez, Maria; Isabel Colado, Maria] Univ Complutense, Fac Med, Dept Farmacol & Toxicol, Pza Ramon y Cajal S-N, E-28040 Madrid, Spain; [Gimenez-Gomez, Pablo; Perez-Hernandez, Mercedes; O'Shea, Esther; Dolores Gutierrez-Lopez, Maria; Isabel Colado, Maria] Univ Complutense, Fac Med, IUIN, Madrid, Spain; [Alou Cervera, Luis; Gomez-Lus Centelles, Maria Luisa] Univ Complutense, Fac Med, Area Microbiol, Dept Med, Madrid, Spain; [Gimenez-Gomez, Pablo; Perez-Hernandez, Mercedes; O'Shea, Esther; Caso, Javier R.; Martin-Hernandez, David; Dolores Gutierrez-Lopez, Maria; Isabel Colado, Maria] Hosp 12 Octubre, Inst Invest Sanitaria, Madrid, Spain; [Gimenez-Gomez, Pablo; Perez-Hernandez, Mercedes; O'Shea, Esther; Dolores Gutierrez-Lopez, Maria; Isabel Colado, Maria] Inst Salud Carlos III, Red Trastornos Adict, Madrid, Spain; [Caso, Javier R.; Martin-Hernandez, David] Ctr Invest Biomed Salud Mental CIBERSAM, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid; Hospital Universitario 12 de Octubre; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Gutierrez-Lopez, MD; Colado, MI (corresponding author), Univ Complutense, Fac Med, Dept Farmacol & Toxicol, Pza Ramon y Cajal S-N, E-28040 Madrid, Spain.	mdgutier@ucm.es; colado@ucm.es	MD, Gutierrez-Lopez/P-2965-2014; Alou, Luis/B-8170-2011; Caso, Javier R/G-2243-2017; Martín-Hernández, David/B-9172-2016; Gimenez Gomez, Pablo/AFV-9002-2022; O'Shea, Esther/H-6147-2015	Alou, Luis/0000-0002-0859-008X; Caso, Javier R/0000-0001-8622-749X; Martín-Hernández, David/0000-0003-0195-2604; Gimenez Gomez, Pablo/0000-0002-9404-4615; Gutierrez Lopez, Maria Dolores/0000-0002-9979-5573; O'Shea, Esther/0000-0001-5008-882X	Ministerio de Economia y Competitividad [SAF2016-78864-R]; Ministerio de Sanidad, Servicios Sociales e Igualdad [Plan Nacional Sobre Drogas (PNSD)] [2014I015, 2017I017]; Instituto de Salud Carlos III Redes Tematicas de Investigacion Cooperativa en Salud-Red de Trastornos Adictivos (ISCII RETICS-RTA) Grants [RD12/0028/0002, RD16/0017/0021]; UCM Grant [910258]; Ministerio de Educacion, Cultura y Deporte;  [PNSD 2017I017]	Ministerio de Economia y Competitividad(Spanish Government); Ministerio de Sanidad, Servicios Sociales e Igualdad [Plan Nacional Sobre Drogas (PNSD)]; Instituto de Salud Carlos III Redes Tematicas de Investigacion Cooperativa en Salud-Red de Trastornos Adictivos (ISCII RETICS-RTA) Grants; UCM Grant; Ministerio de Educacion, Cultura y Deporte(Spanish Government); 	The authors thank Centro de Asistencia a Ia Investigacion (CAI) Animalario, Universidad Complutense de Madrid (UCM) for the care and maintenance of the mice used in the study. This work was supported by Ministerio de Economia y Competitividad Grant SAF2016-78864-R, the Ministerio de Sanidad, Servicios Sociales e Igualdad [Plan Nacional Sobre Drogas (PNSD) 2014I015 and 2017I017)], Instituto de Salud Carlos III Redes Tematicas de Investigacion Cooperativa en Salud-Red de Trastornos Adictivos (ISCII RETICS-RTA) Grants RD12/0028/0002 and RD16/0017/0021, and UCM Grant 910258. P.G.-G. is the recipient of a predoctoral fellowship (FPU) from the Ministerio de Educacion, Cultura y Deporte. M.P.-H. is the recipient of a postdoctoral research contract (PNSD 2017I017); D.M.-H. is a postdoctoral fellow; J.R.C. is a Ramon y Cajal Fellow (Ministerio de Ciencia, Innovacion y Universidades). The authors declare no conflicts of interest.	Achur RN, 2010, J NEUROIMMUNE PHARM, V5, P83, DOI 10.1007/s11481-009-9185-z; Agus A, 2018, CELL HOST MICROBE, V23, P716, DOI 10.1016/j.chom.2018.05.003; Al-Sadi R, 2011, AM J PHYSIOL-GASTR L, V300, pG1054, DOI 10.1152/ajpgi.00055.2011; Alfonso-Loeches S, 2010, J NEUROSCI, V30, P8285, DOI 10.1523/JNEUROSCI.0976-10.2010; Ando T, 2000, AM J PHYSIOL-REG I, V279, pR2164, DOI 10.1152/ajpregu.2000.279.6.R2164; [Anonymous], 2016, GLOB STAT REP ALC HL; Badawy AAB, 2002, NUTR RES REV, V15, P123, DOI 10.1079/NRR200133; Badawy AAB, 2011, ALCOHOL ALCOHOLISM, V46, P651, DOI 10.1093/alcalc/agr134; Badawy AAB, 2017, INT J TRYPTOPHAN RES, V10, DOI 10.1177/1178646917691938; Badawy AAB, 2009, ALCOHOL ALCOHOLISM, V44, P267, DOI 10.1093/alcalc/agp005; Bala S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096864; Banan A, 2000, J PHARMACOL EXP THER, V294, P997; Becker HC, 2004, ALCOHOL CLIN EXP RES, V28, P1829, DOI 10.1097/01.ALC.0000149977.95306.3A; BJARNASON I, 1984, LANCET, V1, P179; Bode C, 2003, BEST PRACT RES CL GA, V17, P575, DOI 10.1016/S1521-6918(03)00034-9; BODE C, 1987, J HEPATOL, V4, P8, DOI 10.1016/S0168-8278(87)80003-X; BODE C, 1991, ANN NY ACAD SCI, V625, P837, DOI 10.1111/j.1749-6632.1991.tb33931.x; Boden JM, 2011, ADDICTION, V106, P906, DOI 10.1111/j.1360-0443.2010.03351.x; Campbell BM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00012; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Ledesma JC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172956; Castaneda FE, 2005, GASTROENTEROLOGY, V129, P1991, DOI 10.1053/j.gastro.2005.09.017; Chen X, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7207268; Cho YE, 2018, REDOX BIOL, V18, P266, DOI 10.1016/j.redox.2018.07.012; Clarke G, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00090; Connor TJ, 2008, NEUROSCI LETT, V441, P29, DOI 10.1016/j.neulet.2008.06.007; Cox BR, 2013, ALCOHOL CLIN EXP RES, V37, P1688, DOI 10.1111/acer.12145; Crews FT, 2006, ALCOHOL CLIN EXP RES, V30, P720, DOI 10.1111/j.1530-0277.2006.00084.x; Crews FT, 2015, ALCOHOL RES-CURR REV, V37, P331, DOI 10.17615/kbjf-fa93; Cross RK, 2003, INFLAMM BOWEL DIS, V9, P179, DOI 10.1097/00054725-200305000-00006; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Dastidar SG, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8010003; Donnadieu-Rigole H, 2018, ALCOHOL CLIN EXP RES, V42, P32, DOI 10.1111/acer.13527; DRAPER LR, 1983, GUT, V24, P399, DOI 10.1136/gut.24.5.399; Forsyth CB, 2011, ALCOHOL CLIN EXP RES, V35, P1635, DOI 10.1111/j.1530-0277.2011.01510.x; Fredenburgh LE, 2011, J IMMUNOL, V187, P5255, DOI 10.4049/jimmunol.1101186; GAL EM, 1978, J NEUROCHEM, V30, P607, DOI 10.1111/j.1471-4159.1978.tb07815.x; Garate I, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-151; Gimenez-Gomez P, 2018, NEUROPHARMACOLOGY, V135, P581, DOI 10.1016/j.neuropharm.2018.04.016; Hoban AE, 2016, NEUROSCIENCE, V339, P463, DOI 10.1016/j.neuroscience.2016.10.003; Justinova Z, 2013, NAT NEUROSCI, V16, P1652, DOI 10.1038/nn.3540; Katsu M, 2010, J CEREBR BLOOD F MET, V30, P1939, DOI 10.1038/jcbfm.2010.45; KATZ RJ, 1982, PHARMACOL BIOCHEM BE, V16, P965, DOI 10.1016/0091-3057(82)90053-3; Kelley KW, 2011, BRAIN BEHAV IMMUN, V25, pS13, DOI 10.1016/j.bbi.2010.12.013; Kennedy PJ, 2017, NEUROPHARMACOLOGY, V112, P399, DOI 10.1016/j.neuropharm.2016.07.002; Keshavarzian A, 1999, AM J GASTROENTEROL, V94, P200; Keshavarzian A, 2009, J HEPATOL, V50, P538, DOI 10.1016/j.jhep.2008.10.028; Khan KMF, 2004, J BIOL CHEM, V279, P22039, DOI 10.1074/jbc.M312735200; Kim H, 2012, J CLIN INVEST, V122, P2940, DOI 10.1172/JCI61884; Larroya-Garcia A, 2019, CRIT REV FOOD SCI, V59, P3102, DOI 10.1080/10408398.2018.1484340; Larsson MK, 2016, NEUROCHEM RES, V41, P2243, DOI 10.1007/s11064-016-1939-4; Leclercq S, 2014, P NATL ACAD SCI USA, V111, pE4485, DOI 10.1073/pnas.1415174111; Leclercq S, 2012, BRAIN BEHAV IMMUN, V26, P911, DOI 10.1016/j.bbi.2012.04.001; LEMARQUAND D, 1994, BIOL PSYCHIAT, V36, P395, DOI 10.1016/0006-3223(94)91215-7; Lieben CKJ, 2004, NEUROCHEM INT, V44, P9, DOI 10.1016/S0197-0186(03)00102-5; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lin JC, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12547; Linderholm KR, 2016, NEUROPHARMACOLOGY, V102, P42, DOI 10.1016/j.neuropharm.2015.10.028; Luczynski P, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw020; Martin-Hernandez D, 2016, NEUROPHARMACOLOGY, V103, P122, DOI 10.1016/j.neuropharm.2015.12.003; McCarthy KM, 1996, J CELL SCI, V109, P2287; Medina C, 2003, AM J PHYSIOL-GASTR L, V284, pG116, DOI 10.1152/ajpheart.00036.2002; Melendez RI, 2011, ALCOHOL CLIN EXP RES, V35, P652, DOI 10.1111/j.1530-0277.2010.01383.x; Mir H, 2016, BBA-GEN SUBJECTS, V1860, P765, DOI 10.1016/j.bbagen.2015.12.013; Moreau M, 2008, BRAIN BEHAV IMMUN, V22, P1087, DOI 10.1016/j.bbi.2008.04.001; Morris EP, 2005, CLIN PSYCHOL REV, V25, P734, DOI 10.1016/j.cpr.2005.05.004; Nagpal R, 2017, ANN NUTR METAB, V71, P11, DOI 10.1159/000479918; Neupane SP, 2015, ALCOHOL CLIN EXP RES, V39, P514, DOI 10.1111/acer.12651; Nighot P, 2015, AM J PHYSIOL-GASTR L, V309, pG988, DOI 10.1152/ajpgi.00256.2015; Nishizawa S, 1997, P NATL ACAD SCI USA, V94, P5308, DOI 10.1073/pnas.94.10.5308; O'Connor JC, 2009, J IMMUNOL, V182, P3202, DOI 10.4049/jimmunol.0802722; O'Sullivan S., 2015, MEDIAT INFLAMM, V2015, P2015; Obad A, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00081; Osna NA, 2017, ALCOHOL RES-CURR REV, V38, P147; Osterndorff-Kahanek E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059870; Parlesak A, 2000, J HEPATOL, V32, P742, DOI 10.1016/S0168-8278(00)80242-1; Parrott JM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0590-y; Pascual M, 2015, NEUROPHARMACOLOGY, V89, P352, DOI 10.1016/j.neuropharm.2014.10.014; Peterson VL, 2017, BEHAV BRAIN RES, V323, P172, DOI 10.1016/j.bbr.2017.01.049; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Rhodes JS, 2005, PHYSIOL BEHAV, V84, P53, DOI 10.1016/j.physbeh.2004.10.007; Rico-Barrio I., 2018, ADDICT BIOL; Ridnour LA, 2007, P NATL ACAD SCI USA, V104, P16898, DOI 10.1073/pnas.0702761104; Rieder R, 2017, BRAIN BEHAV IMMUN, V66, P9, DOI 10.1016/j.bbi.2017.01.016; Rivera CA, 1998, AM J PHYSIOL-GASTR L, V275, pG1252, DOI 10.1152/ajpgi.1998.275.6.G1252; Rosell A, 2006, STROKE, V37, P1399, DOI 10.1161/01.STR.0000223001.06264.af; Rossi M., 2018, CANCERS, V10, P172; Rubio-Araiz A, 2017, ADDICT BIOL, V22, P1103, DOI 10.1111/adb.12376; Salazar A, 2012, HORM BEHAV, V62, P202, DOI 10.1016/j.yhbeh.2012.03.010; Samak G, 2016, SCI REP-UK, V6, DOI 10.1038/srep38899; Scheggi S, 2018, INT J NEUROPSYCHOPH, V21, P1049, DOI 10.1093/ijnp/pyy083; Schrocksnadel K, 2006, CLIN CHIM ACTA, V364, P82, DOI 10.1016/j.cca.2005.06.013; SCHWARCZ R, 1993, BIOCHEM SOC T, V21, P77, DOI 10.1042/bst0210077; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Singer II, 1996, GASTROENTEROLOGY, V111, P871, DOI 10.1016/S0016-5085(96)70055-0; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Steck N, 2012, GUT, V61, P1610, DOI 10.1136/gutjnl-2011-300775; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Tang YM, 2008, ALCOHOL CLIN EXP RES, V32, P355, DOI 10.1111/j.1530-0277.2007.00584.x; Tang YM, 2009, ALCOHOL CLIN EXP RES, V33, P1220, DOI 10.1111/j.1530-0277.2009.00946.x; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vecil GG, 2000, J NEUROSCI RES, V61, P212, DOI 10.1002/1097-4547(20000715)61:2<212::AID-JNR12>3.0.CO;2-9; Vecsei L, 2013, NAT REV DRUG DISCOV, V12, P64, DOI 10.1038/nrd3793; Vengeliene V, 2016, PSYCHOPHARMACOLOGY, V233, P3449, DOI 10.1007/s00213-016-4384-9; Vidal R, 2019, MOL NEUROBIOL, V56, P553, DOI 10.1007/s12035-018-1100-2; Volynets V, 2016, DIGEST DIS SCI, V61, P737, DOI 10.1007/s10620-015-3935-y; von Gleissenthall G, 2014, ALCOHOL ALCOHOLISM, V49, P251, DOI 10.1093/alcalc/agu011; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Wang H. Y., 2019, J DIG DIS; Wang L, 2003, P NATL ACAD SCI USA, V100, P1393, DOI 10.1073/pnas.0336351100; Wilcox MV, 2014, NEUROPSYCHOPHARMACOL, V39, P579, DOI 10.1038/npp.2013.230; Xiao HW, 2018, TOXICOL LETT, V287, P23, DOI 10.1016/j.toxlet.2018.01.021; YOSHIDA R, 1978, P NATL ACAD SCI USA, V75, P3998, DOI 10.1073/pnas.75.8.3998	113	15	15	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12900	12914		10.1096/fj.201900491RR	http://dx.doi.org/10.1096/fj.201900491RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31509716	Green Published			2022-12-28	WOS:000507461600100
J	Hou, X; Wu, QT; Rajagopalan, C; Zhang, C; Bouhamdan, M; Wei, HG; Chen, XQ; Zaman, K; Li, CY; Sun, XN; Chen, S; Frizzell, RA; Sun, F				Hou, Xia; Wu, Qingtian; Rajagopalan, Carthic; Zhang, Chunbing; Bouhamdan, Mohamad; Wei, Hongguang; Chen, Xuequn; Zaman, Khalequz; Li, Chunying; Sun, Xiaonan; Chen, Song; Frizzell, Raymond A.; Sun, Fei			CK19 stabilizes CFTR at the cell surface by limiting its endocytic pathway degradation	FASEB JOURNAL			English	Article						K19; lysosomal degradation; membrane stability; Rab7	TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; QUALITY-CONTROL; RAB7 EFFECTOR; KERATIN 19; HALF-LIFE; IN-VITRO; TRAFFICKING; PROTEIN; MEMBRANE	Protein interactions that stabilize the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) at the apical membranes of epithelial cells have not yet been fully elucidated. We identified keratin 19 (CK19 or K19) as a novel CFTR-interacting protein. CK19 overexpression stabilized both wild-type (WT)-CFTR and Lumacaftor (VX-809)-rescued F508del-CFTR (where F508del is the deletion of the phenylalanine residue at position 508) at the plasma membrane (PM), promoting Cl- secretion across human bronchial epithelial (HBE) cells. CK19 prevention of Rab7A-mediated lysosomal degradation was a key mechanism in apical CFTR stabilization. Unexpectedly, CK19 expression was decreased by similar to 40% in primary HBE cells from homogenous F508del patients with CF relative to non-CF controls. CK19 also positively regulated multidrug resistance-associated protein 4 expression at the PM, suggesting that this keratin may regulate the apical expression of other ATP-binding cassette proteins as well as CFTR.	[Hou, Xia; Wu, Qingtian; Rajagopalan, Carthic; Bouhamdan, Mohamad; Wei, Hongguang; Chen, Xuequn; Sun, Fei] Wayne State Univ, Sch Med, Dept Physiol, Scott Hall,Room 5229,540 E Canfield St, Detroit, MI 48201 USA; [Hou, Xia; Zhang, Chunbing] Jiamusi Univ, Sch Basic Med, Dept Biochem & Mol Biol, Jiamusi, Peoples R China; [Zaman, Khalequz] Univ Virginia, Sch Med, Dept Pediat Resp Med, Charlottesville, VA 22908 USA; [Li, Chunying; Sun, Xiaonan] Georgia State Univ, Ctr Mol & Translat Med, Atlanta, GA 30303 USA; [Chen, Song] Jiangsu Coll Nursing, Inst Med Biotechnol, Huaian, Peoples R China; [Frizzell, Raymond A.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Frizzell, Raymond A.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA USA	Wayne State University; Jiamusi University; University of Virginia; University System of Georgia; Georgia State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hou, X; Sun, F (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, Scott Hall,Room 5229,540 E Canfield St, Detroit, MI 48201 USA.	xhou@med.wayne.edu; fsun@med.wayne.edu	Hou, Xia/AAD-2235-2020	Hou, Xia/0000-0002-6733-086X	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL133162]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [DK068196]; Cystic Fibrosis Foundation [SUN15XX0, FRIZZE13XX0]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068196] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank all the people mentioned in this study and their laboratory members. The authors specifically thank the Cystic Fibrosis (CF) Research Center, University of Pittsburgh, for primary human bronchial epithelial (HBE) cells, helpful comments, and laboratory support. The authors also thank Carol A. Bertrand (Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA) for whole-cell current recordings, and Dr. Yongming Xie (Karmanos Cancer Institute and Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA) for comments on the manuscript. Additionally, the authors thank the Lipidomics Core Facility and the Imaging and Histopathology Core of Wayne State University School of Medicine. This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant HL133162 (to F.S.) and NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant DK068196 (to R.A.F.), and Cystic Fibrosis Foundation Grants SUN15XX0 (to F.S.) and FRIZZE13XX0 (to R.A.F.). The authors declare no conflicts of interest.	Aloisi AL, 2013, HISTOL HISTOPATHOL, V28, P839, DOI 10.14670/HH-28.839; Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Ameen N, 2007, J CYST FIBROS, V6, P1, DOI 10.1016/j.jcf.2006.09.002; Arin MJ, 2009, HUM GENET, V125, P355, DOI 10.1007/s00439-009-0646-5; Asai K, 2005, SCAND J GASTROENTERO, V40, P326, DOI 10.1080/00365520510011605; Begicevic RR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112362; Bertrand CA, 2017, AM J PHYSIOL-LUNG C, V312, pL912, DOI 10.1152/ajplung.00178.2016; Boswell-Casteel RC, 2018, AAPS J, V20, DOI 10.1208/s12248-017-0165-6; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Chandel DS, 2011, PEDIATR RES, V70, P153, DOI 10.1203/PDR.0b013e3182225ac9; Cholon DM, 2010, AM J PHYSIOL-LUNG C, V298, pL304, DOI 10.1152/ajplung.00016.2009; Colombat M, 2003, J PATHOL, V201, P260, DOI 10.1002/path.1451; Duan YY, 2012, J BIOL CHEM, V287, P40547, DOI 10.1074/jbc.M112.403584; Dupre DJ, 2003, J BIOL CHEM, V278, P48228, DOI 10.1074/jbc.M304082200; Favia M, 2010, MOL BIOL CELL, V21, P73, DOI 10.1091/mbc.E09-03-0185; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Fischer H, 2004, P NATL ACAD SCI USA, V101, P3691, DOI 10.1073/pnas.0308393100; Fradette J, 1998, J BIOL CHEM, V273, P35176, DOI 10.1074/jbc.273.52.35176; Ganeshan R, 2007, BBA-MOL CELL RES, V1773, P192, DOI 10.1016/j.bbamcr.2006.09.031; Ganley IG, 2004, MOL BIOL CELL, V15, P5420, DOI 10.1091/mbc.E04-08-0747; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Gong XY, 2019, MOL BIOL CELL, V30, P4, DOI 10.1091/mbc.E18-04-0252; Greene NP, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00950; Guggino WB, 2004, AM J RESP CRIT CARE, V170, P815, DOI 10.1164/rccm.200403-381WS; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Haggie PM, 2006, MOL BIOL CELL, V17, P4937, DOI 10.1091/mbc.E06-08-0670; Hampton TH, 2012, AM J PHYSIOL-LUNG C, V303, pL509, DOI 10.1152/ajplung.00226.2011; Heda GD, 2001, AM J PHYSIOL-CELL PH, V280, pC166, DOI 10.1152/ajpcell.2001.280.1.C166; Holleran JP, 2013, J CELL SCI, V126, P2692, DOI 10.1242/jcs.120196; Hou X, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23284-8; Hou YN, 2015, STEM CELL RES, V14, P133, DOI 10.1016/j.scr.2014.12.001; Howard M, 2000, AM J PHYSIOL-CELL PH, V279, pC375, DOI 10.1152/ajpcell.2000.279.2.C375; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Jurkuvenaite A, 2010, AM J RESP CELL MOL, V42, P363, DOI 10.1165/rcmb.2008-0434OC; Ku NO, 2016, HEPATOLOGY, V64, P966, DOI 10.1002/hep.28493; Kumari V, 2017, J CYST FIBROS, V16, P327, DOI 10.1016/j.jcf.2017.03.012; Lee JS, 2012, J PROTEOMICS, V75, P3952, DOI 10.1016/j.jprot.2012.05.017; Lee S, 2014, MOL CELL BIOL, V34, P2554, DOI 10.1128/MCB.01042-13; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Lobo MJ, 2016, J CELL SCI, V129, P2599, DOI 10.1242/jcs.185629; Luz S, 2014, J BIOL CHEM, V289, P15080, DOI 10.1074/jbc.M114.563742; Marozkina NV, 2010, P NATL ACAD SCI USA, V107, P11393, DOI 10.1073/pnas.0909128107; Marwaha R, 2017, J CELL BIOL, V216, P1051, DOI 10.1083/jcb.201607085; McNamara J, 2019, LANCET RESP MED, V7, P325, DOI 10.1016/S2213-2600(18)30460-0; Michel M, 1996, J CELL SCI, V109, P1017; Okiyoneda T, 2007, BBA-MOL CELL RES, V1773, P476, DOI 10.1016/j.bbamcr.2007.01.004; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Onishi Y, 2018, DRUG DISCOV TODAY, V23, P1556, DOI 10.1016/j.drudis.2018.05.037; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; Premchandar A, 2017, PROTEIN SCI, V26, P343, DOI 10.1002/pro.3086; Ramachandran S, 2016, J BIOL CHEM, V291, P25489, DOI 10.1074/jbc.M116.754283; Rasgado-Flores H, 2013, AM J PHYSIOL-CELL PH, V305, pC1114, DOI 10.1152/ajpcell.00166.2013; Romani L, 2018, NAT MED, V24, P1481, DOI 10.1038/s41591-018-0100-0; Romani L, 2017, NAT MED, V23, P590, DOI 10.1038/nm.4305; Sapmaz A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09437-x; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Shen KY, 2014, J IMMUNOL, V192, P4233, DOI 10.4049/jimmunol.1302850; Shinde SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10689; Silverman Ed, 2015, Manag Care, V24, P16; Snider NT, 2016, KIDNEY INT, V89, P738, DOI 10.1016/j.kint.2015.12.040; Sun F, 2008, FASEB J, V22, P3255, DOI 10.1096/fj.07-105338; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Tang DD, 2008, AM J PHYSIOL-CELL PH, V294, pC869, DOI 10.1152/ajpcell.00154.2007; Tazi MF, 2016, AUTOPHAGY, V12, P2026, DOI 10.1080/15548627.2016.1217370; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Vasiliou Vasilis, 2009, Human Genomics, V3, P281; Wang TL, 2011, CELL SIGNAL, V23, P516, DOI 10.1016/j.cellsig.2010.09.012; Wang W, 2017, P NATL ACAD SCI USA, V114, P8366, DOI 10.1073/pnas.1701289114; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; WELSH MJ, 1995, SCI AM, V273, P52, DOI 10.1038/scientificamerican1295-52; Willett R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01871-z; Wilson JD, 2016, TRAFFIC, V17, P1027, DOI 10.1111/tra.12418; Yap CC, 2018, J CELL BIOL, V217, P3141, DOI 10.1083/jcb.201711039; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zhang L.J., 2009, ETHYLENE IND, V25, P7, DOI DOI 10.1371/J0URNAL.PBI0.1000155; Zhang YN, 2018, J VIROL, V92, DOI [10.1128/jvi.00797-18, 10.1128/JVI.00797-18]	83	7	7	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12602	12615		10.1096/fj.201901050R	http://dx.doi.org/10.1096/fj.201901050R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31450978	Green Published			2022-12-28	WOS:000507461600078
J	Kesireddy, VS; Chillappagari, S; Ahuja, S; Knudsen, L; Henneke, I; Graumann, J; Meiners, S; Ochs, M; Ruppert, C; Korfei, M; Seeger, W; Mahavadi, P				Kesireddy, Vidya Sagar; Chillappagari, Shashi; Ahuja, Saket; Knudsen, Lars; Henneke, Ingrid; Graumann, Johannes; Meiners, Silke; Ochs, Matthias; Ruppert, Clemens; Korfei, Martina; Seeger, Werner; Mahavadi, Poornima			Susceptibility of microtubule-associated protein 1 light chain 3 beta (MAP1LC3B/LC3B) knockout mice to lung injury and fibrosis	FASEB JOURNAL			English	Article						alveolar epithelial cells; lamellar bodies; autophagy; aging; lysosome	IDIOPATHIC PULMONARY-FIBROSIS; LAMELLAR BODIES; CATHEPSIN-A; AUTOPHAGY; CELL; STRESS; HOMEOSTASIS; INHIBITION; SECRETION; APOPTOSIS	Insufficient autophagy has been reported in idiopathic pulmonary fibrosis (IPF) lungs. Specific roles of autophagy-related proteins in lung fibrosis development remain largely unknown. Here, we investigated the role of autophagy marker protein microtubule-associated protein 1 light chain 3 beta (LC3B) in the development of lung fibrosis. LC3B(-/-) mice upon aging show smaller lamellar body profiles, increased cellularity, alveolar epithelial cell type II (AECII) apoptosis, surfactant alterations, and lysosomal and endoplasmic reticulum stress. Autophagosomal soluble N-ethylmaleimide-sensitive factor attachment protein receptor syntaxin 17 is increased in the AECII of aged LC3B(-/-) mice and patients with IPF. Proteasomal activity, however, remained unaltered in LC3B(-/- )mice. In vitro knockdown of LC3B sensitized mouse lung epithelial cells to bleomycin-induced apoptosis, but its overexpression was protective. In vivo, LC3B(-/-) mice displayed increased susceptibility to bleomycin-induced lung injury and fibrosis. We identified cathepsin A as a novel LC3B binding partner and its overexpression in vitro drives MLE12 cells to apoptosis. Additionally, cathepsin A is increased in the AECII of aged LC3B(-/-) mice and in the lungs of patients with IPF. Our study reveals that LC3B mediated autophagy plays essential roles in AECII by modulating the functions of proteins like cathepsin A and protects alveolar epithelial cells from apoptosis and subsequent lung injury and fibrosis.	[Kesireddy, Vidya Sagar; Ahuja, Saket; Henneke, Ingrid; Ruppert, Clemens; Korfei, Martina; Seeger, Werner; Mahavadi, Poornima] JLU, Dept Internal Med, Giessen, Germany; [Chillappagari, Shashi] JLU, Fac Med, Dept Biochem, Giessen, Germany; [Seeger, Werner] JLU, Cardiopulm Inst, Giessen, Germany; [Kesireddy, Vidya Sagar; Ahuja, Saket; Henneke, Ingrid; Ruppert, Clemens; Korfei, Martina; Seeger, Werner; Mahavadi, Poornima] UGMLC, German Ctr Lung Res DZL, Giessen, Germany; [Knudsen, Lars; Ochs, Matthias] Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany; [Knudsen, Lars; Ochs, Matthias] DZL, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany; [Knudsen, Lars; Ochs, Matthias] Regenerat Biol & Reconstruct Therapies REBIRTH Cl, Hannover, Germany; [Graumann, Johannes] Max Planck Inst Heart & Lung Res, Biomol Mass Spectrometry, Bad Nauheim, Germany; [Graumann, Johannes] German Ctr Cardiovasc Res DZHK, Partner Site Rhine Main, Frankfurt, Germany; [Meiners, Silke] LMU, Helmholtz Zentrum M unchen, Univ Hosp, CPC,DZL, Munich, Germany; [Ochs, Matthias] Charite Univ Med Berlin, Inst Vegetat Anat, Berlin, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen; Hannover Medical School; Max Planck Society; German Centre for Cardiovascular Research; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Mahavadi, P (corresponding author), Univ Giessen, Marburg Lung Ctr, Justus Liebig Univ Giessen, Dept Internal Med, Seltersberg House C EG,Gaffkystr 11, D-35392 Giessen, Germany.	poornima.mahavadi@innere.med.uni-giessen.de	Graumann, Johannes/C-5241-2008; Mahavadi, Poornima/AAC-2500-2020; Meiners, S/M-9822-2014; Knudsen, Lars/G-3146-2013	Graumann, Johannes/0000-0002-3015-5850; Mahavadi, Poornima/0000-0002-7580-4738; Meiners, S/0000-0003-3678-7995; Knudsen, Lars/0000-0002-7926-3879; Seeger, Werner/0000-0003-1946-0894	German Research Foundation	German Research Foundation(German Research Foundation (DFG))	The authors thank the German Research Foundation for supporting this study through an independent research grant to P.M. The authors also thank Silke Haendel, Stefanie Hezel [Department of Internal Medicine, Justus-Liebig University (JLU) Giessen], and Susanne Fassbender (Institute of Functional and Applied Anatomy, Hannover Medical School) for their excellent technical support. The authors also thank Prof. Dr. Saverio Bellusci (Department of Internal Medicine, JLU Giessen) and laboratory members for help with fluorescence miscroscopy. The authors declare no conflicts of interest.	Ahuja S, 2016, AM J PHYSIOL-LUNG C, V310, pL519, DOI 10.1152/ajplung.00213.2015; Alers S, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-7; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Bueno M, 2015, J CLIN INVEST, V125, P521, DOI 10.1172/JCI74942; Cabrera S, 2015, AUTOPHAGY, V11, P670, DOI 10.1080/15548627.2015.1034409; Cann GM, 2008, DEV DYNAM, V237, P187, DOI 10.1002/dvdy.21392; Cheong H, 2014, AUTOPHAGY, V10, P45, DOI 10.4161/auto.26505; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Cuervo AM, 2003, EMBO J, V22, P47, DOI 10.1093/emboj/cdg002; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hiraiwa M, 1999, CELL MOL LIFE SCI, V56, P894, DOI 10.1007/s000180050482; Janen SB, 2010, GLIA, V58, P1766, DOI 10.1002/glia.21047; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Lahm T, 2012, AUTOPHAGY, V8, P1146, DOI 10.4161/auto.20520; Lee SJ, 2011, AM J RESP CRIT CARE, V183, P649, DOI 10.1164/rccm.201005-0746OC; Lee VY, 2005, AM J PHYSIOL-LUNG C, V289, pL521, DOI 10.1152/ajplung.00340.2004; Lutz D, 2015, AM J RESP CELL MOL, V52, P232, DOI 10.1165/rcmb.2014-0078OC; Mahavadi P, 2015, J PATHOL CLIN RES, V1, P252, DOI 10.1002/cjp2.20; Mahavadi P, 2014, TOXICOL SCI, V142, P285, DOI 10.1093/toxsci/kfu177; Mahavadi P, 2010, AM J RESP CRIT CARE, V182, P207, DOI 10.1164/rccm.200909-1414OC; Martens S, 2016, J CELL BIOL, V215, P761, DOI 10.1083/jcb.201611116; MILLER BE, 1990, ENVIRON HEALTH PERSP, V85, P15, DOI 10.2307/3430661; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; MYERS JL, 1988, CHEST, V94, P1309, DOI 10.1378/chest.94.6.1309; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Patel AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041394; Petrera A, 2016, J PROTEOME RES, V15, P3188, DOI 10.1021/acs.jproteome.6b00413; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rasmussen MS, 2017, AUTOPHAGY, V13, P834, DOI 10.1080/15548627.2017.1287651; SCHMITZ G, 1991, J LIPID RES, V32, P1539; Selman Moises, 2006, Proc Am Thorac Soc, V3, P364, DOI 10.1513/pats.200601-003TK; Tang BZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091482; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Travis W.D., 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Tschanz S, 2014, ANN ANAT, V196, P3, DOI 10.1016/j.aanat.2013.04.011; Tsuboyama K, 2016, SCIENCE, V354, P1036, DOI 10.1126/science.aaf6136; Wang RQ, 2000, AM J PHYSIOL-LUNG C, V279, pL143, DOI 10.1152/ajplung.2000.279.1.L143; Weaver TE, 2002, SEMIN CELL DEV BIOL, V13, P263, DOI 10.1016/S1084952102000551; Welk V, 2016, J BIOL CHEM, V291, P13147, DOI 10.1074/jbc.M116.717652; Zhu K, 2010, ONCOGENE, V29, P451, DOI 10.1038/onc.2009.343	42	7	9	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12392	12408		10.1096/fj.201900854R	http://dx.doi.org/10.1096/fj.201900854R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31431059	Green Published			2022-12-28	WOS:000507461600062
J	Pi, HF; Liu, MY; Xi, Y; Chen, MY; Tian, L; Xie, J; Chen, ML; Wang, Z; Yang, M; Yu, ZP; Zhou, Z; Gao, F				Pi, Huifeng; Liu, Mengyu; Xi, Yu; Chen, Mengyan; Tian, Li; Xie, Jia; Chen, Mingliang; Wang, Zhen; Yang, Min; Yu, Zhengping; Zhou, Zhou; Gao, Feng			Long-term exercise prevents hepatic steatosis: a novel role of FABP1 in regulation of autophagy-lysosomal machinery	FASEB JOURNAL			English	Article						swimming; ingenuity pathway analysis; NAFLD; quantitative proteomic analysis	FATTY LIVER-DISEASE; LIPID-METABOLISM; AEROBIC EXERCISE; PHYSICAL-ACTIVITY; PROTEIN; DIET; HEPATOCYTE; STRESS; MICE; HEPATOTOXICITY	Nonalcoholic fatty liver disease (NAFLD) is one of the most prevalent diseases worldwide. Exercise is a first-line therapy and an important preventive measure for patients with NAFLD, but the underlying mechanisms are not clear. C57BL/6 mice were fed a high-fat diet (HFD) and subjected to 12 wk swimming exercise. Exercise protected against hepatic lipid accumulation and alleviated hepatocyte damage in HFD mice. Tandem mass tag- based quantitative proteomic analyses and ingenuity pathway analysis revealed that exercise down-regulated fatty acid-binding protein (FABP)1 signaling pathway, which was most closely associated with lipid metabolism. Moreover, exercise significantly decreased FABP1 expression, and liver-specific overexpression of FABP1 abolished the protective effect of exercise in NAFLD mice. Specifically, exercise significantly increased autophagic flux via restoring lysosomal function, including lysosomal proteolysis and lysosomal acidification maintenance, contributing to enhancement in autophagic clearance and subsequently alleviation of hepatic steatosis. Conversely, Fabp1 overexpression in the mouse liver blocked the protective effect of exercise via inhibiting autophagy flux. The present study identified FABP1 inhibition-mediated replenishment of the autophagy-lysosomal machinery as a novel endogenous mechanism whereby long-term exercise improves lipid homeostasis and ameliorates hepatic steatosis in NAFLD.	[Pi, Huifeng; Wang, Zhen; Gao, Feng] Fourth Mil Med Univ, Sch Aerosp Med, Xian, Peoples R China; [Pi, Huifeng; Liu, Mengyu; Chen, Mengyan; Tian, Li; Xie, Jia; Yu, Zhengping] Third Mil Med Univ, Dept Occupat Hlth, Chongqing, Peoples R China; [Chen, Mingliang] Third Mil Med Univ, Inst Pathol, Chongqing, Peoples R China; [Chen, Mingliang] Third Mil Med Univ, Southwest Hosp, Minist Educ, Southwest Canc Ctr,Key Lab Tumor Immunopathol, Chongqing, Peoples R China; [Yang, Min] Third Mil Med Univ, Xinqiao Hosp, Dept Gastroenterol, Chongqing, Peoples R China; [Xi, Yu; Zhou, Zhou] Zhejiang Univ, Sch Med, Dept Environm Med, Hangzhou, Peoples R China; [Xi, Yu; Zhou, Zhou] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Emergency Med, Hangzhou, Peoples R China	Air Force Military Medical University; Army Medical University; Army Medical University; Army Medical University; Army Medical University; Zhejiang University; Zhejiang University	Gao, F (corresponding author), Fourth Mil Med Univ, Sch Aerosp Med, Xian, Peoples R China.; Zhou, Z (corresponding author), Zhejiang Univ, Sch Med, Dept Environm Med, Hangzhou, Peoples R China.	lunazhou@zju.edu.cn; fgao@fmmu.edu.cn	Chen, Mingliang/AGH-3195-2022		National Postdoctoral Program for Innovative Talents [BX201700107]; National Natural Science Foundation of China [81870273]	National Postdoctoral Program for Innovative Talents; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Postdoctoral Program for Innovative Talents (BX201700107 to H.P.) and the National Natural Science Foundation of China (81870273 to F.G.). The authors declare no conflicts of interest.	Asrani SK, 2019, J HEPATOL, V70, P151, DOI 10.1016/j.jhep.2018.09.014; Botezelli JD, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-116; Cardoso GH, 2018, INFLAMMATION, V41, P2060, DOI 10.1007/s10753-018-0849-9; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Chen AP, 2013, HEPATOLOGY, V57, P2202, DOI 10.1002/hep.26318; Chun SK, 2017, EXERC SPORT SCI REV, V45, P181, DOI 10.1249/JES.0000000000000116; Dallak MA, 2018, ULTRASTRUCT PATHOL, V42, P155, DOI 10.1080/01913123.2017.1422581; Fan TF, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12457; Farah BL, 2016, J HEPATOL, V64, P370, DOI 10.1016/j.jhep.2015.10.008; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Ghareghani P, 2018, OBES RES CLIN PRACT, V12, P80, DOI 10.1016/j.orcp.2017.01.004; Goncalves IO, 2016, APPL PHYSIOL NUTR ME, V41, P298, DOI 10.1139/apnm-2015-0470; Guo R, 2015, HEPATOB PANCREAT DIS, V14, P139, DOI 10.1016/S1499-3872(15)60355-1; Guo YZ, 2018, CARDIOVASC RES, V114, P979, DOI 10.1093/cvr/cvy052; Hashida R, 2017, J HEPATOL, V66, P142, DOI 10.1016/j.jhep.2016.08.023; Hou ZX, 2019, CIRC RES, V124, P1386, DOI 10.1161/CIRCRESAHA.118.314635; Hung YH, 2019, BBA-MOL CELL BIOL L, V1864, P587, DOI 10.1016/j.bbalip.2018.10.007; Ipsen DH, 2018, CELL MOL LIFE SCI, V75, P3313, DOI 10.1007/s00018-018-2860-6; Johnson NA, 2009, HEPATOLOGY, V50, P1105, DOI 10.1002/hep.23129; Katsagoni CN, 2017, METABOLISM, V68, P119, DOI 10.1016/j.metabol.2016.12.006; Kim HS, 2017, J HEPATOL, V66, P664, DOI 10.1016/j.jhep.2016.11.024; Kim H, 2019, FASEB J, V33, P7896, DOI 10.1096/fj.201802528R; Klein ZA, 2017, NEURON, V95, P281, DOI 10.1016/j.neuron.2017.06.026; Li M, 2016, J PINEAL RES, V61, P353, DOI 10.1111/jpi.12353; Martin GG, 2015, ARCH BIOCHEM BIOPHYS, V580, P41, DOI 10.1016/j.abb.2015.06.009; Martinez-Lopez N, 2015, ANNU REV NUTR, V35, P215, DOI 10.1146/annurev-nutr-071813-105336; Martins DF, 2017, MOL NEUROBIOL, V54, P5620, DOI 10.1007/s12035-016-0095-9; Mukai T, 2017, FEBS OPEN BIO, V7, P1009, DOI 10.1002/2211-5463.12240; Orlicky DJ, 2019, J PHYSIOL-LONDON, V597, P1565, DOI 10.1113/JP277140; Park MY, 2015, J SCI FOOD AGR, V95, P828, DOI 10.1002/jsfa.6973; Pi H., 2019, J CELL MOL MED; Pi HF, 2019, AUTOPHAGY, V15, P565, DOI 10.1080/15548627.2018.1531198; Pi HF, 2017, SCI REP-UK, V7, DOI 10.1038/srep43466; Pi HF, 2015, AUTOPHAGY, V11, P1037, DOI 10.1080/15548627.2015.1052208; Pi HF, 2013, AUTOPHAGY, V9, P1780, DOI 10.4161/auto.25665; Romero-Gomez M, 2017, J HEPATOL, V67, P829, DOI 10.1016/j.jhep.2017.05.016; Rosa-Caldwell ME, 2017, APPL PHYSIOL NUTR ME, V42, P148, DOI 10.1139/apnm-2016-0280; Sakr Hussein F., 2018, Journal of Basic and Clinical Physiology and Pharmacology, V29, P61, DOI 10.1515/jbcpp-2017-0069; Shi Y, 2015, AUTOPHAGY, V11, P769, DOI 10.1080/15548627.2015.1034411; Smathers Rebecca L., 2011, Human Genomics, V5, P170; Stefan N, 2019, LANCET DIABETES ENDO, V7, P313, DOI 10.1016/S2213-8587(18)30154-2; Straczkowski M, 2001, DIABETES METAB, V27, P19; Ueno T, 2017, NAT REV GASTRO HEPAT, V14, P170, DOI 10.1038/nrgastro.2016.185; Vila L, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.39; Wang B, 2017, CAN J PHYSIOL PHARM, V95, P667, DOI 10.1139/cjpp-2016-0611; Wang GQ, 2015, J LIPID RES, V56, P2238, DOI 10.1194/jlr.R056705; Wang LL, 2017, MOL GENET METAB, V120, P299, DOI 10.1016/j.ymgme.2017.02.011; Wang XJ, 2018, FASEB J, V32, P37, DOI 10.1096/fj.201601393R; Wolfrum C, 1999, BBA-MOL CELL BIOL L, V1437, P194, DOI 10.1016/S1388-1981(99)00008-6; Wu H, 2015, BIOCHEM BIOPH RES CO, V458, P862, DOI 10.1016/j.bbrc.2015.02.046; Wu YL, 2017, CELL PHYSIOL BIOCHEM, V44, P2243, DOI 10.1159/000486058; Wu YL, 2016, J VIROL, V90, P1729, DOI 10.1128/JVI.02604-15; Xing WJ, 2013, AM J PHYSIOL-HEART C, V305, pH1111, DOI 10.1152/ajpheart.00290.2013; Younossi ZM, 2018, HEPATOLOGY, V68, P2405, DOI 10.1002/hep.30125; Zeng XL, 2019, ANTIOXID REDOX SIGN, V30, P163, DOI 10.1089/ars.2017.7172; Zhang KR, 2007, APOPTOSIS, V12, P1579, DOI 10.1007/s10495-007-0090-8; Zhang QJ, 2007, CARDIOVASC RES, V75, P369, DOI 10.1016/j.cardiores.2007.04.015; Zhao DJ, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4079041; Zheng F, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-018-0933-z	60	18	22	2	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11870	11883		10.1096/fj.201900812R	http://dx.doi.org/10.1096/fj.201900812R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31366243	Green Published, Bronze			2022-12-28	WOS:000507461600023
J	Liu, ZH; Jiang, J; He, Q; Liu, ZG; Yang, Z; Xu, J; Huang, ZH; Wu, B				Liu, Zhihao; Jiang, Jie; He, Qiong; Liu, Zhigang; Yang, Zhen; Xu, Jia; Huang, Zhenhua; Wu, Bin			beta-Arrestin1-mediated decrease in endoplasmic reticulum stress impairs intestinal stem cell proliferation following radiation	FASEB JOURNAL			English	Article						PERK; intestinal stem; progenitor cell; intestinal injury	APOPTOSIS; DIFFERENTIATION; PROGRESSION; INHIBITION; INJURY	Gastrointestinal toxicity limits the clinical application of abdominal and pelvic radiotherapy and currently has no effective treatment. Intestinal leucine-rich-repeat-containing GPCR 5 (Lgr5)-positive stem cell depletion and loss of proliferative ability due to radiation may be the primary factors causing intestinal injury following radiation. Here, we report the critical role of beta-arrestin1 (beta arr1) in radiation-induced intestinal injury. Intestinal beta arr1 was highly expressed in radiation enteritis and in a radiation model. beta arr1 knockout (KO) or knockdown mice exhibited increased proliferation in intestinal Lgr5+ stem cell, crypt reproduction, and survival following radiation. Unexpectedly, the beneficial effects of beta arr1 deficiency on intestinal stem cells in response to radiation were compromised when the endoplasmic reticulum stress-related protein kinase RNA-like ER kinase (PERK)/eukaryotic initiation factor-2 alpha (eIF2 alpha) pathway was inhibited, and this result was further supported in vitro. Furthermore, we found that beta arr1 knockdown with small interfering RNA significantly enhanced intestinal Lgr5(+) stem cell proliferation after radiation via directly targeting PERK. beta arr1 offers a promising target for mitigating radiation-induced intestinal injury.-Liu, Z., Jiang, J., He, Q., Liu, Z., Yang, Z., Xu, J., Huang, Z., Wu, B. beta-Arrestin1-mediated decrease in endoplasmic reticulum stress impairs intestinal stem cell proliferation following radiation.	[Liu, Zhihao; Yang, Zhen; Xu, Jia; Huang, Zhenhua] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gen Internal Med, Div Emergency Med, Guangzhou, Guangdong, Peoples R China; [Liu, Zhihao; Yang, Zhen; Xu, Jia; Huang, Zhenhua] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Emergency, Intens Care Unit, Guangzhou, Guangdong, Peoples R China; [He, Qiong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Jiang, Jie; Wu, Bin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Gastroenterol, 600 Tianhe Rd, Guangzhou 510630, Guangdong, Peoples R China; [Liu, Zhigang] Sun Yat Sen Univ, Affiliated Hosp 5, Canc Ctr, Dept Head & Neck Oncol,Phase Clin Trial Ward 1, Zhuhai, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Wu, B (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Gastroenterol, 600 Tianhe Rd, Guangzhou 510630, Guangdong, Peoples R China.	wubin6@mail.sysu.edu.cn			National Natural Scientific Foundation of China [81602660, U1501224]; Guangdong Natural Science Foundation [2016A030310159]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	The authors are grateful to Prof. Robert J. Lefkowitz (Duke University, Durham, NC, USA) for providing the beta-arrestin knockout mice and the beta-arrestin antibody. The authors thank Prof. Zhen Yang, Dr. Weigang Dai, and Dr. Yunjiu Cheng (all from Sun Yat-sen University) for independently counting apoptotic index under microscope in a single-blinding way. The authors also thank other members of the laboratories for helpful discussion and comments. This work was supported by Grants-in-Aid from National Natural Scientific Foundation of China (81602660, U1501224) and Guangdong Natural Science Foundation (2016A030310159). The authors declare no conflicts of interest.	Andreyev HJN, 2013, LANCET, V382, P2084, DOI 10.1016/S0140-6736(13)61648-7; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Das M, 2016, MOL NEUROBIOL, V53, P5178, DOI 10.1007/s12035-015-9422-9; Giannakis M, 2006, J BIOL CHEM, V281, P11292, DOI 10.1074/jbc.M512118200; Gilbert S, 2015, STEM CELL REP, V4, P209, DOI 10.1016/j.stemcr.2014.12.004; Heijmans J, 2013, CELL REP, V3, P1128, DOI 10.1016/j.celrep.2013.02.031; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hua GQ, 2012, GASTROENTEROLOGY, V143, P1266, DOI 10.1053/j.gastro.2012.07.106; Lan T, 2017, EXP CELL RES, V357, P51, DOI 10.1016/j.yexcr.2017.04.023; Liu Z, 2016, CELL DEATH DIFFER, V23, P1529, DOI 10.1038/cdd.2016.38; Liu ZH, 2014, AM J PHYSIOL-GASTR L, V307, pG1033, DOI 10.1152/ajpgi.00151.2014; Pillai S, 2015, CANCER RES, V75, P1009, DOI 10.1158/0008-5472.CAN-14-0681; Poindexter SV, 2015, AM J PHYSIOL-GASTR L, V308, pG562, DOI 10.1152/ajpgi.00253.2014; POTTEN CS, 1990, INT J RADIAT BIOL, V58, P925, DOI 10.1080/09553009014552281; Potten CS, 2004, RADIAT RES, V161, P123, DOI 10.1667/RR3104; POTTEN CS, 1977, NATURE, V269, P518, DOI 10.1038/269518a0; POTTEN CS, 1990, INT J RADIAT BIOL, V57, P185, DOI 10.1080/09553009014550431; POTTEN CS, 1994, INT J RADIAT BIOL, V65, P71, DOI 10.1080/09553009414550101; Qiu W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.125; Qiu W, 2008, CELL STEM CELL, V2, P576, DOI 10.1016/j.stem.2008.03.009; Qu DF, 2014, AM J PHYSIOL-GASTR L, V306, pG404, DOI 10.1152/ajpgi.00088.2013; Rosekrans SL, 2015, GUT, V64, P195, DOI 10.1136/gutjnl-2013-306347; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Stappenbeck TS, 2003, P NATL ACAD SCI USA, V100, P1004, DOI 10.1073/pnas.242735899; Sweeney P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10188; Talmasov D, 2015, AM J PHYSIOL-GASTR L, V308, pG121, DOI 10.1152/ajpgi.00080.2014; Tan SW, 2015, FREE RADICAL BIO MED, V87, P69, DOI 10.1016/j.freeradbiomed.2015.06.004; Wang LF, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005220; Wang LW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004021; WITHERS HR, 1970, INT J RADIAT BIOL RE, V17, P261, DOI 10.1080/09553007014550291; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Zhan Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.136; Zhang B, 2010, INT J RADIAT BIOL, V86, P429, DOI 10.3109/09553001003668014	35	2	2	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10165	10176		10.1096/fj.201900376RRR	http://dx.doi.org/10.1096/fj.201900376RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31207192	Bronze			2022-12-28	WOS:000482214200036
J	Wang, XL; Russell-Lodrigue, KE; Ratterree, MS; Veazey, RS; Xu, HB				Wang, Xiaolei; Russell-Lodrigue, Kasi E.; Ratterree, Marion S.; Veazey, Ronald S.; Xu, Huanbin			Chemokine receptor CCR5 correlates with functional CD8(+) T cells in SIV-infected macaques and the potential effects of maraviroc on T-cell activation	FASEB JOURNAL			English	Article						SIV; differentiation; effector memory T-cell; cytotoxic T lymphocyte	HIV-1 INFECTION; MOLECULAR-INTERACTIONS; TYPE-1; ENTRY; INHIBITORS; EXPRESSION; MEMORY; CD4; TRANSMISSION; INDIVIDUALS	C-C chemokine receptor 5 (CCR5) plays an essential role in HIV pathogenesis as the major coreceptor on CD4(+) T cells used by HIV, yet the function of CCR5 on CD8 T cells is not well understood. Furthermore, the immunologic effects of the CCR5 inhibitor maraviroc (MVC), despite approval for clinical use, have not yet been well evaluated for their potential effects on cytotoxic T-cell responses. In this study, we characterized the development and function of CCR5(+)CD8(+) T cells in rhesus macaques with or without Simian immunodeficiency virus (SIV) infection. We also investigated the effects of the CCR5 antagonist MVC on functional CCR5(+)CD8(+) T-cell responses in vitro. The data show that CCR5(+)CD8(+) T cells have an effector memory phenotype and increase with age in systemic and mucosal lymphoid tissues as a heterogeneous population of polyfunctional CD8 T cells. In addition, CCR5 is highly expressed on SIV gag-specific (CM9(+)) CD8(+) T cells in SIV-infected macaques, yet CCR5(+)CD8(+) T cells are significantly reduced in mucosal lymphoid tissues with disease progression. Furthermore, in vitro MVC treatment reduced activation and cytokine secretion of CD8(+) T cells via a CCR5-independent pathway. These findings suggest that surface CCR5 protein plays an important role in differentiation and activation of CD8(+) T cells. Although MVC may be helpful in reducing chronic inflammation and activation, it may also inhibit virus-specific CD8(+) T-cell responses. Thus optimal use of CCR5 antagonists either alone or in combination with other drugs should be defined by further investigation.-Wang, X., Russell-Lodrigue, K. E., Ratterree, M. S., Veazey, R. S., Xu, H. Chemokine receptor CCR5 correlates with functional CD8(+) T cells in SIV-infected macaques and the potential effects of maraviroc on T-cell activation.	[Wang, Xiaolei; Russell-Lodrigue, Kasi E.; Ratterree, Marion S.; Veazey, Ronald S.; Xu, Huanbin] Tulane Univ, Sch Med, Tulane Natl Primate Res Ctr, Covington, LA USA	Tulane University	Xu, HB (corresponding author), Tulane Natl Primate Res Ctr, Div Comparat Pathol, 18703 Three Rivers Rd, Covington, LA 70433 USA.	hxu@tulane.edu	Russell-Lodrigue, Kasi E/G-7084-2016	Russell-Lodrigue, Kasi E/0000-0003-3719-0779	U.S. National Institutes of Health (NIH); National Institute of Dental & Craniofacial Research Grant [R01 DE025432]; U.S. National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases [R01 AI099795, R01 AI084793]; National Center for Research Resources; Office of Research Infrastructure Programs (ORIP) of the NIH [OD011104]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025432] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Dental & Craniofacial Research Grant; U.S. National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs (ORIP) of the NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Meagan Watkins and Maury Duplantis (Tulane National Primate Research Center) for technical support. This work was supported in part by U.S. National Institutes of Health (NIH), National Institute of Dental & Craniofacial Research Grant R01 DE025432, and U.S. National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases Grants R01 AI099795 and R01 AI084793; the National Center for Research Resources; and the Office of Research Infrastructure Programs (ORIP) of the NIH through Grant OD011104. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Arberas H, 2013, J ANTIMICROB CHEMOTH, V68, P577, DOI 10.1093/jac/dks432; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Brogdon J, 2016, SCI REP-UK, V6, DOI 10.1038/srep39032; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Cerwenka A, 1999, J EXP MED, V189, P423, DOI 10.1084/jem.189.2.423; Cillo AR, 2015, AIDS, V29, P2121, DOI 10.1097/QAD.0000000000000810; Cooper DA, 2010, J INFECT DIS, V201, P803, DOI 10.1086/650697; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Dragic T, 2000, P NATL ACAD SCI USA, V97, P5639, DOI 10.1073/pnas.090576697; Durrant DM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0447-9; Fukada K, 2002, J IMMUNOL, V168, P2225, DOI 10.4049/jimmunol.168.5.2225; Funderburg N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013188; Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530; Glass WG, 2003, VIROLOGY, V312, P407, DOI 10.1016/S0042-6822(03)00237-X; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Grygorczuk S, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0511-0; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Hugues S, 2007, NAT IMMUNOL, V8, P921, DOI 10.1038/ni1495; Husman AMD, 1997, ANN INTERN MED, V127, P882, DOI 10.7326/0003-4819-127-10-199711150-00004; Jiang GC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005066; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; Kohlmeier JE, 2008, IMMUNITY, V29, P101, DOI 10.1016/j.immuni.2008.05.011; Kohlmeier JE, 2011, J EXP MED, V208, P1621, DOI 10.1084/jem.20102110; Kondru R, 2008, MOL PHARMACOL, V73, P789, DOI 10.1124/mol.107.042101; Kuritzkes DR, 2009, CURR OPIN HIV AIDS, V4, P82, DOI 10.1097/COH.0b013e328322402e; Latinovic O, 2009, CLIN MED INSIGHTS-TH, V1, P1497; Lederman MM, 2006, JAMA-J AM MED ASSOC, V296, P815, DOI 10.1001/jama.296.7.815; Lee B, 1999, P NATL ACAD SCI USA, V96, P5215, DOI 10.1073/pnas.96.9.5215; Littman DR, 1998, CELL, V93, P677, DOI 10.1016/S0092-8674(00)81429-4; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Madrid-Elena N, 2018, J VIROL, V92, DOI [10.1128/JVI.01931-17, 10.1128/jvi.01931-17]; Maeda K, 2006, J BIOL CHEM, V281, P12688, DOI 10.1074/jbc.M512688200; Michael NL, 1997, NAT MED, V3, P338, DOI 10.1038/nm0397-338; Michlmayr D, 2016, J IMMUNOL, V196, P4622, DOI 10.4049/jimmunol.1502452; Moy RH, 2017, BLOOD, V129, P906, DOI 10.1182/blood-2016-08-735076; Murphy PM, 2001, NAT IMMUNOL, V2, P116, DOI 10.1038/84214; Nansen A, 2000, EUR J IMMUNOL, V30, P1797, DOI 10.1002/1521-4141(200007)30:7<1797::AID-IMMU1797>3.0.CO;2-B; Olive AJ, 2011, MUCOSAL IMMUNOL, V4, P208, DOI 10.1038/mi.2010.58; Oswald-Richter K, 2007, PLOS PATHOG, V3, P553, DOI 10.1371/journal.ppat.0030058; Palendira U, 2008, BLOOD, V112, P3293, DOI 10.1182/blood-2008-02-138040; Poles MA, 2001, J VIROL, V75, P8390, DOI 10.1128/JVI.75.18.8390-8399.2001; Lopez-Huertas MR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02634-y; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Seibert C, 2006, VIROLOGY, V349, P41, DOI 10.1016/j.virol.2006.01.018; Shacklett BL, 2003, J VIROL, V77, P5621, DOI 10.1128/JVI.77.10.5621-5631.2003; Sierra-Madero JG, 2014, LANCET HIV, V1, pE60, DOI 10.1016/S2352-3018(14)70027-X; Spivak AM, 2015, ANTIMICROB AGENTS CH, V59, P5984, DOI 10.1128/AAC.01077-15; Stepanyuk O, 2009, AIDS, V23, P1911, DOI 10.1097/QAD.0b013e32832f3c65; VANTWOUT AB, 1994, J CLIN INVEST, V94, P2060, DOI 10.1172/JCI117560; Vemula SV, 2015, VIRUSES-BASEL, V7, P543, DOI 10.3390/v7020543; Warrilow D, 2006, AIDS RES HUM RETROV, V22, P854, DOI 10.1089/aid.2006.22.854; Woollard SM, 2015, DRUG DES DEV THER, V9, DOI 10.2147/DDDT.S90580; Xu H, 2012, MUCOSAL IMMUNOL, V5, P658, DOI 10.1038/mi.2012.39	54	6	6	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					8905	8912		10.1096/fj.201802703R	http://dx.doi.org/10.1096/fj.201802703R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31034775	Green Published			2022-12-28	WOS:000478832900017
J	Zhu, QJ; Zhu, M; Xu, XX; Meng, XM; Wu, YG				Zhu, Qi-Jin; Zhu, Mei; Xu, Xing-Xin; Meng, Xiao-Ming; Wu, Yong-Gui			Exosomes from high glucose-treated macrophages activate glomerular mesangial cells via TGF-beta 1/Smad3 pathway in vivo and in vitro	FASEB JOURNAL			English	Article						diabetic nephropathy; activation; proliferation; fibrosis	KIDNEY-DISEASE; EXTRACELLULAR VESICLES; DIABETIC-NEPHROPATHY; INJURY; PROTEINURIA; PROGRESSION; MECHANISMS; INSIGHTS; PODOCYTE	Diabetes nephropathy (DN) is characterized by abnormal interactions between kidney-infiltrating macrophages and glomerular mesangial cells. Recently, a novel cell-cell communication mediated by exosomes has gained attention. Exosomes are membrane-bound vesicles that contain a variety of molecules such as proteins, lipids, DNA, mRNA, and microRNAs. Exosomes play an important role in the pathogenesis of DN. In this study, we show that high glucose (HG) led to increased excretion of exosomes from macrophages. Mesangial cells took up exosomes in vitro, which resulted in the activation and proliferation of mesangial cells and the secretion of extracellular matrix and inflammatory cytokines. In addition, C57BL/6 mice injected with exosomes from HG-treated macrophages showed morphologic and functional changes. We then showed that exosomes from HG-treated TGF-beta 1 knockdown macrophages induced less extracellular matrix and fewer inflammatory factors in mesangial cells compared with vector control. Our findings suggest that TGF-beta 1 mRNA in exosomes serves a role between macrophages and mesangial cells by activating the TGF-beta 1/ mothers against decapentaplegic homolog 3 pathway.-Zhu, Q.-J., Zhu, M., Xu, M.-X., Meng, X.-M., Wu, Y.-G. Exosomes from high glucose-treated macrophages activate glomerular mesangial cells via TGF-beta 1/Smad3 pathway in vivo and in vitro.	[Zhu, Qi-Jin; Zhu, Mei; Xu, Xing-Xin; Wu, Yong-Gui] Anhui Med Univ, Affiliated Hosp 1, Dept Nephrol, 218 Jixi Rd, Hefei 230032, Anhui, Peoples R China; [Meng, Xiao-Ming] Anhui Med Univ, Sch Pharm, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Wu, YG (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Nephrol, 218 Jixi Rd, Hefei 230032, Anhui, Peoples R China.; Meng, XM (corresponding author), Anhui Med Univ, Sch Pharm, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.	mengxiaoming@ahmu.edu.cn; wuyonggui@medmail.com.cn			National Natural Science Foundation of China [81770722]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported financially by National Natural Science Foundation of China (No. 81770722). The authors declare no conflicts of interest.	Abboud HE, 2012, EXP CELL RES, V318, P979, DOI 10.1016/j.yexcr.2012.02.025; Alvarez ML, 2012, KIDNEY INT, V82, P1024, DOI 10.1038/ki.2012.256; Badal SS, 2014, AM J KIDNEY DIS, V63, pS63, DOI 10.1053/j.ajkd.2013.10.047; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Dai CS, 2004, J AM SOC NEPHROL, V15, P1402, DOI 10.1097/01.ASN.0000130568.53923.FD; Fan Z, 2018, IMMUNOL INVEST, V47, P303, DOI 10.1080/08820139.2018.1428199; Hickey FB, 2018, CURR DIABETES REP, V18, DOI 10.1007/s11892-018-0984-6; Jefferson JA, 2008, KIDNEY INT, V74, P22, DOI 10.1038/ki.2008.128; Krause M, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00065; Kumar A, 2018, PHARMACOL REP, V70, P614, DOI 10.1016/j.pharep.2017.12.008; Li JJ, 2007, KIDNEY INT, V72, pS36, DOI 10.1038/sj.ki.5002384; Li YC, 2018, EXP THER MED, V15, P4067, DOI 10.3892/etm.2018.5993; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Lv LL, 2018, J CELL MOL MED, V22, P728, DOI 10.1111/jcmm.13407; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Meng XM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00082; Meng XM, 2014, NAT REV NEPHROL, V10, P493, DOI 10.1038/nrneph.2014.114; Pavenstadt H, 2000, AM J PHYSIOL-RENAL, V278, pF173, DOI 10.1152/ajprenal.2000.278.2.F173; Qian Y, 2008, DIABETES, V57, P1439, DOI 10.2337/db08-0061; Sagoo MK, 2018, FREE RADICAL BIO MED, V116, P50, DOI 10.1016/j.freeradbiomed.2017.12.040; Sasaki M, 2011, ACTA MED OKAYAMA, V65, P81; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Tesch GH, 2017, CLIN SCI, V131, P2183, DOI 10.1042/CS20160636; Tesch GH, 2010, SEMIN NEPHROL, V30, P290, DOI 10.1016/j.semnephrol.2010.03.007; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Vikram A, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/679754; Wang YY, 2018, EUR J PHARMACOL, V824, P185, DOI 10.1016/j.ejphar.2018.01.034; Wu CC, 2011, EXP DIABETES RES, DOI 10.1155/2011/514738; Wu CC, 2010, CLIN CHIM ACTA, V411, P700, DOI 10.1016/j.cca.2010.01.036; Yan YM, 2018, ONCOL LETT, V15, P7479, DOI 10.3892/ol.2018.8348; Yu SMW, 2018, ADV CHRONIC KIDNEY D, V25, P166, DOI 10.1053/j.ackd.2017.12.005; Zhang LX, 2016, NEW ENGL J MED, V375, P905, DOI 10.1056/NEJMc1602469	33	42	46	6	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9279	9290		10.1096/fj.201802427RRR	http://dx.doi.org/10.1096/fj.201802427RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31162940				2022-12-28	WOS:000478832900046
J	Pirisinu, M; Blasco, P; Tian, XL; Sen, Y; Bode, AM; Liu, KD; Dong, ZG				Pirisinu, Marco; Blasco, Pilar; Tian, Xueli; Sen, Yang; Bode, Ann M.; Liu, Kangdong; Dong, Zigang			Analysis of hydrophobic and hydrophilic moments of short penetrating peptides for enhancing mitochondrial localization: prediction and validation	FASEB JOURNAL			English	Article						cell-penetrating peptides; molecular dynamics; drug delivery; specificity	CELLULAR UPTAKE; MEMBRANE INTERACTION; SECONDARY STRUCTURE; DRUG-DELIVERY; ACID; ANALOGS; MODELS	Pharmaceutical interest in targeting mitochondria is increasing because of their contribution in incurable diseases. However, the inner mitochondrial layer represents a major hurdle to overcome for most drugs. Penetrating peptides are a promising strategy for drug delivery, but the absence of standard principles and reliable prediction tools limits the design and discovery of sequences with improved organelle specificity. In our hypothesis, peptide local flexibility represents a valuable source to predict peptide performance. Here, a pool of short nonnatural peptides was designed with the same amino acid content but different positioning. Molecular dynamics and membrane-transfer simulations were used to generate the low-energy conformers in extra, intracellular, and membrane-inserted environments. The contributions of the hydrophobic and hydrophilic side chain-exposed surfaces revealed that the amino acid's relative position significantly affected the simulated peptide's dynamics. Based on the structural versatility, we predicted the peptides' behavior and the sequence with the most efficient membrane penetration and mitochondrial localization. The prediction and the improved performance of our peptides were experimentally confirmed and compared with a reported mitochondrial-targeting sequence. We demonstrated that an accurate understanding of the structural versatility is a valid aid for future works in designing sequences with improved mitochondrial targeting.-Pirisinu, M., Blasco, P., Tian, X., Sen, Y., Bode, A. M., Liu, K., Dong, Z. Analysis of hydrophobic and hydrophilic moments of short penetrating peptides for enhancing mitochondrial localization: prediction and validation.	[Pirisinu, Marco; Blasco, Pilar; Tian, Xueli; Sen, Yang; Liu, Kangdong; Dong, Zigang] China US Henan Hormel Canc Inst, Zhengzhou, Henan, Peoples R China; [Pirisinu, Marco; Blasco, Pilar; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Tian, Xueli; Liu, Kangdong; Dong, Zigang] Zhengzhou Univ, Pathophysiol Dept, Sch Basic Med Sci, Zhengzhou, Henan, Peoples R China; [Liu, Kangdong; Dong, Zigang] Zhengzhou Univ, Affiliated Canc Hosp, Zhengzhou, Henan, Peoples R China; [Liu, Kangdong; Dong, Zigang] Canc Chemoprevent Henan, Collaborat Innovat Ctr, Zhengzhou, Henan, Peoples R China	University of Minnesota System; Zhengzhou University; Zhengzhou University	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.; Liu, KD (corresponding author), Zhengzhou Univ, Affiliated Canc Hosp, Henan Canc Hosp, 127 Dongming Rd, Zhengzhou 450008, Henan, Peoples R China.	kdliu@zzu.edu.cn; zgdong@hi.umn.edu	Pirisinu, Marco/AAR-5399-2021	Pirisinu, Marco/0000-0002-7834-4386; Blasco Morales, Pilar/0000-0001-6703-5417	Key Program of Henan Province [161100510300]; National Natural Science Foundation of China [81572812, 81872335]	Key Program of Henan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Key Program of Henan Province (Grant 161100510300) and the National Natural Science Foundation of China (Grants 81572812 and 81872335). The authors declare no conflicts of interest.	Agemy L, 2011, P NATL ACAD SCI USA, V108, P17450, DOI 10.1073/pnas.1114518108; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Bolhassani A, 2011, BBA-REV CANCER, V1816, P232, DOI 10.1016/j.bbcan.2011.07.006; Cabra V, 2006, BBA-PROTEINS PROTEOM, V1764, P1110, DOI 10.1016/j.bbapap.2006.04.002; Cerrato CP, 2015, FASEB J, V29, P4589, DOI 10.1096/fj.14-269225; Dimauro Ivan, 2012, BMC Res Notes, V5, P513, DOI 10.1186/1756-0500-5-513; Eiriksdottir E, 2010, BBA-BIOMEMBRANES, V1798, P1119, DOI 10.1016/j.bbamem.2010.03.005; FAUCHERE JL, 1988, INT J PEPT PROT RES, V32, P269; Fonseca SB, 2011, CHEM BIOL, V18, P445, DOI 10.1016/j.chembiol.2011.02.010; Gautam A, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas015; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Guidotti G, 2017, TRENDS PHARMACOL SCI, V38, P406, DOI 10.1016/j.tips.2017.01.003; Gupta A, 2011, EUR BIOPHYS J BIOPHY, V40, P727, DOI 10.1007/s00249-011-0685-4; Herst PM, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00296; Horton KL, 2008, CHEM BIOL, V15, P375, DOI 10.1016/j.chembiol.2008.03.015; Horton KL, 2012, CHEMBIOCHEM, V13, P476, DOI 10.1002/cbic.201100415; Horton KL, 2009, J MED CHEM, V52, P3293, DOI 10.1021/jm900178n; Huang Y, 2014, PROTEIN CELL, V5, P194, DOI 10.1007/s13238-014-0028-1; Jobin ML, 2015, BBA-BIOMEMBRANES, V1848, P593, DOI 10.1016/j.bbamem.2014.11.013; Kelley SO, 2011, PHARM RES-DORDR, V28, P2808, DOI 10.1007/s11095-011-0530-6; Kovacs JM, 2006, BIOPOLYMERS, V84, P283, DOI 10.1002/bip.20417; Kristensen M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020185; Kuhlbrandt W, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0201-x; Leopold P.L., 2016, LYSOSOMES BIOL DIS T, P383; Leung SSF, 2016, J CHEM INF MODEL, V56, P924, DOI 10.1021/acs.jcim.6b00005; Leung SSF, 2012, J CHEM INF MODEL, V52, P1621, DOI [10.1021/ci0120503t, 10.1021/ci200583t]; Mallick S, 2018, COLLOID SURFACE B, V161, P356, DOI 10.1016/j.colsurfb.2017.10.052; Marrache S, 2012, P NATL ACAD SCI USA, V109, P16288, DOI 10.1073/pnas.1210096109; Mellert K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052473; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; Mueller J, 2008, BIOCONJUGATE CHEM, V19, P2363, DOI 10.1021/bc800194e; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Oliver M, 2018, RSC ADV, V8, P14597, DOI 10.1039/c8ra02511h; Patterson MJ, 1996, MED MICROBIOLOGY; Pereira MP, 2011, J AM CHEM SOC, V133, P3260, DOI 10.1021/ja110246u; Rezgui R, 2016, BBA-BIOMEMBRANES, V1858, P1499, DOI 10.1016/j.bbamem.2016.03.023; Rink R, 2010, J PHARMACOL TOX MET, V61, P210, DOI 10.1016/j.vascn.2010.02.010; Rydberg HA, 2012, BIOCHEMISTRY-US, V51, P5531, DOI 10.1021/bi300454k; Sandberg M, 1998, J MED CHEM, V41, P2481, DOI 10.1021/jm9700575; Schmid S, 2017, BIOCONJUGATE CHEM, V28, P382, DOI 10.1021/acs.bioconjchem.6b00535; Schmidt N, 2010, FEBS LETT, V584, P1806, DOI 10.1016/j.febslet.2009.11.046; Smith LJ, 1996, FOLD DES, V1, pR95, DOI 10.1016/S1359-0278(96)00046-6; Soomets Ursel, 2005, V298, P241; Sun S, 2017, METHODS MOL BIOL, V1567, P1, DOI 10.1007/978-1-4939-6824-4_1; Verdurmen WPR, 2011, CHEM BIOL, V18, P1000, DOI 10.1016/j.chembiol.2011.06.006; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Woldetsadik AD, 2017, FASEB J, V31, P2168, DOI 10.1096/fj.201601173R; Yamashita H, 2016, SCI REP-UK, V6, DOI 10.1038/srep33003; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200; Zheng N, 2017, ACTA BIOMATER, V58, P146, DOI 10.1016/j.actbio.2017.05.001	52	2	2	0	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					7970	7984		10.1096/fj.201802748RR	http://dx.doi.org/10.1096/fj.201802748RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30917009	Bronze			2022-12-28	WOS:000476234700014
J	Zeng, H; Hu, MJ; Lu, YK; Zhang, ZH; Xu, Y; Wang, S; Chen, M; Shen, MQ; Wang, C; Chen, F; Du, CH; Tang, Y; Su, YP; Chen, SL; Wang, JP				Zeng, Hao; Hu, Mengjia; Lu, Yukai; Zhang, Zihao; Xu, Yang; Wang, Song; Chen, Mo; Shen, Mingqiang; Wang, Cheng; Chen, Fang; Du, Changhong; Tang, Yong; Su, Yongping; Chen, Shilei; Wang, Junping			MicroRNA 34a promotes ionizing radiation-induced DNA damage repair in murine hematopoietic stem cells	FASEB JOURNAL			English	Article						irradiation; apoptosis; hematopoiesis	MIR-34A; INFLAMMATION; ACTIVATION; MECHANISMS; APOPTOSIS; INJURY; P53	Hematopoietic stem cells (HSCs) establish the entire hematopoietic system and maintain lifelong hematopoiesis. Previous studies have reported the significance of microRNAs (miRNAs) in the regulation of self-renewal and differentiation of HSCs. In this study, we show that the expression of miRNA 34a (miR-34a) is markedly up-regulated in HSCs from mice subjected to ionizing radiation (IR). Reduced numbers and DNA damage repair, as well as increased apoptosis, are observed in HSCs from miR-34a-deficient mice induced by irradiation, although miR-34a is dispensable for steady-state hematopoiesis. Further investigations show that HSCs deficient in miR-34a exhibit decreased expressions of DNA repair-associated genes involved in homologous recombination and nonhomologous end joining. Competitive transplantation confirms that loss of miR-34a leads to more severe impairment of the long-term hematopoietic function of HSCs after irradiation exposure. Consistently, treating mice with an miR-34a agomir can significantly alleviate irradiation-induced DNA damage in HSCs. Our findings demonstrate that miR-34a contributes to promoting HSCs' survival after irradiation, which provides a promising approach for protecting HSCs from IR.-Zeng, H., Hu, M., Lu, Y., Zhang, Z., Xu, Y., Wang, S., Chen, M., Shen, M., Wang, C., Chen, F., Du, C., Tang, Y., Su,Y., Chen, S., Wang, J. MicroRNA 34a promotes ionizing radiation-induced DNA damage repair in murine hematopoietic stem cells.	[Zeng, Hao; Hu, Mengjia; Lu, Yukai; Zhang, Zihao; Xu, Yang; Wang, Song; Chen, Mo; Shen, Mingqiang; Wang, Cheng; Chen, Fang; Du, Changhong; Tang, Yong; Su, Yongping; Chen, Shilei; Wang, Junping] Third Mil Med Univ, Coll Prevent Med, Chongqing Engn Res Ctr Nanomed, State Key Lab Trauma Burns & Combined Injury,Inst, Gaotanyan St 30, Chongqing 400038, Peoples R China	Army Medical University	Chen, SL; Wang, JP (corresponding author), Third Mil Med Univ, Coll Prevent Med, Chongqing Engn Res Ctr Nanomed, State Key Lab Trauma Burns & Combined Injury,Inst, Gaotanyan St 30, Chongqing 400038, Peoples R China.	chen.shilei@foxmail.com; wangjunping@tmmu.edu.cn	Du, Changhong/GXH-2720-2022; Wang, Cheng/AAK-7457-2021	Du, Changhong/0000-0002-1537-0325; Wang, Cheng/0000-0002-6690-6433; Xu, Yang/0000-0002-8083-6750; Wang, Cheng/0000-0001-5850-4533	National Natural Science Fund of China [81725019, 81573084, 81500087]; Program for Scientific and Technological Innovation Leaders of Chongqing [CSTCKJCXLJRC06]; Scientific Research Project of the Chinese People's Liberation Army (PLA) [AWS16J014]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Program for Scientific and Technological Innovation Leaders of Chongqing; Scientific Research Project of the Chinese People's Liberation Army (PLA)	The authors thank Prof. Jun Peng (Qilu Hospital, Shandong University, Jinan, China) for providing miR-34a<SUP>-/-</SUP> mice, Prof. Jinyong Wang (Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Science, Guangzhou, China) for providing CD45.1 mice, Haiying Ran and Yang Liu (both from the Third Military Medical University) for technical support in flow cytometry, and Liting Wang (Third Military Medical University) for technical assistance in immunofluorescence microscopy. This work was supported by grants from the National Natural Science Fund of China (81725019, 81573084, and 81500087), the Program for Scientific and Technological Innovation Leaders of Chongqing (CSTCKJCXLJRC06), and the Scientific Research Project of the Chinese People's Liberation Army (PLA) (AWS16J014). The authors declare no conflicts of interest.	Acharya SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa6593; Asada N, 2017, NAT CELL BIOL, V19, P214, DOI 10.1038/ncb3475; Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Beg MS, 2017, INVEST NEW DRUG, V35, P180, DOI 10.1007/s10637-016-0407-y; Ben Nasr M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam7543; Bianchi E, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010145; Bu PC, 2016, CELL STEM CELL, V18, P189, DOI 10.1016/j.stem.2016.01.006; Carrelha J, 2018, NATURE, V554, P106, DOI 10.1038/nature25455; Chen SL, 2018, BLOOD, V132, P210, DOI 10.1182/blood-2018-01-825927; Choi J, 2016, BLOOD, V128, P2117, DOI 10.1182/blood-2016-02-702464; Choi YJ, 2017, SCIENCE, V355, DOI 10.1126/science.aag1927; Cosco D, 2015, SCI REP-UK, V5, DOI 10.1038/srep17579; de Laval B, 2014, BLOOD, V123, P509, DOI 10.1182/blood-2013-07-515874; de Leeuw DC, 2016, LEUKEMIA, V30, P742, DOI 10.1038/leu.2015.160; Fang CY, 2017, CANCER LETT, V410, P50, DOI 10.1016/j.canlet.2017.09.012; Gougelet A, 2016, GUT, V65, P1024, DOI 10.1136/gutjnl-2014-308969; Guo F, 2013, LEUKEMIA, V27, P2040, DOI 10.1038/leu.2013.93; Haetscher N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9928; Halimi M, 2016, RADIAT ENVIRON BIOPH, V55, P423, DOI 10.1007/s00411-016-0661-6; Hong SH, 2015, STEM CELLS, V33, P1, DOI 10.1002/stem.1810; Hu MJ, 2018, BLOOD, V132, P911, DOI 10.1182/blood-2018-02-831669; Huang AF, 2014, EXP CELL RES, V326, P259, DOI 10.1016/j.yexcr.2014.04.010; Insinga A, 2013, P NATL ACAD SCI USA, V110, P3931, DOI 10.1073/pnas.1213394110; Itkin T, 2017, LEUKEMIA, V31, P1247, DOI 10.1038/leu.2017.50; Jiang LC, 2017, CANCER RES, V77, P2746, DOI 10.1158/0008-5472.CAN-16-2183; Kraft D, 2015, LEUKEMIA, V29, P1543, DOI 10.1038/leu.2015.28; Lacombe J, 2017, CRIT REV ONCOL HEMAT, V109, P69, DOI 10.1016/j.critrevonc.2016.11.017; Lechman ER, 2016, CANCER CELL, V29, P214, DOI 10.1016/j.ccell.2015.12.011; Li XJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.270; Liu L, 2017, CELL PHYSIOL BIOCHEM, V41, P1981, DOI 10.1159/000475277; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Morgado AL, 2015, MOL NEUROBIOL, V51, P1168, DOI 10.1007/s12035-014-8794-6; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; Pietras EM, 2017, BLOOD, V130, P1693, DOI 10.1182/blood-2017-06-780882; Rao DS, 2010, IMMUNITY, V33, P48, DOI 10.1016/j.immuni.2010.06.013; Salzman DW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10954; Shao LJ, 2014, BLOOD, V123, P3105, DOI 10.1182/blood-2013-07-515619; Shao LJ, 2014, ANTIOXID REDOX SIGN, V20, P1447, DOI 10.1089/ars.2013.5635; Slabakova E, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.495; Sotillo E, 2011, ONCOGENE, V30, P2587, DOI 10.1038/onc.2010.634; Sun YX, 2017, ONCOTARGET, V8, P6142, DOI 10.18632/oncotarget.14046; Takeda Y, 2015, CELL CYCLE, V14, P3830, DOI 10.1080/15384101.2015.1064202; Tan JL, 2012, J CELL BIOCHEM, V113, P2903, DOI 10.1002/jcb.24167; Yamashita M, 2015, CELL STEM CELL, V17, P23, DOI 10.1016/j.stem.2015.05.013; Zhang HJ, 2016, CELL STEM CELL, V18, P668, DOI 10.1016/j.stem.2016.03.002	46	9	10	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8138	8147		10.1096/fj.201802639R	http://dx.doi.org/10.1096/fj.201802639R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30922079	Bronze			2022-12-28	WOS:000476234700027
J	Saul, MJ; Baumann, I; Bruno, A; Emmerich, AC; Wellstein, J; Ottinger, SM; Contursi, A; Dovizio, M; Donnini, S; Tacconelli, S; Raouf, J; Idborg, H; Stein, S; Korotkova, M; Savai, R; Terzuoli, E; Sala, G; Seeger, W; Jakobsson, PJ; Patrignani, P; Suess, B; Steinhilber, D				Saul, Meike J.; Baumann, Isabell; Bruno, Annalisa; Emmerich, Anne C.; Wellstein, Julia; Ottinger, Sarah M.; Contursi, Annalisa; Dovizio, Melania; Donnini, Sandra; Tacconelli, Stefania; Raouf, Joan; Idborg, Helena; Stein, Stefan; Korotkova, Marina; Savai, Rajkumar; Terzuoli, Erika; Sala, Gianluca; Seeger, Werner; Jakobsson, Per-Johan; Patrignani, Paola; Suess, Beatrix; Steinhilber, Dieter			miR-574-5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES-1 induction	FASEB JOURNAL			English	Article						PGE(2); lung cancer; A549 cells; alternative splicing; prostaglandins	PROSTAGLANDIN-E SYNTHASE-1; GU-RICH ELEMENTS; POSTTRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; TETRANOR PGDM; UP-REGULATION; MICRORNAS; CANCER; CYCLOOXYGENASE-2; OVEREXPRESSION	MicroRNAs (miRs) are important posttranscriptional regulators of gene expression. Besides their well-characterized inhibitory effects on mRNA stability and translation, miRs can also activate gene expression. In this study, we identified a novel noncanonical function of miR-574-5p. We found that miR-574-5p acts as an RNA decoy to CUG RNA-binding protein 1 (CUGBP1) and antagonizes its function. MiR-574-5p induces microsomal prostaglandin E synthase-1 (mPGES-1) expression by preventing CUGBP1 binding to its 3 ' UTR, leading to an enhanced alternative splicing and generation of an mPGES-1 3 ' UTR isoform, increased mPGES-1 protein expression, PGE(2) formation, and tumor growth in vivo. miR-574-5p-induced tumor growth in mice could be completely inhibited with the mPGES-1 inhibitor CIII. Moreover, miR-574-5p is induced by IL-1 beta and is strongly overexpressed in human nonsmall cell lung cancer where high mPGES-1 expression correlates with a low survival rate. The discovered function of miR-574-5p as a CUGBP1 decoy opens up new therapeutic opportunities. It might serve as a stratification marker to select lung tumor patients who respond to the pharmacological inhibition of PGE(2) formation.-Saul, M. J., Baumann, I., Bruno, A., Emmerich, A. C., Wellstein, J., Ottinger, S. M., Contursi, A., Dovizio, M., Donnini, S., Tacconelli, S., Raouf, J., Idborg, H., Stein, S., Korotkova, M., Savai, R., Terzuoli, E., Sala, G., Seeger, W., Jakobsson, P.-J., Patrignani, P., Suess, B., Steinhilber, D. miR-574-5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES-1 induction.	[Saul, Meike J.; Baumann, Isabell; Emmerich, Anne C.; Wellstein, Julia; Steinhilber, Dieter] Goethe Univ Frankfurt, Inst Pharmaceut Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Saul, Meike J.; Baumann, Isabell; Emmerich, Anne C.; Wellstein, Julia; Ottinger, Sarah M.; Suess, Beatrix] Tech Univ Darmstadt, Dept Biol, Schnittspahnstr 10, D-64287 Darmstadt, Germany; [Bruno, Annalisa; Contursi, Annalisa; Dovizio, Melania; Tacconelli, Stefania; Patrignani, Paola] Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Sect Cardiovasc & Pharmacol Sci, Sch Med, Chieti, Italy; [Bruno, Annalisa; Contursi, Annalisa; Dovizio, Melania; Tacconelli, Stefania; Sala, Gianluca; Patrignani, Paola] Univ G dAnnunzio, Ctr Sci Invecchiamento & Med Traslaz CeSI MeT, Chieti, Italy; [Sala, Gianluca] Univ G dAnnunzio, Dept Med & Oral Sci & Biotechnol, Chieti, Italy; [Donnini, Sandra; Terzuoli, Erika] Univ Siena, Dept Life Sci, Siena, Italy; [Raouf, Joan; Idborg, Helena; Korotkova, Marina; Jakobsson, Per-Johan] Karolinska Inst, Karolinska Univ Hosp, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Stein, Stefan] Georg Speyer Haus, Frankfurt, Germany; [Savai, Rajkumar; Seeger, Werner] Max Planck Inst Heart & Lung Res, German Ctr Lung Res DZL, Dept Lung Dev & Remodeling, Bad Nauheim, Germany; [Seeger, Werner] Univ Giessen, Marburg Lung Ctr UGMLC, Dept Internal Med 2, Giessen, Germany	Goethe University Frankfurt; Technical University of Darmstadt; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Siena; Karolinska Institutet; Karolinska University Hospital; Max Planck Society; Justus Liebig University Giessen	Steinhilber, D (corresponding author), Goethe Univ Frankfurt, Inst Pharmaceut Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany.; Suess, B (corresponding author), Tech Univ Darmstadt, Dept Biol, Schnittspahnstr 10, D-64287 Darmstadt, Germany.	bsuess@bio-tu-darmstadt.de; steinhilber@em.uni-frankfurt.de	Sala, Gianluca/C-2056-2017; Patrignani, Paola/B-4844-2011; Jakobsson, Per-Johan/ABC-5594-2021; Terzuoli, Erika/M-7346-2016	Sala, Gianluca/0000-0002-4494-915X; Patrignani, Paola/0000-0003-1419-2691; Terzuoli, Erika/0000-0001-9248-4505; Donnini, Sandra/0000-0001-6617-1644; Donzelli, Julia/0000-0001-8790-9142; TACCONELLI, Stefania/0000-0003-4907-1822; Dovizio, Melania/0000-0003-0301-7767; Idborg, Helena/0000-0003-4041-4729; Stein, Stefan/0000-0003-1473-9706	Else Kroner-Fresenius Stiftung [2013_A265]; Else Kroner-Fresenius Stiftung (Else Kroner-Fresenius-Graduiertenkolleg); Deutsche Forschungsgemeinschaft (ECCPS); Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) CompuGene; Associazione Italiana per la Ricerca sul Cancero [IG-12111]; Swedish Cancer Society; Swedish Rheumatism Association; Swedish Agency for Innovation Systems (Vinnova); Apotekare Hedbergs Foundation; Sigurd and Elsa Goljes Minnesfond; Stockholm County Council; King Gustaf V 80 Years Foundation	Else Kroner-Fresenius Stiftung; Else Kroner-Fresenius Stiftung (Else Kroner-Fresenius-Graduiertenkolleg); Deutsche Forschungsgemeinschaft (ECCPS)(German Research Foundation (DFG)); Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) CompuGene; Associazione Italiana per la Ricerca sul Cancero(Fondazione AIRC per la ricerca sul cancro); Swedish Cancer Society(Swedish Cancer Society); Swedish Rheumatism Association; Swedish Agency for Innovation Systems (Vinnova)(Vinnova); Apotekare Hedbergs Foundation; Sigurd and Elsa Goljes Minnesfond; Stockholm County Council(Stockholm County Council); King Gustaf V 80 Years Foundation	The authors are grateful to Julia Weigand and Katrin Kemmerer [Technische Universitat (TU) Darmstadt] for generously providing pCUGBP1 and pCMV-MS plasmid. The authors give special thanks to Michaela Muller-McNicoll (Goethe University Frankfurt) for scientific discussion and technical support concerning the RIP assays. The authors also thank M. Cristina Cardoso for providing access to microscope facilities, and Theresa Greiner and Eva Wolf for technical support (all from TU Darmstadt). This project was supported by the Else Kroner-Fresenius Stiftung (2013_A265 and Else Kroner-Fresenius-Graduiertenkolleg), the Deutsche Forschungsgemeinschaft (ECCPS), the Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) CompuGene, the Associazione Italiana per la Ricerca sul Cancero (Grant IG-12111) (to P.P.), and the Swedish Cancer Society, the Swedish Rheumatism Association, King Gustaf V 80 Years Foundation, Swedish Agency for Innovation Systems (Vinnova), the Apotekare Hedbergs Foundation, the Sigurd and Elsa Goljes Minnesfond, and the Stockholm County Council. M.J.S., I.B., P.-J.J., B.S., and D.S. have filed a patent application, "MiRNA-574-5p as a biomarker for stratification of prostaglandin E-dependent tumors" (FH59330EP). The remaining authors declare no conflicts of interests.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Audic Y, 2004, BIOL CELL, V96, P479, DOI 10.1016/j.biolcel.2004.05.002; Banat GA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139073; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Behm-Ansmant I, 2006, COLD SPRING HARB SYM, V71, P523, DOI 10.1101/sqb.2006.71.013; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; Chaudhury A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13362; Cifdaloz M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02353-y; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Daskalova E, 2006, EVOL BIOINFORM, V2, P103; Del Vescovo V, 2014, WORLD J CLIN ONCOL, V5, P604, DOI 10.5306/wjco.v5.i4.604; Diaz-Munoz MD, 2010, CELL SIGNAL, V22, P1427, DOI 10.1016/j.cellsig.2010.05.011; Dovizio M, 2013, MOL PHARMACOL, V84, P25, DOI 10.1124/mol.113.084988; Eiring AM, 2010, CELL, V140, P652, DOI 10.1016/j.cell.2010.01.007; Fitzpatrick T, 2012, NUCLEUS-PHILA, V3, P359, DOI 10.4161/nucl.20827; Foss KM, 2011, J THORAC ONCOL, V6, P482, DOI 10.1097/JTO.0b013e318208c785; Gao CH, 2015, TUMOR BIOL, V36, P4583, DOI 10.1007/s13277-015-3103-1; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Idborg H, 2013, PROSTAG OTH LIPID M, V107, P18, DOI 10.1016/j.prostaglandins.2013.07.004; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Leclerc P, 2013, SCAND J IMMUNOL, V77, P350, DOI 10.1111/sji.12041; Leclerc P, 2013, PROSTAG OTH LIPID M, V107, P26, DOI 10.1016/j.prostaglandins.2013.09.001; Li QC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048278; Masuda A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00209; Masuko-Hongo K, 2004, ARTHRITIS RHEUM-US, V50, P2829, DOI 10.1002/art.20437; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Ochs MJ, 2014, BASIC CLIN PHARMACOL, V114, P92, DOI 10.1111/bcpt.12116; Ochs MJ, 2013, J PROTEOME RES, V12, P2622, DOI 10.1021/pr301193f; Ochs MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031363; PATRIGNANI P, 1994, J PHARMACOL EXP THER, V271, P1705; Peng Y, 2016, SIGNAL TRANSDUCT TAR, V1, DOI 10.1038/sigtrans.2015.4; Pereira B, 2017, TRENDS CANCER, V3, P506, DOI 10.1016/j.trecan.2017.05.003; Sambandan S, 2017, SCIENCE, V355, P634, DOI 10.1126/science.aaf8995; Saul MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep31995; Savai R, 2014, NAT MED, V20, P1289, DOI 10.1038/nm.3695; Savai R, 2012, AM J RESP CRIT CARE, V186, P897, DOI 10.1164/rccm.201202-0335OC; Shah MY, 2016, EBIOMEDICINE, V12, P34, DOI 10.1016/j.ebiom.2016.09.017; Smit AF., 2018, REPEATMASKER; Song WL, 2008, J BIOL CHEM, V283, P1179, DOI 10.1074/jbc.M706839200; Song WL, 2007, METHOD ENZYMOL, V433, P51, DOI 10.1016/S0076-6879(07)33003-6; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Vlasova IA, 2008, RNA BIOL, V5, P201, DOI 10.4161/rna.7056; Vlasova-St Louis I, 2011, CURR OPIN GENET DEV, V21, P444, DOI 10.1016/j.gde.2011.03.002; Vockenhuber MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120147; Walker SC, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng082; Wang D, 2006, GUT, V55, P115, DOI 10.1136/gut.2004.047100; Westman M, 2004, ARTHRITIS RHEUM-US, V50, P1774, DOI 10.1002/art.20286; Wu YC, 2010, J THORAC ONCOL, V5, P1167, DOI 10.1097/JTO.0b013e3181e2f4f5; Yao P, 2017, NUCLEIC ACIDS RES, V45, P7950, DOI 10.1093/nar/gkx440; Yoshimatsu K, 2001, CLIN CANCER RES, V7, P2669; Zhang YZ, 2011, J MASS SPECTROM, V46, P705, DOI 10.1002/jms.1941; Zhou R, 2016, SCI REP-UK, V6, DOI 10.1038/srep35714; Zhou R, 2015, ONCOTARGET, V6, P44609, DOI 10.18632/oncotarget.6338	54	14	17	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6933	6947		10.1096/fj.201802547R	http://dx.doi.org/10.1096/fj.201802547R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30922080				2022-12-28	WOS:000476114200021
J	Mewes, M; Lenders, M; Stappers, F; Scharnetzki, D; Nedele, J; Fels, J; Wedlich-Soldner, R; Brand, SM; Schmitz, B; Brand, E				Mewes, Mirja; Lenders, Malte; Stappers, Franciska; Scharnetzki, David; Nedele, Johanna; Fels, Johannes; Wedlich-Soeldner, Roland; Brand, Stefan-Martin; Schmitz, Boris; Brand, Eva			Soluble adenylyl cyclase (sAC) regulates calcium signaling in the vascular endothelium	FASEB JOURNAL			English	Article						IP3R; endoplasmic reticulum; vasoconstriction; protein kinase A; actin	SMOOTH-MUSCLE; CA2+; ACTIVATION; PERMEABILITY; DEFINES; IP3	The vascular endothelium acts as a selective barrier between the bloodstream and extravascular tissues. Intracellular [Ca2+](i) signaling is essential for vasoactive agonist induced stimulation of endothelial cells (ECs), typically including Ca2+ release from the endoplasmic reticulum (ER). Although it is known that interactions of Ca2+ and cAMP as ubiquitous messengers are involved in this process, the individual contribution of cAMP-generating adenylyl cyclases (ACs), including the only soluble AC (sAC; ADCY10), remains less clear. Using life-cell microscopy and plate reader based [Ca2+](i) measurements, we found that human immortalized ECs, primary aortic and cardiac microvascular ECs, and primary vascular smooth muscle cells treated with sAC-specific inhibitor KH7 or anti-sAC-small interfering RNA did not show endogenous or exogenous ATP-induced [Ca2+](i) elevation. Of note, a transmembrane AC (tmAC) inhibitor did not prevent ATP-induced [Ca2+](i) elevation in ECs. Moreover, L-phenylephrine dependent constriction of ex vivo mouse aortic ring segments was also reduced by KH7. Analysis of the inositol-1,4,5-trisphosphate (IP3) pathway revealed reduced IP3 receptor phosphorylation after KH7 application, which also prevented [Ca2+](i) elevation induced by IP3 receptor agonist adenophostin A. Our results suggest that sAC rather than tmAC controls the agonist-induced ER-dependent Ca2+ response in ECs and may represent a treatment target in arterial hypertension and heart failure.	[Mewes, Mirja; Lenders, Malte; Stappers, Franciska; Scharnetzki, David; Nedele, Johanna; Brand, Eva] Univ Hosp Muenster, Internal Med D, Dept Nephrol Hypertens & Rheumatol, Munster, Germany; [Brand, Stefan-Martin; Schmitz, Boris] Univ Hosp Muenster, Inst Sports Med Mol Genet Cardiovasc Dis, Horstmarer Landweg 39, D-48149 Munster, Germany; [Fels, Johannes; Wedlich-Soeldner, Roland] Univ Munster, Fac Med, Inst Cell Dynam & Imaging, Munster, Germany; [Fels, Johannes] Univ Witten Herdecke, Dept Physiol Pathophysiol & Toxicol, Witten, Germany; [Fels, Johannes] Univ Witten Herdecke, Ctr Biomed Educ & Res ZBAF, Witten, Germany	University of Munster; University of Munster; University of Munster; Witten Herdecke University; Witten Herdecke University	Schmitz, B (corresponding author), Univ Hosp Muenster, Inst Sports Med Mol Genet Cardiovasc Dis, Horstmarer Landweg 39, D-48149 Munster, Germany.	boris.schmitz@ukmuenster.de	Schmitz, Boris/M-3205-2019	Schmitz, Boris/0000-0001-7041-7424	German Research Foundation via the Collaborative Research Centre 1009; Interdisciplinary Centre for Clinical Research (IZKF) Munster [Wed2/022/18]; German Research Foundation via the Cluster of Excellence 1003-Cells in Motion (CiM)	German Research Foundation via the Collaborative Research Centre 1009; Interdisciplinary Centre for Clinical Research (IZKF) Munster; German Research Foundation via the Cluster of Excellence 1003-Cells in Motion (CiM)	The authors thank Samira Schiwek and Birgit Orlowski (both from University Hospital Muenster) for excellent technical assistance. R.W.-S. and J.F. were supported by the German Research Foundation via the Collaborative Research Centre 1009 and the Cluster of Excellence 1003-Cells in Motion (CiM), and by the Interdisciplinary Centre for Clinical Research (IZKF) Munster (Wed2/022/18). The authors declare no conflicts of interest.	Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Atienza JM, 2006, ASSAY DRUG DEV TECHN, V4, P597, DOI 10.1089/adt.2006.4.597; Bitterman JL, 2013, J PHARMACOL EXP THER, V347, P589, DOI 10.1124/jpet.113.208496; Boulanger CM, 2016, ARTERIOSCL THROM VAS, V36, pE26, DOI 10.1161/ATVBAHA.116.306940; Burnstock G, 2014, EXP PHYSIOL, V99, P16, DOI 10.1113/expphysiol.2013.071951; CABLE HC, 1995, BIOCHEM J, V307, P169, DOI 10.1042/bj3070169; Cahill PA, 2016, ATHEROSCLEROSIS, V248, P97, DOI 10.1016/j.atherosclerosis.2016.03.007; Denelavas A, 2011, BBA-MOL CELL RES, V1813, P754, DOI 10.1016/j.bbamcr.2011.01.016; Dermitzaki E, 2001, ENDOCRINOLOGY, V142, P2022, DOI 10.1210/en.142.5.2022; Dessauer CW, 2017, PHARMACOL REV, V69, P93, DOI 10.1124/pr.116.013078; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Frooninckx Lotte, 2012, Front Endocrinol (Lausanne), V3, P167, DOI 10.3389/fendo.2012.00167; Godo S, 2017, ARTERIOSCL THROM VAS, V37, pE108, DOI 10.1161/ATVBAHA.117.309813; HALLAM TJ, 1986, FEBS LETT, V207, P95, DOI 10.1016/0014-5793(86)80019-9; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Hobi N, 2012, AM J PHYSIOL-LUNG C, V303, pL117, DOI 10.1152/ajplung.00340.2011; Hu H, 2016, CELL, V164, P433, DOI 10.1016/j.cell.2015.12.042; Jackson WF, 2008, BRIT J PHARMACOL, V155, P514, DOI 10.1038/bjp.2008.276; Kania E, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00140; Kleinboelting S, 2014, P NATL ACAD SCI USA, V111, P3727, DOI 10.1073/pnas.1322778111; Kuszak A. J., 2010, HDB CELL SIGNALING, P1389; Lu XA, 2011, AM J PHYSIOL-HEART C, V300, pH94, DOI 10.1152/ajpheart.00708.2010; Mewes M, 2017, PFLUG ARCH EUR J PHY, V469, P1401, DOI 10.1007/s00424-017-1999-6; Moore TM, 1998, AM J PHYSIOL-LUNG C, V275, pL203, DOI 10.1152/ajplung.1998.275.2.L203; Pati S, 2011, STEM CELLS DEV, V20, P89, DOI 10.1089/scd.2010.0013; Politi A, 2006, BIOPHYS J, V90, P3120, DOI 10.1529/biophysj.105.072249; Raabe I, 2009, J MICROSC-OXFORD, V234, P1, DOI 10.1111/j.1365-2818.2009.03142.x; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Saleem H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058027; Schmitz B, 2014, BBA-MOL BASIS DIS, V1842, P2601, DOI 10.1016/j.bbadis.2014.05.036; Schmitz B, 2014, HYPERTENSION, V63, P753, DOI 10.1161/HYPERTENSIONAHA.113.02061; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulze U, 2014, MOL CELL PROTEOMICS, V13, P1397, DOI 10.1074/mcp.M113.034108; Solly K, 2004, ASSAY DRUG DEV TECHN, V2, P363, DOI 10.1089/adt.2004.2.363; Steegborn C, 2014, BBA-MOL BASIS DIS, V1842, P2535, DOI 10.1016/j.bbadis.2014.08.012; Stessin AM, 2006, J BIOL CHEM, V281, P17253, DOI 10.1074/jbc.M603500200; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Taylor CW, 2017, CELL CALCIUM, V63, P48, DOI 10.1016/j.ceca.2016.10.005; Tresguerres M, 2011, KIDNEY INT, V79, P1277, DOI 10.1038/ki.2011.95; Valsecchi F, 2017, J CELL SCI, V130, P3713, DOI 10.1242/jcs.206318; Vanderheyden V, 2009, BBA-MOL CELL RES, V1793, P959, DOI 10.1016/j.bbamcr.2008.12.003; Viana F, 1998, CELL CALCIUM, V24, P117, DOI 10.1016/S0143-4160(98)90079-3; Walentek P, 2016, ELIFE, V5, DOI 10.7554/eLife.17557; Wang LW, 2002, J CARDIOVASC PHARM, V40, P841, DOI 10.1097/00005344-200212000-00005; Wennmann DO, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.476; Zhang AY, 2006, J CELL MOL MED, V10, P407, DOI 10.1111/j.1582-4934.2006.tb00408.x; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje; Zippin JH, 2010, J INVEST DERMATOL, V130, P1279, DOI 10.1038/jid.2009.440	49	6	6	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13762	13774		10.1096/fj.201900724R	http://dx.doi.org/10.1096/fj.201900724R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31585052	Bronze			2022-12-28	WOS:000507466100056
J	Nasyrov, E; Nolan, KA; Wenger, RH; Marti, HH; Kunze, R				Nasyrov, Emil; Nolan, Karen A.; Wenger, Roland H.; Marti, Hugo H.; Kunze, Reiner			The neuronal oxygen-sensing pathway controls postnatal vascularization of the murine brain	FASEB JOURNAL			English	Article						PHD; HIF; VEGF; adrenomedullin; cerebral angiogenesis	CENTRAL-NERVOUS-SYSTEM; ADRENOMEDULLIN-RAMP2 SYSTEM; ENDOTHELIAL-CELLS; HYPOXIC RESPONSE; SURVIVAL; ANGIOGENESIS; HIF-1-ALPHA; DEFICIENCY; MECHANISMS; EXPRESSION	The contribution of neurons to growth and refinement of the microvasculature during postnatal brain development is only partially understood. Tissue hypoxia is the physiologic stimulus for angiogenesis by enhancing angiogenic mediators partly through activation of hypoxia-inducible factors (HIFs). Hence, we investigated the HIF oxygen-sensing pathway in postmitotic neurons for physiologic angiogenesis in the murine forebrain during postnatal development by using mice lacking the HIF suppressing enzyme prolyl-4-hydroxylase domain (PHD)2 and/or HIF-1/2 alpha in postmitotic neurons. Perinatal activation or inactivation of the HIF pathway in neurons inversely modulated brain vascularization, including endothelial cell number and proliferation, density of total and perfused microvessels, and vascular branching. Accordingly, several angiogenesis-related genes were up-regulated in vivo and in primary neurons derived from PHD2-deficient mice. Among them, only VEGF and adrenomedullin (Adm) promoted angiogenic sprouting of brain endothelial cells. VEGF and Adm additively enhanced endothelial sprouting through activation of multiple pathways. PHD2 deficiency in neurons caused HIF-alpha stabilization and increased VEGF mRNA levels not only in neurons but unexpectedly also in astrocytes, suggesting a new mechanism of neuron-to-astrocyte signaling. Collectively, our results identify the PHD-HIF pathway in neurons as an important determinant for vascularization of the brain during postnatal development.	[Nasyrov, Emil; Marti, Hugo H.; Kunze, Reiner] Heidelberg Univ, Inst Physiol & Pathophysiol, Dept Cardiovasc Physiol, Neuenheimer Feld 326, D-69120 Heidelberg, Germany; [Nolan, Karen A.; Wenger, Roland H.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Nolan, Karen A.; Wenger, Roland H.] Natl Ctr Competence Res Kidney CH, Zurich, Switzerland	Ruprecht Karls University Heidelberg; University of Zurich	Kunze, R (corresponding author), Heidelberg Univ, Inst Physiol & Pathophysiol, Dept Cardiovasc Physiol, Neuenheimer Feld 326, D-69120 Heidelberg, Germany.	reiner.kunze@physiologie.uni-heidelberg.de	Kunze, Reiner/K-8048-2019; Wenger, Roland/B-7953-2009	Kunze, Reiner/0000-0002-8428-1027; Marti, Hugo/0000-0002-8456-334X; Nolan, Karen A./0000-0003-1999-1417; Wenger, Roland/0000-0001-7592-4839	Boehringer Ingelheim Fonds; National Centre of Competence in Research (NCCR) Kidney; European Union's Seventh Framework Programme for Research, Technological Development, and Demonstration [608847]	Boehringer Ingelheim Fonds(Boehringer Ingelheim); National Centre of Competence in Research (NCCR) Kidney; European Union's Seventh Framework Programme for Research, Technological Development, and Demonstration	The authors thank Dr. Caroline Arnold (Heidelberg University) for help with the angiogenic sprouting assay. The expert technical assistance of Nadine Heselmaier, Maria Harlacher, and Inge Keller (all from Heidelberg University) is gratefully acknowledged. E.N. was supported by a travel grant of the Boehringer Ingelheim Fonds. R.H.W. was supported by the National Centre of Competence in Research (NCCR) Kidney.CH. K.A.N. was supported by the European Union's Seventh Framework Programme for Research, Technological Development, and Demonstration (Grant 608847). The authors declare no conflicts of interest.	Andreone BJ, 2015, ANNU REV NEUROSCI, V38, P25, DOI 10.1146/annurev-neuro-071714-033835; Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Bai YY, 2009, J PATHOL, V219, P446, DOI 10.1002/path.2611; Barteczek P, 2017, J CEREBR BLOOD F MET, V37, P291, DOI 10.1177/0271678X15624933; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bickler PE, 2002, J EXP BIOL, V205, P3579; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Ding K, 2005, INVEST OPHTH VIS SCI, V46, P1010, DOI 10.1167/iovs.04-0788; Durkee CA, 2019, NEUROSCIENCE, V396, P73, DOI 10.1016/j.neuroscience.2018.11.010; Ernst AS, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0669-7; Fernandez AP, 2008, P NATL ACAD SCI USA, V105, P12581, DOI 10.1073/pnas.0803174105; Fernandez AP, 2010, ENDOCRINOLOGY, V151, P4908, DOI 10.1210/en.2010-0121; Fields RD, 2000, TRENDS NEUROSCI, V23, P625, DOI 10.1016/S0166-2236(00)01674-X; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gruneberg D, 2016, EXP NEUROL, V286, P93, DOI 10.1016/j.expneurol.2016.10.001; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Heiss M, 2015, FASEB J, V29, P3076, DOI 10.1096/fj.14-267633; Himmels P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14583; Hirayama Y, 2017, GLIA, V65, P523, DOI 10.1002/glia.23109; Hirayama Y, 2015, J NEUROSCI, V35, P3794, DOI 10.1523/JNEUROSCI.4218-14.2015; Igarashi K, 2014, PEPTIDES, V62, P21, DOI 10.1016/j.peptides.2014.08.013; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kis B, 2002, J NEUROENDOCRINOL, V14, P283, DOI 10.1046/j.1365-2826.2002.00778.x; Koyama T, 2015, J ATHEROSCLER THROMB, V22, P647, DOI 10.5551/jat.29967; Kunze R, 2012, STROKE, V43, P2748, DOI 10.1161/STROKEAHA.112.669598; Li LX, 2016, NEUROBIOL DIS, V91, P221, DOI 10.1016/j.nbd.2016.03.018; Lin-Holderer J, 2016, NEUROPHARMACOLOGY, V105, P228, DOI 10.1016/j.neuropharm.2016.01.023; Maurice T, 2013, J PSYCHOPHARMACOL, V27, P1044, DOI 10.1177/0269881113494939; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Nakamura-Ishizu A, 2012, DEV BIOL, V363, P106, DOI 10.1016/j.ydbio.2011.12.027; Paredes I, 2018, DEV CELL, V45, P10, DOI 10.1016/j.devcel.2018.01.023; Peeters C, 2003, BRAIN RES, V963, P72, DOI 10.1016/S0006-8993(02)03843-X; Raab S, 2004, THROMB HAEMOSTASIS, V91, P595, DOI 10.1160/TH03-09-0582; Rabie T, 2011, INT J DEV NEUROSCI, V29, P655, DOI 10.1016/j.ijdevneu.2011.06.003; Regen T, 2011, BRAIN BEHAV IMMUN, V25, P957, DOI 10.1016/j.bbi.2010.10.009; Religa P, 2013, SCI REP-UK, V3, DOI 10.1038/srep02053; Rey S, 2010, CARDIOVASC RES, V86, P236, DOI 10.1093/cvr/cvq045; Sapieha P, 2008, NAT MED, V14, P1067, DOI 10.1038/nm.1873; Schoch HJ, 2002, BRAIN, V125, P2549, DOI 10.1093/brain/awf257; Scott A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011863; Segura I, 2016, CELL REP, V14, P2653, DOI 10.1016/j.celrep.2016.02.047; Semenza GL, 2019, ANNU REV PHARMACOL, V59, P379, DOI 10.1146/annurev-pharmtox-010818-021637; Serrano J, 2000, BRAIN RES, V853, P245, DOI 10.1016/S0006-8993(99)02273-8; Shindo T, 2019, PEPTIDES, V111, P55, DOI 10.1016/j.peptides.2018.04.004; Simons M, 2016, NAT REV MOL CELL BIO, V17, P611, DOI 10.1038/nrm.2016.87; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Takeda K, 2007, CIRCULATION, V116, P774, DOI 10.1161/CIRCULATIONAHA.107.701516; Tata M, 2015, MECH DEVELOP, V138, P26, DOI 10.1016/j.mod.2015.07.001; Usui V, 2015, J CLIN INVEST, V125, P2335, DOI 10.1172/JCI80297; Walchli T, 2015, NEURON, V87, P271, DOI 10.1016/j.neuron.2015.06.038; Weidemann A, 2010, GLIA, V58, P1177, DOI 10.1002/glia.20997; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025	53	5	5	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12812	12824		10.1096/fj.201901385RR	http://dx.doi.org/10.1096/fj.201901385RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31469589	Green Published			2022-12-28	WOS:000507461600094
J	Sato, M; Aoki-Saito, H; Fukuda, H; Ikeda, H; Koga, Y; Yatomi, M; Tsurumaki, H; Maeno, T; Saito, T; Nakakura, T; Mori, T; Yanagawa, M; Abe, M; Sako, Y; Dobashi, K; Ishizuka, T; Yamada, M; Shuto, S; Hisada, T				Sato, Makiko; Aoki-Saito, Haruka; Fukuda, Hayato; Ikeda, Hiroyuki; Koga, Yasuhiko; Yatomi, Masakiyo; Tsurumaki, Hiroaki; Maeno, Toshitaka; Saito, Tsugumichi; Nakakura, Takashi; Mori, Tetsuya; Yanagawa, Masataka; Abe, Mitsuhiro; Sako, Yasushi; Dobashi, Kunio; Ishizuka, Tamotsu; Yamada, Masanobu; Shuto, Satoshi; Hisada, Takeshi			Resolvin E3 attenuates allergic airway inflammation via the interleukin-23-interleukin-17A pathway	FASEB JOURNAL			English	Article						house dust mite; omega-3 fatty acid; IL-17A	LEUKOTRIENE B-4 RECEPTOR; RESOLUTION; IL-23; CELLS; E1; ASTHMA; PSORIASIS; MODEL; FISH	We investigated the effects of resolvin E (RvE) 1, RvE2, and RvE3 on IL-4- and IL-33-stimulated bone marrow-derived dendritic cells (BMDCs) from house dust mite (HDM)-sensitized mice. We also investigated the role of RvE3 in a murine model of HDM-induced airway inflammation. In vitro, BMDCs from HDM-sensitized mice were stimulated with IL-4 and IL-33 and then treated with RvE1, RvE2, RvE3, or vehicle. RvE1, RvE2, and RvE3 suppressed IL-23 release from BMDCs. In vivo, RvE3 administrated to HDM-sensitized and challenged mice in the resolution phase promoted a decline in total numbers of inflammatory cells and eosinophils, reduced levels of IL-23 and IL-17 in lavage fluid, and suppressed IL-23 and IL-17A mRNA expression in lung and peribronchial lymph nodes. RvE3 also reduced resistance in the lungs of HDM-sensitized mice. A NanoBiT beta-arrestin recruitment assay using human embryonic kidney 293 cells revealed that pretreatment with RvE3 suppressed the leukotriene B4 (LTB4)-induced beta-arrestin 2 binding to LTB4 receptor 1 (BLT1R), indicating that RvE3 antagonistically interacts with BLT1R. Collectively, these findings indicate that RvE3 facilitates the resolution of allergic airway inflammation, partly by regulating BLT1R activity and selective cytokine release by dendritic cells. Our results accordingly identify RvE3 as a potential therapeutic target for the management of asthma.	[Sato, Makiko; Aoki-Saito, Haruka; Koga, Yasuhiko; Yatomi, Masakiyo; Tsurumaki, Hiroaki; Maeno, Toshitaka; Dobashi, Kunio; Hisada, Takeshi] Gunma Univ, Grad Sch Med, Dept Resp Med, 3-39-22 Showa Machi, Maebashi, Gunma 3718514, Japan; [Sato, Makiko; Saito, Tsugumichi; Yamada, Masanobu] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Gunma, Japan; [Fukuda, Hayato] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki, Japan; [Ikeda, Hiroyuki; Shuto, Satoshi] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido, Japan; [Ikeda, Hiroyuki; Shuto, Satoshi] Hokkaido Univ, Ctr Res & Educ Drug Discovery, Sapporo, Hokkaido, Japan; [Nakakura, Takashi] Teikyo Univ, Dept Anat, Tokyo, Japan; [Mori, Tetsuya] Takasaki Univ Hlth & Welf, Fac Pharm, Lab Allergy & Immunol, Gunma, Japan; [Yanagawa, Masataka; Abe, Mitsuhiro; Sako, Yasushi] RIKEN, Cluster Pioneering Res, Cellular Informat Lab, Saitama, Japan; [Ishizuka, Tamotsu] Univ Fukui, Fac Med Sci, Dept Internal Med 3, Fukui, Japan; [Hisada, Takeshi] Gunma Univ, Grad Sch Hlth Sci, Gunma, Japan	Gunma University; Gunma University; Nagasaki University; Hokkaido University; Hokkaido University; Teikyo University; RIKEN; University of Fukui; Gunma University	Aoki-Saito, H (corresponding author), Gunma Univ, Grad Sch Med, Dept Resp Med, 3-39-22 Showa Machi, Maebashi, Gunma 3718514, Japan.	a-haruka@gunma-u.ac.jp	KOGA, YASUHIKO/GQG-9830-2022; Yanagawa, Masataka/C-3789-2017; Abe, Mitsuhiro/C-3602-2017; Tsurumaki, Hiroaki/HDL-6889-2022; Shuto, Satoshi/AAH-4998-2020; Abe, Mitsuhiro/AAN-1275-2020	KOGA, YASUHIKO/0000-0002-4974-9026; Yanagawa, Masataka/0000-0001-7832-0918; Shuto, Satoshi/0000-0001-7850-8064; Abe, Mitsuhiro/0000-0002-6244-1771; Nakakura, Takashi/0000-0003-1898-563X; Tsurumaki, Hiroaki/0000-0003-0837-9329	Japan Society for the Promotion of Science (JSPS) Kakenhi [15K19412, 18K08382, 18K08404]; Novartis Foundation (Tokyo, Japan) for the Promotion of Science	Japan Society for the Promotion of Science (JSPS) Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Novartis Foundation (Tokyo, Japan) for the Promotion of Science	The authors thank Y. Ebara, Y. Yamashita, and A. Sato (Gunma University) for technical assistance. The authors also thank Y. Shichida (Ritsumeikan University, Kusatsu, Japan) for providing the HEK293S cell line, R. J. Lefkowitz (Duke University Medical Center, Durham, NC, USA) for providing b-arrestin 2 cDNA, and B. L. Roth (University of North Carolina, Chapel Hill, NC, USA) for providing BLT1R cDNA. This study was supported by the Japan Society for the Promotion of Science (JSPS) Kakenhi (15K19412, 18K08382, and 18K08404) and the Novartis Foundation (Tokyo, Japan) for the Promotion of Science. The authors declare no conflicts of interest.	Aoki H, 2008, BIOCHEM BIOPH RES CO, V367, P509, DOI 10.1016/j.bbrc.2008.01.012; Aoki H, 2010, BIOCHEM BIOPH RES CO, V400, P128, DOI 10.1016/j.bbrc.2010.08.025; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Barros R, 2011, BRIT J NUTR, V106, P441, DOI 10.1017/S0007114511000328; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gold MJ, 2014, J ALLERGY CLIN IMMUN, V133, P1142, DOI 10.1016/j.jaci.2014.02.033; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Haworth O, 2008, NAT IMMUNOL, V9, P873, DOI 10.1038/ni.1627; Haworth O, 2011, J IMMUNOL, V186, P6129, DOI 10.4049/jimmunol.1004007; Hiroshima M, 2018, J MOL BIOL, V430, P1386, DOI 10.1016/j.jmb.2018.02.018; HORROBIN DF, 1987, MED HYPOTHESES, V22, P421, DOI 10.1016/0306-9877(87)90037-5; Isobe Y, 2012, J BIOL CHEM, V287, P10525, DOI 10.1074/jbc.M112.340612; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lewkowich IP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003879; Li JJ, 2013, AM J CLIN NUTR, V97, P173, DOI 10.3945/ajcn.112.041145; Martinez GJ, 2008, ANN NY ACAD SCI, V1143, P188, DOI 10.1196/annals.1443.021; Mickleborough TD, 2006, CHEST, V129, P39, DOI 10.1378/chest.129.1.39; Mogi C, 2009, J IMMUNOL, V182, P3243, DOI 10.4049/jimmunol.0803466; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Nakajima Hiroshi, 2010, Immune Netw, V10, P1, DOI 10.4110/in.2010.10.1.1; Nakamura M, 2011, CHEM REV, V111, P6231, DOI 10.1021/cr100392s; Nakanishi Y, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao5390; Oh SF, 2012, J IMMUNOL, V188, P4527, DOI 10.4049/jimmunol.1103652; Okuno T, 2003, J BIOL CHEM, V278, P41500, DOI 10.1074/jbc.M307335200; Peng J, 2010, CELL RES, V20, P62, DOI 10.1038/cr.2009.128; Pichavant M, 2008, J EXP MED, V205, P385, DOI 10.1084/jem.20071507; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Shenoy SK, 2005, J BIOL CHEM, V280, P15315, DOI 10.1074/jbc.M412418200; Vroman H, 2015, IMMUNOBIOLOGY, V220, P254, DOI 10.1016/j.imbio.2014.09.016; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; Yago T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2297; Yanagawa M, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao1917	41	22	24	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12750	12759		10.1096/fj.201900283R	http://dx.doi.org/10.1096/fj.201900283R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31469599	Green Published, Bronze			2022-12-28	WOS:000507461600089
J	Seib, KL; Haag, AF; Oriente, F; Fantappie, L; Borghi, S; Semchenko, EA; Schulz, BL; Ferlicca, F; Taddei, AR; Giuliani, MM; Pizza, M; Delany, I				Seib, Kate L.; Haag, Andreas F.; Oriente, Francesca; Fantappie, Laura; Borghi, Sara; Semchenko, Evgeny A.; Schulz, Benjamin L.; Ferlicca, Francesca; Taddei, Anna Rita; Giuliani, Marzia M.; Pizza, Mariagrazia; Delany, Isabel			The meningococcal vaccine antigen GNA2091 is an analogue of YraP and plays key roles in outer membrane stability and virulence	FASEB JOURNAL			English	Article						Bexsero; 4CMenB; outer membrane; phospholipid; zinc	HEPARIN-BINDING PROTEIN; NEISSERIA-MENINGITIDIS; PHOSPHOLIPID-SYNTHESIS; ESCHERICHIA-COLI; CELL-SEPARATION; GENES; PHOSPHATIDYLETHANOLAMINE; VESICLES; IDENTIFICATION; INVOLVEMENT	GNA2091 is one of the components of the 4-component meningococcal serogroup B vaccine (4CMenB) vaccine and is highly conserved in all meningococcal strains. However, its functional role has not been fully characterized. Here we show that nmb2091 is part of an operon and is cotranscribed with the nmb2089, nmb2090, and nmb2092 adjacent genes, and a similar but reduced operon arrangement is conserved in many other gram-negative bacteria. Deletion of the nmb2091 gene causes an aggregative phenotype with a mild defect in cell separation; differences in the outer membrane composition and phospholipid profile, in particular in the phosphoethanolamine levels; an increased level of outer membrane vesicles; and deregulation of the zinc-responsive genes such as znuD. Finally, the A2091 strain is attenuated with respect to the wild-type strain in competitive index experiments in the infant rat model of meningococcal infection. Altogether these data suggest that GNA2091 plays important roles in outer membrane architecture, biogenesis, homeostasis, and in meningococcal survival in vivo, and a model for its role is discussed. These findings highlight the importance of GNA2091 as a vaccine component.	[Seib, Kate L.; Semchenko, Evgeny A.] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia; [Haag, Andreas F.; Oriente, Francesca; Fantappie, Laura; Borghi, Sara; Ferlicca, Francesca; Giuliani, Marzia M.; Pizza, Mariagrazia; Delany, Isabel] GlaxoSmithKline GSK Vaccines, Siena, Italy; [Schulz, Benjamin L.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Taddei, Anna Rita] Univ Tuscia, Interdept Ctr Electron Microscopy CIME, Tuscia, Italy; [Oriente, Francesca] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Fantappie, Laura] Toscana Life Sci, Siena, Italy; [Borghi, Sara] Rockefeller Univ, Leonard Wagner Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10021 USA	Griffith University; University of Queensland; Tuscia University; University of Glasgow; Rockefeller University	Delany, I (corresponding author), GSK Vaccines, Via Fiorentina 1, I-53100 Siena, Italy.	isabel.x.delany@gsk.com	Haag, Andreas F/R-8775-2019; Seib, Kate L/B-4670-2015	Haag, Andreas F/0000-0002-6783-0231; Seib, Kate L/0000-0002-7094-3528; Semchenko, Evgeny/0000-0002-5188-7946	Australian National Health and Medical Research Council (NHMRC); Marie Curie Fellowship [PIEF-GA-2012328377]; Novartis fellowship from University of Siena (Siena, Italy); Novartis fellowship from University of Bologna (Bologna, Italy); Novartis Vaccines	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Marie Curie Fellowship(European Commission); Novartis fellowship from University of Siena (Siena, Italy); Novartis fellowship from University of Bologna (Bologna, Italy); Novartis Vaccines	K.L.S. was supported by the Australian National Health and Medical Research Council (NHMRC) C. J. Martin Fellowship and Career Development Fellowship. A.F.H. was supported by a Marie Curie Fellowship (PIEF-GA-2012328377). F.O., L.F., and S.B. were recipients of Novartis fellowships from the Ph.D. program of the University of Siena (Siena, Italy) and University of Bologna (Bologna, Italy), respectively. The authors thank Dr. Amanda Nouwens (The University of Queensland, School of Chemistry and Molecular Biosciences Mass Spectrometry Facility) for assistance and expertise. This study was sponsored by Novartis Vaccines, now acquired by the GlaxoSmithKline (GSK) group of companies. F.O., F.F., M.G., M.P., and I.D. are employees of the GSK group of companies. Bexsero is a trademark of the GSK group of companies. This study was sponsored by Novartis Vaccines now acquired by GSK group of companies. Authors have declared the following interests: F.O., F.F., M. M.G., M.P., and I. D. are employees of the GSK group of companies. M.M. G., M.P., and I.D. report ownership of GSK stocks. M.M. G., and M.P. are listed as inventors on patents on vaccine candidates owned by the GSK group of companies. The remaining authors declare no conflicts of interest.	Adu-Bobie J, 2004, INFECT IMMUN, V72, P1914, DOI 10.1128/IAI.72.4.1914-1919.2004; Arenas J, 2013, MOL MICROBIOL, V87, P254, DOI 10.1111/mmi.12097; BARFIELD KD, 1985, BIOCHEM BIOPH RES CO, V128, P389, DOI 10.1016/0006-291X(85)91691-2; Binder H, 2001, BIOPHYS CHEM, V90, P57, DOI 10.1016/S0301-4622(01)00130-2; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bogdanov M, 1998, EMBO J, V17, P5255, DOI 10.1093/emboj/17.18.5255; Bogdanov M, 1999, J BIOL CHEM, V274, P12339, DOI 10.1074/jbc.274.18.12339; BOGDANOV M, 1995, J BIOL CHEM, V270, P732, DOI 10.1074/jbc.270.2.732; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Bos MP, 2014, J BIOL CHEM, V289, P15602, DOI 10.1074/jbc.M113.539510; Brooke JS, 1996, J BACTERIOL, V178, P3339, DOI 10.1128/jb.178.11.3339-3341.1996; Carman GM, 2007, BBA-MOL CELL BIOL L, V1771, P322, DOI 10.1016/j.bbalip.2006.05.006; Delany I, 2006, J BACTERIOL, V188, P2483, DOI 10.1128/JB.188.7.2483-2492.2006; Delany I, 2004, MOL MICROBIOL, V52, P1081, DOI 10.1111/j.1365-2958.2004.04030.x; Donnarumma D, 2015, FASEB J, V29, P2260, DOI 10.1096/fj.14-263954; Dowhan W, 2013, BBA-MOL CELL BIOL L, V1831, P471, DOI 10.1016/j.bbalip.2012.08.007; Echenique-Rivera H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002027; Ekiert DC, 2017, CELL, V169, P273, DOI 10.1016/j.cell.2017.03.019; Ercoli G, 2015, MBIO, V6, DOI 10.1128/mBio.02575-14; Fagnocchi L, 2013, INFECT IMMUN, V81, P560, DOI 10.1128/IAI.01085-12; Fantappie L, 2011, MICROBIOL-SGM, V157, P2235, DOI 10.1099/mic.0.048033-0; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Hadad R, 2012, APMIS, V120, P750, DOI 10.1111/j.1600-0463.2012.02903.x; Hooda Y, 2017, PATHOG DIS, V75, DOI 10.1093/femspd/ftx010; Jacobsson S, 2009, VACCINE, V27, P1579, DOI 10.1016/j.vaccine.2008.12.052; Konovalova A, 2017, ANNU REV MICROBIOL, V71, P539, DOI 10.1146/annurev-micro-090816-093754; Lappann M, 2016, INFECT IMMUN, V84, P3484, DOI 10.1128/IAI.00584-16; Lenz JD, 2016, J BIOL CHEM, V291, P10916, DOI 10.1074/jbc.M116.715573; Malinverni JC, 2009, P NATL ACAD SCI USA, V106, P8009, DOI 10.1073/pnas.0903229106; Metruccio MME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000710; Morris FC, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00829-17; Muzzi A, 2013, MBIO, V4, DOI 10.1128/mBio.00163-13; O'Ryan M, 2014, DRUGS, V74, P15, DOI 10.1007/s40265-013-0155-7; Onufryk C, 2005, J BACTERIOL, V187, P4552, DOI 10.1128/JB.187.13.4552-4561.2005; Patel GJ, 2013, BIOCHEMISTRY-US, V52, P3974, DOI 10.1021/bi400103t; Pawlik MC, 2012, J BACTERIOL, V194, P6594, DOI 10.1128/JB.01091-12; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Rahman MM, 2000, MICROBIOL-UK, V146, P1901, DOI 10.1099/00221287-146-8-1901; Roier S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10515; Seib KL, 2015, EXPERT REV VACCINES, V14, P841, DOI 10.1586/14760584.2015.1016915; Seib KL, 2011, INFECT IMMUN, V79, P970, DOI 10.1128/IAI.00891-10; Seib KL, 2010, VACCINE, V28, P2416, DOI 10.1016/j.vaccine.2009.12.082; Serruto D, 2010, P NATL ACAD SCI USA, V107, P3770, DOI 10.1073/pnas.0915162107; Stephens DS, 2007, FEMS MICROBIOL REV, V31, P3, DOI 10.1111/j.1574-6976.2006.00051.x; Stork M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000969; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Toneatto D, 2017, EXPERT REV VACCINES, V16, P433, DOI 10.1080/14760584.2017.1308828; Tsang MJ, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006888; Vacca I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162878; Vitrac H, 2015, P NATL ACAD SCI USA, V112, P13874, DOI 10.1073/pnas.1512994112; Volokhina EB, 2011, J BACTERIOL, V193, P1612, DOI 10.1128/JB.00532-10; WAI SN, 1995, MICROBIOL IMMUNOL, V39, P451, DOI 10.1111/j.1348-0421.1995.tb02228.x; White T, 1998, ANAL BIOCHEM, V258, P109, DOI 10.1006/abio.1997.2545; Wu HJ, 2006, MOL MICROBIOL, V60, P401, DOI 10.1111/j.1365-2958.2006.05079.x; Yeats C, 2003, TRENDS BIOCHEM SCI, V28, P352, DOI 10.1016/S0968-0004(03)00115-4; YIM HH, 1992, J BACTERIOL, V174, P3637, DOI 10.1128/JB.174.11.3637-3644.1992	56	3	3	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12324	12335		10.1096/fj.201900669R	http://dx.doi.org/10.1096/fj.201900669R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31442078	Green Published, Green Accepted			2022-12-28	WOS:000507461600057
J	Dias, BT; Dias-Teixeira, KL; Godinho, JP; Faria, MS; Calegari-Silva, T; Mukhtar, MM; Lopes, U; Mottram, JC; Lima, APCA				Dias, Bruna T.; Dias-Teixeira, Karina Luisa; Godinho, Joseane P.; Faria, Marilia S.; Calegari-Silva, Teresa; Mukhtar, Maowia M.; Lopes, Ulisses; Mottram, Jeremy C.; Lima, Ana Paula C. A.			Neutrophil elastase promotes Leishmania donovani infection via interferon-beta	FASEB JOURNAL			English	Article						toll; serine protease; inhibitor; ISP	SERINE PEPTIDASES; IMMUNE-RESPONSE; HOST-DEFENSE; MACROPHAGES; INHIBITOR; TLR4; ACTIVATION; EXPRESSION; SURVIVAL	Visceral leishmaniasis is a deadly illness caused by Leishmania donovani that provokes liver and spleen inflammation and tissue destruction. In cutaneous leishmaniasis, the protein of L. major, named inhibitor of serine peptidases (ISP) 2, inactivates neutrophil elastase (NE) present at the macrophage surface, resulting in blockade of TLR4 activation, prevention of TNF-alpha and IFN-beta production, and parasite survival. We report poor intracellular growth of L. donovani in macrophages from knockout mice for NE (ela(-/-)), TLR4, or TLR2. NE and TLR4 colocalized with the parasite in the parasitophorous vacuole. Parasite load in the liver and spleen of ela(-/-) mice were reduced and accompanied by increased NO and decreased TGF-beta production. Expression of ISP2 was not detected in L. donovani, and a transgenic line constitutively expressing ISP2, displayed poor intracellular growth in macrophages and decreased burden in mice. Infected ela(-/-) macrophages displayed significantly lower IFN-beta mRNA than background mice macrophages, and the intracellular growth was fully restored by exogenous IFN-beta. We propose that L. donovani utilizes the host NE-TLR machinery to induce IFN-beta necessary for parasite survival and growth during early infection. Low or absent expression of parasite ISP2 in L. donovani is necessary to preserve the activation of the NE-TLR pathway.-Dias, B. T., Dias-Teixeira, K. L., Godinho, J. P., Faria, M. S., Calegari-Silva, T., Mukhtar, M. M., Lopes, U. G., Mottram, J. C., Lima, A. P. C. A. Neutrophil elastase promotes Leishmania donovani infection via interferon-beta.	[Dias, Bruna T.; Dias-Teixeira, Karina Luisa; Godinho, Joseane P.; Faria, Marilia S.; Calegari-Silva, Teresa; Lopes, Ulisses; Lima, Ana Paula C. A.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Mukhtar, Maowia M.] Ibn Sina Univ, Biosci Res Inst, Khartoum, Sudan; [Mottram, Jeremy C.] Univ York, York Biomed Res Inst, Dept Biol, York, N Yorkshire, England	Universidade Federal do Rio de Janeiro; University of York - UK	Lima, APCA (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Ctr Ciencias Saude, Ave Carlos Chagas Filho 373,Bloco G,Cidade Univ, BR-21941902 Rio De Janeiro, RJ, Brazil.	anapaula@biof.ufrj.br	Dias Teixeira, Karina/J-4918-2017; Lima, Ana Paula CA/G-4122-2012	Dias Teixeira, Karina/0000-0002-6115-6768; 	Medical Reserve Corps (MRC)-Newton [MR/N017269/1]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); United Kingdom Research and Innovation via the Global Challenges Research Fund [MR/P027989/1]; MRC [MR/N017269/1, MR/P027989/1] Funding Source: UKRI	Medical Reserve Corps (MRC)-Newton; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); United Kingdom Research and Innovation via the Global Challenges Research Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Leticia Maneiras (Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro) for technical assistance, Dr. Bernhard Ryffel [Centre de Recherche Scientifique, (CNRS), Orleans, France] for the donation of ela2<SUP>-/-</SUP> mice, and Dr. Marcelo Bozza (Instituto de Microbiologia, Universidade Federal do Rio de Janeiro) for the donation of tlr4<SUP>-/-</SUP> and tlr2<SUP>-/-</SUP> mice. This work was supported by grants from Medical Reserve Corps (MRC)-Newton (MR/N017269/1), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ; to A.P.C.A.L), and from United Kingdom Research and Innovation via the Global Challenges Research Fund under grant agreement "A Global Network for Neglected Tropical Diseases" (MR/P027989/1). A.P.C.A.L. and U.L. are National Council of Scientific and Technological Development (CNPq) fellows. The authors declare no conflicts of interest.	Alam MN, 2018, BIOCHIMIE, V147, P105, DOI 10.1016/j.biochi.2018.01.005; Alam MN, 2016, LIFE SCI, V144, P218, DOI 10.1016/j.lfs.2015.12.004; Albergante L, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003334; Beattie L, 2011, INFECT IMMUN, V79, P1057, DOI 10.1128/IAI.00633-10; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Bergin DA, 2008, J BIOL CHEM, V283, P31736, DOI 10.1074/jbc.M803732200; Devaney JM, 2003, FEBS LETT, V544, P129, DOI 10.1016/S0014-5793(03)00482-4; Eschenlauer SCP, 2009, CELL MICROBIOL, V11, P106, DOI 10.1111/j.1462-5822.2008.01243.x; Faria MS, 2014, FASEB J, V28, P3050, DOI 10.1096/fj.13-245126; Faria Marilia S., 2012, Journal of Parasitology Research, P930257, DOI 10.1155/2012/930257; Faria MS, 2011, J IMMUNOL, V186, P411, DOI 10.4049/jimmunol.1002175; Cezario GAG, 2011, MEM I OSWALDO CRUZ, V106, P573, DOI 10.1590/S0074-02762011000500010; Gomes NA, 2000, J IMMUNOL, V164, P2001, DOI 10.4049/jimmunol.164.4.2001; Goundry A, 2018, FASEB J, V32, P1315, DOI 10.1096/fj.201700797R; Gupta P, 2014, FASEB J, V28, P1756, DOI 10.1096/fj.13-238428; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Karmakar S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002646; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Kaye PM, 2011, CLIN MICROBIOL INFEC, V17, P1462, DOI 10.1111/j.1469-0691.2011.03610.x; Khouri R, 2009, J IMMUNOL, V182, P2525, DOI 10.4049/jimmunol.0802860; McCall LI, 2015, J PROTEOME RES, V14, P1033, DOI 10.1021/pr5010604; Morrison LS, 2012, CELL MICROBIOL, V14, P1271, DOI 10.1111/j.1462-5822.2012.01798.x; Murray HW, 2013, INFECT IMMUN, V81, P2318, DOI 10.1128/IAI.01468-12; Nieto A, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-39; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Ozato K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/jbc.R700003200; Paul J, 2014, INDIAN J BIOCHEM BIO, V51, P531; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Phillips R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000813; Podinovskaia M, 2015, FUTURE MICROBIOL, V10, P111, DOI 10.2217/fmb.14.103; Polando RE, 2018, PARASITE IMMUNOL, V40, DOI 10.1111/pim.12521; Rannikko EH, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0192-0; Ribeiro-Gomes FL, 2007, J IMMUNOL, V179, P3988, DOI 10.4049/jimmunol.179.6.3988; Rossi M, 2017, P NATL ACAD SCI USA, V114, P4987, DOI 10.1073/pnas.1621447114; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Smith DF, 2007, INT J PARASITOL, V37, P1173, DOI 10.1016/j.ijpara.2007.05.015; Srivastav S, 2015, EUR J IMMUNOL, V45, P2787, DOI 10.1002/eji.201445336; Teixeira DE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003594; Verma S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00063; Verma S, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2239-9; Vivarini AD, 2011, FASEB J, V25, P4162, DOI 10.1096/fj.11-185165	41	8	8	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10794	10807		10.1096/fj.201900524R	http://dx.doi.org/10.1096/fj.201900524R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31284755	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000489166300018
J	Hwang, HJ; Yang, YR; Kim, HY; Choi, Y; Park, KS; Lee, H; Ma, JS; Yamamoto, M; Kim, J; Chae, YC; Choi, JH; Cocco, L; Berggren, PO; Jang, HJ; Suh, PG				Hwang, Hyeon-Jeong; Yang, Yong Ryoul; Kim, Hye Yun; Choi, Yoonii; Park, Kyoung-Su; Lee, Ho; Ma, Ji Su; Yamamoto, Masahiro; Kim, Jaeyoon; Chae, Young Chan; Choi, Jang Hyun; Cocco, Lucio; Berggren, Per-Olof; Jang, Hyun-Jun; Suh, Pann-Ghill			Phospholipase C-beta 1 potentiates glucose-stimulated insulin secretion	FASEB JOURNAL			English	Article						GPCR; GSIS; intracellular Ca2+; PLC-beta 1	PANCREATIC BETA-CELLS; PROTEIN-COUPLED RECEPTORS; 5-HYDROXYTRYPTAMINE RELEASE; DEPENDENT ACTIVATION; SIGNALING PATHWAYS; C ISOZYMES; CROSS-TALK; ISLETS; EXPRESSION; RESISTANCE	PLC-beta exerts biologic influences through GPCR. GPCRs are involved in regulating glucose-stimulated insulin secretion (GSIS). Previous studies have suggested that PLC-beta s might play an important role in pancreatic beta cells. However, because of a lack of the specific inhibitors of PLC-beta isozymes and appropriate genetic models, the in vivo function of specific PLC-beta isozymes in pancreatic beta cells and their physiologic relevance in the regulation of insulin secretion have not been studied so far. The present study showed that PLC-beta 1 was crucial for beta-cell function by generation of each PLC-beta conditional knockout mouse. Mice lacking PLC-beta 1 in beta cells exhibited a marked defect in GSIS, leading to glucose intolerance. In ex vivo studies, the secreted insulin level and Ca2+ response in Plcb1(f/f); pancreas/duodenum homeobox protein 1 (Pdx1)-Cre recombinase-estrogen receptor T2 (CreERt2) islets was lower than those in the Plcb1(f/f) islets under the high-glucose condition. PLC-beta 1 led to potentiate insulin secretion via stimulation of particular G(q)-protein-coupled receptors. Plcb1(f/f); Pdx1-CreERt2 mice fed a high-fat diet developed more severe glucose intolerance because of a defect in insulin secretion. The present study identified PLC-beta 1 as an important molecule that regulates beta cell insulin secretion and can be considered a candidate for therapeutic intervention in diabetes mellitus.-Hwang, H.-J., Yang, Y. R., Kim, H. Y., Choi, Y., Park, K.-S., Lee, H., Ma, J. S., Yamamoto, M., Kim, J., Chae, Y. C., Choi, J. H., Cocco, L., Berggren, P.-O., Jang, H.-J., Suh, P.-G. Phospholipase C beta 1 potentiates glucose-stimulated insulin secretion.	[Hwang, Hyeon-Jeong; Kim, Hye Yun; Choi, Yoonii; Park, Kyoung-Su; Chae, Young Chan; Choi, Jang Hyun; Jang, Hyun-Jun; Suh, Pann-Ghill] Ulsan Natl Inst Sci & Technol, Sch Life Sci, 50 UNIST Gil, Ulsan, South Korea; [Choi, Jang Hyun] Ulsan Natl Inst Sci & Technol, Korea Mouse Phenotyping Ctr, Ulsan, South Korea; [Yang, Yong Ryoul] Korea Res Inst Biosci & Biotechnol, Aging Res Ctr, Daejeon, South Korea; [Lee, Ho] Natl Canc Ctr, Canc Expt Resources Branch, Goyang Si, South Korea; [Ma, Ji Su; Yamamoto, Masahiro] Osaka Univ, Res Inst Microbial Dis, Dept Immunoparasitol, Suita, Osaka, Japan; [Kim, Jaeyoon; Berggren, Per-Olof] Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, Dept Mol Med & Surg, Stockholm, Sweden; [Kim, Jaeyoon; Berggren, Per-Olof] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, South Korea; [Cocco, Lucio] Univ Bologna, Dept Biomed Sci, Signalling Lab, Bologna, Italy	Ulsan National Institute of Science & Technology (UNIST); Ulsan National Institute of Science & Technology (UNIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); National Cancer Center - Korea (NCC); Osaka University; Karolinska Institutet; Pohang University of Science & Technology (POSTECH); University of Bologna	Jang, HJ; Suh, PG (corresponding author), Ulsan Natl Inst Sci & Technol, Sch Life Sci, 50 UNIST Gil, Ulsan, South Korea.	hyunjun86@unist.ac.kr; pgsuh@unist.ac.kr	Cocco, Lucio/AAI-2206-2020	Cocco, Lucio/0000-0002-9206-8277; Berggren, Per-Olof/0000-0001-8991-413X	Bio and Medical Technology Development Program of the National Research Foundation (NRF) [NRF-2014M3A9D8034456, NRF-2017R1E1A1A01074510]; Korea Mouse Phenotyping Project of the Ministry of Science and Information and Communications Technology (ICT) through the NRF [2016M3A9D5A01952411]	Bio and Medical Technology Development Program of the National Research Foundation (NRF); Korea Mouse Phenotyping Project of the Ministry of Science and Information and Communications Technology (ICT) through the NRF	The authors thank Prof. Jun-Ichi Miyazaki (Osaka University, Suita, Japan) for the gift of mouse pancreatic beta-cell line MIN6; Il Shin Kim, Jeong Woo Shin, and Dohee Kim [all from Ulsan national Institute of Science (UNIST)-Optical Biomed Imaging Center] for help with mice; and Jin-Hoe Hur and Hong-Chan Jung (both from UNIST-Optical Biomed Imaging Center) for technical help. This work was supported by a grant from the Bio and Medical Technology Development Program of the National Research Foundation (NRF) (NRF-2014M3A9D8034456 and NRF-2017R1E1A1A01074510) and by Korea Mouse Phenotyping Project (2016M3A9D5A01952411) of the Ministry of Science and Information and Communications Technology (ICT) through the NRF. The authors declare no conflicts of interest.	Adamski FM, 1999, BBA-GENE STRUCT EXPR, V1444, P55, DOI 10.1016/S0167-4781(98)00260-7; Barbour LA, 2007, DIABETES CARE, V30, pS112, DOI 10.2337/dc07-s202; Berggren PO, 2004, CELL, V119, P273, DOI 10.1016/j.cell.2004.09.033; BIDEN TJ, 1987, J BIOL CHEM, V262, P3567; Blad CC, 2012, NAT REV DRUG DISCOV, V11, P603, DOI 10.1038/nrd3777; Bunney TD, 2011, TRENDS BIOCHEM SCI, V36, P88, DOI 10.1016/j.tibs.2010.08.003; Doyle ME, 2003, PHARMACOL REV, V55, P105, DOI 10.1124/pr.55.1.7; FEHMANN HC, 1990, FEBS LETT, V262, P279, DOI 10.1016/0014-5793(90)80210-A; Fiume R, 2012, FASEB J, V26, P203, DOI 10.1096/fj.11-186510; Fridlyand LE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152869; Gorogawa S, 2004, BIOCHEM BIOPH RES CO, V319, P1159, DOI 10.1016/j.bbrc.2004.05.095; Guillausseau PJ, 2008, DIABETES METAB, V34, pS43, DOI 10.1016/S1262-3636(08)73394-9; GYLFE E, 1978, J ENDOCRINOL, V78, P239, DOI 10.1677/joe.0.0780239; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hezel AF, 2008, MOL CELL BIOL, V28, P2414, DOI 10.1128/MCB.01621-07; HOMMA Y, 1989, BIOCHEM BIOPH RES CO, V164, P406, DOI 10.1016/0006-291X(89)91734-8; HUTTON JC, 1983, BIOCHEM J, V210, P297, DOI 10.1042/bj2100297; JHON DY, 1993, J BIOL CHEM, V268, P6654; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Kim JK, 2012, J BIOL CHEM, V287, P21012, DOI 10.1074/jbc.M111.337865; Kim MJ, 2001, PANCREAS, V22, P47, DOI 10.1097/00006676-200101000-00008; Kim SS, 2001, EXP MOL MED, V33, P164, DOI 10.1038/emm.2001.28; Kong KC, 2010, P NATL ACAD SCI USA, V107, P21181, DOI 10.1073/pnas.1011651107; Kyriazis GA, 2012, P NATL ACAD SCI USA, V109, pE524, DOI 10.1073/pnas.1115183109; Lee YS, 2013, CELL, V153, P413, DOI 10.1016/j.cell.2013.03.001; Liu DY, 2008, HYPERTENS RES, V31, P1989, DOI 10.1291/hypres.31.1989; Malbon CC, 2004, BIOCHEM J, V379, P1, DOI 10.1042/BJ20031648; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; Meszaros JG, 2000, AM J PHYSIOL-CELL PH, V278, pC154, DOI 10.1152/ajpcell.2000.278.1.C154; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; MONTAGUE W, 1985, BIOCHEM J, V227, P483, DOI 10.1042/bj2270483; Navarro G, 2016, CELL METAB, V23, P837, DOI 10.1016/j.cmet.2016.03.015; Ning SL, 2015, BRIT J PHARMACOL, V172, P5050, DOI 10.1111/bph.13271; Ohara-Imaizumi M, 2013, P NATL ACAD SCI USA, V110, P19420, DOI 10.1073/pnas.1310953110; Olokoba Abdulfatai B, 2012, Oman Med J, V27, P269, DOI 10.5001/omj.2012.68; PARK D, 1992, J BIOL CHEM, V267, P16048; Ryzhov S, 2006, MOL PHARMACOL, V70, P727, DOI 10.1124/mol.106.022780; Sassmann A, 2010, J CLIN INVEST, V120, P2184, DOI 10.1172/JCI41541; Schraenen A, 2010, DIABETOLOGIA, V53, P2589, DOI 10.1007/s00125-010-1913-7; Shang WB, 2002, PANCREAS, V25, P393, DOI 10.1097/00006676-200211000-00012; Shirakawa O, 2001, PROG NEURO-PSYCHOPH, V25, P867, DOI 10.1016/S0278-5846(01)00149-X; Smith PA, 1999, J PHYSIOL-LONDON, V521, P651, DOI 10.1111/j.1469-7793.1999.00651.x; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Thore S, 2005, J CELL SCI, V118, P4463, DOI 10.1242/jcs.02577; Tian YR, 2001, DIABETES, V50, P2505, DOI 10.2337/diabetes.50.11.2505; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Winzell MS, 2007, PHARMACOL THERAPEUT, V116, P437, DOI 10.1016/j.pharmthera.2007.08.002; WOLF BA, 1988, J BIOL CHEM, V263, P3565; Xie LH, 1999, P NATL ACAD SCI USA, V96, P15292, DOI 10.1073/pnas.96.26.15292; Xuan SH, 2002, J CLIN INVEST, V110, P1011, DOI 10.1172/JCI200215276; Yamada H, 2016, SCI REP-UK, V6, DOI 10.1038/srep25912; Yang Yong Ryoul, 2013, Advances in Biological Regulation, V53, P232, DOI 10.1016/j.jbior.2013.08.003; ZAWALICH WS, 1995, ENDOCRINOLOGY, V136, P4903, DOI 10.1210/en.136.11.4903	55	12	13	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10668	10679		10.1096/fj.201802732RR	http://dx.doi.org/10.1096/fj.201802732RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31268747				2022-12-28	WOS:000489166300008
J	Jana, A; Nookaew, I; Singh, J; Behkam, B; Franco, AT; Nain, AS				Jana, Aniket; Nookaew, Intawat; Singh, Jugroop; Behkam, Bahareh; Franco, Aime T.; Nain, Amrinder S.			Crosshatch nanofiber networks of tunable interfiber spacing induce plasticity in cell migration and cytoskeletal response	FASEB JOURNAL			English	Article						persistent cell migration; 2D migration; 3D migration; nucleus geometry; cell-ECM interaction	NANONET FORCE MICROSCOPY; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; ACTIN CYTOSKELETON; ALIGNED NANOFIBERS; COLLAGEN-FIBERS; TISSUE; DYNAMICS; ADHESION; MECHANICS	Biomechanical cues within tissue microenvironments are critical for maintaining homeostasis, and their disruption can contribute to malignant transformation and metastasis. Once transformed, metastatic cancer cells can migrate persistently by adapting (plasticity) to changes in the local fibrous extracellular matrix, and current strategies to recapitulate persistent migration rely exclusively on the use of aligned geometries. Here, the controlled interfiber spacing in suspended crosshatch networks of nanofibers induces cells to exhibit plasticity in migratory behavior (persistent and random) and the associated cytoskeletal arrangement. At dense spacing (3 and 6 mu m), unexpectedly, elongated cells migrate persistently (in 1 dimension) at high speeds in 3-dimensional shapes with thick nuclei, and short focal adhesion cluster (FAC) lengths. With increased spacing (18 and 36 mu m), cells attain 2-dimensional morphologies, have flattened nuclei and longer FACs, and migrate randomly by rapidly detaching their trailing edges that strain the nuclei by similar to 35%. At 54-mu m spacing, kite-shaped cells become near stationary. Poorly developed filamentous actin stress fibers are found only in cells on 3-mu m networks. Gene-expression profiling shows a decrease in transcriptional potential and a differential up-regulation of metabolic pathways. The consistency in observed phenotypes across cell lines supports using this platform to dissect hallmarks of plasticity in migration in vitro.-Jana, A., Nookaew, I., Singh, J., Behkam, B., Franco, A. T., Nain, A. S. Crosshatch nanofiber networks of tunable interfiber spacing induce plasticity in cell migration and cytoskeletal response.	[Jana, Aniket; Behkam, Bahareh; Nain, Amrinder S.] Virginia Polytech Inst & State Univ, Dept Mech Engn, Blacksburg, VA 24061 USA; [Singh, Jugroop; Behkam, Bahareh; Nain, Amrinder S.] Virginia Polytech Inst & State Univ, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA; [Nookaew, Intawat; Franco, Aime T.] Univ Arkansas Med Sci, Coll Med, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [Nookaew, Intawat] Univ Arkansas Med Sci, Dept Biomed Informat, Little Rock, AR 72205 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Nain, AS (corresponding author), Virginia Tech, MC 0710,Randolph Hall, Blacksburg, VA 24061 USA.	nain@vt.edu		Jana, Aniket/0000-0003-2830-8210; Franco, Aime/0000-0002-1677-5228	Institute of Critical Technologies and Sciences (ICTAS) at Virginia Tech; National Science Foundation (NSF) [1437101, 1462916]; NSF [1454226]; U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) [P20GM125503]; U.S. NIH National Cancer Institute (NCI) [R01CA214511-01A1]; American Thyroid Association Thyroid Cancer Survivors Association (ThyCa); NATIONAL CANCER INSTITUTE [R01CA214511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM125503] Funding Source: NIH RePORTER	Institute of Critical Technologies and Sciences (ICTAS) at Virginia Tech; National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS); U.S. NIH National Cancer Institute (NCI); American Thyroid Association Thyroid Cancer Survivors Association (ThyCa); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.S.N. thanks the late Patricia Keely (University of Wisconsin-Madison, WI) for discussions and guidance on cell biology and dedicates this manuscript in her memory. A.S.N. also thanks Julie Phillippi and Thomas Gleason at University of Pittsburgh School of Medicine (Pittsburgh, PA, USA) for providing smooth muscle cells. A.J. and A.S.N. thank members of the Spinneret-based Tunable Engineering Parameters (STEP) Laboratory, Virginia Polytechnic Institute and State University (Virginia Tech), for helpful suggestions and discussions. The authors thank the Institute of Critical Technologies and Sciences (ICTAS) at Virginia Tech for the support to conduct this study. This work is supported by the National Science Foundation (NSF) (Grants 1437101 and 1462916 awarded to A.S.N.), the NSF Faculty Early Career Development Program (CAREER) (Grant 1454226 to B.B.), the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) (Grant P20GM125503 to I.N.), the U.S. NIH National Cancer Institute (NCI) (Grant R01CA214511-01A1 to A.T.F.), and an American Thyroid Association Thyroid Cancer Survivors Association (ThyCa) research grant to A.T.F. The authors declare no conflicts of interest.	Andresen V, 2009, CURR OPIN BIOTECH, V20, P54, DOI 10.1016/j.copbio.2009.02.008; Aubin H, 2010, BIOMATERIALS, V31, P6941, DOI 10.1016/j.biomaterials.2010.05.056; Biela SA, 2009, ACTA BIOMATER, V5, P2460, DOI 10.1016/j.actbio.2009.04.003; Bischofs IB, 2008, BIOPHYS J, V95, P3488, DOI 10.1529/biophysj.108.134296; Bredfeldt JS, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.016007; Charras G, 2014, NAT REV MOL CELL BIO, V15, P813, DOI 10.1038/nrm3897; Chen B, 2013, SCI REP-UK, V3, DOI 10.1038/srep02827; CHEN WT, 1981, J CELL BIOL, V90, P187, DOI 10.1083/jcb.90.1.187; Clark AG, 2015, CURR OPIN CELL BIOL, V36, P13, DOI 10.1016/j.ceb.2015.06.004; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058; Dalton BA, 2001, J BIOMED MATER RES, V56, P195, DOI 10.1002/1097-4636(200108)56:2<195::AID-JBM1084>3.0.CO;2-7; DICKINSON RB, 1994, ANN BIOMED ENG, V22, P342, DOI 10.1007/BF02368241; Dieterich P, 2008, P NATL ACAD SCI USA, V105, P459, DOI 10.1073/pnas.0707603105; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Fernandez M, 2002, PHYS MED BIOL, V47, P577, DOI 10.1088/0031-9155/47/4/303; Fraley SI, 2015, SCI REP-UK, V5, DOI 10.1038/srep14580; Friedl P, 2012, NAT REV MOL CELL BIO, V13, P743, DOI 10.1038/nrm3459; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Gilkes DM, 2014, NAT REV CANCER, V14, P430, DOI 10.1038/nrc3726; Glentis A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00985-8; Grantab R, 2006, CANCER RES, V66, P1033, DOI 10.1158/0008-5472.CAN-05-3077; Gritsenko PG, 2012, J PATHOL, V226, P185, DOI 10.1002/path.3031; Hakkinen KM, 2011, TISSUE ENG PT A, V17, P713, DOI 10.1089/ten.TEA.2010.0273; Hall A, 2017, MOL BIOL CELL, V28, P1894, DOI 10.1091/mbc.E17-01-0053; Han WJ, 2016, P NATL ACAD SCI USA, V113, P11208, DOI 10.1073/pnas.1610347113; Hung WC, 2013, J CELL BIOL, V202, P807, DOI 10.1083/jcb.201302132; Jolly LA, 2016, CANCER RES, V76, P1804, DOI 10.1158/0008-5472.CAN-15-2351; Kaiser JP, 2006, BIOMATERIALS, V27, P5230, DOI 10.1016/j.biomaterials.2006.06.002; Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062; Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042; Kim DH, 2009, ADV FUNCT MATER, V19, P1579, DOI 10.1002/adfm.200801174; Kim DH, 2014, J CELL SCI, V127, P2528, DOI 10.1242/jcs.144345; Kim DH, 2013, FASEB J, V27, P1351, DOI 10.1096/fj.12-220160; Ko YG, 2013, BIOMATERIALS, V34, P353, DOI 10.1016/j.biomaterials.2012.09.071; Koons B, 2017, ACS NANO, V11, P12037, DOI 10.1021/acsnano.7b04567; Kutys ML, 2014, NAT CELL BIOL, V16, P909, DOI 10.1038/ncb3026; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li S, 2001, BIORHEOLOGY, V38, P101; Liliensiek SJ, 2009, TISSUE ENG PT A, V15, P2643, DOI [10.1089/ten.tea.2008.0284, 10.1089/ten.TEA.2008.0284]; Liu QF, 2017, CANCER CELL INT, V17, DOI 10.1186/s12935-017-0437-3; Lohela M, 2010, CURR OPIN GENET DEV, V20, P72, DOI 10.1016/j.gde.2009.10.011; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; McClendon MT, 2012, BIOMATERIALS, V33, P5713, DOI 10.1016/j.biomaterials.2012.04.040; Meehan S, 2014, BIOPHYS J, V107, P2604, DOI 10.1016/j.bpj.2014.09.045; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Metzner C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8516; Mukherjee RN, 2016, NUCLEUS-PHILA, V7, P167, DOI 10.1080/19491034.2016.1162933; Nain AS, 2008, SMALL, V4, P1153, DOI 10.1002/smll.200800101; Netti PA, 2000, CANCER RES, V60, P2497; Nisenholz N, 2014, SOFT MATTER, V10, P7234, DOI 10.1039/c4sm00780h; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; Park J, 2018, BIOPHYS J, V114, P1257, DOI 10.1016/j.bpj.2017.11.3813; Passucci G, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006732; Pathak A, 2012, P NATL ACAD SCI USA, V109, P10334, DOI 10.1073/pnas.1118073109; Paul CD, 2017, NAT REV CANCER, V17, P131, DOI 10.1038/nrc.2016.123; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Phillippi JA, 2009, CIRCULATION, V119, P2498, DOI 10.1161/CIRCULATIONAHA.108.770776; Pickup MW, 2014, EMBO REP, V15, P1243, DOI 10.15252/embr.201439246; Reinhart-King CA, 2005, BIOPHYS J, V89, P676, DOI 10.1529/biophysj.104.054320; Riching KM, 2014, BIOPHYS J, V107, P2546, DOI 10.1016/j.bpj.2014.10.035; Sharma P, 2017, MOL BIOL CELL, V28, P2579, DOI 10.1091/mbc.E17-05-0305; Sharma P, 2013, INTEGR BIOL-UK, V5, P1036, DOI 10.1039/c3ib40073e; Sheets K, 2016, BIOPHYS J, V111, P197, DOI 10.1016/j.bpj.2016.05.031; Sheets K, 2013, ACTA BIOMATER, V9, P7169, DOI 10.1016/j.actbio.2013.03.042; Shen MH, 2018, FRONT MED-PRC, V12, P426, DOI 10.1007/s11684-018-0663-7; Starke J, 2014, BIOCHEM SOC T, V42, P1356, DOI 10.1042/BST20140139; STOKES CL, 1991, J CELL SCI, V99, P419; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Swaminathan V, 2011, CANCER RES, V71, P5075, DOI 10.1158/0008-5472.CAN-11-0247; Taylor EN, 2015, BIOPHYS J, V108, P2740, DOI 10.1016/j.bpj.2015.03.061; Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150; Ushiki T, 2002, ARCH HISTOL CYTOL, V65, P109, DOI 10.1679/aohc.65.109; van Helvert S, 2018, NAT CELL BIOL, V20, P8, DOI 10.1038/s41556-017-0012-0; Varemo L, 2013, NUCLEIC ACIDS RES, V41, P4378, DOI 10.1093/nar/gkt111; Versaevel M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1668; Wang J, 2014, LANGMUIR, V30, P13641, DOI 10.1021/la503011u; Weigelin Bettina, 2012, Intravital, V1, P32, DOI 10.4161/intv.21223; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Wong IY, 2014, NAT MATER, V13, P1063, DOI [10.1038/nmat4062, 10.1038/NMAT4062]; Woringer M, 2014, CURR OPIN CHEM BIOL, V20, P112, DOI 10.1016/j.cbpa.2014.05.009; Wu PH, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2015.030; Wu PH, 2014, P NATL ACAD SCI USA, V111, P3949, DOI 10.1073/pnas.1318967111; Xu WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046609; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430; Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799	91	18	18	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10618	10632		10.1096/fj.201900131R	http://dx.doi.org/10.1096/fj.201900131R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31225977	Green Published, Bronze			2022-12-28	WOS:000489166300005
J	Govers, LC; Phillips, TR; Mattiske, DM; Rashoo, N; Black, JR; Sinclair, A; Baskin, LS; Risbridger, GP; Pask, AJ				Govers, Luke C.; Phillips, Tiffany R.; Mattiske, Deidre M.; Rashoo, Nineveh; Black, Jay R.; Sinclair, Adriane; Baskin, Laurence S.; Risbridger, Gail P.; Pask, Andrew J.			A critical role for estrogen signaling in penis development	FASEB JOURNAL			English	Article						hypospadias; urethral closure alpha ERKO; exogenous estrogen	MALE REPRODUCTIVE HEALTH; EXTERNAL GENITALIA; RECEPTOR-ALPHA; MOLECULAR-MECHANISMS; FEMALE MOUSE; HYPOSPADIAS; DIETHYLSTILBESTROL; BETA; DISRUPTION; EXPRESSION	Hypospadias, a developmental defect of the penis, is one of the most common congenital malformations in humans. Its incidence has rapidly increased over recent decades, and this has been largely attributed to our increased exposure to endocrine-disrupting chemicals. Penis development is primarily an androgen-driven process; however, estrogen and xenoestrogens are known to affect penis development in both humans and mice. Here, we investigated the role of estrogen in the developing penis. Using a novel penis culture system, we showed that exogenous estrogen directly targets the developing penis in utero to cause hypospadias. In addition, we also uncovered an unexpected endogenous role for estrogen in normal postnatal penis development and showed that a loss of estrogen signaling results in a mild hypospadias phenotype, the most common manifestation of this disease in humans. Our findings demonstrated that both androgen and estrogen signaling are intrinsically required for normal urethral closure. These findings confirmed that penis development is not an entirely androgen-driven process but one in which endogenous estrogen signaling also plays a critical role.-Govers, L. C., Phillips, T. R., Mattiske, D. M., Rashoo, N., Black, J. R., Sinclair, A., Baskin, L. S., Risbridger, G. P., Pask, A. J. A critical role for estrogen signaling in penis development.	[Govers, Luke C.; Phillips, Tiffany R.; Mattiske, Deidre M.; Rashoo, Nineveh; Pask, Andrew J.] Univ Melbourne, Sch BioSci, Melbourne, Vic 3010, Australia; [Black, Jay R.] Univ Melbourne, Sch Earth Sci, Melbourne, Vic, Australia; [Sinclair, Adriane; Baskin, Laurence S.] Univ Calif San Francisco, Benioff Childrens Hosp, Div Pediat Urol, San Francisco, CA 94143 USA; [Risbridger, Gail P.] Monash Univ, Monash Biomed Discovery Inst, Melbourne, Vic, Australia; [Risbridger, Gail P.] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne; University of California System; University of California San Francisco; Monash University; Monash University	Pask, AJ (corresponding author), Univ Melbourne, Sch BioSci, Melbourne, Vic 3010, Australia.	ajpask@unimelb.edu.au	Risbridger, Gail P/B-8655-2008; Phillips, Tiffany/AAB-8067-2019; Black, Jay/K-3705-2013	Risbridger, Gail P/0000-0003-3089-4028; Phillips, Tiffany/0000-0001-6920-7710; Black, Jay/0000-0003-1872-9345; Pask, Andrew/0000-0002-1900-2263	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Grant [R01DK096263]; National Health and Medical Research Council of Australia [APP1098480]	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Grant; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The authors acknowledge technical support by the Melbourne Trace Analysis for Chemical, Earth, and Environmental Sciences (TrACEES) Platform for access to the GE Phoenix Nanotom M Micro-CT instrument. Research reported in this publication was supported by the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Grant R01DK096263 (to A.J.P.), and by the National Health and Medical Research Council of Australia Project Grant APP1098480 (to G.P.R. and A.J.P.). The authors declare no conflicts of interest.	Abney TO, 1999, STEROIDS, V64, P610, DOI 10.1016/S0039-128X(99)00041-0; Agras K, 2007, J UROLOGY, V177, P2386, DOI 10.1016/j.juro.2007.01.111; Ban S, 2008, HUM REPROD, V23, P1466, DOI 10.1093/humrep/den098; Beleza-Meireles A, 2006, J ENDOCRINOL INVEST, V29, P5, DOI 10.1007/BF03349170; Beleza-Meireles A, 2007, J CLIN ENDOCR METAB, V92, P3712, DOI 10.1210/jc.2007-0543; Blaschko SD, 2013, ANAT REC, V296, P1127, DOI 10.1002/ar.22708; Blaschko SD, 2012, DIFFERENTIATION, V84, P261, DOI 10.1016/j.diff.2012.06.003; Buckanan DL, 1998, ENDOCRINOLOGY, V139, P4345, DOI 10.1210/en.139.10.4345; Carmichael SL, 2012, BIRTH DEFECTS RES A, V94, P499, DOI 10.1002/bdra.23021; Choudhry S, 2015, J UROLOGY, V193, P1625, DOI 10.1016/j.juro.2014.11.087; COUSE JF, 1995, MOL ENDOCRINOL, V9, P1441, DOI 10.1210/me.9.11.1441; Crescioli C, 2003, J CLIN ENDOCR METAB, V88, P1815, DOI 10.1210/jc.2002-021085; Cunha GR, 2014, DIFFERENTIATION, V87, P4, DOI 10.1016/j.diff.2013.12.003; Deng CK, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2288-0; Dietrich W, 2004, J HISTOCHEM CYTOCHEM, V52, P355, DOI 10.1177/002215540405200306; Fernandez MF, 2016, REPROD TOXICOL, V59, P89, DOI 10.1016/j.reprotox.2015.11.002; Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025; Giordano F, 2010, BIRTH DEFECTS RES A, V88, P241, DOI 10.1002/bdra.20657; Goyal HO, 2004, BIOL REPROD, V70, P1504, DOI 10.1095/biolreprod.103.026328; Hynes PJ, 2004, BRIT J PLAST SURG, V57, P203, DOI 10.1016/j.bjps.2003.08.017; Jesmin S, 2004, J MOL ENDOCRINOL, V33, P343, DOI 10.1677/jme.1.01548; Jesmin S, 2002, ENDOCRINOLOGY, V143, P4764, DOI 10.1210/en.2002-220628; JONES TM, 1978, J CLIN ENDOCR METAB, V47, P1368, DOI 10.1210/jcem-47-6-1368; Kalfa N, 2015, EUR UROL, V68, P1023, DOI 10.1016/j.eururo.2015.05.008; Klip H, 2002, LANCET, V359, P1102, DOI 10.1016/S0140-6736(02)08152-7; Kojima Y, 2002, J UROLOGY, V167, P1532, DOI 10.1016/S0022-5347(05)65358-X; Korach KS, 2003, J STEROID BIOCHEM, V86, P387, DOI 10.1016/S0960-0760(03)00348-0; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Ma LM, 2009, J UROLOGY, V182, P2511, DOI 10.1016/j.juro.2009.07.008; Mahawong P, 2014, DIFFERENTIATION, V88, P70, DOI 10.1016/j.diff.2014.09.004; Mahawong P, 2014, DIFFERENTIATION, V88, P51, DOI 10.1016/j.diff.2014.09.005; Miyagawa S, 2002, ANAT RECORD, V266, P43, DOI 10.1002/ar.10033; Morales-Suarez-Varela MM, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-3; MURAKAMI R, 1987, J ANAT, V153, P223; Ogino Y, 2001, ANN NY ACAD SCI, V948, P13; Paulozzi LJ, 1999, ENVIRON HEALTH PERSP, V107, P297, DOI 10.2307/3434597; Paulozzi LJ, 1997, PEDIATRICS, V100, P831, DOI 10.1542/peds.100.5.831; Phillips TR, 2015, SEX DEV, V9, P162, DOI 10.1159/000431010; Qiao L, 2012, J UROLOGY, V187, P1427, DOI 10.1016/j.juro.2011.12.008; Rodriguez E, 2012, DIFFERENTIATION, V84, P269, DOI 10.1016/j.diff.2012.07.003; Rodriguez E, 2011, BIOL REPROD, V85, P1216, DOI 10.1095/biolreprod.111.091504; Schlatt S, 1999, CELL TISSUE RES, V298, P335, DOI 10.1007/s004419900084; Schlomer BJ, 2013, J UROLOGY, V190, P1610, DOI 10.1016/j.juro.2013.02.3198; Schneuer FJ, 2015, ARCH DIS CHILD, V100, P1038, DOI 10.1136/archdischild-2015-308809; Scott S, 1999, MALE AND FEMALE CIRCUMCISION, P9, DOI 10.1007/978-0-585-39937-9_2; Skakkebaek NE, 2016, PHYSIOL REV, V96, P55, DOI 10.1152/physrev.00017.2015; Stewart MK, 2018, BIOL REPROD, V99, P1184, DOI 10.1093/biolre/ioy142; Syed F, 2005, BIOCHEM BIOPH RES CO, V328, P688, DOI 10.1016/j.bbrc.2004.11.097; Tannour-Louet M, 2014, NAT MED, V20, P715, DOI 10.1038/nm.3580; Toppari J, 1996, ENVIRON HEALTH PERSP, V104, P741, DOI 10.2307/3432709; Uda A, 2004, J UROLOGY, V171, P1362, DOI 10.1097/01.ju.0000100140.42618.54; van der Zanden LFM, 2010, J CLIN ENDOCR METAB, V95, P2384, DOI 10.1210/jc.2009-2101; Vignozzi L, 2004, ENDOCRINOLOGY, V145, P1823, DOI 10.1210/en.2003-0962; Vilela MLB, 2007, UROLOGY, V70, P618, DOI 10.1016/j.urology.2007.05.004; Watanabe M, 2007, HUM REPROD, V22, P1279, DOI 10.1093/humrep/del513; WILSON JD, 1981, HUM GENET, V58, P78, DOI 10.1007/BF00284153; Winston JJ, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0161-9; Yamada G, 2003, DIFFERENTIATION, V71, P445, DOI 10.1046/j.1432-0436.2003.7108001.x; Zheng ZG, 2015, P NATL ACAD SCI USA, V112, pE7194, DOI 10.1073/pnas.1515981112	59	19	19	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10383	10392		10.1096/fj.201802586RR	http://dx.doi.org/10.1096/fj.201802586RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31225966	Green Published			2022-12-28	WOS:000482214200053
J	Lv, XM; He, CB; Huang, C; Wang, HB; Hua, GH; Wang, ZF; Zhou, J; Chen, XC; Ma, BW; Timm, BK; Maclin, V; Dong, JX; Rueda, BR; Davis, JS; Wang, C				Lv, Xiangmin; He, Chunbo; Huang, Cong; Wang, Hongbo; Hua, Guohua; Wang, Zhengfeng; Zhou, Jin; Chen, Xingcheng; Ma, Bowen; Timm, Barbara K.; Maclin, Victoria; Dong, Jixin; Rueda, Bo R.; Davis, John S.; Wang, Cheng			Timely expression and activation of YAP1 in granulosa cells is essential for ovarian follicle development	FASEB JOURNAL			English	Article						Hippo pathway; Yes-Associated Protein 1; Steroidogenesis; fertility	EPIDERMAL-GROWTH-FACTOR; HIPPO SIGNALING PATHWAY; YES-ASSOCIATED PROTEIN; ORGAN SIZE CONTROL; FACTOR NETWORK; SELF-RENEWAL; STEM-CELLS; TGF-BETA; DIFFERENTIATION; PROLIFERATION	Although the role of the Hippo signaling pathway in development and tumorigenesis has been extensively studied in multiple organs, its role in ovarian follicle development remains largely unknown. Here, we report that Yes-Associated Protein 1 (YAP1), the major effector of Hippo signaling, is spatiotemporally expressed in ovarian granulosa cells and plays a critical role in the regulation of follicle development. We found that the active form of YAP1 (nuclear YAP1) was predominantly expressed in proliferative granulosa cells, whereas the inactive form of YAP1 (cytoplasmic YAP1) was mainly detected in luteal cells (terminally differentiated granulosa cells). Pharmacological inhibition of YAP1 activity disrupted mouse ovarian follicle development in vitro and in vivo. Foxl2 promoter-driven knockout of Yap1 in ovarian granulosa cells resulted in increased apoptosis of granulosa cells, decreased number of corpora lutea, reduced ovarian size, and subfertility in transgenic mice. However, Cyp19a1 promoter-driven knockout of Yap1 in differentiated granulosa cells of preovulatory follicles and luteal cells of corpora lutea had no effect on ovarian morphology and fertility. Mechanistic studies demonstrated that YAP1 interacted with epidermal growth factor receptor and TGF-beta signaling pathways to regulate granulosa cell proliferation, differentiation, and survival. Results from this study identify YAP1 as a critical regulator of granulosa cell proliferation and differentiation. Balanced expression and activation of YAP1 is essential for follicle development and successful reproduction. YAP1 is a promising target for treatment of subfertility associated with abnormal granulosa cell function.-Lv, X., He, C., Huang, C., Wang, H., Hua, G., Wang, Z., Zhou, J., Chen, X., Ma, B., Timm, B. K., Maclin, V., Dong, J., Rueda, B. R., Davis, J. S., Wang, C. Timely expression and activation of YAP1 in granulosa cells is essential for ovarian follicle development.	[Lv, Xiangmin; He, Chunbo; Huang, Cong; Wang, Hongbo; Rueda, Bo R.; Wang, Cheng] Harvard Med Sch, Massachusetts Gen Hosp, Dept Obstet & Gynecol, Vincent Ctr Reprod Biol, Boston, MA 02114 USA; [Lv, Xiangmin; He, Chunbo; Hua, Guohua; Wang, Zhengfeng; Zhou, Jin; Ma, Bowen; Davis, John S.; Wang, Cheng] Univ Nebraska Med Ctr, Olson Ctr Womens Hlth, Dept Obstet & Gynecol, Omaha, NE USA; [Chen, Xingcheng; Dong, Jixin] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE USA; [Chen, Xingcheng] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [He, Chunbo; Hua, Guohua] Huazhong Agr Univ, Coll Anim Sci & Vet Med, Wuhan, Hubei, Peoples R China; [Wang, Hongbo] Sun Yat Sen Univ, Affiliated Hosp 3, Guangdong Prov Key Lab Liver Dis Res, Guangzhou, Guangdong, Peoples R China; [Zhou, Jin] Sun Yat Sen Univ, Affiliated Hosp 8, Dept Obstet & Gynecol, Shenzhen, Peoples R China; [Timm, Barbara K.; Maclin, Victoria] Heartland Ctr Reprod Med PC, Omaha, NE USA; [Davis, John S.] Vet Affairs Nebraska Western Iowa Hlth Care Syst, Omaha, NE USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Huazhong Agricultural University; Sun Yat Sen University; Sun Yat Sen University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System	Wang, C (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Obstet & Gynecol, Vincent Ctr Reprod Biol, Boston, MA 02114 USA.	cwang34@mgh.harvard.edu	Chen, Xingcheng/AAL-3210-2020	Davis, John/0000-0003-3468-4079	University of Nebraska Medical Center Fellowship; Eunice Kennedy Shriver National Institute of Child Health and Human Development [5R00HD059985]; National Cancer Institute [1R01CA197976, 1R01CA201500]; U.S. National Institutes of Health (NIH) [1R01CA197976, 1R01CA201500]; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital-Harvard Medical School; Olson Center for Women's Health at the University of Nebraska Medical Center; Department of Veteran's Affairs; Colleen's Dream Foundation; NATIONAL CANCER INSTITUTE [R01CA201500, R01CA197976] Funding Source: NIH RePORTER	University of Nebraska Medical Center Fellowship; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital-Harvard Medical School; Olson Center for Women's Health at the University of Nebraska Medical Center; Department of Veteran's Affairs(US Department of Veterans Affairs); Colleen's Dream Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Eric N. Olson (University of Texas Southwestern Medical Center, Dallas, TX) for providing the Yap1-floxed mouse model. The authors also thank Janice A. Taylor and James R. Talaska of the Advanced Microscopy Core Facility at the University of Nebraska Medical Center for providing assistance with confocal microscopy. This work was supported by a University of Nebraska Medical Center Fellowship; the Eunice Kennedy Shriver National Institute of Child Health and Human Development (5R00HD059985); The National Cancer Institute and U.S. National Institutes of Health (NIH) (1R01CA197976, 1R01CA201500), the Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital-Harvard Medical School; the Olson Center for Women's Health at the University of Nebraska Medical Center; The Department of Veteran's Affairs, and the Colleen's Dream Foundation. X.L., C. He, and C. Huang are co-first authors. The authors declare no conflicts of interest.	ADASHI EY, 1989, MOL CELL ENDOCRINOL, V61, P247, DOI 10.1016/0303-7207(89)90136-6; Amsterdam A, 1997, ENDOCR REV, V18, P435, DOI 10.1210/er.18.4.435; Badouel C, 2009, CURR OPIN CELL BIOL, V21, P837, DOI 10.1016/j.ceb.2009.09.010; Barry ER, 2013, CURR OPIN CELL BIOL, V25, P247, DOI 10.1016/j.ceb.2012.12.006; Beverdam A, 2013, J INVEST DERMATOL, V133, P1497, DOI 10.1038/jid.2012.430; Chen Q, 2015, GENE DEV, V29, P1285, DOI 10.1101/gad.264234.115; Cheng Y, 2015, FASEB J, V29, P2423, DOI 10.1096/fj.14-267856; Conti M, 2006, MOL ENDOCRINOL, V20, P715, DOI 10.1210/me.2005-0185; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Finch-Edmondson ML, 2015, J BIOL CHEM, V290, P27928, DOI 10.1074/jbc.M115.692285; Fu D, 2014, ENDOCR-RELAT CANCER, V21, P297, DOI 10.1530/ERC-13-0339; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; He C, 2015, ONCOGENE, V34, P6040, DOI 10.1038/onc.2015.52; Hsueh AJW, 2015, ENDOCR REV, V36, P1, DOI 10.1210/er.2014-1020; Huang JH, 2014, J CELL BIOL, V205, P325, DOI 10.1083/jcb.201309141; Ingman WV, 2006, ENDOCRINOLOGY, V147, P835, DOI 10.1210/en.2005-1189; Jamnongjit M, 2005, P NATL ACAD SCI USA, V102, P16257, DOI 10.1073/pnas.0508521102; Kawamura K, 2013, P NATL ACAD SCI USA, V110, P17474, DOI 10.1073/pnas.1312830110; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Lange AW, 2015, J MOL CELL BIOL, V7, P35, DOI 10.1093/jmcb/mju046; Lenz S, 2004, MOL REPROD DEV, V67, P406, DOI 10.1002/mrd.20000; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Mahoney JE, 2014, DEV CELL, V30, P137, DOI 10.1016/j.devcel.2014.06.003; Markstrom E, 2002, REPRODUCTION, V123, P23, DOI 10.1530/rep.0.1230023; Meignin C, 2007, CURR BIOL, V17, P1871, DOI 10.1016/j.cub.2007.09.062; Musah S, 2014, P NATL ACAD SCI USA, V111, P13805, DOI 10.1073/pnas.1415330111; Pan BC, 2004, MOL CELL ENDOCRINOL, V214, P1, DOI 10.1016/j.mce.2003.12.003; Pan BC, 2002, MOL HUM REPROD, V8, P734, DOI 10.1093/molehr/8.8.734; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Plouffe SW, 2018, J BIOL CHEM, V293, P11230, DOI 10.1074/jbc.RA118.002715; Polesello C, 2007, CURR BIOL, V17, P1864, DOI 10.1016/j.cub.2007.09.049; Puri P, 2016, SCI REP-UK, V6, DOI 10.1038/srep28132; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; RANTA T, 1984, ENDOCRINOLOGY, V114, P845, DOI 10.1210/endo-114-3-845; Richani D, 2018, HUM REPROD UPDATE, V24, P1, DOI 10.1093/humupd/dmx029; ROY SK, 1993, BIOL REPROD, V48, P552, DOI 10.1095/biolreprod48.3.552; Sarikaya DP, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004962; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Seo E, 2013, CELL REP, V3, P2075, DOI 10.1016/j.celrep.2013.05.029; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; Sun TX, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.114.118604; TILLY JL, 1992, MOL ENDOCRINOL, V6, P1942, DOI 10.1210/me.6.11.1942; Vanderhyden BC, 2003, REPRODUCTION, P55; Vitale AM, 2006, FERTIL STERIL, V85, P1064, DOI 10.1016/j.fertnstert.2005.09.061; Wang C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.397; Wang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048299; Yamashita Y, 2012, J REPROD DEVELOP, V58, P510, DOI 10.1262/jrd.2012-056; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060; Yu C, 2016, CELL RES, V26, P275, DOI 10.1038/cr.2016.20; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao R, 2014, DEV CELL, V30, P151, DOI 10.1016/j.devcel.2014.06.004	57	40	41	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10049	10064		10.1096/fj.201900179RR	http://dx.doi.org/10.1096/fj.201900179RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31199671	Green Published, Bronze			2022-12-28	WOS:000482214200027
J	Sorensen, JR; Kaluhiokalani, JP; Hafen, PS; Deyhle, MR; Parcell, AC; Hyldahl, RD				Sorensen, Jacob R.; Kaluhiokalani, Jamie P.; Hafen, Paul S.; Deyhle, Michael R.; Parcell, Allen C.; Hyldahl, Robert D.			An altered response in macrophage phenotype following damage in aged human skeletal muscle: implications for skeletal muscle repair	FASEB JOURNAL			English	Article						satellite cell; immune cells; muscle damage; inflammation; primary myoblasts	LENGTHENING CONTRACTIONS; EXTRACELLULAR-MATRIX; SATELLITE CELL; MOUSE MODEL; INJURY; FIBROSIS; INFLAMMATION; RESOLUTION; YOUNG	The purpose of this study was to test the hypothesis that macrophage polarization is altered in old compared to young skeletal muscle, possibly contributing to the poor satellite cell response observed in older muscle tissue. Muscle biopsies were collected prior to and at 3, 24, and 72 h following a muscle-damaging exercise in young and old individuals. Immunohistochemistry was used to measure i.m. macrophage content and phenotype, and cell culture experiments tested macrophage behavior and influence on primary myoblasts from older individuals. We found that macrophage infiltration was similar between groups at 24 (young: 3712 +/- 2407 vs. old: 5035 +/- 2978 cells/mm(3)) and 72 (young: 4326 +/- 2622 vs. old: 5287 +/- 2248 cells/mm(3)) hours postdamage, yet the proportion of macrophages that expressed the proinflammatory marker CD11b were markedly lower in the older subjects (young: 74.5 +/- 15 vs. old: 52.6 +/- 17%). This finding was coupled with a greater overall proportion of CD206(+), anti-inflammatory macrophages in the old (group: P = 0.0005). We further demonstrate in vitro that proliferation, and in some cases differentiation, of old primary human myoblasts increase as much as 30% when exposed to a young macrophage-conditioned environment. Collectively, the data suggest that old macrophages appear less capable of adapting and maintaining inflammatory function, which may contribute to poor satellite cell activation and delayed recovery from muscle damage.-Sorensen, J. R., Kaluhiokalani, J. P., Hafen, P. S., Deyhle, M. R., Parcell, A. C., Hyldahl, R. D. An altered response in macrophage phenotype following damage in aged human skeletal muscle: implications for skeletal muscle repair.	[Sorensen, Jacob R.; Kaluhiokalani, Jamie P.; Hafen, Paul S.; Deyhle, Michael R.; Parcell, Allen C.; Hyldahl, Robert D.] Brigham Young Univ, Dept Exercise Sci, Provo, UT 84602 USA; [Sorensen, Jacob R.] Univ Minnesota, Sch Kinesiol, 1900 Univ Ave SE, Minneapolis, MN 55455 USA	Brigham Young University; University of Minnesota System; University of Minnesota Twin Cities	Sorensen, JR (corresponding author), Univ Minnesota, Sch Kinesiol, 1900 Univ Ave SE, Minneapolis, MN 55455 USA.	sorensej@umn.edu	Hyldahl, Robert/AAZ-3960-2020	Kaluhiokalani, Jamie/0000-0001-7431-7033; Deyhle, Michael/0000-0001-8526-4758; Sorensen, Jacob/0000-0001-5945-542X				Agley CC, 2015, JOVE-J VIS EXP, DOI 10.3791/52049; Akahori H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8792; Alexakis C, 2007, AM J PHYSIOL-CELL PH, V293, pC661, DOI 10.1152/ajpcell.00061.2007; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Aspinall Richard, 2007, Immun Ageing, V4, P9, DOI 10.1186/1742-4933-4-9; Brigitte M, 2010, ARTHRITIS RHEUM-US, V62, P268, DOI 10.1002/art.27183; CARLSON BM, 1989, AM J PHYSIOL, V256, pC1262; Chistiakov DA, 2017, LAB INVEST, V97, P4, DOI 10.1038/labinvest.2016.116; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180; Deyhle MR, 2016, JOVE-J VIS EXP, DOI 10.3791/54859; Deyhle MR, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00424; Dreyer HC, 2006, MUSCLE NERVE, V33, P242, DOI 10.1002/mus.20461; Fei F, 2016, SCI REP-UK, V6, DOI 10.1038/srep22637; Hall JK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001081; Heppner HJ, 2013, CRIT CARE CLIN, V29, P757, DOI 10.1016/j.ccc.2013.03.016; Herrero C, 2001, J CLIN INVEST, V107, P485, DOI 10.1172/JCI11696; Hyldahl RD, 2015, FASEB J, V29, P2894, DOI 10.1096/fj.14-266668; Katz JM, 2004, IMMUNOL RES, V29, P113, DOI 10.1385/IR:29:1-3:113; Keefe AC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8087; Kosmac K, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2883; Lemos DR, 2015, NAT MED, V21, P786, DOI 10.1038/nm.3869; Linehan E, 2015, EUR J MICROBIOL IMMU, V5, P14, DOI [10.1556/EuJMI-D-14-00035, 10.1556/EUJMI-D-14-00035]; Lockhart NC, 2008, J APPL PHYSIOL, V104, P1109, DOI 10.1152/japplphysiol.00850.2007; Londhe P, 2011, MOL CELL BIOL, V31, P2854, DOI 10.1128/MCB.05397-11; Mackey AL, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0142-x; Mahbub S, 2012, J INTERF CYTOK RES, V32, P18, DOI 10.1089/jir.2011.0058; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Mills CD, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00212; Paulsen G, 2012, EXERC IMMUNOL REV, V18, P42; Perdiguero E, 2011, J CELL BIOL, V195, P307, DOI 10.1083/jcb.201104053; Pizza FX, 2005, J PHYSIOL-LONDON, V562, P899, DOI 10.1113/jphysiol.2004.073965; Przybyla B, 2006, EXP GERONTOL, V41, P320, DOI 10.1016/j.exger.2005.12.007; Rebo J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13363; Reidy PT, 2019, ACTA PHYSIOL, V226, DOI 10.1111/apha.13251; Reidy PT, 2018, EXP GERONTOL, V107, P37, DOI 10.1016/j.exger.2017.07.001; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Saclier M, 2013, STEM CELLS, V31, P384, DOI 10.1002/stem.1288; Shirernan PK, 2007, J LEUKOCYTE BIOL, V81, P775, DOI 10.1189/jlb.0506356; Sloboda DD, 2018, J GERONTOL A-BIOL, V73, P1581, DOI 10.1093/gerona/gly086; Snijders T, 2014, AGE, V36, DOI 10.1007/s11357-014-9699-z; Sorensen JR, 2018, EXP GERONTOL, V106, P28, DOI 10.1016/j.exger.2018.02.013; Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419; Van den Bossche J, 2015, JOVE-J VIS EXP, DOI 10.3791/53424; Van Thienen R, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.286; Villalta SA, 2011, J IMMUNOL, V187, P5419, DOI 10.4049/jimmunol.1101267; Wang Y, 2019, FASEB J, V33, P1415, DOI 10.1096/fj.201800973R; Wang Y, 2015, AGING CELL, V14, P678, DOI 10.1111/acel.12350	50	12	12	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10353	10368		10.1096/fj.201900519R	http://dx.doi.org/10.1096/fj.201900519R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31208207				2022-12-28	WOS:000482214200051
J	van Bussel, IPG; Fazelzadeh, P; Frost, GS; Rundle, M; Afman, LA				van Bussel, Inge P. G.; Fazelzadeh, Parastoo; Frost, Gary S.; Rundle, Milena; Afman, Lydia A.			Measuring phenotypic flexibility by transcriptome time-course analyses during challenge tests before and after energy restriction	FASEB JOURNAL			English	Article						PBMCs; whole-genome gene expression; OGTT; mixed-meal test	BLOOD MONONUCLEAR-CELLS; GENE-EXPRESSION; CALORIC RESTRICTION; INSULIN SENSITIVITY; LIFE-SPAN; DIET; METABOLISM; INDEX; MEN	Metabolic challenge tests may be a valuable tool to magnify the effects of diet on health. The use of transcriptomics enables a more extensive characterization of the effects of diet. The question remains whether transcriptome time-course analyses during challenge tests will deliver more information on the effect of diet than a static fasting measurement. A dietary intervention known to improve health is energy restriction (ER). Seventy-two healthy, overweight men and women aged 50-65 were subjected to an oral glucose tolerance test (OGTT) and a mixed-meal test (MMT) before and after 12 wk of a 20% ER diet or control diet. Whole-genome gene expression of peripheral blood mononuclear cells was performed before and after the intervention. This was done during fasting, during the OGTT at 30, 60, and 120 min, and during the MMT at 60, 120, 240, and 360 min. Upon ER, the OGTT resulted in a faster and more pronounced down-regulation in gene expression of oxidative phosphorylation, cell adhesion, and DNA replication compared with the control. The MMT showed less-consistent effects. The OGTT combined with transcriptomics can be used to measure dynamic cellular adaptation upon an intervention that cannot be determined with a static fasting measurement.-Van Bussel, I. P. G., Fazelzadeh, P., Frost, G. S., Rundle, M., Afman, L. A. Measuring phenotypic flexibility by transcriptome time-course analyses during challenge tests before and after energy restriction.	[van Bussel, Inge P. G.; Fazelzadeh, Parastoo; Afman, Lydia A.] Wageningen Univ & Res Ctr, Div Human Nutr & Hlth, Wageningen, Netherlands; [Frost, Gary S.; Rundle, Milena] Imperial Coll London, Div Diabet Endocrinol & Metab, Dept Med, London, England	Wageningen University & Research; Imperial College London	Afman, LA (corresponding author), Wageningen Univ & Res Ctr, Div Human Nutr, POB 17,Stippeneng 4, NL-6700 AA Wageningen, Netherlands.	lydia.afman@wur.nl		Frost, Gary/0000-0003-0529-6325; Rundle, Milena/0000-0001-9908-5195	NutriTech - European Commission in the Seventh Framework Programme (FP7) [289511]	NutriTech - European Commission in the Seventh Framework Programme (FP7)	The authors thank the participants, Mechteld Grootte-Bromhaar, Jenny Jansen, and the nurses and dieticians (all from the Division of Human Nutrition and Health, Wageningen University and Research Centre, Wageningen, The Netherlands) for their practical work during the study. Furthermore, the authors thank Philip de Groot, Mark Boekschoten, and Guido Hooiveld Division of Human Nutrition and Health for helping with microarray analysis. Funding was provided by NutriTech, which is financed by the European Commission in the Seventh Framework Programme (FP7) (Grant 289511; 2012-11-30). Membership of the NutriTech Consortium is provided at http://nutrigenomics.topshare.com/nutritech/. The authors declare no conflicts of interest.	Alipour A, 2008, ARTERIOSCL THROM VAS, V28, P792, DOI 10.1161/ATVBAHA.107.159749; Backx EMP, 2016, INT J OBESITY, V40, P299, DOI 10.1038/ijo.2015.182; Blumenthal JA, 2010, HYPERTENSION, V55, P1199, DOI 10.1161/HYPERTENSIONAHA.109.149153; Boren J, 2014, CLIN CHIM ACTA, V431, P131, DOI 10.1016/j.cca.2014.01.015; Bouwens M, 2009, AM J CLIN NUTR, V90, P415, DOI 10.3945/ajcn.2009.27680; Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598; Chen CN, 2015, AM J PHYSIOL-ENDOC M, V308, pE942, DOI 10.1152/ajpendo.00508.2014; Colin S, 2014, IMMUNOL REV, V262, P153, DOI 10.1111/imr.12218; Crujeiras AB, 2008, OMICS, V12, P251, DOI 10.1089/omi.2008.0001; Davis LM, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-11; Esser D, 2015, MOL NUTR FOOD RES, V59, P1563, DOI 10.1002/mnfr.201400853; Esser D, 2013, J NUTR, V143, P843, DOI 10.3945/jn.113.174540; Ghosh S, 2011, OBESITY, V19, P457, DOI 10.1038/oby.2010.209; Hill AA, 2014, IMMUNOL REV, V262, P134, DOI 10.1111/imr.12216; Huber Machteld, 2011, BMJ, V343, pd4163, DOI 10.1136/bmj.d4163; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Larsen TM, 2010, NEW ENGL J MED, V363, P2102, DOI 10.1056/NEJMoa1007137; Leder L, 2016, GENES NUTR, V11, DOI 10.1186/s12263-016-0521-4; Lin K, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-160; Loftus RM, 2016, J BIOL CHEM, V291, P1, DOI 10.1074/jbc.R115.693903; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Pirillo A, 2014, CURR MED RES OPIN, V30, P1489, DOI 10.1185/03007995.2014.909394; Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Sathananthan M, 2015, J NUTR, V145, P2046, DOI 10.3945/jn.115.210617; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stroeve JHM, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0459-1; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Van Bussel IPG, 2016, GENES NUTR, V11, DOI 10.1186/s12263-016-0528-0; van Dijk SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041388; van Dijk SJ, 2012, J NUTR, V142, P1219, DOI 10.3945/jn.111.155283; van Ommen B, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0423-5; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1	38	4	4	3	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10280	10290		10.1096/fj.201900148R	http://dx.doi.org/10.1096/fj.201900148R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31238007	Bronze			2022-12-28	WOS:000482214200045
J	Yang, CL; Shen, SN; Zheng, XL; Ye, K; Sun, YA; Lu, YF; Ge, H				Yang, Chengliang; Shen, Sining; Zheng, Xiaoli; Ye, Ke; Sun, Yanan; Lu, Yufei; Ge, Hong			Long noncoding RNA HAGLR acts as a microRNA-143-5p sponge to regulate epithelial-mesenchymal transition and metastatic potential in esophageal cancer by regulating LAMP3	FASEB JOURNAL			English	Article						metastasis; EC; lysosome-associated membrane glycoprotein	SQUAMOUS-CELL CARCINOMA; EXPRESSION ANALYSIS; PROGNOSTIC VALUE; BREAST-CANCER; GROWTH; PROMOTES; OVEREXPRESSION; KNOCKDOWN; BIOMARKER; INVASION	Homeobox D gene cluster antisense growth-associated long noncoding RNA (HAGLR) functions as a crucial regulator in the progression and development of human cancers. We analyzed effects of HAGLR, microRNA (miR)-143-5p and lysosome-associated membrane glycoprotein (LAMP)3 on esophageal cancer (EC) and the related mechanisms. Microarray analysis was used to screen out EC-related genes and the regulation network among HAGLR, miR-143-5p, and LAMP3. The regulatory mechanisms of HAGLR and miR-143-5p in EC were analyzed following the treatment of miR-143-5p mimic, miR-143-5p inhibitor, HAGLR vector, or small interfering RNA against HAGLR in EC cells. The expression of N-cadherin, vimentin, Twist1, Snail1, and E-cadherin as well as the abilities of cell proliferation, invasion, and migration were measured. The effects of the HAGLR/miR-143-5p/LAMP3 axis were determined in vivo by assessing tumor formation in nude mice. The expression of HAGLR and LAMP3 was increased, whereas that of miR-143-5p was diminished in EC tissues and cells. HAGLR could competitively bind to miR-143-5p, and miR-143-5p targeted LAMP3. Down-regulated HAGLR or up-regulated miR-143-5p increased E-cadherin expression and significantly diminished expression of LAMP3, N-cadherin, vimentin, Twist1, and Snail1. Moreover, down-regulated HAGLR inhibited cell proliferation, invasion, migration, epithelial-mesenchymal transition (EMT), and tumor growth. Moreover, down-regulation of HAGLR inhibited LAMP3 expression by sponging miR-143-5p, thereby suppressing the progression of EC. Taken together, our results suggest HAGLR acts as a competing endogenous RNA of miR-143-5p to increase the expression of LAMP3, thus promoting EMT, proliferation, invasion, and migration in EC cells.-Yang, C., Shen, S., Zheng, X., Ye, K., Sun, Y., Lu, Y., Ge, H. Long noncoding RNA HAGLR acts as a microRNA-143-5p sponge to regulate epithelial-mesenchymal transition and metastatic potential in esophageal cancer by regulating LAMP3.	[Yang, Chengliang; Zheng, Xiaoli; Ye, Ke; Sun, Yanan; Lu, Yufei; Ge, Hong] Zhengzhou Univ, Affiliated Canc Hosp, Dept Radiat Oncol, 127 Dongming Rd, Zhengzhou 450008, Henan, Peoples R China; [Shen, Sining] Zhengzhou Univ, Affiliated Canc Hosp, Dept Thorac Surg, Zhengzhou, Henan, Peoples R China	Zhengzhou University; Zhengzhou University	Ge, H (corresponding author), Zhengzhou Univ, Affiliated Canc Hosp, Dept Radiat Oncol, 127 Dongming Rd, Zhengzhou 450008, Henan, Peoples R China.	gehong666@126.com						Akagi I, 2017, GENOM DATA, V12, P4, DOI 10.1016/j.gdata.2017.02.002; Ansari MH, 2016, TUMOR BIOL, V37, P3097, DOI 10.1007/s13277-015-3987-9; Backemar L, 2015, WORLD J SURG, V39, P2282, DOI 10.1007/s00268-015-3093-6; Bednarczyk M., 2017, J BIOSCI MED, V5, P24, DOI [10.4236/jbm.2017.512004, DOI 10.4236/JBM.2017.512004]; Dave N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.168625; Dominguez-Bautista JA, 2015, EUR J CELL BIOL, V94, P148, DOI 10.1016/j.ejcb.2015.01.003; Fang Wentao, 2017, Zhonghua Wei Chang Wai Ke Za Zhi, V20, P1122; Feng JF, 2013, ASIAN PAC J CANCER P, V14, P1803, DOI 10.7314/APJCP.2013.14.3.1803; Fujita A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-469; Gu Zhen-dong, 2007, Zhonghua Wei Chang Wai Ke Za Zhi, V10, P365; He M, 2017, CELL PHYSIOL BIOCHEM, V42, P2078, DOI 10.1159/000479903; Ilson DH, 2018, GASTROENTEROLOGY, V154, P437, DOI 10.1053/j.gastro.2017.09.048; Jia XZ, 2015, INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY AND INDUSTRIAL AUTOMATION (ICITIA 2015), P6; Jiang CL, 2018, ANAL CELL PATHOL, V2018, DOI 10.1155/2018/8759745; Jiao CJ, 2016, ONCOL REP, V36, P2960, DOI 10.3892/or.2016.5121; Kanao H, 2005, CANCER RES, V65, P8640, DOI 10.1158/0008-5472.CAN-04-4112; Khan MA, 2013, TUMOR BIOL, V34, P2497, DOI 10.1007/s13277-013-1002-x; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li B, 2009, MOL CANCER THER, V8, P2635, DOI 10.1158/1535-7163.MCT-09-0162; Li X, 2018, INT J ONCOL, V53, P21, DOI 10.3892/ijo.2018.4400; Li Y, 2017, MOL MED REP, V16, P5947, DOI 10.3892/mmr.2017.7349; Liao JQ, 2016, GENE, V578, P158, DOI 10.1016/j.gene.2015.12.032; Liao XY, 2015, INT J MOL SCI, V16, P17655, DOI 10.3390/ijms160817655; Liu FY, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0698-4; Lu CW, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317697574; Lu S, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0676-x; Mayne GC, 2013, CURR PHARM DESIGN, V19, P1211; Natalwala A, 2008, WORLD J GASTROENTERO, V14, P3792, DOI 10.3748/wjg.14.3792; Ni Y, 2013, GENE, V517, P197, DOI 10.1016/j.gene.2012.12.031; Oze I, 2011, JPN J CLIN ONCOL, V41, P677, DOI 10.1093/jjco/hyr026; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Siosaki MD, 2013, J SURG CASE REP, DOI 10.1093/jscr/rjt017; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Stanisavljevic J, 2011, J CELL SCI, V124, P4159, DOI 10.1242/jcs.078824; Sun RW, 2014, ONCOTARGET, V5, P12398, DOI 10.18632/oncotarget.2643; Wang D, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317695014; Wang HS, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701301; Wang QH, 2017, ONCOTARGETS THER, V10, P4753, DOI 10.2147/OTT.S143787; Wu XL, 2013, WORLD J GASTROENTERO, V19, P7758, DOI 10.3748/wjg.v19.i43.7758; Xu J, 2017, J ECON ENTOMOL, V110, P683, DOI 10.1093/jee/tow297; Xu Y, 2018, NEOPLASMA, V65, P469, DOI 10.4149/neo_2018_170529N384; Xu ZY, 2013, INT J BIOL SCI, V9, P587, DOI 10.7150/ijbs.6339; Yan C, 2017, CANCER SCI, V108, P868, DOI 10.1111/cas.13212; Yip C, 2014, RADIOLOGY, V270, P141, DOI 10.1148/radiol.13122869; Zhai LM, 2016, MOL CARCINOGEN, V55, P1990, DOI 10.1002/mc.22445; Zhang Q, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317711312; Zhang YR, 2017, WIRELESS NETW-GER, P1, DOI 10.1007/978-3-319-53288-2_1; Zheng L, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317705335	49	33	34	2	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10490	10504		10.1096/fj.201802543RR	http://dx.doi.org/10.1096/fj.201802543RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31311326	Bronze			2022-12-28	WOS:000482214200061
J	Angireddy, R; Kazmi, HR; Srinivasan, S; Sun, L; Iqbal, J; Fuchs, SY; Guha, M; Kijima, T; Yuen, T; Zaidi, M; Avadhani, NG				Angireddy, Rajesh; Kazmi, Hasan Raza; Srinivasan, Satish; Sun, Li; Iqbal, Jameel; Fuchs, Serge Y.; Guha, Manti; Kijima, Takashi; Yuen, Tony; Zaidi, Mone; Avadhani, Narayan G.			Cytochrome c oxidase dysfunction enhances phagocytic function and osteoclast formation in macrophages	FASEB JOURNAL			English	Article						Subunit IVi1; retrograde signaling; inflammatory cytokines; reactive oxygen species; respiratory changes	NITRIC-OXIDE; MITOCHONDRIAL-DNA; MPV17 ENCODES; ACTIVATION; STRESS; HYPOXIA; RESORPTION; METABOLISM; INNATE; HEALTH	The mitochondria-to-nucleus retrograde signaling (MtRS) pathway aids in cellular adaptation to stress. We earlier reported that the Ca2+- and calcineurin-dependent MtRS induces macrophage differentiation to bone-resorbing osteoclasts. However, mechanisms through which macrophages sense and respond to cellular stress remain unclear. Here, we induced mitochondrial stress in macrophages by knockdown (KD) of subunits IVi1 or Vb of cytochrome c oxidase (CcO). Whereas both IVi1 and Vb KD impair CcO activity, IVi1 KD cells produced higher levels of cellular and mitochondrial reactive oxygen species with increased glycolysis. Additionally, IVi1 KD induced the activation of MtRS factors NF-kappa B, NFAT2, and C/EBP delta as well as inflammatory cytokines, NOS 2, increased phagocytic activity, and a greater osteoclast differentiation potential at suboptimal RANK-L concentrations. The osteoclastogenesis in IVi1 KD cells was reversed fully with an IL-6 inhibitor LMT-28, whereas there was minimal rescue of the enhanced phagocytosis in these cells. In agreement with our findings in cultured macrophages, primary bone marrow-derived macrophages from MPV17(-/-) mice, a model for mitochondrial dysfunction, also showed higher propensity for osteoclast formation. This is the first report showing that CcO dysfunction affects inflammatory pathways, phagocytic function, and osteoclastogenesis.-Angireddy, R., Kazmi, H. R., Srinivasan, S., Sun, L., Iqbal, J., Fuchs, S. Y., Guha, M., Kijima, T., Yuen, T., Zaidi, M., Avadhani, N. G. Cytochrome c oxidase dysfunction enhances phagocytic function and osteoclast formation in macrophages.	[Angireddy, Rajesh; Kazmi, Hasan Raza; Srinivasan, Satish; Fuchs, Serge Y.; Guha, Manti; Kijima, Takashi; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Dept Biomed Sci, Philadelphia, PA 19104 USA; [Sun, Li; Iqbal, Jameel; Yuen, Tony; Zaidi, Mone] Icahn Sch Med Mt Sinai, Dept Med, Mt Sinai Bone Program, New York, NY 10029 USA; [Srinivasan, Satish] Roche Mol Syst, Branchburg, NJ USA	University of Pennsylvania; Icahn School of Medicine at Mount Sinai; Roche Holding	Avadhani, NG (corresponding author), Univ Penn, Sch Vet Med, 189E Vet,3800 Spruce St, Philadelphia, PA 19104 USA.	narayan@vet.upenn.edu	Kazmi, Hasan Raza/AAY-1682-2021; Angireddy, Rajesh/GMX-3147-2022	Angireddy, Rajesh/0000-0002-9215-2209	U.S. National Institutes of Health (NIH) National Institutes of Arthritis and Musculoskeletal and Skin Diseases [R01AR06066, R01AR6592]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [R01DK113627]; Harrington Discovery Institute; NATIONAL CANCER INSTITUTE [R01CA092900, P01CA165997] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institutes of Arthritis and Musculoskeletal and Skin Diseases; NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Harrington Discovery Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge the technical help of Maura Sheehan and Liam Piscetelli (Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA). The authors acknowledge Dr. Pavan from Dr. Anna Kashina's laboratory for helping with live cell imaging (both from Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania). The authors also acknowledge the help of Dr. Gordon Ruthel (Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania) and the PENN Vet imaging core (University of Pennsylvania School of Veterinary Medicine) in confocal imaging. This work was supported in part by the U.S. National Institutes of Health (NIH) National Institutes of Arthritis and Musculoskeletal and Skin Diseases Grants R01AR06066 (to M.Z. and N.G.A) and R01AR6592 (to M.Z.), NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant R01DK113627 (to M.Z.), as well as the Harrington Discovery Institute. N.G.A. also acknowledges an endowment from the Harriet Ellison Woodward foundation. The authors declare no conflicts of interest.	Abu-Amer Y, 2013, OSTEOPOROSIS INT, V24, P2377, DOI 10.1007/s00198-013-2313-x; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Amuthan G, 2001, EMBO J, V20, P1910, DOI 10.1093/emboj/20.8.1910; Antonenkov VD, 2015, J BIOL CHEM, V290, P13840, DOI 10.1074/jbc.M114.608083; Arnett TR, 2003, J CELL PHYSIOL, V196, P2, DOI 10.1002/jcp.10321; Bansal S, 2012, J BIOL CHEM, V287, P15284, DOI 10.1074/jbc.M111.314062; Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Biswas SK, 2012, CELL METAB, V15, P432, DOI 10.1016/j.cmet.2011.11.013; Cantu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007095; Castro L, 2001, NUTRITION, V17, P161, DOI 10.1016/S0899-9007(00)00570-0; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Diaz F, 2010, BBA-MOL BASIS DIS, V1802, P100, DOI 10.1016/j.bbadis.2009.07.013; Dong DW, 2015, GENOM DATA, V6, P99, DOI 10.1016/j.gdata.2015.07.031; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Galati D, 2009, BIOCHEM J, V420, P439, DOI 10.1042/BJ20090214; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Guha M, 2016, ANN NY ACAD SCI, V1364, P52, DOI 10.1111/nyas.12709; Guha M, 2010, MOL BIOL CELL, V21, P3578, DOI 10.1091/mbc.E10-03-0192; Guha M, 2010, BBA-BIOENERGETICS, V1797, P1055, DOI 10.1016/j.bbabio.2010.02.008; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Holvoet P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170307; Hong SS, 2015, J IMMUNOL, V195, P237, DOI 10.4049/jimmunol.1402908; KASTEN TP, 1994, P NATL ACAD SCI USA, V91, P3569, DOI 10.1073/pnas.91.9.3569; Knowles HJ, 2015, HYPOXIA, V3, P73, DOI 10.2147/HP.S95960; Knowles HJ, 2010, FASEB J, V24, P4648, DOI 10.1096/fj.10-162230; Knowles HJ, 2009, J PATHOL, V218, P256, DOI 10.1002/path.2534; MACINTYRE I, 1991, P NATL ACAD SCI USA, V88, P2936, DOI 10.1073/pnas.88.7.2936; McGettrick AF, 2013, J BIOL CHEM, V288, P22893, DOI 10.1074/jbc.R113.486464; MEAGHER LC, 1991, BIOCHEM BIOPH RES CO, V177, P460, DOI 10.1016/0006-291X(91)92006-6; Melendez AJ, 2008, BIOSCIENCE REP, V28, P287, DOI 10.1042/BSR20080082; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; NIRANJAN BG, 1980, J BIOL CHEM, V255, P6575; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200; Ravi S, 2014, INT J BIOCHEM CELL B, V53, P202, DOI 10.1016/j.biocel.2014.05.019; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Sarti P, 2012, BBA-BIOENERGETICS, V1817, P610, DOI 10.1016/j.bbabio.2011.09.002; Silverton SF, 1999, BIOCHEM BIOPH RES CO, V259, P73, DOI 10.1006/bbrc.1999.0703; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Srinivasan S, 2016, ONCOGENE, V35, P1585, DOI 10.1038/onc.2015.227; Srinivasan S, 2007, ANN NY ACAD SCI, V1117, P51, DOI 10.1196/annals.1402.067; Srinivasan S, 2012, FREE RADICAL BIO MED, V53, P1252, DOI 10.1016/j.freeradbiomed.2012.07.021; Srinivasan S, 2010, ANN NY ACAD SCI, V1192, P245, DOI 10.1111/j.1749-6632.2009.05377.x; Sunyer T, 1996, J CELL BIOCHEM, V60, P469, DOI 10.1002/(SICI)1097-4644(19960315)60:4<469::AID-JCB4>3.0.CO;2-Q; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Taylor CT, 2010, ARTERIOSCL THROM VAS, V30, P643, DOI 10.1161/ATVBAHA.108.181628; Tejle K, 2002, BIOSCIENCE REP, V22, P529, DOI 10.1023/A:1022025903688; Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	58	8	8	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9167	9181		10.1096/fj.201900010RR	http://dx.doi.org/10.1096/fj.201900010RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31063702	Green Published			2022-12-28	WOS:000478832900038
J	Bedenbender, K; Scheller, N; Fischer, S; Leiting, S; Preissner, KT; Schmeck, BT; Vollmeister, E				Bedenbender, Katrin; Scheller, Nicoletta; Fischer, Silvia; Leiting, Silke; Preissner, Klaus T.; Schmeck, Bernd T.; Vollmeister, Evelyn			Inflammation-mediated deacetylation of the ribonuclease 1 promoter via histone deacetylase 2 in endothelial cells	FASEB JOURNAL			English	Article						chromatin immunoprecipitation; vascular homeostasis; MS275; histone acetylation; TNF-alpha	EXTRACELLULAR RNA; GENE-EXPRESSION; CHROMATIN; TRANSCRIPTION; INHIBITOR; HDAC2; ACTIVATION; ACETYLATION; GROWTH; PROLIFERATION	Ribonuclease 1 (RNase1) is a circulating extracellular endonuclease that regulates the vascular homeostasis of extracellular RNA and acts as a vessel- and tissue-protective enzyme. Upon long-term inflammation, high amounts of proinflammatory cytokines affect endothelial cell (EC) function by down-regulation of RNase1. Here, we investigated the transcriptional regulation of RNase1 upon inflammation in HUVECs. TNF-alpha or IL-1 beta stimulation reduced the expression of RNase1 relative to the acetylation state of histone 3 at lysine 27 and histone 4 of the RNASE1 promoter. Inhibition of histone deacetylase (HDAC) 1, 2, and 3 by the specific class I HDAC inhibitor MS275 abolished the TNF-alpha- or IL-1 beta-mediated effect on the mRNA and chromatin levels of RNase1. Moreover, chromatin immunoprecipitation kinetics revealed that HDAC2 accumulates at the RNASE1 promoter upon TNF-alpha stimulation, indicating an essential role for HDAC2 in regulating RNase1 expression. Thus, proinflammatory stimulation induced recruitment of HDAC2 to attenuate histone acetylation at the RNASE1 promoter site. Consequently, treatment with HDAC inhibitors may provide a new therapeutic strategy to stabilize vascular homeostasis in the context of inflammation by preventing RNase1 down-regulation in ECs.-Bedenbender, K., Scheller, N., Fischer, S., Leiting, S., Preissner, K. T., Schmeck, B. T., Vollmeister, E. Inflammation-mediated deacetylation of the ribonuclease 1 promoter via histone deacetylase 2 in endothelial cells.	[Bedenbender, Katrin; Scheller, Nicoletta; Schmeck, Bernd T.; Vollmeister, Evelyn] Philipps Univ Marburg, German Ctr Lung Res DZL, Univ Giessen & Marburg Lung Ctr, Inst Lung Res, Marburg, Germany; [Schmeck, Bernd T.] Philipps Univ Marburg, German Ctr Lung Res DZL, Univ Giessen & Marburg Lung Ctr, Dept Pulm & Crit Care Med, Marburg, Germany; [Fischer, Silvia; Leiting, Silke; Preissner, Klaus T.] Justus Liebig Univ, Fac Med, Dept Biochem, Giessen, Germany	Philipps University Marburg; Philipps University Marburg; Justus Liebig University Giessen	Schmeck, BT (corresponding author), Philipps Univ Marburg, German Ctr Lung Res, Univ Giessen & Marburg Lung Ctr, Inst Lung Res, Hans Meerwein Str 2, D-35043 Marburg, Germany.	bernd.schmeck@uni-marburg.de	Fischer, Silvia/ABG-3104-2021; Vollmeister, Evelyn/ABA-7940-2021	Vollmeister, Evelyn/0000-0002-0539-7874	Von-Behring-Rontgen-Stiftung (Marburg, Germany) [61-0040, 62-0002]; ERACoSySMed (European Research Area Networks "Collaboration on Systems Medicine"); SySMed-COPD (Systems Medicine of COPD) (Berlin, Germany) [031L0140]	Von-Behring-Rontgen-Stiftung (Marburg, Germany); ERACoSySMed (European Research Area Networks "Collaboration on Systems Medicine"); SySMed-COPD (Systems Medicine of COPD) (Berlin, Germany)	The authors thank Siegmund Kohler and the Department of Obstetrics of the Philipps-University Marburg (Hesse, Germany) as well as all participants for providing umbilical cords for HUVEC isolation, Uta-Maria Bauer [Institute for Molecular Biology and Tumor Research (IMT), Philipps-University Marburg) for technical advice, and Isabell Beinborn and Nadine Siebert [both of the Institute for Lung Research, Universities of Giessen and Marburg Lung Center, Philipps-University Marburg, Member of the German Center for Lung Research (DZL)] for excellent technical assistance. The authors also thank Lukas Jerrentrup (Institute for Lung Research) for contribution to the ethical approval application and all lab members for support and discussion. This work was supported by the Von-Behring-Rontgen-Stiftung (61-0040 and 62-0002, Marburg, Germany) and ERACoSySMed (European Research Area Networks "Collaboration on Systems Medicine"), SySMed-COPD (Systems Medicine of COPD) (031L0140, Berlin, Germany). The authors declare no conflicts of interest.	ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Aurora AB, 2010, BLOOD, V116, P475, DOI 10.1182/blood-2009-07-232132; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Brenner D, 2015, NAT REV IMMUNOL, V15, P362, DOI 10.1038/nri3834; Cabrera-Fuentes HA, 2015, EUR J CARDIO-THORAC, V48, P732, DOI 10.1093/ejcts/ezu519; Cabrera-Fuentes HA, 2014, THROMB HAEMOSTASIS, V112, P1110, DOI 10.1160/TH14-08-0703; Caslini C, 2006, ONCOGENE, V25, P5446, DOI 10.1038/sj.onc.1209533; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; DURRIN LK, 1991, CELL, V65, P1023, DOI 10.1016/0092-8674(91)90554-C; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Edelstein LC, 2005, J BIOL CHEM, V280, P11192, DOI 10.1074/jbc.M412997200; Eom GH, 2011, CIRCULATION, V123, P2392, DOI 10.1161/CIRCULATIONAHA.110.003665; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Findeisen HM, 2011, ARTERIOSCL THROM VAS, V31, P851, DOI 10.1161/ATVBAHA.110.221952; Fischer S, 2007, BLOOD, V110, P2457, DOI 10.1182/blood-2006-08-040691; Fischer S, 2014, CELL TISSUE RES, V355, P635, DOI 10.1007/s00441-014-1850-8; Fischer S, 2013, CANCER RES, V73, P5080, DOI 10.1158/0008-5472.CAN-12-4657; Fischer S, 2012, THROMB HAEMOSTASIS, V108, P730, DOI 10.1160/TH12-03-0186; Futami J, 1997, DNA CELL BIOL, V16, P413, DOI 10.1089/dna.1997.16.413; Gansler J, 2014, FASEB J, V28, P752, DOI 10.1096/fj.13-238600; GERSHEY EL, 1968, J BIOL CHEM, V243, P5018; Granger A, 2008, FASEB J, V22, P3549, DOI 10.1096/fj.08-108548; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Huang BH, 2005, CELL DEATH DIFFER, V12, P395, DOI 10.1038/sj.cdd.4401567; Jaboin J, 2002, CANCER RES, V62, P6108; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jamaladdin S, 2014, P NATL ACAD SCI USA, V111, P9840, DOI 10.1073/pnas.1321330111; Jiang L, 2015, CIRC RES, V117, P364, DOI 10.1161/CIRCRESAHA.115.306829; Joksimovic SM, 2018, MOL NEUROBIOL, V55, P222, DOI 10.1007/s12035-017-0735-8; Jurkin J, 2011, CELL CYCLE, V10, P406, DOI 10.4161/cc.10.3.14712; Kalin JH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02242-4; Kallsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050000; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kee HJ, 2011, VASC PHARMACOL, V55, P127, DOI 10.1016/j.vph.2011.07.001; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Kelly RDW, 2013, BIOCHEM SOC T, V41, P741, DOI 10.1042/BST20130010; Kong XC, 2009, J MOL CELL CARDIOL, V46, P292, DOI 10.1016/j.yjmcc.2008.10.023; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Landre JBP, 2002, J CELL BIOCHEM, V86, P540, DOI 10.1002/jcb.10234; Lee YH, 2014, CANCER RES, V74, P4752, DOI 10.1158/0008-5472.CAN-13-3531; Leus NGJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45047; Li RJ, 2012, GENOMICS, V100, P297, DOI 10.1016/j.ygeno.2012.07.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01012; Ma PP, 2012, P NATL ACAD SCI USA, V109, pE481, DOI 10.1073/pnas.1118403109; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; McLaughlin F, 1998, CELL ADHES COMMUN, V6, P381, DOI 10.3109/15419069809109147; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; Mercado N, 2011, BIOCHEM BIOPH RES CO, V406, P292, DOI 10.1016/j.bbrc.2011.02.035; Moenner M, 1997, IN VITRO CELL DEV-AN, V33, P553; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Nusinzon I, 2006, MOL CELL BIOL, V26, P3106, DOI 10.1128/MCB.26.8.3106-3113.2006; Okamoto H, 2006, J ATHEROSCLER THROMB, V13, P183, DOI 10.5551/jat.13.183; Pakala SB, 2010, J BIOL CHEM, V285, P23590, DOI 10.1074/jbc.M110.139469; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Poredos P, 2002, PATHOPHYSIOL HAEMO T, V32, P274, DOI 10.1159/000073580; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Roche J, 2016, EUR J MED CHEM, V121, P451, DOI 10.1016/j.ejmech.2016.05.047; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Seto E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018713; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shakespear MR, 2011, TRENDS IMMUNOL, V32, P335, DOI 10.1016/j.it.2011.04.001; Simsekyilmaz S, 2014, CIRCULATION, V129, P598, DOI 10.1161/CIRCULATIONAHA.113.002562; Singh AK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06924-5; Sitia S, 2010, AUTOIMMUN REV, V9, P830, DOI 10.1016/j.autrev.2010.07.016; Song J, 2005, APMIS, V113, P264, DOI 10.1111/j.1600-0463.2005.apm_04.x; Tarakhovsky A, 2010, NAT IMMUNOL, V11, P565, DOI 10.1038/ni0710-565; Wagner FF, 2015, CHEM SCI, V6, P804, DOI 10.1039/c4sc02130d; Walberer M, 2009, CURR NEUROVASC RES, V6, P12, DOI 10.2174/156720209787466037; Wang XW, 2009, GENOME RES, V19, P266, DOI 10.1101/gr.081638.108; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Yamaguchi T, 2010, GENE DEV, V24, P455, DOI 10.1101/gad.552310; Yamakawa H, 2017, CELL REP, V20, P1319, DOI 10.1016/j.celrep.2017.07.044; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yoon Somy, 2016, Chonnam Med J, V52, P1, DOI 10.4068/cmj.2016.52.1.1; Zampetaki A, 2010, CIRCULATION, V121, P132, DOI 10.1161/CIRCULATIONAHA.109.890491; Zernecke A, 2016, CIRC RES, V118, P469, DOI 10.1161/CIRCRESAHA.115.307961; Zhang Q, 2015, NATURE, V525, P389, DOI 10.1038/nature15252	87	10	11	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9017	9029		10.1096/fj.201900451R	http://dx.doi.org/10.1096/fj.201900451R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31039328				2022-12-28	WOS:000478832900027
J	Stark, A; Schwenk, R; Wack, G; Zuchtriegel, G; Hatemler, MG; Brautigam, J; Schmidtko, A; Reichel, CA; Bischoff, I; Furst, R				Stark, Anna; Schwenk, Rebecca; Wack, Gesine; Zuchtriegel, Gabriele; Hatemler, Melissa G.; Braeutigam, Jacqueline; Schmidtko, Achim; Reichel, Christoph A.; Bischoff, Iris; Fuerst, Robert			Narciclasine exerts anti-inflammatory actions by blocking leukocyte-endothelial cell interactions and down-regulation of the endothelial TNF receptor 1	FASEB JOURNAL			English	Article						inflammation; vascular endothelial cells; cell adhesion molecules; nuclear factor-kappa B	INFLAMMATION; PAIN; STRATEGY; INTEGRIN; ANTIBODY; ZYMOSAN; SITE; MICE	The alkaloid narciclasine has been characterized extensively as an anticancer compound. Accumulating evidence suggests that narciclasine has anti-inflammatory potential; however, the underlying mechanism remains poorly understood. We hypothesized that narciclasine affects the activation of endothelial cells (ECs), a hallmark of inflammatory processes, which is a prerequisite for leukocyte-EC interaction. Thus, we aimed to investigate narciclasine's action on this process in vivo and to analyze the underlying mechanisms in vitro. In a murine peritonitis model, narciclasine reduced leukocyte infiltration, proinflammatory cytokine expression, and inflammation-associated abdominal pain. Moreover, narciclasine decreased rolling and blocked adhesion and transmigration of leukocytes in vivo. In cultured ECs, narciclasine inhibited the expression of cell adhesion molecules intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin and blocked crucial steps of the NF-kappa B activation cascade: NF-kappa B promotor activity, p65 nuclear translocation, inhibitor of kappa B alpha (I kappa B alpha) phosphorylation and degradation, and I kappa B alpha kinase beta and TGF-beta-activated kinase 1 phosphorylation. Interestingly, these effects were based on the narciclasine-triggered loss of TNF receptor 1 (TNFR1). Our study highlights narciclasine as an interesting anti-inflammatory compound that effectively inhibits the interaction of leukocytes with ECs by blocking endothelial activation processes. Most importantly, we showed that the observed inhibitory action of narciclasine on TNF-triggered signaling pathways is based on the loss of TNFR1.-Stark, A., Schwenk, R., Wack, G., Zuchtriegel, G., Hatemler, M. G., Brautigam, J., Schmidtko, A., Reichel, C. A., Bischoff, I., Furst, R. Narciclasine exerts anti-inflammatory actions by blocking leukocyte-endothelial cell interactions and down-regulation of the endothelial TNF receptor 1.	[Stark, Anna; Schwenk, Rebecca; Hatemler, Melissa G.; Braeutigam, Jacqueline; Bischoff, Iris; Fuerst, Robert] Goethe Univ Frankfurt, Fac Biochem Chem & Pharm, Inst Pharmaceut Biol, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Wack, Gesine; Schmidtko, Achim] Goethe Univ Frankfurt, Fac Biochem Chem & Pharm, Inst Pharmacol, Frankfurt, Germany; [Zuchtriegel, Gabriele; Reichel, Christoph A.] Univ Munich, Walter Brendel Ctr Expt Med, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany	Goethe University Frankfurt; Goethe University Frankfurt; University of Munich	Furst, R (corresponding author), Goethe Univ Frankfurt, Fac Biochem Chem & Pharm, Inst Pharmaceut Biol, Max von Laue Str 9, D-60438 Frankfurt, Germany.	fuerst@em.uni-frankfurt.de	Schmidtko, Achim/AAB-2122-2019	Schmidtko, Achim/0000-0001-7270-5075; Furst, Robert/0000-0002-9926-7578	Else Kroner-Fresenius Foundation (EKFS), Research Training Group Translational Research Innovation - Pharma (TRIP)	Else Kroner-Fresenius Foundation (EKFS), Research Training Group Translational Research Innovation - Pharma (TRIP)	The authors thank Jennifer Reis (Institute of Pharmaceutical Biology, Goethe University-Frankfurt, Frankfurt, Germany) for excellent technical assistance and Tamara Gobel (Institute of Pharmaceutical Chemistry) for valuable help during cytometric bead array measurements. This research was supported by the Else Kroner-Fresenius Foundation (EKFS), Research Training Group Translational Research Innovation - Pharma (TRIP). The authors declare no conflicts of interest.	BAEZ S, 1973, MICROVASC RES, V5, P384, DOI 10.1016/0026-2862(73)90054-X; Baumgart M, 1998, P NATL ACAD SCI USA, V95, P6936, DOI 10.1073/pnas.95.12.6936; BOYUM A, 1976, SCAND J IMMUNOL, P9, DOI 10.1111/j.1365-3083.1976.tb03851.x; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Cash JL, 2009, METHOD ENZYMOL, V461, P379, DOI 10.1016/S0076-6879(09)05417-2; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Cobos EJ, 2012, PAIN, V153, P876, DOI 10.1016/j.pain.2012.01.016; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Cook-Mills JM, 2005, J LEUKOCYTE BIOL, V77, P487, DOI 10.1189/jlb.0904554; DOHERTY NS, 1985, PROSTAGLANDINS, V30, P769, DOI 10.1016/0090-6980(85)90006-1; Fuchs S, 2015, J CELL MOL MED, V19, P1021, DOI 10.1111/jcmm.12493; Furst R, 2016, PLANTA MED, V82, P1389, DOI 10.1055/s-0042-115034; Gordon FH, 2001, GASTROENTEROLOGY, V121, P268, DOI 10.1053/gast.2001.26260; Imaizumi Tadaatsu, 2004, J Atheroscler Thromb, V11, P15; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Laux-Biehlmann A, 2016, EUR J PAIN, V20, P742, DOI 10.1002/ejp.800; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lefranc F, 2009, MOL CANCER THER, V8, P1739, DOI 10.1158/1535-7163.MCT-08-0932; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li JX, 2013, ADV IMMUNOL, V119, P135, DOI 10.1016/B978-0-12-407707-2.00005-9; Lubahn C, 2012, RHEUMATOL INT, V32, P3751, DOI 10.1007/s00296-011-2217-z; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Middleton J, 2002, BLOOD, V100, P3853, DOI 10.1182/blood.V100.12.3853; Mikami M, 1999, BIOL PHARM BULL, V22, P674; Muller WA, 2013, VET PATHOL, V50, P7, DOI 10.1177/0300985812469883; Netea MG, 2017, NAT IMMUNOL, V18, P826, DOI 10.1038/ni.3790; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; OBRIG TG, 1971, J BIOL CHEM, V246, P174; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Scrivo R, 2011, AUTOIMMUN REV, V10, P369, DOI 10.1016/j.autrev.2010.12.006; Soler D, 2009, J PHARMACOL EXP THER, V330, P864, DOI 10.1124/jpet.109.153973; Umehara H, 2004, ARTERIOSCL THROM VAS, V24, P34, DOI 10.1161/01.ATV.0000095360.62479.1F; Van Goietsenoven G, 2010, FASEB J, V24, P4575, DOI 10.1096/fj.10-162263; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597	36	14	14	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					8771	8781		10.1096/fj.201802440R	http://dx.doi.org/10.1096/fj.201802440R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31017817				2022-12-28	WOS:000478832900007
J	Hou, LM; Tang, SD; Wu, B; Ong, KL; Westerterp, M; Barter, PJ; Cochran, BJ; Tabet, F; Rye, KA				Hou, Liming; Tang, Shudi; Wu, Ben J.; Ong, Kwok-Leung; Westerterp, Marit; Barter, Philip J.; Cochran, Blake J.; Tabet, Fatiha; Rye, Kerry-Anne			Apolipoprotein A-I improves pancreatic beta-cell function independent of the ATP-binding cassette transporters ABCA1 and ABCG1	FASEB JOURNAL			English	Article						apoA-I; beta cells; cholesterol metabolism; glucose metabolism; inflammation	HIGH-DENSITY-LIPOPROTEINS; INSULIN-SECRETION; GLUCOSE-UPTAKE; CHOLESTEROL ACCUMULATION; ADIPOSE-TISSUE; HOMEOSTASIS; HDL; DYSFUNCTION; EXPRESSION; PROTEINS	Apolipoprotein A-I (apoA-I), the main protein constituent of HDLs, increases insulin synthesis and insulin secretion in pancreatic beta cells. ApoA-I also accepts cholesterol that effluxes from cells expressing ATP-binding cassette transporter A1 (ABCA1) and ATP-binding cassette transporter G(1) (ABCG1). Mice with conditional deletion of ABCA1 and ABCG1 in beta cells [beta-double knockout (DKO) mice] have increased islet cholesterol levels and reduced glucose-stimulated insulin secretion (GSIS). The project asks whether metabolic pathways are dysregulated in beta-DKO mouse islets and whether this can be corrected, and GSIS improved, by treatment with apoA-I. beta-DKO mice were treated with apoA-I or PBS, and islets were isolated for determination of GSIS. Total RNA was extracted from beta-DKO and control mouse islets for microarray analysis. Metabolic pathways were interrogated by functional enrichment analysis. ApoA-I treatment improved GSIS in beta-DKO but not control mouse islets. Plasma lipid and lipoprotein levels and islet cholesterol levels were also unaffected by treatment with apoA-I. Cholesterol metabolism, glucose metabolism, and inflammation pathways were dysregulated in beta-DKO mouse islets. This was not corrected by treatment with apoA-I. In summary, apoA-I treatment improves GSIS by a cholesterol-independent mechanism, but it does not correct metabolic dysregulation in beta-DKO mouse islets.-Hou, L., Tang, S., Wu, B. J., Ong, K.-L., Westerterp, M., Barter, P. J., Cochran, B. J., Tabet, F., Rye, K.-A. Apolipoprotein A-I improves pancreatic beta-cell function independent of the ATP-binding cassette transporters ABCA1 and ABCG1.	[Hou, Liming; Tang, Shudi; Wu, Ben J.; Ong, Kwok-Leung; Barter, Philip J.; Cochran, Blake J.; Tabet, Fatiha; Rye, Kerry-Anne] Univ New South Wales Sydney, Fac Med, Sch Med Sci, Lipid Res Grp, Level 4E,Wallace Wurth Bldg, Sydney, NSW 2052, Australia; [Westerterp, Marit] Univ Groningen, Dept Pediat, Sect Med Genet, Univ Med Ctr Groningen, Groningen, Netherlands	University of New South Wales Sydney; University of Groningen	Rye, KA (corresponding author), Univ New South Wales Sydney, Fac Med, Sch Med Sci, Lipid Res Grp, Level 4E,Wallace Wurth Bldg, Sydney, NSW 2052, Australia.	k.rye@unsw.edu.au		Cochran, Blake/0000-0002-9615-7939; Hou, Liming/0000-0002-4551-5636; Ong, Kwok Leung/0000-0001-7229-7614; Westerterp, Marit/0000-0003-2230-1659	National Health and Medical Research Council of Australia [1037903]; National Heart Foundation of Australia [100090]; Australian National Health and Medical Research Council [1122854]; Netherlands Organization of Scientific Research [917.15.350]; Rosalind Franklin Fellowship from the University Medical Center Groningen	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); Rosalind Franklin Fellowship from the University Medical Center Groningen	This study was supported by National Health and Medical Research Council of Australia Grant 1037903 to K.-A.R. and P.J.B. F.T. is supported by a National Heart Foundation of Australia Future Leader Fellowship (Award 100090). K.-L.O. is supported by an Australian National Health and Medical Research Council Career Development Fellowship (1122854). M.W. is supported by Vidi Grant 917.15.350 from The Netherlands Organization of Scientific Research, and a Rosalind Franklin Fellowship from the University Medical Center Groningen. These funding sources were not involved in the decision to submit the article for publication. B.J.C., F.T., and K.-A.R. are equal last authors. The authors declare no conflicts of interest.	Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Barroso I, 2003, PLOS BIOL, V1, P41, DOI 10.1371/journal.pbio.0000020; Barter PJ, 2011, CIRCULATION, V124, P555, DOI 10.1161/CIRCULATIONAHA.111.018259; Bommer GT, 2011, CELL METAB, V13, P241, DOI 10.1016/j.cmet.2011.02.004; Brun T, 2016, BBA-MOL CELL RES, V1863, P2540, DOI 10.1016/j.bbamcr.2016.03.012; Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; Brunham LR, 2010, CURR DIABETES REP, V10, P55, DOI 10.1007/s11892-009-0090-x; Cavelier C, 2012, ARTERIOSCL THROM VAS, V32, P131, DOI 10.1161/ATVBAHA.111.238063; Cochran BJ, 2016, DIABETES, V65, P3610, DOI 10.2337/db16-0668; Cochran BJ, 2016, DIABETOLOGIA, V59, P1977, DOI 10.1007/s00125-016-3993-5; Cochran BJ, 2014, ARTERIOSCL THROM VAS, V34, P2261, DOI 10.1161/ATVBAHA.114.304131; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Domingo-Espin J, 2016, DIABETES, V65, P1838, DOI 10.2337/db15-1493; Drew BG, 2009, CIRCULATION, V119, P2103, DOI 10.1161/CIRCULATIONAHA.108.843219; Fryirs MA, 2010, ARTERIOSCL THROM VAS, V30, P1642, DOI 10.1161/ATVBAHA.110.207373; Gerber PA, 2017, ANTIOXID REDOX SIGN, V26, P501, DOI 10.1089/ars.2016.6755; Guillam MT, 2000, DIABETES, V49, P1485, DOI 10.2337/diabetes.49.9.1485; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hao M, 2007, DIABETES, V56, P2328, DOI 10.2337/db07-0056; Hasnain SZ, 2016, J MOL ENDOCRINOL, V56, pR33, DOI 10.1530/JME-15-0232; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HPS3 TIMI55-REVEAl Collaborative, 2017, NEW ENGL J MED, V377, P1217, DOI 10.1056/NEJMoa1706444; Ishikawa M, 2008, J LIPID RES, V49, P2524, DOI 10.1194/jlr.M800238-JLR200; IVERIUS PH, 1967, BIOCHIM BIOPHYS ACTA, V133, P371, DOI 10.1016/0005-2795(67)90079-7; Kaneko Y, 2003, AM J PHYSIOL-CELL PH, V284, pC1215, DOI 10.1152/ajpcell.00223.2002; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; KRITHARIDES L, 1993, ANAL BIOCHEM, V213, P79, DOI 10.1006/abio.1993.1389; Kruit JK, 2012, DIABETES, V61, P659, DOI 10.2337/db11-1341; Kruit JK, 2011, DIABETES, V60, P3186, DOI 10.2337/db11-0081; Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5; Maahs DM, 2010, ENDOCRIN METAB CLIN, V39, P481, DOI 10.1016/j.ecl.2010.05.011; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; McCurdy CE, 2012, DIABETES, V61, P2495, DOI 10.2337/db11-1433; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Sturek JM, 2010, J CLIN INVEST, V120, P2575, DOI 10.1172/JCI41280; THORENS B, 1988, CELL, V55, P281, DOI 10.1016/0092-8674(88)90051-7; Vestal DJ, 2011, J INTERF CYTOK RES, V31, P89, DOI 10.1089/jir.2010.0102; WEISWEILER P, 1987, CLIN CHIM ACTA, V169, P249, DOI 10.1016/0009-8981(87)90325-1; Xu GF, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k1497	43	10	11	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8479	8489		10.1096/fj.201802512RR	http://dx.doi.org/10.1096/fj.201802512RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30970222	Green Submitted, Bronze			2022-12-28	WOS:000476234700053
J	Han, EC; Choi, SY; Lee, Y; Park, JW; Hong, SH; Lee, HJ				Han, Eun-Chong; Choi, Song-Yi; Lee, Youngkyun; Park, Jin-Woo; Hong, Su-Hyung; Lee, Heon-Jin			Extracellular RNAs in periodontopathogenic outer membrane vesicles promote TNF-alpha production in human macrophages and cross the blood-brain barrier in mice	FASEB JOURNAL			English	Article						microRNA; periodontitis; small RNA; extracellular vesicle; Aggregatibacter actinomycetemcomitans	CYTOLETHAL DISTENDING TOXIN; NECROSIS-FACTOR-ALPHA; AGGREGATIBACTER-ACTINOMYCETEMCOMITANS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; ALZHEIMERS-DISEASE; MICRORNAS; EXOSOMES; INTERLEUKIN-1-BETA; PERIODONTITIS; SECRETION	Among the main bacteria implicated in the pathology of periodontal disease, Aggregatibacter actinomycetemcomitans (Aa) is well known for causing loss of periodontal attachment and systemic disease. Recent studies have suggested that secreted extracellular RNAs (exRNAs) from several bacteria may be important in periodontitis, although their role is unclear. Emerging evidence indicates that exRNAs circulate in nanosized bilayered and membranous extracellular vesicles (EVs) known as outer membrane vesicles (OMVs) in gram-negative bacteria. In this study, we analyzed the small RNA expression profiles in activated human macrophage-like cells (U937) infected with OMVs from Aa and investigated whether these cells can harbor exRNAs of bacterial origin that have been loaded into the host RNA-induced silencing complex, thus regulating host target transcripts. Our results provide evidence for the cytoplasmic delivery and activity of microbial EV-derived small exRNAs in host gene regulation. The production of TNF-alpha was promoted by exRNAs via the TLR-8 and NF-kappa B signaling pathways. Numerous studies have linked periodontal disease to neuroinflammatory diseases but without elucidating specific mechanisms for the connection. We show here that intracardiac injection of Aa OMVs in mice showed successful delivery to the brain after crossing the blood brain barrier, the exRNA cargos increasing expression of TNF-alpha in the mouse brain. The current study indicates that host gene regulation by microRNAs originating from OMVs of the periodontal pathogen Aa is a novel mechanism for host gene regulation and that the transfer of OMV exRNAs to the brain may cause neuroinflammatory diseases like Alzheimer's.	[Han, Eun-Chong; Choi, Song-Yi; Hong, Su-Hyung; Lee, Heon-Jin] Kyungpook Natl Univ, Sch Dent, Dept Microbiol & Immunol, 2177 Dalgubeol Daero, Daegu 41940, South Korea; [Lee, Youngkyun] Kyungpook Natl Univ, Sch Dent, Dept Biochem, Daegu, South Korea; [Park, Jin-Woo] Kyungpook Natl Univ, Sch Dent, Dept Periodontol, Daegu, South Korea; [Lee, Heon-Jin] Kyungpook Natl Univ, Brain Sci & Engn Inst, Daegu, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University	Lee, HJ (corresponding author), Kyungpook Natl Univ, Sch Dent, Dept Microbiol & Immunol, 2177 Dalgubeol Daero, Daegu 41940, South Korea.	heonlee@knu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Korean Government [MSIT 2017R1A5A2015391, 2018R1D1A3B07043539]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Korean Government(National Research Foundation of Korea)	The authors thank Dr. Eph Tunkle and Dr. Scott Young (U.S. National Institutes of Health, Bethesda, MD, USA) for critical reading of this manuscript. This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Korean Government (MSIT 2017R1A5A2015391 and 2018R1D1A3B07043539). The authors declare no conflicts of interest.	Ando-Suguimoto ES, 2014, CYTOKINE, V66, P46, DOI 10.1016/j.cyto.2013.12.014; Andras IE, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2015.1131804; Belibasakis GN, 2012, CYTOKINE, V59, P124, DOI 10.1016/j.cyto.2012.03.016; Bitto NJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07288-4; Blix IJS, 1999, J PERIODONTAL RES, V34, P34, DOI 10.1111/j.1600-0765.1999.tb02219.x; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; CHATTERJ.SN, 1967, J GEN MICROBIOL, V49, P1; Chen NH, 2017, IUBMB LIFE, V69, P297, DOI 10.1002/iub.1625; Choi JW, 2017, J DENT RES, V96, P458, DOI 10.1177/0022034516685071; Choi JW, 2018, CELL BIOCHEM BIOPHYS, V76, P293, DOI 10.1007/s12013-016-0770-5; Choi JW, 2017, EXP BIOL MED, V242, P1475, DOI 10.1177/1535370217723166; Choi S, 2019, J AM GERIATR SOC, V67, P1234, DOI 10.1111/jgs.15828; Choi SY, 2019, TISSUE ENG PT A, V25, P1146, DOI [10.1089/ten.tea.2018.0257, 10.1089/ten.TEA.2018.0257]; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Dinkins MB, 2014, NEUROBIOL AGING, V35, P1792, DOI 10.1016/j.neurobiolaging.2014.02.012; Dominy SS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3333; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Furuse Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106434; Gantier MP, 2008, J IMMUNOL, V180, P2117, DOI 10.4049/jimmunol.180.4.2117; Gao L, 2018, PROTEIN CELL, V9, P488, DOI 10.1007/s13238-018-0548-1; Garcia-Contreras M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05787-y; Gaur S, 2015, GERIATR GERONTOL INT, V15, P391, DOI 10.1111/ggi.12425; Ghosal A, 2015, MICROBIOLOGYOPEN, V4, P252, DOI 10.1002/mbo3.235; Graves D, 2008, J PERIODONTOL, V79, P1585, DOI 10.1902/jop.2008.080183; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Han XB, 2012, J BIOL CHEM, V287, P13778, DOI 10.1074/jbc.M112.342683; Henderson B, 2010, PERIODONTOL 2000, V54, P78, DOI 10.1111/j.1600-0757.2009.00331.x; Henry T, 2004, RES MICROBIOL, V155, P437, DOI 10.1016/j.resmic.2004.04.007; Kamer AR, 2008, ALZHEIMERS DEMENT, V4, P242, DOI 10.1016/j.jalz.2007.08.004; Kamer AR, 2009, J NEUROIMMUNOL, V216, P92, DOI 10.1016/j.jneuroim.2009.08.013; Kaparakis-Liaskos M, 2015, NAT REV IMMUNOL, V15, P375, DOI 10.1038/nri3837; Kato S, 2002, MICROB PATHOGENESIS, V32, P1, DOI 10.1006/mpat.2001.0474; Kieselbach T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138591; Kononen E, 2014, PERIODONTOL 2000, V65, P46, DOI 10.1111/prd.12016; Koeppen K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005672; Konig MF, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaj1921; Kourembanas S, 2015, ANNU REV PHYSIOL, V77, P13, DOI 10.1146/annurev-physiol-021014-071641; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Lee HJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061487; Lee HJ, 2014, EXP BIOL MED, V239, P1275, DOI 10.1177/1535370214544269; Lee HJ, 2013, EXP BIOL MED, V238, P339, DOI 10.1258/ebm.2012.012251; Lee HJ, 2012, FEMS MICROBIOL LETT, V326, P131, DOI 10.1111/j.1574-6968.2011.02441.x; Matsumoto J, 2017, CURR PHARM DESIGN, V23, P6206, DOI 10.2174/1381612823666170913164738; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; Naqvi AR, 2014, INNATE IMMUN-LONDON, V20, P540, DOI 10.1177/1753425913501914; Nishihara T, 2004, PERIODONTOL 2000, V36, P14, DOI 10.1111/j.1600-0757.2004.03671.x; Njock MS, 2015, BLOOD, V125, P3202, DOI 10.1182/blood-2014-11-611046; O'Donoghue EJ, 2016, CELL MICROBIOL, V18, P1508, DOI 10.1111/cmi.12655; Okinaga T, 2015, J INTERF CYTOK RES, V35, P431, DOI 10.1089/jir.2014.0127; Olsen I, 2016, J ORAL MICROBIOL, V8, DOI 10.3402/jom.v8.33029; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Patton JG, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27494; Pritchard AB, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00336; Rompikuntal PK, 2012, INFECT IMMUN, V80, P31, DOI 10.1128/IAI.06069-11; Thay B, 2014, INFECT IMMUN, V82, P4034, DOI 10.1128/IAI.01980-14; WISPELWEY B, 1989, INFECT IMMUN, V57, P2559, DOI 10.1128/IAI.57.8.2559-2562.1989; Wu YF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07991-4; Yoon YJ, 2014, BMB REP, V47, P531, DOI 10.5483/BMBRep.2014.47.10.164; Yuan DF, 2017, BIOMATERIALS, V142, P1, DOI 10.1016/j.biomaterials.2017.07.011; Yucel-Lindberg T, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.8; Yuyama K, 2015, FEBS LETT, V589, P84, DOI 10.1016/j.febslet.2014.11.027; Yuyama K, 2014, J BIOL CHEM, V289, P24488, DOI 10.1074/jbc.M114.577213	65	46	49	10	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13412	13422		10.1096/fj.201901575R	http://dx.doi.org/10.1096/fj.201901575R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31545910	Bronze, Green Published			2022-12-28	WOS:000507466100030
J	Yagi, H; Onoyama, I; Asanoma, K; Hori, E; Yasunaga, M; Kodama, K; Kijima, M; Ohgami, T; Kaneki, E; Okugawa, K; Yahata, H; Kato, K				Yagi, Hiroshi; Onoyama, Ichiro; Asanoma, Kazuo; Hori, Emiko; Yasunaga, Masafumi; Kodama, Keisuke; Kijima, Masako; Ohgami, Tatsuhiro; Kaneki, Eisuke; Okugawa, Kaoru; Yahata, Hideaki; Kato, Kiyoko			G alpha(13)-mediated LATS1 down-regulation contributes to epithelial-mesenchymal transition in ovarian cancer	FASEB JOURNAL			English	Article						EMT; ITCH; GPCR; Hippo signaling pathway; ubiquitination	PROMOTES CELL-PROLIFERATION; HETEROTRIMERIC G-PROTEINS; HIPPO SIGNALING PATHWAY; YES-ASSOCIATED PROTEIN; BREAST-CANCER; ALPHA-SUBUNIT; SIZE-CONTROL; G12 FAMILY; YAP; ACTIVATION	G alpha(13), a heterotrimeric G-protein of the G alpha(12/13) subfamily, is associated with aggressive phenotypes in various human cancers. However, the mechanisms by which G alpha(13) promotes cancer progression have not been fully elucidated. Here, we demonstrate that the activation of G alpha(13) induces epithelial-mesenchymal transition in ovarian cancer (OvCa) cells through down-regulation of large tumor suppressor kinase (LATS) 1, a critical component of the Hippo signaling pathway. A synthetic biology approach using a mutant GPCR and chimeric G-protein revealed that G alpha(13)-regulated phosphorylation of LATS1 at serine 909 within its activation loop induced recruitment of the itchy E3 ubiquitin protein ligase to trigger LATS1 degradation. Our findings uncover novel mechanisms through which G alpha(13) activation induces dysregulation of the Hippo signaling pathway, which leads to aggressive cancer phenotypes, and thereby identify a potential target for preventing the metastatic spread of OvCa.	[Yagi, Hiroshi; Onoyama, Ichiro; Asanoma, Kazuo; Hori, Emiko; Yasunaga, Masafumi; Kodama, Keisuke; Kijima, Masako; Ohgami, Tatsuhiro; Kaneki, Eisuke; Okugawa, Kaoru; Yahata, Hideaki; Kato, Kiyoko] Kyushu Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Fukuoka, Japan	Kyushu University	Yagi, H (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yagih@med.kyushu-u.ac.jp	Yasunaga, Masafumi/ABE-4630-2021	Yasunaga, Masafumi/0000-0002-0545-0428; kodama, keisuke/0000-0001-7031-6359	Ministry of Education, Culture, Sports, Science, and Technology of Japan [17K11282]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank Liwen Bianji (Edanz Group China, Beijing, China; www.liwenbianji.cn/ac) for editing the English text of a draft of this manuscript. The authors are grateful to Akari Yasumoto and the Research Support Center of the Graduate School of Medical Science at Kyushu University for technical support. This study was supported, in part, by a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (17K11282). The authors declare no conflicts of interest.	Allred DC, 1998, MODERN PATHOL, V11, P155; Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Cancer Genome Atlas Research Network, 2011, NATURE, V490, P298; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Conklin BR, 2008, NAT METHODS, V5, P673, DOI 10.1038/nmeth.1232; Deng J, 2016, ONCOTARGET, V7, P10037, DOI 10.18632/oncotarget.7048; Domingo E, 2018, LANCET GASTROENTEROL, V3, P635, DOI 10.1016/S2468-1253(18)30117-1; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Gan CP, 2014, ONCOTARGET, V5, P9626, DOI 10.18632/oncotarget.2437; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Ho KC, 2011, P NATL ACAD SCI USA, V108, P4870, DOI 10.1073/pnas.1101273108; Iglesias-Bartolome R, 2015, NAT CELL BIOL, V17, P793, DOI 10.1038/ncb3164; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Kim Y, 2018, BMB REP, V51, P143, DOI 10.5483/BMBRep.2018.51.3.017; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Ni LS, 2015, GENE DEV, V29, P1416, DOI 10.1101/gad.264929.115; Nishio M, 2016, P NATL ACAD SCI USA, V113, pE71, DOI 10.1073/pnas.1517188113; O'Hayre M, 2014, CURR OPIN CELL BIOL, V27, P126, DOI 10.1016/j.ceb.2014.01.005; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Patra KC, 2018, NAT CELL BIOL, V20, P811, DOI 10.1038/s41556-018-0122-3; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Plouffe SW, 2016, MOL CELL, V64, P993, DOI 10.1016/j.molcel.2016.10.034; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Robertson AG, 2017, CANCER CELL, V32, P204, DOI 10.1016/j.ccell.2017.07.003; Salah Z, 2013, CELL CYCLE, V12, P3817, DOI 10.4161/cc.26672; Salah Z, 2011, CANCER RES, V71, P2010, DOI 10.1158/0008-5472.CAN-10-3516; Si Y, 2017, CANCER RES, V77, P4868, DOI 10.1158/0008-5472.CAN-17-0391; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; XU NZ, 1993, P NATL ACAD SCI USA, V90, P6741, DOI 10.1073/pnas.90.14.6741; XU NZ, 1994, BIOCHEM BIOPH RES CO, V201, P603, DOI 10.1006/bbrc.1994.1744; Xu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep35948; Yabuta N, 2013, J CELL SCI, V126, P508, DOI 10.1242/jcs.113431; Yagi H, 2016, ONCOGENE, V35, P4471, DOI 10.1038/onc.2015.505; Yagi H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002221; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang H, 2014, J BIOL CHEM, V289, P18681, DOI 10.1074/jbc.M114.554584; Zhang JX, 2016, ONCOTARGET, V7, P4414, DOI 10.18632/oncotarget.6780; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	51	11	11	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13683	13694		10.1096/fj.201901278R	http://dx.doi.org/10.1096/fj.201901278R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31569999	Bronze			2022-12-28	WOS:000507466100050
J	Bianchi, F; Veggi, D; Santini, L; Buricchi, F; Bartolini, E; Lo Surdo, P; Martinelli, M; Finco, O; Masignani, V; Bottomley, MJ; Maione, D; Cozzi, R				Bianchi, Federica; Veggi, Daniele; Santini, Laura; Buricchi, Francesca; Bartolini, Erika; Lo Surdo, Paola; Martinelli, Manuele; Finco, Oretta; Masignani, Vega; Bottomley, Matthew J.; Maione, Domenico; Cozzi, Roberta			Cocrystal structure of meningococcal factor H binding protein variant 3 reveals a new crossprotective epitope recognized by human mAb 1E6	FASEB JOURNAL			English	Article						Neisseria meningitidis; fHbp; human antibodies; vaccine	COMPLEMENT FACTOR-H; NEISSERIA-MENINGITIDIS; MONOCLONAL-ANTIBODIES; BACTERICIDAL ACTIVITY; CONJUGATE VACCINE; OPEN-LABEL; HUMAN-IGG; IMMUNOGENICITY; DISEASE; ANTIGEN	The 4 component meningococcus B vaccine (4CMenB) vaccine is the first vaccine containing recombinant proteins licensed for the prevention of invasive meningococcal disease caused by meningococcal serogroup B strains. 4CMenB contains 3 main recombinant proteins, including the Neisseria meningitidis factor H binding protein (fHbp), a lipoprotein able to bind the human factor H. To date, over 1000 as sequences of fHbp have been identified, and they can be divided into variant groups 1, 2, and 3, which are usually not crossprotective. Nevertheless, previous characterizations of a small set (n = 10) of mAbs generated in humans after 4CMenB immunization revealed 2 human Fabs (huFabs) (1A12, 1G3) with some crossreactivity for variants 1, 2, and 3. This unexpected result prompted us to examine a much larger set of human mAbs (n = 110), with the aim of better understanding the extent and nature of crossreactive anti-fHbp antibodies. In this study, we report an analysis of the human antibody response to fHbp, by the characterization of 110 huFabs collected from 3 adult vaccinees during a 6-mo study. Although the 4CMenB vaccine contains fHbp variant 1,13 huFabs were also found to be crossreactive with variants 2 and 3. The crystal structure of the crossreactive huFab 1E6 in complex with fHbp variant 3 was determined, revealing a novel, highly conserved epitope distinct from the epitopes recognized by 1A12 or 1G3. Further, functional characterization shows that human mAb 1E6 is able to elicit rabbit, but not human, complement-mediated bactericidal activity against meningococci displaying fHbp from any of the 3 different variant groups. This functional and structural information about the human antibody response upon 4CMenB immunization contributes to further unraveling the immunogenic properties of fHbp. Knowledge gained about the epitope profile recognized by the human antibody repertoire could guide future vaccine design.	[Bianchi, Federica; Veggi, Daniele; Santini, Laura; Buricchi, Francesca; Bartolini, Erika; Martinelli, Manuele; Finco, Oretta; Masignani, Vega; Maione, Domenico; Cozzi, Roberta] GlaxoSmithKline, Siena, Italy; [Bianchi, Federica] Univ Florence, Florence, Italy; [Lo Surdo, Paola; Bottomley, Matthew J.] GlaxoSmithKline, Rockville, MD USA	GlaxoSmithKline; University of Florence; GlaxoSmithKline	Maione, D; Cozzi, R (corresponding author), GSK Vaccines, Via Fiorentina 1, I-53100 Siena, Italy.	domenico.x.maione@gsk.com; roberta.x.cozzi@gsk.com			Novartis Vaccines; Diagnostics Srl; GlaxoSmithKline	Novartis Vaccines; Diagnostics Srl; GlaxoSmithKline(GlaxoSmithKline)	N. meningitidis strains used in this work were kindly provided by the following people and institutions: MC58 by E. Richard Moxon (University of Oxford, Oxford, United Kingdom); M08-240104 and M01-0240320 by Ray Borrow (Health Protection Agency, Manchester, United Kingdom); M11295 by the Centers for Disease Control and Prevention (Atlanta, GA, USA). The authors thank Alexander H. Lucas and Donald C. Reason (Children's Hospital Oakland Research Institute, Oakland, CA, USA) for single-cell variable region of the IgG heavylight chain pairs amplification, cloning, and sequencing. The authors are grateful to Dr. Enrico Malito (GlaxoSmithKline) for useful discussions regarding structure refinement. The authors thank the clinical studies participants. This study was sponsored by Novartis Vaccines and Diagnostics Srl (the Novartis noninfluenza vaccines business was acquired by the GlaxoSmithKline group of companies in March 2015). F.B. participated in a postgraduate studentship program at GlaxoSmithKline. All authors were permanent employees of Novartis Vaccines at the time of the study, and are now permanent employees of the GlaxoSmithKline group of companies. All authors are listed as inventors on patents owned by the GlaxoSmithKline group of companies. Bexsero is a trademark owned by or licensed to the GlaxoSmithKline group of companies.	AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Anderson AS, 2011, EXPERT REV VACCINES, V10, P617, DOI [10.1586/ERV.11.50, 10.1586/erv.11.50]; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beernink PT, 2008, INFECT IMMUN, V76, P4232, DOI 10.1128/IAI.00367-08; Beernink PT, 2015, MBIO, V6, DOI 10.1128/mBio.00842-15; Biagini M, 2016, P NATL ACAD SCI USA, V113, P2714, DOI 10.1073/pnas.1521142113; Cantini F, 2009, J BIOL CHEM, V284, P9022, DOI 10.1074/jbc.C800214200; Cendron L, 2011, ACTA CRYSTALLOGR F, V67, P531, DOI 10.1107/S1744309111006154; Chang Qiuzhi, 2012, Clin Epidemiol, V4, P237, DOI 10.2147/CLEP.S28410; Cooper B, 2011, EXPERT REV VACCINES, V10, P21, DOI 10.1586/ERV.10.147; Costa I, 2014, MBIO, V5, DOI 10.1128/mBio.01625-14; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Domina M, 2016, SCI REP-UK, V6, DOI 10.1038/srep31458; Faleri A, 2014, FASEB J, V28, P1644, DOI 10.1096/fj.13-239012; Findlow J, 2010, CLIN INFECT DIS, V51, P1127, DOI 10.1086/656741; FINNE J, 1987, J IMMUNOL, V138, P4402; Giuliani M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22057-7; Giuliani MM, 2005, INFECT IMMUN, V73, P1151, DOI 10.1128/IAI.73.2.1151-1160.2005; Giuntini S, 2015, INFECT IMMUN, V83, P1536, DOI 10.1128/IAI.02984-14; Giuntini S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034272; Giuntini S, 2012, INFECT IMMUN, V80, P187, DOI 10.1128/IAI.05956-11; Giuntini S, 2011, INFECT IMMUN, V79, P3751, DOI 10.1128/IAI.05182-11; Hall DA, 2007, MECH AGEING DEV, V128, P161, DOI 10.1016/j.mad.2006.11.021; Jodar Luis, 2000, Biologicals, V28, P193, DOI 10.1006/biol.2000.0253; Johnson S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002981; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Keyserling H, 2005, ARCH PEDIAT ADOL MED, V159, P907, DOI 10.1001/archpedi.159.10.907; Koeberling O, 2011, VACCINE, V29, P4728, DOI 10.1016/j.vaccine.2011.04.095; Konar M, 2015, P NATL ACAD SCI USA, V112, P14823, DOI 10.1073/pnas.1507829112; Konar M, 2013, J INFECT DIS, V208, P627, DOI 10.1093/infdis/jit239; Lopez-Sagaseta J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02827-7; Lucidarme J, 2010, CLIN VACCINE IMMUNOL, V17, P919, DOI 10.1128/CVI.00027-10; MacRaild CA, 2016, STRUCTURE, V24, P148, DOI 10.1016/j.str.2015.10.028; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Malito E, 2016, BIOCHEM J, V473, P4699, DOI 10.1042/BCJ20160806; Malito E, 2014, P NATL ACAD SCI USA, V111, P17128, DOI 10.1073/pnas.1419686111; Malito E, 2013, P NATL ACAD SCI USA, V110, P3304, DOI 10.1073/pnas.1222845110; Marshall HS, 2013, VACCINE, V31, P1569, DOI 10.1016/j.vaccine.2013.01.021; Mascioni A, 2010, BBA-BIOMEMBRANES, V1798, P87, DOI 10.1016/j.bbamem.2009.09.021; Masignani V, 2003, VACCINE, V21, pS110, DOI 10.1016/S0264-410X(03)00209-3; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNeil LK, 2009, VACCINE, V27, P3417, DOI 10.1016/j.vaccine.2009.01.075; Parikh SR, 2016, LANCET, V388, P2775, DOI 10.1016/S0140-6736(16)31921-3; Pizza M, 2015, CURR OPIN MICROBIOL, V23, P68, DOI 10.1016/j.mib.2014.11.006; Poolman JT, 2015, EXPERT REV VACCINES, V14, P1277, DOI 10.1586/14760584.2015.1071670; Rosenstein N, 2001, INT J EPIDEMIOL, V30, P1447, DOI 10.1093/ije/30.6.1447; Rosenstein NE, 2001, METH MOLEC MED, V67, P333, DOI 10.1385/1-59259-149-3:333; Rouphael NG, 2012, METHODS MOL BIOL, V799, P1, DOI 10.1007/978-1-61779-346-2_1; Rubinstein ND, 2008, MOL IMMUNOL, V45, P3477, DOI 10.1016/j.molimm.2007.10.016; Sadarangani M, 2016, CLIN MICROBIOL INFEC, V22, pS103, DOI 10.1016/j.cmi.2016.03.006; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Scarselli M, 2009, J MOL BIOL, V386, P97, DOI 10.1016/j.jmb.2008.12.005; Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Seib KL, 2011, INFECT IMMUN, V79, P970, DOI 10.1128/IAI.00891-10; Stanfield RL, 2006, J MOL BIOL, V357, P1566, DOI 10.1016/j.jmb.2006.01.023; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; Vu DM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00341; Zimmer SM, 2004, EXPERT OPIN PHARMACO, V5, P855, DOI 10.1517/14656566.5.4.855	61	3	3	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12099	12111		10.1096/fj.201900374R	http://dx.doi.org/10.1096/fj.201900374R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31442074	Green Published, hybrid			2022-12-28	WOS:000507461600039
J	Furigo, IC; de Souza, GO; Teixeira, PDS; Guadagnini, D; Frazao, R; List, EO; Kopchick, JJ; Prada, PO; Donato, J				Furigo, Isadora C.; de Souza, Gabriel O.; Teixeira, Pryscila D. S.; Guadagnini, Dioze; Frazao, Renata; List, Edward O.; Kopchick, John J.; Prada, Patricia O.; Donato, Jose, Jr.			Growth hormone enhances the recovery of hypoglycemia via ventromedial hypothalamic neurons	FASEB JOURNAL			English	Article						autonomic nervous system; counter-regulatory response; cytokine; GH; hypothalamus	ACTIVATED PROTEIN-KINASE; HEPATIC GLUCOSE-PRODUCTION; FEEDING RESPONSES; SENSING NEURONS; RECEPTOR GHR; LEPTIN; CELLS; BRAIN; REVEALS; LESIONS	Growth hormone (GH) is secreted during hypoglycemia, and GH-responsive neurons are found in brain areas containing glucose-sensing neurons that regulate the counter-regulatory response (CRR). However, whether GH modulates the CRR to hypoglycemia via specific neuronal populations is currently unknown. Mice carrying ablation of GH receptor (GHR) either in leptin receptor (LepR)- or steroidogenic factor-1 (SF1)-expressing cells were studied. We also investigated the importance of signal transducer and activator of transcription 5 (STAT5) signaling in SF1 cells for the CRR. GHR ablation in LepR cells led to impaired capacity to recover from insulin-induced hypoglycemia and to a blunted CRR caused by 2-deoxy-D-glucose (2DG) administration. GHR inactivation in SF1 cells, which include ventromedial hypothalamic neurons, also attenuated the CRR. The reduced CRR was prevented by parasympathetic blockers. Additionally, infusion of 2DG produced an abnormal hyperactivity of parasympathetic preganglionic neurons, whereas the 2DG-induced activation of anterior bed nucleus of the stria terminalis neurons was reduced in mice without GHR in SF1 cells. Mice carrying ablation of Stat5 a/b genes in SF1 cells showed no defects in the CRR. In summary, GHR expression in SF1 cells is required for a normal CRR, and these effects are largely independent of STAT5 pathway.	[Furigo, Isadora C.; de Souza, Gabriel O.; Teixeira, Pryscila D. S.; Donato, Jose, Jr.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Av Prof Lineu Prestes 1524, BR-05508000 Sao Paulo, Brazil; [Frazao, Renata] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, Brazil; [Guadagnini, Dioze; Prada, Patricia O.] Univ Estadual Campinas, Sch Appl Sci, Limeira, Brazil; [List, Edward O.; Kopchick, John J.] Ohio Univ, Edison Biotechnol Inst, Athens, OH 45701 USA; [List, Edward O.; Kopchick, John J.] Ohio Univ, Heritage Coll Osteopath Med, Athens, OH 45701 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas; University System of Ohio; Ohio University; University System of Ohio; Ohio University	Donato, J (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Av Prof Lineu Prestes 1524, BR-05508000 Sao Paulo, Brazil.	jdonato@icb.usp.br	Donato, Jose/ABB-3686-2020; Donato, Jose/A-9662-2010; Furigo, Isadora/G-3575-2016; Orefice de Souza, Gabriel/GVS-4178-2022; Frazao, Renata/D-1374-2012	Donato, Jose/0000-0002-4166-7608; Furigo, Isadora/0000-0002-4387-3878; Orefice de Souza, Gabriel/0000-0003-2534-542X; de Oliveira Prada, Patricia/0000-0002-4245-8867; Frazao, Renata/0000-0002-0877-8453	Sao Paulo Research Foundation (FAPESP) [17/02983-2, 16/09679-4, 17/18498-6, 18/20087-7, 17/218408]; Pfizer, Inc.; U.S. National Institutes of Health, National Institute on Aging [R01AG059779]; NATIONAL INSTITUTE ON AGING [R01AG059779] Funding Source: NIH RePORTER	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Pfizer, Inc.(Pfizer); U.S. National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Ana Maria P. Campos (Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil) for expert technical assistance. This work was supported by the Sao Paulo Research Foundation (FAPESP; Grants 17/02983-2 to J.D.; 16/09679-4 to I.C.F.; 17/18498-6 and 18/20087-7 to P.O.P.; and 17/218408 to R.F.), Pfizer, Inc. [2017 Global Advancing Science Through Pfizer-Investigator Research Exchange (ASPIRE) Young Investigator Research Award to J.D.], and U.S. National Institutes of Health, National Institute on Aging, Grant R01AG059779 (to J.J.K. and E.O.L.). The authors declare no conflicts of interest.	BALKAN B, 1991, AM J PHYSIOL, V260, pR368, DOI 10.1152/ajpregu.1991.260.2.R368; BICK T, 1992, ENDOCRINOLOGY, V131, P423, DOI 10.1210/en.131.1.423; Buonfiglio DC, 2015, HORM BEHAV, V71, P60, DOI 10.1016/j.yhbeh.2015.04.004; Cady G, 2017, MOL METAB, V6, P393, DOI 10.1016/j.molmet.2017.03.001; Campbell JN, 2017, NAT NEUROSCI, V20, P484, DOI 10.1038/nn.4495; CANTERAS NS, 1994, J COMP NEUROL, V348, P41, DOI 10.1002/cne.903480103; Chan JL, 2003, J CLIN INVEST, V111, P1409, DOI 10.1172/JCI200317490; Clegg DJ, 2003, PHYSIOL BEHAV, V78, P331, DOI 10.1016/S0031-9384(02)01000-4; Coutinho EA, 2017, DIABETES, V66, P2372, DOI 10.2337/db16-1344; D'souza AM, 2017, MOL METAB, V6, P1052, DOI 10.1016/j.molmet.2017.04.011; Dehkhoda F, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00035; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Dong HW, 2006, J COMP NEUROL, V494, P142, DOI 10.1002/cne.20788; Faber CL, 2018, DIABETES, V67, P2518, DOI 10.2337/db18-0380; Fan Y, 2009, J BIOL CHEM, V284, P19937, DOI 10.1074/jbc.M109.014308; Flak JN, 2014, NAT NEUROSCI, V17, P1744, DOI 10.1038/nn.3861; Furigo IC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09022-2; Furigo IC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08607-1; Furigo IC, 2018, BRAIN STRUCT FUNCT, V223, P2229, DOI 10.1007/s00429-018-1627-z; Furigo IC, 2017, BRAIN STRUCT FUNCT, V222, P341, DOI 10.1007/s00429-016-1221-1; Furigo IC, 2016, MOL CELL ENDOCRINOL, V438, P70, DOI 10.1016/j.mce.2016.04.019; Garfield AS, 2014, CELL METAB, V20, P1030, DOI 10.1016/j.cmet.2014.11.006; GREENWOOFC, 1966, NATURE, V210, P540, DOI DOI 10.1038/210540A0; Han SM, 2005, DIABETOLOGIA, V48, P2170, DOI 10.1007/s00125-005-1913-1; Huang LL, 2014, J NEUROSCI, V34, P16309, DOI 10.1523/JNEUROSCI.4622-13.2014; Hussain K, 2003, J CLIN ENDOCR METAB, V88, P3715, DOI 10.1210/jc.2003-030137; IKEDA H, 1980, AM J PHYSIOL, V239, pE379, DOI 10.1152/ajpendo.1980.239.5.E379; Kalsbeek A, 2010, ANN NY ACAD SCI, V1212, P114, DOI 10.1111/j.1749-6632.2010.05800.x; Kim KW, 2012, J CLIN INVEST, V122, P2578, DOI 10.1172/JCI62848; LAURSEN T, 1995, J CLIN ENDOCR METAB, V80, P2410, DOI 10.1210/jc.80.8.2410; Li RL, 2012, J BIOL CHEM, V287, P17942, DOI 10.1074/jbc.M112.358051; Liao ST, 2016, ENDOCRINE, V54, P169, DOI 10.1007/s12020-016-1060-0; LILJENQUIST JE, 1977, J CLIN INVEST, V59, P369, DOI 10.1172/JCI108649; Lin J, 2000, DOMEST ANIM ENDOCRIN, V19, P53, DOI 10.1016/S0739-7240(00)00064-3; Lindberg D, 2013, J COMP NEUROL, V521, P3167, DOI 10.1002/cne.23338; List EO, 2015, AGING-US, V7, P500, DOI 10.18632/aging.100766; List EO, 2014, ENDOCRINOLOGY, V155, P1793, DOI 10.1210/en.2013-2086; List EO, 2013, MOL ENDOCRINOL, V27, P524, DOI 10.1210/me.2012-1330; Luquet S, 2007, PEPTIDES, V28, P214, DOI 10.1016/j.peptides.2006.08.036; Matsuhisa M, 2000, METABOLISM, V49, P11, DOI 10.1016/S0026-0495(00)90538-9; McCrimmon RJ, 2004, DIABETES, V53, P1953, DOI 10.2337/diabetes.53.8.1953; McCrimmon RJ, 2008, DIABETES, V57, P444, DOI 10.2337/db07-0837; McCrimmon RJ, 2006, DIABETES, V55, P1755, DOI 10.2337/db05-1359; Meek TH, 2016, P NATL ACAD SCI USA, V113, pE2073, DOI 10.1073/pnas.1521160113; Minokoshi Y, 1999, DIABETES, V48, P287, DOI 10.2337/diabetes.48.2.287; Mittenbuhler MJ, 2018, MOL METAB, V17, P122, DOI 10.1016/j.molmet.2018.08.010; Mizuno K, 2017, HEPATOL RES, V47, P160, DOI 10.1111/hepr.12760; Ozawa Y, 2011, PEPTIDES, V32, P763, DOI 10.1016/j.peptides.2010.12.009; Paes AMA, 2006, INT J NEUROSCI, V116, P1295, DOI 10.1080/00207450600920910; Pedroso JAB, 2017, J ENDOCRINOL, V235, P207, DOI 10.1530/JOE-17-0255; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; Ramos-Lobo AM, 2017, NEUROSCIENCE, V365, P114, DOI 10.1016/j.neuroscience.2017.09.048; Ramos-Lobo Angela M, 2017, Temperature (Austin), V4, P258, DOI 10.1080/23328940.2017.1327003; RIZZA RA, 1979, J CLIN INVEST, V64, P62, DOI 10.1172/JCI109464; ROHNERJEANRENAUD F, 1983, J AUTONOM NERV SYST, V9, P173, DOI 10.1016/0165-1838(83)90139-X; ROTH J, 1963, SCIENCE, V140, P987, DOI 10.1126/science.140.3570.987; Routh VH, 2010, SENSORS-BASEL, V10, P9002, DOI 10.3390/s101009002; Rupp AC, 2018, MOL METAB, V14, P130, DOI 10.1016/j.molmet.2018.06.001; SAKAGUCHI T, 1990, INT J OBESITY, V14, P127; Sakharova AA, 2008, J CLIN ENDOCR METAB, V93, P2755, DOI 10.1210/jc.2008-0079; Seoane-Collazo P, 2015, ENDOCRINE, V50, P276, DOI 10.1007/s12020-015-0658-y; SHIMAZU T, 1966, NATURE, V210, P1178, DOI 10.1038/2101178a0; Silveira MA, 2017, MOL CELL ENDOCRINOL, V448, P55, DOI 10.1016/j.mce.2017.03.024; Stanley S, 2013, CELL METAB, V18, P596, DOI 10.1016/j.cmet.2013.09.002; Steyn FJ, 2012, ENDOCRINOLOGY, V153, P273, DOI 10.1210/en.2011-1681; Suzuki Y, 2014, DIABETES, V63, P1637, DOI 10.2337/db13-0636; SZABO AJ, 1983, AM J PHYSIOL, V244, pE467, DOI 10.1152/ajpendo.1983.244.5.E467; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Tennese AA, 2011, ENDOCRINOLOGY, V152, P967, DOI 10.1210/en.2010-0709; THOMPSON CI, 1979, PHYSIOL BEHAV, V23, P187, DOI 10.1016/0031-9384(79)90142-2; Valensi P, 2003, OBES RES, V11, P54, DOI 10.1038/oby.2003.10; Verberne AJM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00038; WINKLER B, 1964, AM J PHYSIOL, V206, P174, DOI 10.1152/ajplegacy.1964.206.1.174; Yi CX, 2010, BBA-MOL BASIS DIS, V1802, P416, DOI 10.1016/j.bbadis.2010.01.006; Zanotto T. M., 2016, MOL METAB, V6, P206; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107	76	20	20	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11909	11924		10.1096/fj.201901315R	http://dx.doi.org/10.1096/fj.201901315R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31366244	Bronze, Green Published			2022-12-28	WOS:000507461600026
J	Huertas, JR; Ruiz-Ojeda, FJ; Plaza-Diaz, J; Nordsborg, NB; Martin-Albo, J; Rueda-Robles, A; Casuso, RA				Huertas, Jesus R.; Javier Ruiz-Ojeda, Francisco; Plaza-Diaz, Julio; Nordsborg, Nikolai B.; Martin-Albo, Jesus; Rueda-Robles, Ascension; Casuso, Rafael A.			Human muscular mitochondrial fusion in athletes during exercise	FASEB JOURNAL			English	Article						physical activity; mitochondrial fission; skeletal muscle; mitofusin 2	HUMAN SKELETAL-MUSCLE; MEMBRANE INTERACTIONS; FISSION; PROTEIN; RETICULUM; ADAPTATIONS; ACTIVATION; FIS1	The main objective of this work was to investigate whether mitochondrial fusion occurs in the skeletal muscle of well-trained athletes in response to high-intensity exercise. Well-trained swimmers (n = 9) performed a duration-matched sprint interval training (SIT) and high-intensity high-volume training (HIHVT) session on separate days. Muscle samples from triceps brachii were taken before, immediately after, and 3 h after the training sessions. Transmission electron microscopy (TEM) was applied to assess mitochondrial morphology. Moreover, expression of genes coding for regulators of mitochondrial fusion and fission were assessed by real-time quantitative PCR. In addition, mitofusin (MFN)2 and optic atrophy 1 (OPA1) were quantified by Western blot analysis. TEM analyses showed that mitochondrial morphology remained altered for 3 h after HIHVT, whereas SIT-induced changes were only evident immediately after exercise. Only SIT increased MFN1 and MFN2 mRNA expression, whereas SIT and HIHVT both increased MFN2 protein content 3 h after exercise. Notably, only HIHVT increased OPA1 protein content. Mitochondrial morphologic changes that suggest fusion occurs in well-adapted athletes during exercise. However, HIHVT appears as a more robust inducer of mitochondrial fusion events than SIT. Indeed, SIT induces a rapid and transient change in mitochondrial morphology.	[Huertas, Jesus R.; Casuso, Rafael A.] Univ Granada, Sch Pharm, Dept Physiol, Granada, Spain; [Huertas, Jesus R.; Plaza-Diaz, Julio; Martin-Albo, Jesus; Rueda-Robles, Ascension; Casuso, Rafael A.] Univ Granada, Biomed Res Ctr, Jose Mataix Inst Nutr & Food Technol, Lab 116,Ave Conocimiento S-N, Granada 18100, Spain; [Javier Ruiz-Ojeda, Francisco; Plaza-Diaz, Julio] Univ Granada, Sch Pharm, Dept Biochem & Mol Biol 2, Granada, Spain; [Javier Ruiz-Ojeda, Francisco; Plaza-Diaz, Julio] Complejo Hosp Univ Granada, Inst Invest Biosanitaria Granada IBS GRANADA, Granada, Spain; [Javier Ruiz-Ojeda, Francisco] Helmholtz Ctr Munich, Helmholtz Diabet Ctr, Inst Diabet & Obes, Adipocytes & Metab Unit, Munich, Germany; [Nordsborg, Nikolai B.] Univ Copenhagen, Sect Integrat Physiol, Dept Nutr Exercise & Sports NEXS, Copenhagen, Denmark	University of Granada; University of Granada; University of Granada; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Copenhagen	Huertas, JR; Casuso, RA (corresponding author), Univ Granada, Biomed Res Ctr, Jose Mataix Inst Nutr & Food Technol, Lab 116,Ave Conocimiento S-N, Granada 18100, Spain.	jhuertas@ugr.es; casusopt@gmail.es	Rueda, Ascensión/AAB-7765-2021; Huertas, Jesus Francisco Rodriguez/G-8188-2015; Plaza-Diaz, Julio/C-8094-2016; Casuso, Rafael/E-9617-2016; Nordsborg, Nikolai/O-6173-2014	Rueda, Ascensión/0000-0003-1048-2448; Huertas, Jesus Francisco Rodriguez/0000-0002-7446-0857; Plaza-Diaz, Julio/0000-0002-5171-9408; Casuso, Rafael/0000-0002-4482-3186; Nordsborg, Nikolai/0000-0001-7077-9265	Ministerio de Economia y Competitividad [SAF2015-65786-R]; Fundacion General Empresa-Universidad de Granada [3650]; CTS-454 investigation group, "Impacto Fisiologico del estres Oxidativo, Deporte, Actividad Fisica y Salud"	Ministerio de Economia y Competitividad(Spanish Government); Fundacion General Empresa-Universidad de Granada; CTS-454 investigation group, "Impacto Fisiologico del estres Oxidativo, Deporte, Actividad Fisica y Salud"	The authors thank Daniel Camiletti Moiron (University of Cadiz, Cadiz, Spain) and Jeronimo Aragon-Vela (University of Granada) for technical assistance, and Mohamed Tassi Mzanzi (University of Granada) for helpful comments on transmission electron microscopy analysis. F.J.R.-O. and J.P.-D. are part of the University of Granada Plan Propio de Investigacion 2016. This study was partially supported by Grant SAF2015-65786-R from the Ministerio de Economia y Competitividad, Grant 3650 managed by Fundacion General Empresa-Universidad de Granada, and the CTS-454 investigation group, "Impacto Fisiologico del estres Oxidativo, Deporte, Actividad Fisica y Salud." The authors declare no conflicts of interest.	Axelrod CL, 2019, ACTA PHYSIOL, V225, DOI 10.1111/apha.13216; Boushel R, 2011, MITOCHONDRION, V11, P303, DOI 10.1016/j.mito.2010.12.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cartoni R, 2005, J PHYSIOL-LONDON, V567, P349, DOI 10.1113/jphysiol.2005.092031; Casuso RA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185494; Casuso RA, 2014, J SPORT SCI MED, V13, P958; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Del Dotto V, 2017, CELL REP, V19, P2557, DOI 10.1016/j.celrep.2017.05.073; Drake JC, 2016, FASEB J, V30, P13, DOI 10.1096/fj.15-276337; Eisner V, 2014, J CELL BIOL, V205, P179, DOI 10.1083/jcb.201312066; Fealy CE, 2014, J APPL PHYSIOL, V117, P239, DOI 10.1152/japplphysiol.01064.2013; Feng Q, 2018, J CELL SCI, V131, DOI 10.1242/jcs.218479; Fiorenza M, 2018, J PHYSIOL-LONDON, V596, P2823, DOI 10.1113/JP275972; Franco A, 2016, NATURE, V540, P74, DOI 10.1038/nature20156; GAITANOS GC, 1993, J APPL PHYSIOL, V75, P712, DOI 10.1152/jappl.1993.75.2.712; GALE JB, 1974, MED SCI SPORT EXER, V6, P182; Gibala MJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE235; Glancy B, 2015, NATURE, V523, P617, DOI 10.1038/nature14614; GOLLNICK PD, 1969, AM J PHYSIOL, V216, P1502, DOI 10.1152/ajplegacy.1969.216.6.1502; Gomes LC, 2008, BBA-BIOENERGETICS, V1777, P860, DOI 10.1016/j.bbabio.2008.05.442; Granata C, 2018, SPORTS MED, V48, P1809, DOI 10.1007/s40279-018-0936-y; Granata C, 2017, SCI REP-UK, V7, DOI 10.1038/srep44227; Granata C, 2016, FASEB J, V30, P959, DOI 10.1096/fj.15-276907; Greggio C, 2017, CELL METAB, V25, P301, DOI 10.1016/j.cmet.2016.11.004; Helle SCJ, 2017, ELIFE, V6, DOI 10.7554/eLife.30292; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; HOPPELER H, 1986, INT J SPORTS MED, V7, P187, DOI 10.1055/s-2008-1025758; Huertas JR, 2017, REDOX BIOL, V13, P477, DOI 10.1016/j.redox.2017.07.009; Huertas JR, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/7058350; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Koyano F, 2019, J BIOL CHEM, V294, P10300, DOI 10.1074/jbc.RA118.006302; Larsen FJ, 2016, FASEB J, V30, P417, DOI 10.1096/fj.15-276857; Lundby AKM, 2018, ACTA PHYSIOL, V222, DOI 10.1111/apha.12905; MacInnis MJ, 2017, J PHYSIOL-LONDON, V595, P2915, DOI 10.1113/JP273196; Mathai AS, 2008, J APPL PHYSIOL, V105, P1098, DOI 10.1152/japplphysiol.00847.2007; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Nielsen J, 2011, J PHYSIOL-LONDON, V589, P2871, DOI 10.1113/jphysiol.2010.204487; Niklas P, 2010, EUR J APPL PHYSIOL, V110, P597, DOI 10.1007/s00421-010-1544-1; Ortenblad N, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01031; Ortenblad N, 2011, J PHYSIOL-LONDON, V589, P711, DOI 10.1113/jphysiol.2010.195982; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; Picard M, 2013, J APPL PHYSIOL, V115, P1562, DOI 10.1152/japplphysiol.00819.2013; Picard M, 2013, J APPL PHYSIOL, V114, P161, DOI 10.1152/japplphysiol.01096.2012; Schwalm C, 2017, MED SCI SPORT EXER, V49, P1552, DOI 10.1249/MSS.0000000000001256; Sebastian D, 2018, CURR OPIN PHYSIOL, V3, P34, DOI 10.1016/j.cophys.2018.02.006; Shen QF, 2014, MOL BIOL CELL, V25, P145, DOI 10.1091/mbc.E13-09-0525; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; TERJUNG RL, 1972, AM J PHYSIOL, V223, P549, DOI 10.1152/ajplegacy.1972.223.3.549; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; West Mark J, 2012, Cold Spring Harb Protoc, V2012, P1129, DOI 10.1101/pdb.top071787; Zinner C, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00426	53	14	15	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12087	12098		10.1096/fj.201900365RR	http://dx.doi.org/10.1096/fj.201900365RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31398297	Bronze			2022-12-28	WOS:000507461600038
J	Hughes, R; Chen, XY; Hunter, KD; Hobbs, JK; Holen, I; Brown, NJ				Hughes, Russell; Chen, Xinyue; Hunter, Keith D.; Hobbs, Jamie K.; Holen, Ingunn; Brown, Nicola J.			Bone marrow osteoprogenitors are depleted whereas osteoblasts are expanded independent of the osteogenic vasculature in response to zoledronic acid	FASEB JOURNAL			English	Article						ZOL; bone microenvironment; bone microvasculature; mesenchymal stromal cells	NITROGEN-CONTAINING BISPHOSPHONATES; OSTEOCLAST DIFFERENTIATION FACTOR; MESENCHYMAL STEM-CELLS; IN-VIVO; MORPHOGENETIC PROTEINS; POSTMENOPAUSAL WOMEN; MEVALONATE PATHWAY; DENDRITIC CELLS; DISTINCT ROLES; ANGIOGENESIS	Zoledronic acid (ZOL) is an antiresorptive drug used to prevent bone loss in a variety of conditions, acting mainly through suppression of osteoclast activity. There is growing evidence that ZOL can also affect cells of the mesenchymal lineage in bone. We present novel data revealing significant changes in the abundance of perivascular mesenchymal stromal cells (MSCs)/osteoprogenitors and osteoblasts following the injection of ZOL, in vivo. In young mice with high bone turnover and an abundance of perivascular osteoprogenitors, ZOL significantly (P < 0.0001) increased new bone formation. This was accompanied by a decline in osterix-positive osteoprogenitors and a corresponding increase in osteoblasts. However, these effects were not observed in mature mice with low bone turnover. Interestingly, the ZOL-induced changes in cells of the mesenchymal lineage occurred independently of effects on the osteogenic vasculature. Thus, we demonstrate that a single, clinically relevant dose of ZOL can induce new bone formation in microenvironments enriched for perivascular MSC/osteoprogenitors and high osteogenic potential. This arises from the differentiation of perivascular osterix-positive MSC/osteoprogenitors into osteoblasts at sites that are innately osteogenic. Collectively, our data demonstrate that ZOL affects multiple cell types in bone and has differential effects depending on the level of bone turnover.	[Hughes, Russell; Chen, Xinyue; Holen, Ingunn; Brown, Nicola J.] Univ Sheffield, Expt Canc Med Ctr, Dept Oncol & Metab, Sheffield, S Yorkshire, England; [Chen, Xinyue; Hobbs, Jamie K.] Univ Sheffield, Dept Phys & Astron, Sheffield, S Yorkshire, England; [Hunter, Keith D.] Univ Sheffield, Sch Clin Dent, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Brown, NJ (corresponding author), Univ Sheffield, Dept Oncol & Metab, Beech Hill Rd, Sheffield S10 4RX, S Yorkshire, England.	n.j.brown@sheffield.ac.uk	Hunter, Keith D/B-5670-2009; chen, xinyue/HHR-9308-2022	Holen, Ingunn/0000-0002-8759-6913; Chen, Xinyue/0000-0001-6987-5540	Cancer Research UK; Engineering and Physical Sciences Research Council [A21082]; Weston Park Cancer Charity (Sheffield, United Kingdom)	Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Weston Park Cancer Charity (Sheffield, United Kingdom)	The authors thank the Wolfson Light Microscopy Facility at the University of Sheffield for use of the Nikon A1 (Wellcome Trust Grant WT093134AIA) and Zeiss LSM880 AiryScan microscopes. This research was supported by Cancer Research UK and the Engineering and Physical Sciences Research Council (Grant A21082). Histology support was provided by Alyson Evans (Department of Oncology and Metabolism, University of Sheffield), who is funded by Weston Park Cancer Charity (Sheffield, United Kingdom); both are gratefully acknowledged. I.H. and N.J.B. are joint senior authors. The authors declare no conflicts of interest.	Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Baek WY, 2009, J BONE MINER RES, V24, P1055, DOI [10.1359/JBMR.081248, 10.1359/jbmr.081248]; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Biver E, 2010, BONE, V46, P643, DOI 10.1016/j.bone.2009.10.034; BLUM CB, 1994, AM J CARDIOL, V74, P639; Borghese C, 2017, ONCOTARGET, V8, P42926, DOI 10.18632/oncotarget.17216; Brufsky A, 2007, J CLIN ONCOL, V25, P829, DOI 10.1200/JCO.2005.05.3744; Bundred NJ, 2008, CANCER-AM CANCER SOC, V112, P1001, DOI 10.1002/cncr.23259; Chen TL, 2002, J CLIN PHARMACOL, V42, P1228, DOI 10.1177/009127002762491316; CORSINI A, 1995, PHARMACOL RES, V31, P9, DOI 10.1016/1043-6618(95)80042-5; Coxon FP, 2000, J BONE MINER RES, V15, P1467, DOI 10.1359/jbmr.2000.15.8.1467; Dalle Carbonare L., 2017, INT J MOL SCI, V18, pE1261; Drake MT, 2008, MAYO CLIN PROC, V83, P1032, DOI 10.4065/83.9.1032; Ebert R, 2009, BONE, V44, P858, DOI 10.1016/j.bone.2009.01.009; Fournier P, 2002, CANCER RES, V62, P6538; Grcevic D, 2012, STEM CELLS, V30, P187, DOI 10.1002/stem.780; Haider MT, 2014, BONE, V66, P240, DOI 10.1016/j.bone.2014.06.023; Holen I, 2010, CURR PHARM DESIGN, V16, P1262, DOI 10.2174/138161210791034003; Horwood NJ, 1998, ENDOCRINOLOGY, V139, P4743, DOI 10.1210/en.139.11.4743; Hustedt Joshua W., 2014, Yale Journal of Biology and Medicine, V87, P549; Ikebuchi Y, 2018, NATURE, V561, P195, DOI 10.1038/s41586-018-0482-7; Jacome-Galarza CE, 2013, J BONE MINER RES, V28, P1203, DOI 10.1002/jbmr.1822; Kaiser T, 2013, BREAST CANCER RES TR, V140, P35, DOI 10.1007/s10549-013-2613-z; Kalajzic Z, 2008, BONE, V43, P501, DOI 10.1016/j.bone.2008.04.023; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Kavanagh KL, 2006, P NATL ACAD SCI USA, V103, P7829, DOI 10.1073/pnas.0601643103; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Lang M, 2016, BRIT J ORAL MAX SURG, V54, P889, DOI 10.1016/j.bjoms.2016.05.030; Llombart A, 2012, CLIN BREAST CANCER, V12, P40, DOI 10.1016/j.clbc.2011.08.002; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Maeda T, 2001, BIOCHEM BIOPH RES CO, V280, P874, DOI 10.1006/bbrc.2000.4232; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Michailidou M, 2010, J VASC RES, V47, P481, DOI 10.1159/000313876; Misso G, 2012, CANCER BIOL THER, V13, P1491, DOI 10.4161/cbt.22274; Miyamoto T, 2001, BLOOD, V98, P2544, DOI 10.1182/blood.V98.8.2544; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Ottewell PD, 2008, CLIN CANCER RES, V14, P4658, DOI 10.1158/1078-0432.CCR-07-1545; Ottewell PD, 2014, CLIN CANCER RES, V20, P2922, DOI 10.1158/1078-0432.CCR-13-1246; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ramasamy SK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13601; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Reszka AA, 1999, J BIOL CHEM, V274, P34967, DOI 10.1074/jbc.274.49.34967; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sanchez-Fernandez MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003537; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Soki FN, 2013, J CELL BIOCHEM, V114, P67, DOI 10.1002/jcb.24301; Stresing V, 2011, BONE, V48, P259, DOI 10.1016/j.bone.2010.09.035; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tan SH, 2014, P NATL ACAD SCI USA, V111, pE5262, DOI 10.1073/pnas.1420463111; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Tokunaga A, 2008, J BONE MINER RES, V23, P1519, DOI 10.1359/JBMR.080409; Ubellacker JM, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0815-8; Walker EC, 2008, J BONE MINER RES, V23, P2025, DOI 10.1359/JBMR.080706; Wood J, 2002, J PHARMACOL EXP THER, V302, P1055, DOI 10.1124/jpet.102.035295; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yoshida CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032364	62	4	4	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12768	12779		10.1096/fj.201900553RR	http://dx.doi.org/10.1096/fj.201900553RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31490705	Green Published			2022-12-28	WOS:000507461600091
J	Li, ZL; Lv, LL; Wang, B; Tang, TT; Feng, Y; Cao, JY; Jiang, LQ; Sun, YB; Liu, H; Zhang, XL; Ma, KL; Tang, RN; Liu, BC				Li, Zuo-Lin; Lv, Lin-Li; Wang, Bin; Tang, Tao-Tao; Feng, Ye; Cao, Jing-Yuan; Jiang, Li-Qiong; Sun, Yan-Bei; Liu, Hong; Zhang, Xiao-Liang; Ma, Kun-Ling; Tang, Ri-Ning; Liu, Bi-Cheng			The profibrotic effects of MK-8617 on tubulointerstitial fibrosis mediated by the KLF5 regulating pathway	FASEB JOURNAL			English	Article						HIF-PHI; tubulointerstitial fibrosis; HIF-1; Kruppel-like factor 5; TGF-beta 1	HYDROXYLASE INHIBITOR GSK1278863; ROXADUSTAT FG-4592; KIDNEY INJURY; TGF-BETA; HYPOXIA; CELLS; ANEMIA; EXPRESSION; ERYTHROPOIETIN; HIF-1-ALPHA	The discovery of hypoxia-inducible factor (HIF)-prolyl hydroxylase inhibitor (PHI) has revolutionized the treatment strategy for renal anemia. However, the presence of multiple transcription targets of HIF raises safety concerns regarding HIF-PHI. Here, we explored the dose-dependent effect of MK-8617 (MK), a kind of HIF-PHI, on renal fibrosis. MK was administered by oral gavage to mice for 12 wk at doses of 1.5, 5, and 12.5 mg/kg. In vitro, the human proximal tubule epithelial cell line HK-2 was treated with increasing doses of MK administration. Transcriptome profiling was performed, and fibrogenesis was evaluated. The dose-dependent biphasic effects of MK on tubulointerstitial fibrosis (TIF) were observed in chronic kidney disease mice. Accordingly, high-dose MK treatment could significantly enhance TIF. Using RNA-sequencing, combined with in vivo and in vitro experiments, we found that Kriippel-like factor 5 (KLF5) expression level was significantly increased in the proximal tubular cells, which could be transcriptionally regulated by HIF-la with high-dose MK treatment but not low-dose MK. Furthermore, our study clarified that HIF-1 alpha-KLF5-TGF-beta 1 signaling activation is the potential mechanism of high-dose MK-induced TIF, as knockdown of KLF5 reduced TIF in vivo. Collectively, our study demonstrates that high-dose MK treatment initiates TIF by activating HIF-1 alpha-KLF5-TGF-beta 1 signaling. These findings provide novel insights into TIF induction by high-dose MK (HIF-PHI), suggesting that the safety dosage window needs to be emphasized in future clinical applications.	[Li, Zuo-Lin; Lv, Lin-Li; Wang, Bin; Tang, Tao-Tao; Feng, Ye; Cao, Jing-Yuan; Jiang, Li-Qiong; Sun, Yan-Bei; Liu, Hong; Zhang, Xiao-Liang; Ma, Kun-Ling; Tang, Ri-Ning; Liu, Bi-Cheng] Southeast Univ, Inst Nephrol, Zhong Da Hosp, Sch Med, 87 Dingjiaqiao Rd, Nanjing 210000, Peoples R China	Southeast University - China	Lv, LL; Liu, BC (corresponding author), Southeast Univ, Inst Nephrol, Zhong Da Hosp, Sch Med, 87 Dingjiaqiao Rd, Nanjing 210000, Peoples R China.	linlilv2000@hotmail.com; Liubc64@163.com		Liu, Bi-cheng/0000-0002-4584-1853; Li, Zuo-lin/0000-0002-6694-8406	National Natural Scientific Foundation of China [81720108007, 81470922, 31671194, 81470997, 81670696]; National Key Research and Development Program of China [2018YFC1314002]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	The authors thank Fang-Yuan Qian (Southeast University School of Medicine) for the valuable comments and suggestions in histological analysis. The authors also thank Chen-Chen Zhang (Southeast University School of Medicine) for confocal image acquisition and valuable technical support. This study is supported by the National Natural Scientific Foundation of China (Grants 81720108007, 81470922, 31671194, 81470997, and 81670696) and National Key Research and Development Program of China (2018YFC1314002). The authors declare no conflicts of interest.	Baek JH, 2015, J CLIN INVEST, V125, P3198, DOI 10.1172/JCI81166; Baumann B, 2016, KIDNEY INT, V90, P797, DOI 10.1016/j.kint.2016.05.026; Besarab A, 2016, J AM SOC NEPHROL, V27, P1225, DOI 10.1681/ASN.2015030241; Brigandi RA, 2016, AM J KIDNEY DIS, V67, P861, DOI 10.1053/j.ajkd.2015.11.021; Chen N, 2017, NEPHROL DIAL TRANSPL, V32, P1373, DOI 10.1093/ndt/gfx011; Chen WC, 2015, AM J PATHOL, V185, P2468, DOI 10.1016/j.ajpath.2015.05.019; Debenham JS, 2016, J MED CHEM, V59, P11039, DOI 10.1021/acs.jmedchem.6b01242; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Ganz T, 2016, SEMIN NEPHROL, V36, P87, DOI 10.1016/j.semnephrol.2016.02.001; Gerl K, 2015, KIDNEY INT, V88, P1345, DOI 10.1038/ki.2015.274; Haase VH, 2017, EXP CELL RES, V356, P160, DOI 10.1016/j.yexcr.2017.05.004; Haase VH, 2013, BLOOD REV, V27, P41, DOI 10.1016/j.blre.2012.12.003; Hanna C, 2013, AM J PHYSIOL-RENAL, V305, pF1323, DOI 10.1152/ajprenal.00155.2013; Higashi AY, 2019, J AM SOC NEPHROL, V30, P80, DOI 10.1681/ASN.2018060644; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Holdstock L, 2016, J AM SOC NEPHROL, V27, P1234, DOI 10.1681/ASN.2014111139; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kalucka J, 2015, J MOL MED, V93, P891, DOI 10.1007/s00109-015-1264-4; Kim DH, 2015, CELL STEM CELL, V16, P88, DOI 10.1016/j.stem.2014.11.005; Kimura K, 2008, AM J PHYSIOL-RENAL, V295, pF1023, DOI 10.1152/ajprenal.90209.2008; Kobayashi H, 2016, J CLIN INVEST, V126, P1926, DOI 10.1172/JCI83551; Koury MJ, 2015, NAT REV NEPHROL, V11, P394, DOI 10.1038/nrneph.2015.82; Li ZL, 2019, KIDNEY INT, V95, P388, DOI 10.1016/j.kint.2018.09.013; Liu BC, 2018, KIDNEY INT, V93, P568, DOI 10.1016/j.kint.2017.09.033; Liu D, 2015, J BIOL CHEM, V290, P18018, DOI 10.1074/jbc.M115.662064; Luo RN, 2015, HYPERTENSION, V66, P75, DOI 10.1161/HYPERTENSIONAHA.115.05578; Maxwell PH, 2016, NAT REV NEPHROL, V12, P157, DOI 10.1038/nrneph.2015.193; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Paliege A, 2010, KIDNEY INT, V77, P312, DOI 10.1038/ki.2009.460; Pergola PE, 2016, KIDNEY INT, V90, P1115, DOI 10.1016/j.kint.2016.07.019; Provenzano R, 2016, CLIN J AM SOC NEPHRO, V11, P982, DOI 10.2215/CJN.06890615; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Semenza GL, 2019, ANNU REV PHARMACOL, V59, P379, DOI 10.1146/annurev-pharmtox-010818-021637; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Souma T, 2013, J AM SOC NEPHROL, V24, P1599, DOI 10.1681/ASN.2013010030; Sugahara M, 2017, KIDNEY INT, V92, DOI 10.1016/j.kint.2017.02.035; Sun SR, 2009, KIDNEY INT, V75, P1278, DOI 10.1038/ki.2009.62; Szeto SG, 2016, J AM SOC NEPHROL, V27, P3117, DOI 10.1681/ASN.2015050499; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Wang LY, 2015, INT J BIOCHEM CELL B, V58, P17, DOI 10.1016/j.biocel.2014.10.030; Yokoro M, 2017, J AM SOC NEPHROL, V28, P2671, DOI 10.1681/ASN.2016111184	42	15	17	3	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12630	12643		10.1096/fj.201901087RR	http://dx.doi.org/10.1096/fj.201901087RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31451021	Green Published			2022-12-28	WOS:000507461600080
J	Mao, SS; Zhang, SS; Zhou, SS; Huang, T; Feng, W; Gu, XS; Yu, B				Mao, Susu; Zhang, Shanshan; Zhou, Shuoshuo; Huang, Tao; Feng, Wei; Gu, Xiaosong; Yu, Bin			A Schwann cell-enriched circular RNA circ-Ankib1 regulates Schwann cell proliferation following peripheral nerve injury	FASEB JOURNAL			English	Article						Cyp26b1; competing endogenous RNA; sciatic nerve injury; axon regeneration	MIGRATION; BINDING; REGENERATION; BIOGENESIS; INDUCTION; ABUNDANT; ROLES	Schwann cells (SCs) play an essential role in nerve injury repair. A striking feature of the cellular response to peripheral nerve injury is the proliferation of SCs. Circular (circ)RNAs are enriched in the nervous system and are involved in physiologic and pathologic processes. However, the potential role of circRNAs in SC proliferation post nerve injury remains largely unknown. Using a sciatic nerve crush model, we obtained an expression profiling of circRNAs in injured sciatic nerves in rats by RNA sequencing and bioinformatics analysis, and we further identified a circRNA [circ-ankyrin repeat and in-between Ring finger (IBR) domain containing 1 (Ankib1)] involved in SC proliferation by the transfection of specific small interfering RNAs. Overexpression of circ-Ankib1, which was specifically and highly enriched in SCs, impaired SC proliferation and axon regeneration following sciatic nerve injury. Mechanistically, increased expression of DEx/H-box helicase 9 (DHX9) postinjury might contribute to the down-regulation of circ-Ankib1, which further suppressed cytochrome P450, family 26, subfamily B, polypeptide 1 expression by sponging miR-423-5p, miR-485-5p, and miR-666-3p, leading to the induction of SC proliferation and nerve regeneration. Taken together, our results reveal a crucial role for circRNAs in regulating proliferation of SCs involved in sciatic nerve regeneration; as such, circRNAs may serve as a potential therapeutic avenue for nerve injury repair.	[Mao, Susu; Zhang, Shanshan; Zhou, Shuoshuo; Huang, Tao; Feng, Wei; Gu, Xiaosong; Yu, Bin] Nantong Univ, Affiliated Hosp, Key Lab Neuroregenerat Jiangsu, Nantong, Peoples R China; [Mao, Susu; Zhang, Shanshan; Zhou, Shuoshuo; Huang, Tao; Feng, Wei; Gu, Xiaosong; Yu, Bin] Nantong Univ, Affiliated Hosp, Minist Educ, Coinnovat Ctr Neuroregenerat, Nantong, Peoples R China; [Gu, Xiaosong; Yu, Bin] Nantong Univ, Affiliated Hosp, Jiangsu Clin Med Ctr Tissue Engn & Nerve Injury R, Nantong, Peoples R China	Nantong University; Nantong University; Nantong University	Yu, B (corresponding author), Nantong Univ, Key Lab Neuroregenerat Jiangsu, Bldg 7,19 Qixiu Rd, Nantong 226001, Peoples R China.; Yu, B (corresponding author), Nantong Univ, Minist Educ, Coinnovat Ctr Neuroregenerat, Bldg 7,19 Qixiu Rd, Nantong 226001, Peoples R China.	yubin@ntu.edu.cn			National Major Project of Research and Development [2017YFA0104701]; National Natural Science Foundation of China [31730031, 81771326, 31700925]; Jiangsu Provincial Natural Science Foundation [BK20170442]; Jiangsu Government Scholarship for Overseas Studies [JS2018-189]; Jiangsu Provincial Key Medical Center of Jiangsu Higher Education Institution; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institution	National Major Project of Research and Development; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Jiangsu Government Scholarship for Overseas Studies; Jiangsu Provincial Key Medical Center of Jiangsu Higher Education Institution; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institution	This work was supported by the National Major Project of Research and Development (2017YFA0104701 to B.Y.), the National Natural Science Foundation of China (31730031 to X.G., 81771326 to B.Y., and 31700925 to S.M.), the Jiangsu Provincial Natural Science Foundation (BK20170442 to S.M.), a Jiangsu Government Scholarship for Overseas Studies (JS2018-189 to S.M.), and the Jiangsu Provincial Key Medical Center and Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions. The authors declare no conflicts of interest.	Aktas T, 2017, NATURE, V544, P115, DOI 10.1038/nature21715; Allodi I, 2014, GLIA, V62, P1736, DOI 10.1002/glia.22712; Arthur-Farraj PJ, 2017, CELL REP, V20, P2719, DOI 10.1016/j.celrep.2017.08.064; Chang HM, 2014, J PINEAL RES, V56, P322, DOI 10.1111/jpi.12125; Chen LL, 2016, NAT REV MOL CELL BIO, V17, P205, DOI 10.1038/nrm.2015.32; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; Doyle KL, 2008, J NEUROCHEM, V105, P641, DOI 10.1111/j.1471-4159.2007.05188.x; Engedal N, 2006, J IMMUNOL, V177, P2851, DOI 10.4049/jimmunol.177.5.2851; Gao Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0571-3; Guertin AD, 2005, J NEUROSCI, V25, P3478, DOI 10.1523/JNEUROSCI.3766-04.2005; Gupta SK, 2018, CIRC RES, V122, P246, DOI 10.1161/CIRCRESAHA.117.311335; Hall S, 2005, J BONE JOINT SURG BR, V87B, P1309, DOI 10.1302/0301-620X.87B10.16700; Haque S, 2017, GENES-BASEL, V8, DOI 10.3390/genes8120353; Hu X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.424; Hua WF, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.252; Ivanov A, 2015, CELL REP, V10, P170, DOI 10.1016/j.celrep.2014.12.019; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Jessen KR, 2016, J PHYSIOL-LONDON, V594, P3521, DOI 10.1113/JP270874; Kipp JL, 2011, ENDOCRINOLOGY, V152, P303, DOI 10.1210/en.2010-0749; Kleaveland B, 2018, CELL, V174, P350, DOI 10.1016/j.cell.2018.05.022; Koeppen AH, 2004, J NEUROL SCI, V220, P115, DOI 10.1016/j.jns.2004.03.008; KOMIYAMA A, 1991, J NEUROSCI RES, V29, P308, DOI 10.1002/jnr.490290306; Kramer MC, 2015, GENE DEV, V29, P2168, DOI 10.1101/gad.270421.115; Latasa MJ, 2016, BBA-MOL CELL RES, V1863, P1510, DOI 10.1016/j.bbamcr.2016.04.009; Latasa MJ, 2010, GLIA, V58, P1451, DOI 10.1002/glia.21020; Legnini I, 2017, MOL CELL, V66, P22, DOI 10.1016/j.molcel.2017.02.017; Li ZY, 2015, NAT STRUCT MOL BIOL, V22, P256, DOI 10.1038/nsmb.2959; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; Mao SS, 2018, EXP NEUROL, V308, P80, DOI 10.1016/j.expneurol.2018.07.003; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Miller SLH, 2004, J BIOL CHEM, V279, P33528, DOI 10.1074/jbc.M313097200; Mishra S, 2018, STEM CELL REP, V10, P1705, DOI 10.1016/j.stemcr.2018.04.024; Muscarella LA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/854737; Noe L, 2005, NUCLEIC ACIDS RES, V33, pW540, DOI 10.1093/nar/gki478; Qu SB, 2018, CANCER LETT, V414, P301, DOI 10.1016/j.canlet.2017.11.022; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Scheib J, 2013, NAT REV NEUROL, V9, P668, DOI 10.1038/nrneurol.2013.227; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Triolo D, 2006, J CELL SCI, V119, P3981, DOI 10.1242/jcs.03168; Vaidyanathan G, 2004, ONCOGENE, V23, P5858, DOI 10.1038/sj.onc.1207774; Verrier JD, 2010, J NEUROSCI RES, V88, P2558, DOI 10.1002/jnr.22418; Viader A, 2011, J NEUROSCI, V31, P17358, DOI 10.1523/JNEUROSCI.3931-11.2011; Xie LL, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00354; Xu JY, 2019, FASEB J, V33, P2659, DOI 10.1096/fj.201800243RRR; Yao C, 2018, J NEUROSCI, V38, P6574, DOI 10.1523/JNEUROSCI.3790-16.2018; You XT, 2015, NAT NEUROSCI, V18, P603, DOI 10.1038/nn.3975; Yu B, 2012, NUCLEIC ACIDS RES, V40, P10356, DOI 10.1093/nar/gks750; Yu B, 2012, J CELL SCI, V125, P2675, DOI 10.1242/jcs.098996; Yu J, 2018, J HEPATOL, V68, P1214, DOI 10.1016/j.jhep.2018.01.012; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001; Zhang Y, 2013, MOL CELL, V51, P792, DOI 10.1016/j.molcel.2013.08.017; Zhelyaznik N, 2003, EUR J NEUROSCI, V18, P1033, DOI 10.1046/j.1460-9568.2003.02834.x; Zhou SL, 2014, J CELL SCI, V127, P967, DOI 10.1242/jcs.131672; Zhou ZB, 2018, MOL THER-NUCL ACIDS, V12, P718, DOI 10.1016/j.omtn.2018.07.011; Zochodne DW, 2012, J PERIPHER NERV SYST, V17, P1, DOI 10.1111/j.1529-8027.2012.00378.x	59	15	17	5	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12409	12424		10.1096/fj.201900965R	http://dx.doi.org/10.1096/fj.201900965R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31415184	Green Published, Bronze			2022-12-28	WOS:000507461600063
J	Ramesh, M; Campos, JC; Lee, P; Song, Y; Hernandez, G; Sin, J; Tucker, KC; Saadaeijahromi, H; Gurney, M; Ferreira, JCB; Andres, AM				Ramesh, Mridula; Campos, Juliane C.; Lee, Pamela; Song, Yang; Hernandez, Genaro; Sin, Jon; Tucker, Kyle C.; Saadaeijahromi, Hannaneh; Gurney, Michael; Ferreira, Julio C. B.; Andres, Allen M.			Mitophagy protects against statin-mediated skeletal muscle toxicity	FASEB JOURNAL			English	Article						myopathy; simvastatin; mitochondria	FOXO TRANSCRIPTION FACTORS; MITOCHONDRIAL-FUNCTION; UBIQUITIN LIGASES; AUTOPHAGY; PARKIN; ACTIVATION; MECHANISM; PROMOTES; CELLS; DEGRADATION	The deleterious effects of statins on skeletal muscle are well known, but the mechanism associated with these effects remains unresolved. Statins are associated with mitochondrial damage, which may contribute to muscle myopathy. Here we demonstrate that simvastatin induces mitophagy in skeletal muscle cells and hypothesized that attenuating this process by silencing the mitophagy adapter p62/sequestosome-1 (SQSTM1) might mitigate myotoxicity. Surprisingly, silencing p62/SQSTM1 in differentiated C2C12 muscle cells exacerbated rather than attenuated myotoxicity. This inhibition of mitophagy in the face of statin challenge correlated with increased release of cytochrome c to the cytosol, activation of caspase-3, and lactate dehydrogenase (LDH) release. Correspondingly, targeted knockdown of Parkin, a canonical E3 ubiquitin ligase important for mitophagy, mirrored the effects of p62/SQSTM1 silencing. To corroborate these findings in vivo, we treated Parkin knockout mice with simvastatin for 2 wk. In line with our findings in vitro, these mitophagy-compromised mice displayed reduced spontaneous activity, loss of grip strength, and increased circulating levels of muscle damage marker LDH. Our findings demonstrate that mitophagy is an important mechanism to resist statin-induced skeletal muscle damage.	[Ramesh, Mridula; Lee, Pamela; Hernandez, Genaro; Gurney, Michael] San Diego State Univ, Donald P Shiley BioSci Ctr, San Diego, CA 92182 USA; [Campos, Juliane C.; Song, Yang; Sin, Jon; Tucker, Kyle C.; Saadaeijahromi, Hannaneh; Andres, Allen M.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Campos, Juliane C.; Ferreira, Julio C. B.] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil	California State University System; San Diego State University; Cedars Sinai Medical Center; Universidade de Sao Paulo	Andres, AM (corresponding author), Cedars Sinai Heart Inst, Adv Hlth Sci Pavil,127 South San Vicente Blvd, Los Angeles, CA 90048 USA.	allen.andres@cshs.org	Ferreira, Julio Cesar Batista/AEU-0494-2022; Ferreira, Julio Cesar Batista/I-3177-2012; Ferreira, Julio/L-4687-2019; Campos, Juliane/G-5997-2014	Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Campos, Juliane/0000-0003-0075-7209; Hernandez, Genaro/0000-0003-3666-8769	American Heart Association (AHA) [15SDG23230013]; Sao Paulo Research Foundation [2016/01633-5]	American Heart Association (AHA)(American Heart Association); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by American Heart Association (AHA) Scientist Development Grant 15SDG23230013 (to A.M.A.), and a fellowship from Sao Paulo Research Foundation (2016/01633-5 to J.C.C.). The authors declare no conflicts of interest.	Andres AM, 2014, ANTIOXID REDOX SIGN, V21, P1960, DOI 10.1089/ars.2013.5416; Araki M, 2012, EUR J PHARMACOL, V674, P95, DOI 10.1016/j.ejphar.2011.10.044; Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8; Armour Ryan, 2013, J Clin Neuromuscul Dis, V14, P103, DOI 10.1097/CND.0b013e3182852558; Bhagavan HN, 2006, FREE RADICAL RES, V40, P445, DOI 10.1080/10715760600617843; Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Boengler K, 2017, J CACHEXIA SARCOPENI, V8, P349, DOI 10.1002/jcsm.12178; Bouitbir J, 2012, EUR HEART J, V33, P1397, DOI 10.1093/eurheartj/ehr224; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chen CCW, 2018, SKELET MUSCLE, V8, DOI 10.1186/s13395-018-0157-y; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Fernandez Genaro, 2011, Cleve Clin J Med, V78, P393, DOI 10.3949/ccjm.78a.10073; Funk JA, 2010, J PHARMACOL EXP THER, V333, P593, DOI 10.1124/jpet.109.161992; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gensler S, 2001, NUCLEIC ACIDS RES, V29, P3657, DOI 10.1093/nar/29.17.3657; Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gouspillou G, 2018, J PHYSIOL-LONDON, V596, P2565, DOI 10.1113/JP275604; Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741; Hansen KE, 2005, ARCH INTERN MED, V165, P2671, DOI 10.1001/archinte.165.22.2671; Huang CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022689; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kaufmann P, 2006, CELL MOL LIFE SCI, V63, P2415, DOI 10.1007/s00018-006-6235-z; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Larsen S, 2013, J AM COLL CARDIOL, V61, P44, DOI 10.1016/j.jacc.2012.09.036; Ludman A, 2009, PHARMACOL THERAPEUT, V122, P30, DOI 10.1016/j.pharmthera.2009.01.002; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; McGinnis B, 2007, ANN PHARMACOTHER, V41, P1805, DOI 10.1345/aph.1K209; Mikus CR, 2013, J AM COLL CARDIOL, V62, P709, DOI 10.1016/j.jacc.2013.02.074; Mullen PJ, 2011, BBA-MOL CELL RES, V1813, P2079, DOI 10.1016/j.bbamcr.2011.07.019; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Ogura Takeharu, 2007, Journal of Toxicological Sciences, V32, P57, DOI 10.2131/jts.32.57; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Parikh A, 2010, PROSTATE, V70, P971, DOI 10.1002/pros.21131; Pasternak RC, 2002, J AM COLL CARDIOL, V40, P567, DOI 10.1016/S0735-1097(02)02030-2; Poluzzi E, 2008, EUR J CLIN PHARMACOL, V64, P425, DOI 10.1007/s00228-007-0428-8; Powers SK, 2011, COMPR PHYSIOL, V1, P941, DOI 10.1002/cphy.c100054; Sanchez AMJ, 2012, J CELL BIOCHEM, V113, P695, DOI 10.1002/jcb.23399; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sathasivam S, 2012, EUR J INTERN MED, V23, P317, DOI 10.1016/j.ejim.2012.01.004; Sebori R, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9179270; Seibenhener ML, 2013, BBA-MOL CELL RES, V1833, P452, DOI 10.1016/j.bbamcr.2012.11.004; Shalansky SJ, 2004, ANN PHARMACOTHER, V38, P1363, DOI 10.1345/aph.1E071; Siddals KW, 2004, J BIOL CHEM, V279, P38353, DOI 10.1074/jbc.M404838200; Sinzinger H, 2002, J CARDIOVASC PHARM, V40, P163, DOI 10.1097/00005344-200208000-00001; Sirvent P, 2005, BIOCHEM BIOPH RES CO, V338, P1426, DOI 10.1016/j.bbrc.2005.10.108; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Stringer HAJ, 2013, J NEUROL SCI, V325, P142, DOI 10.1016/j.jns.2012.12.023; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Tiwari A, 2006, EXPERT OPIN DRUG SAF, V5, P651, DOI 10.1517/14740338.5.5.651; Tomasetti M, 1999, BIOFACTORS, V9, P231, DOI 10.1002/biof.5520090218; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Vaughan RA, 2013, EUR J PHARMACOL, V711, P1, DOI 10.1016/j.ejphar.2013.04.009; Zhang Q, 2012, STEM CELLS DEV, V21, P1321, DOI 10.1089/scd.2011.0684; Zhao JH, 2008, AUTOPHAGY, V4, P378, DOI 10.4161/auto.5633; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	62	11	11	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11857	11869		10.1096/fj.201900807RR	http://dx.doi.org/10.1096/fj.201900807RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31365836	Green Published			2022-12-28	WOS:000507461600022
J	Sessions, GA; Copp, ME; Liu, JY; Sinkler, MA; D'Costa, S; Diekman, BO				Sessions, Garrett A.; Copp, Michaela E.; Liu, Jie-Yu; Sinkler, Margaret A.; D'Costa, Susan; Diekman, Brian O.			Controlled induction and targeted elimination of p16(INK4a)-expressing chondrocytes in cartilage explant culture	FASEB JOURNAL			English	Article						osteoarthritis; aging; senolytic; ABT-263; senescence	SENESCENT CELLS; IN-VIVO; CELLULAR SENESCENCE; OSTEOARTHRITIS; P16(INK4A); EXPRESSION; CLEARANCE; BIOMARKER; DISEASE; MICE	Cellular senescence is a phenotypic state that contributes to age-related diseases through the secretion of matrix-degrading and inflammatory molecules. An emerging therapeutic strategy for osteoarthritis (OA) is to selectively eliminate senescent cells by initiating apoptosis. This study establishes a cartilage explant model of senescence induction and senolytic clearance using p16(Ink4a) expression as a biomarker of senescence. Growth-factor stimulation of explants increased the expression of p16(Ink4a) at both the mRNA and protein levels. Applying this culture system to cartilage from p16tdTom reporter mice (a knockin allele with tdTomato fluorescent protein regulated by the endogenous p16Ink4a promoter) demonstrated the emergence of a p16-high population that was quantified using flow cytometry for tdTomato. Cell sorting was used to separate chondrocytes based on tdTomato fluorescence and p16-high cells showed higher senescence-associated beta-galactosidase activity and increased gene expression of the senescence-associated secretory phenotype as compared with p16-low cells. The potential for effective senolysis within the cartilage extracellular matrix was assessed using navitoclax (ABT-263). Navitoclax treatment reduced the percentage of p16-high cells from 17.9 to 6.1% (mean of 13 matched pairs; P < 0.001) and increased cleaved caspase-3 confirmed apoptotic activity. Together, these findings establish a physiologically relevant cartilage explant model for testing the induction and elimination of senescent chondrocytes, which will support investigations of senolytic therapy for OA.	[Sessions, Garrett A.; Sinkler, Margaret A.; D'Costa, Susan; Diekman, Brian O.] Univ N Carolina, Thurston Arthrit Res Ctr, Chapel Hill, NC 27515 USA; [Liu, Jie-Yu; Diekman, Brian O.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Copp, Michaela E.; Diekman, Brian O.] North Carolina North Carolina State Univ, Univ North Carolina Chapel Hill, Joint Dept Biomed Engn, Raleigh, NC USA; [Sinkler, Margaret A.] Augusta Univ, Med Coll Georgia, Augusta, GA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University System of Georgia; Augusta University	Diekman, BO (corresponding author), Univ N Carolina, Sch Med, Thurston Arthrit Res Ctr, 104 Manning Dr,3300 Thurston Bldg,Campus Box 7280, Chapel Hill, NC 27599 USA.	bdiekman@email.unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022; , Pathology Services Core/CEZ-2246-2022	Diekman, Brian/0000-0001-9055-4282; Sessions, Garrett/0000-0003-2853-0612	U.S. National Institutes of Health (NIH) National Institute on Aging [F32 AG050399]; Arthritis National Research Foundation (ANRF); American Federation for Aging Research; ANRF; NIH National Institute on Aging [NIA 2T35-AG038047-08]; Cancer Center Core Support Grant [P30 CA016086]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG050399, T35AG038047] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute on Aging; Arthritis National Research Foundation (ANRF); American Federation for Aging Research; ANRF; NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Cancer Center Core Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank the members of Dr. Richard Loeser's laboratory [University of North Carolina (UNC) at Chapel Hill] for valuable feedback, and the UNC Animal Histopathology and UNC Flow Cytometry Cores. This work was supported by the U.S. National Institutes of Health (NIH) National Institute on Aging (Grant F32 AG050399 to B.O.D.), and was conducted while B.O. D. was an Arthritis and Aging Research Grant recipient from the Arthritis National Research Foundation (ANRF) and the American Federation for Aging Research, as well as second-year funding from the ANRF. Support from the NIH National Institute on Aging was provided to M.A.S. for the UNC Summer Research in Aging for Medical Students (NIA 2T35-AG038047-08). The UNC Flow Cytometry Core Facility is supported, in part, by the P30 CA016086 Cancer Center Core Support Grant to the UNC Lineberger Comprehensive Cancer Center. The authors declare no conflicts of interest.	Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2; Blagosklonny MV, 2014, CELL CYCLE, V13, P3628, DOI 10.4161/15384101.2014.985507; Boehme KA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082282; Burd CE, 2013, CELL, V152, P340, DOI 10.1016/j.cell.2012.12.010; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Cao X, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1193-1; Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010; Childs BG, 2016, SCIENCE, V354, P472, DOI 10.1126/science.aaf6659; Chong KW, 2013, ARTHRITIS RHEUM-US, V65, P2346, DOI 10.1002/art.38039; Chonghaile TN, 2008, ONCOGENE, V27, pS149, DOI 10.1038/onc.2009.52; Colins JA, 2018, CURR OPIN RHEUMATOL, V30, P101, DOI 10.1097/BOR.0000000000000456; Coppe JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009188; Dai CY, 2000, ONCOGENE, V19, P1613, DOI 10.1038/sj.onc.1203438; Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012; Diekman BO, 2018, J AM ACAD ORTHOP SUR, V26, pE455, DOI 10.5435/JAAOS-D-18-00394; Diekman BO, 2018, AGING CELL, V17, DOI 10.1111/acel.12771; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Fuhrmann-Stroissnigg H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00314-z; He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015; Henry SP, 2009, GENESIS, V47, P805, DOI 10.1002/dvg.20564; Jeck WR, 2012, AGING CELL, V11, P727, DOI 10.1111/j.1474-9726.2012.00871.x; Jeon OH, 2018, J CLIN INVEST, V128, P1229, DOI 10.1172/JCI95147; Jeon OH, 2017, NAT MED, V23, P775, DOI 10.1038/nm.4324; Kirkland JL, 2017, J AM GERIATR SOC, V65, P2297, DOI 10.1111/jgs.14969; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Li W, 2019, AGING-US, V11, P771, DOI 10.18632/aging.101787; Liu JY, 2019, P NATL ACAD SCI USA, V116, P2603, DOI 10.1073/pnas.1818313116; Loeser RF, 2016, NAT REV RHEUMATOL, V12, P412, DOI 10.1038/nrrheum.2016.65; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Martin JA, 2001, J GERONTOL A-BIOL, V56, pB172, DOI 10.1093/gerona/56.4.B172; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Novais EJ, 2019, MATRIX BIOL, V82, P54, DOI 10.1016/j.matbio.2019.02.004; Ovadya Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07825-3; Ozsvari B, 2018, AGING-US, V10, P3294, DOI 10.18632/aging.101633; Pan J, 2017, INT J RADIAT ONCOL, V99, P353, DOI 10.1016/j.ijrobp.2017.02.216; Philipot D, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4494; Potter DS, 2016, COLD SH Q B, V81, P131, DOI 10.1101/sqb.2016.81.030841; Price JS, 2002, AGING CELL, V1, P57, DOI 10.1046/j.1474-9728.2002.00008.x; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960; Stanton H, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.179; Tang XD, 2018, ANN RHEUM DIS, V77, P1372, DOI 10.1136/annrheumdis-2018-212964; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Wang YY, 2016, AGING-US, V8, P2915, DOI 10.18632/aging.101100; Wood WA, 2016, EBIOMEDICINE, V11, P227, DOI 10.1016/j.ebiom.2016.08.029; Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9; Xu M, 2017, J GERONTOL A-BIOL, V72, P780, DOI 10.1093/gerona/glw154; Yamakoshi K, 2009, J CELL BIOL, V186, P393, DOI 10.1083/jcb.200904105; Yousefzadeh MJ, 2018, EBIOMEDICINE, V36, P18, DOI 10.1016/j.ebiom.2018.09.015; Zhou HW, 2004, RHEUMATOLOGY, V43, P555, DOI 10.1093/rheumatology/keh127; Zhu Y, 2017, AGING-US, V9, P955, DOI 10.18632/aging.101202; Zhu Y, 2016, AGING CELL, V15, P428, DOI 10.1111/acel.12445; Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344	59	22	23	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12364	12373		10.1096/fj.201900815RR	http://dx.doi.org/10.1096/fj.201900815RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31408372	Green Published			2022-12-28	WOS:000507461600060
J	Balczon, R; Pittet, JF; Wagener, BM; Moser, SA; Voth, S; Vorhees, CV; Williams, MT; Bridges, JP; Alvarez, DF; Koloteva, A; Xu, YY; Zha, XM; Audia, JP; Stevens, T; Lin, MT				Balczon, Ron; Pittet, Jean-Francois; Wagener, Brant M.; Moser, Stephen A.; Voth, Sarah; Vorhees, Charles V.; Williams, Michael T.; Bridges, James P.; Alvarez, Diego F.; Koloteva, Anna; Xu, Yuanyuan; Zha, Xiang-Ming; Audia, Jonathon P.; Stevens, Troy; Lin, Mike T.			Infection-induced endothelial amyloids impair memory	FASEB JOURNAL			English	Article						nosocomial pneumonia; cerebrospinal fluid; learning; dementia; depression	TERM COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; BETA PROTEIN; AMPA RECEPTORS; TAU PHOSPHORYLATION; PATHOLOGICAL TAU; CRITICAL ILLNESS; WATER MAZE; OLIGOMERS; POTENTIATION	Patients with nosocomial pneumonia exhibit elevated levels of neurotoxic amyloid and tau proteins in the cerebrospinal fluid (CSF). In vitro studies indicate that pulmonary endothelium infected with clinical isolates of either Pseudomonas aeruginosa, Klebsiella pneumoniae, or Staphylococcus aureus produces and releases cytotoxic amyloid and tau proteins. However, the effects of the pulmonary endothelium-derived amyloid and tau proteins on brain function have not been elucidated. Here, we show that P. aeruginosa infection elicits accumulation of detergent insoluble tau protein in the mouse brain and inhibits synaptic plasticity. Mice receiving endothelium-derived amyloid and tau proteins via intracerebroventricular injection exhibit a learning and memory deficit in object recognition, fear conditioning, and Morris water maze studies. We compared endothelial supernatants obtained after the endothelia were infected with P. aeruginosa possessing an intact [P. aeruginosa isolated from patient 103 (PA103) supernatant] or defective [mutant strain of P. aeruginosa lacking a functional type 3 secretion system needle tip complex (Delta PcrV) supernatant] type 3 secretion system. Whereas the PA103 supernatant impaired working memory, the Delta PcrV supernatant had no effect. Immunodepleting amyloid or tau proteins from the PA103 supernatant with the A11 or T22 antibodies, respectively, overtly rescued working memory. Recordings from hippocampal slices treated with endothelial supernatants or CSF from patients with or without nosocomial pneumonia indicated that endothelium-derived neurotoxins disrupted the postsynaptic synaptic response. Taken together, these results establish a plausible mechanism for the neurologic sequelae consequent to nosocomial bacterial pneumonia.-Balczon, R., Pittet, J.-F., Wagener, B. M., Moser, S. A., Voth, S., Vorhees, C. V., Williams, M. T., Bridges, J. P., Alvarez, D. F., Koloteva, A., Xu, Y., Zha, X.-M., Audia, J. P., Stevens, T., Lin, M. T. Infection-induced endothelial amyloids impair memory.	[Balczon, Ron] Univ S Alabama, Dept Biochem & Mol Biol, Mobile, AL 36688 USA; [Balczon, Ron] Univ S Alabama, Ctr Lung Biol, Mobile, AL 36688 USA; [Voth, Sarah; Alvarez, Diego F.; Koloteva, Anna; Xu, Yuanyuan; Zha, Xiang-Ming; Stevens, Troy; Lin, Mike T.] Univ S Alabama, Dept Physiol & Cell Biol, Mobile, AL 36688 USA; [Audia, Jonathon P.] Univ S Alabama, Dept Microbiol & Immunol, Mobile, AL 36688 USA; [Stevens, Troy] Univ S Alabama, Dept Internal Med, Mobile, AL 36688 USA; [Pittet, Jean-Francois; Wagener, Brant M.] Univ Alabama Birmingham, Sch Med, Dept Anesthesiol & Perioperat Med, Birmingham, AL USA; [Moser, Stephen A.] Univ Alabama Birmingham, Sch Med, Dept Pathol, Birmingham, AL USA; [Vorhees, Charles V.; Williams, Michael T.; Bridges, James P.] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA; [Vorhees, Charles V.] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA	University of South Alabama; University of South Alabama; University of South Alabama; University of South Alabama; University of South Alabama; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Lin, MT (corresponding author), Univ S Alabama, Coll Med, Ctr Lung Biol, Dept Physiol & Cell Biol, 5851 USA Dr N MSB3074, Mobile, AL 36688 USA.	mlin@southalabama.edu	Voth, Sarah B./AGJ-8666-2022; Wagener, Brant/AAI-7480-2020	Voth, Sarah B./0000-0003-3796-7154; Vorhees, Charles/0000-0003-3558-8812; Williams, Michael/0000-0001-9841-9683; Bridges, James P./0000-0002-4815-117X; Zha, Xiangming/0000-0001-9490-2731	College of Medicine Intramural Award; U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL140182, HL118334, HL66299, HL135003, HL60024]; NIH National Institute of Neurological Disorders and Stroke [NS102495]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL140182, P01HL066299, R01HL118334, R37HL060024, R01HL135003, T32HL076125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS102495] Funding Source: NIH RePORTER	College of Medicine Intramural Award; U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank the members of the Department of Comparative Medicine and the University of South Alabama for their efforts in animal husbandry, and the members of the Intensive Care Unit team and Clinical Microbiology Laboratory at the University of Alabama at Birmingham for their care in handling and processing clinical samples. The authors also thank Dr. James Maylie (Oregon Health and Science University) for generous help with Igor Pro. This work was funded by a College of Medicine Intramural Award and U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants HL140182 (to M.T.L.), HL118334 (to J.P.A. and D.F.A.), HL66299 and HL135003 (to T.S. and R.B.), HL60024 (to T.S.), and NIH National Institute of Neurological Disorders and Stroke Grant NS102495 (to X.-M.Z.). S.V. is a predoctoral fellow (T32 HL076125). The authors declare no conflicts of interest.	Allen D, 2011, NAT NEUROSCI, V14, P744, DOI 10.1038/nn.2832; Annane D, 2015, LANCET RESP MED, V3, P61, DOI 10.1016/S2213-2600(14)70246-2; Balczon R, 2018, JOVE-J VIS EXP, DOI 10.3791/57447; Balczon R, 2017, FASEB J, V31, P2785, DOI 10.1096/fj.201601042RR; Balczon R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074343; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Boutajangout A, 2010, J NEUROSCI, V30, P16559, DOI 10.1523/JNEUROSCI.4363-10.2010; Castillo-Carranza DL, 2015, J NEUROSCI, V35, P4857, DOI 10.1523/JNEUROSCI.4989-14.2015; Choi J, 2016, HEART LUNG, V45, P140, DOI 10.1016/j.hrtlng.2015.12.002; Clark RE, 2000, J NEUROSCI, V20, P8853; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Ehlenbach WJ, 2010, JAMA-J AM MED ASSOC, V303, P763, DOI 10.1001/jama.2010.167; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Garcia-Osta A, 2009, LEARN MEMORY, V16, P267, DOI 10.1101/lm.1310209; Girard TD, 2018, LANCET RESP MED, V6, P213, DOI 10.1016/S2213-2600(18)30062-6; Hammond RS, 2006, J NEUROSCI, V26, P1844, DOI 10.1523/JNEUROSCI.4106-05.2006; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hatami A, 2017, J BIOL CHEM, V292, P3172, DOI 10.1074/jbc.M116.755264; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; LEDOUX JE, 1993, BEHAV BRAIN RES, V58, P69, DOI 10.1016/0166-4328(93)90091-4; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041; Lin MT, 2018, AM J RESP CRIT CARE, V198, P1575, DOI 10.1164/rccm.201801-0060LE; Lin MT, 2010, J NEUROSCI, V30, P11726, DOI 10.1523/JNEUROSCI.1411-10.2010; Lindsey AS, 2019, PULM CIRC, V9, DOI 10.1177/2045894019826941; Liu P, 2015, CELL REP, V11, P1760, DOI 10.1016/j.celrep.2015.05.021; Mahmood K, 2012, CRIT CARE, V16, DOI [10.1186/cc11355, 10.1186/CC11355]; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; MCDONALD RJ, 1994, BEHAV NEURAL BIOL, V61, P260, DOI 10.1016/S0163-1047(05)80009-3; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Morrow KA, 2016, AM J PHYSIOL-LUNG C, V310, P1337, DOI 10.1152/ajplung.00103.2015; Needham DM, 2013, AM J RESP CRIT CARE, V188, P567, DOI 10.1164/rccm.201304-0651OC; Ochoa CD, 2012, J BIOL CHEM, V287, P25407, DOI 10.1074/jbc.M111.301440; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Patel MB, 2015, INTENS CARE MED, V41, P708, DOI 10.1007/s00134-014-3632-x; Pisani MA, 2009, AM J RESP CRIT CARE, V180, P1092, DOI 10.1164/rccm.200904-0537OC; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rice HC, 2019, SCIENCE, V363, P143, DOI 10.1126/science.aao4827; Rizzo V, 2017, BIOL PSYCHIAT-COGN N, V2, P158, DOI 10.1016/j.bpsc.2016.10.002; Samson AL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16171; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Shah FA, 2013, AM J RESP CRIT CARE, V188, P586, DOI 10.1164/rccm.201212-2154OC; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Stackman RW, 2002, HIPPOCAMPUS, V12, P291, DOI 10.1002/hipo.1112; Stevens TC, 2014, AM J PHYSIOL-LUNG C, V306, pL915, DOI 10.1152/ajplung.00135.2013; Sunderland T, 2003, JAMA-J AM MED ASSOC, V289, P2094, DOI 10.1001/jama.289.16.2094; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Vnek N, 1996, J NEUROSCI, V16, P2780; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wu WW, 2013, J NEUROSCI, V33, P16158, DOI 10.1523/JNEUROSCI.2001-13.2013; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010	62	12	12	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10300	10314		10.1096/fj.201900322R	http://dx.doi.org/10.1096/fj.201900322R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31211919	Green Published, Bronze			2022-12-28	WOS:000482214200047
J	Lane, SL; Dodson, RB; Doyle, AS; Park, H; Rathi, H; Matarrazo, CJ; Moore, LG; Lorca, RA; Wolfson, GH; Julian, CG				Lane, Sydney L.; Dodson, R. Blair; Doyle, Alexandrea S.; Park, Haemin; Rathi, Hinal; Matarrazo, Christopher J.; Moore, Lorna G.; Lorca, Ramon A.; Wolfson, Gabriel H.; Julian, Colleen G.			Pharmacological activation of peroxisome proliferator-activated receptor gamma (PPAR-gamma) protects against hypoxia-associated fetal growth restriction	FASEB JOURNAL			English	Article						altitude; IUGR; placenta; vascularity; pioglitazone	ARTERY BLOOD-FLOW; BIRTH-WEIGHT; PLACENTAL MORPHOLOGY; UMBILICAL ARTERY; GENE-EXPRESSION; MURINE PLACENTA; HIGH-ALTITUDE; RISK-FACTORS; PREGNANCY; MECHANISM	The hypoxia of high-altitude (HA) residence increases the risk of intrauterine growth restriction (IUGR) and preeclampsia 3-fold, augmenting perinatal morbidity and mortality and the risk for childhood and adult disease. Currently, no effective therapies exist to prevent these vascular disorders of pregnancy. The peroxisome proliferator-activated receptor gamma (PPAR-gamma) is an important regulator of uteroplacental vascular development and function and has been implicated in the pathogenesis of IUGR and preeclampsia. Here, we used a model of HA pregnancy in mice to determine whether hypoxia-induced fetal growth restriction reduces placental PPAR-gamma protein expression and placental vascularization and, if so, to evaluate the effectiveness of the selective PPAR-gamma agonist pioglitazone (PIO) for preventing hypoxia-induced IUGR. Hypoxia resulted in asymmetric IUGR, placental insufficiency, and reduced placental PPAR-gamma expression; PIO prevented approximately half of the fetal growth restriction and attenuated placental insufficiency. PIO did not affect fetal growth under normoxia. Although PIO was beneficial for fetal growth, PIO treatment reduced placental vascular density of the labrynthine zone in normoxic and hypoxic (Hx) conditions, and mean vascular area was reduced in the Hx group. Our results suggest that pharmacological PPAR-gamma activation is a potential strategy for preventing IUGR in pregnancies complicated by hypoxia, although further studies are needed to identify its likely metabolic or vascular mechanisms.-Lane, S. L., Dodson, R. B., Doyle, A. S., Park, H., Rathi, H., Matarrazo, C. J., Moore, L. G., Lorca, R. A., Wolfson, G. H., Julian, C. G. Pharmacological activation of peroxisome proliferator-activated receptor gamma (PPAR-gamma) protects against hypoxia-associated fetal growth restriction.	[Lane, Sydney L.] Univ Colorado, Sch Med, Integrated Physiol Program, Aurora, CO USA; [Lane, Sydney L.; Dodson, R. Blair] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Matarrazo, Christopher J.; Wolfson, Gabriel H.; Julian, Colleen G.] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA; [Moore, Lorna G.; Lorca, Ramon A.] Univ Colorado, Sch Med, Dept Obstet & Gynecol, Aurora, CO USA; [Doyle, Alexandrea S.; Rathi, Hinal] Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA; [Park, Haemin] Univ Colorado, Colorado Undergrad Res Environm Hlth Sci, Denver, CO 80202 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver	Julian, CG (corresponding author), Univ Colorado Denver, Dept Med, 12700 East 19th Ave,Mailstop 8611, Aurora, CO 80045 USA.	colleen.julian@ucdenver.edu		Lane, Sydney/0000-0003-0345-2849	U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development Building Interdisciplinary Research Careers Women's Health Grant [5 K12 HD057022-07]; American Heart Association (AHA) [15BGIA25680022]; AHA Pre-Doctoral Award [7PRE33410652]; NIH National Heart, Lung, and Blood Institute (NHLBI) [R01 HL138181]; NIH NHLBI [R01 HD088590]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD088590, K12HD057022] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL138181] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development Building Interdisciplinary Research Careers Women's Health Grant; American Heart Association (AHA)(American Heart Association); AHA Pre-Doctoral Award; NIH National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in part, by U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development Building Interdisciplinary Research Careers Women's Health Grant (5 K12 HD057022-07 to C.G.J.), American Heart Association (AHA) Beginning Grant-in-Aid (15BGIA25680022 to C.G.J.), AHA Pre-Doctoral Award (7PRE33410652 to S.L.L.), NIH National Heart, Lung, and Blood Institute (NHLBI) Grant R01 HL138181 (to C.G.J.), and NIH NHLBI Grant R01 HD088590 (to L.G.M. and C.G.J.). The authors declare no conflicts of interest.	Barak Y, 2008, PPAR RES, V2008, DOI 10.1155/2008/142082; Barker DJP, 2003, EUR J EPIDEMIOL, V18, P733, DOI 10.1023/A:1025388901248; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Baschat AA, 2004, OBSTET GYNECOL SURV, V59, P617, DOI 10.1097/01.OGX.0000133943.54530.76; Burton GJ, 1996, PLACENTA, V17, P49, DOI 10.1016/S0143-4004(05)80643-5; Chen ZG, 2015, SCI REP-UK, V5, DOI 10.1038/srep12650; Coletta DK, 2009, DIABETOLOGIA, V52, P723, DOI 10.1007/s00125-008-1256-9; Cookson MW, 2018, AM J PERINAT, V35, P1260, DOI 10.1055/s-0038-1642033; Cuffe JSM, 2014, J PHYSIOL-LONDON, V592, P3127, DOI 10.1113/jphysiol.2014.272856; Delerive P, 1999, CIRC RES, V85, P394, DOI 10.1161/01.RES.85.5.394; Diaz M, 2012, J CLIN ENDOCR METAB, V97, pE1468, DOI 10.1210/jc.2012-1064; DICKEY RP, 1995, HUM REPROD, V10, P2448; Echeverria F, 2016, PROSTAG LEUKOTR ESS, V114, P28, DOI 10.1016/j.plefa.2016.10.001; Froment P, 2006, PPAR RES, V2006, DOI 10.1155/PPAR/2006/73986; Furuya M, 2008, LAB INVEST, V88, P416, DOI 10.1038/labinvest.2008.7; Garnier V, 2015, AM J PHYSIOL-ENDOC M, V309, pE357, DOI 10.1152/ajpendo.00093.2015; Geach Tim, 2015, Nat Rev Endocrinol, V11, P446, DOI 10.1038/nrendo.2015.101; Gheorghe CP, 2007, REPROD SCI, V14, P223, DOI 10.1177/1933719107302860; Gilbert WM, 2003, AM J OBSTET GYNECOL, V188, P1596, DOI 10.1067/mob.2003.384; Gokina NI, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00184; Gong KZ, 2011, AM J PHYSIOL-LUNG C, V301, pL899, DOI 10.1152/ajplung.00062.2011; Holobotovskyy V, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5038; Hu XQ, 2012, HYPERTENSION, V60, P214, DOI 10.1161/HYPERTENSIONAHA.112.196097; JACKSON MR, 1995, AM J OBSTET GYNECOL, V172, P518, DOI 10.1016/0002-9378(95)90566-9; Jensen GM, 1997, AM J PUBLIC HEALTH, V87, P1003, DOI 10.2105/AJPH.87.6.1003; Julian CG, 2014, FASEB J, V28, P1268, DOI 10.1096/fj.13-239749; Julian CG, 2008, AM J PHYSIOL-REG I, V295, pR906, DOI 10.1152/ajpregu.00164.2008; Kernan WN, 2016, NEW ENGL J MED, V374, P1321, DOI 10.1056/NEJMoa1506930; Ketsawatsomkron P, 2012, CIRC RES, V111, P1446, DOI 10.1161/CIRCRESAHA.112.271577; Krebs C, 1996, AM J OBSTET GYNECOL, V175, P1534, DOI 10.1016/S0002-9378(96)70103-5; Krishnan J, 2009, CELL METAB, V9, P512, DOI 10.1016/j.cmet.2009.05.005; Kronke G, 2007, ARTERIOSCL THROM VAS, V27, P1276, DOI 10.1161/ATVBAHA.107.142638; Kung J, 2012, EXPERT OPIN DRUG SAF, V11, P565, DOI 10.1517/14740338.2012.691963; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Mateev S, 2003, AM J PHYSIOL-HEART C, V284, pH820, DOI 10.1152/ajpheart.00701.2002; Matheson H, 2016, J PHYSIOL-LONDON, V594, P1371, DOI 10.1113/JP271073; McCarthy FP, 2011, HYPERTENSION, V58, P882, DOI 10.1161/HYPERTENSIONAHA.111.179440; McCarthy FP, 2011, HYPERTENSION, V58, P280, DOI 10.1161/HYPERTENSIONAHA.111.172627; MEIS PJ, 1987, AM J OBSTET GYNECOL, V156, P1165, DOI 10.1016/0002-9378(87)90133-5; Meis PJ, 1998, AM J OBSTET GYNECOL, V178, P562, DOI 10.1016/S0002-9378(98)70439-9; Nadra K, 2010, ENDOCRINOLOGY, V151, P4969, DOI 10.1210/en.2010-0131; Osol G, 2014, MICROCIRCULATION, V21, P38, DOI 10.1111/micc.12080; Parast MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008055; Polikandriotis JA, 2005, ARTERIOSCL THROM VAS, V25, P1810, DOI 10.1161/01.ATV.0000177805.65864.d4; Reynolds LP, 2005, PLACENTA, V26, P689, DOI 10.1016/j.placenta.2004.11.010; Skeffington KL, 2016, J PHYSIOL-LONDON, V594, P1357, DOI 10.1113/JP270995; Stevens W, 2017, AM J OBSTET GYNECOL, V217, P237, DOI 10.1016/j.ajog.2017.04.032; Tache V, 2013, STEM CELLS DEV, V22, P2815, DOI 10.1089/scd.2012.0596; van Patot MCT, 2009, PLACENTA, V30, P523, DOI 10.1016/j.placenta.2009.04.002; Waite LL, 2005, J CLIN ENDOCR METAB, V90, P620, DOI 10.1210/jc.2004-0849; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; ZAMUDIO S, 1995, J APPL PHYSIOL, V79, P7, DOI 10.1152/jappl.1995.79.1.7; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012	53	18	19	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					8999	9007		10.1096/fj.201900214R	http://dx.doi.org/10.1096/fj.201900214R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31039323	Green Published			2022-12-28	WOS:000478832900025
J	Wang, LH; Tang, H; Wang, C; Hu, YH; Wang, SL; Shen, LZ				Wang, Liuhua; Tang, Hua; Wang, Chao; Hu, Yuhuan; Wang, Shoulin; Shen, Lizong			Aquaporin 4 deficiency alleviates experimental colitis in mice	FASEB JOURNAL			English	Article						ulcerative colitis; AQP4; gut microbiota	INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; GUT MICROBIOTA; MOUSE MODELS; BRAIN; EXPRESSION; INNATE	Aquaporin (AQP) 4 is expressed in the basolateral membrane of colonic epithelial cells, and the purpose of this study was to explore the mechanistic role of AQP4 in experimental colitis. Experimental colitis was induced in AQP4 knockout (AQP4(-/-)) CD-1 mice and AQP4 wild-type (AQP4(wt)) mice by oral administration of dextran sulfate sodium (DSS). Experimental colitis was clinically established. Compared with AQP4(wt) mice, AQP4(-/-) mice showed increased tolerance to DSS-induced experimental colitis, including lesser degree of weight loss, diarrhea and bleeding, lower disease activity index scores, longer colon lengths, and lesser histologic scores. DSS-treated AQP4(-/-) mice had lower serum levels of IL-6 and TNF, higher IL-10 level, and lesser inflammatory cell infiltration. DSS-treated AQP4(-/-) mice also had lower immunostaining of NF-kappa B p65 as well as nuclear levels of p65 and phosphorylated p65. Sequencing of 16S rRNA indicated that DSS-treated AQP4(-/-) mice maintained intestinal microbial diversity and had higher Firmicutes/Bacteroidetes ratios and greater relative abundance of Erysipelotrichaceae species. These results suggested for the first time that AQP4 deficiency alleviates experimental colitis in mice. Our study helps to understand the pathogenesis of inflammatory bowel diseases, and blocking AQP4 may represent a novel therapeutic approach for ulcerative colitis.-Wang, L., Tang, H., Wang, C., Hu, Y., Wang, S., Shen, L. Aquaporin 4 deficiency alleviates experimental colitis in mice.	[Wang, Liuhua; Tang, Hua; Shen, Lizong] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Div Gastrointestinal Surg, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China; [Wang, Chao; Hu, Yuhuan; Wang, Shoulin] Nanjing Med Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Wang, Liuhua] Yangzhou Univ, Sch Clin Med, Northern Jiangsu Peoples Hosp, Dept Gen Surg, Yangzhou, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Yangzhou University	Shen, LZ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Div Gastrointestinal Surg, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	shenlz@njmu.edu.cn			National Natural Science Foundation of China [81272711, 81871959]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions [JX10231801]; Key Medical Talents Program of Jiangsu Province [ZDRCA2016014]; Key R&D Program of Jiangsu Province [BE2018758]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; Key Medical Talents Program of Jiangsu Province; Key R&D Program of Jiangsu Province	The authors are grateful to Prof. Gang Hu (Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University; Department of Pharmacology, Nanjing University of Chinese Medicine) for kindly providing CD-1 mice and AQP4 knockout mice. This work was supported by the National Natural Science Foundation of China (Grants 81272711 and 81871959 to L.S.), the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions (JX10231801 to L.S.), the Key Medical Talents Program of Jiangsu Province (ZDRCA2016014 to L.S.), and the Key R&D Program of Jiangsu Province (Social Development, BE2018758 to L.S.). The authors declare no conflicts of interest.	Bajic JE, 2016, WORLD J GASTROENTERO, V22, P8322, DOI 10.3748/wjg.v22.i37.8322; Cao Meiwan, 2014, Virologica Sinica, V29, P211, DOI 10.1007/s12250-014-3469-z; de Souza HSP, 2017, NAT REV GASTRO HEPAT, V14, P739, DOI 10.1038/nrgastro.2017.110; Dey N, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-131; Elson CO, 2005, IMMUNOL REV, V206, P260, DOI 10.1111/j.0105-2896.2005.00291.x; Fan Y, 2005, J NEUROSCI RES, V82, P458, DOI 10.1002/jnr.20664; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Hardin JA, 2004, CELL TISSUE RES, V318, P313, DOI 10.1007/s00441-004-0932-4; Hering NA, 2012, J PHYSIOL-LONDON, V590, P1035, DOI 10.1113/jphysiol.2011.224568; Hoivik ML, 2013, GUT, V62, P368, DOI 10.1136/gutjnl-2012-302311; Holm A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00915; Ito H, 2006, J NEUROCHEM, V99, P107, DOI 10.1111/j.1471-4159.2006.04036.x; Jin BR, 2017, SCI REP-UK, V7, DOI 10.1038/srep46252; Kaakoush NO, 2015, FRONT CELL INFECT MI, V5, DOI [10.3309/fcimb.2015.00004, 10.3389/fcimb.2015.00084]; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li LH, 2011, FASEB J, V25, P1556, DOI 10.1096/fj.10-177279; Loh G, 2012, GUT MICROBES, V3, P544, DOI 10.4161/gmic.22156; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; McIlroy J, 2018, ALIMENT PHARM THER, V47, P26, DOI 10.1111/apt.14384; Meli R, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00101; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Nagaraju GP, 2016, CANCER LETT, V373, P12, DOI 10.1016/j.canlet.2016.01.003; Papadopoulos MC, 2005, J BIOL CHEM, V280, P13906, DOI 10.1074/jbc.M413627200; Planell N, 2013, GUT, V62, P967, DOI 10.1136/gutjnl-2012-303333; Sakai H, 2014, PHARMACOL RES, V87, P71, DOI 10.1016/j.phrs.2014.05.012; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Thiagarajah JR, 2007, GUT, V56, P1529, DOI 10.1136/gut.2006.104620; Ungaro R, 2017, LANCET, V389, P1756, DOI 10.1016/S0140-6736(16)32126-2; Verkman AS, 2014, NAT REV DRUG DISCOV, V13, P259, DOI 10.1038/nrd4226; Wen JF, 2018, ONCOGENE, V37, P3549, DOI 10.1038/s41388-018-0208-1; Wirtz S, 2017, NAT PROTOC, V12, P1295, DOI 10.1038/nprot.2017.044; Yadav V, 2016, TRANSL RES, V176, P38, DOI 10.1016/j.trsl.2016.04.009; Zanello G, 2014, NESTLE NUTR WORKS SE, V79, P41, DOI 10.1159/000360676; Zhang D, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02655; Zhu N, 2011, FASEB J, V25, P4233, DOI 10.1096/fj.11-182808	37	11	12	2	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					8935	8944		10.1096/fj.201802769RR	http://dx.doi.org/10.1096/fj.201802769RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31034776				2022-12-28	WOS:000478832900020
J	Wang, Y; Gao, B; Tan, PY; Handoko, YA; Sekar, K; Deivasigamani, A; Seshachalam, VP; OuYang, HY; Shi, M; Xie, C; Goh, BKP; Ooi, LL; Hui, KM				Wang, Yu; Gao, Bin; Tan, Peng Yang; Handoko, Yohana Ayupriyanti; Sekar, Karthik; Deivasigamani, Amudha; Seshachalam, Veerabrahma Pratap; OuYang, Han-Yue; Shi, Ming; Xie, Chan; Goh, Brian Kim Poh; Ooi, London Lucien; Hui, Kam Man			Genome-wide CRISPR knockout screens identify NCAPG as an essential oncogene for hepatocellular carcinoma tumor growth	FASEB JOURNAL			English	Article						cell cycle; therapeutic target; tumor recurrence	CANCER; MANAGEMENT; SORAFENIB; THERAPIES; RESECTION	Hepatocellular carcinoma (HCC) is a common and deadly cancer with limited treatment options. Through genome-wide growth depletion screens using clustered regularly interspaced short palindromic repeats and expression profiling of primary HCC tumors, we identified 13 clinically relevant target genes with therapeutic potential. Subsequent functional annotation analysis revealed significant enrichment of these 13 genes in the cell cycle, cell death, and survival pathways. Non-structural maintenance of chromosomes condensin I complex subunit G (NCAPG) was ranked the highest among the depletion screens and multiple HCC expression datasets. Transient inhibition of NCAPG using specific small interfering RNAs resulted in a significant reduction in cell growth, migration, and the down-regulation of mitochondrial gene expression in vitro. Small homologous RNA-mediated knockdown of NCAPG significantly impaired cell viability, caused aberrant mitotic division, fragmented the mitochondrial network, and increased cell death in vitro. HCC cells with a reduced expression of NCAPG formed significantly smaller xenograft tumors in vivo. Importantly, high NCAPG expression was significantly associated with poorer overall and disease-free survival in HCC patients. High NCAPG expression is a novel prognostic biomarker to predict HCC early recurrence after surgical resection. In conclusion, NCAPG is an essential gene for HCC tumor cell survival. It represents a promising novel target for treating HCC and a prognostic biomarker for clinical management of HCC.-Wang, Y., Gao, B., Tan, P. Y., Handoko, Y. A., Sekar, K., Deivasigamani, A., Seshachalam, V. P., OuYang, H.-Y., Shi, M., Xie, C., Goh, B. K. P., Ooi, L. L., Hui, K. M. Genome-wide CRISPR knockout screens identify NCAPG as an essential oncogene for hepatocellular carcinoma tumor growth.	[Wang, Yu; Gao, Bin; Tan, Peng Yang; Handoko, Yohana Ayupriyanti; Sekar, Karthik; Deivasigamani, Amudha; Seshachalam, Veerabrahma Pratap; Hui, Kam Man] Natl Canc Ctr Singapore, Div Cellular & Mol Res, 11 Hosp Dr, Singapore 169610, Singapore; [Ooi, London Lucien] Natl Canc Ctr Singapore, Div Surg Oncol, Singapore, Singapore; [OuYang, Han-Yue; Shi, Ming] Sun Yat Sen Univ, Canc Ctr, Dept Hepatobiliary Oncol, Guangzhou, Guangdong, Peoples R China; [Xie, Chan] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China; [Goh, Brian Kim Poh; Ooi, London Lucien] Singapore Gen Hosp, Dept Hepatopancreatobiliary & Transplant Surg, Singapore, Singapore; [Hui, Kam Man] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [Hui, Kam Man] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Hui, Kam Man] Duke NUS Med Sch, Singapore, Singapore	National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS); Sun Yat Sen University; Sun Yat Sen University; Singapore General Hospital; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Wang, Y; Hui, KM (corresponding author), Natl Canc Ctr Singapore, Div Cellular & Mol Res, 11 Hosp Dr, Singapore 169610, Singapore.	wang.yu@nccs.com.sg; cmrhkm@nccs.com.sg	Ooi, London Lucien/AGK-1395-2022	CHEN, Gao Bin/0000-0001-9988-1773	National Medical Research Council (NMRC) Singapore; Cooperative Basic Research Grant New Investigator Grant [NMRC/BNIG/2037/2015]; Open Fund - Young Individual Research Grant [NMRC/OFYIRG/0076/2018]; SingHealth ONCO-ACP grant [NCCRF-OACPCCS-YR2015-AUG-1]	National Medical Research Council (NMRC) Singapore(National Medical Research Council, Singapore); Cooperative Basic Research Grant New Investigator Grant; Open Fund - Young Individual Research Grant; SingHealth ONCO-ACP grant	The authors thank the staff of the National Cancer Centre Singapore, Sun Yat-Sen University Cancer Center, Singapore General Hospital, and the SingHealth Research Cores (Tissue Repository, Advanced Bioimaging, and Flow Cytometry) for assistance in this study. This work was supported by grants from National Medical Research Council (NMRC) Singapore (to K.M.H.) and specifically a Cooperative Basic Research Grant New Investigator Grant - (NMRC/BNIG/2037/2015) and a Open Fund - Young Individual Research Grant (NMRC/OFYIRG/0076/2018) to Y.W. This work was also supported by a SingHealth ONCO-ACP grant (NCCRF-OACPCCS-YR2015-AUG-1) to Y. W. The authors declare no conflicts of interest.	Belghiti J, 2012, LIVER CANCER, V1, P71, DOI 10.1159/000342403; Berasain C, 2013, GUT, V62, P1674, DOI 10.1136/gutjnl-2013-304564; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Crawford S, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00068; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Gao JJ, 2012, DRUG DISCOV THER, V6, P108, DOI 10.5582/ddt.2012.v6.2.108; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Kan ZY, 2013, GENOME RES, V23, P1422, DOI 10.1101/gr.154492.113; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Li Y, 2003, J CANCER RES CLIN, V129, P43, DOI 10.1007/s00432-002-0396-4; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2015, NAT REV CLIN ONCOL, V12, P408, DOI [10.1038/nrclinonc.2015.103, 10.1038/nrclinonc.2015.121]; Murphy LA, 2008, BIOCHEM BIOPH RES CO, V377, P1007, DOI 10.1016/j.bbrc.2008.10.114; Nault JC, 2011, SEMIN LIVER DIS, V31, P173, DOI 10.1055/s-0031-1276646; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shi M, 2014, EUR J CANCER, V50, P928, DOI 10.1016/j.ejca.2013.11.026; Stevens JB, 2007, CANCER RES, V67, P7686, DOI 10.1158/0008-5472.CAN-07-0472; Stewart B, 2014, WORLD CANC REPORT 20; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Tabrizian P, 2015, ANN SURG, V261, P947, DOI 10.1097/SLA.0000000000000710; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Worns MA, 2014, NAT REV GASTRO HEPAT, V11, P447, DOI 10.1038/nrgastro.2014.10; Zhang Q, 2018, ONCOL RES, V26, P269, DOI 10.3727/096504017X15075967560980	28	39	42	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					8759	8770		10.1096/fj.201802213RR	http://dx.doi.org/10.1096/fj.201802213RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31022357	Green Published, hybrid			2022-12-28	WOS:000478832900006
J	Zhang, XM; Nie, YP; Cai, SF; Ding, SY; Fu, BQ; Wei, H; Chen, LX; Liu, XH; Liu, MG; Yuan, RQ; Qiu, BQ; He, ZY; Cong, PQ; Chen, YS; Mo, DL				Zhang, Xumeng; Nie, Yaping; Cai, Shufang; Ding, Suying; Fu, Bingqiang; Wei, Hong; Chen, Luxi; Liu, Xiaohong; Liu, Minggui; Yuan, Renqiang; Qiu, Boqin; He, Zuyong; Cong, Peiqing; Chen, Yaosheng; Mo, Delin			Earlier demethylation of myogenic genes contributes to embryonic precocious terminal differentiation of myoblasts in miniature pigs	FASEB JOURNAL			English	Article						DNA methylation; WGBS; embryonic myogenesis; Tet1; Swine	ACTIVE DNA DEMETHYLATION; METHYLATION; MYOD; EXPRESSION; GENOME; FIBROBLASTS; METHYLOME; 5-METHYLCYTOSINE; IDENTIFICATION; TRANSCRIPTION	Here, we performed whole-genome bisulfite sequencing of longissimus dorsi muscle from Landrace and Wuzhishan (WZS) miniature pigs during 18, 21, and 28 d postcoitum. It was uncovered that in regulatory regions only around transcription start sites (TSSs), gene expression and methylation showed negative correlation, whereas in gene bodies, positive correlation occurred. Furthermore, earlier myogenic gene demethylation around TSSs and earlier hypermethylation of myogenic genes in gene bodies were considered to trigger their earlier expression in miniature pigs. Furthermore, by analyzing the methylation pattern of the myogenic differentiation 1(MyoD) promoter and distal enhancer, we found that earlier demethylation of the MyoD distal enhancer in WZSs contributes to its earlier expression. Moreover, DNA demethylase Tet1 was found to be involved in the demethylation of the myogenin promoter and promoted immortalized mouse myoblast cell line (C2C12) and porcine embryonic myogenic cell differentiation. This study reveals that earlier demethylation of myogenic genes contributes to precocious terminal differentiation of myoblasts in miniature pigs.-Zhang, X., Nie, Y., Cai, S., Ding, S., Fu, B., Wei, H., Chen, L., Liu, X., Liu, M., Yuan, R., Qiu, B., He, Z., Cong, P., Chen, Y., Mo, D. Earlier demethylation of myogenic genes contributes to embryonic precocious terminal differentiation of myoblasts in miniature pigs.	[Zhang, Xumeng; Nie, Yaping; Cai, Shufang; Ding, Suying; Fu, Bingqiang; Chen, Luxi; Liu, Xiaohong; Yuan, Renqiang; Qiu, Boqin; He, Zuyong; Cong, Peiqing; Chen, Yaosheng; Mo, Delin] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China; [Zhang, Xumeng; Wei, Hong] Shenzhen Kingsino Technol Co Ltd, Shenzhen, Peoples R China; [Liu, Minggui] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China	Sun Yat Sen University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Mo, DL (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Higher Educ Mega Ctr, North Third Rd, Guangzhou 510006, Guangdong, Peoples R China.	modelin@mail.sysu.edu.cn	He, Zuyong/AAU-9430-2021	Mo, Delin/0000-0002-8738-4486	National Natural Science Foundation of China [31772565]; Sail Plan [2014YT02H042]; Science and Technology Project of Guangdong Province [2014B020202001]; Ministry of Science and Technology of China [2014FY120800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sail Plan; Science and Technology Project of Guangdong Province; Ministry of Science and Technology of China(Ministry of Science and Technology, China)	The authors thank Gene Denovo (Guangzhou, China) for providing us with technical assistance and bioinformatic analyses. This research was supported by the National Natural Science Foundation of China (31772565), Sail Plan (2014YT02H042), the Science and Technology Project of Guangdong Province (2014B020202001), and the Ministry of Science and Technology of China (2014FY120800). The authors declare no conflicts of interest.	Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R87, 10.1186/gb-2012-13-10-r87]; Andersson L, 2012, J INTERN MED, V271, P1, DOI 10.1111/j.1365-2796.2011.02450.x; Bar-Nur O, 2018, STEM CELL REP, V10, P1505, DOI 10.1016/j.stemcr.2018.04.009; Beck S, 2008, TRENDS GENET, V24, P231, DOI 10.1016/j.tig.2008.01.006; Brinkman AB, 2010, METHODS, V52, P232, DOI 10.1016/j.ymeth.2010.06.012; Brunk BP, 1996, DEV BIOL, V177, P490, DOI 10.1006/dbio.1996.0180; Chen JCJ, 2001, DEV DYNAM, V221, P274, DOI 10.1002/dvdy.1138; Congras A, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119610; Dalton SR, 2012, EPIGENOMICS-UK, V4, P459, DOI [10.2217/EPI.12.36, 10.2217/epi.12.36]; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DAVIS RL, 1992, SCIENCE, V256, P1027, DOI 10.1126/science.1317057; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/EPI.11.105, 10.2217/epi.11.105]; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Fouse SD, 2010, EPIGENOMICS-UK, V2, P105, DOI 10.2217/EPI.09.35; Ginestet C, 2011, J R STAT SOC A STAT, V174, P245, DOI 10.1111/j.1467-985X.2010.00676_9.x; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Harada A, 2015, NUCLEIC ACIDS RES, V43, P775, DOI 10.1093/nar/gku1346; Hayatsu Hikoya, 2008, Curr Protoc Nucleic Acid Chem, VChapter 6, DOI 10.1002/0471142700.nc0610s33; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YZ, 2014, SCI REP-UK, V4, P1, DOI 10.1038/srep06546; Hyldig SMW, 2011, BIOL REPROD, V84, P1087, DOI 10.1095/biolreprod.110.086082; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Koch A, 2018, NAT REV CLIN ONCOL, V15, P459, DOI 10.1038/s41571-018-0004-4; Koh KP, 2013, CURR OPIN CELL BIOL, V25, P152, DOI 10.1016/j.ceb.2013.02.014; L'honore A, 2007, MOL BIOL CELL, V18, P1992, DOI 10.1091/mbc.E06-09-0867; Leikina E, 2018, DEV CELL, V46, P767, DOI 10.1016/j.devcel.2018.08.006; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li MZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1854; Li QN, 2018, REPROD FERT DEVELOP, V30, P1713, DOI 10.1071/RD18002; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li Y, 2010, PROCEEDINGS OF 2010 ASIA-PACIFIC YOUTH CONFERENCE ON COMMUNICATION, VOLS 1 AND 2, P10, DOI 10.1371/journal.pbio.1000533; Luo W, 2015, INT J MOL SCI, V16, P26186, DOI 10.3390/ijms161125946; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Niehrs C, 2012, TRENDS CELL BIOL, V22, P220, DOI 10.1016/j.tcb.2012.01.002; Rao YS, 2016, POULTRY SCI, V95, P1750, DOI 10.3382/ps/pew136; Rasmussen KD, 2016, GENE DEV, V30, P733, DOI 10.1101/gad.276568.115; Reizel Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04456-6; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rothschild MF, 2004, GENET RES, V83, P1, DOI 10.1017/S0016672303006621; Schmitz RJ, 2013, GENOME RES, V23, P1663, DOI 10.1101/gr.152538.112; Seisenberger S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0330; Serre D, 2010, NUCLEIC ACIDS RES, V38, P391, DOI 10.1093/nar/gkp992; Slieker RC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005583; Slieker RC, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-26; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Song MY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29390; STICKLAND NC, 1986, J ANAT, V147, P181; Sun Q, 2014, ANIMAL, V8, P1851, DOI 10.1017/S1751731114001700; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Wang KY, 2014, EPIGENOMICS-UK, V6, P353, DOI [10.2217/EPI.14.21, 10.2217/epi.14.21]; Wang XL, 2006, J REPROD DEVELOP, V52, P639, DOI 10.1262/jrd.18048; Womack JE, 2005, GENOME RES, V15, P1699, DOI 10.1101/gr.3809105; Wu H, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv715; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xiang H, 2010, NAT BIOTECHNOL, V28, P516, DOI 10.1038/nbt.1626; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yamashita M, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.157412; Yang C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016229; Yang YL, 2017, SCI REP-UK, V7, DOI 10.1038/srep39883; Yuan XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep20005; Zhang XM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2464-1; Zhao YQ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1580-7; Zhong X, 2017, SCI REP-UK, V7, DOI 10.1038/srep43539	70	7	8	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9638	9655		10.1096/fj.201900388R	http://dx.doi.org/10.1096/fj.201900388R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31145867	Bronze			2022-12-28	WOS:000478832900073
J	Fuente, R; Gil-Pena, H; Claramunt-Taberner, D; Hernandez-Frias, O; Fernandez-Iglesias, A; Alonso-Duran, L; Rodriguez-Rubio, E; Hermida-Prado, F; Anes-Gonzalez, G; Rubio-Aliaga, I; Wagner, C; Santos, F				Fuente, Rocio; Gil-Pena, Helena; Claramunt-Taberner, Debora; Hernandez-Frias, Olaya; Fernandez-Iglesias, Angela; Alonso-Duran, Laura; Rodriguez-Rubio, Enrique; Hermida-Prado, Francisco; Anes-Gonzalez, Gonzalo; Rubio-Aliaga, Isabel; Wagner, Carsten; Santos, Fernando			MAPK inhibition and growth hormone: a promising therapy in XLH	FASEB JOURNAL			English	Article						Hyp mouse; growth plate; bone deformities; PHEX gene; FGF23	X-LINKED HYPOPHOSPHATEMIA; ANTI-FGF23 ANTIBODY KRN23; BONE-MINERAL DENSITY; FGF23; CHILDREN; RETARDATION; ADULTS; PHOSPHORUS; TRIAL	X-linked hypophosphatemia (XLH) leads to growth retardation and bone deformities, which are not fully avoided by conventional treatment with phosphate and vitamin D analogs. Pediatric patients have been treated with growth hormone (GH), and recent findings suggest that blocking fibroblast growth factor 23 actions may be the most effective therapy, but its effects on growth are not known. We here report the effect of MAPK inhibition alone or associated with GH on growth and growth plate and bone structure of young Hyp (the XLH animal model) mice. Untreated Hyp mice were severely growth retarded and had marked alterations in both growth plate structure and dynamics as well as defective bone mineralization. GH accelerated growth and improved mineralization and the cortical bone, but it failed in normalizing growth plate and trabecular bone structures. MAPK inhibition improved growth and rickets and, notably, almost normalized the growth plate organization. The administration of a MAPK pathway inhibitor plus GH was the most beneficial treatment because of the positive synergistic effect on growth plate and bone structures. Thus, the growth-promoting effect of GH is likely linked to increased risk of bone deformities, whereas the association of GH and MAPK inhibition emerges as a promising new therapy for children with XLH.-Fuente, R., Gil-Pena, H., Claramunt-Taberner, D., Hernandez-Frias, O., Fernandez-Iglesias, a., Alonso-Duran, L., Rodriguez-Rubio, E., Hermida-Prado, F., Anes-Gonzalez, G., Rubio-Aliaga, I., Wagner, C., Santos, F. MAPK inhibition and growth hormone: a promising therapy in XLH.	[Fuente, Rocio; Claramunt-Taberner, Debora; Hernandez-Frias, Olaya; Fernandez-Iglesias, Angela; Alonso-Duran, Laura; Rodriguez-Rubio, Enrique; Santos, Fernando] Univ Oviedo, Fac Med & Hlth Sci, Dept Med, Div Pediat, Oviedo, Spain; [Fuente, Rocio] Harvard Univ, Harvard Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Gil-Pena, Helena; Anes-Gonzalez, Gonzalo; Santos, Fernando] Hosp Univ Cent Asturias, Dept Pediat, Ave Roma S-N, Oviedo 33011, Spain; [Hermida-Prado, Francisco] Hosp Univ Cent Asturias, Inst Univ Oncol Principado Asturias, Dept Otorhinolaryngol, Oviedo, Spain; [Rubio-Aliaga, Isabel; Wagner, Carsten] Univ Zurich, Inst Physiol, Kidney & Acid Base Physiol Grp, Zurich, Switzerland	University of Oviedo; Harvard University; Harvard School of Dental Medicine; Central University Hospital Asturias; Central University Hospital Asturias; University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Zurich	Gil-Pena, H (corresponding author), Hosp Univ Cent Asturias, Dept Pediat, Ave Roma S-N, Oviedo 33011, Spain.	hgilpena@gmail.com	Hermida-Prado, Francisco/F-9502-2016	Hermida-Prado, Francisco/0000-0002-2916-0337; Rubio-Aliaga, Isabel/0000-0003-1051-9511; FUENTE, ROCIO/0000-0002-2311-2836	Fundacion Nutricion y Crecimiento from the Instituto de Salud Carlos III (Madrid, Spain) [PI12/00987, PI15/02122, PI18/01757]; Fondo Europeo de Desarrollo Regional (FEDER)	Fundacion Nutricion y Crecimiento from the Instituto de Salud Carlos III (Madrid, Spain); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	This study was supported by Fundacion Nutricion y Crecimiento, Grants PI12/00987 (National Plan I + D + I 2008-2011), PI15/02122 (Plan Estatal I + D + I 2013-2016), and PI18/01757 (Plan Estatal I + D + I 2017-2020) from the Instituto de Salud Carlos III (Madrid, Spain), and Fondo Europeo de Desarrollo Regional (FEDER). The authors declare no conflicts of interest.	Alvarez-Garcia O, 2010, KIDNEY INT, V78, P561, DOI 10.1038/ki.2010.173; Aono Y, 2009, J BONE MINER RES, V24, P1879, DOI [10.1359/JBMR.090509, 10.1359/jbmr.090509]; Bourgeois S, 2013, PFLUG ARCH EUR J PHY, V465, P1557, DOI 10.1007/s00424-013-1298-9; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Carpenter TO, 2018, NEW ENGL J MED, V378, P1987, DOI 10.1056/NEJMoa1714641; Carpenter TO, 2014, J CLIN INVEST, V124, P1587, DOI 10.1172/JCI72829; Claramunt D, 2015, AM J PHYSIOL-RENAL, V309, pF57, DOI 10.1152/ajprenal.00051.2015; Neto GPC, 2017, OSTEOPOROSIS INT, V28, P1685, DOI 10.1007/s00198-017-3949-8; Du E, 2017, J CELL PHYSIOL, V232, P610, DOI 10.1002/jcp.25458; Efthymiadou A, 2016, EUR J ENDOCRINOL, V174, P473, DOI 10.1530/EJE-15-1018; FRIEDMAN NE, 1993, J CLIN ENDOCR METAB, V76, P839, DOI 10.1210/jc.76.4.839; Fuente R, 2017, REV ENDOCR METAB DIS, V18, P107, DOI 10.1007/s11154-017-9408-1; Fuente R, 2018, BONE, V116, P187, DOI 10.1016/j.bone.2018.08.004; Fukumoto S, 2016, CALCIFIED TISSUE INT, V98, P334, DOI 10.1007/s00223-015-0029-y; Gardner J, 2011, J PEDIATR ENDOCR MET, V24, P645, DOI 10.1515/JPEM.2011.301; Gattineni J, 2009, AM J PHYSIOL-RENAL, V297, pF282, DOI 10.1152/ajprenal.90742.2008; Huiming YM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001479.pub3; Hutchison MR, 2012, MOL ENDOCRINOL, V26, P1406, DOI 10.1210/me.2012-1063; Imel EA, 2015, J CLIN ENDOCR METAB, V100, P2565, DOI 10.1210/jc.2015-1551; Makitie O, 2003, J CLIN ENDOCR METAB, V88, P3591, DOI 10.1210/jc.2003-030036; Molinos I, 2006, KIDNEY INT, V70, P1955, DOI 10.1038/sj.ki.5001949; Oh CD, 2000, J BIOL CHEM, V275, P5613, DOI 10.1074/jbc.275.8.5613; OLIVERI MB, 1991, BONE MINER, V12, P91, DOI 10.1016/0169-6009(91)90038-2; Ovejero D, 2016, OSTEOPOROSIS INT, V27, P3615, DOI 10.1007/s00198-016-3702-8; PARFITT AM, 1988, CALCIFIED TISSUE INT, V42, P284, DOI 10.1007/BF02556360; Ranch D, 2011, J BONE MINER RES, V26, P1883, DOI 10.1002/jbmr.401; Reusz GS, 1997, PEDIATR NEPHROL, V11, P573, DOI 10.1007/s004670050340; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schutt SM, 2003, EUR J ENDOCRINOL, V149, P317, DOI 10.1530/eje.0.1490317; Wohrle S, 2013, J BONE MINER RES, V28, P899, DOI 10.1002/jbmr.1810; Yamashita T, 2002, J BIOL CHEM, V277, P28265, DOI 10.1074/jbc.M202527200; Zhang XP, 2016, J CLIN PHARMACOL, V56, P176, DOI 10.1002/jcph.570; Zivicnjak M, 2011, PEDIATR NEPHROL, V26, P223, DOI 10.1007/s00467-010-1705-9	33	6	8	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8349	8362		10.1096/fj.201802007R	http://dx.doi.org/10.1096/fj.201802007R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30974062	Bronze			2022-12-28	WOS:000476234700044
J	Little, HC; Rodriguez, S; Lei, X; Tan, SY; Stewart, AN; Sahagun, A; Sarver, DC; Wong, GW				Little, Hannah C.; Rodriguez, Susana; Lei, Xia; Tan, Stefanie Y.; Stewart, Ashley N.; Sahagun, Ageline; Sarver, Dylan C.; Wong, G. William			Myonectin deletion promotes adipose fat storage and reduces liver steatosis	FASEB JOURNAL			English	Article						myokine; lipid metabolism; carbohydrate metabolism; obesity; diabetes	FACTOR-RELATED PROTEIN-9; SKELETAL-MUSCLE; INSULIN-RESISTANCE; ISCHEMIA-REPERFUSION; TISSUE INFLAMMATION; HEPATIC STEATOSIS; MYOCARDIAL INJURY; INDUCED MYOKINE; ACID OXIDATION; FOOD-INTAKE	We recently described myonectin (also known as erythroferrone) as a novel skeletal muscle-derived myokine with metabolic functions. Here, we use a genetic mouse model to determine myonectin's requirement for metabolic homeostasis. Female myonectin-deficient mice had larger gonadal fat pads and developed mild insulin resistance when fed a high-fat diet (HFD) and had reduced food intake during refeeding after an unfed period but were otherwise indistinguishable from wild-type littermates. Male mice lacking myonectin, however, had reduced physical activity when fed ad libitum and in the postprandial state but not during the unfed period. When stressed with an HFD, myonectin-knockout male mice had significantly elevated VLDL-triglyceride (TG) and strikingly impaired lipid clearance from circulation following an oral lipid load. Fat distribution between adipose and liver was also altered in myonectin-deficient male mice fed an HFD. Greater fat storage resulted in significantly enlarged adipocytes and was associated with increased postprandial lipoprotein lipase activity in adipose tissue. Parallel to this was a striking reduction in liver steatosis due to significantly reduced TG accumulation. Liver metabolite profiling revealed additional significant changes in bile acids and 1-carbon metabolism pathways. Combined, our data affirm the physiologic importance of myonectin in regulating local and systemic lipid metabolism.-Little, H. C., Rodriguez, S., Lei, X., Tan, S. Y., Stewart, A. N., Sahagun, A., Sarver, D. C., Wong, G. W. Myonectin deletion promotes adipose fat storage and reduces liver steatosis.	[Little, Hannah C.; Rodriguez, Susana; Lei, Xia; Tan, Stefanie Y.; Stewart, Ashley N.; Sahagun, Ageline; Sarver, Dylan C.; Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, 855 N Wolfe St, Baltimore, MD 21205 USA; [Little, Hannah C.; Rodriguez, Susana; Lei, Xia; Tan, Stefanie Y.; Stewart, Ashley N.; Sahagun, Ageline; Sarver, Dylan C.; Wong, G. William] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, 855 N Wolfe St, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 855 N Wolfe St, Baltimore, MD 21205 USA.; Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, 855 N Wolfe St, Baltimore, MD 21205 USA.	gwwong@jhmi.edu			U.S. National Institutes of Health (NIH), National Institute of Diabtes and Digestive and Kidney Diseases [DK084171]; National Research Service Award pre-doctoral fellowship [F31DK116537]; NIH, National Institute of General Medical Sciences training grant [T32 GM007445]; American Diabetes Association [1-18-PMF-022]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084171, F31DK116537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Institute of Diabtes and Digestive and Kidney Diseases; National Research Service Award pre-doctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Institute of General Medical Sciences training grant; American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Susan Aja (Johns Hopkins University) for help with indirect calorimetry. This work was supported in part by a Grant from the U.S. National Institutes of Health (NIH), National Institute of Diabtes and Digestive and Kidney Diseases (DK084171 to G.W.W.). H.C.L. was supported by a National Research Service Award pre-doctoral fellowship (F31DK116537) and a NIH, National Institute of General Medical Sciences training grant (T32 GM007445). S.R. was supported by a postdoctoral fellowship from the American Diabetes Association (1-18-PMF-022). The authors declare no conflicts of interest.	Appari M, 2017, CIRC RES, V120, P66, DOI 10.1161/CIRCRESAHA.116.309398; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Broholm C, 2011, J APPL PHYSIOL, V111, P251, DOI 10.1152/japplphysiol.01399.2010; Byerly MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062862; Chan XCY, 2007, J PROTEOME RES, V6, P698, DOI 10.1021/pr060448k; Coffey R, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13890; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Guo TQ, 2012, DIABETES, V61, P2414, DOI 10.2337/db11-0915; Hartwig S, 2014, BBA-PROTEINS PROTEOM, V1844, P1011, DOI 10.1016/j.bbapap.2013.08.004; Haugen F, 2010, AM J PHYSIOL-CELL PH, V298, pC807, DOI 10.1152/ajpcell.00094.2009; Henningsen J, 2010, MOL CELL PROTEOMICS, V9, P2482, DOI 10.1074/mcp.M110.002113; Hojman P, 2009, DIABETES, V58, P2797, DOI 10.2337/db09-0713; Hong J, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-11; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Kambara T, 2015, MOL CELL BIOL, V35, P2173, DOI 10.1128/MCB.01518-14; Kambara T, 2012, J BIOL CHEM, V287, P18965, DOI 10.1074/jbc.M112.357939; Kautz L, 2014, BLOOD, V124, P2569, DOI 10.1182/blood-2014-06-584607; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Koh A, 2018, CELL, V175, P947, DOI 10.1016/j.cell.2018.09.055; Lei X, 2017, J BIOL CHEM, V292, P14836, DOI [10.1074/jbc.m116.766808, 10.1074/jbc.M116.766808]; Leick L, 2008, AM J PHYSIOL-ENDOC M, V294, pE463, DOI 10.1152/ajpendo.00666.2007; Li KJ, 2018, J CLIN ENDOCR METAB, V103, P139, DOI 10.1210/jc.2017-01604; Little HC, 2018, MOL CELL PROTEOMICS, V17, P1546, DOI 10.1074/mcp.RA118.000794; Lu L, 2016, EUR HEART J, V37, P1762, DOI 10.1093/eurheartj/ehv649; Mathis D, 2011, NAT REV IMMUNOL, V11, P81, DOI 10.1038/nri2922; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Mizunoya W, 2005, LIPIDS, V40, P265, DOI 10.1007/s11745-005-1381-5; Nishizawa H, 2004, J BIOL CHEM, V279, P19391, DOI 10.1074/jbc.C400066200; Otaka N, 2018, CIRC RES, V123, P1326, DOI 10.1161/CIRCRESAHA.118.313777; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Pedersen BK, 2013, COMPR PHYSIOL, V3, P1337, DOI 10.1002/cphy.c120033; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pedersen BK, 2009, J APPL PHYSIOL, V107, P1006, DOI 10.1152/japplphysiol.00734.2009; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Petersen PS, 2017, AM J PHYSIOL-ENDOC M, V312, pE309, DOI 10.1152/ajpendo.00344.2016; Peterson JM, 2013, AM J PHYSIOL-REG I, V305, pR522, DOI 10.1152/ajpregu.00110.2013; Peterson JM, 2013, AM J PHYSIOL-GASTR L, V305, pG214, DOI 10.1152/ajpgi.00102.2013; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Qiao LP, 2008, DIABETES, V57, P1824, DOI 10.2337/db07-0435; Quinn LS, 2009, AM J PHYSIOL-ENDOC M, V296, pE191, DOI 10.1152/ajpendo.90506.2008; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Rodriguez S, 2016, AM J PHYSIOL-ENDOC M, V311, pE678, DOI 10.1152/ajpendo.00087.2016; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seldin MM, 2013, J BIOL CHEM, V288, P36073, DOI 10.1074/jbc.M113.500736; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Shan TZ, 2013, FASEB J, V27, P1981, DOI 10.1096/fj.12-225755; Staiger H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061903; Su H, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0315-z; Subbotina E, 2015, P NATL ACAD SCI USA, V112, P16042, DOI 10.1073/pnas.1514250112; Sun Y, 2013, CIRCULATION, V128, pS113, DOI 10.1161/CIRCULATIONAHA.112.000010; Tan SY, 2016, PHYSIOL GENOMICS, V48, P936, DOI 10.1152/physiolgenomics.00111.2016; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Toloza FJK, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00005; Trayhurn Paul, 2011, Archives of Physiology and Biochemistry, V117, P47, DOI 10.3109/13813455.2010.535835; Uemura Y, 2013, FASEB J, V27, P25, DOI 10.1096/fj.12-213744; Varlamov O, 2015, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00241; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Wasserman DH, 2011, J EXP BIOL, V214, P254, DOI 10.1242/jeb.048041; Wei ZK, 2014, AM J PHYSIOL-ENDOC M, V306, pE779, DOI 10.1152/ajpendo.00593.2013; Wei ZK, 2013, J BIOL CHEM, V288, P10214, DOI 10.1074/jbc.M113.458711; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Welc SS, 2013, EXP PHYSIOL, V98, P359, DOI 10.1113/expphysiol.2012.068189; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Wolf RM, 2016, AM J PHYSIOL-ENDOC M, V310, pE332, DOI 10.1152/ajpendo.00248.2015; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Yan WJ, 2017, CIRCULATION, V136, P2162, DOI 10.1161/CIRCULATIONAHA.117.029557; Yang YB, 2014, OBESITY, V22, P2147, DOI 10.1002/oby.20811; Yuasa D, 2016, FASEB J, V30, P1065, DOI 10.1096/fj.15-279885; Zeng L, 2010, J BIOL CHEM, V285, P36060, DOI 10.1074/jbc.M110.160879; Zhang R, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150272	77	38	38	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8666	8687		10.1096/fj.201900520R	http://dx.doi.org/10.1096/fj.201900520R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	31002535	Green Published			2022-12-28	WOS:000476234700068
J	Xiong, CX; Guan, YJ; Zhou, XX; Liu, LR; Zhuang, MA; Zhang, W; Zhang, YH; Masucci, MV; Bayliss, G; Zhao, T; Zhuang, SG				Xiong, Chongxiang; Guan, Yingjie; Zhou, Xiaoxu; Liu, Lirong; Zhuang, Michelle A.; Zhang, Wei; Zhang, Yunhe; Masucci, Monica, V; Bayliss, George; Zhao, Ting C.; Zhuang, Shougang			Selective inhibition of class IIa histone deacetylases alleviates renal fibrosis	FASEB JOURNAL			English	Article						HDAC4; inflammation; unilateral ureteral obstruction; renal epithelial cells; MC1568	TO-MESENCHYMAL TRANSITION; CELL-CYCLE ARREST; MATRIX METALLOPROTEINASES; KAPPA-B; TUBULOINTERSTITIAL FIBROSIS; INTERSTITIAL FIBROSIS; EPIGENETIC REGULATION; TGF-BETA; KIDNEY; KLOTHO	In this study, we examined the effect of MC1568, a selective class IIa histone deacetylase (HDAC) inhibitor, on the development and progression of renal fibrosis in a murine model of renal fibrosis induced by unilateral ureteral obstruction (UUO). All 4 class IIa HDAC isoforms, in particular HDAC4, were up-regulated in renal epithelial cells of the injured kidney. Administration of MC1568 immediately after UUO injury reduced expression of alpha-smooth muscle actin (alpha-SMA), fibronectin, and collagen 1. MC1568 treatment or small interfering RNA-mediated silencing of HDAC4 also suppressed expression of those proteins in cultured renal epithelial cells. Mechanistically, MC1568 abrogated UUO-induced phosphorylation of Smad3, NF-kappa B, and up-regulation of integrin ?V beta 6 in the kidney and inhibited TGF-beta 1-induced responses in cultured renal epithelial cells. MC1568 also increased renal expression of klotho, bone morphogenetic protein 7, and Smad7. Moreover, delayed administration of MC1568 at 3 d after ureteral obstruction reversed the expression of alpha-SMA, fibronectin, and collagen 1 and increased expression of matrix metalloproteinase (MMP)-2 and -9. Collectively, these results suggest that selectively targeting class IIa HDAC isoforms (in particular HDAC4) may inhibit development and progression of renal fibrosis by suppressing activation and expression of multiple profibrotic molecules and increasing expression of antifibrotic proteins and MMPs.-Xiong, C., Guan, Y., Zhou, X., Liu, L., Zhuang, M. A., Zhang, W., Zhang, Y., Masucci, M. V., Bayliss, G., Zhao, T. C., Zhuang, S. Selective inhibition of class IIa histone deacetylases alleviates renal fibrosis.	[Xiong, Chongxiang; Guan, Yingjie; Zhou, Xiaoxu; Liu, Lirong; Zhuang, Michelle A.; Zhang, Wei; Zhang, Yunhe; Masucci, Monica, V; Bayliss, George; Zhuang, Shougang] Brown Univ, Dept Med, Rhode Isl Hosp, Warren Alpert Med Sch, Providence, RI 02912 USA; [Xiong, Chongxiang] Southern Med Univ, Affiliated Hosp 3, Dept Nephrol, Guangzhou, Guangdong, Peoples R China; [Zhao, Ting C.] Boston Univ, Dept Surg, Med Sch, Roger Williams Med Ctr, Providence, RI USA; [Zhuang, Shougang] Tongji Univ, Shanghai East Hosp, Dept Nephrol, Sch Med, Shanghai 200092, Peoples R China	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Southern Medical University - China; Boston University; Roger Williams Medical Center; Tongji University	Zhuang, SG (corresponding author), Tongji Univ, Shanghai East Hosp, Dept Nephrol, Sch Med, Shanghai 200092, Peoples R China.	szhuang@lifespan.org		Masucci, Monica/0000-0001-6614-2851	National Nature Science Foundation of China [81470920, 81670623, 81830021]; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [5R01DK085065]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK113256, R01DK085065] Funding Source: NIH RePORTER	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Nature Science Foundation of China (Grants 81470920, 81670623, 81830021, to S.Z.) and the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (Grant 5R01DK085065, to S.Z.). The authors declare no conflicts of interest.	Annes JP, 2002, FEBS LETT, V511, P65, DOI 10.1016/S0014-5793(01)03280-X; Bolbrinker J, 2006, J PHARMACOL EXP THER, V316, P8, DOI 10.1124/jpet.105.093112; Choi SY, 2015, VASC PHARMACOL, V72, P130, DOI 10.1016/j.vph.2015.04.006; Conforti F, 2017, ONCOTARGET, V8, P48737, DOI 10.18632/oncotarget.17114; De Souza C, 2015, RECENT PAT ANTI-CANC, V10, P145; Di Giorgio E, 2016, EPIGENOMICS-UK, V8, P251, DOI 10.2217/epi.15.106; Ding W, 2012, LIFE SCI, V90, P600, DOI 10.1016/j.lfs.2012.02.022; ERNEST S, 1995, AM J PHYSIOL-CELL PH, V269, pC323, DOI 10.1152/ajpcell.1995.269.2.C323; Fu QW, 2016, CLIN MED RES, V14, P15, DOI 10.3121/cmr.2015.1282; Fu WC, 2012, RENAL FAILURE, V34, P1297, DOI 10.3109/0886022X.2012.723775; Fujihara CK, 2007, AM J PHYSIOL-RENAL, V292, pF92, DOI 10.1152/ajprenal.00184.2006; Gong R, 2003, J AM SOC NEPHROL, V14, P3047, DOI 10.1097/01.ASN.0000098686.72971.DB; Hadden MJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092630; Hahm K, 2007, AM J PATHOL, V170, P110, DOI 10.2353/ajpath.2007.060158; Hu MC, 2017, KIDNEY INT, V91, P1104, DOI 10.1016/j.kint.2016.10.034; Hu MC, 2012, NEPHROL DIAL TRANSPL, V27, P2650, DOI 10.1093/ndt/gfs160; Hu MC, 2012, ADV EXP MED BIOL, V728, P126, DOI 10.1007/978-1-4614-0887-1_9; Kumar P, 2017, AM J PHYSIOL-RENAL, V313, pF781, DOI 10.1152/ajprenal.00166.2017; Lin JM, 2005, NAT MED, V11, P387, DOI 10.1038/nm1217; Lin WJ, 2017, KIDNEY INT, V92, P669, DOI 10.1016/j.kint.2017.02.023; Lin WJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep46195; Liu AH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056536, 10.1371/journal.pone.0057359, 10.1371/journal.pone.0056570, 10.1371/journal.pone.0054001]; Liu N, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00121; Liu N, 2011, J PHARMACOL EXP THER, V338, P758, DOI 10.1124/jpet.111.181727; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Lv WS, 2018, EUR J PHARMACOL, V820, P65, DOI 10.1016/j.ejphar.2017.12.016; Ma LJ, 2003, AM J PATHOL, V163, P1261, DOI 10.1016/S0002-9440(10)63486-4; Manson SR, 2015, VITAM HORM, V99, P91, DOI 10.1016/bs.vh.2015.05.003; Maric C, 2004, J AM SOC NEPHROL, V15, P1546, DOI 10.1097/01.ASN.0000128219.65330.EA; Marumo T, 2008, J AM SOC NEPHROL, V19, P1311, DOI 10.1681/ASN.2007091040; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Meng XM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00082; Meng XM, 2014, NAT REV NEPHROL, V10, P493, DOI 10.1038/nrneph.2014.114; Mottamal M, 2015, MOLECULES, V20, P3898, DOI 10.3390/molecules20033898; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Parrish AR, 2017, PROG MOL BIOL TRANSL, V148, P31, DOI 10.1016/bs.pmbts.2017.03.001; Ponnusamy M, 2014, J PHARMACOL EXP THER, V350, P243, DOI 10.1124/jpet.113.212076; Rodriguez WE, 2006, AM J PHYSIOL-RENAL, V291, pF694, DOI 10.1152/ajprenal.00398.2005; Schnaper HW, 2009, FRONT BIOSCI-LANDMRK, V14, P2448, DOI 10.2741/3389; Spallotta F, 2013, J BIOL CHEM, V288, P22915, DOI 10.1074/jbc.M113.484337; Sun SZ, 2006, CHINESE MED J-PEKING, V119, P814, DOI 10.1097/00029330-200605020-00004; Tang JH, 2013, CLIN SCI, V124, P651, DOI 10.1042/CS20120504; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Uchio K, 2000, NEPHRON, V86, P145, DOI 10.1159/000045733; Uchio-Yamada K, 2005, J VET MED SCI, V67, P35, DOI 10.1292/jvms.67.35; Wang X., 2014, KIDNEY INT, V86, P666; Xu LQ, 2017, ONCOTARGET, V8, P88730, DOI 10.18632/oncotarget.20982; Xu Z, 2017, CLIN SCI, V131, P1841, DOI 10.1042/CS20170064; Yanagita M, 2006, J CLIN INVEST, V116, P70, DOI 10.1172/JCI25445; Yang JW, 2002, J CLIN INVEST, V110, P1525, DOI 10.1172/JC1200216219; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yoshikawa M, 2007, J AM SOC NEPHROL, V18, P58, DOI 10.1681/ASN.2005111187; Zeisberg M, 2003, AM J PHYSIOL-RENAL, V285, pF1060, DOI 10.1152/ajprenal.00191.2002; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zeisberg M, 2006, PLOS MED, V3, P535, DOI 10.1371/journal.pmed.0030100; Zhang Q, 2017, KIDNEY INT, V91, P144, DOI 10.1016/j.kint.2016.07.040; Zhao Hong, 2013, World J Nephrol, V2, P84, DOI 10.5527/wjn.v2.i3.84; Zhao M, 2016, ONCOTARGET, V7, P64690, DOI 10.18632/oncotarget.11811; Zwergel C, 2015, EXPERT OPIN DRUG DIS, V10, P599, DOI 10.1517/17460441.2015.1038236	59	27	29	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8249	8262		10.1096/fj.201801067RR	http://dx.doi.org/10.1096/fj.201801067RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30951378	Bronze, Green Published			2022-12-28	WOS:000476234700037
J	Han, JL; Shao, JJ; Chen, Q; Sun, HZ; Guan, LL; Li, YX; Liu, JX; Liu, HY				Han, Jialiang; Shao, Juanjuan; Chen, Qiong; Sun, Huizeng; Guan, Leluo; Li, Yongxin; Liu, Jianxin; Liu, Hongyun			Transcriptional changes in the hypothalamus, pituitary, and mammary gland underlying decreased lactation performance in mice under heat stress	FASEB JOURNAL			English	Article						hormone; high temperature; RNA-Seq; the neuroendocrine system	GENE-EXPRESSION; GROWTH-HORMONE; BLOOD-FLOW; BONE MASS; PROTEIN; DEATH; RAT; SOMATOTROPIN; ENVIRONMENT; ACTIVATION	Because of climate change, heat stress (HS) causes more and more impacts on dairy animals to decrease lactation performance. The neuroendocrine system is key in regulating systemic physiological processes and milk synthesis. However, the hypothalamic-pituitary axis response to HS is still unclear. In this study, a group of lactating mice underwent a daily 2-h heat treatment (36 degrees C) for 14 d to explore possible cross-talk between the hypothalamic-pituitary axis and mammary gland under HS. Transcriptome analyses by multitissue RNA-Seq indicated the possible mechanisms of reduced lactation performance in animals under HS. In the hypothalamus, the cAMP signaling pathway was activated to resist neuronal death, and the expression of downstream genes was increased to promote cell survival under HS. Reduced food intake might be caused by down-regulated appetite-related peptide, whereas up-regulated neuropeptide Y acted to attenuate reduced food intake. In pituitary, energy stress from lower food intake might result in reduced secretion of prolactin and growth hormone. Under HS, the mammary gland may undergo hypoxic stress, causing mammary epithelial cell apoptosis. Together, these data showed systemic changes in tissues to accommodate the effects of HS on lactation.	[Han, Jialiang; Shao, Juanjuan; Chen, Qiong; Sun, Huizeng; Guan, Leluo; Li, Yongxin; Liu, Jianxin; Liu, Hongyun] Zhejiang Univ, Coll Anim Sci, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China; [Sun, Huizeng; Guan, Leluo] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	Zhejiang University; University of Alberta	Liu, HY (corresponding author), Zhejiang Univ, Coll Anim Sci, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China.	hyliu@zju.edu.cn	Sun, Hui-Zeng/AES-8969-2022		National Key Research and Development Program of China [2016YFD0500503, 2018YFD0501600]; National Natural Science Foundation of China [31672447]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Jie Cai (Zhejiang University) for assistance in data analysis and visualization. This work is supported by the National Key Research and Development Program of China (2016YFD0500503 and 2018YFD0501600) and the National Natural Science Foundation of China (31672447). The authors declare no conflicts of interest.	Alamer M, 2009, SMALL RUMINANT RES, V84, P76, DOI 10.1016/j.smallrumres.2009.06.009; ALBRIGHT JL, 1971, J ANIM SCI, V32, P566; Azara CRP, 2008, BIOL RES, V41, P317, DOI [/S0716-97602008000300008, 10.4067/S0716-97602008000300008]; Bahry MA, 2017, NEUROPEPTIDES, V62, P93, DOI 10.1016/j.npep.2016.11.008; Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; BAUMAN DE, 1993, ANNU REV NUTR, V13, P437, DOI 10.1146/annurev.nu.13.070193.002253; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernabucci U, 2013, CELL MOL BIOL, V59, P67, DOI 10.1170/T948; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Collier R.J., 1985, NUTR GRAZING RUMINAN, P59, DOI DOI 10.1016/B978-0-12-483370-8.50011-2; Cowley FC, 2015, J DAIRY SCI, V98, P2356, DOI 10.3168/jds.2014-8442; Cypess AM, 2011, ENDOCRINOLOGY, V152, P3680, DOI 10.1210/en.2011-1229; Das R, 2016, VET WORLD, V9, P260, DOI 10.14202/vetworld.2016.260-268; Davis SL, 2006, J APPL PHYSIOL, V100, P221, DOI 10.1152/japplphysiol.00867.2005; DOBNIG H, 1995, J CLIN ENDOCR METAB, V80, P3699, DOI 10.1210/jc.80.12.3699; Etherton TD, 1998, PHYSIOL REV, V78, P745, DOI 10.1152/physrev.1998.78.3.745; Faure E, 2000, CELL TISSUE RES, V300, P89, DOI 10.1007/s004410000183; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; FOLLEY SJ, 1946, BIOCHEM J, V40, P46, DOI 10.1042/bj0400046; Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Greene E, 2016, COMP BIOCHEM PHYS A, V191, P18, DOI 10.1016/j.cbpa.2015.08.016; Hadsell DL, 2002, J DAIRY SCI, V85, P365, DOI 10.3168/jds.S0022-0302(02)74083-6; HALDAR J, 1981, P SOC EXP BIOL MED, V168, P10, DOI 10.3181/00379727-168-41227; Hu H, 2016, ANIM PROD SCI, V56, P918, DOI 10.1071/AN14420; Hu H, 2016, ANIM SCI J, V87, P84, DOI 10.1111/asj.12375; KAISER PK, 1990, NEURON, V5, P373, DOI 10.1016/0896-6273(90)90173-D; KOVACS CS, 1995, J CLIN ENDOCR METAB, V80, P3036, DOI 10.1210/jc.80.10.3036; Kumsta C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14337; LaKind JS, 2009, ENVIRON INT, V35, P994, DOI 10.1016/j.envint.2009.03.013; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Li CM, 2016, BIOMATERIALS, V110, P24, DOI 10.1016/j.biomaterials.2016.09.014; LIGHTMAN SL, 1992, ANN NY ACAD SCI, V652, P340, DOI 10.1111/j.1749-6632.1992.tb34365.x; Liu Y, 2016, CELL CYCLE, V15, P357, DOI 10.1080/15384101.2015.1120924; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOUGH DS, 1990, J DAIRY SCI, V73, P325, DOI 10.3168/jds.S0022-0302(90)78677-8; Luo M, 2016, MOL CELL BIOCHEM, V412, P81, DOI 10.1007/s11010-015-2610-0; Matthews TKR, 2017, P NATL ACAD SCI USA, V114, P3861, DOI 10.1073/pnas.1617526114; MEPHAM TB, 1984, HORM METAB RES, V16, P248, DOI 10.1055/s-2007-1014757; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Raynes DA, 1998, J BIOL CHEM, V273, P32883, DOI 10.1074/jbc.273.49.32883; Rhoads ML, 2010, J DAIRY SCI, V93, P170, DOI 10.3168/jds.2009-2469; Rhoads ML, 2009, J DAIRY SCI, V92, P1986, DOI 10.3168/jds.2008-1641; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; SAMPSON DA, 1984, J PEDIATR GASTR NUTR, V3, P613, DOI 10.1097/00005176-198409000-00023; Schwimmer H, 2006, J APPL PHYSIOL, V100, P1992, DOI 10.1152/japplphysiol.00850.2005; Shao Y, 2014, AM J PHYSIOL-REG I, V307, pR237, DOI 10.1152/ajpregu.00093.2014; Siegel JM, 2004, ANNU REV PSYCHOL, V55, P125, DOI 10.1146/annurev.psych.55.090902.141545; STOCKER R, 1987, P NATL ACAD SCI USA, V84, P5918, DOI 10.1073/pnas.84.16.5918; Tan CL, 2016, CELL, V167, P47, DOI 10.1016/j.cell.2016.08.028; Tao S, 2011, J DAIRY SCI, V94, P5976, DOI 10.3168/jds.2011-4329; Theodosis DT, 2002, FRONT NEUROENDOCRIN, V23, P101, DOI 10.1006/frne.2001.0226; THEODOSIS DT, 1993, NEUROSCIENCE, V57, P501, DOI 10.1016/0306-4522(93)90002-W; Trevisi E, 2012, RES VET SCI, V93, P695, DOI 10.1016/j.rvsc.2011.11.008; VanHouten J, 2004, J CLIN INVEST, V113, P598, DOI 10.1172/JCI200418776; VanHouten JN, 2003, J CLIN INVEST, V112, P1429, DOI 10.1172/JCI200319504; VOGEL Z, 1993, J NEUROCHEM, V61, P352, DOI 10.1111/j.1471-4159.1993.tb03576.x; Walton M, 1998, J NEUROSCI RES, V53, P330, DOI 10.1002/(SICI)1097-4547(19980801)53:3<330::AID-JNR7>3.0.CO;2-B; Wheelock JB, 2010, J DAIRY SCI, V93, P644, DOI 10.3168/jds.2009-2295; White MG, 2003, J NEUROCHEM, V87, P958, DOI 10.1046/j.1471-4159.2003.02077.x; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Zhang L, 2014, MOL METAB, V3, P581, DOI 10.1016/j.molmet.2014.05.001; Zhao ZJ, 2010, PHYSIOL BEHAV, V101, P59, DOI 10.1016/j.physbeh.2010.04.017; Zhu K, 2006, AM J CLIN NUTR, V83, P714, DOI 10.1093/ajcn.83.3.714	65	16	17	3	26	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12588	12601		10.1096/fj.201901045R	http://dx.doi.org/10.1096/fj.201901045R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31480864	Green Published			2022-12-28	WOS:000507461600077
J	Li, XZ; Ballantyne, LL; Yu, Y; Funk, CD				Li, Xinzhi; Ballantyne, Laurel L.; Yu, Ying; Funk, Colin D.			Perivascular adipose tissue-derived extracellular vesicle miR-221-3p mediates vascular remodeling	FASEB JOURNAL			English	Article						exosome; microRNAs; smooth muscle cell; inflammation; obesity	MUSCLE-CELL-PROLIFERATION; OBESE MICE; EXPRESSION; FAT; COACTIVATOR; PGC-1-ALPHA; PHENOTYPE; MICRORNA-221; DYSFUNCTION; MODULATION	Adipose tissue-secreted extracellular vesicles (EVs) containing microRNAs (miRNAs) convey intercellular message signaling. The biogenesis of EV-miRNAs from perivascular adipose tissue (PVAT) and their roles in intercellular communication in response to obesity-associated inflammation have not yet been fully explored. By feeding mice a high-fat diet for 16 wk, we established obesity-associated, chronic low-grade inflammation in PVAT, characterized as hypertrophy of perivascular adipocytes, decreased adipogenesis, and proinflammatory macrophage infiltration. We show that PVAT-derived EVs and their encapsulated miRNAs can be taken up into vascular smooth muscle cells (VSMCs) in vivo and in vitro. miR-221-3p is one of the highly enriched miRNAs in obese PVAT and PVAT-derived EVs. Transfer and direct overexpression of miR-221-3p dramatically enhances VSMC proliferation and migration. Peroxisome proliferator-activated receptor gamma coactivator 1 alpha is identified as a miR-221-3p target in VSMC phenotypic modulation. Obese mice secrete abundant miRNA-containing EVs, evoking inflammatory responses in PVAT and vascular phenotypic switching in abdominal aorta of lean mice. Local delivery of miR-221-3p mimic in femoral artery causes vascular dysfunction by suppressing the contractile genes in the arterial wall. Our findings provide an EV-miR-221-3p-mediated mechanism by which PVAT triggers an early-stage vascular remodeling in the context of obesity-associated inflammation.	[Li, Xinzhi; Ballantyne, Laurel L.; Funk, Colin D.] Queens Univ, Dept Biomed & Mol Sci, 433 Botterell Hall,18 Stuart St, Kingston, ON K7L 3N6, Canada; [Yu, Ying] Tianjin Med Univ, Sch Basic Med Sci, Dept Pharmacol, Tianjin, Peoples R China	Queens University - Canada; Tianjin Medical University	Funk, CD (corresponding author), Queens Univ, Dept Biomed & Mol Sci, 433 Botterell Hall,18 Stuart St, Kingston, ON K7L 3N6, Canada.	funkc@queensu.ca			Canadian Institutes of Health Research (CIHR) [MOP142476]; Tier 1 Canada Research Chair in Molecular, Cellular, and Physiological Medicine	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Tier 1 Canada Research Chair in Molecular, Cellular, and Physiological Medicine	The authors thank Brooke Ring-Snetsinger for the technical assistance in NanoString analysis, and Xiaohu Yan for help with electron microscopy (both from Queen's University). This work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP142476. C.D.F. was supported by a Tier 1 Canada Research Chair in Molecular, Cellular, and Physiological Medicine. The authors declare no conflicts of interest.	Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Bang C, 2014, J CLIN INVEST, V124, P2136, DOI 10.1172/JCI70577; Bidarimath M, 2017, SCI REP-UK, V7, DOI 10.1038/srep40476; Britton KA, 2011, CLIN LIPIDOL, V6, P79, DOI 10.2217/CLP.10.89; Brown NK, 2014, ARTERIOSCL THROM VAS, V34, P1621, DOI 10.1161/ATVBAHA.114.303029; Chatterjee TK, 2009, CIRC RES, V104, P541, DOI 10.1161/CIRCRESAHA.108.182998; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Coleman CB, 2013, MOL CELL ENDOCRINOL, V374, P125, DOI 10.1016/j.mce.2013.04.019; Connolly KD, 2018, ENDOCRINOLOGY, V159, P3259, DOI 10.1210/en.2018-00266; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Crewe C, 2018, CELL, V175, P695, DOI 10.1016/j.cell.2018.09.005; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; Deng ZB, 2009, DIABETES, V58, P2498, DOI 10.2337/db09-0216; Eguchi A, 2016, J MOL MED, V94, P1241, DOI 10.1007/s00109-016-1446-8; Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588; Fitzgibbons TP, 2011, AM J PHYSIOL-HEART C, V301, pH1425, DOI 10.1152/ajpheart.00376.2011; Flaherty SE, 2019, SCIENCE, V363, P989, DOI 10.1126/science.aaw2586; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hill DA, 2018, P NATL ACAD SCI USA, V115, pE5096, DOI 10.1073/pnas.1802611115; Hou NN, 2016, J MOL CELL CARDIOL, V99, P188, DOI 10.1016/j.yjmcc.2016.09.005; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Jia LY, 2018, FASEB J, V32, P4534, DOI 10.1096/fj.201701337RR; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Kapustin AN, 2015, CIRC RES, V116, P1312, DOI 10.1161/CIRCRESAHA.116.305012; Kingsley K, 2002, BIOCHEM BIOPH RES CO, V293, P1000, DOI 10.1016/S0006-291X(02)00331-5; Kranendonk MEG, 2014, OBESITY, V22, P1296, DOI 10.1002/oby.20679; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Li XL, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001412; Li XZ, 2018, J LIPID RES, V59, P89, DOI 10.1194/jlr.M079996; Lightell DJ, 2018, ATHEROSCLEROSIS, V269, P71, DOI 10.1016/j.atherosclerosis.2017.12.016; Liu GZ, 2018, FASEB J, V32, P5413, DOI 10.1096/fj.201800173R; Liu XJ, 2012, J MOL CELL CARDIOL, V52, P245, DOI 10.1016/j.yjmcc.2011.11.008; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Meerson A, 2013, DIABETOLOGIA, V56, P1971, DOI 10.1007/s00125-013-2950-9; Morales-Kastresana A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01731-2; Mysore R, 2017, J CLIN ENDOCR METAB, V102, P4001, DOI 10.1210/jc.2017-00453; Nie XW, 2019, VASC PHARMACOL, V116, P24, DOI 10.1016/j.vph.2017.07.002; Ogawa R, 2010, BIOCHEM BIOPH RES CO, V398, P723, DOI 10.1016/j.bbrc.2010.07.008; Padilla J, 2013, AM J PHYSIOL-REG I, V304, pR543, DOI 10.1152/ajpregu.00567.2012; Pardo R, 2019, FASEB J, V33, P2343, DOI 10.1096/fj.201800310R; Peng J, 2018, J CELL BIOCHEM, V119, P6418, DOI 10.1002/jcb.26589; Perez S, 2019, J PATHOL, V247, P48, DOI 10.1002/path.5166; Police SB, 2010, AM J PHYSIOL-HEART C, V298, pH1932, DOI 10.1152/ajpheart.00961.2009; Prats-Puig A, 2013, J CLIN ENDOCR METAB, V98, pE1655, DOI 10.1210/jc.2013-1496; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Qu AJ, 2009, AM J PHYSIOL-CELL PH, V297, pC645, DOI 10.1152/ajpcell.00469.2008; Rajsheker S, 2010, CURR OPIN PHARMACOL, V10, P191, DOI 10.1016/j.coph.2009.11.005; Seeley JJ, 2018, NATURE, V559, P114, DOI 10.1038/s41586-018-0253-5; Seta F, 2009, AM J PHYSIOL-REG I, V296, pR1751, DOI 10.1152/ajpregu.90985.2008; Sharma H, 2018, FASEB J, V32, P5174, DOI 10.1096/fj.201701558R; Sun XH, 2016, CIRC RES, V118, P810, DOI 10.1161/CIRCRESAHA.115.308166; Tang YF, 2017, AM J PHYSIOL-HEART C, V313, pH641, DOI 10.1152/ajpheart.00660.2016; Thomou T, 2017, NATURE, V542, P450, DOI 10.1038/nature21365; Togliatto G, 2018, DIABETES, V67, P704, DOI 10.2337/db17-0371; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; de Voorde J, 2013, METABOLISM, V62, P1513, DOI 10.1016/j.metabol.2013.06.004; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Wang YC, 2013, DIABETOLOGIA, V56, P2275, DOI 10.1007/s00125-013-2996-8; Wei YY, 2013, AM J PHYSIOL-HEART C, V304, pH1050, DOI 10.1152/ajpheart.00267.2012; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xie ZL, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007442; Xue YX, 2015, ATHEROSCLEROSIS, V241, P671, DOI 10.1016/j.atherosclerosis.2015.06.031; Yang F, 2018, CIRCULATION, V137, P1824, DOI 10.1161/CIRCULATIONAHA.117.027799; Ying W, 2017, CELL, V171, P372, DOI 10.1016/j.cell.2017.08.035; Zhang YQ, 2016, J MOL CELL BIOL, V8, P505, DOI 10.1093/jmcb/mjw040; Zhang ZB, 2018, DIABETES, V67, P1549, DOI 10.2337/db18-0098; Zhu LY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004182	73	48	51	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12704	12722		10.1096/fj.201901548R	http://dx.doi.org/10.1096/fj.201901548R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31469602	Green Published			2022-12-28	WOS:000507461600086
J	van Bodegraven, EJ; van Asperen, JV; Sluijs, JA; van Deursen, CBJ; van Strien, ME; Stassen, OMJA; Robe, PAJ; Hol, EM				van Bodegraven, Emma J.; van Asperen, Jessy V.; Sluijs, Jacqueline A.; van Deursen, Coen B. J.; van Strien, Miriam E.; Stassen, Oscar M. J. A.; Robe, Pierre A. J.; Hol, Elly M.			GFAP alternative splicing regulates glioma cell-ECM interaction in a DUSP4-dependent manner	FASEB JOURNAL			English	Article						glioblastoma multiforme; intermediate filaments; GFAP isoforms; cytoskeleton; extracellular matrix	FIBRILLARY ACIDIC PROTEIN; JUN NH2-TERMINAL KINASE; GLIOBLASTOMA-MULTIFORME; DUSP4 DEFICIENCY; JNK ACTIVATION; GELATINASE-A; EXPRESSION; INVASION; VIMENTIN; MIGRATION	Gliomas are the most common primary brain tumors. Their highly invasive character and the heterogeneity of active oncogenic pathways within single tumors complicate the development of curative therapies and cause poor patient prognosis. Glioma cells express the intermediate filament protein glial fibrillary acidic protein (GFAP), and the level of its alternative splice variant GFAP-delta, relative to its canonical splice variant GFAP-alpha, is higher in grade IV compared with lower-grade and lower malignant glioma. In this study we show that a high GFAP-delta/alpha ratio induces the expression of the dual-specificity phosphatase 4 (DUSP4) in focal adhesions. By focusing on pathways up- and downstream of DUSP4 that are involved in the cell-extracellular matrix interaction, we show that a high GFAP-delta/alpha ratio equips glioma cells to better invade the brain. This study supports the hypothesis that glioma cells with a high GFAP-delta/alpha ratio are highly invasive and more malignant cells, thus making GFAP alternative splicing a potential therapeutic target.	[van Bodegraven, Emma J.; van Asperen, Jessy V.; Sluijs, Jacqueline A.; van Deursen, Coen B. J.; van Strien, Miriam E.; Hol, Elly M.] Univ Utrecht, Dept Translat Neurosci, Brain Ctr, Univ Med Ctr Utrecht, Utrecht, Netherlands; [Robe, Pierre A. J.] Univ Utrecht, Dept Neurol & Neurosurg, Brain Ctr, Univ Med Ctr Utrecht, Utrecht, Netherlands; [Stassen, Oscar M. J. A.] Abo Akad Univ, Fac Sci & Engn, Turku, Finland; [Stassen, Oscar M. J. A.] Univ Turku, Turku Biosci Ctr, Turku, Finland; [Stassen, Oscar M. J. A.] Abo Akad Univ, Turku, Finland; [Hol, Elly M.] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Abo Akademi University; University of Turku; Abo Akademi University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Hol, EM (corresponding author), Univ Med Ctr Utrecht, Translat Neurosci, Brain Ctr Rudolf Magnus, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.	e.m.hol-2@umcutrecht.nl	Hol, Elly M/F-1891-2013; Stassen, Oscar/I-9075-2014	Hol, Elly M/0000-0001-5604-2603; Stassen, Oscar/0000-0001-7485-0903; van Bodegraven, Emma J./0000-0002-3796-2516; van Deursen, Coen/0000-0002-7483-293X	Foundation for Fundamental Research on Matter (FOM) [09MMC06]; Netherlands Organization for Scientific Research (NWO) [865.09.003]; T. and P. Bohnenn Foundation; Dutch Cancer Society [KWF 10123]	Foundation for Fundamental Research on Matter (FOM)(FOM (The Netherlands)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); T. and P. Bohnenn Foundation; Dutch Cancer Society(KWF Kankerbestrijding)	The results shown here are in part based upon data generated by the The Cancer Genome Atlas (TCGA) Research Network (http://cancergenome.nih.gov/). This work was supported by the research program of the Foundation for Fundamental Research on Matter (FOM; Grant 09MMC06), the Netherlands Organization for Scientific Research (NWO; VICI Grant 865.09.003), the T. and P. Bohnenn Foundation, and the Dutch Cancer Society [KWF 10123]. P.A.J.R. and E.M.H. share senior authorship. The authors declare no conflicts of interest.	Al-Mutairi M, 2010, BRIT J PHARMACOL, V161, P782, DOI 10.1111/j.1476-5381.2010.00952.x; Alapati K, 2014, STEM CELL RES, V12, P716, DOI 10.1016/j.scr.2014.02.008; Antonyak MA, 2002, ONCOGENE, V21, P5038, DOI 10.1038/sj.onc.1205593; Balko JM, 2012, NAT MED, V18, P1052, DOI 10.1038/nm.2795; Barajas-Espinosa A, 2015, FREE RADICAL BIO MED, V89, P170, DOI 10.1016/j.freeradbiomed.2015.07.013; Bhaskara VK, 2005, NEUROPATHOLOGY, V25, P48, DOI 10.1111/j.1440-1789.2004.00585.x; Boulding T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148065; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Brehar FM, 2015, BRAIN TUMOR PATHOL, V32, P90, DOI 10.1007/s10014-014-0199-8; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cadalbert L, 2005, CELL SIGNAL, V17, P1254, DOI 10.1016/j.cellsig.2005.01.003; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Choi KC, 2009, NEUROSCI LETT, V463, P182, DOI 10.1016/j.neulet.2009.07.076; Chou YC, 2015, ONCOL REP, V34, P2489, DOI 10.3892/or.2015.4260; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Claes A, 2007, ACTA NEUROPATHOL, V114, P443, DOI 10.1007/s00401-007-0293-7; Clairembault T, 2014, J NEUROCHEM, V130, P805, DOI 10.1111/jnc.12742; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; Ferrer VP, 2018, GLIA, V66, P1542, DOI 10.1002/glia.23309; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Givant-Horwitz V, 2004, CANCER RES, V64, P3572, DOI 10.1158/0008-5472.CAN-03-3424; Godsel LM, 2008, TRENDS CELL BIOL, V18, P28, DOI 10.1016/j.tcb.2007.11.004; Havel LS, 2015, ONCOGENE, V34, P1979, DOI 10.1038/onc.2014.123; Ho VKY, 2014, EUR J CANCER, V50, P2309, DOI 10.1016/j.ejca.2014.05.019; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ichikawa N, 2009, J CELL SCI, V122, P289, DOI 10.1242/jcs.030338; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Jeuken J, 2007, ACTA NEUROPATHOL, V114, P121, DOI 10.1007/s00401-007-0239-0; Jiang YW, 2017, CELL REP, V19, P1080, DOI 10.1016/j.celrep.2017.04.053; Kim K. M., 2017, ONCOTARGET, V9, P5588; Klotzsche O, 1998, ONCOGENE, V16, P3423, DOI 10.1038/sj.onc.1202155; Lawan A, 2011, J BIOL CHEM, V286, P12933, DOI 10.1074/jbc.M110.181370; Lee JH, 2018, NATURE, V560, P243, DOI 10.1038/s41586-018-0389-3; Li JY, 2008, J NEURO-ONCOL, V88, P11, DOI 10.1007/s11060-008-9529-1; Lin H, 2017, BIOMED PHARMACOTHER, V92, P340, DOI 10.1016/j.biopha.2017.05.072; Lopez-Gines C, 2008, NEUROPATHOLOGY, V28, P507, DOI 10.1111/j.1440-1789.2008.00911.x; Mangiola A, 2007, CLIN CANCER RES, V13, P6970, DOI 10.1158/1078-0432.CCR-07-1229; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Moeton M, 2016, CELL MOL LIFE SCI, V73, P4101, DOI 10.1007/s00018-016-2239-5; Moeton M, 2014, FASEB J, V28, P2942, DOI 10.1096/fj.13-245837; Mruthyunjaya S, 2010, BIOCHEM BIOPH RES CO, V391, P43, DOI 10.1016/j.bbrc.2009.10.158; Nakagawa T, 1996, J NEURO-ONCOL, V28, P13, DOI 10.1007/BF00300442; Pandey V, 2016, J NEUROSCI RES, V94, P114, DOI 10.1002/jnr.23687; Panicker SP, 2010, ONCOTARGET, V1, P289; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Paumelle R, 2000, MOL BIOL CELL, V11, P3751, DOI 10.1091/mbc.11.11.3751; Pearson JRD, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.40; PEDERSEN PH, 1993, CANCER RES, V53, P5158; Pereira AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026182; Perng MD, 2008, MOL BIOL CELL, V19, P4521, DOI 10.1091/mbc.E08-03-0284; Pitre A, 2012, MOL BIOL CELL, V23, P1243, DOI 10.1091/mbc.E11-08-0685; Ramachandran RK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172234; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; REICH R, 1995, CLIN EXP METASTAS, V13, P134, DOI 10.1007/BF00133618; Roelofs RF, 2005, GLIA, V52, P289, DOI 10.1002/glia.20243; Sankar S, 2013, MOL CELL BIOL, V33, P4448, DOI 10.1128/MCB.00241-13; Schmid CA, 2015, J EXP MED, V212, P775, DOI 10.1084/jem.20141957; Sembritzki O, 2002, NEURO-ONCOLOGY, V4, P171, DOI 10.1093/neuonc/4.3.171; Snider JL, 2008, J BIOL CHEM, V283, P13952, DOI 10.1074/jbc.M800289200; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Stassen OMJA, 2017, ONCOTARGET, V8, P88104, DOI 10.18632/oncotarget.21540; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tong JJ, 2012, ONCOL LETT, V4, P495, DOI 10.3892/ol.2012.777; Tsuiki H, 2003, CANCER RES, V63, P250; Turck N, 2006, J CELL PHYSIOL, V206, P545, DOI 10.1002/jcp.20501; Tysnes BB, 1999, INT J DEV NEUROSCI, V17, P531, DOI 10.1016/S0736-5748(99)00055-6; van den Berge SA, 2010, AGING CELL, V9, P313, DOI 10.1111/j.1474-9726.2010.00556.x; Vehlow A, 2017, ONCOTARGET, V8, P49224, DOI 10.18632/oncotarget.17480; VELASCO ME, 1980, CANCER, V45, P484, DOI 10.1002/1097-0142(19800201)45:3<484::AID-CNCR2820450312>3.0.CO;2-9; Velpula KK, 2012, CELL SIGNAL, V24, P2076, DOI 10.1016/j.cellsig.2012.07.002; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Virtakoivu R, 2015, CANCER RES, V75, P2349, DOI 10.1158/0008-5472.CAN-14-2842; Watson MB, 2007, ACTA ONCOL, V46, P651, DOI 10.1080/02841860601156157; Winkler F, 2009, GLIA, V57, P1306, DOI 10.1002/glia.20850; Zamecnik J, 2005, ACTA NEUROPATHOL, V110, P435, DOI 10.1007/s00401-005-1078-5; Zhang R, 2017, J CELL MOL MED, V21, P1117, DOI 10.1111/jcmm.13043; Zou W, 2010, GLIA, V58, P1640, DOI 10.1002/glia.21038	81	9	9	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12941	12959		10.1096/fj.201900916R	http://dx.doi.org/10.1096/fj.201900916R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31480854				2022-12-28	WOS:000507461600103
J	Woo, JA; Castano, M; Goss, A; Kim, D; Lewandowski, EM; Chen, Y; Liggett, SB				Woo, Jung A.; Castano, Maria; Goss, Ashley; Kim, Donghwa; Lewandowski, Eric M.; Chen, Yu; Liggett, Stephen B.			Differential long-term regulation of TAS2R14 by structurally distinct agonists	FASEB JOURNAL			English	Article						desensitization; internalization; down-regulation; beta-arrestin; [Ca2+](i)	AIRWAY SMOOTH-MUSCLE; BITTER TASTE RECEPTORS; BETA(2)-ADRENERGIC RECEPTORS; SWISS-MODEL; DESENSITIZATION; ASTHMA; BRONCHODILATORS; EXPRESSION; DOCKING	Bitter taste receptor-14 (TAS2R14) is a GPCR also expressed on human airway smooth muscle cells, which signals to intracellular [Ca2+], resulting in relaxation of the airway, and is a novel target for bronchodilators. Here, we examine long-term, agonist-promoted down-regulation of TAS2R14 expression because tachyphylaxis would be an undesirable therapeutic characteristic. Five TAS2R structurally distinct full agonists were studied to ascertain biasing away from down-regulation. Agonist exposure for 18 h caused minimal desensitization by diphenhydramine (DPD) compared with similar to 50% desensitization with all other agonists. Agonists evoked beta-arrestin recruitment to TAS2R14, which was not seen with a phosphoacceptor-deficient mutant, TAS2R14-10A. All agonists except for DPD also caused subsequent TAS2R14 internalization and trafficking via early and late endosomes to down-regulation. TAS2R14-10A failed to undergo these events with any agonist. Molecular docking showed that DPD has specific interactions deep within a binding pocket that are not observed with the other agonists, which may lock the receptor in a conformation that does not internalize and therefore does not undergo down-regulation. Thus, TAS2R14 is subject to beta-arrestin-mediated internalization and subsequent down-regulation with chronic exposure to most agonists. However, by manipulating the agonist structure, biasing toward G-protein coupling but away from long-term down-regulation can be achieved.	[Woo, Jung A.; Liggett, Stephen B.] Univ S Florida, Dept Mol Pharmacol & Physiol, Morsani Coll Med, Tampa, FL 33620 USA; [Castano, Maria; Goss, Ashley; Kim, Donghwa; Liggett, Stephen B.] Univ S Florida, Dept Med, Morsani Coll Med, Tampa, FL 33620 USA; [Lewandowski, Eric M.; Chen, Yu] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL 33620 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Liggett, SB (corresponding author), Univ S Florida, Morsani Coll Med, 12901 Bruce B Downs Blvd,MDC 2, Tampa, FL 33635 USA.	sliggett@health.usf.edu	Kim, Donghwa/AAJ-8148-2021	Kim, Donghwa/0000-0002-8994-8513; Woo, Jung A/0000-0002-9194-1361; Liggett, Stephen B./0000-0002-0128-3669	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL114471, HL045967]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045967, P01HL114471] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Melissa Steward (University of South Florida Morsani College of Medicine) for manuscript preparations. This work was funded by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants HL114471 and HL045967. The authors declare no conflicts of interest.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; An SS, 2017, CELL SIGNAL, V41, P82, DOI 10.1016/j.cellsig.2017.02.002; Belvisi MG, 2011, NAT MED, V17, P776, DOI [10.1038/nm0711-776a, 10.1038/nm0711-776b]; Bengtsson T, 1996, J BIOL CHEM, V271, P33366, DOI 10.1074/jbc.271.52.33366; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bertoni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09654-8; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Clark AA, 2012, FASEB J, V26, P4827, DOI 10.1096/fj.12-215087; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Drazen JM, 2000, BRIT MED BULL, V56, P1054, DOI 10.1258/0007142001903535; EASON MG, 1994, MOL PHARMACOL, V45, P696; EASON MG, 1992, J BIOL CHEM, V267, P25473; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; GREEN SA, 1995, AM J RESP CELL MOL, V13, P25, DOI 10.1165/ajrcmb.13.1.7598936; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Irannejad R, 2015, CURR OPIN CELL BIOL, V35, P137, DOI 10.1016/j.ceb.2015.05.005; Jewell-Motz EA, 2000, J BIOL CHEM, V275, P28989, DOI 10.1074/jbc.M005381200; Kim D, 2019, AM J RESP CELL MOL, V60, P532, DOI 10.1165/rcmb.2018-0189OC; Kim DW, 2017, AM J RESP CELL MOL, V56, P762, DOI 10.1165/rcmb.2016-0373OC; Kim D, 2016, J BIOL CHEM, V291, P17616, DOI 10.1074/jbc.M116.722736; Liggett Stephen B, 2014, Trans Am Clin Climatol Assoc, V125, P64; Liggett SB, 2013, EXPERT OPIN THER TAR, V17, P721, DOI 10.1517/14728222.2013.782395; Lim VJY, 2018, PROTEINS, V86, P978, DOI 10.1002/prot.25533; Lorber DM, 2005, CURR TOP MED CHEM, V5, P739, DOI 10.2174/1568026054637683; Lorber DM, 1998, PROTEIN SCI, V7, P938; Malmstrom K, 1999, ANN INTERN MED, V130, P487, DOI 10.7326/0003-4819-130-6-199903160-00005; Matera MG, 2011, TRENDS PHARMACOL SCI, V32, P495, DOI 10.1016/j.tips.2011.04.003; MENG EC, 1993, PROTEINS, V17, P266, DOI 10.1002/prot.340170305; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Rajagopal S, 2017, CELL SIGNAL, V41, P9, DOI 10.1016/j.cellsig.2017.01.024; Robinett KS, 2011, AM J RESP CELL MOL, V45, P1069, DOI 10.1165/rcmb.2011-0061OC; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Salazar NC, 2007, BBA-BIOMEMBRANES, V1768, P1006, DOI 10.1016/j.bbamem.2007.02.010; Sharma S, 2008, J ALLERGY CLIN IMMUN, V122, P921, DOI 10.1016/j.jaci.2008.09.004; Shoichet BK, 1999, PROTEINS, V34, P4, DOI 10.1002/(SICI)1097-0134(19990101)34:1<4::AID-PROT2>3.0.CO;2-6; Shrewsbury S, 2000, BMJ-BRIT MED J, V320, P1368, DOI 10.1136/bmj.320.7246.1368; Swift SM, 2007, AM J RESP CELL MOL, V36, P236, DOI 10.1165/rcmb.2006-0257OC; TURKI J, 1995, AM J PHYSIOL-LUNG C, V269, pL709, DOI 10.1152/ajplung.1995.269.5.L709; Wang WCH, 2011, P NATL ACAD SCI USA, V108, P6246, DOI 10.1073/pnas.1101439108; Wang WCH, 2009, P NATL ACAD SCI USA, V106, P15007, DOI 10.1073/pnas.0906034106; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008	45	6	6	5	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12213	12225		10.1096/fj.201802627RR	http://dx.doi.org/10.1096/fj.201802627RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31430434	Green Published			2022-12-28	WOS:000507461600048
J	Xu, CY; Wu, XL; Lu, MP; Tang, LF; Yao, HY; Wang, JR; Ji, X; Hussain, M; Wu, JS; Wu, XM				Xu, Chengyun; Wu, Xiling; Lu, Meiping; Tang, Lanfang; Yao, Hongyi; Wang, Jirong; Ji, Xing; Hussain, Musaddique; Wu, Junsong; Wu, Ximei			Protein tyrosine phosphatase 11 acts through RhoA/ROCK to regulate eosinophil accumulation in the allergic airway	FASEB JOURNAL			English	Article						SHP2; asthma; cell migration; airway inflammation	EMBRYONIC LUNG DEVELOPMENT; FACTOR-RECEPTOR; SHP2; RHOA; ACTIVATION; ASTHMA; TARGET; MACROPHAGES; EPITHELIA; SUBSTRATE	Src homology domain 2-containing protein tyrosine phosphatase 2 (SHP2) participates in multiple cell functions including cell shape, movement, and differentiation. Therefore, we investigated the potential role of SHP2 in eosinophil recruitment into lungs in allergic airway inflammation and explored the underlying mechanism. Both SHP2 and Ras homolog family member A (RhoA) kinase were robustly activated in the airway eosinophils of children with allergic asthma and of a mouse model with allergic airway inflammation. Moreover, inhibition of SHP2 activity by its specific inhibitors reverses the dephosphorylation of p190-A Rho GTPase-activating protein and in turn attenuates RhoA/Rho-associated protein kinase (ROCK) signaling, resulting in the attenuation of eosinophil migration in response to platelet-activating factor stimulation. Specifically, SHP2 deletion in myeloid cells did not affect the number and classification of circulating leukocytes but significantly attenuated the allergen-induced inflammatory cell, especially eosinophil, infiltration into lungs, and airway hyperreactivity. Notably, genetic interaction between RhoA and SHP2 indicated that RhoA inactivation and SHP2 deletion synergistically attenuated the allergen-induced eosinophil infiltration into lungs and airway hyperreactivity, whereas overexpression of active RhoA robustly restored the SHP2 deletion-resultant attenuation of allergen-induced eosinophil recruitment into lungs and airway hyperreactivity as well. Thus, this study demonstrates that SHP2 via RhoA/ROCK signaling regulates eosinophil recruitment in allergic airway inflammation and possibly in allergic asthma.	[Xu, Chengyun; Wang, Jirong; Ji, Xing; Hussain, Musaddique; Wu, Ximei] Zhejiang Univ, Dept Pharmacol, Hangzhou, Peoples R China; [Wu, Xiling; Lu, Meiping; Tang, Lanfang] Zhejiang Univ, Dept Resp Med, Affiliated Childrens Hosp, Hangzhou, Peoples R China; [Yao, Hongyi] Zhejiang Univ, Dept Pharm, Affiliated Hosp 2, Hangzhou, Peoples R China; [Wu, Junsong] Zhejiang Univ, Dept Orthoped Surg, Affiliated Hosp 1, Sch Med, 79 Qingchun Rd, Hangzhou 310003, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Wu, JS (corresponding author), Zhejiang Univ, Dept Orthoped Surg, Affiliated Hosp 1, Sch Med, 79 Qingchun Rd, Hangzhou 310003, Peoples R China.; Wu, XM (corresponding author), Zhejiang Univ, Sch Med, Dept Pharmacol, 866 Yuhangtang Rd, Hangzhou 310058, Peoples R China.	wjs1288@zju.edu.cn; xiwu@zju.edu.cn		Wu, Ximei/0000-0002-3316-893X; Hussain, Musaddique/0000-0001-8766-6339	National Natural Science Foundation of China [81170016, 81170787, 81200022, 81200023, 81270067, 81470214, 31571493, 8157080078, 81571928]; Natural Science Foundation of Zhejiang Province [LY18H150002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Natural Science Foundation of China (81170016, 81170787, 81200022, 81200023, 81270067, 81470214, 31571493, 8157080078, and 81571928) and the Natural Science Foundation of Zhejiang Province (LY18H150002). The authors declare no conflicts of interest.	Agazie YM, 2003, J BIOL CHEM, V278, P13952, DOI 10.1074/jbc.M210670200; Amison RT, 2015, J ALLERGY CLIN IMMUN, V135, P528, DOI 10.1016/j.jaci.2014.09.032; Baker MJ, 2016, CURR OPIN HEMATOL, V23, P44, DOI 10.1097/MOH.0000000000000199; Bel EH, 2017, CHEST, V152, P1276, DOI 10.1016/j.chest.2017.05.019; Bhattacharya M, 2014, J CLIN INVEST, V124, P4895, DOI 10.1172/JCI76658; Biro M, 2014, BRIT J PHARMACOL, V171, P5491, DOI 10.1111/bph.12658; Bregeon J, 2009, AM J PHYSIOL-CELL PH, V297, pC1062, DOI 10.1152/ajpcell.00174.2009; Castro M, 2011, AM J RESP CRIT CARE, V184, P1125, DOI 10.1164/rccm.201103-0396OC; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cypcar D, 1996, J LEUKOCYTE BIOL, V60, P101, DOI 10.1002/jlb.60.1.101; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Hussain M, 2017, MOL PHARMACOL, V92, P676, DOI 10.1124/mol.117.110254; Hussain M, 2017, BBA-MOL BASIS DIS, V1863, P3226, DOI 10.1016/j.bbadis.2017.08.031; Julia V, 2015, NAT REV IMMUNOL, V15, P308, DOI 10.1038/nri3830; Kobayashi K, 2004, J NEUROSCI, V24, P3480, DOI 10.1523/JNEUROSCI.0295-04.2004; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; Kontaridis MI, 2004, MOL CELL BIOL, V24, P5340, DOI 10.1128/MCB.24.12.5340-5352.2004; Kume H, 2008, CURR MED CHEM, V15, P2876, DOI 10.2174/092986708786242831; Landolina NAC, 2014, CURR OPIN PHARMACOL, V17, P71, DOI 10.1016/j.coph.2014.07.014; Lee HH, 2008, J CELL BIOL, V181, P999, DOI 10.1083/jcb.200710187; Lee HJ, 2017, J MICROBIOL IMMUNOL, V50, P145, DOI 10.1016/j.jmii.2015.05.017; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Li FF, 2012, J IMMUNOL, V189, P3159, DOI 10.4049/jimmunol.1200197; McBrien CN, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00093; Mishra RK, 2005, ALLERGY, V60, P1204, DOI 10.1111/j.1398-9995.2005.00845.x; Pazdrak K, 2008, J IMMUNOL, V180, P4182, DOI 10.4049/jimmunol.180.6.4182; Qin XJ, 2012, ALLERGY, V67, P1547, DOI 10.1111/all.12048; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; SANJAR S, 1990, BRIT J PHARMACOL, V99, P267, DOI 10.1111/j.1476-5381.1990.tb14692.x; Tang LF, 2009, WORLD J PEDIATR, V5, P191, DOI 10.1007/s12519-009-0036-z; Tao B, 2014, J IMMUNOL, V193, P2801, DOI 10.4049/jimmunol.1303463; Tsutsumi R, 2006, MOL CELL BIOL, V26, P261, DOI 10.1128/MCB.26.1.261-276.2006; Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983; Xia LX, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.74; Xu CY, 2018, MUCOSAL IMMUNOL, V11, P1306, DOI 10.1038/s41385-018-0033-4; Xu D, 2011, J EXP MED, V208, P1977, DOI 10.1084/jem.20110450; Yao HY, 2011, BBA-GEN SUBJECTS, V1810, P666, DOI 10.1016/j.bbagen.2011.03.020; Yao HY, 2015, ONCOTARGET, V6, P17501, DOI 10.18632/oncotarget.3766; Zhang X, 2012, FASEB J, V26, P2338, DOI 10.1096/fj.11-200139	40	17	18	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11706	11720		10.1096/fj.201900698R	http://dx.doi.org/10.1096/fj.201900698R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31361966	Green Published			2022-12-28	WOS:000507461600011
J	Guo, M; Ma, XY; Feng, YW; Han, SD; Dong, Q; Cui, M; Zhao, YX				Guo, Min; Ma, Xiaoye; Feng, Yiwei; Han, Sida; Dong, Qiang; Cui, Mei; Zhao, Yanxin			In chronic hypoxia, glucose availability and hypoxic severity dictate the balance between HIF-1 and HIF-2 in astrocytes	FASEB JOURNAL			English	Article						neuron apoptosis; hypoxic preconditioning; EPO; VEGF; iNOS	INDUCIBLE FACTOR-1-ALPHA; NEUROTROPHIC FACTOR; BRAIN-INJURY; ERYTHROPOIETIN; STROKE; EXPRESSION; PROTEINS; MOUSE; NEUROPROTECTION; NEUROGENESIS	Astrocyte function is an important contributor to cellular viability during brain hypoxia and ischemia. Levels of the hypoxia-inducible transcription factors (HIFs) HIF-1 and HIF-2 are increased in hypoxic conditions and impact the neuroprotective properties of astrocytes. For example, HIF-2 induces levels of erythropoietin (EPO), a neuroprotectant, by astrocytes. In contrast, HIF-1 activity in astrocytes diminishes the viability of neurons in cocultures during hypoxia. Thus, HIF-1 and HIF-2 may have opposing effects on astrocytes. In this study, we explore the balance of HIF-1 and HIF-2 signaling in astrocytes during chronic (1-7 d) hypoxia while altering the degree of hypoxia and glucose availability. In addition, we investigate the effects of these conditions on neuron apoptosis. During exposure to chronic moderate hypoxia (2% O-2) and plentiful glucose (10 mM), HIF-2 and EPO abundance increases from d 1 to 7. Similarly, pretreatment with moderate hypoxia markedly increases the abundance of HIF-2 and EPO when astrocytes are subsequently exposed to severe hypoxia (0.5% O-2; 24 h) in 10 mM glucose, which inhibits neuron apoptosis in coculture. Although HIF-1 targets the expression increase during the 7 d in chronic moderate hypoxia (2% O-2) and limited glucose (2 mM), further exposure to severe hypoxia (0.5% O-2; 24 h) induces a decrease of most HIF-1 targets in astrocytes. Notably, in astrocyte exposure to 2% O-2 prior to 0.5% O-2, the expression of iNOS, an HIF-1-regulated protein, keeps increasing when glucose is limited, whereas EPO and VEGF abundance is suppressed, inducing increased apoptosis of neurons in coculture under limited glucose (2 mM). Thus, both hypoxic severity and glucose abundance regulate the balance of HIF-1 and HIF-2 activity in astrocytes, leading to diverse effects on neurons. These results could have important implications on the adaptive or pathologic role of astrocytes during chronic hypoxia and ischemia.-Guo, M., Ma, X., Feng, Y., Han, S., Dong, Q., Cui, M., Zhao, Y. In chronic hypoxia, glucose availability and hypoxic severity dictate the balance between HIF-1 and HIF-2 in astrocytes.	[Guo, Min; Feng, Yiwei; Han, Sida; Cui, Mei] Fudan Univ, Huashan Hosp, Minist Educ, Frontiers Ctr Brain Sci,Dept Neurol, Shanghai, Peoples R China; [Ma, Xiaoye; Zhao, Yanxin] Fudan Univ, Huashan Hosp, State Key Lab Med Neurobiol, Frontiers Ctr Brain Sci,Dept Neurol,Minist Educ, Shanghai, Peoples R China; [Dong, Qiang] Tongji Univ, Peoples Hosp 10, Dept Neurol, Shanghai, Peoples R China	Fudan University; Fudan University; Tongji University	Cui, M (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurol, 12 Middle Urumqi Rd, Shanghai 200040, Peoples R China.; Zhao, YX (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Dept Neurol, Sch Med, Shanghai 200072, Peoples R China.	cuimei@fudan.edu.cn; zhao_yanxin@126.com			National Natural Science Foundation of China [81870915, 81571109, 81571033]; Science and Technology Commission of Shanghai Municipality [16411970200, 18140901900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	The authors thank Dr. Randall Johnson (University of California, San Diego, La Jolla, CA, USA) and Dr. M. Celeste Simon (University of Pennsylvania School of Medicine, Philadelphia, PA, USA) for permission to use the floxed HIF-1 alpha and -2 alpha mice, respectively. This study was supported by the National Natural Science Foundation of China (81870915, 81571109, and 81571033) and grants from the Science and Technology Commission of Shanghai Municipality (16411970200 and 18140901900). The authors declare no conflicts of interest.	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Arai Ken, 2009, Exp Transl Stroke Med, V1, P6, DOI 10.1186/2040-7378-1-6; Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Bardos JI, 2005, BBA-REV CANCER, V1755, P107, DOI 10.1016/j.bbcan.2005.05.001; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Brunelle JK, 2004, J BIOL CHEM, V279, P4305, DOI 10.1074/jbc.M312241200; Byts Nadiya, 2009, Exp Transl Stroke Med, V1, P4, DOI 10.1186/2040-7378-1-4; Chang YS, 2005, PEDIATR RES, V58, P106, DOI 10.1203/01.PDR.0000163616.89767.69; Chavez JC, 2006, J NEUROSCI, V26, P9471, DOI 10.1523/JNEUROSCI.2838-06.2006; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Diaz Z, 2005, J NEUROCHEM, V93, P392, DOI 10.1111/j.1471-4159.2005.03038.x; Fernando MS, 2006, STROKE, V37, P1391, DOI 10.1161/01.STR.0000221308.94473.14; Fogal B, 2007, J NEUROSCI, V27, P10094, DOI 10.1523/JNEUROSCI.2459-07.2007; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Gonzalez FF, 2007, DEV NEUROSCI-BASEL, V29, P321, DOI 10.1159/000105473; GROTE J, 1981, PFLUG ARCH EUR J PHY, V391, P195, DOI 10.1007/BF00596170; Grote J, 1996, J AUTONOM NERV SYST, V57, P168, DOI 10.1016/0165-1838(95)00096-8; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hainsworth AH, 2008, J CEREBR BLOOD F MET, V28, P1877, DOI 10.1038/jcbfm.2008.91; Harvey BK, 2003, EXP NEUROL, V183, P47, DOI 10.1016/S0014-4886(03)00080-3; Harvey BK, 2005, PHARMACOL THERAPEUT, V105, P113, DOI 10.1016/j.pharmthera.2004.09.003; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; HEWETT SJ, 1994, NEURON, V13, P487, DOI 10.1016/0896-6273(94)90362-X; Hirayama Y, 2017, GLIA, V65, P523, DOI 10.1002/glia.23109; Hirayama Y, 2015, J NEUROSCI, V35, P3794, DOI 10.1523/JNEUROSCI.4218-14.2015; Holmquist L, 2005, INT J CANCER, V116, P218, DOI 10.1002/ijc.21024; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Iwai M, 2007, STROKE, V38, P2795, DOI 10.1161/STROKEAHA.107.483008; Jelkmann W, 2004, INTERNAL MED, V43, P649, DOI 10.2169/internalmedicine.43.649; Li DD, 2005, EUR J NEUROSCI, V22, P1319, DOI 10.1111/j.1460-9568.2005.04335.x; Lin JHC, 2008, J NEUROSCI, V28, P681, DOI 10.1523/JNEUROSCI.3827-07.2008; Liu J, 2006, GLIA, V53, P360, DOI 10.1002/glia.20289; Lofstedt T, 2007, CELL CYCLE, V6, P919, DOI 10.4161/cc.6.8.4133; Malhotra S, 2006, J NEUROSCI RES, V83, P19, DOI 10.1002/jnr.20705; Marti HH, 2004, J EXP BIOL, V207, P3233, DOI 10.1242/jeb.01049; MASUDA S, 1994, J BIOL CHEM, V269, P19488; METZGER H, 1977, PFLUG ARCH EUR J PHY, V370, P201, DOI 10.1007/BF00581695; Prass K, 2003, STROKE, V34, P1981, DOI 10.1161/01.STR.0000080381.76409.B2; Reitmeir R, 2011, BRAIN, V134, P84, DOI 10.1093/brain/awq344; Rempe DA, 2007, J BIOL CHEM, V282, P16187, DOI 10.1074/jbc.M702203200; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; Ryan HE, 2000, CANCER RES, V60, P4010; Sheldon RA, 2009, DEV NEUROSCI-BASEL, V31, P452, DOI 10.1159/000232563; Smith EE, 2010, STROKE, V41, pS139, DOI 10.1161/STROKEAHA.110.596056; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Studer L, 2000, J NEUROSCI, V20, P7377; Trollmann R, 2009, BRAIN DEV-JPN, V31, P503, DOI 10.1016/j.braindev.2009.03.007; Uchida T, 2004, J BIOL CHEM, V279, P14871, DOI 10.1074/jbc.M400461200; Vangeison G, 2008, J NEUROSCI, V28, P1988, DOI 10.1523/JNEUROSCI.5323-07.2008; Vangeison G, 2009, NEUROSCIENTIST, V15, P579, DOI 10.1177/1073858409332405; Weidemann A, 2009, J CLIN INVEST, V119, P3373, DOI 10.1172/JCI39378; Zhao YX, 2011, J CEREBR BLOOD F MET, V31, P1412, DOI 10.1038/jcbfm.2010.230; Zhao YX, 2010, NEUROTHERAPEUTICS, V7, P439, DOI 10.1016/j.nurt.2010.07.004	55	15	16	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11123	11136		10.1096/fj.201900402RR	http://dx.doi.org/10.1096/fj.201900402RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31298941				2022-12-28	WOS:000489166300046
J	Hong, H; Song, HK; Hwang, ES; Lee, AR; Han, DS; Kim, SE; Oh, ES				Hong, Heejeong; Song, Hyun-Kuk; Hwang, Eun Sook; Lee, A. Reum; Han, Dong Soo; Kim, Seong-Eun; Oh, Eok-Soo			Up-regulation of syndecan-2 in proximal colon correlates with acute inflammation	FASEB JOURNAL			English	Article						colitis; IL17RA; proteoglycan	BOWEL-DISEASE; T-CELLS; COLITIS; EXPRESSION; LYMPHOCYTES; ADHESION; MODELS	We previously reported that syndecan-2 expression is increased on the colonic epithelium during chronic inflammation. Here, we report that syndecan-2 exhibits a different pattern of site-specific colonic expression during acute inflammation. Syndecan-2 expression was up-regulated predominantly in the proximal colon of dextran sulfate sodium-induced colitis mice. The colitis-associated up-regulation of syndecan-2 was barely detected in Rag-1(-/-) (recombination activating gene 1 knockout) mice under colitis-inducing conditions. Increased syndecan-2 expression correlated with increased levels of infiltrated CD4(+) IL-17A(+) T cells in the proximal colon. Serum levels of IL-17A were increased during the acute inflammatory response in normal mice but not Rag-1(-/-) mice. IL-17A directly induced IL-17 receptor (IL-17RA) and syndecan-2 expression in ex vivo-cultured proximal colon tissues and adenoma cell lines from proximal colon. IL-17RA knockdown reduced the IL-17A-mediated syndecan-2 expression in SNU1235 cells. No elevation of syndecan-2 or IL-17RA was observed in colonic tissues from IL-17A(-/-) mice during colitis induction. Finally, increased expression of syndecan-2 and IL-17RA was observed in the proximal colons of cecal ligation and puncture-induced sepsis mice and infectious pan colitis patients. Together, these data suggest that acute inflammation induces syndecan-2 expression predominantly in the proximal colon via IL-17A-IL-17RA signaling during the early stage of the inflammatory response and that proximal colonic syndecan-2 might be a biomarker for acute inflammation.-Hong, H., Song, H.-K., Hwang, E. S., Lee, A. R., Han, D. S., Kim, S.-E., Oh, E.-S. Up-regulation of syndecan-2 in proximal colon correlates with acute inflammation.	[Hong, Heejeong; Song, Hyun-Kuk; Oh, Eok-Soo] Ewha Womans Univ, Dept Life Sci, 52 Ewhayeodae Gil, Seoul 03760, South Korea; [Hong, Heejeong; Song, Hyun-Kuk; Oh, Eok-Soo] Ewha Womans Univ, Res Ctr Cellular Homeostasis, Seoul, South Korea; [Hwang, Eun Sook] Ewha Womans Univ, Dept Pharm, Seoul, South Korea; [Hwang, Eun Sook] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea; [Lee, A. Reum; Han, Dong Soo] Hanyang Univ, Dept Internal Med, Coll Med, Guri, South Korea; [Kim, Seong-Eun] Ewha Womans Univ, Dept Internal Med, Sch Med, Ewha Med Res Inst, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University; Ewha Womans University; Hanyang University; Ewha Womans University	Oh, ES (corresponding author), Ewha Womans Univ, Dept Life Sci, 52 Ewhayeodae Gil, Seoul 03760, South Korea.	ohes@ewha.ac.kr	Han, Dong Soo/P-1753-2015; Han, Dong Soo/AHD-6285-2022	Han, Dong Soo/0000-0001-7103-3318	National Research Foundation of Korea (NRF) - Korean government (MSIP) [2019R1A2C2009011, 2018R1A2B6004475]; Ewha Womans University Research Grant [2016-1575-001-1]	National Research Foundation of Korea (NRF) - Korean government (MSIP); Ewha Womans University Research Grant	This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP; 2019R1A2C2009011 to E.-S. O., 2018R1A2B6004475 to D.S. H.) and the Ewha Womans University Research Grant (2016-1575-001-1 to E.-S. O.). The authors declare no conflicts of interest.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Arai C, 2017, FOOD SCI TECHNOL RES, V23, P305, DOI 10.3136/fstr.23.305; Au-Whittem CG, 2010, JOVE-J VIS EXP, P1; Bento AF, 2011, J IMMUNOL, V187, P1957, DOI 10.4049/jimmunol.1101305; Chen LG, 2004, J BIOL CHEM, V279, P15715, DOI 10.1074/jbc.C300430200; Choi S, 2017, FASEB J, V31, P1516, DOI 10.1096/fj.201601098R; Choi S, 2015, ONCOTARGET, V6, P3874, DOI 10.18632/oncotarget.2885; Choi S, 2009, BIOCHEM BIOPH RES CO, V384, P231, DOI 10.1016/j.bbrc.2009.04.093; Cioffi Michele, 2015, World J Gastrointest Pathophysiol, V6, P13, DOI 10.4291/wjgp.v6.i1.13; Clasper S, 1999, J BIOL CHEM, V274, P24113, DOI 10.1074/jbc.274.34.24113; Eichele DD, 2017, WORLD J GASTROENTERO, V23, P6016, DOI 10.3748/wjg.v23.i33.6016; Gallimidi AB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174343; Garcillan B, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00020; Halden Y, 2004, BIOCHEM J, V377, P533, DOI 10.1042/BJ20030729; Hayashida K, 2009, BLOOD, V114, P3033, DOI 10.1182/blood-2009-02-204966; Hyun YS, 2012, CARCINOGENESIS, V33, P931, DOI 10.1093/carcin/bgs106; Jaiswal AK, 2018, WORLD J DIABETES, V9, P220, DOI 10.4239/wjd.v9.i12.220; Jaiswal AK, 2017, J IMMUNOL, V198; Kiesler P, 2015, CELL MOL GASTROENTER, V1, P154, DOI 10.1016/j.jcmgh.2015.01.006; Kim KW, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0563-z; Kirby JA, 2003, J CLIN PATHOL, V56, P158, DOI 10.1136/jcp.56.2.158; Kohnke T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/748160; Koutroubakis Ioannis E, 2010, World J Gastrointest Pharmacol Ther, V1, P43, DOI 10.4292/wjgpt.v1.i2.43; Ku JL, 2010, CARCINOGENESIS, V31, P1003, DOI 10.1093/carcin/bgq043; Laroui H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032084; Li X, 2014, INT J CLIN EXP PATHO, V7, P2153; M'Koma AE, 2013, CLIN MED INSIGHTS-GA, V6, P33, DOI 10.4137/CGast.S12731; Masterson C, 2018, ANESTHESIOLOGY, V129, P502, DOI 10.1097/ALN.0000000000002327; Mendoza JL, 2009, GASTROEN CLIN BIOL, V33, pS158, DOI 10.1016/S0399-8320(09)73151-3; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0; Norouzinia Mohsen, 2017, Gastroenterol Hepatol Bed Bench, V10, P155; Park H, 2002, J BIOL CHEM, V277, P29730, DOI 10.1074/jbc.M202435200; Patterson AM, 2012, INFLAMM BOWEL DIS, V18, P1112, DOI 10.1002/ibd.21879; Rayudu Vinay, 2014, Ayu, V35, P333, DOI 10.4103/0974-8520.153787; Rosen MJ, 2015, JAMA PEDIATR, V169, P1053, DOI 10.1001/jamapediatrics.2015.1982; Ruiz Stephanie, 2016, Intensive Care Med Exp, V4, P22, DOI 10.1186/s40635-016-0096-z; Schroll M.M., 2018, CALCITRIOL SUPPLEMEN, V8, P5; SELBY WS, 1981, GUT, V22, P169, DOI 10.1136/gut.22.3.169; Teixe T, 2008, MOL IMMUNOL, V45, P2905, DOI 10.1016/j.molimm.2008.01.033; Toscano Miguel G, 2011, J Vis Exp, DOI 10.3791/2860; Yablecovitch D, 2011, J PHARMACOL EXP THER, V337, P391, DOI 10.1124/jpet.110.174276; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073; Zhang Y, 2017, J CELL MOL MED, V21, P13, DOI 10.1111/jcmm.12934; Zheng B, 2013, BBA-MOL BASIS DIS, V1832, P2162, DOI 10.1016/j.bbadis.2013.07.004; 2007, J PEDIATR GASTR NUTR, V44, P653	46	5	5	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11381	11395		10.1096/fj.201900561R	http://dx.doi.org/10.1096/fj.201900561R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31311305	Bronze			2022-12-28	WOS:000489166300065
J	Jia, BL; Yuan, DP; Lan, WJ; Xuan, YH; Jeon, CO				Jia, Baolei; Yuan, De Peng; Lan, Wen Jun; Xuan, Yuan Hu; Jeon, Che Ok			New insight into the classification and evolution of glucose transporters in the Metazoa (vol 33, pg 7519, 2019)	FASEB JOURNAL			English	Correction									[Jia, Baolei; Lan, Wen Jun] Qilu Univ Technol, Shandong Acad Sci, Sch Bioengn, Jinan, Shandong, Peoples R China; [Jia, Baolei; Jeon, Che Ok] Chung Ang Univ, Dept Life Sci, 84 HeukSeok Ro, Seoul 06974, South Korea; [Yuan, De Peng; Xuan, Yuan Hu] Shenyang Agr Univ, Coll Plant Protect, Dongling Rd 120, Shenyang 110866, Liaoning, Peoples R China	Qilu University of Technology; Chung Ang University; Shenyang Agricultural University	Jeon, CO (corresponding author), Chung Ang Univ, Dept Life Sci, 84 HeukSeok Ro, Seoul 06974, South Korea.; Xuan, YH (corresponding author), Shenyang Agr Univ, Coll Plant Protect, Dongling Rd 120, Shenyang 110866, Liaoning, Peoples R China.	xuanyuanhu115@syau.edu.cn; cojeon@cau.ac.kr	Jia, Baolei/AIF-1053-2022					Jia BL, 2019, FASEB J, V33, P7519, DOI 10.1096/fj.201802617R	1	0	0	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11615	11615		10.1096/fj.201802617RERR	http://dx.doi.org/10.1096/fj.201802617RERR			1	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31560598	Bronze			2022-12-28	WOS:000489166300083
J	Wan, S; van Der Veen, JN; N'Goma, JCB; Nelson, RC; Vance, DE; Jacobs, RL				Wan, Sereana; van Der Veen, Jelske N.; N'Goma, Jean-Claude Bakala; Nelson, Randal C.; Vance, Dennis E.; Jacobs, Rene L.			Hepatic PEMT activity mediates liver health, weight gain, and insulin resistance	FASEB JOURNAL			English	Article						phosphatidylcholine; PC; PE ratio; IR; obesity; NAFLD	METABOLIC SYNDROME; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLCHOLINE; DISEASE; OBESITY; INFLAMMATION; METHYLATION; RATIO; MICE	Phosphatidylethanolamine (PE) N-methyltransferase (PEMT) accounts for similar to 30% of hepatic phosphatidylcholine (PC) biosynthesis. Pemt(-/-) mice fed a high-fat diet are protected against diet-induced obesity (DIO) and insulin resistance (IR) but develop nonalcoholic fatty liver disease (NAFLD) associated with a decreased PC:PE ratio. We investigated whether the lack of hepatic PEMT or the lack of PEMT in other tissues (where it is expressed at low levels) is responsible for or contributes to the protection against DIO and IR in Pemt(-/-) mice. Furthermore, we investigated whether decreasing PEMT expression with antisense oligonucleotides (ASOs) would result in metabolic benefits in both lean and obese mice without negatively impacting liver health. We both restored hepatic PEMT in Pemt(-/-) mice via adeno-associated virus delivery and decreased hepatic PEMT with ASOs in wild-type and ob/ob mice. Weight gain, insulin sensitivity, and indices of liver function were determined. We report that the protection against DIO and IR and the development of NAFLD is dependent on hepatic PEMT activity. NAFLD, associated with a significant decrease in the hepatic PC:PE ratio, was exacerbated by PEMT deficiency in obese mice, suggesting that phospholipid insufficiency promotes NAFLD progression during obesity or overnutrition. Hepatic PEMT is critical for maintaining phospholipid balance, which is crucial for a healthy liver.-Wan, S., van der Veen, J. N., Bakala N'Goma, J.-C., Nelson, R. C., Vance, D. E., Jacobs, R. L. Hepatic PEMT activity mediates liver health, weight gain, and insulin resistance.	[Wan, Sereana; van Der Veen, Jelske N.; N'Goma, Jean-Claude Bakala; Nelson, Randal C.; Vance, Dennis E.; Jacobs, Rene L.] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Jacobs, Rene L.] Univ Alberta, Dept Agr Food & Nutr Sci, 4002 E Li Ka Shing Ctr Hlth Res Innovat, Edmonton, AB T6G 2E1, Canada	University of Alberta; University of Alberta	Jacobs, RL (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, 4002 E Li Ka Shing Ctr Hlth Res Innovat, Edmonton, AB T6G 2E1, Canada.	rjacobs@ualberta.ca			Canadian Institutes of Health [MOP5182]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	The authors thank Susanne Lingrell (University of Alberta) for excellent technical assistance, and Ionis Pharmaceuticals (Carlsbad, CA, USA) for providing ASOs. The authors also thank Mark Graham (Ionis Pharmaceuticals) for important assistance and suggestions in these studies. This research was supported by a grant from the Canadian Institutes of Health (MOP5182). The authors declare no conflicts of interest.	Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; BLEISCH VR, 1952, AM J PATHOL, V28, P369; Castro AVB, 2014, ARQ BRAS ENDOCRINOL, V58, P600, DOI 10.1590/0004-2730000003223; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Gaggini M, 2013, NUTRIENTS, V5, P1544, DOI 10.3390/nu5051544; Gao X, 2015, BBA-MOL BASIS DIS, V1852, P2689, DOI 10.1016/j.bbadis.2015.09.006; Gao X, 2015, BBA-MOL CELL BIOL L, V1851, P152, DOI 10.1016/j.bbalip.2014.11.006; Hartz CS, 2006, J NUTR, V136, P3005, DOI 10.1093/jn/136.12.3005; Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514; Lebeaupin C, 2018, J HEPATOL, V69, P927, DOI 10.1016/j.jhep.2018.06.008; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Lian JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep25747; Ling J, 2012, HEPATOLOGY, V55, P1094, DOI 10.1002/hep.24782; Lu FB, 2018, EXPERT REV GASTROENT, V12, P491, DOI 10.1080/17474124.2018.1460202; Martinez-Chantar ML, 2008, HEPATOLOGY, V47, P1191, DOI 10.1002/hep.22159; Martinez-Una M, 2013, HEPATOLOGY, V58, P1296, DOI 10.1002/hep.26399; Oh MS, 2016, PEDIATR GASTROENTERO, V19, P199, DOI 10.5223/pghn.2016.19.3.199; Perfield JW, 2013, J OBES, V2013, DOI 10.1155/2013/296537; RIDGWAY ND, 1992, METHOD ENZYMOL, V209, P366; Schmitt J, 2015, LIVER INT, V35, P1133, DOI 10.1111/liv.12456; Sung KC, 2018, ATHEROSCLEROSIS, V275, P50, DOI 10.1016/j.atherosclerosis.2018.05.042; van der Veen JN, 2019, FASEB J, V33, P5045, DOI 10.1096/fj.201802117R; van der Veen JN, 2017, BBA-BIOMEMBRANES, V1859, P1558, DOI 10.1016/j.bbamem.2017.04.006; van der Veen JN, 2017, J LIPID RES, V58, P656, DOI 10.1194/jlr.M070631; van der Veen JN, 2016, AM J PHYSIOL-GASTR L, V310, pG526, DOI 10.1152/ajpgi.00243.2015; Vance DE, 2014, BBA-BIOMEMBRANES, V1838, P1477, DOI 10.1016/j.bbamem.2013.10.018; Watanabe M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092647; Yu RZ, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.26	29	18	18	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10986	10995		10.1096/fj.201900679R	http://dx.doi.org/10.1096/fj.201900679R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31284753				2022-12-28	WOS:000489166300034
J	Wei, S; Zhou, HM; Wang, Q; Zhou, S; Li, CY; Liu, R; Qiu, JN; Shi, CY; Lu, L				Wei, Song; Zhou, Haoming; Wang, Qi; Zhou, Shun; Li, Changyong; Liu, Rui; Qiu, Jiannan; Shi, Chengyu; Lu, Ling			RIP3 deficiency alleviates liver fibrosis by inhibiting ROCK1-TLR4-NF-kappa B pathway in macrophages	FASEB JOURNAL			English	Article						CCl4; BDL; HFD; inflammation	HEPATIC STELLATE CELLS; PROTEIN-KINASE 3; KAPPA-B; INJURY; REGENERATION; INFLAMMATION; MOLECULES	Liver fibrosis is an important pathologic process in injured liver tissues. A protein kinase, receptor-interacting protein (RIP)3, plays a crucial role in mediating different diseases. However, the role of RIP3 in macrophages in liver fibrosis has not yet been studied. In our study, we found that RIP3 expression was up-regulated in liver tissues and macrophages of humans and mice with liver fibrosis. Absence of RIP3 in macrophages could alleviate inflammation and macrophage or neutrophil accumulation in mice after carbon tetrachloride (CCl4) or bile duct ligation (BDL) treatment. Importantly, RIP3 deficiency in macrophages could decrease CCl4-induced and BDL-induced liver fibrosis in mice. Moreover, RIP3 deficiency could inhibit the TLR4-NF-kappa B pathway through suppressing Rho-associated coiled-coil containing protein kinase (ROCK)1 in macrophages. To explore the connection of ROCK1 and RIP3 in macrophages of mice with liver fibrosis in vivo, ROCK1-overexpressed macrophages were infused to RIP3-deficient mice, which resulted in increased inflammation and liver fibrosis. In conclusion, our findings suggest that RIP3 plays a crucial proinflammatory role in liver fibrosis by regulating the ROCK1-TLR4-NF-kappa B signaling pathway in macrophages and therefore may be a potential therapeutic target for immune-mediated liver fibrosis.-Wei, S., Zhou, H., Wang, Q., Zhou, S., Li, C., Liu, R., Qiu, J., Shi, C., Lu, L. RIP3 deficiency alleviates liver fibrosis by inhibiting ROCK1-TLR4-NF-kappa B pathway in macrophages.	[Wei, Song; Lu, Ling] Southeast Univ, Sch Med, 87 Ding Jia Qiao Rd, Nanjing 210009, Jiangsu, Peoples R China; [Zhou, Haoming; Wang, Qi; Zhou, Shun; Liu, Rui; Qiu, Jiannan; Shi, Chengyu; Lu, Ling] Nanjing Med Univ, Hepatobiliary Ctr, Collaborat Innovat Ctr Canc Med, Jiangsu Key Lab Xenotransplantat,Affiliated Hosp, Nanjing, Jiangsu, Peoples R China; [Zhou, Haoming; Wang, Qi; Zhou, Shun; Liu, Rui; Qiu, Jiannan; Shi, Chengyu; Lu, Ling] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Li, Changyong] Wuhan Univ, Sch Basic Med Sci, Dept Physiol, Wuhan, Hubei, Peoples R China	Southeast University - China; Nanjing Medical University; Nanjing Medical University; Wuhan University	Lu, L (corresponding author), Southeast Univ, Sch Med, 87 Ding Jia Qiao Rd, Nanjing 210009, Jiangsu, Peoples R China.	lvling@njmu.edu.cn	lu, lu/HII-7530-2022; lu, lu/HGA-0894-2022	Li, Changyong/0000-0003-4001-037X	National Natural Science Foundation of China [81521004, 1310108001, 81100270, 81210108017, 81600450, 31700791]; National Science Foundation of Jiangsu Province [BK20131024, BE2016766]; 863 Young Scientists Special Fund [SS2015AA0209322]; Foundation of Jiangsu Collaborative Innovation Center of Biomedical Functional Materials; Dumont Research Foundation - Priority Academic Program Development (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Jiangsu Province; 863 Young Scientists Special Fund; Foundation of Jiangsu Collaborative Innovation Center of Biomedical Functional Materials; Dumont Research Foundation - Priority Academic Program Development (PAPD)	This study was supported by the National Natural Science Foundation of China (Grants 81521004, 1310108001, 81100270, 81210108017, 81600450, and 31700791), the National Science Foundation of Jiangsu Province (Grants BK20131024 and BE2016766), the 863 Young Scientists Special Fund (Grant SS2015AA0209322), the Foundation of Jiangsu Collaborative Innovation Center of Biomedical Functional Materials (to L.L.), the Dumont Research Foundation, and a project funded by the Priority Academic Program Development (PAPD). The authors declare no conflicts of interest.	Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Cai ZY, 2014, NAT CELL BIOL, V16, P200, DOI 10.1038/ncb2908; Chen LY, 2002, J IMMUNOL, V169, P3934, DOI 10.4049/jimmunol.169.7.3934; Chen WW, 2019, FASEB J, V33, P3451, DOI 10.1096/fj.201801086RR; Chen Z, 2019, ADV SCI, V6, DOI 10.1002/advs.201801361; Freise N., 2019, BLOOD; Gagliardi PA, 2019, MOL BIOL EVOL, V36, P376, DOI 10.1093/molbev/msy229; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Koyama Y, 2017, J CLIN INVEST, V127, P55, DOI 10.1172/JCI88881; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Lu L, 2018, HEPATOLOGY, V67, P1041, DOI 10.1002/hep.29593; Ma LP, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0752-1; Matsuda M, 2018, HEPATOLOGY, V67, P296, DOI 10.1002/hep.29421; Mokdad AA, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0145-y; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Nitschke M, 2012, BLOOD, V120, P2249, DOI 10.1182/blood-2012-03-417923; Pan Q, 2018, GASTROENTEROLOGY, V155, P1578, DOI 10.1053/j.gastro.2018.07.031; Pradere JP, 2013, HEPATOLOGY, V58, P1461, DOI 10.1002/hep.26429; Ramachandran A, 2013, HEPATOLOGY, V58, P2099, DOI 10.1002/hep.26547; Ren JM, 2017, CELL MOL IMMUNOL, V14, P639, DOI 10.1038/cmi.2017.31; Roychowdhury S, 2013, HEPATOLOGY, V57, P1773, DOI 10.1002/hep.26200; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Segain JP, 2003, GASTROENTEROLOGY, V124, P1180, DOI 10.1016/S0016-5085(03)00283-X; Son G, 2007, AM J PHYSIOL-GASTR L, V293, pG631, DOI 10.1152/ajpgi.00185.2007; Tanimizu N, 2013, J CELL SCI, V126, P5239, DOI 10.1242/jcs.133082; Thomas JA, 2011, HEPATOLOGY, V53, P2003, DOI 10.1002/hep.24315; Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Zhang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114071; Zhou S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00948	33	15	18	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11180	11193		10.1096/fj.201900752R	http://dx.doi.org/10.1096/fj.201900752R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31295018				2022-12-28	WOS:000489166300050
J	Adebiyi, MG; Zhao, ZY; Ye, YQ; Manalo, J; Hong, Y; Lee, CC; Xian, W; McKeon, F; Culp-Hill, R; D' Alessandro, A; Kellems, RE; Yoo, SH; Han, L; Xia, Y				Adebiyi, Morayo G.; Zhao, Zhaoyang; Ye, Youqiong; Manalo, Jeanne; Hong, Yue; Lee, Cheng Chi; Xian, Wa; McKeon, Frank; Culp-Hill, Rachel; D' Alessandro, Angelo; Kellems, Rodney E.; Yoo, Seung-Hee; Han, Leng; Xia, Yang			Circadian period 2: a missing beneficial factor in sickle cell disease by lowering pulmonary inflammation, iron overload, and mortality	FASEB JOURNAL			English	Article						circadian clock; lung; heme-iron metabolism	MOLECULAR OSCILLATOR; ELEVATED ADENOSINE; CARBON-MONOXIDE; VASOOCCLUSION; PROMOTES; GENETICS; RHYTHMS; PROTECT; CLOCK	The circadian clock is important for cellular and organ function. However, its function in sickle cell disease (SCD), a life-threatening hemolytic disorder, remains unknown. Here, we performed an unbiased microarray screen, which revealed significantly altered expression of circadian rhythmic genes, inflammatory response genes, and iron metabolic genes in SCD Berkeley transgenic mouse lungs compared with controls. Given the vital role of period 2 (Per2) in the core clock and the unrecognized role of Per2 in SCD, we transplanted the bone marrow (BM) of SCD mice to Per2(Luciferase) mice, which revealed that Per2 expression was up-regulated in SCD mouse lung. Next, we transplanted the BM of SCD mice to period 1 (Per1)/Per2 double deficient [Per1/Per2 double knockout (dKO)] and wild-type mice, respectively. We discovered that Per1/Per2 dKO mice transplanted with SCD BM (SCD -> Per1/Per2 dKO) displayed severe irradiation sensitivity and were more susceptible to an early death. Although we observed an increase of peripheral inflammatory cells, we did not detect differences in erythrocyte sickling. However, there was further lung damage due to elevated pulmonary congestion, inflammatory cell infiltration, iron overload, and secretion of IL-6 in lavage fluid. Overall, we demonstrate that Per1/Per2 is beneficial to counteract elevated systemic inflammation, lung tissue inflammation, and iron overload in SCD.-Adebiyi, M. G., Zhao, Z., Ye, Y., Manalo, J., Hong, Y., Lee, C. C., Xian, W., McKeon, F., Culp-Hill, R., D' Alessandro, A., Kellems, R. E., Yoo, S.-H., Han, L., Xia, Y. Circadian period 2: a missing beneficial factor in sickle cell disease by lowering pulmonary inflammation, iron overload, and mortality.	[Adebiyi, Morayo G.; Zhao, Zhaoyang; Ye, Youqiong; Manalo, Jeanne; Lee, Cheng Chi; Kellems, Rodney E.; Yoo, Seung-Hee; Han, Leng; Xia, Yang] Univ Texas Houston, McGovern Med Sch, Dept Biochem & Mol Biol, 6431 Fannin St,MSB 6-200, Houston, TX 77030 USA; [Xian, Wa; Han, Leng; Xia, Yang] Univ Texas Houston, McGovern Med Sch, Inst Mol Med, Houston, TX USA; [Hong, Yue; McKeon, Frank] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Culp-Hill, Rachel; D' Alessandro, Angelo] Univ Colorado, Dept Biochem & Mol Genet, Anschutz Med Campus, Aurora, CO USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Houston System; University of Houston; University of Colorado System; University of Colorado Anschutz Medical Campus	Xia, Y (corresponding author), Univ Texas Houston, McGovern Med Sch, Dept Biochem & Mol Biol, 6431 Fannin St,MSB 6-200, Houston, TX 77030 USA.	yang.xia@uth.tmc.edu	D'Alessandro, Angelo/AAA-4695-2019; Han, Leng/HCH-3491-2022; Culp-Hill, Rachel/AAH-3234-2021	D'Alessandro, Angelo/0000-0002-2258-6490; Han, Leng/0000-0002-7380-2640; Manalo, Jeanne/0000-0001-7289-8102	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL114457, HL113574, HL137990, HL136969]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL137990, R01HL113574, P01HL114457, R01HL136969] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank all the supporting authors, members of Y.X.'s laboratory for expertise, and the core facility at the University of Houston for providing the expertise needed to perform the microarray studies. Studies were performed with support of U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants HL114457 (to Y.X.), HL113574 (to Y.X.), HL137990 (to Y.X.), and HL136969 (to Y.X.). The authors declare no conflicts of interest.	Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887; Belcher JD, 2013, BLOOD, V122, P2757, DOI 10.1182/blood-2013-02-486282; Bennewitz MF, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89761; Blanco RA, 2007, AM J CLIN NUTR, V86, P1016, DOI 10.1093/ajcn/86.4.1016; Boehning D, 2002, SCIENCE, V298, P2339, DOI 10.1126/science.1080339; Chen XM, 2017, FOOD CHEM, V218, P15, DOI 10.1016/j.foodchem.2016.09.016; da Silva JB, 2012, MICROB PATHOGENESIS, V52, P206, DOI 10.1016/j.micpath.2012.01.002; DESANCHEZ VC, 1995, CAN J PHYSIOL PHARM, V73, P339, DOI 10.1139/y95-044; Eckle T, 2012, NAT MED, V18, P774, DOI 10.1038/nm.2728; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gage Gregory J, 2012, J Vis Exp, DOI 10.3791/3564; Ghosh S, 2013, J CLIN INVEST, V123, P4809, DOI 10.1172/JCI64578; Gile J, 2018, CRIT CARE MED, V46, pE600, DOI 10.1097/CCM.0000000000003077; Hadden H, 2012, J APPL PHYSIOL, V113, P385, DOI 10.1152/japplphysiol.00244.2012; Hassell KL, 2010, AM J PREV MED, V38, pS512, DOI 10.1016/j.amepre.2009.12.022; He BK, 2016, CELL METAB, V23, P610, DOI 10.1016/j.cmet.2016.03.007; Hu X, 2016, CELL REP, V16, P106, DOI 10.1016/j.celrep.2016.05.080; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Keikhaei B, 2013, EUR CYTOKINE NETW, V24, P45, DOI 10.1684/ecn.2013.0328; Korencic A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05782; Liu H, 2018, BLOOD ADV, V2, P1957, DOI 10.1182/bloodadvances.2018015784; Liu YF, 2018, BLOOD, V131, P1600, DOI 10.1182/blood-2017-12-819870; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Rees DC, 2012, BRIT J HAEMATOL, V156, P433, DOI 10.1111/j.1365-2141.2011.08961.x; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Richards J, 2012, FASEB J, V26, P3602, DOI 10.1096/fj.12-203554; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Sun KQ, 2015, BLOOD, V125, P1643, DOI 10.1182/blood-2014-08-595751; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Wen JM, 2010, FASEB J, V24, P740, DOI 10.1096/fj.09-144147; Wu HY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29637; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang DC, 2016, BLOOD, V127, P801, DOI 10.1182/blood-2015-09-618538; Zhang YJ, 2014, J CLIN INVEST, V124, P2750, DOI 10.1172/JCI74604; Zhang YJ, 2012, MICROBES INFECT, V14, P863, DOI 10.1016/j.micinf.2012.05.005; Zhang YJ, 2011, NAT MED, V17, P79, DOI 10.1038/nm.2280; Zhao SS, 2018, FASEB J, V32, P2855, DOI 10.1096/fj.201600788RR; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	40	2	2	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10528	10537		10.1096/fj.201900246RR	http://dx.doi.org/10.1096/fj.201900246RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31260634	Green Published			2022-12-28	WOS:000482214200064
J	Yang, SC; Liu, JJ; Wang, CK; Lin, YT; Tsai, SY; Chen, WJ; Huang, WK; Tu, PWA; Lin, YC; Chang, CF; Cheng, CL; Lin, H; Lai, CY; Lin, CY; Lee, YH; Chiu, YC; Hsu, CC; Hsu, SC; Hsiao, M; Schuyler, SC; Lu, FL; Lu, J				Yang, Shang-Chih; Liu, Jan-Jan; Wang, Cheng-Kai; Lin, Yu-Tsen; Tsai, Su-Yi; Chen, Wei-Ju; Huang, Wei-Kai; Tu, Po-Wen A.; Lin, Yu-Chen; Chang, Ching-Fang; Cheng, Chih-Lun; Lin, Hsuan; Lai, Chien-Ying; Lin, Chun-Yu; Lee, Yi-Hsuan; Chiu, Yen-Chun; Hsu, Chiao-Ching; Hsu, Shu-Ching; Hsiao, Michael; Schuyler, Scott C.; Lu, Frank Leigh; Lu, Jean			Down-regulation of ATF1 leads to early neuroectoderm differentiation of human embryonic stem cells by increasing the expression level of SOX2	FASEB JOURNAL			English	Article						gatekeeper; early development; high-throughput screen	ACTIVATING TRANSCRIPTION FACTOR-1; BINDING-PROTEIN-BETA; PLURIPOTENCY FACTORS; FACTOR-I; NEURAL DIFFERENTIATION; RESPONSIVE ELEMENT; CEREBRAL ORGANOIDS; WIDE ANALYSIS; SELF-RENEWAL; MOUSE	We reveal by high-throughput screening that activating transcription factor 1 (ATF1) is a novel pluripotent regulator in human embryonic stem cells (hESCs). The knockdown of ATF1 expression significantly up-regulated neuroectoderm (NE) genes but not mesoderm, endoderm, and trophectoderm genes. Of note, down-regulation or knockout of ATF1 with short hairpin RNA (shRNA), small interfering RNA (siRNA), or clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) was sufficient to up-regulate sex-determining region Y-box (SOX)2 and paired box 6 (PAX6) expression under the undifferentiated or differentiated conditions, whereas overexpression of ATF1 suppressed NE differentiation. Endogenous ATF1 was spontaneously down-regulated after d 1-3 of neural induction. By double-knockdown experiments, up-regulation of SOX2 was critical for the increase of PAX6 and SOX1 expression in shRNA targeting Atf1 hESCs. Using the luciferase reporter assay, we identified ATF1 as a negative transcriptional regulator of Sox2 gene expression. A novel function of ATF1 was discovered, and these findings contribute to a broader understanding of the very first steps in regulating NE differentiation in hESCs.-Yang, S.-C., Liu, J.-J., Wang, C.-K., Lin, Y.-T., Tsai, S.-Y., Chen, W.-J., Huang, W.-K., Tu, P.-W. A., Lin, Y.-C., Chang, C.-F., Cheng, C.-L., Lin, H., Lai, C.-Y., Lin, C.-Y., Lee, Y.-H., Chiu, Y.-C., Hsu, C.-C., Hsu, S.-C., Hsiao, M., Schuyler, S. C., Lu, F. L., Lu, J. Down-regulation of ATF1 leads to early neuroectoderm differentiation of human embryonic stem cells by increasing the expression level of SOX2.	[Yang, Shang-Chih; Wang, Cheng-Kai; Lu, Jean] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei, Taiwan; [Yang, Shang-Chih; Liu, Jan-Jan; Wang, Cheng-Kai; Lin, Yu-Tsen; Chen, Wei-Ju; Huang, Wei-Kai; Chang, Ching-Fang; Cheng, Chih-Lun; Lin, Hsuan; Lai, Chien-Ying; Lin, Chun-Yu; Lee, Yi-Hsuan; Chiu, Yen-Chun; Hsu, Chiao-Ching; Hsiao, Michael; Lu, Jean] Acad Sinica, Genom Res Ctr, 128 Acad Rd,Sect 2, Taipei 115, Taiwan; [Tsai, Su-Yi; Lin, Yu-Chen] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Life Sci, Taipei, Taiwan; [Tu, Po-Wen A.; Lin, Hsuan; Lu, Frank Leigh] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Pediat, Taipei, Taiwan; [Hsu, Shu-Ching] Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan; [Hsu, Shu-Ching] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Schuyler, Scott C.] Chang Gung Univ, Dept Biomed Sci, Coll Med, Taoyuan, Taiwan; [Schuyler, Scott C.] Chang Gung Mem Hosp, Div Head & Neck Surg, Dept Otolaryngol, Taoyuan, Taiwan; [Lu, Jean] Acad Sinica, Natl Core Facil, RNAi Core, Taipei, Taiwan; [Lu, Jean] Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan; [Lu, Jean] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Kaohsiung Medical University; Chang Gung University; Chang Gung Memorial Hospital; Academia Sinica - Taiwan; Tzu Chi University; National Defense Medical Center	Lu, J (corresponding author), Acad Sinica, Genom Res Ctr, 128 Acad Rd,Sect 2, Taipei 115, Taiwan.; Lu, FL (corresponding author), Natl Taiwan Univ Hosp, Dept Pediat, 8 Zhongshan S Rd, Taipei 100, Taiwan.; Lu, FL (corresponding author), Natl Taiwan Univ, Med Coll, 8 Zhongshan S Rd, Taipei 100, Taiwan.	frankllu@ntu.edu.tw; jeanlu@gate.sinica.edu.tw	Chen, Wei-Ju/HCG-9205-2022; Lu, Frank Leigh/G-6196-2012; Huang, Wei-Kai/GRR-9057-2022; Hsiao, Michael/U-6238-2019	Lu, Frank Leigh/0000-0002-5225-7751; Hsiao, Michael/0000-0001-8529-9213; TSAI, SU-YI/0000-0002-7423-645X; Cheng, Chih-Lun/0000-0002-5409-823X	Data Science Statistical Cooperation Center of Academia Sinica [AS-CFII-108-117]; National Health Research Institute [NHRI-EX106-10415SI]; National Science Council [NSC 102-2321-B-001-013, 102-2321-B-039-002, 102-2325-B-039-002, 102-2320-B-008-002, 102-2311-B-182-004]; Ministry of Health and Welfare [MOHW102-TD-PB-111-NSC105]; Chang Gung Memorial Hospital [BMRPC59, CMRPD1F0353]; Taiwan Ministry of Science and Technology [103-2321-B-001-064, 104-2320-B-001-005, 104-0210-01-09-02, 105-0210-01-13-01, 105-2320-B-001-026-MY2, 106-0210-01-15-02, 107-0210-01-19-01, 107-2320-B-002-026, AS-Summit-108]; Academia Sinica [AS-CFII-108-106]	Data Science Statistical Cooperation Center of Academia Sinica; National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Taiwan Ministry of Science and Technology; Academia Sinica(Academia Sinica - Taiwan)	The authors thank Dr. Douglas A. Melton (Harvard University, Boston, MA, USA), Dr. Yoshiaki Tsuji (North Carolina State University, Raleigh, NC, USA), Dr. Cheng-Wen Wu (Academia Sinica), Dr. Joanne Jeou-Yuan Chen (Academia Sinica), Dr. Han-Chung Wu (Academia Sinica), Dr. Chih-Cheng Chen (Academia Sinica), Dr. Hung-Chih Kuo (Academia Sinica), and Dr. Ching Hwa Tsai (National Taiwan University) for assistance in this study. The authors also thank Dr. Yu-Chi Chou (RNAi Core Facility, Academia Sinica) and Dr. Sin-Jhong Cheng [Neuroscience Core Facility (AS-CFII-108-106), Academia Sinica] for technical support and the Data Science Statistical Cooperation Center of Academia Sinica (AS-CFII-108-117) for statistical support. This study was supported by the National Health Research Institute (NHRI-EX106-10415SI), the National Science Council (NSC 102-2321-B-001-013, 102-2321-B-039-002, 102-2325-B-039-002, 102-2320-B-008-002, and 102-2311-B-182-004), The Ministry of Health and Welfare (MOHW102-TD-PB-111-NSC105), Chang Gung Memorial Hospital (BMRPC59 and CMRPD1F0353), and the Taiwan Ministry of Science and Technology (103-2321-B-001-064, 104-2320-B-001-005, 104-0210-01-09-02, 105-0210-01-13-01,105-2320-B-001-026-MY2, 106-0210-01-15-02, 107-0210-01-19-01, 107-2320-B-002-026, and AS-Summit-108). The authors declare no conflicts of interest.	Aloia L, 2014, GENE DEV, V28, P182, DOI 10.1101/gad.228510.113; Aota S, 2003, DEV BIOL, V257, P1, DOI 10.1016/S0012-1606(03)00058-7; Atlas E, 2001, ONCOGENE, V20, P7110, DOI 10.1038/sj.onc.1204890; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Belmonte N, 2001, MOL ENDOCRINOL, V15, P2037, DOI 10.1210/me.15.11.2037; Berger RP, 2016, STEM CELLS, V34, P1742, DOI 10.1002/stem.2379; Bleckmann SC, 2002, MOL CELL BIOL, V22, P1919, DOI 10.1128/MCB.22.6.1919-1925.2002; Blum B, 2009, NAT BIOTECHNOL, V27, P281, DOI 10.1038/nbt.1527; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; BROWN AD, 1995, ONCOGENE, V10, P1749; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Chitilian JM, 2014, STEM CELLS, V32, P204, DOI 10.1002/stem.1564; Chou YT, 2013, STEM CELLS, V31, P2607, DOI 10.1002/stem.1518; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Desbordes SC, 2008, CELL STEM CELL, V2, P602, DOI 10.1016/j.stem.2008.05.010; Desmarais JA, 2012, STEM CELLS, V30, P1385, DOI 10.1002/stem.1117; Dong Y, 2002, EXP CELL RES, V276, P328, DOI 10.1006/excr.2002.5534; Du ZW, 2013, DEVELOPMENT, V140, P2611, DOI 10.1242/dev.092809; Ebert AD, 2012, J CARDIOVASC PHARM, V60, P408, DOI 10.1097/FJC.0b013e318247f642; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Foldy C, 2016, P NATL ACAD SCI USA, V113, pE5222, DOI 10.1073/pnas.1610155113; Gonzalez R, 2010, P NATL ACAD SCI USA, V107, P3552, DOI 10.1073/pnas.0914019107; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Gupta P, 2002, J BIOL CHEM, V277, P50550, DOI 10.1074/jbc.M209799200; Hailemariam K, 2010, J CELL SCI, V123, P3863, DOI 10.1242/jcs.073627; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hou PS, 2013, NUCLEIC ACIDS RES, V41, P7753, DOI 10.1093/nar/gkt567; Houlard M, 2006, PLOS GENET, V2, P1686, DOI 10.1371/journal.pgen.0020181; HSUEH YP, 1995, J IMMUNOL, V154, P5675; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Iwasaki K, 2007, J BIOL CHEM, V282, P22335, DOI 10.1074/jbc.M701477200; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jang J, 2016, CELL, V165, P410, DOI 10.1016/j.cell.2016.02.014; Jean D, 2000, ONCOGENE, V19, P2721, DOI 10.1038/sj.onc.1203569; Jin XL, 2014, REPRODUCTION, V148, P147, DOI 10.1530/REP-13-0535; Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005; Kingsley-Kallesen ML, 1999, J BIOL CHEM, V274, P34020, DOI 10.1074/jbc.274.48.34020; Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lee BK, 2015, CELL REP, V13, P52, DOI 10.1016/j.celrep.2015.08.067; Lee MG, 2003, J BIOL CHEM, V278, P41047, DOI 10.1074/jbc.M307031200; Li KR, 2016, DIS MODEL MECH, V9, P759, DOI 10.1242/dmm.025783; Li L, 2010, AM J HUM GENET, V87, P400, DOI 10.1016/j.ajhg.2010.08.003; Liao BY, 2008, P NATL ACAD SCI USA, V105, P6987, DOI [10.1073/pnas.0800387105, 10.1073/pnas.0806419105]; Lin YP, 2009, INVEST OPHTH VIS SCI, V50, P68, DOI 10.1167/iovs.07-1619; Lippmann ES, 2014, STEM CELLS, V32, P1032, DOI 10.1002/stem.1622; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mignone JL, 2010, CIRC J, V74, P2517, DOI 10.1253/circj.CJ-10-0958; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okaty BW, 2009, J NEUROSCI, V29, P7040, DOI 10.1523/JNEUROSCI.0105-09.2009; Okuyama Y, 1996, FEBS LETT, V397, P219, DOI 10.1016/S0014-5793(96)01178-7; Otani T, 2016, CELL STEM CELL, V18, P467, DOI 10.1016/j.stem.2016.03.003; Peters OM, 2015, NEURON, V88, P902, DOI 10.1016/j.neuron.2015.11.018; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Rizzino A, 2016, BBA-GENE REGUL MECH, V1859, P780, DOI 10.1016/j.bbagrm.2016.03.006; Rolli M, 1999, J BIOL CHEM, V274, P19559, DOI 10.1074/jbc.274.28.19559; Ryan SJ, 2016, BRAIN STRUCT FUNCT, V221, P839, DOI 10.1007/s00429-014-0939-x; Salnikow K, 1997, CANCER RES, V57, P5060; Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859; Shen J, 2005, MOL CELL BIOL, V25, P3639, DOI 10.1128/MCB.25.9.3639-3647.2005; Shimomura A, 1998, J NEUROCHEM, V70, P1029; Sierra RA, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.161075; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Tripathy SJ, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005814; Tripathy SJ, 2015, J NEUROPHYSIOL, V113, P3474, DOI 10.1152/jn.00237.2015; Tzatzalos E, 2016, ADV DRUG DELIVER REV, V96, P234, DOI 10.1016/j.addr.2015.09.010; Wang CH, 2012, STEM CELLS, V30, P2199, DOI 10.1002/stem.1203; Wang Y, 2000, ONCOGENE, V19, P1379, DOI 10.1038/sj.onc.1203443; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Wei WJ, 2015, STEM CELLS, V33, P2664, DOI 10.1002/stem.2057; Wen JH, 2008, NEUROREPORT, V19, P413, DOI 10.1097/WNR.0b013e3282f64377; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107; Yang XD, 2016, J IMMUNOL, V197, P2369, DOI 10.4049/jimmunol.1600627; Yu HB, 2009, J BIOL CHEM, V284, P31327, DOI 10.1074/jbc.M109.016162; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zaman K, 1999, J NEUROSCI, V19, P9821; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200; Zhang Shuchen, 2014, World J Stem Cells, V6, P305, DOI 10.4252/wjsc.v6.i3.305; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102; Zhou JX, 2010, STEM CELLS, V28, P1741, DOI 10.1002/stem.504	87	4	4	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10577	10592		10.1096/fj.201800220RR	http://dx.doi.org/10.1096/fj.201800220RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31242772	Green Published, Bronze			2022-12-28	WOS:000482214200068
J	Getter, T; Gulati, S; Zimmerman, R; Chen, YY; Vinberg, F; Palczewski, K				Getter, Tamar; Gulati, Sahil; Zimmerman, Remy; Chen, Yuanyuan; Vinberg, Frans; Palczewski, Krzysztof			Stereospecific modulation of dimeric rhodopsin	FASEB JOURNAL			English	Article						GPCR dimerization; high-throughput screening; G-protein-coupled receptors; chromophore; isomerization	PROTEIN-COUPLED RECEPTOR; METARHODOPSIN-II; VISUAL PIGMENT; TRANSDUCIN; BIOLUMINESCENCE; ORGANIZATION; ACTIVATION; DETERGENT; MODEL; PHOTORECEPTORS	The classic concept that GPCRs function as monomers has been challenged by the emerging evidence of GPCR dimerization and oligomerization. Rhodopsin (Rh) is the only GPCR whose native oligomeric arrangement was revealed by atomic force microscopy demonstrating that Rh exists as a dimer. However, the role of Rh dimerization in retinal physiology is currently unknown. In this study, we identified econazole and sulconazole, two small molecules that disrupt Rh dimer contacts, by implementing a cell-based high-throughput screening assay. Racemic mixtures of identified lead compounds were separated and tested for their stereospecific binding to Rh using UV-visible spectroscopy and intrinsic fluorescence of tryptophan (Trp) 265 after illumination. By following the changes in UV-visible spectra and Trp265 fluorescence in vitro, we found that binding of R-econazole modulates the formation of Meta III and quenches the intrinsic fluorescence of Trp265. In addition, electrophysiological ex vivo recording revealed that R-econazole slows photoresponse kinetics, whereas S-econazole decreased the sensitivity of rods without effecting the kinetics. Thus, this study contributes new methodology to identify compounds that disrupt the dimerization of GPCRs in general and validates the first active compounds that disrupt the Rh dimer specifically.-Getter, T., Gulati, S., Zimmerman, R., Chen, Y., Vinberg, F., Palczewski, K. Stereospecific modulation of dimeric rhodopsin.	[Getter, Tamar; Gulati, Sahil; Zimmerman, Remy; Palczewski, Krzysztof] Univ Calif Irvine, Gavin Herbert Eye Inst, Dept Ophthalmol, 850 Hlth Sci Rd, Irvine, CA 92697 USA; [Gulati, Sahil; Palczewski, Krzysztof] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA; [Getter, Tamar; Gulati, Sahil; Palczewski, Krzysztof] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Chen, Yuanyuan] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA; [Chen, Yuanyuan] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Vinberg, Frans] Univ Utah, Dept Ophthalmol & Visual Sci, Salt Lake City, UT USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Case Western Reserve University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Utah System of Higher Education; University of Utah	Getter, T; Palczewski, K (corresponding author), Univ Calif Irvine, Gavin Herbert Eye Inst, Dept Ophthalmol, 850 Hlth Sci Rd, Irvine, CA 92697 USA.	tgetter@uci.edu; kpalczew@uci.edu	Vinberg, Frans/AAK-8615-2021	Vinberg, Frans/0000-0003-3439-4979; Chen, Yuanyuan/0000-0001-9625-1610; Gulati, Sahil/0000-0002-8255-479X	U.S. National Institutes of Health (NIH) National Eye Institute [EY R24024864, R24EY027283, EY024992, EY026651]; Research to Prevent Blindness (RPB); Canadian Institute for Advanced Research (CIFAR); Alcon Research Institute (ARI); NATIONAL EYE INSTITUTE [R00EY026651, R24EY027283] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); Alcon Research Institute (ARI); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Drs. Philip Kiser [Physiology & Biophysics Department, University of California-Irvine, Irvine, CA, USA (UCI)], Timothy Kern (Ophthalmology Department, UCI), and Angele Nalbandian (Ophthalmology Department, UCI) for helpful comments on this manuscript. The authors wish to thank members of the Small Molecule Drug Development Core facilities at Case Western Reserve University for guidance through the development of our high-throughput screening (HTS) assay. This research was supported in part by grants from the U.S. National Institutes of Health (NIH) National Eye Institute (EY R24024864 and R24EY027283 to K.P., EY024992 to Y.C., and EY026651 to F.V.), an unrestricted Research to Prevent Blindness (RPB) grant to the Department of Ophthalmology at UCI; the Canadian Institute for Advanced Research (CIFAR); and the Alcon Research Institute (ARI). K.P. is the Leopold Chair of Ophthalmology. The authors declare no conflicts of interest.	Aboul-Enein HY, 2002, J PHARMACEUT BIOMED, V27, P441, DOI 10.1016/S0731-7085(01)00575-1; Alexiev U, 2014, BBA-BIOENERGETICS, V1837, P694, DOI 10.1016/j.bbabio.2013.10.008; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Baker BY, 2015, METHOD ENZYMOL, V557, P439, DOI 10.1016/bs.mie.2014.11.045; Baldini L, 2004, J AM CHEM SOC, V126, P5656, DOI 10.1021/ja039562j; Bartl FJ, 2007, PHYS CHEM CHEM PHYS, V9, P1648, DOI 10.1039/b616365c; Chankvetadze B, 1996, J PHARMACEUT BIOMED, V14, P1295, DOI 10.1016/S0731-7085(96)01748-7; Chen YY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04261-1; Chen YY, 2015, INVEST OPHTH VIS SCI, V56, P2553, DOI 10.1167/iovs.14-16298; Chen Yuanyuan, 2015, Methods Mol Biol, V1271, P369, DOI 10.1007/978-1-4939-2330-4_24; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; FUNG BKK, 1981, P NATL ACAD SCI-BIOL, V78, P152, DOI 10.1073/pnas.78.1.152; Gulati S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04432-0; Gulati S, 2017, P NATL ACAD SCI USA, V114, pE2608, DOI 10.1073/pnas.1617446114; Gunkel M, 2015, STRUCTURE, V23, P628, DOI 10.1016/j.str.2015.01.015; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Hofmann L, 2016, ANAL BIOCHEM, V499, P63, DOI 10.1016/j.ab.2016.01.016; Imamoto Y, 2015, PHOTOCH PHOTOBIO SCI, V14, P1965, DOI 10.1039/c5pp00175g; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Janz JM, 2004, J BIOL CHEM, V279, P55886, DOI 10.1074/jbc.M408766200; Jastrzebska B, 2004, J BIOL CHEM, V279, P54663, DOI 10.1074/jbc.M408691200; Jastrzebska B, 2015, J BIOL CHEM, V290, P25728, DOI 10.1074/jbc.M115.662684; Jastrzebska B, 2013, J STRUCT BIOL, V182, P164, DOI 10.1016/j.jsb.2013.02.014; Jastrzebska B, 2013, FASEB J, V27, P1572, DOI 10.1096/fj.12-225383; Jastrzebska B, 2011, J STRUCT BIOL, V176, P387, DOI 10.1016/j.jsb.2011.08.016; Kandori H, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1197, DOI 10.1023/A:1013123016803; Knepp AM, 2012, BIOCHEMISTRY-US, V51, P1819, DOI 10.1021/bi3001598; Kojima K, 2014, J BIOL CHEM, V289, P5061, DOI 10.1074/jbc.M113.508507; KONIG B, 1989, FEBS LETT, V257, P163, DOI 10.1016/0014-5793(89)81811-3; Lane JR, 2013, ACS CHEM NEUROSCI, V4, P527, DOI 10.1021/cn400005t; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Levi J, 2007, J AM CHEM SOC, V129, P11900, DOI 10.1021/ja073936h; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200; Luttrell LM, 2002, J CELL SCI, V115, P455; MACKE JP, 1993, AM J HUM GENET, V53, P80; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Miranda OR, 2010, J AM CHEM SOC, V132, P5285, DOI 10.1021/ja1006756; Mustafi D, 2009, MOL PHARMACOL, V75, P1, DOI 10.1124/mol.108.051938; Nemoto W, 2005, PROTEINS, V58, P644, DOI 10.1002/prot.20332; Nguyen Lien Ai, 2006, Int J Biomed Sci, V2, P85; Otto-Duessel M, 2006, MOL IMAGING, V5, P57, DOI 10.2310/7290.2006.00006; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Palczewski K, 2010, TRENDS BIOCHEM SCI, V35, P595, DOI 10.1016/j.tibs.2010.05.002; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Periole X, 2012, J AM CHEM SOC, V134, P10959, DOI 10.1021/ja303286e; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Ploier B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12832; Ramon E, 2003, VISION RES, V43, P3055, DOI 10.1016/j.visres.2003.08.009; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; SAEVA FD, 1980, J AM CHEM SOC, V102, P299, DOI 10.1021/ja00521a047; SAKMAR TP, 1991, P NATL ACAD SCI USA, V88, P3079, DOI 10.1073/pnas.88.8.3079; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Salon JA, 2011, PHARMACOL REV, V63, P901, DOI 10.1124/pr.110.003350; SCHLEICHER A, 1987, BIOCHEMISTRY-US, V26, P5908, DOI 10.1021/bi00392a050; Shichida Y, 1998, CELL MOL LIFE SCI, V54, P1299, DOI 10.1007/s000180050256; Simpson LM, 2010, CURR OPIN PHARMACOL, V10, P30, DOI 10.1016/j.coph.2009.11.001; Vinberg F, 2015, HUM MOL GENET, V24, P5915, DOI 10.1093/hmg/ddv319; Vinberg F, 2014, VISION RES, V101, P108, DOI 10.1016/j.visres.2014.06.003; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang T, 2016, P NATL ACAD SCI USA, V113, P9093, DOI 10.1073/pnas.1609018113	70	3	3	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9526	9539		10.1096/fj.201900443RR	http://dx.doi.org/10.1096/fj.201900443RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31121099	Bronze, Green Published			2022-12-28	WOS:000478832900064
J	Guo, HZ; Niu, LT; Qiang, WT; Chen, J; Wang, J; Yang, H; Zhang, W; Zhu, J; Yu, SH				Guo, He-Zhou; Niu, Li-Ting; Qiang, Wan-Ting; Chen, Juan; Wang, Juan; Yang, Hui; Zhang, Wu; Zhu, Jiang; Yu, Shan-He			Leukemic IL-17RB signaling regulates leukemic survival and chemoresistance	FASEB JOURNAL			English	Article						AML; IL-17B-IL-17RB signaling; cytokines; drug resistance	ACUTE MYELOID-LEUKEMIA; MESSENGER-RNA EXPRESSION; NF-KAPPA-B; FAMILY CYTOKINES; IDENTIFICATION; INFLAMMATION; METASTASIS; PROGRAM; PATHWAY; PLAYERS	Secreted proteins provide crucial signals that have been implicated in the development of acute myeloid leukemia (AML) in the bone marrow microenvironment. Here we identify aberrant expressions of inflammatory IL-17B and its receptor (IL-17RB) in human and mouse mixed lineage leukemia-rearranged AML cells, which were further increased after exposure to chemotherapy. Interestingly, silencing of IL-17B or IL-17RB led to significant suppression of leukemic cell survival and disease progression in vivo. Moreover, the IL-17B-IL-17RB axis protected leukemic cells from chemotherapeutic agent-induced apoptotic effects. Mechanistic studies revealed that IL-17B promoted AML cell survival by enhancing ERK, NF-kappa B phosphorylation, and the expression of antiapoptotic protein B-cell lymphoma 2, which were reversed by small-molecule inhibitors. Thus, the inhibition of the IL-17B-IL-17RB axis may be a valid strategy to enhance sensitivity and therapeutic benefit of AML chemotherapy.-Guo, H.-Z., Niu, L.-T., Qiang, W.-T., Chen, J., Wang, J., Yang, H., Zhang, W., Zhu, J., Yu, S.-H. Leukemic IL-17RB signaling regulates leukemic survival and chemoresistance.	[Guo, He-Zhou; Niu, Li-Ting; Qiang, Wan-Ting; Chen, Juan; Yang, Hui; Zhang, Wu; Zhu, Jiang; Yu, Shan-He] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, State Key Lab Med Genom,Shanghai Inst Hematol, 197 Rui Jin Rd 2,Room 806,Sci & Educ Plaza, Shanghai, Peoples R China; [Guo, He-Zhou; Niu, Li-Ting; Qiang, Wan-Ting; Chen, Juan; Yang, Hui; Zhang, Wu; Zhu, Jiang; Yu, Shan-He] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai, Peoples R China; [Wang, Juan] Penn State Univ, Bioinformat & Genom Program, Huck Inst Life Sci, University Pk, PA 16802 USA	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Guo, HZ; Yu, SH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, State Key Lab Med Genom,Shanghai Inst Hematol, 197 Rui Jin Rd 2,Room 806,Sci & Educ Plaza, Shanghai, Peoples R China.	redd22@sjtu.edu.cn; 2005150107@sjtu.edu.cn		Yu, Shanhe/0000-0002-0268-7374	National Scientific Foundation of China [81430002, 81770206, 81800099]; Chinese National Key Basic Research Project [2013CB966803]; National Major Scientific and Technological Special Project [2018ZX09101001]; Samuel Waxman Cancer Research Foundation	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Key Basic Research Project(National Basic Research Program of China); National Major Scientific and Technological Special Project; Samuel Waxman Cancer Research Foundation	This work was supported by grants from the National Scientific Foundation of China (81430002, 81770206, and 81800099), the Chinese National Key Basic Research Project (2013CB966803), the National Major Scientific and Technological Special Project (2018ZX09101001), and Samuel Waxman Cancer Research Foundation. The authors declare no conflicts of interest.	Agger K, 2016, GENE DEV, V30, P1278, DOI 10.1101/gad.280495.116; Al-Samadi A, 2016, TUMOR BIOL, V37, P1609, DOI 10.1007/s13277-015-3941-x; Alinejad V, 2017, BIOMED PHARMACOTHER, V88, P795, DOI 10.1016/j.biopha.2017.01.120; Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Anstee N. S., 2018, CELL DEATH DIFFER; Bagger FO, 2013, NUCLEIC ACIDS RES, V41, pD1034, DOI 10.1093/nar/gks1021; Benatar T, 2010, CANCER IMMUNOL IMMUN, V59, P805, DOI 10.1007/s00262-009-0802-8; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Bie QL, 2017, MOL IMMUNOL, V90, P50, DOI 10.1016/j.molimm.2017.07.004; Bie QL, 2017, ONCOTARGET, V8, P18914, DOI 10.18632/oncotarget.14835; Bie QL, 2016, SCI REP-UK, V6, DOI 10.1038/srep25447; Carey A, 2017, CELL REP, V18, P3204, DOI 10.1016/j.celrep.2017.03.018; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crusz SM, 2015, NAT REV CLIN ONCOL, V12, P584, DOI 10.1038/nrclinonc.2015.105; de Boer J, 2013, LEUKEMIA, V27, P1224, DOI 10.1038/leu.2013.78; Eckfeldt CE, 2005, PLOS BIOL, V3, P1449, DOI 10.1371/journal.pbio.0030254; El Rassi F, 2013, CLIN MED INSIGHTS-ON, V7, P181, DOI 10.4137/CMO.S8528; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Fabre J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091433; Furuta S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001374; Gu CF, 2013, CYTOKINE, V64, P477, DOI 10.1016/j.cyto.2013.07.022; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Hemmati S, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00265; Huang CK, 2014, ONCOGENE, V33, P2968, DOI 10.1038/onc.2013.268; Iida T, 2014, ONCOL REP, V31, P605, DOI 10.3892/or.2013.2911; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Kohlmann A, 2008, BRIT J HAEMATOL, V142, P802, DOI 10.1111/j.1365-2141.2008.07261.x; Lee J, 2001, J BIOL CHEM, V276, P1660, DOI 10.1074/jbc.M008289200; Li HZ, 2000, P NATL ACAD SCI USA, V97, P773, DOI 10.1073/pnas.97.2.773; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; Mei SL, 2017, NUCLEIC ACIDS RES, V45, pD658, DOI 10.1093/nar/gkw983; Mirantes C, 2014, EXP CELL RES, V329, P248, DOI 10.1016/j.yexcr.2014.08.017; Mitchell K, 2018, J EXP MED, V215, P1709, DOI 10.1084/jem.20180147; Nakamura A, 2016, J NEUROSCI, V36, P5448, DOI 10.1523/JNEUROSCI.4247-15.2016; Naumenko VS, 2015, NEUROSCIENCE, V284, P730, DOI 10.1016/j.neuroscience.2014.10.045; Ofengeim D, 2012, NAT NEUROSCI, V15, P574, DOI 10.1038/nn.3054; Pappu R, 2011, IMMUNOLOGY, V134, P8, DOI 10.1111/j.1365-2567.2011.03465.x; Park HA, 2018, MOLECULES, V23, DOI 10.3390/molecules23113019; Prange KHM, 2017, ONCOGENE, V36, P3346, DOI 10.1038/onc.2016.488; Ren L, 2017, MOL IMMUNOL, V90, P126, DOI 10.1016/j.molimm.2017.06.034; Reynolds JM, 2015, IMMUNITY, V42, P692, DOI 10.1016/j.immuni.2015.03.008; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; Song XY, 2013, CELL SIGNAL, V25, P2335, DOI 10.1016/j.cellsig.2013.07.021; Teh TC, 2018, LEUKEMIA, V32, P303, DOI 10.1038/leu.2017.243; Tian EM, 2000, ONCOGENE, V19, P2098, DOI 10.1038/sj.onc.1203577; Turzanski J, 2004, LEUKEMIA, V18, P1662, DOI 10.1038/sj.leu.2403457; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Winters AC, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00004; Wong SHK, 2015, CANCER CELL, V28, P198, DOI 10.1016/j.ccell.2015.06.003; Wu HH, 2015, J EXP MED, V212, P333, DOI 10.1084/jem.20141702; Yu SH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05548-z; Zhu N, 2016, J CLIN INVEST, V126, P997, DOI 10.1172/JCI82978	54	5	6	6	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9565	9576		10.1096/fj.201900099R	http://dx.doi.org/10.1096/fj.201900099R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31136196	Bronze			2022-12-28	WOS:000478832900067
J	Petrov, AM; Mast, N; Li, Y; Pikuleva, IA				Petrov, Alexey M.; Mast, Natalia; Li, Yong; Pikuleva, Irina A.			The key genes, phosphoproteins, processes, and pathways affected by efavirenz-activated CYP46A1 in the amyloid-decreasing paradigm of efavirenz treatment	FASEB JOURNAL			English	Article						24-hydroxycholesterol; Alzheimer disease; 5XFAD mice	POTENTIAL THERAPEUTIC TARGET; GLYCOGEN-SYNTHASE KINASE-3; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; CHOLESTEROL 24-HYDROXYLASE; BRAIN CHOLESTEROL; LIPID RAFTS; NEUROFIBRILLARY TANGLES; PRECURSOR PROTEIN; NMDA RECEPTOR	Efavirenz (EFV) is an anti-HIV drug, and cytochrome P450 46A1 (CYP46A1) is the major brain cholesterol hydroxylase. Previously, we discovered that EFV activates CYP46A1 and improves behavioral performance in 5XFAD mice, an Alzheimer's disease model. Herein, the unbiased omics and other approaches were used to study 5XFAD mice in the amyloid-decreasing paradigm of CYP46A1 activation by EFV. These approaches revealed increases in the brain levels of postsynaptic density protein 95, gephyrin, synaptophysin, synapsin, glial fibrillary acidic protein, and CYP46A1 and documented altered expression and phosphorylation of 66 genes and 77 proteins, respectively. The data obtained pointed to EFV effects at the synaptic level, plasmin-depended amyloid clearance, inflammation and microglia phenotype, oxidative stress and cellular hypoxia, autophagy and ubiquitin-proteasome systems as well as apoptosis. These effects could be realized in part via changes in the Ca2+-, small GTPase, and catenin signaling. A model is proposed, in which CYP46A1-dependent lipid raft rearrangement and subsequent decrease of protein phosphorylation are central in EFV effects and explain behavioral improvements in EFV-treated 5XFAD mice.-Petrov, A. M., Mast, N., Li, Y., Pikuleva, I. A. The key genes, phosphoproteins, processes, and pathways affected by efavirenz-activated CYP46A1 in the amyloid-decreasing paradigm of efavirenz treatment.	[Petrov, Alexey M.; Mast, Natalia; Li, Yong; Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 2085 Adelbert Rd,Room 303, Cleveland, OH 44106 USA	Case Western Reserve University	Pikuleva, IA (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 2085 Adelbert Rd,Room 303, Cleveland, OH 44106 USA.	iap8@case.edu	Petrov, Alexey/O-4500-2017	Petrov, Alexey/0000-0002-1432-3455; Pikuleva, Irina/0000-0001-9742-6232	U.S. National Institutes of Health (NIH) Grant [P30 EY11373]; National Institute of General Medical Sciences Grant [GM062882]; NATIONAL EYE INSTITUTE [R01EY018383, P30EY011373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062882] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the Case Western Reserve University Visual Sciences Research Center Core Facilities [supported by U.S. National Institutes of Health (NIH) Grant P30 EY11373] for assistance with mouse breeding (Heather Butler and Kathryn Franke), animal genotyping (John Denker), tissue sectioning (Catherine Doller), and microscopy (Anthony Gardella). The authors are also grateful to Jean Moon for initial Western blots of CYP46A1 and Iba1 as well as Case Genomics Core for conducting whole transcriptome sequencing and the Proteomics Core at the Cleveland Clinic Foundation for carrying out brain phoshoproteomics. This work was supported in part in by National Institute of General Medical Sciences Grant GM062882 (to I.A.P.). The authors declare no conflicts of interest.	Aguilar BJ, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0320-4; Alfieri A, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00212; Alfonso SI, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf6209; Antal CE, 2013, MOL CELL PROTEOMICS, V12, P3498, DOI 10.1074/mcp.R113.029819; APEL ED, 1991, J BIOL CHEM, V266, P10544; Arstikaitis P, 2008, MOL BIOL CELL, V19, P2026, DOI 10.1091/mbc.E07-08-0802; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Avrahami L, 2013, J BIOL CHEM, V288, P1295, DOI 10.1074/jbc.M112.409250; Baines AJ, 2001, CELL MOL BIOL LETT, V6, P691; Barnat M, 2016, MOL CELL NEUROSCI, V72, P9, DOI 10.1016/j.mcn.2016.01.001; Bjorkhem I, 1998, J LIPID RES, V39, P1594; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bogdanovica N, 2001, NEUROSCI LETT, V314, P45, DOI 10.1016/S0304-3940(01)02277-7; Boland B, 2018, NAT REV DRUG DISCOV, V17, P660, DOI 10.1038/nrd.2018.109; Boussicault L, 2018, BIOCHIMIE, V153, P70, DOI 10.1016/j.biochi.2018.07.019; Boussicault L, 2016, BRAIN, V139, P953, DOI 10.1093/brain/awv384; Bretillon L, 2000, NEUROSCI LETT, V293, P87, DOI 10.1016/S0304-3940(00)01466-X; Brittain JM, 2012, FEBS LETT, V586, P3813, DOI 10.1016/j.febslet.2012.09.022; Brown J, 2004, J BIOL CHEM, V279, P34674, DOI 10.1074/jbc.M402324200; Brudvig JJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00407; Bryleva EY, 2010, P NATL ACAD SCI USA, V107, P3081, DOI 10.1073/pnas.0913828107; Burlot MA, 2015, HUM MOL GENET, V24, P5965, DOI 10.1093/hmg/ddv268; Cai J, 2010, GLIA, V58, P458, DOI 10.1002/glia.20937; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Carlisle HJ, 2011, J NEUROSCI, V31, P16194, DOI 10.1523/JNEUROSCI.5877-10.2011; Caspi M, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-164; Chen Y, 2009, CELL CYCLE, V8, P257, DOI 10.4161/cc.8.2.7551; Chin LS, 2002, J BIOL CHEM, V277, P35071, DOI 10.1074/jbc.M203300200; Choii G, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.5; Chung KM, 2019, NEUROSCI LETT, V697, P49, DOI 10.1016/j.neulet.2018.05.017; Chung SH, 2009, BMB REP, V42, P467, DOI 10.5483/BMBRep.2009.42.8.467; Clarke CJ, 2007, AM J PHYSIOL-HEART C, V292, pH2248, DOI 10.1152/ajpheart.01170.2006; Cole AR, 2008, J BIOL CHEM, V283, P18227, DOI 10.1074/jbc.M801645200; Cole AR, 2007, J NEUROCHEM, V103, P1132, DOI 10.1111/j.1471-4159.2007.04829.x; Colie S, 2017, SCI REP-UK, V7, DOI 10.1038/srep45306; Collingridge GL, 2013, NEUROPHARMACOLOGY, V64, P13, DOI 10.1016/j.neuropharm.2012.06.051; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; Cordy JM, 2006, MOL MEMBR BIOL, V23, P111, DOI 10.1080/09687860500496417; de la Monte SM, 2000, CELL MOL LIFE SCI, V57, P1471, DOI 10.1007/PL00000630; Deloulme JC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8246; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Djelti F, 2015, BRAIN, V138, P2383, DOI 10.1093/brain/awv166; Drummond E, 2017, ACTA NEUROPATHOL, V133, P933, DOI 10.1007/s00401-017-1691-0; Duman JG, 2015, NEUROSCI LETT, V601, P4, DOI 10.1016/j.neulet.2015.05.034; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Feng J, 2017, J INNATE IMMUN, V9, P419, DOI 10.1159/000460294; Fujita K, 2016, SCI REP-UK, V6, DOI 10.1038/srep31895; Gamo K, 2008, J NEUROSCI, V28, P11980, DOI 10.1523/JNEUROSCI.2920-08.2008; Gewurz BE, 2012, P NATL ACAD SCI USA, V109, P2467, DOI 10.1073/pnas.1120542109; Gitler D, 2004, J NEUROSCI, V24, P11368, DOI 10.1523/JNEUROSCI.3795-04.2004; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Goldschmidt HL, 2016, CELL REP, V14, P200, DOI 10.1016/j.celrep.2015.12.022; Gonzales ML, 2012, MOL CELL BIOL, V32, P2894, DOI 10.1128/MCB.06728-11; Gu YJ, 2000, BIOCHEMISTRY-US, V39, P4267, DOI 10.1021/bi992323h; Guglielmotto M, 2009, THESCIENTIFICWORLDJO, V9, P781, DOI 10.1100/tsw.2009.93; Han XJ, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00397; Haruta T, 1997, BIOCHEM J, V325, P455, DOI 10.1042/bj3250455; He MQ, 2016, NEUROCHEM RES, V41, P3063, DOI 10.1007/s11064-016-2027-5; He YD, 2009, J CEREBR BLOOD F MET, V29, P596, DOI 10.1038/jcbfm.2008.145; Hegde AN, 2017, NEUROBIOL LEARN MEM, V138, P98, DOI 10.1016/j.nlm.2016.09.003; Heidbreder M, 2003, FASEB J, V17, P1541, DOI 10.1096/fj.02-0963fje; Hensley K, 2016, J ALZHEIMERS DIS, V53, P1, DOI 10.3233/JAD-160076; Hernandez P, 2009, J ALZHEIMERS DIS, V16, P149, DOI 10.3233/JAD-2009-0933; Holahan MR, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00266; Honorat JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071329; Hua KX, 2017, DEV COMP IMMUNOL, V76, P255, DOI 10.1016/j.dci.2017.06.014; Hudry E, 2010, MOL THER, V18, P44, DOI 10.1038/mt.2009.175; Ip JPK, 2014, NEUROSCIENTIST, V20, P589, DOI 10.1177/1073858413514278; Isono T, 2013, NEUROSCI RES, V77, P180, DOI 10.1016/j.neures.2013.08.005; Izawa I, 2002, J BIOL CHEM, V277, P5345, DOI 10.1074/jbc.M110052200; Jacobo SMP, 2009, J PHARMACOL EXP THER, V330, P283, DOI 10.1124/jpet.109.150672; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Ji ZG, 2018, AM J TRANSL RES, V10, P1784; Jiang Z., 2017, CLIN SCI LOND; Jones SB, 2002, NEUROSCIENCE, V115, P1009, DOI 10.1016/S0306-4522(02)00532-8; Jurado S, 2010, NAT NEUROSCI, V13, P1053, DOI 10.1038/nn.2613; Juszczak GR, 2018, PROG NEURO-PSYCHOPH, V82, P136, DOI 10.1016/j.pnpbp.2017.11.020; Kaiser F, 2004, J CELL SCI, V117, P1747, DOI 10.1242/jcs.01039; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Kamphuis W, 2016, BBA-MOL BASIS DIS, V1862, P1847, DOI 10.1016/j.bbadis.2016.07.007; Keith DJ, 2012, J NEUROSCI, V32, P7119, DOI 10.1523/JNEUROSCI.0784-12.2012; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kim YJ, 2018, BIOCHEM BIOPH RES CO, V503, P2673, DOI 10.1016/j.bbrc.2018.08.022; Kim YJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003149; Kimura T, 2000, NEUROREPORT, V11, P869, DOI 10.1097/00001756-200003200-00042; Kolsch H, 2004, NEUROSCI LETT, V368, P303, DOI 10.1016/j.neulet.2004.07.031; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kotti T, 2008, P NATL ACAD SCI USA, V105, P11394, DOI 10.1073/pnas.0805556105; Kotti TJ, 2006, P NATL ACAD SCI USA, V103, P3869, DOI 10.1073/pnas.0600316103; Kutz Stacie M, 2012, Mol Med Ther, V1, P106; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; Lao GF, 2000, NEURON, V25, P191, DOI 10.1016/S0896-6273(00)80882-X; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Lee JK, 2017, MOLECULES, V22, DOI 10.3390/molecules22081287; Li MY, 2017, NEURON, V94, P1155, DOI 10.1016/j.neuron.2017.05.022; Liang YT, 2018, CURR OPIN NEUROBIOL, V48, P113, DOI 10.1016/j.conb.2017.12.006; Libro R, 2016, LIFE SCI, V158, P78, DOI 10.1016/j.lfs.2016.06.024; Lin Z, 2018, NEUROCHEM RES, V43, P1599, DOI 10.1007/s11064-018-2574-z; Lisowski P, 2013, J MOL NEUROSCI, V50, P33, DOI 10.1007/s12031-012-9850-1; Liu SL, 2016, MOL NEUROBIOL, V53, P4328, DOI 10.1007/s12035-015-9369-x; Liu XF, 2016, DEV CELL, V38, P275, DOI 10.1016/j.devcel.2016.06.019; Lu FX, 2018, PEDIATR RES, V83, P1218, DOI 10.1038/pr.2018.49; Luchena C, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/2530414; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; Lutjohann D, 2000, J LIPID RES, V41, P195; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Luziga C, 2016, ACTA HISTOCHEM, V118, P704, DOI 10.1016/j.acthis.2016.08.003; Mahadevan V, 2017, ELIFE, V6, DOI 10.7554/eLife.28270; Markus T, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0415-2; Martinez-Moreno M, 2017, CELL REP, V20, P1950, DOI 10.1016/j.celrep.2017.07.068; MASLIAH E, 1992, BRAIN RES, V574, P312, DOI 10.1016/0006-8993(92)90831-S; Mast N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187168; Mast N, 2017, NEUROPHARMACOLOGY, V123, P465, DOI 10.1016/j.neuropharm.2017.06.026; Mast N, 2014, J BIOL CHEM, V289, P3529, DOI 10.1074/jbc.M113.532846; McEuen JG, 2008, J NEUROSCI, V28, P8169, DOI 10.1523/JNEUROSCI.0004-08.2008; Medina M, 2013, EXPERT REV NEUROTHER, V13, P495, DOI [10.1586/ERN.13.39, 10.1586/ern.13.39]; Meller R, 2008, J NEUROSCI, V28, P50, DOI 10.1523/JNEUROSCI.3474-07.2008; Miyazaki K, 2004, J BIOL CHEM, V279, P11327, DOI 10.1074/jbc.M312389200; Mohan H, 2010, BRAIN PATHOL, V20, P966, DOI 10.1111/j.1750-3639.2010.00399.x; Moutinho M, 2016, SCI REP-UK, V6, DOI 10.1038/srep30928; Moutinho M, 2015, MOL NEUROBIOL, V51, P1489, DOI 10.1007/s12035-014-8828-0; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Paul SM, 2013, J NEUROSCI, V33, P17290, DOI 10.1523/JNEUROSCI.2619-13.2013; Peers C, 2009, ANN NY ACAD SCI, V1177, P169, DOI 10.1111/j.1749-6632.2009.05026.x; Petrov AM, 2019, NEUROTHERAPEUTICS, V16, P710, DOI 10.1007/s13311-019-00737-0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pickel VM, 1996, NEUROSCIENCE, V71, P167, DOI 10.1016/0306-4522(95)00441-6; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Puchkov D, 2011, CEREB CORTEX, V21, P2217, DOI 10.1093/cercor/bhq283; Regard JB, 2004, J NEUROSCI, V24, P4092, DOI 10.1523/JNEUROSCI.4252-03.2004; Roncagalli R, 2016, J EXP MED, V213, P2437, DOI 10.1084/jem.20160579; Ronzitti G, 2014, J NEUROSCI, V34, P10603, DOI 10.1523/JNEUROSCI.0608-14.2014; Rossier-Pansier L, 2008, J CELL BIOCHEM, V103, P957, DOI 10.1002/jcb.21463; Rudrabhatla P, 2011, FASEB J, V25, P3896, DOI 10.1096/fj.11-181297; Russell DW, 2009, ANNU REV BIOCHEM, V78, P1017, DOI 10.1146/annurev.biochem.78.072407.103859; Sano T, 2018, NEUROSCI RES, V136, P33, DOI 10.1016/j.neures.2018.02.006; Schneider P, 2018, BEHAV BRAIN RES, V336, P1, DOI 10.1016/j.bbr.2017.08.032; Scott C, 2001, EUR J BIOCHEM, V268, P1084, DOI 10.1046/j.1432-1327.2001.01968.x; Sen A, 2016, J BIOL CHEM, V291, P16462, DOI 10.1074/jbc.M116.730440; Seong E, 2015, CELL ADHES MIGR, V9, P202, DOI 10.4161/19336918.2014.994919; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Shi MD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5820; Shukla V, 2013, FASEB J, V27, P174, DOI 10.1096/fj.12-217497; SIHAG RK, 1994, BRAIN RES, V656, P14, DOI 10.1016/0006-8993(94)91361-7; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Smiljanic K, 2010, HISTOCHEM CELL BIOL, V134, P159, DOI 10.1007/s00418-010-0718-6; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Storer CL, 2011, TRENDS ENDOCRIN MET, V22, P481, DOI 10.1016/j.tem.2011.08.001; Su R, 2010, NEUROSCI BULL, V26, P338, DOI 10.1007/s12264-010-0131-0; Su SC, 2012, NEURON, V75, P675, DOI 10.1016/j.neuron.2012.06.023; Sugawara Y, 2007, CELL SIGNAL, V19, P1301, DOI 10.1016/j.cellsig.2007.01.012; Sui Z, 2006, BIOCHEM BIOPH RES CO, V345, P1643, DOI 10.1016/j.bbrc.2006.05.087; Sun MY, 2016, J NEUROPHYSIOL, V115, P1263, DOI 10.1152/jn.00890.2015; Suzuki T, 2011, J NEUROCHEM, V119, P64, DOI 10.1111/j.1471-4159.2011.07404.x; Takeda K, 2007, J BIOL CHEM, V282, P7522, DOI 10.1074/jbc.M607177200; Tian GL, 2010, J NEUROCHEM, V113, P978, DOI 10.1111/j.1471-4159.2010.06661.x; Tong B. C., 2018, BIOCH BIOPHYS ACTA M; Torres VI, 2018, MOL NEUROBIOL, V55, P4513, DOI 10.1007/s12035-017-0661-9; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Urano Y, 2013, FASEB J, V27, P4305, DOI 10.1096/fj.13-231456; Vienberg SG, 2015, MOL METAB, V4, P144, DOI 10.1016/j.molmet.2014.11.003; Wang Q, 2005, FASEB J, V19, P869, DOI 10.1096/fj.04-3210fje; Wang Q, 2017, J ALZHEIMERS DIS, V56, P1525, DOI 10.3233/JAD-161032; Wang Yuying, 2010, Commun Integr Biol, V3, P172; Watanabe M, 2009, J BIOL CHEM, V284, P27980, DOI 10.1074/jbc.M109.043620; Wojsiat J, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/6435861; Woodling NS, 2014, J NEUROSCI, V34, P5882, DOI 10.1523/JNEUROSCI.0410-14.2014; Xia MQ, 1998, AM J PATHOL, V153, P31, DOI 10.1016/S0002-9440(10)65542-3; Xu HC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-499; Xu J, 2015, EMBO REP, V16, P709, DOI 10.15252/embr.201440006; Yuan L, 2017, SEMIN CELL DEV BIOL, V69, P70, DOI 10.1016/j.semcdb.2017.05.027; Zhang PJ, 2010, BIOCHEM BIOPH RES CO, V398, P457, DOI 10.1016/j.bbrc.2010.06.099; Zhong X., 2018, NEUROBIOL LEARN MEM; Zhu ZC, 2014, CARCINOGENESIS, V35, P1901, DOI 10.1093/carcin/bgu123	178	14	15	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					8782	8798		10.1096/fj.201900092R	http://dx.doi.org/10.1096/fj.201900092R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31063705	Green Published			2022-12-28	WOS:000478832900008
J	Kim, JH; Hwang, KH; Eom, M; Kim, M; Park, EY; Jeong, Y; Park, KS; Cha, SK				Kim, Ji-Hee; Hwang, Kyu-Hee; Eom, Minseob; Kim, Minseon; Park, Eun Young; Jeong, Yangsik; Park, Kyu-Sang; Cha, Seung-Kuy			WNK1 promotes renal tumor progression by activating TRPC6-NFAT pathway	FASEB JOURNAL			English	Article						renal-cell carcinoma; calcieurin; calcium signaling; phosphatidylinositol-4; 5-bishosphate	CELL CARCINOMA; CALCIUM-CHANNELS; GROWTH-FACTOR; CANCER; ENDOCYTOSIS; EXPRESSION; KINASES; PROTEIN; TRPV5; GENE	Deregulation of Ca2+ signaling has been regarded as one of the key features of cancer progression. Lysine-deficient protein kinase 1 (WNK1), a major regulator of renal ion transport, regulates Ca2+ signaling through stimulating the phosphatidylinositol 4-kinase III alpha (PI4KIII alpha) to activate G alpha q-coupled receptor/PLC-beta signaling. However, the contribution of WNK1-mediated Ca2+ signaling in the development of clear-cell renal-cell carcinoma (ccRCC) is yet unknown. We found that the canonical transient receptor potential channel (TRPC)6 was widely expressed in ccRCC tissues and functioned as a primary Ca2+ influx mechanism. We further identified that the expressions of WNK1, PI4KIII alpha, TRPC6, and the nuclear factor of activated T cells cytoplasmic 1 (NFATc1) were elevated in the tumor tissues compared with the adjacent normal tissues. WNK1 expression was directly associated with the nuclear grade of ccRCC tissues. Functional experiments showed that WNK1 activated TRPC6-mediated Ca2+ influx and current by stimulating PI4KIII alpha. Notably, the inhibition of WNK1-mediated TRPC6 activation and its downstream substrate calcineurin attenuated NFATc1 activation and the subsequent migration and proliferation of ccRCC. These findings revealed a novel perspective of WNK1 signaling in targeting the TRPC6-NFATc1 pathway as a therapeutic potential for renal-cell carcinoma.-Kim, J.-H., Hwang, K.-H., Eom, M., Kim, M., Park, E. Y., Jeong, Y., Park, K.-S., Cha, S.-K. WNK1 promotes renal tumor progression by activating TRPC6-NFAT pathway.	[Kim, Ji-Hee; Hwang, Kyu-Hee; Park, Kyu-Sang; Cha, Seung-Kuy] Yonsei Univ, Wonju Coll Med, Dept Physiol, 20 Ilsan Ro, Wonju 20426, Gangwondo, South Korea; [Kim, Ji-Hee; Hwang, Kyu-Hee; Jeong, Yangsik; Park, Kyu-Sang; Cha, Seung-Kuy] Yonsei Univ, Wonju Coll Med, Inst Lifestyle Med, Wonju, South Korea; [Kim, Ji-Hee; Hwang, Kyu-Hee; Jeong, Yangsik; Park, Kyu-Sang; Cha, Seung-Kuy] Yonsei Univ, Wonju Coll Med, Inst Mitochondrial Med, Wonju, South Korea; [Kim, Ji-Hee; Hwang, Kyu-Hee; Jeong, Yangsik; Park, Kyu-Sang; Cha, Seung-Kuy] Yonsei Univ, Wonju Coll Med, Mitohormesis Res Ctr, Wonju, South Korea; [Hwang, Kyu-Hee; Park, Kyu-Sang; Cha, Seung-Kuy] Yonsei Univ, Wonju Coll Med, Dept Global Med Sci, Wonju, South Korea; [Eom, Minseob] Yonsei Univ, Wonju Coll Med, Dept Pathol, Wonju, South Korea; [Kim, Minseon] Yonsei Univ, Wonju Coll Med, Dept Med, Wonju, South Korea; [Park, Eun Young] Yonsei Univ, Wonju Coll Med, Dept Obstet & Gynecol, Wonju, South Korea; [Jeong, Yangsik] Yonsei Univ, Wonju Coll Med, Dept Biochem, Wonju, South Korea	Yonsei University; Yonsei University; Yonsei University; Yonsei University; Yonsei University; Yonsei University; Yonsei University; Yonsei University; Yonsei University	Cha, SK (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Physiol, 20 Ilsan Ro, Wonju 20426, Gangwondo, South Korea.	skcha@yonsei.ac.kr		Park, Kyu-Sang/0000-0003-0322-9807; Kim, Ji-Hee/0000-0002-7980-4014	Myung-Sun Kim Memorial Foundation	Myung-Sun Kim Memorial Foundation	The authors thank the following professors: Chou-Long Huang (University of Iowa, Iowa City, IA, USA), Shmuel Muallem [U.S. National Institutes of Health (NIH)], and Joseph Yuan (University of North Texas, Denton, TX, USA) for materials and Dr. Sohyun Kim (Yonsei University, Wonju, Korea) for proofreading. This study was supported by a grant from the Myung-Sun Kim Memorial Foundation (2010). The authors declare no conflicts of interest.	An SW, 2011, CURR BIOL, V21, P1979, DOI 10.1016/j.cub.2011.11.002; Balla A, 2008, MOL BIOL CELL, V19, P711, DOI 10.1091/mbc.E07-07-0713; Buchholz M, 2007, CELL CYCLE, V6, P16, DOI 10.4161/cc.6.1.3650; Buchholz M, 2006, EMBO J, V25, P3714, DOI 10.1038/sj.emboj.7601246; Buttner F, 2015, EUR UROL, V68, P1016, DOI 10.1016/j.eururo.2015.05.045; Cha SK, 2013, BBA-MOL CELL RES, V1833, P3046, DOI 10.1016/j.bbamcr.2013.08.017; Cha SK, 2010, J BIOL CHEM, V285, P6604, DOI 10.1074/jbc.M109.056044; Chavez-Canales M, 2014, HYPERTENSION, V64, P1047, DOI 10.1161/HYPERTENSIONAHA.114.04036; Cheng CJ, 2011, J AM SOC NEPHROL, V22, P460, DOI 10.1681/ASN.2010060681; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Delaloy C, 2003, MOL CELL BIOL, V23, P9208, DOI 10.1128/MCB.23.24.9208-9221.2003; Finley DS, 2011, ONCOLOGIST, V16, P4, DOI 10.1634/theoncologist.2011-S2-04; Fu Y, 2006, AM J PHYSIOL-RENAL, V290, pF1305, DOI 10.1152/ajprenal.00391.2005; Goel M, 2006, AM J PHYSIOL-RENAL, V290, pF1241, DOI 10.1152/ajprenal.00376.2005; Hall DP, 2014, CANCER CELL, V26, P738, DOI 10.1016/j.ccell.2014.09.015; He GC, 2007, J CLIN INVEST, V117, P1078, DOI 10.1172/JCI30087; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hu SL, 2016, J AM SOC NEPHROL, V27, P2227, DOI 10.1681/ASN.2015121335; Jiang Y, 2007, AM J PHYSIOL-RENAL, V292, pF545, DOI 10.1152/ajprenal.00187.2006; Kim JH, 2017, J AM SOC NEPHROL, V28, P140, DOI 10.1681/ASN.2015080888; Kim JH, 2014, BIOCHEM BIOPH RES CO, V448, P76, DOI 10.1016/j.bbrc.2014.04.064; Lazrak A, 2006, P NATL ACAD SCI USA, V103, P1615, DOI 10.1073/pnas.0510609103; Maier T, 2015, BRIT J PHARMACOL, V172, P3650, DOI 10.1111/bph.13151; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; McCormick JA, 2011, PHYSIOL REV, V91, P177, DOI 10.1152/physrev.00017.2010; Moniz S, 2010, CELL MOL LIFE SCI, V67, P1265, DOI 10.1007/s00018-010-0261-6; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Monteith GR, 2017, NAT REV CANCER, V17, P367, DOI 10.1038/nrc.2017.18; Monteith GR, 2012, J BIOL CHEM, V287, P31666, DOI 10.1074/jbc.R112.343061; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Nijenhuis T, 2011, AM J PATHOL, V179, P1719, DOI 10.1016/j.ajpath.2011.06.033; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; O'Reilly M, 2006, J AM SOC NEPHROL, V17, P2402, DOI 10.1681/ASN.2005111197; Pepper K, 2007, J GEN INTERN MED, V22, P1042, DOI 10.1007/s11606-007-0189-1; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Sengelaub CA, 2016, EMBO J, V35, P62, DOI 10.15252/embj.201591973; Seo K, 2014, P NATL ACAD SCI USA, V111, P1551, DOI 10.1073/pnas.1308963111; Shekarabi M, 2017, CELL METAB, V25, P285, DOI 10.1016/j.cmet.2017.01.007; Shroff EH, 2015, P NATL ACAD SCI USA, V112, P6539, DOI 10.1073/pnas.1507228112; Song JY, 2013, MOL BIOL REP, V40, P5115, DOI 10.1007/s11033-013-2613-4; Urban N, 2012, CELL CALCIUM, V51, P194, DOI 10.1016/j.ceca.2012.01.001; Werner H, 2012, ONCOGENE, V31, P2703, DOI 10.1038/onc.2011.447; Weroha S, 2008, J MAMMARY GLAND BIOL, V13, P471, DOI 10.1007/s10911-008-9104-6; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Xu BE, 2005, P NATL ACAD SCI USA, V102, P10315, DOI 10.1073/pnas.0504422102; Yang CL, 2005, J CLIN INVEST, V115, P1379, DOI 10.1172/JCI200522452; Zhang W, 2008, AM J PHYSIOL-RENAL, V295, pF1472, DOI 10.1152/ajprenal.90229.2008	49	21	22	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8588	8599		10.1096/fj.201802019RR	http://dx.doi.org/10.1096/fj.201802019RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	31022353				2022-12-28	WOS:000476234700062
J	Koay, YC; Wali, JA; Luk, AWS; Macia, L; Cogger, VC; Pulpitel, TJ; Wahl, D; Solon-Biet, SM; Holmes, A; Simpson, SJ; O'Sullivan, JF				Koay, Yen Chin; Wali, Jibran A.; Luk, Alison W. S.; Macia, Laurence; Cogger, Victoria C.; Pulpitel, Tamara J.; Wahl, Devin; Solon-Biet, Samantha M.; Holmes, Andrew; Simpson, Stephen J.; O'Sullivan, John F.			Ingestion of resistant starch by mice markedly increases microbiome-derived metabolites	FASEB JOURNAL			English	Article						microbiome-accessible carbohydrate; plasma; metabolomics; gut microbiome	CHAIN FATTY-ACIDS; GUT MICROBIOTA; INSULIN SENSITIVITY; ENERGY-METABOLISM; OXIDATIVE STRESS; DIETARY FIBER; LIVER-DISEASE; HEALTH; GLUTATHIONE; TOLERANCE	Recent research has shown significant health benefits deriving from high-dietary fiber or microbiome-accessible carbohydrate consumption. Compared with native starch (NS), dietary resistant starch (RS) is a high microbiome-accessible carbohydrate that significantly alters the gut microbiome. The aim of this study was to determine the systemic metabolic effects of high microbiome-accessible carbohydrate. Male C57BL/6 mice were divided into 2 groups and fed either NS or RS for 18 wk (n = 20/group). Metabolomic analyses revealed that plasma levels of numerous metabolites were significantly different between the RS-fed and NS-fed mice, many of which are microbiome-derived. Most strikingly, we observed a 22-fold increase in gut microbiome-derived tryptophan metabolite indole-3-propionate (IPA), which was positively correlated with several gut microbiota, including Allobaculum, Bifidobacterium, and Lachnospiraceae, with Allobaculum having the most consistently increased abundance of all the IPA-associated taxa across all RS-fed mice. In addition, major changes were observed for metabolites solely or primarily metabolized in the gut (e.g., trimethylamine-N-oxide), metabolites that have a significant entero-hepatic circulation (i.e., bile acids), lipid metabolites (e.g., cholesterol sulfate), metabolites indicating increased energy turnover (e.g., tricarboxylic acid cycle intermediates and ketone bodies), and increased antioxidants such as reduced glutathione. Our findings reveal potentially novel mediators of high microbiome-accessible carbohydrate-derived health benefits.-Koay,Y. C., Wali. J. A., Luk, A. W. S., Macia, L., Cogger, V. C., Pulpitel, T. J., Wahl, D., Solon-Biet, S. M., Holmes, A., Simpson, S. J., O'Sullivan, J. F. Ingestion of resistant starch by mice markedly increases microbiome-derived metabolites.	[Koay, Yen Chin; Wali, Jibran A.; Luk, Alison W. S.; Macia, Laurence; Cogger, Victoria C.; Pulpitel, Tamara J.; Wahl, Devin; Solon-Biet, Samantha M.; Holmes, Andrew; Simpson, Stephen J.; O'Sullivan, John F.] Univ Sydney, Sydney Med Sch, Charles Perkins Ctr, Sydney, NSW, Australia; [Koay, Yen Chin; O'Sullivan, John F.] Univ Sydney, Sydney Med Sch, Heart Res Inst, Sydney, NSW, Australia; [Wali, Jibran A.; Luk, Alison W. S.; Pulpitel, Tamara J.; Solon-Biet, Samantha M.; Holmes, Andrew; Simpson, Stephen J.] Univ Sydney, Sydney Med Sch, Fac Sci, Sch Life & Environm Sci, Sydney, NSW, Australia; [Koay, Yen Chin; Macia, Laurence; Cogger, Victoria C.; Wahl, Devin; O'Sullivan, John F.] Univ Sydney, Sydney Med Sch, Fac Med, Sydney, NSW, Australia; [Cogger, Victoria C.] Concord Hosp, Ageing & Alzheimers Inst, Concord, NSW, Australia; [Cogger, Victoria C.] Concord Hosp, Ctr Educ & Res Ageing, Concord, NSW, Australia; [O'Sullivan, John F.] Royal Prince Alfred Hosp, Dept Cardiol, Camperdown, NSW, Australia	University of Sydney; University of Sydney; Heart Research Institute; University of Sydney; University of Sydney; Concord Repatriation General Hospital; Concord Repatriation General Hospital; University of Sydney	O'Sullivan, JF (corresponding author), Univ Sydney, Heart Res Inst, D17 Charles Perkin Ctr, Camperdown, NSW 2006, Australia.	john.osullivan@hri.org.au	Macia, laurence/D-5983-2016; Holmes, Andrew/AAI-2845-2020; Wali, Jibran/K-9843-2019; Macia, Loreto/AAN-2021-2021; Wahl, Devin/R-9621-2018; Solon-Biet, Samantha/R-6551-2017	Macia, laurence/0000-0003-0835-851X; Wali, Jibran/0000-0002-8524-5773; Macia, Loreto/0000-0002-1801-7607; Wahl, Devin/0000-0003-2794-0185; Solon-Biet, Samantha/0000-0003-0608-958X; Luk, Alison/0000-0003-1221-7023; Simpson, Stephen J./0000-0003-0256-7687	Heart Research Institute; National Health and Medical Research Council Early Career Fellowship; Diabetes Australia Project Grant [Y17G-WALJ]; University of Sydney a Beckett Fellowship; Sydney Medical School Foundation Chapman Fellowship; New South Wales Health Early-Mid Career Fellowship	Heart Research Institute(University of Sydney); National Health and Medical Research Council Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Project Grant; University of Sydney a Beckett Fellowship; Sydney Medical School Foundation Chapman Fellowship; New South Wales Health Early-Mid Career Fellowship	The authors thank Tim Dodgson (The University of Sydney) for excellent technical assistance. The authors acknowledge the technical assistance of Sydney Mass Spectrometry (SydneyMS) at The University of Sydney. This work was supported by the Heart Research Institute (to J.F.O. and Y.C.K.), National Health and Medical Research Council Early Career Fellowship (to J.A.W.), Diabetes Australia Project Grant (Y17G-WALJ to J.A.W.), University of Sydney a Beckett Fellowship (to L.M.), Sydney Medical School Foundation Chapman Fellowship (to J.F.O.), and New South Wales Health Early-Mid Career Fellowship (to J.F.O.). The authors declare no conflicts of interest.	[Anonymous], 2014, R LANG ENV STAT COMP; Barton S, 2015, FOOD FUNCT, V6, P2949, DOI [10.1039/c5fo00287g, 10.1039/C5FO00287G]; Bergeron N, 2016, BRIT J NUTR, V116, P2020, DOI 10.1017/S0007114516004165; BEUTLER E, 1985, J LAB CLIN MED, V105, P581; Bindels LB, 2015, CURR OPIN CLIN NUTR, V18, P559, DOI 10.1097/MCO.0000000000000223; Blad CC, 2012, NAT REV DRUG DISCOV, V11, P603, DOI 10.1038/nrd3777; Borrelli A, 2018, REDOX BIOL, V15, P467, DOI 10.1016/j.redox.2018.01.009; BROWNE JL, 1977, PROC R SOC SER B-BIO, V195, P307, DOI 10.1098/rspb.1977.0011; BROWNE JL, 1978, PROC R SOC SER B-BIO, V200, P117, DOI 10.1098/rspb.1978.0010; Calabrese V, 2012, BBA-MOL BASIS DIS, V1822, P729, DOI 10.1016/j.bbadis.2011.12.003; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cervenka I, 2017, SCIENCE, V357, DOI 10.1126/science.aaf9794; Cusi K, 2016, DIABETOLOGIA, V59, P1112, DOI 10.1007/s00125-016-3952-1; Davila AM, 2013, PHARMACOL RES, V68, P95, DOI 10.1016/j.phrs.2012.11.005; De Haen Paul, 1944, JOUR AMER PHARM ASSOC SCI ED, V33, P161; de Mello VD, 2017, SCI REP-UK, V7, DOI 10.1038/srep46337; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Devaraj S, 2013, CLIN CHEM, V59, P617, DOI 10.1373/clinchem.2012.187617; Dickert S, 2002, MOL MICROBIOL, V44, P49, DOI 10.1046/j.1365-2958.2002.02867.x; Dodd D, 2017, NATURE, V551, P648, DOI 10.1038/nature24661; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eren AM, 2015, ISME J, V9, P968, DOI 10.1038/ismej.2014.195; Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y; Fuentes-Zaragoza E, 2011, STARCH-STARKE, V63, P406, DOI 10.1002/star.201000099; Fukiya S, 2009, FEMS MICROBIOL LETT, V293, P263, DOI 10.1111/j.1574-6968.2009.01531.x; GLORE SR, 1994, J AM DIET ASSOC, V94, P425, DOI 10.1016/0002-8223(94)90099-X; Holmes AJ, 2017, CELL METAB, V25, P140, DOI 10.1016/j.cmet.2016.10.021; Jakobsdottir G, 2014, NUTRITION, V30, P497, DOI 10.1016/j.nut.2013.08.013; Janssen AWF, 2015, FASEB J, V29, P3111, DOI 10.1096/fj.14-269514; Johnston KL, 2010, DIABETIC MED, V27, P391, DOI 10.1111/j.1464-5491.2010.02923.x; JULIUS M, 1994, J CLIN EPIDEMIOL, V47, P1021, DOI 10.1016/0895-4356(94)90117-1; Kaczmarczyk MM, 2012, METABOLISM, V61, P1058, DOI 10.1016/j.metabol.2012.01.017; Keenan MJ, 2015, ADV NUTR, V6, P198, DOI 10.3945/an.114.007419; Kieffer DA, 2016, J NUTR, V146, P2476, DOI 10.3945/jn.116.238931; Krajmalnik-Brown R, 2012, NUTR CLIN PRACT, V27, P201, DOI 10.1177/0884533611436116; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Levine ME, 2014, CELL METAB, V19, P407, DOI 10.1016/j.cmet.2014.02.006; Li J, 2003, METABOLISM, V52, P1206, DOI 10.1016/S0026-0495(03)00159-8; Lunn J, 2007, NUTR BULL, V32, P21, DOI 10.1111/j.1467-3010.2007.00616.x; Maki KC, 2012, J NUTR, V142, P717, DOI 10.3945/jn.111.152975; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Mardinoglu A, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156487; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Menni C, 2017, INT J OBESITY, V41, P1099, DOI 10.1038/ijo.2017.66; Nuttall SL, 1998, LANCET, V351, P645, DOI 10.1016/S0140-6736(05)78428-2; O'Sullivan J., 2016, CIRCULATION, V134, pA13814, DOI [10.1161/circ.134, DOI 10.1161/CIRC.134]; Patsch C, 2015, NAT CELL BIOL, V17, P994, DOI 10.1038/ncb3205; Piper MDW, 2011, CELL METAB, V14, P154, DOI 10.1016/j.cmet.2011.06.013; Ravussin Y, 2012, OBESITY, V20, P738, DOI 10.1038/oby.2011.111; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Robertson MD, 2005, AM J CLIN NUTR, V82, P559, DOI 10.1093/ajcn/82.3.559; Rowland I, 2018, EUR J NUTR, V57, P1, DOI 10.1007/s00394-017-1445-8; Sanchez G., 2012, PLSDEPOT PARTIAL LEA; Schonfeld P, 2016, J LIPID RES, V57, P943, DOI 10.1194/jlr.R067629; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shapiro H, 2018, J EXP MED, V215, P383, DOI 10.1084/jem.20171965; Slavin J, 2013, NUTRIENTS, V5, P1417, DOI 10.3390/nu5041417; Solanky KS, 2005, J NUTR BIOCHEM, V16, P236, DOI 10.1016/j.jnutbio.2004.12.005; Solon-Biet SM, 2016, CELL METAB, V24, P555, DOI 10.1016/j.cmet.2016.09.001; Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009; Stamler JS, 1996, NUTR REV, V54, P1; Tachon S, 2013, FEMS MICROBIOL ECOL, V83, P299, DOI 10.1111/j.1574-6941.2012.01475.x; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Thaiss CA, 2016, CELL, V167, P1495, DOI 10.1016/j.cell.2016.11.003; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Torell F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129260; van den Boogaart KG, 2018, COMPOSITIONS COMPOSI; Velasquez MT, 2016, TOXINS, V8, DOI 10.3390/toxins8110326; Vital M, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01562-18; Warren CR, 2017, CELL STEM CELL, V20, P547, DOI 10.1016/j.stem.2017.01.010; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Wlodarska M, 2017, CELL HOST MICROBE, V22, P25, DOI 10.1016/j.chom.2017.06.007; WOLFFRAM S, 1990, J NUTR, V120, P767, DOI 10.1093/jn/120.7.767; Wu W.-K., 2018, GUT; Zhou JN, 2012, MOL NUTR FOOD RES, V56, P515, DOI 10.1002/mnfr.201100521	80	24	26	9	62	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8033	8042		10.1096/fj.201900177R	http://dx.doi.org/10.1096/fj.201900177R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30925066	Bronze			2022-12-28	WOS:000476234700019
J	Lofthouse, EM; Torrens, C; Manousopoulou, A; Nahar, M; Cleal, JK; O'Kelly, IM; Sengers, BG; Garbis, SD; Lewis, RM				Lofthouse, Emma M.; Torrens, Christopher; Manousopoulou, Antigoni; Nahar, Monica; Cleal, Jane K.; O'Kelly, Ita M.; Sengers, Bram G.; Garbis, Spiros D.; Lewis, Rohan M.			Ursodeoxycholic acid inhibits uptake and vasoconstrictor effects of taurocholate in human placenta	FASEB JOURNAL			English	Article						OATP4A1; membrane transport; vasoconstriction	INTRAHEPATIC-CHOLESTASIS; BILE-ACIDS; PREGNANCY; MODEL	Intrahepatic cholestasis of pregnancy (ICP) causes increased transfer of maternal bile acids to the fetus and an increased incidence of sudden fetal death. Treatment includes ursodeoxycholic acid (UDCA), but it is not clear if UDCA protects the fetus. This study explores the placental transport of the bile acid taurocholate (TC) by the organic anion-transporting polypeptide, (OATP)4A1, its effects on the placental proteome and vascular function, and how these are modified by UDCA. Various methodological approaches including placental villous fragments and Xenopus laevis oocytes were used to investigate UDCA transport. Placental perfusions and myography investigated the effect of TC on vasculature. The effects of acute TC exposure on placental tissue were investigated using quantitative proteomics. UDCA inhibited OATP4A1 activity in placental villous fragments and oocytes. TC induced vasoconstriction in placental and rat vasculature, which was attenuated by UDCA. Quantitative proteomic analysis of villous fragments showed direct effects of TC on multiple placental pathways, including oxidative stress and autophagy. The effects of TC on the placental proteome and vasculature demonstrate how bile acids may cause fetal distress in ICP. UDCA inhibition of OATP4A1 suggests it will protect the mother and fetus against the vascular effects of TC by inhibiting its cellular uptake. UDCA may protect the fetus in ICP by inhibiting OATP4A1-mediated bile acid transfer and TC-induced placental vasoconstriction. Understanding the physiologic mechanisms of UDCA may allow better therapeutic interventions to be designed specifically for the fetus in the future.-Lofthouse, E. M., Torrens, C., Manousopoulou, A., Nahar, M., Cleal, J. K., O'Kelly, I. M., Sengers, B. G., Garbis, S. D., Lewis, R. M. Ursodeoxycholic acid inhibits uptake and vasoconstrictor effects of taurocholate in human placenta.	[Lofthouse, Emma M.; Torrens, Christopher; Manousopoulou, Antigoni; Nahar, Monica; Cleal, Jane K.; O'Kelly, Ita M.; Garbis, Spiros D.; Lewis, Rohan M.] Univ Southampton, Fac Med, Southampton, Hants, England; [Lofthouse, Emma M.; Torrens, Christopher; Sengers, Bram G.; Garbis, Spiros D.; Lewis, Rohan M.] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Cleal, Jane K.; Sengers, Bram G.] Univ Southampton, Fac Engn, Southampton, Hants, England; [Garbis, Spiros D.] CALTECH, Beckman Inst, Div Biol & Biol Engn, Proteome Explorat Lab, Pasadena, CA 91125 USA	University of Southampton; University of Southampton; University of Southampton; California Institute of Technology	Lofthouse, EM (corresponding author), Univ Southampton, Southampton Gen Hosp, Fac Med, MP 887 IDS Bldg,Tremona Rd, Southampton SO16 6YD, Hants, England.	e.m.lofthouse@soton.ac.uk	Cleal, Jane/AAC-9070-2019; Cleal, Jane/AAC-5062-2019; Lewis, Rohan/C-9350-2011; Garbis, Spiros/L-3099-2013	Cleal, Jane/0000-0001-7978-4327; Lewis, Rohan/0000-0003-4044-9104; Lofthouse, Emma/0000-0002-0175-5590; Garbis, Spiros/0000-0002-1050-0805	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L020823/1, BB/R002762/1]; BBSRC [BB/R002762/1, BB/L020823/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank the midwives at the Princess Anne Hospital (Southampton, United Kingdom) for their assistance in collecting placentas. This work was funded by project grants from the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/L020823/1 and BB/R002762/1). The authors declare no conflicts of interest.	Ajouz H, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-164; Chappell LC, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k104; Cleal JK, 2011, J PHYSIOL-LONDON, V589, P987, DOI 10.1113/jphysiol.2010.198549; Desai MS, 2013, HEART, V99, P1629, DOI 10.1136/heartjnl-2013-304546; Dolinsky BM, 2014, J REPROD MED, V59, P367; Estiu MC, 2015, BRIT J CLIN PHARMACO, V79, P316, DOI 10.1111/bcp.12480; Fujiwara K, 2001, ENDOCRINOLOGY, V142, P2005, DOI 10.1210/en.142.5.2005; Geenes VL, 2011, PLACENTA, V32, P1026, DOI 10.1016/j.placenta.2011.09.006; Geenes V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083828; Geenes V, 2014, HEPATOLOGY, V59, P1482, DOI 10.1002/hep.26617; Ghosh Sangita, 2013, Indian J Dermatol, V58, P327, DOI 10.4103/0019-5154.113971; Gorelik J, 2002, CLIN SCI, V103, P191, DOI 10.1042/cs1030191; Gu H., 2017, HAINAN YIXUEYUAN XUE, V23, P70; Imai Y, 2003, MOL PHARMACOL, V64, P610, DOI 10.1124/mol.64.3.610; Joutsiniemi T, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0324-0; Lee P, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-1; Lofthouse EM, 2018, BIOCHEM BIOPH RES CO, V506, P237, DOI 10.1016/j.bbrc.2018.10.074; MANDRUZZATO GP, 1991, ULTRASOUND OBST GYN, V1, P192, DOI 10.1046/j.1469-0705.1991.01030192.x; Manousopoulou A, 2017, NEUROPATH APPL NEURO, V43, P492, DOI 10.1111/nan.12342; Manousopoulou A, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.10; Miragoli M, 2011, HEPATOLOGY, V54, P1282, DOI 10.1002/hep.24492; Papacleovoulou G, 2013, J CLIN INVEST, V123, P3172, DOI 10.1172/JCI68927; Patel P, 2003, PLACENTA, V24, P39, DOI 10.1053/plac.2002.0879; Patel S, 2014, FETAL PEDIATR PATHOL, V33, P210, DOI 10.3109/15513815.2014.899413; Roma MG, 2011, CLIN SCI, V121, P523, DOI 10.1042/CS20110184; SCHNEIDE.H, 1972, AM J OBSTET GYNECOL, V114, P822, DOI 10.1016/0002-9378(72)90909-X; SEPULVEDA WH, 1991, EUR J OBSTET GYN R B, V42, P211, DOI 10.1016/0028-2243(91)90222-7; Shemer EW, 2013, BJOG-INT J OBSTET GY, V120, P717, DOI 10.1111/1471-0528.12174; SHNEIDER BL, 1993, J BIOL CHEM, V268, P6985; Wang H., 2014, J INT OBSTET GYNECOL, V41, P692; Williamson C, 2001, CLIN SCI, V100, P363, DOI 10.1042/CS20000164; Xia YM, 2018, BIOPHARM DRUG DISPOS, V39, P335, DOI 10.1002/bdd.2150; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083281; Zhang YH, 2016, J MOL CELL BIOL, V8, P530, DOI 10.1093/jmcb/mjw025	34	18	19	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8211	8220		10.1096/fj.201900015RR	http://dx.doi.org/10.1096/fj.201900015RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30922127	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000476234700033
J	Sakuma, M; Khan, MAS; Yasuhara, S; Martyn, JA; Palaniyar, N				Sakuma, Miyuki; Khan, Mohammed A. S.; Yasuhara, Shingo; Martyn, Jeevendra A.; Palaniyar, Nades			Mechanism of pulmonary immunosuppression: extrapulmonary burn injury suppresses bacterial endotoxin-induced pulmonary neutrophil recruitment and neutrophil extracellular trap (NET) formation	FASEB JOURNAL			English	Article						lung; animal model; cytokines; LPS	INFLAMMATORY CYTOKINES; IMPROVES SURVIVAL; FAMILY CYTOKINES; IL-12 FAMILY; TH17 CELLS; T-CELLS; LUNG; LIPOPOLYSACCHARIDE; DIFFERENTIATION; INTERLEUKIN-6	Pulmonary immunosuppression often occurs after burn injury (BI). However, the reasons for BI-induced pulmonary immunosuppression are not clearly understood. Neutrophil recruitment and neutrophil extracellular trap (NET) formation (NETosis) are important components of a robust pulmonary immune response, and we hypothesized that pulmonary inflammation and NETosis are defective after BI. To test this hypothesis, we established a mouse model with intranasal LPS instillation in the presence or absence of BI (15% of body surface burn) and determined the degree of immune cell infiltration, NETosis, and the cytokine levels in the airways and blood on d 2. Presence of LPS recruited monocytes and large numbers of neutrophils to the airways and induced NETosis (citrullinated histone H3, DNA, myeloperoxidase). By contrast, BI significantly reduced LPS-mediated leukocyte recruitment and NETosis. This BI-induced immunosuppression is attributable to the reduction of chemokine (C-C motif) ligand (CCL) 2 (monocyte chemoattractant protein 1) and CCL3 (macrophage inflammatory protein 1 alpha). BI also suppressed LPS-induced increase in IL-17A, IL-17C, and IL-17E/IL-25 levels in the airways. Therefore, BI-mediated reduction in leukocyte recruitment and NETosis in the lungs are attributable to these cytokines. Regulating the levels of some of these key cytokines represents a potential therapeutic option for mitigating BI-mediated pulmonary immunosuppression.	[Sakuma, Miyuki; Khan, Mohammed A. S.; Yasuhara, Shingo; Martyn, Jeevendra A.; Palaniyar, Nades] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Sakuma, Miyuki; Khan, Mohammed A. S.; Yasuhara, Shingo; Martyn, Jeevendra A.; Palaniyar, Nades] Harvard Med Sch, Shriners Hosp Children Boston, Boston, MA 02115 USA; [Palaniyar, Nades] Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Toronto, ON, Canada; [Palaniyar, Nades] Univ Toronto, Inst Med Sci, Dept Lab Med & Pathobiol, Fac Med, Toronto, ON, Canada	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Palaniyar, N (corresponding author), Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Program Translat Med, 686 Bay St, Toronto, ON M5G0A4, Canada.	nades.palaniyar@sickkids.ca	Sakuma, Miyuki/ABA-3498-2021	Palaniyar, Nades/0000-0002-2170-8548	Centre for the Study of Inflammatory Bowel Disease [DK043351]; Boston Area Diabetes and Endocrinology Research Center (BADERC) Award [DK057521]; U.S. National Institutes of Health (NIH) Shared Instrumentation Grant [1S10OD021577-01]; Canadian Institutes of Health Research [MOP-111012]; NIH National Institute of General Medical Sciences Grant [RO1 GM 11847]; Shriners Hospital Philanthropy [86300, 85124]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, P30DK057521] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021577] Funding Source: NIH RePORTER	Centre for the Study of Inflammatory Bowel Disease; Boston Area Diabetes and Endocrinology Research Center (BADERC) Award; U.S. National Institutes of Health (NIH) Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH National Institute of General Medical Sciences Grant; Shriners Hospital Philanthropy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Most of the work for this study was performed at Shriners Hospitals for Children-Boston. The authors thank Dr. YongMing Yu and Dr. Sarah S. Kelangi (Massachusetts General Hospital and Shriners Hospitals for Children-Boston) for administrative support. The authors also thank the Scadden laboratory (Massachusetts General Hospital) for the use their equipment. Animals were housed at Center for Comparative Medicine (CCM) in Shriners Hospitals for Children-Boston. Immunofluorescent imaging was performed at the Microscopy Core of the Program in Membrane Biology, which is partially supported by a Centre for the Study of Inflammatory Bowel Disease Grant DK043351 and Boston Area Diabetes and Endocrinology Research Center (BADERC) Award DK057521. The Zeiss LSM 800 Airyscan confocal microscope was purchased using U.S. National Institutes of Health (NIH) Shared Instrumentation Grant 1S10OD021577-01. Pulmonary neutrophil extracellular trap formation (NETosis) studies of N.P. were supported by Canadian Institutes of Health Research (MOP-111012). This work was also partially supported by NIH National Institute of General Medical Sciences Grant RO1 GM 11847, and from Shriners Hospital Philanthropy (86300 and 85124 to J.A.M.). The authors thank Dr. Anil V. Nair and Dr. Richard Bouley (both from Massachusetts General Hospital) for technical support at the Core. Meso scale analysis was performed at the Metabolism and Mitochondrial Research Core (Beth Israel Deaconess Medical Center, Boston, MA, USA). The authors also thank Dr. Xiaowen Liu (Beth Israel Deaconess Medical Center) for technical support at the Core. The authors declare no conflicts of interest.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; American Burn Association, BURN INC TREATM US; Balamayooran G, 2010, AM J RESP CELL MOL, V43, P5, DOI 10.1165/rcmb.2009-0047TR; Barner M, 1998, CURR BIOL, V8, P669, DOI 10.1016/S0960-9822(98)70256-8; Berard M, 2003, J IMMUNOL, V170, P5018, DOI 10.4049/jimmunol.170.10.5018; Berger A, 2000, BRIT MED J, V321, P424, DOI 10.1136/bmj.321.7258.424; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Campanella GSV, 2006, J IMMUNOL, V177, P6991, DOI 10.4049/jimmunol.177.10.6991; Cayrol C, 2018, IMMUNOL REV, V281, P154, DOI 10.1111/imr.12619; Cheng OZ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00001; Colgan J, 2006, NAT IMMUNOL, V7, P899, DOI 10.1038/ni0906-899; Cooper AM, 2007, TRENDS IMMUNOL, V28, P33, DOI 10.1016/j.it.2006.11.002; Cortjens B, 2016, J PATHOL, V238, P401, DOI 10.1002/path.4660; Cruikshank W, 2008, CRIT REV IMMUNOL, V28, P467; Davis CS, 2012, J BURN CARE RES, V33, P26, DOI 10.1097/BCR.0b013e318234d903; Delgado-Rizo V, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00081; Ding FX, 2018, CELL PHYSIOL BIOCHEM, V46, P1263, DOI 10.1159/000489109; DOERSCHUK CM, 1987, J APPL PHYSIOL, V63, P1806, DOI 10.1152/jappl.1987.63.5.1806; Douda DN, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-29; Douda DN, 2011, J IMMUNOL, V187, P1856, DOI 10.4049/jimmunol.1004201; Ethuin F, 2004, LAB INVEST, V84, P1363, DOI 10.1038/labinvest.3700148; Farrera C, 2013, J IMMUNOL, V191, P2647, DOI 10.4049/jimmunol.1300436; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Fillion I, 2001, J IMMUNOL, V166, P7353, DOI 10.4049/jimmunol.166.12.7353; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Griffin GK, 2012, J IMMUNOL, V188, P6287, DOI 10.4049/jimmunol.1200385; Gu CF, 2013, CYTOKINE, V64, P477, DOI 10.1016/j.cyto.2013.07.022; Guillot L, 2008, INFECT IMMUN, V76, P4745, DOI 10.1128/IAI.00341-08; Gupta S, 1996, AM J RESP CELL MOL, V15, P656, DOI 10.1165/ajrcmb.15.5.8918372; Gurczynski SJ, 2018, AM J PHYSIOL-LUNG C, V314, pL6, DOI 10.1152/ajplung.00344.2017; Hampson P, 2017, ANN SURG, V265, P1241, DOI 10.1097/SLA.0000000000001807; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; HOGG JC, 1987, PHYSIOL REV, V67, P1249, DOI 10.1152/physrev.1987.67.4.1249; HUANG S, 1992, AM J PATHOL, V141, P981; Hur J, 2015, ANN LAB MED, V35, P105, DOI 10.3343/alm.2015.35.1.105; Inatsu A, 2011, J IMMUNOL, V187, P2155, DOI 10.4049/jimmunol.1003235; Inoue G, 2000, J Infect Chemother, V6, P51, DOI 10.1007/s101560050050; Iwasaki Y, 2015, INT J MOL SCI, V16, P2851, DOI 10.3390/ijms16022851; Jakiela B, 2012, RHEUMATOLOGY, V51, P1887, DOI 10.1093/rheumatology/kes171; Kang JW, 2017, AM J PHYSIOL-LUNG C, V313, pL466, DOI 10.1152/ajplung.00103.2017; Kariya S, 2013, LARYNGOSCOPE, V123, P1514, DOI 10.1002/lary.23795; Kaufman T, 2017, CLIN IMMUNOL, V183, P254, DOI 10.1016/j.clim.2017.08.014; Kelly E, 2002, J IMMUNOL, V168, P597, DOI 10.4049/jimmunol.168.2.597; Khan MAS, 2017, SHOCK, V48, P227, DOI 10.1097/SHK.0000000000000849; Khan MAS, 2012, SHOCK, V38, P213, DOI 10.1097/SHK.0b013e31825d628c; Kim A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040758; Korkmaz HI, 2017, WOUND REPAIR REGEN, V25, P609, DOI 10.1111/wrr.12560; Kundu-Raychaudhuri S, 2016, CYTOKINE, V79, P45, DOI 10.1016/j.cyto.2015.12.020; Laan M, 1999, J IMMUNOL, V162, P2347; Lai H, 2010, J AEROSOL MED PULM D, V23, P219, DOI 10.1089/jamp.2009.0802; Lee HY, 2011, SHOCK, V36, P580, DOI 10.1097/SHK.0b013e3182366872; Lenzo JC, 2012, IMMUNOL CELL BIOL, V90, P429, DOI 10.1038/icb.2011.58; Lin F, 2004, BIOCHEM BIOPH RES CO, V319, P576, DOI 10.1016/j.bbrc.2004.05.029; Liu H, 2019, BIOL OPEN, V8, DOI 10.1242/bio.046342; Ma L, 2019, SHOCK, V51, P569, DOI 10.1097/SHK.0000000000001300; Martinez GJ, 2008, ANN NY ACAD SCI, V1143, P188, DOI 10.1196/annals.1443.021; Masuda S, 2016, CLIN CHIM ACTA, V459, P89, DOI 10.1016/j.cca.2016.05.029; Neely CJ, 2011, J TRAUMA, V70, P681, DOI 10.1097/TA.0b013e31820d18a6; Ovrevik J, 2009, TOXICOLOGY, V259, P46, DOI 10.1016/j.tox.2009.01.028; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; PRUITT BA, 1975, J TRAUMA, V15, P369; Pujic R, 2007, EUR J PHARMACOL, V557, P230, DOI 10.1016/j.ejphar.2006.11.023; Rathore JS, 2016, VACCINE, V34, P1504, DOI 10.1016/j.vaccine.2016.02.021; Reber LL, 2017, J EXP MED, V214, P1249, DOI 10.1084/jem.20161238; Rendon JL, 2012, J LEUKOCYTE BIOL, V92, P529, DOI 10.1189/jlb.0212083; Rimington Tracy L, 2017, F1000Res, V6, P460, DOI 10.12688/f1000research.10961.1; Rittirsch D, 2008, J IMMUNOL, V180, P7664, DOI 10.4049/jimmunol.180.11.7664; Robins E V, 1989, Crit Care Nurs Clin North Am, V1, P767; Sasaki JR, 2011, BURNS, V37, P646, DOI 10.1016/j.burns.2011.01.028; Schwacha MG, 2002, INT J MOL MED, V10, P239; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Sedgwick JB, 2002, J ALLERGY CLIN IMMUN, V110, P752, DOI 10.1067/mai.2002.128581; Silva L, 2016, Ann Burns Fire Disasters, V29, P178; Singer M, 2004, J IMMUNOL, V173, P4197, DOI 10.4049/jimmunol.173.6.4197; SMITH RE, 1995, J LEUKOCYTE BIOL, V57, P782, DOI 10.1002/jlb.57.5.782; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Sun L, 2015, CYTOKINE, V75, P249, DOI 10.1016/j.cyto.2015.01.030; Takei H, 1996, J LEUKOCYTE BIOL, V59, P229, DOI 10.1002/jlb.59.2.229; Tanimoto N, 2007, BIOCHEM BIOPH RES CO, V361, P533, DOI 10.1016/j.bbrc.2007.07.060; Thorley AJ, 2005, AM J RESP CELL MOL, V32, P262, DOI 10.1165/rcmb.2004-0196OC; Thurley K, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004206; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Tsai HC, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/267971; VANOTTEREN GM, 1994, AM J RESP CELL MOL, V10, P8, DOI 10.1165/ajrcmb.10.1.8292385; Vermeer PD, 2003, AM J RESP CELL MOL, V28, P286, DOI 10.1165/rcmb.4887; Vlahos R, 2010, AM J RESP CRIT CARE, V182, P34, DOI 10.1164/rccm.200912-1794OC; Whittaker L, 2002, AM J RESP CELL MOL, V27, P593, DOI 10.1165/rcmb.4838; Williams AE, 2017, THORAX, V72, P66, DOI 10.1136/thoraxjnl-2016-208597; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wright JF, 2008, J IMMUNOL, V181, P2799, DOI 10.4049/jimmunol.181.4.2799; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Xu S, 2010, CELL MOL IMMUNOL, V7, P164, DOI 10.1038/cmi.2010.21; Yildiz C, 2015, ANESTHESIOLOGY, V122, P864, DOI 10.1097/ALN.0000000000000605; Yipp BG, 2013, BLOOD, V122, P2784, DOI 10.1182/blood-2013-04-457671; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Zhang Y, 2014, ADV EXP MED BIOL, V841, P15, DOI 10.1007/978-94-017-9487-9_2	97	7	7	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13602	13616		10.1096/fj.201901098R	http://dx.doi.org/10.1096/fj.201901098R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31577450	Green Published, Bronze			2022-12-28	WOS:000507466100044
J	Collodet, C; Foretz, M; Deak, M; Bultot, L; Metairon, S; Viollet, B; Lefebvre, G; Raymond, F; Parisi, A; Civiletto, G; Gut, P; Descombes, P; Sakamoto, K				Collodet, Caterina; Foretz, Marc; Deak, Maria; Bultot, Laurent; Metairon, Sylviane; Viollet, Benoit; Lefebvre, Gregory; Raymond, Frederic; Parisi, Alice; Civiletto, Gabriele; Gut, Philipp; Descombes, Patrick; Sakamoto, Kei			AMPK promotes induction of the tumor suppressor FLCN through activation of TFEB independently of mTOR	FASEB JOURNAL			English	Article						AICAR; 991; folliculin; folliculin interacting protein; Birt-Hogg-Dube syndrome	PROTEIN-KINASE ACTIVATOR; GLUCOSE-UPTAKE; TRANSCRIPTION FACTORS; LYSOSOMAL BIOGENESIS; THERAPEUTIC TARGET; LIPID-METABOLISM; STRUCTURAL BASIS; IMMUNE-RESPONSE; AICA RIBOSIDE; ENERGY SENSOR	AMPK is a central regulator of energy homeostasis. AMPK not only elicits acute metabolic responses but also promotes metabolic reprogramming and adaptations in the long-term through regulation of specific transcription factors and coactivators. We performed a whole-genome transcriptome profiling in wild-type (WT) and AMPK-deficient mouse embryonic fibroblasts (MEFs) and primary hepatocytes that had been treated with 2 distinct classes of small-molecule AMPK activators. We identified unique compound-dependent gene expression signatures and several AMPK-regulated genes, including folliculin (Flcn), which encodes the tumor suppressor FLCN. Bioinformatics analysis highlighted the lysosomal pathway and the associated transcription factor EB (TFEB) as a key transcriptional mediator responsible for AMPK responses. AMPK-induced Flcn expression was abolished in MEFs lacking TFEB and transcription factor E3, 2 transcription factors with partially redundant function; additionally, the promoter activity of Flcn was profoundly reduced when its putative TFEB-binding site was mutated. The AMPK-TFEB-FLCN axis is conserved across species; swimming exercise in WT zebrafish induced Flcn expression in muscle, which was significantly reduced in AMPK-deficient zebrafish. Mechanistically, we have found that AMPK promotes dephosphorylation and nuclear localization of TFEB independently of mammalian target of rapamycin activity. Collectively, we identified the novel AMPK-TFEB-FLCN axis, which may function as a key cascade for cellular and metabolic adaptations.	[Collodet, Caterina; Deak, Maria; Bultot, Laurent; Metairon, Sylviane; Lefebvre, Gregory; Raymond, Frederic; Parisi, Alice; Civiletto, Gabriele; Gut, Philipp; Descombes, Patrick; Sakamoto, Kei] Ecole Polytech, Nestle Res, Lausanne, Switzerland; [Collodet, Caterina; Descombes, Patrick; Sakamoto, Kei] Ecole Polytech Fed Lausanne, Sch Life Sci, Innovat Pk, Lausanne, Switzerland; [Foretz, Marc; Viollet, Benoit] Inst Cochin, INSERM, Unit e 1016, Paris, France; [Foretz, Marc; Viollet, Benoit] CNRS, UMR 8104, Paris, France; [Foretz, Marc; Viollet, Benoit] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Bultot, Laurent] Catholic Univ Louvain, Inst Rech Expt & Clin, Pole Rech Cardiovasc, Brussels, Belgium	Nestle SA; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite Catholique Louvain	Sakamoto, K (corresponding author), Ecole Polytech Fed Lausanne, Nestle Res, Innovat Pk,B atiment H, CH-1015 Lausanne, Switzerland.	kei.sakamoto@rd.nestle.com	Viollet, Benoit/N-2397-2019; FORETZ, Marc/O-7334-2017; Viollet, Benoit/O-6927-2017; Sakamoto, Kei/C-8806-2019	Viollet, Benoit/0000-0002-0121-0224; FORETZ, Marc/0000-0001-7017-9032; Viollet, Benoit/0000-0002-0121-0224; Sakamoto, Kei/0000-0001-8839-5980; Lefebvre, Greg/0000-0001-7519-2316; Raymond, Frederic/0000-0002-6148-6898; Collodet, Caterina/0000-0002-2332-4599; Gut, Philipp/0000-0002-0689-9518				Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; Benziane B, 2009, AM J PHYSIOL-CELL PH, V297, pC1554, DOI 10.1152/ajpcell.00010.2009; Brady OA, 2018, AUTOPHAGY, V14, P181, DOI 10.1080/15548627.2017.1313943; Bultot L, 2016, AM J PHYSIOL-ENDOC M, V311, pE706, DOI 10.1152/ajpendo.00237.2016; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Coughlan KA, 2014, DIABET METAB SYND OB, V7, P241, DOI 10.2147/DMSO.S43731; Day EA, 2017, TRENDS ENDOCRIN MET, V28, P545, DOI 10.1016/j.tem.2017.05.004; Ducommun S, 2019, CELL SIGNAL, V57, P45, DOI 10.1016/j.cellsig.2019.02.001; Ducommun S, 2015, CELL SIGNAL, V27, P978, DOI 10.1016/j.cellsig.2015.02.008; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032; Gilbert MJH, 2014, EXP GERONTOL, V50, P106, DOI 10.1016/j.exger.2013.11.013; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Gowans GJ, 2013, CELL METAB, V18, P556, DOI 10.1016/j.cmet.2013.08.019; Green GH, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1302; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Guigas B, 2009, IUBMB LIFE, V61, P18, DOI 10.1002/iub.135; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Hellemans J, 2014, METHODS MOL BIOL, V1160, P19, DOI 10.1007/978-1-4939-0733-5_3; Hoffman NJ, 2015, CELL METAB, V22, P922, DOI 10.1016/j.cmet.2015.09.001; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hunter RW, 2018, NAT MED, V24, P1395, DOI 10.1038/s41591-018-0159-7; Hunter RW, 2014, CHEM BIOL, V21, P866, DOI 10.1016/j.chembiol.2014.05.014; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Lai YC, 2014, BIOCHEM J, V460, P363, DOI 10.1042/BJ20131673; Langendorf CG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10912; Li XJ, 2017, MOL CELL, V66, P684, DOI 10.1016/j.molcel.2017.04.026; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Mansueto G, 2017, CELL METAB, V25, P182, DOI 10.1016/j.cmet.2016.11.003; Martina JA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004754; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Moreno D, 2008, FEBS LETT, V582, P2650, DOI 10.1016/j.febslet.2008.06.044; Myers RW, 2017, SCIENCE, V357, P507, DOI 10.1126/science.aah5582; Napolitano G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05862-6; Napolitano G, 2016, J CELL SCI, V129, P2475, DOI 10.1242/jcs.146365; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Pastore N, 2017, EMBO MOL MED, V9, P605, DOI 10.15252/emmm.201607204; Possik E, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005520; Raben N, 2016, ANNU REV CELL DEV BI, V32, P255, DOI 10.1146/annurev-cellbio-111315-125407; Salatto CT, 2017, J PHARMACOL EXP THER, V361, P303, DOI 10.1124/jpet.116.237925; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schaffer BE, 2015, CELL METAB, V22, P907, DOI 10.1016/j.cmet.2015.09.009; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Thomson DM, 2008, J APPL PHYSIOL, V104, P429, DOI 10.1152/japplphysiol.00900.2007; Treebak JT, 2009, AM J PHYSIOL-CELL PH, V297, pC1041, DOI 10.1152/ajpcell.00051.2009; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vincent MF, 1996, DIABETOLOGIA, V39, P1148, DOI 10.1007/BF02658500; Wada S, 2016, GENE DEV, V30, P2551, DOI 10.1101/gad.287953.116; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Wu J, 2013, J BIOL CHEM, V288, P35904, DOI 10.1074/jbc.M113.508747; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Yan M, 2016, GENE DEV, V30, P1034, DOI 10.1101/gad.281410.116; Yan M, 2014, J CLIN INVEST, V124, P2640, DOI 10.1172/JCI71749; Young NP, 2016, GENE DEV, V30, P535, DOI 10.1101/gad.274142.115; Zibrova D, 2017, BIOCHEM J, V474, P983, DOI 10.1042/BCJ20160980	80	35	37	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12374	12391		10.1096/fj.201900841R	http://dx.doi.org/10.1096/fj.201900841R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31404503	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000507461600061
J	Logun, MT; Wynens, KE; Simchick, G; Zhao, WJ; Mao, LD; Zhao, Q; Mukherjee, S; Brat, DJ; Karumbaiah, L				Logun, Meghan T.; Wynens, Kallie E.; Simchick, Gregory; Zhao, Wujun; Mao, Leidong; Zhao, Qun; Mukherjee, Subhas; Brat, Daniel J.; Karumbaiah, Lohitash			Surfen-mediated blockade of extratumoral chondroitin sulfate glycosaminoglycans inhibits glioblastoma invasion	FASEB JOURNAL			English	Article						tumor microenvironment; glioma; extracellular matrix	BINDING GROWTH-FACTORS; EXTRACELLULAR-MATRIX; STEM-CELLS; GLIOMA INVASION; ANTITUMOR-ACTIVITY; CD133 PROTEIN; RECEPTOR; BRAIN; MIGRATION; EXPRESSION	Invasive spread of glioblastoma (GBM) is linked to changes in chondroitin sulfate (CS) proteoglycan (CSPG)-associated sulfated glycosaminoglycans (GAGs) that are selectively up-regulated in the tumor microenvironment (TME). We hypothesized that inhibiting CS-GAG signaling in the TME would stem GBM invasion. Rat F98 GBM cells demonstrated enhanced preferential cell invasion into oversulfated 3-dimensional composite of CSA and CS-E [4- and 4,6-sulfated CS-GAG (COMP)] matrices compared with monosulfated (4-sulfated) and unsulfated hyaluronic acid matrices in microfluidics-based choice assays, which is likely influenced by differential GAG receptor binding specificities. Both F98 and human patient-derived glioma stem cells (GSCs) demonstrated a high degree of colocalization of the GSC marker CD133 and CSPGs. The small molecule sulfated GAG antagonist bis-2-methyl-4-amino-quinolyl-6-carbamide (surfen) reduced invasion and focal adhesions in F98 cells encapsulated in COMP matrices and blocked CD133 and antichondroitin sulfate antibody (CS-56) detection of respective antigens in F98 cells and human GSCs. Surfen-treated F98 cells down-regulated CSPG-binding receptor transcripts and protein, as well as total and activated ERK and protein kinase B. Lastly, rats induced with frontal lobe tumors and treated with a single intratumoral dose of surfen demonstrated reduced tumor burden and spread compared with untreated controls. These results present a first demonstration of surfen as an inhibitor of sulfated GAG signaling to stem GBM invasion.	[Logun, Meghan T.; Wynens, Kallie E.; Mao, Leidong; Zhao, Qun; Karumbaiah, Lohitash] Univ Georgia, Regenerat Biosci Ctr, 425 River Rd, Athens, GA 30605 USA; [Logun, Meghan T.; Karumbaiah, Lohitash] Univ Georgia, Biomed & Hlth Sci Inst, Div Neurosci, Athens, GA 30602 USA; [Logun, Meghan T.; Karumbaiah, Lohitash] Univ Georgia, Coll Agr & Environm Sci, Edgar L Rhodes Ctr Anim & Dairy Sci, Athens, GA 30602 USA; [Simchick, Gregory; Zhao, Qun] Univ Georgia, Dept Phys & Astron, Athens, GA 30602 USA; [Zhao, Wujun] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Mao, Leidong] Univ Georgia, Sch Elect & Comp Engn, Coll Engn, Athens, GA 30602 USA; [Mukherjee, Subhas; Brat, Daniel J.] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Northwestern University; Feinberg School of Medicine	Karumbaiah, L (corresponding author), Univ Georgia, Regenerat Biosci Ctr, 425 River Rd, Athens, GA 30605 USA.	lohitash@uga.edu	Zhao, Qun/C-3813-2011	Zhao, Qun/0000-0003-0784-1024; Simchick, Gregory/0000-0001-9326-7203; Karumbaiah, Lohitash/0000-0001-7969-417X	U.S. National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke [1R01NS099596-01A1]; National Science Foundation (NSF) Engineering Research Center for Cell Manufacturing Technologies (CMaT) Grant [EEC-1648035]; Achievement Rewards for College Scientists (ARCS) Foundation, Inc.; NIH Office of the Director [1S10OD021719-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS099596] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021719] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke; National Science Foundation (NSF) Engineering Research Center for Cell Manufacturing Technologies (CMaT) Grant(National Science Foundation (NSF)); Achievement Rewards for College Scientists (ARCS) Foundation, Inc.; NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Dr. Jesse Schank and laboratory members [University of Georgia (UGA)] for providing access to the Applied Biosystems real-time qPCR instrument. The authors also thank Dr. Tarun Saxena (Duke University, Durham, NC, USA) for technical inputs regarding the use of cell lines and conduct of surgical procedures. This work is supported by the U.S. National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (Grant 1R01NS099596-01A1), and National Science Foundation (NSF) Engineering Research Center for Cell Manufacturing Technologies (CMaT) Grant EEC-1648035 (to L.K.). M.T.L. acknowledges funding from the Achievement Rewards for College Scientists (ARCS) Foundation, Inc.. The authors also acknowledge support by the NIH Office of the Director (Grant 1S10OD021719-01A1) for the purchase of the Imagestream X MK II for the UGA Center for Tropical and Emerging Global Diseases Cytometry Shared Resource Laboratory. The authors declare no conflicts of interest.	Abouzid K, 2008, BIOORGAN MED CHEM, V16, P7543, DOI 10.1016/j.bmc.2008.07.038; Alqasoumi SI, 2009, BIOORG MED CHEM LETT, V19, P6939, DOI 10.1016/j.bmcl.2009.10.065; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Barbero S, 2002, ANN NY ACAD SCI, V973, P60, DOI 10.1111/j.1749-6632.2002.tb04607.x; BERTOLOTTO A, 1986, J NEURO-ONCOL, V4, P43, DOI 10.1007/BF02158001; Betancur MI, 2017, ACS BIOMATER SCI ENG, V3, P420, DOI 10.1021/acsbiomaterials.6b00805; Bouchet A, 2014, TUMOR BIOL, V35, P6221, DOI 10.1007/s13277-014-1783-6; Brat DJ, 2004, CANCER RES, V64, P920, DOI 10.1158/0008-5472.CAN-03-2073; Brown DV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172791; Cai C, 2012, CARBOHYD POLYM, V87, P822, DOI 10.1016/j.carbpol.2011.08.075; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Campos B, 2011, INT J CANCER, V128, P501, DOI 10.1002/ijc.25687; Cheng Y, 2008, BIOORGAN MED CHEM, V16, P4617, DOI 10.1016/j.bmc.2008.02.036; Conover JC, 2008, CELL TISSUE RES, V331, P211, DOI 10.1007/s00441-007-0503-6; Craig SEL, 2011, ANTI-CANCER AGENT ME, V11, P133; Cuddapah VA, 2014, NAT REV NEUROSCI, V15, P455, DOI 10.1038/nrn3765; de Aguiar CBNM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-31; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Dyck S, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1128-2; Ehtesham M, 2006, ONCOGENE, V25, P2801, DOI 10.1038/sj.onc.1209302; Fisher D, 2011, J NEUROSCI, V31, P14051, DOI 10.1523/JNEUROSCI.1737-11.2011; Gaedicke S, 2014, P NATL ACAD SCI USA, V111, pE692, DOI 10.1073/pnas.1314189111; Gao P, 2016, INT J MOL MED, V38, P1190, DOI 10.3892/ijmm.2016.2725; Giese A, 1996, NEUROSURGERY, V39, P235, DOI 10.1097/00006123-199608000-00001; Goffart N, 2015, NEURO-ONCOLOGY, V17, P81, DOI 10.1093/neuonc/nou144; Gopal M, 2003, J PHOTOCH PHOTOBIO B, V72, P69, DOI 10.1016/j.jphotobiol.2003.09.003; Griffin ME, 2013, CURR OPIN CHEM BIOL, V17, P1014, DOI 10.1016/j.cbpa.2013.09.015; Gros C, 2015, J BIOL CHEM, V290, P6293, DOI 10.1074/jbc.M114.594671; Guan Y, 2018, ONCOL LETT, V15, P7595, DOI 10.3892/ol.2018.8269; He JY, 2018, J MOL MED, V96, P265, DOI 10.1007/s00109-017-1618-1; Huang ML, 2018, STEM CELLS, V36, P45, DOI 10.1002/stem.2714; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Jaime-Ramirez AC, 2017, J GENE MED, V19, DOI 10.1002/jgm.2942; Jing H, 2016, THERANOSTICS, V6, P862, DOI 10.7150/thno.12890; Kahlert UD, 2012, J NEUROPATH EXP NEUR, V71, P1086, DOI 10.1097/NEN.0b013e3182772d83; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Kim Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204865; Kim YH, 2005, BIOCHEM PHARMACOL, V69, P1333, DOI 10.1016/j.bcp.2004.12.019; Kleihues P, 2000, CANCER, V88, P2887, DOI 10.1002/1097-0142(20000615)88:12<2887::AID-CNCR32>3.0.CO;2-F; Kobayashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054278; Laguri C, 2008, CARBOHYD RES, V343, P2018, DOI 10.1016/j.carres.2008.01.047; Lau LW, 2013, NAT REV NEUROSCI, V14, P722, DOI 10.1038/nrn3550; Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089; Logun MT, 2016, J MATER CHEM B, V4, P6052, DOI [10.1039/c6tb01083k, 10.1039/C6TB01083K]; Mak AB, 2011, J BIOL CHEM, V286, P41046, DOI 10.1074/jbc.M111.261545; Markovic DS, 2005, J NEUROPATH EXP NEUR, V64, P754, DOI 10.1097/01.jnen.0000178445.33972.a9; Matsumoto H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12065-4; McDowell KA, 2011, CURR PHARM DESIGN, V17, P2411; Mizoguchi M, 2006, J NEUROPATH EXP NEUR, V65, P1181, DOI 10.1097/01.jnen.0000248549.14962.b2; Mizumoto S, 2013, GLYCOCONJUGATE J, V30, P619, DOI 10.1007/s10719-012-9463-5; Mizumoto S, 2012, J BIOL CHEM, V287, P18985, DOI 10.1074/jbc.M111.313437; Molina JR, 2010, NEOPLASIA, V12, P453, DOI 10.1593/neo.10126; Mooney KL, 2016, J CLIN NEUROSCI, V34, P1, DOI 10.1016/j.jocn.2016.05.012; Mulvihill MJ, 2008, BIOORGAN MED CHEM, V16, P1359, DOI 10.1016/j.bmc.2007.10.061; Munson JM, 2013, CANCER RES, V73, P1536, DOI 10.1158/0008-5472.CAN-12-2838; Nandini CD, 2004, J BIOL CHEM, V279, P50799, DOI 10.1074/jbc.M404746200; Nandini CD, 2006, ADV PHARMACOL, V53, P253, DOI 10.1016/S1054-3589(05)53012-6; Nishii H, 2010, BIOORG MED CHEM LETT, V20, P1405, DOI 10.1016/j.bmcl.2009.12.109; Pellegatta S, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat6463; Pellegatta S, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao2731; Ramirez YP, 2013, PHARMACEUTICALS, V6, P1475, DOI 10.3390/ph6121475; Rao SS, 2013, ACS APPL MATER INTER, V5, P9276, DOI 10.1021/am402097j; Reinhard J, 2016, INT J BIOCHEM CELL B, V81, P174, DOI 10.1016/j.biocel.2016.05.002; Schuksz M, 2008, P NATL ACAD SCI USA, V105, P13075, DOI 10.1073/pnas.0805862105; Serratos IN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120221; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Shteingauz A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1085-9; Siddiqi FS, 2015, ENDOCRINOLOGY, V156, P1121, DOI 10.1210/en.2014-1650; Silver DJ, 2013, J NEUROSCI, V33, P15603, DOI 10.1523/JNEUROSCI.3004-12.2013; Sirko S, 2010, STEM CELLS, V28, P775, DOI 10.1002/stem.309; Smock RG, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180026; Sunayama J, 2010, STEM CELLS, V28, P1930, DOI 10.1002/stem.521; Surve CR, 2014, J BIOL CHEM, V289, P17791, DOI 10.1074/jbc.M114.576827; Svendsen A, 2011, ACTA NEUROPATHOL, V122, P495, DOI 10.1007/s00401-011-0867-2; Tabernero A, 2016, NEUROSCIENCE, V323, P183, DOI 10.1016/j.neuroscience.2015.02.029; ten Dam GB, 2007, AM J PATHOL, V171, P1324, DOI 10.2353/ajpath.2007.070111; Tsidulko AY, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01104; Turetsky A, 2015, THERANOSTICS, V5, P796, DOI 10.7150/thno.11220; UMBER F., 1938, Klinische Wochenschrift, V17, P443, DOI 10.1007/BF01775866; Vecino E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125250; Velpula KK, 2012, CELL SIGNAL, V24, P2076, DOI 10.1016/j.cellsig.2012.07.002; von Thun A, 2012, J CELL SCI, V125, P1465, DOI 10.1242/jcs.092916; Wang J. -G., 2011, FRESHW FISH, V4, P6, DOI DOI 10.1371/J0URNAL.P0NE.0023062; Wei YY, 2013, P NATL ACAD SCI USA, V110, P6829, DOI 10.1073/pnas.1217002110; Wenzel NI, 2010, J MED CHEM, V53, P3214, DOI 10.1021/jm9018383; Yadav DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep38128; Yang YL, 2011, BIOMATERIALS, V32, P7932, DOI 10.1016/j.biomaterials.2011.07.018; Zhou FB, 2010, J BIOCHEM, V148, P273, DOI 10.1093/jb/mvq062; Ziegler J, 2019, AM J NUCL MED MOLEC, V9, P93; Zsila F, 2015, CHIRALITY, V27, P605, DOI 10.1002/chir.22471	91	12	12	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11973	11992		10.1096/fj.201802610RR	http://dx.doi.org/10.1096/fj.201802610RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31398290	Green Published, Bronze			2022-12-28	WOS:000507461600030
J	Sun, XW; Zhang, BY; Pan, X; Huang, H; Xie, Z; Ma, Y; Hu, B; Wang, JY; Chen, ZJ; Shi, PH				Sun, Xuewu; Zhang, Boya; Pan, Xin; Huang, Hai; Xie, Ziang; Ma, Yan; Hu, Bin; Wang, Jiying; Chen, Zhijun; Shi, Peihua			Octyl itaconate inhibits osteoclastogenesis by suppressing Hrd1 and activating Nrf2 signaling	FASEB JOURNAL			English	Article						osteoporosis; osteoclast; metabolite	SUCCINATE-DEHYDROGENASE; OXIDATIVE STRESS; GENE-1; ACID	The endogenous metabolite itaconate has emerged as a regulator of macrophage function that limits inflammation. However, its effect on cell differentiation and osteoclast-related diseases is unclear. Here, for the first time, we explored the effect of itaconate and its cell-permeable itaconate derivative, 4-octyl itaconate (OI) on osteoclast differentiation in vitro and in vivo. Firstly, we demonstrated that itaconate concentration was lower in estrogen-deficient mice. OI released itaconate and induced the expression of nuclear factor-erythroid 2-related factor 2 (Nrf2) in bone marrow-derived macrophages during osteoclastogenesis. Furthermore, OI significantly suppressed the early, middle, and late stages of osteoclastogenesis induced by receptor activator of NF-kappa B ligand in vitro, as confirmed by tartrate-resistant acid phosphatase staining. Moreover, it significantly inhibited fibrous actin ring formation and bone resorption in vitro. Mechanistically, we observed that OI enhanced Nrf2 expression by suppressing its association with ubiquitin via inhibition of the E3 ubiquitin ligase (Hrd1). OI also inhibited LPS-induced the reactive oxygen species and inflammatory responses via Hrd1. An estrogen deficiency (via ovariectomy)-induced osteoporosis model was also established. Here, on micro-computed tomography and histologic analysis showed that OI effectively suppressed ovariectomy-induced bone loss. In summary, OI, an itaconate derivative, can inhibit osteoclastogenesis in vitro and in vivo, indicating that OI could be a potential drug to treat osteoclast-related diseases; our results also link itaconate to the development of osteoporosis.	[Sun, Xuewu; Pan, Xin; Huang, Hai; Xie, Ziang; Ma, Yan; Wang, Jiying; Chen, Zhijun; Shi, Peihua] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Orthopaed Surg, Sch Med, Hangzhou, Peoples R China; [Sun, Xuewu; Pan, Xin; Huang, Hai; Xie, Ziang; Ma, Yan; Wang, Jiying; Chen, Zhijun; Shi, Peihua] Key Lab Musculoskeletal Syst Degenerat & Regenera, Hangzhou, Peoples R China; [Zhang, Boya] Key Lab Biotherapy Zhejiang Prov, Hangzhou, Peoples R China; [Hu, Bin] Zhejiang Univ, Affiliated Hosp 2, Dept Orthoped Surg, Hangzhou, Peoples R China	Zhejiang University; Zhejiang University	Chen, ZJ; Shi, PH (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Orthopaed, Sch Med, Hangzhou 310016, Peoples R China.	21418223@zju.edu.cn; peihua_shi@zju.edu.cn			Nature Science Foundation of China [81874015, 81873985]; National Natural Science Fund of Zhejiang Province [LY16H060004]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Fund of Zhejiang Province	This work was funded by grants from the Nature Science Foundation of China (81874015; 81873985) and the National Natural Science Fund of Zhejiang Province (LY16H060004). The authors declare no conflicts of interest.	Armour KE, 1999, J BONE MINER RES, V14, P2137, DOI 10.1359/jbmr.1999.14.12.2137; Bambouskova M, 2018, NATURE, V556, P501, DOI 10.1038/s41586-018-0052-z; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Cordes T, 2016, J BIOL CHEM, V291, P14274, DOI 10.1074/jbc.M115.685792; Dhakshinamoorthy S, 2005, J BIOL CHEM, V280, P16891, DOI 10.1074/jbc.M500166200; Dominguez-Andres J, 2019, CELL METAB, V29, P211, DOI 10.1016/j.cmet.2018.09.003; Guo YQ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15621; Hu B, 2019, FASEB J, V33, P2574, DOI 10.1096/fj.201800920R; Hyeon S, 2013, FREE RADICAL BIO MED, V65, P789, DOI 10.1016/j.freeradbiomed.2013.08.005; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jing XZ, 2019, J CELL PHYSIOL, V234, P10123, DOI 10.1002/jcp.27678; Kim HS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01527-y; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Lee J, 2019, FASEB J, V33, P2026, DOI 10.1096/fj.201800866RR; Lee OH, 2007, J BIOL CHEM, V282, P36412, DOI 10.1074/jbc.M706517200; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; Murphy MP, 2018, CELL, V174, P780, DOI 10.1016/j.cell.2018.07.030; Nazrun AS, 2012, ADV PHARMACOL SCI, V2012, DOI 10.1155/2012/142702; Oh JY, 2019, FREE RADICAL BIO MED, V130, P328, DOI 10.1016/j.freeradbiomed.2018.11.003; Romisch K, 2017, TRENDS BIOCHEM SCI, V42, P171, DOI 10.1016/j.tibs.2016.10.005; Salazar M, 2006, J BIOL CHEM, V281, P14841, DOI 10.1074/jbc.M513737200; Shin JH, 2016, INT J MOL MED, V38, P1075, DOI 10.3892/ijmm.2016.2694; Silva-Palacios A, 2018, AGEING RES REV, V47, P31, DOI 10.1016/j.arr.2018.06.003; Tan EM, 2017, J BONE MINER RES, V32, P846, DOI 10.1002/jbmr.3031; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Weiss JM, 2018, J CLIN INVEST, V128, P3794, DOI 10.1172/JCI99169; Wu TD, 2014, GENE DEV, V28, P708, DOI 10.1101/gad.238246.114; Xie Z, 2018, J BONE MINER RES, V33, P667, DOI 10.1002/jbmr.3334; Xu YM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12073; Zhang Q, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01028	31	26	26	2	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12929	12940		10.1096/fj.201900887RR	http://dx.doi.org/10.1096/fj.201900887RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31490085	Bronze, Green Published			2022-12-28	WOS:000507461600102
J	Wichert, R; Scharfenberg, F; Colmorgen, C; Koudelka, T; Schwarz, J; Wetzel, S; Potempa, B; Potempa, J; Bartsch, JW; Sagi, I; Tholey, A; Saftig, P; Rose-John, S; Becker-Pauly, C				Wichert, Rielana; Scharfenberg, Franka; Colmorgen, Cynthia; Koudelka, Tomas; Schwarz, Jeanette; Wetzel, Sebastian; Potempa, Barbara; Potempa, Jan; Bartsch, Joerg W.; Sagi, Irit; Tholey, Andreas; Saftig, Paul; Rose-John, Stefan; Becker-Pauly, Christoph			Meprin beta induces activities of A disintegrin and metalloproteinases 9, 10, and 17 by specific prodomain cleavage	FASEB JOURNAL			English	Article						proteolysis; zymogen activation; inflammation; ADAM	ALPHA-CONVERTING-ENZYME; ADAM10; SECRETASE; PROTEIN; IRHOM2; TACE; PHOSPHORYLATION; INHIBITION; DISRUPTION; ACTIVATION	Meprin beta is a membrane-bound metalloprotease involved in extracellular matrix assembly and inflammatory processes in health and disease. A disintegrin and metalloproteinase (ADAM)10 and ADAM17 are physiologic relevant sheddases of inactive promeprin beta, which influences its substrate repertoire and subsequent biologic functions. Proteomic analysis also revealed several ADAMs as putative meprin beta substrates. Here, we demonstrate specific N-terminal processing of ADAM9, 10, and 17 by meprin beta and identify cleavage sites within their prodomains. Because ADAM prodomains can act as specific inhibitors, we postulate a role for meprin beta in the regulation of ADAM activities. Indeed, prodomain cleavage by meprin beta caused increased ADAM protease activities, as observed by peptide-based cleavage assays and demonstrated by increased ectodomain shedding activity. Direct interaction of meprin beta and ADAM proteases could be shown by immunofluorescence microscopy and immunoprecipitation experiments. As demonstrated by a bacterial activator of meprin beta and additional measurement of TNF-alpha shedding on bone marrow-derived macrophages, meprin beta/ADAM protease interactions likely influence inflammatory conditions. Thus, we identified a novel proteolytic pathway of meprin beta with ADAM proteases to control protease activities at the cell surface as part of the protease web.	[Wichert, Rielana; Scharfenberg, Franka; Colmorgen, Cynthia; Schwarz, Jeanette; Wetzel, Sebastian; Saftig, Paul; Rose-John, Stefan; Becker-Pauly, Christoph] Univ Kiel, Inst Biochem, Kiel, Germany; [Koudelka, Tomas; Tholey, Andreas] Univ Kiel, Inst Expt Med, Kiel, Germany; [Potempa, Barbara; Potempa, Jan] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, Krakow, Poland; [Potempa, Jan] Univ Louisville, Sch Dent, Oral Immunol & Infect Dis, Louisville, KY 40292 USA; [Bartsch, Joerg W.] Philipps Univ Marburg, Dept Neurosurg, Marburg, Germany; [Sagi, Irit] Weizmann Inst Sci, Dept Biol Regulat, Rehovot, Israel	University of Kiel; University of Kiel; Jagiellonian University; University of Louisville; Philipps University Marburg; Weizmann Institute of Science	Becker-Pauly, C (corresponding author), Univ Kiel, Inst Biochem, Unit Degrad Protease Web, Otto Hahn Pl 9, D-24118 Kiel, Germany.	cbeckerpauly@biochem.uni-kiel.de	Scharfenberg, Franka/AAS-9798-2021; Saftig, Paul/A-7966-2010; Becker-Pauly, Christoph/B-7569-2011; Potempa, Jan/AAA-6850-2021	Bartsch, Prof. Joerg Walter/0000-0002-2773-3357	Deutsche Forschungsgemeinschaft (DFG) [BE4086/2-2, SFB 877]; DFG Excellence Cluster [306]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG Excellence Cluster(German Research Foundation (DFG))	The authors thank Carl P. Blobel (Weill Cornell Medical College, New York, NY, USA) for providing the C-terminal anti-ADAM9 antibody and alkaline phosphatase-tagged shedding constructs. The authors also thank Athena Chalaris-Rissmann (Biochemical Institute, University of Kiel) for providing the N-and C-terminal tagged ADAM constructs. In addition, the authors thank Britta Hansen (Biochemical Institute, University of Kiel) for excellent technical support. This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants BE4086/2-2 (to C. B.-P.), SFB 877 (Proteolysis as a Regulatory Event in Pathophysiology, Projects A1, A3, A9, and Z2), and DFG Excellence Cluster No. 306 "Inflammation at Interfaces." The authors declare no conflicts of interest.	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Arnold P, 2017, SCI REP-UK, V7, DOI 10.1038/srep44053; Banerjee S, 2008, J BIOL CHEM, V283, P31371, DOI 10.1074/jbc.M802814200; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Bedau T, 2017, ONCOTARGET, V8, P54873, DOI 10.18632/oncotarget.18966; Bedau T, 2017, FASEB J, V31, P1226, DOI 10.1096/fj.201601113R; Bien J, 2012, J BIOL CHEM, V287, P33304, DOI 10.1074/jbc.M112.395608; Broder C, 2013, P NATL ACAD SCI USA, V110, P14219, DOI 10.1073/pnas.1305464110; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cavadas M, 2017, CELL REP, V21, P745, DOI 10.1016/j.celrep.2017.09.074; Crisman JM, 2004, J IMMUNOL, V172, P4510, DOI 10.4049/jimmunol.172.7.4510; DUMERMUTH E, 1991, J BIOL CHEM, V266, P21381; Endres K, 2003, EUR J BIOCHEM, V270, P2386, DOI 10.1046/j.1432-1033.2003.03606.x; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Gonzales PE, 2004, J BIOL CHEM, V279, P31638, DOI 10.1074/jbc.M401311200; Goulas T, 2011, P NATL ACAD SCI USA, V108, P1856, DOI 10.1073/pnas.1012173108; Grieve AG, 2017, ELIFE, V6, DOI 10.7554/eLife.23968; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hedrich J, 2010, BIOCHEMISTRY-US, V49, P8599, DOI 10.1021/bi1004238; Herzog C, 2009, BIOCHEM BIOPH RES CO, V379, P904, DOI 10.1016/j.bbrc.2008.12.161; Jefferson T, 2013, CELL MOL LIFE SCI, V70, P309, DOI 10.1007/s00018-012-1106-2; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Liu HL, 2009, J BIOL CHEM, V284, P29077, DOI 10.1074/jbc.M109.014258; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Meier A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004343; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; Moss ML, 2011, J BIOL CHEM, V286, P40443, DOI 10.1074/jbc.M111.280495; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Norman LP, 2003, MOL CELL BIOL, V23, P1221, DOI 10.1128/MCB.23.4.1221-1230.2003; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Roghani M, 1999, J BIOL CHEM, V274, P3531, DOI 10.1074/jbc.274.6.3531; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Scharfenberg F., 2019, CELL MOL LIFE SCI; Schonherr C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0084-5; Schutte A, 2014, P NATL ACAD SCI USA, V111, P12396, DOI 10.1073/pnas.1407597111; Schwarz J, 2013, BBA-MOL CELL RES, V1833, P3355, DOI 10.1016/j.bbamcr.2013.10.005; Seegar TCM, 2017, CELL, V171, P1638, DOI 10.1016/j.cell.2017.11.014; Seipold L, 2018, CELL MOL LIFE SCI, V75, P3251, DOI 10.1007/s00018-018-2791-2; Seipold L, 2017, BBA-MOL CELL RES, V1864, P217, DOI 10.1016/j.bbamcr.2016.11.003; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sztukowska M, 2012, BIOL CHEM, V393, P971, DOI 10.1515/hsz-2012-0175; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Tucher J, 2014, J PROTEOME RES, V13, P2205, DOI 10.1021/pr401135u; Veillard F, 2015, BIOL CHEM, V396, P377, DOI 10.1515/hsz-2014-0304; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wichert R, 2017, CELL REP, V21, P2090, DOI 10.1016/j.celrep.2017.10.087; Wong E, 2016, SCI REP-UK, V6, DOI 10.1038/srep35598; Wong ET, 2015, J BIOL CHEM, V290, P12135, DOI 10.1074/jbc.M114.624072; Zheng YF, 2002, J BIOL CHEM, V277, P42463, DOI 10.1074/jbc.M207459200	53	11	11	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11925	11940		10.1096/fj.201801371R	http://dx.doi.org/10.1096/fj.201801371R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31381863	Bronze, Green Published			2022-12-28	WOS:000507461600027
J	Ye, H; Qian, L; Zhu, SY; Deng, SR; Wang, X; Zhu, J; Chan, GL; Yu, Y; Han, W				Ye, Hao; Qian, Lan; Zhu, Shunying; Deng, Shaorong; Wang, Xia; Zhu, Jiang; Chan, Gerald L.; Yu, Yan; Han, Wei			IL-1Ra protects hematopoietic cells from chemotoxicity through p53-induced quiescence	FASEB JOURNAL			English	Article						rhIL-1Ra; chemotherapy; neutropenia; cell cycle arrest; hematopoietic progenitor cell	INTERLEUKIN-1 RECEPTOR; TRANSCRIPTIONAL REGULATION; TGF-BETA; CANCER; STEM; P53; PROLIFERATION; TOXICITY; CHEMOTHERAPY; SUPPRESSION	The protection of constantly proliferating gut epithelia and hematopoietic tissues from cytotoxicity could improve conventional chemotherapy efficacy and widen its therapeutic window. Previously, we reported that, in mouse models, pretreatment of recombinant human IL-1 receptor antagonist (rhIL-1Ra) protected both types of vulnerable tissues from chemotherapeutics. Here, we showed that rhIL-1Ra treatment up-regulated the protein levels of phosphorylated p38, p53, and p21 and induced transient hematopoietic stem/progenitor cell (HS/PC) quiescence. Knockout of IL-1 receptor I (IL-1RI), p53, or p21 alleles and pharmacological inactivation of p38 mapped the rhIL-1Ra pathway in the induction of HS/PC quiescence. Therefore, rhIL-1Ra administration before but not after chemotherapy alleviated 5-fluorouracil-induced neutropenia. In addition, in vivo and in vitro cell proliferation assays revealed that the rhIL-1Ra treatment did not affect cancer cell proliferation or chemosensitivity. Lastly, we propose an IL-1/IL-1Ra pathway (IL-1RI -> p38 -> p53 -> p21), which regulates HS/PC quiescence. The rhIL-1Ra may provide a new route for p53-based cyclotherapy, which spares normal cells but kills cancer cells during chemotherapy.	[Ye, Hao; Qian, Lan; Deng, Shaorong; Wang, Xia; Han, Wei] Shanghai Jiao Tong Univ, Sch Pharm, Lab Regener, Shanghai, Peoples R China; [Zhu, Shunying] Shanghai Jiao Tong Univ, Natl Infrastruct Translat Med, Shanghai, Peoples R China; [Zhu, Jiang] Shanghai Jiao Tong Univ, Blood Res Inst, Sch Med, Ruijin Hosp, Shanghai, Peoples R China; [Yu, Yan] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai Municipal Key Lab Vet Biotechnol, Shanghai, Peoples R China; [Chan, Gerald L.] Peking Univ, Morningside Peking Univ Joint Lab Integrat Pathob, Beijing, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Peking University	Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biotechnol, Room 3-405,800 Dongchuan Rd, Shanghai 200240, Peoples R China.; Han, W (corresponding author), Shanghai Jiao Tong Univ, Sch Pharm, Room 6-212,800 Dongchuan Rd, Shanghai 200240, Peoples R China.	yanyu@sjtu.edu.cn; weihan@sjtu.edu.cn			National Science and Technology Major Project [2018ZX09733001-001-004]; National Natural Science Foundation of China [30901873]; Shanghai Science and Technology Committee [111431921300]	National Science and Technology Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This work was supported by grants from the National Science and Technology Major Project (2018ZX09733001-001-004), the National Natural Science Foundation of China (30901873), and the Shanghai Science and Technology Committee (111431921300). The authors declare no conflicts of interest.	Batchelor E, 2009, NAT REV CANCER, V9, P371, DOI 10.1038/nrc2604; Blagosklonny MV, 2002, CELL CYCLE, V1, P375, DOI 10.4161/cc.1.6.259; Blagosklonny MV, 2002, CELL CYCLE, V1, P103, DOI 10.4161/cc.1.2.108; Blagosklonny MV, 2001, CANCER RES, V61, P4301; Boraschi D, 2013, SEMIN IMMUNOL, V25, P394, DOI 10.1016/j.smim.2013.10.023; Carey A, 2017, CELL REP, V18, P3204, DOI 10.1016/j.celrep.2017.03.018; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; GALLAGHER R, 1979, BLOOD, V54, P713; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; GRZEGORZEWSKI K, 1994, J EXP MED, V180, P1047, DOI 10.1084/jem.180.3.1047; He SH, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3986; Hoe KK, 2014, NAT REV DRUG DISCOV, V13, P217, DOI 10.1038/nrd4236; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Jiang LJ, 2011, P NATL ACAD SCI USA, V108, P1897, DOI 10.1073/pnas.1019059108; Johnson A, 2013, CURR OPIN CELL BIOL, V25, P717, DOI 10.1016/j.ceb.2013.07.010; Karimian A, 2016, DNA REPAIR, V42, P63, DOI 10.1016/j.dnarep.2016.04.008; Khemissa F, 2016, DIGEST LIVER DIS, V48, P327, DOI 10.1016/j.dld.2015.11.025; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Olson TS, 2013, BLOOD, V121, P5238, DOI 10.1182/blood-2012-10-463414; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Qian L, 2013, BIOMED PHARMACOTHER, V67, P108, DOI 10.1016/j.biopha.2012.11.002; Rao B, 2013, BRIT J CANCER, V109, P2954, DOI 10.1038/bjc.2013.702; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Rumman M, 2015, STEM CELLS, V33, P2903, DOI 10.1002/stem.2056; Spencer SL, 2013, CELL, V155, P369, DOI 10.1016/j.cell.2013.08.062; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Taylor SJ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam8060; van Leeuwen IMM, 2012, ONCOTARGET, V3, P596; Velardi E, 2018, NAT MED, V24, P239, DOI 10.1038/nm.4470; Wang X, 2014, PHARMACOL RES, V82, P21, DOI 10.1016/j.phrs.2014.03.007; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Xiang D, 2011, CANCER CHEMOTH PHARM, V67, P1445, DOI 10.1007/s00280-010-1439-1; Yu HJ, 2016, AM J TRANSL RES, V8, P1237; Zhang J, 2009, BIOMED PHARMACOTHER, V63, P501, DOI 10.1016/j.biopha.2008.09.014; Zhang Y, 2015, CANCER BIOL THER, V16, P1775, DOI 10.1080/15384047.2015.1095404	46	2	2	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12135	12145		10.1096/fj.201900788RR	http://dx.doi.org/10.1096/fj.201900788RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31373847	Green Published, Bronze			2022-12-28	WOS:000507461600042
J	Catanzaro, MP; Weiner, A; Kaminaris, A; Li, CR; Cai, F; Zhao, FY; Kobayashi, S; Kobayashi, T; Huang, Y; Sesaki, H; Liang, QR				Catanzaro, Michael P.; Weiner, Ashley; Kaminaris, Amanda; Li, Cairong; Cai, Fei; Zhao, Fengyi; Kobayashi, Satoru; Kobayashi, Tamayo; Huang, Yuan; Sesaki, Hiromi; Liang, Qiangrong			Doxorubicin-induced cardiomyocyte death is mediated by unchecked mitochondrial fission and mitophagy	FASEB JOURNAL			English	Article						cardiotoxicity; anti-tumor agents; mitochondrial quality control; heart failure	CARDIAC MITOCHONDRIA; HEART; ANTHRACYCLINES; DEXRAZOXANE; ADRIAMYCIN; PROTECTION; CARDIOTOXICITY; RECRUITMENT; RESISTANCE; AUTOPHAGY	Doxorubicin (Dox) is a widely used antineoplastic agent that can cause heart failure. Dox cardiotoxicity is closely associated with mitochondrial damage. Mitochondrial fission and mitophagy are quality control mechanisms that normally help maintain a pool of healthy mitochondria. However, unchecked mitochondrial fission and mitophagy may compromise the viability of cardiomyocytes, predisposing them to cell death. Here, we tested this possibility by using Dox-treated H9c2 cardiac myoblast cells expressing either the mitochondria-targeted fluorescent protein MitoDsRed or the novel dual-fluorescent mitophagy reporter mt-Rosella. Dox induced mitochondrial fragmentation as shown by reduced form factor, aspect ratio, and mean mitochondrial size. This effect was abolished by short interference RNA-mediated knockdown of dynamin-related protein 1 (DRP1), a major regulator of fission. Importantly, DRP1 knockdown decreased cell death as indicated by the reduced number of propidium iodide-positive cells and the cleavage of caspase-3 and poly (ADP-ribose) polymerase. Moreover, DRP1-deficient mice were protected from Dox-induced cardiac damage, strongly supporting a role for DRP1-dependent mitochondrial fragmentation in Dox cardiotoxicity. In addition, Dox accelerated mitophagy flux, which was attenuated by DRP1 knockdown, as assessed by the mitophagy reporter mt-Rosella, suggesting the necessity of mitochondrial fragmentation in Dox-induced mitophagy. Knockdown of parkin, a positive regulator of mitophagy, dramatically diminished Dox-induced cell death, whereas overexpression of parkin had the opposite effect. Together, these results suggested that Dox cardiotoxicity was mediated, at least in part, by the increased mitochondrial fragmentation and accelerated mitochondrial degradation by the lysosome. Strategies that limit mitochondrial fission and mitophagy in the physiologic range may help reduce Dox cardiotoxicity.-Catanzaro, M. P., Weiner, A., Kaminaris, A., Li, C., Cai, F., Zhao, F., Kobayashi, S., Kobayashi, T., Huang, Y., Sesaki, H., Liang, Q. Doxorubicin-induced cardiomyocyte death is mediated by unchecked mitochondrial fission and mitophagy.	[Catanzaro, Michael P.; Weiner, Ashley; Kaminaris, Amanda; Kobayashi, Satoru; Kobayashi, Tamayo; Huang, Yuan; Liang, Qiangrong] New York Inst Technol, Coll Osteopath Med, Dept Biomed Sci, New York, NY USA; [Li, Cairong] Hubei Univ Sci & Technol, Clin Med Coll, Xianning, Peoples R China; [Cai, Fei] Hubei Univ Sci & Technol, Hubei Key Lab Diabet & Angiopathy, Xianning, Peoples R China; [Zhao, Fengyi] Xi An Jiao Tong Univ, Hlth Sci Ctr, Affiliated Hosp 1, Dept Endocrinol, Xian, Shaanxi, Peoples R China; [Sesaki, Hiromi] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD USA	New York Institute Technology; Hubei University of Science & Technology; Hubei University of Science & Technology; Xi'an Jiaotong University; Johns Hopkins University	Liang, QR (corresponding author), New York Inst Technol, Coll Osteopath Med, Northern Blvd,POB 8000, Old Westbury, NY 11568 USA.	qliang03@nyit.edu			U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [1R15HL137130-01A1]; American Heart Association [15SDG25080077]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL137130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123266] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Q.L. was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant 1R15HL137130-01A1, and S.K. was supported by American Heart Association Grant 15SDG25080077. The authors declare no conflicts of interest.	Ackers-Johnson M, 2016, CIRC RES, V119, P909, DOI 10.1161/CIRCRESAHA.116.309202; Basit F, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.133; Berthiaume JM, 2007, CELL BIOL TOXICOL, V23, P15, DOI 10.1007/s10565-006-0140-y; BIANCHI C, 1987, EXP MOL PATHOL, V46, P123, DOI 10.1016/0014-4800(87)90036-0; Branco AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129303; Chang YW, 2013, MOL CELL PROTEOMICS, V12, P3094, DOI 10.1074/mcp.M113.027649; DAVIES KJA, 1986, J BIOL CHEM, V261, P3060; DOROSHOW JH, 1986, J BIOL CHEM, V261, P3068; Elliott AM, 2009, MOL CANCER RES, V7, P79, DOI 10.1158/1541-7786.MCR-08-0235; Gharanei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077713; Hasinoff BB, 2007, CARDIOVASC TOXICOL, V7, P140, DOI 10.1007/s12012-007-0023-3; Hoshino A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3308; Ichikawa Y, 2014, J CLIN INVEST, V124, P617, DOI 10.1172/JCI72931; Injac R, 2008, TECHNOL CANCER RES T, V7, P497, DOI 10.1177/153303460800700611; Kageyama Y, 2012, J CELL BIOL, V197, P535, DOI 10.1083/jcb.201110034; Kitay BM, 2013, HUM MOL GENET, V22, P1601, DOI 10.1093/hmg/ddt009; Koleini N, 2017, ONCOTARGET, V8, P46663, DOI 10.18632/oncotarget.16944; Lee Y, 2011, AM J PHYSIOL-HEART C, V301, pH1924, DOI 10.1152/ajpheart.00368.2011; Li DL, 2016, CIRCULATION, V133, P1668, DOI 10.1161/CIRCULATIONAHA.115.017443; Liang QR, 2016, J MOL CELL CARDIOL, V95, P57, DOI 10.1016/j.yjmcc.2015.12.025; Link G, 1996, J LAB CLIN MED, V127, P272, DOI 10.1016/S0022-2143(96)90095-5; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Maeda Miho, 2008, Journal of Nippon Medical School, V75, P320; Mijaljica D, 2011, JOVE-J VIS EXP, DOI 10.3791/2779; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Mizumura K, 2014, J CLIN INVEST, V124, P3987, DOI 10.1172/JCI74985; Mohammad IS, 2018, BIOMED PHARMACOTHER, V100, P335, DOI 10.1016/j.biopha.2018.02.038; Nah J, 2017, COMPR PHYSIOL, V7, P1407, DOI 10.1002/cphy.c170005; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Pereira GC, 2011, CURR PHARM DESIGN, V17, P2113; Sardao VA, 2009, CELL BIOL TOXICOL, V25, P227, DOI 10.1007/s10565-008-9070-1; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Song MS, 2017, CELL METAB, V26, P872, DOI 10.1016/j.cmet.2017.09.023; Song MS, 2015, CIRC RES, V117, P346, DOI 10.1161/CIRCRESAHA.117.306859; Swain SM, 1997, J CLIN ONCOL, V15, P1318, DOI 10.1200/JCO.1997.15.4.1318; Swain SM, 2003, CANCER, V97, P2869, DOI 10.1002/cncr.11407; Tebbi CK, 2007, J CLIN ONCOL, V25, P493, DOI 10.1200/JCO.2005.02.3879; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; van der Pal HJ, 2010, ARCH INTERN MED, V170, P1247, DOI 10.1001/archinternmed.2010.233; Wallace KB, 2003, PHARMACOL TOXICOL, V93, P105, DOI 10.1034/j.1600-0773.2003.930301.x; Wallace KB, 2007, CARDIOVASC TOXICOL, V7, P101, DOI 10.1007/s12012-007-0008-2; Wang JX, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.41; Wei SN, 2015, CARDIOVASC TOXICOL, V15, P377, DOI 10.1007/s12012-014-9306-7; Xu XM, 2013, J BIOL CHEM, V288, P18077, DOI 10.1074/jbc.M113.474650; Xu XM, 2012, J PHARMACOL EXP THER, V341, P183, DOI 10.1124/jpet.111.189589; Yin J, 2018, TOXICOL IN VITRO, V51, P1, DOI 10.1016/j.tiv.2018.05.001; Zhou SY, 2001, CANCER RES, V61, P771	47	73	76	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11096	11108		10.1096/fj.201802663R	http://dx.doi.org/10.1096/fj.201802663R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31291545	Green Published			2022-12-28	WOS:000489166300044
J	Zhao, L; Gao, XP; Zhuang, JG; Wallen, M; Leng, SG; Xu, FD				Zhao, Lei; Gao, Xiuping; Zhuang, Jianguo; Wallen, Morgan; Leng, Shuguang; Xu, Fadi			Prolongation of bronchopulmonary C-fiber-mediated apnea by prenatal nicotinic exposure in rat pups: role of 5-HT3 receptors	FASEB JOURNAL			English	Article						sudden infant death syndrome; vagal sensory neurons; cardiovascular activity; TRPV1	PULMONARY NEUROEPITHELIAL BODIES; SEROTONERGIC SYNAPTIC FUNCTION; INFANT-DEATH-SYNDROME; CIGARETTE-SMOKING; CALCIUM TRANSIENT; SUBUNIT ALTERS; BRAIN-STEM; RESPONSES; MEMBRANE; HYPOXIA	Prenatal nicotinic exposure (PNE) reportedly sensitizes bronchopulmonary C-fibers (PCFs) and prolongs PCF-mediated apnea in rat pups, contributing to the pathogenesis of sudden infant death syndrome. Serotonin, or 5-hydroxytryptamine (5-HT), induces apnea via acting on 5-HT receptor 3 (5-HT3R) in PCFs, and among the 5-HT3R subunits, 5-HT3B is responsible for shortening the decay time of 5-HT3R-mediated currents. We examined whether PNE would promote pulmonary 5-HT secretion and prolong the apnea mediated by 5-HT(3)Rs in PCFs via affecting the 5-HT3B subunit. To this end, the following variables were compared between the control and PNE rat pups: 1) the 5-HT content in bronchoalveolar lavage fluid, 2) the apneic response to the right atrial bolus injection of phenylbiguanide (a 5-HT3R agonist) before and after PCF inactivation, 3) 5-HT3R currents and the stimulus threshold of the action currents of vagal pulmonary C-neurons, and 4) the immunoreactivity (IR) and mRNA expression of 5-HT3A and 5-HT3B in these neurons. Our results showed that PNE up-regulated the pulmonary 5-HT concentration and strengthened the PCF 5-HT3R-mediated apnea. PNE significantly facilitated neural excitability by shortening the decay time of 5-HT3R currents, lowering the stimulus threshold, and increasing 5-HT3B IR. In summary, PNE prolongs the apnea mediated by 5-HT(3)Rs in PCFs, likely by increasing 5-HT3B subunits to enhance the excitability of 5-HT3 channels.-Zhao, L., Gao, X., Zhuang, J., Wallen, M., Leng, S., Xu, F. Prolongation of bronchopulmonary C-fiber-mediated apnea by prenatal nicotinic exposure in rat pups: role of 5-HT3 receptors.	[Zhao, Lei; Gao, Xiuping; Zhuang, Jianguo; Leng, Shuguang; Xu, Fadi] Lovelace Resp Res Inst, Pathophysiol Program, 2425 Ridgecrest Dr SE, Albuquerque, NM 87108 USA; [Wallen, Morgan] Univ Tennessee, Dept Arts & Sci, Knoxville, TN USA	Lovelace Respiratory Research Institute; University of Tennessee System; University of Tennessee Knoxville	Xu, FD (corresponding author), Lovelace Resp Res Inst, Pathophysiol Program, 2425 Ridgecrest Dr SE, Albuquerque, NM 87108 USA.	fxu@lrri.org			U.S. National Institutes of Health (NIH), National Heart, Lung and Blood Institute [HL-107462, HL-119683]	U.S. National Institutes of Health (NIH), National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors are grateful to Ellen Blake for editing. This study was supported in part by U.S. National Institutes of Health (NIH), National Heart, Lung and Blood Institute Grants HL-107462 and HL-119683 (to F.X.). The authors declare no conflicts of interest.	Adams EJ, 1998, PEDIATRICS, V102, P1445, DOI 10.1542/peds.102.6.1445; ASHLEY CC, 1970, J PHYSIOL-LONDON, V209, P105, DOI 10.1113/jphysiol.1970.sp009158; Ballanyi Klaus, 2004, Current Neuropharmacology, V2, P221, DOI 10.2174/1570159043476828; Barnes NM, 2009, NEUROPHARMACOLOGY, V56, P273, DOI 10.1016/j.neuropharm.2008.08.003; BENOWITZ NL, 1982, CLIN PHARMACOL THER, V32, P758, DOI 10.1038/clpt.1982.233; Bodineau L, 2004, RESP PHYSIOL NEUROBI, V141, P47, DOI 10.1016/j.resp.2004.03.007; Campos M, 2009, CLIN EXP PHARMACOL P, V36, P1205, DOI 10.1111/j.1440-1681.2009.05214.x; CUTZ E, 1993, ANAT RECORD, V236, P41, DOI 10.1002/ar.1092360109; Das P, 2003, MOL BRAIN RES, V119, P207, DOI 10.1016/j.molbrainres.2003.09.003; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; Dutta A, 2010, ACTA PHYSIOL, V200, P87, DOI 10.1111/j.1748-1716.2010.02105.x; Fanburg BL, 1997, AM J PHYSIOL-LUNG C, V272, pL795, DOI 10.1152/ajplung.1997.272.5.L795; Feetham CH, 2015, BRIT J PHARMACOL, V172, P1753, DOI 10.1111/bph.13023; Fewell JE, 2001, RESP PHYSIOL, V127, P61, DOI 10.1016/S0034-5687(01)00232-8; Froen TF, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e52; Fu XW, 2009, ADV EXP MED BIOL, V648, P439, DOI 10.1007/978-90-481-2259-2_50; Fuller DD, 2002, J PHYSIOL-LONDON, V538, P947, DOI 10.1113/jphysiol.2001.012908; Gao XP, 2017, FASEB J, V31, P4325, DOI 10.1096/fj.201700163R; Gdovin MJ, 2010, ETHNIC DIS, V20, pS1; Goda Yukiko, 1993, Hokkaido Journal of Medical Science, V68, P29; Gu QH, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00065; Hafstrom O, 2002, AM J RESP CRIT CARE, V166, P1544, DOI 10.1164/rccm.200204-289OC; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hapfelmeier G, 2003, BIOPHYS J, V84, P1720, DOI 10.1016/S0006-3495(03)74980-7; Harper RM, 2000, RESP PHYSIOL, V119, P123, DOI 10.1016/S0034-5687(99)00107-3; Haynes RL, 2017, P NATL ACAD SCI USA, V114, P7695, DOI 10.1073/pnas.1617374114; Hong JL, 1997, J PHYSIOL-LONDON, V500, P319, DOI 10.1113/jphysiol.1997.sp022023; Hu YM, 2010, AM J PHYSIOL-LUNG C, V299, pL483, DOI 10.1152/ajplung.00111.2010; ISAAC PF, 1972, NATURE, V236, P308, DOI 10.1038/236308a0; Jiang X, 2015, CELL PHYSIOL BIOCHEM, V37, P1712, DOI 10.1159/000438536; JOHNSON DE, 1989, AM REV RESPIR DIS, V140, P1807, DOI 10.1164/ajrccm/140.6.1807; Kalra R, 2002, J PHARMACOL EXP THER, V302, P935, DOI 10.1124/jpet.302.3.935; Lee LY, 2013, PULM PHARMACOL THER, V26, P491, DOI 10.1016/j.pupt.2013.03.010; Lee LY, 2003, ANAT REC PART A, V270A, P17, DOI 10.1002/ar.a.10005; Lee LY, 2001, RESP PHYSIOL, V125, P47, DOI 10.1016/S0034-5687(00)00204-8; Lin YJ, 2013, J APPL PHYSIOL, V114, P361, DOI 10.1152/japplphysiol.00977.2012; Linnoila RI, 2006, LAB INVEST, V86, P425, DOI 10.1038/labinvest.3700412; Livermore S, 2015, AM J PHYSIOL-LUNG C, V308, pL807, DOI 10.1152/ajplung.00208.2014; Loyd DR, 2011, PAIN, V152, P2267, DOI 10.1016/j.pain.2011.06.002; Morales M, 2002, J NEUROSCI, V22, P6732; Paterson DS, 2006, JAMA-J AM MED ASSOC, V296, P2124, DOI 10.1001/jama.296.17.2124; PETSCHE U, 1983, BRAIN RES, V265, P233, DOI 10.1016/0006-8993(83)90337-2; Potenzieri C, 2012, J PHYSIOL-LONDON, V590, P5449, DOI 10.1113/jphysiol.2012.237115; Schuller HM, 2003, ANAT REC PART A, V270A, P51, DOI 10.1002/ar.a.10019; Shea AK, 2008, NICOTINE TOB RES, V10, P267, DOI 10.1080/14622200701825908; Slotkin TA, 2007, NEUROPSYCHOPHARMACOL, V32, P1082, DOI 10.1038/sj.npp.1301231; Slotkin TA, 2015, BRAIN RES BULL, V111, P84, DOI 10.1016/j.brainresbull.2015.01.003; Slotkin TA, 2011, NEUROTOXICOL TERATOL, V33, P431, DOI 10.1016/j.ntt.2011.02.001; Stephan-Blanchard E, 2013, RESP PHYSIOL NEUROBI, V185, P110, DOI 10.1016/j.resp.2012.06.023; Stephenson R, 2001, J PHYSIOL-LONDON, V536, P225, DOI 10.1111/j.1469-7793.2001.00225.x; Stewart A, 2003, NEUROPHARMACOLOGY, V44, P214, DOI 10.1016/S0028-3908(02)00376-3; TASAKI I, 1955, J GEN PHYSIOL, V39, P211, DOI 10.1085/jgp.39.2.211; Wang C, 2017, ARTERIOSCL THROM VAS, V37, P53, DOI 10.1161/ATVBAHA.116.307264; Warshaviak DT, 2011, BBA-BIOMEMBRANES, V1808, P2608, DOI 10.1016/j.bbamem.2011.06.010; Weigand LA, 2009, J PHYSIOL-LONDON, V587, P3355, DOI 10.1113/jphysiol.2009.173054; Xu F, 2003, J APPL PHYSIOL, V94, P1446, DOI 10.1152/japplphysiol.00767.2002; Xu J, 2008, AM J PHYSIOL-LUNG C, V295, pL162, DOI 10.1152/ajplung.00282.2007; Zhang ZX, 2013, NEUROSCI LETT, V552, P1, DOI 10.1016/j.neulet.2013.07.024; Zhang ZX, 2012, RESP PHYSIOL NEUROBI, V183, P211, DOI 10.1016/j.resp.2012.06.032; Zhao L, 2016, TOXICOL APPL PHARM, V303, P58, DOI 10.1016/j.taap.2016.05.008; Zhao L, 2016, TOXICOL APPL PHARM, V290, P107, DOI 10.1016/j.taap.2015.10.023; Zhuang J., 2014, FASEB J, V28, P713; Zhuang JG, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12023; Zhuang JG, 2015, AM J PHYSIOL-LUNG C, V308, pL922, DOI 10.1152/ajplung.00241.2014	64	2	2	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10731	10741		10.1096/fj.201900279RR	http://dx.doi.org/10.1096/fj.201900279RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31251077	Bronze, Green Published			2022-12-28	WOS:000489166300013
J	Jee, J; Jeong, SY; Kim, HK; Choi, SY; Jeong, S; Lee, J; Ko, JS; Kim, MS; Kwon, MS; Yoo, J				Jee, JooHyun; Jeong, Sang Yun; Kim, Han Kyung; Choi, Seon Young; Jeong, Sukin; Lee, Joongwoon; Ko, Ji Su; Kim, Mi Sun; Kwon, Min-Soo; Yoo, Jongman			In vivo evaluation of scaffolds compatible for colonoid engraftments onto injured mouse colon epithelium	FASEB JOURNAL			English	Article						fibrin glue; collagen; gelatin; colonoid; transplantation	INFLAMMATORY-BOWEL-DISEASE; STEM-CELLS; POTENTIAL USE; COLLAGEN; MECHANISMS; GELATIN; SYSTEM; VITRO; TRANSPLANTATION; STRATEGIES	Colon organoids (colonoids) are known to be similar to colon tissue in structure and function, which makes them useful in the treatment of intestinal de-epithelialized disease. Matrigel, which is used as a transplantation scaffold for colonoids, cannot be used in clinical applications because of its undefined composition and tumorigenicity. This study identifies clinically available scaffolds that are effective for colonoid transplantation in damaged intestinal mucosa. The colon crypt was isolated and cultured from C57BL/6-Tg[CAG enhanced green fluorescent protein (EGFP)131Osb/LeySopJ mice into EGFP + colonoids and subsequently transplanted into the EDTA colitis mouse model using gelatin, collagen, or fibrin glue scaffolds. To identify scaffolds suitable for colonoid engraftment in injured colon mucosa, the success rates of transplantation and secondary EGFP colonoid formation were measured, and the scaffolds' mediated toxicity in vitro and in vivo was observed in recipient mice. When colonoids were transplanted with gelatin, collagen, and fibrin glue into the EDTA colitis mouse model, all groups were found to be successfully engrafted. Fibrin glue, especially, showed significant increase in the engrafted area compared with Matrigel after 4 wk. The scaffolds used in the study did not induce colonic toxicity after transplantation into the recipients' colons and were thus deemed safe when locally administrated. This study suggests new methods for and provides evidence of the safety and utility of the clinical application of colonoid-based therapeutics. Furthermore, the methods introduced in this study will be helpful in developing cell treatment using the esophagus or a stomach organoid for various digestive-system diseases.-Jee, J., Jeong, S. Y., Kim, H. K., Choi, S. Y., Jeong, S., Lee, J., Ko, J. S., Kim, M. S., Kwon, M.-S., Yoo, J. In vivo evaluation of scaffolds compatible for colonoid engraftments onto injured mouse colon epithelium.	[Jee, JooHyun; Jeong, Sang Yun; Kim, Han Kyung; Choi, Seon Young; Jeong, Sukin; Lee, Joongwoon; Ko, Ji Su; Kim, Mi Sun; Yoo, Jongman] CHA Univ, Sch Med, Dept Microbiol, 712 CHA Bio Complex,335 Pangyo Ro, Seongnam Si 13488, Gyeonggi Do, South Korea; [Jee, JooHyun; Jeong, Sang Yun; Kim, Han Kyung; Choi, Seon Young; Jeong, Sukin; Lee, Joongwoon; Ko, Ji Su; Kim, Mi Sun; Kwon, Min-Soo; Yoo, Jongman] CHA Univ, Sch Med, CHA Organoid Res Ctr, 712 CHA Bio Complex,335 Pangyo Ro, Seongnam Si 13488, Gyeonggi Do, South Korea; [Kwon, Min-Soo] CHA Univ, Sch Med, Dept Pharmacol, Seongnam Si, Gyeonggi Do, South Korea	Pochon Cha University; Pochon Cha University; Pochon Cha University	Yoo, J (corresponding author), CHA Univ, Sch Med, Dept Microbiol, 712 CHA Bio Complex,335 Pangyo Ro, Seongnam Si 13488, Gyeonggi Do, South Korea.; Yoo, J (corresponding author), CHA Univ, Sch Med, CHA Organoid Res Ctr, 712 CHA Bio Complex,335 Pangyo Ro, Seongnam Si 13488, Gyeonggi Do, South Korea.	jongmanyoo@cha.ac.kr	Kwon, Minsoo/AAF-1224-2020	Kwon, Minsoo/0000-0002-2837-881X	Korea Health Technology Research & Development Project through the Korea Health Industry Development Institute - Ministry of Health and Welfare, Republic of Korea [HI16C1634, HI16C1559, HI17C2094, HI18C2458]; Basic Science Research Program through the National Research Foundation of Korea, Ministry of Science, Information and Communication Technology, and Future Planning, Republic of Korea [NRF-2018R1D1A1A02050030]	Korea Health Technology Research & Development Project through the Korea Health Industry Development Institute - Ministry of Health and Welfare, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea, Ministry of Science, Information and Communication Technology, and Future Planning, Republic of Korea(National Research Foundation of Korea)	This work was supported by a grant from the Korea Health Technology Research & Development Project through the Korea Health Industry Development Institute funded by the Ministry of Health and Welfare, Republic of Korea (Grants HI16C1634, HI16C1559, HI17C2094, HI18C2458) and the Basic Science Research Program through the National Research Foundation of Korea by the Ministry of Science, Information and Communication Technology, and Future Planning, Republic of Korea (Grant NRF-2018R1D1A1A02050030). The authors thank Enoch Park and Chang Lim Yoo (both of CHA University, Department of Microbiology and CHA Organoid Research Center, School of Medicine) for editing. The authors also thank Jong-Moon Park and Hookeun Lee (both of Gachon University, College of Pharmacy, Seongnam-si, Gyeonggi-do, Republic of Korea) for additional experiments. J.J., S.Y.J., H.K.K., S.Y.C., S.J., J.L., J.S.K., M.S.K., and M.-S.K. are first authors. The authors declare no conflicts of interest.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; [Anonymous], LARYNGOSCOPE; Balagholi S, 2018, J BIOMATER APPL, V33, P514, DOI 10.1177/0885328218799506; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BAUM CA, 1989, DIGEST DIS SCI, V34, P758, DOI 10.1007/BF01540349; Chattopadhyay S, 2014, BIOPOLYMERS, V101, P821, DOI 10.1002/bip.22486; Chowdhury SR, 2018, ADV EXP MED BIOL, V1077, P389, DOI 10.1007/978-981-13-0947-2_21; Colombel JF, 2017, GASTROENTEROLOGY, V152, P351, DOI 10.1053/j.gastro.2016.09.046; Danese S, 2011, ALIMENT PHARM THER, V33, P857, DOI 10.1111/j.1365-2036.2011.04598.x; Melo FDE, 2017, NATURE, V543, P676, DOI 10.1038/nature21713; Dignass AU, 2001, INFLAMM BOWEL DIS, V7, P68, DOI 10.1097/00054725-200102000-00014; Echave MC, 2017, CURR PHARM DESIGN, V23, P3567, DOI 10.2174/0929867324666170511123101; Georgopoulou A, 2018, J MATER SCI-MATER M, V29, DOI 10.1007/s10856-018-6064-2; Hamidabadi Hatef Ghasemi, 2018, Med Arch, V72, P88, DOI 10.5455/medarh.2018.72.88-93; Hong SN, 2017, STEM CELL TRANSL MED, V6, P666, DOI 10.5966/sctm.2016-0153; Kanayama Y, 2007, BIOL PHARM BULL, V30, P237, DOI 10.1248/bpb.30.237; Kassam A, 2003, NEUROSURGERY, V52, P1102, DOI 10.1227/01.NEU.0000057699.37541.76; Kleinman H K, 2001, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1002s00; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Koo BK, 2016, DEV BIOL, V420, P197, DOI 10.1016/j.ydbio.2016.10.017; Lai JY, 2007, TRANSPLANTATION, V84, P1222, DOI 10.1097/01.tp.0000287336.09848.39; Luo LJ, 2018, ACTA BIOMATER, V65, P123, DOI 10.1016/j.actbio.2017.11.018; Malik TA, 2015, SURG CLIN N AM, V95, P1105, DOI 10.1016/j.suc.2015.07.006; Malinda Katherine M., 2009, V467, P287, DOI 10.1007/978-1-59745-241-0_17; Mendenhall WM, 2014, AM J CLIN ONCOL-CANC, V37, P517, DOI 10.1097/COC.0b013e318271b1aa; Meneses Andre M C, 2016, Vet Sci, V3, DOI 10.3390/vetsci3040031; Miyoshi H, 2013, NAT PROTOC, V8, P2471, DOI 10.1038/nprot.2013.153; Nakamura T, 2018, CELL MOL GASTROENTER, V5, P51, DOI 10.1016/j.jcmgh.2017.10.006; Nakamura T, 2017, J GASTROENTEROL, V52, P151, DOI 10.1007/s00535-016-1288-8; O'Rourke KP, 2017, NAT BIOTECHNOL, V35, P577, DOI 10.1038/nbt.3837; Okamoto R, 2005, DIGEST DIS SCI, V50, pS34, DOI 10.1007/s10620-005-2804-5; Okamoto R, 2016, J GASTROENTEROL, V51, P11, DOI 10.1007/s00535-015-1098-4; Pang YG, 2010, J INVEST MED, V58, P845, DOI 10.231/JIM.0b013e3181ee81f7; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Rose JB, 2014, MATERIALS, V7, P3106, DOI 10.3390/ma7043106; Rosen MJ, 2015, JAMA PEDIATR, V169, P1053, DOI 10.1001/jamapediatrics.2015.1982; Shi JJ, 2007, ARCH IMMUNOL THER EX, V55, P61, DOI 10.1007/s00005-007-0009-7; Soreide E, 2018, J CELL BIOCHEM, V119, P5715, DOI 10.1002/jcb.26755; Sugimoto S, 2018, CELL STEM CELL, V22, P171, DOI 10.1016/j.stem.2017.11.012; Whelan D, 2014, J CONTROL RELEASE, V196, P1, DOI 10.1016/j.jconrel.2014.09.023; Yamashita S, 2002, J PAIN SYMPTOM MANAG, V24, P543, DOI 10.1016/S0885-3924(02)00498-0; Yang CL, 2004, BIODRUGS, V18, P103, DOI 10.2165/00063030-200418020-00004; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695	43	7	8	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10116	10125		10.1096/fj.201802692RR	http://dx.doi.org/10.1096/fj.201802692RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31211931	Bronze			2022-12-28	WOS:000482214200032
J	Nan, D; Jin, HQ; Deng, JW; Yu, WW; Liu, R; Sun, WP; Huang, YN				Nan, Ding; Jin, Haiqiang; Deng, Jianwen; Yu, Weiwei; Liu, Ran; Sun, Weiping; Huang, Yining			Cilostazol ameliorates ischemia/reperfusion-induced tight junction disruption in brain endothelial cells by inhibiting endoplasmic reticulum stress	FASEB JOURNAL			English	Article						Ischemia; reperfusion injury; blood-brain barrier disruption; endothelial cell; paracellular permeability	CEREBRAL-ISCHEMIA; HEMORRHAGIC TRANSFORMATION; BARRIER; STROKE; PROTECTS; PATHWAY; INJURY; PERMEABILITY; ACTIVATION; MECHANISMS	Endoplasmic reticulum (ER) stress is essential for brain ischemia/reperfusion (I/R) injury. However, whether it contributes to I/R-induced blood-brain barrier (BBB) injury remains unclear. cilostazol exerts protective effects toward I/R-induced BBB injury, with unclear mechanisms. This study explored the potential role of ER stress in I/R-induced endothelial cell damage and determined whether the therapeutic potential of cilostazol, with respect to I/R-induced endothelial cell damage, is related to inhibition of ER stress. We found that exposing brain endothelial cells (bEnd.3) to oxygen-glucose deprivation/reoxygenation (OGD/R) significantly activated ER stress and diminished the barrier function of cell monolayers; treatment with the ER stress inhibitor 4-phenylbutyric acid (4-PBA) or cilostazol prevented OGD/R-induced ER stress and preserved barrier function. Furthermore, OGD/R induced the expression and secretion of matrix metalloproteinase-9 and nuclear translocation of phosphorylated NF-kappa B. These changes were partially reversed by 4-PBA or cilostazol treatment. In vivo, 4-PBA or cilostazol significantly attenuated I/R-induced ER stress and ameliorated Evans blue leakage and tight junction loss. These results demonstrate that I/R-induced ER stress participates in BBB disruption. Targeting ER stress could be a useful strategy to protect the BBB from ischemic stroke, and cilostazol is a promising therapeutic agent for this process.-Nan, D., Jin, H., Deng, J., Yu, W., Liu, R., Sun, W., Huang, Y. Cilostazol ameliorates ischemia/reperfusion-induced tight junction disruption in brain endothelial cells by inhibiting endoplasmic reticulum stress.	[Nan, Ding; Jin, Haiqiang; Deng, Jianwen; Yu, Weiwei; Liu, Ran; Sun, Weiping; Huang, Yining] Peking Univ, Hosp 1, Dept Neurol, Beijing, Peoples R China	Peking University	Huang, YN (corresponding author), Peking Univ, Hosp 1, 8 Xishiku St, Beijing 100034, Peoples R China.	ynhuang@bjmu.edu.cn		Deng, Jianwen/0000-0003-1206-1778	National Natural Science Foundation of China [81400941]; Neurovascular Disease Discovery Laboratory (NDDL), Beijing [BZ0250]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Neurovascular Disease Discovery Laboratory (NDDL), Beijing	This work was supported by grants from the National Natural Science Foundation of China (81400941) and Neurovascular Disease Discovery Laboratory (NDDL), Beijing (BZ0250). The authors declare no conflicts of interest.	AKIYAMA H, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1133; Castellanos M, 2003, STROKE, V34, P40, DOI 10.1161/01.STR.0000046764.57344.31; Chen WJ, 2018, EXP CELL RES, V362, P83, DOI 10.1016/j.yexcr.2017.11.005; Chen XZ, 2008, J NEUROCHEM, V106, P1563, DOI 10.1111/j.1471-4159.2008.05501.x; Cho JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110086; DeGracia DJ, 2004, J NEUROCHEM, V91, P1, DOI 10.1111/j.1471-4159.2004.02703.x; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Duehrkop C, 2014, BIOCHEM PHARMACOL, V88, P12, DOI 10.1016/j.bcp.2013.12.013; Feng DY, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12395; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; He ZL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08052-4; Horai S, 2013, CELL MOL NEUROBIOL, V33, P291, DOI 10.1007/s10571-012-9896-1; Ishiguro M, 2011, CURR NEUROVASC RES, V8, P86, DOI 10.2174/156720211795495385; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kim KY, 2002, J PHARMACOL EXP THER, V300, P709, DOI 10.1124/jpet.300.2.709; Maestri NE, 1996, NEW ENGL J MED, V335, P855, DOI 10.1056/NEJM199609193351204; McColl BW, 2008, J NEUROSCI, V28, P9451, DOI 10.1523/JNEUROSCI.2674-08.2008; Nonaka Y, 2009, NEUROSCI LETT, V452, P156, DOI 10.1016/j.neulet.2009.01.039; Pan J, 2007, NEURORADIOLOGY, V49, P93, DOI 10.1007/s00234-006-0183-z; Paschen W, 2005, PHARMACOL THERAPEUT, V108, P362, DOI 10.1016/j.pharmthera.2005.05.008; Paschen W, 1999, J CEREBR BLOOD F MET, V19, P1, DOI 10.1097/00004647-199901000-00001; Planas AM, 2001, NEUROBIOL DIS, V8, P834, DOI 10.1006/nbdi.2001.0435; Qi X, 2004, MOL PHARMACOL, V66, P899, DOI 10.1124/mol.104.001339; Qie XJ, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00639; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Shu Q, 2018, J CELL BIOCHEM, V119, P6584, DOI 10.1002/jcb.26790; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tajes M, 2014, MOL MEMBR BIOL, V31, P152, DOI 10.3109/09687688.2014.937468; Tajiri S, 2004, CELL DEATH DIFFER, V11, P403, DOI 10.1038/sj.cdd.4401365; Tanaka Y, 2010, NEUROSCIENCE, V171, P1367, DOI 10.1016/j.neuroscience.2010.10.008; Torii H, 2007, PHARMACOL RES, V55, P104, DOI 10.1016/j.phrs.2006.10.010; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Watanabe T, 2013, BIOL PHARM BULL, V36, P492, DOI 10.1248/bpb.b12-00915; Xin Q, 2014, NEUROCHEM INT, V68, P18, DOI 10.1016/j.neuint.2014.02.001; Yamazaki H, 2009, J IMMUNOL, V183, P1480, DOI 10.4049/jimmunol.0900017; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yu ZH, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00319	39	24	24	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10152	10164		10.1096/fj.201900326R	http://dx.doi.org/10.1096/fj.201900326R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31184927				2022-12-28	WOS:000482214200035
J	Panizza, E; Zhang, L; Fontana, JM; Hamada, K; Svensson, D; Akkuratov, EE; Scott, L; Mikoshiba, K; Brismar, H; Lehtio, J; Aperia, A				Panizza, Elena; Zhang, Liang; Fontana, Jacopo Maria; Hamada, Kozo; Svensson, Daniel; Akkuratov, Evgeny E.; Scott, Lena; Mikoshiba, Katsuhiko; Brismar, Hjalmar; Lehtio, Janne; Aperia, Anita			Ouabain-regulated phosphoproteome reveals molecular mechanisms for Na+, K+-ATPase control of cell adhesion, proliferation, and survival	FASEB JOURNAL			English	Article						calcium and calmodulin-dependent protein kinase; phosphoproteomics; apoptosis; inositol triphosphate receptor; kidney	DEPENDENT PROTEIN-KINASE; TRIGGERED APOPTOSIS; CATALYTIC SUBUNIT; DOWN-REGULATION; PHOSPHORYLATION; SIGNAL; GROWTH; ACTIVATION; BIOCHEMISTRY; PROTEOLYSIS	The ion pump Na+, K+-ATPase (NKA) is a receptor for the cardiotonic steroid ouabain. Subsaturating concentration of ouabain triggers intracellular calcium oscillations, stimulates cell proliferation and adhesion, and protects from apoptosis. However, it is controversial whether ouabain-bound NKA is considered a signal transducer. To address this question, we performed a global analysis of protein phosphorylation in COS-7 cells, identifying 2580 regulated phosphorylation events on 1242 proteins upon 10- and 20-min treatment with ouabain. Regulated phosphorylated proteins include the inositol triphosphate receptor and stromal interaction molecule, which are essential for initiating calcium oscillations. Hierarchical clustering revealed that ouabain triggers a structured phosphorylation response that occurs in a well-defined, time-dependent manner and affects specific cellular processes, including cell proliferation and cell-cell junctions. We additionally identify regulation of the phosphorylation of several calcium and calmodulin-dependent protein kinases (CAMKs), including 2 sites of CAMK type II-gamma (CAMK2G), a protein known to regulate apoptosis. To verify the significance of this result, CAMK2G was knocked down in primary kidney cells. CAMK2G knockdown impaired ouabain-dependent protection from apoptosis upon treatment with high glucose or serum deprivation. In conclusion, we establish NKA as the coordinator of a broad, tightly regulated phosphorylation response in cells and define CAMK2G as a downstream effector of NKA.-Panizza, E., Zhang, L., Fontana, J. M., Hamada, K., Svensson, D., Akkuratov, E. E., Scott, L., Mikoshiba, K., Brismar, H., Lehtio, J., Aperia, A. Ouabain-regulated phosphoproteome reveals molecular mechanisms for Na+, K+-ATPase control of cell adhesion, proliferation, and survival.	[Panizza, Elena; Lehtio, Janne] Karolinska Inst, Sci Life Lab, Dept Oncol Pathol, Solna, Sweden; [Zhang, Liang; Svensson, Daniel; Scott, Lena; Brismar, Hjalmar; Aperia, Anita] Karolinska Inst, Dept Womens & Childrens Hlth, Solna, Sweden; [Fontana, Jacopo Maria; Akkuratov, Evgeny E.; Brismar, Hjalmar] Royal Inst Technol, Sci Life Lab, Dept Appl Phys, Stockholm, Sweden; [Hamada, Kozo; Mikoshiba, Katsuhiko] RIKEN, Brain Sci Inst, Lab Dev Neurobiol, Saitama, Japan; [Panizza, Elena] Cornell Univ, Ithaca, NY USA	Karolinska Institutet; Karolinska Institutet; Royal Institute of Technology; RIKEN; Cornell University	Lehtio, J (corresponding author), Res Grp Lehtio, Sci Life Lab, Dept Oncol Pathol, Mass Spectrometry, K7,Tomtebodavagen 23A,Alfa Floor 1, S-17165 Stockholm, Sweden.; Aperia, A (corresponding author), Karolinska Inst, Sci Life Lab, Dept Womens & Childrens Hlth KBH, K6,Box 1031, S-17121 Solna, Sweden.	janne.lehtio@ki.se; anita.aperia@ki.se	Fontana, Jacopo Maria/GQP-4980-2022; Brismar, Hjalmar/E-8524-2011; Fontana, Jacopo Maria/AAC-4766-2022; Svensson, Daniel/C-6279-2014	Brismar, Hjalmar/0000-0003-0578-4003; Fontana, Jacopo Maria/0000-0003-4784-4713; Svensson, Daniel/0000-0001-6670-2142; Panizza, Elena/0000-0003-3490-4107; Zhang, Liang/0000-0001-6967-7384; Akkuratov, Evgeny/0000-0002-2552-9512	Swedish Research Council (VR); Swedish Foundation for Strategic Research (SSF); Swedish Cancer Society (Cancerfonden); Erling-Persson Family Foundation; Marta and Gunnar V. Philipsons Foundation; Swedish Childhood Cancer Society (Barncancerfonden); Karolinska Institutet Doctoral (KID) fund; Novo Nordisk; Karolinska Institutet	Swedish Research Council (VR)(Swedish Research Council); Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Erling-Persson Family Foundation; Marta and Gunnar V. Philipsons Foundation; Swedish Childhood Cancer Society (Barncancerfonden); Karolinska Institutet Doctoral (KID) fund; Novo Nordisk(Novo Nordisk); Karolinska Institutet(Karolinska Institutet)	This work was supported by the Swedish Research Council (VR), the Swedish Foundation for Strategic Research (SSF), the Swedish Cancer Society (Cancerfonden), the Erling-Persson Family Foundation, the Marta and Gunnar V. Philipsons Foundation, the Swedish Childhood Cancer Society (Barncancerfonden), and the Karolinska Institutet Doctoral (KID) funding. D.S. is supported by a Novo Nordisk postdoctoral fellowship run in partnership with the Karolinska Institutet. The authors declare no conflicts of interest.	Abramowitz J, 2003, CIRCULATION, V108, P3048, DOI 10.1161/01.CIR.0000101919.00548.86; Allen JC, 2003, ANN NY ACAD SCI, V986, P504, DOI 10.1111/j.1749-6632.2003.tb07235.x; Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711; Barrera LA, 2016, SCIENCE, V351, P1450, DOI 10.1126/science.aad2257; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Branca RMM, 2014, NAT METHODS, V11, P59, DOI [10.1038/NMETH.2732, 10.1038/nmeth.2732]; Burlaka I, 2016, KIDNEY INT, V90, P135, DOI 10.1016/j.kint.2016.03.026; Burlaka I, 2013, J AM SOC NEPHROL, V24, P1413, DOI 10.1681/ASN.2012101044; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Chou Michael F, 2011, Curr Protoc Bioinformatics, VChapter 13, DOI [10.1002/0471250953.bi1315s35, 10.1002/0471250953.bi1316s36]; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Diaz F, 2000, CELL CALCIUM, V27, P315, DOI 10.1054/ceca.2000.0126; Dmitrieva RI, 2003, J BIOL CHEM, V278, P28160, DOI 10.1074/jbc.M303768200; Douglass J, 2012, AM J PHYSIOL-CELL PH, V303, pC715, DOI 10.1152/ajpcell.00166.2012; Duan GY, 2015, NUCLEIC ACIDS RES, V43, pD531, DOI 10.1093/nar/gku1009; Dvela-Levitt M, 2015, J AM SOC NEPHROL, V26, P1103, DOI 10.1681/ASN.2014020130; Feldmann T, 2011, CELL CALCIUM, V50, P424, DOI 10.1016/j.ceca.2011.07.001; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gao TS, 2013, NUCLEIC ACIDS RES, V41, pD445, DOI 10.1093/nar/gks1103; Ghadhanfar E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108909; Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200; Habib SL, 2013, WORLD J DIABETES, V4, P27, DOI 10.4239/wjd.v4.i2.27; Hamada K, 2017, P NATL ACAD SCI USA, V114, P4661, DOI 10.1073/pnas.1701420114; Hamlyn JM, 2016, HYPERTENSION, V68, P526, DOI 10.1161/HYPERTENSIONAHA.116.06599; Ho J, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00128; Hojabrpour P, 2012, BIOCHEM J, V442, P139, DOI 10.1042/BJ20111256; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Khundmiri SJ, 2006, AM J PHYSIOL-CELL PH, V291, pC1247, DOI 10.1152/ajpcell.00593.2005; Kometiani P, 1998, J BIOL CHEM, V273, P15249, DOI 10.1074/jbc.273.24.15249; Larre I, 2010, P NATL ACAD SCI USA, V107, P11387, DOI 10.1073/pnas.1000500107; Lee HJ, 2012, MOL BIOL CELL, V23, P1376, DOI 10.1091/mbc.E11-07-0634; Li JA, 2006, J AM SOC NEPHROL, V17, P1848, DOI 10.1681/ASN.2005080894; Li JA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1043; Li ZC, 2009, PFLUG ARCH EUR J PHY, V457, P635, DOI 10.1007/s00424-008-0470-0; Liu LJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1489, DOI 10.1152/ajpcell.00158.2007; Liu X, 2008, J BIOL CHEM, V283, P11461, DOI 10.1074/jbc.M706942200; Maes K, 2001, J BIOL CHEM, V276, P3492, DOI 10.1074/jbc.M006082200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Miyakawa-Naito A, 2003, J BIOL CHEM, V278, P50355, DOI 10.1074/jbc.M305378200; Mohammadi K, 2003, J CARDIOVASC PHARM, V41, P609, DOI 10.1097/00005344-200304000-00014; Murata Y, 1996, JPN J PHARMACOL, V72, P347, DOI 10.1254/jjp.72.347; Nyblom M, 2013, SCIENCE, V342, P123, DOI 10.1126/science.1243352; Okuno S, 2001, J BIOCHEM, V130, P503, DOI 10.1093/oxfordjournals.jbchem.a003013; Panizza E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04798-z; Peng M, 1996, J BIOL CHEM, V271, P10372, DOI 10.1074/jbc.271.17.10372; Ponce A, 2016, CELL PHYSIOL BIOCHEM, V39, P1329, DOI 10.1159/000447837; Ponce A, 2014, CELL PHYSIOL BIOCHEM, V34, P2081, DOI 10.1159/000366403; Pongrakhananon V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068623; Roth KA, 2001, MENT RETARD DEV D R, V7, P261, DOI 10.1002/mrdd.1036; Schoner W, 2005, SEMIN NEPHROL, V25, P343, DOI 10.1016/j.semnephrol.2005.03.010; Shekarabi M, 2017, CELL METAB, V25, P285, DOI 10.1016/j.cmet.2017.01.007; Stratton MM, 2013, CURR OPIN STRUC BIOL, V23, P292, DOI 10.1016/j.sbi.2013.04.002; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Thillaiappan NB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01644-8; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Tomas-Martin P, 2015, CELL SIGNAL, V27, P545, DOI 10.1016/j.cellsig.2014.12.017; Trebak M, 2012, J PHYSIOL-LONDON, V590, P4201, DOI 10.1113/jphysiol.2012.233353; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; Uhlen P, 2010, BIOCHEM BIOPH RES CO, V396, P28, DOI 10.1016/j.bbrc.2010.02.117; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wang LW, 2017, J BIOL CHEM, V292, P11714, DOI 10.1074/jbc.M117.789917; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wojcikiewicz RJH, 1999, GASTROENTEROLOGY, V116, P1194, DOI 10.1016/S0016-5085(99)70023-5; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; YODA A, 1974, ANN NY ACAD SCI, V242, P598, DOI 10.1111/j.1749-6632.1974.tb19120.x; Zandy NL, 2007, P NATL ACAD SCI USA, V104, P17686, DOI 10.1073/pnas.0703077104; Zhang SB, 2006, J BIOL CHEM, V281, P21954, DOI 10.1074/jbc.M601578200	72	13	13	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10193	10206		10.1096/fj.201900445R	http://dx.doi.org/10.1096/fj.201900445R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31199885	Green Published, hybrid			2022-12-28	WOS:000482214200038
J	Cai, L; Brophy, RH; Tycksen, ED; Duan, X; Nunley, RM; Rai, MF				Cai, Lei; Brophy, Robert H.; Tycksen, Eric D.; Duan, Xin; Nunley, Ryan M.; Rai, Muhammad Farooq			Distinct expression pattern of periostin splice variants in chondrocytes and ligament progenitor cells	FASEB JOURNAL			English	Article						cartilage; anterior cruciate ligament; periostin isoforms; RNA-seq; osteoarthritis	NF-KAPPA-B; GENE-EXPRESSION; PERIODONTAL-LIGAMENT; EXTRACELLULAR-MATRIX; TUMOR-SUPPRESSOR; POOR-PROGNOSIS; CARTILAGE; ISOFORMS; PROTEIN; OVEREXPRESSION	Periostin (POSTN), a secretory matricellular matrix protein, plays a multitude of biologic functions. Various splice variants of POSTN have been described; however, their expression pattern and functional implications are not completely understood. This study was undertaken to decipher the differential expression pattern of POSTN and its splice variants in various tissues and cell types. We show that POSTN was more highly expressed in anterior cruciate ligament (ACL) remnants compared with articular cartilage at the cellular and tissue level. Isoforms 1 and 8 were highly expressed only in articular chondrocytes, suggesting their splice-specific regulation in chondrocytes. To discern the role of total POSTN and full-length human POSTN isoform 1 (hPOSTN-001), we stably transfected human chondrosarcoma 1 (hCh-1) cell line with hPOSTN-001 using a pcDNA3.1-hPOSTN-001 construct. RNA-sequencing analysis of hCh-1 cells identified differentially expressed genes with a known role in chondrocyte function and osteoarthritis. Similar expression of a subset of candidate genes was revealed in ACL progenitor cells and chondrocytes as well as in ACL progenitor cells in which POSTN activity was altered by overexpression and by small interfering RNA gene knockdown. Cells expressing total POSTN, not isoform 1, exhibited increased cell adhesion potential. These findings suggest an important role for POSTN in the knee.-Cai, L., Brophy, R. H., Tycksen, E. D., Duan, X., Nunley, R. M., Rai, M. F. Distinct expression pattern of periostin splice variants in chondrocytes and ligament progenitor cells.	[Cai, Lei; Brophy, Robert H.; Duan, Xin; Nunley, Ryan M.; Rai, Muhammad Farooq] Washington Univ, Sch Med, Musculoskeletal Res Ctr, Dept Orthopaed Surg, Campus Box 8233,660 South Euclid Ave, St Louis, MO 63110 USA; [Tycksen, Eric D.] Washington Univ, Sch Med, Genome Technol Access Ctr, St Louis, MO 63110 USA; [Rai, Muhammad Farooq] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Rai, MF (corresponding author), Washington Univ, Sch Med, Musculoskeletal Res Ctr, Dept Orthopaed Surg, Campus Box 8233,660 South Euclid Ave, St Louis, MO 63110 USA.	rai.m@wustl.edu	Brophy, Robert H/AAX-8562-2021; Farooq, Muhammad/ABE-6335-2021	Brophy, Robert H/0000-0002-2912-8265; Tycksen, Eric/0000-0001-6362-0141	Department of Orthopaedic Surgery, Washington University; U.S. National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R00-AR-064837]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R00AR064837] Funding Source: NIH RePORTER	Department of Orthopaedic Surgery, Washington University; U.S. National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Washington University Genome Technology Access Center (GTAC) for assistance with RNA-seq analysis. This study was supported by research funds provided by the Department of Orthopaedic Surgery, Washington University. Dr. M. F. Rai is supported through the Pathway to Independence Award (R00-AR-064837) from the U.S. National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or NIAMS. The authors declare no conflicts of interest.	Attur M, 2015, FASEB J, V29, P4107, DOI 10.1096/fj.15-272427; Bai YH, 2010, JPN CLIN MED, V1, P13, DOI 10.4137/JCM.S5899; Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Brophy RH, 2018, OSTEOARTHR CARTILAGE, V26, P422, DOI 10.1016/j.joca.2017.12.004; Brophy RH, 2016, AM J SPORT MED, V44, P2064, DOI 10.1177/0363546516643810; Brophy RH, 2012, J BONE JOINT SURG AM, V94A, P385, DOI 10.2106/JBJS.K.00919; Buczkowicz P, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00147; Byrne JA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-497; Chamberlain CS, 2013, ANN BIOMED ENG, V41, P477, DOI 10.1007/s10439-012-0689-y; Chansky H, 1998, J ORTHOPAED RES, V16, P521, DOI 10.1002/jor.1100160502; Chen YJ, 2018, J CLIN MED, V7, DOI 10.3390/jcm7120535; Chijimatsu R, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0682-3; Chinzei N, 2018, OSTEOARTHR CARTILAGE, V26, P588, DOI 10.1016/j.joca.2018.01.017; Clohisy JC, 2003, J IMMUNOL, V171, P5547, DOI 10.4049/jimmunol.171.10.5547; Cobo T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147837; Conway SJ, 2014, CELL MOL LIFE SCI, V71, P1279, DOI 10.1007/s00018-013-1494-y; Coutu DL, 2008, J BIOL CHEM, V283, P17991, DOI 10.1074/jbc.M708029200; del Valle I, 2013, DEVELOPMENT, V140, P1684, DOI 10.1242/dev.088690; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Giusca SE, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8701386; Hoersch S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-30; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Hu F, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-287; Ismail RS, 2000, CANCER RES, V60, P6744; Kim CJ, 2008, INT J ONCOL, V32, P161; Kim CJ, 2011, INT J ONCOL, V38, P1759, DOI 10.3892/ijo.2011.997; Kumar SR, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3134-7; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Litherland GJ, 2010, J BIOL CHEM, V285, P22414, DOI 10.1074/jbc.M110.120121; Little D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096526; Litvin J, 2004, J CELL BIOCHEM, V92, P1044, DOI 10.1002/jcb.20115; Liu CX, 2001, J BIOL CHEM, V276, P28889, DOI 10.1074/jbc.M102727200; Liu RJ, 2015, NUCLEIC ACIDS RES, V43, pE97, DOI 10.1093/nar/gkv412; Lock JG, 2008, SEMIN CANCER BIOL, V18, P65, DOI 10.1016/j.semcancer.2007.10.001; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Morra L, 2011, AM J PATHOL, V179, P1513, DOI 10.1016/j.ajpath.2011.05.035; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Ozdemir C, 2014, GENE, V553, P130, DOI 10.1016/j.gene.2014.10.014; Padial-Molina M, 2014, J PERIODONTAL RES, V49, P405, DOI 10.1111/jre.12120; Rai MF, 2018, J ORTHOP RES, V36, P484, DOI 10.1002/jor.23661; Rios HF, 2008, J PERIODONTOL, V79, P1480, DOI [10.1902/jop.2008.070624, 10.1902/jop.2008.070624 ]; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roman-Blas JA, 2006, OSTEOARTHR CARTILAGE, V14, P839, DOI 10.1016/j.joca.2006.04.008; Shih Barbara, 2009, Hand (N Y), V4, P294, DOI 10.1007/s11552-009-9164-0; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Tilman G, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-80; Viloria Katrina, 2016, BioMolecular Concepts, V7, P117, DOI 10.1515/bmc-2016-0004; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang W, 2014, INT J CLIN EXP PATHO, V7, P593; Wei YC, 2018, ONCOTARGETS THER, V11, P3205, DOI 10.2147/OTT.S163626; Zhang L, 2015, J MOL MED, V93, P691, DOI 10.1007/s00109-015-1255-5; ZHAO SL, 2014, BIOMED RES INT, DOI DOI 10.1155/2014/986048; Zhu SM, 2008, J HISTOCHEM CYTOCHEM, V56, P329, DOI 10.1369/jhc.7A7321.2007; Zhu SM, 2009, J CELL PHYSIOL, V218, P584, DOI 10.1002/jcp.21633	58	16	16	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8386	8405		10.1096/fj.201802281R	http://dx.doi.org/10.1096/fj.201802281R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30991832	Green Published			2022-12-28	WOS:000476234700047
J	De Palma, RM; Parnham, SR; Lo, YT; Oaks, JJ; Peterson, YK; Szulc, ZM; Roth, BM; Xing, YN; Ogretmen, B				De Palma, Ryan M.; Parnham, Stuart R.; Lo, Yitong; Oaks, Joshua J.; Peterson, Yuri K.; Szulc, Zdzislaw M.; Roth, Braden M.; Xing, Yongna; Ogretmen, Besim			The NMR-based characterization of the FTY720-SET complex reveals an alternative mechanism for the attenuation of the inhibitory SET-PP2A interaction	FASEB JOURNAL			English	Article						ceramide; sphingolipid; fingolimod; lipid-protein binding	PROTEIN PHOSPHATASE 2A; TRANSFER DIFFERENCE NMR; TUMOR-SUPPRESSOR PP2A; ACTIVATING FACTOR-I; COUPLING-CONSTANTS; STRUCTURAL BASIS; SKELETAL-MUSCLE; OKADAIC ACID; CELL-GROWTH; SET	The su(var)3-9, enhancer of zeste, trithorax (SET)/inhibitor 2 of protein phosphatase 2A (PP2A) oncoprotein binds and inhibits PP2A, composed of various isoforms of scaffolding, regulatory, and catalytic subunits. Targeting SET with a sphingolipid analog drug fingolimod (FTY720) or ceramide leads to the reactivation of tumor suppressor PP2A. However, molecular details of the SET-FTY720 or SET-ceramide, and mechanism of FTY720-dependent PP2A activation, remain unknown. Here, we report the first in solution examination of the SET-FTY720 or SET-ceramide complexes by NMR spectroscopy. FTY720-ceramide binding resulted in chemical shifts of residues residing at the N terminus of SET, preventing its dimerization or oligomerization. This then released SET from PP2AC alpha, resulting in PP2A activation, while monomeric SET remained associated with the B56 gamma. Our data also suggest that the PP2A holoenzyme, composed of PP2A-A beta, PP2A-B56 gamma, and PP2AC alpha subunits, is selectively activated in response to the formation of the SET-FTY720 complex in A549 cells. Various PP2A-associated downstream effector proteins in the presence or absence of FTY720 were then identified by stable isotope labeling with amino cells in cell culture, including tumor suppressor nonmuscle myosin IIA. Attenuation of FTY720-SET association by point mutations of residues that are involved in FTY720 binding or dephosphorylation of SET at Serine 171, enhanced SET oligomerization and the formation of the SET-PP2A inhibitory complex, leading to resistance to FTY720-dependent PP2A activation.-De Palma, R. M., Parnham, S. R., Li, Y., Oaks, J. J., Peterson, Y. K., Szulc, Z. M., Roth, B. M., Xing, Y., Ogretmen, B. The NMR-based characterization of the FTY720-SET complex reveals an alternative mechanism for the attenuation of the inhibitory SET-PP2A interaction.	[De Palma, Ryan M.; Szulc, Zdzislaw M.; Roth, Braden M.; Ogretmen, Besim] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [De Palma, Ryan M.; Szulc, Zdzislaw M.; Roth, Braden M.; Ogretmen, Besim] Med Univ South Carolina, Hollings Canc Ctr, 86 Jonathan Lucas St, Charleston, SC 29425 USA; [Peterson, Yuri K.] Med Univ South Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA; [Parnham, Stuart R.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA; [Lo, Yitong; Xing, Yongna] Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA; [Oaks, Joshua J.] Phanes Therapeut, San Diego, CA USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; University of North Carolina; University of North Carolina Chapel Hill; University of Wisconsin System; University of Wisconsin Madison	Ogretmen, B (corresponding author), Med Univ South Carolina, Hollings Canc Ctr, 86 Jonathan Lucas St, Charleston, SC 29425 USA.	ogretmen@musc.edu	Li, Yitong/V-9378-2018; Roth, Braden/L-9386-2015	Li, Yitong/0000-0002-7866-8460; De Palma, Ryan/0000-0001-7460-5676; Roth, Braden/0000-0001-7559-7671	U.S. National Institutes of Health (NIH) National Cancer Institute [CA088932, CA173687, CA214461, P01 CA203628]; NIH National Institute of Dental and Craniofacial Research [DE016572]; NIH National Center for Research Resources [C06 RR015455]; Hollings Cancer Center Support Grant [P30 CA138313]; Center of Biomedical Research Excellence (CoBRE) in Lipidomics and Pathobiology [P30 GM103339]; NATIONAL CANCER INSTITUTE [P30CA138313, R01CA214461, P01CA203628, R01CA173687, R01CA088932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103339] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Hollings Cancer Center Support Grant; Center of Biomedical Research Excellence (CoBRE) in Lipidomics and Pathobiology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Aiping Bai and Mr. Jason Pierce for help in ceramide measurements at the Lipidomics Shared Resource facility, Department of Biochemistry and Molecular Biology, Medical University of South Carolina. The authors also thank Mr. Brett Bechtol (Hollings Cancer Center, Medical University of South Carolina) for editorial review and assistance. The authors thank the members of the B.O. laboratory for technical support and helpful discussions. The authors also thank Dr. Do-Sung Kim (Department of Biochemistry and Molecular Biology, Hollings Cancer Center, Medical University of South Carolina) for help and assistance in our experimental procedures. This work is supported by research funding from the U.S. National Institutes of Health (NIH) National Cancer Institute (CA088932, CA173687, CA214461, and P01 CA203628, to B.O.), and the NIH National Institute of Dental and Craniofacial Research (DE016572, to B.O.). The core facilities utilized were constructed using support from NIH National Center for Research Resources (C06 RR015455), Hollings Cancer Center Support Grant (P30 CA138313), or Center of Biomedical Research Excellence (CoBRE) in Lipidomics and Pathobiology (P30 GM103339). B.O. is the founder and Chief Scientific Officer of LipoImmuno Tech, LLC., and Z.M.S. is the director of synthetic chemistry of the Lipo-Immuno Tech. The authors declare no conflicts of interest.	Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; Agarwal A, 2014, CLIN CANCER RES, V20, P2092, DOI 10.1158/1078-0432.CCR-13-2575; Amati F, 2011, DIABETES, V60, P2588, DOI 10.2337/db10-1221; Anazawa Y, 2005, CANCER RES, V65, P4578, DOI 10.1158/0008-5472.CAN-04-4564; Bharath LP, 2015, DIABETES, V64, P3914, DOI 10.2337/db15-0244; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Boyer RD, 2003, J MAGN RESON, V165, P253, DOI 10.1016/j.jmr.2003.08.009; BRAUTIGAN DL, 1995, SEMIN CANCER BIOL, V6, P211, DOI 10.1006/scbi.1995.0028; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Carlson SG, 1998, J AM SOC NEPHROL, V9, P1873; Chalfant CE, 2004, J LIPID RES, V45, P496, DOI 10.1194/jlr.M300347-JLR200; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Chen LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103033; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen WB, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/675429; Christensen DJ, 2011, BLOOD, V118, P4150, DOI 10.1182/blood-2011-04-351072; Cicero DO, 2001, J MAGN RESON, V148, P209, DOI 10.1006/jmre.2000.2234; Deichmann M, 2001, MELANOMA RES, V11, P577, DOI 10.1097/00008390-200112000-00004; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; Favier A, 2011, J BIOMOL NMR, V49, P9, DOI 10.1007/s10858-010-9461-5; FAVRE B, 1994, J BIOL CHEM, V269, P16311; Furuya H, 2011, CANCER METAST REV, V30, P567, DOI 10.1007/s10555-011-9304-1; GRIESINGER C, 1987, J MAGN RESON, V75, P474, DOI 10.1016/0022-2364(87)90102-8; GUO H, 1993, J BIOL CHEM, V268, P11193; Herzog F, 2012, SCIENCE, V337, P1348, DOI 10.1126/science.1221483; Irie A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051242; Janghorban M, 2014, P NATL ACAD SCI USA, V111, P9157, DOI 10.1073/pnas.1317630111; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Johnson CS, 1999, PROG NUCL MAG RES SP, V34, P203, DOI 10.1016/S0079-6565(99)00003-5; Karetsou Z, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-10; Koyrakh L, 2005, AM J TRANSPLANT, V5, P529, DOI 10.1111/j.1600-6143.2005.00754.x; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Miyaji-Yamaguchi M, 1999, J MOL BIOL, V290, P547, DOI 10.1006/jmbi.1999.2898; Mukhopadhyay A, 2013, CANCER BIOL THER, V14, P962, DOI 10.4161/cbt.25943; Mukhopadhyay A, 2009, FASEB J, V23, P751, DOI 10.1096/fj.08-120550; Muto S, 2007, P NATL ACAD SCI USA, V104, P4285, DOI 10.1073/pnas.0603762104; Nagahara Y, 2001, JPN J CANCER RES, V92, P680, DOI 10.1111/j.1349-7006.2001.tb01148.x; NAGATA K, 1995, P NATL ACAD SCI USA, V92, P4279, DOI 10.1073/pnas.92.10.4279; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Neviani P, 2014, CLIN CANCER RES, V20, P2026, DOI 10.1158/1078-0432.CCR-14-0166; Nilsson M, 2009, J MAGN RESON, V200, P296, DOI 10.1016/j.jmr.2009.07.022; Nobumori Y, 2013, MOL CANCER RES, V11, P995, DOI 10.1158/1541-7786.MCR-12-0633; Oaks JJ, 2013, BLOOD, V122, P1923, DOI 10.1182/blood-2013-03-492181; Ouellet V, 2006, INT J CANCER, V119, P2119, DOI 10.1002/ijc.22054; Rai V, 2011, EUKARYOT CELL, V10, P604, DOI 10.1128/EC.00296-10; Roberts KG, 2010, CANCER RES, V70, P5438, DOI 10.1158/0008-5472.CAN-09-2544; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Saddoughi SA, 2013, EMBO MOL MED, V5, P105, DOI 10.1002/emmm.201201283; Saito S, 1999, BIOCHEM BIOPH RES CO, V259, P471, DOI 10.1006/bbrc.1999.0790; Saito S, 2004, INT J CANCER, V111, P501, DOI 10.1002/ijc.20296; Saydam G, 2003, LEUKEMIA RES, V27, P709, DOI 10.1016/S0145-2126(02)00347-8; Schramek D, 2014, SCIENCE, V343, P309, DOI 10.1126/science.1248627; Schulte-Herbruggen T, 2000, J MAGN RESON, V144, P123, DOI 10.1006/jmre.2000.2020; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Shouse GP, 2010, ONCOGENE, V29, P3933, DOI 10.1038/onc.2010.161; Stanevich V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086955; Stanevich V, 2011, MOL CELL, V41, P331, DOI 10.1016/j.molcel.2010.12.030; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; SUGANUMA M, 1988, P NATL ACAD SCI USA, V85, P1768, DOI 10.1073/pnas.85.6.1768; Tamaki M, 2004, ONCOL REP, V11, P655; Vasudevan NT, 2011, MOL CELL, V41, P636, DOI 10.1016/j.molcel.2011.02.025; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wagner R, 1996, J MAGN RESON SER A, V123, P119, DOI 10.1006/jmra.1996.0222; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; WU DH, 1995, J MAGN RESON SER A, V115, P260, DOI 10.1006/jmra.1995.1176; Wuthrich K, 1976, NMR BIOL RES PEPTIDE; Xing Y, 2006, CELL, V127, P341, DOI 10.1016/j.cell.2006.09.025; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Xu Z, 2010, ACTA CRYSTALLOGR F, V66, P926, DOI 10.1107/S1744309110021779; Yu G, 2013, NEUROBIOL AGING, V34, P1748, DOI 10.1016/j.neurobiolaging.2012.12.025; Zhou J, 2003, BIOCHEM J, V369, P387, DOI 10.1042/BJ20021244	77	22	22	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7647	7666		10.1096/fj.201802264R	http://dx.doi.org/10.1096/fj.201802264R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30917007	Green Published, Bronze			2022-12-28	WOS:000476114200079
J	Ravindran, D; Cartland, SP; Bursill, CA; Kavurma, MM				Ravindran, Dhanya; Cartland, Sian P.; Bursill, Christina A.; Kavurma, Mary M.			Broad-spectrum chemokine inhibition blocks inflammation-induced angiogenesis, but preserves ischemia-driven angiogenesis	FASEB JOURNAL			English	Article						M3; chemokine blockade; blood vessel remodeling	SMOOTH-MUSCLE-CELLS; FRACTALKINE RECEPTOR CX(3)CR1; ENDOTHELIAL GROWTH-FACTOR; INTIMAL HYPERPLASIA; MOUSE MODEL; NEOINTIMA FORMATION; IN-VIVO; TUMOR ANGIOGENESIS; LIMB ISCHEMIA; INJURY	M3 is a broad-spectrum chemokine-binding protein that inactivates inflammatory chemokines, including CCL2, CCL5, and CX(3)CL1. The aim of this study was to compare whether M3 could inhibit angiogenesis driven by inflammation or ischemia. Here, apolipoprotein E-/- mice were injected with adenoviral M3 (AdM3) or control adenoviral green fluorescent protein (AdGFP) 3 d prior to stimulating angiogenesis using 2 established models that distinctly represent inflammatory or ischemia-driven angiogenesis, namely the periarterial femoral cuff and hind limb ischemia. AdM3 reduced intimal thickening, adventitial capillary density, and macrophage accumulation in femoral arteries 21 d after periarterial femoral cuff placement compared with AdGFP-treated mice (P < 0.05). AdM3 also reduced mRNA expression of proangiogenic VEGF, inflammatory markers IL-6 and IL-1 beta, and vascular smooth muscle cell (VSMC)-activated synthetic markers Kriippel-like family of transcription factor 4 (KLF4) and platelet-derived growth factor receptor beta (PDGFR beta) in the inflammatory cuff model. In contrast, capillary density, VSMC content, blood flow perfusion, and VEGF gene expression were unaltered between groups in skeletal muscle following hind limb ischemia. In vitro, AdM3 significantly reduced human microvascular endothelial cell 1 proliferation, migration, and tubule formation by similar to 17, 71.3, and 8.7% (P < 0.05) in macrophage-conditioned medium associating with reduced VEGF and hypoxia-inducible factor la mRNA but not in hypoxia (1% O-2). Compared with AdGFP, AdM3 also inhibited VSMC proliferation and migration and reduced mRNA expression of KLF4 and PDGFRI3 under inflammatory conditions. In contrast, AdM3 had no effect on VSMC processes in response to hypoxia in vitro. Our findings show that broad-spectrum inhibition of inflammatory chemokines by M3 inhibits inflammatory-driven but not ischemia-driven angiogenesis, presenting a novel strategy for the treatment of diseases associated with inflammatory-driven angiogenesis.	[Ravindran, Dhanya; Cartland, Sian P.; Kavurma, Mary M.] Heart Res Inst, 7 Eliza St, Sydney, NSW 2042, Australia; [Ravindran, Dhanya; Cartland, Sian P.; Kavurma, Mary M.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Bursill, Christina A.] South Australian Hlth & Med Res Inst, Heart Hlth, Adelaide, SA, Australia	University of Sydney; Heart Research Institute; University of Sydney; South Australian Health & Medical Research Institute (SAHMRI)	Kavurma, MM (corresponding author), Heart Res Inst, 7 Eliza St, Sydney, NSW 2042, Australia.	mary.kavurma@hri.org.au		Bursill, Christina/0000-0002-0682-8760; Cartland, Sian/0000-0003-1723-2679				ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Barcelos LS, 2004, INFLAMM RES, V53, P576, DOI 10.1007/s00011-004-1299-4; Basatemur GL, 2019, NAT REV CARDIOL, V16, P727, DOI [10.1038/s41569-019-0227-9, 10.1161/CIRCRESAHA.115.306361]; Bhardwaj S, 2011, ATHEROSCLEROSIS, V219, P84, DOI 10.1016/j.atherosclerosis.2011.07.103; Bosco MC, 2004, J IMMUNOL, V172, P1681, DOI 10.4049/jimmunol.172.3.1681; Brenes RA, 2012, J VASC SURG, V56, P1669, DOI 10.1016/j.jvs.2012.04.067; Cai JJ, 2015, ARTERIOSCL THROM VAS, V35, P2579, DOI 10.1161/ATVBAHA.115.305789; Camare C, 2017, REDOX BIOL, V12, P18, DOI 10.1016/j.redox.2017.01.007; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Carmeliet P, 1998, CARDIOVASC RES, V39, P8, DOI 10.1016/S0008-6363(98)00108-4; Cartland SP, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122025; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chan J, 2010, CIRC RES, V106, P1061, DOI 10.1161/CIRCRESAHA.109.206029; CHANG MW, 1995, J CLIN INVEST, V96, P2260, DOI 10.1172/JCI118281; Chen TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113752; Conway EM, 2001, CARDIOVASC RES, V49, P507, DOI 10.1016/S0008-6363(00)00281-9; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Dar A, 2006, EXP HEMATOL, V34, P967, DOI 10.1016/j.exphem.2006.04.002; Denger S, 1999, ATHEROSCLEROSIS, V144, P15, DOI 10.1016/S0021-9150(99)00033-7; Dewald O, 2005, CIRC RES, V96, P881, DOI 10.1161/01.RES.0000163017.13772.3a; Di Bartolo BA, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002527; Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036; Egashira K, 2002, CIRC RES, V90, P1167, DOI 10.1161/01.RES.0000020561.03244.7E; Elice F, 2012, THROMB RES, V129, pS50, DOI 10.1016/S0049-3848(12)70016-6; Furukawa Y, 1999, CIRC RES, V84, P306, DOI 10.1161/01.RES.84.3.306; Galvez BG, 2005, J BIOL CHEM, V280, P1292, DOI 10.1074/jbc.M408673200; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; INDOLFI C, 1995, CIRCULATION, V92, P1230, DOI 10.1161/01.CIR.92.5.1230; Jaipersad AS, 2014, J AM COLL CARDIOL, V63, P1, DOI 10.1016/j.jacc.2013.09.019; Jensen KK, 2003, J VIROL, V77, P624, DOI 10.1128/JVI.77.1.624-630.2003; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Kolluru GK, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/918267; Krock Bryan L, 2011, Genes Cancer, V2, P1117, DOI 10.1177/1947601911423654; Kubota Yoshiaki, 2012, Keio Journal of Medicine, V61, P47; Lee Kyung-Bok, 2009, Int J Stem Cells, V2, P11; Liekens S, 2010, CURR PHARM DESIGN, V16, P3903, DOI 10.2174/138161210794455003; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Lin CS, 2018, CELL PHYSIOL BIOCHEM, V47, P707, DOI 10.1159/000490024; Lira SA, 2009, METHOD ENZYMOL, V460, P193, DOI 10.1016/S0076-6879(09)05209-4; Liu P, 2006, ARTERIOSCL THROM VAS, V26, P2056, DOI 10.1161/01.ATV.0000234947.47788.8c; Logsdon EA, 2014, J CELL MOL MED, V18, P1491, DOI 10.1111/jcmm.12164; Lu HX, 2007, P NATL ACAD SCI USA, V104, P12140, DOI 10.1073/pnas.0704966104; Lucas AD, 2003, CIRCULATION, V108, P2498, DOI 10.1161/01.CIR.0000097119.57756.EF; Madeddu P, 2006, VASC PHARMACOL, V45, P281, DOI 10.1016/j.vph.2006.08.008; Martin AP, 2006, J IMMUNOL, V177, P7296, DOI 10.4049/jimmunol.177.10.7296; Niida T, 2012, CARDIOVASC RES, V93, P371, DOI 10.1093/cvr/cvr323; Parry CM, 2000, J EXP MED, V191, P573, DOI 10.1084/jem.191.3.573; Pyo R, 2004, AM J PATHOL, V164, P2289, DOI 10.1016/S0002-9440(10)63785-6; Ravindran D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173224; Ridiandries A, 2017, FASEB J, V31, P1179, DOI 10.1096/fj.201600540R; Roque M, 2000, ARTERIOSCL THROM VAS, V20, P335, DOI 10.1161/01.ATV.20.2.335; Salcedo R, 2001, J IMMUNOL, V166, P7571, DOI 10.4049/jimmunol.166.12.7571; SAREMBOCK IJ, 1989, CIRCULATION, V80, P1029, DOI 10.1161/01.CIR.80.4.1029; Schober A, 2002, CIRCULATION, V106, P1523, DOI 10.1161/01.CIR.0000028590.02477.6F; Shibuya Masabumi, 2011, Genes Cancer, V2, P1097, DOI 10.1177/1947601911423031; Simas JP, 1999, J GEN VIROL, V80, P75, DOI 10.1099/0022-1317-80-1-75; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Strasly M, 2004, BLOOD, V103, P40, DOI 10.1182/blood-2003-05-1387; Tanaka T, 2005, CANCER SCI, V96, P317, DOI 10.1111/j.1349-7006.2005.00059.x; Tang G, 2004, J VASC SURG, V40, P786, DOI 10.1016/j.jvs.2004.07.012; Turner L, 1999, EUR J IMMUNOL, V29, P2280, DOI 10.1002/(SICI)1521-4141(199907)29:07<2280::AID-IMMU2280>3.0.CO;2-C; Ucuzian AA, 2010, J BURN CARE RES, V31, P158, DOI 10.1097/BCR.0b013e3181c7ed82; van Weel V, 2007, ARTERIOSCL THROM VAS, V27, P1426, DOI 10.1161/ATVBAHA.107.139642; Velazquez OC, 2007, J VASC SURG, V45, p39A, DOI 10.1016/j.jvs.2007.02.068; Wang SW, 2015, CARCINOGENESIS, V36, P104, DOI 10.1093/carcin/bgu218; Wei ZW, 2015, CANCER LETT, V359, P335, DOI 10.1016/j.canlet.2015.01.033; Wong BWC, 2002, CARDIOVASC PATHOL, V11, P332, DOI 10.1016/S1054-8807(02)00111-4; Zhang J, 2010, JNCI-J NATL CANCER I, V102, P522, DOI 10.1093/jnci/djq044	68	4	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13423	13434		10.1096/fj.201900232RR	http://dx.doi.org/10.1096/fj.201900232RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31574232				2022-12-28	WOS:000507466100031
J	Bailey, KA; Moreno, E; Haj, FG; Simon, SI; Passerini, AG				Bailey, Keith A.; Moreno, Emily; Haj, Fawaz G.; Simon, Scott I.; Passerini, Anthony G.			Mechanoregulation of p38 activity enhances endoplasmic reticulum stress-mediated inflammation by arterial endothelium	FASEB JOURNAL			English	Article						mechanotransduction; shear stress; VCAM-1; MAPK; atherosclerosis	SHEAR-STRESS; TNF-ALPHA; VCAM-1 EXPRESSION; MAP KINASE; FLOW; ACTIVATION; CELLS; ATHEROSCLEROSIS	Endothelial up-regulation of VCAM-1 at susceptible sites in arteries modulates the recruitment efficiency of inflammatory monocytes that initiates atherosclerotic lesion formation. We reported that hydrodynamic shear stress (SS) mechanoregulates inflammation in human aortic endothelial cells through endoplasmic reticulum (ER) stress via activation of the transcription factor x-box binding protein 1 (XBP1). Here, a microfluidic flow channel that produces a linear gradient of SS along a continuous monolayer of endothelium was used to delve the mechanisms underlying transcriptional regulation of TNF-alpha-stimulated VCAM-1 expression. High-resolution immunofluorescence imaging enabled continuous detection of platelet endothelial cell adhesion molecule 1 (PECAM-1)- dependent, outside-in signaling as a function of SS magnitude. Differential expression of VCAM-1 and intercellular adhesion molecule 1 (ICAM-1) was regulated by the spatiotemporal activation of MAPKs, ER stress markers, and transcription factors, which was dependent on the mechanosensing of SS through PECAM-1 and PI3K. Inhibition of p38 specifically abrogated the rise to peak VCAM-1 at low SS (2 dyn/cm(2)), whereas inhibition of ERK1/2 attenuated peak ICAM-1 at high SS (12 dyn/cm(2)). A shear stress-regulated temporal rise in p38 phosphorylation activated the nuclear translocation of XBP1, which together with the transcription factor IFN regulatory factor 1, promoted maximum VCAM-1 expression. These data reveal a mechanism by which SS sensitizes the endothelium to a cytokine-induced ER stress response to spatially regulate inflammation promoting atherosclerosis.	[Bailey, Keith A.; Moreno, Emily; Simon, Scott I.; Passerini, Anthony G.] Univ Calif Davis, Dept Biomed Engn, 451 Hlth Sci Dr,GBSF 3319, Davis, CA 95616 USA; [Haj, Fawaz G.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Haj, Fawaz G.] Univ Calif Davis, Dept Internal Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Passerini, AG (corresponding author), Univ Calif Davis, Dept Biomed Engn, 451 Hlth Sci Dr,GBSF 3319, Davis, CA 95616 USA.	agpasserini@ucdavis.edu		Passerini, Anthony/0000-0001-8007-4672	U.S. National Institute of Health (NIH) National Heart, Lung, and Blood Institute [HL082689]; NIH National Institute of Allergy and Infectious Diseases [AI047294]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [RO1DK095359]; NIH National Institute of Environmental Health Sciences [P42 ES04699]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699] Funding Source: NIH RePORTER	U.S. National Institute of Health (NIH) National Heart, Lung, and Blood Institute; NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Dr. Drew E. Glaser (Dr. Steven C. George Laboratory, University of California-Davis) for assistance with confocal imaging. This study was supported by the U.S. National Institute of Health (NIH) National Heart, Lung, and Blood Institute (Grant HL082689 to S.I.S. and A.G.P.) and the NIH National Institute of Allergy and Infectious Diseases (Grant AI047294 to S.I.S.). Research in the F.G.H. laboratory was funded by NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant RO1DK095359 and NIH National Institute of Environmental Health Sciences Grant P42 ES04699. The authors declare no conflicts of interest.	Azuma N, 2001, AM J PHYSIOL-HEART C, V280, pH189, DOI 10.1152/ajpheart.2001.280.1.H189; Bailey KA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08417-9; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Berk BC, 2008, CIRCULATION, V117, P1082, DOI 10.1161/CIRCULATIONAHA.107.720730; Civelek M, 2009, CIRC RES, V105, P453, DOI 10.1161/CIRCRESAHA.109.203711; Collins C, 2012, CURR BIOL, V22, P2087, DOI 10.1016/j.cub.2012.08.051; Dagia NM, 2004, J IMMUNOL, V173, P2041, DOI 10.4049/jimmunol.173.3.2041; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; DeVerse JS, 2013, AM J PHYSIOL-HEART C, V305, pH1149, DOI 10.1152/ajpheart.00311.2013; Feaver RE, 2008, ARTERIOSCL THROM VAS, V28, P1534, DOI 10.1161/ATVBAHA.108.167999; Foster GA, 2013, P NATL ACAD SCI USA, V110, P13944, DOI 10.1073/pnas.1300651110; GLAGOV S, 1988, ARCH PATHOL LAB MED, V112, P1018; Hoefen RJ, 2002, VASC PHARMACOL, V38, P271, DOI 10.1016/S1537-1891(02)00251-3; Ishida T, 1996, CIRC RES, V79, P310, DOI 10.1161/01.RES.79.2.310; Jo H, 1997, J BIOL CHEM, V272, P1395, DOI 10.1074/jbc.272.2.1395; Lee J, 2011, NAT MED, V17, P1251, DOI 10.1038/nm.2449; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; McCue S, 2006, CIRC RES, V98, P939, DOI 10.1161/01.RES.0000216595.15868.55; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Nam D, 2009, AM J PHYSIOL-HEART C, V297, pH1535, DOI 10.1152/ajpheart.00510.2009; Russell-Puleri S, 2017, AM J PHYSIOL-HEART C, V312, pH485, DOI 10.1152/ajpheart.00035.2016; Surapisitchat J, 2001, P NATL ACAD SCI USA, V98, P6476, DOI 10.1073/pnas.101134098; Tsou JK, 2008, MICROCIRCULATION, V15, P311, DOI 10.1080/10739680701724359; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; USAMI S, 1993, ANN BIOMED ENG, V21, P77, DOI 10.1007/BF02368167; Wang YI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078322; Yamawaki H, 2003, CIRCULATION, V108, P1619, DOI 10.1161/01.CIR.0000089373.49941.C4; Zakkar M, 2008, CIRC RES, V103, P726, DOI 10.1161/CIRCRESAHA.108.183913; Zakkar M, 2009, ARTERIOSCL THROM VAS, V29, P1851, DOI 10.1161/ATVBAHA.109.193375; Zeng LF, 2009, P NATL ACAD SCI USA, V106, P8326, DOI 10.1073/pnas.0903197106; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	31	13	14	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12888	12899		10.1096/fj.201900236R	http://dx.doi.org/10.1096/fj.201900236R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31499005	Green Published			2022-12-28	WOS:000507461600099
J	Yue, MF; Tao, Y; Fang, YL; Lian, XP; Zhang, Q; Xia, YF; Wei, ZF; Dai, Y				Yue, Mengfan; Tao, Yu; Fang, Yulai; Lian, Xingpan; Zhang, Qin; Xia, Yufeng; Wei, Zhifeng; Dai, Yue			The gut microbiota modulator berberine ameliorates collagen-induced arthritis in rats by facilitating the generation of butyrate and adjusting the intestinal hypoxia and nitrate supply	FASEB JOURNAL			English	Article						rheumatoid arthritis; BUT; butyrate synthesis	RHEUMATOID-ARTHRITIS; PPAR-GAMMA; METABOLISM; INFLAMMATION; DYSBIOSIS; IMMUNITY; BACTERIA	The commensal microbiota is one of the environmental triggers of rheumatoid arthritis (RA). Recent studies have identified the characteristics of the gut microbiota in patients with RA. However, it is still unclear how the microbiota can be modulated to slow down disease progression. In the present study, berberine, a modulator of gut microbiota with substantial anti-RA effect, was chosen to explore the mechanisms by which the microbiota modulators ameliorate RA. The results showed that oral administration of berberine alleviated collagen-induced arthritis (CIA) in rats in a gut microbiota-dependent manner. Berberine down-regulated the diversity and richness of the gut bacteria, reduced the abundance of Prevotella, and elevated the abundance of butyrate-producing bacteria in CIA rats as determined by the 16S rRNA gene sequence, which might function through limiting the generation of nitrate and stabilizing the physiologic hypoxia in the intestine. Moreover, berberine treatment significantly increased the intestinal butyrate level and promoted the expression and activity of butyryl-CoA:acetate-CoA transferase (BUT). The coadministration of a BUT inhibitor largely diminished the adjustment of intestinal environment and the antiarthritic effect of berberine. In conclusion, modulators of the gut microbiota might serve as therapeutic agents for RA by inducing the butyrate generation through promoting the expression and activity of BUT.	[Yue, Mengfan; Tao, Yu; Fang, Yulai; Lian, Xingpan; Zhang, Qin; Xia, Yufeng; Wei, Zhifeng; Dai, Yue] China Pharmaceut Univ, Sch Tradit Chinese Pharm, Dept Pharmacol Chinese Mat Med, Nanjing, Peoples R China	China Pharmaceutical University	Wei, ZF; Dai, Y (corresponding author), China Pharmaceut Univ, Dept Pharmacol Chinese Mat Med, 24 Tong Jia Xiang, Nanjing 210009, Peoples R China.	zhifeng-wei@hotmail.com; yuedaicpu@126.com			National Natural Science Foundation of China [81673441]; "Double First-Class" University Project [CPU2018GY10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Double First-Class" University Project	This work was supported by the National Natural Science Foundation of China (81673441) and the "Double First-Class" University Project (CPU2018GY10). The authors declare no conflicts of interest.	Breban M, 2017, ANN RHEUM DIS, V76, P1614, DOI 10.1136/annrheumdis-2016-211064; Byndloss MX, 2017, SCIENCE, V357, P570, DOI 10.1126/science.aam9949; Chatzidionisyou A, 2016, CURR OPIN RHEUMATOL, V28, P76, DOI 10.1097/BOR.0000000000000238; Darrah E, 2018, CURR OPIN RHEUMATOL, V30, P72, DOI 10.1097/BOR.0000000000000452; de Groot PF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188475; Demoruelle MK, 2014, CURR OPIN RHEUMATOL, V26, P64, DOI 10.1097/BOR.0000000000000017; Dinan TG, 2017, J PHYSIOL-LONDON, V595, P489, DOI 10.1113/JP273106; Dubin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10391; Fei N, 2013, ISME J, V7, P880, DOI 10.1038/ismej.2012.153; Gao ZZ, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/1813086; Gilbert JA, 2016, NATURE, V535, P94, DOI 10.1038/nature18850; Grander C, 2018, GUT, V67, P892, DOI 10.1136/gutjnl-2016-313432; Guo Y, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1367-7; HOLOSHITZ J, 1986, LANCET, V2, P305; Jethwa H, 2017, RHEUMATOLOGY, V56, P1452, DOI 10.1093/rheumatology/kew374; Jia X, 2019, J DENT RES, V98, P107, DOI 10.1177/0022034518797275; Kelly CJ, 2015, CELL HOST MICROBE, V17, P662, DOI 10.1016/j.chom.2015.03.005; Kim DS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01525; Kim JH, 2015, ARCH PHARM RES, V38, P302, DOI 10.1007/s12272-015-0559-x; Kokkola R, 2003, ARTHRITIS RHEUM, V48, P2052, DOI 10.1002/art.11161; Lee N, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.36; Li J, 2016, P NATL ACAD SCI USA, V113, pE1306, DOI 10.1073/pnas.1518189113; Li M, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0987-5; Lin HP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031286, 10.1371/journal.pone.0035240]; Lin Q, 2018, IEEE INT C MICROELEC, P3; Liu XF, 2013, CURR MICROBIOL, V67, P170, DOI 10.1007/s00284-013-0338-1; Liu YT, 2010, DRUG METAB DISPOS, V38, P1779, DOI 10.1124/dmd.110.033936; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Maeda Y, 2017, J CLIN MED, V6, DOI 10.3390/jcm6060060; Marino E, 2017, NAT IMMUNOL, V18, P951, DOI 10.1038/ni0817-951c; Mathewson ND, 2016, NAT IMMUNOL, V17, P1235, DOI 10.1038/ni1016-1235b; Mizuno M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173032; Nieuwenhuis EES, 2000, ARTHRITIS RHEUM, V43, P2583, DOI 10.1002/1529-0131(200011)43:11<2583::AID-ANR28>3.0.CO;2-U; Ozkan J, 2019, OCUL SURF, V17, P111, DOI 10.1016/j.jtos.2018.11.005; Qiu S, 2014, CHIN J NAT MEDICINES, V12, P401, DOI 10.1016/S1875-5364(14)60063-7; Rivera-Chavez F, 2016, MBIO, V7, DOI 10.1128/mBio.00960-16; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Schirmer M, 2016, CELL, V167, P1897, DOI 10.1016/j.cell.2016.11.046; SCHULMAN M, 1976, J BACTERIOL, V128, P372, DOI 10.1128/JB.128.1.372-381.1976; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Smolen JS, 2016, LANCET, V388, P1984; Song M, 2019, CLIN GASTROENTEROL H, V17, P275, DOI 10.1016/j.cgh.2018.07.012; Sun RB, 2017, MOL PHARMACOL, V91, P110, DOI 10.1124/mol.116.106617; Teng F, 2016, IMMUNITY, V44, P875, DOI 10.1016/j.immuni.2016.03.013; Villeger R, 2018, WORLD J GASTROENTERO, V24, P2327, DOI 10.3748/wjg.v24.i22.2327; Vital M, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00130-17; Vital M, 2014, MBIO, V5, DOI 10.1128/mBio.00889-14; Wang FY, 2017, TOXICOL PATHOL, V45, P150, DOI 10.1177/0192623316679898; Wang LL, 2017, J CHROMATOGR B, V1057, P70, DOI 10.1016/j.jchromb.2017.05.004; Wang XK, 2015, SCI REP-UK, V5, DOI 10.1038/srep12676; Wang Y, 2017, THERANOSTICS, V7, P2443, DOI 10.7150/thno.18290; Wang Y, 2017, METABOLISM, V70, P72, DOI 10.1016/j.metabol.2017.02.003; Weingarden A, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0070-0; Weissmann G, 2006, BULL HOSP JT DIS, V64, P12; WHITEHOUSE MW, 1986, LANCET, V2, P688; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345; Wu Q, 2017, J IND MICROBIOL BIOT, V44, P1245, DOI 10.1007/s10295-017-1956-6; Yao J, 2015, SCI CHINA LIFE SCI, V58, P854, DOI 10.1007/s11427-013-4568-z; Yue MF, 2017, FEBS J, V284, P2786, DOI 10.1111/febs.14147	60	30	32	5	35	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12311	12323		10.1096/fj.201900425RR	http://dx.doi.org/10.1096/fj.201900425RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31425655	Green Published			2022-12-28	WOS:000507461600056
J	Galindo-Moreno, M; Giraldez, S; Limon-Mortes, MC; Belmonte-Fernandez, A; Reed, SI; Saez, C; Japon, MA; Tortolero, M; Romero, F				Galindo-Moreno, Maria; Giraldez, Servando; Cristina Limon-Mortes, M.; Belmonte-Fernandez, Alejandro; Reed, Steven, I; Saez, Carmen; Japon, Miguel A.; Tortolero, Maria; Romero, Francisco			SCF(FBXW7)-mediated degradation of p53 promotes cell recovery after UV-induced DNA damage	FASEB JOURNAL			English	Article						ubiquitylation; proliferation; cancer; FBXW7 inhibitors	FBW7 UBIQUITIN LIGASE; F-BOX PROTEINS; TUMOR-SUPPRESSOR; BETA-TRCP; CYCLIN-E; C-MYC; PHOSPHORYLATION; PATHWAY; HCDC4; SPECIFICITY	Eukaryotic cells have developed sophisticated mechanisms to ensure the integrity of the genome and prevent the transmission of altered genetic information to daughter cells. If this control system fails, accumulation of mutations would increase risk of diseases such as cancer. Ubiquitylation, an essential process for protein degradation and signal transduction, is critical for ensuring genome integrity as well as almost all cellular functions. Here, we investigated the role of the SKP1-Cullin-1-F-box protein (SCF)-[F-box and tryptophan-aspartic acid (WD) repeat domain containing 7 (FBXW7)] ubiquitin ligase in cell proliferation by searching for targets implicated in this process. We identified a hitherto-unknown FBXW7-interacting protein, p53, which is phosphorylated by glycogen synthase kinase 3 at serine 33 and then ubiquitylated by SCF(FBXW7) and degraded. This ubiquitylation is carried out in normally growing cells but primarily after DNA damage. Specifically, we found that SCF(FBXW7)-specific targeting of p53 is crucial for the recovery of cell proliferation after UV-induced DNA damage. Furthermore, we observed that amplification of FBXW7 in wild-type p53 tumors reduced the survival of patients with breast cancer. These results provide a rationale for using SCF(FBXW7) inhibitors in the treatment of this subset of tumors.-Galindo-Moreno, M., Giraldez, S., Limon-Mortes, M. C., Belmonte-Fernandez, A., Reed, S. I., Saez, C., Japon, M. a., Tortolero, M., Romero, F. SCF(FBXW7)-mediated degradation of p53 promotes cell recovery after UV-induced DNA damage.	[Galindo-Moreno, Maria; Giraldez, Servando; Cristina Limon-Mortes, M.; Belmonte-Fernandez, Alejandro; Tortolero, Maria; Romero, Francisco] Univ Seville, Fac Biol, Dept Microbiol, Ave Reina Mercedes 6, E-41012 Seville, Spain; [Giraldez, Servando] Scripps Res Inst, Dept Mol Med, San Diego, CA USA; [Saez, Carmen; Japon, Miguel A.] Univ Seville, Inst Biomed Sevilla IBiS, Hosp Univ Virgen del Rocio, CSIC, Seville, Spain; [Saez, Carmen; Japon, Miguel A.] Hosp Univ Virgen del Rocio, Dept Anat Patol, Seville, Spain	University of Sevilla; Scripps Research Institute; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Virgen del Rocio University Hospital	Romero, F (corresponding author), Univ Seville, Fac Biol, Dept Microbiol, Ave Reina Mercedes 6, E-41012 Seville, Spain.	frport@us.es	Moreno, María Galindo/AAA-5574-2020; Tortolero, Maria/K-5744-2014; Romero, Francisco/K-2101-2014; Sáez, CARMEN/AAH-6431-2021; Saez, Carmen/B-9468-2015; GIRALDEZ, SERVANDO/K-3927-2014	Moreno, María Galindo/0000-0003-3201-4098; Tortolero, Maria/0000-0003-1797-9940; Romero, Francisco/0000-0002-9588-6881; Sáez, CARMEN/0000-0002-4657-4048; Saez, Carmen/0000-0002-8600-0508; GIRALDEZ, SERVANDO/0000-0001-9543-9347	Ministry of Economy and Competitiveness (MINECO) [SAF2014-53799, SAF2017-87358]; Junta de Andalucia [2017/BIO-211]; U.S. National Institutes of Health (NIH) National Cancer Institute [CA078343]; NIH National Institute of General Medical Sciences [GM115170]; Vicerrectorado de Investigacion Plan Propio de Investigacion (VI PPI) from Universidad de Sevilla; NATIONAL CANCER INSTITUTE [R01CA078343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115170] Funding Source: NIH RePORTER	Ministry of Economy and Competitiveness (MINECO); Junta de Andalucia(Junta de Andalucia); U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Vicerrectorado de Investigacion Plan Propio de Investigacion (VI PPI) from Universidad de Sevilla; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Spanish grants from the Ministry of Economy and Competitiveness (MINECO; SAF2014-53799 and SAF2017-87358) and Junta de Andalucia (2017/BIO-211), and U.S. National Institutes of Health (NIH) National Cancer Institute Grant CA078343, and NIH National Institute of General Medical Sciences Grant GM115170 (to S.I.R.). A.B.-F. is the recipient of a Ph.D. fellowship from the Vicerrectorado de Investigacion Plan Propio de Investigacion (VI PPI) from Universidad de Sevilla. The authors declare no conflicts of interest.	Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; BREEDEN L, 1985, COLD SPRING HARB SYM, V50, P643, DOI 10.1101/SQB.1985.050.01.078; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen JD, 1996, MOL CELL BIOL, V16, P2445; Davis RJ, 2014, CANCER CELL, V26, P455, DOI 10.1016/j.ccell.2014.09.013; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Fukuda T, 2009, GENES CELLS, V14, P113, DOI 10.1111/j.1365-2443.2008.01256.x; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Giraldez S, 2014, ONCOTARGET, V5, P4370, DOI 10.18632/oncotarget.2021; Grim JE, 2008, J CELL BIOL, V181, P913, DOI 10.1083/jcb.200802076; Hakem A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002360; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Heo JH, 2016, SEMIN CANCER BIOL, V36, P33, DOI 10.1016/j.semcancer.2015.09.015; Ji CH, 2017, MOL CELLS, V40, P441, DOI 10.14348/molcells.2017.0115; Kaiser P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-233; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kitade S, 2016, CANCER SCI, V107, P1399, DOI 10.1111/cas.13026; Klotz K, 2009, EXP CELL RES, V315, P1832, DOI 10.1016/j.yexcr.2008.11.017; Lee JY, 2007, MOL CELL BIOL, V27, P3187, DOI 10.1128/MCB.01461-06; Leman AR, 2013, GENES-BASEL, V4, P1, DOI 10.3390/genes4010001; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Lu ZX, 2013, CELL SIGNAL, V25, P796, DOI 10.1016/j.cellsig.2012.12.014; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Martinico SCM, 2006, CANCER RES, V66, P8233, DOI 10.1158/0008-5472.CAN-06-1209; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; OConnor PM, 1997, CANCER RES, V57, P4285; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Romero F, 2004, MOL CELL BIOL, V24, P2720, DOI 10.1128/MCB.24.7.2720-2733.2004; Romero F, 1996, MOL CELL BIOL, V16, P37; Romero F, 2001, NUCLEIC ACIDS RES, V29, P1300, DOI 10.1093/nar/29.6.1300; Sane S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020442; Shaltiel IA, 2014, P NATL ACAD SCI USA, V111, P7313, DOI 10.1073/pnas.1322021111; Shang X, 2010, ONCOGENE, V29, P4938, DOI 10.1038/onc.2010.244; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Takeishi S, 2013, CANCER CELL, V23, P347, DOI 10.1016/j.ccr.2013.01.026; Tang XJ, 2005, METHOD ENZYMOL, V399, P433, DOI 10.1016/S0076-6879(05)99030-7; Turenne GA, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-12; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Welcker M, 2013, GENE DEV, V27, P2531, DOI 10.1101/gad.229195.113; Xia YF, 2009, P NATL ACAD SCI USA, V106, P2629, DOI 10.1073/pnas.0812256106; Yang WS, 2007, J BIOL CHEM, V282, P3273, DOI 10.1074/jbc.M610793200	53	12	12	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11420	11430		10.1096/fj.201900885R	http://dx.doi.org/10.1096/fj.201900885R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31337255	Green Published, Bronze			2022-12-28	WOS:000489166300068
J	Zhou, GN; Liao, MM; Wang, F; Qi, XY; Yang, P; Berceli, SA; Sharma, AK; Upchurch, GR; Jiang, ZH				Zhou, Guannan; Liao, Mingmei; Wang, Fen; Qi, Xiaoyan; Yang, Pu; Berceli, Scott A.; Sharma, Ashish K.; Upchurch, Gilbert R., Jr.; Jiang, Zhihua			Cyclophilin A contributes to aortopathy induced by postnatal loss of smooth muscle TGFBR1	FASEB JOURNAL			English	Article						AAD; receptor; growth factor	AORTIC-ANEURYSM PROGRESSION; NEOINTIMAL HYPERPLASIA; MARFAN-SYNDROME; CYCLOSPORINE-A; MUTATIONS; RECEPTOR; CELLS; MODEL; DEFICIENCY; ACTIVATION	Recent recognition that TGF-beta signaling disruption is involved in the development of aortic aneurysms has led to renewed investigations into the role of TGF-beta biology in the aortic wall. We previously found that the type I receptor of TGF-beta (TGFBR2) receptor contributes to formation of ascending aortic aneurysms and dissections (AADs) induced by smooth muscle cell (SMC)-specific, postnatal deletion of Tgfbr1 (Tgfbr1(iko)). Here, we aimed to decipher the mechanistic signaling pathway underlying the pathogenic effects of TGFBR2 in this context. Gene expression profiling demonstrated that Tgfbr1(iko) triggers an acute inflammatory response in developing AADs, and Tgfbr1(iko) SMCs express an inflammatory phenotype in culture. Comparative proteomics profiling and mass spectrometry revealed that Tgfbr1(iko) SMCs respond to TGF-beta 1 stimulation via robust up-regulation of cyclophilin A (CypA). This up-regulation is abrogated by inhibition of TGFBR2 kinase activity, small interfering RNA silencing of Tgfbr2 expression, or inhibition of SMAD3 activation. In mice, Tgfbr1(iko) rapidly promotes CypA production in SMCs of developing AADs, whereas treatment with a CypA inhibitor attenuates aortic dilation by 56% (P = 0.003) and ameliorates aneurysmal degeneration (P = 0.016). These protective effects are associated with reduced aneurysm-promoting inflammation. Collectively, these results suggest a novel mechanism, wherein loss of type I receptor of TGF-beta triggers promiscuous, proinflammatory TGFBR2 signaling in SMCs, thereby promoting AAD formation.-Zhou, G., Liao, M., Wang, F., Qi, X., Yang, P., Berceli, S. A., Sharma, A. K., Upchurch, G. R., Jr., Jiang, Z. Cyclophilin A contributes to aortopathy induced by postnatal loss of smooth muscle TGFBR1.	[Zhou, Guannan; Liao, Mingmei; Wang, Fen; Qi, Xiaoyan; Yang, Pu; Berceli, Scott A.; Sharma, Ashish K.; Upchurch, Gilbert R., Jr.; Jiang, Zhihua] Univ Florida, Coll Med, Div Vasc Surg & Endovasc Therapy, 1600 SW Archer Rd,POB 100286, Gainesville, FL 32610 USA; [Berceli, Scott A.] Malcom Randall Vet Affairs Med Ctr, Gainesville, FL USA; [Liao, Mingmei; Yang, Pu] Cent S Univ, Dept Surg, Xiangya Hosp, Changsha, Hunan, Peoples R China	State University System of Florida; University of Florida; Central South University	Jiang, ZH (corresponding author), Univ Florida, Coll Med, Div Vasc Surg & Endovasc Therapy, 1600 SW Archer Rd,POB 100286, Gainesville, FL 32610 USA.	jiangzh@surgery.ufl.edu			U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [RO1HL105764]; Florida Health James and Esther King Biomedical Research Program [7JK05]	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Florida Health James and Esther King Biomedical Research Program	The authors express gratitude to Ricky F. Ungaro (University of Florida College of Medicine) for help with the NanoString Assays. This study was supported by grants from the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (RO1HL105764 to Z.J.), and Florida Health James and Esther King Biomedical Research Program (7JK05 to Z.J.). The authors declare no conflicts of interest.	Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Chen XF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153811; Cook JR, 2015, ARTERIOSCL THROM VAS, V35, P911, DOI 10.1161/ATVBAHA.114.305150; Dai JN, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021891, 10.1371/journal.pone.0028903]; Daugherty A, 2010, CLIN SCI, V118, P681, DOI 10.1042/CS20090372; de Jager SCA, 2011, J EXP MED, V208, P217, DOI 10.1084/jem.20100370; Doyle AJ, 2012, NAT GENET, V44, P1249, DOI 10.1038/ng.2421; El-Hamamsy I, 2009, NAT REV CARDIOL, V6, P771, DOI 10.1038/nrcardio.2009.191; Fu CH, 2012, ARTERIOSCL THROM VAS, V32, P2418, DOI 10.1161/ATVBAHA.112.255786; Gahllo EM, 2014, J CLIN INVEST, V124, P448, DOI 10.1172/JCI69666; Gillis E, 2013, CIRC RES, V113, P327, DOI 10.1161/CIRCRESAHA.113.300675; Gomez D, 2013, CIRC RES, V113, P881, DOI 10.1161/CIRCRESAHA.113.301989; Gomez D, 2011, CARDIOVASC RES, V89, P446, DOI 10.1093/cvr/cvq291; HANNAMHARRIS AC, 1985, J LEUKOCYTE BIOL, V38, P231, DOI 10.1002/jlb.38.2.231; He RM, 2008, J THORAC CARDIOV SUR, V136, P922, DOI 10.1016/j.jtcvs.2007.12.063; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Hu JH, 2015, ARTERIOSCL THROM VAS, V35, P2647, DOI 10.1161/ATVBAHA.115.306573; Humphrey JD, 2014, SCIENCE, V344, P476, DOI 10.1126/science.1253026; Ikonomidis JS, 2003, J SURG RES, V115, P157, DOI 10.1016/S0022-4804(03)00193-8; Isselbacher EM, 2016, CIRCULATION, V133, P2516, DOI 10.1161/CIRCULATIONAHA.116.009762; Iwata J, 2012, J CLIN INVEST, V122, P873, DOI 10.1172/JCI61498; Jiang ZH, 2004, AM J PHYSIOL-HEART C, V286, pH240, DOI 10.1152/ajpheart.00760.2003; Jiang ZH, 2009, AM J PHYSIOL-HEART C, V297, pH1200, DOI 10.1152/ajpheart.00268.2009; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Johnston WF, 2014, CIRCULATION, V130, pS51, DOI 10.1161/CIRCULATIONAHA.113.006800; Jondeau G, 2016, CIRC-CARDIOVASC GENE, V9, P548, DOI 10.1161/CIRCGENETICS.116.001485; Kockx M, 2010, PHARMACOL THERAPEUT, V128, P106, DOI 10.1016/j.pharmthera.2010.06.001; Lan TH, 2013, CARDIOVASC PATHOL, V22, P401, DOI 10.1016/j.carpath.2013.01.003; LeMaire SA, 2011, NAT REV CARDIOL, V8, P103, DOI 10.1038/nrcardio.2010.187; Li W, 2014, J CLIN INVEST, V124, P755, DOI 10.1172/JCI69942; Liao MM, 2017, GENESIS, V55, DOI 10.1002/dvg.23054; Lindsay ME, 2012, NAT GENET, V44, P922, DOI 10.1038/ng.2349; Liu W, 2017, ELIFE, V6, DOI 10.7554/eLife.24425; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Lu CM, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00118; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Nigro P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.410; Nigro P, 2011, J EXP MED, V208, P53, DOI 10.1084/jem.20101174; Orr AW, 2010, J VASC RES, V47, P168, DOI 10.1159/000250095; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Ruvolo G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/349476; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; Schmit BM, 2015, AM J PHYSIOL-HEART C, V308, pH115, DOI 10.1152/ajpheart.00521.2014; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tang PCY, 2005, FASEB J, V19, P1528, DOI 10.1096/fj.05-3671fje; Tran-Fadulu V, 2009, J MED GENET, V46, P607, DOI 10.1136/jmg.2008.062844; Wang Y, 2010, J CLIN INVEST, V120, P422, DOI 10.1172/JCI38136; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Wu D, 2017, ARTERIOSCL THROM VAS, V37, P694, DOI 10.1161/ATVBAHA.116.307648; Wu J, 2016, J CLIN INVEST, V126, P50, DOI 10.1172/JCI80761; Xue C, 2018, ARTERIOSCL THROM VAS, V38, P986, DOI 10.1161/ATVBAHA.117.310661; Yang P, 2016, SCI REP-UK, V6, DOI 10.1038/srep35444	54	4	5	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11396	11410		10.1096/fj.201900601RR	http://dx.doi.org/10.1096/fj.201900601RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31311317	Green Published			2022-12-28	WOS:000489166300066
J	Xue, YF; Guo, CZ; Hu, F; Zhu, WY; Mao, SY				Xue, Yanfeng; Guo, Changzheng; Hu, Fan; Zhu, Weiyun; Mao, Shengyong			Maternal undernutrition induces fetal hepatic lipid metabolism disorder and affects the development of fetal liver in a sheep model	FASEB JOURNAL			English	Article						fetus; fatty acid; triglyceride; cell cycle; DNA replication	CELL-CYCLE PROGRESSION; FATTY-ACID SYNTHASE; LATE PREGNANCY; GROWTH-RATE; APOPTOSIS; RESTRICTION; PLASMA; BIRTH; EWES; PHOSPHATIDYLETHANOLAMINE	Undernutrition accelerates body fat mobilization to alleviate negative energy balance, which disrupts homeostasis of lipid metabolism in maternal liver. However, little is known about its effect on fetal metabolism and development. Here, a sheep model was used to explore whether maternal undernutrition induces fetal lipid metabolism disorder and further inhibits fetal hepatic development. Twenty pregnant ewes were either fed normally or restricted to 30% level for 15 d, after which fetal hepatic samples were collected to conduct transcriptome, metabolome, histomorphology, and biochemical analysis. Results showed that maternal undernutrition altered the general transcriptome profile and metabolic mode in fetal liver. Fatty acid oxidation and ketogenesis were enhanced in fetal livers of undernourished ewes, which might be promoted by the activated peroxisome proliferator-activated receptor alpha signaling pathway, whereas cholesterol, steroid, and fatty acid synthesis were repressed. Maternal undernutrition increased triglyceride synthesis, decreased triglyceride degradation, and inhibited phospholipid degradation and synthesis in fetal liver. In addition, our data revealed that maternal undernutrition extremely inhibited DNA replication, cell cycle progression, and antiapoptosis and broke the balance between cell proliferation and apoptosis in fetal liver, indicating that maternal undernutrition affects the growth and development of fetal liver. Generally, these findings provide evidence that maternal undernutrition during pregnancy disturbs fetal lipid metabolism and inhibits fetal hepatic development in sheep, which greatly contribute to the further study of fetal metabolism and development in human beings.-Xue, Y., Guo, C., Hu, F., Zhu, W., Mao, S. Maternal undernutrition induces fetal hepatic lipid metabolism disorder and affects the development of fetal liver in a sheep model.	[Xue, Yanfeng; Guo, Changzheng; Hu, Fan; Zhu, Weiyun; Mao, Shengyong] Nanjing Agr Univ, Coll Anim Sci & Technol, Jiangsu Key Lab Gastrointestinal Nutr & Anim Hlth, Lab Gastrointestinal Microbiol, Nanjing, Jiangsu, Peoples R China; [Xue, Yanfeng; Guo, Changzheng; Hu, Fan; Zhu, Weiyun; Mao, Shengyong] Nanjing Agr Univ, Natl Expt Teaching Demonstrat Ctr Anim Sci, Natl Ctr Int Res Anim Gut Nutr, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Mao, SY (corresponding author), Nanjing Agr Univ, Weigang 1, Nanjing 210095, Jiangsu, Peoples R China.	maoshengyong@njau.edu.cn			National Key Research and Development Program of China [2016YFD0501200]	National Key Research and Development Program of China	The present study was supported by the National Key Research and Development Program of China (Grant 2016YFD0501200). The authors declare no conflicts of interest.	Abu-Saad K, 2010, EPIDEMIOL REV, V32, P5, DOI 10.1093/epirev/mxq001; Artwohl M, 2004, FASEB J, V18, P146, DOI 10.1096/fj.03-0301fje; Bandyopadhyay S, 2006, CANCER RES, V66, P5934, DOI 10.1158/0008-5472.CAN-05-3197; Bastian M., 2009, ICWSM, V3, P361, DOI 10.13140/2.1.1341.1520; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Cal L, 2009, ARQ BRAS MED VET ZOO, V61, P306, DOI 10.1590/S0102-09352009000200004; Cal-Pereyra L, 2015, NEW ZEAL VET J, V63, P141, DOI 10.1080/00480169.2014.971083; Cavanaugh SE, 2015, ALCOHOL ALCOHOLISM, V50, P251, DOI 10.1093/alcalc/agu108; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLINKENBEARD KD, 1975, J BIOL CHEM, V250, P3108; Eitel K, 2003, DIABETES, V52, P991, DOI 10.2337/diabetes.52.4.991; Grover Z, 2009, PEDIATR CLIN N AM, V56, P1055, DOI 10.1016/j.pcl.2009.07.001; Herrera E, 2006, HORM RES, V65, P59, DOI 10.1159/000091507; Herrera E, 2002, ENDOCRINE, V19, P43, DOI 10.1385/ENDO:19:1:43; Ismail ZAB, 2008, VET CLIN PATH, V37, P434, DOI 10.1111/j.1939-165X.2008.00076.x; Jobgen WS, 2008, J ANIM SCI, V86, P820, DOI 10.2527/jas.2007-0624; Kwon H, 2004, BIOL REPROD, V71, P901, DOI 10.1095/biolreprod.104.029645; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Martinez-Botas J, 1999, FASEB J, V13, P1359, DOI 10.1096/fasebj.13.11.1359; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; MELLOR DJ, 1983, BRIT VET J, V139, P307, DOI 10.1016/S0007-1935(17)30436-0; Noga AA, 2003, J BIOL CHEM, V278, P21851, DOI 10.1074/jbc.M301982200; Pizer ES, 1998, CANCER RES, V58, P4611; POND WG, 1969, J NUTR, V99, P61, DOI 10.1093/jn/99.1.61; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; RODRIGUEZ JC, 1994, J BIOL CHEM, V269, P18767; Rush D, 2000, AM J CLIN NUTR, V72, p212S, DOI 10.1093/ajcn/72.1.212S; Scholl TO, 2000, AM J CLIN NUTR, V71, p1295S, DOI 10.1093/ajcn/71.5.1295s; Stein AD, 2004, INT J EPIDEMIOL, V33, P831, DOI 10.1093/ije/dyh083; Suarez Y, 2002, EUR J BIOCHEM, V269, P1761, DOI 10.1046/j.1432-1327.2002.02822.x; Surette ME, 1999, CARCINOGENESIS, V20, P757, DOI 10.1093/carcin/20.5.757; Swanson AM, 2015, PLACENTA, V36, P623, DOI 10.1016/j.placenta.2015.03.003; Vance D. E., 1991, BIOCH LIPIDS LIPOPRO; Wang M., 2014, AGR SCI TECHNOL, V15, P470; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wellner N, 2013, BBA-MOL CELL BIOL L, V1831, P652, DOI 10.1016/j.bbalip.2012.08.019; WHO/FAO UNU, 1985, WHO TECHN REP SER, V724, P220; WILLIAMS.DH, 1968, BIOCHEM J, V108, P353, DOI 10.1042/bj1080353; Williamson D H, 1978, Biochem Soc Symp, P137; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Wu GY, 2012, PAEDIATR PERINAT EP, V26, P4, DOI 10.1111/j.1365-3016.2012.01291.x; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Xue YF, 2019, ANIMAL, V13, P992, DOI 10.1017/S1751731118002136; Xue YF, 2018, METABOLITES, V8, DOI 10.3390/metabo8040085; Zhang CZ, 2015, CZECH J ANIM SCI, V60, P557, DOI 10.17221/8598-CJAS	48	17	18	2	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9990	10004		10.1096/fj.201900406R	http://dx.doi.org/10.1096/fj.201900406R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31167079				2022-12-28	WOS:000482214200023
J	Zhou, L; Kohncke, C; Hu, ZY; Roepke, TK; Abbott, GW				Zhou, Leng; Koehncke, Clemens; Hu, Zhaoyang; Roepke, Torsten K.; Abbott, Geoffrey W.			The KCNE2 potassium channel beta subunit is required for normal lung function and resilience to ischemia and reperfusion injury	FASEB JOURNAL			English	Article						KCNQ1; MiRP1; pulmonary; K-v channel; epithelial	GENOME-WIDE ASSOCIATION; K+ CHANNEL; ANION SECRETION; KCNQ1; EXPRESSION; DELETION; MINK; PROTEINS; ISK; SENSITIVITY	The KCNE2 single transmembrane-spanning voltage-gated potassium (K-v) channel beta subunit is ubiquitously expressed and essential for normal function of a variety of cell types, often via regulation of the KCNQ1 K-v channel. A polymorphism upstream of KCNE2 is associated with reduced lung function in human populations, but the pulmonary consequences of KCNE2 gene disruption are unknown. Here, germline deletion of mouse Kcne2 reduced pulmonary expression of potassium channel alpha subunits Kcnq1 and Kcnb1 but did not alter expression of other Kcne genes. Kcne2 colocalized and coimmunoprecipitated with Kcnq1 in mouse lungs, suggesting the formation of pulmonary Kcnq1-Kcne2 potassium channel complexes. Kcne2 deletion reduced blood O-2, increased CO2, increased pulmonary apoptosis, and increased inflammatory mediators TNF-alpha, IL-6, and leukocytes in bronchoalveolar lavage (BAL) fluids. Consistent with increased pulmonary vascular leakage, Kcne2 deletion increased plasma, BAL albumin, and the BAL:plasma albumin concentration ratio. Kcne2(-/-) mouse lungs exhibited baseline induction of the reperfusion injury salvage kinase pathway but were less able to respond via this pathway to imposed pulmonary ischemia/reperfusion injury (IRI). We conclude that KCNE2 regulates KCNQ1 in the lungs and is required for normal lung function and resistance to pulmonary IRI. Our data support a causal relationship between KCNE2 gene disruption and lung dysfunction.-Zhou, L., Kohncke, C., Hu, Z., Roepke, T. K., Abbott, G. W. The KCNE2 potassium channel beta subunit is required for normal lung function and resilience to ischemia and reperfusion injury.	[Zhou, Leng] Sichuan Univ, Dept Anesthesiol, Translat Neurosci Ctr, West China Hosp, Chengdu, Sichuan, Peoples R China; [Hu, Zhaoyang] Sichuan Univ, Lab Anesthesiol & Crit Care Med, Translat Neurosci Ctr, West China Hosp, Chengdu 610041, Sichuan, Peoples R China; [Koehncke, Clemens; Roepke, Torsten K.] Max Delbruck Ctr Mol Med, Expt & Clin Res Ctr, Berlin, Germany; [Roepke, Torsten K.] Charite Berlin Univ Med, Campus Mitte, Clin Cardiol & Angiol, Berlin, Germany; [Roepke, Torsten K.] Klinikum Niederlausitz, Clin Internal Med & Cardiol, Senftenberg, Germany; [Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Bioelect Lab, Dept Physiol & Biophys, D337 Med Sci 1, Irvine, CA 92697 USA	Sichuan University; Sichuan University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California Irvine	Hu, ZY (corresponding author), Sichuan Univ, Lab Anesthesiol & Crit Care Med, Translat Neurosci Ctr, West China Hosp, Chengdu 610041, Sichuan, Peoples R China.; Abbott, GW (corresponding author), Univ Calif Irvine, Sch Med, Bioelect Lab, Dept Physiol & Biophys, D337 Med Sci 1, Irvine, CA 92697 USA.	zyhu@hotmail.com; abbottg@uci.edu			National Natural Science Foundation of China [81700074, 81670300]; U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [GM115189, GM130377]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115189, R35GM130377] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Siegfried Breitling (Charite Universitatsmedizin, Berlin), Angele de Silva (University of California-Irvine), and Dr. Maria Papanikolaou (University of California-Irvine) for technical assistance. This study was supported by Grants 81700074 (to L.Z.) and 81670300 (to Z.H.) from the National Natural Science Foundation of China and GM115189 and GM130377 from the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (to G.W.A.). The authors declare no conflicts of interest.	Abbott GW, 2016, GENE, V593, P249, DOI 10.1016/j.gene.2016.07.069; Abbott GW, 2016, GENE, V576, P1, DOI 10.1016/j.gene.2015.09.059; Abbott GW, 2015, GENE, V569, P162, DOI 10.1016/j.gene.2015.06.061; Abbott GW, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005025; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Abbott GW, 2014, NEW J SCI, V2014, P1, DOI [10.1155/2014/237431, DOI 10.1155/2014/237431]; Alzamora R, 2011, J PHYSIOL-LONDON, V589, P5091, DOI 10.1113/jphysiol.2011.215772; Anantharam Arun, 2005, V266, P100; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Boini KM, 2009, AM J PHYSIOL-REG I, V296, pR1695, DOI 10.1152/ajpregu.90839.2008; Brueggemann LI, 2014, AM J PHYSIOL-LUNG C, V306, pL476, DOI 10.1152/ajplung.00253.2013; Choi E, 2010, FASEB J, V24, P1518, DOI 10.1096/fj.09-145219; Cowley EA, 2002, J PHYSIOL-LONDON, V543, P201, DOI 10.1113/jphysiol.2002.022400; Cowley EA, 2002, J PHYSIOL-LONDON, V538, P747, DOI 10.1113/jphysiol.2001.013300; Cuthbert AW, 2003, BRIT J PHARMACOL, V140, P81, DOI 10.1038/sj.bjp.0705403; Dedek K, 2001, PFLUG ARCH EUR J PHY, V442, P896, DOI 10.1007/s004240100609; Demolombe S, 2001, AM J PHYSIOL-CELL PH, V280, pC359, DOI 10.1152/ajpcell.2001.280.2.C359; Finley MR, 2002, AM J PHYSIOL-HEART C, V283, pH126, DOI 10.1152/ajpheart.00622.2001; Franco D, 2001, CARDIOVASC RES, V52, P65, DOI 10.1016/S0008-6363(01)00349-2; Gordon E, 2008, CARDIOVASC RES, V77, P98, DOI 10.1093/cvr/cvm030; Grahammer F, 2001, J BIOL CHEM, V276, P42268, DOI 10.1074/jbc.M105014200; Grahammer F, 2001, GASTROENTEROLOGY, V120, P1363, DOI 10.1053/gast.2001.24053; Hausenloy DJ, 2005, TRENDS CARDIOVAS MED, V15, P69, DOI 10.1016/j.tcm.2005.03.001; Heitzmann D, 2004, J PHYSIOL-LONDON, V561, P547, DOI 10.1113/jphysiol.2004.075168; Heitzmann D, 2007, CELL PHYSIOL BIOCHEM, V19, P21, DOI 10.1159/000099189; Hu ZY, 2016, CARDIOVASC RES, V110, P227, DOI 10.1093/cvr/cvw048; Hu ZY, 2014, CIRC-CARDIOVASC GENE, V7, P33, DOI 10.1161/CIRCGENETICS.113.000315; Jiang M, 2004, CIRCULATION, V109, P1783, DOI 10.1161/01.CIR.0000124225.43852.50; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; KELLEY J, 1990, AM REV RESPIR DIS, V141, P765, DOI 10.1164/ajrccm/141.3.765; Kredel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004391; Kroncke BM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501228; Kundu P, 2008, MOL CELL ENDOCRINOL, V292, P50, DOI 10.1016/j.mce.2008.06.003; Lecour S, 2009, J MOL CELL CARDIOL, V47, P32, DOI 10.1016/j.yjmcc.2009.03.019; Lee MP, 2000, J CLIN INVEST, V106, P1447, DOI 10.1172/JCI10897; Lee SM, 2017, FASEB J, V31, P2674, DOI 10.1096/fj.201601347; Lee SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23118; Lee SM, 2015, J MOL CELL CARDIOL, V87, P148, DOI 10.1016/j.yjmcc.2015.08.013; Lundquist Andrew L, 2005, J Mol Cell Cardiol, V38, P277, DOI 10.1016/j.yjmcc.2004.11.012; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; McCrossan ZA, 2009, J MEMBRANE BIOL, V228, P1, DOI 10.1007/s00232-009-9154-8; Moser SL, 2008, J MEMBRANE BIOL, V221, P153, DOI 10.1007/s00232-008-9093-9; Nakajo K, 2007, J GEN PHYSIOL, V130, P269, DOI 10.1085/jgp.200709805; Pan Q, 2010, MOL BIOL REP, V37, P1329, DOI 10.1007/s11033-009-9511-9; Panaghie G, 2007, J GEN PHYSIOL, V129, P121, DOI 10.1085/jgp.200609612; Rapetti-Mauss R, 2013, J PHYSIOL-LONDON, V591, P2813, DOI 10.1113/jphysiol.2013.251678; Roepke TK, 2008, FASEB J, V22, P3648, DOI 10.1096/fj.08-110171; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Roepke TK, 2011, FASEB J, V25, P4264, DOI 10.1096/fj.11-187609; Roepke TK, 2011, FASEB J, V25, P727, DOI 10.1096/fj.10-173682; Roepke TK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011451; Roepke TK, 2009, NAT MED, V15, P1186, DOI 10.1038/nm.2029; Sabater-Lleal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104082; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Wakil SM, 2016, ATHEROSCLEROSIS, V245, P62, DOI 10.1016/j.atherosclerosis.2015.11.019	58	4	4	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9762	9774		10.1096/fj.201802519R	http://dx.doi.org/10.1096/fj.201802519R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31162977	Green Published			2022-12-28	WOS:000482214200007
J	de Oliveira, V; Schaefer, J; Calder, M; Lydon, JP; DeMayo, FJ; Bhattacharya, M; Radovick, S; Babwah, AV				de Oliveira, Vanessa; Schaefer, Jennifer; Calder, Michele; Lydon, John P.; DeMayo, Francesco J.; Bhattacharya, Moshmi; Radovick, Sally; Babwah, Andy V.			Uterine G alpha(q/11) signaling, in a progesterone-dependent manner, critically regulates the acquisition of uterine receptivity in the female mouse	FASEB JOURNAL			English	Article						GPCR; uterus; aquaporin; myometrium; epithelium	ENDOMETRIAL GLAND DEVELOPMENT; SITE-SPECIFIC PHOSPHORYLATION; CONDITIONAL ABLATION; FLUID ACCUMULATION; EPITHELIAL-CELL; RECEPTOR; EXPRESSION; IMPLANTATION; UTERUS; INHIBITION	A nonreceptive uterus is a major cause of embryo implantation failure. This study examined the importance of the G alpha(q/11)-coupled class of GPCRs as regulators of uterine receptivity. Mice were created lacking uterine G alpha(q) and G alpha(11); as a result, signaling by all uterine G alpha(q/11)-coupled receptors was disrupted. Reproductive profiling of the knockout females revealed that on d 4 of pregnancy, despite adequate serum progesterone (P4) levels and normal P4 receptor (PR) expression, there was no evidence of PR signaling. This resulted in the down-regulation of heart and neural crest derivatives expressed 2, Kruppel-like factor 15, and cyclin G1 and the subsequent persistent proliferation of the luminal epithelium. Aquaporin (Aqp) 11 was also potently down-regulated, whereas Aqp5/AQP5 expression persisted, resulting in the inhibition of luminal closure. Hypertrophy of the myometrial longitudinal muscle was also dramatically diminished, likely contributing to the observed implantation failure. Further analyses revealed that a major mechanism via which uterine G alpha(q/11) signaling induces PR signaling is through the transcriptional up-regulation of leucine-rich repeat-containing GPCR 4 (Lgr4). LGR4 was previously identified as a trigger of PR activation and signaling. Overall, this study establishes that G alpha(q/11) signaling, in a P4-dependent manner, critically regulates the acquisition of uterine receptivity in the female mouse, and disruption of such signaling results in P4 resistance.-de Oliveira, V., Schaefer, J., Calder, M., Lydon, J. P., DeMayo, F. J., Bhattacharya, M., Radovick, S., Babwah, A. V. Uterine G alpha(q/11) signaling, in a progesterone-dependent manner, critically regulates the acquisition of uterine receptivity in the female mouse.	[de Oliveira, Vanessa; Schaefer, Jennifer; Radovick, Sally; Babwah, Andy V.] Rutgers State Univ, Dept Pediat, New Brunswick, NJ USA; [Bhattacharya, Moshmi] Rutgers State Univ, Dept Med, Robert Wood Johnson Med Sch, New Brunswick, NJ USA; [de Oliveira, Vanessa; Schaefer, Jennifer; Bhattacharya, Moshmi; Radovick, Sally; Babwah, Andy V.] Child Hlth Inst New Jersey, New Brunswick, NJ USA; [Calder, Michele] Western Univ, Dept Obstet & Gynaecol, London, ON, Canada; [Lydon, John P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [DeMayo, Francesco J.] NIEHS, Reprod & Dev Biol Lab, POB 12233, Res Triangle Pk, NC 27709 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Western University (University of Western Ontario); Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Babwah, AV (corresponding author), Rutgers State Univ, Dept Pediat, Robert Wood Johnson Med Sch, Clin Acad Bldg Room 7107,125 Paterson St, New Brunswick, NJ 08901 USA.	avb58@rwjms.rutgers.edu			Robert Wood Johnson Foundation; Eunice Kennedy Shriver National Institute of Child Health and Human Development, U.S. National Institutes of Health (NIH) [R01-HD-068777]; Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH [R01-HD042311]; National Institute of Environmental Health Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042311, R01HD068777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007148, ZIAES103311] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Eunice Kennedy Shriver National Institute of Child Health and Human Development, U.S. National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Dr. Stefan Offermanns (Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany) for the kind gift of the Gnaq<SUP>fl/fl</SUP>; Gna11<SUP>-/-</SUP> mouse. The authors also thank Drs. Milan Bagchi (University of Illinois at Urbana-Champaign, Champaign, IL, USA) and Bruce Murphy (University of Montreal, Montreal, Canada) for PgrCre mouse breeding pairs. The authors also thank the Robert Wood Johnson Foundation for their support of the Child Health Institute of New Jersey; the views expressed here do not necessarily reflect the views of the Robert Wood Johnson Foundation. This work was supported by funds awarded to A.V.B.; S.R. [R01-HD-068777 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, U.S. National Institutes of Health (NIH)]; J.P.L. (R01-HD042311 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH); and F.J.D. (National Institute of Environmental Health Sciences). The authors declare no conflicts of interest.	Abdel-Hafiz HA, 2014, J STEROID BIOCHEM, V140, P80, DOI 10.1016/j.jsbmb.2013.12.008; Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; Babwah AV, 2015, J NEUROSCI, V35, P12903, DOI 10.1523/JNEUROSCI.0041-15.2015; Beck CA, 1996, J BIOL CHEM, V271, P1209, DOI 10.1074/jbc.271.2.1209; Beck CA, 1996, J BIOL CHEM, V271, P19546, DOI 10.1074/jbc.271.32.19546; BHATT H, 1991, P NATL ACAD SCI USA, V88, P11408, DOI 10.1073/pnas.88.24.11408; Bhattacharya M, 2015, ENDOCRINOLOGY, V156, P1218, DOI 10.1210/en.2014-1915; Bouskine A, 2009, ENVIRON HEALTH PERSP, V117, P1053, DOI 10.1289/ehp.0800367; Breen SM, 2013, MOL ENDOCRINOL, V27, P1483, DOI 10.1210/me.2013-1130; Calder M, 2014, ENDOCRINOLOGY, V155, P3065, DOI 10.1210/en.2013-1916; Cha J, 2014, CELL REP, V8, P381, DOI 10.1016/j.celrep.2014.06.027; Chien LW, 2002, HUM REPROD, V17, P351, DOI 10.1093/humrep/17.2.351; Clark NC, 2017, ENDOCRINOLOGY, V158, P640, DOI 10.1210/en.2016-1701; Conneely OM, 2002, RECENT PROG HORM RES, V57, P339, DOI 10.1210/rp.57.1.339; Daniel AR, 2007, MOL ENDOCRINOL, V21, P2890, DOI 10.1210/me.2007-0248; Dennis AP, 2005, J STEROID BIOCHEM, V94, P337, DOI 10.1016/j.jsbmb.2004.11.009; Dettlaff-Swiercz DA, 2005, DEV BIOL, V282, P174, DOI 10.1016/j.ydbio.2005.03.006; Diao HL, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.131110; Ducza E, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122593; Escobar J, 2012, EARLY HUM DEV, V88, P589, DOI 10.1016/j.earlhumdev.2012.01.009; Fayazi M, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0105-1; Haraguchi H, 2014, MOL ENDOCRINOL, V28, P1108, DOI 10.1210/me.2014-1097; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Ishibashi K, 2009, CLIN EXP NEPHROL, V13, P107, DOI 10.1007/s10157-008-0118-6; Jeong JW, 2010, BIOL REPROD, V83, P396, DOI 10.1095/biolreprod.109.083154; Kayisli UA, 2015, P NATL ACAD SCI USA, V112, P5153, DOI 10.1073/pnas.1424814112; Kelleher AM, 2017, P NATL ACAD SCI USA, V114, pE1018, DOI 10.1073/pnas.1618433114; Kida T, 2014, BIOSCI BIOTECH BIOCH, V78, P1813, DOI 10.1080/09168451.2014.936353; Lange CA, 2000, P NATL ACAD SCI USA, V97, P1032, DOI 10.1073/pnas.97.3.1032; Leon S, 2016, SCI REP-UK, V6, DOI 10.1038/srep29073; Li QX, 2011, SCIENCE, V331, P912, DOI 10.1126/science.1197454; Li YJ, 2015, CELL REP, V11, P358, DOI 10.1016/j.celrep.2015.03.035; Liu FJ, 2002, J BIOL CHEM, V277, P32099, DOI 10.1074/jbc.M203639200; McCallum ML, 2016, ENDOCRINOLOGY, V157, P3309, DOI 10.1210/en.2016-1081; Mittelman-Smith MA, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00165; Mohri Y, 2010, FERTIL STERIL, V94, P2878, DOI 10.1016/j.fertnstert.2010.05.050; Naor Z, 2000, TRENDS ENDOCRIN MET, V11, P91, DOI 10.1016/S1043-2760(99)00232-5; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Pampillo M, 2009, MOL ENDOCRINOL, V23, P2060, DOI 10.1210/me.2009-0013; Pandy-Szekeres G, 2018, NUCLEIC ACIDS RES, V46, pD440, DOI 10.1093/nar/gkx1109; Pang YF, 2013, ENDOCRINOLOGY, V154, P283, DOI 10.1210/en.2012-1772; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; Ray S, 2012, P NATL ACAD SCI USA, V109, pE1334, DOI 10.1073/pnas.1118515109; Rossi M, 2015, P NATL ACAD SCI USA, V112, pE6818, DOI 10.1073/pnas.1519430112; SCHLAFKE S, 1985, ANAT REC, V212, P47, DOI 10.1002/ar.1092120107; Schultz JR, 2003, MOL CELL ENDOCRINOL, V201, P165, DOI 10.1016/S0303-7207(02)00415-X; Shore DM, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00069; Shynlova O, 2004, BIOL REPROD, V70, P986, DOI 10.1095/biolreprod.103.023648; Sone M, 2013, FASEB J, V27, P4917, DOI 10.1096/fj.13-232215; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; U. S. Department of Health and Human Services Office on Women's Health, 2019, INFERTILITY; WARSOP H, 1993, J DEV PHYSIOL, V19, P91; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Yang ZM, 1997, BIOL REPROD, V56, P368, DOI 10.1095/biolreprod56.2.368; Yoshinaga K, 2013, J ASSIST REPROD GEN, V30, P1017, DOI 10.1007/s10815-013-0093-z; Yuan DZ, 2014, HORM METAB RES, V46, P761, DOI 10.1055/s-0034-1383647; Yue LM, 2005, ENDOCRINOLOGY, V146, P2424, DOI 10.1210/en.2004-1605; Zhang Y, 2015, CELL RES, V25, P139, DOI 10.1038/cr.2014.139; Zhu LJ, 1998, ENDOCRINOLOGY, V139, P330, DOI 10.1210/en.139.1.330	59	9	9	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9374	9387		10.1096/fj.201900026R	http://dx.doi.org/10.1096/fj.201900026R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31091422	Green Published			2022-12-28	WOS:000478832900053
J	Roth, M; Gaceb, A; Enstrom, A; Padel, T; Genove, G; Ozen, I; Paul, G				Roth, Michaela; Gaceb, Abderahim; Enstrom, Andreas; Padel, Thomas; Genove, Guillem; Ozen, Ilknur; Paul, Gesine			Regulator of G-protein signaling 5 regulates the shift from perivascular to parenchymal pericytes in the chronic phase after stroke	FASEB JOURNAL			English	Article						PDGFR-beta; ischemia; vascular remodeling	FOCAL CEREBRAL-ISCHEMIA; FACTOR RECEPTOR-BETA; PDGFR-BETA; BLOOD-FLOW; BRAIN; RECRUITMENT; INTERNALIZATION; MECHANISMS; RGS5; ACTIVATION	Poststroke recovery requires multiple repair mechanisms, including vascular remodeling and blood-brain barrier (BBB) restoration. Brain pericytes are essential for BBB repair and angiogenesis after stroke, but they also give rise to scar-forming platelet-derived growth factor receptor beta (PDGFR-beta)-expressing cells. However, many of the molecular mechanisms underlying this pericyte response after stroke still remain unknown. Regulator of G-protein signaling 5 (RGS5) has been associated with pericyte detachment from the vascular wall, but whether it regulates pericyte function and vascular stabilization in the chronic phase of stroke is not known. Using RGS5-knockout (KO) mice, we study how loss of RGS5 affects the pericyte response and vascular remodeling in a stroke model at 7 d after ischemia. Loss of RGS5 leads to a shift toward an increase in the number of perivascular pericytes and reduction in the density of parenchymal PDGFR-beta-expressing cells associated with normalized PDGFR-beta activation after stroke. The redistribution of pericytes resulted in higher pericyte coverage, increased vascular density, preservation of vessel lengths, and a significant reduction in vascular leakage in RGS5-KO mice compared with controls. Our study demonstrates RGS5 in pericytes as an important target to enhance vascular remodeling.-Roth, M., Gaceb, A., Enstrom, A., Padel, T., Genove, G., ozen, I., Paul, G. Regulator of G-protein signaling 5 regulates the shift from perivascular to parenchymal pericytes in the chronic phase after stroke.	[Roth, Michaela; Gaceb, Abderahim; Enstrom, Andreas; Padel, Thomas; Ozen, Ilknur; Paul, Gesine] Lund Univ, Dept Clin Sci, Translat Neurol Grp, Solvegatan 19, S-22184 Lund, Sweden; [Paul, Gesine] Lund Univ, Wallenberg Ctr Mol Med, Lund, Sweden; [Genove, Guillem] Karolinska Inst, Integrated Cardio Metab Ctr, Dept Med, Huddinge, Sweden; [Paul, Gesine] Scania Univ Hosp, Dept Neurol, Lund, Sweden	Lund University; Lund University; Karolinska Institutet	Paul, G (corresponding author), Lund Univ, Dept Clin Sci, Translat Neurol Grp, Solvegatan 19, S-22184 Lund, Sweden.	gesine.paul-visse@med.lu.se		Roth, Michaela/0000-0001-7565-7574; Genove, Guillem/0000-0002-8558-3107	Swedish Medical Research Council; Olle Engkvist Stiftelse; Crafoord Foundation; Aners Foundation	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Olle Engkvist Stiftelse; Crafoord Foundation; Aners Foundation	The authors thank Alicja Flasch (Lund University, Sweden) for excellent technical help with immunohistochemistry. This study was funded by grants from the Swedish Medical Research Council, Olle Engkvist Stiftelse, Crafoord Foundation, and Aners Foundation. I.O. and G.P. shared last authorship. The authors declare no conflicts of interest.	Arimura K, 2012, CURR NEUROVASC RES, V9, P1; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Bai Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124362; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Berger M, 2005, BLOOD, V105, P1094, DOI 10.1182/blood-2004-06-2315; Bondjers C, 2003, AM J PATHOL, V162, P721, DOI 10.1016/S0002-9440(10)63868-0; Carmichael S Thomas, 2005, NeuroRx, V2, P396; Chen CH, 1997, J BIOL CHEM, V272, P8679, DOI 10.1074/jbc.272.13.8679; Cho H, 2003, FASEB J, V17, P440, DOI 10.1096/fj.02-0340fje; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Darland DC, 2003, DEV BIOL, V264, P275, DOI 10.1016/j.ydbio.2003.08.015; del Zoppo GJ, 2003, J CEREBR BLOOD F MET, V23, P879, DOI 10.1097/01.WCB.0000078322.96027.78; Fernandez-Klett F, 2013, J CEREBR BLOOD F MET, V33, P428, DOI 10.1038/jcbfm.2012.187; Gaceb A, 2018, J CEREBR BLOOD F MET, V38, P45, DOI 10.1177/0271678X17719645; Ghori A, 2017, ARTERIOSCL THROM VAS, V37, P867, DOI 10.1161/ATVBAHA.116.308620; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Gouveia A, 2017, STEM CELL REP, V9, P1735, DOI 10.1016/j.stemcr.2017.10.021; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Jansson D, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0722-4; Jastrzebski K, 2017, J CELL SCI, V130, P577, DOI 10.1242/jcs.191213; KAPELLER R, 1993, MOL CELL BIOL, V13, P6052, DOI 10.1128/MCB.13.10.6052; Knowland D, 2014, NEURON, V82, P603, DOI 10.1016/j.neuron.2014.03.003; Kocabayoglu P, 2015, J HEPATOL, V63, P141, DOI 10.1016/j.jhep.2015.01.036; Kokovay E, 2006, J CEREBR BLOOD F MET, V26, P545, DOI 10.1038/sj.jcbfm.9600214; LeBlanc NJ, 2018, MOL NEUROBIOL, V55, P3611, DOI 10.1007/s12035-017-0478-6; Liu JL, 2014, PROG NEUROBIOL, V115, P138, DOI 10.1016/j.pneurobio.2013.11.004; Llovera G, 2014, JOVE-J VIS EXP, DOI 10.3791/51729; Mahoney WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061421; Makihara N, 2015, EXP NEUROL, V264, P127, DOI 10.1016/j.expneurol.2014.12.007; Montmayeur JP, 1997, J BIOL CHEM, V272, P32670, DOI 10.1074/jbc.272.51.32670; Nakayama A, 2013, GENE DEV, V27, P2576, DOI 10.1101/gad.224089.113; Navaratna D, 2009, CELL ADHES MIGR, V3, P216, DOI 10.4161/cam.3.2.8396; Nisancioglu MH, 2008, MOL CELL BIOL, V28, P2324, DOI 10.1128/MCB.01252-07; Nishimura A, 2016, J CEREBR BLOOD F MET, V36, P1143, DOI 10.1177/0271678X15606456; Ozen I, 2018, STROKE, V49, P2182, DOI 10.1161/STROKEAHA.118.020124; Ozen I, 2014, ACTA NEUROPATHOL, V128, P381, DOI 10.1007/s00401-014-1295-x; Renner O, 2003, MOL BRAIN RES, V113, P44, DOI 10.1016/S0169-328X(03)00085-8; Shen FX, 2006, STROKE, V37, P2601, DOI 10.1161/01.STR.0000240407.14765.e8; Shen J, 2012, J CEREBR BLOOD F MET, V32, P353, DOI 10.1038/jcbfm.2011.136; Stratman AN, 2010, BLOOD, V116, P4720, DOI 10.1182/blood-2010-05-286872; Tallquist MD, 2003, PLOS BIOL, V1, P288, DOI 10.1371/journal.pbio.0000052; Veevers-Lowe J, 2011, J CELL SCI, V124, P1288, DOI 10.1242/jcs.076935; Wang ZQ, 2016, BIOCHEM BIOPH RES CO, V473, P551, DOI 10.1016/j.bbrc.2016.03.114; Yao QY, 2014, BLOOD, V123, P2429, DOI 10.1182/blood-2013-06-508689; Yu J, 2005, P NATL ACAD SCI USA, V102, P10999, DOI 10.1073/pnas.0501444102; Zechariah A, 2013, STROKE, V44, P1690, DOI 10.1161/STROKEAHA.111.000240	46	11	11	5	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					8990	8998		10.1096/fj.201900153R	http://dx.doi.org/10.1096/fj.201900153R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31039042	Green Published, hybrid			2022-12-28	WOS:000478832900024
J	Lu, JW; Wang, WS; Zhou, Q; Gan, XW; Myatt, L; Sun, K				Lu, Jiang-Wen; Wang, Wang-Sheng; Zhou, Qiong; Gan, Xiao-Wen; Myatt, Leslie; Sun, Kang			Activation of prostaglandin EP4 receptor attenuates the induction of cyclooxygenase-2 expression by EP2 receptor activation in human amnion fibroblasts: implications for parturition	FASEB JOURNAL			English	Article						COX-2; PI3K; fetal membranes; preterm birth	DEHYDROGENASE TYPE-1 EXPRESSION; H SYNTHASE TYPE-2; PROSTANOID RECEPTORS; GLUCOCORTICOIDS STIMULATE; FETAL MEMBRANES; BINDING PROTEIN; HUMAN PLACENTA; PRETERM BIRTH; IN-VITRO; E-2	Human amnion fibroblasts produce abundant prostaglandin E2 (PGE2), which plays a crucial role in parturition by stimulating not only myometrial contraction and cervical ripening but also the expression of the rate-limiting enzyme in PGE2 synthesis-namely, cyclooxygenase-2 (COX-2). This feed-forward induction of COX-2 expression by PGE2 is mediated via its receptors coupled with the cAMP and PKA pathway and subsequent phosphorylation of the transcription factors cAMP-response element binding protein (CREB) and signal transducer and activator of transcription 3 (STAT3). Although prostaglandin E receptor (EP)-2 and EP4 for PGE2 are coupled with activation of the cAMP and PKA pathway, the exact roles of these 2 receptors in the regulation of COX-2 expression in amnion fibroblasts remain to be determined. Here, we clarify this issue by employing human amnion tissue and fibroblasts with the long-term objective of specific targeting of prostaglandin synthesis in prevention of preterm birth. We find that an EP2 agonist caused long-lasting increases in CREB phosphorylation and COX-2 expression, whereas an EP4 agonist induced only transient increases in CREB phosphorylation and COX-2 expression in amnion fibroblasts. Moreover, only EP2 stimulation increased STAT3 phosphorylation, whereas only EP4 stimulation increased PI3K activity. EP4 antagonist or inhibition of PI3K enhanced the induction of CREB and STAT3 phosphorylation and COX-2 expression by PGE2 or EP2 stimulation, which was attenuated by EP4 overexpression. Of interest, PGE2 and cortisol, both well-demonstrated stimulants of COX-2 expression in amnion fibroblasts, increased EP2 but decreased EP4 receptor expression. Furthermore, increased EP2 but decreased EP4 abundance were observed in amnion tissue at parturition. We conclude that EP2 and EP4 receptors play different roles in the regulation of COX-2 expression in human amnion fibroblasts. EP2 is the dominant PGE2 receptor mediating the induction of COX-2 at parturition, which can be attenuated by simultaneous activation of PI3K coupled to the EP4 receptor.-Lu, J.-W., Wang, W.-S., Zhou, Q., Gan, X.-W., Myatt, L., Sun, K. Activation of prostaglandin EP4 receptor attenuates the induction of cyclooxygenase-2 expression by EP2 receptor activation in human amnion fibroblasts: implications for parturition.	[Lu, Jiang-Wen; Wang, Wang-Sheng; Gan, Xiao-Wen; Sun, Kang] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Ctr Reprod Med, 845 Lingshan Rd, Shanghai 200135, Peoples R China; [Zhou, Qiong] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Obstet & Gynecol, Shanghai, Peoples R China; [Lu, Jiang-Wen; Wang, Wang-Sheng; Gan, Xiao-Wen; Sun, Kang] Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai, Peoples R China; [Myatt, Leslie] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Oregon Health & Science University	Sun, K (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Ctr Reprod Med, 845 Lingshan Rd, Shanghai 200135, Peoples R China.	sungangrenji@hotmail.com	Wang, Wang-sheng/E-9811-2017	Wang, Wang-sheng/0000-0003-1429-9237; Sun, Kang/0000-0003-2727-141X	National Natural Science Foundation of China [81830042, 81330018]; National Key Technologies Research and Development Program of China [2017YFC1001403]; Doctorial Innovation Fund of Shanghai Jiao Tong University School of Medicine [BXJ201825]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies Research and Development Program of China(National Key Technology R&D Program); Doctorial Innovation Fund of Shanghai Jiao Tong University School of Medicine	This work was supported by The National Natural Science Foundation of China (Grants 81830042 and 81330018), the National Key Technologies Research and Development Program of China (2017YFC1001403), and the Doctorial Innovation Fund of Shanghai Jiao Tong University School of Medicine (BXJ201825). The authors declare no conflicts of interest.	Abramovitz M, 2000, BBA-MOL CELL BIOL L, V1483, P285, DOI 10.1016/S1388-1981(99)00164-X; af Forselles KJ, 2011, BRIT J PHARMACOL, V164, P1847, DOI 10.1111/j.1476-5381.2011.01495.x; Ansari KM, 2007, CARCINOGENESIS, V28, P2063, DOI 10.1093/carcin/bgm011; BERNAL AL, 1982, J ENDOCRINOL, V93, P141, DOI 10.1677/joe.0.0930141; Billot X, 2003, BIOORG MED CHEM LETT, V13, P1129, DOI 10.1016/S0960-894X(03)00042-8; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; CASEY ML, 1985, J CLIN INVEST, V75, P1852, DOI 10.1172/JCI111899; Challis JRG, 1997, ANN NY ACAD SCI, V828, P254, DOI 10.1111/j.1749-6632.1997.tb48546.x; Claria J, 2003, CURR PHARM DESIGN, V9, P2177, DOI 10.2174/1381612033454054; Desai S, 2000, MOL PHARMACOL, V58, P1279, DOI 10.1124/mol.58.6.1279; DRAY F, 1976, AM J OBSTET GYNECOL, V126, P13, DOI 10.1016/0002-9378(76)90457-9; DUCHESNE MJ, 1978, PROSTAG OTH LIPID M, V15, P19, DOI 10.1016/S0090-6980(78)80003-3; Economopoulos P, 1996, MOL CELL ENDOCRINOL, V117, P141, DOI 10.1016/0303-7207(95)03739-X; Fujino H, 2005, MOL PHARMACOL, V68, P251, DOI 10.1124/mol.105.011833; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200; Grigsby PL, 2006, AM J OBSTET GYNECOL, V195, P260, DOI 10.1016/j.ajog.2006.01.082; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Jo SH, 2002, CIRC RES, V91, P46, DOI 10.1161/01.RES.0000024115.67561.54; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; KREDENTSER JV, 1995, AM J OBSTET GYNECOL, V173, P199, DOI 10.1016/0002-9378(95)90190-6; Legler DF, 2010, INT J BIOCHEM CELL B, V42, P198, DOI 10.1016/j.biocel.2009.09.015; Li JN, 2011, J CLIN ENDOCR METAB, V96, pE899, DOI 10.1210/jc.2010-2852; Li XQ, 2014, PLACENTA, V35, P291, DOI 10.1016/j.placenta.2014.03.005; Liu C, 2016, MOL CELL ENDOCRINOL, V424, P118, DOI 10.1016/j.mce.2016.01.022; Lu JW, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aac6160; Majumder M, 2016, STEM CELLS, V34, P2290, DOI 10.1002/stem.2426; Menon R, 2016, HUM REPROD UPDATE, V22, P535, DOI 10.1093/humupd/dmw022; Myatt L, 2010, INT J DEV BIOL, V54, P545, DOI 10.1387/ijdb.082771lm; Nishigaki N, 1996, MOL PHARMACOL, V50, P1031; Olson DM, 2003, BEST PRACT RES CL OB, V17, P717, DOI 10.1016/S1521-6934(03)00069-5; PHILLIPS CA, 1981, BRIT J PHARMACOL, V73, P75, DOI 10.1111/j.1476-5381.1981.tb16773.x; Pino MS, 2005, CANCER BIOL THER, V4, P1263, DOI 10.4161/cbt.4.11.2138; POYSER NL, 1981, PROSTAGLANDINS REPRO; REGAN JW, 1994, MOL PHARMACOL, V46, P213; REHNSTROM J, 1983, PROSTAGLANDINS, V26, P973, DOI 10.1016/0090-6980(83)90158-2; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Rundhaug JE, 2011, CANCER METAST REV, V30, P465, DOI 10.1007/s10555-011-9317-9; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; SENIOR J, 1993, BRIT J PHARMACOL, V108, P501, DOI 10.1111/j.1476-5381.1993.tb12832.x; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Sun K, 2003, ENDOCRINOLOGY, V144, P5568, DOI 10.1210/en.2003-0780; Sun K, 2003, J CLIN ENDOCR METAB, V88, P5564, DOI 10.1210/jc.2003-030875; Tamiji J, 2010, BIOCHEM BIOPH RES CO, V399, P565, DOI 10.1016/j.bbrc.2010.07.112; Vo BT, 2013, ENDOCRINOLOGY, V154, P1768, DOI 10.1210/en.2012-2074; Wang WS, 2018, ENDOCR REV, V39, P241, DOI 10.1210/er.2017-00188; Wang WS, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac6151; WIKLAND M, 1982, ACTA OBSTET GYN SCAN, V61, P467, DOI 10.3109/00016348209156592; Winkler M, 1997, OBSTET GYNECOL, V89, P398, DOI 10.1016/S0029-7844(96)00500-5; Yang Z, 2007, J ENDOCRINOL, V195, P241, DOI 10.1677/JOE-07-0303; ZAKAR T, 1995, ENDOCRINOLOGY, V136, P1610, DOI 10.1210/en.136.4.1610; Zhu XO, 2009, MOL ENDOCRINOL, V23, P1839, DOI 10.1210/me.2009-0201	54	15	15	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8148	8160		10.1096/fj.201802642R	http://dx.doi.org/10.1096/fj.201802642R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30917001				2022-12-28	WOS:000476234700028
J	Sole, L; Roig, SR; Sastre, D; Vallejo-Gracia, A; Serrano-Albarras, A; Ferrer-Montiel, A; Fernandez-Ballester, G; Tamkun, MM; Felipe, A				Sole, Laura; Roig, Sara R.; Sastre, Daniel; Vallejo-Gracia, Albert; Serrano-Albarras, Antonio; Ferrer-Montiel, Antonio; Fernandez-Ballester, Gregorio; Tamkun, Michael M.; Felipe, Antonio			The calmodulin-binding tetraleucine motif of KCNE4 is responsible for association with Kv1.3	FASEB JOURNAL			English	Article						intracellular retention; leukocytes; potassium channels; regulatory subunits	INHIBITORY SUBUNIT; POTASSIUM CHANNELS; BETA-SUBUNIT; SWISS-MODEL; KCNQ1; MODULATION; ACTIVATION; SUBDOMAINS; PROTEINS; RECEPTOR	The voltage-dependent potassium (Kv) channel Kv1.3 regulates leukocyte proliferation, activation, and apoptosis, and altered expression of this channel is linked to autoimmune diseases. Thus, the fine-tuning of Kv1.3 function is crucial for the immune system response. The Kv1.3 accessory protein, potassium voltage-gated channel subfamily E (KCNE) subunit 4, acts as a dominant negative regulatory subunit to both enhance inactivation and induce intracellular retention of Kv1.3. Mutations in KCNE4 also cause immune system dysfunction. Although the formation of Kv1.3-KCNE4 complexes has profound consequences for leukocyte physiology, the molecular determinants involved in the Kv1.3-KCNE4 association are unknown. We now show that KCNE4 associates with Kv1.3 via a tetraleucine motif situated within the carboxy-terminal domain of this accessory protein. This motif would function as an interaction platform, in which Kv1.3 and Ca2+/calmodulin compete for the KCNE4 interaction. Finally, we propose a structural model of the Kv1.3-KCNE4 complex. Our experimental data and the in silico structure suggest that the KCNE4 interaction hides a forward-trafficking motif within Kv1.3 in addition to adding a strong endoplasmic reticulum retention signature to the Kv1.3-KCNE4 complex. Thus, the oligomeric composition of the Kv1.3 channelosome fine-tunes the precise balance between anterograde and intracellular retention elements that control the cell surface expression of Kv1.3 and immune system physiology.-Sole, L., Roig, S. R., Sastre, D., Vallejo-Gracia, A., Serrano-Albarras, A., Ferrer-Montiel, A., Fernandez-Ballester, G., Tamkun, M. M., Felipe, A. The calmodulin-binding tetraleucine motif of KCNE4 is responsible for association with Kv1.3.	[Sole, Laura; Sastre, Daniel; Vallejo-Gracia, Albert; Serrano-Albarras, Antonio; Felipe, Antonio] Univ Barcelona, Inst Biomed IBUB, Dept Bioquim & Biomed Mol, Mol Physiol Lab, Barcelona, Spain; [Sole, Laura; Roig, Sara R.; Tamkun, Michael M.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Ferrer-Montiel, Antonio; Fernandez-Ballester, Gregorio] Univ Miguel Hernandez, Inst Biol Mol & Celular, Alicante, Spain	University of Barcelona; Colorado State University; Universidad Miguel Hernandez de Elche	Felipe, A (corresponding author), Univ Barcelona, Dept Bioquim & Biomed Mol, Avda Diagonal 643, E-08028 Barcelona, Spain.	afelipe@ub.edu	Martínez, Daniel Sastre/AAK-9772-2020; Roig, Sara Raquel/D-4784-2018; Felipe, Antonio/M-8297-2015; Sole, Laura/AAT-7332-2020; Ferrer-Montiel, Antonio/C-3072-2015	Martínez, Daniel Sastre/0000-0001-9471-9398; Felipe, Antonio/0000-0002-7294-6431; Ferrer-Montiel, Antonio/0000-0002-2973-6607	Ministerio de Economia y Competitividad (MINECO) [BFU2014-54928-R, BFU2017-87104-R, SAF2015-66275-C2-1-1]; Fondo Europeo de Desarrollo Regional (FEDER); MINECO; Generalitat de Catalunya	Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); MINECO(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This study was supported by the Ministerio de Economia y Competitividad (MINECO) (Grants BFU2014-54928-R, BFU2017-87104-R, and SAF2015-66275-C2-1-1) and Fondo Europeo de Desarrollo Regional (FEDER). L.S, S.R.R., D.S., and A.V.-G. hold fellowships from the MINECO. A.S.-A. was supported by a fellowship from the Generalitat de Catalunya. The English editorial assistance of the American Journal Experts (Durham, NC, USA) is also acknowledged. The authors declare no conflicts of interest.	AIYAR J, 1993, AM J PHYSIOL, V265, pC1571, DOI 10.1152/ajpcell.1993.265.6.C1571; Beeton C, 2005, NEUROSCIENTIST, V11, P550, DOI 10.1177/1073858405278016; Chang MC, 2001, CELL PHYSIOL BIOCHEM, V11, P123, DOI 10.1159/000047800; Chen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005143; Ciampa EJ, 2011, J BIOL CHEM, V286, P4141, DOI 10.1074/jbc.M110.158865; de la Fuente-Ortega E, 2015, MOL BIOL CELL, V26, P1728, DOI 10.1091/mbc.E15-01-0047; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fanger CM, 1999, J BIOL CHEM, V274, P5746, DOI 10.1074/jbc.274.9.5746; Freidin MB, 2011, MOL BIOL+, V45, P421, DOI 10.1134/S0026893311020075; Gage SD, 2004, J GEN PHYSIOL, V124, P759, DOI 10.1085/jgp.200409114; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; Gomis-Perez C, 2015, J CELL SCI, V128, P3155, DOI 10.1242/jcs.174128; Govers P, 1998, J BIOL CHEM, V273, P16426, DOI 10.1074/jbc.273.26.16426; Grunnet M, 2003, BIOPHYS J, V85, P1525, DOI 10.1016/S0006-3495(03)74585-8; Grunnet M, 2002, J PHYSIOL-LONDON, V542, P119, DOI 10.1113/jphysiol.2002.017301; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haitin Y, 2009, EMBO J, V28, P1994, DOI 10.1038/emboj.2009.157; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jablonka-Shariff A, 2011, MOL CELL ENDOCRINOL, V339, P7, DOI 10.1016/j.mce.2011.03.013; Kanda VA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00231; Kang CB, 2008, BIOCHEMISTRY-US, V47, P7999, DOI 10.1021/bi800875q; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lundquist Andrew L, 2005, J Mol Cell Cardiol, V38, P277, DOI 10.1016/j.yjmcc.2004.11.012; Manderfield LJ, 2009, J PHYSIOL-LONDON, V587, P303, DOI 10.1113/jphysiol.2008.161281; Martens JR, 1999, TRENDS CARDIOVAS MED, V9, P253, DOI 10.1016/S1050-1738(00)00037-2; Martinez-Marmol R, 2013, J CELL SCI, V126, P5681, DOI 10.1242/jcs.134825; Martinez-Pinna J, 2014, ACTA PHYSIOL, V212, P41; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; Melman YF, 2002, J BIOL CHEM, V277, P25187, DOI 10.1074/jbc.M200564200; Melman YF, 2002, TRENDS CARDIOVAS MED, V12, P182, DOI 10.1016/S1050-1738(02)00158-5; Melman YF, 2004, NEURON, V42, P927, DOI 10.1016/j.neuron.2004.06.001; Melman YF, 2001, J BIOL CHEM, V276, P6439, DOI 10.1074/jbc.M010713200; Nakajo K, 2011, J GEN PHYSIOL, V138, P521, DOI 10.1085/jgp.201110677; Panaghie G, 2006, J PHYSIOL-LONDON, V570, P455, DOI 10.1113/jphysiol.2005.100644; Panaghie G, 2006, CURR PHARM DESIGN, V12, P2285, DOI 10.2174/138161206777585175; Panyi G, 2004, P NATL ACAD SCI USA, V101, P1285, DOI 10.1073/pnas.0307421100; Poulsen AN, 2007, BIOCHEM BIOPH RES CO, V363, P133, DOI 10.1016/j.bbrc.2007.08.146; Romey G, 1997, J BIOL CHEM, V272, P16713, DOI 10.1074/jbc.272.27.16713; Roura-Ferrer M, 2010, J CELL PHYSIOL, V225, P692, DOI 10.1002/jcp.22265; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sole L, 2016, J CELL SCI, V129, P4265, DOI 10.1242/jcs.191650; Sole L, 2013, CHANNELS, V7, P85, DOI 10.4161/chan.23258; Sole L, 2009, J CELL SCI, V122, P3738, DOI 10.1242/jcs.056689; Spear JM, 2015, BMC BIOCHEM, V16, DOI 10.1186/s12858-015-0045-6; TAKUMI T, 1991, J BIOL CHEM, V266, P22192; Tapper AR, 2000, J GEN PHYSIOL, V116, P379, DOI 10.1085/jgp.116.3.379; Trevino LR, 2009, NAT GENET, V41, P1001, DOI 10.1038/ng.432; Vanoye CG, 2010, CHANNELS, V4, P108, DOI 10.4161/chan.4.2.11141; Vanoye CG, 2009, J GEN PHYSIOL, V134, P207, DOI 10.1085/jgp.200910234; Wang Q, 2007, EXP CELL RES, V313, P3349, DOI 10.1016/j.yexcr.2007.06.014; Wu JJ, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0190-x; Xu SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158269; Zheng RJ, 2010, BIOCHEM J, V428, P75, DOI 10.1042/BJ20090977	58	6	6	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8263	8279		10.1096/fj.201801164RR	http://dx.doi.org/10.1096/fj.201801164RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30969795	Bronze			2022-12-28	WOS:000476234700038
J	Wang, TQ; Sun, GY; Wang, YN; Li, SX; Zhao, XY; Zhang, CP; Jin, H; Tian, D; Liu, K; Shi, W; Tian, Y; Zhang, D				Wang, Tianqi; Sun, Guangyong; Wang, Yaning; Li, Shuxiang; Zhao, Xinyan; Zhang, Chunpan; Jin, Hua; Tian, Dan; Liu, Kai; Shi, Wen; Tian, Yue; Zhang, Dong			The immunoregulatory effects of CD8 T-cell-derived perforin on diet-induced nonalcoholic steatohepatitis	FASEB JOURNAL			English	Article						monocyte; immunology; inflammation apoptosis	DISEASE; INFLAMMATION; RECRUITMENT; CHEMOKINES; REGULATOR; EXPANSION	The liver is a central immunologic organ with a high density of myeloid and lymphoid immune cells that play important roles in the development and progression of nonalcoholic steatohepatitis (NASH). However, the immune-cell-mediated regulation of NASH and its underlying mechanisms remain obscure. In this study, Prf1(null) mice showed significantly higher plasma alanine transaminase levels, with increased liver fat accumulation, lobular inflammation, and focal necrosis compared with wild-type (WT) mice after 4 wk of feeding on a methionine- and choline-deficient diet (MCD) or 16 wk of feeding on a high-fat diet. Perforin deficiency promoted the M1 polarization of infiltrated monocytes. Moreover, MCD-fed Prf1(null) mice exhibited increased accumulation, survival, activation, and proinflammatory cytokine production of CD8 T cells but not NK cells or CD4 T cells. Adoptive transfer of CD8 T cells or NK cells from WT or Prf1(null) mice, together with non-CD8 cells or non-NK cells from WT mice, indicated that CD8 T-cell-derived perforin participates in the mechanism regulating liver inflammation and thus plays a protective role in the development of NASH. Perforin-deficient CD8 T cells exhibited decreased cytotoxicity toward bone marrow-derived M1 monocytes and macrophages. According to the RNA sequencing data, the perforin deficiency inhibited cell apoptosis and enhanced the activation, migration, and proinflammatory cytokine production of CD8 T cells in mice with NASH. Furthermore, we found higher plasma soluble perforin levels and hepatic perforin expression in NASH patients, suggesting clinical relevance of the findings. We have elucidated an important role for the cytotoxic immune effector molecule perforin from CD8 T cells in restricting hepatic inflammation in mice with NASH and suggest that therapies designed to maximize the function of endogenous perforin in CD8 T cells might have potential benefits as NASH treatments.-Wang, T., Sun, G., Wang, Y., Li, S., Zhao, X., Zhang, C., Jin, H., Tian, D., Liu, K., Shi, W., Tian, Y., Zhang, D. The immunoregulatory effects of CD8 T-cell-derived perforin on diet-induced nonalcoholic steatohepatitis.	[Wang, Tianqi; Sun, Guangyong; Wang, Yaning; Zhang, Chunpan; Jin, Hua; Tian, Dan; Liu, Kai; Shi, Wen; Tian, Yue; Zhang, Dong] Capital Med Univ, Beijing Friendship Hosp, Expt & Translat Res Ctr, Beijing, Peoples R China; [Zhang, Dong] Capital Med Univ, Beijing Friendship Hosp, Gen Surg Dept, Beijing, Peoples R China; [Wang, Tianqi; Sun, Guangyong; Wang, Yaning; Zhang, Chunpan; Jin, Hua; Tian, Dan; Liu, Kai; Shi, Wen; Tian, Yue; Zhang, Dong] Beijing Clin Res Inst, Beijing, Peoples R China; [Wang, Tianqi; Sun, Guangyong; Wang, Yaning; Zhang, Chunpan; Jin, Hua; Tian, Dan; Liu, Kai; Shi, Wen; Tian, Yue; Zhang, Dong] Beijing Key Lab Tolerance Induct & Organ Protect, Beijing, Peoples R China; [Li, Shuxiang; Zhao, Xinyan; Zhang, Dong] Natl Clin Res Ctr Digest Dis, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Zhang, D (corresponding author), Capital Med Univ, Beijing Friendship Hosp, 95 Yong An Rd, Beijing 100050, Peoples R China.	zhangd@ccmu.edu.cn	Tian, Dan/AAR-4019-2020; Zhang, Dong/AAU-5380-2020	Tian, Dan/0000-0002-6894-2673; Zhang, Dong/0000-0002-3404-5173; zhao, xinyan/0000-0002-8016-4368	National Natural Science Foundation of China [81570510, 81870399]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Dr. Xiaoge Zhou and Dr. Liwei Liu (both from Beijing Friendship Hospital, Capital Medical University) for technical support. This study was supported by grants from the National Natural Science Foundation of China (81570510 and 81870399). The authors declare no conflicts of interest.	Alsharifi M, 2008, J GEN VIROL, V89, P1942, DOI 10.1099/vir.0.83626-0; [Anonymous], [No title captured]; Arindkar S, 2013, J GASTROEN HEPATOL, V28, P1403, DOI 10.1111/jgh.12186; Badovinac VP, 2003, IMMUNITY, V18, P463, DOI 10.1016/S1074-7613(03)00079-7; Bhattacharjee J, 2014, J NUTR BIOCHEM, V25, P219, DOI 10.1016/j.jnutbio.2013.10.010; Blanco P, 2005, ARTHRITIS RHEUM, V52, P201, DOI 10.1002/art.20745; Blazar BR, 2000, J IMMUNOL, V165, P4901, DOI 10.4049/jimmunol.165.9.4901; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; Gadd VL, 2014, HEPATOLOGY, V59, P1393, DOI 10.1002/hep.26937; Ghazarian M, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai7616; Han KQ, 2015, WORLD J GASTROENTERO, V21, P4864, DOI 10.3748/wjg.v21.i16.4864; Janka GE, 2012, ANNU REV MED, V63, P233, DOI 10.1146/annurev-med-041610-134208; Jenkins MR, 2015, J EXP MED, V212, P307, DOI 10.1084/jem.20140964; Ju C, 2016, CELL MOL IMMUNOL, V13, P316, DOI 10.1038/cmi.2015.104; Kagi D, 1996, J EXP MED, V183, P2143, DOI 10.1084/jem.183.5.2143; Lykens JE, 2011, BLOOD, V118, P618, DOI 10.1182/blood-2010-12-324533; Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043; Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011; Nati M, 2016, REV ENDOCR METAB DIS, V17, P29, DOI 10.1007/s11154-016-9339-2; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; Revelo XS, 2015, DIABETES, V64, P90, DOI 10.2337/db13-1524; Schuster S, 2018, NAT REV GASTRO HEPAT, V15, P349, DOI 10.1038/s41575-018-0009-6; Smith DF, 2005, AM J PHYSIOL-HEART C, V289, pH1976, DOI 10.1152/ajpheart.00153.2005; Tacke F, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S27; Terrell CE, 2013, BLOOD, V121, P5184, DOI 10.1182/blood-2013-04-495309; Tsunetsugu-Yokota Y, 2002, J LEUKOCYTE BIOL, V72, P115; Vizuete J, 2017, J CLIN TRANSL HEPATO, V5, P67, DOI 10.14218/JCTH.2016.00061; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Voskoboinik I, 2015, NAT REV IMMUNOL, V15, P388, DOI 10.1038/nri3839; Voskoboinik I, 2010, IMMUNOL REV, V235, P35, DOI 10.1111/j.0105-2896.2010.00896.x; Wolf MJ, 2014, CANCER CELL, V26, P549, DOI 10.1016/j.ccell.2014.09.003	32	16	16	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8490	8503		10.1096/fj.201802534RR	http://dx.doi.org/10.1096/fj.201802534RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30951375	Bronze			2022-12-28	WOS:000476234700054
J	Ko, J; Kang, HJ; Kim, DA; Kim, MJ; Ryu, ES; Lee, S; Ryu, JH; Roncal, C; Johnson, RJ; Kang, DH				Ko, Jiyeon; Kang, Hyun-Jung; Kim, Dal-Ah; Kim, Mi-Jin; Ryu, Eun-Sun; Lee, Shina; Ryu, Jung-Hwa; Roncal, Carlos; Johnson, Richard J.; Kang, Duk-Hee			Uric acid induced the phenotype transition of vascular endothelial cells via induction of oxidative stress and glycocalyx shedding	FASEB JOURNAL			English	Article						EndoMT; reactive oxygen species; hyperuricemia; syndecan-1	EPITHELIAL-MESENCHYMAL TRANSITION; FIBROBLASTS; ALLOPURINOL; DYSFUNCTION; FIBROSIS; MYOFIBROBLASTS; PROLIFERATION; INHIBITION; GENERATION; MECHANISM	Recent data suggested a causative role of uric acid (UA) in the development of renal disease, in which endothelial dysfunction is regarded as the key mechanism. Endothelial-to-mesenchymal transition (EndoMT) and shedding of the glycocalyx are early changes of endothelial dysfunction. We investigated whether UA induced EndoMT in HUVECs and an animal model of hyperuricemia fed with 2% oxonic acid for 4 wk. UA induced EndoMT in HUVECs with a generation of reactive oxygen species via the activation of membranous NADPH oxidase (from 15 min) and mitochondria (from 6 h) along with glycocalyx shedding (from 6 h), which were blocked by probenecid. GM6001, an inhibitor of matrix metalloproteinase, alleviated UA-induced glycocalyx shedding and EndoMT. Antioxidants including N-acetyl cysteine, apocynin, and mitotempo ameliorated EndoMT; however, they did not change glycocalyx shedding in HUVECs. In the kidney of hyperuricemic rats, endothelial staining in peritubular capillaries (PTCs) was substantially decreased with a de novo expression of alpha-smooth muscle actin in PTCs. Plasma level of syndecan-1 was increased in hyperuricemic rats, which was ameliorated by allopurinol. UA caused a phenotypic transition of endothelial cells via induction of oxidative stress with glycocalyx shedding, which could be one of the mechanisms of UA-induced endothelial dysfunction and kidney disease.	[Ko, Jiyeon; Kang, Hyun-Jung; Kim, Dal-Ah; Ryu, Eun-Sun; Lee, Shina; Ryu, Jung-Hwa; Kang, Duk-Hee] Ewha Womans Univ, Coll Med, Ewha Med Res Ctr, Div Nephrol,Dept Internal Med, Seoul, South Korea; [Kim, Mi-Jin] CHA Univ, Dept Biotechnol, Seongnam, South Korea; [Roncal, Carlos; Johnson, Richard J.] Univ Colorado, Div Renal Dis & Hypertens, Anschutz Med Campus, Aurora, CO USA	Ewha Womans University; Pochon Cha University; University of Colorado System; University of Colorado Anschutz Medical Campus	Kang, DH (corresponding author), Ewha Womans Univ, Coll Med, Div Nephrol, 260 Gonghang Daero, Seoul 07804, South Korea.	dhkang@ewha.ac.kr			National Research Foundation of Korea (NRF) - Government of Korea (MSIT) [NRF-2015R1A2A1A15053374, NRF-2017R1A2B2005849]	National Research Foundation of Korea (NRF) - Government of Korea (MSIT)	This work was supported by the National Research Foundation of Korea (NRF) funded by the Government of Korea (MSIT) (NRF-2015R1A2A1A15053374 and NRF-2017R1A2B2005849). The authors declare no conflicts of interest.	Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Butler R, 2000, HYPERTENSION, V35, P746, DOI 10.1161/01.HYP.35.3.746; Chappell D, 2009, CIRC RES, V104, P1313, DOI 10.1161/CIRCRESAHA.108.187831; Corry DB, 2008, J HYPERTENS, V26, P269, DOI 10.1097/HJH.0b013e3282f240bf; Dejana E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14361; Doehner W, 2002, CIRCULATION, V105, P2619, DOI 10.1161/01.CIR.0000017502.58595.ED; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Farquharson CA, 2002, CIRCULATION, V106, P221, DOI 10.1161/01.CIR.0000022140.61460.1D; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Fukawa T, 2012, EXP CELL RES, V318, P1926, DOI 10.1016/j.yexcr.2012.05.023; Henry CBS, 2000, AM J PHYSIOL-HEART C, V279, pH2815, DOI 10.1152/ajpheart.2000.279.6.H2815; Hofmann-Kiefer KF, 2009, EUR J MED RES, V14, P526; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kanbay M, 2013, HEART, V99, P759, DOI 10.1136/heartjnl-2012-302535; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kang DH, 2002, J AM SOC NEPHROL, V13, P2888, DOI 10.1097/01.ASN.0000034910.58454.FD; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Lanaspa MA, 2012, J BIOL CHEM, V287, P40732, DOI 10.1074/jbc.M112.399899; Li JH, 2009, AM J PATHOL, V175, P1380, DOI 10.2353/ajpath.2009.090096; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Mazzali M, 2002, AM J PHYSIOL-RENAL, V282, pF991, DOI 10.1152/ajprenal.00283.2001; Montorfano I, 2014, LAB INVEST, V94, P1068, DOI 10.1038/labinvest.2014.100; Nieuwdorp M, 2005, CURR OPIN LIPIDOL, V16, P507, DOI 10.1097/01.mol.0000181325.08926.9c; Noble MIM, 2008, QJM-INT J MED, V101, P513, DOI 10.1093/qjmed/hcn024; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Ryu ES, 2013, AM J PHYSIOL-RENAL, V304, pF471, DOI 10.1152/ajprenal.00560.2012; Sanchez-Lozada LG, 2007, AM J PHYSIOL-RENAL, V292, pF1238, DOI 10.1152/ajprenal.00164.2006; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Schwartz IF, 2011, J VASC RES, V48, P252, DOI 10.1159/000320356; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Torres IP, 2016, AM J PHYSIOL-HEART C, V310, pH1468, DOI 10.1152/ajpheart.00006.2016; VanTeeffelen JW, 2007, TRENDS CARDIOVAS MED, V17, P101, DOI 10.1016/j.tcm.2007.02.002; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Weiner DE, 2008, J AM SOC NEPHROL, V19, P1204, DOI 10.1681/ASN.2007101075; Xavier S, 2015, J AM SOC NEPHROL, V26, P817, DOI 10.1681/ASN.2013101137; Yu MA, 2010, J HYPERTENS, V28, P1234, DOI 10.1097/HJH.0b013e328337da1d; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zharikov S, 2008, AM J PHYSIOL-CELL PH, V295, pC1183, DOI 10.1152/ajpcell.00075.2008; Zuurbier CJ, 2005, J APPL PHYSIOL, V99, P1471, DOI 10.1152/japplphysiol.00436.2005	44	36	36	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13334	13345		10.1096/fj.201901148R	http://dx.doi.org/10.1096/fj.201901148R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31553887	Bronze			2022-12-28	WOS:000507466100024
J	Park, R; Kim, H; Jang, M; Jo, D; Park, YI; Namkoong, S; Lee, JI; Jang, IS; Park, J				Park, Rackhyun; Kim, Hyunju; Jang, Minsu; Jo, Daum; Park, Yea-In; Namkoong, Sim; Lee, Jin I.; Jang, Ik-Soon; Park, Junsoo			LNX1 contributes to tumor growth by down-regulating p53 stability	FASEB JOURNAL			English	Article						MDM2; Numb; ubiquitination	E3 UBIQUITIN LIGASE; PROTEIN; MDM2; NUMB; SUPPRESSOR; INTERACTS; LEUKEMIA; DOMAIN	The well-known tumor suppressor p53 inhibits the formation of various cancers by inducing cell cycle arrest and apoptosis. Although p53 mutations are commonly found in many cancers, p53 is functionally inactivated in tumor cells that retain wild-type p53. Here, we show that the ligand of numb protein X1 (LNX1) inhibited p53-dependent transcription by decreasing the half-life of p53. We generated LNX1 knockout (KO) cells in p53 wild-type cancer cells (A549, HCT116, and MCF7) using the clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 gene-editing system. LNX1 KO activated p53-dependent transcription by increasing the stability of p53. Moreover, lentivirus-mediated overexpression of LNX1 decreased p53 protein levels and inhibited p53-dependent transcription. LNX1 interacted with p53 and mouse double minute 2 (MDM2) and increased the ubiquitination of p53 in an MDM2-dependent manner. Finally, we demonstrated that LNX1 was required for efficient tumor growth both in cell culture and in a mouse tumor xenograft model. These results collectively indicated that LNX1 contributed to tumor growth by inhibiting p53-dependent signaling in p53 wild-type cancer cells.	[Park, Rackhyun; Kim, Hyunju; Jang, Minsu; Jo, Daum; Park, Yea-In; Lee, Jin I.; Park, Junsoo] Yonsei Univ, Div Biol Sci & Technol, 1 Yonseidae Gil, Wonju 26493, Kangwon Provinc, South Korea; [Namkoong, Sim] Kangwon Natl Univ, Dept Biochem, Chunchon, South Korea; [Jang, Ik-Soon] Korea Basic Sci Inst, Div Bioconvergence Anal, Daejeon, South Korea	Yonsei University; Kangwon National University; Korea Basic Science Institute (KBSI)	Park, J (corresponding author), Yonsei Univ, Div Biol Sci & Technol, 1 Yonseidae Gil, Wonju 26493, Kangwon Provinc, South Korea.	junsoo@yonsei.ac.kr			National Research Foundation of Korea (NRF) - Korean government [2016R1A2B4009665, 2019R1A2C1006511]	National Research Foundation of Korea (NRF) - Korean government(National Research Foundation of Korea)	This study was supported by National Research Foundation of Korea (NRF) grants funded by the Korean government (2016R1A2B4009665 and 2019R1A2C1006511). The authors declare no conflicts of interest.	Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Carter S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-221; Chen JX, 2005, INT J BIOCHEM CELL B, V37, P2273, DOI 10.1016/j.biocel.2005.02.028; Chene P, 2004, MOL CANCER RES, V2, P20; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Danovi SA, 2010, NAT REV CANCER, V10, P602, DOI 10.1038/nrc2919; den Engelsman J, 2003, J BIOL CHEM, V278, P4699, DOI 10.1074/jbc.M211403200; Dho SE, 1998, J BIOL CHEM, V273, P9179, DOI 10.1074/jbc.273.15.9179; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Hu TT, 2015, CELL BIOCHEM FUNCT, V33, P443, DOI 10.1002/cbf.3130; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Juven-Gershon T, 1998, MOL CELL BIOL, V18, P3974, DOI 10.1128/MCB.18.7.3974; Lenihan JA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187352; Lenihan JA, 2014, GENE, V552, P39, DOI 10.1016/j.gene.2014.09.011; Ma L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188665; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Nie J, 2002, EMBO J, V21, P93, DOI 10.1093/emboj/21.1.93; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Sheng WW, 2017, FASEB J, V31, P2429, DOI 10.1096/fj.201601240R; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Weiss A, 2007, FEBS LETT, V581, P5131, DOI 10.1016/j.febslet.2007.09.062; Wolting CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026248; Young P, 2005, MOL CELL NEUROSCI, V30, P238, DOI 10.1016/j.mcn.2005.07.015; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zheng D, 2011, MOL BIOL REP, V38, P2771, DOI 10.1007/s11033-010-0422-6	27	4	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13216	13227		10.1096/fj.201900366R	http://dx.doi.org/10.1096/fj.201900366R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31533005	Bronze			2022-12-28	WOS:000507466100015
J	Raybuck, AL; Lee, K; Cho, SH; Li, JX; Thomas, JW; Boothby, MR				Raybuck, Ariel L.; Lee, Keunwook; Cho, Sung Hoon; Li, Jingxin; Thomas, James W.; Boothby, Mark R.			mTORC1 as a cell-intrinsic rheostat that shapes development, preimmune repertoire, and function of B lymphocytes	FASEB JOURNAL			English	Article						immunity; signaling; protein malnutrition	LIVED PLASMA-CELLS; ANTIBODY-RESPONSES; IMMUNE-RESPONSE; VITAMIN-A; DIFFERENTIATION; EXPRESSION; ROLES; MICE; METABOLISM; COMPLEX	Ample evidence indicates that nutrient concentrations in extracellular milieux affect signaling mediated by environmental sensor proteins. For instance, the mechanistic target of rapamycin (mTOR) is reduced during protein malnutrition and is known to be modulated by concentrations of several amino acids when in a multiprotein signaling complex that contains regulatory-associated protein of mTOR. We hypothesized that a partial decrease in mTOR complex 1 (mTORC1) activity intrinsic to B-lineage cells would perturb lymphocyte development or function, or both. We show that a cell-intrinsic decrease in mTORC1 activity impacted developmental progression, antigen receptor repertoire, and function along the B lineage. Thus, preimmune repertoires of B-lineage cells were altered in the marrow and periphery in a genetic model of regulatory-associated protein of mTOR haploinsufficiency. An additional role for mTORC1 was revealed when a B-cell antigen receptor transgene was found to circumvent the abnormal B-cell development haploinsufficient B cells were profoundly impaired in responses to antigen in vivo. Collectively, our findings indicate that mTORC1 serves as a rheostat that shapes differentiation along the B lineage, the preimmune repertoire, and antigen-driven selection of mature B cells. The findings also reveal a range in the impact of this nutrient sensor on activity-response relationships for distinct endpoints.	[Raybuck, Ariel L.; Cho, Sung Hoon; Li, Jingxin; Boothby, Mark R.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, A-5301 MCN,1161 21st Ave S, Nashville, TN 37232 USA; [Cho, Sung Hoon; Boothby, Mark R.] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Infect Immunol & Inflammat, Nashville, TN USA; [Thomas, James W.; Boothby, Mark R.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Boothby, Mark R.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Lee, Keunwook] Hallym Univ, Dept Biomed Sci, Chunchon, Gangwon Do, South Korea	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Hallym University	Boothby, MR (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, A-5301 MCN,1161 21st Ave S, Nashville, TN 37232 USA.	mark.boothby@vanderbilt.edu	Li, Jing/GYU-5036-2022	Thomas, James/0000-0002-2098-6458	U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases [AI113292, AI051448]; NIH National Heart, Lung, and Blood Institute Grant [HL106812]; Korean Ministry of Science [NRF-2014M3A9D5A01073841]; NIH Shared Instrumentation Grant [1S10OD018015]; Cancer Center Support Grant [CA068485]; Diabetes Research Center Grant [DK0205930]	U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases; NIH National Heart, Lung, and Blood Institute Grant; Korean Ministry of Science; NIH Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; Diabetes Research Center Grant	This work was supported by U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases Grant AI113292 to M.R.B., and AI051448 to J.W.T., NIH National Heart, Lung, and Blood Institute Grant HL106812 to M.R.B., Korean Ministry of Science Grant NRF-2014M3A9D5A01073841 to K.L., and NIH Shared Instrumentation Grant 1S10OD018015, as well as a scholarships via the Cancer Center Support Grant CA068485 and Diabetes Research Center Grant DK0205930 to help defray costs of Vanderbilt cores. The authors declare no conflicts of interest.	Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bennett Nancy M., 2012, Morbidity and Mortality Weekly Report, V61, P816; Boothby M, 2017, IMMUNITY, V46, P743, DOI 10.1016/j.immuni.2017.04.009; Boothby MR, 2019, GENE DEV, V33, P26, DOI 10.1101/gad.320192.118; Bortnick A, 2013, J IMMUNOL, V190, P5913, DOI 10.4049/jimmunol.1300161; Cancro MP, 2004, IMMUNOL REV, V197, P89, DOI 10.1111/j.0105-2896.2004.0099.x; CARLOMAGNO MA, 1982, INFECT IMMUN, V38, P195, DOI 10.1128/IAI.38.1.195-200.1982; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Caro-Maldonado A, 2012, SEMIN IMMUNOL, V24, P405, DOI 10.1016/j.smim.2012.12.002; Cho SH, 2013, J IMMUNOL, V191, P3169, DOI 10.4049/jimmunol.1301106; Clark MR, 2014, NAT REV IMMUNOL, V14, P69, DOI 10.1038/nri3570; Cohen S, 2017, EUR J IMMUNOL, V47, P225, DOI 10.1002/eji.201646423; Corcoran AE, 1996, EMBO J, V15, P1924, DOI 10.1002/j.1460-2075.1996.tb00543.x; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Dorner T, 2007, IMMUNITY, V27, P384, DOI 10.1016/j.immuni.2007.09.002; DREIZEN S, 1979, INT J VITAM NUTR RES, V49, P220; Duan B, 2006, AUTOIMMUN REV, V5, P403, DOI 10.1016/j.autrev.2005.10.007; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Foci RA, 2010, NUTRITION, V26, P1021, DOI 10.1016/j.nut.2009.08.026; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; Gronwall C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00066; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Harputlugil E, 2014, CELL REP, V8, P1160, DOI 10.1016/j.celrep.2014.07.018; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; HOLT L E Jr, 1960, Bull N Y Acad Med, V36, P431; Hoshii T, 2012, J CLIN INVEST, V122, P2114, DOI 10.1172/JCI62279; Howard JK, 1999, J CLIN INVEST, V104, P1051, DOI 10.1172/JCI6762; Ibrahim MK, 2017, CLIN MICROBIOL REV, V30, P919, DOI 10.1128/CMR.00119-16; Iwata TN, 2016, J IMMUNOL, V197, P2250, DOI 10.4049/jimmunol.1600492; Jones DD, 2016, J CLIN INVEST, V126, P4250, DOI 10.1172/JCI86504; Kalaitzidis D, 2012, CELL STEM CELL, V11, P429, DOI 10.1016/j.stem.2012.06.009; Keating R, 2013, NAT IMMUNOL, V14, P1266, DOI 10.1038/ni.2741; Kometani K, 2015, CURR OPIN IMMUNOL, V33, P64, DOI 10.1016/j.coi.2015.01.017; Lamming DW, 2015, ONCOTARGET, V6, P31233, DOI 10.18632/oncotarget.5180; Lee JH, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf2885; Lee K, 2013, BLOOD, V122, P2369, DOI 10.1182/blood-2013-01-477505; Lee K, 2012, J EXP MED, V209, P713, DOI 10.1084/jem.20111470; Lee SK, 2011, J EXP MED, V208, P1377, DOI 10.1084/jem.20102065; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; Malin S, 2010, NAT IMMUNOL, V11, P171, DOI 10.1038/ni.1827; MALYNN BA, 1990, J EXP MED, V171, P843, DOI 10.1084/jem.171.3.843; MCMURRAY DN, 1981, AM J CLIN NUTR, V34, P2117, DOI 10.1093/ajcn/34.10.2117; Mejia P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7050; Merrell KT, 2006, IMMUNITY, V25, P953, DOI 10.1016/j.immuni.2006.10.017; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Meyer-Bahlburg A, 2008, J EXP MED, V205, P155, DOI 10.1084/jem.20071088; Montecino-Rodriguez E, 2012, IMMUNITY, V36, P13, DOI 10.1016/j.immuni.2011.11.017; Najera O, 2004, CLIN DIAGN LAB IMMUN, V11, P577, DOI 10.1128/CDLI.11.3.577-580.2004; NOHR CW, 1986, J SURG RES, V40, P432, DOI 10.1016/0022-4804(86)90211-8; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Pallard C, 1999, IMMUNITY, V10, P525, DOI 10.1016/S1074-7613(00)80052-7; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Peng YJ, 2006, J PHYSIOL-LONDON, V577, P705, DOI 10.1113/jphysiol.2006.114033; Petro JB, 2002, J BIOL CHEM, V277, P48009, DOI 10.1074/jbc.M200305200; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Ray JP, 2015, IMMUNITY, V43, P690, DOI 10.1016/j.immuni.2015.08.017; Raybuck AL, 2018, J IMMUNOL, V200, P2627, DOI 10.4049/jimmunol.1701321; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Ross AC, 2012, AM J CLIN NUTR, V96, p1166S, DOI 10.3945/ajcn.112.034637; Rother MB, 2016, SCI REP-UK, V6, DOI 10.1038/srep33924; Rowland SL, 2013, IMMUNOL RES, V55, P231, DOI 10.1007/s12026-012-8366-7; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Shapiro-Shelef M, 2005, J EXP MED, V202, P1471, DOI 10.1084/jem.20051611; Su TT, 2004, IMMUNOL REV, V197, P161, DOI 10.1111/j.0105-2896.2004.0102.x; Teague BN, 2007, J IMMUNOL, V178, P7511, DOI 10.4049/jimmunol.178.12.7511; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Villamor E, 2005, CLIN MICROBIOL REV, V18, P446, DOI 10.1128/CMR.18.3.446-464.2005; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; YANCOPOULOS GD, 1988, J EXP MED, V168, P417, DOI 10.1084/jem.168.1.417; Yang JL, 2016, ELIFE, V5, DOI 10.7554/eLife.17936; Zeng H, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar5701; Zeng H, 2016, IMMUNITY, V45, P540, DOI 10.1016/j.immuni.2016.08.017	78	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13202	13215		10.1096/fj.201900069R	http://dx.doi.org/10.1096/fj.201900069R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31533002	Bronze, Green Published			2022-12-28	WOS:000507466100014
J	Liou, CJ; Dai, YW; Wang, CL; Fang, LW; Huang, WC				Liou, Chian-Jiun; Dai, Yi-Wen; Wang, Chia-Ling; Fang, Li-Wen; Huang, Wen-Chung			Maslinic acid protects against obesity-induced nonalcoholic fatty liver disease in mice through regulation of the Sirt1/AMPK signaling pathway	FASEB JOURNAL			English	Article						HepG2; lipogenesis; lipolysis; hepatic steatosis	ADIPOSE-TISSUE; TRANSCRIPTIONAL REGULATION; GROWTH-FACTOR; DIET; ACCUMULATION; INFLAMMATION; CELLS; DYSREGULATION; METABOLISM; LIPOLYSIS	Maslinic acid is a pentacyclic triterpenoid that is distributed in the peel of olives. Previous studies found that maslinic acid inhibited inflammatory response and antioxidant effects. We investigated whether maslinic acid ameliorates nonalcoholic fatty liver disease in mice with high-fat-diet (HFD)-induced obesity and evaluated the regulation of lipogenesis in hepatocytes. Male C57BL/6 mice fed a normal diet or HFD (60% fat, w/w) were tested for 16 wk. After the fourth week, mice were injected intraperitoneally with maslinic acid for 12 wk. In another experiment, HepG2 cells were treated with oleic acid to induce lipid accumulation or maslinic acid to evaluate lipogenesis. Maslinic acid significantly reduced body weight compared with HFD-fed mice. Maslinic acid reduced liver weight and liver lipid accumulation and improved hepatocyte steatosis. Furthermore, serum glucose, leptin, and free fatty acid concentrations significantly reduced, but the serum adiponectin concentration was higher, in the maslinic acid group than in the HFD group. In liver tissue, maslinic acid suppressed transcription factors involved in lipogenesis and increased adipose triglyceride lipase. In vitro, maslinic acid decreased lipogenesis by activating AMPK. These findings suggest that maslinic acid acts against hepatic steatosis by regulating enzyme activity involved in lipogenesis, lipolysis, and fatty acid oxidation in the liver.	[Liou, Chian-Jiun] Chang Gung Univ Sci & Technol, Dept Nursing, Res Ctr Chinese Herbal Med, Div Basic Med Sci, Taoyuan, Taiwan; [Dai, Yi-Wen; Wang, Chia-Ling; Huang, Wen-Chung] Chang Gung Univ Sci & Technol, Coll Human Ecol, Grad Inst Hlth Ind Technol, Res Ctr Food & Cosmet Safety, Taoyuan, Taiwan; [Liou, Chian-Jiun; Huang, Wen-Chung] Chang Gung Mem Hosp, Dept Pediat, Div Allergy Asthma & Rheumatol, Taoyuan, Taiwan; [Fang, Li-Wen] I Shou Univ, Dept Nutr, Kaohsiung, Taiwan	Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; I Shou University	Huang, WC (corresponding author), Chang Gung Univ Sci & Technol, Res Ctr Food & Cosmet Safety, Res Ctr Chinese Herbal Med, Grad Inst Hlth Ind Technol,Coll Human Ecol, 261 Wenhua Ist Rd, Taoyuan 33303, Taiwan.	wchuang@mail.cgust.edu.tw			Chang Gung Memorial Hospital [CMRPF1H0022, CMRPF1G0232, CMRPF1H0042]; Ministry of Science and Technology in Taiwan [106-2320-B-255-007-MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported, in part, by grants from Chang Gung Memorial Hospital (CMRPF1H0022, CMRPF1G0232, and CMRPF1H0042) and the Ministry of Science and Technology in Taiwan (106-2320-B-255-007-MY3). The authors declare no conflicts of interest.	Asrih M, 2015, CELL PHYSIOL BIOCHEM, V37, P1767, DOI 10.1159/000438540; Bujanda L, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-40; Chang YH, 2018, BIOCHEM BIOPH RES CO, V495, P197, DOI 10.1016/j.bbrc.2017.11.022; Choi KM, 2014, J NUTR BIOCHEM, V25, P201, DOI 10.1016/j.jnutbio.2013.10.007; Coppari R, 2012, NAT REV DRUG DISCOV, V11, P692, DOI 10.1038/nrd3757; Cui HX, 2017, NAT REV ENDOCRINOL, V13, P338, DOI 10.1038/nrendo.2016.222; de Sa PM, 2017, COMPR PHYSIOL, V7, P635, DOI 10.1002/cphy.c160022; Fukumitsu S, 2016, MOL NUTR FOOD RES, V60, P399, DOI 10.1002/mnfr.201500465; Hazlehurst JM, 2016, METABOLISM, V65, P1096, DOI 10.1016/j.metabol.2016.01.001; Huang WC, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030218; Huang WC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00134; Huang WC, 2013, MOL NUTR FOOD RES, V57, P1803, DOI 10.1002/mnfr.201300001; Ippagunta SM, 2018, J NUTR, V148, P510, DOI 10.1093/jn/nxy022; Kim B, 2017, J NUTR BIOCHEM, V43, P27, DOI 10.1016/j.jnutbio.2016.01.006; Kitade H, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040387; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kobori M, 2016, MOL NUTR FOOD RES, V60, P300, DOI 10.1002/mnfr.201500595; Lee JW, 2012, J LIPID RES, V53, P1277, DOI 10.1194/jlr.M022897; Lei P, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201800795; Li M, 2017, MOL MED REP, V16, P680, DOI 10.3892/mmr.2017.6637; Liou CJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050447; Liou CJ, 2018, CELL PHYSIOL BIOCHEM, V49, P1870, DOI 10.1159/000493650; Liou CJ, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00635; Liou CJ, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00589; Liou CJ, 2011, J CLIN IMMUNOL, V31, P656, DOI 10.1007/s10875-011-9529-3; LIU L, 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/607531; Lopez M, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12996; Merola N, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101062; Miller RA, 2010, J CLIN INVEST, V120, P2267, DOI 10.1172/JCI43661; Neuschwander-Tetri BA, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0806-8; Norris GH, 2017, NUTR REV, V75, P274, DOI 10.1093/nutrit/nux004; Perez-Jimenez A, 2016, PHYTOMEDICINE, V23, P1301, DOI 10.1016/j.phymed.2016.07.001; Pisonero-Vaquero S, 2015, MOL NUTR FOOD RES, V59, P879, DOI 10.1002/mnfr.201400913; Qin XF, 2014, MOL CELL BIOCHEM, V390, P61, DOI 10.1007/s11010-013-1956-4; Sanchez-Gonzalez M, 2013, MOL NUTR FOOD RES, V57, P339, DOI 10.1002/mnfr.201200481; Saponaro C, 2015, NUTRIENTS, V7, P9453, DOI 10.3390/nu7115475; Shaw RJ, 2013, NAT MED, V19, P1570, DOI 10.1038/nm.3414; Smith MM, 2012, J PHYSIOL-LONDON, V590, P1787, DOI 10.1113/jphysiol.2011.221036; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tian YL, 2016, MOL CELL BIOCHEM, V422, P75, DOI 10.1007/s11010-016-2807-x; Wang YH, 2015, NAT REV MOL CELL BIO, V16, P678, DOI 10.1038/nrm4074; Wu LY, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00122; Yang SM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/429207; Yang YW, 2015, J AGR FOOD CHEM, V63, P10243, DOI 10.1021/acs.jafc.5b04156; Zhang YL, 2017, MOL METAB, V6, P138, DOI 10.1016/j.molmet.2016.11.002; Zhang YY, 2017, MAR DRUGS, V15, DOI 10.3390/md15060163; Zhu W, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-35; Zhu Y, 2016, ACTA PHARM SIN B, V6, P409, DOI 10.1016/j.apsb.2016.07.008	48	34	35	5	33	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11791	11803		10.1096/fj.201900413RRR	http://dx.doi.org/10.1096/fj.201900413RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31361524	Green Published			2022-12-28	WOS:000507461600017
J	Wessely, A; Waltera, A; Reichert, TE; Stockl, S; Grassel, S; Bauer, RJ				Wessely, Anja; Waltera, Anna; Reichert, Torsten E.; Stoeckl, Sabine; Graessel, Susanne; Bauer, Richard J.			Induction of ALP and MMP9 activity facilitates invasive behavior in heterogeneous human BMSC and HNSCC 3D spheroids	FASEB JOURNAL			English	Article						mesenchymal stem cells; HNSCC; matrix-metalloproteinase; RUNX2; spheroid culture	SQUAMOUS-CELL CARCINOMA; MESENCHYMAL STEM-CELLS; ALKALINE-PHOSPHATASE; BONE-MARROW; FACTOR RUNX2; CANCER; HEAD; TRANSCRIPTION; METASTASIS; EXPRESSION	Mesenchymal stem cells (MSCs) are multipotent progenitor cells capable of differentiating into adipocytic, osteogenic, chondrogenic, and myogenic lineages. There is growing evidence that MSCs home into the tumor microenvironment attracted by a variety of signals such as chemokines, growth factors, and cytokines. Tumor-homing stem cells may originate from bone marrow-derived MSCs (BMSCs) or adipose tissue-derived MSCs. Recent scientific data suggest that MSCs in combination with tumor cells can either promote or inhibit tumorigenic behavior. In head and neck squamous cell carcinoma (HNSCC), BMSCs are reported to be enriched with a potential negative role. Here, we evaluated the effect of BMSCs from 4 different donors in combination with 4 HNSCC cell lines in a 3-dimensional multicellular spheroid model. Heterogeneous combinations revealed an up-regulation of gene and protein expression of osteogenic markers runt-related transcription factor 2 (RUNX2) and alkaline phosphatase (ALP) together with a substantial secretion of matrix metalloproteinase 9. Moreover, heterogenous BMSC/tumor spheroids showed increased invasion compared with homogenous spheroids in a Boyden chamber invasion assay. Furthermore, inhibition of ALP resulted in a substantially decreased spreading of heterogeneous spheroids on laminin-rich matrix. In summary, our data suggest a prometastatic effect of BMSCs combined with HNSCC.	[Wessely, Anja] Ludwig Maximilian Univ Munich, Univ Hosp, Dept Dermatol & Allergy, Munich, Germany; [Waltera, Anna; Reichert, Torsten E.; Bauer, Richard J.] Univ Hosp Regensburg, Dept Oral & Maxillofacial Surg, Regensburg, Germany; [Stoeckl, Sabine; Graessel, Susanne] Univ Hosp Regensburg, Ctr Med Biotechnol, Dept Orthoped Surg, Expt Orthoped, Regensburg, Germany; [Bauer, Richard J.] Univ Hosp Regensburg, Ctr Med Biotechnol, Dept Oral & Maxillofacial Surg, Regensburg, Germany	University of Munich; University of Regensburg; University of Regensburg; University of Regensburg	Bauer, RJ (corresponding author), Univ Hosp Regensburg, Biopk 9, D-93053 Regensburg, Germany.	richard.bauer@ukr.de		Wessely, Anja/0000-0003-1940-5115	German Research Foundation (DFG) [GR1301/18-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	The authors thank Brigitta Hauer (Department of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany) for excellent technical assistance. This work was supported by a German Research Foundation (DFG) grant to S.G. (GR1301/18-1). The authors declare no conflicts of interest.	Acharya S, 2017, SOUTH ASIAN J CANCER, V6, P125, DOI 10.4103/2278-330X.214574; Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Akech J, 2010, ONCOGENE, V29, P811, DOI 10.1038/onc.2009.389; Albergaria A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055749; Anthony DF, 2013, TRANSPLANT RES, V2, DOI 10.1186/2047-1440-2-10; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Bassi Enio Jose, 2011, World J Stem Cells, V3, P1, DOI 10.4252/wjsc.v3.i1.1; Beckermann BM, 2008, BRIT J CANCER, V99, P622, DOI 10.1038/sj.bjc.6604508; Bedal KB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086777; Cai C, 2017, APPL BIOCHEM BIOTECH, V183, P444, DOI 10.1007/s12010-017-2456-x; Chang WM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41131; Clutter SD, 2005, EXP HEMATOL, V33, P1192, DOI 10.1016/j.exphem.2005.06.022; Cornelissen AS, 2015, IMMUNOL LETT, V168, P159, DOI 10.1016/j.imlet.2015.06.019; De Boeck A, 2010, ORAL ONCOL, V46, P336, DOI 10.1016/j.oraloncology.2010.01.016; de Jong RJB, 2001, HEAD NECK-J SCI SPEC, V23, P718; FARLEY JR, 1991, METABOLISM, V40, P664, DOI 10.1016/0026-0495(91)90081-7; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Ganapathi MK, 2016, INT J CANCER, V138, P679, DOI 10.1002/ijc.29815; Gonzalez ME, 2017, CELL REP, V18, P1215, DOI 10.1016/j.celrep.2016.12.079; Li HC, 2006, WORLD J GASTROENTERO, V12, P363, DOI 10.3748/wjg.v12.i3.363; Heikkila P, 2006, INT J CANCER, V118, P2202, DOI 10.1002/ijc.21540; Henriques ACG, 2012, J ORAL SCI, V54, P105, DOI 10.2334/josnusd.54.105; HEO DS, 1989, CANCER RES, V49, P5167; Hill BS, 2017, ONCOTARGET, V8, P73296, DOI 10.18632/oncotarget.20265; Hu XX, 2012, ARCH GYNECOL OBSTET, V286, P1537, DOI 10.1007/s00404-012-2456-6; Hutchinson L, 2011, STEM CELLS DEV, V20, P11, DOI 10.1089/scd.2010.0139; Iwai S, 2008, ORAL DIS, V14, P144, DOI 10.1111/j.1601-0825.2007.01360.x; Javed A, 1999, MOL CELL BIOL, V19, P7491; KAWASHIMA A, 1993, J CANCER RES CLIN, V120, P35, DOI 10.1007/BF01200722; Kayed H, 2007, BRIT J CANCER, V97, P1106, DOI 10.1038/sj.bjc.6603984; Kidd S, 2009, STEM CELLS, V27, P2614, DOI 10.1002/stem.187; Koontongkaew S, 2013, J CANCER, V4, P66, DOI 10.7150/jca.5112; Lee HP, 2015, ONCOTARGET, V6, P36746, DOI 10.18632/oncotarget.5479; Li WP, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/456534; Lin CJ, 2007, HEAD NECK-J SCI SPEC, V29, P163, DOI 10.1002/hed.20478; Liotta F, 2015, BRIT J CANCER, V112, P745, DOI 10.1038/bjc.2015.15; Martin J. W., 2011, Sarcoma, V2011, P282745, DOI 10.1155/2011/282745; Matheu A, 2012, CANCER RES, V72, P1301, DOI 10.1158/0008-5472.CAN-11-3660; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Neve A, 2011, CELL TISSUE RES, V343, P289, DOI 10.1007/s00441-010-1086-1; Niu DF, 2012, LAB INVEST, V92, P1181, DOI 10.1038/labinvest.2012.84; Ogbureke KUE, 2012, ONCOTARGET, V3, P286; Oremek GM, 2003, ANTICANCER RES, V23, P987; Pratap J, 2005, MOL CELL BIOL, V25, P8581, DOI 10.1128/MCB.25.19.8581-8591.2005; Pratap J, 2008, CANCER RES, V68, P7795, DOI 10.1158/0008-5472.CAN-08-1078; Rao SR, 2017, BRIT J CANCER, V116, P227, DOI 10.1038/bjc.2016.402; Ries C, 2007, BLOOD, V109, P4055, DOI 10.1182/blood-2006-10-051060; Stappenbeck TS, 2009, SCIENCE, V324, P1666, DOI 10.1126/science.1172687; Tamamura R, 2013, ACTA HISTOCHEM, V115, P113, DOI 10.1016/j.acthis.2012.05.001; Van Kilsdonk JWJ, 2010, MELANOMA RES, V20, P372, DOI 10.1097/CMR.0b013e32833d8d70; Vodyanik MA, 2010, CELL STEM CELL, V7, P718, DOI 10.1016/j.stem.2010.11.011; Wang H, 2008, CANCER RES, V68, P1625, DOI 10.1158/0008-5472.CAN-07-5915; WEI JS, 1993, CLIN CHEM, V39, P540; Weng JJ, 2013, BBA-GEN SUBJECTS, V1830, P2839, DOI 10.1016/j.bbagen.2012.12.021; Yang LP, 2016, HUM GENE THER, V27, P267, DOI 10.1089/hum.2015.135; Zielske SP, 2009, INT J RADIAT ONCOL, V75, P843, DOI 10.1016/j.ijrobp.2008.06.1953	57	20	20	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11884	11893		10.1096/fj.201900925R	http://dx.doi.org/10.1096/fj.201900925R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31366234	Green Published, Bronze			2022-12-28	WOS:000507461600024
J	McCrary, MR; Jiang, MQ; Giddens, MM; Zhang, JY; Owino, S; Wei, ZZ; Zhong, WW; Gu, XH; Xin, H; Hall, RA; Wei, L; Yu, SP				McCrary, Myles R.; Jiang, Michael Q.; Giddens, Michelle M.; Zhang, James Y.; Owino, Sharon; Wei, Zheng Z.; Zhong, Weiwei; Gu, Xiaohuan; Xin, Huang; Hall, Randy A.; Wei, Ling; Yu, Shan P.			Protective effects of GPR37 via regulation of inflammation and multiple cell death pathways after ischemic stroke in mice	FASEB JOURNAL			English	Article						apoptosis; autophagy; mTOR; microglial; astrogliosis	PROTEIN-COUPLED RECEPTORS; FOCAL CEREBRAL-ISCHEMIA; PHARMACOLOGICALLY INDUCED HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; REACTIVE ASTROCYTES; BRAIN-INJURY; PROSAPOSIN; EXPRESSION; AUTOPHAGY; RECOVERY	GPCR 37 (GPR37) is a GPCR expressed in the CNS; its physiological and pathophysiological functions are largely unknown. We tested the role of GPR37 in the ischemic brain of GPR37 knockout (KO) mice, exploring the idea that GPR37 might be protective against ischemic damage. In an ischemic stroke model, GPR37 KO mice exhibited increased infarction and cell death compared with wild-type (WT) mice, measured by 2,3,5-triphenyl-2H-tetrazolium chloride and TUNEL staining 24 h after stroke. Moreover, more severe functional deficits were detected in GPR37 KO mice in the adhesive-removal and corner tests. In the peri-infarct region of GPR37 KO mice, there was significantly more apoptotic and autophagic cell death accompanied by caspase-3 activation and attenuated mechanistic target of rapamycin signaling. GPR37 deletion attenuated astrocyte activation and astrogliosis compared with WT stroke controls 24-72 h after stroke. Immunohistochemical staining showed more ionized calcium-binding adapter molecule 1-positive cells in the ischemic cortex of GPR37 KO mice, and RT-PCR identified an enrichment of M1-type microglia or macrophage markers in the GPR37 KO ischemic cortex. Western blotting demonstrated higher levels of inflammatory factors IL-1 beta, IL-6, monocyte chemoattractant protein, and macrophage inflammatory protein-1 alpha in GPR37-KO mice after ischemia. Thus, GPR37 plays a multifaceted role after stroke, suggesting a novel target for stroke therapy.-McCrary, M. R., Jiang, M. Q., Giddens, M. M., Zhang, J. Y., Owino, S., Wei, Z. Z., Zhong, W., Gu, X., Xin, H., Hall, R. A., Wei, L., Yu, S. P. Protective effects of GPR37 via regulation of inflammation and multiple cell death pathways after ischemic stroke in mice.	[McCrary, Myles R.; Jiang, Michael Q.; Zhang, James Y.; Wei, Zheng Z.; Zhong, Weiwei; Gu, Xiaohuan; Xin, Huang; Wei, Ling; Yu, Shan P.] Emory Univ, Dept Anesthesiol, Sch Med, 101 Woodruff Circle,Suite 620B, Atlanta, GA 30322 USA; [Giddens, Michelle M.; Owino, Sharon; Hall, Randy A.] Emory Univ, Dept Pharmacol, Sch Med, Atlanta, GA 30322 USA; [Yu, Shan P.] Atlanta Vet Affairs Med Ctr, Ctr Visual & Neurocognit Rehabil, Decatur, GA USA	Emory University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Yu, SP (corresponding author), Emory Univ, Dept Anesthesiol, Sch Med, 101 Woodruff Circle,Suite 620B, Atlanta, GA 30322 USA.	spyu@emory.edu	Wei, Zheng Zachory/I-2109-2019; Zhang, James/HHS-8616-2022	Wei, Zheng Zachory/0000-0001-7682-9286; McCrary, Myles/0000-0002-4572-7372	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke [NS085568, NS091585, NS088413, NS073378]; Veterans Affairs National Merit Grant [RX000666]; American Heart Association [POST25710112, PRE25710020]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088413, R42NS073378, R01NS091585, R44NS073378, R01NS085568] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000666] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs National Merit Grant; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke Grants NS085568 (to L.W. and S.P.Y.), NS091585 (to L.W.), NS088413 (to R.A.H.), and NS073378 (to S.P.Y.), a Veterans Affairs National Merit Grant RX000666 (to S.P.Y.), an American Heart Association Postdoctoral Fellowship POST25710112 (to Z.Z.W.), and a Predoctoral Fellowship PRE25710020 (to J.Z.). The authors declare no conflicts of interest.	Alavi MS, 2018, BIOMED PHARMACOTHER, V98, P222, DOI 10.1016/j.biopha.2017.12.056; Bang SS, 2018, J CLIN INVEST, V128, P3568, DOI 10.1172/JCI99888; Barreto GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027881; Bazan NG, 2012, EXP NEUROL, V236, P122, DOI 10.1016/j.expneurol.2012.04.007; Belayev L, 2017, CELL DEATH DIFFER, V24, P1091, DOI 10.1038/cdd.2017.55; Choi KE, 2012, FASEB J, V26, P2799, DOI 10.1096/fj.11-201822; Choudhury GR, 2016, NEUROBIOL DIS, V85, P234, DOI 10.1016/j.nbd.2015.05.003; Donohue PJ, 1998, MOL BRAIN RES, V54, P152, DOI 10.1016/S0169-328X(97)00336-7; Eglen RM, 2007, ASSAY DRUG DEV TECHN, V5, P425, DOI 10.1089/adt.2007.062; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fujita-Jimbo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051155; Gandia J, 2013, J NEUROCHEM, V125, P362, DOI 10.1111/jnc.12196; Giddens MM, 2017, NEUROBIOL DIS, V106, P181, DOI 10.1016/j.nbd.2017.07.006; Girard S, 2013, GLIA, V61, P813, DOI 10.1002/glia.22478; Hayakawa K, 2010, J CEREBR BLOOD F MET, V30, P871, DOI 10.1038/jcbfm.2009.257; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; Huang YH, 2015, FEBS LETT, V589, P1607, DOI 10.1016/j.febslet.2015.05.007; Igase K, 1999, J CEREBR BLOOD F MET, V19, P298, DOI 10.1097/00004647-199903000-00008; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Imai Y, 2007, NEUROSCI RES, V59, P413, DOI 10.1016/j.neures.2007.08.005; Jiang MQ, 2017, BRAIN PATHOL, V27, P480, DOI 10.1111/bpa.12425; Jolly S, 2018, GLIA, V66, P47, DOI 10.1002/glia.23198; Kadowaki M, 2009, METHOD ENZYMOL, V452, P199, DOI 10.1016/S0076-6879(08)03613-6; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kotani Y, 1996, J NEUROCHEM, V66, P2019; Lee EJ, 2011, AUTOPHAGY, V7, P689, DOI 10.4161/auto.7.7.15450; Lee JH, 2018, EXP NEUROL, V305, P1, DOI 10.1016/j.expneurol.2018.02.015; Lee JH, 2017, NEURAL REGEN RES, V12, P341, DOI 10.4103/1673-5374.202915; Lee JH, 2016, NEUROBIOL DIS, V96, P248, DOI 10.1016/j.nbd.2016.09.013; Lee JH, 2014, J NEUROTRAUM, V31, P1417, DOI 10.1089/neu.2013.3251; Lin CW, 2016, NEUROSCI BULL, V32, P137, DOI 10.1007/s12264-016-0017-x; Liu BH, 2018, GLIA, V66, P2414, DOI 10.1002/glia.23480; Lopes JP, 2015, J NEUROCHEM, V134, P135, DOI 10.1111/jnc.13109; de Maturana RL, 2010, CNS NEUROL DISORD-DR, V9, P601, DOI 10.2174/187152710793361531; Lu AG, 2000, NEUROREPORT, V11, P1791, DOI 10.1097/00001756-200006050-00039; Lundius EG, 2014, J BIOL CHEM, V289, P4660, DOI 10.1074/jbc.M113.510883; Mandillo S, 2013, GENES BRAIN BEHAV, V12, P465, DOI 10.1111/gbb.12041; Marazziti D, 2004, P NATL ACAD SCI USA, V101, P10189, DOI 10.1073/pnas.0403661101; Marazziti D, 2007, P NATL ACAD SCI USA, V104, P9846, DOI 10.1073/pnas.0703368104; Marazziti D, 2009, FASEB J, V23, P1978, DOI 10.1096/fj.08-121210; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Meyer RC, 2013, P NATL ACAD SCI USA, V110, P9529, DOI 10.1073/pnas.1219004110; Mohamad O, 2013, J PHYSIOL-LONDON, V591, P149, DOI 10.1113/jphysiol.2012.239251; Morato X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10147-x; Niu B, 2017, NEUROSCI BULL, V33, P627, DOI 10.1007/s12264-017-0156-8; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Prabhakaran S, 2015, JAMA-J AM MED ASSOC, V313, P1451, DOI 10.1001/jama.2015.3058; Rezgaoui M, 2006, J CELL SCI, V119, P542, DOI 10.1242/jcs.02766; Rial D, 2017, NEUROSCI LETT, V638, P162, DOI 10.1016/j.neulet.2016.12.040; ROSENBERG PA, 1989, NEUROSCI LETT, V103, P162, DOI 10.1016/0304-3940(89)90569-7; Selenica MLB, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-86; Sims NR, 2017, NEUROCHEM INT, V107, P88, DOI 10.1016/j.neuint.2016.12.016; Sladek CD, 2012, J NEUROENDOCRINOL, V24, P554, DOI 10.1111/j.1365-2826.2011.02268.x; Smith BM, 2017, NEUROSCIENCE, V358, P49, DOI 10.1016/j.neuroscience.2017.06.006; Smith NJ, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00275; Tomita Hiroaki, 2013, Frontiers in Genetics, V4, P297, DOI 10.3389/fgene.2013.00297; Valdenaire O, 1998, FEBS LETT, V424, P193, DOI 10.1016/S0014-5793(98)00170-7; Wang LK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096765; Wang P, 2018, PROG NEUROBIOL, V163, P98, DOI 10.1016/j.pneurobio.2018.01.001; Wei HP, 2016, TRANSL STROKE RES, V7, P497, DOI 10.1007/s12975-016-0484-4; Yang HJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10884; Yao CY, 2013, MOL MED REP, V8, P543, DOI 10.3892/mmr.2013.1543; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	64	26	27	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10680	10691		10.1096/fj.201900070R	http://dx.doi.org/10.1096/fj.201900070R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31268736	Bronze, Green Published			2022-12-28	WOS:000489166300009
J	Chai, HH; Fu, XC; Ma, L; Sun, HT; Chen, GZ; Song, MY; Chen, WX; Chen, YS; Tan, MX; Guo, YW; Li, SP				Chai, Hui-Hui; Fu, Xiao-Chun; Ma, Liang; Sun, Hai-Tao; Chen, Gui-Zeng; Song, Min-Ying; Chen, Wei-Xuan; Chen, Yong-Sheng; Tan, Min-Xuan; Guo, Yan-Wu; Li, Shao-Peng			The chemokine CXCL1 and its receptor CXCR2 contribute to chronic stress-induced depression in mice	FASEB JOURNAL			English	Article						UCMS; inflammation; GSK3 beta BDNF; CREB	GLYCOGEN-SYNTHASE KINASE-3; MAJOR DEPRESSION; NEUROINFLAMMATION; CYTOKINES; BRAIN; MECHANISMS; PATHOPHYSIOLOGY; BDNF; CREB; PHOSPHORYLATION	Depression is increasingly recognized as an inflammatory disease, with inflammatory crosstalk in the brain contributing its pathogenesis. Life stresses may up-regulate inflammatory processes and promote depression. Although cytokines are central to stress-related immune responses, their contribution to stress-induced depression remains unclear. Here, we used unpredictable chronic mild stress (UCMS) to induce depression-like behaviors in mice, as assessed through a suite of behavioral tests. C-X-C motif chemokine ligand 1 (CXCL1)-related molecular networks responsible for depression-like behaviors were assessed through intrahippocampal microinjection of lenti-CXCL1, the antidepressant fluoxetine, the C-X-C motif chemokine receptor 2 (CXCR2) inhibitor SB265610, and the glycogen synthase kinase-3 beta (GSK3 beta) inhibitor AR-A014418. Modulation of apoptosis-related pathways and neuronal plasticity were assessed via quantification of cleaved caspase-3, B-cell lymphoma 2-associated X protein, cAMP response element-binding protein (CREB), and brain-derived neurotrophic factor (BDNF) protein expression. CXCL1/CXCL2 expression was correlated with depression-like behaviors in response to chronic stress or antidepressant treatment in the UCMS depression model. Intrahippocampal microinjection of lenti-CXCL1 increased depression-like behaviors, activated GSK3 beta, increased apoptosis pathways, suppressed CREB activation, and decreased BDNF. Administration of the selective GSK3 beta inhibitor AR-A014418 abolished the effects of lenti-CXCL1, and the CXCR2 inhibitor SB265610 prevented chronic stress-induced depression-like behaviors, inhibited GSK3 beta activity, blocked apoptosis pathways, and restored BDNF expression. The CXCL1/CXCR2 axis appears to play a critical role in stress-induced depression, and CXCR2 is a potential novel therapeutic target for patients with depression.-Chai, H.-H., Fu, X.-C., Ma, L., Sun, H.-T., Chen, G.-Z., Song, M.-Y., Chen, W.-X., Chen, Y.-S., Tan, M.-X., Guo, Y.-W., Li, S.-P. The chemokine CXCL1 and its receptor CXCR2 contribute to chronic stress-induced depression in mice.	[Chai, Hui-Hui; Chen, Gui-Zeng; Song, Min-Ying; Chen, Wei-Xuan; Chen, Yong-Sheng; Tan, Min-Xuan; Li, Shao-Peng] Southern Med Univ, Affiliated Dongguan Peoples Hosp, Dongguan Peoples Hosp, Dept Neurosurg, New Guchong Rd, Dongguan 523059, Peoples R China; [Fu, Xiao-Chun] Guangdong Food & Drug Vocat Coll, Guangzhou, Guangdong, Peoples R China; [Ma, Liang] Suzhou Univ, Affiliated Hosp 3, Peoples Hosp Changzhou 1, Dept Gastroenterol, Suzhou, Peoples R China; [Sun, Hai-Tao; Guo, Yan-Wu] Southern Med Univ, Zhujiang Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Soochow University - China; Southern Medical University - China	Li, SP (corresponding author), Southern Med Univ, Affiliated Dongguan Peoples Hosp, Dongguan Peoples Hosp, Dept Neurosurg, New Guchong Rd, Dongguan 523059, Peoples R China.; Guo, YW (corresponding author), Southern Med Univ, Neurosurgery Inst Guangdong Prov, Guangdong Prov Key Lab Brain Funct Repair & Regen, Dept Neurosurg,Zhujiang Hosp,Natl Key Clin Specia, 253 Gongye Rd, Guangzhou 510282, Guangdong, Peoples R China.	chguoyanwu@126.com; shaopengli2018@outlook.com	Chen, Yongsheng/D-3256-2011	Chen, Yongsheng/0000-0003-1448-8177; /0000-0001-7925-9506	Key Sci-Tech Research Projects of Dongguan [2015108101016]; National Natural Science Foundation of China [81700500, 8167050110, H0910]; Applied Basic Research Programs of Science and Technology Department of Changzhou City [CJ20160031]	Key Sci-Tech Research Projects of Dongguan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Applied Basic Research Programs of Science and Technology Department of Changzhou City	This work was supported by grants from Key Sci-Tech Research Projects of Dongguan (2015108101016) to S.-P.L., National Natural Science Foundation of China (8167050110, H0910) to Y.-W.G., and National Natural Science Foundation of China (81700500) and the Applied Basic Research Programs of Science and Technology Department of Changzhou City (CJ20160031) to L.M. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Ahmed S, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/296356; Anacker Christoph, 2014, Curr Top Behav Neurosci, V18, P25, DOI 10.1007/7854_2014_275; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Black CN, 2015, PSYCHONEUROENDOCRINO, V51, P164, DOI 10.1016/j.psyneuen.2014.09.025; Bogdan R, 2006, BIOL PSYCHIAT, V60, P1147, DOI 10.1016/j.biopsych.2006.03.037; Borsini A, 2015, TRENDS NEUROSCI, V38, P145, DOI 10.1016/j.tins.2014.12.006; Breitbart W, 2014, PSYCHO-ONCOLOGY, V23, P339, DOI 10.1002/pon.3422; BRESLAU N, 1986, ARCH GEN PSYCHIAT, V43, P309; Brites D, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00476; Campbell S, 2004, J PSYCHIATR NEUROSCI, V29, P417; Chai HH, 2014, TRANSPLANTATION, V98, P729, DOI 10.1097/TP.0000000000000319; Cheng YY, 2016, BRAIN BEHAV IMMUN, V53, P207, DOI 10.1016/j.bbi.2015.12.012; Chintakuntlawar AV, 2009, J INTERF CYTOK RES, V29, P657, DOI 10.1089/jir.2009.0006; Cole AR, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00004; Crupi R, 2016, CNS NEUROL DISORD-DR, V15, P464, DOI 10.2174/1871527315666160321105339; Duman RS, 2012, TRENDS NEUROSCI, V35, P47, DOI 10.1016/j.tins.2011.11.004; Elenkov IJ, 2002, ANN NY ACAD SCI, V966, P290, DOI 10.1111/j.1749-6632.2002.tb04229.x; Erickson MA, 2011, BRAIN BEHAV IMMUN, V25, P1637, DOI 10.1016/j.bbi.2011.06.006; Felger JC, 2013, NEUROSCIENCE, V246, P199, DOI 10.1016/j.neuroscience.2013.04.060; Ferguson JM, 2001, J CLIN PSYCHIAT, V62, P22; Furtado M, 2015, PSYCHIAT RES, V229, P27, DOI 10.1016/j.psychres.2015.06.009; Galic MA, 2012, FRONT NEUROENDOCRIN, V33, P116, DOI 10.1016/j.yfrne.2011.12.002; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Gould TD, 2004, INT J NEUROPSYCHOPH, V7, P387, DOI 10.1017/S1461145704004535; Grigoryan GA, 2013, ZH VYSSH NERV DEYAT+, V63, P507, DOI 10.7868/S0044467713050043; Grimes CA, 2001, J NEUROCHEM, V78, P1219, DOI 10.1046/j.1471-4159.2001.00495.x; Hestad KA, 2016, NEUROPSYCH DIS TREAT, V12, P817, DOI 10.2147/NDT.S101925; Hillhouse TM, 2015, EXP CLIN PSYCHOPHARM, V23, P1, DOI 10.1037/a0038550; Huang W, 2007, ONCOGENE, V26, P2471, DOI 10.1038/sj.onc.1210033; Jeon SW, 2016, WORLD J PSYCHIATR, V6, P283, DOI 10.5498/wjp.v6.i3.283; Jope RS, 2006, CURR DRUG TARGETS, V7, P1421, DOI 10.2174/1389450110607011421; Kalueff AV, 2006, SCIENCE, V312, P1598, DOI 10.1126/science.312.5780.1598; Koch JM, 2009, PSYCHOTHER PSYCHOSOM, V78, P187, DOI 10.1159/000209350; Konrad FM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/740987; Lee BH, 2010, PSYCHIAT INVEST, V7, P231, DOI 10.4306/pi.2010.7.4.231; Leonard BE, 1999, ADV EXP MED BIOL, V461, P251; Lesch KP, 2004, J PSYCHIATR NEUROSCI, V29, P174; Liu XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16024; Mazzardo-Martins L, 2012, NEUROSCIENCE, V226, P411, DOI 10.1016/j.neuroscience.2012.09.020; McCubrey JA, 2017, ONCOTARGET, V8, P14221, DOI 10.18632/oncotarget.13991; McKernan DP, 2009, PROG NEUROBIOL, V88, P246, DOI 10.1016/j.pneurobio.2009.04.006; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Miller AH, 2013, DEPRESS ANXIETY, V30, P297, DOI 10.1002/da.22084; Morales-Garcia JA, 2012, ACS CHEM NEUROSCI, V3, P963, DOI 10.1021/cn300110c; Nair A, 2006, J BIOSCIENCES, V31, P423, DOI 10.1007/BF02704114; Nutt DJ, 2007, J CLIN PSYCHIAT, V68, P42; Omari KM, 2006, GLIA, V53, P24, DOI 10.1002/glia.20246; Overstreet DH, 2012, METHODS MOL BIOL, V829, P125, DOI 10.1007/978-1-61779-458-2_7; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Podolin PL, 2002, J IMMUNOL, V169, P6435, DOI 10.4049/jimmunol.169.11.6435; Raison CL, 2011, CURR PSYCHIAT REP, V13, P467, DOI 10.1007/s11920-011-0232-0; Reddy M S, 2010, Indian J Psychol Med, V32, P1, DOI 10.4103/0253-7176.70510; Riazi K, 2010, EPILEPSY RES, V89, P34, DOI 10.1016/j.eplepsyres.2009.09.004; Rossi S, 2017, NEUROLOGY, V89, P1338, DOI 10.1212/WNL.0000000000004411; de Porras VR, 2016, SCI REP-UK, V6, DOI 10.1038/srep24675; Ryu JK, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0339-z; Salcedo-Tello Pamela, 2011, Int J Alzheimers Dis, V2011, P189728, DOI 10.4061/2011/189728; Stein DJ, 2018, BIOL PSYCHIAT, V83, P5, DOI 10.1016/j.biopsych.2017.10.025; Tafet GE, 2004, ANN NY ACAD SCI, V1032, P276, DOI 10.1196/annals.1314.037; Taupin P, 2006, DRUG TARGET INSIGHT, V1, P13; Theoharides TC, 2004, J CLIN PSYCHOPHARM, V24, P577, DOI 10.1097/01.jcp.0000148026.86483.4f; Tian R, 2014, SCI WORLD J, DOI 10.1155/2014/780616; Timasheva YR, 2015, CEREBROVASC DIS EXTR, V5, P124, DOI 10.1159/000441529; Van Praag HM, 2005, WORLD J BIOL PSYCHIA, V6, P5, DOI [10.1080/15622970510030018, 10.1016/j.pnpbp.2004.05.031]; Veenstra M, 2012, J NEUROIMMUNOL, V246, P1, DOI 10.1016/j.jneuroim.2012.02.016; Zhang JX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00005; Zhang TZ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/438506	68	18	18	2	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					8853	8864		10.1096/fj.201802359RR	http://dx.doi.org/10.1096/fj.201802359RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31034777				2022-12-28	WOS:000478832900013
J	Dakin, SG; Colas, RA; Newton, J; Gwilym, S; Jones, N; Reid, HAB; Wood, S; Appleton, L; Wheway, K; Watkins, B; Dalli, J; Carr, AJ				Dakin, Stephanie G.; Colas, Romain A.; Newton, Julia; Gwilym, Stephen; Jones, Natasha; Reid, Hamish A. B.; Wood, Simon; Appleton, Louise; Wheway, Kim; Watkins, Bridget; Dalli, Jesmond; Carr, Andrew J.			15-Epi-LXA(4) and MaR1 counter inflammation in stromal cells from patients with Achilles tendinopathy and rupture	FASEB JOURNAL			English	Article						resolution; tendon; 15-epi-LipoxinA(4); maresin-1	RESOLVIN D3; LYN KINASE; TENDON; IDENTIFICATION	Resolution of inflammation is poorly understood in Achilles tendon disorders. Herein, we investigated the bioactive lipid mediator profiles of tendon-derived stromal cells isolated from patients with Achilles tendinopathy (AT) or Achilles rupture (AR) under baseline and IL-1 beta-stimulated conditions. We also determined whether incubating these cells with 2 of the mediators produced by tendon-derived stromal cells, 15-epi-Lipoxin A(4) (15-epi-LXA(4)) or maresin (MaR)-1, moderated their proinflammatory phenotype. Under baseline conditions, AT cells showed concurrent increased levels of proinflammatory eicosanoids and proresolving mediators compared with AR cells. IL-1 beta treatment induced profound prostaglandin E-2 release in AR compared with AT cells. Incubation of IL-1 beta treated AT and AR tendon-derived stromal cells in 15-epi-LXA(4) or MaR1 reduced proinflammatory eicosanoids and potentiated the release of proresolving mediators. These mediators also induced specialized proresolving mediator (SPM) biosynthetic enzymes arachidonate lipoxygenase (ALOX) 12 and ALOX15 and up-regulated the proresolving receptor ALX compared with vehicle-treated cells. Incubation in 15-epi-LXA(4) or MaR1 also moderated the proinflammatory phenotype of AT and AR cells, regulating podoplanin, CD90, signal transducer and activator of transcription (STAT)-1, IL-6, IFN regulatory factor (IRF) 5, and TLR4 and suppressed c-Jun N-terminal kinase 1/2/3, Lyn, STAT-3, and STAT-6 phosphokinase signaling. In summary, we identify proresolving mediators that are active in AT and AR and propose SPMs, including 15-epi-LXA(4) or MaR1, as a potential strategy to counterregulate inflammatory processes in these cells.-Dakin, S. G., Colas, R. A., Newton, J., Gwilym, S., Jones, N., Reid, H. A. B., Wood, S., Appleton, L., Wheway, K., Watkins, B., Dalli, J., Carr, A. J. 15-Epi-LXA(4) and MaR1 counter inflammation in stromal cells from patients with Achilles tendinopathy and rupture.	[Dakin, Stephanie G.; Newton, Julia; Gwilym, Stephen; Jones, Natasha; Reid, Hamish A. B.; Wood, Simon; Appleton, Louise; Wheway, Kim; Watkins, Bridget; Carr, Andrew J.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Res Ctr, Nuffield Orthopaed Ctr, Oxford, England; [Colas, Romain A.; Dalli, Jesmond] Queen Mary Univ London, Lipid Mediator Unit, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Dalli, Jesmond] Queen Mary Univ London, Ctr Inflammat & Therapeut Innovat, London, England	Nuffield Orthopaedic Centre; University of Oxford; University of London; Queen Mary University London; University of London; Queen Mary University London	Dakin, SG (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Nuffield Orthopaed Ctr, Oxford OX3 7LD, England.	stephanie.dakin@ndorms.ox.ac.uk		Reid, Hamish/0000-0003-2094-5506; Dakin, Stephanie Georgina/0000-0003-2470-1031; Dalli, Jesmond/0000-0001-6328-3640	Oxford-Union Chimique Belge (UCB) Prize Fellowship in Biomedical Research; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [677542]; Barts Charity [MGU0343]; Sir Henry Dale Fellowship - Wellcome Trust; Sir Henry Dale Fellowship - Royal Society [107613/Z/15/Z]; National Institute for Health Research (NIHR) Oxford Musculoskeletal Biomedical Research Centre (BRC); MRC [MR/J006815/1] Funding Source: UKRI	Oxford-Union Chimique Belge (UCB) Prize Fellowship in Biomedical Research; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC)); Barts Charity; Sir Henry Dale Fellowship - Wellcome Trust; Sir Henry Dale Fellowship - Royal Society; National Institute for Health Research (NIHR) Oxford Musculoskeletal Biomedical Research Centre (BRC)(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank the clinical and nursing teams at the Nuffield Orthopaedic Centre and the John Radcliffe Trauma Unit for facilitating the collection of tendinopathic and ruptured Achilles tendon tissue samples used for this study. S.G.D. is a recipient of an Oxford-Union Chimique Belge (UCB) Prize Fellowship in Biomedical Research. J.D. received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (Grant 677542) and the Barts Charity (Grant MGU0343). J.D. is also supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant 107613/Z/15/Z). Research at Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences (NDORMS), University of Oxford, is supported through the National Institute for Health Research (NIHR) Oxford Musculoskeletal Biomedical Research Centre (BRC). The views expressed are those of the authors and not necessarily those of the National Health Service (NHS), the NIHR, or the Department of Health. The authors declare no conflicts of interest.	Abate M, 2019, PHYSICIAN SPORTSMED, V47, P232, DOI 10.1080/00913847.2018.1548886; Alfredson H, 2000, SPORTS MED, V29, P135, DOI 10.2165/00007256-200029020-00005; Almekinders LC, 1998, MED SCI SPORT EXER, V30, P1183, DOI 10.1097/00005768-199808000-00001; Arnardottir HH, 2016, J IMMUNOL, V197, P2362, DOI 10.4049/jimmunol.1502268; Ban T, 2016, IMMUNITY, V45, P319, DOI 10.1016/j.immuni.2016.07.015; Bussin ER, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015126; Challoumas D, 2019, BRIT J SPORT MED, V53, P251, DOI 10.1136/bjsports-2018-099552; Colas RA, 2016, J IMMUNOL, V197, P4444, DOI 10.4049/jimmunol.1600837; Colas RA, 2014, AM J PHYSIOL-CELL PH, V307, pC39, DOI 10.1152/ajpcell.00024.2014; Collins M, 2009, MED SPORT SCI, V54, P136, DOI 10.1159/000235701; Dakin SG, 2018, NAT REV RHEUMATOL, V14, P714, DOI 10.1038/s41584-018-0112-7; Dakin SG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11188-y; Dakin SG, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-016-1218-4; Dakin SG, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4269; Dakin SG, 2018, BRIT J SPORT MED, V52, P359, DOI 10.1136/bjsports-2017-098161; Dalli J, 2018, METHODS MOL BIOL, V1730, P59, DOI 10.1007/978-1-4939-7592-1_4; Dalli J, 2013, CHEM BIOL, V20, P188, DOI 10.1016/j.chembiol.2012.11.010; de Vos RJ, 2010, JAMA-J AM MED ASSOC, V303, P144, DOI 10.1001/jama.2009.1986; Dudhia J, 2007, AGING CELL, V6, P547, DOI 10.1111/j.1474-9726.2007.00307.x; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Habets B, 2015, SCAND J MED SCI SPOR, V25, P3, DOI 10.1111/sms.12208; Hsiao HM, 2015, AM J PATHOL, V185, P3189, DOI 10.1016/j.ajpath.2015.08.008; Jarvinen Tero A H, 2005, Foot Ankle Clin, V10, P255, DOI 10.1016/j.fcl.2005.01.013; KANNUS P, 1991, J BONE JOINT SURG AM, V73A, P1507, DOI 10.2106/00004623-199173100-00009; Kragsnaes MS, 2014, AM J SPORT MED, V42, P2435, DOI 10.1177/0363546514542329; Kujala UM, 2005, CLIN J SPORT MED, V15, P133, DOI 10.1097/01.jsm.0000165347.55638.23; Lenskjold A, 2015, SCAND J MED SCI SPOR, V25, P25, DOI 10.1111/sms.12143; Maffulli N, 2013, PHYS THER SPORT, V14, P163, DOI 10.1016/j.ptsp.2012.07.002; Meulenkamp B, 2018, SYST REV-LONDON, V7, DOI 10.1186/s13643-018-0912-5; Morita W, 2017, BONE JOINT RES, V6, P656, DOI 10.1302/2046-3758.612.BJR-2017-0112.R1; Norling LV, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85922; Ochen Y, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k5120; Paavola M, 2002, BRIT J SPORT MED, V36, P178, DOI 10.1136/bjsm.36.3.178; Robinson JM, 2001, BRIT J SPORT MED, V35, P335, DOI 10.1136/bjsm.35.5.335; Romano M, 2007, THESCIENTIFICWORLDJO, V7, P1393, DOI 10.1100/tsw.2007.186; Scapini P, 2009, IMMUNOL REV, V228, P23, DOI 10.1111/j.1600-065X.2008.00758.x; Tallon C, 2001, MED SCI SPORT EXER, V33, P1983, DOI 10.1097/00005768-200112000-00002; Xu YK, 2005, IMMUNITY, V22, P9, DOI 10.1016/j.immuni.2004.12.004	39	12	12	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8043	8054		10.1096/fj.201900196R	http://dx.doi.org/10.1096/fj.201900196R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30916999	hybrid, Green Published			2022-12-28	WOS:000476234700020
J	Liu, JH; Li, HW; Zhu, WY; Mao, SY				Liu, Junhua; Li, Hongwei; Zhu, Weiyun; Mao, Shengyong			Dynamic changes in rumen fermentation and bacterial community following rumen fluid transplantation in a sheep model of rumen acidosis: implications for rumen health in ruminants	FASEB JOURNAL			English	Article						rumen microbiota; rumen morphology; rumen function; tight junction protein; cytokine	LACTIC-ACID; CATTLE; FEED; DIET; OLIGOFRUCTOSE; POPULATION; EPITHELIUM; MICROBIOTA; CHALLENGE; SEQUENCES	Over the years, rumen fluid transplantation (RT) has been successfully applied to treat acute rumen acidosis in ruminants, but how it functions in the ruminal microbial homeostasis and host function remains largely unknown. Here, we investigated the dynamic changes of rumen fermentation and bacterial communities following RT and its beneficial effects on rumen epithelial morphology and function in a sheep model of rumen acidosis. The results showed that RT resulted in dynamic changes in rumen fermentation and increased the concentrations of total volatile fatty acid, acetate, propionate, and butyrate, but it decreased the levels of lactate and LPS in the rumen. Illumina MiSeq Sequencing data showed that RT facilitated rapid rebuilt of ruminal bacterial homeostasis (8 d in control vs. 2 d in RT) from a markedly dysbiotic acidosis state to a healthy level (similar with those of donors). At the genus level, RT increased the relative abundance of unclassified Bacteroidales, unclassified Prevotellaceae, unclassified Ruminococcaceae, and Acetitomaculum. Additionally, RT also accelerated recovery of the predicted metagenomic function of ruminal bacteria. Rumen papillae morphology results showed that RT alleviated the damage of rumen epithelia induced by acute rumen acidosis and increased the length of rumen papillae. Furthermore, real-time PCR results showed that RT modulated mRNA expression of genes related to cytokines and tight junctions in the rumen epithelia. In summary, these results reveal that RT accelerates recovery of rumen fermentation and bacterial homeostasis and modulates rumen epithelial morphology and function for sheep suffering from rumen acidosis.-Liu, J., Li, H., Zhu, W., Mao, S. Dynamic changes in rumen fermentation and bacterial community following rumen fluid transplantation in a sheep model of rumen acidosis: implications for rumen health in ruminants.	[Liu, Junhua; Li, Hongwei; Zhu, Weiyun; Mao, Shengyong] Nanjing Agr Univ, Coll Anim Sci & Technol, Lab Gastrointestinal Microbiol, Jiangsu Key Lab Gastrointestinal Nutr & Anim Hlth, Nanjing, Jiangsu, Peoples R China; [Liu, Junhua; Li, Hongwei; Zhu, Weiyun; Mao, Shengyong] Nanjing Agr Univ, Natl Ctr Int Res Anim Gut Nutr, Nanjing, Jiangsu, Peoples R China; [Liu, Junhua; Li, Hongwei; Zhu, Weiyun; Mao, Shengyong] Nanjing Agr Univ, Coll Anim Sci & Technol, Natl Expt Teaching Demonstrat Ctr Anim Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University; Nanjing Agricultural University	Mao, SY (corresponding author), Nanjing Agr Univ, Weigang 1, Nanjing 210095, Jiangsu, Peoples R China.	maoshengyong@njau.edu.cn			Natural Science Foundation of China (NSFC) [31872384, 31572436]; National Key Research and Development Plan of China [2018YFD0501900]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Research and Development Plan of China	This work was supported by Grants from the Natural Science Foundation of China (NSFC) (31872384 and 31572436) and the National Key Research and Development Plan of China (2018YFD0501900). The authors declare no conflicts of interest.	Barker SB, 1941, J BIOL CHEM, V138, P535; Beatty DT, 2008, J THERM BIOL, V33, P437, DOI 10.1016/j.jtherbio.2008.07.002; Bickhart DM, 2018, J DAIRY SCI, V101, P7680, DOI 10.3168/jds.2017-13328; Campbell BJ, 2010, ENVIRON MICROBIOL, V12, P1842, DOI 10.1111/j.1462-2920.2010.02189.x; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cheng SS, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00137-18; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLE NA, 1985, J ANIM SCI, V61, P692, DOI 10.2527/jas1985.613692x; Concha C, 2014, J VET SCI, V15, P217, DOI 10.4142/jvs.2014.15.2.217; DePeters EJ, 2014, IMMUNOL LETT, V162, P69, DOI 10.1016/j.imlet.2014.05.009; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fluharty FL, 1996, J ANIM SCI, V74, P465; Hernandez JD, 2008, J APPL MICROBIOL, V104, P1754, DOI 10.1111/j.1365-2672.2007.03696.x; HOLLE SA, 1990, NEW ZEAL VET J, V38, P89, DOI 10.1080/00480169.1990.35625; HOOVER WH, 1991, J DAIRY SCI, V74, P3630, DOI 10.3168/jds.S0022-0302(91)78553-6; Jasmin BH, 2011, J AM ASSOC LAB ANIM, V50, P27; Khafipour E, 2009, J DAIRY SCI, V92, P1060, DOI 10.3168/jds.2008-1389; KUNG LM, 1995, J ANIM SCI, V73, P250; Liu JH, 2016, MICROB BIOTECHNOL, V9, P257, DOI 10.1111/1751-7915.12345; Liu JH, 2013, AM J PHYSIOL-REG I, V305, pR232, DOI 10.1152/ajpregu.00068.2013; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mao SY, 2016, ENVIRON MICROBIOL, V18, P525, DOI 10.1111/1462-2920.12724; Nagaraja TG, 2007, J DAIRY SCI, V90, pE17, DOI 10.3168/jds.2006-478; NRC, 2007, NUTR REQ SMALL RUM, DOI [10.17226/11654, DOI 10.17226/11654]; Odongo NE, 2006, J ANIM SCI, V84, P447, DOI 10.2527/2006.842447x; Owens FN, 1998, J ANIM SCI, V76, P275; Parmar NR, 2014, J MOL MICROB BIOTECH, V24, P249, DOI 10.1159/000365054; Pitta DW, 2016, ANAEROBE, V38, P50, DOI 10.1016/j.anaerobe.2015.12.003; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seekatz AM, 2014, MBIO, V5, DOI 10.1128/mBio.00893-14; Steele MA, 2011, AM J PHYSIOL-REG I, V300, pR1515, DOI 10.1152/ajpregu.00120.2010; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; Thoefner MB, 2004, J DAIRY SCI, V87, P2932, DOI 10.3168/jds.S0022-0302(04)73424-4; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weimer PJ, 2010, J DAIRY SCI, V93, P5902, DOI 10.3168/jds.2010-3500; Weimer PJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00296; Weingarden A, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0070-0; Wells JE, 1996, APPL ENVIRON MICROB, V62, P1342, DOI 10.1128/AEM.62.4.1342-1346.1996; WOLIN MJ, 1981, SCIENCE, V213, P1463, DOI 10.1126/science.7280665; Zhang K, 2018, J AGR FOOD CHEM, V66, P8729, DOI 10.1021/acs.jafc.8b03108	43	13	16	8	45	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8453	8467		10.1096/fj.201802456R	http://dx.doi.org/10.1096/fj.201802456R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30973755				2022-12-28	WOS:000476234700051
J	Morgan, MM; Arendt, LM; Alarid, ET; Beebe, DJ; Johnson, BP				Morgan, Molly M.; Arendt, Lisa M.; Alarid, Elaine T.; Beebe, David J.; Johnson, Brian P.			Mammary adipose stromal cells derived from obese women reduce sensitivity to the aromatase inhibitor anastrazole in an organotypic breast model	FASEB JOURNAL			English	Article						obesity; estrogen; cancer; hormone therapy	BODY-MASS INDEX; ENDOCRINE THERAPY; POSTMENOPAUSAL PATIENTS; RECIPROCAL INTERACTIONS; CANCER; EXPRESSION; ESTROGEN; RECEPTOR; TAMOXIFEN; ANASTROZOLE	Aromatase inhibitors are the preferred treatment for certain women with estrogen receptor (ER)-positive breast cancer, but evidence suggests that women with obesity experience aromatase inhibitor resistance at higher rates. To compare how stromal cells derived from women who are lean or obese influence response to the aromatase inhibitor (anastrazole), we incorporated patient-derived stroma in a previously characterized MCF7-derived in vitro duct model. Coculture with adipose stromal cells enabled the metabolism of testosterone (T) to E-2, which induced estrogen response element activity, epithelial proliferation, and hyperplasia in MCF7 cells. The effects of T were inhibited by the ER antagonist tamoxifen and aromatase inhibitor anastrazole and were increased by the aromatase inducer dexamethasone. Primary mammary adipose stromal cells derived from women with obesity displayed increased aromatase mRNA compared with lean controls. MCF7-derived ducts cocultured with obese stromal cells exhibited higher maximal aromatization-induced ER transactivation and reduced anastrazole sensitivity, a difference not seen in 2-dimensional coculture. Finally, tamoxifen was more effective than anastrazole at reducing aromatization-induced ER transactivation and proliferation. These findings suggest that patient-specific responses to hormone therapies can be modeled and studied organotypically in vitro and add to evidence advocating obesity as a parameter to consider when identifying treatments for patients with ER-positive breast cancer.-Morgan, M. M., Arendt, L. M., Alarid, E. T., Beebe, D. J., Johnson, B. P. Mammary adipose stromal cells derived from obese women reduce sensitivity to the aromatase inhibitor anastrazole in an organotypic breast model.	[Morgan, Molly M.; Beebe, David J.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53705 USA; [Arendt, Lisa M.] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53705 USA; [Alarid, Elaine T.] Univ Wisconsin, Dept Oncol, Madison, WI 53705 USA; [Beebe, David J.; Johnson, Brian P.] Univ Wisconsin, Dept Biomed Engn, 6009 WIMR,1111 Highland Ave, Madison, WI 53705 USA; [Arendt, Lisa M.; Alarid, Elaine T.; Beebe, David J.] Univ Wisconsin, Carbone Comprehens Canc Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Beebe, DJ; Johnson, BP (corresponding author), Univ Wisconsin, Dept Biomed Engn, 6009 WIMR,1111 Highland Ave, Madison, WI 53705 USA.	djbeebe@wisc.edu; bpjohnson5@wisc.edu		Johnson, Brian/0000-0001-8163-4731	University of Wisconsin Carbone Cancer Center Support Grant [P30 CA014520]; Environmental Protection Agency (EPA) Science to Achieve Results (STAR) Grant [83573701]; U.S. National Institutes of Health (NIH), National Cancer Institute (NCI) [R01 CA186134, T32 CA157322]; National Institute of Environmental Health Science (NIEHS) [K99ES028744]; NIEHS [T32 ES007015-39]; Susan G. Komen Grant [CCR15332611]; NATIONAL CANCER INSTITUTE [P30CA014520, R01CA186134, T32CA157322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K99ES028744, T32ES007015] Funding Source: NIH RePORTER	University of Wisconsin Carbone Cancer Center Support Grant; Environmental Protection Agency (EPA) Science to Achieve Results (STAR) Grant; U.S. National Institutes of Health (NIH), National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health Science (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Susan G. Komen Grant(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Linda Schuler for guidance, expertise, and positivity. The authors acknowledge Megan Livingston and Jordan Ciciliano for support. This work was supported by the University of Wisconsin Carbone Cancer Center Support Grant P30 CA014520, Environmental Protection Agency (EPA) Science to Achieve Results (STAR) Grant 83573701, U.S. National Institutes of Health (NIH), National Cancer Institute (NCI) Grants R01 CA186134 (to D.J.B.) and T32 CA157322, and National Institute of Environmental Health Science (NIEHS) Grant K99ES028744 to B.P.J., NIEHS Grant T32 ES007015-39 to M.M.M., and Susan G. Komen Grant CCR15332611 to L.M.A. Three of the authors have competing financial interests. D.J.B. holds equity in Bellbrook Labs, Tasso, Turba, Stacks to the Future, Salus Discovery, Lynx Biosciences, and Onexio Biosystems. B.P.J. holds equity in Onexio Biosystems. M.M.M. is an employee at Salus Discovery and has received compensation.	Baer Patrick C, 2014, World J Stem Cells, V6, P256, DOI 10.4252/wjsc.v6.i3.256; Bourin P, 2013, CYTOTHERAPY, V15, P641, DOI 10.1016/j.jcyt.2013.02.006; Brown KA, 2017, J CLIN ENDOCR METAB, V102, P1692, DOI 10.1210/jc.2016-3606; Bulun SE, 2012, TRENDS ENDOCRIN MET, V23, P83, DOI 10.1016/j.tem.2011.10.003; Chamberlin T, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0921-7; Chen SA, 2006, J STEROID BIOCHEM, V102, P232, DOI 10.1016/j.jsbmb.2006.09.012; Chottanapund S, 2013, J STEROID BIOCHEM, V138, P54, DOI 10.1016/j.jsbmb.2013.03.007; Dabydeen SA, 2014, ENDOCR-RELAT CANCER, V21, pR195, DOI 10.1530/ERC-13-0512; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; DEMIRPENCE E, 1993, J STEROID BIOCHEM, V46, P355, DOI 10.1016/0960-0760(93)90225-L; Dignam JJ, 2003, JNCI-J NATL CANCER I, V95, P1467, DOI 10.1093/jnci/djg060; Dowsett M, 2015, LANCET, V386, P1341, DOI 10.1016/S0140-6736(15)61074-1; Folkerd EJ, 2012, J CLIN ONCOL, V30, P2977, DOI 10.1200/JCO.2012.42.0273; Furuta S, 2016, COLD SH Q B, V81, P207, DOI 10.1101/sqb.2016.81.030825; Giles ED, 2018, BREAST CANCER RES, V20, DOI 10.1186/s13058-018-0974-2; Gnant M, 2013, BRIT J CANCER, V109, P589, DOI 10.1038/bjc.2013.367; Goodwin PJ, 2013, BREAST, V22, pS44, DOI 10.1016/j.breast.2013.07.008; Heneweer M, 2005, TOXICOL SCI, V83, P257, DOI 10.1093/toxsci/kfi025; Hopkinson BM, 2017, ONCOTARGET, V8, P10580, DOI 10.18632/oncotarget.14554; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; Ioannides SJ, 2014, BREAST CANCER RES TR, V147, P237, DOI 10.1007/s10549-014-3091-7; Lelievre SA, 1998, P NATL ACAD SCI USA, V95, P14711, DOI 10.1073/pnas.95.25.14711; Milla-Santos A, 2003, AM J CLIN ONCOL-CANC, V26, P317, DOI 10.1097/00000421-200306000-00022; Morgan MM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25461-1; Morgan MM, 2016, PHARMACOL THERAPEUT, V165, P79, DOI 10.1016/j.pharmthera.2016.05.007; Morris PG, 2011, CANCER PREV RES, V4, P1021, DOI 10.1158/1940-6207.CAPR-11-0110; Oh TG, 2014, MOL ENDOCRINOL, V28, P1166, DOI 10.1210/me.2013-1403; Ortmann J, 2002, GYNECOL ENDOCRINOL, V16, P113, DOI 10.1080/713603030; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Pfeiler G, 2013, BRIT J CANCER, V109, P1522, DOI 10.1038/bjc.2013.499; Pfeiler G, 2011, J CLIN ONCOL, V29, P2653, DOI 10.1200/JCO.2010.33.2585; Rugo HS, 2016, J CLIN ONCOL, V34, P3069, DOI 10.1200/JCO.2016.67.1487; Santner SJ, 1997, J CLIN ENDOCR METAB, V82, P200, DOI 10.1210/jc.82.1.200; Sasano H, 2009, PATHOL INT, V59, P777, DOI 10.1111/j.1440-1827.2009.02444.x; Sestak I, 2010, J CLIN ONCOL, V28, P3411, DOI 10.1200/JCO.2009.27.2021; Shamir ER, 2014, NAT REV MOL CELL BIO, V15, P647, DOI 10.1038/nrm3873; Simpson ER, 2003, J STEROID BIOCHEM, V86, P225, DOI 10.1016/S0960-0760(03)00360-1; Strong AL, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0622-z; Subbaramaiah K, 2011, CANCER PREV RES, V4, P329, DOI 10.1158/1940-6207.CAPR-10-0381; Sung KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076373; Vantangoli MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135426; Vidi Pierre-Alexandre, 2013, Methods Mol Biol, V945, P193, DOI 10.1007/978-1-62703-125-7_13; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Warrick JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145081; Wolters R, 2012, BREAST CANCER RES TR, V131, P925, DOI 10.1007/s10549-011-1874-7; Yaghjyan L, 2011, CANCER CAUSE CONTROL, V22, P529, DOI 10.1007/s10552-011-9729-4; Yu HM, 2007, LAB CHIP, V7, P726, DOI 10.1039/b618793e; Zaitseva M, 2006, MOL HUM REPROD, V12, P187, DOI 10.1093/molehr/gal018; Zhao H, 2016, J MOL ENDOCRINOL, V57, pR19, DOI 10.1530/JME-15-0310; Zhao H, 2012, ENDOCRINOLOGY, V153, P2701, DOI 10.1210/en.2011-1761	50	15	15	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8623	8633		10.1096/fj.201802347RRR	http://dx.doi.org/10.1096/fj.201802347RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	31002529	Green Published			2022-12-28	WOS:000476234700065
J	Rocca, C; Scavello, F; Colombo, B; Gasparri, AM; Dallatomasina, A; Granieri, MC; Amelio, D; Pasqua, T; Cerra, MC; Tota, B; Corti, A; Angelone, T				Rocca, Carmine; Scavello, Francesco; Colombo, Barbara; Gasparri, Anna Maria; Dallatomasina, Alice; Granieri, Maria Concetta; Amelio, Daniela; Pasqua, Teresa; Cerra, Maria Carmela; Tota, Bruno; Corti, Angelo; Angelone, Tommaso			Physiological levels of chromogranin A prevent doxorubicin-induced cardiotoxicity without impairing its anticancer activity	FASEB JOURNAL			English	Article						cardioprotection; intracellular signaling; cancer	IN-VIVO; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; PROTEIN-KINASE; HEART-FAILURE; CELL-DEATH; PEPTIDES; APOPTOSIS; OXIDASE; MUSCLE	The clinical use of doxorubicin (Doxo), a widely used anticancer chemotherapeutic drug, is limited by dose-dependent cardiotoxicity. We have investigated whether chromogranin A (CgA), a cardioregulatory protein released in the blood by the neuroendocrine system and by the heart itself, may contribute to regulation of the cardiotoxic and antitumor activities of Doxo. The effects of a physiologic dose of full-length recombinant CgA on Doxo-induced cardiotoxicity and antitumor activity were investigated in rats using in vivo and ex vivo models and in murine models of melanoma, fibrosarcoma, lymphoma, and lung cancer, respectively. The effect of Doxo on circulating levels of CgA was also investigated. In vivo and ex vivo mechanistic studies showed that CgA can prevent Doxo-induced heart inflammation, oxidative stress, apoptosis, fibrosis, and ischemic injury. On the other hand, CgA did not impair the anticancer activity of Doxo in all the murine models investigated. Furthermore, we observed that Doxo can reduce the intracardiac expression and release of CgA in the blood (i.e., an important cardioprotective agent). These findings suggest that administration of low-dose CgA to patients with low levels of endogenous CgA might represent a novel approach to prevent Doxo-induced adverse events without impairing antitumor effects.-Rocca, C., Scavello, F., Colombo, B., Gasparri, A. M., Dallatomasina, A., Granieri, M. C., Amelio, D., Pasqua, T., Cerra, M. C., Tota, B., Corti, A., Angelone, T. Physiological levels of chromogranin A prevent doxorubicin-induced cardiotoxicity without impairing its anticancer activity.	[Rocca, Carmine; Scavello, Francesco; Granieri, Maria Concetta; Amelio, Daniela; Pasqua, Teresa; Cerra, Maria Carmela; Tota, Bruno; Angelone, Tommaso] Univ Calabria, Lab Cellular & Mol Cardiac Pathophysiol, Dept Biol Ecol & Earth Sci, Cosenza, Italy; [Colombo, Barbara; Gasparri, Anna Maria; Dallatomasina, Alice; Corti, Angelo] Univ Vita Salute San Raffaele, IRCCS, San Raffaele Sci Inst, Div Expt Oncol, Milan, Italy; [Cerra, Maria Carmela; Tota, Bruno; Angelone, Tommaso] Natl Inst Cardiovasc Res INRC, Bologna, Italy	University of Calabria; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Corti, A (corresponding author), San Raffaele Vita Salute Univ, Div Expt Oncol, I-20132 Milan, Italy.; Corti, A (corresponding author), IRCCS, San Raffaele Sci Inst, I-20132 Milan, Italy.; Angelone, T (corresponding author), Univ Calabria, Via Ponte Pietro Bucci,Cubo6c, I-87036 Arcavacata Di Rende, Italy.	corti.angelo@hsr.it; tommaso.angelone@unical.it	Colombo, Barbara/AAN-5045-2020; Rocca, Carmine/AAN-1969-2020; Pasqua, Teresa/AAA-9067-2022; Scavello, Francesco/AHE-5653-2022; Angelone, Tommaso/AAM-1230-2020; Gasparri, Anna Maria/AAN-5071-2020; Scavello, Francesco/AAB-9630-2019	Colombo, Barbara/0000-0002-5887-5868; Scavello, Francesco/0000-0002-0297-0946; Angelone, Tommaso/0000-0001-7797-7862; Gasparri, Anna Maria/0000-0002-1757-8699; Cerra, Maria Carmela/0000-0002-2091-928X; Rocca, Carmine/0000-0002-1743-4724	Ministry of Education, Universities and Research (MIUR) of Italy; Dottorato di Ricerca in Scienze della Vita; Associazione Italiana per la Ricerca sul Cancro of Italy [AIRC IG-19220, 9965]	Ministry of Education, Universities and Research (MIUR) of Italy(Ministry of Education, Universities and Research (MIUR)); Dottorato di Ricerca in Scienze della Vita; Associazione Italiana per la Ricerca sul Cancro of Italy(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Ministry of Education, Universities and Research (MIUR) of Italy (ex 60%), Dottorato di Ricerca in Scienze della Vita, and, in part, by the Associazione Italiana per la Ricerca sul Cancro of Italy (AIRC IG-19220 and 9965). The authors declare no conflicts of interest.	Abderrazak A, 2015, REDOX BIOL, V4, P296, DOI 10.1016/j.redox.2015.01.008; Aluise CD, 2009, CANCER LETT, V282, P25, DOI 10.1016/j.canlet.2009.02.047; Angelone T, 2012, CURR MED CHEM, V19, P4042, DOI 10.2174/092986712802430009; Angelone T, 2008, ENDOCRINOLOGY, V149, P4780, DOI 10.1210/en.2008-0318; Bartolomucci A, 2011, ENDOCR REV, V32, P755, DOI 10.1210/er.2010-0027; Bell RM, 2011, J MOL CELL CARDIOL, V50, P940, DOI 10.1016/j.yjmcc.2011.02.018; Carling D, 2012, BIOCHEM J, V445, P11, DOI 10.1042/BJ20120546; Ceconi C, 2002, EUR HEART J, V23, P967, DOI 10.1053/euhj.2001.2977; Cerra MC, 2006, BASIC RES CARDIOL, V101, P43, DOI 10.1007/s00395-005-0547-2; Chassany O, 1996, CANCER CHEMOTH PHARM, V38, P571, DOI 10.1007/s002800050529; Childs AC, 2002, CANCER RES, V62, P4592; Corti A, 2018, PFLUG ARCH EUR J PHY, V470, P199, DOI 10.1007/s00424-017-2030-y; Crippa L, 2013, BLOOD, V121, P392, DOI 10.1182/blood-2012-05-430314; Curnis F, 2016, ONCOTARGET, V7, P72716, DOI 10.18632/oncotarget.12237; Delgado RM, 2004, CIRCULATION, V109, P1428, DOI 10.1161/01.CIR.0000121354.34067.48; Dirks-Naylor AJ, 2013, J CACHEXIA SARCOPENI, V4, P239, DOI 10.1007/s13539-013-0104-z; Gianni L, 2008, J CLIN ONCOL, V26, P3777, DOI 10.1200/JCO.2007.14.9401; Glattard E, 2006, FEBS J, V273, P3311, DOI 10.1111/j.1742-4658.2006.05334.x; Goetze JP, 2014, BIOMARK MED, V8, P133, DOI 10.2217/bmm.13.102; Gustafsson AB, 2007, AM J PHYSIOL-CELL PH, V292, pC45, DOI 10.1152/ajpcell.00229.2006; Hausenloy DJ, 2005, TRENDS CARDIOVAS MED, V15, P69, DOI 10.1016/j.tcm.2005.03.001; Helle KB, 2007, CELL MOL LIFE SCI, V64, P2863, DOI 10.1007/s00018-007-7254-0; Herman EH, 1999, J CLIN ONCOL, V17, P2237, DOI 10.1200/JCO.1999.17.7.2237; Ichikawa Y, 2014, J CLIN INVEST, V124, P617, DOI 10.1172/JCI72931; Kim J, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.16; Kundu TK, 2012, BIOCHEMISTRY-US, V51, P2930, DOI 10.1021/bi3000879; LEGHA SS, 1982, ANN INTERN MED, V96, P133, DOI 10.7326/0003-4819-96-2-133; Lu DY, 2013, J BIOL CHEM, V288, P8491, DOI 10.1074/jbc.M112.442061; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Mukhopadhyay P, 2009, AM J PHYSIOL-HEART C, V296, pH1466, DOI 10.1152/ajpheart.00795.2008; Nagi MN, 2000, PHARMACOL RES, V41, P283, DOI 10.1006/phrs.1999.0585; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; Pasqua T, 2015, J ENDOCRINOL, V227, P167, DOI 10.1530/JOE-15-0199; Pasqua T, 2013, ENDOCRINOLOGY, V154, P3353, DOI 10.1210/en.2012-2210; Penna C, 2006, BASIC RES CARDIOL, V101, P180, DOI 10.1007/s00395-006-0584-5; Penna C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102536; Pieroni M, 2007, EUR HEART J, V28, P1117, DOI 10.1093/eurheartj/ehm022; Quintieri AM, 2016, NUTR METAB CARDIOVAS, V26, P603, DOI 10.1016/j.numecd.2016.02.009; Ratti S, 2000, J BIOL CHEM, V275, P29257, DOI 10.1074/jbc.M003796200; Reichardt P, 2018, FUTURE ONCOL, V14, P2663, DOI 10.2217/fon-2018-0210; Rocca C, 2018, ACTA PHYSIOL, V223, DOI 10.1111/apha.13067; Saleem Z, 2016, PAK J PHARM SCI, V29, P1555; Singal P, 2000, MOL CELL BIOCHEM, V207, P77, DOI 10.1023/A:1007094214460; STEINER HJ, 1990, J HISTOCHEM CYTOCHEM, V38, P845, DOI 10.1177/38.6.2139887; Su X, 2010, CYTOKINE, V51, P60, DOI 10.1016/j.cyto.2010.04.014; Swain SM, 2004, J CANCER RES CLIN, V130, P1, DOI 10.1007/s00432-003-0498-7; Swerdlow AJ, 2007, J NATL CANCER I, V99, P206, DOI 10.1093/jnci/djk029; Szabo Z, 2014, HYPERTENSION, V63, P1235, DOI 10.1161/HYPERTENSIONAHA.114.03279; Tota B, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00064; Tota B, 2012, FASEB J, V26, P2888, DOI 10.1096/fj.11-201111; Wang LT, 2016, CANCER RES, V76, P6631, DOI 10.1158/0008-5472.CAN-15-3034; Wardill HR, 2016, INT J CANCER, V139, P2635, DOI 10.1002/ijc.30252; Weiergraber M, 2000, J HISTOCHEM CYTOCHEM, V48, P807, DOI 10.1177/002215540004800609; Wojnowski L, 2005, CIRCULATION, V112, P3754, DOI 10.1161/CIRCULATIONAHA.105.576850; Yee SB, 1997, ARCH BIOCHEM BIOPHYS, V347, P235, DOI 10.1006/abbi.1997.0340; Yeh ETH, 2009, J AM COLL CARDIOL, V53, P2231, DOI 10.1016/j.jacc.2009.02.050; Yen HC, 1996, J CLIN INVEST, V98, P1253, DOI 10.1172/JCI118909; Yuan YP, 2018, J MOL CELL CARDIOL, V114, P38, DOI 10.1016/j.yjmcc.2017.10.008; Zhang J, 2016, AM J TRANSL RES, V8, P2862; Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919; Zhu WQ, 2009, CIRCULATION, V119, P99, DOI 10.1161/CIRCULATIONAHA.108.799700	61	15	15	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7734	7747		10.1096/fj.201802707R	http://dx.doi.org/10.1096/fj.201802707R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30973759	Bronze			2022-12-28	WOS:000476114200085
J	Chen, YL; Chen, JL; Zhang, CX; Yang, SS; Zhang, XP; Liu, Y; Su, ZG				Chen, Yulong; Chen, Jinglu; Zhang, Caixia; Yang, Shanshan; Zhang, Xueping; Liu, Yin; Su, Zhiguang			Deficiency in the short-chain acyl-CoA dehydrogenase protects mice against diet-induced obesity and insulin resistance	FASEB JOURNAL			English	Article						SCAD; lipogenesis; AMPK; PKC-epsilon; GRP78	ENDOPLASMIC-RETICULUM STRESS; HORMONE-SENSITIVE LIPASE; FATTY-ACID OXIDATION; KINASE; PHOSPHORYLATION; DYSFUNCTION; ACTIVATION; GRP78/BIP; LIPOLYSIS; KNOCKOUT	Acyl-CoA dehydrogenases (CADs) participate in mitochondrial fatty acid oxidation; abnormal fatty acid oxidation is associated with obesity and related metabolic disorders. We decipher the impact of short-chain CAD (SCAD) on adiposity and insulin resistance. BALB/cBy strain mice derived from BALB/c strain are deficient in SCAD activity because of a spontaneous deletion in the acyl-CoA dehydrogenases (Acads) gene. Adiposity, lipogenesis, and insulin sensitivity were compared in BALB/c and BALB/cBy mice subjected to high-fat diets (HFDs). A whole hepatic transcriptome profiling experiment with microarrays was performed to evaluate the mechanisms by which SCAD deficiency protects against insulin resistance. Acads-deficient mice were significantly resistant to HFD-induced obesity and insulin resistance as compared with control mice. Reduced obesity results from decreased triglyceride content due to activation of AMPK in liver that would reduce hepatic content of malonyl-CoA, resulting in decreased hepatic de novo lipogenesis. Improved insulin sensitivity was associated with reduced diacylglycerol content commensurate with reduced PKC-epsilon activity and increased protein kinase B (AKT) activation in liver and skeletal muscle. Additionally, Acads-deficient mice displayed significantly higher expression of the endoplasmic chaperone 78-kDa glucose-regulated protein, which was further associated with the AKT activation in the primary hepatocytes. Modulation of SCAD expression may therefore be a novel therapeutic approach to manage and prevent obesity and related metabolic diseases, such as diabetes.	Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Mol Med Res Ctr, Chengdu, Peoples R China; Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Natl Clin Res Ctr Geriatr, Chengdu, Peoples R China	Sichuan University; Sichuan University	Su, ZG (corresponding author), Sichuan Univ, West China Hosp, Mol Med Res Ctr, 1 Keyuan 4th Rd,Gaopeng St, Chengdu 610041, Peoples R China.	zhiguang.su@scu.edu.cn	Su, Zhiguang/AFS-0022-2022	Su, Zhiguang/0000-0001-8635-9310	National Natural Science Foundation of China [81770814]; Sichuan Province Science and Technology Support Program [2018SZ0171]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Province Science and Technology Support Program	Funding for this study was provided by the National Natural Science Foundation of China (81770814) and the Sichuan Province Science and Technology Support Program (2018SZ0171). The authors declare no conflicts of interest.	Ameer F, 2014, METABOLISM, V63, P895, DOI 10.1016/j.metabol.2014.04.003; An Se Jin, 2016, Korean J Pediatr, V59, pS45, DOI 10.3345/kjp.2016.59.11.S45; Bi XK, 2018, CIRC RES, V122, P1545, DOI 10.1161/CIRCRESAHA.117.312641; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cerezo M, 2017, AUTOPHAGY, V13, P216, DOI 10.1080/15548627.2016.1246107; den Besten G, 2015, DIABETES, V64, P2398, DOI 10.2337/db14-1213; Eamin EE, 2013, J NUTR, V143, P1872, DOI 10.3945/jn.113.179549; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foster DW, 2012, J CLIN INVEST, V122, P1958, DOI 10.1172/JCI63967; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fu Y, 2008, P NATL ACAD SCI USA, V105, P19444, DOI 10.1073/pnas.0807691105; GARTON AJ, 1989, EUR J BIOCHEM, V179, P249, DOI 10.1111/j.1432-1033.1989.tb14548.x; Ghaben AL, 2019, NAT REV MOL CELL BIO, V20, P242, DOI 10.1038/s41580-018-0093-z; Ghosh S, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0075-0; Hardie DG, 2002, BIOCHEM SOC T, V30, P1064, DOI 10.1042/BST0301064; Hornbak M, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-4; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005; Kelber JA, 2009, ONCOGENE, V28, P2324, DOI 10.1038/onc.2009.97; Kim SJ, 2016, MOL CELL BIOL, V36, P1961, DOI 10.1128/MCB.00244-16; Kruger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041709; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Li Y, 2012, INT J OBESITY, V36, P1503, DOI 10.1038/ijo.2011.279; Liu Y, 2017, J BIOL CHEM, V292, P13959, DOI [10.1074/jbc.M117.782391, 10.1074/jbc.m117.782391]; Liu YL, 2017, MOL CELL BIOCHEM, V426, P47, DOI 10.1007/s11010-016-2879-7; Magkos F, 2012, GASTROENTEROLOGY, V142, P1444, DOI 10.1053/j.gastro.2012.03.003; Merritt JL, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.10.57; Moller CL, 2011, MOL CELL ENDOCRINOL, V341, P9, DOI 10.1016/j.mce.2011.03.010; Palladino AA, 2012, MOL GENET METAB, V107, P679, DOI 10.1016/j.ymgme.2012.10.007; Petersen MC, 2017, TRENDS PHARMACOL SCI, V38, P649, DOI 10.1016/j.tips.2017.04.004; Petersen MC, 2016, J CLIN INVEST, V126, P4361, DOI 10.1172/JCI86013; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Pieralisi A, 2016, REDOX BIOL, V9, P39, DOI 10.1016/j.redox.2016.05.006; Shirao K, 2010, HUM GENET, V127, P619, DOI 10.1007/s00439-010-0822-7; Su ZG, 2010, J LIPID RES, V51, P2706, DOI 10.1194/jlr.M008110; Wey S, 2012, BLOOD, V119, P817, DOI 10.1182/blood-2011-06-357384; Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104; Zhang DY, 2010, CELL METAB, V11, P402, DOI 10.1016/j.cmet.2010.03.012; Zhang XP, 2019, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00802; Zhang YJ, 2018, J BIOL CHEM, V293, P7894, DOI 10.1074/jbc.RA117.000508; Zhang YJ, 2013, ENGINEERING, V5, P4, DOI DOI 10.1371/J0URNAL.P0NE.0080071	41	10	11	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13722	13733		10.1096/fj.201901474RR	http://dx.doi.org/10.1096/fj.201901474RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31585505	Bronze			2022-12-28	WOS:000507466100053
J	Kim, SM; Park, M; Yee, SM; Ji, KY; Lee, EH; Nguyen, TV; Nguyen, THL; Jang, J; Kim, EM; Choi, HR; Yun, CH; Kang, HS				Kim, Su-Man; Park, Min; Yee, Su-Min; Ji, Kon-Young; Lee, Eun-Hee; Thi-Van Nguyen; Thi Hong-Loan Nguyen; Jang, Jin; Kim, Eun-Mi; Choi, Ha-Rim; Yun, Chul-Ho; Kang, Hyung-Sik			Axl is a key regulator of intestinal gamma delta T-cell homeostasis	FASEB JOURNAL			English	Article						CCL25; migration; bacterial resistance	RECEPTOR TYROSINE KINASE; EPITHELIAL-CELLS; CHEMOKINE TECK; LYMPHOCYTES; EXPRESSION; MIGRATION; TRAFFICKING; ADHESION; ORIGIN; CCL25	Gut-homing gamma delta T cells are induced by chemokines and cell adhesion molecules and play a critical role in homeostasis and mucosal immunity; however, little is known regarding their upstream regulators. We investigated the role of Axl as a specific regulator of chemokines and cell adhesion molecule in the distribution of intestinal gamma delta T cells. The population of gamma delta T-cell receptor-positive cells including V gamma 1 and V gamma 7 subsets was remarkably increased in the intraepithelial lymphocytes of Axl(-/-) mice compared with those of wild-type (WT) mice. An increased number of migrated gamma delta T cells were observed in the coculture with intraepithelial cells from Axl(-/-) mice. The mRNA expression level of chemokine (C-C motif) ligand (CCL) 25 was specifically higher in the small intestine of Axl(-/-) mice than in WT mice. In adoptive transfer, the migration of both thymic and extrathymic gamma delta T cells was increased in Axl(-/-) mice. The activation of Axl signaling down-regulated CCL25 expression via ERK signaling pathway and reduced the population of gamma delta T cells. Systemic dissemination was suppressed in Axl(-/-) mice infected with Salmonella typhimurium. Thus, our findings suggest that Axl plays a critical role in regulating the migration of gamma delta T cells for the maintenance of homeostasis and bacterial resistance.	[Kim, Su-Man; Park, Min; Yee, Su-Min; Ji, Kon-Young; Thi-Van Nguyen; Thi Hong-Loan Nguyen; Jang, Jin; Yun, Chul-Ho; Kang, Hyung-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, 77 Yongbong Ro, Gwangju 500757, South Korea; [Lee, Eun-Hee] Deagu Gyeongbuk Med Innovat Fdn, Daegu, South Korea; [Kim, Eun-Mi] Korea Inst Toxicol, Predict Model Res Ctr, Daejeon, South Korea; [Choi, Ha-Rim] Nambu Univ, Dept Nursing, Gwangju, South Korea	Chonnam National University; Korea Institute of Toxicology; Nambu University	Kang, HS (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, 77 Yongbong Ro, Gwangju 500757, South Korea.	kanghs@jnu.ac.kr	Ji, Kon-Young/GZB-2640-2022	Kim, Su-Man/0000-0002-0588-8294	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science [NRF-2018R1A2B6005139]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Basic Research Laboratory [NRF-2018R1A4A1023882]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Basic Research Laboratory(National Research Foundation of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), and funded by the Ministry of Science (NRF-2018R1A2B6005139) and the Basic Research Laboratory (NRF-2018R1A4A1023882). The authors declare no conflicts of interest.	Allen MP, 2002, MOL CELL BIOL, V22, P599, DOI 10.1128/MCB.22.2.599-613.2002; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; Costa MFS, 2012, EUR J IMMUNOL, V42, P1250, DOI 10.1002/eji.201142021; Cox D, 2010, NAT REV DRUG DISCOV, V9, P804, DOI 10.1038/nrd3266; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Edelblum KL, 2015, GASTROENTEROLOGY, V148, P1417, DOI 10.1053/j.gastro.2015.02.053; Ericsson A, 2004, EUR J IMMUNOL, V34, P2720, DOI 10.1002/eji.200425125; FUJIHASHI K, 1992, J EXP MED, V175, P695, DOI 10.1084/jem.175.3.695; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Guy-Grand D, 2013, J EXP MED, V210, P1839, DOI 10.1084/jem.20122588; Hayday A, 2008, MUCOSAL IMMUNOL, V1, P172, DOI 10.1038/mi.2008.8; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Inagaki-Ohara K, 2004, J IMMUNOL, V173, P1390, DOI 10.4049/jimmunol.173.2.1390; Jameson JM, 2004, FRONT BIOSCI-LANDMRK, V9, P2640, DOI 10.2741/1423; JANEWAY CA, 1988, IMMUNOL TODAY, V9, P73, DOI 10.1016/0167-5699(88)91267-4; Kim SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11634-x; KOMANO H, 1995, P NATL ACAD SCI USA, V92, P6147, DOI 10.1073/pnas.92.13.6147; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Kurd N, 2014, IMMUNITY, V41, P167, DOI 10.1016/j.immuni.2014.08.004; Linger RMA, 2013, ONCOGENE, V32, P3420, DOI 10.1038/onc.2012.355; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Marsal J, 2002, EUR J IMMUNOL, V32, P3488, DOI 10.1002/1521-4141(200212)32:12<3488::AID-IMMU3488>3.0.CO;2-E; Miles A, 2008, AM J PHYSIOL-GASTR L, V294, pG1257, DOI 10.1152/ajpgi.00266.2007; Mudduluru G, 2011, ONCOGENE, V30, P2888, DOI 10.1038/onc.2011.13; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; NEUBAUER A, 1994, BLOOD, V84, P1931; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; Parmo-Cabanas M, 2007, J LEUKOCYTE BIOL, V82, P380, DOI 10.1189/jlb.1206726; Penido C, 2008, INT IMMUNOL, V20, P129, DOI 10.1093/intimm/dxm128; Qin G, 2009, J INFECT DIS, V200, P858, DOI 10.1086/605413; Ribeiro S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00015; Bono MR, 2007, CYTOKINE GROWTH F R, V18, P33, DOI 10.1016/j.cytogfr.2007.01.004; Shankar SL, 2006, J NEUROSCI, V26, P5638, DOI 10.1523/JNEUROSCI.5063-05.2006; Sokol CL, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016303; Su DL, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/985753; Suzuki S, 1998, EUR J IMMUNOL, V28, P3719, DOI 10.1002/(SICI)1521-4141(199811)28:11<3719::AID-IMMU3719>3.3.CO;2-F; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Uehara S, 2002, J IMMUNOL, V168, P2811, DOI 10.4049/jimmunol.168.6.2811; Waldmann TA, 2003, NAT MED, V9, P269, DOI 10.1038/nm0303-269; Wang X, 1997, J MED MICROBIOL, V46, P657, DOI 10.1099/00222615-46-8-657; Wu YL, 2014, INT J BIOL SCI, V10, P119, DOI 10.7150/ijbs.7823; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; Wurbel MA, 2001, BLOOD, V98, P2626, DOI 10.1182/blood.V98.9.2626; Wurbel MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016442; Zeremski M, 2007, J VIRAL HEPATITIS, V14, P675, DOI 10.1111/j.1365-2893.2006.00838.x; Zhang JH, 2005, CELL MOL IMMUNOL, V2, P271; Zhang LY, 2013, J MED VIROL, V85, P149, DOI 10.1002/jmv.23435; Zheng J, 2013, CELL MOL IMMUNOL, V10, P50, DOI 10.1038/cmi.2012.43; Zlotnik A, 2011, NAT REV IMMUNOL, V11, P597, DOI 10.1038/nri3049	54	3	3	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13386	13397		10.1096/fj.201901356R	http://dx.doi.org/10.1096/fj.201901356R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31550172				2022-12-28	WOS:000507466100028
J	Guo, LJ; Bramkamp, M				Guo, Lijun; Bramkamp, Marc			Bacterial dynamin-like protein DynA mediates lipid and content mixing	FASEB JOURNAL			English	Article						Bacillus subtilis; membrane fusion; lipid tethering; hemifusion; phospholipid preference	MITOCHONDRIAL FUSION; MEMBRANE; SNARE; FISSION; MECHANISM; REQUIRES	Many bacterial species contain dynamin-like proteins (DLPs). However, so far the functional mechanisms of bacterial DLPs are poorly understood. DynA in Bacillus subtilis is a 2-headed DLP, mediating nucleotide-independent membrane tethering in vitro and contributing to the innate immunity of bacteria against membrane stress and phage infection. Here, we employed content mixing and lipid mixing assays in reconstituted systems to study if DynA induces membrane full fusion, characterize its subunits in membrane fusion, and further test the possibility that GTP hydrolysis of DynA may act on the fusion-through-hemifusion pathway. Our results based on fluorescence resonance energy transfer indicated that DynA could induce aqueous content mixing even in the absence of GTP. Moreover, DynA-induced membrane fusion in vitro is a thermo-promoted slow process, and it has phospholipid and membrane curvature preferences. The D1 part of DynA is crucial for membrane binding and fusion, whereas D2 subunit plays a role in facilitating membrane fusion. Surprisingly, digestion of DynA mediated an instant rise of content exchange, supporting the assumption that disassembly of DynA is a driving force for fusion-through-hemifusion. DynA is a rare example of a membrane fusion catalyst that lacks a transmembrane domain and hence sets this system apart from well-characterized fusion systems such as the soluble N-ethyl maleimide sensitive factor attachment protein receptor complexes.	[Guo, Lijun; Bramkamp, Marc] Ludwig Maximilians Univ Munchen, Fak Biol, Planegg Martinsried, Germany	University of Munich	Bramkamp, M (corresponding author), LMU Munchen, Fak Biol, Grosshaderner Str 2-4, D-82152 Planegg Martinsried, Germany.	marc.bramkamp@lmu.de		Bramkamp, Marc/0000-0002-7704-3266	China Scholarship Council (CSC); Deutsche Forschungsgemeinschaft (DFG) [INST 86/1452-1, BR2915/4-1]	China Scholarship Council (CSC)(China Scholarship Council); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors acknowledge funding from the China Scholarship Council (CSC; fellowship to L.G.) and the Deutsche Forschungsgemeinschaft (DFG; INST 86/1452-1 and BR2915/4-1 to M.B.). The authors are grateful for the help of Giacomo Giacomelli and Helge Feddersen [Ludwig-Maximilians-Universit at (LMU) Munchen] for fluorescence microscopy and usage of ImageJ, and Dr. Karin Schubert (LMU Munchen) for HPLC. The authors declare no conflicts of interest.	Alavi MV, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-32; Anton F, 2013, MOL CELL, V49, P487, DOI 10.1016/j.molcel.2012.12.003; Antonny B, 2016, EMBO J, V35, P2270, DOI 10.15252/embj.201694613; ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Ban T, 2010, HUM MOL GENET, V19, P2113, DOI 10.1093/hmg/ddq088; Bohuszewicz O, 2016, J STRUCT BIOL, V196, P3, DOI 10.1016/j.jsb.2016.05.010; Bowen ME, 2004, BIOPHYS J, V87, P3569, DOI 10.1529/biophysj.104.048637; Bramkamp M, 2012, BIOL CHEM, V393, P1203, DOI 10.1515/hsz-2012-0185; Burmann F, 2011, MOL MICROBIOL, V79, P1294, DOI 10.1111/j.1365-2958.2011.07523.x; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; Chi RJ, 2014, J CELL BIOL, V204, P793, DOI 10.1083/jcb.201309084; Colangeli R, 2005, MOL MICROBIOL, V55, P1829, DOI 10.1111/j.1365-2958.2005.04510.x; Daste F, 2018, EMBO REP, V19, DOI 10.15252/embr.201643637; Fukuda R, 2000, NATURE, V407, P198, DOI 10.1038/35025084; Gao HB, 2003, P NATL ACAD SCI USA, V100, P4328, DOI 10.1073/pnas.0530206100; Harner M, 2018, J BIOL CHEM, V293, P1346, DOI 10.1074/jbc.RA117.000791; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Jackson MB, 2008, NAT STRUCT MOL BIOL, V15, P684, DOI 10.1038/nsmb.1449; Jilly R, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00206; Koirala S, 2013, P NATL ACAD SCI USA, V110, pE1342, DOI 10.1073/pnas.1300855110; Kweon DH, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00065; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Liu JW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05523-8; Low HH, 2006, NATURE, V444, P766, DOI 10.1038/nature05312; Low HH, 2009, CELL, V139, P1342, DOI 10.1016/j.cell.2009.11.003; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Michie KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107211; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Ngo CC, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12791; OPDENKAMP JA, 1969, J BACTERIOL, V99, P298, DOI 10.1128/JB.99.1.298-303.1969; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Prince A, 2017, SCI REP-UK, V7, DOI 10.1038/srep41346; Risselada HJ, 2014, P NATL ACAD SCI USA, V111, P11043, DOI 10.1073/pnas.1323221111; Sawant P, 2016, ENVIRON MICROBIOL, V18, P2705, DOI 10.1111/1462-2920.13110; Schlimpert S, 2017, P NATL ACAD SCI USA, V114, pE6176, DOI 10.1073/pnas.1704612114; Schrepfer E, 2016, MOL CELL, V61, P683, DOI 10.1016/j.molcel.2016.02.022; Shepard KA, 1999, J CELL BIOL, V144, P711, DOI 10.1083/jcb.144.4.711; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; Song HF, 2017, ELIFE, V6, DOI [10.7554/eLife.21492, 10.7554/elife.21492]; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Toyofuku M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00492-w; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; Verhelst J, 2013, MICROBIOL MOL BIOL R, V77, P551, DOI 10.1128/MMBR.00024-13; Wu Z, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00315; Yu JJQ, 2008, VIROLOGY, V379, P78, DOI 10.1016/j.virol.2008.05.030; Zick M, 2014, ELIFE, V3, DOI 10.7554/eLife.03251; Zucchi PC, 2011, MOL BIOL CELL, V22, P4635, DOI 10.1091/mbc.E11-08-0680	48	7	7	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11746	11757		10.1096/fj.201900844RR	http://dx.doi.org/10.1096/fj.201900844RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31361971	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000507461600014
J	Hasan, M; Kanna, MS; Jun, W; Ramkrishnan, AS; Iqbal, Z; Lee, Y; Li, Y				Hasan, Mahadi; Kanna, Murugappan Suresh; Jun, Wang; Ramkrishnan, Aruna Surendran; Iqbal, Zafar; Lee, Youngjin; Li, Ying			Schema-like learning and memory consolidation acting through myelination	FASEB JOURNAL			English	Article						brain oscillations; anterior cingulate cortex; hippocampus; myelin plasticity; circuitry synchronization	ANTERIOR CINGULATE CORTEX; WHITE-MATTER; DECISION-MAKING; NERVOUS-SYSTEM; PHASE-LOCKING; HIPPOCAMPAL; PLASTICITY; OSCILLATIONS; IMPAIRMENT; ACTIVATION	Memory is a dynamic brain function that is continually processed after encoding. Although psychologic concepts of mental schema are now well established, they have rarely been considered in animal studies. We used a behavior paradigm of multiple flavor-place paired associates (PAs) and showed that memory schema facilitates fast acquisition of new PAs in a single trial. The hippocampus is necessary for the encoding of new PAs and for memory retrieval within a certain time window-24 h following new PA consolidation. Whereas the anterior cingulate cortex (ACC) plays a critical role for dynamic PA learning and consolidation during training sessions, ACC is essential in schema representation and activation. New myelin generation is essential for learning. Neural activity in the cortical regions impacts myelination by regulating oligodendrocyte (OL) proliferation, differentiation, and myelin formation. Here, we show that newly formed OL progenitor cells and mature OLs are increased following repeated PA learning and that establishment of the memory schema is associated with enhanced myelin strength in the ACC region. Furthermore, to ensure that myelination is necessary for the acquisition of paired-associate learning, ACC lysolecithin-induced demyelination revealed impaired PA learning associated with decrease in ACC theta band power and reduced spike-field coherence and phase-locking in ACC.	[Hasan, Mahadi; Kanna, Murugappan Suresh; Jun, Wang; Ramkrishnan, Aruna Surendran; Iqbal, Zafar; Lee, Youngjin; Li, Ying] City Univ Hong Kong, Dept Biomed Sci, Kowloon,Tat Chee Ave, Hong Kong 999077, Peoples R China; [Hasan, Mahadi; Kanna, Murugappan Suresh; Jun, Wang; Ramkrishnan, Aruna Surendran; Iqbal, Zafar; Lee, Youngjin; Li, Ying] City Univ Hong Kong, Ctr Biosyst Neurosci & Nanotechnol, Kowloon, Hong Kong, Peoples R China; [Jun, Wang] Zhejiang Univ, Sch Basic Med Sci, Sch Med, Hangzhou, Peoples R China	City University of Hong Kong; City University of Hong Kong; Zhejiang University	Li, Y (corresponding author), City Univ Hong Kong, Dept Biomed Sci, Kowloon,Tat Chee Ave, Hong Kong 999077, Peoples R China.	yingli@cityu.edu.hk	Iqbal, Zafar/S-9011-2018	LEE, Youngjin/0000-0002-5942-6204; LI, Ying/0000-0003-3683-9695; Ramkrishnan, Aruna Surendran/0000-0002-8335-0510; Murugappan, Suresh Kanna/0000-0003-0734-4634	Research Grants Council (RGC) of Hong Kong [11100914, 11166116, 11101315, 160713]; National Natural Science Foundation of China (NSFC) [N_CityU114/17, 3171101014]; RGC [N_CityU114/17, 3171101014]; Innovation and Technology Support Programme [ITS/300/15]; City University of Hong Kong Neuroscience Research Infrastructure [9610211]; Centre for Biosystems, Neuroscience, and Nanotechnology [9360148]	Research Grants Council (RGC) of Hong Kong(Hong Kong Research Grants Council); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); RGC(Hong Kong Research Grants Council); Innovation and Technology Support Programme; City University of Hong Kong Neuroscience Research Infrastructure(City University of Hong Kong); Centre for Biosystems, Neuroscience, and Nanotechnology	This work was supported by the Research Grants Council (RGC) of Hong Kong (11100914, 11166116, 11101315, and 160713), the National Natural Science Foundation of China (NSFC) and RGC Joint Research Scheme (N_CityU114/17 and 3171101014), the Innovation and Technology Support Programme (ITS/300/15), City University of Hong Kong Neuroscience Research Infrastructure (9610211), and Centre for Biosystems, Neuroscience, and Nanotechnology (9360148). The authors express their gratitude to Dr. Thomas A. Cleland and Dr. David Smith (Department of of Psychology, Cornell University, Ithaca, NY, USA) for their valuable comments during our preliminary data presentation. The authors declare no conflicts of interest.	Barco A, 2008, NEUROSCI BIOBEHAV R, V32, P831, DOI 10.1016/j.neubiorev.2008.01.002; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bethus I, 2010, J NEUROSCI, V30, P1610, DOI 10.1523/JNEUROSCI.2721-09.2010; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cao B, 2016, EXP NEUROL, V286, P21, DOI 10.1016/j.expneurol.2016.09.010; Cao B, 2016, NEUROBIOL LEARN MEM, V136, P74, DOI 10.1016/j.nlm.2016.09.015; Cao B, 2016, SCI REP-UK, V6, DOI 10.1038/srep35135; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fan J, 2009, GASTROENTEROLOGY, V136, P1732, DOI 10.1053/j.gastro.2009.01.069; Fields RD, 2015, NAT REV NEUROSCI, V16, P756, DOI 10.1038/nrn4023; Fields RD, 2013, NATURE, V501, P25, DOI 10.1038/501025a; Fields RD, 2010, SCIENCE, V330, P768, DOI 10.1126/science.1199139; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Ghosh VE, 2014, J NEUROSCI, V34, P12057, DOI 10.1523/JNEUROSCI.0740-14.2014; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; HALL SM, 1972, J CELL SCI, V10, P535; Hill RA, 2018, NAT NEUROSCI, V21, P683, DOI 10.1038/s41593-018-0120-6; Hines JH, 2015, NAT NEUROSCI, V18, P683, DOI 10.1038/nn.3992; Huntenburg JM, 2017, CEREB CORTEX, V27, P981, DOI 10.1093/cercor/bhx030; Knierim JJ, 2015, CURR BIOL, V25, pR1116, DOI 10.1016/j.cub.2015.10.049; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Lu Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10962; Maguire EA, 1999, BRAIN, V122, P1839, DOI 10.1093/brain/122.10.1839; Majd AM, 2018, BEHAV BRAIN RES, V336, P111, DOI 10.1016/j.bbr.2017.08.046; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960; Mensch S, 2015, NAT NEUROSCI, V18, P628, DOI 10.1038/nn.3991; Mitew S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02719-2; Moncada D, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/650780; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; Mu L, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0125-y; Pajevic S, 2014, NEUROSCIENCE, V276, P135, DOI 10.1016/j.neuroscience.2013.11.007; Plemel JR, 2018, GLIA, V66, P327, DOI 10.1002/glia.23245; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; Richards BA, 2014, NAT NEUROSCI, V17, P981, DOI 10.1038/nn.3736; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Sampaio-Baptista C, 2017, NEURON, V96, P1239, DOI 10.1016/j.neuron.2017.11.026; Sampaio-Baptista C, 2013, J NEUROSCI, V33, P19499, DOI 10.1523/JNEUROSCI.3048-13.2013; Sanchez MM, 1998, BRAIN RES, V812, P38, DOI 10.1016/S0006-8993(98)00857-9; Schlegel AA, 2012, J COGNITIVE NEUROSCI, V24, P1664, DOI 10.1162/jocn_a_00240; Schlichting ML, 2015, CURR OPIN BEHAV SCI, V1, P1, DOI 10.1016/j.cobeha.2014.07.005; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Squire LR, 2007, SCIENCE, V316, P57, DOI 10.1126/science.1141812; Takehara-Nishiuchi K, 2008, SCIENCE, V322, P960, DOI 10.1126/science.1161299; Teixeira CM, 2006, J NEUROSCI, V26, P7555, DOI 10.1523/JNEUROSCI.1068-06.2006; Tomlinson L, 2016, NEUROPHARMACOLOGY, V110, P548, DOI 10.1016/j.neuropharm.2015.09.016; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Tse D, 2011, SCIENCE, V333, P891, DOI 10.1126/science.1205274; van Kesteren MTR, 2012, TRENDS NEUROSCI, V35, P211, DOI 10.1016/j.tins.2012.02.001; van Kesteren MTR, 2010, P NATL ACAD SCI USA, V107, P7550, DOI 10.1073/pnas.0914892107; von Nicolai C, 2014, J NEUROSCI, V34, P5938, DOI 10.1523/JNEUROSCI.5007-13.2014; Wang J, 2017, CELL REP, V21, P2407, DOI 10.1016/j.celrep.2017.11.012; Wang J, 2015, CEREB CORTEX, V25, P859, DOI 10.1093/cercor/bht273; Wang SH, 2012, LEARN MEMORY, V19, P315, DOI 10.1101/lm.026336.112; Xiao L, 2016, NAT NEUROSCI, V19, P1210, DOI 10.1038/nn.4351; Yang YJ, 2017, CEREB CORTEX, V27, P2871, DOI 10.1093/cercor/bhw121; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zeithamova D, 2012, NEURON, V75, P168, DOI 10.1016/j.neuron.2012.05.010	63	16	17	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11758	11775		10.1096/fj.201900910R	http://dx.doi.org/10.1096/fj.201900910R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31366238	hybrid, Green Published			2022-12-28	WOS:000507461600015
J	Masmudi-Martin, M; Navarro-Lobato, I; Lopez-Aranda, MF; Delgado, G; Martin-Montanez, E; Quiros-Ortega, ME; Carretero-Rey, M; Narvaez, L; Garcia-Garrido, MF; Posadas, S; Lopez-Tellez, JF; Blanco, E; Jimenez-Recuerda, I; Granados-Duran, P; Paez-Rueda, J; Lopez, JC; Khan, ZU				Masmudi-Martin, Mariam; Navarro-Lobato, Irene; Lopez-Aranda, Manuel F.; Delgado, Gloria; Martin-Montanez, Elisa; Quiros-Ortega, Maria E.; Carretero-Rey, Marta; Narvaez, Lucia; Garcia-Garrido, Maria F.; Posadas, Sinforiano; Lopez-Tellez, Juan F.; Blanco, Eduardo; Jimenez-Recuerda, Inmaculada; Granados-Duran, Pablo; Paez-Rueda, Jose; Lopez, Juan C.; Khan, Zafar U.			RGS14(414) treatment induces memory enhancement and rescues episodic memory deficits	FASEB JOURNAL			English	Article						cognitive dysfunction; BDNF; memory circuit activation; recovery of memory functions; behavioral performance	NEUROTROPHIC FACTOR; SPATIAL MEMORY; RECOGNITION MEMORY; PERIRHINAL CORTEX; D-CYCLOSERINE; GOLOCO MOTIF; AGING BRAIN; BDNF; MECHANISMS; PLASTICITY	Memory deficits affect a large proportion of the human population and are associated with aging and many neurologic, neurodegenerative, and psychiatric diseases. Treatment of this mental disorder has been disappointing because all potential candidates studied thus far have failed to produce consistent effects across various types of memory and have shown limited to no effects on memory deficits. Here, we show that the promotion of neuronal arborization through the expression of the regulator of G-protein signaling 14 of 414 amino acids (RGS14(414)) not only induced robust enhancement of multiple types of memory but was also sufficient for the recovery of recognition, spatial, and temporal memory, which are kinds of episodic memory that are primarily affected in patients or individuals with memory dysfunction. We observed that a surge in neuronal arborization was mediated by up-regulation of brain-derived neurotrophic factor (BDNF) signaling and that the deletion of BDNF abrogated both neuronal arborization activation and memory enhancement. The activation of BDNF-dependent neuronal arborization generated almost 2-fold increases in synapse numbers in dendrites of pyramidal neurons and in neurites of nonpyramidal neurons. This increase in synaptic connections might have evoked reorganization within neuronal circuits and eventually supported an increase in the activity of such circuits. Thus, in addition to showing the potential of RGS14(414) for rescuing memory deficits, our results suggest that a boost in circuit activity could facilitate memory enhancement and the reversal of memory deficits.	[Masmudi-Martin, Mariam; Navarro-Lobato, Irene; Lopez-Aranda, Manuel F.; Delgado, Gloria; Quiros-Ortega, Maria E.; Carretero-Rey, Marta; Narvaez, Lucia; Garcia-Garrido, Maria F.; Posadas, Sinforiano; Lopez-Tellez, Juan F.; Jimenez-Recuerda, Inmaculada; Granados-Duran, Pablo; Paez-Rueda, Jose; Khan, Zafar U.] Univ Malaga, Ctr Invest Med Sanitaria CIMES, Lab Neurobiol, Calle Marqu es Beccaria,3 Campus Teatinos S-N, Malaga 29010, Spain; [Masmudi-Martin, Mariam; Navarro-Lobato, Irene; Lopez-Aranda, Manuel F.; Delgado, Gloria; Quiros-Ortega, Maria E.; Carretero-Rey, Marta; Narvaez, Lucia; Garcia-Garrido, Maria F.; Posadas, Sinforiano; Lopez-Tellez, Juan F.; Jimenez-Recuerda, Inmaculada; Granados-Duran, Pablo; Khan, Zafar U.] Univ Malaga, Dept Med, Malaga, Spain; [Martin-Montanez, Elisa] Univ Malaga, Dept Pharmacol, Fac Med, Campus Teatinos, Malaga, Spain; [Martin-Montanez, Elisa; Khan, Zafar U.] Univ Malaga, Inst Biomed Res Malaga IBIMA, Malaga, Spain; [Blanco, Eduardo] Univ Lleida, Dept Pedag & Psychol, Lleida, Spain; [Lopez, Juan C.] Univ Seville, Fac Psychol, Dept Expt Psychol, Anim Behav & Neurosci Lab, Seville, Spain; [Khan, Zafar U.] Inst Hlth Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Lopez-Aranda, Manuel F.] Univ Calif Los Angeles, Gonda Neurosci & Genet Ctr, Los Angeles, CA USA; [Garcia-Garrido, Maria F.] Univ Exeter, Med Sch, Hatherly Labs, Exeter, Devon, England	Universidad de Malaga; Universidad de Malaga; Universidad de Malaga; Universidad de Malaga; Universitat de Lleida; University of Sevilla; CIBERNED; University of California System; University of California Los Angeles; University of Exeter	Khan, ZU (corresponding author), Univ Malaga, Ctr Invest Med Sanitaria CIMES, Lab Neurobiol, Calle Marqu es Beccaria,3 Campus Teatinos S-N, Malaga 29010, Spain.	zkhan@uma.es	Lopez, Juan C/H-6028-2015; Martín-Montañez, Elisa/H-8999-2017; Calvo, Eduardo Blanco/H-5805-2013; López-Aranda, Manuel F./GNM-7102-2022; Al-Masmudi Martin, Mariam/B-1119-2016; KHAN, Zafaruddin/J-6217-2012	Martín-Montañez, Elisa/0000-0002-3637-3285; Calvo, Eduardo Blanco/0000-0003-0357-1151; López-Aranda, Manuel F./0000-0001-9063-0740; Garcia Garrido, Maria/0000-0002-2656-6382; Lopez-Tellez, Juan Felix/0000-0003-4115-3380; Al-Masmudi Martin, Mariam/0000-0001-5005-9199; KHAN, Zafaruddin/0000-0003-0742-399X; Lopez-Garcia, Juan-Carlos/0000-0001-8106-5006	Ministerio de Economia y Competitividad [BFU2013-43458-R]; Junta de Andalucia [P12-CTS-1694, PI-0542-2013]	Ministerio de Economia y Competitividad(Spanish Government); Junta de Andalucia(Junta de Andalucia)	The authors thank Zafar I. Bashir [Medical Research Council (MRC) Centre for Synaptic Plasticity, University of Bristol, Bristol, United Kingdom] for reading and providing critical feedback during the preparation of the manuscript. This research was supported by grants from the Ministerio de Economia y Competitividad (BFU2013-43458-R) and Junta de Andalucia (P12-CTS-1694 and PI-0542-2013 to Z.U. K.). The authors thank C. Vivar Rios [Laboratory of Neurobiology, Centro de Investigaciones Medico Sanitaria (CIMES), University of Malaga] for help preparing graphs and figures for this manuscript. The authors declare no conflicts of interest.	Andero R, 2014, PROG MOL BIOL TRANSL, V122, P169, DOI 10.1016/B978-0-12-420170-5.00006-4; Bailey CH, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021758; BAXTER MG, 1994, NEUROBIOL AGING, V15, P207, DOI 10.1016/0197-4580(94)90114-7; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Bibb JA, 2010, J NEUROSCI, V30, P14987, DOI 10.1523/JNEUROSCI.4419-10.2010; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Brickman AM., 2009, HDB NEUROSCIENCE AGI, V1, P175, DOI [10.1016/B978-008045046-9.00745-2, DOI 10.1016/B978, DOI 10.1016/B978-008045046-9.00745-2]; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Cacciamani L, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00092; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Daselaar SM, 2003, NEUROBIOL AGING, V24, P1005, DOI 10.1016/S0197-4580(03)00032-0; Dickerson BC, 2010, NEUROPSYCHOPHARMACOL, V35, P86, DOI 10.1038/npp.2009.126; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Escribano L, 2009, BIOCHEM BIOPH RES CO, V379, P406, DOI 10.1016/j.bbrc.2008.12.071; Evans PR, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0353-17.2018; Griffin AL, 2007, J NEUROSCI, V27, P2416, DOI 10.1523/JNEUROSCI.4083-06.2007; Harward SC, 2016, NATURE, V538, P99, DOI 10.1038/nature19766; Hock C, 2000, J NEURAL TRANSM-SUPP, P171; Hof PR, 2004, TRENDS NEUROSCI, V27, P607, DOI 10.1016/j.tins.2004.07.013; Kalisch R, 2009, CEREB CORTEX, V19, P187, DOI 10.1093/cercor/bhn076; Khan ZU, 2014, PROG MOL BIOL TRANSL, V122, P1, DOI 10.1016/B978-0-12-420170-5.00001-5; Khan ZU, 1998, P NATL ACAD SCI USA, V95, P7731, DOI 10.1073/pnas.95.13.7731; KHAN ZU, 1993, J NEUROCHEM, V60, P961, DOI 10.1111/j.1471-4159.1993.tb03243.x; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Kowianski P, 2018, CELL MOL NEUROBIOL, V38, P579, DOI 10.1007/s10571-017-0510-4; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lee SE, 2010, P NATL ACAD SCI USA, V107, P16994, DOI 10.1073/pnas.1005362107; Linssen AMW, 2012, PSYCHOPHARMACOLOGY, V221, P611, DOI 10.1007/s00213-011-2605-9; Lopez-Aranda MF, 2006, EUR J NEUROSCI, V23, P2971, DOI 10.1111/j.1460-9568.2006.04838.x; Lopez-Aranda MF, 2009, SCIENCE, V325, P87, DOI 10.1126/science.1170869; Lynch G, 2006, CURR OPIN PHARMACOL, V6, P82, DOI 10.1016/j.coph.2005.09.005; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Michalski B, 2003, MOL BRAIN RES, V111, P148, DOI 10.1016/S0169-328X(03)00003-2; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Morrison JH, 2012, NAT REV NEUROSCI, V13, P240, DOI 10.1038/nrn3200; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Murray EA, 2001, CURR OPIN NEUROBIOL, V11, P188, DOI 10.1016/S0959-4388(00)00195-1; NarisawaSaito M, 1996, NEUROREPORT, V7, P2925, DOI 10.1097/00001756-199611250-00024; Nolan BC, 2005, BEHAV NEUROSCI, V119, P190, DOI 10.1037/0735-7044.119.1.190; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Pepeu G, 2010, CHEM-BIOL INTERACT, V187, P403, DOI 10.1016/j.cbi.2009.11.018; Robitsek RJ, 2008, J NEUROSCI, V28, P8945, DOI 10.1523/JNEUROSCI.1893-08.2008; Samson RD, 2013, EUR J NEUROSCI, V37, P1903, DOI 10.1111/ejn.12183; Shu FJ, 2010, CELL SIGNAL, V22, P366, DOI 10.1016/j.cellsig.2009.10.005; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Stern SA, 2013, WIRES SYST BIOL MED, V5, P37, DOI 10.1002/wsbm.1196; Traissard N, 2007, NEUROPSYCHOPHARMACOL, V32, P851, DOI 10.1038/sj.npp.1301116; Tronel S, 2003, J NEUROSCI, V23, P5472; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wang L, 2015, J NEUROSCI, V35, P8384, DOI 10.1523/JNEUROSCI.4682-14.2015; Waterhouse EG, 2009, MOL CELL NEUROSCI, V42, P81, DOI 10.1016/j.mcn.2009.06.009; Winters BD, 2008, NEUROSCI BIOBEHAV R, V32, P1055, DOI 10.1016/j.neubiorev.2008.04.004	58	5	6	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11804	11820		10.1096/fj.201900429RR	http://dx.doi.org/10.1096/fj.201900429RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31365833	Bronze			2022-12-28	WOS:000507461600018
J	Watanabe, Y; Nagai, Y; Honda, H; Okamoto, N; Yanagibashi, T; Ogasawara, M; Yamamoto, S; Imamura, R; Takasaki, I; Hara, H; Sasahara, M; Arita, M; Hida, S; Taniguchi, S; Suda, T; Takatsu, K				Watanabe, Yasuharu; Nagai, Yoshinori; Honda, Hiroe; Okamoto, Naoki; Yanagibashi, Tsutomu; Ogasawara, Masaru; Yamamoto, Seiji; Imamura, Ryu; Takasaki, Ichiro; Hara, Hiromitsu; Sasahara, Masakiyo; Arita, Makoto; Hida, Shigeaki; Taniguchi, Shun'ichiro; Suda, Takashi; Takatsu, Kiyoshi			Bidirectional crosstalk between neutrophils and adipocytes promotes adipose tissue inflammation	FASEB JOURNAL			English	Article						IL-1 beta inflammasome; metabolic disorder; fatty acid	NLRP3 INFLAMMASOME; INSULIN-RESISTANCE; CUTTING EDGE; TARGETED DISRUPTION; PATTERN-RECOGNITION; INNATE IMMUNITY; ACTIVATION; RECEPTOR; INTERLEUKIN-1-BETA; MACROPHAGES	Chronic activation of the IL-1 beta system in adipose tissue on metabolic disorders is well demonstrated. However, a mechanism for its expression and activation in the tissue has remained unexplored. Here, we demonstrate that IL-1 beta transcript was enriched in neutrophils of white adipose tissue (WAT) from lean mice. Mechanistically, the interaction of neutrophils with adipocytes induced IL-1 beta expression via NF-kappa B pathway. Lipolysis of adipocytes accumulated neutrophils prior to macrophages in WAT and produced high levels of IL-1 beta via an inflammasome pathway. Leukotriene B-4 (LTB4) production in WAT also contributed to neutrophil accumulation. Furthermore, an LTB4-inflammasome axis contributed to the expression of chemotactic molecules involved in high-fat diet-induced macrophage infiltration into WAT. We have identified previously unappreciated roles for neutrophils in the development of adipose tissue inflammation: robust IL-1 beta production and infiltration of macrophages to initiate chronic inflammation.	[Watanabe, Yasuharu; Nagai, Yoshinori; Honda, Hiroe; Okamoto, Naoki; Yanagibashi, Tsutomu; Takatsu, Kiyoshi] Univ Toyama, Dept Immunobiol & Pharmacol Genet, Grad Sch Med & Pharmaceut Sci, Toyama, Japan; [Yamamoto, Seiji; Sasahara, Masakiyo] Univ Toyama, Dept Pathol, Grad Sch Med & Pharmaceut Sci, Toyama, Japan; [Takasaki, Ichiro] Univ Toyama, Dept Pharmacol, Grad Sch Med & Pharmaceut Sci, Toyama, Japan; [Watanabe, Yasuharu; Honda, Hiroe; Yanagibashi, Tsutomu; Ogasawara, Masaru; Takatsu, Kiyoshi] Toyama Prefectural Inst Pharmaceut Res, 17-1 Nakataikouyama, Toyama 9390363, Japan; [Nagai, Yoshinori] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Tokyo, Japan; [Nagai, Yoshinori] Toyama Prefectural Univ, Dept Pharmaceut Engn, Fac Engn, 5180 Kurokawa, Toyama 9390398, Japan; [Okamoto, Naoki] Teika Pharmaceut Co, Toyama, Japan; [Imamura, Ryu; Suda, Takashi] Kanazawa Univ, Div Immunol & Mol Biol, Canc Res Inst, Kanazawa, Ishikawa, Japan; [Hara, Hiromitsu] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Immunol, Kagoshima, Japan; [Arita, Makoto] Riken Ctr Integrat Med Sci IMS, Lab Metabol, Yokohama, Kanagawa, Japan; [Arita, Makoto] Yokohama Univ, Grad Sch Med Life Sci, Yokohama, Kanagawa, Japan; [Arita, Makoto] Keio Univ, Grad Sch Pharmaceut Sci, Div Physiol Chem & Metab, Tokyo, Japan; [Taniguchi, Shun'ichiro] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Hlth Sci, Nagoya, Aichi, Japan; [Taniguchi, Shun'ichiro] Shinshu Univ, Dept Comprehens Canc Therapy, Sch Med, Matsumoto, Nagano, Japan; [Imamura, Ryu] Kanazawa Univ, Div Tumor Dynam & Regulat, Canc Res Inst, Kanazawa, Ishikawa, Japan	University of Toyama; University of Toyama; University of Toyama; Japan Science & Technology Agency (JST); Toyama Prefectural University; Kanazawa University; Kagoshima University; RIKEN; Yokohama City University; Keio University; Nagoya City University; Shinshu University; Kanazawa University	Takatsu, K (corresponding author), Toyama Prefectural Inst Pharmaceut Res, 17-1 Nakataikouyama, Toyama 9390363, Japan.; Nagai, Y (corresponding author), Toyama Prefectural Univ, Dept Pharmaceut Engn, Fac Engn, 5180 Kurokawa, Toyama 9390398, Japan.	ynagai@pu-toyama.ac.jp; kiyoshi.takatsu@pref.toyama.lg.jp		Arita, Makoto/0000-0001-9902-0463	Japan Society for the Promotion of Science (JSPS Kakenhi) [JP16K19532, JP15K08527]; Presto, Japan Science and Technology Agency (JST); Hokuriku Life Science Cluster, Ministry of Education, Culture, Sports, Science and Technology (MEXT) Regional Innovation Strategy Support Program; Takeda Science Foundation; First Bank of Toyama Scholarship Foundation; Tokyo Biochemical Research Foundation	Japan Society for the Promotion of Science (JSPS Kakenhi)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Presto, Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Hokuriku Life Science Cluster, Ministry of Education, Culture, Sports, Science and Technology (MEXT) Regional Innovation Strategy Support Program; Takeda Science Foundation(Takeda Science Foundation (TSF)); First Bank of Toyama Scholarship Foundation; Tokyo Biochemical Research Foundation	The authors thank all members of the University of Toyama and Toyama Prefectural Institute for Pharmaceutical Research laboratories for helpful discussions. The authors are grateful to Dr. Shizuo Akira (Immunology Frontier Research Center, Osaka University, Osaka, Japan) for providing Tlr<SUP>-/-</SUP>, Myd88<SUP>-/-</SUP>, and Ticam1<SUP>-/-</SUP> mice. The authors also thank Dr. Kensuke Miyake (The University of Tokyo, Tokyo, Japan) and Dr. Hiroko Tsutsui (Hyogo Medical College, Hyogo, Japan) for providing Rp105<SUP>-/-</SUP> mice and Casp1<SUP>-/-</SUP> mice, respectively; Dr. Paul W. Kincade (Oklahoma Medical Research Foundation, Oklahoma City, OK, USA) for critical review of the manuscript; and Michelle Kahmeyer-Gabbe (Edanz Group, Fukoka, Japan; www.edanz.com/ac) for editing a draft of this manuscript. The authors sincerely thank Toyama Prefecture for laboratory support. This work was also supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS Kakenhi Grants JP16K19532 to Y.W. and JP15K08527 to Y.N.), and grants from Presto, Japan Science and Technology Agency (JST; to Y.N.), Hokuriku Life Science Cluster, Ministry of Education, Culture, Sports, Science and Technology (MEXT) Regional Innovation Strategy Support Program (to K.T.), Takeda Science Foundation (to Y.W.), First Bank of Toyama Scholarship Foundation (Y.W.), and the Tokyo Biochemical Research Foundation (to Y.W.). Y.N. and K.T. are joint senior authors. The authors declare no conflicts of interest.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Amaral FA, 2012, ARTHRITIS RHEUM-US, V64, P474, DOI 10.1002/art.33355; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; CHEN XS, 1994, NATURE, V372, P179, DOI 10.1038/372179a0; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Flach RJR, 2013, J BIOL CHEM, V288, P2882, DOI 10.1074/jbc.M112.412346; Flaherty SE, 2019, SCIENCE, V363, P989, DOI 10.1126/science.aaw2586; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Grailer JJ, 2014, J IMMUNOL, V192, P5974, DOI 10.4049/jimmunol.1400368; Guma M, 2009, ARTHRITIS RHEUM-US, V60, P3642, DOI 10.1002/art.24959; Han CY, 2010, DIABETES, V59, P386, DOI 10.2337/db09-0925; Harada H, 2010, J MOL BIOL, V400, P838, DOI 10.1016/j.jmb.2010.05.063; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Honda H, 2014, J LEUKOCYTE BIOL, V96, P1087, DOI 10.1189/jlb.3A0114-005RR; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Huber J, 2008, J CLIN ENDOCR METAB, V93, P3215, DOI 10.1210/jc.2007-2630; Juge-Aubry CE, 2005, CYTOKINE, V29, P270, DOI 10.1016/j.cyto.2004.10.017; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Karmakar M, 2012, J IMMUNOL, V189, P4231, DOI 10.4049/jimmunol.1201447; Kaur H, 2013, METAB SYNDR RELAT D, V11, P128, DOI 10.1089/met.2012.0179; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Li PP, 2015, NAT MED, V21, P239, DOI 10.1038/nm.3800; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Ogata H, 2000, J EXP MED, V192, P23, DOI 10.1084/jem.192.1.23; Oliveira SHP, 2008, INFLAMMATION, V31, P36, DOI 10.1007/s10753-007-9047-x; Osborn O, 2008, CYTOKINE, V44, P141, DOI 10.1016/j.cyto.2008.07.004; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; Sanada Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep38697; Sekimoto R, 2015, P NATL ACAD SCI USA, V112, pE2058, DOI 10.1073/pnas.1409480112; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Spite M, 2011, J IMMUNOL, V187, P1942, DOI 10.4049/jimmunol.1100196; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Tynan GA, 2014, DIABETES, V63, P2037, DOI 10.2337/db13-1476; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Watanabe Y, 2012, DIABETES, V61, P1199, DOI 10.2337/db11-1182; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	49	27	27	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11821	11835		10.1096/fj.201900477RR	http://dx.doi.org/10.1096/fj.201900477RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31355683	Bronze			2022-12-28	WOS:000507461600019
J	Wei, HC; Sundararaman, A; Dickson, E; Rennie-Campbell, L; Cross, E; Heesom, KJ; Mellor, H				Wei, Haoche; Sundararaman, Ananthalakshmy; Dickson, Emily; Rennie-Campbell, Lewis; Cross, Eloise; Heesom, Kate J.; Mellor, Harry			Characterization of the polarized endothelial secretome	FASEB JOURNAL			English	Article						endothelial cell; secretion; extracellular matrix; polarization; intracellular traffic	EXTRACELLULAR VESICLES; CELLS; PROTEIN; MORPHOGENESIS; DYSTROGLYCAN; PHYSIOLOGY; PROTEOMICS; SITES	Endothelial cells (ECs) form an active barrier between the circulation and the body. In addition to controlling transport of molecules between these 2 compartments, the endothelium is a major secretory organ, releasing proteins both into the circulation and into the vascular matrix. Although it is clearly important that proteins are correctly sorted into these 2 spaces, we currently know little of the polarization of this secretion or how it is controlled. Here, we present an optimized system for the analysis of polarized secretion and show that it allows the derivation of deep, robust proteomes from small numbers of primary ECs. We present the first endothelial apically and basolaterally secreted proteomes, demonstrating that ECs polarize the secretion of extracellular vesicle cargoes to the apical surface. Conversely, we find that protein secretion at the basolateral surface is focused on components of the extracellular matrix (ECM). Finally, we examine the role of liprin-alpha 1 in secretion toward the basolateral compartment and identify a subset of ECM components that share this route with fibronectin.	[Wei, Haoche] Sichuan Univ, Coll Life Sci, Ctr Growth Metab & Aging, Minist Educ,Key Lab Bioresource & Ecoenvironm, Chengdu, Peoples R China; [Wei, Haoche; Sundararaman, Ananthalakshmy; Dickson, Emily; Rennie-Campbell, Lewis; Cross, Eloise; Heesom, Kate J.; Mellor, Harry] Univ Bristol, Fac Life Sci, Sch Biochem, Biomed Sci Bldg, Bristol, Avon, England	Sichuan University; University of Bristol	Mellor, H (corresponding author), Univ Bristol, Sch Biochem, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England.	h.mellor@bristol.ac.uk		Cross, Eloise/0000-0002-9982-8056; Sundararaman, Ananthalakshmy/0000-0002-5661-4656	Chinese Scholarship Council [PG/16/62/32295]; British Heart Foundation	Chinese Scholarship Council(China Scholarship Council); British Heart Foundation(British Heart Foundation)	The authors thank Sarah George (University of Bristol, Bristol, United Kingdom) for help and advice with human coronary artery endothelial cells. H.W. was supported by a scholarship from the Chinese Scholarship Council. A.S. was supported by project grant PG/16/62/32295 from the British Heart Foundation. The authors declare no conflicts of interest.	Albers JJ, 2012, BBA-MOL CELL BIOL L, V1821, P345, DOI 10.1016/j.bbalip.2011.06.013; Augustin HG, 2017, SCIENCE, V357, DOI 10.1126/science.aal2379; Bal G, 2013, CELL TRANSPLANT, V22, P1185, DOI 10.3727/096368912X657288; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Burghoff S, 2011, J PROTEOME RES, V10, P1160, DOI 10.1021/pr100937a; Chautard E, 2009, BIOINFORMATICS, V25, P690, DOI 10.1093/bioinformatics/btp025; Chen ZH, 2017, CARDIOVASC RES, V113, P620, DOI 10.1093/cvr/cvx001; Cines DB, 1998, BLOOD, V91, P3527; Cortazar AR, 2017, DATABASE-OXFORD, DOI 10.1093/database/baw171; D'Souza-Schorey C, 2018, ESSAYS BIOCHEM, V62, P125, DOI 10.1042/EBC20170078; da Silva ML, 2016, BLOOD, V128, P277, DOI 10.1182/blood-2015-10-677054; Fung KYY, 2018, TRAFFIC, V19, P5, DOI 10.1111/tra.12533; Galley HF, 2004, BRIT J ANAESTH, V93, P105, DOI 10.1093/bja/aeh163; Galvagni F, 2016, ONCOTARGET, V7, P10090, DOI 10.18632/oncotarget.7136; GHITESCU L, 1986, J CELL BIOL, V102, P1304, DOI 10.1083/jcb.102.4.1304; Glembotski CC, 2012, J BIOL CHEM, V287, P25893, DOI 10.1074/jbc.M112.356345; Hamidi H, 2017, CURR BIOL, V27, pR158, DOI 10.1016/j.cub.2016.12.036; Hawksworth J, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708454; Hromada C, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00275; Kim DK, 2015, BIOINFORMATICS, V31, P933, DOI 10.1093/bioinformatics/btu741; Korf-Klingebiel M, 2015, NAT MED, V21, P140, DOI 10.1038/nm.3778; KOWALCZYK AP, 1990, BLOOD, V75, P2335; Lugano R, 2018, J CLIN INVEST, V128, P3280, DOI 10.1172/JCI97459; Lynch M, 2016, J INTERN MED, V280, P325, DOI 10.1111/joim.12486; Mana G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13546; Martinez-Martinez E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12305-7; McCormack JJ, 2017, J CELL SCI, V130, P3611, DOI 10.1242/jcs.208033; Mohr T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179065; Muniyappa R, 2013, REV ENDOCR METAB DIS, V14, P5, DOI 10.1007/s11154-012-9229-1; Neumueller Josef, 2008, P520, DOI 10.1007/978-3-211-76310-0_31; Noda K, 2010, MOL BIOL CELL, V21, P584, DOI 10.1091/mbc.E09-07-0580; Richards M, 2015, CURR BIOL, V25, P2325, DOI 10.1016/j.cub.2015.07.045; Rodriguez C, 2008, CARDIOVASC RES, V79, P7, DOI 10.1093/cvr/cvn102; Sercu S, 2008, CANCER INVEST, V26, P375, DOI 10.1080/07357900701788148; Thurston G, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006650; Todorova D, 2017, CIRC RES, V120, P1658, DOI 10.1161/CIRCRESAHA.117.309681; Tunica DG, 2009, PROTEOMICS, V9, P4991, DOI 10.1002/pmic.200900065; UNEMORI EN, 1990, J BIOL CHEM, V265, P445; Verma S, 2006, BRAIN BEHAV IMMUN, V20, P449, DOI 10.1016/j.bbi.2005.10.005; WAGNER OF, 1992, J BIOL CHEM, V267, P16066; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911; Zanivan S, 2013, MOL CELL PROTEOMICS, V12, P3599, DOI 10.1074/mcp.M113.031344; ZERWES HG, 1987, J CELL BIOL, V105, P2037, DOI 10.1083/jcb.105.5.2037; Zhang LC, 2017, METHODS MOL BIOL, V1550, P185, DOI 10.1007/978-1-4939-6747-6_14; Zhang XF, 2007, MICROVASC RES, V74, P90, DOI 10.1016/j.mvr.2007.04.007	45	13	13	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12277	12287		10.1096/fj.201900262R	http://dx.doi.org/10.1096/fj.201900262R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31431053	Green Submitted			2022-12-28	WOS:000507461600053
J	Wu, H; Jiang, X; Gao, YX; Liu, WH; Wang, F; Gong, ML; Chen, R; Yu, XQ; Zhang, WJ; Gao, B; Song, CY; Han, DS				Wu, Han; Jiang, Xing; Gao, Yunxiao; Liu, Weihua; Wang, Fei; Gong, Maolei; Chen, Ran; Yu, Xiaoqin; Zhang, Wenjing; Gao, Bo; Song, Chengyi; Han, Daishu			Mumps virus infection disrupts blood-testis barrier through the induction of TNF-alpha in Sertoli cells	FASEB JOURNAL			English	Article						male infertility; transepithelial electrical resistance; Occludin; ZO-1; spermatogenesis	NECROSIS-FACTOR-ALPHA; SYSTEMIC TREATMENT; ORCHITIS; INTERFERON-ALPHA-2B; MICROFILAMENTS; PERMEABILITY; INFERTILITY; RESPONSES; DYNAMICS; OCCLUDIN	Mumps virus (MuV) has high tropism to the testis and may lead to male infertility. Sertoli cells are the major targets of MuV infection. However, the mechanisms by which MuV infection impairs male fertility and Sertoli cell function remain unclear. The present study elucidated the effect of MuV infection on the blood-testis barrier (BTB). The transepithelial electrical resistance of MuV-infected mouse Sertoli cells was monitored, and the expression of major proteins of the BTB was examined. We demonstrated that MuV infection disrupted the BTB by reducing the levels of occludin and zonula occludens 1. Sertoli cells derived from Tlr2(-/-) and Tnfa(-/-) mice were analyzed for mediating MuV-induced impairment. TLR2-mediated TNF-alpha production by Sertoli cells in response to MuV infection impaired BTB integrity. MuV-impaired BTB was not observed in Tlr2(-/-) and Tnfa(-/-) Sertoli cells. Moreover, an inhibitor of TNF-alpha, pomalidomide, prevents the disruption of BTB in response to MuV infection. FITC-labeled biotin tracing assay confirmed that BTB permeability and spermatogenesis were transiently impaired by MuV infection in vivo. These findings suggest that the disruption of the BTB could be one of the mechanisms underlying MuV-impaired male fertility, in which TNF-alpha could play a critical role.	[Wu, Han; Gao, Bo; Song, Chengyi] Yangzhou Univ, Inst Mobilome & Genome, Coll Anim Sci & Technol, 88 Daxue South Rd, Yangzhou 225009, Jiangsu, Peoples R China; [Wu, Han; Jiang, Xing; Liu, Weihua; Wang, Fei; Gong, Maolei; Chen, Ran; Yu, Xiaoqin; Zhang, Wenjing; Han, Daishu] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Beijing, Peoples R China; [Jiang, Xing] Shenzhen Univ, Sch Med, Guangdong Key Lab Genome Stabil & Dis Prevent, Shenzhen, Peoples R China; [Gao, Yunxiao] China Japan Friendship Hosp, Dept Androl, Beijing, Peoples R China	Yangzhou University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Shenzhen University; China-Japan Friendship Hospital	Song, CY (corresponding author), Yangzhou Univ, Inst Mobilome & Genome, Coll Anim Sci & Technol, 88 Daxue South Rd, Yangzhou 225009, Jiangsu, Peoples R China.; Han, DS (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Cell Biol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	cysong@yzu.edu.cn; dshan@ibms.pumc.edu.cn	song, chengyi/AHA-9123-2022; Zhang, Wenjing/G-5932-2012	song, chengyi/0000-0002-0488-4718; Zhang, Wenjing/0000-0001-6931-900X	Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine [2017-IZM-BR-06, 2017-IZM-3-007]; Major State Basic Research Project of China [2016YFA0101001, 2018YFC1003902]; National Natural Science Foundation of China [1701430]; China Postdoctoral Science Foundation [2017M611931]	Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine; Major State Basic Research Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The authors thank Prof. Qihan Li (Institute of Medical Biology, Chinese Academy of Medical Sciences, Kunming, China) for the gift of mumps virus strain. The authors also thank LetPub (Shanghai, China) for its linguistic assistance during the preparation of this manuscript. This work was supported by grants from the Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine (Grants 2017-IZM-B&R-06 and 2017-IZM-3-007), the Major State Basic Research Project of China (Grants 2016YFA0101001 and 2018YFC1003902), the National Natural Science Foundation of China (Grant 1701430), and the China Postdoctoral Science Foundation (Grant 2017M611931). The authors declare no conflicts of interest.	ADAMOPOULOS DA, 1978, BMJ-BRIT MED J, V1, P1177, DOI 10.1136/bmj.1.6121.1177; AIMAN J, 1980, J CLIN ENDOCR METAB, V50, P380, DOI 10.1210/jcem-50-2-380; Brainard J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004475; Coffin KM, 2018, CELL HOST MICROBE, V24, P405, DOI 10.1016/j.chom.2018.08.003; Davis NF, 2010, BJU INT, V105, P1060, DOI 10.1111/j.1464-410X.2009.09148.x; ERPENBACH KHJ, 1991, J UROLOGY, V146, P54, DOI 10.1016/S0022-5347(17)37713-3; Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556; HEW KW, 1993, BIOL REPROD, V49, P840, DOI 10.1095/biolreprod49.4.840; HUME DA, 1984, ANAT REC, V210, P503, DOI 10.1002/ar.1092100311; Hviid A, 2008, LANCET, V371, P932, DOI 10.1016/S0140-6736(08)60419-5; Jacobo P, 2011, AUTOIMMUN REV, V10, P201, DOI 10.1016/j.autrev.2010.09.026; Jalal H, 2004, J MED VIROL, V73, P147, DOI 10.1002/jmv.10544; Jiang Q, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0834-0; Jiang Q, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.560; Ku JH, 1999, BJU INT, V84, P839; Lane TM, 2006, BJU INT, V97, P1, DOI 10.1111/j.1464-410X.2006.05869.x; Le Tortorec A, 2008, HUM REPROD, V23, P2095, DOI 10.1093/humrep/den207; Li MWM, 2006, J ENDOCRINOL, V190, P313, DOI 10.1677/joe.1.06781; Liang Y, 2014, HUM VACC IMMUNOTHER, V10, P1382, DOI 10.4161/hv.28334; Lie PPY, 2011, FASEB J, V25, P1244, DOI 10.1096/fj.10-169995; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lui WY, 2001, ENDOCRINOLOGY, V142, P1865, DOI 10.1210/en.142.5.1865; Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016; Masarani M, 2006, J ROY SOC MED, V99, P573, DOI 10.1258/jrsm.99.11.573; Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509; Meng J, 2005, P NATL ACAD SCI USA, V102, P16696, DOI 10.1073/pnas.0506084102; Mruk DD, 2015, ENDOCR REV, V36, P681, DOI [10.1210/er.2015-1127, 10.1210/er.2014-1101]; Patel LN, 2017, CLIN INFECT DIS, V64, P408, DOI 10.1093/cid/ciw762; Philip J, 2006, BJU INT, V97, P138, DOI 10.1111/j.1464-410X.2006.05902.x; Rubin S, 2015, J PATHOL, V235, P242, DOI 10.1002/path.4445; RUTHER U, 1995, EUR UROL, V27, P174; Salam AP, 2017, EMERG INFECT DIS, V23, P1922, DOI 10.3201/eid2311.171049; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272; Siu MKY, 2003, ENDOCRINOLOGY, V144, P371, DOI 10.1210/en.2002-220786; Tsigos C, 1999, J INTERF CYTOK RES, V19, P1271, DOI 10.1089/107999099312948; Wiebe JP, 2000, J ANDROL, V21, P625; Willocks LJ, 2017, EPIDEMIOL INFECT, V145, P3219, DOI [10.1017/S0950268817002102, 10.1017/s0950268817002102]; Wu H, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00117; Wu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep19507; Xia WL, 2009, DEV BIOL, V327, P48, DOI 10.1016/j.ydbio.2008.11.028; XIONG YT, 1993, ENDOCRINOLOGY, V132, P2438, DOI 10.1210/en.132.6.2438; YULE TD, 1988, J IMMUNOL, V141, P1161; Zeng XK, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.113; Zhao ST, 2014, CELL MOL IMMUNOL, V11, P428, DOI 10.1038/cmi.2014.38	45	26	29	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12528	12540		10.1096/fj.201901089R	http://dx.doi.org/10.1096/fj.201901089R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31450968	Green Published			2022-12-28	WOS:000507461600072
J	Zhu, D; Yan, QJ; Liu, J; Wu, X; Jiang, ZQ				Zhu, Di; Yan, Qiaojuan; Liu, Jun; Wu, Xia; Jiang, Zhengqiang			Can functional oligosaccharides reduce the risk of diabetes mellitus?	FASEB JOURNAL			English	Review						dietary supplementation; antidiabetic activity; risk factors; molecular mechanism	GLUCAGON-LIKE PEPTIDE-1; DIET-INDUCED OBESITY; FATTY LIVER-DISEASE; INSULIN SENSITIVITY; GUT-MICROBIOTA; ALPHA-GLUCOSIDASE; NONDIGESTIBLE OLIGOSACCHARIDES; CHITOSAN OLIGOSACCHARIDES; FRUCTO-OLIGOSACCHARIDES; ATTENUATE HYPERTENSION	Diabetes significantly affects the life quality and length of patients with diabetes, and almost half of the 4 million people who die from diabetes are under the age of 60. Because of the increasing number of patients with diabetes and the side effects of antidiabetic drugs, the search for new dietary supplementation from natural resources, especially functional oligosaccharides, has attracted much attention among scientific researchers. Functional oligosaccharides are potential antidiabetic treatments because of their nondigestible, low-calorie, and probiotic features. The antidiabetic activity of multiple functional oligosaccharides such as fructo-oligosaccharides, galacto-oligosaccharides, and xylo-oligosaccharides has been reviewed in this paper. Molecular mechanisms involved in the antidiabetic activity of oligosaccharides have been systematically discussed from multiple perspectives, including the improvement of pancreas function, a-glucosidase inhibition, the relief of insulin and leptin resistance, anti-inflammatory effects, regulation of gut microbiota and hormones, and the intervention of diabetic risk factors. In addition, the antidiabetic effects of functional oligosaccharides through the complex gut-brain-liver axis are summarized. The concepts addressed in this review have important clinical implications, although more works are needed to confirm the antidiabetic mechanisms of functional oligosaccharides, standardize safe dose levels, and clarify their metabolism in the human body.	[Zhu, Di; Liu, Jun; Jiang, Zhengqiang] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China; [Yan, Qiaojuan; Wu, Xia] China Agr Univ, Coll Engn, Beijing, Peoples R China	China Agricultural University; China Agricultural University	Jiang, ZQ (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Post Box 294, Beijing 100083, Peoples R China.	zhqjiang@cau.edu.cn	LIU, JUN/GYD-5780-2022		National Key Research and Development Program of China [2017YFD0400204]; National Postdoctoral Program for Innovative Talents [BX201700285]	National Key Research and Development Program of China; National Postdoctoral Program for Innovative Talents	This work was supported by the National Key Research and Development Program of China (Grant 2017YFD0400204), and the National Postdoctoral Program for Innovative Talents (BX201700285). The authors declare no conflicts of interest.	Al-Sheraji SH, 2013, J FUNCT FOODS, V5, P1542, DOI 10.1016/j.jff.2013.08.009; Aldworth J, 2017, IDF DIABETES ATLAS, V8th; Aliasgharzadeh A, 2015, ADV PHARM BULL, V5, P507, DOI 10.15171/apb.2015.069; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Asemi Z, 2015, INT J DIABETES DEV C, V35, P90, DOI 10.1007/s13410-013-0187-2; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bai YB, 2018, MAR DRUGS, V16, DOI 10.3390/md16110455; Barra NG, 2012, DIABETES OBES METAB, V14, P190, DOI 10.1111/j.1463-1326.2011.01495.x; Bekkering P, 2013, EXPERT REV CLIN IMMU, V9, P1031, DOI 10.1586/1744666X.2013.848793; Bianchi G., 2016, SCAND J GASTROENTERO, V222, P62; BISCHOFF H, 1994, EUR J CLIN INVEST, V24, P3; Cai LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136741; Canfora EE, 2017, GASTROENTEROLOGY, V153, P87, DOI 10.1053/j.gastro.2017.03.051; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2006, DIABETES, V55, P1484, DOI 10.2337/db05-1360; Canibano-Hernandez A, 2018, INT J PHARMACEUT, V543, P107, DOI 10.1016/j.ijpharm.2018.03.041; Marin-Manzano MC, 2013, J AGR FOOD CHEM, V61, P7560, DOI 10.1021/jf402218z; Cernea S, 2006, NAT CLIN PRACT ENDOC, V2, P89, DOI 10.1038/ncpendmet0082; Chan C, 2016, SCI REP-UK, V6, DOI 10.1038/srep37627; Chappuis E, 2017, MOLECULES, V22, DOI 10.3390/molecules22101725; Chu KY, 2009, CURR PROTEIN PEPT SC, V10, P75, DOI 10.2174/138920309787315176; Cox AJ, 2015, LANCET DIABETES ENDO, V3, P207, DOI 10.1016/S2213-8587(14)70134-2; Cummings JH, 2001, AM J CLIN NUTR, V73, p415S, DOI 10.1093/ajcn/73.2.415s; de Goffau MC, 2013, DIABETES, V62, P1238, DOI 10.2337/db12-0526; de Luis DA, 2011, NUTR HOSP, V26, P827, DOI [10.1590/S0212-16112011000400024, 10.3305/nh.2011.26.4.5143]; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; Dehghan P, 2014, NUTRITION, V30, P418, DOI 10.1016/j.nut.2013.09.005; Delzenne NM, 2015, DIABETOLOGIA, V58, P2206, DOI 10.1007/s00125-015-3712-7; Delzenne NM, 2003, P NUTR SOC, V62, P177, DOI 10.1079/PNS2002225; Derosa G, 2012, ARCH MED SCI, V8, P899, DOI 10.5114/aoms.2012.31621; Dewulf EM, 2013, GUT, V62, P1112, DOI 10.1136/gutjnl-2012-303304; Diamant M, 2011, OBES REV, V12, P272, DOI 10.1111/j.1467-789X.2010.00797.x; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Fang WS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01868-0; Fei BB, 2014, FOOD CHEM, V158, P429, DOI 10.1016/j.foodchem.2014.02.106; Forsythe P, 2012, CURR OPIN GASTROEN, V28, P557, DOI 10.1097/MOG.0b013e3283572ffa; Gobinath D, 2010, BRIT J NUTR, V104, P40, DOI 10.1017/S0007114510000243; Gregg EW, 2016, LANCET DIABETES ENDO, V4, P537, DOI 10.1016/S2213-8587(16)30010-9; Ha BG, 2016, MAR BIOTECHNOL, V18, P475, DOI 10.1007/s10126-016-9709-5; Halmos T, 2017, ORVOSI HETILAP, V158, P2051, DOI 10.1556/650.2017.30936; Hao Cui, 2011, Journal of Ocean University of China, V10, P336, DOI 10.1007/s11802-011-1860-z; Hao JS, 2015, EURASIP J ADV SIG PR, P1, DOI 10.1186/s13634-015-0248-4; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hong SJ, 2017, MAR DRUGS, V15, DOI 10.3390/md15040090; Hoshino-Takao U, 2008, J NUTR SCI VITAMINOL, V54, P181, DOI 10.3177/jnsv.54.181; Hussain M., 2019, EXP CLIN ENDOCRINOL; Hussain M, 2018, CLIN EXP HYPERTENS, V40, P344, DOI 10.1080/10641963.2017.1377218; Ju CX, 2010, BIOL PHARM BULL, V33, P1511, DOI 10.1248/bpb.33.1511; Kang S, 2016, TRENDS CELL BIOL, V26, P341, DOI 10.1016/j.tcb.2016.01.002; Kassaian N, 2018, ACTA DIABETOL, V55, P1019, DOI 10.1007/s00592-018-1175-2; Katiyar D, 2011, EUR J PHARM SCI, V44, P534, DOI 10.1016/j.ejps.2011.09.015; KATO K, 1970, AGR BIOL CHEM TOKYO, V34, P532, DOI 10.1080/00021369.1970.10859645; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Kim HJ, 2014, FOOD FUNCT, V5, P2662, DOI 10.1039/c4fo00469h; Kim JG, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-272; Kirpich IA, 2015, CLIN BIOCHEM, V48, P923, DOI 10.1016/j.clinbiochem.2015.06.023; Kothari D, 2014, J FOOD SCI, V79, pR1491, DOI 10.1111/1750-3841.12536; Kumar SG, 2009, PROTEOMICS, V9, P2149, DOI 10.1002/pmic.200800571; Li Z., 2015, FASEB J S1, V29, P924; Lin WL, 2011, INT J BIOL MACROMOL, V49, P194, DOI 10.1016/j.ijbiomac.2011.04.011; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Liu B, 2007, WORLD J GASTROENTERO, V13, P725, DOI 10.3748/wjg.v13.i5.725; Liu FT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10722-2; Liu TF, 2012, INFLAMMATION, V35, P1676, DOI 10.1007/s10753-012-9484-z; Ma JX, 2016, URBANIZATION AND PUBLIC HEALTH IN CHINA, P69; Mizote A, 2016, J NUTR SCI VITAMINOL, V62, P380, DOI 10.3177/jnsv.62.380; Mohler ML, 2009, MED RES REV, V29, P125, DOI 10.1002/med.20142; Morel FB, 2015, J NUTR, V145, P2052, DOI 10.3945/jn.114.204909; Moriya C, 2013, CLIN EXP HYPERTENS, V35, P607, DOI 10.3109/10641963.2013.776568; Muanprasat C, 2017, PHARMACOL THERAPEUT, V170, P80, DOI 10.1016/j.pharmthera.2016.10.013; Murri M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-46; Muthukumaran P, 2018, CHEM-BIOL INTERACT, V284, P80, DOI 10.1016/j.cbi.2018.02.011; Nakakuki T, 2002, PURE APPL CHEM, V74, P1245, DOI 10.1351/pac200274071245; NATH A, 2018, MEDICINA-LITHUANIA, V54, DOI DOI 10.3390/MEDICINA54060098; Naveed M, 2019, INT J BIOL MACROMOL, V129, P827, DOI 10.1016/j.ijbiomac.2019.01.192; Ni QQ, 2019, ADV DRUG DELIVER REV, V139, P83, DOI 10.1016/j.addr.2018.12.003; Nieuwdorp M, 2014, GASTROENTEROLOGY, V146, P1525, DOI 10.1053/j.gastro.2014.02.008; Nurunnabi M, 2017, J CONTROL RELEASE, V268, P305, DOI 10.1016/j.jconrel.2017.08.035; Ohashi N, 2017, DIABETES, V66, P2351, DOI 10.2337/db16-1427; Ose R, 2018, ANAEROBE, V51, P110, DOI 10.1016/j.anaerobe.2018.04.018; Parnell JA, 2009, AM J CLIN NUTR, V89, P1751, DOI 10.3945/ajcn.2009.27465; Pejnovic NN, 2013, DIABETES, V62, P1932, DOI 10.2337/db12-0222; Rastall RA, 2015, CURR OPIN BIOTECH, V32, P42, DOI 10.1016/j.copbio.2014.11.002; Rios M, 2013, TRENDS NEUROSCI, V36, P83, DOI 10.1016/j.tins.2012.12.009; Roberfroid M, 2000, CRIT REV FOOD SCI, V40, P461, DOI 10.1080/10408690091189239; Rosa JS, 2008, J INVEST MED, V56, P701, DOI 10.2310/JIM.0b013e31816c0fba; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Sang-Pill H., 1998, KOREA J FOOD SCI TEC, V30, P1476; Sangwan V, 2015, J DAIRY RES, V82, P70, DOI 10.1017/S0022029914000582; Santamaria P, 2010, IMMUNITY, V32, P437, DOI 10.1016/j.immuni.2010.04.003; Sarao LK, 2017, CRIT REV FOOD SCI, V57, P344, DOI 10.1080/10408398.2014.887055; Sheng XY, 2011, AM J PHYSIOL-ENDOC M, V300, pE886, DOI 10.1152/ajpendo.00332.2010; Sheu WHH, 2008, J NUTR SCI VITAMINOL, V54, P396, DOI 10.3177/jnsv.54.396; Shinoki A, 2011, BRIT J NUTR, V106, P1190, DOI 10.1017/S000711451100167X; Singh DP, 2017, PHARMACOL RES, V123, P103, DOI 10.1016/j.phrs.2017.06.015; Singh SP, 2017, APPL BIOCHEM BIOTECH, V183, P613, DOI 10.1007/s12010-017-2605-2; Solis-Herrera C, 2000, CLASSIFICATION DIABE; Swennen K, 2006, CRIT REV FOOD SCI, V46, P459, DOI 10.1080/10408390500215746; Tajabadi-Ebrahimi M, 2017, EXP CLIN ENDOCR DIAB, V125, P21, DOI 10.1055/s-0042-105441; Terakado S, 2012, CLIN EXP HYPERTENS, V34, P99, DOI 10.3109/10641963.2011.618196; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Tusi SK, 2011, BIOMATERIALS, V32, P5438, DOI 10.1016/j.biomaterials.2011.04.024; Ueno M, 2012, CLIN EXP HYPERTENS, V34, P305, DOI 10.3109/10641963.2011.577484; van de Wouw M, 2018, J PHYSIOL-LONDON, V596, P4923, DOI 10.1113/JP276431; Vera C, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-016-2159-4; Vulevic J, 2013, J NUTR, V143, P324, DOI 10.3945/jn.112.166132; Wang HS, 2018, FOOD FUNCT, V9, P3916, DOI 10.1039/c8fo00209f; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wijesekara I, 2010, MAR DRUGS, V8, P1080, DOI 10.3390/md8041080; Xiao L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22052-y; Yang JP, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00216; Yeo SK, 2009, INT J MOL SCI, V10, P3517, DOI 10.3390/ijms10083517; Yu SY, 2017, BIOFACTORS, V43, P90, DOI 10.1002/biof.1311; Zeng WW, 2015, CELL, V163, P84, DOI 10.1016/j.cell.2015.08.055; Zhang CM, 2014, BIOORG MED CHEM LETT, V24, P4053, DOI 10.1016/j.bmcl.2014.03.083; Zhang RX, 2014, PHYTOMEDICINE, V21, P607, DOI 10.1016/j.phymed.2013.11.008; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774; Zheng JL, 2018, J AGR FOOD CHEM, V66, P5821, DOI [10.1021/acsjafc.8b00829, 10.1021/acs.jafc.8b00829]	120	20	20	9	65	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11655	11667		10.1096/fj.201802802RRR	http://dx.doi.org/10.1096/fj.201802802RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31415188	Green Published			2022-12-28	WOS:000507461600007
J	Bickes, MS; Pirr, S; Heinemann, AS; Fehlhaber, B; Halle, S; Vollger, L; Willers, M; Richter, M; Bohne, C; Albrecht, M; Langer, M; Pfeifer, S; Jonigk, D; Vieten, G; Ure, B; von Kaisenberg, C; Forster, R; Von Koeckritz-Blickwede, M; Hansen, G; Viemann, D				Bickes, Marie Sophie; Pirr, Sabine; Heinemann, Anna Sophie; Fehlhaber, Beate; Halle, Stephan; Voellger, Lena; Willers, Maike; Richter, Manuela; Boehne, Carolin; Albrecht, Melanie; Langer, Melissa; Pfeifer, Sandra; Jonigk, Danny; Vieten, Gertrud; Ure, Benno; von Kaisenberg, Constantin; Foerster, Reinhold; Von Koeckritz-Blickwede, Maren; Hansen, Gesine; Viemann, Dorothee			Constitutive TNF-alpha signaling in neonates is essential for the development of tissue-resident leukocyte profiles at barrier sites	FASEB JOURNAL			English	Article						newborn infant; endothelium; leukocyte trafficking; neonatal immunity; sepsis	ENDOTHELIAL-CELL ACTIVATION; NECROSIS-FACTOR-ALPHA; ADHESION MOLECULES; DENDRITIC CELL; MACROPHAGE ONTOGENY; GENE-EXPRESSION; CRITICALLY-ILL; SEPTIC SHOCK; SEPSIS; MONOCYTES	Newborn infants have a high disposition to develop systemic inflammatory response syndromes (SIRSs) upon inflammatory or infectious challenges. Moreover, there is a considerable trafficking of hematopoietic cells to tissues already under noninflammatory conditions. These age-specific characteristics suggest a hitherto unappreciated crucial role of the vascular endothelium during the neonatal period. Here, we demonstrate that healthy neonates showed already strong endothelial baseline activation, which was mediated by a constitutively increased production of TNF-alpha. In mice, pharmacological inhibition of TNF-alpha directly after birth prevented subsequent fatal SIRS but completely abrogated the recruitment of leukocytes to sites of infection. Importantly, in healthy neonates, blocking TNF-alpha at birth disrupted the physiologic leukocyte trafficking, which resulted in persistently altered leukocyte profiles at barrier sites. Collectively, these data suggest that constitutive TNF-alpha-mediated sterile endothelial activation in newborn infants contributes to the increased risk of developing SIRS but is needed to ensure the postnatal recruitment of leukocytes to organs and interfaces.-Bickes, M. S., Pirr, S., Heinemann, A. S., Fehlhaber, B., Halle, S., Vollger, L., Willers, M., Richter, M., Bohne, C., Albrecht, M., Langer, M., Pfeifer, S., Jonigk, D., Vieten, G., Ure, B., von Kaisenberg, C., Forster, R., von Kockritz-Blickwede, M., Hansen, G., Viemann, D. Constitutive TNF-alpha signaling in neonates is essential for the development of tissue-resident leukocyte profiles at barrier sites.	[Bickes, Marie Sophie; Pirr, Sabine; Heinemann, Anna Sophie; Fehlhaber, Beate; Voellger, Lena; Willers, Maike; Richter, Manuela; Boehne, Carolin; Albrecht, Melanie; Hansen, Gesine; Viemann, Dorothee] Hannover Med Sch, Dept Pediat Pneumol Allergol & Neonatol, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Pirr, Sabine; Foerster, Reinhold; Hansen, Gesine; Viemann, Dorothee] Hannover Med Sch, Cluster Excellence Resolving Infect Susceptibil R, Hannover, Germany; [Halle, Stephan; Foerster, Reinhold] Hannover Med Sch, Inst Immunol, Hannover, Germany; [Jonigk, Danny] Hannover Med Sch, Dept Pathol, Hannover, Germany; [Vieten, Gertrud; Ure, Benno] Hannover Med Sch, Dept Pediat Surg, Hannover, Germany; [von Kaisenberg, Constantin] Hannover Med Sch, Dept Obstet & Gynecol, Hannover, Germany; [Richter, Manuela] Childrens Hosp Auf der Bult, Hannover, Germany; [Langer, Melissa; Pfeifer, Sandra; Von Koeckritz-Blickwede, Maren] Univ Vet Med Hannover, Res Ctr Emerging Infect & Zoonoses RIZ, Dept Physiol Chem, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; University of Veterinary Medicine Hannover, Foundation	Viemann, D (corresponding author), Hannover Med Sch, Dept Pediat Pneumol Allergol & Neonatol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	viemann.dorothee@mh-hannover.de	von Kaisenberg, Constantin/AAR-2756-2021	Viemann, Dorothee/0000-0002-9009-3559	Appenrodt Foundation; German Research Foundation [VI 538/6-1]; Volkswagen Foundation [Az 90005]; German Research Foundation under Germany's Cluster of Excellence Resolving Infection Susceptibility (RESIST) [EXC 2155-390874280]; MSD Sharp and Dohme (Haar, Germany); Hannover Medical School	Appenrodt Foundation; German Research Foundation(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen); German Research Foundation under Germany's Cluster of Excellence Resolving Infection Susceptibility (RESIST); MSD Sharp and Dohme (Haar, Germany); Hannover Medical School	The authors thank Sabine Schreek, Jennifer Schoning (both from the Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany), and Christiane Ritter (Institute of Immunology, Hannover Medical School, Hannover, Germany) for excellent technical support. The authors thank all parents contributing to this study. The authors also thank the doctors and nurses of the Neonatal Intensive Care Unit of the Hannover Medical School for support and cooperation. This work was supported by grants from the Appenrodt Foundation, the German Research Foundation (VI 538/6-1), and the Volkswagen Foundation (Az 90005) to D.V., the German Research Foundation under Germany's Cluster of Excellence Resolving Infection Susceptibility (RESIST; EXC 2155-390874280; Project ID B1 and B3 to G.H. and D.V.), and from MSD Sharp and Dohme (Haar, Germany) (2014) and a clinical leave stipend of the Hannover Medical School to S.P. The authors declare no conflicts of interest.	Aird WC, 2005, J THROMB HAEMOST, V3, P1392, DOI 10.1111/j.1538-7836.2005.01328.x; Ait-Oufella H, 2010, INTENS CARE MED, V36, P1286, DOI 10.1007/s00134-010-1893-6; Austermann J, 2014, CELL REP, V9, P2112, DOI 10.1016/j.celrep.2014.11.020; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; BAUSS F, 1987, INFECT IMMUN, V55, P1622, DOI 10.1128/IAI.55.7.1622-1625.1987; Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; Boldt J, 1996, INTENS CARE MED, V22, P122, DOI 10.1007/BF01720718; Brook B, 2017, SEMIN IMMUNOPATHOL, V39, P615, DOI 10.1007/s00281-017-0651-z; Cook Donald N, 2007, Proc Am Thorac Soc, V4, P234, DOI 10.1513/pats.200701-026AW; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Doster RS, 2018, J INNATE IMMUN, V10, P3, DOI 10.1159/000480373; Fehlhaber B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42414-4; Fei Y, 2011, J INFECT DIS, V204, P348, DOI 10.1093/infdis/jir266; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; FREUDENBERG MA, 1991, INFECT IMMUN, V59, P2110, DOI 10.1128/IAI.59.6.2110-2115.1991; Galloway JB, 2011, RHEUMATOLOGY, V50, P124, DOI 10.1093/rheumatology/keq242; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Habtezion A, 2016, GASTROENTEROLOGY, V150, P340, DOI 10.1053/j.gastro.2015.10.046; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Heinemann AS, 2017, FASEB J, V31, P1153, DOI 10.1096/fj.201601083R; Hofer S, 2009, CRIT CARE, V13, DOI 10.1186/cc7923; Ikumi N, 2013, HEMODIAL INT, V17, P133, DOI 10.1111/j.1542-4758.2012.00723.x; Jang JC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004579; Kayal S, 1998, AM J RESP CRIT CARE, V157, P776, DOI 10.1164/ajrccm.157.3.9705034; Khakpour S, 2015, INNATE IMMUN-LONDON, V21, P827, DOI 10.1177/1753425915606525; Kjaergaard AG, 2016, APMIS, V124, P846, DOI 10.1111/apm.12585; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Kopf M, 2015, NAT IMMUNOL, V16, P36, DOI 10.1038/ni.3052; Lee CZW, 2018, NAT REV IMMUNOL, V18, P716, DOI 10.1038/s41577-018-0054-y; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lories RJU, 2007, ARTHRITIS RHEUM, V56, P489, DOI 10.1002/art.22372; Marques M, 2010, J CROHNS COLITIS, V4, P110, DOI 10.1016/j.crohns.2009.08.005; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; McGovern N, 2017, NATURE, V546, P662, DOI 10.1038/nature22795; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Nussbaum C, 2013, J LEUKOCYTE BIOL, V93, P175, DOI 10.1189/jlb.0912468; Nussbaum C, 2011, J REPROD IMMUNOL, V90, P74, DOI 10.1016/j.jri.2011.01.022; Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; Schlichting DE, 2011, MICROVASC RES, V81, P216, DOI 10.1016/j.mvr.2010.11.011; Schuetz P, 2011, SHOCK, V36, P104, DOI 10.1097/SHK.0b013e31821e4e04; Seleme MC, 2017, J VIROL, V91, DOI 10.1128/JVI.01983-16; Shapiro NI, 2010, CRIT CARE, V14, DOI 10.1186/cc9290; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; SILVA AT, 1990, J INFECT DIS, V162, P421, DOI 10.1093/infdis/162.2.421; Skibsted S, 2013, SHOCK, V39, P427, DOI 10.1097/SHK.0b013e3182903f0d; Takahashi M, 1996, CARDIOVASC RES, V32, P422, DOI 10.1016/0008-6363(96)00085-5; Tanoue T, 2016, NAT REV IMMUNOL, V16, P295, DOI 10.1038/nri.2016.36; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; Ulas T, 2017, NAT IMMUNOL, V18, P622, DOI 10.1038/ni.3745; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; Vassiliou AG, 2014, CYTOKINE, V69, P240, DOI 10.1016/j.cyto.2014.06.010; Viemann D, 2005, BLOOD, V105, P2955, DOI 10.1182/blood-2004-07-2520; Viemann D, 2004, BLOOD, V103, P3365, DOI 10.1182/blood-2003-09-3296; Viemann D, 2006, J LEUKOCYTE BIOL, V80, P174, DOI 10.1189/jlb.0905530; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Yoo JW, 2015, INFECT DIS-NOR, V47, P393, DOI 10.3109/00365548.2014.1001999; Zhang XM, 2017, NAT REV IMMUNOL, V17, P495, DOI 10.1038/nri.2017.54; Zhao J, 2008, P NATL ACAD SCI USA, V105, P7528, DOI 10.1073/pnas.0800152105; Zonneveld R, 2014, CRIT CARE, V18, DOI 10.1186/cc13733	71	4	4	1	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10633	10647		10.1096/fj.201900796R	http://dx.doi.org/10.1096/fj.201900796R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31262195				2022-12-28	WOS:000489166300006
J	Gommers, LMM; Ederveen, THA; van der Wijst, J; Overmars-Bos, C; Kortman, GAM; Boekhorst, J; Bindels, RJM; de Baaij, JHF; Hoenderop, JGJ				Gommers, Lisanne M. M.; Ederveen, Thomas H. A.; van der Wijst, Jenny; Overmars-Bos, Caro; Kortman, Guus A. M.; Boekhorst, Jos; Bindels, Ren J. M.; de Baaij, Jeroen H. F.; Hoenderop, Joost G. J.			Low gut microbiota diversity and dietary magnesium intake are associated with the development of PPI-induced hypomagnesemia	FASEB JOURNAL			English	Article						omeprazole; organic acids; gut microbiome; magnesium deficiency	PROTON-PUMP INHIBITORS; CHAIN FATTY-ACIDS; MG2+; DISEASE; RATS	Proton pump inhibitors (PPIs) are used by millions of patients for the treatment of stomach acid-reflux diseases. Although PPIs are generally considered safe, about 13% of the users develop hypomagnesemia. Despite rising attention for this issue, the underlying mechanism is still unknown. Here, we examine whether the gut microbiome is involved in the development of PPI-induced hypomagnesemia in wild-type C57BL/6J mice. After 4 wk of treatment under normal or low dietary Mg2+ availability, omeprazole significantly reduced serum Mg2+ levels only in mice on a low-Mg2+ diet without affecting the mRNA expression of colonic or renal Mg2+ transporters. Overall, 16S rRNA gene sequencing revealed a lower gut microbial diversity in omeprazole-treated mice. Omeprazole induced a shift in microbial composition, which was associated with a 3- and 2-fold increase in the abundance of Lactobacillus and Bifidobacterium, respectively. To examine the metabolic consequences of these microbial alterations, the colonic composition of organic acids was evaluated. Low dietary Mg2+ intake, independent of omeprazole treatment, resulted in a 10-fold increase in formate levels. Together, these results imply that both omeprazole treatment and low dietary Mg2+ intake disturb the gut internal milieu and may pose a risk for the malabsorption of Mg2+ in the colon.-Gommers, L. M. M., Ederveen, T. H. A., van der Wijst, J., Overmars-Bos, C., Kortman, G. A. M., Boekhorst, J., Bindels, R. J. M., de Baaij, J. H. F., Hoenderop, J. G. J. Low gut microbiota diversity and dietary magnesium intake are associated with the development of PPI-induced hypomagnesemia.	[Gommers, Lisanne M. M.; van der Wijst, Jenny; Overmars-Bos, Caro; Bindels, Ren J. M.; de Baaij, Jeroen H. F.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Med Ctr Radboudumc, Dept Physiol, RIMLS, Nijmegen, Netherlands; [Ederveen, Thomas H. A.; Boekhorst, Jos] Radboud Univ Nijmegen, Med Ctr Radboudumc, CMBI, RIMLS, Nijmegen, Netherlands; [Ederveen, Thomas H. A.; Kortman, Guus A. M.; Boekhorst, Jos] NIZO Food Res, Ede, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; NIZO Food Research	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Physiol 286, Geert Grootepl 26-28,POB 9101, NL-6500 HB Nijmegen, Netherlands.	joost.hoenderop@radboudumc.nl	Ederveen, Thomas HA/G-6294-2016; van der Wijst, Jenny/T-1620-2019; Kortman, Guus AM/F-9690-2010; de Baaij, Jeroen/P-5704-2015; Bos, Caro/V-2390-2017; Gommers, Lisanne/O-8313-2016	Ederveen, Thomas HA/0000-0003-0068-1275; van der Wijst, Jenny/0000-0002-1547-516X; de Baaij, Jeroen/0000-0003-2372-8486; Bos, Caro/0000-0001-5016-9435; Kortman, Guus/0000-0002-8076-0661; Boekhorst, Jos/0000-0002-4807-7838	Netherlands Organization for Scientific Research [NWO VICI 016.130.668, NWO VENI 016.186.012]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	The authors thank D. Reijnen (Radboud University Medical Center, Nijmegen, The Netherlands), H. Janssen-Wagener (Radboud University Medical Center, Nijmegen, The Netherlands), M. Berkt-van Ginkel (Radboud University Medical Center, Nijmegen, The Netherlands), S. van Boxtel (Radboud University Medical Center, Nijmegen, The Netherlands), and A. Hanssen (Radboud University Medical Center, Nijmegen, The Netherlands) for their excellent technical support with the animal study, and H. Dijkman (Radboud University Medical Center, Nijmegen, The Netherlands) for the technical support and expertise in the histological evaluation. This study was approved by the animal ethics board of Radboud University Nijmegen (RU DEC 2015-0112), and by the Dutch Central Commission for Animal Experiments (CCD; AVD103002016382). This work was supported by grants from the Netherlands Organization for Scientific Research (NWO VICI 016.130.668 to J.G.J.H. and NWO VENI 016.186.012 to J.H.F.D.B.). The authors declare no conflicts of interest.	Alou M.T., 2016, HUM MICROBIOME J, V1, P3, DOI [10.1016/j.humic.2016.09.001, DOI 10.1016/J.HUMIC.2016.09.001]; BIRCH JR, 1971, J CELL SCI, V8, P693; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clooney AG, 2016, ALIMENT PHARM THER, V43, P974, DOI 10.1111/apt.13568; de Baaij JHF, 2016, SCI REP-UK, V6, DOI 10.1038/srep28565; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Florentin Matilda, 2012, World J Nephrol, V1, P151, DOI 10.5527/wjn.v1.i6.151; Groenestege WMT, 2006, J AM SOC NEPHROL, V17, P1035, DOI 10.1681/ASN.2005070700; Heidelbaugh JJ, 2012, THER ADV GASTROENTER, V5, P219, DOI 10.1177/1756283X12437358; Hess MW, 2016, ALIMENT PHARM THER, V43, P1178, DOI 10.1111/apt.13619; Hess MW, 2012, ALIMENT PHARM THER, V36, P405, DOI 10.1111/j.1365-2036.2012.05201.x; Hoorn EJ, 2010, AM J KIDNEY DIS, V56, P112, DOI 10.1053/j.ajkd.2009.11.019; Hughes ER, 2017, CELL HOST MICROBE, V21, P208, DOI 10.1016/j.chom.2017.01.005; Imhann F, 2016, GUT, V65, P740, DOI 10.1136/gutjnl-2015-310376; Jackson MA, 2016, GUT, V65, P749, DOI 10.1136/gutjnl-2015-310861; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Kurstjens S, 2019, FASEB J, V33, P7192, DOI 10.1096/fj.201801778RR; Kurstjens S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38351-3; Lameris ALL, 2013, PFLUG ARCH EUR J PHY, V465, P1613, DOI 10.1007/s00424-013-1306-0; Lameris AL, 2015, AM J PHYSIOL-GASTR L, V308, pG206, DOI 10.1152/ajpgi.00093.2014; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Malfertheiner P, 2017, NAT REV GASTRO HEPAT, V14, P697, DOI 10.1038/nrgastro.2017.117; Morrison DJ, 2016, GUT MICROBES, V7, P189, DOI 10.1080/19490976.2015.1134082; Mosca A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00455; Nakashima A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143656; Naser SA, 2014, WORLD J DIABETES, V5, P527, DOI 10.4239/wjd.v5.i4.527; Naughton V, 2011, APPL PHYSIOL NUTR ME, V36, P161, DOI 10.1139/H10-088; Nehra AK, 2018, MAYO CLIN PROC, V93, P240, DOI 10.1016/j.mayocp.2017.10.022; NRC (National Research Council), 1995, NUTR REQ LAB AN, VFourth Revised, DOI [10.17226/4758, DOI 10.17226/4758]; Pachikian BD, 2010, J NUTR, V140, P509, DOI 10.3945/jn.109.117374; Pham TAN, 2014, CURR OPIN MICROBIOL, V17, P67, DOI 10.1016/j.mib.2013.12.002; Ramakrishna BS, 2013, J GASTROEN HEPATOL, V28, P9, DOI 10.1111/jgh.12294; Scanlan BJ, 2007, MOL CELL BIOCHEM, V306, P59, DOI 10.1007/s11010-007-9554-y; Schmidt TSB, 2018, CELL, V172, P1198, DOI 10.1016/j.cell.2018.02.044; Schnoll-Sussman Felice, 2017, Curr Treat Options Gastroenterol, V15, P1, DOI 10.1007/s11938-017-0115-5; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sundararajan A, 2007, BE J THEOR ECON, V7, DOI 10.1186/1471-2180-7-108; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Thursby E, 2017, BIOCHEM J, V474, P1823, DOI 10.1042/BCJ20160510; Vindigni SM, 2016, THER ADV GASTROENTER, V9, P606, DOI 10.1177/1756283X16644242; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weaver CM, 2011, J AGR FOOD CHEM, V59, P6501, DOI 10.1021/jf2009777; William JH, 2014, NEPHROLOGY, V19, P798, DOI 10.1111/nep.12330	45	24	25	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11235	11246		10.1096/fj.201900839R	http://dx.doi.org/10.1096/fj.201900839R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31299175				2022-12-28	WOS:000489166300054
J	Juanola, O; Ferrusquia-Acosta, J; Garcia-Villalba, R; Zapater, P; Magaz, M; Marin, A; Olivas, P; Baiges, A; Bellot, P; Turon, F; Hernandez-Gea, V; Gonzalez-Navajas, JM; Tomas-Barberan, FA; Garcia-Pagan, JC; Frances, R				Juanola, Oriol; Ferrusquia-Acosta, Jose; Garcia-Villalba, Rocio; Zapater, Pedro; Magaz, Marta; Marin, Alicia; Olivas, Pol; Baiges, Anna; Bellot, Pablo; Turon, Fanny; Hernandez-Gea, Virginia; Gonzalez-Navajas, Jose M.; Tomas-Barberan, Francisco A.; Garcia-Pagan, Juan C.; Frances, Ruben			Circulating levels of butyrate are inversely related to portal hypertension, endotoxemia, and systemic inflammation in patients with cirrhosis	FASEB JOURNAL			English	Article						SCFAs; liver; hemodynamics; cytokines	CHAIN FATTY-ACIDS; HUMAN GUT MICROBIOME; BACTERIAL TRANSLOCATION; LIVER-DISEASE; METABOLISM; HEALTH; NUTRITION; RECEPTOR; ARTICLE; DIET	Short-chain fatty acids (SCFAs) are gut microbiota-derived products that participate in maintaining the gut barrier integrity and host's immune response. We hypothesize that reduced SCFA levels are associated with systemic inflammation, endotoxemia, and more severe hemodynamic alterations in cirrhosis. Patients with cirrhosis referred for a hepatic venous pressure gradient (HVPG) measurement (n = 62) or a transjugular intrahepatic portosystemic shunt placement (n = 12) were included. SCFAs were measured in portal (when available), hepatic, and peripheral blood samples by GC-MS. Serum endotoxins, proinflammatory cytokines, and NO levels were quantified. SCFA levels were significantly higher in portal vs. hepatic and peripheral blood. There were inverse relationships between SCFAs and the severity of disease. SCFAs (mainly butyric acid) inversely correlated with the model for end-stage liver disease score and were further reduced in patients with history of ascites, hepatic encephalopathy, and spontaneous bacterial peritonitis. There was an inverse relationship between butyric acid and HVPG values. SCFAs were directly related with systemic vascular resistance and inversely with cardiac index. Butyric acid inversely correlated with inflammatory markers and serum endotoxin. A global reduction in the blood levels of SCFA in patients with cirrhosis is associated with a more advanced liver disease, suggesting its contribution to disease progression.-Juanola, O., Ferrusquia-Acosta, J., Garcia-Villalba, R., Zapater, P., Magaz, M., Marin, A., Olivas, P., Baiges, A., Bellot, P., Turon, F., Hernandez-Gea, V., Gonzalez-Navajas, J. M., Tomas-Barberan, F. A., Garcia-Pagan, J. C., Frances, R. Circulating levels of butyrate are inversely related to portal hypertension, endotoxemia, and systemic inflammation in patients with cirrhosis.	[Juanola, Oriol; Zapater, Pedro; Frances, Ruben] Univ Miguel Hernandez, Grp Inmunobiol Hepat & Intestinal, Dept Med Clin, Alacant, Spain; [Juanola, Oriol; Zapater, Pedro; Bellot, Pablo; Gonzalez-Navajas, Jose M.; Frances, Ruben] Hosp Gen Univ Alicante, Inst Invest Sanitaria & Biorned Alicante ISABIAL, Alicante, Spain; [Ferrusquia-Acosta, Jose; Magaz, Marta; Olivas, Pol; Baiges, Anna; Turon, Fanny; Hernandez-Gea, Virginia; Garcia-Pagan, Juan C.] Univ Barcelona, Inst Investc Biomed August Pi & Sunyer IDIBAPS, Liver Unit, Hepat Hemodynam Lab,Hosp Clin, Barcelona, Spain; [Ferrusquia-Acosta, Jose; Zapater, Pedro; Magaz, Marta; Olivas, Pol; Baiges, Anna; Bellot, Pablo; Turon, Fanny; Hernandez-Gea, Virginia; Gonzalez-Navajas, Jose M.; Garcia-Pagan, Juan C.; Frances, Ruben] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain; [Garcia-Villalba, Rocio; Marin, Alicia; Tomas-Barberan, Francisco A.] CSIC, CEBAS, Qual Safety & Bioact Plant Foods, Murcia, Spain	Universidad Miguel Hernandez de Elche; General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS)	Frances, R (corresponding author), Univ Miguel Hernandez, Dept Med Clin, Grp Inmunobiol Hepat & Intestinal, CIBERehd, Carretera Alicante Valencia Km 8-7, Alacant 03550, Spain.	rfrances@umh.es	González-Navajas, Jose Manuel/AAB-1575-2019; Zapater, Pedro/H-8450-2019; Francés, Rubén/V-4120-2019; Tomas-Barberan, Francisco/D-6686-2011; Ferrusquia-Acosta, Jose/P-4297-2015	González-Navajas, Jose Manuel/0000-0002-1591-939X; Zapater, Pedro/0000-0001-7927-858X; Francés, Rubén/0000-0001-5105-1201; Tomas-Barberan, Francisco/0000-0002-0790-1739; Garcia Villalba, Rocio/0000-0003-1883-1673; Magaz, Marta/0000-0002-9787-1739; Olivas, Pol/0000-0002-1919-0284; Juanola, Oriol/0000-0001-7432-8808; Ferrusquia-Acosta, Jose/0000-0001-8034-1291; Baiges, Anna/0000-0002-6963-9203; BELLOT, PABLO/0000-0001-8307-1813	Instituto de Salud Carlos III [PI16/0967, PIE15/00027]; Ministry of Education and Science [FEDER "Una manera de hacer Europa"] [SAF-2016-75767-R]; Conselleria de Educacion, Generalitat Valenciana, Valencia, Spain [PROMETEO 2016/001]; Instituto de Salud Carlos III Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministry of Education and Science [FEDER "Una manera de hacer Europa"]; Conselleria de Educacion, Generalitat Valenciana, Valencia, Spain; Instituto de Salud Carlos III Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)	This study was funded by Instituto de Salud Carlos III (Grants PI16/0967 and PIE15/00027)), the Ministry of Education and Science [(SAF-2016-75767-R) FEDER "Una manera de hacer Europa"], and PROMETEO 2016/001 (Conselleria de Educacion, Generalitat Valenciana, Valencia, Spain). The Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd) is funded by the Instituto de Salud Carlos III. Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS) takes part in the Centres de Recerca de Catalunya (CERCA) Programme/Generalitat de Catalunya. J.C.G.-P. and R.F. share senior authorship. The authors declare no conflicts of interest.	Arnoldussen IAC, 2017, INT J OBESITY, V41, P935, DOI 10.1038/ijo.2017.52; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Arroyo V, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.41; Bajaj JS, 2018, HEPATOLOGY, V68, P1549, DOI 10.1002/hep.30037; Bajaj JS, 2014, AM J PHYSIOL-GASTR L, V307, pG951, DOI 10.1152/ajpgi.00268.2014; Bashiardes S, 2016, MOL METAB, V5, P782, DOI 10.1016/j.molmet.2016.06.003; Bosch J, 2000, J HEPATOL, V32, P141, DOI 10.1016/S0168-8278(00)80422-5; Bosch J, 2009, NAT REV GASTRO HEPAT, V6, P573, DOI 10.1038/nrgastro.2009.149; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Chen YF, 2011, HEPATOLOGY, V54, P562, DOI 10.1002/hep.24423; Cheung K, 2012, CLIN GASTROENTEROL H, V10, P117, DOI 10.1016/j.cgh.2011.08.016; Cook SI, 1998, ALIMENT PHARM THER, V12, P499, DOI 10.1046/j.1365-2036.1998.00337.x; Crawford PA, 2009, P NATL ACAD SCI USA, V106, P11276, DOI 10.1073/pnas.0902366106; Davis BC, 2017, SEMIN LIVER DIS, V37, P128, DOI 10.1055/s-0037-1602763; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Fouts DE, 2012, J HEPATOL, V56, P1283, DOI 10.1016/j.jhep.2012.01.019; Gomez-Hurtado I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023037; Gunsar F, 2006, ALIMENT PHARM THER, V24, P563, DOI 10.1111/j.1365-2036.2006.03003.x; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Jenkins DJA, 1998, J AM COLL NUTR, V17, P609, DOI 10.1080/07315724.1998.10718810; Jin M., 2019, LIVER INT; Juanola O, 2018, HEPATOL COMMUN, V2, P1610, DOI 10.1002/hep4.1268; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Kles KA, 2006, GASTROENTEROLOGY, V130, pS100, DOI 10.1053/j.gastro.2005.11.048; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Leonel AJ, 2012, CURR OPIN CLIN NUTR, V15, P474, DOI 10.1097/MCO.0b013e32835665fa; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mehta G, 2014, J HEPATOL, V61, P155, DOI 10.1016/j.jhep.2014.03.014; Munoz L, 2018, HEPATOLOGY; Onori L, 2001, DIGEST DIS SCI, V46, P2084, DOI 10.1023/A:1011982024849; Pluznick JL, 2014, GUT MICROBES, V5, P202, DOI 10.4161/gmic.27492; Puertollano E, 2014, CURR OPIN CLIN NUTR, V17, P139, DOI 10.1097/MCO.0000000000000025; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Ramakrishna BS, 2013, J GASTROEN HEPATOL, V28, P9, DOI 10.1111/jgh.12294; Rockey DC, 2014, HEPATOLOGY, V59, P1073, DOI 10.1002/hep.26611; ROTH RI, 1990, J LAB CLIN MED, V116, P153; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Tilg H, 2016, GUT, V65, P2035, DOI 10.1136/gutjnl-2016-312729; Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5; Vilstrup H, 2014, HEPATOLOGY, V60, P715, DOI 10.1002/hep.27210; WENNMALM A, 1993, CIRC RES, V73, P1121, DOI 10.1161/01.RES.73.6.1121; Wiest R, 2005, HEPATOLOGY, V41, P422, DOI 10.1002/hep.20632; Wiest R, 2014, J HEPATOL, V60, P197, DOI 10.1016/j.jhep.2013.07.044; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Ye JZ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01967; Yoon S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061329; Zhang YJ, 2015, INT J MOL SCI, V16, P7493, DOI 10.3390/ijms16047493; Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369	52	44	48	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11595	11605		10.1096/fj.201901327R	http://dx.doi.org/10.1096/fj.201901327R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31345057	Bronze			2022-12-28	WOS:000489166300081
J	Li, HD; Zhou, X; Li, YJ; Ma, XK; Gonzales, RJ; Qiu, SF; Shi, FD; Liu, Q				Li, Handong; Zhou, Xing; Li, Yujing; Ma, Xiaokuang; Gonzales, Rayna J.; Qiu, Shenfeng; Shi, Fu-Dong; Liu, Qiang			The selective sphingosine 1-phosphate receptor 1 modulator RP101075 improves microvascular circulation after cerebrovascular thrombosis	FASEB JOURNAL			English	Article						immune modulation; inflammation; S1PR; microcirculation; 2-photon imaging	ACUTE ISCHEMIC-STROKE; FINGOLIMOD; FTY720; COMBINATION; ACTIVATION; MODELS; MICE	Sphingosine-1-phosphate receptor (S1PR) modulators provide protection in preclinical and clinical studies for ischemic stroke, but the influences of S1PR modulation on microvascular thrombosis remain poorly understood. This study investigates the impact of a selective S1PR1 modulator RP101075 on microvascular circulation in a mouse model of laser-induced thrombosis. The flow velocity of cortical arterioles in mice was measured in vivo under 2-photon laser scanning microscopy. Thrombosis was induced in cortical arterioles by laser irritation. At 30 min after laser-induced thrombosis, mice were treated with either RP101075 or vehicle. RP101075 did not alter the flow velocity of cortical arterioles under physiologic conditions. Laser-induced thrombosis led to a pronounced reduction of flow velocity in cortical arterioles that persisted for >= 90 min. The reduction of flow velocity in cortical arterioles following thrombosis was significantly attenuated following RP101075 treatment. RP101075 did not significantly affect coagulation time, bleeding time, heart rate, and blood pressure. In addition, RP101075 treatment reduced thrombus volume, which was accompanied by a reduction of leukocyte content in the thrombus. Our findings demonstrate that the selective S1PR1 modulator RP101075 improves microvascular circulation after thrombosis, implying a component of improved microvascular circulation to the benefit of S1PR modulation in cerebral ischemia.-Li, H., Zhou, X., Li, Y., Ma, X., Gonzales, R. J., Qiu, S., Shi, F.-D., Liu, Q. The selective sphingosine 1-phosphate receptor 1 modulator RP101075 improves microvascular circulation after cerebrovascular thrombosis.	[Li, Handong; Li, Yujing; Ma, Xiaokuang; Gonzales, Rayna J.; Qiu, Shenfeng; Liu, Qiang] Univ Arizona, Coll Med, Dept Basic Med Sci, Phoenix, AZ USA; [Zhou, Xing] Tsinghua Univ, Sch Med, Inst Immunol, Dept Basic Med Sci, Beijing, Peoples R China; [Li, Yujing; Shi, Fu-Dong; Liu, Qiang] St Josephs Hosp, Barrow Neurol Inst, 350 West Thomas Rd, Phoenix, AZ 85013 USA	University of Arizona; Tsinghua University; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center	Liu, Q (corresponding author), St Josephs Hosp, Barrow Neurol Inst, 350 West Thomas Rd, Phoenix, AZ 85013 USA.	qiang.liu@dignityhealth.org	li, yu/HGL-9518-2022; Liu, Qiang/HHZ-3181-2022; Li, yujing/GQA-4109-2022; Ma, Xiaokuang/GWC-2936-2022	Ma, Xiaokuang/0000-0001-7900-6779; Gonzales, Rayna/0000-0003-1716-8988	American Heart Association; Arizona Biomedical Research Center; Valley Partner research grant	American Heart Association(American Heart Association); Arizona Biomedical Research Center; Valley Partner research grant	The authors thank Dr. Hai Qi (Tsinghua University) for helpful discussion and Kristofer Wood (Barrow Neurological Institute) for editorial assistance. This study was supported, in part, by an American Heart Association research grant, an Arizona Biomedical Research Center grant, and a Valley Partner research grant. The authors declare no conflicts of interest.	Aktas O, 2010, NAT REV NEUROL, V6, P373, DOI 10.1038/nrneurol.2010.76; Brait VH, 2016, STROKE, V47, P3053, DOI 10.1161/STROKEAHA.116.015371; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; De Meyer SF, 2016, STROKE, V47, P1165, DOI 10.1161/STROKEAHA.115.011238; Fu Y, 2014, P NATL ACAD SCI USA, V111, P18315, DOI 10.1073/pnas.1416166111; Hasegawa Y, 2010, STROKE, V41, P368, DOI 10.1161/STROKEAHA.109.568899; Jin WN, 2016, J CEREBR BLOOD F MET, V36, P1464, DOI 10.1177/0271678X15611137; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Kono M, 2014, J CLIN INVEST, V124, P2076, DOI 10.1172/JCI71194; Kraft P, 2013, STROKE, V44, P3202, DOI 10.1161/STROKEAHA.113.002880; Lou NH, 2016, P NATL ACAD SCI USA, V113, P1074, DOI 10.1073/pnas.1520398113; Nishimura N, 2006, NAT METHODS, V3, P99, DOI 10.1038/NMETH844; Sandborn WJ, 2016, NEW ENGL J MED, V374, P1754, DOI 10.1056/NEJMoa1513248; Scott F. L., 2013, METABOLITES RPC1063, P05; Sun N, 2016, STROKE, V47, P1899, DOI 10.1161/STROKEAHA.115.012236; Timony G. A., 2014, PHARMACOKINETICS PHA, P1; Wei Y, 2011, ANN NEUROL, V69, P119, DOI 10.1002/ana.22186; Zhang JH, 2012, NAT REV NEUROL, V8, P711, DOI 10.1038/nrneurol.2012.210; Zhang L, 2012, TRENDS PHARMACOL SCI, V33, P415, DOI 10.1016/j.tips.2012.04.006; Zhu ZL, 2015, CIRCULATION, V132, P1104, DOI 10.1161/CIRCULATIONAHA.115.016371	20	6	6	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10935	10941		10.1096/fj.201900282R	http://dx.doi.org/10.1096/fj.201900282R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31284754				2022-12-28	WOS:000489166300029
J	Ghosh, A; Dai, Y; Biswas, P; Stuehr, DJ				Ghosh, Arnab; Dai, Yue; Biswas, Pranjal; Stuehr, Dennis J.			Myoglobin maturation is driven by the hsp90 chaperone machinery and by soluble guanylyl cyclase	FASEB JOURNAL			English	Article						hemeprotein; myoblasts; myotubes	SHOCK-PROTEIN 90; MOLECULAR CHAPERONE; NITRIC-OXIDE; ATPASE ACTIVITY; HEME; EXPRESSION; ACTIVATION; OXYGEN; O-2; INHIBITION	Myoglobin (Mb) maturation involves heme incorporation as a final step. We investigated a role for heat shock protein (hsp) 90 in Mb maturation in C2C12 skeletal muscle myoblasts and cell lines. We found the following: 1) Hsp90 directly interacts preferentially with heme-free Mb both in purified form and in cells. 2) Hsp90 drives heme insertion into apoprotein-Mb in an ATP-dependent process. 3) During differentiation of C2C12 myoblasts into myotubes, the apo-Mb-hsp90 complex associates with 5 cell cochaperons, Hsp70, activator of hsp90 ATPase protein 1 (Aha1), alanyl-tRNA synthetase domain containing 1 (Aarsd1), cell division cycle 37 (Cdc37), and stress induced phosphoprotein 1 (STIP1) in a pattern that is consistent with their enabling Mb maturation. 4) Mb heme insertion was significantly increased in cells that had a functional soluble guanylyl cyclase (sGC)-cGMP signaling pathway and was diminished upon small interfering RNA knockdown of sGC beta 1 or upon overexpression of a phosphodiesterase to prevent cGMP buildup. Together, our findings suggest that hsp90 works in concert with cochaperons (Hsp70, Aha1, Aarsd1, STIP1, and Cdc37) and an active sGC-cGMP signaling pathway to promote heme insertion into immature apo-Mb, and thus generate functional Mb during muscle myotube formation. This fills gaps in our understanding and suggests new ways to potentially control these processes.-Ghosh, A., Dai, Y., Biswas, P., Stuehr, D. J. Myoglobin maturation is driven by the hsp90 chaperone machinery and by soluble guanylyl cyclase.	[Ghosh, Arnab; Dai, Yue; Biswas, Pranjal; Stuehr, Dennis J.] Cleveland Clin, Dept Inflammat & Immun, Lerner Res Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Ghosh, A; Stuehr, DJ (corresponding author), Cleveland Clin, Dept Inflammat & Immun NC22, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	ghosha3@ccf.org; stuehrd@ccf.org	Dai, Yue/AAD-9906-2019; Biswas, Pranjal/AGG-8515-2022	Dai, Yue/0000-0001-9368-7769; Biswas, Pranjal/0000-0003-4173-4214; GHOSH, ARNAB/0000-0002-7498-1994	U.S. National Institutes of Health (NIH) National Heart, Lung and Blood Institute [HL081064, HL0103453]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081064, P01HL103453] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung and Blood Institute Grants HL081064 (to D.J.S. and A.G.) and HL0103453 (to D.J.S.). The authors declare no conflicts of interest.	AKABOSHI E, 1985, GENE, V33, P241; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; CARVER TE, 1992, J BIOL CHEM, V267, P14443; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Cokic VP, 2003, J CLIN INVEST, V111, P231, DOI 10.1172/JCI200316672; COLLMAN JP, 1976, P NATL ACAD SCI USA, V73, P3333, DOI 10.1073/pnas.73.10.3333; Culbertson DS, 2010, BIOCHEMISTRY-US, V49, P6052, DOI 10.1021/bi1006942; Dantsker D, 2005, J BIOL CHEM, V280, P38740, DOI 10.1074/jbc.M506333200; Echeverria PC, 2016, MOL CELL BIOL, V36, P1310, DOI 10.1128/MCB.01099-15; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; Flonta SE, 2009, AM J PATHOL, V175, P201, DOI 10.2353/ajpath.2009.081124; Ghosh A, 2018, P NATL ACAD SCI USA, V115, pE1117, DOI 10.1073/pnas.1717993115; Ghosh A, 2014, J BIOL CHEM, V289, P15259, DOI 10.1074/jbc.M114.559393; Ghosh A, 2012, P NATL ACAD SCI USA, V109, P12998, DOI 10.1073/pnas.1205854109; Ghosh A, 2011, FASEB J, V25, P2049, DOI 10.1096/fj.10-180554; Godecke A, 1999, P NATL ACAD SCI USA, V96, P10495, DOI 10.1073/pnas.96.18.10495; GRABER SG, 1986, J BIOL CHEM, V261, P9150; Gros G, 2010, J EXP BIOL, V213, P2713, DOI 10.1242/jeb.043075; HUBBARD SR, 1990, J MOL BIOL, V213, P215, DOI 10.1016/S0022-2836(05)80181-0; Kanatous SB, 2002, J EXP BIOL, V205, P3601; Kanatous SB, 2010, J EXP BIOL, V213, P2741, DOI 10.1242/jeb.041442; Karagoz GE, 2015, TRENDS BIOCHEM SCI, V40, P117, DOI 10.1016/j.tibs.2014.12.002; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Lele Z, 1999, DEV BIOL, V210, P56, DOI 10.1006/dbio.1999.9262; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Liu L, 2008, J BIOL CHEM, V283, P13185, DOI 10.1074/jbc.M800757200; Luengo TM, 2019, TRENDS CELL BIOL, V29, P164, DOI 10.1016/j.tcb.2018.10.004; Makhnevych T, 2012, BBA-MOL CELL RES, V1823, P674, DOI 10.1016/j.bbamcr.2011.09.001; Mukai K, 2011, PROTEIN PEPTIDE LETT, V18, P1251, DOI 10.2174/092986611797642733; Ordway GA, 2004, J EXP BIOL, V207, P3441, DOI 10.1242/jeb.01172; PACKER BS, 1969, AM J PHYSIOL, V217, P903, DOI 10.1152/ajplegacy.1969.217.3.903; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Panneton WM, 2013, PHYSIOLOGY, V28, P284, DOI 10.1152/physiol.00020.2013; Prodromou C, 2012, BBA-MOL CELL RES, V1823, P614, DOI 10.1016/j.bbamcr.2011.07.020; Radli M, 2018, J MOL BIOL, V430, P3029, DOI 10.1016/j.jmb.2018.05.026; Rayner BS, 2009, BIOCHEM J, V423, P169, DOI 10.1042/BJ20090716; Sahasrabudhe P, 2017, MOL CELL, V67, P947, DOI 10.1016/j.molcel.2017.08.004; Samuel PP, 2015, J BIOL CHEM, V290, P23479, DOI 10.1074/jbc.M115.672204; Sarkar A, 2015, J BIOL CHEM, V290, P21615, DOI 10.1074/jbc.M115.645515; Sass JB, 1999, INT J DEV BIOL, V43, P835; Schopf FH, 2017, NAT REV MOL CELL BIO, V18, P345, DOI 10.1038/nrm.2017.20; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; SPRINGER BA, 1987, P NATL ACAD SCI USA, V84, P8961, DOI 10.1073/pnas.84.24.8961; Taniuchi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32886; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; Tsuji N, 2014, FEBS OPEN BIO, V4, P796, DOI 10.1016/j.fob.2014.09.003; Wagatsuma A, 2011, MOL CELL BIOCHEM, V358, P265, DOI 10.1007/s11010-011-0977-0; Waheed SM, 2010, FREE RADICAL BIO MED, V48, P1548, DOI 10.1016/j.freeradbiomed.2010.02.038; WITTENBERG BA, 1989, ANNU REV PHYSIOL, V51, P857, DOI 10.1146/annurev.physiol.51.1.857; Wittenberg JB, 2003, J EXP BIOL, V206, P2011, DOI 10.1242/jeb.00243; Wright TJ, 2015, J EXP BIOL, V218, P2180, DOI 10.1242/jeb.119321; WYMAN J, 1966, J BIOL CHEM, V241, P115; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; YUEN PST, 1994, J BIOL CHEM, V269, P791; Yun BG, 2005, EXP CELL RES, V307, P212, DOI 10.1016/j.yexcr.2005.03.003; Zhou ZM, 2004, J BIOL CHEM, V279, P24935, DOI 10.1074/jbc.M402105200; Zuehlke A, 2010, BIOPOLYMERS, V93, P211, DOI 10.1002/bip.21292	60	12	12	3	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9885	9896		10.1096/fj.201802793RR	http://dx.doi.org/10.1096/fj.201802793RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31170354	Green Published, Bronze			2022-12-28	WOS:000482214200016
J	Luo, C; Wu, MQ; Su, XF; Yu, FY; Brautigan, DL; Chen, JH; Zhou, J				Luo, Chong; Wu, Maoqing; Su, Xuefeng; Yu, Fangyan; Brautigan, David L.; Chen, Jianghua; Zhou, Jing			Protein phosphatase 1 alpha interacts with a novel ciliary targeting sequence of polycystin-1 and regulates polycystin-1 trafficking	FASEB JOURNAL			English	Article						PP1; primary cilium; CTS	PRIMARY CILIUM; KIDNEY-DISEASE; CATALYTIC SUBUNIT; STRUCTURAL BASIS; CELL-CYCLE; PHOSPHORYLATION; IDENTIFICATION; LOCALIZATION; CALCIUM; COMPLEX	Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic disorder causing renal failure. Mutations of polycystic kidney disease 1 (PKD1) account for most ADPKD cases. Defective ciliary localization of polycystin-1 (PC1), a large integral membrane protein encoded by PKD1, underlies the pathogenesis of a subgroup of patients with ADPKD. However, the mechanisms by which PC1 and other ciliary proteins traffic to the primary cilium remain poorly understood. A ciliary targeting sequence (CTS) that resides in ciliary receptors is considered to function in the process. It has been reported that the VxP motif in the intracellular C-terminal tail of PC1 functions as a CTS in an ADP ribosylation factor 4 (Arf4)/ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1)-dependent manner. However, other recent studies have revealed that this motif is dispensable for PC1 trafficking to cilia. In this study, we identified a novel CTS consisting of 8 residues (RHKVRFEG) in the PC1 C tail. We found that this motif is sufficient to bind protein phosphatase 1 (PP1)alpha, a ubiquitously expressed phosphatase in the phosphoprotein phosphatase (PPP) family. Mutations in this CTS motif disrupt binding with PP1 alpha and impair ciliary localization of PC1. Additionally, short hairpin RNA-mediated knockdown of PP1 alpha results in reduced ciliary localization of PC1 and elongated cilia, suggesting a role for PP1 alpha in the regulation of ciliary structure and function.-Luo, C., Wu, M., Su, X., Yu, F., Brautigan, D. L., Chen, J., Zhou, J. Protein phosphatase 1 alpha interacts with a novel ciliary targeting sequence of polycystin-1 and regulates polycystin-1 trafficking.	[Luo, Chong; Chen, Jianghua] Zhejiang Univ, Natl Key Clin Dept Kidney Dis, Affiliated Hosp 1, Coll Med,Kidney Dis Ctr,Inst Nephrol, Hangzhou, Zhejiang, Peoples R China; [Luo, Chong; Wu, Maoqing; Su, Xuefeng; Yu, Fangyan; Zhou, Jing] Harvard Med Sch, Brigham & Womens Hosp, Harvard Ctr Polycyst Kidney Dis Res, Renal Div,Dept Med, Boston, MA 02115 USA; [Brautigan, David L.] Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Ctr Cell Signaling, Charlottesville, VA 22908 USA	Zhejiang University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Virginia	Chen, JH (corresponding author), Zhejiang Univ, Kidney Dis Ctr, Affiliated Hosp 1, Coll Med, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.; Chen, JH (corresponding author), Zhejiang Univ, Natl Key Clin Dept Kidney Dis, Inst Nephrol, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.; Zhou, J (corresponding author), Brigham & Womens Hosp, Harvard Ctr Polycyst Kidney Dis Res, 77 Ave Louis Pasteur, Boston, MA 02115 USA.; Zhou, J (corresponding author), Brigham & Womens Hosp, Renal Div, Dept Med, 77 Ave Louis Pasteur, Boston, MA 02115 USA.; Zhou, J (corresponding author), Harvard Med Sch, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	zjukidney@zju.edu.cn; jzhou@bwh.harvard.edu			U.S. National Institutes of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases [RO1DK099532, R37DK51050]; National Natural Science Foundation of China [81470938, 81770687, 81770752, 81770750]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099532] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank the members of the Zhou laboratory and Harvard Center for Polycystic Kidney Disease Research for scientific discussions and support. This work was supported by grants from the U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (RO1DK099532 and R37DK51050 to J.Z.) and by grants from National Natural Science Foundation of China (81470938, 81770687, 81770752, 81770750). The authors declare no conflicts of interest.	Badgandi HB, 2017, J CELL BIOL, V216, P743, DOI 10.1083/jcb.201607095; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Bonnet CS, 2009, HUM MOL GENET, V18, P2166, DOI 10.1093/hmg/ddp149; Boucher CA, 2011, BBA-MOL BASIS DIS, V1812, P1225, DOI 10.1016/j.bbadis.2010.11.006; Braun D, 2016, JACC-CARDIOVASC INTE, V9, pe153; Cai YQ, 2014, J CLIN INVEST, V124, P5129, DOI 10.1172/JCI67273; Chauvet V, 2004, J CLIN INVEST, V114, P1433, DOI 10.1172/JCI200421753; Chebib FT, 2015, NAT REV NEPHROL, V11, P451, DOI 10.1038/nrneph.2015.39; Chernova MN, 2005, KIDNEY INT, V68, P632, DOI 10.1111/j.1523-1755.2005.00441.x; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Colbran RJ, 1997, J NEUROCHEM, V69, P920; Delmas P, 2002, J BIOL CHEM, V277, P11276, DOI 10.1074/jbc.M110483200; Deretic D, 1998, P NATL ACAD SCI USA, V95, P10620, DOI 10.1073/pnas.95.18.10620; DiBella LM, 2009, HUM MOL GENET, V18, P595, DOI 10.1093/hmg/ddn384; Doerr N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161525; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Gainullin VG, 2015, J CLIN INVEST, V125, P607, DOI 10.1172/JCI76972; Geng L, 2006, J CELL SCI, V119, P1383, DOI 10.1242/jcs.02818; Geng L, 2000, BBA-MOL BASIS DIS, V1535, P21, DOI 10.1016/S0925-4439(00)00079-X; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Hartman TR, 2009, HUM MOL GENET, V18, P151, DOI 10.1093/hmg/ddn325; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; Hsiao Yi-Chun, 2012, Cilia, V1, P4, DOI 10.1186/2046-2530-1-4; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Ishikawa H, 2012, CURR BIOL, V22, P414, DOI 10.1016/j.cub.2012.01.031; Kim H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6482; Lesage B, 2011, CURR BIOL, V21, pR898, DOI 10.1016/j.cub.2011.08.063; Li HP, 1999, BIOCHEM BIOPH RES CO, V259, P356, DOI 10.1006/bbrc.1999.0780; Liu PW, 2018, P NATL ACAD SCI USA, V115, pE934, DOI 10.1073/pnas.1713226115; Loktev AV, 2013, CELL REP, V5, P1316, DOI 10.1016/j.celrep.2013.11.011; MacMillan LB, 1999, J BIOL CHEM, V274, P35845, DOI 10.1074/jbc.274.50.35845; Malicki JJ, 2017, TRENDS CELL BIOL, V27, P126, DOI 10.1016/j.tcb.2016.08.002; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Moorhead Greg B. G., 2008, BMC Biochemistry, V9, P28, DOI 10.1186/1471-2091-9-28; Mukhopadhyay S, 2017, MOL BIOL CELL, V28, P233, DOI 10.1091/mbc.E16-07-0505; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2008, CIRCULATION, V117, P1161, DOI 10.1161/CIRCULATIONAHA.107.710111; Parnell SC, 1998, BIOCHEM BIOPH RES CO, V251, P625, DOI 10.1006/bbrc.1998.9514; Parnell SC, 1999, BIOCHEM BIOPH RES CO, V259, P539, DOI 10.1006/bbrc.1999.0810; Parnell SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036798; Pearring JN, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006740; Peters C, 1999, SCIENCE, V285, P1084, DOI 10.1126/science.285.5430.1084; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Phua SC, 2017, CELL, V168, P264, DOI 10.1016/j.cell.2016.12.032; Rebelo S, 2015, CELL SIGNAL, V27, P2589, DOI 10.1016/j.cellsig.2015.08.007; Roitbak T, 2004, MOL BIOL CELL, V15, P1334, DOI 10.1091/mbc.E03-05-0296; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Streets AJ, 2006, HUM MOL GENET, V15, P1465, DOI 10.1093/hmg/ddl070; Streets AJ, 2013, HUM MOL GENET, V22, P1924, DOI 10.1093/hmg/ddt031; Su XF, 2015, J CELL SCI, V128, P4063, DOI 10.1242/jcs.160556; Su XF, 2014, HUM MOL GENET, V23, P5441, DOI 10.1093/hmg/ddu267; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Wang SX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095630; Ward HH, 2011, MOL BIOL CELL, V22, P3289, DOI 10.1091/mbc.E11-01-0082; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Xu C, 2007, AM J PHYSIOL-RENAL, V292, pF930, DOI 10.1152/ajprenal.00285.2006; Xu YX, 2016, J AM SOC NEPHROL, V27, P1159, DOI 10.1681/ASN.2014111074; Zhou J, 2009, ANNU REV PHYSIOL, V71, P83, DOI 10.1146/annurev.physiol.70.113006.100621	63	8	8	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9945	9958		10.1096/fj.201900338R	http://dx.doi.org/10.1096/fj.201900338R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31157564	Green Published, Bronze			2022-12-28	WOS:000482214200020
J	Zhang, L; Shi, MX; Ji, JF; Hu, XS; Chen, F				Zhang, Lu; Shi, Mengxuan; Ji, Junfu; Hu, Xiaosong; Chen, Fang			Gut microbiota determines the prevention effects of Luffa cylindrica (L.) Roem supplementation against obesity and associated metabolic disorders induced by high-fat diet	FASEB JOURNAL			English	Article						LC; blautia; SCFA; lipid synthesis; antibiotic treatment	INSULIN-RESISTANCE; BILE-ACID; INFLAMMATION; DYSFUNCTION; MODULATION	The gut microbiota, identified as the target for vegetables, can affect the development of obesity and associated metabolic syndromes. As a medicinal and edible plant, Luffa cylindrica (L.) Roem (LC) has abundant nutrients that can effectively reduce obesity risk. However, the interaction between the prevention effects of LC against obesity and the modulating gut microbiota of LC remain obscure. This study demonstrated LC supplementation improved high-fat diet (HFD)-induced gut microbiota dysbiosis and significantly enhanced short-chain fatty acid (SCFA)-producing bacteria (e.g., Blautia) along with SCFA content accumulation in the gut. Meanwhile, LC supplementation substantially restored gut barrier damage in long-term HFD treatment. Moreover, LC supplementation improved HFD-induced overweight, hyperlipidemia, insulin resistance, and chronic inflammation. Gene expression profiles showed that LC displayed an important impact on hepatic lipid transport and lipid synthesis (sterol regulatory element binding transcriptional factor 1c-peroxisome proliferator-activated receptor gamma signaling pathway). More importantly, an antibiotic treatment experiment demonstrated that the beneficial effects of LC in reducing obesity risk largely depended on the gut microbiota, especially SCFA-producing bacteria (e.g., Blautia). Therefore, LC supplementation improved gut microbiota dysbiosis via enhancing SCFA-producing bacteria (e.g., Blautia), maintained gut barrier integrity, and alleviated the development of obesity. Overall, LC would provide a potential dietary intervention strategy against obesity and enteral homeostasis dysbiosis through modulating the gut microbiota.-Zhang, L., Shi, M., Ji, J., Hu, X., Chen, F. Gut microbiota determines the prevention effects of Luffa cylindrica (L.) Roem supplementation against obesity and associated metabolic disorders induced by high-fat diet.	[Zhang, Lu] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China; [Zhang, Lu; Shi, Mengxuan; Ji, Junfu; Hu, Xiaosong; Chen, Fang] China Agr Univ, Coll Food Sci & Nutr Engn, Natl Engn Res Ctr Fruit & Vegetable Proc,Minist E, Key Lab Fruit & Vegetables Proc,Minist Agr,Engn R, Beijing, Peoples R China	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs	Chen, F (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, 17 Qinghua Donglu, Beijing 100083, Peoples R China.	chenfangch@sina.com			Chinese National Key Research and Development Program [2017YFD0400705]; Beijing Municipal Science and Technology Commission [D161100005416001]	Chinese National Key Research and Development Program; Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission)	This work was supported by grants from the Chinese National Key Research and Development Program (2017YFD0400705) and the Beijing Municipal Science and Technology Commission (D161100005416001). The authors declare no conflicts of interest.	Abdel-Salam IM, 2019, J ETHNOPHARMACOL, V229, P89, DOI 10.1016/j.jep.2018.09.034; Anuj Modi, 2014, Asian Pacific Journal of Tropical Disease, V4, pS7; Arner P, 2015, OBESITY FACTS, V8, P147, DOI 10.1159/000381224; Bai J, 2018, J FUNCT FOODS, V41, P127, DOI 10.1016/j.jff.2017.12.050; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Caesar R, 2015, CELL METAB, V22, P658, DOI 10.1016/j.cmet.2015.07.026; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2014, NAT REV ENDOCRINOL, V10, P74, DOI 10.1038/nrendo.2013.240; Chatterjee TK, 2009, CIRC RES, V104, P541, DOI 10.1161/CIRCRESAHA.108.182998; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Ding QA, 2017, FOOD HYDROCOLLOID, V63, P646, DOI 10.1016/j.foodhyd.2016.10.018; Du QZ, 2006, J AGR FOOD CHEM, V54, P4186, DOI 10.1021/jf0604790; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eteberria U, 2015, J NUTR BIOCHEM, V26, P651, DOI 10.1016/j.jnutbio.2015.01.002; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Golubeva AV, 2017, EBIOMEDICINE, V24, P166, DOI 10.1016/j.ebiom.2017.09.020; Greenhill C, 2017, NAT REV ENDOCRINOL, V13, P498, DOI 10.1038/nrendo.2017.89; He Y, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0557-6; Kang C, 2017, MBIO, V8, DOI [10.1128/mBio.00470-17, 10.1128/mbio.00470-17, 10.1128/mBio.00900-17]; Kao TH, 2012, FOOD CHEM, V135, P386, DOI 10.1016/j.foodchem.2012.04.128; Khajuria A, 2007, BIOORG MED CHEM LETT, V17, P1608, DOI 10.1016/j.bmcl.2006.12.091; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li DT, 2019, CRIT REV FOOD SCI, V59, P181, DOI 10.1080/10408398.2017.1363708; Liu XM, 2013, CELL RES, V23, P851, DOI 10.1038/cr.2013.64; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Miller TA, 2005, BIOCHEM BIOPH RES CO, V336, P309, DOI 10.1016/j.bbrc.2005.08.088; Miyazaki M, 2009, BIOCHEM BIOPH RES CO, V380, P818, DOI 10.1016/j.bbrc.2009.01.183; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Park SK, 2013, INT J SYST EVOL MICR, V63, P599, DOI 10.1099/ijs.0.036541-0; Pelaseyed T, 2014, IMMUNOL REV, V260, P8, DOI 10.1111/imr.12182; Ravachol J, 2016, SCI REP-UK, V6, DOI 10.1038/srep22770; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI [10.1172/JCI92035, 10.1172/jci92035]; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847; Tong XL, 2018, MBIO, V9, DOI 10.1128/mBio.02392-17; Tulipani S, 2016, CLIN CHIM ACTA, V463, P53, DOI 10.1016/j.cca.2016.10.005; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Wang JJ, 2015, ISME J, V9, P1, DOI 10.1038/ismej.2014.99; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Wang ZN, 2015, CELL, V163, P1585, DOI 10.1016/j.cell.2015.11.055; Xu PF, 2017, EBIOMEDICINE, V16, P251, DOI 10.1016/j.ebiom.2017.01.019; Yang X., 2003, ENCY REFERENCE TRADI; Yano JM, 2015, CELL, V163, P258, DOI 10.1016/j.cell.2015.09.017; Zhang CH, 2012, ISME J, V6, P1848, DOI 10.1038/ismej.2012.27; Zhang L, 2016, PLANT CELL PHYSIOL, V57, P616, DOI 10.1093/pcp/pcw018; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774; Zhao LP, 2013, NAT REV MICROBIOL, V11, P639, DOI 10.1038/nrmicro3089; Zietak M, 2016, CELL METAB, V23, P1216, DOI 10.1016/j.cmet.2016.05.001	64	38	39	5	51	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10339	10352		10.1096/fj.201900488R	http://dx.doi.org/10.1096/fj.201900488R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31211921				2022-12-28	WOS:000482214200050
J	Flores, RR; Carbo, L; Kim, E; Van Meter, M; De Padilla, CML; Zhao, J; Colangelo, D; Yousefzadeh, MJ; Angelini, LA; Zhang, L; Pola, E; Vo, N; Evans, CH; Gambotto, A; Niedernhofer, LJ; Robbins, PD				Flores, Rafael R.; Carbo, Lana; Kim, Eun; Van Meter, Montina; De Padilla, Consuelo M. Lopez; Zhao, Jing; Colangelo, Debora; Yousefzadeh, Matthew J.; Angelini, Luise A.; Zhang, Lei; Pola, Enrico; Nam Vo; Evans, Christopher H.; Gambotto, Andrea; Niedernhofer, Laura J.; Robbins, Paul D.			Adenoviral gene transfer of a single-chain IL-23 induces psoriatic arthritis-like symptoms in NOD mice	FASEB JOURNAL			English	Article						psoriasis; type 1 diabetes; interleukin-23; adenovirus; interleukin-17	INFLAMMATORY SKIN-DISEASE; TRANSGENIC MICE; CUTTING EDGE; IFN-GAMMA; EPIDERMAL HYPERPLASIA; MOUSE MODEL; T-CELLS; KERATINOCYTES; CYTOKINE; LESIONS	Previously, we demonstrated that intratumoral delivery of adenoviral vector encoding single-chain (sc)IL-23 (Ad.scIL-23) was able to induce systemic antitumor immunity. Here, we examined the role of IL-23 in diabetes in nonobese diabetic mice. Intravenous delivery of Ad.scIL-23 did not accelerate the onset of hyperglycemia but instead resulted in the development of psoriatic arthritis. Ad.scIL-23-treated mice developed erythema, scales, and thickening of the skin, as well as intervertebral disc degeneration and extensive synovial hypertrophy and loss of articular cartilage in the knees. Immunological analysis revealed activation of conventional T helper type 17 cells and IL-17-producing gamma delta T cells along with a significant depletion and suppression of T cells in the pancreatic lymph nodes. Furthermore, treatment with anti-IL-17 antibody reduced joint and skin psoriatic arthritis pathologies. Thus, these Ad.scIL-23-treated mice represent a physiologically relevant model of psoriatic arthritis for understanding disease progression and for testing therapeutic approaches.-Flores, R. R., Carbo, L., Kim, E., Van Meter, M., De Padilla, C. M. L., Zhao, J., Colangelo, D., Yousefzadeh, M. J., Angelini, L. A., Zhang, L., Pola, E., Vo, N., Evans, C. H., Gambotto, A., Niedernhofer, L. J., Robbins, P. D. Adenoviral gene transfer of a single-chain IL-23 induces psoriatic arthritis-like symptoms in NOD mice.	[Flores, Rafael R.; Colangelo, Debora; Yousefzadeh, Matthew J.; Angelini, Luise A.; Zhang, Lei; Niedernhofer, Laura J.; Robbins, Paul D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, 321 Church St SE,4-112 Nils Hasselmo Hall, Minneapolis, MN 55455 USA; [Flores, Rafael R.; Colangelo, Debora; Yousefzadeh, Matthew J.; Angelini, Luise A.; Zhang, Lei; Niedernhofer, Laura J.; Robbins, Paul D.] Univ Minnesota, Inst Biol Aging & Metab, Minneapolis, MN USA; [Flores, Rafael R.; Carbo, Lana; Van Meter, Montina; Zhao, Jing; Yousefzadeh, Matthew J.; Angelini, Luise A.; Niedernhofer, Laura J.; Robbins, Paul D.] Scripps Res Inst, Dept Mol Med, Jupiter, FL USA; [Flores, Rafael R.; Carbo, Lana; Van Meter, Montina; Zhao, Jing; Yousefzadeh, Matthew J.; Angelini, Luise A.; Niedernhofer, Laura J.; Robbins, Paul D.] Scripps Res Inst, Ctr Aging, Jupiter, FL USA; [Kim, Eun; Gambotto, Andrea] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [Nam Vo] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Pittsburgh, PA 15261 USA; [Gambotto, Andrea] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA USA; [De Padilla, Consuelo M. Lopez; Evans, Christopher H.] Mayo Clin, Rehabil Med Res Ctr, Rochester, MN USA; [Pola, Enrico] Univ Cattolica Sacro Cuore, Sch Med, Dept Orthopaed Surg, Agostino Gemelli Univ Hosp, Rome, Italy	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Scripps Research Institute; Scripps Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Mayo Clinic; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Robbins, PD (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, 321 Church St SE,4-112 Nils Hasselmo Hall, Minneapolis, MN 55455 USA.	probbins@umn.edu	ZHANG, LEI/AAV-8848-2020; Colangelo, Debora/ABI-5242-2020	ZHANG, LEI/0000-0001-7409-6090; Yousefzadeh, Negar/0000-0002-2569-5860; Robbins, Paul/0000-0003-1068-7099; Flores, Rafael/0000-0002-5580-6381; Niedernhofer, Laura/0000-0002-1074-1385	U.S. National Institutes of Health (NIH) National Institute on Aging [AG024827, AG044376]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR051456]; Juvenile Diabetes Research Foundation; T32 grant from NIH on Autoimmunity and Immunopathology; University of Pittsburgh's NIH Cancer Center Support Grant [P30 CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG044376, P30AG024827] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute on Aging; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); T32 grant from NIH on Autoimmunity and Immunopathology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh's NIH Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Biviana Torres (The Scripps Research Institute) for her assistance with flow cytometry and Shannon Howard, Sara McGowan, and Tokio Sano (all from The Scripps Research Institute) for their assistance in collecting and the processing of tissues. The authors acknowledge and extend gratitude to Yuan Yuan Ling (retired, formerly of The Scripps Research Institute) for years of service to science. This work was supported by Grants from the U.S. National Institutes of Health (NIH) National Institute on Aging (AG024827, AG044376), NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR051456), and a program grant from the Juvenile Diabetes Research Foundation to P. D. R. R. R. F. was supported by a T32 grant from NIH on Autoimmunity and Immunopathology. This project used the University of Pittsburgh Cancer Institute Vector Facilities (Pittsburgh, PA, USA) supported by the University of Pittsburgh's NIH Cancer Center Support Grant P30 CA047904. The authors declare no conflicts of interest.	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Alleva DG, 2000, DIABETES, V49, P1106, DOI 10.2337/diabetes.49.7.1106; Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Atochina O, 2006, EXP DERMATOL, V15, P461, DOI 10.1111/j.1600-0625.2006.00431.x; Baraliakos X., 2012, J RHEUMATOL, V39, P418; BEAMER WG, 1995, BLOOD, V86, P3220; Bellemore SM, 2016, CLIN EXP IMMUNOL, V183, P380, DOI 10.1111/cei.12735; Bellemore SM, 2015, CLIN EXP IMMUNOL, V182, P261, DOI 10.1111/cei.12691; Bilbao R, 2003, GENE THER, V10, P1821, DOI 10.1038/sj.gt.3302084; Boyman O, 2004, J EXP MED, V199, P731, DOI 10.1084/jem.20031482; Caruso R, 2009, NAT MED, V15, P1013, DOI 10.1038/nm.1995; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Cho ML, 2006, J IMMUNOL, V176, P5652, DOI 10.4049/jimmunol.176.9.5652; Deng YX, 2016, CLIN REV ALLERG IMMU, V50, P377, DOI 10.1007/s12016-016-8535-x; Flores RR, 2015, EUR J IMMUNOL, V45, P3114, DOI 10.1002/eji.201445403; Gambotto A, 1999, CANCER GENE THER, V6, P45, DOI 10.1038/sj.cgt.7700013; Gao WT, 2004, BIOTECHNOL PROGR, V20, P443, DOI 10.1021/bp0300467; GATES AH, 1965, SCIENCE, V148, P1471, DOI 10.1126/science.148.3676.1471; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; GROVES RW, 1995, P NATL ACAD SCI USA, V92, P11874, DOI 10.1073/pnas.92.25.11874; Hedrick MN, 2009, J CLIN INVEST, V119, P2317, DOI 10.1172/JCI37378; Hida S, 2000, IMMUNITY, V13, P643, DOI 10.1016/S1074-7613(00)00064-9; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Honkanen J, 2010, J IMMUNOL, V185, P1959, DOI 10.4049/jimmunol.1000788; Huffmeier U, 2009, J INVEST DERMATOL, V129, P355, DOI 10.1038/jid.2008.233; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; KATZ JD, 1995, SCIENCE, V268, P1185, DOI 10.1126/science.7761837; Kerschbaumer A, 2016, WIEN KLIN WOCHENSCHR, V128, P791, DOI 10.1007/s00508-016-1111-9; Kiani C, 2002, CELL RES, V12, P19, DOI 10.1038/sj.cr.7290106; Kopp T, 2003, J IMMUNOL, V170, P5438, DOI 10.4049/jimmunol.170.11.5438; Kopp T, 2001, J INVEST DERMATOL, V117, P618, DOI 10.1046/j.1523-1747.2001.01441.x; Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733; Kumar P, 2015, CYTOKINE, V71, P366, DOI 10.1016/j.cyto.2014.10.010; Li AG, 2004, EMBO J, V23, P1770, DOI 10.1038/sj.emboj.7600183; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Mabuchi T, 2013, J INVEST DERMATOL, V133, P164, DOI 10.1038/jid.2012.260; Mitra A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3781; Nakajima K, 2011, J IMMUNOL, V186, P4481, DOI 10.4049/jimmunol.1000148; Nickoloff BJ, 1999, AM J PATHOL, V155, P145, DOI 10.1016/S0002-9440(10)65109-7; Nitta Y, 2001, J AUTOIMMUN, V16, P97, DOI 10.1006/jaut.2000.0469; Oji V, 2015, CLIN EXP RHEUMATOL, V33, pS14; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Piskin G, 2006, J IMMUNOL, V176, P1908, DOI 10.4049/jimmunol.176.3.1908; Raychaudhuri SP, 2017, J AUTOIMMUN, V76, P21, DOI 10.1016/j.jaut.2016.10.009; Reay J, 2012, CANCER GENE THER, V19, P135, DOI 10.1038/cgt.2011.78; Reay J, 2009, CANCER GENE THER, V16, P776, DOI 10.1038/cgt.2009.27; Reddy M, 2010, J DERMATOL, V37, P413, DOI 10.1111/j.1346-8138.2010.00802.x; Reinert-Hartwall L, 2015, J IMMUNOL, V194, P68, DOI 10.4049/jimmunol.1401653; Rizzo HL, 2011, J IMMUNOL, V186, P1495, DOI 10.4049/jimmunol.1001001; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Shepherd J, 2004, J INVEST DERMATOL, V122, P665, DOI 10.1111/j.0022-202X.2004.22305.x; Sieve AN, 2010, EUR J IMMUNOL, V40, P2236, DOI 10.1002/eji.200939759; Simpson PB, 2003, J IMMUNOL, V171, P3333, DOI 10.4049/jimmunol.171.7.3333; Stratis A, 2006, J CLIN INVEST, V116, P2094, DOI 10.1172/JCI27179; Suarez-Farinas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084634; Sundberg JP, 1997, PATHOBIOLOGY, V65, P271, DOI 10.1159/000164138; SUNDBERG JP, 1994, J INVEST DERMATOL, V102, P781, DOI 10.1111/1523-1747.ep12377741; SUNDBERG JP, 1990, J INVEST DERMATOL, V95, pS62, DOI 10.1111/1523-1747.ep12505816; Tonel G, 2010, J IMMUNOL, V185, P5688, DOI 10.4049/jimmunol.1001538; Trembleau S, 2003, J IMMUNOL, V170, P5491, DOI 10.4049/jimmunol.170.11.5491; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Vo N, 2010, J ORTHOP RES, V28, P1600, DOI 10.1002/jor.21153; Walker LSK, 2016, CLIN EXP IMMUNOL, V183, P16, DOI 10.1111/cei.12672; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Xia YP, 2003, BLOOD, V102, P161, DOI 10.1182/blood-2002-12-3793; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	67	5	5	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9505	9515		10.1096/fj.201900420R	http://dx.doi.org/10.1096/fj.201900420R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31170010	Green Published			2022-12-28	WOS:000478832900062
J	Ji, JJ; Ge, XY; Chen, YG; Zhu, B; Wu, QA; Zhang, JF; Shan, JJ; Cheng, HB; Shi, LY				Ji, Jianjian; Ge, Xiaoyin; Chen, Yugen; Zhu, Bo; Wu, Qinan; Zhang, Junfeng; Shan, Jinjun; Cheng, Haibo; Shi, Liyun			Daphnetin ameliorates experimental colitis by modulating microbiota composition and T-reg/T(h)17 balance	FASEB JOURNAL			English	Article						gut microbiota; SCFA; colonic immune; SCFA-producing microbiota	CHAIN FATTY-ACIDS; GUT MICROBIOTA; ACTIVATION; TH17; DIFFERENTIATION; HOMEOSTASIS; METABOLITES; CONTRIBUTE; DISEASE; SYSTEM	Inflammatory bowel diseases (IBDs) are characterized by chronic pathologies associated with extensive gut dysbiosis and intestinal inflammation. Hence, endeavors to improve the inflammatory pathology by manipulating gut microbiota are ongoing. Daphnetin (DAPH) is a coumarin derivative extracted from Daphne odora var with anti-inflammatory and immune-regulatory properties that has been widely used in treating inflammatory disorders. Herein, we showed that DAPH remarkably alleviated experimental colitis by reducing colonic inflammation, improving colonic integrity, and reestablishing immune and metabolic homeostasis in the inflicted intestines. Our analysis showed that DAPH modified the composition of gut microbiota and altered the metabolic profiles in dextran sulfate sodium-treated mice. In particular, this agent significantly elevated the abundance of short-chain fatty acid (SCFA)-producing gut microbiota, causatively related with the enhanced development of T-reg cells and the reduced proinflammatory T(h)17 cell differentiation. More critically, the protective effect of DAPH was shown to be transmissible among colitic mice through cohousing or fecal microbiota transplantation, further substantiating the importance of SCFA-producing gut microbiota in DAPH action. We thus for the first time reveal the potential of DAPH in resetting the gut microbiome and reestablishing immune homeostasis in colitic mice, which may have clinical implications for treating IBD.-Ji, J., Ge, X., Chen, Y., Zhu, B., Wu, Q., Zhang, J., Shan, J., Cheng, H., Shi, L. Daphnetin ameliorates experimental colitis by modulating microbiota composition and T-reg/T(h)17 balance.	[Ji, Jianjian; Ge, Xiaoyin; Zhu, Bo; Zhang, Junfeng; Shi, Liyun] Nanjing Univ Chinese Med, Key Lab Inflammat & Immunoregulat, Sch Med & Life Sci, Nanjing, Jiangsu, Peoples R China; [Wu, Qinan] Nanjing Univ Chinese Med, Collaborat Innovat Ctr Chinese Med Resources Indu, Nanjing, Jiangsu, Peoples R China; [Cheng, Haibo] Nanjing Univ Chinese Med, Sch Clin Med 1, Nanjing, Jiangsu, Peoples R China; [Ji, Jianjian; Shan, Jinjun] Nanjing Univ Chinese Med, Jiangsu Key Lab Pediat Resp Dis, Inst Pediat, Nanjing, Jiangsu, Peoples R China; [Chen, Yugen] Nanjing Univ Chinese Med, Dept Colorectal Surg, Affiliated Hosp, Nanjing, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine	Shi, LY (corresponding author), Nanjing Univ Chinese Med, 138 Xianlin Ave, Nanjing 210023, Jiangsu, Peoples R China.	shi_liyun@msn.com		Zhu, Bo/0000-0001-6043-8774; Shi, Liyun/0000-0003-1767-0126	National Natural Scientific Funds [81270066, 81470210, 81770014]; National Key Research and Development Program Project [2012CB911200]; Natural Science Foundation of Jiangsu Province Fund [BK20180825]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Scientific Funds; National Key Research and Development Program Project; Natural Science Foundation of Jiangsu Province Fund(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Scientific Funds (81270066, 81470210, and 81770014), the National Key Research and Development Program Project (2012CB911200), the Natural Science Foundation of Jiangsu Province Fund (BK20180825), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors declare no conflicts of interest.	Amato KR, 2013, ISME J, V7, P1344, DOI 10.1038/ismej.2013.16; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Blazejewski AJ, 2017, CELL REP, V19, P2319, DOI 10.1016/j.celrep.2017.05.058; Chassaing B, 2015, NATURE, V519, P92, DOI 10.1038/nature14232; Chen L, 2017, NAT IMMUNOL, V18, P951, DOI 10.1038/ni0817-951e; Chu HT, 2016, SCIENCE, V352, P1116, DOI 10.1126/science.aad9948; Fujimura KE, 2016, NAT MED, V22, P1187, DOI 10.1038/nm.4176; Geng J, 2017, NAT IMMUNOL, V18, P800, DOI 10.1038/ni.3748; Goncalves P, 2018, INFLAMM BOWEL DIS, V24, P558, DOI 10.1093/ibd/izx029; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Ji JJ, 2016, CLIN SCI, V130, P1453, DOI 10.1042/CS20160311; Jubair WK, 2018, ARTHRITIS RHEUMATOL, V70, P1220, DOI 10.1002/art.40490; Khosravi A, 2014, CELL HOST MICROBE, V15, P374, DOI 10.1016/j.chom.2014.02.006; Luhrs H, 2002, SCAND J GASTROENTERO, V37, P458, DOI 10.1080/003655202317316105; LYON L, 2018, BRAIN 3, V141, DOI DOI 10.1093/BRAIN/AWY017; Ma XL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00987; Malik A, 2018, IMMUNITY, V49, P515, DOI 10.1016/j.immuni.2018.08.024; Maloy KJ, 2008, MUCOSAL IMMUNOL, V1, P339, DOI 10.1038/mi.2008.28; Nanjundappa RH, 2017, CELL, V171, P655, DOI 10.1016/j.cell.2017.09.022; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Pigneur B, 2016, MUCOSAL IMMUNOL, V9, P1360, DOI 10.1038/mi.2016.67; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scott NA, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao4755; Sharon G, 2016, CELL, V167, P915, DOI 10.1016/j.cell.2016.10.027; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sordillo JE, 2017, J ALLERGY CLIN IMMUN, V139, P482, DOI 10.1016/j.jaci.2016.08.045; Steed AL, 2017, SCIENCE, V357, P498, DOI 10.1126/science.aam5336; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Tu LN, 2012, INT IMMUNOPHARMACOL, V13, P417, DOI 10.1016/j.intimp.2012.04.001; Vieira SM, 2018, SCIENCE, V359, P1156, DOI 10.1126/science.aar7201; Wang D, 2016, CNS NEUROSCI THER, V22, P558, DOI 10.1111/cns.12537; Witaicenis A, 2014, PHYTOMEDICINE, V21, P240, DOI 10.1016/j.phymed.2013.09.001; Xiang G, 2018, BIOCHEM PHARMACOL, V150, P150, DOI 10.1016/j.bcp.2018.02.003; Yan H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179586; Yao RF, 2011, EUR J PHARMACOL, V670, P286, DOI 10.1016/j.ejphar.2011.08.019; Yu WW, 2014, INT IMMUNOPHARMACOL, V21, P1, DOI 10.1016/j.intimp.2014.04.005; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774; Zheng L, 2017, J IMMUNOL, V199, P2976, DOI 10.4049/jimmunol.1700105; Zhu WH, 2018, NATURE, V553, P208, DOI 10.1038/nature25172	41	29	31	7	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9308	9322		10.1096/fj.201802659RR	http://dx.doi.org/10.1096/fj.201802659RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31145641				2022-12-28	WOS:000478832900048
J	Trujillo-Gonzalez, I; Friday, WB; Munson, CA; Bachleda, A; Weiss, ER; Alam, NM; Sha, W; Zeisel, SH; Surzenko, N				Trujillo-Gonzalez, Isis; Friday, Walter B.; Munson, Carolyn A.; Bachleda, Amelia; Weiss, Ellen R.; Alam, Nazia M.; Sha, Wei; Zeisel, Steven H.; Surzenko, Natalia			Low availability of choline in utero disrupts development and function of the retina	FASEB JOURNAL			English	Article						retinal development; Nf2; Merlin; visual sensitivity; maternal nutrition	DIETARY-INTAKE; PROGENITOR CELLS; DNA METHYLATION; STEM-CELLS; MOUSE; ADULT; NF2; EXPRESSION; RECEPTOR; SUPPLEMENTATION	Adequate supply of choline, an essential nutrient, is necessary to support proper brain development. Whether prenatal choline availability plays a role in development of the visual system is currently unknown. In this study, we addressed the role of in utero choline supply for the development and later function of the retina in a mouse model. We lowered choline availability in the maternal diet during pregnancy and assessed proliferative and differentiation properties of retinal progenitor cells (RPCs) in the developing prenatal retina, as well as visual function in adult offspring. We report that low choline availability during retinogenesis leads to persistent retinal cytoarchitectural defects, ranging from focal lesions with displacement of retinal neurons into subretinal space to severe hypocellularity and ultrastructural defects in photoreceptor organization. We further show that low choline availability impairs timely differentiation of retinal neuronal cells, such that the densities of early-born retinal ganglion cells, amacrine and horizontal cells, as well as cone photoreceptor precursors, are reduced in low choline embryonic d 17.5 retinas. Maintenance of higher proportions of RPCs that fail to exit the cell cycle underlies aberrant neuronal differentiation in low choline embryos. Increased RPC cell cycle length, and associated reduction in neurofibromin 2/Merlin protein, an upstream regulator of the Hippo signaling pathway, at least in part, explain aberrant neurogenesis in low choline retinas. Furthermore, we find that animals exposed to low choline diet in utero exhibit a significant degree of intraindividual variation in vision, characterized by marked functional discrepancy between the 2 eyes in individual animals. Together, our findings demonstrate, for the first time, that choline availability plays an essential role in the regulation of temporal progression of retinogenesis and provide evidence for the importance of adequate supply of choline for proper development of the visual system.-Trujillo-Gonzalez, I., Friday, W. B., Munson, C. A., Bachleda, A., Weiss, E. R., Alam, N. M., Sha, W., Zeisel, S. H., Surzenko, N. Low availability of choline in utero disrupts development and function of the retina.	[Trujillo-Gonzalez, Isis; Friday, Walter B.; Munson, Carolyn A.; Zeisel, Steven H.; Surzenko, Natalia] Univ North Carolina Chapel Hill, Inst Nutr Res, 500 Laureate Way,Room 2218, Kannapolis, NC 28081 USA; [Bachleda, Amelia; Weiss, Ellen R.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA; [Zeisel, Steven H.; Surzenko, Natalia] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Alam, Nazia M.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA; [Alam, Nazia M.] Burke Neurol Inst, Ctr Visual Restorat, White Plains, NY USA; [Sha, Wei] Univ North Carolina Charlotte, Bioinformat Serv Div, Kannapolis, NC USA; [Bachleda, Amelia] Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Cornell University; University of North Carolina; University of North Carolina Charlotte; University of Washington; University of Washington Seattle	Zeisel, SH (corresponding author), Univ North Carolina Chapel Hill, Inst Nutr Res, 500 Laureate Way,Room 2218, Kannapolis, NC 28081 USA.; Surzenko, N (corresponding author), Univ North Carolina Chapel Hill, Inst Nutr Res, 500 Laureate Way,Room 2204, Kannapolis, NC 28081 USA.	steven_zeisel@unc.edu; surzenko@email.unc.edu	Weiss, Ellen/AAK-9868-2020; Ariel, Pablo/AGJ-4118-2022		U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases [DK056350, DK115380]; Cancer Center Core Support Grant [P30 CA016086]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK115380, P30DK056350] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cancer Center Core Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. David Horita [Nutrition Research Institute, University of North Carolina (UNC)-Chapel Hill, Kannapolis, NC, USA] for critically evaluating this manuscript; Ms. Lorian Molina-Torres (Nutrition Research Institute, UNC-Chapel Hill) for help with data acquisition and analyses; The Microscopy Services Laboratory, Department of Pathology and Laboratory Medicine at the UNC-Chapel Hill (Chapel Hill, NC, USA), especially Mrs. Victoria Madden (UNC-Chapel Hill), for transmission electron microscopy sample preparation and imaging. This work was supported by U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases Grants DK056350 and DK115380 (to S.H.Z.). The Microscopy Services Laboratory, Department of Pathology and Laboratory Medicine, is supported in part by P30 CA016086 Cancer Center Core Support Grant to the UNC-Chapel Hill Lineberger Comprehensive Cancer Center. Listed funding sources were not involved in the progress and outcomes of this study or in publication decision. The corresponding authors had full access to all the data reported in this study and had final responsibility to submit this work for publication. The authors declare no conflicts of interest.	Amenta F, 2008, CURR MED CHEM, V15, P488, DOI 10.2174/092986708783503203; Asthagiri AR, 2009, LANCET, V373, P1974, DOI 10.1016/S0140-6736(09)60259-2; Bachleda AR, 2016, INVEST OPHTH VIS SCI, V57, P1488, DOI 10.1167/iovs.15-17994; Baye LM, 2008, BRAIN RES, V1192, P29, DOI 10.1016/j.brainres.2007.05.021; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry KAZ, 2014, J LIPID RES, V55, P504, DOI 10.1194/jlr.M044990; Blusztajn Jan Krzysztof, 2012, Central Nervous System Agents in Medicinal Chemistry, V12, P82; Boeke CE, 2013, AM J EPIDEMIOL, V177, P1338, DOI 10.1093/aje/kws395; Bonaccorsi J, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00082; Bremond-Gignac Dominique, 2011, Curr Opin Ophthalmol, V22 Suppl, pS1, DOI 10.1097/01.icu.0000397180.37316.5d; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Cabochette P, 2015, ELIFE, V4, DOI 10.7554/eLife.08488; Cahill H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002055; Campbell M, 2007, EXP EYE RES, V85, P714, DOI 10.1016/j.exer.2007.08.004; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Caudill MA, 2018, FASEB J, V32, P2172, DOI 10.1096/fj.201700692RR; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; Cook T, 2003, BIOESSAYS, V25, P921, DOI 10.1002/bies.10356; Cooper J, 2014, FEBS LETT, V588, P2743, DOI 10.1016/j.febslet.2014.04.001; Craciunescu CN, 2003, J NUTR, V133, P3614, DOI 10.1093/jn/133.11.3614; Curto M, 2008, BRIT J CANCER, V98, P256, DOI 10.1038/sj.bjc.6604002; Dominguez-Salas P, 2013, AM J CLIN NUTR, V97, P1217, DOI 10.3945/ajcn.112.048462; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; Finlay BL, 2008, BRAIN RES, V1192, P5, DOI 10.1016/j.brainres.2007.07.005; Fischer LM, 2007, AM J CLIN NUTR, V85, P1275; Fuhrmann S, 2010, CURR TOP DEV BIOL, V93, P61, DOI [10.1016/B978-0-12-385044-7.00003-5, 10.1016/S0070-2153(10)93003-2]; Gilbert CE, 2008, INVEST OPHTH VIS SCI, V49, P877, DOI 10.1167/iovs.07-0973; Goldberg AFX, 2016, PROG RETIN EYE RES, V55, P52, DOI 10.1016/j.preteyeres.2016.05.003; Gosens I, 2008, EXP EYE RES, V86, P713, DOI 10.1016/j.exer.2008.02.005; Gossell-Williams M, 2005, W INDIAN MED J, V54, P355; Gyawali R, 2017, BMC OPHTHALMOL, V17, DOI 10.1186/s12886-017-0609-x; Hafler BP, 2012, P NATL ACAD SCI USA, V109, P7882, DOI 10.1073/pnas.1203138109; Hanemann CO, 2007, BRAIN PATHOL, V17, P371, DOI 10.1111/j.1750-3639.2007.00086.x; Heavner WE, 2014, NEURAL DEV, V9, DOI 10.1186/1749-8104-9-27; Javed A, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00105; Kelly ML, 2013, CELL MOL LIFE SCI, V70, P4223, DOI 10.1007/s00018-013-1347-8; Kissil JL, 2003, MOL CELL, V12, P841, DOI 10.1016/S1097-2765(03)00382-4; Kolb H., 1995, WEBVISION ORG RETINA, P98; Kolb H., 1995, WEBVISION ORG RETINA, P1; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lavado A, 2013, DEVELOPMENT, V140, P3323, DOI 10.1242/dev.096537; Lee M, 2018, DEV DYNAM, V247, P794, DOI 10.1002/dvdy.24628; Liang KJ, 2017, MOL THER, V25, P765, DOI 10.1016/j.ymthe.2016.12.016; Lien EL, 2011, PROG RETIN EYE RES, V30, P188, DOI 10.1016/j.preteyeres.2011.01.001; Lillien L, 1998, MOL CELL NEUROSCI, V10, P296, DOI 10.1006/mcne.1997.0659; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marquardt T, 2003, PROG RETIN EYE RES, V22, P567, DOI 10.1016/S1350-9462(03)00036-3; Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005; MASLAND RH, 1980, P NATL ACAD SCI-BIOL, V77, P1671, DOI 10.1073/pnas.77.3.1671; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mattar Pierre, 2015, Neurogenesis (Austin), V2, pe1125409, DOI 10.1080/23262133.2015.1125409; McCall MA, 2008, J PHYSIOL-LONDON, V586, P4385, DOI 10.1113/jphysiol.2008.159327; McLaughlin ME, 2007, P NATL ACAD SCI USA, V104, P3261, DOI 10.1073/pnas.0700044104; Meck WH, 2008, FRONT INTEGR NEUROSC, V1, DOI 10.3389/neuro.07.007.2007; MECK WH, 1988, DEV PSYCHOBIOL, V21, P339, DOI 10.1002/dev.420210405; Meck WH, 1997, NEUROREPORT, V8, P3053, DOI 10.1097/00001756-199709290-00010; Meck WH, 2003, NEUROSCI BIOBEHAV R, V27, P385, DOI 10.1016/S0149-7634(03)00069-1; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Mehedint MG, 2010, FASEB J, V24, P184, DOI 10.1096/fj.09-140145; Moon KH, 2018, DEV CELL, V44, P13, DOI 10.1016/j.devcel.2017.11.011; Niculescu MD, 2006, FASEB J, V20, P43, DOI 10.1096/fj.05-4707com; Omri S, 2010, CLIN OPHTHALMOL, V4, P183; Pan XX, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0124-z; Phillips MJ, 2008, INVEST OPHTH VIS SCI, V49, P2148, DOI 10.1167/iovs.07-1012; Prusky GT, 2006, J NEUROSCI, V26, P11554, DOI 10.1523/JNEUROSCI.3396-06.2006; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; PU GAW, 1983, INVEST OPHTH VIS SCI, V24, P288; Ramamurthy V, 2009, CLIN GENET, V76, P137, DOI 10.1111/j.1399-0004.2009.01240.x; Resseguie ME, 2011, J BIOL CHEM, V286, P1649, DOI 10.1074/jbc.M110.106922; Robson JG, 2014, PROG RETIN EYE RES, V39, P1, DOI 10.1016/j.preteyeres.2013.12.003; Schulz A, 2013, NAT NEUROSCI, V16, P426, DOI 10.1038/nn.3348; Selvam S, 2018, PROG RETIN EYE RES, V63, P1, DOI 10.1016/j.preteyeres.2017.11.001; Shaw GM, 2006, EPIDEMIOLOGY, V17, P285, DOI 10.1097/01.ede.0000208348.30012.35; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Surzenko N, 2013, DEVELOPMENT, V140, P1445, DOI 10.1242/dev.071878; Suzuki-Kerr H, 2018, EXP EYE RES, V171, P142, DOI 10.1016/j.exer.2018.03.017; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Tayebati SK, 2015, CURR MED CHEM, V22, P4328, DOI 10.2174/0929867322666151029104152; Trujillo-Gonzalez I, 2019, FASEB J, V33, P3601, DOI 10.1096/fj.201801094RR; Wallace TC, 2016, J AM COLL NUTR, V35, P108, DOI 10.1080/07315724.2015.1080127; Wallace TC, 2014, J AM COLL NUTR, V33, P94, DOI 10.1080/07315724.2013.846806; Wang YY, 2016, FASEB J, V30, P1566, DOI 10.1096/fj.15-282426; Wheway G, 2014, ORGANOGENESIS, V10, P69, DOI 10.4161/org.26710; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; Zeisel SH, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050445; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	88	6	7	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9194	9209		10.1096/fj.201900444R	http://dx.doi.org/10.1096/fj.201900444R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31091977	Green Submitted, Green Published			2022-12-28	WOS:000478832900040
J	Al Khazal, F; Holte, MN; Bolon, B; White, TA; LeBrasseur, N; Maher, LJ				Al Khazal, Fatimah; Holte, Molly Nelson; Bolon, Brad; White, Thomas A.; LeBrasseur, Nathan; Maher, L. James, III			A conditional mouse model of complex II deficiency manifesting as Leigh-like syndrome	FASEB JOURNAL			English	Article						mitochondrial disease; succinate dehydrogenase; familial paraganglioma; hypoxia	JOINT PUBLICATION; REVISED GUIDES; MICE; MUTATIONS; DISEASE; RATS; RITA; DYSFUNCTION; BRAIN; CYCLE	Leigh syndrome embodies degenerative disorders with a collection of symptoms secondary to inborn errors of metabolism. Combinations of hypomorphic and loss-of-function alleles in many genes have been shown to result in Leigh syndrome. Interestingly, deficiency for the tricarboxylic acid cycle enzyme succinate dehydrogenase (SDH) can lead to Leigh-like syndrome in some circumstances and to cancer (paraganglioma, renal cell carcinoma, gastrointestinal stromal tumor) in others. In our experiments originally intended to create an inducible whole-body SDH-loss mouse model of tumorigenesis, we generated a condition reminiscent of Leigh-like syndrome that is lethal to mice within 4 wk. Remarkably, as has been shown for other mitochondrial diseases, chronic hypoxia offers substantial protection to mice from this condition after systemic SDH loss, allowing survival in the context of profoundly impaired oxidative metabolism.	[Al Khazal, Fatimah; Holte, Molly Nelson; Maher, L. James, III] Mayo Clin, Coll Med & Sci, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA; [White, Thomas A.; LeBrasseur, Nathan] Mayo Clin, Robert & Arlene Kogod Ctr Aging, Rochester, MN USA; [Bolon, Brad] GEMpath, Longmont, CO USA	Mayo Clinic; Mayo Clinic	Maher, LJ (corresponding author), Mayo Clin, Coll Med & Sci, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.	maher@mayo.edu			Paradifference Foundation; U.S. National Institutes of Health (NIH) National Cancer Institute [RO1 CA166025]; Robert and Arlene Kogod Center on Aging (Mayo Clinic); NIH National Institute of Diabetes and Digestive and Kidney Diseases [U24DK100469]; NIH Director's Common Fund; NATIONAL CANCER INSTITUTE [R01CA166025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK100469] Funding Source: NIH RePORTER	Paradifference Foundation; U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Robert and Arlene Kogod Center on Aging (Mayo Clinic); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH Director's Common Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge the European Conditional Mouse Mutagenesis Program (Wellcome Sanger Institute, Hinxton, United Kingdom) for providing the SDHC gene trap mouse line. The technical assistance of Jenny Pattengill and the Mayo Clinic Metabolomics Core Facility and the Mayo Clinic Mouse Histology Core Facility is acknowledged. This work was supported by generous funding from the Paradifference Foundation, U.S. National Institutes of Health (NIH) National Cancer Institute Grant RO1 CA166025 (to L. J. M), and by the Robert and Arlene Kogod Center on Aging (Mayo Clinic). Funding of the Mayo Clinic Metabolomics Resource Core was by NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant U24DK100469, and originated from the NIH Director's Common Fund. The authors declare no conflicts of interest.	Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038; Alston CL, 2012, J MED GENET, V49, P569, DOI 10.1136/jmedgenet-2012-101146; Astrom K, 2003, HUM GENET, V113, P228, DOI 10.1007/s00439-003-0969-6; Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426; Bailis W, 2019, NATURE, V571, P403, DOI 10.1038/s41586-019-1311-3; Baric I, 2013, EUR J HUM GENET, V21, P871, DOI 10.1038/ejhg.2012.272; Birch-Machin MA, 2000, ANN NEUROL, V48, P330, DOI 10.1002/1531-8249(200009)48:3<330::AID-ANA7>3.0.CO;2-A; Bolon B, 2013, TOXICOL PATHOL, V41, P1028, DOI 10.1177/0192623312474865; Cawthorne Christopher, 2007, J Biomol Tech, V18, P120; de Haas R, 2016, BEHAV BRAIN RES, V296, P191, DOI 10.1016/j.bbr.2015.09.006; Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x; Gill AJ, 2010, HUM PATHOL, V41, P805, DOI 10.1016/j.humpath.2009.12.005; Her YF, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/296167; Her YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127471; Hoekstra AS, 2013, BBA-BIOENERGETICS, V1827, P543, DOI 10.1016/j.bbabio.2012.11.005; Horvath R, 2006, J NEUROL NEUROSUR PS, V77, P74, DOI 10.1136/jnnp.2005.067041; Jabeen SA, 2016, ANN INDIAN ACAD NEUR, V19, P140, DOI 10.4103/0972-2327.175437; Jackson CB, 2014, J MED GENET, V51, P170, DOI 10.1136/jmedgenet-2013-101932; Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642; Kittel B, 2004, EXP TOXICOL PATHOL, V55, P413, DOI 10.1078/0940-2993-00349; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Maher L. J., 2011, PHEOCHROMOCYTOMA NEW, P25, DOI DOI 10.5772/25346; Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159; Mochel F, 2005, J CLIN ENDOCR METAB, V90, P3780, DOI 10.1210/jc.2005-0009; Morawietz G, 2004, EXP TOXICOL PATHOL, V55, P433, DOI 10.1078/0940-2993-00350; Moslemi AR, 2005, NEUROPEDIATRICS, V36, P314, DOI 10.1055/s-2005-872845; Oh EH, 2017, NEUROLOGY, V89, P1754, DOI 10.1212/WNL.0000000000004528; Pal G, 2013, NEUROLOGY, V80; Peters JP, 2015, BIOL OPEN, V4, P1281, DOI 10.1242/bio.013623; Phadke R, 2017, J CLIN MED, V6, DOI 10.3390/jcm6070064; Piruat JI, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00200; Quintana A, 2012, J CLIN INVEST, V122, P2359, DOI 10.1172/JCI62923; Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311; Ruehl-Fehlert C, 2003, EXP TOXICOL PATHOL, V55, P91, DOI 10.1016/S0940-2993(04)70148-7; Ruhoy LS, 2014, APPL CLIN GENET, V7, P221, DOI 10.2147/TACG.S46176; Rustin P, 1997, BBA-MOL BASIS DIS, V1361, P185, DOI 10.1016/S0925-4439(97)00035-5; Sakushima K, 2011, NEUROLOGIST, V17, P222, DOI 10.1097/NRL.0b013e318217357a; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Spinazzi M, 2019, P NATL ACAD SCI USA, V116, P277, DOI 10.1073/pnas.1811938116; Wang YM, 2015, WORLD J GASTROENTERO, V21, P2303, DOI 10.3748/wjg.v21.i8.2303; Wesolowska Maria, 2015, J Neuromuscul Dis, V2, P409; Williamson SR, 2015, MODERN PATHOL, V28, P80, DOI 10.1038/modpathol.2014.86	43	4	4	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13189	13201		10.1096/fj.201802655RR	http://dx.doi.org/10.1096/fj.201802655RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31469588	Bronze, Green Published			2022-12-28	WOS:000507466100013
J	Allawzi, A; McDermott, I; Delaney, C; Nguyen, K; Banimostafa, L; Trumpie, A; Hernandez-Lagunas, L; Riemondy, K; Gillen, A; Hesselberth, J; El Kasmi, K; Sucharov, CC; Janssen, WJ; Stenmark, K; Bowler, R; Nozik-Grayck, E				Allawzi, Ayed; McDermott, Ivy; Delaney, Cassidy; Nguyen, Kianna; Banimostafa, Laith; Trumpie, Ashley; Hernandez-Lagunas, Laura; Riemondy, Kent; Gillen, Austin; Hesselberth, Jay; El Kasmi, Karim; Sucharov, Carmen C.; Janssen, William J.; Stenmark, Kurt; Bowler, Russell; Nozik-Grayck, Eva			Redistribution of EC-SOD resolves bleomycin-induced inflammation via increased apoptosis of recruited alveolar macrophages	FASEB JOURNAL			English	Article						SOD3; extracellular superoxide dismutase; acute lung injury; pulmonary fibrosis	EXTRACELLULAR-SUPEROXIDE DISMUTASE; LUNG; RESOLUTION; POLYMORPHISM; ACTIVATION; CLEARANCE; FIBROSIS; MODEL; MICE	A human single nucleotide polymorphism (SNP) in the matrix-binding domain of extracellular superoxide dismutase (EC-SOD), with arginine to glycine substitution at position 213 (R213G), redistributes EC-SOD from the matrix into extracellular fluids. We reported that, following bleomycin (bleo), knockin mice harboring the human R213G SNP (R213G mice) exhibit enhanced resolution of inflammation and protection against fibrosis, compared with wild-type (WT) littermates. In this study, we tested the hypothesis that the EC-SOD R213G SNP promotes resolution via accelerated apoptosis of recruited alveolar macrophage (AM). RNA sequencing and Ingenuity Pathway Analysis 7 d postbleo in recruited AM implicated increased apoptosis and blunted inflammatory responses in the R213G strain exhibiting accelerated resolution. We validated that the percentage of apoptosis was significantly elevated in R213G recruited AM vs. WT at 3 and 7 d postbleo in vivo. Recruited AM numbers were also significantly decreased in R213G mice vs. WT at 3 and 7 d postbleo. ChaC glutathione-specific gamma-glutamylcyclotransferase 1 (Chad), a proapoptotic gamma-glutamyl cyclotransferase that depletes glutathione, was increased in the R213G recruited AM. Overexpression of Chad in vitro induced apoptosis of macrophages and was blocked by administration of cell-permeable glutathione. In summary, we provide new evidence that redistributed EC-SOD accelerates the resolution of inflammation through redox-regulated mechanisms that increase recruited AM apoptosis.	[Allawzi, Ayed; McDermott, Ivy; Delaney, Cassidy; Nguyen, Kianna; Banimostafa, Laith; Trumpie, Ashley; Hernandez-Lagunas, Laura; El Kasmi, Karim; Stenmark, Kurt; Nozik-Grayck, Eva] Univ Colorado, Cardiovasc Pulm Res Labs, Dept Pediat, Anschutz Med Campus,12700 E 19th Ave,B131, Aurora, CO 80045 USA; [Allawzi, Ayed; McDermott, Ivy; Delaney, Cassidy; Nguyen, Kianna; Banimostafa, Laith; Trumpie, Ashley; Hernandez-Lagunas, Laura; El Kasmi, Karim; Stenmark, Kurt; Nozik-Grayck, Eva] Univ Colorado, Cardiovasc Pulm Res Labs, Dept Med, Anschutz Med Campus,12700 E 19th Ave,B131, Aurora, CO 80045 USA; [Riemondy, Kent; Gillen, Austin; Hesselberth, Jay] Univ Colorado, RNA Biosci Initiat, Anschutz Med Campus, Aurora, CO USA; [Hesselberth, Jay] Univ Colorado, Dept Biochem & Mol Genet, Anschutz Med Campus, Aurora, CO USA; [Sucharov, Carmen C.] Univ Colorado, Dept Med, Div Cardiol, Anschutz Med Campus, Aurora, CO USA; [El Kasmi, Karim] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany; [Janssen, William J.; Bowler, Russell] Natl Jewish Hlth, Dept Med, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Boehringer Ingelheim; National Jewish Health	Nozik-Grayck, E (corresponding author), Univ Colorado, Cardiovasc Pulm Res Labs, Dept Pediat, Anschutz Med Campus,12700 E 19th Ave,B131, Aurora, CO 80045 USA.; Nozik-Grayck, E (corresponding author), Univ Colorado, Cardiovasc Pulm Res Labs, Dept Med, Anschutz Med Campus,12700 E 19th Ave,B131, Aurora, CO 80045 USA.	eva.grayck@ucdenver.edu	stenmark, kurt/AFI-6776-2022; stenmark, kurt/AAH-3124-2022; Nozik, Eva/AAP-5395-2020	Gillen, Austin/0000-0003-2928-6308; Allawzi, Ayed/0000-0002-1178-8927; Nguyen, Kianna/0000-0003-0186-2510	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) [T32 HL007171]; AHA [19POST34380396, R01 HL119533, 5 R01 HL086680, 1R35HL139726-01]; University of Colorado Cancer Center Flow Cytometry Shared Resource NIH National Cancer Institute (NCI) [P30CA046934]; RNA Bioscience Initiative at the University of Colorado School of Medicine; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086680, T32HL007171, R35HL139726, R01HL119533] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AHA(American Heart Association); University of Colorado Cancer Center Flow Cytometry Shared Resource NIH National Cancer Institute (NCI); RNA Bioscience Initiative at the University of Colorado School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Alexandra McCubbrey for technical insight and feedback. This work was funded by the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) Grants T32 HL007171 (to A.A.), AHA 19POST34380396 (to A.A.), R01 HL119533, 5 R01 HL086680, and 1R35HL139726-01 (to E.N.-G.). This work was supported, in part, by the University of Colorado Cancer Center Flow Cytometry Shared Resource NIH National Cancer Institute (NCI; P30CA046934). This work was also supported by the RNA Bioscience Initiative at the University of Colorado School of Medicine (to K.R. and A.G.). The authors declare no conflicts of interest.	Allawzi AM, 2018, AM J RESP CELL MOL, V58, P658, DOI 10.1165/rcmb.2016-0344OC; Bowers R, 2004, AM J RESP CRIT CARE, V169, P764, DOI 10.1164/rccm.200301-147OC; Bowler RP, 2004, AM J RESP CELL MOL, V31, P432, DOI 10.1165/rcmb.2004-0057OC; Dahl M, 2008, AM J RESP CRIT CARE, V178, P906, DOI 10.1164/rccm.200804-549OC; Dockrell DH, 2003, J IMMUNOL, V171, P5380, DOI 10.4049/jimmunol.171.10.5380; El Kasmi KC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03764-1; Fattman CL, 2001, FREE RADICAL BIO MED, V31, P1198, DOI 10.1016/S0891-5849(01)00699-2; Garcia AM, 2018, PHYSIOL GENOMICS, V50, P807, DOI 10.1152/physiolgenomics.00053.2018; Gaurav R, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.95072; Good RJ, 2018, AM J PHYSIOL-LUNG C, V315, pL584, DOI 10.1152/ajplung.00073.2017; Gottfredsen RH, 2014, FREE RADICAL BIO MED, V69, P348, DOI 10.1016/j.freeradbiomed.2014.01.038; Hartney JM, 2014, CIRC-CARDIOVASC GENE, V7, P659, DOI 10.1161/CIRCGENETICS.113.000504; Janssen WJ, 2011, AM J RESP CRIT CARE, V184, P547, DOI 10.1164/rccm.201011-1891OC; Kinnula VL, 2003, AM J RESP CRIT CARE, V167, P1600, DOI 10.1164/rccm.200212-1479SO; Kolahian S, 2016, AM J RESP CELL MOL, V55, P309, DOI 10.1165/rcmb.2016-0121TR; Loenders B, 1998, FREE RADICAL BIO MED, V24, P1097, DOI 10.1016/S0891-5849(97)00434-6; Lopes F, 2011, ARTHRITIS RHEUM-US, V63, P2651, DOI 10.1002/art.30448; McCubbrey AL, 2018, AM J RESP CELL MOL, V58, P66, DOI 10.1165/rcmb.2017-0154OC; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Mouradian GC, 2017, AM J RESP CELL MOL, V56, P362, DOI 10.1165/rcmb.2016-0153OC; Nonas S, 2006, AM J RESP CRIT CARE, V173, P1130, DOI 10.1164/rccm.200511-1737OC; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Ortiz LA, 1998, AM J PHYSIOL-LUNG C, V275, pL1208, DOI 10.1152/ajplung.1998.275.6.L1208; Patel BV, 2015, AM J PHYSIOL-LUNG C, V309, pL639, DOI 10.1152/ajplung.00140.2015; Petersen SV, 2004, J BIOL CHEM, V279, P13705, DOI 10.1074/jbc.M310217200; Pugliese SC, 2017, J IMMUNOL, V198, P4802, DOI 10.4049/jimmunol.1601692; Redente EF, 2014, AM J RESP CELL MOL, V50, P825, DOI 10.1165/rcmb.2013-0386OC; Reis AC, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.580; SANDSTROM J, 1994, J BIOL CHEM, V269, P19163; Tan RJ, 2004, J APPL PHYSIOL, V97, P2006, DOI 10.1152/japplphysiol.00480.2004; Taut K, 2008, AM J RESP CELL MOL, V38, P105, DOI 10.1165/rcmb.2007-0132OC; WARE LB, 2000, NEW ENGL J MED, V342, P1334, DOI [DOI 10.1056/NEJM200005043421806, 10.1056/NEJM200005043421806]; Zgheib C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177453; Zizzo G, 2012, J IMMUNOL, V189, P3508, DOI 10.4049/jimmunol.1200662	34	5	6	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13465	13475		10.1096/fj.201901038RR	http://dx.doi.org/10.1096/fj.201901038RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31560857	Green Published, Bronze			2022-12-28	WOS:000507466100034
J	Kalpage, HA; Vaishnav, A; Liu, J; Varughese, A; Wan, JM; Turner, AA; Ji, QQ; Zurek, MP; Kapralov, AA; Kagan, VE; Brunzelle, JS; Recanati, MA; Grossman, LI; Sanderson, TH; Lee, I; Salomon, AR; Edwards, BFP; Huttemann, M				Kalpage, Hasini A.; Vaishnav, Asmita; Liu, Jenney; Varughese, Ashwathy; Wan, Junmei; Turner, Alice A.; Ji, Qinqin; Zurek, Matthew P.; Kapralov, Alexandr A.; Kagan, Valerian E.; Brunzelle, Joseph S.; Recanati, Maurice-Andre; Grossman, Lawrence I.; Sanderson, Thomas H.; Lee, Icksoo; Salomon, Arthur R.; Edwards, Brian F. P.; Huttemann, Maik			Serine-47 phosphorylation of cytochrome c in the mammalian brain regulates cytochrome c oxidase and caspase-3 activity	FASEB JOURNAL			English	Article						apoptosis; electron transport chain; ischemia; respiration; signaling	OXIDATIVE-PHOSPHORYLATION; IN-VIVO; MITOCHONDRIA; RESPIRATION; CARDIOLIPIN; MECHANISMS; LIPIDOMICS; DYNAMICS; COMPLEX; LIVER	Cytochrome c (Cytc) is a multifunctional protein that operates as an electron carrier in the mitochondrial electron transport chain and plays a key role in apoptosis. We have previously shown that tissue-specific phosphorylations of Cytc in the heart, liver, and kidney play an important role in the regulation of cellular respiration and cell death. Here, we report that Cytc purified from mammalian brain is phosphorylated on S47 and that this phosphorylation is lost during ischemia. We have characterized the functional effects in vitro using phosphorylated Cytc purified from pig brain tissue and a recombinant phosphomimetic mutant (S47E). We crystallized S47E phosphomimetic Cytc at 1.55 angstrom and suggest that it spatially matches S47-phosphorylated Cytc, making it a good model system. Both S47-phosphorylated and phosphomimetic Cytc showed a lower oxygen consumption rate in reaction with isolated Cytc oxidase, which we propose maintains intermediate mitochondrial membrane potentials under physiologic conditions, thus minimizing production of reactive oxygen species. S47-phosphorylated and phosphomimetic Cytc showed lower caspase-3 activity. Furthermore, phosphomimetic Cytc had decreased cardiolipin peroxidase activity and is more stable in the presence of H2O2. Our data suggest that S47 phosphorylation of Cytc is tissue protective and promotes cell survival in the brain.	[Kalpage, Hasini A.; Liu, Jenney; Varughese, Ashwathy; Wan, Junmei; Turner, Alice A.; Zurek, Matthew P.; Recanati, Maurice-Andre; Grossman, Lawrence I.; Huttemann, Maik] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI USA; [Vaishnav, Asmita; Varughese, Ashwathy; Wan, Junmei; Turner, Alice A.; Edwards, Brian F. P.; Huttemann, Maik] Wayne State Univ, Dept Biochem Microbiol & Immunol, Detroit, MI USA; [Recanati, Maurice-Andre] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI USA; [Ji, Qinqin; Salomon, Arthur R.] Brown Univ, Dept Chem, Providence, RI 02912 USA; [Kapralov, Alexandr A.; Kagan, Valerian E.] Univ Pittsburgh, Ctr Free Rad & Antioxidant Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Kagan, Valerian E.] IM Sechenov Moscow Med State Univ, Lab Nav Redox Lipid, Moscow, Russia; [Brunzelle, Joseph S.] Northwestern Univ, Ctr Synchrotron Res, Argonne, IL USA; [Sanderson, Thomas H.] Univ Michigan, Sch Med, Dept Emergency Med, Ann Arbor, MI USA; [Sanderson, Thomas H.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Sanderson, Thomas H.; Huttemann, Maik] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI USA; [Lee, Icksoo] Dankook Univ, Coll Med, Cheonan Si, South Korea	Wayne State University; Wayne State University; Wayne State University; Brown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Wayne State University; Dankook University	Huttemann, M (corresponding author), Wayne State Univ, Sch Med, Ctr Mol Med & Genet, 540 East Canfield St, Detroit, MI 48201 USA.	mhuttema@med.wayne.edu	; Sanderson, Thomas/K-6656-2012	Recanati, Maurice Andre/0000-0003-0974-3962; Sanderson, Thomas/0000-0003-0112-8164; Huttemann, Maik/0000-0001-6310-7081; Kagan, Valerian E./0000-0002-7245-1885; Kapralov, Oleksandr/0000-0002-3006-916X; Brunzelle, Joseph/0000-0001-9197-0018	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [R01 GM116807, R01 GM113908]; NIH National Institute of Neurological Disorders and Stroke [R01 NS091242, R42 NS105238]; Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program [W81XWH-16-1-0175]; Department of Defense or the NIH; U.S. Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor [085P1000817]; Wayne State University Office of the Vice-President for Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113908, R01GM116807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091242, R42NS105238] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program; Department of Defense or the NIH; U.S. Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor; Wayne State University Office of the Vice-President for Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grants R01 GM116807 and R01 GM113908, NIH National Institute of Neurological Disorders and Stroke Grants R01 NS091242 and R42 NS105238, and by the Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program under Award W81XWH-16-1-0175. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the funding agencies including the Department of Defense or the NIH. This research used resources of the Advanced Photon Source, a U.S. Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. Use of the Life Sciences Collaborative Access Team (LS-CAT) Sector 21 was supported by the Michigan Economic Development Corp., the Michigan Technology Tri-Corridor (Grant 085P1000817), and Wayne State University Office of the Vice-President for Research. The authors declare no conflicts of interest.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arachiche A, 2008, J BIOL CHEM, V283, P24406, DOI 10.1074/jbc.M709217200; Bassols A, 2014, PROTEOM CLIN APPL, V8, P715, DOI 10.1002/prca.201300099; Cammack R., 1995, BIOENERGETICS PRACTI, P93; Cheng TC, 2016, ELIFE, V5, DOI 10.7554/eLife.17755; Dalmonte ME, 2009, J BIOL CHEM, V284, P32331, DOI 10.1074/jbc.M109.050146; Deacon OM, 2018, BIOCHEMISTRY-US, V57, P4276, DOI 10.1021/acs.biochem.8b00520; Dickerson R., 1975, ENZYMES, V11, P397; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Guerra-Castellano A, 2016, BBA-BIOENERGETICS, V1857, P387, DOI 10.1016/j.bbabio.2016.01.011; Hannibal L, 2016, BIOCHEMISTRY-US, V55, P407, DOI 10.1021/acs.biochem.5b01385; Helling S, 2012, PROTEOMICS, V12, P950, DOI 10.1002/pmic.201100618; HINKLE PC, 1991, BIOCHEMISTRY-US, V30, P3576, DOI 10.1021/bi00228a031; Hoffman NJ, 2015, CELL METAB, V22, P922, DOI 10.1016/j.cmet.2015.09.001; Hojlund K, 2009, J PROTEOME RES, V8, P4954, DOI 10.1021/pr9007267; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; Huttemann M, 2000, BBA-GENE STRUCT EXPR, V1492, P252, DOI 10.1016/S0167-4781(00)00087-7; Huttemann M, 2003, MOL REPROD DEV, V66, P8, DOI 10.1002/mrd.10327; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Jaradat SA, 1998, GENOMICS, V49, P363, DOI 10.1006/geno.1998.5279; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KADENBACH B, 1983, ANAL BIOCHEM, V129, P517, DOI 10.1016/0003-2697(83)90586-9; Kagan VE, 2006, CHEM-BIOL INTERACT, V163, P15, DOI 10.1016/j.cbi.2006.04.019; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kagan VE, 2004, FREE RADICAL BIO MED, V37, P1963, DOI 10.1016/j.freeradbiomed.2004.08.016; Kalpage HA, 2019, FASEB J, V33, P1540, DOI 10.1096/fj.201801417R; Karsisiotis AI, 2016, SCI REP-UK, V6, DOI 10.1038/srep30447; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Krieger E, 2015, J COMPUT CHEM, V36, P996, DOI 10.1002/jcc.23899; KUHNNENTWIG L, 1985, EUR J BIOCHEM, V149, P147, DOI 10.1111/j.1432-1033.1985.tb08905.x; Lee I, 2006, BIOCHEMISTRY-US, V45, P9121, DOI 10.1021/bi060585v; Lee I, 2009, METHOD ENZYMOL, V457, P193, DOI 10.1016/S0076-6879(09)05011-3; Liu SS, 1999, J BIOENERG BIOMEMBR, V31, P367; Liu Z, 2006, P NATL ACAD SCI USA, V103, P8965, DOI 10.1073/pnas.0603327103; Mahapatra G, 2017, J BIOL CHEM, V292, P64, DOI 10.1074/jbc.M116.744664; Maity H, 2004, J MOL BIOL, V343, P223, DOI 10.1016/j.jmb.2004.08.005; MARGOLIASH E, 1959, BIOCHEM J, V71, P570, DOI 10.1042/bj0710570; MICHEL B, 1984, J BIOL CHEM, V259, P85; Nicholls D. G., 1992, BIOENERGETICS; Pecina P, 2010, BIOCHEMISTRY-US, V49, P6705, DOI 10.1021/bi100486s; Pereverzev MO, 2003, BIOCHEM SOC T, V31, P1312; Piccoli C, 2006, BIOCHEM J, V396, P573, DOI 10.1042/BJ20060077; Pierron D, 2012, ADV EXP MED BIOL, V748, P185, DOI 10.1007/978-1-4614-3573-0_8; Pierron D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026269; Raichle ME, 2002, P NATL ACAD SCI USA, V99, P10237, DOI 10.1073/pnas.172399499; Roberts VA, 1999, J BIOL CHEM, V274, P38051, DOI 10.1074/jbc.274.53.38051; Rottenberg H, 2009, J BIOL CHEM, V284, P19203, DOI 10.1074/jbc.M109.017376; Sanderson TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078627; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; SANISHVILI R, 1995, STRUCTURE, V3, P707, DOI 10.1016/S0969-2126(01)00205-2; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Sinkler CA, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1534056; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Yu H, 2008, BBA-BIOENERGETICS, V1777, P1066, DOI 10.1016/j.bbabio.2008.04.023; Zaidi S, 2014, CELL MOL LIFE SCI, V71, P229, DOI 10.1007/s00018-013-1341-1; Zhao XL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000299	60	10	10	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13503	13514		10.1096/fj.201901120R	http://dx.doi.org/10.1096/fj.201901120R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31570002	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000507466100037
J	McMurray, F; MacFarlane, M; Kim, K; Patten, DA; Wei-LaPierre, L; Fullerton, MD; Harper, ME				McMurray, Fiona; MacFarlane, Megan; Kim, Kijoo; Patten, David A.; Wei-LaPierre, Lan; Fullerton, Morgan D.; Harper, Mary-Ellen			Maternal diet-induced obesity alters muscle mitochondrial function in offspring without changing insulin sensitivity	FASEB JOURNAL			English	Article						type 2 diabetes; mitochondria; reactive oxygen species; maternal overnutrition; insulin resistance	PROTEIN-KINASE-C; SKELETAL-MUSCLE; OXIDATIVE STRESS; SUPEROXIDE FLASHES; METABOLIC SYNDROME; ANIMAL-MODELS; BIRTH-WEIGHT; RESISTANCE; PREGNANCY; PHOSPHORYLATION	In utero overnutrition can predispose offspring to metabolic disease. Although the mechanisms are unclear, increased oxidative stress accelerating cellular aging has been shown to play a role. Mitochondria are the main site of reactive oxygen species (ROS) production in most cell types. Levels of ROS and the risk for oxidative damage are dictated by the balance between ROS production and antioxidant defense mechanisms. Originally considered as toxic species, physiologic levels of ROS are now known to be essential cell signaling molecules. Using a model of maternal over-nutrition in C57BL6N mice, we investigate the mechanisms involved in the development of insulin resistance (IR) in muscle. In red and white gastrocnemius musdes of offspring, we are the first to report characteristics of oxidative phosphorylation, H2O2 production, activity of mitoflashes, and electron transport chain supercomplex formation. Results demonstrate altered mitochondrial function with reduced response to glucose in offspring of mice fed a high-fat and high-sucrose diet, increases in mitochondrial leak respiration, and a reduction in ROS production in red gastrocnemius in response to palmitoyl carnitine. We also demonstrate differences in supercomplex formation between red and white gastrocnemius, which may be integral to fiber-type specialization. We condude that in this model of maternal overnutrition, mitochondrial alterations occur before the development of IR.	[McMurray, Fiona; MacFarlane, Megan; Kim, Kijoo; Patten, David A.; Fullerton, Morgan D.; Harper, Mary-Ellen] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada; [McMurray, Fiona; Patten, David A.; Harper, Mary-Ellen] Ottawa Inst Syst Biol, Ottawa, ON, Canada; [Wei-LaPierre, Lan] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY USA	University of Ottawa; University of Ottawa; University of Rochester	Harper, ME (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	mharper@uottawa.ca			Canadian Institutes of Health Research (CIHR) [FDN143278, PJT148634]; CIHR New Investigator Award	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR))	The authors thank Jian Xuan and the animal care staff at the University of Ottawa for dedicated assistance during this study. The authors thank Chantal Pileggi and Gaganvir Parmar (University of Ottawa) for technical assistance addressing the reviewer comments. The authors also thank Prof. Robert Dirksen (University of Rochester) for providing us with the mitochondrially targeted circularly permuted yellow fluorescent protein (mt-cpYFP) mice. This work was also supported by Canadian Institutes of Health Research (CIHR) funding to M.E.H. (FDN143278) and to M.D.F. (PJT148634). M.D.F. is supported by a CIHR New Investigator Award. The authors declare no conflicts of interest.	Abdul-Ghani MA, 2009, DIABETOLOGIA, V52, P574, DOI 10.1007/s00125-009-1264-4; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Antoun G, 2015, DIABETOLOGIA, V58, P2861, DOI 10.1007/s00125-015-3772-8; Battista MC, 2005, J PHYSIOL-LONDON, V565, P197, DOI 10.1113/jphysiol.2004.078139; Beauchamp B, 2015, INT J OBESITY, V39, P702, DOI 10.1038/ijo.2014.120; Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Bonomini F, 2015, AGING DIS, V6, P109, DOI 10.14336/AD.2014.0305; Boudina S, 2012, ENDOCRINOLOGY, V153, P2677, DOI 10.1210/en.2011-2147; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Chandel NS, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-34; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dabelea D, 2000, J Matern Fetal Med, V9, P83, DOI 10.1002/(SICI)1520-6661(200001/02)9:1<83::AID-MFM17>3.0.CO;2-O; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; DelPrado M, 1997, J NUTR, V127, P458, DOI 10.1093/jn/127.3.458; Ding Y, 2015, J MOL MED, V93, P1119, DOI 10.1007/s00109-015-1278-y; Eckel RH, 2011, J CLIN ENDOCR METAB, V96, P1654, DOI 10.1210/jc.2011-0585; Fang HQ, 2011, CELL RES, V21, P1295, DOI 10.1038/cr.2011.81; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Gale CR, 2007, J CLIN ENDOCR METAB, V92, P3904, DOI 10.1210/jc.2007-0088; Genova ML, 2015, ANTIOXID REDOX SIGN, V23, P208, DOI 10.1089/ars.2014.6214; Giussani DA, 2013, J DEV ORIG HLTH DIS, V4, P328, DOI 10.1017/S204017441300010X; Gonzalez-Franquesa A., 2017, ADV EXPT MED BIOL, V982; Greggio C, 2017, CELL METAB, V25, P301, DOI 10.1016/j.cmet.2016.11.004; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Jimenez-Chillaron JC, 2009, DIABETES, V58, P460, DOI 10.2337/db08-0490; Kammoun M, 2014, EUR J HISTOCHEM, V58, P163, DOI 10.4081/ejh.2014.2254; Kanaan GN, 2019, CAN J DIABETES, V43, P67, DOI 10.1016/j.jcjd.2018.05.007; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Larsen S, 2011, DIABETOLOGIA, V54, P1427, DOI 10.1007/s00125-011-2098-4; Latouche C, 2014, J NUTR, V144, P237, DOI 10.3945/jn.113.186775; Lawlor DA, 2007, AM J EPIDEMIOL, V165, P418, DOI 10.1093/aje/kwk030; Lee JH, 1997, INT J OBESITY, V21, P935, DOI 10.1038/sj.ijo.0800498; Lehtovirta M, 2000, DIABETOLOGIA, V43, P285, DOI 10.1007/s001250050046; Maranzana E, 2013, ANTIOXID REDOX SIGN, V19, P1469, DOI 10.1089/ars.2012.4845; McBride S, 2019, ARCH BIOCHEM BIOPHYS, V663, P239, DOI 10.1016/j.abb.2019.01.018; McMurray F, 2016, OBESITY, V24, P2301, DOI 10.1002/oby.21654; McMurray F, 2011, MAMM GENOME, V22, P390, DOI 10.1007/s00335-011-9345-3; Metzger BE, 2010, BJOG-INT J OBSTET GY, V117, P575, DOI 10.1111/j.1471-0528.2009.02486.x; Milenkovic D, 2017, CELL METAB, V25, P765, DOI 10.1016/j.cmet.2017.03.009; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; National Center for Chronic Disease Prevention and Health Promotion, 2017, NAT DIAB STAT REP 20; Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349; Petersen KF, 2005, PLOS MED, V2, P879, DOI 10.1371/journal.pmed.0020233; Petropoulos S, 2015, ENDOCRINOLOGY, V156, P2222, DOI 10.1210/en.2014-1643; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Poulsen P, 2002, DIABETOLOGIA, V45, P1649, DOI 10.1007/s00125-002-0983-6; Pouvreau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013035; Radford EJ, 2012, PLOS GENET, V8, P41, DOI 10.1371/journal.pgen.1002605; Roberts CK, 2013, COMPR PHYSIOL, V3, P1, DOI 10.1002/cphy.c110062; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Samuelsson AM, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00014; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; Schwarzlander M, 2014, NATURE, V514, pE12, DOI 10.1038/nature13858; Schwarzlander M, 2012, TRENDS CELL BIOL, V22, P503, DOI 10.1016/j.tcb.2012.07.007; Simmons RA, 2006, FREE RADICAL BIO MED, V40, P917, DOI 10.1016/j.freeradbiomed.2005.12.018; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wang W, 2016, ANTIOXID REDOX SIGN, V25, P534, DOI 10.1089/ars.2016.6739; Wei L, 2011, FASEB J, V25, P3068, DOI 10.1096/fj.11-187252; Wei-LaPierre L, 2013, J BIOL CHEM, V288, P10567, DOI 10.1074/jbc.M113.455709; Whitaker RC, 2004, PEDIATRICS, V114, pE29, DOI 10.1542/peds.114.1.e29; Williams L, 2014, BBA-MOL BASIS DIS, V1842, P507, DOI 10.1016/j.bbadis.2013.07.006; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yzydorczyk C, 2008, HYPERTENSION, V52, P889, DOI 10.1161/HYPERTENSIONAHA.108.116251	68	8	8	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13515	13526		10.1096/fj.201901150R	http://dx.doi.org/10.1096/fj.201901150R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31581846	Bronze			2022-12-28	WOS:000507466100038
J	Srivastava, AC; Thompson, YG; Singhal, J; Stellern, J; Srivastava, A; Du, J; O'Connor, TR; Riggs, AD				Srivastava, Avinash C.; Thompson, Yesenia Guadalupe; Singhal, Jyotsana; Stellern, Jordan; Srivastava, Anviksha; Du, Juan; O'Connor, Timothy R.; Riggs, Arthur D.			Elimination of human folypolyglutamate synthetase alters programming and plasticity of somatic cells	FASEB JOURNAL			English	Article						C1 metabolism; CRISPR/Cas9; GABA; glutamate-induced pluripotency	GAMMA-GLUTAMATE SYNTHETASE; ONE-CARBON METABOLISM; GLOBAL DNA METHYLATION; FOLYLPOLYGLUTAMATE SYNTHETASE; SERINE HYDROXYMETHYLTRANSFERASE; GENE-EXPRESSION; MOLECULAR-MECHANISMS; FOLATE-DEFICIENCY; PROTEIN; CANCER	Folates are vital cofactors for the regeneration of S-adenosyl methionine, which is the methyl source for DNA methylation, protein methylation, and other aspects of one-carbon (C1) metabolism. Thus, folates are critical for establishing and preserving epigenetic programming. Folypolyglutamate synthetase (FPGS) is known to play a crucial role in the maintenance of intracellular folate levels. Therefore, any modulation in FPGS is expected to alter DNA methylation and numerous other metabolic pathways. To explore the role of polyglutamylation of folate, we eliminated both isoforms of FPGS in human cells (293T), producing FPGS knockout (FPGS(ko)) cells. The elimination of FPGS significantly decreased cell proliferation, with a major effect on oxidative phosphorylation and a lesser effect on glycolysis. We found a substantial reduction in global DNA methylation and noteworthy changes in gene expression related to C1 metabolism, cell division, DNA methylation, pluripotency, Glu metabolism, neurogenesis, and cardiogenesis. The expression levels of NANOG, octamer-binding transcription factor 4, and sex-determining region Y-box 2 levels were increased in the mutant, consistent with the transition to a stem cell like state. Gene expression and metabolite data also indicate a major change in Glu and GABA metabolism. In the appropriate medium, FPGS(ko) cells can differentiate to produce mainly cells with characteristics of either neural stem cells or cardiomyocytes.	[Srivastava, Avinash C.; Singhal, Jyotsana; Riggs, Arthur D.] City Hope Natl Med Ctr, Dept Diabet Complicat & Metab, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Thompson, Yesenia Guadalupe; Stellern, Jordan; Srivastava, Anviksha; O'Connor, Timothy R.] City Hope Natl Med Ctr, Dept Canc Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Du, Juan] City Hope Natl Med Ctr, Integrat Genom Core Facil, 1500 E Duarte Rd, Duarte, CA 91010 USA	City of Hope; City of Hope; City of Hope	Srivastava, AC; Riggs, AD (corresponding author), City Hope Natl Med Ctr, Dept Diabet Complicat & Metab, 1500 E Duarte Rd, Duarte, CA 91010 USA.	asrivastava@coh.org; ariggs@coh.org		O'Connor, Timothy/0000-0001-5848-3592	Diabetes and Metabolism Research Institute; City of Hope National Medical Center Tobacco-Related Disease Research Program [28IR-0050]; City of Hope Cancer Center [P30 CA 033572]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER	Diabetes and Metabolism Research Institute; City of Hope National Medical Center Tobacco-Related Disease Research Program; City of Hope Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. Xiwei Wu, Hanjun Qin, and Chao Guo (City of Hope Integrative Genomics Core) and Lucy Brown, Shaun Hsueh, and Alexander Spalla (Analytical Cytometry Core, City of Hope) for helping with the transcriptomics and single-cell sorting. The authors also thank Prof. Oliver Fiehn and his team (U.S. National Institutes of Health West Coast Metabolomics Center, University of California-Davis Genome Center, Davis, CA, USA) for support in metabolomics. The authors thank Avinash Srivastava for designing and producing Figure 1 using BioRender (https://biorender.com/).This work was supported by the Diabetes and Metabolism Research Institute, City of Hope National Medical Center Tobacco-Related Disease Research Program (28IR-0050 to T.R.O.), and the City of Hope Cancer Center (P30 CA 033572). A.C.S., T.R.O., and A.D.R. contributed equally to this work. The authors declare no conflicts of interest.	Jimenez NA, 2018, DEV BIOL, V444, pS193, DOI 10.1016/j.ydbio.2018.08.001; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Andreassi JL, 2002, BIOCHEMISTRY-US, V41, P226, DOI 10.1021/bi015644d; Atkinson IJ, 1998, PHYTOCHEMISTRY, V49, P2221, DOI 10.1016/S0031-9422(98)00317-3; Ausubel FM, 1989, CURRENT PROTOCOLS MO, V1-3; BALAGHI M, 1993, BIOCHEM BIOPH RES CO, V193, P1184, DOI 10.1006/bbrc.1993.1750; Beaudin Anna E., 2007, Birth Defects Research, V81, P183, DOI 10.1002/bdrc.20100; Bienemann K, 2013, CANCER GENE THER, V20, P514, DOI 10.1038/cgt.2013.48; Burgos-Barragan G, 2017, NATURE, V548, P549, DOI 10.1038/nature23481; Cajka T, 2016, ANAL CHEM, V88, P524, DOI 10.1021/acs.analchem.5b04491; Chang YC, 1996, J NEUROSCI, V16, P5415; Chen L, 1996, J BIOL CHEM, V271, P13077, DOI 10.1074/jbc.271.22.13077; Chen ZX, 2011, J BIOL CHEM, V286, P18347, DOI 10.1074/jbc.R110.205286; CHU W, 1995, J BIOL CHEM, V270, P10236, DOI 10.1074/jbc.270.17.10236; CODY V, 1992, J MOL BIOL, V224, P1179, DOI 10.1016/0022-2836(92)90480-8; Crider KS, 2012, ADV NUTR, V3, P21, DOI 10.3945/an.111.000992; Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009; El Fadili A, 2002, MOL BIOCHEM PARASIT, V124, P63, DOI 10.1016/S0166-6851(02)00163-9; Endo Y, 2012, DEV CELL, V23, P305, DOI 10.1016/j.devcel.2012.07.006; Feng HC, 2017, INT J CANCER, V141, P2537, DOI 10.1002/ijc.31008; FINKELSTEIN JD, 1990, J NUTR BIOCHEM, V1, P228, DOI 10.1016/0955-2863(90)90070-2; FREEMANTLE SJ, 1995, J BIOL CHEM, V270, P9579, DOI 10.1074/jbc.270.16.9579; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gonda TA, 2012, GASTROENTEROLOGY, V142, P824, DOI 10.1053/j.gastro.2011.12.058; Hanafy S. M., 2011, AM J MOL BIOL, V1, P62; Heil SG, 2001, MOL GENET METAB, V73, P164, DOI 10.1006/mgme.2001.3175; Hertz Leif, 2013, Front Endocrinol (Lausanne), V4, P59, DOI 10.3389/fendo.2013.00059; Hu JW, 2018, CELLS TISSUES ORGANS, V205, P1, DOI 10.1159/000485501; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang Z, 2016, MED SCI MONITOR, V22, P4967, DOI 10.12659/MSM.899021; Iskandar BJ, 2010, J CLIN INVEST, V120, P1603, DOI 10.1172/JCI40000; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Kang Eunchai, 2015, Neurogenesis (Austin), V2, pe1081715, DOI 10.1080/23262133.2015.1081715; Kim JM, 2009, J NUTR BIOCHEM, V20, P172, DOI 10.1016/j.jnutbio.2008.01.010; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim SE, 2016, J NUTR BIOCHEM, V29, P27, DOI 10.1016/j.jnutbio.2015.10.019; Kim SE, 2015, GENES NUTR, V10, DOI [10.1007/s12263-014-0444-0, 10.1007/s12263-015-0475-1]; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Korshunova I, 2008, J NEUROSCI RES, V86, P2201, DOI 10.1002/jnr.21678; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Lawrence SA, 2014, J BIOL CHEM, V289, P29386, DOI 10.1074/jbc.M114.593244; Leclerc GJ, 2001, CLIN CANCER RES, V7, P942; Leil TA, 2007, CANCER RES, V67, P8772, DOI 10.1158/0008-5472.CAN-07-0156; Li Y, 2018, PHYSIOL GENOMICS, V50, P158, DOI 10.1152/physiolgenomics.00094.2017; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Lim U, 2005, J NUTR, V135, P1989, DOI 10.1093/jn/135.8.1989; LIN BF, 1993, J BIOL CHEM, V268, P21674; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Lorente P, 2000, P NATL ACAD SCI USA, V97, P8664, DOI 10.1073/pnas.97.15.8664; Luciano-Mateo F, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020121; Mato JM, 1997, PHARMACOL THERAPEUT, V73, P265, DOI 10.1016/S0163-7258(96)00197-0; Mattson MP, 2003, TRENDS NEUROSCI, V26, P137, DOI 10.1016/S0166-2236(03)00032-8; MCCLOSKEY DE, 1991, J BIOL CHEM, V266, P6181; MCGUIRE JJ, 1981, MOL CELL BIOCHEM, V38, P19, DOI 10.1007/BF00235686; MORAN RG, 1988, BIOCHEM PHARMACOL, V37, P1997, DOI 10.1016/0006-2952(88)90547-3; Moran RG, 1999, SEMIN ONCOL, V26, P24; Morrissey C, 2008, CANCER RES, V68; Oka M, 2013, J BIOL CHEM, V288, P15085, DOI 10.1074/jbc.M112.448837; Padmanabhan N, 2013, CELL, V155, P81, DOI 10.1016/j.cell.2013.09.002; Padron-Barthe L, 2018, J AM COLL CARDIOL, V71, P654, DOI 10.1016/j.jacc.2017.11.067; Pahnke A, 2016, BIOCHEM BIOPH RES CO, V473, P698, DOI 10.1016/j.bbrc.2015.11.060; Pennarossa G, 2013, P NATL ACAD SCI USA, V110, P8948, DOI 10.1073/pnas.1220637110; Piyathilake CJ, 2000, NUTR CANCER, V37, P99, DOI 10.1207/S15327914NC3701_13; Riekstina U, 2009, STEM CELL REV REP, V5, P378, DOI 10.1007/s12015-009-9094-9; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; Rosowsky A, 1999, J MED CHEM, V42, P3510, DOI 10.1021/jm9807205; Roxburgh J, 2016, CYTOTECHNOLOGY, V68, P957, DOI 10.1007/s10616-015-9848-y; Salabei JK, 2015, STEM CELLS, V33, P2613, DOI 10.1002/stem.2047; Schlett K, 2006, CURR TOP MED CHEM, V6, P949, DOI 10.2174/156802606777323665; SHANE B, 1985, ANNU REV NUTR, V5, P115, DOI 10.1146/annurev.nu.05.070185.000555; Sheaffer KL, 2014, GENE DEV, V28, P652, DOI 10.1101/gad.230318.113; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Srivastava AC, 2011, PLANT PHYSIOL, V155, P1237, DOI 10.1104/pp.110.168278; Srivastava S, 2014, AM J MED GENET A, V164, P2914, DOI 10.1002/ajmg.a.36714; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAYLOR RT, 1982, ARCH BIOCHEM BIOPHYS, V217, P609, DOI 10.1016/0003-9861(82)90543-4; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Tyagi N, 2007, CLIN CHEM LAB MED, V45, P1777, DOI 10.1515/CCLM.2007.342; Vicini S, 2008, J PHYSIOL-LONDON, V586, P3737, DOI 10.1113/jphysiol.2008.159046; Wallingford JB, 2013, SCIENCE, V339, P1011, DOI 10.1126/science.1222002; Walls AB, 2015, NEUROCHEM RES, V40, P402, DOI 10.1007/s11064-014-1473-1; Wang INE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038328; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121; Wojtuszkiewicz A, 2016, INT J CANCER, V138, P1645, DOI 10.1002/ijc.29919; Yannarelli G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189131; Yoshioka J, 2004, CIRCULATION, V109, P2581, DOI 10.1161/01.CIR.0000129771.32215.44; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao RB, 2000, CLIN CANCER RES, V6, P3687; Zhou HR, 2013, PLANT CELL, V25, P2545, DOI 10.1105/tpc.113.114678; Ziller MJ, 2018, CELL STEM CELL, V22, P559, DOI 10.1016/j.stem.2018.02.012	94	4	4	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13747	13761		10.1096/fj.201901721R	http://dx.doi.org/10.1096/fj.201901721R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31585510	Bronze, Green Published			2022-12-28	WOS:000507466100055
J	Felizardo, RJF; de Almeida, DC; Pereira, RL; Watanabe, IKM; Doimo, NTS; Ribeiro, WR; Cenedeze, MA; Hiyane, MI; Amano, MT; Braga, TT; Ferreira, CM; Parmigiani, RB; Andrade-Oliveira, V; Volpini, RA; Vinolo, MAR; Marino, E; Robert, R; Mackay, CR; Camara, NOS				Felizardo, Raphael J. F.; de Almeida, Danilo C.; Pereira, Rafael L.; Watanabe, Ingrid K. M.; Doimo, Nayara T. S.; Ribeiro, Willian R.; Cenedeze, Marcos A.; Hiyane, Meire I.; Amano, Mariane T.; Braga, Tarcio T.; Ferreira, Caroline M.; Parmigiani, Raphael B.; Andrade-Oliveira, Vinicius; Volpini, Rildo A.; Vinolo, Marco Aurelio R.; Marino, Eliana; Robert, Remy; Mackay, Charles R.; Camara, Niels O. S.			Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms	FASEB JOURNAL			English	Article						glomerulopathy; podocyte; ADR nephropathy; SCFA	CHAIN FATTY-ACIDS; DIETARY FIBER; SODIUM-BUTYRATE; INFLAMMATION; RECEPTOR; ACTIVATION; GLOMERULOSCLEROSIS; ACETYLATION; PROGRESSION; EXPRESSION	Butyrate is a short-chain fatty acid derived from the metabolism of indigestible carbohydrates by the gut microbiota. Butyrate contributes to gut homeostasis, but it may also control inflammatory responses and host physiology in other tissues. Butyrate inhibits histone deacetylases, thereby affecting gene transcription, and also signals through the metabolite-sensing G protein receptor (GPR)109a. We produced an mAb to mouse GPR109a and found high expression on podocytes in the kidney. Wild-type and Gpr109a(-/-) mice were induced to develop nephropathy by a single injection of Adriamycin and treated with sodium butyrate or high butyrate-releasing high-amylose maize starch diet. Butyrate improved proteinuria by preserving podocyte at glomerular basement membrane and attenuated glomerulosclerosis and tissue inflammation. This protective phenotype was associated with increased podocyte-related proteins and a normalized pattern of acetylation and methylation at promoter sites of genes essential for podocyte function. We found that GPR109a is expressed by podocytes, and the use of Gpr109a(-/-) mice showed that the protective effects of butyrate depended on GPR109a expression. A prebiotic diet that releases high amounts of butyrate also proved highly effective for protection against kidney disease. Butyrate and GPR109a play a role in the pathogenesis of kidney disease and provide one of the important molecular connections between diet, the gut microbiota, and kidney disease.	[Felizardo, Raphael J. F.; de Almeida, Danilo C.; Watanabe, Ingrid K. M.; Cenedeze, Marcos A.; Camara, Niels O. S.] Univ Fed Sao Paulo, Dept Med, Nephrol Div, Sao Paulo, Brazil; [Felizardo, Raphael J. F.; de Almeida, Danilo C.; Watanabe, Ingrid K. M.; Hiyane, Meire I.; Amano, Mariane T.; Braga, Tarcio T.; Andrade-Oliveira, Vinicius; Camara, Niels O. S.] Univ Sao Paulo, Fac Med, Inst Biomed Sci 4, Dept Immunol, Sao Paulo, Brazil; [Volpini, Rildo A.] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, LIM12, Sao Paulo, Brazil; [Felizardo, Raphael J. F.; Marino, Eliana; Robert, Remy; Mackay, Charles R.] Monash Univ, Dept Biochem & Mol Biol, Biodiscovery Inst, Clayton, Vic, Australia; [Pereira, Rafael L.] Univ Fed Parana, Dept Physiol, Curitiba, Parana, Brazil; [Doimo, Nayara T. S.; Amano, Mariane T.] Hosp Sirio Liban es, Ctr Mol Oncol, Sao Paulo, Brazil; [Ribeiro, Willian R.; Ferreira, Caroline M.] Univ Fed Sao Paulo, Inst Environm Chem & Pharmaceut Sci, Dept Pharmaceut Sci, Diadema, Brazil; [Parmigiani, Raphael B.] Idengene Med Diagnost, Sao Paulo, Brazil; [Vinolo, Marco Aurelio R.] Univ Estadual Campinas, Inst Biol, Dept Genet Evolut Microbiol & Immunol, Campinas, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Monash University; Universidade Federal do Parana; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Estadual de Campinas	Mackay, CR (corresponding author), Monash Univ, Fac Med Nursing & Hlth Serv, Biodiscovery Res Inst, Dept Microbiol, Wellington Rd, Clayton, Vic 3800, Australia.; Camara, NOS (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Av Prof Lineu Prestes 1730, BR-05508000 Sao Paulo, Brazil.	charles.mackay@monash.edu; niels@icb.usp	PARMIGIANI, RAPHAEL B/A-7475-2014; Volpini, Rildo Aparecido/L-5690-2019; robert, remy/E-6881-2012; Braga, Tarcio/AAG-4475-2020; de Almeida, Danilo/AAK-2399-2021; Mariño, Eliana/GPK-6544-2022; Mackay, Charles R/A-9673-2008; de Andrade Oliveira, Vinicius/S-1176-2019; Vinolo, Marco Aurélio R/K-3753-2012; Braga, Tarcio T/E-4827-2014; Felizardo, Raphael J F/B-3844-2016; Ribeiro, Willian/AAC-1656-2021; Volpini, Rildo A/B-7521-2013; Olsen Saraiva Camara, Niels/AAX-3269-2020; Marino, Eliana/C-5135-2011	PARMIGIANI, RAPHAEL B/0000-0001-8360-3584; Volpini, Rildo Aparecido/0000-0001-6611-2249; robert, remy/0000-0003-2416-9268; Mackay, Charles R/0000-0002-6338-7340; de Andrade Oliveira, Vinicius/0000-0002-0426-1828; Braga, Tarcio T/0000-0002-2989-1076; Felizardo, Raphael J F/0000-0001-9650-6273; Volpini, Rildo A/0000-0001-6611-2249; Olsen Saraiva Camara, Niels/0000-0001-5436-1248; AMANO, MARIANE/0000-0003-4321-3375; Rodrigues Ribeiro, Willian/0000-0001-5080-956X; Marino, Eliana/0000-0001-5371-8778	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/15205-4, 2012/50410-8, 2012/02270-2, 2014/13135-4, 2017/06222-06, 2017/05264-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, (CNPq); Instituto Nacional de Ciencia e Tecnologia (INCT) REGENERA; National Health and Medical Research Council of Australia; Coordenacao de Aperfeicoamento de Pessoal de N'ivel Superior-Brasil (CAPES) [001]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia (INCT) REGENERA; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Coordenacao de Aperfeicoamento de Pessoal de N'ivel Superior-Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors thank Paulo Albe (Institute of Biomedical Sciences IV, Universidade de Sao Paulo, Sao Paulo, Brazil) for preparing the histology slides, Caroline Ang and Linda Mason (both from Biodiscovery Institute, Monash University, Melbourne, Australia) for technical assistance, and Centro de Facilidades de Apoio a Pesquisa (CEFAP-USP). This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; Grants 2012/15205-4, 2012/50410-8, 2012/02270-2, 2014/13135-4, 2017/06222-06, and 2017/05264-7), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, (CNPq), Instituto Nacional de Ciencia e Tecnologia (INCT) REGENERA, and the National Health and Medical Research Council of Australia. This study was also financed, in part, by the Coordenacao de Aperfeicoamento de Pessoal de N ' ivel Superior-Brasil (CAPES), Finance Code 001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Andrade-Oliveira V, 2015, J AM SOC NEPHROL, V26, P1877, DOI 10.1681/ASN.2014030288; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Blattner SM, 2013, KIDNEY INT, V84, P920, DOI 10.1038/ki.2013.175; Burford JL, 2014, J CLIN INVEST, V124, P2050, DOI 10.1172/JCI71702; Chauveau P, 2018, NEPHROL DIAL TRANSPL, V33, P725, DOI 10.1093/ndt/gfx085; Correa RO, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.17; Correa-Costa M, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/291024; de Almeida DC, 2017, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00645; den Besten G, 2015, DIABETES, V64, P2398, DOI 10.2337/db14-1213; Felizardo RJF, 2019, PHARMACOL RES, V141, P366, DOI 10.1016/j.phrs.2019.01.019; Felizardo RJF, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.36; Frost G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4611; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Grahammer F, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86177; Grahammer F, 2013, NAT REV NEPHROL, V9, P587, DOI 10.1038/nrneph.2013.169; HOVERSTAD T, 1986, J NUTR, V116, P1772, DOI 10.1093/jn/116.9.1772; Jang HR, 2009, AM J PHYSIOL-RENAL, V297, pF1457, DOI 10.1152/ajprenal.90769.2008; Jeansson M, 2009, J AM SOC NEPHROL, V20, P114, DOI 10.1681/ASN.2007111205; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Krishnamurthy VMR, 2012, KIDNEY INT, V81, P300, DOI 10.1038/ki.2011.355; Lefevre GM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001142; Lin CL, 2014, J AM SOC NEPHROL, V25, P1698, DOI 10.1681/ASN.2013050527; Liu F, 2016, SCI REP-UK, V6, DOI 10.1038/srep33676; Liu N, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00121; Lukasova M, 2011, J CLIN INVEST, V121, P1163, DOI 10.1172/JCI41651; Machado RA, 2012, NEPHROL DIAL TRANSPL, V27, P3136, DOI 10.1093/ndt/gfr807; Macia L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7734; Marino E, 2017, NAT IMMUNOL, V18, P1271, DOI 10.1038/ni1117-1271c; Marques FZ, 2017, CIRCULATION, V135, P964, DOI [10.1161/CIRCULATIONAHA.116.024545, 10.1161/circulationaha.116.024545]; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mendes E, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01732; Pereira RL, 2014, DIS MODEL MECH, V7, P701, DOI 10.1242/dmm.014548; Perico L, 2016, NAT REV NEPHROL, V12, P692, DOI 10.1038/nrneph.2016.127; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Psichas A, 2015, INT J OBESITY, V39, P424, DOI 10.1038/ijo.2014.153; Rossaint J, 2016, J CLIN INVEST, V126, P962, DOI 10.1172/JCI83470; Sayyed SG, 2010, NEPHROL DIAL TRANSPL, V25, P1811, DOI 10.1093/ndt/gfp730; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Streja E, 2015, AM J KIDNEY DIS, V65, P785, DOI 10.1053/j.ajkd.2014.11.033; Sun XF, 2013, EUR J PHARMACOL, V707, P147, DOI 10.1016/j.ejphar.2013.03.018; Tan J, 2016, CELL REP, V15, P2809, DOI 10.1016/j.celrep.2016.05.047; Tan JK, 2017, ANNU REV IMMUNOL, V35, P371, DOI 10.1146/annurev-immunol-051116-052235; Thorburn AN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8320; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Ueda H, 2001, J BIOL CHEM, V276, P6846, DOI 10.1074/jbc.M007541200; Van Beneden K, 2011, J AM SOC NEPHROL, V22, P1863, DOI 10.1681/ASN.2010111196; Vaziri ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114881; Vaziri ND, 2013, KIDNEY INT, V83, P308, DOI 10.1038/ki.2012.345; Verbeke K, 2010, EUR J CLIN NUTR, V64, P678, DOI 10.1038/ejcn.2010.92; Wang LM, 2012, KIDNEY INT, V81, P1075, DOI 10.1038/ki.2011.472; Wang XJ, 2014, KIDNEY INT, V86, P712, DOI 10.1038/ki.2014.111; Wong J, 2014, AM J NEPHROL, V39, P230, DOI 10.1159/000360010; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681; Yu HY, 2013, MOL CELL BIOL, V33, P4755, DOI 10.1128/MCB.00730-13; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774	60	45	47	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11894	11908		10.1096/fj.201901080R	http://dx.doi.org/10.1096/fj.201901080R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31366236				2022-12-28	WOS:000507461600025
J	Fink, BD; Yu, LP; Sivitz, WI				Fink, Brian D.; Yu, Liping; Sivitz, William I.			Modulation of complex II-energized respiration in muscle, heart, and brown adipose mitochondria by oxaloacetate and complex I electron flow	FASEB JOURNAL			English	Article						mitochondrial respiratory chain; brown adipose tissue; succinate dehydrogenase; S1QEL 1.1	HYDROGEN-PEROXIDE; REACTIVE OXYGEN; TISSUE; SUCCINATE; OXIDATION; IDENTIFICATION; SUPEROXIDE; INHIBITION; ACTIVATION; BRAIN	We recently reported that membrane potential (Delta Psi) primarily determines the relationship of complex II-supported respiration by isolated skeletal muscle mitochondria to ADP concentrations. We observed that O-2 flux peaked at low ADP concentration ([ADP]) (high Delta Psi) before declining at higher [ADP] (low Delta Psi). The decline resulted from oxaloacetate (OAA) accumulation and inhibition of succinate dehydrogenase. This prompted us to question the effect of incremental [ADP] on respiration in interscapular brown adipose tissue (IBAT) mitochondria, wherein Delta Psi is intrinsically low because of uncoupling protein 1 (UCP1). We found that succinate-energized IBAT mitochondria, even in the absence of ADP, accumulate OAA and manifest limited respiration, similar to muscle mitochondria at high [ADP]. This could be prevented by guanosine 5'-diphosphate inhibition of UCP1. NAD + cycling with NADH requires complex I electron flow and is needed to form OAA. Therefore, to assess the role of electron transit, we perturbed flow using a small molecule, N1-(3-acetamidophenyl)-N2-(2-(4-methyl-2-(p-tolyl) thiazol-5-yl)ethyl)oxalamide. We observed decreased OAA, increased NADH/NAD(+), and increased succinatesupported mitochondrial respiration under conditions of low Delta Psi (IBAT) but not high Delta Psi (heart). In summary, complex II-energized respiration in IBAT mitochondria is tempered by complex I-derived OAA in a manner dependent on UCP1. These dynamics depend on electron transit in complex I.	[Fink, Brian D.; Sivitz, William I.] Univ Iowa, Vet Affairs Hlth Care Syst, Dept Internal Med, Div Endocrinol & Metab, Iowa City, IA USA; [Yu, Liping] Univ Iowa, Vet Affairs Hlth Care Syst, Dept Biochem, Iowa City, IA USA; [Yu, Liping] Univ Iowa, Vet Affairs Hlth Care Syst, NMR Core Facil, Iowa City, IA USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Sivitz, WI (corresponding author), Univ Iowa, Dept Internal Med, Div Endocrinol & Metab, E401-6 GH,200 Hawkins Dr, Iowa City, IA 52242 USA.	william-sivitz@uiowa.edu		Fink, Brian/0000-0002-1149-7935; Sivitz, William/0000-0002-7829-0189	U.S. Department of Veterans Affairs, Biomedical Laboratory Research and Development Service [2 I01 BX000285-05]; Iowa Fraternal Order of the Eagles	U.S. Department of Veterans Affairs, Biomedical Laboratory Research and Development Service(US Department of Veterans Affairs); Iowa Fraternal Order of the Eagles	This work was supported by Merit Review Award 2 I01 BX000285-05 from the U.S. Department of Veterans Affairs, Biomedical Laboratory Research and Development Service, and by the Iowa Fraternal Order of the Eagles. The authors declare no conflicts of interest.	Al Kadhi O, 2017, J ANAL METHODS CHEM, V2017, DOI 10.1155/2017/5391832; AZZONE GF, 1960, NATURE, V188, P552, DOI 10.1038/188552a0; Bai F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154982; Banba A, 2019, J BIOL CHEM, V294, P6550, DOI 10.1074/jbc.RA119.007687; Brand MD, 2016, CELL METAB, V24, P582, DOI 10.1016/j.cmet.2016.08.012; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; CHANCE B, 1960, NATURE, V185, P666, DOI 10.1038/185666a0; CHANCE B, 1962, J BIOL CHEM, V237, P3540; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fink BD, 2018, J BIOL CHEM, V293, P19932, DOI 10.1074/jbc.RA118.005144; Hildyard JCW, 2005, BBA-BIOENERGETICS, V1707, P221, DOI 10.1016/j.bbabio.2004.12.005; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; O'Malley Y, 2006, J BIOL CHEM, V281, P39766, DOI 10.1074/jbc.M608268200; Panov AV, 2010, B EXP BIOL MED+, V149, P187, DOI 10.1007/s10517-010-0904-5; Panov AV, 2011, AM J PHYSIOL-REG I, V300, pR844, DOI 10.1152/ajpregu.00528.2010; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Rhee SG, 2010, MOL CELLS, V29, P539, DOI 10.1007/s10059-010-0082-3; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; SCHOLLMEYER P, 1961, BIOCHEM BIOPH RES CO, V4, P43, DOI 10.1016/0006-291X(61)90252-2; Scialo F, 2016, CELL METAB, V23, P725, DOI 10.1016/j.cmet.2016.03.009; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; WOJTCZAK AB, 1964, BIOCHIM BIOPHYS ACTA, V89, P560, DOI 10.1016/0926-6569(64)90088-4; WOJTCZAK L, 1972, ACTA BIOCHIM POL, V19, P227; Wong HS, 2019, FREE RADICAL BIO MED, V130, P140, DOI 10.1016/j.freeradbiomed.2018.10.448; Wong HS, 2017, J BIOL CHEM, V292, P16804, DOI 10.1074/jbc.R117.789271; Yu Liping, 2015, Methods Mol Biol, V1264, P149, DOI 10.1007/978-1-4939-2257-4_14; Yu LP, 2014, J BIOENERG BIOMEMBR, V46, P33, DOI 10.1007/s10863-013-9530-z; Yu LP, 2013, DIABETES, V62, P1833, DOI 10.2337/db12-1152; Zimmermann M, 2014, ANAL CHEM, V86, P3232, DOI 10.1021/ac500472c	32	9	9	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11696	11705		10.1096/fj.201900690R	http://dx.doi.org/10.1096/fj.201900690R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31361970	Green Published, Bronze			2022-12-28	WOS:000507461600010
J	Lang, I; Jung, M; Niemeyer, BA; Ruth, P; Engel, J				Lang, Isabelle; Jung, Martin; Niemeyer, Barbara A.; Ruth, Peter; Engel, Jutta			Expression of the LRRC52 gamma subunit (gamma 2) may provide Ca2+ -independent activation of BK currents in mouse inner hair cells	FASEB JOURNAL			English	Article						KCNMA; Ca(v)1.3; cochlea; proximity ligation assay; hearing	POTASSIUM CHANNELS; SYNAPTIC-TRANSMISSION; CA(V)1.3 CHANNELS; AUXILIARY SUBUNIT; SPLICE VARIANTS; MICE LACKING; MODULATION; OTOFERLIN; DEAFNESS; BETA	Mammalian inner hair cells (IHCs) transduce sound into depolarization and transmitter release. Big conductance and voltage- and Ca2+-activated K+ (BK) channels are responsible for fast membrane repolarization and small time constants of mature IHCs. For unknown reasons, they activate at around -75 mV with a voltage of half-maximum activation (V-half) of -50 mV although being largely insensitive to Ca2+ influx. Ca2+-independent activation of BK channels was observed by others in heterologous expression systems if y subunits leucine-rich repeat-containing protein (LRRC)26 (gamma 1) and LRRC52 (gamma 2) were coexpressed with the pore-forming BK alpha subunit, which shifted V-half by -140 and -100 mV, respectively. Using nested PCR, we consistently detected transcripts for LRRC52 but not for LRRC26 in IHCs of 3-wk-old mice. Confocal immunohistochemistry showed synchronous up-regulation of LRRC52 protein with BK alpha at the onset of hearing. Colocalization of LRRC52 protein and BK alpha at the IHC neck within 540 nm was specified using an in situ proximity ligation assay. Mice deficient for the voltage-gated Ca(v)1.3 Ca2+ channel encoded by Cacnald do not express BK alpha protein. LRRC52 protein was neither expressed in IHCs of BK alpha nor in IHCs of Ca(v)1.3 knockout mice. Together, LRRC52 is a gamma 2 subunit of BK channel complexes and is a strong candidate for causing the Ca2+ -independent activation of BK currents at negative membrane potentials in mouse IHCs.	[Lang, Isabelle; Engel, Jutta] Saarland Univ, Hearing Res, Homburg, Germany; [Jung, Martin] Saarland Univ, Mol Biophys, Dept Biophys, Homburg, Germany; [Jung, Martin] Saarland Univ, CIPMM, Homburg, Germany; [Niemeyer, Barbara A.] Saarland Univ, Dept Biochem & Mol Biol, Homburg, Germany; [Ruth, Peter] Univ Tubingen, Dept Pharmacol Toxicol & Clin Pharm, Inst Pharm, Tubingen, Germany	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Engel, J (corresponding author), Saarland Univ, Sch Med, Dept Biophys, CIPMM, Kirrberger St 100,Bldg 48, D-66421 Homburg, Germany.	jutta.engel@uni-saarland.de	Niemeyer, Barbara A./AAL-8972-2021; Jung, Martin/D-2207-2012; Jung, Martin/AAM-4547-2021	Jung, Martin/0000-0002-1482-7020; Jung, Martin/0000-0002-1482-7020; Niemeyer, Barbara A./0000-0002-6963-0575	German Research Foundation (DFG); International Research Training Group (IRTG) 1830; Collaborative Research Center [(SFB) 894 A4, SFB 1027]; Saarland University	German Research Foundation (DFG)(German Research Foundation (DFG)); International Research Training Group (IRTG) 1830; Collaborative Research Center; Saarland University	The authors thank Jennifer Ihl, Kerstin Fischer, and Angela Di Turi (Saarland University) for excellent technical assistance, Marlen Dierich (Philipps University Marburg, Marburg, and Saarland University) for providing a proximity ligation assay protocol for the organ of Corti, Dalia Alansary (Saarland University) for help with the sequencing process, Petra Wei beta gerber and Femke Lux (both from Saarland University) for providing tissue cryosections, Veit Flockerzi (Saarland University) for providing a claudin-14 antibody, and Stefan Munkner (Saarland University) for help and discussion. This work was supported by the German Research Foundation (DFG), the International Research Training Group (IRTG) 1830, the Collaborative Research Center (SFB) 894 A4 (to J.E.), P3 (to M.J.), SFB 1027 (to B.A.N.), and Saarland University. The authors declare no conflicts of interest.	Almassy J, 2012, MOL PHARMACOL, V81, P21, DOI 10.1124/mol.111.075234; ART JJ, 1987, J PHYSIOL-LONDON, V385, P207, DOI 10.1113/jphysiol.1987.sp016492; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bortolozzi M, 2018, NEUROSCI LETT, V663, P18, DOI 10.1016/j.neulet.2017.09.059; Brandt A, 2003, J NEUROSCI, V23, P10832; Martin JZD, 2010, J NEUROSCI, V30, P12157, DOI 10.1523/JNEUROSCI.2541-10.2010; Duncker SV, 2013, J NEUROSCI, V33, P9508, DOI 10.1523/JNEUROSCI.5689-12.2013; Eckrich S, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00225; EHRET G, 1985, ACTA OTO-LARYNGOL, P31; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Evanson KW, 2014, CIRC RES, V115, P423, DOI 10.1161/CIRCRESAHA.115.303407; Fell B, 2016, J NEUROSCI, V36, P11024, DOI 10.1523/JNEUROSCI.3468-14.2016; Fettiplace R, 2017, COMPR PHYSIOL, V7, P1197, DOI 10.1002/cphy.c160049; FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P529, DOI 10.1113/jphysiol.1990.sp018271; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Gonzalez-Perez V, 2019, ANNU REV PHYSIOL, V81, P113, DOI 10.1146/annurev-physiol-022516-034038; Gonzalez-Perez V, 2014, P NATL ACAD SCI USA, V111, P4868, DOI 10.1073/pnas.1322123111; Hafidi A, 2005, NEUROSCIENCE, V130, P475, DOI 10.1016/j.neuroscience.2004.09.038; Housley GD, 2006, J MEMBRANE BIOL, V209, P89, DOI 10.1007/s00232-005-0835-7; HUDSPETH AJ, 1988, J PHYSIOL-LONDON, V400, P275, DOI 10.1113/jphysiol.1988.sp017120; Kang HW, 2011, BBA-BIOMEMBRANES, V1808, P1629, DOI 10.1016/j.bbamem.2010.11.014; Kearney G, 2019, J NEUROSCI, V39, P3360, DOI 10.1523/JNEUROSCI.2746-18.2019; Knirsch M, 2007, J NEUROSCI, V27, P6442, DOI 10.1523/JNEUROSCI.5364-06.2007; KROS CJ, 1990, J PHYSIOL-LONDON, V421, P263, DOI 10.1113/jphysiol.1990.sp017944; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Kurt S, 2012, FASEB J, V26, P3834, DOI 10.1096/fj.11-200535; Langer P, 2003, J COMP NEUROL, V455, P198, DOI 10.1002/cne.10471; Li Q, 2016, INT REV NEUROBIOL, V128, P51, DOI 10.1016/bs.irn.2016.03.015; Li Q, 2016, J GEN PHYSIOL, V147, P337, DOI 10.1085/jgp.201511551; Li Q, 2015, J GEN PHYSIOL, V145, P543, DOI 10.1085/jgp.201511356; Manley G. A., 2004, EVOLUTION VERTEBRATE, V22; Marcotti W, 2004, J PHYSIOL-LONDON, V557, P613, DOI 10.1113/jphysiol.2003.060137; Michna M, 2003, J PHYSIOL-LONDON, V553, P747, DOI 10.1113/jphysiol.2003.053256; Navaratnam DS, 1997, NEURON, V19, P1077, DOI 10.1016/S0896-6273(00)80398-0; Nemzou RM, 2006, NEUROSCIENCE, V141, P1849, DOI 10.1016/j.neuroscience.2006.05.057; Oliver D, 2006, J NEUROSCI, V26, P6181, DOI 10.1523/JNEUROSCI.1047-06.2006; Oliver D, 2003, J NEUROSCI, V23, P2141; Oliver D, 2000, NEURON, V26, P595, DOI 10.1016/S0896-6273(00)81197-6; Pangrsic T, 2012, TRENDS NEUROSCI, V35, P671, DOI 10.1016/j.tins.2012.08.002; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Pyott SJ, 2016, INT REV NEUROBIOL, V128, P369, DOI 10.1016/bs.irn.2016.03.016; Pyott SJ, 2004, J NEUROSCI, V24, P9469, DOI 10.1523/JNEUROSCI.3162-04.2004; Pyott SJ, 2007, J BIOL CHEM, V282, P3312, DOI 10.1074/jbc.M608726200; Ramanathan K, 2000, J NEUROSCI, V20, P1675; Ramanathan K, 1999, SCIENCE, V283, P215, DOI 10.1126/science.283.5399.215; ROBERTS WM, 1993, NATURE, V363, P74, DOI 10.1038/363074a0; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; Rosenblatt KP, 1997, NEURON, V19, P1061, DOI 10.1016/S0896-6273(00)80397-9; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Rutherford MA, 2015, SYNAPSE, V69, P242, DOI 10.1002/syn.21812; Ruttiger L, 2004, P NATL ACAD SCI USA, V101, P12922, DOI 10.1073/pnas.0402660101; Sakai Y, 2011, J NEUROSCI RES, V89, P1747, DOI 10.1002/jnr.22713; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shipston MJ, 2016, INT REV NEUROBIOL, V128, P91, DOI 10.1016/bs.irn.2016.02.012; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; Thurm H, 2005, J PHYSIOL-LONDON, V569, P137, DOI 10.1113/jphysiol.2005.094680; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; vonBekesy G., 1960, EXPT HEARING; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; Wersinger E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013836; Wilcox ER, 2001, CELL, V104, P165, DOI 10.1016/S0092-8674(01)00200-8; Wong AB, 2014, EMBO J, V33, P247, DOI 10.1002/embj.201387110; Yan JS, 2012, P NATL ACAD SCI USA, V109, P7917, DOI 10.1073/pnas.1205435109; Yan JS, 2010, NATURE, V466, P513, DOI 10.1038/nature09162; Yang CT, 2017, P NATL ACAD SCI USA, V114, pE3739, DOI 10.1073/pnas.1703081114; Yang CT, 2011, P NATL ACAD SCI USA, V108, P19419, DOI 10.1073/pnas.1111104108; Zeng XH, 2015, P NATL ACAD SCI USA, V112, P2599, DOI 10.1073/pnas.1423869112; Zeng XH, 2011, P NATL ACAD SCI USA, V108, P5879, DOI 10.1073/pnas.1100240108	71	3	3	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11721	11734		10.1096/fj.201900701RR	http://dx.doi.org/10.1096/fj.201900701RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31348683	Bronze			2022-12-28	WOS:000507461600012
J	Ruan, ZY; Zhao, D				Ruan, Zhengyi; Zhao, Dong			Long intergenic noncoding RNA LINC00284 knockdown reduces angiogenesis in ovarian cancer cells via up-regulation of MEST through NF-kappa B1	FASEB JOURNAL			English	Article						mesoderm-specific transcript; proliferation; apoptosis; tumorigenicity	KAPPA-B; PROMOTES PROLIFERATION; EXPRESSION; INVASION; PROGRESSION; PEG1/MEST; GENE; OVEREXPRESSION; FIBROBLASTS; METASTASIS	Ovarian cancer (OC) is one of the major causes of cancer-related mortality in women worldwide. Long noncoding RNAs might play a role as oncogenes or tumor suppressors. Therefore, we investigated the effect and underlying mechanisms of long intergenic noncoding RNA (LINC00) 284 on angiogenesis in OC cells. Expression of LINC00284 in OC tissues and cells was determined. Next, the interaction between LINC00284 and mesoderm-specific transcript (MEST) was evaluated. Subsequently, OC cells were transfected with overexpressed (oe)-LINC00284, silenced (si)-LINC00284, si-NF-kappa B1, oe-MEST, or si-MEST plasmids to investigate the underlying mechanism of LINC00284 in OC. Afterwards, the expression of matrix metalloproteinase (MMP)-2, MMP-9, B-cell lymphoma 2 (Bcl-2), Bcl-2-associated protein x (Bax), VEGF, and CD31 was determined to assess the effect of LINC00284 on OC cell proliferation, invasion, migration angiogenesis, and apoptosis. Finally, the effect of LINC00284 on tumorigenesis was investigated in nude mice models of OC. LINC00284 was highly expressed in OC. si-LINC00284 increased expression of MEST. si-LINC00284 or si-NF-kappa B1 led to the reduction in cell proliferation, migration, invasion, tube formation, angiogenesis, and tumorigenic ability and promoted apoptosis in OC by down-regulating MMP-2, MMP-9, Bcl-2, VEGF, and CD31 and up-regulating Bax. These effects were all reversed following the si-MEST. In vivo experiments found the same results, confirming the aforementioned findings. Taken together, LINC00284 is involved in angiogenesis during OC development by recruiting NF-kappa B1 and down-regulating MEST.-Ruan, Z., Zhao, D. Long intergenic noncoding RNA LINC00284 knockdown reduces angiogenesis in ovarian cancer cells via up-regulation of MEST through NF-kappa B1.	[Ruan, Zhengyi; Zhao, Dong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Obstet & Gynecol, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China	Shanghai Jiao Tong University	Ruan, ZY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Obstet & Gynecol, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.	hendryz@gmail.com	Ruan, Zhengyi/GZK-9467-2022		National Science Foundation of China [81771548]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors acknowledge and appreciate their colleagues for their valuable efforts and comments on this article. This study was supported by the National Science Foundation of China (81771548). The authors declare no conflicts of interest.	An JH, 2017, ONCOTARGETS THER, V10, P5377, DOI 10.2147/OTT.S147586; Anderson JD, 2016, STEM CELLS, V34, P601, DOI 10.1002/stem.2298; Ayuk SM, 2016, J PHOTOCH PHOTOBIO B, V161, P368, DOI 10.1016/j.jphotobiol.2016.05.027; Bamias A, 2012, CRIT REV ONCOL HEMAT, V84, P314, DOI 10.1016/j.critrevonc.2012.04.002; Cai H, 2017, ONCOGENE, V36, P318, DOI 10.1038/onc.2016.212; Chen Y, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0243-0; Cheng ZP, 2015, ONCOTARGET, V6, P25381, DOI 10.18632/oncotarget.4541; Dong R, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.143; Dunagin M, 2015, METHODS MOL BIOL, V1262, P3, DOI 10.1007/978-1-4939-2253-6_1; Fu X, 2017, AM J TRANSL RES, V9, P4094; Gao Y, 2015, HUM MOL GENET, V24, P841, DOI 10.1093/hmg/ddu502; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Ge J, 2018, EUR REV MED PHARMACO, V22, P329, DOI 10.26355/eurrev_201801_14176; Giopanou I, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/178410; Gupta S, 2010, CANCER RES, V70, P6735, DOI 10.1158/0008-5472.CAN-10-0244; Huang SY, 2016, DIAGN PATHOL, V11, DOI 10.1186/s13000-016-0499-x; Huntriss JD, 2013, EUR J HUM GENET, V21, P40, DOI 10.1038/ejhg.2012.102; Huo ZH, 2013, GENET MOL RES, V12, P3435, DOI 10.4238/2013.March.11.6; Jin Y, 2017, EUR REV MED PHARMACO, V21, P3176; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kataoka H, 2009, YONAGO ACTA MED, V52, P85; Kim JW, 2012, J BIOL CHEM, V287, P7780, DOI 10.1074/jbc.M111.278465; Kim T. H., 2018, COLD SPRING HARB PRO, V2018; Kondo Y, 2017, CANCER SCI, V108, P1927, DOI 10.1111/cas.13342; Kuang DF, 2016, EXP MOL PATHOL, V101, P267, DOI 10.1016/j.yexmp.2016.09.008; Lili LN, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/846387; Liu EL, 2015, INT J CLIN EXP MED, V8, P20565; Lu ZL, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0518-0; Lv Y, 2017, CANCER BIOTHER RADIO, V32, P91, DOI 10.1089/cbr.2017.2178; Ma X, 2017, AM J TRANSL RES, V9, P5012; Mao XH, 2017, IMMUNOLOGY, V150, P379, DOI 10.1111/imm.12698; Mayer W, 2000, DEV DYNAM, V217, P1, DOI 10.1002/(SICI)1097-0177(200001)217:1<1::AID-DVDY1>3.0.CO;2-4; Nakanishi H, 2004, ONCOL REP, V12, P1273; Pedersen IS, 1999, CANCER RES, V59, P5449; Peng WZ, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0197-7; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sun M, 2016, CANCER RES, V76, P6299, DOI 10.1158/0008-5472.CAN-16-0356; Svalkauskiene Vilma, 2015, Stomatologija, V17, P3; Tee AE, 2016, ONCOTARGET, V7, P8663, DOI 10.18632/oncotarget.6675; Vidal AC, 2014, CLIN TRANSL ONCOL, V16, P266, DOI 10.1007/s12094-013-1067-4; Wang SJ, 2011, CANCER CHEMOTH PHARM, V68, P1421, DOI 10.1007/s00280-011-1643-7; Xing C, 2018, CLIN LAB, V64, P1661, DOI 10.7754/Clin.Lab.2018.180419; Yan M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-437; Yang Fangfang, 2015, Eur J Pharmacol, V754, P105, DOI 10.1016/j.ejphar.2015.02.015; Yang ZF, 2010, J CELL PHYSIOL, V225, P266, DOI 10.1002/jcp.22261; Yildiz-Arslan S, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.116.140327; Yu Y, 2015, ONCOL REP, V33, P1683, DOI 10.3892/or.2015.3755; Zhang H, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-37; Zhang LQ, 2017, ANAL CELL PATHOL, V2017, P1, DOI 10.1155/2017/8267863; Zhao LJ, 2017, CANCER RES, V77, P1369, DOI 10.1158/0008-5472.CAN-16-1615; Zhao YJ, 2018, ONCOL REP, V39, P1197, DOI 10.3892/or.2018.6207; Zheng XG, 2013, CANCER LETT, V329, P146, DOI 10.1016/j.canlet.2012.10.026; Zhou JF, 2017, MOL MED REP, V16, P5235, DOI 10.3892/mmr.2017.7233; Zhou M, 2016, ONCOTARGET, V7, P12598, DOI 10.18632/oncotarget.7181	54	23	23	4	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12047	12059		10.1096/fj.201900101RR	http://dx.doi.org/10.1096/fj.201900101RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31574234	Green Published, Bronze			2022-12-28	WOS:000507461600035
J	Lim, SW; Shin, YJ; Luo, K; Quan, Y; Ko, EJ; Ha Chung, B; Yang, CW				Lim, Sun Woo; Shin, Yoo Jin; Luo, Kang; Quan, Yi; Ko, Eun Jeong; Ha Chung, Byung; Yang, Chul Woo			Host cell in vivo production of the synthetic drug anti-CD25/IL-10 using minicircle vector	FASEB JOURNAL			English	Article						biological drug; transplantation; graft rejection; immune tolerance	GENE-THERAPY; GRAFT-SURVIVAL; DNA VECTOR; RAT-LIVER; EXPRESSION; ALLOGRAFT; CYCLOSPORINE; REJECTION; DETERMINANTS; BASILIXIMAB	Synthetic biologic drugs are highly successful for induction therapy in transplantation, but the development of novel biologics is limited because of the high cost of synthesis and purification. In this study, we developed a novel strategy for the production of synthetic protein drugs in vivo by the host itself. We utilized minicircle (MC) technology, which can robustly express a target molecule and secrete it from cells, as an indirect method to produce a protein of interest in vivo. We designed an MC vector containing the sequences of basiliximab (anti-CD25 mAb) and IL-10. We verified the substantial production of the anti-CD25/IL-10 protein from the MC in vitro and in vivo. The therapeutic effect of MC-derived anti-CD25/IL-10 was evaluated in a skin allograft mouse model by single intravenous infusion. Mice treated with the MC encoding anti-CD25/IL-10 exhibited prolonged skin allograft survival times accompanied by improved histologic changes and immunologic regulation. These findings indicate that the anti-CD25/IL-10 protein drug obtained by MC technology is functionally active and relevant for reducing allograft rejection. This self-reproducible strategy for synthetic protein drugs using MCs is a promising tool for transplantation.-Lim, S. W., Shin, Y. J., Luo, K., Quan, Y., Ko, E. J., Chung, B. H., Yang, C. W. Host cell in vivo production of the synthetic drug anti-CD25/IL-10 using minicircle vector.	[Lim, Sun Woo; Shin, Yoo Jin; Luo, Kang; Quan, Yi; Ko, Eun Jeong; Ha Chung, Byung; Yang, Chul Woo] Catholic Univ Korea, Seoul St Marys Hosp, Convergent Res Consortium Immunol Dis, Seoul, South Korea; [Lim, Sun Woo; Shin, Yoo Jin; Luo, Kang; Quan, Yi; Ko, Eun Jeong; Ha Chung, Byung; Yang, Chul Woo] Catholic Univ Korea, Transplant Res Ctr, Seoul, South Korea; [Ko, Eun Jeong; Ha Chung, Byung; Yang, Chul Woo] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Nephrol,Dept Internal Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Yang, CW (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Sch Med, Div Nephrol,Dept Internal Med, 222 Banpo Daero, Seoul 06591, South Korea.	yangch@catholic.ac.kr		Ko, Eun Jeong/0000-0002-5604-1296	Korean Health Technology Research and Development Project, Ministry for Health and Welfare [HI16C1641, HI14C3417]	Korean Health Technology Research and Development Project, Ministry for Health and Welfare	This work was supported by the Korean Health Technology Research and Development Project, Ministry for Health and Welfare (HI16C1641 and HI14C3417). The authors declare no conflicts of interest.	Andrianaivo F, 2004, J GENE MED, V6, P877, DOI 10.1002/jgm.574; Bunnapradist S, 2003, J AM SOC NEPHROL, V14, P208, DOI 10.1097/01.ASN.0000037678.54984.41; Buscail L, 2015, MOL THER, V23, P779, DOI 10.1038/mt.2015.1; Chen ZY, 2005, HUM GENE THER, V16, P126, DOI 10.1089/hum.2005.16.126; Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0; Flechner SM, 1996, TRANSPLANTATION, V62, P1235, DOI 10.1097/00007890-199611150-00009; Gill DR, 2009, GENE THER, V16, P165, DOI 10.1038/gt.2008.183; Grenda R, 2015, PEDIATR NEPHROL, V30, P1087, DOI 10.1007/s00467-014-2886-4; Hamawy MM, 2003, DRUG NEWS PERSPECT, V16, P277, DOI 10.1358/dnp.2003.16.5.829315; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Heidt S, 2010, CLIN EXP IMMUNOL, V159, P199, DOI 10.1111/j.1365-2249.2009.04051.x; Herweijer H, 2007, GENE THER, V14, P99, DOI 10.1038/sj.gt.3302891; Huang M, 2009, CIRCULATION, V120, pS230, DOI 10.1161/CIRCULATIONAHA.108.841155; Kay MA, 2010, NAT BIOTECHNOL, V28, P1287, DOI 10.1038/nbt.1708; Kobayashi N, 2004, J GENE MED, V6, P584, DOI 10.1002/jgm.541; Lebranchu Y, 2002, AM J TRANSPLANT, V2, P48, DOI 10.1034/j.1600-6143.2002.020109.x; Malek TR, 2002, TRENDS IMMUNOL, V23, P465, DOI 10.1016/S1471-4906(02)02308-6; Maniar LEG, 2013, MOL THER, V21, P131, DOI 10.1038/mt.2012.244; Maruyama H, 2002, J GENE MED, V4, P333, DOI 10.1002/jgm.281; McFarland HI, 2009, CURRENT PROTOCOLS IM, V84, P441; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P378, DOI 10.1111/j.1600-6143.2004.00332.x; Munye MM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23125; Nashan B, 1997, LANCET, V350, P1193, DOI 10.1016/S0140-6736(97)09278-7; Osborn MJ, 2011, MOL THER, V19, P450, DOI 10.1038/mt.2010.249; Pirsch JD, 1996, TRANSPLANTATION, V61, P1581, DOI 10.1097/00007890-199606150-00006; REEM GH, 1984, J BIOL RESP MODIF, V3, P195; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Suda T, 2007, MOL THER, V15, P2063, DOI 10.1038/sj.mt.6300314; UEDA H, 1991, TRANSPLANTATION, V52, P437, DOI 10.1097/00007890-199109000-00008; UEDA H, 1990, TRANSPLANTATION, V50, P545, DOI 10.1097/00007890-199010000-00002; WELTE K, 1984, J EXP MED, V160, P1390, DOI 10.1084/jem.160.5.1390; Wolff JA, 2005, ADV GENET, V54, P3, DOI 10.1016/S0065-2660(05)54001-X; Yi H, 2014, SCI REP-UK, V4, DOI 10.1038/srep05961; Zhang XH, 2001, HUM GENE THER, V12, P2179, DOI 10.1089/10430340152710522; Zuo YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019407	35	1	1	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10889	10901		10.1096/fj.201900833R	http://dx.doi.org/10.1096/fj.201900833R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31266358				2022-12-28	WOS:000489166300025
J	Schultz, F; Swiatlowska, P; Alvarez-Laviada, A; Sanchez-Alonso, JL; Song, QQ; de Vries, AAF; Pijnappels, DA; Ongstad, E; Braga, VMM; Entcheva, E; Gourdie, RG; Miragoli, M; Gorelik, J				Schultz, Francisca; Swiatlowska, Pamela; Alvarez-Laviada, Anita; Sanchez-Alonso, Jose L.; Song, Qianqian; de Vries, Antoine A. F.; Pijnappels, Daniel A.; Ongstad, Emily; Braga, Vania M. M.; Entcheva, Emilia; Gourdie, Robert G.; Miragoli, Michele; Gorelik, Julia			Cardiomyocyte-myofibroblast contact dynamism is modulated by connexin-43	FASEB JOURNAL			English	Article						heart failure; myocardial infarction; Cx43; heterocellular coupling	CARDIAC ELECTRICAL-ACTIVITY; VENTRICULAR MYOCYTES; GAP-JUNCTIONS; FIBROBLASTS; CONDUCTION; EXPRESSION; PROTEIN; ACTIN; TRAFFICKING; FIBROSIS	Healthy cardiomyocytes are electrically coupled at the intercalated discs by gap junctions. In infarcted hearts, adverse gap-junctional remodeling occurs in the border zone, where cardiomyocytes are chemically and electrically influenced by myofibroblasts. The physical movement of these contacts remains unquantified. Using scanning ion conductance microscopy, we show that intercellular contacts between cardiomyocytes and myofibroblasts are highly dynamic, mainly owing to the edge dynamics (lamellipodia) of the myofibroblasts. Decreasing the amount of functional connexin-43 (Cx43) at the membrane through Cx43 silencing, suppression of Cx43 trafficking, or hypoxia-induced Cx43 internalization attenuates heterocellular contact dynamism. However, we found decreased dynamism and stabilized membrane contacts when cellular coupling was strengthened using 4-phenylbutyrate (4PB). Fluorescent-dye transfer between cells showed that the extent of functional coupling between the 2 cell types correlated with contact dynamism. Intercellular calcein transfer from myofibroblasts to cardiomyocytes is reduced after myofibroblast-specific Cx43 down-regulation. Conversely, 4PB-treated myofibroblasts increased their functional coupling to cardiomyocytes. Consistent with lamellipodia-mediated contacts, latrunculin-B decreases dynamism, lowers physical communication between heterocellular pairs, and reduces Cx43 intensity in contact regions. Our data show that heterocellular cardiomyocyte-myofibroblast contacts exhibit high dynamism. Therefore, Cx43 is a potential target for prevention of aberrant cardiomyocyte coupling and myofibroblast proliferation in the infarct border zone.-Schultz, F., Swiatlowska, P., Alvarez-Laviada, A., Sanchez-Alonso, J. L., Song, Q., de Vries, A. A. F., Pijnappels, D. A., Ongstad, E., Braga, V. M. M., Entcheva, E., Gourdie, R. G., Miragoli, M., Gorelik, J. Cardiomyocyte-myofibroblast contact dynamism is modulated by connexin-43.	[Schultz, Francisca; Swiatlowska, Pamela; Alvarez-Laviada, Anita; Sanchez-Alonso, Jose L.; Song, Qianqian; Gorelik, Julia] Imperial Coll London, Natl Heart & Lung Inst, London, England; [de Vries, Antoine A. F.; Pijnappels, Daniel A.] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Ongstad, Emily; Gourdie, Robert G.] Virginia Tech, Caril Res Inst, Ctr Heart & Regenerat Med, Roanoke, VA USA; [Braga, Vania M. M.] Imperial Coll London, Dept Resp Sci, Fac Med, Natl Heart & Lung Inst, London, England; [Entcheva, Emilia] George Washington Univ, Dept Biomed Engn, Washington, DC USA; [Miragoli, Michele] Humanitas Clin & Res Ctr, Milan, Italy; [Miragoli, Michele] Univ Parma, Dept Med & Surg, Via Gramsci 14, I-43124 Parma, Italy	Imperial College London; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Virginia Polytechnic Institute & State University; Imperial College London; George Washington University; University of Parma; University Hospital of Parma	Miragoli, M (corresponding author), Univ Parma, Dept Med & Surg, Via Gramsci 14, I-43124 Parma, Italy.; Gorelik, J (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Imperial Ctr Translat & Expt Med, 4th Floor,Hammersmith Campus,Du Cane Rd, London W12 0NN, England.	michele.miragoli@unipr.it; j.gorelik@imperial.ac.uk	Miragoli, Michele/K-6418-2016; song, qianqian/GXH-5161-2022; Pijnappels, Daniël/AAA-2304-2022; de Vries, Antoine/ABG-5787-2021; Pijnappels, Daniël/GLN-2810-2022	Miragoli, Michele/0000-0002-4058-4368; Pijnappels, Daniël/0000-0001-6731-4125; Sanchez Alonso-Mardones, Jose Luis/0000-0003-2942-0079; Braga, Vania/0000-0003-0546-7163; Gorelik, Julia/0000-0003-1148-9158; Schultz, Francisca/0000-0002-8923-2128	British Heart Foundation [RG/17/13/33173]; Medical Research Council [MR/L006855/1]; National Heart, Lung, and Blood Institute (NHLBI), U.S. National Institutes of Health [1R01HL141855-01]; Heart Research UK; Italian Ministry of Education, Universities and Research (FFABR-MIUR-2017); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL141855] Funding Source: NIH RePORTER; BBSRC [BB/D019400/1, BB/M022617/1] Funding Source: UKRI; MRC [MR/L006855/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Heart, Lung, and Blood Institute (NHLBI), U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Heart Research UK; Italian Ministry of Education, Universities and Research (FFABR-MIUR-2017); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank P. O'Gara (Imperial College London, London, United Kingdom) for the assistance with the isolation of adult rat ventricular fibroblasts and M. Sikkel (Imperial College London, London) and C. Mansfield (Imperial College London, London) for generating rat models of myocardial infarction. This work was supported by British Heart Foundation (RG/17/13/33173 to J.G.), Medical Research Council (MR/L006855/1 to J.G.), National Heart, Lung, and Blood Institute (NHLBI), U.S. National Institutes of Health Grant-1R01HL141855-01 (to R.G., J.G. and A.A.-L.), Heart Research UK, and by Italian Ministry of Education, Universities and Research (FFABR-MIUR-2017 to M.M.). M.M. and J.G. jointly supervised this work. The authors declare no conflicts of interest.	Aasen T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051296; Alvarez-Maubecin V, 2000, J NEUROSCI, V20, P4091; Askar SF, 2012, CARDIOVASC RES, V93, P434, DOI 10.1093/cvr/cvr351; Asklund T, 2004, EUR J CANCER, V40, P1073, DOI 10.1016/j.ejca.2003.11.034; Biernacka A, 2011, AGING DIS, V2, P158; Camelliti P, 2004, CARDIOVASC RES, V62, P415, DOI 10.1016/j.cardiores.2004.01.027; Connolly A, 2015, IEEE T BIO-MED ENG, V62, P2251, DOI 10.1109/TBME.2015.2421296; Danon A, 2010, GEN PHYSIOL BIOPHYS, V29, P222, DOI 10.4149/gpb_2010_03_222; FOO ITH, 1992, LAB INVEST, V67, P727; Froes MM, 1999, P NATL ACAD SCI USA, V96, P7541, DOI 10.1073/pnas.96.13.7541; Fu HY, 2016, CIRC RES, V118, P798, DOI 10.1161/CIRCRESAHA.115.307604; Gaudesius G, 2003, CIRC RES, V93, P421, DOI 10.1161/01.RES.0000089258.40661.0C; Gokhale TA, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006276; Gorelik J, 2006, CARDIOVASC RES, V72, P422, DOI 10.1016/j.cardiores.2006.09.009; Gourdie RG, 2016, NAT REV DRUG DISCOV, V15, P620, DOI 10.1038/nrd.2016.89; Haefliger JA, 2004, CARDIOVASC RES, V62, P345, DOI 10.1016/j.cardiores.2003.11.015; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hubbard ML, 2012, EUROPACE, V14, pV3, DOI 10.1093/europace/eus267; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Jia ZH, 2012, BIOPHYS J, V102, P1294, DOI 10.1016/j.bpj.2012.02.034; Jiang B, 2016, CIRCULATION, V134; Johnstone SR, 2012, J MEMBRANE BIOL, V245, P319, DOI 10.1007/s00232-012-9453-3; Kohl P, 2014, J MOL CELL CARDIOL, V70, P37, DOI 10.1016/j.yjmcc.2013.12.024; Kuwahara F, 2002, CIRCULATION, V106, P130, DOI 10.1161/01.CIR.0000020689.12472.E0; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; Lauf U, 2002, P NATL ACAD SCI USA, V99, P10446, DOI 10.1073/pnas.162055899; Lefroy DC, 1998, AM J CARDIOL, V82, P444, DOI 10.1016/S0002-9149(98)00359-2; Lewis CJ, 2004, BRIT J PHARMACOL, V141, P813, DOI 10.1038/sj.bjp.0705668; Lyon AR, 2009, P NATL ACAD SCI USA, V106, P6854, DOI 10.1073/pnas.0809777106; Mahoney VM, 2016, SCI REP-UK, V6, DOI 10.1038/srep26744; Mahoney VM, 2016, PROG BIOPHYS MOL BIO, V120, P128, DOI 10.1016/j.pbiomolbio.2015.12.006; Majumder R, 2016, SCI REP-UK, V6, DOI 10.1038/srep24334; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Miragoli M, 2006, CIRC RES, V98, P801, DOI 10.1161/01.RES.0000214537.44195.a3; Miragoli M, 2007, CIRC RES, V101, P755, DOI 10.1161/CIRCRESAHA.107.160549; Miragoli M, 2011, J R SOC INTERFACE, V8, P913, DOI 10.1098/rsif.2010.0597; Nikolaev VO, 2010, SCIENCE, V327, P1653, DOI 10.1126/science.1185988; Novak P, 2009, NAT METHODS, V6, P279, DOI [10.1038/NMETH.1306, 10.1038/nmeth.1306]; O'Quinn MP, 2011, CIRC RES, V108, P704, DOI 10.1161/CIRCRESAHA.110.235747; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; Pogoda K, 2016, BMC CELL BIOL, V17, DOI 10.1186/s12860-016-0099-3; Rhee S, 2009, EXP MOL MED, V41, P858, DOI 10.3858/emm.2009.41.12.096; Rhett JM, 2011, MOL BIOL CELL, V22, P1516, DOI 10.1091/mbc.E10-06-0548; Rhett JM, 2012, HEART RHYTHM, V9, P619, DOI 10.1016/j.hrthm.2011.10.003; Roell W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25147-8; Rohr S, 2009, HEART RHYTHM, V6, P848, DOI 10.1016/j.hrthm.2009.02.038; Rosker C, 2011, CIRC RES, V109, P1120, DOI 10.1161/CIRCRESAHA.111.244798; Rubart M, 2018, CARDIOVASC RES, V114, P389, DOI 10.1093/cvr/cvx163; Rutherford SL, 2012, CIRC RES, V111, P301, DOI 10.1161/CIRCRESAHA.111.260943; Sacan A, 2008, BIOINFORMATICS, V24, P1647, DOI 10.1093/bioinformatics/btn247; Salvarani N, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.116.004567; Schultz F, 2016, PROG BIOPHYS MOL BIO, V120, P149, DOI 10.1016/j.pbiomolbio.2016.01.003; Shinde AV, 2014, J MOL CELL CARDIOL, V70, P74, DOI 10.1016/j.yjmcc.2013.11.015; Smyth JW, 2012, CIRC RES, V110, P978, DOI 10.1161/CIRCRESAHA.111.257964; Smyth JW, 2010, J CLIN INVEST, V120, P266, DOI 10.1172/JCI39740; Takatori O, 2017, J CARDIOVASC PHARM T, V22, P283, DOI 10.1177/1074248416679308; TAKENSKWAK BR, 1992, AM J PHYSIOL, V262, pC1531, DOI 10.1152/ajpcell.1992.262.6.C1531; Thompson SA, 2014, J MOL CELL CARDIOL, V68, P29, DOI 10.1016/j.yjmcc.2013.12.025; Thompson SA, 2011, CIRCULATION, V123, P2083, DOI 10.1161/CIRCULATIONAHA.110.015057; Truskey George A, 2010, Int J High Throughput Screen, V2010, P171; van Veen TAB, 2001, CARDIOVASC RES, V51, P217, DOI 10.1016/S0008-6363(01)00324-8; Zhang P, 2012, AM J PHYSIOL-HEART C, V303, pH1385, DOI 10.1152/ajpheart.01167.2011; Zhang Y, 2008, CELL COMMUN ADHES, V15, P289, DOI 10.1080/15419060802198736	63	14	14	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10453	10468		10.1096/fj.201802740RR	http://dx.doi.org/10.1096/fj.201802740RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31253057	Green Published, Bronze			2022-12-28	WOS:000482214200058
J	Volpe, M; Levinton, N; Rosenstein, N; Prag, G; Ben-Aroya, S				Volpe, Marina; Levinton, Nelly; Rosenstein, Nethanel; Prag, Gali; Ben-Aroya, Shay			Regulation of the anaphase promoting complex/cyclosome by the degradation of its unassembled catalytic subunit, Apc11	FASEB JOURNAL			English	Article						ubiquitin proteasome system; mitosis; protein quality control; cell cycle; cohesion	SACCHAROMYCES-CEREVISIAE; GENE DISRUPTION; DEGRON SYSTEM; PROTEIN; COMPLEX; YEAST; UBIQUITINATION; IDENTIFICATION; PRINCIPLES; ANEUPLOIDY	One of the challenges encountered by the protein quality control machinery is the need to ensure that members of multiprotein complexes are available in the correct proportions. In this study, we demonstrate that the ubiquitin proteasome system (UPS) mediates the degradation of Apc11, the catalytic core subunit of the anaphase promoting complex/cyclosome (APC/C). In vitro studies have shown that Apc11, together with its E2 enzyme, is sufficient to ubiquitinate substrates independently of the APC/C. Here, we establish that this can occur in living yeast cells. We show that the tight controls regulating the function of the fully assembled APC/C can be circumvented when its substrates are ubiquitinated by the excess levels of Apc11 independently of the assembled complex. We thus suggest that the UPS-mediated degradation of Apc11 is an overlooked mechanism ensuring that proper function of the APC/C is limited to suitably delimited holoenzymes and that an imbalance in protein expression may result in detrimental gain-of-function activity, rather than merely the disruption of protein complex stoichiometry.-Volpe, M., Levinton, N., Rosenstein, N., Prag, G., Ben-Aroya, S. Regulation of the anaphase promoting complex/cyclosome by the degradation of its unassembled catalytic subunit, Apc11.	[Volpe, Marina; Levinton, Nelly; Rosenstein, Nethanel; Ben-Aroya, Shay] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel; [Prag, Gali] Tel Aviv Univ, Dept Biochem & Mol Biol, Tel Aviv, Israel	Bar Ilan University; Tel Aviv University	Ben-Aroya, S (corresponding author), Bar Ilan Univ, Fac Life Sci, Nano Ctr, Bldg 206 Room B-840, IL-52900 Ramat Gan, Israel.	shay.ben-aroya@biu.ac.il						Barford D, 2011, Q REV BIOPHYS, V44, P153, DOI 10.1017/S0033583510000259; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; Benmaamar R, 2005, CELL CYCLE, V4, P1230, DOI 10.4161/cc.4.9.2048; Brachmann CB, 1998, YEAST, V14, P115; Chang LF, 2015, NATURE, V522, P450, DOI 10.1038/nature14471; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Davey NE, 2016, MOL CELL, V64, P12, DOI 10.1016/j.molcel.2016.09.006; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; Dephoure N, 2014, ELIFE, V3, DOI 10.7554/eLife.03023; Drouet Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25631-1; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Finka A, 2013, CELL STRESS CHAPERON, V18, P591, DOI 10.1007/s12192-013-0413-3; GERRING SL, 1990, EMBO J, V9, P4347, DOI 10.1002/j.1460-2075.1990.tb07884.x; Gmachl M, 2000, P NATL ACAD SCI USA, V97, P8973, DOI 10.1073/pnas.97.16.8973; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Keren-Kaplan T, 2012, EMBO J, V31, P378, DOI 10.1038/emboj.2011.397; Lev I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003838; Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Listovsky T, 2004, EMBO J, V23, P1619, DOI 10.1038/sj.emboj.7600149; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maier T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.38; Morawska M, 2013, YEAST, V30, P341, DOI 10.1002/yea.2967; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Pfleger CM, 2000, GENE DEV, V14, P655; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; SIKORSKI RS, 1989, GENETICS, V122, P19; Sung MK, 2016, ELIFE, V5, DOI 10.7554/eLife.19105; Sung MK, 2016, MOL BIOL CELL, V27, P2642, DOI 10.1091/mbc.E16-05-0290; Tang ZY, 2001, MOL BIOL CELL, V12, P3839, DOI 10.1091/mbc.12.12.3839; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Torres EM, 2010, CELL, V143, P71, DOI 10.1016/j.cell.2010.08.038; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Yerbury JJ, 2016, J NEUROCHEM, V137, P489, DOI 10.1111/jnc.13575; Yuen KWY, 2007, P NATL ACAD SCI USA, V104, P3925, DOI 10.1073/pnas.0610642104; Zachariae W, 1998, SCIENCE, V279, P1216, DOI 10.1126/science.279.5354.1216; Zhou JY, 2018, ONCOTARGETS THER, V11, P7125, DOI 10.2147/OTT.S177252	45	3	3	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9752	9761		10.1096/fj.201802300R	http://dx.doi.org/10.1096/fj.201802300R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31162950				2022-12-28	WOS:000482214200006
J	Bavelloni, A; Focaccia, E; Piazzi, M; Raffini, M; Cesarini, V; Tomaselli, S; Orsini, A; Ratti, S; Faenza, I; Cocco, L; Gallo, A; Blalock, WL				Bavelloni, Alberto; Focaccia, Enrico; Piazzi, Manuela; Raffini, Mirco; Cesarini, Valeriana; Tomaselli, Sara; Orsini, Arianna; Ratti, Stefano; Faenza, Irene; Cocco, Lucio; Gallo, Angela; Blalock, William L.			AKT-dependent phosphorylation of the adenosine deaminases ADAR-1 and-2 inhibits deaminase activity	FASEB JOURNAL			English	Article						oncology; protein-protein interaction; kinase; RNA editing; nucleus	PROTEIN-KINASE PKR; ROLES; ACTIVATION; CELLS; SPECIFICITY; EXPRESSION; MUTATIONS; SUBSTRATE; ISOFORMS; AKT/PKB	Murine thymoma viral oncogene homolog (AKT) kinases target both cytosolic and nuclear substrates for phosphorylation. Whereas the cytosolic substrates are known to be closely associated with the regulation of apoptosis and autophagy or metabolism and protein synthesis, the nuclear substrates are, for the most part, poorly understood. To better define the role of nuclear AKT, potential AKT substrates were isolated from the nuclear lysates of leukemic cell lines using a phosphorylated AKT substrate antibody and identified in tandem mass spectrometry. Among the proteins identified was adenosine deaminase acting on RNA (ADAR)1p110, the predominant nuclear isoform of the adenosine deaminase acting on double-stranded RNA. Coimmunoprecipitation studies and in vitro kinase assays revealed that AKT-1, -2, and -3 interact with both ADAR1p110 and ADAR2 and phosphorylate these RNA editases. Using site-directed mutagenesis of suspected AKT phosphorylation sites, AKT was found to primarily phosphorylate ADAR1p110 and ADAR2 on T738 and T553, respectively, and overexpression of the phosphomimic mutants ADAR1p110 (T738D) and ADAR2 (T553D) resulted in a 50-100% reduction in editase activity. Thus, activation of AKT has a direct and major impact on RNA editing.-Bavelloni, A., Focaccia, E., Piazzi, M., Raffini, M., Cesarini, V., Tomaselli, S., Orsini, A., Ratti, S., Faenza, I., Cocco, L., Gallo, A., Blalock, W. L. AKT-dependent phosphorylation of the adenosine deaminases ADAR-1 and -2 inhibits deaminase activity.	[Bavelloni, Alberto; Focaccia, Enrico; Piazzi, Manuela; Raffini, Mirco; Blalock, William L.] IRCSS Ist Ortoped Rizzoli IOR, Bologna, Italy; [Focaccia, Enrico; Piazzi, Manuela; Blalock, William L.] Natl Res Council CNR Italy, Inst Mol Genet, Bologna, Italy; [Cesarini, Valeriana; Tomaselli, Sara; Gallo, Angela] IRCCS Osped Pediat Bambino Gesu, RNA Editing Lab, Oncohaematol Dept, Rome, Italy; [Orsini, Arianna; Ratti, Stefano; Faenza, Irene; Cocco, Lucio] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Bambino Gesu; University of Bologna	Gallo, A (corresponding author), Bambino Gesu Pediat Hosp, IRCSS, RNA Editing Lab, Oncohaematol Dept, Viale San Paolo 15, I-00146 Rome, Italy.; Blalock, WL (corresponding author), CNR, IGM, Rizzoli Orthoped Inst, Via Barbiano 1-10, I-40136 Bologna, Italy.	angela.gallo@opbg.net; william.blalock@cnr.it	Cocco, Lucio/AAI-2206-2020; Gallo, Angela/E-7837-2011; Piazzi, Manuela/AAD-5016-2020; Faenza, Irene/AAC-4606-2022; ratti, stefano/AAC-8714-2022; Gallo, Angela/AAA-5003-2020; Bavelloni, Alberto/E-5726-2019	Cocco, Lucio/0000-0002-9206-8277; Gallo, Angela/0000-0003-0297-1807; Piazzi, Manuela/0000-0002-9072-2757; Faenza, Irene/0000-0002-5227-3567; Gallo, Angela/0000-0003-0297-1807; RATTI, STEFANO/0000-0002-6258-5345; Bavelloni, Alberto/0000-0002-6467-1431	Leukemia Research Foundation; Associazione Italiana per la Ricerca sul Cancro (AIRC) [17137, 17615]; Del Monte Foundation; Intesa San Paolo Foundation; Italian Ministero dell'Istruzione dell'Universita' e della Ricerca-Progetti di Rilevante Interesse Nazionale (MIUR-PRIN); 5 X 1000 fund of the Rizzoli Orthopedic Institute	Leukemia Research Foundation; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Del Monte Foundation; Intesa San Paolo Foundation; Italian Ministero dell'Istruzione dell'Universita' e della Ricerca-Progetti di Rilevante Interesse Nazionale (MIUR-PRIN); 5 X 1000 fund of the Rizzoli Orthopedic Institute	The authors thank the Interdepartmental Center for Large Instrumentation (CIGS) at the University of Modena and Reggio Emilia. This work was supported by grants from the Leukemia Research Foundation 2015 New Investigator Grant (to W.L.B.), the Associazione Italiana per la Ricerca sul Cancro (AIRC-IG2015; Grant 17137 to W.L.B. and AIRC-IG2015; Grant 17615 to A.G.), the Del Monte Foundation (to I.F.), Intesa San Paolo Foundation (to L.C.), the Italian Ministero dell'Istruzione dell'Universita' e della Ricerca-Progetti di Rilevante Interesse Nazionale (MIUR-PRIN) (to L.C.); and the 5 X 1000 fund of the Rizzoli Orthopedic Institute. The authors declare no conflicts of interest.	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; BASILIO C, 1962, P NATL ACAD SCI USA, V48, P613, DOI 10.1073/pnas.48.4.613; Bavelloni A, 2014, FASEB J, V28, P2009, DOI 10.1096/fj.13-244368; Blalock WL, 2011, LEUKEMIA, V25, P236, DOI 10.1038/leu.2010.264; Blalock WL, 2014, J CELL PHYSIOL, V229, P1047, DOI 10.1002/jcp.24529; Cenci C, 2008, J BIOL CHEM, V283, P7251, DOI 10.1074/jbc.M708316200; Cesarini V, 2018, NUCLEIC ACIDS RES, V46, P2045, DOI 10.1093/nar/gkx1257; Chen YB, 2017, INT J ONCOL, V50, P622, DOI 10.3892/ijo.2016.3823; Cohen MM, 2013, AM J MED GENET A, V161, P2931, DOI 10.1002/ajmg.a.36101; DeCerbo J, 2005, CURR OPIN CELL BIOL, V17, P302, DOI 10.1016/j.ceb.2005.04.008; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Gallo A, 2017, HUM GENET, V136, P1265, DOI 10.1007/s00439-017-1837-0; George CX, 2005, J BIOL CHEM, V280, P15020, DOI 10.1074/jbc.M500476200; Gerber A, 1997, RNA, V3, P453; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Han EKH, 2007, ONCOGENE, V26, P5655, DOI 10.1038/sj.onc.1210343; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Hao CC, 2016, ONCOTARGET, V7, P38235, DOI 10.18632/oncotarget.9428; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Jain MV, 2015, CELL CYCLE, V14, P2109, DOI 10.1080/15384101.2015.1041692; Joy A, 2016, J NEURO-ONCOL, V130, P43, DOI 10.1007/s11060-016-2220-z; Kane LP, 2002, MOL CELL BIOL, V22, P5962, DOI 10.1128/MCB.22.16.5962-5974.2002; Kawanishi S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081808; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Kriplani Nisha, 2015, Advances in Biological Regulation, V59, P53, DOI 10.1016/j.jbior.2015.05.002; LARDER BA, 1993, NATURE, V365, P671, DOI 10.1038/365671a0; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mannion N, 2015, BIOMOLECULES, V5, P2338, DOI 10.3390/biom5042338; Marelli G, 2017, CURR OPIN PHARMACOL, V35, P57, DOI 10.1016/j.coph.2017.05.007; Matkovic K, 2006, LEUKEMIA, V20, P941, DOI 10.1038/sj.leu.2404204; Mielcarek M, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-015-0076-z; Mure H, 2010, NEURO-ONCOLOGY, V12, P221, DOI 10.1093/neuonc/nop026; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Pfaller CK, 2011, CURR OPIN IMMUNOL, V23, P573, DOI 10.1016/j.coi.2011.08.009; Radetskyy R, 2018, CYTOKINE GROWTH F R, V40, P48, DOI 10.1016/j.cytogfr.2018.03.007; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Sakurai M, 2017, NAT STRUCT MOL BIOL, V24, P534, DOI 10.1038/nsmb.3403; Samuel CE, 2011, VIROLOGY, V411, P180, DOI 10.1016/j.virol.2010.12.004; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sergeeva OA, 2007, CELL MOL NEUROBIOL, V27, P669, DOI 10.1007/s10571-007-9153-1; Shelton PM, 2018, CELL REP, V23, P1178, DOI 10.1016/j.celrep.2018.03.118; Shiraishi I, 2004, CIRC RES, V94, P884, DOI 10.1161/01.RES.0000124394.01180.BE; Tomaselli S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0575-z; Van de Sande T, 2005, J PATHOL, V206, P214, DOI 10.1002/path.1760; VanItallie TB, 2017, METABOLISM, V69, pS41, DOI 10.1016/j.metabol.2017.01.014; Velazquez-Torres G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02851-7; Vesely C, 2014, NUCLEIC ACIDS RES, V42, P12155, DOI 10.1093/nar/gku844; Yang KQ, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3879-z; Zipeto MA, 2016, CELL STEM CELL, V19, P177, DOI 10.1016/j.stem.2016.05.004	52	12	13	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9044	9061		10.1096/fj.201800490RR	http://dx.doi.org/10.1096/fj.201800490RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31095429				2022-12-28	WOS:000478832900029
J	Kague, E; Hughes, SM; Lawrence, EA; Cross, S; Martin-Silverstone, E; Hammond, CL; Hinits, Y				Kague, Erika; Hughes, Simon M.; Lawrence, Elizabeth A.; Cross, Stephen; Martin-Silverstone, Elizabeth; Hammond, Chrissy L.; Hinits, Yaniv			Scleraxis genes are required for normal musculoskeletal development and for rib growth and mineralization in zebrafish	FASEB JOURNAL			English	Article						zebrafish; tendon; ribs; craniofacial; muscle	TENDON DEVELOPMENT; CELL BEHAVIOR; MUSCLE; BONE; EXPRESSION; CARTILAGE; SKELETON; LIGAMENT; CHICK; DIFFERENTIATION	Tendons are an essential part of the musculoskeletal system, connecting muscle and skeletal elements to enable force generation. The transcription factor scleraxis marks vertebrate tendons from early specification. Scleraxis-null mice are viable and have a range of tendon and bone defects in the trunk and limbs but no described cranial phenotype. We report the expression of zebrafish scleraxis orthologs: scleraxis homolog (scx)-a and scxb in cranial and intramuscular tendons and in other skeletal elements. Single mutants for either scxa or scxb, generated by clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), are viable and fertile as adult fish. Although scxb mutants show no obvious phenotype, scxa mutant embryos have defects in cranial tendon maturation and muscle misalignment. Mutation of both scleraxis genes results in more severe defects in cranial tendon differentiation, muscle and cartilage dysmorphogenesis and paralysis, and lethality by 2-5 wk, which indicates an essential function of scleraxis for craniofacial development. At juvenile and adult stages, ribs in scxa mutants fail to mineralize and/or are small and heavily fractured. Scxa mutants also have smaller muscle volume, abnormal swim movement, and defects in bone growth and composition. Scleraxis function is therefore essential for normal craniofacial form and function and vital for fish development.-Kague, E., Hughes, S. M., Lawrence, E. A., Cross, S., Martin-Silverstone, E., Hammond, C. L., Hinits, Y. Scleraxis genes are required for normal musculoskeletal development and for rib growth and mineralization in zebrafish.	[Kague, Erika; Lawrence, Elizabeth A.; Cross, Stephen; Martin-Silverstone, Elizabeth; Hammond, Chrissy L.] Univ Bristol, Dept Physiol Pharmacol & Neurosci, Med Sci, Bristol, Avon, England; [Hughes, Simon M.; Hinits, Yaniv] Kings Coll London, Fac Life Sci & Med, Sch Basic & Med Biosci, Randall Ctr Cell & Mol Biophys, London, England	University of Bristol; University of London; King's College London	Hammond, CL (corresponding author), Univ Bristol, Dept Physiol Pharmacol & Neurosci, Med Sci, Bristol, Avon, England.; Hinits, Y (corresponding author), Kings Coll London, Randall Ctr Cell & Mol Biophys, 3rd Floor North,New Hunts House,Guys Campus, London SE1 1UL, England.	chrissy.hammond@bristol.ac.uk; yaniv.hinits@kcl.ac.uk	Hughes, Simon M/S-1073-2016; Hinits, Yaniv/AAP-6148-2020; Hammond, Chrissy/D-6568-2013	Hughes, Simon M/0000-0001-8227-9225; Hinits, Yaniv/0000-0002-2682-1603; Lawrence, Elizabeth/0000-0002-8953-7183; Martin-Silverstone, Elizabeth/0000-0003-0139-2109; Kague, Erika/0000-0002-0266-9424; Cross, Stephen/0000-0003-3565-0479; Hammond, Chrissy/0000-0002-4935-6724	Arthritis Research UK [19476, 21937, 21121]; MRC scientific staff with Programme [G1001029, MR/N021231/1]; Wellcome Trust Dynamic Molecular Cell Biology PhD programme; Elizabeth Blackwell Institute through its Wellcome Trust ISSF Award; BHF [PG/14/12/30664]; MRC [G1001029, MR/N021231/1] Funding Source: UKRI	Arthritis Research UK(Versus Arthritis); MRC scientific staff with Programme; Wellcome Trust Dynamic Molecular Cell Biology PhD programme(Wellcome Trust); Elizabeth Blackwell Institute through its Wellcome Trust ISSF Award; BHF(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	E.K., E.M.-S., and C.L.H. are funded by Arthritis Research UK Grants 19476, 21937, and 21121; S.M.H. is a member of the MRC scientific staff with Programme Grant G1001029 and MR/N021231/1 support; E.L. is funded by the Wellcome Trust Dynamic Molecular Cell Biology PhD programme; S.C. is partially funded by the Elizabeth Blackwell Institute through its Wellcome Trust ISSF Award; and Y.H. was funded by BHF Grant PG/14/12/30664. The authors declare no conflicts of interest.	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Albertson RC, 2005, P NATL ACAD SCI USA, V102, P16287, DOI 10.1073/pnas.0506649102; Amores A, 2004, GENOME RES, V14, P1, DOI 10.1101/gr.1717804; Aoyama H, 2005, INT J DEV BIOL, V49, P325, DOI 10.1387/ijdb.041932ha; Bird NC, 2003, DEV DYNAM, V228, P337, DOI 10.1002/dvdy.10387; Blagden CS, 1997, GENE DEV, V11, P2163, DOI 10.1101/gad.11.17.2163; Blitz E, 2013, DEVELOPMENT, V140, P2680, DOI 10.1242/dev.093906; Blitz E, 2009, DEV CELL, V17, P861, DOI 10.1016/j.devcel.2009.10.010; Braun Saori I, 2015, Prev Med Rep, V2, P300, DOI 10.1016/j.pmedr.2015.04.012; Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; Bricard Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091876; Brunt LH, 2016, OSTEOARTHR CARTILAGE, V24, P1940, DOI 10.1016/j.joca.2016.06.015; Brunt LH, 2015, J BIOMECH, V48, P3112, DOI 10.1016/j.jbiomech.2015.07.017; Charvet B, 2011, CELL TISSUE RES, V346, P439, DOI 10.1007/s00441-011-1266-7; Chen JW, 2017, METHOD CELL BIOL, V138, P299, DOI 10.1016/bs.mcb.2016.10.003; Chen JW, 2014, DEVELOPMENT, V141, P2035, DOI 10.1242/dev.104067; Chen XY, 2012, NAT PROTOC, V7, P654, DOI 10.1038/nprot.2012.009; CHRIST B, 1992, ANN ANAT, V174, P23, DOI 10.1016/S0940-9602(11)80337-7; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Cross S., 2018, SJCROSS MODULARIMAGE; CSERJESI P, 1995, DEVELOPMENT, V121, P1099; della Gaspera B, 2009, DEV BIOL, V328, P392, DOI 10.1016/j.ydbio.2009.01.039; Descamps E, 2014, BELG J ZOOL, V144, P20; Evans DJR, 2003, DEV BIOL, V256, P114, DOI 10.1016/S0012-1606(02)00117-3; Eyal S, 2015, DEVELOPMENT, V142, P1831, DOI 10.1242/dev.121970; Felsenthal N, 2017, DEVELOPMENT, V144, P4271, DOI 10.1242/dev.151266; Fin L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05017-5; Fisher S, 2003, DEV BIOL, V264, P64, DOI 10.1016/S0012-1606(03)00399-3; Goody MF, 2015, DEV BIOL, V401, P75, DOI 10.1016/j.ydbio.2015.01.002; Grenier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004381; Grifone R, 2008, DEV DYNAM, V237, P3071, DOI 10.1002/dvdy.21718; Hammond CL, 2009, DEVELOPMENT, V136, P3991, DOI 10.1242/dev.042150; Higashijima S, 1997, DEV BIOL, V192, P211, DOI 10.1006/dbio.1997.8760; Hinits Y, 2007, DEVELOPMENT, V134, P2511, DOI 10.1242/dev.007088; Hinits Y, 2011, DEV BIOL, V358, P102, DOI 10.1016/j.ydbio.2011.07.015; Hinits Y, 2009, DEVELOPMENT, V136, P403, DOI 10.1242/dev.028019; Hirao A, 2004, DEV GROWTH DIFFER, V46, P351; Hosokawa R, 2010, DEV BIOL, V341, P186, DOI 10.1016/j.ydbio.2010.02.030; Huang RJ, 2003, DEV BIOL, V255, P30, DOI 10.1016/S0012-1606(02)00051-9; Huang RJ, 2000, DEVELOPMENT, V127, P527; Jones RE, 1999, AQUACULT ENG, V20, P261, DOI 10.1016/S0144-8609(99)00020-5; Kato N, 1998, DEVELOPMENT, V125, P3437; Killian ML, 2016, FASEB J, V30, P301, DOI 10.1096/fj.14-258236; Kouskoura T, 2016, J DENT RES, V95, P453, DOI 10.1177/0022034515621869; Lawrence EA, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0335; Lejard V, 2011, J BIOL CHEM, V286, P5855, DOI 10.1074/jbc.M110.153106; McGurk PD, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007112; McKenzie JA, 2017, FASEB J, V31, P882, DOI 10.1096/fj.201600969R; Muffato M, 2010, BIOINFORMATICS, V26, P1119, DOI 10.1093/bioinformatics/btq079; MUNKRES J, 1957, J SOC IND APPL MATH, V5, P32, DOI 10.1137/0105003; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Nichols JT, 2016, DEVELOPMENT, V143, P4430, DOI 10.1242/dev.141036; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; PREWITT JMS, 1966, ANN NY ACAD SCI, V128, P1035; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Satoh A, 2006, DEV DYNAM, V235, P1065, DOI 10.1002/dvdy.20701; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulze-Tanzil G, 2004, HISTOCHEM CELL BIOL, V122, P219, DOI 10.1007/s00418-004-0694-9; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Schweitzer R, 2010, DEVELOPMENT, V137, P2807, DOI 10.1242/dev.047498; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Shwartz Y, 2012, DEV BIOL, V370, P154, DOI 10.1016/j.ydbio.2012.07.026; Smith TG, 2005, DEVELOPMENT, V132, P1305, DOI 10.1242/dev.01699; Stevenson NL, 2017, J CELL SCI, V130, P4132, DOI 10.1242/jcs.212308; Subramanian A, 2014, ELIFE, V3, DOI 10.7554/eLife.02372; Subramanian A, 2015, DEVELOPMENT, V142, P4191, DOI 10.1242/dev.114777; Sugimoto Y, 2013, DEVELOPMENT, V140, P2280, DOI 10.1242/dev.096354; Suniaga S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21776-1; Tozer Samuel, 2005, Birth Defects Research, V75, P226, DOI 10.1002/bdrc.20049; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Watts SA, 2012, ILAR J, V53, P144, DOI 10.1093/ilar.53.2.144; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wood AJ, 2017, CURR PATHOBIOL REP, V5, P197, DOI 10.1007/s40139-017-0140-z; Xu YF, 2000, DEV DYNAM, V219, P201, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1043>3.3.CO;2-9; Yan YL, 2002, DEVELOPMENT, V129, P5065; Yao WJ, 2015, BIOL OPEN, V4, P1727, DOI 10.1242/bio.012856; Yoshimoto Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep45010	79	20	23	2	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9116	9130		10.1096/fj.201802654RR	http://dx.doi.org/10.1096/fj.201802654RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31100023	hybrid, Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000478832900034
J	Sudevan, S; Takiura, M; Kubota, Y; Higashitani, N; Cooke, M; Ellwood, RA; Etheridge, T; Szewczyk, NJ; Higashitani, A				Sudevan, Surabhi; Takiura, Mai; Kubota, Yukihiko; Higashitani, Nahoko; Cooke, Michael; Ellwood, Rebecca A.; Etheridge, Timothy; Szewczyk, Nathaniel J.; Higashitani, Atsushi			Mitochondrial dysfunction causes Ca2+ overload and ECM degradation-mediated muscle damage in C. elegans	FASEB JOURNAL			English	Article						Antimycin A; collagen; Furin; DMD; MMP	COLLAGEN-VI; CALCIUM; MATRIX	Mitochondrial dysfunction impairs muscle health and causes subsequent muscle wasting. This study explores the role of mitochondrial dysfunction as an intramuscular signal for the extracellular matrix (ECM)-based proteolysis and, consequentially, muscle cell dystrophy. We found that inhibition of the mitochondrial electron transport chain causes paralysis as well as muscle structural damage in the nematode Caenorhabditis elegans. This was associated with a significant decline in collagen content. Both paralysis and muscle damage could be rescued with collagen IV overexpression, matrix metalloproteinase (MMP), and Furin inhibitors in Antimycin A-treated animal as well as in the C. elegans Duchenne muscular dystrophy model. Additionally, muscle cytosolic calcium increased in the Antimycin A-treated worms, and its down-regulation rescued the muscle damage, suggesting that calcium overload acts as one of the early triggers and activates Furin and MMPs for collagen degradation. In conclusion, we have established ECM degradation as an important pathway of muscle damage.-Sudevan, S., Takiura, M., Kubota, Y., Higashitani, N., Cooke, M., Ellwood, R. A., Etheridge, T., Szewczyk, N. J., Higashitani, A. Mitochondrial dysfunction causes Ca2+ overload and ECM degradation-mediated muscle damage in C. elegans.	[Sudevan, Surabhi; Takiura, Mai; Kubota, Yukihiko; Higashitani, Nahoko; Higashitani, Atsushi] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi, Japan; [Cooke, Michael; Etheridge, Timothy] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Cooke, Michael; Ellwood, Rebecca A.; Szewczyk, Nathaniel J.] Univ Nottingham, Med Res Council, Nottingham, England; [Cooke, Michael; Ellwood, Rebecca A.; Szewczyk, Nathaniel J.] Univ Nottingham, Arthrit Res United Kingdom ARUK Ctr Musculoskelet, Nottingham, England; [Cooke, Michael; Ellwood, Rebecca A.; Szewczyk, Nathaniel J.] Univ Nottingham, Nottingham Biomed Res Ctr, Natl Inst Hlth Res, Nottingham, England	Tohoku University; University of Exeter; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Nottingham; University of Nottingham; University of Nottingham	Kubota, Y (corresponding author), Ritsumeikan Univ, Kusatsu, Japan.; Higashitani, A (corresponding author), Tohoku Univ, Grad Sch Life Sci, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	ahigashi@m.tohoku.ac.jp	Higashitani, Atsushi/AAT-9617-2021	Higashitani, Atsushi/0000-0001-6920-0594; Cooke, Mike/0000-0003-2081-3466; Szewczyk, Nathaniel/0000-0003-4425-9746; Ellwood, Rebecca/0000-0002-0412-7530; Kubota, Yukihiko/0000-0002-8151-9888	U.S. National Institutes of Health (NIH) Office of Research Infrastructure Program [P40OD010440]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [15H05937, 15K21745]; Cross-Ministerial Strategic Innovation Promotion Program [14537491]; Advanced Research and Development Programs for Medical Innovation (AMED-CREST) [16814305]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/N015894/1, BB/P025781/1]; UK Space Agency; Science and Technology Facilities Council [ST/R005737/1]; Otsuka Toshimi Foundation; Tohoku University President scholarship; Japan Student Services Organization; BBSRC [BB/P025781/1, BB/N015894/1] Funding Source: UKRI; STFC [2116193] Funding Source: UKRI; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) Office of Research Infrastructure Program; Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cross-Ministerial Strategic Innovation Promotion Program; Advanced Research and Development Programs for Medical Innovation (AMED-CREST); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Space Agency; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Otsuka Toshimi Foundation(Otsuka Pharmaceutical); Tohoku University President scholarship; Japan Student Services Organization(Japan Student Services Organization); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NF3620 was kindly provided by Prof. Kiyoji Nishiwaki (Kwansei Gakuin University, Nishinomiya, Japan). Other strains used in this study were provided by the Caenorhabditis Genetics Center funded by the U.S. National Institutes of Health (NIH) Office of Research Infrastructure Program (P40OD010440). Liquid chromatography and tandem mass spectrometry analysis was supported by Drs. Kazuhiko Igarashi and Hiroki Shima. This work was funded in part by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Grants-in-Aid for Scientific Research (KAKENHI) (Grants 15H05937 and 15K21745), the Cross-Ministerial Strategic Innovation Promotion Program (14537491), the Advanced Research and Development Programs for Medical Innovation (AMED-CREST; Grant 16814305), the Biotechnology and Biological Sciences Research Council (BBSRC; Grants BB/N015894/1 and BB/P025781/1), the UK Space Agency, and the Science and Technology Facilities Council (Grant ST/R005737/1). S.S. obtained a scholarship from the Otsuka Toshimi Foundation, the Tohoku University President scholarship, and a scholarship from the Japan Student Services Organization. The authors declare no conflicts of interest.	Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Bratcher PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041881; Calvani R, 2013, BIOL CHEM, V394, P393, DOI 10.1515/hsz-2012-0247; Cescon M, 2015, J CELL SCI, V128, P3525, DOI 10.1242/jcs.169748; Etheridge T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002471; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Gorlach A, 2015, REDOX BIOL, V6, P260, DOI 10.1016/j.redox.2015.08.010; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Hewitt JE, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.036137; Higashibata A, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2015.22; Hughes KJ, 2019, P NATL ACAD SCI USA, V116, P3508, DOI 10.1073/pnas.1811379116; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Jospin M, 2002, J CELL BIOL, V159, P337, DOI 10.1083/jcb.200203055; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kelly-Worden M., 2014, OPEN J ENDOCRINE MET, V04, P211, DOI [10.4236/ojemd.2014.48020, DOI 10.4236/OJEMD.2014.48020]; Kendall GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3005054; Koppers AJ, 2008, J CLIN ENDOCR METAB, V93, P3199, DOI 10.1210/jc.2007-2616; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; Makowski GS, 2005, CLIN CHIM ACTA, V358, P182, DOI 10.1016/j.cccn.2005.03.012; Mariol MC, 2007, NEUROMUSCULAR DISORD, V17, P56, DOI 10.1016/j.nmd.2006.09.012; Meraz-Cruz N, 2006, MOL HUM REPROD, V12, P633, DOI 10.1093/molehr/gal072; Momma K, 2017, GENETICS, V206, P1985, DOI 10.1534/genetics.117.202747; Onopiuk M, 2009, BIOCHEM BIOPH RES CO, V386, P463, DOI 10.1016/j.bbrc.2009.06.053; Pancha I, 2019, PLANT J, V97, P485, DOI 10.1111/tpj.14136; Schwarz J, 2011, CURR BIOL, V21, pR983, DOI 10.1016/j.cub.2011.10.046; Shephard F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024686; Shibata Y, 2016, G3-GENES GENOM GENET, V6, P1449, DOI 10.1534/g3.116.028019; SULSTON JE, 1974, GENETICS, V77, P95; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Timpani CA, 2015, MED HYPOTHESES, V85, P1021, DOI 10.1016/j.mehy.2015.08.015; Wang XH, 2014, NAT COMMUN, V5, P1, DOI 10.1038/ncomms3957; Zucchi R, 1997, PHARMACOL REV, V49, P1	33	14	14	3	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9540	9550		10.1096/fj.201802298R	http://dx.doi.org/10.1096/fj.201802298R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31162948	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000478832900065
J	Wang, Q; Groenendyk, J; Paskevicius, T; Qin, WY; Kor, KC; Liu, YJ; Hiess, F; Knollmann, BC; Chen, SRW; Tang, JF; Chen, XZ; Agellon, LB; Michalak, M				Wang, Qian; Groenendyk, Jody; Paskevicius, Tautvydas; Qin, Wenying; Kor, Kaylen C.; Liu, Yingjie; Hiess, Florian; Knollmann, Bjorn C.; Chen, S. R. Wayne; Tang, Jingfeng; Chen, Xing-Zhen; Agellon, Luis B.; Michalak, Marek			Two pools of IRE1 alpha in cardiac and skeletal muscle cells	FASEB JOURNAL			English	Article						calcium; calsequestrin; ER stress; sarcoplasmic reticulum	UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; SARCOPLASMIC-RETICULUM; RYANODINE RECEPTOR; ER STRESS; TERMINAL CISTERNAE; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; CALCIUM-BINDING; CALSEQUESTRIN	The endoplasmic reticulum (ER) plays a central role in cellular stress responses via mobilization of ER stress coping responses, such as the unfolded protein response (UPR). The inositol-requiring 1 alpha (IRE1 alpha) is an ER stress sensor and component of the UPR. Muscle cells also have a well-developed and highly subspecialized membrane network of smooth ER called the sarcoplasmic reticulum (SR) surrounding myofibrils and specialized for Ca2+ storage, release, and uptake to control muscle excitation-contraction coupling. Here, we describe 2 distinct pools of IRE1 alpha in cardiac and skeletal muscle cells, one localized at the perinuclear ER and the other at the junctional SR. We discovered that, at the junctional SR, calsequestrin binds to the ER luminal domain of IRE1 alpha, inhibiting its dimerization. This novel interaction of IRE1 alpha with calsequestrin, one of the highly abundant Ca2+ handling proteins at the junctional SR, provides new insights into the regulation of stress coping responses in muscle cells.-Wang, Q., Groenendyk, J., Paskevicius, T., Qin, W., Kor, K. C., Liu, Y., Hiess, F., Knollmann, B. C., Chen, S. R. W., Tang, J., Chen, X.-Z., Agellon, L. B., Michalak, M. Two pools of IRE1 alpha in cardiac and skeletal muscle cells.	[Wang, Qian; Groenendyk, Jody; Paskevicius, Tautvydas; Michalak, Marek] Univ Alberta, Dept Biochem, 474 Med Sci Bldg, Edmonton, AB T6G 2S7, Canada; [Chen, Xing-Zhen] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Qin, Wenying; Tang, Jingfeng; Chen, Xing-Zhen; Michalak, Marek] Hubei Univ Technol, Natl 111 Ctr Cellular Regulat & Mol Pharmaceut, Wuhan, Hubei, Peoples R China; [Kor, Kaylen C.; Knollmann, Bjorn C.] Vanderbilt Univ, Sch Med, Div Pharmacol, Nashville, TN 37212 USA; [Liu, Yingjie; Hiess, Florian; Chen, S. R. Wayne] Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Cumming Sch Med, Calgary, AB, Canada; [Agellon, Luis B.] McGill Univ, Sch Human Nutr, Ste Anne De Bellevue, PQ H9X 3V9, Canada	University of Alberta; University of Alberta; Hubei University of Technology; Vanderbilt University; Libin Cardiovascular Institute Of Alberta; University of Calgary; McGill University	Michalak, M (corresponding author), Univ Alberta, Dept Biochem, 474 Med Sci Bldg, Edmonton, AB T6G 2S7, Canada.; Agellon, LB (corresponding author), McGill Univ, Sch Human Nutr, Ste Anne De Bellevue, PQ H9X 3V9, Canada.	luis.agellon@mcgill.ca; marek.michalak@ualberta.ca			Canadian Institutes of Health Research [MOP-15291, MOP-15415, MOP-53050, PS-153325]; SynAD Program (University of Alberta); U.S. National Institutes of Health, National Heart, Lung and Blood Institute Grant [R35-HL144980]; National Natural Science Foundation of China [31871420, 81602448]; Heart and Stroke Foundation of Alberta, Northwest Territories and Nunavut; Natural Sciences Engineering Research Council of Canada; Heart and Stroke Foundation Chair in Cardiovascular Research; Canadian Institutes of Health [MOP-15291, PS-153325]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL144980] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); SynAD Program (University of Alberta); U.S. National Institutes of Health, National Heart, Lung and Blood Institute Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heart and Stroke Foundation of Alberta, Northwest Territories and Nunavut; Natural Sciences Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation Chair in Cardiovascular Research; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Monika Dabrowska (University of Alberta, Edmonton, AB, Canada) for technical help. The pRL-IXFL X-box binding protein 1 splicing reporter and pED-IRE1-NLD-His6-KDEL expression vectors were a generous gift from Dr. R. Kaufman (Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA). Mouse anti-skeletal muscle calsequestrin VIIID1-2C was a generous gift from Dr. K. P. Campbell (University of Iowa, Iowa City, IA, USA). This work was supported by the Canadian Institutes of Health Research Grants MOP-15291, MOP-15415, MOP-53050, and PS-153325 to M.M.; a grant from the SynAD Program (University of Alberta) to M.M.; a generous donation from the Kenneth and Sheelagh McCourt family; Canadian Institutes of Health Research Grant MOP-15291 and PS-153325 to L.B.A.; U.S. National Institutes of Health, National Heart, Lung and Blood Institute Grant R35-HL144980 to B.C.K.; National Natural Science Foundation of China, Grant 31871420 and 81602448 to J.F.T.; and by research grants from the Heart and Stroke Foundation of Alberta, Northwest Territories and Nunavut, the Natural Sciences Engineering Research Council of Canada, and the Heart and Stroke Foundation Chair in Cardiovascular Research to S.R.W.C. The authors declare no conflicts of interest.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Barone V, 2015, J MUSCLE RES CELL M, V36, P501, DOI 10.1007/s10974-015-9421-5; Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Beard NA, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0029-7; Beard NA, 2009, EUR BIOPHYS J BIOPHY, V39, P27, DOI 10.1007/s00249-009-0449-6; Bers DM, 2014, ANNU REV PHYSIOL, V76, P107, DOI 10.1146/annurev-physiol-020911-153308; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Braakman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013201; CALA SE, 1983, J BIOL CHEM, V258, P1932; CAMPBELL KP, 1987, J BIOL CHEM, V262, P6460; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; Chopra N, 2013, CARDIOVASC RES, V98, P187, DOI 10.1093/cvr/cvt023; COSTELLO B, 1986, J CELL BIOL, V103, P741, DOI 10.1083/jcb.103.3.741; Dicks N, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00011; Eisner DA, 2017, CIRC RES, V121, P181, DOI 10.1161/CIRCRESAHA.117.310230; Eletto D, 2014, MOL CELL, V53, P562, DOI 10.1016/j.molcel.2014.01.004; Gaburjakova M, 2013, CELL MOL LIFE SCI, V70, P2935, DOI 10.1007/s00018-012-1199-7; Gatti G, 2001, J CELL BIOL, V154, P525, DOI 10.1083/jcb.200103002; Groenendyk J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34891-w; Groenendyk J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159682; Groenendyk J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004983; Groenendyk J, 2013, ANNU REV PHYSIOL, V75, P49, DOI 10.1146/annurev-physiol-030212-183707; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; Gyorke S, 2009, J PHYSIOL-LONDON, V587, P3091, DOI 10.1113/jphysiol.2009.172049; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hiess F, 2015, J BIOL CHEM, V290, P20477, DOI 10.1074/jbc.M115.650531; Hunt DJ, 2007, BIOCHEM J, V404, P431, DOI 10.1042/BJ20070135; JORGENSEN AO, 1985, J CELL BIOL, V101, P257, DOI 10.1083/jcb.101.1.257; Kimata Y, 2004, J CELL BIOL, V167, P445, DOI 10.1083/jcb.200405153; Knollmann BC, 2009, J PHYSIOL-LONDON, V587, P3081, DOI 10.1113/jphysiol.2009.172098; KNUDSON CM, 1989, J BIOL CHEM, V264, P1345; Kobayashi YM, 2000, J BIOL CHEM, V275, P17639, DOI 10.1074/jbc.M002091200; Kozlov G, 2010, FEBS J, V277, P3924, DOI 10.1111/j.1742-4658.2010.07793.x; Kraskiewicz H, 2012, TRENDS PHARMACOL SCI, V33, P53, DOI 10.1016/j.tips.2011.10.002; Krebs J, 2015, BIOCHEM BIOPH RES CO, V460, P114, DOI 10.1016/j.bbrc.2015.02.004; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Lee JM, 2004, J BIOL CHEM, V279, P6994, DOI 10.1074/jbc.M312446200; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Liu CY, 2003, J BIOL CHEM, V278, P17680, DOI 10.1074/jbc.M300418200; Liu CY, 2002, J BIOL CHEM, V277, P18346, DOI 10.1074/jbc.M112454200; Ma K, 2002, J BIOL CHEM, V277, P18728, DOI 10.1074/jbc.M200903200; MACLENNAN DH, 1971, P NATL ACAD SCI USA, V68, P1231, DOI 10.1073/pnas.68.6.1231; Marambio P, 2010, BBA-MOL BASIS DIS, V1802, P509, DOI 10.1016/j.bbadis.2010.02.002; MCPHERSON PS, 1991, NEURON, V7, P17, DOI 10.1016/0896-6273(91)90070-G; Michalak M, 2009, TRENDS CELL BIOL, V19, P253, DOI 10.1016/j.tcb.2009.03.006; MILNER RE, 1991, J BIOL CHEM, V266, P7155; Oikawa D, 2007, J CELL SCI, V120, P1681, DOI 10.1242/jcs.002808; Oikawa D, 2009, EXP CELL RES, V315, P2496, DOI 10.1016/j.yexcr.2009.06.009; Park HJ, 2004, J BIOL CHEM, V279, P18026, DOI 10.1074/jbc.M311553200; Paul PK, 2012, MOL CELL BIOL, V32, P1248, DOI 10.1128/MCB.06351-11; Pierre N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065061; Reddish FN, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051024; Rossi AE, 2006, MUSCLE NERVE, V33, P715, DOI 10.1002/mus.20512; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Schwarz DS, 2016, CELL MOL LIFE SCI, V73, P79, DOI 10.1007/s00018-015-2052-6; Sepulveda D, 2018, MOL CELL, V69, P238, DOI 10.1016/j.molcel.2017.12.028; Tufanli O, 2017, P NATL ACAD SCI USA, V114, pE1395, DOI 10.1073/pnas.1621188114; Wang L, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500463; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wang SR, 1998, NAT STRUCT BIOL, V5, P476, DOI 10.1038/nsb0698-476; Wray S, 2010, PHYSIOL REV, V90, P113, DOI 10.1152/physrev.00018.2008; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003; Young P, 2001, J CELL BIOL, V154, P123, DOI 10.1083/jcb.200102110; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	68	15	15	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					8892	8904		10.1096/fj.201802626R	http://dx.doi.org/10.1096/fj.201802626R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31051095	Green Published			2022-12-28	WOS:000478832900016
J	Zhan, LX; Liu, DD; Wen, HX; Hu, JY; Pang, TY; Sun, WW; Xu, E				Zhan, Lixuan; Liu, Dandan; Wen, Haixia; Hu, Jiaoyue; Pang, Taoyan; Sun, Weiwen; Xu, En			Hypoxic postconditioning activates the Wnt/beta-catenin pathway and protects against transient global cerebral ischemia through Dkk1 Inhibition and GSK-3 beta inactivation	FASEB JOURNAL			English	Article						neuroprotection; Wnt; beta-catenin signal pathway; hippocampus; postconditioning	GLYCOGEN-SYNTHASE KINASE-3; SIGNALING PATHWAY; HIPPOCAMPAL NEUROGENESIS; SURVIVIN EXPRESSION; FUNCTIONAL RECOVERY; NEGATIVE MODULATOR; NEURONAL DEATH; WNT PROTEINS; NEUROPROTECTION; DICKKOPF-1	The Wingless/Int (Wnt)/beta-catenin pathway plays an essential role in cell survival. Although postconditioning with 8% oxygen can alleviate transient global cerebral ischemia (tGCI)-induced neuronal damage in hippocampal CA1 subregion in adult rats as demonstrated by our previous studies, little is understood about the role of Wnt/beta-catenin pathway in hypoxic postconditioning (HPC)-induced neuroprotection. This study tried to investigate the involvement of Wnt/beta-catenin pathway in HPC-induced neuroprotection against tGCI and explore the underlying molecular mechanism thereof. We observed that HPC elevated nuclear beta-catenin level as well as increased Wnt3a and decreased Dickkopf-1 (Dkk1) expression in CA1 after tGCI. Accordingly, HPC enhanced the expression of survivin and reduced the ratio of B-cell lymphoma/lewkmia-2 (Bcl-2)-associated X protein (Bax) to Bcl-2 following reperfusion. Moreover, our study has shown that these effects of HPC were abolished by lentivirus-mediated overexpression of Dkk1, and that the overexpression of Dkk1 completely reversed HPC-induced neuroprotection. Furthermore, HPC suppressed the activity of glycogen synthase kinase-3 beta (GSK-3 beta) in CA1 after tGCI, and the inhibition of GSK-3 beta activity with SB216763 increased the nuclear accumulation of beta-catenin, up-regulated the expression of survivin, and reduced the ratio of Bax to Bcl-2, thus preventing the delayed neuronal death after tGCI. Finally, the administration of LY294002, an inhibitor of PI3K, increased GSK-3 beta activity and blocked nuclear beta-catenin accumulation, thereby decreasing survivin expression and elevating the Bax-to-Bcl-2 ratio after HPC. These results suggest that activation of the Wnt/beta-catenin pathway through Dkk1 inhibition and PI3K/protein kinase B pathway-mediated GSK-3 beta inactivation contributes to the neuroprotection of HPC against tGCI.-Zhan, L., Liu, D., Wen, H., Hu, J., Pang, T., Sun, W., Xu, E. Hypoxic postconditioning activates the Wnt/beta-catenin pathway and protects against transient global cerebral ischemia through Dkk1 inhibition and GSK-3 beta inactivation.	[Zhan, Lixuan; Liu, Dandan; Wen, Haixia; Hu, Jiaoyue; Pang, Taoyan; Sun, Weiwen; Xu, En] Guangzhou Med Univ, Key Lab Neurogenet & Channelopathies Guangdong Pr, Inst Neurosci, Guangzhou, Guangdong, Peoples R China; [Zhan, Lixuan; Liu, Dandan; Wen, Haixia; Hu, Jiaoyue; Pang, Taoyan; Sun, Weiwen; Xu, En] Guangzhou Med Univ, Key Lab Neurogenet & Channelopathies Guangdong Pr, Dept Neurol, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China; [Zhan, Lixuan; Liu, Dandan; Wen, Haixia; Hu, Jiaoyue; Pang, Taoyan; Sun, Weiwen; Xu, En] Minist Educ China, Guangzhou, Guangdong, Peoples R China; [Zhan, Lixuan] Capital Med Univ, Xuanwu Hosp, Beijing Key Lab Hypoxia Conditioning Translat Med, Beijing, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Ministry of Education, China; Capital Medical University	Xu, E (corresponding author), Guangzhou Med Univ, Affiliated Hosp 2, Inst Neurosci, 250 Changgang Dong Rd, Guangzhou 510260, Guangdong, Peoples R China.; Xu, E (corresponding author), Guangzhou Med Univ, Affiliated Hosp 2, Dept Neurol, 250 Changgang Dong Rd, Guangzhou 510260, Guangdong, Peoples R China.	enxu@163.net			National Key R&D Program of China [2017YFC1308401]; Project of Science and Technology Program of Guangzhou Bureau of Education, China [1201630280]; National Natural Science Foundation of China [81873745]; Science and Technology Program of Guangzhou, China [201804010124]	National Key R&D Program of China; Project of Science and Technology Program of Guangzhou Bureau of Education, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guangzhou, China	The authors thank Peifeng Du (Guangzhou International Bio-island Investment & Development, Guangdong, China) for editing the manuscript. This work is supported by National Key R&D Program of China (2017YFC1308401), the Project of Science and Technology Program of Guangzhou Bureau of Education, China (1201630280), the National Natural Science Foundation of China (81873745), and the Science and Technology Program of Guangzhou, China (201804010124). The authors declare no conflicts of interest.	Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Boonen RACM, 2009, AGEING RES REV, V8, P71, DOI 10.1016/j.arr.2008.11.003; Buttrick GJ, 2008, CELL CYCLE, V7, P2621, DOI 10.4161/cc.7.17.6514; Cappuccio I, 2005, J NEUROSCI, V25, P2647, DOI 10.1523/JNEUROSCI.5230-04.2005; Caricasole A, 2004, J NEUROSCI, V24, P6021, DOI 10.1523/JNEUROSCI.1381-04.2004; Cheung CHA, 2013, ONCOTARGETS THER, V6, P1453, DOI 10.2147/OTT.S33374; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Crowder RJ, 2000, J BIOL CHEM, V275, P34266, DOI 10.1074/jbc.M006160200; De Ferrari GV, 2003, MOL PSYCHIATR, V8, P195, DOI 10.1038/sj.mp.4001208; Delavaran H, 2013, EUR J NEUROL, V20, P473, DOI 10.1111/j.1468-1331.2012.03877.x; Er E, 2006, BBA-BIOENERGETICS, V1757, P1301, DOI 10.1016/j.bbabio.2006.05.032; Fan YY, 2014, J CEREBR BLOOD F MET, V34, P275, DOI 10.1038/jcbfm.2013.193; Farias GG, 2004, NEUROBIOL DIS, V17, P337, DOI 10.1016/j.nbd.2004.07.016; Gao XW, 2008, J NEUROCHEM, V105, P943, DOI 10.1111/j.1471-4159.2008.05218.x; Halleskog C, 2011, GLIA, V59, P119, DOI 10.1002/glia.21081; Hay E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008284; He X, 2016, NEUROCHEM INT, V97, P124, DOI 10.1016/j.neuint.2016.03.011; Huang C, 2015, NEUROCHEM RES, V40, P1319, DOI 10.1007/s11064-015-1614-1; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Jover-Mengual T, 2010, BRAIN RES, V1321, P1, DOI 10.1016/j.brainres.2010.01.046; Kaga S, 2006, J MOL CELL CARDIOL, V40, P138, DOI 10.1016/j.yjmcc.2005.09.009; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Komiya Yuko, 2008, Organogenesis, V4, P68; Kuncewitch M, 2015, SHOCK, V43, P268, DOI 10.1097/SHK.0000000000000293; Lei ZN, 2012, NEUROCHEM INT, V61, P34, DOI 10.1016/j.neuint.2012.04.004; Li XJ, 2015, GLIA, V63, P1553, DOI 10.1002/glia.22826; Li YN, 2015, BIOMED REP, V3, P19, DOI 10.3892/br.2014.381; Liang JG, 2012, FREE RADICAL BIO MED, V53, P1459, DOI 10.1016/j.freeradbiomed.2012.08.003; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Ma YY, 2017, PROG NEUROBIOL, V157, P247, DOI 10.1016/j.pneurobio.2016.01.005; Mastroiacovo F, 2009, J CEREBR BLOOD F MET, V29, P264, DOI 10.1038/jcbfm.2008.111; Miranda CJ, 2012, AGING CELL, V11, P542, DOI 10.1111/j.1474-9726.2012.00816.x; Nakka VP, 2008, MOL NEUROBIOL, V37, P7, DOI 10.1007/s12035-007-8013-9; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; Okamoto M, 2011, FASEB J, V25, P3570, DOI 10.1096/fj.11-184697; Oliva CA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00224; Orellana JA, 2014, J NEUROCHEM, V128, P752, DOI 10.1111/jnc.12492; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Phukan S, 2010, BRIT J PHARMACOL, V160, P1, DOI 10.1111/j.1476-5381.2010.00661.x; Polakis P, 2000, GENE DEV, V14, P1837; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; Qiao YX, 2015, J MOL NEUROSCI, V55, P923, DOI 10.1007/s12031-014-0447-8; Seifert-Held T, 2011, ATHEROSCLEROSIS, V218, P233, DOI 10.1016/j.atherosclerosis.2011.05.015; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Sun FL, 2014, EUR J PHARMACOL, V738, P214, DOI 10.1016/j.ejphar.2014.05.019; Tapia JC, 2006, P NATL ACAD SCI USA, V103, P15079, DOI 10.1073/pnas.0606845103; Tell S, 2006, BIOCHEM BIOPH RES CO, V349, P261, DOI 10.1016/j.bbrc.2006.08.044; Vigneron F, 2011, CARDIOVASC RES, V90, P49, DOI 10.1093/cvr/cvr002; Wang W, 2017, INT J MED SCI, V14, P333, DOI 10.7150/ijms.17514; Wang ZX, 2004, ONCOGENE, V23, P8146, DOI 10.1038/sj.onc.1207992; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Willert K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007864; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yang T, 2018, REDOX BIOL, V17, P323, DOI 10.1016/j.redox.2018.05.001; Zhan LX, 2017, BRAIN PATHOL, V27, P822, DOI 10.1111/bpa.12472; Zhan LX, 2012, NEUROPHARMACOLOGY, V63, P873, DOI 10.1016/j.neuropharm.2012.06.035; Zhan LX, 2010, J NEUROCHEM, V114, P897, DOI 10.1111/j.1471-4159.2010.06816.x; Zhang QG, 2008, J NEUROSCI, V28, P8430, DOI 10.1523/JNEUROSCI.2752-08.2008; Zhao H, 2006, J CEREBR BLOOD F MET, V26, P1114, DOI 10.1038/sj.jcbfm.9600348; Zhou CF, 2011, NEUROCHEM INT, V59, P749, DOI 10.1016/j.neuint.2011.08.008; Zhu PP, 2014, MOL NEUROBIOL, V49, P1338, DOI 10.1007/s12035-013-8611-7; Zhu TN, 2014, J NEUROPATH EXP NEUR, V73, P975, DOI 10.1097/NEN.0000000000000118; Zhu XL, 2014, INT J NEUROPSYCHOPH, V17, P1511, DOI 10.1017/S1461145714000315	66	15	17	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9291	9307		10.1096/fj.201802633R	http://dx.doi.org/10.1096/fj.201802633R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31120770				2022-12-28	WOS:000478832900047
J	Gusev, FE; Reshetov, DA; Mitchell, AC; Andreeva, TV; Dincer, A; Grigorenko, AP; Fedonin, G; Halene, T; Aliseychik, M; Goltsov, AY; Solovyev, V; Brizgalov, L; Filippova, E; Weng, ZP; Akbarian, S; Rogaev, EI				Gusev, Fedor E.; Reshetov, Denis A.; Mitchell, Amanda C.; Andreeva, Tatiana, V; Dincer, Aslihan; Grigorenko, Anastasia P.; Fedonin, Gennady; Halene, Tobias; Aliseychik, Maria; Goltsov, Andrey Y.; Solovyev, Victor; Brizgalov, Leonid; Filippova, Elena; Weng, Zhiping; Akbarian, Schahram; Rogaev, Evgeny, I			Epigenetic-genetic chromatin footprinting identifies novel and subject-specific genes active in prefrontal cortex neurons	FASEB JOURNAL			English	Article						ChIP-seq; H3K4me3; brain; histone	TRANSCRIPTION FACTOR; EXPRESSION ANALYSIS; READ ALIGNMENT; HUMAN BRAIN; EVOLUTION; SEQUENCE; BINDING; ARCHITECTURE; ASSOCIATION; DATABASE	Human prefrontal cortex (PFC) is associated with broad individual variabilities in functions linked to personality, social behaviors, and cognitive functions. The phenotype variabilities associated with brain functions can be caused by genetic or epigenetic factors. The interactions between these factors in human subjects is, as of yet, poorly understood. The heterogeneity of cerebral tissue, consisting of neuronal and nonneuronal cells, complicates the comparative analysis of gene activities in brain specimens. To approach the underlying neurogenomic determinants, we performed a deep analysis of open chromatin-associated histone methylation in PFC neurons sorted from multiple human individuals in conjunction with whole-genome and transcriptome sequencing. Integrative analyses produced novel unannotated neuronal genes and revealed individual-specific chromatin blueprints of neurons that, in part, relate to genetic background. Surprisingly, we observed gender-dependent epigenetic signals, implying that gender may contribute to the chromatin variabilities in neurons. Finally, we found epigenetic, allele-specific activation of the testis-specific gene nucleoporin 210 like (NUP210L) in brain in some individuals, which we link to a genetic variant occurring in <3% of the human population. Recently, the NUP210L locus has been associated with intelligence and mathematics ability. Our findings highlight the significance of epigenetic-genetic footprinting for exploring neurologic function in a subject-specific manner.-Gusev, F. E., Reshetov, D. A., Mitchell, A. C., Andreeva, T. V., Dincer, A., Grigorenko, A. P., Fedonin, G., Halene, T., Aliseychik, M., Goltsov, A. Y., Solovyev, V., Brizgalov, L., Filippova, E., Weng, Z., Akbarian, S., Rogaev, E. I. Epigenetic-genetic chromatin footprinting identifies novel and subject-specific genes active in prefrontal cortex neurons.	[Gusev, Fedor E.; Grigorenko, Anastasia P.; Filippova, Elena; Akbarian, Schahram; Rogaev, Evgeny, I] Univ Massachusetts, Med Sch, Dept Psychiat, Shrewsbury, MA 01545 USA; [Weng, Zhiping] Univ Massachusetts, Med Sch, Program Bioinformat & Integrat Biol, Shrewsbury, MA 01545 USA; [Gusev, Fedor E.; Reshetov, Denis A.; Andreeva, Tatiana, V; Grigorenko, Anastasia P.; Fedonin, Gennady; Aliseychik, Maria; Goltsov, Andrey Y.; Rogaev, Evgeny, I] Russian Acad Sci, Dept Human Genet & Genom, Lab Evolutionary Genom, Vavilov Inst Gen Genet, Moscow, Russia; [Gusev, Fedor E.; Reshetov, Denis A.; Andreeva, Tatiana, V; Grigorenko, Anastasia P.; Brizgalov, Leonid] Russian Acad Sci, Siberian Branch, Inst Cytol & Genet, Ctr Brain Neurobiol & Neurogenet, Novosibirsk, Russia; [Solovyev, Victor] Russian Acad Sci, Siberian Branch, Inst Cytol & Genet, Dept Cell Biol, Novosibirsk, Russia; [Mitchell, Amanda C.; Dincer, Aslihan; Halene, Tobias; Akbarian, Schahram] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Dept Psychiat, New York, NY 10029 USA; [Dincer, Aslihan; Halene, Tobias; Akbarian, Schahram] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Dept Neurosci, New York, NY 10029 USA; [Aliseychik, Maria; Rogaev, Evgeny, I] Lomonosov Moscow State Univ, Ctr Genet & Genet Technol, Fac Biol, Moscow, Russia; [Rogaev, Evgeny, I] Lomonosov Moscow State Univ, Fac Bioengn & Bioinformat, Moscow, Russia	University of Massachusetts System; University of Massachusetts System; Russian Academy of Sciences; Vavilov Institute of General Genetics; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Lomonosov Moscow State University; Lomonosov Moscow State University	Rogaev, EI (corresponding author), Univ Massachusetts, Med Sch, 222 Maple Ave,Rose Gordon Bldg, Shrewsbury, MA 01545 USA.	evgeny.rogaev@umassmed.edu	Grigorenko, Anastasia/AAN-8226-2020; Fedonin, Gennady/M-5786-2014; Gusev, Fedor/AAN-9347-2020; Andreeva, Tatiana V/C-8198-2016; Rogaev, Evgeny/AAN-7662-2020	Fedonin, Gennady/0000-0002-9427-8083; Gusev, Fedor/0000-0001-9859-4721; Mitchell, Amanda/0000-0003-4253-8717	U.S. National Institutes of Health (NIH)/National Institute on Aging (NIA) [R01 AG054712]; Government of the Russian Federation [14.B25.31.0033]; Russian Scientific Foundation (RSF) [14-44-00077]; Russian Foundation for Basic Research (RFBR) [18-29-13051]; Brain and Behavior Research Foundation; Autism Speaks; NIH/National Institute of Mental Health (NIMH) [R01 MH106056]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890, R01MH106056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG054712] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Institute on Aging (NIA); Government of the Russian Federation; Russian Scientific Foundation (RSF)(Russian Science Foundation (RSF)); Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Brain and Behavior Research Foundation; Autism Speaks; NIH/National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Andree Lessard (Maryland Psychiatric Research Center, Catonsville, MD, USA), Dr. William E. Bunney Jr. (University of California-Irvine, Irvine, CA, USA), and Dr. Edward G. Jones (deceased; University of California-Davis, Davis, CA, USA) for providing post mortem brain tissue. The authors also thank Dr. Hennady Shulha (University of Massachusetts Medical School, Worcester, MA, USA) for helpful discussions on chromatin immunoprecipitation followed by sequencing (ChIP-seq) analysis, Dr. Iris Cheung (University of Massachusetts Medical School) for help with performing ChIP-seq assays, and the University of Massachusetts Flow Cytometry and Deep Sequencing Cores, including Dr. R. Konz (Flow Cytometry Core Facility, University of Massachusetts Medical School) and Dr. E. Kittler (Deep Sequencing Core Lab, University of Massachusetts Medical School), for technical support. This work was supported in part by the U.S. National Institutes of Health (NIH)/National Institute on Aging (NIA; Grant R01 AG054712 to E.I.R.), the Government of the Russian Federation (Grant 14.B25.31.0033, sequencing analysis, and gel-shift assay), the Russian Scientific Foundation (RSF; Grant 14-44-00077, bioinformatic analysis of ChIP-seq data), the Russian Foundation for Basic Research (RFBR; Grant 18-29-13051), and the Brain and Behavior Research Foundation, Autism Speaks, and the NIH/National Institute of Mental Health (NIMH; Grant R01 MH106056 to S.A., A.C.M., and A.D.). The authors declare no conflicts of interest.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Akbarian S, 2015, NAT NEUROSCI, V18, P1707, DOI 10.1038/nn.4156; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Briegel KJ, 2001, DEV BIOL, V233, P291, DOI 10.1006/dbio.2001.0225; Bryzgalov LO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078833; Buckner RL, 2013, TRENDS COGN SCI, V17, P648, DOI 10.1016/j.tics.2013.09.017; Chen L, 2016, CELL, V167, P1398, DOI 10.1016/j.cell.2016.10.026; Cuccia V, 2006, ACTA NEUROCHIR, V148, P865, DOI 10.1007/s00701-006-0846-x; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dincer A, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.169; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; FREIJE D, 1992, SCIENCE, V258, P1784, DOI 10.1126/science.1465614; Fu X, 2011, P NATL ACAD SCI USA, V108, P6181, DOI 10.1073/pnas.1019164108; Gianfrancesco F, 1998, HUM MOL GENET, V7, P407, DOI 10.1093/hmg/7.3.407; Grove J, 2019, NAT GENET, V51, P431, DOI 10.1038/s41588-019-0344-8; Grubert F, 2015, CELL, V162, P1051, DOI 10.1016/j.cell.2015.07.048; Hattab EM, 2005, AM J SURG PATHOL, V29, P368, DOI 10.1097/01.pas.0000149709.19958.a7; Horakova AH, 2012, HUM MOL GENET, V21, P4367, DOI 10.1093/hmg/dds270; Houston I, 2013, NEUROPSYCHOPHARMACOL, V38, P183, DOI 10.1038/npp.2012.78; Hu HY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-457; Jiang Y, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-42; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kulakovskiy IV, 2015, P INT C BIOINF MOD M, V1, P102, DOI DOI 10.5220/0005189301020108; Kulakovskiy IV, 2018, NUCLEIC ACIDS RES, V46, pD252, DOI 10.1093/nar/gkx1106; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee JJ, 2018, NAT GENET, V50, P1112, DOI 10.1038/s41588-018-0147-3; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Mitchell AC, 2018, MOL PSYCHIATR, V23, P123, DOI 10.1038/mp.2016.254; Pardinas AF, 2018, NAT GENET, V50, P381, DOI 10.1038/s41588-018-0059-2; Pratto F, 2018, SCIENCE, V362, DOI 10.1126/science.aav6294; Pratto F, 2014, SCIENCE, V346, P826, DOI 10.1126/science.1256442; Preumont A, 2010, BIOCHEM J, V431, P237, DOI 10.1042/BJ20100174; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rogaev Evgeny I., 2012, Frontiers in Genetics, V3, P45, DOI 10.3389/fgene.2012.00045; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Roussos P, 2014, CELL REP, V9, P1417, DOI 10.1016/j.celrep.2014.10.015; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Savage JE, 2018, NAT GENET, V50, P912, DOI 10.1038/s41588-018-0152-6; Shen E, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0514; Sherwood CC, 2006, P NATL ACAD SCI USA, V103, P13606, DOI 10.1073/pnas.0605843103; Shulha HP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003433; Shulha HP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001427; Shulha HP, 2012, ARCH GEN PSYCHIAT, V69, P314, DOI 10.1001/archgenpsychiatry.2011.151; Singh R, 2016, BIOINFORMATICS, V32, P639, DOI 10.1093/bioinformatics/btw427; Somel M, 2014, CURR OPIN GENET DEV, V29, P110, DOI 10.1016/j.gde.2014.09.001; Stahl Eli A, 2019, Nat Genet, V51, P793, DOI 10.1038/s41588-019-0397-8; Starnawska A, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.181; Trabzuni D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3771; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vawter MP, 2004, NEUROPSYCHOPHARMACOL, V29, P373, DOI 10.1038/sj.npp.1300337; Waszak SM, 2015, CELL, V162, P1039, DOI 10.1016/j.cell.2015.08.001; Wray NR, 2018, NAT GENET, V50, P668, DOI 10.1038/s41588-018-0090-3; Wu JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036351; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao H, 2014, BIOINFORMATICS, V30, P1006, DOI 10.1093/bioinformatics/btt730	68	7	7	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8161	8173		10.1096/fj.201802646R	http://dx.doi.org/10.1096/fj.201802646R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30970224	Green Published, Bronze			2022-12-28	WOS:000476234700029
J	Parekh, PA; Garcia, TX; Waheeb, R; Jain, V; Gandhi, P; Meistrich, ML; Shetty, G; Hofmann, MC				Parekh, Parag A.; Garcia, Thomas X.; Waheeb, Reham; Jain, Vivek; Gandhi, Pooja; Meistrich, Marvin L.; Shetty, Gunapala; Hofmann, Marie-Claude			Undifferentiated spermatogonia regulate Cyp26b1 expression through NOTCH signaling and drive germ cell differentiation	FASEB JOURNAL			English	Article						JAG1; spermatogenesis; Sertoli cell	MOUSE SERTOLI-CELLS; RETINOIC ACID; STEM-CELLS; FUNCTIONAL ASSESSMENT; TESTIS DEVELOPMENT; ALKYLATING AGENT; RENEWAL; SPERMATOGENESIS; POPULATION; KINETICS	Cytochrome P450 family 26 subfamily B member 1 (CYP26B1) regulates the concentration of all-trans retinoic acid (RA) and plays a key role in germ cell differentiation by controlling local distribution of RA. The mechanisms regulating Cyp26b1 expression in postnatal Sertoli cells, the main components of the stem cell niche, are so far unknown. During gonad development, expression of Cyp26b1 is maintained by Steroidogenic Factor 1 (SF-1) and Sex-Determining Region Y Box-9 (SOX9), which ensure that RA is degraded and germ cell differentiation is blocked. Here, we show that the NOTCH target Hairy/Enhancer-of-Split Related with YRPW Motif 1 (HEY1), a transcriptional repressor, regulates germ cell differentiation via direct binding to the Cyp26b1 promoter and thus inhibits its expression in Sertoli cells. Further, using in vivo germ cell ablation, we demonstrate that undifferentiated type A spermatogonia are the cells that activate NOTCH signaling in Sertoli cells through their expression of the NOTCH ligand JAGGED-1 (JAG1) at stage VIII of the seminiferous epithelium cycle, therefore mediating germ cell differentiation by a ligand concentration-dependent process. These data therefore provide more insights into the mechanisms of germ cell differentiation after birth and potentially explain the spatiotemporal RA pulses driving the transition between undifferentiated to differentiating spermatogonia.-Parekh, P. A., Garcia, T. X., Waheeb, R., Jain, V., Gandhi, P., Meistrich, M. L., Shetty, G., Hofmann, M.-C. Undifferentiated spermatogonia regulate Cyp26b1 expression through NOTCH signaling and drive germ cell differentiation.	[Parekh, Parag A.; Garcia, Thomas X.; Waheeb, Reham; Jain, Vivek; Gandhi, Pooja; Hofmann, Marie-Claude] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Unit 1105,1515 Holcombe Blvd, Houston, TX 77030 USA; [Meistrich, Marvin L.; Shetty, Gunapala] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Garcia, Thomas X.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Garcia, Thomas X.; Jain, Vivek] Univ Houston Clear Lake, Dept Biol & Biotechnol, Houston, TX USA; [Waheeb, Reham] Univ Alexandria, Dept Theriogenol, Alexandria, Egypt	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Houston System; University of Houston; University of Houston Clear Lake; Egyptian Knowledge Bank (EKB); Alexandria University	Hofmann, MC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Unit 1105,1515 Holcombe Blvd, Houston, TX 77030 USA.	mhofmann@mdanderson.org	Waheeb, Reham/AAB-3677-2021; Parekh, Parag/ABE-2100-2021	Waheeb, Reham/0000-0001-8156-813X; Hofmann, Marie-Claude/0000-0002-4899-8039	U.S. National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD081244]; M. D. Anderson Cancer Center Core Facilities Support Grant [CA16672]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD081244, R01HD095341] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development; M. D. Anderson Cancer Center Core Facilities Support Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by U.S. National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant R01HD081244 (to M.-C.H.) and M. D. Anderson Cancer Center Core Facilities Support Grant CA16672. The authors declare no conflicts of interest.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Boisvert A, 2016, ENVIRON RES, V150, P496, DOI 10.1016/j.envres.2016.06.033; Bowles J, 2018, CELL REP, V24, P1330, DOI 10.1016/j.celrep.2018.06.111; Bray S, 2010, CURR TOP DEV BIOL, V92, P253, DOI 10.1016/S0070-2153(10)92008-5; Canete A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020159; Chan F, 2014, GENE DEV, V28, P1351, DOI 10.1101/gad.240465.114; Chenery A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072308; Chung SSW, 2005, DIFFERENTIATION, V73, P188, DOI 10.1111/j.1432-0436.2005.00018.x; Cinquin O, 2010, P NATL ACAD SCI USA, V107, P2048, DOI 10.1073/pnas.0912704107; Das BC, 2014, BIOORGAN MED CHEM, V22, P673, DOI 10.1016/j.bmc.2013.11.025; de Rooij D G, 1970, Virchows Arch B Cell Pathol, V4, P267; de Rooij DG, 2017, DEVELOPMENT, V144, P3022, DOI 10.1242/dev.146571; DEROOIJ DG, 1968, Z ZELLFORSCH MIK ANA, V92, P400; Drumond AL, 2011, REPRODUCTION, V142, P145, DOI 10.1530/REP-10-0431; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Endo T, 2017, P NATL ACAD SCI USA, V114, pE10132, DOI 10.1073/pnas.1710837114; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Fisher GJ, 1996, FASEB J, V10, P1002, DOI 10.1096/fasebj.10.9.8801161; Garcia TX, 2017, STEM CELLS DEV, V26, P585, DOI 10.1089/scd.2016.0318; Garcia TX, 2014, DEVELOPMENT, V141, P4468, DOI 10.1242/dev.113969; Garcia TX, 2013, CELL CYCLE, V12, P2538, DOI 10.4161/cc.25627; Garcia TX, 2013, DEV BIOL, V377, P188, DOI 10.1016/j.ydbio.2013.01.031; GRISWOLD MD, 1989, ANN NY ACAD SCI, V564, P154, DOI 10.1111/j.1749-6632.1989.tb25895.x; Griswold MD, 2016, PHYSIOL REV, V96, P1, DOI 10.1152/physrev.00013.2015; Griswold MD, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096610; Haushalter C, 2017, DEV BIOL, V430, P129, DOI 10.1016/j.ydbio.2017.08.006; Hofmann MC, 2005, STEM CELLS, V23, P200, DOI 10.1634/stemcells.2003-0036; Hogarth CA, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.129718; Hogarth CA, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.126326; HUCKINS C, 1971, CELL TISSUE KINET, V4, P335, DOI 10.1111/j.1365-2184.1971.tb01544.x; Iso T, 2001, MOL CELL BIOL, V21, P6080, DOI 10.1128/MCB.21.17.6080-6089.2001; Kanatsu-Shinohara M, 2003, BIOL REPROD, V68, P1801, DOI 10.1095/biolreprod.102.012575; Kashimada K, 2011, FASEB J, V25, P3561, DOI 10.1096/fj.11-184333; Kimble J, 2013, STEMBOOK; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Li H, 2011, BIOL REPROD, V84, P336, DOI 10.1095/biolreprod.110.086157; Li H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007501; Lind Thomas, 2018, Bone Rep, V9, P27, DOI 10.1016/j.bonr.2018.06.006; Liu MX, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.114.117754; Lord T, 2018, STEM CELL RES, V29, P129, DOI 10.1016/j.scr.2018.03.016; Lucas BEG, 2012, TOXICOLOGY, V299, P10, DOI 10.1016/j.tox.2012.04.011; MacLean G, 2007, ENDOCRINOLOGY, V148, P4560, DOI 10.1210/en.2007-0492; Mammadova A, 2016, DIFFERENTIATION, V92, P326, DOI 10.1016/j.diff.2016.05.001; Morkmued S, 2017, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00673; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; O'Shaughnessy PJ, 2008, REPRODUCTION, V135, P839, DOI 10.1530/REP-08-0012; OAKBERG EF, 1956, AM J ANAT, V99, P391, DOI 10.1002/aja.1000990303; OAKBERG EF, 1971, ANAT REC, V169, P515, DOI 10.1002/ar.1091690305; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Rydeen A, 2015, DEV BIOL, V405, P47, DOI 10.1016/j.ydbio.2015.06.008; Saitou M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008375; Sakai Y, 2001, GENE DEV, V15, P213, DOI 10.1101/gad.851501; Scarpino S, 1998, MOL CELL ENDOCRINOL, V146, P121, DOI 10.1016/S0303-7207(98)00190-7; Simon L, 2010, STEM CELLS, V28, P1882, DOI 10.1002/stem.508; Thatcher JE, 2009, EXPERT OPIN DRUG MET, V5, P875, DOI 10.1517/17425250903032681; Topletz AR, 2012, BIOCHEM PHARMACOL, V83, P149, DOI 10.1016/j.bcp.2011.10.007; Uehara M, 2007, DEV BIOL, V302, P399, DOI 10.1016/j.ydbio.2006.09.045; VANKEULEN CJG, 1975, CELL TISSUE KINET, V8, P543, DOI 10.1111/j.1365-2184.1975.tb01240.x; VANPELT AMM, 1991, ENDOCRINOLOGY, V128, P697, DOI 10.1210/endo-128-2-697; VANPELT AMM, 1995, BIOL REPROD, V53, P570, DOI 10.1095/biolreprod53.3.570; Ward EJ, 2006, CURR BIOL, V16, P2352, DOI 10.1016/j.cub.2006.10.022; Weber D, 2014, CURR TOP DEV BIOL, V110, P285, DOI 10.1016/B978-0-12-405943-6.00008-7; White RJ, 2008, DEV DYNAM, V237, P2775, DOI 10.1002/dvdy.21695; Wu JW, 2008, ASIAN J ANDROL, V10, P569, DOI 10.1111/j.1745-7262.2008.00408.x; Zhang Y, 2010, GENE, V464, P32, DOI 10.1016/j.gene.2010.05.004; Zohni K, 2012, HUM REPROD, V27, P44, DOI 10.1093/humrep/der357	69	16	16	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8423	8435		10.1096/fj.201802361R	http://dx.doi.org/10.1096/fj.201802361R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30991836	Green Published			2022-12-28	WOS:000476234700049
J	Dirks, JH				Dirks, John H.			Donald W. Seldin, 1920-2018	FASEB JOURNAL			English	Biographical-Item									[Dirks, John H.] Univ Toronto, 231 David Naylor Bldg,6 Queens Pk, Toronto, ON M5S 3H2, Canada	University of Toronto	Dirks, JH (corresponding author), Univ Toronto, 231 David Naylor Bldg,6 Queens Pk, Toronto, ON M5S 3H2, Canada.	john.dirks@utoronto.ca						SELDIN DW, PUBLICATION LIST	1	0	0	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4657	4659		10.1096/fj.190402ufm	http://dx.doi.org/10.1096/fj.190402ufm			3	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30920891				2022-12-28	WOS:000462888500002
J	Xiao, H; Wen, YX; Pan, ZQ; Shangguan, YF; Magdalou, J; Wang, H; Chen, LB				Xiao, Hao; Wen, Yinxian; Pan, Zhengqi; Shangguan, Yangfan; Magdalou, Jacques; Wang, Hui; Chen, Liaobin			Nicotine exposure during pregnancy programs osteopenia in male offspring rats via alpha 4 beta 2-nAChR-p300-ACE pathway	FASEB JOURNAL			English	Article						prenatal nicotine exposure; developmental toxicity; renin angiotensin system; intrauterine programming; histone acetylation	RENIN-ANGIOTENSIN SYSTEM; MESENCHYMAL STEM-CELLS; GROWTH-RETARDATION; DIFFERENTIATION; BONE; TOBACCO; SMOKING; KIDNEY; MATRIX; RISK	Prenatal nicotine exposure (PNE) induces developmental toxicity in offspring. However, the long-term harmful effects on bone development and the intrauterine programming mechanism attributed to PNE remain unclear. In the present research, pregnant Wistar rats were injected subcutaneously with nicotine (2 mg/kg/d) to obtain and analyze bone samples from the fetal and adult offspring. Bone marrow mesenchymal stem cells (BMSCs) were treated with nicotine during osteogenic differentiation to clarify the related molecular mechanisms. The results indicated that PNE led to bone dysplasia in the fetuses and reduced bone mass in the adult offspring, which was mediated by the sustained activation of the local bone renin angiotensin system (RAS) and suppressed osteogenic differentiation before and after birth. In vitro, nicotine suppressed BMSCs' osteogenic function through promoting angiotensin-converting enzyme (ACE) expression and activating RAS. Furthermore, nicotine induced histone acetylase p300 into the nuclei of the BMSCs by acting on the alpha 4 beta 2-nicotinic acetylcholine receptor (alpha 4 beta 2-nAChR), leading to the increased histone 3 lysine 9 acetylation level of ACE and RAS activation. Taken together, the sustained activation of local bone RAS mediated prenatal nicotine-induced osteopenia in adult offspring via the alpha 4 beta 2-nAChR-p300-ACE pathway.	[Xiao, Hao; Wen, Yinxian; Pan, Zhengqi; Shangguan, Yangfan; Chen, Liaobin] Wuhan Univ, Zhongnan Hosp, Dept Orthoped Surg, 169 Donghu Rd, Wuhan 430071, Peoples R China; [Wen, Yinxian; Pan, Zhengqi; Shangguan, Yangfan; Wang, Hui; Chen, Liaobin] Hubei Prov Key Lab Dev Originated Dis, Wuhan, Peoples R China; [Magdalou, Jacques] Univ Lorraine, CNRS, UMR 7365, Nancy, France; [Wang, Hui] Wuhan Univ, Sch Basic Med Sci, Dept Pharmacol, Wuhan, Peoples R China	Wuhan University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Lorraine; Wuhan University	Chen, LB (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Orthoped Surg, 169 Donghu Rd, Wuhan 430071, Peoples R China.	lbchen@whu.edu.cn			National Natural Science Foundation of China [81673490, 81430089, 81673524]; Hubei Province Health and Family Planning Scientific Research Project [WJ2017C0003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Province Health and Family Planning Scientific Research Project	This work was supported by grants from the National Natural Science Foundation of China (81673490, 81430089, and 81673524) and the Hubei Province Health and Family Planning Scientific Research Project (WJ2017C0003). The authors declare no conflicts of interest.	Behrooz L, 2018, RESP MED, V140, P21, DOI 10.1016/j.rmed.2018.05.013; Carmines EL, 2003, TOXICOL SCI, V75, P134, DOI 10.1093/toxsci/kfg155; Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725; Colombo G, 2012, FREE RADICAL BIO MED, V52, P1584, DOI 10.1016/j.freeradbiomed.2012.02.030; Cui Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084640; DAHLSTROM A, 1990, ACTA PAEDIATR SCAND, V79, P142, DOI 10.1111/j.1651-2227.1990.tb11430.x; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Deng Y, 2013, TOXICOL APPL PHARM, V269, P25, DOI 10.1016/j.taap.2013.02.008; Farag E, 2017, J CLIN NEUROSCI, V46, P1, DOI 10.1016/j.jocn.2017.08.055; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; Gautam AK, 2011, J NUTR BIOCHEM, V22, P318, DOI 10.1016/j.jnutbio.2010.02.010; Guan M, 2012, NAT MED, V18, P456, DOI 10.1038/nm.2665; Holbrook BD, 2016, BIRTH DEFECTS RES C, V108, P181, DOI 10.1002/bdrc.21128; Hu H, 2018, TOXICOL LETT, V295, P249, DOI 10.1016/j.toxlet.2018.07.005; Huang LZ, 2006, LIFE SCI, V78, P1483, DOI 10.1016/j.lfs.2005.07.047; Li P, 2019, J BONE MINER RES, V34, P295, DOI 10.1002/jbmr.3596; Ling C, 2019, CELL METAB, V29, P1028, DOI 10.1016/j.cmet.2019.03.009; Liu L, 2012, TOXICOL LETT, V214, P307, DOI 10.1016/j.toxlet.2012.09.001; Liu L, 2016, AAPS PHARMSCITECH, V17, P757, DOI 10.1208/s12249-015-0399-5; McEvoy CT, 2017, PAEDIATR RESPIR REV, V21, P27, DOI 10.1016/j.prrv.2016.08.005; MITCHELL JA, 1985, J REPROD FERTIL, V74, P71; Mys K, 2019, J BONE MINER RES, V34, P867, DOI 10.1002/jbmr.3673; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Rogers JM, 2009, REPROD TOXICOL, V28, P152, DOI 10.1016/j.reprotox.2009.03.012; Sadik NAH, 2017, BIOCHIMIE, V137, P132, DOI 10.1016/j.biochi.2017.03.002; Shafabakhsh R, 2019, J CELL PHYSIOL, V234, P7839, DOI 10.1002/jcp.27844; Shan M, 2015, J PAK MED ASSOC, V65, P1094; Sparks MA, 2014, COMPR PHYSIOL, V4, P1201, DOI 10.1002/cphy.c130040; Talati A, 2017, PSYCHIAT RES, V252, P346, DOI 10.1016/j.psychres.2017.03.016; Tong VT, 2013, MMWR SURVEILL SUMM, V62, P1; Wen YX, 2019, TOXICOL APPL PHARM, V363, P1, DOI 10.1016/j.taap.2018.11.003; Wu CT, 2014, ENVIRON HEALTH PERSP, V122, P559, DOI 10.1289/ehp.1307832; Xie Z, 2018, TOXICOL APPL PHARM, V352, P107, DOI 10.1016/j.taap.2018.03.018; Xu XY, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0527-0; Yan YE, 2014, TOXICOL APPL PHARM, V277, P231, DOI 10.1016/j.taap.2014.03.019; Zhang Y, 2017, BONE, V97, P222, DOI 10.1016/j.bone.2017.01.029; Zhou J, 2019, FASEB J, V33, P1110, DOI 10.1096/fj.201800172R; Zhou J, 2018, TOXICOL APPL PHARM, V344, P1, DOI 10.1016/j.taap.2018.02.017	38	6	7	9	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12972	12982		10.1096/fj.201901145RR	http://dx.doi.org/10.1096/fj.201901145RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31500447	Green Published			2022-12-28	WOS:000507461600105
J	Ke, DS; Ji, LM; Wang, Y; Fu, XM; Chen, JY; Wang, F; Zhao, DB; Xue, Y; Lan, XH; Hou, JM				Ke, Dianshan; Ji, Lianmei; Wang, Yu; Fu, Xiaomin; Chen, Jinyan; Wang, Fan; Zhao, Dongbao; Xue, Ying; Lan, Xuhua; Hou, Jianming			JNK1 regulates RANKL-induced osteoclastogenesis via activation of a novel Bcl-2-Beclin1-autophagy pathway	FASEB JOURNAL			English	Article						metabolic bone diseases; osteoclast precursors; p-JNK1; p-Bcl-2; LC3	INDUCED AUTOPHAGY; BECLIN 1; C-JUN; POSTMENOPAUSAL WOMEN; UP-REGULATION; BONE LOSS; APOPTOSIS; PROTEIN; LIGAND; CELLS	JNK1 plays an important role in osteoclastogenesis in response to the osteoclastogenic cytokine receptor activator for nuclear factor-kappa B ligand (RANKL). JNK1 is widely accepted as an autophagy regulator under stress conditions. However, the role of JNK1-mediated autophagy in osteoclastogenesis remains largely unknown. In the current study, our data showed that JNK1 inhibition by a pharmacological inhibitor or RNA interference significantly reduced the autophagic response induced by RANKL in osteoclast precursors (OCPs) derived from bone marrow-derived macrophages. Overexpression of the key autophagy protein Beclin1 rescued autophagy deficiency and osteoclastogenesis in the presence of a JNK inhibitor (SP600125). In contrast, JNK activator (anisomycin)-induced autophagy was blocked by Beclin1 knockdown in OCPs. In addition, JNK1 inhibition increased apoptosis and blocked autophagy, whereas overexpression of Beclin1 reversed the enhanced apoptosis induced by JNK1 inhibition in OCPs. Furthermore, RANKL could induce the phosphorylation of Bcl-2, subsequently dissociating Beclin1 from the Bcl-2-Beclin1 complex, which could be blocked by JNK1 inhibition. Collectively, this study revealed that JNK1 regulated osteoclastogenesis by activating Bcl-2-Beclin1-autophagy signaling in addition to the classic c-Jun/activator protein 1 pathway, which provided the first evidence for the contribution of JNK1 signaling to OCP autophagy and the autophagic mechanism underlying JNK1-regulated osteoclastogenesis. An important osteoclastogenesis-regulating signaling pathway (JNK1-Bcl-2-Beclin1-autophagy activation) was identified, which provides novel potential targets for the clinical therapy of metabolic bone diseases.-Ke, D., Ji, L., Wang, Y., Fu, X., Chen, J., Wang, F., Zhao, D., Xue, Y., Lan, X., Hou, J. JNK1 regulates RANKL-induced osteoclastogenesis via activation of a novel Bcl-2-Beclin1-autophagy pathway.	[Ke, Dianshan; Xue, Ying; Lan, Xuhua; Hou, Jianming] Fujian Med Univ, Shengli Clin Med Coll, Fuzhou, Fujian, Peoples R China; [Ke, Dianshan] Southern Med Univ, Affiliated Hosp 3, Acad Orthoped Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Ji, Lianmei; Zhao, Dongbao] Naval Med Univ, Changhai Hosp, Dept Rheumatol & Immunol, Shanghai, Peoples R China; [Wang, Yu] Chifeng Hosp, Dept Orthopaed, Chifeng, Peoples R China; [Fu, Xiaomin] Johns Hopkins Univ, Dept Pediat, Div Metab & Endocrinol, Baltimore, MD USA; [Chen, Jinyan; Wang, Fan] Fujian Acad Med Sci, Inst Immunol, Fuzhou, Fujian, Peoples R China; [Xue, Ying; Lan, Xuhua; Hou, Jianming] Fujian Prov Hosp, Dept Endocrinol, Key Lab Endocrinol, 134 Dong Jie Rd, Fuzhou 350001, Fujian, Peoples R China	Fujian Medical University; Southern Medical University - China; Naval Medical University; Johns Hopkins University; Fujian Provincial Hospital	Hou, JM (corresponding author), Fujian Prov Hosp, Dept Endocrinol, Key Lab Endocrinol, 134 Dong Jie Rd, Fuzhou 350001, Fujian, Peoples R China.	hjm996@126.com			Fujian Provincial Hospital, Fujian Province [2017LHJJ05]; Fourth Round of the Fujian Provincial Joint Tackling Project between the Health and Education Joint Research Fund of National Health and the Family Planning Commission of China [wkj2016-2-02]; National Natural Science Foundation of China [81471607]; Sailing Fund from Fujian Medical University [2017XQ1131]	Fujian Provincial Hospital, Fujian Province; Fourth Round of the Fujian Provincial Joint Tackling Project between the Health and Education Joint Research Fund of National Health and the Family Planning Commission of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sailing Fund from Fujian Medical University	The authors thank Professor Lin Chen (Third Military Medical University; Chongqing, China) and Dr. Wenquan Liang (Southern Medical University) for providing support of experimental technique and Dr. Wang Zheng (Center for Cancer and Immunology Research, Children's National Medical Center; Washington, D. C., USA) for reviewing the article. This work was supported by high-level hospital grants from Fujian Provincial Hospital, Fujian Province (2017LHJJ05), the Fourth Round of the Fujian Provincial Joint Tackling Project between the Health and Education Joint Research Fund of National Health and the Family Planning Commission of China (wkj2016-2-02), The National Natural Science Foundation of China (81471607), and The Sailing Fund from Fujian Medical University (2017XQ1131). The authors declare no conflicts of interest.	Alayev A, 2014, CELL CYCLE, V13, P371, DOI 10.4161/cc.27355; Boyce BF, 2013, J BONE MINER RES, V28, P711, DOI 10.1002/jbmr.1885; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Burgess TL, 1999, J CELL BIOL, V145, P527, DOI 10.1083/jcb.145.3.527; Chen YQ, 2017, J CELL COMMUN SIGNAL, V11, P219, DOI 10.1007/s12079-016-0364-4; Chung YH, 2014, J CELL PHYSIOL, V229, P1963, DOI 10.1002/jcp.24646; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Dai QG, 2017, J BIOL CHEM, V292, P196, DOI 10.1074/jbc.M116.764761; Datta HK, 2008, J CLIN PATHOL, V61, P577, DOI 10.1136/jcp.2007.048868; David JP, 2002, J CELL SCI, V115, P4317, DOI 10.1242/jcs.00082; DeSelm CJ, 2011, DEV CELL, V21, P966, DOI 10.1016/j.devcel.2011.08.016; Hariharan N, 2011, ANTIOXID REDOX SIGN, V14, P2179, DOI 10.1089/ars.2010.3488; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hazzalin CA, 1998, MOL CELL BIOL, V18, P1844, DOI 10.1128/MCB.18.4.1844; He WY, 2012, AUTOPHAGY, V8, P1811, DOI 10.4161/auto.22145; Hou W, 2010, AUTOPHAGY, V6, P891, DOI 10.4161/auto.6.7.13038; Hua F, 2011, J CELL SCI, V124, P3235, DOI 10.1242/jcs.082875; Ikeda F, 2004, J CLIN INVEST, V114, P475, DOI 10.1172/JCI200419657; Ikeda F, 2008, J BONE MINER RES, V23, P907, DOI 10.1359/JBMR.080211; Jin HO, 2016, SCI REP-UK, V6, DOI 10.1038/srep28945; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Karakashev S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03031-3; Ke DS, 2018, BIOCHEM BIOPH RES CO, V497, P890, DOI 10.1016/j.bbrc.2018.02.164; Kikuchi Y, 2005, NEPHROL DIAL TRANSPL, V20, P1573, DOI 10.1093/ndt/gfh888; Kim J, 2012, J CELL BIOCHEM, V113, P220, DOI 10.1002/jcb.23347; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kobayashi N, 2001, EMBO J, V20, P1271, DOI 10.1093/emboj/20.6.1271; Li RF, 2014, J HISTOCHEM CYTOCHEM, V62, P879, DOI 10.1369/0022155414551367; Lin NY, 2016, ANN RHEUM DIS, V75, P1203, DOI 10.1136/annrheumdis-2015-207240; Lin NY, 2013, ANN RHEUM DIS, V72, P761, DOI 10.1136/annrheumdis-2012-201671; Liu WJ, 2014, AUTOPHAGY, V10, P243, DOI 10.4161/auto.27004; Liu XQ, 2014, BIOMATERIALS, V35, P5721, DOI 10.1016/j.biomaterials.2014.04.006; Liu YW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33614; Lu XM, 2009, BIOCHEM BIOPH RES CO, V390, P494, DOI 10.1016/j.bbrc.2009.09.123; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; Ni ZH, 2014, FREE RADICAL BIO MED, V70, P194, DOI 10.1016/j.freeradbiomed.2014.02.012; Ochotny N, 2013, J CELL BIOCHEM, V114, P2823, DOI 10.1002/jcb.24630; Park H, 2015, ANTIOXID REDOX SIGN, V22, P63, DOI 10.1089/ars.2013.5748; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2009, AUTOPHAGY, V5, P558, DOI 10.4161/auto.5.4.8390; Sambandam Y, 2016, J CELL BIOCHEM, V117, P118, DOI 10.1002/jcb.25255; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Smink JJ, 2012, J MOL MED, V90, P25, DOI 10.1007/s00109-011-0823-6; Srivastava S, 2001, J BIOL CHEM, V276, P8836, DOI 10.1074/jbc.M010764200; Tang H, 2009, HEPATOLOGY, V49, P60, DOI 10.1002/hep.22581; Teitelbaum SL, 2004, J CLIN INVEST, V114, P463, DOI 10.1172/JCI200422644; Teitelbaum SL, 2011, ANN NY ACAD SCI, V1240, P14, DOI 10.1111/j.1749-6632.2011.06283.x; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Udagawa N, 2000, ENDOCRINOLOGY, V141, P3478, DOI 10.1210/en.141.9.3478; Wang GY, 2017, INT J MED SCI, V14, P698, DOI 10.7150/ijms.19800; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Wu HB, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0540-y; Wu XJ, 2005, J BONE MINER RES, V20, P107, DOI 10.1359/JBMR.041022; Wu YT, 2008, AUTOPHAGY, V4, P457, DOI 10.4161/auto.5662; Xiu Y, 2014, J CLIN INVEST, V124, P297, DOI 10.1172/JCI66947; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	56	24	25	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11082	11095		10.1096/fj.201802597RR	http://dx.doi.org/10.1096/fj.201802597RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31295022				2022-12-28	WOS:000489166300043
J	Lee, JJ; Park, IH; Rhee, WJ; Kim, HS; Shin, JS				Lee, Je-Jung; Park, In Ho; Rhee, Woo Joong; Kim, Hee Sue; Shin, Jeon-Soo			HMGB1 modulates the balance between senescence and apoptosis in response to genotoxic stress	FASEB JOURNAL			English	Article						cancer; metastasis; cell fate; doxorubicin; camptothecin	CELLULAR SENESCENCE; SECRETORY PHENOTYPE; CANCER CELLS; PROTEIN; TUMORIGENESIS; SUPPRESSION; AUTOPHAGY; RELEASE; COMPLEX; P53	High mobility group box-1 (HMGB1) is involved in various diseases and is associated with the resistance of many types of human cancers to chemotherapy; however, its role in cancer metastasis remains unexplored. This study examined the HMGB1 status of both highly and poorly metastatic cancer cells in response to genotoxic stress. The weakly and highly metastatic mouse melanoma cell lines (B16 vs. B16-F10), human melanoma cell lines (SK-MEL-28 vs. SK-MEL-24), colon cancer cell lines (DLD-1 vs. LS174T), and wild-type (WT) vs. HMGB1 knockout (KO) mouse embryonic fibroblasts (MEFs) were treated with doxorubicin (Dox) and camptothecin (CPT), and then cellular morphology, senescence-associated beta-galactosidase staining, lactate dehydrogenase release, and caspase-3 activation were used to assess cell fate. To investigate the role of HMGB1 in p21 expression, HMGB1 and p21 expressions were examined by Western blotting, and the HMGB1-mediated p21 promoter luciferase assay was performed after small interfering RNA or overexpression of HMGB1 prior to Dox treatment. Although highly metastatic mouse melanoma B16-F10 cells preferred senescence, with persistent HMGB1 expression, poorly metastatic B16 cells entered apoptosis, with decreasing HMGB1 levels via cleavage under Dox treatment. Similarly, more metastatic human melanoma SK-MEL-24 and human colon cancer LS174T cells underwent senescence, whereas fewer metastatic melanoma SK-MEL-28 and DLD-1 cells exhibited apoptosis under Dox stimulation. In senescent B16-F10, SK-MEL-24, and LS174T cells treated with Dox, p21 levels were increased by persistent HMGB1 expression. Furthermore, HMGB1 depletion caused a senescence-apoptosis shift with p21 down-regulation in B16-F10 cells, and HMGB1 overexpression switched from apoptosis to senescence concomitantly with increased p21 expression in B16 cells after Dox treatment. The same effects were observed in both cell pairs of mouse melanoma and human colon cancer cells treated with CPT, another genotoxic stressor. Indeed, although WT MEF entered senescence accompanied by p21 increase, HMGB1 KO underwent apoptosis with p21 decrease by Dox treatment. In our cell model system, we demonstrated that highly metastatic cancer cells preferentially enter senescence, whereas apoptosis predominates in weakly metastatic cancer cells under genotoxic stress, which depends on the presence or absence of HMGB1, suggesting that the HMGB1-p21 axis is required for genotoxic stress-induced senescence. These findings suggest that HMGB1 modulation of cancers with different metastatic status could be a strategy for selectively enforcing tumor suppression.-Lee, J.-J., Park, I. H., Rhee, W. J., Kim, H. S., Shin, J.-S. HMGB1 modulates the balance between senescence and apoptosis in response to genotoxic stress.	[Lee, Je-Jung; Rhee, Woo Joong; Kim, Hee Sue; Shin, Jeon-Soo] Yonsei Univ, Coll Med, Dept Microbiol, 50-1 Yonsei Ro, Seoul 03722, South Korea; [Lee, Je-Jung; Park, In Ho; Shin, Jeon-Soo] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul, South Korea; [Park, In Ho; Shin, Jeon-Soo] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Rhee, Woo Joong; Shin, Jeon-Soo] Inst for Basic Sci Korea, Ctr Nanomed, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Institute for Basic Science - Korea (IBS)	Shin, JS (corresponding author), Yonsei Univ, Coll Med, Dept Microbiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.	jsshin6203@yuhs.ac		Park, In Ho/0000-0003-2190-5469; Rhee, Woo Joong/0000-0001-9690-0553; Shin, Jeon-Soo/0000-0002-8294-3234	National Research Foundation of Korea (NRF) - Korean government [2014R1A4A1008625, 2017R1A2B3006704, 2017R1D1A1B03028551, 2019R1I1A1A01041284, 2019R1A6A1A03032869]; Research Center Program of the Institute for Basic Science (IBS) in Korea [IBS-R026-D1]; Brain Korea 21 PLUS Project for Medical Science	National Research Foundation of Korea (NRF) - Korean government; Research Center Program of the Institute for Basic Science (IBS) in Korea; Brain Korea 21 PLUS Project for Medical Science	This work was supported by grants from the National Research Foundation of Korea (NRF) funded by the Korean government (2014R1A4A1008625, 2017R1A2B3006704, 2017R1D1A1B03028551, 2019R1I1A1A01041284, and 2019R1A6A1A03032869), the Research Center Program of the Institute for Basic Science (IBS) in Korea (IBS-R026-D1), and the Brain Korea 21 PLUS Project for Medical Science. The authors declare no conflicts of interest.	Biran A, 2017, AGING CELL, V16, P661, DOI 10.1111/acel.12592; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Byun HO, 2009, CANCER RES, V69, P4638, DOI 10.1158/0008-5472.CAN-08-4042; Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245; Cianfrocca R, 2017, CELL DEATH DIFFER, V24, P1811, DOI 10.1038/cdd.2017.121; CILLO C, 1987, CANCER RES, V47, P2604; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Davalos AR, 2013, J CELL BIOL, V201, P613, DOI 10.1083/jcb.201206006; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Efstathiou JA, 1999, P NATL ACAD SCI USA, V96, P2316, DOI 10.1073/pnas.96.5.2316; Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364; Galanos P, 2016, NAT CELL BIOL, V18, P777, DOI 10.1038/ncb3378; Georgakopoulou E, 2016, MECH AGEING DEV, V156, P17, DOI 10.1016/j.mad.2016.03.010; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jiao Y, 2007, ACTA PHARMACOL SIN, V28, P1957, DOI 10.1111/j.1745-7254.2007.00669.x; Jin YH, 2000, J BIOL CHEM, V275, P30256, DOI 10.1074/jbc.M001902200; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Laine A, 2013, CANCER DISCOV, V3, P182, DOI 10.1158/2159-8290.CD-12-0292; LeBlanc PM, 2014, J BIOL CHEM, V289, P7777, DOI 10.1074/jbc.M113.541474; Lee JJ, 2011, CELL DEATH DIFFER, V18, P666, DOI 10.1038/cdd.2010.139; Li QL, 2014, ONCOTARGET, V5, P6387, DOI 10.18632/oncotarget.2201; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Livesey KM, 2012, CANCER RES, V72, P1996, DOI 10.1158/0008-5472.CAN-11-2291; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Mao Zhiyong, 2012, Aging (Albany NY), V4, P431; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Nehil M, 2014, ONCOGENE, V33, P5151, DOI 10.1038/onc.2013.459; Papazoglu C, 2007, J PATHOL, V211, P124, DOI 10.1002/path.2086; Prieur A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1473; Roberson RS, 2005, CANCER RES, V65, P2795, DOI 10.1158/0008-5472.CAN-04-1270; Ru H, 2015, CELL, V163, P1807, DOI 10.1016/j.cell.2015.12.003; Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006; Swift LH, 2014, INT J MOL SCI, V15, P3403, DOI 10.3390/ijms15033403; Tang D, 2010, ONCOGENE, V29, P5299, DOI 10.1038/onc.2010.261; Tsou SH, 2016, INT J MOL MED, V37, P233, DOI 10.3892/ijmm.2015.2406; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; Warfel NA, 2013, CURR OPIN ONCOL, V25, P52, DOI 10.1097/CCO.0b013e32835b639e; Zagelbaum J, 2016, P NATL ACAD SCI USA, V113, P11853, DOI 10.1073/pnas.1606721113	39	24	25	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10942	10953		10.1096/fj.201900288R	http://dx.doi.org/10.1096/fj.201900288R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31284735				2022-12-28	WOS:000489166300030
J	Liu, SQ; Li, X; Yang, J; Zhu, RM; Fan, ZQ; Xu, XX; Feng, WL; Cui, JQ; Sun, JH; Liu, M				Liu, Shiqun; Li, Xin; Yang, Jing; Zhu, Ruimin; Fan, Zhenqian; Xu, Xiaoxi; Feng, Wenli; Cui, Jingqiu; Sun, Jinhong; Liu, Ming			Misfolded proinsulin impairs processing of precursor of insulin receptor and insulin signaling in beta cells	FASEB JOURNAL			English	Article						MIDY; proinsulin misfolding; insulin resistance; pancreatic; beta cells; ER stress	ENDOPLASMIC-RETICULUM; ER STRESS; INS GENE; MUTATIONS; BIOSYNTHESIS; PATHOGENESIS; HOMEOSTASIS; PRORECEPTOR; DYSFUNCTION; ACTIVATION	Insulin resistance in classic insulin-responsive tissues is a hallmark of type 2 diabetes (T2D). However, the pathologic significance of beta-cell insulin resistance and the underlying mechanisms contributing to defective insulin signaling in beta cells remain largely unknown. Emerging evidence indicates that proinsulin misfolding is not only the molecular basis of mutant INS-gene-induced diabetes of youth (MIDY) but also an important contributor in the development and progression of T2D. However, the molecular basis of beta-cell failure caused by misfolded proinsulin is still incompletely understood. Herein, using Akita mice expressing diabetes-causing mutant proinsulin, we found that misfolded proinsulin abnormally interacted with the precursor of insulin receptor (ProIR) in the endoplasmic reticulum (ER), impaired ProIR maturation to insulin receptor (IR), and decreased insulin signaling in beta cells. Importantly, using db/db insulin-resistant mice, we found that oversynthesis of proinsulin led to an increased proinsulin misfolding, which resulted in impairments of ProIR processing and insulin signaling in beta cells. These results reveal for the first time that misfolded proinsulin can interact with ProIR in the ER, impairing intracellular processing of ProIR and leading to defective insulin signaling that may contribute to beta-cell failure in both MIDY and T2D.-Liu, S., Li, X., Yang, J., Zhu, R., Fan, Z., Xu, X., Feng, W., Cui, J., Sun, J., Liu, M. Misfolded proinsulin impairs processing of precursor of insulin receptor and insulin signaling in beta cells.	[Liu, Shiqun; Li, Xin; Yang, Jing; Zhu, Ruimin; Fan, Zhenqian; Xu, Xiaoxi; Feng, Wenli; Cui, Jingqiu; Liu, Ming] Tianjin Med Univ Gen Hosp, Dept Endocrinol & Metab, 154 Anshan Rd, Tianjin 300052, Peoples R China; [Sun, Jinhong] Tianjin Med Univ Gen Hosp, Dept Hlth Management, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Cui, JQ; Liu, M (corresponding author), Tianjin Med Univ Gen Hosp, Dept Endocrinol & Metab, 154 Anshan Rd, Tianjin 300052, Peoples R China.	cuijingqiu@sina.com; mingliu@tmu.edu.cn		Liu, Ming/0000-0003-2665-4072	Tianjin Municipal Science and Technology Bureau [17ZXMFSY00150, 18JCYBJC93900]; National Natural Science Foundation of China [81570699, 81620108004, 81830025, 81870533]	Tianjin Municipal Science and Technology Bureau; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors acknowledge the support of the Tianjin Municipal Science and Technology Bureau (Grants 17ZXMFSY00150 and 18JCYBJC93900). This work was also supported by research grants from the National Natural Science Foundation of China (81570699, 81620108004, 81830025, and 81870533). The authors declare no conflicts of interest.	Alarcon C, 2016, DIABETES, V65, P438, DOI 10.2337/db15-0792; Balboa D, 2018, ELIFE, V7, DOI 10.7554/eLife.38519; Bass J, 1998, J CELL BIOL, V141, P637, DOI 10.1083/jcb.141.3.637; Castelnau P, 2000, EUR J PEDIATR, V159, P631, DOI 10.1007/PL00008394; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; Colombo C, 2008, J CLIN INVEST, V118, P2148, DOI 10.1172/JCI33777; De Meyts P, 2012, ENDOCRINOLOGY, V153, P2054, DOI 10.1210/en.2012-1234; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; Guo H, 2014, J BIOL CHEM, V289, P16290, DOI 10.1074/jbc.M114.562355; Haataja L, 2013, J BIOL CHEM, V288, P1896, DOI 10.1074/jbc.M112.420018; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Hodish I, 2010, J BIOL CHEM, V285, P685, DOI 10.1074/jbc.M109.038042; Hubbard SR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008946; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Kitamoto T, 2018, METABOLISM, V82, P100, DOI 10.1016/j.metabol.2017.12.017; KODAMA H, 1994, DIABETOLOGIA, V37, P739, DOI 10.1007/s001250050173; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; LANE MD, 1985, BIOCHIMIE, V67, P1069, DOI 10.1016/S0300-9084(85)80104-8; Lee HC, 2000, NATURE, V408, P483, DOI 10.1038/35044106; Liew CW, 2014, P NATL ACAD SCI USA, V111, pE2319, DOI 10.1073/pnas.1323066111; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Liu M, 2018, DIABETES OBES METAB, V20, P28, DOI 10.1111/dom.13378; Liu M, 2015, MOL ASPECTS MED, V42, P3, DOI 10.1016/j.mam.2014.12.001; Liu M, 2014, VITAM HORM, V95, P35, DOI 10.1016/B978-0-12-800174-5.00002-8; Liu M, 2012, DIABETES, V61, P828, DOI 10.2337/db11-0878; Liu M, 2010, TRENDS ENDOCRIN MET, V21, P652, DOI 10.1016/j.tem.2010.07.001; Liu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013333; Malaguarnera R, 2012, ENDOCRINOLOGY, V153, P2152, DOI 10.1210/en.2011-1843; Modi H, 2018, ELIFE, V7, DOI 10.7554/eLife.43475; Nobile S, 2012, J PEDIATR ENDOCR MET, V25, P363, DOI 10.1515/jpem-2011-0448; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Park SY, 2010, BIOCHEM BIOPH RES CO, V391, P1449, DOI 10.1016/j.bbrc.2009.12.090; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Riahi Y, 2018, ELIFE, V7, DOI 10.7554/eLife.38472; Richter M, 2016, CELL DEATH DIFFER, V23, P814, DOI 10.1038/cdd.2015.146; RONNETT GV, 1984, J BIOL CHEM, V259, P4566; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Shaheen A, 2018, CELL STRESS CHAPERON, V23, P797, DOI 10.1007/s12192-018-0905-2; Sparrow LG, 1997, J BIOL CHEM, V272, P29460, DOI 10.1074/jbc.272.47.29460; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; SUGIBAYASHI M, 1992, METABOLISM, V41, P820, DOI 10.1016/0026-0495(92)90161-3; Sun JH, 2015, MOL ASPECTS MED, V42, P105, DOI 10.1016/j.mam.2015.01.001; Tsuchiya Y, 2018, J CELL BIOL, V217, P1287, DOI 10.1083/jcb.201707143; VANDERVORM ER, 1994, J BIOL CHEM, V269, P14297; Wang QH, 2009, ISLETS, V1, P95, DOI 10.4161/isl.1.2.9263; Wright J, 2013, J CLIN INVEST, V123, P3124, DOI 10.1172/JCI67260; Zaccai TCF, 2014, MOL GENET GENOM MED, V2, P64, DOI 10.1002/mgg3.43; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhu RM, 2019, MOL CELL ENDOCRINOL, V493, DOI 10.1016/j.mce.2019.110470; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086	56	8	8	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11338	11348		10.1096/fj.201900442R	http://dx.doi.org/10.1096/fj.201900442R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31311313	hybrid, Green Published			2022-12-28	WOS:000489166300062
J	Rathod, S; Ramsey, M; DiGiorgio, D; Berrios, R; Finkelman, FD; Fernandez, CA				Rathod, Sanjay; Ramsey, Manda; DiGiorgio, Danielle; Berrios, Roberto; Finkelman, Fred D.; Fernandez, Christian A.			Asparaginase immune complexes induce Fc-gamma RIII-dependent hypersensitivity in naive mice	FASEB JOURNAL			English	Article						antidrug antibodies; leukemia; basophil activation test; anaphylaxis; immunogenicity	ACUTE LYMPHOBLASTIC-LEUKEMIA; ESCHERICHIA-COLI ASPARAGINASE; HIGHER-RISK; CHILDREN; ANTIBODIES; ANAPHYLAXIS; EXPRESSION; BASOPHILS; IMPACT	Asparaginase (ASNase) is an important drug for the treatment of leukemias. However, hypersensitivity to ASNase can increase the risk of leukemia relapse. Two mechanisms of ASNase hypersensitivity have been identified in mice. The existence of a pathway involving anti-ASNase IgG and Fc-gamma receptor III (Fc-gamma RIII) implies that IgG and ASNase immune complexes (ICs) could directly induce hypersensitivity. The aim of this study was to detect ASNase ICs in mice after hypersensitivity reactions and determine their role in hypersensitivity. Protein G beads were used to detect plasma ASNase ICs by flow cytometry. Anti-ASNase IgG was purified from the plasma of sensitized mice, and ASNase ICs were prepared ex vivo at various ratios of ASNase to anti-ASNase IgG. The levels of ASNase ICs detected after hypersensitivity reactions correlated with reaction severity (R-2 = 0.796; P = 0.0005). ASNase ICs prepared ex vivo required high levels of anti-ASNase IgG for formation, and binding to naive and sensitized immune cells depended on soluble anti-ASNase IgG, antigen:antibody ratio, and Fc-gamma RIII. Similarly, basophil activation by ASNase ICs depended on the antigen:antibody ratio and Fc-gamma RIII. Consistent with the ex vivo results, naive mice receiving ASNase ICs developed hypersensitivity reactions. Our data demonstrate that ASNase ICs can directly contribute to the onset and severity of ASNase hypersensitivity.-Rathod, S., Ramsey, M., DiGiorgio, D., Berrios, R., Finkelman, F. D., Fernandez, C. A. Asparaginase immune complexes induce Fc-gamma RIII-dependent hypersensitivity in naive mice.	[Rathod, Sanjay; Ramsey, Manda; DiGiorgio, Danielle; Berrios, Roberto; Fernandez, Christian A.] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA; [Rathod, Sanjay; Ramsey, Manda; DiGiorgio, Danielle; Berrios, Roberto; Fernandez, Christian A.] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Finkelman, Fred D.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Immunol Allergy & Rheumatol, Cincinnati, OH USA; [Finkelman, Fred D.] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Fernandez, CA (corresponding author), Univ Pittsburgh, Ctr Pharmacogenet, Sch Pharm, Dept Pharmaceut Sci, 335 Sutherland Dr, Pittsburgh, PA 15261 USA.	chf63@pitt.edu	Rathod, Sanjay/AAT-2556-2021; Rathod, Sanjay/AAQ-6512-2020; Rathod, Sanjay/AAX-9224-2021	Rathod, Sanjay/0000-0003-1755-8222; 	University of Pittsburgh School of Pharmacy (Pittsburgh, PA, USA); U.S. National Institutes of Health, National Cancer Institute [RO1 CA216815]; NATIONAL CANCER INSTITUTE [R01CA216815] Funding Source: NIH RePORTER	University of Pittsburgh School of Pharmacy (Pittsburgh, PA, USA); U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the University of Pittsburgh School of Pharmacy (Pittsburgh, PA, USA) and U.S. National Institutes of Health, National Cancer Institute Grant RO1 CA216815. The authors declare no conflicts of interest.	Asselin B, 2015, LEUKEMIA LYMPHOMA, V56, P2273, DOI 10.3109/10428194.2014.1003056; Avramis VI, 2002, BLOOD, V99, P1986, DOI 10.1182/blood.V99.6.1986; Bandyopadhyay S, 2005, J IMMUNOL METHODS, V297, P13, DOI 10.1016/j.jim.2004.11.014; Bhatt VR, 2014, FUTURE ONCOL, V10, P2593, DOI 10.2217/fon.14.239; Burke MJ, 2014, FUTURE ONCOL, V10, P2615, DOI 10.2217/fon.14.138; Chauhan AK, 2015, J BIOL CHEM, V290, P5127, DOI 10.1074/jbc.M114.599266; DAVIES KA, 1990, J IMMUNOL, V144, P4613; Fernandez CA, 2015, BLOOD, V126, P69, DOI 10.1182/blood-2015-02-628800; Fernandez CA, 2015, J PHARMACOL EXP THER, V352, P541, DOI 10.1124/jpet.114.220780; Fernandez CA, 2014, BLOOD, V124, P1266, DOI 10.1182/blood-2014-03-563742; Fernandez CA, 2013, INT J CLIN EXP MED, V6, P478; Finkelman FD, 2007, J ALLERGY CLIN IMMUN, V120, P506, DOI 10.1016/j.jaci.2007.07.033; Iwamoto H, 2016, TOXICOL LETT, V242, P53, DOI 10.1016/j.toxlet.2015.11.024; Iwamoto H, 2015, IMMUN INFLAMM DIS, V3, P280, DOI 10.1002/iid3.67; Kawedia JD, 2011, BLOOD, V117, P2340, DOI 10.1182/blood-2010-10-311969; Liu C, 2012, LEUKEMIA, V26, P2303, DOI 10.1038/leu.2012.102; Lux A, 2013, J IMMUNOL, V190, P4315, DOI 10.4049/jimmunol.1200501; Muller HJ, 1998, CRIT REV ONCOL HEMAT, V28, P97, DOI 10.1016/S1040-8428(98)00015-8; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; OETTGEN H F, 1970, Cancer, V25, P253, DOI 10.1002/1097-0142(197002)25:2<253::AID-CNCR2820250204>3.0.CO;2-U; Panosyan EH, 2004, J PEDIAT HEMATOL ONC, V26, P217, DOI 10.1097/00043426-200404000-00002; Rathod S, 2019, HAEMATOLOGICA, V104, P319, DOI 10.3324/haematol.2018.199448; Reber LL, 2017, J ALLERGY CLIN IMMUN, V140, P335, DOI 10.1016/j.jaci.2017.06.003; Strait RT, 2002, J ALLERGY CLIN IMMUN, V109, P658, DOI 10.1067/mai.2002.123302; Tsujimura Y, 2008, IMMUNITY, V28, P581, DOI 10.1016/j.immuni.2008.02.008; Vrooman LM, 2013, J CLIN ONCOL, V31, P1202, DOI 10.1200/JCO.2012.43.2070; Woo MH, 1998, LEUKEMIA, V12, P1527, DOI 10.1038/sj.leu.2401162; Woo MH, 2000, J CLIN ONCOL, V18, P1525, DOI 10.1200/JCO.2000.18.7.1525	28	3	3	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10996	11005		10.1096/fj.201900857	http://dx.doi.org/10.1096/fj.201900857			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31284767	Green Published			2022-12-28	WOS:000489166300035
J	Lee, JY; Mehrazarin, S; Alshaikh, A; Kim, S; Chen, W; Lux, R; Gwack, Y; Kim, RH; Kang, MK				Lee, Jae Young; Mehrazarin, Shebli; Alshaikh, Abdullah; Kim, Sol; Chen, Wei; Lux, Renate; Gwack, Yousang; Kim, Reuben H.; Kang, Mo K.			Histone Lys demethylase KDM3C demonstrates anti-inflammatory effects by suppressing NF-kappa B signaling and osteoclastogenesis	FASEB JOURNAL			English	Article						epigenetics; histone methylation; oral inflammation; JMJD1C; periodontitis	PORPHYROMONAS-GINGIVALIS; GENE-EXPRESSION; BONE-RESORPTION; PERIODONTITIS; METHYLATION; H3; INTERLEUKIN-1; INHIBITION; COMPLEXES; ALPHA	Histone Lys-specific demethylases (KDMs) play a key role in many biological processes through epigenetic mechanisms. However, the role of KDMs in inflammatory responses to oral bacterial infection is poorly understood. Here, we show a novel regulatory role of KDM3C in inflammatory responses to oral bacterial infection. KDM3C expression is transiently suppressed in human and mouse macrophages exposed to LPS from Porphyromonas gingivalis (Pg LPS). Loss of KDM3C in both human and mouse macrophages led to notable induction of proinflammatory cytokines in response to Pg LPS stimulation. Also, KDM3C depletion led to strong induction of p65 phosphorylation and accelerated nuclear translocation in cells exposed to Pg LPS. Kdm3C knockout (KO) in mice led to increased alveolar bone destruction upon induction of experimental periodontitis or pulp exposure compared with those of the wild-type (WT) littermates. The Kdm3C KO mice also revealed an increased number of osteoclasts juxtaposed to the bony lesions. We also confirmed enhanced osteoclastogenesis by bone marrow-derived macrophages isolated from the Kdm3C KO compared with the WT controls. These findings suggest an anti-inflammatory function of KDM3C in regulating the inflammatory responses against oral bacterial infection through suppression of NF-kappa B signaling and osteoclastogenesis.-Lee, J. Y., Mehrazarin, S., Alshaikh, A., Kim, S., Chen, W., Lux, R., Gwack, Y., Kim, R. H., Kang, M. K. Histone Lys demethylase KDM3C demonstrates anti-inflammatory effects by suppressing NF-kappa B signaling and osteoclastogenesis.	[Lee, Jae Young; Mehrazarin, Shebli; Alshaikh, Abdullah; Kim, Sol; Chen, Wei; Kim, Reuben H.; Kang, Mo K.] Univ Calif Los Angeles, Sch Dent, Div Constitut & Regenerat Sci, Shapiro Family Lab Viral Oncol & Aging Res, Los Angeles, CA 90024 USA; [Lee, Jae Young; Chen, Wei; Kang, Mo K.] Univ Calif Los Angeles, Sch Dent, Div Constitut & Regenerat Sci, Sect Endodont, Los Angeles, CA 90024 USA; [Lux, Renate] Univ Calif Los Angeles, Sch Dent, Div Constitut & Regenerat Sci, Sect Periodont, Los Angeles, CA 90024 USA; [Gwack, Yousang] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kang, MK (corresponding author), Univ Calif Los Angeles, Sch Dent, Ctr Hlth Sci, Room 43-007,10833 Conte Ave, Los Angeles, CA 90095 USA.	mkang@dentistry.ucla.edu			U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research [R21DE028269, R56DE024593, R03DE024259]; American Association of Endodontists Foundation; Jack A. Weichman Endowed Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE024259, R21DE028269] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research; American Association of Endodontists Foundation; Jack A. Weichman Endowed Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in part, by grants from the U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research (R21DE028269, R56DE024593, and R03DE024259) and a grant from the American Association of Endodontists Foundation. M.K.K. is also supported by the Jack A. Weichman Endowed Fund. The authors declare no conflicts of interest.	Abe T, 2013, J IMMUNOL METHODS, V394, P49, DOI 10.1016/j.jim.2013.05.002; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chen XP, 2009, J BIOL CHEM, V284, P27857, DOI 10.1074/jbc.M109.000950; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Demmer RT, 2008, J PERIODONTOL, V79, P2112, DOI [10.1902/jop.2008.080139, 10.1902/jop.2008.080139 ]; Ding GJF, 1998, J BIOL CHEM, V273, P28897, DOI 10.1074/jbc.273.44.28897; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; Ea CK, 2012, J BIOL CHEM, V287, P31207, DOI 10.1074/jbc.M112.365601; El Gazzar M, 2008, J BIOL CHEM, V283, P32198, DOI 10.1074/jbc.M803446200; El Gazzar M, 2010, J BIOL CHEM, V285, P1259, DOI 10.1074/jbc.M109.067330; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Haddad JJE, 2001, BIOCHEM J, V355, P29, DOI 10.1042/bj3550029; He Y, 2017, J ENDODONT, V43, P90, DOI 10.1016/j.joen.2016.09.003; Izawa A, 2014, INFECT IMMUN, V82, P1904, DOI 10.1128/IAI.01618-13; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Kajikawa T, 2017, J CLIN PERIODONTOL, V44, P472, DOI 10.1111/jcpe.12707; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Kim KC, 2003, CANCER RES, V63, P7619; Kuroki S, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108597; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lam RS, 2014, J IMMUNOL, V193, P2349, DOI 10.4049/jimmunol.1400853; Lee HT, 2014, INFLAMM RES, V63, P389, DOI 10.1007/s00011-014-0711-y; Leveillard Thierry, 1993, Gene Expression, V3, P135; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; MUNDY GR, 1993, J CELL BIOCHEM, V53, P296, DOI 10.1002/jcb.240530405; Nakajima R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163466; Ni W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091083; Oz HS, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/754857; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; PFEILSCHIFTER J, 1989, J BONE MINER RES, V4, P113, DOI 10.1002/jbmr.5650040116; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Saccani S, 2002, GENE DEV, V16, P2219, DOI 10.1101/gad.232502; Santos-Barriopedro I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02586-x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Suuronen T, 2003, J NEUROCHEM, V87, P407, DOI 10.1046/j.1471-4159.2003.02004.x; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Takatsuna H, 2005, J BONE MINER RES, V20, P653, DOI 10.1359/JBMR.041213; To M, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0588-8; van't Hof RJ, 2017, BONE, V99, P69, DOI 10.1016/j.bone.2017.03.051; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Watanabe S, 2013, NAT STRUCT MOL BIOL, V20, P1425, DOI 10.1038/nsmb.2702; Xiao F, 2017, STEM CELL REP, V9, P927, DOI 10.1016/j.stemcr.2017.07.013; Yoza BK, 2011, CYTOKINE, V53, P145, DOI 10.1016/j.cyto.2010.10.007; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005	49	13	15	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10515	10527		10.1096/fj.201900154RR	http://dx.doi.org/10.1096/fj.201900154RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31251083	Green Published			2022-12-28	WOS:000482214200063
J	Liu, J; Dong, S; Wang, H; Li, L; Ye, QM; Li, YH; Miao, JX; Jhiang, S; Zhao, J; Zhao, YT				Liu, Jia; Dong, Su; Wang, Heather; Li, Lian; Ye, Qinmao; Li, Yanhui; Miao, Jiaxing; Jhiang, Sissy; Zhao, Jing; Zhao, Yutong			Two distinct E3 ligases, SCFFBXL19 and HECW1, degrade thyroid transcription factor 1 in normal thyroid epithelial and follicular thyroid carcinoma cells, respectively	FASEB JOURNAL			English	Article						TTF1; ubiquitination; HECW1; FBXL19; different cell types	FACTOR-I; UBIQUITIN LIGASES; GENE; PULMONARY; PROTEIN; DIFFERENTIATION; EXPRESSION; PAX8; RECEPTOR; TTF-1	Thyroid transcription factor 1 (TTF1) regulates the tissue-specific expression of genes. However, the molecular regulation of TTF1 in thyroid normal and carcinoma cells has not been revealed. Here we identify 2 distinct ubiquitin E3 ligases that are responsible for TTF1 degradation in normal thyroid cells and carcinoma cells, respectively. Phorbol myristate acetate induced TTF1 protein degradation in the ubiquitin-proteasome system in both HTori3 thyroid follicular epithelial cells and follicular thyroid carcinoma 133 (FTC133) cells. Lysine 151 residue was identified as a ubiquitin acceptor site within TTF1 in both cell types. Overexpression of E3 ubiquitin protein ligase 1 containing HECT, C2, and WW domain (HECW1) induced TTF1 degradation and ubiquitination in Htori3 cells but not in FTC133 cells. Overexpression of ubiquitin E3 ligase subunit FBXL19 increased TTF1 ubiquitination and degradation in FTC133 cells, but it had no effect on TTF1 levels in Htori3 cells. Overexpression of TTF1 increased thyroglobulin and sodium/iodide symporter mRNA levels, cell migration, and proliferation in HTori3 cells, whereas the effects were reversed by the overexpression of HECW1. This study reveals an undiscovered molecular mechanism by which TTF1 ubiquitination and degradation is regulated by different E3 ligases in thyroid normal and tumor cells.-Liu, J., Dong, S., Wang, H., Li, L., Ye, Q., Li, Y., Miao, J., Jhiang, S., Zhao, J., Zhao, Y. Two distinct E3 ligases, SCFFBXL19 and HECW1, degrade thyroid transcription factor 1 in normal thyroid epithelial and follicular thyroid carcinoma cells, respectively.	[Liu, Jia] Jilin Univ, Hosp 1, Dept Thyroid Surg, Changchun, Jilin, Peoples R China; [Dong, Su; Li, Yanhui] Jilin Univ, Hosp 1, Dept Anesthesia, Changchun, Jilin, Peoples R China; [Liu, Jia; Dong, Su; Wang, Heather; Li, Lian; Ye, Qinmao; Li, Yanhui; Miao, Jiaxing; Jhiang, Sissy; Zhao, Jing; Zhao, Yutong] Ohio State Univ, Dept Physiol & Cell Biol, 333 10th Ave,Graves Hall 2166E, Columbus, OH 43065 USA	Jilin University; Jilin University; University System of Ohio; Ohio State University	Zhao, YT (corresponding author), Ohio State Univ, Dept Physiol & Cell Biol, 333 10th Ave,Graves Hall 2166E, Columbus, OH 43065 USA.	yutong.zhao@osumc.edu			U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [R01GM115389]; NIH National Heart, Lung, and Blood Institute [HL136294, HL131665]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136294, R01HL131665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115389] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grant R01GM115389 (to J.Z.) and NIH National Heart, Lung, and Blood Institute Grants HL136294 and HL131665 (to Y.Z.). The authors declare no conflicts of interest.	Afrasiabi E, 2008, MOL CELL ENDOCRINOL, V292, P26, DOI 10.1016/j.mce.2008.04.018; Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Boggaram V, 2009, CLIN SCI, V116, P27, DOI 10.1042/CS20080068; Cai JT, 2018, PROTEIN CELL, V9, P754, DOI 10.1007/s13238-017-0486-3; Chen C, 2007, CANCER METAST REV, V26, P587, DOI 10.1007/s10555-007-9091-x; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Dong S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-76; Gong T, 2018, TRENDS BIOCHEM SCI, V43, P685, DOI 10.1016/j.tibs.2018.06.008; Huang HB, 2017, J CELL BIOCHEM, V118, P3444, DOI 10.1002/jcb.26001; Jendrzejewski J, 2016, THYROID, V26, P1276, DOI 10.1089/thy.2015.0665; Katoh R, 2000, HUM PATHOL, V31, P386, DOI 10.1016/S0046-8177(00)80255-5; Kaufmann O, 2000, HISTOPATHOLOGY, V36, P8; Keijzer R, 2001, DEVELOPMENT, V128, P503; Kenny SL, 2012, AM J SURG PATHOL, V36, P799, DOI 10.1097/PAS.0b013e31824a72c6; Keyes BE, 2016, CELL, V167, P1323, DOI 10.1016/j.cell.2016.10.052; Kimura S, 1996, TRENDS ENDOCRIN MET, V7, P247, DOI 10.1016/S1043-2760(96)00115-4; Kiryluk K, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006609; Li Y, 2008, ONCOGENE, V27, P3700, DOI 10.1038/sj.onc.1211032; Li Y, 2013, STEM CELLS DEV, V22, P1433, DOI 10.1089/scd.2012.0620; Liu Z, 2017, ONCOGENE, V36, P3740, DOI 10.1038/onc.2016.524; Lonigro R, 2001, J BIOL CHEM, V276, P47807, DOI 10.1074/jbc.M107692200; Lopez-Campistrous A, 2016, EBIOMEDICINE, V12, P86, DOI 10.1016/j.ebiom.2016.09.007; Ma RS, 2013, THYROID, V23, P385, DOI 10.1089/thy.2012.0644; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; Micel LN, 2013, J CLIN ONCOL, V31, P1231, DOI 10.1200/JCO.2012.44.0958; Missero C, 2000, MOL CELL BIOL, V20, P2783, DOI 10.1128/MCB.20.8.2783-2793.2000; Mithoe SC, 2018, CURR OPIN PLANT BIOL, V45, P162, DOI 10.1016/j.pbi.2018.07.008; Miyazaki K, 2004, J BIOL CHEM, V279, P11327, DOI 10.1074/jbc.M312389200; Mu D, 2012, CANCER GENE THER, V19, P402, DOI 10.1038/cgt.2012.13; Nettore IC, 2013, J ENDOCRINOL INVEST, V36, P654, DOI 10.3275/8973; Pelizzoi R, 2008, INT J DEV BIOL, V52, P55, DOI 10.1387/ijdb.062196rp; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Plantinga TS, 2014, J CLIN ENDOCR METAB, V99, pE1368, DOI 10.1210/jc.2014-1171; Pohlenz J, 2002, J CLIN INVEST, V109, P469, DOI 10.1172/JCI200214192; Postiglione MP, 2002, P NATL ACAD SCI USA, V99, P15462, DOI 10.1073/pnas.242328999; Schwingshackl A, 2017, AM J PHYSIOL-LUNG C, V313, pL1030, DOI 10.1152/ajplung.00121.2017; Shimura H, 2001, CANCER RES, V61, P3640; Shinada K, 2011, BIOCHEM BIOPH RES CO, V404, P143, DOI 10.1016/j.bbrc.2010.11.082; Shinohara H, 2018, THYROID, V28, P1071, DOI 10.1089/thy.2017.0481; Son HY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15966; Steiner F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071093; Wei JX, 2018, FASEB J, V32, P4284, DOI 10.1096/fj.201701069R; Wei JX, 2013, BBA-MOL CELL RES, V1833, P2757, DOI 10.1016/j.bbamcr.2013.07.005; Weissferdt A, 2013, MODERN PATHOL, V26, P1554, DOI 10.1038/modpathol.2013.111; Yamaguchi T, 2013, CANCER CELL, V23, P718, DOI 10.1016/j.ccr.2013.04.002; Yi M, 2002, J BIOL CHEM, V277, P2997, DOI 10.1074/jbc.M109793200; Zhang X, 2012, FASEB J, V26, P2338, DOI 10.1096/fj.11-200139; Zhao J, 2013, FASEB J, V27, P2611, DOI 10.1096/fj.12-223099; Zhao J, 2012, NAT IMMUNOL, V13, P651, DOI 10.1038/ni.2341; Zheng N, 2017, ANNU REV BIOCHEM, V86, P129, DOI 10.1146/annurev-biochem-060815-014922	50	8	8	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10538	10550		10.1096/fj.201900415R	http://dx.doi.org/10.1096/fj.201900415R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31238008	Green Published, Bronze			2022-12-28	WOS:000482214200065
J	Zhang, XZ; Peng, YH; Grace, PM; Metcalf, MD; Kwilasz, AJ; Wang, YB; Zhang, TS; Wu, SR; Selfridge, BR; Portoghese, PS; Rice, KC; Watkins, LR; Hutchinson, MR; Wang, XH				Zhang, Xiaozheng; Peng, Yinghua; Grace, Peter M.; Metcalf, Matthew D.; Kwilasz, Andrew J.; Wang, Yibo; Zhang, Tianshu; Wu, Siru; Selfridge, Brandon R.; Portoghese, Philip S.; Rice, Kenner C.; Watkins, Linda R.; Hutchinson, Mark R.; Wang, Xiaohui			Stereochemistry and innate immune recognition: (+)-norbinaltorphimine targets myeloid differentiation protein 2 and inhibits toll-like receptor 4 signaling	FASEB JOURNAL			English	Article						norbinaltorphimine; enantioselective modulation; TLR4; MD-2; morphine analgesia	MOLECULAR-DYNAMICS SIMULATIONS; STRUCTURAL BASIS; BINDING MODE; ACTIVATION; (+)-NALTREXONE; DOCKING; SYSTEM; ABUSE	Deregulation of innate immune TLR4 signaling contributes to various diseases including neuropathic pain and drug addiction. Naltrexone is one of the rare TLR4 antagonists with good blood-brain barrier permeability and showing no stereoselectivity for TLR4. By linking 2 naltrexone units through a rigid pyrrole spacer, the bivalent ligand norbinaltorphimine was formed. Interestingly, (+)-norbinaltorphimine [(+)-1] showed similar to 25 times better TLR4 antagonist activity than naltrexone in microglial BV-2 cell line, whereas (-)-norbinaltorphimine [(-)-1] lost TLR4 activity. The enantioselectivity of norbinaltorphimine was further confirmed in primary microglia, astrocytes, and macrophages. The activities of meso isomer of norbinaltorphimine and the molecular dynamic simulation results demonstrate that the stereochemistry of (+)-1 is derived from the (+)-naltrexone pharmacophore. Moreover, (+)-1 significantly increased and prolonged morphine analgesia in vivo. The efficacy of (+)-1 is long lasting. This is the first report showing enantioselective modulation of the innate immune TLR signaling.-Zhang, X., Peng, Y., Grace, P. M., Metcalf, M. D., Kwilasz, A. J., Wang, Y., Zhang, T., Wu, S., Selfridge, B. R., Portoghese, P. S., Rice, K. C., Watkins, L. R., Hutchinson, M. R., Wang, X. Stereochemistry and innate immune recognition: (+)-norbinaltorphimine targets myeloid differentiation protein 2 and inhibits toll-like receptor 4 signaling.	[Zhang, Xiaozheng; Wang, Yibo; Zhang, Tianshu; Wu, Siru; Wang, Xiaohui] Chinese Acad Sci, Changchun Inst Appl Chem, Biol Chem Lab, Changchun, Jilin, Peoples R China; [Zhang, Xiaozheng; Wang, Yibo; Zhang, Tianshu; Wu, Siru; Wang, Xiaohui] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Zhang, Xiaozheng; Wang, Xiaohui] Univ Chinese Acad Sci, Beijing, Peoples R China; [Peng, Yinghua] Chinese Acad Agr Sci, Inst Special Wild Econ Anim & Plants, State Key Lab Mol Biol Special Econ Anim, Changchun, Jilin, Peoples R China; [Grace, Peter M.; Kwilasz, Andrew J.; Watkins, Linda R.] Univ Colorado Boulder, Dept Psychol & Neurosci, Ctr Neurosci, Boulder, CO USA; [Metcalf, Matthew D.; Portoghese, Philip S.] Univ Minnesota, Coll Pharm, Dept Med Chem, Minneapolis, MN 55455 USA; [Selfridge, Brandon R.; Rice, Kenner C.] NIDA, Drug Design & Synth Sect, Bethesda, MD 20892 USA; [Selfridge, Brandon R.; Rice, Kenner C.] NIAAA, Bethesda, MD USA; [Hutchinson, Mark R.] Univ Adelaide, Discipline Physiol, Adelaide Med Sch, Adelaide, SA, Australia; [Hutchinson, Mark R.] Univ Adelaide, Australian Res Council ARC, Ctr Excellence Nanoscale Biophoton, Adelaide, SA, Australia; [Wang, Xiaohui] Univ Sci & Technol China, Dept Appl Chem & Engn, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Nanjing University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Agricultural Sciences; Institute of Special Animal & Plant Sciences, CAAS; University of Colorado System; University of Colorado Boulder; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Adelaide; University of Adelaide; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wang, XH (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, 5625 Renmin St, Changchun 130022, Jilin, Peoples R China.	xiaohui.wang@ciac.ac.cn	Hutchinson, Mark/N-1815-2019; zhang, tian/GZK-6001-2022; Grace, Peter/I-5507-2013; Wang, Xiaohui/B-8126-2011	Hutchinson, Mark/0000-0003-2154-5950; Wang, Yibo/0000-0003-1262-4497; Grace, Peter/0000-0002-8999-1220; Zhang, Xiaozheng/0000-0003-2449-057X; Wang, Xiaohui/0000-0002-3415-5612	National Key Research and Development Program of China [2016YFC0800907]; National Natural Science Foundation of China [21850410455, 21750110432, 21877106]; Central Public-interest Scientific Institution Basal Research Fund [1610342016013]; Natural Science Foundation of Jilin Province [20180101021JC]; Open Fund of State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University [KF-GN-201601]; U.S. National Institutes of Health (NIH) National Institute of Dental and Craniofacial Research Grant [R01 DE017782]; 100 Talents Program of Chinese Academy of Sciences; Young Talents Program of Chinese Academy of Agricultural Sciences; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000530] Funding Source: NIH RePORTER	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central Public-interest Scientific Institution Basal Research Fund; Natural Science Foundation of Jilin Province; Open Fund of State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University; U.S. National Institutes of Health (NIH) National Institute of Dental and Craniofacial Research Grant; 100 Talents Program of Chinese Academy of Sciences(Chinese Academy of Sciences); Young Talents Program of Chinese Academy of Agricultural Sciences; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank the Drug Supply Program of National Institute of Drug Abuse (Bethesda, MD, USA) for providing (-)-norbinaltorphimine. The authors also thank the Network and Coumputing Center, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, National Supercomputer Center of China in Guangzhou and the Computing Center of Jilin Province for the supply of computational resources. This work was supported by the National Key Research and Development Program of China (2016YFC0800907), the National Natural Science Foundation of China (21850410455, 21750110432, 21877106), the 100 Talents Program of Chinese Academy of Sciences, Young Talents Program of Chinese Academy of Agricultural Sciences, Central Public-interest Scientific Institution Basal Research Fund (NO. 1610342016013), Natural Science Foundation of Jilin Province (20180101021JC), Open Fund of State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University (Grant No. KF-GN-201601), and U.S. National Institutes of Health (NIH) National Institute of Dental and Craniofacial Research Grant R01 DE017782 (to L. R. W.). The authors declare no conflicts of interest.	Bachtell R, 2015, CNS NEUROL DISORD-DR, V14, P692, DOI 10.2174/1871527314666150529132503; BAXTER J, 1981, J OPER RES SOC, V32, P815, DOI 10.2307/2581397; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Blum C, 2008, STUD COMPUT INTELL, V114, P1, DOI 10.1007/978-3-540-78295-7; Coller JK, 2012, PHARMACOL THERAPEUT, V134, P219, DOI 10.1016/j.pharmthera.2012.01.008; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dennington R., 2009, GAUSSVIEW VERSION 5; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fu WT, 2016, DRUG DES DEV THER, V10, P455, DOI 10.2147/DDDT.S98466; Genheden S, 2015, EXPERT OPIN DRUG DIS, V10, P449, DOI 10.1517/17460441.2015.1032936; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Hutchinson MR, 2012, J NEUROSCI, V32, P11187, DOI 10.1523/JNEUROSCI.0684-12.2012; Hutchinson MR, 2010, BRAIN BEHAV IMMUN, V24, P83, DOI 10.1016/j.bbi.2009.08.004; Ikeda H, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-43; Jerala R, 2007, INT J MED MICROBIOL, V297, P353, DOI 10.1016/j.ijmm.2007.04.001; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lacagnina MJ, 2018, PHARMACOL THERAPEUT, V184, P145, DOI 10.1016/j.pharmthera.2017.10.006; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lewis SS, 2010, NEUROSCIENCE, V165, P569, DOI 10.1016/j.neuroscience.2009.10.011; Manning TJ, 1999, J NEUROSCI METH, V91, P73, DOI 10.1016/S0165-0270(99)00083-7; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; MIEHLICH B, 1989, CHEM PHYS LETT, V157, P200, DOI 10.1016/0009-2614(89)87234-3; Neumann H, 2013, NAT NEUROSCI, V16, P253, DOI 10.1038/nn.3338; Northcutt AL, 2015, MOL PSYCHIATR, V20, P1525, DOI 10.1038/mp.2014.177; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohto U, 2012, P NATL ACAD SCI USA, V109, P7421, DOI 10.1073/pnas.1201193109; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Peri F, 2012, BIOTECHNOL ADV, V30, P251, DOI 10.1016/j.biotechadv.2011.05.014; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PORTOGHESE PS, 1988, J MED CHEM, V31, P836, DOI 10.1021/jm00399a026; PORTOGHESE PS, 1988, J MED CHEM, V31, P1344, DOI 10.1021/jm00402a015; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Selfridge BR, 2015, J MED CHEM, V58, P5038, DOI 10.1021/acs.jmedchem.5b00426; Shah M, 2016, SCI REP-UK, V6, DOI 10.1038/srep39271; Spackova N, 2003, J AM CHEM SOC, V125, P1759, DOI 10.1021/ja025660d; Sun HY, 2014, PHYS CHEM CHEM PHYS, V16, P16719, DOI 10.1039/c4cp01388c; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Theberge FR, 2013, BIOL PSYCHIAT, V73, P729, DOI 10.1016/j.biopsych.2012.12.019; TORRIE GM, 1974, CHEM PHYS LETT, V28, P578, DOI 10.1016/0009-2614(74)80109-0; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang X, 2016, BRIT J PHARMACOL, V173, P856, DOI 10.1111/bph.13394; Wang X., 2014, MICROGLIA HLTH DIS, P299; Wang XH, 2013, FASEB J, V27, P2713, DOI 10.1096/fj.12-222992; Wang XH, 2013, CHEM SOC REV, V42, P4859, DOI 10.1039/c3cs60039d; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Wang Z, 2015, MOL BIOSYST, V11, P1933, DOI 10.1039/c5mb00085h; Watkins LR, 2009, TRENDS PHARMACOL SCI, V30, P581, DOI 10.1016/j.tips.2009.08.002; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Zhang T. S., 2016, PROG PHARM SCI, V39, P56; Zhang XZ, 2018, J CHEM INF MODEL, V58, P816, DOI 10.1021/acs.jcim.7b00717; [张晓铮 Zhang Xiaozheng], 2016, [应用化学, Chinese Journal of Applied Chemistry], V33, P876	58	11	12	3	33	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9577	9587		10.1096/fj.201900173RRR	http://dx.doi.org/10.1096/fj.201900173RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31162938	Green Published			2022-12-28	WOS:000478832900068
J	Zhang, YT; Zhang, CH; Zhang, H; Zeng, WW; Li, S; Chen, CP; Song, XB; Sun, J; Sun, ZY; Cui, CC; Cao, X; Zheng, LR; Wang, P; Zhao, W; Zhang, Z; Xu, Y; Zhu, MS; Chen, HQ				Zhang, Yiteng; Zhang, Chenghai; Zhang, He; Zeng, Weiwei; Li, Shuai; Chen, Caiping; Song, Xiaobin; Sun, Jie; Sun, Zhiyuan; Cui, Congcong; Cao, Xiang; Zheng, Lirong; Wang, Pei; Zhao, Wei; Zhang, Zhao; Xu, Yun; Zhu, Minsheng; Chen, Huaqun			ZIPK mediates endothelial cell contraction through myosin light chain phosphorylation and is required for ischemic-reperfusion injury	FASEB JOURNAL			English	Article						MLC phosphorylation; stroke; ischemia-reperfusion injury	SMOOTH-MUSCLE CONTRACTION; BLOOD-BRAIN-BARRIER; MOLECULAR-ORGANIZATION; ADHERENS JUNCTIONS; VE-CADHERIN; KINASE; MECHANISMS; STROKE; PERMEABILITY; PHOSPHATASE	The paracellular gap formed by endothelial cell (EC) contraction is fundamental for endothelium permeability, but the mechanism underlying EC contraction has yet to be determined. Here, we identified the zipper-interacting protein kinase (ZIPK) as the kinase for EC contraction and myosin light chain (MLC) phosphorylation. Inhibition of ZIPK activity by pharmacological inhibitors and small interfering RNAs led to a significant decrease in the mono- and diphosphorylation of MLCs along with a contractile response to thrombin, suggesting an essential role of ZIPK in EC paracellular permeability. To assess the role of ZIPK in vivo, we established mouse lines with conditional deletion of Zipk gene. The endothelium-specific deletion of Zipk led to embryonic lethality, whereas the UBC-Cre(ERT2)-mediated deletion of Zipk by tamoxifen induction at adulthood caused no apparent phenotype. The induced deletion of Zipk significantly inhibited ischemia-reperfusion-induced blood-brain barrier dysfunction and neuronal injuries from middle cerebral artery occlusion and reperfusion, as evidenced by reduced infarct and edema volume, attenuated Evans blue dye leakage, and improved neuronal behavior. We thus concluded that ZIPK and its phosphorylation of MLC were required for EC contraction and ischemic neuronal injuries. ZIPK may be a prospective therapeutic target for stroke.-Zhang, Y., Zhang, C., Zhang, H., Zeng, W., Li, S., Chen, C., Song, X., Sun, J., Sun, Z., Cui, C., Cao, X., Zheng, L., Wang, P., Zhao, W., Zhang, Z., Xu, Y., Zhu, M., Chen, H. ZIPK mediates endothelial cell contraction through myosin light chain phosphorylation and is required for ischemic-reperfusion injury.	[Zhang, Yiteng; Zeng, Weiwei; Li, Shuai; Song, Xiaobin; Sun, Zhiyuan; Cui, Congcong; Zheng, Lirong; Zhang, Zhao; Chen, Huaqun] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China; [Zhang, Chenghai; Chen, Caiping; Sun, Jie; Wang, Pei; Zhao, Wei; Zhu, Minsheng] Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Zhang, Chenghai; Chen, Caiping; Sun, Jie; Wang, Pei; Zhao, Wei; Zhu, Minsheng] Nanjing Univ, MOE, Key Lab Model Anim Dis Study, Nanjing, Jiangsu, Peoples R China; [Zhang, He; Cao, Xiang; Xu, Yun] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University; Nanjing University; Nanjing University; Nanjing University	Zhu, MS (corresponding author), Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China.; Chen, HQ (corresponding author), Nanjing Normal Univ, Coll Life Sci, 1 Wenyuan Rd, Nanjing 210023, Jiangsu, Peoples R China.	zhums@nju.edu.cn; chenhuaqun@njnu.edu.cn	Chen, Caiping/HII-8998-2022		National Natural Science Foundation of China (Beijing, China) [31371356, 30971540, 31330034]; Jiangsu Major Natural Science Foundation of Higher Education [13KJA180004]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China (Beijing, China)(National Natural Science Foundation of China (NSFC)); Jiangsu Major Natural Science Foundation of Higher Education; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	The authors thank Qianqian Zhang, Wen Yuan, and Tengxiang Ma (all from Nanjing Normal University, College of Life Sciences, Nanjing, China) for assistance in preparation of the revised version of this manuscript. The authors thank Dr. Jincai Luo from Peking University (Beijing, China) for providing primary HUVECs and Dr. Yin Lu from the Nanjing University of Chinese Medicine (Nanjing, China) for the transendothelial electrical resistance measurement of the endothelial cell monolayer. The study was supported by the National Natural Science Foundation of China (31371356, 30971540, and 31330034; Beijing, China), the Jiangsu Major Natural Science Foundation of Higher Education (13KJA180004), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The authors declare no conflicts of interest.	Al-Ghabkari A, 2016, SCI REP-UK, V6, DOI 10.1038/srep32118; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Borman MA, 2007, BIOCHEM CELL BIOL, V85, P111, DOI 10.1139/O06-209; Borovski T, 2009, INT J CANCER, V125, P1222, DOI 10.1002/ijc.24408; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chu J, 2012, NEUROGASTROENT MOTIL, V24, P257, DOI 10.1111/j.1365-2982.2011.01855.x; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; Fantin A, 2013, NAT PROTOC, V8, P418, DOI 10.1038/nprot.2013.015; Frasier CR, 2016, P NATL ACAD SCI USA, V113, P12838, DOI 10.1073/pnas.1612746113; Fujiwara N, 2016, J BIOL CHEM, V291, P10858, DOI 10.1074/jbc.M115.704908; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; Gautam N, 2001, NAT MED, V7, P1123, DOI 10.1038/nm1001-1123; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Hagerty L, 2007, J BIOL CHEM, V282, P4884, DOI 10.1074/jbc.M609990200; HARA H, 1990, J CEREBR BLOOD F MET, V10, P646, DOI 10.1038/jcbfm.1990.117; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; He WQ, 2011, AM J PHYSIOL-HEART C, V301, pH584, DOI 10.1152/ajpheart.01212.2010; Hirano M, 2016, SCI REP-UK, V6, DOI 10.1038/srep20989; Hosoba K, 2015, BIOCHEM BIOPH RES CO, V459, P686, DOI 10.1016/j.bbrc.2015.03.005; Huang JA, 2006, BIOCHEM J, V396, P193, DOI 10.1042/BJ20051772; Ihara E, 2009, AM J PHYSIOL-GASTR L, V297, pG361, DOI 10.1152/ajpgi.00112.2009; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kawai T, 1998, MOL CELL BIOL, V18, P1642, DOI 10.1128/MCB.18.3.1642; Kocher BA, 2015, MOL CANCER RES, V13, P358, DOI 10.1158/1541-7786.MCR-14-0333; Kom C, 2015, DEV CELL, V34, P5, DOI 10.1016/j.devcel.2015.06.004; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Komatsu S, 2004, J CELL BIOL, V165, P243, DOI 10.1083/jcb.200309056; LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; MacDonald JA, 2001, FEBS LETT, V493, P91, DOI 10.1016/S0014-5793(01)02277-3; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Mills JC, 1998, J CELL BIOL, V140, P627, DOI 10.1083/jcb.140.3.627; Monaghan-Benson E, 2011, METHODS MOL BIOL, V763, P281, DOI 10.1007/978-1-61779-191-8_19; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Mukhopadhyay R, 2008, MOL CELL, V32, P371, DOI 10.1016/j.molcel.2008.09.019; Murata-Hori M, 2001, ONCOGENE, V20, P8175, DOI 10.1038/sj.onc.1205055; Navone SE, 2013, NAT PROTOC, V8, P1680, DOI 10.1038/nprot.2013.107; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Niiro N, 2001, J BIOL CHEM, V276, P29567, DOI 10.1074/jbc.M102753200; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Opal SM, 2015, J INTERN MED, V277, P277, DOI 10.1111/joim.12331; Prabhakaran S, 2015, JAMA-J AM MED ASSOC, V313, P1451, DOI 10.1001/jama.2015.3058; Rosenberg GA, 1998, STROKE, V29, P2189, DOI 10.1161/01.STR.29.10.2189; Sato N, 2006, IMMUNOL LETT, V103, P127, DOI 10.1016/j.imlet.2005.10.015; Sato N, 2005, INT IMMUNOL, V17, P1543, DOI 10.1093/intimm/dxh331; Schaefer A, 2015, J CELL SCI, V128, P2221, DOI 10.1242/jcs.163055; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; SCHNITTLER HJ, 1990, J PHYSIOL-LONDON, V431, P379, DOI 10.1113/jphysiol.1990.sp018335; Shi YJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10523; Shinde AV, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003425; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Stockton RA, 2004, J BIOL CHEM, V279, P46621, DOI 10.1074/jbc.M408877200; Stolwijk JA, 2016, J BIOL CHEM, V291, P22894, DOI 10.1074/jbc.M116.756114; Sukriti S, 2014, PULM CIRC, V4, P535, DOI 10.1086/677356; Tinsley JH, 2000, AM J PHYSIOL-CELL PH, V279, pC1285, DOI 10.1152/ajpcell.2000.279.4.C1285; Van Hinsbergh VWM, 2015, CARDIOVASC RES, V107, P400, DOI 10.1093/cvr/cvv194; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Xie ZH, 2012, BLOOD, V119, P4321, DOI 10.1182/blood-2011-08-375816; Yu Y, 2012, FEBS J, V279, P1485, DOI 10.1111/j.1742-4658.2012.08541.x; Yuan SY, 2002, CIRC RES, V90, P1214, DOI 10.1161/01.RES.0000020402.73609.F1; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	69	10	10	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9062	9074		10.1096/fj.201802052RRR	http://dx.doi.org/10.1096/fj.201802052RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31180722	Green Published			2022-12-28	WOS:000478832900030
J	Li, ZX; Shi, XJ; Liu, JB; Shao, F; Huang, G; Zhou, ZG; Zheng, PL				Li, Zhixia; Shi, Xiajie; Liu, Junbin; Shao, Feng; Huang, Gan; Zhou, Zhiguang; Zheng, Peilin			Artesunate prevents type 1 diabetes in NOD mice mainly by inducing protective IL-4-producing T cells and regulatory T cells	FASEB JOURNAL			English	Article						Chinese traditional medicine; autoimmunity; beta cells	ANTIMALARIAL-DRUG; QINGHAOSU ARTEMISININ; EXPRESSION; ONSET; MAINTENANCE; ISLETS; CANCER; MODEL; VITRO	Type 1 diabetes (T1D) is an autoimmune disease characterized by the immune-mediated destruction of insulin-producing beta cells. Recent studies showed that in addition to malaria, artemisinin and its derivative, artesunate (AS), could alleviate several autoimmune diseases. However, whether AS has a role in the prevention or treatment of T1D is still unknown. Therefore, in this study we administrated AS or DMSO in the drinking water of nonobese diabetic (NOD) mice, a mouse model of T1D. We found that AS administration significantly prevented the incidence of T1D. The frequency of IL-4-producing CD4(+) single-positive T cells and CD8(+) T cells was significantly elevated, and IFN-gamma-producing T cells were reduced in the spleen and pancreatic lymph nodes. In the pancreas, the skewing to IL-4-producing T cells was also observed. In addition, more regulatory T cells were found in the pancreas. mRNA levels of proinflammatory cytokines, including TNF-alpha and IL-6, were decreased. In addition, AS administration promoted the functional maturity of beta cells in vitro. Our findings demonstrate that AS administration can prevent T1D in NOD mice mainly by reducing autoimmune T cells and increasing protective T cells. Our data constitute the first functional study of AS in T1D, which may provide a new rationale for future translational studies.-Li, Z., Shi, X., Liu, J., Shao, F., Huang, G., Zhou, Z., Zheng, P. Artesunate prevents type 1 diabetes in NOD mice mainly by inducing protective IL-4-producing T cells and regulatory T cells.	[Li, Zhixia; Shi, Xiajie; Liu, Junbin; Shao, Feng; Huang, Gan; Zhou, Zhiguang; Zheng, Peilin] Second Xiangya Hosp, Dept Metab & Endocrinol, Changsha, Hunan, Peoples R China; [Li, Zhixia; Shi, Xiajie; Liu, Junbin; Shao, Feng; Huang, Gan; Zhou, Zhiguang; Zheng, Peilin] Cent S Univ, Natl Clin Res Ctr Metab Dis, Key Lab Diabet Immunol, Minist Educ, Changsha, Hunan, Peoples R China; [Zheng, Peilin] Jinan Univ, Dept Endocrinol, Shenzhen Peoples Hosp, Affiliated Hosp 1,Southern Univ Sci & Technol,Cli, Shenzhen, Peoples R China	Central South University; Jinan University; Southern University of Science & Technology	Zhou, ZG; Zheng, PL (corresponding author), Cent S Univ, Dept Metab & Endocrinol, Xiangya Hosp 2, 139 Rennin Middle Rd, Changsha 410011, Hunan, Peoples R China.	zhouzhiguang@csu.edu.cn; peilinz@csu.edu.cn	Zheng, Peilin/B-4360-2015	Zheng, Peilin/0000-0002-4712-4903	National Natural Science Foundation of China [81670716, 81500600]; Hunan Science Fund for Excellent Young Scholars [2019JJ30036]; Graduate Innovation Project of Central South University [502211703, 2018zzts921]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Science Fund for Excellent Young Scholars; Graduate Innovation Project of Central South University	The authors thank Stephan Kissler (Joslin Diabetes Center, Harvard Medical School) for helpful discussion and editing the manuscript. This work is supported by the National Natural Science Foundation of China (Grants 81670716, 81500600), Hunan Science Fund for Excellent Young Scholars (Grant 2019JJ30036), and the Graduate Innovation Project of Central South University (Grants 502211703, 2018zzts921). The authors declare no conflicts of interest.	Ackermann AM, 2018, CELL METAB, V28, P787, DOI 10.1016/j.cmet.2018.07.002; Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; CAMPBELL IL, 1991, J CLIN INVEST, V87, P739, DOI 10.1172/JCI115055; Cheng C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020932; Cui C, 2015, INT IMMUNOPHARMACOL, V27, P110, DOI 10.1016/j.intimp.2015.05.004; Da Rosa LC, 2018, DIABETOLOGIA, V61, P1397, DOI 10.1007/s00125-018-4597-z; De Vas MG, 2015, DEVELOPMENT, V142, P871, DOI 10.1242/dev.110759; DEBRAYSACHS M, 1991, J AUTOIMMUN, V4, P237, DOI 10.1016/0896-8411(91)90021-4; Gao T, 2014, CELL METAB, V19, P259, DOI 10.1016/j.cmet.2013.12.002; Green EA, 2003, P NATL ACAD SCI USA, V100, P10878, DOI 10.1073/pnas.1834400100; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; He XY, 2018, DIABETOLOGIA, V61, P881, DOI 10.1007/s00125-017-4523-9; Ho WE, 2012, FREE RADICAL BIO MED, V53, P498, DOI 10.1016/j.freeradbiomed.2012.05.021; Hou LF, 2011, ARTHRITIS RHEUM-US, V63, P2445, DOI 10.1002/art.30392; Hou LF, 2009, INT IMMUNOPHARMACOL, V9, P1509, DOI 10.1016/j.intimp.2009.09.003; Hou LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104762; Jin OY, 2009, CELL MOL IMMUNOL, V6, P461, DOI 10.1038/cmi.2009.58; Joseph J, 2012, J IMMUNOL, V188, P216, DOI 10.4049/jimmunol.1101215; KATZ JD, 1995, SCIENCE, V268, P1185, DOI 10.1126/science.7761837; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; Li J, 2017, CELL, V168, P86, DOI 10.1016/j.cell.2016.11.010; Li X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074108; Li Y, 2003, CURR MED CHEM, V10, P2197, DOI 10.2174/0929867033456710; Marwaha AK, 2010, J IMMUNOL, V185, P3814, DOI 10.4049/jimmunol.1001860; Mueller R, 1996, J EXP MED, V184, P1093, DOI 10.1084/jem.184.3.1093; Nishimura W, 2015, DIABETOLOGIA, V58, P566, DOI 10.1007/s00125-014-3464-9; Ogura H, 2018, J IMMUNOL, V201, P1662, DOI 10.4049/jimmunol.1800267; RABINOVITCH A, 1994, DIABETES, V43, P613, DOI 10.2337/diabetes.43.5.613; RAPOPORT MJ, 1993, J EXP MED, V178, P87, DOI 10.1084/jem.178.1.87; SARVETNICK N, 1988, CELL, V52, P773, DOI 10.1016/0092-8674(88)90414-X; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Szot Gregory L, 2007, J Vis Exp, P255, DOI 10.3791/255; Tai NW, 2016, J EXP MED, V213, P2129, DOI 10.1084/jem.20160526; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Thome R, 2016, CNS NEUROSCI THER, V22, P707, DOI 10.1111/cns.12561; Tu YY, 2011, NAT MED, V17, P1217, DOI 10.1038/nm.2471; van der Meulen T, 2018, CELL METAB, V27, P218, DOI 10.1016/j.cmet.2017.10.002; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; Walker LSK, 2016, CLIN EXP IMMUNOL, V183, P16, DOI 10.1111/cei.12672; Wang JX, 2008, BRIT J PHARMACOL, V153, P1303, DOI 10.1038/bjp.2008.11; Wong FS, 1996, J EXP MED, V183, P67, DOI 10.1084/jem.183.1.67; Yang Z, 2012, CURR MED CHEM, V19, P4541, DOI 10.2174/092986712803251575; Zhang LX, 2014, CELL BIOL INT, V38, P639, DOI 10.1002/cbin.10244; Zhang XN, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035700, 10.1371/journal.pone.0035991]; Zheng PL, 2018, DIABETES-METAB RES, V34, DOI 10.1002/dmrr.3043; Zheng PL, 2013, DIABETES, V62, P896, DOI 10.2337/db12-0929	46	19	23	2	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8241	8248		10.1096/fj.201900146R	http://dx.doi.org/10.1096/fj.201900146R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30916998				2022-12-28	WOS:000476234700036
J	Eiraku, N; Chiba, N; Nakamura, T; Amir, MS; Seong, CH; Ohnishi, T; Kusuyama, J; Noguchi, K; Matsuguchi, T				Eiraku, Nahoko; Chiba, Norika; Nakamura, Toshiaki; Amir, Muhammad Subhan; Seong, Chang-Hwan; Ohnishi, Tomokazu; Kusuyama, Joji; Noguchi, Kazuyuki; Matsuguchi, Tetsuya			BMP9 directly induces rapid GSK3-beta phosphorylation in a Wnt-independent manner through class I PI3K-Akt axis in osteoblasts	FASEB JOURNAL			English	Article						endoglin; osteoblast differentiation; GIPC1	ALKALINE-PHOSPHATASE EXPRESSION; BONE MORPHOGENETIC PROTEINS; CELL-DIFFERENTIATION; ENDOGLIN; ALK1; MINERALIZATION	Bone morphogenetic protein (BMP)9 has been reported to be the most potent BMP to induce bone formation. However, the details of BMP9-transduced intracellular signaling remain ambiguous. Here, we have investigated signal transduction mechanisms of BMP9 in comparison to BMP2, another potent inducer of bone formation, in osteoblasts. In a mouse osteoblast cell line, BMP9 induced higher mRNA levels of alkaline phosphatase (ALP) and runt-related transcription factor 2 (Runx2) than BMP2 within 2 h. Unlike BMP2, BMP9 induced rapid phosphorylation of glycogen synthase kinase 3-beta (GSK3-beta) and protein kinase B (Akt) and increased the cellular protein content of beta-catenin. BMP9 moderately increased mRNA levels of several canonical Wingless-related integration site to lower degrees than BMP2. Furthermore, BMP9-induced GSK3-beta phosphorylation was not inhibited by pretreatment with actinomycin D, cycloheximide, or Brefeldin A, indicating it is independent of Wnt protein secretion. BMP9-induced GSK3-beta phosphorylation was abrogated by Akt or class I PI3K-specific inhibitors. Moreover, inactivation of GSK3-beta by LiCl did not further promote ALP and Runx2 mRNA induction by BMP9 as significantly as that by BMP2. Notably, BMP9-induced GSK3-beta phosphorylation was inhibited by small interfering RNA against endoglin and GIPC PDZ domain-containing family, member 1. Taken together, our present findings have indicated that BMP9 directly activates GSK3-beta-catenin signaling pathway through class I PI3K-Akt Axis in osteoblasts, which may be essential for the potent osteoinductive activity of BMP9.	[Eiraku, Nahoko; Nakamura, Toshiaki; Noguchi, Kazuyuki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Periodontol, Kagoshima, Japan; [Chiba, Norika; Ohnishi, Tomokazu; Kusuyama, Joji; Matsuguchi, Tetsuya] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral Biochem, Kagoshima, Japan; [Amir, Muhammad Subhan; Seong, Chang-Hwan] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral & Maxillofacial Surg, Kagoshima, Japan	Kagoshima University; Kagoshima University; Kagoshima University	Matsuguchi, T (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Field Dev Med, Dept Oral Biochem, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	tmatsugu@dent.kagoshima-u.ac.jp	Kusuyama, Joji/AAQ-7547-2020; Matsuguchi, Tetsuya/HGU-0412-2022; Amir, Muhammad Subhan/AAD-3006-2021	Amir, Muhammad Subhan/0000-0002-0522-9758; Kusuyama, Joji/0000-0003-4054-1939	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors declare no conflicts of interest.	Bergeron E, 2009, TISSUE ENG PT A, V15, P3341, DOI 10.1089/ten.TEA.2009.0189; Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74; Bidart M, 2012, CELL MOL LIFE SCI, V69, P313, DOI 10.1007/s00018-011-0751-1; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Brazil DP, 2015, TRENDS CELL BIOL, V25, P249, DOI 10.1016/j.tcb.2014.12.004; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Fujioka-Kobayashi M, 2017, CLIN ORAL IMPLAN RES, V28, P381, DOI 10.1111/clr.12804; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hamidouche Z, 2008, FASEB J, V22, P3813, DOI 10.1096/fj.08-106302; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Lamplot JD, 2013, AM J STEM CELLS, V2, P1; Lane JM, 2005, J ORTHOP TRAUMA, V19, pS17, DOI 10.1097/00005131-200511101-00006; Leblanc E, 2011, J BONE MINER RES, V26, P1166, DOI 10.1002/jbmr.311; Lee NY, 2012, MOL BIOL CELL, V23, P2412, DOI 10.1091/mbc.E11-12-0993; Luo JY, 2010, J BIOL CHEM, V285, P29588, DOI 10.1074/jbc.M110.130518; Matsuguchi T, 2009, J BONE MINER RES, V24, P398, DOI 10.1359/JBMR.081107; Matsuzaki E, 2006, J BONE MINER RES, V21, P1307, DOI 10.1359/JBMR.060512; Poniatowski LA, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/137823; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Saito T, 2017, CELL REP, V19, P1917, DOI 10.1016/j.celrep.2017.05.011; Salie R, 2010, BONE, V46, P680, DOI 10.1016/j.bone.2009.10.022; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Townson SA, 2012, J BIOL CHEM, V287, P27313, DOI 10.1074/jbc.M112.377960; Weber D, 2014, CURR TOP DEV BIOL, V110, P285, DOI 10.1016/B978-0-12-405943-6.00008-7; WHYTE MP, 1994, ENDOCR REV, V15, P439, DOI 10.1210/er.15.4.439; Yano M, 2012, ENDOCR J, V59, P653, DOI 10.1507/endocrj.EJ12-0022	32	15	16	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12124	12134		10.1096/fj.201900733RR	http://dx.doi.org/10.1096/fj.201900733RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31365832	Green Published			2022-12-28	WOS:000507461600041
J	Moghadamrad, S; Hassan, M; McCoy, KD; Kirundi, J; Kellmann, P; De Gottardi, A				Moghadamrad, Sheida; Hassan, Mohsin; McCoy, Kathy D.; Kirundi, Jorum; Kellmann, Philipp; De Gottardi, Andrea			Attenuated fibrosis in specific pathogen-free microbiota in experimental cholestasis- and toxin-induced liver injury	FASEB JOURNAL			English	Article						altered Schaedler flora; portal hypertension; bile duct ligation; alpha-SMA; carbon tetrachloride	OBSTRUCTIVE CHOLESTASIS; BACTERIAL TRANSLOCATION; INTESTINAL MICROBIOME; GUT MICROBIOME; STELLATE CELLS; OSTEOPONTIN; DISEASE; MUCIN; NEUTROPHILS; EXPRESSION	In advanced chronic liver disease (CLD), the translocation of intestinal bacteria and the resultant increase of proinflammatory cytokines in the splanchnic and systemic circulation may contribute to the progression of fibrosis. We therefore speculated that fibrosis and portal hypertension (PHT) would be attenuated in a mouse model of limited intestinal colonization with altered Schaedler flora (ASF) compared to a more complex colonization with specific pathogen-free (SPF) flora. We induced liver fibrosis in ASF and SPF mice by common bile duct ligation (BDL) or by carbon tetrachloride (CCl4) treatment. We then measured portal pressure (PP), portosystemic shunts (PSSs), and harvested tissues for further analyses. There were no differences in PP between sham-treated ASF or SPF mice. After BDL or CCl4 treatment, PP, PSSs, and hepatic collagen deposition increased in both groups. However, the increase in PP and the degree of fibrosis was significantly higher in ASF than SPF mice. Expression of fibrotic markers alpha-smooth muscle actin, desmin, and platelet-derived growth factor receptor beta were significantly higher in ASF than SPF mice. This was associated with higher activation of hepatic immune cells (macrophages, neutrophils) and decreased expression of the intestinal epithelial tight junction proteins (claudin-1, occludin-1). In 2 models of advanced CLD, SPF mice presented significantly attenuated liver injury, fibrosis, and PHT compared to ASF mice. In contrast to our hypothesis, these findings suggest that a complex intestinal microbiota may play a "hepato-protective" role.	[Moghadamrad, Sheida; Hassan, Mohsin; Kellmann, Philipp; De Gottardi, Andrea] Univ Bern, Dept Biomed Res, Hepatol, Murtenstr 35, Bern, Switzerland; [McCoy, Kathy D.; Kirundi, Jorum] Univ Bern, Dept Biomed Res, Gastroenterol, Bern, Switzerland; [Moghadamrad, Sheida; De Gottardi, Andrea] Inselspital Bern, Clin Visceral Surg & Med, Bern, Switzerland; [McCoy, Kathy D.] Univ Calgary, Cumming Sch Med, Dept Physiol & Pharmacol, Calgary, AB, Canada	University of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Calgary	Moghadamrad, S; De Gottardi, A (corresponding author), Univ Bern, Dept Biomed Res, Hepatol, Murtenstr 35, Bern, Switzerland.; Moghadamrad, S; De Gottardi, A (corresponding author), Univ Bern, Clin Visceral Surg & Med, Murtenstr 35, CH-3008 Bern, Switzerland.	sheida.moghadamrad@dbmr.unibe.ch; andrea.degottardi@insel.ch	McCoy, Kathy/ABD-5814-2021; Moghadamrad, Sheida/AAV-5199-2021	Moghadamrad, Sheida/0000-0001-7322-4759; Kirundi, Jorum/0000-0001-9617-0634	Novartis Foundation for Medical-Biological Research [10A19]; Swiss National Science Foundation [31003A_129842]	Novartis Foundation for Medical-Biological Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors thank Dr. Deborah Stroka and Felix Baier (Department for Biomedical Research, University of Berne), for help in total bile acids measurement, and the staff from the Clean Mouse Facility of the University of Bern for help during experiments with ASF mice. This work was supported by a grant from the Novartis Foundation for Medical-Biological Research (Project 10A19) and from the Swiss National Science Foundation (Grant 31003A_129842 to A.D.G.). The authors declare no conflicts of interest.	Albillos A, 2014, J HEPATOL, V61, P1385, DOI 10.1016/j.jhep.2014.08.010; [Anonymous], 2018, GUT; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Assimakopoulos SF, 2007, WORLD J GASTROENTERO, V13, P6458, DOI 10.3748/wjg.13.6458; Bosch J, 2015, J HEPATOL, V62, pS121, DOI 10.1016/j.jhep.2015.01.003; Cacopardo B, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.7611; Fickert P, 2010, LAB INVEST, V90, P844, DOI 10.1038/labinvest.2010.61; Fouts DE, 2012, J HEPATOL, V56, P1283, DOI 10.1016/j.jhep.2012.01.019; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Georgiev P, 2008, BRIT J SURG, V95, P646, DOI 10.1002/bjs.6050; GROSZMANN RJ, 1982, AM J PHYSIOL, V242, pG156, DOI 10.1152/ajpgi.1982.242.2.G156; Gujral JS, 2003, HEPATOLOGY, V38, P355, DOI 10.1053/jhep.2003.50341; Kawashima R, 1999, BIOCHEM BIOPH RES CO, V256, P527, DOI 10.1006/bbrc.1999.0372; Li H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9292; LIN RS, 1995, J HEPATOL, V22, P165, DOI 10.1016/0168-8278(95)80424-2; Lorena D, 2006, J HEPATOL, V44, P383, DOI 10.1016/j.jhep.2005.07.024; Macpherson AJ, 2016, CELL HOST MICROBE, V20, P561, DOI 10.1016/j.chom.2016.10.016; Mazagova M, 2015, FASEB J, V29, P1043, DOI 10.1096/fj.14-259515; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; Mcguckin MA, 2007, GASTROENTEROLOGY, V133, P1210, DOI 10.1053/j.gastro.2007.07.003; Nishida A, 2012, GASTROENTEROLOGY, V142, P865, DOI 10.1053/j.gastro.2011.12.036; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Riva A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00167; Rosshart SP, 2017, CELL, V171, P1015, DOI 10.1016/j.cell.2017.09.016; Sato A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114065; Sato A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092515; SCHAEDLER RW, 1965, J EXP MED, V122, P59, DOI 10.1084/jem.122.1.59; Schnabl B, 2014, GASTROENTEROLOGY, V146, P1513, DOI 10.1053/j.gastro.2014.01.020; Schon Hans-Theo, 2014, Hepatobiliary Surg Nutr, V3, P386, DOI 10.3978/j.issn.2304-3881.2014.11.06; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Tabibian JH, 2016, HEPATOLOGY, V63, P185, DOI 10.1002/hep.27927; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Tilg H, 2016, GUT, V65, P2035, DOI 10.1136/gutjnl-2016-312729; Wang B, 2009, J HEPATOL, V51, P1037, DOI 10.1016/j.jhep.2009.06.020; Wiest R, 2017, J HEPATOL, V67, P1084, DOI 10.1016/j.jhep.2017.05.007; Wiest R, 2014, J HEPATOL, V60, P197, DOI 10.1016/j.jhep.2013.07.044; Xu RN, 2014, CELL MOL IMMUNOL, V11, P224, DOI 10.1038/cmi.2014.2; Yang M, 2014, TOXICOL LETT, V224, P186, DOI 10.1016/j.toxlet.2013.10.030	40	11	11	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12464	12476		10.1096/fj.201901113R	http://dx.doi.org/10.1096/fj.201901113R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31431085	Green Published			2022-12-28	WOS:000507461600067
J	Ni, SS; Zhou, Y; Chen, Y; Du, XY; Zhang, SC				Ni, Shousheng; Zhou, Yang; Chen, Yan; Du, Xiaoyuan; Zhang, Shicui			Identification of ATP synthase alpha subunit as a new maternal factor capable of protecting zebrafish embryos from bacterial infection	FASEB JOURNAL			English	Article						Danio rerio; maternal immunity; antibacterial activity; depolarization; permeabilization	ZINC-FINGER PROTEIN; GENE-EXPRESSION; BINDING PROTEIN; HYBRIDIZATION; PROGRESSION; RESOLUTION; MECHANISM; SUGGESTS; COMPLEX	Previous studies have shown that ATP synthase alpha subunit (ATP5A1) plays multiple roles, but our understanding of its biologic functions remains poor and incomprehensive. Here, we clearly demonstrated that zebrafish ATP5A1 was a newly characterized lipoteichoic acid (LTA)- and LPS-binding protein abundantly stored in the eggs and embryos of zebrafish. Zebrafish ATP5A1 acted not only as a pattern recognition receptor, capable of identifying LTA and LPS, but also as an effector molecule, capable of inhibiting the growth of both gram-positive and -negative bacteria. ATP5A1 could disrupt the bacterial membranes by a combined action of membrane depolarization and permeabilization. We also found that the N-terminal 65 residues were critical for the antibacterial activity of zebrafish ATP5A1. In particular, we showed that microinjection of exogenous recombinant (r)ATP5A1 into early embryos could promote their resistance against pathogenic Aeromonas hydrophila challenge, and this pathogen-resistant activity was markedly reduced by the coinjection of anti-ATP5A1 antibody or by the knockdown with morpholino for atp5a1 but not by the coinjection of anti-actin antibody. Moreover, each egg/embryo contains a sufficient amount of ATP5A1 in vivo to kill A. hydrophila. Furthermore, the N-terminal 65 residues 1-65 of ATP5A1 alpha subunit (rA(1-)(65)) with in vitro antibacterial activity also promoted the resistance of embryos against A. hydrophila, but the N-terminal 69 residues 66-134 (rA(66)(-)(134)) or C-terminal residues 135-551 (rA(135)(-)(551)) of ATP5A1 alpha subunit without in vitro antibacterial activity did not. Finally, we showed that the antibacterial activity of the N-terminal 65 residues of ATP5A1 alpha subunit was conserved throughout animal evolution. Collectively, these results indicate that ATP5A1 is a novel maternal immunocompetent factor that can protect the early embryos of zebrafish from bacterial infection. This work also provides a new viewpoint for understanding the biologic roles of ATP5A1, which is ubiquitously present in animals.	[Ni, Shousheng; Zhou, Yang; Chen, Yan; Zhang, Shicui] Ocean Univ China, Inst Evolut & Marine Biodivers, Dept Marine Biol, Qingdao, Peoples R China; [Du, Xiaoyuan] State Ocean Adm, North China Sea Environm Monitoring Ctr, Qingdao, Peoples R China; [Zhang, Shicui] Pilot Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China	Ocean University of China; State Oceanic Administration; Qingdao National Laboratory for Marine Science & Technology	Zhang, SC (corresponding author), Ocean Univ China, Dept Marine Biol, 5 Yushan Rd, Qingdao 266003, Peoples R China.	sczhang@ouc.edu.cn			Ministry of Science and Technology (MOST) of China [2018YFD0900505]; Fundamental Research Funds for the Central Universities [201562029, 201861022]	Ministry of Science and Technology (MOST) of China(Ministry of Science and Technology, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors are grateful to Dr. Bo Dong (Institute of Evolution and Marine Biodiversity, Ocean University of China) for the gift of ascidian cDNAs. This work was supported by the Ministry of Science and Technology (MOST) of China (2018YFD0900505) and the Fundamental Research Funds for the Central Universities (201562029 and 201861022). The authors declare no conflicts of interest.	AKIYAMA S, 1994, BBA-GENE STRUCT EXPR, V1219, P129, DOI 10.1016/0167-4781(94)90255-0; Artuso L, 2012, BBA-BIOENERGETICS, V1817, P1002, DOI 10.1016/j.bbabio.2012.03.019; AVNI A, 1991, J BIOL CHEM, V266, P7317; Baran AA, 2007, GENOME RES, V17, P566, DOI 10.1101/gr.6089707; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; CHEN XJ, 1995, EMBO J, V14, P3277, DOI 10.1002/j.1460-2075.1995.tb07331.x; Das N, 2015, FREE RADICAL RES, V49, P954, DOI 10.3109/10715762.2015.1017477; Du XY, 2018, FASEB J, V32, P979, DOI 10.1096/fj.201700694R; Feng J, 2008, J GERONTOL A-BIOL, V63, P1137, DOI 10.1093/gerona/63.11.1137; Gao Z, 2014, EUR J IMMUNOL, V44, P3680, DOI 10.1002/eji.201444734; Ginsburg I, 2002, LANCET INFECT DIS, V2, P171, DOI 10.1016/S1473-3099(02)00226-8; Godbout R, 1997, CYTOGENET CELL GENET, V77, P253, DOI 10.1159/000134588; Ishii H, 2012, DEV GROWTH DIFFER, V54, P753, DOI 10.1111/dgd.12003; Jonckheere AI, 2013, BRAIN, V136, P1544, DOI 10.1093/brain/awt086; Li ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001940; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez-Cruz O, 2011, J BIOENERG BIOMEMBR, V43, P119, DOI 10.1007/s10863-011-9340-0; Minoda Y, 2006, BIOCHEM BIOPH RES CO, V344, P1023, DOI 10.1016/j.bbrc.2006.04.006; NELSON N, 1973, J BIOL CHEM, V248, P2049; Neupane Prashant, 2019, BioMolecular Concepts, V10, P1, DOI 10.1515/bmc-2019-0001; Okuno D, 2011, J BIOCHEM, V149, P655, DOI 10.1093/jb/mvr049; Reed TT, 2009, BRAIN RES, V1274, P66, DOI 10.1016/j.brainres.2009.04.009; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; Sergeant N, 2003, NEUROSCIENCE, V117, P293, DOI 10.1016/S0306-4522(02)00747-9; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Wang X, 2016, J BIOL CHEM, V291, P4019, DOI 10.1074/jbc.M115.679167; Wang ZP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004498; Xu GY, 2016, J NEURO-ONCOL, V126, P405, DOI 10.1007/s11060-015-1984-x; YOTOV WV, 1993, BIOCHEM BIOPH RES CO, V191, P142, DOI 10.1006/bbrc.1993.1195; YUAN HB, 1992, J BIOL CHEM, V267, P14697; Yuan LS, 2018, ONCOL REP, V39, P525, DOI 10.3892/or.2017.6132	32	11	11	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12983	13001		10.1096/fj.201901290R	http://dx.doi.org/10.1096/fj.201901290R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31518507	Green Published			2022-12-28	WOS:000507461600106
J	Chen, WY; Peng, R; Sun, Y; Liu, HD; Zhang, LY; Peng, HM; Zhang, Z				Chen, Wenyun; Peng, Rui; Sun, Yan; Liu, Handeng; Zhang, Luyu; Peng, Huimin; Zhang, Zheng			The topological key lncRNA H2k2 from the ceRNA network promotes mesangial cell proliferation in diabetic nephropathy via the miR-449a/b/Trim11/Mek signaling pathway	FASEB JOURNAL			English	Article						miRNA; bioinformatics; MCs; DN	EXTRACELLULAR-MATRIX ACCUMULATION; ENDOGENOUS RNA NETWORK; TRIM PROTEINS; BIOMARKERS; FIBROSIS; IDENTIFICATION; INHIBITION; MIGRATION; U0126; MIRNA	Evidence has shown that long noncoding RNAs (lncRNAs) in the competing endogenous RNA (ceRNA) network are involved in various diseases. However, there is a lack of studies of the ceRNA network in diabetic nephropathy (DN). In this study, we investigated the effect of lncRNAs on mesangial cell (MC) proliferation in DN-related ceRNA networks. Differences in lncRNA and mRNA expression between DN and normal mouse kidney tissues were detected with RNA-seq, and DN-related lncRNA/mRNA/microRNA (miRNA) ceRNA networks were constructed by R3.4.3. Computational analysis was performed, and expression and interactions between the topological RNAs were detected by bioinformatics methods, real-time quantitative PCR (qPCR), and luciferase assay. Cell proliferation ability was measured by 5-ethynyl-2'-deoxyuridine (EdU) in MCs cultured under high- or low-glucose conditions. Moreover, the effect of the topological key lncRNA histocompatibility 2 K region locus 2 (H2k2) H2k2 on MC proliferation via the miRNA (miR)-449a/b/triplet motif 11 (Trim11)/Mek signaling pathway was examined by EdU, flow cytometry analysis, and Western blot. In total, 153 lncRNAs, 428 mRNAs, and 2242 interactions were included in the constructed DN-related ceRNA network. There were 15 RNAs in the top 5% of degree and betweenness. The expression of lncRNA H2k2 and mRNA Trim11 in MCs was increased in DN, which is consistent with the results of RNA-seq and real-time qPCR in vivo and in vitro. miR-449a and miR-449b, which were down-regulated in MCs cultured with high glucose, were selected for further analysis. The results of real-time qPCR and luciferase assay revealed the lncRNA H2k2-miR-449a/b-Trim11 interaction in MCs. In addition, the data showed that H2k2 regulates MC proliferation via the miR-449ab/Trim11/Mek signaling pathway. Taken together, these results provide new insight into the association between the topological key lncRNA H2k2 in the DN-related ceRNA network and the miR-449a/b/Trim11/Mek signaling pathway during MC proliferation in DN.-Chen, W., Peng, R., Sun, Y., Liu, H., Zhang, L., Peng, H., Zhang, Z. The topological key lncRNA H2k2 from the ceRNA network promotes mesangial cell proliferation in diabetic nephropathy via the miR-449a/b/Trim11/Mek signaling pathway.	[Chen, Wenyun; Sun, Yan; Liu, Handeng; Zhang, Luyu; Peng, Huimin; Zhang, Zheng] Chongqing Med Univ, Mol Med & Canc Res Ctr, 1 Med Coll Rd, Chongqing 400016, Peoples R China; [Peng, Rui] Chongqing Med Univ, Dept Bioinformat, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Zhang, Z (corresponding author), Chongqing Med Univ, Mol Med & Canc Res Ctr, 1 Med Coll Rd, Chongqing 400016, Peoples R China.	zhangzheng@cqmu.edu.cn	zhang, zheng/AAG-9966-2020		National Natural Science Foundations of China [81570747, 81770811]; Natural Science Foundation of Chongqing [cstc2018jcy-jAX0244]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing)	This study was supported by the National Natural Science Foundations of China (81570747 and 81770811) and the Natural Science Foundation of Chongqing (cstc2018jcy-jAX0244). W. C. and R. P. are cofirst authors. The authors declare no conflicts of interest.	Alvarez ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077468; Bai XY, 2018, ANTIOXID REDOX SIGN, V29, P355, DOI 10.1089/ars.2017.7278; Cove-Smith A, 2008, NEPHRON EXP NEPHROL, V108, pE74, DOI 10.1159/000127359; Di K, 2013, ONCOGENE, V32, P5038, DOI 10.1038/onc.2012.531; Duan LJ, 2017, BIOCHEM BIOPH RES CO, V484, P598, DOI 10.1016/j.bbrc.2017.01.145; Fan QW, 2018, ONCOTARGETS THER, V11, P2453, DOI 10.2147/OTT.S158309; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Gao XR, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20181441; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hanson RL, 2007, DIABETES, V56, P975, DOI 10.2337/db06-1072; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Ikari A, 2010, LIFE SCI, V86, P766, DOI 10.1016/j.lfs.2010.03.016; Ikeda K, 2012, ADV EXP MED BIOL, V770, P27; Jiang H, 2018, CANCER LETT, V425, P78, DOI 10.1016/j.canlet.2018.03.038; Li AL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0527-8; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Li X, 2017, EXP CELL RES, V350, P327, DOI 10.1016/j.yexcr.2016.12.006; Ling L, 2018, INT J MOL MED, V41, P2704, DOI 10.3892/ijmm.2018.3457; Liu JJ, 2018, INT CONF MEAS, P1, DOI 10.1109/ICMTMA.2018.00008; Liu JJ, 2017, CELL PHYSIOL BIOCHEM, V44, P255, DOI 10.1159/000484678; Ma YL, 2018, BIOMED PHARMACOTHER, V98, P18, DOI 10.1016/j.biopha.2017.12.032; Matoba K, 2013, KIDNEY INT, V84, P545, DOI 10.1038/ki.2013.130; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Ong QX, 2015, ACS CHEM NEUROSCI, V6, P130, DOI 10.1021/cn500288n; Papadopoulou-Marketou N, 2017, CRIT REV CL LAB SCI, V54, P326, DOI 10.1080/10408363.2017.1377682; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sandbothe M, 2017, J HEPATOL, V66, P1012, DOI 10.1016/j.jhep.2017.01.004; Shang J, 2017, BIOCHEM BIOPH RES CO, V484, P435, DOI 10.1016/j.bbrc.2017.01.155; Shao TT, 2015, MOL BIOSYST, V11, P3048, DOI 10.1039/c5mb00364d; Smutny T, 2014, ARCH TOXICOL, V88, P2243, DOI 10.1007/s00204-014-1254-2; Sun SF, 2018, DIABETES, V67, P731, DOI 10.2337/db17-0816; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Le TY, 2017, BRIEF BIOINFORM, V18, P577, DOI 10.1093/bib/bbw042; Wang JY, 2017, J PHARM PHARMACOL, V69, P182, DOI 10.1111/jphp.12677; Wang M, 2016, ENDOCRINE, V54, P81, DOI 10.1007/s12020-016-0950-5; Wang M, 2016, MOL CELL ENDOCRINOL, V426, P136, DOI 10.1016/j.mce.2016.02.020; Wu XH, 2017, EUR J OBSTET GYN R B, V217, P161, DOI 10.1016/j.ejogrb.2017.08.036; Xia T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06088; Xie Y, 2018, KIDNEY INT, V94, P567, DOI 10.1016/j.kint.2018.04.011; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009; Yao KY, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317707882; Yi H, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.451; Yin Y, 2016, ONCOTARGET, V7, P86755, DOI 10.18632/oncotarget.13550; Zhou L, 2015, BIOCHEM BIOPH RES CO, V468, P726, DOI 10.1016/j.bbrc.2015.11.023; Zhou M, 2016, ONCOTARGET, V7, P12598, DOI 10.18632/oncotarget.7181	45	18	20	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11492	11506		10.1096/fj.201900522R	http://dx.doi.org/10.1096/fj.201900522R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31336052				2022-12-28	WOS:000489166300074
J	Radhakrishnan, J; Baetiong, A; Kaufman, H; Huynh, M; Leschinsky, A; Fresquez, A; White, C; DiMario, JX; Gazmuri, RJ				Radhakrishnan, Jeejabai; Baetiong, Alvin; Kaufman, Harrison; Huynh, Michelle; Leschinsky, Angela; Fresquez, Adriana; White, Carl; DiMario, Joseph X.; Gazmuri, Raul J.			Improved exercise capacity in cyclophilin-D knockout mice associated with enhanced oxygen utilization efficiency and augmented glucose uptake via AMPK-TBC1D1 signaling nexus	FASEB JOURNAL			English	Article						oxygen consumption; skeletal muscle; electrical stimulation	ACTIVATED PROTEIN-KINASE; MITOCHONDRIAL PERMEABILITY TRANSITION; ACETYL-COA CARBOXYLASE; SKELETAL-MUSCLE; AMP; PHOSPHORYLATION; CONTRACTION; INSULIN; TBC1D1; METABOLISM	We previously reported in HEK 293T cells that silencing the mitochondrial peptidyl prolyl isomerase cyclophilin-D (Cyp-D) reduces Vo(2). We now report that in vivo Cyp-D ablation using constitutive Cyp-D knockout (KO) mice also reduces Vo(2) both at rest (similar to 15%) and during treadmill exercise (similar to 12%). Yet, despite Vo(2) reduction, these Cyp-D KO mice ran longer (1071 +/- 77 vs. 785 +/- 79 m; P = 0.002), for longer time (43 +/- 3 vs. 34 +/- 3 min; P = 0.004), and at higher speed (34 +/- 1 vs. 29 +/- 1 m/s; P <= 0.001), resulting in increased work (87 +/- 6 vs. 58 +/- 6 J; P <= 0.001). There were parallel reductions in carbon dioxide production, but of lesser magnitude, yielding a 2.3% increase in the respiratory exchange ratio consistent with increased glucose utilization as respiratory substrate. In addition, primary skeletal muscle cells of Cyp-D KO mice subjected to electrical stimulation exhibited higher glucose uptake (4.4 +/- 0.55 vs. 2.6 +/- 0.04 pmol/mg/min; P <= 0.001) with enhanced AMPK activation (0.58 +/- 0.06 vs. 0.38 +/- 0.03 pAMPK/beta-tubulin ratio; P <= 0.01) and TBC1 (Tre-2/USP6, BUB2, Cdc16) domain family, member 1 (TBC1D1) inactivation. Likewise, pharmacological activation of AMPK also increased glucose uptake (3.2 +/- 0.3 vs. 2.3 +/- 0.2 pmol/mg/min; P <= 0.001). Moreover, lactate and ATP levels were increased in these cells. Taken together, Cyp-D ablation triggered an adaptive response resulting in increased exercise capacity despite less oxygen utilization associated with increased glucose uptake and utilization involving AMPK-TBC1D1 signaling nexus.-Radhakrishnan, J., Baetiong, A., Kaufman, H., Huynh, M., Leschinsky, A., Fresquez, A., White, C., DiMario, J. X., Gazmuri, R. J. Improved exercise capacity in cyclophilin-D knockout mice associated with enhanced oxygen utilization efficiency and augmented glucose uptake via AMPK-TBC1D1 signaling nexus.	[Radhakrishnan, Jeejabai; Baetiong, Alvin; Kaufman, Harrison; Huynh, Michelle; Leschinsky, Angela; Gazmuri, Raul J.] Rosalind Franklin Univ Med & Sci, Resuscitat Inst, 3333 Green Bay Rd, N Chicago, IL 60064 USA; [Radhakrishnan, Jeejabai; Gazmuri, Raul J.] Rosalind Franklin Univ Med & Sci, Dept Clin Sci, N Chicago, IL 60064 USA; [Fresquez, Adriana; White, Carl] Rosalind Franklin Univ Med & Sci, Discipline Physiol & Biophys, N Chicago, IL 60064 USA; [Fresquez, Adriana; White, Carl] Rosalind Franklin Univ Med & Sci, Ctr Canc Cell Biol Immunol & Infect, N Chicago, IL 60064 USA; [Fresquez, Adriana; DiMario, Joseph X.] Rosalind Franklin Univ Med & Sci, Sch Grad & Postdoctoral Studies, N Chicago, IL 60064 USA; [DiMario, Joseph X.] Rosalind Franklin Univ Med & Sci, Dept Biomed Res, N Chicago, IL 60064 USA; [Gazmuri, Raul J.] Captain James A Lovell Fed Hlth Care Ctr, 3333 Green Bay Rd, N Chicago, IL 60064 USA	Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science	Radhakrishnan, J; Gazmuri, RJ (corresponding author), Rosalind Franklin Univ Med & Sci, Resuscitat Inst, 3333 Green Bay Rd, N Chicago, IL 60064 USA.; Gazmuri, RJ (corresponding author), Captain James A Lovell Fed Hlth Care Ctr, 3333 Green Bay Rd, N Chicago, IL 60064 USA.; Gazmuri, RJ (corresponding author), Rosalind Franklin Univ Med & Sci, Med, 3333 Green Bay Rd, N Chicago, IL 60064 USA.; Gazmuri, RJ (corresponding author), Rosalind Franklin Univ Med & Sci, Physiol & Biophys, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	jeejabai.radhakrishnan@rosalindfranklin.edu; raul.gazmuri@rosalindfranklin.edu		White, Carl/0000-0002-0535-6968; Fresquez, Adriana/0000-0002-6424-1773; Gazmuri, Raul J./0000-0002-3848-7227	DePaul-Rosalind Franklin University of Medicine and Science (RFUMS) Pilot Grant; Veterans Affairs Merit Review Award [1 101 BX002771 01]; Monica Ply Unrestricted Funds for Cardiac Research; Veterans Affairs [I01BX002771] Funding Source: NIH RePORTER	DePaul-Rosalind Franklin University of Medicine and Science (RFUMS) Pilot Grant; Veterans Affairs Merit Review Award(US Department of Veterans Affairs); Monica Ply Unrestricted Funds for Cardiac Research; Veterans Affairs(US Department of Veterans Affairs)	The authors thank the Center for Cancer Cell Biology, Immunology, and Infection microscopy facility at Rosalind Franklin University of Medicine and Science. The authors are thankful for the funding support by DePaul-Rosalind Franklin University of Medicine and Science (RFUMS) Pilot Grant (to J.R. and R.J.G.), Veterans Affairs Merit Review Award (1 101 BX002771 01) entitled "Cyclophilin D: A Regulator of Mitochondrial Oxidative Phosphorylation" (to R.J.G.), and Monica Ply Unrestricted Funds for Cardiac Research (to R.J.G.). The authors declare no conflicts of interest.	Abbott MJ, 2014, J APPL PHYSIOL, V117, P869, DOI 10.1152/japplphysiol.01380.2013; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Atherton PJ, 2005, FASEB J, V19, P786, DOI 10.1096/fj.04-2179fje; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Burch N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010970; Calera MR, 1998, J BIOL CHEM, V273, P7201, DOI 10.1074/jbc.273.13.7201; Casuso RA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185494; Chavez JA, 2008, J BIOL CHEM, V283, P9187, DOI 10.1074/jbc.M708934200; CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430; CHOMYN A, 1985, NATURE, V314, P592, DOI 10.1038/314592a0; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Crompton M, 1998, EUR J BIOCHEM, V258, P729, DOI 10.1046/j.1432-1327.1998.2580729.x; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; FITTS RH, 1994, PHYSIOL REV, V74, P49, DOI 10.1152/physrev.1994.74.1.49; Fritzen AM, 2015, J PHYSIOL-LONDON, V593, P4765, DOI 10.1113/JP270821; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Gowans GJ, 2013, CELL METAB, V18, P556, DOI 10.1016/j.cmet.2013.08.019; Granata C, 2017, SCI REP-UK, V7, DOI 10.1038/srep44227; Han F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07188-9; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; HOCHACHKA PW, 1991, J APPL PHYSIOL, V70, P1720, DOI 10.1152/jappl.1991.70.4.1720; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P1215, DOI 10.1073/pnas.93.3.1215; HOLDEN JE, 1995, J APPL PHYSIOL, V79, P222, DOI 10.1152/jappl.1995.79.1.222; Hutber CA, 1997, AM J PHYSIOL-ENDOC M, V272, pE262, DOI 10.1152/ajpendo.1997.272.2.E262; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jessen N, 2011, AM J PHYSIOL-ENDOC M, V301, pE164, DOI 10.1152/ajpendo.00042.2011; Jha Pooja, 2016, Curr Protoc Mouse Biol, V6, P1, DOI 10.1002/9780470942390.mo150182; Jorgensen SB, 2005, FASEB J, V19, P1146, DOI 10.1096/fj.04-3144fje; Jorgensen SB, 2007, AM J PHYSIOL-ENDOC M, V292, pE331, DOI 10.1152/ajpendo.00243.2006; Kjobsted R, 2016, DIABETES, V65, P1219, DOI 10.2337/db15-1034; Klawitter J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10076-9; Klawitter J, 2017, J CELL BIOCHEM, V118, P2933, DOI 10.1002/jcb.25947; Lantier L, 2014, FASEB J, V28, P3211, DOI 10.1096/fj.14-250449; Lee-Young RS, 2011, INT J OBESITY, V35, P982, DOI 10.1038/ijo.2010.220; Leick L, 2010, AM J PHYSIOL-ENDOC M, V299, pE456, DOI 10.1152/ajpendo.00648.2009; MACREADIE IG, 1983, NUCLEIC ACIDS RES, V11, P4435, DOI 10.1093/nar/11.13.4435; Mafakheri S, 2018, J BIOL CHEM, V293, P17853, DOI 10.1074/jbc.RA118.005040; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marks AR, 1996, PHYSIOL REV, V76, P631, DOI 10.1152/physrev.1996.76.3.631; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; Menazza S, 2013, J MOL CELL CARDIOL, V56, P81, DOI 10.1016/j.yjmcc.2012.12.004; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Miura S, 2013, AM J PHYSIOL-ENDOC M, V305, pE213, DOI 10.1152/ajpendo.00114.2013; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1191, DOI 10.1152/ajpendo.90280.2008; Nikolic N, 2017, ACTA PHYSIOL, V220, P310, DOI 10.1111/apha.12830; Olesen J, 2010, PFLUG ARCH EUR J PHY, V460, P153, DOI 10.1007/s00424-010-0834-0; Opie L.H., 1991, HEART PHYSL METABOLI; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pauly M, 2015, J GERONTOL A-BIOL, V70, P1077, DOI 10.1093/gerona/glu147; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; Petrosino JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148010; Radhakrishnan J, 2015, FASEB J, V29, P2734, DOI 10.1096/fj.14-263855; Radhakrishnan J, 2013, AM J TRANSL RES, V5, P316; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466; Schippers MP, 2012, CURR BIOL, V22, P2350, DOI 10.1016/j.cub.2012.10.043; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shahini A, 2018, STEM CELL RES, V30, P122, DOI 10.1016/j.scr.2018.05.017; Stanley William C, 2002, Heart Fail Rev, V7, P115, DOI 10.1023/A:1015320423577; Steinberg GR, 2010, J BIOL CHEM, V285, P37198, DOI 10.1074/jbc.M110.102434; Tavecchio M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15981; Tavecchio M, 2013, J BIOL CHEM, V288, P5553, DOI 10.1074/jbc.M112.433045; Taylor EB, 2008, J BIOL CHEM, V283, P9787, DOI 10.1074/jbc.M708839200; Treebak JT, 2014, J PHYSIOL-LONDON, V592, P351, DOI 10.1113/jphysiol.2013.266338; Tubbs E, 2014, DIABETES, V63, P3279, DOI 10.2337/db13-1751; Vavvas D, 1997, J BIOL CHEM, V272, P13255, DOI 10.1074/jbc.272.20.13255; Vichaiwong K, 2010, BIOCHEM J, V431, P311, DOI 10.1042/BJ20101100; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wojtaszewski JFP, 2002, DIABETES, V51, P284, DOI 10.2337/diabetes.51.2.284; Wojtaszewski JFP, 2000, J PHYSIOL-LONDON, V528, P221, DOI 10.1111/j.1469-7793.2000.t01-1-00221.x; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	76	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11443	11457		10.1096/fj.201802238R	http://dx.doi.org/10.1096/fj.201802238R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31339770	Bronze			2022-12-28	WOS:000489166300070
J	Zhang, YP; Liu, KL; Wang, YX; Yang, Z; Han, ZW; Lu, BS; Qi, JC; Yin, YW; Teng, ZH; Chang, XL; Li, JD; Xin, H; Li, W				Zhang, Yan-Ping; Liu, Kai-Long; Wang, Ya-Xuan; Yang, Zhan; Han, Zhen-Wei; Lu, Bao-Sai; Qi, Jin-Chun; Yin, Yue-Wei; Teng, Zhi-Hai; Chang, Xue-Liang; Li, Jing-Dong; Xin, Hong; Li, Wei			Down-regulated RBM5 inhibits bladder cancer cell apoptosis by initiating an miR-432-5p/beta-catenin feedback loop	FASEB JOURNAL			English	Article						bladder urothelial carcinoma; RNA-binding motif protein 5; TCF; LEF element; gene expression	TUMOR-SUPPRESSOR GENE; BETA-CATENIN; EXPRESSION; 3P21.3; ALPHA; RBM5/LUCA-15/H37; IDENTIFICATION; CARCINOMA; ISOFORM	RNA-binding motif protein 5 (RBM5) acts as a tumor suppressor in various human cancers and presents with several important characteristics, such as the potentiation of apoptosis, inhibition of the cell cycle, and alternative splicing of Fas and caspase-2 precursor mRNA. However, its role in bladder urothelial carcinoma (BUC) remains unknown. In this study, we found that RBM5 expression was significantly down-regulated in BUC tissues when compared with the adjacent nontumor tissues. The down-regulation of RBM5 activates beta-catenin, which binds to the T-cell factor/lymphocyte enhancer factor element of the miR-432-5p promoter and elevates the expression of miR-432-5p in bladder cancer cells. The up-regulated miR-432-5p directly targets 3 '-UTR and depresses RBM5 expression. Thus, RBM5-miR-432-5p-beta-catenin forms a feedback loop in regulating bladder cancer cell apoptosis. Our findings provide evidence that the regulatory feedback loop among RBM5, miR-432-5p, and Wnt-beta-catenin is responsible for the progress of bladder cancer cells.-Zhang, Y.-P., Liu, K.-L., Wang, Y.-X., Yang, Z., Han, Z.-W., Lu, B.-S., Qi, J.-C., Yin, Y.-W., Teng, Z.-H., Chang, X.-L., Li, J.-D., Xin, H., Li, W. Down-regulated RBM5 inhibits bladder cancer cell apoptosis by initiating an miR-432-5p/beta-catenin feedback loop.	[Zhang, Yan-Ping; Xin, Hong] Hebei Med Univ, Hosp 2, Dept Obstet, 215 Heping West Rd, Shijiazhuang 050000, Hebei, Peoples R China; [Zhang, Yan-Ping; Liu, Kai-Long; Wang, Ya-Xuan; Yang, Zhan; Han, Zhen-Wei; Lu, Bao-Sai; Qi, Jin-Chun; Yin, Yue-Wei; Teng, Zhi-Hai; Chang, Xue-Liang; Li, Jing-Dong; Li, Wei] Hebei Med Univ, Hosp 2, Dept Urol, Shijiazhuang 050000, Hebei, Peoples R China	Hebei Medical University; Hebei Medical University	Xin, H (corresponding author), Hebei Med Univ, Hosp 2, Dept Obstet, 215 Heping West Rd, Shijiazhuang 050000, Hebei, Peoples R China.; Li, W (corresponding author), Hebei Med Univ, Hosp 2, Dept Urol, Shijiazhuang 050000, Hebei, Peoples R China.	xinhong_hb2h@163.com; weili_hb2h@163.com	Yang, Zhan/GQG-9995-2022; qi, jinchun/HDM-7017-2022	Yang, Zhan/0000-0001-7191-2910	National Natural Science Foundation of China [81600237]; Natural Science Foundation of Hebei Province [H2018206275]; Higher Education Science and Technology Research Project of Hebei Province [BJ2018001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Higher Education Science and Technology Research Project of Hebei Province	The authors thank the Qian Du (Biocaring Biotechnology, Shijiazhuang, China) for technical support. This study was supported by the National Natural Science Foundation of China (Grant 81600237), The Natural Science Foundation of Hebei Province (Grant H2018206275), and the Higher Education Science and Technology Research Project of Hebei Province (Grant BJ2018001). The authors declare no conflicts of interest.	Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bonnal S, 2008, MOL CELL, V32, P81, DOI 10.1016/j.molcel.2008.08.008; Chen L, 2016, ONCOTARGET, V7, P20041, DOI 10.18632/oncotarget.7884; Chen YG, 2017, MOL CELL, V67, P228, DOI 10.1016/j.molcel.2017.05.022; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Czerniak B, 2016, ANNU REV PATHOL-MECH, V11, P149, DOI 10.1146/annurev-pathol-012513-104703; Fushimi K, 2008, P NATL ACAD SCI USA, V105, P15708, DOI 10.1073/pnas.0805569105; Graham TA, 2001, NAT STRUCT BIOL, V8, P1048, DOI 10.1038/nsb718; Han ZW, 2018, CANCER RES, V78, P2550, DOI 10.1158/0008-5472.CAN-17-1575; Hao YQ, 2015, ONCOL REP, V33, P2438, DOI 10.3892/or.2015.3828; Hu YY, 2017, ONCOTARGET, V8, P94554, DOI 10.18632/oncotarget.21791; Huang YD, 2015, ONCOL REP, V33, P3075, DOI 10.3892/or.2015.3933; Jiang YP, 2017, WORLD J SURG ONCOL, V15, DOI 10.1186/s12957-016-1084-1; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Kennell JA, 2003, MOL CELL BIOL, V23, P5366, DOI 10.1128/MCB.23.15.5366-5375.2003; Kobayashi T, 2011, INT J CANCER, V128, P304, DOI 10.1002/ijc.25345; Kotlajich MV, 2008, MOL CELL, V32, P162, DOI 10.1016/j.molcel.2008.10.008; Koutsioumpa M, 2018, MOL CANCER THER, V17, P1430, DOI 10.1158/1535-7163.MCT-17-1049; Lerman MI, 2000, CANCER RES, V60, P6116; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang ZF, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.452; Liu YH, 2018, BIOCHEM BIOPH RES CO, V502, P358, DOI 10.1016/j.bbrc.2018.05.166; Lotan Y, 2005, J CLIN ONCOL, V23, P6533, DOI 10.1200/JCO.2005.05.516; Lv XR, 2013, BIOCHEM J, V456, P35, DOI 10.1042/BJ20130418; Mourtada-Maarabouni M, 2003, GENES CELLS, V8, P109, DOI 10.1046/j.1365-2443.2003.00619.x; Mourtada-Maarabouni M, 2002, APOPTOSIS, V7, P421, DOI 10.1023/A:1020083008017; Mourtada-Maarabouni M, 2006, EXP CELL RES, V312, P1745, DOI 10.1016/j.yexcr.2006.02.009; Nemlich Y, 2013, J CLIN INVEST, V123, P2703, DOI 10.1172/JCI62980; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Oh JJ, 2006, CANCER RES, V66, P3419, DOI 10.1158/0008-5472.CAN-05-1667; Oh JJ, 2002, CANCER RES, V62, P3207; Oh JJ, 1999, NUCLEIC ACIDS RES, V27, P4008, DOI 10.1093/nar/27.20.4008; Oh JJ, 2010, LUNG CANCER, V70, P253, DOI 10.1016/j.lungcan.2010.02.012; Orengo JP, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl967; Palmbos PL, 2015, CANCER RES, V75, P5155, DOI 10.1158/0008-5472.CAN-15-0603; Rintala-Maki ND, 2004, CELL BIOCHEM FUNCT, V22, P307, DOI 10.1002/cbf.1106; Rintala-Maki ND, 2007, J CELL BIOCHEM, V100, P1440, DOI 10.1002/jcb.21134; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Sun Y, 2017, CIRC RES, V121, P628, DOI 10.1161/CIRCRESAHA.117.311441; Sutherland LC, 2001, ONCOGENE, V20, P2713, DOI 10.1038/sj.onc.1204371; Sutherland LC, 2010, J THORAC ONCOL, V5, P294, DOI 10.1097/JTO.0b013e3181c6e330; Wang XL, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-308; Welling DB, 2002, OTOL NEUROTOL, V23, P736, DOI 10.1097/00129492-200209000-00022; Xie DL, 2017, ONCOTARGET, V8, P88689, DOI 10.18632/oncotarget.20927; Xu MJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0206-1; Yang JG, 2017, ONCOTARGET, V8, P68721, DOI 10.18632/oncotarget.19878; Yang Z, 2017, TRANSPORT RES REC, P36, DOI 10.3141/2635-05; Zhang Q, 2017, INT J E-NAVIG MARIT, V7, P34, DOI 10.1016/j.enavi.2017.06.004; Zhao LJ, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-247	50	13	15	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10973	10985		10.1096/fj.201900537R	http://dx.doi.org/10.1096/fj.201900537R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31318608				2022-12-28	WOS:000489166300033
J	Kobayashi, J; Hasegawa, T; Sugeno, N; Yoshida, S; Akiyama, T; Fujimori, K; Hatakeyama, H; Miki, Y; Tomiyama, A; Kawata, Y; Fukuda, M; Kawahata, I; Yamakuni, T; Ezura, M; Kikuchi, A; Baba, T; Takeda, A; Kanzaki, M; Wakabayashi, K; Okano, H; Aoki, M				Kobayashi, Junpei; Hasegawa, Takafumi; Sugeno, Naoto; Yoshida, Shun; Akiyama, Tetsuya; Fujimori, Koki; Hatakeyama, Hiroyasu; Miki, Yasuo; Tomiyama, Arata; Kawata, Yasushi; Fukuda, Mitsunori; Kawahata, Ichiro; Yamakuni, Tohru; Ezura, Michinori; Kikuchi, Akio; Baba, Toru; Takeda, Atsushi; Kanzaki, Makoto; Wakabayashi, Koichi; Okano, Hideyuki; Aoki, Masashi			Extracellular alpha-synuclein enters dopaminergic cells by modulating flotillin-1-assisted dopamine transporter endocytosis	FASEB JOURNAL			English	Article						Parkinson's disease; endocytosis; DAT; endosome; Lewy body	PARKINSONS-DISEASE; MEMBRANE MICRODOMAINS; SUBSTANTIA-NIGRA; RAFT DOMAINS; PROTEINS; DIFFERENTIATION; TRAFFICKING; FLOTILLINS; NEURONS; PATHWAY	The neuropathological hallmarks of Parkinson's disease (PD) include the appearance of alpha-synuclein (alpha-SYN)-positive Lewy bodies (LBs) and the loss of catecholaminergic neurons. Thus, a potential mechanism promoting the uptake of extracellular alpha-SYN may exist in susceptible neurons. Of the various differentially expressed proteins, we are interested in flotillin (FLOT)-1 because this protein is highly expressed in the brainstem catecholaminergic neurons and is strikingly up-regulated in PD brains. In this study, we found that extracellular monomeric and fibrillar alpha-SYN can potentiate FLOT1-dopamine transporter (DAT) binding and pre-endocytic clustering of DAT on the cell surface, thereby facilitating DAT endocytosis and down-regulating its transporter activity. Moreover, we demonstrated that alpha-SYN itself exploited the DAT endocytic process to enter dopaminergic neuron-like cells, and both FLOT1 and DAT were found to be the components of LBs. Altogether, these findings revealed a novel role of extracellular alpha-SYN on cellular trafficking of DAT and may provide a rationale for the cell type-specific, functional, and pathologic alterations in PD.-Kobayashi, J., Hasegawa, T., Sugeno, N., Yoshida, S., Akiyama, T., Fujimori, K., Hatakeyama, H., Miki, Y., Tomiyama, A., Kawata, Y., Fukuda, M., Kawahata, I., Yamakuni, T., Ezura, M., Kikuchi, A., Baba, T., Takeda, A., Kanzaki, M., Wakabayashi, K., Okano, H., Aoki, M. Extracellular alpha-synuclein enters dopaminergic cells by modulating flotillin-1-assisted dopamine transporter endocytosis.	[Kobayashi, Junpei; Hasegawa, Takafumi; Sugeno, Naoto; Yoshida, Shun; Akiyama, Tetsuya; Ezura, Michinori; Kikuchi, Akio; Aoki, Masashi] Tohoku Univ, Grad Sch Med, Dept Neurosci & Sensory Organs, Div Neurol, Sendai, Miyagi, Japan; [Kobayashi, Junpei] Natl Hosp Org Yonezawa Hosp, Dept Neurol, Yonezawa, Yamagata, Japan; [Akiyama, Tetsuya; Fujimori, Koki; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo, Japan; [Hatakeyama, Hiroyasu] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi, Japan; [Hatakeyama, Hiroyasu; Kanzaki, Makoto] Tohoku Univ, Dept Biomed Engn, Grad Sch Biomed Engn, Sendai, Miyagi, Japan; [Fukuda, Mitsunori] Tohoku Univ, Lab Membrane Trafficking Mech, Dept Integrat Life Sci, Grad Sch Life Sci, Sendai, Miyagi, Japan; [Kawahata, Ichiro; Yamakuni, Tohru] Tohoku Univ, Dept Pharmacotherapy, Grad Sch Pharmaceut Sci, Sendai, Miyagi, Japan; [Miki, Yasuo; Wakabayashi, Koichi] Hirosaki Univ, Grad Sch Med, Inst Brain Sci, Dept Neuropathol, Hirosaki, Aomori, Japan; [Tomiyama, Arata] Natl Def Med Coll, Dept Neurosurg, Saitama, Japan; [Kawata, Yasushi] Tottori Univ, Dept Chem & Biotechnol, Grad Sch Engn, Tottori, Japan; [Kawata, Yasushi] Tottori Univ, Dept Biomed Sci, Inst Regenerat Med & Biofunct, Grad Sch Med Sci, Tottori, Japan; [Baba, Toru; Takeda, Atsushi] Natl Hosp Org Sendai Nishitaga Hosp, Dept Neurol, Sendai, Miyagi, Japan	Tohoku University; Keio University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Hirosaki University; National Defense Medical College - Japan; Tottori University; Tottori University	Hasegawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Neurosci & Sensory Organs, Div Neurol,Aoba Ku, 1-1,Seiryo Machi, Sendai, Miyagi 9808574, Japan.	thasegawa@med.tohoku.ac.jp	Perry, George/A-8611-2009; Akiyama, Tetsuya/GOE-4034-2022; Kawahata, Ichiro/N-4414-2019; Fukuda, MItsunori/I-1511-2015; Kawata, Yasushi/ABA-9608-2021; Yamakuni, Tohru/AAE-3541-2019; Okano, Hideyuki/X-9131-2019; Kawahata, Ichiro/A-6443-2017; Kanzaki, Makoto/H-6680-2017; MIKI, YASUO/F-5704-2013; Tomiyama, Arata/H-9851-2019	Perry, George/0000-0002-6547-0172; Kawahata, Ichiro/0000-0002-5916-7847; Fukuda, MItsunori/0000-0002-8620-5853; Okano, Hideyuki/0000-0001-7482-5935; Kawahata, Ichiro/0000-0002-5916-7847; Kanzaki, Makoto/0000-0002-6884-2955; Kawata, Yasushi/0000-0002-2744-1506; Yamakuni, Tohru/0000-0003-3968-7949; Tomiyama, Arata/0000-0003-2944-6535; Akiyama, Tetsuya/0000-0002-8076-1242	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [17K09744, 15H01550, 18H062060]; Acceleration Program for Intractable Diseases Research utilizing Disease-specific iPSCs from the Japan Agency for Medical Research and Development (AMED) [19bm0804003h0003]; Novartis Pharma Research grants;  [17ek0109222h0001];  [18ek0109222h0002];  [16lm0103007j0005];  [17dm0107071];  [18dm0107071];  [17dm0107072];  [18dm0107072];  [18dm0107073]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Acceleration Program for Intractable Diseases Research utilizing Disease-specific iPSCs from the Japan Agency for Medical Research and Development (AMED); Novartis Pharma Research grants; ; ; ; ; ; ; ; 	The authors thank Tomoe Ito and Shun Ishiyama (Division of Neurology, Department of Neuroscience and Sensory Organs, Tohoku University Graduate School of Medicine) for excellent technical assistance. This work was supported in part by a Grant-in-Aid for Scientific Research (C) (Grant 17K09744 to T.H.), a Grant-in-Aid for Scientific Research on Innovative Areas (Brain Protein Aging and Dementia Control) (Grant 15H01550 to T.H.), and a Grant-in-Aid for Research Activity Start-Up (Grant 18H062060 to J.K.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT). This work was also supported by a Grant-in-Aid for the Research Committee for Ataxic Diseases (to A.T.), a Grant-in-Aid for Practical Research Projects for Rare/Intractable Diseases (Grants 17ek0109222h0001 and 18ek0109222h0002 to T.H.), a Grant-in-Aid for Translational Research Network Program (Tohoku University) (Grant 16lm0103007j0005 to T.H.), a Grant-in-Aid for the Strategic Research Program for Brain Sciences (Grants 17dm0107071 and 18dm0107071 to T.H.; 17dm0107072 and 18dm0107072 to A.T.; and 18dm0107073 to Y.K.), the Acceleration Program for Intractable Diseases Research utilizing Disease-specific iPSCs (Grant 19bm0804003h0003 to H.O.) from the Japan Agency for Medical Research and Development (AMED), and Novartis Pharma Research grants (to T.H.). The authors declare no conflicts of interest.	Ait-Slimane T, 2009, MOL BIOL CELL, V20, P3792, DOI 10.1091/mbc.E09-04-0275; Amaddii M, 2012, J BIOL CHEM, V287, P7265, DOI 10.1074/jbc.M111.287599; Angot E, 2010, LANCET NEUROL, V9, P1128, DOI 10.1016/S1474-4422(10)70213-1; Bodin S, 2014, J CELL SCI, V127, P5139, DOI 10.1242/jcs.159764; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Butler B, 2015, J BIOL CHEM, V290, P29542, DOI 10.1074/jbc.M115.691592; Calo L, 2016, MOVEMENT DISORD, V31, P169, DOI 10.1002/mds.26479; Carballo-Carbajal I, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08858-y; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Cremona ML, 2011, NAT NEUROSCI, V14, P469, DOI 10.1038/nn.2781; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Del Tredici K, 2016, NEUROPATH APPL NEURO, V42, P33, DOI 10.1111/nan.12298; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; Eriksen J, 2010, J NEUROCHEM, V113, P27, DOI 10.1111/j.1471-4159.2010.06599.x; Frick M, 2007, CURR BIOL, V17, P1151, DOI 10.1016/j.cub.2007.05.078; Fujimori K, 2017, STEM CELL REP, V9, P1675, DOI 10.1016/j.stemcr.2017.09.024; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; Gainetdinov RR, 1999, BIOL PSYCHIAT, V46, P303, DOI 10.1016/S0006-3223(99)00122-5; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Goren MA, 2009, METHOD ENZYMOL, V463, P647, DOI 10.1016/S0076-6879(09)63037-8; Gustot A, 2015, BIOCHEM J, V471, P323, DOI 10.1042/BJ20150617; Hasegawa T, 2006, FEBS LETT, V580, P2147, DOI 10.1016/j.febslet.2006.03.018; Hasegawa T, 2004, BRAIN RES, V1013, P51, DOI 10.1016/j.brainres.2004.04.018; Hasegawa T, 2018, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00743; Hasegawa T, 2017, TOHOKU J EXP MED, V242, P63, DOI 10.1620/tjem.242.63; Hasegawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029460; Hasegawa T, 2010, NEUROCHEM INT, V57, P857, DOI 10.1016/j.neuint.2010.09.002; HAYASHIDA K, 1993, ACTA NEUROPATHOL, V85, P445, DOI 10.1007/BF00334457; HIRSCH EC, 1992, ANN NEUROL, V32, pS88, DOI 10.1002/ana.410320715; Hong WMC, 2013, FASEB J, V27, P2995, DOI 10.1096/fj.12-218727; Jacobowitz DM, 2004, NEUROTOX RES, V6, P245, DOI 10.1007/BF03033435; Konno M, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-38; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kordower JH, 2013, BRAIN, V136, P2419, DOI 10.1093/brain/awt192; Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S; Langhorst MF, 2007, FEBS LETT, V581, P4697, DOI 10.1016/j.febslet.2007.08.074; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Lee BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023939; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Longhena F, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061611; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; Meister M, 2014, MEMBRANES-BASEL, V4, P356, DOI 10.3390/membranes4030356; Melikian HE, 1999, J NEUROSCI, V19, P7699; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Muller HK, 2006, J BIOL CHEM, V281, P28901, DOI 10.1074/jbc.M602848200; Munderloh C, 2009, J NEUROSCI, V29, P6607, DOI 10.1523/JNEUROSCI.0870-09.2009; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Obeso JA, 2017, MOVEMENT DISORD, V32, P1264, DOI 10.1002/mds.27115; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Parker LK, 2010, BRIT J PHARMACOL, V159, P797, DOI 10.1111/j.1476-5381.2009.00574.x; Rodriguez L, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00344; Sannerud R, 2011, P NATL ACAD SCI USA, V108, pE559, DOI 10.1073/pnas.1100745108; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Sorkina T, 2018, ELIFE, V7, DOI 10.7554/eLife.32293; Sorkina T, 2013, TRAFFIC, V14, P709, DOI 10.1111/tra.12059; Sugeno N, 2014, J BIOL CHEM, V289, P18137, DOI 10.1074/jbc.M113.529461; Takeda A, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/19365; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Wu S, 2015, P NATL ACAD SCI USA, V112, P15480, DOI 10.1073/pnas.1512957112; Xie SW, 2016, MOL BIOL CELL, V27, P108, DOI 10.1091/mbc.E15-07-0514; Yoshida S, 2018, HUM MOL GENET, V27, P823, DOI 10.1093/hmg/ddy003; Zahniser NR, 2004, NEUROPHARMACOLOGY, V47, P80, DOI 10.1016/j.neuropharm.2004.07.010; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	69	12	12	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10240	10256		10.1096/fj.201802051R	http://dx.doi.org/10.1096/fj.201802051R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31211923	Bronze			2022-12-28	WOS:000482214200042
J	Liu, ZC; Yang, K; Yan, XM; Wang, TQ; Jiang, T; Zhou, Q; Qi, J; Qian, ND; Zhou, HB; Chen, B; Huang, P; Guo, L; Zhang, XK; Xu, X; Jiang, M; Deng, L				Liu, Zhuochao; Yang, Kai; Yan, Xueming; Wang, Tianqi; Jiang, Tao; Zhou, Qi; Qi, Jin; Qian, Niandong; Zhou, Hanbing; Chen, Bo; Huang, Ping; Guo, Lei; Zhang, Xingkai; Xu, Xing; Jiang, Min; Deng, Lianfu			The effects of tranylcypromine on osteoclastogenesis in vitro and in vivo	FASEB JOURNAL			English	Article						osteoclasts; monoamine oxidase inhibitor; bone loss	DIFFERENTIATION; INHIBITORS; CANCER; DERIVATIVES; ACTIVATION; LSD1; EXPRESSION; DENOSUMAB; DRUGS; NFAT2	Identification of anti-osteoclastogenic agents is important for the treatment of bone loss diseases that feature excessive osteoclast (OC) activity and bone resorption. Tranylcypromine (TCP), an irreversible inhibitor of monoamine oxidase (MAO), has been used as an antidepressant and anxiolytic agent in the clinical treatment of mood and anxiety disorders. TCP has been discovered to exert anabolic effect on osteoblasts, and MAO-A has also been verified as an important mediator in prostate cancer cells to accelerate osteoclastogenesis. In current study, we were focused on TCP and MAO-A effects on osteoclastogenesis. As illustrated by tartrate-resistant acid phosphatase staining, TCP was capable of inhibiting osteoclastogenesis induced by receptor activators of the NF-kappa B ligand (RANKL) in bone marrow-derived macrophage cells without any cytotoxicity. It was also shown to effectively suppress bone resorption of OCs. The subsequent study revealed that TCP inhibited osteoclastogenesis-related genes in a time-dependent manner through protein kinase B (AKT)-mediated mechanism followed by the nuclear factor of activated T cells, cytoplasmic 1 (NFATc1)-c-fos pathway. And TCP could overcome the osteoclastogenic effects of AKT activator SC79. In addition, our results indicated that the expression and catalytic activity of MAO-A were up-regulated by RANKL stimulation and down-regulated by TCP in vitro and in vivo. Furthermore, the effects of MAO-A knockdown on OC differentiation indicated that MAO-A played an important role in osteoclastogenesis in vitro and might contribute to the inhibitory effects of TCP. And AKT, NFATc1, and c-fos were involved in the MAO-A pathway. Notably, our in vivo study reflected that TCPs were capable of restoring the bone loss in LPS-induced calvaria osteolysis and estrogen deficiency-induced osteoporosis models. Thus, our current work provided a potential option for the treatment of bone loss diseases and highlighted the important role of MAO-A in osteoclastogenesis as well.-Liu, Z., Yang, K., Yan, X., Wang, T., Jiang, T., Zhou, Q., Qi, J., Qian, N., Zhou, H., Chen, B., Huang, P., Guo, L., Zhang, X., Xu, X., Jiang, M., Deng, L. The effects of tranylcypromine on osteoclastogenesis in vitro and in vivo.	[Liu, Zhuochao; Yang, Kai; Yan, Xueming; Wang, Tianqi; Jiang, Tao; Zhou, Qi; Qi, Jin; Qian, Niandong; Zhou, Hanbing; Chen, Bo; Huang, Ping; Guo, Lei; Xu, Xing; Jiang, Min; Deng, Lianfu] Shanghai Jiao Tong Univ, Shanghai Key Lab Bone & Joint Dis, Shanghai Ruijin Hosp, Shanghai Inst Traumatol & Orthopaed,Sch Med, Shanghai, Peoples R China; [Liu, Zhuochao; Zhang, Xingkai] Shanghai Jiao Tong Univ, Sch Med, Shanghai Ruijin Hosp, Dept Orthoped, Shanghai, Peoples R China; [Jiang, Tao] Shanghai Jiao Tong Univ, Sch Med, Shanghai Ruijin Hosp, Dept Traumatol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xu, X; Jiang, M (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Ruijin Hosp, Shanghai Inst Traumatol & Orthopaed, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China.	xuxing0510315@126.com; jiangm263@163.com			Natural Science Foundation of China [81703576, 81502902]; Shanghai Municipal Health Bureau Young Scientific Research Project [20154Y0005, 201840185]; Committee of Science and Technology Young Scientific Research Foundation of Shanghai [16ZR1431900]; Natural Science Foundation of Shanghai [17140901800]; Ruijing Young Talent Program [GCQN-2017-A16, GCQN-2017-B22]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Health Bureau Young Scientific Research Project; Committee of Science and Technology Young Scientific Research Foundation of Shanghai; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Ruijing Young Talent Program	This work was supported by the Natural Science Foundation of China (81703576, 81502902), Shanghai Municipal Health Bureau Young Scientific Research Project (20154Y0005, 201840185), Committee of Science and Technology Young Scientific Research Foundation of Shanghai (16ZR1431900), Natural Science Foundation of Shanghai (17140901800), and Ruijing Young Talent Program (GCQN-2017-A16, GCQN-2017-B22). The authors declare no conflicts of interest.	Altar CA, 2003, BIOL PSYCHIAT, V54, P703, DOI 10.1016/S0006-3223(03)00073-8; Anagnostis P, 2015, CLIMACTERIC, V18, P32, DOI 10.3109/13697137.2015.1099092; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Bartell SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4773; Battaglino R, 2004, J BONE MINER RES, V19, P1420, DOI 10.1359/JBMR.040606; Binda C, 2010, J AM CHEM SOC, V132, P6827, DOI 10.1021/ja101557k; Binder NB, 2009, NAT MED, V15, P417, DOI 10.1038/nm.1945; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brown JP, 2014, CAN FAM PHYSICIAN, V60, P324; BURGER A, 1948, J AM CHEM SOC, V70, P2198, DOI 10.1021/ja01186a062; Campas Clara, 2009, Drug News Perspect, V22, P126, DOI 10.1358/dnp.2009.22.2.1334453; Cao X, 2011, NAT MED, V17, P1344, DOI 10.1038/nm.2499; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Duan YC, 2017, EUR J MED CHEM, V140, P392, DOI 10.1016/j.ejmech.2017.09.038; Furuya M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02541-w; Gokosmanoglu F, 2016, J RES MED SCI, V21, DOI 10.4103/1735-1995.193503; Halleen JM, 2006, CLIN LAB, V52, P499; Huang J, 2017, CHEM ECOL, V8, P1, DOI DOI 10.3389/FNEUR.2017.00626]; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Ivy AS, 2003, PHARMACOL BIOCHEM BE, V75, P81, DOI 10.1016/S0091-3057(03)00044-3; Jones LH, 2017, NAT REV DRUG DISCOV, V16, P285, DOI 10.1038/nrd.2016.244; Kawamura N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001058; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Koide M, 2017, J BONE MINER RES, V32, P2074, DOI 10.1002/jbmr.3175; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Metozzi A, 2015, EXPERT REV ENDOCRINO, V10, P153, DOI 10.1586/17446651.2015.979787; Mollard E, 2018, INT J WOMENS HEALTH, V10, P1, DOI 10.2147/IJWH.S147006; Mukherjee A, 2012, MOL CELL BIOL, V32, P490, DOI 10.1128/MCB.06361-11; Poole L, 2018, J PSYCHOSOM RES, V113, P30, DOI 10.1016/j.jpsychores.2018.07.009; Sawant A, 2013, CANCER RES, V73, P672, DOI 10.1158/0008-5472.CAN-12-2202; Schulz-Fincke J, 2018, EUR J MED CHEM, V144, P52, DOI 10.1016/j.ejmech.2017.12.001; Shi CG, 2016, J BONE MINER RES, V31, P1003, DOI 10.1002/jbmr.2770; Soysa NS, 2016, BIOCHEM BIOPH RES CO, V476, P115, DOI 10.1016/j.bbrc.2016.05.019; Stopeck AT, 2010, J CLIN ONCOL, V28, P5132, DOI 10.1200/JCO.2010.29.7101; Strittmatter SM, 2014, NAT MED, V20, P590, DOI 10.1038/nm.3595; Sun J, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0015-x; Sun K, 2017, BIOORG MED CHEM LETT, V27, P5036, DOI 10.1016/j.bmcl.2017.10.003; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Ulrich S, 2017, EUR NEUROPSYCHOPHARM, V27, P697, DOI 10.1016/j.euroneuro.2017.05.007; Wilson SR, 2009, J BIOL CHEM, V284, P2584, DOI 10.1074/jbc.M805280200; Wu JB, 2017, CANCER CELL, V31, P368, DOI 10.1016/j.ccell.2017.02.003; Xiong JH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05244-y; Xiong JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138189; Xu X, 2016, EUR J MED CHEM, V123, P769, DOI 10.1016/j.ejmech.2016.08.004; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zheng YC, 2016, CURR TOP MED CHEM, V16, P2179, DOI 10.2174/1568026616666160216154042	49	9	9	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9828	9841		10.1096/fj.201802242RR	http://dx.doi.org/10.1096/fj.201802242RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31291555				2022-12-28	WOS:000482214200012
J	Liu, Y; Fu, WY; Seese, K; Yin, A; Yin, H				Liu, Yang; Fu, Wenyan; Seese, Kendall; Yin, Amelia; Yin, Hang			Ectopic brown adipose tissue formation within skeletal muscle after brown adipose progenitor cell transplant augments energy expenditure	FASEB JOURNAL			English	Article						engraftment; thermogenesis; UCP1; obesity; diabetes	ENDOTHELIAL GROWTH-FACTOR; ADIPOCYTE PROGENITORS; STEM-CELLS; FAT-CELL; BEIGE; WHITE; OBESITY; MICE; IDENTIFICATION; HOMEOSTASIS	Brown adipose tissue (BAT) thermogenesis increases energy expenditure (EE). Expanding the volume of active BAT via transplantation holds promise as a therapeutic strategy for morbid obesity and diabetes. Brown adipose progenitor cells (BAPCs) can be isolated and expanded to generate autologous brown adipocyte implants. However, the transplantation of brown adipocytes is currently impeded by poor efficiency of BAT tissue formation in vivo and undesirably short engraftment time. In this study, we demonstrated that transplanting BAPCs into limb skeletal muscles consistently led to the ectopic formation of uncoupling protein 1 (UCP1)(+pos) adipose tissue with long-term engraftment (>4 mo). Combining VEGF with the BAPC transplant further improved BAT formation in muscle. Ectopic engraftment of BAPC-derived BAT in skeletal muscle augmented the EE of recipient mice. Although UCP1 expression declined in long-term BAT grafts, this deterioration can be reversed by swimming exercise because of sympathetic activation. This study suggests that intramuscular transplantation of BAPCs represents a promising approach to deriving functional BAT engraftment, which may be applied to therapeutic BAT transplantation and tissue engineering.-Liu, Y., Fu, W., Seese, K., Yin, A., Yin, H. Ectopic brown adipose tissue formation within skeletal muscle after brown adipose progenitor cell transplant augments energy expenditure.	[Liu, Yang; Fu, Wenyan; Yin, Amelia; Yin, Hang] Univ Georgia, Ctr Mol Med, Athens, GA 30602 USA; [Liu, Yang; Fu, Wenyan; Seese, Kendall; Yin, Amelia; Yin, Hang] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Yin, H (corresponding author), Univ Georgia, 325 Riverbend Rd,CMM 2228, Athens, GA 30602 USA.	hyin@uga.edu	Liu, Yang/GSN-4444-2022	Liu, Yang/0000-0001-8364-1476	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the U.S. National Institutes of Health (NIH) [1R01AR070178]; American Heart Association [17GRNT33700260]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR070178] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the U.S. National Institutes of Health (NIH); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the U.S. National Institutes of Health (NIH) under Award 1R01AR070178 and American Heart Association Grant-in-Aid 17GRNT33700260 to H.Y. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or American Heart Association. The authors declare no conflicts of interest.	Ahfeldt T, 2012, NAT CELL BIOL, V14, P209, DOI 10.1038/ncb2411; Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Altshuler-Keylin S, 2016, CELL METAB, V24, P402, DOI 10.1016/j.cmet.2016.08.002; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bostrom P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036; BOWMAN WC, 1969, PHARMACOL REV, V21, P27; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carey AL, 2013, DIABETOLOGIA, V56, P147, DOI 10.1007/s00125-012-2748-1; Chandran M, 2003, DIABETES CARE, V26, P2442, DOI 10.2337/diacare.26.8.2442; Crisan M, 2008, STEM CELLS, V26, P2425, DOI 10.1634/stemcells.2008-0325; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DELLAGIACOMA G, 1992, TRANSPLANT P, V24, P2986; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferren L, 1966, Trans Kans Acad Sci, V69, P350, DOI 10.2307/3627430; Gunawardana SC, 2015, AM J PHYSIOL-ENDOC M, V308, pE1043, DOI 10.1152/ajpendo.00570.2014; Gunawardana SC, 2012, DIABETES, V61, P674, DOI 10.2337/db11-0510; Hafner AL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32490; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hausman GJ, 2014, ADIPOCYTE, V3, P242, DOI 10.4161/adip.28546; Jo DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134308; Kikai M, 2018, BIOCHEM BIOPH RES CO, V497, P1097, DOI 10.1016/j.bbrc.2018.02.185; Kishida T, 2015, STEM CELL REP, V5, P569, DOI 10.1016/j.stemcr.2015.08.007; Lee CW, 2017, TRANSL RES, V182, P61, DOI 10.1016/j.trsl.2016.11.003; Lee KY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166763; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liu XM, 2015, ENDOCRINOLOGY, V156, P2461, DOI 10.1210/en.2014-1598; Liu XM, 2013, CELL RES, V23, P851, DOI 10.1038/cr.2013.64; Mandaviani K, 2016, METABOLISM, V65, P26, DOI 10.1016/j.metabol.2015.09.012; Martin B, 2010, P NATL ACAD SCI USA, V107, P6127, DOI 10.1073/pnas.0912955107; Min SY, 2016, NAT MED, V22, P312, DOI 10.1038/nm.4031; Morrison S, 2015, ADIPOCYTE, V4, P295, DOI 10.1080/21623945.2015.1040612; NECHAD M, 1983, BIOL CELL, V48, P167; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Orava J, 2013, OBESITY, V21, P2279, DOI 10.1002/oby.20456; Park J, 2017, DIABETES, V66, P1479, DOI 10.2337/db16-1081; Roh HC, 2018, CELL METAB, V27, P1121, DOI 10.1016/j.cmet.2018.03.005; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Shamsi F, 2017, METHODS MOL BIOL, V1566, P77, DOI 10.1007/978-1-4939-6820-6_8; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Silva FJ, 2014, STEM CELLS, V32, P572, DOI 10.1002/stem.1595; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Sun K, 2014, MOL METAB, V3, P474, DOI 10.1016/j.molmet.2014.03.010; Suzuki S, 2012, CELL STEM CELL, V10, P753, DOI 10.1016/j.stem.2012.04.021; Tanis RM, 2015, BBA-MOL CELL RES, V1853, P213, DOI 10.1016/j.bbamcr.2014.10.012; Tharp KM, 2015, DIABETES, V64, P3713, DOI 10.2337/db15-0728; Tran TT, 2010, NAT REV ENDOCRINOL, V6, P195, DOI 10.1038/nrendo.2010.20; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wilson R, 2015, STEM CELL TRANSL MED, V4, P905, DOI 10.5966/sctm.2014-0196; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yin H, 2013, CELL METAB, V17, P210, DOI 10.1016/j.cmet.2013.01.004; Zhu Z, 2014, PHYSIOL BEHAV, V125, P21, DOI 10.1016/j.physbeh.2013.11.008; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546; Zouhal H, 2008, SPORTS MED, V38, P401, DOI 10.2165/00007256-200838050-00004	56	2	2	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					8822	8835		10.1096/fj.201802162RR	http://dx.doi.org/10.1096/fj.201802162RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31059287	Green Published			2022-12-28	WOS:000478832900011
J	Patten, DA; Ouellet, M; Allan, DS; Germain, M; Baird, SD; Harper, ME; Richardson, RB				Patten, David A.; Ouellet, Mathieu; Allan, David S.; Germain, Marc; Baird, Stephen D.; Harper, Mary-Ellen; Richardson, Richard B.			Mitochondrial adaptation in human mesenchymal stem cells following ionizing radiation	FASEB JOURNAL			English	Article						IR; bioenergetics; ETC supercomplexes; mitochondrial dynamics	OXIDATIVE STRESS; ATP LOSS; COENZYME-Q10; MUSCLE; DIFFERENTIATION; SUPERCOMPLEXES; MECHANISM; RESPONSES; PROTEINS; OBESITY	Mitochondria are highly dynamic organelles that respond rapidly to a number of stressors to regulate energy transduction, cell death signaling, and reactive oxygen species generation. We hypothesized that mitochondrial remodeling, comprising both structural and functional alterations, following ionizing radiation (IR) may underlie some of the tenets of radiobiology. Mesenchymal stem cells (MSCs) are precursors of bone marrow stroma and are altered in acute myeloid leukemia and by radiation and chemotherapy. Here, we report on changes in mitochondrial remodeling in human MSCs following X-ray IR. Mitochondrial function was significantly increased in MSCs 4 h after IR as measured by mitochondrial oxygen consumption. Consistent with this elevated functional effect, electron transport chain supercomplexes were also increased in irradiated samples. In addition, mitochondria were significantly, albeit modestly, elongated, as measured by high-throughput automated confocal imaging coupled with automated mitochondrial morphometric analyses. We also demonstrate in fibroblasts that mitochondrial remodeling is required for the adaptation of cells to IR. To determine novel mechanisms involved in mitochondrial remodeling, we performed quantitative proteomics on isolated mitochondria from cells following IR. Label-free quantitative mitochondrial proteomics revealed notable changes in proteins in irradiated samples and identified prosaposin, and potentially its daughter protein saposin-B, as a potential candidate for regulating mitochondrial function following IR. Whereas research into the biologic effects of cellular irradiation has long focused on nuclear DNA effects, our experimental work, along with that of others, is finding that mitochondrial effects may have broader implications in the field of stress adaptation and cell death in cancer (including leukemia) and other disease states.-Patten, D. A., Ouellet, M., Allan, D. S., Germain, M., Baird, S. D., Harper, M.-E., Richardson, R. B. Mitochondrial adaptation in human mesenchymal stem cells following ionizing radiation.	[Patten, David A.; Richardson, Richard B.] CNL, Chalk River Labs, Radiobiol & Hlth Branch, Chalk River, ON K0J 1J0, Canada; [Patten, David A.; Allan, David S.; Harper, Mary-Ellen] Univ Ottawa, Dept Biochem Microbiol & Immunol, Fac Med, Ottawa, ON, Canada; [Patten, David A.; Harper, Mary-Ellen] Ottawa Inst Syst Biol, Ottawa, ON, Canada; [Ouellet, Mathieu; Germain, Marc] Univ Quebec Trois Rivieres, Dept Biol Med, Trois Rivieres, PQ, Canada; [Baird, Stephen D.] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada; [Richardson, Richard B.] Cedars Canc Ctr, McGill Med Phys Unit, Glen Site, Montreal, PQ, Canada	Atomic Energy of Canada Limited; University of Ottawa; University of Ottawa; University of Quebec; University of Quebec Trois Rivieres; University of Ottawa; Children's Hospital of Eastern Ontario	Richardson, RB (corresponding author), CNL, Chalk River Labs, Radiobiol & Hlth Branch, Chalk River, ON K0J 1J0, Canada.; Harper, ME (corresponding author), Univ Ottawa, Fac Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	mharper@uottawa.ca; richard.richardson@cnl.ca		Allan, David/0000-0003-3261-8289	Atomic Energy of Canada Limited Federal Nuclear Science and Technology Work Plan; CNL	Atomic Energy of Canada Limited Federal Nuclear Science and Technology Work Plan; CNL	The authors thank Jian Xuan for technical assistance, Dr. Chantal Pileggi for protocol development, Dr. Zhibin Ning of the Proteomics Resource Centre of the Ottawa Institute of Systems Biology (OISB) for technical support, and Dr. Patrick Giguere for access to essential equipment. This work was supported by the Atomic Energy of Canada Limited Federal Nuclear Science and Technology Work Plan. D.A.P. was supported by a postdoctoral fellowship from the CNL. The authors declare no conflicts of interest.	Akyurekli C, 2015, STEM CELL REV REP, V11, P150, DOI 10.1007/s12015-014-9545-9; Ali A, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0636-6; Antoun G, 2015, DIABETOLOGIA, V58, P2861, DOI 10.1007/s00125-015-3772-8; Azimzadeh O, 2012, J PROTEOMICS, V75, P2384, DOI 10.1016/j.jprot.2012.02.019; Bakshi MV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156952; Bertolo A, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-016-0452-7; Brand MD, 2005, BIOCHEM SOC T, V33, P897, DOI 10.1042/BST0330897; Broome EJ, 2002, RADIAT RES, V158, P181, DOI 10.1667/0033-7587(2002)158[0181:DRFATL]2.0.CO;2; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Connell PP, 2009, CANCER RES, V69, P383, DOI 10.1158/0008-5472.CAN-07-6871; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Enriquez JA, 2014, MOL SYNDROMOL, V5, P119, DOI 10.1159/000363364; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Hamalainen RH, 2015, CELL REP, V11, P1614, DOI 10.1016/j.celrep.2015.05.009; Hofmann AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035160; Hong M, 2010, BRIT J CANCER, V103, P1263, DOI 10.1038/sj.bjc.6605888; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jin G, 2008, J CLIN BIOCHEM NUTR, V42, P167, DOI 10.3164/jcbn.2008024; Kam WWY, 2013, FREE RADICAL BIO MED, V65, P607, DOI 10.1016/j.freeradbiomed.2013.07.024; Kasahara A, 2013, SCIENCE, V342, P734, DOI 10.1126/science.1241359; Kashiba M, 2017, J CLIN BIOCHEM NUTR, V60, P81, DOI 10.3164/jcbn.16-32; Kashiba M, 2014, J CLIN BIOCHEM NUTR, V55, P85, DOI 10.3164/jcbn.13-106; Khacho M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4550; Ki Y, 2017, J KOREAN MED SCI, V32, P757, DOI 10.3346/jkms.2017.32.5.757; Kiang JG, 2006, AM J PHYSIOL-GASTR L, V291, pG117, DOI 10.1152/ajpgi.00397.2005; Kiang JG, 2016, HEALTH PHYS, V111, P198, DOI 10.1097/HP.0000000000000459; Kloner RA, 2006, CARDIOVASC RES, V70, P297, DOI 10.1016/j.cardiores.2006.01.012; Lall R, 2014, CELL DEATH DIFFER, V21, P836, DOI 10.1038/cdd.2014.24; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Le Y, 2016, STEM CELL REV REP, V12, P235, DOI 10.1007/s12015-015-9639-z; Li QQ, 2017, PROTEIN CELL, V8, P439, DOI 10.1007/s13238-017-0385-7; Li WW, 2016, SCI REP-UK, V6, DOI 10.1038/srep32933; Liu XQ, 2009, ACTA PHARMACOL SIN, V30, P1071, DOI 10.1038/aps.2009.105; Lulli M, 2012, J RADIAT RES, V53, P695, DOI 10.1093/jrr/rrs025; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Maranzana E, 2013, ANTIOXID REDOX SIGN, V19, P1469, DOI 10.1089/ars.2012.4845; McMurray F, 2016, OBESITY, V24, P2301, DOI 10.1002/oby.21654; Meyer RC, 2014, BRAIN RES, V1585, P1, DOI 10.1016/j.brainres.2014.08.022; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Miura Y, 2004, J RADIAT RES, V45, P357, DOI 10.1269/jrr.45.357; Miura Y, 2007, J BIOCHEM, V142, P145, DOI 10.1093/jb/mvm118; Mookerjee SA, 2017, J BIOL CHEM, V292, P7189, DOI 10.1074/jbc.M116.774471; Moreno-Loshuertos R, 2016, FREE RADICAL BIO MED, V100, P5, DOI 10.1016/j.freeradbiomed.2016.04.018; Nias AHW, 1998, INTRO RADIOBIOLOGY; Nicholson AM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11992; Nicolay NH, 2015, ONCOTARGET, V6, P19366, DOI 10.18632/oncotarget.4358; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; OBRIEN JS, 1991, FASEB J, V5, P301, DOI 10.1096/fasebj.5.3.2001789; Ouellet M, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005612; Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349; Picard M, 2013, AM J PHYSIOL-REG I, V304, pR393, DOI 10.1152/ajpregu.00584.2012; Pileggi CA, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00546; Richardson RB, 2016, ONCOTARGET, V7, P21469, DOI 10.18632/oncotarget.7412; Richardson RB, 2011, INT J RADIAT BIOL, V87, P343, DOI 10.3109/09553002.2010.537430; Sart S, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/105135; Sokolov MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014195; Swift JM, 2015, RADIAT RES, V183, P684, DOI 10.1667/RR13853.1; Teslaa T, 2015, EMBO J, V34, P138, DOI 10.15252/embj.201490446; Thrush AB, 2018, INT J OBESITY, V42, P353, DOI 10.1038/ijo.2017.286; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Ullah I, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150025; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yamamori T, 2012, FREE RADICAL BIO MED, V53, P260, DOI 10.1016/j.freeradbiomed.2012.04.033; Zhang XY, 2018, METABOLISM, V81, P71, DOI 10.1016/j.metabol.2017.12.001; Zhang YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069715; Zhao YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121289	70	5	5	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9263	9278		10.1096/fj.201801483RR	http://dx.doi.org/10.1096/fj.201801483RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31112400	Green Published, hybrid			2022-12-28	WOS:000478832900045
J	Best, KT; Loiselle, AE				Best, Katherine T.; Loiselle, Alayna E.			Scleraxis lineage cells contribute to organized bridging tissue during tendon healing and identify a subpopulation of resident tendon cells	FASEB JOURNAL			English	Article						S100a4; myofibroblast; heterogeneity; regeneration; tenocyte	EXPRESSION; FIBROBLASTS; GENE; RECOMBINATION; MACROPHAGES; REPORTERS; TAMOXIFEN; FIBROSIS; FORCE	During tendon healing, it is postulated that tendon cells drive tissue regeneration, whereas extrinsic cells drive pathologic scar formation. Tendon cells are frequently described as a homogenous, fibroblast population that is positive for the marker Scleraxis (Scx). It is controversial whether tendon cells localize within the forming scar tissue during adult tendon healing. We have previously demonstrated that S100 calcium-binding protein A4 (S100a4) is a driver of tendon scar formation and marks a subset of tendon cells. The relationship between Scx and S100a4 has not been explored. In this study, we assessed the localization of Scx lineage cells (Scx(Lin)) following adult murine flexor tendon repair and established the relationship between Scx and S100a4 throughout both homeostasis and healing. We showed that adult Scx(Lin) localize within the scar tissue and organize into a cellular bridge during tendon healing. Additionally, we demonstrate that markers Scx and S100a4 label distinct populations in tendon during homeostasis and healing, with Scx found in the organized bridging tissue and S100a4 localized throughout the entire scar region. These studies define a heterogeneous tendon cell environment and demonstrate discrete contributions of subpopulations during healing. These data enhance our understanding and ability to target the cellular environment of the tendon.-Best, K. T., Loiselle, A. E. Scleraxis lineage cells contribute to organized bridging tissue during tendon healing and identify a subpopulation of resident tendon cells.	[Best, Katherine T.; Loiselle, Alayna E.] Univ Rochester, Med Ctr, Dept Orthopaed & Rehabil, Ctr Musculoskeletal Res, Rochester, NY 14642 USA	University of Rochester	Loiselle, AE (corresponding author), Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, 601 Elmwood Ave,Box 665, Rochester, NY 14642 USA.	alayna_loiselle@urmc.rochester.edu			U.S. National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [K01AR068386, R01AR073169]; NIH/NIAMS [P30AR069655]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR069655, K01AR068386, R01AR073169] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank the Histology, Biochemistry and Molecular Imaging (HBMI; University of Rochester, Rochester, NY, USA) Core for technical assistance. This work was supported in part by the U.S. National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (Grants K01AR068386 and R01AR073169 to A.E.L.). The HBMI and BBMTI Cores are supported by NIH/NIAMS Grant P30AR069655. The authors declare no conflicts of interest.	Abe H, 2012, J BIOL CHEM, V287, P20430, DOI 10.1074/jbc.M111.275610; Ackerman JE, 2019, ELIFE, V8, DOI 10.7554/eLife.45342; Ackerman JE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09407-7; Ackerman JE, 2016, JOVE-J VIS EXP, DOI 10.3791/54433; Al-Hattab DS, 2018, AM J PHYSIOL-HEART C, V315, pH658, DOI 10.1152/ajpheart.00092.2018; Bagchi RA, 2016, CELL TISSUE RES, V366, P381, DOI 10.1007/s00441-016-2439-1; Bagchi RA, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0243-8; Baum J, 2011, J CARDIOVASC PHARM, V57, P376, DOI 10.1097/FJC.0b013e3182116e39; Beredjiklian PK, 2003, ANN BIOMED ENG, V31, P1143, DOI 10.1114/1.1616931; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dyment NA, 2016, JOVE-J VIS EXP, DOI 10.3791/54468; Dyment NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096113; Dyment NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059944; Espira L, 2009, J MOL CELL CARDIOL, V47, P188, DOI 10.1016/j.yjmcc.2009.03.024; Favata M, 2006, J ORTHOP RES, V24, P2124, DOI 10.1002/jor.20271; Howell K, 2017, SCI REP-UK, V7, DOI 10.1038/srep45238; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Lejard V, 2007, J BIOL CHEM, V282, P17665, DOI 10.1074/jbc.M610113200; Li YA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01776; Liu J, 2013, GENESIS, V51, P436, DOI 10.1002/dvg.22384; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maeda T, 2011, CURR BIOL, V21, P933, DOI 10.1016/j.cub.2011.04.007; Mendias CL, 2012, J ORTHOP RES, V30, P606, DOI 10.1002/jor.21550; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Pakshir P, 2018, MATRIX BIOL, V68-69, P81, DOI 10.1016/j.matbio.2018.01.019; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Sakabe T, 2018, J BIOL CHEM, V293, P5766, DOI 10.1074/jbc.RA118.001987; Sato F, 2017, HISTOCHEM CELL BIOL, V148, P617, DOI 10.1007/s00418-017-1597-x; Weng DY, 2008, MOL VIS, V14, P562	30	33	33	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8578	8587		10.1096/fj.201900130RR	http://dx.doi.org/10.1096/fj.201900130RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30951381	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000476234700061
J	Fu, YX; Liu, SH; Wang, YY; Ren, FL; Fan, XZ; Liang, J; Liu, CX; Li, J; Ju, YF; Chang, ZJ				Fu, Yanxia; Liu, Sihan; Wang, Yinyin; Ren, Fangli; Fan, Xuanzi; Liang, Jiao; Liu, Chunxiao; Li, Jun; Ju, Yanfang; Chang, Zhijie			GdX/UBL4A-knockout mice resist collagen-induced arthritis by balancing the population of T(h)1/T(h)17 and regulatory T cells	FASEB JOURNAL			English	Article						autoimmune disease; rheumatoid arthritis; T-cell subset; inflammation	RHEUMATOID-ARTHRITIS; MONOCLONAL-ANTIBODY; RADIX LINDERAE; DOUBLE-BLIND; AUTOIMMUNE; INTERLEUKIN-17; TH17; DESTRUCTION; CD4(+); INFLAMMATION	Rheumatoid arthritis (RA) is an autoimmune disease associated with synovial hyperplasia and bone and cartilage destruction. T cells, notably T helper (T-h)-1 and T(h)17 cells, play a critical role in the pathologic process of RA. However, it remains unclear how T(h)1 and T(h)17 cells are regulated during RA. In this study, we report that the small ubiquitin-like protein X-linked gene in the G6PD cluster at Xq28 (GdX) regulates the balance of T(h)17 and regulatory T (T-reg) cells during collagen-induced arthritis (CIA). We discovered that the splenocytes of GdX-knockout (KO) mice were insensitive to T-cell stimulants. Correspondingly, GdX-KO mice showed alleviative T(h)1-mediated delayed-type hypersensitivity and were resistant to CIA compared with wild-type mice. GdX-KO mice showed fewer swollen paws, lower serum proinflammatory cytokine and anti-collagen IgG levels, and decreased synovial hyperplasia. Mechanistically, we observed that deletion of GdX decreased the transcription of proinflammatory cytokines and impaired the T(h)1 and T(h)17 differentiation but increased the T-reg cell proliferation. Consistently, deletion of GdX decreased the transcription level of T-cell-specific T-box transcription factor and RAR-related orphan receptor-gamma transcription factor but increased that of forkhead box P3 after being challenged with type-II collagen. These findings suggested that GdX functions as an important regulator of T(h)1 or T(h)17 and T-reg cell balance during the inflammatory responses. Therefore, GdX may be a potential target for the therapy of RA.-Fu, Y., Liu, S., Wang, Y., Ren, F., Fan, X., Liang, J., Liu, C., Li, J., Ju, Y., Chang, Z. GdX/UBL4A-knockout mice resist collagen-induced arthritis by balancing the population of T(h)1/T(h)17 and regulatory T cells.	[Fu, Yanxia; Liu, Sihan; Wang, Yinyin; Ren, Fangli; Fan, Xuanzi; Liang, Jiao; Liu, Chunxiao; Chang, Zhijie] Tsinghua Univ, Sch Med, State Key Lab Membrane Biol, Beijing, Peoples R China; [Fu, Yanxia] Tsinghua Univ Peking Univ Joint Ctr Life Sci, Beijing, Peoples R China; [Li, Jun] Third Mil Med Univ, PLA, Inst Immunol, Chongqing, Peoples R China; [Ju, Yanfang] Peoples Liberat Army Gen Hosp, Dept Gastroenterol, Beijing, Peoples R China	Tsinghua University; Army Medical University; Chinese People's Liberation Army General Hospital	Chang, ZJ (corresponding author), Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.	zhijiec@tsinghua.edu.cn	Wang, Yin/HCI-9352-2022; Chang, Zhijie/AAH-8109-2019	Chang, Zhijie/0000-0003-1567-3227	Chinese National Major Scientific Research Program [2016YFA0500301]; National Natural Science Foundation of China [81830092, 81572729, 81572728, 81872244, 81872249]; Tsinghua University-Perking University Joint Center for Life Sciences	Chinese National Major Scientific Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University-Perking University Joint Center for Life Sciences	This work was supported by a grant from the Chinese National Major Scientific Research Program (2016YFA0500301), grants from the National Natural Science Foundation of China (81830092, 81572729, 81572728, 81872244, and 81872249), and the Tsinghua University-Perking University Joint Center for Life Sciences. The authors declare no conflicts of interest.	Beringer A, 2016, TRENDS MOL MED, V22, P230, DOI 10.1016/j.molmed.2016.01.001; Blanco FJ, 2017, ARTHRITIS RHEUMATOL, V69, P1144, DOI 10.1002/art.40070; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Bystrom J, 2017, CLIN REV ALLERG IMMU, V53, P265, DOI 10.1007/s12016-017-8610-y; Chabaud M, 2000, CYTOKINE, V12, P1092, DOI 10.1006/cyto.2000.0681; Chen MG, 2013, ARTHRITIS RHEUM-US, V65, P1181, DOI 10.1002/art.37894; Cheng Y, 2018, J IND INF INTEGR, V9, P1, DOI 10.1016/j.jii.2017.08.001; Chyuan IT, 2018, CELL MOL IMMUNOL, V15, P846, DOI 10.1038/cmi.2017.2; Nguyen DX, 2016, J EXP MED, V213, P1241, DOI 10.1084/jem.20151255; Delgado M, 2001, NAT MED, V7, P563, DOI 10.1038/87887; Fu YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098137; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Gizinski AM, 2014, CURR OPIN RHEUMATOL, V26, P204, DOI 10.1097/BOR.0000000000000036; Hashimoto M, 2017, J CLIN MED, V6, DOI 10.3390/jcm6070073; Hussein MR, 2008, PATHOL ONCOL RES, V14, P321, DOI 10.1007/s12253-008-9016-1; Kim EY, 2017, CYTOKINE, V98, P87, DOI 10.1016/j.cyto.2017.04.012; Koenders MI, 2005, ARTHRITIS RHEUM-US, V52, P3239, DOI 10.1002/art.21342; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Krenciute G, 2013, J BIOL CHEM, V288, P20547, DOI 10.1074/jbc.M112.443416; Leung S, 2010, CELL MOL IMMUNOL, V7, P182, DOI 10.1038/cmi.2010.22; Liang J, 2018, CELL BIOCHEM FUNCT, V36, P129, DOI 10.1002/cbf.3324; Liu CX, 2019, THERANOSTICS, V9, P1369, DOI 10.7150/thno.32451; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Luo Y, 2010, PHYTOMEDICINE, V17, P726, DOI 10.1016/j.phymed.2010.01.013; Ma AL, 2017, MOL MED REP, V15, P3615, DOI 10.3892/mmr.2017.6484; Marcinska K, 2016, PHARMACOL REP, V68, P483, DOI 10.1016/j.pharep.2015.11.004; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Mellado M, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00384; Metawi SA, 2011, CLIN RHEUMATOL, V30, P1201, DOI 10.1007/s10067-011-1737-y; Miller DC, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-015-0909-6; Noack M, 2014, AUTOIMMUN REV, V13, P668, DOI 10.1016/j.autrev.2013.12.004; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Park JS, 2014, J IMMUNOL, V192, P4417, DOI 10.4049/jimmunol.1300514; Pickens SR, 2010, J IMMUNOL, V184, P3233, DOI 10.4049/jimmunol.0903271; Ren YN, 2014, INT IMMUNOPHARMACOL, V21, P247, DOI 10.1016/j.intimp.2014.05.004; Roberts CA, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00571; Sarkar S, 2013, ARTHRITIS RHEUM-US, V65, P960, DOI 10.1002/art.37849; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Toussirot E, 2018, EXPERT OPIN BIOL TH, V18, P101, DOI 10.1080/14712598.2018.1410133; Wang C, 2007, J ETHNOPHARMACOL, V111, P322, DOI 10.1016/j.jep.2006.11.031; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Wang YM, 2014, MOL CELL, V53, P752, DOI 10.1016/j.molcel.2014.01.020; Wang YM, 2012, GENESIS, V50, P534, DOI 10.1002/dvg.20832; Xia M, 2013, IMMUNITY, V39, P470, DOI 10.1016/j.immuni.2013.08.016; Zhao Y, 2015, P NATL ACAD SCI USA, V112, P9644, DOI 10.1073/pnas.1508647112	47	4	5	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8375	8385		10.1096/fj.201802217RR	http://dx.doi.org/10.1096/fj.201802217RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	31002527				2022-12-28	WOS:000476234700046
J	Hu, DL; Dong, RL; Yang, Y; Chen, ZH; Tang, Y; Fu, ML; Wang, DW; Xu, XZ; Tu, L				Hu, Danli; Dong, Ruolan; Yang, Yan; Chen, Zhihui; Tang, Ying; Fu, Menglu; Wang, Dao Wen; Xu, Xizhen; Tu, Ling			Human kallikrein overexpression alleviates cardiac aging by alternatively regulating macrophage polarization in aged rats	FASEB JOURNAL			English	Article						oxidative stress; mitochondria dysfunction; cardiac fibrosis	CARDIOVASCULAR-DISEASE ENTERPRISES; MYOCARDIAL-INFARCTION; MAJOR SHAREHOLDERS; B2 RECEPTOR; FIBROSIS; HYPERTROPHY; HEART; INFLAMMATION; ARTERIAL; ACTIVATION	Cardiac aging is characterized by myocardial hypertrophy, fibrosis, and diastolic dysfunction. Human kallikrein (hKLK1) protects against fibrosis in various pathogenic states. However, the effects of hKLK1 overexpression on cardiac aging-related fibrosis and the underlying mechanisms remain unknown. Moreover, the role of hKLK1 in regulating macrophage function leading to cardiac fibrosis has not been investigated. Thus, in this study, we determined the effects of hKLK1 on cardiac aging and explored the mechanisms through which hKLK1 regulated aging-related fibrosis. Echocardiographic measurements showed that aging caused significant alternations in cardiac morphology, hypertrophy, and fibrosis in rats, and hKLK1 overexpression protected against aging-induced cardiac dysfunction. Compared with wild-type hearts, the hKLK1 transgene decreased the expression of monocyte chemoattractant protein 1 and suppressed mitochondrial dysfunction and excess oxidative stress, leading to decreased recruitment and retention of alternatively activated (M2) macrophages and reduced secretion of profibrotic cytokines mediated by the TGF-beta 1-Smad3 signaling pathway in hearts of aging rats. Furthermore, these cardioprotective effects of hKLK1 overexpression were associated with the Janus kinase-signal transducer and activator of transcription 3 signaling pathway. H2O2-induced senescence promoted the differentiation of RAW264.7 cells into M2-type cells induced by IL-4 treatment. Bradykinin treatment relieved the migratory capacity of macrophages induced by H2O2. Thus, hKLK1 overexpression reduced cardiac fibrosis and improved aging-related cardiac dysfunction through reduced shift of macrophages to M2 macrophages, indicating that hKLK1 may alleviate aging-related cardiac dysfunction.-Hu, D., Dong, R., Yang, Y., Chen, Z., Tang, Y., Fu, M., Wang, D. W., Xu, X., Tu, L. Human kallikrein overexpression alleviates cardiac aging by alternatively regulating macrophage polarization in aged rats.	[Hu, Danli; Yang, Yan; Chen, Zhihui; Tang, Ying; Fu, Menglu; Tu, Ling] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Geriatr Med, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China; [Dong, Ruolan] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Inst Integrated Tradit Chinese & Western Med, Wuhan, Hubei, Peoples R China; [Wang, Dao Wen; Xu, Xizhen] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Div Cardiol,Dept Internal Med, Wuhan, Hubei, Peoples R China; [Hu, Danli] Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Natl Clin Res Ctr Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Hu, Danli] Peking Union Med Coll, Beijing, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Tu, L (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Geriatr Med, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China.; Xu, XZ (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Internal Med, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China.	xzxu@tjh.tjmu.edu.cn; lingtu@tjh.tjmu.edu.cn	fu, meng/GZG-3120-2022		National Natural Science Foundation of China [81170111, 81471021]; Hu Bei Health and Family Planning Commission [WJ2015MB006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hu Bei Health and Family Planning Commission	The authors thank Dr. Michael Bader for providing the hKLK1-overexpressing rats. This work was partially supported by funding from the National Natural Science Foundation of China (81170111 and 81471021) and the Hu Bei Health and Family Planning Commission (WJ2015MB006). The authors declare no conflicts of interest.	Ardiles L, 2013, AM J PHYSIOL-RENAL, V304, pF1399, DOI 10.1152/ajprenal.00604.2012; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; Cieslik KA, 2014, J MOL CELL CARDIOL, V70, P56, DOI 10.1016/j.yjmcc.2013.10.017; Dong RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077034; Donlin LT, 2014, J IMMUNOL, V193, P2373, DOI 10.4049/jimmunol.1400486; Feng WJ, 2016, J GERONTOL A-BIOL, V71, P178, DOI 10.1093/gerona/glu210; Fontes MSC, 2015, J MOL CELL CARDIOL, V88, P82, DOI 10.1016/j.yjmcc.2015.09.015; Glezeva N, 2015, J MOL CELL CARDIOL, V89, P136, DOI 10.1016/j.yjmcc.2015.10.029; Goh J, 2014, MECH AGEING DEV, V139, P41, DOI 10.1016/j.mad.2014.06.004; Hariharan N, 2015, J MOL CELL CARDIOL, V83, P32, DOI 10.1016/j.yjmcc.2015.04.008; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Kapoor N, 2015, J IMMUNOL, V194, P6011, DOI 10.4049/jimmunol.1402797; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lakatta EG, 2003, CIRCULATION, V107, P490, DOI 10.1161/01.CIR.0000048894.99865.02; Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111; Li HJ, 2007, CARDIOVASC RES, V73, P130, DOI 10.1016/j.cardiores.2006.10.014; Liu X, 2015, J BIOL CHEM, V290, P25933, DOI 10.1074/jbc.M115.663542; Ma YG, 2015, CARDIOVASC RES, V106, P421, DOI 10.1093/cvr/cvv128; Maurer M, 2011, ALLERGY, V66, P1397, DOI 10.1111/j.1398-9995.2011.02686.x; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; O'Donoghue RJJ, 2012, EMBO MOL MED, V4, P939, DOI 10.1002/emmm.201100604; Rahmutula D, 2013, CARDIOVASC RES, V99, P769, DOI 10.1093/cvr/cvt074; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Sakai N, 2006, J LEUKOCYTE BIOL, V79, P555, DOI 10.1189/jlb.0305127; Sangaralingham SJ, 2011, HYPERTENSION, V57, P201, DOI 10.1161/HYPERTENSIONAHA.110.160796; Sen N, 2011, MOL CELL, V44, P621, DOI 10.1016/j.molcel.2011.08.044; Shen JZ, 2014, ENDOCRINOLOGY, V155, P1057, DOI 10.1210/en.2013-1772; Shivshankar P, 2014, J MOL CELL CARDIOL, V76, P84, DOI 10.1016/j.yjmcc.2014.07.020; Silva JA, 2008, INT IMMUNOPHARMACOL, V8, P267, DOI 10.1016/j.intimp.2007.09.005; Silva JA, 2000, FASEB J, V14, P1858; Toba H, 2015, AM J PHYSIOL-CELL PH, V308, pC972, DOI 10.1152/ajpcell.00402.2014; Ullevig S, 2012, ARTERIOSCL THROM VAS, V32, P415, DOI 10.1161/ATVBAHA.111.238899; Wang XW, 2015, J MOL CELL CARDIOL, V80, P101, DOI 10.1016/j.yjmcc.2015.01.001; White DA, 2014, J MOL CELL CARDIOL, V69, P32, DOI 10.1016/j.yjmcc.2014.01.015; Xia Ying, 2007, Inflammation & Allergy Drug Targets, V6, P101; Xu DC, 2011, HYPERTENSION, V58, P303, DOI 10.1161/HYPERTENSIONAHA.110.166819; Xu Q, 2016, J BIOL CHEM, V291, P20030, DOI 10.1074/jbc.M116.731216; Xu XZ, 2010, DIABETES, V59, P997, DOI 10.2337/db09-1241; Yabluchanskiy A, 2016, J GERONTOL A-BIOL, V71, P475, DOI 10.1093/gerona/glv034; Yan L, 2013, AGE, V35, P2177, DOI 10.1007/s11357-012-9508-5; Yang M, 2012, ARTERIOSCL THROM VAS, V32, P1675, DOI 10.1161/ATVBAHA.112.248732; Zandi S, 2015, CELL REP, V10, P1173, DOI 10.1016/j.celrep.2015.01.050; Zhang B, 2015, EXP NEUROL, V273, P83, DOI 10.1016/j.expneurol.2015.08.001; Zhang Y, 2013, CELL RES, V23, P898, DOI 10.1038/cr.2013.75; Zhao G, 2012, HUM GENE THER, V23, P688, DOI 10.1089/hum.2011.135	45	6	6	1	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8436	8452		10.1096/fj.201802371RR	http://dx.doi.org/10.1096/fj.201802371RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30995868				2022-12-28	WOS:000476234700050
J	Lee, HJ; Yoon, JW; Jung, KM; Kim, YM; Park, JS; Lee, KY; Park, KJ; Hwang, YS; Park, YH; Rengaraj, D; Han, JY				Lee, Hong Jo; Yoon, Jong Won; Jung, Kyung Mm; Kim, Young Mm; Park, Jin Se; Lee, Kyung Youn; Park, Kyung Je; Hwang, Young Sun; Park, Young Hyun; Rengaraj, Deivendran; Han, Jae Yong			Targeted gene insertion into Z chromosome of chicken primordial germ cells for avian sexing model development	FASEB JOURNAL			English	Article						CRISPR; Cas9; genome modification; Z chromosome targeting; chicken sexing	HOMOLOGOUS RECOMBINATION; READ ALIGNMENT; DNA-REPAIR; CLEAVAGE; CAS9; CRISPR/CAS9	Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein 9 (Cas9) have facilitated the production of genome-edited animals for use as models. Because of their unique developmental system, avian species offer many advantages as model vertebrates. Here, we report the development of novel chicken models using the CRISPR/Cas9-mediated nonhomologous end joining repair pathway in chicken primordial germ cells (PGCs). Through the introduction of a donor plasmid containing short guide RNA recognition sequences and CRISPR/Cas9 plasmids into chicken PGCs, exogenous genes of donor plasmids were precisely inserted into target loci, and production of transgenic chickens was accomplished through subsequent transplantation of the Z chromosome-targeted PGCs. Using this method, we successfully accomplished the targeted gene insertion to the chicken sex Z chromosome without detected off-target effects. The genome-modified chickens robustly expressed green fluorescent protein from the Z chromosome, which could then be used for easy sex identification during embryogenesis. Our results suggest that this powerful genome-editing method could be used to develop many chicken models and should significantly expand the application of genome-modified avians.-Lee, H. J., Yoon, J. W., Jung, K. M., Kim, Y. M., Park, J. S., Lee, K. Y., Park, K. J., Hwang, Y. S., Park, Y. H., Rengaraj, D., Han, J. Y. Targeted gene insertion into Z chromosome of chicken primordial germ cells for avian sexing model development.	[Lee, Hong Jo; Yoon, Jong Won; Jung, Kyung Mm; Kim, Young Mm; Park, Jin Se; Lee, Kyung Youn; Park, Kyung Je; Hwang, Young Sun; Park, Young Hyun; Rengaraj, Deivendran; Han, Jae Yong] Seoul Natl Univ, Res Inst Agr & Life Sci, Dept Agr Biotechnol, Seoul, South Korea	Seoul National University (SNU)	Han, JY (corresponding author), Seoul Natl Univ, 1 Gwanak Ro, Seoul 08826, South Korea.	jaehan@snu.ac.kr	Rengaraj, Deivendran/C-5593-2015	Rengaraj, Deivendran/0000-0001-9274-9921; Hwang, Young Sun/0000-0002-6443-9579; Jung, Kyung Min/0000-0002-5791-2655	National Research Foundation of Korea (NRF) - Korea government (Ministry of Science, Information & Communication Technology (ICT), and Future Planning; MSIT) [2015R1A3A2033826]; BK21 Plus Program of the Department of Agricultural Biotechnology, Seoul National University, Seoul, Korea	National Research Foundation of Korea (NRF) - Korea government (Ministry of Science, Information & Communication Technology (ICT), and Future Planning; MSIT); BK21 Plus Program of the Department of Agricultural Biotechnology, Seoul National University, Seoul, Korea	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (Ministry of Science, Information & Communication Technology (ICT), and Future Planning; MSIT) (No.2015R1A3A2033826)". This work was also supported by the BK21 Plus Program of the Department of Agricultural Biotechnology, Seoul National University, Seoul, Korea. The patent application was submitted (10-2018-0163115). All data generated or analyzed during this study are included in this published article. The authors declare no conflicts of interest.	Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bertram K, 2017, CELL, V170, P701, DOI 10.1016/j.cell.2017.07.011; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Burgess DJ, 2018, NAT REV DRUG DISCOV, V17, P95, DOI 10.1038/nrd.2018.3; Cao MM, 2014, J VIROL, V88, P14078, DOI 10.1128/JVI.02475-14; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cristea S, 2013, BIOTECHNOL BIOENG, V110, P871, DOI 10.1002/bit.24733; Dimitrov L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154303; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Galli R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192554; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Hisano Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08841; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Keane TM, 2013, BIOINFORMATICS, V29, P389, DOI 10.1093/bioinformatics/bts697; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Kimura Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06545; Lackner DH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10237; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee HJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112245; Lee HJ, 2016, FASEB J, V30, P555, DOI 10.1096/fj.15-274712; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Oishi I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28438-2; Oishi I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23980; Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; Parrales A, 2016, NAT CELL BIOL, V18, P1233, DOI 10.1038/ncb3427; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reardon S, 2016, NATURE, V531, P160, DOI 10.1038/531160a; Rengaraj D, 2013, THERIOGENOLOGY, V79, P28, DOI 10.1016/j.theriogenology.2012.09.004; Rong ZL, 2014, PROTEIN CELL, V5, P258, DOI 10.1007/s13238-014-0032-5; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Schmid-Burgk JL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12338; Taylor L, 2017, DEVELOPMENT, V144, P928, DOI 10.1242/dev.145367; Tena JJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1301; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431; Zheng QT, 2017, P NATL ACAD SCI USA, V114, pE9474, DOI 10.1073/pnas.1707853114; Zlotorynski E, 2016, NAT REV GENET, V17, P65, DOI 10.1038/nrg.2015.35; Zu Y, 2013, NAT METHODS, V10, P329, DOI 10.1038/NMETH.2374	48	21	22	1	39	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8519	8529		10.1096/fj.201802671R	http://dx.doi.org/10.1096/fj.201802671R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30951374	Bronze			2022-12-28	WOS:000476234700056
J	Trigiani, LJ; Royea, J; Tong, XK; Hamel, E				Trigiani, Lianne J.; Royea, Jessika; Tong, Xin-Kang; Hamel, Edith			Comparative benefits of simvastatin and exercise in a mouse model of vascular cognitive impairment and dementia	FASEB JOURNAL			English	Article						white matter; inflammation; memory; cerebrovascular reactivity; cerebral blood flow	WHITE-MATTER INTEGRITY; CEREBRAL-BLOOD-FLOW; ALZHEIMERS-DISEASE; PHYSICAL-EXERCISE; TRANSFORMING GROWTH-FACTOR-BETA-1; HIPPOCAMPAL NEUROGENESIS; REDUCED RISK; CHOLESTEROL; MEMORY; PATHOLOGY	Aerobic physical exercise (EX) and controlling cardiovascular risk factors in midlife can improve and protect cognitive function in healthy individuals and are considered to be effective at reducing late-onset dementia incidence. By investigating commonalities between these preventative approaches, we sought to identify possible targets for effective interventions. We compared the efficacy of EX and simvastatin (SV) pharmacotherapy to counteract cognitive deficits induced by a high-cholesterol diet (2%, HCD) in mice overexpressing TGF-beta 1 (TGF mice), a model of vascular cognitive impairment and dementia. Cognitive deficits were found in hypercholesterolemic mice for object recognition memory, and both SV and EX prevented this decline. EX improved stimulus-evoked cerebral blood flow responses and was as effective as SV in normalizing endothelium-dependent vasodilatory responses in cerebral arteries. The up-regulation of galectin-3 positive microglial cells in white matter (WM) of HCD-fed TGF mice with cognitive deficits was significantly reduced by both SV and EX concurrently with cognitive recovery. Altered hippocampal neurogenesis, gray matter astrogliosis, or microgliosis did not correlate with cognitive deficits or benefits. Overall, results indicate that SV and EX prevented cognitive decline in hypercholesterolemic mice and that they share common sites of action in preventing endothelial cell dysfunction and reducing WM inflammation.	[Trigiani, Lianne J.; Royea, Jessika; Tong, Xin-Kang; Hamel, Edith] McGill Univ, Montreal Neurol Inst, Lab Cerebrovasc Res, 3801 Univ St, Montreal, PQ H3A 2B4, Canada	McGill University	Trigiani, LJ; Hamel, E (corresponding author), McGill Univ, Montreal Neurol Inst, Lab Cerebrovasc Res, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	lianne.trigiani@mail.mcgill.ca; edith.hamel@mcgill.ca			Canadian Institutes of Health Research (CIHR) [MOP-126001]; Alzheimer Society of Canada; Canadian Vascular Network (CVN); Canadian Consortium on Neurodegeneration in Aging (CCNA); CIHR; Fonds de Recherche du Quebec-Sante; Healthy Brains for Healthy Lives	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alzheimer Society of Canada; Canadian Vascular Network (CVN); Canadian Consortium on Neurodegeneration in Aging (CCNA); CIHR(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Healthy Brains for Healthy Lives	The authors thank Dr. L. Mucke and the J. David Gladstone Institutes for providing the TGF transgenic mice for breeding (Gladstone Institute of Neurological Disease and Department of Neurology, University of California-San Francisco San Francisco, CA, USA). This study was supported by grants from the Canadian Institutes of Health Research (CIHR; Grant MOP-126001 to E.H.), the Alzheimer Society of Canada, the Canadian Vascular Network (CVN), and the Canadian Consortium on Neurodegeneration in Aging (CCNA), and studentships (to L.J.T.) from CIHR, Alzheimer Society of Canada, Fonds de Recherche du Quebec-Sante, and Healthy Brains for Healthy Lives. The authors declare no conflicts of interest.	Ahlskog JE, 2011, MAYO CLIN PROC, V86, P876, DOI 10.4065/mcp.2011.0252; Angelopoulos P, 2008, INT J NEUROSCI, V118, P1659, DOI 10.1080/00207450701392068; Anstey KJ, 2008, AM J GERIAT PSYCHIAT, V16, P343, DOI 10.1097/JGP.0b013e31816b72d4; Barnes Jill N, 2018, Brain Plast, V4, P65, DOI 10.3233/BPL-180075; Belarbi K, 2011, NEUROBIOL DIS, V43, P486, DOI 10.1016/j.nbd.2011.04.022; Bettermann K, 2012, J STROKE CEREBROVASC, V21, P436, DOI 10.1016/j.jstrokecerebrovasdis.2010.11.002; Bherer Louis, 2013, J Aging Res, V2013, P197326, DOI [10.1155/2013/657508, 10.1155/2013/197326]; Boyle PA, 2016, ANN CLIN TRANSL NEUR, V3, P791, DOI 10.1002/acn3.343; Brugniaux JV, 2014, J CEREBR BLOOD F MET, V34, P1873, DOI 10.1038/jcbfm.2014.142; Buckwalter MS, 2006, AM J PATHOL, V169, P154, DOI 10.2353/ajpath.2006.051272; Chapman SB, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00075; Chen BR, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000787; Cuello AC, 2017, TRENDS PHARMACOL SCI, V38, P956, DOI 10.1016/j.tips.2017.07.005; Czuba E, 2017, METAB BRAIN DIS, V32, P935, DOI 10.1007/s11011-017-0015-3; Dalla Y, 2010, PHARMACOL REP, V62, P784, DOI 10.1016/S1734-1140(10)70339-X; Dao AT, 2015, MOL NEUROBIOL, V52, P1067, DOI 10.1007/s12035-014-8916-1; de Assis GG, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00584; deIpolyi AR, 2008, NEUROBIOL AGING, V29, P253, DOI 10.1016/j.neurobiolaging.2006.10.021; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; DeVito LM, 2010, BEHAV BRAIN RES, V215, P318, DOI 10.1016/j.bbr.2009.09.014; Diederich K, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00047; Dougherty Ryan J, 2016, Alzheimers Dement (Amst), V4, P14, DOI 10.1016/j.dadm.2016.03.005; Dufouil C, 2005, NEUROLOGY, V64, P1531, DOI 10.1212/01.WNL.0000160114.42643.31; Endo F, 2015, CELL REP, V11, P592, DOI 10.1016/j.celrep.2015.03.053; Fields RD, 2010, SCIENCE, V330, P768, DOI 10.1126/science.1199139; Franciosi S, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-42; Gaertner RF, 2005, NEUROBIOL DIS, V19, P38, DOI 10.1016/j.nbd.2004.11.008; Garcia-Mesa Y, 2011, J ALZHEIMERS DIS, V24, P421, DOI 10.3233/JAD-2011-101635; Gomez-Pinilla F, 2013, COMPR PHYSIOL, V3, P403, DOI 10.1002/cphy.c110063; Graham NL, 2004, J NEUROL NEUROSUR PS, V75, P61; Grammas P, 2002, AM J PATHOL, V160, P1583, DOI 10.1016/S0002-9440(10)61105-4; Haag MDM, 2009, J NEUROL NEUROSUR PS, V80, P13, DOI 10.1136/jnnp.2008.150433; Harris JJ, 2012, J NEUROSCI, V32, P356, DOI 10.1523/JNEUROSCI.3430-11.2012; Heverin M, 2015, BEHAV BRAIN RES, V278, P356, DOI 10.1016/j.bbr.2014.10.018; Hillis JM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0651-2; Hohsfield LA, 2014, MOL CELL NEUROSCI, V63, P83, DOI 10.1016/j.mcn.2014.10.006; Holmberg E, 2006, J NEUROTRAUM, V23, P1366, DOI 10.1089/neu.2006.23.1366; Horder H, 2018, NEUROLOGY, V90, pE1298, DOI 10.1212/WNL.0000000000005290; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Iturria-Medina Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11934; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kantarci K, 2017, NEUROBIOL AGING, V56, P172, DOI 10.1016/j.neurobiolaging.2017.04.024; Kitabatake Y, 2007, NEUROSURG CLIN N AM, V18, P105, DOI 10.1016/j.nec.2006.10.008; Kitayama J, 2007, STROKE, V38, P2136, DOI 10.1161/STROKEAHA.107.481879; Kril JJ, 2002, J NEUROL NEUROSUR PS, V72, P747, DOI 10.1136/jnnp.72.6.747; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; Li L, 2006, ANN NEUROL, V60, P729, DOI 10.1002/ana.21053; Lifshitz V, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.01.006; Malaguarnera L, 2006, NEUROPATHOLOGY, V26, P307, DOI 10.1111/j.1440-1789.2006.00701.x; Martin MG, 2014, EMBO REP, V15, P1036, DOI 10.15252/embr.201439225; McFarland AJ, 2014, INT J MOL SCI, V15, P20607, DOI 10.3390/ijms151120607; Murrell CJ, 2013, AGE, V35, P905, DOI 10.1007/s11357-012-9414-x; Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5; Nicolakakis N, 2011, J CEREBR BLOOD F MET, V31, P200, DOI 10.1038/jcbfm.2010.78; Notkola IL, 1998, NEUROEPIDEMIOLOGY, V17, P14, DOI 10.1159/000026149; Padurariu M, 2012, PSYCHIAT DANUB, V24, P152; Patten Anna R, 2015, Brain Plast, V1, P97, DOI 10.3233/BPL-150016; Prins ND, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.10; Rahimian R, 2018, DRUG DISCOV TODAY, V23, P375, DOI 10.1016/j.drudis.2017.11.004; Raj D, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00206; Schreurs BG, 2010, NEUROSCI BIOBEHAV R, V34, P1366, DOI 10.1016/j.neubiorev.2010.04.010; Shabir O, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0465-5; Shobin E, 2017, GEROSCIENCE, V39, P199, DOI 10.1007/s11357-017-9965-y; Smit RAJ, 2016, CIRCULATION, V134, P212, DOI 10.1161/CIRCULATIONAHA.115.020627; Stapleton PA, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-54; Stein A, 2015, MOL THER, V23, P1160, DOI 10.1038/mt.2015.69; Sun ZY, 2017, PSYCHIAT RES, V257, P249, DOI 10.1016/j.psychres.2017.07.075; Tarkowski E, 2002, NEUROBIOL AGING, V23, P237, DOI 10.1016/S0197-4580(01)00285-8; Tarkowski E, 2003, BRAIN RES BULL, V61, P255, DOI 10.1016/S0361-9230(03)00088-1; Tong X. K., 2015, BRAIN BRAIN PET C VA; Tong XK, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1199-0; Tong XK, 2015, J CEREBR BLOOD F MET, V35, P512, DOI 10.1038/jcbfm.2014.226; Tong XK, 2012, J NEUROSCI, V32, P4705, DOI 10.1523/JNEUROSCI.0169-12.2012; Tong XK, 2005, J NEUROSCI, V25, P11165, DOI 10.1523/JNEUROSCI.4031-05.2005; Trigiani LJ, 2017, J CEREBR BLOOD F MET, V37, P2649, DOI 10.1177/0271678X17714655; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32; Voss MW, 2013, HUM BRAIN MAPP, V34, P2972, DOI 10.1002/hbm.22119; Vuorinen M, 2011, DEMENT GERIATR COGN, V31, P119, DOI 10.1159/000323810; Wang XX, 2015, AM J ALZHEIMERS DIS, V30, P729, DOI 10.1177/1533317513495107; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Wiesmann M, 2013, J CEREBR BLOOD F MET, V33, P1696, DOI 10.1038/jcbfm.2013.159; Wyss-Coray T, 2000, AM J PATHOL, V156, P139, DOI 10.1016/S0002-9440(10)64713-X; Yamamoto N, 2016, GLIA, V64, P952, DOI 10.1002/glia.22974; Zambon D, 2010, AM J MED, V123, P267, DOI 10.1016/j.amjmed.2009.08.015; Zissimopoulos JM, 2017, JAMA NEUROL, V74, P225, DOI [10.1001/jamaneurol.2016.3783, 10.1001/ja]; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	86	7	8	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13280	13293		10.1096/fj.201901002R	http://dx.doi.org/10.1096/fj.201901002R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31557051	Green Published, hybrid			2022-12-28	WOS:000507466100020
J	Wu, Y; Yue, ZJ; Wang, QG; Lv, Q; Liu, H; Bai, YG; Li, SH; Xie, MJ; Bao, JX; Ma, J; Wang, ZC; Zhu, XY				Wu, Yue; Yue, Zhijie; Wang, Qiguang; Lv, Qiang; Liu, Huan; Bai, Yungang; Li, Shaohua; Xie, Manjiang; Bao, Junxiang; Ma, Jin; Wang, Zhongchao; Zhu, Xianyang			BKCa compensates impaired coronary vasoreactivity through RhoA/ROCK pathway in hind-limb unweighted rats	FASEB JOURNAL			English	Article						hind-limb unweighting; coronary artery; vasoconstriction	RHO-KINASE PATHWAY; SIMULATED MICROGRAVITY; ARTERIES; CHANNEL; SPACEFLIGHT; BETA-1-SUBUNIT; ADAPTATION; EXPRESSION; PREVENTION; RECEPTOR	Previous studies have demonstrated cardiac and vascular remodeling induced by microgravity exposure. Yet, as the most important branch of vasculatures circulating the heart, the coronary artery has been seldomly studied about its adaptations under microgravity conditions. Large-conductance Ca2+-activated potassium channel (BKCa) and the Ras homolog family member A (RhoA)/Rho kinase (ROCK) pathway play key roles in control of vascular tone and mediation of microgravity-induced vascular adjustments. Therefore, we investigated the adaptation of coronary vasoreactivity to simulated microgravity and the role of BKCa and the RhoA/ROCK pathway in it. Four-week-old hind-limb unweighted (HU) rats were adopted to simulate effects of microgravity. Right coronary artery (RCA) constriction was measured by isometric force recording. The activity and expression of BKCa and the RhoA/ROCK pathway were examined by Western blot, patch-clamp recordings, and immunoprecipitation. We found HU significantly decreased RCA vasoconstriction to KC1, serotonin, and U-46619, but increased protein expression and current densities of BKCa, inhibition of which by iberiotoxin (IBTX) further decreased RCA vasoconstriction (P < 0.05). Expression of RhoA and ROCK as well as active RhoA and phosphorylation of myosin light chain (MLC) at Ser(19) and MLC phosphatase target-1 at Thr(696) were significantly increased by HU, and ROCK inhibitor Y-27632 exerted greater suppressing effect on HU RCA vasoconstriction than that of control (P < 0.05). BKca opener NS1619 increased HU RCA vasoconstriction, which was blocked by both RhoA and ROCK inhibitor, similar to the effect of IBTX. These results indicate that HU impairs coronary vasoconstriction but enhances BKca activity acting as a protective mechanism avoiding excessive decrease of coronary vasoreactivity through activation of the RhoA/ROCK pathway.	[Wu, Yue; Wang, Qiguang; Wang, Zhongchao; Zhu, Xianyang] Northern Theater Command, Gen Hosp, Dept Congenital Heart Dis, 83 Wenhua Rd, Shenyang 110016, Peoples R China; [Wu, Yue] Northern Theater Command, Gen Hosp, Dept Med Adm, Shenyang, Peoples R China; [Yue, Zhijie; Lv, Qiang; Liu, Huan; Bai, Yungang; Li, Shaohua; Xie, Manjiang; Bao, Junxiang; Ma, Jin; Wang, Zhongchao] Fourth Mil Med Univ, Dept Aerosp Physiol, Xian, Peoples R China; [Yue, Zhijie] Army Med Univ, Affiliated Hosp, Bethune Med Noncommissioned Officer NCO Sch, Dept Cardiol, Shijiazhuang, Hebei, Peoples R China	Air Force Military Medical University; Army Medical University	Wang, ZC; Zhu, XY (corresponding author), Northern Theater Command, Gen Hosp, Dept Congenital Heart Dis, 83 Wenhua Rd, Shenyang 110016, Peoples R China.	5139005wzc@163.com; xyangz2011@163.com			National Natural Science Foundation of China [81701858]; Natural Science Foundation of Liaoning Province [20180540108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	The experiments in this study were performed in the Department of Congenital Heart Disease, General Hospital of Northern Theater Command, and Department of Aerospace Physiology, Fourth Military Medical University. The authors thank their staffs for help with the animal and equipment maintenance. This study was supported by the National Natural Science Foundation of China (Grant 81701858) and the Natural Science Foundation of Liaoning Province (Grant 20180540108). The authors declare no conflicts of interest.	Amberg GC, 2003, CIRC RES, V93, P965, DOI 10.1161/01.RES.0000100068.43006.36; Arbeille P, 2001, EUR J APPL PHYSIOL, V86, P157, DOI 10.1007/s004210100473; Barnes EA, 2018, AM J PHYSIOL-LUNG C, V315, pL265, DOI 10.1152/ajplung.00060.2018; Behnke BJ, 2013, FASEB J, V27, P399, DOI 10.1096/fj.12-218503; Carrick-Ranson G, 2013, EXP PHYSIOL, V98, P501, DOI 10.1113/expphysiol.2012.067488; Demontis GC, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00547; Dong Ming, 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P322; Dorfman TA, 2007, J APPL PHYSIOL, V103, P8, DOI 10.1152/japplphysiol.01162.2006; Feng J, 2008, CIRCULATION, V118, pS46, DOI 10.1161/CIRCULATIONAHA.107.755827; Gao Fang, 2012, Shengli Xuebao, V64, P14; Hu XQ, 2012, DRUG DISCOV TODAY, V17, P974, DOI 10.1016/j.drudis.2012.04.002; Hu Y, 2014, J TRAUMA ACUTE CARE, V76, P394, DOI 10.1097/TA.0b013e3182aa2d98; Hughson RL, 2018, NAT REV CARDIOL, V15, P167, DOI 10.1038/nrcardio.2017.157; Li M, 2010, P NATL ACAD SCI USA, V107, P19096, DOI 10.1073/pnas.1002685107; Lin LJ, 2009, J APPL PHYSIOL, V107, P1710, DOI 10.1152/japplphysiol.00493.2009; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; Loirand G, 2013, PHYSIOL REV, V93, P1659, DOI 10.1152/physrev.00021.2012; Loirand G, 2010, NAT REV CARDIOL, V7, P637, DOI 10.1038/nrcardio.2010.136; Morey-Holton E, 2005, ADV SPACE B, V10, P7, DOI 10.1016/S1569-2574(05)10002-1; Satoh K, 2011, AM J PHYSIOL-HEART C, V301, pH287, DOI 10.1152/ajpheart.00327.2011; Shimokawa H, 2014, EUR HEART J, V35, P3180, DOI 10.1093/eurheartj/ehu427; Singh H, 2012, J PHYSIOL-LONDON, V590, P5937, DOI 10.1113/jphysiol.2011.215533; Summers SM, 2008, VASC PHARMACOL, V48, P208, DOI 10.1016/j.vph.2008.03.006; Taylor CR, 2013, FASEB J, V27, P2282, DOI 10.1096/fj.12-222687; Wang ZC, 2015, J PHYSIOL BIOCHEM, V71, P205, DOI 10.1007/s13105-015-0398-8; Wang ZC, 2017, CELL PHYSIOL BIOCHEM, V42, P1013, DOI 10.1159/000478683; Wang ZC, 2015, J PHYSIOL-LONDON, V593, P4561, DOI 10.1113/JP270823; Xie MJ, 2010, AM J PHYSIOL-CELL PH, V298, pC1489, DOI 10.1152/ajpcell.00474.2009; Xie Man-Jiang, 2005, Shengli Xuebao, V57, P439; Xie MJ, 2005, AM J PHYSIOL-HEART C, V289, pH1265, DOI 10.1152/ajpheart.00074.2005; Zhang LF, 2001, J APPL PHYSIOL, V91, P2415, DOI 10.1152/jappl.2001.91.6.2415; Zhang LF, 2018, PHYSIOL REV, V98, P59, DOI 10.1152/physrev.00017.2016; Zhang LF, 2013, EUR J APPL PHYSIOL, V113, P2873, DOI 10.1007/s00421-013-2597-8; Zhang R, 2009, J APPL PHYSIOL, V106, P251, DOI 10.1152/japplphysiol.01278.2007	34	4	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13358	13366		10.1096/fj.201901273R	http://dx.doi.org/10.1096/fj.201901273R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31530101	Bronze			2022-12-28	WOS:000507466100026
J	Cicaloni, V; Spiga, O; Dimitri, GM; Maiocchi, R; Millucci, L; Giustarini, D; Bernardini, G; Bernini, A; Marzocchi, B; Braconi, D; Santucci, A				Cicaloni, Vittoria; Spiga, Ottavia; Dimitri, Giovanna Maria; Maiocchi, Rebecca; Millucci, Lia; Giustarini, Daniela; Bernardini, Giulia; Bernini, Andrea; Marzocchi, Barbara; Braconi, Daniela; Santucci, Annalisa			Interactive alkaptonuria database: investigating clinical data to improve patient care in a rare disease	FASEB JOURNAL			English	Article						precision medicine; machine learning; biomarkers	THIOLATION INDEX PTI; SERUM AMYLOID-A; OXIDATIVE STRESS; ASCORBIC-ACID; CHITOTRIOSIDASE ACTIVITY; HOMOGENTISIC ACID; INFLAMMATION; BIOMARKER; HISTORY; PATHWAY	Alkaptonuria (AKU) is an ultrarare autosomal recessive disorder (MIM 203500) that is caused byby a complex set of mutations in homogentisate 1,2-dioxygenasegene and consequent accumulation of homogentisic acid (HGA), causing a significant protein oxidation. A secondary form of amyloidosis was identified in AKU and related to high circulating serum amyloid A (SAA) levels, which are linked with inflammation and oxidative stress and might contribute to disease progression and patients' poor quality of life. Recently, we reported that inflammatory markers (SAA and chitotriosidase) and oxidative stress markers (protein thiolation index) might be disease activity markers in AKU. Thanks to an international network, we collected genotypic, phenotypic, and clinical data from more than 200 patients with AKU. These data are currently stored in our AKU database, named ApreciseKUre. In this work, we developed an algorithm able to make predictions about the oxidative status trend of each patient with AKU based on 55 predictors, namely circulating HGA, body mass index, total cholesterol, SAA, and chitotriosidase. Our general aim is to integrate the data of apparently heterogeneous patients with AKUAKU by using specific bioinformatics tools, in order to identify pivotal mechanisms involved in AKU for a preventive, predictive, and personalized medicine approach to AKU.	[Cicaloni, Vittoria; Spiga, Ottavia; Maiocchi, Rebecca; Millucci, Lia; Giustarini, Daniela; Bernardini, Giulia; Bernini, Andrea; Marzocchi, Barbara; Braconi, Daniela; Santucci, Annalisa] Univ Siena, Dept Biotechnol Chem & Pharm, Via A Moro 2, I-53100 Siena, Italy; [Cicaloni, Vittoria; Maiocchi, Rebecca] Toscana Life Sci Fdn, Siena, Italy; [Dimitri, Giovanna Maria] Univ Cambridge, Dept Comp Sci, Cambridge, England; [Marzocchi, Barbara] Azienda Osped Senese, UOC, Patol Clin, Siena, Italy	University of Siena; University of Cambridge; University of Siena; University Hospital of Siena	Spiga, O (corresponding author), Univ Siena, Dept Biotechnol Chem & Pharm, Via A Moro 2, I-53100 Siena, Italy.	ottavia.spiga@unisi.it	Santucci, Annalisa/K-1932-2018; Bernini, Andrea/H-9412-2012; Dimitri, Giovanna Maria/AGG-4991-2022; Giustarini, Daniela/AAV-6629-2021; Bernardini, Giulia/ABG-2209-2020; Braconi, Daniela/J-9616-2018	Santucci, Annalisa/0000-0001-6976-9086; Bernini, Andrea/0000-0002-7528-2749; Dimitri, Giovanna Maria/0000-0002-2728-4272; Bernardini, Giulia/0000-0003-0016-0728; Braconi, Daniela/0000-0002-9657-4169; Cicaloni, Vittoria/0000-0002-8329-1565	Telethon Italy [GGP10058]; Toscana Life Sciences Orphan_1 Project; Associazione Italiana Malati di Alkaptonuria Alkaptonuria [ORPHA263402]; Tuscany Region Pegaso Ph.D. School in Biochemistry and Molecular Biology (Fondazione Vita Its Probits) [113195]	Telethon Italy(Fondazione Telethon); Toscana Life Sciences Orphan_1 Project; Associazione Italiana Malati di Alkaptonuria Alkaptonuria; Tuscany Region Pegaso Ph.D. School in Biochemistry and Molecular Biology (Fondazione Vita Its Probits)	The authors acknowledge support from Telethon Italy Grant GGP10058, the Toscana Life Sciences Orphan_1 Project, and Associazione Italiana Malati di Alkaptonuria Alkaptonuria (ORPHA263402). The authors thank the Toscana Life Sciences Foundation. V.C. was supported by a Ph.D. fellowship from the Tuscany Region Pegaso Ph.D. School in Biochemistry and Molecular Biology (Fondazione Vita Its Probits, 113195). The authors declare no conflicts of interest.	Albatayneh Eman M, 2019, J Clin Med Res, V11, P337, DOI 10.14740/jocmr3801; Ally MMTM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/183653; Basok BI, 2014, J MED BIOCHEM, V33, P245, DOI 10.2478/jomb-2014-0010; Bernardini G, 2012, PROTEOMICS, V12, P708, DOI 10.1002/pmic.201100358; Braconi D, 2018, OSTEOARTHR CARTILAGE, V26, P1078, DOI 10.1016/j.joca.2018.05.017; Braconi D, 2016, INT J BIOCHEM CELL B, V81, P271, DOI 10.1016/j.biocel.2016.08.016; Braconi D, 2015, FREE RADICAL BIO MED, V88, P70, DOI 10.1016/j.freeradbiomed.2015.02.021; Braconi D, 2012, J CELL PHYSIOL, V227, P3333, DOI 10.1002/jcp.24033; Braconi D, 2011, J INHERIT METAB DIS, V34, P1163, DOI 10.1007/s10545-011-9377-6; Braconi D, 2010, J CELL BIOCHEM, V111, P922, DOI 10.1002/jcb.22780; Braconi D, 2010, RHEUMATOLOGY, V49, P1975, DOI 10.1093/rheumatology/keq175; Bruce B, 2003, J RHEUMATOL, V30, P167; Brunner JKH, 2008, RHEUMATOL INT, V28, P949, DOI 10.1007/s00296-008-0558-z; Calkins MJ, 2009, ANTIOXID REDOX SIGN, V11, P497, DOI [10.1089/ars.2008.2242, 10.1089/ARS.2008.2242]; Cantarini L, 2012, YONSEI MED J, V53, P1045, DOI 10.3349/ymj.2012.53.5.1045; Chambers J. M., 1992, STAT MMODELS S, V251; Cicaloni V., 2016, PEERJ PREPRINTS, V4, DOI DOI 10.7287/PEERJ.PREPRINTS.2174V1; Ciftci S, 2016, J CLIN LAB ANAL, V30, P1158, DOI 10.1002/jcla.21997; Cox TF, 2011, J INHERIT METAB DIS, V34, P1153, DOI 10.1007/s10545-011-9367-8; Davison AS, 2016, J INHERIT METAB DIS, V39, P203, DOI 10.1007/s10545-015-9902-0; de Seny D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066769; Duzova A, 2003, CLIN EXP RHEUMATOL, V21, P509; FernandezCanon JM, 1996, NAT GENET, V14, P19, DOI 10.1038/ng0996-19; Gillmore JD, 2001, LANCET, V358, P24, DOI 10.1016/S0140-6736(00)05252-1; Giustarini D, 2017, ANAL BIOCHEM, V538, P38, DOI 10.1016/j.ab.2017.09.010; Giustarini D, 2012, FREE RADICAL BIO MED, V53, P907, DOI 10.1016/j.freeradbiomed.2012.06.022; Guo YF, 1995, J INHERIT METAB DIS, V18, P717, DOI 10.1007/BF02436762; Hughes AT, 2015, ANN CLIN BIOCHEM, V52, P597, DOI 10.1177/0004563215571969; Jung SY, 2007, YONSEI MED J, V48, P218, DOI 10.3349/ymj.2007.48.2.218; Li JQ, 2009, EXPERT OPIN THER TAR, V13, P785, DOI 10.1517/14728220903025762; Manna P, 2015, METAB SYNDR RELAT D, V13, P423, DOI 10.1089/met.2015.0095; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Marseglia L, 2015, INT J MOL SCI, V16, P378, DOI 10.3390/ijms16010378; Mayatepek E, 1998, EUR J PEDIATR, V157, P867, DOI 10.1007/s004310050956; Millucci L, 2015, J INHERIT METAB DIS, V38, P797, DOI 10.1007/s10545-015-9842-8; Millucci L, 2015, J CELL PHYSIOL, V230, P1148, DOI 10.1002/jcp.24850; Millucci L, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0185-9; Millucci L, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/258471; Millucci L, 2014, INT J CARDIOL, V172, pE121, DOI 10.1016/j.ijcard.2013.12.117; Millucci L, 2012, BBA-MOL BASIS DIS, V1822, P1682, DOI 10.1016/j.bbadis.2012.07.011; Mistry JB, 2013, RARE DIS, V1, DOI 10.4161/rdis.27475; Morava E, 2003, ANN CLIN BIOCHEM, V40, P108, DOI 10.1258/000456303321016268; Nemethova M, 2016, EUR J HUM GENET, V24, P66, DOI 10.1038/ejhg.2015.60; Phornphutkul C, 2002, NEW ENGL J MED, V347, P2111, DOI 10.1056/NEJMoa021736; Ramos LF, 2008, J AM SOC NEPHROL, V19, P593, DOI 10.1681/ASN.2007030355; Ranganath LR, 2016, ANN RHEUM DIS, V75, P362, DOI 10.1136/annrheumdis-2014-206033; Ranganath LR, 2013, J CLIN PATHOL, V66, P367, DOI 10.1136/jclinpath-2012-200877; Rencher A. C., 2008, LINEAR MMODELS SSTAT; Ruiz S, 2013, KIDNEY INT, V83, P1029, DOI 10.1038/ki.2012.439; Shimojima Y, 2005, INTERNAL MED, V44, P1009, DOI 10.2169/internalmedicine.44.1009; Spiga O, 2018, COMPUT BIOL MED, V103, P1, DOI 10.1016/j.compbiomed.2018.10.002; Spiga O, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0438-0; Su XH, 2018, FREE RADICAL BIO MED, V115, P471, DOI 10.1016/j.freeradbiomed.2017.12.004; Team RC., 2022, LANG ENV STAT COMP; Tharini Gk, 2011, Indian J Dermatol, V56, P194, DOI 10.4103/0019-5154.80415; Tinti L, 2010, J CELL PHYSIOL, V225, P84, DOI 10.1002/jcp.22199; Vilboux T, 2009, HUM MUTAT, V30, P1611, DOI 10.1002/humu.21120; WILKINSON GN, 1973, ROY STAT SOC C-APP, V22, P392; WOLFF JA, 1989, PEDIATR RES, V26, P140, DOI 10.1203/00006450-198908000-00015; Wu K., 2018, EUR J RHEUMATOL, V6, P1; Yang RL, 2008, J CLIN BIOCHEM NUTR, V43, P154, DOI 10.3164/jcbn.2008044	61	9	9	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12696	12703		10.1096/fj.201901529R	http://dx.doi.org/10.1096/fj.201901529R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31462106	Green Published			2022-12-28	WOS:000507461600085
J	Toudic, C; Vargas, A; Xiao, Y; St-Pierre, G; Bannert, N; Lafond, J; Rassart, E; Sato, S; Barbeau, B				Toudic, Caroline; Vargas, Amandine; Xiao, Yong; St-Pierre, Guillaume; Bannert, Norbert; Lafond, Julie; Rassart, Eric; Sato, Sachiko; Barbeau, Benoit			Galectin-1 interacts with the human endogenous retroviral envelope protein syncytin-2 and potentiates trophoblast fusion in humans	FASEB JOURNAL			English	Article						ERVFRD-1; beta-galactoside-binding lectin; villous cytotrophoblasts; syncytialization	PROMOTES HIV-1 INFECTIVITY; FRIEDENREICH TF ANTIGEN; W ENV GLYCOPROTEIN; CELLS IN-VITRO; EXTRAVILLOUS TROPHOBLAST; HUMAN PLACENTA; BEWO CELLS; EXPRESSION; DIFFERENTIATION; VIRUS	Syncytin (Syn)-2 is an important fusogenic protein that contributes to the formation of the placental syncytiotrophoblast. Galectin (Gal)-1, a soluble lectin, is also involved in trophoblast cell fusion and modulates the interaction of certain retroviral envelopes with their cellular receptor. This study aimed to investigate the association between Syn-2 and Gal-1 during human trophoblast cell fusion. This association was evaluated in vitro on primary villous cytotrophoblasts (vCTBs) and cell lines using recombinant Gal-1 and Syn-2-pseudotyped viruses. Using lactose, a Gal antagonist, and Gal-1-specific small interfering RNA (siRNA) transfections, we confirmed the implication of Gal-1 in vCTBs and BeWo cell fusion, although RT-PCR and ELISA analyses suggested that Gal-1 alone did not induce syncytialization. Infection assays showed a specific and significant effect of Gal-1 on the infectivity of Syn-2-pseudotyped viruses that depended on the expression of major facilitator superfamily domain-containing 2A (MFSD2a). Moreover, Gal-3, another placental Gal, did not modulate the infectivity of Syn-2-positive viruses, strengthening the specific association between Gal-1 and Syn-2. Interestingly, Gal-1 significantly reduced the infectivity of Syn-1-pseudotyped viruses, suggesting the opposite effects of Gal-1 on Syn-1 and -2. Finally, coimmunoprecipitation experiments showed a glycan-dependent interaction between Syn-2-bearing virions and Gal-1. We conclude that Gal-1 specifically interacts with Syn-2 and possibly regulates Syn-2/MFSD2a interaction during syncytialization of trophoblastic cells.	[Toudic, Caroline; Vargas, Amandine; Xiao, Yong; Lafond, Julie; Rassart, Eric; Barbeau, Benoit] Univ Quebec Montreal, Ctr Rech BioMed, Dept Sci Biol, Montreal, PQ, Canada; [St-Pierre, Guillaume; Sato, Sachiko] Laval Univ, Fac Med, Res Ctr Infect Dis, Glycobiol & Bioimaging Lab, Quebec City, PQ, Canada; [Bannert, Norbert] Robert Koch Inst, Berlin, Germany	University of Quebec; University of Quebec Montreal; Laval University; Robert Koch Institute	Barbeau, B (corresponding author), Univ Quebec Montreal, Dept Biol Sci, 141 Ave President Kennedy,Room SB R860, Montreal, PQ H2X 1Y4, Canada.	barbeau.benoit@uqam.ca	Barbeau, Benoit/A-1174-2010	Barbeau, Benoit/0000-0002-4108-8155	National Sciences and Engineering Research Council of Canada [298527-2013]; Canadian Institutes of Health Research [MOP130561]	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors thank Denis Flipo, Xavier Elisseeff, and Antoine Beaulieu (all from Universite du Quebec a Montreal) for their technical assistance. The authors are also grateful to the researchers who supplied expression vectors. This study was supported by the National Sciences and Engineering Research Council of Canada (298527-2013), and by an operating grant from the Canadian Institutes of Health Research (MOP130561). The authors declare no conflicts of interest.	Barrientos G, 2014, HUM REPROD UPDATE, V20, P175, DOI 10.1093/humupd/dmt040; Bhaumik P, 2013, J IMMUNOL, V190, P630, DOI 10.4049/jimmunol.1103197; Blaise S, 2004, J VIROL, V78, P1050, DOI 10.1128/JVI.78.2.1050-1054.2004; Blaise S, 2003, P NATL ACAD SCI USA, V100, P13013, DOI 10.1073/pnas.2132646100; Blidner AG, 2013, AM J REPROD IMMUNOL, V69, P369, DOI 10.1111/aji.12090; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; Chen CP, 2008, BIOL REPROD, V79, P815, DOI 10.1095/biolreprod.108.069765; Chen QS, 2016, MOL CELL PROTEOMICS, V15, P1857, DOI 10.1074/mcp.M115.055798; Cheynet V, 2005, J VIROL, V79, P5585, DOI 10.1128/JVI.79.9.5585-5593.2005; Cooper DNW, 1999, GLYCOBIOLOGY, V9, P979, DOI 10.1093/glycob/9.10.979; Costa MA, 2016, MOL CELL ENDOCRINOL, V420, P180, DOI 10.1016/j.mce.2015.11.010; Cui L, 2016, CELL ADHES MIGR, V10, P39, DOI 10.1080/19336918.2015.1093720; Dalton P, 2007, FEBS J, V274, P2715, DOI 10.1111/j.1742-4658.2007.05806.x; Dolcini G, 2003, AIDS RES HUM RETROV, V19, P857, DOI 10.1089/088922203322493021; Esnault C, 2008, P NATL ACAD SCI USA, V105, P17532, DOI 10.1073/pnas.0807413105; Esnault C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003400; Fischer I, 2010, PLACENTA, V31, P825, DOI 10.1016/j.placenta.2010.06.016; Fischer I, 2009, PLACENTA, V30, P1078, DOI 10.1016/j.placenta.2009.10.003; Fischer I, 2011, MOL HUM REPROD, V17, P747, DOI 10.1093/molehr/gar053; Fisher SJ, 2015, AM J OBSTET GYNECOL, V213, pS115, DOI 10.1016/j.ajog.2015.08.042; FOWLIS D, 1995, DEV DYNAM, V203, P241, DOI 10.1002/aja.1002030211; Freitag N, 2013, P NATL ACAD SCI USA, V110, P11451, DOI 10.1073/pnas.1303707110; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Frendo JL, 2003, J CELL SCI, V116, P3413, DOI 10.1242/jcs.00648; Garner OB, 2015, J VIROL, V89, P2520, DOI 10.1128/JVI.02435-14; Gauster M, 2009, PLACENTA, V30, P547, DOI 10.1016/j.placenta.2009.03.007; Gauthier S, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-105; Gerbaud P, 2015, PLACENTA, V36, pS35, DOI 10.1016/j.placenta.2014.12.015; Getsios S, 2003, DEV BIOL, V257, P41, DOI 10.1016/S0012-1606(03)00041-1; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; HIRABAYASHI J, 1993, GLYCOBIOLOGY, V3, P297, DOI 10.1093/glycob/3.4.297; Hirashima C, 2018, HYPERTENS RES, V41, P45, DOI 10.1038/hr.2017.85; Hong SH, 2009, J VIROL, V83, P6995, DOI 10.1128/JVI.00268-09; Huang Q, 2014, CELL MOL LIFE SCI, V71, P3151, DOI 10.1007/s00018-013-1533-8; Huang Q, 2013, CELL SIGNAL, V25, P1027, DOI 10.1016/j.cellsig.2013.01.008; Huppertz B, 2011, ADV EXP MED BIOL, V713, P81, DOI 10.1007/978-94-007-0763-4_6; Hutter S, 2016, CELL ADHES MIGR, V10, P28, DOI 10.1080/19336918.2015.1089377; Jeschke U, 2007, PLACENTA, V28, P1165, DOI 10.1016/j.placenta.2007.06.006; Jeschke U, 2004, HISTOCHEM CELL BIOL, V121, P501, DOI 10.1007/s00418-004-0660-6; Jeschke U, 2013, PLACENTA, V34, P863, DOI 10.1016/j.placenta.2013.07.005; Jeschke U, 2006, HISTOCHEM CELL BIOL, V126, P437, DOI 10.1007/s00418-006-0178-1; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Knerr I, 2007, APOPTOSIS, V12, P37, DOI 10.1007/s10495-006-0329-9; Knerr I, 2008, J CELL BIOCHEM, V105, P766, DOI 10.1002/jcb.21874; Lavillette D, 2002, J VIROL, V76, P6442, DOI 10.1128/JVI.76.13.6442-6452.2002; Le Bellego Frederique, 2009, Methods Mol Biol, V550, P73, DOI 10.1007/978-1-60327-009-0_4; Lemieux AM, 2004, J BIOL CHEM, V279, P52949, DOI 10.1074/jbc.M409896200; Lokossou AG, 2020, BIOL REPROD, V102, P185, DOI 10.1093/biolre/ioz124; Lokossou AG, 2014, VIRUSES-BASEL, V6, P4609, DOI 10.3390/v6114609; Lu XY, 2017, CELL REP, V21, P1150, DOI 10.1016/j.celrep.2017.10.019; Malassine A, 2007, PLACENTA, V28, P185, DOI 10.1016/j.placenta.2006.03.001; Malassine A, 2005, PLACENTA, V26, P556, DOI 10.1016/j.placenta.2004.09.002; Maquoi E, 1997, PLACENTA, V18, P433, DOI 10.1016/S0143-4004(97)80044-6; Marin M, 2003, J VIROL, V77, P2936, DOI 10.1128/JVI.77.5.2936-2945.2003; Mercier S, 2008, VIROLOGY, V371, P121, DOI 10.1016/j.virol.2007.09.034; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Muir A, 2006, J GEN VIROL, V87, P2067, DOI 10.1099/vir.0.81412-0; Ouellet M, 2005, J IMMUNOL, V174, P4120, DOI 10.4049/jimmunol.174.7.4120; Ouellet M, 2015, METHODS MOL BIOL, V1207, P397, DOI 10.1007/978-1-4939-1396-1_26; Pidoux G, 2010, AM J PHYSIOL-CELL PH, V298, pC1517, DOI 10.1152/ajpcell.00484.2008; POIRIER F, 1992, DEVELOPMENT, V115, P143; Ramhorst RE, 2012, GLYCOBIOLOGY, V22, P1374, DOI 10.1093/glycob/cws104; Reiling JH, 2011, P NATL ACAD SCI USA, V108, P11756, DOI 10.1073/pnas.1018098108; Sato S, 2002, J IMMUNOL, V168, P1813, DOI 10.4049/jimmunol.168.4.1813; SATO S, 1994, EUR J IMMUNOL, V24, P216, DOI 10.1002/eji.1830240134; Schubert SW, 2008, NUCLEIC ACIDS RES, V36, P3834, DOI 10.1093/nar/gkn306; Segura MM, 2008, J VIROL, V82, P1107, DOI 10.1128/JVI.01909-07; Spinola M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-62; St-Pierre C, 2011, J VIROL, V85, P11742, DOI 10.1128/JVI.05351-11; St-Pierre C, 2010, METHOD ENZYMOL, V480, P267, DOI 10.1016/S0076-6879(10)80013-8; Than NG, 2008, J MATERN-FETAL NEO M, V21, P429, DOI 10.1080/14767050802041961; Tirado-Gonzalez I, 2013, MOL HUM REPROD, V19, P43, DOI 10.1093/molehr/gas043; Tolosa JM, 2012, PLACENTA, V33, P933, DOI 10.1016/j.placenta.2012.08.004; Toudic C., 2017, HUMAN RETROTRANSPOSO, P215; Toufaily C, 2013, PLACENTA, V34, P85, DOI 10.1016/j.placenta.2012.10.012; Toufaily C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121468; Unverdorben L, 2016, HISTOL HISTOPATHOL, V31, P1095, DOI 10.14670/HH-11-739; Unverdorben L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050644; Vargas A, 2014, FASEB J, V28, P3703, DOI 10.1096/fj.13-239053; Vargas A, 2011, REPROD SCI, V18, P1085, DOI 10.1177/1933719111404608; Vargas A, 2009, J MOL BIOL, V392, P301, DOI 10.1016/j.jmb.2009.07.025; Vasta GR, 2017, PATHOG DIS, V75, DOI 10.1093/femspd/ftx046; Vicovac L, 1998, HUM REPROD, V13, P730, DOI 10.1093/humrep/13.3.730; Vidricaire G, 2003, J BIOL CHEM, V278, P15832, DOI 10.1074/jbc.M210470200; WICE B, 1990, EXP CELL RES, V186, P306, DOI 10.1016/0014-4827(90)90310-7; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200	86	7	8	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12873	12887		10.1096/fj.201900107R	http://dx.doi.org/10.1096/fj.201900107R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31499012	Green Published			2022-12-28	WOS:000507461600098
J	Yu, JH; Lim, SW; Luo, K; Cui, S; Quan, Y; Shin, YJ; Lee, KE; Kim, HL; Ko, EJ; Chung, BH; Kim, JH; Chung, SJ; Yang, CW				Yu, Ji Hyun; Lim, Sun Woo; Luo, Kang; Cui, Sheng; Quan, Yi; Shin, Yoo Jin; Lee, Kyung Eun; Kim, Hong Lim; Ko, Eun Jeong; Chung, Byung Ha; Kim, Ju Hwan; Chung, Sang J.; Yang, Chul Woo			Coenzyme Q(10) alleviates tacrolimus-induced mitochondrial dysfunction in kidney	FASEB JOURNAL			English	Article						3D reconstruction; nephrotoxicity; reactive oxygen species	CHRONIC CYCLOSPORINE NEPHROPATHY; ASCORBIC-ACID PALMITATE; OXIDATIVE STRESS; FK506 NEPHROTOXICITY; EXPERIMENTAL-MODEL; BETA-CAROTENE; REDUCED FORM; VITAMIN-E; TROLOX-C; ACETYLCYSTEINE	The major side effect of tacrolimus (Tac) is nephrotoxicity. We studied whether supplementation of coenzyme Q(10), (CoQ(10)) a potent antioxidant, can reduce Tac-induced nephrotoxicity via improving mitochondrial function. In an in vitro study, CoQ(10) reduced the production of Tac-induced mitochondrial reactive oxygen species and abolished the loss of mitochondrial membrane potential in proximal tubular cell line. Assessment of mitochondrial function revealed that CoQ(10) decreased oxygen consumption and mitochondrial respiration rate increased by Tac, suggesting improvement of mitochondrial function to synthesize ATP with CoQ(10) treatment. The effect of the CoQ(10) in vitro study was observed in an experimental model of chronic Tac-induced nephropathy. CoQ(10) attenuated Tac-induced oxidative stress and was accompanied by function and histologic improvement. On electron microscopy, addition of CoQ(10) increased not only the number but also the volume of mitochondria compared with Tac treatment only. Our data indicate that CoQ(10) improves Tac-induced mitochondrial dysfunction in kidney. Supplementary CoQ(10) treatment may be a promising approach to reduce Tac-induced nephrotoxicity.	[Yu, Ji Hyun; Ko, Eun Jeong; Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Sch Med, Dept Internal Med, Seoul, South Korea; [Lim, Sun Woo; Luo, Kang; Cui, Sheng; Quan, Yi; Shin, Yoo Jin; Ko, Eun Jeong; Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Sch Med, Seoul St Marys Hosp, Convergent Res Consortium Immunol Dis, Seoul, South Korea; [Lim, Sun Woo; Luo, Kang; Cui, Sheng; Quan, Yi; Shin, Yoo Jin; Ko, Eun Jeong; Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Sch Med, Transplant Res Ctr, Seoul, South Korea; [Kim, Hong Lim] Catholic Univ Korea, Sch Med, Integrat Res Support Ctr, Seoul, South Korea; [Lee, Kyung Eun] Korea Inst Sci & Technol, Adv Anal Ctr, Seoul, South Korea; [Kim, Ju Hwan] Abtis, Suwon, South Korea; [Chung, Sang J.] Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea	Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea; Korea Institute of Science & Technology (KIST); Sungkyunkwan University (SKKU)	Yang, CW (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Sch Med, Dept Internal Med, 222 Banpo Daero, Seoul 06591, South Korea.	yangch@catholic.ac.kr		Ko, Eun Jeong/0000-0002-5604-1296	Korean Health Technology Research and Development Project, Ministry for Health and Welfare [HI14C3417, HI16C1641]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communications Technology (ICT) and Future Planning [NRF-2018R1D1A1A02043014]	Korean Health Technology Research and Development Project, Ministry for Health and Welfare; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communications Technology (ICT) and Future Planning	This work was supported by the Korean Health Technology Research and Development Project, Ministry for Health and Welfare (HI14C3417, HI16C1641), and the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science, Information and Communications Technology (ICT) and Future Planning (NRF-2018R1D1A1A02043014). The authors declare no conflicts of interest.	Acosta MJ, 2016, BBA-BIOENERGETICS, V1857, P1079, DOI 10.1016/j.bbabio.2016.03.036; ANDOH TF, 1994, TRANSPLANTATION, V57, P483; ANDOH TF, 1995, CLIN EXP PHARMACOL P, V22, P646, DOI 10.1111/j.1440-1681.1995.tb02082.x; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Back JH, 2015, TRANSPL P, V47, P2032, DOI 10.1016/j.transproceed.2015.06.008; Bentinger M, 2003, FREE RADICAL BIO MED, V34, P563, DOI 10.1016/S0891-5849(02)01357-6; Bhagavan HN, 2007, MITOCHONDRION, V7, pS78, DOI 10.1016/j.mito.2007.03.003; Carrasco J, 2014, BJU INT, V113, P942, DOI 10.1111/bju.12485; CHEN H, 1995, FREE RADICAL RES, V22, P177, DOI 10.3109/10715769509147537; CHEN H, 1995, FREE RADICAL BIO MED, V18, P949, DOI 10.1016/0891-5849(94)00238-F; Chevalier RL, 2016, AM J PHYSIOL-RENAL, V311, pF145, DOI 10.1152/ajprenal.00164.2016; Crane FL, 2001, J AM COLL NUTR, V20, P591, DOI 10.1080/07315724.2001.10719063; Doh KC, 2013, AM J NEPHROL, V37, P421, DOI 10.1159/000349921; Dott W, 2014, REDOX BIOL, V2, P224, DOI 10.1016/j.redox.2013.12.028; Fouad AA, 2010, TOXICOLOGY, V274, P49, DOI 10.1016/j.tox.2010.05.007; Hernandez-Camacho JD, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00044; Huo J, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/3181759; Ishikawa A, 2012, INT BRAZ J UROL, V38, P230, DOI 10.1590/S1677-55382012000200011; Jin J, 2017, AM J TRANSPLANT, V17, P2601, DOI 10.1111/ajt.14316; Lim SW, 2015, LAB INVEST, V95, P1174, DOI 10.1038/labinvest.2015.93; Lim SW, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.365; Modi K, 2006, BIOL TRACE ELEM RES, V109, P25, DOI 10.1385/BTER:109:1:025; Montini G, 2008, NEW ENGL J MED, V358, P2849, DOI 10.1056/NEJMc0800582; Moreira PI, 2005, EXP NEUROL, V196, P112, DOI 10.1016/j.expneurol.2005.07.012; Olyaei A J, 2001, Curr Opin Crit Care, V7, P384, DOI 10.1097/00075198-200112000-00003; Piao SG, 2014, TRANSPLANTATION, V98, P22, DOI 10.1097/TP.0000000000000146; Piao SG, 2013, TRANSPLANTATION, V96, P146, DOI 10.1097/TP.0b013e318296c9a9; Piao SG, 2012, TRANSPLANTATION, V93, P383, DOI 10.1097/TP.0b013e3182421604; Sato T, 2013, EXP CLIN TRANSPLANT, V11, P17, DOI 10.6002/ect.2012.0126; Shihab FS, 1997, TRANSPLANTATION, V64, P1829, DOI 10.1097/00007890-199712270-00034; Sohet FM, 2009, BIOCHEM PHARMACOL, V78, P1391, DOI 10.1016/j.bcp.2009.07.008; Spindler M, 2009, NEUROPSYCH DIS TREAT, V5, P597; Stillman IE, 1995, LAB INVEST, V73, P794; Sun IO, 2019, KOREAN J INTERN MED, V34, P365, DOI 10.3904/kjim.2017.004; Upaganlawar Anian, 2006, Indian Journal of Experimental Biology, V44, P416; Venegoni W, 2017, J ADV NURS, V73, P1331, DOI 10.1111/jan.13259; Yoon Hye Eun, 2009, Korean Journal of Internal Medicine, V24, P81, DOI 10.3904/kjim.2009.24.2.81; Zorzano A, 2009, CURR OPIN DRUG DISC, V12, P597	38	17	18	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12288	12298		10.1096/fj.201900386RR	http://dx.doi.org/10.1096/fj.201900386RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31431058	Green Published			2022-12-28	WOS:000507461600054
J	Kim, GD; Ng, HP; Patel, N; Mahabeleshwar, GH				Kim, Gun-Dong; Ng, Hang Pong; Patel, Nibedita; Mahabeleshwar, Ganapati H.			Kruppel-like factor 6 and miR-223 signaling axis regulates macrophage-mediated inflammation	FASEB JOURNAL			English	Article						myeloid cells; gene regulation; transcription factor; tissue inflammation	TRANSCRIPTION FACTORS; ADIPOSE-TISSUE; MICRORNA-223; EXPRESSION; PROGENITOR; ALPHA	Macrophage-mediated inflammation is an explicitly robust biologic response that plays a critical role in maintaining tissue homeostasis by eliminating deleterious agents. These tissue macrophages tailor appropriate responses to external cues by altering inflammatory gene expression. Therefore, transcription factors and regulators that modulate inflammatory gene expression play an essential role in shaping the macrophage inflammatory response. Here, we identify that Kruppel-like factor (KLF)6 promotes inflammation by restraining microRNA-223 (miR-223) expression in macrophages. We uncovered that pro- and anti-inflammatory agents oppositely regulate KLF6 and miR-223 expression in macrophages. Using complementary gain- and loss-of-function studies, we observed that overexpression of KLF6 attenuates and deficiency of KLF6 elevates miR-223 expression in macrophages. Furthermore, heightened miR-223 expression in KLF6-deficient macrophages significantly attenuates inducible proinflammatory gene expression. Concordantly, myeloid-Klf6 deficiency significantly curbs diet-induced adipose tissue inflammation, obesity, glucose intolerance, and insulin resistance. At the molecular level, KLF6 directly represses miR-223 expression by occupying its promoter region. More importantly, genetic inhibition of miR-223-3P in KLF6-deficient macrophages completely reversed attenuated proinflammatory gene expression in macrophages. Collectively, our studies reveal that KLF6 promotes proinflammatory gene expression and functions by repressing miR-223 expression in macrophages.-Kim, G.-D., Ng, H. P., Patel, N., Mahabeleshwar, G. H. Kruppel-like factor 6 and miR-223 signaling axis regulates macrophage-mediated inflammation.	[Kim, Gun-Dong; Ng, Hang Pong; Mahabeleshwar, Ganapati H.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Patel, Nibedita; Mahabeleshwar, Ganapati H.] Case Western Reserve Univ, Sch Med, Cardiovasc Res Inst, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Mahabeleshwar, GH (corresponding author), Case Western Reserve Univ, 2103 Cornell Rd,Room WRB-5527, Cleveland, OH 44106 USA.	ghm4@case.edu	NG, Hang Pong/AAB-2427-2020		U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL126626, HL141423]; Crohn's and Colitis Foundation of America Senior Research Award [421904]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL141423, R01HL126626] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Crohn's and Colitis Foundation of America Senior Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants HL126626 and HL141423, as well as the Crohn's and Colitis Foundation of America Senior Research Award 421904 (to G.H.M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Bauernfeind F, 2012, J IMMUNOL, V189, P4175, DOI 10.4049/jimmunol.1201516; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chu AY, 2017, NAT GENET, V49, P125, DOI 10.1038/ng.3738; Date D, 2014, J BIOL CHEM, V289, P10318, DOI 10.1074/jbc.M113.526749; De Graeve F, 2003, GENE, V314, P55, DOI 10.1016/S0378-1119(03)00720-0; Deiuliis JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165962; Deschamps M, 2016, AM J HUM GENET, V98, P5, DOI 10.1016/j.ajhg.2015.11.014; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Goodman WA, 2016, MUCOSAL IMMUNOL, V9, P1250, DOI 10.1038/mi.2016.1; Hotamisligil GS, 2017, IMMUNITY, V47, P406, DOI 10.1016/j.immuni.2017.08.009; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kim CK, 2017, GASTROENTEROLOGY, V152, P1845, DOI 10.1053/j.gastro.2017.03.035; Kim GD, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00452-17; Kim GD, 2016, J BIOL CHEM, V291, P21271, DOI 10.1074/jbc.M116.738617; Koritschoner NP, 1997, J BIOL CHEM, V272, P9573; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Lopez YON, 2017, MOL BIOSYST, V13, P106, DOI 10.1039/c6mb00596a; Milagro FI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054319; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Neudecker V, 2017, J EXP MED, V214, P1737, DOI 10.1084/jem.20160462; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Qi WE, 2011, INT J BIOCHEM CELL B, V43, P383, DOI 10.1016/j.biocel.2010.11.008; Russo L, 2018, IMMUNOLOGY, V155, P407, DOI 10.1111/imm.13002; Salinas YD, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0387-0; Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220; Vian L, 2014, CELL DEATH DIFFER, V21, P290, DOI 10.1038/cdd.2013.145; Vickers KC, 2014, P NATL ACAD SCI USA, V111, P14518, DOI 10.1073/pnas.1215767111; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Wen DZ, 2015, OBES RES CLIN PRACT, V9, P398, DOI 10.1016/j.orcp.2015.01.006; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Ying W, 2015, J CLIN INVEST, V125, P4149, DOI 10.1172/JCI81656; Zhou WQ, 2018, CELL REP, V22, P1810, DOI 10.1016/j.celrep.2018.01.058; Zhuang GQ, 2012, CIRCULATION, V125, P2892, DOI 10.1161/CIRCULATIONAHA.111.087817	43	23	23	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10902	10915		10.1096/fj.201900867RR	http://dx.doi.org/10.1096/fj.201900867RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31262200	Green Published			2022-12-28	WOS:000489166300026
J	Simchovitz, A; Hanan, M; Niederhoffer, N; Madrer, N; Yayon, N; Bennett, ER; Greenberg, DS; Kadener, S; Soreq, H				Simchovitz, Alon; Hanan, Mor; Niederhoffer, Naomi; Madrer, Nimrod; Yayon, Nadav; Bennett, Estelle R.; Greenberg, David S.; Kadener, Sebastian; Soreq, Hermona			NEAT1 is overexpressed in Parkinson's disease substantia nigra and confers drug-inducible neuroprotection from oxidative stress	FASEB JOURNAL			English	Article						lncRNA; neurodegeneration; paraspeckles	LONG NONCODING RNA; MITOCHONDRIAL DYSFUNCTION; STATIN USE; RISK; METAANALYSIS; EXPRESSION; TRANSCRIPTION; PARASPECKLES; ASSOCIATION; SIMVASTATIN	Recent reports attribute numerous regulatory functions to the nuclear paraspeckle-forming long noncoding RNA, nuclear enriched assembly transcript 1 (NEAT1), but the implications of its involvement in Parkinson's disease (PD) remain controversial. To address this issue, we assessed NEAT1 expression levels and cell type patterns in the substantia nigra (SN) from 53 donors with and without PD, as well as in interference tissue culture tests followed by multiple in-house and web-available models of PD. PCR quantification identified elevated levels of NEAT1 expression in the PD SN compared with control brains, an elevation that was reproducible across a multitude of disease models. In situ RNA hybridization supported neuron-specific formation of NEAT1-based paraspeckles at the SN and demonstrated coincreases of NEAT1 and paraspeckles in cultured cells under paraquat (PQ)-induced oxidative stress. Furthermore, neuroprotective agents, including fenofibrate and simvastatin, induced NEAT1 up-regulation, whereas RNA interference-mediated depletion of NEAT1 exacerbated death of PQ-exposed cells in a leucine-rich repeat kinase 2-mediated manner. Our findings highlight a novel protective role for NEAT1 in PD and suggest a previously unknown mechanism for the neuroprotective traits of widely used preventive therapeutics.-Simchovitz, A., Hanan, M., Niederhoffer, N., Madrer, N., Yayon, N., Bennett, E. R., Greenberg, D. S., Kadener, S., Soreq, H. NEAT1 is overexpressed in Parkinson's disease substantia nigra and confers drug-inducible neuroprotection from oxidative stress.	[Simchovitz, Alon; Hanan, Mor; Niederhoffer, Naomi; Madrer, Nimrod; Yayon, Nadav; Bennett, Estelle R.; Greenberg, David S.; Soreq, Hermona] Hebrew Univ Jerusalem, Dept Biol Chem, Edmond J Safra Campus, IL-9190401 Jerusalem, Israel; [Simchovitz, Alon; Hanan, Mor; Niederhoffer, Naomi; Madrer, Nimrod; Yayon, Nadav; Bennett, Estelle R.; Greenberg, David S.; Soreq, Hermona] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Edmond J Safra Campus, IL-9190401 Jerusalem, Israel; [Kadener, Sebastian] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Brandeis University	Soreq, H (corresponding author), Hebrew Univ Jerusalem, Dept Biol Chem, Edmond J Safra Campus, IL-9190401 Jerusalem, Israel.; Soreq, H (corresponding author), Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Edmond J Safra Campus, IL-9190401 Jerusalem, Israel.	hermona.soreq@mail.huji.ac.il	Bennett, Estelle R/A-5067-2017	Soreq, Hermona/0000-0002-0955-526X; Madrer, Nimrod/0000-0002-8467-5085; Greenberg, David/0000-0001-8959-8640	Michael J. Fox Foundation for Parkinson's Research [11183]; Edmond and Lily Safra Center of Brain Sciences (ELSC) Postdoctoral Fellowship; Israeli Ministry of Science, Technology, and Space [53140]; The Clore Foundation Scholars Fellowship	Michael J. Fox Foundation for Parkinson's Research; Edmond and Lily Safra Center of Brain Sciences (ELSC) Postdoctoral Fellowship; Israeli Ministry of Science, Technology, and Space; The Clore Foundation Scholars Fellowship	The authors acknowledge support by the Michael J. Fox Foundation for Parkinson's Research (Grant 11183 to S.K. and H. S.); the Edmond and Lily Safra Center of Brain Sciences (ELSC) Postdoctoral Fellowship (to M. H.); the Israeli Ministry of Science, Technology, and Space (Grant 53140 to H. S.); and The Clore Foundation Scholars Fellowship (to A. S.). The authors appreciate the Netherlands Brain Bank contribution of brain tissues. The authors declare no conflicts of interest.	Alcalay RN, 2013, MOVEMENT DISORD, V28, P1966, DOI 10.1002/mds.25647; Rubiolo JA, 2008, EUR J PHARMACOL, V591, P66, DOI 10.1016/j.ejphar.2008.06.067; Ascherio A, 2016, LANCET NEUROL, V15, P1255, DOI 10.1016/S1474-4422(16)30230-7; Barbiero JK, 2014, PROG NEURO-PSYCHOPH, V53, P35, DOI 10.1016/j.pnpbp.2014.02.009; Bastias-Candia S, 2019, MOL NEUROBIOL, V56, P1044, DOI 10.1007/s12035-018-1148-z; Berson A, 2018, TRENDS NEUROSCI, V41, P587, DOI 10.1016/j.tins.2018.05.005; Botta-Orfila T, 2014, J NEUROSCI RES, V92, P1071, DOI 10.1002/jnr.23377; Buxbaum AR, 2015, TRENDS CELL BIOL, V25, P468, DOI 10.1016/j.tcb.2015.05.005; Carroll CB, 2017, J PARKINSON DIS, V7, P545, DOI 10.3233/JPD-171203; Chakravarty D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6383; Chazotte Brad, 2011, Cold Spring Harb Protoc, V2011, P990, DOI 10.1101/pdb.prot5648; Choudhry H, 2015, ONCOGENE, V34, P4482, DOI 10.1038/onc.2014.378; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Costello S, 2009, AM J EPIDEMIOL, V169, P919, DOI 10.1093/aje/kwp006; Di Fonzo A, 2005, LANCET, V365, P412; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fong KW, 2013, J CELL BIOL, V203, P149, DOI 10.1083/jcb.201303145; Fox AH, 2018, TRENDS BIOCHEM SCI, V43, P124, DOI 10.1016/j.tibs.2017.12.001; Gillies GE, 2014, FRONT NEUROENDOCRIN, V35, P370, DOI 10.1016/j.yfrne.2014.02.002; Gollamudi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036191; Guedes-Dias P, 2016, NEUROBIOL DIS, V90, P51, DOI 10.1016/j.nbd.2015.09.008; Hadwen J, 2018, HUM MOL GENET, V27, P3206, DOI 10.1093/hmg/ddy221; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hauser DN, 2013, NEUROBIOL DIS, V51, P35, DOI 10.1016/j.nbd.2012.10.011; Helley MP, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00177; Henderson JL, 2015, J MED CHEM, V58, P419, DOI 10.1021/jm5014055; Hirose T, 2014, MOL BIOL CELL, V25, P169, DOI 10.1091/mbc.E13-09-0558; Hwang Onyou, 2013, Exp Neurobiol, V22, P11, DOI 10.5607/en.2013.22.1.11; Imamura K, 2014, MOL CELL, V53, P393, DOI 10.1016/j.molcel.2014.01.009; Jiang L, 2017, NAT STRUCT MOL BIOL, V24, P816, DOI 10.1038/nsmb.3455; Khorkova O, 2017, NAT BIOTECHNOL, V35, P249, DOI 10.1038/nbt.3784; Lake BB, 2018, NAT BIOTECHNOL, V36, P70, DOI 10.1038/nbt.4038; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Li RH, 2017, RNA, V23, P872, DOI 10.1261/rna.059477.116; Little S, 2013, ANN NEUROL, V74, P449, DOI 10.1002/ana.23951; Liu Y, 2018, CLIN EXP PHARMACOL P, V45, P841, DOI 10.1111/1440-1681.12932; LLOYD KG, 1975, J PHARMACOL EXP THER, V195, P453; Marchese FP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1348-2; Meixner A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001172; Minones-Moyano E, 2011, HUM MOL GENET, V20, P3067, DOI 10.1093/hmg/ddr210; Naganuma T, 2012, EMBO J, V31, P4020, DOI 10.1038/emboj.2012.251; Nakagawa S, 2011, J CELL BIOL, V193, P31, DOI 10.1083/jcb.201011110; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Pagan F, 2016, J PARKINSON DIS, V6, P503, DOI 10.3233/JPD-160867; Palacino J, 2015, NAT CHEM BIOL, V11, P741, DOI 10.1038/nchembio0915-741a; Parry TL, 2016, CARDIOVASC PATHOL, V25, P127, DOI 10.1016/j.carpath.2015.09.008; Poly TN, 2017, NEUROEPIDEMIOLOGY, V49, P142, DOI 10.1159/000480401; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salasova A, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0193-9; Sodersten E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03538-9; Soltis AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00267-9; Soreq L, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00010; Sunwoo JS, 2017, MOL NEUROBIOL, V54, P1577, DOI 10.1007/s12035-016-9928-9; Undela K, 2013, J NEUROL, V260, P158, DOI 10.1007/s00415-012-6606-3; Wang G, 2016, SCI REP-UK, V6, DOI 10.1038/srep35783; Wang Y, 2018, NAT CELL BIOL, V20, P1145, DOI 10.1038/s41556-018-0204-2; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6; Yan W, 2018, BIOCHEM BIOPH RES CO, V496, P1019, DOI 10.1016/j.bbrc.2017.12.149; Yayon N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22489-1; Yu FJ, 2017, J MOL MED, V95, P1191, DOI 10.1007/s00109-017-1586-5	64	58	59	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11223	11234		10.1096/fj.201900830R	http://dx.doi.org/10.1096/fj.201900830R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31311324	Green Published, hybrid			2022-12-28	WOS:000489166300053
J	Yamada, H; Munetsuna, E; Yamazaki, M; Mizuno, G; Sadamoto, I; Ando, Y; Fujii, R; Shiogama, K; Ishikawa, H; Suzuki, K; Shimono, Y; Ohashi, K; Hashimoto, S				Yamada, Hiroya; Munetsuna, Eiji; Yamazaki, Mirai; Mizuno, Genki; Sadamoto, IINao; Ando, Yoshitaka; Fujii, Ryosuke; Shiogama, Kazuya; Ishikawa, Hiroaki; Suzuki, Koji; Shimono, Yohei; Ohashi, Koji; Hashimoto, Shuji			Maternal fructose-induced oxidative stress occurs via Tfam and Ucp5 epigenetic regulation in offspring hippocampi	FASEB JOURNAL			English	Article						DOHaD; developmental programming; DNA methylation; epigenetics	MITOCHONDRIAL TRANSCRIPTION FACTOR; EARLY-LIFE STRESS; LOW-PROTEIN DIET; FACTOR-A; DNA METHYLATION; FATTY LIVER; CONSUMPTION; PREGNANCY; HEALTH; NEUROGENESIS	Fructose consumption is rising globally, but maternal high fructose intake might adversely affect offspring. Our previous report demonstrated that excess maternal fructose intake impairs hippocampal function in offspring, indicating that the hippocampi of offspring are highly sensitive to maternal fructose. Here, we examined the effect of maternal high fructose on mitochondrial physiology and uncoupling protein (UCP) expression. Rat dams received a 20% fructose solution during gestation and lactation. Immediately after weaning, offspring hippocampi were isolated. Maternal high fructose consumption attenuated the mitochondrial O-2 consumption rate and stimulated lipid hydroperoxide production in the hippocampi of offspring. Reduced Ucp5 and mitochondrial transcription factor A (Tfam) mRNA levels were also observed after maternal exposure to fructose. We assessed the promoter regions of both genes and found that this treatment enhanced DNA methylation levels. In addition, luciferase assays showed that this DNA methylation could reduce the transcription of both genes. Chromatin immunoprecipitation analysis demonstrated that specificity protein 1 binding to the Ucp5 promoter regions was reduced by DNA methylation. In addition, Ucp5 knockdown induced the up-regulation of reactive oxygen species levels in a rat brain glioma cell line, whereas reduced O-2 consumption was observed with Tfam knockdown. Maternal high fructose intake thus induces reduced O-2 oxygen consumption and increases oxidative stress in offspring, at least partly through epigenetic mechanisms involving Ucp5 and Tfam.-Yamada, H., Munetsuna, E., Yamazaki, M., Mizuno, G., Sadamoto, N., Ando, Y., Fujii, R., Shiogama, K., Ishikawa, H., Suzuki, K., Shimono, Y., Ohashi, K., Hashimoto, S. Maternal fructose-induced oxidative stress occurs via Tfam and Ucp5 epigenetic regulation in offspring hippocampi.	[Yamada, Hiroya; Hashimoto, Shuji] Fujita Hlth Univ, Sch Med Sci, Dept Hyg, 1-98, Toyoake, Aichi 4701192, Japan; [Munetsuna, Eiji; Shimono, Yohei] Fujita Hlth Univ, Sch Med Sci, Dept Biochem, Toyoake, Aichi, Japan; [Yamazaki, Mirai; Sadamoto, IINao; Ando, Yoshitaka; Ishikawa, Hiroaki; Ohashi, Koji] Fujita Hlth Univ, Sch Med Sci, Dept Clin Biochem, Toyoake, Aichi, Japan; [Mizuno, Genki] Fujita Hlth Univ, Sch Med Sci, Joint Res Lab Clin Med, Toyoake, Aichi, Japan; [Fujii, Ryosuke; Suzuki, Koji] Fujita Hlth Univ, Sch Med Sci, Dept Prevent Med Sci, Toyoake, Aichi, Japan; [Shiogama, Kazuya] Fujita Hlth Univ, Sch Med Sci, Dept Clin Examinat, Toyoake, Aichi, Japan; [Yamazaki, Mirai] Kagawa Prefectural Univ Hlth Sci, Dept Med Technol, Takamatsu, Kagawa, Japan	Fujita Health University; Fujita Health University; Fujita Health University; Fujita Health University; Fujita Health University; Fujita Health University	Yamada, H (corresponding author), Fujita Hlth Univ, Sch Med Sci, Dept Hyg, 1-98, Toyoake, Aichi 4701192, Japan.	hyamada@fujita-hu.ac.jp		Mizuno, Genki/0000-0001-8052-5146; Fujii, Ryosuke/0000-0003-1730-2059; Ando, Yoshitaka/0000-0002-1213-8096; Suzuki, Koji/0000-0002-3235-9558	Ministry of Education, Culture, Sports, Science, and Technology of Japan [18K17987, 18K05493, 17K07805]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Financial support for this study was provided by the Ministry of Education, Culture, Sports, Science, and Technology of Japan via Grants-in-Aid for Young Scientists (B) and Scientific Research (C) (18K17987, 18K05493, and 17K07805). The authors declare no conflicts of interest.	Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Bai SY, 2012, J DEV ORIG HLTH DIS, V3, P342, DOI 10.1017/S2040174412000256; Bray GA, 2013, ADV NUTR, V4, P220, DOI 10.3945/an.112.002816; Campos VC, 2016, INT J OBESITY, V40, pS6, DOI 10.1038/ijo.2016.8; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; Choi YS, 2002, BBA-GENE STRUCT EXPR, V1574, P200, DOI 10.1016/S0167-4781(01)00361-X; Cohen JFW, 2018, AM J PREV MED, V54, P727, DOI 10.1016/j.amepre.2018.02.020; Dornas WC, 2015, ADV NUTR, V6, P729, DOI 10.3945/an.114.008144; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Gage SH, 2016, ANNU REV PSYCHOL, V67, P567, DOI 10.1146/annurev-psych-122414-033352; Gallagher EAL, 2005, J PHYSIOL-LONDON, V568, P553, DOI 10.1113/jphysiol.2005.092825; Gemma C, 2010, MOL GENET METAB, V100, P83, DOI 10.1016/j.ymgme.2010.02.004; Ghezzi AC, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-3; Hayashi Y, 2008, J NEUROSCI, V28, P8624, DOI 10.1523/JNEUROSCI.1957-08.2008; Hiratsuka I, 2016, THYROID, V26, P1431, DOI 10.1089/thy.2016.0062; JEN KLC, 1991, J NUTR, V121, P1999, DOI 10.1093/jn/121.12.1999; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; Khacho M, 2018, DEV DYNAM, V247, P47, DOI 10.1002/dvdy.24538; Kim-Han JS, 2001, J NEUROCHEM, V79, P658, DOI 10.1046/j.1471-4159.2001.00604.x; Korosi A, 2012, BEHAV BRAIN RES, V227, P400, DOI 10.1016/j.bbr.2011.07.037; Kwok KHH, 2010, FREE RADICAL BIO MED, V49, P1023, DOI 10.1016/j.freeradbiomed.2010.06.017; Lajud N, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00003; Lakhan SE, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-114; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Medvedev AV, 2001, J BIOL CHEM, V276, P10817, DOI 10.1074/jbc.M010587200; Mizuno G, 2017, ENDOCR RES, V42, P71, DOI 10.1080/07435800.2016.1182186; Mortensen OH, 2014, J CEREBR BLOOD F MET, V34, P1205, DOI 10.1038/jcbfm.2014.72; Munetsuna E, 2019, J NUTR BIOCHEM, V67, P44, DOI 10.1016/j.jnutbio.2019.01.016; Munetsuna E, 2018, LIFE SCI, V202, P117, DOI 10.1016/j.lfs.2018.04.006; Munetsuna E, 2009, ENDOCRINOLOGY, V150, P4260, DOI 10.1210/en.2008-1644; Ohashi K, 2015, BIOCHEM BIOPH RES CO, V468, P185, DOI 10.1016/j.bbrc.2015.10.134; Ohashi K, 2015, NUTR RES, V35, P259, DOI 10.1016/j.nutres.2014.11.001; Ramsden DB, 2012, BRAIN BEHAV, V2, P468, DOI 10.1002/brb3.55; Rodrigo S, 2018, J NUTR BIOCHEM, V61, P163, DOI 10.1016/j.jnutbio.2018.08.011; Rodriguez L, 2016, J NUTR BIOCHEM, V32, P115, DOI 10.1016/j.jnutbio.2016.02.013; Shi XR, 2008, J BIOL CHEM, V283, P30658, DOI 10.1074/jbc.M800510200; Shore A, 2010, DIABETOLOGIA, V53, P1164, DOI 10.1007/s00125-010-1701-4; Sokpor G, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00226; Stebbings KA, 2016, NEUROBIOL AGING, V42, P101, DOI 10.1016/j.neurobiolaging.2016.03.006; Stetler RA, 2012, J NEUROCHEM, V123, P125, DOI 10.1111/j.1471-4159.2012.07951.x; Sutton GM, 2010, ENDOCRINOLOGY, V151, P1570, DOI 10.1210/en.2009-1133; Tain YL, 2015, J NUTR BIOCHEM, V26, P642, DOI 10.1016/j.jnutbio.2014.12.017; Tappy L, 2012, CURR OPIN CLIN NUTR, V15, P357, DOI 10.1097/MCO.0b013e328354727e; Vickers MH, 2011, ENDOCRINOLOGY, V152, P1378, DOI 10.1210/en.2010-1093; Vos Miriam B, 2008, Medscape J Med, V10, P160; Wu KLH, 2016, NEUROBIOL LEARN MEM, V130, P105, DOI 10.1016/j.nlm.2016.02.004; Yamada H, 2015, CLIN CHIM ACTA, V446, P267, DOI 10.1016/j.cca.2015.05.002; Yamazaki M, 2018, FASEB J, V32, P2549, DOI 10.1096/fj.201700783RR; Yamazaki M, 2016, LIFE SCI, V149, P146, DOI 10.1016/j.lfs.2016.02.020; Yu XX, 2000, AM J PHYSIOL-ENDOC M, V279, pE433, DOI 10.1152/ajpendo.2000.279.2.E433; Zheng J, 2014, BRIT J NUTR, V112, P1850, DOI 10.1017/S0007114514002827; Zou M, 2012, NUTR RES, V32, P588, DOI 10.1016/j.nutres.2012.06.012	53	16	15	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11431	11442		10.1096/fj.201901072R	http://dx.doi.org/10.1096/fj.201901072R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31314594	Bronze			2022-12-28	WOS:000489166300069
J	Zeng, X; Qu, XJ; Zhao, CY; Xu, L; Hou, KZ; Liu, YP; Zhang, N; Feng, J; Shi, S; Zhang, LY; Xiao, JW; Guo, ZG; Teng, YE; Che, XF				Zeng, Xue; Qu, Xiujuan; Zhao, Chenyang; Xu, Lu; Hou, Kezuo; Liu, Yunpeng; Zhang, Na; Feng, Jing; Shi, Sha; Zhang, Lingyun; Xiao, Jiawen; Guo, Zhigang; Teng, Yuee; Che, Xiaofang			FEN1 mediates miR-200a methylation and promotes breast cancer cell growth via MET and EGFR signaling	FASEB JOURNAL			English	Article						flap endonuclease 1; PCNA; DNA methyltransferases; tumor progression	FLAP ENDONUCLEASE-1; DNA METHYLTRANSFERASES; MICRORNA-200 FAMILY; ADJUVANT THERAPY; GENE-EXPRESSION; PROSTATE-CANCER; DNMT1; HYPOMETHYLATION; PROGRESSION; TRANSITION	Flap endonuclease 1 (FEN1) is recognized as a pivotal factor in DNA replication, long-patch excision repair, and telomere maintenance. Excessive FEN1 expression has been reported to be closely associated with cancer progression, but the specific mechanism has not yet been explored. In the present study, we demonstrated that FEN1 promoted breast cancer cell proliferation via an epigenetic mechanism of FEN1-mediated up-regulation of DNA methyltransferase (DNMT)1 and DNMT3a. FEN1 was proved to interact with DNMT3a through proliferating cell nuclear antigen (PCNA) to suppress microRNA (miR)-200a-5p expression mediated by methylation. Furthermore, miR-200a-5p was identified to repress breast cancer cell proliferation by inhibiting the expression of its target genes, hepatocyte growth factor (MET), and epidermal growth factor receptor (EGFR). Overall, our data surprisingly demonstrate that FEN1 promotes breast cancer cell growth via the formation of FEN1/PCNA/DNMT3a complex to inhibit miR-200a expression by DNMT-mediated methylation and to recover the target genes expression of miR-200a, MET, and EGFR. The novel epigenetic mechanism of FEN1 on proliferation promotion provides a significant clue that FEN1 might serve as a predictive biomarker and therapeutic target for breast cancer.-Zeng, X., Qu, X., Zhao, C., Xu, L., Hou, K., Liu, Y., Zhang, N., Feng, J., Shi, S., Zhang, L., Xiao, J., Guo, Z., Teng, Y., Che, X. FEN1 mediates miR-200a methylation and promotes breast cancer cell growth via MET and EGFR signaling.	[Zeng, Xue; Qu, Xiujuan; Xu, Lu; Hou, Kezuo; Liu, Yunpeng; Feng, Jing; Shi, Sha; Zhang, Lingyun; Teng, Yuee; Che, Xiaofang] China Med Univ, Hosp 1, Dept Med Oncol, 155 North Nanjing St, Shenyang 110001, Liaoning, Peoples R China; [Zeng, Xue; Qu, Xiujuan; Xu, Lu; Hou, Kezuo; Liu, Yunpeng; Feng, Jing; Shi, Sha; Zhang, Lingyun; Teng, Yuee; Che, Xiaofang] China Med Univ, Hosp 1, Key Lab Anticanc Drugs & Biotherapy Liaoning Prov, Shenyang, Liaoning, Peoples R China; [Zeng, Xue; Zhang, Na] China Med Univ, Canc Hosp, Liaoning Canc Hosp & Inst, Dept Radiotherapy, Shenyang, Liaoning, Peoples R China; [Zhao, Chenyang] China Med Univ, Res Ctr Med Genom, Shenyang, Liaoning, Peoples R China; [Xiao, Jiawen] Shenyang Fifth People Hosp, Dept Med Oncol, Shenyang, Liaoning, Peoples R China; [Guo, Zhigang] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University; Nanjing Normal University	Teng, YE; Che, XF (corresponding author), China Med Univ, Hosp 1, Dept Med Oncol, 155 North Nanjing St, Shenyang 110001, Liaoning, Peoples R China.	yeteng@cmu.edu.cn; xfche@cmu.edu.cn			National Natural Science Foundation of China [81672605]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2017ZX09304025]; Science and Technology Plan Project of Liaoning Province [2015020457, 2015020458, 201602452]; General Project of Liaoning Province, Department of Education [L2015588]; Foundation for Selected Overseas Chinese Scholar; Centre Leading Local Special Fund for Science and Technology of Liaoning Province [2016007010]; Key Research and Development Program of Shenyang [17-230-9-01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of the Ministry of Science and Technology of China; Science and Technology Plan Project of Liaoning Province; General Project of Liaoning Province, Department of Education; Foundation for Selected Overseas Chinese Scholar; Centre Leading Local Special Fund for Science and Technology of Liaoning Province; Key Research and Development Program of Shenyang	This work was supported by the National Natural Science Foundation of China (81672605), the National Science and Technology Major Project of the Ministry of Science and Technology of China (2017ZX09304025), the Science and Technology Plan Project of Liaoning Province (2015020457, 2015020458, 201602452), the General Project of Liaoning Province, Department of Education (L2015588), the Foundation for Selected Overseas Chinese Scholar 2015, the Centre Leading Local Special Fund for Science and Technology of Liaoning Province (2016007010), and the Key Research and Development Program of Shenyang (17-230-9-01). The authors declare no conflicts of interest.	Abdel-Fatah TMA, 2014, MOL ONCOL, V8, P1326, DOI 10.1016/j.molonc.2014.04.009; Castilla MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047709; Balakrishnan L, 2013, ANNU REV BIOCHEM, V82, P119, DOI 10.1146/annurev-biochem-072511-122603; Baretti M, 2018, CURR PROB CANCER, V42, P530, DOI 10.1016/j.currproblcancer.2018.03.001; Beattie TR, 2011, BIOCHEM SOC T, V39, P70, DOI 10.1042/BST0390070; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; da Cruz AT, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/528345; Eades G, 2011, J BIOL CHEM, V286, P25992, DOI 10.1074/jbc.M111.229401; Finger L David, 2012, Subcell Biochem, V62, P301, DOI 10.1007/978-94-007-4572-8_16; Gao Y, 2018, EBIOMEDICINE, V31, P243, DOI 10.1016/j.ebiom.2018.04.025; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Hamidi T, 2015, EPIGENOMICS-UK, V7, P247, DOI [10.2217/EPI.14.80, 10.2217/epi.14.80]; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hata K, 2002, DEVELOPMENT, V129, P1983; He LF, 2017, MOL ONCOL, V11, P1302, DOI 10.1002/1878-0261.12118; He LF, 2016, EBIOMEDICINE, V14, P32, DOI 10.1016/j.ebiom.2016.11.012; Hermann A, 2004, J BIOL CHEM, V279, P48350, DOI 10.1074/jbc.M403427200; Hervouet E, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0450-y; Hilmarsdottir B, 2014, GENES-BASEL, V5, P804, DOI 10.3390/genes5030804; Humphries B, 2015, ONCOTARGET, V6, P6472, DOI 10.18632/oncotarget.3052; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kinney SRM, 2008, MOL CANCER RES, V6, P1365, DOI 10.1158/1541-7786.MCR-08-0040; Krause A, 2005, CANCER LETT, V225, P111, DOI 10.1016/j.canlet.2004.10.035; Lam JS, 2006, BJU INT, V98, P445, DOI 10.1111/j.1464-410X.2006.06224.x; Lim YY, 2013, J CELL SCI, V126, P2256, DOI 10.1242/jcs.122275; Linklater ES, 2016, ONCOTARGET, V7, P69903, DOI 10.18632/oncotarget.12065; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Lyko F, 2018, NAT REV GENET, V19, P81, DOI 10.1038/nrg.2017.80; Neves Rui, 2010, BMC Res Notes, V3, P219, DOI 10.1186/1756-0500-3-219; Nikolova T, 2009, ANTICANCER RES, V29, P2453; Nimura K, 2006, GENES CELLS, V11, P1225, DOI 10.1111/j.1365-2443.2006.01012.x; Ning XH, 2015, CANCER LETT, V359, P198, DOI 10.1016/j.canlet.2015.01.005; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Parashar S, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4482-7; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Robaina MC, 2015, EXP MOL PATHOL, V98, P200, DOI 10.1016/j.yexmp.2015.03.006; Romagnolo DF, 2016, MOL NUTR FOOD RES, V60, P1310, DOI 10.1002/mnfr.201501063; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Sato M, 2003, ONCOGENE, V22, P7243, DOI 10.1038/sj.onc.1206977; Schermelleh L, 2007, NUCLEIC ACIDS RES, V35, P4301, DOI 10.1093/nar/gkm432; Shen BH, 2005, BIOESSAYS, V27, P717, DOI 10.1002/bies.20255; Shimamura S, 2008, CANCER SCI, V99, P1960, DOI 10.1111/j.1349-7006.2008.00913.x; Singh P, 2008, MOL CANCER RES, V6, P1710, DOI 10.1158/1541-7786.MCR-08-0269; Thomas ML, 2018, CANCERS, V10, DOI 10.3390/cancers10040101; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200; Wang J., 2015, BMC CANCER, V15; Wang KJ, 2014, INT J MOL MED, V33, P1268, DOI 10.3892/ijmm.2014.1682; Yi YW, 2015, INT J ONCOL, V47, P122, DOI 10.3892/ijo.2015.2982; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599; Zheng L, 2011, NUCLEIC ACIDS RES, V39, P781, DOI 10.1093/nar/gkq884	55	26	27	6	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10717	10730		10.1096/fj.201900273R	http://dx.doi.org/10.1096/fj.201900273R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31266372				2022-12-28	WOS:000489166300012
J	Xian, YF; Ip, SP; Li, HQ; Qu, C; Su, ZR; Chen, JN; Lin, ZX				Xian, Yan-Fang; Ip, Siu-Po; Li, Hui-Qin; Qu, Chang; Su, Zi-Ren; Chen, Jian-Nan; Lin, Zhi-Xiu			Isorhynchophylline exerts antidepressant-like effects in mice via modulating neuroinflammation and neurotrophins: involvement of the PI3K/Akt/GSK-3 beta signaling pathway	FASEB JOURNAL			English	Article						Chinese medicine; depression; behavioral tests; mechanism	UNPREDICTABLE MILD STRESS; NERVE GROWTH-FACTOR; EXTINCTION-INDUCED DESPAIR; FORCED SWIMMING TEST; UNCARIA-SINENSIS; HPA AXIS; BRAIN; DEPRESSION; MODEL; BDNF	Isorhynchophylline (IRN), an oxindole alkaloid isolated from Uncaria rhynchophylla, elicited distinct antidepressant-like activity in mice. The present study aimed to investigate the antidepressant-like effects of IRN in chronic unpredictable mild stress (CUMS)-induced depressive-like behaviors in mice and to illustrate its possible mechanisms of action. The mice were subjected to CUMS for 6 wk and administered with IRN (20 or 40 mg/kg) daily by oral gavage for 3 wk. The PI3K/protein kinase B (Akt) inhibitor and glycogen synthase kinase-3 beta (GSK-3 beta) inhibitors were used to determine the involvement of the PI3K/Akt/GSK-3 beta pathway in the antidepressant-like effects of IRN in the mice. The results showed that CUMS caused depression-like behaviors in the mice, such as behavioral despair by the forced swim test (FST) and anhedonia by the sucrose preference test. In addition, CUMS could significantly reduce the levels of nerve growth factor and brain-derived neurotrophic factor but markedly increase the release of TNF-alpha and IL-6 in the hippocampus and cerebral cortex of the mice. Western blotting analysis showed that CUMS markedly suppressed the levels of phosphorylated GSK-3 beta (Ser9) and phosphorylated Akt (Ser473) but significantly enhanced the translocation of NF-kappa B p65 from cytosol to nuclei in the hippocampus and cerebral cortex of the mice. CUMS could also significantly increase the NF-kappa B binding activity in the hippocampus and cerebral cortex of the mice, whereas IRN treatment could significantly reverse the behavioral and biochemical changes induced by CUMS in the mice. Moreover, the antidepressant-like effect of IRN was completely abolished by the PI3K/Akt inhibitor. Combination treatment with IRN and GSK-3 beta inhibitors in the mice exerted a synergistic anti-immobility action in the FST. The results of mechanistic investigations indicated that the antidepressant-like action of IRN was mediated, at least in part, by enhancing neurotrophins and attenuating neuroinflammation via modulating the PI3K/Akt/GSK-3 beta pathway.-Xian, Y.-F., Ip, S.-P., Li, H.-Q., Qu, C., Su, Z.-R., Chen, J.-N., Lin, Z.-X. Isorhynchophylline exerts antidepressant-like effects in mice via modulating neuroinflammation and neurotrophins: involvement of the PI3K/Akt/GSK-3 beta signaling pathway.	[Xian, Yan-Fang; Ip, Siu-Po; Li, Hui-Qin; Qu, Chang; Lin, Zhi-Xiu] Chinese Univ Hong Kong, Sch Chinese Med, Fac Med, Hong Kong, Peoples R China; [Xian, Yan-Fang; Ip, Siu-Po; Lin, Zhi-Xiu] Chinese Univ Hong Kong, Brain Res Ctr, Sch Chinese Med, Fac Med, Hong Kong, Peoples R China; [Lin, Zhi-Xiu] Chinese Univ Hong Kong, Hong Kong Inst Integrat Med, Hong Kong, Peoples R China; [Su, Zi-Ren; Chen, Jian-Nan] Guangzhou Univ Chinese Med, Guangdong Prov Key Lab New Drug Dev & Res Chinese, Math Engn Acad Chinese Med, Guangzhou, Guangdong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Guangzhou University of Chinese Medicine	Xian, YF; Lin, ZX (corresponding author), Chinese Univ Hong Kong, Sch Chinese Med, Fac Med, Shatin, Hong Kong, Peoples R China.	lisaxian@cuhk.edu.hk; linzx@cuhk.edu.hk	Ip, Paul/M-8831-2014; Lin, Zhi-Xiu/H-2807-2016; Xian, Yan-Fang/AAA-6876-2020	Ip, Paul/0000-0001-8657-6585; 	General Research Fund from the Research Grants Council of Hong Kong [14110814]; Chinese University of Hong Kong (CUHK) [2015.1.081, 2017.076]	General Research Fund from the Research Grants Council of Hong Kong; Chinese University of Hong Kong (CUHK)(Chinese University of Hong Kong)	This work was supported by the General Research Fund from the Research Grants Council of Hong Kong (14110814) and The Chinese University of Hong Kong (CUHK) Direct Grants 2015.1.081 and 2017.076. The authors declare no conflicts of interest.	Angelucci F, 2003, INT J NEUROPSYCHOPH, V6, P225, DOI 10.1017/S1461145703003468; Autry AE, 2009, BIOL PSYCHIAT, V66, P84, DOI 10.1016/j.biopsych.2009.02.007; Basterzi AD, 2009, PROG NEURO-PSYCHOPH, V33, P281, DOI 10.1016/j.pnpbp.2008.11.016; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; Budni J, 2012, J PSYCHOPHARMACOL, V26, P714, DOI 10.1177/0269881111424456; Castren E, 2007, CURR OPIN PHARMACOL, V7, P18, DOI 10.1016/j.coph.2006.08.009; Chourbaji S, 2005, BEHAV BRAIN RES, V164, P100, DOI 10.1016/j.bbr.2005.06.003; Chourbaji S, 2012, NEUROSCIENCE, V220, P267, DOI 10.1016/j.neuroscience.2012.06.016; Christensen NL, 1997, ECOSYSTEM FUNCTION AND HUMAN ACTIVITIES, P1; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cunha MP, 2016, MOL NEUROBIOL, V53, P2954, DOI 10.1007/s12035-015-9192-4; Dwivedi Y, 2005, BIOL PSYCHIAT, V58, P315, DOI 10.1016/j.biopsych.2005.04.014; Farooq RK, 2012, BEHAV BRAIN RES, V231, P130, DOI 10.1016/j.bbr.2012.03.020; Fernandes BS, 2011, J PSYCHIATR RES, V45, P995, DOI 10.1016/j.jpsychires.2011.03.002; Fuchs E, 2004, EUR NEUROPSYCHOPHARM, V14, pS481, DOI 10.1016/j.euroneuro.2004.09.002; Givens CJ, 2016, NURS CLIN N AM, V51, P309, DOI 10.1016/j.cnur.2016.01.013; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Guillet BA, 2005, NEUROCHEM INT, V46, P337, DOI 10.1016/j.neuint.2004.10.006; Han TK, 2015, METAB BRAIN DIS, V30, P711, DOI 10.1007/s11011-014-9624-2; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Hellweg R, 2002, MOL PSYCHIATR, V7, P604, DOI 10.1038/sj.mp.4001042; Hirschfeld Robert M A, 2012, J Clin Psychiatry, V73 Suppl 1, P5, DOI 10.4088/JCP.11096su1c.01; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huston JP, 2009, J NEURAL TRANSM, V116, P1029, DOI 10.1007/s00702-009-0210-4; Iwata M, 2013, BRAIN BEHAV IMMUN, V31, P105, DOI 10.1016/j.bbi.2012.12.008; Jiang H, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.43; Kaidanovich-Beilin O, 2004, BIOL PSYCHIAT, V55, P781, DOI 10.1016/j.biopsych.2004.01.008; KANATANI H, 1985, J PHARM PHARMACOL, V37, P401, DOI 10.1111/j.2042-7158.1985.tb03023.x; Kang TH, 2004, LIFE SCI, V76, P331, DOI 10.1016/j.lfs.2004.08.012; Karege F, 2007, BIOL PSYCHIAT, V61, P240, DOI 10.1016/j.biopsych.2006.04.036; Kaster MP, 2012, NEUROPHARMACOLOGY, V62, P419, DOI 10.1016/j.neuropharm.2011.08.018; Kingeter LM, 2010, CELL SIGNAL, V22, P9, DOI 10.1016/j.cellsig.2009.09.033; Kitagishi Yasuko, 2012, Depress Res Treat, V2012, P752563, DOI 10.1155/2012/752563; Koprdova R, 2016, NEUROENDOCRINOL LETT, V37, P103; Lang UE, 2004, STRESS, V7, P39, DOI 10.1080/10253890310001638145; Lang UE, 2004, NEUROPSYCHOPHARMACOL, V29, P795, DOI 10.1038/sj.npp.1300382; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Li S, 2007, LIFE SCI, V80, P1373, DOI 10.1016/j.lfs.2006.12.027; Lu JH, 2012, AUTOPHAGY, V8, P98, DOI 10.4161/auto.8.1.18313; Ludka FK, 2016, J PSYCHIATR RES, V82, P50, DOI 10.1016/j.jpsychires.2016.07.004; Luo DD, 2008, BRAIN RES BULL, V77, P8, DOI 10.1016/j.brainresbull.2008.05.010; Manji H K, 2001, Psychopharmacol Bull, V35, P5; Mao QQ, 2009, PROG NEURO-PSYCHOPH, V33, P1211, DOI 10.1016/j.pnpbp.2009.07.002; Matrisciano F, 2008, J PSYCHIATR RES, V43, P247, DOI 10.1016/j.jpsychires.2008.03.014; Matsumoto K, 2005, EUR J PHARMACOL, V517, P191, DOI 10.1016/j.ejphar.2005.05.015; Mizuno M, 2003, MOL PSYCHIATR, V8, P217, DOI 10.1038/sj.mp.4001215; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Raison CL, 2011, CURR PSYCHIAT REP, V13, P467, DOI 10.1007/s11920-011-0232-0; Rodrigues ALS, 1996, PHARMACOL TOXICOL, V79, P150, DOI 10.1111/j.1600-0773.1996.tb00259.x; Rosa AO, 2008, PROG NEURO-PSYCHOPH, V32, P1549, DOI 10.1016/j.pnpbp.2008.05.020; Shi HS, 2012, NEUROPSYCHOPHARMACOL, V37, P2671, DOI 10.1038/npp.2012.131; Shimada Y, 1999, J PHARM PHARMACOL, V51, P715, DOI 10.1211/0022357991772853; Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Thakare VN, 2018, J PSYCHOPHARMACOL, V32, P223, DOI 10.1177/0269881117742666; Topic B, 2008, NEUROBIOL LEARN MEM, V90, P519, DOI 10.1016/j.nlm.2008.06.011; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; World Health Organization (WHO), 2017, DEPRESSION; Xian YF, 2017, NEUROCHEM RES, V42, P678, DOI 10.1007/s11064-016-2124-5; Xian YF, 2014, J ALZHEIMERS DIS, V39, P331, DOI 10.3233/JAD-131457; Xian YF, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/163057; Xian YF, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/802625; Xian YF, 2012, CELL MOL NEUROBIOL, V32, P353, DOI 10.1007/s10571-011-9763-5; Xie H, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0747-8; Yang XH, 2017, NEUROPSYCH DIS TREAT, V13, P2727, DOI 10.2147/NDT.S150028; Yuan D, 2009, INT IMMUNOPHARMACOL, V9, P1549, DOI 10.1016/j.intimp.2009.09.010; Zheng H, 2006, BEHAV BRAIN RES, V168, P47, DOI 10.1016/j.bbr.2005.10.007	70	27	30	5	38	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10393	10408		10.1096/fj.201802743RR	http://dx.doi.org/10.1096/fj.201802743RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31233346				2022-12-28	WOS:000482214200054
J	Yang, GL; Han, ZY; Xiong, JH; Wang, SZ; Wei, HJ; Qin, TT; Xiao, HY; Liu, Y; Xu, LX; Qi, JW; Zhang, ZS; Jiang, RC; Zhang, JN; Li, LY				Yang, Gui-Li; Han, Zhenying; Xiong, Jianhua; Wang, Shizhao; Wei, Huijie; Qin, Ting-Ting; Xiao, Huaiyuan; Liu, Ye; Xu, Li-Xia; Qi, Jian-Wei; Zhang, Zhi-Song; Jiang, Rongcai; Zhang, Jianning; Li, Lu-Yuan			Inhibition of intracranial hemangioma growth and hemorrhage by TNFSF15	FASEB JOURNAL			English	Article						hemangioblastoma; TNF superfamily; VEGF	ENDOTHELIAL-CELLS; UP-REGULATION; EXPRESSION; SUPPRESSES; VEGF; ACTIVATION; MICROGLIA; ANGIOGENESIS; MACROPHAGES; ISOFORMS	Hemangioblastoma (HB) is an abnormal intracranial buildup of blood vessels that exhibit a great potential for hemorrhage. Surgical options are limited, and few medications are available for treatment. We show here by immunohistochemical analysis that HB lesions display highly increased levels of VEGF expression and macrophage/microglia infiltration compared with those in normal brain tissues. In the meantime, TNF superfamily 15 (TNFSF15) (also known as vascular endothelial growth inhibitor), an antiangiogenic cytokine, is highly expressed in normal brain blood vessels but diminished in HB lesions. We set up a brain hemangioma model by using mouse bEnd.3 cells of a T antigen-transformed endothelial cell line that produce a large amount of VEGF. When implanted in mouse brains, these cells form lesions that closely resemble the pathologic characteristics of HB. Retroviral infection of bEnd.3 cells with TNFSF15 leads to inhibition of VEGF production and retardation of hemangioma formation. Similar results are obtained when wild-type bEnd.3 cells are implanted in the brains of transgenic mice overexpressing TNFSF15. Additionally, TNFSF15 treatment results in enhanced pericyte coverage of the blood vessels in the lesions together with reduced inflammatory cell infiltration and decreased hemorrhage. These findings indicate that the ability of TNFSF15 to counterbalance the abnormally highly angiogenic and inflammatory potential of the microenvironment of HB is of therapeutic value for the treatment of this disease.-Yang, G.-L., Han, Z., Xiong, J., Wang, S., Wei, H., Qin, T.-T., Xiao, H., Liu, Y., Xu, L.-X., Qi, J.-W., Zhang, Z.-S., Jiang, R., Zhang, J., Li, L.-Y. Inhibition of intracranial hemangioma growth and hemorrhage by TNFSF15.	[Yang, Gui-Li; Han, Zhenying; Xiong, Jianhua; Wang, Shizhao; Wei, Huijie; Liu, Ye; Jiang, Rongcai; Zhang, Jianning] Tianjin Med Univ, Key Lab Postneuroinjury Repair & Regenerat Cent N, Minist Educ, Tianjin Neurol Inst,Gen Hosp, Tianjin, Peoples R China; [Qin, Ting-Ting; Xiao, Huaiyuan] Tianjin Med Univ, Key Lab Canc Prevent & Therapy, Tianjins Clin Res Ctr Canc, Canc Inst & Hosp,Natl Clin Res Ctr Canc, Tianjin, Peoples R China; [Xu, Li-Xia; Qi, Jian-Wei; Zhang, Zhi-Song; Li, Lu-Yuan] Nankai Univ, Coll Pharm, Tianjin Key Lab Mol Drug Res, State Key Lab Med Chem Biol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Nankai University	Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, 154 Shan St, Tianjin 300052, Peoples R China.; Li, LY (corresponding author), Nankai Univ, 94 Weijin Rd,New Life Sci Bldg A307, Tianjin 300071, Peoples R China.	jnzhang@tmu.edu.cn; liluyuan@nankai.edu.cn	Xu, Lixia/CAJ-5305-2022	Xu, Lixia/0000-0002-1843-0127	Natural Science Foundation of China [81874167, 81330029, 81501069, 81502173, 81601039, 81802296]; Municipal Science and Technology Commission [15ZXLCSY00060]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Municipal Science and Technology Commission	This study is supported in part by the Natural Science Foundation of China (Grants 81874167, 81330029, 81501069, 81502173, 81601039, and 81802296) and the Municipal Science and Technology Commission (15ZXLCSY00060). The authors declare no conflicts of interest.	Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Cheng SY, 1997, P NATL ACAD SCI USA, V94, P12081, DOI 10.1073/pnas.94.22.12081; Chew LJ, 2002, FASEB J, V16, P742, DOI 10.1096/fj.01-0757fje; Christoffersson G, 2012, BLOOD, V120, P4653, DOI 10.1182/blood-2012-04-421040; Conway Kevin P, 2007, Int Wound J, V4, P55, DOI 10.1111/j.1742-481X.2006.00295.x; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Deng HT, 2017, FEBS OPEN BIO, V7, P108, DOI 10.1002/2211-5463.12171; Deng WM, 2012, ANGIOGENESIS, V15, P71, DOI 10.1007/s10456-011-9244-y; Eyo UB, 2013, J NEUROIMMUNE PHARM, V8, P494, DOI 10.1007/s11481-013-9434-z; Forstreuter F, 2002, J NEUROIMMUNOL, V132, P93, DOI 10.1016/S0165-5728(02)00315-6; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; HO KL, 1987, ACTA NEUROPATHOL, V74, P345, DOI 10.1007/BF00687211; Hou W, 2005, CLIN CANCER RES, V11, P5595, DOI 10.1158/1078-0432.CCR-05-0384; Huang JZ, 2003, P NATL ACAD SCI USA, V100, P7785, DOI 10.1073/pnas.1432908100; Kerber M, 2008, CANCER RES, V68, P7342, DOI 10.1158/0008-5472.CAN-07-6241; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Liang PH, 2011, ANGIOGENESIS, V14, P61, DOI 10.1007/s10456-010-9195-8; Marin-Teva JL, 2011, NEURON GLIA BIOL, V7, P25, DOI 10.1017/S1740925X12000014; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; MORII K, 1993, BIOCHEM BIOPH RES CO, V194, P749, DOI 10.1006/bbrc.1993.1885; Mun-Bryce S, 1998, J CEREBR BLOOD F MET, V18, P1163, DOI 10.1097/00004647-199811000-00001; Muramatsu R, 2014, NEUROSCI RES, V81-82, P38, DOI 10.1016/j.neures.2014.01.007; Park S, 2012, HISTOL HISTOPATHOL, V27, P975, DOI 10.14670/HH-27.975; Parr Christian, 2006, Angiogenesis, V9, P73, DOI 10.1007/s10456-006-9033-1; Qi JW, 2013, P NATL ACAD SCI USA, V110, P13863, DOI 10.1073/pnas.1304529110; Qin TT, 2015, J PATHOL, V237, P307, DOI 10.1002/path.4577; Rockenfeller R, 2017, J THEOR BIOL, V431, P11, DOI 10.1016/j.jtbi.2017.07.023; Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785; SHEIBANI N, 1995, P NATL ACAD SCI USA, V92, P6788, DOI 10.1073/pnas.92.15.6788; Takano S, 1996, CANCER RES, V56, P2185; Tian F, 2007, J IMMUNOL, V179, P3742, DOI 10.4049/jimmunol.179.6.3742; Tian F, 2009, BLOOD, V113, P5352, DOI 10.1182/blood-2008-08-173773; WIZIGMANNVOOS S, 1995, CANCER RES, V55, P1358; Yang GL, 2017, FASEB J, V31, P2001, DOI 10.1096/fj.201600800R; Yu JY, 2001, CIRC RES, V89, P1161, DOI 10.1161/hh2401.101909; Zhai YF, 1999, FASEB J, V13, P181, DOI 10.1096/fasebj.13.1.181; Zhang K, 2016, ONCOTARGET, V7, P69436, DOI 10.18632/oncotarget.11683; Zhang N, 2010, ANTICANCER RES, V30, P87; Zhao Q, 2018, APPL IMMUNOHISTO M M, V26, P727, DOI 10.1097/PAI.0000000000000517; Zhou J, 2011, ONCOGENE, V30, P1892, DOI 10.1038/onc.2010.575	40	2	3	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10505	10514		10.1096/fj.201802758RRR	http://dx.doi.org/10.1096/fj.201802758RRR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31242765	Bronze			2022-12-28	WOS:000482214200062
J	Bilotta, MT; Abruzzese, MP; Molfetta, R; Scarno, G; Fionda, C; Zingoni, A; Soriani, A; Garofalo, T; Petrucci, MT; Ricciardi, MR; Paolini, R; Santoni, A; Cippitelli, M				Bilotta, Maria Teresa; Abruzzese, Maria Pia; Molfetta, Rosa; Scarno, Gianluca; Fionda, Cinzia; Zingoni, Alessandra; Soriani, Alessandra; Garofalo, Tina; Petrucci, Maria Teresa; Ricciardi, Maria Rosaria; Paolini, Rossella; Santoni, Angela; Cippitelli, Marco			Activation of liver X receptor up-regulates the expression of the NKG2D ligands MICA and MICB in multiple myeloma through different molecular mechanisms	FASEB JOURNAL			English	Article						LXR; cholesterol; natural killer	NATURAL-KILLER-CELLS; NUCLEAR RECEPTOR; CLASS-I; LXR; PROLIFERATION; METABOLISM; DEATH; CYTOTOXICITY; DYSFUNCTION; INHIBITION	NK cells have an important role in immunosurveillance of multiple myeloma (MM) progression, and their activity is enhanced by combination therapies able to regulate the expression of specific activating ligands. Liver X receptors (LXRs) are nuclear receptors and important regulators of intracellular cholesterol and lipid homeostasis. Moreover, they have regulatory roles in both cancer and immune response. Indeed, they can regulate inflammation and innate and acquired immunity. Furthermore, LXR activation directly acts in cancer cells (e.g., prostate, breast, melanoma, colon cancer, hepatocarcinoma, glioblastoma, and MM) that show an accumulation of cholesterol and alteration of LXR-mediated metabolic pathways. Here, we investigated the role of LXR and cholesterol on the expression of the NK cell-activating ligands major histocompatibility complex class I chain-related molecule A and B (MICA and MICB) in MM cells. The results shown in this work indicate that MM cells are responsive to LXR activation, which induces changes in the intracellular cholesterol content. These changes correlate with an enhanced expression of MICA and MICB in human MM cell lines and in primary malignant plasma cells, 2 ligands of the NK group 2D receptor (NKG2D)/CD314 activating receptor expressed in cytotoxic lymphocytes, rendering MM cells more sensitive to recognition, degranulation, and killing by NK cells. Mechanistically, we observed that LXR activation regulates MICA and MICB expression at different levels: MICA at the transcriptional level, enhancing mica promoter activity, and MICB by inhibiting its degradation in lysosomes. The present study provides evidence that activation of LXR, by enhancing NKG2D ligand expression, can promote NK cell-mediated cytotoxicity and suggests a novel immune-mediated mechanism involving modulation of intracellular cholesterol levels in cancer cells.-Bilotta, M. T., Abruzzese, M. P., Molfetta, R., Scarno, G., Fionda, C., Zingoni, A., Soriani, A., Garofalo, T., Petrucci, M. T., Ricciardi, M. R., Paolini, R., Santoni, A., Cippitelli, M. Activation of liver X receptor up-regulates the expression of the NKG2D ligands MICA and MICB in multiple myeloma through different molecular mechanisms.	[Bilotta, Maria Teresa; Abruzzese, Maria Pia; Molfetta, Rosa; Scarno, Gianluca; Fionda, Cinzia; Zingoni, Alessandra; Soriani, Alessandra; Paolini, Rossella; Santoni, Angela; Cippitelli, Marco] Sapienza Univ Rome, Dept Mol Med, Viale Regina Elena 291, I-00161 Rome, Italy; [Garofalo, Tina] Sapienza Univ Rome, Dept Expt Med, Rome, Italy; [Petrucci, Maria Teresa] Sapienza Univ Rome, Dept Cellular Biotechnol & Hematol, Div Hematol, Rome, Italy; [Ricciardi, Maria Rosaria] Sapienza Univ Rome, Dept Clin & Mol Med, Hematol, Rome, Italy; [Santoni, Angela] Fdn Cenci Bolognetti, Ist Pasteur, Rome, Italy; [Santoni, Angela] Ist Mediterraneo Neurosci Neuromed, Pozzilli, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Fondazione Cenci Bolognetti; IRCCS Neuromed	Santoni, A; Cippitelli, M (corresponding author), Sapienza Univ Rome, Dept Mol Med, Viale Regina Elena 291, I-00161 Rome, Italy.	angela.santoni@uniroma1.it; marco.cippitelli@uniroma1.it	Abruzzese, Maria Pia/AAJ-9019-2020; ABRUZZESE, MARIA PIA/AAJ-8628-2020; Cippitelli, Marco/AAF-4857-2021; Ricciardi, Maria Rosaria/Z-5810-2019; Molfetta, Rosa/N-4529-2015; Zingoni, Alessandra/AAC-5481-2022; Bilotta, Maria Teresa/AAS-3135-2021	Abruzzese, Maria Pia/0000-0003-4433-4670; Cippitelli, Marco/0000-0002-9620-538X; Ricciardi, Maria Rosaria/0000-0002-8772-3521; Molfetta, Rosa/0000-0003-2904-6371; Scarno, Gianluca/0000-0002-2183-5942; Bilotta, Maria Teresa/0000-0002-0293-7214; PAOLINI, Rossella/0000-0001-7605-1531	Italian Association for Cancer Research (AIRC Investigator Grant); Italian Association for Cancer Research (AIRC 5x1000); Sapienza University of Rome [Ateneo - RG11816426E8448B]; Ministero dell'Istruzione, dell'Universita e della Ricerca - MIUR/Progetti di Rilevante Interesse Nazionale (PRIN) [2017NTK4HY_005]	Italian Association for Cancer Research (AIRC Investigator Grant)(Fondazione AIRC per la ricerca sul cancro); Italian Association for Cancer Research (AIRC 5x1000)(Fondazione AIRC per la ricerca sul cancro); Sapienza University of Rome; Ministero dell'Istruzione, dell'Universita e della Ricerca - MIUR/Progetti di Rilevante Interesse Nazionale (PRIN)	The authors thank Dr. Skov (University of Copenhagen, Frederiksberg, Denmark) for providing the 3.2 kb wild-type MICA/GFP vector promoter reporter and the Center for Life Nano Science (CLNS) imaging facility of the Istituto Italiano di Tecnologia (IIT, Rome, Italy), where the fluorescent images were collected. This work was supported by grants from the Italian Association for Cancer Research (AIRC Investigator Grant and AIRC 5x1000), the Sapienza University of Rome (Ateneo - RG11816426E8448B), Ministero dell'Istruzione, dell'Universita e della Ricerca - MIUR/Progetti di Rilevante Interesse Nazionale (PRIN) (2017NTK4HY_005). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Abruzzese MP, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1562-9; Abruzzese MP, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0362-2; Agarwal JR, 2014, MOL CANCER THER, V13, P1873, DOI 10.1158/1535-7163.MCT-13-0997; Aguera-Gonzalez S, 2009, J IMMUNOL, V182, P4800, DOI 10.4049/jimmunol.0800713; Antonangeli F, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1218105; APFEL R, 1994, MOL CELL BIOL, V14, P7025, DOI 10.1128/MCB.14.10.7025; Appelqvist H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050262; Appelqvist H, 2011, AM J PATHOL, V178, P629, DOI 10.1016/j.ajpath.2010.10.030; Beceiro S, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00534-17; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Bovenga F, 2015, CELL METAB, V21, P517, DOI 10.1016/j.cmet.2015.03.002; Calkin AC, 2010, ARTERIOSCL THROM VAS, V30, P1513, DOI 10.1161/ATVBAHA.109.191197; Carbone E, 2005, BLOOD, V105, P251, DOI 10.1182/blood-2004-04-1422; Cui GL, 2011, J CLIN INVEST, V121, P658, DOI 10.1172/JCI42974; Derangere V, 2014, CELL DEATH DIFFER, V21, P1914, DOI 10.1038/cdd.2014.117; El-Sherbiny YM, 2007, CANCER RES, V67, P8444, DOI 10.1158/0008-5472.CAN-06-4230; Fionda C, 2018, CANCER TREAT REV, V70, P255, DOI 10.1016/j.ctrv.2018.10.005; Fionda C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/178698; Fionda C, 2013, J IMMUNOL, V190, P6662, DOI 10.4049/jimmunol.1201426; Fionda C, 2009, J IMMUNOL, V183, P4385, DOI 10.4049/jimmunol.0901797; Frohn C, 2002, BRIT J HAEMATOL, V119, P660, DOI 10.1046/j.1365-2141.2002.03879.x; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Geyeregger R, 2009, J LEUKOCYTE BIOL, V86, P1039, DOI 10.1189/jlb.1008663; Godfrey J, 2012, LEUKEMIA LYMPHOMA, V53, P1666, DOI 10.3109/10428194.2012.676175; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Guillerey C, 2016, CELL MOL LIFE SCI, V73, P1569, DOI 10.1007/s00018-016-2135-z; Guillerey C, 2015, J CLIN INVEST, V125, P2077, DOI 10.1172/JCI77181; Guo DL, 2011, CANCER DISCOV, V1, P442, DOI 10.1158/2159-8290.CD-11-0102; HUBER LA, 1991, EUR J IMMUNOL, V21, P2761, DOI 10.1002/eji.1830211117; Hungria VTM, 2004, CANCER CHEMOTH PHARM, V53, P51, DOI 10.1007/s00280-003-0692-y; Iannelli F, 2018, RECENT PAT ANTI-CANC, V13, P184, DOI 10.2174/1574892812666171129141211; Jaishy B, 2016, J LIPID RES, V57, P1619, DOI 10.1194/jlr.R067520; Ju XL, 2017, ONCOL LETT, V14, P7676, DOI 10.3892/ol.2017.7259; Kwiatkowska K, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-64; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; Lin CY, 2015, NAT REV CANCER, V15, P216, DOI 10.1038/nrc3912; Lo Sasso G, 2013, GASTROENTEROLOGY, V144, P1497, DOI 10.1053/j.gastro.2013.02.005; Pignoloni B, 2016, J IMMUNOL, V197, P4066, DOI 10.4049/jimmunol.1502527; Ponzetta A, 2015, CANCER RES, V75, P4766, DOI 10.1158/0008-5472.CAN-15-1320; Pourcet B, 2016, SCI REP-UK, V6, DOI 10.1038/srep25481; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Reiners JJ, 2011, FREE RADICAL BIO MED, V50, P281, DOI 10.1016/j.freeradbiomed.2010.11.006; Solt LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046615; Soriani A, 2014, J IMMUNOL, V193, P950, DOI 10.4049/jimmunol.1400271; Soriani A, 2009, BLOOD, V113, P3503, DOI 10.1182/blood-2008-08-173914; Tavazoie MF, 2018, CELL, V172, P825, DOI 10.1016/j.cell.2017.12.026; Traversari C, 2014, EUR J IMMUNOL, V44, P1896, DOI 10.1002/eji.201344292; Valledor AF, 2005, IMMUNOBIOLOGY, V210, P127, DOI 10.1016/j.imbio.2005.05.007; Vedin Lise-Lotte, 2013, Mol Carcinog, V52, P835, DOI 10.1002/mc.21924; Vedin LL, 2009, CARCINOGENESIS, V30, P575, DOI 10.1093/carcin/bgp029; Viennois E, 2012, MOL CELL ENDOCRINOL, V351, P129, DOI 10.1016/j.mce.2011.08.036; Villa GR, 2016, CANCER CELL, V30, P683, DOI 10.1016/j.ccell.2016.09.008; Villablanca EJ, 2010, NAT MED, V16, P98, DOI 10.1038/nm.2074; Walcher D, 2010, BASIC RES CARDIOL, V105, P487, DOI 10.1007/s00395-010-0092-5; Wang B, 2018, CELL STEM CELL, V22, P206, DOI 10.1016/j.stem.2017.12.017; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Xu X, 2016, ONCOTARGET, V7, P75539, DOI 10.18632/oncotarget.12265; Yavasoglu I, 2008, ANN HEMATOL, V87, P223, DOI 10.1007/s00277-007-0375-6; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zingoni A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00926; Zingoni A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00476; Zingoni A, 2015, J IMMUNOL, V195, P736, DOI 10.4049/jimmunol.1402643; Zitti B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10403-0	66	12	14	4	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9489	9504		10.1096/fj.201900319R	http://dx.doi.org/10.1096/fj.201900319R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31125275	Bronze			2022-12-28	WOS:000478832900061
J	Blanco, C; Morales, D; Mogollones, I; Vergara-Jaque, A; Vargas, C; Alvarez, A; Riquelme, D; Leiva-Salcedo, E; Gonzalez, W; Morales, D; Maureira, D; Aldunate, I; Caceres, M; Varela, D; Cerda, O				Blanco, Constanza; Morales, Danna; Mogollones, Ignacio; Vergara-Jaque, Ariela; Vargas, Carla; Alvarez, Alhejandra; Riquelme, Denise; Leiva-Salcedo, Elias; Gonzalez, Wendy; Morales, Diego; Maureira, Diego; Aldunate, Ismael; Caceres, Monica; Varela, Diego; Cerda, Oscar			EB1-and EB2-dependent anterograde trafficking of TRPM4 regulates focal adhesion turnover and cell invasion	FASEB JOURNAL			English	Article						TRP channels; EB proteins; ER export	CATION CHANNEL TRPM4; MICROARRAY ANALYSIS; MOLECULAR-DYNAMICS; PROSTATE-CANCER; ION CHANNELS; PROTEIN EB1; TRACKING; EXPRESSION; STIM1; LOCALIZATION	Transient receptor potential melastatin 4 (TRPM4) is a Ca2+-activated nonselective cationic channel involved in a wide variety of physiologic and pathophysiological processes. Bioinformatics analyses of the primary sequence of TRPM4 allowed us to identify a putative motif for interaction with end-binding (EB) proteins, which are microtubule plus-end tracking proteins. Here, we provide novel data suggesting that TRPM4 interacts with EB proteins. We show that mutations of the putative EB binding motif abolish the TRPM4-EB interaction, leading to a reduced expression of the mature population of the plasma membrane channel and instead display an endoplasmic reticulum-associated distribution. Furthermore, we demonstrate that EB1 and EB2 proteins are required for TRPM4 trafficking and functional activity. Finally, we demonstrated that the expression of a soluble fragment containing the EB binding motif of TRPM4 reduces the plasma membrane expression of the channel and affects TRPM4-dependent focal adhesion disassembly and cell invasion processes.-Blanco, C., Morales, D., Mogollones, I., Vergara-Jaque, A., Vargas, C., alvarez, A., Riquelme, D., Leiva-Salcedo, E., Gonzalez, W., Morales, D., Maureira, D., Aldunate, I., Caceres, M., Varela, D., Cerda, O. EB1- and EB2-dependent anterograde trafficking of TRPM4 regulates focal adhesion turnover and cell invasion.	[Blanco, Constanza; Mogollones, Ignacio; Vargas, Carla; Alvarez, Alhejandra; Morales, Diego; Maureira, Diego; Aldunate, Ismael; Caceres, Monica; Cerda, Oscar] Univ Chile, Program Cellular & Mol Biol, Santiago, Chile; [Morales, Danna; Vergara-Jaque, Ariela; Varela, Diego] Univ Chile, Program Physiol & Biophys, Inst Biomed Sci, Fac Med, Santiago, Chile; [Blanco, Constanza; Morales, Danna; Mogollones, Ignacio; Vargas, Carla; Alvarez, Alhejandra; Gonzalez, Wendy; Morales, Diego; Maureira, Diego; Caceres, Monica; Varela, Diego; Cerda, Oscar] Millennium Nucleus Ion Channels Associated Dis Mi, Santiago, Chile; [Vergara-Jaque, Ariela] Univ Talca, Multidisciplinary Sci Nucleus, Talca, Chile; [Vergara-Jaque, Ariela; Gonzalez, Wendy] Univ Talca, Ctr Bioinformat & Mol Simulat, Talca, Chile; [Riquelme, Denise; Leiva-Salcedo, Elias] Univ Santiago Chile, Fac Chem & Biol, Dept Biol, Santiago, Chile; [Caceres, Monica; Cerda, Oscar] Wound Repair Treatment & Hlth WoRTH Initiat, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Talca; Universidad de Talca; Universidad de Santiago de Chile	Cerda, O (corresponding author), Univ Chile, Fac Med, Inst Biomed Sci, Program Cellular & Mol Biol, Independencia 1027, Santiago 8380453, Chile.	oscarcerda@uchile.cl	Cerda, Oscar/N-3895-2018; Varela, Diego/AAG-7489-2019; Vergara, Ariela/AAD-3594-2020	Cerda, Oscar/0000-0003-2873-5722; Varela, Diego/0000-0002-9352-414X; Gonzalez, Wendy/0000-0002-7535-6883; Morales, Diego/0000-0002-5834-3685	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1160518]; FONDECYT [11170223, 1140624, 1181814, 1181263, 1160900]; Programa de Equipamiento Cientifico y Tecnologico (FONDEQUIP) [EQM150069]; Iniciativa Cientifica Milenio of the Ministry of Economy, Development, and Tourism (Chile)	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Programa de Equipamiento Cientifico y Tecnologico (FONDEQUIP); Iniciativa Cientifica Milenio of the Ministry of Economy, Development, and Tourism (Chile)	The authors thank Nicanor Villarroel (Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile) and Cecilia Zuniga and Herve Camus (Microscopy Core Facility, Faculty of Medicine, Universidad de Chile) for technical support; Daniel Valdes and Dr. Claudio Acuna (Microscopy Core Facility, Universidad de Santiago de Chile) for helpful advice on confocal microscopy acquisition; Anibal Romero, Patricio Merino, (Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Chile) and Christian Olivera (Universidad de Talca, Chile) for preliminary studies; Drs. Pierre Launay (INSERM, France), Marc Simard (University of Maryland School of Medicine, Baltimore, MD, USA), Anna Akmanova (Utrecht University, The Netherlands), Franck Perez (Institut Curie, France), and Michael Davidson (Florida State University, Tallahassee, FL, USA) for sharing plasmids; and Drs. James S. Trimmer (University of California-Davis, Davis, CA, USA) and Jose Ignacio Valenzuela (Institut Curie, France) for discussion and critical comments to the manuscript. This research was funded by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) Grant 1160518 to O.C. The Millennium Nucleus of Ion Channels-Associated Diseases (MiNICAD) is a Millennium Nucleus supported by the Iniciativa Cientifica Milenio of the Ministry of Economy, Development, and Tourism (Chile). FONDECYT Grants 11170223, 1140624, 1181814, 1181263, and 1160900 were made to A.V.-J., W.G., E.L.-S., M.C., and D.V., respectively. Confocal microscopy acquisition was performed at the Microscopy Core Facility at Universidad de Santiago de Chile, funded by Programa de Equipamiento Cientifico y Tecnologico (FONDEQUIP) EQM150069. The authors declare no conflicts of interest.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Akhmanova A, 2009, TRAFFIC, V10, P268, DOI 10.1111/j.1600-0854.2008.00869.x; Armisen R, 2011, J CELL PHYSIOL, V226, P103, DOI 10.1002/jcp.22310; Ashida S, 2004, CANCER RES, V64, P5963, DOI 10.1158/0008-5472.CAN-04-0020; Autzen HE, 2018, SCIENCE, V359, P228, DOI 10.1126/science.aar4510; Barbet G, 2008, NAT IMMUNOL, V9, P1148, DOI 10.1038/ni.1648; Boncompain G, 2012, NAT METHODS, V9, P493, DOI [10.1038/NMETH.1928, 10.1038/nmeth.1928]; Caceres M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130540; Cerda O, 2015, PFLUG ARCH EUR J PHY, V467, P1723, DOI 10.1007/s00424-014-1610-3; Chang CL, 2018, J CELL BIOL, V217, P2047, DOI 10.1083/jcb.201711151; Cheng H, 2007, CELL CALCIUM, V41, P51, DOI 10.1016/j.ceca.2006.04.032; Cho CH, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0052-3; Crnich R, 2010, AM J PHYSIOL-CELL PH, V299, pC682, DOI 10.1152/ajpcell.00101.2010; De Groot CO, 2010, J BIOL CHEM, V285, P5802, DOI 10.1074/jbc.M109.068130; Earley S, 2004, CIRC RES, V95, P922, DOI 10.1161/01.RES.0000147311.54833.03; Echeverria C, 2015, J HYPERTENS, V33, P981, DOI 10.1097/HJH.0000000000000496; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Gerzanich V, 2009, NAT MED, V15, P185, DOI 10.1038/nm.1899; Geyer M, 2015, CELL REP, V12, P79, DOI 10.1016/j.celrep.2015.06.001; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Gu C, 2006, NEURON, V52, P803, DOI 10.1016/j.neuron.2006.10.022; Gu YZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011931; Guinamard R, 2010, PHYSIOLOGY, V25, P155, DOI 10.1152/physiol.00004.2010; Guo JT, 2017, NATURE, V552, P205, DOI 10.1038/nature24997; Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Honore S, 2008, MOL CANCER THER, V7, P2080, DOI 10.1158/1535-7163.MCT-08-0156; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang K, 2012, CURR BIOL, V22, P1800, DOI 10.1016/j.cub.2012.07.047; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kruse M, 2014, CURR OPIN PHARMACOL, V15, P68, DOI 10.1016/j.coph.2013.12.003; Kruse M, 2009, J CLIN INVEST, V119, P2737, DOI 10.1172/JCI38292; Kumar P, 2012, TRENDS CELL BIOL, V22, P418, DOI 10.1016/j.tcb.2012.05.005; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Lee Jooyoung, 2009, P3, DOI 10.1007/978-1-4020-9058-5_1; Leiva-Salcedo E, 2017, CHANNELS, V11, P624, DOI 10.1080/19336950.2017.1375072; Lesniewska K, 2014, MOL BIOL CELL, V25, P1025, DOI 10.1091/mbc.E13-08-0504; Liu H, 2015, J BIOL CHEM, V290, P30771, DOI 10.1074/jbc.M115.671743; Liu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054131; Liu H, 2010, CIRC-CARDIOVASC GENE, V3, P374, DOI 10.1161/CIRCGENETICS.109.930867; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Narayan G, 2007, GENE CHROMOSOME CANC, V46, P373, DOI 10.1002/gcc.20418; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Patel DM, 2014, J CELL BIOL, V206, P779, DOI 10.1083/jcb.201312110; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piao HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121703; Pozo-Guisado E, 2013, J CELL SCI, V126, P3170, DOI 10.1242/jcs.125054; Raveh B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018934; Rovini A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065694; Sagredo AI, 2018, MOL ONCOL, V12, P151, DOI 10.1002/1878-0261.12100; Schattling B, 2012, NAT MED, V18, P1805, DOI 10.1038/nm.3015; Schober JM, 2012, BIOCHEM BIOPH RES CO, V417, P67, DOI 10.1016/j.bbrc.2011.11.056; Schober JM, 2009, CANCER LETT, V284, P30, DOI 10.1016/j.canlet.2009.04.007; Schulte U, 2011, SEMIN CELL DEV BIOL, V22, P132, DOI 10.1016/j.semcdb.2010.09.015; Schulte U, 2008, CNS NEUROL DISORD-DR, V7, P172, DOI 10.2174/187152708784083795; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; Shimizu T, 2009, CELL CALCIUM, V45, P226, DOI 10.1016/j.ceca.2008.10.005; Siesser PF, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002871; Simon F, 2010, J BIOL CHEM, V285, P37150, DOI 10.1074/jbc.M110.155390; Singh J, 2006, CANCER LETT, V237, P298, DOI 10.1016/j.canlet.2005.06.008; Smyth JW, 2010, HEART RHYTHM, V7, P1135, DOI 10.1016/j.hrthm.2010.05.030; Smyth JW, 2010, J CLIN INVEST, V120, P266, DOI 10.1172/JCI39740; Smyth JT, 2012, CURR BIOL, V22, P1487, DOI 10.1016/j.cub.2012.05.057; Stallmeyer B, 2012, HUM MUTAT, V33, P109, DOI 10.1002/humu.21599; Stoilova-McPhie Svetla, 2013, Austin J Pharmacol Ther, V1; Su LK, 2001, GENOMICS, V71, P142, DOI 10.1006/geno.2000.6428; Suguro M, 2006, CANCER SCI, V97, P868, DOI 10.1111/j.1349-7006.2006.00267.x; Syam N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00052; Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Vacher H, 2011, J CELL BIOL, V192, P813, DOI 10.1083/jcb.201007113; Vergara-Jaque A, 2013, J PHYS CHEM B, V117, P6801, DOI 10.1021/jp4000363; Wakana Y, 2013, J CELL BIOL, V202, P241, DOI 10.1083/jcb.201303163; Wang JL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078393, 10.1371/journal.pone.0073683, 10.1371/journal.pone.0063924, 10.1371/journal.pone.0066563, 10.1371/journal.pone.0070587]; Wang Z, 2014, J CELL SCI, V127, P4904, DOI 10.1242/jcs.155408; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Weber KS, 2010, J IMMUNOL, V185, P2836, DOI 10.4049/jimmunol.1000880; Winkler PA, 2017, NATURE, V552, P200, DOI 10.1038/nature24674; Woo SK, 2013, J BIOL CHEM, V288, P36409, DOI 10.1074/jbc.M113.530584; Yue JP, 2014, DEV CELL, V31, P572, DOI 10.1016/j.devcel.2014.10.025; Zhang LY, 2013, SCI REP-UK, V3, DOI 10.1038/srep01681	91	11	11	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9434	9452		10.1096/fj.201900136R	http://dx.doi.org/10.1096/fj.201900136R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31112396	Bronze			2022-12-28	WOS:000478832900057
J	Fiorenza, M; Lemminger, AK; Marker, M; Eibye, K; Iaia, FM; Bangsbo, J; Hostrup, M				Fiorenza, Matteo; Lemminger, Anders K.; Marker, Mathias; Eibye, Kasper; Iaia, F. Marcello; Bangsbo, Jens; Hostrup, Morten			High-intensity exercise training enhances mitochondrial oxidative phosphorylation efficiency in a temperature-dependent manner in human skeletal muscle: implications for exercise performance	FASEB JOURNAL			English	Article						mitochondrial respiratory function; mitochondrial efficiency; high-intensity interval training (HIIT); uncoupling proteins; exercise efficiency	CROSS-SECTIONAL AREA; OXYGEN-UPTAKE; RESPIRATORY CAPACITY; PERMEABILIZED FIBERS; PROTEIN EXPRESSION; OXPHOS PROTOCOLS; SMALL BIOPSIES; HUMAN-CELLS; ADAPTATIONS; INTERVAL	The purpose of the present study was to investigate whether exercise training-induced adaptations in human skeletal muscle mitochondrial bioenergetics are magnified under thermal conditions resembling sustained intense contractile activity and whether training-induced changes in mitochondrial oxidative phosphorylation (OXPHOS) efficiency influence exercise efficiency. Twenty healthy men performed 6 wk of high-intensity exercise training [i.e., speed endurance training (SET; n = 10)], or maintained their usual lifestyle (n = 10). Before and after the intervention, mitochondrial respiratory function was determined ex vivo in permeabilized muscle fibers under experimentally-induced normothermia (35 degrees C) and hyperthermia (40 degrees C) mimicking in vivo muscle temperature at rest and during intense exercise, respectively. In addition, activity and content of muscle mitochondrial enzymes and proteins were quantified. Exercising muscle efficiency was determined in vivo by measurements of leg hemodynamics and blood parameters during one-legged knee-extensor exercise. SET enhanced maximal OXPHOS capacity and OXPHOS efficiency at 40 degrees C, but not at 35 degrees C, and attenuated hyperthermia-induced decline in OXPHOS efficiency. Furthermore, SET increased expression of markers of mitochondrial content and up-regulated content of MFN2, DRP1, and ANT1. Also, SET improved exercise efficiency and capacity. These findings indicate that muscle mitochondrial bioenergetics adapts to high-intensity exercise training in a temperature-dependent manner and that enhancements in mitochondrial OXPHOS efficiency may contribute to improving exercise performance.-Fiorenza, M., Lemminger, A. K., Marker, M., Eibye, K., Iaia, F. M., Bangsbo, J., Hostrup, M. High-intensity exercise training enhances mitochondrial oxidative phosphorylation efficiency in a temperature-dependent manner in human skeletal muscle: implications for exercise performance.	[Fiorenza, Matteo; Lemminger, Anders K.; Marker, Mathias; Eibye, Kasper; Bangsbo, Jens; Hostrup, Morten] Univ Copenhagen, Dept Nutr Exercise & Sports, Sect Integrat Physiol, August Krogh Bldg,Univ Pk 13, DK-2100 Copenhagen, Denmark; [Fiorenza, Matteo] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Iaia, F. Marcello] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy	University of Copenhagen; University of Verona; University of Milan	Hostrup, M (corresponding author), Univ Copenhagen, Dept Nutr Exercise & Sports, Sect Integrat Physiol, August Krogh Bldg,Univ Pk 13, DK-2100 Copenhagen, Denmark.	mhostrup@nexs.ku.dk	Iaia, F. Marcello/L-6067-2015; Fiorenza, Matteo/AAA-1887-2020; Bangsbo, Jens/A-7192-2015; Hostrup, Morten/D-9053-2015	Iaia, F. Marcello/0000-0003-0981-6471; Fiorenza, Matteo/0000-0002-8377-0857; Lemminger, Anders K./0000-0002-7929-7147; Bangsbo, Jens/0000-0003-1305-9274; Eibye, Kasper/0000-0002-5737-691X; Hostrup, Morten/0000-0002-6201-2483	Danish Ministry of Culture (Exercise Science Council)	Danish Ministry of Culture (Exercise Science Council)	The authors thank the participants in the trial. Jens Jung Nielsen, Martin Thomassen, Soren Jessen, and Kasper Bengt sen (all from the Section of Integrative Physiology, Depart ment of Nutrition, Exercise and Sports at the University of Copenhagen) are gratefully acknowledged for valuable help in data collection during the experiments. This work was supported by the Danish Ministry of Culture (Exercise Science Council). The authors declare no conflicts of interest.	Bakkman L, 2007, ACTA PHYSIOL, V190, P243, DOI 10.1111/j.1748-1716.2007.01683.x; Bangsbo J, 2000, AM J PHYSIOL-REG I, V279, pR899, DOI 10.1152/ajpregu.2000.279.3.R899; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; BERG HE, 1993, ACTA PHYSIOL SCAND, V148, P379, DOI 10.1111/j.1748-1716.1993.tb09573.x; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Brandt N, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13651; BROOKS GA, 1971, AM J PHYSIOL, V220, P1053, DOI 10.1152/ajplegacy.1971.220.4.1053; BROOKS GA, 1971, AM J PHYSIOL, V221, P427, DOI 10.1152/ajplegacy.1971.221.2.427; Cerniglia LM, 2007, CLIN PHYSIOL FUNCT I, V27, P249, DOI 10.1111/j.1475-097X.2007.00742.x; CHANCE B, 1955, NATURE, V175, P1120, DOI 10.1038/1751120a0; CHANCE B, 1955, J BIOL CHEM, V217, P409; Christensen PM, 2016, J APPL PHYSIOL, V120, P1319, DOI 10.1152/japplphysiol.00115.2015; Conley KE, 2016, J EXP BIOL, V219, P243, DOI 10.1242/jeb.126623; Daussin FN, 2008, AM J PHYSIOL-REG I, V295, pR264, DOI 10.1152/ajpregu.00875.2007; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; Doerrier C, 2018, METHODS MOL BIOL, V1782, P31, DOI 10.1007/978-1-4939-7831-1_3; Dohlmann TL, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13857; Drust B, 2005, ACTA PHYSIOL SCAND, V183, P181, DOI 10.1111/j.1365-201X.2004.01390.x; Fernstrom M, 2004, J PHYSIOL-LONDON, V554, P755, DOI 10.1113/jphysiol.2003.055202; Fiorenza M, 2018, J PHYSIOL-LONDON, V596, P2823, DOI 10.1113/JP275972; Fiorenza M., 2019, MED SCI SPORTS EXERC; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; Granata C, 2018, SPORTS MED, V48, P1809, DOI 10.1007/s40279-018-0936-y; Granata C, 2016, FASEB J, V30, P959, DOI 10.1096/fj.15-276907; Granata C, 2016, FASEB J, V30, P3413, DOI 10.1096/fj.201500100R; Grassi B, 2015, EXERC SPORT SCI REV, V43, P75, DOI 10.1249/JES.0000000000000043; Henstridge DC, 2014, DIABETES, V63, P1881, DOI 10.2337/db13-0967; Hostrup M, 2018, J PHYSIOL-LONDON, V596, P231, DOI 10.1113/JP274970; Hostrup M, 2017, J PHYSIOL-LONDON, V595, P2897, DOI 10.1113/JP273218; Iaia FM, 2009, J APPL PHYSIOL, V106, P73, DOI 10.1152/japplphysiol.90676.2008; Irrcher I, 2003, SPORTS MED, V33, P783, DOI 10.2165/00007256-200333110-00001; Irving BA, 2015, J CLIN ENDOCR METAB, V100, P1654, DOI 10.1210/jc.2014-3081; Jacobs RA, 2011, J APPL PHYSIOL, V111, P1422, DOI 10.1152/japplphysiol.00625.2011; Jacobs RA, 2012, FASEB J, V26, P5192, DOI 10.1096/fj.12-218206; Jacobs RA, 2013, J APPL PHYSIOL, V115, P785, DOI 10.1152/japplphysiol.00445.2013; Jarmuszkiewicz W, 2015, FREE RADICAL BIO MED, V83, P12, DOI 10.1016/j.freeradbiomed.2015.02.012; Jeukendrup AE, 2005, INT J SPORTS MED, V26, pS28, DOI 10.1055/s-2004-830512; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Lark DS, 2016, AM J PHYSIOL-CELL PH, V311, pC239, DOI 10.1152/ajpcell.00124.2016; Larsen FJ, 2016, FASEB J, V30, P417, DOI 10.1096/fj.15-276857; Larsen FJ, 2011, CELL METAB, V13, P149, DOI 10.1016/j.cmet.2011.01.004; Lundby AKM, 2018, ACTA PHYSIOL, V222, DOI 10.1111/apha.12905; Lundby C, 2016, EXP PHYSIOL, V101, P17, DOI 10.1113/EP085319; MacInnis MJ, 2017, J PHYSIOL-LONDON, V595, P2955, DOI 10.1113/JP272570; Mogensen M, 2006, J PHYSIOL-LONDON, V571, P669, DOI 10.1113/jphysiol.2005.101691; Montero D, 2015, SPORTS MED, V45, P1603, DOI 10.1007/s40279-015-0380-1; Montero D, 2015, J PHYSIOL-LONDON, V593, P4677, DOI 10.1113/JP270250; Morris JG, 2005, INT J SPORTS MED, V26, P805, DOI 10.1055/s-2005-837448; Nauciene Z, 2012, MEDICINA-LITHUANIA, V48, P249, DOI 10.3390/medicina48050036; Nyberg M, 2014, EXP PHYSIOL, V99, P1399, DOI 10.1113/expphysiol.2014.081141; Parkin JM, 1999, J APPL PHYSIOL, V86, P902, DOI 10.1152/jappl.1999.86.3.902; Passonneau J.V., 1972, FLEXIBLE SYSTEM ENZY; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; Perry CGR, 2011, BIOCHEM J, V437, P215, DOI 10.1042/BJ20110366; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Pesta D, 2011, AM J PHYSIOL-REG I, V301, pR1078, DOI 10.1152/ajpregu.00285.2011; POOLE DC, 1992, J APPL PHYSIOL, V72, P805, DOI 10.1152/jappl.1992.72.2.805; Porter C, 2015, MED SCI SPORT EXER, V47, P1922, DOI 10.1249/MSS.0000000000000605; Porter C, 2015, AM J PHYSIOL-ENDOC M, V309, pE224, DOI 10.1152/ajpendo.00125.2015; Power A, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12138; Robinson MM, 2017, CELL METAB, V25, P581, DOI 10.1016/j.cmet.2017.02.009; Rowe GC, 2013, CELL REP, V3, P1449, DOI 10.1016/j.celrep.2013.04.023; Ruas JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150967; Russell A, 2002, INT J OBESITY, V26, P157, DOI 10.1038/sj.ijo.0801885; Russell AP, 2003, PFLUG ARCH EUR J PHY, V445, P563, DOI 10.1007/s00424-002-0943-5; Russell AP, 2003, J PHYSIOL-LONDON, V550, P855, DOI 10.1113/jphysiol.2003.040162; Sammut IA, 2003, CLIN EXP PHARMACOL P, V30, P110, DOI 10.1046/j.1440-1681.2003.03799.x; Schrauwen P, 1999, INT J OBESITY, V23, P966, DOI 10.1038/sj.ijo.0801026; SIGGAARDANDERSEN O, 1988, SCAND J CLIN LAB INV, V48, P7; STAINBSY WN, 1980, J APPL PHYSIOL, V48, P518, DOI 10.1152/jappl.1980.48.3.518; Thomassen M, 2018, J APPL PHYSIOL, V125, P470, DOI 10.1152/japplphysiol.01042.2017; Tonkonogi M, 2000, J PHYSIOL-LONDON, V528, P379, DOI 10.1111/j.1469-7793.2000.00379.x; Vincent G, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00051; Walsh B, 2001, PFLUG ARCH EUR J PHY, V442, P420, DOI 10.1007/s004240100538; WILLIS WT, 1994, MED SCI SPORT EXER, V26, P1347; Ydfors M, 2016, J PHYSIOL-LONDON, V594, P3127, DOI 10.1113/JP271259; Zoladz JA, 2016, PFLUG ARCH EUR J PHY, V468, P1709, DOI 10.1007/s00424-016-1867-9	77	30	31	2	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					8976	8989		10.1096/fj.201900106RRR	http://dx.doi.org/10.1096/fj.201900106RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31136218	Green Submitted			2022-12-28	WOS:000478832900023
J	Miotto, PM; McGlory, C; Bahniwal, R; Kamal, M; Phillips, SM; Holloway, GP				Miotto, Paula M.; McGlory, Chris; Bahniwal, Ravninder; Kamal, Michael; Phillips, Stuart M.; Holloway, Graham P.			Supplementation with dietary omega-3 mitigates immobilization-induced reductions in skeletal muscle mitochondrial respiration in young women	FASEB JOURNAL			English	Article						mitochondrial function; oxidative stress; metabolism	DISUSE ATROPHY; LIPID-PEROXIDATION; PGC-1-ALPHA OVEREXPRESSION; PROTEIN-SYNTHESIS; FATTY-ACIDS; BED REST; EXPRESSION; OIL; REHABILITATION; SENSITIVITY	Omega-3 (omega-3) supplementation attenuates immobilization-induced atrophy; however, the underlying mechanisms remain unclear. Since mitochondrial dysfunction and oxidative stress have been implicated in muscle atrophy, we examined whether omega-3 supplementation could mitigate disuse-mediated mitochondrial dysfunction. Healthy young women (age = 22 +/- 3 yr) randomly received control (n = 9) or omega-3 supplementation (n = 11; 3 g eicosapentaenoic acid, 2 g docosahexaenoic acid) for 4 wk prior to and throughout 2 wk of single-limb immobilization. Biopsies were performed before and after 3 and 14 d of immobilization for the assessment of mitochondrial respiration, H2O2 emission, and markers of ADP transport/lipid metabolism. In controls, immobilization rapidly (3 d) reduced (similar to 20%) ADP-stimulated mitochondrial respiration without altering ADP sensitivity or the abundance of mitochondrial proteins. Extending immobilization to 14 d did not further reduce mitochondrial coupled respiration; however, unlike following 3 d, mitochondrial proteins were reduced similar to 20%. In contrast, omega-3 supplementation prevented immobilization-induced reductions in mitochondrial content and respiration throughout the immobilization period. Regardless of dietary supplement, immobilization did not alter mitochondrial H2O2 emission in the presence or absence of ADP, markers of cellular redox state, mitochondrial lipid-supported respiration, or lipid-related metabolic proteins. These data highlight the rapidity of mitochondrial adaptations in response to muscle disuse, challenge the necessity for increased oxidative stress during inactivity, and establish that omega-3 supplementation preserves oxidative phosphorylation function and content during immobilization.-Miotto, P. M., McGlory, C., Bahniwal, R., Kamal, M., Phillips, S. M., Holloway, G. P. Supplementation with dietary omega-3 mitigates immobilization-induced reductions in skeletal muscle mitochondrial respiration in young women.	[Miotto, Paula M.; Holloway, Graham P.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON, Canada; [McGlory, Chris; Bahniwal, Ravninder; Kamal, Michael; Phillips, Stuart M.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada	University of Guelph; McMaster University	Miotto, PM; Holloway, GP (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON, Canada.	pau-la.miotto@unimelb.edu.au; ghollowa@uoguelph.ca	Phillips, Stuart/B-2343-2009	Phillips, Stuart/0000-0002-1956-4098; Kamal, Michael/0000-0002-3055-6793	Natural Sciences and Engineering Research Council (NSERC); Ontario Women's Health Scholars Award (OWHSA) doctoral award; Diabetes Canada; European Society for Clinical Nutrition and Metabolism; Canadian Institutes of Health Research; NSERC	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Women's Health Scholars Award (OWHSA) doctoral award; Diabetes Canada; European Society for Clinical Nutrition and Metabolism; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	P.M.M. was supported by a Natural Sciences and Engineering Research Council (NSERC) graduate scholarship and an Ontario Women's Health Scholars Award (OWHSA) doctoral award. C.M. was supported by research fellowships from Diabetes Canada and the European Society for Clinical Nutrition and Metabolism. This research was funded by NSERC (to G.P.H.) and Canadian Institutes of Health Research (to S.M.P.). The authors declare no conflicts of interest.	Abadi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006518; Anderson EJ, 2006, AM J PHYSIOL-CELL PH, V290, pC844, DOI 10.1152/ajpcell.00402.2005; Ando K, 2000, LIPIDS, V35, P401, DOI 10.1007/s11745-000-538-6; BAR PR, 1988, LIFE SCI, V42, P2677, DOI 10.1016/0024-3205(88)90243-3; Brocca L, 2012, J PHYSIOL-LONDON, V590, P5211, DOI 10.1113/jphysiol.2012.240267; Busquets-Cortes C, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8950384; Cree MG, 2010, METABOLISM, V59, P703, DOI 10.1016/j.metabol.2009.09.014; Dalla Libera L, 2009, J APPL PHYSIOL, V107, P549, DOI 10.1152/japplphysiol.00280.2009; de Boer MD, 2007, J PHYSIOL-LONDON, V585, P241, DOI 10.1113/jphysiol.2007.142828; Dirks ML, 2016, DIABETES, V65, P2862, DOI 10.2337/db15-1661; Glover EI, 2008, J PHYSIOL-LONDON, V586, P6049, DOI 10.1113/jphysiol.2008.160333; Gram M, 2015, J PHYSIOL-LONDON, V593, P4011, DOI 10.1113/JP270211; Gram M, 2014, EXP GERONTOL, V58, P269, DOI 10.1016/j.exger.2014.08.013; HALLIWELL B, 1993, AM J CLIN NUTR, V57, P715; Herbst EAF, 2014, J PHYSIOL-LONDON, V592, P1341, DOI 10.1113/jphysiol.2013.267336; Hespel P, 2001, J PHYSIOL-LONDON, V536, P625, DOI 10.1111/j.1469-7793.2001.0625c.xd; Holloway GP, 2018, CELL REP, V22, P2837, DOI 10.1016/j.celrep.2018.02.069; Huang CW, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101689; Jones SW, 2004, FASEB J, V18, P1025, DOI 10.1096/fj.03-1228fje; Kang CH, 2016, FREE RADICAL BIO MED, V93, P32, DOI 10.1016/j.freeradbiomed.2015.12.032; Kang CH, 2015, FASEB J, V29, P4092, DOI 10.1096/fj.14-266619; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; Lionetti L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092753; MCGARRY JD, 1983, BIOCHEM J, V214, P21, DOI 10.1042/bj2140021; McGlory C, 2019, FASEB J, V33, P4586, DOI 10.1096/fj.201801857RRR; MEYDANI M, 1991, J NUTR, V121, P484, DOI 10.1093/jn/121.4.484; Min K, 2011, J APPL PHYSIOL, V111, P1459, DOI 10.1152/japplphysiol.00591.2011; Miotto PM, 2018, DIABETES, V67, P2199, DOI 10.2337/db18-0417; Moriggi M, 2010, PROTEOMICS, V10, P3756, DOI 10.1002/pmic.200900817; PICHE LA, 1988, LIPIDS, V23, P370, DOI 10.1007/BF02537352; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Schonfeld P, 2008, FREE RADICAL BIO MED, V45, P231, DOI 10.1016/j.freeradbiomed.2008.04.029; Seifert EL, 2010, J BIOL CHEM, V285, P5748, DOI 10.1074/jbc.M109.026203; Smith BK, 2013, J PHYSIOL-LONDON, V591, P6089, DOI 10.1113/jphysiol.2013.259226; Song JH, 2000, J NUTR, V130, P3028, DOI 10.1093/jn/130.12.3028; Tiidus PM, 2003, EXERC SPORT SCI REV, V31, P40, DOI 10.1097/00003677-200301000-00008; Vainshtein A, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0033-y; Wall BT, 2013, AGEING RES REV, V12, P898, DOI 10.1016/j.arr.2013.07.003; You JS, 2010, APPL PHYSIOL NUTR ME, V35, P310, DOI 10.1139/H10-022; Zhang Y, 2011, METABOLISM, V60, P767, DOI 10.1016/j.metabol.2010.07.026	40	27	27	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8232	8240		10.1096/fj.201900095R	http://dx.doi.org/10.1096/fj.201900095R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30970218	Bronze			2022-12-28	WOS:000476234700035
J	Boucsein, A; Rizwan, MZ; Tups, A				Boucsein, Alisa; Rizwan, Mohammed Z.; Tups, Alexander			Hypothalamic leptin sensitivity and health benefits of time-restricted feeding are dependent on the time of day in male mice	FASEB JOURNAL			English	Article						energy metabolism; periodic fasting; daily rhythm; biological clock; diet	CIRCADIAN ORGANIZATION; FOOD-INTAKE; RESISTANCE; METABOLISM; OBESITY; RHYTHMS; PROTEIN; CLOCK	Synchronization between biologic clocks and metabolism is crucial for most species. Here, we examined the ability of leptin, important in the control of energy metabolism, to induce leptin signaling at the molecular as well as the behavioral level throughout the 24-h day in mice fed either a control or a high-fat diet (HFD). Furthermore, we investigated the effects of time-restricted feeding (TRF; a limitation of HFD access to 6 h each day) on energy metabolism during different periods throughout the 24-h day. In control mice, molecular leptin sensitivity was highest at zeitgeber time (ZT)0 (lights on), declining during the light phase, and increasing during the dark phase. Surprisingly, leptin resistance in HFD-fed mice was only present from the middle of the dark to the middle of the light period. Specifically, when TRF occurred from ZT21 to ZT3 (when leptin resistance in HFD-fed mice was most profound), it resulted in a disruption of the daily rhythms of locomotor activity and energy expenditure and in increased plasma insulin levels compared with other TRF periods. These data provide evidence that leptin sensitivity is controlled by the circadian rhythm and that TRF periods may be most efficient when aligned with the leptin-sensitive period.	[Boucsein, Alisa; Rizwan, Mohammed Z.; Tups, Alexander] Univ Otago, Brain Hlth Res Ctr, Ctr Neuroendocrinol, Dept Physiol, Dunedin, New Zealand; [Rizwan, Mohammed Z.] Univ Otago, Sch Biomed Sci, Dept Anat, Dunedin, New Zealand; [Tups, Alexander] Philipps Univ Marburg, Dept Anim Physiol, Fac Biol, Marburg, Germany; [Rizwan, Mohammed Z.; Tups, Alexander] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand	University of Otago; University of Otago; Philipps University Marburg; University of Auckland	Tups, A (corresponding author), Univ Otago, Dept Physiol, Great King St,POB 56, Dunedin 9054, New Zealand.	alexander.tups@otago.ac.nz		Boucsein, Alisa/0000-0002-6266-8802	German Ministry of Education and Research; German Research Foundation; Royal Society of New Zealand; British Society for Neuroendocrinology	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); Royal Society of New Zealand(Royal Society of New Zealand); British Society for Neuroendocrinology	This work was supported by the German Ministry of Education and Research and by the German Research Foundation (to A.T.), the Royal Society of New Zealand (to A.T. and A.B.), and the British Society for Neuroendocrinology (to A.B.). The authors declare no conflicts of interest.	Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Benzler J, 2013, ENDOCRINOLOGY, V154, P4737, DOI 10.1210/en.2013-1746; Benzler J, 2012, BIOCHEM J, V447, P175, DOI 10.1042/BJ20120834; Branecky KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137970; Bunney PE, 2017, PHYSIOL BEHAV, V176, P139, DOI 10.1016/j.physbeh.2017.03.040; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Coomans CP, 2013, DIABETES, V62, P1102, DOI 10.2337/db12-0507; Delahaye LB, 2018, APPL PHYSIOL NUTR ME, V43, P1033, DOI 10.1139/apnm-2017-0706; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gerhart-Hines Z, 2015, ENDOCR REV, V36, P289, DOI 10.1210/er.2015-1007; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Kettner NM, 2015, CELL METAB, V22, P448, DOI 10.1016/j.cmet.2015.06.005; Knight ZA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011376; Koch CE, 2014, J NEUROENDOCRINOL, V26, P58, DOI 10.1111/jne.12131; Koch C, 2010, J NEUROSCI, V30, P16180, DOI 10.1523/JNEUROSCI.3202-10.2010; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; KRIEGER DT, 1977, SCIENCE, V197, P398, DOI 10.1126/science.877566; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Morton GJ, 2005, CELL METAB, V2, P411, DOI 10.1016/j.cmet.2005.10.009; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Pendergast JS, 2013, EUR J NEUROSCI, V37, P1350, DOI 10.1111/ejn.12133; Piekorz R, 1998, BIOCHEM BIOPH RES CO, V250, P436, DOI 10.1006/bbrc.1998.9335; Prolo P, 1998, INT J BIOCHEM CELL B, V30, P1285, DOI 10.1016/S1357-2725(98)00094-6; Rizwan MZ, 2017, J NEUROENDOCRINOL, V29, DOI 10.1111/jne.12481; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Romanatto T, 2007, PEPTIDES, V28, P1050, DOI 10.1016/j.peptides.2007.03.006; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shi SQ, 2013, CURR BIOL, V23, P372, DOI 10.1016/j.cub.2013.01.048; Skinner NJ, 2019, ENDOCRINOLOGY, V160, P2257, DOI 10.1210/en.2018-00935; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P545, DOI 10.1016/S0163-1047(79)90332-7; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tan K, 2014, MOL METAB, V3, P694, DOI 10.1016/j.molmet.2014.07.002; Tups A, 2012, J COMP PHYSIOL B, V182, P553, DOI 10.1007/s00360-011-0637-4; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Wilsey J, 2004, J ENDOCRINOL, V181, P297, DOI 10.1677/joe.0.1810297; Yamazaki S, 2009, J BIOL RHYTHM, V24, P55, DOI 10.1177/0748730408328438; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	46	10	10	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12175	12187		10.1096/fj.201901004R	http://dx.doi.org/10.1096/fj.201901004R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31366239	Green Published, Bronze			2022-12-28	WOS:000507461600045
J	Somsuan, K; Peerapen, P; Boonmark, W; Plumworasawat, S; Samol, R; Sakulsak, N; Thongboonkerd, V				Somsuan, Keerakarn; Peerapen, Paleerath; Boonmark, Wanida; Plumworasawat, Sirikanya; Samol, Ratirath; Sakulsak, Natthiya; Thongboonkerd, Visith			ARID1A knockdown triggers epithelial-mesenchymal transition and carcinogenesis features of renal cells: role in renal cell carcinoma	FASEB JOURNAL			English	Article						cell cycle; chemoresistance; EMT; invasion; snaill	REMODELING GENE ARID1A; SWI/SNF COMPLEX; DOWN-REGULATION; EXPRESSION; PATHOGENESIS; EMT; ACTIVATION; MUTATIONS; MIGRATION; COMPONENT	Down-regulation/mutation of AT-rich interactive domain 1A (ARID1A), a novel tumor suppressor gene, has been reported in various cancers. Nevertheless, its role in renal cell carcinoma (RCC) remained unclear and underinvestigated. We thus evaluated carcinogenesis effects of ARID1A knockdown in nonmalignant Madin-Darby canine kidney (MDCK) renal cells using small interfering RNA (siRNA) against ARID1A (siARID1A). The siARID1A-transfected cells had decreased cell death, increased cell proliferation, and cell cycle shift (from G(0)/G(1) to G(2)/M) compared with those transfected with controlled siRNA (siControl). Additionally, the siARID1A-transfected cells exhibited epithelial-mesenchymal transition (EMT) shown by greater spindle index, increased mesenchymal markers (fibronectin/vimentin), and decreased epithelial markers (E-cadherin/zonula occludens-1). Moreover, the siARID1A-transfected cells had increases in migratory activity, nuclear size, self-aggregated multicellular spheroid size, invasion capability, chemoresistance (to docetaxel), Snail family transcriptional repressor 1 expression, and TGF-beta 1 secretion. All of these siARID1A-knockdown effects on the carcinogenic features were reproducible in malignant RCC (786-0) cells, which exhibited a higher degree of carcinogenic phenotypes compared with the nonmalignant MDCK cells. Finally, immunohistochemistry showed obvious decrease in ARID1A protein expression in human RCC tissues (n = 23) compared with adjacent normal renal tissues (n = 23). These data indicate that ARID1A down-regulation triggers EMT and carcinogenesis features of renal cells in vitro, and its role in RCC could be proven in human tissues.	[Somsuan, Keerakarn; Sakulsak, Natthiya] Naresuan Univ, Dept Anat, Fac Med Sci, Phitsanulok, Thailand; [Peerapen, Paleerath; Boonmark, Wanida; Plumworasawat, Sirikanya; Thongboonkerd, Visith] Mahidol Univ, Siriraj Hosp, Fac Med, Med Prote Unit,Off Res & Dev, 6th Floor,SiMR Bldg,2 Wanglang Rd, Bangkok 10700, Thailand; [Samol, Ratirath] Sawanpracharak Hosp, Dept Anat Pathol, Nakorn Sawan, Thailand	Naresuan University; Mahidol University	Thongboonkerd, V (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Med Prote Unit,Off Res & Dev, 6th Floor,SiMR Bldg,2 Wanglang Rd, Bangkok 10700, Thailand.	thongboonkerd@dr.com	Thongboonkerd, Visith/C-6920-2009; Sakulsak, Natthiya/AAO-9327-2021	Thongboonkerd, Visith/0000-0001-7865-0765; Somsuan, Keerakarn/0000-0002-9848-8010	Mahidol University; Thailand Research Fund [IRN60W0004, IRG5980006]; Chalermphrakiat; Faculty of Medicine, Siriraj Hospital	Mahidol University; Thailand Research Fund(Thailand Research Fund (TRF)); Chalermphrakiat; Faculty of Medicine, Siriraj Hospital	The authors are grateful to Sunisa Yoodee and Patoomporn Prasatthong (both from the Faculty of Medicine, Siriraj Hospital, Mahidol University) for technical assistance. This study was supported by a Mahidol University research grant and the Thailand Research Fund (IRN60W0004 and IRG5980006). V.T. was supported by Chalermphrakiat and Research Staff Grants from Faculty of Medicine, Siriraj Hospital. The authors declare no conflicts of interest.	Agaimy A, 2018, HUM PATHOL, V77, P139, DOI 10.1016/j.humpath.2018.04.004; Aluksanasuwan S, 2017, FASEB J, V31, P2157, DOI 10.1096/fj.201600910RR; Bianchi M, 2012, ANN ONCOL, V23, P973, DOI 10.1093/annonc/mdr362; Brodaczewska KK, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0565-8; Chen Y, 2017, ONCOTARGET, V8, P36787, DOI 10.18632/oncotarget.16375; Fong-Ngern K, 2017, METABOLISM, V74, P47, DOI 10.1016/j.metabol.2016.12.014; Foty R., 2011, J VIS EXP, V2720; Guan B, 2011, AM J SURG PATHOL, V35, P625, DOI 10.1097/PAS.0b013e318212782a; Halliday GM, 2009, INT J BIOCHEM CELL B, V41, P725, DOI 10.1016/j.biocel.2008.04.026; He F, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0164-3; Ibarrola-Villava M, 2015, ONCOTARGET, V6, P26935, DOI 10.18632/oncotarget.4775; Jia ZJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0094-4; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kadoch C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500447; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kanlaya R, 2016, TRANSL CANCER RES, V5, pS1177, DOI 10.21037/tcr.2016.11.59; Kanlaya R, 2016, SCI REP-UK, V6, DOI 10.1038/srep30233; Kapincharanon C, 2018, CELL ADHES MIGR, V12, P247, DOI 10.1080/19336918.2017.1356554; Khoury H, 2005, MOL BIOL CELL, V16, P550, DOI 10.1091/mbc.E04-07-0567; Landolt L, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13305; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Liu RY, 2014, INT J ONCOL, V44, P1643, DOI 10.3892/ijo.2014.2310; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mamo A, 2012, ONCOGENE, V31, P2090, DOI 10.1038/onc.2011.386; Manissorn J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28808; Manley BJ, 2016, CURR OPIN UROL, V26, P383, DOI 10.1097/MOU.0000000000000307; Matsumoto T, 2018, MOL CARCINOGEN, V57, P957, DOI 10.1002/mc.22816; Miao D, 2018, SCIENCE, V359, P801, DOI 10.1126/science.aan5951; Nargund AM, 2017, CELL REP, V18, P2893, DOI 10.1016/j.celrep.2017.02.074; Ni T, 2016, NAT CELL BIOL, V18, P1221, DOI 10.1038/ncb3425; Niu N, 2017, ONCOGENE, V36, P4887, DOI 10.1038/onc.2017.72; Noman MZ, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1345415; Pal SK, 2018, EUR UROL, V73, P71, DOI 10.1016/j.eururo.2017.05.033; Pang MF, 2016, ONCOGENE, V35, P748, DOI 10.1038/onc.2015.133; Peerapen P, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201800008; Pongsakul N, 2016, FASEB J, V30, P3368, DOI 10.1096/fj.201600426R; Protzel C, 2012, EUR UROL SUPPL, V11, P52, DOI 10.1016/j.eursup.2012.05.002; Rao Q, 2014, INT J CLIN EXP PATHO, V7, P1782; Ricketts CJ, 2018, CELL REP, V23, P313, DOI [10.1016/j.celrep.2018.03.075, 10.1016/j.celrep.2018.06.032]; Sarnowska E, 2017, AM J CANCER RES, V7, P2275; Sato Y, 2010, AM J PATHOL, V177, P141, DOI 10.2353/ajpath.2010.090747; Savas S, 2018, CRIT REV ONCOL HEMAT, V123, P114, DOI 10.1016/j.critrevonc.2018.01.009; Shigetomi H, 2011, ONCOL LETT, V2, P591, DOI 10.3892/ol.2011.316; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sun HM, 2016, ANAT REC, V299, P869, DOI 10.1002/ar.23357; Sun XX, 2017, CANCER CELL, V32, P574, DOI 10.1016/j.ccell.2017.10.007; Takao C, 2017, J CANCER, V8, P1, DOI 10.7150/jca.16602; Takeshima H, 2015, CANCER LETT, V357, P328, DOI 10.1016/j.canlet.2014.11.038; Thanomkitti K, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0053-6; Toret CP, 2014, J CELL BIOL, V204, P265, DOI 10.1083/jcb.201306082; Wang SJ, 2018, ONCOGENE, V37, P4164, DOI 10.1038/s41388-018-0252-x; Wang WJ, 2019, GUT, V68, P1245, DOI 10.1136/gutjnl-2017-315541; Wang XM, 2004, INT J CANCER, V112, P636, DOI 10.1002/ijc.20450; Wang YF, 2013, CURR CANCER DRUG TAR, V13, P963, DOI 10.2174/15680096113136660102; Wu RC, 2014, CANCER BIOL THER, V15, P655, DOI 10.4161/cbt.28411; Yamamoto S, 2012, VIRCHOWS ARCH, V460, P77, DOI 10.1007/s00428-011-1169-8; Yan HB, 2014, CARCINOGENESIS, V35, P867, DOI 10.1093/carcin/bgt398; Zhang JX, 2018, ONCOL LETT, V15, P4619, DOI 10.3892/ol.2018.7861; Zhang L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/903542; Zhang S, 2014, ONCOGENE, V33, P116, DOI 10.1038/onc.2013.96; Zhang XY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053931, 10.1371/journal.pone.0061922, 10.1371/journal.pone.0060781]; Zhu QC, 2013, ASIAN PAC J CANCER P, V14, P2689, DOI 10.7314/APJCP.2013.14.5.2689; Zhu Y, 2018, MOL THER, V26, P744, DOI 10.1016/j.ymthe.2017.12.023	63	18	21	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12226	12239		10.1096/fj.201802720RR	http://dx.doi.org/10.1096/fj.201802720RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31424966	Green Published			2022-12-28	WOS:000507461600049
J	Impellizzeri, D; Peritore, AF; Cordaro, M; Gugliandolo, E; Siracusa, R; Crupi, R; D'Amico, R; Fusco, R; Evangelista, M; Cuzzocrea, S; Di Paola, R				Impellizzeri, Daniela; Peritore, Alessio Filippo; Cordaro, Marika; Gugliandolo, Enrico; Siracusa, Rosalba; Crupi, Rosalia; D'Amico, Ramona; Fusco, Roberta; Evangelista, Maurizio; Cuzzocrea, Salvatore; Di Paola, Rosanna			The neuroprotective effects of micronized PEA (PEA-m) formulation on diabetic peripheral neuropathy in mice	FASEB JOURNAL			English	Article						neuroinflammation; oxidative stress; pain; PPAR-alpha; DPN	OXIDATIVE STRESS; SPINAL-CORD; ANTIINFLAMMATORY ACTIONS; MICROGLIA ACTIVATION; PALMITOYLETHANOLAMIDE; PAIN; STREPTOZOTOCIN; HYPERALGESIA; MODEL; NERVE	Diabetic peripheral neuropathy (DPN) is a complication of diabetes connected with morbidity and mortality. DPN presents deterioration of peripheral nerves with pain, feebleness, and loss of sensation. Particular medications might display their remedial potential by controlling neuroinflammation. Palmitoylethanolamide (PEA) is an autacoid local injury antagonist distinguished for its neuroprotective, analgesic, and anti-inflammatory properties in numerous experimental models of neuroinflammation. Based on these findings, the goal of this work was to better test the neuroprotective effects of a formulation of micronized PEA (PEA-m) and the probable mechanism of action in a mouse model of DPN induced by streptozotocin (STZ) injection. Diabetic and control animals received PEA-m (10 mg/kg) by oral gavage daily starting 2 wk from STZ injection. After 16 wk, the animals were euthanized, and blood, urine, spinal cord, and sciatic nerve tissues were collected. Our results demonstrated that after diabetes induction, PEA-m was able to reduce mechanical, thermal hyperalgesia, and motor alterations as well as reduce mast cell activation and nerve growth factor expression. In addition, PEA-m decreased neural histologic damage, oxidative and nitrosative stress, cytokine release, angiogenesis, and apoptosis. Moreover, spinal microglia activation (IBA-1), phospho-P38 MAPK, and nuclear factor NF-kappa B inflammatory pathways were also inhibited. The protective effects of PEA-m could be correlated at least in part to peroxisome proliferator-activated receptor-alpha activation. In summary, we demonstrated that PEA-m represents a new therapeutic strategy for neuroinflammation pain associated with mixed neuropathies.-Impellizzeri, D., Peritore, A. F., Cordaro, M., Gugliandolo, E., Siracusa, R., Crupi, R., D'Amico, R., Fusco, R., Evangelista, M., Cuzzocrea, S., Di Paola, R. The neuroprotective effects of micronized PEA (PEA-m) formulation on diabetic peripheral neuropathy in mice.	[Impellizzeri, Daniela; Peritore, Alessio Filippo; Cordaro, Marika; Gugliandolo, Enrico; Siracusa, Rosalba; Crupi, Rosalia; D'Amico, Ramona; Fusco, Roberta; Cuzzocrea, Salvatore; Di Paola, Rosanna] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Viale Ferdinando Stagno DAlcontres 31, I-98166 Messina, Italy; [Evangelista, Maurizio] Univ Cattolica Sacro Cuore, Inst Anaesthesiol & Reanimat, Rome, Italy; [Cuzzocrea, Salvatore] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA	University of Messina; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Saint Louis University	Cuzzocrea, S (corresponding author), Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Viale Ferdinando Stagno DAlcontres 31, I-98166 Messina, Italy.	salvator@unime.it	Peritore, Alessio/HGB-1327-2022; Siracusa, Rosalba/AAC-3110-2022; Gugliandolo, Enrico/AAB-9972-2019; Cordaro, Marika/K-7329-2016; D'Amico, Ramona/AAC-9061-2019; FUSCO, Roberta/AAC-1745-2019; evangelista, maurizio/G-6820-2012; di paola, rosanna/U-4356-2019	Siracusa, Rosalba/0000-0001-7868-2505; Gugliandolo, Enrico/0000-0001-6840-3154; Cordaro, Marika/0000-0002-3980-0043; D'Amico, Ramona/0000-0003-0389-3871; FUSCO, Roberta/0000-0003-0223-1403; Cuzzocrea, Salvatore/0000-0001-6131-3690; Impellizzeri, Daniela/0000-0001-9492-3161; di paola, rosanna/0000-0001-6725-8581; peritore, alessio filippo/0000-0001-8545-990X; Crupi, Rosalia/0000-0002-7629-3132				Ahmad A, 2012, BRAIN BEHAV IMMUN, V26, P1310, DOI 10.1016/j.bbi.2012.07.021; AlSharari SD, 2014, TROP J PHARM RES, V13, P1429, DOI 10.4314/tjpr.v13i9.8; Atef MM, 2019, BIOCHEM PHARMACOL, V159, P1, DOI 10.1016/j.bcp.2018.11.006; Bartolucci ML, 2018, INFLAMM RES, V67, P891, DOI 10.1007/s00011-018-1179-y; Calcutt NA, 2002, INT REV NEUROBIOL, V50, P205; Campardelli R, 2017, POWDER TECHNOL, V305, P217, DOI 10.1016/j.powtec.2016.09.084; Campbell AM, 2012, BRAIN RES, V1472, P138, DOI 10.1016/j.brainres.2012.07.006; Costa B, 2008, PAIN, V139, P541, DOI 10.1016/j.pain.2008.06.003; Crupi R, 2018, MOL NEUROBIOL, V55, P8455, DOI 10.1007/s12035-018-0959-2; Cunha JM, 2008, METABOLISM, V57, P873, DOI 10.1016/j.metabol.2008.01.021; D'Agostino G, 2007, J PHARMACOL EXP THER, V322, P1137, DOI 10.1124/jpet.107.123265; D'Agostino G, 2009, EUR J PHARMACOL, V613, P54, DOI 10.1016/j.ejphar.2009.04.022; De Filippis D, 2009, J CELL MOL MED, V13, P1086, DOI 10.1111/j.1582-4934.2008.00353.x; Deguchi T, 2009, DIABETIC MED, V26, P247, DOI 10.1111/j.1464-5491.2009.02680.x; Di Paola R, 2016, SHOCK, V46, P202, DOI 10.1097/SHK.0000000000000578; Doupis J, 2009, J CLIN ENDOCR METAB, V94, P2157, DOI 10.1210/jc.2008-2385; Esposito E, 2016, EUR J PHARMACOL, V782, P107, DOI 10.1016/j.ejphar.2016.03.033; Esposito E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041880; Esposito E, 2011, BRAIN BEHAV IMMUN, V25, P1099, DOI 10.1016/j.bbi.2011.02.006; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Farshid AA, 2015, AVICENNA J PHYTOMEDI, V5, P469; Figueroa-Romero C, 2008, REV ENDOCR METAB DIS, V9, P301, DOI 10.1007/s11154-008-9104-2; Fusco Roberta, 2018, Oncotarget, V9, P31355, DOI 10.18632/oncotarget.25823; Gugliandolo E, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1303-5; Impellizzeri D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0136-0; Impellizzeri D, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4382; Kles KA, 2006, CURR DIABETES REV, V2, P131, DOI 10.2174/157339906776818569; Lee JY, 2019, J GINSENG RES, V43, P58, DOI 10.1016/j.jgr.2017.08.004; Lee KM, 2004, EUR J NEUROSCI, V19, P3375, DOI 10.1111/j.0953-816X.2004.03441.x; Leleux J, 2014, DRUG DEV IND PHARM, V40, P289, DOI 10.3109/03639045.2013.828217; Lim H, 2017, PAIN, V158, P1666, DOI 10.1097/j.pain.0000000000000959; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Mannelli LD, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/328797; Matough F.A., 2012, SULTAN QABOOS U MED, V12, P5, DOI [10.12816/0003082, DOI 10.12816/0003082]; Mazzari S, 1996, EUR J PHARMACOL, V300, P227, DOI 10.1016/0014-2999(96)00015-5; Morgado C, 2007, DIABETES-METAB RES, V23, P644, DOI 10.1002/dmrr.751; MYERS RR, 1984, ANN NEUROL, V16, P587, DOI 10.1002/ana.410160510; O'Brien PD, 2014, ILAR J, V54, P259, DOI 10.1093/ilar/ilt052; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Olechowski CJ, 2009, PAIN, V141, P156, DOI 10.1016/j.pain.2008.11.002; Paterniti I, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-91; Paterniti I, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-20; Petrosino S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00249; Ramos KM, 2007, DIABETES, V56, P1569, DOI 10.2337/db06-1269; Sandireddy R, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/674987; Sawant S, 2016, CLIN ORAL INVEST, V20, P43, DOI 10.1007/s00784-015-1476-6; Sayyed SG, 2006, LIFE SCI, V79, P777, DOI 10.1016/j.lfs.2006.02.033; Schifilliti C, 2014, PAIN RES TREAT, V2014, DOI 10.1155/2014/849623; Schreiber AK, 2015, WORLD J DIABETES, V6, P432, DOI 10.4239/wjd.v6.i3.432; Sekido H, 2004, BIOCHEM BIOPH RES CO, V320, P241, DOI 10.1016/j.bbrc.2004.05.159; Siniscalco D, 2011, CURR NEUROPHARMACOL, V9, P523, DOI 10.2174/157015911798376208; Siracusa R, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00871; Siracusa R, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00233; Skaper SD, 2017, IMMUNOLOGY, V151, P1, DOI 10.1111/imm.12717; Skaper SD, 2014, INFLAMMOPHARMACOLOGY, V22, P79, DOI 10.1007/s10787-013-0191-7; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Sun JS, 2015, MOL MED REP, V12, P2677, DOI 10.3892/mmr.2015.3735; Tsuda M, 2016, J DIABETES INVEST, V7, P17, DOI 10.1111/jdi.12379; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-0019; Vincent AM, 2002, ANN NY ACAD SCI, V959, P368, DOI 10.1111/j.1749-6632.2002.tb02108.x; Wang DM, 2014, EUR J PHARMACOL, V728, P59, DOI 10.1016/j.ejphar.2014.01.057; Zychowska M, 2013, PHARMACOL REP, V65, P1601, DOI 10.1016/S1734-1140(13)71521-4	63	47	49	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11364	11380		10.1096/fj.201900538R	http://dx.doi.org/10.1096/fj.201900538R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31344333	Bronze			2022-12-28	WOS:000489166300064
J	van der Bent, ML; da Silva, OP; Willemse, M; Hallbrink, M; Wansink, DG; Brock, R				van der Bent, M. Leontien; da Silva Filho, Omar Paulino; Willemse, Marieke; Hallbrink, Mattia; Wansink, Derick G.; Brock, Roland			The nuclear concentration required for antisense oligonucleotide activity in myotonic dystrophy cells	FASEB JOURNAL			English	Article						drug delivery; live-cell imaging; muscleblind; neuromuscular disorder; trinucleotide repeat	RNA TOXICITY; PENETRATING PEPTIDE; INTRACELLULAR-DISTRIBUTION; GENE DELIVERY; MOLECULES; EFFICIENT; REVERSAL; RELEASE; MODELS; FOCUS	Antisense oligonucleotides (ASOs) are a promising class of therapeutics that are starting to emerge in the clinic. Determination of intracellular concentrations required for biologic effects and identification of effective delivery vehicles are crucial for understanding the mode of action and required dosing. Here, we investigated which nuclear oligonucleotide concentration is needed for a therapeutic effect for a triplet repeat-targeting ASO in a muscle cell model of myotonic dystrophy type 1 (DM1). For cellular delivery, ASOs were complexed into nanoparticles using the cationic cell-penetrating peptides nona-arginine and PepFect14 (PF14). Although both peptides facilitated uptake, only PF14 led to a dose-dependent correction of disease-typical abnormal splicing. In line with this observation, time-lapse confocal microscopy demonstrated that only PF14 mediated translocation of the ASOs to the nucleus, which is the main site of action. Through fluorescence lifetime imaging, we could distinguish intact oligonucleotide from free fluorophore, showing that PF14 also shielded the ASOs from degradation. Finally, we employed a combination of live-cell fluorescence correlation spectroscopy and immunofluorescence microscopy and demonstrated that intranuclear blocking-type oligonucleotide concentrations in the upper nanomolar range were required to dissolve nuclear muscleblind-like protein 1 foci, a hallmark of DM1. Our findings have important implications for the clinical use of ASOs in DM1 and provide a basis for further research on other types of ASOs.-Van der Bent, M. L., Paulino da Silva Filho, O., Willemse, M., Hallbrink, M., Wansink, D. G., Brock, R. The nuclear concentration required for antisense oligonucleotide activity in myotonic dystrophy cells.	[van der Bent, M. Leontien; Willemse, Marieke; Wansink, Derick G.] Radboud Univ Nijmegen, Med Ctr, Dept Cell Biol, Radboud Inst Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [van der Bent, M. Leontien; da Silva Filho, Omar Paulino; Brock, Roland] Radboud Univ Nijmegen, Med Ctr, Dept Biochem, Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [da Silva Filho, Omar Paulino] Minist Educ Brazil, Coordenacao Aperfeicoamento Pessoal Nivel Super C, Brasilia, DF, Brazil; [Hallbrink, Mattia] Stockholm Univ, Dept Neurochem, Stockholm, Sweden	Radboud University Nijmegen; Radboud University Nijmegen; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Stockholm University	Wansink, DG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Cell Biol, Radboud Inst Mol Life Sci, NL-6525 GA Nijmegen, Netherlands.; Brock, R (corresponding author), Radboud Univ Nijmegen, Dept Biochem, Med Ctr, POB 9101,Internal Route 286,Geert Grootepl 26, NL-6525 GA Nijmegen, Netherlands.	rick.wansink@radboudumc.nl; roland.brock@radboudumc.nl	van der Bent, Leontien/L-6837-2015; van der Bent, M. Leontien/AAQ-7354-2020; Brock, Roland/K-2590-2012	van der Bent, Leontien/0000-0002-1274-6227; van der Bent, M. Leontien/0000-0002-1274-6227; Brock, Roland/0000-0003-1395-6127	Prinses Beatrix Spierfonds [W.OR14-19]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Foundation [13173/13-8]	Prinses Beatrix Spierfonds; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors thank Dr. Denis Furling and Dr. Vincent Mouly (both from the Institut de Myologie, Paris, France) for providing the human myoblasts that were used in this study; Dr. J. Berndt (Leica Microsystems, Buffalo Grove, IL, USA) for support with the fluorescence lifetime imaging microscopy and fluorescence correlation spectroscopy analyses; and Rozemarijn van der Veen (Radboud University) for experimental work with fibroblasts. This work was supported by the Prinses Beatrix Spierfonds [Grant W.OR14-19] and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Foundation [Grant 13173/13-8]. D.G.W. and R.B. are joint senior authors. The authors declare no conflicts of interest.	Aartsma-Rus A, 2017, NUCLEIC ACID THER, V27, P67, DOI 10.1089/nat.2017.0665; Arandel L, 2017, DIS MODEL MECH, V10, P487, DOI 10.1242/dmm.027367; Boisguerin P, 2015, ADV DRUG DELIVER REV, V87, P52, DOI 10.1016/j.addr.2015.02.008; Buntz A, 2019, NUCLEIC ACIDS RES, V47, P953, DOI 10.1093/nar/gky1158; Buschmann V, 2003, BIOCONJUGATE CHEM, V14, P195, DOI 10.1021/bc025600x; de la Torre BG, 2019, MOLECULES, V24, DOI 10.3390/molecules24040809; Ezzat K, 2011, NUCLEIC ACIDS RES, V39, P5284, DOI 10.1093/nar/gkr072; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Gao ZH, 2013, HUM GENE THER, V24, P499, DOI 10.1089/hum.2012.212; Godfrey C, 2017, EMBO MOL MED, V9, P545, DOI 10.15252/emmm.201607199; Gonzalez-Barriga A, 2017, NUCLEIC ACID THER, V27, P144, DOI 10.1089/nat.2016.0641; Gonzalez-Barriga A, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.9; Gudde AEEG, 2016, HUM MOL GENET, V25, P1648, DOI 10.1093/hmg/ddw042; Huang ZX, 2006, J PHYS CHEM A, V110, P45, DOI 10.1021/jp0562936; Huang ZX, 2005, COLLOID SURFACE A, V257-58, P203, DOI 10.1016/j.colsurfa.2004.10.108; Juks C, 2015, BBA-BIOMEMBRANES, V1848, P3205, DOI 10.1016/j.bbamem.2015.09.019; Juliano RL, 1999, PHARM RES-DORDR, V16, P494, DOI 10.1023/A:1011958726518; Kim SA, 2007, NAT METHODS, V4, P963, DOI 10.1038/NMETH1104; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Kurrikoff K, 2016, EXPERT OPIN DRUG DEL, V13, P373, DOI 10.1517/17425247.2016.1125879; Leger AJ, 2013, NUCLEIC ACID THER, V23, P109, DOI 10.1089/nat.2012.0404; Lehto T, 2017, BIOCONJUGATE CHEM, V28, P782, DOI 10.1021/acs.bioconjchem.6b00680; LEONETTI JP, 1991, P NATL ACAD SCI USA, V88, P2702, DOI 10.1073/pnas.88.7.2702; Lorenz S, 2011, MICROSC MICROANAL, V17, P440, DOI 10.1017/S1431927611000249; McClorey G, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6020051; Milletti F, 2012, DRUG DISCOV TODAY, V17, P850, DOI 10.1016/j.drudis.2012.03.002; Mulders SAM, 2010, HUM MOL GENET, V19, pR90, DOI 10.1093/hmg/ddq161; Mulders SAM, 2009, P NATL ACAD SCI USA, V106, P13915, DOI 10.1073/pnas.0905780106; Nakamori M, 2013, ANN NEUROL, V74, P862, DOI 10.1002/ana.23992; Pettersson OJ, 2015, NUCLEIC ACIDS RES, V43, P2433, DOI 10.1093/nar/gkv029; Rhee WJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq050; Sardone V, 2017, MOLECULES, V22, DOI 10.3390/molecules22040563; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sicot G, 2013, BBA-MOL BASIS DIS, V1832, P1390, DOI 10.1016/j.bbadis.2013.03.002; Srimanee A, 2018, PEPTIDES, V104, P62, DOI 10.1016/j.peptides.2018.04.015; Stein CA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp841; Tinnefeld P., 2000, SINGLE MOL, V1, P215; Tomcin S, 2014, INT J NANOMED, V9, P5471, DOI 10.2147/IJN.S70908; UHLMANN E, 1990, CHEM REV, V90, P543, DOI 10.1021/cr00102a001; Urgard E, 2017, NUCLEIC ACID THER, V27, P295, DOI 10.1089/nat.2017.0670; van Agtmaal EL, 2017, MOL THER, V25, P24, DOI 10.1016/j.ymthe.2016.10.014; Veiman KL, 2015, J CONTROL RELEASE, V209, P238, DOI 10.1016/j.jconrel.2015.04.038; Veiman KL, 2013, MOL PHARMACEUT, V10, P199, DOI 10.1021/mp3003557; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Wheeler TM, 2007, J CLIN INVEST, V117, P3952, DOI 10.1172/JCI33355; Wheeler TM, 2012, NATURE, V488, P111, DOI 10.1038/nature11362; Wheeler TM, 2009, SCIENCE, V325, P336, DOI 10.1126/science.1173110; Wittrup A, 2015, NAT BIOTECHNOL, V33, P870, DOI 10.1038/nbt.3298; Wojtkowiak-Szlachcic A, 2015, NUCLEIC ACIDS RES, V43, P3318, DOI 10.1093/nar/gkv163	49	8	8	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11314	11325		10.1096/fj.201900263R	http://dx.doi.org/10.1096/fj.201900263R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31311315	Bronze			2022-12-28	WOS:000489166300060
J	Waasdorp, M; Florquin, S; Duitman, J; Spek, CA				Waasdorp, Maaike; Florquin, Sandrine; Duitman, JanWillem; Spek, C. Arnold			Pharmacological PAR-1 inhibition reduces blood glucose levels but does not improve kidney function in experimental type 2 diabetic nephropathy	FASEB JOURNAL			English	Article						vorapaxar; BTBRob; ob type 2 diabetes; mesangial expansion; protease-activated receptor	RECEPTOR ANTAGONIST; VORAPAXAR; MODEL; RISK	Vorapaxar-dependent protease-activated receptor (PAR)-1 inhibition diminishes diabetic nephropathy in experimental type 1 diabetes. As most patients with diabetic nephropathy suffer from type 2 diabetes, the aim of this study was to investigate whether PAR-1 inhibition also limits diabetic nephropathy in experimental type 2 diabetes. Consequently, leptin-deficient black and tan brachyuric (BTBRob/ob) mice were randomly assigned to vorapaxar (1.75 mg/kg; twice weekly via oral gavage) or vehicle treatment, whereas matched wild-type (WT) BTBR (BTBRWT) mice served as nondiabetic controls. Weight and (nonfasting) blood glucose levels were monitored for up to 18 wk, after which kidney function and histologic damage was evaluated postmortem. We show that blood glucose levels and body weight increased in diabetic BTBRob/ob mice compared with nondiabetic BTBRWT controls. Vorapaxar-dependent PAR-1 inhibition reduced but did not normalize blood glucose levels in BTBRob/ob mice, whereas it potentiated the increase in body weight. Vorapaxar did not, however, preserve kidney function, whereas it only minimally reduced histopathological signs of kidney injury. Overall, we thus show that PAR-1 inhibition reduces blood glucose levels during the progression of diabetic nephropathy in experimental type 2 diabetes but does not improve renal function. This is in contrast to the therapeutic potential of vorapaxar in type 1 diabetes-induced nephropathy, highlighting the importance of disease-dependent treatment modalities.-Waasdorp, M., Florquin, S., Duitman, J., Spek, C. A. Pharmacological PAR-1 inhibition reduces blood glucose levels but does not improve kidney function in experimental type 2 diabetic nephropathy.	[Waasdorp, Maaike; Duitman, JanWillem; Spek, C. Arnold] Univ Amsterdam, Amsterdam Univ Med Ctr UMC, Amsterdam Infect & Immun Inst, Ctr Expt & Mol Med, Amsterdam, Netherlands; [Florquin, Sandrine] Univ Amsterdam, Amsterdam Univ Med Ctr UMC, Amsterdam Infect & Immun Inst, Dept Pathol, Amsterdam, Netherlands; [Waasdorp, Maaike] Vrije Univ Amsterdam, Amsterdam Infect & Immun Inst, Amsterdam UMC, Mol Cell Biol & Immunol, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	Waasdorp, M (corresponding author), Vrije Univ Amsterdam, Amsterdam UMC, Mol Cell Biol & Immunol, De Boelelaan 1117, NL-1081 HZ Amsterdam, Netherlands.	m.waasdorp@vumc.nl	Duitman, JanWillem/AFX-7298-2022; Spek, Arnold/AAC-5866-2019	Duitman, JanWillem/0000-0003-4254-3380; Spek, Arnold/0000-0002-2149-4068; Florquin, Sandrine/0000-0002-9676-1722; Waasdorp, Maaike/0000-0002-1103-7875	Dutch Diabetes Foundation [2012.00.1471]	Dutch Diabetes Foundation	The authors thank Joost Daalhuisen and Marieke ten Brink (Center for Molecular and Experimental Medicine, Amsterdam University Medical Center) for their technical assistance during the animal experiments. This work was supported by the Dutch Diabetes Foundation (2012.00.1471). The authors declare no conflicts of interest.	Afkarian M, 2013, J AM SOC NEPHROL, V24, P302, DOI 10.1681/ASN.2012070718; Fiseha T, 2016, INT J NEPHROL, V2016, DOI 10.1155/2016/4647685; Gryka RJ, 2017, DRUGS R&D, V17, P65, DOI 10.1007/s40268-016-0158-4; Guan Y, 2017, J PHARMACOL SCI, V135, P81, DOI 10.1016/j.jphs.2017.09.002; Hudkins KL, 2010, J AM SOC NEPHROL, V21, P1533, DOI 10.1681/ASN.2009121290; Kopec AK, 2017, J CLIN INVEST, V127, P3152, DOI [10.1172/JCI92744, 10.1172/jci92744]; Mihara M, 2010, ENDOCRINOLOGY, V151, P513, DOI 10.1210/en.2009-0661; Mosnier LO, 2012, BLOOD, V120, P5237, DOI 10.1182/blood-2012-08-452169; Neuman JC, 2017, DIABETES, V66, P1572, DOI 10.2337/db16-1362; Ruggenenti P, 2000, NEPHROL DIAL TRANSPL, V15, P1900, DOI 10.1093/ndt/15.12.1900; Sharma R, 2017, J AM SOC NEPHROL, V28, P2619, DOI 10.1681/ASN.2016070789; Tricoci P, 2012, NEW ENGL J MED, V366, P20, DOI 10.1056/NEJMoa1109719; Waasdorp Maaike, 2018, Oncotarget, V9, P21655, DOI 10.18632/oncotarget.25069; Waasdorp M, 2017, AM J TRANSL RES, V9, P4512; Waasdorp Maaike, 2017, Biochem Biophys Rep, V10, P152, DOI 10.1016/j.bbrep.2017.03.009; Waasdorp M, 2016, SCI REP-UK, V6, DOI 10.1038/srep33030; Wang H, 2011, BLOOD, V117, P5231, DOI 10.1182/blood-2010-10-314773	17	5	5	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10966	10972		10.1096/fj.201900516R	http://dx.doi.org/10.1096/fj.201900516R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31287960				2022-12-28	WOS:000489166300032
J	Yoo, JY; Jung, NC; Lee, JH; Choi, SY; Choi, HJ; Park, SY; Jang, JS; Byun, SH; Hwang, SU; Noh, KE; Park, Y; Lee, J; Song, JY; Seo, HG; Lee, HS; Lim, DS				Yoo, Ji-Young; Jung, Nam-Chul; Lee, Jun-Ho; Choi, So-Yeon; Choi, Hyun-Ji; Park, Soo-Yeoun; Jang, Ji-Su; Byun, Sei-Hee; Hwang, Sung-Uk; Noh, Kyung-Eun; Park, Yunok; Lee, Jongwon; Song, Jie-Young; Seo, Han Geuk; Lee, Hyun Soo; Lim, Dae-Seog			Pdlim4 is essential for CCR7-JNK-mediated dendritic cell migration and F-actin-related dendrite formation	FASEB JOURNAL			English	Article						DCs; DC maturation; DC marker	T-CELL; ANTIGEN PRESENTATION; PROTEIN RIL; PDZ; CYTOSKELETON; ACTIVATION; MECHANISMS; EXPRESSION; DYNAMICS; DOMAIN	Dendritic cells (DCs) are the most potent professional antigen (Ag)-presenting cells and inducers of T cell-mediated immunity. A previous microarray analysis identified PDZ and LIM domain protein 4 (Pdlim4) as a candidate marker for DC maturation. The aim of this study was to investigate whether Pdlim4 influences DC migration and maturation. Mouse bone marrow-derived DCs were transduced lentivirally with Pdlim4 short hairpin RNA and examined by confocal microscopy, flow cytometry, ELISA, and Western blotting. Pdlim4 was highly induced in LPS-stimulated mature DCs (mDCs). Pdlim4-knockdown mDCs showed reduced expression of molecules associated with Ag presentation and T-cell costimulation, reduced cytokine production, and functional defects in their ability to activate T cells. Moreover, Pdlim4 was necessary for mDC migration via C-C chemokine receptor type 7 (CCR7)-JNK in in vitro Transwell assays. The importance of Pdlim4 in DC migration was confirmed with an in vivo migration model in which C57BL/6 mice were injected with fluorescently labeled DCs in the footpad and migration to the popliteal lymph nodes was assessed by flow cytometry. Moreover, dendrite formation in mDCs was remarkably attenuated under Pdlim4 knockdown. Taken together, these results demonstrate that Pdlim4 is necessary for DC migration via CCR7-JNK, dendrite formation, and subsequent development of functional T-cell responses.-Yoo, J.-Y., Jung, N.-C., Lee, J.-H., Choi, S.-Y., Choi, H.-J., Park, S.-Y., Jang, J.-S., Byun, S.-H., Hwang, S.-U., Noh, K.-E., Park, Y., Lee, J., Song, J.-Y., Seo, H. G., Lee, H. S., Lim, D.-S. Pdlim4 is essential for CCR7-JNK-mediated dendritic cell migration and F-actin-related dendrite formation.	[Yoo, Ji-Young; Jung, Nam-Chul; Choi, So-Yeon; Jang, Ji-Su; Noh, Kyung-Eun; Park, Yunok; Lee, Jongwon; Lim, Dae-Seog] CHA Univ, Dept Biotechnol, 335 Pangyo Ro, Seongnam 13488, South Korea; [Jung, Nam-Chul; Lee, Jun-Ho; Hwang, Sung-Uk; Lee, Hyun Soo] Pharos Vaccine, Seongnam, South Korea; [Choi, Hyun-Ji] JW CreaGene Co, Seongnam, South Korea; [Park, Soo-Yeoun; Byun, Sei-Hee] Aprogen, Seongnam, South Korea; [Song, Jie-Young] Korea Inst Radiol & Med Sci, Dept Radiat Canc Sci, Seoul, South Korea; [Seo, Han Geuk] Konkuk Univ, Sanghuh Coll Life Sci, Dept Food Sci & Biotechnol Anim Resources, Seoul, South Korea	Pochon Cha University; Korea Institute of Radiological & Medical Sciences; Konkuk University	Lim, DS (corresponding author), CHA Univ, Dept Biotechnol, 335 Pangyo Ro, Seongnam 13488, South Korea.	dslim@cha.ac.kr	Song, Jie-Young/AAH-1254-2019; Song, Jie-Young/AAG-6684-2019	Song, Jie-Young/0000-0002-5769-3886	Bio and Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, Information and Communications Technology (ICT), and Future Planning (MSIP) of the Korean government [NRF-2017M3A9C8062622]	Bio and Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, Information and Communications Technology (ICT), and Future Planning (MSIP) of the Korean government	This research was supported by the Bio and Medical Technology Development Program of the National Research Foundation (NRF), funded by the Ministry of Science, Information and Communications Technology (ICT), and Future Planning (MSIP) of the Korean government (NRF-2017M3A9C8062622). The authors declare no conflicts of interest.	Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; An H, 2016, EXP NEUROBIOL, V25, P48, DOI 10.5607/en.2016.25.1.48; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Blom M, 2017, EXP CELL RES, V352, P255, DOI 10.1016/j.yexcr.2017.02.013; Boumber YA, 2007, CANCER RES, V67, P1997, DOI 10.1158/0008-5472.CAN-06-3093; Byun SH, 2016, BIOCHEM PHARMACOL, V115, P85, DOI 10.1016/j.bcp.2016.05.009; Choo EH, 2017, CIRCULATION, V135, P1444, DOI 10.1161/CIRCULATIONAHA.116.023106; Cuppen E, 2000, EUR J CELL BIOL, V79, P283, DOI 10.1078/S0171-9335(04)70031-X; Davis DM, 2009, NAT REV IMMUNOL, V9, P543, DOI 10.1038/nri2602; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Granucci F, 1999, MICROBES INFECT, V1, P1079, DOI 10.1016/S1286-4579(99)00209-9; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Guy PM, 1999, MOL BIOL CELL, V10, P1973, DOI 10.1091/mbc.10.6.1973; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Lee EG, 2016, AUTOIMMUNITY, V49, P90, DOI 10.3109/08916934.2015.1124424; Liechtenstein T., 2012, J CLIN CELL IMMUNOL; Liechtenstein T, 2013, VIRUS RES, V176, P1, DOI 10.1016/j.virusres.2013.05.007; Manjunath N, 2009, ADV DRUG DELIVER REV, V61, P732, DOI 10.1016/j.addr.2009.03.004; Ocana-Morgner C, 2009, BLOOD, V113, P1474, DOI 10.1182/blood-2008-04-152587; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Shurin GV, 2005, J IMMUNOL, V174, P3394, DOI 10.4049/jimmunol.174.6.3394; Steinman RM, 2007, EUR J IMMUNOL, V37, pS53, DOI 10.1002/eji.200737400; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Swetman CA, 2002, EUR J IMMUNOL, V32, P2074, DOI 10.1002/1521-4141(200207)32:7<2074::AID-IMMU2074>3.0.CO;2-S; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Vallenius T, 2004, EXP CELL RES, V293, P117, DOI 10.1016/j.yexcr.2003.09.004; Vallenius T, 2000, J BIOL CHEM, V275, P11100, DOI 10.1074/jbc.275.15.11100; Vallenius T, 2002, J CELL SCI, V115, P2067; van den Berk LCJ, 2004, MOL BIOL REP, V31, P203; Vargas P, 2016, NAT CELL BIOL, V18, P43, DOI 10.1038/ncb3284; Verdijk P, 2004, EUR J IMMUNOL, V34, P156, DOI 10.1002/eji.200324241; Vicente-Manzanares M, 2002, INT REV CYTOL, V216, P233; Xia HH, 1997, J CELL BIOL, V139, P507, DOI 10.1083/jcb.139.2.507; Xu Y, 2014, J IMMUNOL, V192, P3559, DOI 10.4049/jimmunol.1300695	43	8	8	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11035	11044		10.1096/fj.201901031	http://dx.doi.org/10.1096/fj.201901031			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31287961				2022-12-28	WOS:000489166300039
J	Zhuang, CL; Ma, Q; Zhuang, CS; Ye, J; Zhang, FT; Gui, YT				Zhuang, Chengle; Ma, Qian; Zhuang, Changshui; Ye, Jing; Zhang, Fangting; Gui, Yaoting			LncRNA GClnc1 promotes proliferation and invasion of bladder cancer through activation of MYC	FASEB JOURNAL			English	Article						LIN28B; let-7a; migration	LONG NONCODING RNA; LIN28/LET-7 AXIS; IMPRINTED H19; PROGRESSION; TRANSACTIVATION; RECURRENCE; EXPRESSION; CARCINOMA; PROSTATE; GENE	Various studies demonstrate that long noncoding RNAs (lncRNAs) act as oncogenes or tumor suppressors in cancer. However, the function of lncRNAs in bladder cancer still remains largely unknown. In this study, we identified an lncRNA, gastric cancer-associated lncRNA1 (GClnc1), which was in high abundance in bladder cancer tissues and its expression was related to poor survival rates in patients with bladder cancer. In vitro and in vivo assays showed that GClnc1 significantly promoted cell proliferation, metastasis, and invasiveness in bladder cancer. Mechanistically, we first found that GClnc1 bound to LIN28B and promoted the expression of myelocytomatosis proto-oncogene (MYC) through the LIN28B/let-7a/MYC pathway. In short, GClnc1 is clinically, functionally, and mechanistically oncogenic in bladder cancer. GClnc1 may be a potential target for treating patients with bladder cancer.-Zhuang, C., Ma, Q., Zhuang, C., Ye, J., Zhang, F., Gui, Y. LncRNA GClnc1 promotes proliferation and invasion of bladder cancer through activation of MYC.	[Zhuang, Chengle; Ma, Qian; Zhuang, Changshui; Ye, Jing; Zhang, Fangting; Gui, Yaoting] Peking Univ, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Inst Urol, Shenzhen Hosp, Shenzhen 518000, Peoples R China; [Zhuang, Chengle; Ma, Qian; Zhuang, Changshui; Ye, Jing; Zhang, Fangting; Gui, Yaoting] Peking Univ, Shenzhen 518000, Peoples R China; [Zhuang, Chengle; Ma, Qian; Zhuang, Changshui; Ye, Jing; Zhang, Fangting; Gui, Yaoting] Hong Kong Univ Sci & Technol, Med Ctr, Shenzhen 518000, Peoples R China	Peking University; Peking University; Hong Kong University of Science & Technology	Zhang, FT; Gui, YT (corresponding author), Peking Univ, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Inst Urol, Shenzhen Hosp, Shenzhen 518000, Peoples R China.; Zhang, FT; Gui, YT (corresponding author), Peking Univ, Shenzhen 518000, Peoples R China.; Zhang, FT; Gui, YT (corresponding author), Hong Kong Univ Sci & Technol, Med Ctr, Shenzhen 518000, Peoples R China.	fangtingzhang@126.com; guiyaoting2007@aliyun.com	gui, yaoting/GLT-3684-2022		Guangdong Key Laboratory of Male Reproductive Medicine and Genetics [2017B030314074]; Shenzhen Project of Science and Technology [JCYJ20170413100245260]; "San-ming" Project of Medicine in Shenzhen [SZSM201612066]	Guangdong Key Laboratory of Male Reproductive Medicine and Genetics; Shenzhen Project of Science and Technology; "San-ming" Project of Medicine in Shenzhen	This work was supported by grants from the Guangdong Key Laboratory of Male Reproductive Medicine and Genetics (2017B030314074), the Shenzhen Project of Science and Technology (JCYJ20170413100245260), and the "San-ming" Project of Medicine in Shenzhen (SZSM201612066). The authors thank all researchers whose names were not included in the author list, but who participated in this program. The authors declare no conflicts of interest.	Albino D, 2016, CANCER RES, V76, P3629, DOI 10.1158/0008-5472.CAN-15-2665; Allione A, 2018, CARCINOGENESIS, V39, P1254, DOI 10.1093/carcin/bgy098; Ariel I, 2000, J CLIN PATHOL-MOL PA, V53, P320, DOI 10.1136/mp.53.6.320; Balzeau J, 2017, FRONT GENET, V8, P1, DOI 10.3389/fgene.2017.00031; Bellucci M, 2011, NAT METHODS, V8, P444, DOI 10.1038/nmeth.1611; Blondeau JJC, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0047-7; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Calle AS, 2018, CANCER SCI, V109, P2093, DOI 10.1111/cas.13642; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chen H, 2012, CANCER LETT, V320, P40, DOI 10.1016/j.canlet.2012.01.027; Chen JB, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-015-0282-y; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; ELKIN M, 1995, FEBS LETT, V374, P57, DOI 10.1016/0014-5793(95)01074-O; Fernandez-Gomez J, 2009, J UROLOGY, V182, P2195, DOI 10.1016/j.juro.2009.07.016; Guo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022387; Han YH, 2013, J SURG ONCOL, V107, P555, DOI 10.1002/jso.23264; Han YH, 2013, UROLOGY, V81, DOI 10.1016/j.urology.2012.08.044; Holdt LM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12429; Huang GQ, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0794-3; Lan T., 2019, CANC RES; Li GL, 2017, PAIN, V158, P2042, DOI 10.1097/j.pain.0000000000001013; Mahe M, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708163; Martens-Uzunova ES, 2014, EUR UROL, V65, P1140, DOI 10.1016/j.eururo.2013.12.003; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Muys B. R., 2019, CANC RES; Park SJ, 2016, ONCOGENE, V35, P1292, DOI 10.1038/onc.2015.187; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Sun TT, 2016, CANCER DISCOV, V6, P784, DOI 10.1158/2159-8290.CD-15-0921; Sun X, 2016, J CELL MOL MED, V20, P1779, DOI 10.1111/jcmm.12861; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Takai D, 2001, HUM MOL GENET, V10, P2619, DOI 10.1093/hmg/10.23.2619; Wang F, 2008, FEBS LETT, V582, P1919, DOI 10.1016/j.febslet.2008.05.012; Wang J, 2018, NEOPLASMA, V65, P769, DOI 10.4149/neo_2018_171204N794; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Wang XX, 2016, MATER TODAY CHEM, V1-2, P7, DOI 10.1016/j.mtchem.2016.10.005; Wang ZH, 2018, CANCER CELL, V33, P706, DOI 10.1016/j.ccell.2018.03.006; Wu D, 2018, CANCER LETT, V438, P116, DOI 10.1016/j.canlet.2018.09.016; Yarmishyn AA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S9-S7; Zhang X, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201706523; Zhong ZY, 2017, CANCER LETT, V403, P305, DOI 10.1016/j.canlet.2017.06.027; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhuang CL, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0626-x	42	53	54	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11045	11059		10.1096/fj.201900078RR	http://dx.doi.org/10.1096/fj.201900078RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31298933				2022-12-28	WOS:000489166300040
J	Yang, M; Liang, ZR; Yang, ML; Jia, YJ; Yang, GY; He, YR; Li, XR; Gu, HF; Zheng, HT; Zhu, ZM; Li, L				Yang, Min; Liang, Zerong; Yang, Mengliu; Jia, Yanjun; Yang, Gangyi; He, Yirui; Li, Xinrun; Gu, Harvest F.; Zheng, Hongting; Zhu, Zhiming; Li, Ling			Role of bone morphogenetic protein-9 in the regulation of glucose and lipid metabolism	FASEB JOURNAL			English	Article						BMP9; metabolism; insulin resistance; cytokine	ELEMENT-BINDING PROTEIN; TRANSCRIPTION FACTOR; INSULIN SENSITIVITY; CELLS; DIFFERENTIATION; EXPRESSION; BMP-9; CYTOKINE; PROMOTER; SREBP-1C	Bone morphogenetic protein (BMP)-9 has been reported to regulate energy balance in vivo. However, the mechanisms underlying BMP9-mediated regulation of energy balance remain incompletely understood. Here, we investigated the role of BMP9 in energy metabolism. In the current study, we found that hepatic BMP9 expression was down-regulated in insulin resistance (IR) mice and in patients who are diabetic. In mice fed a high-fat diet (HFD), the overexpression of hepatic BMP9 improved glucose tolerance and IR. The expression of gluconeogenic genes was down-regulated, whereas the level of insulin signaling molecule phosphorylation was increased in the livers of Adenovirus-BMP9-treated mice and glucosamine-treated hepatocytes. Furthermore, BMP9 overexpression ameliorated triglyceride accumulation and inhibited the expression of lipogenic genes in both human hepatocellular carcinoma HepG2 cells treated with a fatty acid mixture as well as the livers of HFD-fed mice. In hepatocytes isolated from sterol regulatory element-binding protein (SREBP)-1c knockout mice, the effects of BMP9 were ablated. Mechanistically, BMP9 inhibited SREBP-1c expression through the inhibition of liver X receptor response element 1 activity in the SREBP-1c promoter. Taken together, our results show that BMP9 is an important regulator of hepatic glucose and lipid metabolism.-Yang, M., Liang, Z., Yang, M., Jia, Y., Yang, G., He, Y., Li, X., Gu, H. F., Zheng, H., Zhu, Z., Li, L. Role of bone morphogenetic protein-9 in the regulation of glucose and lipid metabolism.	[Yang, Min; Li, Ling] Chongqing Med Univ, Coll Lab Med, Dept Clin Biochem, Key Lab Diagnost Med,Minist Educ, 1 Yixueyuan Rd, Chongqing 400016, Peoples R China; [Liang, Zerong; Yang, Mengliu; Jia, Yanjun; Yang, Gangyi; He, Yirui; Li, Xinrun] Chongqing Med Univ, Chongqing Clin Res Ctr Geriatr, Affiliated Hosp 2, Dept Endocrinol, Chongqing, Peoples R China; [Gu, Harvest F.] Karolinska Inst, Karolinska Univ Hosp, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Zheng, Hongting] Third Mil Med Univ, Xinqiao Hosp, Dept Endocrinol, Chongqing, Peoples R China; [Zhu, Zhiming] Third Mil Med Univ, Chongqing Inst Hypertens, Daping Hosp, Dept Hypertens & Endocrinol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Karolinska Institutet; Karolinska University Hospital; Army Medical University; Army Medical University	Li, L (corresponding author), Chongqing Med Univ, Coll Lab Med, Dept Clin Biochem, Key Lab Diagnost Med,Minist Educ, 1 Yixueyuan Rd, Chongqing 400016, Peoples R China.	liling@cqmu.edu.cn		Li, Ling/0000-0002-0087-3034	National Natural Science Foundation [81873658, 81570752, 81500666, 81670755]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation (81873658, 81570752, 81500666, and 81670755). The authors declare no conflicts of interest.	AHRENS M, 1993, DNA CELL BIOL, V12, P871, DOI 10.1089/dna.1993.12.871; Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Cagen LM, 2005, BIOCHEM J, V385, P207, DOI 10.1042/BJ20040162; Caperuto LC, 2008, ENDOCRINOLOGY, V149, P6326, DOI 10.1210/en.2008-0655; Chen C, 2003, NAT BIOTECHNOL, V21, P294, DOI 10.1038/nbt795; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Herrera B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069535; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; Kuo MMC, 2014, BIOMATERIALS, V35, P3172, DOI 10.1016/j.biomaterials.2013.12.063; Lee J, 2015, MOL CELL ENDOCRINOL, V414, P148, DOI 10.1016/j.mce.2015.07.031; Li L, 2011, MOL MED, V17, P1168, DOI 10.2119/molmed.2011.00051; Luo Y, 2017, CLIN SCI, V131, P239, DOI 10.1042/CS20160543; Miller AF, 2000, J BIOL CHEM, V275, P17937, DOI 10.1074/jbc.275.24.17937; Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Schulz TJ, 2009, CYTOKINE GROWTH F R, V20, P523, DOI 10.1016/j.cytogfr.2009.10.019; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; SONG JJ, 1995, ENDOCRINOLOGY, V136, P4293, DOI 10.1210/en.136.10.4293; Sottile V, 2000, FEBS LETT, V475, P201, DOI 10.1016/S0014-5793(00)01655-0; Tang JX, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.555; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Tobin JF, 2006, DRUG DISCOV TODAY, V11, P405, DOI 10.1016/j.drudis.2006.03.016; Townsend KL, 2012, FASEB J, V26, P2187, DOI 10.1096/fj.11-199067; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Vella A, 2009, DIABETES, V58, P2168, DOI 10.2337/db09-0318; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Xiao F, 2014, DIABETES, V63, P2631, DOI 10.2337/db13-1689; Xiao F, 2011, DIABETES, V60, P746, DOI 10.2337/db10-1246; Yamamoto Y, 2004, NATURWISSENSCHAFTEN, V91, P519, DOI 10.1007/s00114-004-0575-z; Yang ML, 2014, FEBS J, V281, P3193, DOI 10.1111/febs.12853; Yuan L, 2015, INT J OBESITY, V39, P949, DOI 10.1038/ijo.2015.5; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188	34	25	25	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10077	10088		10.1096/fj.201802544RR	http://dx.doi.org/10.1096/fj.201802544RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31237775	Bronze			2022-12-28	WOS:000482214200029
J	Biswas, D; Duffley, L; Pulinilkunnil, T				Biswas, Dipsikha; Duffley, Luke; Pulinilkunnil, Thomas			Role of branched-chain amino acid-catabolizing enzymes in intertissue signaling, metabolic remodeling, and energy homeostasis	FASEB JOURNAL			English	Review						BCKA; BCKDH; BCAT; PPM1K; KLF15	KETOACID DEHYDROGENASE COMPLEX; CORONARY-ARTERY-DISEASE; MUSCLE INSULIN SENSITIVITY; TYPE-2 DIABETES-MELLITUS; PROTEIN PHOSPHATASE 2CM; SYRUP-URINE-DISEASE; RAT SKELETAL-MUSCLE; WEIGHT-LOSS DIETS; ADIPOSE-TISSUE; GENE-EXPRESSION	Beyond their contribution as fundamental building blocks of life, branched-chain amino acids (BCAAs) play a critical role in physiologic and pathologic processes. Importantly, BCAAs are associated with insulin resistance, obesity, cardiovascular disease, and genetic disorders. However, several metabolome-wide studies in recent years could not attribute alterations in systemic BCAAs as the sole driver of endocrine perturbations, suggesting that a snapshot of global BCAA changes does not always reveal the underlying modifications. Because enzymes catabolizing BCAAs have a unique distribution, it is plausible that the tissue-specific roles of BCAA-catabolic enzymes could precipitate changes in systemic BCAA levels, flux, and action. We review the genetic and pharmacological approaches dissecting the role of BCAA-catabolic enzyme dysfunctions. We summarized emerging evidence on BCAA metabolic intermediates, tissue specificity of BCAA-catabolizing enzymes, and crosstalk between different metabolites in driving metabolic maladaptation in health and pathology. This review substantiates the understanding that tissue-specific dysfunction of the BCAA-catabolic enzymes and accumulating intermediary metabolites could act as better surrogates of metabolic imbalances, highlighting the biochemical communication among the nutrient triad of BCAAs, glucose, and fatty acid.-Biswas, D., Duffley, L., Pulinilkunnil, T. Role of branched-chain amino acid-catabolizing enzymes in intertissue signaling, metabolic remodeling, and energy homeostasis.	[Biswas, Dipsikha; Duffley, Luke; Pulinilkunnil, Thomas] Dalhousie Univ, Dalhousie Med New Brunswick, Fac Med, Dept Biochem & Mol Biol, 100 Tucker Pk, St John, NB E2L 4L5, Canada	Dalhousie University	Pulinilkunnil, T (corresponding author), Dalhousie Univ, Dalhousie Med New Brunswick, Fac Med, Dept Biochem & Mol Biol, 100 Tucker Pk, St John, NB E2L 4L5, Canada.	tpulinil@dal.ca	Pulinilkunnil, Thomas/H-4387-2019; Biswas, Dipsikha/AAP-3682-2020	Pulinilkunnil, Thomas/0000-0003-1228-893X; Biswas, Dipsikha/0000-0003-0990-9678	Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-03687]; Diabetes Canada [NOD_OG-3-15-5037-TP]; New Brunswick Health Research Foundation Postdoctoral fellowship; Dalhousie Medicine Postdoctoral Fellowship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Diabetes Canada; New Brunswick Health Research Foundation Postdoctoral fellowship; Dalhousie Medicine Postdoctoral Fellowship	This work was supported by Natural Sciences and Engineering Research Council of Canada (RGPIN-2014-03687 to T.P.) and Diabetes Canada (NOD_OG-3-15-5037-TP to T.P.) and a New Brunswick Health Research Foundation Postdoctoral fellowship and Dalhousie Medicine Postdoctoral Fellowship to D.B. Drs. D.B. and T.P. are the guarantors of this work. The authors declare no conflicts of interest.	Adams SH, 2011, ADV NUTR, V2, P445, DOI 10.3945/an.111.000737; Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Adeva MM, 2012, AMINO ACIDS, V43, P171, DOI 10.1007/s00726-011-1088-7; Ananieva EA, 2018, BRIT J CANCER, V119, P1009, DOI 10.1038/s41416-018-0283-7; Ananieva EA, 2017, J NUTR BIOCHEM, V40, P132, DOI 10.1016/j.jnutbio.2016.10.014; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Badoud F, 2014, J PROTEOME RES, V13, P3455, DOI 10.1021/pr500416v; BAQUET A, 1991, BIOCHEM J, V273, P57, DOI 10.1042/bj2730057; Basak T, 2015, J PROTEOMICS, V127, P169, DOI 10.1016/j.jprot.2015.03.011; Batch BC, 2013, METABOLISM, V62, P961, DOI 10.1016/j.metabol.2013.01.007; Bertrand SM, 2015, J MED CHEM, V58, P7140, DOI 10.1021/acs.jmedchem.5b00313; Binder E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074705; Blanchard PG, 2018, METABOLISM, V89, P27, DOI 10.1016/j.metabol.2018.09.007; Bledsoe RK, 1997, BBA-PROTEIN STRUCT M, V1339, P9, DOI 10.1016/S0167-4838(97)00044-7; Bogl LH, 2016, METABOLISM, V65, P111, DOI 10.1016/j.metabol.2015.10.027; Bong HY, 2010, NUTR RES PRACT, V4, P106, DOI 10.4162/nrp.2010.4.2.106; Boulet MM, 2015, AM J PHYSIOL-ENDOC M, V309, pE736, DOI 10.1152/ajpendo.00231.2015; Brunetti-Pierri N, 2011, HUM MOL GENET, V20, P631, DOI 10.1093/hmg/ddq507; Burrage LC, 2014, MOL GENET METAB, V113, P131, DOI 10.1016/j.ymgme.2014.06.005; Burrill JS, 2015, MOL ENDOCRINOL, V29, P411, DOI 10.1210/me.2014-1275; Calder PC, 2006, J NUTR, V136, p288S, DOI 10.1093/jn/136.1.288S; Chen TL, 2016, SCI REP-UK, V6, DOI 10.1038/srep20594; Chen W, 2015, SCI REP-UK, V5, DOI 10.1038/srep09884; Cummings NE, 2018, J PHYSIOL-LONDON, V596, P623, DOI 10.1113/JP275075; Doisaki M, 2010, BIOCHEM BIOPH RES CO, V393, P303, DOI 10.1016/j.bbrc.2010.02.004; Drake KJ, 2012, EXP BIOL MED, V237, P1369, DOI 10.1258/ebm.2012.012025; Du XY, 2018, LIFE SCI, V209, P167, DOI 10.1016/j.lfs.2018.08.011; Fan LY, 2018, PHARMACOL RES, V130, P123, DOI 10.1016/j.phrs.2017.12.018; Fan Y, 2016, J AM COLL CARDIOL, V68, P1281, DOI 10.1016/j.jacc.2016.06.044; FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503; Ferguson JF, 2016, CLIN CHEM, V62, P545, DOI 10.1373/clinchem.2016.254318; Ferrannini E, 2013, DIABETES, V62, P1730, DOI 10.2337/db12-0707; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Fontana L, 2016, CELL REP, V16, P520, DOI 10.1016/j.celrep.2016.05.092; Fujii H, 1998, BIOCHEM MOL BIOL INT, V44, P1211; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Ganna A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004801; Giesbertz P, 2016, CURR OPIN CLIN NUTR, V19, P48, DOI 10.1097/MCO.0000000000000235; Gong YY, 2018, MOL CELL ENDOCRINOL, V471, P22, DOI 10.1016/j.mce.2017.05.024; Goni L, 2017, AM J CLIN NUTR, V106, P902, DOI 10.3945/ajcn.117.156281; GOODWIN GW, 1988, METHOD ENZYMOL, V166, P189; Gray S, 2002, J BIOL CHEM, V277, P34322, DOI 10.1074/jbc.M201304200; Gray S, 2007, CELL METAB, V5, P305, DOI 10.1016/j.cmet.2007.03.002; Greco D, 2008, AM J PHYSIOL-GASTR L, V294, pG1281, DOI 10.1152/ajpgi.00074.2008; Green CR, 2016, NAT CHEM BIOL, V12, P15, DOI [10.1038/nchembio.1961, 10.1038/NCHEMBIO.1961]; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Guo X, 2016, BIOCHEM BIOPH RES CO, V480, P106, DOI 10.1016/j.bbrc.2016.09.162; Haldar SM, 2012, P NATL ACAD SCI USA, V109, P6739, DOI 10.1073/pnas.1121060109; Haldar SM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000502; Han BJ, 2018, PEDIATR NEONATOL, V59, P515, DOI 10.1016/j.pedneo.2018.01.006; HARPER AE, 1984, ANNU REV NUTR, V4, P409, DOI 10.1146/annurev.nu.04.070184.002205; Harris LALS, 2017, DIABETES, V66, P1871, DOI 10.2337/db16-1475; Harris RA, 2004, BIOCHEM BIOPH RES CO, V313, P391, DOI 10.1016/j.bbrc.2003.11.007; Harris RA, 2001, J NUTR, V131, p841S, DOI 10.1093/jn/131.3.841S; Hatazawa Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129084; Hatazawa Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091006; Haufe S, 2017, NUTR METAB CARDIOVAS, V27, P858, DOI 10.1016/j.numecd.2017.07.001; Herman MA, 2010, J BIOL CHEM, V285, P11348, DOI 10.1074/jbc.M109.075184; Hernandez-Alvarez MI, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14120-6; Hiltunen JK, 2010, PROG LIPID RES, V49, P27, DOI 10.1016/j.plipres.2009.08.001; Hirata Y, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124952; Holecek M, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0271-1; Hong SG, 2017, NAT MED, V23, P223, DOI 10.1038/nm.4245; Hsiao G, 2011, AM J PHYSIOL-ENDOC M, V300, pE164, DOI 10.1152/ajpendo.00219.2010; Huang Y, 2011, CARDIOVASC RES, V90, P220, DOI 10.1093/cvr/cvr070; Hull J, 2018, NEUROCHEM INT, V112, P49, DOI 10.1016/j.neuint.2017.10.014; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; HUTSON SM, 1992, J BIOL CHEM, V267, P15681; Hutson SM, 2005, J NUTR, V135, p1557S, DOI 10.1093/jn/135.6.1557S; Isanejad M, 2017, BRIT J NUTR, V117, P1523, DOI 10.1017/S0007114517001568; Ishiguro H, 2006, LIFE SCI, V79, P737, DOI 10.1016/j.lfs.2006.02.037; Ishikawa T, 2017, SCI REP-UK, V7, DOI 10.1038/srep39825; Iwasa M, 2015, OBES RES CLIN PRACT, V9, P293, DOI 10.1016/j.orcp.2015.01.003; Jang C, 2016, NAT MED, V22, P421, DOI 10.1038/nm.4057; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; Joshi M, 2007, BIOCHEM BIOPH RES CO, V356, P38, DOI 10.1016/j.bbrc.2007.02.108; Joshi MA, 2006, BIOCHEM J, V400, P153, DOI 10.1042/BJ20060869; Jung DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077851; Kadota Y, 2013, OBES RES CLIN PRACT, V7, pE439, DOI 10.1016/j.orcp.2013.07.003; Kadota Y, 2012, JPEN-PARENTER ENTER, V36, P337, DOI 10.1177/0148607111414578; Kakazu E, 2013, HEPATOL INT, V7, P577, DOI 10.1007/s12072-012-9395-y; Kappel BA, 2017, CIRCULATION, V136, P969, DOI 10.1161/CIRCULATIONAHA.117.029166; KEDISHVILI NY, 1994, ARCH BIOCHEM BIOPHYS, V315, P317, DOI 10.1006/abbi.1994.1506; Kingsbury JM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005714; Kobayashi R, 2002, ARCH BIOCHEM BIOPHYS, V407, P231, DOI 10.1016/S0003-9861(02)00472-1; Koch L, 2008, J CLIN INVEST, V118, P2132, DOI 10.1172/JCI31073; Krebs M, 2003, DIABETOLOGIA, V46, P917, DOI 10.1007/s00125-003-1129-1; Krebs M, 2002, DIABETES, V51, P599, DOI 10.2337/diabetes.51.3.599; Kuzuya T, 2008, BIOCHEM BIOPH RES CO, V373, P94, DOI 10.1016/j.bbrc.2008.05.167; Lackey DE, 2013, AM J PHYSIOL-ENDOC M, V304, pE1175, DOI 10.1152/ajpendo.00630.2012; Lake AD, 2015, AMINO ACIDS, V47, P603, DOI 10.1007/s00726-014-1894-9; Lang CH, 2010, AM J PHYSIOL-REG I, V299, pR935, DOI 10.1152/ajpregu.00297.2010; Lang CH, 2010, J NUTR, V140, P932, DOI 10.3945/jn.109.120501; Layman DK, 2003, J NUTR, V133, p261S, DOI 10.1093/jn/133.1.261S; Lee CC, 2016, DIABETES CARE, V39, P582, DOI 10.2337/dc15-2284; Lerin C, 2016, MOL METAB, V5, P926, DOI 10.1016/j.molmet.2016.08.001; LETTO J, 1986, BIOCHEM J, V240, P909, DOI 10.1042/bj2400909; Li HL, 2012, AM J PHYSIOL-ENDOC M, V303, pE1234, DOI 10.1152/ajpendo.00198.2012; Li M, 2012, ARCH BIOCHEM BIOPHYS, V519, P69, DOI 10.1016/j.abb.2011.10.015; Li RT, 2016, AMINO ACIDS, V48, P1523, DOI 10.1007/s00726-016-2212-5; Li T, 2017, CELL METAB, V25, P374, DOI 10.1016/j.cmet.2016.11.005; Li X, 2013, MOL NUTR FOOD RES, V57, P1067, DOI 10.1002/mnfr.201200311; Li YH, 2016, ANIM NUTR, V2, P24, DOI 10.1016/j.aninu.2016.01.003; Li ZH, 2001, J NUTR SCI VITAMINOL, V47, P345, DOI 10.3177/jnsv.47.345; Lian K, 2015, DIABETES, V64, P49, DOI 10.2337/db14-0312; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lips MA, 2014, DIABETES CARE, V37, P3150, DOI 10.2337/dc14-0195; Liu R, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060565; Liu Y, 2013, DIABETES, V62, P743, DOI 10.2337/db12-0687; Liu YX, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00853; Lombardo YB, 1998, P ASSOC AM PHYSICIAN, V110, P40; Lotta LA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002179; Lu G, 2007, GENE DEV, V21, P784, DOI 10.1101/gad.1499107; Lu G, 2009, METHOD ENZYMOL, V457, P255, DOI 10.1016/S0076-6879(09)05014-9; Lu G, 2009, J CLIN INVEST, V119, P1678, DOI 10.1172/JCI38151; Lynch CJ, 2015, PHYSIOL GENOMICS, V47, P569, DOI 10.1152/physiolgenomics.00055.2015; Lynch CJ, 2014, NAT REV ENDOCRINOL, V10, P723, DOI 10.1038/nrendo.2014.171; Magnusson M, 2013, EUR HEART J, V34, P1982, DOI 10.1093/eurheartj/ehs424; Marzieh T., 2012, FASEB J S, V26; Matoba K, 2017, CELL REP, V21, P3129, DOI 10.1016/j.celrep.2017.11.032; Mayers JR, 2016, SCIENCE, V353, P1161, DOI 10.1126/science.aaf5171; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Nagata C, 2013, AM J EPIDEMIOL, V178, P1226, DOI 10.1093/aje/kwt112; Neinast MD, 2019, CELL METAB, V29, P417, DOI 10.1016/j.cmet.2018.10.013; Neishabouri SH, 2015, AMINO ACIDS, V47, P1167, DOI 10.1007/s00726-015-1944-y; Nellis MM, 2002, AM J PHYSIOL-ENDOC M, V283, pE853, DOI 10.1152/ajpendo.00133.2002; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nie CX, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19040954; Nishimura J, 2010, J NUTR, V140, P496, DOI 10.3945/jn.109.108977; NOBUKUNI Y, 1991, J CLIN INVEST, V87, P1862, DOI 10.1172/JCI115209; Novarino G, 2012, SCIENCE, V338, P394, DOI 10.1126/science.1224631; O'Connell TM, 2013, METABOLITES, V3, P931, DOI 10.3390/metabo3040931; Okekunle AP, 2017, DIABETES RES CLIN PR, V132, P45, DOI 10.1016/j.diabres.2017.07.023; OKU H, 1988, J BIOL CHEM, V263, P18386; PALMER TN, 1985, BIOSCIENCE REP, V5, P1015, DOI 10.1007/BF01119623; Pan BF, 2015, ACTA PHARMACOL SIN, V36, P1480, DOI 10.1038/aps.2015.119; Patterson BW, 2002, AM J PHYSIOL-ENDOC M, V282, pE931, DOI 10.1152/ajpendo.00359.2001; Paul HS, 1996, BIOCHEM J, V317, P411, DOI 10.1042/bj3170411; Paynter NP, 2018, CIRCULATION, V137, P841, DOI 10.1161/CIRCULATIONAHA.117.029468; Piccolo BD, 2016, AM J PHYSIOL-ENDOC M, V310, pE958, DOI 10.1152/ajpendo.00052.2016; Prosdocimo DA, 2014, J BIOL CHEM, V289, P5914, DOI 10.1074/jbc.M113.531384; Purpera MN, 2012, J ENDOCRINOL, V212, P85, DOI 10.1530/JOE-11-0270; Rietman A, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2015.37; Roberts LD, 2014, CELL METAB, V19, P96, DOI 10.1016/j.cmet.2013.12.003; Roberts LD, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r75; Rodriguez T, 1997, BIOCHEM MOL MED, V61, P87, DOI 10.1006/bmme.1997.2585; Saad MJA, 2016, PHYSIOLOGY, V31, P283, DOI 10.1152/physiol.00041.2015; Sailer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063950; Salinas-Rubio D, 2018, J NUTR BIOCHEM, V59, P29, DOI 10.1016/j.jnutbio.2018.05.011; Sansbury BE, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00453; Schakman O, 2013, INT J BIOCHEM CELL B, V45, P2163, DOI 10.1016/j.biocel.2013.05.036; Sears DD, 2009, P NATL ACAD SCI USA, V106, P18745, DOI 10.1073/pnas.0903032106; Serralde-Zuniga AE, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0431-5; Shah SH, 2012, DIABETOLOGIA, V55, P321, DOI 10.1007/s00125-011-2356-5; Shah SH, 2010, CIRC-CARDIOVASC GENE, V3, P207, DOI 10.1161/CIRCGENETICS.109.852814; Shao D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05362-7; She PX, 2007, AM J PHYSIOL-ENDOC M, V293, pE1552, DOI 10.1152/ajpendo.00134.2007; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; She PX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059443; She PX, 2010, J APPL PHYSIOL, V108, P941, DOI 10.1152/japplphysiol.01248.2009; Shearer J, 2008, DIABETES OBES METAB, V10, P950, DOI 10.1111/j.1463-1326.2007.00837.x; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; SHIMOMURA Y, 1995, J NUTR, V125, pS1762; Shimomura Y, 2004, HEPATOL RES, V30, pS3, DOI 10.1016/j.hepres.2004.09.001; Shimomura Y, 2001, CURR OPIN CLIN NUTR, V4, P419, DOI 10.1097/00075197-200109000-00013; Shin AC, 2014, CELL METAB, V20, P898, DOI 10.1016/j.cmet.2014.09.003; Smith CL, 2018, NUCLEIC ACIDS RES, V46, pD836, DOI 10.1093/nar/gkx1006; Sonnet DS, 2016, SCI REP-UK, V6, DOI 10.1038/srep28775; Sperringer JE, 2017, NEUROCHEM RES, V42, P1697, DOI 10.1007/s11064-017-2261-5; Su X, 2015, OBESITY, V23, P329, DOI 10.1002/oby.20923; Sugi K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192376; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Sun HP, 2016, CIRCULATION, V133, P2038, DOI 10.1161/CIRCULATIONAHA.115.020226; Sun HP, 2012, PHYSIOLOGY, V27, P43, DOI 10.1152/physiol.00034.2011; Sun HP, 2011, PEDIATR CARDIOL, V32, P305, DOI 10.1007/s00246-010-9856-9; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Tai ES, 2010, DIABETOLOGIA, V53, P757, DOI 10.1007/s00125-009-1637-8; Takashima M, 2010, DIABETES, V59, P1608, DOI 10.2337/db09-1679; Takashina C, 2016, NUTR METAB, V13, DOI 10.1186/s12986-015-0059-5; Takeuchi Y, 2016, CELL REP, V16, P2373, DOI 10.1016/j.celrep.2016.07.069; Tanada Y, 2015, LIFE SCI, V137, P20, DOI 10.1016/j.lfs.2015.06.021; Tandler B, 2015, ULTRASTRUCT PATHOL, V39, P336, DOI 10.3109/01913123.2015.1042610; Tarlungeanu DC, 2016, CELL, V167, P1481, DOI 10.1016/j.cell.2016.11.013; Tillin T, 2015, DIABETOLOGIA, V58, P968, DOI 10.1007/s00125-015-3517-8; Tobias DK, 2018, CURR OPIN CARDIOL, V33, P558, DOI 10.1097/HCO.0000000000000552; Tso SC, 2014, J BIOL CHEM, V289, P20583, DOI 10.1074/jbc.M114.569251; Walford GA, 2013, METABOLISM, V62, P1772, DOI 10.1016/j.metabol.2013.07.003; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang W, 2016, AM J PHYSIOL-HEART C, V311, pH1160, DOI 10.1152/ajpheart.00114.2016; Wang YP, 2012, GENE, V498, P112, DOI 10.1016/j.gene.2012.01.082; White PJ, 2018, CELL METAB, V27, P1281, DOI 10.1016/j.cmet.2018.04.015; White PJ, 2016, MOL METAB, V5, P538, DOI 10.1016/j.molmet.2016.04.006; Wurtz P, 2013, DIABETES CARE, V36, P648, DOI 10.2337/dc12-0895; Wurtz P, 2012, DIABETES CARE, V35, P1749, DOI 10.2337/dc11-1838; Wurtz P, 2012, DIABETES, V61, P1372, DOI 10.2337/db11-1355; Xie GX, 2014, J PROTEOME RES, V13, P4062, DOI 10.1021/pr500434s; Xu M, 2013, CIRCULATION, V127, P1283, DOI 10.1161/CIRCULATIONAHA.112.000586; Xu MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180989; Xuan LP, 2018, ACTA DIABETOL, V55, P901, DOI 10.1007/s00592-018-1165-4; Xue PP, 2017, EBIOMEDICINE, V20, P50, DOI 10.1016/j.ebiom.2017.05.001; Yamada C, 2015, J DIABETES INVEST, V6, P408, DOI 10.1111/jdi.12323; Yoon MS, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070405; Yoshizawa F, 2012, J PHARMACOL SCI, V118, P149, DOI 10.1254/jphs.11R05FM; Zhang FY, 2016, EBIOMEDICINE, V13, P157, DOI 10.1016/j.ebiom.2016.10.013; Zhang LL, 2015, CELL REP, V13, P2368, DOI 10.1016/j.celrep.2015.11.038; Zhang XZ, 2017, MED SCI MONITOR, V23, P613, DOI 10.12659/MSM.896298; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123; Zhang ZY, 2018, HYPERTENSION, V72, P1012, DOI 10.1161/HYPERTENSIONAHA.118.10919; Zheng Y, 2016, INT J EPIDEMIOL, V45, P1482, DOI 10.1093/ije/dyw143; Zhou MY, 2012, J BIOL CHEM, V287, P23397, DOI 10.1074/jbc.M112.351031; Zimmerman HA, 2013, MOL GENET METAB, V109, P345, DOI 10.1016/j.ymgme.2013.05.010	214	39	42	6	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					8711	8731		10.1096/fj.201802842RR	http://dx.doi.org/10.1096/fj.201802842RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31084571				2022-12-28	WOS:000478832900003
J	Boitet, ER; Reish, NJ; Hubbard, MG; Gross, AK				Boitet, Evan R.; Reish, Nicholas J.; Hubbard, Meredith G.; Gross, Alecia K.			NudC regulates photoreceptor disk morphogenesis and rhodopsin localization	FASEB JOURNAL			English	Article						photoreceptor disk formation; protein trafficking; rab11a; rod photoreceptors	ROD OUTER SEGMENT; NUCLEAR MIGRATION GENE; PIGMENT-EPITHELIUM; XENOPUS-LAEVIS; CHAPERONE ACTIVITY; MOLECULAR-CLONING; PROTEIN; IDENTIFICATION; TRANSPORT; MOVEMENT	The outer segment (OS) of rod photoreceptors consist of a highly modified primary cilium containing phototransduction machinery necessary for light detection. The delivery and organization of the phototransduction components within and along the cilium into the series of stacked, highly organized disks is critical for cell function and viability. How disks are formed within the cilium remains an area of active investigation. We have found nuclear distribution protein C (nudC), a key component of mitosis and cytokinesis during development, to be present in the inner segment region of these postmitotic cells in several species, including mouse, tree shrew, monkey, and frog. Further, we found nudC interacts with rhodopsin and the small GTPase rab11a. Here, we show through transgenic tadpole studies that nudC is integral to rod cell disk formation and photoreceptor protein localization. Finally, we demonstrate that short hairpin RNA knockdown of nudC in tadpole rod photoreceptors, which leads to the inability of rod cells to maintain their OS, is rescued through coexpression of murine nudC.-Boitet, E. R., Reish, N. J., Hubbard, M. G., Gross, A. K. NudC regulates photoreceptor disk morphogenesis and rhodopsin localization.	[Boitet, Evan R.; Reish, Nicholas J.; Gross, Alecia K.] Univ Alabama Birmingham, Sch Med, Evelyn F McKnight Brain Inst, Birmingham, AL USA; [Boitet, Evan R.; Hubbard, Meredith G.; Gross, Alecia K.] Univ Alabama Birmingham, Sch Optometry, Dept Optometry & Vis Sci, Birmingham, AL 35294 USA; [Reish, Nicholas J.; Gross, Alecia K.] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Reish, Nicholas J.] Univ Iowa, Iowa City, IA USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Iowa	Gross, AK (corresponding author), Univ Alabama Birmingham, 1825 Univ Blvd,SHEL 906, Birmingham, AL 35294 USA.	agross@uab.edu	Gross, Alecia K./AAJ-1792-2021; Reish, Nicholas/ACC-7587-2022	Gross, Alecia K./0000-0003-1857-6633; Reish, Nicholas/0000-0001-5677-3895	U.S. National Institutes of Health (NIH), National Eye Institute Grants [R01EY019311, P30EY003039]; E. Matilda Ziegler Foundation for the Blind; NATIONAL EYE INSTITUTE [P30EY003039] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Eye Institute Grants; E. Matilda Ziegler Foundation for the Blind; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Melissa F. Chimento and the University of Alabama at Birmingham (UAB) High Resolution Imaging Facility for their help with transmission electron microscopy sample preparations and image acquisition, Russell Veale and UAB Tree Shrew Core for their kind gift of T. belangeri retinal sections and Paul Gamlin (UAB) for the gift of retinal cryosections from M. mulatta, David Redden and the UAB Center for Clinical and Translational Science for statistical support, TJ Hollingsworth (University of Tenessee Health Science Center, Memphis, TN, USA) for artistic assistance, Xiaogang Cheng (UAB) for technical assistance, and Elizabeth Sztul and Skyler Boehm (both of UAB) for helpful discussions. This work was supported by the U.S. National Institutes of Health (NIH), National Eye Institute Grants R01EY019311 (to A.K.G) and P30EY003039 (to the UAB Vision Science Research Center), and a grant from the E. Matilda Ziegler Foundation for the Blind (to A.K.G.). The authors declare no conflicts of interest.	Aumais JP, 2003, J CELL SCI, V116, P1991, DOI 10.1242/jcs.00412; Batni S, 1996, J BIOL CHEM, V271, P3179, DOI 10.1074/jbc.271.6.3179; Bogea TH, 2015, INVEST OPHTH VIS SCI, V56, P7947, DOI 10.1167/iovs.15-16799; BOK D, 1971, J CELL BIOL, V49, P664, DOI 10.1083/jcb.49.3.664; Cappello S, 2011, DEV BIOL, V357, P326, DOI 10.1016/j.ydbio.2011.07.001; CHAITIN MH, 1989, INVEST OPHTH VIS SCI, V30, P2461; Chang Kenneth, 2013, Cold Spring Harb Protoc, V2013, P631, DOI 10.1101/pdb.prot075853; Chiu YH, 1997, MOL BIOL CELL, V8, P1735, DOI 10.1091/mbc.8.9.1735; De Rienzo G, 2012, ZEBRAFISH, V9, P97, DOI 10.1089/zeb.2012.0770; DERETIC D, 1995, J CELL SCI, V108, P215; Ding JD, 2015, J CELL BIOL, V211, P495, DOI 10.1083/jcb.201508093; Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2; Fu QQ, 2016, SCI CHINA LIFE SCI, V59, P455, DOI 10.1007/s11427-016-5029-2; Gocke CD, 2000, HISTOCHEM CELL BIOL, V114, P293; Hale IL, 1996, J COMP NEUROL, V376, P128, DOI 10.1002/(SICI)1096-9861(19961202)376:1<128::AID-CNE8>3.0.CO;2-5; HALL MO, 1969, J MOL BIOL, V45, P397, DOI 10.1016/0022-2836(69)90114-4; Hollingsworth TJ, 2012, INT REV CEL MOL BIO, V293, P1, DOI 10.1016/B978-0-12-394304-0.00006-3; Ishibashi S., 2017, BASIC SCI METHODS CL, P264; KINNEY MS, 1978, PROC R SOC SER B-BIO, V201, P149, DOI 10.1098/rspb.1978.0037; LATIES AM, 1976, EXP EYE RES, V23, P139, DOI 10.1016/0014-4835(76)90197-4; Li M, 2006, CELL RES, V16, P99, DOI 10.1038/sj.cr.7310013; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Matsumoto N, 1999, HUM GENET, V104, P498, DOI 10.1007/s004390050994; Moritz OL, 1999, INVEST OPHTH VIS SCI, V40, P3276; OSMANI AH, 1990, J CELL BIOL, V111, P543, DOI 10.1083/jcb.111.2.543; PAPERMASTER DS, 1985, INVEST OPHTH VIS SCI, V26, P1386; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; Reish NJ, 2014, J NEUROSCI, V34, P14854, DOI 10.1523/JNEUROSCI.1943-14.2014; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Sparrow D B, 2000, Nucleic Acids Res, V28, pE12, DOI 10.1093/nar/28.4.e12; Tam BM, 2006, J NEUROSCI, V26, P203, DOI 10.1523/JNEUROSCI.3849-05.2006; Tam BM, 2000, J CELL BIOL, V151, P1369, DOI 10.1083/jcb.151.7.1369; WILLIAMS DS, 1988, J COMP NEUROL, V272, P161, DOI 10.1002/cne.902720202; XIANG X, 1995, P NATL ACAD SCI USA, V92, P9890, DOI 10.1073/pnas.92.21.9890; Xiong WH, 2002, J GEN PHYSIOL, V120, P817, DOI 10.1085/jgp.20028702; Ying GX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161236; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; Zhang C, 2016, CELL RES, V26, P239, DOI 10.1038/cr.2015.152; Zhao L, 2016, GENOME RES, V26, P660, DOI 10.1101/gr.198911.115; Zheng MY, 2011, J MOL BIOL, V409, P722, DOI 10.1016/j.jmb.2011.04.018; Zhou T, 2003, DEV CELL, V5, P127, DOI 10.1016/S1534-5807(03)00186-2; Zhu XJ, 2010, J BIOL CHEM, V285, P29903, DOI 10.1074/jbc.M110.105494	43	4	4	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					8799	8808		10.1096/fj.201801740RR	http://dx.doi.org/10.1096/fj.201801740RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31022349	Green Published			2022-12-28	WOS:000478832900009
J	Li, YX; Wang, WZ; Chao, YL; Zhang, FX; Wang, C				Li, Yongxia; Wang, Wenzhe; Chao, Yuelin; Zhang, Fengxao; Wang, Cheng			CTRP13 attenuates vascular calcification by regulating Runx2	FASEB JOURNAL			English	Article						phenotypic switch; mRNA decay; vascular smooth muscle cells; chronic renal failure	MAMMALIAN TARGET; IN-VIVO; ADIPOKINES; DIFFERENTIATION; TRISTETRAPROLIN; INHIBITION; CONVERSION; PROTEINS; FAMILY; CELLS	Vascular calcification is strongly associated with increased cardiovascular mortality and morbidity. C1q/TNF-related protein-13 (CTRP13) is a secreted adipokine that plays important roles in the cardiovascular system. However, the functional role of CTRP13 in the development of vascular calcification has yet to be explored. In this study, we collected blood samples from patients with chronic renal failure (CRF) and from rats with adenine-induced CRF. We found that the serum CTRP13 levels were decreased in patients and rats with CRF and were negatively associated with calcium deposition in the abdominal aorta. Compared to those of the controls, ectopic CTRP13 treatment significantly attenuated the calcium accumulation and alkaline phosphatase activity in the abdominal aorta of CRF rats, and beta-glycerophosphate induced the formation of arterial rings and of vascular smooth muscle cells (VSMCs) and decreased the number of VSMCs that transitioned from a contractile to an osteogenic phenotype. The overexpression of Runx2 blocked CTRP13-reduced VSMC calcification. Mechanistically, CTRP13 repressed the phosphorylation of tristetraprolin (TTP), thereby activating TTP and increasing the TTP binding to the 3 ' untranslated region of the Runx2 mRNA, accelerating the Runx2 mRNA destabilization and degradation. In summary, these findings reveal that CTRP13 regulation is a novel method for the prevention of vascular calcification, representing a novel mechanism of the regulation of Runx2 expression in VSMCs.-Li, Y., Wang, W., Chao, Y., Zhang, F., Wang, C. CTRP13 attenuates vascular calcification by regulating Runx2.	[Li, Yongxia; Wang, Wenzhe; Zhang, Fengxao] Cent Hosp Wuhan, Dept Nephrol, Wuhan, Hubei, Peoples R China; [Wang, Cheng] Huazhong Univ Sci & Technol, Dept Rheumatol, Union Hosp, Tongji Med Coll, 1277 Jiefang Ave, Wuhan 430000, Hubei, Peoples R China; [Chao, Yuelin] Nanjing Med Univ, Nanjing Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China	Huazhong University of Science & Technology; Nanjing Medical University	Wang, C (corresponding author), Huazhong Univ Sci & Technol, Dept Rheumatol, Union Hosp, Tongji Med Coll, 1277 Jiefang Ave, Wuhan 430000, Hubei, Peoples R China.	cwangunion@hust.edu.cn						Catalanotto C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101712; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; Ding M, 2011, ARTERIOSCL THROM VAS, V31, P1403, DOI 10.1161/ATVBAHA.110.216804; Durham AL, 2018, CARDIOVASC RES, V114, P590, DOI 10.1093/cvr/cvy010; Frasca D, 2007, J IMMUNOL, V179, P918, DOI 10.4049/jimmunol.179.2.918; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Jono S, 2006, J BONE MINER METAB, V24, P176, DOI 10.1007/s00774-005-0668-6; Knights AJ, 2014, ADIPOCYTE, V3, P88, DOI 10.4161/adip.27552; Leopold JA, 2015, TRENDS CARDIOVAS MED, V25, P267, DOI 10.1016/j.tcm.2014.10.021; Lu KC, 2014, SCI WORLD J, DOI 10.1155/2014/637065; Lu Y, 2015, INT J CLIN EXP PATHO, V8, P2545; Mancuso P, 2016, IMMUNOTARGETS THER, V5, P47, DOI 10.2147/ITT.S73223; Matoulkova E, 2012, RNA BIOL, V9, P563, DOI 10.4161/rna.20231; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Mizobuchi M, 2009, J AM SOC NEPHROL, V20, P1453, DOI 10.1681/ASN.2008070692; Nakamura K, 2014, J CARDIOL, V63, P250, DOI 10.1016/j.jjcc.2013.11.006; Palit S, 2014, CURR PHARM DESIGN, V20, P5829, DOI 10.2174/1381612820666140212194926; Paloian NJ, 2014, AM J PHYSIOL-RENAL, V307, pF891, DOI 10.1152/ajprenal.00163.2014; Schaffler A, 2012, TRENDS ENDOCRIN MET, V23, P194, DOI 10.1016/j.tem.2011.12.003; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Tanaka T, 2008, MOL CELL BIOL, V28, P1147, DOI 10.1128/MCB.01771-07; Wang C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09174-1; Wang C, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1108-6; Wang C, 2019, FASEB J, V33, P2290, DOI 10.1096/fj.201801267RR; Wang C, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0875-4; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Zeadin M, 2009, ARTERIOSCL THROM VAS, V29, P2069, DOI 10.1161/ATVBAHA.109.195255; Zhang J, 2014, BIOSCIENCE REP, V34, P663, DOI 10.1042/BSR20140103; Zhao GX, 2012, KIDNEY INT, V82, P34, DOI 10.1038/ki.2012.40; Zhao Y, 2015, KIDNEY INT, V88, P711, DOI 10.1038/ki.2015.160; Zheng QJ, 2011, ARTERIOSCL THROM VAS, V31, P2616, DOI 10.1161/ATVBAHA.111.231050; Zhou Y, 2014, ARTERIOSCL THROM VAS, V34, P1002, DOI 10.1161/ATVBAHA.114.303301	33	7	8	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9627	9637		10.1096/fj.201900293RRR	http://dx.doi.org/10.1096/fj.201900293RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31145871	Bronze			2022-12-28	WOS:000478832900072
J	Liu, ZQ; Shan, HH; Chen, SY; Chen, M; Zhang, QJ; Lai, LX; Li, ZJ				Liu, Zhiquan; Shan, Huanhuan; Chen, Siyu; Chen, Mao; Zhang, Quanjun; Lai, Liangxue; Li, Zhanjun			Improved base editor for efficient editing in GC contexts in rabbits with an optimized AID-Cas9 fusion	FASEB JOURNAL			English	Article						CRISPR; Cas9; Tyr rabbit; NG PAMs; base editing	OCULOCUTANEOUS ALBINISM; TYROSINASE GENE; STRUCTURAL BASIS; DNA; MUTATIONS	Cytidine base editors, which are composed of a cytidine deaminase fused to clustered regularly interspaced short palindromic repeat (CRISPR)-associated protein 9 (Cas9) nickase, enable the efficient conversion of the CG base pair to TA in various organisms. However, the currently used rat apolipoprotein B mRNA-editing enzyme, catalytic polypeptide 1(rA1)-based BE3 is often inefficient in target Cs that are immediately downstream of a G (GC context). Here, we observed that, with an 11-nt editing window, an optimized activation-induced cytidine deaminase (AID)-Cas9 fusion can efficiently convert C to T in a variety of sequence contexts in rabbits. Strikingly, the enhanced AID-Cas9 fusion (eAID-BE4max) has significant effectiveness of inducing Tyr p.R299H mutation in GC contexts (from 16.67 to 83.33%) in comparison with BE3 in founder rabbits. Furthermore, the engineered AID-Cas9 variants were produced with reduced bystander activity [eAID (N51G)-BE4max] and increased genome-targeting scope (eAID-NG-BE4max). Overall, this work provides a series of improved tools that were generated using optimized AID-Cas9 fusions and associated engineered variants that can be used for efficient and versatile C-to-T base editing, especially in GC contexts.-Liu, Z., Shan, H., Chen, S., Chen, M., Zhang, Q., Lai, L., Li, Z. Improved base editor for efficient editing in GC contexts in rabbits with an optimized AID-Cas9 fusion.	[Liu, Zhiquan; Shan, Huanhuan; Chen, Siyu; Chen, Mao; Lai, Liangxue; Li, Zhanjun] Jilin Univ, Coll Anim Sci, Key Lab Zoonosis Res, Minist Educ, Changchun, Jilin, Peoples R China; [Zhang, Quanjun; Lai, Liangxue] GRMH GDL, Guangzhou, Guangdong, Peoples R China	Jilin University; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory)	Li, ZJ (corresponding author), Jilin Univ, Coll Anim Sci, Key Lab Zoonosis Res, Minist Educ, Changchun, Jilin, Peoples R China.; Lai, LX (corresponding author), GRMH GDL, Guangzhou, Guangdong, Peoples R China.	lai_liangxue@gibh.ac.cn; lizj_1998@jlu.edu.cn		Liu, Zhiquan/0000-0001-5433-5656; li, zhanjun/0000-0001-6914-8589	National Key Research and Development Program of China Stem Cell and Translational Research [2017YFA0105101]; Program for Changjiang Scholars and Innovative Research Team in University [IRT_16R32]; Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2018GZR110104004]	National Key Research and Development Program of China Stem Cell and Translational Research; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory	The authors thank Peiran Hu and Nannan Li for assistance at the Embryo Engineering Center (College of Animal Sciences, Jilin University) for the critical technical assistance. This study was financially supported by the National Key Research and Development Program of China Stem Cell and Translational Research (2017YFA0105101), The Program for Changjiang Scholars and Innovative Research Team in University (IRT_16R32), and the Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory (2018GZR110104004). The authors declare no conflicts of interest.	Adikusuma F, 2018, NATURE, V560, pE8, DOI 10.1038/s41586-018-0380-z; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Chatterjee P, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau0766; Cullot G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09006-2; Endo M, 2019, NAT PLANTS, V5, P14, DOI 10.1038/s41477-018-0321-8; Gehrke JM, 2018, NAT BIOTECHNOL, V36, P977, DOI 10.1038/nbt.4199; GERSHONIBARUCH R, 1994, AM J HUM GENET, V54, P586; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Hu JH, 2018, NATURE, V556, P57, DOI 10.1038/nature26155; Jiang W, 2018, CELL RES, V28, P855, DOI 10.1038/s41422-018-0052-4; Jin S, 2019, SCIENCE, V364, P292, DOI 10.1126/science.aaw7166; Kim YB, 2017, NAT BIOTECHNOL, V35, P371, DOI 10.1038/nbt.3803; Knott GJ, 2018, SCIENCE, V361, P866, DOI 10.1126/science.aat5011; Koblan LW, 2018, NAT BIOTECHNOL, V36, P843, DOI 10.1038/nbt.4172; Komor AC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao4774; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kouno T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15024; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; Li XL, 2018, J METAMORPH GEOL, V36, P1, DOI 10.1111/jmg.12280; Liang PP, 2017, PROTEIN CELL, V8, P601, DOI 10.1007/s13238-017-0418-2; Liu ZQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05232-2; Ma YQ, 2016, NAT METHODS, V13, P1029, DOI [10.1038/NMETH.4027, 10.1038/nmeth.4027]; Nishimasu H, 2018, SCIENCE, V361, P1259, DOI 10.1126/science.aas9129; Oetting WS, 2000, PIGM CELL RES, V13, P320, DOI 10.1034/j.1600-0749.2000.130503.x; Oetting WS, 1999, HUM MUTAT, V13, P99, DOI 10.1002/(SICI)1098-1004(1999)13:2<99::AID-HUMU2>3.3.CO;2-3; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Pham P, 2016, DNA REPAIR, V43, P48, DOI 10.1016/j.dnarep.2016.05.029; Pollex RL, 2004, CLIN GENET, V66, P375, DOI 10.1111/j.1399-0004.2004.00315.x; Qiao Q, 2017, MOL CELL, V67, P361, DOI 10.1016/j.molcel.2017.06.034; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Rees HA, 2018, NAT REV GENET, V19, P770, DOI 10.1038/s41576-018-0059-1; Ren B, 2018, MOL PLANT, V11, P623, DOI 10.1016/j.molp.2018.01.005; Saraconi G, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0417-z; Song YN, 2016, CELL MOL LIFE SCI, V73, P2959, DOI 10.1007/s00018-016-2143-z; TRIPATHI RK, 1992, AM J MED GENET, V43, P865, DOI 10.1002/ajmg.1320430523; Wang M, 2009, NAT STRUCT MOL BIOL, V16, P769, DOI 10.1038/nsmb.1623; Wang X, 2018, NAT BIOTECHNOL, V36, P946, DOI 10.1038/nbt.4198; Wei AH, 2010, J INVEST DERMATOL, V130, P716, DOI 10.1038/jid.2009.339; Zafra MP, 2018, NAT BIOTECHNOL, V36, P888, DOI 10.1038/nbt.4194; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zong Y, 2018, NAT BIOTECHNOL, V36, P950, DOI 10.1038/nbt.4261; Zuo EW, 2019, SCIENCE, V364, P289, DOI 10.1126/science.aav9973	42	19	21	3	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9210	9219		10.1096/fj.201900476RR	http://dx.doi.org/10.1096/fj.201900476RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31071267				2022-12-28	WOS:000478832900041
J	El Mammeri, N; Hierrezuelo, J; Tolchard, J; Camara-Almiron, J; Caro-Astorga, J; Alvarez-Mena, A; Dutour, A; Berbon, M; Shenoy, J; Morvan, E; Grelard, A; Kauffmann, B; Lecomte, S; de Vicente, A; Habenstein, B; Romero, D; Loquet, A				El Mammeri, Nadia; Hierrezuelo, Jesus; Tolchard, James; Camara-Almiron, Jesus; Caro-Astorga, Joaquin; Alvarez-Mena, Ana; Dutour, Antoine; Berbon, Melanie; Shenoy, Jayakrishna; Morvan, Estelle; Grelard, Axelle; Kauffmann, Brice; Lecomte, Sophie; de Vicente, Antonio; Habenstein, Birgit; Romero, Diego; Loquet, Antoine			Molecular architecture of bacterial amyloids in Bacillus biofilms	FASEB JOURNAL			English	Article						functional amyloids; extracellular matrix; solid-state NMR	SECONDARY STRUCTURE; FIBRIL FORMATION; CHEMICAL-SHIFTS; ALPHA-SYNUCLEIN; PROTEIN; POLYMORPHISM; AGGREGATION; INSIGHTS; FIBERS; ANGLE	The formation of biofilms provides structural and adaptive bacterial response to the environment. In Bacillus species, the biofilm extracellular matrix is composed of exopolysaccharides, hydrophobins, and several functional amyloid proteins. We report, using multiscale approaches such as solid-state NMR (SSNMR), electron microscopy, X-ray diffraction, dynamic light scattering, attenuated total reflection Fourier transform infrared (FTIR), and immune-gold labeling, the molecular architecture of B. subtilis and pathogenic B. cereus functional amyloids. SSNMR data reveal that the major amyloid component TasA in its fibrillar amyloid form contain beta-sheet and a-helical secondary structure, suggesting a nontypical amyloid architecture in B. subtilis. Proteinase K digestion experiments indicate the amyloid moiety is similar to 100 as long, and subsequent SSNMR and FTIR signatures for B. subtilis and B. cereus TasA filaments highlight a conserved amyloid fold, albeit with substantial differences in structural polymorphism and secondary structure composition. Structural analysis and coassembly data on the accessory protein TapA in B. subtilis and its counterpart camelysin in B. cereus reveal a catalyzing effect between the functional amyloid proteins and a common structural architecture, suggesting a coassembly in the context of biofilm formation. Our findings highlight nontypical amyloid behavior of these bacterial functional amyloids, underlining structural variations between biofilms even in closely related bacterial species.	[El Mammeri, Nadia; Tolchard, James; Dutour, Antoine; Berbon, Melanie; Shenoy, Jayakrishna; Grelard, Axelle; Lecomte, Sophie; Habenstein, Birgit; Loquet, Antoine] Univ Bordeaux, Inst Chim & Biol Membranes & Nanoobjets CBMN, UMR 5248, Pessac, France; [Morvan, Estelle; Kauffmann, Brice] Univ Bordeaux, Ctr Natl Rech CNRS, IECB, UMS 3033,US 001, Pessac, France; [Hierrezuelo, Jesus; Camara-Almiron, Jesus; Caro-Astorga, Joaquin; Alvarez-Mena, Ana; de Vicente, Antonio; Romero, Diego] Univ Malaga, Dept Microbiol, Malaga, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Universidad de Malaga	Romero, D (corresponding author), Univ Malaga, Dept Microbiol, Malaga, Spain.; Loquet, A (corresponding author), Univ Bordeaux, CNRS, CBMN, IECB, F-33607 Pessac, France.	diego_romero@uma.es; a.loquet@iecb.u-bordeaux.fr	Almirón, Jesús Cámara/AAM-6664-2021; de Vicente, Antonio/G-4405-2011; Romero, Diego/D-3849-2013; León, Jesús Hierrezuelo/F-7156-2016; Kauffmann, Brice/L-6029-2015; Loquet, Antoine/A-1465-2010; Habenstein, Birgit/E-4425-2013	Almirón, Jesús Cámara/0000-0002-6107-4260; de Vicente, Antonio/0000-0003-2716-9861; Romero, Diego/0000-0002-2052-6515; León, Jesús Hierrezuelo/0000-0002-0056-0927; Kauffmann, Brice/0000-0002-2932-3255; Alvarez, Ana/0000-0002-5357-8944; El Mammeri, Nadia/0000-0002-9979-3359; GRELARD, Axelle/0000-0002-6708-2253; Morvan, Estelle/0000-0003-4071-7885; Tolchard, James/0000-0002-5779-4935; Loquet, Antoine/0000-0001-7176-7813; , Jayakrishna Shenoy/0000-0002-0360-645X; Habenstein, Birgit/0000-0003-3723-9552; Caro-Astorga, Joaquin/0000-0003-4650-6376	European Research Council [ERC-2014-StG BacBio GA 637971]; European Research Council (European Resuscitation Council (ERC)-2015-StG Weakinteract) [GA 639020]; Agence Nationale de la Recherche [ANR-14-CE09-0020-01]; Contrat de Plan Etat-Region (CPER) CAMPUSB; Ministerio de Economia y Competitividad Spanish Government [AGL2016-78662-R]; CNRS [IR-RMN FR3050]; Ministerio de Economia y Competitividad (Madrid, Spain) [BES-2013-064134, BES-2017-081275]	European Research Council(European Research Council (ERC)European Commission); European Research Council (European Resuscitation Council (ERC)-2015-StG Weakinteract)(European Research Council (ERC)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Contrat de Plan Etat-Region (CPER) CAMPUSB; Ministerio de Economia y Competitividad Spanish Government(Spanish Government); CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministerio de Economia y Competitividad (Madrid, Spain)(Spanish Government)	The authors thank Juan Felix (Bionand, Malaga, Spain) and Adolfo Mart ' inez [The Society for Cardiovascular Angiography and Interventions-International Management Assistants (SCAI-IMA)] for electron microscopy guidance, and Casimiro C ' ardenas (Universidad de Malaga) for mass spectrometry analysis. This work has benefited from the facilities and expertise of the Biophysical and Structural Chemistry Platform at Institut Europeen de Chimie et Biologie (IECB), Centre National de la Recherche (CNRS) Unite Mixte de Service (UMS) 3033, INSERM US001. This research was supported by the European Research Council (ERC-2014-StG BacBio GA 637971 to D.R. and the European Resuscitation Council (ERC)-2015-StG Weakinteract GA 639020 to A.L.), the Agence Nationale de la Recherche (ANR-14-CE09-0020-01 to A.L.), the Contrat de Plan Etat-Region (CPER) CAMPUSB, the Ministerio de Economia y Competitividad Spanish Government Grant (AGL2016-78662-R to D.R.), and the CNRS (IR-RMN FR3050). J.C.-A. and A.A.-M. were recipients of fixed-price incentive contracts (BES-2013-064134 and BES-2017-081275) from the Ministerio de Economia y Competitividad (Madrid, Spain). The authors declare no conflicts of interest.	Abbasi R, 2019, CHEMBIOCHEM, V20, P355, DOI 10.1002/cbic.201800634; Ahimou F, 2000, ENZYME MICROB TECH, V27, P749, DOI 10.1016/S0141-0229(00)00295-7; Bauer T, 2017, J BIOMOL NMR, V67, P51, DOI 10.1007/s10858-016-0083-4; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Candela T, 2019, MOL MICROBIOL, V111, P1416, DOI 10.1111/mmi.14184; Caro-Astorga J, 2015, FRONT MICROBIOL, V5; Chai L, 2013, J BIOL CHEM, V288, P17559, DOI 10.1074/jbc.M113.453605; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Daebel V, 2012, J AM CHEM SOC, V134, P13982, DOI 10.1021/ja305470p; Deshmukh M, 2018, J MOL BIOL, V430, P3631, DOI 10.1016/j.jmb.2018.07.007; Diehl A, 2018, P NATL ACAD SCI USA, V115, P3237, DOI 10.1073/pnas.1718102115; Dragos A, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7030060; Dragos A, 2017, TRENDS MICROBIOL, V25, P257, DOI 10.1016/j.tim.2016.12.010; Eisenberg DS, 2017, ANNU REV BIOCHEM, V86, P69, DOI 10.1146/annurev-biochem-061516-045104; Erskine E, 2018, MOL MICROBIOL, V110, P897, DOI 10.1111/mmi.13985; Fandrich M, 2007, CELL MOL LIFE SCI, V64, P2066, DOI 10.1007/s00018-007-7110-2; Friedland RP, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006654; Goormaghtigh E, 1994, Subcell Biochem, V23, P405; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Hyberts SG, 2012, TOP CURR CHEM, V316, P125, DOI 10.1007/128_2011_187; Linden AH, 2011, J BIOMOL NMR, V51, P283, DOI 10.1007/s10858-011-9535-z; Linser R, 2017, SOLID STATE NUCL MAG, V87, P45, DOI 10.1016/j.ssnmr.2017.08.003; Loquet A, 2018, J MOL BIOL, V430, P3629, DOI 10.1016/j.jmb.2018.07.024; Loquet A, 2018, METHODS, V138, P26, DOI 10.1016/j.ymeth.2018.03.014; Loquet A, 2009, J MOL BIOL, V394, P108, DOI 10.1016/j.jmb.2009.09.016; Luca S, 2001, J BIOMOL NMR, V20, P325, DOI 10.1023/A:1011278317489; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Meier BH, 2017, TRENDS BIOCHEM SCI, V42, P777, DOI 10.1016/j.tibs.2017.08.001; Otzen D, 2010, PRION, V4, P256, DOI 10.4161/pri.4.4.13676; Pham CLL, 2014, ESSAYS BIOCHEM, V56, P207, DOI [10.1042/bse0560207, 10.1042/BSE0560207]; Ramirez-Alvarado M, 2000, P NATL ACAD SCI USA, V97, P8979, DOI 10.1073/pnas.150091797; Riek R, 2016, NATURE, V539, P227, DOI 10.1038/nature20416; Romero D, 2014, INT MICROBIOL, V17, P65, DOI 10.2436/20.1501.01.208; Romero D, 2014, J BACTERIOL, V196, P1505, DOI 10.1128/JB.01363-13; Romero D, 2011, MOL MICROBIOL, V80, P1155, DOI 10.1111/j.1365-2958.2011.07653.x; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Rouse SL, 2018, J MOL BIOL, V430, P3685, DOI 10.1016/j.jmb.2018.05.004; Shen Y, 2007, J BIOMOL NMR, V38, P289, DOI 10.1007/s10858-007-9166-6; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Stefani M, 2010, CURR PROTEIN PEPT SC, V11, P343, DOI 10.2174/138920310791330631; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Taylor JD, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00033; Tycko R, 2013, ACCOUNTS CHEM RES, V46, P1487, DOI 10.1021/ar300282r; van der Wel PCA, 2017, SOLID STATE NUCL MAG, V88, P1, DOI 10.1016/j.ssnmr.2017.10.001; Van Gerven N, 2015, TRENDS MICROBIOL, V23, P693, DOI 10.1016/j.tim.2015.07.010; Van Gervent N, 2018, J MOL BIOL, V430, P3657, DOI 10.1016/j.jmb.2018.07.010; Vetri V, 2015, FEBS LETT, V589, P2448, DOI 10.1016/j.febslet.2015.07.006; Wang YJ, 2002, PROTEIN SCI, V11, P852, DOI 10.1110/ps.3180102; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Yao J, 1997, FEBS LETT, V419, P285, DOI 10.1016/S0014-5793(97)01474-9; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zhou YZ, 2012, METHODS MOL BIOL, V849, P303, DOI 10.1007/978-1-61779-551-0_21	57	27	27	4	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12146	12163		10.1096/fj.201900831R	http://dx.doi.org/10.1096/fj.201900831R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31370706				2022-12-28	WOS:000507461600043
J	Lu, R; Zhang, YG; Xia, YL; Sun, J				Lu, Rong; Zhang, Yong-Guo; Xia, Yinglin; Sun, Jun			Imbalance of autophagy and apoptosis in intestinal epithelium lacking the vitamin D receptor	FASEB JOURNAL			English	Article						Beclin-1; colonoids; enteroids; inflammation; VDR	ACTIVATION; CROSSTALK; CELLS; INFLAMMATION; BARRIER; INJURY; ANALOG; GENE; AVRA	Apoptosis and autophagy are dynamic processes that determine the fate of cells. Vitamin D receptor (VDR) deficiency in the intestine leads to abnormal Paneth cells and impaired autophagy function. Here, we will elucidate the mechanisms of the intestinal epithelial VDR regulation of autophagy and apoptosis. We used in vivo VDRlox and VDR Delta IEC mice and ex vivo organoids generated from small intestine and colon tissues. We found that VDR deficiency induced more apoptotic cells and significantly increased cell death in the small intestine and colon of VDR Delta IEC mice. The proapoptotic protein B-cell lymphoma 2 (BCL-2) associated X protein (Bax) was enhanced, whereas autophagy related 16 like 1 (ATG16L1) and Beclin-1 were decreased in the intestines of VDR(Delta IEC)mice. Apoptosis induced by Bax reduced autophagy by decreasing Beclin-1. Physical interactions between Beclin-1 and Bcl-2 were increased in the VDR-deficient epithelia from mice. The growth of VDR Delta IEC organoids was significantly slower with fewer Paneth cells than that of VDR+/+ organoids. The expression levels of Beclin-1 and lysozyme were decreased in VDR Delta IEC organoids. Bacterial endotoxin levels were high in the serum from VDR Delta IEC mice and made mice susceptible to colitis. In the organoids and colitis IL-10(-/-) mice, vitamin D-3 treatment increased VDR and ATG16L1 protein expression levels, which activated autophagic responses. In summary, intestinal epithelial VDR regulates autophagy and apoptosis through ATG16L1 and Beclin-1. Our studies provide fundamental insights into the tissue-specific function of VDR in modulating the balance between autophagy and apoptosis.	[Lu, Rong; Zhang, Yong-Guo; Xia, Yinglin; Sun, Jun] Univ Illinois, Dept Med, Chicago, IL USA; [Sun, Jun] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA; [Sun, Jun] Univ Illinois, Canc Ctr, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Sun, J (corresponding author), Univ Illinois, Dept Med, Div Gastroenterol & Hepatol, 840 S Wood St,Room 704 CSB,MC716, Chicago, IL 60612 USA.	junsun7@uic.edu			U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK105118, R01DK114126]; U.S. Department of Defense [BC160450P1, W81XWH-17-1-0039]; University of Illinois Cancer Center; American Gastroenterological Association (AGA) Young Investigator Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK114126, R01DK105118] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. Department of Defense(United States Department of Defense); University of Illinois Cancer Center; American Gastroenterological Association (AGA) Young Investigator Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grants R01 DK105118 and R01DK114126; U.S. Department of Defense Grant BC160450P1, Funding Opportunity W81XWH-17-1-0039; and the University of Illinois Cancer Center (to J.S.). R.L. is a recipient of the American Gastroenterological Association (AGA) Young Investigator Award, and orally presented some of these data at the Digestive Disease Week 2017. The authors declare no conflicts of interest.	Angel B, 2018, NUTR DIABETES, V8, DOI 10.1038/s41387-018-0038-9; Bakke Danika, 2018, Nucl Receptor Res, V5, DOI 10.11131/2018/101377; Bakke D, 2018, INFLAMM BOWEL DIS, V24, P1149, DOI 10.1093/ibd/izy092; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846; DeMasters G, 2006, MOL CANCER THER, V5, P2786, DOI 10.1158/1535-7163.MCT-06-0316; Duan YL, 2007, LAB INVEST, V87, P613, DOI 10.1038/labinvest.3700545; Eun CS, 2014, INFECT IMMUN, V82, P2239, DOI 10.1128/IAI.01513-13; Farhadi A, 2003, J GASTROEN HEPATOL, V18, P479, DOI 10.1046/j.1440-1746.2003.03032.x; Glenn DJ, 2016, J STEROID BIOCHEM, V164, P292, DOI 10.1016/j.jsbmb.2015.09.034; Hoyer-Hansen M, 2005, CELL DEATH DIFFER, V12, P1297, DOI 10.1038/sj.cdd.4401651; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Laukoetter MG, 2007, J EXP MED, V204, P3067, DOI 10.1084/jem.20071416; Liao AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002369; Ling J, 2008, J BIOL CHEM, V283, P30585, DOI 10.1074/jbc.M803548200; Liu WC, 2013, J CLIN INVEST, V123, P3983, DOI 10.1172/JCI65842; Liu XY, 2010, FEBS LETT, V584, P911, DOI 10.1016/j.febslet.2010.01.024; Lu R, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.20; Lu R, 2017, ALCOHOL CLIN EXP RES, V41, P727, DOI 10.1111/acer.13351; Lu R, 2012, AM J PHYSIOL-GASTR L, V303, pG1113, DOI 10.1152/ajpgi.00453.2011; Luderer HF, 2013, ENDOCRINOLOGY, V154, P16, DOI 10.1210/en.2012-1579; Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121; Maiuri MC, 2010, EMBO J, V29, P515, DOI 10.1038/emboj.2009.377; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Murthy A, 2014, NATURE, V506, P456, DOI 10.1038/nature13044; Naydenov NG, 2012, CELL CYCLE, V11, P4613, DOI 10.4161/cc.22885; Parrish AB, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008672; Rajapaksa TE, 2010, J CONTROL RELEASE, V142, P196, DOI 10.1016/j.jconrel.2009.10.033; Rubinstein AD, 2012, J CELL SCI, V125, P5259, DOI 10.1242/jcs.115865; Salminen A, 2013, AGEING RES REV, V12, P520, DOI 10.1016/j.arr.2012.11.004; Shen L, 2006, AM J PHYSIOL-GASTR L, V290, pG577, DOI 10.1152/ajpgi.00439.2005; Sumagin R, 2016, MUCOSAL IMMUNOL, V9, P1151, DOI 10.1038/mi.2015.135; Sun J, 2010, CURR OPIN GASTROEN, V26, P591, DOI 10.1097/MOG.0b013e32833d4b9f; Sun J, 2017, CLIN TRANSL GASTROEN, V8, DOI 10.1038/ctg.2017.31; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Wu SP, 2015, GUT, V64, P1082, DOI 10.1136/gutjnl-2014-307436; Wu SP, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-22; Wu SP, 2010, AM J PATHOL, V177, P686, DOI 10.2353/ajpath.2010.090998; Wu SP, 2010, AM J PHYSIOL-GASTR L, V298, pG784, DOI 10.1152/ajpgi.00526.2009; Xiao YJ, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12271; Xu DC, 2015, AUTOPHAGY, V11, P617, DOI 10.1080/15548627.2015.1023982; Yao TB, 2015, ANTIOXID REDOX SIGN, V22, P633, DOI 10.1089/ars.2014.5887; Yu YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069620; Zhang Y. G., 2016, METHODS MOL BIOL; Zhang YG, 2019, INFLAMM BOWEL DIS, V25, P97, DOI 10.1093/ibd/izy292; Zhang YG, 2015, SCI REP-UK, V5, DOI 10.1038/srep10642; Zhang YG, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.23118; Zhang Y, 2014, PHYSIOL REP, V2, DOI [10.14814/phy2.12008, 10.14814/phy2.12147]; Zhang YC, 2021, ASIA PAC J MANAG, V38, P371, DOI 10.1007/s10490-018-9639-z; Zhu XR, 2015, J CLIN INVEST, V125, P1098, DOI 10.1172/JCI76344; Zhu YS, 2010, PROTEIN CELL, V1, P468, DOI 10.1007/s13238-010-0048-4	52	34	34	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11845	11856		10.1096/fj.201900727R	http://dx.doi.org/10.1096/fj.201900727R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31361973	Green Published, Bronze			2022-12-28	WOS:000507461600021
J	Sinden, DS; Holman, CD; Bare, CJ; Sun, XL; Gade, AR; Cohen, DE; Pitt, GS				Sinden, Daniel S.; Holman, Corey D.; Bare, Curtis J.; Sun, Xiaolu; Gade, Aravind R.; Cohen, David E.; Pitt, Geoffrey S.			Knockout of the X-linked Fgf13 in the hypothalamic paraventricular nucleus impairs sympathetic output to brown fat and causes obesity	FASEB JOURNAL			English	Article						brown adipose tissue; thermogenesis; fibroblast; growth factor homologous factor; FHF2	FACTOR HOMOLOGOUS FACTORS; DIET-INDUCED THERMOGENESIS; ADIPOSE-TISSUE; NA+ CHANNELS; MICE; NEURONS; SYSTEM; GENE; REACTIVATION; SUPERFAMILY	Fibroblast growth factor (FGF)13, a nonsecreted, X-linked, FGF homologous factor, is differentially expressed in adipocytes in response to diet, yet Fgf13's role in metabolism has not been explored. Heterozygous Fgf13 knockouts fed normal chow and housed at 22 degrees C showed hyperactivity accompanying reduced core temperature and obesity when housed at 30 degrees C. Those heterozygous knockouts showed defects in thermogenesis even at 30 degrees C and an inability to protect core temperature. Surprisingly, we detected trivial FGF13 in adipose of wild-type mice fed normal chow and no obesity in adipose-specific heterozygous knockouts housed at 30 degrees C, and we detected an intact brown fat response through exogenous beta 3 agonist stimulation, suggesting a defect in sympathetic drive to brown adipose tissue. In contrast, hypothalamic-specific ablation of Fgf13 recapitulated weight gain at 30 degrees C. Norepinephrine turnover in brown fat was reduced at both housing temperatures. Thus, our data suggest that impaired CNS regulation of sympathetic activation of brown fat underlies obesity and thermogenesis in Fgf13 heterozygous knockouts fed normal chow.-Sinden, D. S., Holman, C. D., Bare, C. J., Sun, X., Gade, A. R., Cohen, D. E., Pitt, G. S. Knockout of the X-linked Fgf13 in the hypothalamic paraventricular nucleus impairs sympathetic output to brown fat and causes obesity.	[Sinden, Daniel S.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [Sinden, Daniel S.; Sun, Xiaolu; Gade, Aravind R.; Pitt, Geoffrey S.] Weill Cornell Med Coll, Cardiovasc Res Inst, 413 E 69th St,Belfer Bldg 502, New York, NY 10021 USA; [Holman, Corey D.; Bare, Curtis J.; Cohen, David E.] Weill Cornell Med Coll, Div Gastroenterol & Hepatol, New York, NY 10021 USA	Duke University; Cornell University; Cornell University	Pitt, GS (corresponding author), Weill Cornell Med Coll, Cardiovasc Res Inst, 413 E 69th St,Belfer Bldg 502, New York, NY 10021 USA.	geoffrey.pitt@med.cornell.edu	Pitt, Geoffrey/L-4927-2019		U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [F30 HL131217, R01 HL112918, R01 HL071165, R01 HL122967]; U.S. National Institutes of Health, National Institute of General Medical Sciences [T32 GM007171]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK103046, R01 DK056626, R37 DK048873]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL131217, R01HL071165, R01HL112918, R01HL122967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK048873, R01DK103046, R01DK056626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Roberto Levi and Dr. Alice Marino (Weill Cornell Medical College, New York, NY, USA) for valuable assistance with norepinephrine turnover assay sample preparation and data acquisition; Dr. Conor Liston and Dr. Thu Huynh (Weill Cornell, Medical College, New York, NY, USA) for valuable technical assistance with intracranial injections; Dr. Jeffrey Friedman and Dr. Luca Parolari (The Rockefeller University, New York, NY, USA) for assistance with RNAscope in situ hybridization protocols and imaging; and Dr. James Lo (Weill Cornell, Medical College, New York, NY, USA) and Dr. Paul Cohen (Rockefeller University, NY, NY, USA) for insightful discussion and comments on the manuscript. This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants F30 HL131217 to D.S.S., R01 HL112918, R01 HL071165, and R01 HL122967 to G.S.P., U.S. National Institutes of Health, National Institute of General Medical Sciences Grant T32 GM007171 to D.S.S., and NIH National Institute of Diabetes and Digestive and Kidney Diseases Grants R01 DK103046, R01 DK056626, and R37 DK048873 to D.E.C. The authors declare no conflicts of interest.	An JJ, 2015, CELL METAB, V22, P175, DOI 10.1016/j.cmet.2015.05.008; Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Bartness TJ, 2007, PHYSIOL BEHAV, V91, P343, DOI 10.1016/j.physbeh.2007.04.002; Berry R, 2014, METHOD ENZYMOL, V537, P47, DOI 10.1016/B978-0-12-411619-1.00004-5; Branco T, 2016, CELL, V165, P1749, DOI 10.1016/j.cell.2016.05.019; Bublik DR, 2017, P NATL ACAD SCI USA, V114, pE496, DOI 10.1073/pnas.1614876114; Butler AA, 2001, NAT NEUROSCI, V4, P605, DOI 10.1038/88423; Carrette LLG, 2018, P NATL ACAD SCI USA, V115, pE668, DOI 10.1073/pnas.1715124115; Council NR., 2011, GUIDE CARE USE LAB A; Declercq J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135502; DELUCA B, 1989, PHYSIOL BEHAV, V46, P685, DOI 10.1016/0031-9384(89)90352-1; Desai A, 2018, J LIPID RES, V59, P368, DOI [10.1194/jlr.M081455, 10.1194/jlr.m081455]; DeStefano GM, 2013, P NATL ACAD SCI USA, V110, P7790, DOI 10.1073/pnas.1216412110; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Ferguson AV, 2008, EXPERT OPIN THER TAR, V12, P717, DOI [10.1517/14728222.12.6.717, 10.1517/14728222.12.6.717 ]; Fischer AW, 2018, MOL METAB, V7, P161, DOI 10.1016/j.molmet.2017.10.009; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Gargiulo S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/253067; Garland T, 2011, J EXP BIOL, V214, P206, DOI 10.1242/jeb.048397; Glancy J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004283; Goldfarb M, 2005, CYTOKINE GROWTH F R, V16, P215, DOI 10.1016/j.cytogfr.2005.02.002; Goodwin LO, 2019, GENOME RES, V29, P494, DOI 10.1101/gr.233866.117; GRANNEMAN JG, 1992, ENDOCRINOLOGY, V130, P109, DOI 10.1210/en.130.1.109; Hageman RS, 2010, PHYSIOL GENOMICS, V42, P55, DOI 10.1152/physiolgenomics.00072.2009; Hennessey JA, 2013, HEART RHYTHM, V10, P1886, DOI 10.1016/j.hrthm.2013.09.064; Hennessey JA, 2013, CIRC RES, V113, P381, DOI 10.1161/CIRCRESAHA.113.301215; Kasahara Y, 2007, BIOSCI BIOTECH BIOCH, V71, P3122, DOI 10.1271/bbb.70498; Kim SS, 2016, MOL GENET GENOMICS, V291, P831, DOI 10.1007/s00438-015-1150-3; Kotzbeck P, 2018, J LIPID RES, V59, P784, DOI 10.1194/jlr.M079665; Labbe SM, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00150; Leibel RL, 2008, INT J OBESITY, V32, pS98, DOI 10.1038/ijo.2008.245; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu CJ, 2001, J BIOL CHEM, V276, P18925, DOI 10.1074/jbc.M101606200; Lu HZ, 2015, CELL PROLIFERAT, V48, P550, DOI 10.1111/cpr.12200; Macotela Y, 2012, DIABETES, V61, P1691, DOI 10.2337/db11-1753; Madden CJ, 2009, AM J PHYSIOL-REG I, V296, pR831, DOI 10.1152/ajpregu.91007.2008; Miller RS, 2008, J NUTR, V138, P1033, DOI 10.1093/jn/138.6.1033; Modesto A, 2019, PEDIATR DENT, V41, P132; Morris MJ, 1998, REGUL PEPTIDES, V75-6, P441, DOI 10.1016/S0167-0115(98)00100-1; Morrison SF, 2016, AUTON NEUROSCI-BASIC, V196, P14, DOI 10.1016/j.autneu.2016.02.010; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Morton NM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023944; Olsen SK, 2003, J BIOL CHEM, V278, P34226, DOI 10.1074/jbc.M303183200; Park DS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12966; Peaston RT, 2004, ANN CLIN BIOCHEM, V41, P17, DOI 10.1258/000456304322664663; Puranam RS, 2015, J NEUROSCI, V35, P8866, DOI 10.1523/JNEUROSCI.3470-14.2015; Reddy MA, 2016, ARTERIOSCL THROM VAS, V36, P864, DOI 10.1161/ATVBAHA.115.306770; Romanov RA, 2017, NAT NEUROSCI, V20, P176, DOI 10.1038/nn.4462; Rowland LA, 2015, J BIOL CHEM, V290, P12282, DOI 10.1074/jbc.M115.637603; Smallwood PM, 1996, P NATL ACAD SCI USA, V93, P9850, DOI 10.1073/pnas.93.18.9850; Sripathy S, 2017, P NATL ACAD SCI USA, V114, P1619, DOI 10.1073/pnas.1621356114; Staffas A, 2018, CELL HOST MICROBE, V23, P447, DOI 10.1016/j.chom.2018.03.002; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Tolson KP, 2010, J NEUROSCI, V30, P3803, DOI 10.1523/JNEUROSCI.5444-09.2010; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; van Swieten JC, 2003, AM J HUM GENET, V72, P191, DOI 10.1086/345488; Vaughan CH, 2014, METHOD ENZYMOL, V537, P199, DOI 10.1016/B978-0-12-411619-1.00011-2; Virtue S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00128; Wang CJ, 2012, STRUCTURE, V20, P1167, DOI 10.1016/j.str.2012.05.001; Wang CJ, 2011, J BIOL CHEM, V286, P24253, DOI 10.1074/jbc.M111.245803; Wang C, 2011, CIRC RES, V109, P775, DOI 10.1161/CIRCRESAHA.111.247957; Wang XC, 2017, J MOL CELL CARDIOL, V104, P63, DOI 10.1016/j.yjmcc.2017.01.009; Wei EQ, 2017, P NATL ACAD SCI USA, V114, pE4010, DOI 10.1073/pnas.1616393114; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Wittmack EK, 2004, J NEUROSCI, V24, P6765, DOI 10.1523/JNEUROSCI.1628-04.2004; Wu QF, 2012, CELL, V149, P1549, DOI 10.1016/j.cell.2012.04.046; Xiao CY, 2015, OBESITY, V23, P1450, DOI 10.1002/oby.21124; Xu X, 2018, HEPATOLOGY, V68, P2167, DOI 10.1002/hep.30060; Yang J, 2016, CHANNELS, V10, P410, DOI 10.1080/19336950.2016.1190055; Yang LC, 2017, ACS CATAL, V7, P93, DOI 10.1021/acscatal.6b02959; Yang XY, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00149; YOUNG JB, 1982, J CLIN INVEST, V69, P1061, DOI 10.1172/JCI110541	73	5	5	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11579	11594		10.1096/fj.201901178R	http://dx.doi.org/10.1096/fj.201901178R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31339804	Bronze, Green Published			2022-12-28	WOS:000489166300080
J	Wang, JL; Hu, JN; Chen, XM; Huang, OG; Lin, JL; Shao, ZX; Gu, MB; Wu, YS; Tian, NF; Gao, WY; Zhou, YF; Wang, XY; Zhang, XL				Wang, Jianle; Hu, Jianing; Chen, Ximiao; Huang, Chongan; Lin, Jialiang; Shao, Zhenxuan; Gu, Mingbao; Wu, Yaosen; Tian, Naifeng; Gao, Weiyang; Zhou, Yifei; Wang, Xiangyang; Zhang, Xiaolei			BRD4 inhibition regulates MAPK, NF-kappa B signals, and autophagy to suppress MMP-13 expression in diabetic intervertebral disc degeneration	FASEB JOURNAL			English	Article						diabetes; BRD4; IVDD	GLYCATION END-PRODUCTS; LOW-BACK-PAIN; NUCLEUS PULPOSUS; GENE-EXPRESSION; MATRIX METALLOPROTEINASES; INFLAMMATORY RESPONSES; APOPTOSIS; CELLS; CHONDROCYTES; INDUCTION	Diabetes mellitus may lead to intervertebral disc degeneration (IVDD). Matrix metalloproteinase-13 (MMP-13) is one of the major catabolic factors in extracellular matrix (ECM) metabolism of nucleus pulposus cells (NPCs) and contributes to diabetic IVDD. Bromodomain-containing protein 4 (BRD4) is a member of the bromodomain and extraterminal protein family and is implicated in chronic inflammation. Here, we report that the expression of BRD4 and MMP-13 was elevated in diabetic nucleus pulposus tissues as well as in advanced glycation end products (AGEs)-treated NPCs; also, the regulatory effect of BRD4 on MMP-13 was studied. We found that MMP-13 was regulated by MAPK and NF-kappa B signaling as well as autophagy in AGEs-treated NPCs. Next, we explored the role of BRD4 in regulation of MAPK, NF-kappa B signaling, and autophagy. The results showed that BRD4 is the upstream regulator of all of these 3 factors, and inhibition of BRD4 may suppress MAPK and NF-kappa B signaling while activating autophagy in AGEs-treated NPCs. Finally, we demonstrated that BRD4 inhibition may suppress MMP-13 expression in diabetic NPCs in vitro as well as in vivo; meanwhile, it may preserve ECM in diabetic rats. Our study demonstrates that inhibition of BRD4 may suppress MAPK and NF-kappa B signaling and activate autophagy to suppress MMP-13 expression in diabetic IVDD, and diabetic IVDD may be compromised by BRD4 inhibitors.-Wang, J., Hu, J., Chen, X., Huang, C., Lin, J., Shao, Z., Gu, M., Wu, Y., Tian, N., Gao, W., Zhou, Y., Wang, X., Zhang, X. BRD4 inhibition regulates MAPK, NF-kappa B signals, and autophagy to suppress MMP-13 expression in diabetic intervertebral disc degeneration.	[Wang, Jianle; Chen, Ximiao; Huang, Chongan; Lin, Jialiang; Shao, Zhenxuan; Gu, Mingbao; Wu, Yaosen; Tian, Naifeng; Gao, Weiyang; Zhou, Yifei; Wang, Xiangyang; Zhang, Xiaolei] Wenzhou Med Univ, Yuying Childrens Hosp, Affiliated Hosp 2, Dept Orthopaed, Wenzhou, Peoples R China; [Wang, Jianle; Hu, Jianing; Huang, Chongan; Lin, Jialiang; Shao, Zhenxuan; Gu, Mingbao; Wu, Yaosen; Tian, Naifeng; Gao, Weiyang; Zhou, Yifei; Wang, Xiangyang; Zhang, Xiaolei] Wenzhou Med Univ, Sch Med 2, Wenzhou, Peoples R China; [Wang, Jianle; Huang, Chongan; Lin, Jialiang; Shao, Zhenxuan; Gu, Mingbao; Wu, Yaosen; Tian, Naifeng; Gao, Weiyang; Zhou, Yifei; Wang, Xiangyang; Zhang, Xiaolei] Key Lab Orthopaed Zhejiang Prov, Wenzhou, Peoples R China; [Chen, Ximiao] Guilin Med Coll, Affiliated Hosp, Dept Orthopaed, Guilin, Peoples R China; [Zhang, Xiaolei] Chinese Orthopaed Regenerat Med Soc, Hangzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Guilin Medical University	Wang, XY; Zhang, XL (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Orthopaed, 109 West Xueyuan Rd, Wenzhou 325027, Zhejiang, Peoples R China.; Wang, XY; Zhang, XL (corresponding author), Wenzhou Med Univ, Yuying Childrens Hosp, 109 West Xueyuan Rd, Wenzhou 325027, Zhejiang, Peoples R China.	xiangyangwang@wmu.edu.cn; zhangxiaolei@wmu.edu.cn			National Nature Foundation of China [81871806]; Zhejiang Public Service Technology Research Program/Social Development [LGF18H060008]; Zhejiang Provincial Natural Science Foundation of China [LY17H060010, LY18H060012]; Major Scientific and Technological Project of Medical and Health in Zhejiang Province [WKJ-ZJ-1527]; Zhejiang Provincial Project for Medical and Health Science and Technology [2017KY463]; Zhejiang Undergraduate Talent Project [2018R413074]	National Nature Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Public Service Technology Research Program/Social Development; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Major Scientific and Technological Project of Medical and Health in Zhejiang Province; Zhejiang Provincial Project for Medical and Health Science and Technology; Zhejiang Undergraduate Talent Project	This work is supported by grants from the National Nature Foundation of China (81871806), the Zhejiang Public Service Technology Research Program/Social Development (LGF18H060008), the Zhejiang Provincial Natural Science Foundation of China (LY17H060010 and LY18H060012), the Major Scientific and Technological Project of Medical and Health in Zhejiang Province (WKJ-ZJ-1527), the Zhejiang Provincial Project for Medical and Health Science and Technology (2017KY463), and the Zhejiang Undergraduate Talent Project (2018R413074). The authors declare no conflicts of interest.	Andrieu GP, 2018, J LEUKOCYTE BIOL, V104, P265, DOI 10.1002/JLB.5RI0917-380RR; AUFDERMAUR M, 1980, EXP CELL BIOL, V48, P89; Bonnet F, 2018, DIABETES METAB, V44, P457, DOI 10.1016/j.diabet.2018.09.005; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Chen WP, 2015, J CELL MOL MED, V19, P1910, DOI 10.1111/jcmm.12564; Chen YS, 2017, INT J MOL MED, V40, P987, DOI 10.3892/ijmm.2017.3097; Chen YJ, 2016, J ORTHOP RES, V34, P791, DOI 10.1002/jor.23083; Chen YJ, 2015, J ORTHOP RES, V33, P373, DOI 10.1002/jor.22770; Dey A, 2019, EMBO J, V38, DOI 10.15252/embj.2018100293; Dong W L, 2017, Zhonghua Yu Fang Yi Xue Za Zhi, V51, P132, DOI 10.3760/cma.j.issn.0253-9624.2017.02.007; Duan QM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5084; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Jensen CE, 2017, PAIN, V158, P891, DOI 10.1097/j.pain.0000000000000851; Jiang LB, 2013, J ORTHOP RES, V31, P692, DOI 10.1002/jor.22289; Jiang YF, 2017, BBA-MOL BASIS DIS, V1863, P3001, DOI 10.1016/j.bbadis.2017.08.009; Jin HM, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0177-z; Kimura H, 2009, J PHARMACOL SCI, V110, P201, DOI 10.1254/jphs.09076FP; Kivimaki M, 2007, DIABETIC MED, V24, P1043, DOI 10.1111/j.1464-5491.2007.02216.x; Le Maitre CL, 2004, J PATHOL, V204, P47, DOI 10.1002/path.1608; Liu XM, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0755-8; Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016; MacLean JJ, 2005, J ORTHOP RES, V23, P1120, DOI 10.1016/j.orthres.2005.01.020; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Nonaka K, 2018, J PERIODONTAL RES, V53, P334, DOI 10.1111/jre.12518; Omlor GW, 2006, J ORTHOP RES, V24, P385, DOI 10.1002/jor.20055; Ouyang L, 2017, J MED CHEM, V60, P9990, DOI 10.1021/acs.jmedchem.7b00275; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Prasad C, 2014, AGING DIS, V5, P212, DOI 10.14336/AD.2014.0500212; Robinson D, 1998, SPINE, V23, P849, DOI 10.1097/00007632-199804150-00001; Sakamaki JI, 2017, MOL CELL, V66, P517, DOI 10.1016/j.molcel.2017.04.027; Sasaki H, 2012, ARTHRITIS RHEUM-US, V64, P1920, DOI 10.1002/art.34323; Sun ZY, 2015, SPINE, V40, P224, DOI 10.1097/BRS.0000000000000733; Teraguchi M, 2017, OSTEOARTHR CARTILAGE, V25, P1122, DOI 10.1016/j.joca.2017.01.001; Tsai TT, 2014, J ORTHOP RES, V32, P238, DOI 10.1002/jor.22508; Waldron AL, 2018, J DIABETES COMPLICAT, V32, P249, DOI 10.1016/j.jdiacomp.2017.11.012; Wang H, 2018, WIRES COMPUT MOL SCI, V8, DOI 10.1002/wcms.1330; Wang JR, 2013, ARTHRITIS RHEUM-US, V65, P832, DOI 10.1002/art.37819; Wen X, 2017, AUTOPHAGY, V13, P1801, DOI 10.1080/15548627.2017.1364334; World Medical Association General Assembly, 2001, HIV Clin Trials, V2, P92; Zhang HB, 2016, APOPTOSIS, V21, P1082, DOI 10.1007/s10495-016-1280-z; ZHANG Z, 2018, AM J CHINESE MED, V46, P1	41	39	41	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11555	11566		10.1096/fj.201900703R	http://dx.doi.org/10.1096/fj.201900703R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31331201	Bronze			2022-12-28	WOS:000489166300078
J	Numaga-Tomita, T; Shimauchi, T; Oda, S; Tanaka, T; Nishiyama, K; Nishimura, A; Birnbaumer, L; Mori, Y; Nishida, M				Numaga-Tomita, Takuro; Shimauchi, Tsukasa; Oda, Sayaka; Tanaka, Tomohiro; Nishiyama, Kazuhiro; Nishimura, Akiyuki; Birnbaumer, Lutz; Mori, Yasuo; Nishida, Motohiro			TRPC6 regulates phenotypic switching of vascular smooth muscle cells through plasma membrane potential-dependent coupling with PTEN	FASEB JOURNAL			English	Article						VSMCs; phenotype switching; membrane potential; transient receptor potential; Ca2(+) channel	10T1/2 CELLS; CA2+ ENTRY; ACTIVATION; CHANNELS; PROTEIN; DIFFERENTIATION; CONTRACTILE; BETA; EXPRESSION; HYPERFORIN	Vascular smooth muscle cells (VSMCs) play critical roles in the stability and tonic regulation of vascular homeostasis. VSMCs can switch back and forth between highly proliferative synthetic and fully differentiated contractile phenotypes in response to changes in the vessel environment. Although abnormal phenotypic switching of VSMCs is a hallmark of vascular disorders such as atherosclerosis and restenosis after angioplasty, how control of VSMC phenotypic switching is dysregulated in pathologic conditions remains obscure. We found that inhibition of canonical transient receptor potential 6 (TRPC6) channels facilitated contractile differentiation of VSMCs through plasma membrane hyperpolarization. TRPC6-deficient VSMCs exhibited more polarized resting membrane potentials and higher protein kinase B (Akt) activity than wild-type VSMCs in response to TGF-beta 1 stimulation. Ischemic stress elicited by oxygen-glucose deprivation suppressed TGF-beta 1-induced hyperpolarization and VSMC differentiation, but this effect was abolished by TRPC6 deletion. TRPC6-mediated Ca2+ influx and depolarization coordinately promoted the interaction of TRPC6 with lipid phosphatase and tensin homolog deleted from chromosome 10 (PTEN), a negative regulator of Akt activation. Given the marked up-regulation of TRPC6 observed in vascular disorders, our findings suggest that attenuation of TRPC6 channel activity in pathologic VSMCs could be a rational strategy to maintain vascular quality control by fine-tuning of VSMC phenotypic switching.-Numaga-Tomita, T., Shimauchi, T., Oda, S., Tanaka, T., Nishiyama, K., Nishimura, A., Birnbaumer, L., Mori, Y., Nishida, M. TRPC6 regulates phenotypic switching of vascular smooth muscle cells through plasma membrane potential-dependent coupling with PTEN.	[Numaga-Tomita, Takuro; Shimauchi, Tsukasa; Oda, Sayaka; Tanaka, Tomohiro; Nishida, Motohiro] NIPS, Okazaki, Aichi, Japan; [Numaga-Tomita, Takuro; Oda, Sayaka; Tanaka, Tomohiro; Nishida, Motohiro] Natl Inst Nat Sci, Exploratory Res Ctr Life & Living Syst ExCELLS, Okazaki, Aichi, Japan; [Numaga-Tomita, Takuro; Oda, Sayaka; Nishida, Motohiro] Grad Univ Adv Studies, Sch Life Sci, SOKENDAI, Okazaki, Aichi, Japan; [Shimauchi, Tsukasa; Nishiyama, Kazuhiro; Nishimura, Akiyuki; Nishida, Motohiro] Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka, Fukuoka, Japan; [Shimauchi, Tsukasa] Kyushu Univ, Grad Sch Med Sci, Fukuoka, Fukuoka, Japan; [Birnbaumer, Lutz] NIEHS, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Birnbaumer, Lutz] Catholic Univ Argentina, Inst Biomed Res BIOMED, Buenos Aires, DF, Argentina; [Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); National Institutes of Natural Sciences (NINS) - Japan; The Exploratory Research Center on Life & Living Systems (ExCELLS); Graduate University for Advanced Studies - Japan; Kyushu University; Kyushu University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Kyoto University	Nishida, M (corresponding author), Natl Inst Physiol Sci, Div Cardiocirculatory Signaling, Higashiyama 5-1,Myodaiji Cho, Okazaki, Aichi 4448787, Japan.; Nishida, M (corresponding author), Natl Inst Nat Sci, Exploratory Res Ctr Life & Living Syst, Higashiyama 5-1,Myodaiji Cho, Okazaki, Aichi 4448787, Japan.	nishida@nips.ac.jp		Nishida, Motohiro/0000-0002-2587-5458; SHIMAUCHI, Tsukasa/0000-0002-9834-4770; Nishiyama, Kazuhiro/0000-0002-6263-3562; sha shi xiang, xiao tian/0000-0003-3901-4760	JSPS KAKENHI [16H05092, 19H03383, 17K15585]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [15K21759, 18H04993]; Ono Medical Research Foundation; Intramural Research Program of the U.S. National Institutes of Health (Bethesda, MD, USA) [ZO1-ES-101684]; Cooperative Study Program of National Institute for Physiological Sciences; Spectrography and Bioimaging Facility, National Institute for Basic Biology Core Research Facilities	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ono Medical Research Foundation; Intramural Research Program of the U.S. National Institutes of Health (Bethesda, MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cooperative Study Program of National Institute for Physiological Sciences; Spectrography and Bioimaging Facility, National Institute for Basic Biology Core Research Facilities	The authors thank Edanz Group (www.edanzediting.com/ac) for editing a draft of this manuscript. This research was funded by grants from JSPS KAKENHI [16H05092 and 19H03383 (to M.N.) and 17K15585 (to T.N.-T.)]; Scientific Research on Innovative Areas (Research in a Proposed Research Area 15K21759 "Oxygen Biology" to Y.M. and M.N., and 18H04993 "Living in Space" to T.N.-T.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ono Medical Research Foundation (to M.N.); and by the Intramural Research Program of the U.S. National Institutes of Health (Bethesda, MD, USA) (Project ZO1-ES-101684 to L.B.). This work was also supported by the Cooperative Study Program of National Institute for Physiological Sciences and Spectrography and Bioimaging Facility, National Institute for Basic Biology Core Research Facilities. The authors declare no conflicts of interest.	Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Berra-Romani R, 2008, AM J PHYSIOL-CELL PH, V295, pC779, DOI 10.1152/ajpcell.00173.2008; Burtenshaw D, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6040090; Chiong M, 2013, VASA, V42, P8, DOI 10.1024/0301-1526/a000243; Corbalan-Garcia S, 2014, BBA-BIOMEMBRANES, V1838, P1536, DOI 10.1016/j.bbamem.2014.01.008; Davis-Dusenbery BN, 2011, ARTERIOSCL THROM VAS, V31, P2370, DOI 10.1161/ATVBAHA.111.226670; Fernandez RA, 2015, AM J PHYSIOL-CELL PH, V308, pC581, DOI 10.1152/ajpcell.00202.2014; Frismantiene A, 2018, CELL SIGNAL, V52, P48, DOI 10.1016/j.cellsig.2018.08.019; Golovina VA, 2001, AM J PHYSIOL-HEART C, V280, pH746, DOI 10.1152/ajpheart.2001.280.2.H746; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Ichikawa J, 2014, BRIT J PHARMACOL, V171, P5280, DOI 10.1111/bph.12840; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Inoue R, 2006, CIRC RES, V99, P119, DOI 10.1161/01.RES.0000233356.10630.8a; Itsuki K, 2014, J GEN PHYSIOL, V143, P183, DOI 10.1085/jgp.201311033; Johansson-Percival A, 2015, CELL REP, V13, P2687, DOI 10.1016/j.celrep.2015.12.004; Kini V, 2010, J BIOL CHEM, V285, P33082, DOI 10.1074/jbc.M110.142034; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Leuner K, 2007, FASEB J, V21, P4101, DOI 10.1096/fj.07-8110com; Levin M, 2012, BIOESSAYS, V34, P205, DOI 10.1002/bies.201100136; Lien SC, 2006, CELL SIGNAL, V18, P1270, DOI 10.1016/j.cellsig.2005.10.013; Malczyk M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00707; Mancarella S, 2013, FASEB J, V27, P893, DOI 10.1096/fj.12-215293; Merlet E, 2013, CARDIOVASC RES, V98, P458, DOI 10.1093/cvr/cvt045; Monet M, 2012, J BIOL CHEM, V287, P17672, DOI 10.1074/jbc.M112.341354; Muto A, 2007, J VASC SURG, V45, p15A, DOI 10.1016/j.jvs.2007.02.061; Nishimura A, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac9187; Nishioka K, 2011, ARTERIOSCL THROM VAS, V31, P2278, DOI 10.1161/ATVBAHA.110.221010; Numaga T, 2010, J CELL SCI, V123, P927, DOI 10.1242/jcs.061051; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Otsuka H, 2006, ANN VASC SURG, V20, P646, DOI 10.1007/s10016-006-9100-5; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Park B, 2010, J VASC SURG, V51, P165, DOI 10.1016/j.jvs.2009.08.045; Schaper W, 2009, BASIC RES CARDIOL, V104, P5, DOI 10.1007/s00395-008-0760-x; Shi N, 2012, J BIOL CHEM, V287, P6860, DOI 10.1074/jbc.M111.306209; Takahashi S, 2008, J PHYSIOL-LONDON, V586, P4209, DOI 10.1113/jphysiol.2008.156083; Tu P, 2010, J NEUROCHEM, V112, P204, DOI 10.1111/j.1471-4159.2009.06446.x; Waldron GJ, 1999, CLIN EXP PHARMACOL P, V26, P180, DOI 10.1046/j.1440-1681.1999.03006.x; Yao X., 2007, V179, P527; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101; Zhou Y, 2015, SCIENCE, V349, P873, DOI 10.1126/science.aaa5619	41	18	21	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9785	9796		10.1096/fj.201802811R	http://dx.doi.org/10.1096/fj.201802811R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31162976	Green Published			2022-12-28	WOS:000482214200009
J	Shehadeh, A; Bruck-Haimson, R; Saidemberg, D; Zacharia, A; Herzberg, S; Ben-Meir, A; Moussaieff, A				Shehadeh, Alaa; Bruck-Haimson, Reut; Saidemberg, Daniel; Zacharia, Anish; Herzberg, Shmuel; Ben-Meir, Assaf; Moussaieff, Arieh			A shift in follicular fluid from triacylglycerols to membrane lipids is associated with positive pregnancy outcome	FASEB JOURNAL			English	Article						In vitro fertilization (IVF); lipidomics; phospholipids; sphingolipids; vitamin D	VITAMIN-D LEVELS; CELL-FUNCTION; OOCYTE; EXTRACTION; WOMEN; PHOSPHOLIPIDS; BIOMARKERS; RESISTANCE; STEROLS; LESSONS	Follicular fluid (FF) is a liquid that surrounds the ovum. Its metabolite and, specifically, its lipid content have been associated with oocyte development. To characterize possible association between the lipid composition of FF and the outcome of pregnancy, we carried out a lipidomics study and compared the abundance of lipids from FF of patients with positive and negative outcomes. We found a differential lipid network wiring in positive-outcome FF, with a significant decrease (similar to 2 fold; P < 0.001) in triacylglycerol levels and higher accumulation (10-50%; P < 0.001) of membrane lipids groups (phospholipids and sphingolipids). In addition to this major metabolic alteration, other lipid groups such as cholesteryl esters showed lower levels in positive-outcome patients, whereas derivatives of vitamin D were highly accumulated in positive-outcome FF, supporting previous studies that associate vitamin D levels in FF to pregnancy outcome. Our data also point to specific lipid species with a differential accumulation pattern in positive-outcome FF that predicted pregnancy in a receiver operating characteristic analysis. Altogether, our results suggest that FF lipid network is associated with the oocyte development, with possible implications in diagnostics and treatment.-Shehadeh, A., Bruck-Haimson, R., Saidemberg, D., Zacharia. A., Herzberg, S., Ben-Meir, A., Moussaieff, A. A shift in follicular fluid from triacylglycerols to membrane lipids is associated with positive pregnancy outcome.	[Shehadeh, Alaa; Bruck-Haimson, Reut; Saidemberg, Daniel; Zacharia, Anish; Moussaieff, Arieh] Hebrew Univ Jerusalem, Inst Drug Res, Jerusalem, Israel; [Herzberg, Shmuel; Ben-Meir, Assaf] Hebrew Univ Jerusalem, Hadassah Med Ctr, IVF Unit, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center	Moussaieff, A (corresponding author), Hebrew Univ Jerusalem, Inst Drug Res, Hadassah Kerem, IL-91120 Jerusalem, Israel.	ariehm@ekmd.huji.ac.il		Moussaieff, Arieh/0000-0003-1289-4737				Anifandis GM, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-91; Antunes RA, 2018, REPROD BIOMED ONLINE, V36, P277, DOI 10.1016/j.rbmo.2017.12.010; Baltsen M, 1999, BIOMED CHROMATOGR, V13, P382, DOI 10.1002/(SICI)1099-0801(199910)13:6<382::AID-BMC896>3.0.CO;2-D; Baritaki S, 2007, ADV CANCER RES, V98, P149, DOI 10.1016/S0065-230X(06)98005-1; BILLIAR TR, 1988, SURGERY, V104, P343; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boesze-Battaglia K, 1997, J EXP BIOL, V200, P2927; BYSKOV AG, 1995, NATURE, V374, P559, DOI 10.1038/374559a0; Cataldi T, 2013, HUM FERTIL, V16, P269, DOI 10.3109/14647273.2013.852255; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Ciepiela P, 2018, J ASSIST REPROD GEN, V35, P1265, DOI 10.1007/s10815-018-1179-4; Fayezi S, 2014, J OBSTET GYNAECOL, V34, P259, DOI 10.3109/01443615.2013.851657; Gonzalez MB, 2018, J REPROD IMMUNOL, V130, P25, DOI 10.1016/j.jri.2018.08.005; Gu L, 2015, CELL MOL LIFE SCI, V72, P251, DOI 10.1007/s00018-014-1739-4; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Irani M, 2014, FERTIL STERIL, V102, P460, DOI 10.1016/j.fertnstert.2014.04.046; Jungheim ES, 2010, AM J OBSTET GYNECOL, V203, P525, DOI 10.1016/j.ajog.2010.06.043; Karavani G, 2017, FERTIL STERIL, V107, P1159, DOI 10.1016/j.fertnstert.2017.01.023; Law DCG, 2007, HUM REPROD, V22, P414, DOI 10.1093/humrep/de1400; Liu LY, 2019, J STEROID BIOCHEM, V185, P142, DOI 10.1016/j.jsbmb.2018.08.008; Los DA, 2013, PHOTOSYNTH RES, V116, P489, DOI 10.1007/s11120-013-9823-4; Luzzo KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049217; Nandi S, 2007, DEV GROWTH DIFFER, V49, P61, DOI [10.1111/j.1440-169x.2007.00901.x, 10.1111/j.1440-169X.2007.00901.x]; O'Gorman A, 2013, REPRODUCTION, V146, P389, DOI 10.1530/REP-13-0184; Ozkan S, 2010, FERTIL STERIL, V94, P1314, DOI 10.1016/j.fertnstert.2009.05.019; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; Reis A, 2013, J LIPID RES, V54, P1812, DOI 10.1194/jlr.M034330; Revelli A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-40; RICHEDWARDS JW, 1994, AM J OBSTET GYNECOL, V171, P171, DOI 10.1016/0002-9378(94)90465-0; Roberts LD, 2014, LANCET DIABETES ENDO, V2, P65, DOI 10.1016/S2213-8587(13)70143-8; Rudick B, 2012, HUM REPROD, V27, P3321, DOI 10.1093/humrep/des280; Rudick BJ, 2014, FERTIL STERIL, V101, P447, DOI 10.1016/j.fertnstert.2013.10.008; RYAN DP, 1992, J ANIM SCI, V70, P3505, DOI 10.2527/1992.70113505x; Schneider H, 2010, INT J MOL SCI, V11, P4149, DOI 10.3390/ijms11104149; Valckx SDM, 2012, HUM REPROD, V27, P3531, DOI 10.1093/humrep/des350; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; van Montfoort APA, 2014, J REPROD IMMUNOL, V104, P32, DOI 10.1016/j.jri.2014.04.003; Wallace M, 2012, FERTIL STERIL, V97, P1078, DOI 10.1016/j.fertnstert.2012.01.122; Wu LLY, 2012, REPROD FERT DEVELOP, V24, P29, DOI 10.1071/RD11904; Wu LLY, 2010, ENDOCRINOLOGY, V151, P5438, DOI 10.1210/en.2010-0551; Yang X, 2012, FERTIL STERIL, V97, P1438, DOI 10.1016/j.fertnstert.2012.02.034	41	3	4	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10291	10299		10.1096/fj.201900318RR	http://dx.doi.org/10.1096/fj.201900318RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31219705				2022-12-28	WOS:000482214200046
J	Sheng, L; Chen, MM; Cai, KS; Song, Y; Yu, DS; Zhang, H; Xu, GX				Sheng, Liang; Chen, Mingming; Cai, Keshu; Song, Yu; Yu, Dongsheng; Zhang, Hui; Xu, Guangxu			Microglial Trem2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice	FASEB JOURNAL			English	Article						Alzheimer's disease; microglia; synaptic plasticity; cognitive impairment	MYELOID CELLS 2; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; MOUSE MODEL; DEFICIENCY; RECEPTOR; VARIANTS; INFLAMMATION; PROGRESSION; CLEARANCE	Triggering receptor expressed in myeloid cells (TREM)2 is a genetic high-risk factor for sporadic Alzheimer's disease (AD) and is considered a potential target for AD diagnosis and therapy, although its role in the different stages of AD remains controversial. We generated an embryonic deletion of Trem2 (whole body deletion) and induced hippocampal- and cortical-specific knockdown of microglial Trem2 at different stages of the AD process in amyloid precursor protein/Psen1 mice by adeno-associated virus (AAV) infection. AAV infection induced microglial Trem2 overexpression in the hippocampus of wild-type (WT) and thymus cell antigen 1-enhanced green fluorescent protein mice. Mice were subjected to ethological and pathologic tests. Whole body genetic deletion of Trem2 exerted different electrophysiological outcomes between different AD pathologic stages, which results from a complex integration of synaptic loss and amyloid aggregation. Interestingly, knockdown of Trem2 at the early-middle stage of AD (2-6 mo) prevents synaptic loss through directly inhibiting microglial phagocytosis, whereas knockdown of Trem2 at the middle-late stage of AD (6-10 mo) accelerates synaptic dysfunction because of more severe amyloid deposition caused by the depression of microglial phagocytosis. Additionally, hippocampal overexpression of Trem2 in WT mice results in significant synaptic impairment. Here, with transgenic technology and electrophysiological assay, we revealed that TREM2 up-regulation promotes microglial phagocytosis equally against synapse and amyloid plaques and eventually results in different outcomes. During the early-middle pathologic stage, TREM2 enhancing microglial phagocytosis mainly causes synaptic loss. However, TREM2 up-regulating microglial phagocytosis gradually supports a positive role when amyloid deposition occupies the leading position at the middle-late pathologic stage. In this study, we highlighted that TREM2 triggers synaptic loss during AD pathology development.-Sheng, L., Chen, M., Cai, K., Song, Y., Yu, D., Zhang, H., Xu, G. Microglial Trem2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice.	[Sheng, Liang; Yu, Dongsheng] Nanjing Med Univ, Sch Basic Med Sci, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China; [Song, Yu; Zhang, Hui] Xinxiang Med Univ, Pharm Coll, Xinxiang, Henan, Peoples R China; [Chen, Mingming] China Pharmaceut Univ, Jiangsu Key Lab Drug Screening, Nanjing, Jiangsu, Peoples R China; [Cai, Keshu; Xu, Guangxu] Nanjing Med Univ, Affiliated Hosp 1, Dept Rehabil Med, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University; Xinxiang Medical University; China Pharmaceutical University; Nanjing Medical University	Xu, GX (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Rehabil Med, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	xuguangxu1@126.com		Chen, Mingming/0000-0002-9702-103X	National Natural Science Foundation of China [81770862]; Psychology and Neuroscience, Xinxiang Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Psychology and Neuroscience, Xinxiang Medical University	This work was supported by grants from the National Natural Science Foundation of China (81770862) and the support project for the disciplinary group of Psychology and Neuroscience, Xinxiang Medical University (to L.S.). The authors declare no conflicts of interest.	Bateman R, 2015, LANCET NEUROL, V14, P4, DOI 10.1016/S1474-4422(14)70301-1; Bellenguez C, 2017, NEUROBIOL AGING, V59, DOI 10.1016/j.neurobiolaging.2017.07.001; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Chen MK, 2018, JAMA NEUROL, V75, P1215, DOI 10.1001/jamaneurol.2018.1836; Chen MM, 2017, J NUTR BIOCHEM, V46, P57, DOI 10.1016/j.jnutbio.2017.04.006; Chung WS, 2015, NAT NEUROSCI, V18, P1539, DOI 10.1038/nn.4142; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Colonna M, 2016, NAT REV NEUROSCI, V17, P201, DOI 10.1038/nrn.2016.7; Gispert JD, 2016, ALZHEIMERS DEMENT, V12, P1259, DOI 10.1016/j.jalz.2016.06.005; Filipello F, 2018, IMMUNITY, V48, P979, DOI 10.1016/j.immuni.2018.04.016; Guerreiro R, 2013, CELL, V155, P968, DOI 10.1016/j.cell.2013.10.037; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hansen DV, 2018, J CELL BIOL, V217, P459, DOI 10.1083/jcb.201709069; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Henjum K, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0182-1; Irwin D, 2017, LANCET NEUROL, V16, P55, DOI 10.1016/S1474-4422(16)30291-5; Jay TR, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0197-5; Jay TR, 2017, J NEUROSCI, V37, P637, DOI [10.1523/JNEUROSCI.2110-16.2017, 10.1523/JNEUROSCI.2110-16.2016]; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jiang T, 2014, NEUROPSYCHOPHARMACOL, V39, P2949, DOI 10.1038/npp.2014.164; Jiang T, 2014, NEUROBIOL AGING, V35, P1243, DOI 10.1016/j.neurobiolaging.2013.11.026; Jin SC, 2014, HUM MOL GENET, V23, P5838, DOI 10.1093/hmg/ddu277; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kester MI, 2015, JAMA NEUROL, V72, P1275, DOI 10.1001/jamaneurol.2015.1867; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Kober DL, 2016, ELIFE, V5, DOI 10.7554/eLife.20391; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Ma L, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0137-9; Mazaheri F, 2017, EMBO REP, V18, P1186, DOI 10.15252/embr.201743922; Medina DX, 2014, NEUROBIOL AGING, V35, P79, DOI 10.1016/j.neurobiolaging.2013.07.006; Mehta D, 2017, EXPERT OPIN INV DRUG, V26, P735, DOI 10.1080/13543784.2017.1323868; N'Diaye EN, 2009, J CELL BIOL, V184, P215, DOI 10.1083/jcb.200808080; Palop JJ, 2016, NAT REV NEUROSCI, V17, P777, DOI 10.1038/nrn.2016.141; Paolicelli RC, 2017, NEURON, V95, P297, DOI 10.1016/j.neuron.2017.05.037; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Scheff SW, 2015, J ALZHEIMERS DIS, V43, P1073, DOI 10.3233/JAD-141518; Scheff SW, 2011, J ALZHEIMERS DIS, V24, P547, DOI 10.3233/JAD-2011-101782; Shi Y, 2018, NAT REV IMMUNOL, V18, P759, DOI 10.1038/s41577-018-0051-1; Song W, 2017, ALZHEIMERS DEMENT, V13, P381, DOI 10.1016/j.jalz.2016.07.004; Spangenberg EE, 2017, BRAIN BEHAV IMMUN, V61, P1, DOI 10.1016/j.bbi.2016.07.003; Srinivasan K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11295; Suarez-Calvet M, 2016, EMBO MOL MED, V8, P466, DOI 10.15252/emmm.201506123; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Tan CC, 2014, J ALZHEIMERS DIS, V42, P1051, DOI 10.3233/JAD-140843; Tarawneh R, 2015, JAMA NEUROL, V72, P656, DOI 10.1001/jamaneurol.2015.0202; Upadhaya AR, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-77; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Wendeln AC, 2018, NATURE, V556, P332, DOI 10.1038/s41586-018-0023-4; Xiang XY, 2016, EMBO MOL MED, V8, P992, DOI 10.15252/emmm.201606370; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Yuan P, 2016, NEURON, V90, P724, DOI 10.1016/j.neuron.2016.05.003; Zheng HH, 2016, NEUROBIOL AGING, V42, P132, DOI 10.1016/j.neurobiolaging.2016.03.004	54	24	26	0	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10425	10442		10.1096/fj.201900527R	http://dx.doi.org/10.1096/fj.201900527R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31219699				2022-12-28	WOS:000482214200056
J	Wang, YF; Zhao, WJ; Shi, JX; Wang, JC; Hao, J; Pang, XW; Huang, XJ; Chen, XP; Li, YZ; Jin, R; Ge, Q				Wang, Yifan; Zhao, Weijia; Shi, Junxiu; Wang, Jiachi; Hao, Jie; Pang, Xuewen; Huang, Xiaojun; Chen, Xiaoping; Li, Yongzhi; Jin, Rong; Ge, Qing			Intestinal microbiota contributes to altered glucose metabolism in simulated microgravity mouse model	FASEB JOURNAL			English	Article						glucose intolerance; hind limb unloading; endotoxemia	INSULIN-RESISTANCE; AKKERMANSIA-MUCINIPHILA; GUT MICROBIOME; ENDOTOXEMIA; HOMEOSTASIS; PHYSIOLOGY; MISSIONS; OBESITY; SYSTEM	Exposure to space environment induces alterations in glucose and lipid metabolism that contribute to muscular atrophy, bone loss, and cardiovascular disorders. Intestinal microbiota is also changed, but its impact on spaceflight-related metabolic disorder is not clear. We investigated the relationship between glucose metabolic changes and gut dysbiosis in a hind limb-unloading (HU) mouse model, a well-accepted ground-based spaceflight analog. Impaired body weight gain, glucose intolerance, and peripheral insulin resistance were found in 2-4-wk HU mice. Reduced abundance of gut Bifidobacterium spp. and Akkermansia muciniphila was observed within 3 d of HU. The ground-based control (Ctrl) mice that were cohoused with HU mice showed similar patterns of dysbiosis and metabolic changes. Compared with the Ctrls, higher levels of plasma LPS-binding protein and altered transcription of Tnfa and glucose metabolism-related genes in the liver were observed in HU mice. The supplementation of Bifidobacterium spp. suppressed endotoxemia and liver inflammation and improved glucose tolerance in HU mice. The results indicate a close relationship between dysbiosis and altered glucose metabolism in the HU model and also emphasize the importance of evaluating intestinal microbiota in astronauts and its effect on glucose metabolism.-Wang, Y., Zhao, W., Shi, J., Wang, J., Hao, J., Pang, X., Huang, X., Chen, X., Li, Y., Jin, R., Ge, Q. Intestinal microbiota contributes to altered glucose metabolism in simulated microgravity mouse model.	[Wang, Yifan; Zhao, Weijia; Wang, Jiachi; Hao, Jie; Pang, Xuewen; Jin, Rong; Ge, Qing] Peking Univ, NHC Key Lab Med Immunol, Sch Basic Med Sci, Dept Immunol, Beijing, Peoples R China; [Shi, Junxiu] China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Dept Dev Cell Biol, Shenyang, Liaoning, Peoples R China; [Shi, Junxiu] China Med Univ, Minist Educ, Key Lab Med Cell Biol, Shenyang, Liaoning, Peoples R China; [Huang, Xiaojun] Peking Univ Peoples Hosp, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing, Peoples R China; [Huang, Xiaojun] Inst Hematol, Beijing, Peoples R China; [Chen, Xiaoping; Li, Yongzhi] Chinese Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China; [Ge, Qing] Peking Univ, Sch Basic Med Sci, Dept Integrat Chinese & Western Med, Beijing, Peoples R China	Peking University; China Medical University; China Medical University; Peking University	Jin, R; Ge, Q (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Immunol, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	jinrong@bjmu.edu.cn; qingge@bjmu.edu.cn	Shi, Junxiu/GXH-8588-2022; Huang, Xiao-Jun/HIK-3759-2022	Huang, Xiao-Jun/0000-0002-2145-6643	National Key Research and Development Program of China [2017YFA0104500]; National Natural Science Foundation of China [81471525, 31671244, 31872734, 31872733]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [81621001]; Beijing Natural Science Foundation [7172114]; Non-Profit Central Research Institute Fund of Chinese Academy of Medical Sciences [2018PT31039]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Non-Profit Central Research Institute Fund of Chinese Academy of Medical Sciences	The authors wish to thank Prof. Xiaoyan Qiu (Peking University) for critical comments and helpful discussions. This work was supported by grants from the National Key Research and Development Program of China (2017YFA0104500), the National Natural Science Foundation of China (81471525, 31671244, 31872734, Q.G., 31872733, R.J.), the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (81621001), Beijing Natural Science Foundation (7172114, R.J.), the Non-Profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2018PT31039). The authors declare no conflicts of interest.	Alibegovic AC, 2009, DIABETES, V58, P2749, DOI 10.2337/db09-0369; AMIDON GL, 1991, J CLIN PHARMACOL, V31, P968, DOI 10.1002/j.1552-4604.1991.tb03658.x; Anselm V, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081763; Barzegari A, 2012, FUTURE MICROBIOL, V7, P571, DOI [10.2217/FMB.12.37, 10.2217/fmb.12.37]; Bederman IR, 2013, EXP PHYSIOL, V98, P278, DOI 10.1113/expphysiol.2012.067074; Bergouignan A, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.29; Bienso RS, 2012, DIABETES, V61, P1090, DOI 10.2337/db11-0884; Botta M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041197; BROWN LR, 1976, J AM DENT ASSOC, V93, P357, DOI 10.14219/jada.archive.1976.0502; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2018, GUT, V67, P1716, DOI 10.1136/gutjnl-2018-316723; Chopra V, 2006, J TOXICOL ENV HEAL A, V69, P1345, DOI 10.1080/15287390500361792; Crucian BE, 2014, J INTERF CYTOK RES, V34, P778, DOI 10.1089/jir.2013.0129; De Abreu S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00799; De Vadder F, 2016, CELL METAB, V24, P151, DOI 10.1016/j.cmet.2016.06.013; Egawa T, 2015, AM J PHYSIOL-ENDOC M, V309, pE651, DOI 10.1152/ajpendo.00165.2015; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Faraj TA, 2017, INT REV IMMUNOL, V36, P125, DOI 10.1080/08830185.2017.1280483; Gaignier F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092664; Garrett-Bakelman FE, 2019, SCIENCE, V364, P144, DOI 10.1126/science.aau8650; Globus RK, 2016, J APPL PHYSIOL, V120, P1196, DOI 10.1152/japplphysiol.00997.2015; Gubern C, 2006, DIABETES, V55, P216, DOI 10.2337/diabetes.55.1.216; Hamburg NM, 2007, ARTERIOSCL THROM VAS, V27, P2650, DOI 10.1161/ATVBAHA.107.153288; Han HS, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.122; Heer M, 2014, SCI WORLD J, DOI 10.1155/2014/803083; Hughson RL, 2016, AM J PHYSIOL-HEART C, V310, pH628, DOI 10.1152/ajpheart.00802.2015; Ilyin VK, 2005, ACTA ASTRONAUT, V56, P839, DOI 10.1016/j.actaastro.2005.01.009; Jin ML, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00729; Jonscher KR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152877; Kikuchi K, 2018, BIOCHEM BIOPH RES CO, V501, P1041, DOI 10.1016/j.bbrc.2018.05.105; Li PP, 2015, FASEB J, V29, P3263, DOI 10.1096/fj.15-271700; LIZKO NN, 1991, ACTA ASTRONAUT, V23, P163, DOI 10.1016/0094-5765(91)90115-L; Macho L, 2003, ADV SPACE RES, V31, P1605, DOI 10.1016/S0273-1177(03)00097-8; Mardanov AV, 2013, ACTA NATURAE, V5, P116, DOI 10.32607/20758251-2013-5-3-116-125; Maurel DB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158381; McKenzie C, 2017, IMMUNOL REV, V278, P277, DOI 10.1111/imr.12556; Merrill A., 1985, J APPL PHYSIOL, V73, P142; Mithieux G, 2018, GUT, V67, P1373, DOI 10.1136/gutjnl-2017-315732; Moreno-Navarrete JM, 2010, INT J OBESITY, V34, P240, DOI 10.1038/ijo.2009.242; Postler TS, 2017, CELL METAB, V26, P110, DOI 10.1016/j.cmet.2017.05.008; Rabot S, 2000, DIGEST DIS SCI, V45, P1687, DOI 10.1023/A:1005508532629; Ritchie LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125792; Rivera CA, 2003, J APPL PHYSIOL, V95, P1656, DOI 10.1152/japplphysiol.00302.2003; Shi JX, 2017, FASEB J, V31, P3695, DOI 10.1096/fj.201700034R; Sittipo P, 2018, J MICROBIOL, V56, P154, DOI 10.1007/s12275-018-7548-y; SMIRNOV KV, 1987, NAHRUNG, V31, P563; Somova LA, 2005, ADV SPACE RES-SERIES, V35, P1621, DOI 10.1016/j.asr.2004.12.046; Stein TP, 2005, J NUTR, V135, p1824S, DOI 10.1093/jn/135.7.1824S; STEIN TP, 1994, AVIAT SPACE ENVIR MD, V65, P1091; STUART CA, 1988, METABOLISM, V37, P802, DOI 10.1016/0026-0495(88)90018-2; VERNIKOSDANELLIS J, 1976, AVIAT SPACE ENVIR MD, V47, P583; Yang YT, 2018, MOL MED REP, V17, P2313, DOI 10.3892/mmr.2017.8109	54	17	19	6	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10140	10151		10.1096/fj.201900238RR	http://dx.doi.org/10.1096/fj.201900238RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31238017				2022-12-28	WOS:000482214200034
J	Episcopio, D; Aminov, S; Benjamin, S; Germain, G; Datan, E; Landazuri, J; Lockshin, RA; Zakeri, Z				Episcopio, Donna; Aminov, Sarah; Benjamin, Shawna; Germain, Gabrielle; Datan, Emmanuel; Landazuri, Joselyn; Lockshin, Richard A.; Zakeri, Zahra			Atorvastatin restricts the ability of influenza virus to generate lipid droplets and severely suppresses the replication of the virus	FASEB JOURNAL			English	Article						autophagy; ER stress; cholesterol; statin; viral infection	ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; MAMMALIAN TARGET; AUTOPHAGY; RAPAMYCIN; LEVEL; DEPHOSPHORYLATION; CHOLESTEROL; ACTIVATION; INHIBITOR	Influenza virus causes infected cells to generate large numbers of lipid droplets. Because the virus envelope contains substantial cholesterol, we applied atorvastatin (ATV) to Madin-Darby Canine Kidney cells before infecting them. Five micromolars ATV, within physiologic range, strongly (>95%) inhibits reproduction of influenza A as measured by PCR of viral RNA, plaque assay for viable virus, and production of virus nucleoprotein (NP). Inhibition of any of the following can suppress formation of lipid droplets (>-50%) but does not interfere with the production of NP: endoplasmic reticulum stress, autophagy, or production of reactive oxygen substances (ROS). We conclude that, regardless of whether this widely used statin, which is generally considered to be safe, can prevent infection or minimize its severity, inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway to protect against infection by influenza virus or to mitigate its severity warrants further exploration.-Episcopio, D., Aminov, S., Benjamin, S., Germain, G., Datan, E., Landazuri, J., Lockshin, R. A., Zakeri, Z. Atorvastatin restricts the ability of influenza virus to generate lipid droplets and severely suppresses the replication of the virus.	[Episcopio, Donna; Aminov, Sarah; Benjamin, Shawna; Germain, Gabrielle; Datan, Emmanuel; Landazuri, Joselyn; Lockshin, Richard A.; Zakeri, Zahra] CUNY Queens Coll, Dept Biol, Flushing, NY 11367 USA; [Episcopio, Donna; Aminov, Sarah; Benjamin, Shawna; Germain, Gabrielle; Datan, Emmanuel; Landazuri, Joselyn; Lockshin, Richard A.; Zakeri, Zahra] CUNY, Grad Ctr, Flushing, NY USA; [Benjamin, Shawna] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [Germain, Gabrielle] CUNY Brooklyn Coll, Brooklyn, NY 11210 USA; [Germain, Gabrielle] CUNY, Grad Ctr, Brooklyn, NY 11210 USA; [Datan, Emmanuel] Johns Hopkins Sch Med, Baltimore, MD USA	City University of New York (CUNY) System; Queens College NY (CUNY); City University of New York (CUNY) System; University of Virginia; City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System; Johns Hopkins University; Johns Hopkins Medicine	Zakeri, Z (corresponding author), CUNY Queens Coll, Dept Biol, 65-30 Kissena Blvd, New York, NY 11367 USA.	zahra_zakeri@hotmail.com	Datan, Emmanuel/T-8987-2019	Benjamin, Shawna/0000-0003-4645-8140; Datan, Emmanuel/0000-0001-9820-3233	U.S. National Institutes of Health National Institute of General Medical Sciences (NIGMS) (MARC-USTAR) [T 34 GM070387]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM070387] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Institute of General Medical Sciences (NIGMS) (MARC-USTAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the Queens College Core Facility for Imaging, Molecular and Cellular Biology, for access to their facilities. This work was supported in part by funding from the U.S. National Institutes of Health National Institute of General Medical Sciences (NIGMS) (MARC-USTAR) Grant T 34 GM070387 to Z.Z. The authors declare no conflicts of interest.	Agarwal D, 2018, IMMUN AGEING, V15, DOI 10.1186/s12979-018-0124-9; Barman S, 2007, J VIROL, V81, P12169, DOI 10.1128/JVI.00835-07; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chiramel Abhilash I, 2013, Cells, V2, P83, DOI 10.3390/cells2010083; Chiu HT, 2018, VACCINE, V36, P6133, DOI 10.1016/j.vaccine.2018.08.067; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Dall'Armi C, 2013, CURR BIOL, V23, pR33, DOI 10.1016/j.cub.2012.10.041; Datan E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.409; Datan E, 2014, VIROLOGY, V452, P175, DOI 10.1016/j.virol.2014.01.008; El-Sayed I, 2016, BIOCHEM RES INT, V2016, DOI 10.1155/2016/1738237; Fedson DS, 2006, CLIN INFECT DIS, V43, P199, DOI 10.1086/505116; Feng B, 2011, BBA-MOL BASIS DIS, V1812, P1130, DOI 10.1016/j.bbadis.2011.05.007; Frost FJ, 2007, CHEST, V131, P1006, DOI 10.1378/chest.06-1997; HAN JW, 1995, J BIOL CHEM, V270, P21396, DOI 10.1074/jbc.270.36.21396; Hassan IH, 2012, J BIOL CHEM, V287, P4679, DOI 10.1074/jbc.M111.284695; Havers FP, 2018, CLIN INFECT DIS; Herker E, 2012, J BIOL CHEM, V287, P2280, DOI 10.1074/jbc.R111.300202; KATES M, 1962, COLD SPRING HARB SYM, V27, P293, DOI 10.1101/SQB.1962.027.001.027; Knaevelsrud H, 2012, BBA-MOL CELL BIOL L, V1821, P1133, DOI 10.1016/j.bbalip.2012.01.001; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Levine B, 2008, CELL, V132, P162; Lin L, 2006, CELL DEATH DIFFER, V13, P141, DOI 10.1038/sj.cdd.4401717; Liu L, 2015, CELL, V160, P177, DOI 10.1016/j.cell.2014.12.019; Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f; Marjuki H, 2006, J BIOL CHEM, V281, P16707, DOI 10.1074/jbc.M510233200; McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500; Mehrbod P, 2014, INT J MOL MED, V34, P61, DOI 10.3892/ijmm.2014.1761; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Orafaie A, 2018, CANCER METAST REV, V37, P397, DOI 10.1007/s10555-018-9738-9; Promlek T, 2011, MOL BIOL CELL, V22, P3520, DOI 10.1091/mbc.E11-04-0295; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Roberson EC, 2012, AM J RESP CELL MOL, V46, P573, DOI 10.1165/rcmb.2010-0460OC; Rumschlag-Booms E, 2013, ADV VIROL, V2013, DOI 10.1155/2013/121924; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Sekulic A, 2000, CANCER RES, V60, P3504; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Sun LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032503; Sun XJ, 2003, J VIROL, V77, P12543, DOI 10.1128/JVI.77.23.12543-12551.2003; Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Villareal VA, 2015, ANTIVIR RES, V124, P110, DOI 10.1016/j.antiviral.2015.10.013; Vlahos R, 2012, TRENDS PHARMACOL SCI, V33, P3, DOI 10.1016/j.tips.2011.09.001; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Zhang XB, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/247275; Zhou JJ, 2009, VIRUS GENES, V39, P76, DOI 10.1007/s11262-009-0365-y; Zhou Z, 2009, AUTOPHAGY, V5, P321, DOI 10.4161/auto.5.3.7406	49	29	29	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9516	9525		10.1096/fj.201900428RR	http://dx.doi.org/10.1096/fj.201900428RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31125254	Green Published, Bronze			2022-12-28	WOS:000478832900063
J	Poser, SW; Otto, O; Arps-Forker, C; Ge, Y; Herbig, M; Andree, C; Gruetzmann, K; Adasme, MF; Stodolak, S; Nikolakopoulou, P; Park, DM; Mcintyre, A; Lesche, M; Dahl, A; Lennig, P; Bornstein, SR; Schroeck, E; Klink, B; Leker, RR; Bickle, M; Chrousos, GP; Schroeder, M; Cannistraci, CV; Guck, J; Androutsellis-Theotokis, A				Poser, Steven W.; Otto, Oliver; Arps-Forker, Carina; Ge, Yan; Herbig, Maik; Andree, Cordula; Gruetzmann, Konrad; Adasme, Melissa F.; Stodolak, Szymon; Nikolakopoulou, Polyxeni; Park, Deric M.; Mcintyre, Alan; Lesche, Mathias; Dahl, Andreas; Lennig, Petra; Bornstein, Stefan R.; Schroeck, Evelin; Klink, Barbara; Leker, Ronen R.; Bickle, Marc; Chrousos, George P.; Schroeder, Michael; Cannistraci, Carlo Vittorio; Guck, Jochen; Androutsellis-Theotokis, Andreas			Controlling distinct signaling states in cultured cancer cells provides a new platform for drug discovery	FASEB JOURNAL			English	Article						signal transduction; glioblastoma; brain tumor; glioma; drug repurposing	MINIMUM CURVILINEARITY; STEM-CELLS; DEFORMABILITY; HES3; EXPRESSION; GROWTH; PROLIFERATION; ACTIVATION; MECHANICS; MIGRATION	Cancer cells can switch between signaling pathways to regulate growth under different conditions. In the tumor microenvironment, this likely helps them evade therapies that target specific pathways. We must identify all possible states and utilize them in drug screening programs. One such state is characterized by expression of the transcription factor Hairy and Enhancer of Split 3 (HES3) and sensitivity to HES3 knockdown, and it can be modeled in vitro. Here, we cultured 3 primary human brain cancer cell lines under 3 different culture conditions that maintain low, medium, and high HES3 expression and characterized gene regulation and mechanical phenotype in these states. We assessed gene expression regulation following HES3 knockdown in the HES3-high conditions. We then employed a commonly used human brain tumor cell line to screen Food and Drug Administration (FDA)-approved compounds that specifically target the HES3-high state. We report that cells from multiple patients behave similarly when placed under distinct culture conditions. We identified 37 FDA-approved compounds that specifically kill cancer cells in the high-HES3-expression conditions. Our work reveals a novel signaling state in cancer, biomarkers, a strategy to identify treatments against it, and a set of putative drugs for potential repurposing.-Poser, S. W., Otto, O., Arps-Forker, C., Ge, Y., Herbig, M., Andree, C., Gruetzmann, K., Adasme, M. F., Stodolak, S., Nikolakopoulou, P., Park, D. M., Mcintyre, A., Lesche, M., Dahl, A., Lennig, P., Bornstein, S. R., Schroeck, E., Klink, B., Leker, R. R., Bickle, M., Chrousos, G. P., Schroeder, M., Cannistraci, C. V., Guck, J., Androutsellis-Theotokis, A. Controlling distinct signaling states in cultured cancer cells provides a new platform for drug discovery.	[Poser, Steven W.; Arps-Forker, Carina; Nikolakopoulou, Polyxeni; Bornstein, Stefan R.; Androutsellis-Theotokis, Andreas] Tech Univ Dresden, Dept Internal Med 3, Dresden, Germany; [Otto, Oliver; Ge, Yan; Herbig, Maik; Adasme, Melissa F.; Lesche, Mathias; Dahl, Andreas; Schroeder, Michael; Guck, Jochen] Tech Univ Dresden, Biotechnol Ctr BIOTEC, Dresden, Germany; [Ge, Yan; Cannistraci, Carlo Vittorio] Tech Univ Dresden, Biomed Cybernet Grp, Dept Phys, Biotechnol Ctr BIOTEC,CMCB,CSBD, Dresden, Germany; [Lennig, Petra] Tech Univ Dresden, B CUBE Ctr Mol Bioengn, Dresden, Germany; [Schroeck, Evelin; Klink, Barbara] Tech Univ Dresden, Inst Clin Genet, Fac Med Carl Gustav Carus, Dresden, Germany; [Andree, Cordula; Bickle, Marc] Max Planck Inst Mol Cell Biol & Genet, Technol Dev Studio, Dresden, Germany; [Gruetzmann, Konrad; Schroeck, Evelin; Klink, Barbara] NCT, Core Unit Mol Tumor Diagnost CMTD, Dresden, Germany; [Gruetzmann, Konrad; Schroeck, Evelin; Klink, Barbara] German Canc Consortium DKTK, Dresden, Germany; [Gruetzmann, Konrad] German Canc Res Ctr, Heidelberg, Germany; [Stodolak, Szymon; Mcintyre, Alan; Androutsellis-Theotokis, Andreas] Univ Nottingham, Div Canc & Stem Cells, Nottingham, England; [Park, Deric M.] Univ Chicago, Dept Neurol, Comm Clin Pharmacol & Pharmacogen, Chicago, IL 60637 USA; [Park, Deric M.; Bornstein, Stefan R.; Androutsellis-Theotokis, Andreas] Innate Repair, London, England; [Lesche, Mathias; Dahl, Andreas; Androutsellis-Theotokis, Andreas] Ctr Regenerat Therapies Dresden, Dresden, Germany; [Leker, Ronen R.] Hadassah Hebrew Univ Med Ctr, Stroke Unit, Dept Neurol, Stroke Ctr, Jerusalem, Israel; [Leker, Ronen R.] Hadassah Hebrew Univ Med Ctr, Peritz & Chantal Sheinberg Cerebrovasc Res Lab, Jerusalem, Israel; [Chrousos, George P.] Univ Athens, Sch Med, Dept Pediat 1, Athens, Greece; [Chrousos, George P.] Aghia Sophia Childrens Hosp, Athens, Greece; [Cannistraci, Carlo Vittorio] IRCCS Ctr Neurolesi Bonino Pulejo, BBC Lab, Messina, Italy	Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Nottingham; University of Chicago; Technische Universitat Dresden; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Athens Medical School; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; IRCCS Bonino Pulejo	Androutsellis-Theotokis, A (corresponding author), Tech Univ Dresden, Univ Klinikum Carl Gustav, Med Klin & Poliklin 3, Haus 27 DINZ,1-OG,Zimmer 1-642,Fetscherstr 74, D-01307 Dresden, Germany.; Androutsellis-Theotokis, A (corresponding author), Tech Univ Dresden, Univ Klinikum Carl Gustav, Zentrum Innere Med, Haus 27 DINZ,1-OG,Zimmer 1-642,Fetscherstr 74, D-01307 Dresden, Germany.	andreas.theotokis@uniklinikum-dresden.de	Nikolakopoulou, Polyxeni/GOV-7024-2022; Dahl, Andreas/E-3783-2017; Herbig, Maik/AAN-4418-2021; Leker, Ronen/ABC-6096-2020; Guck, Jochen/B-4412-2014; Otto, Oliver/Q-9016-2017	Nikolakopoulou, Polyxeni/0000-0002-1695-9545; Dahl, Andreas/0000-0002-2668-8371; Herbig, Maik/0000-0001-7592-7829; Leker, Ronen/0000-0003-4794-0334; Guck, Jochen/0000-0002-1453-6119; Adasme, Melissa/0000-0003-2217-4629; McIntyre, Alan/0000-0002-4791-7292; Poser, Steven/0000-0003-4868-1389; Otto, Oliver/0000-0003-0280-5374; Androutsellis-Theotokis, Andreas/0000-0002-1985-4589; Klink, Barbara/0000-0002-8753-8238	Europaischen Fonds fur regionale Entwicklung (EFRE); Deutsche Forschungsgemeinschaft [KFO249, GU 612/2-2, CRC/Transregio 205/1, IRTG 2251]; Alexander-von-Humboldt Foundation; Sachsisches Ministerium fur Wissenschaft und Kunst [TG70]; Technische Universitat Dresden; TransCampus initiative; MRC [MR/P010334/1] Funding Source: UKRI	Europaischen Fonds fur regionale Entwicklung (EFRE); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alexander-von-Humboldt Foundation(Alexander von Humboldt Foundation); Sachsisches Ministerium fur Wissenschaft und Kunst; Technische Universitat Dresden; TransCampus initiative; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors are grateful to the Microstructure Facility of Biotechnology Center (BIOTEC)/Center for Regenerative Therapies Dresden (CRTD), Technische Universitat Dresden, funded by the Europaischen Fonds fur regionale Entwicklung (EFRE) for the production of real-time deformability cytometry microfluidic chips. The Technische Universitaet Dresden has intellectual property (patented and patent-pending) on aspects described in this manuscript for use in oncology (Inventors: A.A.-T. and S.W.P.). J.G. was supported by the Deutsche Forschungsgemeinschaft (Grant KFO249, GU 612/2-2), the Alexander-von-Humboldt Foundation (Humboldt Professorship), and the Sachsisches Ministerium fur Wissenschaft und Kunst (Grant TG70). O.O. was supported by the Sachsisches Ministerium fur Wissenschaft und Kunst (Grant TG70). C.V.C. was supported by the independent group leader starting grant of the Technische Universitat Dresden. A.A.T. was supported by the Deutsche Forschungsgemeinschaft (Grant SFB 655, "Cells into Tissues," Project A24). A.A.T. and S.R.B. were supported by the Deutsche Forschungsgemeinschaft (Grant CRC/Transregio 205/1 and Grant IRTG 2251). A. A. T. and S. R. B. were supported by the TransCampus initiative between Technische Universitat Dresden and King's College London and the Transcelerator. O.O. is cofounder at Zellmechanik Dresden (http://www.zellmechanik.com).A.A.-T.and S. R. B. are cofounders of Innate Repair (www.innaterepair.com).The authors declare no other conflicts of interest.	Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Androutsellis-Theotokis A, 2009, P NATL ACAD SCI USA, V106, P13570, DOI 10.1073/pnas.0905125106; ANDROUTSELLISTH.A, 2010, PLOS ONE, V0005; Bates DM, 2014, IME4 LINEAR MIXED EF; Bates D, 2013, J STAT SOFTW, V52, P1, DOI 10.18637/jss.v052.i05; Behan FM, 2019, NATURE; Brocard E, 2015, ONCOTARGET, V6, P6840, DOI 10.18632/oncotarget.3160; Buchert M, 2016, ONCOGENE, V35, P939, DOI 10.1038/onc.2015.150; Byun S, 2013, P NATL ACAD SCI USA, V110, P7580, DOI 10.1073/pnas.1218806110; Cannistraci CV, 2013, BIOINFORMATICS, V29, P199, DOI 10.1093/bioinformatics/btt208; Cannistraci CV, 2010, BIOINFORMATICS, V26, pi531, DOI 10.1093/bioinformatics/btq376; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Fang CQ, 2019, INT J MED SCI, V16, P470, DOI 10.7150/ijms.28139; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Hirata H, 2001, EMBO J, V20, P4454, DOI 10.1093/emboj/20.16.4454; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Imayoshi I, 2014, NEURON, V82, P9, DOI 10.1016/j.neuron.2014.03.018; Kendall GC, 2018, ELIFE, V7, DOI 10.7554/eLife.33800; Kodack DP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal4682; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Lautenschlager F, 2009, P NATL ACAD SCI USA, V106, P15696, DOI 10.1073/pnas.0811261106; Li Y, 2017, ONCOTARGET, V8, P39896, DOI 10.18632/oncotarget.16379; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lobe CG, 1997, MECH DEVELOP, V62, P227, DOI 10.1016/S0925-4773(97)00665-5; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo J, 2002, SCIENCE, V298, P425, DOI 10.1126/science.1074549; Masjkur J, 2016, DIABETES, V65, P314, DOI 10.2337/db15-1099; Masjkur J, 2014, J BIOL CHEM, V289, P35503, DOI 10.1074/jbc.M114.590687; Masjkur J, 2014, STEM CELL TRANSL MED, V3, P801, DOI 10.5966/sctm.2013-0211; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Mietke A, 2015, BIOPHYS J, V109, P2023, DOI 10.1016/j.bpj.2015.09.006; Mukthavaram R, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0627-5; Nikolakopoulou P, 2016, HORM METAB RES, V48, P77, DOI 10.1055/s-0041-111699; Ohta S, 2012, J CELL SCI, V125, P3210, DOI 10.1242/jcs.102210; Osanai K, 2017, HUM CELL, V30, P209, DOI 10.1007/s13577-017-0169-7; Otto O, 2015, NAT METHODS, V12, P199, DOI 10.1038/nmeth.3281; Park DM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01095; Poser SW, 2015, STEM CELL TRANSL MED, V4, P1251, DOI 10.5966/sctm.2015-0105; Poser SW, 2013, JOVE-J VIS EXP, DOI 10.3791/50880; Qin HR, 2008, CANCER RES, V68, P7736, DOI 10.1158/0008-5472.CAN-08-1125; Remmerbach TW, 2009, CANCER RES, V69, P1728, DOI 10.1158/0008-5472.CAN-08-4073; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Salewski RP, 2013, STEM CELLS DEV, V22, P383, DOI 10.1089/scd.2012.0218; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shibue T, 2017, NAT REV CLIN ONCOL, V14, P611, DOI 10.1038/nrclinonc.2017.44; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Soeda A, 2008, J BIOL CHEM, V283, P10958, DOI 10.1074/jbc.M704205200; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Toutouna L, 2016, BRAIN RES, V1642, P124, DOI 10.1016/j.brainres.2016.03.014; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Zhang CC, 2012, CLIN CANCER RES, V18, P5008, DOI 10.1158/1078-0432.CCR-12-1379; Zhang WJ, 2012, P NATL ACAD SCI USA, V109, P18707, DOI 10.1073/pnas.1209893109; Zheng Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep07613	56	3	3	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9235	9249		10.1096/fj.201802603RR	http://dx.doi.org/10.1096/fj.201802603RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31145643	Bronze			2022-12-28	WOS:000478832900043
J	Wang, C; Zhang, B; Ratliff, AC; Arrington, J; Chen, JJ; Xiong, Y; Yue, F; Nie, YH; Hu, KP; Jin, W; Tao, WA; Hrycyna, CA; Sun, XB; Kuang, SH				Wang, Chao; Zhang, Bin; Ratliff, Anna C.; Arrington, Justine; Chen, Jingjuan; Xiong, Yan; Yue, Feng; Nie, Yaohui; Hu, Keping; Jin, Wen; Tao, W. Andy; Hrycyna, Christine A.; Sun, Xiaobo; Kuang, Shihuan			Methyltransferase-like 21e inhibits 26S proteasome activity to facilitate hypertrophy of type IIb myofibers	FASEB JOURNAL			English	Article						Mettl21e; Myostatin; non-histone methylation; muscle atrophy; VCP/p97	GENE-EXPRESSION; PROTEIN-SYNTHESIS; MUSCLE; SLOW; CALCINEURIN; METHYLATION; ACTIVATION; MYOSTATIN; IDENTIFICATION; STIMULATION	Skeletal muscles contain heterogeneous myofibers that are different in size and contractile speed, with type IIb myofiber being the largest and fastest. Here, we identify methyltransferase-like 21e (Mettl21e), a member of newly classified nonhistone methyltransferases, as a gene enriched in type IIb myofibers. The expression of Mettl21e was strikingly up-regulated in hypertrophic muscles and during myogenic differentiation in vitro and in vivo. Knockdown (KD) of Mettl21e led to atrophy of cultured myotubes, and targeted mutation of Mettl21e in mice reduced the size of IIb myofibers without affecting the composition of myofiber types. Mass spectrometry and methyltransferase assay revealed that Mettl21e methylated valosin-containing protein (Vcp/p97), a key component of the ubiquitin-proteasome system. KD or knockout of Mettl21e resulted in elevated 26S proteasome activity, and inhibition of proteasome activity prevented atrophy of Mettl21e KD myotubes. These results demonstrate that Mettl21e functions to maintain myofiber size through inhibiting proteasome-mediated protein degradation.-Wang, C., Zhang, B., Ratliff, A. C., Arrington, J., Chen, J., Xiong, Y., Yue, F., Nie, Y., Hu, K., Jin, W., Tao, W. A., Hrycyna, C. A., Sun, X., Kuang, S. Methyltransferase-like 21e inhibits 26S proteasome activity to facilitate hypertrophy of type IIb myofibers.	[Wang, Chao; Chen, Jingjuan; Yue, Feng; Nie, Yaohui; Kuang, Shihuan] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Ratliff, Anna C.; Arrington, Justine; Hrycyna, Christine A.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Tao, W. Andy] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Tao, W. Andy; Hrycyna, Christine A.; Kuang, Shihuan] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Zhang, Bin; Xiong, Yan; Hu, Keping; Jin, Wen; Sun, Xiaobo] Chinese Acad Med Sci, Inst Med Plant Dev, Peking Union Med Coll, Beijing, Peoples R China	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College	Wang, C; Kuang, SH (corresponding author), Purdue Univ, 174B Smith Hall,901 West State St, W Lafayette, IN 47907 USA.	wang1438@purdue.edu; skuang@purdue.edu	Wang, Chao/V-8994-2019	Wang, Chao/0000-0002-4051-364X; Arrington, Justine/0000-0003-1511-8805	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01AR071649]; Innovation Fund for Medical Sciences (CIFMS) from Chinese Academy of Medical Sciences [2016-I2M-1-012]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR071649] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Innovation Fund for Medical Sciences (CIFMS) from Chinese Academy of Medical Sciences; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Fengfeng Zhang (ViewSolid Biotech, Beijing, China) for generating the methyltransferase-like 21e knockout mice, Chris Bidwell (Purdue University, West Lafayette, IN, USA) for discussion and sharing Callipyge sheep data, Jessie Ellis (Purdue University) for technical assistance, Jun Wu (Purdue University) and Mary Larimore (Purdue University) for mouse colony maintenance, and members of the Kuang laboratory for valuable comments. This work was supported by a grant from the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (R01AR071649) and Innovation Fund for Medical Sciences (CIFMS) from Chinese Academy of Medical Sciences (2016-I2M-1-012). The authors declare no conflicts of interest.	Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; Bidwell CA, 2014, ANIM GENET, V45, P51, DOI 10.1111/age.12132; Biggar KK, 2015, NAT REV MOL CELL BIO, V16, P5, DOI 10.1038/nrm3915; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Caetano-Anolles K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116828; Carpenter E, 1996, J ANIM SCI, V74, P388; Clemen CS, 2015, BIOCHEM BIOPH RES CO, V463, P1210, DOI 10.1016/j.bbrc.2015.06.086; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; El-Brolosy MA, 2019, NATURE, V568, P193, DOI 10.1038/s41586-019-1064-z; Fleming-Waddell JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007399; GOLDBERG AL, 1967, NATURE, V216, P1219, DOI 10.1038/2161219a0; Hamey JJ, 2017, MOL CELL PROTEOMICS, V16, P2229, DOI 10.1074/mcp.M116.066308; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Imai J, 2003, EMBO J, V22, P3557, DOI 10.1093/emboj/cdg349; Jakobsson ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131426; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; Kloppsteck P, 2012, BBA-MOL CELL RES, V1823, P125, DOI 10.1016/j.bbamcr.2011.09.006; Kubik RM, 2018, TRANSL ANIM SCI, V2, pS53, DOI 10.1093/tas/txy053; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lee KY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9054; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu N, 2017, NAT CELL BIOL, V19, P202, DOI 10.1038/ncb3477; Ma ZP, 2019, NATURE, V568, P259, DOI 10.1038/s41586-019-1057-y; Malecki J, 2017, NUCLEIC ACIDS RES, V45, P4370, DOI 10.1093/nar/gkx002; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Quiat D, 2011, P NATL ACAD SCI USA, V108, P10196, DOI 10.1073/pnas.1107413108; Reza MM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01131-0; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; SMERDU V, 1994, AM J PHYSIOL-CELL PH, V267, pC1723, DOI 10.1152/ajpcell.1994.267.6.C1723; Stark DA, 2015, J CELL BIOL, V211, P1077, DOI 10.1083/jcb.201502036; TSENG BS, 1994, CELL TISSUE RES, V275, P39, DOI 10.1007/BF00305374; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; van Wessel T, 2010, EUR J APPL PHYSIOL, V110, P665, DOI 10.1007/s00421-010-1545-0; Wang C, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2279; Wang C, 2017, DEVELOPMENT, V144, P235, DOI 10.1242/dev.138099; Welle S, 2009, PHYSIOL GENOMICS, V38, P342, DOI 10.1152/physiolgenomics.00054.2009; Welle S, 2009, AM J PHYSIOL-ENDOC M, V296, pE567, DOI 10.1152/ajpendo.90862.2008; Wiederstein JL, 2018, CELL REP, V23, P1342, DOI 10.1016/j.celrep.2018.03.136; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100; Zhang ZD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r26	50	7	7	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9672	9684		10.1096/fj.201900582R	http://dx.doi.org/10.1096/fj.201900582R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31162944	Green Published			2022-12-28	WOS:000478832900075
J	Wright, JD; An, SW; Xie, J; Lim, C; Huang, CL				Wright, Jon D.; An, Sung-Wan; Xie, Jian; Lim, Carmay; Huang, Chou-Long			Soluble klotho regulates TRPC6 calcium signaling via lipid rafts, independent of the FGFR-FGF23 pathway	FASEB JOURNAL			English	Article						alpha 2-3-sialyllactose; sialoganglioside; molecular dynamic simulation	DEPENDENT ROTAMER LIBRARY; PROTEIN SIDE-CHAIN; STRUCTURAL-INSIGHTS; DOCKING; CHARMM; MECHANISM; RECEPTOR; MODEL; GUI	Soluble klotho (sKlotho), the shed ectodomain of alpha-klotho, protects the heart by down-regulating transient receptor potential canonical isoform 6 (TRPC6)-mediated calcium signaling. Binding to alpha 2-3-sialyllactose moiety of gangliosides in lipid rafts and inhibition of raft-dependent signaling underlies the mechanism. A recent 3-angstrom X-ray structure of sKlotho in complex with fibroblast growth factor receptor (FGFR) and fibroblast growth factor 23 (FGF23) indicates that its beta 6 alpha 6 loop might block access to the proposed binding site for alpha 2-3-sialyllactose. It was concluded that sKlotho only functions in complex with FGFR and FGF23 and that sKlotho's pleiotropic effects all depend on FGF23. Here, we report that sKlotho can inhibit TRPC6 channels expressed in cells lacking endogenous FGFRs. Structural modeling and molecular docking show that a repositioned beta 6 alpha 6 loop allows sKlotho to bind alpha 2-3-sialyllactose. Molecular dynamic simulations further show the alpha 2-3-sialyllactose-bound sKlotho complex to be stable. Domains mimicking sKlotho's sialic acid-recognizing activity inhibit TRPC6. The results strongly support the hypothesis that sKlotho can exert effects independent of FGF23 and FGFR.-Wright, J. D., An, S.-W., Xie, J., Lim, C., Huang, C.-L. Soluble klotho regulates TRPC6 calcium signaling via lipid rafts, independent of the FGFR-FGF23 pathway.	[Wright, Jon D.; Lim, Carmay] Acad Sinica, Inst Biomed Sci, 128,Sect 2,Acad Rd, Taipei 115, Taiwan; [An, Sung-Wan; Xie, Jian; Huang, Chou-Long] Univ Iowa, Carver Coll Med, Dept Internal Med, Div Nephrol, 200 Hawkins Dr,E300 GH, Iowa City, IA 52242 USA; [Lim, Carmay] Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan	Academia Sinica - Taiwan; University of Iowa; National Tsing Hua University	Lim, C (corresponding author), Acad Sinica, Inst Biomed Sci, 128,Sect 2,Acad Rd, Taipei 115, Taiwan.; Huang, CL (corresponding author), Univ Iowa, Carver Coll Med, Dept Internal Med, Div Nephrol, 200 Hawkins Dr,E300 GH, Iowa City, IA 52242 USA.	carmay@gate.sinica.edu.tw; chou-long-huang@uiowa.edu	Lim, Carmay/N-9648-2015; Wright, Jon D/C-9541-2019	Lim, Carmay/0000-0001-9077-7769; Xie, Jian/0000-0001-9454-1358	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK100605, DK109887]; Ministry of Science & Technology, Taiwan [106-14]; Academia Sinica, Taiwan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100605, R01DK109887] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Ministry of Science & Technology, Taiwan; Academia Sinica, Taiwan(Academia Sinica - Taiwan); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Lokesh Gakhar and Nicholas Schnicker (Both from the University of Iowa Carver College of Medicine) for comments. The study is supported in part by the U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (Grants DK100605, DK109887 to C.-L.H.) and by funds from the Ministry of Science & Technology, Taiwan (Grant 106-14) and Academia Sinica, Taiwan (to C.L.). C.-L.H. holds the Roy J. Carver Chair in Internal Medicine in the University of Iowa Carver College of Medicine. The authors declare no conflicts of interest.	Allen WJ, 2015, J COMPUT CHEM, V36, P1132, DOI 10.1002/jcc.23905; Amaya MF, 2004, STRUCTURE, V12, P775, DOI 10.1016/j.str.2004.02.036; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen GZ, 2018, NATURE, V553, P461, DOI 10.1038/nature25451; Connaris H, 2014, P NATL ACAD SCI USA, V111, P6401, DOI 10.1073/pnas.1404205111; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Dalton G, 2017, P NATL ACAD SCI USA, V114, P752, DOI 10.1073/pnas.1620301114; Dalton GD, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00323; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Guvench O, 2011, J CHEM THEORY COMPUT, V7, P3162, DOI 10.1021/ct200328p; HOLST M, 1993, J COMPUT CHEM, V14, P105, DOI 10.1002/jcc.540140114; HOLST MJ, 1995, J COMPUT CHEM, V16, P337, DOI 10.1002/jcc.540160308; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Jayaram B, 1999, J COMPUT PHYS, V151, P333, DOI 10.1006/jcph.1998.6173; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jo S, 2011, J COMPUT CHEM, V32, P3135, DOI 10.1002/jcc.21886; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kubota M, 2016, P NATL ACAD SCI USA, V113, P11579, DOI 10.1073/pnas.1608383113; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kurosu H, 2008, CURR OPIN NEPHROL HY, V17, P368, DOI 10.1097/MNH.0b013e3282ffd994; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Liu F, 2011, NAT CELL BIOL, V13, P254, DOI 10.1038/ncb2167; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Mills JEJ, 1996, J COMPUT AID MOL DES, V10, P607, DOI 10.1007/BF00134183; Owen CD, 2015, J BIOL CHEM, V290, P27736, DOI 10.1074/jbc.M115.673632; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Razzaque MS, 2007, J ENDOCRINOL, V194, P1, DOI 10.1677/JOE-07-0095; REED AE, 1985, J CHEM PHYS, V83, P735, DOI 10.1063/1.449486; Reiher W. E., 1985, THESIS; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; Ruiz FM, 2015, CHEM-EUR J, V21, P13558, DOI 10.1002/chem.201501961; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SHARP KA, 1991, SCIENCE, V252, P106, DOI 10.1126/science.2011744; SHOICHET BK, 1992, J COMPUT CHEM, V13, P380, DOI 10.1002/jcc.540130311; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Wright JD, 2017, FASEB J, V31, P3574, DOI 10.1096/fj.201700043R; Xie J, 2015, J AM SOC NEPHROL, V26, P1150, DOI 10.1681/ASN.2014040325; Xie J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2240; Yuan P, 2005, STRUCTURE, V13, P803, DOI 10.1016/j.str.2005.02.019	53	17	19	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9182	9193		10.1096/fj.201900321R	http://dx.doi.org/10.1096/fj.201900321R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31063704	Green Published			2022-12-28	WOS:000478832900039
J	Bartoszewski, R; Moszynska, A; Serocki, M; Cabaj, A; Polten, A; Ochocka, R; Dell'Italia, L; Bartoszewska, S; Kroliczewski, J; Dabrowski, MD; Collawn, JF				Bartoszewski, Rafal; Moszynska, Adrianna; Serocki, Marcin; Cabaj, Aleksandra; Polten, Andreas; Ochocka, Renata; Dell'Italia, Louis; Bartoszewska, Sylwia; Kroliczewski, Jaroslaw; Dabrowski, Michal D.; Collawn, James F.			Primary endothelial cell-specific regulation of hypoxia-inducible factor (HIF)-1 and HIF-2 and their target gene expression profiles during hypoxia	FASEB JOURNAL			English	Article						human endothelial cells; HIF1A; EPAS1	MESSENGER-RNA; PROLINE HYDROXYLATION; BINDING-SITES; FACTOR-I; PROTEIN; HIF-1-ALPHA; ALPHA; TRANSLATION; DEGRADATION; REPRESSION	During hypoxia, a cellular adaptive response activates hypoxia-inducible factors (HIFs; HIF-1 and HIF-2) that respond to low tissue-oxygen levels and induce the expression of a number of genes that promote angiogenesis, energy metabolism, and cell survival. HIF-1 and HIF-2 regulate endothelial cell (EC) adaptation by activating gene-signaling cascades that promote endothelial migration, growth, and differentiation. An HIF-1 to HIF-2 transition or switch governs this process from acute to prolonged hypoxia. In the present study, we evaluated the mechanisms governing the HIF switch in 10 different primary human ECs from different vascular beds during the early stages of hypoxia. The studies demonstrate that the switch from HIF-1 to HIF-2 constitutes a universal mechanism of cellular adaptation to hypoxic stress and that HIF1A and HIF2A mRNA stability differences contribute to HIF switch. Furthermore, using 4 genome-wide mRNA expression arrays of HUVECs during normoxia and after 2, 8, and 16 h of hypoxia, we show using bioinformatics analyses that, although a number of genes appeared to be regulated exclusively by HIF-1 or HIF-2, the largest number of genes appeared to be regulated by both.-Bartoszewski, R., Moszyska, A., Serocki, M., Cabaj, A., Polten, A., Ochocka, R., Dell'Italia, L., Bartoszewska, S., Kroliczewski, J., Dbrowski, M., Collawn, J. F. Primary endothelial cell-specific regulation of hypoxia-inducible factor (HIF)-1 and HIF-2 and their target gene expression profiles during hypoxia.	[Bartoszewski, Rafal; Moszynska, Adrianna; Serocki, Marcin; Ochocka, Renata; Kroliczewski, Jaroslaw] Med Univ Gdansk, Dept Biol & Pharmaceut Bot, Hallera 107, PL-80416 Gdansk, Poland; [Bartoszewska, Sylwia] Med Univ Gdansk, Dept Inorgan Chem, Gdansk, Poland; [Cabaj, Aleksandra; Dabrowski, Michal D.] Polish Acad Sci, Lab Bioinformat, Nencki Inst Expt Biol, Warsaw, Poland; [Polten, Andreas] Agilent Technol Sales & Serv, Waldbronn, Germany; [Dell'Italia, Louis] Birmingham Vet Affairs VA Med Ctr, Dept Med, Birmingham, AL USA; [Collawn, James F.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham	Bartoszewski, R (corresponding author), Med Univ Gdansk, Dept Biol & Pharmaceut Bot, Hallera 107, PL-80416 Gdansk, Poland.	rafalbar@gumed.edu.pl	Cabaj, Aleksandra/U-9449-2019; Bartoszewski, Rafal A/D-6311-2011; Bartoszewska, Sylwia/L-3922-2019; Dąbrowski, Michał/K-4384-2012; Króliczewski, Jarosław/H-5930-2019	Cabaj, Aleksandra/0000-0002-3341-9137; Bartoszewski, Rafal A/0000-0002-2864-6757; Bartoszewska, Sylwia/0000-0001-8063-1272; Króliczewski, Jarosław/0000-0002-5895-5104; Dabrowski, Michal/0000-0002-5335-158X; Collawn, James/0000-0002-2528-2759; Moszynska, Adrianna/0000-0002-7262-4117	National Science Center SONATA BIS Program [UMO-2015/18/E/NZ3/00687]; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [P30 DK072482]; Cystic Fibrosis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482] Funding Source: NIH RePORTER	National Science Center SONATA BIS Program; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Perlan Technologies, Polska Spolka z ograniczona odpowiedzialnoscia (Sp. z o. o.) for performing microarray experiments and analysis. This research was funded by National Science Center SONATA BIS Program under contract UMO-2015/18/E/NZ3/00687 (to R.B.). J.F.C. was funded by the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant P30 DK072482, and a Research Development Program grant from the Cystic Fibrosis Foundation. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. The authors declare no conflicts of interest.	Alizadeh E, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123846; [Anonymous], 2008, R LANG ENV STAT COMP, P1; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Bartoszewska S, 2017, CELL MOL BIOL LETT, V22, DOI 10.1186/s11658-017-0054-0; Bartoszewska S, 2015, FASEB J, V29, P1467, DOI 10.1096/fj.14-267054; Bartoszewski R, 2008, J BIOL CHEM, V283, P12154, DOI 10.1074/jbc.M707610200; Bartoszewski R, 2017, EUR J CELL BIOL, V96, P758, DOI 10.1016/j.ejcb.2017.10.001; Bartoszewski R, 2011, METHOD ENZYMOL, V491, P3, DOI 10.1016/B978-0-12-385928-0.00001-8; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Ben-Ari Fuchs S, 2016, OMICS, V20, P139, DOI 10.1089/omi.2015.0168; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chamboredon S, 2011, MOL BIOL CELL, V22, P3366, DOI 10.1091/mbc.E10-07-0617; Choudhry H, 2014, EMBO REP, V15, P70, DOI 10.1002/embr.201337642; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fahling M, 2009, J CELL MOL MED, V13, P2770, DOI 10.1111/j.1582-4934.2009.00875.x; Fallmann J, 2016, NUCLEIC ACIDS RES, V44, pD90, DOI 10.1093/nar/gkv1238; Fish JE, 2007, J BIOL CHEM, V282, P15652, DOI 10.1074/jbc.M608318200; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Ho JJD, 2012, J BIOL CHEM, V287, P29003, DOI 10.1074/jbc.M112.373365; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Janaszak-Jasiecka A, 2018, ANGIOGENESIS, V21, P711, DOI 10.1007/s10456-018-9620-y; Janaszak-Jasiecka A, 2016, SCI REP-UK, V6, DOI 10.1038/srep22775; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kalinowski L, 2016, CELL MOL BIOL LETT, V21, DOI 10.1186/s11658-016-0017-x; Kawanami D, 2009, J BIOL CHEM, V284, P20522, DOI 10.1074/jbc.M109.025346; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kim TW, 2010, BIOCHEM BIOPH RES CO, V391, P963, DOI 10.1016/j.bbrc.2009.11.174; Koh MY, 2012, TRENDS BIOCHEM SCI, V37, P364, DOI 10.1016/j.tibs.2012.06.004; Koh MY, 2006, CAN RES S, V66, P409; Krystkowiaky I, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat069; Kulakovskiy IV, 2018, NUCLEIC ACIDS RES, V46, pD252, DOI 10.1093/nar/gkx1106; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep29311; Liu YV, 2007, CELL CYCLE, V6, P656, DOI 10.4161/cc.6.6.3981; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loboda A, 2012, VASC PHARMACOL, V56, P245, DOI 10.1016/j.vph.2012.02.006; Loboda A, 2010, MOL CELLS, V29, P435, DOI 10.1007/s10059-010-0067-2; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Mammadzada P, 2016, ACTA OPHTHALMOL, V94, P805, DOI [10.1111/aos.13119, 10.1111/j.1755-3768.2016.0399]; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MCQUILLAN LP, 1994, AM J PHYSIOL-HEART C, V267, pH1921; Nauta TD, 2017, ANGIOGENESIS, V20, P39, DOI 10.1007/s10456-016-9527-4; Robb GB, 2004, J BIOL CHEM, V279, P37982, DOI 10.1074/jbc.M400271200; Safran M, 2003, J CLIN INVEST, V111, P779, DOI 10.1172/JCI200318181; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Serocki M, 2018, ANGIOGENESIS, V21, P183, DOI 10.1007/s10456-018-9600-2; Smythies JA, 2019, EMBO REP, V20, DOI 10.15252/embr.201846401; Stelzer G, 2009, OMICS, V13, P477, DOI 10.1089/omi.2009.0069; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Weigand JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042697; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098	67	61	67	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					7929	7941		10.1096/fj.201802650RR	http://dx.doi.org/10.1096/fj.201802650RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30917010	Green Published, Bronze			2022-12-28	WOS:000476234700011
J	Botten, N; Hodges, RR; Li, DY; Bair, JA; Shatos, MA; Utheim, TP; Serhan, CN; Dartt, DA				Botten, Nora; Hodges, Robin R.; Li, Dayu; Bair, Jeffrey A.; Shatos, Marie A.; Utheim, Tor P.; Serhan, Charles N.; Dartt, Darlene A.			Resolvin D2 elevates cAMP to increase intracellular [Ca2+] and stimulate secretion from conjunctival goblet cells	FASEB JOURNAL			English	Article						allergic eye disease; inflammation; signal transduction; resolution of inflammation; specialized proresolving mediators	PROTEIN SECRETION; LIPID MEDIATORS; ACUTE-INFLAMMATION; SIGNALING PATHWAY; MUCIN SECRETION; CYCLIC-AMP; RAT; RECEPTOR; D1; RESOLUTION	Under physiologic conditions, conjunctival goblet cells (CGCs) secrete mucins into the tear film to preserve ocular surface homeostasis. Specialized proresolving mediators (SPMs), like resolvins (Rvs), regulate secretion from CGCs and actively terminate inflammation. The purpose of this study was to determine if RvD2 stimulated mucin secretion and to investigate the cellular signaling components. Goblet cells were cultured from rat conjunctiva. Secretion was measured by an enzyme-linked lectin assay, change in intracellular [Ca2+] ([Ca2+](i)) using Fura-2, and cellular cAMP levels by ELISA. RvD2 (10(-11)-10(-8) M) stimulated secretion, increased cellular cAMP levels and the [Ca2+](i). RvD2-stimulated increase in [Ca2+](i) and secretion was blocked by Ca2+ chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N ',N '-tetraacetic acid tetrakis and the PKA inhibitor N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide dihydrochloride but not by the cAMP exchange protein inhibitor alpha-[2-(3-chlorophenyl)hydrazinylidene]-5-(1,1-dimethylethyl)-b-oxo-3-isoxazolepropanenitrile. Forskolin, 3-isobutyl-1-methylxanthine, and 8-bromo-cAMP (8-Br-cAMP) increased [Ca2+](i). Increasing cAMP with 8-Br-cAMP inhibited the increase in [Ca2+](i) stimulated by the cAMP-independent agonist cholinergic agonist carbachol. In conclusion, RvD2 uses both cellular cAMP and [Ca2+](i) to stimulate glycoconjugate secretion from CGCs, but the interaction of cAMP and [Ca2+](i) is context dependent. Thus RvD2 likely assists in the maintenance of the mucous layer of the tear film to sustain ocular surface homeostasis and has potential as a novel treatment for dry eye disease.-Botten, N., Hodges, R. R., Li, D., Bair, J. A., Shatos, M. A., Utheim, T. P., Serhan, C. N., Dartt, D. A. Resolvin D2 elevates cAMP to increase intracellular [Ca2+] and stimulate secretion from conjunctival goblet cells.	[Botten, Nora; Hodges, Robin R.; Li, Dayu; Bair, Jeffrey A.; Shatos, Marie A.; Utheim, Tor P.; Dartt, Darlene A.] Harvard Med Sch, Schepens Eye Res Inst, Massachusetts Eye & Ear, Brigham & Womens Hosp, Boston, MA 02114 USA; [Botten, Nora; Hodges, Robin R.; Li, Dayu; Bair, Jeffrey A.; Shatos, Marie A.; Utheim, Tor P.; Dartt, Darlene A.] Harvard Med Sch, Dept Ophthalmol, Brigham & Womens Hosp, Boston, MA 02114 USA; [Serhan, Charles N.] Harvard Med Sch, Ctr Expt Therapeut & Reperfus Injury, Brigham & Womens Hosp, Boston, MA 02114 USA; [Serhan, Charles N.] Harvard Med Sch, Dept Anesthesiol Perioperat & Pain Med, Brigham & Womens Hosp, Boston, MA 02114 USA; [Botten, Nora; Utheim, Tor P.] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Botten, Nora; Utheim, Tor P.] Oslo Univ Hosp, Dept Plast & Reconstruct Surg, Oslo, Norway; [Botten, Nora] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Oslo; University of Oslo; University of Oslo	Dartt, DA (corresponding author), Harvard Med Sch, Schepens Eye Res Inst, Massachusetts Eye & Ear, 20 Staniford St, Boston, MA 02114 USA.	darlene_dartt@meei.harvard.edu			U.S. National Institutes of Health (NIH), National Eye Institute [RO1EY019470]; U.S. National Institutes of Health (NIH), National Institute of General Medical Sciences [RO1GM038765]; Norwegian Research Council; NATIONAL EYE INSTITUTE [R01EY019470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038765] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); U.S. National Institutes of Health (NIH), National Institute of General Medical Sciences; Norwegian Research Council(Research Council of NorwayEuropean Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health (NIH), National Eye Institute Grant RO1EY019470 (to D.A.D.) and National Institute of General Medical Sciences Grant RO1GM038765 (to C.N.S.), and by the Norwegian Research Council (to N.B.) The authors declare no conflicts of interest.	Arnardottir H, 2016, MUCOSAL IMMUNOL, V9, P757, DOI 10.1038/mi.2015.99; Billington CK, 2012, BRIT J PHARMACOL, V166, P401, DOI 10.1111/j.1476-5381.2011.01719.x; Chiang N, 2017, J IMMUNOL, V198, P842, DOI 10.4049/jimmunol.1601650; Chiang N, 2015, J EXP MED, V212, P1203, DOI 10.1084/jem.20150225; Claria J, 2012, J IMMUNOL, V189, P2597, DOI 10.4049/jimmunol.1201272; Colas RA, 2014, AM J PHYSIOL-CELL PH, V307, pC39, DOI 10.1152/ajpcell.00024.2014; Dalli J, 2017, CRIT CARE MED, V45, P58, DOI 10.1097/CCM.0000000000002014; Dartt DA, 2014, CURR OPIN ALLERGY CL, V14, P464, DOI 10.1097/ACI.0000000000000098; Dartt DA, 2011, J IMMUNOL, V186, P4455, DOI 10.4049/jimmunol.1000833; de Paiva CS, 2012, CORNEA, V31, P1299, DOI 10.1097/ICO.0b013e31823f789e; English JT, 2017, PROSTAG LEUKOTR ESS, V117, P17, DOI 10.1016/j.plefa.2017.01.004; Evans V, 2000, CLIN EXP OPHTHALMOL, V28, P208, DOI 10.1046/j.1442-9071.2000.00285.x; Frediani JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108854; Funaki C, 2007, AM J PHYSIOL-CELL PH, V293, pC1551, DOI 10.1152/ajpcell.00013.2007; Garcia-Posadas L, 2016, MUCOSAL IMMUNOL, V9, P206, DOI 10.1038/mi.2015.53; Gipson IK, 2003, INT REV CYTOL, V231, P1, DOI 10.1016/S0074-7696(03)31001-0; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Hodges RR, 2017, MUCOSAL IMMUNOL, V10, P46, DOI 10.1038/mi.2016.33; Hodges RR, 2012, EXP EYE RES, V103, P99, DOI 10.1016/j.exer.2012.08.010; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Keelan JA, 2015, REPRODUCTION, V149, P171, DOI 10.1530/REP-14-0549; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Li D, 2013, MUCOSAL IMMUNOL, V6, P1119, DOI 10.1038/mi.2013.7; Li D, 2013, INVEST OPHTH VIS SCI, V54, P2872, DOI 10.1167/iovs.12-11264; Li N, 2010, J OCUL PHARMACOL TH, V26, P431, DOI 10.1089/jop.2010.0019; Lippestad M, 2018, EXP EYE RES, V173, P64, DOI 10.1016/j.exer.2018.04.015; Lippestad M, 2017, INVEST OPHTH VIS SCI, V58, P4530, DOI 10.1167/iovs.17-21914; Mantelli F, 2008, CURR OPIN ALLERGY CL, V8, P477, DOI 10.1097/ACI.0b013e32830e6b04; Mas E, 2012, CLIN CHEM, V58, P1476, DOI 10.1373/clinchem.2012.190199; MAUDUIT P, 1983, FEBS LETT, V153, P21, DOI 10.1016/0014-5793(83)80111-2; Mayati A, 2012, J BIOL CHEM, V287, P4041, DOI 10.1074/jbc.M111.319970; Pereira L, 2007, J PHYSIOL-LONDON, V583, P685, DOI 10.1113/jphysiol.2007.133066; Rajasagi NK, 2011, J IMMUNOL, V186, P1735, DOI 10.4049/jimmunol.1003456; Rios JD, 1999, INVEST OPHTH VIS SCI, V40, P1102; Saban DR, 2019, MUCOSAL IMMUNOL, V12, P145, DOI 10.1038/s41385-018-0089-1; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Serhan CN, 2018, MOL ASPECTS MED, V64, P1, DOI 10.1016/j.mam.2017.08.002; Serhan CN, 2017, MOL ASPECTS MED, V58, P1, DOI 10.1016/j.mam.2017.03.001; Serhan CN, 2015, SEMIN IMMUNOL, V27, P200, DOI 10.1016/j.smim.2015.03.004; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Settimio R, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/318621; Shah AU, 2008, AM J PHYSIOL-GASTR L, V294, pG1328, DOI 10.1152/ajpgi.00440.2007; Shatos MA, 2001, INVEST OPHTH VIS SCI, V42, P1455; Shi HS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185383; Tovey SC, 2008, J CELL BIOL, V183, P297, DOI 10.1083/jcb.200803172; Zhang ZZ, 2018, MOL VIS, V24, P274; Zoukhri D, 2000, INVEST OPHTH VIS SCI, V41, P386	47	13	14	2	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8468	8478		10.1096/fj.201802467R	http://dx.doi.org/10.1096/fj.201802467R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	31013438	Green Published			2022-12-28	WOS:000476234700052
J	Chen, LH; Wu, M; Zhang, SN; Tan, WJ; Guan, M; Feng, LQ; Chen, C; Tao, J; Chen, L; Qu, LB				Chen, Longhui; Wu, Min; Zhang, Shengnan; Tan, Wenjuan; Guan, Min; Feng, Liqiang; Chen, Chen; Tao, Jun; Chen, Ling; Qu, Linbing			Estrogen-related receptor gamma regulates hepatic triglyceride metabolism through phospholipase A2 G12B	FASEB JOURNAL			English	Article						hypertriglyceridemia; VLDL secretion; ERR gamma; PLA2G12B	ERR-GAMMA; ORPHAN; EXPRESSION; VLDL; A(2); OVERPRODUCTION; SECRETION; HYPERTRIGLYCERIDEMIA; PGC-1-ALPHA; INHIBITION	Hypersecretion of hepatic very LDL (VLDL)-associated triglyceride (TG) is the hallmark of hypertriglyceridemia. The estrogen-related receptor gamma (ERR gamma), an orphan nuclear receptor, plays crucial roles in the regulation of metabolic homeostasis, including TG formation in the liver. It remains unclear whether ERR gamma regulates hepatic VLDL-TG secretion. We demonstrated that knockdown of ERR gamma impairs hepatic VLDL-TG secretion in mice, whereas overexpression of ERR gamma favors the secretion, indicating a novel role of ERR gamma in hepatic TG metabolism. We found that ERR gamma transcriptionally regulates the expression of PLA2G12B by binding to the promoter region of the Pla2g12b gene. In Pla2g12b-null mice, ERR gamma fails to regulate hepatic VLDL-TG secretion. There is an apparent accumulation of large lipid droplets in the liver of Pla2g12b-null mice. These data suggest that ERR gamma is a novel regulator of hepatic VLDL-TG secretion, which is mediated through the action on PLA2G12B.-Chen, L., Wu, M., Zhang, S., Tan, W., Guan, M., Feng, L., Chen, C., Tao, J., Chen, L., Qu, L. Estrogen-related receptor gamma regulates hepatic triglyceride metabolism through phospholipase A2 G12B.	[Chen, Longhui; Wu, Min; Zhang, Shengnan; Feng, Liqiang; Chen, Ling; Qu, Linbing] Chinese Acad Sci, Guangdong Lab Computat Biomed, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Feng, Liqiang; Chen, Ling] Chinese Acad Sci, Ghuangzhou Inst Biomed & Hlth, State Key Labs Resp Dis, Guangzhou, Guangdong, Peoples R China; [Zhang, Shengnan; Chen, Ling] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China; [Tan, Wenjuan] Chinese Univ Hong Kong, Fac Sci, Sch Life Sci, Hong Kong, Peoples R China; [Guan, Min] Chinese Acad Sci, Ctr Human Tissues & Organs Degenerat, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Chen, Chen] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Tao, Jun] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hypertens & Vasc Dis, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese University of Hong Kong; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; University of Queensland; Sun Yat Sen University	Chen, L; Qu, LB (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, 190 Kaiyuan Ave, Guangzhou 510530, Guangdong, Peoples R China.	chen_ling@gibh.ac.cn; qu_linbing@gibh.ac.cn	chen, chen/GRY-7085-2022; Chen, Chen/B-4284-2010; CHEN, CHEN/HDM-6657-2022	Chen, Chen/0000-0003-2104-534X; Guan, Min/0000-0003-3851-8553	National Natural Science Foundation of China [81470570]; Department of Science and Technology of Guangdong Province [2015A030312017]; Guangzhou Health Care and Cooperative Innovation Major Project [201704020212]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Guangdong Province; Guangzhou Health Care and Cooperative Innovation Major Project	The authors thank Qingqing Wang and Xuehua Zheng (Guangzhou Institutes of Biomedicine and Health) for technical assistance in lentivirus and adenovirus vector preparation. The authors also thank Zheyu Cai and Erjun Zhang (Laboratory Animal Center, Beijing, China) for assistance in animal experiments. This work was supported by the National Natural Science Foundation of China (81470570), a grant from the Department of Science and Technology of Guangdong Province (2015A030312017), and by the Guangzhou Health Care and Cooperative Innovation Major Project (201704020212). The authors declare no conflicts of interest.	Adiels M, 2005, ARTERIOSCL THROM VAS, V25, P1697, DOI 10.1161/01.ATV.0000172689.53992.25; Adiels M, 2008, ARTERIOSCL THROM VAS, V28, P1225, DOI 10.1161/ATVBAHA.107.160192; Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Alaynick WA, 2010, MOL ENDOCRINOL, V24, P299, DOI 10.1210/me.2009-0114; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Bryant KJ, 2011, J BIOL CHEM, V286, P2492, DOI 10.1074/jbc.M110.123927; Eudy JD, 1998, GENOMICS, V50, P382, DOI 10.1006/geno.1998.5345; Granata F, 2005, J IMMUNOL, V174, P464, DOI 10.4049/jimmunol.174.1.464; Guan M, 2011, HEPATOLOGY, V53, P458, DOI 10.1002/hep.24066; Hassing HC, 2012, BBA-MOL CELL BIOL L, V1821, P826, DOI 10.1016/j.bbalip.2011.11.010; Hodges BDM, 2010, J LIPID RES, V51, P262, DOI 10.1194/jlr.R003582; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Kim DK, 2014, DIABETOLOGIA, V57, P2576, DOI 10.1007/s00125-014-3366-x; Kim DK, 2013, DIABETES, V62, P3093, DOI 10.2337/db12-0946; Kim DK, 2013, GUT, V62, P1044, DOI 10.1136/gutjnl-2012-303347; Kim DK, 2012, J BIOL CHEM, V287, P21628, DOI 10.1074/jbc.M111.315168; Kim DK, 2011, J BIOL CHEM, V286, P38035, DOI 10.1074/jbc.M111.250613; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Li XH, 1996, J LIPID RES, V37, P210; Li XL, 2014, J VIROL, V88, P612, DOI 10.1128/JVI.02068-13; Misra J, 2017, TRENDS ENDOCRIN MET, V28, P261, DOI 10.1016/j.tem.2016.12.005; Misra J, 2016, DIABETES, V65, P2835, DOI 10.2337/db15-1523; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Olofsson SO, 2009, BBA-MOL CELL BIOL L, V1791, P448, DOI 10.1016/j.bbalip.2008.08.001; Park DW, 2003, J IMMUNOL, V170, P2093, DOI 10.4049/jimmunol.170.4.2093; Pedersen SB, 2016, JAMA INTERN MED, V176, P1834, DOI 10.1001/jamainternmed.2016.6875; Razzaque MA, 2004, GENE, V340, P275, DOI 10.1016/j.gene.2004.07.010; Ren Y, 2011, HUM MOL GENET, V20, P1074, DOI 10.1093/hmg/ddq550; Rouault M, 2003, BIOCHEMISTRY-US, V42, P11494, DOI 10.1021/bi0349930; Rygiel K, 2018, CURR CARDIOL REV, V14, P67, DOI 10.2174/1573403X14666180123165542; Silliman CC, 2002, AM J PHYSIOL-CELL PH, V283, pC1102, DOI 10.1152/ajpcell.00608.2001; Sorensen LP, 2011, DIABETES, V60, P2257, DOI 10.2337/db11-0040; Sparks JD, 2012, ARTERIOSCL THROM VAS, V32, P2104, DOI 10.1161/ATVBAHA.111.241463; SPARKS JD, 1990, J BIOL CHEM, V265, P8854; von Allmen CE, 2009, P NATL ACAD SCI USA, V106, P11673, DOI 10.1073/pnas.0812569106; Walther TC, 2017, ANNU REV CELL DEV BI, V33, P491, DOI 10.1146/annurev-cellbio-100616-060608; Wang JJ, 2009, FEBS LETT, V583, P643, DOI 10.1016/j.febslet.2009.01.030; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Xiao CT, 2011, AM J PHYSIOL-ENDOC M, V301, pE429, DOI 10.1152/ajpendo.00178.2011; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013; Yoshihara E, 2016, CELL METAB, V23, P622, DOI 10.1016/j.cmet.2016.03.005; Zhang YC, 2015, BIOCHEM J, V470, P181, DOI 10.1042/BJ20141494; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200	44	4	4	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					7942	7952		10.1096/fj.201802704R	http://dx.doi.org/10.1096/fj.201802704R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30922124	Bronze			2022-12-28	WOS:000476234700012
J	Xu, C; Xu, J; Ji, GX; Liu, Q; Shao, WT; Chen, YY; Gu, J; Weng, ZK; Zhang, X; Wang, YB; Gu, AH				Xu, Cheng; Xu, Jin; Ji, Guixiang; Liu, Qian; Shao, Wentao; Chen, Yaoyao; Gu, Jie; Weng, Zhenkun; Zhang, Xin; Wang, Yubang; Gu, Aihua			Deficiency of X-ray repair cross-complementing group 1 in primordial germ cells contributes to male infertility	FASEB JOURNAL			English	Article						Xrcc1 spermatogenesis; mitochondrial dysfunction; oxidative stress	BASE EXCISION-REPAIR; SPERMATOGONIAL STEM-CELLS; DNA-DAMAGE; IDIOPATHIC AZOOSPERMIA; APOPTOSIS; XRCC1; POLYMORPHISMS; GENE; MITOCHONDRIA; ASSOCIATION	X-ray repair cross-complementing group 1 (Xrcc1), a key DNA repair gene, plays a vital role in maintaining genomic stability and is highly expressed in the early stages of spermatogenesis, but the exact functions remain elusive. Here we generated primordial germ cell-specific Xrcc1 knockout (cXrcc1(-/-)) mice to elucidate the effects of Xrcc1 on spermatogenesis. We demonstrated that Xrcc1 deficiency results in infertility in male mice due to impaired spermatogenesis. We found that cXrcc1(-/-) mice exhibited smaller size of testes as well as lower sperm concentration and motility than the wild-type mice. Mechanistically, we demonstrated that Xrcc1 deficiency in primordial germ cells induced elevated levels of reactive oxygen species, mitochondria dysfunction, apoptosis, and loss of stemness of spermatogonial stem cells (SSCs) in testes. In Xrcc1-deficienct SSCs, elevated oxidative stress and mitochondrial dysfunction could be partially reversed by treatment with the antioxidant N-acetylcysteine (NAC), whereas NAC treatment did not restore the fertility or ameliorate the apoptosis caused by loss of Xrcc1. Overall, our findings provided new insights into understanding the crucial role of Xrcc1 during spermatogenesis.-Xu, C., Xu, J., Ji, G., Liu, Q., Shao, W., Chen, Y., Gu, J., Weng, Z., Zhang, X., Wang, Y., Gu, A. Deficiency of X-ray repair cross-complementing group 1 in primordial germ cells contributes to male infertility.	[Xu, Cheng; Xu, Jin; Liu, Qian; Shao, Wentao; Chen, Yaoyao; Gu, Jie; Weng, Zhenkun; Zhang, Xin; Wang, Yubang; Gu, Aihua] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Xu, Cheng; Xu, Jin; Liu, Qian; Shao, Wentao; Chen, Yaoyao; Gu, Jie; Weng, Zhenkun; Zhang, Xin; Wang, Yubang; Gu, Aihua] Nanjing Med Univ, Key Lab Modern Toxicol, Minist Educ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Xu, Jin] Nanjing Med Univ, Dept Maternal Child & Adolescent Hlth, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Wang, Yubang] Nanjing Med Univ, Safety Assessment & Res Ctr Drugs Pesticides & Ve, Nanjing, Jiangsu, Peoples R China; [Xu, Cheng] Nanjing Med Univ, Dept Cardiothorac Surg, Childrens Hosp, Nanjing, Jiangsu, Peoples R China; [Ji, Guixiang] Minist Environm Protect, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Gu, AH (corresponding author), Nanjing Med Univ, Sch Publ Hlth, 818 Tianyuan East Rd, Nanjing 211166, Jiangsu, Peoples R China.	aihuagu@njmu.edu.cn	Xu, Cheng/AAV-5113-2020; shao, wentao/GWR-0572-2022	Xu, Cheng/0000-0003-2605-2100; xu, cheng/0000-0002-1083-8590	National Natural Science Foundation of China [81722040, 81573174, 81703261]; National Key Research and Development Program of China [2018YFC1004203]; Natural Science Foundation of Jiangsu Province [BK20171060]; Natural Science Foundation of Jiangsu Higher Education Institutions [17KJB330002]; Foundation of Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine); Topnotch Academic Programs Project of Jiangsu Higher Education Institutions (TAPP) [PPZY2015A067]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of Jiangsu Higher Education Institutions; Foundation of Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine); Topnotch Academic Programs Project of Jiangsu Higher Education Institutions (TAPP)	This work was supported by the National Natural Science Foundation of China (81722040, 81573174, and 81703261), the National Key Research and Development Program of China (2018YFC1004203), the Natural Science Foundation of Jiangsu Province (BK20171060), the Natural Science Foundation of Jiangsu Higher Education Institutions (17KJB330002), the Foundation of Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine), and the Topnotch Academic Programs Project of Jiangsu Higher Education Institutions (TAPP; PPZY2015A067). C.X., J.X., and G.J. are co-first authors. The authors declare no conflicts of interest.	Ahmed EA, 2010, MUTAT RES-FUND MOL M, V683, P84, DOI 10.1016/j.mrfmmm.2009.10.011; Aitken RJ, 2013, INT J DEV BIOL, V57, P265, DOI 10.1387/ijdb.130146ja; Aitken RJ, 2011, ASIAN J ANDROL, V13, P36, DOI 10.1038/aja.2010.68; Aitken RJ, 2014, ASIAN J ANDROL, V16, P31, DOI 10.4103/1008-682X.122203; Aitken RJ, 2011, ANTIOXID REDOX SIGN, V14, P367, DOI 10.1089/ars.2010.3186; Alves H, 2010, J CELL MOL MED, V14, P2729, DOI 10.1111/j.1582-4934.2009.00931.x; Baarends WM, 2001, REPRODUCTION, V121, P31, DOI 10.1530/rep.0.1210031; Bandey I, 2015, ONCOGENE, V34, P1853, DOI 10.1038/onc.2014.92; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; Cassina A, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.130989; El-Domyati MM, 2009, FERTIL STERIL, V91, P2221, DOI 10.1016/j.fertnstert.2008.03.027; Erkkila K, 2006, AM J PHYSIOL-ENDOC M, V290, pE1145, DOI 10.1152/ajpendo.00142.2005; Ferreira ID, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-1; Garcia-Rodriguez A, 2018, ANDROLOGIA, V50, DOI 10.1111/and.13115; Gartner Anton, 2008, WormBook, P1, DOI 10.1895/wormbook.1.145.1; Gu AH, 2007, ASIAN J ANDROL, V9, P781, DOI 10.1111/j.1745-7262.2007.00325.x; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Guerriero G, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00056; Gunes S, 2015, REPROD BIOMED ONLINE, V31, P309, DOI 10.1016/j.rbmo.2015.06.010; Habas K, 2017, TOXICOLOGY, V382, P117, DOI 10.1016/j.tox.2017.03.013; Intano GW, 2002, MOL CELL BIOL, V22, P2410, DOI 10.1128/MCB.22.7.2410-2418.2002; Intano GW, 2001, NUCLEIC ACIDS RES, V29, P1366, DOI 10.1093/nar/29.6.1366; Ji GX, 2010, TOXICOL SCI, V116, P92, DOI 10.1093/toxsci/kfq112; Ruiz-Lopez MJ, 2010, P ROY SOC B-BIOL SCI, V277, P2541, DOI 10.1098/rspb.2010.0333; Ko EY, 2014, FERTIL STERIL, V102, P1518, DOI 10.1016/j.fertnstert.2014.10.020; Lee Y, 2009, NAT NEUROSCI, V12, P973, DOI 10.1038/nn.2375; Lomeli H, 2000, GENESIS, V26, P116, DOI 10.1002/(SICI)1526-968X(200002)26:2<116::AID-GENE4>3.0.CO;2-X; Lord T, 2018, STEM CELL REP, V10, P538, DOI 10.1016/j.stemcr.2018.01.003; Luo Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004730; Nakada K, 2006, P NATL ACAD SCI USA, V103, P15148, DOI 10.1073/pnas.0604641103; Olsen AK, 2001, NUCLEIC ACIDS RES, V29, P1781, DOI 10.1093/nar/29.8.1781; Shaughnessy DT, 2014, ENVIRON HEALTH PERSP, V122, P1271, DOI 10.1289/ehp.1408418; Shukla Kamla Kant, 2012, Front Biosci (Elite Ed), V4, P746; Tesarik J, 1998, MOL HUM REPROD, V4, P757, DOI 10.1093/molehr/4.8.757; Walter CA, 1996, BIOL REPROD, V55, P630, DOI 10.1095/biolreprod55.3.630; WALTER CA, 1994, SOMAT CELL MOLEC GEN, V20, P451, DOI 10.1007/BF02255837; Zhang S, 2018, NEUROSCIENCE, V377, P126, DOI 10.1016/j.neuroscience.2018.02.035; Zheng LR, 2012, REPROD BIOMED ONLINE, V25, P402, DOI 10.1016/j.rbmo.2012.06.014; Zhou Q, 2015, J CELL MOL MED, V19, P521, DOI 10.1111/jcmm.12407	39	7	7	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7427	7436		10.1096/fj.201801962RR	http://dx.doi.org/10.1096/fj.201801962RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30998386				2022-12-28	WOS:000476114200061
J	Huang, H; Lennikov, A; Saddala, MS; Gozal, D; Grab, DJ; Khalyfa, A; Fan, LJ				Huang, Hu; Lennikov, Anton; Saddala, Madhu Sudhana; Gozal, David; Grab, Dennis J.; Khalyfa, Abdelnaby; Fan, Lijuan			Placental growth factor negatively regulates retinal endothelial cell barrier function through suppression of glucose-6-phosphate dehydrogenase and antioxidant defense systems	FASEB JOURNAL			English	Article						diabetic retinopathy; G6PD; P1GF; retina; EC	VASCULAR-PERMEABILITY; DIABETIC-RETINOPATHY; PATHWAY; ANGIOGENESIS; BEVACIZUMAB; INHIBITION; ANTIBODIES; DELETION; ASSAY; VEGF	We report that placental growth factor (PlGF) negatively affects the endothelial cell (EC) barrier function through a novel regulatory mechanism. The PlGF mAb promotes (but recombinant protein disrupts) EC barrier function, thus affecting the barrier-forming protein levels, membrane distribution, and EC monolayer impedance by the electrical cell-impedance sensing system, Western blot, and immunofluorescence staining. RNA sequencing-based transcriptome analysis identified the up-regulation of the pentose phosphate pathway (PPP) and the antioxidant defense protein by PlGF blockade. The PlGF and PlGF/VEGF dimers (but not VEGF-A) down-regulated the protein expression of glucose-6-phosphate dehydrogenase (G6PD) and peroxiredoxin (PRDX). G6PD inhibition and gene silencing (small interfering RNA) abolished the beneficial effects of PlGF inhibition on EC barrier function and PRDX3/6 protein expression. VEGF receptor (VEGFR)1 or VEGFR2 blockade prevented the inhibitory effect of PlGF on G6PD protein expression and EC barrier function. The PRDX6 played dual roles in EC barrier function through glutathione peroxidase and phospholipase A2 activity. In sum, PlGF negatively regulates EC barrier function through the activation of VEGFR1 and VEGFR2 and the suppression of the G6PD/PPP and the antioxidant pathways.	[Huang, Hu; Lennikov, Anton; Saddala, Madhu Sudhana; Fan, Lijuan] Univ Missouri, Dept Ophthalmol, 1 Hosp Dr, Columbia, MO 65212 USA; [Gozal, David; Khalyfa, Abdelnaby] Univ Missouri, Child Hlth Res Inst, Columbia, MO USA; [Grab, Dennis J.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Grab, Dennis J.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Johns Hopkins University; Uniformed Services University of the Health Sciences - USA	Huang, H (corresponding author), Univ Missouri, Dept Ophthalmol, 1 Hosp Dr, Columbia, MO 65212 USA.	huangh1@missouri.edu	Gozal, David/ABH-3805-2020; Saddala, Madhu Sudhana/C-6147-2018	Saddala, Madhu Sudhana/0000-0002-6373-7080; behar cohen, francine/0000-0001-8571-9513	U.S. National Institutes of Health, National Eye Institute [R01 EY027824]; Missouri University Start-Up Fund; NATIONAL EYE INSTITUTE [R01EY027824] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Missouri University Start-Up Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Dmitry Rumyancev (Belgorod, Russia) for graphical abstract artwork assets design. This work was supported by the U.S. National Institutes of Health, National Eye Institute (Grant R01 EY027824 to H.H.), and the Missouri University Start-Up Fund (to H.H.). The authors declare no conflicts of interest.	Al Kahtani E, 2017, EYE, V31, P529, DOI 10.1038/eye.2016.246; ANTONELLIORLIDGE A, 1989, P NATL ACAD SCI USA, V86, P4544, DOI 10.1073/pnas.86.12.4544; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Arjunan P, 2018, P NATL ACAD SCI USA, V115, P10351, DOI 10.1073/pnas.1801379115; Bierhansl L, 2017, PHYSIOLOGY, V32, P126, DOI 10.1152/physiol.00031.2016; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cai J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018076; Cappai G, 2011, DIABETOLOGIA, V54, P1539, DOI 10.1007/s00125-011-2099-3; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; CARSON PE, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484-a; Chen LY, 2016, DIABETES, V65, P1099, DOI 10.2337/db15-0661; Cianfarani F, 2006, AM J PATHOL, V169, P1167, DOI 10.2353/ajpath.2006.051314; Cosentino C, 2011, EMBO J, V30, P546, DOI 10.1038/emboj.2010.330; Deissler HL, 2013, EXP EYE RES, V115, P162, DOI 10.1016/j.exer.2013.07.018; Fisher AB, 2018, J LIPID RES, V59, P1132, DOI 10.1194/jlr.R082578; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Hagberg CE, 2012, NATURE, V490, P426, DOI 10.1038/nature11464; He M, 2011, NUTR METAB CARDIOVAS, V21, P277, DOI 10.1016/j.numecd.2009.12.008; Huang HZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059482, 10.1371/journal.pone.0076982, 10.1371/journal.pone.0071808]; Huang H, 2015, DIABETES, V64, P200, DOI 10.2337/db14-0016; Huang H, 2011, INVEST OPHTH VIS SCI, V52, P7565, DOI 10.1167/iovs.11-8002; Huang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021411; Jiang P, 2014, PROTEIN CELL, V5, P592, DOI 10.1007/s13238-014-0082-8; Kowalczuk L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017462; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; MAGLIONE D, 1991, P NATL ACAD SCI USA, V88, P9267, DOI 10.1073/pnas.88.20.9267; Miyamoto N, 2007, DIABETOLOGIA, V50, P461, DOI 10.1007/s00125-006-0539-2; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Quaegebeur A, 2016, CELL METAB, V23, P280, DOI 10.1016/j.cmet.2015.12.007; Nguyen QD, 2018, ACTA OPHTHALMOL, V96, pE1, DOI 10.1111/aos.13325; Rupprecht KR, 2010, ANAL BIOCHEM, V407, P160, DOI 10.1016/j.ab.2010.08.003; Saddala MS, 2019, HUM GENOMICS, V13, DOI 10.1186/s40246-019-0199-1; Saddala MS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34955-x; Snuderl M, 2013, CELL, V152, P1065, DOI 10.1016/j.cell.2013.01.036; STERNBERG J, 1983, J IMMUNOL METHODS, V64, P39, DOI 10.1016/0022-1759(83)90382-4; Van Bergen T, 2019, PROG RETIN EYE RES, V69, P116, DOI 10.1016/j.preteyeres.2018.10.006; Van Bergen T, 2017, EXP EYE RES, V165, P136, DOI 10.1016/j.exer.2017.09.012; Verlohren S, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.07.037; Wells JA, 2015, NEW ENGL J MED, V372, P1193, DOI 10.1056/NEJMoa1414264; Xu YZ, 2010, FASEB J, V24, P609, DOI 10.1096/fj.09-135731; Zhang ZQ, 2000, J BIOL CHEM, V275, P40042, DOI 10.1074/jbc.M007505200; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067	44	9	9	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13695	13709		10.1096/fj.201901353R	http://dx.doi.org/10.1096/fj.201901353R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31585507	Green Published			2022-12-28	WOS:000507466100051
J	Keshari, S; Sipayung, AD; Hsieh, CC; Su, LJ; Chiang, YR; Chang, HC; Yang, WC; Chuang, TH; Chen, CL; Huang, CM				Keshari, Sunita; Sipayung, Apriska Dewi; Hsieh, Ching-Chuan; Su, Li-Jen; Chiang, Yun-Ru; Chang, Huan-Cheng; Yang, Wu-Chang; Chuang, Tsung-Hsien; Chen, Chien-Lung; Huang, Chun-Ming			IL-6/p-BTK/p-ERK signaling mediates calcium phosphate-induced pruritus	FASEB JOURNAL			English	Article						Bruton's tyrosine kinase; CaP; CKD	BRUTONS TYROSINE KINASE; POSITIVE FEEDBACK LOOP; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR-DISEASE; MOUSE MODEL; HEMODIALYSIS-PATIENTS; SCRATCHING BEHAVIOR; BTK FUNCTION; ITCH; INTERLEUKIN-6	Uremic pruritus with elevated levels of calcium phosphate (CaP) in skin is a common symptom in patients with chronic kidney disease (CKD). In this study, we demonstrate that intradermal injection of CaP into mice triggered scratching by up-regulating the IL-6 in skin and phosphorylation of ERKs in dorsal root ganglion (DRG) in a dose-dependent manner. IL-6 is essential because the CaP-induced up-regulation of phosphorylated (p)-ERK in DRG was considerably reduced in the IL-6 knockout mice. Microarray analysis in conjunction with real-time PCR revealed a higher mRNA expression of Bruton's tyrosine kinase (BTK) gene in DRG after CaP injection. The inhibition of BTK by ibrutinib noticeably diminish the CaP-induced up-regulation of IL-6 and p-ERK in mice. A high amount of IL-6 was detected in itchy skin and blood of patients with CKD. The expressions of p-BTK and p-ERK in DRG primary cells reached maximum levels at 1 and 10 min, respectively, after treatment of recombinant IL-6 and were significantly reduced by treatment of IL-6 along with ibrutinib. The mechanism by which the CaP-induced pruritus mediated by the IL-6/p-BTK/p-ERK signaling was revealed.	[Keshari, Sunita; Sipayung, Apriska Dewi; Huang, Chun-Ming] Natl Cent Univ, Dept Life Sci, Taoyuan, Taiwan; [Su, Li-Jen; Chiang, Yun-Ru; Chen, Chien-Lung; Huang, Chun-Ming] Natl Cent Univ, Dept Biomed Sci & Engn, Taoyuan, Taiwan; [Hsieh, Ching-Chuan] Chang Gung Mem Hosp, Dept Surg, Div Gen Surg, Chiayi, Taiwan; [Chang, Huan-Cheng; Yang, Wu-Chang; Chen, Chien-Lung] Landseed Hosp, Div Nephrol, Taoyuan, Taiwan; [Chuang, Tsung-Hsien] Natl Hlth Res Inst, Immunol Res Ctr, Zhunan, Taiwan; [Huang, Chun-Ming] Univ Calif San Diego, Dept Dermatol, San Diego, CA 92103 USA	National Central University; National Central University; Chang Gung Memorial Hospital; National Health Research Institutes - Taiwan; University of California System; University of California San Diego	Huang, CM (corresponding author), Natl Cent Univ, Dept Biomed Sci & Engn, Taoyuan, Taiwan.; Chen, CL (corresponding author), Landseed Hosp, Div Nephrol, Taoyuan, Taiwan.	chencl4922@gmail.com; chunming@ncu.edu.tw	Keshari, Sunita/AAK-9842-2021; Chiang, Yun/GRJ-5251-2022; , Chun-Ming/AAM-1856-2020; Chuang, Tsung-Hsien/F-9679-2010; Sipayung, Apriska Dewi/CAJ-3741-2022	, Chun-Ming/0000-0002-3352-5394; 	Landseed Hospital-NCU joint grants [106/107]; National Health Research Institutes (NHRI) [NHRIEX106-10607SI]; Ministry of Science and Technology (MOST) [107-2314-B-008 -001, 107-2622-B-008-002-CC1, 106/107-2622-B-008-001-CC1]	Landseed Hospital-NCU joint grants; National Health Research Institutes (NHRI)(National Health Research Institutes - Taiwan); Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China)	The authors thank Wei-Hsin Sun [National Central University (NCU)], and postdoctoral scholar, Wei-Shin Chen (Academic Sinica, Taipei, Taiwan) for teaching isolation of DRG from mice and DRG primary cell culture. This work was supported by 106/107-Landseed Hospital-NCU joint grants, National Health Research Institutes (NHRI) Grant NHRIEX106-10607SI, and Ministry of Science and Technology (MOST) Grants 107-2314-B-008 -001, 107-2622-B-008-002-CC1, and 106/107-2622-B-008-001-CC1. The authors declare no conflicts of interest.	Akiyama T, 2015, ACTA DERM-VENEREOL, V95, P147, DOI 10.2340/00015555-1879; Barnes TC, 2011, INT J RHEUMATOL, V2011, DOI DOI 10.1155/2011/721608; Bautista DM, 2014, NAT NEUROSCI, V17, P175, DOI 10.1038/nn.3619; Block G, 2003, SEMIN DIALYSIS, V16, P140, DOI 10.1046/j.1525-139X.2003.160301.x; Brancaccio D, 2002, NEPHROL DIAL TRANSPL, V17, P201, DOI 10.1093/ndt/17.2.201; Bruun JM, 2003, AM J PHYSIOL-ENDOC M, V285, pE527, DOI 10.1152/ajpendo.00110.2003; Cevikbas F, 2014, J ALLERGY CLIN IMMUN, V133, P448, DOI 10.1016/j.jaci.2013.10.048; Chalmers SA, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-017-1500-0; Chalmers SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep26164; Chang BY, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3400; Che Q, 2014, INT J CANCER, V135, P282, DOI 10.1002/ijc.28679; Chen Y, 2009, OSTEOARTHR CARTILAGE, V17, P244, DOI 10.1016/j.joca.2008.06.015; Cordova KB, 2009, SEMIN DIALYSIS, V22, P45, DOI 10.1111/j.1525-139X.2008.00534.x; CUI SL, 1993, LAB ANIM, V27, P116, DOI 10.1258/002367793780810397; Eddington H, 2009, CLIN KIDNEY J, V2, P267, DOI 10.1093/ndtplus/sfp044; Hoenich NA, 2007, BLOOD PURIFICAT, V25, P62, DOI 10.1159/000096400; Jeffry J, 2011, PHYSIOLOGY, V26, P286, DOI 10.1152/physiol.00007.2011; Kimura K, 1999, KIDNEY INT, V56, pS238, DOI 10.1046/j.1523-1755.1999.07163.x; Konda D, 2015, ASIAN J PSYCHIATR, V17, P24, DOI 10.1016/j.ajp.2015.07.010; Kong W, 2018, CLIN RHEUMATOL, V37, P43, DOI 10.1007/s10067-017-3717-3; LaMotte RH, 2014, NAT REV NEUROSCI, V15, P19, DOI 10.1038/nrn3641; Li SR, 2017, SCI CHINA LIFE SCI, V60, P617, DOI 10.1007/s11427-016-9058-6; Linnskog R, 2016, ONCOTARGET, V7, P37790, DOI 10.18632/oncotarget.9332; Liu BY, 2016, P NATL ACAD SCI USA, V113, pE7572, DOI 10.1073/pnas.1606608113; Liu T, 2012, J CLIN INVEST, V122, P2195, DOI 10.1172/JCI45414; Locatelli F, 2003, NEPHROL DIAL TRANSPL, V18, P2, DOI 10.1093/ndt/gfg1072; Lopez-Herrera G, 2014, J LEUKOCYTE BIOL, V95, P243, DOI 10.1189/jlb.0513307; Ma TKW, 2017, NEPHROL DIAL TRANSPL, V32, P129, DOI 10.1093/ndt/gfw336; MENON GK, 1991, ARCH DERMATOL, V127, P57, DOI 10.1001/archderm.127.1.57; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Mohamed AJ, 2009, IMMUNOL REV, V228, P58, DOI 10.1111/j.1600-065X.2008.00741.x; Mohan C, 2015, NAT REV NEPHROL, V11, P329, DOI 10.1038/nrneph.2015.33; Momose A, 2004, NEPHROL DIAL TRANSPL, V19, P2061, DOI 10.1093/ndt/gfh287; Morton CA, 1996, NEPHROL DIAL TRANSPL, V11, P2031, DOI 10.1093/oxfordjournals.ndt.a027092; Nadra I, 2005, CIRC RES, V96, P1248, DOI 10.1161/01.RES.0000171451.88616.c2; Nechemia-Arbely Y, 2008, J AM SOC NEPHROL, V19, P1106, DOI 10.1681/ASN.2007070744; Oliveira FA, 2004, PHARMACOL BIOCHEM BE, V78, P719, DOI 10.1016/j.pbb.2004.05.013; Omori S, 2006, J AM SOC NEPHROL, V17, P1604, DOI 10.1681/ASN.2004090800; Palmer SC, 2011, JAMA-J AM MED ASSOC, V305, P1119, DOI 10.1001/jama.2011.308; Park H, 1996, IMMUNITY, V4, P515, DOI 10.1016/S1074-7613(00)80417-3; Pecoits R, 2003, NEPHROL DIAL TRANSPL, V18, P1042, DOI 10.1093/ndt/gfg111; Pecoits-Filho R, 2002, NEPHROL DIAL TRANSPL, V17, P1684, DOI 10.1093/ndt/17.9.1684; Pisoni RL, 2006, NEPHROL DIAL TRANSPL, V21, P3495, DOI 10.1093/ndt/gfl461; Ren L, 2016, J BIOL CHEM, V291, P3043, DOI 10.1074/jbc.M115.687251; SMITH CIE, 1994, J IMMUNOL, V152, P557; Sun J, 2016, CLIN J AM SOC NEPHRO, V11, P1163, DOI 10.2215/CJN.10441015; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; TakahashiTezuka M, 1997, ONCOGENE, V14, P2273, DOI 10.1038/sj.onc.1201071; Thomsen JS, 2001, ACTA DERM-VENEREOL, V81, P250, DOI 10.1080/00015550152572868; Vaziri ND, 2006, AM J PHYSIOL-RENAL, V290, pF262, DOI 10.1152/ajprenal.00099.2005; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Woyach JA, 2014, NEW ENGL J MED, V370, P2286, DOI 10.1056/NEJMoa1400029; Yamaura K, 2011, J TOXICOL SCI, V36, P669; Yosipovitch G, 2003, LANCET, V361, P690, DOI 10.1016/S0140-6736(03)12570-6; Zakrzewska-Pniewska B, 2001, NEUROPHYSIOL CLIN, V31, P181, DOI 10.1016/S0987-7053(01)00257-X; Zhang L, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-25; Zhang WR, 2012, HYPERTENSION, V59, P136, DOI 10.1161/HYPERTENSIONAHA.111.173328	59	10	12	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12036	12046		10.1096/fj.201900016RR	http://dx.doi.org/10.1096/fj.201900016RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31365830	Green Published			2022-12-28	WOS:000507461600034
J	Li, J; Wang, TX; Xia, J; Yao, WL; Huang, FR				Li, Juan; Wang, Tongxin; Xia, Jun; Yao, Weilei; Huang, Feiruo			Enzymatic and nonenzymatic protein acetylations control glycolysis process in liver diseases	FASEB JOURNAL			English	Review						acetyltransferase; acetyl-CoA; glucose metabolism; target; progression	PYRUVATE-DEHYDROGENASE KINASE; INDUCED OXIDATIVE STRESS; FATTY LIVER; MITOCHONDRIAL DYSFUNCTION; GLUCOSE-METABOLISM; LYSINE ACETYLATION; ENERGY-METABOLISM; HISTONE ACETYLATION; KINETIC MECHANISM; HEPATIC STEATOSIS	Impaired glycolysis has pathologic effects on the occurrence and progression of liver diseases, and it appears that glycolysis is increased to different degrees in different liver diseases. As an important post-translational modification, reversible lysine acetylation regulates almost all cellular processes, including glycolysis. Lysine acetylation can occur enzymatically with acetyltransferases or nonenzymatically with acetyl-coenzyme A. Accompanied by the progression of liver diseases, there seems to be a temporal and spatial variation between enzymatic and nonenzymatic acetylations in the regulation of glycolysis. Here, we summarize the most recent findings on the functions and targets of acetylation in controlling glycolysis in the different stages of liver diseases. In addition, we discuss the differences and causes between enzymatic and nonenzymatic acetylations in regulating glycolysis throughout the progression of liver diseases. Then, we review these new discoveries to provide the potential implications of these findings for therapeutic interventions in liver diseases.	[Li, Juan; Wang, Tongxin; Xia, Jun; Yao, Weilei; Huang, Feiruo] Huazhong Agr Univ, Coll Anim Sci & Technol, Dept Anim Nutr & Feed Sci, Wuhan 430070, Peoples R China	Huazhong Agricultural University	Huang, FR (corresponding author), Huazhong Agr Univ, Coll Anim Sci & Technol, Dept Anim Nutr & Feed Sci, Wuhan 430070, Peoples R China.	huangfeiruo@mail.hzau.edu.cn			National Natural Science Foundation of China [31572409]; Hubei Provincial Natural Science Foundation of China [2018CFA071]; National Key Research and Development Program [2018YFD0500600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Provincial Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program	This work was supported by the National Natural Science Foundation of China (Grant 31572409), the Hubei Provincial Natural Science Foundation of China (Grant 2018CFA071), and the National Key Research and Development Program (Grant 2018YFD0500600). The authors declare no conflicts of interest.	Agrawal Swastik, 2014, Trop Gastroenterol, V35, P212; Albaugh BN, 2011, CHEMBIOCHEM, V12, P290, DOI 10.1002/cbic.201000438; Albaugh BN, 2010, BIOCHEMISTRY-US, V49, P6375, DOI 10.1021/bi100381y; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Amann T, 2009, EXPERT OPIN THER TAR, V13, P1411, DOI 10.1517/14728220903307509; Amann T, 2009, AM J PATHOL, V174, P1544, DOI 10.2353/ajpath.2009.080596; Asano J, 2010, CANCER SCI, V101, P869, DOI 10.1111/j.1349-7006.2009.01460.x; Ashworth WB, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005105; Baeza J, 2015, ACS CHEM BIOL, V10, P122, DOI 10.1021/cb500848p; Bai X, 2008, J CANCER RES CLIN, V134, P83, DOI 10.1007/s00432-007-0252-7; Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004; Begriche K., 2012, DRUG DISCOV TODAY DI, V6, pe11; Bellanti F, 2018, REDOX BIOL, V15, P86, DOI 10.1016/j.redox.2017.11.016; Bellentani S, 2010, DIGEST DIS, V28, P155, DOI 10.1159/000282080; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P623, DOI 10.1021/bi602513x; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Beyoglu D, 2013, J HEPATOL, V59, P842, DOI 10.1016/j.jhep.2013.05.030; Bhardwaj A, 2016, P NATL ACAD SCI USA, V113, pE538, DOI 10.1073/pnas.1520045113; Bond ST, 2017, FASEB J, V31, P2592, DOI 10.1096/fj.201601215R; Brazil M, 2003, NAT REV DRUG DISCOV, V2, P338, DOI 10.1038/nrd1094; Browning JD, 2012, J LIPID RES, V53, P577, DOI 10.1194/jlr.P020867; BUSTAMANTE E, 1981, J BIOL CHEM, V256, P8699; Carbajo-Pescador S, 2014, CURR MED CHEM, V21, P1231, DOI 10.2174/0929867321666131228205703; Carneiro L, 2017, MOL METAB, V6, P1625, DOI 10.1016/j.molmet.2017.10.005; Carrico C, 2018, CELL METAB, V27, P497, DOI 10.1016/j.cmet.2018.01.016; Caton PW, 2010, J ENDOCRINOL, V205, P97, DOI 10.1677/JOE-09-0345; Cederbaum AI, 2012, CLIN LIVER DIS, V16, P667, DOI 10.1016/j.cld.2012.08.002; Chaves VE, 2012, LIPIDS, V47, P773, DOI 10.1007/s11745-012-3683-0; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Constantinou MA, 2007, TOXICOL APPL PHARM, V218, P11, DOI 10.1016/j.taap.2006.10.007; Czyzyk A, 1973, Pol Arch Med Wewn, V50, P947; DICKMAN KG, 1990, AM J PHYSIOL, V258, pF1608, DOI 10.1152/ajprenal.1990.258.6.F1608; Drazic A, 2016, BBA-PROTEINS PROTEOM, V1864, P1372, DOI 10.1016/j.bbapap.2016.06.007; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Fabbrini E, 2015, NUTRIENTS, V7, P4995, DOI 10.3390/nu7064995; Fan J, 2014, MOL CELL, V53, P534, DOI 10.1016/j.molcel.2013.12.026; Feldman JL, 2015, BIOCHEMISTRY-US, V54, P3037, DOI 10.1021/acs.biochem.5b00150; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; French SW, 2013, ALCOHOL RES-CURR REV, V35, P57; Fritz KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075868; Garcia M, 2015, J DAIRY SCI, V98, P7102, DOI 10.3168/jds.2014-9034; Garcia-Ruiz C, 2013, FREE RADICAL RES, V47, P854, DOI 10.3109/10715762.2013.830717; GARLAND PB, 1965, BIOCHEM J, V97, P587, DOI 10.1042/bj0970587; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Geng H, 2012, J BIOL CHEM, V287, P35496, DOI 10.1074/jbc.M112.400697; Gil J, 2017, J PROTEOMICS, V150, P297, DOI 10.1016/j.jprot.2016.10.003; Gillies RJ, 2002, J MAGN RESON IMAGING, V16, P430, DOI 10.1002/jmri.10181; Gillum MP, 2011, TRENDS MOL MED, V17, P8, DOI 10.1016/j.molmed.2010.09.005; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Go Y, 2016, DIABETES, V65, P2876, DOI 10.2337/db16-0223; Gottfried E, 2006, BLOOD, V107, P2013, DOI 10.1182/blood-2005-05-1795; GRUNICKE HH, 1989, J CANCER RES CLIN, V115, P435, DOI 10.1007/BF00393332; Hall JA, 2013, J CLIN INVEST, V123, P973, DOI 10.1172/JCI64094; Hallows WC, 2012, J BIOL CHEM, V287, P3850, DOI 10.1074/jbc.M111.317404; Harmel R, 2018, NAT CHEM BIOL, V14, P244, DOI [10.1038/NCHEMBIO.2575, 10.1038/nchembio.2575]; Hay N, 2016, NAT REV CANCER, V16, P635, DOI 10.1038/nrc.2016.77; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hitosugi T, 2014, ONCOGENE, V33, P4279, DOI 10.1038/onc.2013.406; Hosp F, 2017, MITOCHONDRION, V33, P58, DOI 10.1016/j.mito.2016.07.012; Howlett K. F., 2013, P AUSTR PHYSL SOC, V44; Hu HG, 2017, HEPATOLOGY, V65, P515, DOI 10.1002/hep.28887; Hwang B, 2009, BIOCHEM J, V423, P243, DOI 10.1042/BJ20090390; Iansante V, 2015, J HEPATOL, V62, pS427, DOI 10.1016/S0168-8278(15)30530-4; Jaisson S, 2010, CLIN CHEM, V56, P1401, DOI 10.1373/clinchem.2010.145201; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jeong DW, 2004, BIOCHEM BIOPH RES CO, V313, P984, DOI 10.1016/j.bbrc.2003.12.033; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; Kaypee S, 2016, PHARMACOL THERAPEUT, V162, P98, DOI 10.1016/j.pharmthera.2016.01.011; Keller MA, 2015, CURR OPIN BIOTECH, V34, P153, DOI 10.1016/j.copbio.2014.12.020; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Konig AC, 2014, MITOCHONDRION, V19, P252, DOI 10.1016/j.mito.2014.03.004; Koentges C, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0493-6; Kowalik MA, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00087; Latham T, 2012, NUCLEIC ACIDS RES, V40, P4794, DOI 10.1093/nar/gks066; Lee CF, 2015, CIRC J, V79, P1863, DOI 10.1253/circj.CJ-15-0742; Lee NCW, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00138; Lee P, 2013, HEPATOLOGY, V57, P515, DOI 10.1002/hep.26028; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Li FL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02950-5; Li LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24156; Li TT, 2014, J BIOL CHEM, V289, P3775, DOI 10.1074/jbc.M113.531640; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Lu W, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001357; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Luo WB, 2012, TRENDS ENDOCRIN MET, V23, P560, DOI 10.1016/j.tem.2012.06.010; Lv L, 2013, MOL CELL, V52, P340, DOI 10.1016/j.molcel.2013.09.004; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Mantena SK, 2008, FREE RADICAL BIO MED, V44, P1259, DOI 10.1016/j.freeradbiomed.2007.12.029; Marchesini G, 2008, J CLIN ENDOCR METAB, V93, pS74, DOI 10.1210/jc.2008-1399; Marrero JA, 2006, CURR OPIN GASTROEN, V22, P248, DOI 10.1097/01.mog.0000218961.86182.8c; Massart J, 2012, BRIT J PHARMACOL, V165, P1361, DOI 10.1111/j.1476-5381.2011.01580.x; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Milic S, 2012, DIGEST DIS, V30, P158, DOI 10.1159/000336669; Nishikawa T, 2014, J HEPATOL, V60, P1203, DOI 10.1016/j.jhep.2014.02.014; Olia AS, 2015, ACS CHEM BIOL, V10, P2034, DOI 10.1021/acschembio.5b00342; PAIK WK, 1970, BIOCHIM BIOPHYS ACTA, V213, P513, DOI 10.1016/0005-2787(70)90058-4; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Paradies G, 2014, WORLD J GASTROENTERO, V20, P14205, DOI 10.3748/wjg.v20.i39.14205; Park J, 2013, MOL CELL, V50, P919, DOI 10.1016/j.molcel.2013.06.001; Park JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep17395; Park SH, 2016, CANCER RES, V76, P3802, DOI 10.1158/0008-5472.CAN-15-2498; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Perry RJ, 2014, NAT MED, V20, P759, DOI 10.1038/nm.3579; Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80; Pirooznia SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041776; Porepa L, 2010, CAN MED ASSOC J, V182, pE526, DOI 10.1503/cmaj.092144; Pougovkina O, 2014, HUM MOL GENET, V23, P3513, DOI 10.1093/hmg/ddu059; Prakasam G, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00022; Quercioli Alessandra, 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P261; Rahman M, 2014, ADV MATER RES-SWITZ, V995, P1, DOI 10.4028/www.scientific.net/AMR.995.1; Rardin MJ, 2013, CELL METAB, V18, P920, DOI 10.1016/j.cmet.2013.11.013; Roberts DJ, 2015, CELL DEATH DIFFER, V22, P248, DOI 10.1038/cdd.2014.173; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Russell JW, 2002, FASEB J, V16, P1738, DOI 10.1096/fj.01-1027com; Sciacovelli M, 2014, METHOD ENZYMOL, V542, P1, DOI 10.1016/B978-0-12-416618-9.00001-7; Scott I, 2012, BIOCHEM J, V443, P655, DOI 10.1042/BJ20120118; Seo KS, 2015, ONCOGENE, V34, P1354, DOI 10.1038/onc.2014.76; Shakespear MR, 2018, TRENDS IMMUNOL, V39, P473, DOI 10.1016/j.it.2018.02.009; Shi L, 2015, CURR OPIN CELL BIOL, V33, P125, DOI 10.1016/j.ceb.2015.02.003; Shirai T, 2016, J EXP MED, V213, P337, DOI 10.1084/jem.20150900; Somvanshi PR, 2016, RSC ADV, V6, P14344, DOI 10.1039/c5ra18128c; Song WW, 2017, EUR REV MED PHARMACO, V21, P4058; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tanner KG, 2000, J BIOL CHEM, V275, P22048, DOI 10.1074/jbc.M002893200; Tanner KG, 2000, BIOCHEMISTRY-US, V39, P11961, DOI 10.1021/bi001272h; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tso SC, 2014, J BIOL CHEM, V289, P4432, DOI 10.1074/jbc.M113.533885; TURNER BM, 1991, J CELL SCI, V99, P13; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wagner GR, 2014, MOL CELL, V54, P5, DOI 10.1016/j.molcel.2014.03.027; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wang CH, 2013, EXP BIOL MED, V238, P450, DOI 10.1177/1535370213493069; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wang TX, 2018, J CELL MOL MED, V22, P5787, DOI 10.1111/jcmm.13877; Wardell SE, 2009, MOL ENDOCRINOL, V23, P388, DOI 10.1210/me.2008-0179; Wei W, 2017, J PROTEOME RES, V16, P1743, DOI 10.1021/acs.jproteome.7b00012; Weinert BT, 2015, EMBO J, V34, P2620, DOI 10.15252/embj.201591271; Weinert BT, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134766; WEINHOUSE S, 1956, SCIENCE, V124, P267, DOI 10.1126/science.124.3215.267; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Wong CM, 2008, LIVER INT, V28, P160, DOI 10.1111/j.1478-3231.2007.01637.x; Xiong XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074340; Yang H, 2015, EMBO J, V34, P1110, DOI 10.15252/embj.201591041; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Yao WL, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8168791; Ye JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep33102; Yoshino J, 2011, MOL CELL, V44, P170, DOI 10.1016/j.molcel.2011.10.005; Yu JW, 2016, J NEUROCHEM, V137, P371, DOI 10.1111/jnc.13587; Yu Y, 2014, CELL MED, V7, P1, DOI 10.3727/215517914X680056; Zhang M., 2017, BIOCH BIOPHYSICAL RE, V495, P582; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhao D, 2013, ONCOTARGET, V4, P802, DOI 10.18632/oncotarget.1007; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	170	12	12	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11640	11654		10.1096/fj.201901175R	http://dx.doi.org/10.1096/fj.201901175R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31370704	Green Published, Bronze			2022-12-28	WOS:000507461600006
J	Liu, LR; Zou, JN; Guan, YJ; Zhang, YH; Zhang, W; Zhou, XX; Xiong, CX; Tolbert, E; Zhao, TC; Bayliss, G; Zhuang, SG				Liu, Lirong; Zou, Jianan; Guan, Yingjie; Zhang, Yunhe; Zhang, Wei; Zhou, Xiaoxu; Xiong, Chongxiang; Tolbert, Evelyn; Zhao, Ting C.; Bayliss, George; Zhuang, Shougang			Blocking the histone lysine 79 methyltransferase DOT1L alleviates renal fibrosis through inhibition of renal fibroblast activation and epithelial-mesenchymal transition	FASEB JOURNAL			English	Article						transforming growth factor; Snail; Notch1; Smad3; ERSD	CELL-CYCLE ARREST; INTERSTITIAL FIBROSIS; THERAPEUTIC TARGET; TGF-BETA; EPIGENETIC REGULATION; PTEN EXPRESSION; EMERGING ROLES; KLOTHO; METHYLATION; GROWTH	Disruptor of telomeric silencing-1 like (DOT1L) protein specifically catalyzes the methylation of histone H3 on Lys79 (H3K79) and is implicated in tumors. But its role in tissue fibrosis remains unclear. Here we demonstrated that injury to the kidney increased DOT1L expression and H3K79 dimethylation in renal tubular epithelial cells and myofibroblasts in a murine model of unilateral ureteral obstruction. Administration of EPZ5676, a highly selective inhibitor of DOT1L, attenuated renal fibrosis. Treatment with EPZ5676 or DOT1L small interfering RNA also inhibited TGF-beta 1 and serum-induced activation of renal interstitial fibroblasts and epithelial-mesenchymal transition (EMT) in vitro. Moreover, blocking DOT1L abrogated injury-induced epithelial G(2)/M arrest; reduced expression of Snail, Twist, and Notch1; and inactivated several profibrotic signaling molecules in the injured kidney, including Smad3, epidermal growth factor receptor, platelet-derived growth factor receptor, signal transducer and activator of transcription 3, protein kinase B, and NF-kappa B. Conversely, DOT1L inhibition increased expression of phosphatase and tensin homolog, a protein associated with dephosphorylation of tyrosine kinase receptors, and prevented decline in levels of Klotho and Smad7, 2 renoprotective factors. Thus, our data indicate that targeting DOT1L attenuates renal fibrosis through inhibition of renal fibroblasts and EMT by suppressing activation of multiple profibrotic signaling pathways while retaining expression of renoprotective factors.	[Liu, Lirong; Zou, Jianan; Guan, Yingjie; Zhang, Yunhe; Zhang, Wei; Zhou, Xiaoxu; Xiong, Chongxiang; Tolbert, Evelyn; Bayliss, George; Zhuang, Shougang] Brown Univ, Rhode Isl Hosp, Dept Med, Alpert Med Sch, Providence, RI 02903 USA; [Liu, Lirong] Guizhou Med Univ, Affiliated Hosp, Dept Clin Hematol, Guiyang, Peoples R China; [Zhao, Ting C.] Boston Univ, Med Sch, Roger Williams Med Ctr, Dept Surg, Providence, RI USA; [Zhuang, Shougang] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Nephrol, Shanghai 200120, Peoples R China	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Guizhou Medical University; Boston University; Roger Williams Medical Center; Tongji University	Zhuang, SG (corresponding author), Tongji Univ, Sch Med, Shanghai East Hosp, Dept Nephrol, Shanghai 200120, Peoples R China.	szhuang@lifespan.org		Zhang, Yunhe/0000-0003-3684-7580	National Nature Science Foundation of China [81670623, 81830021]; Ministry of Science and Technology of China [2018YFA0108802]; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [2R01DK08506505A1]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Nature Science Foundation of China (81670623 and 81830021 to S.Z.), the Ministry of Science and Technology of China (2018YFA0108802 to S.Z.), and the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (Grant 2R01DK08506505A1 to S.Z.). The authors declare no conflicts of interest.	Abouantoun TJ, 2011, J NEURO-ONCOL, V101, P215, DOI 10.1007/s11060-010-0259-9; Annala M, 2014, EMBO MOL MED, V6, P1121, DOI 10.15252/emmm.201404210; Azuma M, 2012, FASEB J, V26, P4264, DOI 10.1096/fj.12-211631; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Bienaime F, 2016, J AM SOC NEPHROL, V27, P3690, DOI 10.1681/ASN.2015091014; Carlson SM, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026435; Chen JC, 2012, J AM SOC NEPHROL, V23, P215, DOI 10.1681/ASN.2011070645; Cho MH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8821; Doi S, 2017, CONTRIB NEPHROL, V189, P178, DOI 10.1159/000450776; Haddadi N, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0803-3; Hein K, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005892; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; Hsu JM, 2011, NAT CELL BIOL, V13, P174, DOI 10.1038/ncb2158; Hu MC, 2013, CONTRIB NEPHROL, V180, P47, DOI 10.1159/000346778; Hu MC, 2012, NAT REV NEPHROL, V8, P423, DOI 10.1038/nrneph.2012.92; Imamura M, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.94979; Irifuku T, 2016, KIDNEY INT, V89, P147, DOI 10.1038/ki.2015.291; Ishii Y, 2017, PATHOL INT, V67, P235, DOI 10.1111/pin.12530; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Lee JY, 2016, CELL MOL LIFE SCI, V73, P4643, DOI 10.1007/s00018-016-2313-z; Levin Adeera, 2017, Lancet, V390, P1888, DOI 10.1016/S0140-6736(17)30788-2; Li JH, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014252.37680.E4; Liu BC, 2018, KIDNEY INT, V93, P568, DOI 10.1016/j.kint.2017.09.033; Liu F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060972; Liu N, 2012, J AM SOC NEPHROL, V23, P854, DOI 10.1681/ASN.2011050493; Liu XY, 2014, CELL SIGNAL, V26, P2276, DOI 10.1016/j.cellsig.2014.05.018; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; McLean CM, 2014, LEUKEMIA, V28, P2131, DOI 10.1038/leu.2014.169; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Morera L, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0223-4; Neyra JA, 2016, VITAM HORM, V101, P257, DOI 10.1016/bs.vh.2016.02.007; Pang MY, 2010, KIDNEY INT, V78, P257, DOI 10.1038/ki.2010.154; Pang MY, 2009, AM J PHYSIOL-RENAL, V297, pF996, DOI 10.1152/ajprenal.00282.2009; Rau RE, 2016, BLOOD, V128, P971, DOI 10.1182/blood-2015-11-684225; Saad S, 2010, INT J BIOCHEM CELL B, V42, P1115, DOI 10.1016/j.biocel.2010.03.016; Samarakoon R, 2015, J PATHOL, V236, P421, DOI 10.1002/path.4538; Sato Y, 2017, INFLAMM REGEN, V37, DOI 10.1186/s41232-017-0048-3; Serrano-Gomez SJ, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0502-x; Song H, 2011, BIOCHEM BIOPH RES CO, V404, P68, DOI 10.1016/j.bbrc.2010.11.064; Sun LD, 2016, CELL MOL LIFE SCI, V73, P4493, DOI 10.1007/s00018-016-2303-1; Tamada S, 2006, J PHARMACOL SCI, V100, P17, DOI 10.1254/jphs.FMJ05003X4; Tang JH, 2013, AM J PATHOL, V183, P160, DOI 10.1016/j.ajpath.2013.04.005; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Wang X, 2016, CURR OPIN GENET DEV, V36, P68, DOI 10.1016/j.gde.2016.03.015; Wanner N, 2017, CELL TISSUE RES, V369, P75, DOI 10.1007/s00441-017-2588-x; Wee P, 2017, CANCERS, V9, DOI 10.3390/cancers9050052; Wood K, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8010011; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Zhang X, 2015, CELL MOL LIFE SCI, V72, P4257, DOI 10.1007/s00018-015-2001-4; Zhou XX, 2016, J AM SOC NEPHROL, V27, P2092, DOI 10.1681/ASN.2015040457; Zhuang SG, 2014, KIDNEY INT SUPPL, V4, P70, DOI 10.1038/kisup.2014.13; Zoccali C, 2017, NAT REV NEPHROL, V13, DOI 10.1038/nrneph.2017.52	52	13	13	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11941	11958		10.1096/fj.201801861R	http://dx.doi.org/10.1096/fj.201801861R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31373855	Green Published			2022-12-28	WOS:000507461600028
J	Montgomery, MK; Osborne, B; Brandon, AE; O'Reilly, L; Fiveash, CE; Brown, SHJ; Wilkins, BP; Samsudeen, A; Yu, J; Devanapalli, B; Hertzog, A; Tolun, AA; Kavanagh, T; Cooper, AA; Mitchell, TW; Biden, TJ; Smith, NJ; Cooney, GJ; Turner, N				Montgomery, Magdalene K.; Osborne, Brenna; Brandon, Amanda E.; O'Reilly, Liam; Fiveash, Corrine E.; Brown, Simon H. J.; Wilkins, Brendan P.; Samsudeen, Azrah; Yu, Josephine; Devanapalli, Beena; Hertzog, Ashley; Tolun, Adviye A.; Kavanagh, Tomas; Cooper, Antony A.; Mitchell, Todd W.; Biden, Trevor J.; Smith, Nicola J.; Cooney, Gregory J.; Turner, Nigel			Regulation of mitochondrial metabolism in murine skeletal muscle by the medium-chain fatty acid receptor Gpr84	FASEB JOURNAL			English	Article						mitochondrial function; insulin secretion; insulin resistance	PROTEIN-COUPLED-RECEPTOR; DIFFERENTIAL EXPRESSION ANALYSIS; INSULIN-SECRETION; PEPTIDE-1 SECRETION; ENERGY-EXPENDITURE; GLUCOSE-METABOLISM; GENE-EXPRESSION; WEIGHT-LOSS; MAP KINASE; PHOSPHORYLATION	Fatty acid receptors have been recognized as important players in glycaemic control. This study is the first to describe a role for the medium-chain fatty acid (MCFA) receptor G-protein-coupled receptor (Gpr) 84 in skeletal muscle mitochondrial function and insulin secretion. We are able to show that Gpr84 is highly expressed in skeletal muscle and adipose tissue. Mice with global deletion of Gpr84 [Gpr84 knockout (KO)] exhibit a mild impairment in glucose tolerance when fed a MCFA-enriched diet. Studies in mice and pancreatic islets suggest that glucose intolerance is accompanied by a defect in insulin secretion. MCFA-fed KO mice also exhibit a significant impairment in the intrinsic respiratory capacity of their skeletal muscle mitochondria, but at the same time also exhibit a substantial increase in mitochondrial content. Changes in canonical pathways of mitochondrial biogenesis and turnover are unable to explain these mitochondrial differences. Our results show that Gpr84 plays a crucial role in regulating mitochondrial function and quality control.	[Montgomery, Magdalene K.; Osborne, Brenna; Fiveash, Corrine E.; Wilkins, Brendan P.; Samsudeen, Azrah; Yu, Josephine; Turner, Nigel] Univ New South Wales UNSW Sydney, Sch Med Sci, Dept Pharmacol, Sydney, NSW, Australia; [Cooper, Antony A.; Biden, Trevor J.; Smith, Nicola J.] Univ New South Wales UNSW Sydney, St Vincents Clin Sch, Sydney, NSW, Australia; [Montgomery, Magdalene K.] Univ Melbourne, Sch Biomed Sci, Dept Physiol, Melbourne, Vic, Australia; [Brandon, Amanda E.; O'Reilly, Liam; Biden, Trevor J.; Cooney, Gregory J.] Garvan Inst Med Res, Diabet & Metab Div, Sydney, NSW, Australia; [Kavanagh, Tomas; Cooper, Antony A.] Garvan Inst Med Res, Neurosci Div, Sydney, NSW, Australia; [Brandon, Amanda E.; Cooney, Gregory J.] Univ Sydney, Fac Med & Hlth, Charles Perkins Ctr, Sydney, NSW, Australia; [Tolun, Adviye A.] Univ Sydney, Fac Med & Hlth, Discipline Genom Med, Sydney, NSW, Australia; [Tolun, Adviye A.] Univ Sydney, Fac Med & Hlth, Discipline Child & Adolescent Hlth, Sydney, NSW, Australia; [Brown, Simon H. J.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Mitchell, Todd W.] Univ Wollongong, Sch Med, Wollongong, NSW, Australia; [Brown, Simon H. J.; Mitchell, Todd W.] Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Wilkins, Brendan P.; Smith, Nicola J.] Victor Chang Cardiac Res Inst, Div Mol Cardiol & Biophys, Sydney, NSW, Australia; [Devanapalli, Beena; Hertzog, Ashley; Tolun, Adviye A.] Sydney Childrens Hosp Network, New South Wales NSW Biochem Genet Lab, Westmead, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of Melbourne; Garvan Institute of Medical Research; Garvan Institute of Medical Research; University of Sydney; University of Sydney; University of Sydney; University of Wollongong; University of Wollongong; University of Wollongong; Victor Chang Cardiac Research Institute	Turner, N (corresponding author), Univ New South Wales, Sch Med Sci, Dept Pharmacol, Kensington, NSW 2052, Australia.	n.turner@unsw.edu.au	Turner, Nigel/H-7176-2013; Osborne, Brenna/F-5950-2018; Fiveash, Corrine E/I-6360-2018; Yu, Josephine/AHI-4832-2022; Biden, Trevor/AAW-2829-2021; Mitchell, Todd/G-7044-2012	Turner, Nigel/0000-0002-0119-9328; Osborne, Brenna/0000-0002-0197-3010; Yu, Josephine/0000-0002-4615-5257; Smith, Nicola J/0000-0002-7247-9562; Fiveash, Corrine/0000-0002-4700-993X; Wilkins, Brendan/0000-0003-1541-3695; Mitchell, Todd/0000-0002-1372-9963; Tolun, Adviye/0000-0003-2321-6667; Montgomery, Magdalene/0000-0003-2551-4174; Biden, Trevor/0000-0001-5211-0234; Kavanagh, Tomas/0000-0003-2184-3552	National Health and Medical Research Council of Australia; Australian Research Council; University of Wollongong; National Health and Medical Research Council (NHMRC) Career Development Fellowship; NIH National Human Genome Research Institute (NHGRI) [U01HG004085]; CSD Consortium [U01HG004080]; Children's Hospital Oakland Research Institute (CHORI) [U42RR024244]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); University of Wollongong; National Health and Medical Research Council (NHMRC) Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NIH National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); CSD Consortium; Children's Hospital Oakland Research Institute (CHORI)	The authors thank Prof. Bob Graham (Victor Chang Cardiac Research Institute) and Dr. Michael Lazarou (Monash University, Melbourne, VIC, Australia) for generous advice on aspects of this study. This work was supported by funding from the National Health and Medical Research Council of Australia, the Australian Research Council, and the University of Wollongong. M.K.M. was supported by a National Health and Medical Research Council (NHMRC) Career Development Fellowship. Gpr84tm1(KOMP)Vlcg embryonic stem cells used for this research project were generated by the Trans-U.S. National Institutes of Health (NIH) Knockout Mouse Project and obtained from the Knockout Mouse Project Repository (www.komp.org).NIH National Human Genome Research Institute (NHGRI) Grant U01HG004085 to Velocigene at Regeneron, and the CSD Consortium (U01HG004080) funded the generation of gene-targeted embryonic stem cells for 8500 genes in the Knockout Mouse Project Program and archived and distributed by the Knockout Mouse Project Repository at the University of California-Davis (Davis, CA, USA), and Children's Hospital Oakland Research Institute (CHORI; U42RR024244). Animal work was made possible thanks to kind staff in the University of New South Wales Biological Resources Centre and the Garvan Institute Biological Testing Facility. The authors declare no conflicts of interest.	Adiconis X, 2013, NAT METHODS, V10, P623, DOI 10.1038/nmeth.2483; Affaitati A, 2003, J BIOL CHEM, V278, P4286, DOI 10.1074/jbc.M209941200; BABA N, 1982, AM J CLIN NUTR, V35, P678, DOI 10.1093/ajcn/35.4.678; Baker JG, 2007, TRENDS PHARMACOL SCI, V28, P374, DOI 10.1016/j.tips.2007.06.011; Biden TJ, 2004, DIABETES, V53, pS159, DOI 10.2337/diabetes.53.2007.S159; Boden MJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE798, DOI 10.1152/ajpendo.00577.2011; Bou R, 2008, ANAL BIOCHEM, V377, P1, DOI 10.1016/j.ab.2008.02.029; Bouchard C, 2007, GLIA, V55, P790, DOI 10.1002/glia.20506; Buege J A, 1978, Methods Enzymol, V52, P302; Cantley J, 2009, DIABETES, V58, P1826, DOI 10.2337/db09-0132; Cleasby ME, 2011, J ENDOCRINOL, V210, P81, DOI 10.1530/JOE-11-0039; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Cotton LM, 2015, MAMM GENOME, V26, P142, DOI 10.1007/s00335-015-9555-1; Dagda RK, 2015, REV NEUROSCIENCE, V26, P359, DOI 10.1515/revneuro-2014-0085; Dickey AS, 2011, J NEUROSCI, V31, P15716, DOI 10.1523/JNEUROSCI.3159-11.2011; Dinkova-Kostova AT, 2015, FREE RADICAL BIO MED, V88, P179, DOI 10.1016/j.freeradbiomed.2015.04.036; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Du Toit E, 2018, EUR J NUTR, V57, P1737, DOI 10.1007/s00394-017-1456-5; Duarte A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100387; Elagizi A, 2018, PROG CARDIOVASC DIS, V61, P76, DOI 10.1016/j.pcad.2018.03.006; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Han JR, 2007, METABOLISM, V56, P985, DOI 10.1016/j.metabol.2007.03.005; Han JR, 2003, OBES RES, V11, P734, DOI 10.1038/oby.2003.103; Herst PM, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00296; Holt LJ, 2018, ENDOCRINOLOGY, V159, P1339, DOI 10.1210/en.2017-00851; Huang QY, 2014, DEV COMP IMMUNOL, V45, P252, DOI 10.1016/j.dci.2014.03.017; Ishikawa Y, 2003, MOL CELL NEUROSCI, V24, P451, DOI 10.1016/S1044-7431(03)00203-3; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jin KL, 2002, J NEUROCHEM, V80, P119, DOI 10.1046/j.0022-3042.2001.00678.x; Jump DB, 1999, ANNU REV NUTR, V19, P63, DOI 10.1146/annurev.nutr.19.1.63; Kebede M, 2008, DIABETES, V57, P2432, DOI 10.2337/db08-0553; Kraegen EW, 2008, CURR OPIN LIPIDOL, V19, P235, DOI 10.1097/01.mol.0000319118.44995.9a; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lauffer LM, 2009, DIABETES, V58, P1058, DOI 10.2337/db08-1237; Lee HJ, 2004, J NEUROCHEM, V88, P647, DOI 10.1111/j.1471-4159.2004.02191.x; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu Y, 2016, ACS MED CHEM LETT, V7, P579, DOI 10.1021/acsmedchemlett.6b00025; Loh JK, 2015, BBA-MOL CELL RES, V1853, P1796, DOI 10.1016/j.bbamcr.2015.04.013; Mahmud Zobaer Al, 2017, Sci Rep, V7, P17953, DOI 10.1038/s41598-017-18159-3; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Montgomery MK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14214-1; Montgomery MK, 2013, J LIPID RES, V54, P3322, DOI 10.1194/jlr.M040451; Montgomery MK, 2012, EXP GERONTOL, V47, P211, DOI 10.1016/j.exger.2011.11.014; Muller MM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00828-y; Nagasaki H, 2012, FEBS LETT, V586, P368, DOI 10.1016/j.febslet.2012.01.001; Nicol LSC, 2015, J NEUROSCI, V35, P8959, DOI 10.1523/JNEUROSCI.3558-14.2015; Oh DY, 2011, CURR OPIN CLIN NUTR, V14, P322, DOI 10.1097/MCO.0b013e3283479230; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Palikaras K, 2018, NAT CELL BIOL, V20, P1013, DOI 10.1038/s41556-018-0176-2; Papamandjaris AA, 1998, LIFE SCI, V62, P1203, DOI 10.1016/S0024-3205(97)01143-0; Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; St-Onge MP, 2008, AM J CLIN NUTR, V87, P621, DOI 10.1093/ajcn/87.3.621; St-Onge MP, 2003, OBES RES, V11, P395, DOI 10.1038/oby.2003.53; Stoddart LA, 2008, PHARMACOL REV, V60, P405, DOI 10.1124/pr.108.00802; Stockli J, 2015, DIABETES, V64, P1914, DOI 10.2337/db13-1489; Sugden PH, 1997, CELL SIGNAL, V9, P337, DOI 10.1016/S0898-6568(96)00191-X; Suzuki M, 2013, J BIOL CHEM, V288, P10684, DOI 10.1074/jbc.M112.420042; Swanson D, 2012, ADV NUTR, V3, P1, DOI 10.3945/an.111.000893; Talukdar S, 2011, TRENDS PHARMACOL SCI, V32, P543, DOI 10.1016/j.tips.2011.04.004; Tang C, 2015, NAT MED, V21, P173, DOI 10.1038/nm.3779; Tiganis T, 2011, TRENDS PHARMACOL SCI, V32, P82, DOI 10.1016/j.tips.2010.11.006; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Trzcionka M, 2008, J EXP BIOL, V211, P1911, DOI 10.1242/jeb.016519; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Turner N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05613-7; Turner N, 2009, DIABETES, V58, P2547, DOI 10.2337/db09-0784; Venkataraman C, 2005, IMMUNOL LETT, V101, P144, DOI 10.1016/j.imlet.2005.05.010; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Wei L, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0970-y; Wein S, 2009, DIABETES-METAB RES, V25, P185, DOI 10.1002/dmrr.925; Wittenberger T, 2001, J MOL BIOL, V307, P799, DOI 10.1006/jmbi.2001.4520; Yousefi S, 2001, J LEUKOCYTE BIOL, V69, P1045	76	13	14	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12264	12276		10.1096/fj.201900234R	http://dx.doi.org/10.1096/fj.201900234R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31415180	Green Published			2022-12-28	WOS:000507461600052
J	Zhao, PP; Li, S; Wang, HA; Dang, YN; Wang, LF; Liu, T; Wang, SH; Li, XH; Zhang, K				Zhao, Panpan; Li, Shuang; Wang, Huanan; Dang, Yanna; Wang, Lefeng; Liu, Tong; Wang, Shaohua; Li, Xinhong; Zhang, Kun			Sin3a regulates the developmental progression through morula-to-blastocyst transition via Hdac1	FASEB JOURNAL			English	Article						preimplantation; Hdac2; trophectoderm; pluripotency; embryo	GENOME INTEGRITY; MOUSE; COMPLEX; P53; EXPRESSION; TRANSCRIPTION; INTERACTS; PROTEIN; ARREST; DOMAIN	Suppressor interacting 3a (Sin3a) is a scaffold component of the chromatin repressive complex Sin3/histone deacetylase (Hdac). Sin3a has been shown as a hub gene driving preimplantation development in both mice and humans. However, its precise functions during preimplantation development remain unclear. Here, we show that the embryos arrested at morula stage upon specific depletion of Sin3a in mouse early embryos. Given the reduced cell number in Sin3a-depleted embryos, blocked cell proliferation is observed, likely because of the increased level of Trp53 acetylation at lysine 379. Moreover, we found that Sin3a depletion reduces Cdx2 and Tir Na Nog (Nanog), suggesting a failure of the first cell fate decision. In addition, we noted a striking increase of genome-wide DNA methylation, likely attributed to the increased nuclear DNA methyltransferase 1 observed in Sin3a-depleted embryos. Notably, RNA sequencing analyses showed 717 genes are differentially expressed, and Gene Ontology analysis of down-regulated genes (e.g., Hdac1) revealed top enriched terms involving protein deacetylation. Consistently, we confirmed a significant decrease of Hdac1 mRNA and protein abundance. Importantly, the development and Trp53 acetylation in Sin3a-depleted embryos could be rescued by expression of Hdac1 but not Hdac2. In summary, our results indicate a vital role of Sin3a in safeguarding the developmental progression through the morula-to-blastocyst transition via Hdac1.	[Zhao, Panpan; Li, Shuang; Wang, Huanan; Dang, Yanna; Wang, Lefeng; Liu, Tong; Wang, Shaohua; Zhang, Kun] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Lab Mammalian Mol Embryol,Coll Anim Sci, Hangzhou, Peoples R China; [Zhao, Panpan; Li, Shuang; Wang, Huanan; Dang, Yanna; Wang, Lefeng; Liu, Tong; Wang, Shaohua; Li, Xinhong; Zhang, Kun] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Assisted Reprod Unit,Dept Obstet & Gynecol, Hangzhou, Peoples R China; [Li, Xinhong; Zhang, Kun] Shanghai Key Lab Vet Biotechnol, Shanghai, Peoples R China	Zhejiang University; Zhejiang University	Zhang, K (corresponding author), Zhejiang Univ, 301 E Bldg,866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	kzhang@zju.edu.cn	shaohua, wang/AAB-7904-2022	Zhang, Kun/0000-0002-2324-9381	National Natural Science Foundation of China [31672416, 31872348]; Zhejiang Provincial Natural Science Foundation of China [LY19C180002]; Foundation of Shanghai Key Laboratory of Veterinary Biotechnology [klab201708]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Foundation of Shanghai Key Laboratory of Veterinary Biotechnology	The authors thank all members of the K.Z. laboratory for their helpful discussions and comments. This study was supported by National Natural Science Foundation of China (31672416 and 31872348 to K.Z.), the Zhejiang Provincial Natural Science Foundation of China (LY19C180002 to H.W.), and the Foundation of Shanghai Key Laboratory of Veterinary Biotechnology (klab201708). The authors declare no conflicts of interest.	Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cao ZB, 2015, DEVELOPMENT, V142, P1606, DOI 10.1242/dev.120238; Chen ZY, 2015, P NATL ACAD SCI USA, V112, P4618, DOI 10.1073/pnas.1422088112; Cowley SM, 2005, MOL CELL BIOL, V25, P6990, DOI 10.1128/MCB.25.16.6990-7004.2005; David G, 2003, GENE DEV, V17, P2396, DOI 10.1101/gad.1109403; Ealy AD, 2019, J ANIM SCI, V97, P2555, DOI 10.1093/jas/skz116; Eckersley-Maslin MA, 2018, NAT REV MOL CELL BIO, V19, P436, DOI 10.1038/s41580-018-0008-z; Fleming TP, 2018, LANCET, V391, P1842, DOI [10.1016/S0140-6736(18)30312-X, 10.1016/s0140-6736(18)30312-x]; Harrington EA, 1998, P NATL ACAD SCI USA, V95, P11945, DOI 10.1073/pnas.95.20.11945; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Icardi L, 2012, P NATL ACAD SCI USA, V109, P12058, DOI 10.1073/pnas.1206458109; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Ji QH, 2014, J CELL SCI, V127, P4679, DOI 10.1242/jcs.154245; Jimenez R, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.133504; Kimura H, 1999, MOL BIOL CELL, V10, p285A; Krisher RL, 2013, ANNU REV ANIM BIOSCI, V1, P393, DOI 10.1146/annurev-animal-031412-103647; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Laugesen A, 2014, CELL STEM CELL, V14, P735, DOI 10.1016/j.stem.2014.05.006; Li E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019133; Liu WQ, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.10; Liu Z, 2018, CELL, V174, P245, DOI 10.1016/j.cell.2018.01.036; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma PP, 2008, DEV BIOL, V319, P110, DOI 10.1016/j.ydbio.2008.04.011; Ma PP, 2015, CELL REP, V13, P1552, DOI 10.1016/j.celrep.2015.10.031; Ma PP, 2012, P NATL ACAD SCI USA, V109, pE481, DOI 10.1073/pnas.1118403109; Mann MRW, 2004, DEVELOPMENT, V131, P3727, DOI 10.1242/dev.01241; Market-Velker BA, 2010, HUM MOL GENET, V19, P36, DOI 10.1093/hmg/ddp465; Matoba S, 2014, CELL, V159, P884, DOI 10.1016/j.cell.2014.09.055; McDonel P, 2012, DEV BIOL, V363, P62, DOI 10.1016/j.ydbio.2011.12.019; Messerschmidt D, 2016, DEVELOPMENT, V143, P1993, DOI 10.1242/dev.133439; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; RIETHMACHER D, 1995, P NATL ACAD SCI USA, V92, P855, DOI 10.1073/pnas.92.3.855; Rivera RM, 2008, HUM MOL GENET, V17, P1, DOI 10.1093/hmg/ddm280; Rossant J, 2018, ANNU REV GENET, V52, P185, DOI 10.1146/annurev-genet-120116-024544; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; Sahraeian SME, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00050-4; Spencer T. E., 2013, Animal Frontiers, V3, P48, DOI 10.2527/af.2013-0033; Suzuki S, 2015, DEVELOPMENT, V142, P2375, DOI 10.1242/dev.120493; Tucci V, 2019, CELL, V176, P952, DOI 10.1016/j.cell.2019.01.043; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang Y, 2013, DEV CELL, V24, P345, DOI 10.1016/j.devcel.2013.01.012; Wen J, 2012, FERTIL STERIL, V97, P1331, DOI 10.1016/j.fertnstert.2012.02.053; Wiltbank MC, 2016, THERIOGENOLOGY, V86, P239, DOI 10.1016/j.theriogenology.2016.04.037; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yao CF, 2017, DEVELOPMENT, V144, P2618, DOI 10.1242/dev.149708; Zenker J, 2017, SCIENCE, V357, P925, DOI 10.1126/science.aam9335; Zhang K, 2013, DEV BIOL, V383, P15, DOI 10.1016/j.ydbio.2013.09.005; Zhang K, 2013, DEV BIOL, V373, P359, DOI 10.1016/j.ydbio.2012.10.026; Zilfou JT, 2001, MOL CELL BIOL, V21, P3974, DOI 10.1128/MCB.21.12.3974-3985.2001	50	8	10	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12541	12553		10.1096/fj.201901213R	http://dx.doi.org/10.1096/fj.201901213R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31450981	Green Published			2022-12-28	WOS:000507461600073
J	Chen, Y; Chen, XY; Gao, JG; Xu, CF; Xu, P; Li, YM; Zhu, Y; Yu, CH				Chen, Yi; Chen, Xueyang; Gao, Jianguo; Xu, Chengfu; Xu, Ping; Li, Youming; Zhu, Yong; Yu, Chaohui			Long noncoding RNA FLRL2 alleviated nonalcoholic fatty liver disease through Arntl-Sirt1 pathway	FASEB JOURNAL			English	Article						lncRNA; NAFLD; lipogenesis; ER stress; hepatic inflammation	POSTTRANSCRIPTIONAL GENE-REGULATION; CIRCADIAN CLOCK; INSULIN-RESISTANCE; HEPATIC STEATOSIS; METABOLISM; MANAGEMENT; OBESITY	Nonalcoholic fatty liver disease (NAFLD), which has an unknown pathogenesis and lacks a curative treatment, is becoming more prevalent. A previous long noncoding RNA (lncRNA) profiling analysis revealed a potential role for fatty liver-related lncRNA 2 (FLRL2) in the pathogenesis of NAFLD. To further understand the role of FLRL2 in NAFLD and explore its therapeutic value, both in vivo and in vitro NAFLD models were constructed. Small interfering RNA and small hairpin RNA interference and adenovirus transfection were adopted to manipulate the expressions of FLRL2, aryl-hydrocarbon receptor nuclear translocator-like (Arntl), and sirtuin 1 (Sirt1) expression. Steatosis was evaluated through histologic staining with hematoxylin and eosin and oil red O and also by quantitative triglyceride measurements. FLRL2 is a widely distributed nuclear lncRNA that is down-regulated in NAFLD. Overexpression of FLRL2 resolved steatosis, lipogenesis, inflammation, and endoplasmic reticulum (ER) stress in NAFLD, and down-regulation of FLRL2 resulted in the opposite effects. Sequence analysis demonstrated that FLRL2 was located in the intronic region of the Arntl gene, and a luciferase assay showed transcriptional activation of the Arntl gene upon FLRL2 overexpression. A similar expression pattern and synergistic effect of Arntl manipulation was observed in NAFLD in vitro. Inhibition of Arntl partially reversed the steatosis amelioration induced by FLRL2 overexpression. Downstream Sirt1 was also inhibited in NAFLD and influenced by both FLRL2 and Arntl. In NAFLD mice, FLRL2 enhancement alleviated steatosis, activated the Arntl-Sirt1 axis, and inhibited lipogenesis, ER stress, and inflammation, providing preliminary evidence of the benefits of FLRL2-mediated gene therapy in NAFLD.-Chen, Y., Chen, X., Gao, J., Xu, C., Xu, P., Li, Y., Zhu, Y., Yu, C. Long noncoding RNA FLRL2 alleviated nonalcoholic fatty liver disease through Arntl-Sirt1 pathway.	[Chen, Yi; Chen, Xueyang; Gao, Jianguo; Xu, Chengfu; Xu, Ping; Li, Youming; Yu, Chaohui] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Gastroenterol, 79 Qingchun Rd, Hangzhou 310000, Zhejiang, Peoples R China; [Zhu, Yong] Yale Univ, Sch Publ Hlth, Dept Environm Hlth Sci, New Haven, CT 06520 USA	Zhejiang University; Yale University	Yu, CH (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Gastroenterol, 79 Qingchun Rd, Hangzhou 310000, Zhejiang, Peoples R China.; Zhu, Y (corresponding author), Yale Univ, Sch Publ Hlth, Dept Environm Hlth Sci, New Haven, CT 06520 USA.	yong.zhu@yale.edu; zyyyych@zju.edu.cn	Xu, Cheng/GXH-4815-2022	Xu, Cheng/0000-0003-1000-733X	National Natural Science Foundation of China [8170054, 81722009]; Science Foundation of Health Bureau of Zhejiang Province [2017183691]; Zhejiang Province Basic Public Benefit Research Program [LGF19H210001]; Natural Science Foundation of Zhejiang Province [LY17H030006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Health Bureau of Zhejiang Province; Zhejiang Province Basic Public Benefit Research Program; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This study was supported by National Natural Science Foundation of China (8170054 to Y.C. and 81722009 to C.X.), the Science Foundation of Health Bureau of Zhejiang Province (2017183691 to Y.C.), the Zhejiang Province Basic Public Benefit Research Program (LGF19H210001 to Y.C.), and the Natural Science Foundation of Zhejiang Province (LY17H030006 to P.X.). The funders did not play any role in the study design, data collection and analysis, decisions regarding data release, or manuscript preparation. The authors declare no conflicts of interest.	Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Beckedorff FC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003705; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Chandrahas VK, 2018, CURR TOP MICROBIOL, V414, P103, DOI 10.1007/82_2017_41; Chen Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010021; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Del Ben M, 2014, WORLD J GASTROENTERO, V20, P8341, DOI 10.3748/wjg.v20.i26.8341; Deutsch MJ, 2014, ANAL BIOCHEM, V445, P87, DOI 10.1016/j.ab.2013.10.001; Dey BK, 2014, TRANSCR-AUSTIN, V5, DOI 10.4161/21541272.2014.944014; Dykes IM, 2017, GENOM PROTEOM BIOINF, V15, P177, DOI 10.1016/j.gpb.2016.12.005; Eckel-Mahan K, 2009, NAT STRUCT MOL BIOL, V16, P462, DOI 10.1038/nsmb.1595; Ferdowsian H, 2011, BIOETHICS, V25, P472, DOI 10.1111/j.1467-8519.2011.01923.x; Geng T, 2013, DIABETOLOGIA, V56, P2078, DOI 10.1007/s00125-013-2973-2; Jain S, 2017, RNA BIOL, V14, P522, DOI 10.1080/15476286.2016.1172756; Li M, 2018, GUT, V67, P2169, DOI 10.1136/gutjnl-2017-313778; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; PAUL IJ, 1975, MOL CELL BIOCHEM, V9, P9, DOI 10.1007/BF01731728; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Sattar N, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4596; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; Takahashi K, 2014, HEPATOLOGY, V60, P744, DOI 10.1002/hep.27043; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Wan XY, 2016, J HEPATOL, V64, P925, DOI 10.1016/j.jhep.2015.11.022; Wong VWS, 2016, LANCET GASTROENTEROL, V1, P56, DOI 10.1016/S2468-1253(16)30011-5; Xu CF, 2015, J HEPATOL, V62, P1412, DOI 10.1016/j.jhep.2015.01.019; Yoon JH, 2013, J MOL BIOL, V425, P3723, DOI 10.1016/j.jmb.2012.11.024; Zhang DG, 2018, HEAD NECK-J SCI SPEC, V40, P2476, DOI 10.1002/hed.25371; Zhang DQ, 2014, J BIOL CHEM, V289, P25925, DOI 10.1074/jbc.M114.567628; Zheng Z, 2016, DIABETES, V65, P3369, DOI 10.2337/db16-0298; Zhou B, 2014, HEPATOLOGY, V59, P2196, DOI 10.1002/hep.26992	35	21	21	3	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11411	11419		10.1096/fj.201900643RRR	http://dx.doi.org/10.1096/fj.201900643RRR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31311301				2022-12-28	WOS:000489166300067
J	Nie, YF; Hu, J; Hou, QL; Zheng, WO; Zhang, XH; Yang, T; Ma, LB; Yan, XH				Nie, Yangfan; Hu, Jun; Hou, Qiliang; Zheng, Wenvong; Zhang, Xianghua; Yang, Tao; Ma, Libao; Yan, Xianghua			Lactobacillus frumenti improves antioxidant capacity via nitric oxide synthase 1 in intestinal epithelial cells	FASEB JOURNAL			English	Article						L; frumenti; ROS; NOS1; proteomics	GERM-FREE MICE; GUT MICROBIOTA; OXIDATIVE STRESS; MODEL; BARRIER; INJURY; IRON; PROBIOTICS; PROTEOMICS; ENZYME	Oxidative damages have adverse effects on mammals. Growing studies have focused on exploring new antioxidants. Here, we report that Lactobacillus frumenti increases the total antioxidation capacity activities and decreases the total reactive oxygen species levels in porcine intestinal epithelial cells. Comparative proteomics revealed that expressions of peroxiredoxin 2, isocitrate dehydrogenase 1, NAD(P)H dehydrogenase quinone 1, antioxidant protein 1, and metallothionein-2A, which are associated with antioxidant defense system, were significantly increased with L. frumenti treatment. In germ-free mice, L. frumenti treatment also remarkably improves the intestinal antioxidant capacity. We further illustrated that nitric oxide production-mediated by nitric oxide synthase 1 activation is essential for L. frumenti-induced improvements in intestinal epithelial antioxidant capacity and barrier function. This study suggested that L. frumenti may be a potential probiotic used to prevent oxidative stress-induced aging and diseases in mammals.-Nie, Y., Hu, J., Hou, Q., Zheng, W., Zhang, X., Yang, T., Ma, L., Yan, X. Lactobacillus frumenti improves antioxidant capacity via nitric oxide synthase 1 in intestinal epithelial cells.	[Nie, Yangfan; Hu, Jun; Hou, Qiliang; Zheng, Wenvong; Zhang, Xianghua; Yang, Tao; Ma, Libao; Yan, Xianghua] Huazhong Agr Univ, Coll Anim Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Nie, Yangfan; Hu, Jun; Hou, Qiliang; Zheng, Wenvong; Zhang, Xianghua; Yang, Tao; Ma, Libao; Yan, Xianghua] Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan, Hubei, Peoples R China; [Nie, Yangfan; Hu, Jun; Hou, Qiliang; Zheng, Wenvong; Zhang, Xianghua; Yang, Tao; Ma, Libao; Yan, Xianghua] Hubei Prov Engn Lab Pig Precis Feeding & Feed Saf, Wuhan, Hubei, Peoples R China; [Nie, Yangfan; Hu, Jun; Hou, Qiliang; Zheng, Wenvong; Zhang, Xianghua; Yang, Tao; Ma, Libao; Yan, Xianghua] Natl Ctr Int Res Anim Genet Breeding & Reprod, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	Yan, XH (corresponding author), Huazhong Agr Univ, Shizishan St, Wuhan 430070, Hubei, Peoples R China.	xhyan@mail.hzau.edu.cn			National Natural Science Foundation of China [31730090, 31520103915, 31322053]; National Key Research and Development Program of China [2017YFD0500503, 2018YFD0500404]; Hubei Provincial Natural Science Foundation of China [2018CFA020]; Fundamental Research Funds for the Central Universities [2013PY056, 2662015PY111, 2013JQ001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Hubei Provincial Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Research funding was provided by the National Natural Science Foundation of China (31730090, 31520103915, and 31322053), the National Key Research and Development Program of China (2017YFD0500503 and 2018YFD0500404), Hubei Provincial Natural Science Foundation of China (2018CFA020), and the Fundamental Research Funds for the Central Universities (2013PY056, 2662015PY111, and 2013JQ001). The authors declare no conflicts of interest.	Al-Asmakh M, 2015, J MICROBIOL BIOTECHN, V25, P1583, DOI 10.4014/jmb.1501.01039; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Bhattarai Y, 2016, METHODS MOL BIOL, V1438, P123, DOI 10.1007/978-1-4939-3661-8_8; Bianchet MA, 2004, METHOD ENZYMOL, V382, P144; Bloodsworth A, 2000, ARTERIOSCL THROM VAS, V20, P1707, DOI 10.1161/01.ATV.20.7.1707; Byndloss MX, 2017, SCIENCE, V357, P570, DOI 10.1126/science.aam9949; Cai X, 2013, MOL CELL BIOCHEM, V378, P73, DOI 10.1007/s11010-013-1595-9; Campbell JM, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-19; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Correa-Aragunde N, 2004, PLANTA, V218, P900, DOI 10.1007/s00425-003-1172-7; Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Garcia CR, 2012, DALTON T, V41, P6458, DOI 10.1039/c2dt30060e; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Gorbunov NV, 1997, J BIOL CHEM, V272, P12328, DOI 10.1074/jbc.272.19.12328; Grover M, 2014, NEUROGASTROENT MOTIL, V26, P745, DOI 10.1111/nmo.12366; Hatori Y, 2017, IUBMB LIFE, V69, P246, DOI 10.1002/iub.1620; Hu J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03025; Hu J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00897; Hu J, 2017, INT J BIOCHEM CELL B, V89, P42, DOI 10.1016/j.biocel.2017.05.026; Hu J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01727; Huang HY, 2015, J BIOL CHEM, V290, P11119, DOI 10.1074/jbc.M114.608075; Huang Y, 2019, PEST MANAG SCI, V75, P444, DOI 10.1002/ps.5135; Jarry A, 2003, KIDNEY INT, V64, P170, DOI 10.1046/j.1523-1755.2003.00078.x; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; Jung M, 2009, TOXICOL APPL PHARM, V234, P236, DOI 10.1016/j.taap.2008.10.014; Kagan VE, 2001, ANTIOXID REDOX SIGN, V3, P189, DOI 10.1089/152308601300185160; Kelly CJ, 2015, CELL HOST MICROBE, V17, P662, DOI 10.1016/j.chom.2015.03.005; Kim H, 2000, J BIOL CHEM, V275, P18266, DOI 10.1074/jbc.275.24.18266; Liu HY, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12355; Maeng O, 2004, BIOCHEM BIOPH RES CO, V317, P558, DOI 10.1016/j.bbrc.2004.03.075; Maxmen A, 2012, NATURE, V486, P453, DOI 10.1038/486453a; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Mishra V, 2015, J AGR FOOD CHEM, V63, P3615, DOI 10.1021/jf506326t; Murakami S, 2014, NEUROTOX RES, V26, P285, DOI 10.1007/s12640-014-9480-1; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Nielsen KL, 2014, AM J CLIN NUTR, V99, P941, DOI 10.3945/ajcn.113.074724; Patlevic P, 2016, INTEGR MED RES, V5, P250, DOI 10.1016/j.imr.2016.07.004; Ramakrishna BS, 2013, J GASTROEN HEPATOL, V28, P9, DOI 10.1111/jgh.12294; RUBBO H, 1994, J BIOL CHEM, V269, P26066; Samoylenko A, 2013, ANTIOXID REDOX SIGN, V19, P2157, DOI 10.1089/ars.2012.4662; Sanchez-Font MF, 2003, CELL MOL LIFE SCI, V60, P1513, DOI 10.1007/s00018-003-3048-1; Shan J, 2007, NITRIC OXIDE-BIOL CH, V17, P25, DOI 10.1016/j.niox.2007.05.001; Sohn SH, 2009, ANN NUTR METAB, V54, P227, DOI 10.1159/000225378; Song DG, 2017, ACS APPL MATER INTER, V9, P14724, DOI 10.1021/acsami.7b03377; Steck N, 2011, GASTROENTEROLOGY, V141, P959, DOI 10.1053/j.gastro.2011.05.035; Tuncer S, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01336; Ubeda C, 2012, TRENDS IMMUNOL, V33, P459, DOI 10.1016/j.it.2012.05.003; Vaiserman AM, 2017, AGEING RES REV, V35, P36, DOI 10.1016/j.arr.2017.01.001; Wang H, 2018, GENE, V677, P119, DOI 10.1016/j.gene.2018.07.059; Wang Y, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050521; Wen B, 2014, PROTEOMICS, V14, P2280, DOI 10.1002/pmic.201300361; Xu WZ, 2018, CELL MOL NEUROBIOL, V38, P735, DOI 10.1007/s10571-017-0540-y; Yi P, 2012, VET MICROBIOL, V157, P1, DOI 10.1016/j.vetmic.2011.10.024; Yin J, 2014, J ANIM SCI, V92, P612, DOI 10.2527/jas.2013-6986; Zhu MM, 2009, MOL CELL PROTEOMICS, V8, P752, DOI 10.1074/mcp.M800343-MCP200	58	8	8	5	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10705	10716		10.1096/fj.201900253RR	http://dx.doi.org/10.1096/fj.201900253RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31262191	Bronze			2022-12-28	WOS:000489166300011
J	Sani, MA; Zhu, SY; Hofferek, V; Separovic, F				Sani, Marc-Antoine; Zhu, Shiying; Hofferek, Vinzenz; Separovic, Frances			Nitroxide spin-labeled peptides for DNP-NMR in-cell studies	FASEB JOURNAL			English	Article						in-cell NMR; antimicrobial peptides; E; coli bacteria; TOAC	DYNAMIC NUCLEAR-POLARIZATION; MEMBRANE-ACTIVE PEPTIDES; SPECTROSCOPY; MECHANISM	Antimicrobial peptides (AMPs) that target lipid membranes show promise as alternatives to conventional antibiotics. However, the molecular mechanisms of membrane perturbation, as most studies are performed in model systems and in-cell structural studies, have yet to be achieved. Solid-state NMR spectroscopy is a valuable technique to investigate peptide-membrane interactions and to determine the structure of peptides, but the short lifespan of bacteria, especially under magic angle spinning conditions, has not permitted in-cell structural studies. Here, we present the first dynamic nuclear polarization (DNP)-NMR in-cell studies of Escherichia coli bacteria incubated with the AMP maculatin 1.1 (Mac1) in combination with novel nitroxide spin-labeled peptides 2,2,6,6-tetramethylpiperidine-N-oxyl-4-amino-4-carboxylic acid (TOAC)-[F3W]-Mac1 (MacW) and TOAC-TOAC-MacW. The in-cell C-13 and N-15 signal NMR enhancements, and H-1 spin-lattice T-1 relaxation times showed that TOAC-MacW and TOAC-TOAC-MacW performed better than the more hydrophilic biradical AMUPol used for DNP studies. Furthermore, the pores formed by the AMP increased the signal enhancements and decreased T-1 values of specifically C-13- and N-15-labeled Mac1. This approach has a great potential for determining the first in situ structures of AMPs in bacteria.-Sani, M.-A., Zhu, S., Hofferek, V., Separovic, F. Nitroxide spin-labeled peptides for DNP-NMR in-cell studies.	[Sani, Marc-Antoine; Zhu, Shiying; Hofferek, Vinzenz; Separovic, Frances] Univ Melbourne, Sch Chem, Bio21 Inst, Melbourne, Vic 3010, Australia	University of Melbourne	Sani, MA (corresponding author), Univ Melbourne, Sch Chem, Bio21 Inst, Melbourne, Vic 3010, Australia.	msani@unimelb.edu.au		Hofferek, Vinzenz/0000-0002-6150-1453; Sani, Marc-antoine/0000-0003-3284-2176	Australian Research Council (ARC) [DP160100959]; Linkage Infrastructure, Equipment and Facilities (LIEF) Grant [LE160100120]	Australian Research Council (ARC)(Australian Research Council); Linkage Infrastructure, Equipment and Facilities (LIEF) Grant	This research was funded by the Australian Research Council (ARC) Discovery Project Grant DP160100959 (to F.S). and Linkage Infrastructure, Equipment and Facilities (LIEF) Grant LE160100120 (to M.-A.S. and F.S.). The authors declare no conflicts of interest.	Aquila M, 2013, CURR PROTEIN PEPT SC, V14, P607; Fernandez-de-Alba C, 2015, CHEM-EUR J, V21, P4512, DOI 10.1002/chem.201404588; Haney EF, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00043; Hong M, 2011, PROTEIN SCI, V20, P641, DOI 10.1002/pro.600; Hubalek Z, 2003, CRYOBIOLOGY, V46, P205, DOI 10.1016/s0011-2240(03)00046-4; Kumar P, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8010004; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; McCoy KM, 2019, J MAGN RESON, V303, P115, DOI 10.1016/j.jmr.2019.04.013; NAKAIE CR, 1981, BRAZ J MED BIOL RES, V14, P173; Ni QZ, 2013, ACCOUNTS CHEM RES, V46, P1933, DOI 10.1021/ar300348n; Overall SA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010181; Porcelli F, 2013, METHODS MOL BIOL, V1063, P159, DOI 10.1007/978-1-62703-583-5_9; Ramamoorthy A, 2006, BIOPHYS J, V91, P206, DOI 10.1529/biophysj.105.073890; Sani MA, 2015, J MAGN RESON, V253, P138, DOI 10.1016/j.jmr.2014.11.016; Sani MA, 2013, ANTIMICROB AGENTS CH, V57, P3593, DOI 10.1128/AAC.00195-13; Sani MA, 2007, J PEPT SCI, V13, P100, DOI 10.1002/psc.803; Sani MA, 2016, ACCOUNTS CHEM RES, V49, P1130, DOI 10.1021/acs.accounts.6b00074; Sani MA, 2015, J BIOL CHEM, V290, P19853, DOI 10.1074/jbc.M115.643262; Sani MA, 2014, NEW DEV NMR, V3, P287; Sani MA, 2014, EUR BIOPHYS J BIOPHY, V43, P445, DOI 10.1007/s00249-014-0970-0; Sani MA, 2012, BBA-BIOMEMBRANES, V1818, P205, DOI 10.1016/j.bbamem.2011.07.015; Schreier Shirley, 2012, Biophys Rev, V4, P45, DOI 10.1007/s12551-011-0064-5; Sergeyev IV, 2017, P NATL ACAD SCI USA, V114, P5171, DOI 10.1073/pnas.1701484114; Smith AN, 2015, ANGEW CHEM INT EDIT, V54, P1542, DOI 10.1002/anie.201410249; Thankamony ASL, 2017, PROG NUCL MAG RES SP, V102, P120, DOI 10.1016/j.pnmrs.2017.06.002; van der Cruijsen EAW, 2015, CHEM-EUR J, V21, P12971, DOI 10.1002/chem.201501376; Vitzthum V, 2011, CHEMPHYSCHEM, V12, P2929, DOI 10.1002/cphc.201100630; Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558; Yamamoto K, 2015, BBA-BIOMEMBRANES, V1848, P342, DOI 10.1016/j.bbamem.2014.07.008; Zagdoun A, 2013, J AM CHEM SOC, V135, P12790, DOI 10.1021/ja405813t	30	22	22	1	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11021	11027		10.1096/fj.201900931R	http://dx.doi.org/10.1096/fj.201900931R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31284743	Bronze			2022-12-28	WOS:000489166300037
J	Oh, HYP; Visvalingam, V; Wahli, W				Oh, Hui Yun Penny; Visvalingam, Vivegan; Wahli, Walter			The PPAR-microbiota-metabolic organ trilogy to fine-tune physiology	FASEB JOURNAL			English	Review						circadian rhythm; intestines; liver; muscle	ACTIVATED-RECEPTOR-ALPHA; CHAIN FATTY-ACIDS; HELIX TRANSCRIPTION FACTOR; MUSCLE-FIBER-TYPE; GROWTH-FACTOR-I; NF-KAPPA-B; PEROXISOME-PROLIFERATOR; GUT MICROBIOTA; SKELETAL-MUSCLE; LIPID-METABOLISM	The human gut is colonized by commensal microorganisms, predominately bacteria that have coevolved in symbiosis with their host. The gut microbiota has been extensively studied in recent years, and many important findings on how it can regulate host metabolism have been unraveled. In healthy individuals, feeding timing and type of food can influence not only the composition but also the circadian oscillation of the gut microbiota. Host feeding habits thus influence the type of microbe-derived metabolites produced and their concentrations throughout the day. These microbe-derived metabolites influence many aspects of host physiology, including energy metabolism and circadian rhythm. Peroxisome proliferator-activated receptors (PPARs) are a group of ligand-activated transcription factors that regulate various metabolic processes such as fatty acid metabolism. Similar to the gut microbiota, PPAR expression in various organs oscillates diurnally, and studies have shown that the gut microbiota can influence PPAR activities in various metabolic organs. For example, short-chain fatty acids, the most abundant type of metabolites produced by anaerobic fermentation of dietary fibers by the gut microbiota, are PPAR agonists. In this review, we highlight how the gut microbiota can regulate PPARs in key metabolic organs, namely, in the intestines, liver, and muscle. Knowing that the gut microbiota impacts metabolism and is altered in individuals with metabolic diseases might allow treatment of these patients using noninvasive procedures such as gut microbiota manipulation.-Oh, H. Y. P., Visvalingam, V., Wahli, W. The PPAR-microbiota-metabolic organ trilogy to fine-tune physiology.	[Oh, Hui Yun Penny] Nanyang Technol Univ, Interdisciplinary Grad Sch, Inst Hlth Technol, Singapore, Singapore; [Oh, Hui Yun Penny; Visvalingam, Vivegan; Wahli, Walter] Nanyang Technol Univ, Lee Kong Chian Sch Med, Clin Sci Bldg,11 Mandalay Rd,Level 10, Singapore 308232, Singapore; [Wahli, Walter] Inst Natl Rech Agron INRA ToxAlim, Unite Mixte Rech UMR 1331, Toulouse, France; [Wahli, Walter] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; INRAE; University of Lausanne	Wahli, W (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Clin Sci Bldg,11 Mandalay Rd,Level 10, Singapore 308232, Singapore.	walter.wahli@ntu.edu.sg	Wahli, Walter/B-1398-2009	Wahli, Walter/0000-0002-5966-9089; Oh, Hui Yun Penny/0000-0003-0782-4099	Lee Kong Chian School of Medicine (Nanyang Technological University, Singapore); Interdisciplinary Graduate School, Nanyang Institute of Technology in Health & Medicine (IGS-NITHM)	Lee Kong Chian School of Medicine (Nanyang Technological University, Singapore)(Nanyang Technological University); Interdisciplinary Graduate School, Nanyang Institute of Technology in Health & Medicine (IGS-NITHM)	This work was supported by the Start-Up Grant (W.W.) of the Lee Kong Chian School of Medicine (Nanyang Technological University, Singapore) and a scholarship from the Interdisciplinary Graduate School, Nanyang Institute of Technology in Health & Medicine (IGS-NITHM) (H.Y.P.O.). The authors declare no conflicts of interest.	Akinrotimi O, 2017, HEPATOLOGY, V66, P1854, DOI 10.1002/hep.29305; Akram M, 2014, CELL BIOCHEM BIOPHYS, V68, P475, DOI 10.1007/s12013-013-9750-1; Al-Asmakh M, 2015, J MICROBIOL BIOTECHN, V25, P1583, DOI 10.4014/jmb.1501.01039; Al-Asmakh M, 2012, GUT MICROBES, V3, P366, DOI 10.4161/gmic.21287; Al-Lahham SH, 2010, BBA-MOL CELL BIOL L, V1801, P1175, DOI 10.1016/j.bbalip.2010.07.007; Alex S, 2013, MOL CELL BIOL, V33, P1303, DOI 10.1128/MCB.00858-12; Annese V, 2012, PPAR RES, V2012, DOI 10.1155/2012/620839; Antya R, 2011, CLIN RES HEPATOL GAS, V35, pS10, DOI 10.1016/S2210-7401(11)70003-1; Araki E, 2018, DIABETES CARE, V41, P538, DOI 10.2337/dc17-1589; Are A, 2008, P NATL ACAD SCI USA, V105, P1943, DOI 10.1073/pnas.0711734105; Azhar S, 2010, FUTUR CARDIOL, V6, P657, DOI [10.2217/FCA.10.86, 10.2217/fca.10.86]; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Beyaz S, 2016, CLIN CANCER RES, V22, P5636, DOI 10.1158/1078-0432.CCR-16-0775; Bischoff SC, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0189-7; Boden G, 1999, DIABETES, V48, P2182, DOI 10.2337/diabetes.48.11.2182; BODIE EA, 1987, J IND MICROBIOL, V1, P349, DOI 10.1007/BF01569331; Botta M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041197; Boulange CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2; Bowcutt R, 2014, WORLD J GASTROENTERO, V20, P15216, DOI 10.3748/wjg.v20.i41.15216; Brandt JM, 1998, J BIOL CHEM, V273, P23786, DOI 10.1074/jbc.273.37.23786; Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; Byndloss MX, 2017, SCIENCE, V357, P570, DOI 10.1126/science.aam9949; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cappola AR, 2003, J CLIN ENDOCR METAB, V88, P2019, DOI 10.1210/jc.2002-021694; Cardona Maria E., 2000, Microbial Ecology in Health and Disease, V12, P219, DOI 10.1080/08910600050216200; Carvalho FA, 2012, ANNU REV PHYSIOL, V74, P177, DOI 10.1146/annurev-physiol-020911-153330; Cerda B, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00051; Chen LH, 2014, PPAR RES, V2014, DOI 10.1155/2014/653017; Chen Y, 2006, BBA-GENE STRUCT EXPR, V1759, P32, DOI 10.1016/j.bbaexp.2006.01.005; Chen YM, 2016, SCI REP-UK, V6, DOI 10.1038/srep19076; Chinetti-Gbaguidi G, 2005, CURR OPIN PHARMACOL, V5, P177, DOI 10.1016/j.coph.2004.11.004; Choi Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep15878; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Cole LK, 2012, BBA-MOL CELL BIOL L, V1821, P754, DOI 10.1016/j.bbalip.2011.09.009; Conchillo M, 2007, REV ESP ENFERM DIG, V99, P156, DOI 10.4321/s1130-01082007000300007; Corton JC, 2000, ANNU REV PHARMACOL, V40, P491, DOI 10.1146/annurev.pharmtox.40.1.491; Couvigny B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125371; Crawford PA, 2009, P NATL ACAD SCI USA, V106, P11276, DOI 10.1073/pnas.0902366106; Crescenzo R, 2015, INT J MOL SCI, V16, P10674, DOI 10.3390/ijms160510674; Cukrowska B, 2002, SCAND J IMMUNOL, V55, P204, DOI 10.1046/j.1365-3083.2002.01005.x; Cukrowska B, 2001, IMMUNOBIOLOGY, V204, P425, DOI 10.1078/0171-2985-00052; D'Argenio G, 2010, J BIOL CHEM, V285, P27078, DOI 10.1074/jbc.M110.109678; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Dobell C, 1920, Proc R Soc Med, V13, P1; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Dubuquoy L, 2003, GASTROENTEROLOGY, V124, P1265, DOI 10.1016/S0016-5085(03)00271-3; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; Dwivedi SKD, 2011, MOL ENDOCRINOL, V25, P922, DOI 10.1210/me.2010-0512; Engelen M, 2012, J INHERIT METAB DIS, V35, P1137, DOI 10.1007/s10545-012-9471-4; Engelen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041013; Enjoji M, 2016, LIVER SYSTEMIC DIS, P10522; Fajas L, 1998, FEBS LETT, V438, P55, DOI 10.1016/S0014-5793(98)01273-3; Fan WW, 2017, CELL METAB, V25, P1186, DOI 10.1016/j.cmet.2017.04.006; Fang SM, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1055-x; FAST DG, 1995, BBA-LIPID LIPID MET, V1258, P159, DOI 10.1016/0005-2760(95)00116-T; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; Ferrell JM, 2015, ACTA PHARM SIN B, V5, P113, DOI 10.1016/j.apsb.2015.01.003; Ferri N, 2017, EXPERT OPIN INV DRUG, V26, P593, DOI 10.1080/13543784.2017.1312339; Ferrucci L, 2002, J AM GERIATR SOC, V50, P1947, DOI 10.1046/j.1532-5415.2002.50605.x; Fink LN, 2007, INT IMMUNOL, V19, P1319, DOI 10.1093/intimm/dxm103; Flanagan JL, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-30; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Foster DW, 2012, J CLIN INVEST, V122, P1958, DOI 10.1172/JCI63967; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; Frost RA, 2002, AM J PHYSIOL-REG I, V283, pR698, DOI 10.1152/ajpregu.00039.2002; Gardner MJ, 2006, BIOCHEM J, V397, P15, DOI 10.1042/BJ20060484; Giel JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008740; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Greene M. E., 1995, Gene Expression, V4, P281; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; Grosicki GJ, 2018, CALCIFIED TISSUE INT, V102, P433, DOI 10.1007/s00223-017-0345-5; Gross B, 2017, NAT REV ENDOCRINOL, V13, P36, DOI 10.1038/nrendo.2016.135; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Haczeyni F, 2017, HEPATOL COMMUN, V1, P663, DOI 10.1002/hep4.1072; Haddad F, 2005, J APPL PHYSIOL, V98, P911, DOI 10.1152/japplphysiol.01026.2004; Hamaguchi H, 2004, BIOCHEM J, V382, P43, DOI 10.1042/BJ20031760; Han L, 2017, FUTUR CARDIOL, V13, DOI 10.2217/fca-2016-0059; Han L, 2017, FUTUR CARDIOL, V13, DOI 10.2217/fca-2017-0019; Harfmann BD, 2015, J BIOL RHYTHM, V30, P84, DOI 10.1177/0748730414561638; Henao-Mejia J, 2013, CELL, V153, P741, DOI 10.1016/j.cell.2013.04.043; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Herzog ED, 2007, NAT REV NEUROSCI, V8, P790, DOI 10.1038/nrn2215; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Hoppeler H, 2002, J EXP BIOL, V205, P2143; Hou YZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2270; Hsu YJ, 2015, J STRENGTH COND RES, V29, P552, DOI 10.1519/JSC.0000000000000644; Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Hui XY, 2009, J BIOL CHEM, V284, P14050, DOI 10.1074/jbc.M109.001107; Hur KY, 2015, DIABETES METAB J, V39, P198, DOI 10.4093/dmj.2015.39.3.198; Hussain MM, 2013, NAT REV ENDOCRINOL, V9, P444, DOI 10.1038/nrendo.2013.129; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Hwang I, 2015, FASEB J, V29, P2397, DOI 10.1096/fj.14-265983; Iannucci LF, 2016, BIOCHEM BIOPH RES CO, V480, P461, DOI 10.1016/j.bbrc.2016.10.072; International Diabetes Federation, IDF DIABETES ATLAS, V10th; International Diabetes Federation, IDF CONS WORLDW DEF; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jain MR, 2018, LIVER INT, V38, P1084, DOI 10.1111/liv.13634; Jain MR, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.136; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; JONES PS, 1995, EUR J BIOCHEM, V233, P219, DOI 10.1111/j.1432-1033.1995.219_1.x; Joyce SA, 2014, P NATL ACAD SCI USA, V111, P7421, DOI 10.1073/pnas.1323599111; Kawamoto T, 2004, BIOCHEM BIOPH RES CO, V313, P117, DOI 10.1016/j.bbrc.2003.11.099; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kersten S, 2014, MOL METAB, V3, P354, DOI 10.1016/j.molmet.2014.02.002; Kiela PR, 2016, BEST PRACT RES CL GA, V30, P145, DOI 10.1016/j.bpg.2016.02.007; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Kondo T, 2009, J AGR FOOD CHEM, V57, P5982, DOI 10.1021/jf900470c; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Korecka A, 2013, AM J PHYSIOL-GASTR L, V304, pG1025, DOI 10.1152/ajpgi.00293.2012; Lagkouvardos I, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.131, 10.1038/nmicrobiol.2016.131]; Lahiri S., SCI TRANSL MED; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li YX, 2003, J BIOL CHEM, V278, P16899, DOI 10.1074/jbc.M300596200; Liang HY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063983, 10.1371/journal.pone.0074121]; Liang X, 2015, P NATL ACAD SCI USA, V112, P10479, DOI 10.1073/pnas.1501305112; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu HB, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060559; Lu YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep18985; Lukovac S, 2014, MBIO, V5, DOI 10.1128/mBio.01438-14; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Luquet S, 2005, BBA-MOL BASIS DIS, V1740, P313, DOI 10.1016/j.bbadis.2004.11.011; Mach N, 2017, J SPORT HEALTH SCI, V6, P179, DOI 10.1016/j.jshs.2016.05.001; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Manickam R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082418; Manickam R, 2017, BIOCHIMIE, V136, P42, DOI 10.1016/j.biochi.2016.11.010; Moreno-Navarrete JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037160; Marschall HU, 2013, GASTROENTEROLOGY, V144, P870, DOI 10.1053/j.gastro.2013.03.018; Mason KL, 2008, ADV EXP MED BIOL, V635, P1, DOI 10.1007/978-0-387-09550-9_1; Matsumoto M, 2008, BIOSCI BIOTECH BIOCH, V72, P572, DOI 10.1271/bbb.70474; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mei L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138078; Mencarelli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022978; Mendoza J, 2007, J NEUROENDOCRINOL, V19, P127, DOI 10.1111/j.1365-2826.2006.01510.x; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Michalik L, 2008, PPAR RES, V2008, DOI 10.1155/2008/134059; Mishra AK, 2016, METABOLISM, V65, P48, DOI 10.1016/j.metabol.2015.10.008; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Monsalve FA, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/549627; Montagner A, 2016, GUT, V65, P1202, DOI 10.1136/gutjnl-2015-310798; Montagner A, 2016, SCI REP-UK, V6, DOI 10.1038/srep20127; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; Murakami M, 2016, EMBO REP, V17, P1292, DOI 10.15252/embr.201642463; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nepelska M, 2017, SCI REP-UK, V7, DOI 10.1038/srep43199; Norin E, 2008, ANN NUTR METAB, V52, P12, DOI 10.1159/000115341; Oh HYP, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040812; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; Onishi JC, 2017, MICROBIOL-SGM, V163, P1189, DOI 10.1099/mic.0.000496; Oriach C., 2016, CLIN NUTR EXP, V6, P25, DOI [10.1016/j.yclnex.2016.01.003, DOI 10.1016/J.YCLNEX.2016.01.003]; Orngreen MC, 2014, NEUROLOGY, V82, P607, DOI 10.1212/WNL.0000000000000118; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Park DY, 2013, WORLD J GASTROENTERO, V19, P274, DOI 10.3748/wjg.v19.i2.274; Park YK, 2012, MOL CELLS, V33, P575, DOI 10.1007/s10059-012-0002-9; Peters JM, 2008, CLIN SCI, V115, P107, DOI 10.1042/CS20080022; Peyrin-Biroulet L, 2010, P NATL ACAD SCI USA, V107, P8772, DOI 10.1073/pnas.0905745107; Piya MK, 2013, J ENDOCRINOL, V216, pT1, DOI 10.1530/JOE-12-0498; Pourcet Benoit, 2006, Expert Opin Emerg Drugs, V11, P379, DOI 10.1517/14728214.11.3.379; Prabha V, 2006, WORLD J MICROB BIOT, V22, P191, DOI 10.1007/s11274-005-9019-y; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Qiao Y, 2014, FOOD FUNCT, V5, P1241, DOI 10.1039/c3fo60630a; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Quigley Eamonn M M, 2013, Gastroenterol Hepatol (N Y), V9, P560; Rando G, 2016, ELIFE, V5, DOI 10.7554/eLife.11853; Ratziu V, 2016, GASTROENTEROLOGY, V150, P1147, DOI 10.1053/j.gastro.2016.01.038; Raza-Iqbal S, 2015, J ATHEROSCLER THROMB, V22, P754, DOI 10.5551/jat.28720; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Robinson MW, 2016, CELL MOL IMMUNOL, V13, P267, DOI 10.1038/cmi.2016.3; Rodriguez MADR, 2017, BBA-MOL CELL BIOL L, V1862, P1212, DOI 10.1016/j.bbalip.2017.07.007; Romano KA, 2015, MBIO, V6, DOI 10.1128/mBio.02481-14; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; ROTHSCHILD MA, 1973, GASTROENTEROLOGY, V64, P324; Sanz Yolanda, 2007, Recent Pat Antiinfect Drug Discov, V2, P148, DOI 10.2174/157489107780832596; Sanz Y, 2010, P NUTR SOC, V69, P434, DOI 10.1017/S0029665110001813; Sato F, 2004, EUR J BIOCHEM, V271, P4409, DOI 10.1111/j.1432-1033.2004.04379.x; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Schaffler H, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00646; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Schneider JL, 2014, NAT REV GASTRO HEPAT, V11, P187, DOI 10.1038/nrgastro.2013.211; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Schulz P, 2009, CNS DRUGS, V23, P3, DOI 10.2165/11318620-000000000-00000; Scott EM, 2008, INT J OBESITY, V32, P658, DOI 10.1038/sj.ijo.0803778; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Selwyn FP, 2016, DRUG METAB DISPOS, V44, P262, DOI 10.1124/dmd.115.067504; SHER T, 1993, BIOCHEMISTRY-US, V32, P5598, DOI 10.1021/bi00072a015; Sinal CJ, 2001, J BIOL CHEM, V276, P47154, DOI 10.1074/jbc.M107000200; Soccio RE, 2014, CELL METAB, V20, P573, DOI 10.1016/j.cmet.2014.08.005; Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23; Spruss A, 2012, LAB INVEST, V92, P1020, DOI 10.1038/labinvest.2012.75; Spruss A, 2009, HEPATOLOGY, V50, P1094, DOI 10.1002/hep.23122; St-Pierre B, 2002, J BIOL CHEM, V277, P46544, DOI 10.1074/jbc.M111652200; Steegenga WT, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-38; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Suarez-Zamorano N, 2015, NAT MED, V21, P1497, DOI 10.1038/nm.3994; Sumanasekera WK, 2003, BIOCHEMISTRY-US, V42, P10726, DOI 10.1021/bi0347353; Sun K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047791; Sutula Justyna, 2013, Microbial Ecology in Health and Disease, V24, P21003, DOI 10.3402/mehd.v24i0.21003; Suzuki A, 2015, GENES CELLS, V20, P77, DOI 10.1111/gtc.12200; Takada I, 2000, MOL ENDOCRINOL, V14, P733, DOI 10.1210/me.14.5.733; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tan CK, 2017, EXPERT OPIN THER TAR, V21, P333, DOI 10.1080/14728222.2017.1280467; Tan NS, 2016, PROG LIPID RES, V64, P98, DOI 10.1016/j.plipres.2016.09.001; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; Thaiss CA, 2016, CELL, V167, P1495, DOI 10.1016/j.cell.2016.11.003; The Nobel Assembly at Karolinska Institutet, SCIENTIFIC BACKGROUN; Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Tomas J, 2016, P NATL ACAD SCI USA, V113, pE5934, DOI 10.1073/pnas.1612559113; Torra IP, 2003, MOL ENDOCRINOL, V17, P259, DOI 10.1210/me.2002-0120; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; US Food and Drug Administration, FDA DRUG SAF COMM UP; US Food and Drug Administration, FDA DRUG SAF COMM FD; van de Weijer T, 2013, CIRC RES, V112, pE51, DOI 10.1161/CIRCRESAHA.113.300944; Vegiopoulos A, 2007, MOL CELL ENDOCRINOL, V275, P43, DOI 10.1016/j.mce.2007.05.015; VERKADE HJ, 1993, J BIOL CHEM, V268, P24990; Vermeulen PS, 1997, J LIPID RES, V38, P447; Wagnerberger S, 2013, J NUTR BIOCHEM, V24, P531, DOI 10.1016/j.jnutbio.2012.01.014; Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Wan MLY, 2018, HEPATOBIL SURG NUTR, V7, P11, DOI 10.21037/hbsn.2017.12.07; Wang HS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01073; Wang LM, 2014, BIOCHEM PHARMACOL, V92, P73, DOI 10.1016/j.bcp.2014.07.018; Wang YC, 2013, CURR OPIN CLIN NUTR, V16, P243, DOI 10.1097/MCO.0b013e328360272d; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Weigl LG, 2012, CURR OPIN PHARMACOL, V12, P377, DOI 10.1016/j.coph.2012.02.017; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Wright MB, 2014, MOL ENDOCRINOL, V28, P1756, DOI 10.1210/me.2013-1427; Xiao L, 2015, NAT BIOTECHNOL, V33, P1103, DOI 10.1038/nbt.3353; Xu F, 2009, DIABETES, V58, pA3, DOI 10.2337/db08-1637; Yamashita H, 2009, BIOSCI BIOTECH BIOCH, V73, P570, DOI 10.1271/bbb.80634; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yan HL, 2016, SCI REP-UK, V6, DOI 10.1038/srep31786; Yanai H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09927-2; YAO ZM, 1988, J BIOL CHEM, V263, P2998; Yokote K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030706; Yoshikawa T, 1996, GENOMICS, V35, P637, DOI 10.1006/geno.1996.0417; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zapolska-Downar D, 2009, J PHYSIOL PHARMACOL, V60, P123; Zarrinpar A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05336-9; Zeng XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072922; Zenhom M, 2011, J NUTR, V141, P971, DOI 10.3945/jn.110.136176; Zenhom M, 2011, IMMUNOBIOLOGY, V216, P715, DOI 10.1016/j.imbio.2010.10.008; Zhou D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01751-y; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348; Vincent ZA, 2007, BBA-MOL CELL BIOL L, V1771, P915, DOI 10.1016/j.bbalip.2007.01.007; Zorn A. M., 2008, STEMBOOK, DOI [10.3824/stembook.1.25.1, DOI 10.3824/STEMBOOK.1.25.1]	276	23	23	5	29	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9706	9730		10.1096/fj.201802681RR	http://dx.doi.org/10.1096/fj.201802681RR			25	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31237779	Bronze			2022-12-28	WOS:000482214200003
J	Cheng, C; Liu, HX; Tan, CC; Tong, DD; Zhao, YX; Liu, X; Si, WX; Wang, LL; Liang, LN; Li, J; Wang, CH; Chen, QY; Du, YM; Wang, QK; Ren, X				Cheng, Chen; Liu, Huixia; Tan, Chengcheng; Tong, Doudou; Zhao, Yongxuan; Liu, Xia; Si, Wenxia; Wang, Linlin; Liang, Lina; Li, Jia; Wang, Chenghui; Chen, Qiuyun; Du, Yimei; Wang, Qing K.; Ren, Xiang			Mutation in NPPA causes atrial fibrillation by activating inflammation and cardiac fibrosis in a knock-in rat model	FASEB JOURNAL			English	Article						cardiac fibroblast; cGMP; IL-1 beta	NF-KAPPA-B; NATRIURETIC PEPTIDES; QRS DURATION; RISK-FACTOR; MECHANISMS; VARIANTS; GENE; ASSOCIATION; ARRHYTHMIA; BIOLOGY	Atrial fibrillation (AF) affects >30 million individuals worldwide. However, no genetic mutation from human patients with AF has been linked to inflammation. Here, we show that AF-associated human variant p.Ile138Thr in natriuretic peptide A (NPPA) encoding the atrial natriuretic peptide (ANP) causes inflammation, fibroblast activation, atrial fibrosis, and AF in knock-in (KI) rats. Variant p.Ile138Thr inhibits the interaction between ANP and its receptor natriuretic peptide receptor A and reduces intracellular cGMP levels. RNA sequencing and follow-up analyses showed that mutant ANP (mANP) activates multiple innate immunity pathways, including TNF-alpha, NF-kappa B, and IL-1 beta signaling. mANP induces differentiation of cardiac fibroblasts (CFs) to myofibroblasts and promotes CF proliferation and fibrosis. These results suggest that NPPA variant p.Ile138Thr causes AF by activating TNF-alpha, NF-kappa B, and IL-1 beta signaling, inflammation, and fibrosis. Multiple computational programs suggest that p.Ile138Thr is damaging or deleterious. Based on the 2015 American College of Medical Genetics and Genomics Standards and Guidelines, p.Ile138Thr can be classified as a likely pathogenic variant. Variant p.Ile138Thr was found only in Asian people in the Genome Aggregation Database and Exome Aggregation Consortium database at an averaged frequency of 0.026%. An estimated 1.15 million Asian people carry the variant and might be at risk of AF. The KI rats may provide an inflammation-based, genetic animal model for AF valuable for testing anti-inflammation or other therapies for AF.-Cheng, C., Liu, H., Tan, C., Tong, D., Zhao, Y., Liu, X., Si, W., Wang, L., Liang, L., Li, J., Wang, C., Chen, Q., Du, Y., Wang, Q. K., Ren, X. Mutation in NPPA causes atrial fibrillation by activating inflammation and cardiac fibrosis in a knock-in rat model.	[Cheng, Chen; Tan, Chengcheng; Tong, Doudou; Zhao, Yongxuan; Liu, Xia; Wang, Linlin; Liang, Lina; Li, Jia; Wang, Chenghui; Wang, Qing K.; Ren, Xiang] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Ctr Human Genome Res, Key Lab Mol Biophys,Minist Educ, Luoyu Rd 1037, Wuhan, Hubei, Peoples R China; [Du, Yimei] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Inst Cardiovasc Dis, Wuhan, Hubei, Peoples R China; [Liu, Huixia] Wuhan Univ, Zhongnan Hosp, Dept Cardiol, Wuhan, Hubei, Peoples R China; [Si, Wenxia] Hubei Polytech Univ, Coll Med, Dept Basic Med, Huangshi, Hubei, Peoples R China; [Chen, Qiuyun; Wang, Qing K.] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44106 USA; [Chen, Qiuyun; Wang, Qing K.] Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44106 USA; [Wang, Qing K.] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Wuhan University; Hubei Polytechnic University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University	Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Ctr Human Genome Res, Key Lab Mol Biophys,Minist Educ, Luoyu Rd 1037, Wuhan, Hubei, Peoples R China.; Ren, X (corresponding author), Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430074, Peoples R China.	wangq2@ccf.org; renxiang@hust.edu.cn	Du, Yimei/E-1581-2012	Du, Yimei/0000-0003-1125-0294; Wang, Qing/0000-0002-5639-8519; Li, Jia/0000-0001-7132-2574; Cheng, Chen/0000-0002-3677-7992	China National Natural Science Foundation [31430047, 81270162, 8163002, 81370206]; Hubei Province's Innovative Team [2017CFA014]; Chinese National Basic Research Programs (973 Programs) [2013CB531101, 2012CB517801]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Hubei Province's Innovative Team; Chinese National Basic Research Programs (973 Programs)(National Basic Research Program of China)	The authors thank the members of the Center for Human Genome Research and Research Center of Ion Channelopathy for a highly collegial collaboration. This study was supported by the China National Natural Science Foundation (Grants 31430047, 81270162, 8163002, and 81370206), the Hubei Province's Innovative Team (Grant 2017CFA014), and the Chinese National Basic Research Programs (973 Programs 2013CB531101 and 2012CB517801). The authors declare no conflicts of interest.	Abraham RL, 2010, J MOL CELL CARDIOL, V48, P181, DOI 10.1016/j.yjmcc.2009.07.020; Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Casaclang-Verzosa G, 2008, J AM COLL CARDIOL, V51, P1, DOI 10.1016/j.jacc.2007.09.026; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Christia P, 2013, J HISTOCHEM CYTOCHEM, V61, P555, DOI 10.1369/0022155413493912; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; El-Chami MF, 2010, CLIN CARDIOL, V33, P132, DOI 10.1002/clc.20714; Fu XX, 2015, INT J MOL MED, V36, P83, DOI 10.3892/ijmm.2015.2204; Golden HB, 2012, METHODS MOL BIOL, V843, P205, DOI 10.1007/978-1-61779-523-7_20; Gopinathannair R, 2015, J AM COLL CARDIOL, V66, P1714, DOI 10.1016/j.jacc.2015.08.038; Guo YT, 2012, J AM COLL CARDIOL, V60, P2263, DOI 10.1016/j.jacc.2012.04.063; Harada M, 2015, CIRC J, V79, P495, DOI 10.1253/circj.CJ-15-0138; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hodgson-Zingman DM, 2008, NEW ENGL J MED, V359, P158, DOI 10.1056/NEJMoa0706300; Hu MM, 2014, P NATL ACAD SCI USA, V111, P1509, DOI 10.1073/pnas.1318227111; Kong Ping, 2014, Cell Mol Life Sci, V71, P549, DOI 10.1007/s00018-013-1349-6; Kotecha D, 2015, EUR HEART J, V36, P3250, DOI 10.1093/eurheartj/ehv513; Lu QL, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002529; Luo CY, 2017, BBA-MOL BASIS DIS, V1863, P2319, DOI 10.1016/j.bbadis.2017.06.015; Maisel WH, 2003, AM J CARDIOL, V91, p2D, DOI 10.1016/S0002-9149(02)03373-8; Marott SCW, 2010, J AM COLL CARDIOL, V56, P789, DOI 10.1016/j.jacc.2010.02.066; Meng GL, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004160; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Mori T, 2004, CARDIOVASC RES, V61, P771, DOI 10.1016/j.cardiores.2003.12.005; Nattel S, 2014, J AM COLL CARDIOL, V63, P2335, DOI 10.1016/j.jacc.2014.02.555; Ogawa H, 2004, J BIOL CHEM, V279, P28625, DOI 10.1074/jbc.M313222200; Olesen MS, 2014, HEART RHYTHM, V11, P246, DOI 10.1016/j.hrthm.2013.10.034; Pandey KN, 1999, ENDOCRINOLOGY, V140, P5112, DOI 10.1210/en.140.11.5112; Papaleo E, 2010, J MOL GRAPH MODEL, V28, P834, DOI 10.1016/j.jmgm.2010.03.003; Patel P, 2010, J CARDIOVASC ELECTR, V21, P1064, DOI 10.1111/j.1540-8167.2010.01774.x; Pekalski J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078887; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Rainer PP, 2016, CARDIOVASC RES, V111, P154, DOI 10.1093/cvr/cvw107; Ren X, 2010, CLIN CHIM ACTA, V411, P481, DOI 10.1016/j.cca.2009.12.019; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Ritchie MD, 2012, J AM COLL CARDIOL, V60, P1173, DOI 10.1016/j.jacc.2012.04.030; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; SCHOTT JJ, 1995, AM J HUM GENET, V57, P1114; Sharma D, 2016, J CELL BIOL, V213, P617, DOI 10.1083/jcb.201602089; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Tian XL, 2004, CARDIOVASC RES, V61, P256, DOI 10.1016/j.cardiores.2003.11.007; Vellaichamy E, 2005, BIOCHEM BIOPH RES CO, V327, P106, DOI 10.1016/j.bbrc.2004.11.153; Weissler-Snir A, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.116.005311; Whitbeck MG, 2014, EUROPACE, V16, P803, DOI 10.1093/europace/eut335; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wu L, 2008, J BIOL CHEM, V283, P6968, DOI 10.1074/jbc.M709721200; Zhang J, 2013, ONCOL LETT, V6, P407, DOI 10.3892/ol.2013.1425; Zhang NX, 2018, PACE, V41, P321, DOI 10.1111/pace.13292; Zhang T, 2016, HUM MOL GENET, V25, P5094, DOI 10.1093/hmg/ddw273; Zhang XQ, 2008, CELL, V135, P1017, DOI 10.1016/j.cell.2008.10.022	50	16	18	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					8878	8891		10.1096/fj.201802455RRR	http://dx.doi.org/10.1096/fj.201802455RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31034774				2022-12-28	WOS:000478832900015
J	Fontaine, MA; Diane, A; Singh, VP; Mangat, R; Krysa, JA; Nelson, R; Willing, BP; Proctor, SD				Fontaine, Melanie A.; Diane, Abdoulaye; Singh, Vijay P.; Mangat, Rabban; Krysa, Jacqueline A.; Nelson, Randy; Willing, Benjamin P.; Proctor, Spencer D.			4 Low birth weight causes insulin resistance and aberrant intestinal lipid metabolism independent of microbiota abundance in Landrace-Large White pigs	FASEB JOURNAL			English	Article						intrauterine growth restriction; swine; lymphatic lipoproteins; microbiota	HIGH-FAT DIET; DEVELOPMENTAL ORIGINS; GUT MICROBIOTA; CARDIOVASCULAR-DISEASE; OBESITY; GROWTH; MODEL; RISK; OVERPRODUCTION; TRIGLYCERIDES	Low birth weight (LBW) and postnatal nutrition are risk factors for adult metabolic diseases. However, the interactions between LBW, diet, and intestinal lipid absorption and secretion leading to adult metabolic disease remain unclear. The current study determined the impact of LBW on intestinal lipid and carbohydrate metabolism under both control and Western diet (high fat, high fructose, and cholesterol) conditions in 5-wk-old LBW and normal birth weight (NBW) Landrace-Large White x Duroc pigs. A 2-step modified oral glucose and fat challenge test was performed. Mesenteric lymph, jejunal mucosal scrapings, and cecal digesta samples were also collected. LBW offspring were lower in weight and gained less weight per day. LBW pigs on either control or Western diets displayed increased triglyceride (TG) secretion into lymph (P = 0.0135). Western diet-fed LBW pigs developed fasting (P = 0.03) and postprandial (P < 0.05) hypertriglyceridemia, muscle steatosis (P = 0.0072), had higher insulin excursion (P < 0.01), increased jejunal stearoyl-CoA desaturase 1 mRNA and increased hepatic fibrosis (P = 0.0017) compared with NBW piglets. Gut microbiota showed significant dysbiosis on Western diet independent of birth weight. In conclusion, LBW pigs fed a Western diet specifically up-regulate TG absorption and secretion, develop dyslipidemia, muscular steatosis, and display early signs of insulin resistance. Interestingly, this study does not provide evidence of altered intestinal microbiome in LBW pigs contributing to increased severity of metabolic diseases.-Fontaine, M. A., Diane, A., Singh, V. P., Mangat, R., Krysa, J. A., Nelson, R., Willing, B. P., Proctor, S. D. Low birth weight causes insulin resistance and aberrant intestinal lipid metabolism independent of microbiota abundance in Landrace-Large White pigs.	[Fontaine, Melanie A.; Diane, Abdoulaye; Singh, Vijay P.; Mangat, Rabban; Krysa, Jacqueline A.; Nelson, Randy; Proctor, Spencer D.] Univ Alberta, Metab & Cardiovasc Dis Lab, Grp Mol & Cell Biol Lipids, Alberta Diabet & Mazankowski Heart Inst, Edmonton, AB, Canada; [Willing, Benjamin P.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	University of Alberta; University of Alberta	Proctor, SD (corresponding author), Univ Alberta, Alberta Diabet & Mazankowski Heart Inst, Grp Mol & Cell Biol Lipids, 4 002J Li Ka Shing Ctr Hlth Res Innovat,Metab, Edmonton, AB T6G 2E1, Canada.	spencer.proctor@ualberta.ca	Willing, Benjamin/AAA-9650-2019		Alberta Livestock and Meat Agency (ALMA); Alberta Agriculture and Forestry (AAF); Natural Sciences and Engineering Research Council of Canada (NSERC)	Alberta Livestock and Meat Agency (ALMA); Alberta Agriculture and Forestry (AAF); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors thank Sandra Kelly and Sharon Sokolik (both from the University of Alberta) for technical assistance. Funding support from Alberta Livestock and Meat Agency (ALMA) and Alberta Agriculture and Forestry (AAF) and the Natural Sciences and Engineering Research Council of Canada (NSERC) discovery grant (Proctor). The authors declare no conflicts of interest.	Adeli K, 2008, CURR OPIN LIPIDOL, V19, P221, DOI 10.1097/MOL.0b013e3282ffaf82; Al K, 2017, PEERJ, V5, DOI 10.7717/peerj.2840; ALjohani AM, 2017, TRENDS ENDOCRIN MET, V28, P831, DOI 10.1016/j.tem.2017.10.003; Attie AD, 2002, J LIPID RES, V43, P1899, DOI 10.1194/jlr.M200189-JLR200; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Barker D J, 2001, Med Health Care Philos, V4, P31, DOI 10.1023/A:1009934412988; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Blanc AK, 2005, B WORLD HEALTH ORGAN, V83, P178; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Costello EK, 2013, MBIO, V4, DOI 10.1128/mBio.00782-13; Council N.R., 2012, NUTR REQ SWIN; Davis Jeremy E, 2013, ISRN Obes, V2013, P584547, DOI 10.1155/2013/584547; de Wit NJW, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-14; Dong XY, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-173; Duez H, 2006, ARTERIOSCL THROM VAS, V26, P1357, DOI 10.1161/01.ATV.0000222015.76038.14; Dyson MC, 2006, COMPARATIVE MED, V56, P35; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Suarez-Ortegon MF, 2016, WORLD J PEDIATR, V12, P477, DOI 10.1007/s12519-016-0008-z; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Ferenc K, 2014, REPROD BIOL, V14, P51, DOI 10.1016/j.repbio.2014.01.005; Field FJ, 2001, J LIPID RES, V42, P1; Gluckman PD, 2004, TRENDS ENDOCRIN MET, V15, P183, DOI 10.1016/j.tem.2004.03.002; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Guilloteau P, 2010, NUTR RES REV, V23, P4, DOI 10.1017/S0954422410000077; HACK M, 1993, J PEDIATR-US, V122, P887, DOI 10.1016/S0022-3476(09)90012-9; Haidari M, 2002, J BIOL CHEM, V277, P31646, DOI 10.1074/jbc.M200544200; Halliday HL, 2009, BEST PRACT RES CL OB, V23, P871, DOI 10.1016/j.bpobgyn.2009.06.005; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hyson Dianne, 2003, Curr Atheroscler Rep, V5, P437, DOI 10.1007/s11883-003-0033-y; Jackson KG, 2012, ATHEROSCLEROSIS, V220, P22, DOI 10.1016/j.atherosclerosis.2011.08.012; Jiang ZH, 2008, INT J BIOL SCI, V4, P345, DOI 10.7150/ijbs.4.345; Kennedy AJ, 2010, DIS MODEL MECH, V3, P156, DOI 10.1242/dmm.003467; Lee L, 2009, HEPATOLOGY, V50, P56, DOI 10.1002/hep.22904; Li H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00969-0; Lian JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep25747; Lim KS, 2015, ASIAN AUSTRAL J ANIM, V28, P151, DOI 10.5713/ajas.14.0529; Liu JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029259; McMillen IC, 2009, ADV EXP MED BIOL, V646, P71, DOI 10.1007/978-1-4020-9173-5_8; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Myrie SB, 2017, APPL PHYSIOL NUTR ME, V42, P1322, DOI 10.1139/apnm-2017-0311; Ntambi JM, 2004, LIPIDS, V39, P1061, DOI 10.1007/s11745-004-1331-2; Ogden Cynthia L, 2010, NCHS Data Brief, P1; Panasevich MR, 2018, AM J PHYSIOL-ENDOC M, V314, pE78, DOI 10.1152/ajpendo.00015.2017; Pedersen R, 2013, GUT MICROBES, V4, P371, DOI 10.4161/gmic.26108; Pedersen R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-30; PLAGEMANN A, 1992, EXP CLIN ENDOCRINOL, V99, P154, DOI 10.1055/s-0029-1211159; Poore KR, 2002, DIABETOLOGIA, V45, P1247, DOI 10.1007/s00125-002-0849-y; Ravandi A, 2000, ARTERIOSCL THROM VAS, V20, P467, DOI 10.1161/01.ATV.20.2.467; Ren J, 2004, ANIM GENET, V35, P255, DOI 10.1111/j.1365-2052.2004.01129.x; Russell JC, 1998, EUR J PHARMACOL, V350, P203, DOI 10.1016/S0014-2999(98)00244-1; Schmidt B, 2003, JAMA-J AM MED ASSOC, V289, P1124, DOI 10.1001/jama.289.9.1124; Schulz LC, 2010, P NATL ACAD SCI USA, V107, P16757, DOI 10.1073/pnas.1012911107; Shepherd PR, 1997, BRIT J NUTR, V78, P121, DOI 10.1079/BJN19970124; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Uwiera RR, 2016, JOVE-J VIS EXP, DOI 10.3791/53457; Vaag AA, 2012, DIABETOLOGIA, V55, P2085, DOI 10.1007/s00125-012-2589-y; van Steijn L, 2009, INT J OBESITY, V33, P1326, DOI 10.1038/ijo.2009.154; Varvarigou AA, 2010, J PEDIATR ENDOCR MET, V23, P215, DOI 10.1515/JPEM.2010.23.3.215; Vine DF, 2007, ATHEROSCLEROSIS, V190, P282, DOI 10.1016/j.atherosclerosis.2006.03.013; Visentin S, 2014, ATHEROSCLEROSIS, V237, P391, DOI 10.1016/j.atherosclerosis.2014.09.027; Vos Miriam B, 2008, Medscape J Med, V10, P160; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Yan HL, 2017, EUR J NUTR, V56, P483, DOI 10.1007/s00394-015-1093-9; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	66	11	13	3	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9250	9262		10.1096/fj.201801302RR	http://dx.doi.org/10.1096/fj.201801302RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31144992	Bronze			2022-12-28	WOS:000478832900044
J	Ikeda, Y; Satoh, A; Horinouchi, Y; Hamano, H; Watanabe, H; Imao, M; Imanishi, M; Zamami, Y; Takechi, K; Izawa-Ishizawa, Y; Miyamoto, L; Hirayama, T; Nagasawa, H; Ishizawa, K; Aihara, KI; Tsuchiya, K; Tamaki, T				Ikeda, Yasumasa; Satoh, Akiho; Horinouchi, Yuya; Hamano, Hirofumi; Watanabe, Hiroaki; Imao, Mizuki; Imanishi, Masaki; Zamami, Yoshito; Takechi, Kenshi; Izawa-Ishizawa, Yuki; Miyamoto, Licht; Hirayama, Tasuku; Nagasawa, Hideko; Ishizawa, Keisuke; Aihara, Ken-Ichi; Tsuchiya, Koichiro; Tamaki, Toshiaki			Iron accumulation causes impaired myogenesis correlated with MAPK signaling pathway inhibition by oxidative stress	FASEB JOURNAL			English	Article						muscle regeneration; muscle differentiation; p38MAPK; ERK1/2	SERUM AMINOTRANSFERASE LEVELS; PROTEIN-KINASE PATHWAY; MUSCLE GENE-EXPRESSION; HUMAN SKELETAL-MUSCLE; SATELLITE CELLS; SARCOPENIC OBESITY; DIFFERENTIATION; REGENERATION; FERRITIN; P38	Skeletal muscle atrophy is caused by disruption in the homeostatic balance of muscle degeneration and regeneration under various pathophysiological conditions. We have previously reported that iron accumulation induces skeletal muscle atrophy via a ubiquitin ligase-dependent pathway. However, the potential effect of iron accumulation on muscle regeneration remains unclear. To examine the effect of iron accumulation on myogenesis, we used a mouse model with cardiotoxin (CTX)-induced muscle regeneration in vivo and C2C12 mouse myoblast cells in vitro. In mice with iron overload, the skeletal muscles exhibited increased oxidative stress and decreased expression of satellite cell markers. Following CTX-induced muscle injury, these mice also displayed delayed muscle regeneration with a decrease in the size of regenerating myofibers, reduced expression of myoblast differentiation markers, and decreased phosphorylation of MAPK signaling pathways. In vitro, iron overload also suppressed the differentiation of C2C12 myoblast cells but the suppression could be reversed by superoxide scavenging using tempol. Excess iron inhibits myogenesis via oxidative stress, leading to an imbalance in skeletal muscle homeostasis.-Ikeda, Y., Satoh, A., Horinouchi, Y., Hamano, H., Watanabe, H., Imao, M., Imanishi, M., Zamami, Y., Takechi, K., Izawa-Ishizawa, Y., Miyamoto, L., Hirayama, T., Nagasawa, H., Ishizawa, K., Aihara, K.-I., Tsuchiya, K., Tamaki, T. Iron accumulation causes impaired myogenesis correlated with MAPK signaling pathway inhibition by oxidative stress.	[Ikeda, Yasumasa; Horinouchi, Yuya; Izawa-Ishizawa, Yuki; Tamaki, Toshiaki] Tokushima Univ, Inst Biomed Sci, Dept Pharmacol, Grad Sch, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan; [Satoh, Akiho; Imao, Mizuki; Miyamoto, Licht; Tsuchiya, Koichiro] Tokushima Univ, Inst Biomed Sci, Dept Med Pharmacol, Grad Sch, Tokushima, Japan; [Watanabe, Hiroaki; Zamami, Yoshito; Ishizawa, Keisuke] Tokushima Univ, Inst Biomed Sci, Dept Clin Pharmacol, Grad Sch, Tokushima, Japan; [Aihara, Ken-Ichi] Tokushima Univ, Inst Biomed Sci, Dept Community Med Diabet & Metab Disorders, Grad Sch, Tokushima, Japan; [Hamano, Hirofumi; Imanishi, Masaki; Zamami, Yoshito; Ishizawa, Keisuke] Tokushima Univ Hosp, Dept Pharm, Tokushima, Japan; [Takechi, Kenshi] Tokushima Univ Hosp, Clin Trial Ctr Dev Therapeut, Tokushima, Japan; [Hirayama, Tasuku; Nagasawa, Hideko] Gifu Pharmaceut Univ, Lab Pharmaceut & Med Chem, Gifu, Japan	Tokushima University; Tokushima University; Tokushima University; Tokushima University; Tokushima University; Tokushima University; Gifu Pharmaceutical University	Ikeda, Y (corresponding author), Tokushima Univ, Inst Biomed Sci, Dept Pharmacol, Grad Sch, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	yasuike@tokushima-u.ac.jp		Imanishi, Masaki/0000-0003-1305-5943; Hamano, Hirofumi/0000-0002-2231-0179; Ikeda, Yasumasa/0000-0003-4318-7349	Japan Society for the Promotion of Science (JSPS) KAKENHI [15K01716, 18K08480]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Editage (www.editage.jp) for help with English language editing. The authors appreciate the excellent technical advice by the Support Center for Advanced Medical Sciences (Institute of Biomedical Sciences, Tokushima University Graduate School). This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI grants (15K01716 and 18K08480 to Y. I.). The authors declare no conflicts of interest.	Altun M, 2007, MUSCLE NERVE, V36, P223, DOI 10.1002/mus.20808; Ardite E, 2004, AM J PATHOL, V165, P719, DOI 10.1016/S0002-9440(10)63335-4; Barbieri Elena, 2012, J Signal Transduct, V2012, P982794, DOI 10.1155/2012/982794; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Bross R, 1999, TRENDS ENDOCRIN MET, V10, P194, DOI 10.1016/S1043-2760(98)00143-X; Buck M, 1996, EMBO J, V15, P1753, DOI 10.1002/j.1460-2075.1996.tb00524.x; Camaschella C, 2005, BLOOD, V106, P3710, DOI 10.1182/blood-2005-05-1857; CARTEE GD, 1995, J GERONTOL A-BIOL, V50, P137; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chung JY, 2013, ARCH GERONTOL GERIAT, V56, P270, DOI 10.1016/j.archger.2012.09.007; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Cooper RN, 1999, J CELL SCI, V112, P2895; Corbu A, 2010, NEUROL RES, V32, P63, DOI 10.1179/174313209X385725; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; D'Souza DM, 2016, DIABETES, V65, P3053, DOI 10.2337/db15-1577; DeRuisseau KC, 2013, EXP GERONTOL, V48, P1294, DOI 10.1016/j.exger.2013.08.011; EVANS WJ, 1995, J GERONTOL A-BIOL, V50, P5, DOI 10.1093/gerona/50A.Special_Issue.5; Fernandez E, 2005, CLIN CHEM, V51, P1014, DOI 10.1373/clinchem.2004.047233; Ford ES, 1999, DIABETES CARE, V22, P1978, DOI 10.2337/diacare.22.12.1978; Fu X, 2016, DIABETES, V65, P188, DOI 10.2337/db15-0647; Fulster S, 2013, EUR HEART J, V34, P512, DOI 10.1093/eurheartj/ehs381; Fujimaki Shin, 2016, Biochem Biophys Rep, V8, P6, DOI 10.1016/j.bbrep.2016.07.004; Fulle S, 2004, EXP GERONTOL, V39, P17, DOI 10.1016/j.exger.2003.09.012; Gallegly JC, 2004, J APPL PHYSIOL, V97, P1082, DOI 10.1152/japplphysiol.00006.2004; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807; Gredinger E, 1998, J BIOL CHEM, V273, P10436, DOI 10.1074/jbc.273.17.10436; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; GUTTRIDGE DC, 2000, SCIENCE, V289, P2363, DOI [10.1126/sci-ence.289.5488.2363, DOI 10.1126/SCI-ENCE.289.5488.2363, DOI 10.1126/science.289.5488.2363, DOI 10.1126/SCIENCE.289.5488.2363]; Halliday JW, 1996, BIOMETALS, V9, P205, DOI 10.1007/BF00144626; Hamano H, 2018, NEPHROL DIAL TRANSPL, V33, P586, DOI 10.1093/ndt/gfx252; Hansen JM, 2007, CELL BIOL INT, V31, P546, DOI 10.1016/j.cellbi.2006.11.027; HAYASHI H, 1995, J HEPATOL, V22, P268, DOI 10.1016/0168-8278(95)80278-9; HAYASHI H, 1994, AM J GASTROENTEROL, V89, P986; Hirayama T, 2013, CHEM SCI, V4, P1250, DOI 10.1039/c2sc21649c; Horinouchi Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29008-2; Houschyar KS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-54; Ikeda Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11089-0; Ikeda Y, 2016, J TRACE ELEM MED BIO, V35, P66, DOI 10.1016/j.jtemb.2016.01.011; Ikeda Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089355; Ikeda Y, 2013, AM J PHYSIOL-RENAL, V304, pF1028, DOI 10.1152/ajprenal.00473.2012; Ishizaka N, 2002, CIRCULATION, V106, P1840, DOI 10.1161/01.CIR.0000031161.77536.02; Iwasaki T, 2005, DIABETES CARE, V28, P2486, DOI 10.2337/diacare.28.10.2486; Jones NC, 2001, J CELL PHYSIOL, V186, P104, DOI 10.1002/1097-4652(200101)186:1<104::AID-JCP1015>3.0.CO;2-0; Kefaloyianni E, 2006, CELL SIGNAL, V18, P2238, DOI 10.1016/j.cellsig.2006.05.004; Kim TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090105; Kim TN, 2010, DIABETES CARE, V33, P1497, DOI 10.2337/dc09-2310; Kuo KL, 2014, J AM SOC NEPHROL, V25, P2596, DOI 10.1681/ASN.2013080838; Lee DH, 2006, DIABETES CARE, V29, P1090, DOI 10.2337/DC05-2471; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Lim S, 2010, DIABETES CARE, V33, P1652, DOI 10.2337/dc10-0107; Lynch G S, 2001, Exerc Sport Sci Rev, V29, P141, DOI 10.1097/00003677-200110000-00002; Mak RH, 2011, J CACHEXIA SARCOPENI, V2, P9, DOI 10.1007/s13539-011-0019-5; Menke A, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-34; Moore DR, 2018, EUR J APPL PHYSIOL, V118, P2225, DOI 10.1007/s00421-018-3954-4; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Naito Y, 2011, HYPERTENSION, V57, P497, DOI 10.1161/HYPERTENSIONAHA.110.159681; Nakanishi T, 2010, AM J NEPHROL, V32, P439, DOI 10.1159/000320733; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Oshima K, 2017, LAB INVEST, V97, P555, DOI 10.1038/labinvest.2017.11; Phillips SM, 2009, J APPL PHYSIOL, V107, P645, DOI 10.1152/japplphysiol.00452.2009; Powers SK, 2010, EXP PHYSIOL, V95, P1, DOI 10.1113/expphysiol.2009.050526; Reardon TF, 2009, EXP PHYSIOL, V94, P720, DOI 10.1113/expphysiol.2008.046045; Renault V, 2002, EXP GERONTOL, V37, P1229, DOI 10.1016/S0531-5565(02)00129-8; Renault V, 2002, AGING CELL, V1, P132, DOI 10.1046/j.1474-9728.2002.00017.x; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Roth SM, 2000, ANAT REC, V260, P351, DOI 10.1002/1097-0185(200012)260:4<350::AID-AR30>3.0.CO;2-6; SALONEN JT, 1992, CIRCULATION, V86, P803, DOI 10.1161/01.CIR.86.3.803; Sarbassov DD, 1997, MOL ENDOCRINOL, V11, P2038, DOI 10.1210/me.11.13.2038; Sato K, 2003, MUSCLE NERVE, V28, P365, DOI 10.1002/mus.10436; Sawada H, 2015, ARTERIOSCL THROM VAS, V35, P1507, DOI 10.1161/ATVBAHA.115.305586; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sestili P, 2009, MOL NUTR FOOD RES, V53, P1187, DOI 10.1002/mnfr.200800504; Tajima S, 2012, AM J PHYSIOL-ENDOC M, V302, pE77, DOI 10.1152/ajpendo.00033.2011; Verdijk LB, 2007, AM J PHYSIOL-ENDOC M, V292, pE151, DOI 10.1152/ajpendo.00278.2006; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Xu JZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002865; Yoshida T, 2013, J BIOL CHEM, V288, P23823, DOI 10.1074/jbc.M112.449074; Zeng L, 2010, J BIOL CHEM, V285, P36060, DOI 10.1074/jbc.M110.160879; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zhang LP, 2010, J AM SOC NEPHROL, V21, P419, DOI 10.1681/ASN.2009060571	84	12	14	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9551	9564		10.1096/fj.201802724RR	http://dx.doi.org/10.1096/fj.201802724RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31145863	Bronze			2022-12-28	WOS:000478832900066
J	Sawant, OB; Jidigam, VK; Fuller, RD; Zucaro, OF; Kpegba, C; Yu, MZ; Peachey, NS; Rao, S				Sawant, Onkar B.; Jidigam, Vijay K.; Fuller, Rebecca D.; Zucaro, Olivia F.; Kpegba, Cristel; Yu, Minzhong; Peachey, Neal S.; Rao, Sujata			The circadian clock gene Bmal1 is required to control the timing of retinal neurogenesis and lamination of Muller glia in the mouse retina	FASEB JOURNAL			English	Article						circadian biology; Bmal1 retinal neurogenesis; VEP; cell cycle	PHOTORECEPTOR DEVELOPMENT; MAMMALIAN RETINA; GANGLION-CELL; MUTANT MICE; PROLIFERATION; PROGENITOR; LIGHT; FATE; RESPONSES; IDENTITY	A single pool of multipotent retinal progenitor cells give rise to the diverse cell types within the mammalian retina. Such cellular diversity is due to precise control of various cellular processes like cell specification, proliferation, differentiation, and maturation. Circadian clock genes can control the expression of key regulators of cell cycle progression and therefore can synchronize the cell cycle state of a heterogeneous population of cells. Here we show that the protein encoded by the circadian clock gene brain and muscle arnt-like protein-1 (Bmal1) is expressed in the embryonic retina and is required to regulate the timing of cell cycle exit. Accordingly, loss of Bmal1 during retinal neurogenesis results in increased S-phase entry and delayed cell cycle exit. Disruption in cell cycle kinetics affects the timely generation of the appropriate neuronal population thus leading to an overall decrease in the number of retinal ganglion cells, amacrine cells, and an increase in the number of the late-born type II cone bipolar cells as well as the Muller glia. Additionally, the mislocalized Muller cells are observed in the photoreceptor layer in the Bmal1 conditional mutants. These changes affect the functional integrity of the visual circuitry as we report a significant delay in visual evoked potential implicit time in the retina-specific Bmal1 null animals. Our results demonstrate that Bmal1 is required to maintain the balance between the neural and glial cells in the embryonic retina by coordinating the timing of cell cycle entry and exit. Thus, Bmal1 plays an essential role during retinal neurogenesis affecting both development and function of the mature retina.-Sawant, O. B., Jidigam, V. K., Fuller, R. D., Zucaro, O. F., Kpegba, C., Yu, M., Peachey, N. S., Rao, S. The circadian clock gene Bmal1 is required to control the timing of retinal neurogenesis and lamination of Muller glia in the mouse retina.	[Sawant, Onkar B.; Jidigam, Vijay K.; Fuller, Rebecca D.; Zucaro, Olivia F.; Yu, Minzhong; Peachey, Neal S.; Rao, Sujata] Cleveland Clin, Cole Eye Inst, Dept Ophthalm Res, Cleveland, OH 44106 USA; [Kpegba, Cristel; Yu, Minzhong; Peachey, Neal S.; Rao, Sujata] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Ophthalmol, Cleveland, OH 44106 USA; [Peachey, Neal S.] Louis Stokes Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH USA; [Zucaro, Olivia F.] Penn State Coll Med, Hershey, PA USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Rao, S (corresponding author), Cleveland Clin, i31-159-9500 Euclid Ave, Clevleand, OH 44195 USA.	raos7@ccf.org	Peachey, Neal/G-5533-2010; Jidigam, Vijay/AAV-4405-2021	Peachey, Neal/0000-0002-4419-7226; Jidigam, Vijay/0000-0002-2814-1783	U.S. National Institutes of Health/National Eye Institute [EY027077-01, RPB1503]; Knights Templar Eye Foundation Career Starter Research Grant [KTEF1806]; U.S. Department of Veterans Affairs; National Eye Institute [P30-EY025585]; Research to Prevent Blindness Challenge Grant; NATIONAL EYE INSTITUTE [R01EY027077, P30EY025585] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Knights Templar Eye Foundation Career Starter Research Grant; U.S. Department of Veterans Affairs(US Department of Veterans Affairs); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness Challenge Grant(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors are grateful to the Biological Resources Unit and Veterinary Services at Cleveland Clinic for their assistance with mouse colony management. This research was funded by grants from the U.S. National Institutes of Health/National Eye Institute EY027077-01 (to S.R.), RPB1503 (to S.R.), the Knights Templar Eye Foundation Career Starter Research Grant KTEF1806 (to O.B.S.), the U.S. Department of Veterans Affairs (to N.S.P.), a National Eye Institute P30-EY025585 Core Grant and Research to Prevent Blindness Challenge Grant. The authors declare no conflicts of interest.	Ait-Hmyed O, 2013, EUR J NEUROSCI, V37, P1048, DOI 10.1111/ejn.12103; Alexiades MR, 1996, DEV DYNAM, V205, P293, DOI 10.1002/(SICI)1097-0177(199603)205:3<293::AID-AJA9>3.0.CO;2-D; Baba K, 2018, P NATL ACAD SCI USA, V115, P13099, DOI 10.1073/pnas.1808137115; Baba K, 2018, J BIOL RHYTHM, V33, P441, DOI 10.1177/0748730418783648; Baba K, 2018, ADV EXP MED BIOL, V1074, P345, DOI 10.1007/978-3-319-75402-4_42; Bassett EA, 2012, TRENDS NEUROSCI, V35, P565, DOI 10.1016/j.tins.2012.05.004; Besharse JC, 2016, J BIOL RHYTHM, V31, P223, DOI 10.1177/0748730416642657; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Bouchard-Cannon P, 2013, CELL REP, V5, P961, DOI 10.1016/j.celrep.2013.10.037; Brown NL, 1998, DEVELOPMENT, V125, P4821; Brown NL, 2001, DEVELOPMENT, V128, P2497; Cameron MA, 2008, J BIOL RHYTHM, V23, P489, DOI 10.1177/0748730408325874; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; Cepko C, 2014, NAT REV NEUROSCI, V15, P615, DOI 10.1038/nrn3767; Clark B. S., 2018, COMPREHENSIVE ANAL R; Cunningham JJ, 2002, MOL CELL NEUROSCI, V19, P359, DOI 10.1006/mcne.2001.1090; Das G, 2012, DEV DYNAM, V241, P941, DOI 10.1002/dvdy.23782; Das G, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-15; Dyer MA, 2000, DEVELOPMENT, V127, P3593; Emanuela P, 2009, J COMP NEUROL, V517, P737, DOI 10.1002/cne.22200; Erskine L, 2000, J NEUROSCI, V20, P4975; Hakkari OAH, 2016, FASEB J, V30, P3690, DOI 10.1096/fj.201600414R; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Hunt T, 2007, CELL, V129, P461, DOI 10.1016/j.cell.2007.04.015; Lin KK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000573; Liu XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050602; Marcucci F, 2019, J COMP NEUROL, V527, P212, DOI 10.1002/cne.24467; Masri S, 2013, CURR OPIN CELL BIOL, V25, P730, DOI 10.1016/j.ceb.2013.07.013; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; McMahon DG, 2014, PROG RETIN EYE RES, V39, P58, DOI 10.1016/j.preteyeres.2013.12.001; Miles A., 2016, NEUROGENESIS AUSTIN, V3, DOI DOI 10.1080/23262133.2016.1161697; Mollema NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017494; Muthukumaraswamy SD, 2013, NEUROPSYCHOPHARMACOL, V38, P1105, DOI 10.1038/npp.2013.9; Nikaido SS, 2000, PHOTOCHEM PHOTOBIOL, V71, P758, DOI 10.1562/0031-8655(2000)071<0758:DACVIS>2.0.CO;2; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Okamura H, 2004, J BIOL RHYTHM, V19, P388, DOI 10.1177/0748730404269169; de Lima LHRG, 2011, CHRONOBIOL INT, V28, P89, DOI 10.3109/07420528.2010.540685; Ridder WH, 2006, VISION RES, V46, P902, DOI 10.1016/j.visres.2005.09.006; Roenneberg T, 1997, PHOTOCHEM PHOTOBIOL, V66, P549, DOI 10.1111/j.1751-1097.1997.tb03188.x; Sakagami K, 2009, J NEUROSCI, V29, P6932, DOI 10.1523/JNEUROSCI.0289-09.2009; Sawant O, 2015, INVEST OPHTH VIS SCI, V56, P8248, DOI 10.1167/iovs.15-17743; Sawant OB, 2017, CELL REP, V21, P692, DOI 10.1016/j.celrep.2017.09.069; Schmidt TM, 2011, TRENDS NEUROSCI, V34, P572, DOI 10.1016/j.tins.2011.07.001; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; Xu LL, 2016, MOL VIS, V22, P275; Yu MZ, 2012, EXP EYE RES, V96, P124, DOI 10.1016/j.exer.2011.12.011; Yu MZ, 2011, BRAIN RES, V1374, P36, DOI 10.1016/j.brainres.2010.12.043	51	14	14	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					8745	8758		10.1096/fj.201801832RR	http://dx.doi.org/10.1096/fj.201801832RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31002540	Green Published			2022-12-28	WOS:000478832900005
J	Zhang, F; Liu, YI; Tang, F; Liang, B; Chen, HM; Zhang, HL; Wang, KW				Zhang, Fan; Liu, Yani; Tang, Feng; Liang, Bo; Chen, Huanming; Zhang, Hailin; Wang, KeWei			Electrophysiological and pharmacological characterization of a novel and potent neuronal Kv7 channel opener SCR2682 for antiepilepsy	FASEB JOURNAL			English	Article						Kv7; KCNQ; M-channel; neurons; seizures	KCNQ2/3 POTASSIUM CHANNELS; ANTICONVULSANT DRUG; K+ CHANNEL; MOLECULAR DETERMINANTS; RETIGABINE; ACTIVATION; MODULATION; PROLONGATION; VALIDATION; EXPRESSION	Voltage-gated Kv7/KCNQ/M potassium channels play an essential role in the control of membrane potential and neuronal excitability. Activation of the neuronal Kv7/KCNQ/M-current represents an attractive therapeutic strategy for treatment of hyperexcitability-related neuropsychiatric disorders such as epilepsy, pain, and depression, which is an unmet medical need. In this study, we synthesized and characterized a novel compound, N-(4-(2-bromo-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide (SCR2682) 2,6-dimethyl-4-(piperidin-yl) phenyl)-amide derivative, that exhibits selective and potent activation of neuronal Kv7/KCNQ/M-channels. Whole-cell patch-clamp recordings of human embryonic kidney 293 cells expressing Kv7.2/Kv7.3 channels show that SCR2682 selectively activates the channel current in a dose-dependent manner with an EC50 of 9.8 +/- 0.4 nM, which is similar to 100-fold more potent than a U.S. Food and Drug Administration-approved antiepileptic drug (retigabine) for treatment of partial epilepsy. SCR2682 shifts voltage-dependent activation of the Kv7.2/7.3 current toward more negative membrane potential, to about -37 mV (V-1/2). SCR2682 also activates the native M-current in rat hippocampal or cortical neurons, causing marked hyperpolarization and potent inhibition of neuronal firings. Mechanistically, mutating the tryptophan residue 236 located at the fifth transmembrane segment of Kv7.2 abolishes the chemical activation of the channel by SCR2682. Furthermore, intraperitoneal or intragastric administration of SCR2682 results in a dose-dependent inhibition of seizures by maximal electroshock. Taken together, our findings demonstrate that a novel small molecule, SCR2682, selectively and potently activates neuronal Kv7 channels and reverses epileptic seizures in rodents. Thus, SCR2682 may warrant further evaluation for clinical development of antiepileptic therapy.-Zhang, F., Liu, Y., Tang, F., Liang, B., Chen, H., Zhang, H., Wang, K. Electrophysiological and pharmacological characterization of a novel and potent neuronal Kv7 channel opener SCR2682 for antiepilepsy.	[Zhang, Fan; Zhang, Hailin] Hebei Med Univ, Key Lab Neural & Vasc Biol, Hebei Prov Dept Pharmacol, Key Lab New Drug Pharmacol & Toxicol,Minist Educ, Shijiazhuang, Hebei, Peoples R China; [Liu, Yani; Wang, KeWei] Qingdao Univ, Sch Pharm, Dept Pharmacol, Qingdao, Shandong, Peoples R China; [Wang, KeWei] Qingdao Univ, Sch Pharm, Inst Innovat Drugs, Qingdao, Shandong, Peoples R China; [Tang, Feng] Simcere Pharmaceut, Med Chem, Nanjing, Jiangsu, Peoples R China; [Liang, Bo; Chen, Huanming] Shanghai Zhimeng BioPharma, Med Chem, Shanghai, Peoples R China; [Wang, KeWei] Ctr Brain Sci & Brain Inspired Intelligence, Guangzhou, Guangdong, Peoples R China	Hebei Medical University; Qingdao University; Qingdao University	Wang, KW (corresponding author), Qingdao Univ, 38 Dengzhou Rd, Qingdao 266021, Shandong, Peoples R China.	wangkw@qdu.edu.cn	张, 凡/GRX-6695-2022	张, 凡/0000-0003-0458-6742	National Natural Sciences Foundation of China [81573410]; Ministry of Science and Technology of China [2018ZX09711001-004-006]; Natural Sciences Foundation of Shandong Province [ZR2015QL008]; Science and Technology Program of Guangdong [2018B030334001]; National Natural Science Foundation of China [91732108, 31872788]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Sciences Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Science and Technology Program of Guangdong; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by research grants awarded to K.W. from the National Natural Sciences Foundation of China (81573410), the Ministry of Science and Technology of China (2018ZX09711001-004-006), the Natural Sciences Foundation of Shandong Province (ZR2015QL008), and Science and Technology Program of Guangdong (2018B030334001) and grants awarded to H.Z. and F.Z. from the National Natural Science Foundation of China (91732108 and 31872788, respectively). The authors declare no conflicts of interest.	Blackburn-Munro G, 2005, CNS DRUG REV, V11, P1, DOI 10.1111/j.1527-3458.2005.tb00033.x; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Cooper EC, 2003, ARCH NEUROL-CHICAGO, V60, P496, DOI 10.1001/archneur.60.4.496; Daniluk Jerzy, 2016, Drugs Real World Outcomes, V3, P155; Devulder J, 2010, CNS DRUGS, V24, P867, DOI 10.2165/11536230-000000000-00000; Du XN, 2011, BRIT J PHARMACOL, V164, P1722, DOI 10.1111/j.1476-5381.2011.01483.x; Du XN, 2013, CURR NEUROPHARMACOL, V11, P621, DOI 10.2174/1570159X113119990042; Fattore C, 2011, DRUGS, V71, P2151, DOI 10.2165/11594640-000000000-00000; Feng SJ, 2016, EMBO REP, V17, P682, DOI 10.15252/embr.201541569; Gao ZB, 2010, J BIOL CHEM, V285, P28322, DOI 10.1074/jbc.M110.116392; Goldberg-Stern H, 2009, PEDIATR NEUROL, V41, P367, DOI 10.1016/j.pediatrneurol.2009.05.009; Gunthorpe MJ, 2012, EPILEPSIA, V53, P412, DOI 10.1111/j.1528-1167.2011.03365.x; Hopkins CR, 2012, ACS CHEM NEUROSCI, V3, P632, DOI 10.1021/cn3000789; Jia CX, 2011, PHARMACOLOGY, V87, P297, DOI 10.1159/000327384; Jow F, 2000, MOL BRAIN RES, V80, P269, DOI 10.1016/S0169-328X(00)00146-7; Jow F, 2007, J BIOMOL SCREEN, V12, P1059, DOI 10.1177/1087057107307448; Kapetanovic IM, 1995, EPILEPSY RES, V22, P167, DOI 10.1016/0920-1211(95)00050-X; Korsgaard MPG, 2005, J PHARMACOL EXP THER, V314, P282, DOI 10.1124/jpet.105.083923; Main MJ, 2000, MOL PHARMACOL, V58, P253, DOI 10.1124/mol.58.2.253; Maljevic S, 2008, J PHYSIOL-LONDON, V586, P1791, DOI 10.1113/jphysiol.2008.150656; Martire M, 2004, J NEUROSCI, V24, P592, DOI 10.1523/JNEUROSCI.3143-03.2004; Mora G, 2005, NEUROCHEM RES, V30, P1557, DOI 10.1007/s11064-005-8834-8; Peretz A, 2010, P NATL ACAD SCI USA, V107, P15637, DOI 10.1073/pnas.0911294107; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Qi J, 2011, EUR J MED CHEM, V46, P934, DOI 10.1016/j.ejmech.2011.01.010; Raol YH, 2009, ANN NEUROL, V65, P326, DOI 10.1002/ana.21593; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Rubi L, 2017, TOXICOL APPL PHARM, V329, P309, DOI 10.1016/j.taap.2017.06.018; Schenzer A, 2005, J NEUROSCI, V25, P5051, DOI 10.1523/JNEUROSCI.0128-05.2005; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Shkolnik TG, 2014, JAMA DERMATOL, V150, P984, DOI 10.1001/jamadermatol.2013.8895; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Svalo J, 2012, BASIC CLIN PHARMACOL, V110, P145, DOI 10.1111/j.1742-7843.2011.00765.x; Szelenyi I, 2013, INFLAMM RES, V62, P251, DOI 10.1007/s00011-013-0592-5; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; Wang AW, 2018, J GEN PHYSIOL, V150, P1432, DOI 10.1085/jgp.201812014; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wang KW, 2004, ASSAY DRUG DEV TECHN, V2, P525, DOI 10.1089/adt.2004.2.525; Weisenberg JLZ, 2011, NEUROPSYCH DIS TREAT, V7, P409, DOI 10.2147/NDT.S14208; Wickenden AD, 2000, MOL PHARMACOL, V58, P591, DOI 10.1124/mol.58.3.591; Wladyka CL, 2006, J PHYSIOL-LONDON, V575, P175, DOI 10.1113/jphysiol.2006.113308; Wu YJ, 2003, J MED CHEM, V46, P3197, DOI 10.1021/jm034073f; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Wuttke TV, 2005, MOL PHARMACOL, V67, P1009, DOI 10.1124/mol.104.010793; Xiong QJ, 2007, NAT CHEM BIOL, V3, P287, DOI 10.1038/nchembio874; Yau MC, 2018, J GEN PHYSIOL, V150, P1421, DOI 10.1085/jgp.201812013; Yeung SYM, 2008, BRIT J PHARMACOL, V155, P62, DOI 10.1038/bjp.2008.231; Yu F, 2011, EPILEPSY RES, V97, P64, DOI 10.1016/j.eplepsyres.2011.07.005; Zaugg Brian E, 2017, Retin Cases Brief Rep, V11, P38, DOI 10.1097/ICB.0000000000000283; Zhang F, 2013, BRIT J PHARMACOL, V168, P1030, DOI 10.1111/j.1476-5381.2012.02232.x	52	13	13	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9154	9166		10.1096/fj.201802848RR	http://dx.doi.org/10.1096/fj.201802848RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31063701				2022-12-28	WOS:000478832900037
J	Cai, H; Wu, FY; Wang, QL; Xu, P; Mou, FF; Shao, SJ; Luo, ZR; Zhu, J; Xuan, SS; Lu, R; Guo, HD				Cai, Hao; Wu, Feng-Ying; Wang, Qiang-Li; Xu, Peng; Mou, Fang-Fang; Shao, Shui-Jin; Luo, Zhi-Rong; Zhu, Jing; Xuan, Shou-Song; Lu, Rong; Guo, Hai-Dong			Self-assembling peptide modified with QHREDGS as a novel delivery system for mesenchymal stem cell transplantation after myocardial infarction	FASEB JOURNAL			English	Article						MI; MSCs; SAP; exosome; miR-21	CARDIAC REPAIR; HEART; SURVIVAL; THERAPY; NANOFIBERS; HYDROGELS; KINASE	The lower cell survival and retention in the hostile microenvironment after transplantation has been implicated as a major bottleneck in the advancement of stem cell therapy for myocardial infarction (MI). In this study, we designed a novel self-assembling peptide (SAP) by attaching prosurvival peptide QHREDGS derived from angiopoeitin-1 to the known SAP, RADA16-I. The mesenchymal stem cells (MSCs) were harvested from male rats and cytoprotective effect of this designer SAP (DSAP) on cultured MSCs was detected by Hoechst 33342 staining after being exposed to oxygen and glucose deprivation (OGD). The cytoprotective effect of MSCs seeded in DSAP (DSAP-MSCs) on OGD treated cardiomyocytes was examined by TUNEL staining, phosphorylated (p-) protein kinase B (Akt) level, and ELISA. The therapeutic potential of MSC transplantation carried in DSAP was evaluated in a female rat MI model. PBS, MSCs alone, MSCs seeded in SAP (SAP-MSCs), or DSAP-MSCs were transplanted into the border of the infarcted area, respectively. DSAP not only increased the proliferation of MSCs and decreased apoptosis of MSCs after OGD treatment but also promoted the secretion of IGF-1 and HGF in MSCs. Treatment with culture supernatant of DSAP-MSCs markedly reduced the percentage of apoptotic cardiomyocytes and increased the level of p-Akt. Compared with the MSC group and SAP-MSC group, DSAP-MSC injection improved cardiac function and reduced infarct size, collagen content, and cell apoptosis. The number of Y chromosome-positive cells and microvessels in the DSAP-MSC group was higher than those in the MSC group and SAP-MSC group. Moreover, DSAP-MSC transplantation down-regulated the expression of IL-6 and IL-1 beta and up-regulated the level of VEGF and HGF. Interestingly, miR-21 was enriched in DSAP-MSC-derived exosomes (DSAP-MSC-Exos) and the protection against cardiomyocyte apoptosis by DSAP-MSC-Exos was inhibited when miR-21 was knocked down. Furthermore, miR-21 contributed to the improvement of cardiac function after DSAP-MSC-Exo injection in a rat model of MI. Additionally, the combination of DSAP and cardiotrophin-1 (Ctf1) pretreatment further improved the survival of MSCs and the efficiency of MSC transplantation. We proposed QHREDGS-modified SAP as an effective cell delivery system and demonstrated that MSC transplantation in this DSAP promoted angiogenesis and paracrine, thereby reducing scar size and cell apoptosis as well as improving cardiac function probably via exosome-mediated miR-21 after MI. Furthermore, for the first time, we proposed that DSAP, especially working together with Ctf1 pretreatment, could be a valuable way to improve the survival of MSCs and the efficiency of MSC transplantation after MI.-Cai, H., Wu, F.-Y., Wang, Q.-L., Xu, P., Mou, F.-F., Shao, S.-J., Luo, Z.-R., Zhu, J., Xuan, S.-S., Lu, R., Guo, H.-D. Self-assembling peptide modified with QHREDGS as a novel delivery system for mesenchymal stem cell transplantation after myocardial infarction.	[Cai, Hao; Mou, Fang-Fang; Shao, Shui-Jin; Luo, Zhi-Rong; Zhu, Jing; Xuan, Shou-Song; Guo, Hai-Dong] Shanghai Univ Tradit Chinese Med, Dept Anat, 1200 Cailun Rd, Shanghai 201203, Peoples R China; [Wang, Qiang-Li; Lu, Rong] Shanghai Univ Tradit Chinese Med, Sch Basic Med, 1200 Cailun Rd, Shanghai 201203, Peoples R China; [Xu, Peng] Jining Med Coll, Affiliated Hosp, Jining, Peoples R China; [Wu, Feng-Ying] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Oncol, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Jining Medical University; Tongji University	Guo, HD (corresponding author), Shanghai Univ Tradit Chinese Med, Dept Anat, 1200 Cailun Rd, Shanghai 201203, Peoples R China.; Lu, R (corresponding author), Shanghai Univ Tradit Chinese Med, Sch Basic Med, 1200 Cailun Rd, Shanghai 201203, Peoples R China.	lurong@shutcm.edu.cn; hdguo8@hotmail.com	wang, qiangli/GVU-4045-2022	Cai, Hao/0000-0003-1024-647X	Natural Science Foundation of China [81673729, 81704157, 81873366]; Natural Science Foundation of Shanghai [16ZR1437300]; Shanghai Municipal Commission of Health and Family Planning [ZY (2018-2020)-CCCX-2001-01]; Budgetary Project [2016YSN03]; Xinglin Scholar Program of Shanghai University of Traditional Chinese Medicine	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Municipal Commission of Health and Family Planning; Budgetary Project; Xinglin Scholar Program of Shanghai University of Traditional Chinese Medicine	This work was supported by grants from the Natural Science Foundation of China (81673729, 81704157, and 81873366), the Natural Science Foundation of Shanghai (16ZR1437300), the Budgetary Project (2016YSN03), and the Xinglin Scholar Program of Shanghai University of Traditional Chinese Medicine and Shanghai Municipal Commission of Health and Family Planning [ZY (2018-2020)-CCCX-2001-01]. The authors declare no conflicts of interest.	Afzal MR, 2015, CIRC RES, V117, P558, DOI 10.1161/CIRCRESAHA.114.304792; Bortolotti F, 2017, CIRCULATION, V136, P1509, DOI 10.1161/CIRCULATIONAHA.117.029003; Boyle AJ, 2006, CIRCULATION, V114, P339, DOI 10.1161/CIRCULATIONAHA.105.590653; Carlson TR, 2001, J BIOL CHEM, V276, P26516, DOI 10.1074/jbc.M100282200; Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001; Dallabrida SM, 2005, CIRC RES, V96, DOI 10.1161/01.RES.0000158285.57191.60; Dang LTH, 2014, BIOMATERIALS, V35, P7786, DOI 10.1016/j.biomaterials.2014.05.018; Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80; Ellison GM, 2011, J AM COLL CARDIOL, V58, P977, DOI 10.1016/j.jacc.2011.05.013; Gallo S, 2014, BIOMEDICINES, V2, P247, DOI 10.3390/biomedicines2040247; Gao XR, 2017, BIOCHEM BIOPH RES CO, V491, P112, DOI 10.1016/j.bbrc.2017.07.056; Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119; Guo HD, 2010, BIOCHEM BIOPH RES CO, V399, P42, DOI 10.1016/j.bbrc.2010.07.031; Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024; Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190; Jia J, 2016, ACTA BIOMATER, V45, P110, DOI 10.1016/j.actbio.2016.09.006; Karam JP, 2012, BIOMATERIALS, V33, P5683, DOI 10.1016/j.biomaterials.2012.04.028; Katsuda T, 2013, PROTEOMICS, V13, P1637, DOI 10.1002/pmic.201200373; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Koutsopoulos S, 2013, ACTA BIOMATER, V9, P5162, DOI 10.1016/j.actbio.2012.09.010; Kraehenbuehl TP, 2008, BIOMATERIALS, V29, P2757, DOI 10.1016/j.biomaterials.2008.03.016; Lai RC, 2010, STEM CELL RES, V4, P214, DOI 10.1016/j.scr.2009.12.003; Li X, 2017, AM J TRANSL RES, V9, P3723; Luther KM, 2018, J MOL CELL CARDIOL, V119, P125, DOI 10.1016/j.yjmcc.2018.04.012; Makarevich PI, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197566; Mayourian J, 2018, CIRC RES, V122, P933, DOI 10.1161/CIRCRESAHA.118.312420; Menasche P, 2008, SEMIN THORAC CARDIOV, V20, P131, DOI 10.1053/j.semtcvs.2008.03.001; Miklas JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072956; Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005; Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005; Pons J, 2009, J GENE MED, V11, P743, DOI 10.1002/jgm.1362; Rask F, 2010, SOFT MATTER, V6, P5089, DOI 10.1039/c0sm00362j; Rask F, 2010, J BIOMED MATER RES A, V95A, P105, DOI 10.1002/jbm.a.32808; Reis LA, 2015, CIRC-HEART FAIL, V8, P333, DOI 10.1161/CIRCHEARTFAILURE.114.001881; Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219; Seko Y, 1996, CIRC RES, V78, P82, DOI 10.1161/01.RES.78.1.82; Sun X, 2017, ONCOTARGET, V8, P36137, DOI 10.18632/oncotarget.16661; Tokunaga M, 2010, J MOL CELL CARDIOL, V49, P972, DOI 10.1016/j.yjmcc.2010.09.015; Van Slyke P, 2009, TISSUE ENG PT A, V15, P1269, DOI 10.1089/ten.tea.2007.0400; Wang K, 2017, STEM CELL TRANSL MED, V6, P209, DOI 10.5966/sctm.2015-0386; Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102	41	24	25	4	41	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8306	8320		10.1096/fj.201801768RR	http://dx.doi.org/10.1096/fj.201801768RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30970221	Bronze			2022-12-28	WOS:000476234700041
J	Huang, LL; Xia, B; Shi, XW; Gao, JB; Yang, YJ; Xu, F; Qi, FY; Liang, C; Huang, JH; Luo, ZJ				Huang, Liangliang; Xia, Bing; Shi, Xiaowei; Gao, Jianbo; Yang, Yujie; Xu, Feng; Qi, Fengyu; Liang, Chao; Huang, Jinghui; Luo, Zhuojing			Time-restricted release of multiple neurotrophic factors promotes axonal regeneration and functional recovery after peripheral nerve injury	FASEB JOURNAL			English	Article						regulated gene expression; Schwann cell; nerve regeneration	SCHWANN-CELL TRANSPLANTATION; SPINAL-CORD-INJURY; GROWTH-FACTOR; C-JUN; GDNF EXPRESSION; MESSENGER-RNAS; GENE-THERAPY; DELIVERY; NEURONS; CONDUIT	Delivery of multiple neurotrophic factors (NTFs), especially with time-restricted release kinetics, holds great potential for nerve repair. In this study, we utilized the tetracycline-regulatable Tet-On 3G system to control the expression of c-Jun, which is a common regulator of multiple NTFs in Schwann cells (SCs). In vitro, Tet-On/c-Jun-modified SCs showed a tightly controllable secretion of multiple NTFs, including glial cell line-derived NTF, nerve growth factor, brain-derived NTF, and artemin, by the addition or removal of doxycycline (Dox). When Tet-On/c-Jun-transduced SCs were grafted in vivo, the expression of NTFs could also be regulated by oral administration or removal of Dox. Fluoro-Gold retrograde tracing results indicated that a biphasic NTF expression scheme (Dox+3/-9, NTFs were up-regulated for 3 wk and declined to physiologic levels for another 9 wk) achieved more axonal regeneration than continuous up-regulation of NTFs (Dox+12) or no NTF induction (Dox-12). More importantly, the Dox+3/-9-group animals showed much better functional recovery than the animals in the Dox+12 and Dox-12 groups. Our findings, for the first time, demonstrated drug-controllable expression of multiple NTFs in nerve repair cells both in vitro and in vivo. These findings provide new hope for developing an optimal therapeutic alternative for nerve repair through the time-restricted release of multiple NTFs using Tet-On/c-Jun-modified SCs.-Huang, L., Xia, B., Shi, X., Gao, J., Yang, Y., Xu, F., Qi, F., Liang, C., Huang, J., Luo, Z. Time-restricted release of multiple neurotrophic factors promotes axonal regeneration and functional recovery after peripheral nerve injury.	[Huang, Liangliang; Xia, Bing; Shi, Xiaowei; Gao, Jianbo; Yang, Yujie; Liang, Chao; Huang, Jinghui; Luo, Zhuojing] Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Changle West Rd 15, Xian 710032, Shaanxi, Peoples R China; [Huang, Liangliang; Xu, Feng; Qi, Fengyu] Cent Theater Command Peoples Liberat Army, Dept Orthopaed, Gen Hosp, Wuhan, Hubei, Peoples R China	Air Force Military Medical University	Huang, JH; Luo, ZJ (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Changle West Rd 15, Xian 710032, Shaanxi, Peoples R China.	huangjh@fmmu.edu.cn; zjluo@fmmu.edu.cn.com		Luo, Zhuojing/0000-0002-0671-8553; Huang, Liangliang/0000-0002-0478-0150; Huang, Jinghui/0000-0002-0991-0591	National Natural Science Foundation of China [81672148, 81201389, 81501064]; National Key Research and Development Plan of China [2016YFC1101700]; National Basic Research Program of China [2014CB542206]; Program for Changjiang Scholar and Innovative Research Team in University [IRT1053, IRT13051]; Wuhan Young and Middle-Aged Key Talents Training Project; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201480]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Plan of China; National Basic Research Program of China(National Basic Research Program of China); Program for Changjiang Scholar and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Wuhan Young and Middle-Aged Key Talents Training Project; Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China)	The authors thank Rui Zhao (Department of Orthopaedics, Xijing Hospital, the Fourth Military Medical University) for English assistance. This work was supported by the National Natural Science Foundation of China (Grants 81672148, 81201389, and 81501064), the National Key Research and Development Plan of China (Grant 2016YFC1101700), the National Basic Research Program of China (Grant 2014CB542206), the Program for Changjiang Scholar and Innovative Research Team in University (Grants IRT1053, IRT13051), Wuhan Young and Middle-Aged Key Talents Training Project, and A Foundation for the Author of National Excellent Doctoral Dissertation of PR China (Grant 201480). The authors declare no conflicts of interest.	Abe T, 2014, DNA REPAIR, V22, P153, DOI 10.1016/j.dnarep.2014.08.003; Allodi I, 2012, PROG NEUROBIOL, V98, P16, DOI 10.1016/j.pneurobio.2012.05.005; Anderson KD, 2017, J NEUROTRAUM, V34, P2950, DOI 10.1089/neu.2016.4895; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Bian YZ, 2009, BIOMATERIALS, V30, P217, DOI 10.1016/j.biomaterials.2008.09.036; Blesch A, 2007, J NEUROSCI, V27, P10535, DOI 10.1523/JNEUROSCI.1903-07.2007; Blits B, 2004, EXP NEUROL, V189, P303, DOI 10.1016/j.expneurol.2004.05.014; Brushart TM, 2005, EXP NEUROL, V194, P221, DOI 10.1016/j.expneurol.2005.02.007; Campochiaro PA, 2017, HUM GENE THER, V28, P99, DOI 10.1089/hum.2016.117; Castiello MC, 2015, J ALLERGY CLIN IMMUN, V136, P692, DOI 10.1016/j.jaci.2015.01.035; Chandran V, 2016, NEURON, V89, P956, DOI 10.1016/j.neuron.2016.01.034; Chen L, 2014, CELL TRANSPLANT, V23, pS35, DOI 10.3727/096368914X685014; Chen L, 2013, CELL TRANSPLANT, V22, pS83, DOI 10.3727/096368913X672154; Chtarto A, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.27; Conti AM, 2004, NEUROBIOL DIS, V15, P106, DOI 10.1016/j.nbd.2003.09.009; Cui Y, 2014, BIOMATERIALS, V35, P7819, DOI 10.1016/j.biomaterials.2014.05.065; De Ravin SS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8856; Deng LX, 2013, J NEUROSCI, V33, P5655, DOI 10.1523/JNEUROSCI.2973-12.2013; Dolbeare D, 2003, J NEUROTRAUM, V20, P1251, DOI 10.1089/089771503770802916; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eggers R, 2008, MOL CELL NEUROSCI, V39, P105, DOI 10.1016/j.mcn.2008.05.018; Eggers R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071076; Eichler F, 2017, NEW ENGL J MED, V377, P1630, DOI 10.1056/NEJMoa1700554; Fan XJ, 2012, ENDOCRINOLOGY, V153, P5637, DOI 10.1210/en.2012-1556; Fazal SV, 2017, J NEUROSCI, V37, P12297, DOI 10.1523/JNEUROSCI.0986-17.2017; Fine EG, 2002, EUR J NEUROSCI, V15, P589, DOI 10.1046/j.1460-9568.2002.01892.x; Fontana X, 2012, J CELL BIOL, V198, P127, DOI 10.1083/jcb.201205025; Georgievska B, 2002, EXP NEUROL, V177, P461, DOI 10.1006/exnr.2002.8006; Gu XS, 2014, BIOMATERIALS, V35, P6143, DOI 10.1016/j.biomaterials.2014.04.064; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hantke J, 2014, BRAIN, V137, P2922, DOI 10.1093/brain/awu257; Hellstrom M, 2011, J NEUROTRAUM, V28, P2475, DOI 10.1089/neu.2011.1928; Hess JR, 2007, PLAST RECONSTR SURG, V119, P246, DOI 10.1097/01.prs.0000245341.71666.97; Hsieh SC, 2011, J BIOMED MATER RES A, V99A, P576, DOI 10.1002/jbm.a.33157; Huang LL, 2015, TISSUE ENG PT A, V21, P1409, DOI [10.1089/ten.tea.2014.0416, 10.1089/ten.TEA.2014.0416]; Huelsenbeck SC, 2012, NEUROTHERAPEUTICS, V9, P185, DOI 10.1007/s13311-011-0072-y; Johnson BN, 2015, ADV FUNCT MATER, V25, P6205, DOI 10.1002/adfm.201501760; Joo Y, 2015, FASEB J, V29, P4133, DOI 10.1096/fj.14-265009; Kashiba H, 1998, NEUROSCI LETT, V252, P107, DOI 10.1016/S0304-3940(98)00558-8; Kelamangalath L, 2015, EXP NEUROL, V271, P262, DOI 10.1016/j.expneurol.2015.06.007; Kemp SWP, 2011, EXP NEUROL, V229, P460, DOI 10.1016/j.expneurol.2011.03.017; Kim TK, 2010, ANAL BIOANAL CHEM, V397, P3173, DOI 10.1007/s00216-010-3821-6; Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9; Lee BK, 2012, BIOMATERIALS, V33, P9027, DOI 10.1016/j.biomaterials.2012.09.008; Madduri S, 2010, BIOMATERIALS, V31, P8402, DOI 10.1016/j.biomaterials.2010.07.052; Madduri S, 2010, J PERIPHER NERV SYST, V15, P93, DOI 10.1111/j.1529-8027.2010.00257.x; Madduri S, 2010, J CONTROL RELEASE, V143, P168, DOI 10.1016/j.jconrel.2009.12.017; Mehrotra S, 2010, ADV FUNCT MATER, V20, P247, DOI 10.1002/adfm.200901172; Mortimer D, 2010, P NATL ACAD SCI USA, V107, P5202, DOI 10.1073/pnas.0909254107; Mortimer D, 2009, P NATL ACAD SCI USA, V106, P10296, DOI 10.1073/pnas.0900715106; Naveilhan P, 1997, EUR J NEUROSCI, V9, P1450, DOI 10.1111/j.1460-9568.1997.tb01499.x; Nho B, 2018, FASEB J, V32, P5119, DOI 10.1096/fj.201800476R; Pabari A, 2011, J CONTROL RELEASE, V156, P2, DOI 10.1016/j.jconrel.2011.07.001; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Popken GJ, 1997, J COMP NEUROL, V386, P8; Ramburrun P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/132350; Saberi H, 2008, NEUROSCI LETT, V443, P46, DOI 10.1016/j.neulet.2008.07.041; Santosa KB, 2013, MUSCLE NERVE, V47, P213, DOI 10.1002/mus.23490; Sessa M, 2016, LANCET, V388, P476, DOI 10.1016/S0140-6736(16)30374-9; Shakhbazau A, 2013, J CONTROL RELEASE, V172, P841, DOI 10.1016/j.jconrel.2013.10.004; SMITH EL, 1983, BEHAV BRAIN RES, V7, P307, DOI 10.1016/0166-4328(83)90022-0; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Tajdaran K, 2016, J BIOMED MATER RES A, V104, P367, DOI 10.1002/jbm.a.35572; TANIUCHI M, 1988, J NEUROSCI, V8, P664; Tannemaat MR, 2008, EUR J NEUROSCI, V28, P1467, DOI 10.1111/j.1460-9568.2008.06452.x; Vetter I, 2010, J NEUROTRAUM, V27, P1379, DOI 10.1089/neu.2010.1279; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Zhang LQ, 2009, GLIA, V57, P1178, DOI 10.1002/glia.20840	69	14	14	2	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8600	8613		10.1096/fj.201802065RR	http://dx.doi.org/10.1096/fj.201802065RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30995417	Bronze			2022-12-28	WOS:000476234700063
J	Niu, T; Zhao, MY; Jiang, Y; Xing, XD; Shi, X; Cheng, L; Jin, HY; Liu, K				Niu, Tian; Zhao, Mengya; Jiang, Yan; Xing, Xindan; Shi, Xin; Cheng, Lu; Jin, Huiyi; Liu, Kun			Endomucin restores depleted endothelial glycocalyx in the retinas of streptozotocin-induced diabetic rats	FASEB JOURNAL			English	Article						inflammation; blood-retinal barrier; diabetic retinopathy	MACULAR EDEMA; INFLAMMATION; PATHOGENESIS; DEGRADATION; RETINOPATHY; MUCINS; LAYER	Endothelial glycocalyx plays a significant role in the development and progression of diabetic complications. Endomucin (EMCN) is an anti-inflammatory membrane glycoprotein that is mainly expressed in venous and capillary endothelial cells. However, the function of EMCN in diabetic retinopathy (DR) progression is still completely unknown. We first investigated the change of EMCN expression in the retina and human retinal microvascular endothelial cells. We then overexpressed EMCN in the retina with adeno-associated virus and induced DR with streptozotocin (STZ). We analyzed EMCN's effect on the integrity of endothelial glycocalyx under conditions of DR. Furthermore, we investigated EMCN's protective effect against inflammation and blood-retinal barrier (BRB) destruction. We found that EMCN is specifically expressed in retinal endothelial cells and that its levels are decreased during hyperglycemia in vitro and in vivo. Overexpression of EMCN can restore the retinal endothelial glycocalyx of STZ-induced diabetic rats. Furthermore, EMCN overexpression can decrease leukocyte -endothelial adhesion to ameliorate inflammation and stabilize the BRB to inhibit vessel leakage in rats with DR. EMCN may protect patients with diabetes from retinal vascular degeneration by restoring the endothelial glycocalyx. EMCN may thus represent a novel therapeutic strategy for DR because it targets endothelial glycocalyx degradation associated with this disease.	[Niu, Tian; Zhao, Mengya; Xing, Xindan; Shi, Xin; Cheng, Lu; Jin, Huiyi; Liu, Kun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Ophthalmol, 100 Haining Rd, Shanghai 200080, Peoples R China; [Jiang, Yan] Nanjing Med Univ, Shanghai Gen Hosp, Dept Ophthalmol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Nanjing Medical University	Liu, K (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Ophthalmol, 100 Haining Rd, Shanghai 200080, Peoples R China.	drliukun@sjtu.edu.cn		Niu, Tian/0000-0002-0377-3151	National Key Research and Development Program of China [2016YFC0904800]; National Natural Science Foundation of China [81470638, 81870667]; Shanghai Medical Excellent Discipline Leader Program [2017BR056]; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support Program [20161426]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Medical Excellent Discipline Leader Program; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support Program	This study was funded by grants from the National Key Research and Development Program of China (2016YFC0904800), the National Natural Science Foundation of China (81470638 and 81870667), the Shanghai Medical Excellent Discipline Leader Program (2017BR056), and the Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support Program (20161426). All study sponsors had no role in the study design or in the collection, analysis, and interpretation of data. The authors declare no conflicts of interest.	Abu El-Asrar AM, 2012, MIDDLE EAST AFR J OP, V19, P70, DOI 10.4103/0974-9233.92118; Argueso P, 2009, J BIOL CHEM, V284, P23037, DOI 10.1074/jbc.M109.033332; Banerjee PJ, 2017, OPHTHALMOLOGY, V124, P757, DOI 10.1016/j.ophtha.2017.01.021; Broekhuizen LN, 2010, DIABETOLOGIA, V53, P2646, DOI 10.1007/s00125-010-1910-x; Brown DM, 2013, OPHTHALMOLOGY, V120, P2013, DOI 10.1016/j.ophtha.2013.02.034; Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254; Capitao M, 2016, J CELL BIOCHEM, V117, P2443, DOI 10.1002/jcb.25575; Chibber R, 2007, CURR DIABETES REV, V3, P3, DOI 10.2174/157339907779802139; Ciulla TA, 2016, RETINA-J RET VIT DIS, V36, P1292, DOI 10.1097/IAE.0000000000000876; Das A, 2015, OPHTHALMOLOGY, V122, P1375, DOI 10.1016/j.ophtha.2015.03.024; dela Paz NG, 2009, CELL TISSUE RES, V335, P5, DOI 10.1007/s00441-008-0706-5; Dogne S, 2016, DIABETES, V65, P2742, DOI 10.2337/db15-1662; Ford JA, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002269; Gilbert RE, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0410-8; Grant MB, 2004, EXPERT OPIN INV DRUG, V13, P1275, DOI 10.1517/13543784.13.10.1275; Hanisch FA, 2001, BIOL CHEM, V382, P143, DOI 10.1515/BC.2001.022; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Kady NM, 2018, DIABETES, V67, P769, DOI 10.2337/db17-1034; Kataoka H, 2016, MICROSC RES TECHNIQ, V79, P31, DOI 10.1002/jemt.22602; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Kinoshita M, 2001, FEBS LETT, V499, P121, DOI 10.1016/S0014-5793(01)02520-0; Klaassen I, 2013, PROG RETIN EYE RES, V34, P19, DOI 10.1016/j.preteyeres.2013.02.001; Kuhn A, 2002, J INVEST DERMATOL, V119, P1388, DOI 10.1046/j.1523-1747.2002.19647.x; Kumase F, 2010, ACTA MED OKAYAMA, V64, P277; Leasher JL, 2016, DIABETES CARE, V39, P1643, DOI 10.2337/dc15-2171; Matter K, 1999, INT REV CYTOL, V186, P117; Middleton J, 2002, BLOOD, V100, P3853, DOI 10.1182/blood.V100.12.3853; Morgan SM, 1999, BLOOD, V93, P165, DOI 10.1182/blood.V93.1.165.401k25_165_175; Mulivor AW, 2002, AM J PHYSIOL-HEART C, V283, pH1282, DOI 10.1152/ajpheart.00117.2002; Park DY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15296; Park-Windhol C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16852-x; Pelaseyed T, 2014, IMMUNOL REV, V260, P8, DOI 10.1111/imr.12182; Pick R, 2017, BLOOD, V130, P847, DOI 10.1182/blood-2016-11-749622; Rabelink TJ, 2015, NAT REV NEPHROL, V11, P667, DOI 10.1038/nrneph.2015.162; Schnoor M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/946509; Seelenmeyer C, 2003, J CELL SCI, V116, P1305, DOI 10.1242/jcs.00312; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Sieve I, 2018, VASC PHARMACOL, V100, P26, DOI 10.1016/j.vph.2017.09.002; Simo R, 2015, PROG RETIN EYE RES, V48, P160, DOI 10.1016/j.preteyeres.2015.04.003; Singh A, 2011, AM J PHYSIOL-RENAL, V300, pF40, DOI 10.1152/ajprenal.00103.2010; Stitt AW, 2013, CLIN SCI, V125, P1, DOI 10.1042/CS20120588; Yu CG, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1803989; Zahr A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10363	45	9	10	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13346	13357		10.1096/fj.201901161R	http://dx.doi.org/10.1096/fj.201901161R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31545913	Bronze			2022-12-28	WOS:000507466100025
J	Wang, Y; Agarwal, E; Bertolini, I; Ghosh, JC; Seo, JH; Altieri, DC				Wang, Yuan; Agarwal, Ekta; Bertolini, Irene; Ghosh, Jagadish C.; Seo, Jae Ho; Altieri, Dario C.			IDH2 reprograms mitochondria! dynamics in cancer through a HIF-1 alpha-regulated pseudohypoxic state	FASEB JOURNAL			English	Article						mitochondria; ROS; tumor cell motility; HIF-1 alpha metastasis	CELL-MIGRATION; OXIDATIVE STRESS; TUMOR-GROWTH; PROMOTES; METASTASIS; DRP1; PHOSPHORYLATION; TUMORIGENESIS; TRAFFICKING; METABOLISM	The role of mitochondria in cancer continues to be debated and paradoxically implicated in opposing functions in tumor growth and tumor suppression. To understand this dichotomy, we explored the function of mitochondrial isocitrate dehydrogenase (IDH)2, a tricarboxylic acid cycle enzyme mutated in subsets of acute leukemias and gliomas, in cancer. Silencing of IDH2 in prostate cancer cells impaired oxidative bioenergetics, elevated reactive oxygen species (ROS) production, and promoted exaggerated mitochondrial dynamics. This was associated with increased subcellular mitochondrial trafficking, turnover of membrane focal adhesion complexes, and enhanced tumor cell migration and invasion, without changes in cell cycle progression. Mechanistically, loss of IDH2 caused ROS-dependent stabilization of hypoxia-inducible factor-1 alpha in normoxia, which was required for increased mitochondrial trafficking and tumor cell movements. Therefore, IDH2 is a dual regulator of cancer bioenergetics and tumor cell motility. This pathway may reprogram mitochondrial dynamics to differentially adjust energy production or promote tumor cell invasion in response to microenvironment conditions.	[Wang, Yuan; Agarwal, Ekta; Bertolini, Irene; Ghosh, Jagadish C.; Seo, Jae Ho; Altieri, Dario C.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA	The Wistar Institute	Altieri, DC (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	daltieri@wistar.org		BERTOLINI, IRENE/0000-0001-5824-6802; Agarwal, Ekta/0000-0002-5992-3358	U.S. National Institutes of Health, National Cancer Institute [P01 CA140043, R35 CA220446]; Cancer Center Support Grant (CCSG) [P30 CA010815]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support Grant (CCSG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank James Hayden and Frederick Keeney (The Wistar Institute Imaging Core Facility) for assistance with time-lapse videomicroscopy. This work was supported by U.S. National Institutes of Health, National Cancer Institute Grants P01 CA140043 and R35 CA220446 (to D.C.A.). The support for Shared Resources utilized in this study was provided by Cancer Center Support Grant (CCSG) P30 CA010815. The authors declare no conflicts of interest.	Amaya ML, 2018, CLIN CANCER RES, V24, P4931, DOI 10.1158/1078-0432.CCR-18-0536; Anderson RG, 2018, BBA-REV CANCER, V1870, P96, DOI 10.1016/j.bbcan.2018.05.005; Bhat TA, 2015, DRUG DISCOV TODAY, V20, P635, DOI 10.1016/j.drudis.2015.03.001; Caino MC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13730; Caino MC, 2015, P NATL ACAD SCI USA, V112, P8638, DOI 10.1073/pnas.1500722112; Caino MC, 2013, J CLIN INVEST, V123, P2907, DOI 10.1172/JCI67841; Chen HC, 2017, CELL METAB, V26, P39, DOI 10.1016/j.cmet.2017.05.016; Chiang S, 2016, CANCER RES, V76, P7118, DOI 10.1158/0008-5472.CAN-16-0298; Cox TR, 2015, NATURE, V522, P106, DOI 10.1038/nature14492; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Cunniff B, 2016, MOL BIOL CELL, V27, P2662, DOI 10.1091/mbc.E16-05-0286; Desai SP, 2013, BIOPHYS J, V104, P2077, DOI 10.1016/j.bpj.2013.03.025; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gagne LM, 2017, TRENDS CELL BIOL, V27, P738, DOI 10.1016/j.tcb.2017.06.002; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoekstra AS, 2013, BBA-BIOENERGETICS, V1827, P543, DOI 10.1016/j.bbabio.2012.11.005; Hu X, 2014, CANCER LETT, V346, P114, DOI 10.1016/j.canlet.2013.12.020; Hurd TR, 2012, TRENDS CELL BIOL, V22, P107, DOI 10.1016/j.tcb.2011.11.002; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; Jo SH, 2001, J BIOL CHEM, V276, P26732; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kim S, 2014, BBA-MOL BASIS DIS, V1842, P135, DOI 10.1016/j.bbadis.2013.11.008; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Lehuede C, 2016, CANCER RES, V76, P5201, DOI 10.1158/0008-5472.CAN-16-0266; Li JJ, 2018, THERANOSTICS, V8, P4050, DOI 10.7150/thno.21524; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Lillig CH, 2004, P NATL ACAD SCI USA, V101, P13227, DOI 10.1073/pnas.0401896101; Ohno N, 2014, P NATL ACAD SCI USA, V111, P9953, DOI 10.1073/pnas.1401155111; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pienta KJ, 2013, CLIN CANCER RES, V19, P5849, DOI 10.1158/1078-0432.CCR-13-2158; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043; Qian W, 2012, J CELL SCI, V125, P5745, DOI 10.1242/jcs.109769; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Rankin EB, 2014, P NATL ACAD SCI USA, V111, P13373, DOI 10.1073/pnas.1404848111; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; SEMENZA GL, 2016, BBA-MOL CELL RES, V1863, P382, DOI DOI 10.1016/J.BBAMCR.2015.05.036; Senft D, 2016, CURR OPIN CELL BIOL, V39, P43, DOI 10.1016/j.ceb.2016.02.001; Seo JH, 2018, CANCER RES, V78, P4215, DOI 10.1158/0008-5472.CAN-18-0595; Serasinghe MN, 2015, MOL CELL, V57, P521, DOI 10.1016/j.molcel.2015.01.003; Tabassum DP, 2015, NAT REV CANCER, V15, P473, DOI 10.1038/nrc3971; Vyas S, 2016, CELL, V166, P555, DOI 10.1016/j.cell.2016.07.002; Waitkus MS, 2018, CANCER CELL, V34, P186, DOI 10.1016/j.ccell.2018.04.011; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wu DD, 2016, TUMOR BIOL, V37, P5225, DOI 10.1007/s13277-015-4358-2; Xie Q, 2015, NAT NEUROSCI, V18, P501, DOI 10.1038/nn.3960; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494; Zhou LS, 2016, EMBO REP, V17, P811, DOI 10.15252/embr.201541643; Zou XH, 2017, CANCER RES, V77, P3990, DOI 10.1158/0008-5472.CAN-16-2393	57	17	17	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13398	13411		10.1096/fj.201901366R	http://dx.doi.org/10.1096/fj.201901366R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31530011	Bronze, Green Published			2022-12-28	WOS:000507466100029
J	Kaftanovskaya, EM; Ng, HH; Soula, M; Rivas, B; Myhr, C; Ho, BA; Cervantes, BA; Shupe, TD; Devarasetty, M; Hu, X; Xu, X; Patnaik, S; Wilson, KJ; Barnaeva, E; Ferrer, M; Southall, NT; Marugan, JJ; Bishop, CE; Agoulnik, IU; Agoulnik, AI				Kaftanovskaya, Elena M.; Ng, Hooi Hooi; Soula, Mariluz; Rivas, Bryan; Myhr, Courtney; Ho, Brian A.; Cervantes, Briana A.; Shupe, Thomas D.; Devarasetty, Mahesh; Hu, Xin; Xu, Xin; Patnaik, Samarjit; Wilson, Kenneth J.; Barnaeva, Elena; Ferrer, Marc; Southall, Noel T.; Marugan, Juan J.; Bishop, Colin E.; Agoulnik, Irina U.; Agoulnik, Alexander I.			Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis	FASEB JOURNAL			English	Article						RXFP1; liver organoids; collagen; carbon tetrachloride	HEPATIC STELLATE CELLS; ACTIVATION; RXFP1	Fibrosis is an underlying cause of cirrhosis and hepatic failure resulting in end stage liver disease with limited pharmacological options. The beneficial effects of relaxin peptide treatment were demonstrated in clinically relevant animal models of liver fibrosis. However, the use of relaxin is problematic because of a short half-life. The aim of this study was to test the therapeutic effects of recently identified small molecule agonists of the human relaxin receptor, relaxin family peptide receptor 1 (RXFP1). The lead compound of this series, ML290, was selected based on its effects on the expression of fibrosis-related genes in primary human stellate cells. RNA sequencing analysis of TGF-beta 1-activated LX-2 cells showed that ML290 treatment primarily affected extracellular matrix remodeling and cytokine signaling, with expression profiles indicating an antifibrotic effect of ML290. ML290 treatment in human liver organoids with LPS-induced fibrotic phenotype resulted in a significant reduction of type I collagen. The pharmacokinetics of ML290 in mice demonstrated its high stability in vivo, as evidenced by the sustained concentrations of compound in the liver. In mice expressing human RXFP1 gene treated with carbon tetrachloride, ML290 significantly reduced collagen content, alpha-smooth muscle actin expression, and cell proliferation around portal ducts. In conclusion, ML290 demonstrated antifibrotic effects in liver fibrosis.	[Kaftanovskaya, Elena M.; Ng, Hooi Hooi; Soula, Mariluz; Rivas, Bryan; Myhr, Courtney; Ho, Brian A.; Cervantes, Briana A.; Agoulnik, Irina U.; Agoulnik, Alexander I.] Florida Int Univ, Herbert Wertheim Coll Med, Dept Human & Mol Genet, 11200 SW 8th St,AHC1 419B, Miami, FL 33199 USA; [Shupe, Thomas D.; Devarasetty, Mahesh; Bishop, Colin E.] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27101 USA; [Hu, Xin; Xu, Xin; Patnaik, Samarjit; Wilson, Kenneth J.; Barnaeva, Elena; Ferrer, Marc; Southall, Noel T.; Marugan, Juan J.] NIH, NIH Chem Genom Ctr, Natl Ctr Adv Translat Sci, Bldg 10, Bethesda, MD 20892 USA	State University System of Florida; Florida International University; Wake Forest University; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS)	Agoulnik, AI (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Dept Human & Mol Genet, 11200 SW 8th St,AHC1 419B, Miami, FL 33199 USA.	aagoulni@fiu.edu	Agoulnik, Irina/AAD-4687-2020; Southall, Noel/H-8991-2012	Agoulnik, Irina/0000-0003-4889-0324; Ho, Brian/0000-0002-8395-6643; Southall, Noel/0000-0003-4500-880X	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [1R01DK110167]; American Heart Association [19POST34380255]; NIH National Institute of General Medical Sciences (NIGMS) [T34GM083688]; NIH/NIGMS [R25GM061347]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB014836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM083688, R25GM061347] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); NIH National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Robert G. Bennett (University of Nebraska Medical Center, Omaha, NE, USA) for valuable advice on CCl<INF>4</INF> mouse experiments, and Dr. Scott Friedman (Icahn School of Medicine at Mount Sinai, New York, NY, USA) for providing LX-2 cells. This work was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant 1R01DK110167 (to A. I.A.). H.H. N. was supported by American Heart Association Postdoctoral Fellowship Grant 19POST34380255. M.S. and B.A.H. were supported by NIH National Institute of General Medical Sciences (NIGMS) T34GM083688, and B.A. C. by NIH/NIGMS R25GM061347 grant fellowships. M.F., N.T.S., J.J.M., I.U.A., and A.I.A. are the inventors in patent WO2013165606, modulators of the relaxin receptor 1. The remaining authors declare no conflicts of interest.	Agoulnik AI, 2017, BRIT J PHARMACOL, V174, P977, DOI 10.1111/bph.13656; Bennett RG, 2007, BIOCHEM PHARMACOL, V73, P1033, DOI 10.1016/j.bcp.2006.12.007; Bennett RG, 2014, LIVER INT, V34, P416, DOI 10.1111/liv.12247; Bennett RG, 2009, TRANSL RES, V154, P1, DOI 10.1016/j.trsl.2009.03.007; Bennett RG, 2009, ANN NY ACAD SCI, V1160, P348, DOI 10.1111/j.1749-6632.2008.03783.x; Chen CZ, 2013, J BIOMOL SCREEN, V18, P670, DOI 10.1177/1087057112469406; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chow BSM, 2014, KIDNEY INT, V86, P75, DOI 10.1038/ki.2013.518; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Du XJ, 2009, ANN NY ACAD SCI, V1160, P278, DOI 10.1111/j.1749-6632.2008.03780.x; Fallowfield JA, 2014, HEPATOLOGY, V59, P1492, DOI 10.1002/hep.26627; Forsythe SD, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00103; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; FRIEDMAN SL, 1989, J BIOL CHEM, V264, P10756; Halls ML, 2015, PHARMACOL REV, V67, P389, DOI 10.1124/pr.114.009472; Hewitson TD, 2010, ENDOCRINOLOGY, V151, P4938, DOI 10.1210/en.2010-0286; Hu X, 2016, BIOCHEMISTRY-US, V55, P1772, DOI 10.1021/acs.biochem.5b01195; Huang ZH, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00128; Kaftanovskaya EM, 2017, J ENDOCR SOC, V1, P712, DOI 10.1210/js.2017-00112; Kaftanovskaya EM, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.127209; Kisseleva T, 2017, HEPATOLOGY, V65, P1039, DOI 10.1002/hep.28948; Kocan M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02916-5; Lee KC, 2019, LAB INVEST, V99, P1203, DOI 10.1038/s41374-019-0240-y; McBride A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10521-9; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Prestigiacomo V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179995; Samuel CS, 2007, CELL MOL LIFE SCI, V64, P1539, DOI 10.1007/s00018-007-6543-y; Samuel CS, 2017, BRIT J PHARMACOL, V174, P962, DOI 10.1111/bph.13529; Samuel CS, 2008, ENDOCRINOLOGY, V149, P3286, DOI 10.1210/en.2008-0250; Samuel CS, 2007, ADV EXP MED BIOL, V612, P88; Samuel CS, 2011, LAB INVEST, V91, P675, DOI 10.1038/labinvest.2010.198; Sendi H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200847; Singh S, 2015, J BIOL CHEM, V290, P950, DOI 10.1074/jbc.M114.589325; Unemori E, 2017, BRIT J PHARMACOL, V174, P921, DOI 10.1111/bph.13695; Weiskirchen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075692; Wilson KJ, 2018, EUR J MED CHEM, V156, P79, DOI 10.1016/j.ejmech.2018.06.008; Xiao J., 2010, PROBE REPORTS NIH MO; Xiao JB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2953; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127	39	11	11	2	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12435	12446		10.1096/fj.201901046R	http://dx.doi.org/10.1096/fj.201901046R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31419161	Green Published			2022-12-28	WOS:000507461600065
J	Nicot, S; Verchere, J; Belondrade, M; Mayran, C; Betemps, D; Bougard, D; Baron, T				Nicot, Simon; Verchere, Jeremy; Belondrade, Maxime; Mayran, Charly; Betemps, Dominique; Bougard, Daisy; Baron, Thierry			Seeded propagation of alpha-synuclein aggregation in mouse brain using protein misfolding cyclic amplification	FASEB JOURNAL			English	Article						prion; seeding; PMCA; alpha-syn	MICE; PATHOLOGY; DISEASE; TRANSMISSION; PRIONS; SYSTEM	alpha-Synuclein (alpha-syn) protein aggregation is associated with several neurodegenerative disorders collectively referred to as synucleinopathies, including Parkinson's disease. We used protein misfolding cyclic amplification (PMCA) to study alpha-syn aggregation in brain homogenates of wild-type or transgenic mice expressing normal (D line) or A53T mutant (M83 line) human alpha-syn. We found that sonication-incubation cycles of M83 mouse brain gradually produce large quantities of SDS-resistant alpha-syn aggregates, involving both human and mouse proteins. These PMCA products, containing partially proteinase K-resistant alpha-syn species, are competent to accelerate the onset of neurologic symptoms after intracerebral inoculation to young M83 mice and to seed aggregate formation of alpha-syn following PMCA, including in D and wild-type mouse brain substrates. PMCA seeding activity in the M83 diseased brain correlates positively with regions mostly targeted by the alpha-syn pathology in this model. Our data indicate that similar to prions, PMCA can reproduce some characteristics of alpha-syn aggregation and seeded propagation in vitro in a complex milieu. This opens new opportunities for the molecular study of synucleinopathies.	[Nicot, Simon; Belondrade, Maxime; Mayran, Charly; Bougard, Daisy] Univ Montpellier, INSERM, Etab Francais Sang, Pathogenesis & Control Chron Infect, Montpellier, France; [Verchere, Jeremy; Betemps, Dominique; Baron, Thierry] Univ Lyon, French Agcy Food Environm & Occupat Hlth & Safety, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES)	Baron, T (corresponding author), ANSES, Lab Lyon, 31 Ave Tony Garnier, F-69364 Lyon 7, France.	thierry.baron@anses.fr		BOUGARD, Daisy/0000-0002-8779-9251; MAYRAN, Charly/0000-0003-0262-5138				Ayers JI, 2018, J VIROL, V92, DOI 10.1128/JVI.00586-18; Ayers JI, 2017, J VIROL, V91, DOI 10.1128/JVI.02095-16; Becker K, 2018, MOL NEUROBIOL, V55, P8728, DOI 10.1007/s12035-018-1007-y; Bencsik A, 2014, J NEUROPATH EXP NEUR, V73, P1144, DOI 10.1097/NEN.0000000000000137; Betemps D, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-29; Betemps D, 2015, JOVE-J VIS EXP, DOI 10.3791/52752; Bougard D, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1257; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Breid S, 2016, J VIROL, V90, P9182, DOI 10.1128/JVI.01399-16; Candelise N, 2019, ANN NEUROL, V85, P691, DOI 10.1002/ana.25446; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Dhillon JKS, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0733-3; Fairfoul G, 2016, ANN CLIN TRANSL NEUR, V3, P812, DOI 10.1002/acn3.338; Fenyi A, 2019, NEUROBIOL DIS, V129, P38, DOI 10.1016/j.nbd.2019.05.002; Ferreira ND, 2019, CURR OPIN PHARMACOL, V44, P1, DOI 10.1016/j.coph.2018.10.001; Flagmeier P, 2016, P NATL ACAD SCI USA, V113, P10328, DOI 10.1073/pnas.1604645113; Froula JM, 2019, J BIOL CHEM, V294, P10392, DOI 10.1074/jbc.RA119.007743; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Herva ME, 2014, J BIOL CHEM, V289, P11897, DOI 10.1074/jbc.M113.542340; Jung BC, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.1; Kang LJ, 2011, J AM CHEM SOC, V133, P13465, DOI 10.1021/ja203979j; Krishnan S, 2003, BIOCHEMISTRY-US, V42, P829, DOI 10.1021/bi026528t; Lazaro DF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004741; Lohmann S., 2019, ACTA NEUROPATHOL; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Mokretar K, 2018, BRAIN, V141, P2419, DOI 10.1093/brain/awy157; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Paciotti S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00415; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Peng C, 2018, NATURE, V557, P558, DOI 10.1038/s41586-018-0104-4; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; Riek R, 2016, NATURE, V539, P227, DOI 10.1038/nature20416; Roostaee A, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-5; Rutherford NJ, 2017, HUM MOL GENET, V26, P4906, DOI 10.1093/hmg/ddx371; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sacino AN, 2014, P NATL ACAD SCI USA, V111, P10732, DOI 10.1073/pnas.1321785111; Sacino AN, 2014, ACTA NEUROPATHOL, V127, P645, DOI 10.1007/s00401-014-1268-0; Sargent D, 2017, J NEUROCHEM, V143, P126, DOI 10.1111/jnc.14139; Shahnawaz M, 2017, JAMA NEUROL, V74, P163, DOI 10.1001/jamaneurol.2016.4547; Specht CG, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-11; Steiner JA, 2018, CELL TISSUE RES, V373, P161, DOI 10.1007/s00441-018-2814-1; Tsika E, 2010, J NEUROSCI, V30, P3409, DOI 10.1523/JNEUROSCI.4977-09.2010; Ugalde CL, 2019, J BIOL CHEM, V294, P9016, DOI 10.1074/jbc.REV119.007500; Watts JC, 2013, P NATL ACAD SCI USA, V110, P19555, DOI 10.1073/pnas.1318268110; Woerman AL, 2018, ACTA NEUROPATHOL, V135, P49, DOI 10.1007/s00401-017-1762-2	48	9	10	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12073	12086		10.1096/fj.201900354R	http://dx.doi.org/10.1096/fj.201900354R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31370680	Green Published			2022-12-28	WOS:000507461600037
J	Qiao, LQ; Wu, XM; Zhang, J; Liu, L; Sui, XX; Zhang, R; Liu, WX; Shen, FQ; Sun, YY; Xi, XW				Qiao, Lianqiao; Wu, Xiaomei; Zhang, Jing; Liu, Lei; Sui, Xiaoxin; Zhang, Ru; Liu, Wenxue; Shen, Fangqian; Sun, Yunyan; Xi, Xiaowei			alpha-NETA induces pyroptosis of epithelial ovarian cancer cells through the GSDMD/caspase-4 pathway	FASEB JOURNAL			English	Article						small molecule compound; tumor cell death; chemotherapy	NONCANONICAL INFLAMMASOME ACTIVATION; CHEMOTHERAPY; RESISTANCE; CASPASES; CLEAVAGE; PORE	Chemotherapy resistance is one of the most common causes of death among patients with ovarian cancer, and identifying novel antitumor agents is a priority. Here, we report that the novel molecule 2-(anaphthoyl)ethyltrimethylammonium iodide (-NETA) induces epithelial ovarian cancer (EOC) cell pyroptosis through the gesdermin-d (GSDMD)/caspase-4 pathway. Furthermore, Cell Counting Kit-8 fluorescence-activated cell sorting analysis showed that alpha-NETA treatment led to cell death in different ovarian cancer cell lines, including Ho8910, Ho8910PM, and A2780. Morphologic examination by electron microscopy indicated that cells treated with alpha-NETA produced multiple microbubbles, typical of cells undergoing pyroptosis. alpha-NETA also significantly increased expression of pyroptosis-associated molecules including caspase-4 and GSDMD in EOC cells. Knockdown of either caspase-4 or GSDMD in ovarian cancer cells strongly interfered with alpha-NETA cell-killing activity, indicating that alpha-NETA acts through the pyroptosis pathway. In vivo, alpha-NETA treatment dramatically decreased the size of EOC tumors in mice. Our findings suggest that alpha-NETA represents a potential new antitumor molecule or lead compound for EOC chemotherapy.	[Qiao, Lianqiao; Wu, Xiaomei; Sui, Xiaoxin; Zhang, Ru; Shen, Fangqian; Sun, Yunyan; Xi, Xiaowei] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Obstet & Gynecol, 650 Xinsongjiang Rd, Shanghai 201600, Peoples R China; [Zhang, Jing] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Dept Obstet & Gynecol, Shanghai, Peoples R China; [Liu, Lei] Shanghai Jiao Tong Univ, Sch Med, Dept Obstet & Gynecol, Shanghai, Peoples R China; [Liu, Wenxue] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Renji Med X Clin Stem Cell Res Ctr, Ren Ji Hosp,Sch Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xi, XW (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Obstet & Gynecol, 650 Xinsongjiang Rd, Shanghai 201600, Peoples R China.	xixiaowei1966@126.com			National Natural Science Foundation of China [DY01.01]; National Science Foundation for Young Scientists of China [010402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation for Young Scientists of China	The authors thank Prof. Zhouluo Ou (Shanghai Cancer Hospital) for assistance with project development. The authors also thank Feng Shao (Beijing National Institute of Biological Sciences) for advice. This work was supported by the National Natural Science Foundation of China (Grants DY01.01.N17.068 and DY01.01.N17.069) and the National Science Foundation for Young Scientists of China (Grant 010402). The authors declare no conflicts of interest.	Abcam, 2019, ALPH NETA INSTR; Chen X, 2016, CELL RES, V26, P1007, DOI 10.1038/cr.2016.100; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; Corrado G, 2017, EXPERT REV ANTICANC, V17, P1147, DOI 10.1080/14737140.2017.1398088; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Graham KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112925; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Jayson GC, 2014, LANCET, V384, P1376, DOI 10.1016/S0140-6736(13)62146-7; Jorgensen I, 2015, IMMUNOL REV, V265, P130, DOI 10.1111/imr.12287; Karakashev S, 2017, FUTURE ONCOL, V13, P2737, DOI 10.2217/fon-2017-0235; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Moore KN, 2018, FUTURE ONCOL, V14, P123, DOI 10.2217/fon-2017-0379; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Tomao F, 2017, EXPERT OPIN PHARMACO, V18, P1443, DOI 10.1080/14656566.2017.1328055; Tummler C, 2017, ONCOTARGET, V8, P95135, DOI 10.18632/oncotarget.19619; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393	21	49	57	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12760	12767		10.1096/fj.201900483RR	http://dx.doi.org/10.1096/fj.201900483RR			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31480859				2022-12-28	WOS:000507461600090
J	Yap, JLY; Tai, YK; Frohlich, J; Fong, CHH; Yin, JN; Foo, ZL; Ramanan, S; Beyer, C; Toh, SJ; Casarosa, M; Bharathy, N; Kala, MP; Egli, M; Taneja, R; Lee, CN; Franco-Obregon, A				Yap, Jasmine Lye Yee; Tai, Yee Kit; Frohlich, Juerg; Fong, Charlene Hui Hua; Yin, Jocelyn Naixin; Foo, Zi Ling; Ramanan, Sharanya; Beyer, Christian; Toh, Shi Jie; Casarosa, Marco; Bharathy, Narendra; Kala, Monica Palanichamy; Egli, Marcel; Taneja, Reshma; Lee, Chuen Neng; Franco-Obregon, Alfredo			Ambient and supplemental magnetic fields promote myogenesis via a TRPC1-mitochondrial axis: evidence of a magnetic mitohormetic mechanism	FASEB JOURNAL			English	Article						pulsed electromagnetic fields; reactive oxygen species; PGC-1 alpha; calcineurin; mitochondriogenesis	MECHANOSENSITIVE ION CHANNELS; MYOBLAST DIFFERENTIATION; C2C12 MYOBLASTS; DISTINCT ROLES; MUSCLE; TRPC1; PGC-1-ALPHA; CALCIUM; PROLIFERATION; CALCINEURIN	We show that both supplemental and ambient magnetic fields modulate myogenesis. A lone 10 min exposure of myoblasts to 1.5 mT amplitude supplemental pulsed magnetic fields (PEMFs) accentuated in vitro myogenesis by stimulating transient receptor potential (TRP)-C1-mediated calcium entry and downstream nuclear factor of activated T cells (NFAT)-transcriptional and P300/CBP-associated factor (PCAF)-epigenetic cascades, whereas depriving myoblasts of ambient magnetic fields slowed myogenesis, reduced TRPC1 expression, and silenced NFAT-transcriptional and PCAF-epigenetic cascades. The expression levels of peroxisome proliferator-activated receptor gamma coactivator 1 alpha, the master regulator of mitochondriogenesis, was also enhanced by brief PEMF exposure. Accordingly, mitochondriogenesis and respiratory capacity were both enhanced with PEMF exposure, paralleling TRPC1 expression and pharmacological sensitivity. Clustered regularly interspaced short palindromic repeats-Cas9 knockdown of TRPC1 precluded proliferative and mitochondrial responses to supplemental PEMFs, whereas small interfering RNA gene silencing of TRPM7 did not, coinciding with data that magnetoreception did not coincide with the expression or function of other TRP channels. The aminoglycoside antibiotics antagonized and down-regulated TRPC1 expression and, when applied concomitantly with PEMF exposure, attenuated PEMF-stimulated calcium entry, mitochondrial respiration, proliferation, differentiation, and epigenetic directive in myoblasts, elucidating why the developmental potential of magnetic fields may have previously escaped detection. Mitochondrial-based survival adaptations were also activated upon PEMF stimulation. Magnetism thus deploys an authentic myogenic directive that relies on an interplay between mitochondria and TRPC1 to reach fruition.	[Yap, Jasmine Lye Yee; Tai, Yee Kit; Frohlich, Juerg; Fong, Charlene Hui Hua; Yin, Jocelyn Naixin; Foo, Zi Ling; Ramanan, Sharanya; Toh, Shi Jie; Lee, Chuen Neng; Franco-Obregon, Alfredo] Natl Univ Singapore, Dept Surg, Singapore, Singapore; [Bharathy, Narendra; Kala, Monica Palanichamy; Taneja, Reshma; Franco-Obregon, Alfredo] Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Singapore, Singapore; [Yap, Jasmine Lye Yee; Tai, Yee Kit; Fong, Charlene Hui Hua; Yin, Jocelyn Naixin; Foo, Zi Ling; Ramanan, Sharanya; Toh, Shi Jie; Franco-Obregon, Alfredo] Natl Univ Singapore, BioIon Currents Elect Pulsing Syst Lab BICEPS, Singapore, Singapore; [Lee, Chuen Neng; Franco-Obregon, Alfredo] Natl Univ Singapore, Inst Hlth Innovat & Technol, iHealthtech, Singapore, Singapore; [Frohlich, Juerg; Beyer, Christian] ETH, Swiss Fed Inst Technol, Inst Elect Fields, Zurich, Switzerland; [Beyer, Christian] Ctr Suisse Elect & Microtech CSEM SA, Neuchatel, Switzerland; [Casarosa, Marco] Univ Florence, Dept Expt & Clin Biomed Sci Mario Serio, Florence, Italy; [Bharathy, Narendra] Childrens Canc Therapy Dev Inst, Beaverton, OR USA; [Egli, Marcel] Lucerne Univ Appl Sci & Arts, Inst Med Engn, Hergiswil, Switzerland	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Center for Electronics & Microtechnology (CSEM); University of Florence	Franco-Obregon, A (corresponding author), Natl Univ Singapore, Natl Univ Hosp, NUHS Tower Block,Level 8,1E Kent Ridge Rd, Singapore 119228, Singapore.	suraf@nus.edu.sg	Tai, Yee Kit/HCH-5864-2022; ELANGOVAN, NARENDRA BHARATHY/X-9367-2018; Tai, Yee Kit/AHB-6200-2022; Lee, Chuen Neng/B-4516-2011; Taneja, Reshma/F-9658-2014	ELANGOVAN, NARENDRA BHARATHY/0000-0002-4697-5044; Lee, Chuen Neng/0000-0001-9748-4424; Taneja, Reshma/0000-0002-2151-2094; Palanichamy Kala, Monica/0000-0003-3447-7360; Reshma, Taneja/0000-0001-6214-6177; Franco-Obregon, Alfredo/0000-0002-2514-1083; Tai, Yee Kit/0000-0003-0798-3575; Egli, Marcel/0000-0002-4064-2871	European Space Agency Grant ESA-CORA-GBF [4000113883]; Fondation Suisse de Recherche sur les Maladies Musculaires; Lee Foundation, Singapore	European Space Agency Grant ESA-CORA-GBF(European Space Agency); Fondation Suisse de Recherche sur les Maladies Musculaires; Lee Foundation, Singapore	The authors acknowledge Dr. T. Benavides Damm [Swiss Space Center, Swiss Federal Institute of Technology (ETH Zurich)] for assisting with the simulated microgravity experiment shown in Fig. 10D, and Dr. Krzysztof Krawczyk (ETH Zurich) for assistance in conducting the fusion index histogram in Fig. 3H. The authors also acknowledge Zac Goh (iHealthtech, National University of Singapore) for the design of graphical abstract shown in Fig. 1. This study was financially supported by the European Space Agency Grant ESA-CORA-GBF (4000113883), the Fondation Suisse de Recherche sur les Maladies Musculaires, and the Lee Foundation, Singapore. J.F., C.B., C.N.L., and A.F.-O. are inventors on patent WO 2016/178631 A1, System and Method for Applying Pulsed Electromagnetic Fields, and J.F., C.N.L. and A.F.-O. are contributors to QuantumTx Pte. Ltd., which elaborates on the use of similar magnetic fields on human health (targeting muscle). The other authors declare no conflicts of interest.	Adhihetty PJ, 2009, AM J PHYSIOL-CELL PH, V297, pC217, DOI 10.1152/ajpcell.00070.2009; Aquilano K, 2013, ANTIOXID REDOX SIGN, V18, P386, DOI 10.1089/ars.2012.4615; Armand AS, 2008, J BIOL CHEM, V283, P29004, DOI 10.1074/jbc.M801297200; Arsenis NC, 2017, ONCOTARGET, V8, P45008, DOI 10.18632/oncotarget.16726; Baek S, 2014, ACS NANO, V8, P10125, DOI 10.1021/nn502923s; Baldelli S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.458; Calabria E, 2009, P NATL ACAD SCI USA, V106, P13335, DOI 10.1073/pnas.0812911106; Chen MS, 2013, CELL PHYSIOL BIOCHEM, V32, P951, DOI 10.1159/000354498; Cheng CF, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113447; Crocetti S, 2014, CYTOM PART A, V85A, P525, DOI 10.1002/cyto.a.22461; Crocetti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072944; Damm TB, 2013, CELL CYCLE, V12, P3001, DOI 10.4161/cc.26029; Dick SA, 2015, P NATL ACAD SCI USA, V112, pE5246, DOI 10.1073/pnas.1512869112; Dilworth FJ, 2004, P NATL ACAD SCI USA, V101, P11593, DOI 10.1073/pnas.0404192101; Eijkelkamp N, 2013, ANNU REV NEUROSCI, V36, P519, DOI 10.1146/annurev-neuro-062012-170412; Enoki R, 2017, SCI REP-UK, V7, DOI 10.1038/srep41733; Fauquier L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31102-4; Fogle KJ, 2015, P NATL ACAD SCI USA, V112, P2245, DOI 10.1073/pnas.1416586112; FRANCO A, 1990, J PHYSIOL-LONDON, V427, P361, DOI 10.1113/jphysiol.1990.sp018176; Fraysse B, 2003, FASEB J, V17, P1916, DOI 10.1096/fj.02-1012fje; Frey N, 2008, J CLIN INVEST, V118, P3598, DOI 10.1172/JCI36277; Gao X, 2010, J CELL BIOCHEM, V110, P162, DOI 10.1002/jcb.22522; Gervasio OL, 2008, J CELL SCI, V121, P2246, DOI 10.1242/jcs.032003; Gorlach A, 2015, REDOX BIOL, V6, P260, DOI 10.1016/j.redox.2015.08.010; Goodpaster BH, 2017, CELL METAB, V25, P1027, DOI 10.1016/j.cmet.2017.04.015; Ho TC, 2012, CHANNELS, V6, P246, DOI 10.4161/chan.20719; Hore PJ, 2016, ANNU REV BIOPHYS, V45, P299, DOI 10.1146/annurev-biophys-032116-094545; Hu HZ, 2009, P NATL ACAD SCI USA, V106, P1626, DOI 10.1073/pnas.0812209106; Hudson MB, 2013, INT J BIOCHEM CELL B, V45, P2173, DOI 10.1016/j.biocel.2013.06.029; Hughes SM, 1999, J CELL BIOL, V145, P633, DOI 10.1083/jcb.145.3.633; Jang Y, 2012, ARCH PHARM RES, V35, P1823, DOI 10.1007/s12272-012-1016-8; Kang CH, 2012, ANN NY ACAD SCI, V1271, P110, DOI 10.1111/j.1749-6632.2012.06738.x; Kattnig DR, 2016, NAT CHEM, V8, P384, DOI [10.1038/NCHEM.2447, 10.1038/nchem.2447]; Kook SH, 2008, MOL CELLS, V25, P479; Kuras Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043859; Lambert N, 2013, NAT PHYS, V9, P10, DOI [10.1038/nphys2474, 10.1038/NPHYS2474]; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Martino CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022753; Matsumura CY, 2011, AM J PHYSIOL-CELL PH, V301, pC1344, DOI 10.1152/ajpcell.00056.2011; Morabito C, 2010, FREE RADICAL BIO MED, V48, P579, DOI 10.1016/j.freeradbiomed.2009.12.005; Morales S, 2007, AM J PHYSIOL-CELL PH, V292, pC553, DOI 10.1152/ajpcell.00096.2006; Murray TVA, 2008, J CELL SCI, V121, P3786, DOI 10.1242/jcs.024547; Nicholls David G, 2010, J Vis Exp, DOI 10.3791/2511; Nilius B, 2015, TRP CHANNELS THERAPE, P419, DOI [10.1016/B978-0-12-420024-1.00023-0, DOI 10.1016/B978-0-12-420024-1.00023-0]; Nunn AVW, 2016, BIOCHEM SOC T, V44, P1101, DOI 10.1042/BST20160096; Ong EC, 2013, J BIOL CHEM, V288, P22219, DOI 10.1074/jbc.M113.459826; Parate D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09892-w; Perroud J, 2017, J CELL SCI, V130, P3083, DOI 10.1242/jcs.198978; Pfluger PT, 2015, CELL METAB, V22, P838, DOI 10.1016/j.cmet.2015.08.022; Portelli LA, 2013, BIOELECTROMAGNETICS, V34, P337, DOI 10.1002/bem.21787; Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow; Roberts-Wilson TK, 2010, BBA-MOL CELL RES, V1803, P960, DOI 10.1016/j.bbamcr.2010.03.019; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Sciancalepore M, 2012, FREE RADICAL BIO MED, V53, P1392, DOI 10.1016/j.freeradbiomed.2012.08.002; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sherrard RM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006229; Sin J, 2016, AUTOPHAGY, V12, P369, DOI 10.1080/15548627.2015.1115172; Surma SV, 2014, BIOELECTROMAGNETICS, V35, P537, DOI 10.1002/bem.21876; Tan N, 2014, J PHYSIOL-LONDON, V592, P3303, DOI 10.1113/jphysiol.2014.274332; Targos B, 2005, ACTA BIOCHIM POL, V52, P397, DOI 10.18388/abp.2005_3452; Trewin AJ, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7010007; Usselman RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38543; Vincent F, 2011, CURR TOP MED CHEM, V11, P2216, DOI 10.2174/156802611796904861; Wade B., 2013, AM J HLTH RES, V1, P51; Wagatsuma A, 2013, SCI WORLD J, DOI 10.1155/2013/593267; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Winegar BD, 1996, J GEN PHYSIOL, V107, P433, DOI 10.1085/jgp.107.3.433; Xia L, 2016, J PHYSIOL-LONDON, V594, P3111, DOI 10.1113/JP271705; Xu HX, 2016, BIOCHEM BIOPH RES CO, V479, P97, DOI 10.1016/j.bbrc.2016.09.044; Zanou N, 2012, J BIOL CHEM, V287, P14524, DOI 10.1074/jbc.M112.341784; Zanou N, 2010, AM J PHYSIOL-CELL PH, V298, pC149, DOI 10.1152/ajpcell.00241.2009	71	20	21	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12853	12872		10.1096/fj.201900057R	http://dx.doi.org/10.1096/fj.201900057R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31518158	hybrid, Green Published			2022-12-28	WOS:000507461600097
J	Nabizadeh, JA; Manthey, HD; Panagides, N; Steyn, FJ; Lee, JD; Li, XX; Akhir, FNM; Chen, WY; Boyle, GM; Taylor, SM; Woodruff, TM; Rolfe, BE				Nabizadeh, Jamileh A.; Manthey, Helga D.; Panagides, Nadya; Steyn, Frederik J.; Lee, John D.; Li, Xaria X.; Akhir, Fazrena N. M.; Chen, Weiyu; Boyle, Glen M.; Taylor, Stephen M.; Woodruff, Trent M.; Rolfe, Barbara E.			C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma	FASEB JOURNAL			English	Article						C5aR1 antagonist; tumor-infiltrating leukocytes	COMPLEMENT ACTIVATION; IMMUNE-RESPONSE; CANCER; CELLS; C5L2; MICROENVIRONMENT; ANAPHYLATOXIN; MODULATOR; BLOCKADE; INNATE	The canonical complement component 5a (C5a) receptor (C5aR) 1 has well-described roles in tumorigenesis but the contribution of the second receptor, C5aR2, is unclear. The present study demonstrates that B16.F0 melanoma cells express mRNA for both C5aR1 and C5aR2 and signal through ERK and p38 MAPKs in response to C5a. Despite this, C5a had no impact on melanoma cell proliferation or migration in vitro. In vivo studies demonstrated that the growth of B16.F0 melanoma tumors was increased in C5aR2(-/-) mice but reduced in C5aR1(-/-) mice and wild-type mice treated with a C5aR1 antagonist. Analysis of tumor-infiltrating leukocyte populations showed no significant differences between wild-type and C5aR2(-/-) mice. Conversely, percentages of myeloid-derived suppressor cells, macrophages, and regulatory T lymphocytes were lower in tumors from C5aR1(-/-) mice, whereas total (CD3(+)) T lymphocytes and CD4(+) subsets were higher. Analysis of cytokine and chemokine levels also showed plasma IFN-gamma was higher and tumor C-C motif chemokine ligand 2 was lower in the absence of C5aR1. The results suggest that C5aR1 signaling supports melanoma growth by promoting infiltration of immunosuppressive leukocyte populations into the tumor microenvironment, whereas C5aR2 has a more restricted but beneficial role in limiting tumor growth. Overall, these data support the potential of C5aR1-inhibitory therapies for melanoma.-Nabizadeh, J. A., Manthey, H. D., Panagides, N., Steyn, F. J., Lee, J. D., Li, X. X., Akhir, F. N. M., Chen, W., Boyle, G. M., Taylor, S. M., Woodruff, T. M., Rolfe, B. E. C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma.	[Nabizadeh, Jamileh A.; Manthey, Helga D.; Panagides, Nadya; Akhir, Fazrena N. M.; Chen, Weiyu; Rolfe, Barbara E.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Cnr Coll & Cooper Rds, Brisbane, Qld 4072, Australia; [Steyn, Frederik J.] Univ Queensland, Ctr Clin Res, Brisbane, Qld, Australia; [Lee, John D.; Li, Xaria X.; Taylor, Stephen M.; Woodruff, Trent M.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Boyle, Glen M.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Akhir, Fazrena N. M.] Univ Teknol Malaysia, MJIIT, Kuala Lumpur, Malaysia; [Chen, Weiyu] Univ Wisconsin, Madison, WI USA	University of Queensland; University of Queensland; University of Queensland; QIMR Berghofer Medical Research Institute; Universiti Teknologi Malaysia; University of Wisconsin System; University of Wisconsin Madison	Rolfe, BE (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Cnr Coll & Cooper Rds, Brisbane, Qld 4072, Australia.; Woodruff, TM (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia.	b.rolfe@uq.edu.au	Chen, Weiyu/M-5972-2018; Woodruff, Trent M/B-4861-2009; Li, Xaria X/ABG-7342-2020; Woodruff, Trent/AAS-4629-2020; Boyle, Glen/G-1347-2013; Akhir, Fazrena Md/AAD-9120-2019; Steyn, FJ/P-4386-2016; Lee, John/Y-2066-2018	Chen, Weiyu/0000-0003-4436-2743; Woodruff, Trent M/0000-0003-1382-911X; Li, Xaria X/0000-0001-5924-2977; Woodruff, Trent/0000-0003-1382-911X; Boyle, Glen/0000-0002-1385-529X; Akhir, Fazrena Md/0000-0003-4874-8379; Steyn, FJ/0000-0002-4782-3608; Lee, John/0000-0002-9976-7396; Rolfe, Barbara/0000-0002-0468-1371	Australian National Health and Medical Research Council (NHMRC) [APP1103951]; Cancer Council Queensland (CCQ); University of Queensland Collaboration and Industry Fund (CIEF); Motor Neurone Disease Research Institute of Australia Postdoctoral Fellowship [PDF1604]; NHMRC Career Development Fellowship [1105420]; University of Queensland Post-Graduate Research Scholarship; University of Queensland Research Training Scholarship	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Queensland (CCQ)(Cancer Council Queensland); University of Queensland Collaboration and Industry Fund (CIEF); Motor Neurone Disease Research Institute of Australia Postdoctoral Fellowship; NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland Post-Graduate Research Scholarship(University of Queensland); University of Queensland Research Training Scholarship	The authors thank Dr. Geoff Osborne for advice on flow cytometric analysis and Dr. Darryl Whitehead (both from The University of Queensland) for histological advice. This work was supported by grants from the Australian National Health and Medical Research Council (NHMRC; APP1103951), Cancer Council Queensland (CCQ), and the University of Queensland Collaboration and Industry Fund (CIEF). J.D.L. was supported by a Motor Neurone Disease Research Institute of Australia Postdoctoral Fellowship (PDF1604). T.M.W. was supported by a NHMRC Career Development Fellowship (1105420)., J.A.N. was supported by a University of Queensland Post-Graduate Research Scholarship, and X.X.L. was supported by a University of Queensland Research Training Scholarship. J.A.N. and H.D.M. are equal first authors. T.M.W. and B.E.R. are equal contributing corresponding authors. The authors declare no conflicts of interest.	Ajona D, 2019, SEMIN CELL DEV BIOL, V85, P153, DOI 10.1016/j.semcdb.2017.11.023; Ajona D, 2017, CANCER DISCOV, V7, P694, DOI 10.1158/2159-8290.CD-16-1184; Ajona D, 2013, JNCI-J NATL CANCER I, V105, P1385, DOI 10.1093/jnci/djt205; Aldinucci D, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/292376; Arbore G, 2016, SCIENCE, V352, DOI 10.1126/science.aad1210; Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Bonavita E, 2015, CELL, V160, P700, DOI 10.1016/j.cell.2015.01.004; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Callahan MK, 2016, CANCER TREAT RES, V167, P231, DOI 10.1007/978-3-319-22539-5_9; Castro F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00847; Chen NJ, 2007, NATURE, V446, P203, DOI 10.1038/nature05559; Cho MS, 2014, CELL REP, V6, P1085, DOI 10.1016/j.celrep.2014.02.014; Corrales L, 2012, J IMMUNOL, V189, P4674, DOI 10.4049/jimmunol.1201654; Croker DE, 2016, IMMUNOL CELL BIOL, V94, P787, DOI 10.1038/icb.2016.43; Croker DE, 2014, IMMUNOL CELL BIOL, V92, P631, DOI 10.1038/icb.2014.32; Ellyard JI, 2007, TISSUE ANTIGENS, V70, P1, DOI 10.1111/j.1399-0039.2007.00869.x; Elso CM, 2004, GENES IMMUN, V5, P93, DOI 10.1038/sj.gene.6364042; Gao HW, 2005, FASEB J, V19, P1003, DOI 10.1096/fj.04-3424fje; Gunn L, 2012, J IMMUNOL, V189, P2985, DOI 10.4049/jimmunol.1200846; Hollmann TJ, 2008, MOL IMMUNOL, V45, P1907, DOI 10.1016/j.molimm.2007.10.037; Horst SA, 2015, PATHOGENS, V4, P722, DOI 10.3390/pathogens4040722; Imamura T, 2016, BREAST CANCER-TOKYO, V23, P876, DOI 10.1007/s12282-015-0654-3; Jablonska J, 2010, J CLIN INVEST, V120, P4163, DOI 10.1172/JCI37223C1; Kaida T, 2016, ONCOTARGET, V7, P84798, DOI 10.18632/oncotarget.12656; Karsten CM, 2017, J IMMUNOL, V199, P3234, DOI 10.4049/jimmunol.1700710; Karsten CM, 2015, J IMMUNOL, V194, P1841, DOI 10.4049/jimmunol.1401401; Klikovits T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16551-7; Klos A, 2013, PHARMACOL REV, V65, P500, DOI 10.1124/pr.111.005223; Lesokhin AM, 2012, CANCER RES, V72, P876, DOI 10.1158/0008-5472.CAN-11-1792; Li R, 2013, FASEB J, V27, P855, DOI 10.1096/fj.12-220509; Li XX, 2019, J IMMUNOL, V202, P3339, DOI 10.4049/jimmunol.1900371; Lv DD, 2013, CELL MOL IMMUNOL, V10, P303, DOI 10.1038/cmi.2012.69; Ma CS, 2016, J EXP MED, V213, P1589, DOI 10.1084/jem.20151467; Makela K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-565; Manthey HD, 2009, INT J BIOCHEM CELL B, V41, P2114, DOI 10.1016/j.biocel.2009.04.005; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Mattes J, 2003, J EXP MED, V197, P387, DOI 10.1084/jem.20021683; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Mrowietz U, 1999, BRIT J CANCER, V79, P1025, DOI 10.1038/sj.bjc.6690164; Nagarsheth N, 2017, NAT REV IMMUNOL, V17, P559, DOI 10.1038/nri.2017.49; NICULESCU F, 1992, AM J PATHOL, V140, P1039; Nishimura T, 1999, J EXP MED, V190, P617, DOI 10.1084/jem.190.5.617; Nunez-Cruz S, 2012, NEOPLASIA, V14, P994, DOI 10.1593/neo.121262; Obermajer N, 2011, CANCER RES, V71, P7463, DOI 10.1158/0008-5472.CAN-11-2449; Pandey S., 2019, J BIOL CHEM; Piao CM, 2015, J BIOL CHEM, V290, P10667, DOI 10.1074/jbc.M114.612622; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Reis ES, 2018, NAT REV IMMUNOL, V18, P5, DOI 10.1038/nri.2017.97; Russkamp NF, 2015, FASEB J, V29, P3762, DOI 10.1096/fj.15-271635; Schupp J, 2017, CELL IMMUNOL; Sorensen MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087831; SPANGTHOMSEN M, 1980, EXP CELL BIOL, V48, P138; Su SC, 2018, CELL, V172, P841, DOI 10.1016/j.cell.2018.01.009; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Vadrevu SK, 2014, CANCER RES, V74, P3454, DOI 10.1158/0008-5472.CAN-14-0157; Woodruff TM, 2011, MOL IMMUNOL, V48, P1631, DOI 10.1016/j.molimm.2011.04.014; Yan CG, 2012, J BIOL CHEM, V287, P3217, DOI 10.1074/jbc.M111.280834; Yang JM, 2018, CANCER IMMUNOL RES, V6, P1186, DOI 10.1158/2326-6066.CIR-18-0045; Yoshimura T, 2018, CELL MOL IMMUNOL, V15, P335, DOI 10.1038/cmi.2017.135; Zha HR, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1349587; Zhang J, 2016, ACTA BIOMATER, V41, P264, DOI 10.1016/j.actbio.2016.05.034; Zollo M, 2012, CLIN EXP METASTAS, V29, P585, DOI 10.1007/s10585-012-9473-5	63	15	16	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11060	11071		10.1096/fj.201800980RR	http://dx.doi.org/10.1096/fj.201800980RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31298935				2022-12-28	WOS:000489166300041
J	Sallustio, F; Stasi, A; Curci, C; Divella, C; Picerno, A; Franzin, R; De Palma, G; Rutigliano, M; Lucarelli, G; Battaglia, M; Staffieri, F; Crovace, A; Pertosa, GB; Castellano, G; Gallone, A; Gesualdo, L				Sallustio, Fabio; Stasi, Alessandra; Curci, Claudia; Divella, Chiara; Picerno, Angela; Franzin, Rossana; De Palma, Giuseppe; Rutigliano, Monica; Lucarelli, Giuseppe; Battaglia, Michele; Staffieri, Francesco; Crovace, Antonio; Pertosa, Giovanni Battista; Castellano, Giuseppe; Gallone, Anna; Gesualdo, Loreto			Renal progenitor cells revert LPS-induced endothelial-to-mesenchymal transition by secreting CXCL6, SAA4, and BPIFA2 antiseptic peptides	FASEB JOURNAL			English	Article						endothelial dysfunction; stem cells; antifibrotic effects	INCREASING PROTEIN; MESSENGER-RNA; MECHANISMS; FIBROSIS; SEPSIS; MOUSE; INFLAMMATION; DYSFUNCTION; ACTIVATION; EXPRESSION	Endothelial dysfunction is a hallmark of LPS-induced acute kidney injury (AKI). Endothelial cells (ECs) acquired a fibroblast-like phenotype and contributed to myofibroblast generation through the endothelial-to-mesenchymal transition (EndMT) process. Of note, human adult renal stem/progenitor cells (ARPCs) enhance the tubular regenerative mechanism during AKI but little is known about their effects on ECs. Following LPS exposure, ECs proliferated, decreased EC markers CD31 and vascular endothelial cadherin, and up-regulated myofibroblast markers, collagen I, and vimentin. The coculture with ARPCs normalized the EC proliferation rate and abrogated the LPS-induced EndMT. The gene expression analysis showed that most of the genes modulated in LPS-stimulated ARPCs belong to cell activation and defense response pathways. We showed that the ARPC-specific antifibrotic effect is exerted by the secretion of CXCL6, SAA4, and BPIFA2 produced after the anaphylatoxin stimulation. Next, we investigated the molecular signaling that underlies the ARPC protective mechanism and found that renal progenitors diverge from differentiated tubular cells and ECs in myeloid differentiation primary response 88-independent pathway activation. Finally, in a swine model of LPS-induced AKI, we observed that activated ARPCs secreted CXCL6, SAA4, and BPIFA2 as a defense response. These data open new perspectives on the treatment of both sepsis- and endotoxemia-induced AKI, suggesting an underestimated role of ARPCs in preventing endothelial dysfunction and novel strategies to protect the endothelial compartment and promote kidney repair.-Sallustio, F., Stasi, A., Curci, C., Divella, C., Picerno, A., Franzin, R., De Palma, G., Rutigliano, M., Lucarelli, G., Battaglia, M., Staffieri, F., Crovace, A., Pertosa, G. B., Castellano, G., Gallone, A., Gesualdo, L. Renal progenitor cells revert LPS-induced endothelial-to-mesenchymal transition by secreting CXCL6, SAA4, and BPIFA2 antiseptic peptides.	[Sallustio, Fabio; Curci, Claudia; Gallone, Anna] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Piazza G Cesare 11, I-70124 Bari, Italy; [Sallustio, Fabio; Stasi, Alessandra; Curci, Claudia; Divella, Chiara; Picerno, Angela; Franzin, Rossana; Pertosa, Giovanni Battista; Castellano, Giuseppe; Gallone, Anna; Gesualdo, Loreto] Univ Bari Aldo Moro, Nephrol Dialysis & Transplantat Unit, Dept Emergency & Organ Transplantat, Bari, Italy; [Rutigliano, Monica; Lucarelli, Giuseppe; Battaglia, Michele] Univ Bari Aldo Moro, Urol Androl & Renal Transplantat Unit, Dept Emergency & Organ Transplantat, Bari, Italy; [Staffieri, Francesco; Crovace, Antonio] Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Vet Surg Unit, Bari, Italy; [De Palma, Giuseppe] Ist Tumori Giovanni Paolo II, IRCCS, Expt Oncol & Biobank Management Unit, Inst Biobank, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; IRCCS Istituto Tumori Bari Giovanni Paolo II	Sallustio, F (corresponding author), Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Piazza G Cesare 11, I-70124 Bari, Italy.	fabio.sallustio@uniba.it	De Palma, Giuseppe/J-4860-2018; stasi, alessandra/AAO-9506-2020; LUCARELLI, GIUSEPPE/AAX-4148-2020; stasi, alessandra/K-5023-2016; Castellano, Giuseppe/H-1626-2012; Franzin, Rossana/AHH-5631-2022; Sallustio, Fabio/AFP-7212-2022; Franzin, Rossana/AAV-6733-2020; Gesualdo, Loreto/K-7751-2016; Franzin, Rossana/AAO-7099-2021; Gallone, Anna/K-5384-2018; Sallustio, Fabio/D-2326-2011; Curci, Claudia/A-6918-2013; Picerno, Angela/AIC-9957-2022; Staffieri, Francesco/K-4230-2016	De Palma, Giuseppe/0000-0002-6108-096X; stasi, alessandra/0000-0003-3652-3623; LUCARELLI, GIUSEPPE/0000-0001-7807-1229; Castellano, Giuseppe/0000-0002-0153-3795; Franzin, Rossana/0000-0001-7907-7614; Sallustio, Fabio/0000-0002-5132-6532; Gesualdo, Loreto/0000-0002-4861-0911; Gallone, Anna/0000-0002-2252-9584; Sallustio, Fabio/0000-0002-5132-6532; Curci, Claudia/0000-0003-2055-7837; Pertosa, Giovanni Battista/0000-0002-2198-5705; Picerno, Angela/0000-0001-5805-4341; Staffieri, Francesco/0000-0002-2085-376X	University of Bari Aldo Moro; Italian Ministry of Health [GR-2011-02351027]; Regional Strategic Grant, Apulia Region [PSR 094]	University of Bari Aldo Moro; Italian Ministry of Health(Ministry of Health, Italy); Regional Strategic Grant, Apulia Region	This study was supported by University of Bari Aldo Moro, the Italian Ministry of Health (Ricerca Finalizzata 2009 to G.C. and GR-2011-02351027 2011-2012 to G.C.). L.G. was supported by a Regional Strategic Grant, Apulia Region (PSR 094). A.G. and L.G. contributed equally to this work as senior authors. The authors declare no conflicts of interest.	Basile DP, 2011, AM J PHYSIOL-RENAL, V300, pF721, DOI 10.1152/ajprenal.00546.2010; Besnard AG, 2013, J LEUKOCYTE BIOL, V94, P1317, DOI 10.1189/jlb.0313140; Bingle CD, 2002, HUM MOL GENET, V11, P937, DOI 10.1093/hmg/11.8.937; Boca SM, 2018, PEERJ, V6, DOI 10.7717/peerj.6035; Bussolati B, 2015, NAT REV NEPHROL, V11, P695, DOI 10.1038/nrneph.2015.126; Castellano G, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0520-2; Curci C, 2014, NEPHROL DIAL TRANSPL, V29, P799, DOI 10.1093/ndt/gft516; Dauphinee SM, 2006, LAB INVEST, V86, P9, DOI 10.1038/labinvest.3700366; Echeverria C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094146; Echeverria C, 2013, J CELL MOL MED, V17, P800, DOI 10.1111/jcmm.12066; Elsbach P, 1998, J LEUKOCYTE BIOL, V64, P14, DOI 10.1002/jlb.64.1.14; Fiorentino M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198269; Gijsbers K, 2005, EXP CELL RES, V303, P331, DOI 10.1016/j.yexcr.2004.09.027; Gomez H, 2014, SHOCK, V41, P3, DOI 10.1097/SHK.0000000000000052; GORR S, 2015, FASEB J S1, V29; Guerrot D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S15; Kisilevsky R, 2012, AMYLOID, V19, P5, DOI 10.3109/13506129.2011.654294; Kizu A, 2009, AM J PATHOL, V175, P1371, DOI 10.2353/ajpath.2009.090698; Kota SK, 2017, J AM SOC NEPHROL, V28, P3473, DOI 10.1681/ASN.2016121265; KUSHNER I, 1982, ANN NY ACAD SCI, V389, P39, DOI 10.1111/j.1749-6632.1982.tb22124.x; Lazzeri E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03753-4; Lazzeri E, 2015, EXPERT OPIN BIOL TH, V15, P1455, DOI 10.1517/14712598.2015.1067300; Lerolle N, 2010, INTENS CARE MED, V36, P471, DOI 10.1007/s00134-009-1723-x; Li XW, 2003, INFECT IMMUN, V71, P4414, DOI 10.1128/IAI.71.8.4414-4420.2003; Linge HM, 2008, ANTIMICROB AGENTS CH, V52, P2599, DOI 10.1128/AAC.00028-08; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Martin L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00404; MEEK RL, 1989, AM J PATHOL, V135, P411; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Olsen HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076695; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Patschan D, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/828369; Peri F, 2010, BIOCHEM SOC T, V38, P1390, DOI 10.1042/BST0381390; Sallustio F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08474-0; Sallustio F, 2015, BIORESEARCH OPEN ACC, V4, P326, DOI 10.1089/biores.2015.0011; Sallustio F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068296; Sallustio F, 2010, FASEB J, V24, P514, DOI 10.1096/fj.09-136481; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Sipe J, 1999, AMYLOID, V6, P67, DOI 10.3109/13506129908993291; Stasi A, 2017, NEPHROL DIAL TRANSPL, V32, P24, DOI 10.1093/ndt/gfw250; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Tarassishin L, 2013, J NEUROIMMUNE PHARM, V8, P132, DOI 10.1007/s11481-012-9360-5; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Usui M, 1998, BBA-GENE STRUCT EXPR, V1397, P202, DOI 10.1016/S0167-4781(97)00228-5; Vivarelli MS, 2004, J EXP MED, V200, P399, DOI 10.1084/jem.20040446; Wang SC, 1998, J SURG RES, V76, P67, DOI 10.1006/jsre.1998.5290; WEISS J, 1992, J CLIN INVEST, V90, P1122, DOI 10.1172/JCI115930; Wu LP, 2007, J AM SOC NEPHROL, V18, P1807, DOI 10.1681/ASN.2006121402; Zarjou A, 2011, J AM SOC NEPHROL, V22, P999, DOI 10.1681/ASN.2010050484; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	52	17	17	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10753	10766		10.1096/fj.201900351R	http://dx.doi.org/10.1096/fj.201900351R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31268775	Green Submitted, Bronze			2022-12-28	WOS:000489166300015
J	Buxbaum, JN				Buxbaum, Joel N.			Unravelling Alzheimer's Disease: It's Not the Whole Story, but A beta Still Matters	FASEB JOURNAL			English	Review							AMYLOID-BETA; NEUROFIBRILLARY TANGLES; MICE; TRANSMISSION; HYPOTHESIS; SEVERITY; MODELS	In late 2016, we solicited a series of reviews covering the variety of processes that appeared to be involved in the pathogenesis of neurodegenerative disorders, particularly Alzheimer's disease (AD). These essays have appeared at regular intervals in The FASEB Journal. My instructions to the researchers were simply not to emphasize A beta per se because there had been many reviews both supporting and questioning the etiologic role of A beta in the late-onset, sporadic form of AD, and reciting either of those scientific positions would be redundant. My colleagues responded admirably, and I believe that their contributions have significantly informed readers' awareness of the current state of knowledge of AD. I have written my epilogue from the perspective of an investigator interested in the role of protein aggregation in human disease and as a physician who may be charged with making a diagnosis and prescribing treatment for a patient. We do not yet have etiology-based therapies of AD, but we continue to gain insight into the mechanisms responsible for synaptic loss and the consequent functional deterioration. A silver therapeutic bullet does not seem to be in the offing. It is more likely that an iterative approach will lead to the development of a group of treatments that are AD specific or applicable to various features of the entire class of neurodegenerative disorders. How and when those therapies succeed or fail will, in turn, provide additional insights into disease pathogenesis, which will inform the development of succeeding generations of therapeutics.-Buxbaum, J. N. Unravelling Alzheimer's disease: it's not the whole story, but A beta still matters.	[Buxbaum, Joel N.] Scripps Res Inst, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Buxbaum, Joel N.] Protego Biopharma, San Diego, CA USA; [Buxbaum, Joel N.] Scintillon Inst, San Diego, CA USA	Scripps Research Institute	Buxbaum, JN (corresponding author), Scripps Res Inst, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	jbux@scripps.edu						ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; BIERER LM, 1995, ARCH NEUROL-CHICAGO, V52, P81, DOI 10.1001/archneur.1995.00540250089017; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; BRICKER NS, 1969, AM J MED, V46, P1, DOI 10.1016/0002-9343(69)90053-9; Buxbaum JN, 2019, AMYLOID, V26, P55, DOI 10.1080/13506129.2019.1575201; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Cummings DM, 2015, BRAIN, V138, P1992, DOI 10.1093/brain/awv127; Currais A, 2017, FASEB J, V31, P5, DOI 10.1096/fj.201601184; Fagoonee S, 2019, INFECT DIS-NOR, V51, P399, DOI 10.1080/23744235.2019.1588472; Fillit H., 2018, CLIN TRIALS REPORT A; Golde TE, 2016, NAT REV NEUROL, V12, P433, DOI 10.1038/nrneurol.2016.105; Guo QX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080706; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Huang YWA, 2017, CELL, V168, P427, DOI 10.1016/j.cell.2016.12.044; Itzhaki RF, 2017, FASEB J, V31, P3216, DOI 10.1096/fj.201700360; Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369; Jucker M, 2018, NAT NEUROSCI, V21, P1341, DOI 10.1038/s41593-018-0238-6; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Lahiri DK, 2005, NEUROBIOL AGING, V26, P1329, DOI 10.1016/j.neurobiolaging.2004.11.005; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Liddelow SA, 2019, FASEB J, V33, P1528, DOI 10.1096/fj.201802592; Maheshwari P, 2015, J ALZHEIMERS DIS, V43, P957, DOI 10.3233/JAD-140621; MARSHALL BJ, 1984, LANCET, V1, P1311; Matarin M, 2015, CELL REP, V10, P633, DOI 10.1016/j.celrep.2014.12.041; Moir RD, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00070; Moir RD, 2018, ALZHEIMERS DEMENT, V14, P1602, DOI 10.1016/j.jalz.2018.06.3040; Montacute R, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0826-5; Moulder KL, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt213; Onos KD, 2016, BRAIN RES BULL, V122, P1, DOI 10.1016/j.brainresbull.2015.12.003; Panza F, 2019, NAT REV NEUROL, V15, P73, DOI 10.1038/s41582-018-0116-6; Pimenova AA, 2018, BIOL PSYCHIAT, V83, P300, DOI 10.1016/j.biopsych.2017.05.014; Pir GJ, 2017, FASEB J, V31, P5137, DOI 10.1096/fj.201701007; Reiman EM, 2011, J ALZHEIMERS DIS, V26, P321, DOI 10.3233/JAD-2011-0059; Ridge PG, 2016, NEUROBIOL AGING, V41, DOI 10.1016/j.neurobiolaging.2016.02.024; Sassi C, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.06.002; Sato C, 2018, NEURON, V98, P861, DOI 10.1016/j.neuron.2018.04.035; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Singh K, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12020062; STEERE AC, 1983, NEW ENGL J MED, V308, P733, DOI 10.1056/NEJM198303313081301; STEERE AC, 1977, ARTHRITIS RHEUM, V20, P7, DOI 10.1002/art.1780200102; Venegas C., 2019, FASEB J; Zott B, 2018, ANNU REV NEUROSCI, V41, P277, DOI 10.1146/annurev-neuro-080317-061725	44	3	3	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9701	9705		10.1096/fj.201901895	http://dx.doi.org/10.1096/fj.201901895			5	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31465249	Bronze			2022-12-28	WOS:000482214200002
J	Hlaing, EEH; Ishihara, Y; Wang, ZY; Odagaki, N; Kamioka, H				Hlaing, Ei Ei Hsu; Ishihara, Yoshihito; Wang, Ziyi; Odagaki, Naoya; Kamioka, Hiroshi			Role of intracellular Ca2+-based mechanotransduction of human periodontal ligament fibroblasts	FASEB JOURNAL			English	Article						hPDL; intracellular calcium; SOST; sclerostin; Rankl; Opg; bone remodeling	CALCIUM OSCILLATIONS; CA2+ OSCILLATIONS; MECHANICAL-STRESS; GENE-EXPRESSION; FLUID-FLOW; BONE; WNT; OSTEOCLASTOGENESIS; SCLEROSTIN; ACTIVATION	Human periodontal ligament (hPDL) fibroblasts are thought to receive mechanical stress (MS) produced by orthodontic tooth movement, thereby regulating alveolar bone remodeling. However, the role of intracellular calcium ([Ca2+](i))-based mechanotransduction is not fully understood. We explored the MS-induced [Ca2+](i) responses both in isolated hPDL fibroblasts and in intact hPDL tissue and investigated its possible role in alveolar bone remodeling. hPDL fibroblasts were obtained from healthy donors' premolars that had been extracted for orthodontic reasons. The oscillatory [Ca2+](i) activity induced by static compressive force was measured by a live-cell Ca2+ imaging system and evaluated by several feature extraction method. The spatial pattern of cell-cell communication was investigated by Moran's I, an index of spatial autocorrelation and the gap junction (GJ) inhibitor. The Ca2+-transporting ionophore A23187 was used to further investigate the role of [Ca2+](i) up-regulation in hPDL cell behavior. hPDL fibroblasts displayed autonomous [Ca2+](i) responses. Compressive MS activated this autonomous responsive behavior with an increased percentage of responsive cells both in vitro and ex vivo. The integration, variance, maximum amplitude, waveform length, and index J in the [Ca2+](i) responses were also significantly increased, whereas the mean power frequency was attenuated in response to MS. The increased Moran's I after MS indicated that MS might affect the pattern of cell-cell communication via GJs. Similar to the findings of MS-mediated regulation, the A23187-mediated [Ca2+](i) uptake resulted in the up-regulation of receptor activator of NF-kappa B ligand (Rankl) and Sost along with increased sclerostin immunoreactivity, suggesting that [Ca2+](i) signaling networks may be involved in bone remodeling. In addition, A23187-treated hPDL fibroblasts also showed the suppression of osteogenic differentiation and mineralization. Our findings suggest that augmented MS-mediated [Ca2+](i) oscillations in hPDL fibroblasts enhance the production and release of bone regulatory signals via Rankl/Osteoprotegerin and the canonical Wnt/beta-catenin pathway as an early process in tooth movement-initiated alveolar bone remodeling.-Ei Hsu Hlaing, E., Ishihara, Y., Wang, Z., Odagaki, N., Kamioka, H. Role of intracellular Ca2+-based mechanotransduction of human periodontal ligament fibroblasts.	[Hlaing, Ei Ei Hsu; Wang, Ziyi; Kamioka, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Orthodont, Okayama, Japan; [Ishihara, Yoshihito; Odagaki, Naoya] Okayama Univ Hosp, Dept Orthodont, Okayama, Japan; [Wang, Ziyi] Japan Soc Promot Sci JSPS DC2, Tokyo, Japan	Okayama University; Okayama University; Japan Society for the Promotion of Science	Ishihara, Y (corresponding author), Okayama Univ Hosp, Dept Orthodont, Kita Ku, 2-5-1 Shikata Cho, Okayama, Okayama 7008558, Japan.	ishihara@md.okayama-u.ac.jp	Hlaing, Ei Ei Hsu/ABF-3646-2020; ISHIHARA, Yoshihito/B-2345-2011; Wang, Ziyi/AAW-6082-2020	Hlaing, Ei Ei Hsu/0000-0002-5539-9499; ISHIHARA, Yoshihito/0000-0002-5999-8253; Wang, Ziyi/0000-0003-1884-8053	Japan Society for the Promotion of Science, Japan [17H04413, 19H03859]	Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The present work was supported by Grant-in-Aid for Scientific Research [to Y.I. (17H04413) and H.K. (19H03859)] from the Japan Society for the Promotion of Science, Japan. The authors declare no conflicts of interest.	ARORA PD, 1994, J CELL PHYSIOL, V161, P187, DOI 10.1002/jcp.1041610202; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Boccafoschi F, 2011, J CELL BIOCHEM, V112, P1403, DOI 10.1002/jcb.23056; Chowdhury RH, 2013, SENSORS-BASEL, V13, P12431, DOI 10.3390/s130912431; DAVIDOVITCH Z, 1988, DENT CLIN N AM, V32, P411; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Glogauer M, 1997, J CELL SCI, V110, P11; Godbout C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064560; Ishihara Y, 2013, BONE, V53, P204, DOI 10.1016/j.bone.2012.12.002; Ishihara Y, 2012, BONE, V50, P842, DOI 10.1016/j.bone.2012.01.021; Jing D, 2014, FASEB J, V28, P1582, DOI 10.1096/fj.13-237578; Kanzaki H, 2002, J BONE MINER RES, V17, P210, DOI 10.1359/jbmr.2002.17.2.210; Kato R, 2013, J DENT RES, V92, P635, DOI 10.1177/0022034513489992; Kawanabe N, 2010, DIFFERENTIATION, V79, P74, DOI 10.1016/j.diff.2009.10.005; Klein-Nulend J, 2013, BONE, V54, P182, DOI 10.1016/j.bone.2012.10.013; Kook SH, 2011, J CELL BIOCHEM, V112, P2891, DOI 10.1002/jcb.23205; Lekic P, 1996, ANAT REC, V245, P327; Li SN, 2015, J ORTHOP RES, V33, P1008, DOI 10.1002/jor.22830; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li Y, 2011, J DENT RES, V90, P115, DOI 10.1177/0022034510385237; Manokawinchoke J, 2015, J DENT RES, V94, P983, DOI 10.1177/0022034515581372; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; McCulloch CAG, 2000, PERIODONTOL 2000, V24, P56, DOI 10.1034/j.1600-0757.2000.2240104.x; Meng GX, 2018, J ORTHOP RES, V36, P2039, DOI 10.1002/jor.23843; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Morita M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137610; Morrell AE, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0007-x; NakagoMatsuo C, 1996, AM J ORTHOD DENTOFAC, V109, P244, DOI 10.1016/S0889-5406(96)70147-6; Nakao K, 2007, J DENT RES, V86, P623, DOI 10.1177/154405910708600708; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; NARUSE K, 1993, AM J PHYSIOL, V264, pC1037, DOI 10.1152/ajpcell.1993.264.4.C1037; Nayak K., 2013, J DENT ORAL HEALTH, V1, P1; Odagaki N, 2018, J DENT RES, V97, P1374, DOI 10.1177/0022034518771331; Pavasant P, 2011, PERIODONTOL 2000, V56, P154, DOI 10.1111/j.1600-0757.2010.00374.x; Phinyomark A., 2012, COMPUTATIONAL INTELL, DOI [10.5772/50639, DOI 10.5772/50639]; RESENDEZ E, 1986, J CELL BIOL, V103, P2145, DOI 10.1083/jcb.103.6.2145; ROBERTS WE, 1982, AM J ANAT, V165, P373, DOI 10.1002/aja.1001650403; Rubin J, 2006, GENE, V367, P1, DOI 10.1016/j.gene.2005.10.028; Ruffinatti FA, 2011, J NEUROSCI METH, V199, P310, DOI 10.1016/j.jneumeth.2011.05.009; SOMJEN D, 1980, BIOCHIM BIOPHYS ACTA, V627, P91, DOI 10.1016/0304-4165(80)90126-9; STERNBERG SR, 1983, COMPUTER, V16, P22, DOI 10.1109/MC.1983.1654163; Su M, 1997, J DENT RES, V76, P1357, DOI 10.1177/00220345970760070501; Tordjmann T, 1997, EMBO J, V16, P5398, DOI 10.1093/emboj/16.17.5398; Turner C H, 1998, J Orthop Sci, V3, P346, DOI 10.1007/s007760050064; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; Wescott DC, 2007, J DENT RES, V86, P1212, DOI 10.1177/154405910708601214; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; Wyles SP, 2016, CTS-CLIN TRANSL SCI, V9, P158, DOI 10.1111/cts.12393; Yamaguchi M, 2009, ORTHOD CRANIOFAC RES, V12, P113, DOI 10.1111/j.1601-6343.2009.01444.x; Yang F, 2010, BIOCHEM BIOPH RES CO, V400, P684, DOI 10.1016/j.bbrc.2010.08.128; Yellowley CE, 1997, AM J PHYSIOL-CELL PH, V273, pC30, DOI 10.1152/ajpcell.1997.273.1.C30; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105	54	11	11	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10409	10424		10.1096/fj.201900484R	http://dx.doi.org/10.1096/fj.201900484R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31238000	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000482214200055
J	Liu, G; Kuang, S; Cao, RB; Wang, J; Peng, QC; Sun, CM				Liu, Ge; Kuang, Shan; Cao, Ruobing; Wang, Ju; Peng, Quancai; Sun, Chaomin			Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids via the ATP-AMPK-mTOR-SREBP1 signaling pathway	FASEB JOURNAL			English	Article						stearoyl CoA desaturase 1; monounsaturated FAs; ATP production	STEAROYL-COA DESATURASE; DE-NOVO LIPOGENESIS; CELLULAR-ENERGY; SREBP ACTIVITY; AMPK; INHIBITION; GROWTH; SYNTHASE; TARGET; DEATH	Sorafenib is a multikinase inhibitor that is effective in treating advanced liver cancer. Although its mechanism of action through several established cancer-related protein kinase targets is well-characterized, sorafenib induces variable responses among human tumors, and the cause for this variation is yet unknown. To investigate the underlying mechanisms, we applied mass spectrometry-based proteomic analysis to Huh7.5 human liver cancer cells and found that sorafenib significantly affected the expression of the key lipogenic enzymes, especially stearoyl coenzyme A desaturase 1 (SCD1), in these cells. Given that SCD1 catalyzes the most crucial and rate-limiting step in the synthesis of monounsaturated fatty acids (FAs), we performed a lipidomic analysis, which showed a dramatically altered lipid profile in sorafenib-treated cells. Detection and analysis of free FAs showed that the levels of monounsaturated FAs, including oleate, were significantly decreased in those cells treated by sorafenib. Addition of oleate protected liver cancer cells from sorafenib-induced death and alleviated the abnormalities of mitochondrial morphology and function caused by the drug. Treatment with sorafenib suppressed ATP production, resulting in AMPK activation via phosphorylation. Further secondary effects included reduction of the levels of sterol regulatory element-binding protein 1 (SREBP1) and the phosphorylation of mammalian target of rapamycin (mTOR) in liver cancer cells. These effects were partly abolished in the presence of compound C (an AMPK inhibitor) and ATP and adenosine, and SREBP1c overexpression also could be resistant to the effects of sorafenib, suggesting that the sorafenib-induced reduction in cell viability was mediated by the ATP-AMPK-mTOR-SREBP1 signaling pathway. Taken together, our results suggest that sorafenib's anticancer activity in liver cancer cells is based on the inhibition of ATP production, SCD1 expression, and monounsaturated FA synthesis. In addition, the decreased monounsaturated FA synthesis further triggered the more serious reduction of ATP production in sorafenib-treated cells. To our knowledge, this is the first evidence that sorafenib disrupts lipogenesis and triggers liver cancer cell death by targeting SCD1 through the ATP-AMPK-mTOR-SREBP1 pathway.-Liu, G., Kuang, S., Cao, R., Wang, J., Peng, Q., Sun, C. Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids via the ATP-AMPK-mTOR- SREBP1 signaling pathway.	[Liu, Ge; Kuang, Shan; Cao, Ruobing; Wang, Ju; Peng, Quancai; Sun, Chaomin] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Shandong, Peoples R China; [Liu, Ge; Kuang, Shan; Cao, Ruobing; Wang, Ju; Sun, Chaomin] Chinese Acad Sci, Ctr Ocean Mega Sci, Qingdao, Shandong, Peoples R China; [Liu, Ge; Kuang, Shan; Cao, Ruobing; Wang, Ju; Sun, Chaomin] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Shandong, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; Qingdao National Laboratory for Marine Science & Technology	Sun, CM (corresponding author), Chiense Acad Sci, Inst Oceanol, 7 Nanhai Rd, Qingdao 266071, Shandong, Peoples R China.	sunchaomin@qdio.ac.cn		Kuang, Shan/0000-0001-7316-0273; Sun, Chaomin/0000-0003-4802-184X	China Ocean Mineral Resources RD Association [DY135-B2-14]; National Key R and D Program of China [2018YFC0310800]; Natural Science Outstanding Youth Fund of Shandong Province [JQ201607]; National Natural Science Foundation of China [31470181]; Taishan Young Scholar Program of Shandong Province [tsqn20161051]; AoShan Talents Program - Qingdao National Laboratory for Marine Science and Technology [2015ASTP]; 100-Talent Project of the Chinese Academy of Sciences	China Ocean Mineral Resources RD Association; National Key R and D Program of China; Natural Science Outstanding Youth Fund of Shandong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Young Scholar Program of Shandong Province; AoShan Talents Program - Qingdao National Laboratory for Marine Science and Technology; 100-Talent Project of the Chinese Academy of Sciences(Chinese Academy of Sciences)	The authors thank Dr. Maria Matveenko (Life Science Editors, Park City, UT, USA) for helpful comments on the manuscript. This work was funded by China Ocean Mineral Resources R&D Association Grant DY135-B2-14, National Key R and D Program of China Grant 2018YFC0310800, the Natural Science Outstanding Youth Fund of Shandong Province (JQ201607), the National Natural Science Foundation of China (31470181), the Taishan Young Scholar Program of Shandong Province (tsqn20161051), the AoShan Talents Program supported by the Qingdao National Laboratory for Marine Science and Technology (2015ASTP), and the 100-Talent Project of the Chinese Academy of Sciences (to C.S.). The authors declare no conflicts of interest.	Beckers A, 2007, CANCER RES, V67, P8180, DOI 10.1158/0008-5472.CAN-07-0389; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Bull VH, 2012, J PROTEOME RES, V11, P1609, DOI 10.1021/pr200790e; Chiou JF, 2009, CANCER BIOL THER, V8, P1904, DOI 10.4161/cbt.8.20.9436; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Fang X, 2017, FORESTS, V8, DOI 10.3390/f8030060; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Fritz V, 2010, MOL CANCER THER, V9, P1740, DOI 10.1158/1535-7163.MCT-09-1064; Gorgani-Firuzjaee S, 2015, FREE RADICAL BIO MED, V89, P679, DOI 10.1016/j.freeradbiomed.2015.10.036; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; Gu Y, 2012, BIOCHEM PHARMACOL, V84, P468, DOI 10.1016/j.bcp.2012.06.002; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; He CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047567; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Janikiewicz J, 2015, J LIPID RES, V56, P1901, DOI 10.1194/jlr.M059980; Kong W, 2004, CURR DRUG METAB, V5, P63, DOI 10.2174/1389200043489162; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Ma MKF, 2017, J HEPATOL, V67, P979, DOI 10.1016/j.jhep.2017.06.015; Mason P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033823; Mauvoisin D, 2011, BIOCHIMIE, V93, P78, DOI 10.1016/j.biochi.2010.08.001; MEDES G, 1953, CANCER RES, V13, P27; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Nolan CJ, 2009, J GASTROEN HEPATOL, V24, P703, DOI 10.1111/j.1440-1746.2009.05823.x; Pizer ES, 1996, CANCER RES, V56, P745; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Potze L, 2016, ONCOGENE, V35, P427, DOI 10.1038/onc.2015.102; Potze L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.139; Quan HY, 2013, BIOCHEM PHARMACOL, V85, P1330, DOI 10.1016/j.bcp.2013.02.007; Roongta UV, 2011, MOL CANCER RES, V9, P1551, DOI 10.1158/1541-7786.MCR-11-0126; Ross FA, 2017, CELL CHEM BIOL, V24, P813, DOI 10.1016/j.chembiol.2017.05.021; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Schuster S, 2015, BIOCHEM BIOPH RES CO, V458, P334, DOI 10.1016/j.bbrc.2015.01.111; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Southam AD, 2015, CANCER RES, V75, P2530, DOI 10.1158/0008-5472.CAN-15-0202; Stoffel W, 2008, EMBO J, V27, P2281, DOI 10.1038/emboj.2008.156; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Wang L, 2016, ONCOTARGET, V7, P32054, DOI 10.18632/oncotarget.8410; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Yang J, 2009, J CELL BIOCHEM, V106, P414, DOI 10.1002/jcb.22024; Zhang CG, 2017, J BIOL CHEM, V292, P15105, DOI 10.1074/jbc.M117.783175; Zhang XN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4295; Zhao XX, 2013, LAB INVEST, V93, P8, DOI 10.1038/labinvest.2012.144; Zhou TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019599	48	50	50	8	43	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10089	10103		10.1096/fj.201802619RR	http://dx.doi.org/10.1096/fj.201802619RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31199678	Bronze			2022-12-28	WOS:000482214200030
J	Chen, YY; Deb, DK; Fu, X; Yi, B; Liang, YM; Du, J; He, L; Li, YC				Chen, Yinyin; Deb, Dilip K.; Fu, Xiao; Yi, Bin; Liang, Yumei; Du, Jie; He, Lei; Li, Yan Chun			ATP-citrate lyase is an epigenetic regulator to promote obesity-related kidney injury	FASEB JOURNAL			English	Article						histone acetylation; de novo lipogenesis; obesity; nephropathy	VITAMIN-D-RECEPTOR; DENSITY-LIPOPROTEIN-CHOLESTEROL; ACTIVATED PROTEIN-KINASE; RENAL LIPID-METABOLISM; BODY-MASS INDEX; RESPONSE ELEMENT; HIGH GLUCOSE; TRANSCRIPTION; P300; MICE	Obesity is a leading cause of chronic kidney disease (CKD), but how obesity promotes renal injury remains poorly understood. Here we showed that ATP-citrate lyase (ACL), an enzyme converting citrate to acetyl-CoA, is highly induced in the kidney of overweight or obese patients with CKD and ob/ob BTBR mice. ACL induction is associated with increased ectopic lipid accumulation (ELA), glomerulosclerosis, and albuminuria. Acetyl-CoA is the substrate for de novo lipogenesis as well as for histone acetylation. By raising acetyl-CoA concentration ACL promotes H3K9/14 and H3K27 hyperacetylation leading to up-regulation of several rate-limiting lipogenic enzymes and fibrogenic factors. On the other hand, the excess acetyl-CoA generated as a result of ACL induction provides the substrate for these lipogenic enzymes to drive de novo lipogenesis leading to ELA, a detrimental event toward renal injury. In mesangial cells, ACL is synergistically induced by high glucose, palmitate, and TNF-alpha via NF-kappa B and PKA pathways. Under these conditions, H3K9/14 and H3K27 hyperacetylation, as well as the induction of the lipogenic and fibrogenic proteins, are completely blocked in the presence of an ACL inhibitor. Collectively, these data suggest that ACL is an epigenetic regulator that promotes renal ELA and fibrogenesis leading to renal injury in obesity.-Chen, Y., Deb, D. K., Fu, X., Yi, B., Liang, Y., Du, J., He, L., Li, Y. C. ATP-citrate lyase is an epigenetic regulator to promote obesity-related kidney injury.	[Chen, Yinyin; Deb, Dilip K.; Fu, Xiao; Yi, Bin; Du, Jie; He, Lei; Li, Yan Chun] Univ Chicago, Dept Med, Div Biol Sci, 900 E 57th St,KCBD 9110, Chicago, IL 60637 USA; [Chen, Yinyin; Liang, Yumei] Hunan Normal Univ, Hunan Prov Peoples Hosp, Dept Nephrol, Changsha, Hunan, Peoples R China; [Chen, Yinyin; Liang, Yumei] Hunan Normal Univ, Hunan Prov Peoples Hosp, Lab Kidney Dis, Changsha, Hunan, Peoples R China; [Fu, Xiao] Cent S Univ, Xiangya Hosp 2, Dept Nephrol, Changsha, Hunan, Peoples R China; [Yi, Bin] Cent S Univ, Xiangya Hosp 3, Dept Nephrol, Changsha, Hunan, Peoples R China	University of Chicago; Hunan Normal University; Hunan Normal University; Central South University; Central South University	Li, YC (corresponding author), Univ Chicago, Dept Med, Div Biol Sci, 900 E 57th St,KCBD 9110, Chicago, IL 60637 USA.	cyan@medicine.bsd.uchicago.edu		He, Lei/0000-0002-3821-2047	U.S. National Institutes of Health (NIH) National Cancer Institute Grant [CA180087]; NATIONAL CANCER INSTITUTE [R01CA180087] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Kathryn E. Wellen (University of Pennsylvania) for providing the ATP-citrate lyase (ACL) expression plasmid and ACL-short hairpin RNA plasmid and Marc Bissonnette for critically reading the manuscript. This work was supported in part by U.S. National Institutes of Health (NIH) National Cancer Institute Grant CA180087. The authors declare no conflicts of interest.	Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Ballantyne CM, 2016, AM J CARDIOL, V117, P1928, DOI 10.1016/j.amjcard.2016.03.043; Ballantyne CM, 2013, J AM COLL CARDIOL, V62, P1154, DOI 10.1016/j.jacc.2013.05.050; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Carling D, 2012, BIOCHEM J, V445, P11, DOI 10.1042/BJ20120546; Centers for Disease Control and Prevention, 2017, PREVALENCE OBESITY A; Centers for Disease Control and Prevention (CDC), 2017, NAT DIAB STAT REP 20; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; D'Agati VD, 2016, NAT REV NEPHROL, V12, P453, DOI 10.1038/nrneph.2016.75; de Vries APJ, 2014, LANCET DIABETES ENDO, V2, P417, DOI 10.1016/S2213-8587(14)70065-8; Deb DK, 2017, AM J PHYSIOL-RENAL, V313, pF423, DOI 10.1152/ajprenal.00029.2017; Deb DK, 2017, FASEB J, V31, P2065, DOI 10.1096/fj.201601116R; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gutierrez MJ, 2014, ARTERIOSCL THROM VAS, V34, P676, DOI 10.1161/ATVBAHA.113.302677; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Hudkins KL, 2010, J AM SOC NEPHROL, V21, P1533, DOI 10.1681/ASN.2009121290; Imamura M, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.94979; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Kong JA, 2010, AM J PATHOL, V177, P622, DOI 10.2353/ajpath.2010.091292; Kume S, 2007, J AM SOC NEPHROL, V18, P2715, DOI 10.1681/ASN.2007010089; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; Li YC, 2001, AM J PHYSIOL-ENDOC M, V281, pE558, DOI 10.1152/ajpendo.2001.281.3.E558; Malik AN, 2014, NAT NEUROSCI, V17, P1330, DOI 10.1038/nn.3808; McDonnell E, 2016, CELL REP, V17, P1463, DOI 10.1016/j.celrep.2016.10.012; Nakayama K, 2013, J BIOL CHEM, V288, P22584, DOI 10.1074/jbc.M112.421636; Pearce NJ, 1998, BIOCHEM J, V334, P113, DOI 10.1042/bj3340113; Pinkosky SL, 2017, TRENDS MOL MED, V23, P1047, DOI 10.1016/j.molmed.2017.09.001; Pinkosky SL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13457; Proctor G, 2006, DIABETES, V55, P2502, DOI 10.2337/db05-0603; Ruan XZ, 2009, NAT REV NEPHROL, V5, P713, DOI 10.1038/nrneph.2009.184; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Taneda S, 2003, J AM SOC NEPHROL, V14, P968, DOI 10.1097/01.ASN.0000054498.83125.90; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774; Wang YL, 2012, J AM SOC NEPHROL, V23, P1977, DOI 10.1681/ASN.2012040383; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yuan WH, 2007, J BIOL CHEM, V282, P29821, DOI 10.1074/jbc.M705495200; Zhang Z, 2008, KIDNEY INT, V73, P163, DOI 10.1038/sj.ki.5002572; Zhang ZL, 2008, PROCEEDINGS OF FIRST INTERNATIONAL CONFERENCE OF MODELLING AND SIMULATION, VOL III, P105; Zhao S, 2016, CELL REP, V17, P1037, DOI 10.1016/j.celrep.2016.09.069; ZIYADEH FN, 1994, J CLIN INVEST, V93, P536, DOI 10.1172/JCI117004	49	14	14	4	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9602	9615		10.1096/fj.201900213R	http://dx.doi.org/10.1096/fj.201900213R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31150280	Bronze, Green Published			2022-12-28	WOS:000478832900070
J	Guerrero-Hue, M; Garcia-Caballero, C; Palomino-Antolin, A; Rubio-Navarro, A; Vazquez-Carballo, C; Herencia, C; Martin-Sanchez, D; Farre-Alins, V; Egea, J; Cannata, P; Praga, M; Ortiz, A; Egido, J; Sanz, AB; Moreno, JA				Guerrero-Hue, Melania; Garcia-Caballero, Cristina; Palomino-Antolin, Alejandra; Rubio-Navarro, Alfonso; Vazquez-Carballo, Cristina; Herencia, Carmen; Martin-Sanchez, Diego; Farre-Alins, Victor; Egea, Javier; Cannata, Pablo; Praga, Manuel; Ortiz, Alberto; Egido, Jesus; Belen Sanz, Ana; Antonio Moreno, Juan			Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis-mediated cell death	FASEB JOURNAL			English	Article						acute kidney injury; myoglobin; kidney; oxidative stress	OXIDATIVE STRESS; MOLECULAR-MECHANISMS; HEME OXYGENASE; KIDNEY INJURY; INFLAMMATION; INHIBITION; ROLES; NRF2; MONOCHLOROBIMANE; NEPHROTOXICITY	Acute kidney injury is a common complication of rhabdomyolysis. A better understanding of this syndrome may be useful to identify novel therapeutic targets because there is no specific treatment so far. Ferroptosis is an iron-dependent form of regulated nonapoptotic cell death that is involved in renal injury. In this study, we investigated whether ferroptosis is associated with rhabdomyolysis-mediated renal damage, and we studied the therapeutic effect of curcumin, a powerful antioxidant with renoprotective properties. Induction of rhabdomyolysis in mice increased serum creatinine levels, endothelial damage, inflammatory chemokines, and cytokine expression, alteration of redox balance (increased lipid peroxidation and decreased antioxidant defenses), and tubular cell death. Treatment with curcumin initiated before or after rhabdomyolysis induction ameliorated all these pathologic and molecular alterations. Although apoptosis or receptor-interacting protein kinase (RIPK)3-mediated necroptosis were activated in rhabdomyolysis, our results suggest a key role of ferroptosis. Thus, treatment with ferrostatin 1, a ferroptosis inhibitor, improved renal function in glycerol-injected mice, whereas no beneficial effects were observed with the pan-caspase inhibitor carbobenzoxy-valyl-alanyl-aspartyl-(O-methyl)-fluoromethylketone or in RIPK3-deficient mice. In cultured renal tubular cells, myoglobin (Mb) induced ferroptosis-sensitive cell death that was also inhibited by curcumin. Mechanistic in vitro studies showed that curcumin reduced Mb-mediated inflammation and oxidative stress by inhibiting the TLR4/NF-kappa B axis and activating the cytoprotective enzyme heme oxygenase 1. Our findings are the first to demonstrate the involvement of ferroptosis in rhabdomyolysis-associated renal damage and its sensitivity to curcumin treatment. Therefore, curcumin may be a potential therapeutic approach for patients with this syndrome.-Guerrero-Hue, M., Garcia-Caballero, C., Palomino-Antolin, A., Rubio-Navarro, A., Vazquez-Carballo, C., Herencia, C., Martin-Sanchez, D., Farre-Alins, V., Egea, J., Cannata, P., Praga, M., Ortiz, A., Egido, J., Sanz, A. B., Moreno, J. A. Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis-mediated cell death.	[Guerrero-Hue, Melania; Garcia-Caballero, Cristina; Rubio-Navarro, Alfonso; Vazquez-Carballo, Cristina; Herencia, Carmen; Martin-Sanchez, Diego; Ortiz, Alberto; Egido, Jesus; Belen Sanz, Ana; Antonio Moreno, Juan] Univ Autonoma Madrid, Fdn Jimenez Diaz, Fdn Inst Invest Sanitarias, Renal Vasc & Diabet Res Lab, Madrid, Spain; [Cannata, Pablo] Univ Autonoma Madrid, Fdn Jimenez Diaz, Fdn Inst Invest Sanitarias, Dept Pathol, Madrid, Spain; [Palomino-Antolin, Alejandra; Farre-Alins, Victor; Egea, Javier] Hosp Univ Princesa, IIS, Madrid, Spain; [Palomino-Antolin, Alejandra; Farre-Alins, Victor; Egea, Javier] Univ Autonoma Madrid, Fac Med, Dept Pharmacol & Therapeut, Inst Teofilo Hernando, Madrid, Spain; [Praga, Manuel] 12 Octubre Hosp, Dept Nephrol, Madrid, Spain; [Egido, Jesus] Diabet & Associated Metab Dis Networking Biomed R, Madrid, Spain; [Antonio Moreno, Juan] Univ Cordoba, Maimonides Biomed Res Inst Cordoba IMIBIC, Dept Cell Biol Physiol & Immunol, Carretera Madrid Cordoba,Km 396, E-14071 Cordoba, Spain; [Antonio Moreno, Juan] Biomed Res Networking Ctr Cardiovasc Dis CIBERCV, Madrid, Spain	Autonomous University of Madrid; Fundacion Jimenez Diaz; Autonomous University of Madrid; Fundacion Jimenez Diaz; Hospital de La Princesa; Autonomous University of Madrid; Hospital Universitario 12 de Octubre; Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV	Moreno, JA (corresponding author), Univ Cordoba, Maimonides Biomed Res Inst Cordoba IMIBIC, Dept Cell Biol Physiol & Immunol, Carretera Madrid Cordoba,Km 396, E-14071 Cordoba, Spain.	juan.moreno@uco.es	Sanz, Ana Belen/C-9489-2013; Carballo, Cristina Vázquez/AAR-3324-2021; Rubio, Alfonso/ABH-5028-2020; ortiz, alberto/Y-7582-2018; Moreno, Juan Antonio/B-3487-2018; Herencia, Carmen/AAA-6843-2020; Egea, Javier/A-1694-2008	Sanz, Ana Belen/0000-0002-0255-5689; Carballo, Cristina Vázquez/0000-0002-1551-7913; Rubio, Alfonso/0000-0001-5677-3123; ortiz, alberto/0000-0002-9805-9523; Moreno, Juan Antonio/0000-0002-7468-2871; Guerrero-Hue, Melania/0000-0002-7965-4175; Egea, Javier/0000-0003-4704-3019; FARRE ALINS, VICTOR/0000-0002-6908-1705; Martin-Sanchez, Diego/0000-0001-5066-0873	FIS/FEDER [CP16/00017, PI16/02057, PI17/00130]; Spanish Ministry of Economy and Competitiveness [RYC-2017-22369]; Spanish Society of Nephrology, Fundacion Renal Inigo Alvarcz de Toledo (FRIAT); Instituto de Salud Carlos III (ISCIII)-RETIC REDinREN [RD016/0009]; Comunidad de Madrid CIFRA2 [B2017/BMD-3686]; Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM); Fundacion Conchita Rabago	FIS/FEDER(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Society of Nephrology, Fundacion Renal Inigo Alvarcz de Toledo (FRIAT); Instituto de Salud Carlos III (ISCIII)-RETIC REDinREN; Comunidad de Madrid CIFRA2(Comunidad de Madrid); Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM); Fundacion Conchita Rabago	This work was supported by grants from FIS/FEDER (CP16/00017, PI16/02057, and PI17/00130), the Spanish Ministry of Economy and Competitiveness (RYC-2017-22369), the Spanish Society of Nephrology, Fundacion Renal Inigo Alvarcz de Toledo (FRIAT), the Instituto de Salud Carlos III (ISCIII)-RETIC REDinREN (RD016/0009), the Comunidad de Madrid CIFRA2 (B2017/BMD-3686), the Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), and the Fundacion Conchita Rabago. The authors declare no conflicts of interest.	Abella V, 2015, BIOMARKERS, V20, P565, DOI 10.3109/1354750X.2015.1123354; Adedoyin O, 2018, AM J PHYSIOL-RENAL, V314, pF702, DOI 10.1152/ajprenal.00044.2017; Ahmed SMU, 2017, BBA-MOL BASIS DIS, V1863, P585, DOI 10.1016/j.bbadis.2016.11.005; Anders HJ, 2004, J AM SOC NEPHROL, V15, P854, DOI 10.1097/01.ASN.0000121781.89599.16; Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Bagley WH, 2007, INTERN EMERG MED, V2, P210, DOI 10.1007/s11739-007-0060-8; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Bayrak O, 2008, WORLD J UROL, V26, P285, DOI 10.1007/s00345-008-0253-4; Bosch X, 2009, NEW ENGL J MED, V361, P62, DOI 10.1056/NEJMra0801327; Chen M.S., 2017, ONCOTARGET, V8, DOI [10.18632/oncotarget.23055, DOI 10.18632/ONCOTARGET.23055]; Chen XL, 2017, CELL PHYSIOL BIOCHEM, V43, P2143, DOI 10.1159/000484233; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Dinkova-Kostova AT, 2008, MOL NUTR FOOD RES, V52, pS128, DOI 10.1002/mnfr.200700195; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; FERNANDEZCHECA JC, 1990, ANAL BIOCHEM, V190, P212, DOI 10.1016/0003-2697(90)90183-A; Ghosh SS, 2012, AM J PHYSIOL-RENAL, V302, pF439, DOI 10.1152/ajprenal.00356.2010; Guerrero-Hues M, 2017, CURR MED CHEM, V24, P3583, DOI 10.2174/0929867324666170511120814; He LY, 2015, CAN J PHYSIOL PHARM, V93, P275, DOI 10.1139/cjpp-2014-0459; Homsi E, 2006, KIDNEY INT, V69, P1385, DOI 10.1038/sj.ki.5000315; Homsi E, 2015, AM J PHYSIOL-RENAL, V308, pF1259, DOI 10.1152/ajprenal.00311.2014; Hosohata K, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111826; Huang RS, 2017, CHINESE MED J-PEKING, V130, P2163, DOI 10.4103/0366-6999.213406; Kamencic H, 2000, ANAL BIOCHEM, V286, P35, DOI 10.1006/abio.2000.4765; Kim JH, 2010, NEPHROL DIAL TRANSPL, V25, P1435, DOI 10.1093/ndt/gfp659; Komada T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10901; Kuhad A, 2007, J AGR FOOD CHEM, V55, P10150, DOI 10.1021/jf0723965; Linkermann A, 2014, J AM SOC NEPHROL, V25, P2689, DOI 10.1681/ASN.2014030262; Linkermann A, 2014, P NATL ACAD SCI USA, V111, P16836, DOI 10.1073/pnas.1415518111; Linkermann A, 2014, NAT REV IMMUNOL, V14, P759, DOI 10.1038/nri3743; Lytle C, 1995, AM J PHYSIOL-CELL PH, V269, pC1496, DOI 10.1152/ajpcell.1995.269.6.C1496; Martin-Sanchez D, 2018, P NATL ACAD SCI USA, V115, P4182, DOI 10.1073/pnas.1716578115; Martin-Sanchez D, 2017, J AM SOC NEPHROL, V28, P218, DOI 10.1681/ASN.2015121376; Min XY, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4013685; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Ortega-Dominguez B, 2017, FOOD CHEM TOXICOL, V107, P373, DOI 10.1016/j.fct.2017.07.018; Panizo N, 2015, KIDNEY BLOOD PRESS R, V40, P520, DOI 10.1159/000368528; Plotnikov EY, 2009, BBA-MOL BASIS DIS, V1792, P796, DOI 10.1016/j.bbadis.2009.06.005; Poveda J, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.89; Reeder BJ, 2005, CURR MED CHEM, V12, P2741, DOI 10.2174/092986705774463021; Roh JL, 2017, REDOX BIOL, V11, P254, DOI 10.1016/j.redox.2016.12.010; Rubio-Navarro A, 2016, THERANOSTICS, V6, P896, DOI 10.7150/thno.14915; Sanz AB, 2008, J AM SOC NEPHROL, V19, P695, DOI 10.1681/ASN.2007050577; Small DM, 2012, NEPHRON EXP NEPHROL, V122, P123, DOI 10.1159/000350726; Soetikno V, 2013, MOL NUTR FOOD RES, V57, P1649, DOI 10.1002/mnfr.201200540; STOCKER R, 1990, FREE RADICAL RES COM, V9, P101, DOI 10.3109/10715769009148577; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Sun XF, 2016, HEPATOLOGY, V63, P173, DOI 10.1002/hep.28251; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Trujillo J, 2013, REDOX BIOL, V1, P448, DOI 10.1016/j.redox.2013.09.003; Vlahovic P, 2007, FOOD CHEM TOXICOL, V45, P1777, DOI 10.1016/j.fct.2007.04.004; VOGT BA, 1995, LAB INVEST, V72, P474; Wagener FADTG, 1997, P SOC EXP BIOL MED, V216, P456; Wu JD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10693-4; Wu TK, 2015, MOL MED REP, V12, P6086, DOI 10.3892/mmr.2015.4167; Wu XN, 2014, CELL DEATH DIFFER, V21, P1709, DOI 10.1038/cdd.2014.77; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yeh JH, 2013, TRANSPL P, V45, P3542, DOI 10.1016/j.transproceed.2013.09.004; Youn HS, 2006, BIOCHEM PHARMACOL, V72, P62, DOI 10.1016/j.bcp.2006.03.022; Zager RA, 2004, KIDNEY INT, V65, P2123, DOI 10.1111/j.1523-1755.2004.00638.x; Zorova LD, 2016, CHEM-BIOL INTERACT, V256, P64, DOI 10.1016/j.cbi.2016.06.020; Zutt R, 2014, NEUROMUSCULAR DISORD, V24, P651, DOI 10.1016/j.nmd.2014.05.005	62	90	96	4	55	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					8961	8975		10.1096/fj.201900077R	http://dx.doi.org/10.1096/fj.201900077R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31034781				2022-12-28	WOS:000478832900022
J	Takita, S; Miyamoto-Matsui, K; Seko, Y				Takita, Shimpei; Miyamoto-Matsui, Kiyoko; Seko, Yuko			Intra- and interspecies comparison of EYS transcripts highlights its characteristics in the eye	FASEB JOURNAL			English	Article						HDF-a; Y79; zebrafish eye; domain structure; photoreceptors	ORTHOLOG; MUTATIONS; VARIANTS; PROTEINS; GENE	Inherited mutations in the eyes shut homolog (EYS) gene cause retinitis pigmentosa. Although knock out of eys in zebrafish is pathogenic, the molecular function of EYS in vertebrate photoreceptors is poorly understood. Here, we show that the 5 ' portion of EYS is eye-specific across vertebrates. We previously determined that a 3 ' fragment of EYS with an unknown transcription start site is expressed in human dermal fibroblasts (HDF). To obtain insights into the molecular function of EYS in vertebrate photoreceptors, we extensively analyzed EYS (eys) expression in the human fibroblast cell line HDF-adult (HDF-a), the Y79 retinoblastoma cell line, and in zebrafish eyes using rapid amplification of cDNA end, cap analysis of gene expression, RNA sequencing, and RT-PCR. In HDF-a cells, we identified a novel transcript variant (tv), tv5, transcribed from exon 37. In Y79 cells and zebrafish eyes, EYS (eys) was predominantly transcribed from exon 1 or 2, whereas it was transcribed exclusively from exon 37 in HDF-a cells. In the zebrafish eye, there were splice variants that introduced stop codons, resulting in complete loss of the 3 ' portion of the RNA. These comparative approaches indicate that the 5 ' portion of the EYS (eys) mRNA appears to be photoreceptor-specific and that the compositions of the deduced EYS proteins in the eye are well-conserved across vertebrates.-Takita, S., Miyamoto-Matsui, K., Seko, Y. Intra- and interspecies comparison of EYS transcripts highlights its characteristics in the eye.	[Takita, Shimpei; Miyamoto-Matsui, Kiyoko; Seko, Yuko] Natl Rehabil Ctr Persons Disabil, Visual Funct Sect, Dept Rehabil Sensory Funct, Res Inst, Tokorozawa, Saitama, Japan		Seko, Y (corresponding author), Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Sensory Funct, 4-1 Namiki, Tokorozawa, Saitama 3598555, Japan.	seko-yuko@rehab.go.jp		Takita, Shimpei/0000-0002-7790-3115	JSPS KAKENHI [15H04998, 17K16995]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Prof. H. Kimura and Prof. Y. Sato (both Tokyo Institute of Technology, Tokyo, Japan) for providing zebrafish AB strain. The authors also thank Dr. Y. Shimokawa (Tokyo Medical and Dental University, Tokyo, Japan) for technical assistance in the initial course of the study. This work was supported by JSPS KAKENHI Grants 15H04998 (to Y.S.) and 17K16995 (to S.T.). The authors thank Dr. S. Kato (National Rehabilitation Center for Persons with Disabilities, Tokorozawa, Japan) for helpful comments on the manuscript. The authors declare no conflicts of interest.	Abd El-Aziz MM, 2008, NAT GENET, V40, P1285, DOI 10.1038/ng.241; Alfano G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166397; Arai Y, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/819760; Collin RWJ, 2008, AM J HUM GENET, V83, P594, DOI 10.1016/j.ajhg.2008.10.014; Di YA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19432; Francis PJ, 2006, J ROY SOC MED, V99, P189, DOI 10.1258/jrsm.99.4.189; Gu S, 2016, MOL VIS, V22, P646; Hosono K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031036; Isackson PJ, 2011, MUSCLE NERVE, V44, P531, DOI 10.1002/mus.22115; Iwanami M, 2012, INVEST OPHTH VIS SCI, V53, P1033, DOI 10.1167/iovs.11-9048; Letunic I, 2018, NUCLEIC ACIDS RES, V46, pD493, DOI 10.1093/nar/gkx922; Liu WZ, 2015, BIOINFORMATICS, V31, P3359, DOI 10.1093/bioinformatics/btv362; Lu ZJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep46098; Messchaert M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200789; Messchaert M, 2018, HUM MUTAT, V39, P177, DOI 10.1002/humu.23371; Nie J, 2012, DEV BIOL, V371, P312, DOI 10.1016/j.ydbio.2012.08.024; Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6; Noguchi S, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.112; Seko Y, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1016-9; Takita S, 2016, SCI REP-UK, V6, DOI 10.1038/srep36590; Udagawa C, 2018, CANCER SCI, V109, P446, DOI 10.1111/cas.13471; Yu M, 2016, BIOL OPEN, V5, P1662, DOI 10.1242/bio.021584; Zelhof AC, 2006, NATURE, V443, P696, DOI 10.1038/nature05128	23	4	4	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9422	9433		10.1096/fj.201900056RR	http://dx.doi.org/10.1096/fj.201900056RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31120796				2022-12-28	WOS:000478832900056
J	Maehara, T; Nakamura, T; Maeda, S; Aritake, K; Nakamura, M; Murata, T				Maehara, Toko; Nakamura, Tatsuro; Maeda, Shingo; Aritake, Kosuke; Nakamura, Masataka; Murata, Takahisa			Epithelial cell-derived prostaglandin D-2 inhibits chronic allergic lung inflammation in mice	FASEB JOURNAL			English	Article						allergy; eosinophil; 15d-PGJ(2); DP receptor	RECEPTOR ANTAGONIST; CYTOKINE PRODUCTION; ASTHMA; ACTIVATION; MECHANISMS; EXPRESSION; MEDIATORS; EFFICACY; RELEASE; ALPHA	The precise role of prostaglandin D (PGD)(2) in allergic lung inflammation remains controversial. Here, we aimed to clarify the role of PGD(2) in chronic allergic lung inflammation using hematopoietic PGD synthase (H-PGDS)-deficient mice. Repeated intranasal administration of ovalbumin (OVA) resulted in eosinophilic infiltration and mucin production in the lungs of wild type (WT) mice, leading to respiratory dysfunction. H-PGDS deficiency exacerbated these effects, which were accompanied by increased mRNA expression of TNF-alpha and eosinophil chemoattractants. The bronchial epithelium expressed both H-PGDS and TNF-alpha in the inflamed WT lung, and H-PGDS deficiency increased TNF-alpha expression further. In cultured bronchial tissue of WT mice, treatment with LPS elevated mRNA expression of TNF-alpha and eosinophil chemoattractants. H-PGDS deficiency promoted the expression of these factors, which was inhibited by treatment with PGD(2) receptor, D prostanoid (DP) receptor agonist, or PGD(2) metabolite 15-deoxy-Delta(12,14)-PGJ(2) (15d-PGJ(2)). Treatment with TNF-alpha receptor antibody inhibited eosinophil chemoattractant expression. In vivo, administration of DP agonist or 15d-PGJ(2) inhibited OVA-induced allergic lung inflammation. Bronchial epithelial cell-derived PGD(2) attenuated lung eosinophilic infiltration with chronic allergic inflammation; these phenomena are at least partly attributed to the inhibition of TNF-alpha production via DP activation or 15-deoxy-Delta(12,14)-PGJ(2) signaling.-Maehara, T., Nakamura, T., Maeda, S., Aritake, K., Nakamura, M., Murata, T. Epithelial cell-derived prostaglandin D-2 inhibits chronic allergic lung inflammation in mice.	[Maehara, Toko; Nakamura, Tatsuro; Maeda, Shingo; Murata, Takahisa] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Radiol, Tokyo, Japan; [Maehara, Toko] Osaka Univ Pharmaceut Sci, Dept Pathobiochem, Osaka, Japan; [Aritake, Kosuke] Daiichi Univ Pharm, Lab Chem Pharmacol, Fukuoka, Fukuoka, Japan; [Nakamura, Masataka] Tokyo Med & Dent Univ, Human Gene Sci Ctr, Tokyo, Japan	University of Tokyo; Osaka University of Pharmaceutical Sciences; Tokyo Medical & Dental University (TMDU)	Murata, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Radiol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amurata@mail.ecc.u-tokyo.ac.jp		Murata, Takahisa/0000-0002-3328-0796	Japan Society for the Promotion of Science [18H06117, 18K14603, 17H01509, 17H06252]; Novartis Foundation for the Promotion of Science; Nipponham Foundation; Hoyu Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Novartis Foundation for the Promotion of Science; Nipponham Foundation; Hoyu Science Foundation	This work was supported by a grant-in-aid from the Japan Society for the Promotion of Science (18H06117 to T.Ma., 18K14603 to T.N., 17H01509 to T.Mu., and 17H06252 to T.Mu.); and the Novartis Foundation for the Promotion of Science, the Nipponham Foundation, and the Hoyu Science Foundation (to T.Mu). The authors declare no conflicts of interest.	Andreakos E, 2004, BLOOD, V103, P2229, DOI 10.1182/blood-2003-04-1356; Angeli W, 2004, J IMMUNOL, V172, P3822, DOI 10.4049/jimmunol.172.6.3822; Arimura A, 2001, J PHARMACOL EXP THER, V298, P411; Busse WW, 2013, J ALLERGY CLIN IMMUN, V131, P339, DOI 10.1016/j.jaci.2012.10.013; Fajt ML, 2013, J ALLERGY CLIN IMMUN, V131, P1504, DOI 10.1016/j.jaci.2013.01.035; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Hall IP, 2015, PULM PHARMACOL THER, V32, P37, DOI 10.1016/j.pupt.2015.03.003; Hammad H, 2007, J EXP MED, V204, P357, DOI 10.1084/jem.20061196; Howarth PH, 2005, THORAX, V60, P1012, DOI 10.1136/thx.2005.045260; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kobayashi I, 2004, ANN ALLERG ASTHMA IM, V93, P390, DOI 10.1016/S1081-1206(10)61399-3; Kobayashi K, 2016, SCI REP-UK, V6, DOI 10.1038/srep32109; Kobayashi K, 2013, ARTERIOSCL THROM VAS, V33, P565, DOI 10.1161/ATVBAHA.112.300993; Kochanek Kenneth D, 2016, Natl Vital Stat Rep, V65, P1; LARIVEE P, 1994, AM J RESP CELL MOL, V11, P199, DOI 10.1165/ajrcmb.11.2.8049080; Lennon AM, 2002, J BIOL CHEM, V277, P29681, DOI 10.1074/jbc.M201517200; LEVINE SJ, 1995, AM J RESP CELL MOL, V12, P196, DOI 10.1165/ajrcmb.12.2.7865217; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; Mohri I, 2006, J NEUROSCI, V26, P4383, DOI 10.1523/JNEUROSCI.4531-05.2006; Murata T, 2013, P NATL ACAD SCI USA, V110, P5205, DOI 10.1073/pnas.1218091110; MURRAY JJ, 1986, NEW ENGL J MED, V315, P800, DOI 10.1056/NEJM198609253151304; Nakae S, 2007, J ALLERGY CLIN IMMUN, V120, P48, DOI 10.1016/j.jaci.2007.02.046; Nakamura T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8514; Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; Paplinska-Goryce M, 2012, ACTA BIOCHIM POL, V59, P371; Pawankar R, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-12; RAIBLE DG, 1992, J IMMUNOL, V148, P3536; Satoh T, 2006, J IMMUNOL, V177, P2621, DOI 10.4049/jimmunol.177.4.2621; Shinagawa K, 2003, INT ARCH ALLERGY IMM, V130, P150, DOI 10.1159/000069005; SPERBER K, 1991, J ALLERGY CLIN IMMUN, V87, P490, DOI 10.1016/0091-6749(91)90007-B; Wall EA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000202; Zhang Y, 2003, FASEB J, V17, P734, DOI 10.1096/fj.02-0962fje	32	7	8	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8202	8210		10.1096/fj.201802817R	http://dx.doi.org/10.1096/fj.201802817R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	31018708	Bronze			2022-12-28	WOS:000476234700032
J	Liu, CH; Abrams, ND; Carrick, DM; Chander, P; Dwyer, J; Hamlet, MRJ; Kindzelski, AL; PrabhuDas, M; Tsai, SYA; Vedamony, MM; Wang, CY; Tandon, P				Liu, Christina H.; Abrams, Natalie D.; Carrick, Danielle M.; Chander, Preethi; Dwyer, Johanna; Hamlet, Michelle R. J.; Kindzelski, Andrei L.; PrabhuDas, Mercy; Tsai, Shang-Yi Anne; Vedamony, Merriline M.; Wang, Chiayeng; Tandon, Pushpa			Imaging inflammation and its resolution in health and disease: current status, clinical needs, challenges, and opportunities	FASEB JOURNAL			English	Review						molecular imaging; in vivo; clinical translation; chronic inflammation; inflammatory status	HYPERPOLARIZED C-13 DEHYDROASCORBATE; MAGNETIC-RESONANCE-SPECTROSCOPY; OXIDATIVE STRESS; CELL ACTIVATION; RISK; PET; NEUROINFLAMMATION; HIV; ATHEROSCLEROSIS; PROGRESSION	Inflammation is a normal process in our body; acute inflammation acts to suppress infections and support wound healing. Chronic inflammation likely leads to a wide range of diseases, including cancer. Tools to locate and monitor inflammation are critical for developing effective interventions to arrest inflammation and promote its resolution. To identify current clinical needs, challenges, and opportunities in advancing imaging-based evaluations of inflammatory status in patients, the U.S. National Institutes of Health convened a workshop on imaging inflammation and its resolution in health and disease. Clinical speakers described their needs for image-based capabilities that could help determine the extent of inflammatory conditions in patients to guide treatment planning and undertake necessary interventions. The imaging speakers showcased the state-of-the-art in vivo imaging techniques for detecting inflammation in different disease areas. Many imaging capabilities developed for 1 organ or disease can be adapted for other diseases and organs, whereas some have promise for clinical utility within the next 5-10 yr. Several speakers demonstrated that multimodal imaging measurements integrated with serum-based measures could improve in robustness for clinical utility. All speakers agreed that multiple inflammatory measures should be acquired longitudinally to comprehend the dynamics of unresolved inflammation that leads to disease development. They also agreed that the best strategies for accelerating clinical translation of imaging inflammation capabilities are through integration between new imaging techniques and biofluid-based biomarkers of inflammation as well as already established imaging measurements.	[Liu, Christina H.; Abrams, Natalie D.; Carrick, Danielle M.; Tandon, Pushpa] NCI, NIH, 9609 Med Ctr Dr,Room 4W216, Rockville, MD 20850 USA; [PrabhuDas, Mercy; Vedamony, Merriline M.] NIAID, NIH, Rockville, MD USA; [Tsai, Shang-Yi Anne] NIDA, NIH, Rockville, MD USA; [Chander, Preethi; Wang, Chiayeng] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD USA; [Dwyer, Johanna] NIH, Off Dietary Supplements, Bldg 10, Bethesda, MD 20892 USA; [Hamlet, Michelle R. J.] NINR, NIH, Bethesda, MD 20892 USA; [Kindzelski, Andrei L.] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Nursing Research (NINR); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Liu, CH (corresponding author), NCI, NIH, 9609 Med Ctr Dr,Room 4W216, Rockville, MD 20850 USA.	liuch2@mail.nih.gov	Abrams, Natalie/AAM-5468-2021; Dwyer, Johanna/AAI-5027-2020	Abrams, Natalie/0000-0001-9698-2819; Liu, Christina/0000-0002-5723-177X				Abd-Elmoniem KZ, 2014, CLIN INFECT DIS, V59, P1779, DOI 10.1093/cid/ciu672; [Anonymous], JACC CARDIOVASC IMAG; Bang SS, 2018, J CLIN INVEST, V128, P3568, DOI 10.1172/JCI99888; Beaver JA, 2018, LANCET ONCOL, V19, P229, DOI 10.1016/S1470-2045(17)30846-X; Bekkering S, 2016, ATHEROSCLEROSIS, V254, P228, DOI 10.1016/j.atherosclerosis.2016.10.019; Beller E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17533-5; Blumenthal GM, 2017, JAMA ONCOL, V3, P1473, DOI 10.1001/jamaoncol.2017.1819; Boccara F, 2013, J AM COLL CARDIOL, V61, P511, DOI 10.1016/j.jacc.2012.06.063; Bogdanov A, 2002, MOL IMAGING, V1, P16, DOI 10.1162/153535002753395671; Chang LD, 2013, J NEUROIMMUNE PHARM, V8, P576, DOI 10.1007/s11481-013-9460-x; Chiou VL, 2015, J CLIN ONCOL, V33, P3541, DOI 10.1200/JCO.2015.61.6870; Cipriano PW, 2018, J NUCL MED, V59, P967, DOI 10.2967/jnumed.117.198259; Cipriano PW, 2018, J PAIN RES, V11, P2353, DOI 10.2147/JPR.S167839; Colas L, 2018, GLIA, V66, P1611, DOI 10.1002/glia.23326; Corcia P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052941; Coughlin JM, 2019, NEUROBIOL DIS, V131, DOI 10.1016/j.nbd.2019.03.016; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Deng FG, 2018, CLIN RESPIR J, V12, P1118, DOI 10.1111/crj.12639; Desai MY, 2019, CARDIOVASC RES, V115, pE3, DOI 10.1093/cvr/cvy282; Duarte-Salles T, 2016, CANCER PREV RES, V9, P758, DOI 10.1158/1940-6207.CAPR-15-0434; Dweck MR, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2017.127; Emami H, 2015, JACC-CARDIOVASC IMAG, V8, P121, DOI 10.1016/j.jcmg.2014.10.009; Fayad ZA, 2018, J AM COLL CARDIOL, V72, P2198, DOI 10.1016/j.jacc.2018.08.2150; Geeraerts X, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00289; Geovanini GR, 2018, CLIN SCI, V132, P1243, DOI 10.1042/CS20180306; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Gilligan MM, 2019, P NATL ACAD SCI USA, V116, P6292, DOI 10.1073/pnas.1804000116; Grobman M, 2018, VET RADIOL ULTRASOUN, V59, P107, DOI 10.1111/vru.12562; Guedeney P, 2019, J AM COLL CARDIOL, V73, P2401, DOI 10.1016/j.jacc.2019.01.077; Hebert JR, 2019, ADV NUTR, V10, P185, DOI 10.1093/advances/nmy071; Hess S, 2015, CLIN NUCL MED, V40, pE23, DOI 10.1097/RLU.0000000000000453; Hodi FS, 2018, LANCET ONCOL, V19, P1480, DOI 10.1016/S1470-2045(18)30700-9; Horti AG, 2019, P NATL ACAD SCI USA, V116, P1686, DOI 10.1073/pnas.1812155116; Horti AG, 2016, J NUCL MED, V57, P1817, DOI 10.2967/jnumed.116.173245; Ji RR, 2014, NAT REV DRUG DISCOV, V13, P533, DOI 10.1038/nrd4334; Jo JG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15147-5; Keshari KR, 2015, DIABETES, V64, P344, DOI 10.2337/db13-1829; Keshari KR, 2014, CHEM SOC REV, V43, P1627, DOI 10.1039/c3cs60124b; Keshari KR, 2011, P NATL ACAD SCI USA, V108, P18606, DOI 10.1073/pnas.1106920108; Kheirouri S, 2019, ADV NUTR, V10, P9, DOI 10.1093/advances/nmy100; Lang S, 2010, AIDS, V24, P1228, DOI 10.1097/QAD.0b013e328339192f; LeBlanc AK, 2016, CLIN CANCER RES, V22, P2133, DOI 10.1158/1078-0432.CCR-15-2347; Lentz MR, 2008, MAGN RESON MED, V59, P475, DOI 10.1002/mrm.21556; Liu CH, 2017, NAT IMMUNOL, V18, P1175, DOI 10.1038/ni.3828; Liu ZY, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aap9302; Loggia ML, 2015, BRAIN, V138, P604, DOI 10.1093/brain/awu377; Loomba R, 2014, HEPATOLOGY, V60, P1920, DOI 10.1002/hep.27362; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Miloushev VZ, 2018, CANCER RES, V78, P3755, DOI 10.1158/0008-5472.CAN-18-0221; Notter T, 2018, MOL PSYCHIATR, V23, P36, DOI 10.1038/mp.2017.232; Notter T, 2018, MOL PSYCHIATR, V23, P323, DOI 10.1038/mp.2016.248; Pouli D, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag2202; Qin H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26296-6; Rabinovich A, 2015, J VASC SURG-VENOUS L, V3, P347, DOI 10.1016/j.jvsv.2015.04.005; Ratai EM, 2018, NEUROIMAGE-CLIN, V20, P357, DOI 10.1016/j.nicl.2018.08.007; Ren Q, 2018, P NATL ACAD SCI USA, V115, pE5815, DOI 10.1073/pnas.1802179115; Ridker PM, 2017, CIRC RES, V120, P617, DOI 10.1161/CIRCRESAHA.116.310527; Rondina MT, 2012, CLIN NUCL MED, V37, P1139, DOI 10.1097/RLU.0b013e3182638934; Serhan CN, 2018, J IMMUNOL, V201, P3161, DOI 10.4049/jimmunol.1800806; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shivappa N, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020200; Shivappa N, 2017, NUTRIENTS, V9, DOI 10.3390/nu9091043; Tabung FK, 2015, ANN EPIDEMIOL, V25, P398, DOI 10.1016/j.annepidem.2015.03.009; Tarkin JM, 2017, J AM COLL CARDIOL, V69, P1774, DOI 10.1016/j.jacc.2017.01.060; Tawakol A, 2017, LANCET, V389, P834, DOI 10.1016/S0140-6736(16)31714-7; Tee SS, 2015, CANCER J, V21, P165, DOI 10.1097/PPO.0000000000000111; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.nbd.2003.12.012; Uderhardt S, 2019, CELL, V177, P541, DOI 10.1016/j.cell.2019.02.028; Uva P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-135; van der Pol CB, 2019, GASTROENTEROLOGY, V156, P976, DOI 10.1053/j.gastro.2018.11.020; Varone A, 2014, CANCER RES, V74, P3067, DOI 10.1158/0008-5472.CAN-13-2713; Wadghiri YZ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25804-y; Wang XD, 2003, NAT BIOTECHNOL, V21, P803, DOI 10.1038/nbt839; Wilson DM, 2017, SCI REP-UK, V7, DOI 10.1038/srep46014; Wolchok JD, 2017, NEW ENGL J MED, V377, P2503; Wong RJ, 2014, LIVER TRANSPLANT, V20, P1454, DOI 10.1002/lt.23981; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624; Yuan J, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.8.086001; Zhu YH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28131-4	80	6	6	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13085	13097		10.1096/fj.201902024	http://dx.doi.org/10.1096/fj.201902024			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31577913	Green Published, Bronze			2022-12-28	WOS:000507466100006
J	Chau, DDL; Yung, KWY; Chan, WWL; An, Y; Hao, Y; Chan, HYE; Ngo, JCK; Lau, KF				Chau, Dennis Dik-Long; Yung, Kristen Wing-Yu; Chan, William Wai-Lun; An, Ying; Hao, Yan; Chan, Ho-Yin Edwin; Ngo, Jacky Chi-Ki; Lau, Kwok-Fai			Attenuation of amyloid-beta generation by atypical protein kinase C-mediated phosphorylation of engulfment adaptor PTB domain containing 1 threonine 35	FASEB JOURNAL			English	Article						Alzheimer's disease; GULP1; amyloid precursor protein	PRECURSOR PROTEIN; A-BETA; ALZHEIMERS-DISEASE; PKC-ZETA; INTRACELLULAR DOMAIN; NEURITE OUTGROWTH; INSULIN; FE65; APP; ACTIVATION	Amyloid-beta (A beta) is derived from the proteolytic processing of amyloid precursor protein (APP), and the deposition of extracellular A beta to form amyloid plaques is a pathologic hallmark of Alzheimer's disease (AD). Although reducing A beta generation and accumulation has been proposed as a means of treating the disease, adverse side effects and unsatisfactory efficacy have been reported in several clinical trials that sought to lower A beta levels. Engulfment adaptor phosphotyrosine-binding (PTB) domain containing 1 (GULP1) is a molecular adaptor that has been shown to interact with APP to alter A beta production. Therefore, the modulation of the GULP1-APP interaction maybe an alternative approach to reducing A beta. However, the mechanisms that regulate GULP1-APP binding remain elusive. As GULP1 is a phosphoprotein, and because phosphorylation is a common mechanism that regulates protein interaction, we anticipated that GULP1 phosphorylation would influence GULP1-APP interaction and thereby A beta production. We show here that the phosphorylation of GULP1 threonine 35 (T35) reduces GULP1-APP interaction and suppresses the stimulatory effect of GULP1 on APP processing. The residue is phosphorylated by an isoform of atypical PKC (PKC zeta). Overexpression of PKC zeta reduces both GULP1-APP interaction and GULP1-mediated A beta generation. Moreover, the activation of PKC zeta via insulin suppresses APP processing. In contrast, GULP1-mediated APP processing is enhanced in PKC zeta knockout cells. Similarly, PKC iota, another member of atypical PKC, also decreases GULP1-mediated APP processing. Intriguingly, our X-ray crystal structure of GULP1 PTB-APP intracellular domain (AICD) peptide reveals that GULP1 T35 is not located at the GULP1-AICD binding interface; rather, it immediately precedes the beta 1-alpha 2 loop that forms a portion of the binding groove for the APP helix alpha C. Phosphorylating the residue may induce an allosteric effect on the conformation of the binding groove. Our results indicate that GULP1 T35 phosphorylation is a mechanism for the regulation of GULP1-APP interaction and thereby APP processing. Moreover, the activation of atypical PKC, such as by insulin, may confer a beneficial effect on AD by lowering GULP1-mediated A beta production.	[Chau, Dennis Dik-Long; Yung, Kristen Wing-Yu; Chan, William Wai-Lun; An, Ying; Hao, Yan; Chan, Ho-Yin Edwin; Ngo, Jacky Chi-Ki; Lau, Kwok-Fai] Chinese Univ Hong Kong, Sch Life Sci, Fac Sci, Hong Kong, Peoples R China	Chinese University of Hong Kong	Ngo, JCK; Lau, KF (corresponding author), Chinese Univ Hong Kong, Fac Sci, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	jackyngo@cuhk.edu.hk; kflau@cuhk.edu.hk	Chan, Edwin/A-9478-2011; An, Ying/GQP-4457-2022; Ngo, Jacky Chi Ki/O-8093-2017	Chan, Edwin/0000-0003-4307-474X; Ngo, Jacky Chi Ki/0000-0002-6004-7041; Lau, Kwok-Fai/0000-0002-0193-1152; Yung, Kristen Wing Yu/0000-0001-7389-3012	Health and Medical Research Fund of Hong Kong; Research Grants Council Hong Kong; Chinese University of Hong Kong (CUHK) Direct Grant Scheme; United College Endowment Fund; TUYF Charitable Trust	Health and Medical Research Fund of Hong Kong; Research Grants Council Hong Kong(Hong Kong Research Grants Council); Chinese University of Hong Kong (CUHK) Direct Grant Scheme; United College Endowment Fund; TUYF Charitable Trust	The authors thank Tommaso Russo (University of Naples Federico II, Naples, Italy) for pRc-CMV-APP695, and Kodi Ravichandran (University of Virginia, Charlottesville, Virginia, USA) for pEBB GULP1. This work was supported by funds from the Health and Medical Research Fund of Hong Kong, the Research Grants Council Hong Kong, The Chinese University of Hong Kong (CUHK) Direct Grant Scheme, United College Endowment Fund and the TUYF Charitable Trust. The authors declare no conflicts of interest.	Aboitiz F, 2002, BRAIN RES BULL, V57, P481, DOI 10.1016/S0361-9230(01)00681-5; Arnold SE, 2018, NAT REV NEUROL, V14, P168, DOI 10.1038/nrneurol.2017.185; Asadbegi M, 2016, BRAIN RES BULL, V121, P178, DOI 10.1016/j.brainresbull.2016.02.005; Bandyopadhyay G, 1997, J BIOL CHEM, V272, P2551; Beeson M, 2003, DIABETES, V52, P1926, DOI 10.2337/diabetes.52.8.1926; Besancon R, 1998, Hum Mutat, V11, P481, DOI 10.1002/(SICI)1098-1004(1998)11:6<481::AID-HUMU13>3.0.CO;2-N; Beyer AS, 2012, NEUROBIOL AGING, V33, P732, DOI 10.1016/j.neurobiolaging.2010.06.006; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Bredeston LM, 2002, BIOCHEM J, V361, P355, DOI 10.1042/0264-6021:3610355; Bukhari H, 2017, PROG NEUROBIOL, V156, P189, DOI 10.1016/j.pneurobio.2017.05.005; Buoso E, 2010, PHARMACOL RES, V62, P308, DOI 10.1016/j.phrs.2010.05.002; Cantin GT, 2008, J PROTEOME RES, V7, P1346, DOI 10.1021/pr0705441; Chaufty J, 2012, J NEUROSCI, V32, P9613, DOI 10.1523/JNEUROSCI.0602-12.2012; Chen RQ, 2009, CANCER RES, V69, P2663, DOI 10.1158/0008-5472.CAN-08-3222; Chow WNV, 2015, BIOCHEM J, V470, P303, DOI 10.1042/BJ20141485; Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200; Colombo A, 2009, NEUROBIOL DIS, V33, P518, DOI 10.1016/j.nbd.2008.12.014; Crary JF, 2006, J NEUROPATH EXP NEUR, V65, P319, DOI 10.1097/01.jnen.0000218442.07664.04; Devi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032792; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Drummond ML, 2016, J MOL BIOL, V428, P1455, DOI 10.1016/j.jmb.2016.03.003; Dunning CJR, 2016, J NEUROCHEM, V137, P518, DOI 10.1111/jnc.13571; Edreira MM, 2009, J BIOL CHEM, V284, P27480, DOI 10.1074/jbc.M109.011312; Frankland PW, 2013, NATURE, V493, P312, DOI 10.1038/nature11850; Gianni D, 2003, J BIOL CHEM, V278, P9290, DOI 10.1074/jbc.M211899200; Glanzman David L, 2013, F1000 Biol Rep, V5, P4, DOI 10.3410/B5-4; Goldberg M, 1996, BIOCHEM PHARMACOL, V51, P1089, DOI 10.1016/0006-2952(96)00046-9; Greer YE, 2013, J BIOL CHEM, V288, P9438, DOI 10.1074/jbc.M112.448282; Guenette S, 2006, EMBO J, V25, P420, DOI 10.1038/sj.emboj.7600926; Gunaratne A, 2013, MOL CELL BIOL, V33, P874, DOI 10.1128/MCB.00837-12; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hao Y, 2011, BIOCHEM J, V437, P576, DOI 10.1042/BJ4370576; Ho A, 2008, J NEUROSCI, V28, P14392, DOI 10.1523/JNEUROSCI.2481-08.2008; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kelly MT, 2007, J NEUROSCI, V27, P3439, DOI 10.1523/JNEUROSCI.5612-06.2007; Khodosevich K, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-18; Kim YB, 2003, DIABETES, V52, P1935, DOI 10.2337/diabetes.52.8.1935; Kiss RS, 2006, J BIOL CHEM, V281, P12081, DOI 10.1074/jbc.M600621200; Koo EH, 1997, MOL MED, V3, P204, DOI 10.1007/BF03401673; Lau KF, 2002, MOL CELL NEUROSCI, V20, P13, DOI 10.1006/mcne.2002.1108; Lau KF, 2000, MOL CELL NEUROSCI, V16, P557, DOI 10.1006/mcne.2000.0898; Lau KF, 2008, J BIOL CHEM, V283, P34728, DOI 10.1074/jbc.M801874200; Law BM, 2018, J ALZHEIMERS DIS, V61, P673, DOI 10.3233/JAD-170393; Le Good JA, 2004, BIOCHEM J, V378, P83, DOI 10.1042/BJ20031194; Lee JH, 2004, J BIOL CHEM, V279, P49099, DOI 10.1074/jbc.M405602200; Lee JH, 2003, J BIOL CHEM, V278, P47025, DOI 10.1074/jbc.M300503200; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Lee YS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12334-2; Li W, 2018, J BIOL CHEM, V293, P7674, DOI 10.1074/jbc.RA117.000505; Liang WS, 2008, PHYSIOL GENOMICS, V33, P240, DOI 10.1152/physiolgenomics.00242.2007; Maimaiti S, 2016, J GERONTOL A-BIOL, V71, P30, DOI 10.1093/gerona/glu314; Martins-Silva C, 2006, BRAIN RES, V1119, P1, DOI 10.1016/j.brainres.2006.08.064; Matt L, 2013, EMBO J, V32, P1348, DOI 10.1038/emboj.2013.81; Mayanglambam A, 2011, BIOCHEM PHARMACOL, V82, P505, DOI 10.1016/j.bcp.2011.05.022; Mertins P, 2014, MOL CELL PROTEOMICS, V13, P1690, DOI 10.1074/mcp.M113.036392; Moore P, 1998, NEUROSCI LETT, V254, P29, DOI 10.1016/S0304-3940(98)00653-3; Nekhoroshkova E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004647; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Radzimanowski J, 2008, EMBO REP, V9, P1134, DOI 10.1038/embor.2008.188; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Reger MA, 2008, J ALZHEIMERS DIS, V13, P323, DOI 10.3233/jad-2008-13309; Ren SQ, 2013, EMBO J, V32, P1365, DOI 10.1038/emboj.2013.60; Saito Y, 2008, J BIOL CHEM, V283, P35763, DOI 10.1074/jbc.M801353200; Sajan MP, 2012, METABOLISM, V61, P459, DOI 10.1016/j.metabol.2011.12.008; Saluja I, 2009, NEUROBIOL DIS, V36, P162, DOI 10.1016/j.nbd.2009.07.006; Sano Y, 2006, J BIOL CHEM, V281, P37853, DOI 10.1074/jbc.M609312200; Santiard-Baron D, 2005, J NEUROCHEM, V93, P330, DOI 10.1111/j.1471-4159.2005.03026.x; Schor NF, 2011, ANN NEUROL, V69, P237, DOI 10.1002/ana.22365; Shineman DW, 2009, BIOCHEMISTRY-US, V48, P3787, DOI 10.1021/bi802070j; Standaert ML, 1999, J BIOL CHEM, V274, P25308, DOI 10.1074/jbc.274.36.25308; Standaert ML, 2001, BIOCHEMISTRY-US, V40, P249, DOI 10.1021/bi0018234; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Sui SH, 2008, PROTEOMICS, V8, P2024, DOI 10.1002/pmic.200700896; Tanabe K, 2010, J NEUROSCI, V30, P16983, DOI 10.1523/JNEUROSCI.3352-10.2010; Taniguchi T, 2001, J BIOL CHEM, V276, P10025, DOI 10.1074/jbc.M007427200; Taru H, 2009, J ALZHEIMERS DIS, V18, P253, DOI 10.3233/JAD-2009-1148; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Vandal M, 2014, DIABETES, V63, P4291, DOI 10.2337/db14-0375; Wagner MJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008987; Wang BP, 2004, J NEUROSCI RES, V75, P12, DOI 10.1002/jnr.10834; Wang J, 2012, CELL STEM CELL, V11, P23, DOI 10.1016/j.stem.2012.03.016; Wang X, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00294; Wang X, 2014, NEUROENDOCRINOL LETT, V35, P224; Watson GS, 2003, NEUROLOGY, V60, P1899, DOI 10.1212/01.WNL.0000065916.25128.25; Wu HY, 2009, ANAL CHEM, V81, P7778, DOI 10.1021/ac9013435; Xie J, 2000, MOL BRAIN RES, V82, P107, DOI 10.1016/S0169-328X(00)00187-X; XU HX, 1995, J BIOL CHEM, V270, P23243, DOI 10.1074/jbc.270.40.23243; Yan KS, 2002, FEBS LETT, V513, P67, DOI 10.1016/S0014-5793(01)03305-1; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200; Zambrano N, 2004, J BIOL CHEM, V279, P16161, DOI 10.1074/jbc.M311027200; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141	95	7	7	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12019	12035		10.1096/fj.201802825RR	http://dx.doi.org/10.1096/fj.201802825RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31373844	Bronze, Green Published			2022-12-28	WOS:000507461600033
J	Shi, ZN; Xu, SY; Xing, SH; Yao, K; Zhang, L; Xue, LX; Zhou, P; Wang, M; Yan, GQ; Yang, PY; Liu, J; Hu, ZP; Lan, F				Shi, Zhennan; Xu, Siyuan; Xing, Shenghui; Yao, Ke; Zhang, Lei; Xue, Luxi; Zhou, Peng; Wang, Ming; Yan, Guoquan; Yang, Pengyuan; Liu, Jing; Hu, Zeping; Lan, Fei			Mettl17, a regulator of mitochondrial ribosomal RNA modifications, is required for the translation of mitochondrial coding genes	FASEB JOURNAL			English	Article						rRNA modification; 12S rRNA; oxidative phosphorylation	MESSENGER-RNA; LARGE SUBUNIT; METHYLTRANSFERASE; METHYLATION; DIFFERENTIATION; PLURIPOTENCY; BIOGENESIS; PATHWAYS	Embryonic stem cells (ESCs) are pluripotent stem cells with the ability to self-renew and to differentiate into any cell types of the 3 germ layers. Recent studies have demonstrated that there is a strong connection between mitochondrial function and pluripotency. Here, we report that methyltransferase like (Mettl) 17, identified from the clustered regularly interspaced short palindromic repeats knockout screen, is required for proper differentiation of mouse embryonic stem cells (mESCs). Mettl17 is located in mitochondria through its N-terminal targeting sequence and specifically interacts with 12S mitochondrial ribosomal RNA (mt-rRNA) as well as small subunits of mitochondrial ribosome (MSSUs). Loss of Mettl17 affects the stability of both 12S mt-rRNA and its associated proteins of MSSUs. We further showed that Mettl17 is an S-adenosyl methionine (SAM)-binding protein and regulates mitochondrial ribosome function in a SAM-binding-dependent manner. Loss of Mettl17 leads to around 70% reduction of m4C840 and 50% reduction of m5C842 of 12S mt-rRNA, revealing the first regulator of the m4C840 and indicating a crosstalk between the 2 nearby modifications. The defects of mitochondrial ribosome caused by deletion of Mettl17 lead to the impaired translation of mitochondrial protein-coding genes, resulting in significant changes in mitochondrial oxidative phosphorylation and cellular metabolome, which are important for mESC pluripotency.	[Shi, Zhennan; Xu, Siyuan; Xing, Shenghui; Xue, Luxi; Lan, Fei] Fudan Univ, Zhongshan Hosp, Key Lab Epigenet & Metab, Minist Sci & Technol,Inst Biomed Sci, Shanghai, Peoples R China; [Shi, Zhennan; Xu, Siyuan; Xing, Shenghui; Xue, Luxi; Lan, Fei] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai, Peoples R China; [Yao, Ke; Hu, Zeping; Lan, Fei] Tsinghua Univ, Sch Pharmaceut Sci, Beijing 100084, Peoples R China; [Zhang, Lei; Yan, Guoquan; Yang, Pengyuan] Fudan Univ, Basic Med Coll, Inst Biomed Sci, Shanghai, Peoples R China; [Zhang, Lei; Yan, Guoquan; Yang, Pengyuan] Fudan Univ, Basic Med Coll, Dept Syst Biol Med, Shanghai, Peoples R China; [Zhou, Peng; Wang, Ming] Chinese Acad Sci, Inst Biophys, Key Lab RNA Biol, Beijing, Peoples R China; [Liu, Jing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou, Peoples R China	Fudan University; Fudan University; Tsinghua University; Fudan University; Fudan University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Hu, ZP (corresponding author), Tsinghua Univ, Sch Pharmaceut Sci, Beijing 100084, Peoples R China.; Lan, F (corresponding author), Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Room 504,Mingdao Bldg,131 Dongan Rd, Shanghai 200032, Peoples R China.	zeping_hu@tsinghua.edu.cn; fei_lan@fudan.edu.cn			Ministry of Science and Technology of China [2016YFA0101800]; Shanghai Municipal Science and Technology Major Project [2017SHZDZX01]; National Science Foundation of China [81773014]; Tsinghua University [53332200517]; National Science and Technology Major Project for Significant New Drugs Development [2017ZX09304015]; Bayer Investigator Award	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shanghai Municipal Science and Technology Major Project; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University; National Science and Technology Major Project for Significant New Drugs Development; Bayer Investigator Award	The authors thank Dr. Yang Yu (Institute of Biophysics, Chinese Academy of Sciences) and Dr. Ye Tian (Institute of Genetics and Developmental Biology, Chines Academy of Sciences) for instructive discussion. F.L. is funded by the Ministry of Science and Technology of China (2016YFA0101800), Shanghai Municipal Science and Technology Major Project (2017SHZDZX01), and National Science Foundation of China (81773014). Z.H. is supported by grants from Tsinghua University (53332200517) and the National Science and Technology Major Project for Significant New Drugs Development (2017ZX09304015). Z.H. is the recipient of a Bayer Investigator Award. The authors declare no conflicts of interest.	Antonicka H, 2013, CELL METAB, V17, P386, DOI 10.1016/j.cmet.2013.02.006; Arroyo JD, 2016, CELL METAB, V24, P875, DOI 10.1016/j.cmet.2016.08.017; BAER RJ, 1981, NUCLEIC ACIDS RES, V9, P323, DOI 10.1093/nar/9.2.323; Bohnsack MT, 2018, CELL MOL LIFE SCI, V75, P241, DOI 10.1007/s00018-017-2598-6; Camara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002; Cartlidge RA, 2005, EMBO J, V24, P1696, DOI 10.1038/sj.emboj.7600648; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Chung S, 2010, J MOL CELL CARDIOL, V48, P725, DOI 10.1016/j.yjmcc.2009.12.014; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Facucho-Oliveira JM, 2007, J CELL SCI, V120, P4025, DOI 10.1242/jcs.016972; Falnes PO, 2016, BIOCHEM J, V473, P1995, DOI 10.1042/BCJ20160117; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; He J, 2012, NUCLEIC ACIDS RES, V40, P6097, DOI 10.1093/nar/gks257; Huang F, 2018, CELL METAB, V28, P369, DOI 10.1016/j.cmet.2018.06.005; Jakobsson ME, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05646-y; Jeong EM, 2018, STEM CELL REP, V10, P600, DOI 10.1016/j.stemcr.2017.12.007; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Lee KW, 2014, J BIOL CHEM, V289, P24936, DOI 10.1074/jbc.C114.581868; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu S, 2019, CELL, V176, P491, DOI 10.1016/j.cell.2018.11.038; Ma HH, 2019, NAT CHEM BIOL, V15, P88, DOI 10.1038/s41589-018-0184-3; Ma JZ, 2017, HEPATOLOGY, V65, P529, DOI 10.1002/hep.28885; Malecki J, 2017, J BIOL CHEM, V292, P17950, DOI 10.1074/jbc.M117.808451; Malecki J, 2017, NUCLEIC ACIDS RES, V45, P4370, DOI 10.1093/nar/gkx002; Malecki J, 2015, J BIOL CHEM, V290, P423, DOI 10.1074/jbc.M114.614115; Martello G, 2014, ANNU REV CELL DEV BI, V30, P647, DOI 10.1146/annurev-cellbio-100913-013116; Menga A, 2017, FEBS J, V284, P967, DOI 10.1111/febs.14028; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Metodiev MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004110; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008; Rorbach J, 2014, MOL BIOL CELL, V25, P2542, DOI 10.1091/mbc.E14-01-0014; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shimazu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105394; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]; Van Haute L, 2015, J INHERIT METAB DIS, V38, P655, DOI 10.1007/s10545-015-9859-z; Varum S, 2009, STEM CELL RES, V3, P142, DOI 10.1016/j.scr.2009.07.002; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wu Q, 2009, STEM CELLS, V27, P2637, DOI 10.1002/stem.131; Xu L, 2017, J BIOL CHEM, V292, P14695, DOI 10.1074/jbc.M117.798298; Xu XL, 2013, CELL METAB, V18, P325, DOI 10.1016/j.cmet.2013.06.005; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Zaganelli S, 2017, J BIOL CHEM, V292, P4519, DOI 10.1074/jbc.M116.771105; Zhang XR, 2014, CELL, V158, P607, DOI 10.1016/j.cell.2014.05.047	51	15	15	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					13040	13050		10.1096/fj.201901331R	http://dx.doi.org/10.1096/fj.201901331R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31487196	Bronze			2022-12-28	WOS:000507461600110
J	Swayden, M; Alzeeb, G; Masoud, R; Berthois, Y; Audebert, S; Camoin, L; Hannouche, L; Vachon, H; Gayet, O; Bigonnet, M; Roques, J; Silvy, F; Carrier, A; Dusetti, N; Iovanna, JL; Soubeyran, P				Swayden, Mirna; Alzeeb, George; Masoud, Rawand; Berthois, Yolande; Audebert, Stephane; Camoin, Luc; Hannouche, Laurent; Vachon, Hortense; Gayet, Odile; Bigonnet, Martin; Roques, Julie; Silvy, Francoise; Carrier, Alice; Dusetti, Nelson; Iovanna, Juan L.; Soubeyran, Philippe			PML hyposumoylation is responsible for the resistance of pancreatic cancer	FASEB JOURNAL			English	Article						chemoresistance; post-translational modification; ubiquitin family; promyelocytic leukemia protein; sumoylation	PROTEIN CONJUGATION; UBIQUITIN; TRANSCRIPTION; SENSITIVITY; MECHANISMS; SURVIVAL; SYSTEM	The dismal prognosis of pancreatic ductal adenocarcinoma (PDAC) is mainly due to its rapidly acquired resistance to all conventional treatments. Despite drug-specific mechanisms of resistance, none explains how these cells resist the stress induced by any kind of anticancer treatment. Activation of stress-response pathways relies on the post-translational modifications (PTMs) of involved proteins. Among all PTMs, those mediated by the ubiquitin family of proteins play a central role. Our aim was to identify alterations of ubiquitination, neddylation, and sumoylation associated with the multiresistant phenotype and demonstrate their implications in the survival of PDAC cells undergoing treatment. This approach pointed at an alteration of promyelocytic leukemia (PML) protein sumoylation associated with both gemcitabine and oxaliplatin resistance. We could show that this alteration of PML sumoylation is part of a general mechanism of drug resistance, which in addition involves the abnormal activation of NF-kappa B and cAMP response element binding pathways. Importantly, using patient-derived tumors and cell lines, we identified a correlation between the levels of PML expression and sumoylation and the sensitivity of tumors to anticancer treatments.	[Swayden, Mirna; Alzeeb, George; Masoud, Rawand; Berthois, Yolande; Audebert, Stephane; Camoin, Luc; Gayet, Odile; Bigonnet, Martin; Roques, Julie; Silvy, Francoise; Carrier, Alice; Dusetti, Nelson; Iovanna, Juan L.; Soubeyran, Philippe] Aix Marseille Univ, CNRS, Inst Paoli Calmettes, CRCM, Marseille, France; [Hannouche, Laurent; Vachon, Hortense] Aix Marseille Univ, INSERM, Eories & Approches Complexit Genom TAGC, TGML, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Soubeyran, P (corresponding author), CNRS, Inst Paoli Calmettes, INSERM, CRCM,Univ U105,UMR1068,UMR7258, Parc Sci Luminy 163,Ave Luminy, F-13288 Marseille 9, France.	philippe.soubeyran@inserm.fr	Inserm U1090, TAGC/ABE-9980-2021; Dusetti, Nelson/O-7919-2017	Dusetti, Nelson/0000-0002-6161-8483; Alzeeb, George/0000-0003-3492-823X; Soubeyran, Philippe/0000-0002-5876-3217; Audebert, Stephane/0000-0002-9409-2588	INSERM; GIS Infrastructures en Biologie Sante et Agronomie (IBiSA); Aix-Marseille Universite; La Ligue Contre le Cancer; Association pour la Recherche sur le Cancer (ARC); Institute National du Cancer (INCa); Canceropole Provence-Alpes-Cote d'Azur (PACA);  [ANR-10-INBS-0009-10]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); GIS Infrastructures en Biologie Sante et Agronomie (IBiSA); Aix-Marseille Universite; La Ligue Contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Institute National du Cancer (INCa)(Institut National du Cancer (INCA) France); Canceropole Provence-Alpes-Cote d'Azur (PACA); 	The authors thank Dr. Arkaitz Carracedo (Center for Cooperative Research in Bioscience, Spain) for providing PML constructs and to Dr. Guillaume Bossis (IGMM, Montpellier, France) for providing anti-SUMO1 and anti-SUMO2/3 hybridomas. High-throughput sequencing was performed at the Transcriptomique and Genomique Marseille Luminy (TGML) Platform and supported by grants from INSERM, GIS Infrastructures en Biologie Sante et Agronomie (IBiSA), Aix-Marseille Universite, and ANR-10-INBS-0009-10. This work was supported by La Ligue Contre le Cancer, Association pour la Recherche sur le Cancer (ARC), Institute National du Cancer (INCa), Canceropole Provence-Alpes-Cote d'Azur (PACA), and INSERM. Proteomic analyses were done using the mass spectrometry facility of Marseille Proteomics (marseille-proteomique.univ-amu.fr) and were supported by IBiSA, Plateforme Technologique Aix-Marseille, Canceropole PACA, the Institut Paoli-Calmettes, and the Centre de Recherche en Cancerologie de Marseille. The authors declare no conflicts of interest.	Adamska Aleksandra, 2018, Advances in Biological Regulation, V68, P77, DOI 10.1016/j.jbior.2017.11.007; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Best JL, 2002, MOL CELL, V10, P843, DOI 10.1016/S1097-2765(02)00699-8; Bian B, 2017, EMBO MOL MED, V9, P482, DOI 10.15252/emmm.201606975; Bonacci T, 2014, J PROTEOME RES, V13, P2478, DOI 10.1021/pr401258d; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Cappadocia L, 2018, CHEM REV, V118, P889, DOI 10.1021/acs.chemrev.6b00737; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Duconseil P, 2015, AM J PATHOL, V185, P1022, DOI 10.1016/j.ajpath.2014.11.029; GOLDSTEIN G, 1975, P NATL ACAD SCI USA, V72, P11, DOI 10.1073/pnas.72.1.11; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Hattersley N, 2011, MOL BIOL CELL, V22, P78, DOI 10.1091/mbc.E10-06-0504; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Hurwitz SN, 2016, ONCOTARGET, V7, P86999, DOI 10.18632/oncotarget.13569; Krueger KE, 2006, MOL CELL PROTEOMICS, V5, P1799, DOI 10.1074/mcp.R600009-MCP200; Lallemand-Breitenbach V, 2018, CURR OPIN CELL BIOL, V52, P154, DOI 10.1016/j.ceb.2018.03.011; Ma CC, 2014, TUMOR BIOL, V35, P12729, DOI 10.1007/s13277-014-2598-1; Maguire O, 2011, CYTOM PART A, V79A, P461, DOI 10.1002/cyto.a.21068; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Schneider G, 2005, GASTROENTEROLOGY, V128, P1606, DOI 10.1053/j.gastro.2005.04.001; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Silvers CR, 2017, ONCOTARGET, V8, P91199, DOI 10.18632/oncotarget.20043; Tauro BJ, 2013, MOL CELL PROTEOMICS, V12, P587, DOI 10.1074/mcp.M112.021303; Tessier S, 2017, ANTIOXID REDOX SIGN, V26, P432, DOI 10.1089/ars.2016.6898; Vertegaal ACO, 2011, CHEM REV, V111, P7923, DOI 10.1021/cr200187e; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wang ZG, 1998, SCIENCE, V279, P1547; Yau R, 2016, NAT CELL BIOL, V18, P579, DOI 10.1038/ncb3358; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yuan LW, 2001, BBA-MOL CELL RES, V1541, P161, DOI 10.1016/S0167-4889(01)00141-0; Zhang CC, 2018, TECHNOL CANCER RES T, V17, DOI 10.1177/1533033818763450	36	7	7	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12447	12463		10.1096/fj.201901091R	http://dx.doi.org/10.1096/fj.201901091R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31557059	Green Published			2022-12-28	WOS:000507461600066
J	Yan, HY; Ren, SW; Lin, Q; Yu, Y; Chen, CY; Hua, XH; Jin, HL; Lu, YY; Zhang, HX; Xie, QP; Huang, CS; Huang, HS				Yan, Huiying; Ren, Shuwei; Lin, Qi; Yu, Yuan; Chen, Caiyi; Hua, Xiaohui; Jin, Honglei; Lu, Yongyong; Zhang, Huxiang; Xie, Qipeng; Huang, Chuanshu; Huang, Haishan			Inhibition of UBE2N-dependent CDK6 protein degradation by miR-934 promotes human bladder cancer cell growth	FASEB JOURNAL			English	Article						proliferation; tumor growth; cell cycle; 3&amp; PRIME; -UTR	DEPENDENT KINASE 6; DOWN-REGULATION; CDK4/6 INHIBITOR; IN-VITRO; EXPRESSION; MICRORNA; PROGRESSION; RECEPTOR	BC cell growth-associated effectors is of great significance. Cyclin-dependent kinase (CDK)6 is a member of the CDK family of cell cycle-related proteins and plays an important role in cancer cell growth. This is borne out by the fact that a CDK6 inhibitor had been approved to treat several types of cancers. Nevertheless, underlying molecular mechanisms concerning how to regulate CDK6 expression in BC remains unclear. In the present study, it was observed that miR-934 was much higher in human BCs and human BC cell lines as well. The results also revealed that miR-934 inhibition dramatically decreased human BC cell monolayer growth in vitro and xenograft tumor growth in vivo; the outcomes were accompanied by CDK6 protein down-regulation and G(0)-G(1) cell cycle arrest. Moreover, overexpression of CDK6 reversed the inhibition of BC cell growth induced by miR-934. Further studies showed that miR-934 binds to a 3'-UTR of ubiquitin-conjugating enzyme 2N (ube2n) mRNA, down-regulated UBE2N protein expression; this, in turn, attenuated CDK6 protein degradation and led to CDK6 protein accumulation as well as the promotion of BC tumor growth. Collectively, this study not only establishes a novel regulatory axis of miR-934/UBE2N of CDK6 but also provides data suggesting that miR-934 and UBE2N may be potentially promising targets for therapeutic strategies against BC.	[Yan, Huiying; Ren, Shuwei; Yu, Yuan; Chen, Caiyi; Hua, Xiaohui; Jin, Honglei; Xie, Qipeng; Huang, Haishan] Wenzhou Med Univ, Zhejiang Prov Key Lab Technol & Applicat Model Or, Key Lab Lab Med, Sch Lab Med & Life Sci,Minist Educ, Wenzhou, Zhejiang, Peoples R China; [Lin, Qi; Lu, Yongyong; Zhang, Huxiang] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China; [Huang, Chuanshu] NYU, Sch Med, Dept Environm Med, 341 East 25th St, New York, NY 10010 USA	Wenzhou Medical University; Wenzhou Medical University; New York University	Huang, CS (corresponding author), NYU, Sch Med, Dept Environm Med, 341 East 25th St, New York, NY 10010 USA.; Huang, HS (corresponding author), Wenzhou Med Univ, Sch Lab Med & Life Sci, Chashan Campus, Wenzhou 325035, Zhejiang, Peoples R China.	chuanshu.huang@nyulangone.org; haishan_333@163.com	xie, qipeng/ABG-5941-2021	Huang, Chuanshu/0000-0003-4133-5096; Huang, Haishan/0000-0002-7658-2188	Natural Science Foundation of China [NSFC81702530, NSFC81872587]; Wenzhou Science and Technology Bureau [Y20170028]; Key Discipline of Zhejiang Province in Medical Technology (First Class, Category A)	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenzhou Science and Technology Bureau; Key Discipline of Zhejiang Province in Medical Technology (First Class, Category A)	The authors thank Dr. Xiaoqun Zheng (Wenzhou Medical University) for providing an experimental resource in the manuscript revision. The authors also thank all of the participants, specimen donors, and research groups who developed The Cancer Genome Atlas (TCGA) bladder cancer dataset resource for their contributions. These results partially based upon data generated by the TCGA Research Network (https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga).This work was partially supported by the Natural Science Foundation of China (NSFC81702530 and NSFC81872587); the Wenzhou Science and Technology Bureau (Y20170028); and the Key Discipline of Zhejiang Province in Medical Technology (First Class, Category A). The authors declare no conflicts of interest.	Acunzo Mario, 2015, Adv Biol Regul, V57, P1, DOI 10.1016/j.jbior.2014.09.013; Castilla MA, 2014, ENDOCR-RELAT CANCER, V21, P587, DOI 10.1530/ERC-13-0485; Asghar U, 2015, NAT REV DRUG DISCOV, V14, P130, DOI 10.1038/nrd4504; Bellail AC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5234; Chen L, 2019, EXP THER MED, V17, P1476, DOI 10.3892/etm.2018.7084; Choo JRE, 2018, EXPERT OPIN DRUG MET, V14, P1123, DOI 10.1080/17425255.2018.1541347; Chowdhari S, 2014, J CELL PHYSIOL, V229, P1630, DOI 10.1002/jcp.24608; Corona SP, 2018, DRUG DES DEV THER, V12, P321, DOI 10.2147/DDDT.S137783; Deng M, 2017, CANCER LETT, V403, P175, DOI 10.1016/j.canlet.2017.06.006; Dinney CPN, 2004, CANCER CELL, V6, P111, DOI 10.1016/j.ccr.2004.08.002; Hou Y, 2019, ONCOL LETT, V17, P73, DOI 10.3892/ol.2018.9594; Huang HS, 2015, CLIN CANCER RES, V21, P3783, DOI 10.1158/1078-0432.CCR-14-2829; Huang HS, 2014, ONCOTARGET, V5, P493, DOI 10.18632/oncotarget.1643; Iwata H, 2018, BREAST CANCER-TOKYO, V25, P402, DOI 10.1007/s12282-017-0827-3; Jiang SH, 2017, NATURE, V544, P460, DOI 10.1038/nature22032; Jin HL, 2018, MOL THER-NUCL ACIDS, V11, P312, DOI 10.1016/j.omtn.2018.03.003; Jin HL, 2016, ONCOTARGET, V7, P56540, DOI 10.18632/oncotarget.10645; Ju LX, 2017, J CANCER, V8, P1311, DOI 10.7150/jca.17817; Li XY, 2018, 2018 INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND BIG DATA (ICAIBD), P1; Li X, 2018, EXPERT OPIN THER PAT, V28, P919, DOI 10.1080/13543776.2018.1549229; Liang Z, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0664-1; Lim JTE, 2005, P NATL ACAD SCI USA, V102, P5156, DOI 10.1073/pnas.0501203102; Liu MH, 2018, ONCOL REP, V39, P901, DOI 10.3892/or.2018.6221; Lopez-Tarruella S, 2017, FUTURE ONCOL, V13, P2137, DOI 10.2217/fon-2017-0183; Luo H., 2017, ENERGY TECHNOL-GER, V5, P1, DOI DOI 10.1177/; Lynce F, 2018, PHARMACOL THERAPEUT, V191, P65, DOI 10.1016/j.pharmthera.2018.06.008; Martin-Sanchez D, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0043-2; Munoz-Rodriguez JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124340; Parylo S, 2019, J ONCOL PHARM PRACT, V25, P110, DOI 10.1177/1078155218770904; Rossi MR, 2001, ENVIRON HEALTH PERSP, V109, P801, DOI 10.1289/ehp.01109801; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Saad MA, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0452-8; Sang HY, 2016, MED SCI MONITOR, V22, P4066, DOI 10.12659/MSM.897254; Sarosiek Tomasz, 2018, Pol Merkur Lekarski, V44, P5; Sherr CJ, 2016, CANCER DISCOV, V6, P353, DOI 10.1158/2159-8290.CD-15-0894; Si WG, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-018-0587-8; Stewart MD, 2016, CELL RES, V26, P423, DOI 10.1038/cr.2016.35; Stone SL, 2019, INT REV CEL MOL BIO, V343, P65, DOI 10.1016/bs.ircmb.2018.05.012; Timmermann S, 1997, CELL GROWTH DIFFER, V8, P361; Wang G, 2012, ONCOL LETT, V4, P43, DOI 10.3892/ol.2012.695; Yang R, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0569-4; Yin L, 2018, EUR J MED CHEM, V144, P1, DOI 10.1016/j.ejmech.2017.12.003; Yu XC, 2013, GENE, V532, P87, DOI 10.1016/j.gene.2013.09.048; Yuan DZ, 2017, ONCOTARGET, V8, P67663, DOI 10.18632/oncotarget.18801; Zeng XR, 2016, MOL CANCER THER, V15, P512, DOI 10.1158/1535-7163.MCT-15-0606; Zhang E, 2017, ONCOTARGET, V8, P114072, DOI 10.18632/oncotarget.23120; Zhang J, 2016, EUR REV MED PHARMACO, V20, P4494; Zhu JL, 2017, MOL THER-NUCL ACIDS, V7, P299, DOI 10.1016/j.omtn.2017.04.012	48	17	17	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12112	12123		10.1096/fj.201900499RR	http://dx.doi.org/10.1096/fj.201900499RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31373842				2022-12-28	WOS:000507461600040
J	Ghimire, K; Chiba, T; Minhas, N; Meijles, DN; Lu, B; O'Connell, P; Rogers, NM				Ghimire, Kedar; Chiba, Takuto; Minhas, Nikita; Meijles, Daniel N.; Lu, Bo; O'Connell, Philip; Rogers, Natasha M.			Deficiency in SIRP-alpha cytoplasmic recruitment confers protection from acute kidney injury	FASEB JOURNAL			English	Article						thrombospondin-1; CD47; AKI; ischemia-reperfusion injury	HUMAN T-CELL; PROTEIN-ALPHA; DOWN-REGULATION; SIGNAL; CD47; ACTIVATION; THROMBOSPONDIN-1; SHPS-1; PROLIFERATION; ASSOCIATION	Acute kidney injury (AKI) remains an important source of progressive chronic kidney injury. Loss of renal blood flow with subsequent restoration, termed ischemia reperfusion (IR), is a common cause of AKI. The cell surface receptor signal regulatory protein alpha (SIRP-alpha) is expressed on macrophages and limits inflammation and phagocytosis. SIRP-alpha has recently been found to have wider cell-based expression and play a role in renal IR. We have explored this in a genetic model of deficient SIRP-alpha signaling. Mice lacking SIRP-alpha cytoplasmic signaling (SIRP-alpha(mut)) and wild-type (WT) littermate controls underwent renal ischemia and reperfusion. Chimeric mice transplanted with WT or SIRP-alpha(mut) bone marrow were similarly challenged following engraftment. Molecular and immunohistochemical analysis of renal function, tissue damage, and key molecular targets was performed. SIRP-alpha(mut) mice were protected from renal IR compared with WT animals, demonstrating improved serum creatinine, less histologic damage, reduced proinflammatory cytokine production, and diminished production of reactive oxygen species (ROS). Resistance to renal IR in SIRP-alpha(mut) occurred alongside down-regulation of CD47 and thrombospondin-1, which are known to exert SIRP-alpha crosstalk and also promote IR. In chimeric mice, lack of SIRP-alpha signaling conferred protection to IR regardless of the genotype of circulating cells. Renal tubular epithelial cells from SIRP-alpha(mut) mice produced fewer ROS and proinflammatory cytokines in vitro. These results identify parenchymal SIRP-alpha as an independent driver of IR-mediated AKI and a potential therapeutic target.-Ghimire, K., Chiba, T., Minhas, N., Meijles, D. N., Lu, B., O'Connell, P., Rogers, N. M. Deficiency in SIRP-alpha cytoplasmic recruitment confers protection from acute kidney injury.	[Ghimire, Kedar; Minhas, Nikita; O'Connell, Philip; Rogers, Natasha M.] Ctr Transplant & Renal Res, Westmead Inst Med Res, 176 Hawkesbury Rd, Westmead, NSW 2145, Australia; [Ghimire, Kedar; Chiba, Takuto; Lu, Bo; Rogers, Natasha M.] Univ Pittsburgh, Sch Med, Heart Lung Blood & Vasc Med Inst, Pittsburgh, PA USA; [Meijles, Daniel N.] St Georges Univ London, Mol & Clin Sci Res Inst, London, England; [O'Connell, Philip; Rogers, Natasha M.] Univ Sydney, Westmead Clin Sch, Dept Med, Sydney, NSW, Australia; [Rogers, Natasha M.] Univ Pittsburgh, Thomas E Starzl Transplantat Inst, Pittsburgh, PA USA	University of Sydney; Westmead Institute for Medical Research; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; St Georges University London; University of Sydney; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rogers, NM (corresponding author), Ctr Transplant & Renal Res, Westmead Inst Med Res, 176 Hawkesbury Rd, Westmead, NSW 2145, Australia.	natasha.rogers@health.nsw.gov.au	Rogers, Natasha/ABC-2546-2020; O'Connell, Philip John/AFK-9353-2022; Meijles, Daniel/J-6457-2014	O'Connell, Philip John/0000-0002-2036-283X; Meijles, Daniel/0000-0002-5557-3549; Ghimire, Kedar/0000-0002-4672-5256	American Heart Association Postdoctoral Fellowship [17POST33670685]; National Health and Medical Research Council (NHMRC) [GNT1138372]; NHMRC Career Development Fellowship [GNT1158597]; NHMRC Practitioner Fellowship; Westmead Charitable Trust Clinical Researcher Award; Royal Australasian College of Physicians Jacquot Research Establishment Award	American Heart Association Postdoctoral Fellowship(American Heart Association); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Westmead Charitable Trust Clinical Researcher Award; Royal Australasian College of Physicians Jacquot Research Establishment Award	This study was supported by American Heart Association Postdoctoral Fellowship 17POST33670685 (to T.C.), National Health and Medical Research Council (NHMRC) Project Grant GNT1138372 (to N.M.R.), NHMRC Career Development Fellowship GNT1158597 (to N.M.R.), the NHMRC Practitioner Fellowship (to P.O'C.), a Westmead Charitable Trust Clinical Researcher Award (to N.M.R.), and a Royal Australasian College of Physicians Jacquot Research Establishment Award (to N.M.R.). The authors declare no conflicts of interest.	Alblas J, 2005, MOL CELL BIOL, V25, P7181, DOI 10.1128/MCB.25.16.7181-7192.2005; Baba N, 2013, J EXP MED, V210, P1251, DOI 10.1084/jem.20122037; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Brown JR, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4278579; Csanyi G, 2012, ARTERIOSCL THROM VAS, V32, P2966, DOI 10.1161/ATVBAHA.112.300031; de Vries HE, 2002, J IMMUNOL, V168, P5832, DOI 10.4049/jimmunol.168.11.5832; Friedewald JJ, 2004, KIDNEY INT, V66, P486, DOI 10.1111/j.1523-1755.2004.761_3.x; Haller H, 2016, CURR OPIN NEPHROL HY, V25, P42, DOI 10.1097/MNH.0000000000000186; Hsu RK, 2016, SEMIN NEPHROL, V36, P283, DOI 10.1016/j.semnephrol.2016.05.005; Inagaki K, 2000, EMBO J, V19, P6721, DOI 10.1093/emboj/19.24.6721; Isenberg JS, 2008, SURGERY, V144, P752, DOI 10.1016/j.surg.2008.07.009; Isenberg JS, 2009, J BIOL CHEM, V284, P1116, DOI 10.1074/jbc.M804860200; Kerr M, 2014, NEPHROL DIAL TRANSPL, V29, P1362, DOI 10.1093/ndt/gfu016; Kong XN, 2007, J EXP MED, V204, P2719, DOI 10.1084/jem.20062611; Kurihara H, 2010, AM J PHYSIOL-RENAL, V299, pF517, DOI 10.1152/ajprenal.00571.2009; Latour S, 2001, J IMMUNOL, V167, P2547, DOI 10.4049/jimmunol.167.5.2547; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Londino JD, 2015, J BIOL CHEM, V290, P31113, DOI 10.1074/jbc.M115.682914; Maile LA, 2012, DIABETOLOGIA, V55, P835, DOI 10.1007/s00125-011-2416-x; Novelli EM, 2012, AM J HEMATOL, V87, P326, DOI 10.1002/ajh.22274; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Raymond M, 2009, J ALLERGY CLIN IMMUN, V124, P1333, DOI 10.1016/j.jaci.2009.07.021; Rewa O, 2014, NAT REV NEPHROL, V10, P193, DOI 10.1038/nrneph.2013.282; Rogers NM, 2017, CARDIOVASC RES, V113, P15, DOI 10.1093/cvr/cvw218; Rogers NM, 2016, KIDNEY INT, V90, P334, DOI 10.1016/j.kint.2016.03.034; Rogers NM, 2012, J AM SOC NEPHROL, V23, P1538, DOI 10.1681/ASN.2012020137; Sierra-Filardi E, 2014, J IMMUNOL, V192, P3858, DOI 10.4049/jimmunol.1302821; Sinclair NRS, 1999, SCAND J IMMUNOL, V50, P10; Stefanidakis M, 2008, BLOOD, V112, P1280, DOI 10.1182/blood-2008-01-134429; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Tien SC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10420; Tsuda M, 1998, J BIOL CHEM, V273, P13223, DOI 10.1074/jbc.273.21.13223; van Beek EM, 2009, FASEB J, V23, P4081, DOI 10.1096/fj.09-131557; van Beek EM, 2005, J IMMUNOL, V175, P7781, DOI 10.4049/jimmunol.175.12.7781; Verma R, 2016, MOL CELL BIOL, V36, P596, DOI 10.1128/MCB.00956-15; Wang L, 2012, J NEUROCHEM, V122, P834, DOI 10.1111/j.1471-4159.2012.07818.x; Win S, 2016, HEPATOLOGY, V63, P1987, DOI 10.1002/hep.28486; Yao MY, 2014, J AM SOC NEPHROL, V25, P1171, DOI 10.1681/ASN.2013040433	40	8	8	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11528	11540		10.1096/fj.201900583R	http://dx.doi.org/10.1096/fj.201900583R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31370677	Bronze			2022-12-28	WOS:000489166300076
J	Vega, MRLOL; Nigro, ALSA; Luti, SMN; Capitini, LD; Fani, L; Gonnelli, LONRO; Boscaro, RCC; Chiti, FRZO				Vega, Mirella Vivoli; Nigro, Alessia; Luti, Simone; Capitini, Claudia; Fani, Giulia; Gonnelli, Leonardo; Boscaro, Francesca; Chiti, Fabrizio			Isolation and characterization of soluble human full-length TDP-43 associated with neurodegeneration	FASEB JOURNAL			English	Article						protein refolding; neurodegenerative diseases; TDP-43 proteinophaties; stress granules; RNA binding protein	FRONTOTEMPORAL LOBAR DEGENERATION; BINDING PROTEIN 43; N-TERMINAL DOMAIN; DIFFERENTIAL SCANNING FLUOROMETRY; NUCLEIC-ACID BINDING; ESCHERICHIA-COLI; RNA RECOGNITION; DNA; EXPRESSION; MUTATIONS	The involvement of transactivation response (TAR) DNA-binding protein 43 (TDP-43) in neurodegenerative diseases was revealed in 2006, when it was first reported to be the main component of the intracellular inclusions in patients with amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration. After 12 yr it is not yet possible to purify to a reasonable yield and in a reproducible manner a stable full-length protein, which has limited so far the characterization of its structure, function, molecular interactors, and pathobiology. Using a novel protocol we have achieved the purification of the full-length TDP-43, with both a short pectate lyase B tag and a glutathione S-transferase tag, which consisted in its expression in bacteria, solubilization from inclusion bodies, purification under denaturing conditions, refolding, and a final size exclusion chromatography (SEC) step. Differential scanning fluorimetry was used to find the best buffers and combination of additives to increase both its solubility and its stability. The protein is pure, as determined with electrophoresis, Western blotting, and mass spectrometry; properly refolded, as revealed by circular dichroism and fluorescence spectroscopies; functional, because it binds to DNA and protein partners; and stable to degradation and aggregation in a physiologic solution. Analyses with dynamic light scattering and SEC revealed that the protein is a dimer.-Vivoli Vega, M., Nigro, A., Luti, S., Capitini, C., Fani, G., Gonnelli, L., Boscaro, F., Chiti, F. Isolation and characterization of soluble human full-length TDP-43 associated with neurodegeneration.	[Vega, Mirella Vivoli; Nigro, Alessia; Luti, Simone; Capitini, Claudia; Fani, Giulia; Chiti, Fabrizio] Univ Florence, Dept Expt & Clin Biomed Sci, Viale Morgagni 50, I-50134 Florence, Italy; [Gonnelli, Leonardo] Univ Florence, Ctr Ric Risonanze Magnet CERM, Florence, Italy; [Boscaro, Francesca] Univ Florence, Mass Spectrometry Ctr, Florence, Italy	University of Florence; University of Florence; University of Florence	Chiti, FRZO (corresponding author), Univ Florence, Dept Expt & Clin Biomed Sci, Viale Morgagni 50, I-50134 Florence, Italy.	fabrizio.chiti@unifi.it		Vivoli Vega, Mirella/0000-0002-1148-5651; Luti, Simone/0000-0001-7050-6590; Capitini, Claudia/0000-0003-2834-1424	Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica (AriSLA) [TDP-43 STRUCT]	Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica (AriSLA)	The authors thank the Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica (AriSLA) for funding (Grant TDP-43 STRUCT). M.V.V. acknowledges the financial funding from the backers who have supported the crowdfunding campaign at Experiment. com for the purchase of the fast protein liquid chromatography (FPLC) instrument. The authors declare no conflicts of interest.	Afroz T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00062-0; Alami NH, 2014, NEURON, V81, P536, DOI 10.1016/j.neuron.2013.12.018; Alibolandi M, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/631607; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Baynes BM, 2005, BIOCHEMISTRY-US, V44, P4919, DOI 10.1021/bi047528r; Belin D, 2004, J MOL BIOL, V335, P437, DOI 10.1016/j.jmb.2003.10.076; Berkmen M, 2012, PROTEIN EXPRES PURIF, V82, P240, DOI 10.1016/j.pep.2011.10.009; Bondos SE, 2003, ANAL BIOCHEM, V316, P223, DOI 10.1016/S0003-2697(03)00059-9; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Capitini C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086720; Casafont I, 2009, J STRUCT BIOL, V167, P235, DOI 10.1016/j.jsb.2009.06.006; Chang CK, 2012, BIOCHEM BIOPH RES CO, V425, P219, DOI 10.1016/j.bbrc.2012.07.071; Chanson JB, 2010, NEURODEGENER DIS, V7, P260, DOI 10.1159/000273591; Chiang CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep21581; Clark EDB, 1998, CURR OPIN BIOTECH, V9, P157; CLELAND JL, 1992, BIO-TECHNOL, V10, P1013, DOI 10.1038/nbt0992-1013; DELATORRE JG, 1981, Q REV BIOPHYS, V14, P81, DOI 10.1017/S0033583500002080; Economou A, 1999, TRENDS MICROBIOL, V7, P315, DOI 10.1016/S0966-842X(99)01555-3; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Georgiou G, 2005, CURR OPIN BIOTECH, V16, P538, DOI 10.1016/j.copbio.2005.07.008; Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; HAUN RS, 1992, BIOTECHNIQUES, V13, P515; Hobson EV, 2016, NAT REV NEUROL, V12, P526, DOI 10.1038/nrneurol.2016.111; Hofmann L, 2016, ANAL BIOCHEM, V499, P63, DOI 10.1016/j.ab.2016.01.016; Jiang LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06263-3; Jiang LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep23928; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Jung JW, 2006, PROTEOMICS, V6, P1110, DOI 10.1002/pmic.200500371; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Khokhlova OV, 2004, MOL BIOL+, V38, P239, DOI 10.1023/B:MBIL.0000023740.66749.b0; Kitamura A, 2018, BIOCHEM BIOPHYS REP, V14, P58, DOI 10.1016/j.bbrep.2018.03.009; Kuo PH, 2014, NUCLEIC ACIDS RES, V42, P4712, DOI 10.1093/nar/gkt1407; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; LEE JC, 1981, J BIOL CHEM, V256, P7193; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Li W, 2017, J BIOL CHEM, V292, P5089, DOI 10.1074/jbc.M116.753913; Lim LZ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002338; Lukavsky PJ, 2013, NAT STRUCT MOL BIOL, V20, P1443, DOI 10.1038/nsmb.2698; Luo Y., 2011, HDB MODERN PHARM ANA, V10, P283; Mackenzie IRA, 2009, ACTA NEUROPATHOL, V117, P15, DOI 10.1007/s00401-008-0460-5; Mompean M, 2017, J BIOL CHEM, V292, P11992, DOI 10.1074/jbc.M117.775965; Mompean M, 2016, FEBS J, V283, P1242, DOI 10.1111/febs.13651; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Qin HN, 2014, P NATL ACAD SCI USA, V111, P18619, DOI 10.1073/pnas.1413994112; Ravits JM, 2009, NEUROLOGY, V73, P805, DOI 10.1212/WNL.0b013e3181b6bbbd; Rohn TT, 2008, BRAIN RES, V1228, P189, DOI 10.1016/j.brainres.2008.06.094; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Singh CR, 2007, METHOD ENZYMOL, V429, P139, DOI 10.1016/S0076-6879(07)29007-X; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stover CM, 2004, MAMM GENOME, V15, P887, DOI 10.1007/s00335-004-3006-8; Tan RH, 2015, BRAIN, V138, P3110, DOI 10.1093/brain/awv220; Tsai RM, 2016, J NEUROCHEM, V138, P211, DOI 10.1111/jnc.13640; Tsoi PS, 2017, ANGEW CHEM INT EDIT, V56, P12590, DOI 10.1002/anie.201706769; Tsumoto K, 2004, BIOTECHNOL PROGR, V20, P1301, DOI 10.1021/bp0498793; Tsumoto K, 2003, PROTEIN EXPRES PURIF, V28, P1, DOI 10.1016/S1046-5928(02)00641-1; Vikis Haris G, 2004, Methods Mol Biol, V261, P175; Vivoli Mirella, 2014, J Vis Exp, P51809, DOI 10.3791/51809; Wang AL, 2018, EMBO J, V37, DOI 10.15252/embj.201797452; Wang YT, 2013, J BIOL CHEM, V288, P9049, DOI 10.1074/jbc.M112.438564; Wei YY, 2016, BIOCHEM BIOPH RES CO, V473, P614, DOI 10.1016/j.bbrc.2016.03.158; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Yoon Sung Ho, 2010, Recent Pat Biotechnol, V4, P23, DOI 10.2174/187220810790069550; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007	74	11	11	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10780	10793		10.1096/fj.201900474R	http://dx.doi.org/10.1096/fj.201900474R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31287959				2022-12-28	WOS:000489166300017
J	Yang, S; Liu, H; Zhu, L; Li, XL; Liu, DQ; Song, XM; Yokota, H; Zhang, P				Yang, Shuang; Liu, Hong; Zhu, Lei; Li, Xinle; Liu, Daquan; Song, Xiaomeng; Yokota, Hiroki; Zhang, Ping			Ankle loading ameliorates bone loss from breast cancer-associated bone metastasis	FASEB JOURNAL			English	Article						mechanical loading; tumor; osteolysis; osteoclast; osteoblast	PHYSICAL-ACTIVITY; TUMOR-GROWTH; PROGRESSION; OSTEOLYSIS; RISK; METAANALYSIS; EXPRESSION; PROTECTS; EXERCISE; EFFICACY	Breast cancer is a serious health problem that preferentially metastasizes to bone. We have previously shown that bone loss can be prevented by mechanical loading, but the efficacy of ankle loading for metastasis-linked bone loss has not been investigated. This study showed that body weight was decreased after inoculation of tumor cells, but ankle loading restored a rapid weight loss. The nonloading group exhibited a decrease in bone volume/tissue volume (BV/TV), trabecular thickness, and trabecular number (all P < 0.01) as well as an increase in trabecular separation (P < 0.001). However, ankle loading improved those changes (all P < 0.05). Furthermore, although the nonloading group increased the tumor bearing as well as expression of IL-8 and matrix metalloproteinase 9, ankle loading decreased them. Induction of tumor in the bone elevated the osteoclast number (P < 0.05) as well as the levels of nuclear factor of activated T-cells cytoplasmic 1, NF-kappa B ligand, cathepsin K, and serum tartrate-resistant acid phosphatase type 5b, but ankle loading reduced osteoclast activity and those levels (all P < 0.05). Tumor bearing was positively correlated with the osteoclast number (P < 0.01) and negatively correlated with BV/TV and the osteoblast number (both P < 0.01). Collectively, these findings demonstrate that ankle loading suppresses tumor growth and osteolysis by inhibiting bone resorption and enhancing bone formation.-Yang, S., Liu, H., Zhu, L., Li, X., Liu, D., Song, X., Yokota, H., Zhang, P. Ankle loading ameliorates bone loss from breast cancer-associated bone metastasis.	[Yang, Shuang; Li, Xinle; Liu, Daquan; Song, Xiaomeng; Zhang, Ping] Tianjin Med Univ, Sch Basic Med Sci, Dept Anat & Histol, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China; [Yang, Shuang; Li, Xinle; Liu, Daquan; Zhang, Ping] Tianjin Med Univ, Key Lab Hormones & Dev, Minist Hlth, Tianjin Key Lab Metab Dis, Tianjin, Peoples R China; [Liu, Hong] Tianjin Med Univ, Key Lab Canc Prevent & Therapy, Minist Educ, Tianjin, Peoples R China; [Zhang, Ping] Tianjin Med Univ, Tianjin Key Lab Spine & Spinal Cord, Tianjin, Peoples R China; [Liu, Hong] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Breast Surg, Tianjin, Peoples R China; [Zhu, Lei] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Mol Imaging & Nucl Med, Tianjin, Peoples R China; [Liu, Hong; Zhu, Lei] Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China; [Yokota, Hiroki; Zhang, Ping] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Indiana University System; Indiana University-Purdue University Indianapolis	Zhang, P (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Dept Anat & Histol, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China.	pizhang@tmu.edu.cn			National Natural Science Foundation of China [81772405, 81572100, 81601863]; Tianjin Science and Technology Program Fund [18PTZWHZ00100]; Science and Technology Development Fund of Tianjin Education Commission for Higher Education [2017KJ223, 2018KJ076]; U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR052144]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Science and Technology Program Fund; Science and Technology Development Fund of Tianjin Education Commission for Higher Education; U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Natural Science Foundation of China (81772405 and 81572100 to P.Z.; 81601863 to X.L.), the Tianjin Science and Technology Program Fund (18PTZWHZ00100 to L.Z.), the Science and Technology Development Fund of Tianjin Education Commission for Higher Education (2017KJ223 to D.L.; 2018KJ076 to X.S.), and U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grant AR052144 to H.Y.). The authors declare no conflicts of interest.	Ashcraft KA, 2016, CANCER RES, V76, P4032, DOI 10.1158/0008-5472.CAN-16-0887; Bendre MS, 2003, BONE, V33, P28, DOI 10.1016/S8756-3282(03)00086-3; Buenrostro D, 2018, BONE, V113, P77, DOI 10.1016/j.bone.2018.05.008; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; D'Oronzo S, 2017, J BONE ONCOL, V9, P1, DOI 10.1016/j.jbo.2017.09.001; Duong LT, 2014, MOL CANCER THER, V13, P2898, DOI 10.1158/1535-7163.MCT-14-0253; Ell B, 2012, CELL, V151, DOI 10.1016/j.cell.2012.10.005; Erdogan B, 2014, ASIAN PAC J CANCER P, V15, P1503, DOI 10.7314/APJCP.2014.15.4.1503; Hong W, 2014, CANCER LETT, V351, P1, DOI 10.1016/j.canlet.2014.04.007; Jones LW, 2013, ACTA ONCOL, V52, P195, DOI 10.3109/0284186X.2012.742564; Kakhki VRD, 2013, NUCL MED REV, V16, P66, DOI 10.5603/NMR.2013.0037; Kamalakar A, 2014, BONE, V61, P176, DOI 10.1016/j.bone.2014.01.015; Kim Jeongseon, 2013, J Cancer Prev, V18, P193; Kim JY, 2014, BMB REP, V47, P451, DOI 10.5483/BMBRep.2014.47.8.206; Kim Jung Ha, 2014, J Bone Metab, V21, P233, DOI 10.11005/jbm.2014.21.4.233; Kuchuk I, 2013, J BONE ONCOL, V2, P137, DOI 10.1016/j.jbo.2013.09.001; Lahart IM, 2015, ACTA ONCOL, V54, P635, DOI 10.3109/0284186X.2014.998275; Lee JH, 2014, BIOCHEM PHARMACOL, V91, P51, DOI 10.1016/j.bcp.2014.06.005; Li X., 2019, FASEB J; Li XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24668; Liu DQ, 2015, BONE, V81, P620, DOI 10.1016/j.bone.2015.09.012; Loibl S, 2015, BREAST, V24, pS73, DOI 10.1016/j.breast.2015.07.018; Lorenzo J, 2017, J CLIN INVEST, V127, P2530, DOI 10.1172/JCI94606; Luftner D, 2018, BREAST, V37, P28, DOI 10.1016/j.breast.2017.10.007; Lumachi F, 2016, CLIN CHIM ACTA, V460, P227, DOI 10.1016/j.cca.2016.07.005; Luo KW, 2015, ONCOL REP, V34, P477, DOI 10.3892/or.2015.4001; Lynch ME, 2013, J BONE MINER RES, V28, P2357, DOI 10.1002/jbmr.1966; Ma YHV, 2018, J CELL BIOCHEM, V119, P5665, DOI 10.1002/jcb.26745; Merdad A, 2014, ANTICANCER RES, V34, P1355; Pagnotti GM, 2016, BONE, V90, P69, DOI 10.1016/j.bone.2016.05.014; Payne C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008427.pub2; Pedersen L, 2016, CELL METAB, V23, P554, DOI 10.1016/j.cmet.2016.01.011; Rollason V, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008455.pub2; Schneeweiss A, 2018, GEBURTSH FRAUENHEILK, V78, P246, DOI 10.1055/s-0044-101614; Selvaduray KR, 2012, GENES NUTR, V7, P53, DOI 10.1007/s12263-011-0223-0; Sheill G, 2018, PM&R, V10, P843, DOI 10.1016/j.pmrj.2018.02.006; Stevens RG, 2014, CA-CANCER J CLIN, V64, P207, DOI 10.3322/caac.21218; Taipaleenmaki H, 2015, CANCER RES, V75, P1433, DOI 10.1158/0008-5472.CAN-14-1026; Tsianakas V, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013719; Vagnildhaug OM, 2017, J CACHEXIA SARCOPENI, V8, P789, DOI 10.1002/jcsm.12220; Wang Q, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0417-0; Wani NA, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3665; Wright LE, 2016, BONEKEY REP, V5, DOI 10.1038/bonekey.2016.31; Yee J, 2014, J CANCER SURVIV, V8, P647, DOI 10.1007/s11764-014-0378-y; Zhang HW, 2018, J BONE ONCOL, V11, P38, DOI 10.1016/j.jbo.2018.01.004; Zhang P, 2008, BRIT J SPORT MED, V42, P556, DOI 10.1136/bjsm.2007.042556; Zhang P, 2009, BONE, V44, P989, DOI 10.1016/j.bone.2009.01.367; Zhang P, 2009, EXERC SPORT SCI REV, V37, P52, DOI 10.1097/JES.0b013e31819121c6; Zhang W, 2011, BONE, V48, P1378, DOI 10.1016/j.bone.2011.03.760; Zhong SL, 2014, EUR J EPIDEMIOL, V29, P391, DOI 10.1007/s10654-014-9916-1	50	9	9	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10742	10752		10.1096/fj.201900306RR	http://dx.doi.org/10.1096/fj.201900306RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31266364	Green Published			2022-12-28	WOS:000489166300014
J	Echtermeyer, F; Eberhardt, M; Risser, L; Herzog, C; Gueler, F; Khalil, M; Engel, M; Vondran, F; Leffler, A				Echtermeyer, Frank; Eberhardt, Mirjam; Risser, Linus; Herzog, Christine; Gueler, Faikah; Khalil, Mohammad; Engel, Matthias; Vondran, Florian; Leffler, Andreas			Acetaminophen-induced liver injury is mediated by the ion channel TRPV4	FASEB JOURNAL			English	Article						hepatotoxicity; analgesic; paracetamol	INDUCED HEPATOTOXICITY; PROTEIN NITRATION; OXIDANT STRESS; CELL-DEATH; ACTIVATION; MECHANISMS; TOXICITY; BLOCKAGE; DISEASE; BRAIN	Overdosing of the analgesic acetaminophen (APAP) is one of the most common causes for acute liver failure in modern countries. Although the exact molecular mechanisms mediating hepatocellular necrosis are still elusive, it is preceded by oxidative stress triggered by excessive levels of the metabolite N-acetyl-para-benzoquinone imine (NAPQI). Here, we describe the role of the redox-sensitive transient receptor potential (TRP) ion channel TRP vanilloid 4 (TRPV4) for APAP-induced hepatoxicity. Both pharmacological inhibition and genetic deletion of TRPV4 ameliorate APAP-induced necrosis in mouse and human hepatocytes in vitro. Liver injury caused by a systemic overdose of APAP is reduced in TRPV4-deficient mice and in wild-type mice treated with a TRPV4 inhibitor. The reduction of hepatotoxicity accomplished by systemic TRPV4 inhibition is comparable to the protective effects of the antioxidant N-acetyl-cysteine. Although TRPV4 does not modulate intrahepatic levels of glutathione, both its inhibition and genetic deletion attenuate APAP-induced oxidative and nitrosative stress as well as mitochondrial membrane depolarization. NAPQI evokes a calcium influx by activating heterologously expressed TRPV4 channels and endogenous TRPV4 channels in hepatoma cells but not in primary mouse hepatocytes. Taken together, our data suggest that TRPV4 mediates APAP-induced hepatotoxicity and thus may be a suitable target for treatment of this critical side effect.-Echtermeyer, F., Eberhardt, M., Risser, L., Herzog, C., Gueler, F., Khalil, M., Engel, M., Vondran, F., Leffler, A. Acetaminophen-induced liver injury is mediated by the ion channel TRPV4.	[Echtermeyer, Frank; Eberhardt, Mirjam; Risser, Linus; Herzog, Christine; Leffler, Andreas] Hannover Med Sch, Dept Anesthesiol & Intens Care Med, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Gueler, Faikah] Hannover Med Sch, Dept Nephrol, Hannover, Germany; [Vondran, Florian] Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, Hannover, Germany; [Khalil, Mohammad; Engel, Matthias] Univ Klinikum Erlangen, Dept Med 1, Erlangen, Germany; [Vondran, Florian] German Ctr Infect Res DZIF Hannover Braunschweig, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; University of Erlangen Nuremberg	Leffler, A (corresponding author), Hannover Med Sch, Dept Anesthesiol & Intens Care Med, Carl Neuberg Str 1, D-30625 Hannover, Germany.	leffler.andreas@mh-hannover.de						Agarwal R, 2012, J PHARMACOL EXP THER, V340, P134, DOI 10.1124/jpet.111.184192; Aminoshariae A, 2015, J ENDODONT, V41, P588, DOI 10.1016/j.joen.2015.01.024; Andersson DA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1559; Atkuri KR, 2007, CURR OPIN PHARMACOL, V7, P355, DOI 10.1016/j.coph.2007.04.005; Badr H, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00019; Banerjee S, 2015, FREE RADICAL BIO MED, V89, P750, DOI 10.1016/j.freeradbiomed.2015.09.022; Bernal W, 2015, J HEPATOL, V62, pS112, DOI 10.1016/j.jhep.2014.12.016; Bernal W, 2013, NEW ENGL J MED, V369, P2525, DOI 10.1056/NEJMra1208937; Bubolz AH, 2012, AM J PHYSIOL-HEART C, V302, pH634, DOI 10.1152/ajpheart.00717.2011; Butenko O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039959; Dong Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep42678; Du K, 2016, REDOX BIOL, V10, P148, DOI 10.1016/j.redox.2016.10.001; Du K, 2015, FOOD CHEM TOXICOL, V86, P253, DOI 10.1016/j.fct.2015.10.016; Eberhardt MJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13054-3; Gentry C, 2015, SCI REP-UK, V5, DOI 10.1038/srep12771; Ghanem CI, 2016, PHARMACOL RES, V109, P119, DOI 10.1016/j.phrs.2016.02.020; Jaeschke Hartmut, 2018, React Oxyg Species (Apex), V5, P145; Jaeschke H, 2015, TOXICOL LETT, V235, P216, DOI 10.1016/j.toxlet.2015.04.002; Jaeschke H, 2012, DRUG METAB REV, V44, P88, DOI 10.3109/03602532.2011.602688; Jie PH, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00141; Kheradpezhouh E, 2014, P NATL ACAD SCI USA, V111, P3176, DOI 10.1073/pnas.1322657111; Lee WM, 2012, BEST PRACT RES CL GA, V26, P3, DOI 10.1016/j.bpg.2012.01.014; Liu ZX, 2006, HEPATOLOGY, V43, P1220, DOI 10.1002/hep.21175; McGill MR, 2012, J CLIN INVEST, V122, P1574, DOI 10.1172/JCI59755; Mirrasekhian E, 2018, FASEB J, V32, P5751, DOI 10.1096/fj.201800272R; MITCHELL JR, 1975, GASTROENTEROLOGY, V68, P392; Nassini R, 2010, FASEB J, V24, P4904, DOI 10.1096/fj.10-162438; Ramachandran Anup, 2017, J Clin Transl Res, V3, P157, DOI 10.18053/jctres.03.2017S1.002; Ramirez A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3928714; Seth RK, 2017, FREE RADICAL BIO MED, V102, P260, DOI 10.1016/j.freeradbiomed.2016.11.047; Sjogren AKM, 2014, ARCH TOXICOL, V88, P1427, DOI 10.1007/s00204-014-1265-z; Vriens J, 2004, CELL CALCIUM, V36, P19, DOI 10.1016/j.ceca.2003.11.006; Waning J, 2007, CELL CALCIUM, V42, P17, DOI 10.1016/j.ceca.2006.11.005; Watkins PB, 2006, JAMA-J AM MED ASSOC, V296, P87, DOI 10.1001/jama.296.1.87; White JPM, 2016, PHYSIOL REV, V96, P911, DOI 10.1152/physrev.00016.2015; Wu QF, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.227	36	7	7	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10257	10268		10.1096/fj.201802233R	http://dx.doi.org/10.1096/fj.201802233R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31207191	Bronze			2022-12-28	WOS:000482214200043
J	Jiang, XH; Yin, S; Fan, SX; Bao, JQ; Jiao, YY; Ali, A; Iqbal, F; Xu, J; Zhang, YW; Shi, Q				Jiang, Xiaohua; Yin, Shi; Fan, Suixing; Bao, Jianqiang; Jiao, Yuying; Ali, Asim; Iqbal, Furhan; Xu, Juan; Zhang, Yuanwei; Shi, Qinghua			Npat-dependent programmed Sertoli cell proliferation is indispensable for testis cord development and germ cell mitotic arrest	FASEB JOURNAL			English	Article						Npat; testis cord; spermatogenesis; gonocyte; Sertoli cell	CYCLIN E-CDK2; GENE; GONOCYTES; MIGRATION; COMPLEX; SPERMATOGENESIS; EXPRESSION; DYNAMICS; BARRIER; FATE	As the major somatic cell type, Sertoli cells undergo active proliferation and play essential roles to establish testis cord at fetal stage. They also function to maintain germ cell development throughout the life of testicular development. However, the significance of Sertoli cell number for testis cord development and gonocyte fate is still unclear. Nuclear protein ataxia-telangiectasia (NPAT, also known as p220), a substrate of cyclin E/cyclin-dependent kinase 2, is well known as a regulator of cell proliferation through regulating histone expression. To study the role of NPAT during Sertoli cell development, we generated a mouse strain carrying conditional floxed Npat alleles, when crossing with anti-Mullerian hormone-cre, leading to the specific deletion of Npat in Sertoli cells. Npat disruption in Sertoli cells inhibited the programmed proliferation of fetal Sertoli cells resulting in disruption of developing testis cords, and subsequent postnatal mutant testes were severely hypoplastic. Germ cells, which are presumed to be in quiescent status during perinatal stage, exited G0 phase arrest and re-enter mitotic cell cycle prematurely. Of particular note, some germ cells possessed the meiotic signal in Npat-deficient testes. Our data thus indicates that the function of Npat-dependent Sertoli cells is essential at multiple steps in testis development, and this study also identifies Sertoli cells as a major regulator of germ cell development, which are required to maintain a local growth niche to repress premature mitosis and meiosis of gonocytes.-Jiang, X., Yin, S., Fan, S., Bao, J., Jiao, Y., Ali, A., Iqbal, F., Xu, J., Zhang, Y., Shi, Q. Npat-dependent programmed Sertoli cell proliferation is indispensable for testis cord development and germ cell mitotic arrest.	[Jiang, Xiaohua; Yin, Shi; Fan, Suixing; Bao, Jianqiang; Jiao, Yuying; Ali, Asim; Iqbal, Furhan; Zhang, Yuanwei; Shi, Qinghua] Univ Sci & Technol China, Affiliated Hosp 1, Hefei Natl Lab Phys Sci Microscale,CAS Ctr Excell, CAS Key Lab Innate Immun & Chron Dis,Sch Life Sci, 96 Jinzhai Rd, Hefei 230027, Anhui, Peoples R China; [Xu, Juan] Nanjing Univ, Natl Resource Ctr Mutant Mice, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Nanjing University	Zhang, YW; Shi, Q (corresponding author), Univ Sci & Technol China, Affiliated Hosp 1, Hefei Natl Lab Phys Sci Microscale,CAS Ctr Excell, CAS Key Lab Innate Immun & Chron Dis,Sch Life Sci, 96 Jinzhai Rd, Hefei 230027, Anhui, Peoples R China.	zyuanwei@ustc.edu.cn; qshi@ustc.edu.cn	Zhang, Yuanwei/C-7695-2016; Fan, Suixing/AAN-3214-2020; Ali, Asim/AAA-4476-2020; Bao, Jianqiang/G-9184-2016	Zhang, Yuanwei/0000-0002-2814-8061; Bao, Jianqiang/0000-0003-1248-2687; Shi, QingHua/0000-0003-1180-9799; Ali, Asim/0000-0001-5791-7918; Fan, Suixing/0000-0002-6133-9759	National Key Research and Developmental Program of China [2018YFC1004700, 2016YFC1000600]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19000000]; National Natural Science Foundation of China [31630050, 31890780, 31771668, 31871514, 31501199]; Major Program of Development Foundation of Hefei Centre for Physical Science and Technology [2018ZYFX005]; Fundamental Research Funds for the Central Universities [WK2340000069, WK2070080005]	National Key Research and Developmental Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of Development Foundation of Hefei Centre for Physical Science and Technology; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors thank Dr. Xingxu Huang (ShanghaiTech University, Shanghai, China) and Dr. Yiting Zhou (Zhejiang University, Hangzhou, China) for their valuable suggestions regarding the experimental design. This work was supported by the National Key Research and Developmental Program of China (Grants 2018YFC1004700 and 2016YFC1000600), the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant XDB19000000), the National Natural Science Foundation of China (Grants 31630050, 31890780, 31771668, 31871514, and 31501199), Major Program of Development Foundation of Hefei Centre for Physical Science and Technology (Grant 2018ZYFX005), and the Fundamental Research Funds for the Central Universities (Grants WK2340000069 and WK2070080005). The authors declare no conflicts of interest.	Archambeault DR, 2010, P NATL ACAD SCI USA, V107, P10526, DOI 10.1073/pnas.1000318107; Bao JQ, 2015, DEVELOPMENT, V142, P352, DOI 10.1242/dev.115642; Barcaroli D, 2006, P NATL ACAD SCI USA, V103, P14808, DOI 10.1073/pnas.0604227103; Basciani S, 2008, ENDOCRINOLOGY, V149, P6226, DOI 10.1210/en.2008-0349; Bellve AR, 1998, SEMIN CELL DEV BIOL, V9, P379, DOI 10.1006/scdb.1998.0254; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Brandeis M, 1998, P NATL ACAD SCI USA, V95, P4344, DOI 10.1073/pnas.95.8.4344; Chen SR, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.137117; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; Cobb J, 1998, SEMIN CELL DEV BIOL, V9, P445, DOI 10.1006/scdb.1998.0202; Cool J, 2012, WIRES DEV BIOL, V1, P847, DOI 10.1002/wdev.62; Das DK, 2011, EUR J MED GENET, V54, pE529, DOI 10.1016/j.ejmg.2011.04.010; Deran M, 2008, MOL CELL BIOL, V28, P435, DOI 10.1128/MCB.00607-07; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Hiramatsu R, 2009, DEVELOPMENT, V136, P129, DOI 10.1242/dev.029587; Holsberger DR, 2005, BIOL REPROD, V72, P1429, DOI 10.1095/biolreprod.105.040386; Jiang XH, 2014, ASIAN J ANDROL, V16, P572, DOI 10.4103/1008-682X.125401; Kashimada K, 2010, DEVELOPMENT, V137, P3921, DOI 10.1242/dev.048983; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; Li H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007501; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; Ma TL, 2000, GENE DEV, V14, P2298, DOI 10.1101/gad.829500; MacLean G, 2007, ENDOCRINOLOGY, V148, P4560, DOI 10.1210/en.2007-0492; MCGUINNESS MP, 1992, ANAT REC, V233, P527, DOI 10.1002/ar.1092330406; McLaren A, 1997, DEV BIOL, V187, P107, DOI 10.1006/dbio.1997.8584; Merlet J, 2007, P NATL ACAD SCI USA, V104, P3615, DOI 10.1073/pnas.0611421104; Moreno SG, 2010, DEV BIOL, V342, P74, DOI 10.1016/j.ydbio.2010.03.007; Mruk DD, 2015, ENDOCR REV, V36, P681, DOI [10.1210/er.2015-1127, 10.1210/er.2014-1101]; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nel-Themaat L, 2011, BIOL REPROD, V84, P342, DOI 10.1095/biolreprod.110.086900; Olaso R, 2000, J ANDROL, V21, P497, DOI 10.1002/j.1939-4640.2000.tb02114.x; Orth JM, 1997, BIOL REPROD, V57, P676, DOI 10.1095/biolreprod57.3.676; Pirngruber J, 2010, ONCOGENE, V29, P2853, DOI 10.1038/onc.2010.42; Rebourcet D, 2014, DEVELOPMENT, V141, P2139, DOI 10.1242/dev.107029; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Svingen T, 2013, GENE DEV, V27, P2409, DOI 10.1101/gad.228080.113; VERGOUWEN RPFA, 1991, J REPROD FERTIL, V93, P233, DOI 10.1530/jrf.0.0930233; Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622; Wolgemuth DJ, 2013, INT J DEV BIOL, V57, P159, DOI 10.1387/ijdb.130047av; Wolgemuth DJ, 2011, RESULTS PROBL CELL D, V53, P391, DOI 10.1007/978-3-642-19065-0_17; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016046; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700; Zhao JY, 1998, GENE DEV, V12, P456, DOI 10.1101/gad.12.4.456	45	7	8	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9075	9086		10.1096/fj.201802289RR	http://dx.doi.org/10.1096/fj.201802289RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31084574				2022-12-28	WOS:000478832900031
J	Lee, HI; Lee, J; Hwang, D; Lee, GR; Kim, N; Kwon, M; Lee, H; Piao, D; Kim, HJ; Kim, NY; Kim, HS; Seo, EK; Kang, D; Jeong, W				Lee, Hye In; Lee, Jiae; Hwang, Donghyun; Lee, Gong-Rak; Kim, Narae; Kwon, Minjeong; Lee, Hana; Piao, Donglan; Kim, Hyun Jin; Kim, Nam Young; Kim, Han Sung; Seo, Eun Kyoung; Kang, Dongmin; Jeong, Woojin			Dehydrocostus lactone suppresses osteoclast differentiation by regulating NFATc1 and inhibits osteoclast activation through modulating migration and lysosome function	FASEB JOURNAL			English	Article						bone; integrin; PKC-beta; Atg5	TYROSINE PHOSPHORYLATION; NUCLEAR FACTOR; BONE LOSS; T-CELLS; PROLIFERATION; DYSFUNCTION; BIOGENESIS; MECHANISMS; EXPRESSION; PROTEINS	Excessive osteoclast activity can lead to an imbalance between the synthesis and breakdown of bone, with pathologic consequences that include osteoporosis and periodontitis. Thus, controlling osteoclast differentiation and function has significant therapeutic implications. In this study, we investigated the effects of dehydrocostus lactone (DL) on osteoclast differentiation and activation and elucidated the possible mechanisms underlying these processes. DL suppressed osteoclast differentiation by reducing the expression of the nuclear factor of activated T-cells, cytoplasmic 1. When used to challenge differentiated osteoclasts, DL also effectively inhibited their enlargement and resorption activity, and biochemical approaches revealed that DL attenuates osteoclast activation by inhibiting the migration and lysosome biogenesis and secretion via the down-regulation of integrin beta(3), PKC-beta, and autophagy related 5 expression. Furthermore, DL prevented bone destruction in inflammation- and ovariectomy-induced osteolytic mouse models. These results indicate that DL has therapeutic potential to treat bone diseases caused by excessive or hyperactive osteoclasts.-Lee, H. I., Lee, J., Hwang, D., Lee, G.-R., Kim, N., Kwon, M., Lee, H., Piao, D., Kim, H. J., Kim, N. Y., Kim, H. S., Seo, E. K., Kang, D., Jeong, W. Dehydrocostus lactone suppresses osteoclast differentiation by regulating NFATc1 and inhibits osteoclast activation through modulating migration and lysosome function.	[Lee, Hye In; Lee, Jiae; Lee, Gong-Rak; Kim, Narae; Kwon, Minjeong; Kim, Hyun Jin; Kim, Nam Young; Kang, Dongmin; Jeong, Woojin] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea; [Piao, Donglan; Seo, Eun Kyoung] Ewha Womans Univ, Coll Pharm, Seoul, South Korea; [Hwang, Donghyun; Lee, Hana; Kim, Han Sung] Yonsei Univ, Dept Biomed Engn, Wonju, South Korea	Ewha Womans University; Ewha Womans University; Yonsei University	Jeong, W (corresponding author), Ewha Womans Univ, Sci Bldg C,Room 211,52 Ewhayeodae Gil, Seoul 03760, South Korea.	jeongw@ewha.ac.kr		Kang, Dongmin/0000-0001-5997-625X; Lee, Hana/0000-0003-0481-0660	National Research Foundation (NRF) - Korean Ministry of Science, ICT, and Future Planning (MSIP) [2017R1A2B2012435, 2012R1A5A1048236, 2019R1C1C1011198, 2018R1D1A1A02049371]	National Research Foundation (NRF) - Korean Ministry of Science, ICT, and Future Planning (MSIP)	This work was supported by the National Research Foundation (NRF) Grants (2017R1A2B2012435, 2012R1A5A1048236, 2019R1C1C1011198, and 2018R1D1A1A02049371) funded by the Korean Ministry of Science, ICT, and Future Planning (MSIP). The authors declare no conflicts of interest.	Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cai H, 2017, J CELL BIOCHEM, V118, P3381, DOI 10.1002/jcb.25994; Choi EM, 2011, EUR J PHARMACOL, V664, P1, DOI 10.1016/j.ejphar.2011.05.005; Choi EM, 2009, TOXICOL IN VITRO, V23, P862, DOI 10.1016/j.tiv.2009.05.005; Chung YH, 2012, INT J BIOCHEM CELL B, V44, P989, DOI 10.1016/j.biocel.2012.03.007; DeSelm CJ, 2011, DEV CELL, V21, P966, DOI 10.1016/j.devcel.2011.08.016; Dong GZ, 2015, PHYTOTHER RES, V29, P680, DOI 10.1002/ptr.5299; Ferron M, 2013, GENE DEV, V27, P955, DOI 10.1101/gad.213827.113; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hong SE, 2017, FREE RADICAL BIO MED, V112, P191, DOI 10.1016/j.freeradbiomed.2017.07.030; Jeong GS, 2007, EUR J PHARMACOL, V565, P37, DOI 10.1016/j.ejphar.2007.02.053; Jiang EP, 2015, INT J GYNECOL CANCER, V25, P1179, DOI 10.1097/IGC.0000000000000474; Kim EJ, 2012, J MED FOOD, V15, P24, DOI 10.1089/jmf.2011.1735; Kim H, 2013, J IMMUNOL, V190, P1312, DOI 10.4049/jimmunol.1202525; Lacombe J, 2013, CELL CYCLE, V12, P2744, DOI 10.4161/cc.25825; Lee J, 2019, FASEB J, V33, P2026, DOI 10.1096/fj.201800866RR; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Nagai Y, 2013, J BONE MINER RES, V28, P2449, DOI 10.1002/jbmr.1936; Nakamura I, 1998, J BIOL CHEM, V273, P11144, DOI 10.1074/jbc.273.18.11144; Park EJ, 2014, INT IMMUNOPHARMACOL, V22, P332, DOI 10.1016/j.intimp.2014.07.012; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Rodan SB, 1997, J ENDOCRINOL, V154, pS47; Ross FP, 2005, IMMUNOL REV, V208, P88, DOI 10.1111/j.0105-2896.2005.00331.x; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Seo MS, 2012, IMMUNOPHARM IMMUNOT, V34, P810, DOI 10.3109/08923973.2012.657799; SHINAR DM, 1993, J BONE MINER RES, V8, P403; Sun XW, 2015, ANTI-CANCER DRUG, V26, P641, DOI 10.1097/CAD.0000000000000229; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Wang JK, 2017, AM J CANCER RES, V7, P1270	37	16	16	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9685	9694		10.1096/fj.201900862R	http://dx.doi.org/10.1096/fj.201900862R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31145860	Bronze			2022-12-28	WOS:000478832900076
J	Zhang, ML; Wang, CY; Jiang, HB; Liu, ML; Yang, N; Zhao, LH; Hou, DR; Jin, Y; Chen, QY; Chen, Y; Wang, JZ; Dai, YF; Li, RF				Zhang, Manling; Wang, Chenyu; Jiang, Haibin; Liu, Manling; Yang, Ning; Zhao, Lihua; Hou, Daorong; Jin, Yong; Chen, Qiaoyu; Chen, Yuan; Wang, Junzheng; Dai, Yifan; Li, Rongfeng			Derivation of novel naive-like porcine embryonic stem cells by a reprogramming factor-assisted strategy	FASEB JOURNAL			English	Article						inner cell mass; reprogramming factor; pluripotency	SELF-RENEWAL; GROUND-STATE; PLURIPOTENT; CULTURE; PIG; DIFFERENTIATION; ESTABLISHMENT; LINES; MAINTENANCE; INDUCTION	The establishment of ungulate embryonic stem cells (ESCs) has been notoriously difficult via a conventional approach. We combined a traditional ESC culture method with reprogramming factors to assist the establishment of porcine naive-like ESCs (nESCs). Pig embryonic fibroblasts were transfected with a tetracycline-inducible vector carrying 4 classic mouse reprogramming factors, followed by somatic cell nuclear transfer and culturing to the blastocyst stage. Then, the inner cell mass was isolated and seeded in culture medium. The naive-like ESCs had characteristic verys similar to those of mouse ESCs and showed no signs of altered morphology or differentiation, even after 130 passages. They depended on leukemia inhibitory factor signals for maintenance of pluripotency, and the female cell lines had low expression of the X-inactive specific transcript gene and no histone H3 lysine 27 trimethylation spot. Notably, the ESCs differentiated into 3 germ layers in vitro and could be induced to undergo directional neural and kidney precursor differentiation under defined conditions, and the ESCs could keep proliferating after doxycycline was removed. nESCs can be established, and the well-characterized ESC lines will be useful for the research of transgenic pig models for human disease.-Zhang, M., Wang, C., Jiang, H., Liu, M., Yang, N., Zhao, L., Hou, D., Jin, Y., Chen, Q., Chen, Y., Wang, J., Dai, Y., Li, R. Derivation of novel naive-like porcine embryonic stem cells by a reprogramming factor-assisted strategy.	[Zhang, Manling; Wang, Chenyu; Jiang, Haibin; Liu, Manling; Yang, Ning; Zhao, Lihua; Hou, Daorong; Jin, Yong; Chen, Qiaoyu; Chen, Yuan; Wang, Junzheng; Dai, Yifan; Li, Rongfeng] Nanjing Med Univ, Jiangsu Key Lab Xenotransplantat, Nanjing 210029, Jiangsu, Peoples R China; [Zhang, Manling; Wang, Chenyu; Jiang, Haibin; Liu, Manling; Yang, Ning; Zhao, Lihua; Hou, Daorong; Jin, Yong; Chen, Qiaoyu; Chen, Yuan; Wang, Junzheng; Dai, Yifan; Li, Rongfeng] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Manling; Zhao, Lihua; Dai, Yifan; Li, Rongfeng] Nanjing Med Univ, Key Lab Targeted Intervent Cardiovasc Dis, Collaborat Innovat Ctr Cardiovasc Dis Translat Me, Nanjing, Jiangsu, Peoples R China; [Jin, Yong] Nanjing Med Univ, Dept Nephrol, Affiliated Sir Run Run Hosp, Nanjing, Jiangsu, Peoples R China; [Zhang, Manling] Inner Mongolia Univ, State Key Lab Reprod Regulat & Breeding Grassland, Hohhot, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Inner Mongolia University	Dai, YF; Li, RF (corresponding author), Nanjing Med Univ, Jiangsu Key Lab Xenotransplantat, Nanjing 210029, Jiangsu, Peoples R China.	daiyifan@njmu.edu.cn; lirongfeng@njmu.edu.cn			National Natural Sciences Foundation of China [31371487]; Jiangsu Key Laboratory of Xenotransplantation [BM2012116]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Key Laboratory of Xenotransplantation	The authors thank all the laboratory staff for help in ensuring the accuracy and completeness of all the data and Prof. Siqin Bao (Inner Mongolia University, Huhhot, China) for reading the manuscript. This work was supported by the National Natural Sciences Foundation of China (Grant 31371487) and a grant from the Jiangsu Key Laboratory of Xenotransplantation (BM2012116). The authors declare no conflicts of interest.	Alberio R, 2010, STEM CELLS DEV, V19, P1627, DOI 10.1089/scd.2010.0012; ANDERSON GB, 1994, THERIOGENOLOGY, V42, P204, DOI 10.1016/0093-691X(94)90676-A; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Chen LR, 1999, THERIOGENOLOGY, V52, P195, DOI 10.1016/S0093-691X(99)00122-3; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; Du XG, 2015, STEM CELLS, V33, P3228, DOI 10.1002/stem.2089; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Fujishiro S, 2013, STEM CELLS DEV, V22, P473, DOI 10.1089/scd.2012.0173; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Gu Q, 2014, PROTEIN CELL, V5, P338, DOI 10.1007/s13238-014-0043-2; Gu Q, 2012, PROTEIN CELL, V3, P71, DOI 10.1007/s13238-012-2007-8; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Haraguchi S, 2012, J REPROD DEVELOP, V58, P707, DOI 10.1262/jrd.2012-008; Hou DR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25838; Huang K, 2014, CELL STEM CELL, V15, P410, DOI 10.1016/j.stem.2014.09.014; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kim HS, 2007, ZYGOTE, V15, P55, DOI 10.1017/S0967199406003972; Kim S, 2010, ZYGOTE, V18, P93, DOI 10.1017/S0967199409990372; Li M, 2004, J REPROD DEVELOP, V50, P237, DOI 10.1262/jrd.50.237; Li M, 2003, MOL REPROD DEV, V65, P429, DOI 10.1002/mrd.10301; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; NOTARIANNI E, 1991, J REPROD FERTIL, P255; NOTARIANNI E, 1990, J REPROD FERTIL, P51; PIEDRAHITA JA, 1990, THERIOGENOLOGY, V34, P879, DOI 10.1016/0093-691X(90)90559-C; STROJEK RM, 1990, THERIOGENOLOGY, V33, P901, DOI 10.1016/0093-691X(90)90825-E; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Telugu Bhanu Prakash V L, 2011, J Biol Chem, V286, P28948, DOI 10.1074/jbc.M111.229468; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	44	7	7	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9350	9361		10.1096/fj.201802809R	http://dx.doi.org/10.1096/fj.201802809R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31125263	Bronze			2022-12-28	WOS:000478832900051
J	Ali, T; Bednarska, J; Vassilopoulos, S; Tran, M; Diakonov, IA; Ziyadeh-Isleem, A; Guicheney, P; Gorelik, J; Korchev, YE; Reilly, MM; Bitoun, M; Sheychuk, A				Ali, Tayyibah; Bednarska, Joanna; Vassilopoulos, Stephane; Tran, Martin; Diakonov, Ivan A.; Ziyadeh-Isleem, Azza; Guicheney, Pascale; Gorelik, Julia; Korchev, Yuri E.; Reilly, Mary M.; Bitoun, Marc; Sheychuk, Andrew			Correlative SICM-FCM reveals changes in morphology and kinetics of endocytic pits induced by disease-associated mutations in dynamin	FASEB JOURNAL			English	Article						clathrin; caveolin; myopathy; Charcot-Marie-Tooth	SCANNING ION-CONDUCTANCE; CLATHRIN-MEDIATED ENDOCYTOSIS; TRANSFERRIN RECEPTOR; MEMBRANE; FLUORESCENCE; MYOPATHY; FISSION; CELLS; SUPERRESOLUTION; CAVEOLAE	Dynamin 2 (DNM2) is a GTP-binding protein that controls endocytic vesicle scission and defines a whole class of dynamin-dependent endocytosis, including clathrin-mediated endocytosis by caveoli. It has been suggested that mutations in the DNM2 gene, associated with 3 inherited diseases, disrupt endocytosis. However, how exactly mutations affect the nanoscale morphology of endocytic machinery has never been studied. In this paper, we used live correlative scanning ion conductance microscopy (SICM) and fluorescence confocal microscopy (FCM) to study how disease-associated mutations affect the morphology and kinetics of clathrin-coated pits (CCPs) by directly following their dynamics of formation, maturation, and internalization in skin fibroblasts from patients with centronuclear myopathy (CNM) and in Cos-7 cells expressing corresponding dynamin mutants. Using SICM-FCM, which we have developed, we show how p.R465W mutation disrupts pit structure, preventing its maturation and internalization, and significantly increases the lifetime of CCPs. Differently, p.R522H slows down the formation of CCPs without affecting their internalization. We also found that CNM mutations in DNM2 affect the distribution of caveoli and reduce dorsal ruffling in human skin fibroblasts. Collectively, our SICM-FCM findings at single CCP level, backed up by electron microscopy data, argue for the impairment of several forms of endocytosis in DNM2-linked CNM.-Ali, T., Bednarska, J., Vassilopoulos, S., Tran, M., Diakonov, I. A., Ziyadeh-Isleem, A., Guicheney, P., Gorelik, J., Korchev, Y. E., Reilly, M. M., Bitoun, M., Shevchuk, A. Correlative SICM-FCM reveals changes in morphology and kinetics of endocytic pits induced by disease-associated mutations in dynamin.	[Ali, Tayyibah; Bednarska, Joanna; Tran, Martin; Korchev, Yuri E.; Sheychuk, Andrew] Imperial Coll London, Dept Med, Div Expt Med, London, England; [Vassilopoulos, Stephane; Bitoun, Marc] Sorbonne Univ, Res Ctr Myol, Inst Myol, UMRS 974,INSERM, Paris, France; [Diakonov, Ivan A.; Gorelik, Julia] Imperial Coll London, Natl Heart & Lung Inst, Dept Cardiac Med, London, England; [Ziyadeh-Isleem, Azza; Guicheney, Pascale] INSERM, UMRS 1166, Inst Cardiometab & Nutr ICAN, Paris, France; [Ziyadeh-Isleem, Azza; Guicheney, Pascale] Sorbonne Univ, UMRS 1166, Paris, France; [Reilly, Mary M.] UCL Inst Neurol, MRC, Ctr Neuromuscular Dis, Queen Sq London, London, England	Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of London; University College London	Sheychuk, A (corresponding author), Imperial Coll London, Dept Med, Hammersmith Campus,Du Cane Rd, London W12 0NN, England.	a.shevchuk@ic.ac.uk	vassilopoulos, stéphane/F-6041-2014; vassilopoulos, stephane/AAF-3865-2021; Bednarska, Joanna/ABG-3589-2020; Bitoun, Marc/M-4720-2017	vassilopoulos, stephane/0000-0003-0172-330X; Reilly, Mary/0000-0003-0686-905X; Gorelik, Julia/0000-0003-1148-9158; Bitoun, Marc/0000-0002-4188-7918	Muscular Dystrophy UK [P49914]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M022080/1]; Agence Nationale de la Recherche [ANR-14-CE12-0009, ANR-14-CE12-0001-01]; British Heart Foundation (BHF) [RG/17/13/33173]; BBSRC [BB/D020875/1, BB/M022080/1, BB/L005816/1] Funding Source: UKRI	Muscular Dystrophy UK; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Agence Nationale de la Recherche(French National Research Agency (ANR)); British Heart Foundation (BHF)(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank Dr. P. Novak (Queen Mary University of London) for scanning software development, Dr. Andy Rogers (Royal Brompton and Harefield NHS Trust) for expertise in TEM, and Dr. Benedict Reilly-O'Donnell (National Heart and Lung Institute, Department of Cardiac Medicine, Imperial College London, London, United Kingdom) for proofreading of the manuscript. This work was supported by PhD studentship to T.A. from Muscular Dystrophy UK (Grant P49914 to A.S.), Biotechnology and Biological Sciences Research Council (BBSRC) funding to A.S. (BB/M022080/1), the Agence Nationale de la Recherche (Grant ANR-14-CE12-0009 to M.B. and Young Researcher Grant ANR-14-CE12-0001-01 to S.V.), and British Heart Foundation (BHF) funding for J.G. and I.A.D. (RG/17/13/33173). A.S. and Y.K. are shareholders in ICAPPIC, Ltd., a company commercializing nanopipette-based instrumentation. The authors declare no other conflicts of interest.	Aguet F, 2016, MOL BIOL CELL, V27, P3418, DOI 10.1091/mbc.E16-03-0164; Antonny B, 2016, EMBO J, V35, P2270, DOI 10.15252/embj.201694613; Basquin C, 2015, EMBO J, V34, P2147, DOI 10.15252/embj.201490788; Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657; Bitoun M, 2009, NEUROLOGY, V72, P93, DOI 10.1212/01.wnl.0000338624.25852.12; Bitoun M, 2009, HUM MUTAT, V30, P1419, DOI 10.1002/humu.21086; Brodsky FM, 2012, ANNU REV CELL DEV BI, V28, P309, DOI 10.1146/annurev-cellbio-101011-155716; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Claeys KG, 2009, BRAIN, V132, P1741, DOI 10.1093/brain/awp115; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Depienne C, 2007, CURR OPIN NEUROL, V20, P674, DOI 10.1097/WCO.0b013e3282f190ba; Durieux AC, 2010, J MOL MED, V88, P339, DOI 10.1007/s00109-009-0587-4; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Fraysse B, 2016, BIOL OPEN, V5, P1691, DOI 10.1242/bio.020263; Fulizio L, 2005, HUM MUTAT, V25, P82, DOI 10.1002/humu.20119; Gonzalez-Jamett AM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04418-w; Gorelik J, 2002, P NATL ACAD SCI USA, V99, P16018, DOI 10.1073/pnas.252458399; Grove J, 2014, MOL BIOL CELL, V25, P3581, DOI 10.1091/mbc.E14-06-1154; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; GUERRA JM, 1995, APPL PHYS LETT, V66, P3555, DOI 10.1063/1.113814; HANSMA PK, 1989, SCIENCE, V243, P641, DOI 10.1126/science.2464851; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; HEUSER J, 1980, J CELL BIOL, V84, P560, DOI 10.1083/jcb.84.3.560; Heuser JE, 2000, TRAFFIC, V1, P35, DOI 10.1034/j.1600-0854.2000.010106.x; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Kenniston JA, 2010, EMBO J, V29, P3054, DOI 10.1038/emboj.2010.187; Keyel PA, 2004, J BIOL CHEM, V279, P13190, DOI 10.1074/jbc.M312717200; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Korchev YE, 1997, BIOPHYS J, V73, P653, DOI 10.1016/S0006-3495(97)78100-1; Korchev YE, 2000, BIOPHYS J, V78, P451, DOI 10.1016/S0006-3495(00)76607-0; Korchev YE, 1997, J MICROSC-OXFORD, V188, P17, DOI 10.1046/j.1365-2818.1997.2430801.x; Koutsopoulos OS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027498; Kumamoto T, 2000, MUSCLE NERVE, V23, P1686, DOI 10.1002/1097-4598(200011)23:11<1686::AID-MUS3>3.0.CO;2-F; Lajoie P, 2009, J CELL MOL MED, V13, P3218, DOI 10.1111/j.1582-4934.2009.00732.x; Lamaze C, 2017, CURR OPIN CELL BIOL, V47, P117, DOI 10.1016/j.ceb.2017.02.014; Li D, 2015, SCIENCE, V349, DOI 10.1126/science.aab3500; Liu YW, 2011, TRAFFIC, V12, P1620, DOI 10.1111/j.1600-0854.2011.01250.x; Liu YW, 2008, MOL BIOL CELL, V19, P5347, DOI 10.1091/mbc.E08-08-0890; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Mettlen M, 2009, BIOCHEM SOC T, V37, P1022, DOI 10.1042/BST0371022; Mooren OL, 2009, J BIOL CHEM, V284, P23995, DOI 10.1074/jbc.M109.024398; Nassoy P, 2012, TRENDS CELL BIOL, V22, P381, DOI 10.1016/j.tcb.2012.04.007; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; Novak P, 2009, NAT METHODS, V6, P279, DOI [10.1038/NMETH.1306, 10.1038/nmeth.1306]; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Puri C, 2009, J BIOL CHEM, V284, P34998, DOI 10.1074/jbc.M109.012328; Rappoport JZ, 2003, J CELL SCI, V116, P847, DOI 10.1242/jcs.00289; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; Sambuughin N, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0481-3; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schlunck G, 2004, MOL BIOL CELL, V15, P256, DOI 10.1091/mbc.E03-01-0019; Schoneberg J, 2018, MOL BIOL CELL, V29, P2959, DOI 10.1091/mbc.E18-06-0375; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Shevchuk AI, 2006, ANGEW CHEM INT EDIT, V45, P2212, DOI 10.1002/anie.200503915; Shevchuk AI, 2008, PFLUG ARCH EUR J PHY, V456, P227, DOI 10.1007/s00424-007-0410-4; Shevchuk AI, 2012, J CELL BIOL, V197, P499, DOI 10.1083/jcb.201109130; Shin W, 2018, CELL, V173, P934, DOI 10.1016/j.cell.2018.02.062; Sidiropoulos PNM, 2012, BRAIN, V135, P1395, DOI 10.1093/brain/aws061; Sochacki KA, 2014, NAT METHODS, V11, P305, DOI 10.1038/nmeth.2816; Stan RV, 2005, BBA-MOL CELL RES, V1746, P334, DOI 10.1016/j.bbamcr.2005.08.008; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Toussaint A, 2011, ACTA NEUROPATHOL, V121, P253, DOI 10.1007/s00401-010-0754-2; Trinder D, 1996, HEPATOLOGY, V23, P1512, DOI 10.1002/hep.510230631; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Wang L, 2010, J BIOL CHEM, V285, P22751, DOI 10.1074/jbc.C110.130013; Wu XF, 2001, J CELL BIOL, V155, P291, DOI 10.1083/jcb.200104085; Yoshida A, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004786; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhao WD, 2016, NATURE, V534, P548, DOI 10.1038/nature18598; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	73	14	14	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8504	8518		10.1096/fj.201802635R	http://dx.doi.org/10.1096/fj.201802635R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	31017801	Green Published, hybrid			2022-12-28	WOS:000476234700055
J	Wixler, V				Wixler, Viktor			The role of FHL2 in wound healing and inflammation	FASEB JOURNAL			English	Review						protein-protein interaction; cell signaling; gene transcription; immune cell infiltration; extracellular matrix remodeling	ONLY PROTEIN FHL2; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-NECROSIS-FACTOR; LIM DOMAIN PROTEIN-2; TRANSCRIPTIONAL COACTIVATOR; EXTRACELLULAR-MATRIX; BETA-CATENIN; EXPRESSION; GENE; CELLS	The 4-and-a-half LIM domain protein 2 (FHL2) is a multifunctional adaptor protein that can interact with cell surface receptors, cytosolic adaptor and structural proteins, kinases, and nuclear transcription factors. It is involved in numerous functional activities, including the epithelial-mesenchymal transition, cell proliferation, apoptosis, adhesion, migration, structural stability, and gene expression. Despite this, FHL2-knockout (KO) mice are viable and fertile with no obvious abnormalities, rather suggesting a high capacity for fine-tuning adjustment and functional redundancy of FHL2. Indeed, challenging FHL2-KO cells or mice provided numerous evidences for the great functional significance of FHL2. In recent years, several reviews have been published describing the high capacity of FHL2 to bind diverse proteins as well as the versatile functions of FHL2, emphasizing in particular its role in cardiovascular diseases and carcinogenesis. Here, we view the function of FHL2 from a different perspective. We summarize the published data demonstrating the impact of FHL2 on wound healing and inflammation. FHL2 seems to be involved in numerous steps of these extremely complex and multidirectional but tightly regulated tissue remodeling processes, supporting tissue repair and coordinating inflammation. Deficiency of FHL2 not only slows down ongoing wound healing but also often turns it into a chronic condition.-Wixler, V. The role of FHL2 in wound healing and inflammation.	[Wixler, Viktor] Westfaelische Wilhelms Univ Muenster, Ctr Mol Biol Inflammat, Inst Mol Virol, Munster, Germany		Wixler, V (corresponding author), Westfaelische Wilhelms Univ Muenster, Inst Mol Virol, Von Esmarch St 56, D-48149 Munster, Germany.	vwixler@uni-muenster.de			Sander Foundation; Deutsche Forschungsgemeinschaft; Interdisciplinary Center for Clinical Research (Muenster, Germany)	Sander Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (Muenster, Germany)	The author is grateful to Drs. Bernd Martin (Medical Affairs, Genzyme, Neu-Isenburg, Germany) and Yvonne Boergeling (Institute of Molecular Virology, Westfaelische Wilhelms-University, Muenster, Germany) for critical reading of the manuscript and valuable suggestions. This study was supported by the Sander Foundation, the Deutsche Forschungsgemeinschaft, and the Interdisciplinary Center for Clinical Research (Muenster, Germany). The author declares no conflicts of interest.	Alnajar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081356; Armstrong DG, 2002, J AM PODIAT MED ASSN, V92, P12, DOI 10.7547/87507315-92-1-12; Bai S, 2008, J BIOL CHEM, V283, P30861, DOI 10.1074/jbc.M802525200; Bai ST, 2005, J CLIN INVEST, V115, P2742, DOI 10.1172/JCI24921; Baranek T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00123; Barros JC, 2005, J CELL SCI, V118, P1663, DOI 10.1242/jcs.02308; Boateng LR, 2016, J BIOL CHEM, V291, P13987, DOI 10.1074/jbc.M116.725739; Cai T, 2018, J CELL MOL MED, V22, P1684, DOI 10.1111/jcmm.13446; Caley MP, 2015, ADV WOUND CARE, V4, P225, DOI 10.1089/wound.2014.0581; Canault M, 2006, J CELL PHYSIOL, V208, P363, DOI 10.1002/jcp.20671; Cao CY, 2015, GENE, V572, P1, DOI 10.1016/j.gene.2015.07.043; Chiquet M, 2007, APPL PHYSIOL NUTR ME, V32, P967, DOI 10.1139/H07-053; Chu Pao-Hsien, 2011, Chang Gung Med J, V34, P127; Chu PH, 2010, LIFE SCI, V86, P365, DOI 10.1016/j.lfs.2010.01.007; Dahan J, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00636-16; Dahan J, 2013, MOL CELL BIOL, V33, P3299, DOI 10.1128/MCB.00105-13; Dantas RL, 2017, AM J PATHOL, V187, P2388, DOI 10.1016/j.ajpath.2017.07.015; Dantas RL, 2016, J PATHOL, V240, P366, DOI 10.1002/path.4786; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Ding LH, 2009, J CLIN INVEST, V119, P349, DOI 10.1172/JCI35930; Ebrahimian T, 2014, CIRC RES, V114, P114, DOI 10.1161/CIRCRESAHA.113.301954; Eckes B, 2006, J INVEST DERM SYMP P, V11, P66, DOI 10.1038/sj.jidsymp.5650003; Enoch S., 2005, SURGERY, V23, P37, DOI DOI 10.1016/J.MPSUR.2007.11.005; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Freire-Aradas A, 2017, Forensic Sci Rev, V29, P121; Friedrich FW, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0451-8; Genini M, 1997, DNA CELL BIOL, V16, P433, DOI 10.1089/dna.1997.16.433; Goltz D, 2016, LIFE SCI, V151, P348, DOI 10.1016/j.lfs.2016.02.084; Gullotti L, 2011, LAB INVEST, V91, P1695, DOI 10.1038/labinvest.2011.109; Gunther T, 2005, EMBO J, V24, P3049, DOI 10.1038/sj.emboj.7600773; Hamidouche Z, 2008, FASEB J, V22, P3813, DOI 10.1096/fj.08-106302; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2015, MATRIX BIOL, V47, P54, DOI 10.1016/j.matbio.2015.05.006; Huang PH, 2013, ARTERIOSCL THROM VAS, V33, P709, DOI 10.1161/ATVBAHA.112.300318; Huss S, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-9; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Joos H, 2008, MOL MED, V14, P150, DOI 10.2119/2007-00118.Joos; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kim SY, 2019, J CELL SCI, V132, DOI 10.1242/jcs.228940; Kirfel J, 2008, EXP CELL RES, V314, P3684, DOI 10.1016/j.yexcr.2008.09.023; Kleiber K, 2007, ANTICANCER RES, V27, P55; Konig K, 2010, J IMMUNOL, V185, P1466, DOI 10.4049/jimmunol.0903449; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Kurakula K, 2015, ALLERGY, V70, P1531, DOI 10.1111/all.12709; Kurakula K, 2015, EUR J IMMUNOL, V45, P3098, DOI 10.1002/eji.201545627; Kwak HB, 2013, J EXERC REHABIL, V9, P212, DOI [10.12965/jer.130049, 10.12965/jer.130002]; Labalette C, 2008, J BIOL CHEM, V283, P15201, DOI 10.1074/jbc.M800708200; Liang Yan, 2018, Biophys Rev, V10, P1073, DOI 10.1007/s12551-018-0434-3; Martin B, 2002, J CELL BIOL, V159, P113, DOI 10.1083/jcb.200202075; Martin BT, 2007, CELL CYCLE, V6, P1779, DOI 10.4161/cc.6.14.4448; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Masemann D, 2018, AM J PATHOL, V188, P1236, DOI 10.1016/j.ajpath.2018.02.004; McGrath MJ, 2006, J BIOL CHEM, V281, P7666, DOI 10.1074/jbc.M512552200; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Morlon A, 2003, P NATL ACAD SCI USA, V100, P3977, DOI 10.1073/pnas.0735923100; Muller JM, 2002, EMBO J, V21, P736, DOI 10.1093/emboj/21.4.736; Nakazawa N, 2016, P NATL ACAD SCI USA, V113, pE6813, DOI 10.1073/pnas.1608210113; Nordhoff C, 2012, CELL MICROBIOL, V14, P1135, DOI 10.1111/j.1462-5822.2012.01787.x; Park J, 2008, FASEB J, V22, P2508, DOI 10.1096/fj.07-095521; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Rafael MS, 2012, BIOCHIMIE, V94, P1128, DOI 10.1016/j.biochi.2012.01.013; Ribatti D, 2018, CRIT REV ONCOL HEMAT, V128, P65, DOI 10.1016/j.critrevonc.2018.05.016; Rohani MG, 2015, MATRIX BIOL, V44-46, P113, DOI 10.1016/j.matbio.2015.03.002; Samson T, 2004, J BIOL CHEM, V279, P28641, DOI 10.1074/jbc.M312894200; Sarasa-Renedo A, 2005, SCAND J MED SCI SPOR, V15, P223, DOI 10.1111/j.1600-0838.2005.00461.x; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schett G, 2008, ANN RHEUM DIS, V67, P909, DOI 10.1136/ard.2007.074278; Schmolke M, 2010, CELL MICROBIOL, V12, P873, DOI 10.1111/j.1462-5822.2010.01475.x; Scholl FA, 2000, J CELL BIOL, V151, P495, DOI 10.1083/jcb.151.3.495; Tran MK, 2016, BBA-MOL CELL RES, V1863, P219, DOI 10.1016/j.bbamcr.2015.11.002; van den Berg LM, 2012, ANN NY ACAD SCI, V1253, P149, DOI 10.1111/j.1749-6632.2011.06392.x; Verset L, 2016, HISTOL HISTOPATHOL, V31, P469, DOI 10.14670/HH-11-709; Wan S, 2002, INT J CARDIOL, V86, P265, DOI 10.1016/S0167-5273(02)00331-5; Wei Y, 2003, J BIOL CHEM, V278, P5188, DOI 10.1074/jbc.M207216200; Westphal P, 2015, AM J CLIN PATHOL, V143, P248, DOI 10.1309/AJCPXEC6CIT2TXAF; Wixler V, 2000, J BIOL CHEM, V275, P33669, DOI 10.1074/jbc.M002519200; Wixler V, 2007, J CELL BIOL, V177, P163, DOI 10.1083/jcb.200606043; Wixler V, 2015, ANN RHEUM DIS, V74, P2216, DOI 10.1136/annrheumdis-2013-205061; Wong CH, 2012, CYTOKINE, V59, P286, DOI 10.1016/j.cyto.2012.04.044; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xia T, 2013, J BIOL CHEM, V288, P1785, DOI 10.1074/jbc.M112.439760; You S, 2018, ARTHRITIS RHEUMATOL, V70, P637, DOI 10.1002/art.40406; Zaal A, 2017, J LEUKOCYTE BIOL, V102, P1035, DOI 10.1189/jlb.2MA0217-058R; Zhang WJ, 2010, CARCINOGENESIS, V31, P1220, DOI 10.1093/carcin/bgq094; Zhou SG, 2018, EUR REV MED PHARMACO, V22, P2734, DOI 10.26355/eurrev_201805_14970	86	11	11	3	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					7799	7809		10.1096/fj.201802765RR	http://dx.doi.org/10.1096/fj.201802765RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30939249	Bronze			2022-12-28	WOS:000476234700002
J	Takakura, A; Zandi-Nejad, K				Takakura, Ayumi; Zandi-Nejad, Kambiz			Lactate-induced activation of HCA2 improves survival in mice with sepsis	FASEB JOURNAL			English	Article						macrophages; acute kidney injury (AKI); PGC1 alpha; CLP; pro-inflammatory cytokines	NICOTINIC-ACID; RINGERS SOLUTION; MOLECULAR-IDENTIFICATION; SYSTEMIC INFLAMMATION; KIDNEY INJURY; NORMAL SALINE; PUMA-G; GPR109A; RECEPTOR; MACROPHAGES	Sepsis is characterized by systemic inflammation that is caused by infection and by activation of proinflammatory pathways, resulting in mitochondrial and cellular dysfunction leading to multiorgan failure. Here, we show the following: 1) in peritoneal immune cells, particularly macrophages, from mice that have undergone cecal ligation and puncture (CLP), hydroxycarboxylic acid receptor 2 (HCA2) expression increased in parallel with proinflammatory cytokines; 2) post-CLP survival rates of Hca2(-/-) knockout mice (n = 22) were lower than those of wild-type (WT) mice (n = 15) (P < 0.011), which is suggestive of a protective role for HCA2 in sepsis; 3) WT mice subjected to CLP-induced sepsis and treated with lactated Ringer's solution (LR, n = 13) survived longer than those treated with normal saline (n = 14; P < 0.027); 4) LR treatment of CLP-induced sepsis reduced proinflammatory cytokine expression in CD11b(+)F4/80(+) macrophages and promoted M2-like polarization; 5) HCA2 was expressed by kidney in the setting of sepsis, but not by normal kidneys; 6) LR administration attenuated sepsis-associated acute kidney injury (AKI), partly restored expression of the key regulator of mitochondrial biogenesis, peroxisome proliferator-activated receptor gamma coactivator 1 alpha (P < 0.03), and reduced proinflammatory cytokine production (TNF-alpha, P < 0.04; IL-1 beta, P < 0.006; IL-6, P < 0.03). Our data suggest that lactate-induced activation of HCA2 during sepsis activates a negative feedback loop to attenuate the inflammatory response. The data further suggest that fluid resuscitation with LR may benefit patients with sepsis, particularly those with sepsis-associated AKI treated with potentially lactate-depleting renal replacement therapies.-Takakura, A., Zandi-Nejad, K. Lactate-induced activation of HCA2 improves survival in mice with sepsis.	[Takakura, Ayumi] Harvard Med Sch, Brigham & Womens Hosp, Renal Div, Boston, MA 02115 USA; [Zandi-Nejad, Kambiz] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Nephrol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Zandi-Nejad, K (corresponding author), Beth Israel Deaconess Med Ctr, Div Nephrol, Res North,Room 330F,E-RN 304,330 Brookline Ave, Boston, MA 02115 USA.	kzandi@bidmc.harvard.edu						Andersen LW, 2013, MAYO CLIN PROC, V88, P1127, DOI 10.1016/j.mayocp.2013.06.012; Benyo Z, 2005, J CLIN INVEST, V115, P3634, DOI 10.1172/JCI23626; Bermudez Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020487; Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Buxbaum J, 2014, CLIN GASTROENTEROL H, V12, P303, DOI 10.1016/j.cgh.2013.07.026; Cho YS, 2007, EMERG MED J, V24, P276, DOI 10.1136/emj.2006.043265; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Doi K, 2009, J CLIN INVEST, V119, P2868, DOI 10.1172/JCI39421; Doi K, 2009, J AM SOC NEPHROL, V20, P1217, DOI 10.1681/ASN.2008060617; Errea A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163694; FISHER CJ, 1994, JAMA-J AM MED ASSOC, V271, P1836, DOI 10.1001/jama.271.23.1836; Gliem M, 2012, ANN NEUROL, V71, P743, DOI 10.1002/ana.23529; Hadimioglu N, 2008, ANESTH ANALG, V107, P264, DOI 10.1213/ane.0b013e3181732d64; Hanson J, 2010, J CLIN INVEST, V120, P2910, DOI 10.1172/JCI42273; Hoque R, 2014, GASTROENTEROLOGY, V146, P1763, DOI 10.1053/j.gastro.2014.03.014; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Khajavi MR, 2008, RENAL FAILURE, V30, P535, DOI 10.1080/08860220802064770; Kostylina G, 2008, CELL DEATH DIFFER, V15, P134, DOI 10.1038/sj.cdd.4402238; Lopez-Bojorquez L, 2004, ARCH MED RES, V35, P465, DOI 10.1016/j.arcmed.2004.07.006; Maciejewski-Lenoir D, 2006, J INVEST DERMATOL, V126, P2637, DOI 10.1038/sj.jid.5700586; Martin PM, 2009, MOL VIS, V15, P362; Mehta A, 2004, SHOCK, V22, P423, DOI 10.1097/01.shk.0000142184.49976.0c; Nemzek JA, 2008, COMPARATIVE MED, V58, P120; Offermanns S, 2011, PHARMACOL REV, V63, P269, DOI 10.1124/pr.110.003301; Osuchowski MF, 2006, J IMMUNOL, V177, P1967, DOI 10.4049/jimmunol.177.3.1967; Rahman M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4944; Reinhart K, 2001, CRIT CARE MED, V29, pS121, DOI 10.1097/00003246-200107001-00037; Reinhart K, 2001, CRIT CARE MED, V29, P765, DOI 10.1097/00003246-200104000-00015; Remick DG, 2000, SHOCK, V13, P110, DOI 10.1097/00024382-200013020-00004; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Schaub A, 2001, EUR J IMMUNOL, V31, P3714, DOI 10.1002/1521-4141(200112)31:12<3714::AID-IMMU3714>3.0.CO;2-1; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Semler MW, 2018, NEW ENGL J MED, V378, P829, DOI 10.1056/NEJMoa1711584; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Tang H, 2008, BIOCHEM BIOPH RES CO, V375, P562, DOI 10.1016/j.bbrc.2008.08.041; Thangaraju M, 2009, CANCER RES, V69, P2826, DOI 10.1158/0008-5472.CAN-08-4466; Todd SR, 2007, J TRAUMA, V62, P636, DOI 10.1097/TA.0b013e31802ee521; Tran M, 2011, J CLIN INVEST, V121, P4003, DOI 10.1172/JCI58662; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; WANG P, 1991, American Journal of Physiology, V261, pR1507; Ward PA, 2012, AM J PATHOL, V181, P2, DOI 10.1016/j.ajpath.2012.05.003; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Wu BU, 2011, CLIN GASTROENTEROL H, V9, P710, DOI 10.1016/j.cgh.2011.04.026; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Zandi-Nejad K, 2013, FASEB J, V27, P4366, DOI 10.1096/fj.12-223933	48	8	8	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7625	7634		10.1096/fj.201801982R	http://dx.doi.org/10.1096/fj.201801982R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30951370	Bronze			2022-12-28	WOS:000476114200077
J	Shah, D; Torres, C; Bhandari, V				Shah, Dilip; Torres, Claudio; Bhandari, Vineet			Adiponectin deficiency induces mitochondrial dysfunction and promotes endothelial activation and pulmonary vascular injury	FASEB JOURNAL			English	Article						PGC-1 alpha mitochondria biogenesis; endothelial dysfunction; acute lung injury; adipokine	ACUTE LUNG INJURY; PYRROLOQUINOLINE QUINONE PQQ; OXIDATIVE STRESS; INFLAMMATION; BIOGENESIS; PROTEIN; SYSTEM; DNA	Adiponectin (APN), an adipocyte-derived adipokine, has been shown to limit lung injury originating from endothelial cell (EC) damage. Previously we reported that obese mice with low circulatory APN levels exhibited pulmonary vascular endothelial dysfunction. This study was designed to investigate the cellular and molecular mechanisms underlying the pulmonary endothelium-dependent protective effects of APN. Our results demonstrated that in APN(-/-) mice, there was an inherent state of endothelium mitochondrial dysfunction that could contribute to endothelial activation and increased susceptibility to LPS-induced acute lung injury (ALI). We noted that APN(-/-) mice showed decreased expression of mitochondrial biogenesis regulatory protein peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 alpha) and its downstream proteins nuclear respiratory factor 1, transcription factor A, mitochondrial, and Sirtuin (Sirt)3 and Sirt1 expression in whole lungs and in freshly isolated lung ECs from these mice at baseline and subjected to LPS-induced ALI. We further showed that treating APN(-/-) mice with PGC-1 alpha activator pyrroloquinoline quinone enhances mitochondrial biogenesis and function in lung endothelium and attenuation of ALI. These results suggest that the pulmonary endothelium-protective properties of APN are mediated, at least in part, by an enhancement of mitochondrial biogenesis through a mechanism involving PGC-1 alpha activation.	[Shah, Dilip; Bhandari, Vineet] Drexel Univ, Coll Med, Dept Pediat, New Coll Bldg,Suite 7408,245 N Broad St, Philadelphia, PA 19104 USA; [Torres, Claudio] Drexel Univ, Coll Med, Dept Neurobiol & Anat Microbiol & Immunol, Philadelphia, PA 19104 USA	Drexel University; Drexel University	Shah, D (corresponding author), Drexel Univ, Coll Med, Dept Pediat, New Coll Bldg,Suite 7408,245 N Broad St, Philadelphia, PA 19104 USA.	dks74@drexel.edu	Bhandari, Vineet/AAS-3365-2020	Shah, Dilip/0000-0002-4248-5611	Departmental of Pediatrics; Drexel University Fund [282656]; U.S. National Institutes of Health, National Institute on Aging [1R56AG056696-01]; Commonwealth Universal Research Enhancement Program (CURE) [450095-5626]; NATIONAL INSTITUTE ON AGING [R56AG056696] Funding Source: NIH RePORTER	Departmental of Pediatrics; Drexel University Fund; U.S. National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Commonwealth Universal Research Enhancement Program (CURE); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Departmental of Pediatrics and Drexel University Fund (282656 to D.S. and V.B.), U.S. National Institutes of Health, National Institute on Aging 1R56AG056696-01 (to C.T.), and the Commonwealth Universal Research Enhancement Program (CURE; 450095-5626 to D.S., C.T., and V.B.). The authors declare no conflicts of interest.	Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Cherry AD, 2014, J BIOL CHEM, V289, P41, DOI 10.1074/jbc.M113.512483; Chowanadisai W, 2010, J BIOL CHEM, V285, P142, DOI 10.1074/jbc.M109.030130; Cloonan SM, 2016, J CLIN INVEST, V126, P809, DOI 10.1172/JCI81113; Eising JB, 2014, EUR RESPIR J, V43, P1189, DOI 10.1183/09031936.00149613; Gurung P, 2015, TRENDS MOL MED, V21, P193, DOI 10.1016/j.molmed.2014.11.008; Harris CB, 2013, J NUTR BIOCHEM, V24, P2076, DOI 10.1016/j.jnutbio.2013.07.008; Henderson WR, 2017, AM J RESP CRIT CARE, V196, P822, DOI 10.1164/rccm.201612-2495CI; Hough RF, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124329; Japiassu AM, 2011, CRIT CARE MED, V39, P1056, DOI 10.1097/CCM.0b013e31820eda5c; Johansson PI, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2275-7; Kang NY, 2018, ADV EXP MED BIOL, V1071, P151, DOI 10.1007/978-3-319-91137-3_19; Konter JM, 2012, J IMMUNOL, V188, P854, DOI 10.4049/jimmunol.1100426; Kumar N, 2015, CHEM-BIOL INTERACT, V240, P278, DOI 10.1016/j.cbi.2015.08.027; Kumar N, 2015, CAN J PHYSIOL PHARM, V93, P71, DOI 10.1139/cjpp-2014-0270; Kung CT, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-130; Kurundkar D, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.120722; Lee Seung Jae, 2017, Biomed Hub, V2, P1, DOI 10.1159/000460813; Lee YL, 2017, SHOCK, V48, P54, DOI 10.1097/SHK.0000000000000838; Liu QY, 2018, MOL IMMUNOL, V103, P115, DOI 10.1016/j.molimm.2018.09.010; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; McGovern TK, 2013, JOVE-J VIS EXP, DOI 10.3791/50172; Mora-Rillo M, 2015, LANCET RESP MED, V3, P554, DOI 10.1016/S2213-2600(15)00180-0; Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367; Nakahira K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001577; Ouedraogo R, 2007, J CLIN INVEST, V117, P1718, DOI 10.1172/JCI29623; Piao LM, 2018, INT J CARDIOL, V267, P150, DOI 10.1016/j.ijcard.2018.05.089; Ponnalagu D, 2016, MITOCHONDRION, V27, P6, DOI 10.1016/j.mito.2016.01.001; Qiao LP, 2012, DIABETES, V61, P1463, DOI 10.2337/db11-1475; Reiss LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024527; Rocco PRM, 2003, EUR RESPIR J, V22, P20, DOI 10.1183/09031936.03.00108603; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rub C, 2017, CELL TISSUE RES, V367, P111, DOI 10.1007/s00441-016-2485-8; SHAH D, 2016, AM J RESP CRIT CARE, V193; Shah D, 2019, AM J RESP CELL MOL, V60, P465, DOI 10.1165/rcmb.2018-0194OC; Shah D, 2015, J BIOL CHEM, V290, P29642, DOI 10.1074/jbc.M115.690784; Shah D, 2015, SCI REP-UK, V5, DOI 10.1038/srep11362; Sliman SM, 2013, CELL BIOCHEM BIOPHYS, V67, P399, DOI 10.1007/s12013-011-9330-1; Stites T, 2006, J NUTR, V136, P390, DOI 10.1093/jn/136.2.390; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; van Meurs M, 2012, SHOCK, V37, P392, DOI 10.1097/SHK.0b013e318248225e; Xu B, 2016, J BIOL CHEM, V291, P19274, DOI 10.1074/jbc.M116.740324; Xu L, 2013, J SURG RES, V183, P752, DOI 10.1016/j.jss.2013.01.055; Yan WJ, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0329-1; Zhang Q, 2010, SHOCK, V34, P55, DOI 10.1097/SHK.0b013e3181cd8c08; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhang Y, 2014, J IMMUNOL, V192, P5296, DOI 10.4049/jimmunol.1400653; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	48	14	14	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13617	13631		10.1096/fj.201901123R	http://dx.doi.org/10.1096/fj.201901123R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31585050	Green Published, Bronze			2022-12-28	WOS:000507466100045
J	Cil, O; Anderson, MO; Yen, R; Kelleher, B; Huynh, TL; Seo, Y; Nilsen, SP; Turner, JR; Verkman, AS				Cil, Onur; Anderson, Marc O.; Yen, Robert; Kelleher, Bryan; Huynh, Tony L.; Seo, Youngho; Nilsen, Steven P.; Turner, Jerrold R.; Verkman, Alan S.			Slowed gastric emptying and improved oral glucose tolerance produced by a nanomolar-potency inhibitor of calcium-activated chloride channel TMEM16A	FASEB JOURNAL			English	Article						transmembrane member 16A; obesity; diabetes mellitus; interstitial cells of Cajal	INTERSTITIAL-CELLS; DUMPING SYNDROME; CAJAL; PROTEIN; KIT; PATHOPHYSIOLOGY; EXPRESSION; DIAGNOSIS; MOTILITY; AGONISTS	Interstitial cells of Cajal, which express the calcium-activated chloride channel transmembrane member 16A (TMEM16A), are an important determinant of gastrointestinal (GI) motility. We previously identified the acylaminocycloalkylthiophene class of TMEM16A inhibitors, which, following medicinal chemistry, gave analog 2-bromodifluoroacetylamino-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxylic acid o-tolylamide (TMinh-23) with 30 nM half-maximal inhibitory concentration. Here, we tested the efficacy of TMinh-23 for inhibition of GI motility in mice. In isolated murine gastric antrum, TMinh-23 strongly inhibited spontaneous and carbachol-stimulated rhythmic contractions. Pharmacokinetic analysis showed predicted therapeutic concentrations of TMinh-23 for at least 4 h following a single oral or intraperitoneal dose at 10 mg/kg. Gastric emptying, as assessed following an oral bolus of phenol red or independently by [Tc-99m]-diethylenetriamine pentaacetic acid scintigraphy, was reduced by TMinh-23 by similar to 60% at 20 min. Interestingly, there was little effect of TMinh-23 on baseline whole-gut transit time or time to diarrhea induced by castor oil. Consequent to the delay in gastric emptying, TMinh-23 administration significantly reduced the elevation in blood sugar in mice following an oral but not intraperitoneal glucose load. These results provide pharmacological evidence for involvement of TMEM16A in gastric emptying and suggest the utility of TMEM16A inhibition in disorders of accelerated gastric emptying, such as dumping syndrome, and potentially for improving glucose tolerance in diabetes mellitus/metabolic syndrome and enhancing satiety in obesity.-Cil, O., Anderson, M. O., Yen, R., Kelleher, B., Huynh, T. L., Seo, Y., Nilsen, S. P., Turner, J. R., Verkman, A. S. Slowed gastric emptying and improved oral glucose tolerance produced by a nanomolar-potency inhibitor of calcium-activated chloride channel TMEM16A.	[Cil, Onur; Verkman, Alan S.] Univ Calif San Francisco, Dept Med & Physiol, San Francisco, CA 94158 USA; [Cil, Onur] Univ Calif San Francisco, Dept Pediat, 550 16th St, San Francisco, CA 94158 USA; [Huynh, Tony L.; Seo, Youngho] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94158 USA; [Anderson, Marc O.; Yen, Robert; Kelleher, Bryan] San Francisco State Univ, Dept Chem & Biochem, San Francisco, CA 94132 USA; [Nilsen, Steven P.; Turner, Jerrold R.] Harvard Med Sch, Dept Pathol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Nilsen, Steven P.; Turner, Jerrold R.] Harvard Med Sch, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; California State University System; San Francisco State University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Cil, O (corresponding author), Univ Calif San Francisco, Dept Pediat, 550 16th St, San Francisco, CA 94158 USA.	onur.cil@ucsf.edu	Seo, Youngho/D-5705-2013; Cil, Onur/AAK-5166-2020	Seo, Youngho/0000-0001-5908-6636; Cil, Onur/0000-0001-5178-0199; Huynh, Tony/0000-0003-2964-1795	American Heart Association [18POST33990365]; Cystic Fibrosis Foundation [VERKMA18G0]; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK72517, DK099803, DK101373]; NIH National Eye Institute [EY13574]; NIH National Institute of General Medical Sciences [GM102874]; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072517, R01DK101373, R24DK099803] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the American Heart Association (18POST33990365), the Cystic Fibrosis Foundation (VERKMA18G0), and grants from the U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (DK72517, DK099803, DK101373), NIH National Eye Institute (EY13574), and NIH National Institute of General Medical Sciences (GM102874). The authors declare no conflicts of interest.	Acosta A, 2015, GASTROENTEROLOGY, V148, P537, DOI 10.1053/j.gastro.2014.11.020; Berg P, 2016, DIGEST DIS SCI, V61, P11, DOI 10.1007/s10620-015-3839-x; Bharucha AE, 2015, CLIN GASTROENTEROL H, V13, P466, DOI 10.1016/j.cgh.2014.06.034; Bharucha AE, 2009, CLIN ENDOCRINOL, V70, P415, DOI 10.1111/j.1365-2265.2008.03351.x; Blair PJ, 2014, J NEUROGASTROENTEROL, V20, P294, DOI 10.5056/jnm14060; Camacho S, 2015, SCI REP-UK, V5, DOI 10.1038/srep07919; Chen CQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145556; Cil O, 2016, CELL MOL GASTROENTER, V2, P317, DOI 10.1016/j.jcmgh.2015.12.010; Cipriani G, 2018, GASTROENTEROLOGY, V154, P2122, DOI 10.1053/j.gastro.2018.02.027; Crutzen R, 2016, PFLUG ARCH EUR J PHY, V468, P573, DOI 10.1007/s00424-015-1758-5; Der-Silaphet T, 1998, GASTROENTEROLOGY, V114, P724, DOI 10.1016/S0016-5085(98)70586-4; Galligan JJ, 2017, HANDB EXP PHARMACOL, V239, P363, DOI 10.1007/164_2016_116; Goineau S, 2015, FUND CLIN PHARMACOL, V29, P86, DOI 10.1111/fcp.12086; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Goyal RK, 2019, NEUROGASTROENT MOTIL, V31, DOI 10.1111/nmo.13546; Hayashi Y, 2017, GASTROENTEROLOGY, V153, P521, DOI 10.1053/j.gastro.2017.04.020; Holst JJ, 2016, DIABETES CARE, V39, P884, DOI 10.2337/dc16-0351; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Hwang SJ, 2019, J PHYSIOL-LONDON, V597, P2337, DOI 10.1113/JP277335; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Ishii S, 2009, J GASTROENTEROL, V44, P834, DOI 10.1007/s00535-009-0077-z; Kamaleddin MA, 2018, J CELL PHYSIOL, V233, P787, DOI 10.1002/jcp.25823; Kramer CK, 2014, DIABETES RES CLIN PR, V105, P88, DOI 10.1016/j.diabres.2014.04.023; Lamont BJ, 2008, DIABETES, V57, P190, DOI 10.2337/db07-1202; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Nesher R, 2002, DIABETES, V51, pS53, DOI 10.2337/diabetes.51.2007.S53; Padmanabhan P, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-60; Picollo A, 2015, J MOL BIOL, V427, P94, DOI 10.1016/j.jmb.2014.09.028; Pietra G, 2016, J GEN PHYSIOL, V148, P293, DOI 10.1085/jgp.201611622; Rauniyar N, 2015, INT J MOL SCI, V16, P28566, DOI 10.3390/ijms161226120; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Sanders KM, 2016, PHYSIOLOGY, V31, P316, DOI 10.1152/physiol.00006.2016; Schirra J, 1996, J CLIN INVEST, V97, P92, DOI 10.1172/JCI118411; Seo Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155771; Sharma D, 2018, BIOMED PHARMACOTHER, V108, P952, DOI 10.1016/j.biopha.2018.08.088; Sobczak M, 2014, EUR J PHARMACOL, V736, P63, DOI 10.1016/j.ejphar.2014.04.038; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Sun TY, 2018, AGING-US, V10, P3851, DOI 10.18632/aging.101677; Takaki M, 2010, PROG BIOPHYS MOL BIO, V102, P129, DOI 10.1016/j.pbiomolbio.2010.05.007; Torihashi S, 1999, J AUTONOM NERV SYST, V75, P38, DOI 10.1016/S0165-1838(98)00174-X; Truong EC, 2017, J MED CHEM, V60, P4626, DOI 10.1021/acs.jmedchem.7b00020; Tunaru S, 2012, P NATL ACAD SCI USA, V109, P9179, DOI 10.1073/pnas.1201627109; van Beek AP, 2017, OBES REV, V18, P68, DOI 10.1111/obr.12467; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Yasutomi E, 2018, DIGEST DIS SCI, V63, P881, DOI 10.1007/s10620-017-4905-3; Yin JY, 2006, DIGEST DIS SCI, V51, P1818, DOI 10.1007/s10620-006-9313-z	46	9	9	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11247	11257		10.1096/fj.201900858R	http://dx.doi.org/10.1096/fj.201900858R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31299174	Green Published			2022-12-28	WOS:000489166300055
J	Diquigiovanni, C; Bergamini, C; Diaz, R; Liparulo, I; Bianco, F; Masin, L; Baldassarro, VA; Rizzardi, N; Tranchina, A; Buscherini, F; Wischmeijer, A; Pippucci, T; Scarano, E; Cordelli, DM; Fato, R; Seri, M; Paracchini, S; Bonora, E				Diquigiovanni, Chiara; Bergamini, Christian; Diaz, Rebeca; Liparulo, Irene; Bianco, Francesca; Masin, Luca; Baldassarro, Vito Antonio; Rizzardi, Nicola; Tranchina, Antonia; Buscherini, Francesco; Wischmeijer, Anita; Pippucci, Tommaso; Scarano, Emanuela; Cordelli, Duccio Maria; Fato, Romana; Seri, Marco; Paracchini, Silvia; Bonora, Elena			A novel mutation in SPART gene causes a severe neurodevelopmental delay due to mitochondrial dysfunction with complex I impairments and altered pyruvate metabolism	FASEB JOURNAL			English	Article						Spartin; Spg20; mitochondria	SYNDROME PROTEIN SPARTIN; TROYER-SYNDROME; SPASTIC PARAPLEGIA; OXIDATIVE STRESS; SPG20; IDENTIFICATION; INACTIVATION; DISORDERS; CHILDREN; FEATURES	Loss-of-function mutations in the SPART gene cause Troyer syndrome, a recessive form of spastic paraplegia resulting in muscle weakness, short stature, and cognitive defects. SPART encodes for Spartin, a protein linked to endosomal trafficking and mitochondrial membrane potential maintenance. Here, we identified with whole exome sequencing (WES) a novel frameshift mutation in the SPART gene in 2 brothers presenting an uncharacterized developmental delay and short stature. Functional characterization in an SH-SY5Y cell model shows that this mutation is associated with increased neurite outgrowth. These cells also show a marked decrease in mitochondrial complex I (NADH dehydrogenase) activity, coupled to decreased ATP synthesis and defective mitochondrial membrane potential. The cells also presented an increase in reactive oxygen species, extracellular pyruvate, and NADH levels, consistent with impaired complex I activity. In concordance with a severe mitochondrial failure, Spartin loss also led to an altered intracellular Ca2+ homeostasis that was restored after transient expression of wild-type Spartin. Our data provide for the first time a thorough assessment of Spartin loss effects, including impaired complex I activity coupled to increased extracellular pyruvate. In summary, through a WES study we assign a diagnosis of Troyer syndrome to otherwise undiagnosed patients, and by functional characterization we show that the novel mutation in SPART leads to a profound bioenergetic imbalance.-Diquigiovanni, C., Bergamini, C., Diaz, R., Liparulo, I., Bianco, F., Masin, L., Baldassarro, V. A., Rizzardi, N., Tranchina, A., Buscherini, F., Wischmeijer, A., Pippucci, T., Scarano, E., Cordelli, D. M., Fato, R., Seri, M., Paracchini, S., Bonora, E. A novel mutation in SPART gene causes a severe neurodevelopmental delay due to mitochondrial dysfunction with complex I impairments and altered pyruvate metabolism.	[Diquigiovanni, Chiara; Bianco, Francesca; Rizzardi, Nicola; Buscherini, Francesco; Pippucci, Tommaso; Seri, Marco; Bonora, Elena] Univ Bologna, St Orsola Malpighi Hosp, Dept Med & Surg Sci DIMEC, Bologna, Italy; [Bergamini, Christian; Liparulo, Irene; Masin, Luca; Tranchina, Antonia; Fato, Romana] Univ Bologna, St Orsola Malpighi Hosp, Dept Pharm & Biotechnol FaBit, Bologna, Italy; [Scarano, Emanuela] Univ Bologna, Rare Dis Unit, Dept Pediat, St Orsola Malpighi Hosp, Bologna, Italy; [Cordelli, Duccio Maria] Univ Bologna, Child Neurol & Psychiat Unit, St Orsola Malpighi Hosp, Bologna, Italy; [Diaz, Rebeca; Paracchini, Silvia] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Baldassarro, Vito Antonio] IRET Fdn, Bologna, Italy; [Wischmeijer, Anita] Reg Hosp South Tyrol, Dept Pediat, Clin Genet Serv, Bolzano, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of St Andrews	Bonora, E (corresponding author), Univ Bologna, Dept Med & Surg Sci DIMEC, Policlin St Orsola Malpighi Hosp, Via Giuseppe Massarenti 9, I-40138 Bologna, Italy.	elena.bonora6@unibo.it	Diquigiovanni, Chiara/AAC-3179-2022; Baldassarro, Vito Antonio/AFN-5106-2022; Cordelli, Duccio Maria/N-4725-2019; Paracchini, Silvia/AAU-6813-2021	Diquigiovanni, Chiara/0000-0003-3124-6946; Baldassarro, Vito Antonio/0000-0003-1020-4261; Cordelli, Duccio Maria/0000-0002-1367-6419; Paracchini, Silvia/0000-0001-9934-8602; Liparulo, Irene/0000-0002-2069-0067; Masin, Luca/0000-0002-5287-6886; Bonora, Elena/0000-0001-6132-7734; Diaz Vazquez, Rebeca/0000-0003-0937-5928	Telethon [GGP15171]; Italian Association for Cancer Research (AIRC) [IG_17069]; Royal Society [RG110387]; European Society for Fish Models in Biology and Medicine (EuFish-BioMed); AIRC	Telethon(Fondazione Telethon); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Royal Society(Royal Society of London); European Society for Fish Models in Biology and Medicine (EuFish-BioMed); AIRC(Fondazione AIRC per la ricerca sul cancro)	The authors thank all patients that participated in the study. The authors thank Dr. A. Astolfi, S. Di Battista, and M. Cratere (all from Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy) for technical help in sequencing analysis and cell culture and A. Martinelli and Dr. M. Gostic (both from School of Medicine, University of St. Andrews, St. Andrews, United Kingdom) for help in zebrafish analysis. The authors also thank Prof. J. M. Lucocq for helpful suggestions and critical revision of the manuscript. This work was supported by Telethon Grant GGP15171 (to E.B.), Italian Association for Cancer Research (AIRC) Grant IG_17069 (to M.S.), and Royal Society Grant RG110387 (to S.P.). Moreover, this work was further supported by the travel fellowship from The European Society for Fish Models in Biology and Medicine (EuFish-BioMed). S.P. is a Royal Society University Research Fellow. F.B. is supported by a Telethon fellowship. C.D. is supported by an AIRC fellowship. The authors declare no conflicts of interest.	Alazami AM, 2015, CELL REP, V10, P148, DOI 10.1016/j.celrep.2014.12.015; Atorino L, 2003, J CELL BIOL, V163, P777, DOI 10.1083/jcb.200304112; Bakowska JC, 2005, BIOCHEM BIOPH RES CO, V334, P1042, DOI 10.1016/j.bbrc.2005.06.201; Bakowska JC, 2008, ARCH NEUROL-CHICAGO, V65, P520, DOI 10.1001/archneur.65.4.520; Bakowska JC, 2007, MOL BIOL CELL, V18, P1683, DOI 10.1091/mbc.E06-09-0833; Bizzari S, 2017, METAB BRAIN DIS, V32, P2155, DOI 10.1007/s11011-017-0104-3; Bonora E, 2015, GASTROENTEROLOGY, V148, P771, DOI 10.1053/j.gastro.2014.12.034; Butler S, 2016, AM J MED GENET A, V170, P1780, DOI 10.1002/ajmg.a.37658; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Cheng AW, 2010, ASN NEURO, V2, P243, DOI 10.1042/AN20100019; Ciccarelli FD, 2003, GENOMICS, V81, P437, DOI 10.1016/S0888-7543(03)00011-9; Court FA, 2012, TRENDS NEUROSCI, V35, P364, DOI 10.1016/j.tins.2012.04.001; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Dardour L, 2017, CSH MOL CASE STUD, V3, DOI 10.1101/mcs.a001537; Demaria M, 2010, AGING-US, V2, P823, DOI 10.18632/aging.100232; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Eastman SW, 2009, J CELL BIOL, V184, P881, DOI 10.1083/jcb.200808041; Edwards TL, 2009, BIOCHEM J, V423, P31, DOI 10.1042/BJ20082398; Estabrook R. W., 1967, METHODS ENZYMOLOGY, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4; Fanti Z, 2008, IEEE ENG MED BIO, P1196, DOI 10.1109/IEMBS.2008.4649377; Fink JK, 2013, ACTA NEUROPATHOL, V126, P307, DOI 10.1007/s00401-013-1115-8; Firth HV, 2011, DEV MED CHILD NEUROL, V53, P702, DOI 10.1111/j.1469-8749.2011.04032.x; Frezza C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024411; Giuliani A, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0593-8; Gray LR, 2014, CELL MOL LIFE SCI, V71, P2577, DOI 10.1007/s00018-013-1539-2; Graziano C, 2015, GENE, V559, P144, DOI 10.1016/j.gene.2015.01.026; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Honrath B, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.76; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hurd TR, 2012, J BIOL CHEM, V287, P35153, DOI 10.1074/jbc.M112.400002; Johri A, 2012, J PHARMACOL EXP THER, V342, P619, DOI 10.1124/jpet.112.192138; JONES DP, 1981, J CHROMATOGR, V225, P446, DOI 10.1016/S0378-4347(00)80293-5; Joshi DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019290; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Khokha MK, 2017, PEDIATR RES, V81, P282, DOI 10.1038/pr.2016.229; Kirk K, 2014, ANN NEUROL, V76, P620, DOI 10.1002/ana.24244; Krabbenborg L, 2016, J GENET COUNS, V25, P1207, DOI 10.1007/s10897-016-9958-5; Liemburg-Apers DC, 2015, ARCH TOXICOL, V89, P1209, DOI 10.1007/s00204-015-1520-y; Lu J, 2006, J NEUROCHEM, V98, P1908, DOI 10.1111/j.1471-4159.2006.04008.x; Manzini MC, 2010, ANN NEUROL, V67, P516, DOI 10.1002/ana.21923; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Milewska M, 2015, CELL BIOL INT, V39, P1007, DOI 10.1002/cbin.10472; Milewska M, 2009, J NEUROCHEM, V111, P1022, DOI 10.1111/j.1471-4159.2009.06382.x; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Patel H, 2002, NAT GENET, V31, P347, DOI 10.1038/ng937; Patron M, 2018, CELL RES, V28, P296, DOI 10.1038/cr.2018.17; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Renvoise B, 2012, HUM MOL GENET, V21, P3604, DOI 10.1093/hmg/dds191; Renvoise B, 2010, MOL BIOL CELL, V21, P3293, DOI 10.1091/mbc.E09-10-0879; Ring J, 2017, MICROB CELL, V4, P411, DOI 10.15698/mic2017.12.603; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Short PJ, 2018, NATURE, V555, P611, DOI 10.1038/nature25983; Spiegel R, 2017, JIMD REP, V33, P55, DOI 10.1007/8904_2016_580; Stark Z, 2016, GENET MED, V18, P1090, DOI 10.1038/gim.2016.1; Su B, 2010, BBA-MOL BASIS DIS, V1802, P135, DOI 10.1016/j.bbadis.2009.09.013; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Tabatabaie T, 1996, ARCH BIOCHEM BIOPHYS, V336, P290, DOI 10.1006/abbi.1996.0560; Tan TY, 2017, JAMA PEDIATR, V171, P855, DOI 10.1001/jamapediatrics.2017.1755; Tawamie H, 2015, MOL CELL PROBE, V29, P315, DOI 10.1016/j.mcp.2015.05.006; Truong T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130455; Tsang HTH, 2009, HUM MOL GENET, V18, P3805, DOI 10.1093/hmg/ddp324; Vissers LELM, 2015, NAT GENET, V47, P1222, DOI 10.1038/ng.3425; Wright CF, 2018, GENET MED, V20, P1216, DOI 10.1038/gim.2017.246; Zhou LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021680	65	9	9	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11284	11302		10.1096/fj.201802722R	http://dx.doi.org/10.1096/fj.201802722R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31314595	Bronze, Green Submitted			2022-12-28	WOS:000489166300058
J	Moverare-Skrtic, S; Nilsson, KH; Henning, P; Funck-Brentano, T; Nethander, M; Rivadeneira, F; Nunes, GC; Koskela, A; Tuukkanen, J; Tuckermann, J; Perret, C; Souza, PPC; Lerner, UH; Ohlsson, C				Moverare-Skrtic, Sofia; Nilsson, Karin H.; Henning, Petra; Funck-Brentano, Thomas; Nethander, Maria; Rivadeneira, Fernando; Nunes, Glaucia Coletto; Koskela, Antti; Tuukkanen, Juha; Tuckermann, Jan; Perret, Christine; Chaves Souza, Pedro Paulo; Lerner, Ulf H.; Ohlsson, Claes			Osteoblast-derived NOTUM reduces cortical bone mass in mice and the NOTUM locus is associated with bone mineral density in humans	FASEB JOURNAL			English	Article						osteoporosis; transgenic; WNT16	OSTEOCLAST PROGENITOR; GROWTH-HORMONE; SOST GENE; WOMEN; WNT; IDENTIFICATION; INHIBITORS; FRAGILITY; DYSPLASIA; MUTATION	Osteoporosis is a common skeletal disease, affecting millions of individuals worldwide. Currently used osteoporosis treatments substantially reduce vertebral fracture risk, whereas nonvertebral fracture risk, mainly caused by reduced cortical bone mass, has only moderately been improved by the osteoporosis drugs used, defining an unmet medical need. Because several wingless-type MMTV integration site family members (WNTs) and modulators of WNT activity are major regulators of bone mass, we hypothesized that NOTUM, a secreted WNT lipase, might modulate bone mass via an inhibition of WNT activity. To characterize the possible role of endogenous NOTUM as a physiologic modulator of bone mass, we developed global, cell-specific, and inducible Notum-inactivated mouse models. Notum expression was high in the cortical bone in mice, and conditional Notum inactivation revealed that osteoblast lineage cells are the principal source of NOTUM in the cortical bone. Osteoblast lineage-specific Notum inactivation increased cortical bone thickness via an increased periosteal circumference. Inducible Notum inactivation in adult mice increased cortical bone thickness as a result of increased periosteal bone formation, and silencing of Notum expression in cultured osteoblasts enhanced osteoblast differentiation. Large-scale human genetic analyses identified genetic variants mapping to the NOTUM locus that are strongly associated with bone mineral density (BMD) as estimated with quantitative ultrasound in the heel. Thus, osteoblast-derived NOTUM is an essential local physiologic regulator of cortical bone mass via effects on periosteal bone formation in adult mice, and genetic variants in the NOTUM locus are associated with BMD variation in adult humans. Therapies targeting osteoblast-derived NOTUM may prevent nonvertebral fractures.-Moverare-Skrtic, S., Nilsson, K. H., Henning, P., Funck-Brentano, T., Nethander, M., Rivadeneira, F., Coletto Nunes, G., Koskela, A., Tuukkanen, J., Tuckermann, J., Perret, C., Souza, P. P. C., Lerner, U. H., Ohlsson, C. Osteoblast-derived NOTUM reduces cortical bone mass in mice and the NOTUM locus is associated with bone mineral density in humans.	[Moverare-Skrtic, Sofia; Nilsson, Karin H.; Henning, Petra; Funck-Brentano, Thomas; Nethander, Maria; Lerner, Ulf H.; Ohlsson, Claes] Univ Gothenburg, Sahlgrenska Acad, Ctr Bone & Arthrit Res, Dept Internal Med & Clin Nutr,Inst Med, Gothenburg, Sweden; [Rivadeneira, Fernando] Erasmus Univ, Dept Internal Med, Rotterdam, Netherlands; [Nunes, Glaucia Coletto; Chaves Souza, Pedro Paulo] Sao Paulo State Univ UNESP, Sch Dent, Bone Biol Res Grp, Araraquara, Brazil; [Koskela, Antti; Tuukkanen, Juha] Univ Oulu, Fac Med, Inst Canc Res & Translat Med, Dept Anat & Cell Biol, Oulu, Finland; [Tuckermann, Jan] Univ Ulm, Inst Gen Zool & Endocrinol, Ulm, Germany; [Perret, Christine] Univ Paris 05, Sorbonne Paris Cite, Inst Cochin, INSERM,U1016, Paris, France; [Perret, Christine] Equipe Labellisee Ligue Natl Canc, Paris, France; [Chaves Souza, Pedro Paulo] Univ Fed Goias, Sch Dent, Goiania, Go, Brazil	University of Gothenburg; Erasmus University Rotterdam; Universidade Estadual Paulista; University of Oulu; Ulm University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universidade Federal de Goias	Lerner, UH; Ohlsson, C (corresponding author), Sahlgrens Univ Hosp, Ctr Bone & Arthrit Res, Vita Straket 11, S-41345 Gothenburg, Sweden.	ulf.lerner@gu.se; claes.ohlsson@medic.gu.se	Ohlsson, Claes/AGP-3544-2022; Souza, Pedro Paulo Chaves/G-3801-2011; Ohlsson, Claes/HIR-6959-2022; Perret-Mayeux, Christine/L-3297-2017; Souza, Pedro/GZH-1275-2022; Funck-Brentano, Thomas/AAS-7201-2020; Rivadeneira, Fernando/O-5385-2015; Skrtic, Sofia/AAQ-1585-2020	Ohlsson, Claes/0000-0002-9633-2805; Souza, Pedro Paulo Chaves/0000-0001-7266-6061; Ohlsson, Claes/0000-0002-9633-2805; Funck-Brentano, Thomas/0000-0001-7684-2405; Rivadeneira, Fernando/0000-0001-9435-9441; Henning, Petra/0000-0002-9330-6265; Nethander, Maria/0000-0003-3688-906X; Lerner, Ulf/0000-0002-3579-1960; perret, christine/0000-0003-4710-7051; Koskela, Antti/0000-0001-7371-2488	Swedish Research Council; Swedish Foundation for Strategic Research; Swedish county councils, the ALF-agreement in Gothenburg [238261, 226481, 237551]; IngaBritt and Arne Lundberg Foundation; Royal 80 Year Fund of King Gustav V; Torsten and Ragnar Soderberg's Foundation; Knut and Alice Wallenberg Foundation; Novo Nordisk Foundation; Sao Paulo Research Foundation [2014/05283-3]; Deutsche Forschungsgemeinschaft (DFG) Collaborative Research Centre (CRC) 1149; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]; Swedish government [238261, 226481, 237551]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish county councils, the ALF-agreement in Gothenburg; IngaBritt and Arne Lundberg Foundation; Royal 80 Year Fund of King Gustav V; Torsten and Ragnar Soderberg's Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Deutsche Forschungsgemeinschaft (DFG) Collaborative Research Centre (CRC) 1149; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Swedish government	The authors thank Lotta Uggla, Biljana Aleksic, Anna Westerlund, and Anette Hansevi (all from the University of Gothenburg) for excellent technical assistance, and Carolina Medina-Gomez (Erasmus University Rotterdam) for support in the human genetic analyses. This study was supported by the Swedish Research Council, the Swedish Foundation for Strategic Research, the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement in Gothenburg (Grants 238261, 226481, and 237551), the IngaBritt and Arne Lundberg Foundation, the Royal 80 Year Fund of King Gustav V, the Torsten and Ragnar Soderberg's Foundation, the Knut and Alice Wallenberg Foundation, the Novo Nordisk Foundation, and Sao Paulo Research Foundation (Grant 2014/05283-3). J.T. was supported by the Deutsche Forschungsgemeinschaft (DFG) Collaborative Research Centre (CRC) 1149, and G.C.N. was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; Finance Code 001). S.M.-S. and K.H.N. share first authorship. The authors declare no conflicts of interest.	Ascenzi MG, 2016, BONE, V84, P104, DOI 10.1016/j.bone.2015.10.010; Ascenzi MG, 2014, J BIOMECH, V47, P2436, DOI 10.1016/j.jbiomech.2014.04.006; Ascenzi MG, 2013, J COMPUT PHYS, V244, P298, DOI 10.1016/j.jcp.2012.05.027; Bakker AD, 2012, METHODS MOL BIOL, V816, P19, DOI 10.1007/978-1-61779-415-5_2; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Baron R, 2012, J CLIN ENDOCR METAB, V97, P311, DOI 10.1210/jc.2011-2332; Bauer DC, 1997, ARCH INTERN MED, V157, P629, DOI 10.1001/archinte.157.6.629; Black DM, 2016, NEW ENGL J MED, V374, P2096, DOI 10.1056/NEJMc1602599; Bonnet N, 2016, MOL CELL ENDOCRINOL, V432, P85, DOI 10.1016/j.mce.2015.12.014; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brommage R, 2019, BONE RES, V7, DOI 10.1038/s41413-018-0038-3; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Canal F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150997; Cosman F, 2016, NEW ENGL J MED, V375, P1532, DOI 10.1056/NEJMoa1607948; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Funck-Brentano T, 2018, J ENDOCRINOL, V238, P13, DOI 10.1530/JOE-18-0153; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gori F, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.36; Granholm S, 2007, J ENDOCRINOL, V195, P415, DOI 10.1677/JOE-07-0338; Granholm S, 2013, BONE, V52, P83, DOI 10.1016/j.bone.2012.09.019; Han Q, 2016, BIOORG MED CHEM LETT, V26, P1184, DOI 10.1016/j.bmcl.2016.01.038; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Jenny A, 2010, CURR TOP DEV BIOL, V93, P189, DOI [10.1016/B978-0-12-385044-7.00007-2, 10.1016/S0070-2153(10)93007-X]; Kakugawa S, 2015, NATURE, V519, P187, DOI 10.1038/nature14259; Kemp JP, 2017, NAT GENET, V49, P1468, DOI 10.1038/ng.3949; Kiper POS, 2016, NEW ENGL J MED, V374, P2553, DOI 10.1056/NEJMoa1509342; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Lerner UH, 2015, J INTERN MED, V277, P630, DOI 10.1111/joim.12368; Little RD, 2002, NEW ENGL J MED, V347, P943; Madan B, 2016, ONCOTARGET, V7, P12386, DOI 10.18632/oncotarget.7157; Mohan S, 2003, ENDOCRINOLOGY, V144, P929, DOI 10.1210/en.2002-220948; Moverare-Skrtic S, 2014, NAT MED, V20, P1279, DOI 10.1038/nm.3654; Nusse R, 2015, NATURE, V519, P163, DOI 10.1038/nature14208; Ohlsson C, 1998, ENDOCR REV, V19, P55, DOI 10.1210/er.19.1.55; Ohlsson C, 2018, J ENDOCRINOL, V237, P113, DOI 10.1530/JOE-18-0020; Ohlsson C, 2017, J CLIN ENDOCR METAB, V102, P516, DOI 10.1210/jc.2016-3177; Peng ZQ, 2004, J BONE MINER RES, V19, P1320, DOI 10.1359/JBMR.040510; Quarta C, 2017, CELL METAB, V26, P620, DOI 10.1016/j.cmet.2017.08.023; Rauch A, 2010, CELL METAB, V11, P517, DOI 10.1016/j.cmet.2010.05.005; Shen Z, 2008, J BONE MINER RES, V23, P1217, DOI 10.1359/JBMR.080322; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tarver JE, 2016, BIOORG MED CHEM LETT, V26, P1525, DOI 10.1016/j.bmcl.2016.02.021; Vidal O, 2000, P NATL ACAD SCI USA, V97, P5474, DOI 10.1073/pnas.97.10.5474; Vogel P, 2016, VET PATHOL, V53, P853, DOI 10.1177/0300985815626778; Wergedal JE, 2015, ENDOCRINOLOGY, V156, P1023, DOI 10.1210/en.2014-1702; Windahl SH, 1999, J CLIN INVEST, V104, P895, DOI 10.1172/JCI6730; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0; Zhong ZD, 2012, P NATL ACAD SCI USA, V109, pE2197, DOI 10.1073/pnas.1120407109	51	15	16	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11163	11179		10.1096/fj.201900707R	http://dx.doi.org/10.1096/fj.201900707R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31307226	hybrid, Green Published			2022-12-28	WOS:000489166300049
J	Rong, N; Mistriotis, P; Wang, XY; Tseropoulos, G; Rajabian, N; Zhang, YL; Wang, JM; Liu, S; Andreadis, ST				Rong, Na; Mistriotis, Panagiotis; Wang, Xiaoyan; Tseropoulos, Georgios; Rajabian, Nika; Zhang, Yali; Wang, Jianmin; Liu, Song; Andreadis, Stelios T.			Restoring extracellular matrix synthesis in senescent stem cells	FASEB JOURNAL			English	Article						aging; elasticity; ECM; collagen; NANOG	SMOOTH-MUSCLE-CELLS; EHLERS-DANLOS-SYNDROME; III COLLAGEN; TGF-BETA; NANOG REVERSES; HAIR FOLLICLE; SELF-RENEWAL; DIFFERENTIATION; SMAD3; PROLIFERATION	Collagen type III (COL3) is one of the 3 major collagens in the body, and loss of expression or mutations in the COL3 gene have been associated with the onset of vascular diseases such the Ehlers-Danlos syndrome. Previous work reported a significant reduction of COL3 in tissues such as skin and vessels with aging. In agreement, we found that COL3 was significantly reduced in senescent human mesenchymal stem cells and myofibroblasts derived from patients with Hutchinson-Gilford progeria syndrome, a premature aging syndrome. Most notably, we discovered that ectopic expression of the embryonic transcription factor Nanog homeobox (NANOG) restored COL3 expression by restoring the activity of the TGF-beta pathway that was impaired in senescent cells. RNA sequencing analysis showed that genes associated with the activation of the TGF-beta pathway were up-regulated, whereas negative regulators of the pathway were down-regulated upon NANOG expression. Chromatin immunoprecipitation sequencing and immunoprecipitation experiments revealed that NANOG bound to the mothers against decapentaplegic (SMAD)2 and SMAD3 promoters, in agreement with increased expression and phosphorylation levels of both proteins. Using chemical inhibition, short hairpin RNA knockdown, and gain of function approaches, we established that both SMAD2 and SMAD3 were necessary to mediate the effects of NANOG, but SMAD3 overexpression was also sufficient for COL3 production. In summary, NANOG restored production of COL3, which was impaired by cellular aging, suggesting novel strategies to restore the impaired extracellular matrix production and biomechanical function of aged tissues, with potential implications for regenerative medicine and anti-aging treatments.-Rong, N., Mistriotis, P., Wang, X., Tseropoulos, G., Rajabian, N., Zhang, Y., Wang, J., Liu, S., Andreadis, S. T. Restoring extracellular matrix synthesis in senescent stem cells.	[Rong, Na; Mistriotis, Panagiotis; Wang, Xiaoyan; Tseropoulos, Georgios; Rajabian, Nika; Andreadis, Stelios T.] Univ Buffalo, Dept Chem & Biol Engn, Buffalo, NY USA; [Andreadis, Stelios T.] Univ Buffalo, Dept Biomed Engn, Buffalo, NY USA; [Zhang, Yali; Wang, Jianmin; Liu, Song] Roswell Pk Comprehens Canc Ctr, Dept Biostat & Bioinformat, Buffalo, NY USA; [Andreadis, Stelios T.] Ctr Excellence Bioinformat & Life Sci, Buffalo, NY USA; [Mistriotis, Panagiotis] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Johns Hopkins University	Andreadis, ST (corresponding author), Univ Buffalo State Univ New York, Dept Chem & Biol Engn, Bioengn Lab, 908 Furnas Hall,North Campus, Amherst, NY 14260 USA.	sandread@buffalo.edu	Mistriotis, Panagiotis/AAJ-5248-2020; Rajabian, Nika/ABA-6479-2020; wang, jian/GVS-0711-2022	Mistriotis, Panagiotis/0000-0002-8069-3278; 	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [R01 HL086582]; New York Stem Cell Science (NYSTEM) [C30290GG]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086582] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); New York Stem Cell Science (NYSTEM); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (R01 HL086582) and New York Stem Cell Science (NYSTEM; C30290GG) to S.T.A. The authors declare no conflicts of interest.	Alimperti S, 2012, GENE THER, V19, P1123, DOI 10.1038/gt.2011.208; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bajpai VK, 2012, STEM CELL RES, V8, P74, DOI 10.1016/j.scr.2011.07.003; Brassard JA, 2016, BIOGERONTOLOGY, V17, P129, DOI 10.1007/s10522-015-9602-z; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Chakravarthy A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06654-8; Cheng W., 2011, AFR J BIOTECHNOL, V10, P13; Davis R, 2012, CELL CYCLE, V11, P109, DOI 10.4161/cc.11.1.18473; de Kroon LMG, 2017, SCI REP-UK, V7, DOI 10.1038/srep43164; Durik M, 2012, CIRCULATION, V126, P468, DOI 10.1161/CIRCULATIONAHA.112.104380; FLEISCHMAJER R, 1990, J STRUCT BIOL, V105, P162, DOI 10.1016/1047-8477(90)90110-X; Gorenne I, 2006, CARDIOVASC RES, V72, P9, DOI 10.1016/j.cardiores.2006.06.004; Gray K, 2015, CIRC RES, V116, P816, DOI 10.1161/CIRCRESAHA.116.304921; Han JH, 2012, STEM CELLS, V30, P2746, DOI 10.1002/stem.1223; Han JH, 2010, CARDIOVASC RES, V87, P147, DOI 10.1093/cvr/cvq024; Hinz B, 2015, MATRIX BIOL, V47, P54, DOI 10.1016/j.matbio.2015.05.006; Horiguchi M, 2012, J BIOCHEM, V152, P321, DOI 10.1093/jb/mvs089; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liu X, 1997, P NATL ACAD SCI USA, V94, P1852, DOI 10.1073/pnas.94.5.1852; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Manea A, 2008, ARTERIOSCL THROM VAS, V28, P878, DOI 10.1161/ATVBAHA.108.163592; McDonnell NB, 2006, AM J MED GENET A, V140A, P129, DOI 10.1002/ajmg.a.31035; Mistriotis P, 2017, AGEING RES REV, V37, P94, DOI 10.1016/j.arr.2017.05.006; Mistriotis P, 2017, STEM CELLS, V35, P207, DOI 10.1002/stem.2452; Mistriotis P, 2013, TISSUE ENG PART B-RE, V19, P265, DOI [10.1089/ten.teb.2012.0422, 10.1089/ten.TEB.2012.0422]; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Morgan RG, 2013, AM J PHYSIOL-HEART C, V305, pH251, DOI 10.1152/ajpheart.00197.2013; Ocampo A, 2016, CELL, V167, P1719, DOI 10.1016/j.cell.2016.11.052; Okumura N, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058000, 10.1371/journal.pone.0075961]; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; Plenz GAM, 2003, ATHEROSCLEROSIS, V166, P1, DOI 10.1016/S0021-9150(01)00766-3; Qiu H, 2007, CIRCULATION, V116, P669, DOI 10.1161/CIRCULATIONAHA.107.689208; Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056; ROBERTS AB, 1992, KIDNEY INT, V41, P557, DOI 10.1038/ki.1992.81; Schwarze U, 2001, AM J HUM GENET, V69, P989, DOI 10.1086/324123; Shahini A, 2017, TISSUE ENG PT A, V23, P535, DOI [10.1089/ten.tea.2016.0494, 10.1089/ten.TEA.2016.0494]; Silver FH, 2001, SKIN RES TECHNOL, V7, P18, DOI 10.1034/j.1600-0846.2001.007001018.x; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tsai CC, 2012, MOL CELL, V47, P169, DOI 10.1016/j.molcel.2012.06.020; Tsamis A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1004; Ungefroren H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-67; Volk SW, 2014, CALCIFIED TISSUE INT, V94, P621, DOI 10.1007/s00223-014-9843-x; Volk SW, 2011, CELLS TISSUES ORGANS, V194, P25, DOI 10.1159/000322399; Yang FY, 2009, HYPERTENSION, V54, P877, DOI 10.1161/HYPERTENSIONAHA.109.136531; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao X, 2008, J BIOL CHEM, V283, P3272, DOI 10.1074/jbc.M708033200; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29	50	6	6	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10954	10965		10.1096/fj.201900377R	http://dx.doi.org/10.1096/fj.201900377R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31287964	Green Published			2022-12-28	WOS:000489166300031
J	Yashiro, T; Takeuchi, H; Nakamura, S; Tanabe, A; Hara, M; Uchida, K; Okumura, K; Kasakura, K; Nishiyama, C				Yashiro, Takuya; Takeuchi, Hiromi; Nakamura, Shusuke; Tanabe, Atsushi; Hara, Mutsuko; Uchida, Koichiro; Okumura, Ko; Kasakura, Kazumi; Nishiyama, Chiharu			PU.1 plays a pivotal role in dendritic cell migration from the periphery to secondary lymphoid organs via regulating CCR7 expression	FASEB JOURNAL			English	Article						chemokine receptor; Ets; PD-L2; MLN; TGF-beta	TRANSCRIPTION FACTOR PU.1; LANGERHANS CELLS; GENE-EXPRESSION; CHEMOKINE; REQUIREMENT; MICE	C-C chemokine receptor type 7 (CCR7) is essential for migration of dendritic cells (DCs) to draining lymph nodes. PU.1/Spi1 is a transcription factor playing a critical role in the gene regulation of DCs. PU.1 knockdown decreased the expression of CCR7 in bone marrow-derived DCs and subsequently attenuated migration in vitro and in vivo. Reporter assays, EMSA, and chromatin immunoprecipitation assays revealed that PU.1 binds to the most proximal Ets motif of the Ccr7 promoter, which is involved in transcriptional activation. The CCR7 expression level, which was higher in the programmed cell death 1 ligand 2 (PD-L2)(+) population than in the PD-L2(-) population and was markedly suppressed by TGF-beta treatment, coincided with the binding level of PU.1 to the Ccr7 promoter. The PU.1 binding level in CCR7(high) mesenteric lymph nodes DCs was higher than in other DC subtypes. The involvement of PU.1 in the expression of the CCR7 gene was also observed in human DCs. We conclude that PU.1 plays a pivotal role in DC migration by transactivating the CCR7 gene via the Ets motif in the promoter in both humans and mice.-Yashiro, T., Takeuchi, H., Nakamura, S., Tanabe, A., Hara, M., Uchida, K., Okumura, K., Kasakura, K., Nishiyama, C. PU.1 plays a pivotal role in dendritic cell migration from the periphery to secondary lymphoid organs via regulating CCR7 expression.	[Yashiro, Takuya; Takeuchi, Hiromi; Nakamura, Shusuke; Kasakura, Kazumi; Nishiyama, Chiharu] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Tokyo, Japan; [Yashiro, Takuya; Tanabe, Atsushi; Hara, Mutsuko; Uchida, Koichiro; Okumura, Ko; Kasakura, Kazumi; Nishiyama, Chiharu] Juntendo Univ, Atopy Res Ctr, Sch Med, Tokyo, Japan	Tokyo University of Science; Juntendo University	Yashiro, T; Nishiyama, C (corresponding author), Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Lab Mol Biol & Immunol,Katsushika Ku, 6-3-1 Niijuku, Tokyo 1258585, Japan.	tyashiro@rs.tus.ac.jp; chinishi@rs.tus.ac.jp	Nishiyama, Chiharu/GPW-9372-2022; yashiro, takuya/Y-1543-2019		Japanese Government (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities (Translational Research Center, Tokyo University of Science); Tokyo Biochemical Research Foundation; Tojuro Iijima Foundation for Food Science and Technology; Takeda Science Foundation; Japanese Society for the Promotion of Science for Young Scientists [3241]	Japanese Government (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities (Translational Research Center, Tokyo University of Science); Tokyo Biochemical Research Foundation; Tojuro Iijima Foundation for Food Science and Technology; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japanese Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors are grateful to the members of the Laboratory of the Molecular and Cellular Immunology (Tokyo University of Science) and Atopy (Allergy) Research Center (Juntendo University) for constructive discussions and technical support. This work was supported by a Grant-in-Aid for Challenging Exploratory Research (to C. N.), a Grant-in-Aid for Young Scientists (B) (to T. Y. and K. K.), the Japanese Government (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities (Translational Research Center, Tokyo University of Science), the Tokyo Biochemical Research Foundation (to C. N.), the Tojuro Iijima Foundation for Food Science and Technology (to C. N. and T. Y.), and the Takeda Science Foundation (to C. N.). K. K. is supported by research fellowships from the Japanese Society for the Promotion of Science for Young Scientists (Fellowship 3241; 2016). The authors declare no conflicts of interest.	Anderson KL, 2000, J IMMUNOL, V164, P1855, DOI 10.4049/jimmunol.164.4.1855; Appel S, 2006, BLOOD, V107, P3265, DOI 10.1182/blood-2005-06-2480; Bajana S, 2012, J IMMUNOL, V189, P3368, DOI 10.4049/jimmunol.1102613; Behre G, 1999, J BIOL CHEM, V274, P4939, DOI 10.1074/jbc.274.8.4939; Chopin M, 2013, J EXP MED, V210, P2967, DOI 10.1084/jem.20130930; Colucci F, 2001, BLOOD, V97, P2625, DOI 10.1182/blood.V97.9.2625; Dong GY, 2015, J IMMUNOL, V194, P3745, DOI 10.4049/jimmunol.1401754; Fainaru O, 2005, P NATL ACAD SCI USA, V102, P10598, DOI 10.1073/pnas.0504787102; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Guerriero A, 2000, BLOOD, V95, P879, DOI 10.1182/blood.V95.3.879.003k13_879_885; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Jimenez F, 2010, J IMMUNOL, V184, P5571, DOI 10.4049/jimmunol.0803494; Kanada S, 2011, BLOOD, V117, P2211, DOI 10.1182/blood-2010-06-291898; Kitamura N, 2012, J ALLERGY CLIN IMMUN, V129, P814, DOI 10.1016/j.jaci.2011.10.019; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Maeda K, 2006, BLOOD, V108, P262, DOI 10.1182/blood-2005-07-2878; Marecki S, 2000, CELL BIOCHEM BIOPHYS, V33, P127, DOI 10.1385/CBB:33:2:127; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Nishiyama C, 1999, J IMMUNOL, V163, P623; Nishiyama C, 2002, J IMMUNOL, V168, P4546, DOI 10.4049/jimmunol.168.9.4546; Oki S, 2018, EMBO REP, V19, DOI 10.15252/embr.201846255; Petrovick HS, 1998, MOL CELL BIOL, V18, P3915, DOI 10.1128/MCB.18.7.3915; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153, DOI 10.4049/jimmunol.176.9.5153; Sasaki I, 2014, CURR TOP MICROBIOL, V381, P257, DOI 10.1007/82_2014_378; Schiavoni G, 2004, BLOOD, V103, P2221, DOI 10.1182/blood-2003-09-3007; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Spain LM, 1999, J IMMUNOL, V163, P2681; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Worbs T, 2007, TRENDS IMMUNOL, V28, P274, DOI 10.1016/j.it.2007.04.002; Yashiro T, 2017, INT IMMUNOL, V29, P87, DOI 10.1093/intimm/dxx009; Yashiro T, 2016, SCI REP-UK, V6, DOI 10.1038/srep34825	40	9	10	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11481	11491		10.1096/fj.201900379RR	http://dx.doi.org/10.1096/fj.201900379RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31314592				2022-12-28	WOS:000489166300073
J	Barakat, A; Nakao, S; Zandi, S; Sun, DW; Schmidt-Ullrich, R; Hayes, KC; Hafezi-Moghadam, A				Barakat, Aliaa; Nakao, Shintaro; Zandi, Souska; Sun, Dawei; Schmidt-Ullrich, Ruth; Hayes, K. C.; Hafezi-Moghadam, Ali			In contrast to Western diet, a plant-based, high-fat, low-sugar diet does not exacerbate retinal endothelial injury in streptozotocin-induced diabetes	FASEB JOURNAL			English	Article						insulin deficiency; lipoprotein metabolism; leukocyte adhesion; endothelial NF-kappa B signaling; molecular imaging	NF-KAPPA-B; INTERCELLULAR-ADHESION MOLECULE-1; METABOLIC SYNDROME; VASCULAR-PERMEABILITY; INSULIN-RESISTANCE; RETINOPATHY; EXPRESSION; HYPERTRIGLYCERIDEMIA; CHOLESTEROL; LIVER	Controversy remains about how diet affects the vascular endothelial dysfunction associated with disordered insulin-glucose homeostasis. It is postulated that the type and level of certain macronutrients contribute to endothelial dysfunction in vascular diabetes complications. However, it is not well understood how specific macronutrients affect the molecular inflammatory response under conditions of hyperglycemia. Here, we examined retinal microvascular endothelial injury in streptozotocin (STZ)-diabetic rats fed a laboratory Western diet (WD). WD, characterized by its high content of saturated fat, cholesterol, and sugar, significantly increased retinal leukocyte accumulation and endothelial injury in the STZ-diabetic rats. Suppression of endothelial NF-kappa B signaling in the STZ model reduced the WD-induced increase in leukocyte accumulation. To isolate the effect of dietary fat, we generated high-fat diets with varying fatty acid balance and type. These diets contained moderate amounts of carbohydrates but no sugar. We found that neither high levels of saturated or unsaturated fats per se increased retinal leukocyte accumulation and endothelial injury in the STZ-diabetic rat model but that the combination of high levels of dietary cholesterol with specific saturated fatty acids that are abundant in WD exacerbated leukocyte accumulation and endothelial injury in the retinas of STZ-diabetic rats.-Barakat, A., Nakao, S., Zandi, S., Sun, D., Schmidt-Ullrich, R., Hayes, K. C., Hafezi-Moghadam, A. In contrast to Western diet, a plant-based, high-fat, low-sugar diet does not exacerbate retinal endothelial injury in streptozotocin-induced diabetes.	[Barakat, Aliaa; Nakao, Shintaro; Zandi, Souska; Sun, Dawei; Hafezi-Moghadam, Ali] Brigham & Womens Hosp, Mol Biomarkers Nanoimaging Lab, 75 Francis St, Boston, MA 02115 USA; [Barakat, Aliaa; Nakao, Shintaro; Zandi, Souska; Sun, Dawei; Hafezi-Moghadam, Ali] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Nakao, Shintaro] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka, Fukuoka, Japan; [Zandi, Souska] Rotkreuz & Berner Augenklin Lindenhofspital, Swiss Eye Inst, Dept Ophthalmol, Bern, Switzerland; [Sun, Dawei] Harbin Med Univ, Affiliated Hosp 2, Dept Ophthalmol, Harbin, Heilongjiang, Peoples R China; [Schmidt-Ullrich, Ruth] Max Delbruck Ctr Mol Med, Dept Signal Transduct Tumor Cells, Berlin, Germany; [Hayes, K. C.] Brandeis Univ, Foster Biomed Res Lab, Dept Biol, Waltham, MA 02254 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Kyushu University; Harbin Medical University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Brandeis University	Barakat, A; Hafezi-Moghadam, A (corresponding author), Brigham & Womens Hosp, Mol Biomarkers Nanoimaging Lab MBNI, 75 Francis St,Thorn Res Bldg, Boston, MA 02115 USA.	abarakat@bwh.harvard.edu; ahm@bwh.harvard.edu		Zandi, Souska/0000-0001-9351-4278	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Impact Award [DK108238-01]; Juvenile Diabetes Research Foundation (JDRF) Innovation Award	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Impact Award; Juvenile Diabetes Research Foundation (JDRF) Innovation Award	This work was supported by the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Impact Award (DK108238-01, to A.H.-M.) and the Juvenile Diabetes Research Foundation (JDRF) Innovation Award (to A.H.-M.). The authors declare no conflicts of interest.	Adamis AP, 2002, BRIT J OPHTHALMOL, V86, P363, DOI 10.1136/bjo.86.4.363; Aurora AB, 2010, BLOOD, V116, P475, DOI 10.1182/blood-2009-07-232132; BAGDADE JD, 1967, NEW ENGL J MED, V276, P427, DOI 10.1056/NEJM196702232760802; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; BRUCKDORFER KR, 1971, BIOCHEM J, V123, pP7, DOI 10.1042/bj1230007P; BRUCKDORFER KR, 1972, P NUTR SOC, V31, pA11; Brunner EJ, 2008, AM J CLIN NUTR, V87, P1414, DOI 10.1093/ajcn/87.5.1414; Chaabo F, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-29; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Cundiff David K, 2005, MedGenMed, V7, P3; Dow C, 2018, EUR J EPIDEMIOL, V33, P141, DOI 10.1007/s10654-017-0338-8; Frimmel Sonja, 2017, J Ophthalmic Vis Res, V12, P175, DOI 10.4103/jovr.jovr_243_16; Garland RC, 2011, FASEB J, V25, P1284, DOI 10.1096/fj.10-160051; Granado-Casas M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091184; GREENFIELD M, 1980, DIABETOLOGIA, V18, P441; Gustafsson E, 2001, J CELL SCI, V114, P671; Gylling H, 2004, DIABETES, V53, P2217, DOI 10.2337/diabetes.53.9.2217; Henke N, 2007, CIRC RES, V101, P268, DOI 10.1161/CIRCRESAHA.107.150474; Joussen AM, 2002, AM J PATHOL, V160, P501, DOI 10.1016/S0002-9440(10)64869-9; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; Lyons TJ, 2004, INVEST OPHTH VIS SCI, V45, P910, DOI 10.1167/iovs.02-0648; MACDONALD I, 1964, CLIN SCI, V27, P23; MACDONALD I, 1972, CLIN SCI, V43, P265, DOI 10.1042/cs0430265; MCLEOD DS, 1995, AM J PATHOL, V147, P642; Miyahara S, 2004, AM J PATHOL, V164, P1697, DOI 10.1016/S0002-9440(10)63728-5; Miyahara S, 2008, FASEB J, V22, P1973, DOI 10.1096/fj.07-096891; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Miyamoto K, 2000, AM J PATHOL, V156, P1733, DOI 10.1016/S0002-9440(10)65044-4; Noda K, 2014, FASEB J, V28, P2038, DOI 10.1096/fj.12-215715; Noda K, 2010, FASEB J, V24, P2443, DOI 10.1096/fj.09-152678; PAWAR SS, 1968, J LIPID RES, V9, P334; RAKIETEN N, 1963, CANCER CHEMOTH REP, P91; REAVEN EP, 1974, J CLIN INVEST, V54, P1167, DOI 10.1172/JCI107860; Reaven G, 2004, ENDOCRIN METAB CLIN, V33, P283, DOI 10.1016/j.ecl.2004.03.002; REAVEN GM, 1981, DIABETES, V30, P66, DOI 10.2337/diab.30.2.S66; REAVEN GM, 1988, DIABETES METAB REV, V4, P639, DOI 10.1002/dmr.5610040703; REAVEN GM, 1984, HORM METAB RES, V16, P230, DOI 10.1055/s-2007-1014753; Sasaki M, 2015, INVEST OPHTH VIS SCI, V56, P7473, DOI 10.1167/iovs.15-17485; Schmidt-Ullrich R, 2001, DEVELOPMENT, V128, P3843; SCHRODER S, 1991, AM J PATHOL, V139, P81; Sun DW, 2014, FASEB J, V28, P3942, DOI 10.1096/fj.14-251934; Sun DW, 2010, FASEB J, V24, P1532, DOI 10.1096/fj.09-148981; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; Wong MYZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0186582; WOODSIDE WF, 1972, ISRAEL J MED SCI, V8, P309; Xie F, 2010, AM J PATHOL, V177, P39, DOI 10.2353/ajpath.2010.100007; YOUNG NL, 1988, DIABETES, V37, P1151, DOI 10.2337/diabetes.37.8.1151; Zandi S, 2015, CELL REP, V10, P1173, DOI 10.1016/j.celrep.2015.01.050	50	5	4	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10327	10338		10.1096/fj.201900462R	http://dx.doi.org/10.1096/fj.201900462R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31264891	Green Published			2022-12-28	WOS:000482214200049
J	Deng, ZH; Gao, XQ; Sun, XY; Amra, S; Lu, AP; Cui, Y; Eltzschig, HK; Lei, GH; Huard, J				Deng, Zhenhan; Gao, Xueqin; Sun, Xuying; Amra, Sarah; Lu, Aiping; Cui, Yan; Eltzschig, Holger K.; Lei, Guanghua; Huard, Johnny			Characterization of articular cartilage homeostasis and the mechanism of superior cartilage regeneration of MRL/MpJ mice	FASEB JOURNAL			English	Article						cartilage regeneration; DMM; osteoarthritis; ear punch; MRL; MpJ	INTERLEUKIN-1 RECEPTOR ANTAGONIST; MESENCHYMAL STEM-CELLS; GENE-EXPRESSION; JOINT INJURY; DIGIT TIP; MRL MICE; PROTEIN; REPAIR; EAR; OSTEOARTHRITIS	This study investigated articular cartilage (AC) homeostasis and different signaling pathways involved in the superior cartilage regeneration of Murphy Roths large (MRL/MpJ) mice previously reported. We collected uninjured and destabilized medial meniscus (DMM)-injured knees from 8-wk-old C57BL/6J and MRL/MpJ mice. We used micro-computed tomography (microCT), histology, and immunohistochemistry to evaluate AC homeostasis and repair. We used the ear punch model to investigate the role of angiogenesis and inflammation in the superior healing of MRL/MpJ mice. We found fewer beta-catenin and more pSMAD5 positive cells in the uninjured AC of MRL/MpJ mice than that from C57BL/6J mice. MRL/MpJ mice exhibited better AC repair in DMM-induced OA, as indicated by microCT results, Alcian blue, and Safranin O staining. Mechanistically, fewer beta-catenin, pSMAD2-, pSMAD3-, a disintegrin and metalloproteinase with thrombospondin motifs 4-, matrix metalloproteinase (MMP) 9-, and MMP13-positive cells and more proliferating cell nuclear antigen- and pSMAD5-positive cells were found in the DMM-injured AC in MRL/MpJ mice than in normal mice. The accelerated ear wound healing of MRL/MpJ mice correlated with enhanced angiogenesis and macrophage polarization toward the M2a phenotype through elevated IL-10 and IL-4 expressing cells. Collectively, our study revealed that down-regulation of pSMAD2/3, beta-catenin, and MMPs and up-regulation of pSMAD5 and M2a macrophage polarization contribute to the enhanced cartilage repair observed in MRL/MpJ mice.-Deng, Z., Gao, X., Sun, X., Amra, S., Lu, A., Cui, Y., Eltzschig, H. K., Lei, G., Huard, J. Characterization of articular cartilage homeostasis and the mechanism of superior cartilage regeneration of MRL/MpJ mice.	[Deng, Zhenhan; Gao, Xueqin; Sun, Xuying; Amra, Sarah; Lu, Aiping; Cui, Yan; Huard, Johnny] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Dept Orthoped Surg, Houston, TX 77030 USA; [Eltzschig, Holger K.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Anesthesiol, Houston, TX 77030 USA; [Deng, Zhenhan; Lei, Guanghua] Cent S Univ, Xiangya Hosp, Dept Orthopaed, Changsha, Hunan, Peoples R China; [Gao, Xueqin; Lu, Aiping; Huard, Johnny] Steadman Philippon Res Inst, Ctr Regenerat Sports Med, 181 West Meadow Dr,Suite 1000, Vail, CO 81657 USA; [Deng, Zhenhan] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Shenzhen, Guangdong, Peoples R China	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Central South University; Steadman Philippon Research Institute; Shenzhen University	Huard, J (corresponding author), Steadman Philippon Res Inst, Ctr Regenerat Sports Med, 181 West Meadow Dr,Suite 1000, Vail, CO 81657 USA.; Gao, XQ (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Orthoped Surg, 6431 Fannin St, Houston, TX 77030 USA.	xueqin.gao@uth.tmc.edu; jhuard@sprivail.org	Deng, Zhenhan/AAB-4968-2021; Deng, Zhenhan/AAR-2420-2021	Deng, Zhenhan/0000-0003-0522-8269; Gao, Xueqin/0000-0001-5833-1548	University of Texas Health Science Center at Houston [02.25668500.33209.15.27048]; Steadman Philippon Research Institute in Vail Colorado; China Scholarship Council [201606370164]	University of Texas Health Science Center at Houston; Steadman Philippon Research Institute in Vail Colorado; China Scholarship Council(China Scholarship Council)	The authors thank Dr. Mary A. Hall (Department of Orthopedic Surgery, University of Texas Health Science center at Houston) and Dr. Lavanya Rajagopalan (BioScience Writers, LLC) for English language editing. The authors also thank Alex C. Scibetta and Elizabeth Morris from the Steadman Philippon Research Institute (Vail, CO, USA) for proof reading the revised manuscript. This work was supported by startup funding from the University of Texas Health Science Center at Houston (02.25668500.33209.15.27048), the Steadman Philippon Research Institute in Vail Colorado, and the China Scholarship Council (Z.D., student identification: 201606370164). The authors declare no conflicts of interest.	Abramson SB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2655; Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Attur M, 2015, OSTEOARTHR CARTILAGE, V23, P1915, DOI 10.1016/j.joca.2015.08.006; Bastakoty D, 2015, FASEB J, V29, P4881, DOI 10.1096/fj.15-275941; Beare AHM, 2006, J ANAT, V209, P547, DOI 10.1111/j.1469-7580.2006.00641.x; Bedelbaeva K, 2010, P NATL ACAD SCI USA, V107, P5845, DOI 10.1073/pnas.1000830107; Buckley G, 2011, J ANAT, V218, P163, DOI 10.1111/j.1469-7580.2010.01313.x; Carballo CB, 2017, CLIN SPORT MED, V36, P413, DOI 10.1016/j.csm.2017.02.001; Chadwick RB, 2007, WOUND REPAIR REGEN, V15, P275, DOI 10.1111/j.1524-475X.2007.00216.x; Chen CG, 2012, ARTHRITIS RHEUM-US, V64, P3278, DOI 10.1002/art.34566; Chen R, 2015, AM J PATHOL, V185, P2875, DOI 10.1016/j.ajpath.2015.07.003; Chinzei N, 2019, ARTHRITIS RHEUMATOL, V71, P370, DOI 10.1002/art.40730; Clark LD, 1998, CLIN IMMUNOL IMMUNOP, V88, P35, DOI 10.1006/clin.1998.4519; Deng ZH, 2018, OSTEOARTHR CARTILAGE, V26, P1153, DOI 10.1016/j.joca.2018.03.007; Deng ZH, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-0918-x; Deng ZH, 2017, J ORTHOP SURG RES, V12, DOI 10.1186/s13018-017-0551-x; Diekman BO, 2013, CELL TRANSPLANT, V22, P1395, DOI 10.3727/096368912X653264; Duan X, 2017, J ORTHOP RES, V35, P524, DOI 10.1002/jor.23413; Elsaid Khaled A, 2016, J Exp Orthop, V3, P18, DOI 10.1186/s40634-016-0054-4; Fitzgerald J, 2008, OSTEOARTHR CARTILAGE, V16, P1319, DOI 10.1016/j.joca.2008.03.014; Gao XQ, 2014, BIOMATERIALS, V35, P6859, DOI 10.1016/j.biomaterials.2014.04.113; Garciadiego-Cazares D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127166; Gourevitch D, 2003, DEV DYNAM, V226, P377, DOI 10.1002/dvdy.10243; Gouze JN, 2003, ARTHRITIS RES THER, V5, pR301, DOI 10.1186/ar795; Han M, 2008, DEV BIOL, V315, P125, DOI 10.1016/j.ydbio.2007.12.025; Heijink A, 2012, KNEE SURG SPORT TR A, V20, P423, DOI 10.1007/s00167-011-1818-0; Hollander AP, 2010, STEM CELLS, V28, P1992, DOI 10.1002/stem.534; Iwakura T, 2013, ARTHRITIS RHEUM-US, V65, P408, DOI 10.1002/art.37768; Kubo S, 2009, ARTHRITIS RHEUM-US, V60, P155, DOI 10.1002/art.24153; Leferovich JM, 2001, P NATL ACAD SCI USA, V98, P9830, DOI 10.1073/pnas.181329398; Levings RSW, 2018, HUM GENE THER CL DEV, V29, P90, DOI 10.1089/humc.2017.142; Levings RSW, 2018, HUM GENE THER CL DEV, V29, P101, DOI 10.1089/humc.2017.143; Lieberthal J, 2015, OSTEOARTHR CARTILAGE, V23, P1825, DOI 10.1016/j.joca.2015.08.015; Lietman C, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.96308; Liu YC, 2014, INT J BIOL SCI, V10, P520, DOI 10.7150/ijbs.8879; Lories RJ, 2011, NAT REV RHEUMATOL, V7, P43, DOI 10.1038/nrrheum.2010.197; Matsumoto T, 2009, ARTHRITIS RHEUM-US, V60, P1390, DOI 10.1002/art.24443; McBrearty BA, 1998, P NATL ACAD SCI USA, V95, P11792, DOI 10.1073/pnas.95.20.11792; Naseem RH, 2007, PHYSIOL GENOMICS, V30, P44, DOI 10.1152/physiolgenomics.00070.2006; Rai MF, 2014, MATRIX BIOL, V39, P50, DOI 10.1016/j.matbio.2014.08.011; Rai MF, 2013, G3-GENES GENOM GENET, V3, P1881, DOI 10.1534/g3.113.007302; Rai MF, 2012, ARTHRITIS RHEUM-US, V64, P2300, DOI 10.1002/art.34396; Rajnoch C, 2003, DEV DYNAM, V226, P388, DOI 10.1002/dvdy.10242; Seo J, 2013, RES VET SCI, V95, P1210, DOI 10.1016/j.rvsc.2013.08.016; Tchetverikov I, 2005, ANN RHEUM DIS, V64, P694, DOI 10.1136/ard.2004.022434; Ueno M, 2005, INVEST OPHTH VIS SCI, V46, P4097, DOI 10.1167/iovs.05-0548; van der Kraan PM, 2009, OSTEOARTHR CARTILAGE, V17, P1539, DOI 10.1016/j.joca.2009.06.008; von Lewinski G, 2006, AM J SPORT MED, V34, P397, DOI 10.1177/0363546505281801; Ward BD, 2008, ARTHRITIS RHEUM-US, V58, P744, DOI 10.1002/art.23288; Wu P, 2014, ARTHRITIS RHEUMATOL, V66, P1256, DOI 10.1002/art.38375; Yang CY, 2017, OSTEOARTHR CARTILAGE, V25, P1000, DOI 10.1016/j.joca.2017.02.791; Zarebska JM, 2017, OSTEOARTHR CARTILAGE, V25, P406, DOI 10.1016/j.joca.2016.10.008	52	11	11	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					8809	8821		10.1096/fj.201802132RR	http://dx.doi.org/10.1096/fj.201802132RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31042406				2022-12-28	WOS:000478832900010
J	Liu, G; Khanna, V; Kirtane, A; Grill, A; Panyam, J				Liu, Garvey; Khanna, Vidhi; Kirtane, Ameya; Grill, Alex; Panyam, Jayanth			Chemopreventive efficacy of oral curcumin: a prodrug hypothesis	FASEB JOURNAL			English	Article						curcumin glucuronide; beta-glucuronidase; cancer prevention	BETA-GLUCURONIDASE; IN-VITRO; CANCER; VIVO; EXPRESSION; STABILITY; BIOTRANSFORMATION; PHARMACOKINETICS; DOXORUBICIN; ACTIVATION	Oral consumption of curcumin, a natural polyphenol, is associated with reduced incidence of cancer. Yet, a significant amount of the orally dosed compound is eliminated in the feces, and a major fraction of the absorbed compound is metabolized to inactive glucuronides, resulting in poor bioavailability (<1%). It is not known how oral curcumin exhibits chemopreventive activity. We propose curcumin glucuronide is an inflammation-responsive natural prodrug that is converted back to curcumin on demand at the site of action. Our studies show elevated levels of beta-glucuronidase, an enzyme that hydrolyzes the glycosidic bond of glucuronides to generate the parent compound, in human breast cancer. Oral administration of curcumin in mouse tumor models generated significant tumor levels of the polyphenol. Intravenous administration of the glucuronide resulted in the formation of curcumin in the tumor tissue. Chronic daily oral curcumin dosing led to tumor accumulation of curcumin and inhibition of tumor growth in tumor models with high beta-glucuronidase activity. Overall, the study presented here provides preliminary evidence for a novel mechanism of action for orally administered curcumin.-Liu, G., Khanna, V., Kirtane, A., Grill, A., Panyam, J. Chemopreventive efficacy of oral curcumin: a prodrug hypothesis.	[Liu, Garvey; Khanna, Vidhi; Kirtane, Ameya; Grill, Alex; Panyam, Jayanth] Univ Minnesota, Coll Pharm, Dept Pharmaceut, 308 Harvard St SE,Weaver Densford Hall, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Panyam, J (corresponding author), Univ Minnesota, Coll Pharm, Dept Pharmaceut, 308 Harvard St SE,Weaver Densford Hall, Minneapolis, MN 55455 USA.	jpanyam@umn.edu	Kirtane, Ameya/Y-8203-2019	Kirtane, Ameya/0000-0002-3779-0363; Panyam, Jayanth/0000-0002-8656-2244	University of Minnesota; U.S. National Institutes of Health, National Cancer Institute [CA 141996]	University of Minnesota(University of Minnesota System); U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge Prof. Yu-Lin Leu of Chia Nan University of Pharmacy and Science (Tainan, Taiwan) for providing us with near-infrared fluorescent difluoromethylphenol-glucuronide probe. The authors thank Brenda Koniar (University of Minnesota, Minneapolis, MN, USA) for assistance with the animal studies and Jim Fischer (University of Minnesota) for assistance with liquid chromatography-mass spectrometry. Supported by a grant-in-aid award from the University of Minnesota and U.S. National Institutes of Health, National Cancer Institute Grant CA 141996 (to J.P.). The authors declare no conflicts of interest.	Arroo RRJ, 2014, PHYTOCHEM REV, V13, P853, DOI 10.1007/s11101-014-9355-3; Bachmeier BE, 2007, CELL PHYSIOL BIOCHEM, V19, P137, DOI 10.1159/000099202; Bertolini F, 2003, CANCER RES, V63, P4342; Bharti AC, 2003, J IMMUNOL, V171, P3863, DOI 10.4049/jimmunol.171.7.3863; Boggio K, 1998, J EXP MED, V188, P589, DOI 10.1084/jem.188.3.589; Bosslet K, 1998, CANCER RES, V58, P1195; Brusselbach S, 2004, METH MOLEC MED, V90, P303; Calogero RA, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1745; Cheng TC, 2012, J AM CHEM SOC, V134, P3103, DOI 10.1021/ja209335z; Choi C, 2014, ONCOGENE, V33, P3668, DOI 10.1038/onc.2013.341; Cummings J, 2004, BIOCHEM PHARMACOL, V67, P31, DOI 10.1016/j.bcp.2003.07.019; Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024; Di Carlo E, 1999, LAB INVEST, V79, P1261; Dodds HM, 2002, J PHARMACOL EXP THER, V303, P649, DOI 10.1124/jpet.102.039040; Grill AE, 2014, DRUG DELIV TRANSL RE, V4, P344, DOI 10.1007/s13346-014-0199-6; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Juan TY, 2009, CLIN CANCER RES, V15, P4600, DOI 10.1158/1078-0432.CCR-09-0090; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kazemi-Lomedasht F, 2013, ADV PHARM BULL, V3, P127, DOI 10.5681/apb.2013.021; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Li L, 2005, CANCER-AM CANCER SOC, V104, P1322, DOI 10.1002/cncr.21300; Liang GA, 2009, BIOORGAN MED CHEM, V17, P2623, DOI 10.1016/j.bmc.2008.10.044; Lin JK, 2007, ADV EXP MED BIOL, V595, P227; MINERS JO, 1991, PHARMACOL THERAPEUT, V51, P347, DOI 10.1016/0163-7258(91)90065-T; Mohanty C, 2010, BIOMATERIALS, V31, P6597, DOI 10.1016/j.biomaterials.2010.04.062; Murdter TE, 2002, J PHARMACOL EXP THER, V301, P223, DOI 10.1124/jpet.301.1.223; Murdter TE, 1997, CANCER RES, V57, P2440; Nanni P, 2001, J EXP MED, V194, P1195, DOI 10.1084/jem.194.9.1195; Nelson KM, 2017, J MED CHEM, V60, P1620, DOI 10.1021/acs.jmedchem.6b00975; Pal A, 2014, BIOORGAN MED CHEM, V22, P435, DOI 10.1016/j.bmc.2013.11.006; Pan MH, 1999, DRUG METAB DISPOS, V27, P486; Prasad, 1997, J Cardiovasc Pharmacol Ther, V2, P309, DOI 10.1177/107424849700200409; Prijovich ZM, 2009, MOL CANCER THER, V8, P940, DOI 10.1158/1535-7163.MCT-08-0812; RAVINDRANATH V, 1980, TOXICOLOGY, V16, P259, DOI 10.1016/0300-483X(80)90122-5; RAVINDRANATH V, 1981, TOXICOLOGY, V22, P337, DOI 10.1016/0300-483X(81)90027-5; Sabolovic N, 2006, BIOPHARM DRUG DISPOS, V27, P181, DOI 10.1002/bdd.498; Sharan S, 2012, DRUG METAB DISPOS, V40, P1993, DOI 10.1124/dmd.112.046417; Sherwood RF, 1996, ADV DRUG DELIVER REV, V22, P269, DOI 10.1016/S0169-409X(96)00450-4; Shimoi K, 2005, METHOD ENZYMOL, V400, P263, DOI 10.1016/S0076-6879(05)00015-7; Shoji M, 2014, FOOD CHEM, V151, P126, DOI 10.1016/j.foodchem.2013.11.021; Sperker B, 2000, N-S ARCH PHARMACOL, V362, P110, DOI 10.1007/s002100000260; Thompson KJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188873; Tomren MA, 2007, INT J PHARM, V338, P27, DOI 10.1016/j.ijpharm.2007.01.013; Vareed SK, 2008, CANCER EPIDEM BIOMAR, V17, P1411, DOI 10.1158/1055-9965.EPI-07-2693; Yuan L, 2003, MUTAT RES-FUND MOL M, V523, P55, DOI 10.1016/S0027-5107(02)00321-4	45	5	5	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9453	9465		10.1096/fj.201900166R	http://dx.doi.org/10.1096/fj.201900166R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31136203	Green Published			2022-12-28	WOS:000478832900058
J	Schroder-Heurich, B; von Hardenberg, S; Brodowski, L; Kipke, B; Meyer, N; Borns, K; von Kaisenberg, CS; Brinkmann, H; Claus, P; von Versen-Hoynck, F				Schroeder-Heurich, Bianca; von Hardenberg, Sandra; Brodowski, Lars; Kipke, Berina; Meyer, Nadia; Borns, Katja; von Kaisenberg, Constantin S.; Brinkmann, Hella; Claus, Peter; von Versen-Hoeynck, Frauke			Vitamin D improves endothelial barrier integrity and counteracts inflammatory effects on endothelial progenitor cells	FASEB JOURNAL			English	Article						endothelial colony-forming cells; TNF-alpha adhesion proteins; VE-cadherin; endothelial dysfunction	VE-CADHERIN; PHOSPHORYLATION; MOBILIZATION; MECHANISMS; PREGNANCY; BIOMARKER; JUNCTIONS; THERAPY; ACTIN	Endothelial colony-forming cells (ECFCs), a proliferative subpopulation of endothelial progenitor cells, are involved in angiogenesis and endothelial repair. In this study, we investigated endothelial barrier characteristics of ECFCs, whether vitamin D supports cell-cell adhesion and barrier integrity, and how it affects ECFC mobilization and actin dynamics. Although ECFC barrier was disrupted under inflammatory conditions, this effect was rescued by vitamin D treatment, leading to higher stability of an ECFC monolayer. Furthermore, vitamin D enhanced ECFC mobilization toward directional migration. In addition, immunocytochemistry, quantitative real-time PCR, and immunoblotting analysis showed that vitamin D increased endothelial interconnections through vascular endothelial cadherin (VE-cadherin) junctions and by impacting cell dynamics through cofilin and VE-cadherin phosphorylation. Our results suggest that vitamin D treatment efficiently counteracts inflammation in an ECFC monolayer, resulting in higher ECFC barrier integrity. This study provides evidence of a new beneficial effect of vitamin D for ECFC homeostasis.-Schroder-Heurich, B., von Hardenberg, S., Brodowski, L., Kipke, B., Meyer, N., Borns, K., von Kaisenberg, C. S., Brinkmann, H., Claus, P., von Versen-Hoynck, F. Vitamin D improves endothelial barrier integrity and counteracts inflammatory effects on endothelial progenitor cells.	[Schroeder-Heurich, Bianca; von Hardenberg, Sandra; Brodowski, Lars; Kipke, Berina; Meyer, Nadia; Borns, Katja; von Versen-Hoeynck, Frauke] Hannover Med Sch, Gynecol Res Unit, Hannover, Germany; [Brodowski, Lars; von Kaisenberg, Constantin S.; von Versen-Hoeynck, Frauke] Hannover Med Sch, Dept Obstet & Gynecol, Hannover, Germany; [Brinkmann, Hella; Claus, Peter] Hannover Med Sch, Inst Neuroanat & Cell Biol, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	von Versen-Hoynck, F (corresponding author), Hannover Med Sch, Gynecol Res Unit OE 6411, Carl Neuberg Str 1, D-30625 Hannover, Germany.	vonversen-hoeynck.frauke@mh-hannover.de	Claus, Peter/A-7978-2008; von Versen-Höynck, Frauke/H-3719-2019; von Kaisenberg, Constantin/AAR-2756-2021	Claus, Peter/0000-0003-3824-9445; von Versen-Höynck, Frauke/0000-0002-1924-5695; Schroder-Heurich, Bianca/0000-0002-5996-2373	Claudia von Schilling Foundation; German Research Foundation (DFG) [VE490/7-1]	Claudia von Schilling Foundation; German Research Foundation (DFG)(German Research Foundation (DFG))	The authors thank the faculty, residents, and staff of the Gynecology Research Unit and the Division of Obstetrics at Hannover Medical School for support in recruiting participants and collecting blood samples. The authors thank the Claudia von Schilling Foundation for supporting the Gynecology Research Unit with the xCelligence instrument. The study was supported by a German Research Foundation (DFG) project grant to F.v.V.-H. (VE490/7-1). The authors declare no conflicts of interest.	Abu Taha A, 2014, CELL ADHES MIGR, V8, P125, DOI 10.4161/cam.28243; Aranow C, 2011, J INVEST MED, V59, P881, DOI 10.2310/JIM.0b013e31821b8755; Bamburg James R, 2010, F1000 Biol Rep, V2, P62, DOI 10.3410/B2-62; Beveridge LA, 2013, OSTEOPOROSIS INT, V24, P2167, DOI 10.1007/s00198-013-2281-1; Caiado F, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-4; Calabrese F, 2003, CARDIOVASC RES, V60, P1, DOI 10.1016/S0008-6363(03)00569-8; Claesson-Welsh L, 2015, UPSALA J MED SCI, V120, P135, DOI 10.3109/03009734.2015.1064501; DEJANA E, 1995, FASEB J, V9, P910, DOI 10.1096/fasebj.9.10.7615160; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Diaz L, 2009, J REPROD IMMUNOL, V81, P17, DOI 10.1016/j.jri.2009.02.005; Edwards N, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00200; Esser S, 1998, J CELL SCI, V111, P1853; Favero G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/801896; Gavard J, 2013, CELL ADHES MIGR, V7, P455, DOI 10.4161/cam.27330; Gavard J, 2009, FEBS LETT, V583, P1, DOI 10.1016/j.febslet.2008.11.032; Ge YZ, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0332-x; Gouni-Berthold I, 2009, CURR VASC PHARMACOL, V7, P414, DOI 10.3390/nu5083005; Groten T, 2000, MOL HUM REPROD, V6, P1027, DOI 10.1093/molehr/6.11.1027; Grundmann M, 2012, AM J PHYSIOL-CELL PH, V303, pC954, DOI 10.1152/ajpcell.00030.2012; Hensel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031202; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hoe E, 2016, NUTRIENTS, V8, DOI 10.3390/nu8120806; Hristov M, 2003, ARTERIOSCL THROM VAS, V23, P1185, DOI 10.1161/01.ATV.0000073832.49290.B5; Marcos-Ramiro B, 2014, THROMB HAEMOSTASIS, V112, P1088, DOI 10.1160/TH14-04-0299; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Mulligan ML, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.002; Munoz-Hernandez R, 2014, HYPERTENSION, V64, P165, DOI 10.1161/HYPERTENSIONAHA.113.03058; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Prasain N, 2009, MICROVASC RES, V77, P53, DOI 10.1016/j.mvr.2008.09.012; Rusterholz C, 2007, SEMIN IMMUNOPATHOL, V29, P151, DOI 10.1007/s00281-007-0071-6; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; Sanchez-Aranguren LC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00372; Schmeisser A, 2001, CARDIOVASC RES, V49, P671, DOI 10.1016/S0008-6363(00)00270-4; Sen S, 2011, CLIN SCI, V120, P263, DOI 10.1042/CS20100429; Skaaby T, 2017, ADV EXP MED BIOL, V996, P221, DOI 10.1007/978-3-319-56017-5_18; Sukmawati D, 2015, AM J TRANSL RES, V7, P411; Taylor RN, 2015, CHESLEY'S HYPERTENSIVE DISORDERS IN PREGNANCY, 4TH EDITION, P1; Tilling L, 2009, BRIT J CLIN PHARMACO, V68, P484, DOI 10.1111/j.1365-2125.2009.03486.x; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; von Versen-Hoynck F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098990; Wallez Y, 2006, TRENDS CARDIOVAS MED, V16, P55, DOI 10.1016/j.tcm.2005.11.008; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Widmer R Jay, 2014, Glob Cardiol Sci Pract, V2014, P291, DOI 10.5339/gcsp.2014.43; Willerson JT, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000129535.04194.38; Yamahara Kenichi, 2009, Ther Adv Cardiovasc Dis, V3, P17, DOI 10.1177/1753944708097728; Yan Y, 2015, INT J CLIN EXP MED, V8, P19466; Yin K, 2014, J INFLAMM RES, V7, P69, DOI 10.2147/JIR.S63898; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081	48	15	16	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9142	9153		10.1096/fj.201802750RR	http://dx.doi.org/10.1096/fj.201802750RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31084577				2022-12-28	WOS:000478832900036
J	Weinert, M; Millet, A; Jonas, EA; Alavian, KN				Weinert, Maria; Millet, Aurelie; Jonas, Elizabeth A.; Alavian, Kambiz N.			The mitochondrial metabolic function of DJ-1 is modulated by 14-3-3 beta	FASEB JOURNAL			English	Article						neuroprotective oncogenes; metabolic plasticity; mitochondrial efficiency	PROTEIN DJ-1; STRUCTURAL BASIS; ALPHA-SYNUCLEIN; RECESSIVE PARKINSONISM; OXIDATIVE STRESS; LRRK2 KINASE; DISEASE; BINDING; LOCALIZATION; DJ-1/PARK7	Mitochondrial metabolic plasticity is a key adaptive mechanism in response to changes in cellular metabolic demand. Changes in mitochondrial metabolic efficiency have been linked to pathophysiological conditions, including cancer, neurodegeneration, and obesity. The ubiquitously expressed DJ-1 (Parkinsonism-associated deglycase) is known as a Parkinson's disease gene and an oncogene. The pleiotropic functions of DJ-1 include reactive oxygen species scavenging, RNA binding, chaperone activity, endocytosis, and modulation of major signaling pathways involved in cell survival and metabolism. Nevertheless, how these functions are linked to the role of DJ-1 in mitochondrial plasticity is not fully understood. In this study, we describe an interaction between DJ-1 and 14-3-3 beta that regulates the localization of DJ-1, in a hypoxia-dependent manner, either to the cytosol or to mitochondria. This interaction acts as a modulator of mitochondrial metabolic efficiency and a switch between glycolysis and oxidative phosphorylation. Modulation of this novel molecular mechanism of mitochondrial metabolic efficiency is potentially involved in the neuroprotective function of DJ-1 as well as its role in proliferation of cancer cells.-Weinert, M., Millet, A., Jonas, E. A., Alavian, K. N. The mitochondrial metabolic function of DJ-1 is modulated by 14-3-3 beta.	[Weinert, Maria; Millet, Aurelie; Alavian, Kambiz N.] Imperial Coll London, Dept Med, Div Brain Sci, London, England; [Jonas, Elizabeth A.; Alavian, Kambiz N.] Yale Univ, Dept Internal Med, Div Endocrinol, New Haven, CT USA	Imperial College London; Yale University	Alavian, KN (corresponding author), Imperial Coll, Dept Med, Div Brain Sci, Hammersmith Hosp, E508,Burlington Danes,DuCane Rd, London W12 0NN, England.	k.alavian@imperial.ac.uk	Alavian, Kambiz N/D-7720-2012; Alavian, Kambiz/O-2831-2017	Weinert, Maria/0000-0001-6187-1000; Alavian, Kambiz/0000-0002-0653-3057	Imperial College London funds; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081746, R37NS045876] Funding Source: NIH RePORTER	Imperial College London funds; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the Imperial College London funds provided to K.N.A. The authors declare no conflicts of interest.	ALAM R, 1994, J BIOCHEM-TOKYO, V116, P416, DOI 10.1093/oxfordjournals.jbchem.a124541; Alessi DR, 2018, SCIENCE, V360, P36, DOI 10.1126/science.aar5683; Beguin P, 2006, J MOL BIOL, V355, P34, DOI 10.1016/j.jmb.2005.10.013; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; Berg D, 2003, ANN NEUROL, V54, P135, DOI 10.1002/ana.10621; Bjorkblom B, 2014, MOL CELL BIOL, V34, P3024, DOI 10.1128/MCB.00286-14; Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Cali T, 2015, HUM MOL GENET, V24, P1045, DOI 10.1093/hmg/ddu519; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Deng H, 2018, AGEING RES REV, V42, P72, DOI 10.1016/j.arr.2017.12.007; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Giaime E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040501; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; HACHIYA N, 1994, EMBO J, V13, P5146, DOI 10.1002/j.1460-2075.1994.tb06844.x; Hayashi T, 2009, BIOCHEM BIOPH RES CO, V390, P667, DOI 10.1016/j.bbrc.2009.10.025; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Henry O, 2011, BIOPROC BIOSYST ENG, V34, P263, DOI 10.1007/s00449-010-0468-9; Ishikawa S, 2009, J BIOL CHEM, V284, P28832, DOI 10.1074/jbc.M109.019950; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Joselin AP, 2012, HUM MOL GENET, V21, P4888, DOI 10.1093/hmg/dds325; Junn E, 2009, J NEUROSCI RES, V87, P123, DOI 10.1002/jnr.21831; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kawamoto Y, 2002, J NEUROPATH EXP NEUR, V61, P245, DOI 10.1093/jnen/61.3.245; Kim KS, 2013, HUM MOL GENET, V22, P4805, DOI 10.1093/hmg/ddt332; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kojima W, 2016, GENES CELLS, V21, P772, DOI 10.1111/gtc.12382; Lev N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127549; Lu LL, 2016, MOL NEUROBIOL, V53, P7363, DOI 10.1007/s12035-016-9772-y; Lundgaard I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7807; Maita C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054087; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; May T, 2000, PLANT CELL, V12, P53, DOI 10.1105/tpc.12.1.53; Mcnally RS, 2011, J BIOL CHEM, V286, P4098, DOI 10.1074/jbc.M110.147371; Mo JS, 2010, J CELL BIOCHEM, V110, P229, DOI 10.1002/jcb.22530; Moscovitz O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7609; Neasta J, 2012, J BIOL CHEM, V287, P322, DOI 10.1074/jbc.M111.272195; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Obel Linea F, 2012, Front Neuroenergetics, V4, P3, DOI 10.3389/fnene.2012.00003; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Pacelli C, 2015, CURR BIOL, V25, P2349, DOI 10.1016/j.cub.2015.07.050; Parsanejad M, 2014, J NEUROSCI, V34, P8043, DOI 10.1523/JNEUROSCI.1244-13.2014; Plotegher N, 2014, HUM MOL GENET, V23, P5615, DOI 10.1093/hmg/ddu275; Ramakrishnan G, 2015, SCI REP-UK, V5, DOI 10.1038/srep08782; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Richarme G, 2015, J BIOL CHEM, V290, P1885, DOI 10.1074/jbc.M114.597815; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Shi SY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8415; Shirakashi Y, 2006, ACTA NEUROPATHOL, V112, P681, DOI 10.1007/s00401-006-0132-2; Song IK, 2016, SCI REP-UK, V6, DOI 10.1038/srep34432; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Toska K, 2002, J NEUROCHEM, V83, P775, DOI 10.1046/j.1471-4159.2002.01172.x; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; Vasseur S, 2009, P NATL ACAD SCI USA, V106, P1111, DOI 10.1073/pnas.0812745106; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211; Zhong N, 2008, HUM MOL GENET, V17, P3357, DOI 10.1093/hmg/ddn230	66	12	12	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					8925	8934		10.1096/fj.201802754R	http://dx.doi.org/10.1096/fj.201802754R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31034784	Green Published			2022-12-28	WOS:000478832900019
J	Zhou, S; Li, YX; Qiao, L; Ge, YX; Huang, XJ; Gao, X; Ju, HX; Wang, W; Zhang, JF; Yan, J; Teng, HJ; Jiang, Q				Zhou, Sheng; Li, Yixuan; Qiao, Liang; Ge, Yuxiang; Huang, Xiaojing; Gao, Xiang; Ju, Huangxian; Wang, Wei; Zhang, Junfeng; Yan, Jun; Teng, Huajian; Jiang, Qing			Inactivation of Lkb1 in postnatal chondrocytes leads to epiphyseal growth-plate abnormalities and promotes enchondroma-like formation	FASEB JOURNAL			English	Article						mTOR; oncology; cartilage biology	OLLIER DISEASE; MOUSE MODEL; CELL; CANCER; EXPRESSION; MUTATIONS; DELETION; TUMORS; GENE; IDH1	Liver serine-threonine kinase B1 (LKB1) is a tumor suppressor that has been linked to many types of tumors. However, the role of LKB1 in cartilaginous tumorigenesis is still poorly understood. In this study, we find that cartilage-specific, tamoxifen-inducible Lkb1 knockout results in multiple enchondroma-like lesions adjacent to the disorganized growth plates. We showed that chondrocytes retain an immature status caused by loss of Lkb1, which may lead to the dramatic expansion of growth-plate cartilage and the formation of enchondroma-like lesions. Additionally, increased mammalian target of rapamycin complex 1 (mTORC1) activity is observed in the Lkb1 conditional knockout (cKO) chondrocytes, and rapamycin (mTORC1 inhibitor) treatment significantly alleviates the expansion of growth-plate cartilage and eliminates the enchondroma-like lesions in Lkb1 cKO mice. Thus, our findings indicate that loss of Lkb1 leads to the expansion of chondrocytes and the formation of enchondroma-like lesions during postnatal cartilage development, and that the up-regulated mTORC1-signaling pathway is implicated in this process. Our findings suggest that modulation of LKB1 and related signaling is a potential therapy in cartilaginous tumorigenesis.-Zhou, S., Li, Y., Qiao, L., Ge, Y., Huang, X., Gao, X., Ju, H., Wang, W., Zhang, J., Yan, J., Teng, H., Jiang, Q. Inactivation of Lkb1 in postnatal chondrocytes leads to epiphyseal growth-plate abnormalities and promotes enchondroma-like formation.	[Zhou, Sheng; Li, Yixuan; Qiao, Liang; Ge, Yuxiang; Jiang, Qing] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Dept Sports Med & Adult Reconstruct Surg, Nanjing Drum Tower Hosp,Affiliated Hosp,Med Sch, Nanjing, Jiangsu, Peoples R China; [Huang, Xiaojing; Gao, Xiang; Yan, Jun; Teng, Huajian; Jiang, Qing] Model Anim Res Ctr MARC, Nanjing, Jiangsu, Peoples R China; [Ju, Huangxian; Wang, Wei; Zhang, Junfeng] Nanjing Univ, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Teng, HJ; Jiang, Q (corresponding author), Nanjing Drum Tower Hosp, Dept Sports Med & Adult Reconstruct Surg, Zhongshan Rd 321, Nanjing 210008, Jiangsu, Peoples R China.	tenghj@hotmail.com; qingj@nju.edu.cn	Yan, Jun/Q-3031-2017	Yan, Jun/0000-0002-1303-1952	National Natural Science Foundation of China (NSFC) [81472116]; Projects of International Cooperation and Exchanges NSFC [81420108021]; Key Program of NSFC [81730067]; Excellent Young Scholars NSFC [81622033]; Jiangsu Provincial Key Medical Center Foundation; Jiangsu Provincial Medical Outstanding Talent Foundation; Jiangsu Provincial Medical Youth Talent Foundation; Jiangsu Provincial Key Medical Talent Foundation	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Projects of International Cooperation and Exchanges NSFC; Key Program of NSFC(National Natural Science Foundation of China (NSFC)); Excellent Young Scholars NSFC; Jiangsu Provincial Key Medical Center Foundation; Jiangsu Provincial Medical Outstanding Talent Foundation; Jiangsu Provincial Medical Youth Talent Foundation; Jiangsu Provincial Key Medical Talent Foundation	This work is supported by the National Natural Science Foundation of China (NSFC; 81472116), the Projects of International Cooperation and Exchanges NSFC (81420108021), the Key Program of NSFC (81730067), the Excellent Young Scholars NSFC (81622033), the Jiangsu Provincial Key Medical Center Foundation, the Jiangsu Provincial Medical Outstanding Talent Foundation, the Jiangsu Provincial Medical Youth Talent Foundation, and the Jiangsu Provincial Key Medical Talent Foundation. The authors declare no conflicts of interest.	Amary MF, 2011, NAT GENET, V43, P1262, DOI 10.1038/ng.994; Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Bovee JVMG, 2010, NAT REV CANCER, V10, P481, DOI 10.1038/nrc2869; Bowen ME, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004364; Bowen ME, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002050; Chen M, 2007, GENESIS, V45, P44, DOI 10.1002/dvg.20261; Fu A, 2009, CELL METAB, V10, P285, DOI 10.1016/j.cmet.2009.08.008; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Gurumurthy S, 2008, CANCER RES, V68, P55, DOI 10.1158/0008-5472.CAN-07-3225; Han Y., 2019, J CLIN INVEST, V130; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; Hirata M, 2015, P NATL ACAD SCI USA, V112, P2829, DOI 10.1073/pnas.1424400112; Hopyan S, 2002, NAT GENET, V30, P306, DOI 10.1038/ng844; Jansen M, 2009, PHYSIOL REV, V89, P777, DOI 10.1152/physrev.00026.2008; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kim HKW, 2014, J BONE MINER RES, V29, P761, DOI 10.1002/jbmr.2062; Kong FF, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.527; Korsse SE, 2013, BBA-REV CANCER, V1835, P194, DOI 10.1016/j.bbcan.2012.12.006; Lai LP, 2014, BONE, V69, P98, DOI 10.1016/j.bone.2014.09.010; Lai LP, 2013, P NATL ACAD SCI USA, V110, P19450, DOI 10.1073/pnas.1309001110; Liang S, 2018, GENE, V677, P340, DOI 10.1016/j.gene.2018.08.013; Marco R A, 2000, J Am Acad Orthop Surg, V8, P292; Pannier S, 2008, BEST PRACT RES CL RH, V22, P45, DOI 10.1016/j.berh.2007.12.004; Pansuriya TC, 2011, NAT GENET, V43, P1256, DOI 10.1038/ng.1004; Presneau N, 2017, BRIT J CANCER, V117, P398, DOI 10.1038/bjc.2017.174; Robinson J, 2008, EXP MOL PATHOL, V85, P223, DOI 10.1016/j.yexmp.2008.07.005; Rozeman LB, 2005, J PATHOL, V205, P476, DOI 10.1002/path.1723; Sanchez-Cespedes M, 2007, ONCOGENE, V26, P7825, DOI 10.1038/sj.onc.1210594; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; SCHWARTZ HS, 1987, J BONE JOINT SURG AM, V69A, P269, DOI 10.2106/00004623-198769020-00016; Shan TZ, 2014, STEM CELLS, V32, P2893, DOI 10.1002/stem.1788; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Sobreira NLM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000991; Sun G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1261, DOI 10.1152/ajpendo.00100.2010; van Lier MGF, 2011, GUT, V60, P141, DOI 10.1136/gut.2010.223750; Xiong Y, 2017, EBIOMEDICINE, V24, P127, DOI 10.1016/j.ebiom.2017.09.017; Yan B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11151; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074; Zhou S, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43245; Zhou SU, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005214	42	1	1	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9476	9488		10.1096/fj.201900294RR	http://dx.doi.org/10.1096/fj.201900294RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31091421				2022-12-28	WOS:000478832900060
J	Kelleher, AM; Behura, SK; Burns, GW; Young, SL; DeMayo, FJ; Spencer, TE				Kelleher, Andrew M.; Behura, Susanta K.; Burns, Gregory W.; Young, Steven L.; DeMayo, Francesco J.; Spencer, Thomas E.			Integrative analysis of the forkhead box A2 (FOXA2) cistrome for the human endometrium	FASEB JOURNAL			English	Article						uterus; ChIP-seq; transcription factor	STROMAL CELL DECIDUALIZATION; TRANSCRIPTION FACTORS; UTERINE GLANDS; EXPRESSION; REVEALS; PROLIFERATION; RECEPTIVITY; PLACENTA; POINTS	The pioneer forkhead box (FOX)A2 transcription factor is specifically expressed in the glands of the uterus, which are central to endometrial function and fertility. In mice, FOXA2 is a critical regulator of uterine gland development in the neonate and gland function in the adult. An integrative approach was used here to define the FOXA2 cistrome in the human endometrium. Genome-wide mapping of FOXA2 binding intervals by chromatin immunoprecipitation sequencing was performed using proliferative (P)- and midsecretory (MS)-phase endometrium and integrated with the transcriptome determined by RNA sequencing. Distinctive FOXA2 binding intervals, enriched for different transcription factor binding site motifs, were detected in the P and MS endometrium. Pathway analysis revealed different biologic processes regulated by genes with FOXA2 binding intervals in the P and MS endometrium. Thus, FOXA2 is postulated to regulate gene expression in concert with other transcription factors and impact uterine gland development and function in a cycle phase-dependent manner. Analyses also identified potential FOXA2-regulated genes that influence uterine receptivity, blastocyst implantation, and stromal cell decidualization, which are key events in pregnancy establishment.-Kelleher, A. M., Behura, S. K., Burns, G. W., Young, S. L., DeMayo, F. J., Spencer, T. E. Integrative analysis of the forkhead box A2 (FOXA2) cistrome for the human endometrium.	[Kelleher, Andrew M.; Behura, Susanta K.; Burns, Gregory W.; Spencer, Thomas E.] Univ Missouri, Div Anim Sci, 920 East Campus Dr, Columbia, MO 65211 USA; [Behura, Susanta K.] Univ Missouri, Informat Inst, Columbia, MO 65211 USA; [Spencer, Thomas E.] Univ Missouri, Dept Obstet Gynecol & Womens Hlth, Columbia, MO 65211 USA; [Young, Steven L.] Univ North Carolina Chapel Hill, Dept Obstet & Gynecol, Chapel Hill, NC USA; [DeMayo, Francesco J.] NIEHS, Reprod & Dev Biol Lab, Durham, NC USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Spencer, TE (corresponding author), Univ Missouri, Div Anim Sci, 920 East Campus Dr, Columbia, MO 65211 USA.	spencerte@missouri.edu	Spencer, Thomas/AAD-6434-2020; , Pathology Services Core/CEZ-2246-2022; Young, Steven L/G-2304-2014	Young, Steven L/0000-0002-5205-4495; Kelleher, Andrew/0000-0002-1484-4998; Burns, Gregory/0000-0003-0021-4319; behura, Susanta/0000-0003-1057-2435	U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development [1 R01 HD096266]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD096266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES103311] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant 1 R01 HD096266 (to T.E.S.). The authors declare no conflicts of interest.	Behura SK, 2019, FASEB J, V33, P4261, DOI 10.1096/fj.201802037R; Brosens I, 2015, AM J OBSTET GYNECOL, V212, P580, DOI 10.1016/j.ajog.2015.01.013; Burton GJ, 2011, J REPROD IMMUNOL, V89, P118, DOI 10.1016/j.jri.2011.02.005; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Conrad KP, 2017, PLACENTA, V60, P119, DOI 10.1016/j.placenta.2017.06.005; Cooke PS, 2013, MOL HUM REPROD, V19, P547, DOI 10.1093/molehr/gat031; Cooke PS, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097188; Das SK, 2009, REPRODUCTION, V137, P889, DOI 10.1530/REP-08-0539; Diaz-Gimeno P, 2013, FERTIL STERIL, V99, P508, DOI 10.1016/j.fertnstert.2012.09.046; Diaz-Gimeno P, 2011, FERTIL STERIL, V95, P50, DOI 10.1016/j.fertnstert.2010.04.063; Dimitriadis E, 2002, MOL HUM REPROD, V8, P636, DOI 10.1093/molehr/8.7.636; Ewington LJ, 2019, J OBSTET GYNAECOL RE, V45, P258, DOI 10.1111/jog.13837; Farah O, 2018, REPRODUCTION, V155, P93, DOI 10.1530/REP-17-0436; Filant J, 2014, FASEB J, V28, P230, DOI 10.1096/fj.13-237446; Filant J, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111971; Filant J, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.107631; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Gargett CE, 2012, REV ENDOCR METAB DIS, V13, P235, DOI 10.1007/s11154-012-9221-9; Garrido-Gomez T, 2017, P NATL ACAD SCI USA, V114, pE8468, DOI 10.1073/pnas.1706546114; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Godini R, 2019, J CELL PHYSIOL, V234, P6489, DOI 10.1002/jcp.27386; Golson ML, 2016, DEVELOPMENT, V143, P4558, DOI 10.1242/dev.112672; Guimaraes-Young A, 2016, DEV BIOL, V414, P219, DOI 10.1016/j.ydbio.2016.04.010; Hawkins SM, 2011, MOL ENDOCRINOL, V25, P821, DOI 10.1210/me.2010-0371; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hu SG, 2014, J CLIN ENDOCR METAB, V99, pE2744, DOI 10.1210/jc.2014-2155; Iwafuchi-Doi M, 2016, MOL CELL, V62, P79, DOI 10.1016/j.molcel.2016.03.001; Jeong JW, 2009, ONCOGENE, V28, P31, DOI 10.1038/onc.2008.363; Jeong JW, 2010, BIOL REPROD, V83, P396, DOI 10.1095/biolreprod.109.083154; Kaestner KH, 2010, CURR OPIN GENET DEV, V20, P527, DOI 10.1016/j.gde.2010.06.005; Kelleher A.M., 2019, ENDOCR REV; Kelleher AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04848-8; Kelleher AM, 2017, P NATL ACAD SCI USA, V114, pE1018, DOI 10.1073/pnas.1618433114; Kelleher AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep38078; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Le Gallo M, 2018, CANCER-AM CANCER SOC, V124, P65, DOI 10.1002/cncr.30971; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin AP, 2018, REPROD BIOMED ONLINE, V36, P181, DOI 10.1016/j.rbmo.2017.11.001; Macdonald LJ, 2011, MOL HUM REPROD, V17, P626, DOI 10.1093/molehr/gar031; Mariee N, 2012, HUM REPROD, V27, P1946, DOI 10.1093/humrep/des134; Marshall AD, 2017, ONCOGENE, V36, P4100, DOI 10.1038/onc.2017.25; Moser G, 2018, HISTOCHEM CELL BIOL, V150, P361, DOI 10.1007/s00418-018-1699-0; Nallasamy S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002500; Nanjappa MK, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.125724; NOYES RW, 1950, FERTIL STERIL, V1, P3, DOI 10.1016/s0015-0282(16)30062-0; Noyes RW, 1973, THE UTERUS, P110; Ramilowski JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8866; Shuya LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025288; Sigurgeirsson B, 2017, BIOL REPROD, V96, P24, DOI 10.1095/biolreprod.116.142547; Smith B, 2016, GYNECOL ONCOL, V143, P398, DOI 10.1016/j.ygyno.2016.08.237; Spencer TE, 2014, SEMIN REPROD MED, V32, P346, DOI 10.1055/s-0034-1376354; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Szwarc MM, 2018, BIOL REPROD, V98, P15, DOI 10.1093/biolre/iox161; Teklenburg G, 2010, MOL HUM REPROD, V16, P886, DOI 10.1093/molehr/gaq079; Tsai SJ, 2002, ENDOCRINOLOGY, V143, P2715, DOI 10.1210/en.143.7.2715; Tulac S, 2003, J CLIN ENDOCR METAB, V88, P3860, DOI 10.1210/jc.2003-030494; Villacorte M, 2013, ONCOGENE, V32, P3477, DOI 10.1038/onc.2012.376; Whirledge S, 2017, ENDOCRINOLOGY, V158, P4076, DOI 10.1210/en.2017-00361; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhou XB, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku310	62	12	13	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8543	8554		10.1096/fj.201900013R	http://dx.doi.org/10.1096/fj.201900013R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30951376	Green Published, Bronze			2022-12-28	WOS:000476234700058
J	Brook, A; Hoaksey, A; Gurung, R; Yoong, EEC; Sneyd, R; Baynes, GC; Bischof, H; Jones, S; Higgins, LE; Jones, C; Greenwood, SL; Jones, RL; Gram, M; Lang, I; Desoye, G; Myers, J; Schneider, H; Hansson, SR; Crocker, IP; Brownbill, P				Brook, Adam; Hoaksey, Annie; Gurung, Rekha; Yoong, Edward E. C.; Sneyd, Rosanna; Baynes, Georgia C.; Bischof, Helen; Jones, Sarah; Higgins, Lucy E.; Jones, Carolyn; Greenwood, Susan L.; Jones, Rebecca L.; Gram, Magnus; Lang, Ingrid; Desoye, Gernot; Myers, Jenny; Schneider, Henning; Hansson, Stefan R.; Crocker, Ian P.; Brownbill, Paul			Cell free hemoglobin in the fetoplacental circulation: a novel cause of fetal growth restriction? (vol 32, pg 5436, 2018)	FASEB JOURNAL			English	Correction									[Brook, Adam; Hoaksey, Annie; Gurung, Rekha; Yoong, Edward E. C.; Sneyd, Rosanna; Baynes, Georgia C.; Bischof, Helen; Higgins, Lucy E.; Jones, Carolyn; Greenwood, Susan L.; Jones, Rebecca L.; Myers, Jenny; Crocker, Ian P.; Brownbill, Paul] Univ Manchester, Maternal & Fetal Hlth Res Ctr, Div Dev Biol & Med, Sch Med Sci,Fac Biol Med & Hlth, Manchester, Lancs, England; [Brook, Adam; Hoaksey, Annie; Gurung, Rekha; Yoong, Edward E. C.; Sneyd, Rosanna; Baynes, Georgia C.; Bischof, Helen; Higgins, Lucy E.; Jones, Carolyn; Greenwood, Susan L.; Jones, Rebecca L.; Myers, Jenny; Crocker, Ian P.; Brownbill, Paul] Manchester Univ Natl Hlth Serv NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, St Marys Hosp, Manchester, Lancs, England; [Jones, Sarah] Manchester Metropolitan Univ, Sch Healthcare Sci, Manchester, Lancs, England; [Gram, Magnus] Lund Univ, Div Infect Med, Lund, Sweden; [Hansson, Stefan R.] Lund Univ, Inst Clin Sci, Dept Obstet & Gynecol, Lund, Sweden; [Lang, Ingrid] Gottfried Schatz Res Ctr, Div Cell Biol Histol & Embryol, Graz, Austria; [Desoye, Gernot] Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria; [Schneider, Henning] Univ Bern, Inselspital, Dept Obstet & Gynecol, Bern, Switzerland	University of Manchester; University of Manchester; Manchester Metropolitan University; Lund University; Lund University; Medical University of Graz; University of Bern; University Hospital of Bern	Brownbill, P (corresponding author), St Marys Hosp, Maternal & Fetal Hlth Res Ctr, Oxford Rd, Manchester M13 9WL, Lancs, England.	paul.brownbill@manchester.ac.uk	; Brownbill, Paul/I-2412-2015	Myers, Jenny/0000-0003-0913-2096; Jones, Carolyn/0000-0002-0026-9494; Desoye, Gernot/0000-0002-5715-3230; Higgins, Lucy/0000-0003-0993-497X; Jones, Sarah/0000-0001-8154-3928; Gram, Magnus/0000-0002-5880-2925; Brownbill, Paul/0000-0002-8328-7072; Lang-Olip, Ingrid/0000-0003-0403-4884				Brook A, 2018, FASEB J, V32, P5436, DOI 10.1096/fj.201800264R; Pederson T, 2008, FASEB J, V22, P949, DOI 10.1096/fj.08-0402ufm	2	0	0	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6682	6682		10.1096/fj.201800264RERR	http://dx.doi.org/10.1096/fj.201800264RERR			1	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	31034282	Bronze			2022-12-28	WOS:000466932600069
J	Wang, LQ; Wang, Y; Chen, A; Teli, M; Kondo, R; Jalali, A; Fan, Y; Liu, SZ; Zhao, XY; Siegel, A; Minami, K; Agarwal, M; Li, BY; Yokota, H				Wang, Luqi; Wang, Yue; Chen, Andy; Teli, Meghana; Kondo, Rika; Jalali, Aydin; Fan, Yao; Liu, Shengzhi; Zhao, Xinyu; Siegel, Amanda; Minami, Kazumasa; Agarwal, Mangilal; Li, Bai-Yan; Yokota, Hiroki			Pitavastatin slows tumor progression and alters urine-derived volatile organic compounds through the mevalonate pathway	FASEB JOURNAL			English	Article						breast cancer; VOC; osteoclasts; bone metastasis	PROLIFERATOR-ACTIVATED RECEPTOR; BREAST-CANCER; CELL-LINES; IN-VITRO; STATINS; OSTEOCLASTOGENESIS; BISPHOSPHONATES; SUPPRESSION; MECHANISM; SNAIL	Bone is a frequent site of metastasis from breast cancer, and a desirable drug could suppress tumor growth as well as metastasis-linked bone loss. Currently, no drug is able to cure breast cancer associated bone metastasis. In this study, we focused on statins that are known to inhibit cholesterol production and act as antitumor agents. After an initial potency screening of 7 U.S. Food and Drug Administration approved statins, we examined pitavastatin as a drug candidate for inhibiting tumor and tumor-induced bone loss. In vitro analysis revealed that pitavastatin acted as an inhibitor of tumor progression by altering stress to the endoplasmic reticulum, down-regulating peroxisome proliferator-activated receptor gamma, and reducing Snail and matrix metalloproteinase 9. In bone homeostasis, it blocked osteoclast development by suppressing transcription factors c-Fos and JunB, but stimulated osteoblast mineralization by regulating bone morphogenetic protein 2 and p53. In a mouse model, pitavastatin presented a dual role in tumor inhibition in the mammary fat pad, as well as in bone protection in the osteolytic tibia. In mass spectrometry based analysis, volatile organic compounds (VOCs) that were linked to lipid metabolism and cholesterol synthesis were elevated in mice from the tumor-grown placebo group. Notably, pitavastatin-treated mice reduced specific VOCs that are linked to lipid metabolites in the mevalonate pathway. Collectively, the results lay a foundation for further investigation of pitavastatin's therapeutic efficacy in tumor-induced bone loss, as well as VOC-based diagnosis of tumor progression and treatment efficacy.	[Wang, Luqi; Wang, Yue; Fan, Yao; Li, Bai-Yan; Yokota, Hiroki] Harbin Med Univ, Sch Pharm, Dept Pharmacol, 157 Baojian Rd, Harbin 150081, Peoples R China; [Wang, Luqi; Wang, Yue; Chen, Andy; Teli, Meghana; Kondo, Rika; Jalali, Aydin; Fan, Yao; Liu, Shengzhi; Zhao, Xinyu; Yokota, Hiroki] Indiana Univ Purdue Univ, Dept Biomed Engn, 723 West Michigan St,SL220, Indianapolis, IN 46202 USA; [Siegel, Amanda; Agarwal, Mangilal; Yokota, Hiroki] Indiana Univ Purdue Univ, Integrated Nanosyst Dev Inst, Indianapolis, IN 46202 USA; [Siegel, Amanda] Indiana Univ Purdue Univ, Dept Chem & Chem Biol, Indianapolis, IN 46202 USA; [Agarwal, Mangilal; Yokota, Hiroki] Indiana Univ Purdue Univ, Dept Mech Engn, Indianapolis, IN 46202 USA; [Kondo, Rika; Minami, Kazumasa] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan; [Zhao, Xinyu] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing, Peoples R China; [Yokota, Hiroki] Indiana Univ Sch Med, Simon Canc Ctr, Indianapolis, IN 46202 USA; [Yokota, Hiroki] Indiana Univ Sch Med, Indiana Ctr Musculoskeletal Hlth, Indianapolis, IN 46202 USA	Harbin Medical University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Osaka University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Li, BY (corresponding author), Harbin Med Univ, Sch Pharm, Dept Pharmacol, 157 Baojian Rd, Harbin 150081, Peoples R China.; Yokota, H (corresponding author), Indiana Univ Purdue Univ, Dept Biomed Engn, 723 West Michigan St,SL220, Indianapolis, IN 46202 USA.	liby@ems.hrbmu.edu.cn; hyokota@iupui.edu	Siegel, Amanda/AAR-7871-2020	Siegel, Amanda/0000-0003-4112-0212	100 Voices of Hope; U.S. National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR052144]; NIH/National Cancer Institute [R03CA238555]; NATIONAL CANCER INSTITUTE [R03CA238555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052144] Funding Source: NIH RePORTER	100 Voices of Hope; U.S. National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Ali Daneshkhah, Paul Grocki, and Mark Woollam (all from Indiana University-Purdue University Indianapolis) for technical support, and Hisako Masuda (Indiana University, Kokomo, IN, USA) for data analysis. This study was supported, in part, by funds from 100 Voices of Hope (to H.Y.) and the U.S. National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR052144) and NIH/National Cancer Institute (R03CA238555 to H.Y.). The authors declare no conflicts of interest.	Ahern TP, 2014, LANCET ONCOL, V15, pE461, DOI 10.1016/S1470-2045(14)70119-6; Baron R, 2011, BONE, V48, P677, DOI 10.1016/j.bone.2010.11.020; Brook N, 2018, INT J BIOCHEM CELL B, V96, P63, DOI 10.1016/j.biocel.2018.01.003; Buhaescu I, 2007, CLIN BIOCHEM, V40, P575, DOI 10.1016/j.clinbiochem.2007.03.016; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Catapano AL, 2012, CLIN LIPIDOL, V7, P3, DOI 10.2217/CLP.12.21; Chiang YR, 2008, J BACTERIOL, V190, P905, DOI 10.1128/JB.01525-07; Chimento A, 2019, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00807; Chou R, 2016, JAMA-J AM MED ASSOC, V316, P2008, DOI 10.1001/jama.2015.15629; Coleman R E, 2000, Breast Cancer, V7, P361, DOI 10.1007/BF02966406; Corsini A, 1999, PHARMACOL THERAPEUT, V84, P413, DOI 10.1016/S0163-7258(99)00045-5; Davies Jonathan T, 2016, Lipid Insights, V9, P13; Drake MT, 2008, MAYO CLIN PROC, V83, P1032, DOI 10.4065/83.9.1032; Dunford JE, 2010, CURR PHARM DESIGN, V16, P2961; Fan M, 2016, CELL PHYSIOL BIOCHEM, V38, P1319, DOI 10.1159/000443076; Gago-Dominguez M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1628; Garrett WS, 2015, SCIENCE, V348, P80, DOI 10.1126/science.aaa4972; Ghavami S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.61; Gobel A, 2015, BREAST CANCER RES TR, V154, P623, DOI 10.1007/s10549-015-3624-8; Hamamura K, 2015, CELL SIGNAL, V27, P353, DOI 10.1016/j.cellsig.2014.11.020; Hamamura K, 2013, J BONE MINER METAB, V31, P618, DOI 10.1007/s00774-013-0450-0; Han L, 2017, FUTUR CARDIOL, V13, DOI 10.2217/fca-2017-0019; Iannelli F, 2018, RECENT PAT ANTI-CANC, V13, P184, DOI 10.2174/1574892812666171129141211; Iarrobino N. A., 2018, AM J CLIN ONCOL; Jadhav SB, 2006, J PHARM PHARMACOL, V58, P3, DOI 10.1211/jpp.58.1.0002; Jiang P, 2014, BRIT J CANCER, V111, P1562, DOI 10.1038/bjc.2014.431; Kamiya Nobuhiro, 2012, Curr Mol Pharmacol, V5, P153; Khalid T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143283; Kobayashi Y, 2017, ONCOTARGET, V8, P72147, DOI 10.18632/oncotarget.20046; Kodama HA., 1981, JPN J ORAL BIOL, V23, P899, DOI DOI 10.2330/JORALBIOSCI1965.23.899; Kotta-Loizou I, 2012, ANTI-CANCER AGENT ME, V12, P1025, DOI 10.2174/187152012803529664; Kwak J, 2012, PHYSIOL BEHAV, V107, P112, DOI 10.1016/j.physbeh.2012.06.008; Lan CH, 2014, ENVIRON POLLUT, V193, P156, DOI 10.1016/j.envpol.2014.06.014; Lavra L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13246; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Liu SZ, 2018, CANCER RES, V78, P3865, DOI 10.1158/0008-5472.CAN-18-0056; Liu YL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-276; Minami K, 2017, SCI REP-UK, V7, DOI 10.1038/srep45686; Miyazaki T, 2011, ANAL BIOCHEM, V410, P7, DOI 10.1016/j.ab.2010.11.014; Murtagh F, 2012, WIRES DATA MIN KNOWL, V2, P86, DOI 10.1002/widm.53; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nomura S, 2006, J EXP CLIN CANC RES, V25, P443; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Rogers MJ, 2000, NAT MED, V6, P21, DOI 10.1038/71484; Siegel AP, 2017, J BREATH RES, V11, DOI 10.1088/1752-7163/aa6ac6; Sopkova J, 2017, GEN PHYSIOL BIOPHYS, V36, P501, DOI 10.4149/gpb_2017045; Summons RE, 2006, PHILOS T R SOC B, V361, P951, DOI 10.1098/rstb.2006.1837; Wang CS, 2014, SCI REP-UK, V4, DOI 10.1038/srep05383; Wang HN, 2017, ONCOTARGET, V8, P88122, DOI 10.18632/oncotarget.21490; Wang LQ, 2018, INT J ONCOL, V53, P1001, DOI 10.3892/ijo.2018.4481; Whitaker M, 2012, NEW ENGL J MED, V366, P2048, DOI 10.1056/NEJMp1202619; Wieczorek E, 2015, TUMOR BIOL, V36, P163, DOI 10.1007/s13277-014-2747-6; Woollam M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38920-0; Xu WX, 2015, CELL SIGNAL, V27, P2332, DOI 10.1016/j.cellsig.2015.08.014; Zhang W, 2018, ONCOTARGET, V9, P3690, DOI [10.18632/oncotarget.23196, 10.18632/oncotarget.24286]	56	12	12	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13710	13721		10.1096/fj.201901388R	http://dx.doi.org/10.1096/fj.201901388R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31585508	Green Published, Bronze			2022-12-28	WOS:000507466100052
J	Balogun, EO; Inaoka, DK; Shiba, T; Tsuge, C; May, B; Sato, T; Kido, Y; Nara, T; Aoki, T; Honma, T; Tanaka, A; Inoue, M; Matsuoka, S; Michels, PAM; Watanabe, YI; Moore, AL; Harada, S; Kita, K				Balogun, Emmanuel Oluwadare; Inaoka, Daniel Ken; Shiba, Tomoo; Tsuge, Chiaki; May, Benjamin; Sato, Tomohiro; Kido, Yasutoshi; Nara, Takeshi; Aoki, Takashi; Honma, Teruki; Tanaka, Akiko; Inoue, Masayuki; Matsuoka, Shigeru; Michels, Paul A. M.; Watanabe, Yoh-Ichi; Moore, Anthony L.; Harada, Shigeharu; Kita, Kiyoshi			Discovery of trypanocidal coumarins with dual inhibition of both the glycerol kinase and alternative oxidase of Trypanosoma brucei brucei	FASEB JOURNAL			English	Article						energy metabolism; African trypanosomiasis; rational drug design; inhibitor; screening	INTERFERENCE COMPOUNDS PAINS; PURIFICATION; CLONING; ASSAY; ACID; TARGET; POTENT; GENE	African trypanosomiasis, sleeping sickness in humans or nagana in animals, is a potentially fatal neglected tropical disease and a threat to 65 million human lives and 100 million small and large livestock animals in sub-Saharan Africa. Available treatments for this devastating disease are few and have limited efficacy, prompting the search for new drug candidates. Simultaneous inhibition of the trypanosomal glycerol kinase (TGK) and trypanosomal alternative oxidase (TAO) is considered a validated strategy toward the development of new drugs. Our goal is to develop a TGK-specific inhibitor for coadministration with ascofuranone (AF), the most potent TAO inhibitor. Here, we report on the identification of novel compounds with inhibitory potency against TGK. Importantly, one of these compounds (compound 17) and its derivatives (17a and 17b) killed trypanosomes even in the absence of AF. Inhibition kinetics revealed that derivative 17b is a mixed-type and competitive inhibitor for TGK and TAO, respectively. Structural data revealed the molecular basis of this dual inhibitory action, which, in our opinion, will aid in the successful development of a promising drug to treat trypanosomiasis. Although the EC50 of compound 17b against trypanosome cells was 1.77 mu M, it had no effect on cultured human cells, even at 50 mu M.	[Balogun, Emmanuel Oluwadare; Kido, Yasutoshi] Ahmadu Bello Univ, Dept Biochem, Zaria 2222, Nigeria; [Balogun, Emmanuel Oluwadare; Inaoka, Daniel Ken; Tsuge, Chiaki; Watanabe, Yoh-Ichi; Kita, Kiyoshi] Univ Tokyo, Dept Biomed Chem, Grad Sch Med, Tokyo, Japan; [Inoue, Masayuki; Matsuoka, Shigeru] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Inaoka, Daniel Ken; Kita, Kiyoshi] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki 8528523, Japan; [Inaoka, Daniel Ken; Kita, Kiyoshi] Nagasaki Univ, Dept Mol Infect Dynam, Shionogi Global Infect Dis Div, Inst Trop Med NEKKEN, Nagasaki, Japan; [Shiba, Tomoo; Harada, Shigeharu] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Appl Biol, Kyoto, Japan; [May, Benjamin; Moore, Anthony L.] Univ Sussex, Biochem & Med, Sch Life Sci, Brighton, E Sussex, England; [Sato, Tomohiro; Honma, Teruki; Tanaka, Akiko] RIKEN, Syst & Struct Biol Ctr, Yokohama, Kanagawa, Japan; [Kido, Yasutoshi] Osaka City Univ, Grad Sch Med, Dept Parasitol, Osaka, Japan; [Nara, Takeshi; Aoki, Takashi] Juntendo Univ, Sch Med, Dept Mol & Cellular Parasitol, Tokyo, Japan; [Michels, Paul A. M.] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Michels, Paul A. M.] Univ Edinburgh, Sch Biol Sci, Ctr Translat & Chem Biol, Edinburgh, Midlothian, Scotland	Ahmadu Bello University; University of Tokyo; University of Tokyo; Nagasaki University; Nagasaki University; Kyoto Institute of Technology; University of Sussex; RIKEN; Osaka Metropolitan University; Juntendo University; University of Edinburgh; University of Edinburgh	Balogun, EO (corresponding author), Ahmadu Bello Univ, Dept Biochem, Zaria 2222, Nigeria.; Kita, K (corresponding author), Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki 8528523, Japan.	balogun1@m.u-tokyo.ac.jp; kitak@nagasaki-u.ac.jp	Kido, Yasutoshi/AAW-3688-2021; Balogun, Emmanuel Oluwadare/AAF-3352-2020; Inaoka, Daniel Ken/GMX-4344-2022; Michels, Paul A/A-5637-2009	Kido, Yasutoshi/0000-0003-3615-2631; Inaoka, Daniel Ken/0000-0002-9791-927X; Michels, Paul A/0000-0003-3726-6104; Balogun, Emmanuel/0000-0002-2092-0045	Government of the United Kingdom as part of the Global Challenge Research Fund (GCRF); African Academy of Sciences [FLR\R1\190353]; Royal Society [FLR\R1\190353]; Science and Technology Research Partnership for Sustainable Development [10000284, 14425718]; Program for the Promotion of Basic and Applied Research for Innovations in Bio-Oriented Industries; Japanese Ministry of Education, Science, Culture, Sports, and Technology (MEXT) [26870119, 93002316, 26440027]; Creative Scientific Research grant [18GS0314]; Japanese Society for the Promotion of Science [18073004]; Japanese Ministry of Health and Welfare	Government of the United Kingdom as part of the Global Challenge Research Fund (GCRF); African Academy of Sciences; Royal Society(Royal Society of London); Science and Technology Research Partnership for Sustainable Development; Program for the Promotion of Basic and Applied Research for Innovations in Bio-Oriented Industries; Japanese Ministry of Education, Science, Culture, Sports, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Creative Scientific Research grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	The authors thank all the staff members of the synchrotron beamlines BL44XU at SPring-8 and BL1A and BL17A at the Photon Factory (Tsukuba, Japan) for their help with X-ray diffraction experiments. Use of the synchrotron beamline BL44XU at SPring-8 was obtained through the Cooperative Research Program of the Institute for Protein Research (Osaka University, Osaka, Japan). The authors also thank the Open Innovation Center for Drug Discovery at The University of Tokyo for providing the kinase-focused library. This work was partly funded by the Government of the United Kingdom as part of the Global Challenge Research Fund (GCRF) through a partnership between the African Academy of Sciences and the Royal Society (FLR\R1\190353 to E.O.B.). E.O.B. is a Future Leaders-African Independent Research (FLAIR) Research Fellow of The Royal Society. This work was supported, in part, by Grants-in-Aid for Infectious Disease Control from the Science and Technology Research Partnership for Sustainable Development (10000284 to K.K. and 14425718 to D.K.I.); a grant from the Program for the Promotion of Basic and Applied Research for Innovations in Bio-Oriented Industries (to S.H. and K.K.); Grants-in-Aid for Scientific Research (B) (26870119 and 93002316 to D.K.I.) and (C) (26440027 to T.S.) from the Japanese Ministry of Education, Science, Culture, Sports, and Technology (MEXT); a Creative Scientific Research grant (18GS0314 to K.K.); a Grant-in-Aid for Scientific Research on Priority Areas from the Japanese Society for the Promotion of Science (18073004 to K.K.); and a Grant-in-Aid for Research on Emerging and Reemerging Infectious Diseases from the Japanese Ministry of Health and Welfare (to K.K.). The authors declare no conflicts of interest.	Achcar F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002352; Affourtit C, 2002, FEBS LETT, V510, P121, DOI 10.1016/S0014-5793(01)03261-6; Baell JB, 2018, ACS CHEM BIOL, V13, P36, DOI 10.1021/acschembio.7b00903; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Balogun EO, 2017, BBA-GEN SUBJECTS, V1861, P2830, DOI 10.1016/j.bbagen.2017.07.028; Balogun EO, 2014, MOL MICROBIOL, V94, P1315, DOI 10.1111/mmi.12831; Balogun EO, 2013, J BIOCHEM, V154, P77, DOI 10.1093/jb/mvt037; Balogun EO, 2010, ACTA CRYSTALLOGR F, V66, P304, DOI 10.1107/S1744309110000369; Barrett MP, 1999, CURR OPIN CELL BIOL, V11, P496, DOI 10.1016/S0955-0674(99)80072-6; Beaglehole R., 2003, WORLD HLTH REPORT 20; Bettoun JD, 1997, J CLIN ENDOCR METAB, V82, P1031, DOI 10.1210/jc.82.4.1031; Bisser S, 2007, J INFECT DIS, V195, P322, DOI 10.1086/510534; Brun R, 2001, TROP MED INT HEALTH, V6, P906, DOI 10.1046/j.1365-3156.2001.00775.x; Chaudhuri M, 2006, TRENDS PARASITOL, V22, P484, DOI 10.1016/j.pt.2006.08.007; Clayton CE, 1996, PARASITOL TODAY, V12, P465, DOI 10.1016/S0169-4758(96)10073-9; Coustou V, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000618; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Ebiloma GU, 2019, MED RES REV, V39, P1553, DOI 10.1002/med.21560; Ebiloma GU, 2018, EUR J MED CHEM, V150, P385, DOI 10.1016/j.ejmech.2018.02.075; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; Fairlamb AH, 2003, TRENDS PARASITOL, V19, P488, DOI 10.1016/j.pt.2003.09.002; FAIRLAMB AH, 1977, NATURE, V265, P270, DOI 10.1038/265270a0; Gonzalez FJF, 2017, J MED CHEM, V60, P1509, DOI 10.1021/acs.jmedchem.6b01740; Harris CJ, 2011, COMB CHEM HIGH T SCR, V14, P521; Inaoka DK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167078; Kido Y, 2010, BBA-BIOENERGETICS, V1797, P443, DOI 10.1016/j.bbabio.2009.12.021; Kralova I, 2000, EUR J BIOCHEM, V267, P2323, DOI 10.1046/j.1432-1327.2000.01238.x; Meco-Navas A, 2018, ACS MED CHEM LETT, V9, P923, DOI 10.1021/acsmedchemlett.8b00282; Menzies SK, 2018, PARASITOLOGY, V145, P175, DOI 10.1017/S0031182016002109; Moore AL, 2008, BBA-BIOENERGETICS, V1777, P327, DOI 10.1016/j.bbabio.2008.01.004; Moore AL, 2013, ANNU REV PLANT BIOL, V64, P637, DOI 10.1146/annurev-arplant-042811-105432; Morooka S, 2015, MOL PHARMACOL, V88, P316, DOI 10.1124/mol.114.097345; Murray CJL., 1996, GLOBAL HLTH STAT COM, V1996; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakano H, 2016, BIOORG MED CHEM LETT, V26, P2370, DOI 10.1016/j.bmcl.2016.03.006; Nihei C, 2003, FEBS LETT, V538, P35, DOI 10.1016/S0014-5793(03)00120-0; Njogu PM, 2013, CURR MED CHEM, V20, P1715; Ohashi-Suzuki M, 2011, J VET MED SCI, V73, P615, DOI 10.1292/jvms.10-0481; Pelfrene E, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007381; Raz B, 1997, ACTA TROP, V68, P139, DOI 10.1016/S0001-706X(97)00079-X; RYLEY JF, 1962, BIOCHEM J, V85, P211, DOI 10.1042/bj0850211; Saitoh Y., 2015, Experimental Oncology, V37, P94; Segel IH., 1993, ENZYME KINETICS BEHA; Shiba T, 2019, BBA-BIOENERGETICS, V1860, P375, DOI 10.1016/j.bbabio.2019.03.008; Shiba T, 2013, P NATL ACAD SCI USA, V110, P4580, DOI 10.1073/pnas.1218386110; Simarro PP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001859; Steverding D, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-15; Sun DY, 2006, CHEM BIOL DRUG DES, V67, P385, DOI 10.1111/j.1747-0285.2006.00396.x; Suzuki T, 2004, PARASITOL INT, V53, P235, DOI 10.1016/j.parint.2004.02.001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; World Health Organization, 2016, TRYP HUM AFR SLEEP S; Yabu Y, 2006, PARASITOL INT, V55, P39, DOI 10.1016/j.parint.2005.09.003	53	15	15	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					13002	13013		10.1096/fj.201901342R	http://dx.doi.org/10.1096/fj.201901342R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31525300	Bronze			2022-12-28	WOS:000507461600107
J	Rabaglino, MB; Conrad, KP				Belen Rabaglino, Maria; Conrad, Kirk P.			Evidence for shared molecular pathways of dysregulated decidualization in preeclampsia and endometrial disorders revealed by microarray data integration	FASEB JOURNAL			English	Article						implantation failure; recurrent miscarriage; pregnancy; endometriosis; transcriptomics	ADVERSE PREGNANCY; NEONATAL OUTCOMES; CYTOSCAPE PLUGIN; GENE-EXPRESSION; WOMEN; RISK; CELLS; IMPLANTATION; RECEPTOR; FETAL	Microarray data of chorionic villous samples (CVSs) obtained from women of similar to 11.5 gestational weeks who developed preeclampsia with severe features (sPE; PE-CVS) revealed a molecular signature of impaired endometrial maturation (decidualization) before and during early pregnancy. Because endometrial disorders are also associated with aberrant decidualization, we asked whether they share molecular features with sPE. We employed microarray data integration to compare the molecular pathologies of PE-CVS and endometrial disorders, as well as decidua obtained postpartum from women with sPE. Eight public databases were reanalyzed with R software to determine differentially expressed genes (DEGs) in pathologic tissues relative to normal controls. DEGs were then compared to explore overlap. Shared DEGs were examined for enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. Principal component and network analyses were subsequently applied to selected DEGs. There was significant overlap of DEGs changing in the same direction for PE-CVS and endometrial disorders, suggesting common molecular pathways. Shared DEGs were enriched for cytokine-cytokine receptor interaction. Genes in this pathway revealed expression patterns forming 2 distinct clusters, one for normal and the other pathologic endometrium. The most affected hub genes were related to decidualization and NK cell function. Few DEGs were shared by PE-CVS, and PE decidua obtained postpartum. sPE may be part of a biologic continuum of "endometrial spectrum disorders."	[Belen Rabaglino, Maria] Consejo Nacl Invest Cient & Tecn CONICET, Inst Invest Ciencias Salud INICSA, Cordoba, Argentina; [Conrad, Kirk P.] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL USA; [Conrad, Kirk P.] Univ Florida, Dept Obstet & Gynecol, Gainesville, FL 32611 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); State University System of Florida; University of Florida; State University System of Florida; University of Florida	Rabaglino, MB (corresponding author), Pabellon Biol Celular, Enfermera Gordillo, Ciudad Univ, RA-5016 Cordoba Capital, Argentina.; Conrad, KP (corresponding author), Univ Florida, Coll Med, Dept Physiol & Funct Gen, 1600 SW Archer Rd,M552,POB 100274, Gainesville, FL 32610 USA.	belenrabaglino@icloud.com; kpconrad@ufl.edu		Rabaglino, Maria/0000-0002-0099-045X	U.S. Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant [P01 HD065647]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD065647] Funding Source: NIH RePORTER	U.S. Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors acknowledge Dr. Matthew Dyson (Feinberg School of Medicine, Northwestern University, Chicago, IL, USA), for providing the microarray data set on endometriosis. This work was partly supported by U.S. Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant P01 HD065647 (to K.P.C.). Portions were published in abstract form (70, 71). The authors declare no conflicts of interest.	Andraweera PH, 2016, J MATERN-FETAL NEO M, V29, P1072, DOI 10.3109/14767058.2015.1034102; Ashkar AA, 2003, J IMMUNOL, V171, P2937, DOI 10.4049/jimmunol.171.6.2937; Backes CH, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/214365; Benirschke KKP, 2000, PATHOLOGY OF THE HUM; Berlac JF, 2017, ACTA OBSTET GYN SCAN, V96, P751, DOI 10.1111/aogs.13111; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Brosens IA, 2007, HUM REPROD, V22, P1725, DOI 10.1093/humrep/dem072; Brosens JJ, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.037; Burke SD, 2010, AM J REPROD IMMUNOL, V63, P472, DOI 10.1111/j.1600-0897.2010.00818.x; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P466, DOI 10.1038/nrneph.2014.102; Conrad KP, 2017, PLACENTA, V60, P119, DOI 10.1016/j.placenta.2017.06.005; Craven CM, 1998, PLACENTA, V19, P241, DOI 10.1016/S0143-4004(98)90055-8; Cubro H, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0833-7; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Duncan WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023595; Dyson MT, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004158; Falconer H, 2013, SEMIN REPROD MED, V31, P178, DOI 10.1055/s-0032-1333484; Founds SA, 2009, PLACENTA, V30, P15, DOI 10.1016/j.placenta.2008.09.015; Garrido-Gomez T, 2017, P NATL ACAD SCI USA, V114, pE8468, DOI 10.1073/pnas.1706546114; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Ghulmiyyah L, 2012, SEMIN PERINATOL, V36, P56, DOI 10.1053/j.semperi.2011.09.011; Glavind MT, 2017, FERTIL STERIL, V107, P160, DOI 10.1016/j.fertnstert.2016.09.020; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Gunnarsdottir J, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.01.041; Hadfield RM, 2009, HUM REPROD, V24, P2348, DOI 10.1093/humrep/dep123; Hanna N, 2000, J IMMUNOL, V164, P5721, DOI 10.4049/jimmunol.164.11.5721; Hashii K, 1998, HUM REPROD, V13, P2738, DOI 10.1093/humrep/13.10.2738; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hutcheon JA, 2011, BEST PRACT RES CL OB, V25, P391, DOI 10.1016/j.bpobgyn.2011.01.006; Jacques M, 2016, REPROD BIOMED ONLINE, V32, P626, DOI 10.1016/j.rbmo.2016.03.005; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jones RL, 1998, J CLIN ENDOCR METAB, V83, P258, DOI 10.1210/jc.83.1.258; Kao LC, 2003, ENDOCRINOLOGY, V144, P2870, DOI 10.1210/en.2003-0043; Kodama A, 2010, HUM REPROD, V25, P751, DOI 10.1093/humrep/dep455; Lagani V, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1153-z; Lalani S, 2018, HUM REPROD, V33, P1854, DOI 10.1093/humrep/dey269; LaMarca B, 2016, AM J PHYSIOL-REG I, V311, pR1, DOI 10.1152/ajpregu.00052.2016; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lazar C, 2013, BRIEF BIOINFORM, V14, P469, DOI 10.1093/bib/bbs037; Ledee N, 2011, J PATHOL, V225, P554, DOI 10.1002/path.2948; Li J., 2014, SCI REP, V4; Lyall F, 2013, HYPERTENSION, V62, P1046, DOI 10.1161/HYPERTENSIONAHA.113.01892; Monsivais D, 2017, ENDOCRINOLOGY, V158, P979, DOI 10.1210/en.2016-1629; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; PAGE EW, 1972, J OBSTET GYN BR COMM, V79, P883; Pan ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181261; Peng J, 2015, P NATL ACAD SCI USA, V112, pE5098, DOI 10.1073/pnas.1514498112; Perez-Lopez FR, 2018, PREGNANCY HYPERTENS, V14, P213, DOI 10.1016/j.preghy.2018.01.003; Pijnenborg R, 2011, PREGNANCY HYPERTENS, V1, P66, DOI 10.1016/j.preghy.2010.10.010; Rabaglino MB, 2017, REPROD SCI, V24, p91A; Rabaglino MB, 2015, HYPERTENSION, V65, P421, DOI 10.1161/HYPERTENSIONAHA.114.04481; RABAGLINO MB, 2018, REPROD SCI, V25, pA31; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Romero R, 2011, BEST PRACT RES CL OB, V25, P313, DOI 10.1016/j.bpobgyn.2011.02.006; Sahu MB, 2019, PREGNANCY HYPERTENS, V15, P64, DOI 10.1016/j.preghy.2018.11.003; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sones JL, 2014, AM J PHYSIOL-REG I, V307, pR490, DOI 10.1152/ajpregu.00176.2014; Silva VRS, 2015, ARCH GYNECOL OBSTET, V291, P1029, DOI 10.1007/s00404-014-3503-2; Stephansson O, 2009, HUM REPROD, V24, P2341, DOI 10.1093/humrep/dep186; Talbi S, 2006, ENDOCRINOLOGY, V147, P1097, DOI 10.1210/en.2005-1076; Tang Y, 2015, BIOSYSTEMS, V127, P67, DOI 10.1016/j.biosystems.2014.11.005; Trogstad L, 2009, BJOG-INT J OBSTET GY, V116, P108, DOI 10.1111/j.1471-0528.2008.01978.x; Venables M.N., 2002, MODERN APPLIED STATI, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2]; Winn VD, 2009, ENDOCRINOLOGY, V150, P452, DOI 10.1210/en.2008-0990; Wu J, 2012, GCRMA BACKGROUND ADJ, P2200; Yang JCS, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8149109; Yin XQ, 2012, J CLIN ENDOCR METAB, V97, pE35, DOI 10.1210/jc.2011-1527; Zullo F, 2017, FERTIL STERIL, V108, P667, DOI 10.1016/j.fertnstert.2017.07.019	71	19	20	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11682	11695		10.1096/fj.201900662R	http://dx.doi.org/10.1096/fj.201900662R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31356122	Green Published			2022-12-28	WOS:000507461600009
J	Diwakar, BT; Yoast, R; Nettleford, S; Qian, FH; Lee, TJ; Berry, S; Huffnagle, I; Rossi, RM; Trebak, M; Paulson, RF; Prabhu, KS				Diwakar, Bastihalli T.; Yoast, Ryan; Nettleford, Shaneice; Qian, Fenghua; Lee, Tai-Jung; Berry, Svanjita; Huffnagle, Ian; Rossi, Randall M.; Trebak, Mohamed; Paulson, Robert F.; Prabhu, K. Sandeep			Crth2 receptor signaling down-regulates lipopolysaccharide-induced NF-kappa B activation in murine macrophages via changes in intracellular calcium	FASEB JOURNAL			English	Article						cyclopentenone prostaglandins; selenium; protein kinase A; cAMP; resolution of inflammation	NITRIC-OXIDE SYNTHASE; PROSTAGLANDIN D-2 RECEPTOR; RAW 264.7 MACROPHAGES; CYCLIC-AMP; TRANSCRIPTIONAL ACTIVITY; MOLECULAR PHARMACOLOGY; NEUTROPHIL MIGRATION; GENE-EXPRESSION; MICRORNAS; CELLS	Prostaglandin D-2 and its cyclopentenone metabolites [cyclopentenone prostaglandins (CyPGs)], Delta(12) prostaglandin J(2) and 15-deoxy-Delta(12,14)prostaglandin J(2), act through 2 GPCRs, D-type prostanoid 1 and the chemoattractant receptor homologous molecule expressed on type 2 T-helper cells (Crth2). In addition to its role in allergy and asthma, the role of Crth2 in the resolution of inflammation, to mediate the proresolving functions of endogenous CyPGs, is not well understood. We investigated the regulation of LPS or zymosan-induced inflammatory response by signals from the Crth2 receptor in macrophages that lack Crth2 expression [knockout (KO)]. Increased expression of proinflammatory genes, including Tnf-alpha, was observed in Crth2 KO cells. Targeting the endogenous biosynthetic pathway of CyPGs with indomethacin or HQL79, which inhibit cyclooxygenases or hematopoietic prostaglandin D synthase, respectively, or use of Crth2 antagonists recapitulated the proinflammatory phenotype as in Crth2 KO cells. Ligand-dependent activation of Crth2 by 13,14-dihydro-15-keto-prostaglandin D-2 increased Ca2+ influx through store-operated Ca2+ entry (SOCE) accompanied by the up-regulation of stromal interaction molecule 1 and calcium release-activated calcium modulator 1 expression, suggesting that the proresolution effects of CyPG-dependent activation of SOCE could be mediated by Crth2 during inflammation. Interestingly, Crth2 signaling down-regulated the Ca2+-regulated heat stable protein 1 that stabilizes Tnf-alpha mRNA via the increased expression of microRNA 155 to dampen inflammatory responses triggered through the TNF-alpha-NF-kappa B axis. In summary, these studies present a novel regulatory role for Crth2 during inflammatory response in macrophages.	[Diwakar, Bastihalli T.; Nettleford, Shaneice; Qian, Fenghua; Lee, Tai-Jung; Berry, Svanjita; Huffnagle, Ian; Paulson, Robert F.; Prabhu, K. Sandeep] Penn State Univ, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA; [Diwakar, Bastihalli T.; Nettleford, Shaneice; Qian, Fenghua; Lee, Tai-Jung; Berry, Svanjita; Huffnagle, Ian; Paulson, Robert F.; Prabhu, K. Sandeep] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Diwakar, Bastihalli T.; Nettleford, Shaneice; Qian, Fenghua; Lee, Tai-Jung; Berry, Svanjita; Huffnagle, Ian; Paulson, Robert F.; Prabhu, K. Sandeep] Penn State Univ, Penn State Canc Inst, University Pk, PA 16802 USA; [Rossi, Randall M.] Penn State Univ, Transgen Mouse Facil, Huck Inst Life Sci, University Pk, PA 16802 USA; [Diwakar, Bastihalli T.] Univ Toledo, Coll Pharm & Pharmaceut Sci, Dept Pharmacol & Expt Therapeut, 2801 W Bancroft St, Toledo, OH 43606 USA; [Yoast, Ryan; Trebak, Mohamed] Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Ohio; University of Toledo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Prabhu, KS (corresponding author), Penn State Univ, Ctr Mol Immunol & Infect Dis, Ctr Mol Toxicol & Carcinogenesis, Dept Vet & Biomed Sci,Penn State Canc Inst, 115 Henning Bldg, University Pk, PA 16802 USA.	ksprabhu@psu.edu			NIH National Human Genome Research Institute [U01HG004085, U01HG004080, U42RR024244]; Public Health Service (PHS) grants from the NIH National Institute of Diabetes and Digestive and Kidney Diseases [DK077152]; Office of Dietary Supplements; U.S. Department of Agriculture (USDA) Hatch Funds [PENO 4605, 1010021, DK080040, PENO 4581, 1005468]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123364, R01HL097111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080040, R01DK077152] Funding Source: NIH RePORTER	NIH National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Public Health Service (PHS) grants from the NIH National Institute of Diabetes and Digestive and Kidney Diseases; Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture (USDA) Hatch Funds(United States Department of Agriculture (USDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Drs. Connie Rogers and Ramesh Ramachandran (Pennsylvania State University, State College, PA, USA) for their help with the MicroBeta microplate counter and fluorescent microscope, respectively. ES cells were from the Trans-U.S. National Institutes of Health (NIH) Knock-Out Mouse Project (KOMP) Repository. NIH National Human Genome Research Institute grants to Velocigene at Regeneron, Inc. (U01HG004085), the Complementary Sex Determination (CSD) Consortium (U01HG004080), and KOMP Repository at University of California-Davis (Davis, CA, USA) and Children's Hospital Oakland Research Institute (CHORI) (U42RR024244) funded the program to generate the gene-targeted ES cells. These studies were funded, in part, by Public Health Service (PHS) grants from the NIH National Institute of Diabetes and Digestive and Kidney Diseases (DK077152) and Office of Dietary Supplements, and U.S. Department of Agriculture (USDA) Hatch Funds (PENO 4605, Accession 1010021 to K.S.P., DK080040; PENO 4581, Accession 1005468 to R.F.P.). The authors declare no conflicts of interest.	Abe H, 1999, GENE, V227, P71, DOI 10.1016/S0378-1119(98)00599-X; Ajuebor MN, 1998, IMMUNOLOGY, V95, P625; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Chen CC, 1999, J BIOL CHEM, V274, P31559, DOI 10.1074/jbc.274.44.31559; Chevalier E, 2005, J IMMUNOL, V175, P2056, DOI 10.4049/jimmunol.175.4.2056; Chinen T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1181; Chio CC, 2004, CELL SIGNAL, V16, P565, DOI 10.1016/j.cellsig.2003.10.003; Choi HK, 2013, BIOCHEM BIOPH RES CO, V436, P473, DOI 10.1016/j.bbrc.2013.05.129; Desai PN, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa8323; Finch ER, 2017, BLOOD, V129, P1802, DOI 10.1182/blood-2016-08-736405; Fujitani Y, 2002, J IMMUNOL, V168, P443, DOI 10.4049/jimmunol.168.1.443; Fullerton JN, 2016, NAT REV DRUG DISCOV, V15, P551, DOI 10.1038/nrd.2016.39; Gandhi UH, 2011, J BIOL CHEM, V286, P27471, DOI 10.1074/jbc.M111.260547; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Haringman JJ, 2005, ANN RHEUM DIS, V64, P834, DOI 10.1136/ard.2004.029751; Hata AN, 2003, J PHARMACOL EXP THER, V306, P463, DOI 10.1124/jpet.103.050955; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; HIROKAWA K, 1994, BRIT J PHARMACOL, V112, P396, DOI 10.1111/j.1476-5381.1994.tb13085.x; Ishii M, 2012, J IMMUNOL, V188, P5655, DOI 10.4049/jimmunol.1102330; Jandl K, 2017, PROSTAG OTH LIPID M, V133, P42, DOI 10.1016/j.prostaglandins.2017.08.006; Jeon YJ, 1996, MOL PHARMACOL, V50, P334; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kojima F, 2008, J IMMUNOL, V180, P8361, DOI 10.4049/jimmunol.180.12.8361; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Lee S, 2014, CELL METAB, V19, P484, DOI 10.1016/j.cmet.2014.01.013; LIU MC, 1990, AM REV RESPIR DIS, V142, P126, DOI 10.1164/ajrccm/142.1.126; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Mandal AK, 2004, J EXP MED, V199, P1317, DOI 10.1084/jem.20031666; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Nusing RM, 1996, BIOCHEM J, V313, P617, DOI 10.1042/bj3130617; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pettipher R, 2008, BRIT J PHARMACOL, V153, pS191, DOI 10.1038/sj.bjp.0707488; Pfeiffer JR, 2011, MOL CELL BIOL, V31, P277, DOI 10.1128/MCB.00775-10; Prabhu KS, 2002, BIOCHEM J, V366, P203, DOI 10.1042/BJ20020256; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Roulis M, 2014, P NATL ACAD SCI USA, V111, pE4658, DOI 10.1073/pnas.1415762111; Sawyer N, 2002, BRIT J PHARMACOL, V137, P1163, DOI 10.1038/sj.bjp.0704973; Schafer C, 2003, AM J PHYSIOL-GASTR L, V285, pG726, DOI 10.1152/ajpgi.00111.2003; Schuligoi R, 2010, PHARMACOLOGY, V85, P372, DOI 10.1159/000313836; Shay AE, 2017, J BIOL CHEM, V292, P14544, DOI 10.1074/jbc.M117.785014; Shibata T, 2002, J BIOL CHEM, V277, P10459, DOI 10.1074/jbc.M110314200; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Tajima T, 2008, J PHARMACOL EXP THER, V326, P493, DOI 10.1124/jpet.108.137992; Trebak M, 2002, J BIOL CHEM, V277, P21617, DOI 10.1074/jbc.M202549200; Trebak M, 2017, PHYSIOLOGY, V32, P332, DOI 10.1152/physiol.00011.2017; Tsubosaka Y, 2014, J IMMUNOL, V193, P5835, DOI 10.4049/jimmunol.1303478; Vunta H, 2007, J BIOL CHEM, V282, P17964, DOI 10.1074/jbc.M703075200; Wang Z, 2014, J IMMUNOL, V192, P2349, DOI 10.4049/jimmunol.1302982; Westman M, 2004, ARTHRITIS RHEUM-US, V50, P1774, DOI 10.1002/art.20286; Wojno EDT, 2015, MUCOSAL IMMUNOL, V8, P1313, DOI 10.1038/mi.2015.21; Wu XC, 2016, SCI REP-UK, V6, DOI 10.1038/srep19000; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhu JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046551	61	6	6	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12838	12852		10.1096/fj.201802608R	http://dx.doi.org/10.1096/fj.201802608R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31518163	Green Published			2022-12-28	WOS:000507461600096
J	El-Rashid, M; Ghimire, K; Sanganeria, B; Lu, B; Rogers, NM				El-Rashid, Maryam; Ghimire, Kedar; Sanganeria, Barkha; Lu, Bo; Rogers, Natasha M.			CD47 limits autophagy to promote acute kidney injury	FASEB JOURNAL			English	Article						AKI; renal tubular epithelial cells	ISCHEMIA-REPERFUSION INJURY; GRAFT FUNCTION; DISEASE; PROTEIN; MYC; PATHOPHYSIOLOGY; TRANSPLANTATION; HYPERTENSION; CONTRIBUTES; ACTIVATION	Acute kidney injury (AKI) initiates a complex pathophysiological cascade leading to epithelial cell death. Recent studies identify autophagy, a key intracellular process that degrades cytoplasmic constituents, as protective against AKI. We have previously reported that the protein thrombospondin-1 and its receptor CD47 are induced in AKI; however, the mechanism underlying their regulation of injury is unknown. Here, we investigated whether CD47 signaling affects autophagy to regulate AKI. Wild-type (WT) and CD47(-/-) mice were challenged with renal ischemia-reperfusion injury. All animals underwent analysis of renal function and biomolecular phenotyping. CD47(-/-) mice were resistant to AKI, with decreased serum creatinine and ameliorated histologic changes compared with WT animals. These mice also displayed increased abundance of key autophagy genes, including autophagyrelated gene (Atg)5, Atg7, beclin-1, and microtubule-associated proteins 1A/1B light chain 3 (LC3) at baseline and post-AKI, which were significantly reduced in WT mice. Changes in protein expression correlated with increased autophagosome and autolysosome formation in renal tubular epithelial cells (RTECs). In mouse kidney transplantation, treatment with a CD47-blocking antibody that improved function was associated with increased autophagy compared with control mice. Primary isolated RTECs from CD47(-/-) mice demonstrated increased basal expression of several autophagy components that was preserved under hypoxic stress. These data suggest that activated CD47 promotes AKI through inhibition of autophagy and point to CD47 as a target to preserve renal function following injury.	[El-Rashid, Maryam; Ghimire, Kedar; Sanganeria, Barkha; Lu, Bo; Rogers, Natasha M.] Westmead Inst Med Res, Ctr Transplant & Renal Res, Westmead, NSW, Australia; [Rogers, Natasha M.] Westmead Hosp, Renal Div, Westmead, NSW, Australia; [Rogers, Natasha M.] Univ Sydney, Westmead Clin Med Sch, Camperdown, NSW, Australia; [Rogers, Natasha M.] Univ Pittsburgh, Sch Med, Dept Surg, Thomas E Starzl Transplantat Inst, Pittsburgh, PA USA	University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Sydney; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rogers, NM (corresponding author), Westmead Inst Med Res, 176 Hawkesbury Rd, Westmead, NSW 2145, Australia.	natasha.rogers@health.nsw.gov.au	Rogers, Natasha/ABC-2546-2020	Ghimire, Kedar/0000-0002-4672-5256; El-Rashid, Maryam/0000-0002-1195-6783	Research Training Program (RTP) scholarship (University of Sydney); National Health and Medical Research Council (NHMRC) Career Development Fellowship [GNT1158977]; NHMRC [GNT1138372]; Jacquot Research Establishment Fellowship; Westmead Charitable Trust Early Career Researcher Grant	Research Training Program (RTP) scholarship (University of Sydney); National Health and Medical Research Council (NHMRC) Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Jacquot Research Establishment Fellowship; Westmead Charitable Trust Early Career Researcher Grant	The authors thank Dr. Hong Yu (Cell Imaging Facility, Westmead Institute for Medical Research) and Dr. Emma Kettle (Electron Microscopy Unit at Westmead Hospital). M.E.R. is supported by a Research Training Program (RTP) scholarship (University of Sydney). N.M.R. is supported by a National Health and Medical Research Council (NHMRC) Career Development Fellowship (GNT1158977), NHMRC project grant (GNT1138372), Jacquot Research Establishment Fellowship, and Westmead Charitable Trust Early Career Researcher Grant. The authors declare no conflicts of interest.	Alshaman R, 2016, CLIN EXP PHARMACOL P, V43, P1087, DOI 10.1111/1440-1681.12648; Bauer PM, 2012, CARDIOVASC RES, V93, P682, DOI 10.1093/cvr/cvr356; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Bretones G, 2015, BBA-GENE REGUL MECH, V1849, P506, DOI 10.1016/j.bbagrm.2014.03.013; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Decuypere JP, 2015, AM J KIDNEY DIS, V66, P699, DOI 10.1053/j.ajkd.2015.05.021; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Frazier WA, 1999, J BIOL CHEM, V274, P8554, DOI 10.1074/jbc.274.13.8554; Huber TB, 2012, AUTOPHAGY, V8, P1009, DOI 10.4161/auto.19821; Humar A, 1997, CLIN TRANSPLANT, V11, P623; Isenberg JS, 2007, BLOOD, V109, P1945, DOI 10.1182/blood-2006-08-041368; Kaur S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01673; Labrousse-Arias D, 2016, CARDIOVASC RES, V109, P115, DOI 10.1093/cvr/cvv243; Leung KCW, 2013, NAT REV NEPHROL, V9, P77, DOI 10.1038/nrneph.2012.280; Liu SY, 2012, AUTOPHAGY, V8, P826, DOI 10.4161/auto.19419; Maxhimer JB, 2009, PLAST RECONSTR SURG, V124, P1880, DOI 10.1097/PRS.0b013e3181bceec3; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Murugan R, 2011, NAT REV NEPHROL, V7, P209, DOI 10.1038/nrneph.2011.13; Nagy P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003664; Nakagawa S, 2012, EUR J PHARMACOL, V696, P143, DOI 10.1016/j.ejphar.2012.09.010; Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169; Phelan MW, 1998, J LAB CLIN MED, V132, P519, DOI 10.1016/S0022-2143(98)90131-7; Roberts DD, 2012, MATRIX BIOL, V31, P162, DOI 10.1016/j.matbio.2012.01.005; Rogers NM, 2017, CARDIOVASC RES, V113, P15, DOI 10.1093/cvr/cvw218; Rogers NM, 2016, KIDNEY INT, V90, P334, DOI 10.1016/j.kint.2016.03.034; Rogers NM, 2013, PULM CIRC, V3, P936, DOI 10.1086/674754; Rogers NM, 2012, AM J PHYSIOL-RENAL, V303, pF1117, DOI 10.1152/ajprenal.00359.2012; Rogers NM, 2012, J AM SOC NEPHROL, V23, P1538, DOI 10.1681/ASN.2012020137; Shoskes DA, 1996, J UROLOGY, V155, P1831, DOI 10.1016/S0022-5347(01)66023-3; Soto-Pantoja DR, 2013, EXPERT OPIN THER TAR, V17, P89, DOI 10.1517/14728222.2013.733699; Soto-Pantoja DR, 2012, AUTOPHAGY, V8, P1628, DOI 10.4161/auto.21562; Thakar CV, 2005, J CLIN INVEST, V115, P3451, DOI 10.1172/JCI25461; Toh PPC, 2013, HUM MOL GENET, V22, P5237, DOI 10.1093/hmg/ddt381; Tsuneoka M, 2003, CELL STRUCT FUNCT, V28, P195; Yang L, 2011, CONTRIB NEPHROL, V174, P149, DOI 10.1159/000329385; Yao MY, 2014, J AM SOC NEPHROL, V25, P1171, DOI 10.1681/ASN.2013040433; ZHANG Z, 1995, MICROSURG, V16, P103, DOI 10.1002/micr.1920160212; Zuk A, 2016, ANNU REV MED, V67, P293, DOI 10.1146/annurev-med-050214-013407	39	5	7	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12735	12749		10.1096/fj.201900120RR	http://dx.doi.org/10.1096/fj.201900120RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31480863				2022-12-28	WOS:000507461600088
J	Golec, E; Rosberg, R; Zhang, EM; Renstrom, E; Blom, AM; King, B				Golec, Ewelina; Rosberg, Rebecca; Zhang, Enming; Renstrom, Erik; Blom, Anna M.; King, Ben C.			A cryptic non-GPI-anchored cytosolic isoform of CD59 controls insulin exocytosis in pancreatic beta-cells by interaction with SNARE proteins	FASEB JOURNAL			English	Article						insulin secretion; glycosylphosphatidylinositol; VAMP2; CD59 isoforms; diabetes	ENDOPLASMIC-RETICULUM; COMPLEMENT; DEGRADATION; INHIBITOR; LYSIS	CD59 is a glycosylphosphatidylinositol (GPI)-anchored cell surface inhibitor of the complement membrane attack complex (MAC). We showed previously that CD59 is highly expressed in pancreatic islets but is down-regulated in rodent models of diabetes. CD59 knockdown but not enzymatic removal of cell surface CD59 led to a loss of glucose-stimulated insulin secretion (GSIS), suggesting that an intracellular pool of CD59 is required. In this current paper, we now report that non-GPI-anchored CD59 is present in the cytoplasm, colocalizes with exocytotic protein vesicle-associated membrane protein 2, and completely rescues GSIS in cells lacking endogenous CD59 expression. The involvement of cytosolic non-GPI-anchored CD59 in GSIS is supported in phosphatidylinositol glycan class A knockout GPI anchor-deficient beta-cells, in which GSIS is still CD59 dependent. Furthermore, site-directed mutagenesis demonstrated different structural requirements of CD59 for its 2 functions, MAC inhibition and GSIS. Our results suggest that CD59 is retrotranslocated from the endoplasmic reticulum to the cytosol, a process mediated by recognition of trimmed N-linked oligosaccharides, supported by the partial glycosylation of non-GPI-anchored cytosolic CD59 as well as the failure of N-linked glycosylation site mutant CD59 to reach the cytosol or rescue GSIS. This study thus proposes the previously undescribed existence of non-GPI-anchored cytosolic CD59, which is required for insulin secretion.	[Golec, Ewelina; Rosberg, Rebecca; Blom, Anna M.; King, Ben C.] Lund Univ, Dept Translat Med, Sect Med Prot Chem, Malmo, Sweden; [Zhang, Enming; Renstrom, Erik] Lund Univ, Diabet Ctr, Dept Clin Sci Malmo, Malmo, Sweden	Lund University; Lund University	Blom, AM (corresponding author), Lund Univ, Lab Med, Dept Translat Med, Sect Med Prot Chem, Wallenberg Lab Floor 4,MAS Entrance 46, S-21428 Malmo, Sweden.	anna.blom@med.lu.se	Blom, Anna/B-9607-2009; Blom, Anna/AFS-7369-2022	Blom, Anna/0000-0002-1348-1734; King, Benjamin/0000-0001-6776-8741; Rosberg, Rebecca/0000-0003-2512-1207; Zhang, Enming/0000-0002-0401-4608	Knut and Alice Wallenberg Foundation; Diabetesfonden; Greta and Johan Kock's Foundation; Royal Physiographical Society in Lund; Lars Hiertas Memorial Fund; Albert Pahlsson Fund; Crafoord Foundation; Tore Nilssons Foundation	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Diabetesfonden; Greta and Johan Kock's Foundation; Royal Physiographical Society in Lund(Royal Society of London); Lars Hiertas Memorial Fund; Albert Pahlsson Fund; Crafoord Foundation; Tore Nilssons Foundation	This work was funded by the Knut and Alice Wallenberg Foundation (to A.B. and E.R.); Diabetesfonden (to A.B.); and the Greta and Johan Kock's Foundation, the Royal Physiographical Society in Lund, the Lars Hiertas Memorial Fund, the Albert Pahlsson Fund, the Crafoord Foundation, and the Tore Nilssons Foundation (all to B.C.K.). Funders played no role in study design or execution. The authors declare no conflicts of interest.	Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; Arborea G, 2017, MOL IMMUNOL, V89, P2, DOI 10.1016/j.molimm.2017.05.012; Bodian DL, 1997, J EXP MED, V185, P507, DOI 10.1084/jem.185.3.507; BROWN D, 1994, BRAZ J MED BIOL RES, V27, P309; Butikofer P, 2001, FASEB J, V15, P545, DOI 10.1096/fj.00-0415hyp; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Chen R, 2002, J CELL BIOCHEM, V84, P68, DOI 10.1002/jcb.1267; Ghosh P, 2014, J CLIN ENDOCR METAB, V99, pE999, DOI 10.1210/jc.2013-4232; Hajishengallis G, 2017, NAT IMMUNOL, V18, P1288, DOI 10.1038/ni.3858; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; HOLGUIN MH, 1990, BLOOD, V75, P284; Karbian N, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000280; King BC, 2019, CELL METAB, V29, P202, DOI 10.1016/j.cmet.2018.09.009; KODUKULA K, 1991, J BIOL CHEM, V266, P4464; Krus U, 2014, CELL METAB, V19, P883, DOI 10.1016/j.cmet.2014.03.001; MERI S, 1990, IMMUNOLOGY, V71, P1; Morito D, 2015, MOL CELL, V59, P335, DOI 10.1016/j.molcel.2015.06.010; Nevo Y, 2013, BLOOD, V121, P129, DOI 10.1182/blood-2012-07-441857; PARKER CJ, 1985, J CLIN INVEST, V75, P2074, DOI 10.1172/JCI111927; Rushmere NK, 1997, IMMUNOLOGY, V90, P640, DOI 10.1046/j.1365-2567.1997.00200.x; Spooner RA, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-26; Takahashi N, 2010, CELL METAB, V12, P19, DOI 10.1016/j.cmet.2010.05.013; Tokunaga F, 2000, J BIOL CHEM, V275, P40757, DOI 10.1074/jbc.M001073200; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	25	7	7	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12425	12434		10.1096/fj.201901007R	http://dx.doi.org/10.1096/fj.201901007R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31412214	Green Published			2022-12-28	WOS:000507461600064
J	Kim, DH; Choi, HI; Park, JS; Kim, CS; Bae, EH; Ma, SK; Kim, SW				Kim, Dong-Hyun; Choi, Hoon-In; Park, Jung Sun; Kim, Chang Seong; Bae, Eun Hui; Ma, Seong Kwon; Kim, Soo Wan			Src-mediated crosstalk between FXR and YAP protects against renal fibrosis	FASEB JOURNAL			English	Article						kidney disease; hippo pathway; nuclear receptor	HIPPO PATHWAY; CELL-PROLIFERATION; LIPID-METABOLISM; PROMOTES; RECEPTOR; INFLAMMATION; INHIBITION; ACTIVATION; KINASE; LIVER	Renal fibrosis is the common pathway of chronic kidney disease progression. The nuclear receptor farnesoid X receptor [FXR, NR1H4 (nuclear receptor subfamily 1 group member 4)], a multifunctional transcription factor, plays a pivotal role in protecting against fibrosis. However, the mechanisms underlying these antifibrotic actions of FXR in kidney disease are largely unknown. Here, we show that agonist GW4064-mediated FXR activation inhibits the activity of the nonreceptor tyrosine kinase Src (proto-oncogene tyrosine-protein kinase), which is critical for regulation of yes-associated protein (YAP) phosphorylation and nuclear localization in renal fibrosis. Activation of FXR suppressed renal fibrosis and Tyr416-Src phosphorylation in TGF-beta-treated human renal proximal tubule epithelial (HK2) cells. Moreover, GW4064 treatment in HK2 cells increased Ser127 phosphorylation, cytosolic accumulation of YAP, and interaction of the hippo core kinases (Ste20-like kinase 1, large tumor suppressor kinase 1, and salvador homolog 1). Inhibition of Src using PP2 (Src kinase inhibitor) prevented renal fibrosis and increased Ser127 phosphorylation and cytosolic accumulation of YAP. The expression of fibrosis markers, inflammatory genes, and YAP target genes was increased in the kidneys of FXR knockout mice compared with those of wild-type mice. In addition, GW4064 or WAY-362450 (turofexorate isopropyl) treatment protected against unilateral ureteral obstruction-induced renal fibrosis. Collectively, our data support the novel conclusion that Src-mediated crosstalk between FXR and YAP protects against renal fibrosis, making this pathway a possible therapeutic target for chronic kidney disease.-Kim, D.-H., Choi, H.-I., Park, J. S., Kim, C. S., Bae, E. H., Ma, S. K., Kim, S. W. Src-mediated crosstalk between FXR and YAP protects against renal fibrosis.	[Kim, Dong-Hyun; Choi, Hoon-In; Park, Jung Sun; Kim, Chang Seong; Bae, Eun Hui; Ma, Seong Kwon; Kim, Soo Wan] Chonnam Natl Univ, Dept Internal Med, Med Sch, 42 Jebongro, Gwangju 61469, South Korea	Chonnam National University	Kim, SW (corresponding author), Chonnam Natl Univ, Dept Internal Med, Med Sch, 42 Jebongro, Gwangju 61469, South Korea.	skimw@chonnam.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2017R1C1B2007139]; Basic Science Research Program through the NRF - Ministry of Science, Information and Communications Technology (ICT), and Future Planning (MSIP) [2016R1A2B4007870]; Bio and Medical Technology Development Program of the NRF - Korean government, MSIT [2017M3A9E8023001]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Basic Science Research Program through the NRF - Ministry of Science, Information and Communications Technology (ICT), and Future Planning (MSIP); Bio and Medical Technology Development Program of the NRF - Korean government, MSIT	The authors thank Jongsook Kim Kemper (University of Illinois at Urbana-Champaign, Champaign, IL, USA) for kindly providing flag-farnesoid x receptor (FXR) plasmid. This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2017R1C1B2007139); the Basic Science Research Program through the NRF funded by the Ministry of Science, Information and Communications Technology (ICT), and Future Planning (MSIP) (2016R1A2B4007870); and the Bio and Medical Technology Development Program of the NRF funded by the Korean government, MSIT (2017M3A9E8023001). The authors declare no conflicts of interest.	Anakk S, 2013, CELL REP, V5, P1060, DOI 10.1016/j.celrep.2013.10.030; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Chen JC, 2016, J AM SOC NEPHROL, V27, P1689, DOI 10.1681/ASN.2015040415; Chen JC, 2012, J AM SOC NEPHROL, V23, P215, DOI 10.1681/ASN.2011070645; Fiorucci S, 2004, GASTROENTEROLOGY, V127, P1497, DOI 10.1053/j.gastro.2004.08.001; Fujii M, 2012, J EXP MED, V209, P479, DOI 10.1084/jem.20111653; Gai ZB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10168-6; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Jiang T, 2007, DIABETES, V56, P2485, DOI 10.2337/db06-1642; Kim DH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12179; Kim DH, 2015, EMBO J, V34, P184, DOI 10.15252/embj.201489527; Kim NG, 2015, J CELL BIOL, V210, P503, DOI 10.1083/jcb.201501025; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Levi M, 2011, BBA-MOL BASIS DIS, V1812, P1061, DOI 10.1016/j.bbadis.2011.04.003; Li P, 2016, GENE DEV, V30, P798, DOI 10.1101/gad.274951.115; Liang M, 2017, J AM SOC NEPHROL, V28, P3277, DOI 10.1681/ASN.2015121354; Liu HL, 2016, J LIPID RES, V57, P1831, DOI 10.1194/jlr.M069807; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Modica Salvatore, 2010, Nucl Recept Signal, V8, pe005, DOI 10.1621/nrs.08005; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Peng ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048461; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Seo E, 2016, SCI REP-UK, V6, DOI 10.1038/srep31931; Szeto SG, 2016, J AM SOC NEPHROL, V27, P3117, DOI 10.1681/ASN.2015050499; Tamm C, 2011, J CELL SCI, V124, P1136, DOI 10.1242/jcs.075796; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wang XXX, 2010, DIABETES, V59, P2916, DOI 10.2337/db10-0019; Wang XX, 2009, AM J PHYSIOL-RENAL, V297, pF1587, DOI 10.1152/ajprenal.00404.2009; Wang YD, 2008, HEPATOLOGY, V48, P1632, DOI 10.1002/hep.22519; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xu J, 2016, CLIN SCI, V130, P349, DOI 10.1042/CS20150385; Yan YL, 2016, KIDNEY INT, V89, P68, DOI 10.1038/ki.2015.293; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao K, 2016, SCI REP-UK, V6, DOI 10.1038/srep37234	42	25	26	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11109	11122		10.1096/fj.201900325R	http://dx.doi.org/10.1096/fj.201900325R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31298930				2022-12-28	WOS:000489166300045
J	Stormberg, T; Stumme-Diers, M; Lyubchenko, YL				Stormberg, Tommy; Stumme-Diers, Micah; Lyubchenko, Yuri L.			Sequence-dependent nucleosome nanoscale structure characterized by atomic force microscopy	FASEB JOURNAL			English	Article						AFM; nucleosome structure; nucleosome interaction; chromatin dynamics	DYNAMICS; DNA	DNA sequence plays an important role in the assembly of nucleosomes, and DNA motifs with high specificity to nucleosomes have been identified. At the same time, important questions such as how the DNA sequence changes DNA wrapping and how the DNA sequence contributes to the interaction between the nucleosomes remain unclear. Here, we addressed these questions by comparing nanoscale properties of nucleosomes assembled on the highest nucleosome positioning sequence, the 601 motif, and essentially random DNA sequences. We used atomic force microscopy to measure the nucleosome positions and the DNA wrapping. The studies showed that nucleosomes assemble on the nonspecific sequence without any preference for position on DNA, but they wrap the same DNA length as DNA of the same length with the 601 sequence. Experiments with longer DNA containing the 601 motif along with nonspecific DNA, capable of forming dinucleosomes, revealed that dinucleosomes assembled on hybrid sequences show a preference for positioning near each other, with one always assembling on the 601 motif. These findings point to the interaction between the nucleosomes and suggest that internucleosomal interactions may play a large role in nucleosome positioning.-Stormberg, T., Stumme-Diers, M., Lyubchenko, Y. L. Sequence-dependent nucleosome nanoscale structure characterized by atomic force microscopy.	[Stormberg, Tommy; Stumme-Diers, Micah; Lyubchenko, Yuri L.] Univ Nebraska Med Ctr, Dept Pharmaceut Sci, 986025 Nebraska Med Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Lyubchenko, YL (corresponding author), Univ Nebraska Med Ctr, Dept Pharmaceut Sci, 986025 Nebraska Med Ctr, Omaha, NE 68198 USA.	ylyubchenko@unmc.edu		Stormberg, Tommy/0000-0001-7526-1318	National Science Foundation [MCB 1515346]; U.S. National Institutes of Health, National Institute of General Medical Sciences [GM096039, GM100156]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096039, R01GM100156] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank G. Warren (University of Nebraska Medical Center) for the assistance in the preparation of nucleosomes and L. Shlyakhtenko (University of Nebraska Medical Center), V. Zhurkin (National Cancer Institute, Bethesda, MD, USA), and K. Zagorski (University of Nebraska Medical Center) for useful insights in the data interpretation. This work was supported by grants to Y.L.L. from the National Science Foundation (MCB 1515346) and the U.S. National Institutes of Health, National Institute of General Medical Sciences (GM096039 and GM100156). The authors declare no conflicts of interest.	Armeev GA, 2019, CURR OPIN STRUC BIOL, V56, P46, DOI 10.1016/j.sbi.2018.11.006; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Eslami-Mossallam B, 2016, ADV COLLOID INTERFAC, V232, P101, DOI 10.1016/j.cis.2016.01.007; Filenko NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016299; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; Kan PY, 2007, MOL CELL BIOL, V27, P2084, DOI 10.1128/MCB.02181-06; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Lowary PT, 1997, P NATL ACAD SCI USA, V94, P1183, DOI 10.1073/pnas.94.4.1183; Lyubchenko YL, 2004, CELL BIOCHEM BIOPHYS, V41, P75, DOI 10.1385/CBB:41:1:075; Lyubchenko Yuri L, 2014, Biophys Rev, V6, P181, DOI 10.1007/s12551-013-0121-3; Menshikova Irina, 2011, Int J Biochem Mol Biol, V2, P129; Miyagi A, 2011, BIOCHEMISTRY-US, V50, P7901, DOI 10.1021/bi200946z; Pisano S, 2007, J MOL BIOL, V369, P1153, DOI 10.1016/j.jmb.2007.04.027; Pisano S, 2006, BIOPHYS CHEM, V124, P81, DOI 10.1016/j.bpc.2006.05.012; Prunell A, 1998, BIOPHYS J, V74, P2531, DOI 10.1016/S0006-3495(98)77961-5; Sauer PV, 2017, ELIFE, V6, DOI 10.7554/eLife.23474; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Shlyakhtenko LS, 2009, BIOCHEMISTRY-US, V48, P7842, DOI 10.1021/bi900977t; Stumme-Diers MP, 2019, JOVE-J VIS EXP, DOI 10.3791/58820; SUSSMAN JL, 1978, P NATL ACAD SCI USA, V75, P103, DOI 10.1073/pnas.75.1.103; Trifonov EN, 2016, J BIOMOL STRUCT DYN, V34, P1156, DOI 10.1080/07391102.2015.1075158; Trifonov EN, 2011, PHYS LIFE REV, V8, P39, DOI 10.1016/j.plrev.2011.01.004; TRIFONOV EN, 1980, P NATL ACAD SCI-BIOL, V77, P3816, DOI 10.1073/pnas.77.7.3816; Wilson MD, 2017, ACTA CRYSTALLOGR D, V73, P541, DOI 10.1107/S2059798317004430; Yang ZY, 2007, J BIOL CHEM, V282, P7930, DOI 10.1074/jbc.M610584200; Yang Z, 2011, BIOCHEMISTRY-US, V50, P9973, DOI 10.1021/bi201377x; Yodh JG, 2002, BIOCHEMISTRY-US, V41, P3565, DOI 10.1021/bi011612e; Zhou BR, 2018, J MOL BIOL, V430, P3093, DOI 10.1016/j.jmb.2018.06.020; Zhou KD, 2019, NAT STRUCT MOL BIOL, V26, P3, DOI 10.1038/s41594-018-0166-x; Zhurkin VB, 2011, PHYS LIFE REV, V8, P64, DOI 10.1016/j.plrev.2011.02.001	30	5	5	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10916	10923		10.1096/fj.201901094R	http://dx.doi.org/10.1096/fj.201901094R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31284760	Green Published, Bronze			2022-12-28	WOS:000489166300027
J	Aoi, W; Hirano, N; Lassiter, DG; Bjornholm, M; Chibalin, AV; Sakuma, K; Tanimura, Y; Mizushima, K; Takagi, T; Naito, Y; Zierath, JR; Krook, A				Aoi, Wataru; Hirano, Nariyuki; Lassiter, David G.; Bjornholm, Marie; Chibalin, Alexander V.; Sakuma, Kunihiro; Tanimura, Yuko; Mizushima, Katsura; Takagi, Tomohisa; Naito, Yuji; Zierath, Juleen R.; Krook, Anna			Secreted protein acidic and rich in cysteine (SPARC) improves glucose tolerance via AMP-activated protein kinase activation	FASEB JOURNAL			English	Article						myokine; skeletal muscle; exercise; glucose uptake	SKELETAL-MUSCLE; LIPID-METABOLISM; MITOCHONDRIAL BIOGENESIS; EXERCISE; INSULIN; EXPRESSION; SPARC/OSTEONECTIN; PHOSPHORYLATION; DIFFERENTIATION; ANGIOGENESIS	During exercise, skeletal muscles release cytokines, peptides, and metabolites that exert autocrine, paracrine, or endocrine effects on glucose homeostasis. In this study, we investigated the effects of secreted protein acidic and rich in cysteine (SPARC), an exercise-responsive myokine, on glucose metabolism in human and mouse skeletal muscle. SPARC-knockout mice showed impaired systemic metabolism and reduced phosphorylation of AMPK and protein kinase B in skeletal muscle. Treatment of SPARC-knockout mice with recombinant SPARC improved glucose tolerance and concomitantly activated AMPK in skeletal muscle. These effects were dependent on AMPK-gamma 3 because SPARC treatment enhanced skeletal muscle glucose uptake in wild-type mice but not in AMPK-gamma 3-knockout mice. SPARC strongly interacted with the voltage-dependent calcium channel, and inhibition of calcium-dependent signaling prevented SPARC-induced AMPK phosphorylation in human and mouse myotubes. Finally, chronic SPARC treatment improved systemic glucose tolerance and AMPK signaling in skeletal muscle of high-fat diet-induced obese mice, highlighting the efficacy of SPARC treatment in the management of metabolic diseases. Thus, our findings suggest that SPARC treatment mimics the effects of exercise on glucose tolerance by enhancing AMPK-dependent glucose uptake in skeletal muscle.-Aoi, W., Hirano, N., Lassiter, D. G., Bjornholm, M., Chibalin, A. V., Sakuma, K., Tanimura, Y., Mizushima, K., Takagi, T., Naito, Y., Zierath, J. R., Krook, A. Secreted protein acidic and rich in cysteine (SPARC) improves glucose tolerance via AMP-activated protein kinase activation.	[Aoi, Wataru; Hirano, Nariyuki] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Kyoto, Japan; [Aoi, Wataru; Zierath, Juleen R.; Krook, Anna] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Lassiter, David G.; Bjornholm, Marie; Chibalin, Alexander V.; Zierath, Juleen R.] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Sakuma, Kunihiro] Tokyo Inst Technol, Sch Environm & Soc, Inst Liberal Arts, Tokyo, Japan; [Tanimura, Yuko] Aichi Toho Univ, Fac Human, Nagoya, Aichi, Japan; [Mizushima, Katsura; Takagi, Tomohisa; Naito, Yuji] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kyoto, Japan	Kyoto Prefectural University; Karolinska Institutet; Karolinska Institutet; Tokyo Institute of Technology; Kyoto Prefectural University of Medicine	Aoi, W (corresponding author), Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Sakyo Ku, 1-5 Hangi Cho, Kyoto 6068522, Japan.	waoi@kpu.ac.jp	Tanimura, Yuko/AAG-9023-2020	Sakuma, Kunihiro/0000-0003-1353-0150	Japan Society for the Promotion of Science (JSPS) [25282199, 17H02176]; Strategic Research Program in Diabetes at Karolinska Institutet; Swedish Research Council [2011-3550]; Swedish Diabetes Foundation [DIA2012-082, DIA2012-047]; Swedish Foundation for Strategic Research [SRL10-0027]; Diabetes Wellness Sweden; Novo Nordisk Foundation; Stockholm County Council	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic Research Program in Diabetes at Karolinska Institutet; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Diabetes Wellness Sweden; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Stockholm County Council(Stockholm County Council)	This work was supported by the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) (B) (25282199 and 17H02176), the Strategic Research Program in Diabetes at Karolinska Institutet, the Swedish Research Council (2011-3550), the Swedish Diabetes Foundation (DIA2012-082; DIA2012-047), the Swedish Foundation for Strategic Research (SRL10-0027), Diabetes Wellness Sweden, Novo Nordisk Foundation, and the Stockholm County Council. The authors declare no conflicts of interest.	Abbott MJ, 2009, AM J PHYSIOL-REG I, V297, pR1724, DOI 10.1152/ajpregu.00179.2009; Al-Khalili L, 2006, MOL ENDOCRINOL, V20, P3364, DOI 10.1210/me.2005-0490; Aoi W, 2008, BIOCHEM BIOPH RES CO, V366, P892, DOI 10.1016/j.bbrc.2007.12.019; Aoi W, 2013, GUT, V62, P882, DOI 10.1136/gutjnl-2011-300776; Aoi W, 2010, AM J PHYSIOL-ENDOC M, V298, pE799, DOI 10.1152/ajpendo.00448.2009; Barnes BR, 2005, FASEB J, V19, P773, DOI 10.1096/fj.04-3221com; Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; Bergeron R, 1999, AM J PHYSIOL-ENDOC M, V276, pE938, DOI 10.1152/ajpendo.1999.276.5.E938; Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025; Bradshaw AD, 2003, P NATL ACAD SCI USA, V100, P6045, DOI 10.1073/pnas.1030790100; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Catoire M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051066; Chlenski A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023880; Cho WJ, 2000, BIOCHEM BIOPH RES CO, V271, P630, DOI 10.1006/bbrc.2000.2682; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Endo M, 2009, PHYSIOL REV, V89, P1153, DOI 10.1152/physrev.00040.2008; Fan WW, 2017, CELL METAB, V25, P242, DOI 10.1016/j.cmet.2016.10.022; Friedenreich C, 2006, CANCER EPIDEM BIOMAR, V15, P2398, DOI 10.1158/1055-9965.EPI-06-0595; Glund S, 2007, DIABETES, V56, P1630, DOI 10.2337/db06-1733; Hawley JA, 2014, CELL, V159, P738, DOI 10.1016/j.cell.2014.10.029; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Jendraschak E, 1996, SEMIN CANCER BIOL, V7, P139, DOI 10.1006/scbi.1996.0019; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V292, pE1308, DOI 10.1152/ajpendo.00456.2006; Koistinen HA, 2003, DIABETES, V52, P1066, DOI 10.2337/diabetes.52.5.1066; Kos K, 2010, NAT REV ENDOCRINOL, V6, P225, DOI 10.1038/nrendo.2010.18; Kos K, 2009, DIABETES, V58, P1780, DOI 10.2337/db09-0211; Lavie CJ, 2015, CIRC RES, V117, P207, DOI 10.1161/CIRCRESAHA.117.305205; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Mahlapuu M, 2004, AM J PHYSIOL-ENDOC M, V286, pE194, DOI 10.1152/ajpendo.00147.2003; Mansergh FC, 2007, PHYSIOL GENOMICS, V32, P64, DOI 10.1152/physiolgenomics.00151.2007; Marcinko K, 2014, EXP PHYSIOL, V99, P1581, DOI 10.1113/expphysiol.2014.082255; Massart J, 2017, DIABETES, V66, P1807, DOI 10.2337/db17-0141; MCDERMOTT JC, 1991, PFLUG ARCH EUR J PHY, V418, P301, DOI 10.1007/BF00550865; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Motamed K, 2003, J CELL BIOCHEM, V90, P408, DOI 10.1002/jcb.10645; Mudry JM, 2017, DIABETES, V66, P651, DOI 10.2337/db16-0882; Nakamura K, 2012, AGING-US, V4, P40; Norose K, 1998, INVEST OPHTH VIS SCI, V39, P2674; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pedersen BK, 2003, J MUSCLE RES CELL M, V24, P113, DOI 10.1023/A:1026070911202; Raney MA, 2008, J APPL PHYSIOL, V104, P1366, DOI 10.1152/japplphysiol.01282.2007; RICHTER EA, 1982, J CLIN INVEST, V69, P785, DOI 10.1172/JCI110517; Rockl KSC, 2008, IUBMB LIFE, V60, P145, DOI 10.1002/iub.21; Safdar A, 2016, NAT REV ENDOCRINOL, V12, P504, DOI 10.1038/nrendo.2016.76; Said N, 2005, AM J PATHOL, V167, P1739, DOI 10.1016/S0002-9440(10)61255-2; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sakuma K, 2008, ACTA NEUROPATHOL, V115, P663, DOI 10.1007/s00401-008-0371-5; Song HY, 2018, BIOCHEM BIOPH RES CO, V497, P667, DOI 10.1016/j.bbrc.2018.02.129; Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005; Tartare-Deckert S, 2001, J BIOL CHEM, V276, P22231, DOI 10.1074/jbc.M010634200; Wall CE, 2016, J MOL ENDOCRINOL, V57, pR49, DOI 10.1530/JME-16-0073; Wang X, 2013, DIABETES, V62, P444, DOI 10.2337/db12-0244; Wei Ming, 2000, Comprehensive Therapy, V26, P176, DOI 10.1007/s12019-000-0006-9; Whitham M, 2016, NAT REV DRUG DISCOV, V15, P719, DOI 10.1038/nrd.2016.153; Yiu GK, 2001, AM J PATHOL, V159, P609, DOI 10.1016/S0002-9440(10)61732-4; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	59	18	18	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10551	10562		10.1096/fj.201900453R	http://dx.doi.org/10.1096/fj.201900453R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31225998	Bronze			2022-12-28	WOS:000482214200066
J	Bayer, ML; Bang, L; Hoegberget-Kalisz, M; Svensson, RB; Olesen, JL; Karlsson, MM; Schjerling, P; Hellsten, Y; Hoier, B; Magnusson, SP; Kjaer, M				Bayer, Monika L.; Bang, Louise; Hoegberget-Kalisz, Maren; Svensson, Rene B.; Olesen, Jens L.; Karlsson, Mads M.; Schjerling, Peter; Hellsten, Ylva; Hoier, Birgitte; Magnusson, S. Peter; Kjaer, Michael			Muscle-strain injury exudate favors acute tissue healing and prolonged connective tissue formation in humans	FASEB JOURNAL			English	Article						trauma; inflammation; fibrosis; fibroblast; myoblast	SKELETAL-MUSCLE; COLLAGEN-SYNTHESIS; INFLAMMATION; TENDON; RETURN; SPORT; REHABILITATION; MACROPHAGES; ORCHESTRATE; FIBROSIS	Traumatic strain injury in skeletal muscle is often associated with fluid accumulation at the site of rupture, but the role of this injury exudate (EX) in cellular responses and healing is unknown. We aimed to characterize the EX sampled from human hamstring or calf muscles following a strain injury (n = 12). The cytokine and growth-factor profile, gene expression, and transcriptome analysis of EX-derived cells were compared with blood taken simultaneously from the same individuals. Cellular responses to the EX were tested in 3-dimensional (3D) culture based on primary human fibroblasts and myoblasts isolated from hamstring muscles. The EX contained a highly proinflammatory profile with a substantial expression of angiogenic factors. The proinflammatory profile was present in samples taken early postinjury and in samples aspirated several weeks postinjury, suggesting persistent inflammation. Cells derived from the EX demonstrated an increased expression of fibrogenic, adipogenic, and angiogenesis-related genes in comparison with blood cells. The injury EX stimulated fibroblast proliferation 2-fold compared with plasma, whereas such an effect was not seen for myoblasts. Finally, in 3D cell culture, the EX induced an up-regulation of connective tissue-related genes. In summary, EX formation following a muscle-strain injury stimulates fibroblast proliferation and the synthesis of connective tissue in fibroblasts. This suggests that the EX promotes an acute tissue-healing response but potentially also contributes to the formation of fibrotic tissue in the later phases of tissue repair.-Bayer, M. L., Bang, L., Hoegberget-Kalisz, M., Svensson, R. B., Olesen, J. L., Karlsson, M. M., Schjerling, P., Hellsten, Y., Hoier, B., Magnusson, S. P., Kjaer, M. Muscle-strain injury exudate favors acute tissue healing and prolonged connective tissue formation in humans.	[Bayer, Monika L.; Bang, Louise; Hoegberget-Kalisz, Maren; Svensson, Rene B.; Olesen, Jens L.; Karlsson, Mads M.; Schjerling, Peter; Magnusson, S. Peter; Kjaer, Michael] Bispebjerg Hosp, Inst Sports Med Copenhagen, Dept Orthoped Surg M, Copenhagen, Denmark; [Magnusson, S. Peter] Bispebjerg Hosp, Dept Phys & Occupat Therapy, Copenhagen, Denmark; [Bayer, Monika L.; Bang, Louise; Hoegberget-Kalisz, Maren; Svensson, Rene B.; Olesen, Jens L.; Karlsson, Mads M.; Schjerling, Peter; Magnusson, S. Peter; Kjaer, Michael] Univ Copenhagen, Ctr Hlth Aging, Fac Hlth & Med Sci, Copenhagen, Denmark; [Hellsten, Ylva; Hoier, Birgitte] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Olesen, Jens L.] Aalborg Univ, Res Unit Gen Practice Aalborg, Dept Clin Med, Aalborg, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Copenhagen; Aalborg University	Bayer, ML (corresponding author), Univ Copenhagen, Bispebjerg Hosp, Inst Sports Med Copenhagen, Dept Orthoped Surg M, Nielsine Nielsensvej 11, DK-2400 Copenhagen, Denmark.	monika.lucia.bayer@regionh.dk	Magnusson, Peter/AAN-1631-2020; Kjaer, Michael/W-6842-2019; Magnusson, S. Peter/AAD-5903-2022; Svensson, Rene B./AGZ-3181-2022; Bayer, Monika/ABE-4909-2020; Schjerling, Peter/F-6194-2011; Hellsten, Ylva/B-3420-2015	Kjaer, Michael/0000-0002-4582-8755; Magnusson, S. Peter/0000-0002-4308-5484; Svensson, Rene B./0000-0002-1607-5379; Schjerling, Peter/0000-0001-7138-3211; Hellsten, Ylva/0000-0002-2435-9558	Novo Nordisk Foundation (Hellerup, Denmark); Lundbeck Foundation (Copenhagen, Denmark); Region Hovedstaden (Copenhagen, Denmark); Bispebjerg Hospital; Danish Rheumatism Association (Gentofte, Denmark); Anti Doping Denmark (Brondbyvester, Denmark); Nordea Foundation Center for Healthy Aging (Copenhagen, Denmark)	Novo Nordisk Foundation (Hellerup, Denmark)(Novo Nordisk Foundation); Lundbeck Foundation (Copenhagen, Denmark)(Lundbeckfonden); Region Hovedstaden (Copenhagen, Denmark); Bispebjerg Hospital; Danish Rheumatism Association (Gentofte, Denmark); Anti Doping Denmark (Brondbyvester, Denmark); Nordea Foundation Center for Healthy Aging (Copenhagen, Denmark)	The authors thank all the patients for their participation. The medical staff of the Institute of Sports Medicine Copenhagen is warmly acknowledged for their assistance and expertise. The authors further thank Karina Olsen (Department of Nutrition, Exercise, and Sports, University of Copenhagen), Cecilie Leidersdorff BechshOft (Institute of Sports Medicine Copenhagen), and Anders Elleby (Meso Scale Discovery, Rockville, MD, USA) for skillful help and technical support. This work was supported by grants from the Novo Nordisk Foundation (Hellerup, Denmark), Lundbeck Foundation (Copenhagen, Denmark), Region Hovedstaden (Copenhagen, Denmark), Bispebjerg Hospital, the Danish Rheumatism Association (Gentofte, Denmark), Anti Doping Denmark (Brondbyvester, Denmark), and the Nordea Foundation Center for Healthy Aging (Copenhagen, Denmark). The authors declare no conflicts of interest.	Agley CC, 2013, J CELL SCI, V126, P5610, DOI 10.1242/jcs.132563; Bayer ML, 2018, SCAND J MED SCI SPOR, V28, P2579, DOI 10.1111/sms.13269; Bayer ML, 2017, NEW ENGL J MED, V377, P1300, DOI 10.1056/NEJMc1708134; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Chazaud B, 2016, IMMUNOL CELL BIOL, V94, P140, DOI 10.1038/icb.2015.97; Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467; Connell DA, 2004, AM J ROENTGENOL, V183, P975, DOI 10.2214/ajr.183.4.1830975; Connizzo BK, 2014, CLIN ORTHOP RELAT R, V472, P2433, DOI 10.1007/s11999-013-3258-2; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Cutting Keith F, 2003, Br J Community Nurs, V8, P4; Davis KL, 2000, MICROCIRCULATION, V7, P269; Doessing S, 2010, J PHYSIOL-LONDON, V588, P341, DOI 10.1113/jphysiol.2009.179325; Eming SA, 2017, SCIENCE, V356, P1026, DOI 10.1126/science.aam7928; GILLERY P, 1992, J CELL PHYSIOL, V152, P389, DOI 10.1002/jcp.1041520221; Gladstone JN, 2007, AM J SPORT MED, V35, P719, DOI 10.1177/0363546506297539; GRUNDNES O, 1993, ACTA ORTHOP SCAND, V64, P47, DOI 10.3109/17453679308994527; Haddad F, 2005, J APPL PHYSIOL, V98, P911, DOI 10.1152/japplphysiol.01026.2004; Hansen M, 2013, SCAND J MED SCI SPOR, V23, P614, DOI 10.1111/j.1600-0838.2011.01431.x; Hauser CJ, 1997, J TRAUMA, V42, P895, DOI 10.1097/00005373-199705000-00021; Heinemeier KM, 2013, FASEB J, V27, P2074, DOI 10.1096/fj.12-225599; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Horst K, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/126060; Jarvinen T.A., 2014, MUSCLES LIGAMENTS TE, V3, P337; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kolar P, 2010, TISSUE ENG PART B-RE, V16, P427, DOI [10.1089/ten.teb.2009.0687, 10.1089/ten.TEB.2009.0687]; Kolar P, 2011, CLIN ORTHOP RELAT R, V469, P3118, DOI 10.1007/s11999-011-1865-3; Koulouris G, 2006, EUR RADIOL, V16, P1478, DOI 10.1007/s00330-005-0075-3; Kreuger J, 2016, NAT REV DRUG DISCOV, V15, P125, DOI 10.1038/nrd.2015.2; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Kwak HS, 2006, KOREAN J RADIOL, V7, P193, DOI 10.3348/kjr.2006.7.3.193; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lech M, 2013, BBA-MOL BASIS DIS, V1832, P989, DOI 10.1016/j.bbadis.2012.12.001; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mackey AL, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0142-x; Mueller-Wohlfahrt HW, 2013, BRIT J SPORT MED, V47, P342, DOI 10.1136/bjsports-2012-091448; Petersen J, 2014, AM J SPORT MED, V42, P399, DOI 10.1177/0363546513512779; Reed RK, 2010, J MOL CELL CARDIOL, V48, P518, DOI 10.1016/j.yjmcc.2009.06.023; Reurink G, 2015, AM J SPORT MED, V43, P1228, DOI 10.1177/0363546515572603; Reurink G, 2014, BRIT J SPORT MED, V48, P1370, DOI 10.1136/bjsports-2013-092450; Saclier M, 2013, STEM CELLS, V31, P384, DOI 10.1002/stem.1288; Sanfilippo JL, 2013, MED SCI SPORT EXER, V45, P448, DOI 10.1249/MSS.0b013e3182776eff; Scallan J., 2010, FLUID EXCHANGE REGUL; Schmidt BA, 2013, DEVELOPMENT, V140, P1517, DOI 10.1242/dev.087593; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Silder A, 2013, J ORTHOP SPORT PHYS, V43, P284, DOI 10.2519/jospt.2013.4452; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Thompson Geoff, 2007, Br J Community Nurs, V12, pS24; TIDBALL JG, 1993, J APPL PHYSIOL, V74, P1280, DOI 10.1152/jappl.1993.74.3.1280; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; WAHL SM, 1992, J CLIN IMMUNOL, V12, P61, DOI 10.1007/BF00918135; Wangensteen A, 2016, AM J SPORT MED, V44, P2112, DOI 10.1177/0363546516646086; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Yu GC, 2016, MOL BIOSYST, V12, P477, DOI 10.1039/c5mb00663e; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	57	6	5	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10369	10382		10.1096/fj.201900542R	http://dx.doi.org/10.1096/fj.201900542R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31211922				2022-12-28	WOS:000482214200052
J	Dumontet, T; Sahut-Barnola, I; Dufour, D; Lefrancois-Martinez, AM; Berthon, A; Montanier, N; Ragazzon, B; Djari, C; Pointud, JC; Roucher-Boulez, F; Batisse-Lignier, M; Tauveron, I; Bertherat, J; Val, P; Martinez, A				Dumontet, Typhanie; Sahut-Barnola, Isabelle; Dufour, Damien; Lefrancois-Martinez, Anne-Marie; Berthon, Annabel; Montanier, Nathanaelle; Ragazzon, Bruno; Djari, Cyril; Pointud, Jean-Christophe; Roucher-Boulez, Florence; Batisse-Lignier, Marie; Tauveron, Igor; Bertherat, Jerome; Val, Pierre; Martinez, Antoine			Hormonal and spatial control of SUMOylation in the human and mouse adrenal cortex	FASEB JOURNAL			English	Article						endocrine diseases; PKA; SENP1; 2; PIAS3; beta-catenin; mouse models	GENE-EXPRESSION; IN-VIVO; ADRENOCORTICAL DEVELOPMENT; SUMO-1 MODIFICATION; REGULATORY SUBUNIT; PROTEASE SENP2; BETA; ACTIVATION; PATHWAY; KINASE	SUMOylation is a highly conserved and dynamic post-translational mechanism primarily affecting nuclear programs for adapting organisms to stressful challenges. Alteration of SUMOylation cycles leads to severe developmental and homeostatic defects and malignancy, but signals coordinating SUMOylation are still unidentified. The adrenal cortex is a zonated endocrine gland that controls body homeostasis and stress response. Here, we show that in human and in mouse adrenals, SUMOylation follows a decreasing centripetal gradient that mirrors cortical differentiation flow and delimits highly and weakly SUMOylated steroidogenic compartments, overlapping glomerulosa, and fasciculata zones. Activation of PKA signaling by acute hormonal treatment, mouse genetic engineering, or in Carney complex results in repression of small ubiquitin-like modifier (SUMO) conjugation in the inner cortex by coordinating expression of SUMO pathway inducers and repressors. Conversely, genetic activation of canonical wingless-related integration site signaling maintains high SUMOylation potential in the outer neoplastic cortex. Thus, SUMOylation is tightly regulated by signaling pathways that orchestrate adrenal zonation and diseases.-Dumontet, T., Sahut-Barnola, I., Dufour, D., Lefrancois-Martinez, A.-M., Berthon, A., Montanier, N., Ragazzon, B., Djari, C., Pointud, J.-C., Roucher-Boulez, F., Batisse-Lignier, M., Tauveron, I., Bertherat, J., Val, P., Martinez, A. Hormonal and spatial control of SUMOylation in the human and mouse adrenal cortex.	[Dumontet, Typhanie; Sahut-Barnola, Isabelle; Dufour, Damien; Lefrancois-Martinez, Anne-Marie; Berthon, Annabel; Montanier, Nathanaelle; Djari, Cyril; Pointud, Jean-Christophe; Roucher-Boulez, Florence; Batisse-Lignier, Marie; Tauveron, Igor; Val, Pierre; Martinez, Antoine] Univ Clermont Auvergne, CHU, CNRS, INSERM,Genet Reprod & Dev GReD, Clermont Ferrand, France; [Batisse-Lignier, Marie; Tauveron, Igor] Univ Clermont Auvergne, CHU, Fac Med, Serv Endocrinol, Clermont Ferrand, France; [Montanier, Nathanaelle] CHR, Hop Source, Serv Endocrinol, Orleans, France; [Ragazzon, Bruno] Univ Paris 05, CNRS, INSERM, Inst Cochin, Paris, France; [Roucher-Boulez, Florence] Univ Claude Bernard Lyon 1, CHU, Endocrinol Mol & Malad Rares, Bron, France; [Bertherat, Jerome] Hop Cochin, AP HP, Serv Endocrinol, Ctr Malad Rares Surrenale, Paris, France	Centre National de la Recherche Scientifique (CNRS); CHU Clermont Ferrand; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); Centre Hospitalier Regional d'Orleans; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Martinez, A (corresponding author), Univ Clermont Auvergne, CNRS, UMR6293, GReD,INSERM,U1103,Fac Med,CRBC, 28 Pl Henri Dunant,BP38, F-63001 Clermont Ferrand, France.	antoine.martinez@uca.fr	Berthon, Annabel/AAG-6890-2019; Dumontet, Typhanie/AAA-3605-2022; Ragazzon, Bruno/E-6541-2017	Ragazzon, Bruno/0000-0001-9476-4973; Val, Pierre/0000-0001-7648-5567; BERTHERAT, Jerome/0000-0003-2551-3008; Berthon, Annabel/0000-0002-5576-9525	Centre national de la Recherche Scientifique, INSERM, Universite Clermont-Auvergne; French government Initiative d'EXcellence-Initiative Science Innovation Territoires Economie (IDEX-ISITE) initiative [16-IDEX-0001 (CAP 20-25)]; Region Auvergne-Rhone-Alpes; Fondation Association pour la Recherche sur le Cancer; Agence Nationale pour la Recherche [ANR-14-CE12-000]	Centre national de la Recherche Scientifique, INSERM, Universite Clermont-Auvergne; French government Initiative d'EXcellence-Initiative Science Innovation Territoires Economie (IDEX-ISITE) initiative; Region Auvergne-Rhone-Alpes(Region Auvergne-Rhone-Alpes); Fondation Association pour la Recherche sur le Cancer; Agence Nationale pour la Recherche(French National Research Agency (ANR))	The authors thank Kaitlin J. Basham (University of Michigan, Ann Arbor, MI, USA) for critical reading of the manuscript. The authors also wish to thank Sandrine Plantade, Philippe Mazuel, and Khirredine Ouchen (all from the Universite Clermont-Auvergne, Clermont-Ferrand, France) for care of the transgenic mice. This work was funded through institutional support from Centre national de la Recherche Scientifique, INSERM, Universite Clermont-Auvergne, and the French government Initiative d'EXcellence-Initiative Science Innovation Territoires Economie (IDEX-ISITE) initiative 16-IDEX-0001 (CAP 20-25) and supported by grants from Region Auvergne-Rhone-Alpes to T.D., Fondation Association pour la Recherche sur le Cancer to T.D., and Agence Nationale pour la Recherche (ANR-14-CE12-000) to A.M. Human adrenal samples were collected by the French Cortico et Medullosurrenale: les Tumeurs Endocrines (COMETE) network. The authors declare no conflicts of interest.	Auchus RJ, 2004, CLIN ENDOCRINOL, V60, P288, DOI 10.1046/j.1365-2265.2003.01858.x; Batisse-Lignier M, 2017, ONCOGENE, V36, P4445, DOI 10.1038/onc.2017.54; Bertherat J, 2009, J CLIN ENDOCR METAB, V94, P2085, DOI 10.1210/jc.2008-2333; Berthon A, 2014, HUM MOL GENET, V23, P889, DOI 10.1093/hmg/ddt484; Berthon A, 2010, HUM MOL GENET, V19, P1561, DOI 10.1093/hmg/ddq029; Bollag WB, 2014, COMPR PHYSIOL, V4, P1017, DOI 10.1002/cphy.c130037; Campbell LA, 2008, MOL CELL BIOL, V28, P7476, DOI 10.1128/MCB.00103-08; CARNEY JA, 1985, MEDICINE, V64, P270, DOI 10.1097/00005792-198507000-00007; Chen WY, 2004, J BIOL CHEM, V279, P38730, DOI 10.1074/jbc.M405006200; Chida D, 2007, P NATL ACAD SCI USA, V104, P18205, DOI 10.1073/pnas.0706953104; Choi HK, 2011, MOL CELL, V43, P203, DOI 10.1016/j.molcel.2011.05.027; Chung SS, 2010, MOL CELL BIOL, V30, P2135, DOI 10.1128/MCB.00852-09; Cougnoux A, 2014, GUT, V63, P1932, DOI 10.1136/gutjnl-2013-305257; Cui CP, 2017, GUT, V66, P2149, DOI 10.1136/gutjnl-2016-313264; de Joussineau C, 2014, HUM MOL GENET, V23, P5418, DOI 10.1093/hmg/ddu265; Demarque MD, 2011, GASTROENTEROLOGY, V140, P286, DOI 10.1053/j.gastro.2010.10.002; Deyrieux AF, 2007, J CELL SCI, V120, P125, DOI 10.1242/jcs.03317; Deyrieux AF, 2017, ADV EXP MED BIOL, V963, P197, DOI 10.1007/978-3-319-50044-7_12; Drelon C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12751; Dumontet T, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98394; Freedman BD, 2013, DEV CELL, V26, P666, DOI 10.1016/j.devcel.2013.07.016; Galleguillos D, 2004, J BIOL CHEM, V279, P2005, DOI 10.1074/jbc.M308113200; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gorrigan RJ, 2011, J MOL ENDOCRINOL, V46, P227, DOI 10.1530/JME-11-0011; Hang J, 2002, J BIOL CHEM, V277, P19961, DOI 10.1074/jbc.M201799200; Heun P, 2007, CURR OPIN CELL BIOL, V19, P350, DOI 10.1016/j.ceb.2007.04.014; Huang HJ, 2015, AM J CANCER RES, V5, P309; Jagannath A, 2013, CELL, V154, P1100, DOI 10.1016/j.cell.2013.08.004; Karami S, 2017, SCI REP-UK, V7, DOI 10.1038/srep46477; King P, 2009, P NATL ACAD SCI USA, V106, P21185, DOI 10.1073/pnas.0909471106; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Komatsu T, 2004, MOL ENDOCRINOL, V18, P2451, DOI 10.1210/me.2004-0173; Lee FY, 2011, DEV CELL, V21, P315, DOI 10.1016/j.devcel.2011.06.028; Lee MB, 2005, MOL CELL BIOL, V25, P1879, DOI 10.1128/MCB.25.5.1879-1890.2005; Lee MH, 2011, MOL CELL, V43, P180, DOI 10.1016/j.molcel.2011.06.017; Lefrancois-Martinez AM, 2011, J BIOL CHEM, V286, P32976, DOI 10.1074/jbc.M111.218016; Li X, 2010, BIOCHEM J, V428, P55, DOI 10.1042/BJ20091672; Lin XZ, 2000, ENDOCR RES, V26, P995, DOI 10.3109/07435800009048629; Liu BT, 2014, J BIOL CHEM, V289, P22358, DOI 10.1074/jbc.M114.571950; Liu Y, 2013, MOL CELL BIOL, V33, P4606, DOI 10.1128/MCB.00723-13; Mathieu M, 2018, P NATL ACAD SCI USA, V115, pE12265, DOI 10.1073/pnas.1809185115; Morohashi K, 2011, MOL CELL ENDOCRINOL, V336, P193, DOI 10.1016/j.mce.2010.11.026; Nayak A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0422-2; Neyret-Kahn H, 2013, GENOME RES, V23, P1563, DOI 10.1101/gr.154872.113; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Ragazzon B, 2006, ENDOCRINOLOGY, V147, P1805, DOI 10.1210/en.2005-1279; Sahut-Barnola I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000980; Seeler JS, 2017, NAT REV CANCER, V17, P184, DOI 10.1038/nrc.2016.143; Shin EJ, 2012, EMBO REP, V13, P339, DOI 10.1038/embor.2012.3; Smolen GA, 2004, CANCER RES, V64, P7846, DOI 10.1158/0008-5472.CAN-04-1502; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; Takemori H, 2008, J STEROID BIOCHEM, V108, P287, DOI 10.1016/j.jsbmb.2007.09.006; Tan MY, 2015, SCI REP-UK, V5, DOI 10.1038/srep13996; Tempe D, 2008, BIOCHEM SOC T, V36, P874, DOI 10.1042/BST0360874; Tirard M, 2012, P NATL ACAD SCI USA, V109, P21122, DOI 10.1073/pnas.1215366110; Tirosh A, 2018, PRESSE MED, V47, pE127, DOI 10.1016/j.lpm.2018.07.005; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Vidal V, 2016, GENE DEV, V30, P1389, DOI 10.1101/gad.277756.116; Vinson GP, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00238; Walczak EM, 2014, MOL ENDOCRINOL, V28, P1471, DOI 10.1210/me.2014-1060; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Yang FM, 2009, FEBS J, V276, P425, DOI 10.1111/j.1742-4658.2008.06785.x; Yang W, 2008, J CEREBR BLOOD F MET, V28, P892, DOI 10.1038/sj.jcbfm.9600601; Yates R, 2013, CURR TOP DEV BIOL, V106, P239, DOI 10.1016/B978-0-12-416021-7.00007-9; Zhang ZK, 2019, MOL CELL, V73, P7, DOI 10.1016/j.molcel.2018.10.030; Zubair M, 2008, MOL CELL BIOL, V28, P7030, DOI 10.1128/MCB.00900-08	66	4	4	1	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10218	10230		10.1096/fj.201900557R	http://dx.doi.org/10.1096/fj.201900557R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31208233	Bronze, Green Submitted			2022-12-28	WOS:000482214200040
J	Guo, SM; Zhang, R; Liu, Q; Wan, QY; Wang, YY; Yu, Y; Liu, GZ; Shen, YJ; Yu, Y; Zhang, J				Guo, Shumin; Zhang, Rui; Liu, Qian; Wan, Qiangyou; Wang, Yuanyang; Yu, Yu; Liu, Guizhu; Shen, Yujun; Yu, Ying; Zhang, Jian			2,3,7,8-Tetrachlorodibenzo-p-dioxin promotes injury-induced vascular neointima formation in mice	FASEB JOURNAL			English	Article						vascular smooth muscle cells; proliferation; neointima formation	ARYL-HYDROCARBON RECEPTOR; SMOOTH-MUSCLE-CELL; C-JUN; TRANSCRIPTION FACTORS; MOLECULAR-MECHANISMS; CYCLE PROGRESSION; ACTIVATION; INHIBITION; DIFFERENTIATION; APOPTOSIS	2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is an environmental pollutant that causes cardiovascular toxicity. The phenotypic transformation of vascular smooth muscle cells (VSMCs) from the contractile to the synthetic phenotype is a hallmark of vascular response to injury. However, the precise role and molecular mechanism of TCDD in vascular remodeling remains unknown. In the present study, we found that TCDD treatment promoted VSMC phenotypic transition from contractile to synthetic phenotype and exaggerated vascular neointimal hyperplasia after wire injury in mice. TCDD treatment enhanced VSMC entry into cell cycle from G0/G1 phase to S and G2/M phase. The expression of cyclin D1, cyclin-dependent kinase 4 (CDK4), and its phosphorylation were coordinately increased in response to TCDD treatment. Knocking down of aryl hydrocarbon receptor (AHR) inhibited VSMC phenotypic transition induced by TCDD and promoted S/G2 phase cell cycle arrest. TCDD treatment markedly increased oncogenic c-Jun gene expression in VSMCs. ChIP assay revealed the direct binding of AHR on the promoter of c-Jun to up-regulate the mRNA expression of c-Jun. Silencing of c-Jun gene enhanced the expression of p53 and p21, whereas attenuated the expression of CDK4 and cyclin D1 leading to the decrease in the TCDD-stimulated VSMC proliferation and synthetic phenotype transition in vitro. In vivo study showed that genetic ablation of c-Jun in VSMCs restricted injury-induced neointimal hyperplasia in TCDD-treated mice. Thus, TCDD exposure exaggerated injury-induced vascular remodeling by the activation of AHR and up-regulation of the expression of its target gene c-Jun, indicating that inhibition of AHR may be a promising prevention strategy for TCDD-associated cardiovascular diseases.-Guo, S., Zhang, R., Liu, Q., Wan, Q., Wang, Y., Yu, Y., Liu, G., Shen, Y., Yu, Y., Zhang, J. 2,3,7,8-Tetrachlorodibenzo-p-dioxin promotes injury-induced vascular neointima formation in mice.	[Guo, Shumin; Zhang, Rui; Liu, Qian; Wang, Yuanyang; Shen, Yujun; Yu, Ying; Zhang, Jian] Tianjin Med Univ, Sch Basic Med Sci, Dept Pharmacol, Tianjin, Peoples R China; [Guo, Shumin; Zhang, Rui; Liu, Qian; Wang, Yuanyang; Shen, Yujun; Yu, Ying; Zhang, Jian] Tianjin Med Univ, Sch Basic Med Sci, Tianjin Key Lab Inflammat Biol, Tianjin, Peoples R China; [Wan, Qiangyou; Yu, Ying] Univ Chinese Acad Sci, Chinese Acad Sci, CAS Key Lab Nutr Metab & Food Safety, Shanghai Inst Nutr & Hlth,Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Yu, Yu] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Pediat Cardiovasc, Shanghai, Peoples R China; [Liu, Guizhu] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Tianjin Medical University; Tianjin Medical University; Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Zhang, J (corresponding author), Tianjin Med Univ, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China.	zhangjian7@tmu.edu.cn		Yu, Yu/0000-0003-2291-0606	Ministry of Science and Technology of China [2017YFC1307402]; National Natural Science Foundation of China [81771513]; Tianjin Natural Science Foundation [17JCYBJC40700, 17JCYBJC26800]; Young Elite Scientists Sponsorship Program, Tianjin [TJSQNTJ-2018-10]; Experts Recruitment Program of Xinhua Hospital [Re-013]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Natural Science Foundation(Natural Science Foundation of Tianjin); Young Elite Scientists Sponsorship Program, Tianjin; Experts Recruitment Program of Xinhua Hospital	The authors thank Dr. Lijian Hui [State Key Laboratory of Cell Biology, Chinese Academy of Sciences (CAS) Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China] for providing c-Jun<SUP>F/F</SUP> mice. This work was supported by grants from the Ministry of Science and Technology of China (2017YFC1307402), the National Natural Science Foundation of China (81771513), the Tianjin Natural Science Foundation (17JCYBJC40700, 17JCYBJC26800), Young Elite Scientists Sponsorship Program by Tianjin (TJSQNTJ-2018-10), and the Experts Recruitment Program of Xinhua Hospital (Re-013). The authors declare no conflicts of interest.	Agbor LN, 2011, BIOCHEM PHARMACOL, V82, P514, DOI 10.1016/j.bcp.2011.06.011; Al-Dhfyan A, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0636-5; Andrysik Z, 2013, ARCH TOXICOL, V87, P491, DOI 10.1007/s00204-012-0963-7; Angelos MG, 2017, BLOOD, V129, P3428, DOI 10.1182/blood-2016-07-730440; Arsenescu V, 2008, ENVIRON HEALTH PERSP, V116, P761, DOI 10.1289/ehp.10554; Bock KW, 2009, BIOL CHEM, V390, P1225, DOI 10.1515/BC.2009.138; Boucher JM, 2013, CIRC RES, V113, P975, DOI 10.1161/CIRCRESAHA.113.301272; Christen T, 2001, CIRCULATION, V103, P882, DOI 10.1161/01.CIR.103.6.882; Christen T, 1999, CIRC RES, V85, P99; Tran C, 2013, BIOCHEM PHARMACOL, V85, P753, DOI 10.1016/j.bcp.2012.12.010; Dalton T P, 2001, Cardiovasc Toxicol, V1, P285, DOI 10.1385/CT:1:4:285; Dong Li-Hua, 2012, Cardiovascular & Hematological Disorders - Drug Targets, V12, P119; FUKUNAGA BN, 1995, J BIOL CHEM, V270, P29270, DOI 10.1074/jbc.270.49.29270; Harrill JA, 2015, HEPATOLOGY, V61, P548, DOI 10.1002/hep.27547; Hattori Y, 2003, CARDIOVASC RES, V58, P186, DOI 10.1016/S0008-6363(02)00855-6; Humblet O, 2008, ENVIRON HEALTH PERSP, V116, P1443, DOI 10.1289/ehp.11579; Ishimura R, 2006, TOXICOL SCI, V91, P265, DOI 10.1093/toxsci/kfj138; Kang DC, 1998, INT J ONCOL, V13, P1117; Kaplan-Albuquerque N, 2005, CIRC RES, V97, P427, DOI 10.1161/01.RES.0000179776.40216.a9; Khachigian LM, 2002, J BIOL CHEM, V277, P22985, DOI 10.1074/jbc.M200977200; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Kolluri SK, 2017, ARCH TOXICOL, V91, P2497, DOI 10.1007/s00204-017-1981-2; Kopf PG, 2010, TOXICOL SCI, V117, P537, DOI 10.1093/toxsci/kfq218; Krishna SM, 2013, INT J CARDIOL, V168, P692, DOI 10.1016/j.ijcard.2013.04.139; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Lanham KA, 2014, TOXICOL SCI, V141, P141, DOI 10.1093/toxsci/kfu111; Liebermann DA, 1998, INT J ONCOL, V12, P685; Liu GZ, 2018, FASEB J, V32, P5413, DOI 10.1096/fj.201800173R; Lu AK, 2015, J CLIN INVEST, V125, P1228, DOI 10.1172/JCI77656; Menyhart O, 2016, BBA-REV CANCER, V1866, P300, DOI 10.1016/j.bbcan.2016.10.002; Pelcl T, 2018, BASIC CLIN PHARMACOL, V123, P356, DOI 10.1111/bcpt.13013; Pierre S, 2011, BIOCHEM PHARMACOL, V81, P304, DOI 10.1016/j.bcp.2010.10.003; Podechard N, 2009, CARDIOVASC RES, V82, P361, DOI 10.1093/cvr/cvp007; Sany SBT, 2015, ENVIRON SCI POLLUT R, V22, P19434, DOI 10.1007/s11356-015-5597-x; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Seok SH, 2017, P NATL ACAD SCI USA, V114, P5431, DOI 10.1073/pnas.1617035114; Sinha S, 2006, STEM CELLS, V24, P1678, DOI 10.1634/stemcells.2006-0002; Sorg O, 2014, TOXICOL LETT, V230, P225, DOI 10.1016/j.toxlet.2013.10.039; Speer MY, 2002, J EXP MED, V196, P1047, DOI 10.1084/jem.20020911; Stepniak E, 2006, GENE DEV, V20, P2306, DOI 10.1101/gad.390506; Sulentic CEW, 2011, TOXICOL SCI, V120, pS171, DOI 10.1093/toxsci/kfq324; Takahashi M, 2003, CIRCULATION, V108, P2524, DOI 10.1161/01.CIR.0000096482.02567.8C; Tellides G, 2015, CIRC RES, V116, P312, DOI 10.1161/CIRCRESAHA.116.301312; Tsaousi A, 2011, CIRC RES, V108, P427, DOI 10.1161/CIRCRESAHA.110.233999; van Eys GJ, 2007, TRENDS CARDIOVAS MED, V17, P26, DOI 10.1016/j.tcm.2006.11.001; Villa M, 2017, EMBO J, V36, P116, DOI 10.15252/embj.201695027; Vogel Christoph F A, 2004, Cardiovasc Toxicol, V4, P363, DOI 10.1385/CT:4:4:363; Wang Q, 2013, ENVIRON HEALTH PERSP, V121, P1334, DOI 10.1289/ehp.1307297; Watson L, 2000, EUR J CLIN INVEST, V30, P11; Weissberg P L, 1995, Blood Press Suppl, V2, P68; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Wu DL, 2011, ARTERIOSCL THROM VAS, V31, P1260, DOI 10.1161/ATVBAHA.110.220202; Yang XH, 2005, ONCOGENE, V24, P7869, DOI 10.1038/sj.onc.1208938; Yu Y, 2017, J CELL MOL MED, V21, P3540, DOI 10.1111/jcmm.13265; Zhang C, 2018, CARDIOVASC RES, V114, P443, DOI 10.1093/cvr/cvx236; Zhang J, 2013, CIRC RES, V113, P104, DOI 10.1161/CIRCRESAHA.113.301033; Zhang MJ, 2016, HISTOCHEM CELL BIOL, V145, P119, DOI 10.1007/s00418-015-1386-3; Zhao MY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11309; Zhu ZM, 2018, HYPERTENSION, V71, P56, DOI [10.1161/HYPERTENSIONAHA.117.09848, 10.1161/HYPERTENSIONAHA.117.09944, 10.1161/HYPERTENSIONAHA.117.10527]	59	4	4	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10207	10217		10.1096/fj.201900546R	http://dx.doi.org/10.1096/fj.201900546R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31216422				2022-12-28	WOS:000482214200039
J	Lu, FI; Wang, YT; Wang, YS; Wu, CY; Li, CC				Lu, Fu-I; Wang, Yi-Ting; Wang, Yi-Shan; Wu, Chang-Yi; Li, Chun-Chun			Involvement of BIG1 and BIG2 in regulating VEGF expression and angiogenesis	FASEB JOURNAL			English	Article						ARFGEF; ARF1; small GTPase; endothelial cell; cell migration	NUCLEOTIDE-EXCHANGE PROTEIN; ADP-RIBOSYLATION FACTORS; ENDOTHELIAL GROWTH-FACTOR; BREFELDIN-A; VASCULAR DEVELOPMENT; RECYCLING ENDOSOMES; ARF ACTIVATION; CELL-MIGRATION; IN-VITRO; ZEBRAFISH	VEGF stimulates the formation of new blood vessels by inducing endothelial cell (EC) proliferation and migration. Brefeldin A (BFA)-inhibited guanine nucleotide-exchange protein (BIG)1 and 2 accelerate the replacement of bound GDP with GTP to activate ADP-ribosylation factor (Arf)1, which regulates vesicular transport between the Golgi and plasma membrane. Although it has been reported that treating cells with BFA interferes with Arf1 activation to inhibit VEGF secretion, the role of BIG1 and BIG2 in VEGF trafficking and expression, EC migration and proliferation, and vascular development remains unknown. Here, we found that inactivation of Arf1 reduced VEGF secretion but did not affect the levels of VEGF protein. Interestingly, however, BIG1 and BIG2 knockdown significantly decreased the levels of VEGF mRNA and protein in glioblastoma U251 cells and HUVECs. Furthermore, depletion of BIG1 and BIG2 inhibited HUVEC angiogenesis by diminishing cell migration. Angioblast migration and intersegmental vessel sprouting were also impaired when the BIG2 homolog, Arf guanine nucleotide exchange factor (arfgef)2, was knocked down in zebrafish with endothelial expression of green fluorescent protein (GFP). Depletion of arfgef2 by clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein 9 (Cas9) also caused defects in vascular development of zebrafish embryos. Taken together, these data reveal that BIG1 and BIG2 participate in endothelial cell angiogenesis.-Lu, F.-I., Wang, Y.-T., Wang, Y.-S., Wu, C.-Y., Li, C.-C. Involvement of BIG1 and BIG2 in regulating VEGF expression and angiogenesis.	[Lu, Fu-I] Natl Cheng Kung Univ, Dept Biotechnol & Bioind Sci, Tainan, Taiwan; [Wang, Yi-Ting; Li, Chun-Chun] Natl Cheng Kung Univ, Dept Life Sci, Tainan, Taiwan; [Lu, Fu-I] Natl Chung Hsing Univ, Integrat Evolutionary Galliforms Genom Res iEGG &, Taichung, Taiwan; [Wang, Yi-Shan; Wu, Chang-Yi] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan	National Cheng Kung University; National Cheng Kung University; National Chung Hsing University; National Sun Yat Sen University	Li, CC (corresponding author), Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Dept Life Sci, 1 Univ Rd, Tainan 701, Taiwan.	ccli@mail.ncku.edu.tw	Wang, Yu/GZL-9655-2022; wang, yi/GVT-8516-2022; wang, yixuan/GXW-2866-2022; Lu, Fu-i/AAC-4555-2019; Wang, Yijun/GXW-1763-2022; Wang, Yixuan/GZK-6559-2022; Wang, Yin/HCI-9352-2022	Lu, Fu-i/0000-0003-2401-7360; Li, Chun-Chun/0000-0002-3601-838X	Laboratory Animal Center, Medical College, National Cheng Kung University; Ministry of Science and Technology in Taiwan (MOST) [MOST 104-2311-B-006-005-MY3, MOST 107-2311-B-006-001, MOST 104-2320-B-006-032-MY3, MOST 107-2320-B-006-041]; Integrative Evolutionary Galliforms Genomics Research (iEGG) from The Feature Area Research Center Program by Ministry of Education (MOE) in Taiwan [MOE-107-S-0023-F]; Animal Biotechnology Center from The Feature Area Research Center Program by Ministry of Education (MOE) in Taiwan [MOE-107-S-0023-F]	Laboratory Animal Center, Medical College, National Cheng Kung University; Ministry of Science and Technology in Taiwan (MOST); Integrative Evolutionary Galliforms Genomics Research (iEGG) from The Feature Area Research Center Program by Ministry of Education (MOE) in Taiwan; Animal Biotechnology Center from The Feature Area Research Center Program by Ministry of Education (MOE) in Taiwan	The authors acknowledge the help of Drs. Wen-Tai Chiu (National Cheng Kung University) and Won-Jing Wang (National Yang Ming University, Taipei, Taiwan) for commenting on this work. The authors thank Drs. Chia-Jung Yu (Chang Gung University, Taoyuan City, Taiwan), Jean-Chen Kuo (National Yang Ming University), and Ya-Wen Liu (National Taiwan University, Taipei, Taiwan) for critical review of this manuscript. The authors also thank Hsiao-Han Huang and Yu-Fang Wang (both from National Cheng Kung University) for technique support. The authors also thank the Taiwan Zebrafish Core Facility at Academia Sinica (TZCAS) and National Health Research Institute (TZeTH), which are supported by Ministry of Science and Technology (MOST105-2321-B-001-029 and MOST104-2321-B-001-045) for providing wild-type zebrafish and plasmids. The authors are also grateful for the support from the Laboratory Animal Center, Medical College, National Cheng Kung University. This work was supported by grants from Ministry of Science and Technology in Taiwan (MOST) awarded to F.-I.L. (MOST 104-2311-B-006-005-MY3; MOST 107-2311-B-006-001) and to C.-C.L. (MOST 104-2320-B-006-032-MY3; MOST 107-2320-B-006-041). This work was, in part, financially supported by the Integrative Evolutionary Galliforms Genomics Research (iEGG) and Animal Biotechnology Center from The Feature Area Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan (MOE-107-S-0023-F). The authors declare no conflicts of interest.	Breier G, 1996, TRENDS CELL BIOL, V6, P454, DOI 10.1016/0962-8924(96)84935-X; Burger A, 2016, DEVELOPMENT, V143, P2025, DOI 10.1242/dev.134809; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Chappell JC, 2009, DEV CELL, V17, P377, DOI 10.1016/j.devcel.2009.07.011; Chatterjee S, 2013, J CLIN INVEST, V123, P1732, DOI 10.1172/JCI65385; Chun CZ, 2006, MOL REPROD DEV, V73, P1112, DOI 10.1002/mrd.20473; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Daher Z, 2010, J BIOL CHEM, V285, P24591, DOI 10.1074/jbc.M110.115311; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Fukuda M, 2011, BBA-GEN SUBJECTS, V1810, P1150, DOI 10.1016/j.bbagen.2011.09.016; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; Gore AV, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006684; Grzmil P, 2010, INT J DEV BIOL, V54, P1259, DOI 10.1387/ijdb.092959pg; Guzman-Hernandez ML, 2014, MOL BIOL CELL, V25, P1061, DOI 10.1091/mbc.E13-07-0418; Habeck H, 2002, CURR BIOL, V12, P1405, DOI 10.1016/S0960-9822(02)01044-8; Han JH, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1444-1; Hashimoto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023359; Huang HZ, 2007, DEVELOPMENT, V134, P979, DOI 10.1242/dev.02782; Ishizaki R, 2008, MOL BIOL CELL, V19, P2650, DOI 10.1091/mbc.E07-10-1067; Islam A, 2007, J BIOL CHEM, V282, P9591, DOI 10.1074/jbc.M607122200; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Jo H, 2012, P NATL ACAD SCI USA, V109, P10581, DOI 10.1073/pnas.1202810109; Ju L, 2017, CELL PHYSIOL BIOCHEM, V41, P1346, DOI 10.1159/000465389; Kajimura S, 2006, MOL CELL BIOL, V26, P1142, DOI 10.1128/MCB.26.3.1142-1155.2006; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Kohli V, 2013, DEV CELL, V25, P196, DOI 10.1016/j.devcel.2013.03.017; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Krens SFG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-196; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Le K, 2013, P NATL ACAD SCI USA, V110, pE3162, DOI 10.1073/pnas.1312531110; Li CC, 2016, P NATL ACAD SCI USA, V113, P5946, DOI 10.1073/pnas.1601918113; Li CC, 2011, P NATL ACAD SCI USA, V108, P19228, DOI 10.1073/pnas.1117011108; Lin TY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101980; Lu FI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6368; Miyamoto Y, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar4471; Morinaga N, 1996, P NATL ACAD SCI USA, V93, P12856, DOI 10.1073/pnas.93.23.12856; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Park HJ, 2006, STEM CELL REV, V2, P93, DOI 10.1007/s12015-006-0015-x; POOLE TJ, 1989, J EXP ZOOL, V251, P224, DOI 10.1002/jez.1402510210; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Puxeddu E, 2009, P NATL ACAD SCI USA, V106, P6158, DOI 10.1073/pnas.0901558106; Saeki N, 2005, J BIOL CHEM, V280, P10128, DOI 10.1074/jbc.M413415200; Shah AN, 2015, NAT METHODS, V12, P535, DOI 10.1038/nmeth.3360; Shen XY, 2012, P NATL ACAD SCI USA, V109, P14464, DOI 10.1073/pnas.1211877109; Shen XY, 2008, P NATL ACAD SCI USA, V105, P18788, DOI 10.1073/pnas.0810104105; Shen XY, 2006, P NATL ACAD SCI USA, V103, P2635, DOI 10.1073/pnas.0510599103; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; Simons M, 2016, NAT REV MOL CELL BIO, V17, P611, DOI 10.1038/nrm.2016.87; Stainier DYR, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007000; Tan WF, 2008, FASEB J, V22, P1829, DOI 10.1096/fj.07-096438; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Teoh JJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175888; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Togawa A, 1999, J BIOL CHEM, V274, P12308, DOI 10.1074/jbc.274.18.12308; Trubiroha A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24036-4; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wilkinson RN, 2012, BLOOD, V120, P477, DOI 10.1182/blood-2011-10-383729; Wu TY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01976-x; Wu YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126750; Yamaji R, 2000, P NATL ACAD SCI USA, V97, P2567, DOI 10.1073/pnas.97.6.2567; Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427; Yoon HY, 2005, METHOD ENZYMOL, V404, P316, DOI 10.1016/S0076-6879(05)04028-0; Zhu H, 2005, DEV BIOL, V281, P256, DOI 10.1016/j.ydbio.2005.01.034	72	4	4	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9959	9973		10.1096/fj.201900342RR	http://dx.doi.org/10.1096/fj.201900342RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31199673	Bronze			2022-12-28	WOS:000482214200021
J	Ricci, D; Marrocco, I; Blumenthal, D; Dibos, M; Eletto, D; Vargas, J; Boyle, S; Iwamoto, Y; Chomistek, S; Paton, JC; Paton, AW; Argon, Y				Ricci, Daniela; Marrocco, Ilaria; Blumenthal, Daniel; Dibos, Miriam; Eletto, Daniela; Vargas, Jade; Boyle, Sarah; Iwamoto, Yuichiro; Chomistek, Steven; Paton, James C.; Paton, Adrienne W.; Argon, Yair			Clustering of IRE1 alpha depends on sensing ER stress but not on its RNase activity	FASEB JOURNAL			English	Article						differential ER Stress; autophosphorylation; BiP; luteolin	UNFOLDED-PROTEIN-RESPONSE; ENDOPLASMIC-RETICULUM; MESSENGER-RNA; CELL FATE; IRE1; KINASE; ACTIVATION; PATHWAY; DECAY; BIP	The sensors of the unfolded protein response react to endoplasmic reticulum (ER) stress by transient activation of their enzymatic activities, which initiate various signaling cascades. In addition, the sensor IRE1 alpha exhibits stress-induced clustering in a transient time frame similar to activation of its endoRNase activity. Previous work had suggested that the clustering response and RNase activity of IRE1 alpha are functionally linked, but here we show that they are independent of each other and have different behaviors and modes of activation. Although both clustering and the RNase activity are responsive to luminal stress conditions and to depletion of the ER chaperone binding protein, RNase-inactive IRE1 alpha still clusters and, conversely, full RNase activity can be accomplished without clustering. The clusters formed by RNase-inactive IRE1 alpha are much larger and persist longer than those induced by ER stress. Clustering requires autophosphorylation, and an IRE1 alpha mutant whose RNase domain is responsive to ligands that bind the kinase domain forms yet a third type of stress-independent cluster, with distinct physical properties and half-lives. These data suggest that IRE1 alpha clustering can follow distinct pathways upon activation of the sensor.-Ricci, D., Marrocco, I., Blumenthal, D., Dibos, M., Eletto, D., Vargas, J., Boyle, S., Iwamoto, Y., Chomistek, S., Paton, J. C., Paton, A. W., Argon, Y. Clustering of IRE1 alpha depends on sensing ER stress but not on its RNase activity.	[Ricci, Daniela; Marrocco, Ilaria; Blumenthal, Daniel; Dibos, Miriam; Eletto, Daniela; Vargas, Jade; Boyle, Sarah; Iwamoto, Yuichiro; Chomistek, Steven; Argon, Yair] Univ Penn, Childrens Hosp Philadelphia, Div Cell Pathol, Philadelphia, PA 19104 USA; [Paton, James C.; Paton, Adrienne W.] Univ Adelaide, Dept Mol & Cellular Biol, Adelaide, SA, Australia; [Marrocco, Ilaria] Weizmann Inst Sci, Rehovot, Israel; [Eletto, Daniela] Univ Salerno, Salerno, Italy; [Iwamoto, Yuichiro] Univ Calif Berkeley, Berkeley, CA 94720 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Adelaide; Weizmann Institute of Science; University of Salerno; University of California System; University of California Berkeley	Argon, Y (corresponding author), Childrens Hosp Philadelphia, Abramson Res Ctr 815, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	argony@email.chop.edu		Eletto, Daniela/0000-0001-6967-1812; MARROCCO, ILARIA/0000-0002-8225-2177; Vargas, Jade/0000-0001-6536-775X	U.S. National Institutes of Health (NIH) National Institute on Aging [AG18001]; NIH National Institute of General Medical Sciences Grant [GM077480]; Italian-American Cancer Foundation; NIH [5 T32 HL 7954-18]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018001] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute on Aging; NIH National Institute of General Medical Sciences Grant; Italian-American Cancer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Nathan Roy and Dr. Ed Williamson (Both from the Children's Hospital of Philadelphia) for help with microscopy; Erik Snapp (Albert Einstein College of Medicine, New York, NY, USA), Peter Walter (University of California-San Francisco, San Francisco, CA, USA), John Christianson (Oxford University, Oxford, United Kingdom), and Daniel Hebert (University of Massachusetts-Amherst, Amherst, MA, USA) for providing plasmids; Andrew Hu (Wistar Institute, Philadelphia, PA, USA) and David Ron (University of Cambridge, United Kingdom) for MEFs, and our colleagues Tali Gidalevitz (Drexel University, Philadelphia, PA, USA) and Janis Burkhardt (University of Pennsylvania, Philadelphia, PA, USA) for critical reading of this manuscript. This work was funded by U.S. National Institutes of Health (NIH) National Institute on Aging Grant AG18001 and NIH National Institute of General Medical Sciences Grant GM077480 to Y.A. D.E. was supported by a postdoctoral fellowship from the Italian-American Cancer Foundation. D.R. was supported by NIH training Grant 5 T32 HL 7954-18. The authors declare no conflicts of interest.	Ali MMU, 2011, EMBO J, V30, P894, DOI 10.1038/emboj.2011.18; Amin-Wetzel N, 2017, CELL, V171, P1625, DOI 10.1016/j.cell.2017.10.040; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Aragon T, 2009, NATURE, V457, P736, DOI 10.1038/nature07641; Bakunts A, 2017, ELIFE, V6, DOI 10.7554/eLife.27518; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Bergmann TJ, 2018, J BIOL CHEM, V293, P5600, DOI 10.1074/jbc.RA117.001484; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Blumenthal D, 2016, J CELL SCI, V129, P3342, DOI 10.1242/jcs.187112; BRODBECK RM, 1992, J BIOL CHEM, V267, P294; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Eletto D, 2016, FASEB J, V30, P653, DOI 10.1096/fj.15-275883; Eletto D, 2014, MOL CELL, V53, P562, DOI 10.1016/j.molcel.2014.01.004; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002; Greene CM, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.51; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Hu CCA, 2009, J EXP MED, V206, P2429, DOI 10.1084/jem.20090782; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; Karagoz GE, 2017, ELIFE, V6, DOI 10.7554/eLife.30700; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kimata Y, 2004, J CELL BIOL, V167, P445, DOI 10.1083/jcb.200405153; Kimata Y, 2007, J CELL BIOL, V179, P75, DOI 10.1083/jcb.200704166; Kitai Y, 2013, GENES CELLS, V18, P798, DOI 10.1111/gtc.12074; Kopp MC, 2018, ELIFE, V7, DOI 10.7554/eLife.30257; Korennykh A, 2012, ANNU REV CELL DEV BI, V28, P251, DOI 10.1146/annurev-cellbio-101011-155826; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Lu M, 2014, SCIENCE, V345, P98, DOI 10.1126/science.1254312; Maurel M, 2014, TRENDS BIOCHEM SCI, V39, P245, DOI 10.1016/j.tibs.2014.02.008; Moore K, 2015, MOL BIOL CELL, V26, P2873, DOI 10.1091/mbc.E15-02-0074; NEEFJES JJ, 1990, J CELL BIOL, V111, P1383, DOI 10.1083/jcb.111.4.1383; Oikawa D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051290; Oikawa D, 2009, EXP CELL RES, V315, P2496, DOI 10.1016/j.yexcr.2009.06.009; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Prischi F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4554; Qiu YF, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000514; Rubio C, 2011, J CELL BIOL, V193, P171, DOI 10.1083/jcb.201007077; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Sundaram A, 2018, MOL BIOL CELL, V29, P1376, DOI 10.1091/mbc.E17-10-0594; Sundaram A, 2017, ELIFE, V6, DOI 10.7554/eLife.27187; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; van Anken E, 2014, ELIFE, V3, DOI 10.7554/eLife.05031; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Welihinda AA, 1996, J BIOL CHEM, V271, P18181, DOI 10.1074/jbc.271.30.18181; Wiseman RL, 2010, MOL CELL, V38, P291, DOI 10.1016/j.molcel.2010.04.001; Zhu X, 2014, J BIOL CHEM, V289, P30567, DOI 10.1074/jbc.M114.562868	71	20	20	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9811	9827		10.1096/fj.201801240RR	http://dx.doi.org/10.1096/fj.201801240RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31199681	Green Published			2022-12-28	WOS:000482214200011
J	Murphy, N; Treacy, O; Lynch, K; Morcos, M; Lohan, P; Howard, L; Fahy, G; Griffin, MD; Ryan, AE; Ritter, T				Murphy, Nick; Treacy, Oliver; Lynch, Kevin; Morcos, Maurice; Lohan, Paul; Howard, Linda; Fahy, Gerry; Griffin, Matthew D.; Ryan, Aideen E.; Ritter, Thomas			TNF-alpha/IL-1 beta-licensed mesenchymal stromal cells promote corneal allograft survival via myeloid cell-mediated induction of Foxp3(+) regulatory T cells in the lung	FASEB JOURNAL			English	Article						immunomodulation; transplantation; immune; MSC priming	HIGH-RISK KERATOPLASTY; STEM-CELLS; NITRIC-OXIDE; CYCLOSPORINE-A; MYCOPHENOLATE-MOFETIL; ALVEOLAR MACROPHAGES; PROSTAGLANDIN E-2; IMMUNE-RESPONSES; IFN-GAMMA; TNF-ALPHA	Mesenchymal stromal cells (MSCs) have shown promise as a therapy for immune-mediated disorders, including transplant rejection. Our group previously demonstrated the efficacy of pretransplant, systemic administration of allogeneic but not syngeneic MSCs in a rat cornea transplant model. The aim of this study was to enhance the immunomodulatory capacity of syngeneic MSCs. In vitro, MSCs licensed with TNF-alpha/IL-1 beta (MSCsTNF-alpha/IL-1 beta) suppress syngeneic lymphocyte proliferation via NO production. In vivo, when administered post-transplantation, nonlicensed syngeneic MSCs improved graft survival from 0 to 50% and MSCsTNF-alpha/IL-1 beta, in an NO-dependent manner, improved survival to 70%. Improved survival was associated with increased CD4(+)CD25(+)forkhead box P3(+) regulatory T (T-reg) cells and decreased proinflammatory cytokine expression in the draining lymph node. MSCsTNF-alpha/IL-1 beta demonstrated a more potent immunomodulatory capacity compared with nonlicensed MSCs, promoting an immune-regulatory CD11b(+)B220(+) monocyte/macrophage population and significantly expanding T-reg cells in the lungs and spleen. Ex vivo, we observed that lung-derived myeloid cells act as intermediaries of MSC immunomodulatory function. MSC-conditioned myeloid cells suppressed stimulated lymphocyte proliferation and promoted expansion of T-reg cells from naive lymphocytes. This work illustrates how syngeneic MSC therapy can be enhanced by licensing and optimization of timing strategies and further highlights the important role of myeloid cells in mediating MSC immunomodulatory capacity.-Murphy, N., Treacy, O., Lynch, K., Morcos, M., Lohan, P., Howard, L., Fahy, G., Griffin, M. D., Ryan, A. E., Ritter, T. TNF-alpha/IL-1 beta-licensed mesenchymal stromal cells promote corneal allograft survival via myeloid cell-mediated induction of Foxp3(+) regulatory T cells in the lung.	[Murphy, Nick; Treacy, Oliver; Lynch, Kevin; Morcos, Maurice; Lohan, Paul; Howard, Linda; Griffin, Matthew D.; Ryan, Aideen E.; Ritter, Thomas] Natl Univ Ireland Galway, Regenerat Med Inst REMEDI, Galway, Ireland; [Treacy, Oliver; Lynch, Kevin; Ryan, Aideen E.] Natl Univ Ireland Galway, Discipline Pharmacol & Therapeut, Sch Med, Coll Med Nursing & Hlth Sci, Galway, Ireland; [Fahy, Gerry] Natl Univ Ireland Galway, Dept Ophthalmol, Univ Hosp Galway, Galway, Ireland; [Griffin, Matthew D.; Ryan, Aideen E.; Ritter, Thomas] Natl Univ Ireland Galway, Coll Med Nursing & Hlth Sci, Sch Med, Ctr Res Med Devices CURAM, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Ritter, T (corresponding author), Natl Univ Ireland Galway, Regenerat Med Inst, Sch Med, Coll Med Nursing & Hlth Sci,Biomed Sci, Galway, Ireland.	tho-mas.ritter@nuigalway.ie	Ryan, Aideen/H-3909-2019; Treacy, Oliver/AAQ-3679-2020	Ryan, Aideen/0000-0002-5831-6783; Griffin, Matthew/0000-0002-8701-8056; Ritter, Thomas/0000-0001-7709-8489; Treacy, Oliver/0000-0003-3898-9806	National University of Ireland-Galway; Irish Government's Programme for Research in Third Level Institutions, Cycle 5; European Regional Development Fund; Irish Government's Programme for Research in Third Level Institutions, Cycle 4, National Development Plan 2007-2013; Irish Government's Programme for Research in Third Level Institutions, Cycle 5, National Development Plan 2007-2013; Science Foundation Ireland [12/IA/1624, 15/SIRG/3456]; Health Research Board of Ireland [HRA_POR/2013/341]; European Union European Commission under the Seventh Framework (EU FP7) Collaborative Health Project VISICORT (Adverse Immune Responses and their Prevention in Corneal Transplantation) [602470]	National University of Ireland-Galway; Irish Government's Programme for Research in Third Level Institutions, Cycle 5; European Regional Development Fund(European Commission); Irish Government's Programme for Research in Third Level Institutions, Cycle 4, National Development Plan 2007-2013; Irish Government's Programme for Research in Third Level Institutions, Cycle 5, National Development Plan 2007-2013; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board of Ireland; European Union European Commission under the Seventh Framework (EU FP7) Collaborative Health Project VISICORT (Adverse Immune Responses and their Prevention in Corneal Transplantation)	The authors acknowledge the advice, assistance, and technical expertise of Georgina Shaw (National University of Ireland Galway, Galway, Ireland). All flow cytometry experiments were performed in the National University of Ireland Galway Flow Cytometry Core Facility, which is supported by funds from the National University of Ireland-Galway, Science Foundation Ireland, the Irish Government's Programme for Research in Third Level Institutions, Cycle 5, and the European Regional Development Fund. The authors acknowledge the facilities as well as the scientific and technical assistance of the National Centre for Biomedical Engineering Science Genomics Facility at the National University of Ireland-Galway, a facility that is funded by the National University of Ireland-Galway and the Irish Government's Programme for Research in Third Level Institutions, Cycles 4 and 5, National Development Plan 2007-2013. This study was supported by a Science Foundation Ireland Investigator Award (Grant 12/IA/1624 to T.R.). This work was also supported by grants from the Health Research Board of Ireland (Grant HRA_POR/2013/341 to M.D.G. and T.R.), the Science Foundation Ireland Starting Investigator grant (15/SIRG/3456 to A.E.R.), the European Union European Commission under the Seventh Framework (EU FP7) Collaborative Health Project VISICORT (Adverse Immune Responses and their Prevention in Corneal Transplantation) (Grant 602470 to M.D.G., and T.R.), and the European Regional Development Fund. The authors declare no conflicts of interest.	Agrawal H, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt532; AYLIFFE W, 1992, BRIT J OPHTHALMOL, V76, P602, DOI 10.1136/bjo.76.10.602; Badillo AT, 2007, BIOL BLOOD MARROW TR, V13, P412, DOI 10.1016/j.bbmt.2006.12.447; Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; Bingisser RM, 1998, J IMMUNOL, V160, P5729; Birnbaum F, 2005, TRANSPLANTATION, V79, P964, DOI 10.1097/01.TP.0000158022.62059.F2; Birnbaum F, 2009, EYE, V23, P2063, DOI 10.1038/eye.2008.402; Braza F, 2016, STEM CELLS, V34, P1836, DOI 10.1002/stem.2344; Casiraghi F, 2012, AM J TRANSPLANT, V12, P2373, DOI 10.1111/j.1600-6143.2012.04115.x; Chen H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08718; Cho PS, 2008, BLOOD, V111, P430, DOI 10.1182/blood-2007-03-078774; de Witte SFH, 2018, STEM CELLS, V36, P602, DOI 10.1002/stem.2779; Durnian JM, 2007, CLIN OPHTHALMOL, V1, P421; Eggenhofer E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00297; Eggenhofer E, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-12; English K, 2009, CLIN EXP IMMUNOL, V156, P149, DOI 10.1111/j.1365-2249.2009.03874.x; English K, 2007, IMMUNOL LETT, V110, P91, DOI 10.1016/j.imlet.2007.04.001; Fan LX, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050650; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Galleu A, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam7828; Ge W, 2010, TRANSPLANTATION, V90, P1312, DOI 10.1097/TP.0b013e3181fed001; Griffin MD, 2013, IMMUNOL CELL BIOL, V91, P40, DOI 10.1038/icb.2012.67; Griffin MD, 2010, HUM GENE THER, V21, P1641, DOI 10.1089/hum.2010.156; Habib A, 1997, J IMMUNOL, V158, P3845; HE YG, 1991, INVEST OPHTH VIS SCI, V32, P2723; Hegde S, 2000, INVEST OPHTH VIS SCI, V41, P3341; Hegde S, 2005, TRANSPLANTATION, V79, P23, DOI 10.1097/01.TP.0000147196.79546.69; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Ko JH, 2016, P NATL ACAD SCI USA, V113, P158, DOI 10.1073/pnas.1522905113; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Leibacher J, 2017, CYTOTHERAPY, V19, P61, DOI 10.1016/j.jcyt.2016.09.010; Lohan P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02666; Luz-Crawford P, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt216; MAGUIRE MG, 1994, OPHTHALMOLOGY, V101, P1536; Melief SM, 2013, STEM CELLS, V31, P1980, DOI 10.1002/stem.1432; Murphy N, 2016, CURR OPIN ORGAN TRAN, V21, P559, DOI 10.1097/MOT.0000000000000360; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Niederkorn JY, 2007, CURR EYE RES, V32, P1005, DOI 10.1080/02713680701767884; Niederkorn JY, 2013, INT REV IMMUNOL, V32, P57, DOI 10.3109/08830185.2012.737877; Niederkorn JY, 2006, TRANSPLANTATION, V81, P1171, DOI 10.1097/01.tp.0000203140.70742.cb; Oh JY, 2012, MOL THER, V20, P2143, DOI 10.1038/mt.2012.165; Polchert D, 2008, EUR J IMMUNOL, V38, P1745, DOI 10.1002/eji.200738129; Prevosto C, 2007, HAEMATOLOGICA, V92, P881, DOI 10.3324/haematol.11240; Rafei M, 2009, MOL THER, V17, P1799, DOI 10.1038/mt.2009.157; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; SALVEMINI D, 1993, P NATL ACAD SCI USA, V90, P7240, DOI 10.1073/pnas.90.15.7240; Sangwan VS, 2005, CLIN EXP OPHTHALMOL, V33, P623, DOI 10.1111/j.1442-9071.2005.01107.x; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Sato Y, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2014.995541; Schu S, 2012, J CELL MOL MED, V16, P2094, DOI 10.1111/j.1582-4934.2011.01509.x; Sharma S, 2005, CANCER RES, V65, P5211, DOI 10.1158/0008-5472.CAN-05-0141; Shinomiya S, 2001, BIOCHEM PHARMACOL, V61, P1153, DOI 10.1016/S0006-2952(01)00586-X; Sinha P, 2011, BLOOD, V117, P5381, DOI 10.1182/blood-2010-11-321752; Sommerer C, 2011, THER DRUG MONIT, V33, P694, DOI 10.1097/FTD.0b013e318237e33c; Strickland D, 1996, IMMUNOLOGY, V87, P250, DOI 10.1046/j.1365-2567.1996.459542.x; STRICKLAND DH, 1994, EUR RESPIR J, V7, P2124, DOI 10.1183/09031936.94.07122124; Tian WJ, 2015, LUNG, V193, P85, DOI 10.1007/s00408-014-9654-x; Treacy O, 2014, AM J TRANSPLANT, V14, P2023, DOI 10.1111/ajt.12828; Vasandan AB, 2016, SCI REP-UK, V6, DOI 10.1038/srep38308; Waldock A, 2000, BRIT J OPHTHALMOL, V84, P813, DOI 10.1136/bjo.84.8.813; Xia XF, 2012, LIVER TRANSPLANT, V18, P696, DOI 10.1002/lt.23414; Yamada J, 1999, INVEST OPHTH VIS SCI, V40, P2614; Yamagami S, 2001, INVEST OPHTH VIS SCI, V42, P1293; Zangi L, 2009, STEM CELLS, V27, P2865, DOI 10.1002/stem.217; Zhou HP, 2006, TRANSPL P, V38, P3046, DOI 10.1016/j.transproceed.2006.10.002; Zinocker S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00062; Zoglmeier C, 2011, CLIN CANCER RES, V17, P1765, DOI 10.1158/1078-0432.CCR-10-2672	69	24	25	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9404	9421		10.1096/fj.201900047R	http://dx.doi.org/10.1096/fj.201900047R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31108041	Green Submitted, Bronze			2022-12-28	WOS:000478832900055
J	Palaniappan, B; Arthur, S; Sundaram, VL; Butts, M; Sundaram, S; Mani, K; Singh, S; Nepal, N; Sundaram, U				Palaniappan, Balasubramanian; Arthur, Subha; Sundaram, Vijaya Lakshmi; Butts, Molly; Sundaram, Shanmuga; Mani, Kathiresh; Singh, Soudamani; Nepal, Niraj; Sundaram, Uma			Inhibition of intestinal villus cell Na/K-ATPase mediates altered glucose and NaCl absorption in obesity-associated diabetes and hypertension	FASEB JOURNAL			English	Article						SGLT1; DRA; PAT1; NHE3; BBM	CONSTITUTIVE NITRIC-OXIDE; ZUCKER-FATTY RAT; CHRONIC INFLAMMATION; NA+; COTRANSPORT; TRANSPORT; EXCHANGE; MOUSE; MICE; ACTIVATION	During obesity, diabetes and hypertension inevitably coexist and cause innumerable health disparities. In the obesity, diabetes, and hypertension triad (ODHT), deregulation of glucose and NaCl homeostasis, respectively, causes diabetes and hypertension. In the mammalian intestine, glucose is primarily absorbed by Na-glucose cotransport 1 (SGLT1) and coupled NaCl by the dual operation of Na-H exchange 3 (NHE3) and Cl-HCO3 [down-regulated in adenoma (DRA) or putative anion transporter 1 (PAT1)] exchange in the brush border membrane (BBM) of villus cells. The basolateral membrane (BLM) Na/K-ATPase provides the favorable transcellular Na gradient for BBM SGLT1 and NHE3. How these multiple, distinct transport processes may be affected in ODHT is unclear. Here, we show the novel and broad regulation by Na/K-ATPase of glucose and NaCl absorption in ODHT in multiple species (mice, rats, and humans). In vivo, during obesity inhibition of villus-cell BLM, Na/K-ATPase led to compensatory stimulation of BBM SGLT1 and DRA or PAT1, whereas NHE3 was unaffected. Supporting this new cellular adaptive mechanism, direct silencing of BLM Na/K-ATPase in intestinal epithelial cells resulted in selective stimulation of BBM SGLT1 and DRA or PAT1 but not NHE3. These changes will lead to an increase in glucose absorption, maintenance of traditional coupled NaCl absorption, and a de novo increase in NaCl absorption from the novel coupling of stimulated SGLT1 with DRA or PAT1. Thus, these novel observations provide the pathophysiologic basis for the deregulation of glucose and NaCl homeostasis of diabetes and hypertension, respectively, during obesity. These observations may lead to more efficacious treatment for obesity-associated diabetes and hypertension.-Palaniappan, B., Arthur, S., Sundaram, V. L., Butts, M., Sundaram, S., Mani, K., Singh, S., Nepal, N., Sundaram, U. Inhibition of intestinal villus cell Na/K-ATPase mediates altered glucose and NaCl absorption in obesity-associated diabetes and hypertension.	[Palaniappan, Balasubramanian; Arthur, Subha; Sundaram, Vijaya Lakshmi; Butts, Molly; Sundaram, Shanmuga; Mani, Kathiresh; Singh, Soudamani; Nepal, Niraj; Sundaram, Uma] Marshall Univ, Dept Clin & Translat Sci, Joan C Edwards Sch Med, 1600 Med Ctr Dr, Huntington, WV 25701 USA	Marshall University	Sundaram, U (corresponding author), Marshall Univ, Dept Clin & Translat Sci, Joan C Edwards Sch Med, 1600 Med Ctr Dr, Huntington, WV 25701 USA.	sundaramu@marshall.edu	Singh, Soudamani/R-6167-2016; Sundaram MD, Uma/GLU-4579-2022	Singh, Soudamani/0000-0001-6689-9942; Nepal, Niraj/0000-0003-1525-3214; Sundaram MD, Uma/0000-0002-9322-6740	American Gastroenterological Association's Eli and Edythe Broad Student Research Fellowship; U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases Grants [DK-067420, DK-108054]; NIH National Institute of General Medical Sciences Grant [P20GM121299-01A1]; Veteran's Administration Merit Review Grant [BX003443-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK108054, R01DK067420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM121299] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003443] Funding Source: NIH RePORTER	American Gastroenterological Association's Eli and Edythe Broad Student Research Fellowship; U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases Grants; NIH National Institute of General Medical Sciences Grant; Veteran's Administration Merit Review Grant(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Dr. Usha Murughiyan (Joan C. Edwards School of Medicine, Marshall University, Huntington, WV, USA) for editorial assistance in the preparation of this manuscript. This work was supported by the American Gastroenterological Association's Eli and Edythe Broad Student Research Fellowship to V.L.S., the U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases Grants DK-067420 and DK-108054, NIH National Institute of General Medical Sciences Grant P20GM121299-01A1, and the Veteran's Administration Merit Review Grant BX003443-01 (to U.S.) B.P. and S.A. share equal first author contributions. The authors declare no conflicts of interest.	Alrefai WA, 2004, AM J PHYSIOL-GASTR L, V286, pG197, DOI 10.1152/ajpgi.00144.2003; Amin MR, 2007, AM J PHYSIOL-GASTR L, V293, pG374, DOI 10.1152/ajpgi.00128.2007; [Anonymous], 2016, HIGH BLOOD PRESS FAC; Bickel CA, 2002, KIDNEY INT, V61, P2099, DOI 10.1046/j.1523-1755.2002.00353.x; BRAY GA, 1977, FED PROC, V36, P148; Centers for Disease Control and Prevention (CDC), 2017, NAT DIAB STAT REP 20; Coon S, 2003, AM J PHYSIOL-GASTR L, V285, pG1084, DOI 10.1152/ajpgi.00013.2003; Coon S, 2008, AM J PHYSIOL-GASTR L, V294, pG1369, DOI 10.1152/ajpgi.00063.2008; Coon S, 2011, AM J PHYSIOL-CELL PH, V300, pC496, DOI 10.1152/ajpcell.00292.2010; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Donowitz M, 2009, J EXP BIOL, V212, P1638, DOI 10.1242/jeb.028605; FORBUSH B, 1983, ANAL BIOCHEM, V128, P159, DOI 10.1016/0003-2697(83)90356-1; Gorboulev V, 2012, DIABETES, V61, P187, DOI 10.2337/db11-1029; He PJ, 2015, J CLIN INVEST, V125, P3519, DOI 10.1172/JCI79552; Hodges K, 2006, AM J PHYSIOL-GASTR L, V291, pG959, DOI 10.1152/ajpgi.00274.2005; Joost HG, 2014, MAMM GENOME, V25, P401, DOI 10.1007/s00335-014-9514-2; Kato A, 2011, ANNU REV PHYSIOL, V73, P261, DOI 10.1146/annurev-physiol-012110-142244; Kiela PR, 2006, J PHYSIOL PHARMACOL, V57, P51; Kim Jung Han, 2012, Methods Mol Biol, V933, P75, DOI 10.1007/978-1-62703-068-7_6; Kumar KM, 2017, REPROD TOXICOL, V69, P84, DOI 10.1016/j.reprotox.2017.02.007; KURTZ TW, 1989, HYPERTENSION, V13, P896, DOI 10.1161/01.HYP.13.6.896; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lenzen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040657; Leung L, 2014, DIABETES METAB SYNDR, V7, P321, DOI 10.2147/DMSO.S63714; Malakooti J, 2011, BIOCHEM J, V435, P313, DOI 10.1042/BJ20102062; Manoharan P, 2015, AM J PHYSIOL-CELL PH, V308, pC650, DOI 10.1152/ajpcell.00355.2014; Manoharan P, 2013, BBA-BIOMEMBRANES, V1828, P179, DOI 10.1016/j.bbamem.2012.08.003; Manokas T, 2000, AM J PHYSIOL-GASTR L, V278, pG585, DOI 10.1152/ajpgi.2000.278.4.G585; Mao X, 2014, J INBORN ERRORS META, V2, P1; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Palaniappan B, 2018, NITRIC OXIDE-BIOL CH, V79, P8, DOI 10.1016/j.niox.2018.04.007; Parkman JK, 2016, EXP CLIN ENDOCR DIAB, V124, P622, DOI 10.1055/s-0042-109605; Poulsen SB, 2015, CURR OPIN NEPHROL HY, V24, P463, DOI 10.1097/MNH.0000000000000152; Rhee SD, 2011, EXP CLIN ENDOCR DIAB, V119, P243, DOI 10.1055/s-0030-1267202; ROBINSON JD, 1979, BIOCHIM BIOPHYS ACTA, V549, P145, DOI 10.1016/0304-4173(79)90013-2; Sanchez-Aguayo I, 2001, SCAND J GASTROENTERO, V36, P494, DOI 10.1080/003655201750153296; Saydah S, 2014, OBESITY, V22, P1888, DOI 10.1002/oby.20761; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Schweinfest CW, 2006, J BIOL CHEM, V281, P37962, DOI 10.1074/jbc.M607527200; Sundaram U, 1998, AM J PHYSIOL-GASTR L, V275, pG483, DOI 10.1152/ajpgi.1998.275.3.G483; Sundaram U, 1997, AM J PHYSIOL-GASTR L, V272, pG732, DOI 10.1152/ajpgi.1997.272.4.G732; SUNDARAM U, 1991, AM J PHYSIOL, V260, pG440, DOI 10.1152/ajpgi.1991.260.3.G440; Sundaram U, 1999, AM J PHYSIOL-GASTR L, V276, pG211, DOI 10.1152/ajpgi.1999.276.1.G211; Sundaram U, 1997, AM J PHYSIOL-GASTR L, V273, pG913, DOI 10.1152/ajpgi.1997.273.4.G913; Sung YY, 2005, BIOCHEM BIOPH RES CO, V338, P1779, DOI 10.1016/j.bbrc.2005.10.160; Turner JR, 2001, AM J PHYSIOL-CELL PH, V281, pC1533, DOI 10.1152/ajpcell.2001.281.5.C1533; Wang ZH, 2005, AM J PHYSIOL-CELL PH, V288, pC957, DOI 10.1152/ajpcell.00505.2004; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Wright EM, 2006, PHYSIOLOGY OF THE GASTROINTESTINAL TRACT, VOLS 1 AND 2, 4TH EDITION, P1653; Yun CC, 2002, J BIOL CHEM, V277, P7676, DOI 10.1074/jbc.M107768200; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004	51	6	6	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9323	9333		10.1096/fj.201802673R	http://dx.doi.org/10.1096/fj.201802673R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31107610	Green Published			2022-12-28	WOS:000478832900049
J	Shiraki, M; Xu, XH; Iovanna, JL; Kukita, T; Hirata, H; Kamohara, A; Kubota, Y; Miyamoto, H; Mawatari, M; Kukita, A				Shiraki, Makoto; Xu, Xianghe; Iovanna, Juan L.; Kukita, Toshio; Hirata, Hirohito; Kamohara, Asana; Kubota, Yasushi; Miyamoto, Hiroshi; Mawatari, Masaaki; Kukita, Akiko			Deficiency of stress-associated gene Nupr1 increases bone volume by attenuating differentiation of osteoclasts and enhancing differentiation of osteoblasts	FASEB JOURNAL			English	Article						bone formation; osteocyte; sclerostin; autophagy	AUTOPHAGIC CELL-DEATH; NUCLEAR-PROTEIN; EXPRESSION; SCLEROSTIN; P8; INDUCTION; MINERALIZATION; SUPPRESSION; FIBROBLASTS; HOMEOSTASIS	Nuclear protein 1 (NUPR1) is a multifunctional stress-induced protein involved in regulating tumorigenesis, apoptosis, and autophagy. Bone homeostasis is maintained by bone-resorbing osteoclasts and bone-forming osteoblasts and osteocytes. We aimed to determine the role of NUPR1 in bone metabolism. Using microcomputed tomography, we found that mice lacking Nupr1 exhibited increased bone volume. Histologic analysis showed that Nupr1 deficiency decreased osteoclast numbers but increased osteoblast numbers and osteoid formation. In vitro culture of bone marrow macrophages showed that receptor activator of NF-kappa B ligand-induced osteoclastogenesis was down-regulated in Nupr1-deficient mice. In contrast, primary osteoblasts from Nupr1-deficient mice revealed that proliferation of osteoblasts and expression of bone matrix proteins were markedly enhanced. In addition, expression of autophagy-related genes, formation of autophagosomes, and cell survival were up-regulated in Nupr1-deficient osteoblasts. In contract, deletion of Nupr1 reduced the formation of osteocyte cellular projection, which is an indicator of mature osteocytes. Importantly, we found that the expression of sclerostin (Sost), an inhibitor of bone formation, was down-regulated in the osteoblasts and osteocytes of Nupr1-deficient mice. Conversely, Nupr1 overexpression enhanced Sost expression in primary osteoblasts. Collectively, these results indicate that Nupr1 deficiency increases bone volume by attenuating production of Sost and osteoclastogenesis and enhancing differentiation of osteoblasts.-Shiraki, M., Xu, X., Iovanna, J. L., Kukita, T., Hirata, H., Kamohara, A., Kubota, Y., Miyamoto, H., Mawatari, M., Kukita, A. Deficiency of stress-associated gene Nupr1 increases bone volume by attenuating differentiation of osteoclasts and enhancing differentiation of osteoblasts.	[Shiraki, Makoto; Xu, Xianghe; Hirata, Hirohito; Kamohara, Asana; Miyamoto, Hiroshi; Kukita, Akiko] Saga Univ, Fac Med, Dept Pathol & Microbiol, 5-1-1 Nabeshima, Saga 8498501, Japan; [Shiraki, Makoto; Hirata, Hirohito; Mawatari, Masaaki] Saga Univ, Fac Med, Dept Orthoped Surg, Saga, Japan; [Kubota, Yasushi] Saga Univ, Fac Med, Dept Internal Med, Div Hematol Resp Med & Oncol, Saga, Japan; [Xu, Xianghe; Kukita, Toshio] Kyushu Univ, Dept Mol Cell Biol & Oral Anat, Fukuoka, Fukuoka, Japan; [Iovanna, Juan L.] Aix Marseille Univ, CNRS, UMR 7258, Ctr Rech Cancerol Marseille,INSERM,U1068, Marseille, France; [Iovanna, Juan L.] Inst Paoli Calmettes, Parc Sci & Technol Luminy, Marseille, France	Saga University; Saga University; Saga University; Kyushu University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Kukita, A (corresponding author), Saga Univ, Fac Med, Dept Pathol & Microbiol, 5-1-1 Nabeshima, Saga 8498501, Japan.	kukita@cc.saga-u.ac.jp			Japan Society for the Promotion of Science (KAKENHI) [16K10908, P15K11046]; Eli Lilly Japan K.K	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Eli Lilly Japan K.K(Eli Lilly)	The authors thank Dr. Akemi Ito (Ito Bone Science Institute, Niigata, Japan) for performing the histomorphometric analysis and Editage for English language editing. This work was supported by the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (KAKENHI; 16K10908 to M.M. and P15K11046 to A.K.) and Eli Lilly Japan K.K. The authors declare no conflicts of interest.	Barbosa-Sampaio HC, 2013, DIABETOLOGIA, V56, P2477, DOI 10.1007/s00125-013-3006-x; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Bartell SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4773; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Cano CE, 2011, J CELL PHYSIOL, V226, P1439, DOI 10.1002/jcp.22324; Capulli M, 2014, ARCH BIOCHEM BIOPHYS, V561, P3, DOI 10.1016/j.abb.2014.05.003; Carracedo A, 2006, CANCER CELL, V9, P301, DOI 10.1016/j.ccr.2006.03.005; Chen JR, 2010, J BONE MINER RES, V25, P2399, DOI 10.1002/jbmr.137; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; DeSelm CJ, 2011, DEV CELL, V21, P966, DOI 10.1016/j.devcel.2011.08.016; Dole NS, 2017, CELL REP, V21, P2585, DOI 10.1016/j.celrep.2017.10.115; Emma MR, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.175; Fujiwara M, 2016, BONE, V85, P91, DOI 10.1016/j.bone.2016.01.024; Funakubo N, 2018, J CELL PHYSIOL, V233, P3105, DOI 10.1002/jcp.26147; Goruppi S, 2004, J BIOL CHEM, V279, P20950, DOI 10.1074/jbc.M312401200; Grasso D, 2015, SCI REP-UK, V5, DOI 10.1038/srep17549; Guo SJ, 2015, AUTOPHAGY, V11, P560, DOI 10.1080/15548627.2015.1017181; Hamidi T, 2012, J CLIN INVEST, V122, P2092, DOI 10.1172/JCI60144; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; King JS, 2011, AUTOPHAGY, V7, P1490, DOI 10.4161/auto.7.12.17924; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Kong DK, 2010, MOL BIOL CELL, V21, P1335, DOI 10.1091/mbc.E09-09-0818; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kukita A, 2013, FUTURE ONCOL, V9, P1609, DOI [10.2217/fon.13.115, 10.2217/FON.13.115]; Kukita A, 2011, ARTHRITIS RHEUM-US, V63, P2744, DOI 10.1002/art.30455; Li HX, 2018, AUTOPHAGY, V14, P1726, DOI 10.1080/15548627.2018.1483807; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Liu F, 2013, J BONE MINER RES, V28, P2414, DOI 10.1002/jbmr.1971; Liu Y, 2015, CELL DEATH DIFFER, V22, P367, DOI 10.1038/cdd.2014.143; Lu YB, 2011, J BONE MINER RES, V26, P331, DOI 10.1002/jbmr.226; Malicet Cedric, 2003, Mol Cancer, V2, P37, DOI 10.1186/1476-4598-2-37; Mallo GV, 1997, J BIOL CHEM, V272, P32360, DOI 10.1074/jbc.272.51.32360; McColm J, 2014, J BONE MINER RES, V29, P935, DOI 10.1002/jbmr.2092; Moriishi T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027487; Nakamura M, 2003, ENDOCRINOLOGY, V144, P5441, DOI 10.1210/en.2003-0717; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nollet M, 2014, AUTOPHAGY, V10, P1965, DOI 10.4161/auto.36182; Onal M, 2013, J BIOL CHEM, V288, P17432, DOI 10.1074/jbc.M112.444190; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Piemontese M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24262; Recker RR, 2015, J BONE MINER RES, V30, P216, DOI 10.1002/jbmr.2351; Ree AH, 2000, CLIN CANCER RES, V6, P1778; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Russell RC, 2014, CELL RES, V24, P42, DOI 10.1038/cr.2013.166; Sahani MH, 2014, AUTOPHAGY, V10, P431, DOI 10.4161/auto.27344; Sebastian A, 2017, BONE, V96, P76, DOI 10.1016/j.bone.2016.10.009; Sevetson B, 2004, J BIOL CHEM, V279, P13849, DOI 10.1074/jbc.M306249200; Shirakawa K, 2006, MOL CELL BIOL, V26, P6105, DOI 10.1128/MCB.02429-05; Sims Natalie A, 2014, Bonekey Rep, V3, P481, DOI 10.1038/bonekey.2013.215; Stegen S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04679-7; Su SB, 2001, CLIN CANCER RES, V7, P309; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Vasseur S, 1999, EUR J BIOCHEM, V259, P670, DOI 10.1046/j.1432-1327.1999.00092.x; Vasseur S, 2002, ONCOGENE, V21, P1685, DOI 10.1038/sj.onc.1205222; Watanabe T, 2004, J ENDOCRINOL, V180, P193, DOI 10.1677/joe.0.1800193; Weivoda MM, 2017, BONE, V96, P45, DOI 10.1016/j.bone.2016.11.024; Wijenayaka AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025900; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yajima A, 2010, J BONE MINER RES, V25, P2374, DOI 10.1002/jbmr.126; Yang WC, 2009, BONE, V44, P32, DOI 10.1016/j.bone.2008.08.133; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhang KQ, 2006, MOL CELL BIOL, V26, P4539, DOI 10.1128/MCB.02120-05	63	10	10	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					8836	8852		10.1096/fj.201802322RR	http://dx.doi.org/10.1096/fj.201802322RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31067083	Bronze			2022-12-28	WOS:000478832900012
J	Siu, KL; Yuen, KS; Castano-Rodriguez, C; Ye, ZW; Yeung, ML; Fung, SY; Yuan, SF; Chan, CP; Yuen, KY; Enjuanes, L; Jin, DY				Siu, Kam-Leung; Yuen, Kit-San; Castano-Rodriguez, Carlos; Ye, Zi-Wei; Yeung, Man-Lung; Fung, Sin-Yee; Yuan, Shuofeng; Chan, Chi-Ping; Yuen, Kwok-Yung; Enjuanes, Luis; Jin, Dong-Yan			Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC	FASEB JOURNAL			English	Article						SARS coronavirus	KAPPA-B ACTIVATION; DEUBIQUITINATING ENZYME; ION-CHANNEL; VIRUS; FORMS; SUPPRESSION; INTERACTS; CALCIUM; CYLD	Severe acute respiratory syndrome coronavirus (SARS-CoV) is capable of inducing a storm of proinflammatory cytokines. In this study, we show that the SARS-CoV open reading frame 3a (ORF3a) accessory protein activates the NLRP3 inflammasome by promoting TNF receptor-associated factor 3 (TRAF3)-mediated ubiquitination of apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC). SARS-CoV and its ORF3a protein were found to be potent activators of pro-IL-1 beta gene transcription and protein maturation, the 2 signals required for activation of the NLRP3 inflammasome. ORF3a induced pro-IL-1 beta transcription through activation of NF-kappa B, which was mediated by TRAF3-dependent ubiquitination and processing of p105. ORF3a-induced elevation of IL-1 beta secretion was independent of its ion channel activity or absent in melanoma 2 but required NLRP3, ASC, and TRAF3. ORF3a interacted with TRAF3 and ASC, colocalized with them in discrete punctate structures in the cytoplasm, and facilitated ASC speck formation. TRAF3-dependent K63-linked ubiquitination of ASC was more pronounced in SARS-CoV-infected cells or when ORF3a was expressed. Taken together, our findings reveal a new mechanism by which SARS-CoV ORF3a protein activates NF-kappa B and the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of p105 and ASC.-Siu, K.-L., Yuen, K.-S., Castano-Rodriguez, C., Ye, Z.-W., Yeung, M.-L., Fung, S.-Y., Yuan, S., Chan, C.-P., Yuen, K.-Y., Enjuanes, L., Jin, D.-Y. Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC.	[Siu, Kam-Leung; Yuen, Kit-San; Fung, Sin-Yee; Chan, Chi-Ping; Jin, Dong-Yan] Univ Hong Kong, Sch Biomed Sci, Pokfulam, 3-F Lab Block,Fac Med Bldg,21 Sassoon Rd, Hong Kong 070, Peoples R China; [Ye, Zi-Wei; Yeung, Man-Lung; Yuan, Shuofeng; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China; [Castano-Rodriguez, Carlos; Enjuanes, Luis] CSIC, CNB, Dept Mol & Cell Biol, Madrid 28049, Spain	University of Hong Kong; University of Hong Kong; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Jin, DY (corresponding author), Univ Hong Kong, Sch Biomed Sci, Pokfulam, 3-F Lab Block,Fac Med Bldg,21 Sassoon Rd, Hong Kong 070, Peoples R China.; Enjuanes, L (corresponding author), CSIC, CNB, Dept Mol & Cell Biol, Madrid 28049, Spain.	l.enjuanes@cnb.csic.es; dyjin@hku.hk	Chan, Chi Ping/AAB-9463-2020; Zi, Ye/GWM-3932-2022; Enjuanes, Luis/F-7845-2016; Jin, Dong-Yan/C-4287-2009	Jin, Dong-Yan/0000-0002-2778-3530; Yuen, Kwok-yung/0000-0002-2083-1552; Yuen, Kit San/0000-0002-1394-7709; Chan, Chi Ping/0000-0001-6876-0864; Yuan, Shuofeng/0000-0001-7996-1119	Hong Kong Health and Medical Research Fund [13121032, 14130822, HKM-15-M01]; Hong Kong Research Grants Council [T11-707/15-R, C7011-15R, 17124415]; Government of Spain [BIO2013-42869-R]; U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases [2P01AI060699-06A1]; European Commission [115760]; Fundacion La Caixa; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI060699] Funding Source: NIH RePORTER	Hong Kong Health and Medical Research Fund; Hong Kong Research Grants Council(Hong Kong Research Grants Council); Government of Spain(Spanish Government); U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases; European Commission(European CommissionEuropean Commission Joint Research Centre); Fundacion La Caixa(La Caixa Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Lilong Jia (Department of Microbiology, The University of Hong Kong) for assistance with the infection study. This work was supported by the Hong Kong Health and Medical Research Fund (13121032, 14130822, and HKM-15-M01), Hong Kong Research Grants Council (T11-707/15-R, C7011-15R, and 17124415), Government of Spain (BIO2013-42869-R), U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (2P01AI060699-06A1), and European Commission (Innovative Medicines Initiative Grant Agreement 115760). C.C.-R. received a fellowship from Fundacion La Caixa. K.-L.S., K.-S.Y., and C.C.-R. are co-first authors. The authors declare no conflicts of interest.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Almazan F, 2006, J VIROL, V80, P10900, DOI 10.1128/JVI.00385-06; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Castano-Rodriguez C, 2018, MBIO, V9, DOI 10.1128/mBio.02325-17; Chan CM, 2009, INT J BIOCHEM CELL B, V41, P2232, DOI 10.1016/j.biocel.2009.04.019; Chan CP, 2018, FASEB J, V32, P4380, DOI 10.1096/fj.201701361R; Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14; Chaudhary V, 2015, J GEN VIROL, V96, P3204, DOI 10.1099/jgv.0.000280; Chen CC, 2011, BBA-BIOMEMBRANES, V1808, P572, DOI 10.1016/j.bbamem.2010.08.004; Chen IY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00050; Cheng Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23938; Chiu HW, 2016, J MOL MED, V94, P809, DOI 10.1007/s00109-016-1389-0; De Lang A, 2007, PLOS PATHOG, V3, P1129, DOI 10.1371/journal.ppat.0030112; De Valck D, 1999, ONCOGENE, V18, P4182, DOI 10.1038/sj.onc.1202787; Fett C, 2013, J VIROL, V87, P6551, DOI 10.1128/JVI.00087-13; Freundt EC, 2010, J VIROL, V84, P1097, DOI 10.1128/JVI.01662-09; Gazdar AF, 2010, JNCI-J NATL CANCER I, V102, P1310, DOI 10.1093/jnci/djq279; Gram AM, 2012, J GEN VIROL, V93, P2063, DOI 10.1099/vir.0.042978-0; Guan K, 2015, J IMMUNOL, V194, P4880, DOI 10.4049/jimmunol.1402851; Guo HC, 2015, VIRUSES-BASEL, V7, P3380, DOI 10.3390/v7072777; Haneklaus M, 2015, IMMUNOL REV, V265, P53, DOI 10.1111/imr.12285; Heyninck K, 1999, FEBS LETT, V442, P147, DOI 10.1016/S0014-5793(98)01645-7; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ito M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002857; Kaminski JJ, 2013, J IMMUNOL, V191, P3876, DOI 10.4049/jimmunol.1300530; Kanzawa N, 2006, FEBS LETT, V580, P6807, DOI 10.1016/j.febslet.2006.11.046; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kravtsova-Ivantsiv Y, 2015, CELL, V161, P333, DOI 10.1016/j.cell.2015.03.001; Kumar M, 2013, J VIROL, V87, P3655, DOI 10.1128/JVI.02667-12; Lu W, 2006, P NATL ACAD SCI USA, V103, P12540, DOI 10.1073/pnas.0605402103; Lui PY, 2017, J IMMUNOL, V199, P1846, DOI 10.4049/jimmunol.1601493; Lui PY, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.33; Lupfer C, 2015, CURR OPIN VIROL, V12, P38, DOI 10.1016/j.coviro.2015.02.007; McAuley JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003392; Menachery VD, 2017, MBIO, V8, DOI 10.1128/mBio.00665-17; Minakshi R, 2014, VIRUS RES, V191, P180, DOI 10.1016/j.virusres.2014.08.001; Minakshi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008342; Narayanan K, 2008, VIRUS RES, V133, P113, DOI 10.1016/j.virusres.2007.10.009; Ng MHJ, 2011, J IMMUNOL, V187, P6473, DOI 10.4049/jimmunol.1100719; Nieto-Torres JL, 2015, VIROLOGY, V485, P330, DOI 10.1016/j.virol.2015.08.010; Nieto-Torres JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004077; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Oostra M, 2006, J VIROL, V80, P2326, DOI 10.1128/JVI.80.5.2326-2336.2006; Padhan K, 2007, J GEN VIROL, V88, P3067, DOI 10.1099/vir.0.82856-0; Parvatiyar K, 2010, J BIOL CHEM, V285, P14999, DOI 10.1074/jbc.M110.109819; Place DE, 2018, CURR OPIN IMMUNOL, V50, P32, DOI 10.1016/j.coi.2017.10.011; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reiley W, 2005, MOL CELL BIOL, V25, P3886, DOI 10.1128/MCB.25.10.3886-3895.2005; Sears C, 1998, J BIOL CHEM, V273, P1409, DOI 10.1074/jbc.273.3.1409; Siu KL, 2014, CELL MOL IMMUNOL, V11, P141, DOI 10.1038/cmi.2013.61; Siu KL, 2009, J BIOL CHEM, V284, P16202, DOI 10.1074/jbc.M109.008227; Siu YT, 2008, MOL BIOL CELL, V19, P4750, DOI 10.1091/mbc.E08-04-0369; Stewart MK, 2016, NAT REV MICROBIOL, V14, P346, DOI 10.1038/nrmicro.2016.50; Stutz Andrea, 2013, Methods Mol Biol, V1040, P91, DOI 10.1007/978-1-62703-523-1_8; Tan YJ, 2006, ANTIVIR RES, V72, P78, DOI 10.1016/j.antiviral.2006.05.010; Tan YJ, 2005, J VIROL, V79, P10083, DOI 10.1128/JVI.79.15.10083-10087.2005; Tang BSF, 2005, J VIROL, V79, P6180, DOI 10.1128/JVI.79.10.6180-6193.2005; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Van Opdenbosch N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4209; Wang PH, 2018, EMBO REP, V19, DOI 10.15252/embr.201845737; Wang PH, 2018, NUCLEIC ACIDS RES, V46, P4054, DOI 10.1093/nar/gky186; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Yeung ML, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.4, 10.1038/nmicrobiol.2016.4]; Yount B, 2005, J VIROL, V79, P14909, DOI 10.1128/JVI.79.23.14909-14922.2005; Yue Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0917-y; Yuen KS, 2015, J GEN VIROL, V96, P626, DOI 10.1099/jgv.0.000012; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	69	294	303	2	39	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					8865	8877		10.1096/fj.201802418R	http://dx.doi.org/10.1096/fj.201802418R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31034780	Green Published			2022-12-28	WOS:000478832900014
J	Lin, WP; Xu, LL; Pan, Q; Lin, SE; Feng, L; Wang, B; Chen, SX; Li, Y; Wang, HX; Li, YC; Wang, Y; Lee, WYW; Sun, D; Li, G				Lin, Weiping; Xu, Liangliang; Pan, Qi; Lin, Sien; Feng, Lu; Wang, Bin; Chen, Shuxun; Li, Ying; Wang, Haixing; Li, Yucong; Wang, Yan; Lee, Wayne Yuk Wai; Sun, Dong; Li, Gang			Lgr5-overexpressing mesenchymal stem cells augment fracture healing through regulation of Wnt/ERK signaling pathways and mitochondrial dynamics	FASEB JOURNAL			English	Article						GPCR; MSCs; fission; osteogenic differentiation; angiogenesis	CRITICAL-SIZE DEFECT; STROMAL CELLS; BONE-DEVELOPMENT; REPAIR; DIFFERENTIATION; TRANSPLANTATION; PLURIPOTENCY; OSTEOGENESIS; REGENERATION; OSTEOBLASTS	Fracture remains one of the most common traumatic conditions in orthopedic surgery. The use of mesenchymal stem cells (MSCs) to augment fracture repair is promising. Leucine-rich repeat-containing GPCR 5 (Lgr5), a transmembrane protein, has been identified as a novel adult stem cell marker in various organs and tissues. However, the roles of Lgr5 in MSCs are not fully understood. In this study, we investigated cellular functions of Lgr5 in MSCs and its potential implications in treating fracture. Lgr5-overexpressing MSCs (MSCLgr5) were established in murine SV40 promoter-driven luciferase reporter MSC line through virus transfection. Results of real-time quantitative PCR and Western blot analysis confirmed the increased expression of Lgr5 in MSCLgr5. MSCLgr5 exhibited increased osteogenic capacity, which may result from elevated expression of beta-catenin and phosphorylated ERK1/2 within the nuclear region of cells. In contrast, inhibition of Lgr5 expression decreased the osteogenic differentiation ability of MSCs, accompanied with increased mitochondrial fragmentation and reduced expression of beta-catenin. Local transplantation of MSCLgr5 at fracture sites accelerated fracture healing via enhanced osteogenesis and angiogenesis. MSCLgr5 stimulated the tube formation capacity of HUVECs in a Matrigel coculture system in vitro significantly. Taken together, results suggest that Lgr5 is implicated in the cellular processes of osteogenic differentiation of MSCs through regulation of Wnt and ERK signaling pathways and mitochondrial dynamics in fusion and fission. Inhibition of Lgr5 expression induced increased mitochondrial fragmentation and suppression of osteogenesis. MSCLgr5 exhibited enhanced therapeutic efficacy for fracture healing, which may serve as a superior cell source for bone tissue repair.-Lin, W., Xu, L., Pan, Q., Lin, S., Feng, L., Wang, B., Chen, S., Li, Y., Wang, H., Li, Y., Wang, Y., Lee, W. Y. W., Sun, D., Li, G. Lgr5-overexpressing mesenchymal stem cells augment fracture healing through regulation of Wnt/ERK signaling pathways and mitochondrial dynamics.	[Lin, Weiping; Pan, Qi; Lin, Sien; Feng, Lu; Wang, Bin; Wang, Haixing; Li, Yucong; Wang, Yan; Lee, Wayne Yuk Wai; Li, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Fac Med, Dept Orthopaed & Traumatol, Hong Kong, Peoples R China; [Lin, Weiping; Pan, Qi; Lin, Sien; Feng, Lu; Wang, Bin; Wang, Haixing; Li, Yucong; Wang, Yan; Lee, Wayne Yuk Wai; Li, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Stem Cells & Regenerat Med Lab, Hong Kong, Peoples R China; [Xu, Liangliang; Li, Ying] Guangzhou Univ Chinese Med, Key Lab Orthopaed & Traumatol, Affiliated Hosp 1, Clin Med Coll 1, Guangzhou, Guangdong, Peoples R China; [Chen, Shuxun; Sun, Dong] City Univ Hong Kong, Dept Biomed Engn, Hong Kong, Peoples R China; [Li, Gang] Chinese Univ Hong Kong, Shenzhen Res Inst, China Astronaut Res & Training Ctr, Space Med Ctr Hlth Maintenance Musculoskeletal Sy, Shenzhen, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Guangzhou University of Chinese Medicine; City University of Hong Kong; Chinese University of Hong Kong, Shenzhen	Li, G (corresponding author), Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Prince Wales Hosp, Shatin, Room 904, Hong Kong, Peoples R China.; Li, G (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Prince Wales Hosp, Shatin, Room 904, Hong Kong, Peoples R China.	gangli@cuhk.edu.hk	Lee, Wayne YW/H-8298-2013; Liangliang, XU/K-9185-2019; chen, shuxun/ABH-1766-2021; Li, Gang/J-7830-2018; Feng, Lu/GWQ-9734-2022; WANG, BIN/O-2346-2019; Lin, Sien/J-7773-2018	Lee, Wayne YW/0000-0002-0486-360X; Liangliang, XU/0000-0002-5249-7480; chen, shuxun/0000-0003-1113-2693; Li, Gang/0000-0002-3981-2239; Feng, Lu/0000-0002-4498-190X; WANG, BIN/0000-0002-1348-1494; Lin, Sien/0000-0002-7292-7062; SUN, Dong/0000-0003-3945-4037	Hong Kong Government Research Grant Council, General Research Fund [14119115, 14160917, 14120118, 9054014 N_CityU102/15]; National Natural Science Foundation of China [81430049, 81772322]; Hong Kong Innovation Technology Commission Funds [ITS/UIM-305]; Sports Medicine and Regenerative Technology program of the Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong	Hong Kong Government Research Grant Council, General Research Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong Innovation Technology Commission Funds; Sports Medicine and Regenerative Technology program of the Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong	This work was supported by grants from the Hong Kong Government Research Grant Council, General Research Fund (14119115, 14160917, 14120118, 9054014 N_CityU102/15), National Natural Science Foundation of China (81430049 and 81772322), and the Hong Kong Innovation Technology Commission Funds (ITS/UIM-305). This study was also supported in part by the Sports Medicine and Regenerative Technology program of the Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, and the research was made possible by resources donated by the Lui Che Woo Foundation Limited. The authors declare no conflicts of interest.	An JH, 2010, BONE, V47, P140, DOI 10.1016/j.bone.2010.04.593; Antmen B, 2005, PEDIATR ANESTH, V15, P214, DOI 10.1111/j.1460-9592.2004.01411.x; Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL REP, V2, P540, DOI 10.1016/j.celrep.2012.08.018; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005; BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303; Chen X, 2006, IMMUNOL CELL BIOL, V84, P413, DOI 10.1111/j.1440-1711.2006.01458.x; Cole JH, 2011, CLIN ORTHOP RELAT R, V469, P2139, DOI 10.1007/s11999-011-1784-3; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Deng YJ, 2016, CELL REP, V14, P2224, DOI 10.1016/j.celrep.2016.02.021; Derubeis AR, 2004, ANN BIOMED ENG, V32, P160, DOI 10.1023/B:ABME.0000007800.89194.95; Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; ERVENKA I, 2011, MOL CELL BIOL, V31, P179, DOI DOI 10.1128/MCB.00550-10; Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849; Ferguson C, 1999, MECH DEVELOP, V87, P57, DOI 10.1016/S0925-4773(99)00142-2; Forni MF, 2016, STEM CELLS, V34, P743, DOI 10.1002/stem.2248; Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Ge CX, 2009, J BIOL CHEM, V284, P32533, DOI 10.1074/jbc.M109.040980; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Gomez-Barrena E, 2015, BONE, V70, P93, DOI 10.1016/j.bone.2014.07.033; Grayson WL, 2015, NAT REV ENDOCRINOL, V11, P140, DOI 10.1038/nrendo.2014.234; He QL, 2007, STEM CELLS, V25, P69, DOI 10.1634/stemcells.2006-0335; He YX, 2011, BONE, V48, P1388, DOI 10.1016/j.bone.2011.03.720; Hogue A, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0042-9; Hu DP, 2017, DEVELOPMENT, V144, P221, DOI 10.1242/dev.130807; Huang S, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0198-7; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Kim I, 2011, AM J PHYSIOL-CELL PH, V300, pC308, DOI 10.1152/ajpcell.00056.2010; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Leucht P, 2008, SEMIN CELL DEV BIOL, V19, P434, DOI 10.1016/j.semcdb.2008.09.002; Leung C, 2018, TRENDS CELL BIOL, V28, P380, DOI 10.1016/j.tcb.2018.01.010; Li QQ, 2017, PROTEIN CELL, V8, P439, DOI 10.1007/s13238-017-0385-7; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Lin W., 2019, J ORTHOP TRANSLAT; Lin WP, 2017, J ORTHOP TRANSL, V9, P19, DOI 10.1016/j.jot.2017.03.002; Liu Y, 2017, FASEB J, V31, P3800, DOI 10.1096/fj.201601181R; Marsh D, 1998, CLIN ORTHOP RELAT R, pS22; Michel S, 2012, J CELL PHYSIOL, V227, P2297, DOI 10.1002/jcp.23021; Niemeyer P, 2010, ACTA BIOMATER, V6, P900, DOI 10.1016/j.actbio.2009.09.007; Niemeyer P, 2010, TISSUE ENG PT A, V16, P33, DOI [10.1089/ten.tea.2009.0190, 10.1089/ten.TEA.2009.0190]; Nombela-Arrieta C, 2011, NAT REV MOL CELL BIO, V12, P126, DOI 10.1038/nrm3049; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; Pignolo RJ, 2011, J BONE MINER RES, V26, P1685, DOI 10.1002/jbmr.370; Plaks V, 2013, CELL REP, V3, P70, DOI 10.1016/j.celrep.2012.12.017; Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516; Rapp AE, 2015, EUR CELLS MATER, V29, P22, DOI 10.22203/eCM.v029a02; Rapp AE, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092526; Rehman J, 2010, J MOL MED, V88, P981, DOI 10.1007/s00109-010-0678-2; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05; Silkstone D, 2008, NAT CLIN PRACT RHEUM, V4, P413, DOI 10.1038/ncprheum0838; Song LG, 2012, J BONE MINER RES, V27, P2344, DOI 10.1002/jbmr.1694; Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001; Wanet A, 2015, STEM CELLS DEV, V24, P1957, DOI 10.1089/scd.2015.0117; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002; Xu LL, 2014, J ORTHOP TRANSL, V2, P1, DOI 10.1016/j.jot.2013.11.002; Xu LL, 2015, FASEB J, V29, P1143, DOI 10.1096/fj.14-254169; Xu XL, 2013, CELL METAB, V18, P325, DOI 10.1016/j.cmet.2013.06.005; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	71	23	23	2	30	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8565	8577		10.1096/fj.201900082RR	http://dx.doi.org/10.1096/fj.201900082RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30991839				2022-12-28	WOS:000476234700060
J	Jiang, M; Fang, H; Shao, S; Dang, EL; Zhang, JY; Qiao, P; Yang, AG; Wang, G				Jiang, Man; Fang, Hui; Shao, Shuai; Dang, Erle; Zhang, Jieyu; Qiao, Pei; Yang, Angang; Wang, Gang			Keratinocyte exosomes activate neutrophils and enhance skin inflammation in psoriasis	FASEB JOURNAL			English	Article						neutrophil communication; NET; proteomic	CELL-DERIVED EXOSOMES; EXTRACELLULAR TRAP FORMATION; T-CELLS; VESICLES; DISEASE; COMMUNICATION; MECHANISMS; CYTOKINE; PROTEINS; DELETION	Psoriasis is a chronic inflammatory skin disease that severely affects patients physiologically and psychologically. The pathogenesis involving communication between psoriatic keratinocytes and infiltrated immune cells such as neutrophils remains unclear. Exosomes are emerging mediators of intercellular communication. Herein we aim to investigate the release and function of psoriatic keratinocyte exosomes, which have not been illustrated to any extent. We first isolated exosomes from both healthy and psoriasis-like keratinocytes treated with psoriatic cytokine cocktail. These exosomes were observed to be endocytosed by neutrophils. Unlike non cytokine-treated keratinocyte exosomes, cytokine-treated keratinocyte exosomes significantly induced NETosis (the process by which neutrophils produce and release neutrophil extracellular traps) and the expressions of IL-6, IL-8, and TNF-alpha in neutrophils. Proteomic analysis showed that cytokine-treated keratinocyte exosomes exhibited a specific protein profile with proteins enriched in immune-related pathways. We then confirmed that NF-kappa B and p38 MAPK signaling pathways were activated in neutrophils stimulated by cytokine-treated keratinocyte exosomes and were responsible for the expressions of proinflammatory factors mentioned above. Finally, we verified in vivo that cytokine-treated keratinocyte exosomes participated in the skin lesion development of imiquimod-induced psoriasis-like mouse model. Collectively, we reveal that the release of exosomes works as a way of keratinocyte-neutrophil communication, indicating that keratinocyte exosomes, with their specific cargoes, are therapeutic candidates for psoriasis.	[Jiang, Man; Fang, Hui; Shao, Shuai; Dang, Erle; Zhang, Jieyu; Qiao, Pei; Wang, Gang] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, 127 Changlexi Rd, Xian 710032, Peoples R China; [Jiang, Man; Yang, Angang] Fourth Mil Med Univ, Dept Immunol, State Key Lab Canc Biol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Wang, G (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, 127 Changlexi Rd, Xian 710032, Peoples R China.; Yang, AG (corresponding author), Fourth Mil Med Univ, Dept Immunol, State Key Lab Canc Biol, Xian 710032, Peoples R China.	agyang@fmmu.edu.cn; xjwgang@fmmu.edu.cn	Wang, Gang/H-6710-2019	Dang, Erle/0000-0003-4761-6673; Wang, Gang/0000-0002-5842-8080	National Natural Science Foundation of China [81502726, 81430073]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Chenming Zhou (Department of Electron Microscopy Centre, Hebei Medical University) for assistance with electron microscopy. This work was supported by grants from the National Natural Science Foundation of China (81502726 and 81430073). The authors declare no conflicts of interest.	Boehncke WH, 2015, LANCET, V386, P983, DOI 10.1016/S0140-6736(14)61909-7; Cai XW, 2017, MOL MED REP, V16, P7032, DOI 10.3892/mmr.2017.7492; Cambier L, 2017, EMBO MOL MED, V9, P337, DOI 10.15252/emmm.201606924; Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049; Chan BD, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201800149; Chaput N, 2011, SEMIN IMMUNOPATHOL, V33, P419, DOI 10.1007/s00281-010-0233-9; Chavez-Munoz C, 2008, J CELL BIOCHEM, V104, P2165, DOI 10.1002/jcb.21774; Chavez-Munoz C, 2009, J CELL PHYSIOL, V221, P221, DOI 10.1002/jcp.21847; Cheng CF, 2008, MOL CELL BIOL, V28, P3344, DOI 10.1128/MCB.01287-07; Cheung KL, 2016, J EXP MED, V213, P2399, DOI 10.1084/jem.20160258; Conrad C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02466-4; Essandoh K, 2015, BBA-MOL BASIS DIS, V1852, P2362, DOI 10.1016/j.bbadis.2015.08.010; Esser J, 2010, J ALLERGY CLIN IMMUN, V126, P1032, DOI 10.1016/j.jaci.2010.06.039; Filipazzi P, 2012, SEMIN CANCER BIOL, V22, P342, DOI 10.1016/j.semcancer.2012.02.005; Garcia-Contreras M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05787-y; Goodman WA, 2009, J IMMUNOL, V183, P3170, DOI 10.4049/jimmunol.0803721; Hu SCS, 2016, SCI REP-UK, V6, DOI 10.1038/srep31119; Jiang M, 2017, J INVEST DERMATOL, V137, P2177, DOI 10.1016/j.jid.2017.06.005; Kennedy-Crispin M, 2012, J INVEST DERMATOL, V132, P105, DOI 10.1038/jid.2011.262; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Kim NH, 2014, J INVEST DERMATOL, V134, P1075, DOI 10.1038/jid.2013.478; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kotzerke K, 2013, EXP DERMATOL, V22, P650, DOI 10.1111/exd.12230; Kulshreshtha A, 2013, J ALLERGY CLIN IMMUN, V131, P1194, DOI 10.1016/j.jaci.2012.12.1565; Lambert S, 2019, J INVEST DERMATOL, V139, P1245, DOI 10.1016/j.jid.2018.11.021; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Lo Cicero A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8506; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Matejuk A, 2018, ARCH IMMUNOL THER EX, V66, P45, DOI 10.1007/s00005-017-0477-3; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Okoye IS, 2014, IMMUNITY, V41, P89, DOI [10.1016/j.immuni.2014.05.019, 10.1016/j.immuni.2014.08.008]; Paredes PT, 2012, ALLERGY, V67, P911, DOI 10.1111/j.1398-9995.2012.02835.x; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Pitt JM, 2016, J CLIN INVEST, V126, P1224, DOI 10.1172/JCI81137; Prieto D, 2017, BLOOD, V130, P777, DOI 10.1182/blood-2017-02-769851; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reich K, 2015, EXP DERMATOL, V24, P529, DOI 10.1111/exd.12710; Robbins PD, 2016, J CLIN INVEST, V126, P1173, DOI 10.1172/JCI81131; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Sanchez-Gomez FJ, 2017, ALLERGY, V72, P385, DOI 10.1111/all.12958; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Schon MP, 2017, EXP DERMATOL, V26, P305, DOI 10.1111/exd.13067; Selmaj I, 2017, J NEUROIMMUNOL, V306, P1, DOI 10.1016/j.jneuroim.2017.02.002; Sen BB, 2014, CUTAN OCUL TOXICOL, V33, P223, DOI 10.3109/15569527.2013.834498; Shao S, 2016, J INVEST DERMATOL, V136, P1418, DOI 10.1016/j.jid.2016.03.002; Sumida H, 2014, J IMMUNOL, V192, P4361, DOI 10.4049/jimmunol.1302959; Terui T, 2000, EXP DERMATOL, V9, P1, DOI 10.1034/j.1600-0625.2000.009001001.x; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thieblemont N, 2016, SEMIN IMMUNOL, V28, P159, DOI 10.1016/j.smim.2016.03.004; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Tofino-Vian M, 2018, BIOCHEM PHARMACOL, V153, P134, DOI 10.1016/j.bcp.2018.02.004; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Whiteside TL, 2016, J CLIN INVEST, V126, P1216, DOI 10.1172/JCI81136; WHO, 2013, EX BOARD 133 SESS AG; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zheng LW, 2018, J PROTEOMICS, V173, P139, DOI 10.1016/j.jprot.2017.12.007	56	35	35	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13241	13253		10.1096/fj.201900642R	http://dx.doi.org/10.1096/fj.201900642R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31539277	Bronze			2022-12-28	WOS:000507466100017
J	Klotz, L; Wendler, O; Frischknecht, R; Shigemoto, R; Schulze, H; Enz, R				Klotz, Lisa; Wendler, Olaf; Frischknecht, Renato; Shigemoto, Ryuichi; Schulze, Holger; Enz, Ralf			Localization of group II and III metabotropic glutamate receptors at pre- and postsynaptic sites of inner hair cell ribbon synapses	FASEB JOURNAL			English	Article						cochlea; mGluR; IHC; mGlu receptor	MAMMALIAN COCHLEA; SYNAPTIC VESICLE; MICE LACKING; RAT RETINA; EXPRESSION; CHANNELS; MGLUR3; IDENTIFICATION; MECHANISMS; PLASTICITY	Glutamate is the major excitatory neurotransmitter in the CNS binding to a variety of glutamate receptors. Metabotropic glutamate receptors (mGluR1 to mGluR8) can act excitatory or inhibitory, depending on associated signal cascades. Expression and localization of inhibitory acting mGluRs at inner hair cells (IHCs) in the cochlea are largely unknown. Here, we analyzed expression of mGluR2, mGluR3, mGluR4, mGluR6, mGluR7, and mGluR8 and investigated their localization with respect to the presynaptic ribbon of IHC synapses. We detected transcripts for mGluR2, mGluR3, and mGluR4 as well as for mGluR7a, mGluR7b, mGluR8a, and mGluR8b splice variants. Using receptor-specific antibodies in cochlear wholemounts, we found expression of mGluR2, mGluR4, and mGluR8b close to presynaptic ribbons. Super resolution and confocal microscopy in combination with 3-dimensional reconstructions indicated a postsynaptic localization of mGluR2 that overlaps with postsynaptic density protein 95 on dendrites of afferent type I spiral ganglion neurons. In contrast, mGluR4 and mGluR8b were expressed at the presynapse close to IHC ribbons. In summary, we localized in detail 3 mGluR types at IHC ribbon synapses, providing a fundament for new therapeutical strategies that could protect the cochlea against noxious stimuli and excitotoxicity.	[Klotz, Lisa; Enz, Ralf] Friedrich Alexander Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, Erlangen, Germany; [Wendler, Olaf] Friedrich Alexander Univ Erlangen Nurnberg, Div Phoniatr & Pediat Audiol, Dept Otorhinolaryngol Head & Neck Surg, Erlangen, Germany; [Frischknecht, Renato] Friedrich Alexander Univ Erlangen Nurnberg, Dept Biol, Anim Physiol, Erlangen, Germany; [Schulze, Holger] Friedrich Alexander Univ Erlangen Nurnberg, Dept Otorhinolaryngol Head & Neck Surg, Expt Otolaryngol, Erlangen, Germany; [Shigemoto, Ryuichi] IST Austria, Klosterneuburg, Austria	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Institute of Science & Technology - Austria	Enz, R (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Inst Biochem, Fahrstr 17, D-91054 Erlangen, Germany.	ralf.enz@fau.de	Klotz-Weigand, Lisa Janina/AGG-1603-2022; Shigemoto, Ryuichi/E-3628-2013	Shigemoto, Ryuichi/0000-0001-8761-9444; Klotz-Weigand, Lisa Janina/0000-0001-9378-5684	Deutsche Forschungsgemeinschaft (DFG); Interdisciplinary Centre for Clinical Research (IZKF) at the University Hospital of the Friedrich-Alexander-Universitat Erlangen-Nurnberg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Interdisciplinary Centre for Clinical Research (IZKF) at the University Hospital of the Friedrich-Alexander-Universitat Erlangen-Nurnberg	The authors thank Jean-Philippe Pin (Institut de Genomique Fonctionnelle, Montpellier, France) for providing expression constructs encoding for mGluR2 or mGluR3, Francesco Ferraguti (Innsbruck Medical University, Innsbruck, Austria) for mGluR4 antibodies, and the Optical Imaging Center Erlangen (OICE) for excellent scientific and technical support. This work was supported by the Deutsche Forschungsgemeinschaft (DFG) and the Interdisciplinary Centre for Clinical Research (IZKF) at the University Hospital of the Friedrich-Alexander-Universitat Erlangen-Nurnberg. The authors declare no conflicts of interest.	Brandstatter JH, 1996, J NEUROSCI, V16, P4749; Brandstatter JH, 1998, VISION RES, V38, P1385, DOI 10.1016/S0042-6989(97)00176-4; Brandt A, 2005, J NEUROSCI, V25, P11577, DOI 10.1523/JNEUROSCI.3411-05.2005; Corti C, 2002, NEUROSCIENCE, V110, P403, DOI 10.1016/S0306-4522(01)00591-7; Corti C, 2007, J NEUROSCI, V27, P8297, DOI 10.1523/JNEUROSCI.1889-07.2007; Delgado DM, 2017, ELIFE, V6, DOI 10.7554/eLife.25233; Dieck ST, 2006, CELL TISSUE RES, V326, P339, DOI 10.1007/s00441-006-0234-0; Doleviczenyi Z, 2005, NEUROSCI LETT, V385, P93, DOI 10.1016/j.neulet.2005.05.017; Doumazane E, 2011, FASEB J, V25, P66, DOI 10.1096/fj.10-163147; Dutting E, 2011, BIOCHEM J, V435, P365, DOI 10.1042/BJ20101854; Duvoisin RM, 2005, EUR J NEUROSCI, V22, P425, DOI 10.1111/j.1460-9568.2005.04210.x; Enz R, 2007, BIOESSAYS, V29, P60, DOI 10.1002/bies.20518; Enz R, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00052; Enz R, 2012, CURR DRUG TARGETS, V13, P145, DOI 10.2174/138945012798868452; Ferraguti F, 2005, J NEUROSCI, V25, P10520, DOI 10.1523/JNEUROSCI.2547-05.2005; Ferraguti F, 2006, CELL TISSUE RES, V326, P483, DOI 10.1007/s00441-006-0266-5; Fettiplace R, 2017, COMPR PHYSIOL, V7, P1197, DOI 10.1002/cphy.c160049; Frank MM, 2018, WIRES DEV BIOL, V7, DOI 10.1002/wdev.324; Friedman RA, 2009, HUM MOL GENET, V18, P785, DOI 10.1093/hmg/ddn402; Fujikawa T, 2014, HEARING RES, V314, P20, DOI 10.1016/j.heares.2014.05.001; Girotto G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085352; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Goutman JD, 2015, FEBS LETT, V589, P3354, DOI 10.1016/j.febslet.2015.08.030; HARTVEIT E, 1995, EUR J NEUROSCI, V7, P1472, DOI 10.1111/j.1460-9568.1995.tb01142.x; Hu SSJ, 2010, J COMP NEUROL, V518, P3848, DOI 10.1002/cne.22429; Jean P, 2019, P NATL ACAD SCI USA, V116, P9084, DOI 10.1073/pnas.1818358116; Jin LE, 2018, CEREB CORTEX, V28, P974, DOI 10.1093/cercor/bhx005; Johnson KA, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00264; Jung SY, 2015, P NATL ACAD SCI USA, V112, pE3141, DOI 10.1073/pnas.1417207112; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; Koga K, 2010, J NEUROSCI RES, V88, P2252, DOI 10.1002/jnr.22382; Koulen P, 2005, INVEST OPHTH VIS SCI, V46, P287, DOI 10.1167/iovs.04-0963; Koulen P, 1996, EUR J NEUROSCI, V8, P2177, DOI 10.1111/j.1460-9568.1996.tb00739.x; Koulen P, 1999, P NATL ACAD SCI USA, V96, P9909, DOI 10.1073/pnas.96.17.9909; Liberman MC, 2017, HEARING RES, V349, P138, DOI 10.1016/j.heares.2017.01.003; Liberman MC, 2016, ADV EXP MED BIOL, V875, P1, DOI 10.1007/978-1-4939-2981-8_1; Linden AM, 2009, NEUROPHARMACOLOGY, V57, P172, DOI 10.1016/j.neuropharm.2009.05.002; Long LL, 2018, INDIAN J OTOLARYNGOL, V70, P425, DOI 10.1007/s12070-018-1448-7; Lu Y, 2014, NEUROSCIENCE, V274, P429, DOI 10.1016/j.neuroscience.2014.05.057; Martemyanov KA, 2014, INVEST OPHTH VIS SCI, V55, P8201, DOI 10.1167/iovs.14-15928; Martinez-Monedero R, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0078-16.2016; Mascia F, 2017, J NEUROCHEM, V141, P577, DOI 10.1111/jnc.14021; Masilamoni GJ, 2018, CURR OPIN PHARMACOL, V38, P72, DOI 10.1016/j.coph.2018.03.004; Mburu P, 2006, P NATL ACAD SCI USA, V103, P10973, DOI 10.1073/pnas.0600923103; Meyer AC, 2009, NAT NEUROSCI, V12, P444, DOI 10.1038/nn.2293; Moller Thor C, 2017, Biophys Rep, V3, P57, DOI 10.1007/s41048-017-0036-9; Moreno JL, 2012, J BIOL CHEM, V287, P44301, DOI 10.1074/jbc.M112.413161; Neef J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02612-y; Newman DL, 2012, HEARING RES, V294, P125, DOI 10.1016/j.heares.2012.08.016; Nouvian R, 2015, CELL TISSUE RES, V361, P301, DOI 10.1007/s00441-015-2158-z; Oh CK, 1999, MOL BRAIN RES, V70, P135, DOI 10.1016/S0169-328X(99)00110-2; Okumura K, 2010, BRAIN RES, V1307, P53, DOI 10.1016/j.brainres.2009.10.039; Pekhletski R, 1996, J NEUROSCI, V16, P6364; Petralia RS, 1996, NEUROSCIENCE, V71, P949, DOI 10.1016/0306-4522(95)00533-1; Petralia RS, 1996, J COMP NEUROL, V372, P356; Pin JP, 2016, NATURE, V540, P60, DOI 10.1038/nature20566; Pootanakit K, 1999, VISUAL NEUROSCI, V16, P221, DOI 10.1017/S0952523899162035; Pujol R, 1999, ANN NY ACAD SCI, V884, P249, DOI 10.1111/j.1749-6632.1999.tb08646.x; Quraishi S, 2007, J COMP NEUROL, V501, P931, DOI 10.1002/cne.21274; Reiner A, 2018, NEURON, V98, P1080, DOI 10.1016/j.neuron.2018.05.018; Rose M, 2008, J NEUROCHEM, V105, P2375, DOI 10.1111/j.1471-4159.2008.05331.x; Roux I, 2016, J NEUROPHYSIOL, V116, P479, DOI 10.1152/jn.01038.2015; Ruel J, 2007, HEARING RES, V227, P19, DOI 10.1016/j.heares.2006.08.017; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Seebahn A, 2008, FEBS LETT, V582, P2453, DOI 10.1016/j.febslet.2008.06.010; Suzuki S, 2017, PEPTIDES, V89, P42, DOI 10.1016/j.peptides.2017.01.007; Takago H, 2018, HEARING RES, V362, P1, DOI 10.1016/j.heares.2018.02.007; Tamaru Y, 2001, NEUROSCIENCE, V106, P481, DOI 10.1016/S0306-4522(01)00305-0; Terreros G, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00134; Tong MJ, 2013, JARO-J ASSOC RES OTO, V14, P321, DOI 10.1007/s10162-013-0374-3; Valenzuela JC, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0606; Van Laer L, 2010, EUR J HUM GENET, V18, P685, DOI 10.1038/ejhg.2009.234; Vogl C, 2015, J CELL SCI, V128, P638, DOI 10.1242/jcs.162099; Wan GQ, 2015, HEARING RES, V329, P1, DOI 10.1016/j.heares.2015.04.008; Wong AB, 2014, EMBO J, V33, P247, DOI 10.1002/embj.201387110; Yin S, 2014, J NEUROSCI, V34, P79, DOI 10.1523/JNEUROSCI.1129-13.2014; Yu PP, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-017-0515-3	77	8	8	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13734	13746		10.1096/fj.201901543R	http://dx.doi.org/10.1096/fj.201901543R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31585509	Bronze			2022-12-28	WOS:000507466100054
J	Yang, SD; Deng, QF; Sun, LQ; Dong, KD; Li, YY; Wu, SY; Huang, R				Yang, Sidi; Deng, Qifeng; Sun, Lanqing; Dong, Kedi; Li, Yuanyuan; Wu, Shuyan; Huang, Rui			Salmonella effector SpvB interferes with intracellular iron homeostasis via regulation of transcription factor NRF2	FASEB JOURNAL			English	Article						salmonellosis; pSLT plasmid; macrophage; hypoferremia; ferroportin	TYPHIMURIUM INFECTION; FPN1 TRANSCRIPTION; CELL-DEATH; FERROPORTIN; VIRULENCE; PROTEIN; IDENTIFICATION; MACROPHAGES; DEFICIENCY; EXPRESSION	Iron is a necessary nutrient for humans and nearly all bacterial species. During Salmonella infection, macrophages limit the availability of iron to intracellular pathogens in one of the central components of nutritional immunity. However, Salmonella also have mechanisms to interfere with the antimicrobial effect of host iron withdrawal and meet their own nutrient requirements by scavenging iron from the host. Here, we provide what is, to our knowledge, the first report that SpvB, a pSLT-encoded cytotoxic protein whose function is associated with the intracellular stage of salmonellosis, perturbs macrophage iron metabolism, thereby facilitating Salmonella survival and intracellular replication. In investigating the underlying mechanism, we observed that the Salmonella effector SpvB down-regulated nuclear factor erythroid-derived 2 related factor 2 (NRF2), and its C-terminal domain was necessary and sufficient for NRF2 degradation via the proteasome pathway. Decreased NRF2 expression in the nucleus resulted in a decrease in its transcriptional target ferroportin, encoding the sole macrophage iron exporter, thus ultimately decreasing iron efflux and increasing the intracellular iron content. Additionally, SpvB contributes to the pathogenesis of Salmonella including severe serum hypoferremia, increased splenic and hepatic bacterial burden, and inflammatory injury in vivo. Together, our observations uncovered a novel contribution of SpvB to Salmonella pathology via interference with host intracellular iron metabolism.	[Yang, Sidi; Deng, Qifeng; Sun, Lanqing; Dong, Kedi; Li, Yuanyuan; Wu, Shuyan; Huang, Rui] Soochow Univ, Coll Med, Dept Med Microbiol, 199 Ren Ai Rd, Suzhou 215123, Jiangsu, Peoples R China	Soochow University - China	Wu, SY; Huang, R (corresponding author), Soochow Univ, Coll Med, Dept Med Microbiol, 199 Ren Ai Rd, Suzhou 215123, Jiangsu, Peoples R China.	wushuyan@suda.edu.cn; hruisdm@163.com			Natural Science Foundation of China [81671976, 31670140]; Postgraduate Research and Practice Innovation Program of Jiangsu Province [KYCX18_2522, KYCX19_1976]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postgraduate Research and Practice Innovation Program of Jiangsu Province; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	The authors thank Ying Xu, Chao Li, Ying Ye, and Kai Huang (Cambridge Suda Genome Resource Center, Soochow University) for excellent technical support and for fruitful discussions. This work was supported by the Natural Science Foundation of China (81671976 and 31670140), the Postgraduate Research and Practice Innovation Program of Jiangsu Province (KYCX18_2522 and KYCX19_1976), and a project funded by the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions. The authors declare no conflicts of interest.	Besser JM, 2018, FOOD MICROBIOL, V71, P55, DOI 10.1016/j.fm.2017.08.018; Bogdan AR, 2016, TRENDS BIOCHEM SCI, V41, P274, DOI 10.1016/j.tibs.2015.11.012; Brasse-Lagnel C, 2011, GASTROENTEROLOGY, V140, P1261, DOI 10.1053/j.gastro.2010.12.037; Brown DE, 2015, INFECT IMMUN, V83, P2290, DOI 10.1128/IAI.02863-14; Browne SH, 2008, FEMS IMMUNOL MED MIC, V52, P194, DOI 10.1111/j.1574-695X.2007.00364.x; Alfredo SIC, 2018, PHARMACOL RES, V134, P92, DOI 10.1016/j.phrs.2018.06.013; Chlosta S, 2006, INFECT IMMUN, V74, P3065, DOI 10.1128/IAI.74.5.3065-3067.2006; Cho-Park PF, 2013, CELL, V153, P614, DOI 10.1016/j.cell.2013.03.040; Chu YY, 2016, ONCOTARGET, V7, P8295, DOI 10.18632/oncotarget.6989; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Drakesmith H, 2015, CELL METAB, V22, P777, DOI 10.1016/j.cmet.2015.09.006; Fabrega A, 2013, CLIN MICROBIOL REV, V26, P308, DOI 10.1128/CMR.00066-12; Gotoh H, 2003, MICROB PATHOGENESIS, V34, P227, DOI 10.1016/S0882-4010(03)00034-2; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Harada N, 2011, ARCH BIOCHEM BIOPHYS, V508, P101, DOI 10.1016/j.abb.2011.02.001; Hochmann H, 2006, BIOCHEMISTRY-US, V45, P1271, DOI 10.1021/bi051810w; Johnson EE, 2010, INFECT IMMUN, V78, P5099, DOI 10.1128/IAI.00498-10; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Kim DK, 2014, NAT MED, V20, P419, DOI 10.1038/nm.3483; Kim KH, 2017, FREE RADICAL BIO MED, V113, P48, DOI 10.1016/j.freeradbiomed.2017.09.011; Kurita A, 2003, MICROB PATHOGENESIS, V35, P43, DOI 10.1016/S0882-4010(03)00066-4; Li YP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0740-2; Mambu J, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00500; Marro S, 2010, HAEMATOL-HEMATOL J, V95, P1261, DOI 10.3324/haematol.2009.020123; Nairz M, 2007, CELL MICROBIOL, V9, P2126, DOI 10.1111/j.1462-5822.2007.00942.x; Nairz M, 2015, CELL HOST MICROBE, V18, P254, DOI 10.1016/j.chom.2015.06.017; Nairz M, 2013, J EXP MED, V210, P855, DOI 10.1084/jem.20121946; Nunez G, 2018, J IMMUNOL, V201, P11, DOI 10.4049/jimmunol.1800325; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Passaris I, 2018, GENETICS, V210, P621, DOI 10.1534/genetics.118.300822; Rao R, 2007, SEMIN FETAL NEONAT M, V12, P54, DOI 10.1016/j.siny.2006.10.007; Sabelli M, 2017, HEPATOLOGY, V65, P1512, DOI 10.1002/hep.29007; Taylor M, 2011, GASTROENTEROLOGY, V140, P2044, DOI 10.1053/j.gastro.2011.03.007; Theurl I, 2009, BLOOD, V113, P5277, DOI 10.1182/blood-2008-12-195651; Troadec MB, 2010, BLOOD, V116, P4657, DOI 10.1182/blood-2010-04-278614; Wang CY, 2019, BLOOD, V133, P18, DOI 10.1182/blood-2018-06-815894; Willemetz A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00498	38	10	11	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13450	13464		10.1096/fj.201900883RR	http://dx.doi.org/10.1096/fj.201900883RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31569998	Bronze			2022-12-28	WOS:000507466100033
J	Zhang, RF; Hou, TT; Cheng, HP; Wang, XH				Zhang, Rufeng; Hou, Tingting; Cheng, Heping; Wang, Xianhua			NDUFAB1 protects against obesity and insulin resistance by enhancing mitochondrial metabolism	FASEB JOURNAL			English	Article						pyruvate dehydrogenase; mitochondrial respiratory complexes; respiratory supercomplexes; metabolic disorder	ACYL CARRIER PROTEIN; SKELETAL-MUSCLE; COMPLEX-I; ARCHITECTURE; ASSEMBLY/STABILITY; MECHANISMS; GLUCOSE; MICE	Mitochondria are fundamental organelles for cellular and systemic metabolism, and their dysfunction has been implicated in the development of diverse metabolic diseases. Boosted mitochondrial metabolism might be able to protect against metabolic stress and prevent metabolic disorders. Here we show that NADH:ubiquinone oxidoreductase (NDU)-FAB1, also known as mitochondrial acyl carrier protein, acts as a novel enhancer of mitochondrial metabolism and protects against obesity and insulin resistance. Mechanistically, NDUFAB1 coordinately enhances lipoylation and activation of pyruvate dehydrogenase mediated by the mitochondrial fatty acid synthesis pathway and increases the assembly of respiratory complexes and supercomplexes. Skeletal muscle specific ablation of NDUFAB1 causes systemic disruption of glucose homeostasis and defective insulin signaling, leading to growth arrest and early death within 5 postnatal days. In contrast, NDUFAB1 overexpression effectively protects mice against obesity and insulin resistance when the animals are challenged with a high-fat diet. Our findings indicate that NDUFAB1 could be a novel mitochondrial target to prevent obesity and insulin resistance by enhancing mitochondrial metabolism.	[Zhang, Rufeng; Hou, Tingting; Cheng, Heping; Wang, Xianhua] Peking Univ, Inst Mol Med, Peking Tsinghua Ctr Life Sci, State Key Lab Membrane Biol,Beijing Key Lab Cardi, Beijing, Peoples R China	Peking University	Wang, XH (corresponding author), Peking Univ, Inst Mol Med, 5 Yi He Yuan Rd, Beijing 100871, Peoples R China.	xianhua@pku.edu.cn	Heping, Cheng/AAE-2680-2019	Heping, Cheng/0000-0002-9604-6702	National Key Basic Research Program of China [2017YFA0504000, 2016YFA0500403]; National Science Foundation of China [31470811, 31670039, 8182780030, 31821091]	National Key Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Dongwei Ma for histology, Dr. Xiaowei Chen for providing Mlc1f-Cre mice, and Drs. Yan Zhang and Ruiping Xiao (all from the Institute of Molecular Medicine) for valuable comments. This work was supported by the National Key Basic Research Program of China (2017YFA0504000 and 2016YFA0500403) and the National Science Foundation of China (31470811, 31670039, 8182780030, and 31821091). The authors declare no conflicts of interest.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2014, BBA-BIOENERGETICS, V1837, P444, DOI 10.1016/j.bbabio.2013.12.009; Antoun G, 2015, DIABETOLOGIA, V58, P2861, DOI 10.1007/s00125-015-3772-8; Barrientos T, 2015, EBIOMEDICINE, V2, P1705, DOI 10.1016/j.ebiom.2015.09.041; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Brody S, 1997, FEBS LETT, V408, P217, DOI 10.1016/S0014-5793(97)00428-6; BRODY S, 1988, EUR J BIOCHEM, V173, P353, DOI 10.1111/j.1432-1033.1988.tb14005.x; DEFRONZO RA, 1985, J CLIN INVEST, V76, P149, DOI 10.1172/JCI111938; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Feng DJ, 2009, J BIOL CHEM, V284, P11436, DOI 10.1074/jbc.M806991200; Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794; Greggio C, 2017, CELL METAB, V25, P301, DOI 10.1016/j.cmet.2016.11.004; Gu JK, 2016, NATURE, V537, P639, DOI 10.1038/nature19359; Guaras A, 2016, CELL REP, V15, P197, DOI 10.1016/j.celrep.2016.03.009; Guo RY, 2017, CELL, V170, P1247, DOI 10.1016/j.cell.2017.07.050; Hesselink MKC, 2016, NAT REV ENDOCRINOL, V12, P633, DOI 10.1038/nrendo.2016.104; Hiltunen JK, 2010, PROG LIPID RES, V49, P27, DOI 10.1016/j.plipres.2009.08.001; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Kraegen EW, 2008, P NATL ACAD SCI USA, V105, P7627, DOI 10.1073/pnas.0803901105; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Letts JA, 2016, NATURE, V537, P644, DOI 10.1038/nature19774; Lopez-Fabuel I, 2016, P NATL ACAD SCI USA, V113, P13063, DOI 10.1073/pnas.1613701113; LYONS GE, 1990, J CELL BIOL, V111, P1465, DOI 10.1083/jcb.111.4.1465; Maio N, 2015, BBA-MOL CELL RES, V1853, P1493, DOI 10.1016/j.bbamcr.2014.09.009; Maranzana E, 2013, ANTIOXID REDOX SIGN, V19, P1469, DOI 10.1089/ars.2012.4845; Milenkovic D, 2017, CELL METAB, V25, P765, DOI 10.1016/j.cmet.2017.03.009; Muoio DM, 2014, CELL, V159, P1253, DOI 10.1016/j.cell.2014.11.034; Nesteruk M, 2014, FUNCT INTEGR GENOMIC, V14, P245, DOI 10.1007/s10142-013-0342-3; Pagel-Langenickel I, 2010, ENDOCR REV, V31, P25, DOI 10.1210/er.2009-0003; Park S, 2018, DIABETES METAB J, V42, P270, DOI 10.4093/dmj.2018.0101; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Petersen MC, 2018, PHYSIOL REV, V98, P2133, DOI 10.1152/physrev.00063.2017; Porras CA, 2015, FRONT BIOSCI-LANDMRK, V20, P621, DOI 10.2741/4327; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; RUNSWICK MJ, 1991, FEBS LETT, V286, P121, DOI 10.1016/0014-5793(91)80955-3; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531; Sousa JS, 2016, ELIFE, V5, DOI [10.7554/eLife.21290, 10.7554/e.Life.21290]; Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138; Van Vranken JG, 2016, ELIFE, V5, DOI 10.7554/eLife.17828; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; Wegener N, 2011, MOL CELL, V44, P191, DOI 10.1016/j.molcel.2011.07.036; Wu M, 2016, CELL, V167, P1598, DOI 10.1016/j.cell.2016.11.012; Zhang F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057766	47	8	8	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13310	13322		10.1096/fj.201901117RR	http://dx.doi.org/10.1096/fj.201901117RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31530015	Green Published, hybrid			2022-12-28	WOS:000507466100022
J	Fuqua, JD; Mere, CP; Kronemberger, A; Blomme, J; Bae, D; Turner, KD; Harris, MP; Scudese, E; Edwards, M; Ebert, SM; de Sousa, LGO; Bodine, SC; Yang, L; Adams, CM; Lira, VA				Fuqua, Jordan D.; Mere, Caleb P.; Kronemberger, Ana; Blomme, Jay; Bae, Dam; Turner, Kristen D.; Harris, Matthew P.; Scudese, Estevao; Edwards, Mitchell; Ebert, Scott M.; de Sousa, Luis G. O.; Bodine, Sue C.; Yang, Ling; Adams, Christopher M.; Lira, Vitor A.			ULK2 is essential for degradation of ubiquitinated protein aggregates and homeostasis in skeletal muscle	FASEB JOURNAL			English	Article						ULK1; p62; NBR1; proteostasis; autophagy; aggrephagy	MAMMALIAN AUTOPHAGY; PATHWAY; INSULIN; GENE; METABOLISM; DEFECTS; GADD45A; DISEASE; GLUCOSE; BINDING	Basal protein turnover, which largely relies on the degradation of ubiquitinated substrates, is instrumental for maintenance of muscle mass and function. However, the regulation of ubiquitinated protein degradation in healthy, nonatrophying skeletal muscle is still evolving, and potential tissue-specific modulators remain unknown. Using an unbiased expression analysis of 34 putative autophagy genes across mouse tissues, we identified unc-51 like autophagy activating kinase (Ulk)2, a homolog of the yeast autophagy related protein 1, as particularly enriched in skeletal muscle. Subsequent experiments revealed accumulations of insoluble ubiquitinated protein aggregates associated with the adaptors sequestosome 1 (SQSTM1, also known as p62) and next to breast cancer type 1 susceptibility protein gene 1 protein (NBR1) in adult muscles with ULK2 deficiency. ULK2 deficiency also led to impaired muscle force and caused myofiber atrophy and degeneration. These features were not observed in muscles with deficiency of the ULK2 paralog, ULK1. Furthermore, short-term ULK2 deficiency did not impair autophagy initiation, autophagosome to lysosome fusion, or protease activities of the lysosome and proteasome. Altogether, our results indicate that skeletal muscle ULK2 has a unique role in basal selective protein degradation by stimulating the recognition and proteolytic sequestration of insoluble ubiquitinated protein aggregates associated with p62 and NBR1. These findings have potential implications for conditions of poor protein homeostasis in muscles as observed in several myopathies and aging.	[Fuqua, Jordan D.; Mere, Caleb P.; Kronemberger, Ana; Blomme, Jay; Bae, Dam; Turner, Kristen D.; Harris, Matthew P.; Scudese, Estevao; Edwards, Mitchell; Lira, Vitor A.] Univ Iowa, Dept Hlth & Human Physiol, Iowa City, IA USA; [Ebert, Scott M.; Adams, Christopher M.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA USA; [de Sousa, Luis G. O.; Bodine, Sue C.; Adams, Christopher M.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Bodine, Sue C.; Yang, Ling; Adams, Christopher M.; Lira, Vitor A.] Univ Iowa, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA; [Yang, Ling] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Yang, Ling; Adams, Christopher M.; Lira, Vitor A.] Univ Iowa, Pappajohn Biomed Inst, Iowa City, IA 52242 USA; [Adams, Christopher M.; Lira, Vitor A.] Univ Iowa, Obes Res & Educ Initiat, Iowa City, IA 52242 USA; [Lira, Vitor A.] Univ Iowa, Francois M Abboud Cardiovasc Res Ctr, Iowa City, IA 52242 USA; [Scudese, Estevao] Fed Univ State Rio de Janeiro, Nursing & Biosci, Rio De Janeiro, Brazil	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Lira, VA (corresponding author), Univ Iowa, 169 Newton Rd,4324PBDB, Iowa City, IA 52242 USA.	vitor-lira@uiowa.edu	Lira, Vitor/AAN-3403-2021; Oliveira de Sousa, Luis Gustavo/M-6807-2017	Lira, Vitor/0000-0002-3162-3804; Adams, Christopher/0000-0002-5795-7212; Turner, Kristen D./0000-0003-4418-5281; Harris, Matthew/0000-0002-8078-3847; Yang, Ling/0000-0002-3105-3063; Oliveira de Sousa, Luis Gustavo/0000-0003-1013-2595	Carver College of Medicine; Fraternal Order of Eagles Pilot Research Grant; American Heart Association [16SDG30360001]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR071762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG060637] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000976] Funding Source: NIH RePORTER	Carver College of Medicine; Fraternal Order of Eagles Pilot Research Grant; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	The authors acknowledge use of the University of Iowa Central Microscopy Research Facility, a core resource supported by the University of Iowa Vice President for Research, and the Carver College of Medicine. This study was supported by a Fraternal Order of Eagles Pilot Research Grant and American Heart Association Grant 16SDG30360001 (to V.A.L.). The authors declare no conflicts of interest.	Ayyadevara S, 2016, AGING-US, V8, P3486, DOI 10.18632/aging.101141; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Bongers KS, 2013, AM J PHYSIOL-ENDOC M, V305, pE907, DOI 10.1152/ajpendo.00380.2013; Buford TW, 2010, AGEING RES REV, V9, P369, DOI 10.1016/j.arr.2010.04.004; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Ebert SM, 2012, J BIOL CHEM, V287, P27290, DOI 10.1074/jbc.M112.374777; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Gavriilidis C, 2018, NAT CELL BIOL, V20, P198, DOI 10.1038/s41556-017-0024-9; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang J, 1998, P NATL ACAD SCI USA, V95, P12100, DOI 10.1073/pnas.95.21.12100; Joo JH, 2011, MOL CELL, V43, P572, DOI 10.1016/j.molcel.2011.06.018; Ju JS, 2010, AUTOPHAGY, V6, P929, DOI 10.4161/auto.6.7.12785; Kamel HK, 2003, NUTR REV, V61, P157, DOI 10.1301/nr.2003.may.157-167; Kitajima Y, 2014, J CELL SCI, V127, P5204, DOI 10.1242/jcs.150961; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Koukourikos Konstantinos, 2014, Acta Inform Med, V22, P406, DOI 10.5455/aim.2014.22.406-410; Larson CM, 2000, J PEDIATR ORTHOPED, V20, P71, DOI 10.1097/00004694-200001000-00016; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lee EJ, 2011, AUTOPHAGY, V7, P689, DOI 10.4161/auto.7.7.15450; Lim J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004987; Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486; Lystad AH, 2015, METHODS, V75, P112, DOI 10.1016/j.ymeth.2014.12.019; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; McMillan EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119382; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Miranda DR, 2017, J GEN PHYSIOL, V149, P55, DOI 10.1085/jgp.201611603; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; O'Neill BT, 2016, J CLIN INVEST, V126, P3433, DOI 10.1172/JCI86522; Park JM, 2016, AUTOPHAGY, V12, P547, DOI 10.1080/15548627.2016.1140293; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Ro SH, 2013, AUTOPHAGY, V9, P2103, DOI 10.4161/auto.26563; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Sathasivam K, 1999, HUM MOL GENET, V8, P813, DOI 10.1093/hmg/8.5.813; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Shukla S, 2014, J BIOL CHEM, V289, P22306, DOI 10.1074/jbc.M114.567032; Solomon V, 1998, J BIOL CHEM, V273, P25216, DOI 10.1074/jbc.273.39.25216; THIEBAUD D, 1982, DIABETES, V31, P957, DOI 10.2337/diacare.31.11.957; Visser M, 2011, CLIN GERIATR MED, V27, P387, DOI 10.1016/j.cger.2011.03.006; Walrand S, 2011, CLIN GERIATR MED, V27, P365, DOI 10.1016/j.cger.2011.03.005; Weihl CC, 2010, CURR OPIN NEUROL, V23, P482, DOI 10.1097/WCO.0b013e32833d3897; Yan Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08480-2; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zhou J, 2017, AGING-US, V9, P583, DOI 10.18632/aging.101181	54	20	21	2	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					11735	11745		10.1096/fj.201900766R	http://dx.doi.org/10.1096/fj.201900766R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31361156	Green Published, hybrid			2022-12-28	WOS:000507461600013
J	Gulman, NK; Armon, L; Shalit, T; Urbach, A				Gulman, Nelly Komarovsky; Armon, Leah; Shalit, Tali; Urbach, Achia			Heterochronic regulation of lung development via the Lin28-Let-7 pathway	FASEB JOURNAL			English	Article						heterochronic genes; miRNA; organogenesis	GROWTH-FACTOR-BETA; PROGENITOR CELLS; EMBRYONIC LUNG; LIN28; MORPHOGENESIS; METABOLISM; MECHANISMS; EXPRESSION; GENERATION; EPITHELIUM	The heterochronic gene Lin28 regulates diverse developmental processes. It was shown previously that global Lin28A overexpression during mouse embryogenesis results in perinatal lethality. However, the reason for this early lethality has not been elucidated. Here, we showed that Lin28A overexpression prevents normal lung development via the inhibition of the Let-7 micro RNAs, thus causing the perinatal lethality. We further found that Lin28A overexpression in lung mesenchymal cells, but not epithelial cells, is sufficient to recapitulate the lung phenotype. Moreover, we defined the specific time window wherein Lin28A expression exerts its effect. Deep characterization of the transgenic lungs suggests that the Lin28A-Let-7 pathway delays the transition from one developmental stage to another but does not completely abrogate the differentiation capacity of the lung progenitor cells. Finally, we suggested that the effect of Lin28A-Let-7 on embryonic lung development is mediated at least in part through the TGF-beta 1-signaling pathway. Altogether, these findings define for the first time the Lin28-Let-7 pathway as a critical heterochronic regulator of lung development.	[Gulman, Nelly Komarovsky; Armon, Leah; Urbach, Achia] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Shalit, Tali] Weizmann Inst Sci, Nancy & Stephen Grand Israel Natl Ctr Personalize, Ilana & Pascal Mantoux Inst Bioinformat, Rehovot, Israel	Bar Ilan University; Weizmann Institute of Science	Urbach, A (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	achia.urbach@biu.ac.il	/GLR-9975-2022	Urbach, Achia/0000-0001-9393-4504	Israel Science Foundation (ISF) [1389/15, 1204/17]	Israel Science Foundation (ISF)(Israel Science Foundation)	The authors thank Dr. Daley (Boston Children's Hospital, Boston, MA, USA) for kindly providing the Lox-stop-Lox-TetOnLin28A mice, Dr. Avi Jacob and Dr. Irit Shoval (Scientific Equipment Center, Bar-Ilan University) for helping with the confocal microscopy analysis, and the staff at the Crown Genomics Institute of the Nancy and Stephen Grand Israel National Center for Personalized Medicine (Weizmann Institute of Science) for performing the RNA sequencing. This work was funded by Israel Science Foundation (ISF) Grants 1389/15 and 1204/17. The authors declare no conflicts of interest.	AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Balzeau J, 2017, FRONT GENET, V8, P1, DOI 10.3389/fgene.2017.00031; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Bragg AD, 2001, MECH DEVELOP, V109, P13, DOI 10.1016/S0925-4773(01)00508-1; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Carmel-Gross I, 2016, STEM CELLS DEV, V25, P367, DOI 10.1089/scd.2015.0322; Chen YW, 2017, NAT CELL BIOL, V19, P542, DOI 10.1038/ncb3510; Conesa A, 2006, BIOINFORMATICS, V22, P1096, DOI 10.1093/bioinformatics/btl056; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Dixit R, 2013, DEVELOPMENT, V140, P4398, DOI 10.1242/dev.098079; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Herriges M, 2014, DEVELOPMENT, V141, P502, DOI 10.1242/dev.098186; Jiang S, 2016, CANCER LETT, V375, P108, DOI 10.1016/j.canlet.2016.02.050; Keyte AL, 2014, SEMIN CELL DEV BIOL, V34, P99, DOI 10.1016/j.semcdb.2014.06.015; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Lu Yun, 2008, Proc Am Thorac Soc, V5, P300, DOI 10.1513/pats.200710-162DR; Ludtke TH, 2016, DEV CELL, V39, P239, DOI 10.1016/j.devcel.2016.08.007; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McCulley D, 2015, CURR OPIN GENET DEV, V32, P98, DOI 10.1016/j.gde.2015.01.011; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Moss EG, 2007, CURR BIOL, V17, pR425, DOI 10.1016/j.cub.2007.03.043; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Orgeig S, 2016, COMPR PHYSIOL, V6, P363, DOI 10.1002/cphy.c150003; Peng SP, 2011, STEM CELLS, V29, P496, DOI 10.1002/stem.591; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Rawlins EL, 2012, AM J RESP CELL MOL, V46, P269, DOI 10.1165/rcmb.2011-0372PS; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Robinton DA, 2019, DEV CELL, V48, P396, DOI 10.1016/j.devcel.2018.12.016; Romer-Seibert JS, 2019, FASEB J, V33, P3291, DOI 10.1096/fj.201801118R; Saito A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082460; Saito A, 2015, AM J PHYSIOL-LUNG C, V309, pL756, DOI 10.1152/ajplung.00238.2015; Sanford EL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149425; Shinoda G, 2013, STEM CELLS, V31, P1563, DOI 10.1002/stem.1423; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Smith KK, 2003, INT J DEV BIOL, V47, P613; Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Tu HC, 2015, GENE DEV, V29, P1074, DOI 10.1101/gad.256693.114; Urbach A, 2014, GENE DEV, V28, P971, DOI 10.1101/gad.237149.113; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Wilbert ML, 2012, MOL CELL, V48, P195, DOI 10.1016/j.molcel.2012.08.004; Yang M, 2015, DEVELOPMENT, V142, P1616, DOI 10.1242/dev.120543; Yermalovich AV, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08127-4; Zhang J, 2016, CELL STEM CELL, V19, P66, DOI 10.1016/j.stem.2016.05.009; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	56	6	7	2	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12008	12018		10.1096/fj.201802702R	http://dx.doi.org/10.1096/fj.201802702R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31373834	Bronze, Green Published			2022-12-28	WOS:000507461600032
J	Baroli, B; Loi, E; Solari, P; Kasture, A; Moi, L; Muroni, P; Kasture, S; Setzu, MD; Liscia, A; Zavattari, P				Baroli, Biancamaria; Loi, Eleonora; Solari, Paolo; Kasture, Ameya; Moi, Loredana; Muroni, Patrizia; Kasture, Sanjay; Setzu, Maria Dolores; Liscia, Anna; Zavattari, Patrizia			Evaluation of oxidative stress mechanisms and the effects of phytotherapic extracts on Parkinson's disease Drosophila PINK1(B9) model	FASEB JOURNAL			English	Article						Drosophila melanogaster; PINK1(B9) mutants; phytotherapic preparations; telomere length	AGING-ASSOCIATED ALTERATION; TELOMERE LENGTH; MITOCHONDRIAL DYSFUNCTION; MELANOGASTER; GLUTATHIONE; MUTATIONS; APOPTOSIS; MUTANTS; MUSCLE; RISK	Oxidative stress is commonly observed in both idiopathic and genetic cases of Parkinson's disease (PD). It plays an important role in the degeneration of dopaminergic neurons, and it has been associated with altered telomere length (TL). There is currently no cure for PD, and extracts of antioxidative plant, such as Mucuna pruriens and Withania somnifera, are commonly used in Ayurveda to treat patients with PD. In this study, we evaluated 2 enzymatic markers of oxidative stress, glutathione (GSH) system and superoxide dismutase (SOD), and TL in a Drosophila melanogaster model for PD [phosphatase and tensin homolog-induced putative kinase 1 (PINK1)(B9)]. This evaluation was also performed after treatment with the phytoextracts. PINK1(B9) mutants showed a decrease in GSH amount and SOD activity and unexpected longer telomeres compared with wild-type flies. M. pruriens treatment seemed to have a beneficial effect on the oxidative stress conditions. On the other hand, W. somnifera treatment did not show any improvements in the studied oxidative stress mechanisms and even seemed to favor the selection of flies with longer telomeres. In summary, our study suggests the importance of testing antioxidant phytoextracts in a PINK1(B9) model to identify beneficial effects for PD.-Baroli, B., Loi, E., Solari, P., Kasture, A., Moi, L., Muroni, P., Kasture, S., Setzu, M. D., Liscia, A., Zavattari, P. Evaluation of oxidative stress mechanisms and the effects of phytotherapic extracts on Parkinson's disease Drosophila PINK1(B9) model.	[Baroli, Biancamaria] Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy; [Loi, Eleonora; Solari, Paolo; Moi, Loredana; Muroni, Patrizia; Setzu, Maria Dolores; Liscia, Anna; Zavattari, Patrizia] Univ Cagliari, Dept Biomed Sci, Univ Campus,SP 8, I-09042 Cagliari, Italy; [Kasture, Ameya] Univ Vienna, Dept Neurobiol, Vienna, Austria; [Kasture, Sanjay] Pinnacle Biomed Res Inst, Bhopal, India	University of Cagliari; University of Cagliari; University of Vienna	Liscia, A (corresponding author), Univ Cagliari, Dept Biomed Sci, Univ Campus,SP 8, I-09042 Cagliari, Italy.	liscia@unica.it	Loi, Eleonora/Y-2968-2019	Loi, Eleonora/0000-0001-6437-4763; Kasture, Ameya/0000-0002-2947-4803; /0000-0001-8785-1438				Ahmed S, 1998, GENETICS, V150, P643; Alam N, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-175; Alviano DS, 2009, CURR PHARM BIOTECHNO, V10, P106, DOI 10.2174/138920109787048607; Bharath S, 2002, BIOCHEM PHARMACOL, V64, P1037, DOI 10.1016/S0006-2952(02)01174-7; Bjorklund A, 2010, PROG BRAIN RES, V184, P3, DOI 10.1016/S0079-6123(10)84001-4; Cai ZY, 2013, NEUROMOL MED, V15, P25, DOI 10.1007/s12017-012-8207-9; Celotto AM, 2005, MOL INTERV, V5, P292, DOI 10.1124/mi.5.5.9; De Rose F, 2017, SCI REP-UK, V7, DOI 10.1038/srep41059; De Rose F, 2016, PARKINSONS DIS-US, V2016, DOI 10.1155/2016/3508073; De Rose F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146140; Degerman S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113387; Deocaris CC, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-14; Dutta K, 2018, EXP NEUROL, V309, P193, DOI 10.1016/j.expneurol.2018.08.008; Forero DA, 2016, EXP GERONTOL, V75, P53, DOI 10.1016/j.exger.2016.01.002; Frydrychova RC, 2008, CYTOGENET GENOME RES, V122, P356, DOI 10.1159/000167823; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Gonzalez-Ebsen AC, 2017, FRONT BIOSCI-LANDMRK, V22, P117, DOI 10.2741/4475; Ichikawa H, 2006, MOL CANCER THER, V5, P1434, DOI 10.1158/1535-7163.MCT-06-0096; Jenner P, 1996, NEUROLOGY, V47, pS161, DOI 10.1212/WNL.47.6_Suppl_3.161S; Kasture S, 2013, ORIENTAL PHARM EXP M, V13, P165, DOI 10.1007/s13596-013-0126-2; Keller MF, 2012, HUM MOL GENET, V21, P4996, DOI 10.1093/hmg/dds335; Korandova M, 2018, J INSECT PHYSIOL, V104, P1, DOI 10.1016/j.jinsphys.2017.11.002; Liu ZH, 2011, PHARMACOL RES, V63, P439, DOI 10.1016/j.phrs.2011.01.004; Maeda T, 2012, J NEUROGENET, V26, P245, DOI 10.3109/01677063.2011.651665; Maeda T, 2009, J GERONTOL A-BIOL, V64, P949, DOI 10.1093/gerona/glp070; Manyam BV, 2004, PHYTOTHER RES, V18, P706, DOI 10.1002/ptr.1514; Misra L, 2007, INDIAN J BIOCHEM BIO, V44, P56; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034; Poddighe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110802; Poddighe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073156; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Raffa G D, 2013, Tsitologiia, V55, P204; Raffa GD, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00112; Roberts RO, 2014, MECH AGEING DEV, V141, P64, DOI 10.1016/j.mad.2014.10.002; Salim S, 2017, J PHARMACOL EXP THER, V360, P201, DOI 10.1124/jpet.116.237503; Savage Sharon A, 2018, F1000Res, V7, DOI 10.12688/f1000research.14068.1; Senthil V, 2007, CHEM-BIOL INTERACT, V167, P19, DOI 10.1016/j.cbi.2007.01.004; Solari P, 2018, J INSECT PHYSIOL, V111, P32, DOI 10.1016/j.jinsphys.2018.10.007; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vasantharaja Raguraman, 2016, Advances in Bioscience and Biotechnology, V7, P199, DOI 10.4236/abb.2016.74018; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Walter MF, 2007, CHROMOSOMA, V116, P41, DOI 10.1007/s00412-006-0081-5; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Wu DF, 2018, STAT PUBLIC POLICY, V5, P1, DOI 10.1080/2330443X.2018.1438939; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103	48	7	8	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11028	11034		10.1096/fj.201901010	http://dx.doi.org/10.1096/fj.201901010			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31291788	Green Submitted			2022-12-28	WOS:000489166300038
J	Salizzato, V; Zanin, S; Borgo, C; Lidron, E; Salvi, M; Rizzuto, R; Pallafacchina, G; Donella-Deana, A				Salizzato, Valentina; Zanin, Sofia; Borgo, Christian; Lidron, Elisa; Salvi, Mauro; Rizzuto, Rosario; Pallafacchina, Giorgia; Donella-Deana, Arianna			Protein kinase CK2 subunits exert specific and coordinated functions in skeletal muscle differentiation and fusogenic activity	FASEB JOURNAL			English	Article						myoblast differentiation; myoblast fusion; MyoD expression; muscle development; fusogenic proteins	TRANSCRIPTIONAL MECHANISMS; MYOBLAST FUSION; SATELLITE CELLS; PHOSPHORYLATION; EXPRESSION; COMPLEX; IDENTIFICATION; CAVEOLIN-3; MYOMAKER; PAX3	Casein kinase 2 (CK2) is a tetrameric protein kinase composed of 2 catalytic (alpha and alpha ') and 2 regulatory beta subunits. Our study provides the first molecular and cellular characterization of the different CK2 subunits, highlighting their individual roles in skeletal muscle specification and differentiation. Analysis of C2C12 cell knockout for each CK2 subunit reveals that: 1) CK2 beta is mandatory for the expression of the muscle master regulator myogenic differentiation 1 in proliferating myoblasts, thus controlling both myogenic commitment and subsequent muscle-specific gene expression and myotube formation; 2) CK2 alpha is involved in the activation of the muscle-specific gene program; and 3) CK2 alpha ' activity regulates myoblast fusion by mediating plasma membrane translocation of fusogenic proteins essential for membrane coalescence, like myomixer. Accordingly, CK2 alpha ' overexpression in C2C12 cells and in mouse regenerating muscle is sufficient to increase myofiber size and myonuclei content via enhanced satellite cell fusion. Consistent with these results, pharmacological inhibition of CK2 activity substantially blocks the expression of myogenic markers and muscle cell fusion both in vitro in C2C12 and primary myoblasts and in vivo in mouse regenerating muscle and zebrafish development. Overall, our work describes the specific and coordinated functions of CK2 subunits in orchestrating muscle differentiation and fusogenic activity, highlighting CK2 relevance in the physiopathology of skeletal muscle tissue.-Salizzato, V., Zanin, S., Borgo, C., Lidron, E., Salvi, M., Rizzuto, R., Pallafacchina, G., Donella-Deana, A. Protein kinase CK2 subunits exert specific and coordinated functions in skeletal muscle differentiation and fusogenic activity.	[Salizzato, Valentina; Borgo, Christian; Lidron, Elisa; Salvi, Mauro; Rizzuto, Rosario; Pallafacchina, Giorgia; Donella-Deana, Arianna] Univ Padua, Dept Biomed Sci, Via Ugo Bassi 58-B, I-35131 Padua, Italy; [Zanin, Sofia] Univ Padua, Dept Med, Padua, Italy; [Salizzato, Valentina; Pallafacchina, Giorgia] Italian Natl Res Council CNR, Neurosci Inst, Via Ugo Bassi 58-B, I-35131 Padua, Italy	University of Padua; University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Pallafacchina, G; Donella-Deana, A (corresponding author), Univ Padua, Dept Biomed Sci, Via Ugo Bassi 58-B, I-35131 Padua, Italy.; Pallafacchina, G (corresponding author), Italian Natl Res Council CNR, Neurosci Inst, Via Ugo Bassi 58-B, I-35131 Padua, Italy.	giorgia.pallafacchina@unipd.it; arianna.donella@unipd.it	Pallafacchina, Giorgia/K-4056-2016; Borgo, Christian/AAB-2712-2020; ZANIN, SOFIA/AAJ-5529-2020; Zanin, Sofia/ABA-3509-2021	Pallafacchina, Giorgia/0000-0001-9766-5970; Salvi, Mauro/0000-0003-3448-6048; Rizzuto, Rosario/0000-0001-7044-5097; Salizzato, Valentina/0000-0003-1027-3259; BORGO, CHRISTIAN/0000-0001-9540-8145	University of Padua [PrAt-CPDA130310]; Italian Ministry of Education, University and Research (FIRB); U.S. National Institutes of Health, National Institute on Aging [1P01AG025532-01A1]; NATIONAL INSTITUTE ON AGING [P01AG025532] Funding Source: NIH RePORTER	University of Padua; Italian Ministry of Education, University and Research (FIRB)(Ministry of Education, Universities and Research (MIUR)); U.S. National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. D. W. Litchfield (University of Western Ontario, London, ON, Canada) for kindly sharing the pRcCMV2-CK2 alpha'-HA construct, Dr. D. P. Millay (Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA) and Dr. O. Marin (Department of Biomedical Sciences, University of Padua) for kindly providing anti-myomaker antibody and the eIF2 beta(1-22) peptide, respectively. This work was supported by the University of Padua (PrAt-CPDA130310 to A.D.-D.), the Italian Ministry of Education, University and Research (FIRB; to R.R.), and U.S. National Institutes of Health, National Institute on Aging Grant 1P01AG025532-01A1(to R.R.). The authors declare no conflicts of interest.	Battistutta R, 2011, BIOCHEMISTRY-US, V50, P8478, DOI 10.1021/bi2008382; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Bi P, 2017, SCIENCE, V356, P323, DOI 10.1126/science.aam9361; Bibby AC, 2005, INT J BIOL SCI, V1, P67; Borgo C, 2017, SCI REP-UK, V7, DOI 10.1038/srep42409; BRAUN T, 1989, EMBO J, V8, P4358; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Brini M, 1997, MOL BIOL CELL, V8, P129, DOI 10.1091/mbc.8.1.129; Brown DM, 2012, J MUSCLE RES CELL M, V32, P383, DOI 10.1007/s10974-011-9267-4; BUCHER EA, 1988, MOL CELL BIOL, V8, P4134, DOI 10.1128/MCB.8.10.4134; Buchou T, 2003, MOL CELL BIOL, V23, P908, DOI 10.1128/MCB.23.3.908-915.2003; Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020; Chen JY, 2015, PLANT CELL, V27, P711, DOI 10.1105/tpc.114.135335; Cheusova T, 2006, GENE DEV, V20, P1800, DOI 10.1101/gad.375206; Cornelison DDW, 2000, DEV BIOL, V224, P122, DOI 10.1006/dbio.2000.9682; Dedieu S, 2002, INT J DEV BIOL, V46, P235; Dick SA, 2015, P NATL ACAD SCI USA, V112, pE5246, DOI 10.1073/pnas.1512869112; Dietz KN, 2011, INT J BIOCHEM CELL B, V43, P936, DOI 10.1016/j.biocel.2011.03.010; Dietz KN, 2009, BIOCHEMISTRY-US, V48, P11786, DOI 10.1021/bi9012947; Filhol O, 2004, EMBO REP, V5, P351, DOI 10.1038/sj.embor.7400115; Galbiati F, 1999, J BIOL CHEM, V274, P30315, DOI 10.1074/jbc.274.42.30315; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; Gamage DG, 2017, J BIOL CHEM, V292, P17272, DOI 10.1074/jbc.M117.811372; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; Girardi C, 2014, BBA-MOL CELL RES, V1843, P1865, DOI 10.1016/j.bbamcr.2014.04.020; Gotz C, 2017, BIOMED REP, V6, P127, DOI 10.3892/br.2016.829; Goh Q, 2017, ELIFE, V6, DOI 10.7554/eLife.20007; Gonzalez N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154919; Guerra B, 1999, ELECTROPHORESIS, V20, P391, DOI 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N; Iyengar AS, 2012, BIOCHEM BIOPH RES CO, V428, P24, DOI 10.1016/j.bbrc.2012.09.141; Johnson SE, 1996, MOL CELL BIOL, V16, P1604; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koreishi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054382; Leikina E, 2018, DEV CELL, V46, P767, DOI 10.1016/j.devcel.2018.08.006; Lou DY, 2008, MOL CELL BIOL, V28, P131, DOI 10.1128/MCB.01119-07; LUSCHER B, 1994, EUR J BIOCHEM, V220, P521, DOI 10.1111/j.1432-1033.1994.tb18651.x; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Messenger MM, 2002, J BIOL CHEM, V277, P23054, DOI 10.1074/jbc.M200111200; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Miller PJ, 2008, PROTEIN SCI, V17, P1979, DOI 10.1110/ps.035956.108; Niefind K, 2001, EMBO J, V20, P5320, DOI 10.1093/emboj/20.19.5320; O'Brien A, 2014, BIOINFORMATICS, V30, P2673, DOI 10.1093/bioinformatics/btu354; Padilla-Benavides T, 2017, J BIOL CHEM, V292, P18592, DOI 10.1074/jbc.M117.799676; Pallafacchina G, 2010, STEM CELL RES, V4, P77, DOI 10.1016/j.scr.2009.10.003; Peng BW, 2005, BIOCHEM BIOPH RES CO, V338, P1490, DOI 10.1016/j.bbrc.2005.10.111; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; Prykhozhij SV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138634; Quinn ME, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15665; Ralston E, 1999, EXP CELL RES, V246, P510, DOI 10.1006/excr.1998.4305; Ruegg MA, 1998, TRENDS NEUROSCI, V21, P22, DOI 10.1016/S0166-2236(97)01154-5; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Salvi M, 2006, FEBS LETT, V580, P3948, DOI 10.1016/j.febslet.2006.06.031; Salvi M, 2009, BBA-MOL CELL RES, V1793, P847, DOI 10.1016/j.bbamcr.2009.01.013; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sarno S, 1996, J BIOL CHEM, V271, P10595, DOI 10.1074/jbc.271.18.10595; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHAINBERG A, 1971, DEV BIOL, V25, P1, DOI 10.1016/0012-1606(71)90017-0; Shi J, 2017, P NATL ACAD SCI USA, V114, P11950, DOI 10.1073/pnas.1715229114; Shi XZ, 2012, BIOCHEM J, V446, P349, DOI 10.1042/BJ20120563; Srinivas BP, 2007, NAT GENET, V39, P781, DOI 10.1038/ng2055; St-Denis NA, 2009, CELL MOL LIFE SCI, V66, P1817, DOI 10.1007/s00018-009-9150-2; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Vilk G, 1999, J BIOL CHEM, V274, P14406, DOI 10.1074/jbc.274.20.14406; WADE R, 1990, DEV BIOL, V142, P270, DOI 10.1016/0012-1606(90)90348-M; Wang C, 2017, EBIOMEDICINE, V16, P212, DOI 10.1016/j.ebiom.2017.01.015; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; Winter B, 1997, BIOL CHEM, V378, P1445, DOI 10.1515/bchm.1997.378.12.1445; Xu X, 1999, NAT GENET, V23, P118, DOI 10.1038/12729; ZALIN R, 1972, BIOCHEM J, V130, pP79; Zhang Q, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15664; Zhang WB, 2017, DEV BIOL, V423, P24, DOI 10.1016/j.ydbio.2017.01.019	72	15	15	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10648	10667		10.1096/fj.201801833RR	http://dx.doi.org/10.1096/fj.201801833RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31268746	Bronze, Green Published			2022-12-28	WOS:000489166300007
J	Tsoi, M; Morin, M; Rico, C; Johnson, RL; Paquet, M; Gevry, N; Boerboom, D				Tsoi, Mayra; Morin, Martin; Rico, Charlene; Johnson, Randy L.; Paquet, Marilene; Gevry, Nicolas; Boerboom, Derek			Lats1 and Lats2 are required for ovarian granulosa cell fate maintenance	FASEB JOURNAL			English	Article						transdifferentiation; Sox9; Bglap; RUNX2; Hippo	YES-ASSOCIATED PROTEIN; HIPPO SIGNALING PATHWAY; BETA-CATENIN; MESENCHYMAL TRANSITION; SERTOLI-CELLS; SIZE-CONTROL; YAP; YAP/TAZ; EXPRESSION; GROWTH	Recent reports suggest that the Hippo signaling pathway influences ovarian follicle development; however, its exact roles remain unknown. Here, we examined the ovarian functions of the Hippo kinases large tumor suppressors (LATS)1 and 2, which serve to inactivate the transcriptional coactivators Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ). Inactivation of Lats1/2 in murine granulosa cells either in vitro or in vivo resulted in a loss of granulosa cell morphology, function, and gene expression. Mutant cells further underwent changes in structure and gene expression suggestive of epithelial-to-mesenchymal transition and transdifferentiation into multiple lineages. In vivo, granulosa cell-specific loss of Lats1/2 caused the ovarian parenchyma to be mostly replaced by bone tissue and seminiferous tubule-like structures. Transdifferentiation into Sertoli-like cells and osteoblasts was attributed in part to the increased recruitment of YAP and TAZ to the promoters of sex-determining region Y box 9 and bone gamma-carboxyglutamate protein, key mediators of male sex determination and osteogenesis, respectively. Together, these results demonstrate for the first time a critical role for Lats1/2 in the maintenance of the granulosa cell genetic program and further highlight the remarkable plasticity of granulosa cells.-Tsoi, M., Morin, M., Rico, C., Johnson, R. L., Paquet, M., Gevry, N., Boerboom, D. Lats1 and Lats2 are required for ovarian granulosa cell fate maintenance.	[Tsoi, Mayra; Rico, Charlene; Boerboom, Derek] Univ Montreal, Fac Med Vet, Ctr Rech Reprod & Fertilite, Dept Biomed Vet, 3200 Sicotte, St Hyacinthe, PQ J25 7C6, Canada; [Paquet, Marilene] Univ Montreal, Fac Med Vet, Ctr Rech Reprod & Fertilite, Dept Pathol & Microbiol, 3200 Sicotte, St Hyacinthe, PQ J25 7C6, Canada; [Morin, Martin; Gevry, Nicolas] Univ Sherbrooke, Fac Sci, Dept Biol, Sherbrooke, PQ, Canada; [Johnson, Randy L.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	Universite de Montreal; Universite de Montreal; University of Sherbrooke; University of Texas System; UTMD Anderson Cancer Center	Boerboom, D (corresponding author), Univ Montreal, Fac Med Vet, Ctr Rech Reprod & Fertilite, Dept Biomed Vet, 3200 Sicotte, St Hyacinthe, PQ J25 7C6, Canada.	derek.boerboom@umontreal.ca			Canadian government through Genome Canada; Canadian Institutes of Health Research (CIHR) [MOP-142445]; U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development Specialized Cooperative Centers Program in Reproduction Research (SCCPRR) [U54-HD28934]; Fonds de Recherche du Quebec-Sante (FRQS)	Canadian government through Genome Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development Specialized Cooperative Centers Program in Reproduction Research (SCCPRR); Fonds de Recherche du Quebec-Sante (FRQS)	The authors thank Claude Paquet, Philippe Godin, and Meggie Girard (all from Universite de Montreal) for technical support. The authors thank Jan Gossen (Osteo-Pharma, Oss, The Netherlands) for CYP19-cre mice. The authors thank McGill University and Genome Quebec Innovation Centre (Montreal, QC, Canada) and the Canadian Center for Computational Genomics (C3G; Montreal, QC, Canada) for generating and analyzing microarray data. C3G is a node of the Canadian Genomic Innovation Network and is supported by the Canadian government through Genome Canada. The authors thank Dagmar Wilhelm (University of Melbourne, Parkville, VIC, Australia) for the FOXL2 antibody. The authors thank the Ligand Assay and Analysis Core at the University of Virginia (Charlottesville, VA, USA) for the hormonal measurements. This work was supported by Canadian Institutes of Health Research (CIHR) operating Grant MOP-142445 (to D.B.). The University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core is supported by U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development Specialized Cooperative Centers Program in Reproduction Research (SCCPRR) Grant U54-HD28934. M.T. was supported by a doctoral research award from the Fonds de Recherche du Quebec-Sante (FRQS). The authors declare no conflicts of interest.	Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Barrionuevo FJ, 2016, ELIFE, V5, DOI 10.7554/eLife.15635; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Boerboom D, 2006, CANCER RES, V66, P1964, DOI 10.1158/0008-5472.CAN-05-3493; Boerboom D, 2005, CANCER RES, V65, P9206, DOI 10.1158/0008-5472.CAN-05-1024; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chen T, 2017, J CELL PHYSIOL, V232, P3261, DOI 10.1002/jcp.25797; Cheng Y, 2015, FASEB J, V29, P2423, DOI 10.1096/fj.14-267856; Cui CB, 2003, MOL CELL BIOL, V23, P1004, DOI 10.1128/MCB.23.3.1004-1013.2003; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Dzafic E, 2013, J ASSIST REPROD GEN, V30, P1255, DOI 10.1007/s10815-013-0068-0; Fan HY, 2008, MOL ENDOCRINOL, V22, P2128, DOI 10.1210/me.2008-0095; Fan HY, 2008, DEVELOPMENT, V135, P2127, DOI 10.1242/dev.020560; Fu V, 2017, CURR OPIN CELL BIOL, V49, P99, DOI 10.1016/j.ceb.2017.12.012; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Heath E, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-18; Hindley CJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23208; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang ZH, 2016, DEVELOPMENT, V143, P2398, DOI 10.1242/dev.130658; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kawamura K, 2013, P NATL ACAD SCI USA, V110, P17474, DOI 10.1073/pnas.1312830110; Kent J, 1996, DEVELOPMENT, V122, P2813; Kossowska-Tomaszczuk K, 2009, STEM CELLS, V27, P210, DOI 10.1634/stemcells.2008-0233; Lee DH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11961; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Levasseur A, 2017, BIOL REPROD, V97, P162, DOI 10.1093/biolre/iox057; Li YQ, 2017, J BIOL CHEM, V292, P17577, DOI 10.1074/jbc.M117.811349; Lindeman RE, 2015, CURR BIOL, V25, P764, DOI 10.1016/j.cub.2015.01.034; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Malik AR, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00237; Mattioli M, 2012, THERIOGENOLOGY, V77, P1425, DOI 10.1016/j.theriogenology.2011.11.008; McNeill H, 2017, J AM SOC NEPHROL, V28, P852, DOI 10.1681/ASN.2016060611; Miesfeld JB, 2015, DEVELOPMENT, V142, P3021, DOI 10.1242/dev.119008; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Oki Y, 2012, BIOCHEM J, V447, P239, DOI 10.1042/BJ20120172; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Park GS, 2016, ONCOTARGET, V7, P24063, DOI 10.18632/oncotarget.8211; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Poon CLC, 2016, CURR BIOL, V26, P1034, DOI 10.1016/j.cub.2016.02.009; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Nguyen Q, 2015, DIGEST LIVER DIS, V47, P826, DOI 10.1016/j.dld.2015.05.011; Roca H, 2008, NUCLEIC ACIDS RES, V36, P1723, DOI 10.1093/nar/gkn022; Sasaki H, 2017, DEV GROWTH DIFFER, V59, P12, DOI 10.1111/dgd.12335; Sforza C, 2003, EARLY HUM DEV, V74, P27, DOI 10.1016/S0378-3782(03)00081-1; Song SM, 2014, CANCER RES, V74, P4170, DOI 10.1158/0008-5472.CAN-13-3569; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Svotelis A, 2009, METHODS MOL BIOL, V543, P243, DOI 10.1007/978-1-60327-015-1_16; Tang Y, 2016, NAT CELL BIOL, V18, P917, DOI 10.1038/ncb3394; Teplyuk NM, 2008, J BIOL CHEM, V283, P27585, DOI 10.1074/jbc.M802453200; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Varras M, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-36; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Vitolol MI, 2007, CANCER BIOL THER, V6, P856, DOI 10.4161/cbt.6.6.4241; Wang R, 2017, ONCOTARGET, V8, P24804, DOI 10.18632/oncotarget.15063; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060; Zhang H, 2014, J BIOL CHEM, V289, P18681, DOI 10.1074/jbc.M114.554584; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	69	14	14	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10819	10832		10.1096/fj.201900609R	http://dx.doi.org/10.1096/fj.201900609R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31268774	Green Published			2022-12-28	WOS:000489166300020
J	Yuan, YY; Zhao, XY; Wang, P; Mei, F; Zhou, JT; Jin, Y; McNutt, MA; Yin, YX				Yuan, Yuyao; Zhao, Xuyang; Wang, Pan; Mei, Fan; Zhou, Juntuo; Jin, Yan; McNutt, Michael A.; Yin, Yuxin			PTEN alpha regulates endocytosis and modulates olfactory function	FASEB JOURNAL			English	Article						Ap2b1; olfaction; neurodegenerative disease; amphiphysin	PROTEIN-KINASE; AMPHIPHYSIN-I; BAR DOMAIN; CLATHRIN; NEUROGENESIS; DYSFUNCTION; NEURONS; CELLS; BULB; PHOSPHORYLATION	Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) alpha is the first identified isoform of the well-known tumor suppressor PTEN. PTEN alpha has an evolutionarily conserved 173-aa N terminus compared with canonical PTEN. Recently, PTEN alpha has been shown to play roles in multiple biologic processes including learning and memory, cardiac homeostasis, and antiviral immunity. Here, we report that PTEN alpha maintains mitral cells in olfactory bulb (OB), regulates endocytosis in OB neurons, and controls olfactory behaviors in mice. We show that PTEN alpha directly dephosphorylates the endocytic protein amphiphysin and promotes its binding to adaptor-related protein complex 2 subunit beta 1 (Ap2b1). In addition, we identified mutations in the N terminus of PTEN alpha in patients with Parkinson disease and Lewy-body dementia, which are neurodegenerative disorders with early olfactory loss. Overexpression of PTEN alpha mutant H169N in mice OB reduces odor sensitivity. Our data demonstrate a role of PTEN alpha in olfactory function and provide insight into the mechanism of olfactory dysfunction in neurologic disorders.-Yuan, Y., Zhao, X., Wang, P., Mei, F., Zhou, J., Jin, Y., McNutt, M. A., Yin, Y. PTEN alpha regulates endocytosis and modulates olfactory function.	[Yuan, Yuyao; Wang, Pan; Mei, Fan; Zhou, Juntuo; Jin, Yan; McNutt, Michael A.; Yin, Yuxin] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Inst Syst Biomed, 38 Xueyuan Rd, Beijing 100191, Peoples R China; [Yuan, Yuyao; Zhao, Xuyang; Wang, Pan; Mei, Fan; Yin, Yuxin] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Pathol, Beijing, Peoples R China; [Yin, Yuxin] Peking Univ, Hlth Sci Ctr, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	Peking University; Peking University; Peking University	Yin, YX (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Inst Syst Biomed, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	yinyuxin@hsc.pku.edu.cn			National Key Research and Development Program of China [2016YFA0500302]; National Natural Science Foundation of China [81430056, 31420103905, 81372491]; Beijing Natural Science Foundation [7161007]; Lam Chung Nin Foundation for Systems Biomedicine; National Natural Scientific Foundation of China [31800849]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Lam Chung Nin Foundation for Systems Biomedicine; National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank X. Meng (Peking University Health Science Center) for genomic DNA extraction from blood samples, Jia Liu (Peking University Health Science Center) for neurotransmitter quantification by liquid chromatography with tandem mass spectrometry (LC-MS-MS), and L. Liang (Peking University Health Science Center) for protein expression and purification from Sf9 cells. This work was supported by grants to Y.Y., including the National Key Research and Development Program of China (Grant 2016YFA0500302), the National Natural Science Foundation of China (Grants 81430056, 31420103905, and 81372491), the Beijing Natural Science Foundation (Key Grant 7161007), and the Lam Chung Nin Foundation for Systems Biomedicine. P.W. was supported by the National Natural Scientific Foundation of China (Grant 31800849). The authors declare no conflicts of interest.	Amiri A, 2012, J NEUROSCI, V32, P5880, DOI 10.1523/JNEUROSCI.5462-11.2012; Ayuso-Sacido A, 2010, J NEURO-ONCOL, V97, P323, DOI 10.1007/s11060-009-0035-x; Bear DM, 2016, CURR BIOL, V26, pR1039, DOI 10.1016/j.cub.2016.09.011; Berg DA, 2013, DEVELOPMENT, V140, P2548, DOI 10.1242/dev.088005; Cao YY, 2018, CELL MOL IMMUNOL, V15, P48, DOI 10.1038/cmi.2017.102; Cave JW, 2016, NPJ PARKINSONS DIS, V2, DOI 10.1038/npjparkd.2016.11; COROTTO FS, 1994, NEUROSCIENCE, V61, P739, DOI 10.1016/0306-4522(94)90397-2; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Craft GE, 2008, MOL CELL PROTEOMICS, V7, P1146, DOI 10.1074/mcp.M700351-MCP200; Daynac M, 2016, SCI REP-UK, V6, DOI 10.1038/srep21505; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; Doty RL, 2008, ANN NEUROL, V63, P7, DOI 10.1002/ana.21327; Doty RL, 2017, LANCET NEUROL, V16, P478, DOI 10.1016/S1474-4422(17)30123-0; Doty RL, 2012, NAT REV NEUROL, V8, P329, DOI 10.1038/nrneurol.2012.80; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Fjorback AW, 2009, J MOL NEUROSCI, V37, P191, DOI 10.1007/s12031-008-9092-4; Floyd SR, 2001, J BIOL CHEM, V276, P8104, DOI 10.1074/jbc.M008932200; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Hong SY, 2013, CANCER RES, V73, P5266, DOI 10.1158/0008-5472.CAN-12-4441; Hopkins BD, 2013, SCIENCE, V341, P399, DOI 10.1126/science.1234907; Hsiao SJ, 2017, CSH MOL CASE STUD, V3, DOI 10.1101/mcs.a001396; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Kawauchi T, 2012, INT J MOL SCI, V13, P4564, DOI 10.3390/ijms13044564; Kobayashi N, 2014, BIOCHEM BIOPH RES CO, V453, P473, DOI 10.1016/j.bbrc.2014.09.108; Kovacs T, 2004, AGEING RES REV, V3, P215, DOI 10.1016/j.arr.2003.10.003; Kreis P, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00023; Li GL, 2018, AUTOPHAGY, V14, P1742, DOI 10.1080/15548627.2018.1489477; Liang H, 2014, CELL METAB, V19, P836, DOI 10.1016/j.cmet.2014.03.023; Masson GR, 2016, BIOCHEM J, V473, P135, DOI 10.1042/BJ20150931; Meinecke M, 2013, J BIOL CHEM, V288, P6651, DOI 10.1074/jbc.M112.444869; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Murphy C, 2002, JAMA-J AM MED ASSOC, V288, P2307, DOI 10.1001/jama.288.18.2307; Nakai W, 2013, MOL BIOL CELL, V24, P2570, DOI 10.1091/mbc.E13-04-0197; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Rosselli-Murai LK, 2018, J CELL SCI, V131, DOI 10.1242/jcs.208926; Saheki Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005645; Sekiguchi M, 2013, ARCH BIOCHEM BIOPHYS, V535, P257, DOI 10.1016/j.abb.2013.04.012; Shang WH, 2004, J BIOL CHEM, V279, P40890, DOI 10.1074/jbc.M404527200; Slepnev VI, 2000, J BIOL CHEM, V275, P17583, DOI 10.1074/jbc.M910430199; Suetsugu S, 2014, PHYSIOL REV, V94, P1219, DOI 10.1152/physrev.00040.2013; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Tojima T, 2014, J NEUROSCI, V34, P7165, DOI 10.1523/JNEUROSCI.5261-13.2014; Tojima T, 2010, NEURON, V66, P370, DOI 10.1016/j.neuron.2010.04.007; Trempe JF, 2009, MOL CELL, V36, P1034, DOI 10.1016/j.molcel.2009.11.021; Wang LM, 2018, CELL RES, V28, P787, DOI 10.1038/s41422-018-0056-0; Wang P, 2017, CELL REP, V19, P2627, DOI 10.1016/j.celrep.2017.05.088; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Wigge P, 1998, TRENDS NEUROSCI, V21, P339, DOI 10.1016/S0166-2236(98)01264-8; Williams MR, 2015, J NEUROSCI, V35, P943, DOI 10.1523/JNEUROSCI.3144-14.2015; Wu YM, 2009, ACTA MED OKAYAMA, V63, P305; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102; Zhao XN, 2013, P NATL ACAD SCI USA, V110, P11023, DOI 10.1073/pnas.1217727110	53	2	2	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11148	11162		10.1096/fj.201900588RR	http://dx.doi.org/10.1096/fj.201900588RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31291551				2022-12-28	WOS:000489166300048
J	Zhang, SY; Zhang, XB				Zhang, Siyuan; Zhang, Xiaobo			Shrimp miRNA suppresses the stemness of human cancer stem cells via the PIN1 pathway	FASEB JOURNAL			English	Article						shrimp mja-miR-35; cross-species; human PIN1; tumorigenesis	PROLYL-ISOMERASE PIN1; VIRUS-INFECTION; BREAST-CANCER; MICRORNAS; PHOSPHORYLATION; ACTIVATION; MARKER; TARGET; NANOG	A tumor can be regarded as a cell mass with a biologic hierarchy that is orchestrated by cancer stem cells. The specific features of cancer stem cells may result from a series of gene expression regulatory mechanisms. As important regulatory factors of gene expression, microRNAs (miRNAs) have critical roles in the self-renewal, pluripotency, differentiation, and tumorigenicity of cancer stem cells. However, the effects of animal miRNAs on cancer stem cells have not been investigated extensively. Here, we report that miRNA of a shrimp, Marsupenaeus japonicus (mja-miR-35-3p), which possesses antiviral activity in shrimp, could suppress the proliferation of melanoma and breast cancer stem cells, but not cancer nonstem cells, by arresting the cell cycle in the G(1) phase and inducing apoptosis. Shrimp mja-miR-35-3p (named mja-miR-35) targets the human peptidylprolyl cis/trans isomerase, never in mitosis gene a-interacting 1 (PIN1) gene, which is up-regulated in cancer stem cells. The results indicated that PIN1 silencing caused cell cycle arrest in the G(1) phase, induced apoptosis, and decreased the sphere-forming capacity of cancer stem cells, but not cancer nonstem cells, showing that PIN1 had beneficial effects against the stemness of cancer stem cells. The in vivo data revealed that shrimp mja-miR-35 suppressed the stemness of cancer stem cells in mice by inhibiting the PIN1 antiapoptotic-cell cycle pathway. These findings demonstrated that the miRNAs of aquatic animals might be an important source for discovering human antitumor drugs.-Zhang, S., Zhang, X. Shrimp miRNA suppresses the stemness of human cancer stem cells via the PIN1 pathway.	[Zhang, Siyuan; Zhang, Xiaobo] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Siyuan; Zhang, Xiaobo] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Shandong, Peoples R China	Zhejiang University; Qingdao National Laboratory for Marine Science & Technology	Zhang, XB (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	zxb0812@zju.edu.cn		Zhang, Xiaobo/0000-0003-4606-212X	China Ocean Mineral Resources Research and Development Association [DY135-B-04]; Marine Biology and Biotechnology of Qingdao National Laboratory for Marine Science and Technology [MS2018N005]	China Ocean Mineral Resources Research and Development Association; Marine Biology and Biotechnology of Qingdao National Laboratory for Marine Science and Technology	This study was supported by the China Ocean Mineral Resources Research and Development Association (DY135-B-04) and the Marine Biology and Biotechnology of Qingdao National Laboratory for Marine Science and Technology (MS2018N005). The authors declare no conflicts of interest.	Abraham BK, 2005, CLIN CANCER RES, V11, P1154; Asghar U, 2015, NAT REV DRUG DISCOV, V14, P130, DOI 10.1038/nrd4504; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berindan-Neagoe I, 2014, CLIN CANCER RES, V20, P6247, DOI 10.1158/1078-0432.CCR-13-2500; Bourguignon LYW, 2012, ONCOGENE, V31, P149, DOI 10.1038/onc.2011.222; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chai S, 2016, HEPATOLOGY, V64, P2062, DOI 10.1002/hep.28821; Chen YL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02071; Cui YL, 2017, MOL THER-NUCL ACIDS, V9, P387, DOI 10.1016/j.omtn.2017.10.016; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; Dick JE, 2009, NAT BIOTECHNOL, V27, P44, DOI 10.1038/nbt0109-44; Ding QQ, 2008, CANCER RES, V68, P6109, DOI 10.1158/0008-5472.CAN-08-0579; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; He TL, 2018, ONCOGENE, V37, P5766, DOI 10.1038/s41388-018-0376-z; He YD, 2017, FASEB J, V31, P2854, DOI 10.1096/fj.201601141RR; Huang TZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-159; Imaizumi A, 2016, ANTICANCER RES, V36, P653; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jin CY, 2016, ONCOTARGETS THER, V9, P5483, DOI 10.2147/OTT.S102386; Liao P, 2017, MOL CELL, V68, P1134, DOI 10.1016/j.molcel.2017.11.006; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Liu C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14270; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu ZM, 2014, CELL RES, V24, P1033, DOI 10.1038/cr.2014.109; Mohamed A, 2013, AM J PATHOL, V183, P1096, DOI 10.1016/j.ajpath.2013.07.005; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Rustighi A, 2014, EMBO MOL MED, V6, P99, DOI 10.1002/emmm.201302909; Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040; Sun X, 2014, ONCOGENE, V33, P4967, DOI [10.1038/onc.2013.492, 10.1038/onc.2014.224]; Wei S, 2015, NAT MED, V21, P457, DOI 10.1038/nm.3839; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yang F, 2017, CANCER RES, V77, P5543, DOI 10.1158/0008-5472.CAN-17-1375; Zhou XZ, 2016, NAT REV CANCER, V16, P463, DOI 10.1038/nrc.2016.49	35	8	9	2	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10767	10779		10.1096/fj.201900395RR	http://dx.doi.org/10.1096/fj.201900395RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31284761				2022-12-28	WOS:000489166300016
J	Patel, S; Tang, JQ; Overstreet, JM; Anorga, S; Lian, F; Arnouk, A; Goldschmeding, R; Higgins, PJ; Samarakoon, R				Patel, Samik; Tang, Jiaqi; Overstreet, Jessica M.; Anorga, Sandybell; Lian, Fei; Arnouk, Alex; Goldschmeding, Roel; Higgins, Paul J.; Samarakoon, Rohan			Rac-GTPase promotes fibrotic TGF-beta 1 signaling and chronic kidney disease via EGFR, p53, and Hippo/YAP/TAZ pathways	FASEB JOURNAL			English	Article						Rac1; renal fibrosis; NADPH oxidases; CTGF; PAI-1	CELL-CYCLE ARREST; NADPH-OXIDASE; RENAL FIBROSIS; TGF-BETA; ANGIOTENSIN-II; TARGET GENES; ACTIVATION; INJURY; MODEL; INHIBITION	Rac-GTPases are major regulators of cytoskeletal remodeling and their deregulation contributes to numerous pathologies. Whether or how Rac promotes tubulointerstitial fibrosis and chronic kidney disease (CKD) is currently unknown. We showed that the major profibrotic cytokine, TGF-beta 1 promoted rapid Rac1-GTP loading in human kidney 2 (HK-2) human renal epithelial cells. A Rac-specific chemical inhibitor, EHT 1864, blocked TGF-beta 1-induced fibrotic reprogramming in kidney epithelial cells and fibroblasts. Stable Rac1 depletion in HK-2 cells, moreover, eliminated TGF-beta 1-mediated non-SMAD pathway activation [e.g., Src, epidermal growth factor receptor (EGFR), p53] and subsequent plasminogen activator inhibitor-1 (PAI-1), connective tissue growth factor, fibronectin, and p21 induction. Rac1 and p22(phox) knockdown abrogated free radical generation by TGF-beta 1 in HK-2 cells, consistent with the role of Rac1 in NAPD(H). TGF-beta 1-induced renal epithelial cytostasis was also completely bypassed by Rac1, p22(phox), p47(phox), and PAI-1 silencing. Rac1b isoform expression was robustly induced in the fibrotic kidneys of mice and humans. Intraperitoneal administration of EHT 1864 in mice dramatically attenuated ureteral unilateral obstruction-driven EGFR, p53, Rac1b, yes-associated protein/transcriptional coactivator with PDZ-binding motif activation/expression, dedifferentiation, cell cycle arrest, and renal fibrogenesis evident in vehicle-treated obstructed kidneys. Thus, the Rac1-directed redox response is critical for TGF-beta 1-driven epithelial dysfunction orchestrated, in part, via PAI-1 up-regulation. Rac pathway inhibition suppressed renal oxidative stress and maladaptive repair, identifying Rac as a novel therapeutic target against progressive CKD.-Patel, S., Tang, J., Overstreet, J. M., Anorga, S., Lian, F., Arnouk, A., Goldschmeding, R., Higgins, P. J., Samarakoon, R. Rac-GTPase promotes fibrotic TGF-beta 1 signaling and chronic kidney disease via EGFR, p53, and Hippo/YAP/TAZ pathways.	[Patel, Samik; Tang, Jiaqi; Anorga, Sandybell; Higgins, Paul J.; Samarakoon, Rohan] Albany Med Ctr, Dept Regenerat & Canc Cell Biol, Albany, NY USA; [Lian, Fei; Arnouk, Alex] Albany Med Ctr, Div Urol, Albany, NY USA; [Overstreet, Jessica M.] Vanderbilt Univ Sch Med, Div Nephrol & Hypertens, Nashville, TN USA; [Goldschmeding, Roel] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands	Albany Medical College; Albany Medical College; Vanderbilt University; Utrecht University; Utrecht University Medical Center	Higgins, PJ; Samarakoon, R (corresponding author), Albany Med Coll, Dept Regenerat & Canc Cell Biol, 47 New Scotland Ave, Albany, NY 12208 USA.	higginp@amc.edu; samarar@amc.edu		Tang, Jiaqi/0000-0002-3544-3456	U.S. National Institutes of Health (NIH), National Institute of General Medical Sciences [GM057242]; Capital Region Medical Research Institute grant; Graver Family Endowment; Friedman Family Fund	U.S. National Institutes of Health (NIH), National Institute of General Medical Sciences; Capital Region Medical Research Institute grant; Graver Family Endowment; Friedman Family Fund	R.G. was previously employed (2008-2009) by, performs contract research for, and receives reagents for CTGF-related research from FibroGen, a company involved in the development of anti-CTGF therapies. This study was supported by U.S. National Institutes of Health (NIH), National Institute of General Medical Sciences Grant GM057242 (to P.J.H.), a Capital Region Medical Research Institute grant (to R.S.), the Graver Family Endowment, and the Friedman Family Fund (to P.J.H.). The authors declare no conflicts of interest.	ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; Anorga S, 2018, FASEB J, V32, P2644, DOI 10.1096/fj.201700722R; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Chen JC, 2012, J AM SOC NEPHROL, V23, P215, DOI 10.1681/ASN.2011070645; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Choi SS, 2006, HEPATOLOGY, V44, P1267, DOI 10.1002/hep.21375; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Ferenbach DA, 2015, NAT REV NEPHROL, V11, P264, DOI 10.1038/nrneph.2015.3; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jha JC, 2014, J AM SOC NEPHROL, V25, P1237, DOI 10.1681/ASN.2013070810; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kawarazaki W, 2012, J AM SOC NEPHROL, V23, P997, DOI 10.1681/ASN.2011070734; Khodo SN, 2012, J AM SOC NEPHROL, V23, P1967, DOI 10.1681/ASN.2012040373; Kramann R, 2013, J PATHOL, V231, P273, DOI 10.1002/path.4253; Lavall D, 2017, J BIOL CHEM, V292, P7542, DOI 10.1074/jbc.M116.764449; Lee K, 2012, MOL BIOL CELL, V23, P4097, DOI 10.1091/mbc.E12-02-0166; Liu SX, 2008, ARTHRITIS RHEUM-US, V58, P2189, DOI 10.1002/art.23595; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Macconi D, 2014, KIDNEY INT SUPPL, V4, P58, DOI 10.1038/kisup.2014.11; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Osborn-Heaford HL, 2012, J BIOL CHEM, V287, P3301, DOI 10.1074/jbc.M111.308387; Overstreet JM, 2015, FASEB J, V29, P1258, DOI 10.1096/fj.14-262527; Overstreet JM, 2014, CELL SIGNAL, V26, P1427, DOI 10.1016/j.cellsig.2014.02.017; Perico N, 2012, NEPHROL DIAL TRANSPL, V27, P19, DOI 10.1093/ndt/gfs284; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ruster C, 2011, J AM SOC NEPHROL, V22, P1189, DOI 10.1681/ASN.2010040384; Samarakoon R, 2016, FASEB J, V30, P3308, DOI 10.1096/fj.201500105R; Samarakoon R, 2015, J PATHOL, V236, P421, DOI 10.1002/path.4538; Samarakoon R, 2013, CELL SIGNAL, V25, P2198, DOI 10.1016/j.cellsig.2013.07.007; Samarakoon R, 2013, CELL SIGNAL, V25, P264, DOI 10.1016/j.cellsig.2012.10.003; Samarakoon R, 2012, CELL TISSUE RES, V347, P117, DOI 10.1007/s00441-011-1181-y; Sedeek M, 2013, CLIN SCI, V124, P191, DOI 10.1042/CS20120330; Shibata S, 2011, J CLIN INVEST, V121, P3233, DOI 10.1172/JCI43124; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Singh A, 2004, ONCOGENE, V23, P9369, DOI 10.1038/sj.onc.1208182; Strutz F, 2003, SPRINGER SEMIN IMMUN, V24, P459, DOI 10.1007/s00281-003-0123-5; Szeto SG, 2016, J AM SOC NEPHROL, V27, P3117, DOI 10.1681/ASN.2015050499; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Wang HT, 2015, KIDNEY INT, V87, P948, DOI 10.1038/ki.2014.386; Yan YL, 2016, KIDNEY INT, V89, P68, DOI 10.1038/ki.2015.293; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yang RH, 2017, SCI REP-UK, V7, DOI 10.1038/srep43409; Ying Y, 2014, J AM SOC NEPHROL, V25, P2707, DOI 10.1681/ASN.2013121270; Zhang DS, 2014, J AM SOC NEPHROL, V25, P2278, DOI 10.1681/ASN.2013080902	46	31	31	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9797	9810		10.1096/fj.201802489RR	http://dx.doi.org/10.1096/fj.201802489RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31095421	Green Published			2022-12-28	WOS:000482214200010
J	Taoro-Gonzalez, L; Cabrera-Pastor, A; Sancho-Alonso, M; Arenas, YM; Meseguer-Estornell, F; Balzano, T; ElMlili, N; Felipo, V				Taoro-Gonzalez, Lucas; Cabrera-Pastor, Andrea; Sancho-Alonso, Maria; Arenas, Yaiza M.; Meseguer-Estornell, Fernando; Balzano, Tiziano; ElMlili, Nisrin; Felipo, Vicente			Differential role of interleukin-1 beta in neuroinflammation-induced impairment of spatial and nonspatial memory in hyperammonemic rats	FASEB JOURNAL			English	Article						perirhinal cortex; postrhinal cortex; hippocampus; neurotransmission	DEPENDENT-PROTEIN-KINASE; LONG-TERM POTENTIATION; WORKING-MEMORY; HEPATIC-ENCEPHALOPATHY; PREFRONTAL CORTEX; RECOGNITION MEMORY; RECEPTOR TRAFFICKING; AMPA RECEPTORS; IL-1 RECEPTOR; TNF-ALPHA	Activated microglia and increased brain IL-1 beta play a main role in cognitive impairment in much pathology. We studied the role of IL-1 beta in neuroinflammation-induced impairment of the following different types of learning and memory: novel object recognition (NOR), novel object location (NOL), spatial learning, reference memory (RM), and working memory (WM). All these processes are impaired in hyperammonemic rats. We assessed which of these types of learning and memory are restored by blocking the IL-1 receptor in vivo in hyperammonemic rats and the possible mechanisms involved. Blocking the IL-1 receptor reversed microglial activation in the hippocampus, perirhinal cortex, and prefrontal cortex but not in the postrhinal cortex. This was associated with the restoration of NOR and WM but not of tasks involving a spatial component (NOL and RM). This suggests that IL-1 beta would be involved in neuroinflammation-induced nonspatial memory impairment, whereas spatial memory impairment would be IL-1 beta-independent and would be mediated by other proinflammatory factors.-Taoro-Gonzalez, L., Cabrera-Pastor, A., Sancho-Alonso, M., Arenas, Y. M., Meseguer-Estornell, F., Balzano, T., ElMlili, N., Felipo, V. Differential role of interleukin-1 beta in neuroinflammation-induced impairment of spatial and nonspatial memory in hyperammonemic rats.	[Taoro-Gonzalez, Lucas; Cabrera-Pastor, Andrea; Sancho-Alonso, Maria; Arenas, Yaiza M.; Meseguer-Estornell, Fernando; Balzano, Tiziano; ElMlili, Nisrin; Felipo, Vicente] Ctr Invest Principe Felipe, Lab Neurobiol, Valencia, Spain; [Cabrera-Pastor, Andrea] Fdn Invest Hosp Clin, Inst Invest Sanitaria INCLIVA, Valencia, Spain	Prince Felipe Research Center	Cabrera-Pastor, A (corresponding author), Prince Felipe Res Ctr, Carrer Eduardo Primo Yufera 3, Valencia 46012, Spain.	acabrera@cipf.es	Sancho-Alonso, María/AAW-1746-2021; Cabrera-Pastor, Andrea/J-6867-2014; Balzano, Tiziano/C-9344-2018; Taoro-Gonzalez, Lucas/ABH-7479-2020; Felipo, Vicente/A-9265-2014	Sancho-Alonso, María/0000-0002-6469-5441; Cabrera-Pastor, Andrea/0000-0002-0729-1045; Balzano, Tiziano/0000-0001-6523-2206; Felipo, Vicente/0000-0003-3145-9538; Taoro-Gonzalez, Lucas/0000-0002-9175-9578; Meseguer Estornell, Fernando/0000-0002-7925-7874	Ministerio de Educacion, Cultura y Deporte [FPU13/02492]; Ministerio de Ciencia e Innovacion [SAF2014-51851-R]; Conselleria Educacion Generalitat Valenciana [PROMETEOII/2014/033]; European Regional Development Fund (ERDF)	Ministerio de Educacion, Cultura y Deporte(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Conselleria Educacion Generalitat Valenciana; European Regional Development Fund (ERDF)(European Commission)	Funding was provided by the Ministerio de Educacion, Cultura y Deporte (FPU13/02492), the Ministerio de Ciencia e Innovacion (SAF2014-51851-R), the Conselleria Educacion Generalitat Valenciana (PROMETEOII/2014/033), and the European Regional Development Fund (ERDF). The authors declare no conflicts of interest.	Ahabrach H, 2010, J NEUROSCI RES, V88, P1605, DOI 10.1002/jnr.22311; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Arias N, 2015, NEUROSCIENCE, V284, P1, DOI 10.1016/j.neuroscience.2014.08.060; Auger ML, 2017, NEUROPHARMACOLOGY, V113, P10, DOI 10.1016/j.neuropharm.2016.09.022; Auger ML, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu013; Aultman JM, 2001, PSYCHOPHARMACOLOGY, V153, P353, DOI 10.1007/s002130000590; Bajaj JS, 2010, GASTROENTEROLOGY, V138, P2332, DOI 10.1053/j.gastro.2010.02.015; Barker GRI, 2007, J NEUROSCI, V27, P2948, DOI 10.1523/JNEUROSCI.5289-06.2007; Barker GRI, 2006, J NEUROSCI, V26, P3561, DOI 10.1523/JNEUROSCI.3154-05.2006; Basu A, 2002, GLIA, V40, P109, DOI 10.1002/glia.10118; Basu A, 2004, J NEUROSCI RES, V78, P151, DOI 10.1002/jnr.20266; BELLINGER FP, 1993, BRAIN RES, V628, P227, DOI 10.1016/0006-8993(93)90959-Q; Bernsen J., 1986, P 8 INT C PATT REC P, P1251; Bialuk I, 2018, BEHAV GENET, V48, P236, DOI 10.1007/s10519-018-9896-0; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Cabrera-Pastor A, 2016, BRAIN BEHAV IMMUN, V57, P360, DOI 10.1016/j.bbi.2016.05.011; Cabrera-Pastor A, 2015, ACS CHEM NEUROSCI, V6, P1913, DOI 10.1021/acschemneuro.5b00212; Chang R, 2017, MOL PHARMACEUT, V14, P2340, DOI 10.1021/acs.molpharmaceut.7b00200; Clausen BH, 2016, ACTA NEUROPATHOL, V131, P775, DOI 10.1007/s00401-016-1541-5; Dadsetan S, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00106; Das S, 2017, J NEUROIMMUNOL, V313, P161, DOI 10.1016/j.jneuroim.2017.11.003; Depino AM, 2004, HIPPOCAMPUS, V14, P526, DOI 10.1002/hipo.10164; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Erceg S, 2005, BRAIN RES, V1036, P115, DOI 10.1016/j.brainres.2004.12.045; Eriksson C, 1999, NEUROSCIENCE, V93, P915, DOI 10.1016/S0306-4522(99)00178-5; FELIPO V, 1988, EUR J BIOCHEM, V176, P567, DOI 10.1111/j.1432-1033.1988.tb14315.x; FELIPO V, 1993, J NEUROCHEM, V60, P1626, DOI 10.1111/j.1471-4159.1993.tb13384.x; Felipo V, 2013, NAT REV NEUROSCI, V14, P851, DOI 10.1038/nrn3587; Felipo V, 2012, HEPATOLOGY, V55, P530, DOI 10.1002/hep.24704; Fiore M, 2000, BEHAV BRAIN RES, V112, P165, DOI 10.1016/S0166-4328(00)00180-7; Frank MG, 2012, J NEUROIMMUNOL, V252, P33, DOI 10.1016/j.jneuroim.2012.07.010; Freudenberg F, 2013, HIPPOCAMPUS, V23, P1359, DOI 10.1002/hipo.22184; Garcia-Moreno L, 2005, BRAZ J MED BIOL RES, V38, P127, DOI 10.1590/S0100-879X2005000100019; Glenn MJ, 1998, BEHAV NEUROSCI, V112, P1353, DOI 10.1037/0735-7044.112.6.1353; Goshen I, 2007, PSYCHONEUROENDOCRINO, V32, P1106, DOI 10.1016/j.psyneuen.2007.09.004; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Hein AM, 2010, BRAIN BEHAV IMMUN, V24, P243, DOI 10.1016/j.bbi.2009.10.002; Heisler JM, 2015, BRAIN BEHAV IMMUN, V50, P115, DOI 10.1016/j.bbi.2015.06.022; Hernandez-Rabaza V, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0505-y; Hewett Sandra J, 2012, Eur J Neurodegener Dis, V1, P195; Heyser CJ, 1997, P NATL ACAD SCI USA, V94, P1500, DOI 10.1073/pnas.94.4.1500; Hryniewicz A, 2007, EUR J PHARMACOL, V577, P219, DOI 10.1016/j.ejphar.2007.08.046; Hueston CM, 2018, BRAIN BEHAV IMMUN, V74, P252, DOI 10.1016/j.bbi.2018.09.015; Hyman JM, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/neuro.07.002.2010; Irikura VM, 2002, J IMMUNOL, V169, P393, DOI 10.4049/jimmunol.169.1.393; Kawai H, 2012, J TOXICOL SCI, V37, P1165, DOI 10.2131/jts.37.1165; Kesner RP, 2011, NEUROBIOL LEARN MEM, V96, P417, DOI 10.1016/j.nlm.2011.07.002; Lai AY, 2006, J NEUROIMMUNOL, V175, P97, DOI 10.1016/j.jneuroim.2006.03.001; Lan KM, 2015, TOXICOL LETT, V234, P30, DOI 10.1016/j.toxlet.2015.02.002; Langston RF, 2010, BEHAV BRAIN RES, V215, P275, DOI 10.1016/j.bbr.2010.07.006; Leke R, 2013, METAB BRAIN DIS, V28, P187, DOI 10.1007/s11011-012-9347-1; Lorenz-Guertin JM, 2018, DEV NEUROBIOL, V78, P238, DOI 10.1002/dneu.22536; Mandolesi G, 2013, J NEUROSCI, V33, P12105, DOI 10.1523/JNEUROSCI.5369-12.2013; McQuail JA, 2016, J NEUROSCI, V36, P12537, DOI 10.1523/JNEUROSCI.2332-16.2016; Monaco SA, 2015, NEUROSCI BIOBEHAV R, V56, P127, DOI 10.1016/j.neubiorev.2015.06.022; Monfort P, 2005, J NEUROCHEM, V94, P934, DOI 10.1111/j.1471-4159.2005.03236.x; Moore AH, 2009, NEUROSCIENCE, V164, P1484, DOI 10.1016/j.neuroscience.2009.08.073; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; Norman G, 2005, BEHAV NEUROSCI, V119, P557, DOI 10.1037/0735-7044.119.2.557; Oberholzer M, 1996, HISTOCHEM CELL BIOL, V105, P333, DOI 10.1007/BF01463655; Osaka M, 2003, NEUROIMAGE, V18, P789, DOI 10.1016/S1053-8119(02)00032-0; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Rosi S, 2006, NEUROSCIENCE, V142, P1303, DOI 10.1016/j.neuroscience.2006.08.017; Ross FM, 2003, J NEUROIMMUNOL, V144, P61, DOI 10.1016/j.jneuroim.2003.08.030; Sanderson DJ, 2010, NEUROPSYCHOLOGIA, V48, P2303, DOI 10.1016/j.neuropsychologia.2010.03.018; Schneider H, 1998, P NATL ACAD SCI USA, V95, P7778, DOI 10.1073/pnas.95.13.7778; Shimshek DR, 2006, J NEUROSCI, V26, P8428, DOI 10.1523/JNEUROSCI.5410-05.2006; Smith DM, 2014, NEUROSCI BIOBEHAV R, V40, P52, DOI 10.1016/j.neubiorev.2014.01.005; Song C, 2003, EUR J NEUROSCI, V18, P1739, DOI 10.1046/j.1460-9568.2003.02886.x; Spulber S, 2009, J NEUROIMMUNOL, V208, P46, DOI 10.1016/j.jneuroim.2009.01.010; Taoro-Gonzalez L, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1082-z; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Vann SD, 2000, J NEUROSCI, V20, P2711; Vann SD, 2011, CURR OPIN NEUROBIOL, V21, P440, DOI 10.1016/j.conb.2011.02.002; Vithlani M, 2011, PHYSIOL REV, V91, P1009, DOI 10.1152/physrev.00015.2010; Viviani B, 2007, INT REV NEUROBIOL, V82, P247, DOI 10.1016/S0074-7742(07)82013-7; Wang DS, 2012, CELL REP, V2, P488, DOI 10.1016/j.celrep.2012.08.022; Ward MT, 1999, NEUROBIOL AGING, V20, P373, DOI 10.1016/S0197-4580(99)00047-0; Wincott CM, 2014, NEUROBIOL LEARN MEM, V114, P32, DOI 10.1016/j.nlm.2014.04.007; Winters BD, 2004, J NEUROSCI, V24, P5901, DOI 10.1523/JNEUROSCI.1346-04.2004; Yirmiya R, 2002, NEUROBIOL LEARN MEM, V78, P379, DOI 10.1006/nlme.2002.4072; Zarezadeh M, 2017, EUR J PHARMACOL, V795, P13, DOI 10.1016/j.ejphar.2016.11.051	89	11	11	2	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9913	9928		10.1096/fj.201900230RR	http://dx.doi.org/10.1096/fj.201900230RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31162953				2022-12-28	WOS:000482214200018
J	Abu Ahmad, N; Raizman, M; Weizmann, N; Wasek, B; Arning, E; Bottiglieri, T; Tirosh, O; Troen, AM				Abu Ahmad, Nur; Raizman, Merav; Weizmann, Nathalie; Wasek, Brandi; Arning, Erland; Bottiglieri, Teodoro; Tirosh, Oren; Troen, Aron M.			Betaine attenuates pathology by stimulating lipid oxidation in liver and regulating phospholipid metabolism in brain of methionine-choline-deficient rats	FASEB JOURNAL			English	Article						methylation; methyl-donor; nonalcoholic steatohepatitis; Alzheimer's disease	NONALCOHOLIC FATTY LIVER; HOMOCYSTEINE S-METHYLTRANSFERASE; METHYL-DONOR DEFICIENCY; CARNITINE PALMITOYLTRANSFERASE; DIETARY METHIONINE; ALZHEIMER-DISEASE; MEMORY DEFICITS; ASSOCIATION; SUPPLEMENTATION; PHOSPHATIDYLCHOLINE	Methyl-donor deficiency is a risk factor for neurodegenerative diseases. Dietary deficiency of the methyl-donors methionine and choline [methionine-choline-deficient (MCD) diet] is a well-established model of nonalcoholic steatohepatitis (NASH), yet brain metabolism has not been studied in this model. We hypothesized that supplemental betaine would protect both the liver and brain in this model and that any benefit to the brain would be due to improved liver metabolism because betaine is a methyl-donor in liver methylation but is not metabolically active in the brain. We fed male Sprague-Dawley rats a control diet, MCD diet, or betaine-supplemented MCD (MCD+B) diet for 8 wk and collected blood and tissue. As expected, betaine prevented MCD diet-induced NASH. However, contrary to our prediction, it did not appear to do so by stimulating methylation; the MCD+B diet worsened hyperhomocysteinemia and depressed liver methylation potential 8-fold compared with the MCD diet. Instead, it significantly increased the expression of genes involved in beta-oxidation: fibroblast growth factor 21 and peroxisome proliferator-activated receptor alpha. In contrast to that of the liver, brain methylation potential was unaffected by diet. Nevertheless, several phospholipid (PL) subclasses involved in stabilizing brain membranes were decreased by the MCD diet, and these improved modestly with betaine. The protective effect of betaine is likely due to the stimulation of beta-oxidation in liver and the effects on PL metabolism in brain.-Abu Ahmad, N., Raizman, M., Weizmann, N., Wasek, B., Arning, E., Bottiglieri, T., Tirosh, O., Troen, A. M. Betaine attenuates pathology by stimulating lipid oxidation in liver and regulating phospholipid metabolism in brain of methionine-choline-deficient rats.	[Abu Ahmad, Nur; Raizman, Merav; Weizmann, Nathalie; Tirosh, Oren; Troen, Aron M.] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Inst Biochem Food & Nutr Sci, Herzl St,POB 12, IL-76100 Rehovot, Israel; [Wasek, Brandi; Arning, Erland; Bottiglieri, Teodoro] Baylor Scott & White Res Inst, Inst Metab Dis, Dallas, TX USA	Hebrew University of Jerusalem; Baylor Health Care System; Baylor University Medical Center	Troen, AM (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Inst Biochem Food & Nutr Sci, Herzl St,POB 12, IL-76100 Rehovot, Israel.	aron.troen@mail.huji.ac.il		Bottiglieri, Teodoro/0000-0002-4199-7551	Hebrew University of Jerusalem; State of Israel Ministry of Science and Technology	Hebrew University of Jerusalem; State of Israel Ministry of Science and Technology	This project was partially funded by a Hebrew University of Jerusalem intramural pilot grant award and by a State of Israel Ministry of Science and Technology Ph.D. scholarship awarded to N.A.A. The authors declare no conflicts of interest.	Ahn CW, 2016, BIOCHEM BIOPH RES CO, V477, P440, DOI 10.1016/j.bbrc.2016.06.080; ARDUINI A, 1992, J BIOL CHEM, V267, P12673; ARDUINI A, 1994, J NEUROCHEM, V62, P1530; BALDESSARINI RJ, 1966, J NEUROCHEM, V13, P769, DOI 10.1111/j.1471-4159.1966.tb09884.x; Bellanti F, 2017, FREE RADICAL BIO MED, V111, P173, DOI 10.1016/j.freeradbiomed.2017.01.023; Blusztajn JK, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080815; Borrione P, 2017, ENDOCRINOL METAB, V1, P1; Cavallaro R., 2016, INT J CLIN NUTR DIET, V2, P110; Chai GS, 2013, J NEUROCHEM, V124, P388, DOI 10.1111/jnc.12094; Dahlhoff C, 2014, MOL METAB, V3, P565, DOI 10.1016/j.molmet.2014.04.010; Dai YN, 2016, J CLIN BIOCHEM NUTR, V58, P76, DOI 10.3164/jcbn.15-54; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Dickinson-Anson H, 2003, MOL THER, V8, P51, DOI 10.1016/S1525-0016(03)00145-X; Ejaz A, 2016, DIABETES, V65, P902, DOI 10.2337/db15-1094; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ge CX, 2016, EUR J PHARMACOL, V770, P154, DOI 10.1016/j.ejphar.2015.11.043; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P7, DOI 10.1016/0031-9384(94)90255-0; Inoue-Choi M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-389; Jones LL, 2010, PROG LIPID RES, V49, P61, DOI 10.1016/j.plipres.2009.08.004; Kallwitz ER, 2008, WORLD J GASTROENTERO, V14, P22, DOI 10.3748/wjg.14.22; Kathirvel E, 2010, AM J PHYSIOL-GASTR L, V299, pG1068, DOI 10.1152/ajpgi.00249.2010; Knight LS, 2017, NEUROCHEM RES, V42, P3490, DOI 10.1007/s11064-017-2397-3; Knopman D, 2001, ALZ DIS ASSOC DIS, V15, P162, DOI 10.1097/00002093-200107000-00008; Koteish A, 2001, SEMIN LIVER DIS, V21, P89, DOI 10.1055/s-2001-12932; Kucera O, 2014, WORLD J GASTROENTERO, V20, P8364, DOI 10.3748/wjg.v20.i26.8364; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Li Danni, 2016, Alzheimers Dement (Amst), V3, P73, DOI 10.1016/j.dadm.2016.02.008; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; del Bas JM, 2019, CLIN SCI, V133, P409, DOI [10.1042/cs20171039, 10.1042/CS20171039]; MASHIMA Y, 1984, CLIN NUTR, V3, P17, DOI 10.1016/S0261-5614(84)80017-5; Mielke MM, 2011, J ALZHEIMERS DIS, V27, P259, DOI 10.3233/JAD-2011-110405; Mielke MM, 2010, NEUROBIOL AGING, V31, P17, DOI 10.1016/j.neurobiolaging.2008.03.011; Mulder C, 2003, J NEURAL TRANSM, V110, P949, DOI 10.1007/s00702-003-0007-9; NAKAE D, 1992, CANCER RES, V52, P5042; Obeid R, 2006, FEBS LETT, V580, P2994, DOI 10.1016/j.febslet.2006.04.088; Obeid R, 2013, NUTRIENTS, V5, P3481, DOI 10.3390/nu5093481; Poly C, 2011, AM J CLIN NUTR, V94, P1584, DOI 10.3945/ajcn.110.008938; Rapoport SI, 1995, NEW CONCEPTS OF A BLOOD-BRAIN BARRIER, P119; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; SAUNDERSON CL, 1990, BRIT J NUTR, V63, P339, DOI 10.1079/BJN19900120; Schaefer EJ, 2006, ARCH NEUROL-CHICAGO, V63, P1545, DOI 10.1001/archneur.63.11.1545; Selhub J, 2000, AM J CLIN NUTR, V71, p614S; Seshadri S, 2008, ARCH NEUROL-CHICAGO, V65, P642, DOI 10.1001/archneur.65.5.642; Shukitt-Hale B, 1999, AGE, V22, P9, DOI 10.1007/s11357-999-0002-7; Sierra AY, 2008, J BIOL CHEM, V283, P6878, DOI 10.1074/jbc.M707965200; Singhal NK, 2015, J NEUROSCI, V35, P15170, DOI 10.1523/JNEUROSCI.4349-14.2015; Sivanesan S, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00061; Spratlen MJ, 2019, ENVIRON RES, V168, P146, DOI 10.1016/j.envres.2018.09.034; Sun JY, 2017, J CLIN LAB ANAL, V31, DOI 10.1002/jcla.22090; Szczepankowska D, 2003, NEUROCHEM RES, V28, P645, DOI 10.1023/A:1022802229921; Teather LA, 2003, PROG NEURO-PSYCHOPH, V27, P711, DOI 10.1016/S0278-5846(03)00086-1; Teng YW, 2012, J BIOL CHEM, V287, P16187, DOI 10.1074/jbc.M111.303255; Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348; Tomizawa H, 2015, GENES BRAIN BEHAV, V14, P301, DOI 10.1111/gbb.12207; Troen AM, 2008, J NUTR, V138, P2502, DOI 10.3945/jn.108.093641; UBBINK JB, 1991, J CHROMATOGR-BIOMED, V565, P441, DOI 10.1016/0378-4347(91)80407-4; WAGNER JG, 1977, HOSP PRACT, V12, P119, DOI 10.1080/21548331.1977.11707065; Weinstein G, 2018, JAMA NEUROL, V75, P97, DOI 10.1001/jamaneurol.2017.3229; Wilcken B, 2017, EXPERT OPIN ORPHAN D, V5, P1, DOI 10.1080/21678707.2017.1259561; Young SN, 2005, J PSYCHIATR NEUROSCI, V30, P44; ZEISEL SH, 1994, ANNU REV NUTR, V14, P269, DOI 10.1146/annurev.nu.14.070194.001413; Zeisel SH, 2003, J NUTR, V133, P1302; Zhang W, 2013, DIGEST DIS SCI, V58, P3198, DOI 10.1007/s10620-013-2775-x; 심문정, 2007, [Korean Journal of Clinical Laboratory Science, 대한임상검사과학회지], V39, P196	64	12	12	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9334	9349		10.1096/fj.201802683R	http://dx.doi.org/10.1096/fj.201802683R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31120771				2022-12-28	WOS:000478832900050
J	Pfannkuch, L; Hurwitz, R; Traulsen, J; Sigulla, J; Poeschke, M; Matzner, L; Kosma, P; Schmid, M; Meyer, TF				Pfannkuch, Lennart; Hurwitz, Robert; Traulsen, Jan; Sigulla, Janine; Poeschke, Marcella; Matzner, Laura; Kosma, Paul; Schmid, Monika; Meyer, Thomas F.			ADP heptose, a novel pathogen-associated molecular pattern identified in Helicobacter pylori	FASEB JOURNAL			English	Article						NF-kappa B; ALPK1; TIFA; LPS; PAMP	D-MANNO-HEPTOSE; NF-KAPPA-B; CHEMICAL-SYNTHESIS; TIFA; PROTEIN	The gastric pathogen Helicobacter pylori activates the NF-kappa B pathway in human epithelial cells via the recently discovered alpha-kinase 1 TRAF-interacting protein with forkhead-associated domain (TIFA) axis. We and others showed that this pathway can be triggered by heptose 1,7-bisphosphate (HBP), an LPS intermediate produced in gram-negative bacteria that represents a new pathogen-associated molecular pattern (PAMP). Here, we report that our attempts to identify HBP in lysates of H. pylori revealed surprisingly low amounts, failing to explain NF-kappa B activation. Instead, we identified ADP-glycero-beta-D-manno-heptose (ADP heptose), a derivative of HBP, as the predominant PAMP in lysates of H. pylori and other gram-negative bacteria. ADP heptose exhibits significantly higher activity than HBP, and cells specifically sensed the presence of the beta-form, even when the compound was added extracellularly. The data lead us to conclude that ADP heptose not only constitutes the key PAMP responsible for H. pylori-induced NF-kappa B activation in epithelial cells, but it acts as a general gram-negative bacterial PAMP.-Pfannkuch, L., Hurwitz, R., Traulsen, J., Sigulla, J., Poeschke, M., Matzner, L., Kosma, P., Schmid, M., Meyer, T. F. ADP heptose, a novel pathogen-associated molecular pattern identified in Helicobacter pylori.	[Pfannkuch, Lennart; Hurwitz, Robert; Traulsen, Jan; Sigulla, Janine; Poeschke, Marcella; Matzner, Laura; Schmid, Monika; Meyer, Thomas F.] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany; [Pfannkuch, Lennart] Univ Hosp Berlin, Charite, Dept Infect Dis & Pulm Med, Berlin, Germany; [Pfannkuch, Lennart] Berlin Inst Hlth, Berlin, Germany; [Kosma, Paul] Univ Nat Resources & Life Sci Vienna, Dept Chem, Vienna, Austria	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; University of Natural Resources & Life Sciences, Vienna	Meyer, TF (corresponding author), Max Planck Inst Infect Biol, Charite Pl 1, D-10117 Berlin, Germany.	meyer@mpiib-berlin.mpg.de	; Meyer, Thomas F./J-2485-2013	Traulsen, Jan/0000-0001-9340-9232; Pfannkuch, Lennart/0000-0003-0163-0453; Meyer, Thomas F./0000-0002-6120-8679				[Anonymous], HELICOBACTER PYLORI; Baccala R, 2009, NAT REV RHEUMATOL, V5, P448, DOI 10.1038/nrrheum.2009.136; Backert S, 2000, CELL MICROBIOL, V2, P155, DOI 10.1046/j.1462-5822.2000.00043.x; Belogolova E, 2013, CELL MICROBIOL, V15, P1896, DOI 10.1111/cmi.12158; Borio A, 2017, TETRAHEDRON LETT, V58, P2826, DOI 10.1016/j.tetlet.2017.06.014; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Gall A, 2017, MBIO, V8, DOI 10.1128/mBio.01168-17; Gaudet RG, 2015, SCIENCE, V348, P1251, DOI 10.1126/science.aaa4921; Guzlek H, 2005, CARBOHYD RES, V340, P2808, DOI 10.1016/j.carres.2005.10.003; Han J, 2013, ANAL CHEM, V85, P5965, DOI 10.1021/ac400769g; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; Kneidinger B, 2002, J BACTERIOL, V184, P363, DOI 10.1128/JB.184.2.363-369.2002; Lin TY, 2016, P NATL ACAD SCI USA, V113, P15078, DOI 10.1073/pnas.1618773114; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Milivojevic M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006224; Nagata S, 2010, NUCLEIC ACIDS RES, V38, P7845, DOI 10.1093/nar/gkq638; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Sambrook J., 2001, MOL CLONING LAB MANU; Sekine T., 1995, NUCL ACIDS S SER, V34, P11; Stein SC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006514; Tanaka H, 2012, ANGEW CHEM INT EDIT, V51, P11531, DOI 10.1002/anie.201205433; Tang W, 2018, P NATL ACAD SCI USA, V115, P2818, DOI 10.1073/pnas.1711665115; Wagner GK, 2009, NAT PROD REP, V26, P1172, DOI 10.1039/b909621n; Zamyatina A, 2003, CARBOHYD RES, V338, P2571, DOI 10.1016/S0008-6215(03)00319-7; Zhou P, 2018, NATURE, V561, P122, DOI 10.1038/s41586-018-0433-3; Zimmermann S, 2017, CELL REP, V20, P2384, DOI 10.1016/j.celrep.2017.08.039	28	67	69	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9087	9099		10.1096/fj.201802555R	http://dx.doi.org/10.1096/fj.201802555R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31075211	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000478832900032
J	Yasumoto, T; Takamura, Y; Tsuji, M; Watanabe-Nakayama, T; Imamura, K; Inoue, H; Nakamura, S; Inoue, T; Kimura, A; Yano, S; Nishijo, H; Kiuchi, Y; Teplow, DB; Ono, K				Yasumoto, Taro; Takamura, Yusaku; Tsuji, Mayumi; Watanabe-Nakayama, Takahiro; Imamura, Keiko; Inoue, Haruhisa; Nakamura, Shiro; Inoue, Tomio; Kimura, Atsushi; Yano, Satoshi; Nishijo, Hisao; Kiuchi, Yuji; Teplow, David B.; Ono, Kenjiro			High molecular weight amyloid beta(1-42) oligomers induce neurotoxicity via plasma membrane damage	FASEB JOURNAL			English	Article						Alzheimer disease; amyloid beta-protein; membrane disruption	BETA-PROTEIN FIBRILLOGENESIS; ATOMIC-FORCE MICROSCOPY; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; LIPID-PEROXIDATION; CALCIUM INFLUX; BRAIN; MECHANISM; HYPOTHESIS; FLUIDITY	Amyloid beta-protein (A beta) molecules tend to aggregate and subsequently form low MW (LMW) oligomers, high MW (HMW) aggregates such as protofibrils, and ultimately fibrils. These A beta species can generally form amyloid plaques implicated in the neurodegeneration of Alzheimer disease (AD), but therapies designed to reduce plaque load have not demonstrated clinical efficacy. Recent evidence implicates amyloid oligomers in AD neuropathology, but the precise mechanisms are uncertain. We examined the mechanisms of neuronal dysfunction from HMW-A beta(1-42) exposure by measuring membrane integrity, reactive oxygen species (ROS) generation, membrane lipid peroxidation, membrane fluidity, intracellular calcium regulation, passive membrane electrophysiological properties, and long-term potentiation (LTP). HMW-A beta(1-42) disturbed membrane integrity by inducing ROS generation and lipid peroxidation, resulting in decreased membrane fluidity, intracellular calcium dysregulation, depolarization, and impaired LTP. The damaging effects of HMW-A beta(1-42) were significantly greater than those of LMW-A beta(1-42). Therapeutic reduction of HMW-A beta(1-42) may prevent AD progression by ameliorating direct neuronal membrane damage.-Yasumoto, T., Takamura, Y., Tsuji, M., Watanabe-Nakayama, T., Imamura, K., Inoue, H., Nakamura, S., Inoue, T., Kimura, A., Yano, S., Nishijo, H., Kiuchi, Y., Teplow, D. B., Ono, K. High molecular weight amyloid beta(1-42) oligomers induce neurotoxicity via plasma membrane damage.	[Yasumoto, Taro; Kimura, Atsushi; Yano, Satoshi; Ono, Kenjiro] Showa Univ, Div Neurol, Dept Internal Med, Tokyo, Japan; [Yasumoto, Taro; Tsuji, Mayumi; Kimura, Atsushi; Kiuchi, Yuji] Showa Univ, Dept Pharmacol, Sch Med, Tokyo, Japan; [Nakamura, Shiro; Inoue, Tomio] Showa Univ, Dept Oral Physiol, Sch Dent, Tokyo, Japan; [Takamura, Yusaku; Nishijo, Hisao] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Syst Emot Sci, Toyama, Japan; [Watanabe-Nakayama, Takahiro] Kanazawa Univ, World Premier Int Res Ctr Initiat WPI, Nano Life Sci Inst, Kakuma Machi, Kanazawa, Ishikawa, Japan; [Imamura, Keiko; Inoue, Haruhisa] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan; [Imamura, Keiko; Inoue, Haruhisa] Riken BioResource Res Ctr BRC, iPSC Based Drug Discovery & Dev Team, Kyoto, Japan; [Imamura, Keiko; Inoue, Haruhisa] Riken Ctr Adv Intelligence Project AIP, Med Risk Avoidance Based iPS Cells Team, Kyoto, Japan; [Teplow, David B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA	Showa University; Showa University; Showa University; University of Toyama; Kanazawa University; Kyoto University; RIKEN; RIKEN; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ono, K (corresponding author), Showa Univ, Sch Med, Div Neurol, Dept Internal Med, Tokyo 1428666, Japan.	onoken@med.showa-u.ac.jp		Inoue, Haruhisa/0000-0003-4736-9537	Japan Society for the Promotion of Science (JSPS) [JP26461266, JP19K07965]; Japan Agency for Medical Research and Development [16dk0207021h0001]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	The authors thank Dr. Hidenobu Shozawa and Mika Honda (Showa University School of Medicine) for technical assistance as well as Prof. T. Ando and Prof. N. Kodera (Kanazawa University) for providing us with experimental instruments. This work was supported by Grants-in-Aid for Scientific Research (Kakenhi) from the Japan Society for the Promotion of Science (JSPS) under Grants JP26461266 and JP19K07965 (to K.O.), and Research and Development Grants from the Japan Agency for Medical Research and Development (16dk0207021h0001) (to K.O.). The authors declare no conflicts of interest.	Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Ansari MA, 2010, J NEUROPATH EXP NEUR, V69, P155, DOI 10.1097/NEN.0b013e3181cb5af4; Arancio O, 2017, ALZHEIMERS DEMENT, V13, P178, DOI 10.1016/j.jalz.2016.12.006; Arispe N, 2004, J MEMBRANE BIOL, V197, P33, DOI 10.1007/s00232-003-0638-7; Berridge MJ, 2017, BIOCHEM BIOPH RES CO, V485, P5, DOI 10.1016/j.bbrc.2017.01.098; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bode DC, 2017, J BIOL CHEM, V292, P1404, DOI 10.1074/jbc.M116.762526; Bradley MA, 2012, NEUROBIOL AGING, V33, P1034, DOI 10.1016/j.neurobiolaging.2010.08.016; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Cheignon C, 2018, REDOX BIOL, V14, P450, DOI 10.1016/j.redox.2017.10.014; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Demuro A, 2011, J CELL BIOL, V195, P515, DOI 10.1083/jcb.201104133; Drews A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31910; Drolle E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182194; Fernandez-Perez EJ, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00226; Hernandez-Zimbron LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042344; Fukaya T, 2007, NEUROBIOL AGING, V28, P1179, DOI 10.1016/j.neurobiolaging.2006.05.023; Gunn AP, 2016, J BIOL CHEM, V291, P6134, DOI 10.1074/jbc.M115.655183; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hilt S, 2018, MOLECULES, V23, DOI 10.3390/molecules23082010; Hureau C, 2009, BIOCHIMIE, V91, P1212, DOI 10.1016/j.biochi.2009.03.013; Ikeda K, 2011, BIOCHEMISTRY-US, V50, P6433, DOI 10.1021/bi200771m; Imamura K, 2016, SCI REP-UK, V6, DOI 10.1038/srep34904; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; Jang H, 2013, J CHEM THEORY COMPUT, V9, P822, DOI 10.1021/ct300916f; Kremer JJ, 2000, BIOCHEMISTRY-US, V39, P10309, DOI 10.1021/bi0001980; Krishtal J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186636; Lee J, 2014, BIOCHEMISTRY-US, V53, P4704, DOI 10.1021/bi500587p; Massaad CA, 2011, ANTIOXID REDOX SIGN, V14, P2013, DOI 10.1089/ars.2010.3208; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; Okimoto Y, 2000, FEBS LETT, V474, P137, DOI 10.1016/S0014-5793(00)01587-8; Ono K, 2018, NEUROCHEM INT, V119, P57, DOI 10.1016/j.neuint.2017.08.010; Ono K, 2012, J BIOL CHEM, V287, P14631, DOI 10.1074/jbc.M111.325456; Ono K, 2010, J BIOL CHEM, V285, P23184, DOI 10.1074/jbc.M109.086496; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Pohanka M, 2014, CURR MED CHEM, V21, P356; Rosini M, 2014, J MED CHEM, V57, P2821, DOI 10.1021/jm400970m; Rowan MJ, 2003, PHILOS T R SOC B, V358, P821, DOI 10.1098/rstb.2002.1240; Sarkar B, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00084; Savage MJ, 2014, J NEUROSCI, V34, P2884, DOI 10.1523/JNEUROSCI.1675-13.2014; Schaeffer EL, 2005, J NEURAL TRANSM, V112, P641, DOI 10.1007/s00702-005-0301-9; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Serra-Batiste M, 2016, P NATL ACAD SCI USA, V113, P10866, DOI 10.1073/pnas.1605104113; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; SMALE G, 1995, EXP NEUROL, V133, P225, DOI 10.1006/exnr.1995.1025; Smith DG, 2007, BBA-BIOMEMBRANES, V1768, P1976, DOI 10.1016/j.bbamem.2007.02.002; Stutzmann GE, 2007, NEUROSCIENTIST, V13, P546, DOI 10.1177/1073858407299730; Supnet C, 2010, CELL CALCIUM, V47, P183, DOI 10.1016/j.ceca.2009.12.014; Takeda S, 2013, FASEB J, V27, P3239, DOI 10.1096/fj.13-229666; Tan Y, 2012, NEURAL REGEN RES, V7, P137, DOI 10.3969/j.issn.1673-5374.2012.02.010; Tofoleanu F, 2012, J MOL BIOL, V421, P572, DOI 10.1016/j.jmb.2011.12.063; Uchihashi T, 2012, NAT PROTOC, V7, P1193, DOI 10.1038/nprot.2012.047; Van der Paal J, 2016, CHEM SCI, V7, P489, DOI 10.1039/c5sc02311d; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Watanabe-Nakayama T, 2018, METHODS MOL BIOL, V1814, P201, DOI 10.1007/978-1-4939-8591-3_12; Watanabe-Nakayama T, 2016, P NATL ACAD SCI USA, V113, P5835, DOI 10.1073/pnas.1524807113; Williams TL, 2011, FEBS J, V278, P3905, DOI 10.1111/j.1742-4658.2011.08228.x; Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565; Yip CM, 2002, J MOL BIOL, V318, P97, DOI 10.1016/S0022-2836(02)00028-1; Zhu DH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00186	66	32	32	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9220	9234		10.1096/fj.201900604R	http://dx.doi.org/10.1096/fj.201900604R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31084283	Bronze, Green Submitted			2022-12-28	WOS:000478832900042
J	Abulizi, A; Camporez, JP; Jurczak, MJ; Royer, KF; Zhang, DY; Cline, GW; Samuel, VT; Shulman, GI; Vatner, DF				Abulizi, Abudukadier; Camporez, Joao-Paulo; Jurczak, Michael J.; Royer, Kasper F.; Zhang, Dongyan; Cline, Gary W.; Samuel, Varman T.; Shulman, Gerald, I; Vatner, Daniel F.			Adipose glucocorticoid action influences whole-body metabolism via modulation of hepatic insulin action	FASEB JOURNAL			English	Article						white adipose tissue; hepatic steatosis; glycogen synthesis; insulin resistance	HORMONE-SENSITIVE LIPASE; LEPTIN LEVELS; RESISTANCE; TISSUE; RECEPTOR; MECHANISM; OBESITY; DEXAMETHASONE; ACTIVATION; LIPOLYSIS	The connection between adipose glucocorticoid action and whole-body metabolism is incompletely understood. Thus, we generated adipose tissue-specific glucocorticoid receptor-knockout (Ad-GcR(-/-)) mice to explore potential mechanisms. Ad-GcR(-/-) mice had a lower concentration of fasting plasma nonesterified fatty acids and less hepatic steatosis. This was associated with increased protein kinase B phosphorylation and increased hepatic glycogen synthesis after an oral glucose challenge. High-fat diet (HFD)-fed Ad-GcR(-/-) mice were protected against the development of hepatic steatosis and diacylglycerol-PKC epsilon-induced impairments in hepatic insulin signaling. Under hyperinsulinemic-euglycemic conditions, hepatic insulin response was similar to 10-fold higher in HFD-fed Ad-GcR(-/-) mice. Insulin-mediated suppression of adipose lipolysis was improved by 40% in Ad-GcR(-/-) mice. Adipose triglyceride lipase expression was decreased and insulin-mediated perilipin dephosphorylation was increased in Ad-GcR(-/-) mice. In metabolic cages, food intake decreased by 3 kcal/kg per hour in Ad-GcR(-/-) mice. Therefore, physiologic adipose glucocorticoid action appears to drive hepatic lipid accumulation during stressors such as fasting. The resultant hepatic insulin resistance prevents hepatic glycogen synthesis, preserving glucose for glucose-dependent organs. Absence of adipose glucocorticoid action attenuates HFD-induced hepatic insulin resistance; potential explanations for reduction in hepatic steatosis include reductions in adipose lipolysis and food intake.-Abulizi, A., Camporez, J.-P., Jurczak, M. J., HOyer, K. F., Zhang, D., Cline, G. W., Samuel, V. T., Shulman, G. I., Vatner, D. F. Adipose glucocorticoid action influences whole-body metabolism via modulation of hepatic insulin action.	[Abulizi, Abudukadier; Camporez, Joao-Paulo; Jurczak, Michael J.; Royer, Kasper F.; Cline, Gary W.; Samuel, Varman T.; Shulman, Gerald, I; Vatner, Daniel F.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Zhang, Dongyan; Shulman, Gerald, I] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Shulman, Gerald, I] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Royer, Kasper F.] Aarhus Univ, Magnet Resonance Res Ctr, Dept Clin Med, Aarhus, Denmark; [Samuel, Varman T.] Vet Affairs Med Ctr, West Haven, CT USA; [Camporez, Joao-Paulo] Univ Sao Paulo, Sao Paulo, Brazil; [Jurczak, Michael J.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Aarhus University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Universidade de Sao Paulo; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vatner, DF (corresponding author), Yale Univ, Sch Med, Dept Internal Med Endocrinol, POB 208020, New Haven, CT 06520 USA.	daniel.vatner@yale.edu		Camporez, Joao Paulo/0000-0003-3486-4301	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [K23 DK10287, K01 DK099402, R01 DK116774, P30 DK045735]; Veterans Health Administration [I01 BX000901]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, R01DK116774] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000901] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Health Administration(US Department of Veterans Affairs); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Mario Kahn, Gina Butrico, Ali Nasiri, Xiaoxian Ma, Irina Smolgovsky, Codruta Todeasa, Maria Batsu (all from the Yale University School of Medicine), and the Yale Diabetes Research Core Facility for excellent technical support. The authors also thank Dr. Jackie Fretz (Yale University School of Medicine) for the use of urine collection cages. This work was supported by grants from the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (K23 DK10287, K01 DK099402, R01 DK116774, and P30 DK045735) and the Veterans Health Administration (Merit Review Award I01 BX000901). The authors declare no conflicts of interest.	Birkenfeld AL, 2011, CELL METAB, V14, P184, DOI 10.1016/j.cmet.2011.06.009; Bose SK, 2016, ENDOCRINOLOGY, V157, P4943, DOI 10.1210/en.2016-1615; Bruun JM, 2004, AM J PHYSIOL-ENDOC M, V286, pE8, DOI 10.1152/ajpendo.00269.2003; Campbell JE, 2011, AM J PHYSIOL-CELL PH, V300, pC198, DOI 10.1152/ajpcell.00045.2010; Cohen DM, 2017, TRENDS ENDOCRIN MET, V28, P531, DOI 10.1016/j.tem.2017.04.001; Cuthbertson DJ, 2017, INT J OBESITY, V41, P853, DOI 10.1038/ijo.2017.4; DagogoJack S, 1997, J CLIN ENDOCR METAB, V82, P3230, DOI 10.1210/jc.82.10.3230; Desarzens S, 2016, J ENDOCRINOL, V230, P1, DOI 10.1530/JOE-16-0121; Fasshauer M, 2015, TRENDS PHARMACOL SCI, V36, P461, DOI 10.1016/j.tips.2015.04.014; Fried SK, 2000, J NUTR, V130, p3127S, DOI 10.1093/jn/130.12.3127S; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Galon J, 2002, FASEB J, V16, P61, DOI 10.1096/fj.01-0245com; Geer EB, 2014, ENDOCRIN METAB CLIN, V43, P75, DOI 10.1016/j.ecl.2013.10.005; Geisler CE, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0122-x; Girousse A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001485; HAUNER H, 1987, J CLIN ENDOCR METAB, V64, P832, DOI 10.1210/jcem-64-4-832; Jeffery E, 2014, ADIPOCYTE, V3, P206, DOI 10.4161/adip.29674; Johnston JC, 2014, BIOCHEM BIOPH RES CO, V451, P473, DOI 10.1016/j.bbrc.2014.07.063; Jornayvaz FR, 2011, P NATL ACAD SCI USA, V108, P5748, DOI 10.1073/pnas.1103451108; Kershaw EE, 2005, DIABETES, V54, P1023, DOI 10.2337/diabetes.54.4.1023; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Kwon Hyokjoon, 2013, Front Endocrinol (Lausanne), V4, P71, DOI 10.3389/fendo.2013.00071; Licinio J, 1997, NAT MED, V3, P575, DOI 10.1038/nm0597-575; Londos C, 2005, BIOCHIMIE, V87, P45, DOI 10.1016/j.biochi.2004.12.010; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Mueller KM, 2017, DIABETES, V66, P272, DOI 10.2337/db16-0381; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Patsouris D, 2009, J BIOL CHEM, V284, P31223, DOI 10.1074/jbc.M109.041665; Peckett AJ, 2011, METABOLISM, V60, P1500, DOI 10.1016/j.metabol.2011.06.012; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qu X, 1999, J ENDOCRINOL, V162, P207, DOI 10.1677/joe.0.1620207; Rose AJ, 2013, MOL CELL ENDOCRINOL, V380, P65, DOI 10.1016/j.mce.2013.03.007; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Seckl JR, 2001, ENDOCRINOLOGY, V142, P1371, DOI 10.1210/en.142.4.1371; Shen YC, 2017, MOL METAB, V6, P1150, DOI 10.1016/j.molmet.2017.06.013; SLAVIN BG, 1994, J LIPID RES, V35, P1535; Takahashi N, 2007, KIDNEY INT, V71, P266, DOI 10.1038/sj.ki.5002033; Tataranni PA, 1996, AM J PHYSIOL-ENDOC M, V271, pE317, DOI 10.1152/ajpendo.1996.271.2.E317; Udden J, 2003, J INTERN MED, V253, P225, DOI 10.1046/j.1365-2796.2003.01099.x; Vatner DF, 2015, P NATL ACAD SCI USA, V112, P1143, DOI 10.1073/pnas.1423952112; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang JC, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-19; Watts LM, 2005, DIABETES, V54, P1846, DOI 10.2337/diabetes.54.6.1846; WURDEMAN R, 1978, J NUTR, V108, P1457, DOI 10.1093/jn/108.9.1457; Xu C, 2009, MOL ENDOCRINOL, V23, P1161, DOI 10.1210/me.2008-0464; Yu CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015188; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Yu J, 2014, POLYMERS, V6, P9, DOI DOI 10.1371/J0UMAL.P0NE.0112628	54	8	8	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8174	8185		10.1096/fj.201802706R	http://dx.doi.org/10.1096/fj.201802706R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30922125	Green Published			2022-12-28	WOS:000476234700030
J	Garcia-Agudo, LF; Janova, H; Sendler, LE; Arinrad, S; Steixner, AA; Hassouna, I; Balmuth, E; Ronnenberg, A; Schopf, N; van der Flier, FJ; Begemann, M; Martens, H; Weber, MS; Boretius, S; Nave, KA; Ehrenreich, H				Garcia-Agudo, Laura Fernandez; Janova, Hana; Sendler, Lea E.; Arinrad, Sahab; Steixner, Agnes A.; Hassouna, Imam; Balmuth, Evan; Ronnenberg, Anja; Schopf, Nadine; van der Flier, Felicia J.; Begemann, Martin; Martens, Henrik; Weber, Martin S.; Boretius, Susann; Nave, Klaus-Armin; Ehrenreich, Hannelore			Genetically induced brain inflammation by Cnp deletion transiently benefits from microglia depletion	FASEB JOURNAL			English	Article						CSF1R inhibitor PLX5622; catatonic signs; executive function; hurdle test; phagocytosis	WHITE-MATTER HYPERINTENSITIES; RECEPTOR; MYELINOGENESIS; SCHIZOPHRENIA; ACTIVATION; ROLES; MOUSE; SIGNS; CELL	Reduced expression of 2'-3 '-cyclic nucleotide 3 '-phosphodiesterase (Cnp) in humans and mice causes white matter inflammation and catatonic signs. These consequences are experimentally alleviated by microglia ablation via colony-stimulating factor 1 receptor (CSF1R) inhibition using PLX5622. Here we address for the first time preclinical topics crucial for translation, most importantly 1) the comparison of 2 long-term PLX5622 applications (prevention and treatment) vs. 1 treatment alone, 2) the correlation of catatonic signs and executive dysfunction, 3) the phenotype of leftover microglia evading depletion, and 4) the role of intercellular interactions for efficient CSF1R inhibition. Based on our Cnp(-/-) mouse model and in vitro time-lapse imaging, we report the unexpected discovery that microglia surviving under PLX5622 display a highly inflammatory phenotype including aggressive premortal phagocytosis of oligodendrocyte precursor cells. Interestingly, ablating microglia in vitro requires mixed glial cultures, whereas cultured pure microglia withstand PLX5622 application. Importantly, 2 extended rounds of CSF1R inhibition are not superior to 1 treatment regarding any readout investigated (magnetic resonance imaging and magnetic resonance spectroscopy, behavior, immunohistochemistry). Catatonia-related executive dysfunction and brain atrophy of Cnp(-/-) mice fail to improve under PLX5622. To conclude, even though microglia depletion is temporarily beneficial and worth pursuing, complementary treatment strategies are needed for full and lasting recovery.-Fernandez Garcia-Agudo, L., Janova, H., Sendler, L. E., Arinrad, S., Steixner, A. A., Hassouna, I., Balmuth, E., Ronnenberg, A., Schopf, N., van der Flier, F. J., Begemann, M., Martens, H., Weber, M. S., Boretius, S., Nave, K.-A., Ehrenreich, H. Genetically induced brain inflammation by Cnp deletion transiently benefits from microglia depletion.	[Garcia-Agudo, Laura Fernandez; Janova, Hana; Sendler, Lea E.; Arinrad, Sahab; Steixner, Agnes A.; Hassouna, Imam; Balmuth, Evan; Ronnenberg, Anja; Schopf, Nadine; van der Flier, Felicia J.; Begemann, Martin; Ehrenreich, Hannelore] Max Planck Inst Expt Med, Clin Neurosci, Hermann Rein Str 3, D-37075 Gottingen, Germany; [Nave, Klaus-Armin] Max Planck Inst Expt Med, Dept Neurogenet, Hermann Rein Str 3, D-37075 Gottingen, Germany; [Janova, Hana; Begemann, Martin; Boretius, Susann; Nave, Klaus-Armin; Ehrenreich, Hannelore] DFG, Ctr Nanoscale Microscopy & Mol Physiol Brain CNMP, Gottingen, Germany; [Begemann, Martin] Georg August Univ, UMG, Dept Psychiat & Psychotherapy, Gottingen, Germany; [Weber, Martin S.] Georg August Univ, UMG, Inst Neuropathol, Gottingen, Germany; [Weber, Martin S.] Georg August Univ, UMG, Dept Neurol, Gottingen, Germany; [Martens, Henrik] Synapt Syst GmbH, Gottingen, Germany; [Boretius, Susann] Leibniz Inst Primate Res, Funct Imaging Lab, Gottingen, Germany	Max Planck Society; Max Planck Society; German Research Foundation (DFG); University of Gottingen; University of Gottingen; University of Gottingen; Deutsches Primatenzentrum (DPZ)	Ehrenreich, H (corresponding author), Max Planck Inst Expt Med, Clin Neurosci, Hermann Rein Str 3, D-37075 Gottingen, Germany.; Nave, KA (corresponding author), Max Planck Inst Expt Med, Dept Neurogenet, Hermann Rein Str 3, D-37075 Gottingen, Germany.	nave@em.mpg.de; ehrenreich@em.mpg.de	Ehrenreich, Hannelore/AAS-6079-2020; Boretius, Susann/ABF-4993-2021; Weber, Martin/GPW-6095-2022	Boretius, Susann/0000-0003-2792-7423; Balmuth, Evan/0000-0002-9762-0905; Steixner-Kumar, Agnes A./0000-0001-7913-2716	Max Planck Society; Deutsche Forschungsgemeinschaft (DFG) Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB)	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft (DFG) Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB)(German Research Foundation (DFG))	This study was supported by the Max Planck Society and the Deutsche Forschungsgemeinschaft (DFG) Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB). L.F.G.-A., H.J., and L.E.S. shared first authorship. H.M. is an employee of Synaptic Systems GmbH. The authors declare no competing financial or other interests.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Begemann M, 2010, ARCH GEN PSYCHIAT, V67, P879, DOI 10.1001/archgenpsychiatry.2010.107; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; BRUMMER E, 1994, INT J IMMUNOPHARMACO, V16, P171, DOI 10.1016/0192-0561(94)90073-6; Caescu CI, 2015, BLOOD, V125, pE1, DOI 10.1182/blood-2014-10-608000; CHEN EYH, 1995, PSYCHIAT RES, V56, P183, DOI 10.1016/0165-1781(95)02535-2; Chistiakov DA, 2017, LAB INVEST, V97, P4, DOI 10.1038/labinvest.2016.116; Chitu V, 2016, TRENDS NEUROSCI, V39, P378, DOI 10.1016/j.tins.2016.03.005; Dagher NN, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0366-9; Dere E, 2014, FRONT BEHAV NEUROSCI, V8, P1, DOI 10.3389/fnbeh.2014.00173; Ebner F, 2013, J IMMUNOL, V191, P5594, DOI 10.4049/jimmunol.1203331; Elmore MRP, 2018, AGING CELL, V17, DOI 10.1111/acel.12832; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; FAZEKAS F, 1991, AM J NEURORADIOL, V12, P915; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Habes M, 2016, BRAIN, V139, P1164, DOI 10.1093/brain/aww008; Hagemeyer N, 2017, ACTA NEUROPATHOL, V134, P441, DOI 10.1007/s00401-017-1747-1; Hagemeyer N, 2012, EMBO MOL MED, V4, P528, DOI 10.1002/emmm.201200230; Hammond TR, 2018, ANNU REV CELL DEV BI, V34, P523, DOI 10.1146/annurev-cellbio-100616-060509; Huang YB, 2018, NAT NEUROSCI, V21, P530, DOI 10.1038/s41593-018-0090-8; Immig K, 2015, GLIA, V63, P611, DOI 10.1002/glia.22771; Jahn O, 2009, MOL NEUROBIOL, V40, P55, DOI 10.1007/s12035-009-8071-2; Janova H, 2018, J CLIN INVEST, V128, P734, DOI 10.1172/JCI97032; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; KUSCHINSKY K, 1972, EUR J PHARMACOL, V19, P119, DOI 10.1016/0014-2999(72)90086-6; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; O'Neil SM, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0636-8; Ozen I, 2014, ACTA NEUROPATHOL, V128, P381, DOI 10.1007/s00401-014-1295-x; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Poggi G, 2016, GLIA, V64, P2025, DOI 10.1002/glia.23039; Ribbe K, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-91; Sakuma R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0523-9; Segaliny AI, 2015, J BONE ONCOL, V4, P1, DOI 10.1016/j.jbo.2015.01.001; Simpson JE, 2007, NEUROPATH APPL NEURO, V33, P670, DOI 10.1111/j.1365-2990.2007.00890.x; Wlodarczyk A, 2017, EMBO J, V36, P3292, DOI 10.15252/embj.201696056; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Yuan XD, 2018, J NEUROSCI, V38, P4610, DOI 10.1523/JNEUROSCI.3030-17.2018; Zhan LH, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000134	40	9	10	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8634	8647		10.1096/fj.201900337R	http://dx.doi.org/10.1096/fj.201900337R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	31090455				2022-12-28	WOS:000476234700066
J	Li, Y; Yao, YF; Li, J; Chen, QY; Zhang, L; Wang, Q				Li, Yong; Yao, Yufeng; Li, Jia; Chen, Qiuyun; Zhang, Lu; Wang, Qing K.			Losartan protects against myocardial ischemia and reperfusion injury via vascular integrity preservation	FASEB JOURNAL			English	Article						I; R; vascular permeability; VEGFR2; VE-cadherin	ENDOTHELIAL-CELL PERMEABILITY; NO-REFLOW PHENOMENON; ANGIOTENSIN-II; ISCHEMIA/REPERFUSION INJURY; PATHOLOGICAL ANGIOGENESIS; GROWTH-FACTOR; CADHERIN; HEART; AT(1); PHOSPHORYLATION	Vascular hyperpermeability caused by distorted endothelial cell-cell junctions is associated with the no-reflow phenomenon after opening of the occluded vessels in patients with coronary artery disease (CAD), the leading cause of death worldwide. Coronary no-reflow is observed in similar to 30% of CAD patients after percutaneous coronary stenting and is associated with a worse prognosis at follow-up and a higher incidence of death. However, limited tools are available to control vascular hyperpermeability and no-reflow. Losartan, an angiotensin II (Ang II) receptor blocker acting on the Ang II type-1 receptor (AT1R) subtype, is a prescription drug for treating hypertension. Here we show that in a murine model of ischemia and reperfusion (I/R), losartan blocked vascular hyperpermeability and decreased infarct size, hemorrhages, edema, and inflammation. Mechanistically, losartan-mediated inhibition of vascular hyperpermeability is mediated by the inhibition of phosphorylation of Src and vascular endothelial cadherin (VE-cadherin), which increases VEGF receptor 2 (VEGFR2)-Src-VE-cadherin complex formation, resulting in increased cell surface VE-cadherin and inhibition of vascular hyperpermeability. On the other hand, hypoxia and reoxygenation increased the phosphorylation levels of Src and VE-cadherin and reduced the formation of the VEGFR2-Src-VE-cadherin complex, which led to reduced cell surface VE-cadherin and increased vascular hyperpermeability; all were inhibited by losartan. These data suggest that losartan may be used for blocking vascular hyperpermeability associated with I/R.-Li, Y., Yao, Y., Li, J., Chen, Q., Zhang, L., Wang, Q. K. Losartan protects against myocardial ischemia and reperfusion injury via vascular integrity preservation.	[Li, Yong; Yao, Yufeng; Li, Jia; Wang, Qing K.] Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Ctr Human Genome Res, Coll Life Sci & Technol,Minist Educ, 1037 Luoyu Rd, Wuhan 430074, Hubei, Peoples R China; [Zhang, Lu; Wang, Qing K.] Huazhong Univ Sci & Technol, Wenhua Coll, Wuhan, Hubei, Peoples R China; [Chen, Qiuyun; Wang, Qing K.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44106 USA; [Chen, Qiuyun] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44106 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Wang, Q (corresponding author), Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Ctr Human Genome Res, Coll Life Sci & Technol,Minist Educ, 1037 Luoyu Rd, Wuhan 430074, Hubei, Peoples R China.	qkwang@hust.edu.cn		Wang, Qing/0000-0002-5639-8519; Li, Jia/0000-0001-7132-2574	China Postdoctoral Science Foundation [2017M622409]; Certificate of China Postdoctoral Science Foundation fund [2018T110754]; National Natural Science Foundation of China [81630002, 31430047, 91439129]; Hubei Province Innovative Team grant [2017CFA014]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Certificate of China Postdoctoral Science Foundation fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Province Innovative Team grant	This work was supported by the China Postdoctoral Science Foundation fund (2017M622409), the Certificate of China Postdoctoral Science Foundation fund (2018T110754), the National Natural Science Foundation of China (Grants 81630002, 31430047, and 91439129), and a Hubei Province Innovative Team grant (2017CFA014). The authors declare no conflicts of interest.	Arumugam S, 2016, TRENDS CARDIOVAS MED, V26, P221, DOI 10.1016/j.tcm.2015.06.004; Barsotti A, 2001, ATHEROSCLEROSIS, V155, P53, DOI 10.1016/S0021-9150(00)00533-5; Benn A, 2016, J CELL SCI, V129, P206, DOI 10.1242/jcs.179960; Billet S, 2008, KIDNEY INT, V74, P1379, DOI 10.1038/ki.2008.358; Chakrabarti S, 2013, CIRC-ARRHYTHMIA ELEC, V6, P392, DOI 10.1161/CIRCEP.111.000206; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Corada M, 2001, BLOOD, V97, P1679, DOI 10.1182/blood.V97.6.1679; Dasgupta C, 2011, DRUG DISCOV TODAY, V16, P22, DOI 10.1016/j.drudis.2010.11.016; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dianat M, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.16664; FYHRQUIST F, 1995, J HUM HYPERTENS, V9, pS19; Galaup A, 2012, CIRCULATION, V125, P140, DOI 10.1161/CIRCULATIONAHA.111.049072; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Han ED, 2002, J CLIN INVEST, V109, P1057, DOI 10.1172/JCI200214211; Hee YJ, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3349-0; Hillis LD, 2006, NEW ENGL J MED, V355, P2475, DOI 10.1056/NEJMe068251; Huang Y, 2016, J BIOL CHEM, V291, P11030, DOI 10.1074/jbc.M115.695080; Ito H, 2006, NAT CLIN PRACT CARD, V3, P499, DOI 10.1038/ncpcardio0632; Kang Hyun-Jae, 2008, Expert Rev Cardiovasc Ther, V6, P703, DOI 10.1586/14779072.6.5.703; Klishadi Mohsen Sharifi, 2015, J Pharm Pharm Sci, V18, P112; KLONER RA, 1974, J CLIN INVEST, V54, P1496, DOI 10.1172/JCI107898; Kuang SQ, 2013, ARTERIOSCL THROM VAS, V33, P2172, DOI 10.1161/ATVBAHA.113.301624; Lee SW, 2011, MOL MED, V17, P1095, DOI 10.2119/molmed.2011.00106; LEFER AM, 1991, FASEB J, V5, P2029, DOI 10.1096/fasebj.5.7.2010056; Li WG, 2008, WORLD J GASTROENTERO, V14, P6681, DOI 10.3748/wjg.14.6681; Liang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020247; Liao YH, 2012, J AM COLL CARDIOL, V59, P420, DOI 10.1016/j.jacc.2011.10.863; Lin ZY, 2010, ARTERIOSCL THROM VAS, V30, P1952, DOI 10.1161/ATVBAHA.110.211474; Lu QL, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002529; Marques-Neto SR, 2014, CARDIOVASC DRUG THER, V28, P125, DOI 10.1007/s10557-013-6503-8; Murakami M, 2008, J CLIN INVEST, V118, P3355, DOI 10.1172/JCI35298; Murakami M, 2009, J MOL MED, V87, P571, DOI 10.1007/s00109-009-0463-2; Niccoli G, 2009, J AM COLL CARDIOL, V54, P281, DOI 10.1016/j.jacc.2009.03.054; Olivares-Reyes JA, 2009, MOL CELL ENDOCRINOL, V302, P128, DOI 10.1016/j.mce.2008.12.011; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Reglero-Real N, 2016, ARTERIOSCL THROM VAS, V36, P2048, DOI 10.1161/ATVBAHA.116.307610; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Rush JWE, 2008, APPL PHYSIOL NUTR ME, V33, P162, DOI 10.1139/H07-147; Strilakou AA, 2013, EUR J PHARMACOL, V709, P20, DOI 10.1016/j.ejphar.2013.03.025; van der Laan AM, 2009, NAT REV CARDIOL, V6, P515, DOI 10.1038/nrcardio.2009.103; Wallby L, 2007, CARDIOVASC PATHOL, V16, P256, DOI 10.1016/j.carpath.2007.06.003; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Xie J, 2017, ONCOTARGET, V8, P57981, DOI 10.18632/oncotarget.19853; Xue Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106827; Yang YJ, 2007, EUR J HEART FAIL, V9, P30, DOI 10.1016/j.ejheart.2006.04.013; Yano K, 2006, J EXP MED, V203, P1447, DOI 10.1084/jem.20060375; Yao YF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00171-w; Yao YF, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005889; Zhang T, 2016, HUM MOL GENET, V25, P5094, DOI 10.1093/hmg/ddw273	52	10	10	4	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8555	8564		10.1096/fj.201900060R	http://dx.doi.org/10.1096/fj.201900060R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30991833				2022-12-28	WOS:000476234700059
J	Yu, J; Luan, XJ; Yan, YD; Qiao, C; Liu, YY; Zhao, D; Xie, B; Zheng, QW; Wang, M; Chen, WY; Shen, C; He, ZY; Hu, X; Huang, XY; Li, H; Chen, BH; Zheng, B; Chen, X; Fang, J				Yu, Jun; Luan, Xiaojin; Yan, Yidan; Qiao, Chen; Liu, Yuanyuan; Zhao, Dan; Xie, Bing; Zheng, Qianwen; Wang, Min; Chen, Wanyin; Shen, Cong; He, Zeyu; Hu, Xing; Huang, Xiaoyan; Li, Hong; Chen, Binghai; Zheng, Bo; Chen, Xia; Fang, Jie			Small ribonucleoprotein particle protein SmD3 governs the homeostasis of germline stem cells and the crosstalk between the spliceosome and ribosome signals in Drosophila	FASEB JOURNAL			English	Article						SmD3; RpL18; GSCs	SELF-RENEWAL; DIFFERENTIATION; MAINTENANCE; SPERMATOGENESIS; MARBLES; LESSONS; LINEAGE; TESTIS; SNRNP; BAG	The ribonucleoprotein (RNP) spliceosome machinery triggers the precursor RNA splicing process in eukaryotes. Major spliceosome defects are implicated in male infertility; however, the underlying mechanistic links between the spliceosome and the ribosome in Drosophila testes remains largely unresolved. Small ribonucleoprotein particle protein SmD3 (SmD3) is a novel germline stem cell (GSC) regulatory gene identified in our previous screen of Drosophila testes. In the present study, using genetic manipulation in a Drosophila model, we demonstrated that SmD3 is required for the GSC niche and controls the self-renewal and differentiation of GSCs in the testis. Using in vitro assays in Schneider 2 cells, we showed that SmD3 also regulates the homeostasis of proliferation and apoptosis in Drosophila. Furthermore, using liquid chromatography-tandem mass spectrometry methods, SmD3 was identified as binding with ribosomal protein (Rp)L18, which is a key regulator of the large subunit in the ribosome. Moreover, SmD3 was observed to regulate spliceosome and ribosome subunit expression levels and controlled spliceosome and ribosome function via RpL18. Significantly, our findings revealed the genetic causes and molecular mechanisms underlying the stem cell niche and the crosstalk between the spliceosome and the ribosome.-Yu, J., Luan, X., Yan, Y., Qiao, C., Liu, Y., Zhao, D., Xie, B., Zheng, Q., Wang, M., Chen, W., Shen, C., He, Z., Hu, X., Huang, X., Li, H., Chen, B., Zheng, B., Chen, X., Fang, J. Small ribonucleoprotein particle protein SmD3 governs the homeostasis of germline stem cells and the crosstalk between the spliceosome and ribosome signals in Drosophila.	[Yu, Jun; Luan, Xiaojin; Yan, Yidan; Zheng, Qianwen; Wang, Min; Chen, Wanyin; Hu, Xing; Chen, Xia; Fang, Jie] Jiangsu Univ, Dept Gynecol, Affiliated Hosp, 438 Jiefang Rd, Zhenjiang 212001, Jiangsu, Peoples R China; [Qiao, Chen] Jiangsu Univ, Dept Clin Pharm, Affiliated Hosp, Zhenjiang, Jiangsu, Peoples R China; [Chen, Binghai] Jiangsu Univ, Dept Urol, Affiliated Hosp, Zhenjiang, Jiangsu, Peoples R China; [Yu, Jun; Luan, Xiaojin; Yan, Yidan; Zhao, Dan; Zheng, Qianwen; Chen, Xia] Jiangsu Univ, Reprod Sci Inst, Zhenjiang, Jiangsu, Peoples R China; [Liu, Yuanyuan; Shen, Cong; Li, Hong; Zheng, Bo] Nanjing Med Univ, Ctr Reprod & Genet, Suzhou Municipal Hosp, Affiliated Suzhou Hosp, Suzhou, Peoples R China; [Zhao, Dan] Jiangsu Univ, Peoples Hosp Zhenjiang 4, Affiliated Hosp 4, Ctr Reprod, Zhenjiang, Jiangsu, Peoples R China; [Xie, Bing] Jiangsu Univ, Peoples Hosp Zhenjiang 4, Affiliated Hosp 4, Dept Obstet & Gynecol, Zhenjiang, Jiangsu, Peoples R China; [He, Zeyu] China Med Univ, Dept Clin Med, Shenyang, Liaoning, Peoples R China; [Huang, Xiaoyan] Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University; Jiangsu University; Jiangsu University; Nanjing Medical University; Jiangsu University; Jiangsu University; China Medical University; Nanjing Medical University	Yu, J; Fang, J (corresponding author), Jiangsu Univ, Dept Gynecol, Affiliated Hosp, 438 Jiefang Rd, Zhenjiang 212001, Jiangsu, Peoples R China.	yujun9117@126.com; fangjie070@163.com	Liu, Yuanyuan/AAO-3761-2021; Zheng, Bo/AAC-6993-2022	Zheng, Bo/0000-0002-1496-0753; liu, Yuanyuan/0000-0003-0127-6060	National Natural Science Foundation of China [31701298, 81803505, 81402100]; Natural Science Foundation of Jiangsu Province [BK20170562, BK20170564]; Key Research Foundation of Zhenjiang Social Development [SH2016028, SH2017013, SH2017020, SH2018065]; Suzhou Key Laboratory of Male Reproduction Research [SZS201718]; Basic Program of Nanjing Medical University [2017NJMU163]; Suzhou Key Medical Center [SZZX201505]; Suzhou Introduced Project of Clinical Medical Expert Team [SZYJTD201708]; Jiangsu Provincial Medical Innovation Team [CXTDB2017013]; Foundation of Health and Family Planning Commission of Jiangsu Province [Q201408]; Foundation for Young Medical Talents of Jiangsu Province [QNRC2016840]; Six Talent Peaks Project in Jiangsu Province [WSW-007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Key Research Foundation of Zhenjiang Social Development; Suzhou Key Laboratory of Male Reproduction Research; Basic Program of Nanjing Medical University; Suzhou Key Medical Center; Suzhou Introduced Project of Clinical Medical Expert Team; Jiangsu Provincial Medical Innovation Team; Foundation of Health and Family Planning Commission of Jiangsu Province; Foundation for Young Medical Talents of Jiangsu Province; Six Talent Peaks Project in Jiangsu Province	The authors thank all study participants, research staff, and students who assisted with this work. The authors also thank Prof. Chao Tong (Zhejiang University, Hangzhou, China) for sharing reagents and stocks. The authors are grateful to the TsingHua Fly Center, the Bloomington Drosophila Stock Center, the Drosophila Genetic Resource Consortium, and the Developmental Studies Hybridoma Bank for providing fly strains and antibodies. This work was supported by the National Natural Science Foundation of China (31701298, 81803505, 81402100), the Natural Science Foundation of Jiangsu Province (BK20170562, BK20170564), the Key Research Foundation of Zhenjiang Social Development (SH2016028, SH2017013, SH2017020, SH2018065), the Suzhou Key Laboratory of Male Reproduction Research (SZS201718), the Basic Program of Nanjing Medical University (2017NJMU163), the Suzhou Key Medical Center (SZZX201505), the Suzhou Introduced Project of Clinical Medical Expert Team (SZYJTD201708), the Jiangsu Provincial Medical Innovation Team (CXTDB2017013), the Foundation of Health and Family Planning Commission of Jiangsu Province (Q201408), the Foundation for Young Medical Talents of Jiangsu Province (QNRC2016840), and the Six Talent Peaks Project in Jiangsu Province (WSW-007). The authors declare no conflicts of interest.	Akpinar M, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006660; Chen D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004797; Cherry CM, 2010, CELL STEM CELL, V6, P557, DOI 10.1016/j.stem.2010.04.018; Davies EL, 2008, COLD SH Q B, V73, P137, DOI 10.1101/sqb.2008.73.063; de Cuevas M, 2011, DEVELOPMENT, V138, P2861, DOI 10.1242/dev.056242; Eun SH, 2013, DEVELOPMENT, V140, P23, DOI 10.1242/dev.086397; Feng LJ, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006571; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Gateff E, 1982, Prog Clin Biol Res, V85 Pt B, P621; Gonsalvez GB, 2008, RNA, V14, P878, DOI 10.1261/rna.940708; Gonsalvez GB, 2006, CURR BIOL, V16, P1077, DOI 10.1016/j.cub.2006.04.037; Hime GR, 2007, INT J ANDROL, V30, P265, DOI 10.1111/j.1365-2605.2007.00767.x; Insco ML, 2012, CELL STEM CELL, V11, P689, DOI 10.1016/j.stem.2012.08.012; Kang Y, 2015, HUM MOL GENET, V24, P7255, DOI 10.1093/hmg/ddv425; Katayama H, 2001, RAPID COMMUN MASS SP, V15, P1416, DOI 10.1002/rcm.379; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Kondo Y, 2015, ELIFE, V4, DOI 10.7554/eLife.04986; Matera AG, 2014, NAT REV MOL CELL BIO, V15, P108, DOI 10.1038/nrm3742; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; Michel M, 2012, DEVELOPMENT, V139, P2663, DOI 10.1242/dev.075242; Pek JW, 2009, DEV CELL, V17, P417, DOI 10.1016/j.devcel.2009.07.017; Pelava A, 2016, BIOCHEM SOC T, V44, P1086, DOI 10.1042/BST20160106; Schulz C, 2002, DEVELOPMENT, V129, P4523; Schwer B, 2015, RNA, V21, P1173, DOI 10.1261/rna.050583.115; Shi YG, 2017, J MOL BIOL, V429, P2640, DOI 10.1016/j.jmb.2017.07.010; Shields AR, 2014, DEVELOPMENT, V141, P73, DOI 10.1242/dev.101931; Singh RK, 2012, TRENDS MOL MED, V18, P472, DOI 10.1016/j.molmed.2012.06.006; Spradling A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002642; Tong Chao, 2007, V397, P215; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; White-Cooper H, 2009, MOL CELL ENDOCRINOL, V306, P66, DOI 10.1016/j.mce.2008.11.026; Wu H, 2016, P NATL ACAD SCI USA, V113, P4134, DOI 10.1073/pnas.1513682113; Yan CY, 2017, SCIENCE, V355, P149, DOI 10.1126/science.aak9979; Yu J, 2016, DEVELOPMENT, V143, P2930, DOI 10.1242/dev.134247; Zhan XC, 2018, SCIENCE, V359, P537, DOI 10.1126/science.aar6401; Zhang XF, 2018, CELL RES, V28, P307, DOI 10.1038/cr.2018.14; Zhang XF, 2017, CELL, V169, P918, DOI 10.1016/j.cell.2017.04.033; Zhang Z, 2013, CELL RES, V23, P573, DOI 10.1038/cr.2013.29; Zitzmann Jan, 2018, Biotechnology Reports, V19, pe00272, DOI 10.1016/j.btre.2018.e00272	43	9	9	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8125	8137		10.1096/fj.201802536RR	http://dx.doi.org/10.1096/fj.201802536RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30921522	Bronze			2022-12-28	WOS:000476234700026
J	Yu, L; Shen, Z; Liu, Q; Zhan, XY; Luo, XY; An, XM; Sun, YL; Li, MX; Wang, S; Nie, Z; Ao, YSQ; Zhao, YN; Peng, GQ; Ben Mamoun, C; He, L; Zhao, JL				Yu, Long; Shen, Zhou; Liu, Qin; Zhan, Xueyan; Luo, Xiaoyin; An, Xiaomeng; Sun, Yali; Li, Muxiao; Wang, Sen; Nie, Zheng; Ao, Yangsiqi; Zhao, Yangnan; Peng, Guiqing; Ben Mamoun, Choukri; He, Lan; Zhao, Junlong			Crystal structures of Babesia microti lactate dehydrogenase BmLDH reveal a critical role for Arg99 in catalysis	FASEB JOURNAL			English	Article						LDH; growth inhibitor; catalytic mechanism; babesiosis	PLASMODIUM-FALCIPARUM; AZITHROMYCIN; ATOVAQUONE; INHIBITORS; GENOME; SITE; IDENTIFICATION; RESISTANCE; EFFICACY; SEQUENCE	The tick- and transfusion-transmitted human pathogen Babesia microti infects host erythrocytes to cause the pathologic symptoms associated with human babesiosis, an emerging disease with worldwide distribution and potentially fatal clinical outcome. Drugs currently recommended for the treatment of babesiosis are associated with a high failure rate and significant adverse events, highlighting the urgent need for more-effective and safer babesiosis therapies. Unlike other apicomplexan parasites, B. microti lacks a canonical lactate dehydrogenase (LDH) but instead expresses a unique enzyme, B. microti LDH (BmLDH), acquired through evolution by horizontal transfer from a mammalian host. Here, we report the crystal structures of BmLDH in apo state and ternary complex (enzyme-NADH-oxamate) solved at 2.79 and 1.89 angstrom. Analysis of these structures reveals that upon binding to the coenzyme and substrate, the active pocket of BmLDH undergoes a major conformational change from an opened and disordered to a closed and stabilized state. Biochemical assays using wild-type and mutant B. microti and human LDHs identified Arg99 as a critical residue for the catalytic activity of BmLDH but not its human counterpart. Interestingly, mutation of Arg99 to Ala had no impact on the overall structure and affinity of BmLDH to NADH but dramatically altered the closure of the enzyme's active pocket. Together, these structural and biochemical data highlight significant differences between B. microti and human LDH enzymes and suggest that BmLDH could be a suitable target for the development of selective antibabesial inhibitors.	[Yu, Long; Shen, Zhou; Liu, Qin; Zhan, Xueyan; Luo, Xiaoyin; An, Xiaomeng; Sun, Yali; Li, Muxiao; Wang, Sen; Nie, Zheng; Ao, Yangsiqi; Zhao, Yangnan; Peng, Guiqing; He, Lan; Zhao, Junlong] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [He, Lan; Zhao, Junlong] Huazhong Agr Univ, Minist Agr, Key Lab Anim Epidem Dis & Infect Zoonoses, Wuhan, Peoples R China; [Yu, Long; Shen, Zhou; Liu, Qin; Zhan, Xueyan; Luo, Xiaoyin; An, Xiaomeng; Sun, Yali; Li, Muxiao; Wang, Sen; Nie, Zheng; Ao, Yangsiqi; Zhao, Yangnan; Peng, Guiqing; He, Lan; Zhao, Junlong] Key Lab Prevent Vet Med, Wuhan, Peoples R China; [Ben Mamoun, Choukri] Yale Sch Med, Infect Dis Sect, Dept Internal Med, New Haven, CT USA	Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Yale University	He, L (corresponding author), Huazhong Agr Univ, 1 Shizishan St, Wuhan 430070, Hubei, Peoples R China.	helan@mail.hzau.edu.cn	He, Lan/AFU-5817-2022	Shen, Zhou/0000-0001-8772-2978	National Key Research and Development Program of China [2017YFD0501201]; National Key Basic Research Program (973 Program) of China [2015CB150302]; National Natural Science Foundation of China [31772729]; Natural Science Foundation of Hubei Province [2017CFA020]	National Key Research and Development Program of China; National Key Basic Research Program (973 Program) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	The authors thank the staff from BL17U/BL19U1/Beamline of the National Centre for Protein Sciences Shanghai (NCPSS), Shanghai Synchrotron Radiation Facility (Pudong, China) for assistance during data collection, and Dr. Deling Zhang (Center for Protein Research, Huazhong Agricultural University), for technical support. This study was supported by the National Key Research and Development Program of China (2017YFD0501201), the National Key Basic Research Program (973 Program) of China (2015CB150302), the National Natural Science Foundation of China (31772729), and the Natural Science Foundation of Hubei Province (2017CFA020). The authors declare no conflicts of interest.	Abraham A, 2018, J BIOL CHEM, V293, P19974, DOI 10.1074/jbc.AC118.005771; Al-Anouti F, 2004, J BIOL CHEM, V279, P52300, DOI 10.1074/jbc.M409175200; Bork S, 2004, MOL BIOCHEM PARASIT, V136, P165, DOI 10.1016/j.molbiopara.2004.03.009; Boucher JI, 2014, ELIFE, V3, DOI 10.7554/eLife.02304; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Bushell E, 2017, CELL, V170, P260, DOI 10.1016/j.cell.2017.06.030; Cameron A, 2004, J BIOL CHEM, V279, P31429, DOI 10.1074/jbc.M402433200; Chaikuad A, 2005, BIOCHEMISTRY-US, V44, P16221, DOI 10.1021/bi051416y; Choi SR, 2007, J COMB CHEM, V9, P292, DOI 10.1021/cc060110n; Conners R, 2005, MOL BIOCHEM PARASIT, V142, P137, DOI 10.1016/j.molbiopara.2005.03.015; Cornillot E, 2012, NUCLEIC ACIDS RES, V40, P9102, DOI 10.1093/nar/gks700; DUNN CR, 1991, PHILOS T ROY SOC B, V332, P177, DOI 10.1098/rstb.1991.0047; Dunn CR, 1996, NAT STRUCT BIOL, V3, P912, DOI 10.1038/nsb1196-912; Gomez MS, 1997, MOL BIOCHEM PARASIT, V90, P235, DOI 10.1016/S0166-6851(97)00140-0; Gray J, 2010, TICKS TICK-BORNE DIS, V1, P3, DOI 10.1016/j.ttbdis.2009.11.003; Hall N, 2002, NATURE, V419, P527, DOI 10.1038/nature01095; Holmes RS, 2009, COMPUT BIOL CHEM, V33, P379, DOI 10.1016/j.compbiolchem.2009.07.006; Hwang SJ, 2010, J VET MED SCI, V72, P765, DOI 10.1292/jvms.09-0535; Iguchi A, 2014, J VET MED SCI, V76, P1291, DOI 10.1292/jvms.14-0139; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kavanagh KL, 2004, BIOCHEMISTRY-US, V43, P879, DOI 10.1021/bi035108g; Kirk SK, 2017, J VET INTERN MED, V31, P1108, DOI 10.1111/jvim.14777; Kletsova EA, 2017, ANN CLIN MICROB ANTI, V16, DOI 10.1186/s12941-017-0198-9; Kolappan S, 2015, ACTA CRYSTALLOGR D, V71, P185, DOI 10.1107/S1399004714024791; Krause PJ, 2000, NEW ENGL J MED, V343, P1454, DOI 10.1056/NEJM200011163432004; Lawres LA, 2016, J EXP MED, V213, P1307, DOI 10.1084/jem.20151519; Madern D, 2004, MOL BIOL EVOL, V21, P489, DOI 10.1093/molbev/msh042; MAKLER MT, 1993, AM J TROP MED HYG, V48, P205, DOI 10.4269/ajtmh.1993.48.205; Mamoun C. B., 2018, ELS, DOI [10.1002/9780470015902.a0001945, DOI 10.1002/9780470015902.A0001945]; Penna-Coutinho J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021237; Raju M, 2007, PEDIATR INFECT DIS J, V26, P181, DOI 10.1097/01.inf.0000250622.11505.8f; Razakantoanina V, 2000, PARASITOL RES, V86, P665, DOI 10.1007/PL00008549; Read JA, 2001, PROTEINS, V43, P175, DOI 10.1002/1097-0134(20010501)43:2<175::AID-PROT1029>3.0.CO;2-#; Schnittger L, 2012, INFECT GENET EVOL, V12, P1788, DOI 10.1016/j.meegid.2012.07.004; Shoemark DK, 2007, FEBS J, V274, P2738, DOI 10.1111/j.1742-4658.2007.05808.x; Silva JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep35284; Simon MS, 2017, CLIN INFECT DIS, V65, P1222, DOI 10.1093/cid/cix477; Vannier EG, 2015, INFECT DIS CLIN N AM, V29, P357, DOI 10.1016/j.idc.2015.02.008; Vivas L, 2005, EXP PARASITOL, V111, P105, DOI 10.1016/j.exppara.2005.06.007; Vudriko P, 2014, DRUG TARGET INSIGHT, V8, P31, DOI 10.4137/DTI.S16504; Wormser GP, 2010, CLIN INFECT DIS, V50, P381, DOI 10.1086/649859; Yang SM, 1997, GENE, V184, P1, DOI 10.1016/S0378-1119(96)00566-5; Yu Y, 2001, BIOCHEM PHARMACOL, V62, P81, DOI 10.1016/S0006-2952(01)00636-0; Zhang HL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005250	44	4	4	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13669	13682		10.1096/fj.201901259R	http://dx.doi.org/10.1096/fj.201901259R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31585506				2022-12-28	WOS:000507466100049
J	Perez-Alos, L; Bayarri-Olmos, R; Skjoedt, MO; Garred, P				Perez-Alos, Laura; Bayarri-Olmos, Rafael; Skjoedt, Mikkel-Ole; Garred, Peter			Combining MAP-1:CD35 or MAP-1:CD55 fusion proteins with pattern-recognition molecules as novel targeted modulators of the complement cascade	FASEB JOURNAL			English	Article						MASPs; RCA family; complement regulation; lectin pathway; chimeric proteins	MANNOSE-BINDING LECTIN; INDUCED ARTHRITIS; CRYSTAL-STRUCTURE; SERINE PROTEASES; PATHWAY; INHIBITOR; SYSTEM; IMMUNE; DEFICIENCY; ACTIVATION	Dysregulation of the complement system is involved in the pathogenesis of several diseases, and its inhibition has been shown to be a feasible therapeutic option. Therefore, there is an interest in the development of complement modulators to treat complement activation-related inflammatory pathologies. Mannose-binding lectin (MBL)/ficolin/collectin-associated protein-1 (MAP-1) is a regulatory molecule of the lectin pathway (LP), whereas complement receptor 1 (CD35) and decay-accelerating factor (CD55) are membrane-anchored regulators with effects on the central effector molecule C3. In this study, we developed 2 novel soluble chimeric inhibitors by fusing MAP-1 to the 3 first domains of CD35 (CD35(1-3)) or the 4 domains of CD55 (CD55(1-4)) to modulate the complement cascade at 2 different stages. The constructs showed biologic properties similar to those of the parent molecules. In functional complement activation assays, the constructs were very efficient in inhibiting LP activation at the level of C3 and in the formation of terminal complement complex. This activity was enhanced when coincubated with recombinant LP recognition molecules MBL and ficolin-3. Recombinant MAP-1 fusion proteins, combined with recombinant LP recognition molecules to target sites of inflammation, represent a novel and effective therapeutic approach involving the initiation and the central and terminal effector functions of the complement cascade.	[Perez-Alos, Laura; Bayarri-Olmos, Rafael; Skjoedt, Mikkel-Ole; Garred, Peter] Rigshosp, Sect 7631, Dept Clin Immunol, Lab Mol Med, Ole Maaloeesvej 26, DK-2200 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Garred, P (corresponding author), Rigshosp, Sect 7631, Dept Clin Immunol, Lab Mol Med, Ole Maaloeesvej 26, DK-2200 Copenhagen, Denmark.	peter.garred@regionh.dk		Skjodt, Mikkel-Ole/0000-0003-1306-6482; Perez-Alos, Laura/0000-0002-0368-4976	Danish Research Foundation of Independent Research [DFF-6110-00489]; Lundbeck Research Foundation; Novo Nordisk Research Foundation; Svend Andersen Research Foundation	Danish Research Foundation of Independent Research; Lundbeck Research Foundation(Lundbeckfonden); Novo Nordisk Research Foundation(Novo Nordisk Foundation); Svend Andersen Research Foundation	The authors thank Jytte Bryde Clausen and Jesper Andresen for excellent technical assistance, and R. P. Taylor (University of Virginia, Charlottesville, VA, USA) for kindly providing the 3D9 anti-complement receptor 1 mAb. This work was supported by the Danish Research Foundation of Independent Research (DFF-6110-00489), the Lundbeck Research Foundation, the Novo Nordisk Research Foundation, and the Svend Andersen Research Foundation. L.P.-A. and R.B.-O. are joint first authors. R.B.-O., M.-O.S., and P.G. are listed as inventors on patent applications and patents using mannose-binding lectin/ficolin/collectin-associated protein-1 as a vehicle for therapeutic inhibition. L.P.-A. declares no conflicts of interest.	Banda NK, 2014, J IMMUNOL, V193, P2455, DOI 10.4049/jimmunol.1400752; Bayarri-Olmos R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02238; Bohlson SS, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01308; Brodbeck WG, 1996, J IMMUNOL, V156, P2528; Degn SE, 2009, J IMMUNOL, V183, P7371, DOI 10.4049/jimmunol.0902388; Dobo J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01851; Forneris F, 2012, CURR OPIN STRUC BIOL, V22, P333, DOI 10.1016/j.sbi.2012.04.001; Fridkis-Hareli M, 2019, MOL IMMUNOL, V105, P150, DOI 10.1016/j.molimm.2018.09.013; Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4; GARRED P, 1988, SCAND J IMMUNOL, V27, P319, DOI 10.1111/j.1365-3083.1988.tb02353.x; Garred P, 2016, IMMUNOL REV, V274, P74, DOI 10.1111/imr.12468; Harboe M, 2008, J CELL MOL MED, V12, P1074, DOI 10.1111/j.1582-4934.2008.00350.x; Harboe M, 2009, MOL IMMUNOL, V47, P373, DOI 10.1016/j.molimm.2009.09.005; Harris CL, 2018, MOL IMMUNOL, V102, P89, DOI 10.1016/j.molimm.2018.06.008; Hein E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015443; Hertz CE, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01945; Holers VM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01057; Hourcade D, 2000, IMMUNOPHARMACOLOGY, V49, P103, DOI 10.1016/S0162-3109(00)80296-9; Kouser L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00093; Larsen F, 2004, J BIOL CHEM, V279, P21302, DOI 10.1074/jbc.M400520200; Linton SM, 2000, ARTHRITIS RHEUM-US, V43, P2590, DOI 10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; Miwa T, 2001, INT IMMUNOPHARMACOL, V1, P445, DOI 10.1016/S1567-5769(00)00043-6; MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P183, DOI 10.1111/j.1365-3083.1985.tb01870.x; Mulligan MS, 1999, J IMMUNOL, V162, P4952; Munthe-Fog L, 2008, MOL IMMUNOL, V45, P2660, DOI 10.1016/j.molimm.2007.12.012; Nordmaj MA, 2015, FASEB J, V29, P4945, DOI 10.1096/fj.15-277103; Ozen A, 2017, NEW ENGL J MED, V377, P52, DOI 10.1056/NEJMoa1615887; Parej K, 2014, MOL IMMUNOL, V59, P1, DOI 10.1016/j.molimm.2013.12.003; Pavlov VI, 2012, CIRCULATION, V126, P2227, DOI 10.1161/CIRCULATIONAHA.112.123968; Ricklin D, 2016, SEMIN IMMUNOL, V28, P208, DOI 10.1016/j.smim.2016.06.001; Ricklin D, 2016, NAT REV NEPHROL, V12, P383, DOI 10.1038/nrneph.2016.70; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rosbjerg A, 2014, J IMMUNOL, V192, P4352, DOI 10.4049/jimmunol.1303263; Schatz-Jakobsen JA, 2016, IMMUNOL REV, V274, P59, DOI 10.1111/imr.12465; Schmidt CQ, 2013, J IMMUNOL, V190, P5712, DOI 10.4049/jimmunol.1203548; Seelen MA, 2005, J IMMUNOL METHODS, V296, P187, DOI 10.1016/j.jim.2004.11.016; SEYA T, 1995, MICROBIOL IMMUNOL, V39, P295, DOI 10.1111/j.1348-0421.1995.tb02205.x; Skerra A, 2000, METHOD ENZYMOL, V326, P271; Skjoedt MO, 2012, J BIOL CHEM, V287, P32913, DOI 10.1074/jbc.M112.386680; Skjoedt MO, 2010, J BIOL CHEM, V285, P8234, DOI 10.1074/jbc.M109.065805; Smith BO, 2002, CELL, V108, P769, DOI 10.1016/S0092-8674(02)00672-4; Teillet F, 2008, J BIOL CHEM, V283, P25715, DOI 10.1074/jbc.M803551200; Tomlinson S, 2018, MOL IMMUNOL, V102, P120, DOI 10.1016/j.molimm.2018.06.005; Wallis R, 2007, IMMUNOBIOLOGY, V212, P289, DOI 10.1016/j.imbio.2006.11.004; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	47	3	3	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12723	12734		10.1096/fj.201901643R	http://dx.doi.org/10.1096/fj.201901643R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31469600	Green Published			2022-12-28	WOS:000507461600087
J	Xu, XM; Kobayashi, S; Timm, D; Huang, Y; Zhao, FY; Shou, WNA; Liang, QR				Xu, Xianmin; Kobayashi, Satoru; Timm, Derek; Huang, Yuan; Zhao, Fengyi; Shou, Weinian; Liang, Qiangrong			Enhanced mTOR complex 1 signaling attenuates diabetic cardiac injury in OVE26 mice	FASEB JOURNAL			English	Article						rapamycin; diabetes; cardiomyopathy; autophagy; oxidative stress	RAPAMYCIN TREATMENT; MAMMALIAN TARGET; MECHANISTIC TARGET; INHIBITION; HEART; REPERFUSION; PROTECTS; OVEREXPRESSION; CARDIOMYOCYTES; HYPERGLYCEMIA	The protein kinase mechanistic target of rapamycin (mTOR) performs diverse cellular functions through 2 distinct multiprotein complexes, mTOR complex (mTORC)1 and 2. Numerous studies using rapamycin, an mTORC1 inhibitor, have implicated a role for mTORC1 in several types of heart disease. People with diabetes are more susceptible to heart failure. mTORC1 activity is increased in the diabetic heart, but its functional significance remains controversial. To investigate the role of mTORC1 in the diabetic heart, we crossed OVE26 type 1 diabetic mice with transgenic mice expressing a constitutively active mTOR (mTORca) or kinase-dead mTOR (mTORkd) in the heart. The expression of mTORca or mTORkd affected only mTORC1 but not mTORC2 activities, with corresponding changes in the activities of autophagy, a cellular degradation pathway negatively regulated by mTORC1. Diabetic cardiac damage in OVE26 mice was dramatically reduced by mTORca but exacerbated by mTORkd expression as assessed by changes in cardiac function, oxidative stress, and myocyte apoptosis. These findings demonstrated that the enhanced mTORC1 signaling in the OVE26 diabetic heart was an adaptive response that limited cardiac dysfunction, suggesting that manipulations that enhance mTORC1 activity may reduce diabetic cardiac injury, in sharp contrast to the results previously obtained with rapamycin.	[Xu, Xianmin; Timm, Derek] Sanford Res, Sioux Falls, SD USA; [Kobayashi, Satoru; Huang, Yuan; Liang, Qiangrong] New York Inst Technol, Coll Osteopath Med, Dept Biomed Sci, Old Westbury, NY 11568 USA; [Zhao, Fengyi] Xi An Jiao Tong Univ, Hlth Sci Ctr, Affiliated Hosp 1, Dept Endocrinol, Xian, Peoples R China; [Shou, Weinian] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Riley Heart Ctr, Dept Pediat, Indianapolis, IN 46202 USA	Sanford Health; New York Institute Technology; Xi'an Jiaotong University; Indiana University System; Indiana University Bloomington	Liang, QR (corresponding author), New York Inst Technol, Coll Osteopath Med, Northern Blvd,POB 8000, Old Westbury, NY 11568 USA.	qliang03@nyit.edu			American Diabetes Association [1-09-CD-09]	American Diabetes Association(American Diabetes Association)	The authors are grateful to the Physiology Core Facility at the Sanford Research/University of South Dakota (USD) for performing echocardiographic and hemodynamic measurements. The authors also thank the Imaging Core Facility for assistance with confocal microscopy. This work was supported by a Career Development Grant (1-09-CD-09) from the American Diabetes Association. Parts of this study were presented at the 74th Scientific Sessions of the American Diabetes Association (June 13-17, 2014, San Francisco, CA, USA). Most of the work was conducted at Sanford Research/USD at the time that corresponding author Q.L. was employed. The authors declare no conflicts of interest.	Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Aoyagi T, 2015, AM J PHYSIOL-HEART C, V308, pH1530, DOI 10.1152/ajpheart.00008.2015; Aoyagi T, 2012, AM J PHYSIOL-HEART C, V303, pH75, DOI 10.1152/ajpheart.00241.2012; Baba Y, 2018, AM J PHYSIOL-HEART C, V314, pH659, DOI 10.1152/ajpheart.00452.2017; Belenchia AM, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8364608; Buss SJ, 2009, J AM COLL CARDIOL, V54, P2435, DOI 10.1016/j.jacc.2009.08.031; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Curtis MJ, 2018, BRIT J PHARMACOL, V175, P987, DOI 10.1111/bph.14153; Das A, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0486-5; EPSTEIN PN, 1989, CELL, V58, P1067, DOI 10.1016/0092-8674(89)90505-9; Filippone SM, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4619720; Fonarow GC, 2006, ENDOCRIN METAB CLIN, V35, P575, DOI 10.1016/j.ecl.2006.05.003; Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Harston RK, 2011, AM J PHYSIOL-HEART C, V300, pH1696, DOI 10.1152/ajpheart.00545.2010; Hausenloy DJ, 2004, CARDIOVASC RES, V63, P305, DOI 10.1016/j.cardiores.2004.04.011; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Huynh K, 2014, PHARMACOL THERAPEUT, V142, P375, DOI 10.1016/j.pharmthera.2014.01.003; Jennings DL, 2018, INT J CARDIOL, V265, P71, DOI 10.1016/j.ijcard.2018.03.111; Kobayashi S, 2007, J BIOL CHEM, V282, P21945, DOI 10.1074/jbc.M703048200; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Lassaletta AD, 2014, ANN THORAC SURG, V97, P901, DOI 10.1016/j.athoracsur.2013.09.059; Liang QR, 2002, DIABETES, V51, P174, DOI 10.2337/diabetes.51.1.174; Luck C, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5724046; Maisch B, 2011, HERZ, V36, P102, DOI 10.1007/s00059-011-3429-4; Maloyan A, 2009, CIRC RES, V104, P1021, DOI 10.1161/CIRCRESAHA.108.193516; Morita M, 2017, MOL CELL, V67, P922, DOI 10.1016/j.molcel.2017.08.013; Morviducci L, 2018, DIABETES RES CLIN PR, V143, P428, DOI 10.1016/j.diabres.2018.04.001; Reifsnyder PC, 2018, ANN NY ACAD SCI, V1418, P106, DOI 10.1111/nyas.13557; Samidurai A, 2017, BRIT J PHARMACOL, V174, P4771, DOI 10.1111/bph.14059; Sciarretta S, 2018, CIRC RES, V122, P489, DOI 10.1161/CIRCRESAHA.117.311147; Shen WH, 2008, J BIOL CHEM, V283, P13842, DOI 10.1074/jbc.M801510200; Shen X, 2004, AM J PHYSIOL-ENDOC M, V287, pE896, DOI 10.1152/ajpendo.00047.2004; Shende P, 2011, CIRCULATION, V123, P1073, DOI 10.1161/CIRCULATIONAHA.110.977066; Song XX, 2010, AM J PHYSIOL-CELL PH, V299, pC1256, DOI 10.1152/ajpcell.00338.2010; Suhara T, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0865-4; Voelkers M, 2013, CIRCULATION, V128, P2132, DOI 10.1161/CIRCULATIONAHA.113.003638; Wang J, 2017, ARCH MED SCI, V13, P947, DOI 10.5114/aoms.2016.59712; Xu LF, 2016, BBA-MOL CELL RES, V1863, P1894, DOI 10.1016/j.bbamcr.2016.01.003; Xu XM, 2013, J BIOL CHEM, V288, P18077, DOI 10.1074/jbc.M113.474650; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008; Zhu WQ, 2009, CIRCULATION, V119, P99, DOI 10.1161/CIRCULATIONAHA.108.799700; Zhu Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054221, 10.1371/journal.pone.0071727]	44	5	5	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12800	12811		10.1096/fj.201901206R	http://dx.doi.org/10.1096/fj.201901206R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31469601				2022-12-28	WOS:000507461600093
J	Chuang, HC; Chen, YM; Chen, MH; Hung, WT; Yang, HY; Tseng, YH; Tan, TH				Chuang, Huai-Chia; Chen, Yi-Ming; Chen, Ming-Han; Hung, Wei-Ting; Yang, Huang-Yu; Tseng, Yang-Hao; Tan, Tse-Hua			AhR-ROR-gamma t complex is a therapeutic target for MAP4K3/GLK(high)IL-17A(high) subpopulation of systemic lupus erythematosus	FASEB JOURNAL			English	Article						SLE; verteporfin; autoimmune disease	ARYL-HYDROCARBON RECEPTOR; TH17; DIFFERENTIATION; CELLS; AUTOIMMUNITY; IMMUNITY; PATHWAY; KINASE	The cytokine IL-17A plays critical roles in the pathogenesis of autoimmune diseases. The frequencies of MAP kinase kinase kinase kinase 3 [also named germinal center kinase-like kinase (GLK)]-overexpressing T cells are correlated with disease severity of systemic lupus erythematosus (SLE). T-cell-specific GLK-transgenic mice develop spontaneous autoimmune responses through IL-17A. GLK signaling selectively stimulates IL-17A production in murine T cells through inducing aryl hydrocarbon receptor (AhR)-retinoic acid receptor-related orphan nuclear receptor-gamma t (ROR-gamma t) complex formation. Here, we investigated whether GLK-induced AhR-ROR-gamma t complex in T cells is a therapeutic target for human SLE. The population of GLK(+)IL-17A(+) T cells was enhanced in the peripheral blood from patients with SLE compared with that of healthy controls using flow cytometry. The receiver operating characteristic curve analysis showed that increased GLK(+)IL-17A(+) T-cell population in peripheral blood reflected an active stage of SLE. In addition, peripheral blood T cells from patients with SLE displayed induction of ROR-gamma t phosphorylation and the AhR-ROR-gamma t (and AhR-phosphorylated ROR-gamma t) complex. Moreover, we identified a small-molecule inhibitor, verteporfin, that inhibited GLK kinase activity and AhR-ROR-gamma t interaction. The small-molecule inhibitor verteporfin suppressed the disease severity in autoimmune mouse models and IL-17A production in T cells from patients with SLE. Collectively, the GLK-induced AhR-ROR-gamma t (and AhR-phosphorylated ROR-gamma t) complex is a therapeutic target for the GLK(high)IL-17A(high) subpopulation of human patients with SLE.-Chuang, H.-C., Chen, Y.-M., Chen, M.-H., Hung, W.-T., Yang, H.-Y., Tseng, Y.-H., Tan, T.-H. AhR-ROR-gamma t complex is a therapeutic target for MAP4K3/GLK(high)IL-17A(high) subpopulation of systemic lupus erythematosus.	[Chuang, Huai-Chia; Tseng, Yang-Hao; Tan, Tse-Hua] Natl Hlth Res Inst, Immunol Res Ctr, Zhunan, Taiwan; [Chen, Yi-Ming; Hung, Wei-Ting] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Ming-Han] Taipei Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taipei, Taiwan; [Yang, Huang-Yu] Chang Gung Mem Hosp, Dept Med, Taoyuan, Taiwan; [Tan, Tse-Hua] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	National Health Research Institutes - Taiwan; Taichung Veterans General Hospital; Taipei Veterans General Hospital; Chang Gung Memorial Hospital; Baylor College of Medicine	Tan, TH (corresponding author), Natl Hlth Res Inst, 35 Keyan Rd, Zhunan 35053, Taiwan.	ttan@nhri.edu.tw	Chuang, Huai-Chia/E-9486-2016; Tan, Tse-Hua/ABD-7080-2021; Chen, Yi-Ming/AAV-3806-2021; Tan, Tse-Hua/E-3983-2010	Tan, Tse-Hua/0000-0003-4969-3170; Chen, Yi-Ming/0000-0001-7593-3065; Tan, Tse-Hua/0000-0003-4969-3170; YANG, HUANG-YU/0000-0001-6826-9717	NHRI [IM-105-PP-01, IM-105-SP-01]; Ministry of Science and Technology, Taiwan [MOST-106-2321B-400-013]	NHRI(National Health Research Institutes - Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The authors thank the Laboratory Animal Center (Association for Assessment and Accreditation of Laboratory Animal Care) of the National Health Research Institutes (NHRI) for mouse housing; the National Research Program for Biopharmaceuticals (ChemBank and High-Throughput Screening Resource Center) for screening the potential germinal center kinase-like kinase inhibitors; and the Biostatistics Task Force of Taichung Veterans General Hospital for assistance in statistical analyses. This work was supported by grants from NHRI (IM-105-PP-01 and IM-105-SP-01, to T.-H.T.) and the Ministry of Science and Technology, Taiwan (MOST-106-2321B-400-013 to T.-H.T.). T.-H.T. is a Taiwan Bio-Development Foundation (TBF) Chair in Biotechnology. The authors declare no conflicts interest.	Chen DY, 2012, LUPUS, V21, P1385, DOI 10.1177/0961203312457718; Chen DY, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-84; Chen YM, 2013, ARTHRITIS RHEUM-US, V65, P2573, DOI 10.1002/art.38067; Chuang HC, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat5401; Chuang HC, 2016, ONCOTARGET, V7, P57593, DOI 10.18632/oncotarget.11419; Chuang HC, 2016, ADV IMMUNOL, V129, P277, DOI 10.1016/bs.ai.2015.09.006; Chuang HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5602; Chuang HC, 2011, NAT IMMUNOL, V12, P1113, DOI 10.1038/ni.2121; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; Cui GL, 2011, J CLIN INVEST, V121, P658, DOI 10.1172/JCI42974; Diener K, 1997, P NATL ACAD SCI USA, V94, P9687, DOI 10.1073/pnas.94.18.9687; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Guendisch U, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188391; Guntermann C, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91127; Henriques A, 2010, CELL IMMUNOL, V264, P97, DOI 10.1016/j.cellimm.2010.05.004; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Liljevald M, 2016, AUTOIMMUN REV, V15, P1062, DOI 10.1016/j.autrev.2016.07.036; Lopez P, 2016, SCI REP-UK, V6, DOI 10.1038/srep20651; Martin JC, 2014, CLIN IMMUNOL, V154, P1, DOI 10.1016/j.clim.2014.05.004; Newman DK, 2016, EYE, V30, P202, DOI 10.1038/eye.2015.251; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Patel DD, 2015, IMMUNITY, V43, P1040, DOI 10.1016/j.immuni.2015.12.003; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2010, P NATL ACAD SCI USA, V107, P20768, DOI 10.1073/pnas.1009201107; Shah K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2964; Shui JW, 2007, NAT IMMUNOL, V8, P84, DOI 10.1038/ni1416; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Yang J, 2009, ARTHRITIS RHEUM-US, V60, P1472, DOI 10.1002/art.24499; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007	32	16	16	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11469	11480		10.1096/fj.201900105RR	http://dx.doi.org/10.1096/fj.201900105RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31318609	Green Published, hybrid			2022-12-28	WOS:000489166300072
J	Gutierrez-Gonzalez, LH; Santos-Mendoza, T				Gutierrez-Gonzalez, Luis H.; Santos-Mendoza, Teresa			Viral targeting of PDZ polarity proteins in the immune system as a potential evasion mechanism	FASEB JOURNAL			English	Article						viral hijacking; immune evasion; PDZ-binding motifs	BORNE ENCEPHALITIS-VIRUS; SYNDROME-ASSOCIATED CORONAVIRUS; HELICOBACTER-PYLORI CAGA; INFLUENZA-A VIRUS; T-CELL POLARITY; VACCINIA VIRUS; INFECTED-CELLS; BINDING MOTIF; HUMAN HOMOLOG; SCRIBBLE	PDZ proteins are highly conserved through evolution; the principal function of this large family of proteins is to assemble protein complexes that are involved in many cellular processes, such as cell-cell junctions, cell polarity, recycling, or trafficking. Many PDZ proteins that have been identified as targets of viral pathogens by promoting viral replication and spread are also involved in epithelial cell polarity. Here, we briefly review the PDZ polarity proteins in cells of the immune system to subsequently focus on our hypothesis that the viral PDZ-dependent targeting of PDZ polarity proteins in these cells may alter the cellular fitness of the host to favor that of the virus; we further hypothesize that this modification of the cellular fitness landscape occurs as a common and widespread mechanism for immune evasion by viruses and possibly other pathogens.-Gutierrez-Gonzalez, L. H., Santos-Mendoza, T. Viral targeting of PDZ polarity proteins in the immune system as a potential evasion mechanism.	[Gutierrez-Gonzalez, Luis H.] Inst Nacl Enfermedades Resp Ismael Cosio, Dept Virol & Mycol, Mexico City, DF, Mexico; [Santos-Mendoza, Teresa] Inst Nacl Enfermedades Resp Ismael Cosio, Lab Autoimmun, Mexico City, DF, Mexico		Santos-Mendoza, T (corresponding author), Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Lab Autoimmun, Calzada Tlalpan 4502,Colonia Secc 16, Ciudad De Mexico 14080, Mexico.	tsantos@iner.gob.mx	Santos-Mendoza, Teresa/AAK-8528-2021	Santos-Mendoza, Teresa/0000-0003-1015-5631; Gutierrez-Gonzalez, Luis Horacio/0000-0003-0708-0448	Instituto Politecnico Nacional, Mexico City, Mexico; National Council of Science and Technology (CONACYT) [CB2015-250579]	Instituto Politecnico Nacional, Mexico City, Mexico; National Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors thank Iris Estrada-Garcia (Escuela Nacional de Ciencias Biologicas, Instituto Politecnico Nacional, Mexico City, Mexico) and Edgar Sevilla-Reyes (Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas) for helpful discussion. This work was supported by the National Council of Science and Technology (CONACYT; Grant CB2015-250579). The authors declare no conflicts of interest.	Ahantarig A, 2009, INTERVIROLOGY, V52, P283, DOI 10.1159/000235741; Al-Saleem J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214059; Arakawa Y, 2007, CELL HOST MICROBE, V1, P227, DOI 10.1016/j.chom.2007.04.006; Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; Barreda D, 2018, J LEUKOCYTE BIOL, V103, P731, DOI 10.1002/JLB.4AB0517-184R; Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005; Best SM, 2017, J VIROL, V91, DOI [10.1128/jvi.01970-16, 10.1128/JVI.01970-16]; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bloom O, 2008, J CELL BIOL, V181, P203, DOI 10.1083/jcb.200711149; Blot V, 2004, J CELL SCI, V117, P3983, DOI 10.1242/jcs.01266; Boxus M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-76; Carvalho G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018159; Castano-Rodriguez C, 2018, MBIO, V9, DOI 10.1128/mBio.02325-17; Chahroudi A, 2005, J VIROL, V79, P10397, DOI 10.1128/JVI.79.16.10397-10407.2005; Cherian MA, 2015, J BIOL CHEM, V290, P26270, DOI 10.1074/jbc.M115.684746; Cheung CY, 2005, J VIROL, V79, P7819, DOI 10.1128/JVI.79.12.7819-7826.2005; De Diego ML, 2014, VIRUS RES, V194, P124, DOI 10.1016/j.virusres.2014.07.024; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; Dong XJ, 2019, J IMMUNOL, V202, P3187, DOI 10.4049/jimmunol.1900089; Ellencrona K, 2009, BIOL CHEM, V390, P319, DOI 10.1515/BC.2009.041; ENJUANES L, 2008, NIDOVIRUSES, P379; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Gmyrek GB, 2013, EUR J IMMUNOL, V43, P1185, DOI 10.1002/eji.201142362; Golebiewski L, 2011, J VIROL, V85, P10639, DOI 10.1128/JVI.05070-11; Gross C, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030074; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hagai T, 2014, CELL REP, V7, P1729, DOI 10.1016/j.celrep.2014.04.052; Hanada T, 1997, J BIOL CHEM, V272, P26899, DOI 10.1074/jbc.272.43.26899; Handa Y, 2013, CELL HOST MICROBE, V14, P51, DOI 10.1016/j.chom.2013.06.006; Hatakeyama M, 2014, CELL HOST MICROBE, V15, P306, DOI 10.1016/j.chom.2014.02.008; Healy NC, 2009, J LEUKOCYTE BIOL, V85, P481, DOI 10.1189/jlb.0408238; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Huse Morgan, 2011, Bioarchitecture, V1, P180; Hyser JM, 2010, MBIO, V1, DOI 10.1128/mBio.00265-10; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Irwin CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084134; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Javier RT, 2011, J VIROL, V85, P11544, DOI 10.1128/JVI.05410-11; Jezek Z, 1988, HUMAN MONKEYPOX; Jimenez-Guardeno JM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004320; Kanzawa N, 2006, FEBS LETT, V580, P6807, DOI 10.1016/j.febslet.2006.11.046; Kellman EM, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10060329; KENNEDY MB, 1995, TRENDS BIOCHEM SCI, V20, P350, DOI 10.1016/S0968-0004(00)89074-X; Kiyono T, 1997, P NATL ACAD SCI USA, V94, P11612, DOI 10.1073/pnas.94.21.11612; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; Law HKW, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-35; Law HKW, 2005, BLOOD, V106, P2366, DOI 10.1182/blood-2004-10-4166; Le SS, 1997, P NATL ACAD SCI USA, V94, P6670, DOI 10.1073/pnas.94.13.6670; Li S, 2016, NAT IMMUNOL, V17, P241, DOI 10.1038/ni.3311; Liu HB, 2010, J VIROL, V84, P11164, DOI 10.1128/JVI.01278-10; Liu WL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002820; Lu W, 2006, P NATL ACAD SCI USA, V103, P12540, DOI 10.1073/pnas.0605402103; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; Makokha GN, 2013, CANCER SCI, V104, P313, DOI 10.1111/cas.12087; Mansfield KL, 2009, J GEN VIROL, V90, P1781, DOI 10.1099/vir.0.011437-0; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Melik W, 2012, VIRUS RES, V169, P54, DOI 10.1016/j.virusres.2012.07.001; Meng XB, 2009, EUR J IMMUNOL, V39, P552, DOI 10.1002/eji.200838474; Minakshi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008342; Miorin L, 2017, BIOCHEM BIOPH RES CO, V492, P587, DOI 10.1016/j.bbrc.2017.05.146; Modjeski KL, 2016, AM J TRANSPLANT, V16, P1383, DOI 10.1111/ajt.13623; Morales I, 2008, TRAFFIC, V9, P1283, DOI 10.1111/j.1600-0854.2008.00762.x; Moss B, 2007, FIELDS VIROLOGY; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Ohshima K, 2015, ONCOLOGY-BASEL, V89, P7, DOI 10.1159/000431058; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Qu ZX, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-23; Rincon E, 2007, MOL CELL PROTEOMICS, V6, P1073, DOI 10.1074/mcp.M700047-MCP200; Rincon E, 2011, J CELL SCI, V124, P776, DOI 10.1242/jcs.072447; Robertson SJ, 2014, J IMMUNOL, V192, P2744, DOI 10.4049/jimmunol.1302110; Robertson SJ, 2009, IMMUNOL RES, V43, P172, DOI 10.1007/s12026-008-8065-6; Round JL, 2005, J EXP MED, V201, P419, DOI 10.1084/jem.20041428; Rousset R, 1998, ONCOGENE, V16, P643, DOI 10.1038/sj.onc.1201567; Russell S, 2008, J CELL SCI, V121, P131, DOI 10.1242/jcs.021253; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Saito Y, 2018, BBA-REV CANCER, V1869, P103, DOI 10.1016/j.bbcan.2017.12.001; Sala-Valdes M, 2012, J CELL SCI, V125, P1235, DOI 10.1242/jcs.094912; Sarrouilhe D, 2006, BIOCHIMIE, V88, P1099, DOI 10.1016/j.biochi.2006.04.010; Seed B, 2008, J CELL BIOL, V181, P181, DOI 10.1083/jcb.200803120; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Silva O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133353; Smed-Sorensen A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002572; Smith GL, 2013, J GEN VIROL, V94, P2367, DOI 10.1099/vir.0.055921-0; Spiegel M, 2006, J GEN VIROL, V87, P1953, DOI 10.1099/vir.0.81624-0; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Tanaka T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001637; Tanaka Y, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0185-1; Tello-Lafoz M, 2017, TRAFFIC, V18, P491, DOI 10.1111/tra.12492; Teoh KT, 2010, MOL BIOL CELL, V21, P3838, DOI 10.1091/mbc.E10-04-0338; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; Thomas M, 2018, J MOL BIOL, V430, P3481, DOI 10.1016/j.jmb.2018.04.016; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Torres J, 2006, BIOPHYS J, V91, P938, DOI 10.1529/biophysj.105.080119; Valderrama F, 2006, SCIENCE, V311, P377, DOI 10.1126/science.1122411; Vennema H, 1996, EMBO J, V15, P2020, DOI 10.1002/j.1460-2075.1996.tb00553.x; Via A, 2015, TRENDS BIOCHEM SCI, V40, P36, DOI 10.1016/j.tibs.2014.11.001; Werme K, 2008, CELL MICROBIOL, V10, P696, DOI 10.1111/j.1462-5822.2007.01076.x; Wigerius M, 2010, MOL CELL NEUROSCI, V44, P260, DOI 10.1016/j.mcn.2010.03.012; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433; Xavier R, 2004, J CELL BIOL, V166, P173, DOI 10.1083/jcb.200309044; Yeh JH, 2008, CELL, V132, P846, DOI 10.1016/j.cell.2008.01.013; Yu JF, 2011, WOODHEAD PUBL MECH E, P1; Yuan XL, 2005, VIRUS RES, V109, P191, DOI 10.1016/j.virusres.2005.01.001; Zheng WY, 2016, NAT CELL BIOL, V18, P1244, DOI 10.1038/ncb3413; Zimmerman SP, 2013, BIOCHEM J, V455, P95, DOI 10.1042/BJ20121755	108	13	13	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					10607	10617		10.1096/fj.201900518R	http://dx.doi.org/10.1096/fj.201900518R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31336050	Bronze			2022-12-28	WOS:000489166300004
J	Huang, JQ; Zhao, QS; Li, M; Duan, QM; Zhao, Y; Zhang, H				Huang, Jingqiu; Zhao, Qinshuo; Li, Mu; Duan, Qiming; Zhao, Yin; Zhang, Hong			The effects of endothelium-specific CYP2J2 overexpression on the attenuation of retinal ganglion cell apoptosis in a glaucoma rat model	FASEB JOURNAL			English	Article						retinal vasculature; senescence; microRNAs; MMPs	PRIMARY OPEN-ANGLE; COHERENCE TOMOGRAPHY ANGIOGRAPHY; OPTIC-NERVE; BLOOD-FLOW; ISCHEMIA/REPERFUSION INJURY; EPOXYEICOSATRIENOIC ACIDS; CAPILLARY DEGENERATION; INTRAOCULAR-PRESSURE; SECRETORY PHENOTYPE; SENESCENCE	Glaucoma is a leading cause of irreversible blindness worldwide. Vascular factors play a substantial role in the pathogenesis of glaucoma. Expressed in the vascular endothelium, cytochrome P450 (CYP) 2J2 is one of the CYP epoxygenases that metabolize arachidonic acid to produce epoxyeicosatrienoic acids and exert pleiotropic protective effects on the vasculature. In the present study, we investigated whether endothelium-specific overexpression of CYP2J2 (tie2-CYP2J2-Tr) protects against retinal ganglion cell (RGC) loss induced by glaucoma and in what way retinal vessels are involved in this process. We used a glaucoma model of retinal ischemia-reperfusion (I/R) injury in rats and found that endothelium-specific overexpression of CYP2J2 attenuated RGC loss induced by retinal I/R. Moreover, retinal I/R triggered retinal vascular senescence, indicated by up-regulated senescence-related proteins p53, p16, and beta-galactosidase activity. The senescent endothelial cells resulted in pericyte loss and increased endothelial secretion of matrix metallopeptidase 9, which further contributed to RGC loss. CYP2J2 overexpression alleviated vascular senescence, pericyte loss, and matrix metallopeptidase 9 secretion. CYP2J2 suppressed endothelial senescence by down-regulating senescence-associated proteins p53 and p16. These 2 proteins were positively regulated by microRNA-128-3p, which was inhibited by CYP2J2. These results suggest that CYP2J2 protects against endothelial senescence and RGC loss in glaucoma, a discovery that may lead to the development of a potential treatment strategy for glaucoma.-Huang, J., Zhao, Q., Li, M., Duan, Q., Zhao, Y., Zhang, H. The effects of endothelium-specific CYP2J2 overexpression on the attenuation of retinal ganglion cell apoptosis in a glaucoma rat model.	[Huang, Jingqiu; Li, Mu; Zhao, Yin; Zhang, Hong] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Ophthalmol, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China; [Zhao, Qinshuo] Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan, Hubei, Peoples R China; [Duan, Qiming] Gladstone Inst, San Francisco, CA USA; [Zhao, Yin] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA	Huazhong University of Science & Technology; Wuhan University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Zhao, Y; Zhang, H (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Ophthalmol, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China.	yin.zhao@ucsf.edu; tjyksys@163.com		Duan, Qiming/0000-0002-6204-3028	National Natural Science Foundation of China [81770921, 31800868]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The current studies were supported by funding from the National Natural Science Foundation of China (81770921, 31800868). The authors declare no conflicts of interest.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abraham NG, 2014, HYPERTENSION, V64, P1352, DOI 10.1161/HYPERTENSIONAHA.114.03884; Anwar-mohamed A, 2010, PHARMACOL RES, V61, P410, DOI 10.1016/j.phrs.2009.12.015; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bach MHM, 2005, MECH AGEING DEV, V126, P467, DOI 10.1016/j.mad.2004.10.005; Blau CW, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.035; Bullitt E, 2010, NEUROBIOL AGING, V31, P290, DOI 10.1016/j.neurobiolaging.2008.03.022; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chang EI, 2007, CIRCULATION, V116, P2818, DOI 10.1161/CIRCULATIONAHA.107.715847; Chauhan BC, 2004, INVEST OPHTH VIS SCI, V45, P144, DOI 10.1167/iovs.03-0687; Chen HSL, 2017, INVEST OPHTH VIS SCI, V58, P3637, DOI 10.1167/iovs.17-21846; Chen HH, 2011, INVEST OPHTH VIS SCI, V52, P36, DOI 10.1167/iovs.09-5115; Chen WS, 2015, CELL PHYSIOL BIOCHEM, V35, P2043, DOI 10.1159/000374011; Chintala SK, 2002, J BIOL CHEM, V277, P47461, DOI 10.1074/jbc.M204824200; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Danesh-Meyer HV, 2012, BRAIN, V135, P506, DOI 10.1093/brain/awr338; DeCicco-Skinner KL, 2014, JOVE-J VIS EXP, DOI 10.3791/51312; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Evangelisti C, 2009, FASEB J, V23, P4276, DOI 10.1096/fj.09-134965; Findl O, 2000, AM J OPHTHALMOL, V130, P589, DOI 10.1016/S0002-9394(00)00636-X; Fleming I, 2014, PHARMACOL REV, V66, P1106, DOI 10.1124/pr.113.007781; Gangadhariah MH, 2017, DIABETOLOGIA, V60, P1066, DOI 10.1007/s00125-017-4260-0; Gherghel D, 2005, INVEST OPHTH VIS SCI, V46, P877, DOI 10.1167/iovs.04-0777; Gottanka J, 2005, INVEST OPHTH VIS SCI, V46, P4170, DOI 10.1167/iovs.05-0289; Goyal A, 2014, CURR EYE RES, V39, P823, DOI 10.3109/02713683.2011.556299; Gross GJ, 2005, CARDIOVASC RES, V68, P18, DOI 10.1016/j.cardiores.2005.06.007; Grunwald JE, 1998, INVEST OPHTH VIS SCI, V39, P2329; Guo SZ, 2008, P NATL ACAD SCI USA, V105, P7582, DOI 10.1073/pnas.0801105105; HAMMES HP, 1991, P NATL ACAD SCI USA, V88, P11555, DOI 10.1073/pnas.88.24.11555; Harada C, 2006, AM J PATHOL, V168, P261, DOI 10.2353/ajpath.2006.050765; Harada C, 2010, CELL DEATH DIFFER, V17, P1751, DOI 10.1038/cdd.2010.62; Hughes S, 2006, NEUROBIOL AGING, V27, P1838, DOI 10.1016/j.neurobiolaging.2005.10.021; Imaoka Susumu, 2005, Drug Metab Pharmacokinet, V20, P478, DOI 10.2133/dmpk.20.478; Janota CS, 2015, BRAIN RES, V1620, P153, DOI 10.1016/j.brainres.2015.04.056; Jia J, 2016, EXP NEUROL, V279, P75, DOI 10.1016/j.expneurol.2016.02.016; Jiang TF, 2016, PROG NEUROBIOL, V147, P1, DOI 10.1016/j.pneurobio.2016.07.005; JUCKER M, 1990, NEUROBIOL AGING, V11, P39, DOI 10.1016/0197-4580(90)90060-D; Kisler K, 2017, NAT REV NEUROSCI, V18, P419, DOI 10.1038/nrn.2017.48; Kisler K, 2017, NAT NEUROSCI, V20, P406, DOI 10.1038/nn.4489; Lahteenvuo J, 2012, CIRC RES, V110, P1252, DOI 10.1161/CIRCRESAHA.111.246116; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liu Y, 2019, BRAIN RES, V1708, P160, DOI 10.1016/j.brainres.2018.12.023; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; Mi XS, 2012, INVEST OPHTH VIS SCI, V53, P4842, DOI 10.1167/iovs.12-9999; Michelson G, 1996, J GLAUCOMA, V5, P91; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Nakazato R, 2017, J NEUROSCI, V37, P10052, DOI 10.1523/JNEUROSCI.3639-16.2017; Navaratna D, 2013, J CLIN INVEST, V123, P3373, DOI 10.1172/JCI65767; Navaratna D, 2011, DIABETES, V60, P1789, DOI 10.2337/db10-1371; Panigrahy D, 2013, P NATL ACAD SCI USA, V110, P13528, DOI 10.1073/pnas.1311565110; Papagiannakopoulos T, 2012, ONCOGENE, V31, P1884, DOI 10.1038/onc.2011.380; Polak K, 2000, BRIT J OPHTHALMOL, V84, P1285, DOI 10.1136/bjo.84.11.1285; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rojas M, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6020043; Roy S, 2010, BIOGERONTOLOGY, V11, P447, DOI 10.1007/s10522-010-9263-x; Russo R, 2008, PROG BRAIN RES, V173, P583, DOI 10.1016/S0079-6123(08)01144-8; Sennlaub F, 2003, CIRCULATION, V108, P198, DOI 10.1161/01.CIR.0000080735.93327.00; Stanimirovic DB, 2012, J CEREBR BLOOD F MET, V32, P1207, DOI 10.1038/jcbfm.2012.25; Strokin M, 2003, BRIT J PHARMACOL, V139, P1014, DOI 10.1038/sj.bjp.0705326; Surgucheva Irina, 2010, J Ocul Biol Dis Infor, V3, P41, DOI 10.1007/s12177-010-9054-2; Trivli A, 2019, EXP THER MED, V17, P563, DOI 10.3892/etm.2018.7011; Tual-Chalot S, 2013, JOVE-J VIS EXP, DOI 10.3791/50546; Ungvari Z, 2018, NAT REV CARDIOL, V15, P555, DOI 10.1038/s41569-018-0030-z; Ungvari Z, 2013, J GERONTOL A-BIOL, V68, P1443, DOI 10.1093/gerona/glt057; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Venkataraman ST, 2010, INVEST OPHTH VIS SCI, V51, P2043, DOI 10.1167/iovs.09-3630; Wang YM, 2011, INVEST OPHTH VIS SCI, V52, P840, DOI 10.1167/iovs.10-5985; Wei YH, 2011, FREE RADICAL BIO MED, V51, P216, DOI 10.1016/j.freeradbiomed.2011.04.026; Xu XZ, 2011, ADV DRUG DELIVER REV, V63, P597, DOI 10.1016/j.addr.2011.03.006; Yang BC, 2001, MOL PHARMACOL, V60, P310, DOI 10.1124/mol.60.2.310; Yang C, 2014, INT J BIOCHEM CELL B, V50, P93, DOI 10.1016/j.biocel.2014.02.020; Zhang SH, 2017, AM J OPHTHALMOL, V182, P194, DOI 10.1016/j.ajo.2017.07.024; Zhao QS, 2018, J MOL CELL CARDIOL, V123, P118, DOI 10.1016/j.yjmcc.2018.08.027; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385; ZWEIER JL, 1987, P NATL ACAD SCI USA, V84, P1404, DOI 10.1073/pnas.84.5.1404	77	4	4	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2019	33	10					11194	11209		10.1096/fj.201900756R	http://dx.doi.org/10.1096/fj.201900756R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	JC3GG	31295013				2022-12-28	WOS:000489166300051
J	Bravo-Navas, S; Yanez, L; Romon, I; Pipaon, C				Bravo-Navas, Sara; Yanez, Lucrecia; Romon, Inigo; Pipaon, Carlos			Elevated FANCA expression determines a worse prognosis in chronic lymphocytic leukemia and interferes with p53 function	FASEB JOURNAL			English	Article						CLL; ATM; NEDD8; NUB1L	BULKY LYMPHADENOPATHY; COMPLEX KARYOTYPE; CELL-CYCLE; ANEMIA; PATHWAY; PROTEIN; NEDD8; GENE; DISRUPTION; RESISTANCE	Chronic lymphocytic leukemia (CLL) is characterized by a failure in the mechanisms of apoptosis that leads to an accumulation of mature B cells in peripheral blood, bone marrow, and lymphoid organs. The molecular basis of CLL remains unknown. Certain cytogenetic and molecular markers determine a bad prognosis in CLL. Fanconi anemia complementation (FANC) proteins have been related to chromosomal instability and alterations in the mechanisms of p53 activation, control of cell cycle, and apoptosis. We investigated the role of certain FANC proteins in CLL. Our data identified a group of patients with CLL with high expression of FANCA in peripheral B-CLL cells and we established its relationship with the deletion of 11q23 and a worse prognosis. When we investigated the molecular mechanisms of this bad prognosis, we observed a reduction in the expression of 2 p53 target genes, p21 and increment Np73, in CLL primary cells transfected with FANCA. Functional studies demonstrated an impairment of p53 by FANCA. Moreover, we obtained evidence of a cooperation between FANCA and the NEDD8-interacting protein NUB1L in the destabilization of p53. For the first time, FANCA is reported as a bad prognosis marker by a mechanism other than its role in the Fanconi anemia-breast cancer DNA repair pathway.-Bravo-Navas, S., Yanez, L., Romon, i., Pipaon, C. Elevated FANCA expression determines a worse prognosis in chronic lymphocytic leukemia and interferes with p53 function.	[Bravo-Navas, Sara; Yanez, Lucrecia; Romon, Inigo; Pipaon, Carlos] Hosp Marques Valdecilla, Inst Invest Marques Valdecilla IDIVAL, Santander, Spain	Hospital Universitario Marques de Valdecilla (HUMV)	Pipaon, C (corresponding author), Hosp Marques Valdecilla, Lab Hematol Mol HEMMOL, Pabellon 20,Avda Valdecilla S-N, Santander 39008, Spain.	carlos.pipaon@scsalud.es	Pipaon, Carlos/L-4922-2014; Yáñez San Segundo, Lucrecia/G-4662-2016; Romón, Iñigo/M-3497-2019	Pipaon, Carlos/0000-0002-3851-6710; Yáñez San Segundo, Lucrecia/0000-0001-9925-3048; Romón, Iñigo/0000-0003-2428-4469; Bravo Navas, Sara/0000-0002-7166-0191	Instituto de Salud Carlos III [PI17/01688]; European Development Regional Fund (FEDER)	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Development Regional Fund (FEDER)	This work has been funded by Project PI17/01688 from the Instituto de Salud Carlos III, cofinanced by the European Development Regional Fund (FEDER). S.B.-N. was supported with funds obtained by L.Y. from clinical trials. pCMV-Tag2B-NUB1L was a kind gift of Dr. Hong-Yu Hu (Shanghai Institute of Biochemistry and Cell Biology, Shanghai, China). MDM2 expression plasmid was a kind gift of Dr. Dimitris Xirodimas [Montpellier Cell Biology Research Center (CRBM), Montpellier, France]. The authors declare no conflicts of interest.	Bonacci T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169988; Buggins AGS, 2010, LEUKEMIA RES, V34, P837, DOI 10.1016/j.leukres.2010.03.011; Ceccaldi R, 2012, CELL STEM CELL, V11, P36, DOI 10.1016/j.stem.2012.05.013; Chen CC, 2007, J MOL MED, V85, P497, DOI 10.1007/s00109-006-0153-2; Chen Q, 2005, BLOOD, V106, P698, DOI 10.1182/blood-2004-11-4286; Chirnomas D, 2006, MOL CANCER THER, V5, P952, DOI 10.1158/1535-7163.MCT-05-0493; Dickinson JD, 2006, LEUKEMIA LYMPHOMA, V47, P231, DOI 10.1080/10428190500254141; DUTRILLAUX B, 1982, HUM GENET, V62, P327, DOI 10.1007/BF00304549; Fischer M, 2017, ONCOGENE, V36, P3943, DOI 10.1038/onc.2016.502; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Molina-Estevez FJ, 2015, CURR GENE THER, V15, P550, DOI 10.2174/1566523215666150929110903; Joshi AD, 2007, CANCER GENET CYTOGEN, V172, P120, DOI 10.1016/j.cancergencyto.2006.07.010; Kao WH, 2011, J INVEST DERMATOL, V131, P2139, DOI 10.1038/jid.2011.181; Kipps TJ, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1038/nrdp.2016.96, 10.1038/nrdp.2017.8]; Liu G, 2010, ONCOGENE, V29, P2252, DOI 10.1038/onc.2009.494; Liu S, 2013, J BIOL CHEM, V288, P31339, DOI 10.1074/jbc.M113.484816; Liu ZM, 2011, MOL CANCER RES, V9, P507, DOI 10.1158/1541-7786.MCR-10-0559; Lyakhovich A, 2006, CANCER LETT, V232, P99, DOI 10.1016/j.canlet.2005.07.038; Pipaon C, 2005, FEBS LETT, V579, P4610, DOI 10.1016/j.febslet.2005.07.026; Poot M, 1996, EXP CELL RES, V222, P262, DOI 10.1006/excr.1996.0033; Reuter TY, 2003, EXP CELL RES, V289, P211, DOI 10.1016/S0014-4827(03)00261-1; Rigolin GM, 2017, BLOOD, V129, P3495, DOI 10.1182/blood-2017-03-772285; Rossi D, 2017, LEUKEMIA LYMPHOMA, V58, P1548, DOI 10.1080/10428194.2016.1250264; Sanchez-Carrera D, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150039; Sanz L, 2004, BIOCHEM BIOPH RES CO, V315, P562, DOI 10.1016/j.bbrc.2004.01.095; Soulier J, 2011, HEMATOL-AM SOC HEMAT, P492, DOI 10.1182/asheducation-2011.1.492; Taniguchi T, 2003, NAT MED, V9, P568, DOI 10.1038/nm852; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Thompson PA, 2015, CANCER-AM CANCER SOC, V121, P3612, DOI 10.1002/cncr.29566; Valeri A, 2011, CLIN TRANSL ONCOL, V13, P215, DOI 10.1007/s12094-011-0645-6; van de Vrugt HJ, 2000, MAMM GENOME, V11, P326, DOI 10.1007/s003350010060; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Zenz T, 2008, BLOOD, V112, P3322, DOI 10.1182/blood-2008-04-154070; Zhu HJ, 2013, LEUKEMIA LYMPHOMA, V54, P2712, DOI 10.3109/10428194.2013.787613	35	4	4	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10477	10489		10.1096/fj.201802439RR	http://dx.doi.org/10.1096/fj.201802439RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31251079	Bronze			2022-12-28	WOS:000482214200060
J	Chen, T; Wang, YF; Xu, Z; Zou, XM; Wang, P; Ou, XW; Li, YW; Peng, T; Chen, DX; Li, ML; Cai, MS				Chen, Tao; Wang, Yuanfang; Xu, Zuo; Zou, Xingmei; Wang, Ping; Ou, Xiaowen; Li, Yiwen; Peng, Tao; Chen, Daixiong; Li, Meili; Cai, Mingsheng			Epstein-Barr virus tegument protein BGLF2 inhibits NF-kappa B activity by preventing p65 Ser536 phosphorylation	FASEB JOURNAL			English	Article						EBV; innate immunity; proinflammatory cytokine	IMMEDIATE-EARLY PROTEIN; INNATE IMMUNE-RESPONSE; SERINE-536 PHOSPHORYLATION; VIRAL APPROPRIATION; CARCINOMA-CELLS; ACTIVATION; EXPRESSION; GENE; EBV; RECEPTOR	Epstein-Barr virus (EBV), a ubiquitous gammaherpesvirus, can regulate the antiviral response of NF-kappa B signaling, which is critical for cell survival, growth transformation, and virus latency. Here, we showed that tegument protein BGLF2 could inhibit TNF-alpha-induced NF-kappa B activity. BGLF2 was shown to interplay with the NF-kappa B subunits p65 and p50, and the Rel homology domain of p65 was the pivotal region to interact with BGLF2. Nonetheless, BGLF2 did not influence the development of p65-p50 dimerization. Yet, overexpression of BGLF2 inhibited the phosphorylation of p65 Ser536 (but not Ser276) and blocked the nuclear translocation of p65. In addition, knockdown of BGLF2 during EBV lytic replication elevated NF-kappa B activity and the phosphorylation of p65 Ser536. Taken together, these results suggest that the inhibition of NF-kappa B activation may serve as a strategy to escape the host's antiviral innate immunity to EBV during its lytic infection.-Chen, T., Wang, Y., Xu, Z., Zou, X., Wang, P., Ou, X., Li, Y., Peng, T., Chen, D., Li, M., Cai, M. Epstein-Barr virus tegument protein BGLF2 inhibits NF-kappa B activity by preventing p65 Ser536 phosphorylation.	[Chen, Tao; Wang, Yuanfang; Xu, Zuo; Zou, Xingmei; Wang, Ping; Ou, Xiaowen; Li, Yiwen; Chen, Daixiong; Li, Meili; Cai, Mingsheng] Guangzhou Med Univ, Affiliated Hosp 2, Guangdong Prov Key Lab Allergy & Clin Immunol, Guangzhou, Guangdong, Peoples R China; [Chen, Tao; Wang, Yuanfang; Xu, Zuo; Zou, Xingmei; Wang, Ping; Ou, Xiaowen; Li, Yiwen; Chen, Daixiong; Li, Meili; Cai, Mingsheng] Guangzhou Med Univ, Sch Basic Med Sci, Sino French Hoffmann Inst, Dept Pathogen Biol & Immunol, 250 Changgang Dong Rd, Guangzhou 510260, Guangdong, Peoples R China; [Peng, Tao] Guangzhou Med Univ, Sch Basic Med Sci, Sino French Hoffmann Inst, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Peng, Tao] South China Vaccine Corp Ltd, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Li, ML; Cai, MS (corresponding author), Guangzhou Med Univ, Sch Basic Med Sci, Sino French Hoffmann Inst, Dept Pathogen Biol & Immunol, 250 Changgang Dong Rd, Guangzhou 510260, Guangdong, Peoples R China.	meili_2011@hotmail.com; mingshengcai@hotmail.com	Wang, Yuan/HHC-1520-2022; wangwangwang, yuanyaun/HHN-6432-2022	Peng, Tao/0000-0001-5260-7128	National Natural Science Foundation of China [81772179]; Natural Science Foundation of Guangdong Province [2018A0303130257, 2015A030313473]; Regular University Distinguished Innovation Project from Education Department of Guangdong Province, China [2018KTSCX184]; Medical Scientific Research Foundation of Guangdong Province, China [A2017055]; Guangzhou Innovation Leading Team Program [CYLJTD-201602]; Science and Technology Plan Projects of Guangzhou City, China [201607010088]; High-Level Universities Academic Backbone Development Program of Guangzhou Medical University; Nanshan Scholar Training Program of Guangzhou Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Regular University Distinguished Innovation Project from Education Department of Guangdong Province, China; Medical Scientific Research Foundation of Guangdong Province, China; Guangzhou Innovation Leading Team Program; Science and Technology Plan Projects of Guangzhou City, China; High-Level Universities Academic Backbone Development Program of Guangzhou Medical University; Nanshan Scholar Training Program of Guangzhou Medical University	The authors thank Dr. Zhengli Shi (NF-kappa B-Luc and pRL-TK) (Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China), Dr. Chunfu Zheng (pFlag-TRADD, pTRAF2-Flag, pRIP1-Flag, and p65-RHD-Flag) (School of Basic Medical Science, Fujian Medical University, Fuzhou, China), Dr. Jun Cui (pFlag-TAK1 and pNIK-Flag) (School of Life Sciences, Sun Yat-sen University, Guangzhou, China), Prof. Gangmin Hur (pHA-IKK-alpha) (College of Medicine, Chungnam National University, Daejeon, South Korea), Prof. Anjana Rao (pFlag-IKK-beta) (Department of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, La Jolla, USA), Prof. Katherine A. Fitzgerald (pCMV-Flag-p65) (Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, USA), Dr. Karl-Klaus Conzelmann (pFlag-p50) (Department of Virology, Max von Pettenkofer Institute and Gene Center, University of Munich, Munich, Germany), Dr. Wenlin Huang (pXP2-pIL-8-Luc) (Institute of Microbiology, Chinese Academy of Sciences, Beijing, China), and Dr. Leiliang Zhang [plasmids Pad-N-p65(1-290)-Flag and Pad-N-p65(291-551)-Flag] (Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China) for the generous gifts of plasmids. The authors thank Dr. Teru Kanda (Division of Microbiology and Oncology, Aichi Cancer Center Research Institute, Nagoya, Japana) for the generous gift of bacterial artificial chromosome DNA of EBV Akata strain. The authors also thank Dr. Masataka Kinjo (p65-IPT-EGFP) (Faculty of Advanced Life Science, Hokkaido University, Sapporo, Japan) and Prof. Hong An (p65-EYFP) (Institute of Biology Engineering, Jinan University, Guangzhou, China) for kindly providing technical help. This work was supported by grants from the National Natural Science Foundation of China (81772179); the Natural Science Foundation of Guangdong Province (2018A0303130257 and 2015A030313473); the Regular University Distinguished Innovation Project from Education Department of Guangdong Province, China (2018KTSCX184); the Medical Scientific Research Foundation of Guangdong Province, China (A2017055); the Guangzhou Innovation Leading Team Program (CYLJTD-201602); the Science and Technology Plan Projects of Guangzhou City, China (201607010088); High-Level Universities Academic Backbone Development Program of Guangzhou Medical University; and the Nanshan Scholar Training Program of Guangzhou Medical University. The authors declare no conflicts of interest.	Ariza ME, 2009, J IMMUNOL, V182, P851, DOI 10.4049/jimmunol.182.2.851; Beisser PS, 2005, J VIROL, V79, P441, DOI 10.1128/JVI.79.1.441-449.2005; Bowie AG, 2004, J CELL BIOCHEM, V91, P1099, DOI 10.1002/jcb.20026; Budt M, 2011, J VIROL, V85, P10415, DOI 10.1128/JVI.05071-11; Cai MS, 2017, ONCOTARGET, V8, P70006, DOI 10.18632/oncotarget.19549; Cai MS, 2017, BIOL CHEM, V398, P509, DOI 10.1515/hsz-2016-0268; Cai MS, 2016, BIOL CHEM, V397, P555, DOI 10.1515/hsz-2015-0299; Cai MS, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0069-7; Cai MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054586; Chang LS, 2012, J VIROL, V86, P12176, DOI 10.1128/JVI.01918-12; Chang MS, 2013, J VIROL, V87, P10515, DOI 10.1128/JVI.00955-13; CHEN MR, 1991, J GEN VIROL, V72, P3047, DOI 10.1099/0022-1317-72-12-3047; Chen SL, 2018, P NATL ACAD SCI USA, V115, pE3798, DOI 10.1073/pnas.1801213115; Chen T, 2018, IRAN J BIOTECHNOL, V16, P85, DOI 10.21859/ijb.1610; de Oliveira DE, 2010, TRENDS MICROBIOL, V18, P248, DOI 10.1016/j.tim.2010.04.001; Dostert C, 2019, PHYSIOL REV, V99, P115, DOI 10.1152/physrev.00045.2017; Du HW, 2015, SCI REP-UK, V5, DOI 10.1038/srep14302; Fagerlund R, 2005, J BIOL CHEM, V280, P15942, DOI 10.1074/jbc.M500814200; Feederle R, 2000, EMBO J, V19, P3080, DOI 10.1093/emboj/19.12.3080; Gao SJ, 2012, CELL MICROBIOL, V14, P1849, DOI 10.1111/cmi.12005; Ghosh G, 2012, IMMUNOL REV, V246, P36, DOI 10.1111/j.1600-065X.2012.01097.x; Glaser R, 2006, VIROLOGY, V346, P205, DOI 10.1016/j.virol.2005.10.034; Guan Y, 2019, NEURAL REGEN RES, V14, P373, DOI 10.4103/1673-5374.245462; Guasparri L, 2008, BLOOD, V111, P3813, DOI 10.1182/blood-2007-03-080309; GUTSCH DE, 1994, MOL CELL BIOL, V14, P1939, DOI 10.1128/MCB.14.3.1939; Hargett D, 2006, J VIROL, V80, P10565, DOI 10.1128/JVI.01119-06; Hiscott J, 2001, J CLIN INVEST, V107, P143, DOI 10.1172/JCI11918; Huang DB, 1997, STRUCTURE, V5, P1427, DOI 10.1016/S0969-2126(97)00293-1; Imai K, 2018, FEBS OPEN BIO, V8, P207; James P, 1996, GENETICS, V144, P1425; Janz A, 2000, J VIROL, V74, P10142, DOI 10.1128/JVI.74.21.10142-10152.2000; Johannsen E, 2004, P NATL ACAD SCI USA, V101, P16286, DOI 10.1073/pnas.0407320101; Kanda T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027758; Kim JE, 2014, MOL CELL BIOL, V34, P325, DOI 10.1128/MCB.00912-13; Konishi N, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00138-18; Lamb A, 2009, EMBO REP, V10, P1242, DOI 10.1038/embor.2009.210; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Li ML, 2012, ACTA VIROL, V56, P315, DOI 10.4149/av_2012_04_315; Li ML, 2018, CELL PHYSIOL BIOCHEM, V51, P1500, DOI 10.1159/000495641; Li MX, 2015, LECT NOTES ENG COMP, P12; Li MZ, 2014, 2014 7TH INTERNATIONAL CONGRESS ON IMAGE AND SIGNAL PROCESSING (CISP 2014), P1, DOI 10.1109/CISP.2014.7003739; Li X, 2006, WORLD J GASTROENTERO, V12, P6658, DOI 10.3748/wjg.v12.i41.6658; Liu HD, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-92; Liu XueQiao, 2016, J Virol, V90, P1129, DOI 10.1128/JVI.01410-15; Lui VWY, 2009, INT J CANCER, V125, P1884, DOI 10.1002/ijc.24567; Mattioli I, 2004, J IMMUNOL, V172, P6336, DOI 10.4049/jimmunol.172.10.6336; May MJ, 1997, SEMIN CANCER BIOL, V8, P63, DOI 10.1006/scbi.1997.0057; Meckes DG, 2007, J VIROL, V81, P13028, DOI 10.1128/JVI.01306-07; Moles A, 2013, HEPATOLOGY, V57, P817, DOI 10.1002/hep.26068; Morrison TE, 2004, VIROLOGY, V328, P219, DOI 10.1016/j.virol.2004.07.020; Nalwanga D, 1996, VIROLOGY, V226, P236, DOI 10.1006/viro.1996.0651; Ning ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058854; O'Neil JD, 2008, J GEN VIROL, V89, P2833, DOI 10.1099/vir.0.2008/003392-0; Oakley F, 2009, GASTROENTEROLOGY, V136, P2334, DOI 10.1053/j.gastro.2009.02.081; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Oh SM, 2007, J IMMUNOL, V179, P5686, DOI 10.4049/jimmunol.179.9.5686; Ok CY, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.82; Okazaki T, 2003, BIOCHEM BIOPH RES CO, V300, P807, DOI 10.1016/S0006-291X(02)02932-7; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Phillips SL, 2012, J VIROL, V86, P2523, DOI 10.1128/JVI.06548-11; Pradere JP, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aab2820; Sadaoka T, 2014, J VIROL, V88, P188, DOI 10.1128/JVI.02245-13; Saito S, 2013, J VIROL, V87, P4060, DOI 10.1128/JVI.02020-12; Santoro MG, 2003, EMBO J, V22, P2552, DOI 10.1093/emboj/cdg267; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Song YJ, 2006, P NATL ACAD SCI USA, V103, P2689, DOI 10.1073/pnas.0511096103; Stewart S, 2004, P NATL ACAD SCI USA, V101, P15730, DOI 10.1073/pnas.0402135101; Takeuchi H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003326; Taylor GS, 2015, ANNU REV IMMUNOL, V33, P787, DOI 10.1146/annurev-immunol-032414-112326; Tiwari M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04499-7; Valentine R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-1; van Gent M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003960; Vereide D, 2010, ADV CANCER RES, V108, P1, DOI 10.1016/S0065.230X(10)08004.8; Vereide DT, 2011, BLOOD, V117, P1977, DOI 10.1182/blood-2010-05-285791; WeberNordt RM, 1996, BLOOD, V88, P809; Wu JJ, 2016, J VIROL, V90, P1741, DOI 10.1128/JVI.02738-15; Xing JJ, 2011, J VIROL, V85, P1881, DOI 10.1128/JVI.01730-10; Ye RJ, 2017, J VIROL, V91, DOI 10.1128/JVI.02417-16; Zhang Q, 2017, CELL, V168, P37, DOI 10.1016/j.cell.2016.12.012; Zhu HF, 2011, J VIROL, V85, P11079, DOI 10.1128/JVI.05098-11; Zuercher E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032168	82	18	19	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10563	10576		10.1096/fj.201901196RR	http://dx.doi.org/10.1096/fj.201901196RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31337264	Bronze			2022-12-28	WOS:000482214200067
J	Kang, LH; Zou, X; Zhang, GW; Xiang, J; Wang, Y; Yang, M; Chen, X; Wu, J; Guan, HJ				Kang, Lihua; Zou, Xi; Zhang, Guowei; Xiang, Jing; Wang, Yong; Yang, Mei; Chen, Xiang; Wu, Jian; Guan, Huaijin			A variant in a microRNA binding site in NEIL2 3 ' UTR confers susceptibility to age-related cataracts	FASEB JOURNAL			English	Article						ARC; DNA repair; BER pathway; SNP; hsa-miR-3912-5p	DNA-REPAIR GENES; BASE-EXCISION-REPAIR; LENS EPITHELIAL-CELLS; SINGLE NUCLEOTIDE POLYMORPHISMS; PERIPHERAL LYMPHOCYTES; MACULAR DEGENERATION; SENILE CATARACT; DAMAGE; RISK; APE1	DNA damage in lens cells is considered a critical trigger for the onset of age-related cataracts (ARCs). Among DNA repair pathways, the base excision repair (BER) pathway is responsible for mending single-strand breaks in DNA. In this case-control study with 993 ARC cases and 993 healthy controls, we genotyped 9 single-nucleotide polymorphisms (SNPs) within microRNA (miRNA) regions of 6 BER pathway genes and examined their associations with ARC susceptibility. We identified rs4639:T > C in the Nei-like DNA glycosylase 2 (NEIL2) gene as significantly associated with ARCs. Individuals carrying different rs4639 alleles had distinct NEIL2 expression in lens capsule tissues from ARC cases and controls. Bioinformatics predicts that the rs4639 T allele could disrupt hsa-miR-3912-5p binding. The results of the luciferase reporter assay were in concordance with this prediction. This study has added more evidence that SNP-modified posttranscriptional gene regulation by miRNA might be a potential pathogenic mechanism of ARCs. SNPs potentially affecting miRNA binding to the 3 ' UTR of BER pathway genes could contribute to discrepant disease susceptibility. NEIL2-rs4639T was strongly associated with a protective role in ARCs. This protective role might be fulfilled by maintaining normal expression of NEIL2 in the mediation of disrupted binding of rs4639T with hsa-miR-3912-5p. A further study to generate model systems (cell lines or animal models) with NEIL2 variants is warranted. The results provide 2 molecular targets (e.g., NEIL2 and hsa-miR-3912-5p) for intervention strategies of ARC in the future.-Kang, L., Zou, X., Zhang, G., Xiang, J., Wang, Y., Yang, M., Chen, X., Wu, J., Guan, H. A variant in a microRNA binding site in NEIL2 3 ' UTR confers susceptibility to age-related cataract.	[Kang, Lihua; Zou, Xi; Zhang, Guowei; Xiang, Jing; Wang, Yong; Yang, Mei; Wu, Jian; Guan, Huaijin] Nantong Univ, Affiliated Hosp, Eye Inst, 20 Xisi Rd, Nantong 226001, Jiangsu, Peoples R China; [Zou, Xi] Third Peoples Hosp Changzhou, Changzhou, Peoples R China; [Chen, Xiang] Nantong Univ, Affiliated Hosp 2, Dept Pathol, Nantong, Peoples R China	Nantong University; Nantong University	Guan, HJ (corresponding author), Nantong Univ, Affiliated Hosp, Eye Inst, 20 Xisi Rd, Nantong 226001, Jiangsu, Peoples R China.	guanhjeye@163.com		Wang, Yong/0000-0003-0989-9764	National Natural Science Foundation of China [81470616, 81770906, 81873676, 81500706]; Science and Technology Project of Nantong, China [YYZ17010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Nantong, China	This study was supported by the National Natural Science Foundation of China (81470616, 81770906, 81873676, and 81500706) and the Science and Technology Project of Nantong, China (YYZ17010). The authors declare no conflicts of interest.	Ates O, 2010, ACTA OPHTHALMOL, V88, P891, DOI 10.1111/j.1755-3768.2009.01583.x; Banerjee D, 2011, J BIOL CHEM, V286, P6006, DOI 10.1074/jbc.M110.198796; Butkiewicz D, 2001, CARCINOGENESIS, V22, P593, DOI 10.1093/carcin/22.4.593; Chan N, 2014, MOL CANCER RES, V12, P1407, DOI 10.1158/1541-7786.MCR-14-0246; Chang JR, 2011, OPHTHALMOLOGY, V118, P2113, DOI 10.1016/j.ophtha.2011.03.032; Chi XX, 2015, MOL VIS, V21, P335; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Duan SW, 2009, RNA BIOL, V6, P412, DOI 10.4161/rna.6.4.8830; Golden RJ, 2017, NATURE, V542, P197, DOI 10.1038/nature21025; Gu SS, 2016, HUM MUTAT, V37, P1223, DOI 10.1002/humu.23073; Hu JY, 2011, OPHTHAL EPIDEMIOL, V18, P137, DOI 10.3109/09286586.2011.574335; Jiang J, 2013, INVEST OPHTH VIS SCI, V54, P932, DOI 10.1167/iovs.12-10948; Jiang SQ, 2013, AGE, V35, P2435, DOI 10.1007/s11357-013-9512-4; Khairallah M, 2015, INVEST OPHTH VIS SCI, V56, P6762, DOI 10.1167/iovs.15-17201; KLEIMAN NJ, 1993, CURR EYE RES, V12, P423, DOI 10.3109/02713689309024624; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P546; Knox B, 2018, ENVIRON MOL MUTAGEN, V59, P134, DOI 10.1002/em.22159; Luo MH, 2004, ANTICANCER RES, V24, P2127; Maynard S, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a025130; McCarty CA, 2001, INVEST OPHTH VIS SCI, V42, P1677; Rong H, 2017, ONCOTARGET, V8, P84945, DOI 10.18632/oncotarget.17600; Sambandan S, 2017, SCIENCE, V355, P634, DOI 10.1126/science.aaf8995; Shiels A, 2015, PROG MOL BIOL TRANSL, V134, P203, DOI 10.1016/bs.pmbts.2015.05.004; Sorte K, 2011, MOL VIS, V17, P1; Su S, 2013, INVEST OPHTH VIS SCI, V54, P1201, DOI 10.1167/iovs.12-10940; Truscott RJW, 2016, BBA-GEN SUBJECTS, V1860, P192, DOI 10.1016/j.bbagen.2015.08.016; Vymetalkova V, 2017, CARCINOGENESIS, V38, P28, DOI 10.1093/carcin/bgw114; Wallace SS, 2014, DNA REPAIR, V19, P14, DOI 10.1016/j.dnarep.2014.03.030; Wallace SS, 2012, CANCER LETT, V327, P73, DOI 10.1016/j.canlet.2011.12.038; Wang C, 2015, INT J CLIN EXP PATHO, V8, P16036; Wang Y, 2017, CELL MOL NEUROBIOL, V37, P537, DOI 10.1007/s10571-016-0393-9; Wang Y, 2017, EXP MOL PATHOL, V102, P219, DOI 10.1016/j.yexmp.2017.02.006; Wang Y, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0229-y; Wang Y, 2015, CURR EYE RES, V40, P815, DOI 10.3109/02713683.2014.957778; Wilson DM, 2011, MUTAT RES-FUND MOL M, V711, P100, DOI 10.1016/j.mrfmmm.2010.12.004; Xu BW, 2015, CURR EYE RES, V40, P378, DOI 10.3109/02713683.2014.924148; Yang X, 2010, BRIT J OPHTHALMOL, V94, P1211, DOI 10.1136/bjo.2009.165811; Zhang JF, 2014, OPHTHALMIC RES, V51, P124, DOI 10.1159/000356399; Zhang Y, 2012, OPHTHALMOLOGY, V119, P900, DOI 10.1016/j.ophtha.2011.11.004; Zou X, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33071-0	41	8	8	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10469	10476		10.1096/fj.201802291R	http://dx.doi.org/10.1096/fj.201802291R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31253066				2022-12-28	WOS:000482214200059
J	Convery, O; Gargan, S; Kickham, M; Schroder, M; O'Farrelly, C; Stevenson, NJ				Convery, Orla; Gargan, Siobhan; Kickham, Michelle; Schroder, Martina; O'Farrelly, Cliona; Stevenson, Nigel J.			The hepatitis C virus (HCV) protein, p7, suppresses inflammatory responses to tumor necrosis factor (TNF)-alpha via signal transducer and activator of transcription (STAT)3 and extracellular signal-regulated kinase (ERK)-mediated induction of suppressor of cytokine signaling (SOCS)3	FASEB JOURNAL			English	Article						inflammation; viral immune evasion; intracellular signaling pathways; immune regulation; JAK-STAT signalling pathway	MESSENGER-RNA STABILITY; KAPPA-B ACTIVATION; CORE PROTEIN; SOCS PROTEINS; UP-REGULATION; PROTEASOMAL DEGRADATION; RAF/MEK/ERK PATHWAY; STAT3 ACTIVATION; ENVELOPE PROTEIN; GENE-EXPRESSION	Viruses use a spectrum of immune evasion strategies that enable infection and replication. The acute phase of hepatitis C virus (HCV) infection is characterized by nonspecific and often mild clinical symptoms, suggesting an immunosuppressive mechanism that, unless symptomatic liver disease presents, allows the virus to remain largely undetected. We previously reported that HCV induced the regulatory protein suppressor of cytokine signaling (SOCS)3, which inhibited TNF-alpha-mediated inflammatory responses. However, the mechanism by which HCV up-regulates SOCS3 remains unknown. Here we show that the HCV protein, p7, enhances both SOCS3 mRNA and protein expression. A p7 inhibitor reduced SOCS3 induction, indicating that p7's ion channel activity was required for optimal up-regulation of SOCS3. Short hairpin RNA and chemical inhibition revealed that both the Janus kinase-signal transducer and activator of transcription (JAK-STAT) and MAPK pathways were required for p7-mediated induction of SOCS3. HCV-p7 expression suppressed TNF-alpha-mediated I kappa B-alpha degradation and subsequent NF-kappa B promoter activity, revealing a new and functional, anti-inflammatory effect of p7. Together, these findings identify a molecular mechanism by which HCV-p7 induces SOCS3 through STAT3 and ERK activation and demonstrate that p7 suppresses proinflammatory responses to TNF-alpha, possibly explaining the lack of inflammatory symptoms observed during early HCV infection.-Convery, O., Gargan, S., Kickham, M., Schroder, M., O'Farrelly, C., Stevenson, N. J. The hepatitis C virus (HCV) protein, p7, suppresses inflammatory responses to tumor necrosis factor (TNF)-alpha via signal transducer and activator of transcription (STAT)3 and extracellular signal-regulated kinase (ERK)-mediated induction of suppressor of cytokine signaling (SOCS)3.	[Convery, Orla; Gargan, Siobhan; O'Farrelly, Cliona; Stevenson, Nigel J.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland; [O'Farrelly, Cliona] Trinity Coll Dublin, Sch Med, Dublin, Ireland; [Kickham, Michelle; Schroder, Martina] Maynooth Univ, Dept Biol, Maynooth, Kildare, Ireland	Trinity College Dublin; Trinity College Dublin; Maynooth University	Stevenson, NJ (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Intracellular Immunol Grp, 152-160 Pearse St, Dublin 2, Ireland.	n.stevenson@tcd.ie		Schroeder, Martina/0000-0003-1899-6048; O'Farrelly, Cliona/0000-0002-0616-2874	Trinity College Dublin College Award; Health Research Board [POR-20120-57]; Science Foundation Ireland [12/IA/1667]	Trinity College Dublin College Award; Health Research Board; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	The authors thank Prof. Ralf Bartenschlager (University of Heidelberg, Heidelberg, Germany) for the Jc1 and p7 constructs, Prof. Ron Hay (University of Dundee, Dundee, United Kingdom) for the I kappa B-alpha antibody, and Dr. Andrew MacDonald (Leeds University, Leeds, United Kingdom) for the PRDIV6 (activating protein 1)-regulated firefly luciferase construct. This study was funded by the Trinity College Dublin College Award, Health Research Board (POR-20120-57), and Science Foundation Ireland (12/IA/1667). The authors declare no conflicts of interest.	Akhtar LN, 2011, J VIROL, V85, P1912, DOI 10.1128/JVI.01857-10; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Au-Yeung Nancy, 2013, JAKSTAT, V2, pe23931, DOI 10.4161/jkst.23931; Auernhammer CJ, 1999, P NATL ACAD SCI USA, V96, P6964, DOI 10.1073/pnas.96.12.6964; Baker BJ, 2008, GLIA, V56, P1250, DOI 10.1002/glia.20694; Bentham MJ, 2013, J GEN VIROL, V94, P2236, DOI 10.1099/vir.0.054338-0; Blackard JT, 2008, HEPATOLOGY, V47, P321, DOI 10.1002/hep.21902; Bode JG, 2003, FASEB J, V17, P488, DOI 10.1096/fj.02-0664fje; Bour S, 2001, J BIOL CHEM, V276, P15920, DOI 10.1074/jbc.M010533200; Canfield S, 2005, J IMMUNOL, V174, P2494, DOI 10.4049/jimmunol.174.5.2494; Cao XZ, 2015, J HEPATOL, V62, P771, DOI 10.1016/j.jhep.2014.11.007; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Carpenter RL, 2014, CANCERS, V6, P897, DOI 10.3390/cancers6020897; Chen Stephen L, 2006, Int J Med Sci, V3, P47; Chen XP, 2000, IMMUNITY, V13, P287, DOI 10.1016/S1074-7613(00)00028-5; Chen YZ, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab2159; Choi SH, 2006, MOL CELL BIOL, V26, P3048, DOI 10.1128/MCB.26.8.3048-3059.2006; Collins AS, 2014, J LEUKOCYTE BIOL, V96, P255, DOI 10.1189/jlb.2A1211-608RRRR; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Cruzalegui FH, 1999, ONCOGENE, V18, P7948, DOI 10.1038/sj.onc.1203362; Dalpke AH, 2001, J IMMUNOL, V166, P7082, DOI 10.4049/jimmunol.166.12.7082; Deutsch M, 2013, SAUDI J GASTROENTERO, V19, P81, DOI 10.4103/1319-3767.108479; Duncan SA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02431; Ehlting C, 2007, J IMMUNOL, V178, P2813, DOI 10.4049/jimmunol.178.5.2813; Ehlting C, 2015, CELL SIGNAL, V27, P555, DOI 10.1016/j.cellsig.2014.12.016; Fink Karin, 2013, JAKSTAT, V2, pe27521, DOI 10.4161/jkst.27521; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Fried MW, 2008, CLIN GASTROENTEROL H, V6, P503, DOI 10.1016/j.cgh.2008.02.040; Frobose H, 2006, MOL ENDOCRINOL, V20, P1587, DOI 10.1210/me.2005-0301; Gatto L, 2004, J BIOL CHEM, V279, P13746, DOI 10.1074/jbc.M308999200; Giambartolomei S, 2001, ONCOGENE, V20, P2606, DOI 10.1038/sj.onc.1204372; Gong GZ, 2001, P NATL ACAD SCI USA, V98, P9599, DOI 10.1073/pnas.171311298; Goossens N, 2015, CLIN MOL HEPATOL, V21, P105, DOI 10.3350/cmh.2015.21.2.105; Hayashi J, 2000, HEPATOLOGY, V32, P958, DOI 10.1053/jhep.2000.19343; He B, 2003, BIOCHEM BIOPH RES CO, V301, P386, DOI 10.1016/S0006-291X(02)03071-1; Hsieh MJ, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-74; Huang Y, 2007, GASTROENTEROLOGY, V132, P733, DOI 10.1053/j.gastro.2006.11.045; Huang YL, 2013, MOLECULES, V18, P12987, DOI 10.3390/molecules181012987; Isobe A, 2006, PLACENTA, V27, P912, DOI 10.1016/j.placenta.2005.10.003; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Joo MS, 2005, J VIROL, V79, P7648, DOI 10.1128/JVI.79.12.7648-7657.2005; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Kawaguchi T, 2004, AM J PATHOL, V165, P1499, DOI 10.1016/S0002-9440(10)63408-6; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Kogut MH, 2008, INNATE IMMUN-LONDON, V14, P213, DOI 10.1177/1753425908094416; Kong LB, 2016, ARCH VIROL, V161, P2149, DOI 10.1007/s00705-016-2892-x; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Liu D, 2015, MOL CELL BIOL, V35, P2400, DOI 10.1128/MCB.00090-15; Mahony R, 2016, CELL MOL LIFE SCI, V73, P3323, DOI 10.1007/s00018-016-2234-x; Mankouri J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000778; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; Marusawa H, 1999, J VIROL, V73, P4713, DOI 10.1128/JVI.73.6.4713-4720.1999; Mazzocca A, 2005, J BIOL CHEM, V280, P11329, DOI 10.1074/jbc.M410161200; McCartney EM, 2013, HEPATOLOGY, V58, P1558, DOI 10.1002/hep.26496; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Mitchell TJ, 2005, IMMUNOLOGY, V114, P301, DOI 10.1111/j.1365-2567.2005.02091.x; Park KH, 2013, J IMMUNOL, V190, P6550, DOI 10.4049/jimmunol.1202284; Pei RJ, 2011, J GEN VIROL, V92, P2237, DOI 10.1099/vir.0.032581-0; Persico M, 2007, HEPATOLOGY, V46, P1009, DOI 10.1002/hep.21782; Pirvulescu M, 2012, BIOCHEM BIOPH RES CO, V422, P321, DOI 10.1016/j.bbrc.2012.04.159; Qi HF, 2017, P NATL ACAD SCI USA, V114, P2018, DOI 10.1073/pnas.1614623114; Qin H, 2007, J IMMUNOL, V179, P5966, DOI 10.4049/jimmunol.179.9.5966; Rebe Cedric, 2013, JAKSTAT, V2, pe23010, DOI 10.4161/jkst.23010; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Sarcar B, 2004, VIROLOGY, V322, P51, DOI 10.1016/j.virol.2004.01.008; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Steen Hakan C, 2013, JAKSTAT, V2, pe25790, DOI 10.4161/jkst.25790; Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103; Stevenson NJ, 2013, FEBS LETT, V587, P1571, DOI 10.1016/j.febslet.2013.03.041; Strebel K, 2014, BBA-BIOMEMBRANES, V1838, P1074, DOI 10.1016/j.bbamem.2013.06.029; Timofeeva OA, 2012, J BIOL CHEM, V287, P14192, DOI 10.1074/jbc.M111.323899; Toshikuni N, 2014, WORLD J GASTROENTERO, V20, P2876, DOI 10.3748/wjg.v20.i11.2876; Tran SC, 2016, J VIROL, V90, P7231, DOI 10.1128/JVI.00326-16; Trengove MC, 2013, AM J CLIN EXP IMMUNO, V2, P1; Vazquez N, 2006, J LEUKOCYTE BIOL, V80, P1136, DOI 10.1189/jlb.0306206; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Walsh MJ, 2006, GUT, V55, P529, DOI 10.1136/gut.2005.069674; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Wetherill LF, 2012, J VIROL, V86, P5341, DOI 10.1128/JVI.06243-11; Wiejak J, 2013, BIOCHEM J, V454, P283, DOI 10.1042/BJ20130481; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Yoshida T, 2002, J EXP MED, V196, P641, DOI 10.1084/jem.20012127; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhao LJ, 2013, CELL STRESS CHAPERON, V18, P495, DOI 10.1007/s12192-013-0405-3; Zhao LJ, 2006, J LEUKOCYTE BIOL, V80, P424, DOI 10.1189/jlb.0106014; Zhou X, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.342; Zhu XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32538	93	7	7	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					8732	8744		10.1096/fj.201800629RR	http://dx.doi.org/10.1096/fj.201800629RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31163989	Green Accepted, Green Submitted			2022-12-28	WOS:000478832900004
J	Jang, KH; Yoon, HN; Lee, J; Yi, H; Park, SY; Lee, SY; Lim, Y; Lee, HJ; Cho, JW; Paik, YK; Hancock, WS; Ku, NO				Jang, Kwi-Hoon; Yoon, Han-Na; Lee, Jongeun; Yi, Hayan; Park, Sang-Yoon; Lee, So-Young; Lim, Younglan; Lee, Hyoung-Joo; Cho, Jin-Won; Paik, Young-Ki; Hancock, Williams S.; Ku, Nam-On			Liver disease-associated keratin 8 and 18 mutations modulate keratin acetylation and methylation	FASEB JOURNAL			English	Article						intermediate filament; MDB; post-translational modification; protein stability	SIMPLE EPITHELIAL KERATINS; INTERMEDIATE-FILAMENT PROTEINS; ARGININE METHYLATION; POSTTRANSLATIONAL MODIFICATIONS; PHOSPHORYLATION; MALLORY; LYSINE; UBIQUITINATION; IDENTIFICATION; METABOLISM	Keratin 8 (K8) and keratin 18 (K18) are the intermediate filament proteins whose phosphorylation/transamidation associate with their aggregation in Mallory-Denk bodies found in patients with various liver diseases. However, the functions of other post-translational modifications in keratins related to liver diseases have not been fully elucidated. Here, using a site-specific mutation assay combined with nano-liquid chromatography-tandem mass spectrometry, we identified K8-Lys108 and K18-Lys187/426 as acetylation sites, and K8-Arg47 and K18-Arg55 as methylation sites. Keratin mutation (Arg-to-Lys/Ala) at the methylation sites, but not the acetylation sites, led to decreased stability of the keratin protein. We compared keratin acetylation/methylation in liver disease-associated keratin variants. The acetylation of K8 variants increased or decreased to various extents, whereas the methylation of K18-del65-72 and K18-I150V variants increased. Notably, the highly acetylated/methylated K18-I150V variant was less soluble and exhibited unusually prolonged protein stability, which suggests that additional acetylation of highly methylated keratins has a synergistic effect on prolonged stability. Therefore, the different levels of acetylation/methylation of the liver disease-associated variants regulate keratin protein stability. These findings extend our understanding of how disease-associated mutations in keratins modulate keratin acetylation and methylation, which may contribute to disease pathogenesis.-Jang, K.-H., Yoon, H.-N., Lee, J., Yi, H., Park, S.-Y., Lee, S.-Y., Lim, Y., Lee, H.-J., Cho, J.-W., Paik, Y.-K., Hancock, W. S., Ku, N.-O. Liver disease-associated keratin 8 and 18 mutations modulate keratin acetylation and methylation.	[Jang, Kwi-Hoon; Yoon, Han-Na; Lee, Jongeun; Yi, Hayan; Lee, So-Young; Lim, Younglan; Lee, Hyoung-Joo; Cho, Jin-Won; Paik, Young-Ki; Ku, Nam-On] Yonsei Univ, Grad Sch, Interdisciplinary Program Integrated OMICS Biomed, Room 407 Cheamdan Bldg,262 Seongsanno, Seoul 120749, South Korea; [Ku, Nam-On] Yonsei Univ, Grad Sch, Underwood Int Coll, Dept Bioconvergence Integrated Sci & Engn Div, Room 407 Cheamdan Bldg,262 Seongsanno, Seoul 120749, South Korea; [Park, Sang-Yoon] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, Bethesda, MD USA; [Hancock, Williams S.] Northeastern Univ, Barnett Inst, Boston, MA 02115 USA; [Hancock, Williams S.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA	Yonsei University; Yonsei University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Northeastern University; Northeastern University	Ku, NO (corresponding author), Yonsei Univ, Grad Sch, Interdisciplinary Program Integrated OMICS Biomed, Room 407 Cheamdan Bldg,262 Seongsanno, Seoul 120749, South Korea.; Ku, NO (corresponding author), Yonsei Univ, Grad Sch, Underwood Int Coll, Dept Bioconvergence Integrated Sci & Engn Div, Room 407 Cheamdan Bldg,262 Seongsanno, Seoul 120749, South Korea.	namonku@yonsei.ac.kr		Yoon, Han-Na/0000-0001-5089-8902	Korean Ministry of Education, Science, and Technology [2016R1A2B4012808, 2018R1D1A1A02086060]; Yonsei University Research Fund [2018-22-0072]; National Research Foundation of Korea - Ministry of Science and Information and Communication Technology (ICT) [NRF-2016R1A5A1010764]	Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Yonsei University Research Fund; National Research Foundation of Korea - Ministry of Science and Information and Communication Technology (ICT)(National Research Foundation of Korea)	This work was supported by the Korean Ministry of Education, Science, and Technology Grants 2016R1A2B4012808 and 2018R1D1A1A02086060, the Yonsei University Research Fund 2018-22-0072 (to N.-O.K.), and the National Research Foundation of Korea funded by the Ministry of Science and Information and Communication Technology (ICT) Grant NRF-2016R1A5A1010764 (to J.-W.C.). The authors declare no conflicts of interest.	Afifiyan N, 2017, EXP MOL PATHOL, V102, P106, DOI 10.1016/j.yexmp.2017.01.011; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Boisvert FM, 2003, MOL CELL PROTEOMICS, V2, P1319, DOI 10.1074/mcp.M300088-MCP200; Bonham K, 2010, FEBS J, V277, P2096, DOI 10.1111/j.1742-4658.2010.07623.x; Bremang M, 2013, MOL BIOSYST, V9, P2231, DOI 10.1039/c3mb00009e; Cha B, 2011, ONCOGENE, V30, P2379, DOI 10.1038/onc.2010.610; Chen WG, 2004, J IMMUNOL, V172, P6744, DOI 10.4049/jimmunol.172.11.6744; Cho EC, 2012, EMBO J, V31, P1785, DOI 10.1038/emboj.2012.17; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Clarke TL, 2017, MOL CELL, V65, P900, DOI 10.1016/j.molcel.2017.01.019; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Fickert P, 2003, J HEPATOL, V38, P387, DOI 10.1016/S0168-8278(02)00439-7; Guldiken N, 2015, HEPATOLOGY, V62, P876, DOI 10.1002/hep.27891; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Harada M, 2007, HEPATOLOGY, V45, P88, DOI 10.1002/hep.21471; HATZFELD M, 1990, J CELL BIOL, V110, P1199, DOI 10.1083/jcb.110.4.1199; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Hou WY, 2018, DEV CELL, V45, P262, DOI 10.1016/j.devcel.2018.03.007; Hu D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9419; Kaniskan HU, 2018, CHEM REV, V118, P989, DOI 10.1021/acs.chemrev.6b00801; Kim S, 1997, BIOCHEMISTRY-US, V36, P5185, DOI 10.1021/bi9625509; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Ku NO, 2007, HEPATOLOGY, V46, P1639, DOI 10.1002/hep.21976; Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146; Ku NO, 2016, HEPATOLOGY, V64, P966, DOI 10.1002/hep.28493; Ku NO, 2010, NAT CELL BIOL, V12, P876, DOI 10.1038/ncb2091; Ku NO, 2004, METHOD CELL BIOL, V78, P489; Ku NO, 2005, GASTROENTEROLOGY, V129, P885, DOI 10.1053/j.gastro.2005.06.065; Ku NO, 2000, J CELL BIOL, V149, P547, DOI 10.1083/jcb.149.3.547; Kwan R, 2012, FASEB J, V26, P2318, DOI 10.1096/fj.11-198580; Liao J, 1996, J CELL BIOL, V133, P345, DOI 10.1083/jcb.133.2.345; Liao J, 1997, J BIOL CHEM, V272, P17565, DOI 10.1074/jbc.272.28.17565; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Omary MB, 2017, AM J PHYSIOL-GASTR L, V312, pG628, DOI 10.1152/ajpgi.00455.2016; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Scholz C, 2015, NAT BIOTECHNOL, V33, P415, DOI 10.1038/nbt.3130; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Shen YD, 2016, J MED CHEM, V59, P9124, DOI 10.1021/acs.jmedchem.6b01033; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Snider NT, 2013, J CELL BIOL, V200, P241, DOI 10.1083/jcb.201209028; Strnad P, 2012, CURR OPIN GASTROEN, V28, P209, DOI 10.1097/MOG.0b013e3283525cb8; Strnad P, 2010, GASTROENTEROLOGY, V139, P828, DOI 10.1053/j.gastro.2010.06.007; Strnad R, 2008, BBA-MOL BASIS DIS, V1782, P764, DOI 10.1016/j.bbadis.2008.08.008; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Yamamoto T, 2011, J CLIN BIOCHEM NUTR, V48, P96, DOI 10.3164/jcbn.11-011FR; Zatloukal K, 2007, EXP CELL RES, V313, P2033, DOI 10.1016/j.yexcr.2007.04.024; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhong BH, 2009, HEPATOLOGY, V50, P546, DOI 10.1002/hep.23041	51	2	2	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9030	9043		10.1096/fj.201800263RR	http://dx.doi.org/10.1096/fj.201800263RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31199680	Bronze, Green Published			2022-12-28	WOS:000478832900028
J	Wan, L; Xia, T; Du, YQ; Liu, J; Xie, YY; Zhang, YJ; Guan, F; Wu, J; Wang, XC; Shi, CW				Wan, Lu; Xia, Tian; Du, Yanqin; Liu, Jie; Xie, Yuyu; Zhang, Yijie; Guan, Fei; Wu, Jun; Wang, Xiaochuan; Shi, Chunwei			Exosomes from activated hepatic stellate cells contain GLUT1 and PKM2: a role for exosomes in metabolic switch of liver nonparenchymal cells	FASEB JOURNAL			English	Article						Hif-1; glycolysis; hepatic fibrosis	INDUCIBLE FACTOR-ALPHA; EXTRACELLULAR VESICLES; HYPOXIA; COMMUNICATION; FIBROSIS; DISEASES	The mechanism of exosomes derived from activated hepatic stellate cells (HSCs) involved in liver fibrosis is poorly understood. We previously reported that hypoxia-inducible factor 1 (Hif-1) regulated HSC activation, and, therefore, we investigated in current work whether Hif-1 regulates exosome secretion and the metabolic switch of HSCs, thus affecting the metabolism of liver nonparenchymal cells. In this study, the characteristics of exosomes from HSCs were assessed via electron microscopy, Western blot analysis, and acetylcholinesterase activity. Confocal microscopy was used to measure the uptake of exosomes by quiescent HSCs, Kupffer cells (KCs), and liver sinusoidal endothelial cells (LSECs). Hif-1 alpha was inhibited via 2-ME or specific small interfering RNAs to investigate its role in exosomes derived from HSCs. It was determined that glucose transporter 1 and pyruvate kinase M2 were increasingly expressed in fibrotic liver samples, cell lysates, and exosomes derived from activated HSCs. Exosomes released from HSCs were associated with activation and glucose uptake of HSCs. Delivery of exosomes from activated HSCs induced glycolysis of quiescent HSCs, KCs, and LSECs. Disruption of Hif-1 expression suppressed the glycolysis effect delivered by exosomes. Conclusively, our results demonstrated that exosomes secreted by activated HSCs affect the metabolic switch of liver nonparenchymal cells via delivery of glycolysis-related proteins. These findings represent a novel mechanism that contributes to liver fibrosis and has significant implications for new diagnosis and treatment of liver diseases.-Wan, L., Xia, T., Du, Y., Liu, J., Xie, Y., Zhang, Y., Guan, F., Wu, J., Wang, X., Shi, C. Exosomes from activated hepatic stellate cells contain GLUT1 and PKM2: a role for exosomes in metabolic switch of liver nonparenchymal cells.	[Wan, Lu; Liu, Jie; Xie, Yuyu; Zhang, Yijie; Guan, Fei; Shi, Chunwei] Huazhong Univ Sci & Technol, Dept Pathogen Biol, Sch Basic Med, Tongji Med Coll, Hongkong Rd 13, Wuhan 430030, Hubei, Peoples R China; [Wan, Lu; Wang, Xiaochuan] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathophysiol, Sch Basic Med, Wuhan, Hubei, Peoples R China; [Du, Yanqin; Wu, Jun] Huazhong Univ Sci & Technol, Dept Infect Dis, Union Hosp, Wuhan, Hubei, Peoples R China; [Xia, Tian] Wuhan Third Hosp, Dept Surg, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Shi, CW (corresponding author), Huazhong Univ Sci & Technol, Dept Pathogen Biol, Sch Basic Med, Tongji Med Coll, Hongkong Rd 13, Wuhan 430030, Hubei, Peoples R China.	chunweishi@hust.edu.cn		Du, Yanqin/0000-0003-1775-5947	National Natural Science Foundation of China [81470855]; Fundamental Research Funds for the Central Universities, Huazhong University of Science and Technology (HUST) [2017KFYXJJ053]; Integrated Innovative Team for Major Human Diseases Program of Tongji Medical College, HUST [500153003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, Huazhong University of Science and Technology (HUST); Integrated Innovative Team for Major Human Diseases Program of Tongji Medical College, HUST	This work was supported by the National Natural Science Foundation of China (81470855 to C.S.), the Fundamental Research Funds for the Central Universities, Huazhong University of Science and Technology (HUST; 2017KFYXJJ053 to C.S.), and the Integrated Innovative Team for Major Human Diseases Program of Tongji Medical College, HUST (500153003). The authors declare no conflicts of interest.	Amann T, 2009, EXPERT OPIN THER TAR, V13, P1411, DOI 10.1517/14728220903307509; Bang C, 2014, J CLIN INVEST, V124, P2136, DOI 10.1172/JCI70577; Barbero-Becerra VJ, 2015, TOXICOL IN VITRO, V29, P1753, DOI 10.1016/j.tiv.2015.07.010; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Chen BL, 2013, WORLD J GASTROENTERO, V19, P1405, DOI 10.3748/wjg.v19.i9.1405; Chen YP, 2012, GASTROENTEROLOGY, V143, P1319, DOI 10.1053/j.gastro.2012.07.115; Chen Z, 2018, J CELL PHYSIOL, V233, P2839, DOI 10.1002/jcp.25998; Corpechot C, 2002, HEPATOLOGY, V35, P1010, DOI 10.1053/jhep.2002.32524; DeLeve LD, 2015, HEPATOLOGY, V61, P1740, DOI 10.1002/hep.27376; Deng J, 2014, BIOCHEM BIOPH RES CO, V454, P328, DOI 10.1016/j.bbrc.2014.10.076; Devhare PB, 2018, MOL ASPECTS MED, V60, P115, DOI 10.1016/j.mam.2017.11.001; Duval F, 2014, ADV PHARMACOL SCI, V2014, DOI 10.1155/2014/373295; Essandoh K, 2015, BBA-MOL BASIS DIS, V1852, P2362, DOI 10.1016/j.bbadis.2015.08.010; Fernandez-Iglesias A, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00007; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Froh M., 2003, CURR PROTOC TOXICOL, V14; Garcia NA, 2016, CARDIOVASC RES, V109, P397, DOI 10.1093/cvr/cvv260; Hong F, 2018, FEBS OPEN BIO, V8, P406, DOI 10.1002/2211-5463.12379; King HW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-421; Lee SH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05858-2; Li T, 2015, INT J CLIN EXP PATHO, V8, P12064; Liu X, 2015, NUCLEIC ACIDS RES, V43, P5081, DOI 10.1093/nar/gkv379; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Nath B, 2012, HEPATOLOGY, V55, P622, DOI 10.1002/hep.25497; Parola M, 2019, MOL ASPECTS MED, V65, P37, DOI 10.1016/j.mam.2018.09.002; Povero D, 2015, CELL MOL GASTROENTER, V1, P646, DOI 10.1016/j.jcmgh.2015.07.007; Samuelson I, 2018, ESSAYS BIOCHEM, V62, P165, DOI 10.1042/EBC20170087; Schorey JS, 2016, J CLIN INVEST, V126, P1181, DOI 10.1172/JCI81132; Semenza GL, 2011, COLD SH Q B, V76, P347, DOI 10.1101/sqb.2011.76.010678; Tkach M, 2018, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0479; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Vella LJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020173; Wang JY, 2018, CELL PHYSIOL BIOCHEM, V49, P869, DOI 10.1159/000493218; Wang RS, 2015, J BIOL CHEM, V290, P30684, DOI 10.1074/jbc.M115.671735; Wang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074051; Wu J, 2007, HEPATOLOGY, V46, P1769, DOI 10.1002/hep.21897; Yang WW, 2013, CANCER LETT, V339, P153, DOI 10.1016/j.canlet.2013.06.008; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zhang W, 2017, AM J PHYSIOL-RENAL, V313, pF906, DOI 10.1152/ajprenal.00178.2017; Zou CH, 2005, J BIOCHEM BIOPH METH, V64, P207, DOI 10.1016/j.jbbm.2005.08.001	42	54	60	2	36	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					8530	8542		10.1096/fj.201802675R	http://dx.doi.org/10.1096/fj.201802675R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30970216	Bronze			2022-12-28	WOS:000476234700057
